FN Thomson Reuters Web of Science™
VR 1.0
PT J
AU Roach, M
   Hanks, G
   Thames, H
   Schellhammer, P
   Shipley, WU
   Sokol, GH
   Sandler, H
AF Roach, Mack, III
   Hanks, Gerald
   Thames, Howard, Jr.
   Schellhammer, Paul
   Shipley, William U.
   Sokol, Gerald H.
   Sandler, Howard
TI Defining biochemical failure following radiotherapy with or without
   hormonal therapy in men with clinically localized prostate cancer:
   Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE biochemical recurrence; prostate cancer; radiotherapy; PSA failure
ID EXTERNAL-BEAM RADIOTHERAPY; ADJUVANT ANDROGEN ABLATION; PHASE-III TRIAL;
   RADIATION-THERAPY; RADICAL PROSTATECTOMY; SEED IMPLANTATION; ANTIGEN
   BOUNCE; FREE SURVIVAL; PSA; BRACHYTHERAPY
AB In 1996 the American Society for Therapeutic Radiology and Oncology (ASTRO) sponsored a Consensus Conference to establish a definition of biochemical failure after external beam radiotherapy (EBRT). The ASTRO definition defined prostate specific antigen (PSA) failure as occurring after three consecutive PSA rises after a nadir with the date of failure as the point halfway between the nadir date and the first rise or any rise great enough to provoke initiation of therapy. This definition was not linked to clinical progression or survival; it performed poorly in patients undergoing hormonal therapy (HT), and backdating biased the Kaplan-Meier estimates of event-free survival. A second Consensus Conference was sponsored by ASTRO and the Radiation Therapy Oncology Group in Phoenix, Arizona, on January 21, 2005, to revise the ASTRO definition. The panel recommended: (1) a rise by 2 ng/mL or more above the nadir PSA be considered the standard definition for biochemical failure after EBRT with or without HT; (2) the date of failure be determined "at call" (not backdated). They recommended that investigators be allowed to use the ASTRO Consensus Definition after EBRT alone (no hormonal therapy) with strict adherence to guidelines as to "adequate follow-up." To avoid the artifacts resulting from short follow-up, the reported date of control should be listed as 2 years short of the median follow-up. For example, if the median follow-up is 5 years, control rates at 3 years should be cited. Retaining a strict version of the ASTRO definition would allow comparisons with a large existing body of literature. (c) 2006 Elsevier Inc.
C1 Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA.
   Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA.
   Eastern Virginia Med Sch, Dept Urol, Norfolk, VA 23501 USA.
   Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02115 USA.
   US FDA, Rockville, MD 20857 USA.
   Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.
RP Roach, M (reprint author), Univ Calif San Francisco, Dept Radiat Oncol, 1600 Divisadero St,Suite H1031, San Francisco, CA 94143 USA.
EM roach@radonc17.ucsf.edu
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Beyer DC, 2000, RADIOTHER ONCOL, V57, P263, DOI 10.1016/S0167-8140(00)00286-3
   Buyyounouski MK, 2005, INT J RADIAT ONCOL, V61, P1291, DOI 10.1016/j.ijrobp.2004.08.034
   CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Connell PP, 1999, UROLOGY, V54, P875, DOI 10.1016/S0090-4295(99)00253-8
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   D'Amico AV, 2002, CANCER, V95, P281, DOI 10.1002/cncr.10657
   Gelet A, 2004, UROLOGY, V63, P625, DOI 10.1016/j.urology.2004.01.002
   Ghafar MA, 2001, J UROLOGY, V166, P1333, DOI 10.1016/S0022-5347(05)65763-1
   Grado GL, 1999, UROLOGY, V53, P2, DOI 10.1016/S0090-4295(98)00492-0
   Hanks GE, 2003, J CLIN ONCOL, V21, P3972, DOI 10.1200/JCO.2003.11.023
   Ito K, 2002, INT J UROL, V9, P316, DOI 10.1046/j.1442-2042.2002.00466.x
   Katz AE, 2002, UROLOGY, V60, P1, DOI 10.1016/S0090-4295(02)01851-4
   Kuban DA, 2003, INT J RADIAT ONCOL, V57, P915, DOI 10.1016/S0360-3016(03)00632-1
   Kupelian PA, 2004, INT J RADIAT ONCOL, V58, P25, DOI 10.1016/S0360-3016(03)00784-3
   Merrick GS, 2001, INT J RADIAT ONCOL, V51, P41, DOI 10.1016/S0360-3016(01)01594-2
   Merrick Gregory S, 2003, Brachytherapy, V2, P181, DOI 10.1016/S1538-4721(03)00130-2
   Parker CC, 1998, RADIOTHER ONCOL, V49, P103, DOI 10.1016/S0167-8140(98)00107-8
   Pickett B, 2004, INT J RADIAT ONCOL, V59, P665, DOI 10.1016/j.ijrobp.2003.11.024
   Pickett B, 2004, INT J RADIAT ONCOL, V60, pS185, DOI 10.1016/S0360-3016(04)01175-7
   Pickles T, 2002, CANCER, V94, P362, DOI 10.1002/cncr.10219
   Pickles T, 2003, INT J RADIAT ONCOL, V57, P11, DOI 10.1016/S0360-3016(03)00439-5
   Roach M 3rd, 1996, Oncology (Williston Park), V10, P1143
   Roach M, 2003, J CLIN ONCOL, V21, P1904, DOI 10.1200/JCO.2003.05.004
   Roach M, 2003, UROLOGY, V61, P730, DOI 10.1016/S0090-4295(02)02425-1
   Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399
   Ross PL, 2001, J UROLOGY, V165, P1562, DOI 10.1016/S0022-5347(05)66349-5
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Stock RG, 2003, INT J RADIAT ONCOL, V56, P448, DOI 10.1016/S0360-3016(02)04470-X
   Sylvester JE, 2003, INT J RADIAT ONCOL, V57, P944, DOI 10.1016/S0360-3016(03)00739-9
   Takamiya R, 2003, INT J RADIAT ONCOL, V56, P1073, DOI 10.1016/S0360-3016(03)00206-2
   Taylor JMG, 2005, J CLIN ONCOL, V23, P816, DOI 10.1200/JCO.2005.12.156
   Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
NR 37
TC 758
Z9 764
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUL 15
PY 2006
VL 65
IS 4
BP 965
EP 974
DI 10.1016/j.ijrobp.2006.04.029
PG 10
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 061NH
UT WOS:000238878800002
PM 16798415
ER

PT J
AU Levine, GN
   Bates, ER
   Blankenship, JC
   Bailey, SR
   Bittl, JA
   Cercek, B
   Chambers, CE
   Ellis, SG
   Guyton, RA
   Hollenberg, SM
   Khot, UN
   Lange, RA
   Mauri, L
   Mehran, R
   Moussa, ID
   Mukherjee, D
   Nallamothu, BK
   Ting, HH
AF Levine, Glenn N.
   Bates, Eric R.
   Blankenship, James C.
   Bailey, Steven R.
   Bittl, John A.
   Cercek, Bojan
   Chambers, Charles E.
   Ellis, Stephen G.
   Guyton, Robert A.
   Hollenberg, Steven M.
   Khot, Umesh N.
   Lange, Richard A.
   Mauri, Laura
   Mehran, Roxana
   Moussa, Issam D.
   Mukherjee, Debabrata
   Nallamothu, Brahmajee K.
   Ting, Henry H.
TI 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A
   Report of the American College of Cardiology Foundation/American Heart
   Association Task Force on Practice Guidelines and the Society for
   Cardiovascular Angiography and Interventions
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE ACCF/AHA Practice Guidelines; acute coronary syndromes; anticoagulants;
   antiplatelet agents; arrhythmias, cardiac; coronary angiography;
   coronary artery revascularization interventions: stents; drug therapy;
   drug delivery systems; heart diseases; myocardial revasularization;
   platelet aggregation inhibitor; ultrasound
ID ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; UNPROTECTED LEFT
   MAIN; DRUG-ELUTING STENTS; ARTERY-BYPASS-SURGERY; RANDOMIZED
   CONTROLLED-TRIAL; CONTRAST-INDUCED NEPHROPATHY; BARE-METAL STENTS;
   LONG-TERM SURVIVAL; GLYCOPROTEIN IIB/IIIA RECEPTOR
AB The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
   The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have jointly produced guidelines in the area of cardiovascular disease since 1980. The ACCF/AHA Task Force on Practice Guidelines (Task Force), charged with developing, updating, and revising practice guidelines for cardiovascular diseases and procedures, directs and oversees this effort. Writing committees are charged with regularly reviewing and evaluating all available evidence to develop balanced, patient-centric recommendations for clinical practice. Experts in the subject under consideration are selected by the ACCF and AHA to examine subject-specific data and write guidelines in partnership with representatives from other medical organizations and specialty groups. Writing committees are asked to perform a formal literature review; weigh the strength of evidence for or against particular tests, treatments, or procedures; and include estimates of expected outcomes where such data exist. Patient-specific modifiers, comorbidities, and issues of patient preference that may influence the choice of tests or therapies are considered. When available, information from studies on cost is considered, but data on efficacy and outcomes constitute the primary basis for the recommendations contained herein.
   In analyzing the data and developing recommendations and supporting text, the writing committee uses evidence-based methodologies developed by the Task Force (1). The Class of Recommendation (COR) is an estimate of the size of the treatment effect considering risks versus benefits in addition to evidence and/or agreement that a given treatment or procedure is or is not useful/effective or in some situations may cause harm. The Level of Evidence (LOE) is an estimate of the certainty or precision of the treatment effect. The writing committee reviews and ranks evidence supporting each recommendation with the weight of evidence ranked as LOE A, B, or C according to specific definitions that are included in Table 1. Studies are identified as observational, retrospective, prospective, or randomized where appropriate. For certain conditions for which inadequate data are available, recommendations are based on expert consensus and clinical experience and are ranked as LOE C. When recommendations at LOE C are supported by historical clinical data, appropriate references (including clinical reviews) are cited if available. For issues for which sparse data are available, a survey of current
   [GRAPHICS]
   practice among the clinicians on the writing committee is the basis for LOE C recommendations and no references are cited. The schema for COR and LOE is summarized in Table 1, which also provides suggested phrases for writing recommendations within each COR. A new addition to this methodology is separation of the Class III recommendations to delineate if the recommendation is determined to be of "no benefit" or is associated with "harm" to the patient. In addition, in view of the increasing number of comparative effectiveness studies, comparator verbs and suggested phrases for writing recommendations for the comparative effectiveness of one treatment or strategy versus another have been added for COR I and IIa, LOE A or B only.
   In view of the advances in medical therapy across the spectrum of cardiovascular diseases, the Task Force has designated the term guideline-directed medical therapy (GDMT) to represent optimal medical therapy as defined by ACCF/AHA guideline recommended therapies (primarily Class I). This new term, GDMT, will be used herein and throughout all future guidelines.
   Because the ACCF/AHA practice guidelines address patient populations (and healthcare providers) residing in North America, drugs that are not currently available in North America are discussed in the text without a specific COR. For studies performed in large numbers of subjects outside North America, each writing committee reviews the potential influence of different practice patterns and patient populations on the treatment effect and relevance to the ACCF/AHA target population to determine whether the findings should inform a specific recommendation.
   The ACCF/AHA practice guidelines are intended to assist healthcare providers in clinical decision making by describing a range of generally acceptable approaches to the diagnosis, management, and prevention of specific diseases or conditions. The guidelines attempt to define practices that meet the needs of most patients in most circumstances. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient. As a result, situations may arise for which deviations from these guidelines may be appropriate. Clinical decision making should involve consideration of the quality and availability of expertise in the area where care is provided. When these guidelines are used as the basis for regulatory or payer decisions, the goal should be improvement in quality of care. The Task Force recognizes that situations arise in which additional data are needed to inform patient care more effectively; these areas will be identified within each respective guideline when appropriate.
   Prescribed courses of treatment in accordance with these recommendations are effective only if followed. Because lack of patient understanding and adherence may adversely affect outcomes, physicians and other healthcare providers should make every effort to engage the patient's active participation in prescribed medical regimens and lifestyles. In addition, patients should be informed of the risks, benefits, and alternatives to a particular treatment and be involved in shared decision making whenever feasible, particularly for COR IIa and IIb, where the benefit-to-risk ratio may be lower.
   The Task Force makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of industry relationships or personal interests among the members of the writing committee. All writing committee members and peer reviewers of the guideline are asked to disclose all such current relationships, as well as those existing 12 months previously. In December 2009, the ACCF and AHA implemented a new policy for relationships with industry and other entities (RWI) that requires the writing committee chair plus a minimum of 50% of the writing committee to have no relevant RWI (Appendix 1 for the ACCF/AHA definition of relevance). These statements are reviewed by the Task Force and all members during each conference call and/or meeting of the writing committee and are updated as changes occur. All guideline recommendations require a confidential vote by the writing committee and must be approved by a consensus of the voting members. Members are not permitted to write, and must recuse themselves from voting on, any recommendation or section to which their RWI apply. Members who recused themselves from voting are indicated in the list of writing committee members, and section recusals are noted in Appendix 1. Authors' and peer reviewers' RWI pertinent to this guideline are disclosed in Appendixes 1 and 2, respectively. Additionally, to ensure complete transparency, writing committee members' comprehensive disclosure information-including RWI not pertinent to this document-is available as an online supplement. Comprehensive disclosure information for the Task Force is also available online at www.cardiosource.org/ACC/About-ACC/Leadership/Guidelines-and-Documents-TaskForces. aspx. The work of the writing committee was supported exclusively by the ACCF, AHA, and the Society for Cardiovascular Angiography and Interventions (SCAI) without commercial support. Writing committee members volunteered their time for this activity.
   In an effort to maintain relevance at the point of care for practicing physicians, the Task Force continues to oversee an ongoing process improvement initiative. As a result, in response to pilot projects, several changes to these guidelines will be apparent, including limited narrative text, a focus on summary and evidence tables (with references linked to abstracts in PubMed) and more liberal use of summary recommendation tables (with references that support LOE) to serve as a quick reference.
   In April 2011, the Institute of Medicine released 2 reports: Finding What Works in Health Care: Standards for Systematic Reviews and Clinical Practice Guidelines We Can Trust (2,3). It is noteworthy that the ACCF/AHA guidelines were cited as being compliant with many of the standards that were proposed. A thorough review of these reports and of our current methodology is under way, with further enhancements anticipated.
   The recommendations in this guideline are considered current until they are superseded by a focused update or the full-text guideline is revised. Guidelines are official policy of both the ACCF and AHA.
C1 [Levine, Glenn N.] Baylor Coll Med, Houston, TX 77030 USA.
   [Bates, Eric R.; Nallamothu, Brahmajee K.] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Blankenship, James C.] Geisinger Med Ctr, Cardiol & Cardiac Catheterizat Labs, Danville, PA USA.
   [Bailey, Steven R.] Univ Texas Med Ctr, Houston, TX USA.
   [Cercek, Bojan] Cedars Sinai Med Ctr, Coronary Care Unit, Los Angeles, CA 90048 USA.
   [Chambers, Charles E.] Penn State Milton S Hershey Med Ctr, Hershey, PA USA.
   [Ellis, Stephen G.] Cleveland Clin Fdn, Sect Head Invas & Intervent Cardiol, Cleveland, OH USA.
   [Hollenberg, Steven M.] Cooper Univ Hosp, Coronary Care Unit, Camden, NJ 08103 USA.
   [Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
   [Mauri, Laura] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02138 USA.
   [Mehran, Roxana] Columbia Univ, Med Ctr, New York, NY 10027 USA.
   [Moussa, Issam D.; Ting, Henry H.] Mayo Clin, Rochester, MN 55905 USA.
   [Mukherjee, Debabrata] Texas Tech Univ, Lubbock, TX 79409 USA.
RP Levine, GN (reprint author), Baylor Coll Med, Houston, TX 77030 USA.
CR Aaberge L, 2002, J AM COLL CARDIOL, V39, P1588, DOI 10.1016/S0735-1097(02)01828-4
   Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Abizaid A, 2001, CIRCULATION, V104, P533, DOI 10.1161/hc3101.093700
   Aboul-Enein F, 2004, J NUCL MED, V45, P950
   Abraham NS, 2010, J AM COLL CARDIOL, V56, P2051, DOI 10.1016/j.jacc.2010.09.010
   ACCF/AHA Task Force on Practice Guidelines, METH POL ACCF AHA TA
   Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943
   Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486
   Adolph E, 2008, CORONARY ARTERY DIS, V19, P413, DOI 10.1097/MCA.0b013e3283021ac6
   Agard A, 2004, HEART, V90, P208, DOI 10.1136/hrt.2003.021501
   Aggarwal A, 2009, AM J CARDIOL, V104, P349, DOI 10.1016/j.amjcard.2009.03.046
   Aguirre FV, 2008, CIRCULATION, V117, P1145, DOI 10.1161/CIRCULATIONAHA.107.728519
   Ahmed B, 2009, CIRC-CARDIOVASC INTE, V2, P423, DOI 10.1161/CIRCINTERVENTIONS.109.860494
   Albiero R, 2004, J AM COLL CARDIOL, V43, P943, DOI 10.1016/j.jacc.2003.09.054
   Alcock RF, 2010, INT J CARDIOL, V140, P66, DOI 10.1016/j.ijcard.2008.11.005
   Alderman E, 1997, CIRCULATION, V96, P1761
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   Alexander KP, 2005, JAMA-J AM MED ASSOC, V294, P3108, DOI 10.1001/jama.294.24.3108
   Ali A, 2006, J AM COLL CARDIOL, V48, P244, DOI 10.1016/j.jacc.2006.03.044
   Aliabadi D, 1997, AM J CARDIOL, V80, P994, DOI 10.1016/S0002-9149(97)00591-2
   Al-Lamee R, 2010, AM J CARDIOL, V106, P1721, DOI 10.1016/j.amjcard.2010.08.013
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Allen KB, 1999, NEW ENGL J MED, V341, P1029, DOI 10.1056/NEJM199909303411403
   Griffith JL, 2003, JAMA-J AM MED ASSOC, V289, P178
   Alpert JS, 2000, J AM COLL CARDIOL, V36, P959
   Al Suwaidi J, 2004, AM HEART J, V147, P815, DOI 10.1016/j.ahj.2003.11.025
   Alter DA, 2003, J AM COLL CARDIOL, V42, P410, DOI 10.1016/S0735-1097(03)00640-5
   Amit G, 2006, AM HEART J, V152, p887e9
   Anderson HV, 2002, J AM COLL CARDIOL, V39, P1096, DOI 10.1016/S0735-1097(02)01733-3
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   [Anonymous], PROTECT 2 PROSPECTIV
   [Anonymous], 1994, LANCET, V344, P1383
   [Anonymous], 2002, LANCET, V360, P7
   [Anonymous], 2002, CIRCULATION, V106, P3143
   Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178
   [Anonymous], 1997, JAMA, V277, P715
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002
   Antoniucci D, 1998, J AM COLL CARDIOL, V31, P294, DOI 10.1016/S0735-1097(97)00496-8
   Antoniucci D, 2003, AM J CARDIOL, V91, P1458, DOI 10.1016/S0002-9149(03)00397-7
   Antoniucci D, 2004, CIRCULATION, V109, P1704, DOI 10.1161/01.CIR.0000126284.40075.98
   Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Applegate RJ, 2008, JACC-CARDIOVASC INTE, V1, P317, DOI 10.1016/j.jcin.2008.03.013
   Aragon J, 2005, CATHETER CARDIO INTE, V65, P346, DOI 10.1002/ccd.20339
   Assali AR, 2000, CATHETER CARDIO INTE, V51, P27, DOI 10.1002/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO;2-0
   ASTER RH, 1995, NEW ENGL J MED, V332, P1374, DOI 10.1056/NEJM199505183322011
   AstraZeneca, 22433 NDA
   Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943
   Aziz O, 2007, BRIT MED J, V334, P617, DOI 10.1136/bmj.39106.476215.BE
   Babaev A, 2002, CIRCULATION, V106, P364
   Babapulle Mohan N, 2007, BMC Cardiovasc Disord, V7, P12, DOI 10.1186/1471-2261-7-12
   Bader BD, 2004, CLIN NEPHROL, V62, P1
   Bader FM, 2006, J HEART LUNG TRANSPL, V25, P298, DOI 10.1016/j.healun.2005.09.016
   Bae Ki Sun, 2007, Korean Journal of Internal Medicine, V22, P139
   Collins R, 2009, LANCET, V373, P1849
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baim DS, 2002, CIRCULATION, V105, P1285, DOI 10.1161/01.CIR.0000012783.63093.0C
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Barber K, 2001, J CLIN EPIDEMIOL, V54, P1025, DOI 10.1016/S0895-4356(01)00375-4
   Barcin C, 2004, CATHETER CARDIO INTE, V61, P484, DOI 10.1002/ccd.20010
   Barlis P, 2009, EUROINTERVENTION, V5, P90
   BARNATHAN ES, 1987, CIRCULATION, V76, P125
   Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295
   Bates ER., 2009, CARDIOGENIC SHOCK, P220, DOI 10.1002/9781444316926.ch10
   Bates ER, 2011, J AM COLL CARDIOL, V57, P1251, DOI 10.1016/j.jacc.2010.11.024
   Bates ER, 1997, J AM COLL CARDIOL, V30, P334, DOI 10.1016/S0735-1097(97)00178-2
   Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050
   Bavry AA, 2008, EUR HEART J, V29, P2989, DOI 10.1093/eurheartj/ehn421
   BELL MR, 1990, J AM COLL CARDIOL, V16, P553
   Bellandi F, 2004, CATHETER CARDIO INTE, V62, P186, DOI 10.1002/ccd.20041
   Beller GA, 2010, JACC-CARDIOVASC INTE, V3, P315, DOI 10.1016/j.jcin.2010.01.007
   Beller GA, 2010, J AM COLL CARDIOL, V56, P1335, DOI 10.1016/j.jacc.2010.04.055
   Benedetto U, 2009, EUR J CARDIO-THORAC, V36, P611, DOI 10.1016/j.ejcts.2009.03.012
   Ben-Gal Y, 2006, ANN THORAC SURG, V82, P2067, DOI 10.1016/j.athoracsur.2006.06.041
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berger PB, 2001, J AM COLL CARDIOL, V38, P1440, DOI 10.1016/S0735-1097(01)01571-6
   Berger PB, 1999, CIRCULATION, V99, P248
   Berger PB, 2002, AM HEART J, V143, P841, DOI 10.1067/mhj.2002.121929
   Bertrand OF, 2009, AM J CARDIOL, V104, P1235, DOI 10.1016/j.amjcard.2009.06.036
   Bertrand OF, 2010, AM J CARDIOL, V105, P1520, DOI 10.1016/j.amjcard.2010.01.006
   Bezerra HG, 2009, JACC-CARDIOVASC INTE, V2, P1035, DOI 10.1016/j.jcin.2009.06.019
   Bhargava B, 2001, CATHETER CARDIO INTE, V54, P295, DOI 10.1002/ccd.1287
   Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964
   Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002
   Biancari F, 2010, AM HEART J, V159, P518, DOI 10.1016/j.ahj.2009.12.027
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   Bittl JA, 2004, J AM COLL CARDIOL, V43, P936, DOI 10.1016/j.jacc.2003.10.039
   Blankenship JC, 2011, J AM COLL CARDIOL, V57, P272, DOI 10.1016/j.jacc.2010.06.056
   Blankenship JC, 2000, CATHETER CARDIO INTE, V49, P130, DOI 10.1002/(SICI)1522-726X(200002)49:2<130::AID-CCD3>3.0.CO;2-T
   Blankenship JC, 2004, CATHETER CARDIO INTE, V63, P444, DOI 10.1002/ccd.20229
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Boersma E, 1999, CIRCULATION, V100, P2045
   Bohmer E, 2010, J AM COLL CARDIOL, V55, P102, DOI 10.1016/j.jacc.2009.08.007
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   Bonz AW, 2002, J AM COLL CARDIOL, V40, P662, DOI 10.1016/S0735-1097(02)02014-4
   Borgia F, 2010, EUR HEART J, V31, P2156, DOI 10.1093/eurheartj/ehq204
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Bourassa MG, 1998, EUR HEART J, V19, P103, DOI 10.1053/euhj.1997.0574
   Boyden TF, 2007, AM J CARDIOL, V99, P1399, DOI 10.1016/j.amjcard.2006.12.069
   Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063
   Brar SS, 2008, JAMA-J AM MED ASSOC, V300, P1038, DOI 10.1001/jama.300.9.1038
   Brar SS, 2009, CLIN J AM SOC NEPHRO, V4, P1584, DOI 10.2215/CJN.03120509
   Bravata DM, 2007, ANN INTERN MED, V147, P703
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V110, P994, DOI 10.1161/01.CIR.0000139868.53594.24
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Bridges CR, 2004, ANN THORAC SURG, V77, P1494, DOI 10.1016/j.athoracsur.2004.01.007
   Brieger D, 2011, CATHETER CARDIO INTE, V77, P182, DOI 10.1002/ccd.22674
   Brieger DB, 1998, J AM COLL CARDIOL, V31, P1449, DOI 10.1016/S0735-1097(98)00134-X
   Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152
   Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005
   Briguori C, 2007, AM J CARDIOL, V99, P779, DOI 10.1016/j.amjcara.2006.10.031
   Briguori C, 2003, AM HEART J, V145, P700, DOI 10.1067/mhj.2003.14
   Briguori C, 2001, AM J CARDIOL, V87, P136, DOI 10.1016/S0002-9149(00)01304-7
   Briguori C, 2004, EUR HEART J, V25, P1822, DOI 10.1016/j.ehj.2004.07.017
   BROGAN WC, 1993, AM J CARDIOL, V71, P794, DOI 10.1016/0002-9149(93)90826-X
   Brophy JM, 2003, ANN INTERN MED, V138, P777
   Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Buller CE, 1999, CIRCULATION, V100, P236
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   CABRI Trial Participants, 1995, LANCET, V346, P1179
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Cameron AAC, 2004, CATHETER CARDIO INTE, V61, P157, DOI 10.1002/ccd.10800
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501
   Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941
   Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106
   Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   Carrie D, 1997, CIRCULATION, V96, pII6
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   Cecil WT, 2008, AM J MANAG CARE, V14, P521
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Chambers CE, 2011, CATHETER CARDIO INTE, V77, P546, DOI 10.1002/ccd.22867
   Chan AW, 2002, AM J CARDIOL, V89, P132, DOI 10.1016/S0002-9149(01)02188-9
   Chaudhry EC, 2007, J THROMB THROMBOLYS, V24, P7, DOI 10.1007/s11239-006-0004-6
   Cheitlin MD, 2003, J AM COLL CARDIOL, V42, P954, DOI 10.1016/S0735-1097(03)01065-9
   Chen BX, 2008, HEART, V94, P566, DOI 10.1136/hrt.2007.118679
   Chen EW, 2003, CIRCULATION, V108, P951, DOI 10.1161/01.CIR.000008508.59734.E4
   Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011
   Chen SL, 2008, ANGIOLOGY, V59, P475, DOI 10.1177/0003319707312519
   Chen SL, 2011, J AM COLL CARDIOL, V57, P914, DOI 10.1016/j.jacc.2010.10.023
   Chen ZM, 2005, LANCET, V366, P1607
   Chew DP, 2001, CIRCULATION, V103, P961
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2005, CIRCULATION, V111, P791, DOI 10.1161/01.CIR.0000155256.88940.F8
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Choudhry NK, 2005, AM J MED, V118, P465, DOI 10.1016/j.amjmed.2005.02.016
   Choussat R, 2002, J AM COLL CARDIOL, V40, P1943, DOI 10.1016/S0735-1097(02)02531-7
   Cisowski M, 2002, ANN THORAC SURG, V74, pS1334
   Cisowski Marek, 2004, Kardiol Pol, V61, P253
   Clark AM, 2005, ANN INTERN MED, V143, P659
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Cohen DJ, 2004, CIRCULATION, V110, P508, DOI 10.1161/01.CIR.0000136821.99814.43
   Cohen M, 2003, EUR HEART J, V24, P1763, DOI 10.1016/j.ehj.2003.07.002
   Cohen M, 2010, CATHETER CARDIO INTE, V75, P928, DOI 10.1002/ccd.22340
   Cole JH, 2002, J AM COLL CARDIOL, V40, P1968, DOI 10.1016/S0735-1097(02)02561-5
   Collet JP, 2004, AM HEART J, V147, P655, DOI 10.1016/j.ahj.2003.10.019
   Collet JP, 2001, CIRCULATION, V103, P658
   Colombo A, 2009, CIRCULATION, V119, P71, DOI 10.1161/CIRCULATIONAHA.108.808402
   Coolong A, 2008, CIRCULATION, V117, P790, DOI 10.1161/CIRCULATIONAHA.106.651232
   Cornuz J, 2002, ANN INTERN MED, V136, P429
   Cosgrave J, 2007, AM HEART J, V153, P354, DOI 10.1016/j.ahj.2006.12.009
   Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034
   Courtis J, 2009, AM J CARDIOL, V103, P943, DOI 10.1016/j.amjcard.2008.11.054
   Cruden NLM, 2010, CIRC-CARDIOVASC INTE, V3, P236, DOI 10.1161/CIRCINTERVENTIONS.109.934703
   CUMMINGS SR, 1989, J GEN INTERN MED, V4, P482, DOI 10.1007/BF02599545
   Cutlip DE, 2001, CIRCULATION, V103, P1967
   Cutlip DE, 2002, J AM COLL CARDIOL, V40, P2082, DOI 10.1016/S0735-1097(02)02597-4
   Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Damman P, 2010, J AM COLL CARDIOL, V55, P858, DOI 10.1016/j.jacc.2009.11.026
   Dangas G, 2009, J AM COLL CARDIOL, V54, P1438, DOI 10.1016/j.jacc.2009.06.021
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   Dangas GD, 2008, JACC-CARDIOVASC INTE, V1, P332, DOI 10.1016/j.jcin.2008.05.001
   Danzi GB, 2006, AM J CARDIOL, V97, P489, DOI 10.1016/j.amjcard.2005.09.080
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320
   Dauerman HL, 2007, J AM COLL CARDIOL, V50, P1617, DOI 10.1016/j.jacc.2007.07.028
   Dauerman Harold L, 2003, J Invasive Cardiol, V15, P380
   Davies RF, 1997, CIRCULATION, V95, P2037
   de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057
   de Boer SPM, 2010, JACC-CARDIOVASC INTE, V3, P324, DOI 10.1016/j.jcin.2009.11.022
   DEFEYTER PIMJ, 1993, J AM COLL CARDIOL, V21, P1539
   DEFEYTER PJ, 1989, AM J CARDIOL, V64, P88, DOI 10.1016/0002-9149(89)90658-9
   Dehmer GJ, 2007, CATHETER CARDIO INTE, V69, P471, DOI 10.1002/ccd.21097
   Deibele AJ, 2006, J THROMB THROMBOLYS, V22, P47, DOI 10.1007/s11239-006-7454-8
   Deibele AJ, 2010, CIRCULATION, V121, P784, DOI 10.1161/CIRCULATIONAHA.109.882746
   de Labriolle A, 2008, AM J CARDIOL, V102, P1175, DOI 10.1016/j.amjcard.2008.06.059
   De Luca G, 2009, THROMB HAEMOSTASIS, V102, P428, DOI 10.1160/TH09-05-0287
   De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759
   De Luca G, 2009, EUR HEART J, V30, P2705, DOI 10.1093/eurheartj/ehp118
   De Luca G, 2009, J AM COLL CARDIOL, V53, P1668, DOI 10.1016/j.jacc.2009.01.053
   Dibra A, 2007, J AM COLL CARDIOL, V49, P616, DOI 10.1016/j.jacc.2006.10.049
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563
   Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8
   Di Sciascio G, 2010, J AM COLL CARDIOL, V56, P550, DOI 10.1016/j.jacc.2010.01.067
   Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028
   Dixon SR, 2009, JACC-CARDIOVASC INTE, V2, P91, DOI 10.1016/j.jcin.2008.11.005
   Doherty TM, 2005, CATHETER CARDIO INTE, V65, P330, DOI 10.1002/ccd.20355
   Drenth DJ, 2004, AM J CARDIOL, V94, P1414, DOI 10.1016/j.amjcard.2004.08.016
   Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6
   Drouet L, 2009, AM HEART J, V158, P177, DOI 10.1016/j.ahj.2009.05.022
   Dukkipati S, 2004, J AM COLL CARDIOL, V43, P1161, DOI 10.1016/j.jacc.2003.11.033
   Dumaine R, 2007, ARCH INTERN MED, V167, P2423, DOI 10.1001/archinte.167.22.2423
   DUNCAN C, 1991, AM J PUBLIC HEALTH, V81, P899, DOI 10.2105/AJPH.81.7.899
   Duvernoy CS, 2010, AM HEART J, V159, P677, DOI 10.1016/j.ahj.2009.12.040
   Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727
   Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C
   Eisenberg MJ, 2004, AM J CARDIOL, V93, P744, DOI 10.1016/j.amjcard.2003.11.071
   Eisenberg MJ, 2007, ACTA CARDIOL, V62, P143, DOI 10.2143/AC.62.2.2020234
   Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179
   El Khoury C, 2010, ARCH CARDIOVASC DIS, V103, P287, DOI 10.1016/j.acvd.2010.04.005
   ELLIS SG, 1994, CIRCULATION, V89, P882
   Ellis SG, 2009, JACC-CARDIOVASC INTE, V2, P909, DOI 10.1016/j.jcin.2009.07.009
   ELLIS SG, 1994, CIRCULATION, V90, P2725
   Ellis SG, 1997, CIRCULATION, V96, P3867
   Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816
   Ellis SG, 1998, J AM COLL CARDIOL, V32, P1619, DOI 10.1016/S0735-1097(98)00403-3
   ELLIS SG, 1990, CIRCULATION, V82, P1193
   CALIFF RM, 1994, NEW ENGL J MED, V330, P956
   Topol EJ, 1997, NEW ENGL J MED, V336, P1689
   EPISTENT Investigators, 1998, Lancet, V352, P87
   Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304
   Erglis A, 2007, J AM COLL CARDIOL, V50, P491, DOI 10.1016/j.jacc.2007.03.055
   Erglis A, 2009, CIRC-CARDIOVASC INTE, V2, P27, DOI 10.1161/CIRCINTERVENTIONS.108.804658
   Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985
   Tcheng JE, 2000, LANCET, V356, P2037
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   Fassa AA, 2005, J AM COLL CARDIOL, V45, P204, DOI 10.1016/j.jacc.2004.09.066
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   FAXON DP, 1992, AM HEART J, V123, P854, DOI 10.1016/0002-8703(92)90687-Q
   Feit F, 2007, AM J CARDIOL, V100, P1364, DOI 10.1016/j.amjcard.2007.06.026
   Feit F, 2000, CIRCULATION, V101, P2795
   Ferenc M, 2008, EUR HEART J, V29, P2859, DOI 10.1093/eurheartj/ehn455
   Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45
   FERGUSON JJ, 1994, J AM COLL CARDIOL, V23, P1061
   Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1
   APPLEBY P, 1994, LANCET, V343, P311
   Fidan D, 2007, QJM-INT J MED, V100, P277, DOI 10.1093/qjmed/hcm020
   Fischell Tim A, 2007, J Invasive Cardiol, V19, P58
   Fischell TA, 1998, CATHETER CARDIO DIAG, V45, P360, DOI 10.1002/(SICI)1097-0304(199812)45:4<360::AID-CCD1>3.0.CO;2-R
   Fischell Tim A, 2008, Cardiovasc Revasc Med, V9, P224, DOI 10.1016/j.carrev.2008.03.002
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   FITZGERALD PJ, 1992, CIRCULATION, V86, P64
   Fleisher LA, 2009, J AM COLL CARDIOL, V54, pe13
   Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960
   Foex BA, 2004, HEART, V90, P1237, DOI 10.1136/hrt.2003.020255
   Fox KAA, 2006, BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55
   Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4
   Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007
   Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X
   Fraund S, 2005, ANN THORAC SURG, V79, P1225, DOI 10.1016/j.arthoracsur.2004.08.082
   Frazier OH, 1999, NEW ENGL J MED, V341, P1021, DOI 10.1056/NEJM199909303411402
   Freestone B, 2010, HEART, V96, P883, DOI 10.1136/hrt.2007.134213
   From AM, 2008, CLIN J AM SOC NEPHRO, V3, P10, DOI 10.2215/CJN.03100707
   Frye RL, 2009, NEW ENGL J MED, V360, P2503
   Fujii K, 2010, JACC-CARDIOVASC IMAG, V3, P168, DOI 10.1016/j.jcmg.2009.11.004
   Galassi AR, 2009, JACC-CARDIOVASC INTE, V2, P185, DOI 10.1016/j.jcin.2008.12.005
   Gao F, 2011, INT J CARDIOL, V148, P96, DOI 10.1016/j.ijcard.2010.11.019
   Garzon P, 2001, CAN J CARDIOL, V17, P41
   GAULT MH, 1992, NEPHRON, V62, P249
   Ge L, 2005, J AM COLL CARDIOL, V46, P613, DOI 10.1016/j.jaac.2005.05.032
   Gershlick AH, 2005, NEW ENGL J MED, V353, P2758, DOI 10.1056/NEJMoa050849
   Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194
   Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2
   Gibson CM, 2003, J AM COLL CARDIOL, V42, P7, DOI 10.1016/S0735-1097(03)00506-0
   Gierlotka M, 2011, AM J CARDIOL, V107, P501, DOI 10.1016/j.amjcard.2010.10.008
   Gil Robert J, 2005, Kardiol Pol, V63, P223
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gilchrist IC, 2001, CIRCULATION, V104, P406, DOI 10.1161/hc2901.093504
   Gill BV, 2009, J ALLERGY CLIN IMMUN, V124, P1055, DOI 10.1016/j.jaci.2009.06.030
   Gioia G, 2007, CATHETER CARDIO INTE, V70, P26, DOI 10.1002/ccd.21072
   Giri S, 2002, AM J CARDIOL, V89, P126, DOI 10.1016/S0002-9149(01)02187-7
   Glaser R, 2002, JAMA-J AM MED ASSOC, V288, P3124, DOI 10.1001/jama.288.24.3124
   Goel K, 2011, CIRCULATION, V123, P2344, DOI 10.1161/CIRCULATIONAHA.110.983536
   Gonzales DA, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-32
   GOSS JE, 1995, CATHETER CARDIO DIAG, V34, P99, DOI 10.1002/ccd.1810340403
   Goy JJ, 2008, J AM COLL CARDIOL, V52, P815, DOI 10.1016/j.jacc.2008.05.037
   GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8
   Goy JJ, 1999, CIRCULATION, V99, P3255
   Goy JJ, 2000, MAYO CLIN PROC, V75, P1116
   Green SM, 2002, ANN EMERG MED, V39, P433, DOI 10.1067/mem.2002.122770
   GREENBERGER PA, 1985, ARCH INTERN MED, V145, P2197, DOI 10.1001/archinte.145.12.2197
   Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jace.2007.01.003
   Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X
   Gross JB, 2002, ANESTHESIOLOGY, V96, P1004
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Grzybowski M, 2003, JAMA-J AM MED ASSOC, V290, P1891, DOI 10.1001/jama.290.14.1891
   Guagliumi G, 2004, CIRCULATION, V110, P1598, DOI 10.1161/01.CIR.0000142862.98817.1F
   Gupta A, 2009, CATHETER CARDIO INTE, V74, P975, DOI 10.1002/ccd.22140
   Gupta M, 2003, EUR HEART J, V24, P1640, DOI 10.1016/S0195-668X(03)00433-0
   Gurbel PA, 2005, CIRCULATION, V111, P1153, DOI 10.1161/01.CIR.0000157138.02645.11
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   Gurm HS, 2009, CIRC-CARDIOVASC INTE, V2, P230, DOI 10.1161/CIRCINTERVENTIONS.108.847996
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F
   Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073
   Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103
   HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601
   Hamon M, 2009, EUROINTERVENTION, V5, P115
   Hamon M, 2008, CIRCULATION, V118, P678, DOI 10.1161/CIRCULATIONAHA.108.784504
   HAMPTON JR, 1993, LANCET, V341, P573
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017
   Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATONAHA.104.528455
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hanrath P, 1997, CIRCULATION, V96, P1445
   Hansen PR, 2010, J INVASIVE CARDIOL, V22, P278
   Hao PP, 2010, TEX HEART I J, V37, P516
   Haskell WL, 1978, DESIGN IMPLANTATION
   Hassan Y, 2009, ANN PHARMACOTHER, V43, P1598, DOI 10.1345/aph.1M187
   Hausleiter J, 2004, J INTERN MED, V256, P388, DOI 10.1111/j.1365-2796.2004.01398.x
   He ZX, 2001, J NUCL CARDIOL, V8, P452, DOI 10.1067/mnc.2001.114799
   Heinrich MC, 2009, RADIOLOGY, V250, P68, DOI 10.1148/radiol.2501080833
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3
   Henriques JPS, 2006, AM J CARDIOL, V97, P990, DOI 10.1016/j.amjcard.2005.10.037
   Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141
   Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB
   Hildick-Smith D, 2010, CIRCULATION, V121, P1235, DOI 10.1161/CIRCULATIONAHA.109.888297
   Hillegass WB, 2001, J AM COLL CARDIOL, V37, P1335, DOI 10.1016/S0735-1097(01)01138-X
   Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009
   Hirshfeld JW, 2004, J AM COLL CARDIOL, V44, P2259, DOI 10.1016/j.jacc.2004.10.014
   Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
   Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139
   Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190
   Hodgson JM, 2010, JACC-CARDIOVASC INTE, V3, P818, DOI 10.1016/j.jcin.2010.07.004
   Hoffer EK, 2003, J VASC INTERV RADIOL, V14, P865, DOI 10.1097/01.RVI.0000071086.764348.8E
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   Hoffmann R, 2007, CORONARY ARTERY DIS, V18, P559
   Hoher M, 1999, J AM COLL CARDIOL, V34, P722, DOI 10.1016/S0735-1097(99)00254-5
   Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264
   Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI [10.1016/j.jacc.2010.07.016, 10.1016/j.jacc.2009.07.016]
   Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   Hong SJ, 2005, CATHETER CARDIO INTE, V64, P75, DOI 10.1002/ccd.20238
   Hospital National Patient Safety Goals, 2011, HOSP NATL PATIENT SA
   Hoste EAJ, 2010, NEPHROL DIAL TRANSPL, V25, P747, DOI 10.1093/ndt/gfp389
   Huang R, 2005, CATHETER CARDIO INTE, V65, P25, DOI 10.1002/ccd.20334
   Huang RI, 2006, CATHETER CARDIO INTE, V68, P671, DOI 10.1002/ccd.20885
   Hubbard CR, 2008, AM J CARDIOL, V102, P1469, DOI 10.1016/j.amjcard.2008.07.040
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065
   Hueb WA, 1999, CIRCULATION, V100, P107
   Hundley WG, 2010, J AM COLL CARDIOL, V55, P2614, DOI DOI 10.1016/J.JACC.2009.11.011
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   Iakovou I, 2004, J AM COLL CARDIOL, V44, P967, DOI 10.1016/j.jacc.2004.05.058
   Institute of Medicine, 2011, CLIN PRACT GUID WE C
   Institute of Medicine, 2011, FIND WHAT WORKS HLTH
   Ioannidis JPA, 2007, AM HEART J, V154, P1065, DOI 10.1016/j.ahj.2007.07.049
   Ito H, 1999, J AM COLL CARDIOL, V33, P654, DOI 10.1016/S0735-1097(98)00604-4
   Iwasaki K, 2006, AM J CARDIOL, V98, P1354, DOI 10.1016/j.amjcard.2006.06.028
   Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010
   Jacobs Alice K, 2008, J Am Coll Cardiol, V51, P355, DOI 10.1016/j.jacc.2007.11.011
   Jaffe R, 2007, CATHETER CARDIO INTE, V69, P815, DOI 10.1002/ccd.21021
   Jaffery Z, 2007, EUR J CARDIO-THORAC, V31, P691, DOI 10.1016/j.ejcts.2007.01.018
   Jain SP, 1997, AM J CARDIOL, V79, P1334, DOI 10.1016/S0002-9149(97)00135-5
   Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148
   Javaid A, 2006, AM J CARDIOL, V98, P911, DOI 10.1016/j.amjcard.2006.04.032
   Iversen Allan, 2008, Curr Cardiol Rev, V4, P293, DOI 10.2174/157340308786349480
   Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800
   Johnman C, 2010, CIRC-CARDIOVASC INTE, V3, P341, DOI 10.1161/CIRCINTERVENTIONS.109.928705
   Joint Commission on Accreditation of Healthcare Organization, 2010, COMPR ACCR MAN CAMH
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Jolly SS, 2009, EUR HEART J, V30, P900, DOI 10.1093/eurheartj/ehn417
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   JONES EL, 1983, AM J CARDIOL, V51, P7, DOI 10.1016/S0002-9149(83)80003-4
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   Juergens CP, 2002, CLIN THER, V24, P1332, DOI 10.1016/S0149-2918(02)80037-6
   Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001
   KAHN JK, 1993, AM HEART J, V126, P561, DOI 10.1016/0002-8703(93)90404-W
   KAISER GA, 1975, SURGERY, V78, P749
   Kakkar AK, 2004, CATHETER CARDIO INTE, V61, P31, DOI 10.1002/ccd.10730
   Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P65, DOI 10.1161/CIRCINTERVENTIONS.110.959148
   Kapadia SR, 1998, CIRCULATION, V98, P2672
   Kaplan BM, 1996, CATHETER CARDIO DIAG, V39, P113, DOI 10.1002/(SICI)1097-0304(199610)39:2<113::AID-CCD1>3.0.CO;2-I
   Kapoor JR, 2008, JACC-CARDIOVASC INTE, V1, P483, DOI 10.1016/j.jcin.2008.07.001
   Kappetein AP, 2011, EUR HEART J, V17, P2125
   Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
   Kar B, 2011, J AM COLL CARDIOL, V57, P688, DOI 10.1016/j.jacc.2010.08.613
   Kar B, 2006, TEX HEART I J, V33, P111
   Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859
   Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944
   Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165
   Katritsis DG, 2007, NEW ENGL J MED, V357, P414
   Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864
   Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503
   Keeley EC, 2004, JAMA-J AM MED ASSOC, V291, P736, DOI 10.1001/jama.291.6.736
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8
   Kelly AM, 2008, ANN INTERN MED, V148, P284
   Kern MJ, 2010, J AM COLL CARDIOL, V55, P173, DOI 10.1016/j.jacc.2009.06.062
   Khattab Ahmed A, 2007, J Interv Cardiol, V20, P100, DOI 10.1111/j.1540-8183.2007.00243.x
   Kim JW, 2005, INT J CARDIOL, V99, P437, DOI 10.1016/j.ijcard.2004.08.045
   Kim Sang-Wook, 2007, J Invasive Cardiol, V19, P377
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   KIMMEL SE, 1995, J AM COLL CARDIOL, V26, P931, DOI 10.1016/0735-1097(95)00294-4
   King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002
   King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602
   Kirschbaum SW, 2008, AM J CARDIOL, V101, P179, DOI 10.1016/j.amjcard.2007.07.060
   Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479
   Klein LW, 2009, CATHETER CARDIO INTE, V74, P728, DOI 10.1002/ccd.22113
   Klocke FJ, 2003, J AM COLL CARDIOL, V42, P1318, DOI 10.1016/S0735-1097(03)01090-8
   Kobashigawa JA, 2005, J AM COLL CARDIOL, V45, P1532, DOI 10.1016/j.jacc.2005.02.035
   Kobayashi Y, 2001, CATHETER CARDIO INTE, V52, P208, DOI 10.1002/1522-726X(200102)52:2<208::AID-CCD1049>3.0.CO;2-H
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Koo BK, 2010, CIRC-CARDIOVASC INTE, V3, P113, DOI 10.1161/CIRCINTERVENTIONS.109.887406
   Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Kovacic JC, 2011, CATHETER CARDIOVASC, DOI [10.1002/ccd.22929, DOI 10.1002/CCD.22929]
   Koyanagi T, 1996, ANN THORAC SURG, V61, P1793, DOI 10.1016/0003-4975(96)00170-1
   Krasuski Richard A, 2003, J Invasive Cardiol, V15, P699
   Krone RJ, 2003, AM J CARDIOL, V92, P389, DOI 10.1016/S0002-9149(03)00655-6
   Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769
   Kubo T, 2008, JACC-CARDIOVASC IMAG, V1, P475, DOI 10.1016/j.jcmg.2008.03.012
   Kuhn MJ, 2008, AM J ROENTGENOL, V191, P151, DOI 10.2214/AJR.07.3370
   Kumbhani DJ, 2009, JAMA-J AM MED ASSOC, V302, P2207, DOI 10.1001/jama.2009.1715
   Kunadian B, 2007, CATHETER CARDIO INTE, V69, P488, DOI 10.1002/ccd.20990
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Kutcher MA, 2009, J AM COLL CARDIOL, V54, P16, DOI 10.1016/j.jacc.2009.03.038
   Kwaan MR, 2006, ARCH SURG-CHICAGO, V141, P353, DOI 10.1001/archsurg.141.4.353
   Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6
   Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Latib A, 2008, AM HEART J, V156, P745, DOI 10.1016/j.ahj.2008.05.024
   Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077
   Lee CW, 2008, CATHETER CARDIO INTE, V71, P594, DOI 10.1002/ccd.21399
   Lee MS, 2007, INT J CARDIOL, V123, P34, DOI 10.1016/j.ijcard.2006.11.103
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2010, AM J CARDIOL, V105, P1076, DOI 10.1016/j.amjcard.2009.12.006
   Lee MS, 2008, JACC-CARDIOVASC INTE, V1, P710, DOI 10.1016/j.jcin.2008.10.001
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   Lemos PA, 2004, CIRCULATION, V109, P2500, DOI 10.1161/01.CIR.0000130173.63105.4E
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Levey AS, 2006, ANN INTERN MED, V145, P247
   Levine GN, 2004, J THROMB THROMBOLYS, V17, P167, DOI 10.1023/B:THRO.0000040484.99422.77
   Levine GN, 2007, CIRCULATION, V116, P2878, DOI 10.1161/CIRCULATIONAHA.107.187256
   Levine GN, 2003, ANN INTERN MED, V139, P123
   Levine GN, 2006, PHARMACOTHERAPY, V26, P1537, DOI 10.1592/phco.26.11.1537
   Levinson W, 2010, NEW ENGL J MED, V362, P948, DOI 10.1056/NEJMclde0911205
   Lewin R, 1999, INT J CARDIOL, V72, P49, DOI 10.1016/S0167-5273(99)00174-6
   Lewis BE, 2002, CATHETER CARDIO INTE, V57, P177, DOI 10.1002/ccd.10276
   Lim CCS, 2011, J AM COLL CARDIOL, V57, P653, DOI 10.1016/j.jacc.2010.07.058
   Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853
   Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696
   Lincoff AM, 2008, JACC-CARDIOVASC INTE, V1, P639, DOI 10.1016/j.jcin.2008.10.004
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Lotan C, 2000, EUR HEART J, V21, P1960, DOI 10.1053/euhj.2000.2295
   Louvard Y, 2004, AM J CARDIOL, V94, P1177, DOI 10.1016/j.amjcard.2004.07.089
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   Madsen JK, 1997, CIRCULATION, V96, P748
   Magni V, 2009, CATHETER CARDIO INTE, V73, P441, DOI 10.1002/ccd.21812
   Mahaffey Kenneth W, 2003, J Invasive Cardiol, V15, P611
   Mahmud E, 2008, J AM COLL CARDIOL, V51, P2385, DOI 10.1016/j.jacc.2008.03.028
   Maioli M, 2007, J AM COLL CARDIOL, V49, P1517, DOI 10.1016/j.jacc.2006.12.036
   Maioli M, 2008, J AM COLL CARDIOL, V52, P599, DOI 10.1016/j.jacc.2008.05.026
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Mangiacapra F, 2010, AM J CARDIOL, V106, P1208, DOI 10.1016/j.amjcard.2010.06.044
   Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027
   Marciniak SJ, 2002, THROMB HAEMOSTASIS, V87, P1020
   Marenzi G, 2009, ANN INTERN MED, V150, P170
   Marshall D, 1999, CATHETER CARDIO INTE, V48, P167, DOI 10.1002/(SICI)1522-726X(199910)48:2<167::AID-CCD9>3.0.CO;2-L
   Martin JL, 2004, CATHETER CARDIO INTE, V61, P163, DOI 10.1002/ccd.10726
   Marzilli M, 2000, CIRCULATION, V101, P2154
   Matsuo H, 2007, AM HEART J, V154, P994
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Mauri L, 2003, AM HEART J, V145, P847, DOI 10.1016/S0002-8703(03)00080-2
   Mauri L, 2002, AM J CARDIOL, V90, P1079, DOI 10.1016/S0002-9149(02)02773-X
   Mauri L, 2007, J AM COLL CARDIOL, V50, P1442, DOI 10.1016/j.jacc.2007.06.039
   Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485
   McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905
   MCGARRY TF, 1992, AM HEART J, V123, P1445, DOI 10.1016/0002-8703(92)90793-U
   McKay RG, 2001, CURR OPIN CARDIOL, V16, P364, DOI 10.1097/00001573-200111000-00009
   Mehilli J, 2009, CIRCULATION, V119, P1933, DOI 10.1161/CIRCULATIONAHA.108.818617
   Mehilli J, 2004, CIRCULATION, V110, P3627, DOI 10.1161/01.CIR.0000148956.93631.4D
   Mehilli J, 2011, LANCET, V378, P1071, DOI 10.1016/S0140-6736(11)61255-5
   Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068
   Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076
   Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7
   Mehran R, 1999, CIRCULATION, V100, P1872
   Mehta RH, 2010, AM HEART J, V159, P141, DOI 10.1016/j.ahj.2009.10.035
   Mehta RH, 2008, AM HEART J, V155, P1059, DOI 10.1016/j.ahj.2008.01.010
   Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741
   Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986
   Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4
   Melberg T, 2006, AM HEART J, V152, P888, DOI 10.1016/j.ahj.2006.06.026
   Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328
   Michaels Andrew D, 2002, J Invasive Cardiol, V14, P299
   Migliorini A, 2010, J AM COLL CARDIOL, V56, P1298, DOI 10.1016/j.jacc.2010.06.011
   Mintz GS, 2007, AM J CARDIOL, V100, P812
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Mishkel GJ, 2007, J AM COLL CARDIOL, V49, P181, DOI 10.1016/j.jacc.2006.08.049
   Mishra S, 2006, AM J CARDIOL, V98, P608, DOI 10.1016/j.amjcard.2006.03.036
   Mizukoshi M, 2010, AM J CARDIOL, V106, P323, DOI 10.1016/j.amjcard.2010.03.027
   Montalescot G, 2004, JAMA-J AM MED ASSOC, V292, P362, DOI 10.1001/jama.292.3.362
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Montalescot G, 2009, JACC-CARDIOVASC INTE, V2, P1083, DOI 10.1016/j.jcin.2009.08.016
   Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267
   Montalescot G, 2007, EUR HEART J, V28, P443, DOI 10.1093/eurheartj/ehl472
   Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503
   Moonen LAA, 2010, NETH HEART J, V18, P129, DOI 10.1007/BF03091751
   Mori M, 1996, AM J CARDIOL, V78, P985, DOI 10.1016/S0002-9149(96)00521-8
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995
   Moscucci M, 2001, CIRCULATION, V104, P263
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Moses JW, 2008, AM J CARDIOL, V102, p24J, DOI 10.1016/j.amjcard.2008.09.006
   Moussa I, 1997, CIRCULATION, V96, P128
   Moussa ID, 2011, CATHETER CARDIO INTE, V77, P537, DOI 10.1002/ccd.22865
   Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329
   Mueller C, 2002, J AM COLL CARDIOL, V40, P245, DOI 10.1016/S0735-1097(02)01949-6
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Nallamothu BK, 2006, CIRCULATION, V113, P222, DOI 10.1161/CIRCULATIONAHA.105.578195
   Nam CW, 2010, JACC-CARDIOVASC INTE, V3, P812, DOI 10.1016/j.jcin.2010.04.016
   Narins CR, 1996, CIRCULATION, V93, P667
   Nasser M, 2005, CATHETER CARDIO INTE, V65, P516, DOI 10.1002/ccd.20391
   Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593
   Neumann FJ, 2000, J AM COLL CARDIOL, V35, P915, DOI 10.1016/S0735-1097(99)00635-X
   Nikolsky E, 2007, EUR HEART J, V28, P1936, DOI 10.1093/eurheartj/ehm194
   Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Noble S, 2008, CATHETER CARDIO INTE, V71, P803, DOI 10.1002/ccd.21490
   Nordmann AJ, 2004, AM J MED, V116, P253, DOI 10.1016/j.amjmed.2003.08.035
   Nundy S, 2008, ARCH SURG-CHICAGO, V143, P1068, DOI 10.1001/archsurg.143.11.1068
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   Okabe T, 2008, J INVASIVE CARDIOL, V20, P635
   OKEEFE JH, 1993, AM J CARDIOL, V71, P897, DOI 10.1016/0002-9149(93)90903-P
   Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7
   Ono H, 2004, AM HEART J, V148, P611, DOI 10.1016/j.ahj.2004.05.014
   Osuna JGG, 2006, REV ESP CARDIOL, V59, P567
   Ozcan EE, 2007, AM HEART J, V154, P539, DOI 10.1016/j.ohi.2007.05.012
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Palmerini T, 2009, EUR HEART J, V30, P2087, DOI 10.1093/eurheartj/ehp223
   Pan M, 2007, AM HEART J, V153
   Pan XH, 2010, J ZHEJIANG UNIV-SC B, V11, P754, DOI 10.1631/jzus.B0900302
   Pannu N, 2004, KIDNEY INT, V65, P1366, DOI 10.1111/j.1523-1755.2004.00516.x
   Parikh SV, 2009, CIRCULATION, P120
   Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109
   Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039
   Park DW, 2007, AM J CARDIOL, V99, P760, DOI 10.1016/j.amjcard.2006.10.028
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603
   Patel MR, 2010, CIRCULATION, V122, P1882, DOI 10.1161/CIR.0b013e3181f9b345
   Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Perera D, 2010, JAMA-J AM MED ASSOC, V304, P867, DOI 10.1001/jama.2010.1190
   Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB
   Peterson ED, 2003, J AM COLL CARDIOL, V42, P1611, DOI 10.1016/S0735-1097(03)01121-5
   Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   PIANA RN, 1994, CIRCULATION, V89, P2514
   Pieper KS, 2009, AM HEART J, V157, P1097, DOI 10.1016/j.ahj.2009.04.004
   Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Pijls NHJ, 2002, CIRCULATION, V105, P2950, DOI 10.1161/01.CIR.0000020547.92091.76
   Piper WD, 2003, AM HEART J, V145, P1022, DOI 10.1016/S0002-8703(03)00079-6
   Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202
   Plante S, 2011, CATHETER CARDIOVASC, V76, P654
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   Pohl T, 2004, CATHETER CARDIO INTE, V62, P323, DOI 10.1002/ccd.20060
   Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162
   Popma JJ, 2004, CHEST, V126, p576S
   Post Piet N, 2010, Eur Heart J, V31, P1985, DOI 10.1093/eurheartj/ehq151
   Prasad A, 2009, J AM COLL CARDIOL, V54, P477, DOI 10.1016/j.jacc.2009.03.063
   Prasad A, 2007, J AM COLL CARDIOL, V49, P1611, DOI 10.1016/j.jacc.2006.12.040
   Prasad A, 2004, AM HEART J, V147, P1066, DOI 10.1016/j.ahj.2003.07.030
   Prasad A, 2008, CIRC-CARDIOVASC INTE, V1, P10, DOI 10.1161/CIRCINTERVENTIONS.108.765610
   Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Price MJ, 2006, J AM COLL CARDIOL, V47, P871, DOI 10.1016/j.jacc.2005.12.015
   Pristipino C, 2009, HEART, V95, P476, DOI 10.1136/hrt.2008.150714
   Ragosta M, 2006, CATHETER CARDIO INTE, V68, P357, DOI 10.1002/ccd.20709
   Rahel BM, 2004, AM HEART J, V147, pe16, DOI 10.1016/j.ahj.2003.11.023
   Rajdev S, 2008, J INVASIVE CARDIOL, V20, P67
   Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007
   Rao SV, 2010, J AM COLL CARDIOL, V55, P2187, DOI 10.1016/j.jacc.2010.01.039
   Rassen JA, 2010, EUR HEART J, V31, P561, DOI 10.1093/eurheartj/ehp437
   Rathore S, 2009, JACC-CARDIOVASC INTE, V2, P489, DOI 10.1016/j.jcin.2009.04.008
   Rathore SS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1807
   Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086
   Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5
   Reddy PR, 2005, AM J CARDIOL, V95, P755, DOI 10.1016/j.amjcard.2004.11.029
   Reed M, 2009, JACC-CARDIOVASC INTE, V2, P645, DOI 10.1016/j.jcin.2009.05.002
   Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Reifart N, 1997, CIRCULATION, V96, P91
   Reimers B, 1996, AM HEART J, V131, P192, DOI 10.1016/S0002-8703(96)90069-1
   Remmelink M, 2010, CATHETER CARDIO INTE, V75, P187, DOI 10.1002/ccd.22263
   Resnic FS, 2001, AM J CARDIOL, V88, P5, DOI 10.1016/S0002-9149(01)01576-4
   Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596
   Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815
   Ritchie JL, 2004, J AM COLL CARDIOL, V44, P1740, DOI 10.1016/j.jacc.2004.08.041
   Robinson JG, 2009, J AM COLL CARDIOL, V53, P316, DOI 10.1016/j.jacc.2008.10.024
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7
   Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4
   RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060
   Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081
   Roffi M, 2001, CIRCULATION, V104, P2767, DOI 10.1161/hc4801.100029
   Roffi M, 2002, CIRCULATION, V106, P3063, DOI 10.1161/01.CIR.0000041250.89627.A9
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Romagnoli E, 2005, INT J CARDIOL, V105, P250, DOI 10.1016/j.ijcard.2004.11.037
   Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061
   ROSSER W, 1992, CAN FAM PHYSICIAN, V38, P1623
   Roy P, 2009, AM J CARDIOL, V103, P950, DOI 10.1016/j.amjcard.2008.12.025
   Rubartelli P, 1998, J AM COLL CARDIOL, V32, P90, DOI 10.1016/S0735-1097(98)00193-4
   Rudnick MR, 2008, AM HEART J, V156, P776, DOI 10.1016/j.ahj.2008.05.023
   RUSSO D, 1995, J AM SOC NEPHROL, V6, P1451
   RYAN TJ, 1993, CIRCULATION, V88, P2987
   Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   Safley DM, 2008, JACC-CARDIOVASC INTE, V1, P295, DOI 10.1016/j.jcin.2008.05.004
   Sanborn TA, 2000, J AM COLL CARDIOL, V36, P1123, DOI 10.1016/S0735-1097(00)00875-5
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Sano K, 2007, AM HEART J, V154, P983, DOI 10.1016/j.ahj.2007.07.001
   Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051
   Schouten O, 2009, AM J CARDIOL, V103, P897, DOI 10.1016/j.amjcard.2008.12.018
   Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275
   Schulz S, 2010, EUR HEART J, V31, P582, DOI 10.1093/eurheartj/ehq008
   Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711
   SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603
   Sdringola S, 2000, CATHETER CARDIO INTE, V51, P394, DOI 10.1002/1522-726X(200012)51:4<394::AID-CCD4>3.0.CO;2-G
   Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043
   Selvanayagam JB, 2005, CIRCULATION, V111, P1027, DOI 10.1161/01.CIR.0000156328.28485.AD
   Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1
   Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Seshadri N, 2002, CIRCULATION, V106, P2346, DOI 10.1161/01.CIR.0000036595.92742.69
   Seto AH, 2010, JACC-CARDIOVASC INTE, V3, P751, DOI 10.1016/j.jcin.2010.04.015
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Seyfarth M, 2008, J AM COLL CARDIOL, V52, P1584, DOI 10.1016/j.jacc.2008.05.065
   Shah BR, 2010, J AM COLL CARDIOL, V56, P1328, DOI 10.1016/j.jacc.2010.03.093
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Sharma AK, 2004, CATHETER CARDIO INTE, V63, P141, DOI 10.1002/ccd.20124
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   SHEHADI WH, 1975, AM J ROENTGENOL, V124, P145
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Siller-Matula JM, 2011, HEART, V97, P98, DOI 10.1136/hrt.2010.195438
   Simoons ML, 1996, NEW ENGL J MED, V335, P275, DOI 10.1056/NEJM199607253350409
   Singh IM, 2010, J AM COLL CARDIOL, V55
   Singh M, 2008, J AM COLL CARDIOL, V51, P2313, DOI 10.1016/j.jacc.2008.01.066
   Singh M, 2009, CIRC-CARDIOVASC INTE, V2, P20, DOI 10.1161/CIRCINTERVENTIONS.108.826172
   Singh M, 2004, CIRCULATION, V109, P2727, DOI 10.1161/01.CIR.0000131898.18849.65
   Singh M, 2005, J AM COLL CARDIOL, V45, P198, DOI 10.1016/j.jacc.2004.05.089
   Singh M, 2004, J AM COLL CARDIOL, V44, P357, DOI 10.1016/j.jacc.2004.03.059
   Singh M, 2007, CIRCULATION, V115, P2835, DOI 10.1161/CIRCULATIONAHA.106.632679
   Singh M, 2002, J AM COLL CARDIOL, V40, P387, DOI 10.1016/S0735-1097(02)01980-0
   Singh PP, 2011, AM J THER, V18, pE22, DOI 10.1097/MJT.0b013e3181bc0f5a
   Sirnes PA, 1996, J AM COLL CARDIOL, V28, P1444, DOI 10.1016/S0735-1097(96)00349-X
   Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602
   Sjauw KD, 2009, J AM COLL CARDIOL, V54, P2430, DOI 10.1016/j.jacc.2009.09.018
   Skelding KA, 2002, CATHETER CARDIO INTE, V57, P305, DOI 10.1002/ccd.10303
   Smith Jr. SC, 2011, CIRCULATION, DOI [10.1161/CIR.0b013e318235eb4d, DOI 10.1161/CIR.0B013E318235EB4D]
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026
   Smith Sidney C Jr, 2006, J Am Coll Cardiol, V47, pe1, DOI 10.1016/j.jacc.2005.12.001
   Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4
   Solinas E, 2007, J AM COLL CARDIOL, V50, P2111, DOI 10.1016/j.jacc.2007.06.056
   SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104
   Solomon RJ, 2007, CIRCULATION, V115, P3189, DOI 10.1161/CIRCULATIONAHA.106.671644
   Song Young Bin, 2010, J Am Coll Cardiol, V55, P1743, DOI 10.1016/j.jacc.2010.02.008
   Sonoda S, 2004, J AM COLL CARDIOL, V43, P1959, DOI 10.1016/j./jacc.2004.01.044
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   Sigwart U, 2002, LANCET, V360, P965
   Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066
   Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056
   Stabile E, 2008, J AM COLL CARDIOL, V52, P2008, DOI 10.1016/j.jacc.2008.07.026
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   Steg PG, 2004, EUR HEART J, V25, P2187, DOI 10.1016/j.ehj.2004.10.019
   Steg PG, 2010, JAMA-J AM MED ASSOC, V304, P1339, DOI 10.1001/jama.2010.1320
   Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920
   Steinhubl SR, 2009, ANN INTERN MED, V150, P379
   Steinhubl SR, 1999, CIRCULATION, V100, P1977
   Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411
   Stella PR, 1997, CATHETER CARDIO DIAG, V40, P156, DOI 10.1002/(SICI)1097-0304(199702)40:2<156::AID-CCD7>3.0.CO;2-A
   Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stettler C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1331
   Stevens LA, 2009, AM J KIDNEY DIS, V54, P33, DOI 10.1053/j.ajkd.2009.03.008
   Stoel MG, 2008, CATHETER CARDIO INTE, V71, P283, DOI 10.1002/ccd.21334
   Stolker JM, 2010, CIRC-CARDIOVASC INTE, V3, P327, DOI 10.1161/CIRCINTERVENTIONS.110.946939
   Stone GW, 1997, J AM COLL CARDIOL, V30, P1714, DOI 10.1016/S0735-1097(97)00387-2
   Stone GW, 2009, CIRCULATION, V119, P680, DOI 10.1161/CIRCULATIONAHA.108.803528
   Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437
   Stone GW, 2002, CIRCULATION, V105, P2347, DOI 10.1161/01.CIR.0000017635.82128.8C
   Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496
   Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116
   Stone GW, 2005, CIRCULATION, V112, P2530, DOI 10.1161/CIRCULATIONAHA.105.583716
   Stone GW, 2003, J AM COLL CARDIOL, V41, P1940, DOI 10.1016/S0735-1097(03)00400-5
   Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191
   Stone GW, 2003, CIRCULATION, V108, P548, DOI 10.1161/01.CIR.0000080894.51311.0A
   Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404
   Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72
   Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Stramba-Badiale M, 2006, EUR HEART J, V27, P994, DOI 10.1093/eurheartj/ehi819
   Stroupe KT, 2006, CIRCULATION, V114, P1251, DOI 10.1161/CIRCULATIONAHA.105.570838
   Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   Suero JA, 2001, J AM COLL CARDIOL, V38, P409, DOI 10.1016/S0735-1097(01)01349-3
   Suh HS, 2011, INT J TECHNOL ASSESS, V27, P11, DOI 10.1017/S0266462310001340
   Swoboda I, 2002, J IMMUNOL, V168, P4576
   Szczech LA, 2002, CIRCULATION, V105, P2253, DOI 10.1161/01.CIR.0000016051.33225.33
   Szczech LA, 2001, KIDNEY INT, V60, P292, DOI 10.1046/j.1523-1755.2001.00799.x
   Takagi A, 1999, CIRCULATION, V100, P250
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   Tamburino C, 2010, JACC-CARDIOVASC INTE, V3, P624, DOI 10.1016/j.jcin.2010.03.016
   TAN K, 1995, J AM COLL CARDIOL, V25, P855, DOI 10.1016/0735-1097(94)00462-Y
   Tanigawa J, 2008, CIRC J, V72, P157, DOI 10.1253/circj.72.157
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Tarantini G, 2009, CATHETER CARDIO INTE, V73, P50, DOI 10.1002/ccd.21757
   Taylor AJ, 1998, CHEST, V114, P1570, DOI 10.1378/chest.114.6.1570
   Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   ten Berg JM, 2010, J AM COLL CARDIOL, V55, P2446, DOI 10.1016/j.jacc.2009.11.091
   Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139
   Testa L, 2009, QJM-INT J MED, V102, P369, DOI 10.1093/qjmed/hcp005
   The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2004, JAMA-J AM MED ASSOC, V291, P2916
   Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   Alderman EL, 1996, NEW ENGL J MED, V335, P217
   PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255
   PEDUZZI P, 1992, CIRCULATION, V86, P121
   Thiele H, 2009, J AM COLL CARDIOL, V53, P2324, DOI 10.1016/j.jacc.2009.03.032
   Thiele H, 2005, CIRCULATION, V112, P3445, DOI 10.1161/CIRCULATIONHA.105.578492
   Thiele H, 2010, EUR HEART J, V31, P1828, DOI 10.1093/eurheartj/ehq220
   Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091
   Thomas RJ, 2007, J AM COLL CARDIOL, V50, P1400, DOI 10.1016/j.jac.2007.04.033
   Thompson PD, 2003, ARTERIOSCL THROM VAS, V23, P1319, DOI 10.1161/01.ATV.0000087143.33998/F2
   Thomsen HS, 2008, INVEST RADIOL, V43, P170, DOI 10.1097/RLI.0b013e31815f3172
   Thuesen L, 2006, AM HEART J, V152, P1140, DOI 10.1016/j.ahj.2006.06.035
   Thygesen K, 2007, EUR HEART J, V28, P2525
   TIME Investigators, 2001, LANCET, V358, P951
   Tolleson TR, 2003, J AM COLL CARDIOL, V41, P386, DOI 10.1016/S0735-1097(02)02767-5
   Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   TOPOL EJ, 1987, J AM COLL CARDIOL, V9, P1214
   Tramer MR, 2006, BRIT MED J, V333, P675, DOI 10.1136/bmj.38905.634132.AE
   Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6
   Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641
   Tsubokawa A, 2002, CIRC J, V66, P1119, DOI 10.1253/circj.66.1119
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Urban P, 1999, EUR HEART J, V20, P1030, DOI 10.1053/euhj.1998.1353
   Vaitkus Paul T, 2004, J Invasive Cardiol, V16, P243
   Vaitkus PT, 2007, AM HEART J, V153, P275, DOI 10.1016/j.ahj.2006.09.014
   Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668
   Valgimigli M, 2004, J AM COLL CARDIOL, V44, P14, DOI 10.1016/j.jacc.2004.03.042
   Valgimigli M, 2007, J AM COLL CARDIOL, V49, P431, DOI 10.1016/j.jacc.2006.06.081
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van der Heijden DJ, 2004, J AM COLL CARDIOL, V44, P20, DOI 10.1016/j.jacc.2004.02.056
   van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0
   van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055
   Vaquerizo B, 2010, J INTERV CARDIOL, V23, P240, DOI 10.1111/j.1540-8183.2010.00547.x
   Varani Elisabetta, 2007, J Invasive Cardiol, V19, P469
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Vavalle John P, 2009, J Invasive Cardiol, V21, p21A
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Vijayalakshmi K, 2006, HEART, V92, P1278, DOI 10.1136/hrt.2005.075077
   VINEBERG AM, 1946, CAN MED ASSOC J, V55, P117
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
   Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8
   vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347
   von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088
   Vranckx P, 2009, CATHETER CARDIO INTE, V74, P302, DOI 10.1002/ccd.22011
   Wahrborg P, 1999, EUR HEART J, V20, P653, DOI 10.1053/euhj.1998.1237
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wallentin L, 1999, LANCET, V354, P708
   Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6
   WARTH DC, 1994, J AM COLL CARDIOL, V24, P641
   Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041
   Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021
   Weiner DE, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-26
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Welke KF, 2007, ANN THORAC SURG, V84, P1538, DOI 10.1016/j.athoracsur.2007.06.022
   Werner GS, 2002, CATHETER CARDIO INTE, V57, P444, DOI 10.1002/ccd.10375
   WEYRENS FJ, 1995, AM J CARDIOL, V75, P849, DOI 10.1016/S0002-9149(99)80430-5
   Whelton SP, 2002, ANN INTERN MED, V136, P493
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   White HD, 2008, CIRCULATION, V118, P219, DOI 10.1161/CIRCULATIONAHA.108.790170
   Widimsky P, 2011, EUR HEART J, V32, P396, DOI 10.1093/eurheartj/ehq410
   Widimsky P, 2008, EUR HEART J, V29, P1495, DOI 10.1093/eurheartj/ehn169
   Wijeysundera HC, 2007, J AM COLL CARDIOL, V49, P422, DOI 10.1016/j.jacc.2006.09.033
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   Williams BF, 2003, LANCET, V361, P918, DOI 10.1016/S0140-6736(03)12773-0
   Williams DO, 2000, CIRCULATION, V102, P2945
   WILLIAMS DO, 1982, CIRCULATION, V66, P693
   Williams M, 2008, JACC-CARDIOVASC IMAG, V1, P61, DOI 10.1016/j.jcmg.2007.09.001
   Wilson SH, 2003, J AM COLL CARDIOL, V42, P234, DOI 10.1016/S0735-1097(03)00622-3
   Wilson Walter, 2007, Circulation, V116, P1736, DOI 10.1161/CIRCULATIONAHA.106.183095
   Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001
   Winchester DE, 2010, J AM COLL CARDIOL, V56, P1099, DOI 10.1016/j.jacc.2010.04.023
   Witt BJ, 2004, J AM COLL CARDIOL, V44, P988, DOI 10.1016/j.jacc.2004.05.062
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wohrle J, 2003, CIRCULATION, V107, P1840, DOI 10.1161/01.CIR.0000066852.98038.D1
   Wöhrle Jochen, 2008, EuroIntervention, V3, P465, DOI 10.4244/EIJV3I4A83
   Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009
   Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011
   Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3
   Wu TG, 2008, CIRC J, V72, P1605, DOI 10.1253/circj.CJ-08-0357
   Yamaguchi T, 2008, AM J CARDIOL, V101, P562, DOI 10.1016/j.amjcard.2007.09.116
   Yan AT, 2005, AM J CARDIOL, V96, P913, DOI 10.1016/j.amjcard.2005.05.046
   Yang EH, 2005, J AM COLL CARDIOL, V46, P2004, DOI 10.1016/j.jacc.2005.06.083
   Yang JH, 2008, ANN THORAC SURG, V85, P65, DOI 10.1016/j.athoracsur.2007.06.027
   Yang Xin-chun, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P517
   Yang Zhen Kun, 2007, J Interv Cardiol, V20, P10, DOI 10.1111/j.1540-8183.2007.00222.x
   Yeung AC, 2008, JACC-CARDIOVASC INTE, V1, P598, DOI 10.1016/j.jcin.2008.09.001
   Yip HK, 2001, AM J CARDIOL, V87, P1184, DOI 10.1016/S0002-9149(01)01491-6
   Yun KH, 2009, INT J CARDIOL, V137, P246, DOI 10.1016/j.ijcard.2008.06.055
   Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519
   Yusuf S, 2006, NEW ENGL J MED, V354, P1464
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Zahn R, 1999, CATHETER CARDIO INTE, V46, P127, DOI 10.1002/(SICI)1522-726X(199902)46:2<127::AID-CCD2>3.0.CO;2-G
   Zeymer U, 2003, CIRCULATION, V108, P1324, DOI 10.1161/01.CIR.0000087605.09362.0E
   Zhang F, 2010, ANN MED, V42, P171, DOI 10.3109/07853890903463976
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002
   1988, J AM COLL CARDIOL, V12, P529
NR 872
TC 376
Z9 404
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD DEC
PY 2011
VL 58
IS 24
BP E44
EP E122
DI 10.1016/j.jacc.2011.08.007
PG 79
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 862ZJ
UT WOS:000298132300002
PM 22070834
ER

PT J
AU GERSONY, WM
   PECKHAM, GJ
   ELLISON, RC
   MIETTINEN, OS
   NADAS, AS
AF GERSONY, WM
   PECKHAM, GJ
   ELLISON, RC
   MIETTINEN, OS
   NADAS, AS
TI EFFECTS OF INDOMETHACIN IN PREMATURE-INFANTS WITH PATENT
   DUCTUS-ARTERIOSUS - RESULTS OF A NATIONAL COLLABORATIVE STUDY
SO JOURNAL OF PEDIATRICS
LA English
DT Article
RP GERSONY, WM (reprint author), COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032, USA.
CR AULD PAM, 1966, J PEDIATR, V69, P61, DOI 10.1016/S0022-3476(66)80362-1
   BELL EF, 1980, NEW ENGL J MED, V302, P598, DOI 10.1056/NEJM198003133021103
   BETKERUR MV, 1981, PEDIATRICS, V68, P99
   BRASH AR, 1981, NEW ENGL J MED, V305, P67, DOI 10.1056/NEJM198107093050203
   BROWN ER, 1979, J PEDIATR, V95, P865, DOI 10.1016/S0022-3476(79)80454-0
   CIFUENTES RF, 1979, J PEDIATR, V95, P583, DOI 10.1016/S0022-3476(79)80775-1
   CORAN AG, 1975, J PEDIATR SURG, V10, P399
   COTTON RB, 1978, J PEDIATR, V93, P647, DOI 10.1016/S0022-3476(78)80910-X
   DANILOWI.D, 1966, PEDIATRICS, V37, P74
   ELLISON RC, EVALUATION PRETERM I
   EVANS MA, 1979, CLIN PHARMACOL THER, V26, P746
   FLOWER RW, 1981, PEDIATR RES, V15, P1293, DOI 10.1203/00006450-198109000-00013
   FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003
   FRIEDMAN Z, 1978, J CLIN PHARMACOL, V18, P272
   GAY JH, 1973, J PEDIATR SURG, V8, P677, DOI 10.1016/0022-3468(73)90406-5
   HEYMANN MA, 1976, NEW ENGL J MED, V295, P530, DOI 10.1056/NEJM197609022951004
   HITTNER HM, 1981, NEW ENGL J MED, V305, P1365, DOI 10.1056/NEJM198112033052301
   IVEY HH, 1979, BRIT HEART J, V41, P304
   JACOB J, 1980, J PEDIATR, V96, P79
   JONES RWA, 1977, ARCH DIS CHILD, V52, P274
   KILMAN JW, 1974, J PEDIATR SURG, V9, P277, DOI 10.1016/S0022-3468(74)80280-0
   KITTERMA.JA, 1972, NEW ENGL J MED, V287, P473, DOI 10.1056/NEJM197209072871001
   KROVETZ LJ, 1972, NEW ENGL J MED, V287, P513, DOI 10.1056/NEJM197209072871010
   MAHONY L, 1982, NEW ENGL J MED, V306, P506, DOI 10.1056/NEJM198203043060903
   MCCARTHY JS, 1978, PEDIATRICS, V62, P706
   MERRITT TA, 1979, J PEDIATR, V95, P588, DOI 10.1016/S0022-3476(79)80776-3
   MERRITT TA, 1978, J PEDIATR, V93, P639
   MERRITT TA, 1981, J PEDIATR, V99, P281, DOI 10.1016/S0022-3476(81)80479-9
   MURPHY DA, 1974, J THORAC CARDIOV SUR, V67, P221
   NEAL WA, 1977, J PEDIATR, V91, P621, DOI 10.1016/S0022-3476(77)80519-2
   NELSON RJ, 1976, J THORAC CARDIOV SUR, V71, P169
   PROCIANOY RS, 1980, ARCH DIS CHILD, V55, P362
   SHARPE GL, 1977, J PEDIATR, V90, P335, DOI 10.1016/S0022-3476(77)80688-4
   SMITH DRS, 1980, CAN MED ASSOC J, V123, P739
   THALJI AA, 1980, J PEDIATR, V97, P995, DOI 10.1016/S0022-3476(80)80445-8
   THIBEAULT DW, 1975, J PEDIATR, V86, P120, DOI 10.1016/S0022-3476(75)80722-0
   WILLIAMS WH, 1976, ANN THORAC SURG, V22, P151
   YAFFE SJ, 1980, J PEDIATR, V97, P1001, DOI 10.1016/S0022-3476(80)80446-X
   YANAGI RM, 1981, PEDIATRICS, V67, P647
   YEH TF, 1981, J PEDIATR, V98, P137, DOI 10.1016/S0022-3476(81)80560-4
NR 40
TC 373
Z9 377
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-3476
J9 J PEDIATR
JI J. Pediatr.
PY 1983
VL 102
IS 6
BP 895
EP 906
DI 10.1016/S0022-3476(83)80022-5
PG 12
WC Pediatrics
SC Pediatrics
GA QU321
UT WOS:A1983QU32100019
PM 6343572
ER

PT J
AU Shroyer, AL
   Grover, FL
   Hattler, B
   Collins, JF
   McDonald, GO
   Kozora, E
   Lucke, JC
   Baltz, JH
   Novitzky, D
AF Shroyer, A. Laurie
   Grover, Frederick L.
   Hattler, Brack
   Collins, Joseph F.
   McDonald, Gerald O.
   Kozora, Elizabeth
   Lucke, John C.
   Baltz, Janet H.
   Novitzky, Dimitri
CA Vet Affairs (ROOBY) Study Grp
TI On-Pump versus Off-Pump Coronary-Artery Bypass Surgery.
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; CARDIOPULMONARY BYPASS; VETERANS-AFFAIRS;
   LIFE OUTCOMES; GRAFT PATENCY; METAANALYSIS; REVASCULARIZATION;
   MORBIDITY; MORTALITY; IMPROVEMENT
AB Background: Coronary-artery bypass grafting (CABG) has traditionally been performed with the use of cardiopulmonary bypass (on-pump CABG). CABG without cardiopulmonary bypass (off-pump CABG) might reduce the number of complications related to the heart-lung machine.
   Methods: We randomly assigned 2203 patients scheduled for urgent or elective CABG to either on-pump or off-pump procedures. The primary short-term end point was a composite of death or complications (reoperation, new mechanical support, cardiac arrest, coma, stroke, or renal failure) before discharge or within 30 days after surgery. The primary long-term end point was a composite of death from any cause, a repeat revascularization procedure, or a nonfatal myocardial infarction within 1 year after surgery. Secondary end points included the completeness of revascularization, graft patency at 1 year, neuropsychological outcomes, and the use of major resources.
   Results: There was no significant difference between off-pump and on-pump CABG in the rate of the 30-day composite outcome (7.0% and 5.6%, respectively; P=0.19). The rate of the 1-year composite outcome was higher for off-pump than for on-pump CABG (9.9% vs. 7.4%, P=0.04). The proportion of patients with fewer grafts completed than originally planned was higher with off-pump CABG than with on-pump CABG (17.8% vs. 11.1%, P<0.001). Follow-up angiograms in 1371 patients who underwent 4093 grafts revealed that the overall rate of graft patency was lower in the off-pump group than in the on-pump group (82.6% vs. 87.8%, P<0.01). There were no treatment-based differences in neuropsychological outcomes or short-term use of major resources.
   Conclusions: At 1 year of follow-up, patients in the off-pump group had worse composite outcomes and poorer graft patency than did patients in the on-pump group. No significant differences between the techniques were found in neuropsychological outcomes or use of major resources. (ClinicalTrials.gov number, NCT00032630.)
   N Engl J Med 2009;361:1827-37.
C1 [Shroyer, A. Laurie] Northport Vet Affairs VA, Med Ctr, Northport, NY USA.
   [Shroyer, A. Laurie; Grover, Frederick L.; Hattler, Brack; Baltz, Janet H.] Eastern Colorado Hlth Care Syst, Dept Vet Affairs, Denver, CO USA.
   [Kozora, Elizabeth] Natl Jewish Hlth, Denver, CO USA.
   [Grover, Frederick L.] Univ Colorado Denver, Dept Surg, Sch Med, Aurora, CO USA.
   [Hattler, Brack; Kozora, Elizabeth] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO USA.
   [Collins, Joseph F.] VA Med Ctr, Cooperat Studies Program Coordinat Ctr, Perry Point, MD USA.
   [McDonald, Gerald O.] Off Patient Care Serv, Dept Vet Affairs, Washington, DC USA.
   [Lucke, John C.] Charles George VA Med Ctr, Asheville, NC USA.
   [Novitzky, Dimitri] James A Haley Vet Hosp, Tampa, FL 33612 USA.
   [Novitzky, Dimitri] Univ S Florida, Dept Surg, Tampa, FL 33620 USA.
RP Collins, JF (reprint author), CSPCC 151E, Boiler House Rd,Bldg 362T, Perry Point, MD 21902 USA.
EM joseph.collins2@va.gov
FU Cooperative Studies Program of the Department of Veterans Affairs (VA)
   Office of Research and Development; VA Central Office, Office of Patient
   Care Services; Offices of Research and Development at the Eastern
   Colorado Health Care System VA Medical Center, Denver; Northport VA
   Medical Center, Northport, NY.
FX Supported by the Cooperative Studies Program of the Department of
   Veterans Affairs (VA) Office of Research and Development and the VA
   Central Office, Office of Patient Care Services, and in part by the
   Offices of Research and Development at the Eastern Colorado Health Care
   System VA Medical Center, Denver, and the Northport VA Medical Center,
   Northport, NY.
CR Al-Ruzzeh S, 2006, BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C
   Balacumaraswami L, 2004, J THORAC CARDIOV SUR, V128, P238, DOI 10.1016/j.jtcvs.2003.11.072
   BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312
   Caputo M, 2005, ANN THORAC SURG, V80, P2141, DOI 10.1016/j.athoracsur.2005.05.077
   Chang WK, 2004, ANN THORAC SURG, V78, P2057, DOI 10.1016/j.athoracsur.2004.05.059
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9
   Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2
   FITZGIBBON GM, 1978, CIRCULATION, V57, P1070
   Gill IS, 2000, ANN THORAC SURG, V69, P56, DOI 10.1016/S0003-4975(99)00861-9
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kobayashi J, 2005, CIRCULATION S1, V112, pI338
   Kozora E, 2007, CLIN NEUROPSYCHOL, V21, P653, DOI 10.1080/13803390600674615
   Marasco SF, 2008, EUR J CARDIO-THORAC, V33, P961, DOI 10.1016/j.ejcts.2008.03.022
   Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas John, 2005, Innovations (Phila), V1, P3, DOI 10.1097/01243895-200500110-00002
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   SAVAGEAU JA, 1982, J THORAC CARDIOV SUR, V84, P595
   Selnes OA, 2005, ANN THORAC SURG, V79, P1201, DOI 10.1016/j.athoracsur.2004.10.011
   SMITH PL, 1988, ANN ROY COLL SURG, V70, P212
   Sweet JJ, 2008, ANN THORAC SURG, V85, P1571, DOI 10.1016/j.athoracsur.2008.01.090
   Taylor KM, 1998, ANN THORAC SURG, V65, pS20, DOI 10.1016/S0003-4975(98)00072-1
   van Dijk Diederik, 2006, Semin Cardiothorac Vasc Anesth, V10, P167, DOI 10.1177/1089253206288999
   Vassiliades TA, 2002, ANN THORAC SURG, V73, P1874, DOI 10.1016/S0003-4975(02)03592-0
   Wan S, 1999, ANN THORAC SURG, V68, P52, DOI 10.1016/S0003-4975(99)00315-X
   WEILAND AP, 1986, HEART LUNG, V15, P34
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 33
TC 338
Z9 356
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD NOV 5
PY 2009
VL 361
IS 19
BP 1827
EP 1837
DI 10.1056/NEJMoa0902905
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA 514OZ
UT WOS:000271405800007
PM 19890125
ER

PT J
AU Khan, NE
   De Souza, A
   Mister, R
   Flather, M
   Clague, J
   Davies, S
   Collins, P
   Wang, DL
   Sigwart, U
   Pepper, J
AF Khan, NE
   De Souza, A
   Mister, R
   Flather, M
   Clague, J
   Davies, S
   Collins, P
   Wang, DL
   Sigwart, U
   Pepper, J
TI A randomized comparison of off-pump and on-pump multivessel
   coronary-artery bypass surgery
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID CARDIOPULMONARY BYPASS; BEATING-HEART; REVASCULARIZATION; OUTCOMES;
   EXPERIENCE; OCTOPUS
AB BACKGROUND:
   The effect of the use of coronary-artery bypass surgery without cardiopulmonary bypass and cardiac arrest ("off pump'') on graft patency remains uncertain. We undertook a prospective, randomized, controlled study to compare graft-patency rates and clinical outcomes in off-pump surgery with conventional, "on-pump'' surgery.
   METHODS:
   We randomly assigned 50 patients to undergo on-pump coronary-artery bypass grafting and 54 to undergo off-pump surgery. Surgical and anesthetic techniques were standardized for both groups. Clinical outcomes and troponin T levels were measured. Three months later, the patients underwent coronary angiography, including quantitative analysis.
   RESULTS:
   The mean age of the patients was 63 years, and 87 percent were men. The on-pump group received a mean of 3.4 grafts, and the off-pump group 3.1 (P=0.41). There were no deaths. There was no significant difference in the median postoperative length of stay between the two groups (seven days in each group). The area under the curve of troponin T levels was higher during the first 72 hours in the on-pump group than in the off-pump group (30.96 hr (bullet) microg per liter vs. 19.33 hr (bullet) microg per liter, P=0.02). At three months, 127 of 130 grafts were patent in the on-pump group (98 percent), as compared with 114 of 130 in the off-pump group (88 percent, P=0.002). The patency rate was higher for all graft territories in the on-pump group than in the off-pump group.
   CONCLUSIONS:
   In this randomized study, off-pump coronary surgery was as safe as on-pump surgery and caused less myocardial damage. However, the graft-patency rate was lower at three months in the off-pump group than in the on-pump group, and this difference has implications with respect to the long-term outcome.
C1 Royal Brompton & Harefield Natl Hlth Serv Trust, London, England.
   Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.
   London Sch Hyg & Trop Med, London WC1, England.
   Univ Hosp Geneva, Ctr Cardiol, Geneva, NY USA.
   Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland.
RP Khan, NE (reprint author), Royal Brompton Hosp, Clin Trials & Evaluat Unit, London SW3 6NP, England.
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X
   BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312
   Bock JL, 1999, AM J CLIN PATHOL, V112, P739
   Bonchek LI, 2002, J THORAC CARDIOV SUR, V124, P431, DOI 10.1067/mtc.2002.124240
   Borst C, 1996, J AM COLL CARDIOL, V27, P1356, DOI 10.1016/0735-1097(96)00039-3
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   Calafiore AM, 1999, ANN THORAC SURG, V67, P450, DOI 10.1016/S0003-4975(98)01194-1
   Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563
   Hernandez F, 2001, ANN THORAC SURG, V72, P1528, DOI 10.1016/S0003-4975(01)03202-7
   Jansen EWL, 1998, J THORAC CARDIOV SUR, V116, P60, DOI 10.1016/S0022-5223(98)70243-0
   Lloyd CT, 2000, J THORAC CARDIOV SUR, V119, P148, DOI 10.1016/S0022-5223(00)70230-3
   Mack M, 2002, J THORAC CARDIOV SUR, V124, P598, DOI 10.1067/mtc.2002.124884
   Magee MJ, 2002, CIRCULATION, V106, P637
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Newman MF, 2001, NEW ENGL J MED, V344, P1876
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Subramanian VA, 1997, ANN THORAC SURG, V64, P1648, DOI 10.1016/S0003-4975(97)01099-0
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
NR 24
TC 313
Z9 329
PU MASSACHUSETTS MEDICAL SOC/NEJM
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JAN 1
PY 2004
VL 350
IS 1
BP 21
EP 28
DI 10.1056/NEJMoa031282
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 758PT
UT WOS:000187659900006
PM 14702424
ER

PT J
AU Michael, E
   Bundy, DAP
   Grenfell, BT
AF Michael, E
   Bundy, DAP
   Grenfell, BT
TI Re-assessing the global prevalence and distribution of lymphatic
   filariasis
SO PARASITOLOGY
LA English
DT Review
DE lymphatic filariasis; global burden; epidemiology
ID BANCROFTIAN FILARIASIS; WUCHERERIA-BANCROFTI; CLINICAL MANIFESTATIONS;
   FREQUENCY-DISTRIBUTION; HUMAN-POPULATIONS; MASS TREATMENT; TAMIL-NADU;
   DISEASE; INFECTION; TRANSMISSION
AB This paper estimates the global burden of lymphatic filariasis based on a review of the published literature on infection and disease surveys. A method for aggregating and projecting prevalence data from individual studies to national, regional and global levels, which also facilitates the estimation of gender and age-specific burdens, is presented. The method weights in favour of the larger, and hence presumbably more reliable, studies and relies on estimated empirical relationships between gender, age, infection and disease in order to correct studies with incomplete data. The results presented here suggest that although the overall prevalence of filariasis cases is 2.0% globally (approximately totalling 119 million cases), the disease continues to be of considerable local importance, particularly in India and Sub-Saharan Africa. Estimates by age and gender clearly show that, unlike other helminth infections, filariasis is mainly a disease of the adult and older age-classes and appears to be more prevalent in males. This work suggests that the derivation of more accurate estimates of the burden of filariasis will require a better understanding of both the epidemiology and the spatial aspects of infection and disease. It also suggests that filariasis is preventable based on a geographically targeted strategy for control.
C1 UNIV CAMBRIDGE,DEPT ZOOL,CAMBRIDGE CB2 3EJ,ENGLAND.
   UNIV OXFORD,CTR EPIDEMIOL & INFECT DIS,OXFORD OX1 3PS,ENGLAND.
RI Michael, Edwin/D-3388-2014
CR ABARU DE, 1980, ACTA TROP, V37, P63
   ABDULCADER M. H. M., 1960, INDIAN JOUR MALARIOL, V14, P521
   Akogun O B, 1991, J Hyg Epidemiol Microbiol Immunol, V35, P383
   Azevedo JF, 1969, ANN ESCOLA NACL SAUD, V3, P3
   AZEVEDO JFD, 1964, ANN I MED TROPICAL, V21, P313
   BARCLAY R, 1969, ANN TROP MED PARASIT, V63, P473
   BARRY C, 1971, AM J TROP MED HYG, V20, P592
   BASU P C, 1967, Bulletin of the Indian Society for Malaria and Other Communicable Diseases, V4, P296
   BEYE HK, 1953, B SOC PATHOL EXOT, V1, P144
   BEYE HK, 1952, AM J TROP MED HYG, V1, P637
   BHATTACH.NC, 1973, INDIAN J MED RES, V61, P8
   BISWAS H, 1989, Journal of Communicable Diseases, V21, P272
   BLANCHY S, 1982, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V20, P153
   BOOTH M, 1992, PARASITOLOGY, V105, P151
   BOUREE P, 1987, B SOC PATHOL EXOT, V80, P634
   BRABIN L, 1990, EPIDEMIOL INFECT, V105, P335
   BRENGUES J, 1975, MEMOIRES OSTROM, V79
   BRENGUES J, 1969, CAHIERS ORSTOM E M P, V8, P279
   Brinkmann UK, 1976, TROPENMED PARASITOL, V28, P71
   BRUNHES J, 1975, MEMOIRES ORSTOM, V81
   Brygoo E. R., 1958, Archs Inst Pasteur Madagascar, V26, P23
   BUNDY DAP, 1991, IMMUNOPARASITOL TOD, pA71
   BUNDY DAP, 1989, ADV PARASIT, V28, P107, DOI 10.1016/S0065-308X(08)60332-2
   Cabrera B D, 1972, Southeast Asian J Trop Med Public Health, V3, P31
   CARTEL JL, 1992, T ROY SOC TROP MED H, V84, P414
   CAUSEY OR, 1945, AM J HYG, V41, P143
   CHAN MS, 1994, PARASITOLOGY, V109, P373
   CHAND D, 1962, Indian J Malariol, V16, P269
   CHAND DIWAN, 1961, INDIAN JOUR MALARIOL, V15, P39
   CHANDRA S, 1973, INDIAN J MED RES, V61, P1127
   CHANDRASEKHARAN A, 1981, INDIAN J MED RES, V73, pS82
   CHARAFOUDINE H, 1986, B SOC PATHOL EXOT, V79, P229
   CIFERRI F, 1989, AM J TROP MED HYG, V18, P369
   Crompton D.W.T., 1989, P45
   CROMPTON DWT, 1988, PARASITOL TODAY, V4, P162, DOI 10.1016/0169-4758(88)90152-4
   DAVID HL, 1965, ANN TROP MED PARASIT, V59, P193
   DENNIS DT, 1976, AM J TROP MED HYG, V25, P797
   DEROOK H, 1959, TROPICAL GEOGRAPHICA, V11, P313
   DEROOK H, 1957, TROPICAL GEOGRAPHICA, V9, P197
   DESOWITZ RS, 1974, AM J TROP MED HYG, V23, P877
   DESOWITZ RS, 1976, B WORLD HEALTH ORGAN, V54, P565
   DISSANAYAKE S, 1989, T ROY SOC TROP MED H, V83, P384, DOI 10.1016/0035-9203(89)90511-7
   DONDERO TJ, 1976, AM J TROP MED HYG, V25, P64
   DONDERO T J JR, 1972, Southeast Asian Journal of Tropical Medicine and Public Health, V3, P355
   DREYER G, 1992, AM J TROP MED HYG, V46, P745
   EL-RIDI A M S, 1984, Journal of the Egyptian Society of Parasitology, V14, P471
   ENARSON DA, 1982, TROP GEOGR MED, V34, P353
   ESTAMBALE BBA, 1994, ANN TROP MED PARASIT, V88, P145
   EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S
   Fahmy M.A.M., 1977, Journal of the Egyptian Society of Parasitology, V7, P3
   FAIN A, 1969, Annales des Societes Belges de Medecine Tropicale de Parasitologie et de Mycologie, V49, P629
   FEINSOD FM, 1987, ANN SOC BELG MED TR, V67, P259
   FRANCO O, 1966, REV BRASILEIRA MALAR, V18, P73
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927
   GALLIARD H, 1949, TROPICAL DIS B, V47, P60
   GRENFELL BT, 1990, PARASITOLOGY, V101, P417
   GRENFELL BT, 1992, PARASITOLOGY, V104, pS81
   GROVE DI, 1978, B WORLD HEALTH ORGAN, V56, P975
   GROVE DI, 1983, REV INFECT DIS, V5, P933
   GUPTAVANIJ P, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P42
   Guptavanij P, 1971, SE Asian J trop Med pub Hlth, V2, P44
   GUYATT HL, 1991, T ROY SOC TROP MED H, V85, P778, DOI 10.1016/0035-9203(91)90453-6
   GYAPONG JO, 1993, J TROP MED HYG, V96, P317
   HARBUT CL, 1983, AM J TROP MED HYG, V32, P764
   HARINASUTA C, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P179
   HARINASUTA C., 1970, Southeast Asian Journal of Tropical Medicine and Public Health, V1, P233
   Hawking F, 1977, Trop Dis Bull, V74, P649
   Hawking F, 1976, Trop Dis Bull, V73, P967
   HAWKING F, 1971, DISTRIBUTION HUMAN F
   Hedges L. V., 1985, STATISTICAL METHODS
   HII J, 1985, TROP GEOGR MED, V37, P93
   HUEHNS ER, 1953, T ROY SOC TROP MED H, V47, P549, DOI 10.1016/S0035-9203(53)80007-6
   HYMA B, 1989, SOC SCI MED, V29, P983, DOI 10.1016/0277-9536(89)90054-3
   ISHII A, 1983, J TROP MED HYG, V86, P59
   IYENGAR M O, 1959, Trop Geogr Med, V11, P287
   IYENGAR M O T, 1952, Bull World Health Organ, V7, P375
   JACHOWSKI LA, 1955, AM J HYG, V61, P334
   Jain D C, 1987, J Commun Dis, V19, P317
   JAIN D C, 1989, Journal of Communicable Diseases, V21, P265
   JOESOEF A, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P480
   JOIRE E, 1988, MED MALADIES INFECT, V4, P251
   JOSEPH C, 1963, Indian J Malariol, V17, P33
   Juminer B, 1971, Archs Inst Pasteur Tunis, V48, P231
   Jung R. K., 1973, Journal of the Nepal Medical Association, V11, P155
   KANT C, 1956, INDIAN J MALARIOL, V10, P199
   KAPOJOS DS, 1976, TROP GEOGR MED, V28, P359
   KAZURA JW, 1984, AM J TROP MED HYG, V33, P1119
   KIM JS, 1987, B WORLD HEALTH ORGAN, V65, P67
   KIMURA E, 1985, B WORLD HEALTH ORGAN, V63, P869
   KNIGHT R, 1980, ANN TROP MED PARASIT, V74, P63
   KNIGHT R, 1979, ANN TROP MED PARASIT, V73, P563
   Krishnaswami A. K., 1955, Indian Journal of Malariology, V9, P1
   KUHLOW F, 1976, TROPENMED PARASITOL, V27, P93
   KUMAR A, 1990, Journal of Communicable Diseases, V22, P209
   LAIGRET J, 1984, EFFECTS TREATMENT AN
   Lambrecht F. L., 1971, SE Asian J trop Med pub Hlth, V2, P222
   LIE KIAN JOE, 1960, Indian J Malariol, V14, P339
   LING JH, 1985, CHINESE J EPIDEMIOLG, V6, P222
   Liu XinJi, 1989, Chinese Journal of Parasitic Disease Control, V2, P65
   MADRIGAL RB, 1979, TECNICA KNOTT ZONA E
   MAHFUDIN H, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P173
   MAK J W, 1977, Medical Journal of Malaysia, V31, P198
   MARCEAU C, 1986, B SOC PATHOL EXOT, V79, P755
   MARWAH SM, 1972, J INDINA MED ASS, V60, P33
   MATAIKA JU, 1971, J HYG-CAMB, V69, P273
   MATAIKA JU, 1971, J HYG-CAMB, V69, P297
   MATOLA YG, 1985, TROP GEOGR MED, V37, P108
   MCCARTHY D. D., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P58, DOI 10.1016/0035-9203(56)90009-8
   MCCARTHY D. D., 1955, TRANS ROY SOC TROP MED AND HYG, V49, P82, DOI 10.1016/0035-9203(55)90088-2
   MCMAHON JE, 1981, ANN TROP MED PARASIT, V75, P415
   MICHAEL E, 1995, IN PRESS BURDEN DIS
   MICHAEL E, 1994, P ROY SOC B-BIOL SCI, V256, P33, DOI 10.1098/rspb.1994.0045
   NAIR C. P., 1960, INDIAN JOUR MALARIOL, V14, P233
   NAIR C P, 1962, Indian J Malariol, V16, P47
   Nathan M B, 1990, Bull Pan Am Health Organ, V24, P301
   NATHAN MB, 1982, W INDIAN MED J, V31, P168
   Oostburg B F, 1985, Acta Leiden, V53, P37
   ORAM R H, 1958, Cent Afr J Med, V4, P99
   ORAM RH, 1960, CENTRAL AFRICAN J ME, V4, P144
   PANI SP, 1995, T ROY SOC TROP MED H, V89, P72, DOI 10.1016/0035-9203(95)90666-5
   PANI SP, 1991, T ROY SOC TROP MED H, V85, P260, DOI 10.1016/0035-9203(91)90048-4
   PANI SP, 1990, INDIAN J MED RES-A, V91, P200
   PANIAGUA F, 1983, AM J TROP MED HYG, V32, P1294
   PARTONO F, 1978, AM J TROP MED HYG, V27, P910
   PARTONO F, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P400
   PARTONO F, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P452
   Partono F., 1972, Southeast Asian Journal of Tropical Medicine and Public Health, V3, P537
   PEROLAT P, 1986, B SOC PATHOL EXOT, V79, P78
   PINHAO RUI COSTA, 1961, AN INST MED TROP, V18, P15
   RACCURT CP, 1986, B SOC PATHOL EXOT, V79, P745
   RACCURT CP, 1988, T ROY SOC TROP MED H, V82, P721, DOI 10.1016/0035-9203(88)90214-3
   RACCURT CP, 1984, AM J TROP MED HYG, V33, P1124
   RAHMAN J., 1959, Bulletin of the National Society of India for Malaria and Other Mosquito-Borne Diseases, V7, P53
   Rahman N M, 1971, J Indian Med Assoc, V56, P363
   RAINA V K, 1990, Journal of Communicable Diseases, V22, P205
   RAJAGOPALAN PK, 1981, J MED RES, V73, P73
   RAJAGOPALAN PK, 1977, INDIAN J MED RES, V66, P200
   RAJAGOPALAN PK, 1989, EPIDEMIOL INFECT, V103, P685
   Ramachandran C P, 1971, Med J Malaya, V25, P273
   RAMAIAH KD, 1989, INDIAN J MED RES-A, V89, P184
   RAO CK, 1980, INDIAN J MED RES, V71, P712
   RATH R N, 1984, Journal of Communicable Diseases, V16, P104
   RATH R N, 1989, Journal of Communicable Diseases, V21, P39
   Ripert C., 1982, Medecine Tropicale, V42, P59
   ROSEN L, 1955, AM J HYG, V61, P219
   ROZEBOOM LLOYD E., 1964, J MED ENTOMOL, V1, P18
   ROZEBOOM LE, 1965, AM J EPIDEMIOL, V81, P216
   RUBIS P, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P30
   RUSSEL S, 1975, J COMMUNICABLE DIS, V1, P15
   Russel S., 1981, Journal of Communicable Diseases, V12, P183
   SARMA RVSN, 1987, INDIAN J MED RES, V85, P522
   Sasa M, 1976, HUMAN FILARIASIS GLO
   SCHULTZ G W, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P207
   SELF LS, 1991, WHOFILF3815
   SELF LS, 1978, T ROY SOC TROP MED H, V72, P581, DOI 10.1016/0035-9203(78)90006-8
   SHARMA S P, 1984, Journal of Communicable Diseases, V16, P282
   Sherlock I. A., 1967, Revista Brasileira de Malariologia e Doencas Tropicais, V19, P373
   SINGH J., 1956, Indian Journal of Malariology, V10, P219
   SINGH M. V., 1964, Bull. Indian Soc. for Malaria & other Communicable Dis., V1, P141
   SINGH M V, 1963, Indian J Malariol, V17, P303
   Southgate B A, 1979, Trop Dis Bull, V76, P1045
   SOUTHGATE BA, 1992, J TROP MED HYG, V95, P1
   SOUTHGATE BA, 1974, ROY SOC TROP MED HYG, V68, P177
   SRIVASTA.RN, 1969, INDIAN J MED RES, V57, P528
   SRIVIDYA A, 1991, PARASITOLOGY, V102, P207
   SRIVIDYA A, 1991, T ROY SOC TROP MED H, V85, P255, DOI 10.1016/0035-9203(91)90046-2
   SUDOMO M, 1982, Southeast Asian Journal of Tropical Medicine and Public Health, V13, P584
   SYMES C B, 1960, J Trop Med Hyg, V63, P31
   TANAKA H, 1980, JPN J EXP MED, V50, P85
   TAWIL N A, 1979, Southeast Asian Journal of Tropical Medicine and Public Health, V10, P483
   UDONSI JK, 1988, FOLIA PARASIT, V35, P147
   UDONSI JK, 1986, ANN TROP MED PARASIT, V80, P425
   UDONSI JK, 1988, ANN TROP MED PARASIT, V82, P75
   Ufomadu G.O., 1991, ACTA TROP, V48, P137
   VAMA BK, 1961, INDIAN J MALARIOL, V15, P185
   VANDEEMTER JJ, 1961, CHEM ENG SCI, V13, P143, DOI 10.1016/0009-2509(61)80005-5
   VARMA B. K., 1961, INDIAN JOUR MALARIOL, V15, P285
   VARMA B. K., 1960, Bulletin of the National Society of India for Malaria and Other Mosquito-Borne Diseases, V8, P149
   VARMA B. K., 1961, INDIAN JOUR MALARIAL, V15, P293
   VINCENT AL, 1987, J PARASITOL, V73, P839, DOI 10.2307/3282426
   WAHDAN MH, 1991, UPDATED INFORMATION
   Warren K.S., 1993, DIS CONTROL PRIORITI, P131
   WEINSTOCK H, 1977, AM J TROP MED HYG, V26, P1148
   Weisberg S., 1985, APPLIED LINEAR REGRE
   WELLER PF, 1982, AM J TROP MED HYG, V31, P942
   Wenceslao J. M., 1972, Southeast Asian Journal of Tropical Medicine and Public Health, V3, P552
   WIJERS DJB, 1977, ANN TROP MED PARASIT, V71, P333
   WIJERS DJB, 1984, ANN TROP MED PARASIT, V78, P383
   WIJERS DJB, 1977, ANN TROP MED PARASIT, V71, P313
   WIJEYARATNE PM, 1982, INDIAN J MED RES, V76, P534
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   WOLFE MS, 1972, AM J TROP MED HYG, V21, P22
   WOLFE MS, 1971, T ROY SOC TROP MED H, V65, P63, DOI 10.1016/0035-9203(71)90186-6
   ZIELKE E, 1979, TROPENMED PARASITOL, V30, P91
   1981, CHINESE J PREVENTIVE, V15, P234
   1994, LYMPHATIC FILARIASIS
   1993, WORLD DEV REPORT 199
   1984, 702 WHO
   1992, 821 WHO
NR 199
TC 289
Z9 298
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211
SN 0031-1820
J9 PARASITOLOGY
JI Parasitology
PD APR
PY 1996
VL 112
BP 409
EP 428
PN 4
PG 20
WC Parasitology
SC Parasitology
GA UF333
UT WOS:A1996UF33300007
PM 8935952
ER

PT J
AU Amling, CL
   Bergstralh, EJ
   Blute, ML
   Slezak, JM
   Zincke, H
AF Amling, CL
   Bergstralh, EJ
   Blute, ML
   Slezak, JM
   Zincke, H
TI Defining prostate specific antigen progression after radical
   prostatectomy: What is the most appropriate cut point?
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostatic neoplasms; prostatectomy; prostate-specific antigen;
   biochemical phenomena; recurrence
ID RADIATION-THERAPY; CANCER; RECURRENCE; NOMOGRAM
AB Purpose: The most appropriate definition of biochemical progression after radical prostatectomy and radiation therapy is uncertain. We analyzed the effect of using various prostate specific antigen (PSA) end point definitions for defining biochemical progression after radical prostatectomy and attempted to determine the best PSA cut point to use. Aspects of the American Society for Therapeutic Radiology and Oncology (ASTRO) definition of biochemical failure after radiation therapy are also analyzed in our radical prostatectomy cases.
   Materials and Methods: A total of 2,782 men with clinically localized prostate cancer (cT1-T2) who had undergone radical prostatectomy between 1987 and 1993 were reviewed. All patients had regular PSA determinations from surgery through followup. Analysis was limited to patients who did not receive adjuvant treatment within 90 days of radical prostatectomy. Biochemical, PSA progression-fi ee percent after radical prostatectomy was determined by the Kaplan-Meier method using several PSA cut points, including 0.2, 0.3, 0.4 and 0.5 ng./ml. or greater, as well as 0.4 ng./ml. or greater and increasing. Progression-free percent was also assessed using the ASTRO definition, which is 3 increases in PSA. To determine which PSA level was most appropriate to define progression after radical prostatectomy, the percentage of patients with a continued PSA increase after reaching each cut point was determined. The relationship between the maximum PSA within 3 years of surgery and subsequent development of clinical disease was also assessed.
   Results: Progression-free percent was dependent on the PSA cut point used. Biochemical progression-free percentages for cut points 0.2, 0.3, 0.4 and 0.5 ng./ml. or greater were 62%, 72%, 76% and 78% at 5 years, and 43%, 54%, 59% and 61% at 10 years, respectively. A subsequent increase in PSA was noted in 49%, 62% and 72% of patients who had PSA 0.2, 0.3 and 0.4 ng./ml., respectively. Subsequent clinical progression (local or systemic) was directly related to the maximum PSA attained within 3 years of radical prostatectomy (p = 0.0001). Progression-free percent for definitions requiring multiple increases in PSA were dependent on when the event was said to occur. Backdating of events at or before the first PSA (ASTRO definition) resulted in poorer, short-term progression-free percent (78% at 5 years), with little apparent Likelihood of long-term failure (78% at 10 years). Coding the event at the last PSA increase when all event criteria had been met resulted in more realistic progression-free percent estimates (85% at 5 and 59% at 10 years).
   Conclusions: Biochemical, PSA progression rates vary markedly depending on the method used to define PSA failure. Methods that require multiple increasing PSA values, for example the ASTRO definition, give misleading results, especially if the event time is backdated. Standards for defining PSA progression would allow more consistent and comparable progression estimates after radical prostatectomy. PSA 0.4 ng./ml. or greater may be the most appropriate cut point to use since a significant number of patients with lower PSA do not have a continued increase in it.
C1 USN, Med Ctr, Dept Urol, San Diego, CA 92152 USA.
   Mayo Clin, Dept Urol, Rochester, MN USA.
   Mayo Clin, Biostat Sect, Rochester, MN USA.
RP Amling, CL (reprint author), USN, Med Ctr, Dept Urol, San Diego, CA 92152 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   ANDERSON JR, 1983, J CLIN ONCOL, V1, P710
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   D'Amico AV, 1999, J CLIN ONCOL, V17, P168
   DIAMANDIS EP, 1995, J CLIN ENDOCR METAB, V80, P1515, DOI 10.1210/jc.80.5.1515
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kattan MW, 1999, J CLIN ONCOL, V17, P1499
   Moul JW, 1996, J UROLOGY, V155, P1667, DOI 10.1016/S0022-5347(01)66160-3
   OESTERLING JE, 1988, J UROLOGY, V139, P766
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Schellhammer PF, 1997, UROL CLIN N AM, V24, P407, DOI 10.1016/S0094-0143(05)70387-6
   Tibbs M. K., 1995, International Journal of Radiation Oncology Biology Physics, V32, P230, DOI 10.1016/0360-3016(95)97841-N
   Vicini FA, 1997, J UROLOGY, V158, P319, DOI 10.1016/S0022-5347(01)64471-9
   WHITE RWD, 1992, J UROLOGY, V147, P947
   YU H, 1995, CLIN CHEM, V41, P430
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   ZINCKE H, 1994, J UROLOGY, V152, P1850
NR 17
TC 259
Z9 272
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2001
VL 165
IS 4
BP 1146
EP 1151
DI 10.1016/S0022-5347(05)66452-X
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 411MK
UT WOS:000167503700026
PM 11257657
ER

PT J
AU Cheng, DC
   Bainbridge, D
   Martin, JE
   Novick, RJ
AF Cheng, DC
   Bainbridge, D
   Martin, JE
   Novick, RJ
CA Evidence based Perioperative Clin
TI Does off-pump coronary artery bypass reduce mortality, morbidity, and
   resource utilization when compared with conventional coronary artery
   bypass? A meta-analysis of randomized trials
SO ANESTHESIOLOGY
LA English
DT Article; Proceedings Paper
CT 25th Annual Meeting of the Society-of-Cardiovascular-Anesthesiologists
CY APR 26-30, 2003
CL Miami, FL
SP Soc Cardiovascular Anesthesiologists
ID LOW-RISK PATIENTS; ON-PUMP; BEATING-HEART; CARDIOPULMONARY BYPASS;
   INFLAMMATORY RESPONSE; EXTRACORPOREAL-CIRCULATION; MYOCARDIAL
   REVASCULARIZATION; MEDIAN STERNOTOMY; CARDIAC-SURGERY; GRAFT-SURGERY
AB The authors undertook a meta-analysis of 37 randomized trials (3369 patients) of off-pump coronary artery bypass surgery versus conventional coronary artery bypass surgery. No significant differences were found for 30-day mortality (odds ratio [OR], 1.02; 95% confidence interval [CI], 0.58-1.80), myocardial infarction (OR, 0.77; 95% CI, 0.48-1.26), stroke (OR, 0.68; 95% CI, 0.33-1.40), renal dysfunction, intraaortic balloon pump, wound infection, rethoracotomy, or reintervention. However, off-pump coronary artery bypass surgery significantly decreased atrial fibrillation (OR, 0.58; 95%CI, 0.44-0.77), transfusion (OR, 0.43; 95%CI, 0.29-0.65), inotrope requirements (OR, 0.48; 95%CI, 0.32-0.73), respiratory infections (OR, 0.41; 95%CI, 0.23-0.74), ventilation time (weighted mean difference, -3.4 h; 95%CI, -5.1 to -1.7 h), intensive care unit stay (weighted mean difference, -0.3 days; 95%CI -0.6 to -0.1 days), and hospital stay (weighted mean difference, -1.0 days; 95%CI -1.5 to -0.5 days). Patency and neurocognitive function results were inconclusive. in-hospital and 1-yr direct costs were generally higher for conventional coronary artery bypass surgery versus off-pump coronary artery bypass surgery. Therefore, this meta-analysis demonstrates that mortality, stroke, myocardial infarction, and renal failure were not reduced in off-pump coronary artery bypass surgery surgery; however, selected short-term and mid-term clinical and resource outcomes were improved compared with conventional coronary artery bypass surgery.
C1 Univ Western Ontario, Dept Anesthesia & Perioperat Med, London Hlth Sci Ctr, London, ON N6A 5A5, Canada.
RP Cheng, DC (reprint author), Univ Western Ontario, Dept Anesthesia & Perioperat Med, London Hlth Sci Ctr, Univ Campus,339 Windermere Rd,Room 3-CA19, London, ON N6A 5A5, Canada.
EM davy.cheng@lhsc.on.ca
CR Alderson P, 2004, COCHRANE REV HDB
   Al-Ruzzeh S, 2003, HEART SURG FORUM, V6, P89
   Altman Douglas G, 2002, BMC Med Res Methodol, V2, P3, DOI 10.1186/1471-2288-2-3
   Altman DG, 1998, BRIT MED J, V317, P1309
   *AM HEART ASS, 2003, HEART DIS STROK STAT, P46
   Anderson RE, 1999, J CARDIOTHOR VASC AN, V13, P698, DOI 10.1016/S1053-0770(99)90123-4
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Antonelli M, 1999, J CARDIOVASC SURG, V40, P487
   Ascione R, 2004, EUR HEART J, V25, P765, DOI 10.1016/j.ehj.2003.11.015
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Ascione R, 2000, CIRCULATION, V102, P1530
   Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X
   Ascione R, 2003, ANN THORAC SURG, V75, P306, DOI 10.1016/S0003-4975(02)04020-1
   BAINBRIDGE D, 2005, IN PRESS ANN THORAC, V79
   BAKER RA, 2001, HEART SURG FORUM, pS19
   Bauer M, 2001, J THORAC CARDIOV SUR, V121, P702, DOI 10.1067/mtc.2001.111380
   Berger PB, 1999, CIRCULATION, V100, P2353
   Caputo M, 2002, ANN THORAC SURG, V74, P2088, DOI 10.1016/S0003-4975(02)04025-0
   Carrier M, 2003, HEART SURG FORUM, V6, pE89
   Cates Christopher J, 2002, BMC Med Res Methodol, V2, P1, DOI 10.1186/1471-2288-2-1
   Chang PP, 2002, AM J CARDIOL, V89, P1107, DOI 10.1016/S0002-9149(02)02293-2
   Cheng DCH, 1998, ANESTHESIOLOGY, V88, P1429, DOI 10.1097/00000542-199806000-00002
   Choi PTL, 2001, ANESTH ANALG, V92, P700
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Cohen JW, 2003, HEALTH AFFAIR, V22, P129, DOI 10.1377/hlthaff.22.2.129
   Covino E, 2001, J CARDIOVASC SURG, V42, P23
   Cox CM, 2000, ANN THORAC SURG, V69, P140, DOI 10.1016/S0003-4975(99)01196-0
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Czerny M, 2000, EUR J CARDIO-THORAC, V17, P737, DOI 10.1016/S1010-7940(00)00420-6
   de Canniere D, 2001, AM HEART J, V142, P563, DOI 10.1067/mhj.2001.118466
   deGuzman BJ, 2004, NEW ENGL J MED, V350, P1791
   Desai Nimesh D, 2004, N Engl J Med, V350, P1791
   Detter C, 2001, EUR J CARDIO-THORAC, V19, P464, DOI 10.1016/S1010-7940(01)00616-9
   Detter C, 2002, ANN THORAC SURG, V74, P497, DOI 10.1016/S0003-4975(02)03734-7
   Dewey Todd M, 2004, N Engl J Med, V350, P1791
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Dogan S, 2002, ANN THORAC SURG, V74, P1537, DOI 10.1016/S0003-4975(02)03947-4
   Dorman BH, 2004, J CARDIOTHOR VASC AN, V18, P25, DOI 10.1053/j.jvca.2003.10.005
   Dusterhoft V, 2001, ANN THORAC SURG, V72, P2038, DOI 10.1016/S0003-4975(01)03047-8
   Egger M, 1997, BRIT MED J, V315, P629
   Falk V, 2000, EUR J CARDIO-THORAC, V17, P38, DOI 10.1016/S1010-7940(99)00356-5
   Farmas A, 2003, HEART SURG FORUM, V6, pS45
   Friedrich GJ, 1997, NEW ENGL J MED, V336, P1454, DOI 10.1056/NEJM199705153362013
   Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Gu YJ, 1998, ANN THORAC SURG, V65, P420
   Guler M, 2001, ANN THORAC SURG, V71, P152, DOI 10.1016/S0003-4975(00)02250-5
   Gulielmos V, 1999, EUR J CARDIO-THORAC, V16, pS34, DOI 10.1016/S1010-7940(99)00266-3
   Gulielmos V, 2000, EUR J CARDIO-THORAC, V18, P594, DOI 10.1016/S1010-7940(00)00553-4
   Hadjinikolaou LK, 1997, ANN THORAC SURG, V63, P1511, DOI 10.1016/S0003-4975(97)82743-9
   Hazama Shiro, 2004, Ann Thorac Cardiovasc Surg, V10, P90
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hirata N, 2000, SURG TODAY, V30, P503
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   JEMIELITY MM, 2003, HEART SURG FORUM S1, V6, pS40
   JOHANSSONSYNNERGRE, 2004, SCAND CARDIOVASC J, V38, P53
   KAPETANAKIS E, 2003, HEART SURG FORUM, V6, pS44
   Keizer AMA, 2003, ANN THORAC SURG, V75, P835, DOI 10.1016/S0003-4975(02)04541-1
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Krejca M, 1999, EUR J CARDIO-THORAC, V16, P337, DOI 10.1016/S1010-7940(99)00234-1
   Laffey JG, 2002, ANESTHESIOLOGY, V97, P215
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Lloyd CT, 2000, J THORAC CARDIOV SUR, V119, P148, DOI 10.1016/S0022-5223(00)70230-3
   Loef BG, 2002, CHEST, V121, P1190, DOI 10.1378/chest.121.4.1190
   Lonn U, 1999, ANN THORAC SURG, V67, P99, DOI 10.1016/S0003-4975(98)01158-8
   Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9
   LUNDELL D, 2003, HEART SURG FORUM, V6, pS45
   MAIR H, 2003, HEART SURG FORUM, V6, pS44
   Martin Janet E, 2003, BMJ, V326, P499
   Massoudy P, 2000, EUR J CARDIO-THORAC, V17, P729, DOI 10.1016/S1010-7940(00)00398-5
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300
   Mehran R, 2001, J AM COLL CARDIOL, V37, p23A
   Menasche P, 2001, ANN THORAC SURG, V72, pS2260, DOI 10.1016/S0003-4975(01)03286-6
   MISHRA YK, 2003, HEART SURG FORUM S1, V6, pS26
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992
   Motallebzadeh R, 2004, EUR J CARDIO-THORAC, V25, P409, DOI 10.1016/j.ejcts.2003.12.018
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Nesher N, 2002, HEART SURG FORUM, V5, P373
   Newman MF, 1996, CIRCULATION, V94, P1174
   Omeroglu SN, 2000, ANN THORAC SURG, V70, P844, DOI 10.1016/S0003-4975(00)01567-8
   OZ M, 2003, HEART SURG FORUM, V6, P115
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   PAUL SR, 1992, STAT MED, V11, P159, DOI 10.1002/sim.4780110203
   Penttila HJ, 2001, ANN THORAC SURG, V71, P565, DOI 10.1016/S0003-4975(00)02002-6
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Prifti E, 2001, CARDIOVASC SURG, V9, P608, DOI 10.1016/S0967-2109(01)00092-8
   PUSKAS J, 2003, HEART SURG FORUM, V6, pS47
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Rose EA, 2003, NEW ENGL J MED, V348, P379, DOI 10.1056/NEJMp020171
   Sahlman A, 2003, SCAND CARDIOVASC J, V37, P211, DOI 10.1080/14017430310001726
   SARKAR K, 2003, HEART SURG FORMU, V6, pS45
   Schulze C, 2000, THORAC CARDIOV SURG, V48, P364, DOI 10.1055/s-2000-8352
   SELLMAN M, 1993, THORAC CARDIOV SURG, V41, P349, DOI 10.1055/s-2007-1013888
   Selvanayagam JB, 2004, CIRCULATION, V109, P345, DOI 10.1161/01.CIR.0000109489.71945.BD
   Sharp SJ, 1996, BRIT MED J, V313, P735
   Shirai K, 2004, AM J CARDIOL, V93, P959, DOI 10.1016/j.amjcard.2003.12.048
   Smith A, 2002, J CARDIOTHOR VASC AN, V16, P413, DOI 10.1053/jcan.2002.125151
   Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22
   Sigwart U, 2002, LANCET, V360, P965
   Stamou SC, 2001, STROKE, V32, P1508
   Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Svedjeholm Rolf, 2004, N Engl J Med, V350, P1791
   Tang ATM, 2002, EUR J CARDIO-THORAC, V22, P118, DOI 10.1016/S1010-7940(02)00220-8
   Alderman EL, 1996, NEW ENGL J MED, V335, P217
   Tramer MR, 1997, BRIT MED J, V315, P635
   Tschernko EM, 2002, J THORAC CARDIOV SUR, V124, P732, DOI 10.1067/mtc.2002.124798
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   van Dijk D, 2004, HEART, V90, P431, DOI 10.1136/hrt.2003.010173
   Vassiliades TA, 2002, ANN THORAC SURG, V74, pS1383
   Velissaris T, 2003, EUR J CARDIO-THORAC, V23, P917, DOI 10.1016/S1010-7940(03)00167-2
   Vural KM, 1995, THORAC CARDIOV SURG, V43, P320, DOI 10.1055/s-2007-1013803
   Wandschneider W, 2000, ANN THORAC SURG, V70, P1577, DOI 10.1016/S0003-4975(00)01843-9
   Wehlin L, 2004, EUR J CARDIO-THORAC, V25, P35, DOI 10.1016/S1010-7940(03)00652-3
   WEST D, 2003, HEART SURG FORUM, V6, pS44
   Wildhirt S M, 2000, Eur J Med Res, V5, P222
   Wildhirt SM, 2001, SHOCK, V16, P55
   WILDHIRT SM, 2000, THORAX GEFASSCHIRUNG, V15, P7
   Yeatman M, 2002, ANN THORAC SURG, V73, P1411, DOI 10.1016/S0003-4975(02)03407-0
   ZAMVAR V, 2003, HEART SURG FORUM S1, V6, pS12
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 134
TC 245
Z9 262
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-3022
J9 ANESTHESIOLOGY
JI Anesthesiology
PD JAN
PY 2005
VL 102
IS 1
BP 188
EP 203
DI 10.1097/00000542-200501000-00028
PG 16
WC Anesthesiology
SC Anesthesiology
GA 885IZ
UT WOS:000226151600027
PM 15618803
ER

PT J
AU Ortner, MEJ
   Caca, K
   Berr, F
   Liebetruth, J
   Mansmann, U
   Huster, D
   Voderholzer, W
   Schachschal, G
   Mossner, J
   Lochs, H
AF Ortner, MEJ
   Caca, K
   Berr, F
   Liebetruth, J
   Mansmann, U
   Huster, D
   Voderholzer, W
   Schachschal, G
   Mossner, J
   Lochs, H
TI Successful photodynamic therapy for nonresectable cholangiocarcinoma: A
   randomized prospective study
SO GASTROENTEROLOGY
LA English
DT Article
ID MALIGNANT BILIARY OBSTRUCTION; QUALITY-OF-LIFE; UNRESECTABLE HILAR
   CHOLANGIOCARCINOMA; ENDOSCOPIC ENDOPROSTHESIS INSERTION; BILE-DUCT
   OBSTRUCTION; PALLIATIVE TREATMENT; PROGNOSTIC-FACTORS; MULTICENTER
   TRIAL; CLINICAL-TRIALS; METALLIC STENT
AB Background & Aims: In nonrandomized trials, photodynamic therapy (PDT) had a promising effect on nonresectable cholanglocarcinoma (NCC). This prospective, open-label, randomized, multicenter study with a group sequential design compared PDT in addition to stenting (group A) with stenting alone (group B) in patients with NCC. Methods: In patients with histologically confirmed cholangiocarcinoma, endoscopic or percutaneous double stenting was performed. Patients fulfilling inclusion criteria were randomized to group A (stenting and subsequent PDT) and group B (stenting alone). For PDT, Photofrin 2 mg/kg body wt was injected intravenously 2 days before intraluminal photoactivation (wavelength, 630 nm; light dose, 180 J/cm(2)). Further treatments were performed in cases of residual tumor in the bile duct. The primary outcome parameter was survival time. Secondary outcome parameters were cholestasis and quality of life. Results: PDT resulted in prolongation of survival (group A: In = 20, median 493 days; group B: n = :19, median 98 days; P < 0.0001). It also improved biliary drainage and quality of life. Conclusions: PDT, given in addition to best supportive care, improves survival in patients with NCC. The study was terminated prematurely because PDT proved to be so superior to simple stenting treatment that further randomization was deemed unethical.
C1 CHU Vaudois, Div Gastroenterol & Hepatol, CH-1011 Lausanne, Switzerland.
   Univ Leipzig, Dept Med 2, Leipzig, Germany.
   St Johann Spital, Landesklin, Dept Med 1, Salzburg, Austria.
   Humboldt Univ, Charite, Fac Med, Dept Surg, Berlin, Germany.
   Humboldt Univ, Charite, Fac Med, Dept Gastroenterol Nephrol Endocrinol Metab & Nut, Berlin, Germany.
   Univ Heidelberg, Inst Biometr & Informat, Heidelberg, Germany.
RP Ortner, MEJ (reprint author), CHU Vaudois, Div Gastroenterol & Hepatol, BH-10N, CH-1011 Lausanne, Switzerland.
EM Maria-Anna.Ortner@hospvd.ch
CR AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365
   Ahrendt S A, 2001, Clin Liver Dis, V5, P191, DOI 10.1016/S1089-3261(05)70161-6
   Berr F, 2000, HEPATOLOGY, V31, P291, DOI 10.1002/hep.510310205
   BHUYA MMR, 1993, WORLD J SURG, V17, P653
   BISMUTH H, 1975, SURG GYNECOL OBSTET, V140, P170
   Blom D, 2001, ARCH SURG-CHICAGO, V136, P209, DOI 10.1001/archsurg.136.2.209
   Born P, 2000, Z GASTROENTEROL, V38, P483, DOI 10.1055/s-2000-14886
   Bowling TE, 1996, GUT, V39, P852, DOI 10.1136/gut.39.6.852
   Brountzos EN, 1999, HEPATO-GASTROENTEROL, V46, P2764
   Burke EC, 1998, ANN SURG, V228, P385, DOI 10.1097/00000658-199809000-00011
   BYRKE V, 2002, CURR TREAT OPTIONS G, V5, P87
   Campbell DA, 2000, AM SURGEON, V66, P714
   Chang WH, 1998, GASTROINTEST ENDOSC, V47, P354, DOI 10.1016/S0016-5107(98)70218-4
   Cheng JLS, 2002, GASTROINTEST ENDOSC, V56, P33, DOI 10.1067/mge.2002.125364
   DAVIDS PH, 1992, LANCET, V34, P1488
   DEVIERE J, 1988, GASTROINTEST ENDOSC, V34, P95, DOI 10.1016/S0016-5107(88)71271-7
   DUCREUX M, 1992, DIGEST DIS SCI, V37, P778, DOI 10.1007/BF01296439
   Dumoulin FL, 2003, GASTROINTEST ENDOSC, V57, P860, DOI 10.1067/mge.2003.250
   England RE, 2000, GUT, V46, P395, DOI 10.1136/gut.46.3.395
   Fayers PM, 1997, LANCET, V350, P1025, DOI 10.1016/S0140-6736(97)03053-5
   Ferlitsch A, 2001, ENDOSCOPY, V33, P645, DOI 10.1055/s-2001-16214
   FINGAR VH, 1990, P SOC PHOTO-OPT INS, V1203, P168, DOI 10.1117/12.17661
   FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x
   Gerhards MF, 2001, EUR J SURG, V167, P274
   Glimelius B, 1996, ANN ONCOL, V7, P593
   Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114
   Havlik R, 2000, HEPATO-GASTROENTEROL, V47, P927
   HENDERSON BW, 1989, CANCER RES, V49, P6869
   Hochwald SN, 1999, ARCH SURG-CHICAGO, V134, P261, DOI 10.1001/archsurg.134.3.261
   Hsi RA, 1999, DRUGS, V57, P725, DOI 10.2165/00003495-199957050-00005
   Jennison C, 2000, GROUP SEQUENTIAL MET
   KARNOFSKY DA, 1948, CANCER, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L
   Johnson SR, 2001, SURGERY, V130, P584, DOI 10.1067/msy.2001.117104
   Klein JP, 1997, SURVIVAL ANAL TECHNI
   Lammer J, 1996, RADIOLOGY, V201, P167
   Liu CL, 1998, ARCH SURG-CHICAGO, V133, P293, DOI 10.1001/archsurg.133.3.293
   MCCAUGHAN JS, 1991, ARCH SURG-CHICAGO, V126, P111
   Miura Y, 2001, J Hepatobiliary Pancreat Surg, V8, P113, DOI 10.1007/s005340170032
   Ortner M A, 2000, Gastrointest Endosc Clin N Am, V10, P481
   Ortner MAEJ, 1998, GASTROENTEROLOGY, V114, P536, DOI 10.1016/S0016-5085(98)70537-2
   Peters RA, 1997, ENDOSCOPY, V29, P10, DOI 10.1055/s-2007-1004054
   PICHLMAYR R, 1996, ANN SURG, V217, P20
   POLYDOROU AA, 1991, GUT, V32, P685, DOI 10.1136/gut.32.6.685
   Prat F, 1998, GASTROINTEST ENDOSC, V47, P1, DOI 10.1016/S0016-5107(98)70291-3
   Prat F, 1998, GUT, V42, P76
   Rumalla A, 2001, GASTROINTEST ENDOSC, V53, P500, DOI 10.1067/mge.2001.113386
   Schmassmann A, 1996, AM J GASTROENTEROL, V91, P654
   Schoder M, 2002, RADIOLOGY, V225, P35, DOI 10.1148/radiol.2251011744
   Shinchi H, 2000, J SURG ONCOL, V75, P89, DOI 10.1002/1096-9098(200010)75:2<89::AID-JSO3>3.0.CO;2-V
   SMITH AC, 1994, LANCET, V344, P1655, DOI 10.1016/S0140-6736(94)90455-3
   Song LMWK, 1998, CANCER, V82, P421, DOI 10.1002/1097-0142(19980115)82:2<421::AID-CNCR25>3.0.CO;2-O
   Terruzzi V, 2000, GASTROINTEST ENDOSC, V51, P23, DOI 10.1016/S0016-5107(00)70381-6
   TSUJINO K, 1995, RADIOLOGY, V196, P275
   van Groeningen CJ, 1999, ANN ONCOL, V10, P305, DOI 10.1023/A:1008361708844
   VAUTHEY JN, 1994, SEMIN LIVER DIS, V14, P109, DOI 10.1055/s-2007-1007302
   WAGNER HJ, 1993, ENDOSCOPY, V25, P213, DOI 10.1055/s-2007-1010295
   Whitehead J, 1997, PLANNING EVALUATION
   Zoepf T, 2001, GASTROINTEST ENDOSC, V54, P763, DOI 10.1067/mge.2001.119605
   Zoepf T, 2001, AM J GASTROENTEROL, V96, P2093, DOI 10.1016/S0002-9270(01)02531-X
   1997, TNM STAGING CRITERIA
NR 60
TC 243
Z9 256
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD NOV
PY 2003
VL 125
IS 5
BP 1355
EP 1363
DI 10.1016/j.gastro.2003.07.015
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 744HF
UT WOS:000186621500012
PM 14598251
ER

PT J
AU Balk, SP
   Ko, YJ
   Bubley, GJ
AF Balk, SP
   Ko, YJ
   Bubley, GJ
TI Biology of prostate-specific antigen
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Review
ID HUMAN GLANDULAR KALLIKREIN-2; DIGITAL RECTAL EXAMINATION;
   ANDROGEN-RESPONSIVE ELEMENT; MULTICENTER CLINICAL-TRIAL; BINDING
   PROTEIN-3 PROTEASE; HORMONE-RELATED PROTEIN; GROWTH-FACTOR-I; RADICAL
   PROSTATECTOMY; CANCER DETECTION; TRANSITION ZONE
AB Prostate-specific antigen (PSA) is an androgen-regulated serine protease produced by both prostate epithelial cells and prostate cancer (PCa) and is the most commonly used serum marker for cancer. It is a member of the tissue kallikrein family, some of the members of which are also prostate specific. PSA is a major protein in semen, where its function is to cleave semenogelins in the seminal coagulum. PSA is secreted into prostatic ducts as an inactive 244-amino acid proenzyme (proPSA) that is activated by cleavage of seven N-terminal amino acids. PSA that enters the circulation intact is rapidly bound by protease inhibitors, primarily alpha 1-antichymotrypsin, although a fraction is inactivated in the lumen by proteolysis and circulates as free PSA. This proteolytic inactivation, as well as the cleavage of proPSA to PSA, is less efficient in PCa. Serum total PSA levels are increased in PCa, and PSA screening has dramatically altered PCa presentation and management. Unfortunately, although high PSA levels are predictive of advanced PCa, a large fraction of organ-confined cancers present with much lower total PSA values that overlap those levels found in men without PCa. Measurement of free versus total PSA can increase specificity for PCa, and tests under development to measure forms of proPSA may further enhance the ability to detect early-stage PCa. PSA is also widely used to monitor responses to therapy and is under investigation as a therapeutic target. Finally, recent data indicate that there may be additional roles for PSA in the pathogenesis of PCa. (C) 2003 by American Society of Clinical Oncology.
C1 Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Biol Program,Hematol Oncol Div, Boston, MA 02215 USA.
RP Balk, SP (reprint author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Biol Program,Hematol Oncol Div, HIM Bldg,Room 1050,330 Brookline Ave, Boston, MA 02215 USA.
CR *AM SOC THER RAD O, 1997, INT J RADIAT ONCOL, V37, P1035
   BENSON MC, 1992, J UROLOGY, V147, P815
   BHOOLA KD, 1992, PHARMACOL REV, V44, P1
   BOSTWICK DG, 1994, AM J CLIN PATHOL, V102, pS31
   BRAWER MK, 1989, AM J CLIN PATHOL, V92, P760
   BRAWER MK, 1992, J UROLOGY, V147, P841
   Bubley GJ, 1996, HEMATOL ONCOL CLIN N, V10, P713, DOI 10.1016/S0889-8588(05)70363-4
   Bubley GJ, 1999, J CLIN ONCOL, V17, P3461
   Bubley GJ, 2002, J UROLOGY, V168, P2249, DOI 10.1097/01.ju.0000031241.95111.4a
   CARTER HB, 1992, CANCER RES, V52, P3323
   Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452
   CATALONA WJ, 1994, J UROLOGY, V152, P2031
   CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702
   Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542
   Catalona WJ, 2000, UROLOGY, V56, P255, DOI 10.1016/S0090-4295(00)00637-3
   CATALONA WJ, 1994, J UROLOGY, V151, P1283
   CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563
   Chen ZX, 1997, J UROLOGY, V157, P2170
   CHRISTENSSON A, 1994, EUR J BIOCHEM, V220, P45, DOI 10.1111/j.1432-1033.1994.tb18597.x
   Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379
   Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148
   COHEN P, 1994, J ENDOCRINOL, V142, P407, DOI 10.1677/joe.0.1420407
   COHEN P, 1992, J CLIN ENDOCR METAB, V75, P1046, DOI 10.1210/jc.75.4.1046
   Connolly JA, 1996, UROLOGY, V47, P225, DOI 10.1016/S0090-4295(99)80421-X
   Cramer SD, 1996, J UROLOGY, V156, P526, DOI 10.1016/S0022-5347(01)65919-6
   Crawford ED, 1999, PROSTATE, V38, P296
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Denmeade SR, 2001, PROSTATE, V48, P1
   Denmeade SR, 1998, CANCER RES, V58, P2537
   Deperthes D, 1997, BBA-PROTEIN STRUCT M, V1343, P102, DOI 10.1016/S0167-4838(97)00135-0
   Djavan B, 1999, UROLOGY, V54, P517, DOI 10.1016/S0090-4295(99)00153-3
   Eder JP, 2000, CLIN CANCER RES, V6, P1632
   Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504
   FONG CJ, 1992, PROSTATE, V21, P121, DOI 10.1002/pros.2990210205
   Fortier AH, 1999, J NATL CANCER I, V91, P1635, DOI 10.1093/jnci/91.19.1635
   GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289
   Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0
   Gotoh A, 1998, J UROLOGY, V160, P220, DOI 10.1016/S0022-5347(01)63094-5
   Gregory CW, 2001, CANCER RES, V61, P4315
   Heidtmann HH, 1999, BRIT J CANCER, V81, P1269, DOI 10.1038/sj.bjc.6692167
   Howarth DJC, 1997, BRIT J CANCER, V75, P1646, DOI 10.1038/bjc.1997.280
   Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756
   HUDSON MA, 1989, J UROLOGY, V142, P1011
   Iwamura M, 1996, UROLOGY, V48, P317, DOI 10.1016/S0090-4295(96)00182-3
   Kadmon D, 1996, J UROLOGY, V155, P1655, DOI 10.1016/S0022-5347(01)66154-8
   Kattan MW, 2000, INT J RADIAT ONCOL, V48, P1469, DOI 10.1016/S0360-3016(00)01359-6
   KELLY WK, 1993, J CLIN ONCOL, V11, P607
   Khan SR, 2000, PROSTATE, V45, P80, DOI 10.1002/1097-0045(20000915)45:1<80::AID-PROS10>3.0.CO;2-Q
   KILLIAN CS, 1993, BIOCHEM BIOPH RES CO, V192, P940, DOI 10.1006/bbrc.1993.1506
   KILLIAN CS, 1985, CANCER RES, V45, P886
   Kumar A, 1997, CANCER RES, V57, P3111
   KURIYAMA M, 1981, CANCER RES, V41, P3874
   LABRIE F, 1992, J UROLOGY, V147, P846
   Latham JPF, 2000, CANCER RES, V60, P334
   LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070
   LILJA H, 1991, CLIN CHEM, V37, P1618
   Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333
   Lovgren J, 1999, J ANDROL, V20, P348
   LUNDWALL A, 1987, FEBS LETT, V214, P317, DOI 10.1016/0014-5793(87)80078-9
   Magklara A, 2000, UROLOGY, V56, P527, DOI 10.1016/S0090-4295(00)00621-X
   Mantzoros CS, 1997, BRIT J CANCER, V76, P1115, DOI 10.1038/bjc.1997.520
   Mikolajczyk SD, 2001, CANCER RES, V61, P6958
   Mikolajczyk SD, 2000, UROLOGY, V55, P41, DOI 10.1016/S0090-4295(99)00372-6
   Mikolajczyk SD, 2000, PROSTATE, V45, P271
   Mikolajczyk SD, 2000, CANCER RES, V60, P756
   Mikolajczyk SD, 1997, UROLOGY, V50, P710, DOI 10.1016/S0090-4295(97)00449-4
   MILLER JI, 1992, J UROLOGY, V147, P956
   Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502
   MURTHA P, 1993, BIOCHEMISTRY-US, V32, P6459, DOI 10.1021/bi00076a020
   Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114
   OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860
   OESTERLING JE, 1993, UROL CLIN N AM, V20, P671
   Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216
   PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5
   Potter SR, 2001, UROLOGY, V57, P1100, DOI 10.1016/S0090-4295(01)00980-3
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   PRETLOW TG, 1991, INT J CANCER, V49, P645, DOI 10.1002/ijc.2910490503
   RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921
   Rodriguez R, 1997, CANCER RES, V57, P2559
   Scher HI, 1999, J NATL CANCER I, V91, P244, DOI 10.1093/jnci/91.3.244
   Schroder FH, 2000, J UROLOGY, V163, P806, DOI 10.1016/S0022-5347(05)67809-3
   Schuur ER, 1996, J BIOL CHEM, V271, P7043
   SEAMAN E, 1993, UROL CLIN N AM, V20, P653
   Papadopoulos I, 2001, CLIN CANCER RES, V7, P1533
   Smith DC, 1998, J CLIN ONCOL, V16, P1835
   STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501
   STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7
   STENMAN UH, 1991, CANCER RES, V51, P222
   Stephan C, 2000, CANCER EPIDEM BIOMAR, V9, P1133
   Sun ZJ, 1997, NUCLEIC ACIDS RES, V25, P3318, DOI 10.1093/nar/25.16.3318
   Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e
   Takayama TK, 1997, J BIOL CHEM, V272, P21582, DOI 10.1074/jbc.272.34.21582
   Taplin ME, 1999, CANCER RES, V59, P2511
   TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101
   Tombal B, 2000, PROSTATE, V43, P303
   VanCangh PJ, 1996, UROLOGY, V48, P67, DOI 10.1016/S0090-4295(96)00613-9
   VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206
   Vashi AR, 1997, UROLOGY, V49, P19, DOI 10.1016/S0090-4295(96)00511-0
   VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401
   WANG MC, 1981, PROSTATE, V2, P89, DOI 10.1002/pros.2990020109
   Wang TJ, 2000, EUR J BIOCHEM, V267, P4040, DOI 10.1046/j.1432-1327.2000.01441.x
   WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166
   Webber MM, 1995, CLIN CANCER RES, V1, P1089
   Yoshida E, 1995, INT J CANCER, V63, P863, DOI 10.1002/ijc.2910630618
   YOUNG CYF, 1992, BIOCHEMISTRY-US, V31, P818, DOI 10.1021/bi00118a026
   Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184
   Yousef GM, 1999, CANCER RES, V59, P4252
   Yousef GM, 1999, ANTICANCER RES, V19, P2843
   Yu DC, 1999, CANCER RES, V59, P4200
   Zhang SB, 1997, BIOCHEM BIOPH RES CO, V231, P784, DOI 10.1006/bbrc.1997.6197
   ZHANG WM, 1995, CLIN CHEM, V41, P1567
   2000, ONCOLOGY HUNTINGT, V14, P267
   2000, ONCOLOGY HUNTINGT, V14, P280
NR 117
TC 243
Z9 260
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 330 JOHN CARLYLE ST, STE 300, ALEXANDRIA, VA 22314 USA
SN 0732-183X
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD JAN 15
PY 2003
VL 21
IS 2
BP 383
EP 391
DI 10.1200/JCO.2003.02.083
PG 9
WC Oncology
SC Oncology
GA 685UG
UT WOS:000183281200028
PM 12525533
ER

PT J
AU Grimm, PD
   Blasko, JC
   Sylvester, JE
   Meier, RM
   Cavanagh, W
AF Grimm, PD
   Blasko, JC
   Sylvester, JE
   Meier, RM
   Cavanagh, W
TI 10-year biochemical (prostate-specific antigen) control of prostate
   cancer with I-125 brachytherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; brachytherapy; prostate-specific antigen; radiotherapy
ID RADICAL PROSTATECTOMY; IMPLANTATION; RADIOTHERAPY; RADIATION; BIOPSIES;
   GRADE
AB Purpose: To report 10-year biochemical (prostate-specific antigen [PSA]) outcomes for patients treated with I-125 brachytherapy as monotherapy for early-stage prostate cancer.
   Methods and Materials: One hundred and twenty-five consecutively treated patients, with clinical Stage T1-T2b prostate cancer were treated with 125I brachytherapy as monotherapy, and followed with PSA determinations. Kaplan-Meier estimates of PSA progression-free survival (PFS), on the basis of a two consecutive elevations of PSA, were calculated. Aggregate PSA response by time interval was assessed. Comparisons were made to an earlier-treated cohort.
   Results: The overall PSA PFS rate achieved at 10 years was 87% for low-risk patients (PSA < 10, Gleason Sum 2-6, T1-T2b). Of 59 patients (47%) followed beyond 7 years, 51 (86%) had serum PSAs less than 0.5 ng/mL; 48 (81%) had serum PSAs less than 0.2 ng/mL. Failures were local , 3.0%; distant, 3.0%. No patients have died of prostate carcinoma. The proportion of patients with a PSA <less than or equal to> 0.2 ng/mL continued to increase until at least 7-8 years posttherapy. A plot of PSA PFS against the proportion of patients achieving serum PSA of less than 0.2 ng/mL suggests a convergence of these two endpoints at 10 years. Patients treated in the era of this study (1988-1990) experienced a statistically improved PFS compared with an earlier era (1986-1987). This difference appears independent of patient selection, suggesting that the maturation of the technique resulted in improved biochemical control.
   Conclusion: With modern technique, monotherapy with 125I achieves a high rate (87%) of biochemical and clinical control in patients with low-risk disease at 10 years. The decline of PSA following brachytherapy with low-dose-rate isotopes can be protracted. Absolute PSA and PFS curves merge, and are comparable at 10 years. (C) 2001 Elsevier Science Inc.
C1 Swedish Med Ctr, Seattle Prostate Inst, Seattle, WA 98104 USA.
   Puget Sound Tumor Inst, Edmonds, WA USA.
RP Grimm, PD (reprint author), Swedish Med Ctr, Seattle Prostate Inst, Suite 1101,1101 Madison St, Seattle, WA 98104 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Beahrs OH, 1992, MANUAL STAGING CANC, P181
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   D'Amico AV, 2000, J CLIN ONCOL, V18, P1164
   Grimm PD, 1994, NEW TECHNIQUES PROST, P113
   Iczkowski KA, 1998, AM J SURG PATHOL, V22, P1169, DOI 10.1097/00000478-199810000-00001
   Ragde H, 2000, CANCER, V89, P135, DOI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
   Steinberg DM, 1997, AM J SURG PATHOL, V21, P566, DOI 10.1097/00000478-199705000-00010
   Zelefsky MJ, 1999, J CLIN ONCOL, V17, P517
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
NR 13
TC 243
Z9 253
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD SEP 1
PY 2001
VL 51
IS 1
BP 31
EP 40
DI 10.1016/S0360-3016(01)01601-7
PG 10
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 468EM
UT WOS:000170745200006
PM 11516848
ER

PT J
AU Lilja, H
   Ulmert, D
   Vickers, AJ
AF Lilja, Hans
   Ulmert, David
   Vickers, Andrew J.
TI Prostate-specific antigen and prostate cancer: prediction, detection and
   monitoring
SO NATURE REVIEWS CANCER
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; EXTERNAL-BEAM RADIOTHERAPY; DIGITAL RECTAL
   EXAMINATION; GLANDULAR KALLIKREIN 2; MULTIINSTITUTIONAL POOLED ANALYSIS;
   BIOCHEMICAL FAILURE DEFINITIONS; MULTICENTER CLINICAL-TRIAL; RADICAL
   PROSTATECTOMY; PROGNOSTIC-SIGNIFICANCE; ENDOCRINE TREATMENT
AB Testing for prostate-specific antigen ( PSA) has profoundly affected the diagnosis and treatment of prostate cancer. PSA testing has enabled physicians to detect prostate tumours while they are still small, low-grade and localized. This very ability has, however, created controversy over whether we are now diagnosing and treating insignificant cancers. PSA testing has also transformed the monitoring of treatment response and detection of disease recurrence. Much current research is directed at establishing the most appropriate uses of PSA testing and at developing methods to improve on the conventional PSA test.
C1 [Lilja, Hans; Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, Dept Urol Surg, Clin Labs, New York, NY 10065 USA.
   [Ulmert, David] Lund Univ, Univ Hosp UMAS, Dept Lab Med, S-20502 Malmo, Sweden.
RP Lilja, H (reprint author), Mem Sloan Kettering Canc Ctr, Dept Urol Surg, Clin Labs, New York, NY 10065 USA.
EM liljah@mskcc.org
CR Ahlgren G, 1995, J ANDROL, V16, P491
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Andriole GL, 2005, J NATL CANCER I, V97, P433, DOI 10.1093/jnci/dji065
   ARAI Y, 1990, J UROLOGY, V144, P1415
   Armstrong AJ, 2007, J CLIN ONCOL, V25, P3965, DOI 10.1200/JCO.2007.11.4769
   Aus G, 2005, ARCH INTERN MED, V165, P1857, DOI 10.1001/archinte.165.16.1857
   Aus G, 2007, EUR UROL, V51, P659, DOI 10.1016/j.eururo.2006.07.012
   Becker C, 2003, J UROLOGY, V170, P1169, DOI 10.1097/01.ju.0000086640.19892.0b
   Benaim EA, 2002, UROLOGY, V59, P73, DOI 10.1016/S0090-4295(01)01440-6
   Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739
   Bjork T, 1998, UROLOGY, V51, P57, DOI 10.1016/S0090-4295(97)00572-4
   Borer JG, 1998, J UROLOGY, V159, P444, DOI 10.1016/S0022-5347(01)63945-4
   CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215
   Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542
   Catalona WJ, 2003, J UROLOGY, V170, P2181, DOI 10.1097/01.ju.0000095460.12999.43
   Catalona WJ, 2000, UROLOGY, V55, P372, DOI 10.1016/S0090-4295(99)00547-6
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   CHRISTENSSON A, 1993, J UROLOGY, V150, P100
   CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x
   Ciatto S, 2006, EUR J CANCER, V42, P1858, DOI 10.1016/j.ejca.2006.01.060
   Coldman AJ, 2003, CAN MED ASSOC J, V168, P31
   Concato J, 2006, ARCH INTERN MED, V166, P38, DOI 10.1001/archinte.166.1.38
   Crawford ED, 1996, UROLOGY, V47, P863
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   Crook J, 2007, INT J RADIAT ONCOL, V69, P426, DOI 10.1016/j.ijrobp.2007.03.031
   D'Amico AV, 2006, INT J RADIAT ONCOL, V65, P656, DOI 10.1016/j.ijrobp.2006.01.053
   D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975
   D'Amico AV, 2005, JAMA-J AM MED ASSOC, V294, P440, DOI 10.1001/jama.294.4.440
   D'Amico AV, 2007, LANCET ONCOL, V8, P21, DOI 10.1016/S1470-2045(06)70981-0
   Denmeade SR, 2003, J NATL CANCER I, V95, P990
   Diamandis EP, 1997, UROL CLIN N AM, V24, P275, DOI 10.1016/S0094-0143(05)70373-6
   Donovan J, 2003, Health Technol Assess, V7, P1
   Fang JY, 2001, UROLOGY, V58, P411, DOI 10.1016/S0090-4295(01)01304-8
   Finne P, 2000, J UROLOGY, V164, P1956, DOI 10.1016/S0022-5347(05)66927-3
   Fowler JE, 1999, UROLOGY, V53, P1175, DOI 10.1016/S0090-4295(99)00006-0
   Furuya Y, 2003, UROL INT, V70, P195, DOI 10.1159/000068769
   Furuya Y., 2001, International Urology and Nephrology, V32, P659, DOI 10.1023/A:1014410026495
   GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289
   Grossklaus DJ, 2002, UROL ONCOL, V7, P195, DOI 10.1016/S1078-1439(02)00190-4
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Hanlon AL, 1998, CANCER, V83, P130, DOI 10.1002/(SICI)1097-0142(19980701)83:1<130::AID-CNCR17>3.3.CO;2-M
   Herrala AM, 2001, CANCER, V92, P2975, DOI 10.1002/1097-0142(20011215)92:12<2975::AID-CNCR10113>3.0.CO;2-K
   Hoedemaeker RF, 2001, J NATL CANCER I, V93, P1153, DOI 10.1093/jnci/93.15.1153
   Horwitz EM, 2006, CANCER, V107, P1496, DOI 10.1002/cncr.22183
   Horwitz EM, 2005, J UROLOGY, V173, P797, DOI 10.1097/01.ju.0000152556.53602.64
   Hugosson J, 2004, CANCER, V100, P1397, DOI 10.1002/cncr.20126
   Jemal A, 2007, CA-CANCER J CLIN, V57, P43
   Karazanashvili G, 2003, J UROLOGY, V169, P445, DOI 10.1097/01.ju.0000047085.42539.1c
   Kopec JA, 2005, J UROLOGY, V174, P495, DOI 10.1097/01.ju.0000165153.83698.42
   Kuban DA, 2006, INT J RADIAT ONCOL, V65, P1487, DOI 10.1016/j.ijrobp.2006.03.027
   Kupelian P, 2005, INT J RADIAT ONCOL, V61, P415, DOI 10.1016/j.ijrobp.2004.05.018
   Kwak C, 2002, J UROLOGY, V168, P995, DOI 10.1097/01.ju.0000024925.67014.21
   Labrie F, 2004, PROSTATE, V59, P311, DOI 10.1002/pros.20017
   Lane JA, 2007, BRIT MED J, V335, P1139, DOI 10.1136/bmj.39381.436829.BE
   Leibovici D, 2007, CANCER, V109, P198, DOI 10.1002/cncr.22372
   Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351
   LILJA H, 1999, J UROLOGY, V162, P2034
   LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185
   LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070
   Lilja H, 1999, J UROLOGY, V162, P2029, DOI 10.1016/S0022-5347(05)68093-7
   LILJA H, 1991, CLIN CHEM, V37, P1618
   Lintula S, 2005, PROSTATE, V63, P324, DOI 10.1002/pros.20194
   Loeb S, 2006, UROLOGY, V67, P316, DOI 10.1016/j.urology.2005.08.040
   Lundwall A, 2006, BIOL CHEM, V387, P243, DOI 10.1515/BC.2006.032
   Lu-Yao G, 2002, BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740
   Marks LS, 2006, J UROLOGY, V176, P868, DOI 10.1016/j.juro.2006.04.024
   MATZKIN H, 1992, CANCER, V70, P2302, DOI 10.1002/1097-0142(19921101)70:9<2302::AID-CNCR2820700915>3.0.CO;2-2
   Mettlin CJ, 1996, CANCER, V77, P2162
   Mikolajczyk SD, 2004, CLIN CHEM, V50, P1017, DOI 10.1373/clinchem.2003.026823
   Mikolajczyk SD, 2000, CANCER RES, V60, P756
   MILLER JI, 1992, J UROLOGY, V147, P956
   Miller N, 2005, CANCER, V103, P2499, DOI 10.1002/cncr.21077
   Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502
   Morote J, 2004, INT J CANCER, V108, P877, DOI 10.1002/ijc.11639
   Morote J, 2002, EUR UROL, V42, P333, DOI 10.1016/S0302-2838(02)00318-4
   MOUL JW, 1995, JAMA-J AM MED ASSOC, V274, P1277, DOI 10.1001/jama.274.16.1277
   Niemela P, 2002, CLIN CHEM, V48, P1257
   Nishio R., 2003, International Urology and Nephrology, V35, P189, DOI 10.1023/B:UROL.0000020306.08275.49
   Nurmikko P, 2001, CLIN CHEM, V47, P1415
   Oberaigner W, 2006, AM J EPIDEMIOL, V164, P376, DOI 10.1093/aje/kwj213
   OESTERLING JE, 1995, J UROLOGY, V154, P1090, DOI 10.1016/S0022-5347(01)66984-2
   OHORI M, 1995, UROLOGY, V46, P666, DOI 10.1016/S0090-4295(99)80298-2
   Oliver S, 2000, LANCET, V355, P1788, DOI 10.1016/S0140-6736(00)02269-8
   Olsson AY, 2004, GENOMICS, V84, P147, DOI 10.1016/j.ygeno.2004.01.009
   Patel C, 2004, UROLOGY, V63, P110, DOI 10.1016/j.urology.2003.08.025
   Peter J, 2001, CANCER RES, V61, P957
   Piironen T, 2001, CLIN CHEM, V47, P703
   Pinsky PF, 2007, CANCER, V109, P1689, DOI 10.1002/cncr.22558
   Postma R, 2007, EUR UROL, V52, P89, DOI 10.1016/j.eururo.2007.01.030
   QIU SD, 1990, J UROLOGY, V144, P1550
   Raaijmakers R, 2007, EUR UROL, V52, P1358, DOI 10.1016/j.eururo.2007.04.037
   Ray ME, 2006, INT J RADIAT ONCOL, V64, P1140, DOI 10.1016/j.ijrobp.2005.07.006
   Reed D, 2003, UROLOGY, V62, P683, DOI 10.1016/S0090-4295(03)00505-3
   Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029
   Roddam AW, 2005, EUR UROL, V48, P386, DOI 10.1016/j.eururo.2005.04.015
   RODDAM AW, 2005, EUR UROL, V48, P398
   Roehl KA, 2006, UROL ONCOL-SEMIN ORI, V24, P465, DOI 10.1016/j.urolonc.2005.11.039
   Rosser CJ, 2005, UROLOGY, V66, P327, DOI 10.1016/j.urology.2005.02.026
   Ryan CJ, 2006, UROLOGY, V68, P834, DOI 10.1016/j.urology.2006.04.016
   Sakr WA, 1996, EUR UROL, V30, P138
   Sandblom G, 2004, EUR UROL, V46, P717, DOI 10.1016/j.eururo.2004.08.011
   Savblom C, 2005, PROSTATE, V65, P66, DOI 10.1002/pros.20254
   Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777
   Shaw PA, 2004, AM J EPIDEMIOL, V160, P1059, DOI 10.1093/aje/kwh336
   Shibata A, 2001, J NATL CANCER I, V93, P1109, DOI 10.1093/jnci/93.14.1109
   SLAWIN K, 2005, REV UROLOGY, V7, P52
   STAMEY TA, 1989, J UROLOGY, V141, P1088
   STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501
   Stanford J. L., 1999, PROSTATE CANC TRENDS
   STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7
   STENMAN UH, 1991, CANCER RES, V51, P222
   Stephan C, 1997, CANCER, V79, P104, DOI 10.1002/(SICI)1097-0142(19970101)79:1<104::AID-CNCR15>3.0.CO;2-8
   Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756
   Steuber T, 2005, PROSTATE, V63, P13, DOI 10.1002/pros.20156
   Steuber T, 2007, CLIN CHEM, V53, P233, DOI 10.1373/clinchem.2006.074963
   TELESCA D, 2007, BIOMETRICS      0514
   Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X
   Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918
   Thompson IM, 2006, J NATL CANCER I, V98, P1128, DOI 10.1093/jnci/djj307
   Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131
   Thompson IM, 2007, J CLIN ONCOL, V25, P3076, DOI 10.1200/JCO.2006.07.6836
   Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66
   Toledano A, 2006, BRACHYTHERAPY, V5, P122, DOI 10.1016/j.brachy.2006.02.003
   Ulmert D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-6
   Ulmert D, 2006, CLIN CHEM, V52, P235, DOI 10.1373/clinchem.2005.050641
   Ulmert D, 2008, J CLIN ONCOL, V26, P835, DOI 10.1200/JCO.2007.13.1490
   Ung JO, 2002, UROLOGY, V60, P458, DOI 10.1016/S0090-4295(02)01814-9
   Vaisanen V, 2006, ANAL CHEM, V78, P7809, DOI 10.1021/ac061201+
   van der Cruijsen-Koeter IW, 2005, J UROLOGY, V174, P121, DOI 10.1097/01.ju.0000162061.40533.0f
   Verhamme KMC, 2002, EUR UROL, V42, P323, DOI 10.1016/S0302-2838(02)00354-8
   Vickers AJ, 2007, INT J CANCER, V121, P2212, DOI 10.1002/ijc.22956
   Weinmann S, 2005, EPIDEMIOLOGY, V16, P367, DOI 10.1097/01.ede.0000158395.05136.02
   ZANETTI G, 1992, EUR UROL, V21, P96
   Zhang WM, 1998, CLIN CHEM, V44, P2471
NR 134
TC 241
Z9 246
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-175X
J9 NAT REV CANCER
JI Nat. Rev. Cancer
PD APR
PY 2008
VL 8
IS 4
BP 268
EP 278
DI 10.1038/nrc2351
PG 11
WC Oncology
SC Oncology
GA 276IC
UT WOS:000254133500015
PM 18337732
ER

PT J
AU Warnes, CA
   Williams, RG
   Bashore, TM
   Child, JS
   Connolly, HM
   Dearani, JA
   del Nido, P
   Fasules, JW
   Graham, TP
   Hijazi, ZM
   Hunt, SA
   King, ME
   Landzberg, MJ
   Miner, PD
   Radford, MJ
   Walsh, EP
   Webb, GD
AF Warnes, Carole A.
   Williams, Roberta G.
   Bashore, Thomas M.
   Child, John S.
   Connolly, Heidi M.
   Dearani, Joseph A.
   del Nido, Pedro
   Fasules, James W.
   Graham, Thomas P., Jr.
   Hijazi, Ziyad M.
   Hunt, Sharon A.
   King, Mary Etta
   Landzberg, Michael J.
   Miner, Pamela D.
   Radford, Martha J.
   Walsh, Edward P.
   Webb, Gary D.
CA Writing Comm Members
TI ACC/AHA 2008 Guidelines for the Management of Adults With Congenital
   Heart Disease
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Review
ID PATENT DUCTUS-ARTERIOSUS; ATRIAL SEPTAL-DEFECT; LEFT CORONARY-ARTERY;
   BICUSPID AORTIC-VALVE; TERM-FOLLOW-UP; RADIOFREQUENCY CATHETER ABLATION;
   MYOCARDIAL PERFORMANCE INDEX; QUALITY-OF-LIFE; INTRAATRIAL REENTRANT
   TACHYCARDIA; BALLOON PULMONARY VALVULOPLASTY
CR Abhaichand R, 2002, CATHETER CARDIO INTE, V56, P278, DOI 10.1002/ccd.10162
   Aboulhosn J, 2006, CIRCULATION, V114, P2412, DOI 10.1161/CIRCULATIONAHA.105.592089
   *ACC AHA TASK FORC, 2006, MAN ACC AHA GUID WRI
   ADDONIZIO LJ, 1987, CIRCULATION, V76, P52
   Agnoletti G, 2004, CIRCULATION, V109, P2314, DOI 10.1161/01.CIR.0000129273.50975.F4
   Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913
   Alexander ME, 2004, J CARDIOVASC ELECTR, V15, P72, DOI 10.1046/j.1540-8167.2004.03388.x
   Alexander ME, 1999, J CARDIOVASC ELECTR, V10, P1033, DOI 10.1111/j.1540-8167.1999.tb00274.x
   ALLWORK SP, 1976, AM J CARDIOL, V38, P910, DOI 10.1016/0002-9149(76)90804-3
   Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9
   Ammash NM, 1999, J AM COLL CARDIOL, V33, P222, DOI 10.1016/S0735-1097(98)00554-3
   Ammash NM, 1997, AM HEART J, V134, P508, DOI 10.1016/S0002-8703(97)70088-7
   Anand N, 2006, EUR HEART J, V27, P2069, DOI 10.1093/eurheartj/ehl080
   Ananthasubramaniam K, 2001, J AM SOC ECHOCARDIOG, V14, P321, DOI 10.1067/mje.2001.109684
   ANDERSON RH, 1974, CIRCULATION, V50, P911
   ANDERSON RH, 1978, THORAX, V33, P825, DOI 10.1136/thx.33.6.825
   ANDERSON RH, 1991, J PERINAT MED S, V1, P201
   Anderson RH, 2005, CARDIOL YOUNG, V15, P1, DOI 10.1017/S1047951105000016
   Angelini Paolo, 2003, J Invasive Cardiol, V15, P507
   Angelini P, 2007, CIRCULATION, V115, P1296, DOI 10.1161/CIRCULATIONAHA.106.618082
   Angelini P, 2002, CIRCULATION, V105, P2449, DOI 10.1161/01.CIR.0000016175.49835.57
   Arai N, 2001, J AM SOC ECHOCARDIOG, V14, P650, DOI 10.1067/mje.2001.110782
   Armsby LR, 2002, J AM COLL CARDIOL, V39, P1026, DOI 10.1016/S0735-1097(02)01742-4
   Arora R, 2001, J Interv Cardiol, V14, P255, DOI 10.1111/j.1540-8183.2001.tb00744.x
   ARORA R, 1994, AM HEART J, V128, P539, DOI 10.1016/0002-8703(94)90629-7
   ARVIDSSON H, 1961, ACTA RADIOL, V56, P466
   Ashrafian H, 2007, HEART, V93, P5, DOI 10.1136/hrt.2006.103689
   AWADALLAH SM, 1991, AM J CARDIOL, V68, P90, DOI 10.1016/0002-9149(91)90717-Y
   BAER PE, 1984, J AM ACAD CHILD PSY, V23, P622, DOI 10.1016/S0002-7138(09)60356-3
   Balaji S, 1997, AM J CARDIOL, V80, P160
   BALLESTER M, 1983, EUR HEART J, V4, P472
   Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   BASSON CT, 1995, CIRCULATION, V91, P1326
   Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30
   Batista R J, 1997, Arq Bras Cardiol, V68, P279
   Bauer M, 2002, ANN THORAC SURG, V74, P58, DOI 10.1016/S0003-4975(02)03650-0
   Bayer AS, 1998, CIRCULATION, V98, P2936
   BAYER AS, 1994, AM J MED, V96, P211, DOI 10.1016/0002-9343(94)90144-9
   Beauchesne LM, 2002, J AM COLL CARDIOL, V40, P285, DOI 10.1016/S0735-1097(02)01952-6
   Beauchesne LM, 2001, J AM COLL CARDIOL, V38, P1728, DOI 10.1016/S0735-1097(01)01617-5
   Beauchesne LM, 2005, J AM COLL CARDIOL, V45, P595, DOI 10.1016/j.jacc.2004.10.056
   Bekeredjian R, 2005, CIRCULATION, V112, P125, DOI 10.1161/CIRCULATIONAHA.104.488825
   Beller CJ, 2004, CIRCULATION, V109, P763, DOI 10.1161/01.CIR.0000112569.27151.F7
   Beller George A, 2008, J Am Coll Cardiol, V51, P335, DOI 10.1016/j.jacc.2007.11.008
   Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6
   Bellinger DC, 2003, HEART, V89, P365, DOI 10.1136/heart.89.4.365
   BENSHACHAR G, 1985, J AM COLL CARDIOL, V5, P754
   Benson DW, 1998, CIRCULATION, V97, P2043
   BEPPU S, 1993, AM J CARDIOL, V71, P322, DOI 10.1016/0002-9149(93)90799-I
   Berul CI, 1997, J CARDIOVASC ELECTR, V8, P1349, DOI 10.1111/j.1540-8167.1997.tb01031.x
   BHARATI S, 1978, AM J CARDIOL, V42, P147, DOI 10.1016/0002-9149(78)91000-7
   Biliciler-Denktas G, 2001, J THORAC CARDIOV SUR, V122, P234, DOI 10.1067/mtc.2001.115241
   Bilkis AA, 2001, J AM COLL CARDIOL, V37, P258, DOI 10.1016/S0735-1097(00)01094-9
   BIZARRO RO, 1970, CIRCULATION, V41, P677
   Blaustein Alvin S., 1996, Cardiology Clinics, V14, P393, DOI 10.1016/S0733-8651(05)70292-7
   BOGERS AJJC, 1988, J CARDIOVASC SURG, V29, P339
   Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F
   Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3
   Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   BONHOEFFER P, 1993, INT J CARDIOL, V39, P181, DOI 10.1016/0167-5273(93)90036-G
   Bonow RO, 2006, J AM COLL CARDIOL, V48, pe1, DOI DOI 10.1016/J.JACC.2006.05.021
   BOWYER JJ, 1986, BRIT HEART J, V55, P385
   Boxt Lawrence M., 2003, Cardiology Clinics, V21, P561, DOI 10.1016/S0733-8651(03)00093-6
   Boxt LM, 2004, J MAGN RESON IMAGING, V19, P827, DOI 10.1002/jmri.20077
   BRANDHAGEN DJ, 1991, MAYO CLIN PROC, V66, P474
   Brauner R, 1997, J AM COLL CARDIOL, V30, P1835, DOI 10.1016/S0735-1097(97)00410-5
   Brickner ME, 2000, NEW ENGL J MED, V342, P334, DOI 10.1056/NEJM200002033420507
   Bromberg JI, 2003, HEART LUNG, V32, P105, DOI 10.1067/mhl.2003.26
   BROWN AK, 1984, AM J CARDIOL, V54, P1170, DOI 10.1016/S0002-9149(84)80184-8
   Buckberg GD, 2004, CIRCULATION, V110, pE333, DOI 10.1161/01.CIR.0000143625.56882.5C
   BURTON ME, 1993, PACE, V16, P2319, DOI 10.1111/j.1540-8159.1993.tb02340.x
   CALDWELL RL, 1971, AM J DIS CHILD, V122, P312
   Canobbio MM, 2004, NURS CLIN N AM, V39, pXIII, DOI 10.1016/j.cnur.2004.08.005
   Canobbio M M, 2001, J Pediatr Nurs, V16, P363, DOI 10.1053/jpdn.2001.26570
   Canobbio MM, 1996, J AM COLL CARDIOL, V28, P763, DOI 10.1016/0735-1097(96)00234-3
   Cantor WJ, 1999, AM J CARDIOL, V84, P677, DOI 10.1016/S0002-9149(99)00415-4
   Carrel T, 2000, THORAC CARDIOV SURG, V48, P224, DOI 10.1055/s-2000-6894
   Carr-White Gerald S., 2001, Circulation, V104, pI, DOI 10.1161/hc37t1.094545
   CECCHIN F, 1995, AM J CARDIOL, V76, P386, DOI 10.1016/S0002-9149(99)80106-4
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V23, P170
   CELERMAJER DS, 1991, MED J AUSTRALIA, V155, P233
   CELERMAJER DS, 1993, BRIT HEART J, V69, P539
   CELERMAJER DS, 1992, J AM COLL CARDIOL, V19, P1041
   CETTA F, 1995, MAYO CLIN PROC, V70, P50
   Chan KL, 2001, AM J CARDIOL, V88, P690, DOI 10.1016/S0002-9149(01)01820-3
   Chan KL, 2003, J AM COLL CARDIOL, V42, P775, DOI 10.1016/S0735-1097(03)00829-5
   Chan KL, 2002, CAN MED ASSOC J, V167, P19
   CHANDAR JS, 1990, AM J CARDIOL, V65, P655, DOI 10.1016/0002-9149(90)91047-A
   CHANDRASHEKHAR YS, 1990, AM HEART J, V120, P1234, DOI 10.1016/0002-8703(90)90147-P
   Cheatham JP, 1998, CATHETER CARDIO DIAG, V45, P162, DOI 10.1002/(SICI)1097-0304(199810)45:2<162::AID-CCD13>3.0.CO;2-N
   Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9
   CHEN JTT, 1969, AMER J ROENTGENOL RA, V107, P343
   CHESLER ELLIOT, 1968, AMER J CARDIOL, V21, P661, DOI 10.1016/0002-9149(68)90263-4
   Chetaille P, 2004, HEART RHYTHM, V1, P168, DOI 10.1016/j.hrthm.2004.03.064
   CHILD JS, 1998, CONGENITAL HEART DIS, P91
   Child JS, 2001, J AM COLL CARDIOL, V37, P1183, DOI 10.1016/S0735-1097(01)01276-1
   CHILD JS, 2002, PRACTICE CLIN ECHOCA, P901
   CHILD JS, 1998, CONGENITAL HEART DIS, P129
   CHILD J S, 1990, Cardiology Clinics, V8, P289
   Choong CK, 2004, J THORAC CARDIOV SUR, V127, P1323, DOI 10.1016/j.jtcvs.2003.11.046
   CHOU TC, 1996, ELECTROCARDIOGRAPHY, P296
   Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F
   Cilliers AM, 2002, HEART, V88, P335, DOI 10.1136/heart.88.4.335
   Coady MA, 1999, ANN THORAC SURG, V67, P1922, DOI 10.1016/S0003-4975(99)00431-2
   COHEN M, 1989, CIRCULATION, V80, P840
   Collins KK, 2000, AM J CARDIOL, V86, P969, DOI 10.1016/S0002-9149(00)01132-2
   Connelly MS, 1996, J AM COLL CARDIOL, V27, P1238, DOI 10.1016/0735-1097(95)00567-6
   Connolly HM, 1999, J AM COLL CARDIOL, V33, P1692, DOI 10.1016/S0735-1097(99)00046-7
   CONNOLLY HM, 1994, J AM COLL CARDIOL, V23, P1194
   Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202
   CORMODE EJ, 1986, AM J MED GENET, V24, P289, DOI 10.1002/ajmg.1320240209
   Corno AF, 2004, ANN THORAC SURG, V78, P1382, DOI 10.1016/j.athorscsur.2004.02.095
   Costello JM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e67
   Coutu M, 2004, ANN THORAC SURG, V77, P1454, DOI 10.1016/S0003-4975(03)01001-4
   CRAIG RJ, 1968, CIRCULATION, V37, P805
   Crossland DS, 2004, EUR J CARDIO-THORAC, V25, P931, DOI 10.1016/j.ejcts.2004.01.040
   Culbert EL, 2003, CIRCULATION, V108, P857, DOI 10.1161/01.CIR.0000084547.93252.9A
   CULLEN S, 1994, J AM COLL CARDIOL, V23, P1151
   CUMMING G, 2003, DIAGNOSIS MANAGEMENT, P151
   DABIZZI RP, 1988, J AM COLL CARDIOL, V12, P486
   Dajani AS, 1997, CIRCULATION, V96, P358
   Daliento L, 1999, HEART, V81, P650
   Daliento L, 1998, EUR HEART J, V19, P1845, DOI 10.1053/euhj.1998.1046
   DAS SK, 1964, CIRCULATION, V30, P429
   Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   Davos CH, 2003, CIRCULATION, V108, P180, DOI 10.1161/01.cir.0000087946.47069.cb
   Davos CH, 2002, CIRCULATION
   Deanfield J, 2003, EUR HEART J, V24, P1035, DOI 10.1016/S0195-668X(03)00131-3
   DEANFIELD JE, 1983, CIRCULATION, V67, P626
   Delacretaz E, 2001, J AM COLL CARDIOL, V37, P1665, DOI 10.1016/S0735-1097(01)01192-5
   Delahaye F, 1999, J AM COLL CARDIOL, V33, P788, DOI 10.1016/S0735-1097(98)00624-X
   DELEVAL MR, 1988, J THORAC CARDIOV SUR, V96, P682
   DEMASO DR, 1991, J PEDIATR PSYCHOL, V16, P137, DOI 10.1093/jpepsy/16.2.137
   de Sa M, 1999, J THORAC CARDIOV SUR, V118, P588, DOI 10.1016/S0022-5223(99)70002-4
   Dhillon R, 1999, HEART, V82, P559
   Di Filippo S, 2006, HEART, V92, P1490, DOI 10.1136/hrt.2005.085332
   Dittrich S, 2000, ANN THORAC SURG, V70, P717, DOI 10.1016/S0003-4975(00)01532-0
   Dodge-Khatami A, 2002, ANN THORAC SURG, V74, P946, DOI 10.1016/S0003-4975(02)03633-0
   Dodo Hidemi, 1996, Cardiology Clinics, V14, P383, DOI 10.1016/S0733-8651(05)70291-5
   Dodo H, 1998, AM HEART J, V136, P109, DOI 10.1016/S0002-8703(98)70190-5
   Dogan OF, 2006, HEART SURG FORUM, V9, pE668, DOI 10.1532/HSF98.2005-1022
   Doorey AJ, 2000, AM J CARDIOL, V86, P580, DOI 10.1016/S0002-9149(00)01023-7
   DORE A, 2003, DIAGNOSIS MANAGEMENT, P299
   Dore A, 2005, CIRCULATION, V112, P2411, DOI 10.1161/CIRCULATIONAHA.105.543470
   Dore A, 2004, PACE, V27, P47, DOI 10.1111/j.1540-8159.2004.00384.x
   DOTY DB, 1982, CIRCULATION, V66, P186
   DOWNAR E, 1992, J AM COLL CARDIOL, V20, P648
   Drinkwater Davis C. Jr., 1996, Cardiology Clinics, V14, P451, DOI 10.1016/S0733-8651(05)70295-2
   DRISCOLL DJ, 1988, J AM COLL CARDIOL, V11, P831
   DRISCOLL DJ, 1992, CIRCULATION, V85, P469
   DRISCOLL DJ, 1993, CIRCULATION, V87, P114
   Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4
   Du ZD, 1998, CARDIOL YOUNG, V8, P500
   DUA R, 1993, J CARDIAC SURG, V8, P384, DOI 10.1111/j.1540-8191.1993.tb00380.x
   DUNNIGAN A, 1984, BRIT HEART J, V52, P198
   DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0
   Earing MG, 2005, MAYO CLIN PROC, V80, P871
   Ebenroth ES, 2000, AM J CARDIOL, V85, P127, DOI 10.1016/S0002-9149(99)00625-6
   Eidem BW, 2000, AM J CARDIOL, V86, P654, DOI 10.1016/S0002-9149(00)01047-X
   Eidem BW, 1998, J AM SOC ECHOCARDIOG, V11, P849, DOI 10.1016/S0894-7317(98)70004-5
   Elkayam U, 2005, J AM COLL CARDIOL, V46, P223, DOI 10.1016/j.jacc.2005.02.085
   Epstein Andrew E, 2008, J Am Coll Cardiol, V51, pe1, DOI 10.1016/j.jacc.2008.02.032
   EUSTACE S, 1994, CLIN RADIOL, V49, P690, DOI 10.1016/S0009-9260(05)82661-3
   Faella HJ, 2000, CATHETER CARDIO INTE, V51, P50, DOI 10.1002/1522-726X(200009)51:1<50::AID-CCD11>3.0.CO;2-6
   Famuyide AO, 2008, MAYO CLIN PROC, V83, P431, DOI 10.4065/83.4.431
   Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8
   Fedoruk LM, 2007, J THORAC CARDIOV SUR, V133, P456, DOI 10.1016/j.jtcvs.2006.10.011
   Feinstein JA, 2001, CIRCULATION, V103, P10
   FELTES TF, 1994, J AM COLL CARDIOL, V24, P1365
   Fernandes SM, 2003, AM J CARDIOL, V91, P632, DOI 10.1016/S0002-9149(02)03328-3
   Fernandes SM, 2004, PEDIATR CLIN N AM, V51, P1739, DOI 10.1016/j.pcl.2004.07.006
   Ferrieri P, 2002, CIRCULATION, V105, P2115, DOI 10.1161/01.CIR.0000013073.22415.90
   Fiane AE, 1996, J HEART VALVE DIS, V5, P337
   FINLEY JP, 1978, AM J CARDIOL, V42, P675, DOI 10.1016/0002-9149(78)90640-9
   Fischer G, 2003, HEART, V89, P199, DOI 10.1136/heart.89.2.199
   Fishberger SB, 1997, J THORAC CARDIOV SUR, V113, P80, DOI 10.1016/S0022-5223(97)70402-1
   FISHER RG, 1986, J AM COLL CARDIOL, V8, P280
   FLANAGAN MF, 1991, AM J CARDIOL, V68, P403, DOI 10.1016/0002-9149(91)90842-9
   FLINN CJ, 1984, NEW ENGL J MED, V310, P1635, DOI 10.1056/NEJM198406213102504
   FOGEL MA, 1995, CIRCULATION, V92, P219
   Fogel MA, 1998, CIRCULATION, V98, P330
   FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240
   Forbess JM, 2002, CIRCULATION S1, V106, pI
   Formigari R, 2003, J THORAC CARDIOV SUR, V126, P1753, DOI 10.1016/S0022-5223(03)01325-4
   Foster E, 2001, J AM COLL CARDIOL, V37, P1176, DOI 10.1016/S0735-1097(01)01277-3
   FOWLER VG, 1994, CURR OPIN CARDIOL, V9, P389, DOI 10.1097/00001573-199405000-00018
   FRAKER TD, 1979, CIRCULATION, V59, P379
   Franco-Paredes C, 2002, AM J MED, V112, P590, DOI 10.1016/S0002-9343(02)01038-0
   Fredriksen PM, 2000, CARDIOL YOUNG, V10, P107
   Fredriksen PM, 2001, AM J CARDIOL, V87, P310, DOI 10.1016/S0002-9149(00)01364-3
   Fredriksen PM, 2002, CARDIOL YOUNG, V12, P554, DOI 10.1017/S1047951102001002
   Fredriksen PM, 2001, HEART, V85, P191, DOI 10.1136/heart.85.2.191
   Fredriksen PM, 2001, HEART, V85, P295, DOI 10.1136/heart.85.3.295
   FREED MD, 1984, J AM COLL CARDIOL, V4, P333
   FREEDOM RM, 2004, NATURAL MODIFIED HIS, P232
   FREEDOM RM, 2003, DIAGNOSIS MANAGEMENT, P85
   FREIJ BJ, 1988, CLIN PERINATOL, V15, P247
   FRIEDBER.DZ, 1970, NEW ENGL J MED, V282, P1053, DOI 10.1056/NEJM197005072821901
   Frommelt PC, 2003, J AM COLL CARDIOL, V42, P148, DOI 10.1016/S0735-1097(03)00503-5
   FRYNS JP, 1992, ANN GENET-PARIS, V35, P186
   Fuster V, 1980, Cardiovasc Clin, V10, P161
   Galie N, 2002, J AM COLL CARDIOL, V39, P1496, DOI 10.1016/S0735-1097(02)01786-2
   Galie N, 2006, CIRCULATION, V114, P48, DOI 10.1161/CIRCULATIONAHA.106.630715
   GALIE N, 2006, PULMONARY ARTERIAL H, P11
   Gamba A, 2004, J THORAC CARDIOV SUR, V127, P555, DOI 10.1016/j.jtcvs.2003.08.016
   Gandhi SK, 2002, ANN THORAC SURG, V73, P88, DOI 10.1016/S0003-4975(01)03292-1
   GARSON A, 1985, J AM COLL CARDIOL, V6, P871
   GARSON A, 1974, J PEDIATR, V85, P429, DOI 10.1016/S0022-3476(74)80136-8
   GARSON A, 1985, J AM COLL CARDIOL, V6, P221
   GATZOULIS MA, 2003, DIAGNOSIS MANAGEMENT
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   GATZOULIS MA, 1995, CIRCULATION, V92, P231
   Gelatt M, 1997, J AM COLL CARDIOL, V29, P194
   GENTLES TL, 1993, J AM COLL CARDIOL, V22, P867
   Gersony WM, 2001, J AM COLL CARDIOL, V38, P843, DOI 10.1016/S0735-1097(01)01454-1
   Gersony W M, 1989, Cardiol Clin, V7, P915
   GERSONY WM, 1993, CIRCULATION, V87, P121
   Geva A, 2007, J AM COLL CARDIOL, V50, P1498, DOI 10.1016/j.jacc.2007.07.013
   Ghai A, 2002, J AM COLL CARDIOL, V40, P1675, DOI 10.1016/S0735-1097(02)02344-6
   Ghai A, 2001, J AM COLL CARDIOL, V37, P585, DOI 10.1016/S0735-1097(00)01141-4
   Gibbs JL, 1997, HEART, V77, P176
   GILLETTE PC, 1977, CIRCULATION, V56, P566
   Gober V, 2005, ANN THORAC SURG, V79, P625, DOI 10.1016/j.athoracsur.2004.07.085
   GOITEIN KJ, 1980, AM J CARDIOL, V45, P604, DOI 10.1016/S0002-9149(80)80011-7
   GOLDBERG S, 1991, J PEDIATR, V119, P661, DOI 10.1016/S0022-3476(05)82425-4
   GOLDNER BG, 1994, PACE, V17, P1441, DOI 10.1111/j.1540-8159.1994.tb02465.x
   Gonska BD, 1996, CIRCULATION, V94, P1902
   Gould FK, 2006, J ANTIMICROB CHEMOTH, V57, P1035, DOI 10.1093/jac/dk1121
   Graham TP, 2000, J AM COLL CARDIOL, V36, P255, DOI 10.1016/S0735-1097(00)00682-3
   GRAHAM TP, 1994, J AM COLL CARDIOL, V24, P867
   Graham TP, 2005, J AM COLL CARDIOL, V45, P1326, DOI 10.1016/j.jacc.2005.02.009
   GRAHAM TP, 1989, MOSS ADAMS HEART DIS, P724
   GRAHAM TP, 1994, MED SCI SPORT EXER, V26, pS246
   Gring CN, 2004, J AM COLL CARDIOL, V44, P1841, DOI 10.1016/j.jacc.2004.07.044
   Guedes A, 2004, J AM COLL CARDIOL, V44, P433, DOI 10.1016/j.jacc.2004.04.037
   Gupta D, 2001, AM J CARDIOL, V87, P241, DOI 10.1016/S0002-9149(00)01330-8
   GUTGESELL HP, 1986, CIRCULATION, V74, P1195
   Hachiro Y, 2001, ANN THORAC SURG, V72, P1520, DOI 10.1016/S0003-4975(01)02982-4
   Hadchouel Michelle, 2002, Indian Journal of Pediatrics, V69, P815, DOI 10.1007/BF02723697
   Hamada H, 2002, CARDIOL YOUNG, V12, P345
   Hameed A, 2001, J AM COLL CARDIOL, V37, P893, DOI 10.1016/S0735-1097(00)01198-0
   Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1
   Harrison DA, 2001, AM J CARDIOL, V87, P584, DOI 10.1016/S0002-9149(00)01435-1
   HARRISON DA, 1995, J AM COLL CARDIOL, V26, P1016, DOI 10.1016/0735-1097(95)00242-7
   Harrison DA, 1996, AM J CARDIOL, V77, P1094, DOI 10.1016/S0002-9149(96)00139-7
   Hart Ellen M., 1993, Cardiology Clinics, V11, P711
   Hartnell GG, 1996, CLIN RADIOL, V51, P851, DOI 10.1016/S0009-9260(96)80081-X
   HAUSDORF G, 1995, AM J CARDIOL, V76, P621, DOI 10.1016/S0002-9149(99)80171-4
   Hauser M, 2001, CIRCULATION, V103, P1875
   HAYES CJ, 1993, CIRCULATION, V87, P28
   HEATH D, 1958, CIRCULATION, V18, P533
   Hechter SJ, 2001, CARDIOL YOUNG, V11, P407, DOI 10.1017/S104795110100052X
   Hechter SJ, 2001, AM J CARDIOL, V87, P660, DOI 10.1016/S0002-9149(00)01452-1
   Helber U, 1997, J AM COLL CARDIOL, V29, P1345
   Higgins Sarah S, 2003, Prog Cardiovasc Nurs, V18, P93, DOI 10.1111/j.1751-7117.2003.tb00310.x
   Hijazi ZM, 1996, AM HEART J, V132, P827, DOI 10.1016/S0002-8703(96)90318-X
   HIJAZI ZM, 1994, AM J CARDIOL, V74, P925, DOI 10.1016/0002-9149(94)90588-6
   Hoare JV, 2001, AUST NZ J OBSTET GYN, V41, P464, DOI 10.1111/j.1479-828X.2001.tb01334.x
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   Hokanson JS, 2001, AM J CARDIOL, V87, P1271, DOI 10.1016/S0002-9149(01)01518-1
   HOLMVANG G, 1995, CIRCULATION, V92, P3473
   HOLT M, 1960, BRIT HEART J, V22, P236
   Holzer R, 2004, J AM COLL CARDIOL, V43, P1257, DOI 10.1016/j.jacc.2003.10.047
   Hong Thomas E, 2002, Indian Heart J, V54, P384
   Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80
   Horner T, 2000, MAYO CLIN PROC, V75, P31
   Hornung TS, 1999, AM J CARDIOL, V84, P1116, DOI 10.1016/S0002-9149(99)00516-0
   Hornung TS, 1998, HEART, V80, P322
   Hornung TS, 2003, AM J CARDIOL, V92, P640, DOI 10.1016/S0002-9149(03)00745-8
   HOROWITZ LN, 1980, AM J CARDIOL, V46, P446, DOI 10.1016/0002-9149(80)90014-4
   Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008
   HOSKING MCK, 1991, CIRCULATION, V84, P2313
   Hovels-Gurich HH, 2002, ARCH DIS CHILD, V87, P506, DOI 10.1136/adc.87.6.506
   HUHTA JC, 1983, CIRCULATION, V67, P1374
   HUNDLEY WG, 1995, CIRCULATION, V91, P2955
   Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022
   HUTCHINS GM, 1978, AM J CARDIOL, V42, P57, DOI 10.1016/0002-9149(78)90985-2
   Hutter PA, 2002, J THORAC CARDIOV SUR, V124, P790, DOI 10.1067/mtc.2002.120714
   Ibrahim T, 2002, CIRCULATION, V105, P2692, DOI 10.1161/01.CIR.0000013206.40857.B6
   Ing FF, 1996, CLIN CARDIOL, V19, P875
   Iserin L, 1997, EUR HEART J, V18, P1350
   Ismat FA, 2002, INT J CARDIOL, V86, P207, DOI 10.1016/S0167-5273(02)00325-X
   Jacobs J P, 2000, Ann Thorac Surg, V69, pS25
   Jais P, 2000, CIRCULATION, V101, P772
   Janousek J, 2004, J AM COLL CARDIOL, V44, P1927, DOI 10.1016/j.jacc.2004.08.044
   Jarrar M, 1999, AM HEART J, V138, P950, DOI 10.1016/S0002-8703(99)70022-0
   Jayakumar KA, 2004, J AM COLL CARDIOL, V44, P2065, DOI 10.1016/j.jacc.2004.08.031
   JOHN S, 1981, J THORAC CARDIOV SUR, V82, P314
   JOHNSON DH, 1975, CIRCULATION, V51, P581
   JONES P, 1995, BRIT J HOSP MED, V54, P214
   JONES RN, 1968, CIRCULATION, V38, P468
   JONSSON H, 1995, SCAND J THORAC CARD, V29, P131, DOI 10.3109/14017439509107219
   Kalman JM, 1996, CIRCULATION, V93, P502
   Kammeraad JAE, 2004, J AM COLL CARDIOL, V44, P1095, DOI 10.1016/j.jace.2004.05.073
   KAN JS, 1982, NEW ENGL J MED, V307, P540, DOI 10.1056/NEJM198208263070907
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Kantoch MJ, 1997, CAN J CARDIOL, V13, P641
   KAPLAN EL, 1979, CIRCULATION, V59, P327
   Kato H, 1996, CIRCULATION, V94, P1379
   KATZ NM, 1977, CIRCULATION, V56, P1034
   KEITH JD, 1959, BRIT HEART J, V21, P149
   Khairy P, 2004, CIRCULATION, V109, P1994, DOI 10.1161/01.CIR.0000126495.11040.BD
   Khairy P, 2006, CIRCULATION, V113, P2391, DOI 10.1161/CIRCULATIONAHA.106.622076
   KHAN MAA, 1989, AM J CARDIOL, V64, P218
   Khositseth A, 2004, J THORAC CARDIOV SUR, V128, P826, DOI 10.1016/j.jtcvs.2004.02.012
   KIDD L, 1993, CIRCULATION, V87, P38
   KIRKLIN JK, 1988, J HEART TRANSPLANT, V7, P331
   Kirsh JA, 2002, AM J CARDIOL, V90, P338, DOI 10.1016/S0002-9149(02)02480-3
   Kiziltan HT, 1998, ANN THORAC SURG, V66, P1539, DOI 10.1016/S0003-4975(98)00961-8
   Knauth AL, 2004, CIRCULATION, V110, P501, DOI 10.1161/01.CIR.0000137116.12176.A6
   Koch K, 2005, EUR RADIOL, V15, P312, DOI 10.1007/s00330-004-2543-6
   KOKKONEN J, 1992, INT J CARDIOL, V36, P23, DOI 10.1016/0167-5273(92)90104-B
   KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801
   Kreutzer J, 1996, CIRCULATION, V93, P1417
   KRICHENKO A, 1989, AM J CARDIOL, V63, P877, DOI 10.1016/0002-9149(89)90064-7
   Krivokapich Janine, 1996, Cardiology Clinics, V14, P363, DOI 10.1016/S0733-8651(05)70290-3
   KRONZON I, 1991, J AM COLL CARDIOL, V17, P537
   Kubak Bernard M., 1996, Cardiology Clinics, V14, P405, DOI 10.1016/S0733-8651(05)70293-9
   KUGLER JD, 1983, AM J CARDIOL, V51, P1137, DOI 10.1016/0002-9149(83)90359-4
   KUMAR A, 1993, AM J MED GENET, V45, P739, DOI 10.1002/ajmg.1320450614
   Kwok O H, 2001, J Invasive Cardiol, V13, P494
   Laforest I, 2002, CIRCULATION S1, V106, P57
   LAKATTA EG, 1993, CIRCULATION, V87, P631
   Lamas CC, 2000, CLIN INFECT DIS, V30, P336, DOI 10.1086/313646
   Landzberg MJ, 2001, J AM COLL CARDIOL, V37, P1187, DOI 10.1016/S0735-1097(01)01275-X
   Lane DA, 2002, HEART, V88, P71, DOI 10.1136/heart.88.1.71
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   LAWRENCE J, 2005, MONOGRAPHS HIGH SCOP, P14
   Lee CH, 2001, JPN HEART J, V42, P533, DOI 10.1536/jhj.42.533
   Lee Chi-Hang, 2003, J Invasive Cardiol, V15, P26
   Legendre A, 2003, CIRCULATION, V108, P186, DOI 10.1161/01.cir.0000087902.67220.2b
   Leier CV, 2004, J AM COLL CARDIOL, V44, P1831, DOI 10.1016/j.jacc.2004.08.013
   Lester SJ, 2001, AM J CARDIOL, V88, P1314, DOI 10.1016/S0002-9149(01)02098-7
   Li W, 1998, EUR HEART J, V19, P166, DOI 10.1053/euhj.1997.0821
   Li W, 2000, INT J CARDIOL, V75, P129, DOI 10.1016/S0167-5273(00)00308-9
   LINDE LM, 1970, ACTA PAEDIATR SCAND, V59, P169, DOI 10.1111/j.1651-2227.1970.tb08984.x
   LINDSAY J, 1988, AM J CARDIOL, V61, P182, DOI 10.1016/0002-9149(88)91327-6
   Lissin LW, 2004, AM J CARDIOL, V93, P654, DOI 10.1016/j.amjcard.2003.11.044
   LLOYD TR, 1987, AM HEART J, V114, P268, DOI 10.1016/0002-8703(87)90489-3
   LLOYD TR, 1993, CIRCULATION, V88, P1412
   LOCK JE, 1988, CIRCULATION, V78, P361
   LOCK JE, 1983, CIRCULATION, V67, P962
   Losay J, 2001, CIRCULATION S1, V104, pI121
   Losay J, 1997, CURR OPIN CARDIOL, V12, P84, DOI 10.1097/00001573-199701000-00013
   LOSCALZO J, 1986, AM HEART J, V112, P141, DOI 10.1016/0002-8703(86)90692-7
   LUNDSTROM U, 1990, AM J CARDIOL, V65, P1222, DOI 10.1016/0002-9149(90)90978-A
   MacLellanTobert SG, 1997, J AM COLL CARDIOL, V29, P1615
   MAHONEY LT, 1991, J AM COLL CARDIOL, V18, P334
   Maisel AS, 2003, HEART FAIL REV, V8, P339, DOI 10.1023/A:1026139130208
   Mandapati R, 2003, J CARDIOVASC ELECTR, V14, P119
   Manning PB, 1996, J THORAC CARDIOV SUR, V111, P833, DOI 10.1016/S0022-5223(96)70344-6
   MARANTZ PM, 1988, J AM COLL CARDIOL, V12, P476
   MARCELLETTI C, 1990, J THORAC CARDIOV SUR, V100, P228
   Marcelletti CF, 2000, J THORAC CARDIOV SUR, V119, P340, DOI 10.1016/S0022-5223(00)70190-5
   Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224
   Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199
   MARTIN MM, 1988, ANN THORAC SURG, V45, P16
   Massin MM, 1998, EUR J PEDIATR, V157, P95, DOI 10.1007/s004310050777
   MASURA J, 1993, J AM COLL CARDIOL, V21, P132
   Masura J, 1998, J AM COLL CARDIOL, V31, P878, DOI 10.1016/S0735-1097(98)00013-8
   MAUTNER GC, 1993, AM J CARDIOL, V72, P194, DOI 10.1016/0002-9149(93)90159-A
   MAVROUDIS C, 2003, DIAGNOSIS MANAGEMENT, P79
   Mavroudis C, 1997, ANN THORAC SURG, V63, P1235, DOI 10.1016/S0003-4975(97)00251-8
   Mavroudis C, 1998, J THORAC CARDIOV SUR, V115, P547, DOI 10.1016/S0022-5223(98)70316-2
   Mavroudis C, 2007, ANN THORAC SURG, V84, P1457, DOI 10.1016/j.athoracsur.2007.06.079
   Mavroudis C, 2001, J THORAC CARDIOV SUR, V122, P863, DOI 10.1067/mtc.2001.117840
   MCCONNELL MV, 1995, CIRCULATION, V92, P3158
   McCrindle BW, 1996, J AM COLL CARDIOL, V28, P1810
   MCCRINDLE BW, 1991, CIRCULATION, V83, P1915
   McElhinney DB, 2003, DIAGNOSIS MANAGEMENT, P305
   MCGRATH KA, 1994, NURS CLIN N AM, V29, P319
   MCKINSEY DS, 1987, AM J MED, V82, P681, DOI 10.1016/0002-9343(87)90001-5
   McLaughlin VV, 1999, ANN INTERN MED, V130, P740
   McMahon CJ, 2001, J AM COLL CARDIOL, V38, P521
   McMahon CJ, 2004, AM J CARDIOL, V94, P459, DOI 10.1016/j.amjcard.2004.05.005
   McMurray JJV, 2004, CIRCULATION, V110, P3281, DOI 10.1161/01.CIR.0000147274.83071.68
   MCNAMARA DG, 1985, J AM COLL CARDIOL, V6, P1200
   MCNAMARA DG, 1982, AM J CARDIOL, V50, P560, DOI 10.1016/0002-9149(82)90325-3
   MEHTA RH, 1990, J AM COLL CARDIOL, V16, P1010
   MEHTA RH, 1991, AM J CARDIOL, V67, P288, DOI 10.1016/0002-9149(91)90561-X
   MENDEZ HMM, 1985, AM J MED GENET, V21, P493, DOI 10.1002/ajmg.1320210312
   Mertens L, 1998, J THORAC CARDIOV SUR, V115, P1063, DOI 10.1016/S0022-5223(98)70406-4
   MILO S, 1988, BRIT HEART J, V60, P128
   Mohanakrishnan Laxmanan, 2003, Asian Cardiovasc Thorac Ann, V11, P74
   Momma K, 2001, GENET MED, V3, P56, DOI 10.1097/00125817-200101000-00012
   Moons P, 2004, ANN THORAC SURG, V77, P1359, DOI 10.1016/j.athoracsur.2003.09.073
   Moons P, 2007, INT J CARDIOL, V121, P30, DOI 10.1016/j.ijcard.2006.10.020
   Moons P, 2001, HEART, V86, P74, DOI 10.1136/heart.86.1.74
   Moons P, 2005, EUR HEART J, V26, P298, DOI 10.1093/eurheartj/ehi054
   Moons P, 2004, HEART, V90, P307, DOI 10.1136/hrt.2002.007138
   Moons P, 2006, EUR J CARDIOV PREV R, V13, P407, DOI 10.1097/00149831-200606000-00017
   MOORE JW, 1994, J AM COLL CARDIOL, V23, P759
   Moran AM, 1998, J AM COLL CARDIOL, V31, P1127, DOI 10.1016/S0735-1097(98)00034-5
   Morris CD, 1998, JAMA-J AM MED ASSOC, V279, P599, DOI 10.1001/jama.279.8.599
   Morwood JG, 2004, HEART RHYTHM, V1, P301, DOI 10.1016/j.hrthm.2004.05.009
   Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Murphy L S, 1993, Del Med J, V65, P329
   Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082
   Nahlawi M, 2004, J AM COLL CARDIOL, V44, P1883, DOI 10.1016/j.jacc.2004.06.074
   Nakagawa H, 2001, CIRCULATION, V103, P699
   Netzer ROM, 2002, HEART, V88, P61, DOI 10.1136/heart.88.1.61
   Neumayer U, 1998, EUR HEART J, V19, P1573, DOI 10.1053/euhj.1998.1083
   NG ASH, 1986, INT J CARDIOL, V11, P277, DOI 10.1016/0167-5273(86)90032-X
   Nielsen JC, 2005, CIRCULATION, V111, P622, DOI 10.1161/01.CIR.0000154549.53684.64
   Nieminen H, 2003, PEDIATRICS, V112, P1345, DOI 10.1542/peds.112.6.1345
   Nistri S, 1999, HEART, V82, P19
   Niwa Koichiro, 2002, J Cardiol, V39, P259
   Niwa K, 2001, CIRCULATION, V103, P393
   Niwa K, 2005, HEART, V91, P795, DOI 10.1136/hrt.2004.043323
   Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5
   Noonan J, 1999, CARDIOL YOUNG, V9, P545
   NORA JJ, 1976, CIRCULATION, V53, P701
   Norgaard MA, 1999, EUR J CARDIO-THORAC, V16, P125, DOI 10.1016/S1010-7940(99)00137-2
   OATES RK, 1995, ARCH DIS CHILD, V72, P298
   OCONNOR BK, 1992, J AM COLL CARDIOL, V20, P169
   Oechslin E, 2000, THORAC CARDIOV SURG, V48, P233, DOI 10.1055/s-2000-6901
   OH JK, 1985, J AM COLL CARDIOL, V6, P1351
   Ohmoto Y, 1997, CATHETER CARDIO DIAG, V42, P48, DOI 10.1002/(SICI)1097-0304(199709)42:1<48::AID-CCD14>3.0.CO;2-I
   Ohuchi H, 2004, CIRCULATION, V110, P2601, DOI 10.1161/01.CIR.0000145545.83564.51
   Ohuchi H, 2001, CIRCULATION, V104, P1513, DOI 10.1161/hc3801.096326
   Ohuchi H, 2002, CIRCULATION, V106, P2819, DOI 10.1161/01.CIR.0000038891.06306.BA
   O'Laughlin MP, 1998, PEDIATR CARDIOL, V19, P48, DOI 10.1007/s002469900245
   OLAUGHLIN MP, 1993, CIRCULATION, V88, P605
   Oliver JM, 2001, J AM COLL CARDIOL, V38, P835, DOI 10.1016/S0735-1097(01)01464-4
   Oliver JM, 2003, J THORAC CARDIOV SUR, V126, P711, DOI 10.1016/S0022-5223(03)00044-8
   OLIVER R, 2004, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003813.pub2
   Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204
   Onat T, 1998, PEDIATR CARDIOL, V19, P230, DOI 10.1007/s002469900291
   Park SJ, 1997, AM J CARDIOL, V80, P1514, DOI 10.1016/S0002-9149(97)00724-8
   Parry AJ, 1999, EUR J CARDIO-THORAC, V15, P631, DOI 10.1016/S1010-7940(99)00060-3
   Pascoe RD, 1996, CIRCULATION, V94, P1049
   Pasquali SK, 2002, CIRCULATION, V106, P2575, DOI 10.1161/01.CIR.0000036745.19310.BB
   PEASE WE, 1976, CIRCULATION, V53, P759
   Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903
   Perloff JK, 2003, AM J CARDIOL, V92, P182, DOI 10.1016/S0002-9149(03)00535-6
   Perloff JK, 2001, CIRCULATION, V103, P2637
   Perloff JK, 2003, CLIN RECOGNITION CON
   PERLOFF JK, 1988, ANN INTERN MED, V109, P406
   PERLOFF JK, 1993, CIRCULATION, V87, P1954
   Perloff Joseph K., 1993, Cardiology Clinics, V11, P689
   Perlowski AA, 2004, J AM COLL CARDIOL, V43, p391A, DOI 10.1016/S0735-1097(04)91655-5
   Peterson C, 2003, ANN THORAC SURG, V76, P1078, DOI 10.1016/S0003-4975(03)00678-7
   Pignatelli RH, 2003, CURR OPIN CARDIOL, V18, P357, DOI 10.1097/00001573-200309000-00006
   Podnar T, 2000, EUR J PEDIATR, V159, P293, DOI 10.1007/s004310050073
   Poirier NC, 2000, SEMIN THORAC CARDIOV, V3, P198
   PONGIGLIONE G, 1982, AM J CARDIOL, V50, P776, DOI 10.1016/0002-9149(82)91233-4
   POWELL AJ, 1995, CIRCULATION, V92, P3282
   Prakash A, 2004, AM J CARDIOL, V93, P657, DOI 10.1016/j.amjcard.2003.11.045
   Prendergast BD, 2002, BRIT MED J, V325, P845, DOI 10.1136/bmj.325.7369.845
   PRESBITERO P, 1994, CIRCULATION, V89, P2673
   Prieto LR, 1998, CIRCULATION, V98, P997
   Prifti E, 2002, EUR J CARDIO-THORAC, V21, P111, DOI 10.1016/S1010-7940(01)01074-0
   PROSAD S, 2003, DIAGNOSIS MANAGEMENT, P171
   Prystowsky EN, 1996, CIRCULATION, V93, P1262
   Puley G, 1999, AM J CARDIOL, V83, P1080, DOI 10.1016/S0002-9149(99)00019-3
   PURUT CM, 1991, J THORAC CARDIOV SUR, V102, P566
   Raff GW, 2000, J AM SOC ECHOCARDIOG, V13, P58, DOI 10.1016/S0894-7317(00)90043-9
   Raisky O, 2007, EUR J CARDIO-THORAC, V31, P894, DOI 10.1016/j.ejcts.2007.02.003
   Randolph GR, 2002, J THORAC CARDIOV SUR, V124, P1176, DOI 10.1067/mtc.2002.125816
   Rao PS, 1996, J INVASIVE CARDIOL, V8, P278
   RAO PS, 1988, AM J CARDIOL, V62, P979, DOI 10.1016/0002-9149(88)90909-5
   Rao PS, 1998, AM J CARDIOL, V82, P827, DOI 10.1016/S0002-9149(98)00441-X
   Rao V, 2000, CIRCULATION, V102, P5
   RASHKIND WJ, 1987, CIRCULATION, V75, P583
   Reich JD, 1998, J CARDIOVASC ELECTR, V9, P1370, DOI 10.1111/j.1540-8167.1998.tb00113.x
   Reid GJ, 2004, PEDIATRICS, V113, pE197, DOI 10.1542/peds.113.3.e197
   RHODES LA, 1995, AM HEART J, V130, P323, DOI 10.1016/0002-8703(95)90448-4
   RHODES LA, 1995, PACE, V18, P1005, DOI 10.1111/j.1540-8159.1995.tb04741.x
   RHODES LA, 1995, J THORAC CARDIOV SUR, V109, P303, DOI 10.1016/S0022-5223(95)70392-6
   RIGBY M, 2003, DIAGNOSIS MANAGEMENT
   Ringel RE, 2003, AM J CARDIOL, V91, P1031, DOI 10.1016/S0002-9149(03)00135-8
   ROBERTS CS, 1991, J AM COLL CARDIOL, V17, P712
   Roberts W C, 1975, Cardiovasc Clin, V7, P1
   ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7
   Robicsek F, 2004, ANN THORAC SURG, V77, P177, DOI 10.1016/S0003-4975(03)01249-9
   Robinson B, 2002, PEDIATR CARDIOL, V23, P618, DOI 10.1007/s00246-002-0046-2
   ROME JJ, 1993, CIRCULATION, V88, P1691
   Romp RL, 2003, ANN THORAC SURG, V76, P589, DOI 10.1016/S0003-4975(03)00436-3
   ROOSHESSELINK J, 1995, CIRCULATION, V91, P2214
   Roos-Hesselink JW, 2004, EUR HEART J, V25, P1264, DOI 10.1016/j.ehj.2004.03.009
   Ropers D, 2001, AM J CARDIOL, V87, P193, DOI 10.1016/S0002-9149(00)01315-1
   Rosenhek R, 2003, J AM SOC ECHOCARDIOG, V16, P1116, DOI 10.1067/S0894-7317(03)00638-2
   ROSOVE MH, 1983, THROMB RES, V29, P225, DOI 10.1016/0049-3848(83)90144-5
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   RUSSO CF, 2002, ANN THORAC SURG, V74, P1773
   Russo G, 2005, J CARDIOVASC ELECTR, V16, P288, DOI 10.1046/j.1540-8167.2005.40312.x
   Sabik JF, 2002, ANN THORAC SURG, V74, P650, DOI 10.1016/S0003-4975(02)03779-7
   Sadr-Ameli MA, 1998, AM J CARDIOL, V82, P398, DOI 10.1016/S0002-9149(98)00302-6
   SAHA A, 1994, INT J CARDIOL, V45, P199, DOI 10.1016/0167-5273(94)90166-X
   SAIMAN L, 1993, J PEDIATR, V122, P847
   Salehian O, 2004, CIRCULATION, V110, P3229, DOI 10.1161/01.CIR.0000147284.54140.73
   Sandoval J, 2001, AM J RESP CRIT CARE, V164, P1682
   SARELI P, 1989, AM J CARDIOL, V63, P1462, DOI 10.1016/0002-9149(89)90008-8
   Sarkar D, 1999, CIRCULATION, V100, P176
   Schaefer C, 2006, THROMB HAEMOSTASIS, V95, P949, DOI 10.1160/TH06-02-0108
   SCHENCK MH, 1993, AM J CARDIOL, V72, P591, DOI 10.1016/0002-9149(93)90357-I
   SCHIEBLER GL, 1961, PEDIATRICS S, P849
   SCHIEVINK WI, 1995, STROKE, V26, P1935
   SCHMIDTKE C, 2001, CIRCULATION S1, V104, P21
   Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108
   SCHREIBER TL, 1980, CIRCULATION, V61, P888
   Schwartz M.L., 2004, CIRCULATION, V110, pII128, DOI 10.1161/01.CIR.0000138392.68841.d3
   SEGUCHI M, 1990, EUR HEART J, V11, P213
   Holmes Sellors T, 1948, LANCET, V251, P988
   SEWARD JB, 1979, MAYO CLIN PROC, V54, P193
   Shaffer KM, 1998, J AM COLL CARDIOL, V31, P661, DOI 10.1016/S0735-1097(97)00535-4
   Shamsham F, 1999, ANGIOLOGY, V50, P519, DOI 10.1177/000331979905000612
   SHIRANI J, 1993, AM J CARDIOL, V72, P368, DOI 10.1016/0002-9149(93)90692-6
   SHIVALKAR B, 1994, J AM COLL CARDIOL, V23, P772
   SHUB C, 1985, J AM COLL CARDIOL, V6, P49
   SIETSEMA KE, 1986, CIRCULATION, V73, P1137
   SIETSEMA KE, 1988, J APPL PHYSIOL, V64, P234
   SIETSEMA KE, 1991, J AM COLL CARDIOL, V18, P322
   Sievers HH, 2003, CIRCULATION, V108, P55, DOI 10.1161/01.cir.0000087443.84392.32
   Sievert H, 1997, EUR HEART J, V18, P1014
   Silka MJ, 1998, J AM COLL CARDIOL, V32, P245, DOI 10.1016/S0735-1097(98)00187-9
   SILKA MJ, 1991, PACE, V14, P499, DOI 10.1111/j.1540-8159.1991.tb02820.x
   SILVERMAN NH, 1995, AM J CARDIOL, V76, P1277, DOI 10.1016/S0002-9149(99)80356-7
   Silversides CK, 2003, AM J CARDIOL, V91, P1386, DOI 10.1016/S0002-9149(03)00340-0
   Silversides CK, 2003, J AM COLL CARDIOL, V42, P1982, DOI 10.1016/j.jacc.2003.07.022
   Silvilairat S, 2005, J AM SOC ECHOCARDIOG, V18, P1143, DOI 10.1016/j.echo.2005.04.003
   Simko Lynn Coletta, 2003, AACN Clin Issues, V14, P42, DOI 10.1097/00044067-200302000-00006
   Simon-Kupilik N, 2002, EUR J CARDIO-THORAC, V21, P470, DOI 10.1016/S1010-7940(02)00016-7
   Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/rccm.2106079
   Simonneau G, 2004, J AM COLL CARDIOL, V43, P5
   Simpson I A, 1995, Am J Card Imaging, V9, P29
   Siu SC, 2001, CIRCULATION, V104, P515, DOI 10.1161/hc3001.093437
   Siu SC, 2001, HEART, V85, P710, DOI 10.1136/heart.85.6.710
   Siu SC, 1997, CIRCULATION, V96, P2789
   Siu SC, 2002, CIRCULATION, V105, P2179, DOI 10.1161/01.CIR.0000015699.48605.08
   Skorton DJ, 2001, J AM COLL CARDIOL, V37, P1193, DOI 10.1016/S0735-1097(01)01274-8
   Sliwa K, 2004, J AM COLL CARDIOL, V44, P1825, DOI 10.1016/j.jacc.2004.05.087
   SMITH WM, 1982, AM J CARDIOL, V49, P1223, DOI 10.1016/0002-9149(82)90048-0
   SONDEL PM, 1981, PEDIATRICS, V67, P667
   SPARKES RS, 1998, CONGENITAL HEART DIS, P165
   Spirito P, 1999, CIRCULATION, V99, P2132
   SPRAY TL, 1992, ANN THORAC SURG, V54, P216
   SREERAM N, 1991, EUR HEART J, V12, P231
   Stamm C, 2001, J THORAC CARDIOV SUR, V121, P28, DOI 10.1067/mtc.2001.111422
   STANGER P, 1990, AM J CARDIOL, V65, P775, DOI 10.1016/0002-9149(90)91387-L
   STATE MW, 1998, CONGENITAL HEART DIS, P227
   STEELE PM, 1987, CIRCULATION, V76, P1037
   Stephenson EA, 2003, AM J CARDIOL, V92, P871, DOI 10.1016/S0002-9149(03)00905-6
   STERN H, 1993, J THORAC CARDIOV SUR, V106, P723
   Swan L, 2000, HEART, V83, P685, DOI 10.1136/heart.83.6.685
   TAKEUCHI S, 1979, J THORAC CARDIOV SUR, V78, P7
   TANEL RE, 1995, AM J CARDIOL, V76, P153, DOI 10.1016/S0002-9149(99)80048-4
   TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640
   Taylor AM, 1999, J CARDIOV MAGN RESON, V1, P43, DOI 10.3109/10976649909080832
   Taylor DO, 2007, J HEART LUNG TRANSPL, V26, P769, DOI 10.1016/j.healun.2007.06.004
   Teerlink JR, 2005, CIRCULATION, V111, P1459, DOI 10.1161/01.CIR.0000160874.48045.54
   Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7
   Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9
   TERRITO MC, 1991, J AM COLL CARDIOL, V18, P320
   Teupe CHJ, 1997, AM J CARDIOL, V80, P240
   Thambo JB, 2004, CIRCULATION, V110, P3766, DOI 10.1161/01.CIR.0000150336.86033.8D
   THAULOW E, 2003, DIAGNOSIS MANAGEMENT, P145
   Therrien J, 2001, CIRCULATION, V103, P2489
   Therrien J, 1999, AM J CARDIOL, V84, P820, DOI 10.1016/S0002-9149(99)00444-0
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Therrien J, 2001, Can J Cardiol, V17, P1135
   Therrien J, 2003, CAN J CARDIOL, V19, P685
   THIENE G, 1981, J THORAC CARDIOV SUR, V82, P928
   Thistlethwaite PA, 2000, J THORAC CARDIOV SUR, V120, P1040, DOI 10.1067/mtc.2000.110493
   Torrent-Guasp F, 2001, J THORAC CARDIOV SUR, V122, P389, DOI 10.1067/mtc.2001.113745
   Tramboo NA, 2002, J PAEDIATR CHILD H, V38, P521, DOI 10.1046/j.1440-1754.2002.00027.x
   Triedman JK, 2002, J AM COLL CARDIOL, V39, P1827, DOI 10.1016/S0735-1097(02)01858-2
   Triedman JK, 1997, J AM COLL CARDIOL, V30, P1032, DOI 10.1016/S0735-1097(97)00252-0
   Triedman JK, 2001, CIRCULATION, V103, P2060
   Triedman J., 2001, CARDIAC ARRHYTHMIAS, P137
   Troughton RW, 2004, J AM COLL CARDIOL, V43, P416, DOI 10.1016/j.jacc.2003.08.046
   Trulock EP, 2001, CLIN CHEST MED, V22, P583, DOI 10.1016/S0272-5231(05)70293-8
   Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X
   Tulevski II, 2002, AM J CARDIOL, V89, P1077, DOI 10.1016/S0002-9149(02)02279-8
   Tworetzky W, 1999, J AM COLL CARDIOL, V33, P228, DOI 10.1016/S0735-1097(98)00518-X
   U. S. Department of Health and Human Services, 1999, MENT HLTH REP SURG G
   UTENS EMWJ, 1993, PSYCHOL MED, V23, P415
   UTENS EMWJ, 1994, J PSYCHOSOM RES, V38, P745, DOI 10.1016/0022-3999(94)90027-2
   van den Bosch AE, 2004, AM J CARDIOL, V93, P1141, DOI 10.1016/j.amjcard.2004.01.041
   Vanderheyden M, 2004, J AM COLL CARDIOL, V44, P2349, DOI 10.1016/j.jacc.2004.09.038
   VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1863, DOI 10.1001/archinte.152.9.1863
   VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1869, DOI 10.1001/archinte.152.9.1869
   van Driel D, 2001, PEDIATRICS, V107, P123, DOI 10.1542/peds.107.1.123
   Van Praagh R, 1998, AM HEART J, V135, P772, DOI 10.1016/S0002-8703(98)70035-3
   van Rijen EHM, 2004, EUR HEART J, V25, P1605, DOI 10.1016/j.ehj.2004.06.025
   VANSON JAM, 1994, J THORAC CARDIOV SUR, V108, P21
   VANSON JAM, 1995, J THORAC CARDIOV SUR, V109, P642, DOI 10.1016/S0022-5223(95)70345-4
   van Straten A, 2005, EUR RADIOL, V15, P702, DOI 10.1007/s00330-004-2574-z
   VARCO RL, 1951, SURGERY, V50, P29
   Veldtman GR, 2003, HEART, V89, P1067, DOI 10.1136/heart.89.9.1067
   Veldtman GR, 2004, J AM COLL CARDIOL, V44, P174, DOI 10.1016/j.jacc.2003.11.067
   VERIN VE, 1993, J AM COLL CARDIOL, V22, P1509
   Vitale N, 1999, J AM COLL CARDIOL, V33, P1637, DOI 10.1016/S0735-1097(99)00044-3
   Vogel M, 2004, J AM COLL CARDIOL, V43, P100, DOI 10.1016/j.jacc.2003.06.018
   Vogel M, 2003, CIRCULATION, V107, P1647, DOI 10.1161/01.CIR.0000058171.62847.90
   Vongpatanasin W, 1998, ANN INTERN MED, V128, P745
   Voskuil M, 1999, AM J CARDIOL, V83, P558, DOI 10.1016/S0002-9149(98)00913-8
   Wada AM, 2003, ARTERIOSCL THROM VAS, V23, P2138, DOI 10.1161/01.ATV.0000098645.38676.CC
   Walker RE, 2004, AM J CARDIOL, V93, P1374, DOI 10.1016/j.amjcard.2004.02.033
   WALSH EP, 1988, CIRCULATION, V77, P1062
   Waltz DA, 2006, J HEART LUNG TRANSPL, V25, P904, DOI 10.1016/j.healun.2006.06.004
   Wang A, 2007, AM J CARDIOL, V100, P1307, DOI 10.1016/j.amjcard.2007.05.059
   Wang JK, 2002, CATHETER CARDIO INTE, V55, P513, DOI 10.1002/ccd.10090
   Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994
   WARD R, 1995, CHEST, V108, P549, DOI 10.1378/chest.108.2.549
   WARNES CA, 1986, BRIT HEART J, V56, P535
   WARNES CA, 1984, AM J CARDIOL, V54, P1383, DOI 10.1016/S0002-9149(84)80111-3
   Warnes CA, 1996, J AM COLL CARDIOL, V27, P1244
   Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352
   Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4
   Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083
   Webb GD, 2001, J AM COLL CARDIOL, V37, P1166, DOI 10.1016/S0735-1097(01)01280-3
   Weindling SN, 1998, AM J CARDIOL, V82, P525, DOI 10.1016/S0002-9149(98)00375-0
   Weiss BM, 1998, J AM COLL CARDIOL, V31, P1650, DOI 10.1016/S0735-1097(98)00162-4
   Wernovsky G, 2000, CIRCULATION, V102, P883
   WERNOVSKY G, 1993, CORONARY ARTERY DIS, V4, P148, DOI 10.1097/00019501-199302000-00005
   Wessel HU, 1999, PEDIATR CARDIOL, V20, P39, DOI 10.1007/s002469900393
   WHITTEMORE R, 1994, J AM COLL CARDIOL, V23, P1459
   Williams RV, 2000, AM J CARDIOL, V86, P1106, DOI 10.1016/S0002-9149(00)01168-1
   Wilson NJ, 1998, J AM COLL CARDIOL, V32, P758, DOI 10.1016/S0735-1097(98)00309-X
   Wilson Walter, 2007, Circulation, V116, P1736, DOI 10.1161/CIRCULATIONAHA.106.183095
   WILSON WR, 1995, JAMA-J AM MED ASSOC, V274, P1706, DOI 10.1001/jama.274.21.1706
   WOLFE RR, 1993, CIRCULATION, V87, P89
   WOLFF GS, 1972, CIRCULATION, V46, P587
   WONG PC, 1991, AM J CARDIOL, V68, P1681, DOI 10.1016/0002-9149(91)90329-J
   Wong T, 2004, CIRCULATION, V109, P2319, DOI 10.1161/01.CIR.0000129766.18065.DC
   WOOD P, 1958, Br Med J, V2, P701
   Wypij D, 2003, J THORAC CARDIOV SUR, V126, P1397, DOI 10.1016/S0022-5223(03)00940-1
   YAMAGUCHI T, 1990, CARDIOVASC INTER RAD, V13, P291, DOI 10.1007/BF02578628
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   Yan AT, 2005, ANN INTERN MED, V142, P132
   Yankah AC, 2002, EUR J CARDIO-THORAC, V21, P260, DOI 10.1016/S1010-7940(01)01084-3
   Yetman AT, 1998, AM J CARDIOL, V81, P749, DOI 10.1016/S0002-9149(97)01009-6
   Yilmaz AT, 1996, ANN THORAC SURG, V62, P1205, DOI 10.1016/0003-4975(96)00383-9
   ZALES VR, 1988, AM J CARDIOL, V62, P225, DOI 10.1016/0002-9149(88)90216-0
   Zanchetta M, 2001, Minerva Cardioangiol, V49, P369
   ZIMMERMANN M, 1991, AM J CARDIOL, V67, P873, DOI 10.1016/0002-9149(91)90622-R
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
   2004, J AM COLL CARDIOL, V44, P216
NR 642
TC 232
Z9 246
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD DEC 2
PY 2008
VL 52
IS 23
BP E1
EP E121
DI 10.1016/j.jacc.2008.10.001
PG 121
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 376LD
UT WOS:000261184200001
PM 19038677
ER

PT J
AU Zelefsky, MJ
   Kuban, DA
   Levy, LB
   Potters, L
   Beyer, DC
   Blasko, JC
   Moran, BJ
   Ciezki, JP
   Zietman, AL
   Pisansky, TM
   Elshaikh, M
   Horwitz, EM
AF Zelefsky, Michael J.
   Kuban, Deborah A.
   Levy, Larry B.
   Potters, Louis
   Beyer, David C.
   Blasko, John C.
   Moran, Brian J.
   Ciezki, Jay P.
   Zietman, Anthony L.
   Pisansky, Thomas M.
   Elshaikh, Mohamed
   Horwitz, Eric M.
TI Multi-institutional analysis of long-term outcome for stages T1-T2
   prostate cancer treated with permanent seed implantation
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE brachytherapy; prostate cancer; prostate-specific antigen; isotope; dose
ID PATIENT SELECTION; BRACHYTHERAPY; I-125; IRRADIATION
AB Purpose: To assess long-term prostate-specific antigen (PSA) outcome after permanent prostate brachytherapy (BT) and identify predictors of improved disease-free survival.
   Methods and Materials: Eleven institutions combined data on 2,693 patients treated with permanent interstitial BT monotherapy for T1-T2 prostate cancer. Of these patients, 1,831 (68%) were treated with I-125 (median dose, 144 Gy) and 862 (32%) were treated with Pd-103 (median dose, 130 Gy). Criteria for inclusion were: available pre-BT PSA, BT >= 5 years before data submission, BT between 1988-1998, and no androgen deprivation before failure. The median follow-up was 63 months.
   Results: Among patients where the I-125 dose to 90% of the prostate (D90) was >= 130 Gy, the 8-year PSA relapse-free survival (PRFS) was 93% compared with 76% for those with lower D90 dose levels (p < 0.001). A multivariable analysis identified tumor stage (p = 0.002), Gleason score (p < 0.001), pretreatment PSA level (p < 0.001), treatment year (p = 0.001), and the isotope used (p = 0.004) as pretreatment and treatment variables associated with PRFS. When restricted to patients with available postimplantation dosimetric information, D90 emerged as a significant predictor of biochemical outcome (p = 0.01), and isotope was not significant. The 8-year PRFS was 92%, 86%, 79%, and 67%, respectively, for patients with PSA nadir values of 0-0.49, 0.5-0.99, 1.0-1.99, and > 2.0 ng/mL (p < 0.001). Among patients free of biochemical relapse at 8 years, the median nadir level was 0.1 ng/mL, and 90% of these patients achieved a nadir PSA level < 0.6 ng/mL.
   Conclusions: Outcome after permanent BT for prostatic cancer relates to tumor stage, Gleason score, pretreatment PSA, BT year, and post-BT dosimetric quality. PSA nadir <= 0.5 ng/mL was particularly associated with durable long-term PSA disease-free survival. The only controllable factor to impact on long-term outcome was the D90 which is a reflection of implant quality. (c) 2007 Elsevier Inc.
C1 Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.
   Arizona Oncol Serv, Scottsdale, AZ USA.
   New York Prostate Inst, Oceanside, NY USA.
   Seattle Prostate Inst, Seattle, WA USA.
   Chicago Prostate Canc Ctr, Chicago, IL USA.
   Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA.
   Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA.
   Mayo Clin & Mayo Fdn, Dept Radiat Oncol, Rochester, MN 55905 USA.
   Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.
   Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA.
RP Zelefsky, MJ (reprint author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.
EM zelefskm@mskcc.org
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Blasko JC, 2002, SEMIN RADIAT ONCOL, V12, P81, DOI 10.1053/srao.2002.28667
   Brachman DG, 2000, INT J RADIAT ONCOL, V48, P111, DOI 10.1016/S0360-3016(00)00598-8
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Kollmeier MA, 2003, INT J RADIAT ONCOL, V57, P645, DOI 10.1016/S0360-3016(03)00627-8
   MERRICK GS, 2005, WV MED J, V4, P168
   Nag S, 2000, INT J RADIAT ONCOL, V46, P221, DOI 10.1016/S0360-3016(99)00351-X
   Potters L, 2005, J UROLOGY, V173, P1562, DOI 10.1097/01.ju.0000154633.73092.8e
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X
   Wallner K, 2003, INT J RADIAT ONCOL, V57, P1297, DOI 10.1016/S0360-3016(03)01448-2
   Zelefsky MJ, 2000, INT J RADIAT ONCOL, V47, P1261, DOI 10.1016/S0360-3016(00)00550-2
NR 13
TC 224
Z9 229
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD FEB 1
PY 2007
VL 67
IS 2
BP 327
EP 333
DI 10.1016/j.ijrobp.2006.08.056
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 128PE
UT WOS:000243669300002
PM 17084558
ER

PT J
AU Hricak, H
   Choyke, PL
   Eberhardt, SC
   Leibel, SA
   Scardino, PT
AF Hricak, Hedvig
   Choyke, Peter L.
   Eberhardt, Steven C.
   Leibel, Steven A.
   Scardino, Peter T.
TI Imaging prostate cancer: A multidisciplinary perspective
SO RADIOLOGY
LA English
DT Review
ID POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE METASTASES; RADICAL RETROPUBIC
   PROSTATECTOMY; INTENSITY-MODULATED RADIOTHERAPY; DOMINANT INTRAPROSTATIC
   LESIONS; SEMINAL-VESICLE INVASION; RADIONUCLIDE BONE-SCAN; CELL
   LUNG-CANCER; EXTRACAPSULAR EXTENSION; LOCAL RECURRENCE
AB The major goal for prostate cancer imaging in the next decade is more accurate disease characterization through the synthesis of anatomic, functional, and molecular imaging information. No consensus exists regarding the use of imaging for evaluating primary prostate cancers. Ultrasonography is mainly used for biopsy guidance and brachytherapy seed placement. Endorectal magnetic resonance ( MR) imaging is helpful for evaluating local tumor extent, and MR spectroscopic imaging can improve this evaluation while providing information about tumor aggressiveness. MR imaging with superparamagnetic nanoparticles has high sensitivity and specificity in depicting lymph node metastases, but guidelines have not yet been developed for its use, which remains restricted to the research setting. Computed tomography (CT) is reserved for the evaluation of advanced disease. The use of combined positron emission tomography/ CT is limited in the assessment of primary disease but is gaining acceptance in prostate cancer treatment follow-up. Evidence-based guidelines for the use of imaging in assessing the risk of distant spread of prostate cancer are available. Radionuclide bone scanning and CT supplement clinical and biochemical evaluation (prostate-specific antigen [PSA], prostatic acid phosphate) for suspected metastasis to bones and lymph nodes. Guidelines for the use of bone scanning (in patients with PSA level > 10 ng/mL) and CT (in patients with PSA level > 20 ng/mL) have been published and are in clinical use. Nevertheless, changes in practice patterns have been slow. This review presents a multidisciplinary perspective on the optimal role of modern imaging in prostate cancer detection, staging, treatment planning, and follow-up.
C1 Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA.
   NCI, Mol Imaging Program, Canc Res Ctr, Bethesda, MD 20892 USA.
   Univ New Mexico, Dept Radiol, Sch Med, Albuquerque, NM 87131 USA.
   Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA.
RP Hricak, H (reprint author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave,C-278, New York, NY 10021 USA.
EM hricakh@mskcc.org
CR Akin O, 2006, RADIOLOGY, V239, P784, DOI 10.1148/radiol.2392050949
   Allsbrook WC, 1999, J UROL PATHOL, V10, P141, DOI 10.1385/JUP:10:2:141
   *AM CANC SOC, 2007, PUBL AM CANC SOC
   Amis E S Jr, 2000, Radiology, V215 Suppl, P703
   Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5
   Bader P, 2002, J UROLOGY, V168, P514, DOI 10.1016/S0022-5347(05)64670-8
   Bader P, 2003, J UROLOGY, V169, P849, DOI 10.1097/01.ju.0000049032.38743.c7
   Bartolozzi C, 1996, EUR RADIOL, V6, P339
   Bartsch G, 2001, UROLOGY, V58, P417, DOI 10.1016/S0090-4295(01)01264-X
   Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788
   Bellin MF, 1998, RADIOLOGY, V207, P799
   BENSON MC, 1992, J UROLOGY, V147, P815
   Bernstein MR, 2000, UROL ONCOL, V5, P104, DOI 10.1016/S1078-1439(99)00049-6
   Bianco FJ, 2005, UROLOGY, V66, P83, DOI 10.1016/j.urology.2005.06.116
   Brown RS, 1999, J NUCL MED, V40, P556
   Buckley DL, 2004, RADIOLOGY, V233, P709, DOI 10.1148/radiol.2333032098
   Burman C, 1997, INT J RADIAT ONCOL, V39, P863, DOI 10.1016/S0360-3016(97)00458-6
   Carroll P, 2001, UROLOGY, V57, P225, DOI 10.1016/S0090-4295(00)00994-8
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   Chaussy C, 2001, J ENDOUROL, V15, P437, DOI 10.1089/089277901300189501
   Chen L, 2004, PHYS MED BIOL, V49, P5157, DOI 10.1088/0031-9155/49/22/010
   Cheng L, 2001, CANCER, V91, P66, DOI 10.1002/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P
   Cher ML, 1998, J UROLOGY, V160, P1387, DOI 10.1016/S0022-5347(01)62545-X
   Claus FG, 2004, RADIOGRAPHICS, V24, pS167, DOI 10.1148/24si045516
   Coakley FV, 2002, UROLOGY, V59, P884, DOI 10.1016/S0090-4295(02)01614-X
   Coakley FV, 2002, J UROLOGY, V168, P1032, DOI 10.1097/01.ju.0000025881.75827.a5
   Cooperberg MR, 2002, J UROLOGY, V168, P491, DOI 10.1016/S0022-5347(05)64665-4
   Cornud F, 2000, AM J ROENTGENOL, V175, P1161
   Cornud F, 2002, RADIOLOGY, V224, P203, DOI 10.1148/radiol.2241011001
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   De la Taille A, 2000, BJU INT, V85, P281, DOI 10.1046/j.1464-410x.2000.00456.x
   Delbeke D, 1999, J NUCL MED, V40, P1706
   Delbeke D, 1999, J NUCL MED, V40, P591
   DELPASSAND ES, 1995, CLIN NUCL MED, V20, P1047, DOI 10.1097/00003072-199512000-00001
   Dotan ZA, 2005, J CLIN ONCOL, V23, P1962, DOI 10.1200/JCO.2005.06.058
   Eastham JA, 2003, J UROLOGY, V170, P2292, DOI 10.1097/01.ju.0000091100.83725.51
   Eastham JA, 2000, COMPREHENSIVE TXB GE, P722
   Effert PJ, 1996, J UROLOGY, V155, P994, DOI 10.1016/S0022-5347(01)66366-3
   Ellegala DB, 2003, CIRCULATION, V108, P336, DOI 10.1161/01.CIR.0000080326.15367.0C
   Engelbrecht MR, 2003, RADIOLOGY, V229, P248, DOI 10.1148/radiol.2291020200
   ENGELER CE, 1992, UROLOGY, V40, P346, DOI 10.1016/0090-4295(92)90386-B
   EVENSAPIR E, 1993, RADIOLOGY, V187, P193
   FLOCKS RH, 1959, J UROLOGY, V81, P194
   Freedland SJ, 2005, J UROLOGY, V174, P1276, DOI 10.1097/01.ju.0000173907.84852.ec
   GERVASI LA, 1989, J UROLOGY, V142, P332
   Gilligan T, 2002, UROLOGY, V60, P94, DOI 10.1016/S0090-4295(02)01583-2
   GLEASON DF, 1974, J UROLOGY, V111, P58
   Gore JL, 2001, J UROLOGY, V165, P1554, DOI 10.1016/S0022-5347(05)66347-1
   Green FL, 2002, AJCC CANC STAGING MA
   Halpern EJ, 2002, RADIOLOGY, V225, P71, DOI 10.1148/radiol.2251011938
   Harisinghani M. G., 2003, NEW ENGL J MED, V349, P1010
   Higashi K, 2000, J NUCL MED, V41, P85
   Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923
   HRICAK H, 1994, RADIOLOGY, V193, P703
   Hricak H, 2004, CANCER, V100, P2655, DOI 10.1002/cncr.20319
   Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169
   Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7
   Ikonen S, 2001, EUR RADIOL, V11, P236, DOI 10.1007/s003300000598
   Ikonen S, 2001, ACTA RADIOL, V42, P70, DOI 10.1034/j.1600-0455.2001.042001070.x
   Ikonen S, 1998, J UROLOGY, V159, P915, DOI 10.1016/S0022-5347(01)63770-4
   Jager GJ, 1997, RADIOLOGY, V203, P645
   Jager PL, 2001, J NUCL MED, V42, P432
   Jemal A, 2005, CA-CANCER J CLIN, V55, P259
   Jhaveri F M, 1999, Semin Urol Oncol, V17, P130
   Kattan MW, 1997, CANCER, V79, P528, DOI 10.1002/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.0.CO;2-5
   Kattan MW, 1999, J CLIN ONCOL, V17, P1499
   Kattan MW, 2000, J CLIN ONCOL, V18, P3352
   Kim CK, 2006, J COMPUT ASSIST TOMO, V30, P7, DOI 10.1097/01.rct.0000185384.27765.09
   Kramer S, 1997, BRIT J RADIOL, V70, P995
   Kuban DA, 2006, INT J RADIAT ONCOL, V65, P1487, DOI 10.1016/j.ijrobp.2006.03.027
   Kuligowska E, 2001, RADIOLOGY, V220, P757, DOI 10.1148/radiol.2203001179
   Laufer M, 2000, UROLOGY, V55, P309, DOI 10.1016/S0090-4295(99)00465-3
   LEE F, 1985, PROSTATE, V7, P117, DOI 10.1002/pros.2990070202
   Leventis AK, 2001, RADIOLOGY, V219, P432
   Lin K, 1999, CLIN NUCL MED, V24, P579, DOI 10.1097/00003072-199908000-00007
   Ling CC, 2000, INT J RADIAT ONCOL, V47, P551, DOI 10.1016/S0360-3016(00)00467-3
   Liu IJ, 2001, UROLOGY, V57, P108, DOI 10.1016/S0090-4295(00)00896-7
   Macapinlac HA, 1999, CLIN POSITRON IMAGIN, V2, P173, DOI 10.1016/S1095-0397(99)00015-1
   Mackie TR, 2003, INT J RADIAT ONCOL, V56, P89, DOI 10.1016/S0360-3016(03)00090-7
   May F, 2001, BJU INT, V87, P66, DOI 10.1046/j.1464-410x.2001.00018.x
   MCSHAN DL, 1990, INT J RADIAT ONCOL, V18, P1485
   Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401
   Morris MJ, 2002, UROLOGY, V59, P913, DOI 10.1016/S0090-4295(02)01509-1
   Mullerad M, 2005, J UROLOGY, V174, P2158, DOI 10.1097/01.ju.0000181224.95276.82
   Mullerad M, 2004, RADIOLOGY, V232, P140, DOI 10.1148/radiol.2321031254
   Nash PA, 1996, J UROLOGY, V155, P607, DOI 10.1016/S0022-5347(01)66464-4
   Nunez R, 2002, J NUCL MED, V43, P46
   ODowd GJ, 1997, J UROLOGY, V158, P687, DOI 10.1016/S0022-5347(01)64295-2
   OESTERLING JE, 1993, UROL CLIN N AM, V20, P705
   Ohori M, 2003, J UROLOGY, V169, P964, DOI 10.1097/01.ju.0000049963.28489.ab
   OHORI M, 1994, CANCER, V74, P104, DOI 10.1002/1097-0142(19940701)74:1<104::AID-CNCR2820740119>3.0.CO;2-5
   Ohori Makoto, 2002, Curr Probl Surg, V39, P833, DOI 10.1067/msg.2002.126335
   OHORI M, 1994, BRIT J UROL, V74, P72, DOI 10.1111/j.1464-410X.1994.tb16550.x
   OHORI M, 1993, BRIT J UROL, V72, P799, DOI 10.1111/j.1464-410X.1993.tb16271.x
   OUTWATER EK, 1994, RADIOLOGY, V193, P333
   Oyama Nobuyuki, 2002, Mol Imaging Biol, V4, P99, DOI 10.1016/S1095-0397(01)00065-6
   OYEN RH, 1994, RADIOLOGY, V190, P315
   PALMER E, 1988, ACTA RADIOL, V29, P445
   Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8
   PARTIN AW, 1994, J UROLOGY, V152, P1358
   Perrotti M, 1996, J UROLOGY, V156, P106, DOI 10.1016/S0022-5347(01)65955-X
   PETROS JA, 1992, J UROLOGY, V147, P1574
   Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226
   Pickett B, 1999, INT J RADIAT ONCOL, V44, P921, DOI 10.1016/S0360-3016(98)00502-1
   PLATT JF, 1987, AM J ROENTGENOL, V149, P315
   Pollack A, 2002, INT J RADIAT ONCOL, V54, P677, DOI 10.1016/S0360-3016(02)02977-2
   Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8
   POLLEN JJ, 1984, AM J ROENTGENOL, V142, P773
   POMERANZ SJ, 1994, SEMIN NUCL MED, V24, P188, DOI 10.1016/S0001-2998(05)80010-8
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Presti JC, 1996, AM J ROENTGENOL, V166, P103
   Pucar D, 2005, RADIOLOGY, V236, P545, DOI 10.1148/radiol.2362040739
   Boyer AL, 2001, INT J RADIAT ONCOL, V51, P880
   Qayyum A, 2004, AM J ROENTGENOL, V183, P1079
   Reske SN, 1997, J NUCL MED, V38, P1344
   RIFKIN MD, 1990, NEW ENGL J MED, V323, P621, DOI 10.1056/NEJM199009063231001
   Roehl KA, 2002, J UROLOGY, V167, P2435, DOI 10.1016/S0022-5347(05)64999-3
   Rorvik J, 1999, EUR RADIOL, V9, P29, DOI 10.1007/s003300050622
   Rorvik J, 1998, SCAND J UROL NEPHROL, V32, P116
   Sala E, 2006, RADIOLOGY, V238, P929, DOI 10.1148/radiol.2383050657
   Sala E, 2006, RADIOLOGY, V238, P176, DOI 10.1148/radiol.2381052345
   Sanz G, 1999, BJU INT, V84, P1028
   Sato C, 2005, J MAGN RESON IMAGING, V21, P258, DOI 10.1002/jmri.20251
   SCARDINO PT, 1989, UROL CLIN N AM, V16, P713
   Scheidler J, 1999, RADIOLOGY, V213, P473
   SCHNALL MD, 1990, UROL RADIOL, V12, P109, DOI 10.1007/BF02923982
   SCHNEIDER JA, 1994, J NUCL MED, V35, P1748
   Sella T, 2004, RADIOLOGY, V231, P379, DOI 10.1148/radiol.2312030011
   Shalev M, 2000, J UROLOGY, V163, P1747, DOI 10.1016/S0022-5347(05)67534-9
   SHINOHARA K, 1989, J UROLOGY, V142, P76
   Shreve PD, 1996, RADIOLOGY, V199, P751
   SHUKLADAVE A, 2007, BJU INT         0111
   SILVERBERG E, 1990, CA-CANCER J CLIN, V40, P9, DOI 10.3322/canjclin.40.1.9
   Silverman JM, 1997, AM J ROENTGENOL, V168, P379
   Soh S, 1997, J UROLOGY, V157, P2212, DOI 10.1016/S0022-5347(01)64721-9
   SU TS, 1990, HEPATOLOGY, V11, P118, DOI 10.1002/hep.1840110120
   Swanson MG, 2003, MAGNET RESON MED, V50, P944, DOI 10.1002/mrm.10614
   Takenaka A, 2006, INT J UROL, V13, P10, DOI 10.1111/j.1442-2042.2006.01221.x
   Taoka T, 2001, AM J ROENTGENOL, V176, P1525
   TERRIS MK, 1991, J UROLOGY, V145, P984
   Thompson I M, 1997, Oncology (Williston Park), V11, P1109
   Touijer K, 2006, EUR UROL, V49, P853, DOI 10.1016/j.eururo.2005.12.065
   Townsend DW, 2001, EUR RADIOL, V11, P1968, DOI 10.1007/s003300101007
   Traill ZC, 1999, CLIN RADIOL, V54, P448, DOI 10.1016/S0009-9260(99)90830-9
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   Turlakow A, 2001, Q J NUCL MED, V45, P235
   Ukimura O, 1998, J UROLOGY, V159, P1251, DOI 10.1016/S0022-5347(01)63575-4
   VANDERWALL H, 1998, NUCL MED CLIN DIAGNO, V2, P1169
   van Lin ENJT, 2006, INT J RADIAT ONCOL, V65, P291, DOI 10.1016/j.ijrobp.2005.12.046
   Vesselle H, 2000, CLIN CANCER RES, V6, P3837
   WALSH JW, 1980, RADIOLOGY, V137, P157
   Wang L, 2004, RADIOLOGY, V232, P133, DOI 10.1148/radiol.2321031086
   Wang L, 2006, AM J ROENTGENOL, V186, P743, DOI 10.2214/AJR.04.1682
   Warburg O, 1931, METABOLISM TUMORS
   WEBER G, 1977, NEW ENGL J MED, V296, P541, DOI 10.1056/NEJM197703102961005
   WEBER G, 1977, NEW ENGL J MED, V296, P486, DOI 10.1056/NEJM197703032960905
   WHITE S, 1995, RADIOLOGY, V195, P385
   WOLF JS, 1995, J UROLOGY, V153, P993, DOI 10.1016/S0022-5347(01)67620-1
   Xia P, 2001, INT J RADIAT ONCOL, V51, P244, DOI 10.1016/S0360-3016(01)01643-1
   YAMAMOTO T, 1990, BIOCHEM BIOPH RES CO, V170, P223, DOI 10.1016/0006-291X(90)91263-R
   Yeung HW, 2002, J NUCL MED, V43, p32P
   Yu KK, 1999, RADIOLOGY, V213, P481
   Yu KK, 1997, RADIOLOGY, V202, P697
   Zakian KL, 2005, RADIOLOGY, V234, P804, DOI 10.1148/radiol.2343040363
   Zakian KL, 2003, RADIOLOGY, V229, P241, DOI 10.1148/radiol.2291021383
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
   Zelefsky MJ, 2000, INT J RADIAT ONCOL, V48, P601, DOI 10.1016/S0360-3016(00)00655-6
   Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233
   ZINCKE H, 1994, J UROLOGY, V152, P1850
NR 169
TC 220
Z9 225
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD APR
PY 2007
VL 243
IS 1
BP 28
EP 53
DI 10.1148/radiol.2431030580
PG 26
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 151TA
UT WOS:000245312500006
PM 17392247
ER

PT J
AU Zoghbi, WA
   Chambers, JB
   Dumesnil, JG
   Foster, E
   Gottdiener, JS
   Grayburn, PA
   Khandheria, BK
   Levine, RA
   Marx, GR
   Miller, FA
   Nakatani, S
   Quinones, MA
   Rakowski, H
   Rodriguez, LL
   Swaminathan, M
   Waggoner, AD
   Weissman, NJ
   Zabalgoitia, M
AF Zoghbi, William A.
   Chambers, John B.
   Dumesnil, Jean G.
   Foster, Elyse
   Gottdiener, John S.
   Grayburn, Paul A.
   Khandheria, Bijoy K.
   Levine, Robert A.
   Marx, Gerald Ross
   Miller, Fletcher A., Jr.
   Nakatani, Satoshi
   Quinones, Miguel A.
   Rakowski, Harry
   Rodriguez, L. Leonardo
   Swaminathan, Madhav
   Waggoner, Alan D.
   Weissman, Neil J.
   Zabalgoitia, Miguel
TI Recommendations for Evaluation of Prosthetic Valves With
   Echocardiography and Doppler Ultrasound A Report From the American
   Society of Echocardiography's Guidelines and Standards Committee and the
   Task Force on Prosthetic Valves, Developed in Conjunction With the
   American College of Cardiology Cardiovascular Imaging Committee, Cardiac
   Imaging Committee of the American Heart Association, the European
   Association of Echocardiography, a registered branch of the European
   Society of Cardiology, the Japanese Society of Echocardiography and the
   Canadian Society of Echocardiography, Endorsed by the American College
   of Cardiology Foundation, American Heart Association, European
   Association of Echocardiography, a registered branch of the European
   Society of Cardiology, the Japanese Society of Echocardiography, and
   Canadian Society of Echocardiography
SO JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
LA English
DT Review
ID VENTRICULAR OUTFLOW TRACT; VELOCITY INTEGRAL RATIO; LONG-TERM SURVIVAL;
   MULTIDETECTOR COMPUTED-TOMOGRAPHY; MEDICAL MECHANICAL PROSTHESES;
   TRANS-SEPTAL CATHETERIZATION; PRESSURE RECOVERY DISTAL; BJORK-SHILEY
   PROSTHESIS; OUTLET STRUT FRACTURE; AORTIC-VALVE
C1 [Zoghbi, William A.; Quinones, Miguel A.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA.
   [Chambers, John B.] St Thomas Hosp, London, England.
   [Dumesnil, Jean G.] Hosp Laval, Quebec City, PQ, Canada.
   [Foster, Elyse] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Gottdiener, John S.] Univ Maryland Hosp, Baltimore, MD 21201 USA.
   [Grayburn, Paul A.] Baylor Univ, Med Ctr, Dallas, TX USA.
   [Khandheria, Bijoy K.] Mayo Clin, Scottsdale, AZ USA.
   [Levine, Robert A.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Marx, Gerald Ross] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA.
   [Miller, Fletcher A., Jr.] Mayo Clin, Rochester, MN USA.
   [Nakatani, Satoshi] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan.
   [Rakowski, Harry] Toronto Gen Hosp, Toronto, ON, Canada.
   [Rodriguez, L. Leonardo] Cleveland Clin, Cleveland, OH 44106 USA.
   [Swaminathan, Madhav] Duke Univ, Med Ctr, Durham, NC USA.
   [Waggoner, Alan D.] Washington Univ, Sch Med, St Louis, MO USA.
   [Weissman, Neil J.] Washington Hosp Ctr, Washington, DC 20010 USA.
   [Zabalgoitia, Miguel] Prairie Cardiovasc Consultants, Springfield, IL USA.
RP Zoghbi, WA (reprint author), 2100 Gateway Ctr Blvd,Suite 310, Morrisville, NC 27560 USA.
CR Adatia I, 1997, J AM COLL CARDIOL, V29, P1089
   AFRIDI I, 1995, J AM COLL CARDIOL, V25, P137, DOI 10.1016/0735-1097(94)00326-L
   ALAM M, 1981, CHEST, V79, P663, DOI 10.1378/chest.79.6.663
   ALI AS, 1994, PROG CARDIOVASC DIS, V37, P149, DOI 10.1016/S0033-0620(05)80040-4
   Allen BS, 2002, ANN THORAC SURG, V74, P771, DOI 10.1016/S0003-4975(02)03767-0
   ALTON ME, 1992, J AM COLL CARDIOL, V20, P1503
   [Anonymous], 1996, ANESTHESIOLOGY, V84, P986
   Aoyagi S, 1993, J Heart Valve Dis, V2, P279
   ASSEY ME, 1993, CATHETER CARDIO DIAG, V30, P287, DOI 10.1002/ccd.1810300405
   Bach David S., 2000, Cardiology Clinics, V18, P751, DOI 10.1016/S0733-8651(05)70178-8
   Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564
   Barbetseas J, 1998, J AM COLL CARDIOL, V32, P1410, DOI 10.1016/S0735-1097(98)00385-4
   Baumgartner H, 1999, J AM COLL CARDIOL, V33, P1655, DOI 10.1016/S0735-1097(99)00066-2
   BAUMGARTNER H, 1993, J AM COLL CARDIOL, V21, P1018
   BAUMGARTNER H, 1993, AM J CARDIOL, V71, P1241, DOI 10.1016/0002-9149(93)90659-Z
   BAUMGARTNER H, 1990, CIRCULATION, V82, P1467
   BAUMGARTNER H, 1992, J AM COLL CARDIOL, V19, P324
   BAYER AS, 1993, CLIN INFECT DIS, V17, P313
   Ben Zekry S, 2008, CIRCULATION, V118, pS1069
   BIRMINGHAM GD, 1992, AM HEART J, V123, P774, DOI 10.1016/0002-8703(92)90519-2
   BITAR JN, 1995, AM J CARDIOL, V76, P287, DOI 10.1016/S0002-9149(99)80083-6
   Blackstone EH, 2003, J THORAC CARDIOV SUR, V126, P783, DOI 10.1016/S0022-5223(03)00591-9
   Blais C, 2003, CIRCULATION, V108, P983, DOI 10.1161/01.CIR.0000085167.67105.32
   Blauwet LA, 2009, J AM SOC ECHOCARDIOG, V22, P388, DOI 10.1016/j.echo.2009.01.014
   BLAUWET LA, 2009, J AM SOC ECHOCARDIOG, V20, P1125
   Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857
   Briand M, 2000, CIRCULATION, V102, P10
   BURSTOW DJ, 1989, CIRCULATION, V80, P504
   CASTANEDAZUNIGA W, 1980, RADIOLOGY, V134, P775
   Castro LJ, 2002, ANN THORAC SURG, V74, P31, DOI 10.1016/S0003-4975(02)03680-9
   CHAFIZADEH ER, 1991, CIRCULATION, V83, P213
   Chambers J, 2005, J AM SOC ECHOCARDIOG, V18, P674, DOI 10.1016/j.echo.2004.09.028
   Chambers J, 2004, J HEART VALVE DIS, V13, P729
   CHAMBERS JB, 1992, BRIT HEART J, V67, P193
   Chambers JB, 2003, J THORAC CARDIOV SUR, V125, P1388, DOI 10.1016/S0022-5223(03)00039-4
   CHAN KC, 1994, J AM COLL CARDIOL, V24, P483
   Christakis GT, 1998, ANN THORAC SURG, V66, P1198, DOI 10.1016/S0003-4975(98)00758-9
   Cohen G I, 1992, J Am Soc Echocardiogr, V5, P620
   COHN LH, 1989, ANN SURG, V210, P435, DOI 10.1097/00000658-198910000-00003
   CONNOLLY HM, 1993, CIRCULATION, V88, P2722
   COOPER J, 1989, TXB COLOR DOPPLER EC, P160
   da Costa F, 1998, J CARDIAC SURG, V13, P177
   Daniel L B, 1990, Echocardiography, V7, P83, DOI 10.1111/j.1540-8175.1990.tb00352.x
   DANIEL WG, 1993, AM J CARDIOL, V71, P210, DOI 10.1016/0002-9149(93)90740-4
   DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203
   Davila-Roman VG, 2004, J AM COLL CARDIOL, V44, P1467, DOI 10.1016/j.jacc.2003.12.060
   DelRizzo DF, 1996, J THORAC CARDIOV SUR, V112, P1431, DOI 10.1016/S0022-5223(96)70001-6
   DEMOL BA, 1994, LANCET, V343, P9, DOI 10.1016/S0140-6736(94)90874-5
   Dinarevic S, 1996, PEDIATR CARDIOL, V17, P257, DOI 10.1007/BF02524805
   Doenst T, 2004, J CARDIOVASC SURG, V45, P449
   Donatelli F, 1994, Cardiologia, V39, P41
   DUMESNIL JG, 1990, AM J CARDIOL, V65, P1443, DOI 10.1016/0002-9149(90)91352-7
   DUMESNIL JG, 1992, EUR J CARDIO-THORAC, V6, pS34, DOI 10.1016/1010-7940(92)90019-T
   Dumesnil JG, 2006, J THORAC CARDIOV SUR, V131, P952, DOI 10.1016/j.jtcvs.2005.12.032
   DUMESNIL JG, 1990, J AM COLL CARDIOL, V16, P637
   DUNN M, 1985, J AM COLL CARDIOL, V5, P1393
   DZAVIK V, 1991, J AM COLL CARDIOL, V18, P1829
   EFFRON MK, 1983, J AM COLL CARDIOL, V2, P597
   Eriksson MJ, 1997, J HEART VALVE DIS, V6, P653
   FALICOV RE, 1979, AM J CARDIOL, V43, P1062, DOI 10.1016/0002-9149(79)90382-5
   Fernandes V, 2002, AM J CARDIOL, V89, P704, DOI 10.1016/S0002-9149(01)02343-8
   Fischer C H, 1998, Arq Bras Cardiol, V71, P741, DOI 10.1590/S0066-782X1998001200002
   Flachskampf F A, 1995, J Am Soc Echocardiogr, V8, P70, DOI 10.1016/S0894-7317(05)80360-8
   Fries R, 2000, ANN THORAC SURG, V69, P817, DOI 10.1016/S0003-4975(99)01409-5
   Gammie JS, 2006, ANN THORAC SURG, V81, P1605, DOI 10.1016/j.athoracsur.2005.11.060
   Garcia D, 2000, CIRCULATION, V101, P765
   Genoni M, 2001, J HEART VALVE DIS, V10, P426
   Goetze S, 2004, J AM SOC ECHOCARDIOG, V17, P981, DOI 10.1016/j.echo.2004.05.006
   GOLDBERG SJ, 1985, AM J CARDIOL, V56, P131, DOI 10.1016/0002-9149(85)90581-8
   Grewal KS, 2000, AM J CARDIOL, V85, P199, DOI 10.1016/S0002-9149(99)00644-X
   Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047
   GUERET P, 1995, CIRCULATION, V91, P103
   GUIT GL, 1985, RADIOLOGY, V154, P298
   Hanayama N, 2002, ANN THORAC SURG, V73, P1822, DOI 10.1016/S0003-4975(02)03582-8
   Heinrich RS, 1996, ANN BIOMED ENG, V24, P685, DOI 10.1007/BF02684181
   Heinrich RS, 1999, J HEART VALVE DIS, V8, P509
   HIRATZKA LF, 1988, J AM COLL CARDIOL, V11, P1130
   HORSTKOTTE D, 1983, CIRCULATION, V68, P161
   Hung J, 2007, J AM SOC ECHOCARDIOG, V20, P213, DOI 10.1016/j.echo.2007.01.010
   Hurrell DG, 1996, MAYO CLIN PROC, V71, P605
   Ionescu A, 2003, HEART, V89, P1316, DOI 10.1136/heart.89.11.1316
   Isada L R, 1994, J Am Soc Echocardiogr, V7, P641
   JAFFE WM, 1990, J THORAC CARDIOV SUR, V100, P167
   Jamieson W R Eric, 2002, Surg Technol Int, V10, P121
   Kanter KR, 2003, ANN THORAC SURG, V76, P1889, DOI 10.1016/S0003-4975(03)01304-3
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   KARALIS DG, 1992, CIRCULATION, V86, P353
   Karamlou T, 2005, CIRCULATION, V112, P3462, DOI 10.1161/CIRCULATIONHA.105.541649
   KARSH DL, 1978, AM J CARDIOL, V41, P893, DOI 10.1016/0002-9149(78)90730-0
   Khambadkone S, 2005, CIRCULATION, V112, P1189, DOI 10.1161/CIRCULATIONAHA.104.523266
   Kilian E, 2004, J HEART VALVE DIS, V13, P554
   Kobayashi Y, 1996, J AM COLL CARDIOL, V27, P1693, DOI 10.1016/0735-1097(96)00056-3
   KOBER G, 1987, CATHETER CARDIO DIAG, V13, P262, DOI 10.1002/ccd.1810130407
   Koch CG, 2005, CIRCULATION, V111, P3221, DOI 10.1161/CIRCULATIONAHA.104.505248
   KOCIS KC, 1994, AM J CARDIOL, V74, P77, DOI 10.1016/0002-9149(94)90499-5
   Koh M, 2005, EUR J CARDIO-THORAC, V27, P807, DOI 10.1016/j.ejcts.2005.01.060
   Kubitz JC, 2006, EUR J CARDIO-THORAC, V30, P90, DOI 10.1016/j.ejcts.2006.04.008
   Kupferwasser I, 1997, ECHOCARDIOGR-J CARD, V14, P363, DOI 10.1111/j.1540-8175.1997.tb00736.x
   Lam BK, 2007, J THORAC CARDIOV SUR, V133, P1464, DOI 10.1016/j.jtcvs.2006.12.071
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Leborgne L, 2006, EUR HEART J, V27, P2537, DOI 10.1093/eurheartj/ehi873
   Lembcke A, 2006, EUR J RADIOL, V57, P351, DOI 10.1016/j.ejrad.2005.12.020
   Lengyel M, 1997, J AM COLL CARDIOL, V30, P1521, DOI 10.1016/S0735-1097(97)00345-8
   LEVINE RA, 1989, J AM COLL CARDIOL, V13, P706
   LEVINE RA, 1993, J AM COLL CARDIOL, V21, P1026
   Levine RA, 2003, J AM COLL CARDIOL, V41, P443, DOI 10.1016/S0735-1097(02)02765-1
   Li MZ, 2005, J AM COLL CARDIOL, V45, P1034, DOI 10.1016/j.jacc.2004.10.073
   LITTLE SH, 2009, CIR HEART FAIL, V1, P293
   LOWRY RW, 1994, AM J CARDIOL, V73, P1089, DOI 10.1016/0002-9149(94)90288-7
   Magne J, 2007, CIRCULATION, V115, P1417, DOI 10.1161/CIRCULATIONAHA.106.631549
   Malouf JF, 2005, J AM SOC ECHOCARDIOG, V18, P252, DOI 10.1016/j.echo.2004.11.011
   Malouf JF, 2005, J AM SOC ECHOCARDIOG, V18, P1399, DOI 10.1016/j.echo.2005.03.031
   Marcus RH, 1998, CIRCULATION, V98, P866
   MARX GR, 1988, AM J CARDIOL, V61, P595, DOI 10.1016/0002-9149(88)90771-0
   Masuda M, 2004, ANN THORAC SURG, V77, P913, DOI 10.1016/j.athoracsur.2003.09.066
   McKinlay KH, 2004, J CARDIOTHOR VASC AN, V18, P404, DOI 10.1053/j.jvcu.2004.05.015
   MEHLMAN DJ, 1988, PROG CARDIOVASC DIS, V30, P441, DOI 10.1016/0033-0620(88)90006-0
   Melina G, 2005, J THORAC CARDIOV SUR, V130, P41, DOI 10.1016/j.jtcvs.2005.02.056
   MELIONES JN, 1989, AM J CARDIOL, V64, P354, DOI 10.1016/0002-9149(89)90534-1
   Milano AD, 2002, ANN THORAC SURG, V73, P37, DOI 10.1016/S0003-4975(01)03306-9
   Mohr-Kahaly S, 1990, J Am Soc Echocardiogr, V3, P187
   Mohr-Kahaly S, 1993, J Am Soc Echocardiogr, V6, P12
   Mohty D, 2009, J AM COLL CARDIOL, V53, P39, DOI 10.1016/j.jacc.2008.09.022
   Mohty-Echahidi D, 2006, CIRCULATION, V113, P420, DOI 10.1161/CIRCULATIONAHA.105.546754
   Moidl R, 1997, EUR J CARDIO-THORAC, V12, P569, DOI 10.1016/S1010-7940(97)00212-1
   Montorsi P, 2002, AM J CARDIOL, V90, P73, DOI 10.1016/S0002-9149(02)02394-9
   Morgan-Hughes GJ, 2003, HEART, V89, P1191, DOI 10.1136/heart.89.10.1191
   Moss RR, 2008, JACC-CARDIOVASC IMAG, V1, P15, DOI 10.1016/j.jcmg.2007.09.004
   MUGGE A, 1993, INFECT DIS CLIN N AM, V7, P877
   Muratori M, 2006, AM J CARDIOL, V97, P94, DOI 10.1016/j.amjcard.2005.07.112
   Niederberger J, 1996, CIRCULATION, V94, P1934
   Novaro GM, 2001, MAYO CLIN PROC, V76, P155
   Numata S, 2007, EUR J CARDIO-THORAC, V31, P934, DOI 10.1016/j.ejcts.2007.02.008
   ODELL JA, 1985, ANN THORAC SURG, V39, P569
   Olmos L, 1999, AM J CARDIOL, V83, P199, DOI 10.1016/S0002-9149(98)00824-8
   O'Rourke DJ, 2001, J AM COLL CARDIOL, V38, P163, DOI 10.1016/S0735-1097(01)01361-4
   ORSINELLI DA, 1995, J AM COLL CARDIOL, V26, P1713, DOI 10.1016/0735-1097(95)00375-4
   OTTO CM, 1986, J AM COLL CARDIOL, V7, P509
   PANIDIS IP, 1986, J AM COLL CARDIOL, V8, P317
   Pibarot P, 2000, J AM COLL CARDIOL, V36, P1131, DOI 10.1016/S0735-1097(00)00859-7
   Pibarot P, 1998, J HEART VALVE DIS, V7, P211
   Pibarot P, 2006, HEART, V92, P1022, DOI 10.1136/hrt.2005.067363
   Pibarot P, 1999, J AM COLL CARDIOL, V34, P1609, DOI 10.1016/S0735-1097(99)00360-5
   Pibarot P, 2001, ANN THORAC SURG, V71, pS265, DOI 10.1016/S0003-4975(01)02509-7
   Piers L H, 2007, Heart, V93, P302, DOI 10.1136/hrt.2006.093724
   Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202
   RAHIMTOOLA SH, 1981, BRIT HEART J, V45, P331
   Rajani R, 2007, J HEART VALVE DIS, V16, P519
   Rallidis LS, 1999, AM HEART J, V138, P351, DOI 10.1016/S0002-8703(99)70124-9
   Rao PS, 1998, HEART, V80, P591
   RASHTIAN MY, 1986, AM J CARDIOL, V58, P743, DOI 10.1016/0002-9149(86)90349-8
   Reeves ST, 2007, J AM SOC ECHOCARDIOG, V20, P427, DOI 10.1016/j.echo.2007.01.011
   Reis G, 2004, J AM COLL CARDIOL, V43, P393, DOI 10.1016/j.jacc.2003.09.037
   Rizzoli G, 1999, EUR J CARDIO-THORAC, V16, P74, DOI 10.1016/S1010-7940(99)00124-4
   Ronderos RE, 2004, J AM SOC ECHOCARDIOG, V17, P664, DOI 10.1016/j.echo.2004.03.024
   Rosenhek R, 2003, J AM SOC ECHOCARDIOG, V16, P1116, DOI 10.1067/S0894-7317(03)00638-2
   Rosti L, 1998, J THORAC CARDIOV SUR, V115, P1074, DOI 10.1016/S0022-5223(98)70407-6
   ROTHBART RM, 1990, J AM COLL CARDIOL, V15, P817
   Ruel M, 2006, J THORAC CARDIOV SUR, V131, P1036, DOI 10.1016/j.jtcvs.2005.10.028
   Saad RM, 1997, AM J CARDIOL, V80, P1239, DOI 10.1016/S0002-9149(97)00652-8
   SANDS MJ, 1982, AM HEART J, V104, P622, DOI 10.1016/0002-8703(82)90237-X
   SCHOENFELD MH, 1985, J AM COLL CARDIOL, V5, P1387
   Schroeder RA, 2005, ANESTH ANALG, V101, P1288, DOI 10.1213/01.ANE.0000181339.39448.F0
   Settepani F, 2005, ANN THORAC SURG, V79, P499, DOI 10.1016/j.athoracsur.2004.07.076
   SHIVELY BK, 1991, J AM COLL CARDIOL, V18, P391
   Sievers HH, 2003, CIRCULATION, V108, P55, DOI 10.1161/01.cir.0000087443.84392.32
   SPRECHER DL, 1987, J AM COLL CARDIOL, V9, P1306
   Sugeng L, 2009, J AM SOC ECHOCARDIOG, V21, P1347
   Tasca G, 2005, ANN THORAC SURG, V79, P505, DOI 10.1016/j.athoracsur.2004.04.042
   Teshima H, 2003, ANN THORAC SURG, V75, P1631, DOI 10.1016/S0003-4975(02)04772-0
   Teshima Hideki, 2005, J Artif Organs, V8, P270, DOI 10.1007/s10047-005-0317-9
   Tong AT, 2004, J AM COLL CARDIOL, V43, P77, DOI 10.1016/j.jacc.2003.08.028
   Vitarelli A, 2004, HEART, V90, P539, DOI 10.1136/hrt.2003.026823
   Walther T, 1996, Cardiovasc Surg, V4, P536, DOI 10.1016/0967-2109(95)00128-X
   Ward KE, 1997, J HEART VALVE DIS, V6, P130
   Waterbolk TW, 2006, EUR J CARDIO-THORAC, V30, P28, DOI 10.1016/j.ejcts.2006.02.069
   Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882
   Weyman AE, 1994, PRINCIPLES PRACTICE, P863
   WHITE AF, 1973, CIRCULATION, V48, P882
   YOGANATHAN AP, 1984, J AM COLL CARDIOL, V3, P313
   Zabalgoitia M, 1993, J Heart Valve Dis, V2, P595
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
   ZOGHBI WA, 2007, PRACTICE CLIN ECHOCA, P605
   Zoghbi W A, 1989, J Am Soc Echocardiogr, V2, P98
   ZOGHBI WA, 1986, CIRCULATION, V73, P452
NR 185
TC 217
Z9 224
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0894-7317
J9 J AM SOC ECHOCARDIOG
JI J. Am. Soc. Echocardiogr.
PD SEP
PY 2009
VL 22
IS 9
BP 975
EP 1014
DI 10.1016/j.echo.2009.07.013
PG 40
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 491GS
UT WOS:000269567200001
PM 19733789
ER

PT J
AU Warnes, CA
   Williams, RG
   Bashore, TM
   Child, JS
   Connolly, HM
   Dearani, JA
   del Nido, P
   Fasules, JW
   Graham, TP
   Hijazi, ZM
   Hunt, SA
   King, ME
   Landzberg, MJ
   Miner, PD
   Radford, MJ
   Walsh, EP
   Webb, GD
AF Warnes, Carole A.
   Williams, Roberta G.
   Bashore, Thomas M.
   Child, John S.
   Connolly, Heidi M.
   Dearani, Joseph A.
   del Nido, Pedro
   Fasules, James W.
   Graham, Thomas P., Jr.
   Hijazi, Ziyad M.
   Hunt, Sharon A.
   King, Mary Etta
   Landzberg, Michael J.
   Miner, Pamela D.
   Radford, Martha J.
   Walsh, Edward P.
   Webb, Gary D.
TI ACC/AHA 2008 Guidelines for the Management of Adults With Congenital
   Heart Disease: A Report of the American College of Cardiology/American
   Heart Association Task Force on Practice Guidelines (Writing Committee
   to Develop Guidelines on the Management of Adults With Congenital Heart
   Disease): Developed in Collaboration With the American Society of
   Echocardiography, Heart Rhythm Society, International Society for Adult
   Congenital Heart Disease, Society for Cardiovascular Angiography and
   Interventions, and Society of Thoracic Surgeons
SO CIRCULATION
LA English
DT Article
DE ACC/AHA Practice Guidelines; congenital heart disease; cardiac defects;
   congenital heart surgery; unoperated/repaired heart defects; medical
   therapy; cardiac catheterization
ID PATENT DUCTUS-ARTERIOSUS; ATRIAL SEPTAL-DEFECT; BICUSPID AORTIC-VALVE;
   LEFT CORONARY-ARTERY; TERM-FOLLOW-UP; RADIOFREQUENCY CATHETER ABLATION;
   QUALITY-OF-LIFE; INTRAATRIAL REENTRANT TACHYCARDIA; BALLOON PULMONARY
   VALVULOPLASTY; MYOCARDIAL PERFORMANCE INDEX
CR Abhaichand R, 2002, CATHETER CARDIO INTE, V56, P278, DOI 10.1002/ccd.10162
   Aboulhosn J, 2006, CIRCULATION, V114, P2412, DOI 10.1161/CIRCULATIONAHA.105.592089
   *ACC AHA TASK FORC, 2006, ACC/AHA TASK FORCE O
   Addonizio L J, 1987, Circulation, V76, pV52
   Agnoletti G, 2004, CIRCULATION, V109, P2314, DOI 10.1161/01.CIR.0000129273.50975.F4
   Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913
   Alexander ME, 2004, J CARDIOVASC ELECTR, V15, P72, DOI 10.1046/j.1540-8167.2004.03388.x
   Alexander ME, 1999, J CARDIOVASC ELECTR, V10, P1033, DOI 10.1111/j.1540-8167.1999.tb00274.x
   ALLWORK SP, 1976, AM J CARDIOL, V38, P910, DOI 10.1016/0002-9149(76)90804-3
   Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9
   Ammash NM, 1999, J AM COLL CARDIOL, V33, P222, DOI 10.1016/S0735-1097(98)00554-3
   Ammash NM, 1997, AM HEART J, V134, P508, DOI 10.1016/S0002-8703(97)70088-7
   Anand N, 2006, EUR HEART J, V27, P2069, DOI 10.1093/eurheartj/ehl080
   Ananthasubramaniam K, 2001, J AM SOC ECHOCARDIOG, V14, P321, DOI 10.1067/mje.2001.109684
   ANDERSON RH, 1974, CIRCULATION, V50, P911
   ANDERSON RH, 1991, J PERINAT MED, P201
   ANDERSON RH, 1978, THORAX, V33, P825, DOI 10.1136/thx.33.6.825
   Anderson Robert H, 2005, Cardiol Young, V15 Suppl 1, P76, DOI 10.1017/S1047951105001083
   Angelini Paolo, 2003, J Invasive Cardiol, V15, P507
   Angelini P, 2007, CIRCULATION, V115, P1296, DOI 10.1161/CIRCULATIONAHA.106.618082
   Angelini P, 2002, CIRCULATION, V105, P2449, DOI 10.1161/01.CIR.0000016175.49835.57
   Arai N, 2001, J AM SOC ECHOCARDIOG, V14, P650, DOI 10.1067/mje.2001.110782
   Armsby LR, 2002, J AM COLL CARDIOL, V39, P1026, DOI 10.1016/S0735-1097(02)01742-4
   Arora R, 2001, J Interv Cardiol, V14, P255, DOI 10.1111/j.1540-8183.2001.tb00744.x
   ARORA R, 1994, AM HEART J, V128, P539, DOI 10.1016/0002-8703(94)90629-7
   ARVIDSSON H, 1961, ACTA RADIOL, V56, P466
   Ashrafian H, 2007, HEART, V93, P5, DOI 10.1136/hrt.2006.103689
   AWADALLAH SM, 1991, AM J CARDIOL, V68, P90, DOI 10.1016/0002-9149(91)90717-Y
   BAER PE, 1984, J AM ACAD CHILD PSY, V23, P622, DOI 10.1016/S0002-7138(09)60356-3
   Balaji S, 1997, AM J CARDIOL, V80, P160
   BALLESTER M, 1983, EUR HEART J, V4, P472
   Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   BASSON CT, 1995, CIRCULATION, V91, P1326
   Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30
   Batista R J, 1997, Arq Bras Cardiol, V68, P279
   Bauer M, 2002, ANN THORAC SURG, V74, P58, DOI 10.1016/S0003-4975(02)03650-0
   Bayer AS, 1998, CIRCULATION, V98, P2936
   BAYER AS, 1994, AM J MED, V96, P211, DOI 10.1016/0002-9343(94)90144-9
   Beauchesne LM, 2002, J AM COLL CARDIOL, V40, P285, DOI 10.1016/S0735-1097(02)01952-6
   Beauchesne LM, 2001, J AM COLL CARDIOL, V38, P1728, DOI 10.1016/S0735-1097(01)01617-5
   Beauchesne LM, 2005, J AM COLL CARDIOL, V45, P595, DOI 10.1016/j.jacc.2004.10.056
   Bekeredjian R, 2005, CIRCULATION, V112, P125, DOI 10.1161/CIRCULATIONAHA.104.488825
   Beller CJ, 2004, CIRCULATION, V109, P763, DOI 10.1161/01.CIR.0000112569.27151.F7
   Beller George A, 2008, J Am Coll Cardiol, V51, P335, DOI 10.1016/j.jacc.2007.11.008
   Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6
   Bellinger DC, 2003, HEART, V89, P365, DOI 10.1136/heart.89.4.365
   BENSHACHAR G, 1985, J AM COLL CARDIOL, V5, P754
   Benson DW, 1998, CIRCULATION, V97, P2043
   BEPPU S, 1993, AM J CARDIOL, V71, P322, DOI 10.1016/0002-9149(93)90799-I
   Berul CI, 1997, J CARDIOVASC ELECTR, V8, P1349, DOI 10.1111/j.1540-8167.1997.tb01031.x
   BHARATI S, 1978, AM J CARDIOL, V42, P147, DOI 10.1016/0002-9149(78)91000-7
   Biliciler-Denktas G, 2001, J THORAC CARDIOV SUR, V122, P234, DOI 10.1067/mtc.2001.115241
   Bilkis AA, 2001, J AM COLL CARDIOL, V37, P258, DOI 10.1016/S0735-1097(00)01094-9
   BIZARRO RO, 1970, CIRCULATION, V41, P677
   Blaustein Alvin S., 1996, Cardiology Clinics, V14, P393, DOI 10.1016/S0733-8651(05)70292-7
   BOGERS AJJC, 1988, J CARDIOVASC SURG, V29, P339
   Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F
   Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3
   Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   BONHOEFFER P, 1993, INT J CARDIOL, V39, P181, DOI 10.1016/0167-5273(93)90036-G
   Bonow RO, 2006, J AM COLL CARDIOL, V48, pe1, DOI DOI 10.1016/J.JACC.2006.05.021
   BOWYER JJ, 1986, BRIT HEART J, V55, P385
   Boxt Lawrence M., 2003, Cardiology Clinics, V21, P561, DOI 10.1016/S0733-8651(03)00093-6
   Boxt LM, 2004, J MAGN RESON IMAGING, V19, P827, DOI 10.1002/jmri.20077
   BRANDHAGEN DJ, 1991, MAYO CLIN PROC, V66, P474
   Brauner R, 1997, J AM COLL CARDIOL, V30, P1835, DOI 10.1016/S0735-1097(97)00410-5
   Brickner ME, 2000, NEW ENGL J MED, V342, P334, DOI 10.1056/NEJM200002033420507
   Bromberg JI, 2003, HEART LUNG, V32, P105, DOI 10.1067/mhl.2003.26
   BROWN AK, 1984, AM J CARDIOL, V54, P1170, DOI 10.1016/S0002-9149(84)80184-8
   Buckberg GD, 2004, CIRCULATION, V110, pE333, DOI 10.1161/01.CIR.0000143625.56882.5C
   BURTON ME, 1993, PACE, V16, P2319, DOI 10.1111/j.1540-8159.1993.tb02340.x
   CALDWELL RL, 1971, AM J DIS CHILD, V122, P312
   Canobbio MM, 2004, NURS CLIN N AM, V39, pXIII, DOI 10.1016/j.cnur.2004.08.005
   Canobbio M M, 2001, J Pediatr Nurs, V16, P363, DOI 10.1053/jpdn.2001.26570
   Canobbio MM, 1996, J AM COLL CARDIOL, V28, P763, DOI 10.1016/0735-1097(96)00234-3
   Cantor WJ, 1999, AM J CARDIOL, V84, P677, DOI 10.1016/S0002-9149(99)00415-4
   Carrel T, 2000, THORAC CARDIOV SURG, V48, P224, DOI 10.1055/s-2000-6894
   Carr-White GS, 2001, CIRCULATION, V104, pI16
   CECCHIN F, 1995, AM J CARDIOL, V76, P386, DOI 10.1016/S0002-9149(99)80106-4
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V23, P170
   CELERMAJER DS, 1991, MED J AUSTRALIA, V155, P233
   CELERMAJER DS, 1993, BRIT HEART J, V69, P539
   CELERMAJER DS, 1992, J AM COLL CARDIOL, V19, P1041
   CETTA F, 1995, MAYO CLIN PROC, V70, P50
   Chan KL, 2001, AM J CARDIOL, V88, P690, DOI 10.1016/S0002-9149(01)01820-3
   Chan KL, 2003, J AM COLL CARDIOL, V42, P775, DOI 10.1016/S0735-1097(03)00829-5
   Chan KL, 2002, CAN MED ASSOC J, V167, P19
   CHANDAR JS, 1990, AM J CARDIOL, V65, P655, DOI 10.1016/0002-9149(90)91047-A
   CHANDRASHEKHAR YS, 1990, AM HEART J, V120, P1234, DOI 10.1016/0002-8703(90)90147-P
   Cheatham JP, 1998, CATHETER CARDIO DIAG, V45, P162, DOI 10.1002/(SICI)1097-0304(199810)45:2<162::AID-CCD13>3.0.CO;2-N
   Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9
   CHEN JTT, 1969, AMER J ROENTGENOL RA, V107, P343
   CHESLER ELLIOT, 1968, AMER J CARDIOL, V21, P661, DOI 10.1016/0002-9149(68)90263-4
   Chetaille P, 2004, HEART RHYTHM, V1, P168, DOI 10.1016/j.hrthm.2004.03.064
   CHILD JS, 1998, CONGENITAL HEART DIS, P91
   Child JS, 2001, J AM COLL CARDIOL, V37, P1183, DOI 10.1016/S0735-1097(01)01276-1
   CHILD JS, 2002, PRACTICE CLIN ECHOCA, P901
   CHILD JS, 1998, CONGENITAL HEART DIS, P129
   CHILD J S, 1990, Cardiology Clinics, V8, P289
   Choong CK, 2004, J THORAC CARDIOV SUR, V127, P1323, DOI 10.1016/j.jtcvs.2003.11.046
   CHOU TC, 1996, ELECTROCARDIOGRAPHY, P296
   Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F
   Cilliers AM, 2002, HEART, V88, P335, DOI 10.1136/heart.88.4.335
   Coady MA, 1999, ANN THORAC SURG, V67, P1922, DOI 10.1016/S0003-4975(99)00431-2
   COHEN M, 1989, CIRCULATION, V80, P840
   Collins KK, 2000, AM J CARDIOL, V86, P969, DOI 10.1016/S0002-9149(00)01132-2
   Connelly MS, 1996, J AM COLL CARDIOL, V27, P1238, DOI 10.1016/0735-1097(95)00567-6
   Connolly HM, 1999, J AM COLL CARDIOL, V33, P1692, DOI 10.1016/S0735-1097(99)00046-7
   CONNOLLY HM, 1994, J AM COLL CARDIOL, V23, P1194
   COOPER WO, 2006, NEW ENGL J MED, V354, P2243
   CORMODE EJ, 1986, AM J MED GENET, V24, P289, DOI 10.1002/ajmg.1320240209
   Corno AF, 2004, ANN THORAC SURG, V78, P1382, DOI 10.1016/j.athorscsur.2004.02.095
   Costello JM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e67
   Coutu M, 2004, ANN THORAC SURG, V77, P1454, DOI 10.1016/S0003-4975(03)01001-4
   CRAIG RJ, 1968, CIRCULATION, V37, P805
   Crossland DS, 2004, EUR J CARDIO-THORAC, V25, P931, DOI 10.1016/j.ejcts.2004.01.040
   Culbert EL, 2003, CIRCULATION, V108, P857, DOI 10.1161/01.CIR.0000084547.93252.9A
   CULLEN S, 1994, J AM COLL CARDIOL, V23, P1151
   CUMMING G, 2003, DIAGNOSIS MANAGEMENT, P151
   DABIZZI RP, 1988, J AM COLL CARDIOL, V12, P486
   Dajani AS, 1997, CIRCULATION, V96, P358
   Daliento L, 1999, HEART, V81, P650
   Daliento L, 1998, EUR HEART J, V19, P1845, DOI 10.1053/euhj.1998.1046
   DAS SK, 1964, CIRCULATION, V30, P429
   Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   Davos CH, 2002, CIRCULATION, V106, pI69, DOI 10.1161/01.cir.0000032886.55215.15
   Davos Constantinos H, 2003, Circulation, V108 Suppl 1, pII180, DOI 10.1161/01.cir.0000087946.47069.cb
   Deanfield J, 2003, EUR HEART J, V24, P1035, DOI 10.1016/S0195-668X(03)00131-3
   DEANFIELD JE, 1983, CIRCULATION, V67, P626
   Delacretaz E, 2001, J AM COLL CARDIOL, V37, P1665, DOI 10.1016/S0735-1097(01)01192-5
   Delahaye F, 1999, J AM COLL CARDIOL, V33, P788, DOI 10.1016/S0735-1097(98)00624-X
   DELEVAL MR, 1988, J THORAC CARDIOV SUR, V96, P682
   DEMASO DR, 1991, J PEDIATR PSYCHOL, V16, P137, DOI 10.1093/jpepsy/16.2.137
   de Sa M, 1999, J THORAC CARDIOV SUR, V118, P588, DOI 10.1016/S0022-5223(99)70002-4
   Dhillon R, 1999, HEART, V82, P559
   Di Filippo S, 2006, HEART, V92, P1490, DOI 10.1136/hrt.2005.085332
   Dittrich S, 2000, ANN THORAC SURG, V70, P717, DOI 10.1016/S0003-4975(00)01532-0
   Dodge-Khatami A, 2002, ANN THORAC SURG, V74, P946, DOI 10.1016/S0003-4975(02)03633-0
   Dodo Hidemi, 1996, Cardiology Clinics, V14, P383, DOI 10.1016/S0733-8651(05)70291-5
   Dodo H, 1998, AM HEART J, V136, P109, DOI 10.1016/S0002-8703(98)70190-5
   Dogan OF, 2006, HEART SURG FORUM, V9, pE668, DOI 10.1532/HSF98.2005-1022
   Doorey AJ, 2000, AM J CARDIOL, V86, P580, DOI 10.1016/S0002-9149(00)01023-7
   DORE A, 2003, DIAGNOSIS MANAGEMENT, P299
   Dore A, 2005, CIRCULATION, V112, P2411, DOI 10.1161/CIRCULATIONAHA.105.543470
   Dore A, 2004, PACE, V27, P47, DOI 10.1111/j.1540-8159.2004.00384.x
   Doty D B, 1982, Circulation, V66, pI186
   DOWNAR E, 1992, J AM COLL CARDIOL, V20, P648
   Drinkwater Davis C. Jr., 1996, Cardiology Clinics, V14, P451, DOI 10.1016/S0733-8651(05)70295-2
   DRISCOLL DJ, 1988, J AM COLL CARDIOL, V11, P831
   DRISCOLL DJ, 1992, CIRCULATION, V85, P469
   Driscoll David J., 1993, Circulation, V87, pI114
   Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4
   Du ZD, 1998, CARDIOL YOUNG, V8, P500
   DUA R, 1993, J CARDIAC SURG, V8, P384, DOI 10.1111/j.1540-8191.1993.tb00380.x
   DUNNIGAN A, 1984, BRIT HEART J, V52, P198
   DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0
   Earing MG, 2005, MAYO CLIN PROC, V80, P871
   Ebenroth ES, 2000, AM J CARDIOL, V85, P127, DOI 10.1016/S0002-9149(99)00625-6
   Eidem BW, 2000, AM J CARDIOL, V86, P654, DOI 10.1016/S0002-9149(00)01047-X
   Eidem BW, 1998, J AM SOC ECHOCARDIOG, V11, P849, DOI 10.1016/S0894-7317(98)70004-5
   Elkayam U, 2005, J AM COLL CARDIOL, V46, P223, DOI 10.1016/j.jacc.2005.02.085
   Epstein Andrew E, 2008, J Am Coll Cardiol, V51, pe1, DOI 10.1016/j.jacc.2008.02.032
   EUSTACE S, 1994, CLIN RADIOL, V49, P690, DOI 10.1016/S0009-9260(05)82661-3
   Faella HJ, 2000, CATHETER CARDIO INTE, V51, P50, DOI 10.1002/1522-726X(200009)51:1<50::AID-CCD11>3.0.CO;2-6
   Famuyide AO, 2008, MAYO CLIN PROC, V83, P431, DOI 10.4065/83.4.431
   Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8
   Fedoruk LM, 2007, J THORAC CARDIOV SUR, V133, P456, DOI 10.1016/j.jtcvs.2006.10.011
   Feinstein JA, 2001, CIRCULATION, V103, P10
   FELTES TF, 1994, J AM COLL CARDIOL, V24, P1365
   Fernandes SM, 2003, AM J CARDIOL, V91, P632, DOI 10.1016/S0002-9149(02)03328-3
   Fernandes SM, 2004, PEDIATR CLIN N AM, V51, P1739, DOI 10.1016/j.pcl.2004.07.006
   Ferrieri P, 2002, CIRCULATION, V105, P2115, DOI 10.1161/01.CIR.0000013073.22415.90
   FIANE AE, 1996, J HEART VALVE DIS, V5, P377
   FINLEY JP, 1978, AM J CARDIOL, V42, P675, DOI 10.1016/0002-9149(78)90640-9
   Fischer G, 2003, HEART, V89, P199, DOI 10.1136/heart.89.2.199
   Fishberger SB, 1997, J THORAC CARDIOV SUR, V113, P80, DOI 10.1016/S0022-5223(97)70402-1
   FISHER RG, 1986, J AM COLL CARDIOL, V8, P280
   FLANAGAN MF, 1991, AM J CARDIOL, V68, P403, DOI 10.1016/0002-9149(91)90842-9
   FLINN CJ, 1984, NEW ENGL J MED, V310, P1635, DOI 10.1056/NEJM198406213102504
   FOGEL MA, 1995, CIRCULATION, V92, P219
   Fogel MA, 1998, CIRCULATION, V98, P330
   FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240
   Forbess JM, 2002, CIRCULATION, V106, pI95, DOI 10.1161/01.cir.0000032915.33237.72
   Formigari R, 2003, J THORAC CARDIOV SUR, V126, P1753, DOI 10.1016/S0022-5223(03)01325-4
   Foster E, 2001, J AM COLL CARDIOL, V37, P1176, DOI 10.1016/S0735-1097(01)01277-3
   FOWLER VG, 1994, CURR OPIN CARDIOL, V9, P389, DOI 10.1097/00001573-199405000-00018
   FRAKER TD, 1979, CIRCULATION, V59, P379
   Franco-Paredes C, 2002, AM J MED, V112, P590, DOI 10.1016/S0002-9343(02)01038-0
   Fredriksen PM, 2000, CARDIOL YOUNG, V10, P107
   Fredriksen PM, 2001, AM J CARDIOL, V87, P310, DOI 10.1016/S0002-9149(00)01364-3
   Fredriksen PM, 2002, CARDIOL YOUNG, V12, P554, DOI 10.1017/S1047951102001002
   Fredriksen PM, 2001, HEART, V85, P191, DOI 10.1136/heart.85.2.191
   Fredriksen PM, 2001, HEART, V85, P295, DOI 10.1136/heart.85.3.295
   FREED MD, 1984, J AM COLL CARDIOL, V4, P333
   FREEDOM RM, 2004, NATURAL MODIFIED HIS, P232
   FREEDOM RM, 2003, DIAGNOSIS MANAGEMENT, P85
   FREIJ BJ, 1988, CLIN PERINATOL, V15, P247
   FRIEDBER.DZ, 1970, NEW ENGL J MED, V282, P1053, DOI 10.1056/NEJM197005072821901
   Frommelt PC, 2003, J AM COLL CARDIOL, V42, P148, DOI 10.1016/S0735-1097(03)00503-5
   FRYNS JP, 1992, ANN GENET-PARIS, V35, P186
   Fuster V, 1980, Cardiovasc Clin, V10, P161
   Galie N, 2002, J AM COLL CARDIOL, V39, P1496, DOI 10.1016/S0735-1097(02)01786-2
   Galie N, 2006, CIRCULATION, V114, P48, DOI 10.1161/CIRCULATIONAHA.106.630715
   GALIE N, 2006, PULMONARY ARTERIAL H, P11
   Gamba A, 2004, J THORAC CARDIOV SUR, V127, P555, DOI 10.1016/j.jtcvs.2003.08.016
   Gandhi SK, 2002, ANN THORAC SURG, V73, P88, DOI 10.1016/S0003-4975(01)03292-1
   GARSON A, 1985, J AM COLL CARDIOL, V6, P871
   GARSON A, 1974, J PEDIATR, V85, P429, DOI 10.1016/S0022-3476(74)80136-8
   GARSON A, 1985, J AM COLL CARDIOL, V6, P221
   GATZOULIS MA, 2003, DIAGNOSIS MANAGEMENT
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   GATZOULIS MA, 1995, CIRCULATION, V92, P231
   Gelatt M, 1997, J AM COLL CARDIOL, V29, P194
   GENTLES TL, 1993, J AM COLL CARDIOL, V22, P867
   Gersony WM, 2001, J AM COLL CARDIOL, V38, P843, DOI 10.1016/S0735-1097(01)01454-1
   Gersony Welton M., 1993, Circulation, V87, pI121
   Gersony W M, 1989, Cardiol Clin, V7, P915
   Geva A, 2007, J AM COLL CARDIOL, V50, P1498, DOI 10.1016/j.jacc.2007.07.013
   Ghai A, 2002, J AM COLL CARDIOL, V40, P1675, DOI 10.1016/S0735-1097(02)02344-6
   Ghai A, 2001, J AM COLL CARDIOL, V37, P585, DOI 10.1016/S0735-1097(00)01141-4
   Gibbs JL, 1997, HEART, V77, P176
   GILLETTE PC, 1977, CIRCULATION, V56, P566
   Gober V, 2005, ANN THORAC SURG, V79, P625, DOI 10.1016/j.athoracsur.2004.07.085
   GOITEIN KJ, 1980, AM J CARDIOL, V45, P604, DOI 10.1016/S0002-9149(80)80011-7
   GOLDBERG S, 1991, J PEDIATR, V119, P661, DOI 10.1016/S0022-3476(05)82425-4
   GOLDNER BG, 1994, PACE, V17, P1441, DOI 10.1111/j.1540-8159.1994.tb02465.x
   Gonska BD, 1996, CIRCULATION, V94, P1902
   Gould FK, 2006, J ANTIMICROB CHEMOTH, V57, P1035, DOI 10.1093/jac/dk1121
   Graham TP, 2000, J AM COLL CARDIOL, V36, P255, DOI 10.1016/S0735-1097(00)00682-3
   GRAHAM TP, 1994, J AM COLL CARDIOL, V24, P867
   Graham TP, 2005, J AM COLL CARDIOL, V45, P1326, DOI 10.1016/j.jacc.2005.02.009
   GRAHAM TP, 1989, MOSS ADAMS HEART DIS, P724
   GRAHAM TP, 1994, MED SCI SPORT EXER, V26, pS246
   Gring CN, 2004, J AM COLL CARDIOL, V44, P1841, DOI 10.1016/j.jacc.2004.07.044
   Guedes A, 2004, J AM COLL CARDIOL, V44, P433, DOI 10.1016/j.jacc.2004.04.037
   Gupta D, 2001, AM J CARDIOL, V87, P241, DOI 10.1016/S0002-9149(00)01330-8
   GUTGESELL HP, 1986, CIRCULATION, V74, P1195
   Hachiro Y, 2001, ANN THORAC SURG, V72, P1520, DOI 10.1016/S0003-4975(01)02982-4
   Hadchouel Michelle, 2002, Indian Journal of Pediatrics, V69, P815, DOI 10.1007/BF02723697
   Hamada H, 2002, CARDIOL YOUNG, V12, P345
   Hameed A, 2001, J AM COLL CARDIOL, V37, P893, DOI 10.1016/S0735-1097(00)01198-0
   Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1
   Harrison DA, 2001, AM J CARDIOL, V87, P584, DOI 10.1016/S0002-9149(00)01435-1
   HARRISON DA, 1995, J AM COLL CARDIOL, V26, P1016, DOI 10.1016/0735-1097(95)00242-7
   Harrison DA, 1996, AM J CARDIOL, V77, P1094, DOI 10.1016/S0002-9149(96)00139-7
   Hart Ellen M., 1993, Cardiology Clinics, V11, P711
   Hartnell GG, 1996, CLIN RADIOL, V51, P851, DOI 10.1016/S0009-9260(96)80081-X
   HAUSDORF G, 1995, AM J CARDIOL, V76, P621, DOI 10.1016/S0002-9149(99)80171-4
   Hauser M, 2001, CIRCULATION, V103, P1875
   Hayes Constance J., 1993, Circulation, V87, pI28
   HEATH D, 1958, CIRCULATION, V18, P533
   Hechter SJ, 2001, CARDIOL YOUNG, V11, P407, DOI 10.1017/S104795110100052X
   Hechter SJ, 2001, AM J CARDIOL, V87, P660, DOI 10.1016/S0002-9149(00)01452-1
   Helber U, 1997, J AM COLL CARDIOL, V29, P1345
   Higgins Sarah S, 2003, Prog Cardiovasc Nurs, V18, P93, DOI 10.1111/j.1751-7117.2003.tb00310.x
   Hijazi ZM, 1996, AM HEART J, V132, P827, DOI 10.1016/S0002-8703(96)90318-X
   HIJAZI ZM, 1994, AM J CARDIOL, V74, P925, DOI 10.1016/0002-9149(94)90588-6
   Hoare JV, 2001, AUST NZ J OBSTET GYN, V41, P464, DOI 10.1111/j.1479-828X.2001.tb01334.x
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   Hokanson JS, 2001, AM J CARDIOL, V87, P1271, DOI 10.1016/S0002-9149(01)01518-1
   HOLMVANG G, 1995, CIRCULATION, V92, P3473
   HOLT M, 1960, BRIT HEART J, V22, P236
   Holzer R, 2004, J AM COLL CARDIOL, V43, P1257, DOI 10.1016/j.jacc.2003.10.047
   Hong Thomas E, 2002, Indian Heart J, V54, P384
   Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80
   Horner T, 2000, MAYO CLIN PROC, V75, P31
   Hornung TS, 1999, AM J CARDIOL, V84, P1116, DOI 10.1016/S0002-9149(99)00516-0
   Hornung TS, 1998, HEART, V80, P322
   Hornung TS, 2003, AM J CARDIOL, V92, P640, DOI 10.1016/S0002-9149(03)00745-8
   HOROWITZ LN, 1980, AM J CARDIOL, V46, P446, DOI 10.1016/0002-9149(80)90014-4
   Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008
   HOSKING MCK, 1991, CIRCULATION, V84, P2313
   Hovels-Gurich HH, 2002, ARCH DIS CHILD, V87, P506, DOI 10.1136/adc.87.6.506
   HUHTA JC, 1983, CIRCULATION, V67, P1374
   HUNDLEY WG, 1995, CIRCULATION, V91, P2955
   Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022
   HUTCHINS GM, 1978, AM J CARDIOL, V42, P57, DOI 10.1016/0002-9149(78)90985-2
   Hutter PA, 2002, J THORAC CARDIOV SUR, V124, P790, DOI 10.1067/mtc.2002.120714
   Ibrahim T, 2002, CIRCULATION, V105, P2692, DOI 10.1161/01.CIR.0000013206.40857.B6
   Ing FF, 1996, CLIN CARDIOL, V19, P875
   Iserin L, 1997, EUR HEART J, V18, P1350
   Ismat FA, 2002, INT J CARDIOL, V86, P207, DOI 10.1016/S0167-5273(02)00325-X
   Jacobs J P, 2000, Ann Thorac Surg, V69, pS25
   Jais P, 2000, CIRCULATION, V101, P772
   Janousek J, 2004, J AM COLL CARDIOL, V44, P1927, DOI 10.1016/j.jacc.2004.08.044
   Jarrar M, 1999, AM HEART J, V138, P950, DOI 10.1016/S0002-8703(99)70022-0
   Jayakumar KA, 2004, J AM COLL CARDIOL, V44, P2065, DOI 10.1016/j.jacc.2004.08.031
   JOHN S, 1981, J THORAC CARDIOV SUR, V82, P314
   JOHNSON DH, 1975, CIRCULATION, V51, P581
   JONES P, 1995, BRIT J HOSP MED, V54, P214
   JONES RN, 1968, CIRCULATION, V38, P468
   JONSSON H, 1995, SCAND J THORAC CARD, V29, P131, DOI 10.3109/14017439509107219
   Kalman JM, 1996, CIRCULATION, V93, P502
   Kammeraad JAE, 2004, J AM COLL CARDIOL, V44, P1095, DOI 10.1016/j.jace.2004.05.073
   KAN JS, 1982, NEW ENGL J MED, V307, P540, DOI 10.1056/NEJM198208263070907
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Kantoch MJ, 1997, CAN J CARDIOL, V13, P641
   KAPLAN EL, 1979, CIRCULATION, V59, P327
   Kato H, 1996, CIRCULATION, V94, P1379
   KATZ NM, 1977, CIRCULATION, V56, P1034
   KEITH JD, 1959, BRIT HEART J, V21, P149
   Khairy P, 2004, CIRCULATION, V109, P1994, DOI 10.1161/01.CIR.0000126495.11040.BD
   Khairy P, 2006, CIRCULATION, V113, P2391, DOI 10.1161/CIRCULATIONAHA.106.622076
   KHAN MAA, 1989, AM J CARDIOL, V64, P218
   Khositseth A, 2004, J THORAC CARDIOV SUR, V128, P826, DOI 10.1016/j.jtcvs.2004.02.012
   Kidd Langford, 1993, Circulation, V87, pI38
   KIRKLIN JK, 1988, J HEART TRANSPLANT, V7, P331
   Kirsh JA, 2002, AM J CARDIOL, V90, P338, DOI 10.1016/S0002-9149(02)02480-3
   Kiziltan HT, 1998, ANN THORAC SURG, V66, P1539, DOI 10.1016/S0003-4975(98)00961-8
   Knauth AL, 2004, CIRCULATION, V110, P501, DOI 10.1161/01.CIR.0000137116.12176.A6
   Koch K, 2005, EUR RADIOL, V15, P312, DOI 10.1007/s00330-004-2543-6
   KOKKONEN J, 1992, INT J CARDIOL, V36, P23, DOI 10.1016/0167-5273(92)90104-B
   KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801
   Kreutzer J, 1996, CIRCULATION, V93, P1417
   KRICHENKO A, 1989, AM J CARDIOL, V63, P877, DOI 10.1016/0002-9149(89)90064-7
   Krivokapich Janine, 1996, Cardiology Clinics, V14, P363, DOI 10.1016/S0733-8651(05)70290-3
   KRONZON I, 1991, J AM COLL CARDIOL, V17, P537
   Kubak Bernard M., 1996, Cardiology Clinics, V14, P405, DOI 10.1016/S0733-8651(05)70293-9
   KUGLER JD, 1983, AM J CARDIOL, V51, P1137, DOI 10.1016/0002-9149(83)90359-4
   KUMAR A, 1993, AM J MED GENET, V45, P739, DOI 10.1002/ajmg.1320450614
   Kwok O H, 2001, J Invasive Cardiol, V13, P494
   Laforest I, 2002, CIRCULATION, V106, pI57, DOI 10.1161/01.cir.0000032912.33237.bc
   LAKATTA EG, 1993, CIRCULATION, V87, P631
   Lamas CC, 2000, CLIN INFECT DIS, V30, P336, DOI 10.1086/313646
   Landzberg MJ, 2001, J AM COLL CARDIOL, V37, P1187, DOI 10.1016/S0735-1097(01)01275-X
   Lane DA, 2002, HEART, V88, P71, DOI 10.1136/heart.88.1.71
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   LAWRENCE J, 2005, LIFETIME EFFECTS MON, P14
   Lee CH, 2001, JPN HEART J, V42, P533, DOI 10.1536/jhj.42.533
   Lee Chi-Hang, 2003, J Invasive Cardiol, V15, P26
   Legendre A, 2003, Circulation, V108 Suppl 1, pII186, DOI 10.1161/01.cir.0000087902.67220.2b
   Leier CV, 2004, J AM COLL CARDIOL, V44, P1831, DOI 10.1016/j.jacc.2004.08.013
   Lester SJ, 2001, AM J CARDIOL, V88, P1314, DOI 10.1016/S0002-9149(01)02098-7
   Li W, 1998, EUR HEART J, V19, P166, DOI 10.1053/euhj.1997.0821
   Li W, 2000, INT J CARDIOL, V75, P129, DOI 10.1016/S0167-5273(00)00308-9
   LINDE LM, 1970, ACTA PAEDIATR SCAND, V59, P169, DOI 10.1111/j.1651-2227.1970.tb08984.x
   LINDSAY J, 1988, AM J CARDIOL, V61, P182, DOI 10.1016/0002-9149(88)91327-6
   Lissin LW, 2004, AM J CARDIOL, V93, P654, DOI 10.1016/j.amjcard.2003.11.044
   LLOYD TR, 1987, AM HEART J, V114, P268, DOI 10.1016/0002-8703(87)90489-3
   LLOYD TR, 1993, CIRCULATION, V88, P1412
   LOCK JE, 1988, CIRCULATION, V78, P361
   LOCK JE, 1983, CIRCULATION, V67, P962
   Losay J, 2001, CIRCULATION, V104, pI121
   Losay J, 1997, CURR OPIN CARDIOL, V12, P84, DOI 10.1097/00001573-199701000-00013
   LOSCALZO J, 1986, AM HEART J, V112, P141, DOI 10.1016/0002-8703(86)90692-7
   LUNDSTROM U, 1990, AM J CARDIOL, V65, P1222, DOI 10.1016/0002-9149(90)90978-A
   MacLellanTobert SG, 1997, J AM COLL CARDIOL, V29, P1615
   MAHONEY LT, 1991, J AM COLL CARDIOL, V18, P334
   Maisel AS, 2003, HEART FAIL REV, V8, P339, DOI 10.1023/A:1026139130208
   Mandapati R, 2003, J CARDIOVASC ELECTR, V14, P119
   Manning PB, 1996, J THORAC CARDIOV SUR, V111, P833, DOI 10.1016/S0022-5223(96)70344-6
   MARANTZ PM, 1988, J AM COLL CARDIOL, V12, P476
   MARCELLETTI C, 1990, J THORAC CARDIOV SUR, V100, P228
   Marcelletti CF, 2000, J THORAC CARDIOV SUR, V119, P340, DOI 10.1016/S0022-5223(00)70190-5
   Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224
   Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199
   MARTIN MM, 1988, ANN THORAC SURG, V45, P16
   Massin MM, 1998, EUR J PEDIATR, V157, P95, DOI 10.1007/s004310050777
   MASURA J, 1993, J AM COLL CARDIOL, V21, P132
   Masura J, 1998, J AM COLL CARDIOL, V31, P878, DOI 10.1016/S0735-1097(98)00013-8
   MAUTNER GC, 1993, AM J CARDIOL, V72, P194, DOI 10.1016/0002-9149(93)90159-A
   MAVROUDIS C, 2003, DIAGNOSIS MANAGEMENT, P79
   Mavroudis C, 1997, ANN THORAC SURG, V63, P1235, DOI 10.1016/S0003-4975(97)00251-8
   Mavroudis C, 1998, J THORAC CARDIOV SUR, V115, P547, DOI 10.1016/S0022-5223(98)70316-2
   Mavroudis C, 2007, ANN THORAC SURG, V84, P1457, DOI 10.1016/j.athoracsur.2007.06.079
   Mavroudis C, 2001, J THORAC CARDIOV SUR, V122, P863, DOI 10.1067/mtc.2001.117840
   MCCONNELL MV, 1995, CIRCULATION, V92, P3158
   McCrindle BW, 1996, J AM COLL CARDIOL, V28, P1810
   MCCRINDLE BW, 1991, CIRCULATION, V83, P1915
   McElhinney DB, 2003, DIAGNOSIS MANAGEMENT, P305
   MCGRATH KA, 1994, NURS CLIN N AM, V29, P319
   MCKINSEY DS, 1987, AM J MED, V82, P681, DOI 10.1016/0002-9343(87)90001-5
   McLaughlin VV, 1999, ANN INTERN MED, V130, P740
   McMahon CJ, 2001, J AM COLL CARDIOL, V38, P521
   McMahon CJ, 2004, AM J CARDIOL, V94, P459, DOI 10.1016/j.amjcard.2004.05.005
   McMurray JJV, 2004, CIRCULATION, V110, P3281, DOI 10.1161/01.CIR.0000147274.83071.68
   MCNAMARA DG, 1985, J AM COLL CARDIOL, V6, P1200
   MCNAMARA DG, 1982, AM J CARDIOL, V50, P560, DOI 10.1016/0002-9149(82)90325-3
   MEHTA RH, 1990, J AM COLL CARDIOL, V16, P1010
   MEHTA RH, 1991, AM J CARDIOL, V67, P288, DOI 10.1016/0002-9149(91)90561-X
   MENDEZ HMM, 1985, AM J MED GENET, V21, P493, DOI 10.1002/ajmg.1320210312
   *MENT HLTH, 1999, MENTAL HEALTH REPORT
   Mertens L, 1998, J THORAC CARDIOV SUR, V115, P1063, DOI 10.1016/S0022-5223(98)70406-4
   MILO S, 1988, BRIT HEART J, V60, P128
   Mohanakrishnan Laxmanan, 2003, Asian Cardiovasc Thorac Ann, V11, P74
   Momma K, 2001, GENET MED, V3, P56, DOI 10.1097/00125817-200101000-00012
   Moons P, 2004, ANN THORAC SURG, V77, P1359, DOI 10.1016/j.athoracsur.2003.09.073
   Moons P, 2007, INT J CARDIOL, V121, P30, DOI 10.1016/j.ijcard.2006.10.020
   Moons P, 2001, HEART, V86, P74, DOI 10.1136/heart.86.1.74
   Moons P, 2005, EUR HEART J, V26, P298, DOI 10.1093/eurheartj/ehi054
   Moons P, 2004, HEART, V90, P307, DOI 10.1136/hrt.2002.007138
   Moons P, 2006, EUR J CARDIOV PREV R, V13, P407, DOI 10.1097/00149831-200606000-00017
   MOORE JW, 1994, J AM COLL CARDIOL, V23, P759
   Moran AM, 1998, J AM COLL CARDIOL, V31, P1127, DOI 10.1016/S0735-1097(98)00034-5
   Morris CD, 1998, JAMA-J AM MED ASSOC, V279, P599, DOI 10.1001/jama.279.8.599
   Morwood JG, 2004, HEART RHYTHM, V1, P301, DOI 10.1016/j.hrthm.2004.05.009
   Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Murphy L S, 1993, Del Med J, V65, P329
   Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082
   Nahlawi M, 2004, J AM COLL CARDIOL, V44, P1883, DOI 10.1016/j.jacc.2004.06.074
   Nakagawa H, 2001, CIRCULATION, V103, P699
   Netzer ROM, 2002, HEART, V88, P61, DOI 10.1136/heart.88.1.61
   Neumayer U, 1998, EUR HEART J, V19, P1573, DOI 10.1053/euhj.1998.1083
   NG ASH, 1986, INT J CARDIOL, V11, P277, DOI 10.1016/0167-5273(86)90032-X
   Nielsen JC, 2005, CIRCULATION, V111, P622, DOI 10.1161/01.CIR.0000154549.53684.64
   Nieminen H, 2003, PEDIATRICS, V112, P1345, DOI 10.1542/peds.112.6.1345
   Nistri S, 1999, HEART, V82, P19
   Niwa Koichiro, 2002, J Cardiol, V39, P259
   Niwa K, 2001, CIRCULATION, V103, P393
   Niwa K, 2005, HEART, V91, P795, DOI 10.1136/hrt.2004.043323
   Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5
   Noonan J, 1999, CARDIOL YOUNG, V9, P545
   NORA JJ, 1976, CIRCULATION, V53, P701
   Norgaard MA, 1999, EUR J CARDIO-THORAC, V16, P125, DOI 10.1016/S1010-7940(99)00137-2
   OATES RK, 1995, ARCH DIS CHILD, V72, P298
   OCONNOR BK, 1992, J AM COLL CARDIOL, V20, P169
   Oechslin E, 2000, THORAC CARDIOV SURG, V48, P233, DOI 10.1055/s-2000-6901
   OH JK, 1985, J AM COLL CARDIOL, V6, P1351
   Ohmoto Y, 1997, CATHETER CARDIO DIAG, V42, P48, DOI 10.1002/(SICI)1097-0304(199709)42:1<48::AID-CCD14>3.0.CO;2-I
   Ohuchi H, 2004, CIRCULATION, V110, P2601, DOI 10.1161/01.CIR.0000145545.83564.51
   Ohuchi H, 2001, CIRCULATION, V104, P1513, DOI 10.1161/hc3801.096326
   Ohuchi H, 2002, CIRCULATION, V106, P2819, DOI 10.1161/01.CIR.0000038891.06306.BA
   O'Laughlin MP, 1998, PEDIATR CARDIOL, V19, P48, DOI 10.1007/s002469900245
   OLAUGHLIN MP, 1993, CIRCULATION, V88, P605
   Oliver JM, 2001, J AM COLL CARDIOL, V38, P835, DOI 10.1016/S0735-1097(01)01464-4
   Oliver JM, 2003, J THORAC CARDIOV SUR, V126, P711, DOI 10.1016/S0022-5223(03)00044-8
   OLIVER R, 2004, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003813.pub2
   Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204
   Onat T, 1998, PEDIATR CARDIOL, V19, P230, DOI 10.1007/s002469900291
   Park SJ, 1997, AM J CARDIOL, V80, P1514, DOI 10.1016/S0002-9149(97)00724-8
   Parry AJ, 1999, EUR J CARDIO-THORAC, V15, P631, DOI 10.1016/S1010-7940(99)00060-3
   Pascoe RD, 1996, CIRCULATION, V94, P1049
   Pasquali SK, 2002, CIRCULATION, V106, P2575, DOI 10.1161/01.CIR.0000036745.19310.BB
   PEASE WE, 1976, CIRCULATION, V53, P759
   Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903
   Perloff JK, 2003, AM J CARDIOL, V92, P182, DOI 10.1016/S0002-9149(03)00535-6
   Perloff JK, 2001, CIRCULATION, V103, P2637
   PERLOFF JK, 1988, ANN INTERN MED, V109, P406
   PERLOFF JK, 2003, CLINICAL RECOGNITION
   PERLOFF JK, 1993, CIRCULATION, V87, P1954
   Perloff Joseph K., 1993, Cardiology Clinics, V11, P689
   PERLOWSKI A, 2004, J AM COLL CARDIOL AS, V43, P391
   Peterson C, 2003, ANN THORAC SURG, V76, P1078, DOI 10.1016/S0003-4975(03)00678-7
   Pignatelli RH, 2003, CURR OPIN CARDIOL, V18, P357, DOI 10.1097/00001573-200309000-00006
   Podnar T, 2000, EUR J PEDIATR, V159, P293, DOI 10.1007/s004310050073
   Poirier NC, 2000, SEMIN THORAC CARDIOV, V3, P198
   PONGIGLIONE G, 1982, AM J CARDIOL, V50, P776, DOI 10.1016/0002-9149(82)91233-4
   POWELL AJ, 1995, CIRCULATION, V92, P3282
   Prakash A, 2004, AM J CARDIOL, V93, P657, DOI 10.1016/j.amjcard.2003.11.045
   Prendergast BD, 2002, BRIT MED J, V325, P845, DOI 10.1136/bmj.325.7369.845
   PRESBITERO P, 1994, CIRCULATION, V89, P2673
   Prieto LR, 1998, CIRCULATION, V98, P997
   Prifti E, 2002, EUR J CARDIO-THORAC, V21, P111, DOI 10.1016/S1010-7940(01)01074-0
   PROSAD S, 2003, DIAGNOSIS MANAGEMENT, P171
   Prystowsky EN, 1996, CIRCULATION, V93, P1262
   Puley G, 1999, AM J CARDIOL, V83, P1080, DOI 10.1016/S0002-9149(99)00019-3
   PURUT CM, 1991, J THORAC CARDIOV SUR, V102, P566
   Raff GW, 2000, J AM SOC ECHOCARDIOG, V13, P58, DOI 10.1016/S0894-7317(00)90043-9
   Raisky O, 2007, EUR J CARDIO-THORAC, V31, P894, DOI 10.1016/j.ejcts.2007.02.003
   Randolph GR, 2002, J THORAC CARDIOV SUR, V124, P1176, DOI 10.1067/mtc.2002.125816
   Rao PS, 1996, J INVASIVE CARDIOL, V8, P278
   RAO PS, 1988, AM J CARDIOL, V62, P979, DOI 10.1016/0002-9149(88)90909-5
   Rao PS, 1998, AM J CARDIOL, V82, P827, DOI 10.1016/S0002-9149(98)00441-X
   Rao Vivek, 2000, Circulation, V102
   RASHKIND WJ, 1987, CIRCULATION, V75, P583
   Reich JD, 1998, J CARDIOVASC ELECTR, V9, P1370, DOI 10.1111/j.1540-8167.1998.tb00113.x
   Reid GJ, 2004, PEDIATRICS, V113, pE197, DOI 10.1542/peds.113.3.e197
   RHODES LA, 1995, AM HEART J, V130, P323, DOI 10.1016/0002-8703(95)90448-4
   RHODES LA, 1995, PACE, V18, P1005, DOI 10.1111/j.1540-8159.1995.tb04741.x
   RHODES LA, 1995, J THORAC CARDIOV SUR, V109, P303, DOI 10.1016/S0022-5223(95)70392-6
   RIGBY M, 2003, DIAGNOSIS MANAGEMENT
   Ringel RE, 2003, AM J CARDIOL, V91, P1031, DOI 10.1016/S0002-9149(03)00135-8
   ROBERTS CS, 1991, J AM COLL CARDIOL, V17, P712
   Roberts W C, 1975, Cardiovasc Clin, V7, P1
   ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7
   Robicsek F, 2004, ANN THORAC SURG, V77, P177, DOI 10.1016/S0003-4975(03)01249-9
   Robinson B, 2002, PEDIATR CARDIOL, V23, P618, DOI 10.1007/s00246-002-0046-2
   ROME JJ, 1993, CIRCULATION, V88, P1691
   Romp RL, 2003, ANN THORAC SURG, V76, P589, DOI 10.1016/S0003-4975(03)00436-3
   ROOSHESSELINK J, 1995, CIRCULATION, V91, P2214
   Roos-Hesselink JW, 2004, EUR HEART J, V25, P1264, DOI 10.1016/j.ehj.2004.03.009
   Ropers D, 2001, AM J CARDIOL, V87, P193, DOI 10.1016/S0002-9149(00)01315-1
   Rosenhek R, 2003, J AM SOC ECHOCARDIOG, V16, P1116, DOI 10.1067/S0894-7317(03)00638-2
   ROSOVE MH, 1983, THROMB RES, V29, P225, DOI 10.1016/0049-3848(83)90144-5
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Russo CF, 2002, ANN THORAC SURG, V74, pS1773, DOI 10.1016/S0003-4975(02)04261-3
   Russo G, 2005, J CARDIOVASC ELECTR, V16, P288, DOI 10.1046/j.1540-8167.2005.40312.x
   Sabik JF, 2002, ANN THORAC SURG, V74, P650, DOI 10.1016/S0003-4975(02)03779-7
   Sadr-Ameli MA, 1998, AM J CARDIOL, V82, P398, DOI 10.1016/S0002-9149(98)00302-6
   SAHA A, 1994, INT J CARDIOL, V45, P199, DOI 10.1016/0167-5273(94)90166-X
   SAIMAN L, 1993, J PEDIATR, V122, P847
   Salehian O, 2004, CIRCULATION, V110, P3229, DOI 10.1161/01.CIR.0000147284.54140.73
   Sandoval J, 2001, AM J RESP CRIT CARE, V164, P1682
   SARELI P, 1989, AM J CARDIOL, V63, P1462, DOI 10.1016/0002-9149(89)90008-8
   Sarkar D, 1999, Circulation, V100, pII176
   Schaefer C, 2006, THROMB HAEMOSTASIS, V95, P949, DOI 10.1160/TH06-02-0108
   SCHENCK MH, 1993, AM J CARDIOL, V72, P591, DOI 10.1016/0002-9149(93)90357-I
   SCHIEBLER GL, 1961, PEDIATRICS S, P849
   SCHIEVINK WI, 1995, STROKE, V26, P1935
   Schmidtke C, 2001, CIRCULATION, V104, pI21
   Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108
   SCHREIBER TL, 1980, CIRCULATION, V61, P888
   Schwartz ML, 2004, CIRCULATION, V110, pII128, DOI 10.1161/01.CIR.0000138392.68841.d3
   SEGUCHI M, 1990, EUR HEART J, V11, P213
   Holmes Sellors T, 1948, LANCET, V251, P988
   SEWARD JB, 1979, MAYO CLIN PROC, V54, P193
   Shaffer KM, 1998, J AM COLL CARDIOL, V31, P661, DOI 10.1016/S0735-1097(97)00535-4
   Shamsham F, 1999, ANGIOLOGY, V50, P519, DOI 10.1177/000331979905000612
   SHIRANI J, 1993, AM J CARDIOL, V72, P368, DOI 10.1016/0002-9149(93)90692-6
   SHIVALKAR B, 1994, J AM COLL CARDIOL, V23, P772
   SHUB C, 1985, J AM COLL CARDIOL, V6, P49
   SIETSEMA KE, 1986, CIRCULATION, V73, P1137
   SIETSEMA KE, 1988, J APPL PHYSIOL, V64, P234
   SIETSEMA KE, 1991, J AM COLL CARDIOL, V18, P322
   Sievers Hans- H, 2003, Circulation, V108 Suppl 1, pII55, DOI 10.1161/01.cir.0000087443.84392.32
   Sievert H, 1997, EUR HEART J, V18, P1014
   Silka MJ, 1998, J AM COLL CARDIOL, V32, P245, DOI 10.1016/S0735-1097(98)00187-9
   SILKA MJ, 1991, PACE, V14, P499, DOI 10.1111/j.1540-8159.1991.tb02820.x
   SILVERMAN NH, 1995, AM J CARDIOL, V76, P1277, DOI 10.1016/S0002-9149(99)80356-7
   Silversides CK, 2003, AM J CARDIOL, V91, P1386, DOI 10.1016/S0002-9149(03)00340-0
   Silversides CK, 2003, J AM COLL CARDIOL, V42, P1982, DOI 10.1016/j.jacc.2003.07.022
   Silvilairat S, 2005, J AM SOC ECHOCARDIOG, V18, P1143, DOI 10.1016/j.echo.2005.04.003
   Simko Lynn Coletta, 2003, AACN Clin Issues, V14, P42, DOI 10.1097/00044067-200302000-00006
   Simon-Kupilik N, 2002, EUR J CARDIO-THORAC, V21, P470, DOI 10.1016/S1010-7940(02)00016-7
   Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/rccm.2106079
   Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037
   Simpson I A, 1995, Am J Card Imaging, V9, P29
   Siu SC, 2001, CIRCULATION, V104, P515, DOI 10.1161/hc3001.093437
   Siu SC, 2001, HEART, V85, P710, DOI 10.1136/heart.85.6.710
   Siu SC, 1997, CIRCULATION, V96, P2789
   Siu SC, 2002, CIRCULATION, V105, P2179, DOI 10.1161/01.CIR.0000015699.48605.08
   Skorton DJ, 2001, J AM COLL CARDIOL, V37, P1193, DOI 10.1016/S0735-1097(01)01274-8
   Sliwa K, 2004, J AM COLL CARDIOL, V44, P1825, DOI 10.1016/j.jacc.2004.05.087
   SMITH WM, 1982, AM J CARDIOL, V49, P1223, DOI 10.1016/0002-9149(82)90048-0
   SONDEL PM, 1981, PEDIATRICS, V67, P667
   SPARKES RS, 1998, CONGENITAL HEART DIS, P165
   Spirito P, 1999, CIRCULATION, V99, P2132
   SPRAY TL, 1992, ANN THORAC SURG, V54, P216
   SREERAM N, 1991, EUR HEART J, V12, P231
   Stamm C, 2001, J THORAC CARDIOV SUR, V121, P28, DOI 10.1067/mtc.2001.111422
   STANGER P, 1990, AM J CARDIOL, V65, P775, DOI 10.1016/0002-9149(90)91387-L
   STATE MW, 1998, CONGENITAL HEART DIS, P227
   STEELE PM, 1987, CIRCULATION, V76, P1037
   Stephenson EA, 2003, AM J CARDIOL, V92, P871, DOI 10.1016/S0002-9149(03)00905-6
   STERN H, 1993, J THORAC CARDIOV SUR, V106, P723
   Swan L, 2000, HEART, V83, P685, DOI 10.1136/heart.83.6.685
   TAKEUCHI S, 1979, J THORAC CARDIOVASC, V79, P7
   TANEL RE, 1995, AM J CARDIOL, V76, P153, DOI 10.1016/S0002-9149(99)80048-4
   TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640
   Taylor AM, 1999, J CARDIOV MAGN RESON, V1, P43, DOI 10.3109/10976649909080832
   Taylor DO, 2007, J HEART LUNG TRANSPL, V26, P769, DOI 10.1016/j.healun.2007.06.004
   Teerlink JR, 2005, CIRCULATION, V111, P1459, DOI 10.1161/01.CIR.0000160874.48045.54
   Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7
   Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9
   TERRITO MC, 1991, J AM COLL CARDIOL, V18, P320
   Teupe CHJ, 1997, AM J CARDIOL, V80, P240
   Thambo JB, 2004, CIRCULATION, V110, P3766, DOI 10.1161/01.CIR.0000150336.86033.8D
   THAULOW E, 2003, DIAGNOSIS MANAGEMENT, P145
   Therrien J, 2001, CIRCULATION, V103, P2489
   Therrien J, 1999, AM J CARDIOL, V84, P820, DOI 10.1016/S0002-9149(99)00444-0
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Therrien J, 2001, Can J Cardiol, V17, P1135
   Therrien J, 2003, CAN J CARDIOL, V19, P685
   THIENE G, 1981, J THORAC CARDIOV SUR, V82, P928
   Thistlethwaite PA, 2000, J THORAC CARDIOV SUR, V120, P1040, DOI 10.1067/mtc.2000.110493
   Torrent-Guasp F, 2001, J THORAC CARDIOV SUR, V122, P389, DOI 10.1067/mtc.2001.113745
   Tramboo NA, 2002, J PAEDIATR CHILD H, V38, P521, DOI 10.1046/j.1440-1754.2002.00027.x
   Triedman JK, 2002, J AM COLL CARDIOL, V39, P1827, DOI 10.1016/S0735-1097(02)01858-2
   Triedman JK, 1997, J AM COLL CARDIOL, V30, P1032, DOI 10.1016/S0735-1097(97)00252-0
   Triedman JK, 2001, CIRCULATION, V103, P2060
   Triedman J., 2001, CARDIAC ARRHYTHMIAS, P137
   Troughton RW, 2004, J AM COLL CARDIOL, V43, P416, DOI 10.1016/j.jacc.2003.08.046
   Trulock EP, 2001, CLIN CHEST MED, V22, P583, DOI 10.1016/S0272-5231(05)70293-8
   Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X
   Tulevski II, 2002, AM J CARDIOL, V89, P1077, DOI 10.1016/S0002-9149(02)02279-8
   Tworetzky W, 1999, J AM COLL CARDIOL, V33, P228, DOI 10.1016/S0735-1097(98)00518-X
   *US DEPT LAB, 2008, US DEPT LABOR FAMILY
   UTENS EMWJ, 1993, PSYCHOL MED, V23, P415
   UTENS EMWJ, 1994, J PSYCHOSOM RES, V38, P745, DOI 10.1016/0022-3999(94)90027-2
   van den Bosch AE, 2004, AM J CARDIOL, V93, P1141, DOI 10.1016/j.amjcard.2004.01.041
   Vanderheyden M, 2004, J AM COLL CARDIOL, V44, P2349, DOI 10.1016/j.jacc.2004.09.038
   VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1863, DOI 10.1001/archinte.152.9.1863
   VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1869, DOI 10.1001/archinte.152.9.1869
   van Driel D, 2001, PEDIATRICS, V107, P123, DOI 10.1542/peds.107.1.123
   Van Praagh R, 1998, AM HEART J, V135, P772, DOI 10.1016/S0002-8703(98)70035-3
   van Rijen EHM, 2004, EUR HEART J, V25, P1605, DOI 10.1016/j.ehj.2004.06.025
   VANSON JAM, 1994, J THORAC CARDIOV SUR, V108, P21
   VANSON JAM, 1995, J THORAC CARDIOV SUR, V109, P642, DOI 10.1016/S0022-5223(95)70345-4
   van Straten A, 2005, EUR RADIOL, V15, P702, DOI 10.1007/s00330-004-2574-z
   VARCO RL, 1951, SURGERY, V50, P29
   Veldtman GR, 2003, HEART, V89, P1067, DOI 10.1136/heart.89.9.1067
   Veldtman GR, 2004, J AM COLL CARDIOL, V44, P174, DOI 10.1016/j.jacc.2003.11.067
   VERIN VE, 1993, J AM COLL CARDIOL, V22, P1509
   Vitale N, 1999, J AM COLL CARDIOL, V33, P1637, DOI 10.1016/S0735-1097(99)00044-3
   Vogel M, 2004, J AM COLL CARDIOL, V43, P100, DOI 10.1016/j.jacc.2003.06.018
   Vogel M, 2003, CIRCULATION, V107, P1647, DOI 10.1161/01.CIR.0000058171.62847.90
   Vongpatanasin W, 1998, ANN INTERN MED, V128, P745
   Voskuil M, 1999, AM J CARDIOL, V83, P558, DOI 10.1016/S0002-9149(98)00913-8
   Wada AM, 2003, ARTERIOSCL THROM VAS, V23, P2138, DOI 10.1161/01.ATV.0000098645.38676.CC
   Walker RE, 2004, AM J CARDIOL, V93, P1374, DOI 10.1016/j.amjcard.2004.02.033
   WALSH EP, 1988, CIRCULATION, V77, P1062
   Waltz DA, 2006, J HEART LUNG TRANSPL, V25, P904, DOI 10.1016/j.healun.2006.06.004
   Wang A, 2007, AM J CARDIOL, V100, P1307, DOI 10.1016/j.amjcard.2007.05.059
   Wang JK, 2002, CATHETER CARDIO INTE, V55, P513, DOI 10.1002/ccd.10090
   Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994
   WARD R, 1995, CHEST, V108, P549, DOI 10.1378/chest.108.2.549
   WARNES CA, 1986, BRIT HEART J, V56, P535
   WARNES CA, 1984, AM J CARDIOL, V54, P1383, DOI 10.1016/S0002-9149(84)80111-3
   Warnes CA, 1996, J AM COLL CARDIOL, V27, P1244
   Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352
   Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4
   Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083
   Webb GD, 2001, J AM COLL CARDIOL, V37, P1166, DOI 10.1016/S0735-1097(01)01280-3
   Weindling SN, 1998, AM J CARDIOL, V82, P525, DOI 10.1016/S0002-9149(98)00375-0
   Weiss BM, 1998, J AM COLL CARDIOL, V31, P1650, DOI 10.1016/S0735-1097(98)00162-4
   Wernovsky G, 2000, CIRCULATION, V102, P883
   WERNOVSKY G, 1993, CORONARY ARTERY DIS, V4, P148, DOI 10.1097/00019501-199302000-00005
   Wessel HU, 1999, PEDIATR CARDIOL, V20, P39, DOI 10.1007/s002469900393
   WHITTEMORE R, 1994, J AM COLL CARDIOL, V23, P1459
   Williams RV, 2000, AM J CARDIOL, V86, P1106, DOI 10.1016/S0002-9149(00)01168-1
   Wilson NJ, 1998, J AM COLL CARDIOL, V32, P758, DOI 10.1016/S0735-1097(98)00309-X
   Wilson Walter, 2007, Circulation, V116, P1736, DOI 10.1161/CIRCULATIONAHA.106.183095
   WILSON WR, 1995, JAMA-J AM MED ASSOC, V274, P1706, DOI 10.1001/jama.274.21.1706
   Wolfe Robert R., 1993, Circulation, V87, pI89
   WOLFF GS, 1972, CIRCULATION, V46, P587
   WONG PC, 1991, AM J CARDIOL, V68, P1681, DOI 10.1016/0002-9149(91)90329-J
   WONG T, 2004, CIRCULATION, V109, P2139
   WOOD P, 1958, Br Med J, V2, P701
   Wypij D, 2003, J THORAC CARDIOV SUR, V126, P1397, DOI 10.1016/S0022-5223(03)00940-1
   YAMAGUCHI T, 1990, CARDIOVASC INTER RAD, V13, P291, DOI 10.1007/BF02578628
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   Yan AT, 2005, ANN INTERN MED, V142, P132
   Yankah AC, 2002, EUR J CARDIO-THORAC, V21, P260, DOI 10.1016/S1010-7940(01)01084-3
   Yetman AT, 1998, AM J CARDIOL, V81, P749, DOI 10.1016/S0002-9149(97)01009-6
   Yilmaz AT, 1996, ANN THORAC SURG, V62, P1205, DOI 10.1016/0003-4975(96)00383-9
   ZALES VR, 1988, AM J CARDIOL, V62, P225, DOI 10.1016/0002-9149(88)90216-0
   Zanchetta M, 2001, Minerva Cardioangiol, V49, P369
   ZIMMERMANN M, 1991, AM J CARDIOL, V67, P873, DOI 10.1016/0002-9149(91)90622-R
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
   2004, J AM COLL CARDIOL, V44, P216
NR 643
TC 217
Z9 228
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD DEC 2
PY 2008
VL 118
IS 23
BP E714
EP E833
DI 10.1161/CIRCULATIONAHA.108.190690
PG 120
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 377RR
UT WOS:000261268800020
PM 18997169
ER

PT J
AU Levine, GN
   Bates, ER
   Blankenship, JC
   Bailey, SR
   Bittl, JA
   Cercek, B
   Chambers, CE
   Ellis, SG
   Guyton, RA
   Hollenberg, SM
   Khot, UN
   Lange, RA
   Mauri, L
   Mehran, R
   Moussa, ID
   Mukherjee, D
   Nallamothu, BK
   Ting, HH
AF Levine, Glenn N.
   Bates, Eric R.
   Blankenship, James C.
   Bailey, Steven R.
   Bittl, John A.
   Cercek, Bojan
   Chambers, Charles E.
   Ellis, Stephen G.
   Guyton, Robert A.
   Hollenberg, Steven M.
   Khot, Umesh N.
   Lange, Richard A.
   Mauri, Laura
   Mehran, Roxana
   Moussa, Issam D.
   Mukherjee, Debabrata
   Nallamothu, Brahmajee K.
   Ting, Henry H.
TI 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A
   Report of the American College of Cardiology Foundation/American Heart
   Association Task Force on Practice Guidelines and the Society for
   Cardiovascular Angiography and Interventions
SO CIRCULATION
LA English
DT Article
DE AHA Scientific Statements; acute coronary syndromes; anticoagulants;
   antiplatelet agents; antiplatelet agents; arrhythmias, cardiac; coronary
   artery revascularization interventions: stents; coronary angiography;
   drug therapy; drug delivery systems; heart diseases; myocardial
   revascularization; platelet aggregation inhibitor; ultrasound
ID ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; UNPROTECTED LEFT
   MAIN; DRUG-ELUTING STENTS; ARTERY-BYPASS-SURGERY; RANDOMIZED
   CONTROLLED-TRIAL; CONTRAST-INDUCED NEPHROPATHY; BARE-METAL STENTS;
   LONG-TERM SURVIVAL; GLYCOPROTEIN IIB/IIIA RECEPTOR
AB The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
C1 [Levine, Glenn N.] Baylor Coll Med, Houston, TX 77030 USA.
   [Bates, Eric R.; Nallamothu, Brahmajee K.] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Blankenship, James C.] Geisinger Med Ctr, Cardiol & Cardiac Catheterizat Labs, Danville, PA USA.
   [Bailey, Steven R.] Univ Texas Med Ctr, Dallas, TX USA.
   [Cercek, Bojan] Cedars Sinai Med Ctr, Coronary Care Unit, Los Angeles, CA USA.
   [Chambers, Charles E.] Penn State Milton S Hershey Med Ctr, Hershey, PA USA.
   [Ellis, Stephen G.] Cleveland Clin Fdn, Cleveland, OH USA.
   [Guyton, Robert A.] Emory Clin Inc, Div Cardiothorac Surg, Atlanta, GA USA.
   [Hollenberg, Steven M.] Cooper Univ Hosp, Coronary Care Unit, Camden, NJ USA.
   [Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA.
   [Mauri, Laura] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02138 USA.
   [Mehran, Roxana] Columbia Univ, Med Ctr, New York, NY 10027 USA.
   [Moussa, Issam D.; Ting, Henry H.] Mayo Clin, Rochester, MN 55905 USA.
   [Mukherjee, Debabrata] Texas Tech Univ, Lubbock, TX 79409 USA.
RP Levine, GN (reprint author), Baylor Coll Med, Houston, TX 77030 USA.
CR Aaberge L, 2002, J AM COLL CARDIOL, V39, P1588, DOI 10.1016/S0735-1097(02)01828-4
   Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Abizaid A, 2001, CIRCULATION, V104, P533, DOI 10.1161/hc3101.093700
   Aboul-Enein F, 2004, J NUCL MED, V45, P950
   Abraham NS, 2010, CIRCULATION, V122, P2619, DOI 10.1161/CIR.0b013e318202f701
   ACCF/AHA Task Force on Practice Guidelines, METH POL ACCF AHA TA
   Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943
   Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486
   Adolph E, 2008, CORONARY ARTERY DIS, V19, P413, DOI 10.1097/MCA.0b013e3283021ac6
   Agard A, 2004, HEART, V90, P208, DOI 10.1136/hrt.2003.021501
   Aggarwal A, 2009, AM J CARDIOL, V104, P349, DOI 10.1016/j.amjcard.2009.03.046
   Aguirre FV, 2008, CIRCULATION, V117, P1145, DOI 10.1161/CIRCULATIONAHA.107.728519
   Ahmed B, 2009, CIRC-CARDIOVASC INTE, V2, P423, DOI 10.1161/CIRCINTERVENTIONS.109.860494
   Albiero R, 2004, J AM COLL CARDIOL, V43, P943, DOI 10.1016/j.jacc.2003.09.054
   Alcock RF, 2010, INT J CARDIOL, V140, P66, DOI 10.1016/j.ijcard.2008.11.005
   Alderman E, 1997, CIRCULATION, V96, P1761
   Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   Alexander KP, 2005, JAMA-J AM MED ASSOC, V294, P3108, DOI 10.1001/jama.294.24.3108
   Ali A, 2006, J AM COLL CARDIOL, V48, P244, DOI 10.1016/j.jacc.2006.03.044
   Aliabadi D, 1997, AM J CARDIOL, V80, P994, DOI 10.1016/S0002-9149(97)00591-2
   Al-Lamee R, 2010, AM J CARDIOL, V106, P1721, DOI 10.1016/j.amjcard.2010.08.013
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Allen KB, 1999, NEW ENGL J MED, V341, P1029, DOI 10.1056/NEJM199909303411403
   Griffith JL, 2003, JAMA-J AM MED ASSOC, V289, P178
   Alpert JS, 2000, J AM COLL CARDIOL, V36, P959
   Al Suwaidi J, 2004, AM HEART J, V147, P815, DOI 10.1016/j.ahj.2003.11.025
   Alter DA, 2003, J AM COLL CARDIOL, V42, P410, DOI 10.1016/S0735-1097(03)00640-5
   Amit G, 2006, AM HEART J, V152
   Anderson HV, 2002, J AM COLL CARDIOL, V39, P1096, DOI 10.1016/S0735-1097(02)01733-3
   Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   [Anonymous], PROTECT 2 PROSPECTIV
   [Anonymous], 1994, LANCET, V344, P1383
   [Anonymous], 2002, LANCET, V360, P7
   [Anonymous], 2002, CIRCULATION, V106, P3143
   Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   Antman Elliott M, 2004, Circulation, V110, P588, DOI 10.1161/01.CIR.0000134791.68010.FA
   Antoniucci D, 1998, J AM COLL CARDIOL, V31, P294, DOI 10.1016/S0735-1097(97)00496-8
   Antoniucci D, 2003, AM J CARDIOL, V91, P1458, DOI 10.1016/S0002-9149(03)00397-7
   Antoniucci D, 2004, CIRCULATION, V109, P1704, DOI 10.1161/01.CIR.0000126284.40075.98
   Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Applegate RJ, 2008, JACC-CARDIOVASC INTE, V1, P317, DOI 10.1016/j.jcin.2008.03.013
   Aragon J, 2005, CATHETER CARDIO INTE, V65, P346, DOI 10.1002/ccd.20339
   Assali AR, 2000, CATHETER CARDIO INTE, V51, P27, DOI 10.1002/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO;2-0
   ASTER RH, 1995, NEW ENGL J MED, V332, P1374, DOI 10.1056/NEJM199505183322011
   *ASTRAZENECA, 22433 REMS NDA ASTRA
   Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943
   Aziz O, 2007, BRIT MED J, V334, P617, DOI 10.1136/bmj.39106.476215.BE
   Babaev A, 2002, CIRCULATION, V106, P364
   Babapulle Mohan N, 2007, BMC Cardiovasc Disord, V7, P12, DOI 10.1186/1471-2261-7-12
   Bader BD, 2004, CLIN NEPHROL, V62, P1
   Bader FM, 2006, J HEART LUNG TRANSPL, V25, P298, DOI 10.1016/j.healun.2005.09.016
   Bae Ki Sun, 2007, Korean Journal of Internal Medicine, V22, P139
   Collins R, 2009, LANCET, V373, P1849
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baim DS, 2002, CIRCULATION, V105, P1285, DOI 10.1161/01.CIR.0000012783.63093.0C
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Barber K, 2001, J CLIN EPIDEMIOL, V54, P1025, DOI 10.1016/S0895-4356(01)00375-4
   Barcin C, 2004, CATHETER CARDIO INTE, V61, P484, DOI 10.1002/ccd.20010
   Barlis P, 2009, EUROINTERVENTION, V5, P90
   BARNATHAN ES, 1987, CIRCULATION, V76, P125
   Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295
   Bates ER., 2009, CARDIOGENIC SHOCK, P220, DOI 10.1002/9781444316926.ch10
   Bates ER, 2011, J AM COLL CARDIOL, V57, P1251, DOI 10.1016/j.jacc.2010.11.024
   Bates ER, 1997, J AM COLL CARDIOL, V30, P334, DOI 10.1016/S0735-1097(97)00178-2
   Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050
   Bavry AA, 2008, EUR HEART J, V29, P2989, DOI 10.1093/eurheartj/ehn421
   BELL MR, 1990, J AM COLL CARDIOL, V16, P553
   Bellandi F, 2004, CATHETER CARDIO INTE, V62, P186, DOI 10.1002/ccd.20041
   Beller GA, 2010, JACC-CARDIOVASC INTE, V3, P315, DOI 10.1016/j.jcin.2010.01.007
   Beller GA, 2010, J AM COLL CARDIOL, V56, P1335, DOI 10.1016/j.jacc.2010.04.055
   Benedetto U, 2009, EUR J CARDIO-THORAC, V36, P611, DOI 10.1016/j.ejcts.2009.03.012
   Ben-Gal Y, 2006, ANN THORAC SURG, V82, P2067, DOI 10.1016/j.athoracsur.2006.06.041
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berger PB, 2001, J AM COLL CARDIOL, V38, P1440, DOI 10.1016/S0735-1097(01)01571-6
   Berger PB, 1999, CIRCULATION, V99, P248
   Berger PB, 2002, AM HEART J, V143, P841, DOI 10.1067/mhj.2002.121929
   Bertrand OF, 2009, AM J CARDIOL, V104, P1235, DOI 10.1016/j.amjcard.2009.06.036
   Bertrand OF, 2010, AM J CARDIOL, V105, P1520, DOI 10.1016/j.amjcard.2010.01.006
   Bezerra HG, 2009, JACC-CARDIOVASC INTE, V2, P1035, DOI 10.1016/j.jcin.2009.06.019
   Bhargava B, 2001, CATHETER CARDIO INTE, V54, P295, DOI 10.1002/ccd.1287
   Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964
   Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087
   Biancari F, 2010, AM HEART J, V159, P518, DOI 10.1016/j.ahj.2009.12.027
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   Bittl JA, 2004, J AM COLL CARDIOL, V43, P936, DOI 10.1016/j.jacc.2003.10.039
   Blankenship JC, 2011, J AM COLL CARDIOL, V57, P272, DOI 10.1016/j.jacc.2010.06.056
   Blankenship JC, 2000, CATHETER CARDIO INTE, V49, P130, DOI 10.1002/(SICI)1522-726X(200002)49:2<130::AID-CCD3>3.0.CO;2-T
   Blankenship JC, 2004, CATHETER CARDIO INTE, V63, P444, DOI 10.1002/ccd.20229
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Boersma E, 1999, CIRCULATION, V100, P2045
   Bohmer E, 2010, J AM COLL CARDIOL, V55, P102, DOI 10.1016/j.jacc.2009.08.007
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   Bonz AW, 2002, J AM COLL CARDIOL, V40, P662, DOI 10.1016/S0735-1097(02)02014-4
   Borgia F, 2010, EUR HEART J, V31, P2156, DOI 10.1093/eurheartj/ehq204
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Bourassa MG, 1998, EUR HEART J, V19, P103, DOI 10.1053/euhj.1997.0574
   Boyden TF, 2007, AM J CARDIOL, V99, P1399, DOI 10.1016/j.amjcard.2006.12.069
   Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063
   Brar SS, 2008, JAMA-J AM MED ASSOC, V300, P1038, DOI 10.1001/jama.300.9.1038
   Brar SS, 2009, CLIN J AM SOC NEPHRO, V4, P1584, DOI 10.2215/CJN.03120509
   Bravata DM, 2007, ANN INTERN MED, V147, P703
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V110, P994, DOI 10.1161/01.CIR.0000139868.53594.24
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Bridges CR, 2004, ANN THORAC SURG, V77, P1494, DOI 10.1016/j.athoracsur.2004.01.007
   Brieger D, 2011, CATHETER CARDIO INTE, V77, P182, DOI 10.1002/ccd.22674
   Brieger DB, 1998, J AM COLL CARDIOL, V31, P1449, DOI 10.1016/S0735-1097(98)00134-X
   Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152
   Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005
   Briguori C, 2007, AM J CARDIOL, V99, P779, DOI 10.1016/j.amjcara.2006.10.031
   Briguori C, 2003, AM HEART J, V145, P700, DOI 10.1067/mhj.2003.14
   Briguori C, 2001, AM J CARDIOL, V87, P136, DOI 10.1016/S0002-9149(00)01304-7
   Briguori C, 2004, EUR HEART J, V25, P1822, DOI 10.1016/j.ehj.2004.07.017
   BROGAN WC, 1993, AM J CARDIOL, V71, P794, DOI 10.1016/0002-9149(93)90826-X
   Brophy JM, 2003, ANN INTERN MED, V138, P777
   Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Buller CE, 1999, CIRCULATION, V100, P236
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   CABRI Trial Participants, 1995, LANCET, V346, P1179
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Cameron AAC, 2004, CATHETER CARDIO INTE, V61, P157, DOI 10.1002/ccd.10800
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501
   Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941
   Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106
   Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   Carrie D, 1997, CIRCULATION, V96, pII6
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   Cecil WT, 2008, AM J MANAG CARE, V14, P521
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Chambers CE, 2011, CATHETER CARDIO INTE, V77, P546, DOI 10.1002/ccd.22867
   Chan AW, 2002, AM J CARDIOL, V89, P132, DOI 10.1016/S0002-9149(01)02188-9
   Chaudhry EC, 2007, J THROMB THROMBOLYS, V24, P7, DOI 10.1007/s11239-006-0004-6
   Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9
   Chen BX, 2008, HEART, V94, P566, DOI 10.1136/hrt.2007.118679
   Chen EW, 2003, CIRCULATION, V108, P951, DOI 10.1161/01.CIR.000008508.59734.E4
   Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011
   Chen SL, 2008, ANGIOLOGY, V59, P475, DOI 10.1177/0003319707312519
   Chen SL, 2011, J AM COLL CARDIOL, V57, P914, DOI 10.1016/j.jacc.2010.10.023
   Chen ZM, 2005, LANCET, V366, P1607
   Chew DP, 2001, CIRCULATION, V103, P961
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2005, CIRCULATION, V111, P791, DOI 10.1161/01.CIR.0000155256.88940.F8
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Choudhry NK, 2005, AM J MED, V118, P465, DOI 10.1016/j.amjmed.2005.02.016
   Choussat R, 2002, J AM COLL CARDIOL, V40, P1943, DOI 10.1016/S0735-1097(02)02531-7
   Cisowski M, 2002, ANN THORAC SURG, V74, pS1334
   Cisowski Marek, 2004, Kardiol Pol, V61, P253
   Clark AM, 2005, ANN INTERN MED, V143, P659
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Cohen DJ, 2004, CIRCULATION, V110, P508, DOI 10.1161/01.CIR.0000136821.99814.43
   Cohen M, 2003, EUR HEART J, V24, P1763, DOI 10.1016/j.ehj.2003.07.002
   Cohen M, 2010, CATHETER CARDIO INTE, V75, P928, DOI 10.1002/ccd.22340
   Cole JH, 2002, J AM COLL CARDIOL, V40, P1968, DOI 10.1016/S0735-1097(02)02561-5
   Collet JP, 2004, AM HEART J, V147, P655, DOI 10.1016/j.ahj.2003.10.019
   Collet JP, 2001, CIRCULATION, V103, P658
   Colombo A, 2009, CIRCULATION, V119, P71, DOI 10.1161/CIRCULATIONAHA.108.808402
   Coolong A, 2008, CIRCULATION, V117, P790, DOI 10.1161/CIRCULATIONAHA.106.651232
   Cornuz J, 2002, ANN INTERN MED, V136, P429
   Cosgrave J, 2007, AM HEART J, V153, P354, DOI 10.1016/j.ahj.2006.12.009
   Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034
   Courtis J, 2009, AM J CARDIOL, V103, P943, DOI 10.1016/j.amjcard.2008.11.054
   Cruden NLM, 2010, CIRC-CARDIOVASC INTE, V3, P236, DOI 10.1161/CIRCINTERVENTIONS.109.934703
   CUMMINGS SR, 1989, J GEN INTERN MED, V4, P482, DOI 10.1007/BF02599545
   Cutlip DE, 2001, CIRCULATION, V103, P1967
   Cutlip DE, 2002, J AM COLL CARDIOL, V40, P2082, DOI 10.1016/S0735-1097(02)02597-4
   Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Damman P, 2010, J AM COLL CARDIOL, V55, P858, DOI 10.1016/j.jacc.2009.11.026
   Dangas G, 2009, J AM COLL CARDIOL, V54, P1438, DOI 10.1016/j.jacc.2009.06.021
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   Dangas GD, 2008, JACC-CARDIOVASC INTE, V1, P332, DOI 10.1016/j.jcin.2008.05.001
   Danzi GB, 2006, AM J CARDIOL, V97, P489, DOI 10.1016/j.amjcard.2005.09.080
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320
   Dauerman HL, 2007, J AM COLL CARDIOL, V50, P1617, DOI 10.1016/j.jacc.2007.07.028
   Dauerman Harold L, 2003, J Invasive Cardiol, V15, P380
   Davies RF, 1997, CIRCULATION, V95, P2037
   de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057
   de Boer SPM, 2010, JACC-CARDIOVASC INTE, V3, P324, DOI 10.1016/j.jcin.2009.11.022
   DEFEYTER PIMJ, 1993, J AM COLL CARDIOL, V21, P1539
   DEFEYTER PJ, 1989, AM J CARDIOL, V64, P88, DOI 10.1016/0002-9149(89)90658-9
   Dehmer GJ, 2007, CATHETER CARDIO INTE, V69, P471, DOI 10.1002/ccd.21097
   Deibele AJ, 2006, J THROMB THROMBOLYS, V22, P47, DOI 10.1007/s11239-006-7454-8
   Deibele AJ, 2010, CIRCULATION, V121, P784, DOI 10.1161/CIRCULATIONAHA.109.882746
   de Labriolle A, 2008, AM J CARDIOL, V102, P1175, DOI 10.1016/j.amjcard.2008.06.059
   De Luca G, 2009, THROMB HAEMOSTASIS, V102, P428, DOI 10.1160/TH09-05-0287
   De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759
   De Luca G, 2009, EUR HEART J, V30, P2705, DOI 10.1093/eurheartj/ehp118
   De Luca G, 2009, J AM COLL CARDIOL, V53, P1668, DOI 10.1016/j.jacc.2009.01.053
   Dibra A, 2007, J AM COLL CARDIOL, V49, P616, DOI 10.1016/j.jacc.2006.10.049
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563
   Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8
   Di Sciascio G, 2010, J AM COLL CARDIOL, V56, P550, DOI 10.1016/j.jacc.2010.01.067
   Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028
   Dixon SR, 2009, JACC-CARDIOVASC INTE, V2, P91, DOI 10.1016/j.jcin.2008.11.005
   Doherty TM, 2005, CATHETER CARDIO INTE, V65, P330, DOI 10.1002/ccd.20355
   Drenth DJ, 2004, AM J CARDIOL, V94, P1414, DOI 10.1016/j.amjcard.2004.08.016
   Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6
   Drouet L, 2009, AM HEART J, V158, P177, DOI 10.1016/j.ahj.2009.05.022
   Dukkipati S, 2004, J AM COLL CARDIOL, V43, P1161, DOI 10.1016/j.jacc.2003.11.033
   Dumaine R, 2007, ARCH INTERN MED, V167, P2423, DOI 10.1001/archinte.167.22.2423
   DUNCAN C, 1991, AM J PUBLIC HEALTH, V81, P899, DOI 10.2105/AJPH.81.7.899
   Duvernoy CS, 2010, AM HEART J, V159, P677, DOI 10.1016/j.ahj.2009.12.040
   Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727
   Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C
   Eisenberg MJ, 2004, AM J CARDIOL, V93, P744, DOI 10.1016/j.amjcard.2003.11.071
   Eisenberg MJ, 2007, ACTA CARDIOL, V62, P143, DOI 10.2143/AC.62.2.2020234
   Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179
   El Khoury C, 2010, ARCH CARDIOVASC DIS, V103, P287, DOI 10.1016/j.acvd.2010.04.005
   ELLIS SG, 1994, CIRCULATION, V89, P882
   Ellis SG, 2009, JACC-CARDIOVASC INTE, V2, P909, DOI 10.1016/j.jcin.2009.07.009
   ELLIS SG, 1994, CIRCULATION, V90, P2725
   Ellis SG, 1997, CIRCULATION, V96, P3867
   Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816
   Ellis SG, 1998, J AM COLL CARDIOL, V32, P1619, DOI 10.1016/S0735-1097(98)00403-3
   ELLIS SG, 1990, CIRCULATION, V82, P1193
   CALIFF RM, 1994, NEW ENGL J MED, V330, P956
   Topol EJ, 1997, NEW ENGL J MED, V336, P1689
   EPISTENT Investigators, 1998, Lancet, V352, P87
   Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304
   Erglis A, 2007, J AM COLL CARDIOL, V50, P491, DOI 10.1016/j.jacc.2007.03.055
   Erglis A, 2009, CIRC-CARDIOVASC INTE, V2, P27, DOI 10.1161/CIRCINTERVENTIONS.108.804658
   Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985
   Tcheng JE, 2000, LANCET, V356, P2037
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   Fassa AA, 2005, J AM COLL CARDIOL, V45, P204, DOI 10.1016/j.jacc.2004.09.066
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   FAXON DP, 1992, AM HEART J, V123, P854, DOI 10.1016/0002-8703(92)90687-Q
   Feit F, 2007, AM J CARDIOL, V100, P1364, DOI 10.1016/j.amjcard.2007.06.026
   Feit F, 2000, CIRCULATION, V101, P2795
   Ferenc M, 2008, EUR HEART J, V29, P2859, DOI 10.1093/eurheartj/ehn455
   Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45
   FERGUSON JJ, 1994, J AM COLL CARDIOL, V23, P1061
   Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1
   APPLEBY P, 1994, LANCET, V343, P311
   Fidan D, 2007, QJM-INT J MED, V100, P277, DOI 10.1093/qjmed/hcm020
   Fischell Tim A, 2007, J Invasive Cardiol, V19, P58
   Fischell TA, 1998, CATHETER CARDIO DIAG, V45, P360, DOI 10.1002/(SICI)1097-0304(199812)45:4<360::AID-CCD1>3.0.CO;2-R
   Fischell Tim A, 2008, Cardiovasc Revasc Med, V9, P224, DOI 10.1016/j.carrev.2008.03.002
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   FITZGERALD PJ, 1992, CIRCULATION, V86, P64
   Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690
   Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960
   Foex BA, 2004, HEART, V90, P1237, DOI 10.1136/hrt.2003.020255
   Fox KAA, 2006, BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55
   Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4
   Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007
   Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X
   Fraund S, 2005, ANN THORAC SURG, V79, P1225, DOI 10.1016/j.arthoracsur.2004.08.082
   Frazier OH, 1999, NEW ENGL J MED, V341, P1021, DOI 10.1056/NEJM199909303411402
   Freestone B, 2010, HEART, V96, P883, DOI 10.1136/hrt.2007.134213
   From AM, 2008, CLIN J AM SOC NEPHRO, V3, P10, DOI 10.2215/CJN.03100707
   Frye RL, 2009, NEW ENGL J MED, V360, P2503
   Fujii K, 2010, JACC-CARDIOVASC IMAG, V3, P168, DOI 10.1016/j.jcmg.2009.11.004
   Galassi AR, 2009, JACC-CARDIOVASC INTE, V2, P185, DOI 10.1016/j.jcin.2008.12.005
   Gao F, 2011, INT J CARDIOL, V148, P96, DOI 10.1016/j.ijcard.2010.11.019
   Garzon P, 2001, CAN J CARDIOL, V17, P41
   GAULT MH, 1992, NEPHRON, V62, P249
   Ge L, 2005, J AM COLL CARDIOL, V46, P613, DOI 10.1016/j.jaac.2005.05.032
   Gershlick AH, 2005, NEW ENGL J MED, V353, P2758, DOI 10.1056/NEJMoa050849
   Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194
   Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15
   Gibson CM, 2003, J AM COLL CARDIOL, V42, P7, DOI 10.1016/S0735-1097(03)00506-0
   Gierlotka M, 2011, AM J CARDIOL, V107, P501, DOI 10.1016/j.amjcard.2010.10.008
   Gil Robert J, 2005, Kardiol Pol, V63, P223
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gilchrist IC, 2001, CIRCULATION, V104, P406, DOI 10.1161/hc2901.093504
   Gill BV, 2009, J ALLERGY CLIN IMMUN, V124, P1055, DOI 10.1016/j.jaci.2009.06.030
   Gioia G, 2007, CATHETER CARDIO INTE, V70, P26, DOI 10.1002/ccd.21072
   Giri S, 2002, AM J CARDIOL, V89, P126, DOI 10.1016/S0002-9149(01)02187-7
   Glaser R, 2002, JAMA-J AM MED ASSOC, V288, P3124, DOI 10.1001/jama.288.24.3124
   Goel K, 2011, CIRCULATION, V123, P2344, DOI 10.1161/CIRCULATIONAHA.110.983536
   Gonzales DA, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-32
   GOSS JE, 1995, CATHETER CARDIO DIAG, V34, P99, DOI 10.1002/ccd.1810340403
   Goy JJ, 2008, J AM COLL CARDIOL, V52, P815, DOI 10.1016/j.jacc.2008.05.037
   GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8
   Goy JJ, 1999, CIRCULATION, V99, P3255
   Goy JJ, 2000, MAYO CLIN PROC, V75, P1116
   Green SM, 2002, ANN EMERG MED, V39, P433, DOI 10.1067/mem.2002.122770
   GREENBERGER PA, 1985, ARCH INTERN MED, V145, P2197, DOI 10.1001/archinte.145.12.2197
   Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jace.2007.01.003
   Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X
   Gross JB, 2002, ANESTHESIOLOGY, V96, P1004
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Grzybowski M, 2003, JAMA-J AM MED ASSOC, V290, P1891, DOI 10.1001/jama.290.14.1891
   Guagliumi G, 2004, CIRCULATION, V110, P1598, DOI 10.1161/01.CIR.0000142862.98817.1F
   Gupta A, 2009, CATHETER CARDIO INTE, V74, P975, DOI 10.1002/ccd.22140
   Gupta M, 2003, EUR HEART J, V24, P1640, DOI 10.1016/S0195-668X(03)00433-0
   Gurbel PA, 2005, CIRCULATION, V111, P1153, DOI 10.1161/01.CIR.0000157138.02645.11
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   Gurm HS, 2009, CIRC-CARDIOVASC INTE, V2, P230, DOI 10.1161/CIRCINTERVENTIONS.108.847996
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F
   Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073
   Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103
   HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601
   Hamon M, 2009, EUROINTERVENTION, V5, P115
   Hamon M, 2008, CIRCULATION, V118, P678, DOI 10.1161/CIRCULATIONAHA.108.784504
   HAMPTON JR, 1993, LANCET, V341, P573
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017
   Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATONAHA.104.528455
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hanrath P, 1997, CIRCULATION, V96, P1445
   Hansen PR, 2010, J INVASIVE CARDIOL, V22, P278
   Hao PP, 2010, TEX HEART I J, V37, P516
   Haskell WL, 1978, DESIGN IMPLANTATION
   Hassan Y, 2009, ANN PHARMACOTHER, V43, P1598, DOI 10.1345/aph.1M187
   Hausleiter J, 2004, J INTERN MED, V256, P388, DOI 10.1111/j.1365-2796.2004.01398.x
   He ZX, 2001, J NUCL CARDIOL, V8, P452, DOI 10.1067/mnc.2001.114799
   Heinrich MC, 2009, RADIOLOGY, V250, P68, DOI 10.1148/radiol.2501080833
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3
   Henriques JPS, 2006, AM J CARDIOL, V97, P990, DOI 10.1016/j.amjcard.2005.10.037
   Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141
   Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB
   Hildick-Smith D, 2010, CIRCULATION, V121, P1235, DOI 10.1161/CIRCULATIONAHA.109.888297
   Hillegass WB, 2001, J AM COLL CARDIOL, V37, P1335, DOI 10.1016/S0735-1097(01)01138-X
   Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e
   Hirshfeld JW, 2005, CIRCULATION, V111, P511, DOI 10.1161/01.CIR.0000157946.29224.5D
   Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
   Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139
   Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190
   Hodgson JM, 2010, JACC-CARDIOVASC INTE, V3, P818, DOI 10.1016/j.jcin.2010.07.004
   Hoffer EK, 2003, J VASC INTERV RADIOL, V14, P865, DOI 10.1097/01.RVI.0000071086.764348.8E
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   Hoffmann R, 2007, CORONARY ARTERY DIS, V18, P559
   Hoher M, 1999, J AM COLL CARDIOL, V34, P722, DOI 10.1016/S0735-1097(99)00254-5
   Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264
   Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI [10.1016/j.jacc.2010.07.016, 10.1016/j.jacc.2009.07.016]
   Holmes DR, 2010, CIRCULATION, V122, P537, DOI 10.1161/CIR.0b013e3181ee08ed
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   Hong SJ, 2005, CATHETER CARDIO INTE, V64, P75, DOI 10.1002/ccd.20238
   Hospital National Patient Safety Goals, 2011, HOSP NATL PATIENT SA
   Hoste EAJ, 2010, NEPHROL DIAL TRANSPL, V25, P747, DOI 10.1093/ndt/gfp389
   Huang R, 2005, CATHETER CARDIO INTE, V65, P25, DOI 10.1002/ccd.20334
   Huang RI, 2006, CATHETER CARDIO INTE, V68, P671, DOI 10.1002/ccd.20885
   Hubbard CR, 2008, AM J CARDIOL, V102, P1469, DOI 10.1016/j.amjcard.2008.07.040
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065
   Hueb WA, 1999, CIRCULATION, V100, P107
   Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   Iakovou I, 2004, J AM COLL CARDIOL, V44, P967, DOI 10.1016/j.jacc.2004.05.058
   Institute of Medicine, 2011, CLIN PRACT GUID WE C
   Institute of Medicine, 2011, FIND WHAT WORKS HLTH
   Ioannidis JPA, 2007, AM HEART J, V154, P1065, DOI 10.1016/j.ahj.2007.07.049
   Ito H, 1999, J AM COLL CARDIOL, V33, P654, DOI 10.1016/S0735-1097(98)00604-4
   Iwasaki K, 2006, AM J CARDIOL, V98, P1354, DOI 10.1016/j.amjcard.2006.06.028
   Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010
   Jacobs Alice K, 2008, J Am Coll Cardiol, V51, P355, DOI 10.1016/j.jacc.2007.11.011
   Jaffe R, 2007, CATHETER CARDIO INTE, V69, P815, DOI 10.1002/ccd.21021
   Jaffery Z, 2007, EUR J CARDIO-THORAC, V31, P691, DOI 10.1016/j.ejcts.2007.01.018
   Jain SP, 1997, AM J CARDIOL, V79, P1334, DOI 10.1016/S0002-9149(97)00135-5
   Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148
   Javaid A, 2006, AM J CARDIOL, V98, P911, DOI 10.1016/j.amjcard.2006.04.032
   Iversen Allan, 2008, Curr Cardiol Rev, V4, P293, DOI 10.2174/157340308786349480
   Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800
   Johnman C, 2010, CIRC-CARDIOVASC INTE, V3, P341, DOI 10.1161/CIRCINTERVENTIONS.109.928705
   Joint Commission on Accreditation of Healthcare Organization, 2010, COMPR ACCR MAN CAMH
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Jolly SS, 2009, EUR HEART J, V30, P900, DOI 10.1093/eurheartj/ehn417
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   JONES EL, 1983, AM J CARDIOL, V51, P7, DOI 10.1016/S0002-9149(83)80003-4
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   Juergens CP, 2002, CLIN THER, V24, P1332, DOI 10.1016/S0149-2918(02)80037-6
   Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001
   KAHN JK, 1993, AM HEART J, V126, P561, DOI 10.1016/0002-8703(93)90404-W
   KAISER GA, 1975, SURGERY, V78, P749
   Kakkar AK, 2004, CATHETER CARDIO INTE, V61, P31, DOI 10.1002/ccd.10730
   Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P65, DOI 10.1161/CIRCINTERVENTIONS.110.959148
   Kapadia SR, 1998, CIRCULATION, V98, P2672
   Kaplan BM, 1996, CATHETER CARDIO DIAG, V39, P113, DOI 10.1002/(SICI)1097-0304(199610)39:2<113::AID-CCD1>3.0.CO;2-I
   Kapoor JR, 2008, JACC-CARDIOVASC INTE, V1, P483, DOI 10.1016/j.jcin.2008.07.001
   Kappetein AP, 2011, EUR HEART J, V17, P2125
   Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
   Kar B, 2011, J AM COLL CARDIOL, V57, P688, DOI 10.1016/j.jacc.2010.08.613
   Kar B, 2006, TEX HEART I J, V33, P111
   Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859
   Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944
   Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165
   Katritsis DG, 2007, NEW ENGL J MED, V357, P414
   Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864
   Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503
   Keeley EC, 2004, JAMA-J AM MED ASSOC, V291, P736, DOI 10.1001/jama.291.6.736
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8
   Kelly AM, 2008, ANN INTERN MED, V148, P284
   Kern MJ, 2010, J AM COLL CARDIOL, V55, P173, DOI 10.1016/j.jacc.2009.06.062
   Khattab Ahmed A, 2007, J Interv Cardiol, V20, P100, DOI 10.1111/j.1540-8183.2007.00243.x
   Kim JW, 2005, INT J CARDIOL, V99, P437, DOI 10.1016/j.ijcard.2004.08.045
   Kim Sang-Wook, 2007, J Invasive Cardiol, V19, P377
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   KIMMEL SE, 1995, J AM COLL CARDIOL, V26, P931, DOI 10.1016/0735-1097(95)00294-4
   King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602
   King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208
   Kirschbaum SW, 2008, AM J CARDIOL, V101, P179, DOI 10.1016/j.amjcard.2007.07.060
   Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479
   Klein LW, 2009, CATHETER CARDIO INTE, V74, P728, DOI 10.1002/ccd.22113
   Klocke FJ, 2003, CIRCULATION, V108, P1404, DOI 10.1161/01.CIR.0000080946.42225.4D
   Kobashigawa JA, 2005, J AM COLL CARDIOL, V45, P1532, DOI 10.1016/j.jacc.2005.02.035
   Kobayashi Y, 2001, CATHETER CARDIO INTE, V52, P208, DOI 10.1002/1522-726X(200102)52:2<208::AID-CCD1049>3.0.CO;2-H
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Koo BK, 2010, CIRC-CARDIOVASC INTE, V3, P113, DOI 10.1161/CIRCINTERVENTIONS.109.887406
   Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Kovacic JC, 2011, CATHETER CARDIOVASC, DOI [10.1002/ccd.22929, DOI 10.1002/CCD.22929]
   Koyanagi T, 1996, ANN THORAC SURG, V61, P1793, DOI 10.1016/0003-4975(96)00170-1
   Krasuski Richard A, 2003, J Invasive Cardiol, V15, P699
   Krone RJ, 2003, AM J CARDIOL, V92, P389, DOI 10.1016/S0002-9149(03)00655-6
   Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769
   Kubo T, 2008, JACC-CARDIOVASC IMAG, V1, P475, DOI 10.1016/j.jcmg.2008.03.012
   Kuhn MJ, 2008, AM J ROENTGENOL, V191, P151, DOI 10.2214/AJR.07.3370
   Kumbhani DJ, 2009, JAMA-J AM MED ASSOC, V302, P2207, DOI 10.1001/jama.2009.1715
   Kunadian B, 2007, CATHETER CARDIO INTE, V69, P488, DOI 10.1002/ccd.20990
   Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663
   Kutcher MA, 2009, J AM COLL CARDIOL, V54, P16, DOI 10.1016/j.jacc.2009.03.038
   Kwaan MR, 2006, ARCH SURG-CHICAGO, V141, P353, DOI 10.1001/archsurg.141.4.353
   Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6
   Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Latib A, 2008, AM HEART J, V156, P745, DOI 10.1016/j.ahj.2008.05.024
   Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077
   Lee CW, 2008, CATHETER CARDIO INTE, V71, P594, DOI 10.1002/ccd.21399
   Lee MS, 2007, INT J CARDIOL, V123, P34, DOI 10.1016/j.ijcard.2006.11.103
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2010, AM J CARDIOL, V105, P1076, DOI 10.1016/j.amjcard.2009.12.006
   Lee MS, 2008, JACC-CARDIOVASC INTE, V1, P710, DOI 10.1016/j.jcin.2008.10.001
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   Lemos PA, 2004, CIRCULATION, V109, P2500, DOI 10.1161/01.CIR.0000130173.63105.4E
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Levey AS, 2006, ANN INTERN MED, V145, P247
   Levine GN, 2004, J THROMB THROMBOLYS, V17, P167, DOI 10.1023/B:THRO.0000040484.99422.77
   Levine GN, 2007, CIRCULATION, V116, P2878, DOI 10.1161/CIRCULATIONAHA.107.187256
   Levine GN, 2003, ANN INTERN MED, V139, P123
   Levine GN, 2006, PHARMACOTHERAPY, V26, P1537, DOI 10.1592/phco.26.11.1537
   Levinson W, 2010, NEW ENGL J MED, V362, P948, DOI 10.1056/NEJMclde0911205
   Lewin R, 1999, INT J CARDIOL, V72, P49, DOI 10.1016/S0167-5273(99)00174-6
   Lewis BE, 2002, CATHETER CARDIO INTE, V57, P177, DOI 10.1002/ccd.10276
   Lim CCS, 2011, J AM COLL CARDIOL, V57, P653, DOI 10.1016/j.jacc.2010.07.058
   Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853
   Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696
   Lincoff AM, 2008, JACC-CARDIOVASC INTE, V1, P639, DOI 10.1016/j.jcin.2008.10.004
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Lotan C, 2000, EUR HEART J, V21, P1960, DOI 10.1053/euhj.2000.2295
   Louvard Y, 2004, AM J CARDIOL, V94, P1177, DOI 10.1016/j.amjcard.2004.07.089
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   Madsen JK, 1997, CIRCULATION, V96, P748
   Magni V, 2009, CATHETER CARDIO INTE, V73, P441, DOI 10.1002/ccd.21812
   Mahaffey Kenneth W, 2003, J Invasive Cardiol, V15, P611
   Mahmud E, 2008, J AM COLL CARDIOL, V51, P2385, DOI 10.1016/j.jacc.2008.03.028
   Maioli M, 2007, J AM COLL CARDIOL, V49, P1517, DOI 10.1016/j.jacc.2006.12.036
   Maioli M, 2008, J AM COLL CARDIOL, V52, P599, DOI 10.1016/j.jacc.2008.05.026
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Mangiacapra F, 2010, AM J CARDIOL, V106, P1208, DOI 10.1016/j.amjcard.2010.06.044
   Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027
   Marciniak SJ, 2002, THROMB HAEMOSTASIS, V87, P1020
   Marenzi G, 2009, ANN INTERN MED, V150, P170
   Marshall D, 1999, CATHETER CARDIO INTE, V48, P167, DOI 10.1002/(SICI)1522-726X(199910)48:2<167::AID-CCD9>3.0.CO;2-L
   Martin JL, 2004, CATHETER CARDIO INTE, V61, P163, DOI 10.1002/ccd.10726
   Marzilli M, 2000, CIRCULATION, V101, P2154
   Matsuo H, 2007, AM HEART J, V154, P994
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Mauri L, 2003, AM HEART J, V145, P847, DOI 10.1016/S0002-8703(03)00080-2
   Mauri L, 2002, AM J CARDIOL, V90, P1079, DOI 10.1016/S0002-9149(02)02773-X
   Mauri L, 2007, J AM COLL CARDIOL, V50, P1442, DOI 10.1016/j.jacc.2007.06.039
   Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485
   McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905
   MCGARRY TF, 1992, AM HEART J, V123, P1445, DOI 10.1016/0002-8703(92)90793-U
   McKay RG, 2001, CURR OPIN CARDIOL, V16, P364, DOI 10.1097/00001573-200111000-00009
   Mehilli J, 2009, CIRCULATION, V119, P1933, DOI 10.1161/CIRCULATIONAHA.108.818617
   Mehilli J, 2004, CIRCULATION, V110, P3627, DOI 10.1161/01.CIR.0000148956.93631.4D
   Mehilli J, 2011, LANCET, V378, P1071, DOI 10.1016/S0140-6736(11)61255-5
   Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068
   Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076
   Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7
   Mehran R, 1999, CIRCULATION, V100, P1872
   Mehta RH, 2010, AM HEART J, V159, P141, DOI 10.1016/j.ahj.2009.10.035
   Mehta RH, 2008, AM HEART J, V155, P1059, DOI 10.1016/j.ahj.2008.01.010
   Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741
   Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986
   Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4
   Melberg T, 2006, AM HEART J, V152, P888, DOI 10.1016/j.ahj.2006.06.026
   Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328
   Michaels Andrew D, 2002, J Invasive Cardiol, V14, P299
   Migliorini A, 2010, J AM COLL CARDIOL, V56, P1298, DOI 10.1016/j.jacc.2010.06.011
   Mintz GS, 2007, AM J CARDIOL, V100, P812
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Mishkel GJ, 2007, J AM COLL CARDIOL, V49, P181, DOI 10.1016/j.jacc.2006.08.049
   Mishra S, 2006, AM J CARDIOL, V98, P608, DOI 10.1016/j.amjcard.2006.03.036
   Mizukoshi M, 2010, AM J CARDIOL, V106, P323, DOI 10.1016/j.amjcard.2010.03.027
   Montalescot G, 2004, JAMA-J AM MED ASSOC, V292, P362, DOI 10.1001/jama.292.3.362
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Montalescot G, 2009, JACC-CARDIOVASC INTE, V2, P1083, DOI 10.1016/j.jcin.2009.08.016
   Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267
   Montalescot G, 2007, EUR HEART J, V28, P443, DOI 10.1093/eurheartj/ehl472
   Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503
   Moonen LAA, 2010, NETH HEART J, V18, P129, DOI 10.1007/BF03091751
   Mori M, 1996, AM J CARDIOL, V78, P985, DOI 10.1016/S0002-9149(96)00521-8
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995
   Moscucci M, 2001, CIRCULATION, V104, P263
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Moses JW, 2008, AM J CARDIOL, V102, p24J, DOI 10.1016/j.amjcard.2008.09.006
   Moussa I, 1997, CIRCULATION, V96, P128
   Moussa ID, 2011, CATHETER CARDIO INTE, V77, P537, DOI 10.1002/ccd.22865
   Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329
   Mueller C, 2002, J AM COLL CARDIOL, V40, P245, DOI 10.1016/S0735-1097(02)01949-6
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Nallamothu BK, 2006, CIRCULATION, V113, P222, DOI 10.1161/CIRCULATIONAHA.105.578195
   Nam CW, 2010, JACC-CARDIOVASC INTE, V3, P812, DOI 10.1016/j.jcin.2010.04.016
   Narins CR, 1996, CIRCULATION, V93, P667
   Nasser M, 2005, CATHETER CARDIO INTE, V65, P516, DOI 10.1002/ccd.20391
   Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593
   Neumann FJ, 2000, J AM COLL CARDIOL, V35, P915, DOI 10.1016/S0735-1097(99)00635-X
   Nikolsky E, 2007, EUR HEART J, V28, P1936, DOI 10.1093/eurheartj/ehm194
   Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Noble S, 2008, CATHETER CARDIO INTE, V71, P803, DOI 10.1002/ccd.21490
   Nordmann AJ, 2004, AM J MED, V116, P253, DOI 10.1016/j.amjmed.2003.08.035
   Nundy S, 2008, ARCH SURG-CHICAGO, V143, P1068, DOI 10.1001/archsurg.143.11.1068
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   Okabe T, 2008, J INVASIVE CARDIOL, V20, P635
   OKEEFE JH, 1993, AM J CARDIOL, V71, P897, DOI 10.1016/0002-9149(93)90903-P
   Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7
   Ono H, 2004, AM HEART J, V148, P611, DOI 10.1016/j.ahj.2004.05.014
   Osuna JGG, 2006, REV ESP CARDIOL, V59, P567
   Ozcan EE, 2007, AM HEART J, V154, P539, DOI 10.1016/j.ohi.2007.05.012
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Palmerini T, 2009, EUR HEART J, V30, P2087, DOI 10.1093/eurheartj/ehp223
   Pan M, 2007, AM HEART J, V153
   Pan XH, 2010, J ZHEJIANG UNIV-SC B, V11, P754, DOI 10.1631/jzus.B0900302
   Pannu N, 2004, KIDNEY INT, V65, P1366, DOI 10.1111/j.1523-1755.2004.00516.x
   Parikh SV, 2009, CIRCULATION, P120
   Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109
   Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039
   Park DW, 2007, AM J CARDIOL, V99, P760, DOI 10.1016/j.amjcard.2006.10.028
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603
   Patel MR, 2010, CIRCULATION, V122, P1882, DOI 10.1161/CIR.0b013e3181f9b345
   Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Perera D, 2010, JAMA-J AM MED ASSOC, V304, P867, DOI 10.1001/jama.2010.1190
   Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB
   Peterson ED, 2003, J AM COLL CARDIOL, V42, P1611, DOI 10.1016/S0735-1097(03)01121-5
   Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   PIANA RN, 1994, CIRCULATION, V89, P2514
   Pieper KS, 2009, AM HEART J, V157, P1097, DOI 10.1016/j.ahj.2009.04.004
   Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Pijls NHJ, 2002, CIRCULATION, V105, P2950, DOI 10.1161/01.CIR.0000020547.92091.76
   Piper WD, 2003, AM HEART J, V145, P1022, DOI 10.1016/S0002-8703(03)00079-6
   Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202
   Plante S, 2011, CATHETER CARDIOVASC, V76, P654
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   Pohl T, 2004, CATHETER CARDIO INTE, V62, P323, DOI 10.1002/ccd.20060
   Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162
   Popma JJ, 2004, CHEST, V126, p576S
   Post Piet N, 2010, Eur Heart J, V31, P1985, DOI 10.1093/eurheartj/ehq151
   Prasad A, 2009, J AM COLL CARDIOL, V54, P477, DOI 10.1016/j.jacc.2009.03.063
   Prasad A, 2007, J AM COLL CARDIOL, V49, P1611, DOI 10.1016/j.jacc.2006.12.040
   Prasad A, 2004, AM HEART J, V147, P1066, DOI 10.1016/j.ahj.2003.07.030
   Prasad A, 2008, CIRC-CARDIOVASC INTE, V1, P10, DOI 10.1161/CIRCINTERVENTIONS.108.765610
   Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Price MJ, 2006, J AM COLL CARDIOL, V47, P871, DOI 10.1016/j.jacc.2005.12.015
   Pristipino C, 2009, HEART, V95, P476, DOI 10.1136/hrt.2008.150714
   Ragosta M, 2006, CATHETER CARDIO INTE, V68, P357, DOI 10.1002/ccd.20709
   Rahel BM, 2004, AM HEART J, V147, pe16, DOI 10.1016/j.ahj.2003.11.023
   Rajdev S, 2008, J INVASIVE CARDIOL, V20, P67
   Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007
   Rao SV, 2010, J AM COLL CARDIOL, V55, P2187, DOI 10.1016/j.jacc.2010.01.039
   Rassen JA, 2010, EUR HEART J, V31, P561, DOI 10.1093/eurheartj/ehp437
   Rathore S, 2009, JACC-CARDIOVASC INTE, V2, P489, DOI 10.1016/j.jcin.2009.04.008
   Rathore SS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1807
   Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086
   Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5
   Reddy PR, 2005, AM J CARDIOL, V95, P755, DOI 10.1016/j.amjcard.2004.11.029
   Reed M, 2009, JACC-CARDIOVASC INTE, V2, P645, DOI 10.1016/j.jcin.2009.05.002
   Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Reifart N, 1997, CIRCULATION, V96, P91
   Reimers B, 1996, AM HEART J, V131, P192, DOI 10.1016/S0002-8703(96)90069-1
   Remmelink M, 2010, CATHETER CARDIO INTE, V75, P187, DOI 10.1002/ccd.22263
   Resnic FS, 2001, AM J CARDIOL, V88, P5, DOI 10.1016/S0002-9149(01)01576-4
   Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596
   Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815
   Ritchie JL, 2004, J AM COLL CARDIOL, V44, P1740, DOI 10.1016/j.jacc.2004.08.041
   Robinson JG, 2009, J AM COLL CARDIOL, V53, P316, DOI 10.1016/j.jacc.2008.10.024
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7
   Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4
   RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060
   Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081
   Roffi M, 2001, CIRCULATION, V104, P2767, DOI 10.1161/hc4801.100029
   Roffi M, 2002, CIRCULATION, V106, P3063, DOI 10.1161/01.CIR.0000041250.89627.A9
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Romagnoli E, 2005, INT J CARDIOL, V105, P250, DOI 10.1016/j.ijcard.2004.11.037
   Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061
   ROSSER W, 1992, CAN FAM PHYSICIAN, V38, P1623
   Roy P, 2009, AM J CARDIOL, V103, P950, DOI 10.1016/j.amjcard.2008.12.025
   Rubartelli P, 1998, J AM COLL CARDIOL, V32, P90, DOI 10.1016/S0735-1097(98)00193-4
   Rudnick MR, 2008, AM HEART J, V156, P776, DOI 10.1016/j.ahj.2008.05.023
   RUSSO D, 1995, J AM SOC NEPHROL, V6, P1451
   RYAN TJ, 1993, CIRCULATION, V88, P2987
   Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   Safley DM, 2008, JACC-CARDIOVASC INTE, V1, P295, DOI 10.1016/j.jcin.2008.05.004
   Sanborn TA, 2000, J AM COLL CARDIOL, V36, P1123, DOI 10.1016/S0735-1097(00)00875-5
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Sano K, 2007, AM HEART J, V154, P983, DOI 10.1016/j.ahj.2007.07.001
   Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051
   Schouten O, 2009, AM J CARDIOL, V103, P897, DOI 10.1016/j.amjcard.2008.12.018
   Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275
   Schulz S, 2010, EUR HEART J, V31, P582, DOI 10.1093/eurheartj/ehq008
   Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711
   SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603
   Sdringola S, 2000, CATHETER CARDIO INTE, V51, P394, DOI 10.1002/1522-726X(200012)51:4<394::AID-CCD4>3.0.CO;2-G
   Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043
   Selvanayagam JB, 2005, CIRCULATION, V111, P1027, DOI 10.1161/01.CIR.0000156328.28485.AD
   Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1
   Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Seshadri N, 2002, CIRCULATION, V106, P2346, DOI 10.1161/01.CIR.0000036595.92742.69
   Seto AH, 2010, JACC-CARDIOVASC INTE, V3, P751, DOI 10.1016/j.jcin.2010.04.015
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Seyfarth M, 2008, J AM COLL CARDIOL, V52, P1584, DOI 10.1016/j.jacc.2008.05.065
   Shah BR, 2010, J AM COLL CARDIOL, V56, P1328, DOI 10.1016/j.jacc.2010.03.093
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Sharma AK, 2004, CATHETER CARDIO INTE, V63, P141, DOI 10.1002/ccd.20124
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   SHEHADI WH, 1975, AM J ROENTGENOL, V124, P145
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Siller-Matula JM, 2011, HEART, V97, P98, DOI 10.1136/hrt.2010.195438
   Simoons ML, 1996, NEW ENGL J MED, V335, P275, DOI 10.1056/NEJM199607253350409
   Singh IM, 2010, J AM COLL CARDIOL, V55
   Singh M, 2008, J AM COLL CARDIOL, V51, P2313, DOI 10.1016/j.jacc.2008.01.066
   Singh M, 2009, CIRC-CARDIOVASC INTE, V2, P20, DOI 10.1161/CIRCINTERVENTIONS.108.826172
   Singh M, 2004, CIRCULATION, V109, P2727, DOI 10.1161/01.CIR.0000131898.18849.65
   Singh M, 2005, J AM COLL CARDIOL, V45, P198, DOI 10.1016/j.jacc.2004.05.089
   Singh M, 2004, J AM COLL CARDIOL, V44, P357, DOI 10.1016/j.jacc.2004.03.059
   Singh M, 2007, CIRCULATION, V115, P2835, DOI 10.1161/CIRCULATIONAHA.106.632679
   Singh M, 2002, J AM COLL CARDIOL, V40, P387, DOI 10.1016/S0735-1097(02)01980-0
   Singh PP, 2011, AM J THER, V18, pE22, DOI 10.1097/MJT.0b013e3181bc0f5a
   Sirnes PA, 1996, J AM COLL CARDIOL, V28, P1444, DOI 10.1016/S0735-1097(96)00349-X
   Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602
   Sjauw KD, 2009, J AM COLL CARDIOL, V54, P2430, DOI 10.1016/j.jacc.2009.09.018
   Skelding KA, 2002, CATHETER CARDIO INTE, V57, P305, DOI 10.1002/ccd.10303
   Smith Jr. SC, 2011, CIRCULATION, DOI [10.1161/CIR.0b013e318235eb4d, DOI 10.1161/CIR.0B013E318235EB4D]
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith S. C., 2006, CIRCULATION, V113, P166
   Smith SC, 2001, CIRCULATION, V103, P3019
   Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516
   Solinas E, 2007, J AM COLL CARDIOL, V50, P2111, DOI 10.1016/j.jacc.2007.06.056
   SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104
   Solomon RJ, 2007, CIRCULATION, V115, P3189, DOI 10.1161/CIRCULATIONAHA.106.671644
   Song Young Bin, 2010, J Am Coll Cardiol, V55, P1743, DOI 10.1016/j.jacc.2010.02.008
   Sonoda S, 2004, J AM COLL CARDIOL, V43, P1959, DOI 10.1016/j./jacc.2004.01.044
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   Sigwart U, 2002, LANCET, V360, P965
   Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066
   Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056
   Stabile E, 2008, J AM COLL CARDIOL, V52, P2008, DOI 10.1016/j.jacc.2008.07.026
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   Steg PG, 2004, EUR HEART J, V25, P2187, DOI 10.1016/j.ehj.2004.10.019
   Steg PG, 2010, JAMA-J AM MED ASSOC, V304, P1339, DOI 10.1001/jama.2010.1320
   Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920
   Steinhubl SR, 2009, ANN INTERN MED, V150, P379
   Steinhubl SR, 1999, CIRCULATION, V100, P1977
   Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411
   Stella PR, 1997, CATHETER CARDIO DIAG, V40, P156, DOI 10.1002/(SICI)1097-0304(199702)40:2<156::AID-CCD7>3.0.CO;2-A
   Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stettler C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1331
   Stevens LA, 2009, AM J KIDNEY DIS, V54, P33, DOI 10.1053/j.ajkd.2009.03.008
   Stoel MG, 2008, CATHETER CARDIO INTE, V71, P283, DOI 10.1002/ccd.21334
   Stolker JM, 2010, CIRC-CARDIOVASC INTE, V3, P327, DOI 10.1161/CIRCINTERVENTIONS.110.946939
   Stone GW, 1997, J AM COLL CARDIOL, V30, P1714, DOI 10.1016/S0735-1097(97)00387-2
   Stone GW, 2009, CIRCULATION, V119, P680, DOI 10.1161/CIRCULATIONAHA.108.803528
   Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437
   Stone GW, 2002, CIRCULATION, V105, P2347, DOI 10.1161/01.CIR.0000017635.82128.8C
   Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496
   Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116
   Stone GW, 2005, CIRCULATION, V112, P2530, DOI 10.1161/CIRCULATIONAHA.105.583716
   Stone GW, 2003, J AM COLL CARDIOL, V41, P1940, DOI 10.1016/S0735-1097(03)00400-5
   Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191
   Stone GW, 2003, CIRCULATION, V108, P548, DOI 10.1161/01.CIR.0000080894.51311.0A
   Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404
   Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72
   Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Stramba-Badiale M, 2006, EUR HEART J, V27, P994, DOI 10.1093/eurheartj/ehi819
   Stroupe KT, 2006, CIRCULATION, V114, P1251, DOI 10.1161/CIRCULATIONAHA.105.570838
   Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   Suero JA, 2001, J AM COLL CARDIOL, V38, P409, DOI 10.1016/S0735-1097(01)01349-3
   Suh HS, 2011, INT J TECHNOL ASSESS, V27, P11, DOI 10.1017/S0266462310001340
   Swoboda I, 2002, J IMMUNOL, V168, P4576
   Szczech LA, 2002, CIRCULATION, V105, P2253, DOI 10.1161/01.CIR.0000016051.33225.33
   Szczech LA, 2001, KIDNEY INT, V60, P292, DOI 10.1046/j.1523-1755.2001.00799.x
   Takagi A, 1999, CIRCULATION, V100, P250
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   Tamburino C, 2010, JACC-CARDIOVASC INTE, V3, P624, DOI 10.1016/j.jcin.2010.03.016
   TAN K, 1995, J AM COLL CARDIOL, V25, P855, DOI 10.1016/0735-1097(94)00462-Y
   Tanigawa J, 2008, CIRC J, V72, P157, DOI 10.1253/circj.72.157
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Tarantini G, 2009, CATHETER CARDIO INTE, V73, P50, DOI 10.1002/ccd.21757
   Taylor AJ, 1998, CHEST, V114, P1570, DOI 10.1378/chest.114.6.1570
   Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   ten Berg JM, 2010, J AM COLL CARDIOL, V55, P2446, DOI 10.1016/j.jacc.2009.11.091
   Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139
   Testa L, 2009, QJM-INT J MED, V102, P369, DOI 10.1093/qjmed/hcp005
   The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2004, JAMA-J AM MED ASSOC, V291, P2916
   Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   Alderman EL, 1996, NEW ENGL J MED, V335, P217
   PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255
   PEDUZZI P, 1992, CIRCULATION, V86, P121
   Thiele H, 2009, J AM COLL CARDIOL, V53, P2324, DOI 10.1016/j.jacc.2009.03.032
   Thiele H, 2005, CIRCULATION, V112, P3445, DOI 10.1161/CIRCULATIONHA.105.578492
   Thiele H, 2010, EUR HEART J, V31, P1828, DOI 10.1093/eurheartj/ehq220
   Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091
   Thomas RJ, 2007, CIRCULATION, V116, P1611, DOI 10.1161/CIRCULATIONAHA.107.185734
   Thompson PD, 2003, ARTERIOSCL THROM VAS, V23, P1319, DOI 10.1161/01.ATV.0000087143.33998/F2
   Thomsen HS, 2008, INVEST RADIOL, V43, P170, DOI 10.1097/RLI.0b013e31815f3172
   Thuesen L, 2006, AM HEART J, V152, P1140, DOI 10.1016/j.ahj.2006.06.035
   Thygesen K, 2007, EUR HEART J, V28, P2525
   TIME Investigators, 2001, LANCET, V358, P951
   Tolleson TR, 2003, J AM COLL CARDIOL, V41, P386, DOI 10.1016/S0735-1097(02)02767-5
   Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   TOPOL EJ, 1987, J AM COLL CARDIOL, V9, P1214
   Tramer MR, 2006, BRIT MED J, V333, P675, DOI 10.1136/bmj.38905.634132.AE
   Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6
   Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641
   Tsubokawa A, 2002, CIRC J, V66, P1119, DOI 10.1253/circj.66.1119
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Urban P, 1999, EUR HEART J, V20, P1030, DOI 10.1053/euhj.1998.1353
   Vaitkus Paul T, 2004, J Invasive Cardiol, V16, P243
   Vaitkus PT, 2007, AM HEART J, V153, P275, DOI 10.1016/j.ahj.2006.09.014
   Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668
   Valgimigli M, 2004, J AM COLL CARDIOL, V44, P14, DOI 10.1016/j.jacc.2004.03.042
   Valgimigli M, 2007, J AM COLL CARDIOL, V49, P431, DOI 10.1016/j.jacc.2006.06.081
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van der Heijden DJ, 2004, J AM COLL CARDIOL, V44, P20, DOI 10.1016/j.jacc.2004.02.056
   van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0
   van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055
   Vaquerizo B, 2010, J INTERV CARDIOL, V23, P240, DOI 10.1111/j.1540-8183.2010.00547.x
   Varani Elisabetta, 2007, J Invasive Cardiol, V19, P469
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Vavalle John P, 2009, J Invasive Cardiol, V21, p21A
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Vijayalakshmi K, 2006, HEART, V92, P1278, DOI 10.1136/hrt.2005.075077
   VINEBERG AM, 1946, CAN MED ASSOC J, V55, P117
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
   Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8
   vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347
   von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088
   Vranckx P, 2009, CATHETER CARDIO INTE, V74, P302, DOI 10.1002/ccd.22011
   Wahrborg P, 1999, EUR HEART J, V20, P653, DOI 10.1053/euhj.1998.1237
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wallentin L, 1999, LANCET, V354, P708
   Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6
   WARTH DC, 1994, J AM COLL CARDIOL, V24, P641
   Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041
   Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021
   Weiner DE, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-26
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Welke KF, 2007, ANN THORAC SURG, V84, P1538, DOI 10.1016/j.athoracsur.2007.06.022
   Werner GS, 2002, CATHETER CARDIO INTE, V57, P444, DOI 10.1002/ccd.10375
   WEYRENS FJ, 1995, AM J CARDIOL, V75, P849, DOI 10.1016/S0002-9149(99)80430-5
   Whelton SP, 2002, ANN INTERN MED, V136, P493
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   White HD, 2008, CIRCULATION, V118, P219, DOI 10.1161/CIRCULATIONAHA.108.790170
   Widimsky P, 2011, EUR HEART J, V32, P396, DOI 10.1093/eurheartj/ehq410
   Widimsky P, 2008, EUR HEART J, V29, P1495, DOI 10.1093/eurheartj/ehn169
   Wijeysundera HC, 2007, J AM COLL CARDIOL, V49, P422, DOI 10.1016/j.jacc.2006.09.033
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   Williams BF, 2003, LANCET, V361, P918, DOI 10.1016/S0140-6736(03)12773-0
   Williams DO, 2000, CIRCULATION, V102, P2945
   WILLIAMS DO, 1982, CIRCULATION, V66, P693
   Williams M, 2008, JACC-CARDIOVASC IMAG, V1, P61, DOI 10.1016/j.jcmg.2007.09.001
   Wilson SH, 2003, J AM COLL CARDIOL, V42, P234, DOI 10.1016/S0735-1097(03)00622-3
   Wilson Walter, 2007, Circulation, V116, P1736, DOI 10.1161/CIRCULATIONAHA.106.183095
   Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001
   Winchester DE, 2010, J AM COLL CARDIOL, V56, P1099, DOI 10.1016/j.jacc.2010.04.023
   Witt BJ, 2004, J AM COLL CARDIOL, V44, P988, DOI 10.1016/j.jacc.2004.05.062
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wohrle J, 2003, CIRCULATION, V107, P1840, DOI 10.1161/01.CIR.0000066852.98038.D1
   Wöhrle Jochen, 2008, EuroIntervention, V3, P465, DOI 10.4244/EIJV3I4A83
   Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e
   Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3
   Wu TG, 2008, CIRC J, V72, P1605, DOI 10.1253/circj.CJ-08-0357
   Yamaguchi T, 2008, AM J CARDIOL, V101, P562, DOI 10.1016/j.amjcard.2007.09.116
   Yan AT, 2005, AM J CARDIOL, V96, P913, DOI 10.1016/j.amjcard.2005.05.046
   Yang EH, 2005, J AM COLL CARDIOL, V46, P2004, DOI 10.1016/j.jacc.2005.06.083
   Yang JH, 2008, ANN THORAC SURG, V85, P65, DOI 10.1016/j.athoracsur.2007.06.027
   Yang Xin-chun, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P517
   Yang Zhen Kun, 2007, J Interv Cardiol, V20, P10, DOI 10.1111/j.1540-8183.2007.00222.x
   Yeung AC, 2008, JACC-CARDIOVASC INTE, V1, P598, DOI 10.1016/j.jcin.2008.09.001
   Yip HK, 2001, AM J CARDIOL, V87, P1184, DOI 10.1016/S0002-9149(01)01491-6
   Yun KH, 2009, INT J CARDIOL, V137, P246, DOI 10.1016/j.ijcard.2008.06.055
   Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519
   Yusuf S, 2006, NEW ENGL J MED, V354, P1464
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Zahn R, 1999, CATHETER CARDIO INTE, V46, P127, DOI 10.1002/(SICI)1522-726X(199902)46:2<127::AID-CCD2>3.0.CO;2-G
   Zeymer U, 2003, CIRCULATION, V108, P1324, DOI 10.1161/01.CIR.0000087605.09362.0E
   Zhang F, 2010, ANN MED, V42, P171, DOI 10.3109/07853890903463976
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002
   1988, CIRCULATION, V78, P486
NR 872
TC 212
Z9 233
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD DEC 6
PY 2011
VL 124
IS 23
BP E574
EP E651
DI 10.1161/CIR.0b013e31823ba622
PG 78
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 863QW
UT WOS:000298183300001
PM 22064601
ER

PT S
AU Smetana, JG
   Campione-Barr, N
   Metzger, A
AF Smetana, JG
   Campione-Barr, N
   Metzger, A
TI Adolescent development in interpersonal and societal contexts
SO ANNUAL REVIEW OF PSYCHOLOGY
SE Annual Review of Psychology
LA English
DT Review; Book Chapter
DE adolescence; parenting; siblings; peers; romantic relationships
ID PARENTAL PSYCHOLOGICAL CONTROL; AFRICAN-AMERICAN FAMILIES; ROMANTIC
   RELATIONSHIPS; SIBLING RELATIONSHIPS; PEER HARASSMENT; PERSONAL
   RELATIONSHIPS; CHILDRENS PERCEPTIONS; EUROPEAN BACKGROUNDS; BEHAVIORAL
   AUTONOMY; CHINESE ADOLESCENTS
AB In this chapter we review theoretical and empirical advances in research on adolescent development in interpersonal and societal contexts. First, we identify several trends in current research, including the current emphasis on ecological models and the focus on diversity in and relational models of adolescent development. Next, we discuss recent research on interpersonal relationships, with an eye toward identifying major research themes and findings. Research on adolescents' relationships with parents, siblings, other relatives, peers, and romantic partners, and adolescents' involvement in community and society is reviewed. Future directions in research on adolescent development are discussed.
C1 Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY 14627 USA.
RP Smetana, JG (reprint author), Univ Rochester, Dept Clin & Social Sci Psychol, 601 Elmwood Ave, Rochester, NY 14627 USA.
EM Smetana@psych.rochester.edu; campione@psych.rochester.edu;
   metzger@psych.rochester.edu
CR Adams Gerald R., 2003, BLACKWELL HDB ADOLES
   Adams R, 2001, J MARRIAGE FAM, V63, P97, DOI 10.1111/j.1741-3737.2001.00097.x
   Adler P. A., 1998, PEER POWER PREADOLES
   ALLEN JP, 1994, J RES ADOLESCENCE, V4, P535, DOI 10.1207/s15327795jra0404_6
   Allen JP, 1998, CHILD DEV, V69, P1406, DOI 10.2307/1132274
   Allen JP, 2005, CHILD DEV, V76, P747, DOI 10.1111/j.1467-8624.2005.00875.x
   ALLEN JP, 1994, CHILD DEV, V65, P179, DOI 10.1111/j.1467-8624.1994.tb00743.x
   Ardelt M, 2002, J EARLY ADOLESCENCE, V22, P310, DOI 10.1177/02731602022003004
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037//0003-066X.55.5.469
   Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.1111/j.1467-8624.1996.tb01915.x
   BARBER BK, 2002, PARENTAL PSYCHOL CON
   Baumrind D., 1991, ADV FAMILY RES, V2, P111
   Bellah R.N., 1985, HABITS HEART INDIVID
   Borg MG, 1999, EDUC RES, V41, P137
   Bornstein M. H., 2002, HDB PARENTING, V1-5
   BOUCHEY HA, 2003, DATING ROMANTIC EXPE, P313
   Branje SJT, 2004, J CHILD PSYCHOL PSYC, V45, P1385, DOI 10.1111/j.1469-7610.2004.00332.x
   BRODY GH, 1992, CHILD DEV, V63, P82, DOI 10.1111/j.1467-8624.1992.tb03597.x
   BRONFENBRENNER U, 1979, ECLOGY HUMAN DEV EXP
   Bronfenbrenner U., 1998, HDB CHILD PSYCHOL, V1, P993
   Brown B, 2004, ADOLESCENTS RELATION, P363
   BROWN BB, 2003, FRIENDSHIPS CLIQUES, P330
   BUCHANAN CM, 1990, J YOUTH ADOLESCENCE, V19, P363, DOI 10.1007/BF01537078
   BUHRMESTER D, 1990, CHILD DEV, V61, P1387, DOI 10.1111/j.1467-8624.1990.tb02869.x
   BUHRMESTER D, 1987, CHILD DEV, V58, P1101, DOI 10.1111/j.1467-8624.1987.tb01444.x
   CALLAN VJ, 1986, J MARRIAGE FAM, V48, P813, DOI 10.2307/352574
   Cauffman E, 2000, BEHAV SCI LAW, V18, P741, DOI 10.1002/bsl.416
   Chao R., 2002, HDB PARENTING, V4, P59
   Chao RK, 2001, CHILD DEV, V72, P1832, DOI 10.1111/1467-8624.00381
   CHAO RK, 1994, CHILD DEV, V65, P1111, DOI 10.1111/j.1467-8624.1994.tb00806.x
   Coleman J.S., 1961, ADOLESCENT SOC
   Coll CG, 1996, CHILD DEV, V67, P1891, DOI 10.1111/j.1467-8624.1996.tb01834.x
   Collins W. A., 1990, CHILDHOOD ADOLESCENC, P85
   Collins W.A., 1999, CONT PERSPECTIVES AD, P125
   Collins WA, 2000, AM PSYCHOL, V55, P218, DOI 10.1037/0003-066X.55.2.218
   COLLINS WA, 2004, PARENT ADOLESCENT RE, P331
   COLLINS WA, 2005, HDB CHILD PSYCHOL
   Collins WAW, 2003, J RES ADOLESCENCE, V13, P1, DOI 10.1111/1532-7795.1301001
   Conger KJ, 1997, J ADOLESCENT RES, V12, P113, DOI 10.1177/0743554897121007
   Conger R. D., 1999, CONFLICT COHESION FA, P185
   CONGER RD, 1993, DEV PSYCHOL, V29, P206, DOI 10.1037//0012-1649.29.2.206
   CONGER RD, 1992, CHILD DEV, V63, P526, DOI 10.1111/j.1467-8624.1992.tb01644.x
   Connolly J, 2000, CHILD DEV, V71, P1395, DOI 10.1111/1467-8624.00235
   Connolly J, 2004, J RES ADOLESCENCE, V14, P185, DOI 10.1111/j.1532-7795.2004.01402003.x
   Connolly JA, 1996, PERS RELATIONSHIP, V3, P185, DOI 10.1111/j.1475-6811.1996.tb00111.x
   Cook TD, 2002, CHILD DEV, V73, P1283, DOI 10.1111/1467-8624.00472
   Crouter A.C., 2002, HDB PARENTING, V3, P461
   DARLING N, 2000, PARENTS ADOLESCENTS
   Darling N., 1993, PSYCHOL BULL, V113, P486
   DIAMOND LM, 2003, INTIMATE RELATIONSHI, P393
   Dornbusch S. M., 1990, J ADOLESCENT RES, V5, P143, DOI DOI 10.1177/074355489052003
   Dowdy BB, 1998, J YOUTH ADOLESCENCE, V27, P473, DOI 10.1023/A:1022852102847
   Dubas JS, 2002, J FAM PSYCHOL, V16, P415, DOI 10.1037//0893-3200.16.4.415
   DUBAS JS, 1996, LEAVING HOME UNDERST, V71, P3
   DuBois DL, 2002, CHILD DEV, V73, P1573, DOI 10.1111/1467-8624.00491
   DANIELS D, 1985, CHILD DEV, V56, P764
   DUNPHY DC, 1963, SOCIOMETRY, V26, P230, DOI 10.2307/2785909
   East PL, 2001, DEV PSYCHOL, V37, P254, DOI 10.1037//0012-1649.37.2.254
   Eccles JS, 2002, COMMUNITY PROGRAMS P
   Eisenberg ME, 2003, J SCHOOL HEALTH, V73, P311
   EISENBERG N, 2004, MORAL COGNITIONS PRO, P155
   Eisenberg N., 1998, HDB CHILD PSYCHOL, V3
   Ennett ST, 1996, J ADOLESCENT RES, V11, P194, DOI 10.1177/0743554896112003
   Farmer TW, 2003, DEV PSYCHOL, V39, P992, DOI 10.1037/0012-1649.39.6.992
   Feinberg M, 2001, J FAM PSYCHOL, V15, P22, DOI 10.1037/0893-3200.15.1.22
   Feinberg ME, 2003, CHILD DEV, V74, P1261, DOI 10.1111/1467-8624.00606
   FEIRING C, 1999, CONT PERSPECTIVES AD, P211
   Finkenauer C, 2002, J YOUTH ADOLESCENCE, V31, P123, DOI 10.1023/A:1014069926507
   FLANAG C, 2001, SOC POLICY REPORT PU, P3
   Flanagan C, 2005, CLAR SYMP, P149
   FLANAGAN CA, 2000, J ADOLESCENT RES, V20, P193
   FLANAGAN CA, 2004, NURTURING MORALITY I, P173
   FLANAGAN CA, 2004, VOLUNTEERISM LEADERS, P721
   FLANAGAN CA, 2003, COMMUNITY YOUTH DEV, P273
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Fletcher AC, 1999, J MARRIAGE FAM, V61, P599, DOI 10.2307/353563
   Fuligni A. J., 2002, CHILD DEV, V73, P306
   Fuligni AJ, 1998, CURR DIR PSYCHOL SCI, V7, P99, DOI 10.1111/1467-8721.ep10774731
   Fuligni AJ, 1998, DEV PSYCHOL, V34, P782, DOI 10.1037/0012-1649.34.4.782
   Fuligni AJ, 1999, CHILD DEV, V70, P1030, DOI 10.1111/1467-8624.00075
   FULIGNI AJ, 1993, DEV PSYCHOL, V29, P622, DOI 10.1037/0012-1649.29.4.622
   Furman W., 1997, ROMANTIC RELATIONSHI, P21
   FURMAN W, 1992, CHILD DEV, V63, P103, DOI 10.1111/j.1467-8624.1992.tb03599.x
   Furman W, 2002, CHILD DEV, V73, P241, DOI 10.1111/1467-8624.00403
   Furman W, 1999, MINN SYM CHILD PSYCH, V30, P133
   FURMAN W, 1985, DEV PSYCHOL, V21, P1016, DOI 10.1037//0012-1649.21.6.1016
   Graham S., 2001, PEER HARASSMENT SCH
   Grant KE, 2003, PSYCHOL BULL, V129, P447, DOI 10.1037/0033-2909.129.3.447
   Gray R. B., 1999, CONT PERSPECTIVES AD, P235
   GROTEVANT HD, 1985, CHILD DEV, V56, P415, DOI 10.1111/j.1467-8624.1985.tb00116.x
   GRUSEC JE, 1994, DEV PSYCHOL, V30, P4, DOI 10.1037/0012-1649.30.1.4
   Gutman LM, 1999, CHILD DEV, V70, P1464, DOI 10.1111/1467-8624.00106
   HAGEN JW, 2004, COMPARISON RES 2 MAJ
   Harris J. R., 1998, NURTURE ASSUMPTION
   HART D, 1995, CHILD DEV, V66, P1346, DOI 10.1111/j.1467-8624.1995.tb00939.x
   Hart D., 2002, APPL DEV SCI, V6, P227, DOI DOI 10.1207/S1532480XADS0604_
   Hartup WW, 1996, CHILD DEV, V67, P1, DOI 10.1111/j.1467-8624.1996.tb01714.x
   HARWOOD R, 2002, PARENTINS LATINO FAM, V4, P21
   Hatchett S. J., 1993, FAMILY ETHNICITY STR, P90
   Hauser S, 1991, ADOLESCENTS THEIR FA
   HELWIG CC, 1995, CHILD DEV, V66, P152, DOI 10.1111/j.1467-8624.1995.tb00862.x
   Helwig CC, 2003, CHILD DEV, V74, P783, DOI 10.1111/1467-8624.00568
   Hetherington E.M, 2002, BETTER WORSE DIVORCE
   Hoff E, 2002, HDB PARENTING, V2, P231
   Holmbeck GN., 1996, TRANSITIONS ADOLESCE, P167
   Horn SS, 2003, DEV PSYCHOL, V39, P71, DOI 10.1037//0012-1649.39.1.71
   Johnson MK, 1998, J RES ADOLESCENCE, V8, P309, DOI 10.1207/s15327795jra0803_2
   Juvonen J, 2000, J EDUC PSYCHOL, V92, P349, DOI 10.1037/0022-0663.92.2.349
   Kahne J, 2001, YOUTH SOC, V32, P421, DOI 10.1177/0044118X01032004002
   KEATING D, 2004, COGNITIVE BRAIN DEV, P45
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Kowal A, 1997, CHILD DEV, V68, P113, DOI 10.2307/1131929
   Kuczynski L., 2003, HDB DYNAMICS PARENT
   LaFontana KA, 2002, DEV PSYCHOL, V38, P635, DOI 10.1037//0012-1649.38.5.635
   LAMBORN S, 1996, CHILD DEV, V66, P283
   Larson R., 1994, DIVERGENT REALITIES
   Larson RW, 1996, DEV PSYCHOL, V32, P744, DOI 10.1037/0012-1649.32.4.744
   Larson RW, 2000, AM PSYCHOL, V55, P170, DOI 10.1037//0003-066X.55.1.170
   Larson RW, 2002, CHILD DEV, V73, P1151, DOI 10.1111/1467-8624.00464
   Laursen B, 1998, CHILD DEV, V69, P817, DOI 10.1111/j.1467-8624.1998.00817.x
   LAURSEN B, 1995, J RES ADOLESCENCE, V5, P55, DOI 10.1207/s15327795jra0501_3
   LAURSEN B, 1994, PSYCHOL BULL, V115, P197, DOI 10.1037//0033-2909.115.2.197
   Laursen B., 1997, ROMANTIC RELATIONSHI, V78, P3, DOI DOI 10.1002/CD.23219977803
   LEMPERS JD, 1992, J YOUTH ADOLESCENCE, V21, P53, DOI 10.1007/BF01536983
   Lerner Richard M., 2004, HDB ADOLESCENT PSYCH
   Lerner RM, 2000, CHILD DEV, V71, P11, DOI 10.1111/1467-8624.00113
   Luthar SS, 2003, CHILD DEV, V74, P1581, DOI 10.1046/j.1467-8624.2003.00625.x
   Luthar SS, 2002, CHILD DEV, V73, P1593, DOI 10.1111/1467-8624.00492
   Maccoby E. E., 1983, HDB CHILD PSYCHOL, VIV, P1
   Markus HR, 1997, CONCEPTUAL SELF CONT, P13
   MARSHALL SK, 2005, IN PRESS J ADOLESC
   MCADOO H, 2002, AFRICAN AM PARENTING, V4, P47
   McElhaney KB, 2001, CHILD DEV, V72, P220
   McGlothlin H., 2002, MONOGRAPHS SOC RES C, V67, P1, DOI 10.1111/1540-5834.00219
   McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185
   Melchior A., 1998, FINAL REPORT NATL EV
   METZ E, 2003, APPL DEV SCI, V7, P148, DOI 10.1207/S1532480XADS0703_5
   Metz EC, 2005, POLIT PSYCHOL, V26, P413, DOI 10.1111/j.1467-9221.2005.00424.x
   MINUCHIN P, 2002, RETROSPECT PROSPECT
   Montemayor R., 1983, J EARLY ADOLESC, V3, P83, DOI 10.1177/027243168331007
   Mounts NS, 2004, J ADOLESCENT RES, V19, P446, DOI 10.1177/074355840328854
   MOUNTS NS, 2001, J EARLY ADOLESC, V21, P91
   Neff KD, 2002, COGNITIVE DEV, V17, P1429, DOI 10.1016/S0885-2014(02)00126-0
   Nishina A, 2005, CHILD DEV, V76, P435, DOI 10.1111/j.1467-8624.2005.00855.x
   NOLLER P, 1986, J ADOLESCENCE, V9, P97, DOI 10.1016/S0140-1971(86)80030-6
   NOLLER P, 1990, J YOUTH ADOLESCENCE, V19, P349, DOI 10.1007/BF01537077
   OLWEUS D, 1993, BULLYING SCH WE KNOW
   Olweus D., 1999, NATURE SCH BULLYING, P7
   OLWEUS D, 1993, SOCIAL WITHDRAWAL, INHIBITION, AND SHYNESS IN CHILDHOOD, P315
   PARKE RD, 1998, SOCIAL EMOTIONAL PER, P463
   Parker JG, 2005, DEV PSYCHOL, V41, P235, DOI 10.1037/0012-1649.41.1.235
   PELLEGRINI AD, 1994, INT J BEHAV DEV, V17, P525
   PERRY DG, 1988, DEV PSYCHOL, V24, P807, DOI 10.1037/0012-1649.24.6.807
   PETERSEN AC, 1988, ANNU REV PSYCHOL, V39, P583, DOI 10.1146/annurev.psych.39.1.583
   Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298
   *PEW INT AM LIF PR, 2004, INT SURV LAT TRENDS
   Phinney JS, 1998, STUDYING MINORITY ADOLESCENTS, P89
   Phinney JS, 2000, CHILD DEV, V71, P528, DOI 10.1111/1467-8624.00162
   Phinney JS, 2005, J ADOLESCENT RES, V20, P8, DOI 10.1177/0743558404271237
   Putnam Robert D., 2000, BOWLING ALONE COLLAP
   RAFFAELLI M, 1987, SIBLING INTERACTIONS
   Richards MH, 1998, CHILD DEV, V69, P154, DOI 10.1111/j.1467-8624.1998.tb06140.x
   Rodkin PC, 2000, DEV PSYCHOL, V36, P14, DOI 10.1037/0012-1649.36.1.14
   Rose AJ, 2002, CHILD DEV, V73, P1830, DOI 10.1111/1467-8624.00509
   Rose AJ, 2004, DEV PSYCHOL, V40, P378, DOI 10.1037/0012-1649.40.3.378
   Roth MA, 2001, J ADOLESCENCE, V24, P281, DOI 10.1006/jado.2001.0408
   Rothbaum F, 2000, CHILD DEV, V71, P1121, DOI 10.1111/1467-8624.00214
   RUBIN K, 1998, PEER INTERACTIONS RE, P619
   RUBIN KH, 1995, DEV PSYCHOPATHOL, V7, P751
   Schachter F. F., 1987, J CHILDREN CONT SOC, V19, P55
   SCHACHTER FF, 1985, FAM PROCESS, V24, P415, DOI 10.1111/j.1545-5300.1985.00415.x
   Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89
   SEMTANA JG, 2005, IN PRESS CHILD DEV
   SHANAHAN L, 2005, DEV DIFFERENTIAL PAR
   Sherrod L., 2002, APPL DEV SCI, V6, P264, DOI DOI 10.1207/S1532480XADS0604_14
   SILVERBERG SB, 1990, DEV PSYCHOL, V26, P658, DOI 10.1037//0012-1649.26.4.658
   Slomkowski C, 2001, CHILD DEV, V72, P271, DOI 10.1111/1467-8624.00278
   Smetana J, 1999, CHILD DEV, V70, P1447, DOI 10.1111/1467-8624.00105
   Smetana J. G., 1991, J RES ADOLESCENCE, V1, P189, DOI 10.1207/s15327795jra0102_5
   Smetana JG, 2006, HANDBOOK OF MORAL DEVELOPMENT, P119
   SMETANA JG, 1989, CHILD DEV, V60, P1052, DOI 10.1111/j.1467-8624.1989.tb03536.x
   SMETANA JG, 1991, DEV PSYCHOL, V27, P1000, DOI 10.1037/0012-1649.27.6.1000
   Smetana JG, 2002, ADV CHILD DEV BEHAV, V29, P51, DOI 10.1016/S0065-2407(02)80051-9
   Smetana JG, 2002, CHILD DEV, V73, P563, DOI 10.1111/1467-8624.00424
   Smetana JG, 2004, CHILD DEV, V75, P932, DOI 10.1111/j.1467-8624.2004.00715.x
   SMETANA JG, 1988, 21 MINN S CHILD PSYC, P77
   Smetana JG, 2004, CHILD DEV, V75, P1418, DOI 10.1111/j.1467-8624.2004.00749.x
   Smith PK, 2003, CAN J PSYCHIAT, V48, P591
   Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2
   SPENCER M, 1996, ADOLESCENCE OPPORTUN, P259
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Steinberg L, 2004, ANN NY ACAD SCI, V1021, P51, DOI 10.1196/annals.1308.005
   Steinberg L, 2002, HDB PARENTING, VI, P103
   Steinberg L, 2001, J RES ADOLESCENCE, V11, P1, DOI 10.1111/1532-7795.00001
   Steinberg L., 1989, ADV ADOLESCENT DEV, V1, P71
   STEINBERG L, 2000, POVERTY RES, V4, P3
   Steinberg L, 2003, AM PSYCHOL, V58, P1009, DOI 10.1037/0003-066X.58.12.1009
   Steinberg L, 2001, ANNU REV PSYCHOL, V52, P83, DOI 10.1146/annurev.psych.52.1.83
   Steinberg L., 1990, THRESHOLD DEV ADOLES, P255
   Stocker CM, 2002, J FAM PSYCHOL, V16, P50, DOI 10.1037//0893-3200.16.1.50
   Taylor RD, 1995, CHILD DEV, V66, P1585, DOI 10.1111/j.1467-8624.1995.tb00953.x
   Tilton-Weaver LC, 2003, J RES ADOLESCENCE, V13, P269, DOI 10.1111/1532-7795.1303002
   UNDERWOOD MK, 2003, ICE FIRE ANGER AGGRE
   Updegraff KA, 2000, CHILD DEV, V71, P1597, DOI 10.1111/1467-8624.00251
   WALKER LJ, 1991, CHILD DEV, V62, P264, DOI 10.1111/j.1467-8624.1991.tb01530.x
   Whiteman SD, 2002, J FAM PSYCHOL, V16, P157, DOI 10.1037//0893-3200.16.2.157
   Whiteman SD, 2003, J MARRIAGE FAM, V65, P608, DOI 10.1111/j.1741-3737.2003.00608.x
   Yates M, 1996, J RES ADOLESCENCE, V6, P271
   Yau J, 1996, CHILD DEV, V67, P1262, DOI 10.1111/j.1467-8624.1996.tb01794.x
   Yau J, 2003, INT J BEHAV DEV, V27, P201, DOI 10.1080/01650250244000209
   Youniss J, 1999, EDUC PSYCHOL REV, V11, P361, DOI 10.1023/A:1022009400250
   Youniss J, 1997, AM BEHAV SCI, V40, P620, DOI 10.1177/0002764297040005008
   Youniss J., 1985, ADOLESCENTS RELATION
   Youniss J, 1999, J ADOLESCENCE, V22, P243, DOI 10.1006/jado.1999.0214
NR 214
TC 204
Z9 209
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0066-4308
BN 978-0-8243-0257-3
J9 ANNU REV PSYCHOL
JI Annu. Rev. Psychol.
PY 2006
VL 57
BP 255
EP 284
DI 10.1146/annurev.psych.57.102904.190124
PG 30
WC Psychology; Psychology, Multidisciplinary
SC Psychology
GA 008PR
UT WOS:000235053700011
PM 16318596
ER

PT J
AU Rockson, SG
AF Rockson, SG
TI Lymphedema
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Review
ID BREAST-CANCER PATIENTS; POSTMASTECTOMY LYMPHEDEMA; PSYCHOLOGICAL
   DISTRESS; HEREDITARY LYMPHEDEMA; RADICAL HYSTERECTOMY;
   SURGICAL-TREATMENT; ADIPOSE-TISSUE; FOLLOW-UP; ARM; THERAPY
AB Lymphedema is a set of pathologic conditions that are characterized by the regional accumulation of excessive amounts of interstitial protein-rich fluid. These occur as a result of an imbalance between the demand for lymphatic flow and the capacity of the lymphatic circulation. Lymphedema can result from either primary or acquired (secondary) disorders. In this review, the pathophysiology, classification, natural history, differential diagnosis, and treatment of lymphedema are discussed.
C1 Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA.
RP Rockson, SG (reprint author), Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA.
CR BARTAL AH, 1985, J SURG ONCOL, V98, P1076
   BAUMEISTER RG, 1986, SCAND J PLAST RECONS, V20, P141
   BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012
   BERGAN JJ, 1986, J VASC SURG, V3, P174, DOI 10.1067/mva.1986.avs0030174
   Brorson H, 1998, PLAST RECONSTR SURG, V102, P1058, DOI 10.1097/00006534-199809040-00021
   Brorson H, 1997, LYMPHOLOGY, V30, P165
   Brorson H, 1997, SCAND J PLAST RECONS, V31, P137
   BROWSE NL, 1985, J CARDIOVASC SURG, V26, P91
   Bull LN, 2000, AM J HUM GENET, V67, P994, DOI 10.1086/303080
   BULL RH, 1993, LANCET, V341, P403, DOI 10.1016/0140-6736(93)92990-B
   BUNCE IH, 1994, MED J AUSTRALIA, V161, P125
   CAMBRIA RA, 1993, J VASC SURG, V18, P773
   CAMPISI C, 1995, MICROSURG, V16, P161, DOI 10.1002/micr.1920160309
   CAMPISI C, 1995, MICROSURG, V16, P463, DOI 10.1002/micr.1920160706
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   Casley-Smith J, 1991, LYMPHEDEMA, P155
   CASLEYSMITH JR, 1993, BRIT MED J, V307, P1037
   CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604
   Casley-Smith JR, 1999, INT ANGIOL, V18, P31
   CLODIUS L, 1976, LYMPHOLOGY, V9, P1
   CLODIUS L, 1982, ANN PLAS SURG, V9, P447, DOI 10.1097/00000637-198212000-00001
   CLODIUS L, 1977, LYMPHEDEMA, P147
   Dimakakos PB, 1997, INT SURG, V82, P411
   Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946
   Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073
   FIORICA JV, 1990, GYNECOL ONCOL, V36, P343, DOI 10.1016/0090-8258(90)90139-C
   FOELDI E, 1985, Angiology, V36, P171
   Foeldi Michael, 1994, Lymphology, V27, P1
   Gloviczki P, 1999, INT ANGIOL, V18, P42
   GOLDSMIT.HS, 1967, SURG GYNECOL OBSTETR, V125, P607
   GREGL A, 1967, STRAHLENTHER ONKOL, V133, P499
   GREGL A, 1988, Z LYMPHOL-J LYMPHOL, V12, P66
   HO LCY, 1983, BRIT J PLAST SURG, V36, P350
   Hojris I, 2000, ACTA ONCOL, V39, P355
   HOLT PJA, 1976, BRIT J DERMATOL, V95, P513, DOI 10.1111/j.1365-2133.1976.tb00861.x
   Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019
   Kim DI, 1998, LYMPHOLOGY, V31, P190
   Ko DSC, 1998, ARCH SURG-CHICAGO, V133, P452, DOI 10.1001/archsurg.133.4.452
   KUBIK S, 1980, ACTA BIOL ACAD SCI H, V31, P191
   Lister RK, 1997, BRIT J DERMATOL, V136, P384, DOI 10.1111/j.1365-2133.1997.tb14950.x
   Mallon E, 1997, BRIT J DERMATOL, V137, P928, DOI 10.1111/j.1365-2133.1997.tb01553.x
   Mangion J, 1999, AM J HUM GENET, V65, P427, DOI 10.1086/302500
   MAUNSELL E, 1993, CAN J SURG, V36, P315
   Mikes DM, 1999, LYMPHOLOGY, V32, P157
   MORGAN RG, 1992, J HAND SURG-BRIT EUR, V17B, P437, DOI 10.1016/S0266-7681(05)80270-0
   OBRIEN BM, 1990, PLAST RECONSTR SURG, V85, P562, DOI 10.1097/00006534-199004000-00011
   Ogawa Y, 1999, LYMPHOLOGY, V32, P151
   Olszewski W, 1977, LYMPHEDEMA, P79
   Passik SD, 1995, PSYCHO-ONCOL, V4, P255, DOI 10.1002/pon.2960040402
   PECKING A, 1991, B CANCER, V78, P373
   Petrek JA, 1998, CANCER, V83, P2776, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2776::AID-CNCR25>3.0.CO;2-V
   PILLER NB, 1988, BRIT J PLAST SURG, V41, P20, DOI 10.1016/0007-1226(88)90139-7
   Piller NB, 1998, LYMPHOLOGY, V31, P74
   PILLER NB, 1976, LYMPHOLOGY, V9, P127
   PILLER NB, 1990, ARCH HISTOL CYTOL, V53, P209, DOI 10.1679/aohc.53.Suppl_209
   PILLER NB, 1980, LYMPHOLOGY, V13, P109
   POTH EJ, 1947, SURG GYNECOL OBSTET, V84, P642
   REED RK, 1990, AM J PHYSIOL, V259, pH1097
   Rockson SG, 1998, CANCER, V83, P2814
   Rockson SG, 1998, CANCER, V83, P2882, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2882::AID-CNCR45>3.0.CO;2-0
   ROSE KE, 1991, PALLIATIVE MED, P52
   RUOCCO V, 1984, INT J DERMATOL, V23, P56, DOI 10.1111/j.1365-4362.1984.tb05664.x
   RYAN TJ, 1989, CLIN DERMATOL, V7, P93, DOI 10.1016/0738-081X(89)90045-X
   Ryan TJ, 1995, CLIN DERMATOL, V13, P493, DOI 10.1016/0738-081X(95)00092-T
   Ryan TJ, 1995, CLIN DERMATOL, V13, P451, DOI 10.1016/0738-081X(95)00091-S
   SAVAGE RC, 1985, SURG GYNECOL OBSTET, V160, P283
   SCANLON EF, 1985, CANCER, V55, P1163, DOI 10.1002/1097-0142(19850315)55:6<1163::AID-CNCR2820550603>3.0.CO;2-I
   SCHIRGER A, 1962, JAMA-J AM MED ASSOC, V182, P124
   SEGERSTROM K, 1992, SCAND J PLAST RECONS, V26, P223
   SIMON MS, 1992, AM J MED, V93, P543, DOI 10.1016/0002-9343(92)90583-W
   SMAHEL J, 1986, ANN PLAS SURG, V16, P444
   SMELTZER DM, 1985, PEDIATRICS, V76, P206
   SOISSON AP, 1990, GYNECOL ONCOL, V37, P390, DOI 10.1016/0090-8258(90)90374-T
   SORIA P, 1994, ANGIOLOGY, V45, P703, DOI 10.1177/000331979404500805
   STEMMER R, 1976, Vasa, V5, P261
   Szuba A, 2000, AM J MED, V109, P296, DOI 10.1016/S0002-9343(00)00503-9
   Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209
   Szuba A, 1997, Vasc Med, V2, P321
   Tengrup I, 2000, ACTA ONCOL, V39, P393
   TER SE, 1993, CLIN NUCL MED, V18, P646, DOI 10.1097/00003072-199308000-00003
   TOBIN MB, 1993, CANCER, V72, P3248, DOI 10.1002/1097-0142(19931201)72:11<3248::AID-CNCR2820721119>3.0.CO;2-Z
   VAUGHAN BF, 1990, CLIN RADIOL, V41, P24, DOI 10.1016/S0009-9260(05)80927-4
   Velanovich V, 1999, AM J SURG, V177, P184, DOI 10.1016/S0002-9610(99)00008-2
   WARD LC, 1995, LYMPHOLOGY, V28, P41
   WARD LC, 1992, EUR J CLIN INVEST, V22, P751, DOI 10.1111/j.1365-2362.1992.tb01440.x
   WERNGRENELGSTROM M, 1994, SCAND J PLAST RECONS, V28, P289
   Williams WH, 2000, CLIN NUCL MED, V25, P451, DOI 10.1097/00003072-200006000-00013
   Witte CL, 1999, INT ANGIOL, V18, P25
   WOLFE JHN, 1981, ARCH SURG-CHICAGO, V116, P1157
   ZEISSLER RH, 1972, ARCH PHYS MED REHAB, V53, P159
   1987, LANCET, V1, P1409
NR 91
TC 190
Z9 204
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011 USA
SN 0002-9343
J9 AM J MED
JI Am. J. Med.
PD MAR
PY 2001
VL 110
IS 4
BP 288
EP 295
DI 10.1016/S0002-9343(00)00727-0
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 405ZK
UT WOS:000167190300007
PM 11239847
ER

PT J
AU Swartz, MA
AF Swartz, MA
TI The physiology of the lymphatic system
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE lymphatic physiology; lymphatic uptake; lymphangiogenesis; edema;
   lymphatic metastasis; review
ID INTERSTITIAL FLUID VOLUME; ENDOTHELIAL-CELLS; INITIAL LYMPHATICS; HUMAN
   SKIN; VEGF-C; SMALL-INTESTINE; THORACIC-DUCT; IN-VIVO; HEMATOGENOUS
   METASTASIS; ELECTRON-MICROSCOPY
AB This paper presents an overview of the anatomy, physiology, and biology of the lymphatic system specifically relevant to lymphatic drug delivery. We will briefly review the classic fluid and solute transport literature, and also examine the current research in lymphatic endothelial cell biology and tumor metastasis in the lymphatics because of the increasing potential for targeted delivery of immunomodulators, chemotherapeutics, and genetic material to specific lymph nodes (Refs. [1-7]). (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
RP Swartz, MA (reprint author), Northwestern Univ, Dept Biomed Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA.
EM m-swartz2@northwestern.edu
RI Swartz, Melody/B-7633-2009; Shen, Xiaolan/E-5159-2011; Swartz,
   Melody/F-9563-2011
CR Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548
   Adair TH, 1985, EXPT BIOL LYMPHATIC, P13
   ADAIR TH, 1982, AM J PHYSIOL, V243, pH351
   AUKLAND K, 1981, PHYSIOL REV, V61, P556
   AUKLAND K, 1993, PHYSIOL REV, V73, P1
   AZUMA T, 1977, P SOC EXP BIOL MED, V155, P270
   AZZALI G, 1982, LYMPHOLOGY, V15, P106
   AZZALI G, 1982, J SUBMICR CYTOL PATH, V14, P45
   Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   BARSKY SH, 1983, AM J SURG PATHOL, V7, P667, DOI 10.1097/00000478-198310000-00007
   BATES DO, 1994, J PHYSIOL-LONDON, V477, P355
   BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012
   BENOIT JN, 1989, AM J PHYSIOL, V257, pH2059
   BERGQVIST L, 1983, SEMIN NUCL MED, V13, P9, DOI 10.1016/S0001-2998(83)80031-2
   Berk DA, 1996, AM J PHYSIOL-HEART C, V270, pH330
   BOLLINGER A, 1981, CIRCULATION, V64, P1195
   BOLLINGER A, 1993, INT J MICROCIRC, V12, P1
   Bollinger A, 1990, CLIN CAPILLAROSCOPY
   BORRON P, 1994, LYMPHOLOGY, V27, P6
   BRACE RA, 1977, MICROVASC RES, V14, P243, DOI 10.1016/0026-2862(77)90023-1
   Brennan MJ, 1996, ARCH PHYS MED REHAB, V77, P74
   BUCKWALTER JA, 1982, J BIOL CHEM, V257, P9830
   BUDGE A, 1880, ARCH ANAT ENTWICKL G, P350
   BUTLER TP, 1975, CANCER RES, V35, P512
   CAMPISI C, 1995, MICROSURG, V16, P463, DOI 10.1002/micr.1920160706
   Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389
   CARR I, 1987, CANCER TREAT REV, V14, P53, DOI 10.1016/0305-7372(87)90050-8
   CASLEYSMITH JR, 1980, LYMPHOLOGY, V13, P120
   CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604
   CASLEYSMITH JR, 1981, MICROVASC RES, V21, P223, DOI 10.1016/0026-2862(81)90034-0
   CASLEYSMITH JR, 1983, MICROVASC RES, V25, P369, DOI 10.1016/0026-2862(83)90026-2
   CASLEYSMITH JR, 1981, J PATHOL, V133, P243, DOI 10.1002/path.1711330307
   CASLEYSMITH JR, 1964, Q J EXP PHYSIOL CMS, V49, P365
   CASTENHOLZ A, 1991, INT J MICROCIRC CLIN, V10, P246
   CASTENHOLZ A, 1984, SCANNING ELECTRON MI, V3, P1343
   Charman WN, 1992, LYMPHATIC TRANSPORT
   COLANTUONI A, 1984, INT J MICROCIRC, V3, P13
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   CORNFORD ME, 1993, LYMPHOLOGY, V26, P67
   Daroczy J, 1995, CLIN DERMATOL, V13, P433, DOI 10.1016/0738-081X(95)00086-U
   DEUTSCH A, 1992, J INVEST DERMATOL, V98, P64, DOI 10.1111/1523-1747.ep12495259
   deWaal RMW, 1997, AM J PATHOL, V150, P1951
   DOBBINS WO, 1970, J ULTRA MOL STRUCT R, V33, P29, DOI 10.1016/S0022-5320(70)90117-6
   Eccles SA, 1996, CANCER RES, V56, P2815
   ENGESET A, 1960, CANCER RES, V20, P613
   FABIAN G, 1983, LYMPHOLOGY, V16, P172
   FADNES HO, 1981, MICROVASC RES, V21, P390, DOI 10.1016/0026-2862(81)90022-4
   Fischer M, 1996, AM J PHYSIOL-HEART C, V270, pH358
   FOELDI E, 1985, Angiology, V36, P171
   FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664
   GASPARINI G, 1994, J CLIN ONCOL, V12, P454
   Gerber LH, 1998, CANCER, V83, P2803, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2803::AID-CNCR29>3.0.CO;2-W
   GERLI R, 1990, ANAT EMBRYOL, V181, P281
   GERLI R, 1991, LYMPHOLOGY, V24, P105
   GERLI R, 1989, LYMPHOLOGY, V22, P167
   GNEPP DR, 1985, IN VITRO CELL DEV B, V21, P200
   GNEPP DR, 1987, LYMPHOLOGY, V20, P36
   GNEPP DR, 1976, LYMPHOLOGY, V9, P75
   GRANGER HJ, 1981, TISSUE FLUID PRESSUR, P43
   GRODZINSKY AJ, 2001, FIELDS FORCES FLOWS
   GRODZINSKY AJ, 1983, CRIT REV BIOMED ENG, V9, P133
   GUYTON AC, 1976, FED PROC, V35, P1861
   HAGIWARA A, 1985, ANTICANCER RES, V6, P1005
   HAGIWARA A, 1987, IN VIVO, V1, P241
   HAGIWARA A, 1989, CRIT REV ONCOL HEMAT, V9, P319, DOI 10.1016/S1040-8428(89)80017-4
   HALL J. G., 1965, J PHYSIOL [LONDON], V180, P336
   HAMMERSEN F, 1985, INITIAL LYMPHATICS, P58
   HARDINGHAM TE, 1992, FASEB J, V6, P861
   HARGENS AR, 1981, TISSUE FLUID PRESSUR
   HARGENS AR, 1977, AM J PHYSIOL, V233, pH57
   Hirano K, 1985, Pharm Res, V2, P271, DOI 10.1023/A:1016337500364
   HOGAN RD, 1986, MICROVASC RES, V31, P317, DOI 10.1016/0026-2862(86)90020-8
   HOGAN RD, 1986, AM J PHYSIOL, V251, pH357
   HOLLANDER W, 1961, J CLIN INVEST, V40, P222, DOI 10.1172/JCI104248
   HUANG GK, 1985, PLAST RECONSTR SURG, V76, P671
   Hudack SS, 1933, J EXP MED, V57, P751, DOI 10.1084/jem.57.5.751
   Ikomi F, 1996, AM J PHYSIOL-HEART C, V271, pH173
   Ikomi F, 1997, LYMPHOLOGY, V30, P13
   IKOMI F, 1994, MICROCIRC ANN JPN SO, V10, P183
   JACKSON AJ, 1981, DRUG METAB DISPOS, V9, P535
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JAIN RK, 1994, SCI AM, V271, P58
   JAIN RK, 1989, J NATL CANCER I, V81, P570, DOI 10.1093/jnci/81.8.570
   Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423
   Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898
   Joukov V, 1996, EMBO J, V15, P1751
   JOYNER WL, 1973, LYMPHOLOGY, V6, P181
   Jussila L, 1998, CANCER RES, V58, P1599
   KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566
   KAMPMEIER OF, 1927, ANAT REC, V35, P43
   KANTER MA, 1987, PLAST RECONSTR SURG, V79, P131, DOI 10.1097/00006534-198701000-00025
   KOYAMA T, 1988, BIORHEOLOGY, V25, P219
   Kurebayashi J, 1999, JPN J CANCER RES, V90, P977
   LAUWERYNS JM, 1976, J CELL BIOL, V68, P163, DOI 10.1083/jcb.68.1.163
   LAUWERYN.JM, 1971, LYMPHOLOGY, V4, P125
   LEAK L V, 1970, Microvascular Research, V2, P361, DOI 10.1016/0026-2862(70)90031-2
   LEAK LV, 1987, LYMPHOLOGY, V20, P196
   LEAK LV, 1968, J CELL BIOL, V36, P129, DOI 10.1083/jcb.36.1.129
   LEAK LV, 1976, FED PROC, V35, P1863
   Leak LV, 1999, MICROCIRCULATION, V6, P63, DOI 10.1038/sj.mn.7300049
   LEAK LV, 1972, J ULTRA MOL STRUCT R, V39, P24, DOI 10.1016/S0022-5320(72)80004-2
   LEAK LV, 1994, IN VITRO CELL DEV-AN, V30A, P512
   LEAK LV, 1980, ENVIRON HEALTH PERSP, V35, P55, DOI 10.2307/3428974
   LEAK LV, 1966, AM J ANAT, V118, P785, DOI 10.1002/aja.1001180308
   LEAK LV, 1985, AM J ANAT, V173, P171, DOI 10.1002/aja.1001730303
   LEAK LV, 1971, J CELL BIOL, V50, P300, DOI 10.1083/jcb.50.2.300
   Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988
   LEEDS SE, 1977, SURG GYNECOL OBSTET, V1, P927
   LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409
   Li B, 1998, MICROVASC RES, V56, P127, DOI 10.1006/mvre.1998.2089
   LIOTTA LA, 1991, CANCER RES, V51, pS5054
   LIOTTA LA, 1991, CANCER INVEST, V9, P543, DOI 10.3109/07357909109018952
   MANDELL GA, 1993, SEMIN NUCL MED, V23, P334, DOI 10.1016/S0001-2998(05)80112-6
   MANGAT S, 1985, LIFE SCI, V36, P1917, DOI 10.1016/0024-3205(85)90440-0
   MARCHETTI C, 1991, LYMPHOLOGY, V24, P26
   MAWHINNEY HJD, 1973, J PHYSIOL-LONDON, V229, P389
   MCGEOWN JG, 1988, J PHYSIOL-LONDON, V397, P449
   MCHALE NG, 1989, MICROVASC RES, V37, P70, DOI 10.1016/0026-2862(89)90073-3
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MISLIN H, 1976, EXPERIENTIA, V32, P820, DOI 10.1007/BF02003701
   MORTILLARO NA, 1976, CIRC RES, V39, P348
   Mortimer PS, 1997, ANGIOLOGY, V48, P87, DOI 10.1177/000331979704800114
   Mortimer PS, 1998, CANCER, V83, P2798, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2798::AID-CNCR28>3.0.CO;2-E
   MORTIMER PS, 1990, J INVEST DERMATOL, V95, P677, DOI 10.1111/1523-1747.ep12514347
   NAGY JA, 1992, BLOOD PURIFICAT, V10, P148, DOI 10.1159/000170042
   Nathanson SD, 1997, ARCH SURG-CHICAGO, V132, P311
   NEGRINI D, 1994, J APPL PHYSIOL, V76, P2267
   Negrini D, 1996, AM J PHYSIOL-HEART C, V270, pH2000
   Negrini D, 1998, AM J PHYSIOL-LUNG C, V274, pL203
   NICOLAYSEN G, 1975, MICROVASC RES, V10, P138, DOI 10.1016/0026-2862(75)90002-3
   NICOLL PA, 1977, ANNU REV PHYSIOL, V39, P73, DOI 10.1146/annurev.ph.39.030177.000445
   NIKI T, 1999, P AACR 90 ANN M
   Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639
   OHHASHI T, 1982, MICROVASC RES, V23, P93, DOI 10.1016/0026-2862(82)90034-6
   OHHASHI T, 1980, AM J PHYSIOL, V239, pH88
   OHSAWA T, 1985, CHEM PHARM BULL, V33, P5013
   OLSZEWSKI W, 1977, ACTA PHYSIOL SCAND, V99, P149, DOI 10.1111/j.1748-1716.1977.tb10365.x
   Olszewski WL, 1980, AM J PHYSIOL, V239, P775
   OMORCHOE CCC, 1987, LYMPHOLOGY, V20, P205
   Parsons RJ, 1938, J EXP MED, V68, P353, DOI 10.1084/jem.68.3.353
   Passi A, 1998, AM J PHYSIOL-LUNG C, V275, pL631
   Patel HM., 1988, LIPOSOMES DRUG CARRI, P51
   PEPPER MS, 1994, EXP CELL RES, V210, P298, DOI 10.1006/excr.1994.1042
   Porter CJH, 1997, CRIT REV THER DRUG, V14, P333
   REDDY NP, 1975, MICROVASC RES, V10, P214, DOI 10.1016/0026-2862(75)90008-4
   REDDY NP, 1981, MICROVASC RES, V21, P183, DOI 10.1016/0026-2862(81)90031-5
   RENKIN EM, 1994, MICROVASC RES, V47, P318, DOI 10.1006/mvre.1994.1025
   Ryan TJ, 1989, J INVEST DERMATOL, V93, P18
   RYAN US, 1988, NEWS PHYSIOL SCI, V3, P93
   Ryman B E, 1978, Ann N Y Acad Sci, V308, P281, DOI 10.1111/j.1749-6632.1978.tb22031.x
   SALA L, 1900, RIC LAB ANAT NORM, V7, P899
   Sauter B, 1998, J HISTOCHEM CYTOCHEM, V46, P165
   SAVAGE RC, 1984, SURG GYNECOL OBSTET, V159, P501
   SCHAD H, 1976, ERGEB ANGIOL, V12, P185
   SCHAD H, 1978, PFLUG ARCH EUR J PHY, V378, P121, DOI 10.1007/BF00584444
   SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987
   SCHMIDSCHONBEIN GW, 1990, ARCH HISTOL CYTOL, V53, P107, DOI 10.1679/aohc.53.Suppl_107
   SKANDALAKIS JE, 1995, AM SURGEON, V61, P799
   Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643
   Slavin SA, 1999, ANN SURG, V229, P421, DOI 10.1097/00000658-199903000-00017
   Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635
   STELLER MA, 1986, CANCER RES, V46, P1830
   STRAND SE, 1989, CRIT REV THER DRUG, V6, P211
   Swartz MA, 1999, BRIT J CANCER, V81, P756, DOI 10.1038/sj.bjc.6690760
   Swartz MA, 1999, J BIOMECH, V32, P1297, DOI 10.1016/S0021-9290(99)00125-6
   Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324
   Takahashi T, 1997, MICROVASC RES, V54, P193, DOI 10.1006/mvre.1997.2043
   TAKESHITA T, 1988, LYMPHOLOGY, V21, P128
   Tan YZ, 1998, JPN J PHYSIOL, V48, P133, DOI 10.2170/jjphysiol.48.133
   Tischendorf F, 1978, Biochem Exp Biol, V14, P86
   Torchilin VP, 1996, J MOL RECOGNIT, V9, P335, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<335::AID-JMR309>3.0.CO;2-0
   TURNER A, 1983, BIOCHIM BIOPHYS ACTA, V760, P119
   ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K
   UNTHANK JL, 1988, AM J PHYSIOL, V254, pG389
   Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016/S0002-9440(10)65392-8
   WATSON PD, 1980, AM J PHYSIOL, V239, pH525
   WAY D, 1987, IN VITRO, V3, P647
   Webb RL, 1944, ANAT REC, V88, P351, DOI 10.1002/ar.1090880405
   WEINSTEIN JN, 1984, CANCER TREAT REP, V68, P257
   WEINSTEIN JN, 1983, SCIENCE, V222, P423, DOI 10.1126/science.6623082
   WEISS L, 1992, CANCER METAST REV, V11, P227, DOI 10.1007/BF01307179
   WEN S, 1994, INT J MICROCIRC, V14, P139, DOI 10.1159/000178821
   Wilting J, 1999, CELL TISSUE RES, V297, P1, DOI 10.1007/s004410051328
   YONG LCJ, 1991, EXP PATHOL-JENA, V42, P11
   ZAUGGVESTI B, 1993, MICROVASC RES, V46, P128, DOI 10.1006/mvre.1993.1041
   ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283
   Zawieja David C., 1996, Microcirculation (Philadelphia), V3, P241, DOI 10.3109/10739689609148296
   ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219
   ZWEIFACH BW, 1975, AM J PHYSIOL, V228, P1326
   Zweifach B W, 1979, Int Rev Physiol, V18, P215
NR 190
TC 181
Z9 192
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD AUG 23
PY 2001
VL 50
IS 1-2
BP 3
EP 20
DI 10.1016/S0169-409X(01)00150-8
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 475DA
UT WOS:000171145500002
PM 11489331
ER

PT J
AU Freytag, SO
   Stricker, H
   Pegg, J
   Paielli, D
   Pradhan, DG
   Peabody, J
   DePeralta-Venturina, M
   Xia, XQ
   Brown, S
   Lu, M
   Kim, JH
AF Freytag, SO
   Stricker, H
   Pegg, J
   Paielli, D
   Pradhan, DG
   Peabody, J
   DePeralta-Venturina, M
   Xia, XQ
   Brown, S
   Lu, M
   Kim, JH
TI Phase I study of replication-competent adenovirus-mediated
   double-suicide gene therapy in combination with conventional-dose
   three-dimensional conformal radiation therapy for the treatment of newly
   diagnosed, intermediate- to high-risk prostate cancer
SO CANCER RESEARCH
LA English
DT Article
ID EXTERNAL-BEAM RADIOTHERAPY; III RANDOMIZED TRIAL; HSV-TK GENE; RADICAL
   PROSTATECTOMY; ANTIGEN LEVELS; SELECTIVE ENHANCEMENT; ANDROGEN
   SUPPRESSION; LOCAL-CONTROL; FUSION GENE; 9L GLIOMA
AB The primary study objective was to determine the safety of intraprostatic administration of a replication-competent, oncolytic adenovirus containing a cytosine deaminase (CD)/herpes simplex virus thymidine kinase (HSV-1 TK) fusion gene concomitant with increasing durations of 5-fluorocytosine and valganciclovir prodrug therapy and conventional-dose three-dimensional conformal radiation therapy (3D-CRT) in patients with newly diagnosed, intermediate- to high-risk prostate cancer. Secondary objectives were to determine the persistence of therapeutic transgene expression in the prostate and to examine early posttreatment response. Fifteen patients in five cohorts received a single intraprostatic injection of 1012 viral particles of the replication-competent Ad5-CD/TKrep adenovirus on day 1. Two days later, patients were administered 5-nuorocytosine and valgancielovir prodrug therapy for 1 (cohorts 1-3), 2 (cohort 4), or 3 (cohort 5) weeks along with 70-74 Gy 3D-CRT. Sextant needle biopsy of the prostate was obtained at 2 (cohort 1), 3 (cohort 2), and 4 (cohort 3) weeks for determination of the persistence of transgene expression. There were no dose-limiting toxicities and no significant treatment-related adverse events. Ninety-four percent of the adverse events observed were mild to moderate and self-limiting. Acute urinary and gastrointestinal toxicities were similar to those expected for conventional-dose 3D-CRT. Therapeutic transgene expression was found to persist in the prostate for up to 3 weeks after the adenovirus injection. As expected for patients receiving definitive radiation therapy, all patients experienced significant declines in prostate-specific antigen (PSA). The mean PSA half-life in patients administered more than I week of prodrug therapy was significantly shorter than that of patients receiving prodrugs for only I week (0.6 versus 2.0 months; P < 0.02) and markedly shorter than that reported previously for patients treated with conventional-dose 3D-CRT alone (2.4 months). With a median follow-up of only 9 months, 5 of 10 (50%) patients not treated with androgen-deprivation therapy achieved a serum PSA less than or equal to 0.5 ng/ml. The results demonstrate that replication-competent adenovirus-mediated double-suicide gene therapy can be combined safely with conventional-dose 3D-CRT in patients with intermediate- to high-risk prostate cancer. The shorter than expected PSA half-life in patients receiving more than I week of prodrug therapy may suggest a possible interaction between the oncolytic adenovirus and/or double-suicide gene therapies and radiation therapy.
C1 Henry Ford Hlth Syst, Dept Radiat Oncol, Detroit, MI 48202 USA.
   Henry Ford Hlth Syst, Dept Urol, Detroit, MI 48202 USA.
   Henry Ford Hlth Syst, Dept Pathol, Detroit, MI 48202 USA.
   Henry Ford Hlth Syst, Dept Biostat, Detroit, MI 48202 USA.
RP Freytag, SO (reprint author), Henry Ford Hlth Syst, Dept Radiat Oncol, 1 Ford Pl,Wing 5D, Detroit, MI 48202 USA.
CR Amling CL, 1998, MAYO CLIN PROC, V73, P401
   Barton KN, 2003, MOL THER, V8, P508, DOI 10.1016/S1525-0016(03)000153-9
   Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4
   Brand K, 1997, CANCER GENE THER, V4, P9
   Chen Y, 2001, CANCER RES, V61, P5453
   Cox JD, 1999, J CLIN ONCOL, V17, P1155
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I
   CROOK JM, 1995, UROLOGY, V45, P624, DOI 10.1016/S0090-4295(99)80054-5
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   Freytag SO, 2002, INT J RADIAT ONCOL, V54, P873, DOI 10.1016/S0360-3016(02)03005-5
   Freytag SO, 2002, CANCER RES, V62, P4968
   Freytag SO, 1998, HUM GENE THER, V9, P1323, DOI 10.1089/hum.1998.9.9-1323
   GABLE M, 1997, INT J RADIAT ONCOL, V41, P883
   Hankey BF, 1999, J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017
   HANKS G, 1988, INT J RADIAT ONCOL, V41, P501
   Hanks G. E., 2000, International Journal of Radiation Oncology Biology Physics, V48, P112, DOI 10.1016/S0360-3016(00)80021-8
   Hanks GE, 2000, INT J RADIAT ONCOL, V46, P823, DOI 10.1016/S0360-3016(99)00498-8
   HANKS GE, 1988, INT J RADIAT ONCOL, V15, P1299
   HANKS GE, 1985, INT J RADIAT ONCOL, V11, P153
   Hanlon AL, 2001, INT J RADIAT ONCOL, V49, P51, DOI 10.1016/S0360-3016(00)01365-1
   Hwang HS, 2000, CANCER RES, V60, P92
   Jhaveri FM, 1999, J CLIN ONCOL, V17, P3167
   Joon DL, 1997, INT J RADIAT ONCOL, V38, P1071, DOI 10.1016/S0360-3016(97)00303-9
   KAPLAN ID, 1991, CANCER, V68, P400, DOI 10.1002/1097-0142(19910715)68:2<400::AID-CNCR2820680231>3.0.CO;2-Z
   KAVADI VS, 1994, INT J RADIAT ONCOL, V30, P279
   Kestin LL, 2002, INT J RADIAT ONCOL, V53, P304, DOI 10.1016/S0360-3016(02)02707-4
   KHIL M, 1995, CLIN CANCER RES, V2, P53
   Kievit E, 2000, CANCER RES, V60, P6649
   KIM JH, 1994, CANCER RES, V54, P6053
   KIM JH, 1995, INT J RADIAT ONCOL, V33, P861, DOI 10.1016/0360-3016(95)00134-9
   Kim JH, 1998, CANCER J SCI AM, V4, P364
   Kim SH, 1997, J NEURO-ONCOL, V33, P189, DOI 10.1023/A:1005764324900
   KUBAN DA, 1992, INT J RADIAT ONCOL, V24, P409
   Lawton CA, 2001, INT J RADIAT ONCOL, V49, P937, DOI 10.1016/S0360-3016(00)01516-9
   McGinn CJ, 1996, J NATL CANCER I, V88, P1193, DOI 10.1093/jnci/88.17.1193
   MEEK AG, 1990, INT J RADIAT ONCOL, V19, P733
   Michalski JM, 2000, INT J RADIAT ONCOL, V46, P391, DOI 10.1016/S0360-3016(99)00443-5
   MOOLTEN F, 1997, CANCER GENE THER, V1, P279
   OESTERLING JE, 1988, J UROLOGY, V139, P766
   PEREZ CA, 1980, INT J RADIAT ONCOL, V6, P555
   PEREZ CA, 1988, NATL CANCER I MONOGR, V7, P85
   Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6
   Pollack A, 2000, J CLIN ONCOL, V18, P3904
   Pollack A, 1997, CANCER RES, V57, P2493
   Pollack A, 2002, INT J RADIAT ONCOL, V54, P677, DOI 10.1016/S0360-3016(02)02977-2
   Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8
   Pollack A, 2001, INT J RADIAT ONCOL, V51, P1002, DOI 10.1016/S0360-3016(01)01750-3
   Pollack A, 1997, INT J RADIAT ONCOL, V39, P1011, DOI 10.1016/S0360-3016(97)00508-7
   Pollack A, 2000, INT J RADIAT ONCOL, V48, P507, DOI 10.1016/S0360-3016(00)00620-9
   PRESTIDGE BR, 1992, INT J RADIAT ONCOL, V24, P403
   RITTER MA, 1992, J CLIN ONCOL, V10, P1208
   Rogulski KR, 1997, HUM GENE THER, V8, P73, DOI 10.1089/hum.1997.8.1-73
   Rogulski KR, 2000, CANCER RES, V60, P1193
   Rogulski KR, 1997, CLIN CANCER RES, V3, P2081
   Rogulski KR, 2000, HUM GENE THER, V11, P67, DOI 10.1089/10430340050016166
   Rosser CJ, 2003, INT J RADIAT ONCOL, V56, P1, DOI 10.1016/S0630-3016(02)04468-1
   Ryu JK, 2002, INT J RADIAT ONCOL, V54, P1036, DOI 10.1016/S0360-3016(02)03006-7
   Scardino PT, 1988, NATL CANCER I MONOGR, V7, P95
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5
   SMIT WGJM, 1990, INT J RADIAT ONCOL, V18, P23
   Teh BS, 2001, INT J RADIAT ONCOL, V51, P605, DOI 10.1016/S0360-3016(01)01692-3
   Vicini FA, 2000, CANCER, V88, P2305, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2305::AID-CNCR15>3.0.CO;2-3
   Vlachaki MT, 2001, INT J RADIAT ONCOL, V51, P1008, DOI 10.1016/S0360-3016(01)01698-4
   Xie YJ, 1999, CLIN CANCER RES, V5, P4224
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   ZAGARS GK, 1992, INT J RADIAT ONCOL, V23, P47
   ZEITMAN AL, 1996, RADIOTHER ONCOL, V40, P159
   ZEITMAN AL, 1997, CANCER J SCI AM, V3, P31
   Zelefsky MJ, 2002, INT J RADIAT ONCOL, V53, P1111, DOI 10.1016/S0360-3016(02)02857-2
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
NR 74
TC 177
Z9 192
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
J9 CANCER RES
JI Cancer Res.
PD NOV 1
PY 2003
VL 63
IS 21
BP 7497
EP 7506
PG 10
WC Oncology
SC Oncology
GA 742UA
UT WOS:000186535400063
PM 14612551
ER

PT J
AU Stephenson, AJ
   Kattan, MW
   Eastham, JA
   Dotan, ZA
   Bianco, FJ
   Lilja, H
   Scardino, PT
AF Stephenson, Andrew J.
   Kattan, Michael W.
   Eastham, James A.
   Dotan, Zohar A.
   Bianco, Fernando J., Jr.
   Lilja, Hans
   Scardino, Peter T.
TI Defining biochemical recurrence of prostate cancer after radical
   prostatectomy: A proposal for standardized definition
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Article; Proceedings Paper
CT 100th Annual Meeting of the American-Urological-Association
CY MAY 21-26, 2005
CL San Antonio, TX
SP Amer Urol Assoc
ID EXTERNAL-BEAM RADIATION; RETROPUBIC PROSTATECTOMY; CONSECUTIVE PATIENTS;
   PROGRESSION; THERAPY; ANTIGEN; RADIOTHERAPY; MORTALITY; GUIDELINES;
   PATTERNS
AB Purpose Prostate-specific antigen (PSA) defined biochemical recurrence (BCR) of prostate cancer is widely used for reporting the outcome of radical prostatectomy (RP). A standardized BCR definition is lacking, and overall progression-free probability and risk of subsequent metastatic disease progression may vary greatly depending on the PSA criterion used. Ten definitions of BCR were evaluated to identify the one that best explains metastatic progression.
   Methods Of 3,125 patients who underwent RP at our institution since 1985, 75 developed distant metastasis during a median follow-up of 49 months. To predict metastasis progression, we modeled the clinical information using multivariable Cox regression analysis. BCR was included in the model as a time-dependent covariate, and separate models were developed for each definition. A goodness-of-fit (R-2) statistic was used to determine the Cox model (and thereby the BCR definition) that best explained metastatic progression.
   Results The 10-year progression-free probability ranged from 63% to 79%, depending on the BCR definition. The model containing BCR defined as a PSA of at least 0.4 ng/mL followed by another increase best explained metastatic progression (R-2 = 0.21). This definition was also associated with a high probability of subsequent secondary therapy, continued PSA progression, and rapid PSA doubling time.
   Conclusion BCR defined as a PSA value of at least 0.4 ng/mL followed by another increase best explains the development of distant metastasis among 10 candidate definitions, after controlling for clinical variables and the use of secondary therapy. On the basis of this evidence, we propose that this definition be adopted as the standard for reporting the outcome of RP.
C1 Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, Dept Urol, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA.
   Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA.
RP Stephenson, AJ (reprint author), Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, Dept Urol, 1275 York Ave, New York, NY 10021 USA.
EM stephena@mskcc.org
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Bianco FJ, 2004, J UROLOGY, V171, P116
   Bianco FJ, 2005, UROLOGY, V66, P83, DOI 10.1016/j.urology.2005.06.116
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043
   EISENBERGER MA, 2003, P AN M AM SOC CLIN, V22, P380
   Freedland SJ, 2003, UROLOGY, V61, P365, DOI 10.1016/S0090-4295(02)02268-9
   Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433
   Gretzer MB, 2002, J UROLOGY, V168, P1419, DOI 10.1097/ju.0000029729.26315.fd
   Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KENT JT, 1988, BIOMETRIKA, V75, P525, DOI 10.1093/biomet/75.3.525
   Kuban DA, 2003, INT J RADIAT ONCOL, V57, P915, DOI 10.1016/S0360-3016(03)00632-1
   Kuban DA, 2005, J UROLOGY, V173, P1871, DOI 10.1097/01.ju.0000157682.40869.65
   Kupelian PA, 2002, J CLIN ONCOL, V20, P3376, DOI 10.1200/JCO.2002.01.150
   Mehta SS, 2004, J UROLOGY, V171, P215, DOI 10.1097/01.ju.0000100087.83112.23
   Park S, 2005, J UROLOGY, V174, P1802, DOI 10.1097/01.ju.0000177089.93728.20
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Dalesio O, 2000, LANCET, V355, P1491
   Ravery V, 1999, Semin Urol Oncol, V17, P127
   Roehl KA, 2004, J UROLOGY, V172, P910, DOI 10.1097/01.ju.0000134888.22332.bb
   Scher HI, 2004, J CLIN ONCOL, V22, P537, DOI 10.1200/JCO.2004.07.099
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Stamey TA, 1999, JAMA-J AM MED ASSOC, V281, P1395, DOI 10.1001/jama.281.15.1395
   Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325
   Therneau TM, 2000, MODELING SURVIVAL DA
   Wei JT, 2002, J CLIN ONCOL, V20, P557, DOI 10.1200/JCO.20.2.557
   Zhou P, 2005, J CLIN ONCOL, V23, P6992, DOI 10.1200/JCO.2005.01.2906
NR 31
TC 176
Z9 177
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 330 JOHN CARLYLE ST, STE 300, ALEXANDRIA, VA 22314 USA
SN 0732-183X
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD AUG 20
PY 2006
VL 24
IS 24
BP 3973
EP 3978
DI 10.1200/JCO.2005.04.0756
PG 6
WC Oncology
SC Oncology
GA 077TD
UT WOS:000240052300026
PM 16921049
ER

PT J
AU Ash, D
   Flynn, A
   Battermann, J
   de Reijke, T
   Lavagnini, P
   Blank, L
AF Ash, D
   Flynn, A
   Battermann, J
   de Reijke, T
   Lavagnini, P
   Blank, L
TI ESTRO/EAU/EORTC recommendations on permanent seed implantation for
   localized prostate cancer
SO RADIOTHERAPY AND ONCOLOGY
LA English
DT Article; Proceedings Paper
CT Symposium on Prostate Brachytherapy
CY MAY, 1999
CL ZEIST, NETHERLANDS
DE seed implantation; prostate cancer; Gleason score
ID PREDICT PATHOLOGICAL STAGE; EXTERNAL-BEAM RADIATION; RADICAL
   PROSTATECTOMY; CLINICAL STAGE; GLEASON SCORE; (125)IODINE IMPLANTATION;
   I-125 IMPLANTATION; URINARY MORBIDITY; BRACHYTHERAPY; ANTIGEN
C1 Cookridge Hosp, Dept Clin Oncol & Med Phys, Leeds LS16 6QB, W Yorkshire, England.
   Acad Ziekenhuis, Dept Radiotherapy, Utrecht, Netherlands.
   Acad Med Centrum, Dept Urol, Amsterdam, Netherlands.
   Inst Tumori, Genoa, Italy.
   Free Univ Amsterdam, Dept Radiotherapy, Amsterdam, Netherlands.
RP Ash, D (reprint author), Cookridge Hosp, Dept Clin Oncol & Med Phys, Leeds LS16 6QB, W Yorkshire, England.
CR ARTERBERY VE, 1993, INT J RADIAT ONCOL, V25, P661
   BASTACKY SI, 1993, AM J SURG PATHOL, V17, P336, DOI 10.1097/00000478-199304000-00003
   Beyer D, 2000, INT J RADIAT ONCOL, V47, P273, DOI 10.1016/S0360-3016(00)00555-1
   Bice WS, 1998, INT J RADIAT ONCOL, V41, P921, DOI 10.1016/S0360-3016(98)90123-7
   BICE WS, 1997, J BRACHYTHER INT, V13, P297
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko JC, 1987, ENDOCURIETHER HYPERT, V3, P131
   Blasko JC, 1993, SEMIN RADIAT ONCOL, V3, P240, DOI 10.1053/SRAO00300240
   Bolla M, 1999, EUR UROL, V35, P23, DOI 10.1159/000052303
   BROSMAN SA, 1991, UROLOGY, V38, P276
   CHELSKY MJ, 1993, J UROLOGY, V150, P391
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   D'Amico AV, 1999, UROLOGY, V54, P201
   DANIELS GF, 1992, J UROLOGY, V147, P870
   Dattoli M, 1997, INT J RADIAT ONCOL, V38, P341, DOI 10.1016/S0360-3016(96)00581-0
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Dubois DF, 1997, INT J RADIAT ONCOL, V39, P1037, DOI 10.1016/S0360-3016(97)00501-4
   EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368
   EPSTEIN JI, 1993, J UROLOGY, V150, P135
   Feygelman V, 1996, Med Dosim, V21, P109, DOI 10.1016/0958-3947(96)00026-X
   FOWLER JE, 1979, J UROLOGY, V121, P447
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537
   Garzotto M, 1998, J UROLOGY, V159, P950, DOI 10.1016/S0022-5347(01)63778-9
   Gelblum DY, 1999, INT J RADIAT ONCOL, V45, P59, DOI 10.1016/S0360-3016(99)00176-5
   GRADO GL, 1995, UROLOGY, V3, P1
   Grimm PD, 1997, INT J RADIAT ONCOL, V39, P219, DOI 10.1016/S0360-3016(97)80726-2
   Grimm PD, 1994, ATLAS UROL CLIN N AM, V2, P113
   Haustermans KMG, 1997, INT J RADIAT ONCOL, V37, P1067, DOI 10.1016/S0360-3016(96)00579-2
   Hu K, 1997, INT J RADIAT ONCOL, V39, P292, DOI 10.1016/S0360-3016(97)80871-1
   Moerland MA, 1997, INT J RADIAT ONCOL, V37, P927, DOI 10.1016/S0360-3016(96)00575-5
   NAG S, 1997, PRINCIPLES PRACTICE, P421
   NAG S, 1997, J BRACHYTHER INT, V13, P243
   Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3
   NAG S, 1995, UROLOGY, V45, P87, DOI 10.1016/S0090-4295(95)96950-0
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   OESTERLING JE, 1988, J UROLOGY, V139, P766
   Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445
   PARTIN AW, 1990, J UROLOGY, V143, P747
   PELLER PA, 1995, CANCER, V75, P530, DOI 10.1002/1097-0142(19950115)75:2<530::AID-CNCR2820750216>3.0.CO;2-Y
   Prestidge BR, 1998, INT J RADIAT ONCOL, V40, P461, DOI 10.1016/S0360-3016(97)00715-3
   Prestidge BR, 1998, INT J RADIAT ONCOL, V40, P1111, DOI 10.1016/S0360-3016(97)00947-4
   PRIESTLY JB, 1992, UROLOGY, V40, P27, DOI 10.1016/0090-4295(92)90431-U
   RAVERY V, 2000, EUR UROL, V37, P396
   ROACH M, 1994, INT J RADIAT ONCOL, V28, P33
   ROACH M, 1993, J UROLOGY, V150, P1923
   ROY JN, 1991, INT J RADIAT ONCOL, V21, P483
   ROY JN, 1993, INT J RADIAT ONCOL, V26, P163, DOI 10.1016/0360-3016(93)90188-2
   STAMEY TA, 1989, J UROLOGY, V141, P1076
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   STONE NN, 1995, RADIAT ONCOL INVEST, V3, P185, DOI 10.1002/roi.2970030407
   Tefilli MV, 1998, UROLOGY, V52, P224, DOI 10.1016/S0090-4295(98)00151-4
   Terk MD, 1998, J UROLOGY, V160, P1379, DOI 10.1016/S0022-5347(01)62542-4
   WALLNER K, 1991, J UROLOGY, V146, P90
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Waterman FM, 1997, INT J RADIAT ONCOL, V38, P335, DOI 10.1016/S0360-3016(97)00114-4
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
NR 59
TC 167
Z9 169
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-8140
J9 RADIOTHER ONCOL
JI Radiother. Oncol.
PD DEC
PY 2000
VL 57
IS 3
BP 315
EP 321
DI 10.1016/S0167-8140(00)00306-6
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 386RA
UT WOS:000166074300013
PM 11104892
ER

PT J
AU Terk, MD
   Stock, RG
   Stone, NN
AF Terk, MD
   Stock, RG
   Stone, NN
TI Identification of patients at increased risk for prolonged urinary
   retention following radioactive seed implantation of the prostate
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostatic neoplasms; radiotherapy; morbidity; brachytherapy
ID TRANSRECTAL ULTRASOUND; CARCINOMA; BRACHYTHERAPY; IRRADIATION; CANCER
AB Purpose: Urinary retention is a frequently reported complication following radioactive seed implantation of the prostate. If retention is refractory, a post-implant transurethral prostatic resection may ultimately be required to relieve obstruction, leading to an increased risk of urinary incontinence. In this series the incidence of prolonged urinary retention was determined, and the effect of pretreatment and treatment related factors was analyzed to identify high risk patients.
   Materials and Methods: A total of 251 patients with organ confined prostate carcinoma underwent transperineal prostate seed implantation. Of the patients 114 were implanted with (103)palladium (Pd-103) and 137 with (125)iodine seeds. Of the patients who were implanted with Pd-103 90 received 3 months of neoadjuvant hormonal therapy. All patients had International Prostate Symptom Scores (I-PSS) recorded before implantation to assess the degree of urinary symptoms. In the patients receiving neoadjuvant hormones prostate volumes and I-PSS were recorded before initiation of hormone treatment and 3 months later at the time of implant.
   Results: Urinary retention developed in 14 patients requiring catheterization for more than 48 hours. Median time to onset was 1 day after implant. Of these patients 6 ultimately required transurethral prostatic resection to relieve urinary obstruction. No patient had urinary incontinence following implantation or transurethral prostatic resection. Multivariate analysis revealed that pretreatment I-PSS, and combined treatment with hormonal therapy and Pd-103 predicted for the development of retention. Patients with I-PSS 20 or greater had a 29% risk, I-PSS 10 to 19, 11% risk and I-PSS less than 10, 2% risk of retention. Neither patient age, clinical stage, prostate specific antigen, Gleason score, use of I-125 nor prostate volume was significant. A subgroup analysis of patients receiving hormonal therapy and Pd-103 revealed that those with persistent urinary symptoms (I-PSS 10 or greater) following 3 months of hormonal therapy had the greatest risk of prolonged retention (37%).
   Conclusions: The overall risk of prolonged urinary retention following prostate implantation was low in our series. Using the I-PSS questionnaire, high risk patients can be identified before treatment. Patients with significant pretreatment urinary symptoms or persistent urinary symptoms following 3 months of hormonal therapy and then implantation with Pd-103 have the greatest risk.
C1 Mt Sinai Med Ctr, Dept Radiat Oncol, New York, NY USA.
   Mt Sinai Med Ctr, Dept Urol, New York, NY USA.
RP Terk, MD (reprint author), Baptist Reg Canc Inst, Dept Radiat Oncol, 1235 San Marro Blvd, Jacksonville, FL 33207 USA.
CR BARRY MJ, 1992, J UROLOGY, V148, P1549
   Beahrs OH, 1992, MANUAL STAGING CANC, P181
   Beyer David C., 1995, International Journal of Radiation Oncology Biology Physics, V32, P254, DOI 10.1016/0360-3016(95)97887-7
   BLASKO JC, 1997, COMMUNICATION    OCT
   Blasko J C, 1991, Scand J Urol Nephrol Suppl, V137, P113
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Dattoli Michael J., 1995, International Journal of Radiation Oncology Biology Physics, V32, P251, DOI 10.1016/0360-3016(95)97881-Z
   EFRON B, 1975, J AM STAT ASSOC, V70, P892, DOI 10.2307/2285453
   Feinberg S.E., 1980, ANAL CROSS CLASSIFIE
   KAYE KW, 1995, J UROLOGY, V153, P1020, DOI 10.1016/S0022-5347(01)67626-2
   KLEINBERG L, 1994, INT J RADIAT ONCOL, V28, P985
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   STONE NN, 1995, RADIAT ONCOL INVEST, V3, P185, DOI 10.1002/roi.2970030407
   STONE N N, 1991, Journal of Endourology, V5, P251, DOI 10.1089/end.1991.5.251
   TERRIS MK, 1991, J UROLOGY, V145, P984
   VIJVERBERG PLM, 1992, EUR UROL, V21, P35
   Wallner K, 1996, J CLIN ONCOL, V14, P449
NR 20
TC 164
Z9 166
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 1998
VL 160
IS 4
BP 1379
EP 1382
DI 10.1016/S0022-5347(01)62542-4
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 120YZ
UT WOS:000075986600043
PM 9751358
ER

PT J
AU KELLY, P
   RUSKIN, JN
   VLAHAKES, GJ
   BUCKLEY, MJ
   FREEMAN, CS
   GARAN, H
AF KELLY, P
   RUSKIN, JN
   VLAHAKES, GJ
   BUCKLEY, MJ
   FREEMAN, CS
   GARAN, H
TI SURGICAL CORONARY REVASCULARIZATION IN SURVIVORS OF PREHOSPITAL
   CARDIAC-ARREST - ITS EFFECT ON INDUCIBLE VENTRICULAR ARRHYTHMIAS AND
   LONG-TERM SURVIVAL
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
RP GARAN, H (reprint author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,CARDIAC UNIT,BOSTON,MA 02114, USA.
CR BAUM RS, 1974, CIRCULATION, V50, P1231
   COX DR, 1972, J R STAT SOC B, V34, P187
   GARAN H, 1983, AM J CARDIOL, V51, P519, DOI 10.1016/S0002-9149(83)80091-5
   GOLDSTEIN S, 1981, CIRCULATION, V64, P977
   KAISER GA, 1975, SURGERY, V78, P749
   MCPHERSON CA, 1985, AM J CARDIOL, V55, P689, DOI 10.1016/0002-9149(85)90138-9
   MORADY F, 1983, AM J CARDIOL, V51, P85, DOI 10.1016/S0002-9149(83)80016-2
   MYERBURG RJ, 1984, CIRCULATION, V70, P538
   MYERBURG RJ, 1980, AM J MED, V68, P568, DOI 10.1016/0002-9343(80)90307-1
   RITCHIE JL, 1985, AM J CARDIOL, V55, P645, DOI 10.1016/0002-9149(85)90129-8
   ROY D, 1983, AM J CARDIOL, V52, P969, DOI 10.1016/0002-9149(83)90514-3
   RUSKIN JN, 1980, NEW ENGL J MED, V303, P607, DOI 10.1056/NEJM198009113031103
   SCHOENFELD MH, 1984, AM J CARDIOL, V54, P564, DOI 10.1016/0002-9149(84)90249-2
   SKALE BT, 1986, AM J CARDIOL, V57, P113, DOI 10.1016/0002-9149(86)90962-8
   WEAVER WD, 1976, CIRCULATION, V54, P895
   WILBER DJ, 1988, NEW ENGL J MED, V318, P19, DOI 10.1056/NEJM198801073180105
NR 16
TC 164
Z9 164
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD FEB
PY 1990
VL 15
IS 2
BP 267
EP 273
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA CN195
UT WOS:A1990CN19500004
PM 2299065
ER

PT J
AU Hyder, AA
   Wunderlich, CA
   Puvanachandra, P
   Gururaj, G
   Kobusingye, OC
AF Hyder, Adnan A.
   Wunderlich, Colleen A.
   Puvanachandra, Prasanthi
   Gururaj, G.
   Kobusingye, Olive C.
TI The impact of traumatic brain injuries: A global perspective
SO NEUROREHABILITATION
LA English
DT Article
DE traumatic brain injury; injury epidemiology; injuries; developing
   countries; brain trauma
ID HEAD-INJURY; NEUROSURGICAL TRAUMA; EMERGENCY-DEPARTMENT; TRAFFIC
   ACCIDENTS; INTENSIVE-CARE; UNITED-STATES; RURAL-AREAS; EPIDEMIOLOGY;
   CHILDREN; MANAGEMENT
AB Traumatic brain injury (TBI), according to the World Health Organization, will surpass many diseases as the major cause of death and disability by the year 2020. With an estimated 10 million people affected annually by TBI, the burden of mortality and morbidity that this condition imposes on society, makes TBI a pressing public health and medical problem. The burden of TBI is manifest throughout the world, and is especially prominent in Low and Middle Income Countries which face a higher preponderance of risk factors for causes of TBI and have inadequately prepared health systems to address the associated health outcomes. Latin America and Sub Saharan Africa demonstrate a higher TBI-related incidence rate varying from 150-170 per 100,000 respectively due to RTIs compared to a global rate of 106 per 100,000. As highlighted in this global review of TBI, there is a large gap in data on incidence, risk factors, sequelae, financial costs, and social impact of TBI. This should be addressed through planning of comprehensive TBI prevention programs in LMICs through well-established surveillance systems. Greater resources for research and prioritized interventions are critical to promote evidence-based policy for TBI.
C1 [Hyder, Adnan A.; Puvanachandra, Prasanthi] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   [Hyder, Adnan A.; Puvanachandra, Prasanthi] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD 21205 USA.
   [Wunderlich, Colleen A.] Virginia Commonwealth Univ, Hlth Syst & Childrens Hosp, Med Coll Virginia, Richmond, VA 23284 USA.
   [Gururaj, G.] Natl Inst Mental Hlth & Neurosci, Bangalore, Karnataka, India.
RP Hyder, AA (reprint author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Suite E-8132, Baltimore, MD 21205 USA.
EM ahyder@jhsph.edu
CR Adesunkanmi ARK, 1998, J TRAUMA, V44, P506, DOI 10.1097/00005373-199803000-00015
   Adesunkanmi ARK, 2000, INJURY, V31, P225, DOI 10.1016/S0020-1383(99)00236-3
   ALI RI, 2001, WORLD J SURG, V25, P1230, DOI 10.1007/s00268-001-0087-3
   [Anonymous], 2006, ICD 10 CLASS MENT BE
   Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E
   Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1
   BRICENOLEON R, VIOLENCE RIGHT KILL
   Bruns John Jr., 2003, Epilepsia, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x
   Canadian institute of Health Information, 2006, HEAD INJ CAN DEC CHA
   Chan H. C., 2005, SMJ Singapore Medical Journal, V46, P219
   Cherpitel CJ, 2006, J STUD ALCOHOL, V67, P890
   COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202
   DAVIS A, TRL REV
   de Andrade AF, 2001, WORLD J SURG, V25, P1186
   EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168
   Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x
   Firsching R, 2001, WORLD J SURG, V25, P1221
   Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0
   GOH KYC, 1995, INJURY, V26, P533, DOI 10.1016/0020-1383(95)00104-H
   GURURAJ G, 2005, MENTAL NEUROLOGICAL, P225
   Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503
   Gururaj G., 1995, NEUROL INDIA, V43, P95
   Gururaj G, 2004, J Coll Physicians Surg Pak, V14, P713
   GURURAJ G, 2005, NIMHANS PUBLICATION, V61, P1
   GURURAJ G, 1994, NEUROSCIENCES
   GURURAJ G, 1999, J ACAD HOSP ADM, V11, P9
   Gururaj G, 2004, J Indian Med Assoc, V102, P157
   Gururaj G., 2005, INJURIES INDIA NATL, P325
   Hijar-Medina MC, 1999, REV SAUDE PUBL, V33, P505, DOI 10.1590/S0034-89101999000500011
   Hillier SL, 1997, BRAIN INJURY, V11, P649
   Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549
   Indrayan A, 2002, NATL MED J INDIA, V15, P7
   Javouhey E, 2006, Arch Pediatr, V13, P528, DOI 10.1016/j.arcped.2006.03.017
   Joshipura MK, 2003, INJURY, V34, P686, DOI 10.1016/S0020-1383(03)00163-3
   Kelly DF, 2001, WORLD J SURG, V25, P1179
   Lalloo R, 2004, SAMJ S AFR MED J, V94, P544
   Lam WH, 1999, PAEDIATR ANAESTH, V9, P377
   Langdon John, 1997, MEDIEVAL FARMING TEC, P1
   Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229
   LANGLOIS JA, 2006, TRAUMATIC BRIAN INJU
   Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375
   Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1
   LEE MC, 1995, INJURY, V26, P467, DOI 10.1016/0020-1383(95)00071-G
   Lehr E, 1990, PSYCHOL MANAGEMENT T
   LEIPZIGER D, 2001, FINANCE DEV, V38
   LEVI L, 1990, NEUROEPIDEMIOLOGY, V9, P278, DOI 10.1159/000110784
   Masiira-Mukasa N, 2002, East Afr Med J, V79, P373
   MATHERS C, 2006, TRACKING TBI DATA WH
   Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027
   MOCK JQ, 2007, SURG CLIN N AM, V87, P1
   Mukhida K, 2006, CHILD NERV SYST, V22, P352, DOI 10.1007/s00381-005-1235-0
   MUNIU E, 1994, E AFR MED J, V71, P346
   Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401
   Murgio A, 1999, J Neurosurg Sci, V43, P15
   MURGIO A, 1999, J NEUROSURG SCI, V43, P23
   Murray C., 1996, GLOBAL BURDEN DIS CO
   MURRAY CJ, 1996, COMPENDIUM INCIDENCE
   Muyembe VM, 1999, E AFR MED J, V76, P200
   NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H
   Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5
   Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405
   *POP DIV DEP EC SO, 2003, WORLD POP PROSP 2004
   *RES TRAIN CTR REH, 1993, PED TRAUM REG
   SAHDEV P, 1994, ACCIDENT ANAL PREV, V26, P377, DOI 10.1016/0001-4575(94)90011-6
   Shen Christina, 2003, West Afr J Med, V22, P287
   SHUKRI AA, 2006, ZH VOPR NEIROKHIR N, V2, P42
   SHUKRI AA, 2006, ZH VOPR NEIROKHIR N, V2, P40
   Sidhu D S, 1993, J Indian Med Assoc, V91, P16
   Singer Michael S, 2004, J Coll Physicians Surg Pak, V14, P709
   Solagberu Babatunde A, 2002, West Afr J Med, V21, P230
   Srinath S, 2005, INDIAN J MED RES, V122, P67
   Sznajder M, 2001, REV EPIDEMIOL SANTE, V49, P125
   Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039
   Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y
   Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x
   Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602
   *UNICEF INN RES CT, 2001, 2 UNICEF
   *WHO, 2002, PORJ MORT BURD DIS 2
   *WHO, 2003, WHO REP 2003 SHAP FU
   World Health Organization, 2004, WORLD HLTH REP CHANG
   Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901
   Zhao YD, 2001, WORLD J SURG, V25, P1202
NR 82
TC 163
Z9 170
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1053-8135
EI 1878-6448
J9 NEUROREHABILITATION
JI Neurorehabilitation
PY 2007
VL 22
IS 5
BP 341
EP 353
PG 13
WC Clinical Neurology; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA 258HW
UT WOS:000252860000002
PM 18162698
ER

PT J
AU ANGELINI, P
AF ANGELINI, P
TI NORMAL AND ANOMALOUS CORONARY-ARTERIES - DEFINITIONS AND CLASSIFICATION
SO AMERICAN HEART JOURNAL
LA English
DT Review
RP ANGELINI, P (reprint author), TEXAS HEART INST,POB 20269,HOUSTON,TX 77225, USA.
CR ABBOTT ME, 1908, OSLER MODERN MED ITS, P420
   ABRAMS HL, 1983, CORONARY ARTERIOGRAP, P283
   ABRAMS LD, 1967, BRIT HEART J, V29, P132
   ACHTEL RA, 1975, J THORAC CARDIOV SUR, V70, P46
   ADAMS P, 1983, AUST PAEDIATR J, V19, P47
   AHMAD M, 1981, AM J CARDIOL, V48, P832, DOI 10.1016/0002-9149(81)90346-5
   AHMED SS, 1982, AM HEART J, V104, P869, DOI 10.1016/0002-8703(82)90024-2
   AKASAKA T, 1981, ANN THORAC SURG, V31, P369
   ALEXANDER RW, 1956, CIRCULATION, V14, P800
   ALLEN HD, 1974, J THORAC CARDIOV SUR, V67, P266
   ALSTRUP P, 1978, J CARDIOVASC SURG, V19, P169
   ANDERSON KR, 1978, J THORAC CARDIOVASC, V6, P135
   ANGELINI P, 1983, PROG CARDIOVASC DIS, V26, P75, DOI 10.1016/0033-0620(83)90019-1
   ANTOPOL W, 1933, AM HEART J, V8, P802, DOI 10.1016/S0002-8703(33)90141-6
   ANZAI N, 1976, CHEST, V70, P775, DOI 10.1378/chest.70.6.775
   ARANI DT, 1978, AM HEART J, V96, P438, DOI 10.1016/0002-8703(78)90152-7
   ARCINIEGAS E, 1980, CIRCULATION, V62, P1180
   ASKENAZI J, 1975, CIRCULATION, V51, P976
   AUFDERHEIDE JF, 1982, PEDIATR CARDIOL, V3, P229, DOI 10.1007/BF02240457
   AYTAC A, 1980, JPN HEART J, V21, P409
   BAIM DS, 1982, CIRCULATION, V65, P810
   BALTAXE HA, 1977, RADIOLOGY, V122, P47
   BANCHI A, 1903, ARCH ITAL ANAT EMBRI, V3, P89
   BANKL H, 1977, CONGENITAL MALFORMAT, P213
   BARBOUR DJ, 1985, AM J CARDIOL, V55, P608
   BAROLDI G, 1967, CORONARY CIRCULATION, P5
   BARRESI V, 1973, AM HEART J, V86, P811, DOI 10.1016/0002-8703(73)90285-8
   BARTH CW, 1986, AM J CARDIOL, V57, P365, DOI 10.1016/0002-9149(86)90931-8
   BARTH CW, 1986, J AM COLL CARDIOL, V7, P366
   BATES HR, 1974, JAMA-J AM MED ASSOC, V230, P1388
   BAUE AE, 1967, CIRCULATION, V36, P878
   Becker AE, 1984, CONGENITAL HEART DIS, P339
   BENGE W, 1980, AM HEART J, V99, P96, DOI 10.1016/0002-8703(80)90319-1
   BERDOFF R, 1986, AM J CARDIOL, V58, P656, DOI 10.1016/0002-9149(86)90298-5
   BERMUDEZ GA, 1979, CATHETER CARDIO DIAG, V5, P371, DOI 10.1002/ccd.1810050409
   BESTETTI RB, 1985, INT J CARDIOL, V8, P331, DOI 10.1016/0167-5273(85)90225-6
   BHARATI S, 1984, J AM COLL CARDIOL, V3, P1565
   BHARATI S, 1984, J AM COLL CARDIOL, V3, P437
   BJORK L, 1966, RADIOLOGY, V87, P33
   BJORK L, 1966, RADIOLOGY, V87, P274
   BLACKMAN MS, 1981, BRIT HEART J, V46, P449
   BLAKE HA, 1964, CIRCULATION, V30, P927
   BLAND EF, 1933, AM HEART J, V8, P787, DOI 10.1016/S0002-8703(33)90140-4
   BLOOMFIELD P, 1983, AM J CARDIOL, V51, P1235, DOI 10.1016/0002-9149(83)90380-6
   BOURLON F, 1981, THORAC CARDIOV SURG, V29, P91, DOI 10.1055/s-2007-1023450
   BRANDT B, 1983, NEW ENGL J MED, V309, P596, DOI 10.1056/NEJM198309083091007
   BREGMAN D, 1976, J THORAC CARDIOV SUR, V72, P626
   BRENNER JI, 1977, J THORAC CARDIOV SUR, V73, P738
   BYRUM CJ, 1980, AM HEART J, V99, P354, DOI 10.1016/0002-8703(80)90351-8
   CHAITMAN BR, 1975, CIRCULATION, V52, P955
   CHAITMAN BR, 1976, CIRCULATION, V53, P122
   CHEATHAM JP, 1987, CATHETER CARDIO DIAG, V13, P321, DOI 10.1002/ccd.1810130508
   CHEE TP, 1981, ARCH INTERN MED, V141, P1703, DOI 10.1001/archinte.141.12.1703
   CHEITLIN MD, 1974, CIRCULATION, V50, P780
   CHEN W, 1982, CARDIOVASC INTER RAD, V5, P241, DOI 10.1007/BF02565404
   CHENG TO, 1982, AM HEART J, V104, P870, DOI 10.1016/0002-8703(82)90025-4
   CHIARIELLO L, 1975, ANN THORAC SURG, V19, P443
   CHOH JH, 1980, THORAC CARDIOV SURG, V28, P239, DOI 10.1055/s-2007-1022086
   COE JY, 1982, THORAC CARDIOV SURG, V30, P84, DOI 10.1055/s-2007-1022217
   CONTE G, 1984, ANAT EMBRYOL, V169, P209, DOI 10.1007/BF00303151
   COOLEY DA, 1980, ANN THORAC SURG, V30, P588
   CORNELL SH, 1966, RADIOLOGY, V86, P421
   COTTRILL CM, 1985, J AM COLL CARDIOL, V6, P237
   Croom R D 3rd, 1967, Ann Thorac Surg, V4, P182
   DABIZZI RP, 1980, CIRCULATION, V61, P95
   DALAL JJ, 1984, CATHETER CARDIO DIAG, V10, P189, DOI 10.1002/ccd.1810100212
   DARK JH, 1985, EUR HEART J, V6, P714
   DAVIA JE, 1984, AM HEART J, V108, P165, DOI 10.1016/0002-8703(84)90560-X
   DAVIS JS, 1977, ANGIOLOGY, V28, P775, DOI 10.1177/000331977702801106
   DEBAKEY ME, 1980, J THORAC CARDIOV SUR, V80, P225
   De Feyter P J, 1981, Eur J Cardiol, V12, P147
   DEMANY MA, 1967, ANGIOLOGY, V18, P370, DOI 10.1177/000331976701800602
   DENEF JJF, 1971, BRIT HEART J, V33, P150
   DENEF JJE, 1971, BRIT HEART J, V33, P857
   DEOLIVEIRA SA, 1977, J CARDIOVASC SURG TO, V18, P599
   DEPELCHIN P, 1985, EUR HEART J, V6, P548
   DEZWAAN C, 1984, J AM COLL CARDIOL, V3, P1345
   DICICCO BS, 1982, AM HEART J
   DICICCO BS, 1982, AM HEART J, V104, P53
   DONALDSON RM, 1983, BRIT J RADIOL, V56, P17
   DONALDSON RM, 1982, THORAC CARDIOV SURG, V30, P7, DOI 10.1055/s-2007-1022198
   DONALDSON RM, 1979, EUR J CARDIOL, V10, P295
   DONALDSON RM, 1982, BRIT HEART J, V47, P62
   DOTY DB, 1976, J THORAC CARDIOV SUR, V71, P787
   DRISCOLL DJ, 1982, CATHETER CARDIO DIAG, V8, P55, DOI 10.1002/ccd.1810080110
   DRISCOLL DJ, 1981, AM J CARDIOL, V47, P642, DOI 10.1016/0002-9149(81)90549-X
   EDELSTEIN J, 1984, CATHETER CARDIO DIAG, V10, P171, DOI 10.1002/ccd.1810100209
   EDWARDS JE, 1964, CIRCULATION, V29, P163
   EDWARDS JE, 1958, CIRCULATION, V17, P1001
   EFFLER DB, 1967, SURGERY, V61, P41
   EHREN H, 1985, Pediatric Pathology, V4, P59
   EL-SAID G M, 1973, European Journal of Cardiology, V1, P63
   el-Said GM, 1973, CIRCULATION       S3, V48, pIII2
   ENGEL HJ, 1975, CATHETER CARDIO DIAG, V1, P157, DOI 10.1002/ccd.1810010205
   EVANS JJ, 1984, J AM COLL CARDIOL, V3, P219
   URRUTIA CO, 1983, ANN THORAC SURG, V35, P300
   FEIGENBERG Z, 1977, VASCULAR SURG, V11, P14, DOI 10.1177/153857447701100103
   FERGUSON DW, 1985, CATHETER CARDIO DIAG, V11, P55, DOI 10.1002/ccd.1810110108
   FISHER J, 1983, CATHETER CARDIO DIAG, V9, P373, DOI 10.1002/ccd.1810090408
   FLOYD WL, 1970, AM J CARDIOL, V25, P716, DOI 10.1016/0002-9149(70)90624-7
   FORTUIN NJ, 1971, AM J MED, V50, P385, DOI 10.1016/0002-9343(71)90227-0
   FRANCIS CK, 1979, CATHETER CARDIO DIAG, V5, P357, DOI 10.1002/ccd.1810050407
   GEIRINGER E, 1951, AM HEART J, V41, P359, DOI 10.1016/0002-8703(51)90036-1
   GENTZLER RD, 1975, CIRCULATION, V52, P490
   GILLEBERT C, 1986, EUR HEART J, V7, P437
   Gittenberger de Groot AC, 1986, J THORAC CARDIOVASC, V91, P566
   GOLDBLATT E, 1984, J THORAC CARDIOV SUR, V87, P59
   GONZALEZ.A, 1966, ANGIOLOGY, V17, P96, DOI 10.1177/000331976601700205
   GOULD SE, 1960, PATHOLOGY HEART
   Grace R R, 1977, Am J Cardiol, V39, P609
   Grayzel DM, 1934, AM J PATHOL, V10, P791
   GRIFFITHS SP, 1983, J AM COLL CARDIOL, V2, P1169
   GUTGESELL HP, 1980, CIRCULATION, V61, P596
   HACKENSELLNER H A, 1956, Z Mikrosk Anat Forsch, V62, P153
   HALLMAN GL, 1976, CHEST, V70, P4, DOI 10.1378/chest.70.1.4
   HAMAZAKI M, 1982, JPN HEART J, V23, P271
   HAMILTON DI, 1979, BRIT HEART J, V41, P121
   HANZLICK R, 1983, AM J CARDIOL, V51, P1467, DOI 10.1016/0002-9149(83)90337-5
   HANZLICK RL, 1983, AM J FOREN MED PATH, V4, P265, DOI 10.1097/00000433-198309000-00014
   HARADA K, 1980, JPN HEART J, V21, P435
   HARAVON A, 1972, NEW YORK STATE J MED, V72, P2196
   HEIFETZ SA, 1986, PEDIATR CARDIOL, V7, P11, DOI 10.1007/BF02315476
   HIRAKOW R, 1983, ACTA ANAT, V115, P220
   HOBBS RE, 1982, CLEVELAND CLIN Q, V49, P191
   Hobbs R E, 1981, Cardiovasc Clin, V12, P43
   HOGANSON G, 1983, ARCH PATHOL LAB MED, V107, P199
   HONEY M, 1975, BRIT HEART J, V37, P937
   HOUSEHAM KC, 1983, S AFR MED J, V63, P325
   HUHTA JC, 1981, J THORAC CARDIOV SUR, V81, P577
   HURWITZ RA, 1980, J THORAC CARDIOV SUR, V80, P129
   HUSAINI SN, 1983, CATHETER CARDIO DIAG, V9, P407, DOI 10.1002/ccd.1810090412
   HYMAN PJY, 1984, J AM COLL CARDIOL, V4, P1329
   IMAMURA T, 1986, CLIN CARDIOL, V9, P77
   ISHIKAWA T, 1985, AM J CARDIOL, V55, P770, DOI 10.1016/0002-9149(85)90154-7
   ISKANDRIAN AS, 1986, CATHETER CARDIO DIAG, V12, P48, DOI 10.1002/ccd.1810120112
   ISNER JM, 1984, AM J MED, V76, P155, DOI 10.1016/0002-9343(84)90765-4
   JAFFE RB, 1973, CIRCULATION, V47, P133
   James TN, 1961, ANATOMY CORONARY ART
   JOHN S, 1981, THORAX, V36, P350, DOI 10.1136/thx.36.5.350
   JORDAN RA, 1950, P STAFF M MAYO CLIN, V25, P673
   JOSA M, 1981, J THORAC CARDIOV SUR, V81, P338
   JOSWIG BC, 1978, CATHETER CARDIO DIAG, V4, P297, DOI 10.1002/ccd.1810040312
   JURISHICA AJ, 1957, AM HEART J, V54, P429, DOI 10.1016/0002-8703(57)90130-8
   KAFROUNI G, 1981, ANN THORAC SURG, V32, P80
   KEETON BR, 1983, BRIT HEART J, V49, P397
   KELLEY MJ, 1977, AM J ROENTGENOL, V128, P257
   KEREN A, 1982, CATHETER CARDIO DIAG, V8, P191, DOI 10.1002/ccd.1810080211
   KIMBIRIS D, 1985, AM J CARDIOL, V55, P765, DOI 10.1016/0002-9149(85)90153-5
   KIMBIRIS D, 1978, CIRCULATION, V58, P606
   KIMBIRIS D, 1970, AM J CARDIOL, V26, P532, DOI 10.1016/0002-9149(70)90713-7
   KING BD, 1982, CATHETER CARDIO DIAG, V8, P277, DOI 10.1002/ccd.1810080311
   KISO I, 1978, THORAX, V33, P253, DOI 10.1136/thx.33.2.253
   KORY WP, 1984, PEDIATR CARDIOL, V5, P301, DOI 10.1007/BF02424976
   KRAJCER Z, 1978, CHEST, V74, P102, DOI 10.1378/chest.74.1.102
   KUCERA J, 1978, COR VASA, V20, P369
   KUROSAWA H, 1981, BRIT HEART J, V46, P211
   LABORDE F, 1981, J THORAC CARDIOV SUR, V82, P423
   LANDOLT CC, 1986, ANN THORAC SURG, V41, P351
   LEA JW, 1986, J THORAC CARDIOV SUR, V92, P796
   LEITCH AG, 1975, THORAX, V30, P352, DOI 10.1136/thx.30.3.352
   LENOX CC, 1972, AM J CARDIOL, V30, P666, DOI 10.1016/0002-9149(72)90607-8
   LERBERG DB, 1979, ANN THORAC SURG, V27, P87
   LEVIN DC, 1978, CIRCULATION, V58, P25
   LEVY MJ, 1963, CIRCULATION, V27, P841
   LIBERTHSON RR, 1979, CIRCULATION, V59, P748
   LIBERTHSON RR, 1983, PEDIATR CARDIOL, V4, P45, DOI 10.1007/BF02281006
   LIBERTHSON RR, 1982, CLIN CARDIOL, V5, P377
   LIBERTHS.RR, 1974, CIRCULATION, V50, P774
   Licata RH, 1962, BLOOD VESSELS LYMPHA, P258
   LIKAR I, 1966, CIRCULATION, V33, P727
   LIM CH, 1977, AM J CARDIOL, V39, P751, DOI 10.1016/S0002-9149(77)80140-9
   LIPTON MJ, 1979, RADIOLOGY, V130, P39
   LOWE JE, 1981, ANN SURG, V194, P373, DOI 10.1097/00000658-198110000-00001
   LOWER RM, 1964, NEW ENGL J MED, V271, P68
   LUKACS L, 1986, J CARDIOVASC SURG, V27, P90
   LYNCH P, 1980, LANCET, V1, P1235
   MACCHI RJ, 1976, CHEST, V69, P565, DOI 10.1378/chest.69.4.565
   MACMAHON HE, 1967, CIRCULATION, V35, P3
   MACMILLAN RM, 1985, AM J CARDIOL, V56, P997, DOI 10.1016/0002-9149(85)90422-9
   MACRI R, 1982, THORAC CARDIOV SURG, V30, P167, DOI 10.1055/s-2007-1022237
   MAHONEY LT, 1982, PEDIATR CARDIOL, V2, P311, DOI 10.1007/BF02426979
   MAHOWALD JM, 1986, CHEST, V89, P668, DOI 10.1378/chest.89.5.668
   Manasek F J, 1970, Am J Cardiol, V25, P149, DOI 10.1016/0002-9149(70)90576-X
   MARTINEZRIOS MA, 1976, ARCH I CARDIOL MEX, V46, P750
   MCCLELLA.JT, 1968, AM J CLIN PATHOL, V50, P229
   MCNAIR M, 1971, P ROY SOC MED, V64, P839
   MENKE DM, 1985, CHEST, V88, P299, DOI 10.1378/chest.88.2.299
   MENKE DM, 1986, AM HEART J, V112, P1319, DOI 10.1016/0002-8703(86)90367-4
   MEYER J, 1975, J CARDIOVASC SURG, V16, P506
   MEYER J, 1975, J THORAC CARDIOV SUR, V69, P373
   MEYER J, 1975, J CARDIOVASC SURG, V16, P500
   MEYERS DG, 1984, CATHETER CARDIO DIAG, V10, P479, DOI 10.1002/ccd.1810100510
   MIDELL AI, 1977, J THORAC CARDIOV SUR, V74, P199
   MINTZ GS, 1983, AM J CARDIOL, V51, P610, DOI 10.1016/S0002-9149(83)80108-8
   MONSELIS.MB, 1970, CHEST, V58, P613, DOI 10.1378/chest.58.6.613
   MOODIE DS, 1980, J THORAC CARDIOV SUR, V80, P198
   MOODIE DS, 1980, J NUCL MED, V21, P1076
   MOODIE DS, 1983, AM HEART J, V106, P381, DOI 10.1016/0002-8703(83)90207-7
   MORI K, 1981, JPN CIRC J, V45, P209
   MULLINS CE, 1972, CIRCULATION, V46, P989
   MURAI T, 1982, ACTA PATHOL JAPON, V32, P1075
   MURAKI H, 1976, JPN HEART J, V17, P531
   MURPHY DA, 1978, J THORAC CARDIOV SUR, V75, P282
   MURPHY ML, 1967, AM HEART J, V74, P557, DOI 10.1016/0002-8703(67)90016-6
   MUUS CJ, 1984, AM HEART J, V107, P1285, DOI 10.1016/0002-8703(84)90297-7
   MUYLDERMANS LLCM, 1985, INT J CARDIOL, V7, P416, DOI 10.1016/0167-5273(85)90097-X
   NECHES WH, 1974, CIRCULATION, V50, P582
   NEUFELD HN, 1983, CORONARY ARTERY DISE
   Ng W L, 1976, Arch Pathol Lab Med, V100, P573
   NOBLE J, 1976, AM J CARDIOL, V37, P993, DOI 10.1016/0002-9149(76)90414-8
   OCHSNER JL, 1984, ANN THORAC SURG, V38, P356
   OCONNOR WN, 1982, CIRCULATION, V66, P1078
   OCONNOR WN, 1988, J AM COLL CARDIOL, V11, P1061
   OGASAWARA K, 1985, JPN HEART J, V26, P597
   OGDEN JA, 1972, J THORAC CARDIOV SUR, V63, P172
   OGDEN JA, 1970, AM J CARDIOL, V25, P474, DOI 10.1016/0002-9149(70)90016-0
   OGDEN JA, 1970, YALE J BIOL MED, V43, P11
   OGDEN JA, 1971, AMER J ROENTGENOL RA, V113, P538
   OTT DA, 1978, J THORAC CARDIOV SUR, V76, P190
   PALOMO AR, 1984, CATHETER CARDIO DIAG, V10, P385, DOI 10.1002/ccd.1810100412
   PALOMO AR, 1985, AM HEART J, V109, P902, DOI 10.1016/0002-8703(85)90657-X
   PARSONNET V, 1985, ANN THORAC SURG, V40, P206
   PARTRIDGE JB, 1986, INT J CARDIOL, V13, P83, DOI 10.1016/0167-5273(86)90083-5
   PATTERN BM, 1968, HUMAN EMBRIOLOGY, P537
   Paulin S, 1976, Cathet Cardiovasc Diagn, V2, P105, DOI 10.1002/ccd.1810020114
   PERRY LW, 1970, CIRCULATION, V41, P1043
   PHILLIPS DA, 1984, CARDIOVASC INTER RAD, V7, P75, DOI 10.1007/BF02552683
   PHILLIPS SJ, 1973, ANN SURG, V177, P63, DOI 10.1097/00000658-197301000-00011
   POLACEK P, 1961, AM HEART J, V61, P44, DOI 10.1016/0002-8703(61)90515-4
   Rajfer S I, 1982, Chest, V81, P687, DOI 10.1378/chest.81.6.687
   RATH S, 1986, AM J CARDIOL, V58, P657, DOI 10.1016/0002-9149(86)90299-7
   REIS RL, 1969, CIRCULATION       S1, V39, P229
   RITTENHOUSE EA, 1975, ANN THORAC SURG, V20, P468
   RIVETT JR, 1979, VIRCHOWS ARCH A, V383, P351, DOI 10.1007/BF00430252
   ROBERTS WC, 1984, AM J CARDIOL, V54, P1381, DOI 10.1016/S0002-9149(84)80110-1
   ROBERTS WC, 1982, AM J CARDIOL, V49, P863, DOI 10.1016/0002-9149(82)91970-1
   ROBERTS WC, 1982, AM HEART J, V104, P638, DOI 10.1016/0002-8703(82)90241-1
   ROBERTS WC, 1982, AM HEART J, V104, P303, DOI 10.1016/0002-8703(82)90206-X
   ROBERTS WC, 1986, AM HEART J, V111, P941, DOI 10.1016/0002-8703(86)90646-0
   Roberts WC, 1987, ADULT CONGENITAL HEA, P583
   ROBERTS WC, 1986, AM J CARDIOL, V57, P179, DOI 10.1016/0002-9149(86)90977-X
   ROBERTS WC, 1962, AM J CARDIOL, V10, P595, DOI 10.1016/0002-9149(62)90389-2
   ROBICSEK F, 1984, AM HEART J, V108, P1377, DOI 10.1016/0002-8703(84)90775-0
   ROBICSEK F, 1967, J THORAC CARDIOV SUR, V53, P602
   ROCHE AHG, 1967, AM J CARDIOL, V20, P561, DOI 10.1016/0002-9149(67)90035-5
   ROSSI MB, 1986, ANN THORAC SURG, V42, P573
   Rou P R, 1975, Br Heart J, V37, P287
   SACKS JH, 1977, J THORAC CARDIOV SUR, V73, P733
   SAENZ CB, 1986, AM HEART J, V112, P1092, DOI 10.1016/0002-8703(86)90327-3
   SAJI T, 1985, JPN HEART J, V26, P6003
   SALOMON J, 1981, AM J MED SCI, V281, P152, DOI 10.1097/00000441-198105000-00005
   SANER HE, 1984, ARCH PATHOL LAB MED, V108, P642
   Schlesinger MJ, 1940, ARCH PATHOL, V30, P403
   SCHLESINGER MJ, 1949, AM HEART J, V38, P823, DOI 10.1016/0002-8703(49)90884-4
   SCHNEEWEISS A, 1981, CARDIOVASC INTER RAD, V4, P148, DOI 10.1007/BF02552415
   SCHNEEWEISS A, 1981, THORAX, V36, P697, DOI 10.1136/thx.36.9.697
   SCHULTE MA, 1985, AM HEART J, V110, P499, DOI 10.1016/0002-8703(85)90182-6
   SCHULZE WB, 1961, ARCH PATHOL, V72, P36
   SENNARI E, 1982, JPN CIRC J, V46, P329
   SHARBAUG.AH, 1974, JAMA-J AM MED ASSOC, V230, P243
   SHEIKHZADEH A, 1982, JPN HEART J, V23, P725
   SHEIKHZADEH A, 1986, JPN HEART J, V27, P533
   SHRIVASTAVA S, 1977, CIRCULATION, V55, P551
   SHRIVASTAVA S, 1978, J THORAC CARDIOV SUR, V76, P130
   SHUBROOKS SJ, 1978, CIRCULATION, V57, P197
   SILVERMAN KJ, 1978, AM J CARDIOL, V41, P1311, DOI 10.1016/0002-9149(78)90891-3
   SIMKOFF WL, 1982, CATHETER CARDIO DIAG, V8, P49, DOI 10.1002/ccd.1810080109
   SINGH N, 1983, CATHETER CARDIO DIAG, V9, P411
   Sissman N J, 1970, Am J Cardiol, V25, P141, DOI 10.1016/0002-9149(70)90575-8
   SMITH A, 1986, INT J CARDIOL, V12, P295, DOI 10.1016/0167-5273(86)90265-2
   SMITH JC, 1950, CIRCULATION, V1, P1168
   SOMERVIL.J, 1970, THORAX, V25, P207, DOI 10.1136/thx.25.2.207
   SPINDOLA FH, 1983, AM HEART J, V105, P445
   St John Sutton M G, 1980, Br Heart J, V44, P460
   STARC TJ, 1986, AM J CARDIOL, V58, P366, DOI 10.1016/0002-9149(86)90083-4
   STEPHENSON LW, 1981, CIRCULATION, V64, P1130
   STEUSSY HF, 1984, AM HEART J, V108, P619, DOI 10.1016/0002-8703(84)90438-1
   SUNG CS, 1979, AM HEART J, V98, P87, DOI 10.1016/0002-8703(79)90324-7
   SWANN WC, 1955, ANN INTERN MED, V42, P873
   TAKEUCHI S, 1979, J THORAC CARDIOV SUR, V78, P7
   TALNER NS, 1965, AM J CARDIOL, V15, P689, DOI 10.1016/0002-9149(65)90358-9
   TAMER DF, 1984, AM HEART J, V108, P341, DOI 10.1016/0002-8703(84)90622-7
   THOMPSON SI, 1976, CATHETER CARDIO DIAG, V2, P397
   TINGELST.JB, 1972, AM J CARDIOL, V30, P670, DOI 10.1016/0002-9149(72)90608-X
   TOPAZ O, 1985, CHEST, V87, P476, DOI 10.1378/chest.87.4.476
   TRIVELLATO M, 1980, CARDIOVASC DIS, V7, P357
   UEDA K, 1983, AM HEART J, V106, P596, DOI 10.1016/0002-8703(83)90711-1
   VACEK JL, 1984, CATHETER CARDIO DIAG, V10, P369, DOI 10.1002/ccd.1810100410
   VACEK JL, 1978, CATHET CARDIOVASC DI, V4, P407
   VIDNE BA, 1979, SCAND J THORAC CARD, V13, P37, DOI 10.3109/14017437909101784
   VIRMANI R, 1984, J AM COLL CARDIOL, V3, P766
   VISSCHER DW, 1983, CATHETER CARDIO DIAG, V9, P493, DOI 10.1002/ccd.1810090508
   Vlodaver Z., 1975, CORONARY ARTERIAL VA
   VOGELBACH KH, 1979, CATHETER CARDIO DIAG, V5, P159, DOI 10.1002/ccd.1810050210
   Vuthoori S, 1980, Clin Cardiol, V3, P67
   WALDMAN JD, 1984, PEDIATR CARDIOL, V5, P221, DOI 10.1007/BF02427050
   WALLER BF, 1983, AM J CARDIOL, V51, P1562, DOI 10.1016/0002-9149(83)90680-X
   WARREN SE, 1977, CHEST, V72, P540, DOI 10.1378/chest.72.4.540
   WESSELHO.H, 1968, CIRCULATION, V38, P403
   WHITE NK, 1948, ARCH PATHOL, V45, P766
   WILCOX WD, 1986, AM J CARDIOL, V57, P361
   WILDE P, 1980, CLIN RADIOL, V31, P301, DOI 10.1016/S0009-9260(80)80223-6
   WILLIAMS J W, 1951, J Fla Med Assoc, V37, P561
   WILSON CL, 1977, J THORAC CARDIOV SUR, V73, P887
   WILSON CL, 1979, AM HEART J, V98, P440, DOI 10.1016/0002-8703(79)90248-5
   WORSHAM C, 1985, AM J CARDIOL, V55, P232, DOI 10.1016/0002-9149(85)90340-6
   YOUNG MW, 1981, CHEST, V79, P473, DOI 10.1378/chest.79.4.473
NR 307
TC 162
Z9 170
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0002-8703
J9 AM HEART J
JI Am. Heart J.
PD FEB
PY 1989
VL 117
IS 2
BP 418
EP 434
DI 10.1016/0002-8703(89)90789-8
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA T2151
UT WOS:A1989T215100021
PM 2644796
ER

PT J
AU Walsh, PC
AF Walsh, PC
TI Radical prostatectomy for localized prostate cancer provides durable
   cancer control with excellent quality of life: A structured debate
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate; prostatectomy; prostatic neoplasms; prostate-specific antigen
ID RETROPUBIC PROSTATECTOMY; RADIOTHERAPY; INCONTINENCE; RADIATION;
   CARCINOMA; IMPOTENCE; ANTIGEN; MEN
AB Purpose: To cure localized prostate cancer, the entire prostate must he eliminated, which is what all forms of treatment must achieve. Although there is no better way to cure localized disease than total surgical removal, the challenge is whether this can he accomplished with acceptable morbidity.
   Materials and Methods: To evaluate quality of life following radical retropubic prostatectomy, patient reported outcomes of 62 men who underwent radical retropubic prostatectomy at this institution were recorded during the first 18 months of followup. By 18 months 93% of the patients were dry (wearing no pads) and 93% to 98% characterized urinary bothersomeness as none or small. Potency, defined as the ability to achieve unassisted intercourse with or without the use of sildenafil, improved gradually and by 18 months 86% of the patients were potent and 84% considered sexual bothersomeness as none or small. In an effort to improve the outcome of radical prostatectomy, the surgical procedures on these 62 patients were videotaped prospectively. The videotapes were reviewed 18 months after the study was initiated and 4 specific steps in the surgical procedure were correlated with patient reported outcomes. Surgeons who wish to improve their outcomes should consider using this technique to identify in their own hands other important arbitrary variations that may improve results.
   Results: The probability of maintaining an undetectable prostate specific antigen was evaluated in men with similar pathological stages of disease who were or were not potent following surgery. Men who were potent had the same outcome as those who were impotent, supporting the premise that preservation of sexual function does not compromise cancer control. Cancer control and quality of life following brachytherapy were analyzed and the following conclusions were made: 1) high dose intensification is necessary if radiation therapy is expected to cure prostate cancer but I doubt that any form of radiotherapy will produce durable cancer control for 20 to 30 years; 2) although brachytherapy is rarely adequate as monotherapy, I am not certain that brachytherapy combined with external beam radiotherapy is any better than 3-dimensional conformal therapy alone and the side effects are uncertain, and 3)1 believe that a prostate specific antigen nadir of less than 0.2 ng./ml. is necessary to confirm an adequate response to radiation.
   Conclusions: I believe that there is no better way to cure organ confined cancer than total surgical removal. Today continence and potency rates should be high. If not, a review of intraoperative videotapes of successful and unsuccessful cases can improve results. In men treated with radiotherapy stringent criteria for treatment response and quality of life outcomes are needed.
C1 Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA.
   Johns Hopkins Hosp, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA.
RP Walsh, PC (reprint author), Johns Hopkins Hosp, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA.
CR BASTACKY SI, 1995, J UROLOGY, V153, P987, DOI 10.1016/S0022-5347(01)67619-5
   Brandeis JM, 2000, J UROLOGY, V163, P851, DOI 10.1016/S0022-5347(05)67818-4
   CATALONA WJ, 1993, J UROLOGY, V150, P905
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   Eastham JA, 1996, J UROLOGY, V156, P1707, DOI 10.1016/S0022-5347(01)65488-0
   FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E
   GEARY ES, 1995, UROLOGY, V45, P1000
   GEARY ES, 1995, J UROLOGY, V154, P145, DOI 10.1016/S0022-5347(01)67251-3
   LEPOR H, 1985, J UROLOGY, V133, P207
   LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129
   MOUL JW, 1998, PROSTATE CANCER P D, V5, P242
   Palapattu Ganesh S., 1996, Journal of Urology, V155, p647A
   Petroni Gina, 1999, Journal of Urology, V161, P339
   Polascik TJ, 1998, UROLOGY, V51, P884, DOI 10.1016/S0090-4295(98)00153-8
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Talcott JA, 1997, J NATL CANCER I, V89, P1117, DOI 10.1093/jnci/89.15.1117
   TALCOTT JA, 1999, P ASCO, V18, pA311
   WALSH PC, 1994, J UROLOGY, V152, P1831
   WALSH PC, 1982, J UROLOGY, V128, P492
   Walsh PC, 2000, UROLOGY, V55, P62, DOI 10.1016/S0090-4295(99)00363-5
   WALSH PC, 1987, UROL CLIN N AM, V14, P663
   Walsh PC, 2000, UROLOGY, V55, P58, DOI 10.1016/S0090-4295(99)00397-0
   Walsh PC, 1998, J UROLOGY, V160, P2418, DOI 10.1016/S0022-5347(01)62202-X
   WALSH PC, 1987, J UROLOGY, V138, P823
   Zelefsky MJ, 1999, J CLIN ONCOL, V17, P517
NR 28
TC 160
Z9 163
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD JUN
PY 2000
VL 163
IS 6
BP 1802
EP 1806
DI 10.1016/S0022-5347(05)67547-7
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 313DK
UT WOS:000086984900054
PM 10799186
ER

PT J
AU Wijeysundera, DN
   Beattie, WS
   Djaiani, G
   Rao, V
   Borger, MA
   Karkouti, K
   Cusimano, RJ
AF Wijeysundera, DN
   Beattie, WS
   Djaiani, G
   Rao, V
   Borger, MA
   Karkouti, K
   Cusimano, RJ
TI Off-pump coronary artery surgery for reducing mortality and morbidity -
   Meta-analysis of randomized and observational studies
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID LOW-RISK PATIENTS; POSTOPERATIVE ATRIAL-FIBRILLATION; PROPENSITY SCORE
   ANALYSIS; ON-PUMP; BYPASS-SURGERY; CARDIOPULMONARY BYPASS;
   BEATING-HEART; MYOCARDIAL REVASCULARIZATION; CONTROLLED-TRIAL;
   INFLAMMATORY RESPONSE
AB OBJECTIVES The purpose of this study was to assess the effects of off-pump coronary bypass surgery (OPCAB) on mortality and morbidity.
   BACKGROUND Despite its potential for reducing morbidity and mortality, OPCAB's role in clinical practice remains controversial.
   METHODS A meta-analysis of 37 randomized controlled trials (RCTs) (n = 3,449) and 22 risk-adjusted (logistic regression or propensity-score) observational studies (n = 293,617) was performed. Two reviewers performed literature searches (MEDLINE, EMBASE, PubMed, reference lists), quality assessment, and data extraction. Treatment effects were calculated as odds ratios (ORs) with 95% confidence intervals (CIs).
   RESULTS In RCTs, OPCAB was associated with reduced atrial fibrillation (OR 0.59; 95% CI 0.46 to 0.77) and trends toward reduced 30-day mortality (OR 0.91 95% CI 0.45 to 1.83), stroke (OR 0.52; 95% CI 0.25 to 1.05), and myocardial infarction (OR 0.79; 95% CI 0.50 to 1.25). Observational studies showed OPCAB to be associated with reduced 30-day mortality (OR 0.72; 95% CI 0.66 to 0.78), stroke (OR 0.62; 95% CI 0.55 to 0.69), infarction (OR 0.66; 95% Cl 0.50 to 0.88), and atrial fibrillation (OR 0.78; 95% CI 0.74 to 0.82). At one to two years, OPCAB was associated with trends toward reduced mortality, but also increased repeat revascularization (RCT: OR 1.75, 95% CI 0.78 to 3.94; Observational: OR 1.35, 95% Cl 0.76 to 2.39).
   CONCLUSIONS Randomized controlled trials did not find, aside from atrial fibrillation, the statistically significant reductions in short-term mortality and morbidity demonstrated by observational studies. These discrepancies might be due to differing patient-selection and study methodology. Future studies must focus on improving research methodology, recruiting high-risk patients, and collecting long-term data.
C1 Toronto Gen Hosp, Dept Anesthesia, Toronto, ON, Canada.
   Toronto Gen Hosp, Div Cardiac Surg, Toronto, ON, Canada.
   Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada.
RP Wijeysundera, DN (reprint author), EN 3-450,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.
EM duminda.wijeysundera@uhn.on.ca
RI Beattie, William /A-4352-2008
CR Aldea GS, 2003, J CARDIAC SURG, V18, P206, DOI 10.1046/j.1540-8191.2003.01800.x
   Al-Ruzzeh S, 2003, ANN THORAC SURG, V76, P444, DOI 10.1016/S0003-4975(03)00348-5
   Alwan K, 2004, ANN THORAC SURG, V77, P2051, DOI 10.1016/j.athoracsur.2003.11.004
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 2003, J THORAC CARDIOV SUR, V125, P779, DOI 10.1067/mtc.2003.11
   Ascione R, 2002, ANN THORAC SURG, V74, P474, DOI 10.1016/S0003-4975(02)03727-X
   Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athorascur.2003.07.002
   Athanasiou T, 2004, ANN THORAC SURG, V77, P1567, DOI 10.1016/j.athoracsur.2003.10.040
   Athanasiou T, 2004, EUR J CARDIO-THORAC, V26, P701, DOI 10.1016/j.ejcts.2004.05.053
   Baker JS, 2001, J SCI MED SPORT, V4, P1, DOI 10.1016/S1440-2440(01)80002-5
   Barbut D, 1997, ANN THORAC SURG, V63, P998
   Boening A, 2003, ANN THORAC SURG, V76, P2000, DOI 10.1016/S0003-4975(03)01298-0
   Bonchek LI, 2002, J THORAC CARDIOV SUR, V124, P431, DOI 10.1067/mtc.2002.124240
   Brown PP, 2002, ANN THORAC SURG, V74, P2113, DOI 10.1016/S0003-4975(02)03988-7
   Bruins P, 1997, CIRCULATION, V96, P3542
   Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9
   Bucerius J, 2004, ANN THORAC SURG, V77, P1250, DOI 10.1016/S0003-4975(03)01346-8
   Calafiore AM, 2001, ANN THORAC SURG, V72, P456, DOI 10.1016/S0003-4975(01)02810-7
   Caputo M, 2002, ANN THORAC SURG, V74, P2088, DOI 10.1016/S0003-4975(02)04025-0
   Carrier M, 2003, HEART SURG FORUM, V6, pE89
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cheng W, 2002, J THORAC CARDIOV SUR, V124, P313, DOI 10.1067/mtc.2002.122304
   Covino E, 2001, J CARDIOVASC SURG, V42, P23
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Egger M, 1998, BRIT MED J, V316, P140
   Gaudino M, 2004, ANN THORAC SURG, V77, P574, DOI 10.1016/S0003-4975(03)01534-0
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Grunkemeier GL, 2002, ANN THORAC SURG, V74, P301, DOI 10.1016/S0003-4975(02)03783-9
   Gu YJ, 1998, ANN THORAC SURG, V65, P420
   Guler M, 2001, ANN THORAC SURG, V71, P152, DOI 10.1016/S0003-4975(00)02250-5
   Gulielmos V, 1999, EUR J CARDIO-THORAC, V16, pS34, DOI 10.1016/S1010-7940(99)00266-3
   Hernandez F, 2001, ANN THORAC SURG, V72, P1528, DOI 10.1016/S0003-4975(01)03202-7
   HIROSE H, 2002, MED SCI MONITOR, V8, P235
   Johansson-Synnergren M, 2004, SCAND CARDIOVASC J, V38, P53, DOI 10.1080/14017430410024847
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kochamba GS, 2000, ANN THORAC SURG, V69, P1466, DOI 10.1016/S0003-4975(00)01142-5
   Krejca M, 1999, EUR J CARDIO-THORAC, V16, P337, DOI 10.1016/S1010-7940(99)00234-1
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Legare JF, 2005, EUR J CARDIO-THORAC, V27, P296, DOI 10.1016/j.ejcts.2004.11.009
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Mack MJ, 2004, J THORAC CARDIOV SUR, V127, P167, DOI 10.1016/j.jtcvs.2003.08.032
   Magee MJ, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.cir.0000089187.51855.77
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Moss M, 2003, CHEST, V123, P923, DOI 10.1378/chest.123.3.923
   Motallebzadeh R, 2004, EUR J CARDIO-THORAC, V25, P409, DOI 10.1016/j.ejcts.2003.12.018
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2003, ANN THORAC SURG, V76, P737, DOI 10.1016/S0003-4975(03)00683-0
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Patel NC, 2002, EUR J CARDIO-THORAC, V22, P255, DOI 10.1016/S1010-7940(02)00301-9
   Penttila HJ, 2001, ANN THORAC SURG, V71, P565, DOI 10.1016/S0003-4975(00)02002-6
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Sabik JF, 2004, J THORAC CARDIOV SUR, V127, P142, DOI 10.1016/j.jtcvs.2003.08.046
   Sahlman A, 2003, SCAND CARDIOVASC J, V37, P211, DOI 10.1080/14017430310001726
   Selvanayagam JB, 2004, CIRCULATION, V109, P345, DOI 10.1161/01.CIR.0000109489.71945.BD
   Sharony R, 2004, J THORAC CARDIOV SUR, V127, P406, DOI 10.1016/j.jtcvs.2003.08.011
   Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6
   Stallwood MI, 2004, ANN THORAC SURG, V77, P968, DOI 10.1016/j.athoracsur.2003.09.063
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Tamis-Holland JE, 2000, J AM COLL CARDIOL, V36, P1884, DOI 10.1016/S0735-1097(00)00974-8
   Tang ATM, 2002, EUR J CARDIO-THORAC, V22, P118, DOI 10.1016/S1010-7940(02)00220-8
   van der Heijden GJMG, 2004, EUR J CARDIO-THORAC, V26, P81, DOI 10.1016/j.ejcts.2004.03.032
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Velissaris T, 2003, EUR J CARDIO-THORAC, V23, P917, DOI 10.1016/S1010-7940(03)00167-2
   Vural KM, 1995, THORAC CARDIOV SURG, V43, P320, DOI 10.1055/s-2007-1013803
   Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043
   Wandschneider W, 2000, ANN THORAC SURG, V70, P1577, DOI 10.1016/S0003-4975(00)01843-9
   Wehlin L, 2004, EUR J CARDIO-THORAC, V25, P35, DOI 10.1016/S1010-7940(03)00652-3
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 77
TC 158
Z9 163
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD SEP 6
PY 2005
VL 46
IS 5
BP 872
EP 882
DI 10.1016/j.jacc.2005.05.064
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 961AW
UT WOS:000231635300021
PM 16139139
ER

PT J
AU Lurz, P
   Coats, L
   Khambadkone, S
   Nordmeyer, J
   Boudjemline, Y
   Schievano, S
   Muthurangu, V
   Lee, TY
   Parenzan, G
   Derrick, G
   Cullen, S
   Walker, F
   Tsang, V
   Deanfield, J
   Taylor, AM
   Bonhoeffer, P
AF Lurz, Philipp
   Coats, Louise
   Khambadkone, Sachin
   Nordmeyer, Johannes
   Boudjemline, Younes
   Schievano, Silvia
   Muthurangu, Vivek
   Lee, Twin Yen
   Parenzan, Giovanni
   Derrick, Graham
   Cullen, Seamus
   Walker, Fiona
   Tsang, Victor
   Deanfield, John
   Taylor, Andrew M.
   Bonhoeffer, Philipp
TI Percutaneous pulmonary valve implantation impact of evolving technology
   and learning curve on clinical outcome
SO CIRCULATION
LA English
DT Article
DE pulmonary valve; heart defects; congenital; catheterization; stenosis;
   regurgitation
ID VENTRICULAR OUTFLOW TRACT; CONGENITAL HEART-DISEASE; TERM-FOLLOW-UP;
   STENT IMPLANTATION; FALLOT REPAIR; RISK-FACTORS; TETRALOGY; REPLACEMENT;
   RECONSTRUCTION; REGURGITATION
AB Background - Percutaneous pulmonary valve implantation was introduced in the year 2000 as a nonsurgical treatment for patients with right ventricular outflow tract dysfunction.
   Methods and Results - Between September 2000 and February 2007, 155 patients with stenosis and/or regurgitation underwent percutaneous pulmonary valve implantation. This led to significant reduction in right ventricular systolic pressure ( from 63 +/- 18 to 45 +/- 13 mm Hg, P < 0.001) and right ventricular outflow tract gradient ( from 37 +/- 20 to 17 +/- 10 mm Hg, P < 0.001). Follow-up ranged from 0 to 83.7 months ( median 28.4 months). Freedom from reoperation was 93% ( +/- 2%), 86% ( +/- 3%), 84% ( +/- 4%), and 70% ( +/- 13%) at 10, 30, 50, and 70 months, respectively. Freedom from transcatheter reintervention was 95% ( +/- 2%), 87% ( +/- 3%), 73% ( +/- 6%), and 73% ( +/- 6%) at 10, 30, 50, and 70 months, respectively. Survival at 83 months was 96.9%. On time-dependent analysis, the first series of 50 patients ( log-rank test P < 0.001) and patients with a residual gradient > 25 mm Hg ( log-rank test P = 0.01) were associated with a higher risk of reoperations.
   Conclusions - Percutaneous pulmonary valve implantation resulted in the ability to avoid surgical right ventricular outflow tract revision in the majority of cases. This procedure might reduce the number of operations needed over the total lifetime of patients with right ventricle - to - pulmonary artery conduits.
C1 [Lurz, Philipp; Coats, Louise; Khambadkone, Sachin; Nordmeyer, Johannes; Schievano, Silvia; Derrick, Graham; Cullen, Seamus; Tsang, Victor; Deanfield, John; Taylor, Andrew M.; Bonhoeffer, Philipp] UCL, Inst Child Hlth, London, England.
   [Lurz, Philipp; Coats, Louise; Khambadkone, Sachin; Nordmeyer, Johannes; Schievano, Silvia; Muthurangu, Vivek; Lee, Twin Yen; Parenzan, Giovanni; Derrick, Graham; Tsang, Victor; Deanfield, John; Taylor, Andrew M.; Bonhoeffer, Philipp] Great Ormond St Hosp Sick Children, Cardiac Unit, London WC1N 3JH, England.
   [Boudjemline, Younes] Hosp Necker Enfants Malades, Serv Cardiol Pediat, Paris, France.
   [Cullen, Seamus; Walker, Fiona; Tsang, Victor; Deanfield, John; Bonhoeffer, Philipp] Heart Hosp NHS Trust, London, England.
RP Bonhoeffer, P (reprint author), Great Ormond St Hosp Sick Children, Cardiac Unit, Great Ormond St, London WC1N 3JH, England.
EM BonhoP@gosh.nhs.uk
RI Taylor, Andrew/C-4311-2008; Lurz, Philipp/B-6558-2009; Schievano,
   Silvia/B-6803-2009; muthurangu, vivek/B-6877-2009
CR Askovich B, 2007, ANN THORAC SURG, V84, P907, DOI 10.1016/j.athoracsur.2007.04.104
   Bielefeld MR, 2001, ANN THORAC SURG, V71, P482, DOI 10.1016/S0003-4975(00)02521-2
   Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   BOVE EL, 1983, J THORAC CARDIOV SUR, V85, P691
   Brown JW, 2005, ANN THORAC SURG, V80, P655, DOI 10.1016/j.athorascur.2005.02.053
   CARVALHO JS, 1992, BRIT HEART J, V67, P470
   Dave HH, 2005, ANN THORAC SURG, V80, P1615, DOI 10.1016/j.athoracsur.2005.04.058
   FOGELMAN R, 1995, CIRCULATION, V92, P881
   Garty Yael, 2005, J Invasive Cardiol, V17, P318
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   Gengsakul A, 2007, EUR J CARDIO-THORAC, V32, P462, DOI 10.1016/j.ejcts.2007.06.009
   Ghez O, 2007, EUR J CARDIO-THORAC, V31, P654, DOI 10.1016/j.ejcts.2006.12.031
   Joyce JJ, 2000, ECHOCARDIOGR-J CARD, V17, P319, DOI 10.1111/j.1540-8175.2000.tb01143.x
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Khambadkone S, 2005, CIRCULATION, V112, P1189, DOI 10.1161/CIRCULATIONAHA.104.523266
   Maheshwari S, 1997, CATHETER CARDIO DIAG, V42, P405
   Nagm Ashraf M, 2003, J Invasive Cardiol, V15, P437
   Nordmeyer J, 2007, CIRCULATION, V115, P1392, DOI 10.1161/CIRCULATIONAHA.106.674259
   Oosterhof T, 2006, EUR HEART J, V27, P1478, DOI 10.1093/eurheartj/ehl033
   Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664
   Peng LF, 2006, CIRCULATION, V113, P2598, DOI 10.1161/CIRCULATIONAHA.105.607127
   POWELL AJ, 1995, CIRCULATION, V92, P3282
   ROME JJ, 1990, CIRCULATION, V82, P751
   Schievano S, 2007, RADIOLOGY, V242, P490, DOI 10.1148/radiol.2422051994
   Schievano S, 2007, J CARDIOVASC MAGN R, V9, P687, DOI 10.1080/10976640601187596
   Sridharan S, 2006, CIRCULATION, V113, pE934, DOI 10.1161/CIRCULATIONAHA.105.599514
   Stark J, 1998, J THORAC CARDIOV SUR, V115, P506, DOI 10.1016/S0022-5223(98)70312-5
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Therrien J, 2001, Can J Cardiol, V17, P1135
   Tweddell JS, 2000, CIRCULATION, V102, P130
   YOCK PG, 1984, CIRCULATION, V70, P657
NR 31
TC 157
Z9 164
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD APR 15
PY 2008
VL 117
IS 15
BP 1964
EP 1972
DI 10.1161/CIRCULATIONAHA.107.735779
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 288DK
UT WOS:000254966200008
PM 18391109
ER

PT J
AU WILSON, JP
   TURNER, HR
   KIRCHNER, KA
   CHAPMAN, SW
AF WILSON, JP
   TURNER, HR
   KIRCHNER, KA
   CHAPMAN, SW
TI NOCARDIAL INFECTIONS IN RENAL-TRANSPLANT RECIPIENTS
SO MEDICINE
LA English
DT Review
C1 UNIV MISSISSIPPI,MED CTR,DEPT INTERNAL MED,DIV INFECT DIS,JACKSON,MS 39216.
   VET ADM MED CTR,JACKSON,MS 39216.
   UNIV MISSISSIPPI,MED CTR,DEPT INTERNAL MED,DIV NEPHROL,JACKSON,MS 39216.
CR ADAMS HG, 1984, AM J MED SCI, V287, P8, DOI 10.1097/00000441-198401000-00002
   AHERN MJ, 1978, YALE J BIOL MED, V51, P513
   ALLEVATO PA, 1985, HUM PATHOL, V16, P743, DOI 10.1016/S0046-8177(85)80163-5
   ANDRIOLE VT, 1964, ANN INTERN MED, V60, P266
   ANGELES AM, 1987, J CLIN MICROBIOL, V25, P2278
   ANGLES AM, 1987, J INFECT DIS, V155, P292
   Anhalt J.P., 1985, MANUAL CLIN MICROBIO, P1009
   ARFANIA D, 1981, ARCH INTERN MED, V141, P161
   ARROYO JC, 1977, AM J MED, V62, P409, DOI 10.1016/0002-9343(77)90839-7
   AVRAM MM, 1978, JAMA-J AM MED ASSOC, V239, P2779, DOI 10.1001/jama.239.26.2779
   AWAD I, 1984, NEUROSURGERY, V15, P254
   BACH MC, 1973, J LAB CLIN MED, V81, P787
   BACH MC, 1973, LANCET, V1, P180
   BACH MC, 1973, JAMA-J AM MED ASSOC, V224, P1378, DOI 10.1001/jama.224.10.1378
   BACH MC, 1973, ANTIMICROB AGENTS CH, V3, P1
   BADDOUR LM, 1986, AM J INFECT CONTROL, V14, P214, DOI 10.1016/0196-6553(86)90120-3
   BALIKIAN JP, 1978, RADIOLOGY, V126, P569
   BARMEIR E, 1981, BRIT J RADIOL, V54, P1107
   BATES RR, 1971, AM J DIS CHILD, V121, P246
   BEAMAN BL, 1976, J INFECT DIS, V134, P286
   BEAMAN BL, 1983, J HYG-CAMBRIDGE, V91, P393
   BEAMAN BL, 1985, INFECT IMMUN, V47, P135
   BEAMAN BL, 1978, INFECT IMMUN, V22, P867
   BEAMAN BL, 1982, CELL WALL DEFECTIVE, P231
   BEAUMONT RJ, 1971, MED J AUSTRALIA, V2, P1123
   BELLIVEAU RR, 1977, WESTERN J MED, V127, P245
   Benbow Edward P., 1944, AMER REV TUBERC, V49, P395
   BENNETT JE, 1978, ANTIMICROB AGENTS CH, V13, P624
   BLACK CM, 1983, J INFECT DIS, V148, P117
   BLACK WA, 1970, J CLIN PATHOL, V23, P423, DOI 10.1136/jcp.23.5.423
   BLANCHARD R, 1896, TRAITE PATHOLOGIE GE, V2, P811
   BLUMER SO, 1979, J CLIN MICROBIOL, V10, P308
   BOJALIL LF, 1963, P SOC EXP BIOL MED, V113, P40
   BOUDOULAS O, 1985, ARCH DERMATOL, V121, P898, DOI 10.1001/archderm.121.7.898
   BRADLEY PP, 1980, ANN INTERN MED, V93, P560
   BRADSHER RW, 1982, AM J CLIN PATHOL, V78, P124
   BRAGG DG, 1973, RADIOL CLIN N AM, V11, P357
   BRAGG DG, 1973, AM J ROENTGENOL, V117, P798
   Bratton AC, 1939, J BIOL CHEM, V128, P537
   BROOKS JB, 1987, J CLIN MICROBIOL, V25, P445
   BROOKS RG, 1985, AM J MED, V79, P412, DOI 10.1016/0002-9343(85)90027-0
   BRUMMER DL, 1969, AM REV RESPIR DIS, V100, P908
   BRYAK JS, 1973, J PEDIATR, V83, P98
   BURGOSCA.R, 1971, SURGERY, V70, P334
   BURPEE JC, 1971, ARCH OPHTHALMOL-CHIC, V86, P666
   BUSHBY SRM, 1973, J INFECT DIS, V128, pS442
   BYRNE E, 1979, J NEUROL NEUROSUR PS, V42, P1038, DOI 10.1136/jnnp.42.11.1038
   CARLSEN ET, 1964, ANN INTERN MED, V60, P275
   CASALE TB, 1984, SOUTHERN MED J, V77, P274
   CAUSEY WA, 1974, AM REV RESPIR DIS, V109, P134
   CAUSEY WA, 1981, AM REV RESPIR DIS, V75, P99
   CAUSEY WA, 1974, APPL MICROBIOL, V28, P193
   CAUSEY WA, 1974, CHEST, V65, P360
   CHAVEZ CM, 1972, CHEST, V61, P79, DOI 10.1378/chest.61.1.79
   CHEN CJ, 1983, OPHTHALMIC SURG LAS, V14, P502
   CLAGUE HW, 1982, J RHEUMATOL, V9, P469
   COCKERILL FR, 1984, AM J MED, V77, P558, DOI 10.1016/0002-9343(84)90121-9
   COHEN ML, 1971, AM J MED, V50, P269, DOI 10.1016/0002-9343(71)90156-2
   CONS F, 1985, J RHEUMATOL, V12, P1019
   COX F, 1975, PEDIATRICS, V55, P135
   CRAIG WA, 1973, J INFECT DIS, V128, pS575
   CROSS RM, 1962, LAB INVEST, V11, P1103
   CUPP CM, 1960, ANN INTERN MED, V52, P223
   CURRY WA, 1980, ARCH INTERN MED, V140, P818, DOI 10.1001/archinte.140.6.818
   CYNAMON MH, 1981, ANTIMICROB AGENTS CH, V20, P841
   DALOVISIO JR, 1978, ANTIMICROB AGENTS CH, V13, P128
   DAVIDSON J M, 1969, British Journal of Diseases of the Chest, V63, P13, DOI 10.1016/S0007-0971(69)80040-9
   DAVISSCIBIENSKI C, 1980, INFECT IMMUN, V28, P610
   DEEM RL, 1982, INFECT IMMUN, V38, P914
   DERESINS.SC, 1974, AM REV RESPIR DIS, V110, P354
   DEWSNUP DH, 1984, ANTIMICROB AGENTS CH, V25, P165
   DIVITTORIO G, 1982, SOUTHERN MED J, V75, P507
   DONNENFELD ED, 1985, AM J OPHTHALMOL, V99, P601
   DRESDALE AR, 1985, CIRCULATION 2, V72, P11237
   DUMA RJ, 1972, TRANSPLANT P, V4, P711
   DUMMER JS, 1983, TRANSPLANTATION, V36, P259, DOI 10.1097/00007890-198309000-00007
   DYSON JE, 1963, AM REV RESPIR DIS, V88, P80
   EICKHOFF TC, 1972, TRANSPLANT P, V4, P693
   Eppinger H, 1891, BEITR PATHOL ANAT AL, V9, P287
   EPSTEIN S, 1963, NEW YORK STATE J MED, V63, P3422
   FALK RH, 1979, BRIT HEART J, V41, P125
   FAUCI AS, 1976, ANN INTERN MED, V84, P304
   FEIGIN DS, 1986, RADIOLOGY, V159, P9
   FIDLER JP, 1973, ARCH SURG-CHICAGO, V107, P256
   FILICE GA, 1980, J INFECT DIS, V142, P432
   FILICE GA, 1985, J INFECT DIS, V151, P47
   FINKELST.FO, 1974, AM J MED SCI, V267, P159, DOI 10.1097/00000441-197403000-00003
   FRAZIER AR, 1975, MAYO CLIN PROC, V50, P657
   GALLIS HA, 1975, ARCH INTERN MED, V135, P1163, DOI 10.1001/archinte.135.9.1163
   GARTY BZ, 1985, PEDIATR INFECT DIS J, V4, P66, DOI 10.1097/00006454-198501000-00017
   GEISELER PJ, 1979, AM J MED SCI, V278, P188, DOI 10.1097/00000441-197911000-00001
   GEORG LK, 1961, AM REV RESPIR DIS, V84, P337
   GILLIGAN BS, 1962, MED J AUST      1110, P747
   GOMBERT ME, 1987, ANTIMICROB AGENTS CH, V31, P2013
   GOMBERT ME, 1983, ANTIMICROB AGENTS CH, V24, P810
   GOMBERT ME, 1982, ANTIMICROB AGENTS CH, V21, P1011
   GONZALEZOCHOA A, 1976, SABOURAUDIA, V14, P255
   GONZALEZOCHOA A, 1962, LAB INVEST, V11, P1118
   GOODMAN AL, 1975, AM REV RESPIR DIS, V111, P707
   GOODMAN JS, 1970, ANN NY ACAD SCI, V174, P552, DOI 10.1111/j.1749-6632.1970.tb45581.x
   Gordon MA, 1985, MANUAL CLIN MICROBIO, P249
   GORDON RE, 1962, J GEN MICROBIOL, V27, P1
   Gordon RE, 1936, J INFECT DIS, V59, P200, DOI 10.1093/infdis/59.2.200
   GOTTLIEB LS, 1979, DIALYSIS TRANSPLANT, V8, P342
   GROSSMAN CB, 1970, RADIOLOGY, V96, P325
   GUTMANN L, 1983, ANTIMICROB AGENTS CH, V23, P248
   HALDE C, 1955, THERAPY FUNGUS DISEA, P147
   HANSEN I, 1973, CHEMOTHERAPY, V19, P221
   HARRIS J A, 1971, Alabama Journal of Medical Sciences, V8, P107
   HATHAWAY BM, 1962, AM J MED, V32, P903, DOI 10.1016/0002-9343(62)90036-0
   HAY RJ, 1983, J HYG-CAMBRIDGE, V91, P385
   HENKLE JQ, 1986, JAMA-J AM MED ASSOC, V256, P1331, DOI 10.1001/jama.256.10.1331
   HICKEY RC, 1953, AMA ARCH SURG, V67, P381
   HILL RB, 1964, NEW ENGL J MED, V271, P1021, DOI 10.1056/NEJM196411122712001
   HILL RB, 1967, AM J MED, V42, P327, DOI 10.1016/0002-9343(67)90260-4
   HIRST LW, 1982, AM J OPHTHALMOL, V94, P123
   HOEPRICH PD, 1968, AM J MED SCI, P255
   HOEPRICH PD, 1977, INFECT DIS, P178
   HOFFLIN JM, 1987, ANN INTERN MED, V106, P209
   HOGSHEAD HP, 1970, J BONE JOINT SURG AM, VA 52, P1229
   HOSTY TS, 1961, J LAB CLIN MED, V58, P107
   Houang E T, 1980, J Hosp Infect, V1, P31, DOI 10.1016/0195-6701(80)90029-8
   HUERTAS VE, 1976, ARCH SURG-CHICAGO, V111, P162
   HUMPHREYS DW, 1975, AM J MED SCI, V269, P323, DOI 10.1097/00000441-197505000-00005
   HUTTER RVP, 1962, LAB INVEST, V11, P1035
   IDRISS ZH, 1975, PEDIATRICS, V55, P479
   JACOB ET, 1985, ISRAEL J MED SCI, V21, P613
   JACOBY GA, 1982, NEW ENGL J MED, V306, P43, DOI 10.1056/NEJM198201073060111
   JAMPOL LM, 1973, AM J OPHTHALMOL, V76, P568
   JORDON GW, CAN MED ASS J S, V112, P915
   KAHN FW, 1981, AM J MED, V70, P859, DOI 10.1016/0002-9343(81)90543-X
   KATZ P, 1977, JAMA-J AM MED ASSOC, V238, P2397
   KAUFMAN N, 1952, AMA ARCH PATHOL, V53, P379
   KHALILI AH, 1982, J NEUROL, V227, P115, DOI 10.1007/BF00313777
   KIRMANI N, 1978, J NEUROSURG, V49, P924, DOI 10.3171/jns.1978.49.6.0924
   KITZIS MD, 1985, J ANTIMICROB CHEMOTH, V15, P23
   KJELLSTRAND CM, 1988, ARCH INTERN MED, V148, P1305
   KOUNTZ SL, 1972, ANN SURG, V176, P509
   KRICK JA, 1975, ANN INTERN MED, V82, P18
   KRICK JA, 1975, J INFECT DIS, V131, P665
   KURUP PV, 1970, MYCOPATH MYCOL APPL, V40, P193, DOI 10.1007/BF02051998
   LAMPE RM, 1981, J PEDIATR-US, V99, P593, DOI 10.1016/S0022-3476(81)80266-1
   LAW BJ, 1982, PEDIATRICS, V70, P560
   LAWSON DH, 1982, REV INFECT DIS, V4, P429
   LERNER G, 1967, AM REV RESPIR DIS, V96, P494
   LERNER PI, 1986, INFECTIONS MED   SEP, P288
   LERNER PI, 1973, ANTIMICROB AGENTS CH, V4, P85
   LOVETT IS, 1981, Q J MED, V50, P123
   LUDMERER KM, 1982, AM J MED, V72, P145
   MADERAZO EG, 1974, AM J MED, V57, P671, DOI 10.1016/0002-9343(74)90022-9
   MAMMANA RB, 1983, ANN THORAC SURG, V36, P700
   MASTERS DL, 1984, J INFECT DIS, V149, P824
   MASUR H, 1982, REV INFECT DIS, V4, P1208
   MATAS AJ, 1980, CRITICAL SURGICAL IL, P552
   MCCLUNG NM, 1960, MYCOLOGIA, V52, P154, DOI 10.2307/3756259
   MEIER B, 1986, ANTIMICROB AGENTS CH, V29, P150
   MILLS SA, 1975, ANN SURG, V182, P617, DOI 10.1097/00000658-197511000-00014
   MILLS VA, 1982, CLIN PEDIATR, V21, P248, DOI 10.1177/000992288202100413
   MISHRA SK, 1969, APPL MICROBIOL, V18, P687
   MISHRA SK, 1973, INFECT IMMUN, V7, P123
   MITCHELL G, 1975, AM REV RESPIR DIS, V112, P721
   MUNDA R, 1978, ANN SURG, V187, P126, DOI 10.1097/00000658-197802000-00005
   MURPHY JF, 1976, ARCH INTERN MED, V136, P670, DOI 10.1001/archinte.136.6.670
   MURRAY JF, 1961, AM REV RESPIR DIS, V83, P315
   MURRAY PR, 1988, J CLIN MICROBIOL, V26, P1219
   MURRAY PR, 1987, J CLIN MICROBIOL, V25, P2010
   MYEROWIT.RL, 1972, AM J MED, V53, P308, DOI 10.1016/0002-9343(72)90173-8
   NATALE RB, 1981, CANCER, V47, P2933, DOI 10.1002/1097-0142(19810615)47:12<2933::AID-CNCR2820471233>3.0.CO;2-G
   NATAS OB, 1983, SCAND J INFECT DIS, V15, P317
   NEU HC, 1967, ANN INTERN MED, V66, P274
   Nocard E., 1888, ANN I PASTEUR, V2, P293
   NORDEN CW, 1983, ARCH NEUROL-CHICAGO, V40, P594
   Ochiai T, 1978, Jpn J Surg, V8, P138, DOI 10.1007/BF02469369
   ORFANAKI.MG, 1972, ANTIMICROB AGENTS CH, V1, P215
   PADRON S, 1973, SOUTHERN MED J, V66, P609
   PALMER DL, 1974, MEDICINE, V53, P391, DOI 10.1097/00005792-197409000-00005
   PANIJAYA.P, 1972, ARCH SURG-CHICAGO, V104, P845
   PATEL NP, 1979, TRANSPLANTATION, V8, P337
   PAVILLAR.ER, 1973, MED J AUSTRALIA, V1, P65
   PEABODY JW, 1960, AM J MED, V28, P99, DOI 10.1016/0002-9343(60)90226-6
   PETERSEN DL, 1978, ARCH INTERN MED, V138, P1164, DOI 10.1001/archinte.138.7.1164
   PETERSEN EA, 1983, JAMA-J AM MED ASSOC, V250, P930
   PETERSEN JM, 1983, CLEVELAND CLIN Q, V50, P453
   PETERSON PK, 1982, MEDICINE, V61, P360
   PETERSON PK, 1981, AM J MED, V71, P345, DOI 10.1016/0002-9343(81)90149-2
   PETERSON PK, 1984, TRANSPLANT P, V16, P1111
   PIER AC, 1981, J CLIN MICROBIOL, V13, P548
   PIER AC, 1962, AM J VET RES, V23, P284
   Pinkerton J A, 1971, Am Surg, V37, P729
   PORTEZ DM, 1975, JAMA-J AM MED ASSOC, V232, P730
   POWELL BL, 1983, INFECT IMMUN, V40, P478
   PRESANT CA, 1973, AM REV RESPIR DIS, V108, P1444
   RAICH RA, 1961, AM REV RESPIR DIS, V83, P505
   RAMOS E, 1980, SOUTHERN MED J, V73, P751
   RAMSEY DE, 1979, ARCH SURG-CHICAGO, V114, P1022
   RAMSEY PG, 1980, MEDICINE, V59, P206
   RAO KV, 1981, ARTHRITIS RHEUM, V24, P99
   REEVE CE, 1969, AM J MED, V47, P410, DOI 10.1016/0002-9343(69)90225-3
   RHOADES E. R., 1962, Antimicrobial Agents and Chemotherapy, P352
   RIFKIND D, 1967, AM J MED, V43, P28, DOI 10.1016/0002-9343(67)90146-5
   RIFKIND D, 1964, JAMA-J AM MED ASSOC, V189, P397
   RIPPON JW, 1982, MED MYCOL, P51
   RODRIGUEZ JL, 1986, CHEST, V90, P912, DOI 10.1378/chest.90.6.912
   ROSETT W, 1978, AM J MED SCI, V276, P279, DOI 10.1097/00000441-197811000-00004
   RUBIN RH, 1981, AM J MED, V70, P405, DOI 10.1016/0002-9343(81)90780-4
   RUEBUSH TK, 1975, AM J CLIN PATHOL, V64, P537
   RUNYON EH, 1951, J LAB CLIN MED, V37, P713
   Sack K, 1985, Scand J Urol Nephrol Suppl, V92, P59
   SANTEN RJ, 1967, ARCH INTERN MED, V119, P202, DOI 10.1001/archinte.119.2.202
   SATTERWHITE TK, 1979, JAMA-J AM MED ASSOC, V242, P333, DOI 10.1001/jama.242.4.333
   SCHNEIDAU JD, 1957, AM REV TUBERC PULM, V76, P770
   SCHROTER GPJ, 1976, ARCH SURG-CHICAGO, V111, P1137
   SCULLY RE, 1978, NEW ENGL J MED, V298, P154
   SHAINHOUSE JZ, 1978, J CLIN MICROBIOL, V8, P516
   SHER NA, 1977, ARCH OPHTHALMOL-CHIC, V95, P1415
   SHNEERSON JM, 1980, BRIT J DIS CHEST, V74, P287, DOI 10.1016/0007-0971(80)90058-3
   SIMMONS RL, 1971, CRITICAL SURGICAL IL, P559
   SIMPSON GL, 1981, REV INFECT DIS, V3, P492
   SIMPSON GL, 1982, J INFECT DIS, V146, P211
   SINGH M, 1987, Journal of Clinical Microbiology, V25, P176
   SMEGO RA, 1984, REV INFECT DIS, V6, P164
   SMEGO RA, 1983, ARCH INTERN MED, V143, P711, DOI 10.1001/archinte.143.4.711
   SMITH EJ, 1980, JAMA-J AM MED ASSOC, V244, P360, DOI 10.1001/jama.244.4.360
   STALLWORTH JR, 1985, PEDIATR INFECT DIS J, V4, P411, DOI 10.1097/00006454-198507000-00018
   STARZL TE, 1970, ANN SURG, V172, P437, DOI 10.1097/00000658-197009000-00011
   STEIN L, 1962, J THORAC CARDIOV SUR, V43, P314
   STEVENS DA, 1983, J HYG-CAMBRIDGE, V91, P377
   STEVENS DA, 1981, AM J MED, V71, P928, DOI 10.1016/0002-9343(81)90302-8
   STRAUSS RE, 1951, AM REV TUBERC PULM, V63, P441
   STUART M, 1979, DIS COLON RECTUM, V22, P183, DOI 10.1007/BF02586817
   SUGAR AM, 1983, J HYG-CAMBRIDGE, V91, P421
   SUGAR AM, 1985, J INFECT DIS, V151, P895
   SUSENS GP, 1967, ANN INTERN MED, V67, P1021
   TALEGNANIFAR M, 1964, AM REV RESPIR DIS, V89, P561
   TALWAR P, 1980, EUR J RESPIR DIS, V61, P103
   TAPIA HR, 1973, ARCH INTERN MED, V131, P204, DOI 10.1001/archinte.131.2.204
   TENBERGE RJM, 1982, CLIN IMMUNOL IMMUNOP, V24, P33
   TENBERGE RJM, 1981, CLIN IMMUNOL IMMUNOP, V21, P20, DOI 10.1016/0090-1229(81)90191-4
   TOLKOFFRUBIN NE, 1982, REV INFECT DIS, V4, P614
   TURCOTTE JG, 1972, SURG CLIN N AM, V52, P1501
   TURNER E, 1969, J NEUROSURG, V31, P227, DOI 10.3171/jns.1969.31.2.0227
   TZAMALOUKAS AH, 1982, TRANSPLANTATION, V33, P569, DOI 10.1097/00007890-198205000-00025
   VLACHAKI.ND, 1973, CHEST, V63, P276, DOI 10.1378/chest.63.2.276
   WALLACE RJ, 1977, J INFECT DIS, V135, P568
   WALLACE RJ, 1979, J INFECT DIS, V140, P244
   WALLACE RJ, 1978, ANTIMICROB AGENTS CH, V14, P704
   WALLACE RJ, 1982, REV INFECT DIS, V4, P315
   WEED LA, 1955, NEW ENGL J MED, V253, P775
   WEISS MH, 1969, J NEUROSURG, V30, P83, DOI 10.3171/jns.1969.30.1.0083
   WELSH JD, 1961, ARCH INTERN MED, V108, P141
   WHITMORE DN, 1961, J CLIN PATHOL, V14, P259, DOI 10.1136/jcp.14.3.259
   WILKERSON RD, 1985, CLIN ORTHOPAEDICS, V197, P206
   WILLIAMS WH, 1981, SOUTHERN MED J, V74, P1007
   WOLFSON JS, 1985, MEDICINE, V64, P115
   YANOFF DB, 1983, CLIN ORTHOP RELAT R, V175, P223
   YOGEV R, 1980, J PEDIATR, V96, P771, DOI 10.1016/S0022-3476(80)80766-9
   YOUNG LS, 1971, AM J MED, V50, P356, DOI 10.1016/0002-9343(71)90224-5
NR 257
TC 142
Z9 144
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0025-7974
J9 MEDICINE
JI Medicine (Baltimore)
PD JAN
PY 1989
VL 68
IS 1
BP 38
EP 57
PG 20
WC Medicine, General & Internal
SC General & Internal Medicine
GA R7672
UT WOS:A1989R767200003
PM 2642586
ER

PT J
AU Hannan, EL
   Wu, C
   Smith, CR
   Higgins, RSD
   Carlson, RE
   Culliford, AT
   Gold, JP
   Jones, RH
AF Hannan, Edward L.
   Wu, Chuntao
   Smith, Craig R.
   Higgins, Robert S. D.
   Carlson, Russell E.
   Culliford, Alfred T.
   Gold, Jeffrey P.
   Jones, Robert H.
TI Off-pump versus on-pump coronary artery bypass graft surgery -
   Differences in short-term outcomes and in long-term mortality and need
   for subsequent revascularization
SO CIRCULATION
LA English
DT Article
DE bypass; surgery; survival; mortality; revascularization
ID CARDIOPULMONARY BYPASS; BEATING HEART; MYOCARDIAL REVASCULARIZATION;
   RANDOMIZED-TRIALS; PROPENSITY SCORE; OCTOPUS METHOD; METAANALYSIS;
   MORBIDITY; OPERATION; PATENCY
AB Background-Off-pump coronary artery bypass graft surgery (OPCAB) has been performed for many years, but its use is increasing in frequency, and it remains an open question whether OPCAB is associated with better outcomes than on-pump coronary artery bypass graft (CABG) surgery.
   Methods and Results-New York State patients who underwent either OPCAB with median sternotomy ( 13 889 patients) or on-pump CABG surgery ( 35 941 patients) between 2001 and 2004 were followed up via New York databases. Short- and long-term outcomes were compared after adjustment for patient risk factors and after patients were matched on the basis of significant predictors of type of CABG surgery. OPCAB had a significantly lower inpatient/30-day mortality rate ( adjusted OR 0.81, 95% confidence interval [CI] 0.68 to 0.97), lower rates for 2 perioperative complications ( stroke: adjusted OR 0.70, 95% CI 0.57 to 0.86; respiratory failure: adjusted OR 0.80, 95% CI 0.68 to 0.93), and a higher rate of unplanned operation in the same admission ( adjusted OR 1.47, 95% CI 1.01 to 2.15). In the matched samples, no difference existed in 3-year mortality ( hazard ratio 1.08, 95% CI 0.96 to 1.22), but OPCAB patients had higher rates of subsequent revascularization ( hazard ratio 1.55, 95% CI 1.33 to 1.80). The 3-year OPCAB and on-pump survival rates for matched patients were 89.4% and 90.1%, respectively (P=0.20). For freedom from subsequent revascularization, the respective rates were 89.9% and 93.6% (P < 0.0001).
   Conclusions-OPCAB is associated with lower in-hospital mortality and complication rates than on-pump CABG, but long-term outcomes are comparable, except for freedom from revascularization, which favors on-pump CABG.
C1 SUNY Albany, Dept Hlth Policy Management & Behav, Rensselaer, NY 12144 USA.
   Columbia Presbyterian Med Ctr, New York, NY 10032 USA.
   Rush Univ, Med Ctr, Chicago, IL 60612 USA.
   Mercy Hosp, Buffalo, NY USA.
   NYU, Med Ctr, New York, NY 10016 USA.
   Med Univ Ohio, Toledo, OH USA.
   Duke Univ, Med Ctr, Durham, NC USA.
RP Hannan, EL (reprint author), SUNY Albany, Dept Hlth Policy Management & Behav, 1 Univ Pl, Rensselaer, NY 12144 USA.
EM elh03@health.state.ny.us
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Ascione R, 2000, CIRCULATION, V102, P1530
   Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X
   BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312
   BINDER DA, 1992, BIOMETRIKA, V79, P139, DOI 10.1093/biomet/79.1.139
   Borst C, 1997, ANN THORAC SURG, V63, pS1, DOI 10.1016/S0003-4975(97)00437-2
   Borst C, 1996, J AM COLL CARDIOL, V27, P1356, DOI 10.1016/0735-1097(96)00039-3
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   Calafiore AM, 2001, ANN THORAC SURG, V72, P456, DOI 10.1016/S0003-4975(01)02810-7
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Hannan EL, 2006, J AM COLL CARDIOL, V47, P661, DOI 10.1016/j.jacc.2005.10.057
   Hart JC, 2000, ANN THORAC SURG, V70, P1017, DOI 10.1016/S0003-4975(00)01799-9
   Hernandez F, 2001, ANN THORAC SURG, V72, P1528, DOI 10.1016/S0003-4975(01)03202-7
   Jansen EWL, 1997, EUR J CARDIO-THORAC, V12, P406, DOI 10.1016/S1010-7940(97)00200-5
   Jansen EWL, 1998, J THORAC CARDIOV SUR, V116, P60, DOI 10.1016/S0022-5223(98)70243-0
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kilger E, 2000, ANN THORAC SURG, V70, P2023, DOI 10.1016/S0003-4975(00)01848-8
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085
   MACK MJ, 1997, INT J CARDIOL S1, V62, P73
   MOSHKOVITZ Y, 1995, J THORAC CARDIOV SUR, V110, P979, DOI 10.1016/S0022-5223(05)80165-5
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Panesar SS, 2006, HEART, V92, P1808, DOI 10.1136/hrt.2006.088450
   Parolari A, 2005, ANN THORAC SURG, V80, P2121, DOI 10.1016/j.athoracsur.2005.05.007
   Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P1897, DOI 10.1001/jama.291.15.1897
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Racz MJ, 2004, J AM COLL CARDIOL, V43, P557, DOI 10.1016/j.jacc.2003.09.045
   REID N, 1985, BIOMETRIKA, V72, P1
   ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41
   ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398
   Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Subramanian VA, 1997, ANN THORAC SURG, V3, P68
   van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
   Williams ML, 2005, CIRCULATION S1, V112
   ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734
NR 44
TC 138
Z9 148
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP 4
PY 2007
VL 116
IS 10
BP 1145
EP 1152
DI 10.1161/CIRCULATIONAHA.106.675595
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 207FZ
UT WOS:000249238300007
PM 17709642
ER

PT J
AU Crook, J
   Malone, S
   Perry, G
   Bahadur, Y
   Robertson, S
   Abdolell, M
AF Crook, J
   Malone, S
   Perry, G
   Bahadur, Y
   Robertson, S
   Abdolell, M
TI Postradiotherapy prostate biopsies: What do they really mean? Results
   for 498 patients
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; radiotherapy; postradiation biopsies; outcome
   prediction
ID EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; DOSE-ESCALATION; ANTIGEN
   NADIR; NEEDLE-BIOPSY; CANCER; CARCINOMA; ADENOCARCINOMA; ULTRASOUND;
   SEXTANT
AB Purpose: Postradiotherapy (RT) prostate biopsies are prone to problems in interpretation. False negatives due to sampling error, false positives due to delayed tumor regression, and indeterminate biopsies showing radiation effect in residual tumor of uncertain viability are common occurrences.
   Methods and Materials: A cohort of 498 men treated with conventional RT from 06/87-10/96 were followed prospectively with systematic transrectal ultrasound (TRUS)-guided post-RT prostate biopsies, starting 12-18 months after RT, If there was residual tumor but further decline in serum prostate-specific antigen (PSA), biopsies were repeated every 6-12 months. Patients with negative biopsies were rebiopsied at 36 months. Residual tumor was evaluated for RT effect and proliferation markers. The 498 men had 978 biopsies. Median time of the first biopsy (n = 498) was 13 months, biopsy #2 (n = 342) 28 months, biopsy #3 (n = 110) 36 months, biopsy #4 (n = 28) 44 months, and biopsy #5 (n = 4) 55 months. Median follow-up is 54 months (range 13-131), One hundred seventy-five patients (34%) had prior hormonal therapy for a median of 5 months (range 1-60).
   Results: Clinical stage distribution was T1b: 46; T1c: 50; T2a: 115; T2b/c: 170; T3: 108; T4: 11; Tx: 1, Distribution by Gleason score was: 28% Gleason score 2-4; 42%: 5-6; 18%: 7; and 12%: 8-10, Seventy-one men have died, 26 of prostate cancer and 45 of other causes. Actuarial failure-free survival by T stage at 5 years is T1b: 78%; T1c: 76%; T2a: 60%; T2b/c: 55%; T3: 30%; and T4: 0%. Actuarial freedom from local failure at 5 years is T1b: 83%; T1c: 88%; T2a: 72%; T2b/c: 66%; T3: 58%; and T4: 0%. The proportion of indeterminate biopsies decreases with time, being 33% for biopsy 1, 24% for biopsy 2, 18% for biopsy 3, and 7% for biopsy 4, Thirty percent of indeterminate biopsies resolved to NED status, regardless of the degree of RT effect, 18% progressed to local failure, and 34% remained as biopsy failures with indeterminate status within the time frame of this report. Positive staining for proliferation markers was associated with both subsequent local failure and also any type of failure. In multivariate analysis, only PSA nadir (p = 0.0002) and biopsy status at 24-36 months (p = 0.0005) were independent predictors of outcome.
   Conclusions: Post-RT prostate biopsies are not a gold standard of treatment efficacy, but are an independent predictor of outcome. Positive immunohistochemical staining for markers of cellular proliferation is associated with subsequent local failure. Indeterminate biopsies, even when showing marked RT effect, cannot be considered negative. (C) 2000 Elsevier Science Inc.
C1 Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada.
   Univ Toronto, Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada.
   Ottawa Reg Canc Ctr, Dept Radiat Oncol, Ottawa, ON K1Y 4K7, Canada.
   King Abdul Aziz Aziz Univ Hosp, Jeddah, Saudi Arabia.
   Ottawa Gen Hosp, Dept Pathol, Ottawa, ON K1H 8L6, Canada.
RP Crook, J (reprint author), Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.
CR Allison PD, 1995, SURVIVAL ANAL USING
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   BABAIAN RJ, 1995, CANCER, V75, P2153, DOI 10.1002/1097-0142(19950415)75:8<2153::AID-CNCR2820750819>3.0.CO;2-G
   Becker R.A., 1988, NEW S LANGUAGE
   BRAWER MK, 1989, CANCER, V63, P454, DOI 10.1002/1097-0142(19890201)63:3<454::AID-CNCR2820630311>3.0.CO;2-E
   COX DR, 1972, J R STAT SOC B, V34, P187
   Cox JD, 1999, J CLIN ONCOL, V17, P1155
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   CROOK J, 1993, INT J RADIAT ONCOL, V27, P31
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I
   CROOK JM, 1995, UROLOGY, V45, P624, DOI 10.1016/S0090-4295(99)80054-5
   Epstein JI, 1997, J UROLOGY, V158, P1886, DOI 10.1016/S0022-5347(01)64159-4
   Fleshner NE, 1997, J UROLOGY, V158, P505, DOI 10.1016/S0022-5347(01)64518-X
   Goldstein NS, 1998, AM J CLIN PATHOL, V110, P765
   Hanks GE, 1996, INT J RADIAT ONCOL, V35, P861, DOI 10.1016/0360-3016(96)00207-6
   HERMANEK P, 1992, ITN UNION CANC TNM C
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KUBAN DA, 1992, INT J RADIAT ONCOL, V24, P409
   Kuban DA, 1998, SEMIN RADIAT ONCOL, V8, P72, DOI 10.1016/S1053-4296(98)80002-7
   Kupelian P, 1997, CANCER J SCI AM, V3, P78
   Laverdiere J, 1997, INT J RADIAT ONCOL, V37, P247, DOI 10.1016/S0360-3016(96)00513-5
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   Ljung G, 1996, PROSTATE, V29, P303
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   MILLER EB, 1993, UROLOGY, V41, P311
   MOSTOFI FK, 1993, CANCER, V71, P906, DOI 10.1002/1097-0142(19930201)71:3+<906::AID-CNCR2820711407>3.0.CO;2-I
   Movsas B, 1999, UROLOGY, V53, P11, DOI 10.1016/S0090-4295(98)00500-7
   Naughton CK, 1998, UROLOGY, V52, P808, DOI 10.1016/S0090-4295(98)00344-6
   Norberg M, 1997, UROLOGY, V50, P562, DOI 10.1016/S0090-4295(97)00306-3
   PILEPICH MV, 1998, INT J RADIAT ONCOL, V4215, pA105
   PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3
   Pollack A, 1997, INT J RADIAT ONCOL, V39, P1011, DOI 10.1016/S0360-3016(97)00508-7
   Rabbani F, 1998, J UROLOGY, V159, P1247, DOI 10.1016/S0022-5347(01)63574-2
   Scardino PT, 1988, NATL CANCER I MONOGR, V7, P95
   Scardino P T, 1983, Semin Urol, V1, P243
   SCHELLHAMMER PF, 1987, J UROLOGY, V137, P897
   Svetec D, 1998, J UROLOGY, V159, P1606, DOI 10.1097/00005392-199805000-00052
   WIATROWSKI BA, 1997, J UROL PATHOL, V6, P131
   ZEITMAN AL, 1996, RADIOTHER ONCOL, V40, P159
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
NR 41
TC 138
Z9 139
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD SEP 1
PY 2000
VL 48
IS 2
BP 355
EP 367
DI 10.1016/S0360-3016(00)00637-4
PG 13
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 349WT
UT WOS:000089069100008
PM 10974448
ER

PT J
AU Knauth, AL
   Gauvreau, K
   Powell, AJ
   Landzberg, MJ
   Walsh, EP
   Lock, JE
   del Nido, PJ
   Geva, T
AF Knauth, A. L.
   Gauvreau, K.
   Powell, A. J.
   Landzberg, M. J.
   Walsh, E. P.
   Lock, J. E.
   del Nido, P. J.
   Geva, T.
TI Ventricular size and function assessed by cardiac MRI predict major
   adverse clinical outcomes late after tetralogy of Fallot repair
SO HEART
LA English
DT Article
ID PULMONARY VALVE-REPLACEMENT; OUTFLOW TRACT OBSTRUCTION; LONG-TERM;
   AORTIC REGURGITATION; ADULTS LATE; SURGICAL REPAIR; GRADIENT-ECHO;
   FOLLOW-UP; DYSFUNCTION; CHILDREN
AB Background: Factors associated with impaired clinical status in a cross-sectional study of patients with repaired tetralogy of Fallot (TOF) have been reported previously.
   Objectives: To determine independent predictors of major adverse clinical outcomes late after TOF repair in the same cohort during follow-up evaluated by cardiac magnetic resonance (CMR).
   Methods: Clinical status at latest follow- up was ascertained in 88 patients (median time from TOF repair to baseline evaluation 20.7 years; median follow- up from baseline evaluation to most recent follow-up 4.2 years). Major adverse outcomes included (a) death; (b) sustained ventricular tachycardia; and (c) increase in NYHA class to grade III or IV.
   Results: 22 major adverse outcomes occurred in 18 patients (20.5%): death in 4, sustained ventricular tachycardia in 8, and increase in NYHA class in 10. Multivariate analysis identified right ventricular (RV) end-diastolic volume Z >= 7 (odds ratio (OR)= 4.55, 95% confidence interval (CI) 1.10 to 18.8, p= 0.037) and left ventricular (LV) ejection fraction < 55% (OR= 8.05, 95% CI 2.14 to 30.2, p= 0.002) as independent predictors of outcome with an area under the receiver operator characteristic curve of 0.850. LV ejection fraction could be replaced by RV ejection fraction < 45% in the multivariate model. QRS duration >= 180 ms also predicted major adverse events but correlated with RV size.
   Conclusions: In this cohort, severe RV dilatation and either LV or RV dysfunction assessed by CMR predicted major adverse clinical events. This information may guide risk stratification and therapeutic interventions.
C1 [Knauth, A. L.; Gauvreau, K.; Powell, A. J.; Landzberg, M. J.; Walsh, E. P.; Lock, J. E.; Geva, T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.
   [Knauth, A. L.; Gauvreau, K.; Powell, A. J.; Landzberg, M. J.; Walsh, E. P.; Lock, J. E.; Geva, T.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.
   [Knauth, A. L.] Harvard Univ, Sch Med, Childrens Hosp, Dept Pediat,Boston Adult Congenital Heart Dis Ser, Boston, MA 02115 USA.
   [Knauth, A. L.] Harvard Univ, Sch Med, Childrens Hosp, Dept Med,Boston Adult Congenital Heart Dis Ser, Boston, MA 02115 USA.
   [del Nido, P. J.] Harvard Univ, Childrens Hosp, Dept Cardiovasc Surg, Boston, MA 02115 USA.
RP Geva, T (reprint author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.
EM geva@cardio.chboston.org
CR Alfakih K, 2003, J MAGN RESON IMAGING, V17, P323, DOI 10.1002/jmri.10262
   Alfakih K, 2002, J MAGN RESON IMAGING, V16, P253, DOI 10.1002/jmri.10164
   BOVE EL, 1985, J THORAC CARDIOV SUR, V90, P50
   Chaliki HP, 2002, CIRCULATION, V106, P2687, DOI 10.1161/01.CIR.0000038498.59829.38
   Cheung Michael M H, 2005, Semin Thorac Cardiovasc Surg, V17, P155, DOI 10.1053/j.semtcvs.2005.02.006
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   DERUIJTER FT, 2002, ANN THORAC SURG, V73, P1800
   de Ruijter FTH, 2002, ANN THORAC SURG, V73, P1794, DOI 10.1016/S0003-4975(02)03586-5
   d'Udekem Y, 2001, J AM COLL CARDIOL, V37, P2008, DOI 10.1016/S0735-1097(01)01256-6
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   Gatzoulis MA, 2000, AM J CARDIOL, V86, P1352, DOI 10.1016/S0002-9149(00)01241-8
   Geva Tal, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P11
   Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045
   Ghai A, 2002, J AM COLL CARDIOL, V40, P1675, DOI 10.1016/S0735-1097(02)02344-6
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Mavroudis C, 2002, ANN THORAC SURG, V73, P1806
   Khairy P, 2004, CIRCULATION, V109, P1994, DOI 10.1161/01.CIR.0000126495.11040.BD
   Klodas E, 1996, J AM COLL CARDIOL, V27, P670, DOI 10.1016/0735-1097(95)00525-0
   KONDO C, 1995, CIRCULATION, V92, P250
   Lorenz CH, 2000, PEDIATR CARDIOL, V21, P37, DOI 10.1007/s002469910006
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5
   Power MK, 2000, AM NETW, V104, P10
   REBERGEN SA, 1993, CIRCULATION, V88, P2257
   Therrien Judith, 2002, Cardiology Clinics, V20, P395, DOI 10.1016/S0733-8651(02)00010-3
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Tornos MP, 1998, AM HEART J, V136, P681, DOI 10.1016/S0002-8703(98)70016-X
   Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8
   Warner KG, 2003, ANN THORAC SURG, V76, P1066, DOI 10.1016/S0003-4975(03)00748-3
   Warner KG, 2003, ANN THORAC SURG, V76, P1071
NR 31
TC 133
Z9 134
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
J9 HEART
JI Heart
PD FEB
PY 2008
VL 94
IS 2
BP 211
EP 216
DI 10.1136/hrt.2006.104745
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 256QX
UT WOS:000252745800020
PM 17135219
ER

PT J
AU Witte, MH
   Bernas, MJ
   Martin, CP
   Witte, CL
AF Witte, MH
   Bernas, MJ
   Martin, CP
   Witte, CL
TI Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical
   lymphology
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Review
DE lymphangiogenesis; vasculogenesis; angiogenesis; angiodysplasia;
   lymphedema; molecular lymphology; lymphatic; endothelium
ID ENDOTHELIAL GROWTH-FACTOR; WHOLE-BODY LYMPHANGIOSCINTIGRAPHY; RECEPTOR
   TYROSINE KINASES; VIII-ASSOCIATED ANTIGEN; KAPOSI-SARCOMA CELLS;
   LYMPHATIC-ENDOTHELIUM; VEGF-C; THORACIC-DUCT; HEREDITARY LYMPHEDEMA;
   PERIPHERAL LYMPHEDEMA
AB The lymph vascular system parallels the blood vasculature and as one of its key functions returns liquid and solutes to the bloodstream, including macromolecules that have escaped from blood capillaries and entered the interstitium. In conjunction with interspersed lymph nodes and lymphoid organs, the lymphatic vasculature also acts as a conduit for trafficking immune cell populations. Echoing the explosion of knowledge about blood vessel angiogenesis (properly termed "hemangiogenesis"), the past two decades have also witnessed a series of significant, yet less-noticed discoveries bearing on "lymphangiogenesis," along with delineation of the spectrum of lymphedema-angiodysplasia syndromes. Failure of lymph transport promotes a brawny proteinaceous edema of the affected limb, organ, or serous space that is disfiguring, disabling, and on occasion even life-threatening. Key members of the vascular endothelial growth factor (VEGF) and angiopoietin families of vascular growth factors (and their corresponding tyrosine kinase endothelial receptors) have been identified which preferentially influence lymphatic growth and, when manipulated in genetically engineered murine models, produce aberrant "lymphatic phenotypes." Moreover, mutations in VEGF receptor and forkhead family developmental genes have now been linked and implicated in the pathogenesis of two familial lymphedema-angiodysplasia syndromes. Thus, recent advances in "molecular lymphology" are elucidating the poorly understood development, physiology, and pathophysiology of the neglected lymphatic vasculature. In combination with fresh insights and refined tools in "clinical lymphology," these advances should lead not only to earlier detection and more rational classification of lymphatic disease but also to better therapeutic approaches, including designer drugs for lymphangiostimulation and lymphangioinhibition and gene therapy to modulate lymphatic growth. (C) 2001 Wiley-Liss, Inc.
C1 Univ Arizona, Coll Med, Dept Surg, Tucson, AZ 85724 USA.
RP Witte, MH (reprint author), Univ Arizona, Coll Med, Dept Surg, 1501 N Campbell Ave,POB 254063, Tucson, AZ 85724 USA.
EM lymph@u.arizona.edu
CR AMARAL F, 1994, AM J TROP MED HYG, V50, P753
   ANDRES RL, 1990, AM J OBSTET GYNECOL, V162, P1331
   ARISTIZABAL SA, 1977, LYMPHOLOGY, V10, P219
   Asellius G., 1627, LACTIBUS SIVE LACTEI
   Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   BAUMEISTER RGH, 1998, LYMPHOLOGY S, V31, P551
   BECKSTEAD JH, 1985, AM J PATHOL, V119, P294
   BELLMAN S, 1958, ACTA CHIR SCAND, V116, P99
   BEVACQUA SJ, 1990, LYMPHOLOGY, V23, P4
   BOLLINGER A, 1981, CIRCULATION, V64, P1195
   BOLLINGER A, 1983, LYMPHOLOGY, V16, P27
   Boris M, 1994, Oncology (Williston Park), V8, P95
   BORRON P, 1994, LYMPHOLOGY, V27, P6
   BOWMAN CA, 1984, LYMPHOLOGY, V17, P15
   Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6
   Brorson H, 1997, SCAND J PLAST RECONS, V31, P137
   Bull LN, 2000, AM J HUM GENET, V67, P994, DOI 10.1086/303080
   BURROWS FJ, 1994, PHARMACOL THERAPEUT, V64, P155, DOI 10.1016/0163-7258(94)90037-X
   Campisi C, 1999, INT ANGIOL, V18, P47
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   CASE TC, 1992, INVEST RADIOL, V27, P293, DOI 10.1097/00004424-199204000-00006
   CASE TC, 1992, ANN TROP MED PARASIT, V86, P435
   CASLEYS.J, 1961, Q J EXP PHYSIOL CMS, V46, P101
   CASLEYSMITH JR, 1983, LYMPHANGIOLOGY, P276
   CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604
   Clark ER, 1932, AM J ANAT, V51, P49, DOI 10.1002/aja.1000510104
   CLODIUS L, 1977, FOLIA ANGIOL, V25, P137
   Consensus document of the International Society of Lymphology Executive Committee, 1995, LYMPHOLOGY, V28, P113
   CRANDALL RB, 1987, AM J TROP MED HYG, V37, P138
   Davis S, 1999, CURR TOP MICROBIOL, V237, P173
   DENEKAMP J, 1993, BRIT J RADIOL, V66, P181
   DICTOR M, 1991, VIRCHOWS ARCH A, V419, P35, DOI 10.1007/BF01600150
   Dictor M, 1996, AM J PATHOL, V148, P2009
   DICTOR M, 1988, LYMPHOLOGY, V21, P53
   DJONEIDI M, 1991, MICROCIRC ENDOTH LYM, V7, P161
   DORFMAN RF, 1988, LYMPHOLOGY, V21, P45
   Drinker CK, 1934, AM J PHYSIOL, V108, P509
   ERICKSON RP, 1995, CYTOGENET CELL GENET, V71, P163, DOI 10.1159/000134099
   Evans AL, 1999, AM J HUM GENET, V64, P547, DOI 10.1086/302248
   FALLS H F, 1964, Trans Am Ophthalmol Soc, V62, P248
   Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073
   FOLDI M, 1983, LYMPHANGIOLOGY, P195
   FOLDI M, 1983, LYMPHANGIOLOGY, P668
   Folkman J, 1995, NEW ENGL J MED, V333, P1757
   Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055
   GNEPP DR, 1985, IN VITRO CELL DEV B, V21, P200
   Goetsch E, 1938, ARCH SURG-CHICAGO, V36, P394
   GOLDSTEIN S, 1985, AM J MED GENET, V20, P283, DOI 10.1002/ajmg.1320200212
   GORHAM LW, 1955, J BONE JOINT SURG AM, V37, P985
   GREENLEE R, 1993, LYMPHOLOGY, V26, P156
   Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48
   HENDRIX MJC, 1994, LYMPHOLOGY, V27, P138
   Holberg CJ, 2001, AM J MED GENET, V98, P303, DOI 10.1002/1096-8628(20010201)98:4<303::AID-AJMG1113>3.0.CO;2-9
   Huntington GS, 1914, AM J ANAT, V16, P259, DOI 10.1002/aja.1000160302
   Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019
   JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9
   JAIN RK, 1989, J NATL CANCER I, V81, P570, DOI 10.1093/jnci/81.8.570
   JARPLID B, 1961, J Comp Pathol, V71, P370
   Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423
   JOHNSTON MG, 1984, IN VITRO CELL DEV B, V20, P566
   Joukov V, 1996, EMBO J, V15, P290
   Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599
   JUNGHANS BM, 1989, CURR EYE RES, V8, P91, DOI 10.3109/02713688909013898
   Jussila L, 1998, CANCER RES, V58, P1599
   KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566
   KAMPMEIER OF, 1969, EVOLUTION COMPARATIV
   KANTER MA, 1990, PLAST RECONSTR SURG, V85, P573, DOI 10.1097/00006534-199004000-00012
   Karkkainen MJ, 2000, NAT GENET, V25, P153
   KATO S, 1998, LYMPHOLOGY, V31, P69
   KINMOTH JB, 1972, LYMPHATICS DIS LYMPH
   Ko DSC, 1998, ARCH SURG-CHICAGO, V133, P452, DOI 10.1001/archsurg.133.4.452
   KUDO T, 1998, LYMPHOLOGY, V31, P75
   Kukk E, 1996, DEVELOPMENT, V122, P3829
   LEAK L V, 1970, Microvascular Research, V2, P361, DOI 10.1016/0026-2862(70)90031-2
   LEAK L V, 1991, Journal of Cell Biology, V115, p365A
   Leak LV, 1999, MICROCIRCULATION, V6, P63, DOI 10.1038/sj.mn.7300049
   LEAK LV, 1993, ANAT REC, V236, P641, DOI 10.1002/ar.1092360408
   LEAK LV, 1994, IN VITRO CELL DEV-AN, V30A, P512
   LEAK LV, 1985, AM J ANAT, V173, P171, DOI 10.1002/aja.1001730303
   Lee-Donaldson L, 1999, LYMPHOLOGY, V32, P111
   Leu Hans Jorg, 1995, P489
   Lymboussaki A, 1998, AM J PATHOL, V153, P395, DOI 10.1016/S0002-9440(10)65583-6
   MAGARI S, 1978, LYMPHOLOGY, V11, P57
   MAGARI S, 1987, LYMPHOLOGY, V20, P189
   Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651
   Mangion J, 1999, AM J HUM GENET, V65, P427, DOI 10.1086/302500
   Martin C, 2000, FASEB J, V14, pA787
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   Meade-Tollin L., 1995, Journal of Investigative Medicine, V43, p311A
   Meade-Tollin LC, 1999, ACTA HISTOCHEM, V101, P305
   MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801
   Mulliken JB, 1988, VASCULAR BIRTHMARKS
   MYLOYDE T, 2000, CONQUERING LYMPHATIC, P181
   NAGLE R, 1985, LYMPHOLOGY, V18, P84
   NAGLE RB, 1987, LYMPHOLOGY, V20, P20
   NEEL JV, 1954, HUM HERED, P50
   NICOSIA RF, 1987, IN VITRO CELL DEV B, V23, P167
   ODEN BO, 1960, ACTA CHIR SCAND, V120, P100
   Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639
   OLSZEWSK.W, 1973, LYMPHOLOGY, V6, P35
   Olszewski WL, 1991, LYMPH STASIS PATHOPH
   PAPENDIECK CM, 1992, ATLAS COLOR TEMAS AN
   Papendieck CM, 1996, LYMPHOLOGY, V29, P27
   Papoutsi M, 2000, HISTOCHEM CELL BIOL, V114, P373
   PATTERSON D. F., 1967, J MED GENET, V4, P145, DOI 10.1136/jmg.4.3.145
   Pepper MS, 2000, LYMPHOLOGY, V33, P144
   PEPPER MS, 1994, EXP CELL RES, V210, P298, DOI 10.1006/excr.1994.1042
   Pittler MH, 1998, ARCH DERMATOL, V134, P1356, DOI 10.1001/archderm.134.11.1356
   PULLINGER DB, 1937, J PATHOL BACTERIOL, V45, P157
   Reichert FL, 1926, ARCH SURG-CHICAGO, V13, P871
   Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413
   ROBINOW M, 1970, AM J DIS CHILD, V119, P343
   RYAN TJ, 1989, J AM ACAD DERMATOL, V21, P115, DOI 10.1016/S0190-9622(89)70156-0
   Ryan TJ, 1995, CLIN DERMATOL, V13, P451, DOI 10.1016/0738-081X(95)00091-S
   Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310
   Sauter B, 1998, J HISTOCHEM CYTOCHEM, V46, P165
   SCHMELZ M, 1994, DIFFERENTIATION, V57, P97, DOI 10.1046/j.1432-0436.1994.5720097.x
   SCHORNACK P, 2001, IN PRESS P INTL SOC, P9
   SCHWARTZ JF, 1980, ANN NEUROL, V7, P340, DOI 10.1002/ana.410070410
   SHOLLEY MM, 1984, LAB INVEST, V51, P624
   SINZINGER H, 1986, LYMPHOLOGY, V19, P153
   SINZINGER H, 1984, LYMPHOLOGY, V17, P39
   SINZINGER H, 1984, LYMPHOLOGY, V17, P43
   SJOBERG T, 1991, LYMPHOLOGY, V24, P113
   Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643
   Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635
   SURESH S, 1997, J ULTRAS MED, V86, P435
   TANOURA T, 1992, AM J ROENTGENOL, V159, P875
   TAYLOR JR, 1990, NEW ENGL J MED, V323, P1254, DOI 10.1056/NEJM199011013231807
   THOMA R, 1896, TXB GEN PATHOLOGY, V1
   TREVELLA W, 1990, PROGR LYMPHOLOGY, P12
   TURNER RR, 1987, AM J CLIN PATHOL, V87, P569
   Unger EC, 1997, INVEST RADIOL, V32, P723, DOI 10.1097/00004424-199712000-00001
   UNGER EC, 1992, RADIOLOGY, V185, P453
   Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016/S0002-9440(10)65392-8
   VANDERPUTTE SCJ, 1975, DEV LYMPHATIC SYSTEM
   WAY D, 1988, IN VITRO, V23, P647
   WAY DL, 1993, LYMPHOLOGY, V26, P79
   WEBER E, 1994, J HISTOCHEM CYTOCHEM, V42, P1109
   Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1
   Williams WH, 2000, CLIN NUCL MED, V25, P451, DOI 10.1097/00003072-200006000-00013
   Wilting J, 2000, DEV DYNAM, V217, P271, DOI 10.1002/(SICI)1097-0177(200003)217:3<271::AID-DVDY5>3.0.CO;2-2
   Wilting J, 2000, LYMPHOLOGY, V33, P81
   WITTE CL, 1980, SURG GYNECOL OBSTET, V150, P75
   WITTE CL, 1980, GASTROENTEROLOGY, V78, P1059
   WITTE CL, 1991, LYMPH STATIS PATHOPH, P327
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   WITTE CL, IN PRESS VASCULAR SU
   WITTE CL, 1984, EDEMA, P521
   WITTE CL, 1999, VASCULAR SURG, P2110
   WITTE M, 1988, LYMPHOLOGY, V21, P251
   Witte MH, 1995, CLIN DERMATOL, V13, P511, DOI 10.1016/0738-081X(95)00093-U
   Witte MH, 1998, LYMPHOLOGY, V31, P145
   WITTE MH, 1990, WESTERN J MED, V153, P17
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   WITTE MH, 2001, P NIH THINK TANK C M
   Witte MH, 1997, PHLEBOLYMPHOLOGY, V16, P19
   Witte MH, 1998, LYMPHOLOGY, V31, P138
   Witte MH, 1998, LYMPHOLOGY, V31, P37
   Witte MH, 1997, LYMPHOLOGY, V30, P1
   WITTE MH, 1990, LYMPHOLOGY, V23, P73
   WITTE MH, 1986, LYMPHOLOGY, V19, P21
   WITTE MH, 1969, CIRCULATION, V39, P723
   WITTE MH, 1989, INT J DERMATOL, V28, P561, DOI 10.1111/j.1365-4362.1989.tb02529.x
   WITTE MH, 1987, LYMPHOLOGY, V20, P167
   Witte MH, 1997, REGULATION ANGIOGENE, P65
   Witzenbichler B, 1998, AM J PATHOL, V153, P381, DOI 10.1016/S0002-9440(10)65582-4
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yoffey JM, 1970, LYMPHATICS LYMPH LYM
   YONG LCJ, 1991, EXP PATHOL-JENA, V42, P11
   ZETTER BR, 1988, ENDOTHELIAL CELLS, V2, P63
   ZICHE M, 1992, LAB INVEST, V67, P711
NR 175
TC 133
Z9 139
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD OCT 15
PY 2001
VL 55
IS 2
BP 122
EP 145
DI 10.1002/jemt.1163
PG 24
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 484TH
UT WOS:000171705300008
PM 11596157
ER

PT J
AU Vesely, I
AF Vesely, I
TI Heart valve tissue engineering
SO CIRCULATION RESEARCH
LA English
DT Review
DE cardiac valves; tissue engineering; review; acellular matrix; scaffold
ID PORCINE AORTIC-VALVE; VENTRICULAR OUTFLOW TRACT; PROSPECTIVE
   RANDOMIZED-TRIAL; VALVULAR INTERSTITIAL-CELLS; LINEAR VISCOELASTIC
   THEORY; SMALL-INTESTINE SUBMUCOSA; INTERNAL SHEAR PROPERTIES; LINKED
   HYALURONAN GELS; HUMAN-SKIN FIBROBLASTS; IN-VIVO REPOPULATION
AB Tissue-engineered heart valves have been proposed by physicians and scientists alike to be the ultimate solution for treating valvular heart disease. Rather than replacing a diseased or defective native valve with a mechanical or animal tissue-derived artificial valve, a tissue-engineered valve would be a living organ, able to respond to growth and physiological forces in the same way that the native aortic valve does. Two main approaches have been attempted over the past 10 to 15 years: regeneration and repopulation. Regeneration involves the implantation of a resorbable matrix that is expected to remodel in vivo and yield a functional valve composed of the cells and connective tissue proteins of the patient. Repopulation involves implanting a whole porcine aortic valve that has been previously cleaned of all pig cells, leaving an intact, mechanically sound connective tissue matrix. The cells of the patients are expected to repopulate and revitalize the acellular matrix, creating living tissue that already has the complex microstructure necessary for proper function and durability. Regrettably, neither of the 2 approaches has fared well in animal experiments, and the only clinical experience with tissue-engineered valves resulted in a number of early failures and patient death. This article reviews the technological details of the 2 main approaches, their rationale, their strengths and weaknesses, and the likely mechanisms for their failure. Alternative approaches to valvular tissue engineering, as well as the role of industry in shaping this field in the future, are also reviewed.
C1 Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Saban Res Inst, Los Angeles, CA 90027 USA.
RP Vesely, I (reprint author), Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Saban Res Inst, 4650 Sunset Blvd MS 137, Los Angeles, CA 90027 USA.
EM ivesely@chla.usc.edu
CR Adamczyk MM, 2002, J HEART VALVE DIS, V11, P75
   Alferiev I, 2003, J BIOMED MATER RES A, V66A, P385, DOI 10.1002/jbm.a.10896
   Al-Halees Z, 1998, ANN THORAC SURG, V65, P601
   *AM HEART ASS, 2003, M REP TISS ENG VALV
   Atala A, 2004, AM J TRANSPLANT, V4, P58, DOI 10.1111/j.1600-6135.2004.0346.x
   BALASZ EA, 1984, CROSSLINKED GELS HYA
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Barron V, 2003, ANN BIOMED ENG, V31, P1017, DOI 10.1114/1.1603260
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BERTHIAUME F, 1995, BIOMEDICAL ENG HDB, P1556
   Bertipaglia B, 2003, ANN THORAC SURG, V75, P1274, DOI 10.1016/S0003-4975(02)04706-9
   Biglioli P, 1994, Cardiovasc Surg, V2, P216
   Biglioli P, 2004, J HEART VALVE DIS, V13, pS49
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   BRENDEL K, 1989, BODY IMPLANTS EXTRAC
   Breuer C, 2004, SEMIN PERINATOL, V28, P164, DOI 10.1053/j.semperi.2004.03.003
   Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725
   Carew EO, 1999, J BIOMECH ENG-T ASME, V121, P386, DOI 10.1115/1.2798335
   Carew EO, 2000, ANN BIOMED ENG, V28, P1093, DOI 10.1114/1.1310221
   CARPENTIER A, 1977, J ASSOC ADV MED INST, V11, P98
   CHRISTIE GW, 1992, EUR J CARDIO-THORAC, V6, pS101
   CHRISTIE GW, 1992, EUR J CARDIO-THORAC, V6, pS95, DOI 10.1016/1010-7940(92)90031-R
   Cimini M, 2003, HISTOCHEM CELL BIOL, V120, P307, DOI 10.1007/s00418-003-0570-z
   Clarke D, 2003, ANN THORAC SURG, V75, P1463
   COURTMAN DW, 1995, J BIOMED MATER RES, V29, P1507, DOI 10.1002/jbm.820291207
   Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8
   Cuy JL, 2003, J BIOMED MATER RES A, V67A, P538, DOI 10.1002/jbm.a.10095
   Della Rocca F, 2000, ANN THORAC SURG, V70, P1594, DOI 10.1016/S0003-4975(00)01979-2
   DENLINGER JL, 1980, EXP EYE RES, V31, P101, DOI 10.1016/0014-4835(80)90093-7
   Doehring TC, 2005, J HEART VALVE DIS, V14, P679
   Dohmen PM, 2005, HEART SURG FORUM, V8, pE100, DOI 10.1532/HSF98.20041140
   Eaglstein WH, 1997, CLIN THER, V19, P894, DOI 10.1016/S0149-2918(97)80043-4
   Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9
   *EDW LIF, 2005, EDW LIF DEL PERC AOR
   EISENBERG LM, 1995, CIRC RES, V77, P1
   Elkins RC, 2002, ANN THORAC SURG, V74, P1434, DOI 10.1016/S0003-4975(02)04351-5
   Elkins Ronald C, 2003, Curr Cardiol Rep, V5, P125, DOI 10.1007/s11886-003-0079-z
   Ellis JT, 1996, J HEART VALVE DIS, V5, P591
   Fath Roland, 2003, Dtsch Med Wochenschr, V128, P912
   Flameng W, 2004, INT J CARDIOL, V95, pS55, DOI 10.1016/j.ijcard.2004.04.000
   Flanagan TC, 2003, EUR CELLS MATER, V6, P45
   Flanagan Thomas C., 2003, European Cells & Materials, V6, P28
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Gloeckner DC, 1999, ASAIO J, V45, P59, DOI 10.1097/00002480-199901000-00014
   Goldstein S, 2000, ANN THORAC SURG, V70, P1962, DOI 10.1016/S0003-4975(00)01812-9
   GONZALEZ.L, 1970, J THORAC CARDIOV SUR, V60, P1
   Grauss RW, 2003, J THORAC CARDIOV SUR, V126, P2003, DOI 10.1016/S0022-5223(03)00956-5
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   GRIMM M, 1991, J THORAC CARDIOV SUR, V102, P195
   GRINNELL F, 1984, J CELL SCI, V66, P51
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Grunkemeier GL, 2004, EUR J CARDIO-THORAC, V25, P371, DOI 10.1016/j.ejcts.2003.12.014
   GUIDRY C, 1985, J CELL SCI, V79, P67
   HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801
   HAVERICH A, 2004, EUR J CARDIO-THORAC, V26, pS60
   Haverich A, 2004, EUR J CARDIO-THORAC, V26, pS59, DOI 10.1016/j.ejctsup.2004.11.016
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   HILBERT S, 2004, CARDIOVASCULAR TISSU, P43
   Hilbert SL, 2004, J HEART VALVE DIS, V13, P831
   Hoerstrup S.P, 2002, CIRCULATION S1, V106, P143
   Hopkins RA, 2005, CIRCULATION, V111, P2712, DOI 10.1161/CIRCULATIONAHA.104.527820
   Jamieson WRE, 1998, EUR J CARDIO-THORAC, V13, P151, DOI 10.1016/S1010-7940(97)00323-0
   Jankowski RJ, 1999, CLIN PLAST SURG, V26, P605
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Julien M, 1997, BIOMATERIALS, V18, P605, DOI 10.1016/S0142-9612(96)00155-X
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Mavroudis C, 2002, ANN THORAC SURG, V73, P1806
   KLEMENT P, 1988, PROCESS PREPARING BI
   Konertz W, 2005, J HEART VALVE DIS, V14, P78
   Korossis SA, 2000, BIO-MED MATER ENG, V10, P83
   Korossis SA, 2002, J HEART VALVE DIS, V11, P463
   Kouchoukos NT, 2004, ANN THORAC SURG, V78, P773, DOI 10.1016/j.athoracsur.2004.02.033
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Larsen NE, 1995, MATER RES SOC SYMP P, V394, P149
   LEE JM, 1984, J BIOMED MATER RES, V18, P61, DOI 10.1002/jbm.820180108
   Leukauf C, 1993, J Heart Valve Dis, V2, P230
   Leyh RG, 2003, ANN THORAC SURG, V75, P1457, DOI 10.1016/S0003-4975(02)04845-2
   Liao J, 2004, ANN BIOMED ENG, V32, P977, DOI 10.1023/B:ABME.0000032460.97278.e9
   Liao J, 2003, J BIOMECH, V36, P1125, DOI 10.1016/S0021-9290(03)00109-X
   Long Li, 2004, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V21, P610
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marchand MA, 2001, ANN THORAC SURG, V71, pS236, DOI 10.1016/S0003-4975(01)02550-4
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   Mayer JE, 1997, CURR OPIN CARDIOL, V12, P528, DOI 10.1097/00001573-199711000-00005
   MCGRATH LB, 1995, ANN THORAC SURG, V60, pS475, DOI 10.1016/0003-4975(95)00444-P
   McIntire L.V, 2002, WTEC PANEL REPORT TI
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Melina G, 2004, J HEART VALVE DIS, V13, P972
   Mitka M, 2000, JAMA-J AM MED ASSOC, V284, P2582, DOI 10.1001/jama.284.20.2582
   Mol A, 2004, J HEART VALVE DIS, V13, P272
   Mol A, 2004, INT J CARDIOL, V95, pS57, DOI 10.1016/j.ijcard.2004.04.000
   Morsi YS, 2004, INT J ARTIF ORGANS, V27, P445
   Neuenschwander S, 2004, TRANSPL IMMUNOL, V12, P359, DOI 10.1016/S0966-3274(03)00116-3
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   OAKES BW, 1982, EUR J CELL BIOL, V27, P34
   O'Brien MF, 1998, J CARDIAC SURG, V13, P376, DOI 10.1111/j.1540-8191.1998.tb01100.x
   Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002
   Papadaki M, 2001, IEEE ENG MED BIOL, V20, P117, DOI 10.1109/51.956007
   Pepper J, 2004, J HEART VALVE DIS, V13, P975
   Perry Tjörvi E, 2003, J Cardiovasc Nurs, V18, P30
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Rabkin-Aikawa E, 2005, ADV BIOCHEM ENG BIOT, V94, P141, DOI 10.1007/b100003
   Rahimtoola SH, 2003, J AM COLL CARDIOL, V41, P893, DOI 10.1016/S0735-1097(02)02965-0
   Ramamurthi A, 2003, J BIOMED MATER RES A, V66A, P317, DOI 10.1002/jbm.a.10588
   Ramamurthi Anand, 2002, J Biomed Mater Res, V60, P195, DOI 10.1002/jbm.10061
   Ramamurthi A, 2005, BIOMATERIALS, V26, P999, DOI 10.1016/j.biomaterials.2004.04.016
   Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Rothenburger M, 2002, ASAIO J, V48, P586, DOI 10.1097/01.MAT.0000033637.90113.1E
   Rothenburger M, 2002, TISSUE ENG, V8, P1049, DOI 10.1089/107632702320934146
   Sacks MS, 1998, BIOMATERIALS, V19, P1027, DOI 10.1016/S0142-9612(98)00002-7
   Sacks MS, 1998, J BIOMED MATER RES, V41, P131, DOI 10.1002/(SICI)1097-4636(199807)41:1<131::AID-JBM16>3.0.CO;2-Q
   Sacks M S, 2001, J Long Term Eff Med Implants, V11, P231
   SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x
   Sarraf CE, 2003, CELL PROLIFERAT, V36, P241, DOI 10.1046/j.1365-2184.2003.00281.x
   Schenke-Layland K, 2004, MATRIX BIOL, V23, P113, DOI 10.1016/j.matbio.2004.03.005
   Schenke-Layland K, 2003, CARDIOVASC RES, V60, P497, DOI 10.1016/j.cardiores.2003.09.002
   Schoen F. J., 1995, J HEART VALVE DIS S1, V4, pS75
   Schoen F J, 1995, J Heart Valve Dis, V4 Suppl 1, pS72
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 1998, J HEART VALVE DIS, V7, P174
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Scott MJ, 1996, J HEART VALVE DIS, V5, P464
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shi YL, 2003, TISSUE ENG, V9, P1233, DOI 10.1089/10763270360728143
   Shi YL, 2004, J BIOMED MATER RES A, V69A, P26, DOI 10.1002/jbm.a.20095
   Shi YL, 2002, BIOMED SCI INSTRUM, V38, P35
   Shinoka T., 1995, ANN THORAC SURG, V60, P513
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1006
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Smith JD, 1998, ANN THORAC SURG, V66, pS212, DOI 10.1016/S0003-4975(98)01115-1
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Spina M, 2003, J BIOMED MATER RES A, V67A, P1338, DOI 10.1002/jbm.a.20025
   Stalenhoef JE, 2003, J HEART VALVE DIS, V12, P635
   Stamm C, 2004, ANN THORAC SURG, V78, P2084, DOI 10.1016/j.athoracsur.2004.03.106
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Stock U A, 2001, J Long Term Eff Med Implants, V11, P249
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Stock UA, 2002, THORAC CARDIOV SURG, V50, P184, DOI 10.1055/s-2002-32406
   Talman EA, 2001, ANN THORAC SURG, V71, pS375, DOI 10.1016/S0003-4975(01)02546-2
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0
   Taylor PM, 2000, J HEART VALVE DIS, V9, P150
   Terada S, 2000, YONSEI MED J, V41, P685
   Tower TT, 2002, ANN BIOMED ENG, V30, P1221, DOI 10.1114/1.1527047
   TRANQUILLO R, 2003, TISSUE EQUIVALENT AP
   TRANQUILLO RT, 1992, CYTOTECHNOLOGY, V10, P225, DOI 10.1007/BF00146673
   VESELY I, 1989, J BIOMECH, V22, P655, DOI 10.1016/0021-9290(89)90016-X
   Vesely I, 2000, J HEART VALVE DIS, V9, P16
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9
   VESELY I, 1995, ANN THORAC SURG, V60, P359
   VESELY I, 1992, CAN J CARDIOL SB, V8, pB65
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   VESELY I, 1995, ANN THORAC SURG, V60, pS379, DOI 10.1016/0003-4975(95)00261-I
   Vesely I, 1998, J BIOMECH, V31, P115
   VESELY I, 1995, ANN THORAC SURG, V60, pS383
   Vesely I, 1998, J HEART VALVE DIS, V7, P34
   Vesely I, 1996, ASAIO J, V42, pM739
   Vrandecic M, 1998, J HEART VALVE DIS, V7, P54
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
   Wu Xiangyang, 2003, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V20, P750
   Wu Zhong, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P132
   Yacoub M, 2000, J HEART VALVE DIS, V9, P774
   Ye Fu-lin, 2003, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V17, P493
   Zimmermann WH, 2003, CARDIOVASC RES, V60, P460, DOI 10.1016/j.cardiores.2003.10.007
NR 174
TC 128
Z9 135
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7330
J9 CIRC RES
JI Circ.Res.
PD OCT 14
PY 2005
VL 97
IS 8
BP 743
EP 755
DI 10.1161/01.RES.0000185326.04010.9f
PG 13
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
SC Cardiovascular System & Cardiology; Hematology
GA 973WT
UT WOS:000232554000004
PM 16224074
ER

PT J
AU Ionin, AA
   Kochetov, IV
   Napartovich, AP
   Yuryshev, NN
AF Ionin, A. A.
   Kochetov, I. V.
   Napartovich, A. P.
   Yuryshev, N. N.
TI Physics and engineering of singlet delta oxygen production in
   low-temperature plasma
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Review
ID BEAM-SUSTAINED DISCHARGE; LOW-ENERGY ELECTRONS; INTRACAVITY LASER
   SPECTROSCOPY; COLLISION-INDUCED EMISSION; CODATA TASK GROUP; IODINE
   LASER; GLOW-DISCHARGE; MOLECULAR-OXYGEN; ATOMIC IODINE; RF DISCHARGE
AB An overview is presented of experimental and theoretical research in the field of physics and engineering of singlet delta oxygen (SDO) production in low-temperature plasma of various electric discharges. Attention is paid mainly to the SDO production with SDO yield adequate for the development of an electric discharge oxygen-iodine laser (DOIL). The review comprises a historical sketch describing the main experimental results on SDO physics in low-temperature plasma obtained since the first detection of SDO in electric discharge in the 1950s and the first attempt to launch a DOIL in the 1970s up to the mid-1980s when several research groups started their activity aimed at DOIL development, stimulated by success in the development of a chemical oxygen-iodine laser (COIL). A detailed analysis of theoretical and experimental research on SDO production in electric discharge from the mid-1980s to the present, when the first DOIL has been launched, is given. Different kinetic models of oxygen low-temperature plasma are compared with the model developed by the authors. The latter comprises electron kinetics based on the accompanying solution of the electron Boltzmann equation, plasma chemistry including reactions of excited molecules and numerous ion-molecular reactions, thermal energy balance and electric circuit equation. The experimental part of the overview is focused on the experimental methods of SDO detection including experiments on the measurements of the Einstein coefficient for SDO transition a (1)Delta(g)-X-3 Sigma(-)(g) and experimental procedures of SDO production in self-sustained and non-self-sustained discharges and analysis of different plasma-chemical processes occurring in oxygen low-temperature plasma which brings limitation to the maximum SDO yield and to the lifetime of the SDO in an electric discharge and its afterglow. Quite recently obtained results on gain and output characteristics of DOIL and some projects aimed at the development of high-power DOIL are discussed.
C1 PN Lebedev Phys Inst, Moscow 119991, Russia.
   Troitsk Inst Innovat & Fus Res, Troitsk 142190, Moscow Region, Russia.
RP Ionin, AA (reprint author), PN Lebedev Phys Inst, Leninsky Prospect 53, Moscow 119991, Russia.
EM aion@sci.lebedev.ru; apn@triniti.ru
CR ABE K, 2006, IN PRESS P SPIE
   ABISHEV AB, 1990, FIZ PLAZMY, V16, P844
   ADAMOVICH I, 2006, 59 ANN GAS EL C COL
   AKISHEV YS, 1994, PLASMA PHYS REP, V20, P511
   Arakoni R, 2005, J APPL PHYS, V98, DOI 10.1063/1.2076428
   ARNOLD SJ, 1964, J CHEM PHYS, V40, P1769, DOI 10.1063/1.1725394
   ARNOLD SJ, 1966, J CHEM PHYS, V44, P2529, DOI 10.1063/1.1727077
   Azyazov VN, 2006, P SOC PHOTO-OPT INS, V6101, pY1011, DOI 10.1117/12.646061
   Azyazov VN, 2007, P SOC PHOTO-OPT INS, V6346, DOI 10.1117/12.737190
   Babaeva NY, 2006, J APPL PHYS, V99, DOI 10.1063/1.2199387
   BADER LW, 1964, DISCUSS FARADAY SOC, P46
   BADGER RM, 1965, J CHEM PHYS, V43, P4345, DOI 10.1063/1.1696694
   Baev VM, 1999, APPL PHYS B-LASERS O, V69, P171, DOI 10.1007/s003400050793
   BALANDIN AA, 1999, FIZ PLAZMY, V25, P969
   Basov N. G., 1990, Proceedings of the SPIE - The International Society for Optical Engineering, V1225
   BASOV NG, 1984, SOV J QUANTUM ELECTR, V11, P1275
   BAULCH DL, 1984, J PHYS CHEM REF DATA, V13, P1259
   BAULCH DL, 1982, J PHYS CHEM REF DATA, V11, P327
   Belostotsky SG, 2005, PLASMA SOURCES SCI T, V14, P532, DOI 10.1088/0963-0252/14/3/016
   Belousov VP, 2003, OPT SPECTROSC+, V95, P830, DOI 10.1134/1.1635461
   BLACK G, 1981, J CHEM PHYS, V74, P6517, DOI 10.1063/1.440994
   BLYABLIN AA, 1989, FIZ PLAZMY, V15, P1012
   BONNET J, 1984, I PHYS C SER, V72, P203
   Braginskii OV, 2005, QUANTUM ELECTRON+, V35, P21, DOI 10.1070/QE2005v035n01ABEH002859
   Braginskiy OV, 2005, J PHYS D APPL PHYS, V38, P3626, DOI 10.1088/0022-3727/38/19/011
   Braginskiy OV, 2005, J PHYS D APPL PHYS, V38, P3609, DOI 10.1088/0022-3727/38/19/010
   Braginsky OV, 2005, P SOC PHOTO-OPT INS, V5777, P238, DOI 10.1117/12.610959
   Brandt O., 1994, Laser und Optoelektronik, V26
   BURCH DE, 1969, APPL OPTICS, V8, P1493, DOI 10.1364/AO.8.001493
   BURROW PD, 1973, J CHEM PHYS, V59, P4922, DOI 10.1063/1.1680707
   CAROLL DL, 2002, 33 AIAA PLASM LAS C
   CAROLL DL, 2001, P SOC PHOTO-OPT INS, V4184, P40
   CAROLL DL, 2003, IEEE J QUANTUM ELECT, V39, P1150
   CAROLL DL, 2005, P SOC PHOTO-OPT INS, V5777, P215
   CAROLL DL, 2003, P SOC PHOTO-OPT INS, V5120, P316
   CAROLL DL, 2003, 34 AIAA PLASM LAS C
   CAROLL DL, 2005, P SPIE, V6053
   CARROL DL, 2002, Patent No. 6501780
   CARROL DL, 2006, IN PRESS P SPIE
   Carroll DL, 2004, APPL PHYS LETT, V85, P1320, DOI 10.1063/1.1784519
   CARROLL DL, 2006, Patent No. 20060078032
   Carroll DL, 2005, IEEE J QUANTUM ELECT, V41, P1309, DOI 10.1109/JQE.2005.854316
   Carroll DL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1883317
   CARROLL DL, 2005, 36 AIAA PLASM LAS C
   Carroll DL, 2005, IEEE J QUANTUM ELECT, V41, P213, DOI 10.1109/JQE.2004.839691
   Carroll DL, 2004, P SOC PHOTO-OPT INS, V5334, P79, DOI 10.1117/12.537749
   CHANIN LM, 1962, PHYS REV, V128, P219, DOI 10.1103/PhysRev.128.219
   Chatterton P.A., 1961, Journal of Electronics and Control, V11
   CLARK ID, 1970, MOL PHYS, V18, P523, DOI 10.1080/00268977000100581
   COXON JA, 1986, APPL SPECTROSC, V52, P203
   David SJ, 2004, P SOC PHOTO-OPT INS, V5448, P859, DOI 10.1117/12.548814
   DAVIS SJ, 2004, P SOC PHOTO-OPT INS, V5777, P32
   DERWENT RG, 1972, FARADAY DISCUSS, V53, P162, DOI 10.1039/dc9725300162
   DERWENT RG, 1971, CHEM PHYS LETT, V9, P591, DOI 10.1016/0009-2614(71)85135-7
   Derwent RG, 1970, CHEM PHYS LETT, V6, P115, DOI 10.1016/0009-2614(70)80146-4
   DERYUGIN AA, UNPUB
   Didyukov A. I., 1982, Soviet Journal of Quantum Electronics, V12, DOI 10.1070/QE1982v012n04ABEH012221
   DOEHRING A, 1952, Z NATURFORSCH A, V7, P253
   Doroshenko V. M., 1992, KHIM VYS ENERG, V26, P291
   DOUGHERTY TJ, 1978, CANCER RES, V38, P2828
   Duschek F, 2005, P SOC PHOTO-OPT INS, V5777, P74, DOI 10.1117/12.610973
   EISENBERG WC, 1986, J PHYS CHEM-US, V90, P1945, DOI 10.1021/j100400a041
   Eliasson B, 1986, KLR8611C
   ELLIAS L, 1959, CAN J CHEM, V37, P1680
   ELSAYEDALI H, 1984, P 9 S GAS FLOW CHEM, P187
   Endo M., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4184, DOI 10.1117/12.414060
   Endo M, 2000, P SOC PHOTO-OPT INS, V3889, P438, DOI 10.1117/12.380914
   FEOKTISTOV VA, 1993, J NUCL MATER, V200, P309, DOI 10.1016/0022-3115(93)90301-E
   FINK EH, 1991, INT J QUANTUM CHEM, V39, P287, DOI 10.1002/qua.560390307
   FONER SN, 1956, J CHEM PHYS, V25, P601, DOI 10.1063/1.1743000
   FOURNIER G, 1981, P 15 INT C PHEN IO 2, P837
   FOURNIER G, 1980, J PHYSIQUE, V41, P449, DOI 10.1051/jphyscol:1980961
   Frimer A. A., 1985, SINGLET O2 PHYS CHEM, VI
   Frolov M, 2004, P SOC PHOTO-OPT INS, V5448, P307, DOI 10.1117/12.547117
   FROLOV M, 2003, 34 AIAA PLASM LAS C
   Frolov MP, 2004, P SOC PHOTO-OPT INS, V5448, P294, DOI 10.1117/12.547382
   Frolov MP, 2005, P SOC PHOTO-OPT INS, V5777, P70, DOI 10.1117/12.610972
   Fujii H, 2000, P SOC PHOTO-OPT INS, V4065, P818, DOI 10.1117/12.407307
   FUJII H, 1994, 25 AIAA PLASM LAS C
   FUJII H, 2003, 34 PLASM LAS C ORL F
   FUJII H, 1989, J APPL PHYS, V66, P1033, DOI 10.1063/1.343489
   FUJII H, 1993, P SOC PHOTO-OPT INS, V1980, P148, DOI 10.1117/12.144515
   Fujii H, 2004, P SOC PHOTO-OPT INS, V5448, P866, DOI 10.1117/12.541475
   Fujii M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.085311
   GALLAGHER JW, 1983, J PHYS CHEM REF DATA, V12, P109
   Gamache RR, 1998, J QUANT SPECTROSC RA, V59, P495, DOI 10.1016/S0022-4073(97)00124-6
   Gamache RR, 2001, J QUANT SPECTROSC RA, V69, P389, DOI 10.1016/S0022-4073(00)00072-8
   GOUSSET G, 1991, J PHYS D APPL PHYS, V24, P290, DOI 10.1088/0022-3727/24/3/010
   GOUSSET G, 1989, PLASMA CHEM PLASMA P, V9, P189, DOI 10.1007/BF01054280
   GOUSSET G, 1987, PLASMA CHEM PLASMA P, V7, P409, DOI 10.1007/BF01030487
   Gupta M, 2004, CHEM PHYS LETT, V400, P42, DOI 10.1016/j.cplett.2004.10.076
   Gylys VT, 1998, APPL OPTICS, V37, P1026, DOI 10.1364/AO.37.001026
   HAAS RA, 1973, PHYS REV A, V8, P1017, DOI 10.1103/PhysRevA.8.1017
   HALL RI, 1975, J PHYS B-AT MOL OPT, V8, pL293, DOI 10.1088/0022-3700/8/12/008
   Hallada M. R., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4184, DOI 10.1117/12.414007
   Hallada M. R., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4184, DOI 10.1117/12.414001
   HAN J, 2004, P SOC PHOTO-OPT INS, V5777, P198
   Han JD, 2004, P SOC PHOTO-OPT INS, V5448, P261, DOI 10.1117/12.548463
   HEIDNER RF, 1981, J CHEM PHYS, V74, P5618, DOI 10.1063/1.440925
   HICKS A, 2006, IN PRESS P SPIE
   HICKS A, 2006, HIGH POW LAS ABL C T
   HICKS A, 2005, 36 AIAA PLASM LAS C
   Hicks A, 2005, J PHYS D APPL PHYS, V38, P3812, DOI 10.1088/0022-3727/38/20/007
   HILL A, 2006, COMMUNICATION
   HILL A, 2004, Patent No. 6826222
   HILL A, 1993, COMMUNICATION
   Hill A. E., 2001, Proceedings of the International Conference on LASERS 2000
   Hill AE, 2002, P SOC PHOTO-OPT INS, V4747, P23, DOI 10.1117/12.460135
   Hill AE, 2004, P SOC PHOTO-OPT INS, V5448, P269, DOI 10.1117/12.548208
   Hill AE, 2004, P SOC PHOTO-OPT INS, V5448, P894, DOI 10.1117/12.548817
   HSU YT, 1992, SPECTROCHIM ACTA A, V48, P1227, DOI 10.1016/0584-8539(92)80258-X
   Huxley L.G.H., 1959, Australian Journal of Physics, V12
   IIONIN AA, 2006, IN PRESS P SPIE
   Ionin A, 2005, P SOC PHOTO-OPT INS, V5777, P207, DOI 10.1117/12.611017
   Ionin AA, 2003, J PHYS D APPL PHYS, V36, P982, DOI 10.1088/0022-3727/36/8/307
   IONIN AA, 2006, P SOC PHOTO-OPT INS, V6101, P516
   IONIN AA, 2005, 36 AIAA PLASM LAS C
   Ionin AA, 2006, LASER PHYS, V16, P155, DOI 10.1134/S1054660X06010154
   IONIN AA, 2002, Patent No. 2206495
   Ionin AA, 2002, P SOC PHOTO-OPT INS, V4760, P506, DOI 10.1117/12.482122
   ISLAMOV RS, 1977, 169 LEB PHYS I, P1
   Itami S, 2000, P SOC PHOTO-OPT INS, V3889, P503, DOI 10.1117/12.380922
   Ivanov VV, 1999, IEEE T PLASMA SCI, V27, P1279, DOI 10.1109/27.799804
   Ivanov V.V., 2000, 200016620 MOSC STAT
   Ivanov VV, 2000, PLASMA PHYS REP+, V26, P980, DOI 10.1134/1.1323563
   Jeon BH, 1998, J PHYS D APPL PHYS, V31, P2145, DOI 10.1088/0022-3727/31/17/011
   Kar A, 1999, J LASER APPL, V11, P119
   KASHA M, 1970, ANN NY ACAD SCI, V171, P5, DOI 10.1111/j.1749-6632.1970.tb39294.x
   KAUFMAN F, 1958, PROC R SOC LON SER-A, V247, P123, DOI 10.1098/rspa.1958.0173
   Kaufman F., 1963, S INT COMBUST P, V9, P659, DOI 10.1016/S0082-0784(63)80074-0
   KEARNS DR, 1971, CHEM REV, V71, P395, DOI 10.1021/cr60272a004
   Kendrick KR, 1998, P SOC PHOTO-OPT INS, V3268, P125, DOI 10.1117/12.308058
   Kharchenko SS, 2005, P SOC PHOTO-OPT INS, V5777, P233, DOI 10.1117/12.611097
   King D. M., 2001, Proceedings of the International Conference on LASERS 2000
   King DM, 2006, 37 AIAA PLASM LAS C
   KLOPOVSKII KS, 1994, COMMUNICATION
   KLOPOVSKII KS, 1992, FIZ PLAZMY, V18, P1606
   KLOPOVSKY KS, 1984, I PHYS C SER, V72, P199
   KODYMOVA J, 1996, P SOC PHOTO-OPT INS, V2767, P243
   KOLOBYANIN Y, 2006, IN PRESS P SPIE
   KOLOBYANIN YV, 2005, 36 PLASM LAS C TOR O
   Kossyi IA, 1992, PLASMA SOURCES SCI T, V1, P207, DOI 10.1088/0963-0252/1/3/011
   Kovalev AS, 2005, J PHYS D APPL PHYS, V38, P2360, DOI 10.1088/0022-3727/38/14/010
   Krupenie P. H., 1972, J PHYS CHEM REF DATA, V1, P423, DOI DOI 10.1063/1.3253101
   Lafferty WJ, 1998, APPL OPTICS, V37, P2264, DOI 10.1364/AO.37.002264
   Lamberson S. E., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4184, DOI 10.1117/12.413960
   Newman SM, 1999, J CHEM PHYS, V110, P10749, DOI 10.1063/1.479018
   LASKA L, 1979, CZECH J PHYS, V29, P498, DOI 10.1007/BF01600172
   LAWTON SA, 1978, J CHEM PHYS, V69, P1055, DOI 10.1063/1.436700
   LILENFELD HV, 1982, CHEM PHYS LETT, V93, P38, DOI 10.1016/0009-2614(82)85051-3
   LIN LB, 1988, J QUANT SPECTROSC RA, V39, P375, DOI 10.1016/0022-4073(88)90102-1
   Lodin VJ, 2005, P SOC PHOTO-OPT INS, V5777, P221, DOI 10.1117/12.611038
   MASEK K, 1984, CZECH J PHYS, V34, P1227, DOI 10.1007/BF01590069
   MCDERMOTT WE, 1978, APPL PHYS LETT, V32, P469, DOI 10.1063/1.90088
   McEwan M.J., 1975, CHEM ATMOSPHERE
   McHale J., 2006, MILITARY AEROSPACE E, V1, P17
   MIKHEEV PA, 2000, IZV AKAD NAUK FIZ+, V64, P1259
   Mikheyev PA, 1999, P SOC PHOTO-OPT INS, V3612, P85, DOI 10.1117/12.350641
   Miley GH, 1998, P SOC PHOTO-OPT INS, V3343, P692, DOI 10.1117/12.321594
   MILEY GH, 1989, LASER PART BEAMS, V7, P411
   Miller HC, 2001, J QUANT SPECTROSC RA, V69, P305, DOI 10.1016/S0022-4073(00)00086-8
   Minaev BF, 2003, SPECTROCHIM ACTA A, V59, P3387, DOI 10.1016/S1386-1425(03)00165-3
   MLYNCZAK MG, 1995, GEOPHYS RES LETT, V22, P1381, DOI 10.1029/95GL01320
   MUKKAVILLI S, 1988, IEEE T PLASMA SCI, V16, P652, DOI 10.1109/27.16554
   NAPARTOVICH AP, 1979, KHIMIYA PLAZMY, P153
   Napartovich AP, 2001, J PHYS D APPL PHYS, V34, P1827, DOI 10.1088/0022-3727/34/12/310
   NOXON JF, 1961, CAN J PHYS, V39, P1110
   Ogryzlo E. A., 1979, SINGLET OXYGEN, P35
   PAKHOMYC.LA, 1970, JETP LETT-USSR, V12, P43
   PALLA AD, 2005, 36 AIAA PLASM LAS C, pR2611
   PALLA AD, 2006, P SOC PHOTO-OPT INS, V6101, P586
   Pazyuk VS, 2001, QUANTUM ELECTRON+, V31, P363, DOI 10.1070/QE2001v031n04ABEH001952
   Pekarek L., 1960, Czechoslovak Journal of Physics, V10, DOI 10.1007/BF01558105
   PERSON JC, 1988, RADIAT PHYS CHEM, V31, P1
   PETTERSO.RC, 1970, ANN NY ACAD SCI, V171, P133, DOI 10.1111/j.1749-6632.1970.tb39315.x
   Phelps A V, 1985, 28 JILA
   Pitz G, 2004, P SOC PHOTO-OPT INS, V5448, P1039, DOI 10.1117/12.548707
   Podmar'kov Yu. P., 1996, Quantum Electronics, V26, DOI 10.1070/QE1996v026n07ABEH000733
   Raizer Yu. P., 1997, GAS DISCHARGE PHYS
   Rakhimova T. V., 2005, 36 AIAA PLASM LAS C
   RAKHIMOVA TV, 2004, 35 AIAA PLASM LAS C
   RAKHIMOVA TV, 2006, IN PRESS P SPIE
   RAKHIMOVA TV, 2003, 34 PLASM LAS C ORL F
   RAPP D, 1965, J CHEM PHYS, V43, P1464, DOI 10.1063/1.1696957
   Rawlins W. T., 2005, 36 AIAA PLASM LAS C
   Rawlins WT, 2004, P SOC PHOTO-OPT INS, V5334, P88, DOI 10.1117/12.537751
   RAWLINS WT, 2006, P SOC PHOTO-OPT INS, V6101, P502
   RAWLINS WT, 2003, 34 PLASM LAS C ORL F
   RAWLINS WT, 2004, APPL PHYS LETT, V86
   REES JA, 1965, AUST J PHYS, V18, P41
   RICHARDSON RJ, 1981, J APPL PHYS, V52, P4962, DOI 10.1063/1.329434
   Rose C. W., 1985, Advances in Soil Science, USA, V2, P1
   Rubin LF, 1997, OPT LETT, V22, P1347, DOI 10.1364/OL.22.001347
   RYSKIN ME, 1981, REACT KINET CATAL L, V17, P41
   Sabadil H., 1966, Beitraege aus der Plasmaphysik, V6, DOI 10.1002/ctpp.19660060503
   Samoilovich V. G., 1989, PHYS CHEM BARRIER DI
   SAVIN YV, 2003, 34 PLASM LAS C ORL F
   Savin YV, 2003, P SOC PHOTO-OPT INS, V5120, P433, DOI 10.1117/12.515594
   Savin YV, 2004, J PHYS D APPL PHYS, V37, P3121, DOI 10.1088/0022-3727/37/22/010
   SCHMIDT R, 1995, J PHYS CHEM-US, V99, P15919, DOI 10.1021/j100043a033
   SCHMIEDBERGER J, 1995, P SOC PHOTO-OPT INS, V2502, P338, DOI 10.1117/12.204934
   Schmiedberger J, 1997, P SOC PHOTO-OPT INS, V3092, P694, DOI 10.1117/12.270166
   Schmiedberger J, 2001, APPL PHYS LETT, V78, P2649, DOI 10.1063/1.1367899
   Schmiedberger J, 2005, P SOC PHOTO-OPT INS, V5777, P211, DOI 10.1117/12.611028
   Schmiedberger J., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4184, DOI 10.1117/12.414080
   Schmiedberger J, 2003, P SOC PHOTO-OPT INS, V5120, P471, DOI 10.1117/12.515803
   Schofield K., 1972, INT J CHEM KINET, V9, P255
   SHARPLESS RL, 1989, J CHEM PHYS, V91, P7947, DOI 10.1063/1.457211
   SHINKARENKO NV, 1981, USP KHIM+, V50, P406
   Spalek O, 1998, P SOC PHOTO-OPT INS, V3574, P550, DOI 10.1117/12.334488
   Stafford DS, 2005, J APPL PHYS, V98, DOI 10.1063/1.2076427
   Stafford DS, 2004, J APPL PHYS, V96, P2451, DOI 10.1063/1.1768615
   STEINFELD JI, 1987, J PHYS CHEM REF DATA, V16, P911
   TACHIBANA K, 1981, J CHEM PHYS, V75, P3315, DOI 10.1063/1.442483
   Thornton SJ, 2005, P SOC PHOTO-OPT INS, V5777, P1008, DOI 10.1117/12.611520
   TOOLLEFSON EL, 1948, J CHEM PHYS, V16, P1057
   TORCHIN L, 1983, J CHEM PHYS, V79, P2100, DOI 10.1063/1.446004
   TOUZEAU M, 1991, J PHYS D APPL PHYS, V24, P41, DOI 10.1088/0022-3727/24/1/008
   TOUZEAU M, 1990, NATO ADV SCI I B-PHY, V220, P571
   Vagin NP, 2003, PLASMA PHYS REP+, V29, P211, DOI 10.1134/1.1561115
   Vagin NP, 2004, QUANTUM ELECTRON+, V34, P865, DOI 10.1070/QE2004v034n09ABEH002883
   Vagin NP, 2005, QUANTUM ELECTRON+, V35, P378, DOI 10.1070/QE2005v035n04ABEH002905
   VAGIN NP, 2007, IN PRESS P SPIE
   VAGIN NP, 2006, PLASMA PHYS REP, V32, P465
   VAGIN NP, 2006, P SCI SESS MOSC ENG, V4, P67
   Vagin NP, 2000, PLASMA PHYS REP+, V26, P278, DOI 10.1134/1.952848
   VALLACE JA, 1963, PLANET SPACE SCI, V11, P961
   VALLACE JA, 1958, J ATMOS TERR PHYS, V13, P45
   VASILEVA AN, 1985, FIZ PLAZMY, V11, P221
   VASILEVA AN, 1989, FIZ PLAZMY, V15, P190
   Vasiljeva AN, 2004, J PHYS D APPL PHYS, V37, P2455, DOI 10.1088/0022-3727/37/17/019
   VASILJEVA AN, 1991, TEPLOFIZ VYS TEMP, V29, P56
   VELIKHOV EP, 1983, DOKL AKAD NAUK SSSR+, V273, P600
   Verdeyen JT, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2346134
   Verdeyen JT, 2002, P SOC PHOTO-OPT INS, V4631, P154, DOI 10.1117/12.465777
   VETROVEC J, 2001, P SOC PHOTO-OPT INS, V3092, P723
   WAI F, 1992, P 2 INT C LAS MAT PR, P127
   Wasserman H.H., 1979, SINGLET OXYGEN
   Wayne RP, 1985, SINGLET O2, V1, P81
   WAYNE RP, 1969, ADV PHOTOCHEM, V7, P311
   WILDT J, 1992, CHEM PHYS, V159, P127, DOI 10.1016/0301-0104(92)80065-4
   Williams S, 2004, OPT LETT, V29, P1066, DOI 10.1364/OL.29.001066
   WILLIAMS WH, 1993, APPL PHYS LETT, V62, P1724, DOI 10.1063/1.109586
   YAMABE C, 1983, J CHEM PHYS, V78, P2983
   Yoshida S., 1989, Proceedings of the SPIE - The International Society for Optical Engineering, V1031
   Yuryshev NN, 2004, P SOC PHOTO-OPT INS, V5448, P790, DOI 10.1117/12.547068
   Zagidullin MV, 2005, QUANTUM ELECTRON+, V35, P907, DOI [10.1070/QE2005v035nl0ABEH013010, 10.1070/QE2005v35n10ABH013010]
   Zakharov A. I., 1988, Soviet Journal of Plasma Physics, V14
   Zakharov SD, 1999, QUANTUM ELECTRON+, V29, P1031, DOI 10.1070/QE1999v029n12ABEH001629
   ZALESSKI.VY, 1974, ZH EKSP TEOR FIZ+, V67, P30
   ZALESSKII VY, 1975, SOV PHYS JETP, V40, P14
   ZEDIKER MS, 1981, P 9 S ENG PROBL FUS, V2, P1560
   ZIMMERMAN JW, 2006, P SPIE, V6261
   Zimmerman JW, 2003, P SOC PHOTO-OPT INS, V4971, P81, DOI 10.1117/12.483511
   ZOLOTAREV VA, 1989, QUANTUM ELECTRON, V19, P709
NR 255
TC 127
Z9 127
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD JAN 21
PY 2007
VL 40
IS 2
BP R25
EP R61
DI 10.1088/0022-3727/40/2/R01
PG 37
WC Physics, Applied
SC Physics
GA 129JQ
UT WOS:000243725800001
ER

PT J
AU Soenens, B
   Vansteenkiste, M
   Luyckx, K
   Goossens, L
AF Soenens, B
   Vansteenkiste, M
   Luyckx, K
   Goossens, L
TI Parenting and adolescent problem behavior: An integrated model with
   adolescent self-disclosure and perceived parental knowledge as
   intervening variables
SO DEVELOPMENTAL PSYCHOLOGY
LA English
DT Article
DE parenting; monitoring; self-disclosure; externalizing problems
ID PSYCHOLOGICAL CONTROL; ANTISOCIAL-BEHAVIOR; SUBSTANCE USE; PEER
   RELATIONSHIPS; DRUG-USE; FAMILY; ADJUSTMENT; MANAGEMENT; LINKS;
   REINTERPRETATION
AB Parental monitoring, assessed as (perceived) parental knowledge of the child's behavior, has been established as a consistent predictor of problem behavior. However, recent research indicates that parental knowledge has more to do with adolescents' self-disclosure than with parents' active monitoring. Although these findings may suggest that parents exert little influence on adolescents' problem behavior, the authors argue that this conclusion is premature, because self-disclosure may in itself be influenced by parents' rearing style. This study (a) examined relations between parenting dimensions and self-disclosure and (b) compared 3 models describing the relations among parenting, self-disclosure, perceived parental knowledge, and problem behavior. Results in a sample of 10th- to 12th-grade students, their parents, and their peers demonstrated that high responsiveness, high behavioral control, and low psychological control are independent predictors of self-disclosure. In addition, structural equation modeling analyses demonstrated that parenting is both indirectly (through self-disclosure) and directly associated with perceived parental knowledge but is not directly related to problem behavior or affiliation with peers engaging in problem behavior.
C1 Katholieke Univ Leuven, Dept Psychol, B-3000 Louvain, Belgium.
RP Soenens, B (reprint author), Katholieke Univ Leuven, Dept Psychol, Tiensestr 102, B-3000 Louvain, Belgium.
EM bart.soenens@psy.kuleuven.be
CR Allen J. P., 1997, DEV PSYCHOPATHOL, P548
   Baerveldt C., 1992, J QUANTITATIVE CRIMI, V8, P79, DOI 10.1007/BF01062760
   Bahr SJ, 1998, J MARRIAGE FAM, V60, P979, DOI 10.2307/353639
   BARBER BK, 1992, J MARRIAGE FAM, V54, P69, DOI 10.2307/353276
   BARBER BK, 2002, UNPUB REGULATION MUL
   Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.1111/j.1467-8624.1996.tb01915.x
   BARBER BK, 1994, CHILD DEV, V65, P1120, DOI 10.1111/j.1467-8624.1994.tb00807.x
   BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238
   Brendgen M, 2000, SOC DEV, V9, P205, DOI 10.1111/1467-9507.00120
   BROWN BB, 1993, CHILD DEV, V64, P467, DOI 10.2307/1131263
   Byrne B. M., 2001, STRUCTURAL EQUATION
   CARON AL, 2003, 70 BIENN M SOC RES C
   COOMBS RH, 1988, J MARRIAGE FAM, V50, P473, DOI 10.2307/352012
   Crouter A.C., 2002, HDB PARENTING, V3, P461
   Crouter AC, 1999, CHILD DEV, V70, P246, DOI 10.1111/1467-8624.00018
   Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380
   DISHION TJ, 1995, DEV PSYCHOPATHOL, V7, P803
   Dorius CJ, 2004, J MARRIAGE FAM, V66, P163
   FLANNERY DJ, 1994, J YOUTH ADOLESCENCE, V23, P195, DOI 10.1007/BF01537445
   Fletcher A. C., 1995, COERCION PUNISHMENT, P259
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   GOTTFREDSON MR, 1994, ADOLESCENT PROBLEM BEHAVIORS, P41
   Gray MR, 1999, J MARRIAGE FAM, V61, P574, DOI 10.2307/353561
   GROLNICK WS, 2002, HDB PARENTING, V5, P89
   Hambleton R. K., 1994, EUROPEAN J PSYCHOL A, V10, P229
   Hayes L, 2004, BEHAV THER, V35, P587, DOI 10.1016/S0005-7894(04)80033-9
   Houtzager B, 1999, SOC BEHAV PERSONAL, V27, P177
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Joreskog K. G., 1996, LISREL 8 STRUCTURAL
   Joreskog KG, 1996, PRELIS 2 USERS REFER
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Kim JE, 1999, CHILD DEV, V70, P1209, DOI 10.1111/1467-8624.00088
   Kosterman R, 2004, J MARRIAGE FAM, V66, P762, DOI 10.1111/j.0022-2445.2004.00051.x
   Laird RD, 2003, SOC DEV, V12, P401, DOI 10.1111/1467-9507.00240
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   Marsh HW, 1998, MULTIVAR BEHAV RES, V33, P181, DOI 10.1207/s15327906mbr3302_1
   Melby JN, 1996, J RES ADOLESCENCE, V6, P113
   MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674
   Mounts NS, 2001, J EARLY ADOLESCENCE, V21, P92, DOI 10.1177/0272431601021001005
   Mounts NS, 2002, J FAM PSYCHOL, V16, P58, DOI 10.1037/0893-3200.16.1.58
   Parke RD, 1998, HDB CHILD PSYCHOL, V3, P463, DOI 10.1002/9780470147658.chpsy0308
   Patterson G. R., 1985, CRIMINOLOGY, V23, P63, DOI 10.1111/j.1745-9125.1985.tb00326.x
   Patterson G. R., 1982, COERCIVE FAMILY PROC
   PATTERSON GR, 1984, CHILD DEV, V55, P1299, DOI 10.2307/1129999
   Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298
   Rogers KN, 2003, J EARLY ADOLESCENCE, V23, P349, DOI 10.1177/0272431603258344
   SATORRA A, 1999, PSYCHOMETRIKA, V66, P507
   Satorra A., 1994, LATENT VARIABLES ANA, P399
   SCHAEFER ES, 1965, CHILD DEV, V36, P413, DOI 10.1111/j.1467-8624.1965.tb05305.x
   SCHWARZ JC, 1985, CHILD DEV, V56, P462, DOI 10.1111/j.1467-8624.1985.tb00120.x
   SHAW DS, 1993, J ABNORM CHILD PSYCH, V21, P493, DOI 10.1007/BF00916316
   Shaw DS, 2003, SOC DEV, V12, P309, DOI 10.1111/1467-9507.t01-1-00235
   Smetana JG, 2002, J RES ADOLESCENCE, V12, P275, DOI 10.1111/1532-7795.00034
   Snyder J., 1987, HDB JUVENILE DELINQU, P216
   Soenens B, 2005, PERS INDIV DIFFER, V38, P487, DOI 10.1016/j.paid.2004.05.008
   Soenens B, 2005, J FAM PSYCHOL, V19, P358, DOI 10.1037/0893-3200.19.3.358
   SOENENS B, 2005, UNPUB ROLE INTRUSIVE
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Kerr M, 2003, CHILDREN'S INFLUENCE ON FAMILY DYNAMICS: THE NEGLECTED SIDE OF FAMILY RELATIONSHIPS, P121
   Steiger J. H., 1980, ANN M PSYCH SOC IOW
   STICE E, 1993, J ABNORM CHILD PSYCH, V21, P609, DOI 10.1007/BF00916446
   Waizenhofer RN, 2004, J FAM PSYCHOL, V18, P348, DOI 10.1037/0893-3200.18.2.348
   Walker-Barnes CJ, 2001, CHILD DEV, V72, P1814, DOI 10.1111/1467-8624.00380
   Weinmann L. L., 1992, DISS ABSTR INT, V53, p2565B
NR 64
TC 124
Z9 127
PU AMER PSYCHOLOGICAL ASSOC/EDUCATIONAL PUBLISHING FOUNDATION
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0012-1649
J9 DEV PSYCHOL
JI Dev. Psychol.
PD MAR
PY 2006
VL 42
IS 2
BP 305
EP 318
DI 10.1073/0012-1649.42.2.305
PG 14
WC Psychology, Developmental
SC Psychology
GA 029DF
UT WOS:000236537800009
PM 16569169
ER

PT J
AU Szuba, A
   Shin, WS
   Strauss, HW
   Rockson, S
AF Szuba, A
   Shin, WS
   Strauss, HW
   Rockson, S
TI The third circulation: Radionuclide lymphoscintigraphy in the evaluation
   of lymphedema
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Editorial Material
DE lymphatic system; radiotracers; lymphatic insufficiency
ID HUMAN-SERUM-ALBUMIN; LYMPHATIC-SYSTEM; QUANTITATIVE LYMPHOSCINTIGRAPHY;
   BREAST-CANCER; INITIAL LYMPHATICS; LOWER-EXTREMITIES; HUMAN SKIN;
   PERIPHERAL LYMPHEDEMA; INDIRECT LYMPHOGRAPHY; AXILLARY DISSECTION
AB Lymphedema-edema that results from chronic lymphatic insufficiency-is a chronic debilitating disease that is frequently misdiagnosed, treated too late, or not treated at all. There are, however, effective therapies for lymphedema that can be implemented, particularly after the disorder is properly diagnosed and characterized with lymphoscintigraphy. On the basis of the lymphoscintigraphic image pattern, it is often possible to determine whether the limb swelling is due to lymphedema and, if so, whether compression garments, massage, or surgery is indicated. Effective use of lymphoscintigraphy to plan therapy requires an understanding of the pathophysiology of lymphedema and the influence of technical factors such as selection of the radiopharmaceutical, imaging times after injection, and patient activity after injection on the images. In addition to reviewing the anatomy and physiology of the lymphatic system, we review physiologic principles of lymphatic imaging with lymphoscintigraphy, discuss different qualitative and quantitative lymphoscintigraphic techniques and their clinical applications, and present clinical cases depicting typical lymphoscintigraphic findings.
C1 Stanford Univ, Sch Med, Div Nucl Med, Stanford, CA 94305 USA.
   Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.
RP Strauss, HW (reprint author), Mem Sloan Kettering Canc Ctr, 1275 York Ave,Room S212, New York, NY 10021 USA.
EM straussh@mskcc.org
CR ADAIR TH, 1991, LYMPH STASIS PATHOPH
   ALLEN JM, 1986, J PHYSIOL-LONDON, V374, P401
   APESOS J, 1991, ANN PLAS SURG, V27, P570, DOI 10.1097/00000637-199112000-00010
   AUKLAND K, 1987, SCAND J CLIN LAB INV, V47, P331
   AUKLAND K, 1993, PHYSIOL REV, V73, P1
   BAULIEU F, 1985, REV CHIR ORTHOP, V71, P327
   BAULIEU F, 1989, NUCL MED COMMUN, V10, P109, DOI 10.1097/00006231-198902000-00005
   BERGQVIST L, 1983, SEMIN NUCL MED, V13, P9, DOI 10.1016/S0001-2998(83)80031-2
   Bland KI, 1999, J AM COLL SURGEONS, V188, P586, DOI 10.1016/S1072-7515(99)00056-3
   Bollinger A, 1997, ANGIOLOGY, V48, P27, DOI 10.1177/000331979704800105
   BOLLINGER A, 1982, LYMPHOLOGY, V15, P60
   Bourgeois P, 1998, CANCER-AM CANCER SOC, V83, P2805
   Brautigam P, 1998, LYMPHOLOGY, V31, P43
   BRAUTIGAM P, 1993, ANGIOLOGY, V44, P464, DOI 10.1177/000331979304400606
   Brautigam P, 1997, HAUTARZT, V48, P556, DOI 10.1007/s001050050627
   Brorson H, 1998, LYMPHOLOGY, V31, P156
   BROWSE NL, 1985, J CARDIOVASC SURG, V26, P91
   CAMBRIA RA, 1993, J VASC SURG, V18, P773
   Campisi C, 1999, INT ANGIOL, V18, P3
   Campisi C, 1999, INT ANGIOL, V18, P14
   CARENA M, 1988, EUR J NUCL MED, V14, P88
   CasleySmith JR, 1996, AVIAT SPACE ENVIR MD, V67, P52
   CasleySmith JR, 1995, LYMPHOLOGY, V28, P174
   CASTENHOLZ A, 1991, LYMPH STASIS PATHOPH, P15
   CASTENHOLZ A, 1984, Z LYMPHOL-J LYMPHOL, V8, P55
   Chatani M, 1998, STRAHLENTHER ONKOL, V174, P504
   CORNFORD ME, 1993, LYMPHOLOGY, V26, P67
   Cox CE, 2000, ANNU REV MED, V51, P525, DOI 10.1146/annurev.med.51.1.525
   DAVIS MA, 1974, J NUCL MED, V15, P923
   EGE GN, 1980, CANCER RES, V40, P3065
   EGE GN, 1979, BRIT J RADIOL, V52, P124
   EISENHOFFER J, 1995, MICROVASC RES, V49, P97, DOI 10.1006/mvre.1995.1008
   Fokin AA, 2000, MICROCIRCULATION, V7, P193, DOI 10.1038/sj.mn.7300104
   FOLDI M, 1999, TXB LYMPHOLOGY
   FRANCOIS A, 1989, VASA-J VASCULAR DIS, V18, P281
   GLOVICZKI P, 1988, J VASC SURG, V7, P647, DOI 10.1067/mva.1988.avs0070647
   GOLTNER E, 1988, LYMPHOLOGY, V21, P134
   GOLUEKE PJ, 1989, J VASC SURG, V10, P306, DOI 10.1067/mva.1989.14117
   HANNEQUIN P, 1988, EUR J NUCL MED, V14, P141, DOI 10.1007/BF00293538
   HENZE E, 1982, J NUCL MED, V23, P923
   Higuchi M, 1999, J APPL PHYSIOL, V86, P1381
   HO LCY, 1988, BRIT J PLAST SURG, V41, P475, DOI 10.1016/0007-1226(88)90003-3
   HUNG JC, 1995, J NUCL MED, V36, P1895
   Hwang JH, 1999, LYMPHOLOGY, V32, P15
   Ikomi F, 1995, CLIN DERMATOL, V13, P419, DOI 10.1016/0738-081X(95)00089-X
   Ikomi F, 1997, LYMPHOLOGY, V30, P13
   Ikomi F, 1999, LYMPHOLOGY, V32, P90
   IKOMI F, 1994, ARTIF CELL BLOOD SUB, V22, P1441, DOI 10.3109/10731199409138848
   Ikomi F, 1996, J APPL PHYSIOL, V81, P2060
   IKOMI F, 1995, RADIOLOGY, V196, P107
   Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019
   Kaindl F, 1970, Langenbecks Arch Chir, V327, P162, DOI 10.1007/BF01259001
   Karkkainen MJ, 2000, NAT GENET, V25, P153
   KATAOKA M, 1991, BRIT J RADIOL, V64, P1119
   KAZEM I, 1968, RADIOLOGY, V90, P905
   KLEINHANS E, 1985, EUR J NUCL MED, V10, P349
   Kubik S, 1985, INITIAL LYMPHATICS, P66
   LEAK L V, 1970, Microvascular Research, V2, P361, DOI 10.1016/0026-2862(70)90031-2
   LEAK LV, 1972, J ULTRA MOL STRUCT R, V39, P24, DOI 10.1016/S0022-5320(72)80004-2
   LEAK LV, 1980, ENVIRON HEALTH PERSP, V35, P55, DOI 10.2307/3428974
   Leduc O, 1988, PROGR LYMPHOLOGY, P551
   LIU NF, 1993, LYMPHOLOGY, V26, P28
   LOGAN V, 1995, J CLIN NURS, V4, P213
   Lubach D, 1996, BRIT J DERMATOL, V135, P733
   MANGAT S, 1985, LIFE SCI, V36, P1917, DOI 10.1016/0024-3205(85)90440-0
   MCGEOWN JG, 1987, J PHYSIOL-LONDON, V387, P83
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   Meek AG, 1998, CANCER, V83, P2788, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2788::AID-CNCR27>3.0.CO;2-I
   Meeusen R, 1998, CLIN J SPORT MED, V8, P266, DOI 10.1097/00042752-199810000-00003
   Moghimi SM, 1999, ADV DRUG DELIVER REV, V37, P295, DOI 10.1016/S0169-409X(98)00099-4
   Moore TA, 1996, CLIN INFECT DIS, V23, P1007
   MORTIMER P, 1990, INT CONGR SER, V887, P215
   Mortimer PS, 1995, INT ANGIOL, V14, P32
   Mortimer PS, 1998, CANCER, V83, P2798, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2798::AID-CNCR28>3.0.CO;2-E
   Mortimer PS, 1996, QJM-MON J ASSOC PHYS, V89, P377
   Mostbeck A, 1999, Wien Med Wochenschr, V149, P87
   NAGAI K, 1982, EUR J NUCL MED, V7, P66
   Nagai K, 1980, Radioisotopes, V29, P549
   Nason KS, 2000, CANCER, V89, P2187, DOI 10.1002/1097-0142(20001201)89:11<2187::AID-CNCR6>3.0.CO;2-#
   NAWAZ K, 1986, CLIN NUCL MED, V11, P653, DOI 10.1097/00003072-198609000-00015
   NAWAZ K, 1985, LYMPHOLOGY, V18, P181
   NAWAZ MK, 1990, CLIN NUCL MED, V15, P794, DOI 10.1097/00003072-199011000-00004
   NERLICH AG, 1991, HISTOCHEMISTRY, V96, P449, DOI 10.1007/BF00316003
   Ogawa Yoji, 1999, Kaku Igaku, V36, P31
   OHHASHI T, 1978, PFLUG ARCH EUR J PHY, V375, P183, DOI 10.1007/BF00584242
   OHTAKE E, 1986, CLIN NUCL MED, V11, P474, DOI 10.1097/00003072-198607000-00002
   OLSZEWSKI W, 1977, ACTA PHYSIOL SCAND, V99, P149, DOI 10.1111/j.1748-1716.1977.tb10365.x
   Olszewski W, 1970, Pol Med J, V9, P1441
   Olszewski W, 2000, ANGIOLOGY, V51, P25, DOI 10.1177/000331970005100106
   OLSZEWSKI W, 1994, LYMPHOLOGY, V27, P148
   OLSZEWSK.W, 1973, LYMPHOLOGY, V6, P35
   Olszewski WL, 1980, AM J PHYSIOL, V239, P775
   OLSZEWSKI WL, 1991, LYMPH STASIS PATHOPH, P4
   OLSZEWSKI WL, 1986, EUR SURG RES, V18, P264, DOI 10.1159/000128534
   OLSZEWSKI WL, 1977, LYMPHOLOGY, V10, P178
   OMORCHOE CCC, 1984, J CELL BIOL, V98, P629, DOI 10.1083/jcb.98.2.629
   OMORCHOE PJ, 1980, MICROVASC RES, V20, P275, DOI 10.1016/0026-2862(80)90029-1
   Partsch H, 1995, CLIN DERMATOL, V13, P445, DOI 10.1016/0738-081X(95)00085-T
   PARTSCH H, 1981, Z LYMPHOL-J LYMPHOL, V5, P35
   Passik SD, 1998, CANCER, V83, P2817, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2817::AID-CNCR32>3.0.CO;2-2
   PATEL HM, 1984, BIOCHIM BIOPHYS ACTA, V801, P76, DOI 10.1016/0304-4165(84)90214-9
   PECKING A, 1988, POST SURG PHYSIOTHER
   Pecking AP, 1995, INT ANGIOL, V14, P39
   Pecking A P, 1999, Wien Med Wochenschr, V149, P105
   PETEREIT DG, 1993, AM J CLIN ONCOL-CANC, V16, P38, DOI 10.1097/00000421-199302000-00010
   PFISTER G, 1990, LYMPHOLOGY, V23, P140
   Porter CJH, 2000, J PHARM SCI, V89, P297, DOI 10.1002/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P
   RAINWATER LM, 1988, J UROLOGY, V140, P1455
   REDDY NP, 1995, MED ENG PHYS, V17, P134, DOI 10.1016/1350-4533(95)91885-K
   RIJKE AM, 1990, J NUCL MED, V31, P990
   Roses DF, 1999, ANN SURG, V230, P194, DOI 10.1097/00000658-199908000-00009
   Ryan TJ, 1995, CLIN DERMATOL, V13, P451, DOI 10.1016/0738-081X(95)00091-S
   SAMUELS LD, 1987, LYMPHOLOGY, V20, P4
   Sanders L J, 1988, Cutis, V42, P406
   Sarosi Zsuzsanna, 1994, Orvosi Hetilap, V135, P743
   SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987
   Schunemann H, 1997, DEUT MED WOCHENSCHR, V122, P536, DOI 10.1055/s-2008-1047650
   SEGERSTROM K, 1992, SCAND J PLAST RECONS, V26, P223
   Shirasawa Y, 2000, AM J PHYSIOL-GASTR L, V278, pG551
   SJOBERG T, 1991, LYMPHOLOGY, V24, P16
   Slavin SA, 1997, PLAST RECONSTR SURG, V99, P730, DOI 10.1097/00006534-199703000-00020
   Solito R, 1997, LYMPHOLOGY, V30, P194
   Solsona E, 1986, Actas Urol Esp, V10, P45
   Spiegel M, 1991, Vasa Suppl, V33, P278
   SPIEGEL M, 1992, AM J PHYSIOL, V262, pH1208
   STOBERL C, 1987, Z HAUTKRANKHEITEN, V62, P56
   STRAND SE, 1979, J NUCL MED, V20, P1038
   STRAND SE, 1989, CRIT REV THER DRUG, V6, P211
   SUGA K, 1991, NUCL MED COMMUN, V12, P907
   Svensson W, 1999, EUR J NUCL MED, V26, P504, DOI 10.1007/s002590050418
   Swartz MA, 1999, J BIOMECH, V32, P1297, DOI 10.1016/S0021-9290(99)00125-6
   Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324
   Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209
   Szuba A, 1997, Vasc Med, V2, P321
   SZUBA A, 2003, IN PRESS NUCL MED CO
   TER SE, 1993, CLIN NUCL MED, V18, P646, DOI 10.1097/00003072-199308000-00003
   WALKER LA, 1950, J LAB CLIN MED, V36, P440
   WARBICK A, 1977, J NUCL MED, V18, P827
   Weiss M, 1996, NUKLEARMED, V35, P236
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729
   WENZELHORA BI, 1987, LYMPHOLOGY, V20, P126
   WERNGRENELGSTROM M, 1994, SCAND J PLAST RECONS, V28, P289
   Williams WH, 2000, CLIN NUCL MED, V25, P451, DOI 10.1097/00003072-200006000-00013
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   Witte CL, 1999, INT ANGIOL, V18, P25
   Witte MH, 1998, LYMPHOLOGY, V31, P145
   ZAWIEJA DC, 1991, AM J PHYSIOL, V260, pH1935
NR 147
TC 123
Z9 137
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA
SN 0161-5505
J9 J NUCL MED
JI J. Nucl. Med.
PD JAN
PY 2003
VL 44
IS 1
BP 43
EP 57
PG 15
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 633HJ
UT WOS:000180276500028
PM 12515876
ER

PT J
AU Ross, PL
   Scardino, PT
   Kattan, MW
AF Ross, PL
   Scardino, PT
   Kattan, MW
TI Catalog of prostate cancer nomograms
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate; prostatic neoplasms; forecasting; prognosis
ID EXTERNAL-BEAM RADIATION; PREDICT PATHOLOGICAL STAGE; SEMINAL-VESICLE
   INVASION; RADICAL PROSTATECTOMY; GLEASON SCORE; DISEASE RECURRENCE;
   NEURAL NETWORKS; CLINICAL STAGE; ANTIGEN; RISK
AB Purpose: Prediction is central to the management of prostate cancer. Nomograms are devices that make predictions. We organized many nomograms for prostate cancer.
   Materials and Methods: Using MEDLINE a literature search was performed on prostate cancer nomograms from January 1966 to February 2000. We recorded input variables, prediction form, the number of patients used to develop the nomogram and the outcome being predicted. We also recorded the accuracy measures reported by the original authors and whether the nomograms have withstood validation. In addition, we noted whether the nomograms were proprietary or in the public domain. Each nomogram was classified into patient clinical disease state and the outcome being predicted.
   Results: The literature search generated 42 published nomograms that may be applied to patients in various clinical stages of disease. Of the 42 nomograms only 18 had undergone validation, of which 2 partially failed. Few nomograms have been compared for predictive superiority and none appears to have been compared with clinical judgment alone.
   Conclusions: Patients with prostate cancer need accurate predictions. Prognostic nomograms are available for many clinical states and outcomes, and may provide the most accurate predictions currently available. Selection among them and progress in this field are hampered by the lack of comparisons for predictive accuracy.
C1 Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.
RP Kattan, MW (reprint author), Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave,C1076A, New York, NY 10021 USA.
CR ACKERMAN DA, 1993, J UROLOGY, V150, P1845
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Babaian RJ, 1998, UROLOGY, V51, P132, DOI 10.1016/S0090-4295(97)00574-8
   Badalament RA, 1996, J UROLOGY, V156, P1375, DOI 10.1016/S0022-5347(01)65590-3
   Bauer JJ, 1997, CANCER, V79, P952, DOI 10.1002/(SICI)1097-0142(19970301)79:5<952::AID-CNCR12>3.0.CO;2-1
   Bauer JJ, 1998, J UROLOGY, V159, P929, DOI 10.1016/S0022-5347(01)63773-X
   Begg CB, 2000, STAT MED, V19, P1997, DOI 10.1002/1097-0258(20000815)19:15<1997::AID-SIM511>3.0.CO;2-C
   BLUESTEIN DL, 1994, J UROLOGY, V151, P1315
   Blute ML, 2000, J UROLOGY, V164, P1591, DOI 10.1016/S0022-5347(05)67035-8
   Bostwick DG, 1996, J UROLOGY, V155, P1361, DOI 10.1016/S0022-5347(01)66267-0
   Carlson GB, 1998, UROLOGY, V52, P455, DOI 10.1016/S0090-4295(98)00205-2
   Carter HB, 1997, J UROLOGY, V157, P2206, DOI 10.1016/S0022-5347(01)64719-0
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   D'Amico AV, 1999, J CLIN ONCOL, V17, P168
   D'Amico AV, 1998, J UROLOGY, V160, P2096, DOI 10.1016/S0022-5347(01)62251-1
   D'Amico AV, 2000, J CLIN ONCOL, V18, P1164
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573
   Duchesne GM, 1996, RADIOTHER ONCOL, V38, P7, DOI 10.1016/0167-8140(95)01645-7
   EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844
   EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368
   Gilliland FD, 1999, J UROLOGY, V162, P1341, DOI 10.1016/S0022-5347(05)68281-X
   Goto Y, 1996, J UROLOGY, V156, P1059, DOI 10.1016/S0022-5347(01)65702-1
   Graefen M, 1999, EUR UROL, V36, P21, DOI 10.1159/000019922
   Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7
   Hogarth R. M., 1987, JUDGMENT CHOICE PSYC
   Kattan MW, 1997, CANCER, V79, P528, DOI 10.1002/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.0.CO;2-5
   Kattan MW, 2000, INT J RADIAT ONCOL, V48, P1469, DOI 10.1016/S0360-3016(00)01359-6
   Kattan MW, 1998, J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766
   Kattan MW, 1999, J CLIN ONCOL, V17, P1499
   Kattan MW, 1997, J GEN INTERN MED, V12, P299, DOI 10.1007/s11606-006-5066-9
   MEEHL PE, 1986, J PERS ASSESS, V50, P370, DOI 10.1207/s15327752jpa5003_6
   NARAYAN P, 1995, UROLOGY, V46, P205, DOI 10.1016/S0090-4295(99)80195-2
   Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445
   PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5
   PARTIN AW, 1993, J UROLOGY, V150, P110
   PELLER PA, 1995, CANCER, V75, P530, DOI 10.1002/1097-0142(19950115)75:2<530::AID-CNCR2820750216>3.0.CO;2-Y
   Pisansky TM, 1997, CANCER, V79, P2154, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2154::AID-CNCR13>3.0.CO;2-V
   Pisansky TM, 1996, INT J RADIAT ONCOL, V36, P585, DOI 10.1016/S0360-3016(96)00359-8
   Potter SR, 1999, UROLOGY, V54, P791, DOI 10.1016/S0090-4295(99)00328-3
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Rabbani F, 1998, J UROLOGY, V160, P1727, DOI 10.1016/S0022-5347(01)62394-2
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   ROACH M, 1994, INT J RADIAT ONCOL, V28, P33
   Scher HI, 2000, UROLOGY, V55, P323, DOI 10.1016/S0090-4295(99)00471-9
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   SNOW PB, 1994, J UROLOGY, V152, P1923
   Stamey TA, 2000, J UROLOGY, V163, P1155, DOI 10.1016/S0022-5347(05)67713-0
   Vollmer RT, 1998, CANCER, V83, P1567, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1567::AID-CNCR12>3.0.CO;2-E
   Zagars GK, 1997, CANCER, V79, P1370, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X
NR 50
TC 121
Z9 124
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAY
PY 2001
VL 165
IS 5
BP 1562
EP 1568
DI 10.1016/S0022-5347(05)66349-5
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 426CP
UT WOS:000168321500042
PM 11342918
ER

PT J
AU Warren, AG
   Brorson, H
   Borud, LJ
   Slavin, SA
AF Warren, Anne G.
   Brorson, Hakan
   Borud, Loren J.
   Slavin, Sumner A.
TI Lymphedema - A comprehensive review
SO ANNALS OF PLASTIC SURGERY
LA English
DT Review
DE lymphedema; breast cancer; extremity swelling
ID CANCER-RELATED LYMPHEDEMA; INTERMITTENT PNEUMATIC COMPRESSION;
   DECONGESTIVE LYMPHATIC THERAPY; RANDOMIZED CONTROLLED-TRIAL; UPPER
   EXTREMITY LYMPHEDEMA; SENTINEL NODE BIOPSY; BREAST-CANCER; ARM
   LYMPHEDEMA; POSTMASTECTOMY LYMPHEDEMA; FOLLOW-UP
AB Background: Lymphedema is a chronic, debilitating condition that has traditionally been seen as refractory or incurable. Recent years have brought new advances in the study of lymphedema pathophysiology. as well as diagnostic and therapeutic tools that are changing this perspective.
   Objective: To provide a systematic approach to evaluating and managing patients with lymphedema.
   Methods: We performed MEDLINE searches of the English-language literature (1966 to March 2006) using the terms lymphedema, breast cancer-associated lymphedema, lymphatic complications, lymphatic imaging, decongestive therapy, and surgical treatment of lymphedema. Relevant bibliographies and International Society of Lymphology guidelines were also reviewed.
   Results: In the United States, the populations primarily affected by lymphedema are patients undergoing treatment of malignancy, particularly women treated for breast cancer. A thorough evaluation of patients presenting with extremity swelling should include identification of prior surgical or radiation therapy for malignancy, as well as documentation of other risk factors for lymphedema, such as prior trauma to or infection of the affected limb. Physical examination should focus on differentiating signs of lymphedema from other causes of systemic or localized swelling. Lymphatic dysfunction can be visualized through lymphoscintigraphy; the diagnosis of lymphedema can also be confirmed through other imaging modalities, including CT or MRI. The mainstay of therapy in diagnosed cases of lymphedema involves compression garment use, as well as intensive bandaging and lymphatic massage. For patients who are unresponsive to conservative therapy; several surgical options with varied proven efficacies have been used in appropriate candidates, including excisional approaches, microsurgical lymphatic anastomoses, and circumferential suction-assisted lipectomy, an approach that has shown promise for long-term relief of symptoms.
   Conclusions: The diagnosis of lymphedema requires careful attention to patient risk factors and specific findings on physical examination. Noninvasive diagnostic tools and lymphatic imaging can be helpful to confirm the diagnosis of lymphedema or to address a challenging clinical presentation. Initial treatment with decongestive lymphatic therapy can provide significant improvement in patient symptoms and volume reduction of edematous extremities. Selected patients who are unresponsive to conservative therapy can achieve similar outcomes with surgical intervention, most promisingly suction-assisted lipectomy.
C1 Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Plast Surg, Boston, MA 02115 USA.
   Lund Univ, Malmo Univ Hosp, Dept Plast & Reconstruct Surg, Malmo, Sweden.
RP Slavin, SA (reprint author), 1101 Beacon St, Brookline, MA 02446 USA.
EM sslavin@bidmc.harvard.edu
CR Andersen L, 2000, ACTA ONCOL, V39, P399
   Armer JM, 2004, LYMPHOLOGY, V37, P73
   Astrom KGO, 2001, ACTA RADIOL, V42, P409, DOI 10.1080/028418501127346909
   Azurdia RM, 1999, CLIN EXP DERMATOL, V24, P270
   Badger C., 2004, COCHRANE DB SYST REV
   Badger CMA, 2000, CANCER, V88, P2832, DOI 10.1002/1097-0142(20000615)88:12<2832::AID-CNCR24>3.0.CO;2-U
   Bagheri Shirin, 2005, Lymphatic Research and Biology, V3, P66, DOI 10.1089/lrb.2005.3.66
   BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012
   Box RC, 2002, BREAST CANCER RES TR, V75, P51, DOI 10.1023/A:1016591121762
   Brennan MJ, 1998, CANCER, V83, P2821, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2821::AID-CNCR33>3.0.CO;2-G
   Brorson H, 1998, PLAST RECONSTR SURG, V102, P1058, DOI 10.1097/00006534-199809040-00021
   Brorson H, 2003, Scand J Surg, V92, P287
   Campisi C, 2004, WORLD J SURG, V28, P609, DOI 10.1007/s00268-004-7252-4
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604
   Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3
   CHARLES H, 1912, SYSTEM TREATMENT
   CHRISTENSEN SB, 1989, ACTA CHIR SCAND, V155, P515
   Classen DA, 2005, J RECONSTR MICROSURG, V21, P93, DOI 10.1055/s-2005-864841
   CLODIUS L, 1990, PLAST SURG OUTLOOK, V4, P1
   Cornish Bruce, 2006, Lymphatic Research and Biology, V4, P47, DOI 10.1089/lrb.2006.4.47
   Cornish BH, 2000, ANN NY ACAD SCI, V904, P571
   Daane S, 1998, ANN PLAS SURG, V40, P128, DOI 10.1097/00000637-199802000-00004
   Didem K, 2005, BREAST CANCER RES TR, V93, P49, DOI 10.1007/s10549-005-3781-2
   Dimakakos PB, 1997, INT SURG, V82, P411
   Dini D, 1998, ANN ONCOL, V9, P187, DOI 10.1023/A:1008259505511
   Erickson VS, 2001, J NATL CANCER I, V93, P96, DOI 10.1093/jnci/93.2.96
   FOLDI E, 1985, ANGIOLOGY, V36, P171, DOI 10.1177/000331978503600306
   GAFFNEY RM, 1981, J PATHOL, V133, P229, DOI 10.1002/path.1711330306
   Gloviczki P, 1999, INT ANGIOL, V18, P42
   Gothard L, 2004, RADIOTHER ONCOL, V73, P133, DOI 10.1016/j.radonc.2004.09.013
   GREENE AK, 2006, PLAST RECONSTR SURG, V118, pC118
   Greene AK, 2005, PLAST RECONSTR SURG, V116, P2058, DOI 10.1097/01.prs.0000192621.97804.d4
   Hayes S, 2005, BREAST CANCER RES TR, V89, P221, DOI 10.1007/s10549-004-2045-x
   Hinrichs CS, 2004, J SURG ONCOL, V85, P187, DOI 10.1002/jso.20020
   Hinrichs CS, 2004, ANN SURG ONCOL, V11, P573, DOI 10.1245/ASO.2004.04.017
   HUDSON TM, 1985, SKELETAL RADIOL, V13, P134
   International Society of Lymphology, 2003, LYMPHOLOGY, V36, P84
   Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019
   Johansson K, 1998, LYMPHOLOGY, V31, P56
   Karkkainen MJ, 2000, NAT GENET, V25, P153
   KIRCHMANN TTT, 1994, J AM ACAD DERMATOL, V31, P861, DOI 10.1016/S0190-9622(94)70247-0
   KISSIN MW, 1986, BRIT J SURG, V73, P580, DOI 10.1002/bjs.1800730723
   KLEIN MJ, 1988, ARCH PHYS MED REHAB, V69, P202
   Ko DSC, 1998, ARCH SURG-CHICAGO, V133, P452, DOI 10.1001/archsurg.133.4.452
   Kocak Z, 2000, ACTA ONCOL, V39, P389
   Langer S, 2004, AM SURGEON, V70, P881
   Leidenius M, 2005, J SURG ONCOL, V92, P23, DOI 10.1002/jso.20373
   Loprinzi CL, 1997, J CLIN ONCOL, V15, P3167
   McNeely ML, 2004, BREAST CANCER RES TR, V86, P95, DOI 10.1023/B:BREA.0000032978.67677.9f
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MEDGYESI S, 1983, BRIT J PLAST SURG, V36, P64, DOI 10.1016/0007-1226(83)90014-0
   Micke O, 2003, INT J RADIAT ONCOL, V56, P40, DOI 10.1016/S0360-3016(02)04390-0
   Mikes DM, 1999, LYMPHOLOGY, V32, P157
   Miranda F, 2001, LYMPHOLOGY, V34, P135
   Mondry TE, 2004, CANCER J, V10, P42, DOI 10.1097/00130404-200401000-00009
   Monnin-Delhom ED, 2002, LYMPHOLOGY, V35, P121
   Mortimer PS, 2000, BRIT MED J, V320, P1527, DOI 10.1136/bmj.320.7248.1527
   Moseley A, 2002, LYMPHOLOGY, V35, P136
   OBRIEN BM, 1990, PLAST RECONSTR SURG, V85, P562, DOI 10.1097/00006534-199004000-00011
   OFFORI TW, 1993, CLIN EXP DERMATOL, V18, P174, DOI 10.1111/j.1365-2230.1993.tb01008.x
   OLSZEWSKI WL, 1988, INT ANGIOL, V7, P312
   Ozaslan C, 2004, AM J SURG, V187, P69, DOI 10.1016/j.amjsurg.2003.12.003
   Pain SJ, 2000, BRIT J SURG, V87, P1128, DOI 10.1046/j.1365-2168.2000.01569.x
   Paskett E.D., 2000, BREAST J, V6, P373, DOI 10.1046/j.1524-4741.2000.99072.x
   Petrek JA, 2000, CA-CANCER J CLIN, V50, P292, DOI 10.3322/canjclin.50.5.292
   Petrek JA, 2001, CANCER, V92, P1368, DOI 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9
   Powell SN, 2003, INT J RADIAT ONCOL, V55, P1209, DOI 10.1016/S0360-3016(02)04273-6
   Purushotham AD, 2005, J CLIN ONCOL, V23, P4312, DOI 10.1200/JCO.2005.03.228
   RICHMAND DM, 1985, ARCH SURG-CHICAGO, V120, P1116
   Rockson SG, 1998, CANCER, V83, P2882, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2882::AID-CNCR45>3.0.CO;2-0
   Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0
   ROVERE GQD, 2003, ANN R COLL SURG ENGL, V85, P158
   Ruocco V, 2002, J AM ACAD DERMATOL, V47, P124, DOI 10.1067/mjd.2002.120909
   Ryan TJ, 1995, CLIN DERMATOL, V13, P493, DOI 10.1016/0738-081X(95)00092-T
   Schijven MP, 2003, EUR J SURG ONCOL, V29, P341, DOI 10.1053/ejso.2002.1385
   Schunemann H, 1997, DEUT MED WOCHENSCHR, V122, P536, DOI 10.1055/s-2008-1047650
   Sinclair SA, 1998, BRIT J DERMATOL, V138, P692
   Slavin SA, 1999, ANN SURG, V229, P421, DOI 10.1097/00000658-199903000-00017
   Slavin SA, 1997, PLAST RECONSTR SURG, V99, P730, DOI 10.1097/00006534-199703000-00020
   SMAHEL J, 1986, ANN PLAS SURG, V16, P444
   SMELTZER DM, 1985, PEDIATRICS, V76, P206
   Soran A, 2005, BREAST J, V11, P370, DOI 10.1111/j.1075-122X.2005.21717.x
   STEMMER R, 1976, Vasa, V5, P261
   Szuba A, 2000, AM J MED, V109, P296, DOI 10.1016/S0002-9343(00)00503-9
   Szuba A, 2003, J NUCL MED, V44, P43
   Szuba A, 2002, CANCER, V95, P2260, DOI 10.1002/cncr.10976
   Szuba A, 2002, NUCL MED COMMUN, V23, P1171, DOI 10.1097/01.mnm.0000046208.83338.da
   VEEN PV, 2004, LYMPHOLOGY, V37, P206
   Vodder E, 1965, Asthet Med (Berl), V14, P190
   Ward Leigh C., 2006, Lymphatic Research and Biology, V4, P51, DOI 10.1089/lrb.2006.4.51
   WARD LC, 1992, EUR J CLIN INVEST, V22, P751, DOI 10.1111/j.1365-2362.1992.tb01440.x
   WATANABE R, 1989, LYMPHOLOGY, V22, P85
   Weiss M, 2002, CLIN NUCL MED, V27, P788, DOI 10.1097/01.RLU.0000033613.05410.34
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729
   WERNER RS, 1991, RADIOLOGY, V180, P177
   WHEELER ES, 1981, PLAST RECONSTR SURG, V67, P362, DOI 10.1097/00006534-198103000-00016
   Williams AF, 2002, EUR J CANCER CARE, V11, P254, DOI 10.1046/j.1365-2354.2002.00312.x
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   WOODWARD AH, 1972, CANCER, V30, P562, DOI 10.1002/1097-0142(197208)30:2<562::AID-CNCR2820300237>3.0.CO;2-V
   Yildirim-Toruner C, 2004, AM J MED GENET A, V131A, P281, DOI 10.1002/ajmg.a.30390
   ZANOLLA R, 1984, J SURG ONCOL, V26, P210, DOI 10.1002/jso.2930260317
   Zimmermann T, 2005, BIOL TRACE ELEM RES, V106, P193, DOI 10.1385/BTER:106:3:193
NR 103
TC 119
Z9 127
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD OCT
PY 2007
VL 59
IS 4
BP 464
EP 472
DI 10.1097/01.sap.0000257149.42922.7e
PG 9
WC Surgery
SC Surgery
GA 213YD
UT WOS:000249702300022
PM 17901744
ER

PT J
AU Stamey, TA
   Yemoto, CM
   McNeal, JE
   Sigal, BM
   Johnstone, IM
AF Stamey, TA
   Yemoto, CM
   McNeal, JE
   Sigal, BM
   Johnstone, IM
TI Prostate cancer is highly predictable: A prognostic equation based on
   all morphological variables in radical prostatectomy specimens
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostatic neoplasms; prostatectomy; prostate; neoplasm staging;
   prostate-specific antigen
ID CLINICAL STAGE; MULTIVARIATE-ANALYSIS; DISEASE RECURRENCE; PATHOLOGICAL
   STAGE; RESIDUAL CANCER; ANTIGEN ASSAYS; GLEASON SCORE; FOLLOW-UP; MEN;
   ADENOCARCINOMA
AB Purpose: We determine whether biochemical prostate specific antigen (PSA) failure can be accurately predicted from preoperative serum PSA combined with 6 morphological variables from radical retropubic prostatectomy specimens in men with peripheral zone cancers. The unexpected limitation imposed by preoperative serum PSA on biochemical failure led us to compare peripheral zone to transition zone cancers.
   Materials and Methods: A total of 326 peripheral zone and 46 transition zone cancers treated only with radical retropubic prostatectomy were followed for a minimum of 3 years (mean and median greater than 5). All prostates were sectioned at 3 mm. intervals and morphological variables were quantitated using the Stanford technique. Biochemical failure was defined as serum PSA 0.07 ng./ml. or greater and increasing. Multivariate logistic regression was used to identify variables with the most independent influence on biochemical failure and derive a clinical equation to predict failure in peripheral zone cancers. The validity of the predictive equation was assessed by out of sample validation and cross validation techniques. The 46 transition zone cancers were compared to the 326 peripheral zone cancers by Student's t and Wilcoxon tests.
   Results: Of the peripheral zone failures 60% occurred in the first year after radical retropubic prostatectomy and 95% had occurred by the end of year 4. The highest preoperative serum PSA was 23 ng./ml. among the 181 men biochemically free of disease. Only 15.8% of 57 men with PSA greater than 15 ng./ml. were biochemically disease-free. For the 48 transition zone cancers cure rates were independent of serum PSA with 6 men having PSA greater than 50 ng./ml. Biochemical disease-free status was noted in 80% of transition zone compared to 56% of peripheral zone cancers (p = 0.0009). The most important variables predicting biochemical disease-free status for peripheral zone cancers were percent Gleason grade 4/5, cancer volume, serum PSA and prostate weight. Foci of vascular invasion, intraductal cancer and lymph nodes were less significant variables, and capsular penetration, positive surgical margins and seminal vesical invasion were insignificant. The multivariate logistic equation for predicting failure in peripheral zone cancers was highly accurate and requires only 2 to 3 minutes with a simple calculator.
   Conclusions: Failure of radical retropubic prostatectomy to cure peripheral zone prostate cancer is highly predictable based on 6 morphological variables from the prostatectomy specimen and serum PSA. The level of serum PSA profoundly limits biochemical cure rates in peripheral zone cancers. Transition zone cancers have a high cure rate, despite high serum PSA and adverse morphological variables. Men with serum PSA greater than 15 and perhaps even greater than 10 ng./ml. have such a low cure rate for peripheral zone cancer that re-biopsy attempts appear indicated to prove a transition zone location or else therapy other than radical retropubic prostatectomy should be sought. Pathologists should indicate whether the primary (largest) cancer is in the peripheral or transition zone to prevent overoptimistic reports of cure with radical prostatectomy procedures, as 85% of all tumors are in the peripheral zone.
C1 Stanford Univ, Med Ctr, Dept Urol, Sch Med, Stanford, CA 94305 USA.
   Stanford Univ, Dept Stat, Stanford, CA 94305 USA.
RP Stamey, TA (reprint author), Stanford Univ, Med Ctr, Dept Urol, Sch Med, S-287,300 Pasteur Dr, Stanford, CA 94305 USA.
CR Bauer JJ, 1998, J UROLOGY, V159, P929, DOI 10.1016/S0022-5347(01)63773-X
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   COHEN P, 1994, J ENDOCRINOL, V142, P407, DOI 10.1677/joe.0.1420407
   COPAS JB, 1983, J R STAT SOC B, V45, P311
   Cox D, 1984, ANAL SURVIVAL DATA, DOI Boca Raton, FL
   Cox D. R., 1989, ANAL BINARY DATA
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   EPSTEIN JI, 1993, J UROLOGY, V149, P1478
   Epstein JI, 1996, AM J SURG PATHOL, V20, P286, DOI 10.1097/00000478-199603000-00004
   Erbersdobler A, 1997, J UROLOGY, V158, P1594, DOI 10.1016/S0022-5347(01)64286-1
   Kattan MW, 1998, J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766
   MCNEAL JE, 1990, AM J SURG PATHOL, V14, P240, DOI 10.1097/00000478-199003000-00005
   MCNEAL JE, 1990, CANCER, V66, P1225, DOI 10.1002/1097-0142(19900915)66:6<1225::AID-CNCR2820660624>3.0.CO;2-X
   McNeal JE, 1996, AM J SURG PATHOL, V20, P802, DOI 10.1097/00000478-199607000-00003
   McNeal JE, 1996, AM J SURG PATHOL, V20, P1351, DOI 10.1097/00000478-199611000-00006
   Mosteller F., 1977, DATA ANAL REGRESSION
   Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445
   PARTIN AW, 1993, J UROLOGY, V150, P110
   PEEHL DM, 1995, CANCER, V75, P2021, DOI 10.1002/1097-0142(19950401)75:7+<2021::AID-CNCR2820751644>3.0.CO;2-R
   PRESTIGIACOMO AF, 1994, J UROLOGY, V152, P1515
   Pruthi RS, 1997, UROLOGY, V49, P737, DOI 10.1016/S0090-4295(97)00231-8
   Ripley B. D., 1996, PATTERN RECOGNITION
   SCHMID HP, 1993, CANCER, V71, P2031, DOI 10.1002/1097-0142(19930315)71:6<2031::AID-CNCR2820710618>3.0.CO;2-Q
   STAMEY TA, 1993, J UROLOGY, V149, P510
   STAMEY TA, 1995, UROLOGY, V45, P2, DOI 10.1016/S0090-4295(95)96168-2
   Stamey TA, 1999, JAMA-J AM MED ASSOC, V281, P1395, DOI 10.1001/jama.281.15.1395
   Stamey TA, 1996, CLIN CHEM, V42, P849
   Stamey TA, 1998, J UROLOGY, V159, P2009, DOI 10.1016/S0022-5347(01)63229-4
   VENABLES WN, 1997, MODERN APPL STAT S P, P357
   WHITTEMORE AS, 1995, J NATL CANCER I, V87, P354, DOI 10.1093/jnci/87.5.354
NR 30
TC 118
Z9 118
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2000
VL 163
IS 4
BP 1155
EP 1160
DI 10.1016/S0022-5347(05)67713-0
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 295NE
UT WOS:000085974000022
PM 10737486
ER

PT J
AU Smetana, JG
   Metzger, A
   Gettman, DC
   Campione-Barr, N
AF Smetana, JG
   Metzger, A
   Gettman, DC
   Campione-Barr, N
TI Disclosure and secrecy in adolescent-parent relationships
SO CHILD DEVELOPMENT
LA English
DT Article
ID AFRICAN-AMERICAN ADOLESCENTS; PSYCHOLOGICAL CONTROL; AUTONOMY;
   AUTHORITY; BEHAVIOR; CONCEPTIONS; ADJUSTMENT; CONFLICT; DOMAIN;
   REINTERPRETATION
AB Beliefs about parents' legitimate authority and adolescents' obligations to disclose to parents and actual disclosure and secrecy in different domains were examined in 276 ethnically diverse, lower middle-class 9th and 12th graders (Ms=14.62 and 17.40 years) and their parents (n=249). Adolescents were seen as more obligated to disclose prudential issues and less obligated to disclose personal than moral, conventional, and multifaceted issues; parents viewed adolescents as more obligated to disclose to parents than adolescents perceived themselves to be. Adolescents disclosed more to mothers than to fathers, particularly regarding personal issues, but mothers overestimated girls' disclosure. Greater trust, perceived obligations to disclose, and, for personal issues, more parental acceptance and psychological control predicted more disclosure and less secrecy.
C1 Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY 14627 USA.
RP Smetana, JG (reprint author), Univ Rochester, Dept Clin & Social Sci Psychol, Meliora Hall,RC 270266, Rochester, NY 14627 USA.
EM smetana@psych.rochester.edu
CR ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939
   BENGTSON VL, 1971, AGING HUM DEVELOP, V2, P249
   BERNDT TJ, 1979, DEV PSYCHOL, V15, P608, DOI 10.1037//0012-1649.15.6.608
   Buhrmester D., 1995, DISCLOSURE PROCESSES, P10, DOI 10.1017/CBO9780511527746.002
   Bumpus M. F., 2001, DEV PSYCHOL, V37, P164
   Chodorow N. J., 1978, REPROD MOTHERING
   Crouter A.C., 2002, HDB PARENTING, V3, P461
   Crouter AC, 1999, CHILD DEV, V70, P246, DOI 10.1111/1467-8624.00018
   CSIKSZENTMIHALY.M, 1984, BEING ADOLESCENT
   DARLING N, 2004, UNPUB ADOLESCENTS AC
   Finkenauer C, 2005, PERS RELATIONSHIP, V12, P387, DOI 10.1111/j.1475-6811.2005.00122.x
   FINKENAUER C, 2002, J YOUTH ADOLESCENCE, V2, P123
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Fuligni AJ, 1998, DEV PSYCHOL, V34, P782, DOI 10.1037/0012-1649.34.4.782
   FURMAN W, 1992, CHILD DEV, V63, P103, DOI 10.1111/j.1467-8624.1992.tb03599.x
   Hasebe Y, 2004, CHILD DEV, V75, P815, DOI 10.1111/j.1467-8624.2004.00708.x
   Hetherington E. M., 1993, J FAMILY PSYCHOL, V7, P39, DOI 10.1037//0893-3200.7.1.39
   Kerr M, 1999, J ADOLESCENCE, V22, P737, DOI 10.1006/jado.1999.0266
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Larson RW, 1996, DEV PSYCHOL, V32, P744, DOI 10.1037/0012-1649.32.4.744
   MARSHALL SK, 2005, J ADOLESCENCE, V22, P633
   Nakao K, 1992, 74 U CHIC NAT OP RES
   NOLLER P, 1990, J YOUTH ADOLESCENCE, V19, P349, DOI 10.1007/BF01537077
   Nucci L., 1996, VALUES KNOWLEDGE, P41
   Parke RD, 1998, HDB CHILD PSYCHOL, V3, P463, DOI 10.1002/9780470147658.chpsy0308
   PERKINS SA, 2005, UNPUB LIE NOT LIE WH
   Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298
   PRINZ RJ, 1979, J APPL BEHAV ANAL, V12, P691, DOI 10.1901/jaba.1979.12-691
   Reis H. T., 1988, HDB PERSONAL RELATIO, P367
   ROBIN AL, 1989, NEGOTIATING PARENT A
   Rosenberg M., 1986, CONCEIVING SELF
   RYAN RM, 1989, CHILD DEV, V60, P340, DOI 10.1111/j.1467-8624.1989.tb02720.x
   SCHAEFER ES, 1965, J CONSULT PSYCHOL, V29, P552, DOI 10.1037/h0022702
   Schaefer E. S., 1965, CHILD DEV, V36, P417
   SCHLUDERMANN S, 1970, J PSYCHOL, V39, P39
   Sim TN, 2003, J RES ADOLESCENCE, V13, P57
   Smetana JG, 2000, CHILD DEV, V71, P1672, DOI 10.1111/1467-8624.00257
   Smetana J. G., 1995, ANN CHILD DEV, V10, P83
   Smetana JG, 2006, HANDBOOK OF MORAL DEVELOPMENT, P119
   Smetana J. G., 1988, 21ST MINN S CHILD PS, P79
   SMETANA JG, 1989, CHILD DEV, V60, P1052, DOI 10.1111/j.1467-8624.1989.tb03536.x
   Smetana JG, 2002, CHILD DEV, V73, P563, DOI 10.1111/1467-8624.00424
   Smetana JG, 2004, CHILD DEV, V75, P1418, DOI 10.1111/j.1467-8624.2004.00749.x
   SMETANA JG, 1988, CHILD DEV, V59, P321, DOI 10.1111/j.1467-8624.1988.tb01469.x
   SMETANA JG, 1994, CHILD DEV, V65, P1147, DOI 10.1111/j.1467-8624.1994.tb00809.x
   STATTIN H, 2000, BIENN M SOC RES AD C
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   STEINBERG L, 1986, CHILD DEV, V57, P841, DOI 10.1111/j.1467-8624.1986.tb00250.x
   Tilton-Weaver LC, 2003, J RES ADOLESCENCE, V13, P269, DOI 10.1111/1532-7795.1303002
   Turiel E., 1983, DEV SOCIAL KNOWLEDGE
   Turiel E, 1998, HDB CHILD PSYCHOL, V3, P863, DOI 10.1002/9780470147658.chpsy0313
   Waizenhofer RN, 2004, J FAM PSYCHOL, V18, P348, DOI 10.1037/0893-3200.18.2.348
   WEINBERGER DA, 1990, CHILD DEV, V61, P1374, DOI 10.2307/1130749
   Youniss J., 1985, ADOLESCENTS RELATION
NR 54
TC 117
Z9 117
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0009-3920
J9 CHILD DEV
JI Child Dev.
PD JAN-FEB
PY 2006
VL 77
IS 1
BP 201
EP 217
DI 10.1111/j.1467-8624.2006.00865.x
PG 17
WC Psychology, Educational; Psychology, Developmental
SC Psychology
GA 010EN
UT WOS:000235169800014
PM 16460534
ER

PT J
AU Scher, HI
   Eisenberger, M
   D'Amico, AV
   Halabi, S
   Small, EJ
   Morris, M
   Kattan, MW
   Roach, M
   Kantoff, P
   Pienta, KJ
   Carducci, MA
   Agus, D
   Slovin, SF
   Heller, G
   Kelly, WK
   Lange, PH
   Petrylak, D
   Berg, W
   Higano, C
   Wilding, G
   Moul, JW
   Partin, AN
   Logothetis, C
   Soule, HR
AF Scher, HI
   Eisenberger, M
   D'Amico, AV
   Halabi, S
   Small, EJ
   Morris, M
   Kattan, MW
   Roach, M
   Kantoff, P
   Pienta, KJ
   Carducci, MA
   Agus, D
   Slovin, SF
   Heller, G
   Kelly, WK
   Lange, PH
   Petrylak, D
   Berg, W
   Higano, C
   Wilding, G
   Moul, JW
   Partin, AN
   Logothetis, C
   Soule, HR
TI Eligibility and outcomes reporting guidelines for clinical trials for
   patients in the state of a rising prostate-specific antigen:
   Recommendations from the prostate-specific antigen working group
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Article
ID EXTERNAL-BEAM RADIATION; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY;
   POSITRON-EMISSION-TOMOGRAPHY; PREDICT PATHOLOGICAL STAGE; RADICAL
   PROSTATECTOMY; BIOCHEMICAL FAILURE; HORMONAL-THERAPY; GLEASON SCORE;
   CANCER; PSA
AB Purpose To define methodology to show clinical benefit for patients in the state of a rising prostate-specific antigen (PSA).
   Results Hypothesis. A clinical states framework was used to address the hypothesis that definitive phase III trials could not be conducted in this patient population.
   Patient Population. The Group focused on men with systemic (nonlocalized) recurrence and a defined risk of developing clinically detectable metastases. Models to define systemic versus local recurrence, and risk of metastatic progression were discussed.
   Intervention. Therapies that have shown favorable effects in more advanced clinical states; meaningful biologic surrogates of activity linked with efficacy in other tumor types; and/or effects on a target or pathway known to contribute to prostate cancer progression in this state can be considered for evaluation.
   Outcomes. An intervention-specific posttherapy PSA-based outcome definition that would justify further testing should be described at the outset.
   Reporting. Trial reports should include a table showing the number of patients who achieve a specific PSA-based outcome, the number who remain enrolled onto the trial, and the number who came off study at different time points. The term PSA response should be abandoned.
   Trial Design. The phases of drug development for this state are optimizing dose and schedule, demonstration of a treatment effect, and clinical benefit. To move a drug forward should require a high bar that includes no rise in PSA in a defined proportion of patients for a specified period of time at a minimum. Agents that do not produce this effect can only be tested in combination. The preferred end point of clinical benefit is prostate cancer-specific survival; the time to development of metastatic disease is an alternative.
   Conclusion Methodology to show that an intervention alters the natural history of prostate cancer is described. At each stage of development, only agents with sufficient activity should be moved forward. (C) 2004 by American Society of Clinical Oncology.
C1 Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA.
   Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA.
   Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.
   Uniformed Serv Univ Hlth Sci, Rockville, MD USA.
   Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA.
   Aventis Pharmaceut, Bridgewater, MA USA.
   Univ Washington, Seattle, WA 98195 USA.
   Univ Michigan, Ann Arbor, MI 48109 USA.
   Duke Univ, Durham, NC USA.
   Prostate Canc Fdn, CaP CURE, Santa Monica, CA USA.
   Cedars Sinai Med Ctr, Prostate Canc Ctr, Los Angeles, CA 90048 USA.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
   Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA.
   Dana Farber Canc Inst, Boston, MA 02115 USA.
   Brigham & Womens Hosp, Boston, MA 02115 USA.
   Columbia Presbyterian Med Ctr, New York, NY 10032 USA.
RP Scher, HI (reprint author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
EM scherh@mskcc.org
CR Agus DB, 1998, CANCER RES, V58, P3009
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Amling Christopher L., 2000, Journal of Urology, V163, P284
   BEYER D, 1999, UROLOGY, V53, P2
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Bubley GJ, 1999, J CLIN ONCOL, V17, P3461
   CARTER HB, 1992, CANCER RES, V52, P3323
   Cher ML, 1998, J UROLOGY, V160, P1387, DOI 10.1016/S0022-5347(01)62545-X
   Connolly JA, 1996, UROLOGY, V47, P225, DOI 10.1016/S0090-4295(99)80421-X
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061
   DAMICO AV, 2003, P AN M AM SOC CLIN, V22, P381
   D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043
   DAMICO AV, 2003, P AN M AM SOC CLIN, P39
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Das P, 2002, INT J RADIAT ONCOL, V54, P698, DOI 10.1016/S0360-3016(02)03036-5
   Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199
   DiPaola RS, 1998, NEW ENGL J MED, V339, P785, DOI 10.1056/NEJM199809173391201
   Dixon SC, 2001, PHARMACOL REV, V53, P73
   EISENBERGER MA, 2003, P AN M AM SOC CLIN, V22, P380
   Fazzari M, 2000, CONTROL CLIN TRIALS, V21, P360, DOI 10.1016/S0197-2456(00)00056-8
   FLEMING C, 1993, JAMA-J AM MED ASSOC, V269, P2650
   GOLDENBERG SL, 1992, J UROLOGY, V147, P1307
   Gretzer MB, 2002, J UROLOGY, V168, P1419, DOI 10.1097/ju.0000029729.26315.fd
   GULLEY JL, 2003, P AN M AM SOC CLIN, V22, P396
   Han M, 2003, J UROLOGY, V169, P517, DOI 10.1097/01.ju.0000045749.90353.c7
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Hinkle GH, 1998, CANCER, V83, P739, DOI 10.1002/(SICI)1097-0142(19980815)83:4<739::AID-CNCR16>3.3.CO;2-0
   Holmes EH, 2001, EXPERT OPIN INV DRUG, V10, P511, DOI 10.1517/13543784.10.3.511
   Izawa JI, 2002, J CLIN ONCOL, V20, P2664, DOI 10.1200/JCO.2002.06.086
   Jemal A, 2002, CA-CANCER J CLIN, V52, P23
   Kao CH, 2000, ANTICANCER RES, V20, P2189
   Kattan MW, 1997, CANCER, V79, P528, DOI 10.1002/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.0.CO;2-5
   Kattan MW, 2000, J CLIN ONCOL, V18, P3352
   Katz MS, 2003, J CLIN ONCOL, V21, P483, DOI 10.1200/JCO.2003.12.043
   Kelly WK, 2000, CLIN CANCER RES, V6, P838
   KELLY WK, 1993, J CLIN ONCOL, V11, P607
   Kwan WB, 2003, P AN M AM SOC CLIN, V22, P380
   Laufer M, 2000, UROLOGY, V55, P309, DOI 10.1016/S0090-4295(99)00465-3
   Lee WR, 1997, J CLIN ONCOL, V15, P230
   Leventis AK, 2001, J CLIN ONCOL, V19, P1030
   Lukka H, 2001, Can J Urol, V8, P1314
   Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401
   MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602
   Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8
   Moul JW, 2001, UROL CLIN N AM, V28, P459, DOI 10.1016/S0094-0143(05)70155-5
   Moul JW, 2001, J UROLOGY, V166, P1322, DOI 10.1016/S0022-5347(05)65761-8
   OESTERLING JE, 1991, J UROLOGY, V145, P907
   Padula GDA, 2002, INT J RADIAT ONCOL, V52, P439, DOI 10.1016/S0360-3016(01)02604-9
   PARTIN AW, 1993, J UROLOGY, V150, P110
   Patel A, 1997, J UROLOGY, V158, P1441, DOI 10.1016/S0022-5347(01)64238-1
   Pilepich MV, 1997, J CLIN ONCOL, V15, P1013
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Roach M, 1996, INT J RADIAT ONCOL, V34, P749, DOI 10.1016/0360-3016(95)02295-3
   Roach M, 2000, INT J RADIAT ONCOL, V47, P609, DOI 10.1016/S0360-3016(00)00578-2
   ROACH M, 1993, J UROLOGY, V150, P1923
   Roberts SG, 2001, MAYO CLIN PROC, V76, P576
   Roth AJ, 1998, CANCER, V82, P1904, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X
   SAAD R, 2003, P AN M AM SOC CLIN, V22, P379
   Sandler HM, 2000, INT J RADIAT ONCOL, V48, P629, DOI 10.1016/S0360-3016(00)00717-3
   SANDLER HM, 2003, P AN M AM SOC CLIN, V22, P381
   Sartor O, 2001, UROLOGY, V57, P399, DOI 10.1016/S0090-4295(00)01084-0
   Scher HI, 1996, J NATL CANCER I, V88, P1623, DOI 10.1093/jnci/88.22.1623
   Scher HI, 2000, UROLOGY, V55, P323, DOI 10.1016/S0090-4295(99)00471-9
   Scher HI, 2003, CANCER, V97, P758, DOI 10.1002/cncr.11151
   Scher HI, 2000, J NATL CANCER I, V92, P1866, DOI 10.1093/jnci/92.23.1866
   See WA, 2002, J UROLOGY, V168, P429, DOI 10.1016/S0022-5347(05)64652-6
   SELLA T, IN PRESS AM J RADIOL
   Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2
   Solit DB, 2002, CLIN CANCER RES, V8, P986
   STEPHENSON AJ, 2003, P AN M AM SOC CLIN, V22, P392
   Svetec D, 1998, ANN ONCOL, V9, P1283, DOI 10.1023/A:1008446208963
   TAPLIN ME, 2003, PPO UPDATES, V17, P1
   Taylor JMG, 2001, INT J RADIAT ONCOL, V50, P1212, DOI 10.1016/S0360-3016(01)01571-1
   Thalmann GN, 1996, J NATL CANCER I, V88, P794, DOI 10.1093/jnci/88.12.794
   GOLDHIRSCH A, 1988, NEW ENGL J MED, V319, P677
   Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
   UEHARA K, 2003, J NATL CANCER I, V95, P458
   Verbel DA, 2002, CLIN CANCER RES, V8, P2576
   Vollmer RT, 2003, AM J CLIN PATHOL, V119, P80, DOI 10.1092/GMEYIBXBYUJJF3QU
   Vollmer RT, 2001, AM J CLIN PATHOL, V116, P864
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
NR 85
TC 117
Z9 117
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 330 JOHN CARLYLE ST, STE 300, ALEXANDRIA, VA 22314 USA
SN 0732-183X
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD FEB 1
PY 2004
VL 22
IS 3
BP 537
EP 556
DI 10.1200/JCO.2004.07.099
PG 20
WC Oncology
SC Oncology
GA 770PJ
UT WOS:000188738900022
PM 14752077
ER

PT J
AU Ragde, H
   Korb, LJ
   Elgamal, AA
   Grado, GL
   Nadir, BS
AF Ragde, H
   Korb, LJ
   Elgamal, AA
   Grado, GL
   Nadir, BS
TI Modern prostate brachytherapy - Prostate specific antigen results in 219
   patients with up to 12 years of observed follow-up
SO CANCER
LA English
DT Article
DE prostate carcinoma; brachytherapy; iodine-125; prostate specific
   antigen; disease free survival; results; external beam radiation;
   radical prostatectomy
ID EXTERNAL-BEAM RADIATION; DISEASE-FREE SURVIVAL; CANCER; I-125;
   RADIOTHERAPY; IMPLANTATION; ULTRASOUND; CARCINOMA; THERAPY
AB BACKGROUND. The purported lack of long term modern prostate brachytherapy outcome data continues to lead many physicians to recommend other, more traditional treatments. This concern for long term results has encouraged the authors to supplement their earlier 10-year follow-up of patients receiving brachytherapy; in the process, an additional 77 patients (> 50%) were added to the original cohort, and the follow-up time was increased by 2 years.
   METHODS, Between January 1987 and September 1989, 229 patients with T1-T3 prostate carcinoma underwent transperineal prostate brachytherapy using iodine-125 (I-125). No patient received adjuvant hormone therapy. The median Gleason sum was 5 (range, 2-10). Of these patients, 147 were determined to have a high probability of organ-confined disease and were treated solely with an I-125 implant. The remaining 82 patients were determined to be at increased risk for extracapsular disease and received pelvic external beam radiation in addition to brachytherapy. All patients were followed continuously. Failure was defined as a positive biopsy, radiographic evidence of metastases, or three consecutive rises in prostate specific antigen (PSA) levels as defined by the American Society for Therapeutic Radiology and Oncology (ASTRO) consensus article.
   RESULTS. Excluding deaths from intercurrent disease, the median follow-up was 122 months (range, 18-144 months). Fourteen patients were excluded from analysis due to insufficient follow-up. Adopting the ASTRO definition of failure resulted in minimal change in survival when compared with the authors' previous study, which used a PSA level > 0.5 ng/mL as the failure point. Observed 10-year disease free survival (DFS) for the entire cohort was 70%. In the brachytherapy only group, the observed 10-year DFS was 66%, whereas those patients treated with the addition of external pelvic radiation achieved a DFS of 79%. None of the patients who were followed for the full 12 years failed between Years 10 and 12. Only 25% of the failures observed occurred > 5 years after treatment, thus confirming the durability of brachytherapy.
   CONCLUSIONS. Prostate brachytherapy provides excellent long term disease control with few late failures reported in the authors' program. The addition of external beam radiation appears to confer survival advantages in selected patients. Using the ASTRO failure criteria for long term follow-up resulted in no significant difference compared with using a PSA failure point of 0.5 ng/mL. (C) 2000 American Cancer Society.
C1 NW Prostate Inst, Seattle, WA 98133 USA.
   NW Biotherapeut, Seattle, WA USA.
RP Ragde, H (reprint author), NW Prostate Inst, Suite 300,10300 Meridan Ave N, Seattle, WA 98133 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Bice WS, 1998, INT J RADIAT ONCOL, V40, P1237, DOI 10.1016/S0360-3016(97)00949-8
   Blasko JC, 1996, UROL CLIN N AM, V23, P633, DOI 10.1016/S0094-0143(05)70342-6
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Grado GL, 1998, INT J RADIAT ONCOL, V42, P289, DOI 10.1016/S0360-3016(98)00209-0
   HOLM HH, 1983, J UROLOGY, V130, P283
   HUDSON R, 1999, BRACHYTHERAPY TREATM, V9, P1
   JOHANSSON JE, 1992, JAMA-J AM MED ASSOC, V267, P2191, DOI 10.1001/jama.267.16.2191
   Ragde H, 1997, SEMIN SURG ONCOL, V13, P438, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<438::AID-SSU8>3.0.CO;2-B
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stone N N, 1995, Tech Urol, V1, P72
   Wallner K, 1991, Oncology (Williston Park), V5, P115
   WALLNER K, 1991, ONCOLOGY HUNTINGTON, V5, P5
NR 18
TC 116
Z9 128
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0008-543X
J9 CANCER
JI Cancer
PD JUL 1
PY 2000
VL 89
IS 1
BP 135
EP 141
DI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
PG 7
WC Oncology
SC Oncology
GA 331KJ
UT WOS:000088017800019
PM 10897010
ER

PT J
AU Ferraris, VA
   Ferraris, SP
   Saha, SP
   Hessel, EA
   Haan, CK
   Royston, BD
   Bridges, CR
   Higgins, RSD
   Despotis, G
   Brown, JR
   Spiess, BD
   Shore-Lesserson, L
   Stafford-Smith, M
   Mazer, CD
   Bennett-Guerrero, E
   Hill, SE
   Body, S
AF Ferraris, Victor A.
   Ferraris, Suellen P.
   Saha, Sibu P.
   Hessel, Eugene A., II
   Haan, Constance K.
   Royston, B. David
   Bridges, Charles R.
   Higgins, Robert S. D.
   Despotis, George
   Brown, Jeremiah R.
   Spiess, Bruce D.
   Shore-Lesserson, Linda
   Stafford-Smith, Mark
   Mazer, C. David
   Bennett-Guerrero, Elliott
   Hill, Steven E.
   Body, Simon
CA Soc Thoracic Surgeons Blood
   Soc Cardiovascular Anesthe
TI Perioperative blood transfusion and blood conservation in cardiac
   surgery: The Society of Thoracic Surgeons and the Society of
   Cardiovascular Anesthesiologists Clinical Practice Guideline
SO ANNALS OF THORACIC SURGERY
LA English
DT Editorial Material
ID CORONARY-ARTERY-BYPASS; OPEN-HEART-SURGERY; ACUTE NORMOVOLEMIC
   HEMODILUTION; ACTIVATED CLOTTING TIME; HIGH-DOSE APROTININ;
   HEPARIN-COATED CIRCUITS; RECOMBINANT FACTOR VIIA; ACUTE
   MYOCARDIAL-INFARCTION; EPSILON-AMINOCAPROIC ACID; PLATELET-RICH PLASMA
AB Background. A minority of patients having cardiac procedures (15% to 20%) consume more than 80% of the blood products transfused at operation. Blood must be viewed as a scarce resource that carries risks and benefits. A careful review of available evidence can provide guidelines to allocate this valuable resource and improve patient outcomes.
   Methods. We reviewed all available published evidence related to blood conservation during cardiac operations, including randomized controlled trials, published observational information, and case reports. Conventional methods identified the level of evidence available for each of the blood conservation interventions. After considering the level of evidence, recommendations were made regarding each intervention using the American Heart Association/ American College of Cardiology classification scheme.
   Results. Review of published reports identified a high-risk profile associated with increased postoperative blood transfusion. Six variables stand out as important indicators of risk: ( 1) advanced age, ( 2) low preoperative red blood cell volume ( preoperative anemia or small body size), ( 3) preoperative antiplatelet or antithrombotic drugs, ( 4) reoperative or complex procedures, ( 5) emergency operations, and ( 6) noncardiac patient comorbidities. Careful review revealed preoperative and perioperative interventions that are likely to reduce bleeding and postoperative blood transfusion. Preoperative interventions that are likely to reduce blood transfusion include identification of high-risk patients who should receive all available preoperative and perioperative blood conservation interventions and limitation of antithrombotic drugs. Perioperative blood conservation interventions include use of antifibrinolytic drugs, selective use of off- pump coronary artery bypass graft surgery, routine use of a cell-saving device, and implementation of appropriate transfusion indications. An important intervention is application of a multimodality blood conservation program that is institution based, accepted by all health care providers, and that involves well thought out transfusion algorithms to guide transfusion decisions.
   Conclusions. Based on available evidence, institution-specific protocols should screen for high- risk patients, as blood conservation interventions are likely to be most productive for this high- risk subset. Available evidence-based blood conservation techniques include ( 1) drugs that increase preoperative blood volume ( eg, erythropoietin) or decrease postoperative bleeding ( eg, antifibrinolytics), ( 2) devices that conserve blood ( eg, intraoperative blood salvage and blood sparing interventions), ( 3) interventions that protect the patient's own blood from the stress of operation ( eg, autologous predonation and normovolemic hemodilution), ( 4) consensus, institution-specific blood transfusion algorithms supplemented with point-of-care testing, and most importantly, ( 5) a multimodality approach to blood conservation combining all of the above.
C1 Univ Kentucky, Albert B Chandler Med Ctr, Div Cardiovasc & Thorac Surg, Lexington, KY 40536 USA.
   Univ Florida, Jacksonville, FL 32209 USA.
   Univ Penn Hlth Syst, Philadelphia, PA USA.
   Harefield Hosp, London, England.
   Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA.
   Washington Univ, Med Ctr, St Louis, MO USA.
   Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Lebanon, NH USA.
   Virginia Commonwealth Univ, Richmond, VA USA.
   Montefiore Med Ctr, Bronx, NY 10467 USA.
   Duke Univ, Med Ctr, Durham, NC USA.
   Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada.
   Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.
RP Ferraris, VA (reprint author), Univ Kentucky, Albert B Chandler Med Ctr, Div Cardiovasc & Thorac Surg, CTW Bldg,Suite 320,900 S Limestone, Lexington, KY 40536 USA.
EM ferraris@earthlink.net
CR Abdel-Rahman U, 2006, HEART SURG FORUM, V9, pE543, DOI 10.1532/HSF98.20051110
   Abdel-Rahman U, 2005, ANN THORAC SURG, V80, P238, DOI 10.1016/j.athoracsur.2005.02.032
   Adams RC, 1942, SURG GYNECOL OBSTET, V74, P10
   AGGARWAL A, 2004, THROMB J, V2, P9, DOI 10.1186/1477-9560-2-9
   Agnelli G, 2000, HAEMOSTASIS, V30, P158
   AGNELLI G, 2000, HAEMOSTASIS       S2, V30, P146
   AKL BF, 1980, J THORAC CARDIOV SUR, V79, P97
   ALAJMO F, 1989, ANN THORAC SURG, V48, P536
   Aldea GS, 1996, ANN THORAC SURG, V62, P410, DOI 10.1016/0003-4975(96)00249-4
   Aldea GS, 1998, ANN THORAC SURG, V65, P425, DOI 10.1016/S0003-4975(97)01347-7
   ALDOURI M, 2000, BLOOD COAGUL FIBRIN, V11, P121
   Alghamdi AA, 2006, J CARDIAC SURG, V21, P320, DOI 10.1111/j.1540-8191.2006.00241.x
   ALVAREZ JM, 1995, J CARDIOTHOR VASC AN, V9, P29, DOI 10.1016/S1053-0770(05)80052-7
   Amand T, 2002, PERFUSION-UK, V17, P117, DOI 10.1191/0267659102pf544oa
   AUDET AM, 1992, ANN INTERN MED, V116, P403
   Andreasen JJ, 2004, EUR J CARDIO-THORAC, V26, P311, DOI 10.1016/j.ejcts.2004.03.012
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700
   ANSELL J, 1992, J THORAC CARDIOV SUR, V104, P117
   Appelblad M, 2002, J THORAC CARDIOV SUR, V124, P377, DOI 10.1067/mtc.2002.122303
   ARIS A, 1975, J THORAC CARDIOV SUR, V69, P183
   Armellin G, 1997, J CARDIOTHOR VASC AN, V11, P13, DOI 10.1016/S1053-0770(97)90245-7
   Ascione R, 2005, ANN THORAC SURG, V79, P1210, DOI 10.1016/j.arthoracsur.2004.09.046
   AuBuchon JP, 1997, ANN INTERN MED, V127, P904
   Avidan MS, 2004, BRIT J ANAESTH, V92, P178, DOI 10.1093/bja/aeh037
   BABKA R, 1977, J THORAC CARDIOV SUR, V73, P780
   Babka RM, 1997, PERFUSION-UK, V12, P187, DOI 10.1177/026765919701200307
   Bachet Jean, 1999, Cardiology Clinics, V17, P779, DOI 10.1016/S0733-8651(05)70114-4
   Badhe B A, 2000, Indian J Pathol Microbiol, V43, P297
   Baele P L, 1992, Acta Anaesthesiol Belg, V43, P103
   Baigent C, 2002, BRIT MED J, V324, P71
   BAILEY CR, 1994, BRIT J SURG, V81, P969, DOI 10.1002/bjs.1800810713
   Baksaas ST, 1999, PERFUSION-UK, V14, P119
   Banbury MK, 2006, J AM COLL SURGEONS, V202, P131, DOI 10.1016/j.jamcollsurg.2005.08.028
   BANNINGER H, 1993, BRIT J HAEMATOL, V85, P528
   BARBER A, 1985, AM J MED, V78, P761, DOI 10.1016/0002-9343(85)90280-3
   BARZU T, 1987, THROMB RES, V47, P601, DOI 10.1016/0049-3848(87)90365-3
   BASHEIN G, 1991, ARCH INTERN MED, V151, P89, DOI 10.1001/archinte.151.1.89
   BASU S, 1995, ANN THORAC SURG, V60, P1255, DOI 10.1016/0003-4975(95)00599-G
   Bata I, 1997, CIRCULATION, V96, P769
   Baufreton C, 1996, PERFUSION-UK, V11, P437, DOI 10.1177/026765919601100603
   Beholz S, 2001, PERFUSION-UK, V16, P485
   Beierlein W, 2005, ANN THORAC SURG, V79, P741, DOI 10.1016/j.athoracsur.2004.03.072
   Belboul A, 2000, J CARDIOVASC SURG, V41, P357
   Belisle S, 1996, ANN THORAC SURG, V62, P1908, DOI 10.1016/S0003-4975(96)00944-7
   Bellucci S, 2002, BLOOD REV, V16, P193, DOI 10.1016/S0268-960X(02)00030-9
   BENNETT J, 1992, DIS MONTH, V38, P581
   BennettGuerrero E, 1997, ANESTH ANALG, V85, P248, DOI 10.1097/00000539-199708000-00002
   BennettGuerrero E, 1997, ANESTHESIOLOGY, V87, P1373, DOI 10.1097/00000542-199712000-00017
   Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506
   Berdat PA, 2004, J THORAC CARDIOV SUR, V127, P1688, DOI 10.1016/j.jtcvs.2004.01.030
   BERGER RL, 1968, CIRCULATION, V37, P154
   Berkowitz SD, 2001, AM J CARDIOL, V88, P1230, DOI 10.1016/S0002-9149(01)02082-3
   Bernet F, 1999, J CARDIAC SURG, V14, P92, DOI 10.1111/j.1540-8191.1999.tb00956.x
   BERRUYER M, 1993, J THORAC CARDIOV SUR, V105, P892
   BERTRAND P, 1993, ARCH MAL COEUR VAISS, V86, P1471
   Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21
   Bingley JA, 2000, ANN THORAC SURG, V69, P1764, DOI 10.1016/S0003-4975(00)01250-9
   Brown Jeremiah R, 2006, N Engl J Med, V354, P1953
   Birmingham B, 2001, ANESTH ANALG, V93, P1627, DOI 10.1097/00000539-200112000-00075
   Bittl JA, 2001, AM HEART J, V142, P952, DOI 10.1067/mhj.2001.119374
   Bjessmo SA, 2000, SCAND CARDIOVASC J, V34, P438
   Blackstone EH, 2001, J THORAC CARDIOV SUR, V122, P430, DOI 10.1067/mtc.2001.117536
   Blanchard N, 2000, J CARDIOTHOR VASC AN, V14, P393, DOI 10.1053/jcan.2000.7925
   BLAUHUT B, 1994, J THORAC CARDIOV SUR, V108, P1083
   BLAUTH CI, 1990, J THORAC CARDIOV SUR, V99, P61
   Blumberg N, 2002, AM J CLIN PATHOL, V118, P376
   Blumenthal D., 1995, IMPROVING CLIN PRACT
   Boccara F, 1997, ARCH MAL COEUR VAISS, V90, P107
   Body SC, 1999, J CARDIOTHOR VASC AN, V13, P410, DOI 10.1016/S1053-0770(99)90212-4
   BOEY SK, 1993, CAN J ANAESTH, V40, P844
   Boga M, 2000, PERFUSION-UK, V15, P143
   BOLDT J, 1994, BRIT J ANAESTH, V73, P639, DOI 10.1093/bja/73.5.639
   BOLDT J, 1990, ANESTHESIOLOGY, V72, P282, DOI 10.1097/00000542-199002000-00013
   Boldt J, 1993, J Cardiothorac Vasc Anesth, V7, P4, DOI 10.1016/1053-0770(93)90110-7
   Boneu B, 1987, Transfus Med Rev, V1, P182, DOI 10.1016/S0887-7963(87)70020-0
   BOONSTRA PW, 1994, J THORAC CARDIOV SUR, V107, P289
   BOONSTRA PW, 1985, J THORAC CARDIOV SUR, V89, P900
   Boris WJ, 1996, J INVEST SURG, V9, P327, DOI 10.3109/08941939609012483
   Borowiec JW, 1997, J CARDIAC SURG, V12, P190, DOI 10.1111/j.1540-8191.1997.tb00122.x
   BOROWIEC JW, 1993, ANN THORAC SURG, V55, P1540
   Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x
   BRACEY AW, 1995, TRANSFUSION, V35, P850, DOI 10.1046/j.1537-2995.1995.351096026367.x
   Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7
   BRAY B, 1989, BIOCHEM J, V262, P225
   BREYER RH, 1987, J THORAC CARDIOV SUR, V93, P512
   BREYER RH, 1985, ANN THORAC SURG, V39, P27
   Brooker RF, 1998, ANN THORAC SURG, V65, P1651, DOI 10.1016/S0003-4975(98)00289-6
   Brown JR, 2006, NEW ENGL J MED, V354, P1954
   Brown RS, 1997, ANESTH ANALG, V85, P963, DOI 10.1097/00000539-199711000-00003
   BRUNKEN R, 1984, ANN THORAC SURG, V38, P406
   Bryson GL, 1998, ANESTH ANALG, V86, P9, DOI 10.1097/00000539-199801000-00003
   Buchman TG, 2006, J AM COLL SURGEONS, V202, P826, DOI 10.1016/j.jamcollsurg.2006.03.011
   BURNS ER, 1986, J THORAC CARDIOV SUR, V92, P310
   Cannon MA, 2003, J CARDIOTHOR VASC AN, V17, P565, DOI 10.1053/S1053-0770(03)00198-8
   Capraro L, 2001, ACTA ANAESTH SCAND, V45, P200, DOI 10.1034/j.1399-6576.2001.450211.x
   Caputo RP, 1997, AM J CARDIOL, V79, P1159, DOI 10.1016/S0002-9149(97)00074-X
   CARDOSO PFG, 1991, J THORAC CARDIOV SUR, V101, P153
   Carmichael FJL, 2001, TRANSFUS APHER SCI, V24, P17
   Carrera A, 1994, Rev Esp Anestesiol Reanim, V41, P13
   Carson JL, 2002, TRANSFUSION, V42, P812, DOI 10.1046/j.1537-2995.2002.00123.x
   CARTMILL TB, 1968, LANCET, V1, P752
   CASAS JI, 1995, J THORAC CARDIOV SUR, V110, P1107, DOI 10.1016/S0022-5223(05)80180-1
   Casati V, 2002, ANESTHESIOLOGY, V97, P367, DOI 10.1097/00000542-200208000-00013
   Casati V, 1999, ANN THORAC SURG, V68, P2252, DOI 10.1016/S0003-4975(99)00866-8
   Casati V, 2000, J THORAC CARDIOV SUR, V120, P520, DOI 10.1067/mtc.2000.108016
   Casella Gianni, 2003, Ital Heart J, V4, P677
   Castaman G, 2003, HAEMATOLOGICA, V88, P94
   CATTANEO M, 1995, THROMB HAEMOSTASIS, V74, P1064
   Chamberlin JR, 1999, CATHETER CARDIO INTE, V47, P143, DOI 10.1002/(SICI)1522-726X(199906)47:2<143::AID-CCD1>3.0.CO;2-M
   CHAPLER CK, 1986, CAN J PHYSIOL PHARM, V64, P7
   CHAUHAN S, 1998, ASIAN CARDIOVASC THO, V6, P270
   Chen YF, 2004, ANN THORAC SURG, V78, P634, DOI 10.1016/j.athoracsur.2004.02.091
   Chen YF, 2002, J THORAC CARDIOV SUR, V123, P218, DOI 10.1067/mtc.2002.119065
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cheng DCH, 2004, J THORAC CARDIOV SUR, V127, P79, DOI 10.1016/j.jtcvs.2003.08.024
   Chesebro J H, 1990, Thromb Res Suppl, V12, P5
   CHOAY J, 1983, BIOCHEM BIOPH RES CO, V116, P492
   Choussat R, 2000, EUR HEART J, V21, P662, DOI 10.1053/euhj.1999.1945
   Christiansen S, 2000, EUR J CARDIO-THORAC, V18, P353, DOI 10.1016/S1010-7940(00)00346-8
   Chung JH, 1996, CIRCULATION, V93, P2014
   CIVETTA JM, 1985, ANN SURG, V202, P524, DOI 10.1097/00000658-198510000-00013
   CLARK RE, 1979, J THORAC CARDIOV SUR, V78, P655
   Clark SC, 2000, ANN THORAC SURG, V69, P762, DOI 10.1016/S0003-4975(99)01366-1
   CMOLIK BL, 1993, J THORAC CARDIOV SUR, V105, P222
   Cohen E, 1993, J Cardiothorac Vasc Anesth, V7, P721, DOI 10.1016/1053-0770(93)90059-T
   COHN LH, 1997, ANN THORAC SURG S, V64, P80
   Cohn LH, 1997, ANN THORAC SURG, V64, P58
   Coletti G, 1995, Cardiovasc Surg, V3, P181, DOI 10.1016/0967-2109(95)90891-8
   COLLER BS, 1995, THROMB HAEMOSTASIS, V74, P302
   Collier B, 2002, ANN THORAC SURG, V74, P1191, DOI 10.1016/S0003-4975(02)03879-1
   Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507
   CORBEAU JJ, 1995, ANN FR ANESTH, V14, P154
   CORDELL AR, 1981, ANN THORAC SURG, V31, P421
   CORWIN HL, 1995, CHEST, V108, P767, DOI 10.1378/chest.108.3.767
   COSGROVE DM, 1992, ANN THORAC SURG, V54, P1031
   COSGROVE DM, 1985, ANN THORAC SURG, V40, P380
   Crocker Christopher H, 2002, J Invasive Cardiol, V14, P728
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Daane CR, 2003, PERFUSION-UK, V18, P115, DOI 10.1191/0267659103pf647oa
   Dalrymple-Hay MJR, 1999, EUR J CARDIO-THORAC, V15, P830, DOI 10.1016/S1010-7940(99)00112-8
   Dalrymple-Hay MJR, 2001, CARDIOVASC SURG, V9, P184, DOI 10.1016/S0967-2109(00)00100-9
   DAmbra MN, 1996, J THORAC CARDIOV SUR, V112, P1081, DOI 10.1016/S0022-5223(96)70110-1
   DAVIES MJ, 1988, MED J AUSTRALIA, V149, P517
   DAVIS PH, 1992, CURR OPIN NEUROL NEU, V5, P39
   DEARING JP, 1998, J EXP CORP TECH, V15, P17
   DeBois William, 2005, J Extra Corpor Technol, V37, P15
   DEBOIS W, 1998, BLOOD CONSERVATION C, P327
   DECATERINA R, 1994, BLOOD, V84, P3363
   DeFoe GR, 2001, ANN THORAC SURG, V71, P769, DOI 10.1016/S0003-4975(00)02393-6
   DEHAAN J, 1995, ANN THORAC SURG, V59, P901, DOI 10.1016/0003-4975(95)00012-A
   Deleuze P, 1990, ASAIO Trans, V36, pM179
   Demirkiran O, 2004, PEDIATR ANESTH, V14, P685, DOI 10.1111/j.1460-9592.2004.01257.x
   Despotis G, 2005, ANN THORAC SURG, V80, P3, DOI 10.1016/j.athersclerosis.2005.04.007
   Despotis GJ, 1996, THROMB HAEMOSTASIS, V76, P902
   Despotis GJ, 1996, ANESTH ANALG, V82, P13, DOI 10.1097/00000539-199601000-00004
   Despotis GJ, 1997, CLIN CHEM, V43, P1684
   DESPOTIS GJ, 1995, CRIT CARE MED, V23, P1674, DOI 10.1097/00003246-199510000-00011
   DESPOTIS GJ, 1994, TRANSFUSION, V34, P290, DOI 10.1046/j.1537-2995.1994.34494233575.x
   DESPOTIS GJ, 1995, J THORAC CARDIOV SUR, V110, P46, DOI 10.1016/S0022-5223(05)80008-X
   Despotis GJ, 1999, LANCET, V354, P106, DOI 10.1016/S0140-6736(98)12494-7
   deVarennes B, 1996, J CARDIAC SURG, V11, P387
   Dial S, 2005, J THORAC CARDIOV SUR, V130, P654, DOI 10.1016/j.jtcvs.2005.02.025
   Dial S, 2003, CHEST, V124, P1847, DOI 10.1378/chest.124.5.1847
   Dietrich W, 2002, ANESTH ANALG, V94, P1369, DOI 10.1097/00000539-200205000-00070
   Dietrich W, 2005, J CARDIOTHOR VASC AN, V19, P589, DOI 10.1053/j.jvca.2005.04.017
   DIETRICH W, 1989, J THORAC CARDIOV SUR, V97, P213
   Dietrich W, 1997, J THORAC CARDIOV SUR, V113, P194, DOI 10.1016/S0022-5223(97)70415-X
   Dignan RJ, 2001, ANN THORAC SURG, V71, P158, DOI 10.1016/S0003-4975(00)01860-9
   Dilthey G, 1993, J Cardiothorac Vasc Anesth, V7, P425, DOI 10.1016/1053-0770(93)90164-G
   Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244
   Diprose P, 2005, BRIT J ANAESTH, V94, P271, DOI 10.1093/bja/aei044
   DOAK GJ, 1995, ANESTH ANALG, V80, P910, DOI 10.1097/00000539-199505000-00010
   Dryden PJ, 1997, CAN J ANAESTH, V44, P934
   Dyke C, 1999, J CARDIOVASC SURG, V40, P505
   Dyke CM, 2000, ANN THORAC SURG, V70, P866, DOI 10.1016/S0003-4975(00)01654-4
   Dyke C M, 1999, Am Heart J, V138, P307
   Efstathiou A, 2003, J CARDIOVASC SURG, V44, P197
   Egan JR, 2004, INTENS CARE MED, V30, P682, DOI 10.1007/s00134-003-2108-1
   Eggebrecht H, 2002, CATHETER CARDIO INTE, V57, P486, DOI 10.1002/ccd.10254
   Eichert I, 2001, THORAC CARDIOV SURG, V49, P149, DOI 10.1055/s-2001-14291
   Eisses MJ, 2006, THROMB RES, V117, P689, DOI 10.1016/j.thromres.2005.05.028
   ENG J, 1990, EUR J CARDIO-THORAC, V4, P595, DOI 10.1016/1010-7940(90)90018-U
   Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9
   ERETH MH, 2001, J CARDIOTHOR VASC AN, V15, P539
   ERETH MH, 1993, ANESTHESIOLOGY, V79, pA527
   ERETH MH, 1993, ANESTHESIOLOGY, V79, P540, DOI 10.1097/00000542-199309000-00018
   Ereth MH, 2001, J CARDIOTHOR VASC AN, V15, P545, DOI 10.1053/jcan.2001.26525
   Fang WC, 1997, CIRCULATION, V96, P194
   FEINDT PR, 1995, ANN THORAC SURG, V60, P1076, DOI 10.1016/0003-4975(95)00525-P
   FERRARI M, 1987, INT J ARTIF ORGANS, V10, P47
   Ferraris VA, 1996, J THORAC CARDIOV SUR, V111, P731, DOI 10.1016/S0022-5223(96)70333-1
   FERRARIS VA, 1993, ANN THORAC SURG, V56, P433
   Ferraris VA, 2002, ANN SURG, V235, P820, DOI 10.1097/00000658-200206000-00009
   Ferraris VA, 1998, ANN THORAC SURG, V65, P352
   FERRARIS VA, 1988, ANN THORAC SURG, V45, P71
   Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008
   Ferraris VA, 1998, J THORAC CARDIOV SUR, V115, P593, DOI 10.1016/S0022-5223(98)70324-1
   FERRARIS VA, 1989, J THORAC CARDIOV SUR, V98, P492
   FERRARIS VA, 1995, TEX HEART I J, V22, P216
   Ferraris VA, 1998, J THORAC CARDIOVASC, V115, P602
   FIORE LD, 1990, AM J CLIN PATHOL, V94, P292
   FISCHLEIN T, 2000, HAMOSTASEOLOGIE, V20, P110
   FISHER JW, 1988, ANNU REV PHARMACOL, V28, P101
   Flom-Halvorsen HI, 2002, PERFUSION-UK, V17, P339, DOI 10.1191/0267659102pf594oa
   Fosse E, 1997, EUR J CARDIO-THORAC, V11, P320, DOI 10.1016/S1010-7940(96)01062-7
   FOULKE GE, 1989, CRIT CARE MED, V17, P1143, DOI 10.1097/00003246-198911000-00008
   FREMES SE, 1994, ANN THORAC SURG, V58, P1580
   Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X
   Fukutomi M, 1996, ARTIF ORGANS, V20, P767, DOI 10.1111/j.1525-1594.1996.tb04538.x
   FULLERTON DA, 1991, ANN THORAC SURG, V51, P825
   Gansera B, 2003, THORAC CARDIOV SURG, V51, P185
   GAUDIANI VA, 1991, ANN THORAC SURG, V51, P823
   Gaynor J William, 2003, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V6, P128, DOI 10.1053/pcsu.2003.50006
   GERRITSEN SW, 1978, BRIT J HAEMATOL, V40, P153, DOI 10.1111/j.1365-2141.1978.tb03649.x
   Gewirtz AS, 1996, ARCH PATHOL LAB MED, V120, P353
   GIORDANO GF, 1988, ANN THORAC SURG, V46, P416
   GIORDANO GF, 1989, ANN THORAC SURG, V47, P897
   Goa KL, 1999, DRUGS, V57, P439, DOI 10.2165/00003495-199957030-00015
   Goldberg MA, 1997, SEMIN HEMATOL, V34, P41
   GOLDMAN S, 1991, CIRCULATION, V84, P520
   GOLDMAN S, 1988, CIRCULATION, V77, P1324
   GOODNOUGH LT, 1993, AM J MED, V94, P509, DOI 10.1016/0002-9343(93)90086-5
   Goodnough LT, 1998, TRANSFUS SCI, V19, P97, DOI 10.1016/S0955-3886(98)00015-0
   Goodnough LT, 2003, LANCET, V361, P161, DOI 10.1016/S0140-6736(03)12195-2
   GOODNOUGH LT, 1993, SURG GYNECOL OBSTET, V177, P345
   GOODNOUGH LT, 1995, AM J SURG, V170, P16
   Goodnough LT, 2004, SEMIN HEMATOL, V41, P25, DOI 10.1053/j.seminhematol.2003.11.006
   GOODNOUGH LT, 1991, JAMA-J AM MED ASSOC, V265, P86, DOI 10.1001/jama.265.1.86
   GOODNOUGH LT, 1995, ANN THORAC SURG, V60, P473, DOI 10.1016/0003-4975(95)98960-3
   Goodnough L T, 2001, Am J Cardiovasc Drugs, V1, P337, DOI 10.2165/00129784-200101050-00004
   GOODNOUGH LT, 1990, ANN THORAC SURG, V50, P675
   Gott JP, 1998, ANN THORAC SURG, V66, P747, DOI 10.1016/S0003-4975(98)00695-X
   Gowda MS, 2003, ANGIOLOGY, V54, P211, DOI 10.1177/000331970305400211
   GRAVLEE GP, 1990, J THORAC CARDIOV SUR, V99, P518
   GRAVLEE GP, 1992, ANESTHESIOLOGY, V76, P393, DOI 10.1097/00000542-199203000-00012
   Green JA, 2003, ANESTH ANALG, V97, P1201, DOI 10.1213/01.ANE.0000077655.77618.B7
   GREEN K, 1987, THROMB RES, V48, P349, DOI 10.1016/0049-3848(87)90447-6
   Greilich Philip E., 2001, Circulation, V104, pI, DOI 10.1161/hc37t1.094781
   Groom RC, 2002, PERFUSION-UK, V17, P99, DOI 10.1191/0267659102pf548oa
   Grubitzsch H, 2001, CARDIOVASC SURG, V9, P510, DOI 10.1016/S0967-2109(01)00049-7
   Grunenfelder J, 2000, EUR J CARDIO-THORAC, V17, P77, DOI 10.1016/S1010-7940(99)00355-3
   GU YJ, 1993, ANN THORAC SURG, V55, P917
   GUFFIN AV, 1976, ANESTH ANALG, V55, P110
   Habib RH, 2003, J THORAC CARDIOV SUR, V125, P1438, DOI 10.1016/S0022-5223(02)125:1438-50
   HALL RI, 1990, CAN J ANAESTH, V37, P618
   Hall TS, 2002, CARDIOVASC SURG, V10, P146, DOI 10.1016/S0967-2109(01)00129-6
   Hankey GJ, 2000, STROKE, V31, P1779
   Hanrath P, 1997, CIRCULATION, V96, P1445
   HARDER MP, 1991, ANN THORAC SURG, V51, P936
   HARDING SA, 1975, J THORAC CARDIOV SUR, V70, P350
   Hardy JF, 1998, ANN THORAC SURG, V65, P371, DOI 10.1016/S0003-4975(97)01016-3
   Hardy JF, 1997, J CARDIAC SURG, V12, P15, DOI 10.1111/j.1540-8191.1997.tb00083.x
   HARDY JF, 1993, CAN J ANAESTH, V40, P625
   Hardy JF, 2001, CAN J ANAESTH S, V48, P24
   HARKE H, 1977, ANAESTHESIST, V26, P64
   HARRINGTON RA, 1995, AM J CARDIOL, V76, P1222, DOI 10.1016/S0002-9149(99)80345-2
   Hashimoto H, 1997, AM J MANAG C, V3, P1141
   Hattori T, 2005, J AM COLL CARDIOL, V46, P707, DOI 10.1016/j.jacc.2005.05.040
   HAY WW, 1989, PEDIATRICS, V83, P717
   Hayashida N, 1997, J THORAC CARDIOV SUR, V114, P261, DOI 10.1016/S0022-5223(97)70154-5
   HAYS LJ, 1988, AM HEART J, V115, P717, DOI 10.1016/0002-8703(88)90870-8
   Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601
   Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618
   Hebert PC, 2001, CRIT CARE MED, V29, P227
   HEDDLE NM, 1993, TRANSFUSION, V33, P794, DOI 10.1046/j.1537-2995.1993.331094054613.x
   Hein OV, 2005, ARTIF ORGANS, V29, P507, DOI 10.1111/j.1525-1594.2005.29084.x
   HELM R, 1998, BLOOD CONSERVATION C, P631
   HELM R, 1998, ERYTHROPOIETIN CARDI
   Helm RE, 1998, ANN THORAC SURG, V65, P125, DOI 10.1016/S0003-4975(97)01004-7
   Helm RE, 1996, ANN THORAC SURG, V62, P1431, DOI 10.1016/0003-4975(96)00755-2
   Henry DA, 2001, COCHRANE DB SYST REV, V1
   HERBERTSON M, 2004, BLOOD COAGUL FIBRIN, V15, P31
   Herwaldt LA, 2003, INFECT CONT HOSP EP, V24, P44, DOI 10.1086/502114
   HESSEL EA, 1980, J THORAC CARDIOV SUR, V80, P111
   HICKS GL, 1979, ARCH SURG-CHICAGO, V114, P1285
   HILGARTN.M, 1965, J THORAC CARDIOV SUR, V49, P974
   Hill SE, 2002, J CARDIOTHOR VASC AN, V16, P695, DOI 10.1053/jcan.2002.128416
   Hill SE, 2000, ANN THORAC SURG, V69, P1070, DOI 10.1016/S0003-4975(99)01442-3
   HIRSH J, 1995, CHEST S, V108, P247
   HIRSH J, 1991, NEW ENGL J MED, V324, P1565
   HOFFMAN WS, 1982, ANN THORAC SURG, V34, P71
   Hohn L, 2002, ANESTHESIOLOGY, V96, P276
   Hongo RH, 2002, J AM COLL CARDIOL, V40, P231, DOI 10.1016/S0735-1097(02)01954-X
   HORROW JC, 1991, CIRCULATION, V84, P2063
   Huang HM, 2003, ANN THORAC SURG, V76, P136, DOI 10.1016/S0003-4975(03)00264-9
   HUBER R, 1994, EUR SURG RES, V26, P210, DOI 10.1159/000129338
   HULL RD, 1986, NEW ENGL J MED, V315, P1109, DOI 10.1056/NEJM198610303151801
   Hunter D, 2006, NEW ENGL J MED, V354, P329, DOI 10.1056/NEJMp058235
   HVASS U, 1995, EUR J CARDIO-THORAC, V9, P75, DOI 10.1016/S1010-7940(05)80022-3
   Hyllner M, 2005, EUR J CARDIO-THORAC, V28, P254, DOI 10.1016/j.ejcts.2005.04.021
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   ILABACA PA, 1980, ANN THORAC SURG, V30, P281
   Ilmakunnas M, 2005, J THORAC CARDIOV SUR, V129, P851, DOI 10.1016/j.jtcvs.2004.07.061
   Inada E, 1990, J Clin Anesth, V2, P393, DOI 10.1016/0952-8180(90)90026-Y
   Ishida T, 2002, Kyobu Geka, V55, P763
   ISRAELS SJ, 1994, AM J PEDIAT HEMATOL, V16, P249
   Iturbe Teodoro, 1997, Sangre (Saragossa), V42, P387
   Jakics J, 1999, J Anesth, V13, P8, DOI 10.1007/s005400050014
   JAKOB H, 1992, EUR J CARDIO-THORAC, V1, P59
   Jakob H, 1984, Circulation, V70, pI138
   Jamnicki M, 2003, J CARDIOTHOR VASC AN, V17, P747, DOI 10.1053/j.jvca.2003.09.018
   JAN KM, 1977, AM J PHYSIOL, V233, pH106
   Jarvis B, 2000, DRUGS, V60, P347, DOI 10.2165/00003495-200060020-00012
   JENICEK M, 2002, FDN EVIDENCE BASED M
   Jeremias A, 2004, CIRCULATION, V109, P1930, DOI 10.1161/01.CIR.0000127105.99982.21
   JETER EK, 1990, ANN CLIN LAB SCI, V20, P79
   Jewell AE, 2003, EUR J CARDIO-THORAC, V23, P633, DOI 10.1016/S1010-7940(02)00834-5
   JOBES DR, 1981, ANN THORAC SURG, V31, P161
   JOBES DR, 1995, J THORAC CARDIOV SUR, V110, P36, DOI 10.1016/S0022-5223(05)80007-8
   JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   JONES JW, 1991, ANN THORAC SURG, V51, P541
   JONES JW, 1990, ANN THORAC SURG, V49, P585
   Jones KW, 2002, CIRCULATION S1, V106, pI19
   Jones RH, 2005, J AM COLL CARDIOL, V45, P1529, DOI 10.1016/j.jacc.2005.03.012
   Jovin IS, 2003, INT J CARDIOL, V92, P235, DOI 10.1016/s0167-5273(03)00091-3
   Jubelirer S J, 1992, W V Med J, V88, P510
   JUMEAN HG, 1983, ACTA HAEMATOL-BASEL, V70, P392
   Juran N B, 1999, Am J Crit Care, V8, P303
   Kabakus N, 2000, HAEMATOLOGIA, V30, P107, DOI 10.1163/15685590051130128
   Kahraman S, 1997, ACTA ANAESTH SCAND, V41, P614
   KALLIS P, 1994, EUR J CARDIO-THORAC, V8, P404, DOI 10.1016/1010-7940(94)90081-7
   Kaplan M, 2002, HEART SURG FORUM, V5, P60
   Karaiskos TE, 2004, ANN THORAC SURG, V78, P1339, DOI 10.1016/j.athorascur.2004.04.040
   Karkouti K, 2001, TRANSFUSION, V41, P1193, DOI 10.1046/j.1537-2995.2001.41101193.x
   Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x
   Karkouti K, 2005, ANN THORAC SURG, V80, P1381, DOI 10.1016/j.athoracsur.2005.03.137
   Karkouti K, 2006, CAN J ANAESTH, V53, P279
   Karrillon GJ, 1996, CIRCULATION, V94, P1519
   Kasper J F, 1992, QRB Qual Rev Bull, V18, P129
   Kazui T, 2001, ANN THORAC SURG, V72, P509, DOI 10.1016/S0003-4975(01)02777-1
   KEELER JF, 1991, ANAESTHESIA, V46, P925, DOI 10.1111/j.1365-2044.1991.tb09848.x
   KEELING MM, 1983, ANN SURG, V197, P536, DOI 10.1097/00000658-198305000-00006
   KELTON JG, 1980, SEMIN HEMATOL, V17, P259
   Kenny D, 1999, BLOOD, V93, P2968
   KESTIN AS, 1993, BLOOD, V82, P107
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Khanna MP, 2003, TRANSFUS MED REV, V17, P110, DOI 10.1053/tmrv.2003.50008
   Kiessling Arndt-H, 2004, Asian Cardiovasc Thorac Ann, V12, P198
   Kincaid EH, 2003, ANN THORAC SURG, V76, P124, DOI 10.1016/S0003-4975(03)00190-5
   Kincaid EH, 2005, ANN THORAC SURG, V80, P1388, DOI 10.1016/j.athoracsur.2005.03-136
   King KE, 2004, TRANSFUSION, V44, P25, DOI 10.1046/j.0041-1132.2004.00609.x
   Kiyama H, 1998, Kyobu Geka, V51, P741
   Kiyama H, 1999, ANN THORAC SURG, V68, P1652, DOI 10.1016/S0003-4975(99)00755-9
   Kiziltepe U, 2001, ANN THORAC SURG, V71, P684, DOI 10.1016/S0003-4975(00)02518-2
   Knutson JE, 2000, ANESTH ANALG, V90, P801
   Kochamba GS, 1996, ANN THORAC SURG, V61, P900, DOI 10.1016/0003-4975(95)01155-2
   Kogan A, 2004, J CARDIOVASC SURG, V45, P569
   Komiya T, 1998, Jpn J Thorac Cardiovasc Surg, V46, P961
   Kong DF, 1999, CIRCULATION, V100, P2049
   Koscielny J, 2004, CLIN APPL THROMB-HEM, V10, P155, DOI 10.1177/107602960401000206
   Koster A, 2004, AM J CARDIOL, V93, P356, DOI 10.1016/j.amjcard.2003.10.021
   Koster A, 2005, J THORAC CARDIOV SUR, V129, P1391, DOI 10.1016/j.jtcvs.2004.09.016
   Kreisler KR, 2005, J CARDIOTHOR VASC AN, V19, P608, DOI 10.1053/j.jvca.2005.07.003
   Kuitunen AH, 1997, ANN THORAC SURG, V63, P438
   KUITUNEN AH, 1992, ANN CHIR GYNAECOL FE, V81, P11
   KULIER AH, 1993, ANESTH ANALG, V76, P102
   Kwapisz MM, 1999, EUR J CARDIO-THORAC, V16, P256
   LANE DA, 1986, J BIOL CHEM, V261, P3980
   LAUB GW, 1993, CHEST, V104, P686, DOI 10.1378/chest.104.3.686
   Laupacis A, 1997, ANESTH ANALG, V85, P1258, DOI 10.1097/00000539-199712000-00014
   LAVEE J, 1989, J THORAC CARDIOV SUR, V97, P204
   LAZENBY WD, 1990, CIRCULATION, V82, P413
   Lederer DJ, 2005, J HEART LUNG TRANSPL, V24, P1697, DOI 10.1016/j.healun.2004.11.015
   Lee J, 1997, Minerva Cardioangiol, V45, P395
   Lee LY, 2002, PERFUSION-UK, V17, P33, DOI 10.1191/0267659102pf532oa
   LEFEMINE AA, 1985, AM SURGEON, V51, P274
   Lemmer JH, 2000, ANN THORAC SURG, V69, P90, DOI 10.1016/S0003-4975(99)01132-7
   LEMMER JH, 2000, ANN THORAC SURG S, V70, P33
   LEMMER JH, 1994, J THORAC CARDIOV SUR, V107, P543
   LEMMER JH, 1995, ANN THORAC SURG, V59, P132, DOI 10.1016/0003-4975(94)00813-M
   Lemmer JH, 1996, ANN THORAC SURG, V62, P1659, DOI 10.1016/S0003-4975(96)00451-1
   Levy JH, 2002, J THORAC CARDIOV SUR, V124, P35, DOI 10.1067/mtc.2002.121505
   LEVY JH, 1995, CIRCULATION, V92, P2236
   Lewis CE, 2005, J CARDIAC SURG, V20, P513, DOI 10.1111/j.1540-8191.2005.00137.x
   LEWISOHN R, 1955, SURG GYNECOL OBSTET, V101, P362
   Ley S J, 2001, AACN Clin Issues, V12, P606, DOI 10.1097/00044067-200111000-00017
   LIDDICOAT JE, 1975, ANN SURG, V181, P747, DOI 10.1097/00000658-197505000-00033
   Lilly KJ, 2002, PERFUSION-UK, V17, P95, DOI 10.1191/0267659102pf547oa
   Lincoff AM, 2004, AM J CARDIOL, V93, P1092, DOI 10.1016/j.amjcard.2004.01.033
   LINDAHL AK, 1991, THROMB RES, V64, P155, DOI 10.1016/0049-3848(91)90115-D
   Linden JV, 2000, TRANSFUSION, V40, P1207, DOI 10.1046/j.1537-2995.2000.40101207.x
   LINDEN JV, 1992, TRANSFUSION, V32, P601, DOI 10.1046/j.1537-2995.1992.32792391030.x
   Linneweber J, 2002, INT J ARTIF ORGANS, V25, P549
   Litmathe J, 2003, THORAC CARDIOV SURG, V51, P17, DOI 10.1055/s-2003-37281
   LIU B, 1993, SCAND J THORAC CARD, V27, P149, DOI 10.3109/14017439309099103
   Liu B, 1996, PERFUSION-UK, V11, P131, DOI 10.1177/026765919601100207
   LIVIO M, 1982, LANCET, V2, P1013
   Locatelli A, 1990, Minerva Anestesiol, V56, P973
   Loewen P, 1998, CAN J CARDIOL, V14, P717
   LOWENSTEIN E, 1981, CLEVELAND CLIN Q, V48, P112
   Lubbe Dieter F, 2002, J Interv Cardiol, V15, P85, DOI 10.1111/j.1540-8183.2002.tb01037.x
   Lust RM, 1996, ASAIO J, V42, pM819
   Maccario M, 1994, Minerva Anestesiol, V60, P315
   Machraoui A, 1997, J INVASIVE CARDIOL, V9, P171
   Mackinlay N, 2000, HAEMOPHILIA, V6, P84
   Madi-Jebara SN, 2004, J CARDIOTHOR VASC AN, V18, P59, DOI 10.1053/j.jvca.2003.10.012
   Magovern JA, 1996, ANN THORAC SURG, V61, P27, DOI 10.1016/0003-4975(95)00808-X
   Mahaffey KW, 1996, AM J CARDIOL, V77, P551, DOI 10.1016/S0002-9149(97)89305-8
   Mahaffey Kenneth W, 2003, J Invasive Cardiol, V15, P611
   Mahoney CB, 1999, EUR J CARDIO-THORAC, V16, P206, DOI 10.1016/S1010-7940(99)00157-8
   Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798
   Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379
   Mann MJ, 2005, J HEART LUNG TRANSPL, V24, P222, DOI 10.1016/j.healun.2003.11.401
   Marquez J, 1992, J Cardiothorac Vasc Anesth, V6, P674, DOI 10.1016/1053-0770(92)90049-D
   Marso SP, 2000, CIRCULATION, V102, P2952
   Martens S, 2001, INT J ARTIF ORGANS, V24, P484
   Martin J, 2000, J THORAC CARDIOV SUR, V120, P499, DOI 10.1067/mtc.2000.108691
   Marumoto Akira, 2005, Ann Thorac Cardiovasc Surg, V11, P48
   MATHEW J, 1995, CHEST, V108, P73, DOI 10.1378/chest.108.1.73
   Mathew TC, 1997, ANN THORAC SURG, V64, P1059, DOI 10.1016/S0003-4975(97)00763-7
   MATHRU M, 1991, CRIT CARE MED, V19, P700, DOI 10.1097/00003246-199105000-00017
   Matot I, 2002, ANESTHESIOLOGY, V97, P794, DOI 10.1097/00000542-200210000-00008
   MAYER ED, 1985, SCAND J THORAC CARD, V19, P165, DOI 10.3109/14017438509102713
   Maze Y, 2003, Kyobu Geka, V56, P765
   McCarthy PM, 1999, ANN THORAC SURG, V67, P1268, DOI 10.1016/S0003-4975(99)00136-8
   MCCARTHY PM, 1988, MAYO CLIN PROC, V63, P225
   McDonald SB, 2002, ANESTHESIOLOGY, V97, P509, DOI 10.1097/00000542-200208000-00033
   McDonald SB, 2005, J CARDIOTHOR VASC AN, V19, P4, DOI 10.1053/j.jvca.2004.11.002
   MEANS RT, 1994, HEMATOL ONCOL CLIN N, V8, P933
   Medalion B, 2003, J THORAC CARDIOV SUR, V126, P1875, DOI 10.1016/S0022-5223(03)01324-2
   Mehra A. P., 1994, Perfusion, V9, P357, DOI 10.1177/026765919400900508
   Menges T, 1996, J CARDIOTHOR VASC AN, V10, P482, DOI 10.1016/S1053-0770(05)80009-6
   Menges T, 1997, EUR J CARDIO-THORAC, V11, P557, DOI 10.1016/S1010-7940(96)01093-7
   Menichetti A, 1996, J CARDIOVASC SURG, V37, P401
   Merry AF, 2004, ANN THORAC SURG, V77, P925, DOI 10.1016/j.athoracsur.2003.09.061
   MERVILLE C, 1991, ANN FR ANESTH, V10, P548, DOI 10.1016/S0750-7658(05)80293-X
   METZ S, 1990, ANN THORAC SURG, V49, P440
   MEYER BJ, 1996, J SCHWEIZ MED WOCHEN, V126, P1961
   Michelson AD, 1999, BRIT J HAEMATOL, V104, P64, DOI 10.1046/j.1365-2141.1999.01146.x
   MICHELSON EL, 1980, AM J SURG, V139, P313, DOI 10.1016/0002-9610(80)90284-6
   MINAMI K, 1993, J THORAC CARDIOV SUR, V106, P934
   Mirow N, 2001, ARTIF ORGANS, V25, P480, DOI 10.1046/j.1525-1594.2001.025006480.x
   Mirow N, 2001, J CARDIOVASC SURG, V42, P579
   Misfeld M, 1998, ANN THORAC SURG, V66, P792, DOI 10.1016/S0003-4975(98)00646-8
   Misoph M, 1997, THORAC CARDIOV SURG, V45, P302, DOI 10.1055/s-2007-1013753
   Mitsumaru A, 2001, ASAIO J, V47, P692, DOI 10.1097/00002480-200111000-00024
   Miyagi Y, 2001, Ann Thorac Cardiovasc Surg, V7, P250
   Miyatake Tsukasa, 2005, Jpn J Thorac Cardiovasc Surg, V53, P317
   MOEN O, 1995, ANN THORAC SURG, V60, P1317, DOI 10.1016/0003-4975(95)00777-I
   Moen O, 1996, PERFUSION-UK, V11, P113, DOI 10.1177/026765919601100205
   MOHR R, 1986, J THORAC CARDIOV SUR, V92, P434
   MOHR R, 1988, J THORAC CARDIOV SUR, V96, P530
   MOLLNES TE, 1991, ANN THORAC SURG, V52, P92
   Mongan PD, 1998, ANESTH ANALG, V87, P258, DOI 10.1097/00000539-199808000-00005
   MONGAN PD, 1992, ANESTHESIOLOGY, V77, P38, DOI 10.1097/00000542-199207000-00007
   MONK TG, 2004, CRIT CARE S2, V8, P45
   Monk TG, 1999, ANESTHESIOLOGY, V91, P24, DOI 10.1097/00000542-199907000-00008
   MONK TG, 1995, AM J SURG, V170, P69
   Montenegro LM, 1998, J CARDIOTHOR VASC AN, V12, P480, DOI 10.1016/S1053-0770(98)90207-5
   MOODY DM, 1995, ANN THORAC SURG, V59, P1304, DOI 10.1016/0003-4975(95)00057-R
   MORAN JM, 1978, J THORAC CARDIOV SUR, V76, P510
   Morgan IS, 1998, EUR J CARDIO-THORAC, V13, P526, DOI 10.1016/S1010-7940(98)00067-0
   MORIAU M, 1977, VOX SANG, V32, P41
   Morice MC, 1998, J INVASIVE CARDIOL, V10, P457
   MORRIS JJ, 1994, ANN THORAC SURG, V58, P502
   Moskowitz DM, 2004, ANN THORAC SURG, V77, P626, DOI 10.1016/S0003-4975(03)01345-6
   Moulton MJ, 1996, J THORAC CARDIOV SUR, V111, P1037, DOI 10.1016/S0022-5223(96)70380-X
   MUELLERECKHARDT C, 1986, BRIT J HAEMATOL, V64, P419, DOI 10.1111/j.1365-2141.1986.tb02198.x
   Mullen JC, 2002, CAN J SURG, V45, P166
   Muller C, 2000, CIRCULATION, V101, P590
   MULLER DWM, 1992, AM J CARDIOL, V69, P63, DOI 10.1016/0002-9149(92)90677-Q
   Munoz JJ, 1999, ANN THORAC SURG, V68, P1321, DOI 10.1016/S0003-4975(99)00728-6
   MUNTEAN W, 1994, ACTA PAEDIATR, V83, P84, DOI 10.1111/j.1651-2227.1994.tb12958.x
   MURPHY DA, 1983, J THORAC CARDIOV SUR, V85, P864
   Murphy GS, 2004, ANESTH ANALG, V98, P1201, DOI 10.1213/01.ANE.0000112306.71113.5E
   Myhre Ulf, 2004, Asian Cardiovasc Thorac Ann, V12, P3
   Nakagawa M, 2001, AM J MED GENET, V99, P286, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1176>3.0.CO;2-T
   Nakajima T, 2000, ANN THORAC SURG, V70, P186, DOI 10.1016/S0003-4975(00)01389-8
   Nakajima T, 2005, ANN THORAC SURG, V79, P1793, DOI 10.1016/j.athoracsur.2003.12.059
   NATAF P, 1989, ARCH MAL COEUR VAISS, V82, P1869
   Ng HJ, 2003, ANN HEMATOL, V82, P257, DOI 10.1007/s00277-003-0633-1
   NIINIKOSKI J, 1984, SCAND J THORAC CARD, V18, P57, DOI 10.3109/14017438409099385
   Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048
   NILSSON INGA MARIE, 1963, THROMBOSIS ET DIATHESIS HAEMORRHAGICA, V10, P223
   Nollert G, 2005, ANN THORAC SURG, V80, P2326, DOI 10.1016/j.athoracsur.2005.05.080
   Nugent W C, 1994, Qual Lett Healthc Lead, V6, P11
   NUGENT WC, 1994, ANN THORAC SURG, V58, P1866
   Nuttall GA, 2001, ANESTHESIOLOGY, V94, P773, DOI 10.1097/00000542-200105000-00014
   Nuttall GA, 2003, J CARDIOTHOR VASC AN, V17, P447, DOI 10.1016/S1053-0770(03)00148-4
   Nuttall GA, 2001, ANESTHESIOLOGY, V94, p775A
   Nuttall GA, 2000, ANESTHESIOLOGY, V92, P674, DOI 10.1097/00000542-200003000-00010
   OCONNOR GT, 1991, JAMA-J AM MED ASSOC, V266, P803, DOI 10.1001/jama.266.6.803
   Oba J, 2000, Jpn J Thorac Cardiovasc Surg, V48, P129
   OCONNOR GT, 1992, CIRCULATION, V85, P2110
   OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841
   O'Gara P J, 2000, J Extra Corpor Technol, V32, P207
   OKIES JE, 1977, J THORAC CARDIOV SUR, V74, P440
   Okita Y, 1997, CIRCULATION, V96, P376
   Okita Y, 1996, CIRCULATION, V94, P177
   OLDS RJ, 1993, GENOMICS, V16, P298, DOI 10.1006/geno.1993.1184
   Olivencia-Yurvati A. H., 2002, Perfusion (London), V17, P35, DOI 10.1191/0267659102pf552oa
   Oliver WC, 2000, ANN THORAC SURG, V70, P1923, DOI 10.1016/S0003-4975(00)02176-7
   Olsson C, 2000, ANN THORAC SURG, V69, P743, DOI 10.1016/S0003-4975(99)01502-7
   ONODA K, 1994, ARTIF ORGANS, V18, P706, DOI 10.1111/j.1525-1594.1994.tb03404.x
   Or T H, 1991, Ma Zui Xue Za Zhi, V29, P586
   Ortel TL, 2001, ANN SURG, V233, P88, DOI 10.1097/00000658-200101000-00014
   Osaka M, 1998, Jpn J Thorac Cardiovasc Surg, V46, P846
   OTAKI M, 1993, CHEST, V104, P1431, DOI 10.1378/chest.104.5.1431
   OTT DA, 1977, JAMA-J AM MED ASSOC, V238, P1256, DOI 10.1001/jama.238.12.1256
   OTTESEN S, 1984, SCAND J THORAC CARD, V18, P123, DOI 10.3109/14017438409102391
   Ovrum E, 2001, J THORAC CARDIOV SUR, V121, P324, DOI 10.1067/mtc.2001.111205
   OVRUM E, 1991, SCAND J THORAC CARD, V25, P13, DOI 10.3109/14017439109098077
   Ozkisacik E, 2001, J CARDIOVASC SURG, V42, P741
   PAGE R, 1989, ANN THORAC SURG, V48, P514
   Paglino JC, 2004, TRANSFUSION, V44, P16, DOI 10.1046/j.0041-1132.2004.00608.x
   Palanzo David A., 1995, Perfusion, V10, P265, DOI 10.1177/026765919501000410
   Palatianos GM, 2004, ANN THORAC SURG, V77, P956, DOI 10.1016/j.athoracsur.2003.10.004
   Palatianos G M, 1991, ASAIO Trans, V37, P620
   Palatianos GM, 2003, ANN THORAC SURG, V76, P129, DOI 10.1016/S0003-4975(03)00338-2
   Pang JTW, 2002, J CARDIAC SURG, V17, P425
   Paparella D, 2005, BLOOD COAGUL FIBRIN, V16, P323
   PARKER JL, 1979, CARDIOVASC DIS, V6, P78
   PAROLARI A, 1995, EUR J CARDIO-THORAC, V9, P77, DOI 10.1016/S1010-7940(05)80023-5
   PAROLARI A, 1995, J CARDIAC SURG, V10, P227, DOI 10.1111/j.1540-8191.1995.tb00603.x
   Parr KG, 2003, J CARDIOTHOR VASC AN, V17, P176, DOI 10.1053/jcan.2003.44
   Parrot D, 1991, J Cardiothorac Vasc Anesth, V5, P454, DOI 10.1016/1053-0770(91)90119-E
   Pedersen TH, 1997, ANN THORAC SURG, V63, P1333, DOI 10.1016/S0003-4975(97)00098-2
   DEPEPPO AP, 1995, TEX HEART I J, V22, P231
   PERTTILA J, 1995, ACTA ANAESTH SCAND, V39, P445
   PERUZZI WT, 1993, CRIT CARE MED, V21, P501, DOI 10.1097/00003246-199304000-00007
   Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB
   Peterson P, 1998, ARCH SURG-CHICAGO, V133, P134, DOI 10.1001/archsurg.133.2.134
   PETITTI DB, 2000, METAANALYSIS DECISIO, P115
   PETRY AF, 1994, J THORAC CARDIOV SUR, V107, P1210
   PFISTERER M, 1989, LANCET, V2, P1
   Philippou H, 2000, THROMB HAEMOSTASIS, V84, P124
   PIFARRE R, 1997, NEW ANTICOAGULANTS C, P1
   PINEDA AA, 1975, TRANSFUSION, V15, P10
   Pivalizza EG, 2003, ANAESTHESIA, V58, P603, DOI 10.1046/j.1365-2044.2003.03207_8.x
   Pleym H, 2004, ANESTH ANALG, V98, P578, DOI 10.1213/01.ANE.0000100682.84799.E8
   Pleym H, 2003, ANESTH ANALG, V96, P923, DOI 10.1213/01.ANE.0000054001.37346.03
   POPOVSKY MA, 1985, MAYO CLIN PROC, V60, P125
   Porte RJ, 2002, DRUGS, V62, P2193, DOI 10.2165/00003495-200262150-00003
   Pothula S, 2004, ANESTH ANALG, V98, P4, DOI 10.1213/01.ANE.0000093227.95876.F4
   PREISS DU, 1985, KLIN WOCHENSCHR, V63, P252, DOI 10.1007/BF01731470
   PREISSNER KT, 1985, BIOCHEM J, V231, P349
   Price S, 2005, ANESTH ANALG, V101, P325, DOI 10.1213/01.ANE.0000159158.70532.D0
   PUGH SC, 1995, J CARDIOTHOR VASC AN, V9, P240, DOI 10.1016/S1053-0770(05)80314-3
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Pychyńska-Pokorska Magdalena, 2004, Pediatr Crit Care Med, V5, P246, DOI 10.1097/01.PCC.0000123546.78900.67
   PAPACONSTANTINOU C, 1981, SCAND J THORAC CARD, V15, P213, DOI 10.3109/14017438109101048
   Raivio P, 2005, ANN THORAC SURG, V80, P66, DOI 10.1016/j.athoracsur.2005.02.044
   RALPHEDWARDS A, 1994, ANN THORAC SURG, V58, P429
   Raman JS, 2003, INT J ARTIF ORGANS, V26, P753
   Ramnath AN, 2003, J THORAC CARDIOV SUR, V125, P1432, DOI 10.1016/S0022-5223(03)00105-3
   Rand M L, 1998, Acta Paediatr Suppl, V424, P57
   Ranucci M, 1996, ANN THORAC SURG, V61, P76, DOI 10.1016/0003-4975(95)00820-9
   Ray JG, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-3
   REDMOND JM, 1993, ANN THORAC SURG, V56, P474
   Reents W, 1999, ANN THORAC SURG, V68, P58, DOI 10.1016/S0003-4975(99)00472-5
   Reffelmann T, 1998, Z KARDIOL, V87, P872, DOI 10.1007/s003920050243
   Reich D L, 1991, J Cardiothorac Vasc Anesth, V5, P142, DOI 10.1016/1053-0770(91)90327-P
   RELMAN AS, 1988, NEW ENGL J MED, V319, P1220, DOI 10.1056/NEJM198811033191810
   Remadi Jean Paul, 2006, Am Heart J, V151, P198
   Remadi JP, 2004, J THORAC CARDIOV SUR, V128, P436, DOI 10.1016/j.jtcvs.2004.01.041
   REYNOLDS LM, 1993, J THORAC CARDIOV SUR, V106, P954
   RICHARDS KM, 1991, J CARDIOVASC SURG, V32, P840
   Rimpilainen J, 2000, J THORAC CARDIOV SUR, V120, P1131, DOI 10.1067/mtc.2000.111050
   ROBERTIE PG, 1990, INT ANESTHESIOL CLIN, V28, P197, DOI 10.1097/00004311-199002840-00004
   ROBERTS SR, 1991, AM J SURG, V162, P477, DOI 10.1016/0002-9610(91)90265-F
   ROCHA E, 1994, CIRCULATION, V90, P921
   ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41
   ROSENGART TK, 1994, ANN THORAC SURG, V58, P1397
   Rosengart TK, 1997, J AM COLL SURGEONS, V184, P618
   Rossi M, 1997, J CARDIOTHOR VASC AN, V11, P835, DOI 10.1016/S1053-0770(97)90116-6
   ROTH JA, 1979, ANN THORAC SURG, V28, P69
   ROUSOU J, 1989, J THORAC CARDIOV SUR, V97, P194
   Royston D, 2001, BRIT J ANAESTH, V86, P575, DOI 10.1093/bja/86.4.575
   ROYSTON D, 1987, LANCET, V2, P1289
   Royston D, 2006, EXPERT OPIN DRUG SAF, V5, P539, DOI 10.1517/14740338.5.4.539
   Rubens FD, 1998, J THORAC CARDIOV SUR, V116, P641, DOI 10.1016/S0022-5223(98)70172-2
   SADE RM, 1980, ANN THORAC SURG, V29, P502
   Saenz A, 1996, EUR J CARDIO-THORAC, V10, P48, DOI 10.1016/S1010-7940(96)80265-X
   Sakert T, 1996, PERFUSION-UK, V11, P71, DOI 10.1177/026765919601100110
   Sakurada T, 1997, Nihon Kyobu Geka Gakkai Zasshi, V45, P836
   SALAMA A, 1988, NEW ENGL J MED, V318, P408, DOI 10.1056/NEJM198802183180704
   Salmenperä M, 1991, J Cardiothorac Vasc Anesth, V5, P146, DOI 10.1016/1053-0770(91)90328-Q
   SANBORN TA, 1993, J AM COLL CARDIOL, V22, P1273
   SANDRELLI L, 1995, ANN THORAC SURG, V59, P730, DOI 10.1016/0003-4975(94)01055-2
   Santamaria A, 2000, HAEMATOLOGICA, V85, P1277
   Santini F, 1997, G Ital Cardiol, V27, P141
   SANZ G, 1990, CIRCULATION, V82, P765
   Savino JS, 2002, J CARDIOTHOR VASC AN, V16, P149, DOI 10.1053/jcan.2002.31055
   Scavetta K, 1999, ANGIOLOGY, V50, P891, DOI 10.1177/000331979905001103
   SCHAFF HV, 1978, J THORAC CARDIOV SUR, V75, P632
   Scher KS, 1996, AM SURGEON, V62, P52
   Schimmer A, 1998, TRANSFUS SCI, V19, P217, DOI 10.1016/S0955-3886(98)00033-2
   Schlag G, 1998, J THORAC CARDIOV SUR, V116, P1082
   Schmid C, 1998, THORAC CARDIOV SURG, V46, P260, DOI 10.1055/s-2007-1010235
   Schmidt H, 1996, ANN THORAC SURG, V61, P1177, DOI 10.1016/0003-4975(96)00002-1
   SCHONBERGER JPAM, 1994, ANN THORAC SURG, V57, P1256
   Scholz M, 2002, INFLAMM RES, V51, P363, DOI 10.1007/PL00000316
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Schved JF, 2005, TRANSFUS CLIN BIOL, V12, P365, DOI 10.1016/j.tracli.2005.10.009
   Schwann TA, 2001, ANN THORAC SURG, V71, P530
   Schwann TA, 2001, ANN THORAC SURG, V71, P521, DOI 10.1016/S0003-4975(00)02038-5
   Scott DA, 2001, J CARDIOTHOR VASC AN, V15, P322, DOI 10.1053/jcan.2001.23279
   SCOTT WJ, 1990, ANN THORAC SURG, V50, P843
   SCOTT WJ, 1992, J THORAC CARDIOV SUR, V103, P1001
   Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041
   SEEBURGER J, 2005, CIRCULATION S1, V112, P224
   SEGUIN JR, 1994, ANN THORAC SURG, V58, P304
   Sellman M, 1997, EUR J CARDIO-THORAC, V11, P521, DOI 10.1016/S1010-7940(96)01111-6
   SETHI GK, 1990, J AM COLL CARDIOL, V15, P15
   SEYBERT AL, 2002, PHARMACOTHERAPY S, V22, P112
   Shah AC, 2000, SCHWEIZ MED WSCHR, V130, P896
   SHERIDAN DP, 1994, CAN J SURG, V37, P33
   SHERMAN MM, 1976, CHEST, V70, P592, DOI 10.1378/chest.70.5.592
   Shimpo H, 1997, CHEST, V111, P1565, DOI 10.1378/chest.111.6.1565
   SHORELESSERSON L, 1995, ANESTH ANALG, V81, P229, DOI 10.1097/00000539-199508000-00004
   Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016
   Shore-Lesserson L, 1998, CAN J ANAESTH, V45, P10
   Shore-Lesserson Linda, 2003, Anesthesiol Clin North America, V21, P511, DOI 10.1016/S0889-8537(03)00036-1
   Silliman CC, 1997, TRANSFUSION, V37, P719, DOI 10.1046/j.1537-2995.1997.37797369448.x
   SILVER MJ, 1993, CRIT CARE MED, V21, P507, DOI 10.1097/00003246-199304000-00008
   SILVESTRY SC, 2000, ANN THORAC SURG S, V70, P12
   SIMON TL, 1984, ANN THORAC SURG, V37, P359
   Sinci V, 1999, Ann Thorac Cardiovasc Surg, V5, P156
   Skubas NJ, 1999, ANESTHESIOLOGY, V91, P869, DOI 10.1097/00000542-199909000-00042
   SMOLLER BR, 1989, AM J CLIN PATHOL, V91, P701
   SOBEL M, 1991, J CLIN INVEST, V87, P1787, DOI 10.1172/JCI115198
   Sohrabi F, 2003, J INVEST MED, V51, P27, DOI 10.2310/6650.2003.33529
   SOLOMON MD, 1988, TRANSFUSION, V28, P379, DOI 10.1046/j.1537-2995.1988.28488265272.x
   Sonzogni V, 2001, BRIT J ANAESTH, V87, P429, DOI 10.1093/bja/87.3.429
   Sowade O, 1997, BLOOD, V89, P411
   Spahn DR, 2002, ANESTHESIOLOGY, V97, P1338, DOI 10.1097/00000542-200212000-00004
   SPAHN DR, 1993, J THORAC CARDIOV SUR, V105, P694
   Spanier T, 2000, PERFUSION-UK, V15, P427
   Speekenbrink RGH, 1996, J THORAC CARDIOV SUR, V112, P523, DOI 10.1016/S0022-5223(96)70281-7
   SPEEKENBRINK RGH, 1995, ANN THORAC SURG, V59, P438, DOI 10.1016/0003-4975(94)00865-5
   SPENCE RK, 1992, J VASC SURG, V16, P825
   SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9
   Spiess Bruce D, 2004, Semin Cardiothorac Vasc Anesth, V8, P267, DOI 10.1177/108925320400800402
   Spiess BD, 2004, TRANSFUSION, V44, P1143, DOI 10.1111/j.1537-2995.2004.03322.x
   Spiess BD, 1998, J THORAC CARDIOV SUR, V116, P460, DOI 10.1016/S0022-5223(98)70012-1
   SPIESS BD, 1995, J CARDIOTHOR VASC AN, V9, P168, DOI 10.1016/S1053-0770(05)80189-2
   Spiess BD, 2005, CRIT CARE MED, V33, P1871, DOI 10.1097/01.CCM.0000174499.98087.40
   Stammers A H, 1999, J Extra Corpor Technol, V31, P135
   Stefanou DC, 2001, PERFUSION-UK, V16, P51
   STEHLING L, 1991, TRANSFUSION, V31, P857, DOI 10.1046/j.1537-2995.1991.31992094675.x
   STEHLING L, 1994, TRANSFUSION, V34, P438, DOI 10.1046/j.1537-2995.1994.34594249058.x
   STEIN PD, 1995, CHEST S, V108, P424
   STELZER P, 1989, CIRCULATION, V80, P209
   Stiles KP, 2001, J NEPHROL, V14, P275
   Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009
   Stratmann G, 2003, ANN THORAC SURG, V76, P2094, DOI 10.1016/S0003-4975(03)01052-X
   SUBRAMANIAN VA, 1976, ANN THORAC SURG, V21, P48
   Suehiro S, 1999, Ann Thorac Cardiovasc Surg, V5, P225
   SURGENOR DM, 1992, TRANSFUSION, V32, P458, DOI 10.1046/j.1537-2995.1992.32592327721.x
   Surgenor SD, 2006, CIRCULATION S1, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271
   Suttner S, 2004, ANESTH ANALG, V99, P2, DOI 10.1213/01.ANE.0000120163.44315.47
   Svenmarker S, 2001, EUR J CARDIO-THORAC, V19, P47, DOI 10.1016/S1010-7940(00)00625-4
   Svenmarker S, 2003, SCAND CARDIOVASC J, V37, P158, DOI 10.1090/14017430310001465
   Svenmarker S, 2002, SCAND CARDIOVASC J, V36, P241, DOI 10.1080/14017430260180418
   SVENNEVIG JL, 1993, J THORAC CARDIOV SUR, V106, P466
   SWART MJ, 1994, ANAESTH INTENS CARE, V22, P529
   Szczerkowski Paweł, 2003, Ann Acad Med Stetin, V49, P247
   TABAK C, 1981, J THORAC CARDIOV SUR, V81, P30
   TABUCHI N, 1993, J THORAC CARDIOV SUR, V106, P828
   TABUCHI N, 1994, EUR J CARDIO-THORAC, V8, P87, DOI 10.1016/1010-7940(94)90098-1
   Taggart D P, 1990, Ann Thorac Surg, V50, P424
   Takarabe K, 1997, ARTIF ORGANS, V21, P760, DOI 10.1111/j.1525-1594.1997.tb03737.x
   Tassani P, 1999, J CARDIOTHOR VASC AN, V13, P285, DOI 10.1016/S1053-0770(99)90265-3
   Tcheng JE, 2001, CIRCULATION, V104, P870, DOI 10.1161/hc3301.094533
   TEMECK BK, 1994, SOUTHERN MED J, V87, P611, DOI 10.1097/00007611-199406000-00006
   Tempe D, 1996, J CARDIOTHOR VASC AN, V10, P502, DOI 10.1016/S1053-0770(05)80012-6
   Tempe DK, 2001, J CARDIOTHOR VASC AN, V15, P326, DOI 10.1053/jcan.2001.23282
   TEOH KH, 1988, J THORAC CARDIOV SUR, V96, P332
   TEOH KHT, 1993, CIRCULATION, V88, P420
   Stehling LC, 1996, ANESTHESIOLOGY, V84, P732
   THELIN S, 1991, EUR J CARDIO-THORAC, V5, P486, DOI 10.1016/1010-7940(91)90145-A
   Thomas D P, 1980, Scand J Haematol Suppl, V36, P40
   THURER RL, 1979, ANN THORAC SURG, V27, P500
   TOBE CE, 1993, J THORAC CARDIOV SUR, V105, P1007
   Tobias Joseph D, 2004, J Intensive Care Med, V19, P270, DOI 10.1177/0885066604267783
   Torres IP, 2005, AM J PHYSIOL-HEART C, V288, pH1071, DOI 10.1152/ajpheart.00884.2004
   Tron Christophe, 2003, J Interv Cardiol, V16, P217, DOI 10.1034/j.1600-0854.2003.8044.x
   Tsai AG, 2004, TRANSFUSION, V44, P1626, DOI 10.1111/j.0041-1132.2004.04128.x
   TSUJINAKA T, 1988, JPN J SURG, V18, P430, DOI 10.1007/BF02471469
   TurnerGomes SO, 1997, ANN THORAC SURG, V63, P482
   TYSON GS, 1989, ANN SURG, V209, P736, DOI 10.1097/00000658-198906000-00011
   Utley J R, 1990, Semin Thorac Cardiovasc Surg, V2, P292
   Utley J R, 1990, J Card Surg, V5, P177, DOI 10.1111/j.1540-8191.1990.tb01036.x
   VALERI CR, 1992, J THORAC CARDIOV SUR, V104, P108
   van der Linden J, 2005, CIRCULATION S9, V112, P276
   van Bommel J, 2001, TRANSFUSION, V41, P1515, DOI 10.1046/j.1537-2995.2001.41121515.x
   VANDERKAMP KWHJ, 1993, INT J ARTIF ORGANS, V16, P836
   VANDERMEER J, 1994, J AM COLL CARDIOL, V24, P1181
   VANDERMEER J, 1993, LANCET, V342, P257, DOI 10.1016/0140-6736(93)91815-4
   van de Watering LMG, 1998, CIRCULATION, V97, P562
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Vanek T, 2004, JPN HEART J, V45, P855, DOI 10.1536/jhj.45.855
   VANPAPENDRECHT MAH, 1992, EUR J SURG, V158, P83
   VANWOERKENS ECSM, 1992, ANESTH ANALG, V75, P818
   VERSKA JJ, 1977, ANN THORAC SURG, V24, P170
   Vertrees RA, 1996, ANN THORAC SURG, V62, P717, DOI 10.1016/S0003-4975(96)00390-6
   VIDEM V, 1992, J THORAC CARDIOV SUR, V103, P806
   VIELE MK, 1994, TRANSFUSION, V34, P396, DOI 10.1046/j.1537-2995.1994.34594249050.x
   Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071
   Vlahakes GJ, 2006, NEW ENGL J MED, V354, P413, DOI 10.1056/NEJMe058272
   von Heymann C, 2005, CRIT CARE MED, V33, P2241, DOI 10.1097/01.CCM.0000181527.47749.57
   von Heymann C, 2003, J THORAC CARDIOV SUR, V126, P1667, DOI 10.1067/S0022-5223(03)01198-X
   VONSEGESSER LK, 1993, TEX HEART I J, V20, P28
   VONSEGESSER LK, 1994, ANN THORAC SURG, V58, P391
   VONSEGESSER LK, 1992, J THORAC CARDIOV SUR, V103, P790
   WAGNER WR, 1994, ANN THORAC SURG, V58, P734
   Wahba A., 1995, Perfusion, V10, P333, DOI 10.1177/026765919501000509
   WAHL GW, 1992, ANN THORAC SURG, V53, P625
   Wajon P, 2001, ANESTH ANALG, V93, P536, DOI 10.1097/00000539-200109000-00004
   Wallis JP, 2002, TRANSFUSION, V42, P1127, DOI 10.1046/j.1537-2995.2002.00181.x
   WALPOTH BH, 1990, SCHWEIZ MED WSCHR, V120, P817
   Walpoth BH, 1999, INT J ARTIF ORGANS, V22, P210
   WANG IW, 1995, ASAIO J, V41, pM782, DOI 10.1097/00002480-199507000-00120
   WARD HB, 1993, ANN THORAC SURG, V56, P137
   WEISEL RD, 1984, J THORAC CARDIOV SUR, V88, P26
   Weiskopf RB, 2001, ANESTHESIOLOGY, V94, P439, DOI 10.1097/00000542-200103000-00013
   Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217
   Weiskopf RB, 2002, ANESTHESIOLOGY, V97, P773, DOI 10.1097/00000542-200210000-00003
   Weiss BM, 1996, J CARDIOTHOR VASC AN, V10, P464, DOI 10.1016/S1053-0770(05)80005-9
   Weitz JI, 2002, THROMB RES, V106, P275
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   Welsby IJ, 2005, ANAESTHESIA, V60, P1203, DOI 10.1111/j.1365-2044.2005.04376.x
   Westerberg M, 2004, ANN THORAC SURG, V78, P54, DOI 10.1016/j.athoracsur.2003.12.029
   WHEELDON D R, 1990, Perfusion (London), V5, P135, DOI 10.1177/026765919000500207
   Wheeldon N, 1997, CATHETER CARDIO DIAG, V42, P249, DOI 10.1002/(SICI)1097-0304(199711)42:3<249::AID-CCD2>3.0.CO;2-C
   Wiesenack C, 2004, ARTIF ORGANS, V28, P1082, DOI 10.1111/j.1525-1594.2004.00030.x
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
   WINTON TL, 1982, ANN THORAC SURG, V33, P379
   WISLOFF F, 1981, SCAND J HAEMATOL, V27, P45
   Wittenstein Birgit, 2005, Pediatr Crit Care Med, V6, P473, DOI 10.1097/01.PCC.0000162449.55887.B9
   Wong BI, 2000, ANN THORAC SURG, V69, P808, DOI 10.1016/S0003-4975(99)01419-8
   WONG CA, 1994, ANESTH ANALG, V78, P29
   WU HF, 1995, BLOOD, V85, P421
   Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615
   Yamagishi I, 1998, Ann Thorac Cardiovasc Surg, V4, P294
   Yamak B, 1999, J HEART VALVE DIS, V8, P665
   Yang Xin, 2005, J Am Coll Cardiol, V46, P1490, DOI 10.1016/j.jacc.2005.06.072
   YASUDA M, 1995, INT IMMUNOL, V7, P251, DOI 10.1093/intimm/7.2.251
   Yazer MH, 2004, TRANSFUSION, V44, P10, DOI 10.1046/j.0041-1132.2003.00518.x
   Yende S, 2001, CRIT CARE MED, V29, P2271, DOI 10.1097/00003246-200112000-00006
   Yip HK, 2000, JPN HEART J, V41, P697, DOI 10.1536/jhj.41.697
   Yoda M, 2004, Kyobu Geka, V57, P367
   Yoda M, 2004, SURG TODAY, V34, P21, DOI 10.1007/s00595-003-2641-0
   YOMTOVIAN R, 1993, TRANSFUSION, V33, P902, DOI 10.1046/j.1537-2995.1993.331194082380.x
   Yoon YS, 1999, AM J CARDIOL, V84, P1375, DOI 10.1016/S0002-9149(99)00579-2
   Yoshikai M, 1996, ARTIF ORGANS, V20, P704, DOI 10.1111/j.1525-1594.1996.tb04507.x
   Yoshikawa Y, 1994, Kyobu Geka, V47, P1059
   YOUNG JA, 1978, ANN THORAC SURG, V26, P231
   Zabeeda D, 2002, ANN THORAC SURG, V74, P733, DOI 10.1016/S0003-4975(02)03784-0
   ZADEH B J, 1987, Perfusion (London), V2, P263, DOI 10.1177/026765918700200404
   Zemour G, 1996, ARCH MAL COEUR VAISS, V89, P291
   ZIMMERMAN JL, 1993, CRIT CARE MED, V21, P495, DOI 10.1097/00003246-199304000-00006
   ZOGNO M, 1991, J CARDIAC SURG, V6, P396, DOI 10.1111/j.1540-8191.1991.tb00336.x
   ZURICK AM, 1982, ANN THORAC SURG, V34, P608
NR 756
TC 115
Z9 116
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAY
PY 2007
VL 83
IS 5
SU 1
BP 27
EP 86
DI 10.1016/j.athoracsur.2007.02.099
PG 60
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 160LZ
UT WOS:000245944100001
ER

PT J
AU Sylvester, JE
   Blasko, JC
   Grimm, PD
   Meier, R
   Malmgren, JA
AF Sylvester, JE
   Blasko, JC
   Grimm, PD
   Meier, R
   Malmgren, JA
TI Ten-year biochemical relapse-free survival after external beam radiation
   and brachytherapy for localized prostate cancer: The Seattle experience
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostatic neoplasms; radiotherapy; brachytherapy; prostate
ID PERMANENT INTERSTITIAL BRACHYTHERAPY; RADICAL PROSTATECTOMY; GLEASON
   GRADE; NEEDLE-BIOPSY; RADIOTHERAPY; CARCINOMA; THERAPY; IMPLANTATION;
   RISK
AB Purpose: The role of external beam radiation therapy in addition to brachytherapy continues to be scrutinized for long term control of PSA levels after prostate cancer diagnosis.
   Methods and Materials: We report 10-year biochemical relapse-free survival (BRFS) on 232 patients presenting with localized prostate cancer and consecutively treated with iodine(125) (I-125) or palladium(103) (Pd-103) brachytherapy and neoadjuvant external beam radiation therapy. Multivariate regression analysis was used to create a pretreatment clinical prognostic risk model using a modified ASTRO consensus definition (two consecutive rises in serum PSA) as the outcome. Gleason scoring was performed by pathologists at a small community hospital. Derived risk categories are the following: low = PSA less than or equal to10 ng/mL, Gleason sum score <7, and stage <T2c; intermediate = PSA > 10 ng/mL or Gleason Score greater than or equal to7 or stage greater than or equal toT2c (I intermediate risk factor); and high = 2 or more intermediate risk factors. Time to PSA failure (local, distant, or biochemical) was calculated and compared using Kaplan-Meier plots.
   Results: Ten-year BRFS for the entire treatment group was 70%. Biochemical control rates by risk cohort analysis (95% confidence interval): low risk, 85% (83.3-90.7%); intermediate risk, 77% (73.0-84.5%); and high risk, 45% (45.4-57.2%). Using a risk grouping proposed by the Mt. Sinai group, the BRFS was: low risk, 84%; intermediate risk, 93%; and high risk, 57%. Grouping by the risk classification used by D'Amico, the BRFS was: low risk, 86%; intermediate risk, 90%; and high risk, 48%.
   Conclusions I-125 or Pd-103 brachytherapy, as a boost combined with EBRT, continues to result in high rates of biochemical control at 10 years. Different risk group classification schemes lead to different BRFS results. (C) 2003 Elsevier Inc.
C1 Swedish Med Ctr, Seattle Prostate Inst, Seattle, WA 98115 USA.
   Stevens Hosp, Swedish Canc Ctr, Edmonds, WA USA.
   HealthStat Consulting Inc, Seattle, WA USA.
   Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
RP Sylvester, JE (reprint author), Swedish Med Ctr, Seattle Prostate Inst, 1101 Madison,Suite 1101, Seattle, WA 98115 USA.
CR Beyer David C., 1995, International Journal of Radiation Oncology Biology Physics, V32, P254, DOI 10.1016/0360-3016(95)97887-7
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   DAMICO AV, 2002, COMMUNICATION
   D'Amico AV, 2000, J CLIN ONCOL, V18, P1164
   Dattoli M, 1999, INT J RADIAT ONCOL, V45, P853, DOI 10.1016/S0360-3016(99)00259-X
   Epstein JI, 2000, AM J SURG PATHOL, V24, P477, DOI 10.1097/00000478-200004000-00001
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Grimm PD, 1994, ATLAS UROL CLIN N AM, V2, P113
   HILARIS B, 1991, INTERVENTIONAL RAD T, P235
   Iczkowski KA, 1998, AM J SURG PATHOL, V22, P1169, DOI 10.1097/00000478-199810000-00001
   Kupelian PA, 1997, INT J RADIAT ONCOL, V37, P1043, DOI 10.1016/S0360-3016(96)00590-1
   Lederman GS, 2001, INT J RADIAT ONCOL, V49, P1297, DOI 10.1016/S0360-3016(00)01442-5
   Lee LN, 2002, INT J RADIAT ONCOL, V52, P444, DOI 10.1016/S0360-3016(01)02598-6
   Merrick GS, 2001, INT J RADIAT ONCOL, V51, P41, DOI 10.1016/S0360-3016(01)01594-2
   Nath R, 1998, MED PHYS, V25, P2293, DOI 10.1118/1.598440
   Potters L, 1999, CANCER J SCI AM, V5, P301
   Potters L, 2001, INT J RADIAT ONCOL, V50, P605, DOI 10.1016/S0360-3016(01)01473-0
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Steinberg DM, 1997, AM J SURG PATHOL, V21, P566, DOI 10.1097/00000478-199705000-00010
   Stock RG, 1997, SEMIN SURG ONCOL, V13, P454, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<454::AID-SSU10>3.0.CO;2-T
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   Sylvester J, 1997, J SURG ONCOL, V66, P65, DOI 10.1002/(SICI)1096-9098(199709)66:1<65::AID-JSO13>3.0.CO;2-N
   Sylvester J, 1999, MOL UROL, V3, P231
   Sylvester J, 2000, MOL UROL, V4, P155
   Sylvester J. E., 2002, International Journal of Radiation Oncology Biology Physics, V54, P38, DOI 10.1016/S0360-3016(02)03120-6
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
NR 27
TC 115
Z9 125
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD NOV 15
PY 2003
VL 57
IS 4
BP 944
EP 952
DI 10.1016/S0360-3016(03)00739-9
PG 9
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 738NB
UT WOS:000186293800006
PM 14575824
ER

PT J
AU McKhann, GM
   Grega, MA
   Borowicz, LM
   Baumgartner, WA
   Selnes, OA
AF McKhann, GM
   Grega, MA
   Borowicz, LM
   Baumgartner, WA
   Selnes, OA
TI Stroke and encephalopathy after cardiac surgery - An update
SO STROKE
LA English
DT Review
DE brain injuries; cardiovascular surgical procedures; cerebrovascular
   accident; coronary artery bypass; outcome assessment
ID CORONARY-ARTERY-BYPASS; HYPOTHERMIC CIRCULATORY ARREST; POSTOPERATIVE
   ATRIAL-FIBRILLATION; NEURONAL NITRIC-OXIDE; WHITE-MATTER LESIONS;
   LENGTH-OF-STAY; GRAFT-SURGERY; CARDIOPULMONARY BYPASS; ON-PUMP;
   ASCENDING AORTA
AB Background and Purpose - As a result of advances in surgical, anesthetic, and medical management, cardiac surgery can now be performed on older, sicker patients, some of whom have had prior cardiac interventions. As surgical mortality has declined in recent years, attention has focused on the complications of stroke and encephalopathy after cardiac surgery.
   Summary of Review - Patients with preexisting cerebrovascular disease are at increased risk for these untoward neurological outcomes, which are associated with longer lengths of hospital stay, higher costs, and greater mortality. The mechanisms underlying these neurological events may include microemboli and hypoperfusion during surgery, and postoperative atrial fibrillation. Predictive models, based on information available before surgery, allow identification of these "high risk" patients.
   Conclusion - Establishing the degree of functionally significant vascular disease of the brain before surgery should be an essential part of the preoperative evaluation, particularly when modifications in surgical technique or novel neuroprotective agents are being evaluated.
C1 Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.
RP McKhann, GM (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurol, 338 Krieger Hall,3400 N Charles St, Baltimore, MD 21218 USA.
EM guy.mckhann@jhu.edu
CR Abu-Omar Y, 2004, J THORAC CARDIOV SUR, V127, P1759, DOI 10.1016/j.jtves.2003.09.048
   Andrell P, 2003, CARDIOLOGY, V99, P20, DOI 10.1159/000068447
   Andrell P, 2005, ANN THORAC SURG, V79, P74, DOI 10.1016/j.athoracsur.2004.06.085
   Ascione R, 2002, ANN THORAC SURG, V74, P474, DOI 10.1016/S0003-4975(02)03727-X
   Baumgartner WA, 2005, ANN THORAC SURG, V79, pS2254, DOI 10.1016/j.athoracsur.2005.02.081
   Bendszus M, 2002, ARCH NEUROL-CHICAGO, V59, P1090, DOI 10.1001/archneur.59.7.1090
   BRETELER MMB, 1994, NEUROLOGY, V44, P1246
   BREUER AC, 1983, STROKE, V14, P682
   Brock MV, 1996, ANN THORAC SURG, V62, P1313, DOI 10.1016/0003-4975(96)00775-8
   Brooker RF, 1998, ANN THORAC SURG, V65, P1651, DOI 10.1016/S0003-4975(98)00289-6
   Brown WR, 2000, STROKE, V31, P707
   Bucerius J, 2004, J THORAC CARDIOV SUR, V127, P57, DOI 10.1016/S0022-5223(03)01281-9
   Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9
   Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475
   Charlesworth DC, 2003, ANN THORAC SURG, V76, P436, DOI 10.1016/S0003-4975(03)00528-9
   COFFEY CE, 1983, NEUROLOGY, V33, P1416
   Crystal E, 2004, COCHRANE DB SYST REV, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2005.12.015
   Dacey LJ, 2005, ANN THORAC SURG, V79, P532, DOI 10.1016/j.athoracsur.2004.07.027
   DAVILAROMAN VG, 1994, STROKE, V25, P2010
   Davila-Roman VG, 1999, J AM COLL CARDIOL, V33, P1308, DOI 10.1016/S0735-1097(99)00034-0
   Djaiani G, 2004, STROKE, V35, pE356, DOI 10.1161/01.STR.0000138783.63858.62
   Durand DJ, 2004, ANN THORAC SURG, V78, P159, DOI 10.1016/j.athorascur.2004.02.024
   Eissa A, 2003, ANZ J SURG, V73, P697, DOI 10.1046/j.1445-2197.2003.02740.x
   Elkins JS, 2005, NEUROLOGY, V64, P1750, DOI 10.1212/01.WNL.0000161850.01792.77
   Emmrich P, 2003, Z KARDIOL, V92, P925, DOI 10.1007/s00392-003-1007-3
   Engelman D T, 1999, Heart Surg Forum, V2, P242
   Eriksson M, 2002, SCAND CARDIOVASC J, V36, P250, DOI 10.1080/14017430260180436
   Friday G, 2005, HEART SURG FORUM, V8, pE105, DOI 10.1532/HSF98.20041146
   Fuchs S, 2002, CIRCULATION, V106, P86, DOI 10.1161/01.CIR.0000020678.16325.E0
   GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6
   Gootjes EC, 2005, MAYO CLIN PROC, V80, P350
   Goto T, 2001, ANN THORAC SURG, V72, P137, DOI 10.1016/S0003-4975(01)02676-5
   Grega MA, 2003, ANN THORAC SURG, V75, P1387, DOI 10.1016/S0003-4975(02)04993-7
   Grigore AM, 2002, ANESTH ANALG, V94, P4, DOI 10.1097/00000539-200201000-00002
   Hangler HB, 2003, J THORAC CARDIOV SUR, V126, P391, DOI 10.1016/S0022-5223(03)00395-7
   Hillis AE, 2003, CEREBROVASC DIS, V16, P236, DOI 10.1159/000071122
   Hillis Argye E, 2004, Curr Atheroscler Rep, V6, P274, DOI 10.1007/s11883-004-0058-x
   Jellinger KA, 2005, J NEUROL SCI, V229, P57, DOI 10.1016/j.jns.2004.11.029
   Kapetanakis EI, 2004, ANN THORAC SURG, V78, P1564, DOI 10.1016/j.athoracsur.2004.05.019
   Knipp SC, 2004, EUR J CARDIO-THORAC, V25, P791, DOI 10.1016/j.ejcts.2004.02.012
   Kovari E, 2004, STROKE, V35, P410, DOI 10.1161/01.STR.0000110791.51378.4E
   Lahtinen J, 2004, ANN THORAC SURG, V77, P1241, DOI 10.1016/j.athoracsur.2003.09.077
   Levetan Claresa S, 2004, Endocr Pract, V10 Suppl 2, P34
   Likosky DS, 2003, STROKE, V34, P2830, DOI 10.1161/01.STR.0000098650.12386.B3
   Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9
   Mackensen GB, 2003, BRIT J ANAESTH, V91, P656, DOI 10.1093/bja/aeg234
   MARTIN WRW, 1982, CAN J NEUROL SCI, V9, P21
   Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720
   McAlister FA, 2003, DIABETES CARE, V26, P1518, DOI 10.2337/diacare.26.5.1518
   McKhann GM, 2002, ARCH NEUROL-CHICAGO, V59, P1422, DOI 10.1001/archneur.59.9.1422
   McKhann GM, 2005, NEUROLOGY, V65, P991, DOI 10.1212/01.wnl.0000175220.78475.99
   McKhann GM, 1997, ANN THORAC SURG, V63, P516
   Millar K, 2001, BRIT J ANAESTH, V86, P63, DOI 10.1093/bja/86.1.63
   Mullges W, 2001, ULTRASOUND MED BIOL, V27, P933
   MURKIN JM, 1995, J THORAC CARDIOV SUR, V110, P349, DOI 10.1016/S0022-5223(95)70230-X
   Nakamura Yoshitsugu, 2004, Ann Thorac Cardiovasc Surg, V10, P81
   Naylor AR, 2002, EUR J VASC ENDOVASC, V23, P283, DOI 10.1053/ejvs.2002.1609
   Neville MJ, 2001, J THORAC CARDIOV SUR, V121, P125, DOI 10.1067/mtc.2001.111378
   Newman MF, 1996, CIRCULATION, V94, P74
   Peel GK, 2004, J AM COLL CARDIOL, V43, P752, DOI 10.1016/j.jacc.2003.09.047
   Perkio J, 2005, STROKE, V36, P44, DOI 10.1161/01.STR.0000150495.96471.95
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Raja PV, 2004, CNS SPECTRUMS, V9, P763
   Rankin KP, 2003, J INT NEUROPSYCH SOC, V9, P913, DOI 10.1017/S1355617703960115
   REDMOND JM, 1994, J THORAC CARDIOV SUR, V107, P776
   Reed BR, 2004, ARCH NEUROL-CHICAGO, V61, P1545, DOI 10.1001/archneur.61.10.1545
   Reineck LA, 2005, NEUROLOGY, V64, P828
   Ritzl A, 2004, J MAGN RESON IMAGING, V20, P201, DOI 10.1002/jmri.20096
   Rolfson D B, 1999, Int Psychogeriatr, V11, P431, DOI 10.1017/S1041610299006043
   Rolfson DB, 1999, CAN J CARDIOL, V15, P771
   Rudolph JL, 2005, J AM GERIATR SOC, V53, P462, DOI 10.1111/j.1532-5415.2005.53165.x
   Salazar JD, 2001, ANN THORAC SURG, V72, P1195, DOI 10.1016/S0003-4975(01)02929-0
   Santos FS, 2004, INT PSYCHOGERIATR, V16, P175, DOI 10.1017/S1041610204000365
   Schmitz C, 2003, J THORAC CARDIOV SUR, V126, P1829, DOI 10.1016/S0022-5223(03)01285-6
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   Selnes OA, 2003, ANN THORAC SURG, V75, P1377, DOI 10.1016/S0003-4975(03)00021-3
   Selnes OA, 1999, LANCET, V353, P1601, DOI 10.1016/S0140-6736(98)07576-X
   Stamou SC, 2005, ANN THORAC SURG, V79, P552, DOI 10.1016/j.athoracsur.2004.07.075
   Stamou SC, 2001, STROKE, V32, P1508
   Tseng Elaine E., 1997, Surgical Forum, V48, P297
   Tseng EE, 1997, ANN THORAC SURG, V64, P1639, DOI 10.1016/S0003-4975(97)01110-7
   van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901
   Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931
   WAREING TH, 1993, ANN THORAC SURG, V55, P1400
   Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253
   Wimmer-Greinecker G, 2003, EUR J CARDIO-THORAC, V23, P159, DOI 10.1016/S1010-7940(02)00742-X
   Wityk RJ, 2001, ARCH NEUROL-CHICAGO, V58, P571, DOI 10.1001/archneur.58.4.571
   Zimmer J, 2003, AM J CARDIOL, V91, P1137, DOI 10.1016/S0002-9149(03)00168-1
NR 88
TC 114
Z9 118
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0039-2499
J9 STROKE
JI Stroke
PD FEB
PY 2006
VL 37
IS 2
BP 562
EP 571
DI 10.1161/01.STR.0000199032.78782.6c
PG 10
WC Clinical Neurology; Peripheral Vascular Disease
SC Neurosciences & Neurology; Cardiovascular System & Cardiology
GA 005NJ
UT WOS:000234829800089
PM 16373636
ER

PT J
AU Blasko, JC
   Mate, T
   Sylvester, JE
   Grimm, PD
   Cavanagh, W
AF Blasko, JC
   Mate, T
   Sylvester, JE
   Grimm, PD
   Cavanagh, W
TI Brachytherapy for carcinoma of the prostate: Techniques, patient
   selection, and clinical outcomes
SO SEMINARS IN RADIATION ONCOLOGY
LA English
DT Article
ID EXTERNAL-BEAM RADIATION; RADIOACTIVE SEED IMPLANTATION; DOSE-RATE
   BRACHYTHERAPY; DISEASE-FREE SURVIVAL; PD-103 BRACHYTHERAPY; INTERSTITIAL
   BRACHYTHERAPY; LOCALIZED ADENOCARCINOMA; SOCIETY RECOMMENDATIONS;
   PERMANENT BRACHYTHERAPY; CANCER
C1 Seattle Prostate Inst, Seattle, WA 98104 USA.
   Swedish Tumor Inst, Seattle, WA USA.
   Puget Sound Tumor Inst, Edmonds, WA USA.
RP Blasko, JC (reprint author), Seattle Prostate Inst, 1101 Madison,1101, Seattle, WA 98104 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   ARTERBERY VE, 1993, INT J RADIAT ONCOL, V25, P661
   BERTERMANN H, 1990, BRACHYTHERAPY, P281
   Beyer D, 2000, INT J RADIAT ONCOL, V47, P273, DOI 10.1016/S0360-3016(00)00555-1
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   BEYER DC, 1998, INT J RAD ONCOL BI S, V42, P309, DOI 10.1016/S0360-3016(98)80470-7
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   BLASKO JC, 1997, MOL UROL, V1, P207
   Blasko JC, 1987, ENDOCURIETHER HYPERT, V3, P131
   Blasko J C, 1991, Scand J Urol Nephrol Suppl, V137, P113
   Blasko JC, 1996, UROL CLIN N AM, V23, P633, DOI 10.1016/S0094-0143(05)70342-6
   Blasko JC, 2000, RADIOTHER ONCOL, V57, P273, DOI 10.1016/S0167-8140(00)00288-7
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Borghede G, 1997, RADIOTHER ONCOL, V44, P237, DOI 10.1016/S0167-8140(97)00121-7
   Brenner DJ, 2000, INT J RADIAT ONCOL, V48, P315, DOI 10.1016/S0360-3016(00)00591-5
   Brenner DJ, 1999, INT J RADIAT ONCOL, V43, P1095, DOI 10.1016/S0360-3016(98)00438-6
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Cha CM, 1999, INT J RADIAT ONCOL, V45, P391, DOI 10.1016/S0360-3016(99)00187-X
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Dattoli MJ, 1997, INT J RADIAT ONCOL, V39, P221
   DAVIS BJ, 1998, INT J RADIAT ONCOL, V42, P132, DOI 10.1016/S0360-3016(98)80116-8
   Duchesne GM, 1999, INT J RADIAT ONCOL, V44, P747
   Eulau S. M., 2000, International Journal of Radiation Oncology Biology Physics, V48, P149, DOI 10.1016/S0360-3016(00)80092-9
   Galalae R. M., 2000, International Journal of Radiation Oncology Biology Physics, V48, P147, DOI 10.1016/S0360-3016(00)80088-7
   Gelblum DY, 1999, INT J RADIAT ONCOL, V45, P59, DOI 10.1016/S0360-3016(99)00176-5
   GELBLUM DY, 2000, INT J RADIAT ONCOL, V48, P1194
   Grado GL, 1998, INT J RADIAT ONCOL, V42, P289, DOI 10.1016/S0360-3016(98)00209-0
   Granfors T, 1998, J UROLOGY, V159, P2030, DOI 10.1016/S0022-5347(01)63235-X
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   GRIMM PD, 1994, NEW TECHNIQUES PROST
   Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3
   HOLM HH, 1983, J UROLOGY, V130, P283
   Hsu ICJ, 2000, INT J RADIAT ONCOL, V46, P851, DOI 10.1016/S0360-3016(99)00501-5
   KLEINBERG L, 1994, INT J RADIAT ONCOL, V28, P985
   Lee L. N., 2000, International Journal of Radiation Oncology Biology Physics, V48, P170, DOI 10.1016/S0360-3016(00)80133-9
   LING CC, 1992, INT J RADIAT ONCOL, V23, P81
   Martinez AA, 2000, INT J RADIAT ONCOL, V47, P343, DOI 10.1016/S0360-3016(00)00436-3
   Martinez AA, 2001, INT J RADIAT ONCOL, V49, P61, DOI 10.1016/S0360-3016(00)01463-2
   Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2
   Merrick GS, 2000, INT J RADIAT ONCOL, V47, P121, DOI 10.1016/S0360-3016(99)00525-8
   Merrick GS, 2000, INT J RADIAT ONCOL, V48, P667, DOI 10.1016/S0360-3016(00)00698-2
   Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3
   Nag S, 2000, INT J RADIAT ONCOL, V46, P221, DOI 10.1016/S0360-3016(99)00351-X
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3
   Pollack A., 1999, International Journal of Radiation Oncology Biology Physics, V45, P146, DOI 10.1016/S0360-3016(99)90022-6
   Potters L, 1999, CANCER J SCI AM, V5, P301
   QUACKENBUSH J, UNPUB HIGH DOSE RATE
   Ragde Haakon, 2000, Journal of Urology, V163, P336
   ROY JN, 1993, INT J RADIAT ONCOL, V26, P163, DOI 10.1016/0360-3016(93)90188-2
   Sharkey J, 1998, UROLOGY, V51, P796, DOI 10.1016/S0090-4295(98)00017-X
   Sharkey J, 2000, J ENDOUROL, V14, P343, DOI 10.1089/end.2000.14.343
   SOHAYDA C, 1998, INT J RADIAT ONCOL, V42, P132, DOI 10.1016/S0360-3016(98)80117-X
   Stock RG, 1997, SEMIN SURG ONCOL, V13, P454, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<454::AID-SSU10>3.0.CO;2-T
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   Stock RG, 1996, INT J RADIAT ONCOL, V35, P267, DOI 10.1016/0360-3016(95)02050-0
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 2001, J UROLOGY, V165, P436, DOI 10.1097/00005392-200102000-00020
   Stone N N, 2000, Tech Urol, V6, P123
   Stone NN, 1999, J UROLOGY, V162, P421, DOI 10.1016/S0022-5347(05)68574-6
   STROMBERG J, 1995, INT J RADIAT ONCOL, V33, P161, DOI 10.1016/0360-3016(95)00035-W
   Stromberg JS, 1997, CANCER J SCI AM, V3, P346
   Sylvester J, 1997, J SURG ONCOL, V66, P65, DOI 10.1002/(SICI)1096-9098(199709)66:1<65::AID-JSO13>3.0.CO;2-N
   Sylvester J, 2000, MOL UROL, V4, P155
   Terk MD, 1998, J UROLOGY, V160, P1379, DOI 10.1016/S0022-5347(01)62542-4
   WALLNER K, 1994, INT J RADIAT ONCOL, V30, P405
   Wallner K, 1997, INT J RADIAT ONCOL, V37, P565, DOI 10.1016/S0360-3016(96)00570-6
   WALLNER K, 1995, INT J RADIAT ONCOL, V32, P465, DOI 10.1016/0360-3016(94)00599-G
   Wallner K, 2001, PROSTATE BRACHYTHERA
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Williamson JF, 2000, MED PHYS, V27, P634, DOI 10.1118/1.598923
   Yoshioka Y, 2000, INT J RADIAT ONCOL, V48, P675, DOI 10.1016/S0360-3016(00)00687-8
   Zelefsky MJ, 2000, INT J RADIAT ONCOL, V47, P1261, DOI 10.1016/S0360-3016(00)00550-2
   Zelefsky MJ, 1998, SEMIN RADIAT ONCOL, V8, P107, DOI 10.1016/S1053-4296(98)80006-4
NR 78
TC 114
Z9 119
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 1053-4296
J9 SEMIN RADIAT ONCOL
JI Semin. Radiat. Oncol.
PD JAN
PY 2002
VL 12
IS 1
BP 81
EP 94
DI 10.1053/srao.2002.28667
PG 14
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 516XZ
UT WOS:000173583200008
PM 11813153
ER

PT J
AU Fihn, SD
   Gardin, JM
   Abrams, J
   Berra, K
   Blankenship, JC
   Dallas, AP
   Douglas, PS
   Foody, JM
   Gerber, TC
   Hinderliter, AL
   King, SB
   Kligfield, PD
   Krumholz, HM
   Kwong, RYK
   Lim, MJ
   Linderbaum, JA
   Mack, MJ
   Munger, MA
   Prager, RL
   Sabik, JF
   Shaw, LJ
   Sikkema, JD
   Smith, CR
   Smith, SC
   Spertus, JA
   Williams, SV
   Anderson, JL
   Halperin, JL
   Jacobs, AK
   Smith, SC
   Adams, CD
   Albert, NM
   Brindis, RG
   Buller, CE
   Creager, MA
   DeMets, D
   Ettinger, SM
   Guyton, RA
   Hochman, JS
   Hunt, SA
   Kovacs, RJ
   Kushner, FG
   Lytle, BW
   Nishimura, RA
   Ohman, EM
   Page, RL
   Riegel, B
   Stevenson, WG
   Tarkington, LG
   Yancy, CW
AF Fihn, Stephan D.
   Gardin, Julius M.
   Abrams, Jonathan
   Berra, Kathleen
   Blankenship, James C.
   Dallas, Apostolos P.
   Douglas, Pamela S.
   Foody, JoAnne M.
   Gerber, Thomas C.
   Hinderliter, Alan L.
   King, Spencer B., III
   Kligfield, Paul D.
   Krumholz, Harlan M.
   Kwong, Raymond Y. K.
   Lim, Michael J.
   Linderbaum, Jane A.
   Mack, Michael J.
   Munger, Mark A.
   Prager, Richard L.
   Sabik, Joseph F.
   Shaw, Leslee J.
   Sikkema, Joanna D.
   Smith, Craig R.
   Smith, Sidney C., Jr.
   Spertus, John A., Jr.
   Williams, Sankey V.
   Anderson, Jeffrey L.
   Halperin, Jonathan L.
   Jacobs, Alice K.
   Smith, Sidney C., Jr.
   Adams, Cynthia D.
   Albert, Nancy M.
   Brindis, Ralph G.
   Buller, Christopher E.
   Creager, Mark A.
   DeMets, David
   Ettinger, Steven M.
   Guyton, Robert A.
   Hochman, Judith S.
   Hunt, Sharon Ann
   Kovacs, Richard J.
   Kushner, Frederick G.
   Lytle, Bruce W.
   Nishimura, Rick A.
   Ohman, E. Magnus
   Page, Richard L.
   Riegel, Barbara
   Stevenson, William G.
   Tarkington, Lynn G.
   Yancy, Clyde W.
TI 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and
   Management of Patients With Stable Ischemic Heart Disease
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE cardiovascular diagnostic techniques; coronary artery disease; coronary
   stenosis; minimally invasive surgical procedures; myocardial ischemia;
   myocardial revascularization; prognosis; risk factors; stable angina
ID CORONARY-ARTERY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; EMISSION
   COMPUTED-TOMOGRAPHY; COLLEGE-OF-CARDIOLOGY; ACUTE MYOCARDIAL-INFARCTION;
   CARDIOVASCULAR-MAGNETIC-RESONANCE; LEFT-VENTRICULAR DYSFUNCTION;
   LONG-TERM SURVIVAL; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; ELUTING STENT
   IMPLANTATION
RI Page, Richard/L-5501-2014
OI Page, Richard/0000-0001-5603-1330
CR Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Abdelmoneim SS, 2010, ECHOCARDIOGR-J CARD, V27, P421, DOI 10.1111/j.1540-8175.2009.01026.x
   Abernethy DR, 1999, NEW ENGL J MED, V341, P1447
   Abidov A, 2003, J AM COLL CARDIOL, V42, P1818, DOI 10.1016/j.jacc.2003.07.010
   Abizaid A, 2001, CIRCULATION, V104, P533, DOI 10.1161/hc3101.093700
   ABRAMS J, 1987, DRUGS, V34, P391
   Abrams J, 2005, NEW ENGL J MED, V352, P2524, DOI 10.1056/NEJMcp042317
   ACCF/AHA Task Force on Practice Guidelines, 2012, METH MAN POL ACCF AH
   AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827
   Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1
   Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1
   Akhtar M, 2006, AM J CARDIOL, V98, P28, DOI 10.1016/j.amjcard.2006.01.053
   Akram K, 2009, ATHEROSCLEROSIS, V203, P533, DOI 10.1016/j.atherosclerosis.2008.07.008
   Albert MA, 2003, CIRCULATION, V107, P443, DOI 10.1161/01.CIR.0000045669.16499.EC
   Alderman E, 1997, CIRCULATION, V96, P1761
   ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   ALDERMAN EL, 1990, CIRCULATION, V82, P1629
   Alderman MH, 1997, LANCET, V349, P594, DOI 10.1016/S0140-6736(96)08359-6
   Alexander KP, 1998, J AM COLL CARDIOL, V32, P1657, DOI 10.1016/S0735-1097(98)00451-3
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Allen KB, 2004, ANN THORAC SURG, V77, P1228, DOI 10.1016/j.athoracsur.2004.01.008
   Allen KB, 1999, NEW ENGL J MED, V341, P1029, DOI 10.1056/NEJM199909303411403
   Al-Mallah MH, 2006, J AM COLL CARDIOL, V47, P1576, DOI 10.1016/j.jacc.2005.11.073
   Al Suwaidi J, 2004, AM HEART J, V147, P815, DOI 10.1016/j.ahj.2003.11.025
   Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100
   AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56
   America YGCJ, 2009, J NUCL CARDIOL, V16, P10, DOI 10.1007/s12350-008-9012-6
   America YGCJ, 2007, J NUCL CARDIOL, V14, P75, DOI 10.1016/j.nuclcard.2006.10.018
   American Academy of Family Physicians, 2000, AM FAM PHYS, V62, P1712
   American Heart Association, 2008, AHA CHOOS MOV
   Amin F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007219.pub2
   Anand SS, 2003, J AM COLL CARDIOL, V41, p62S, DOI 10.1016/S0735-1097(02)02776-6
   Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
   Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   [Anonymous], 1997, ARCH INTERN MED, V157, P657
   [Anonymous], 1985, BR MED J CLIN RES ED, V291, P97
   [Anonymous], 1998, N ENGL J MED, V339, P1349
   [Anonymous], 1984, JAMA, V251, P351
   [Anonymous], 1999, LANCET, V354, P447
   [Anonymous], 2002, LANCET, V360, P965
   [Anonymous], 2006, INC PREV 2006 CHART
   [Anonymous], 1994, LANCET, V344, P1383
   [Anonymous], 1984, JAMA, V251, P365
   [Anonymous], 1984, HYPERTENSION, V6, pI198
   [Anonymous], 1993, LANCET, V341, P573
   [Anonymous], 1998, LANCET, V352, P854
   [Anonymous], 2002, JAMA, V288, P2998
   [Anonymous], 2004, N S W PUBLIC HLTH B, V15, P107
   [Anonymous], 1982, JAMA, V247, P1707
   [Anonymous], 2002, LANCET, V360, P7
   [Anonymous], 1997, LANCET, V350, P461
   [Anonymous], 1994, CIRCULATION, V90, P1765
   [Anonymous], 1988, N ENGL J MED, V319, P385
   [Anonymous], 1995, JAMA, V273, P199
   [Anonymous], 1980, CIRCULATION, V62, pV85
   [Anonymous], 1992, BMJ, V304, P405
   [Anonymous], 2005, WKLY EPIDEMIOL REC, V80, P277
   [Anonymous], 2002, LANCET, V359, P1269
   [Anonymous], 1991, JAMA, V265, P3255
   [Anonymous], 1997, CIRCULATION, V95, P265
   [Anonymous], 1997, LANCET, V349, P1857
   [Anonymous], 1980, LANCET, V2, P491
   [Anonymous], 2002, JAMA, V288, P2981
   [Anonymous], 1996, N ENGL J MED, V335, P217
   [Anonymous], 1979, JAMA, V242, P2562
   [Anonymous], 1982, N ENGL J MED, V307, P976
   [Anonymous], 1998, LANCET, V352, P837
   [Anonymous], 1990, AM J CARDIOL, V66, P779
   [Anonymous], 1995, LANCET, V346, P1179
   [Anonymous], 2011, DIABETES CARE S1, V34, pS11
   [Anonymous], 1984, N ENGL J MED, V311, P1333
   Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178
   [Anonymous], 1983, CIRCULATION, V68, P951
   [Anonymous], 1993, WHO TECH REP SER, V831, P1
   [Anonymous], 1997, JAMA, V277, P715
   [Anonymous], 2002, JAMA, V288, P2015
   [Anonymous], 2006, MED MED STAT SUPPL
   [Anonymous], 1998, CLIN GUID ID EV TREA
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   ANTMAN E, 1980, NEW ENGL J MED, V302, P1269, DOI 10.1056/NEJM198006053022301
   Antman EM, 2008, J AM COLL CARDIOL, V51, P210, DOI DOI 10.1016/J.JACC.2007.10.001
   Antman EM, 2004, J AM COLL CARDIOL, V44, pE1, DOI DOI 10.1016/J.JACC.2004.07.014
   Antman EM, 2009, CIRCULATION, V119, P1180, DOI 10.1161/CIRCULATIONAHA.109.856757
   Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793
   Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083
   ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704
   Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521
   Arnold SV, 2009, CIRC-CARDIOVASC QUAL, V2, P344, DOI 10.1161/CIRCOUTCOMES.108.829523
   Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P107, DOI 10.1161/CIRCOUTCOMES.108.798009
   Arora RR, 1999, J AM COLL CARDIOL, V33, P1833, DOI 10.1016/S0735-1097(99)00140-0
   Atherosclerosis Thrombosis and Vascular Biology Italian Study Group, 2003, CIRCULATION, V107, P1117
   Aubry MC, 2007, J RHEUMATOL, V34, P937
   Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532
   Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003
   Azevedo ER, 2001, J AM COLL CARDIOL, V37, P505, DOI 10.1016/S0735-1097(00)01140-2
   Aziz O, 2007, BRIT MED J, V334, P617, DOI 10.1136/bmj.39106.476215.BE
   Badran HM, 2007, J AM SOC ECHOCARDIOG, V20, P820, DOI 10.1016/j.echo.2007.01.007
   Bae Ki Sun, 2007, Korean Journal of Internal Medicine, V22, P139
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2
   BALLEGAARD S, 1990, J INTERN MED, V227, P25
   BALLEGAARD S, 1986, ACTA MED SCAND, V220, P307
   BALSANO F, 1990, CIRCULATION, V82, P17
   BANDURA A, 1983, J PERS SOC PSYCHOL, V45, P1017, DOI 10.1037//0022-3514.45.5.1017
   Bangalore S, 2007, AM J CARDIOL, V100, P536, DOI 10.1016/j.amjcard.2007.03.057
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Barsness G, 2001, CLIN CARDIOL, V24, P435
   Bateman TM, 2006, J NUCL CARDIOL, V13, P24, DOI 10.1016/j.nuclcard.2005.12.004
   Baumhakel M, 2011, INT J CLIN PRACT, V65, P289, DOI 10.1111/j.1742-1241.2010.02563.x
   Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720
   Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369
   BELL MR, 1990, J AM COLL CARDIOL, V16, P553
   Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60
   Beltrame JF, 2009, ARCH INTERN MED, V169, P1491, DOI 10.1001/archinternmed.2009.295
   Benedetto U, 2009, EUR J CARDIO-THORAC, V36, P611, DOI 10.1016/j.ejcts.2009.03.012
   Ben-Gal Y, 2006, ANN THORAC SURG, V82, P2067, DOI 10.1016/j.athoracsur.2006.06.041
   Beniamini Y, 1999, J Cardiopulm Rehabil, V19, P8, DOI 10.1097/00008483-199901000-00001
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berger PB, 2001, J AM COLL CARDIOL, V38, P1440, DOI 10.1016/S0735-1097(01)01571-6
   Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106
   Berman D, 2004, HURSTS HEART, P563
   Berman DS, 2009, JACC-CARDIOVASC IMAG, V2, P273, DOI 10.1016/j.jcmg.2008.12.012
   BERMAN DS, 1995, J AM COLL CARDIOL, V26, P639, DOI 10.1016/0735-1097(95)00218-S
   Berman DS, 2006, J NUCL CARDIOL, V13, P191, DOI 10.1016/j.nuclcard.2006.01.020
   Bernheim AM, 2011, AM HEART J, V161, P740, DOI 10.1016/j.ahj.2010.12.017
   Bernstein SJ, 1999, HEART, V81, P470
   Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964
   Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025
   Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989
   Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096
   Biagini E, 2006, EUR J NUCL MED MOL I, V33, P1442, DOI 10.1007/s00259-006-0156-9
   Bingham SE, 2011, CIRCULATION, V123, P1509, DOI 10.1161/CIRCULATIONAHA.109.907659
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Blankstein R, 2009, J AM COLL CARDIOL, V54, P1072, DOI 10.1016/j.jacc.2009.06.014
   Blendea Mihaela C, 2003, Curr Diab Rep, V3, P223, DOI 10.1007/s11892-003-0068-z
   BLOCK WJ, 1952, JAMA-J AM MED ASSOC, V150, P259
   Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055
   Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626
   BOBERG J, 1992, CLIN CARDIOL, V15, P591
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Bodi V, 2007, J AM COLL CARDIOL, V50, P1174, DOI 10.1016/j.jacc.2007.06.016
   Boekholdt SM, 2001, CIRCULATION, V104, P3063, DOI 10.1161/hc5001.100793
   Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720
   BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745
   BOMAN K, 1995, EUR J CLIN PHARMACOL, V49, P27
   Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atgersclerosis.2004.08.035
   Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.05.007
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   Bonow RO, 2008, JACC-CARDIOVASC IMAG, V1, P164, DOI 10.1016/j.jcmg.2008.01.004
   Borer JS, 2003, CIRCULATION, V107, P817, DOI 10.1161/01.CIR.0000048143.25023.87
   Borjesson M, 2000, EUR HEART J, V21, P1853, DOI 10.1053/euhj.1999.1994
   Bosworth HB, 2007, CONTEMP CLIN TRIALS, V28, P33, DOI 10.1016/j.cct.2006.08.006
   Bottcher M, 2002, AM J CARDIOL, V89, P1019, DOI 10.1016/S0002-9149(02)02268-3
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Bourassa MG, 1998, EUR HEART J, V19, P103, DOI 10.1053/euhj.1997.0574
   Bouzas-Mosquera A, 2010, EUR J CLIN INVEST, V40, P1122, DOI 10.1111/j.1365-2362.2010.02365.x
   Bouzas-Mosquera A, 2009, J AM COLL CARDIOL, V53, P1981, DOI 10.1016/j.jacc.2009.01.067
   Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048
   Braunwald E, 1994, TREATING TOBACCO USE
   BRAUNWALD E, 1989, CIRCULATION, V80, P410
   Braunwald E, 2006, J AM COLL CARDIOL, V47, pC101, DOI 10.1016/j.jacc.2005.10.072
   Bravata DM, 2007, ANN INTERN MED, V147, P703
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161
   Bridges CR, 2004, ANN THORAC SURG, V77, P1494, DOI 10.1016/j.athoracsur.2004.01.007
   Briguori C, 2007, AM J CARDIOL, V99, P779, DOI 10.1016/j.amjcara.2006.10.031
   Brogden RN, 1996, DRUGS, V51, P792, DOI 10.2165/00003495-199651050-00007
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brophy JM, 2003, ANN INTERN MED, V138, P777
   Brorsson B, 2002, HEART, V87, P140, DOI 10.1136/heart.87.2.140
   Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321
   Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090
   BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901
   Bruder O, 2009, J AM COLL CARDIOL, V54, P1457, DOI 10.1016/j.jacc.2009.07.003
   BRUNELLI C, 1989, EUR HEART J, V10, P292
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Buckley BS, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3058
   Buckley DI, 2009, ANN INTERN MED, V151, P483
   Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031
   Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   Byzova TV, 1997, J BIOL CHEM, V272, P27183, DOI 10.1074/jbc.272.43.27183
   Cademartiri F, 2010, EUR RADIOL, V20, P81, DOI 10.1007/s00330-009-1529-9
   CALIFF RM, 1985, J AM COLL CARDIOL, V5, P1055
   Califf RM, 1996, J AM COLL CARDIOL, V27, P1007, DOI 10.1016/0735-1097(96)87733-3
   CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501
   Calnon DA, 2001, J AM COLL CARDIOL, V38, P1511, DOI 10.1016/S0735-1097(01)01565-0
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   CAMERON A, 1983, CIRCULATION, V68, P484
   Camm A John, 2003, Drugs R D, V4, P83, DOI 10.2165/00126839-200304020-00001
   CAMPEAU L, 1978, CIRCULATION, V57, P1111
   CAMPEAU L, 1976, CIRCULATION, V54, P522
   CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   Cardinal B J, 1996, J Epidemiol, V6, P31
   Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981
   CARNEY RM, 1995, HEALTH PSYCHOL, V14, P88, DOI 10.1037//0278-6133.14.1.88
   CARNEY RM, 1987, AM J CARDIOL, V60, P1273, DOI 10.1016/0002-9149(87)90607-2
   Carney RM, 2001, CIRCULATION, V104, P2024, DOI 10.1161/hc4201.097834
   Carrabba N, 2010, J NUCL CARDIOL, V17, P470, DOI 10.1007/s12350-010-9218-2
   Carrie D, 1997, CIRCULATION, V96, pII6
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   Caulin-Glaser Teresa, 2007, Prev Cardiol, V10, P15, DOI 10.1111/j.1520-037.2007.05666.x
   Cecil MP, 1996, J CLIN EPIDEMIOL, V49, P735, DOI 10.1016/0895-4356(96)00014-5
   Cecil WT, 2008, AM J MANAG CARE, V14, P521
   Centers for Disease Control and Prevention, 2008, 2008 PHYS ACT GUID
   Cerqueira MD, 2010, J NUCL CARDIOL, V17, P709, DOI 10.1007/s12350-010-9244-0
   Chaitman BR, 2009, CIRCULATION, V120, P2529, DOI 10.1161/CIRCULATIONAHA.109.913111
   Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309
   CHAITMAN BR, 1981, CIRCULATION, V64, P360
   Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916
   Chaowalit N, 2006, EUR HEART J, V27, P3039, DOI 10.1093/eurheartj/ehl393
   Charatan F, 2003, BRIT MED J, V326, P1055, DOI 10.1136/bmj.326.7398.1055
   Chatterjee K, 1998, PRIMARY CARDIOLOGY, P234
   Chatziioannou SN, 1999, CIRCULATION, V99, P867
   Cheezum MK, 2011, J CARDIOVASC COMPUT, V5, P101, DOI 10.1016/j.jcct.2010.11.005
   Cheitlin MD, 2005, AM J CARDIOL, V96, p24M, DOI 10.1016/j.amjcard.2005.07.007
   Chen JT, 2005, PHARMACOTHERAPY, V25, P171, DOI 10.1592/phco.25.2.171.56942
   Cheng ASH, 2007, J AM COLL CARDIOL, V49, P2440, DOI 10.1016/j.jacc.2007.03.028
   Cheng Victor Y, 2011, Circulation, V124, P2423, DOI 10.1161/CIRCULATIONAHA.111.039255
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chirinos JA, 2007, INT J CARDIOL, V117, P97, DOI 10.1016/j.ijcard.2006.06.005
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Choudhry NK, 2005, AM J MED, V118, P465, DOI 10.1016/j.amjmed.2005.02.016
   Chow BJW, 2011, JACC-CARDIOVASC IMAG, V4, P496, DOI 10.1016/j.jcmg.2011.01.015
   Chow BJW, 2010, J AM COLL CARDIOL, V55, P1017, DOI 10.1016/j.jacc.2009.10.039
   CHRISTIAN TF, 1994, ANN INTERN MED, V121, P825
   CHRYSANT SG, 1993, AM J CARDIOL, V72, P1249, DOI 10.1016/0002-9149(93)90292-K
   Chuah SC, 1998, CIRCULATION, V97, P1474
   Ciapponi A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14681858.CD003614.pub2
   Cisowski M, 2002, ANN THORAC SURG, V74, pS1334
   Cisowski Marek, 2004, Kardiol Pol, V61, P253
   Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163
   Clark AM, 2010, EUR J CARDIOV PREV R, V17, P261, DOI 10.1097/HJR.0b013e32833090ef
   Clayton TC, 2005, BRIT MED J, V331, P869, DOI 10.1136/bmj.38603.656076.63
   Coelho OR, 2011, JACC-CARDIOVASC IMAG, V4, P850, DOI 10.1016/j.jcmg.2011.04.015
   Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713
   Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804
   Cole JH, 2002, J AM COLL CARDIOL, V40, P1968, DOI 10.1016/S0735-1097(02)02561-5
   Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75
   Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0
   Collins R, 1994, TXB HYPERTENSION
   CONLEY MJ, 1978, CIRCULATION, V57, P947
   Cortigiani L, 2001, AM J MED, V110, P361, DOI 10.1016/S0002-9343(01)00630-1
   Couch RB, 2007, VACCINE, V25, P7656, DOI 10.1016/j.vaccine.2007.08.042
   Critchfield TS, 2001, J APPL BEHAV ANAL, V34, P101, DOI 10.1901/jaba.2001.34-101
   Critchley J, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003041.PUB2
   Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86
   Cromwell J, 2005, MED CARE, V43, P330, DOI 10.1097/01.mlr.0000156864.80880.aa
   Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413
   Cuisset T, 2009, J AM COLL CARDIOL, V54, P1149, DOI 10.1016/j.jacc.2009.05.050
   Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3
   Cury RC, 2010, AM J CARDIOL, V106, P310, DOI 10.1016/j.amjcard.2010.03.025
   CV Therapeutics, 2007, RAN PACK INS
   D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180
   Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P1225, DOI 10.1001/jama.2011.336
   Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X
   Daly C., 2003, European Heart Journal, V24, P532, DOI 10.1016/S0195-668X(02)00820-5
   Daly C, 2006, CIRCULATION, V113, P490, DOI 10.1161/CIRCULATIONAHA.105.561647
   Daly CA, 2006, BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE
   Danchin N, 2006, ARCH INTERN MED, V166, P787, DOI 10.1001/archinte.166.7.787
   Danias PG, 2004, J AM COLL CARDIOL, V44, P1867, DOI 10.1016/j.jacc.2004.07.051
   Dargie HJ, 2001, LANCET, V357, P1385
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320
   Daugherty SL, 2011, AM HEART J, V161, P908, DOI 10.1016/j.ahj.2011.01.021
   Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559
   Davies RF, 1997, CIRCULATION, V95, P2037
   Davis AM, 2007, MED CARE RES REV, V64, p29S, DOI 10.1177/1077558707305416
   DAVIS JW, 1985, J LAB CLIN MED, V105, P479
   Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004
   Dawn B, 2002, ANN NY ACAD SCI, V962, P18
   Tognoni G, 2001, LANCET, V357, P89
   de Azevedo CF, 2011, JACC-CARDIOVASC IMAG, V4, P740, DOI 10.1016/j.jcmg.2011.02.017
   DEBUSK RF, 1994, ANN INTERN MED, V120, P721
   de Diego C, 2009, EUR HEART J, V30, P209, DOI 10.1093/eurheartj/ehn498
   Defoor J, 2006, EUR HEART J, V27, P808, DOI 10.1093/eurheartj/ehi737
   de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440
   de Gonzalez AB, 2010, CIRCULATION, V122, P2403, DOI 10.1161/CIRCULATIONAHA.110.941625
   DEJONGSTE MJL, 1994, BRIT HEART J, V71, P413
   DELANDSHEERE C, 1992, AM J CARDIOL, V69, P1143, DOI 10.1016/0002-9149(92)90926-P
   DEMOTS H, 1989, J AM COLL CARDIOL, V13, P786
   Denollet J, 2006, AM J CARDIOL, V97, P970, DOI 10.1016/j.amjcard.2005.10.035
   de Peuter OR, 2009, NETH J MED, V67, P284
   DETRE K, 1981, CIRCULATION, V63, P1329
   Dey D, 2010, RADIOLOGY, V257, P516, DOI 10.1148/radiol.10100681
   Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537
   DIAMOND GA, 1986, AM J CARDIOL, V57, P1175, DOI 10.1016/0002-9149(86)90694-6
   Diamond GA, 2010, NEW ENGL J MED, V363, P93
   DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402
   DIAMOND GA, 1980, J CLIN INVEST, V65, P1210, DOI 10.1172/JCI109776
   Diamond GA, 2007, J AM COLL CARDIOL, V50, P1604, DOI 10.1016/j.jacc.2007.08.010
   Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190
   Di Carli MF, 2007, J NUCL CARDIOL, V14, P799, DOI 10.1016/j.nuclcard.2007.07.012
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01
   Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563
   DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003
   DIGENIO AG, 1991, S AFR MED J, V79, P188
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   Di Pede F, 2003, AM J CARDIOL, V91, P951, DOI 10.1016/S0002-9149(03)00110-3
   DISOMMA S, 1993, CARDIOVASC DRUG THER, V7, P119
   Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182
   DOBSON AJ, 1991, J CLIN EPIDEMIOL, V44, P1247, DOI 10.1016/0895-4356(91)90157-5
   Doesch C, 2009, JACC-CARDIOVASC IMAG, V2, P424, DOI 10.1016/j.jcmg.2008.11.017
   DOLL R, 1976, BRIT MED J, V2, P1525
   Domanski MJ, 2003, J CARD FAIL, V9, P354, DOI 10.1054/S1071-9164(03)00133-7
   Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765
   DORING G, 1992, J CARDIOVASC PHARM, V20, pS74
   Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9
   Dorr DA, 2008, J AM GERIATR SOC, V56, P2195, DOI 10.1111/j.1532-5415.2008.02005.x
   d'Othee BJ, 2008, EUR J RADIOL, V65, P449, DOI 10.1016/j.ejrad.2007.05.003
   Douglas PS, 1997, CIRCULATION, V95, P299
   Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002
   Dowling RD, 1998, CIRCULATION S2, V98, pII73
   Drenth DJ, 2004, AM J CARDIOL, V94, P1414, DOI 10.1016/j.amjcard.2004.08.016
   Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6
   Drozda J, 2011, J AM COLL CARDIOL, V58, P316, DOI 10.1016/j.jacc.2011.05.002
   Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131
   Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431
   Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544
   Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002
   Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002
   Dusing R, 2005, DRUGS, V65, P773
   Duvall WL, 2006, J NUCL CARDIOL, V13, P202, DOI 10.1016/j.nuclcard.2006.01.003
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Ebrahim S, 2002, J EPIDEMIOL COMMUN H, V56, P99, DOI 10.1136/jech.56.2.99
   Edwards FH, 1998, ANN THORAC SURG, V66, P125, DOI 10.1016/S0003-4975(98)00358-0
   Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C
   Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317
   Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179
   El Fakhri G, 2009, J NUCL MED, V50, P1062, DOI 10.2967/jnumed.104.007831
   Elhendy A, 2002, J AM COLL CARDIOL, V40, P1623, DOI 10.1016/S0735-1097(02)02338-0
   Ellis SG, 1997, CIRCULATION, V96, P3867
   ELVEBACK LR, 1985, MAYO CLIN PROC, V60, P305
   Emanuelsson H, 1999, AM HEART J, V137, P854, DOI 10.1016/S0002-8703(99)70409-6
   EMOND M, 1994, CIRCULATION, V90, P2645
   Epstein FH, 2007, J NUCL CARDIOL, V14, P729, DOI 10.1016/j.nuelcard.2007.07.006
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   EZEKOWITZ MD, 1995, AM HEART J, V129, P527, DOI 10.1016/0002-8703(95)90281-3
   Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   FAXON DP, 1992, AM HEART J, V123, P854, DOI 10.1016/0002-8703(92)90687-Q
   Fazel R, 2011, J NUCL CARDIOL, V18, P562, DOI 10.1007/s12350-011-9403-y
   Feit F, 2000, CIRCULATION, V101, P2795
   Feldman DN, 2006, AM J CARDIOL, V98, P1334, DOI 10.1016/j.amjcard.2006.06.026
   FESMIRE FM, 1991, SOUTHERN MED J, V84, P841
   Feuchtner G, 2011, CIRC-CARDIOVASC IMAG, V4, P540, DOI 10.1161/CIRCIMAGING.110.961250
   Fiechter M, 2011, EUR J NUCL MED MOL I, V39, P430
   Fisher E, 2009, HLTH CARE SPENDING Q
   Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913
   Fleisher LA, 2009, J AM COLL CARDIOL, V54, pe13
   Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935
   Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056
   Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8
   Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001
   Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007
   Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X
   Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI 10.1016/j.jace.2007.08.002
   FRANK CW, 1973, CIRCULATION, V47, P509
   Franklin BA, 1998, CHEST, V114, P902, DOI 10.1378/chest.114.3.902
   Franzen D, 2001, INT J IMPOT RES, V13, P348, DOI 10.1038/sj.ijir.3900787
   FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819
   Frattaroli J, 2008, AM J CARDIOL, V101, P911, DOI 10.1016/j.amjcard.2007.11.039
   Fraund S, 2005, ANN THORAC SURG, V79, P1225, DOI 10.1016/j.arthoracsur.2004.08.082
   Frazier OH, 1999, NEW ENGL J MED, V341, P1021, DOI 10.1056/NEJM199909303411402
   Fred HL, 2008, TEX HEART I J, V35, P6
   FREEMAN WK, 1991, J AM COLL CARDIOL, V18, P29
   Freemantle N, 1999, BRIT MED J, V318, P1730
   Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723
   FRISHMAN WH, 1991, AM J CARDIOL, V67, P665, DOI 10.1016/0002-9149(91)90518-P
   Frishman WH, 2003, CARDIOVASCULAR PHARM
   FROELICHER V, 1984, JAMA-J AM MED ASSOC, V252, P1291, DOI 10.1001/jama.252.10.1291
   Frosch DL, 1999, AM J PREV MED, V17, P285, DOI 10.1016/S0749-3797(99)00097-5
   FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203
   Frye RL, 2009, NEW ENGL J MED, V360, P2503
   Fukushima K, 2011, J NUCL MED, V52, P726, DOI 10.2967/jnumed.110.081828
   Gaede P, 2003, NEW ENGL J MED, V348, P383
   Galinanes M, 2004, ANN THORAC SURG, V78, P122, DOI 10.1016/j.athorascur.2003.12.032
   Garber AM, 1999, ANN INTERN MED, V130, P719
   GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450
   Gebker R, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-46
   Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508
   Gehi AK, 2008, ARCH INTERN MED, V168, P1423, DOI 10.1001/archinte.168.13.1423
   Geleijnse ML, 2007, AM J CARDIOL, V99, P714, DOI 10.1016/j.amjcard.2006.09.124
   George RT, 2011, AM J ROENTGENOL, V197, P829, DOI 10.2214/AJR.10.5689
   Gerber TC, 2010, JACC-CARDIOVASC IMAG, V3, P528, DOI 10.1016/j.jcmg.2010.03.003
   Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650
   GERSH BJ, 1989, CIRCULATION, V79, P46
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545
   GETZ GS, 1993, ARTERIOSCLER THROMB, V13, P459
   GIANROSSI R, 1989, CIRCULATION, V80, P87
   Gibbons RJ, 1999, CIRCULATION, V100, P2140
   Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2
   Gibbons Raymond J., 2003, Journal of the American College of Cardiology, V41, P159, DOI 10.1016/S0735-1097(02)02848-6
   GIBBONS RJ, 1990, ANN INTERN MED, V112, P743
   GIBBONS RJ, 1991, CATHETER CARDIO DIAG, V22, P14, DOI 10.1002/ccd.1810220104
   Gil VM, 1998, J NUCL CARDIOL, V5, P414, DOI 10.1016/S1071-3581(98)90147-7
   Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x
   Gimelli A, 2009, J NUCL MED, V50, P546, DOI 10.2967/jnumed.108.055954
   Ginsberg HN, 1998, ARTERIOSCL THROM VAS, V18, P441
   Gioia G, 2007, CATHETER CARDIO INTE, V70, P26, DOI 10.1002/ccd.21072
   Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701
   Glynn L. G., 2010, COCHRANE DB SYST REV, V3
   Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012
   GOGIA H, 1995, J AM COLL CARDIOL, V26, P1575, DOI 10.1016/0735-1097(95)00368-1
   Goldberg AC, 2006, AM J CARDIOL, V97, P376, DOI 10.1016/j.amjcard.2005.08.056
   GOLDMAN L, 1982, CIRCULATION, V66, P945
   Goldsmith RL, 2000, CORONARY ARTERY DIS, V11, P129, DOI 10.1097/00019501-200003000-00007
   Goldstein S, 1997, CARDIOVASC DRUG THER, V11, P219, DOI 10.1023/A:1007711025487
   Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47
   GORDON T, 1974, LANCET, V2, P1345
   Gori T, 2007, BRIT J CLIN PHARMACO, V64, P145, DOI 10.1111/j.1365-2125.2007.02864.x
   Gori T, 2002, CIRCULATION, V106, P2404, DOI 10.1161/01.CIR.0000036742.52907.91
   Gorin SS, 2004, CANCER EPIDEM BIOMAR, V13, P2012
   Gorman J M, 2000, Am Heart J, V140, P77, DOI 10.1067/mhj.2000.109981
   Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801
   Goy JJ, 2008, J AM COLL CARDIOL, V52, P815, DOI 10.1016/j.jacc.2008.05.037
   GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8
   Goy JJ, 1999, CIRCULATION, V99, P3255
   Goy JJ, 2000, MAYO CLIN PROC, V75, P1116
   Goyal D, 2009, CARDIOVASC THER, V27, P10, DOI 10.1111/j.1755-5922.2008.00067.x
   GRADY D, 1992, ANN INTERN MED, V117, P1016
   Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49
   Greenfield JR, 2005, J CLIN ENDOCR METAB, V90, P661, DOI 10.1210/jc.2004-1511
   Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001
   Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4
   Grimm RH, 1997, HYPERTENSION, V29, P8
   Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291
   Guadagnoli E, 2004, AM J MED, V117, P371, DOI 10.1016/j.amjmed.2004.04.013
   Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50
   Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249
   Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154
   GULDAGER B, 1992, J INTERN MED, V231, P261
   Guleserian KJ, 2003, ANN THORAC SURG, V75, P1842, DOI 10.1016/S0003-4975(03)00178-4
   Gupta S, 2011, CIRCULATION, V123, P1377, DOI 10.1161/CIRCULATIONAHA.110.003236
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   Gurm HS, 2011, J AM COLL CARDIOL, V58, P907, DOI 10.1016/j.jacc.2011.05.023
   Haberl R, 2005, AM HEART J, V149, P1112, DOI 10.1016/j.ahj.2005.02.048
   Hachamovitch R, 2006, J NUCL CARDIOL, V13, P768, DOI 10.1016/j.nuclcard.2006.08.017
   Hachamovitch R, 1998, CIRCULATION, V97, P535
   Hachamovitch R, 2009, J NUCL CARDIOL, V16, P935, DOI 10.1007/s12350-009-9140-7
   Hachamovitch R, 2003, J AM COLL CARDIOL, V41, P1329, DOI 10.1016/S0735-1097(03)00125-6
   Hachamovitch R, 1996, CIRCULATION, V93, P905
   Hachamovitch R, 2007, J NUCL CARDIOL, V14, P634, DOI 10.1016/j.nuclcard.2007.06.118
   Hachamovitch R, 2004, J AM COLL CARDIOL, V43, P200, DOI 10.1016/j.jacc.2003.07.043
   Hachamovitch R, 2005, J AM COLL CARDIOL, V45, P722, DOI 10.1016/j.jacc.2004.08.069
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Hachamovitch R, 1997, AM J CARDIOL, V80, P426
   Hachamovitch R, 2000, Rev Cardiovasc Med, V1, P91
   Hachamovitch R, 2012, J AM COLL CARDIOL, V59, P462, DOI 10.1016/j.jacc.2011.09.066
   Hachamovitch R, 2002, CIRCULATION, V105, P823, DOI 10.1161/hc0702.103973
   Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500
   Hacker M, 2007, NUKLEARMED-NUCL MED, V46, P29
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Haffner SM, 2000, NEW ENGL J MED, V342, P1040, DOI 10.1056/NEJM200004063421408
   Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001
   Hallikainen MA, 2000, J NUTR, V130, P767
   Halpern EJ, 2010, ACAD RADIOL, V17, P577, DOI 10.1016/j.acra.2009.12.015
   Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F
   Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C
   Hambrecht Rainer, 1993, Journal of the American College of Cardiology, V22, P468
   Hamdan A, 2011, JACC-CARDIOVASC IMAG, V4, P50, DOI 10.1016/j.jcmg.2010.10.007
   HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601
   HAMMERMEISTER KE, 1979, CIRCULATION, V59, P421
   Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29
   Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028
   Hamon M, 2008, RADIOLOGY, V247, P679, DOI 10.1148/radiol.2473071132
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 2006, J AM COLL CARDIOL, V47, P661, DOI 10.1016/j.jacc.2005.10.057
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   HARRIS PJ, 1979, CIRCULATION, V60, P1259
   Hashimoto A, 2009, CIRC J, V73, P2288
   HASKELL WL, 1994, CIRCULATION, V89, P975
   Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649
   HaufZachariou U, 1997, EUR J CLIN PHARMACOL, V52, P95, DOI 10.1007/s002280050256
   Hautvast RWM, 1996, AM J CARDIOL, V77, P462, DOI 10.1016/S0002-9149(97)89338-1
   Hautvast RWM, 1998, AM HEART J, V136, P1114, DOI 10.1016/S0002-8703(98)70171-1
   He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459
   Heart Outcomes Prevention Evaluation (HOPE) Study investigators, 2000, LANCET, V355, P253
   HEBERT PR, 1993, ARCH INTERN MED, V153, P578, DOI 10.1001/archinte.153.5.578
   Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927
   Heitzer T, 1998, J AM COLL CARDIOL, V31, P83, DOI 10.1016/S0735-1097(97)00431-2
   Held C, 1997, CIRCULATION, V95, P2380
   Helton TJ, 2007, AM J CARDIOVASC DRUG, V7, P289, DOI 10.2165/00129784-200707040-00006
   Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013
   Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003
   Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3
   Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3
   Henneman MM, 2008, J AM COLL CARDIOL, V52, P216, DOI 10.1016/j.jacc.2008.04.012
   Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB
   Heslop CL, 2010, J AM COLL CARDIOL, V55, P1102, DOI 10.1016/j.jacc.2009.11.050
   Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009
   HIRSH J, 1995, CHEST, V108, pS247, DOI 10.1378/chest.108.4_Supplement.247S
   Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278
   Hlatky MA, 2004, J AM COLL CARDIOL, V43, P583, DOI 10.1016/j.jacc.2003.11.021
   Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203
   Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
   Ho KT, 2002, MAYO CLIN PROC, V77, P515
   Ho PM, 2007, AM HEART J, V154, P489, DOI 10.1016/j.ohi.2007.05.018
   Hochholzer W, 2005, CIRCULATION, V111, P2560, DOI 10.1161/01.CIR.0000160869.75810.98
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   HOLLANDER JE, 1995, NEW ENGL J MED, V333, P1267, DOI 10.1056/NEJM199511093331907
   Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470
   Holmboe ES, 2000, J GEN INTERN MED, V15, P632, DOI 10.1046/j.1525-1497.2000.90823.x
   Holmes DR, 2008, JACC-CARDIOVASC INTE, V1, P34, DOI 10.1016/j.jcin.2007.10.001
   Holubkov R, 2002, AM HEART J, V144, P826, DOI 10.1067/mhj.2002.125505
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   HOMCY CJ, 1982, AM J CARDIOL, V49, P478, DOI 10.1016/0002-9149(82)90528-8
   HONG MK, 1992, AM J CARDIOL, V69, P176, DOI 10.1016/0002-9149(92)91300-S
   Hong SJ, 2005, CATHETER CARDIO INTE, V64, P75, DOI 10.1002/ccd.20238
   Honig A, 2007, PSYCHOSOM MED, V69, P606, DOI 10.1097/PSY.0b013e31814b260d
   Horne BD, 2004, ANN EPIDEMIOL, V14, P143, DOI 10.1016/S1047-2797(03)00125-X
   Hosokawa S, 2003, CIRC J, V67, P221
   HSIEH SD, 1995, INT J OBESITY, V19, P585
   HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2007, ANN THORAC SURG, V83, P93, DOI 10.1016/j.athoracsur.2006.08.050
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065
   Hughes JR, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2
   Hughes JR, 2003, J GEN INTERN MED, V18, P1053, DOI 10.1111/j.1525-1497.2003.20640.x
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Hundley WG, 1999, CIRCULATION, V100, P1697
   Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013
   Iafrate R P Jr, 1983, Pharmacotherapy, V3, P118
   Imran MB, 2003, INT J CARDIOVAS IMAG, V19, P23, DOI 10.1023/A:1021746515555
   Ingkanisorn WP, 2006, J AM COLL CARDIOL, V47, P1427, DOI 10.1016/j.jacc.2005.11.059
   Ingul CB, 2007, CIRCULATION, V115, P1252, DOI 10.1161/CIRCULATIONAHA.106.640334
   Innocenti F, 2011, INT J CARDIOVAS IMAG, V27, P65, DOI 10.1007/s10554-010-9655-7
   Ishikawa K, 1997, CIRCULATION, V95, P2368
   ISNER JM, 1981, CIRCULATION, V63, P1056
   Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010
   Jacobs AK, 2002, J AM COLL CARDIOL, V39, P1608, DOI 10.1016/S0735-1097(02)01835-1
   Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201
   Jaffery Z, 2007, EUR J CARDIO-THORAC, V31, P691, DOI 10.1016/j.ejcts.2007.01.018
   Jagathesan R, 2006, J CARDIOVASC PHARM, V48, P110, DOI 10.1097/01.fjc.0000245404.20922.9f
   Jahnke C, 2007, CIRCULATION, V115, P1769, DOI 10.1161/CIRCULATIONAHA.106.652016
   JANOSI A, 1991, CHEST, V100, P227, DOI 10.1378/chest.100.1.227
   Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148
   Javitz HS, 2004, AM J MANAG CARE, V10, pS358
   Jensen MK, 2008, CIRCULATION, V117, P3062, DOI 10.1161/CIRCULATIONAHA.107.759951
   Jerling M, 2005, CLIN PHARMACOL THER, V78, P288, DOI 10.1016/j.clpt.2005.05.004
   Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004
   Jneid H, 2005, CIRCULATION, V111, P2565, DOI 10.1161/CIRCULATIONAHA.104.515445
   Joannides R, 2006, BRIT J CLIN PHARMACO, V61, P127, DOI 10.1111/j.1365-2125.2005.02544.x
   Johansen A, 2006, CLIN PHYSIOL FUNCT I, V26, P288, DOI 10.1111/j.1475-097X.2006.00690.x
   Johnson JA, 2003, CLIN PHARMACOL THER, V74, P44, DOI 10.1016/S0009-9236(03)00068-7
   JOHNSON SM, 1981, JAMA-J AM MED ASSOC, V245, P1849, DOI 10.1001/jama.245.18.1849
   Joint Commission on Accreditation of Healthcare Organizations, 2007, JT COMM PERSPECT, V27, P9
   Jones CM, 2007, ANN THORAC SURG, V83, P341, DOI 10.1016/j.athoracsur.2006.08.018
   JONES EL, 1983, AM J CARDIOL, V51, P7, DOI 10.1016/S0002-9149(83)80003-4
   Jones JW, 1999, ANN THORAC SURG, V67, P1596, DOI 10.1016/S0003-4975(99)00368-9
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P5
   Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012
   Julius S, 2006, HYPERTENSION, V48, P385, DOI 10.1161/01.HYP.0000236119.96301.f2
   Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004
   JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q
   Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001
   KAISER GA, 1975, SURGERY, V78, P749
   Kamalesh M, 2002, AM HEART J, V143, P163, DOI 10.1067/mhj.2002.119377
   Kang XP, 2006, J AM COLL CARDIOL, V47, P1418, DOI 10.1016/j.jacc.2005.11.062
   KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035
   KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8
   KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9
   Kantor PF, 2000, CIRC RES, V86, P580
   Kapoor JR, 2008, JACC-CARDIOVASC INTE, V1, P483, DOI 10.1016/j.jcin.2008.07.001
   Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213
   Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
   Kardas Przemyslaw, 2007, Vasc Health Risk Manag, V3, P235, DOI 10.2147/vhrm.2007.3.2.235
   KARLSON BW, 1993, CLIN CARDIOL, V16, P397
   Karlsson J, 2004, CLIN CARDIOL, V27, P347, DOI 10.1002/clc.4960270610
   Kasper J F, 1992, QRB Qual Rev Bull, V18, P183
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Katritsis DG, 2007, NEW ENGL J MED, V357, P414
   Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864
   Katzel LI, 1999, J AM GERIATR SOC, V47, P923
   KAUL S, 1995, AM J CARDIOL, V75, pD18
   Keitel WA, 2006, ARCH INTERN MED, V166, P1121, DOI 10.1001/archinte.166.10.1121
   Kelle S, 2011, JACC-CARDIOVASC IMAG, V4, P161, DOI 10.1016/j.jcmg.2010.11.012
   Kelly TN, 2009, ANN INTERN MED, V151, P394
   Ken-Dror Gie, 2004, Harefuah, V143, P566
   Ken-Dror G, 2004, HAREFUAH, V143, P623
   Kernis SJ, 2004, J AM COLL CARDIOL, V43, P1773, DOI 10.1016/j.jacc.2003.09.071
   Khunnawat C, 2008, AM J CARDIOL, V102, P635, DOI 10.1016/j.amjcard.2008.04.035
   Kim JW, 2005, INT J CARDIOL, V99, P437, DOI 10.1016/j.ijcard.2004.08.045
   Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602
   Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E
   Kleisli T, 2005, J THORAC CARDIOV SUR, V129, P1283, DOI 10.1016/j.jtcvs.2004.12.034
   Klem I, 2006, J AM COLL CARDIOL, V47, P1630, DOI 10.1016/j.jacc.2005.10.074
   Kloner RA, 2004, J UROLOGY, V172, P1935, DOI 10.1097/01.ju.0000142687.75577.e4
   KNOCHEL JP, 1961, AM J MED, V30, P299, DOI 10.1016/0002-9343(61)90101-2
   Knudtson ML, 2002, JAMA-J AM MED ASSOC, V287, P481, DOI 10.1001/jama.287.4.481
   Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039
   Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351
   KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503
   Koh KK, 2002, CARDIOVASC RES, V55, P714, DOI 10.1016/S0008-6363(02)00487-X
   Kok G, 1997, PATIENT EDUC COUNS, V30, P19, DOI 10.1016/S0738-3991(96)00953-6
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066
   Kop WJ, 2002, AM J CARDIOL, V89, P419, DOI 10.1016/S0002-9149(01)02264-0
   Korosoglou G, 2010, J AM COLL CARDIOL, V56, P1225, DOI 10.1016/j.jacc.2010.06.020
   Koyanagi T, 1996, ANN THORAC SURG, V61, P1793, DOI 10.1016/0003-4975(96)00170-1
   Kozower BD, 2005, ANN THORAC SURG, V80, P112, DOI 10.1016/j.athoracsur.2005.02.017
   KREPP HP, 1991, CARDIOLOGY, V79, P14, DOI 10.1159/000174919
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1
   Kronish IM, 2006, J GEN INTERN MED, V21, P1178, DOI 10.1111/j.1525-1497.2006.00586.x
   Krumholz HM, 2010, JAMA-J AM MED ASSOC, V303, P1190, DOI 10.1001/jama.2010.309
   Kuntz KM, 1999, ANN INTERN MED, V130, P709
   Kunz R, 2008, ANN INTERN MED, V148, P30
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Kwok JMF, 2002, J AM COLL CARDIOL, V39, P1475, DOI 10.1016/S0735-1097(02)01769-2
   Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1
   Kwong RY, 2003, CIRCULATION, V107, P531, DOI 10.1161/01.CIR.0000047527.11221.29
   Kwong RY, 2011, JACC-CARDIOVASC IMAG, V4, P157, DOI 10.1016/j.jcmg.2010.12.004
   LACOSTE LL, 1994, AM J CARDIOL, V73, P1058
   Ladapo JA, 2009, J AM COLL CARDIOL, V54, P2409, DOI 10.1016/j.jacc.2009.10.012
   LADENHEIM ML, 1987, AM J CARDIOL, V59, P270, DOI 10.1016/0002-9149(87)90798-3
   LADENHEIM ML, 1986, J AM COLL CARDIOL, V7, P464
   LaghrissiThode F, 1997, BIOL PSYCHIAT, V42, P290, DOI 10.1016/S0006-3223(96)00345-9
   Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6
   Lancaster T, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001292.PUB2
   Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197
   Lapenna E, 2006, ANN THORAC SURG, V82, P1704, DOI 10.1016/j.athoracsur.2006.05.096
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754
   Lauer MS, 2011, CIRCULATION, V123, P1364, DOI 10.1161/CIRCULATIONAHA.111.023218
   Lauer MS, 2007, ANN INTERN MED, V147, P821
   Lauer MS, 1998, LANCET, V351, P615, DOI 10.1016/S0140-6736(97)07062-1
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Leape LL, 2000, AM HEART J, V139, P106, DOI 10.1016/S0002-8703(00)90316-8
   Lee AB, 2006, INTERN MED J, V36, P237, DOI 10.1111/j.1445-5994.2006.01044.x
   Lee MS, 2007, INT J CARDIOL, V123, P34, DOI 10.1016/j.ijcard.2006.11.103
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   LEE TH, 1990, J GEN INTERN MED, V5, P381, DOI 10.1007/BF02599421
   Leischik R, 2007, INT J CARDIOL, V119, P297, DOI 10.1016/j.ijcard.2006.07.190
   Leizorovicz A, 2002, AM HEART J, V143, P301, DOI 10.1067/mhj.2002.120768
   Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Lerakis S, 2010, AM J MED SCI, V339, P216, DOI 10.1097/MAJ.0b013e3181c6bfcc
   Lertsburapa K, 2008, J NUCL CARDIOL, V15, P745, DOI 10.1007/BF03007355
   Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   LEVY D, 1989, ANN INTERN MED, V110, P101
   LEVY D, 1994, CIRCULATION, V90, P1786
   LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
   Lewington S, 2002, LANCET, V360, P1903
   Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303
   Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821
   Liao L, 2005, AM J CARDIOL, V95, P1243, DOI 10.1016/j.amjcard.2005.01.057
   Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257
   Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
   Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769
   Lima RSL, 2004, INT J CARDIOL, V93, P137, DOI 10.1016/S0167-5273(03)00149-9
   Lin FY, 2011, J AM COLL CARDIOL, V58, P510, DOI 10.1016/j.jacc.2010.11.078
   Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604
   LITTLE WC, 1988, CIRCULATION, V78, P1157
   Liu J, 2006, CLIN PHARMACOL THER, V80, P23, DOI 10.1016/j.clpt.2006.03.004
   Liu J, 2003, CLIN PHARMACOL THER, V74, P372, DOI 10.1067/S0009-9236(03)00224-8
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Loke YK, 2011, BRIT MED J, V342, P1309
   Lonn E, 2006, NEW ENGL J MED, V354, P1567
   LONN EM, 1994, CIRCULATION, V90, P2056
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Lopez-Jimenez F, 2005, MAYO CLIN PROC, V80, P1157
   Lorenzoni R, 2003, J AM SOC ECHOCARDIOG, V16, P1287, DOI 10.1067/j.echo.2003.07.007
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   MACGREGOR GA, 1989, LANCET, V2, P1244
   Maddox TM, 2008, ARCH INTERN MED, V168, P1310, DOI 10.1001/archinte.168.12.1310
   Mahajan N, 2010, HEART, V96, P956, DOI 10.1136/hrt.2009.182295
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Malfatto Gabriella, 2005, Ital Heart J, V6, P21
   Mannheimer C, 1998, CIRCULATION, V97, P1157
   MANOLIO TA, 1993, CIRCULATION, V88, P2163
   MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141
   Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808
   Manz M, 2003, CARDIOLOGY, V100, P149, DOI 10.1159/000073933
   Manzi S, 1997, AM J EPIDEMIOL, V145, P408
   Maqbool A, 1999, LANCET, V353, P897, DOI 10.1016/S0140-6736(99)00549-8
   Marcassa C, 2008, EUR HEART J, V29, P557, DOI 10.1093/eurheartj/ehm607
   MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204
   MARK DB, 1994, CIRCULATION, V89, P2015
   MARK DB, 1987, ANN INTERN MED, V106, P793
   MARK DB, 2010, J AM COLL CARDIOL, V55, P2663
   Markham A, 2000, DRUGS, V60, P955, DOI 10.2165/00003495-200060040-00007
   Maron DJ, 2009, AM J CARDIOL, V104, P1055, DOI 10.1016/j.amjcard.2009.05.056
   Martini CH, 2005, J THROMB HAEMOST, V3, P177, DOI 10.1111/j.1538-7836.2004.01080.x
   Martuscelli E, 2008, EUR J CARDIO-THORAC, V33, P4, DOI 10.1016/j.ejcts.2007.09.029
   Marwick TH, 1997, J AM COLL CARDIOL, V30, P83
   Marwick TH, 2001, CIRCULATION, V103, P2566
   Marwick TH, 2003, EUR HEART J, V24, P1153, DOI 10.1016/S0195-668X(03)00113-1
   Marwick TH, 2001, J AM COLL CARDIOL, V37, P754, DOI 10.1016/S0735-1097(00)01191-8
   Marzilli M, 2003, CORONARY ARTERY DIS, V14, P171, DOI 10.1097/01.mca.0000062799.53287.82
   Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670
   Matetzky S, 2003, ARCH INTERN MED, V163, P457, DOI 10.1001/archinte.163.4.457
   Mattera JA, 1998, J NUCL CARDIOL, V5, P498, DOI 10.1016/S1071-3581(98)90181-7
   Matzkies FK, 2001, NEPHRON, V89, P10, DOI 10.1159/000046036
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   MAY GA, 1984, PHYS THER, V64, P1361
   MCCARTNEY N, 1991, AM J CARDIOL, V67, P939, DOI 10.1016/0002-9149(91)90164-G
   McCord J, 2008, CIRCULATION, V117, P1897, DOI 10.1161/CIRCULATIONAHA.107.188950
   McCormack J, 2000, BRIT MED J, V320, P1720, DOI 10.1136/bmj.320.7251.1720
   McCully RB, 2002, J AM COLL CARDIOL, V39, P1345, DOI 10.1016/S0735-1097(02)01778-3
   McCully RB, 1998, J AM COLL CARDIOL, V31, P144, DOI 10.1016/S0735-1097(97)00427-0
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McGillion Michael, 2007, Can J Nurs Res, V39, P48
   McKellar JD, 2004, DIABETES EDUCATOR, V30, P485, DOI 10.1177/014572170403000320
   McLellan CS, 2005, AM HEART J, V150, P800, DOI 10.1016/j.ahj.2004.10.037
   McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037
   McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3
   McNulty PH, 2002, CATHETER CARDIO INTE, V56, P174, DOI 10.1002/ccd.10186
   McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79
   Mega JL, 2010, CIRCULATION, V121, P1809, DOI 10.1161/CIRCULATIONAHA.109.897231
   Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171
   Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068
   Mehta NJ, 2003, ANGIOLOGY, V54, P269, DOI 10.1177/000331970305400302
   Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058
   MELIN JA, 1985, CIRCULATION, V71, P535
   Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38
   Merz N B, 2001, Am J Manag Care, V7, P959
   Messerli FH, 2006, ANN INTERN MED, V144, P884
   Metz LD, 2007, J AM COLL CARDIOL, V49, P227, DOI 10.1016/j.jace.2006.08.048
   Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60
   Milani RV, 2004, J AM COLL CARDIOL, V43, P1056, DOI 10.1016/j.jacc.2003.10.041
   Miller JM, 2008, NEW ENGL J MED, V359, P232
   Miller NH, 1995, CURRENT ISSUES CARDI
   MILLER TD, 1994, MAYO CLIN PROC, V69, P626
   Miller TD, 2002, AM J MED, V112, P290, DOI 10.1016/S0002-9343(01)01111-1
   Miller TD, 2005, AM J MED, V118, P866, DOI 10.1016/j.amjmed.2005.03.013
   Miller WR, 2002, MOTIVATIONAL INTERVI
   Min JK, 2010, J AM COLL CARDIOL, V55, P957, DOI 10.1016/j.jacc.2009.08.087
   Min JK, 2008, RADIOLOGY, V249, P62, DOI 10.1148/radiol.2483071453
   Min JK, 2010, RADIOLOGY, V254, P801, DOI 10.1148/radiol.09090349
   Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067
   Min JK, 2008, AM J CARDIOL, V102, P672, DOI 10.1016/j.amjcard.2008.04.045
   Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074
   MOCK MB, 1982, CIRCULATION, V66, P562
   MOE G, 1986, AM J MED, V81, P765, DOI 10.1016/0002-9343(86)90341-4
   Moller J, 2001, HEART, V86, P387, DOI 10.1136/heart.86.4.387
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Montorsi F, 2004, EUR UROL, V45, P339, DOI 10.1016/j.eururo.2003.11.010
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morise AP, 2003, J AM COLL CARDIOL, V42, P842, DOI 10.1016/S0735-1097(03)00837-4
   MORRIS SN, 1978, AM J CARDIOL, V41, P221, DOI 10.1016/0002-9149(78)90160-1
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775
   Morrow DA, 2009, CIRCULATION, V119, P2032, DOI 10.1161/CIRCULATIONAHA.107.763912
   MORROW K, 1993, ANN INTERN MED, V118, P689
   Mosca Lori, 2011, Circulation, V123, P1243, DOI 10.1161/CIR.0b013e31820faaf8
   Moscucci M, 2001, CIRCULATION, V104, P263
   Moss AJ, 2008, J CARDIOVASC ELECTR, V19, P1289, DOI 10.1111/j.1540-8167.2008.01246.x
   Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068
   Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, piii
   Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292
   Mozaffarian D, 2003, AM HEART J, V146, P1015, DOI 10.1016/S0002-8703(03)00436-8
   Mukamal KJ, 2007, J CLIN ENDOCR METAB, V92, P2559, DOI 10.1210/jc.2006-2422
   Mukamal KJ, 2001, JAMA-J AM MED ASSOC, V285, P1965, DOI 10.1001/jama.285.15.1965
   Mukherjee D, 1999, AM J CARDIOL, V84, P598, DOI 10.1016/S0002-9149(99)00387-2
   Muller JE, 2000, AM J CARDIOL, V86, p14F
   Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462
   Muntwyler J, 1998, LANCET, V352, P1882, DOI 10.1016/S0140-6736(98)06351-X
   Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d
   Munzel T, 2002, CIRCULATION, V106, P170, DOI 10.1161/01.CIR.0000021663.39699.30
   MURPHY ML, 1977, NEW ENGL J MED, V297, P621, DOI 10.1056/NEJM197709222971201
   Murphy SL, 2012, NATL VITAL STAT REPO, P60
   Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8
   Murthy VL, 2011, CIRCULATION, V124, P2215, DOI 10.1161/CIRCULATIONAHA.111.050427
   Musselman DL, 1996, AM J PSYCHIAT, V153, P1313
   Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x
   Myers J, 2009, CIRCULATION, V119, P3144, DOI 10.1161/CIRCULATIONAHA.109.192520
   Myers J, 2002, AM HEART J, V143, P1052, DOI 10.1067/mhj.2002.122287
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   MYERS WO, 1987, ANN THORAC SURG, V44, P471
   Nagao T, 2007, CIRC J, V71, P1029, DOI 10.1253/circj.71.1029
   Nagata M, 2011, RADIOLOGY, V259, P384, DOI 10.1148/radiol.11101323
   Nagel E, 1999, CIRCULATION, V99, P763
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011
   Nakagomi A, 1996, AM J CARDIOL, V78, P516, DOI 10.1016/S0002-9149(96)00355-4
   Nakata T, 2009, JACC-CARDIOVASC IMAG, V2, P1393, DOI 10.1016/j.jcmg.2009.09.010
   Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962
   Nallamothu N, 1997, J NUCL CARDIOL, V4, P487, DOI 10.1016/S1071-3581(97)90006-4
   NALLAMOTHU N, 1995, J AM COLL CARDIOL, V25, P830, DOI 10.1016/0735-1097(94)00471-2
   Nandalur KR, 2007, J AM COLL CARDIOL, V50, P1343, DOI 10.1016/j.jacc.2007.06.030
   Nandalur KR, 2008, ACAD RADIOL, V15, P444, DOI 10.1016/j.acra.2007.08.012
   NARAHARA KA, 1990, AM J CARDIOL, V65, P577, DOI 10.1016/0002-9149(90)91033-3
   Nathan DM, 2005, NEW ENGL J MED, V353, P2643
   National Kidney Foundation, 2002, AM J KIDNEY DIS, V39, pS1
   Navare SM, 2004, J NUCL CARDIOL, V11, P551, DOI 10.1016/j.nuclcard.2004.06.128
   National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treat-ment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, CIRCULATION, V106, P3143
   Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE
   Ng ACT, 2009, AM HEART J, V158, P836, DOI 10.1016/j.ahj.2009.09.010
   Nguyen TT, 1999, MAYO CLIN PROC, V74, P1198
   Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338
   Nicorandil study ivestigators, 2003, DRUG THER B, V41, P86
   Nieman K, 2009, AM J CARDIOL, V104, P1499, DOI 10.1016/j.amjcard.2009.07.011
   Nieminen T, 2006, J APPL PHYSIOL, V100, P507, DOI 10.1152/japplphysiol.00899.2005
   Nigam A, 1998, J NUCL MED, V39, P579
   Nikolsky Eugenia, 2004, J Invasive Cardiol, V16, P102
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217
   Nowak Z, 2010, KARDIOL POL, V68, P32
   Nucifora G, 2011, INT J CARDIOVAS IMAG, V27, P777, DOI 10.1007/s10554-010-9725-x
   Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   O'Donoghue M, 2006, CIRCULATION, V113, P1745, DOI 10.1161/CIRCULATIONAHA.105.612630
   O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7
   Oesterle SN, 2000, LANCET, V356, P1705, DOI 10.1016/S0140-6736(00)03203-7
   Oka R, 2008, DIABETES RES CLIN PR, V79, P474, DOI 10.1016/j.diabres.2007.10.016
   OKEEFE JH, 1993, AM J CARDIOL, V71, P897, DOI 10.1016/0002-9149(93)90903-P
   Okin PM, 2003, CIRCULATION, V108, P684, DOI 10.1161/01.CIR.0000083724.28630.C3
   Okin PM, 2009, CIRCULATION, V119, P1883, DOI 10.1161/CIRCULATIONAHA.108.812313
   OLDRIDGE NB, 1989, MED SCI SPORT EXER, V21, P308
   Oremus M, 2008, CLIN BIOCHEM, V41, P260, DOI 10.1016/j.clinbiochem.2007.09.011
   ORNISH D, 1983, JAMA-J AM MED ASSOC, V249, P54, DOI 10.1001/jama.249.1.54
   O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7
   O'Shaughnessy KM, 2000, CLIN SCI, V99, P233, DOI 10.1042/CS20000030
   Osswald BR, 2001, THORAC CARDIOV SURG, V49, P373, DOI 10.1055/s-2001-19017
   Otero HJ, 2010, INT J CARDIOVAS IMAG, V26, P605, DOI 10.1007/s10554-010-9634-z
   Ovrehus KA, 2010, AM J CARDIOL, V105, P773, DOI 10.1016/j.amjcard.2009.11.006
   Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201
   Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101
   Padma-Nathan H, 2002, UROLOGY, V60, P67, DOI 10.1016/S0090-4295(02)01752-1
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410
   Paridon SM, 2006, CIRCULATION, V113, P1905, DOI 10.1161/CIRCULATIONAHA.106.174375
   Parisi AF, 1997, J AM COLL CARDIOL, V30, P1256, DOI 10.1016/S0735-1097(97)00293-3
   Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Parker JD, 1998, NEW ENGL J MED, V338, P520
   PARKER JO, 1995, CIRCULATION, V91, P1368
   PARMLEY WW, 1992, J AM COLL CARDIOL, V19, P1380
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603
   Patel A, 2008, NEW ENGL J MED, V358, P2560
   Patel MR, 2005, J AM COLL CARDIOL, V46, P1606, DOI 10.1016/j.jacc.2005.08.030
   Pazhenkottil AP, 2011, J NUCL MED, V52, P196, DOI 10.2967/jnumed.110.080580
   Pazhenkottil AP, 2011, EUR HEART J, V32, P1465, DOI 10.1093/eurheartj/ehr047
   Pazhenkottil AP, 2010, HEART, V96, P2050, DOI 10.1136/hrt.2010.201996
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403
   Pennell DJ, 2004, EUR HEART J, V25, P1940, DOI 10.1016/j.ehj.2004.06.040
   Pepine CJ, 2004, CIRCULATION, V109, pE44, DOI 10.1161/01.CIR.0000116206.77324.5B
   PEPINE CJ, 1981, AM HEART J, V101, P719, DOI 10.1016/0002-8703(81)90606-2
   Perrone-Filardi P, 2010, J NUCL CARDIOL, V17, P310, DOI 10.1007/s12350-009-9182-x
   Peteiro J, 2006, AM HEART J, V151
   Peteiro J, 2010, EUR HEART J, V31, P187, DOI 10.1093/eurheartj/ehp427
   Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB
   Peterson ED, 2003, J AM COLL CARDIOL, V42, P1611, DOI 10.1016/S0735-1097(03)01121-5
   PETERSON ED, 1994, ANN INTERN MED, V121, P919
   Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
   Pfisterer M, 2004, CIRCULATION, V110, P1213, DOI 10.1161/01.CIR.0000140983.69571.BA
   Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   Philpott S, 2001, SOC SCI MED, V52, P1565, DOI 10.1016/S0277-9536(00)00269-0
   Picano E, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-30
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pilz G, 2010, J MAGN RESON IMAGING, V32, P615, DOI 10.1002/jmri.22289
   Pilz G, 2008, AM J CARDIOL, V101, P1408, DOI 10.1016/j.amjcard.2008.01.019
   Pinkstaff S, 2010, MAYO CLIN PROC, V85, P1095, DOI 10.4065/mcp.2010.0357
   Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202
   Pitt B, 2001, AM J CARDIOL, V87, P1058, DOI 10.1016/S0002-9149(01)01461-8
   Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202
   Pittman M A, 2001, Trustee, V54, P30
   PLOTNICK GD, 1979, ANN INTERN MED, V91, P149
   Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   Pohl T, 2004, CATHETER CARDIO INTE, V62, P323, DOI 10.1002/ccd.20060
   Poldermans D, 1999, CIRCULATION, V99, P757
   Poldermans D, 1997, EUR HEART J, V18, pD86
   Pollock BG, 2000, J CLIN PSYCHOPHARM, V20, P137, DOI 10.1097/00004714-200004000-00004
   Poole-Wilson PA, 2007, EUR HEART J, V28, P1928, DOI 10.1093/eurheartj/ehm198
   Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7
   Poornima IG, 2004, J AM COLL CARDIOL, V43, P194, DOI 10.1016/j.jacc.2003.09.029
   Pope CA, 2007, INHAL TOXICOL, V19, P33, DOI 10.1080/08958370701492961
   Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Porter TR, 2011, CIRC-CARDIOVASC IMAG, V4, P628, DOI 10.1161/CIRCIMAGING.111.966341
   Poses RM, 2002, CHEST, V122, P122, DOI 10.1378/chest.122.1.122
   Pothier CE, 2004, AM J MED, V117, P380
   Prasad A, 1999, J AM COLL CARDIOL, V33, P796, DOI 10.1016/S0735-1097(98)00611-1
   Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165
   Prochaska J, 1984, CHANGING GOOD REVOLU
   PROUDFIT WJ, 1983, CIRCULATION, V68, P986
   PRYOR DB, 1991, AM J MED, V90, P553
   PRYOR DB, 1993, ANN INTERN MED, V118, P81
   Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534
   Pundziute G, 2008, HEART, V94, P48, DOI 10.1136/hrt.2007.116715
   Qureshi MA, 2003, J AM COLL CARDIOL, V42, P1890, DOI 10.1016/j.jacc.2003.06.014
   Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056
   Raftery EB, 1996, EUR HEART J, V17, P30
   Ragosta M, 2006, CATHETER CARDIO INTE, V68, P357, DOI 10.1002/ccd.20709
   Rajaratnam R, 1999, AM J CARDIOL, V83, P1120, DOI 10.1016/S0002-9149(99)00025-9
   randomized A, 1996, LANCET, V348, P1329
   Rao SV, 2004, ARCH INTERN MED, V164, P1128, DOI 10.1001/archinte.164.10.1128
   Rauramaa R, 2001, MED SCI SPORT EXER, V33, pS516, DOI 10.1097/00005768-200106001-00022
   Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8
   Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5
   Rees K, 2004, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD002902.pub2, DOI 10.1002/14651858.CD002902.PUB2]
   Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1
   Rehnqvist N, 1995, Cardiologia, V40, P301
   REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Reid RJ, 2009, AM J MANAG CARE, V15, pE71
   Resnic FS, 2001, AM J CARDIOL, V88, P5, DOI 10.1016/S0002-9149(01)01576-4
   RICHTER A, 1991, EUR HEART J, V12, P175
   Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978
   Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378
   Rieckmann N, 2006, AM HEART J, V152, P922, DOI 10.1016/j.ahj.2006.05.014
   Rieckmann N, 2006, J AM COLL CARDIOL, V48, P2218, DOI 10.1016/j.jacc.2006.07.063
   Rigotti NA, 2009, CAN MED ASSOC J, V180, P1283, DOI 10.1503/cmaj.090729
   Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744
   RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117
   RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004
   RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941
   Rocha JA, 2010, RADIOLOGY, V254, P410, DOI 10.1148/radiol.09091014
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7
   Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4
   RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060
   Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081
   Roger VL, 1997, CIRCULATION, V95, P405
   Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9
   Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONHA.107.183885
   Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0
   ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   Rouleau JL, 2008, CIRCULATION, V117, P24, DOI 10.1161/CIRCULATIONAHA.106.685073
   Rousseau MF, 2005, AM J CARDIOL, V95, P311, DOI 10.1016/j.amjcard.2004.09.025
   Rozanski A, 2010, J NUCL CARDIOL, V17, P999, DOI 10.1007/s12350-010-9300-9
   ROZANSKI A, 1983, NEW ENGL J MED, V309, P518, DOI 10.1056/NEJM198309013090902
   Rozanski A, 1999, CIRCULATION, V99, P2192
   RUBERMAN W, 1980, CIRCULATION, V61, P1172
   Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604
   Rubinshtein R, 2007, AM J CARDIOL, V99, P472, DOI 10.1016/j.amjcard.2006.08.060
   Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0
   Rumsfeld JS, 2003, AM HEART J, V145, P493, DOI 10.1067/mhj.2003.177
   Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298
   Rumsfeld JS, 2005, CIRCULATION, V111, P250, DOI 10.1161/01.CIR.0000154573.62822.89
   Rumsfeld JS, 2003, J AM COLL CARDIOL, V41, P1732, DOI 10.1016/S0735-1097(03)00330-9
   Rumsfeld JS, 2005, AM HEART J, V150, P961, DOI 10.1016/j.ahj.2005.02.036
   Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215
   Rutledge T, 2004, PSYCHOSOM MED, V66, P882, DOI 10.1097/01.psy.0000145819.94041.52
   RYDEN L, 1992, J INTERN MED, V231, P7
   Sabharwal NK, 2007, J NUCL CARDIOL, V14, P174, DOI 10.1016/j.nuclcard.2006.12.324
   Sachdev M, 2004, J AM COLL CARDIOL, V43, P576, DOI 10.1016/j.jacc.2003.10.031
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   Sakuma H, 2011, RADIOLOGY, V258, P340, DOI 10.1148/radiol.10100116
   Sakuma H, 2006, J AM COLL CARDIOL, V48, P1946, DOI 10.1016/j.jacc.2006.07.055
   Sampson UK, 2007, J AM COLL CARDIOL, V49, P1052, DOI 10.1016/j.jacc.2006.12.015
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Santana-Boado C, 1998, J NUCL MED, V39, P751
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031
   Savonitto S, 1996, J AM COLL CARDIOL, V27, P311, DOI 10.1016/0735-1097(95)00489-0
   Saw J, 2007, J AM COLL CARDIOL, V50, P291, DOI 10.1016/j.jacc.2007.01.097
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Sawada SG, 2007, ECHOCARDIOGR-J CARD, V24, P739, DOI 10.1111/j.1540-8175.2007.00471.x
   Schaefer EJ, 1997, AM J CLIN NUTR, V65, P823
   SCHAEFER EJ, 1995, ARTERIOSCL THROM VAS, V15, P1079
   Schappert SM, 2006, VITAL HLTH STAT, V159, P1
   Schinkel AFL, 2005, J NUCL MED, V46, P12
   SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051
   Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008
   Schuijf JD, 2006, AM HEART J, V151, P404, DOI 10.1016/j.ahj.2005.03.022
   SCHULER G, 1992, CIRCULATION, V86, P1
   Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617
   Scirica BM, 2007, CIRCULATION, V116, P1647, DOI 10.1161/CIRCULATIONAHA.107.724880
   SEBRECHTS CP, 1986, AM HEART J, V112, P1217, DOI 10.1016/0002-8703(86)90351-0
   Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043
   Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0
   Shah SA, 2010, PHARMACOTHERAPY, V30, P639, DOI 10.1592/phco.30.7.639
   Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Sharaf BL, 2001, AM J CARDIOL, V87, P937, DOI 10.1016/S0002-9149(01)01424-2
   Sharir T, 2010, J AM COLL CARDIOL, V55, P1965, DOI 10.1016/j.jacc.2010.01.028
   Sharir T, 2008, JACC-CARDIOVASC IMAG, V1, P156, DOI 10.1016/j.jcmg.2007.12.004
   Shark T, 2006, J NUCL CARDIOL, V13, P495, DOI 10.1016/j.nuclcard.2006.03.019
   Sharir T, 1999, CIRCULATION, V100, P1035
   Shaw L, 2012, J NUCL CARDIOL
   Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004
   Shaw LJ, 2005, EUR HEART J, V26, P447, DOI 10.1093/eurheartj/ehi102
   Shaw LJ, 1998, CIRCULATION, V98, P1622
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Shaw LJ, 2005, J AM COLL CARDIOL, V45, P1494, DOI 10.1016/j.jacc.2005.01.036
   Shaw LJ, 2010, CIRC-CARDIOVASC IMAG, V3, P473, DOI 10.1161/CIRCIMAGING.109.860981
   Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990
   Shaw LJ, 2009, CARDIOL CLIN, V27, P597, DOI 10.1016/j.ccl.2009.06.009
   Shaw LJ, 2008, J NUCL CARDIOL, V15, P762, DOI 10.1007/BF03007357
   Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098
   Shaw LJ, 1996, J AM COLL CARDIOL, V27, P787, DOI 10.1016/0735-1097(95)00549-8
   Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072
   Shaw LJ, 2006, EUR HEART J, V27, P2448, DOI 10.1093/eurheartj/ehl204
   Shaw LJ, 2011, CIRCULATION, V124, P1239, DOI 10.1161/CIRCULATIONAHA.111.029660
   Shaw LJ, 2003, J NUCL MED, V44, P134
   Shaw LJ, 2000, AM J CARDIOL, V86, P1, DOI 10.1016/S0002-9149(00)00819-5
   Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X
   Shaw Richard E, 2003, J Invasive Cardiol, V15, P578
   Shechter M, 2003, J AM COLL CARDIOL, V42, P2090, DOI 10.1016/j.jacc.2003.05.013
   Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X
   Sherwood A, 2005, J AM COLL CARDIOL, V46, P656, DOI 10.1016/j.jacc.2005.05.041
   Shimbo D, 2002, AM J CARDIOL, V89, P331, DOI 10.1016/S0002-9149(01)02236-6
   Shmilovich H, 2011, ATHEROSCLEROSIS, V219, P588, DOI 10.1016/j.atherosclerosis.2011.07.128
   Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652
   Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6
   Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232
   Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459
   Sievers B, 2007, CIRCULATION, V115, P236, DOI 10.1161/CIRCULATIONAHA.106.635409
   Silagy C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000146.PUB2
   SILBER S, 1990, EUR J CLIN PHARMACOL, V38, pS35, DOI 10.1007/BF01417564
   Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017
   SIMARI RD, 1991, AM J CARDIOL, V67, P573, DOI 10.1016/0002-9149(91)90894-Q
   Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227
   Simoons ML, 1996, NEW ENGL J MED, V335, P275, DOI 10.1056/NEJM199607253350409
   Singh M, 2008, J AM COLL CARDIOL, V51, P2313, DOI 10.1016/j.jacc.2008.01.066
   Singh M, 2002, J AM COLL CARDIOL, V40, P387, DOI 10.1016/S0735-1097(02)01980-0
   Singh M, 2005, AM J CARDIOL, V96, P907, DOI 10.1016/j.amjcard.2005.05.045
   Sirois C, 2008, INT J CARDIOL, V129, P172, DOI 10.1016/j.ijcard.2008.01.030
   Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254
   Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305
   Slomka PJ, 2005, J NUCL CARDIOL, V12, P66, DOI 10.1016/j.nuclcard.2004.10.006
   Slomka PJ, 2007, J NUCL CARDIOL, V14, P44, DOI 10.1016/j.nuclcard.2006.10.021
   SLOTHNIELSEN J, 1991, AM J SURG, V162, P122, DOI 10.1016/0002-9610(91)90172-A
   Small GR, 2011, J AM COLL CARDIOL, V58, P2389, DOI 10.1016/j.jacc.2011.08.047
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith PM, 2009, CAN MED ASSOC J, V180, P1297, DOI 10.1503/cmaj.080862
   Smith P.M., 2006, IMPLEMENTING INPATIE
   Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824
   Soejima H, 2004, CIRC J, V68, P367, DOI 10.1253/circj.68.367
   Sofowora GG, 2003, CLIN PHARMACOL THER, V73, P366, DOI 10.1016/S0009-9236(02)17734-4
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   Sowers JR, 2001, HYPERTENSION, V37, P1053
   SOX HC, 1990, AM J MED, V89, P7, DOI 10.1016/0002-9343(90)90090-Z
   Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302
   SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X
   SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9
   Spertus JA, 2005, J AM COLL CARDIOL, V45, P1147, DOI 10.1016/j.jacc.2005.03.011
   Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90
   Spertus JA, 2001, AM J MED, V111, P341, DOI 10.1016/S0002-9343(01)00878-6
   Spertus JA, 2000, AM HEART J, V140, P105, DOI 10.1067/mhj.2000.106600
   Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
   STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102
   STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P
   STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003
   Stead LF, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001007.PUB2
   Stead LF, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002850
   Steel K, 2009, CIRCULATION, V120, P1390, DOI 10.1161/CIRCULATIONAHA.108.812503
   Stein PD, 2006, AM J MED, V119, P203, DOI 10.1016/j.amjmed.2005.06.071
   Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1
   Stevens VJ, 2001, ANN INTERN MED, V134, P1
   STEVENS VJ, 1993, ARCH INTERN MED, V153, P849, DOI 10.1001/archinte.153.7.849
   Stone GW, 2002, J AM COLL CARDIOL, V39, P1581, DOI 10.1016/S0735-1097(02)01829-6
   Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044
   STRATMANN HG, 1994, CIRCULATION, V89, P615
   Stroupe KT, 2006, CIRCULATION, V114, P1251, DOI 10.1161/CIRCULATIONAHA.105.570838
   Stys TP, 2002, AM J CARDIOL, V89, P822, DOI 10.1016/S0002-9149(02)02191-4
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   SULLIVAN AK, 1994, BRIT MED J, V308, P883
   Sun ZH, 2006, EUR J RADIOL, V60, P279, DOI 10.1016/j.ejrad.2006.06.009
   Sun ZH, 2010, EUR J RADIOL, V73, P266, DOI 10.1016/j.ejrad.2008.10.025
   Szczech LA, 2001, KIDNEY INT, V60, P292, DOI 10.1046/j.1523-1755.2001.00799.x
   Tabib A, 2000, CORONARY ARTERY DIS, V11, P41, DOI 10.1097/00019501-200002000-00008
   Taillefer R, 1997, J AM COLL CARDIOL, V29, P69
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   Tamaki N, 2011, J NUCL CARDIOL, V18, P135, DOI 10.1007/s12350-010-9305-4
   Tamburino C, 2010, JACC-CARDIOVASC INTE, V3, P624, DOI 10.1016/j.jcin.2010.03.016
   Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182
   Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8
   Tandogan I, 2001, INT J CARDIOVAS IMAG, V17, P339, DOI 10.1023/A:1011973530231
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Tarantini G, 2009, CATHETER CARDIO INTE, V73, P50, DOI 10.1002/ccd.21757
   Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586
   Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597
   TAYLOR AE, 1992, CIRCULATION, V86, P699
   Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005
   Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934
   Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007130.pub2
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   Tepper D, 1999, CONGEST HEART FAIL, V5, P184
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators, 1993, LANCET, V342, P821
   The Criteria Committee of the New York Heart Association I, 1964, DIS HEART BLOOD VESS
   The Diabetes Control and Complications Trial Research Group, 1993, N ENGL J MED, V329, P977
   Fox KM, 2003, LANCET, V362, P782
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   Braunwald E, 2004, NEW ENGL J MED, V351, P2058
   The SOLVD Investigators, 1991, N ENGL J MED, V325, P293
   PEDUZZI P, 1992, CIRCULATION, V86, P121
   Thiele H, 2009, J AM COLL CARDIOL, V53, P2324, DOI 10.1016/j.jacc.2009.03.032
   Thiele H, 2005, CIRCULATION, V112, P3445, DOI 10.1161/CIRCULATIONHA.105.578492
   Thomas RJ, 2010, J AM COLL CARDIOL, V56, P1159, DOI 10.1016/j.jacc.2010.06.006
   Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485
   Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77
   TIME Investigators, 2001, LANCET, V358, P951
   Timmis AD, 2006, EUR HEART J, V27, P42, DOI 10.1093/eurheartj/ehi495
   Tobacco Use and Dependence Guideline Panel, 2008, TREATING TOBACCO USE
   TODD IC, 1992, BRIT HEART J, V68, P560
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565
   TOPOL EJ, 1995, CIRCULATION, V92, P2333
   TREESE N, 1992, J CARDIOVASC PHARM, V20, pS52, DOI 10.1097/00005344-199206203-00010
   Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6
   Trikalinos Thomas A, 2009, Med Decis Making, V29, pE22, DOI 10.1177/0272989X09345022
   TSUYA T, 1990, AM J CARDIOL, V66, P275, DOI 10.1016/0002-9149(90)90835-O
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Tummala PE, 1999, CIRCULATION, V100, P1223
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Agodoa L, 2007, J HYPERTENS, V25, P951
   Turnbull F, 2003, LANCET, V362, P1527
   Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0
   Underwood SR, 1999, EUR HEART J, V20, P157, DOI 10.1053/euhj.1998.1196
   Underwood SR, 2004, EUR J NUCL MED MOL I, V31, P261, DOI 10.1007/s00259-003-1344-5
   Underwood SR, 2004, HEART, V90, pV34, DOI 10.1136/hrt.2003.019133
   Urano H, 2001, J AM COLL CARDIOL, V37, P93, DOI 10.1016/S0735-1097(00)01095-0
   U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A
   U.S. Food and Drug Administration, 2008, INF HEALTHC PROF VAR
   US Food and Drug Administration, 2008, PUBL HLTH ADV IMP IN
   Ussher M., 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002295.PUB2
   Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401
   Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133
   Valdiviezo C, 2010, J NUCL CARDIOL, V17, P1091, DOI 10.1007/s12350-010-9291-6
   VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160
   van der Bijl N, 2011, IMAGING MED, V2, P167
   VANRIJ AM, 1994, CIRCULATION, V90, P1194
   VANDENBURG MJ, 1986, BRIT J CLIN PRACT, V40, P524
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van der Sloot JAP, 2004, ANN THORAC SURG, V78, P875, DOI 10.1016/j.athoracsur.2004.02.073
   van Velzen JE, 2010, CIRC-CARDIOVASC IMAG, V3, P718, DOI 10.1161/CIRCIMAGING.109.913541
   van Werkhoven JM, 2009, J AM COLL CARDIOL, V53, P623, DOI 10.1016/j.jacc.2008.10.043
   Varani Elisabetta, 2007, J Invasive Cardiol, V19, P469
   Vardeny O, 2009, J CARD FAIL, V15, P368, DOI 10.1016/j.cardfail.2008.11.009
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Villarruz MV, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002785
   Villines TC, 2011, J AM COLL CARDIOL, V58, P2540
   VINEBERG AM, 1946, CAN MED ASSOC J, V55, P117
   Vitarelli A, 2003, HEART FAIL REV, V8, P181, DOI 10.1023/A:1023001104207
   Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9
   VONARNIM T, 1995, J AM COLL CARDIOL, V25, P231, DOI 10.1016/0735-1097(94)00345-Q
   von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088
   Vongvanich P, 1996, AM J CARDIOL, V77, P1383, DOI 10.1016/S0002-9149(96)00215-9
   Wagdy HM, 1998, CIRCULATION, V97, P1563
   Wahrborg P, 1999, EUR HEART J, V20, P653, DOI 10.1053/euhj.1998.1237
   Wallace EL, 2009, JACC-CARDIOVASC IMAG, V2, P299, DOI 10.1016/j.jcmg.2008.10.015
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432
   WAYSBORT J, 1991, CARDIOLOGY, V79, P19, DOI 10.1159/000174920
   WEINER DA, 1984, J AM COLL CARDIOL, V3, P772
   Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Wenaweser P, 2008, AM J CARDIOL, V101, P807, DOI 10.1016/j.amjcard.2007.10.046
   WEST JNW, 1991, INT J CARDIOL, V31, P102, DOI 10.1016/0167-5273(91)90275-T
   Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839
   Whelton SP, 2004, AM J CARDIOL, V93, P1119, DOI 10.1016/j.amjcard.2004.01.038
   Whelton SP, 2002, ANN INTERN MED, V136, P493
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874
   Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x
   Wiest FC, 2004, AM J MED, V117, P234, DOI 10.1016/j.amjmed.2004.02.044
   WIGHT LJ, 1992, EUR J CLIN PHARMACOL, V42, P341
   Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102
   Wilson PWF, 1998, CIRCULATION, V97, P1837
   Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427
   WINNIFORD MD, 1987, AM J CARDIOL, V59, P203, DOI 10.1016/0002-9149(87)90785-5
   Winter R, 2007, J AM SOC ECHOCARDIOG, V20, P974, DOI 10.1016/j.echo.2007.01.029
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   WONG ND, 1991, ANN INTERN MED, V115, P687
   Woodcock J, 2010, 021071 NDA CTR DRUG
   Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897
   Wright JT, 2002, ARCH INTERN MED, V162, P1636, DOI 10.1001/archinte.162.14.1636
   Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011
   Wu CT, 2006, J AM COLL CARDIOL, V47, P654, DOI 10.1016/j.jacc.2005.09.071
   Xie HG, 2001, PHARMACOGENETICS, V11, P191, DOI 10.1097/00008571-200104000-00002
   Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424
   Yang JH, 2008, ANN THORAC SURG, V85, P65, DOI 10.1016/j.athoracsur.2007.06.027
   Yang Zhen Kun, 2007, J Interv Cardiol, V20, P10, DOI 10.1111/j.1540-8183.2007.00222.x
   Yao SS, 2012, AM J CARDIOL, V109, P153, DOI 10.1016/j.amjcard.2011.08.023
   Yao SS, 2010, J AM SOC ECHOCARDIOG, V23, P832, DOI 10.1016/j.echo.2010.05.004
   Yao SS, 2003, J AM COLL CARDIOL, V42, P1084, DOI 10.1016/S0735-1097(03)00923-9
   Yoshinaga K, 2006, J AM COLL CARDIOL, V48, P1029, DOI 10.1016/j.jacc.2006.06.025
   Yoshinaga K, 2011, CIRC J, V75, P2628, DOI 10.1253/circj.CJ-11-0502
   Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632
   Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Yusuf S, 2008, NEW ENGL J MED, V358, P1547
   ZEIHER AM, 1995, CIRCULATION, V92, P1094
   Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818
NR 1260
TC 112
Z9 118
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD DEC 18
PY 2012
VL 60
IS 24
BP E44
EP E164
DI 10.1016/j.jacc.2012.07.013
PG 121
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 052LB
UT WOS:000312198000002
PM 23182125
ER

PT J
AU Glenzer, SH
   MacGowan, BJ
   Michel, P
   Meezan, NB
   Suter, LJ
   Dixit, SN
   Kline, JL
   Kyrala, GA
   Bradley, DK
   Callahan, DA
   Dewald, EL
   Divol, L
   Dzenitis, E
   Edwards, MJ
   Hamza, AV
   Haynam, CA
   Hinkel, DE
   Kalantar, DH
   Kilkenny, JD
   Landen, OL
   Lindl, JD
   LePape, S
   Moody, JD
   Nikroo, A
   Parham, T
   Schneider, MB
   Town, RPJ
   Wegner, P
   Widmann, K
   Whitman, P
   Young, BKF
   Van Wonterghem, B
   Atherton, LJ
   Moses, EI
AF Glenzer, S. H.
   MacGowan, B. J.
   Michel, P.
   Meezan, N. B.
   Suter, L. J.
   Dixit, S. N.
   Kline, J. L.
   Kyrala, G. A.
   Bradley, D. K.
   Callahan, D. A.
   Dewald, E. L.
   Divol, L.
   Dzenitis, E.
   Edwards, M. J.
   Hamza, A. V.
   Haynam, C. A.
   Hinkel, D. E.
   Kalantar, D. H.
   Kilkenny, J. D.
   Landen, O. L.
   Lindl, J. D.
   LePape, S.
   Moody, J. D.
   Nikroo, A.
   Parham, T.
   Schneider, M. B.
   Town, R. P. J.
   Wegner, P.
   Widmann, K.
   Whitman, P.
   Young, B. K. F.
   Van Wonterghem, B.
   Atherton, L. J.
   Moses, E. I.
TI Symmetric Inertial Confinement Fusion Implosions at Ultra-High Laser
   Energies
SO SCIENCE
LA English
DT Article
ID NATIONAL-IGNITION-FACILITY; HOHLRAUM PLASMAS; BEAMS; PERFORMANCE
AB Indirect-drive hohlraum experiments at the National Ignition Facility have demonstrated symmetric capsule implosions at unprecedented laser drive energies of 0.7 megajoule. One hundred and ninety-two simultaneously fired laser beams heat ignition-emulate hohlraums to radiation temperatures of 3.3 million kelvin, compressing 1.8-millimeter-diameter capsules by the soft x-rays produced by the hohlraum. Self-generated plasma optics gratings on either end of the hohlraum tune the laser power distribution in the hohlraum, which produces a symmetric x-ray drive as inferred from the shape of the capsule self-emission. These experiments indicate that the conditions are suitable for compressing deuterium-tritium-filled capsules, with the goal of achieving burning fusion plasmas and energy gain in the laboratory.
C1 [Glenzer, S. H.; MacGowan, B. J.; Michel, P.; Meezan, N. B.; Suter, L. J.; Dixit, S. N.; Bradley, D. K.; Callahan, D. A.; Dewald, E. L.; Divol, L.; Dzenitis, E.; Edwards, M. J.; Hamza, A. V.; Haynam, C. A.; Hinkel, D. E.; Kalantar, D. H.; Landen, O. L.; Lindl, J. D.; LePape, S.; Moody, J. D.; Parham, T.; Schneider, M. B.; Town, R. P. J.; Wegner, P.; Widmann, K.; Whitman, P.; Young, B. K. F.; Van Wonterghem, B.; Atherton, L. J.; Moses, E. I.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
   [Kline, J. L.; Kyrala, G. A.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
   [Kilkenny, J. D.; Nikroo, A.] Gen Atom Co, San Diego, CA 92121 USA.
RP Glenzer, SH (reprint author), Lawrence Livermore Natl Lab, POB 808, Livermore, CA 94551 USA.
EM glenzer1@llnl.gov
RI Michel, Pierre/J-9947-2012
FU U. S. Department of Energy by Lawrence Livermore National Laboratory
   [DE-AC52-07NA27344]
FX This work was performed under the auspices of the U. S. Department of
   Energy by Lawrence Livermore National Laboratory under contract
   DE-AC52-07NA27344.
CR Atzeni S, 2004, PHYS INERTIAL FUSION
   Berger RL, 1998, PHYS PLASMAS, V5, P4337, DOI 10.1063/1.873171
   Clery D, 2009, SCIENCE, V324, P326, DOI 10.1126/science.324.5925.326
   Dewald EL, 2004, REV SCI INSTRUM, V75, P3759, DOI 10.1063/1.1788872
   Drake RP, 2006, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/3-540-29315-9
   Fernandez JC, 1997, PHYS PLASMAS, V4, P1849, DOI 10.1063/1.872328
   Froula DH, 2004, REV SCI INSTRUM, V75, P4168, DOI 10.1063/1.1789592
   Garcia RA, 2007, SCIENCE, V316, P1591, DOI 10.1126/science.1140598
   Glenzer SH, 1998, PHYS REV LETT, V80, P2845, DOI 10.1103/PhysRevLett.80.2845
   Gough DO, 1996, SCIENCE, V272, P1296, DOI 10.1126/science.272.5266.1296
   HAUER AA, 1995, PHYS PLASMAS, V2, P2488, DOI 10.1063/1.871210
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   KAUFFMAN RL, 1994, PHYS REV LETT, V73, P2320, DOI 10.1103/PhysRevLett.73.2320
   Kirkwood RK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215003
   Krauser WJ, 1996, PHYS PLASMAS, V3, P2084, DOI 10.1063/1.872006
   Kruer W. L., 1988, PHYS LASER PLASMA IN
   Kruer WL, 1996, PHYS PLASMAS, V3, P382, DOI 10.1063/1.871863
   Landen OL, 1999, PHYS PLASMAS, V6, P2137, DOI 10.1063/1.873465
   Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638
   MacGowan BJ, 1996, PHYS PLASMAS, V3, P2029, DOI 10.1063/1.872000
   Mackinnon AJ, 2004, REV SCI INSTRUM, V75, P4183, DOI 10.1063/1.1789594
   McCrory RL, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2837048
   Michel P, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3103788
   Michel P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025004
   Moses EI, 2005, FUSION SCI TECHNOL, V47, P314
   NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0
   Oertel JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2227439
   Remington BA, 2006, REV MOD PHYS, V78, P755, DOI 10.1103/RevModPhys.78.755
   SUTER LJ, 1994, PHYS REV LETT, V73, P2328, DOI 10.1103/PhysRevLett.73.2328
   Wharton KB, 1998, PHYS REV LETT, V81, P2248, DOI 10.1103/PhysRevLett.81.2248
   Zimmerman G. B., 1975, COMMENTS PLASMA PHYS, V2, P85
NR 31
TC 112
Z9 116
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD MAR 5
PY 2010
VL 327
IS 5970
BP 1228
EP 1231
DI 10.1126/science.1185634
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 563VD
UT WOS:000275162100031
PM 20110465
ER

PT J
AU Mendelson, K
   Schoen, FJ
AF Mendelson, Karen
   Schoen, Frederick J.
TI Heart valve tissue engineering: Concepts, approaches, progress, and
   challenges
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE heart valve remodeling; engineered tissue heart valves; biodegradable
   scaffold; decellularized scaffold; circulating stem cells
ID ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS;
   SMOOTH-MUSCLE-CELLS; OPTICAL COHERENCE TOMOGRAPHY; VALVULAR
   INTERSTITIAL-CELLS; PORCINE AORTIC-VALVE; GROWTH-FACTOR-BETA; IN-VITRO;
   BONE-MARROW; EXTRACELLULAR-MATRIX
AB Potential applications of tissue engineering in regenerative medicine range from structural tissues to organs with complex function. This review focuses on the engineering of heart valve tissue, a goal which involves a unique combination of biological, engineering, and technological hurdles. We emphasize basic concepts, approaches and methods, progress made, and remaining challenges. To provide a framework for understanding the enabling scientific principles, we first examine the elements and features of normal heart valve functional structure, biomechanics, development, maturation, remodeling, and response to injury. Following a discussion of the fundamental principles of tissue engineering applicable to heart valves, we examine three approaches to achieving the goal of an engineered tissue heart valve: (1) cell seeding of biodegradable synthetic scaffolds, (2) cell seeding of processed tissue scaffolds, and (3) in-vivo repopulation by circulating endogenous cells of implanted substrates without prior in-vitro cell seeding. Lastly, we analyze challenges to the field and suggest future directions for both preclinical and translational (clinical) studies that will be needed to address key regulatory issues for safety and efficacy of the application of tissue engineering and regenerative approaches to heart valves. Although modest progress has been made toward the goal of a clinically useful tissue engineered heart valve, further success and ultimate human benefit will be dependent upon advances in biodegradable polymers and other scaffolds, cellular manipulation, strategies for rebuilding the extracellular matrix, and techniques to characterize and potentially non-invasively assess the speed and quality of tissue healing and remodeling.
C1 Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
RP Schoen, FJ (reprint author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.
EM fschoen@partners.org
CR Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292
   Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da
   Badylak SF, 2005, CIRCULATION, V111, P2715, DOI 10.1161/CIRCULATIONAHA.105.542837
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Basilion JP, 2005, CURR TOP DEV BIOL, V70, P1, DOI 10.1016/S0070-2153(05)70001-6
   Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970
   Bertipaglia B, 2003, ANN THORAC SURG, V75, P1274, DOI 10.1016/S0003-4975(02)04706-9
   Blom IE, 2001, J CLIN PATHOL-MOL PA, V54, P192
   Boecker W, 2004, MOL IMAGING, V3, P69, DOI 10.1162/1535350041464847
   Borschel GH, 2005, TISSUE ENG, V11, P778, DOI 10.1089/ten.2005.11.778
   Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725
   BREZINSKI ME, 2006, INT J CARDIOL, V107, P159
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a
   Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002
   Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Davies PF, 2004, ARTERIOSCL THROM VAS, V24, P1331, DOI 10.1161/01.ATV.0000130659.89433.cl
   Dawn B, 2005, BASIC RES CARDIOL, V100, P494, DOI 10.1007/s00395-005-0552-5
   Deb A, 2005, J HEART VALVE DIS, V14, P674
   Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041
   Della Rocca F, 2000, ANN THORAC SURG, V70, P1594, DOI 10.1016/S0003-4975(00)01979-2
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1016/S0039-6060(99)70025-5
   Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283
   Dohmen PM, 2002, ANN THORAC SURG, V74, P1438, DOI 10.1016/S0003-4975(02)03881-X
   Dohmen PM, 2005, HEART SURG FORUM, V8, pE100, DOI 10.1532/HSF98.20041140
   EISENBERG LM, 1995, CIRC RES, V77, P1
   Eisenberg LM, 2005, ANN NY ACAD SCI, V1047, P38, DOI 10.1196/annals.1341.004
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Erez E, 2003, J HEART VALVE DIS, V12, P25
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   EYBL E, 1992, J THORAC CARDIOV SUR, V104, P763
   Fedak PWM, 2004, CIRCULATION, V110, P2401, DOI 10.1161/01.CIR.0000134959.83967.2D
   Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391
   FRAZIER OH, 1993, TEX HEART I J, V20, P78
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Fukuda D, 2006, AM J CARDIOL, V97, P175, DOI 10.1016/j.amjcard.2005.08.020
   Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940
   Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208
   George J, 2005, ARTERIOSCL THROM VAS, V25, P2636, DOI 10.1161/01.ATV.0000188554.49745.9e
   Giannoudis PV, 2005, INJURY, V36, pS2, DOI 10.1016/j.injury.2005.10.006
   Giattina SD, 2006, INT J CARDIOL, V107, P400, DOI 10.1016/J.IJCARD.2005.11.036
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Grossman HB, 2006, JAMA-J AM MED ASSOC, V295, P299, DOI 10.1001/jama.295.3.299
   Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2
   Hill JM, 2003, CIRCULATION, V108, P1009, DOI 10.1161/01.CIR.0000084537.66419.7A
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hopkins RA, 2005, CIRCULATION, V111, P2712, DOI 10.1161/CIRCULATIONAHA.104.527820
   Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009
   Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5
   Ichikawa T, 2002, NEOPLASIA, V4, P523, DOI 10.1038/sj.neo.7900266
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   ISHIHARA T, 1981, AM J CARDIOL, V48, P443, DOI 10.1016/0002-9149(81)90071-0
   Iwai S, 2004, J THORAC CARDIOV SUR, V128, P472, DOI 10.1016/j.jtcvs.2004.04.013
   Iwami Y, 2004, J CELL MOL MED, V8, P488, DOI 10.1111/j.1582-4934.2004.tb00473.x
   Jaffer FA, 2004, CIRC RES, V94, P433, DOI 10.1161/01.RES.0000119321.18573.5A
   Jaffer FA, 2005, JAMA-J AM MED ASSOC, V293, P855, DOI 10.1001/jama.293.7.855
   Jamieson WRE, 2005, J THORAC CARDIOV SUR, V129, P1301, DOI 10.1016/j.jtcvs.2004.09.042
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Jonas Richard A, 2005, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P176
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   KOHN J, 2004, BIOMATERIALS SCI INT
   Konertz W, 2005, J HEART VALVE DIS, V14, P78
   Kumar V., 2004, ROBBINS COTRAN PATHO
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee YM, 2006, DEV DYNAM, V235, P29, DOI 10.1002/dvdy.20559
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005
   Liu CS, 2004, TRENDS CARDIOVAS MED, V14, P288, DOI 10.1016/j.tcm.2004.08.002
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681
   Marron K, 1996, CIRCULATION, V94, P368
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792
   MERRYMAN WD, 2006, ASME SUMM BIO C
   Merryman WD, 2006, AM J PHYSIOL-HEART C, V290, pH224, DOI 10.1152/ajpheart.00521.2005
   MERRYMAN WD, IN PRESS PROG PED CA
   Mitchell RN, 1998, J THORAC CARDIOV SUR, V115, P118, DOI 10.1016/S0022-5223(98)70450-7
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   Mol A, 2005, ANN BIOMED ENG, V33, P1778, DOI 10.1007/s10439-005-8025-4
   Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5
   Mulholland DL, 1996, CAN J CARDIOL, V12, P231
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541
   Narita Y, 2004, TISSUE ENG, V10, P1224, DOI 10.1089/ten.2004.10.1224
   Nerem RM, 2004, AM J TRANSPLANT, V4, P36, DOI 10.1111/j.1600-6135.2004.0343.x
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Ogata T, 2005, J VASC SURG, V41, P1036, DOI 10.1016/j.jvs.2005.02.020
   Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Ota T, 2005, ANN THORAC SURG, V80, P1794, DOI 10.1016/j.athoracsur.2005.05.002
   Ott I, 2005, FASEB J, V19, P992, DOI 10.1096/fj.04-3219fje
   Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5
   Patel NA, 2005, CARDIOVASC INTER RAD, V28, P1, DOI 10.1007/s00270-00270-003-0021-1
   Perry TE, 2003, ANN THORAC SURG, V75, P761, DOI 10.1016/S0003-4975(02)03776-1
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Poh M, 2005, LANCET, V365, P2122, DOI 10.1016/S0140-6736(05)66735-9
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rabkin E, 2002, J HEART VALVE DIS, V11, P308
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489
   Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841
   Rabkin-Aikawa E, 2005, ADV BIOCHEM ENG BIOT, V94, P141, DOI 10.1007/b100003
   Rabkin-Aikawa E, 2004, J THORAC CARDIOV SUR, V128, P552, DOI 10.1016/j.jtcvs.2004.04.016
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552
   Rafii S, 1995, ANN THORAC SURG, V60, P1627, DOI 10.1016/0003-4975(95)00807-1
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Rahimtoola SH, 2003, J AM COLL CARDIOL, V42, P1720, DOI 10.1016/j.jacc.2003.07.008
   Rahimtoola SH, 2003, J AM COLL CARDIOL, V41, P893, DOI 10.1016/S0735-1097(02)02965-0
   Ramamurthi A, 2005, BIOMATERIALS, V26, P999, DOI 10.1016/j.biomaterials.2004.04.016
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Robinson KA, 2005, CIRCULATION, V112, P1135
   Roeder R. A., 2001, Biomedical Instrumentation and Technology, V35, P110
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   ROSSIG L, THROMB VASC BIOL, V24, P1977
   Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200
   Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394
   Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403
   Sata M, 2005, J CELL MOL MED, V9, P557, DOI 10.1111/j.1582-4934.2005.tb00488.x
   Sayk F, 2005, ANN THORAC SURG, V79, P1755, DOI 10.1016/j.athoracsur.2003.11.049
   Schenke-Layland K, 2004, MATRIX BIOL, V23, P113, DOI 10.1016/j.matbio.2004.03.005
   SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944
   Schoen FJ, 1997, J HEART VALVE DIS, V6, P1
   Schoen FJ, 2001, CARDIOVASC PATHOL, P629
   Schoen FJ, 2001, CARDIOVASC PATHOL, P402
   Schoen FJ, 1999, J HEART VALVE DIS, V8, P350
   SCHOEN FJ, 1984, J THORAC CARDIOV SUR, V88, P208
   Schurch W, 1998, AM J SURG PATHOL, V22, P141, DOI 10.1097/00000478-199802000-00001
   Shi Q, 1998, BLOOD, V92, P362
   Shi YL, 2003, TISSUE ENG, V9, P1233, DOI 10.1089/10763270360728143
   Shi YL, 2002, BIOMED SCI INSTRUM, V38, P35
   Shinoka T, 1996, CIRCULATION, V94, P164
   Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8
   Sodian R, 2002, TISSUE ENG, V8, P863, DOI 10.1089/10763270260424222
   Spina M, 2003, J BIOMED MATER RES A, V67A, P1338, DOI 10.1002/jbm.a.20025
   Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Stock UA, 2006, BIOMATERIALS, V27, P1, DOI 10.1016/j.biomaterials.2005.05.100
   Sutherland FWH, 2005, CIRCULATION, V111, P2783, DOI 10.1161/CIRCULATIONAHA.104.498378
   Szmitko PE, 2003, CIRCULATION, V107, P3093, DOI 10.1161/01.CIR.0000074242.66719.4A
   Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291
   Tanaka K, 2005, J AM COLL CARDIOL, V46, P134, DOI 10.1016/j.jacc.2005.03.058
   Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0
   Taylor PM, 2000, J HEART VALVE DIS, V9, P150
   TRANQUILLO R, 2003, TISSUE EQUIVALENT AP
   TRANQUILLO RT, 1992, CYTOTECHNOLOGY, V10, P225, DOI 10.1007/BF00146673
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003
   van den Hoff MJB, 2001, DEV BIOL, V240, P61, DOI 10.1006/dbio.2001.0449
   Van Le TS, 2005, UROLOGY, V66, P1256, DOI 10.1016/j.urolog.2005.07.010
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Weinshilboum R, 2003, NEW ENGL J MED, V348, P529
   Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814
   Williams C, 2004, TISSUE ENG, V10, P930, DOI 10.1089/1076327041348536
   Wood JD, 2005, JAVMA-J AM VET MED A, V226, P1095, DOI 10.2460/javma.2005.226.1095
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Wu XJ, 2005, INT J CARDIOL, V105, P274, DOI 10.1016/j.ijcard.2004.12.090
   Yacoub MH, 2004, CIRCULATION, V109, P942, DOI 10.1161/01.CIR.0000115633.19829.5E
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 188
TC 112
Z9 125
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2006
VL 34
IS 12
BP 1799
EP 1819
DI 10.1007/s10439-006-9163-z
PG 21
WC Engineering, Biomedical
SC Engineering
GA 113PL
UT WOS:000242609700001
PM 17053986
ER

PT J
AU Haslam, SA
   Jetten, J
   Postmes, T
   Haslam, C
AF Haslam, S. Alexander
   Jetten, Jolanda
   Postmes, Tom
   Haslam, Catherine
TI Social Identity, Health and Well-Being: An Emerging Agenda for Applied
   Psychology
SO APPLIED PSYCHOLOGY-AN INTERNATIONAL REVIEW-PSYCHOLOGIE APPLIQUEE-REVUE
   INTERNATIONALE
LA English
DT Article
ID SELF-CATEGORIZATION; AFRICAN-AMERICANS; GROUP MEMBERSHIPS;
   MENTAL-HEALTH; SUPPORT; STRESS; IDENTIFICATION; PERSPECTIVE; CONTEXT;
   PARTICIPATION
AB The social environment comprising communities, families, neighbourhoods, work teams, and various other forms of social group is not simply an external feature of the world that provides a context for individual behaviour. Instead these groups impact on the psychology of individuals through their capacity to be internalised as part of a person's social identity. If groups provide individuals with a sense of meaning, purpose, and belonging (i.e. a positive sense of social identity) they tend to have positive psychological consequences. The impact of these identity processes on health and well-being is explored in the contributions to this special issue. In this editorial, we discuss these contributions in light of five central themes that have emerged from research to date. These themes address the relationship between social identity and (a) symptom appraisal and response, (b) health-related norms and behaviour, (c) social support, (d) coping, and (e) clinical outcomes. The special issue as a whole points to the capacity for a social identity approach to enrich academic understanding in these areas and to play a key role in shaping health-related policy and practice.
C1 [Haslam, S. Alexander] Univ Exeter, Sch Psychol, Exeter EX4 4QG, Devon, England.
   [Jetten, Jolanda] Univ Queensland, Brisbane, Qld 4072, Australia.
   [Postmes, Tom] Univ Groningen, NL-9700 AB Groningen, Netherlands.
RP Haslam, SA (reprint author), Univ Exeter, Sch Psychol, Exeter EX4 4QG, Devon, England.
EM A.Haslam@exeter.ac.uk
RI Postmes, Tom/A-9004-2010; Haslam, Catherine/M-5903-2013; Jetten,
   Jolanda/H-3285-2014
OI Postmes, Tom/0000-0002-8029-7398; Jetten, Jolanda/0000-0002-7588-5355
CR Adams S, 1997, SOC SCI MED, V45, P189, DOI 10.1016/S0277-9536(96)00333-4
   Bailis DS, 2008, SOC SCI MED, V66, P1817, DOI 10.1016/j.socscimed.2007.12.028
   Baron-Cohen S, 2006, BRAIN COGNITION, V61, P1, DOI 10.1016/j.bandc.2006.02.002
   BLAINE B, 1995, PERS SOC PSYCHOL B, V21, P1031, DOI 10.1177/01461672952110004
   Bonanno GA, 2001, APPL PREV PSYCHOL, V10, P193, DOI 10.1016/S0962-1849(01)80014-7
   Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037//0022-3514.77.1.135
   Camp DL, 2002, SOC SCI MED, V55, P823, DOI 10.1016/S0277-9536(01)00205-2
   Campbell C, 2000, J COMMUNITY APPL SOC, V10, P255, DOI 10.1002/1099-1298(200007/08)10:4<255::AID-CASP582>3.0.CO;2-M
   Campbell C, 1997, SOC SCI MED, V45, P273, DOI 10.1016/S0277-9536(96)00343-7
   Chandler Michael J., 1998, TRANSCULT PSYCHIATRY, V35, P191, DOI DOI 10.1177/136346159803500202
   Clare L., 2008, DEMENTIA, V7, P9, DOI DOI 10.1177/1471301207085365
   Clift A., 2008, EUROPEAN J SOCIAL PS, V38, P173, DOI DOI 10.1002/EJSP.417
   Cockerham W. C., 2007, SOCIAL CAUSES HLTH D
   Cole SW, 1997, J PERS SOC PSYCHOL, V72, P320, DOI 10.1037/0022-3514.72.2.320
   Contrada R. J., 1999, SELF SOCIAL IDENTITY
   Cooper LA, 2003, MED CARE, V41, P479, DOI 10.1097/00005650-200304000-00004
   CRABTREE JW, 2008, MENTAL HLTH SU UNPUB
   Craddock S, 2000, T I BRIT GEOGR, V25, P153, DOI 10.1111/j.0020-2754.2000.00153.x
   Drury J., 1999, GROUP PROCESS INTERG, V2, P381, DOI [10.1177/1368430299024005, DOI 10.1177/1368430299024005]
   Ellemers N, 2004, ACAD MANAGE REV, V29, P459
   Ellemers N., 1993, EUROPEAN REV SOCIAL, V4, P27, DOI DOI 10.1080/14792779343000013
   Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P522, DOI 10.1080/09602010802141509
   Hall S, 2002, J COMMUNITY APPL SOC, V12, P30, DOI 10.1002/casp.639
   Harwood J, 2003, HEALTH COMMUN, V15, P145, DOI 10.1207/S15327027HC1502_3
   Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449
   HASLAM C, 2008, CONNECTING GRO UNPUB
   Haslam S. A., 2001, PSYCHOL ORG SOCIAL I
   Haslam SA, 2004, STRESS HEALTH, V20, P3, DOI 10.1002/smi.995
   Haslam SA, 2006, J APPL PSYCHOL, V91, P1037, DOI 10.1037/0021-9010.91.5.1037
   Haslam SA, 2003, BRIT J MANAGE, V14, P357, DOI 10.1111/j.1467-8551.2003.00384.x
   HASLAM SA, REDISCOVERI IN PRESS
   HASLAM SA, STRESS HLTH IN PRESS
   Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468
   Hogan DP, 2004, STUD FAMILY PLANN, V35, P79, DOI 10.1111/j.1728-4465.2004.00010.x
   Iyer A, 2009, BRIT J SOC PSYCHOL, V48, P707, DOI 10.1348/014466608X397628
   Iyer A., 2008, SELF CONTINUITY INDI, P187
   Jacoby A, 2005, LANCET NEUROL, V4, P171, DOI 10.1016/S1474-4422(05)01014-8
   JAMES K, 1994, ACAD MANAGE J, V37, P383, DOI 10.2307/256834
   James K, 1997, J Occup Health Psychol, V2, P108, DOI 10.1037/1076-8998.2.2.108
   Jetten J, 2002, BRIT J SOC PSYCHOL, V41, P281, DOI 10.1348/014466602760060147
   JETTEN J, 2008, DECLINING AUTO UNPUB
   JONES J, 2008, INT NEUR SOC C BUEN
   KNIGHT C, 2008, WHOSE HOME IS UNPUB
   Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x
   Laverie DA, 1998, LEISURE SCI, V20, P277
   Levine M, 2002, J APPL SOC PSYCHOL, V32, P1452, DOI 10.1111/j.1559-1816.2002.tb01446.x
   Levine RM, 2005, PERSONALITY SOCIAL P, V31, P443, DOI DOI 10.1177/0146167204271651
   Levine RM, 1996, BRIT J SOC PSYCHOL, V35, P245
   Matheson K, 2004, J EXP SOC PSYCHOL, V40, P777, DOI 10.1016/j.jesp.2004.04.002
   Michinov E, 2008, INT J AGING HUM DEV, V66, P175, DOI 10.2190/AG.66.3.a
   MILLWARD LJ, 1995, EUR J SOC PSYCHOL, V25, P303, DOI 10.1002/ejsp.2420250305
   Nikitin J, 2008, APPL PSYCHOL-INT REV, V57, P90, DOI 10.1111/j.1464-0597.2008.00356.x
   Oakes P., 1994, STEREOTYPING SOCIAL
   ORFORD J, 1992, COMMUNITY PSYCHOL
   Oyserman D, 2007, J PERS SOC PSYCHOL, V93, P1011, DOI 10.1037/0022-3514.93.6.1011
   Peterson C, 2008, APPL PSYCHOL-INT REV, V57, P19, DOI 10.1111/j.1464-0597.2008.00352.x
   POSTMES T, REDISCOVERI IN PRESS
   Postmes T, 2003, SOCIAL IDENTITY AT WORK: DEVELOPING THEORY FOR ORGANIZATIONAL PRACTICE, P81
   Postmes T, 2002, J PERS SOC PSYCHOL, V83, P735, DOI 10.1037//0022-3514.83.3.735
   Putnam Robert D., 2000, BOWLING ALONE COLLAP
   Reicher S, 2005, LEADERSHIP QUART, V16, P547, DOI 10.1016/j.leaqua.2005.06.007
   Reicher S, 2006, PSYCHOLOGIST, V19, P146
   Reicher S, 2006, BRIT J SOC PSYCHOL, V45, P1, DOI 10.1348/014466605X48998
   Sani F., 2008, INDIVIDUAL COLLECTIV
   Schmitt M. T., 2002, EUROPEAN REV SOCIAL, V12, P167, DOI DOI 10.1080/14792772143000058
   Schofield PE, 2003, J HEALTH PSYCHOL, V8, P291
   SCHWARZER R, 2008, APPL PSYCHOL INT REV, V57
   Shadden BB, 2004, TOP LANG DISORD, V24, P174
   Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33
   Tajfel H., 1986, PSYCHOL INTERGROUP R, P7, DOI DOI 10.1089/CPB.2008.0150
   Tajfel H., 1981, HUMAN GROUPS SOCIAL
   Tajfel H., 1972, CONTEXT SOCIAL PSYCH, P69
   Tucker JL, 2000, MIL MED, V165, P72
   Turner J., 1999, SOCIAL IDENTITY CONT, P6
   Turner J. C., 1982, SOCIAL IDENTITY INTE, P15
   Turner J. C., 1991, SOCIAL INFLUENCE
   Turner J. C., 1985, ADV GROUP PROCESSES, P77
   TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002
   Turner JC, 2005, EUR J SOC PSYCHOL, V35, P1, DOI 10.1002/ejsp.244
   TURNER JC, 2001, GROUPS WORK THEORY R, P25
   Turner John C., 1987, REDISCOVERING SOCIAL
   Wegge J, 2006, WORK STRESS, V20, P60, DOI 10.1080/02678370600655553
   Williams DR, 1999, RUTG SELF SOC ID, V2, P71
   COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310
NR 84
TC 111
Z9 112
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0269-994X
J9 APPL PSYCHOL-INT REV
JI Appl. Psychol.-Int. Rev.-Psychol. Appl.-Rev. Int.
PD JAN
PY 2009
VL 58
IS 1
BP 1
EP 23
DI 10.1111/j.1464-0597.2008.00379.x
PG 23
WC Psychology, Applied
SC Psychology
GA 389XM
UT WOS:000262128900001
ER

PT J
AU van Dijk, D
   Spoor, M
   Hijman, R
   Nathoe, HM
   Borst, C
   Jansen, EWL
   Grobbee, DE
   de Jaegere, PPT
   Kalkman, CJ
AF van Dijk, Diederik
   Spoor, Monique
   Hijman, Ron
   Nathoe, Hendrik M.
   Borst, Cornelius
   Jansen, Erik W. L.
   Grobbee, Diederick E.
   de Jaegere, Peter P. T.
   Kalkman, Cor J.
CA Octopus Study Grp
TI Cognitive and cardiac outcomes 5 years after off-pump vs on-pump
   coronary artery bypass graft surgery
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID RANDOMIZED-TRIAL; CLINICAL-SIGNIFICANCE; RISK PATIENTS; DECLINE;
   DYSFUNCTION; SELECTION; DISEASE; PATENCY; ANGINA; STROKE
AB Context Conventional coronary artery bypass graft surgery with use of cardiopulmonary bypass (on-pump CABG) is associated with excellent long-term cardiac outcomes but also with a high incidence of cognitive decline. The effect of avoiding cardiopulmonary bypass (off-pump CABG) on long-term cognitive and cardiac outcomes is unknown.
   Objective To compare the effect of off-pump CABG and on-pump CABG surgery on long-term cognitive and cardiac outcomes.
   Design, Setting, and Participants The Octopus Study, a multicenter randomized controlled trial conducted in the Netherlands, which enrolled 281 low-risk CABG patients between 1998 and 2000. Five years after their surgery, surviving patients were invited for a follow-up assessment.
   Intervention Patients were randomly assigned to receive either off-pump (n = 142) or on-pump (n = 139) CABG surgery.
   Main Outcome Measure The primary measure was cognitive status 5 years after surgery, which was determined by a psychologist blinded to treatment allocation who administered 10 standardized validated neuropsychological tests. Secondary measures were occurrence of cardiovascular events (all-cause mortality, stroke, myocardial infarction, and coronary reintervention), anginal status, and quality of life.
   Results After 5 years, 130 patients were alive in each group. Cognitive outcomes could be determined in 123 and 117 patients in the off-pump and on-pump groups, respectively. When using a standard definition of cognitive decline (20% decline in performance in 20% of the neuropsychological test variables), 62 (50.4%) of 123 in the off-pump group and 59 (50.4%) of 117 in the on-pump group had cognitive decline (absolute difference, 0%; 95% confidence interval [CI], -12.7% to 12.6%; P > .99). When a more conservative definition of cognitive decline was used, 41 (33.3%) in the off-pump group and 41 (35.0%) in the on-pump group had cognitive decline (absolute difference, -1.7%; 95% CI, -13.7% to 10.3%; P = .79). Thirty off-pump patients (21.1%) and 25 on-pump patients (18.0%) experienced a cardiovascular event (absolute difference, 3.1%; 95% CI, -6.1% to 12.4%; P = .55). No differences were observed in anginal status or quality of life.
   Conclusion In low-risk patients undergoing CABG surgery, avoiding the use of cardiopulmonary bypass had no effect on 5-year cognitive or cardiac outcomes.
C1 Univ Med Ctr Utrecht, Div Perioperat & Emergency Care, Dept Anesthesiol, NL-3508 GA Utrecht, Netherlands.
   Univ Med Ctr Utrecht, Dept Psychiat, NL-3508 GA Utrecht, Netherlands.
   Univ Med Ctr Utrecht, Dept Cardiol, NL-3508 GA Utrecht, Netherlands.
   Univ Med Ctr Utrecht, Dept Cardiothorac Surg, NL-3508 GA Utrecht, Netherlands.
   Univ Med Ctr Utrecht, Julius Ctr Patient Oriented Res, NL-3508 GA Utrecht, Netherlands.
   Erasmus MC, Dept Cardiol, Rotterdam, Netherlands.
RP van Dijk, D (reprint author), Univ Med Ctr Utrecht, Div Perioperat & Emergency Care, Dept Anesthesiol, Mail Stop Q004-2-313,POB 85500, NL-3508 GA Utrecht, Netherlands.
EM d.vandijk@umcutrecht.nl
RI Grobbee, Diederick/C-7651-2014
OI Grobbee, Diederick/0000-0003-4472-4468
CR Ascione R, 2005, CIRCULATION, V112, P3833, DOI 10.1161/CIRCULATIONAHA.105.557462
   Blauw GJ, 2001, EUR HEART J SUPPL, V3, pN16, DOI 10.1016/S1520-765X(01)90133-6
   BRAUNWALD E, 1989, CIRCULATION, V80, P410
   CAMPEAU L, 1976, CIRCULATION, V54, P522
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   EuroQol Group, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9
   HARRIS DN, 1993, LANCET, V342, P586, DOI 10.1016/0140-6736(93)91412-F
   Hartman GS, 1996, ANESTH ANALG, V83, P701, DOI 10.1097/00000539-199610000-00007
   Hlatky MA, 1997, CIRCULATION, V96, P11
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037//0022-006X.59.1.12
   Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931
   Keenan TDL, 2005, CHEST, V128, P363, DOI 10.1378/chest.128.1.363
   Keizer AMA, 2005, ACTA ANAESTH SCAND, V49, P1232, DOI 10.1111/j.1399-6576.2005.00835.x
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9
   Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0
   MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Selnes OA, 2001, ARCH NEUROL-CHICAGO, V58, P598, DOI 10.1001/archneur.58.4.598
   Selnes OA, 2006, ANN THORAC SURG, V82, P388, DOI 10.1016/j.athoracsur.2006.02.060
   STUMP DA, 1995, ANN THORAC SURG, V59, P1340, DOI 10.1016/0003-4975(95)00108-W
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901
   VANSWIETEN JC, 1988, STROKE, V19, P604
   Wahrborg P, 2004, CIRCULATION, V110, P3411, DOI 10.1161/01.CIR.0000148366.80443.2B
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
NR 30
TC 110
Z9 110
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610-0946 USA
SN 0098-7484
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD FEB 21
PY 2007
VL 297
IS 7
BP 701
EP 708
DI 10.1001/jama.297.7.701
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 137KI
UT WOS:000244291100021
PM 17312289
ER

PT J
AU AMARAL, F
   DREYER, G
   FIGUEREDOSILVA, J
   NOROES, J
   CAVALCANTI, A
   SAMICO, SC
   SANTOS, A
   COUTINHO, A
AF AMARAL, F
   DREYER, G
   FIGUEREDOSILVA, J
   NOROES, J
   CAVALCANTI, A
   SAMICO, SC
   SANTOS, A
   COUTINHO, A
TI LIVE ADULT WORMS DETECTED BY ULTRASONOGRAPHY IN HUMAN BANCROFTIAN
   FILARIASIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID NORTHEASTERN BRAZIL; LYMPHANGIOSCINTIGRAPHY; ABNORMALITIES; NODULES
AB Ultrasonographic examination of the scrotal area was performed in 14 asymptomatic individuals with bancroftian filariasis and microfilaremia. While in seven subjects (50%) the ultrasonographic findings were normal, lymphatic dilation and tortuosity were observed in the other seven. In these vessels, structures with peculiar aleatory movements (filaria dance sign) were detected. A segment of the lymphatic tract containing these mobile intraluminal structures that was resected surgically from the left spermatic cord of one individual confirmed that these structures were living Wuchereria bancrofti adult worms (two females and one male). Our study demonstrates for the first time the feasibility of using a low-cost, widely available, noninvasive technique (ultrasonography) to detect and monitor living adult worms and lymphatic dilation in patients with bancroftian filariasis.
C1 CIDADE UNIV,FIOCRUZ MS,CTR PESQUISAS AGGEU MAGALHAES,BR-52020020 RECIFE,PE,BRAZIL.
   HOSP RESTAURACAO,RECIFE,PE,BRAZIL.
   UNIV FED PERNAMBUCO,LAB IMUNOPATOL KEISO ASAMI,RECIFE,PE,BRAZIL.
   UNIV FED PERNAMBUCO,HOSP CLIN,RECIFE,PE,BRAZIL.
CR CASE TC, 1992, INVEST RADIOL, V27, P293, DOI 10.1097/00004424-199204000-00006
   COBBOLD TS, 1977, LANCET          1006, P495
   COBBOLD TS, 1877, LANCET           JUL, P70
   COHEN LB, 1961, AM J TROP MED HYG, V10, P843
   DREYER G, 1992, AM J TROP MED HYG, V46, P745
   DREYER G, 1994, IN PRESS T R SOC TRO
   HOMEIDA MA, 1986, T ROY SOC TROP MED H, V80, P570, DOI 10.1016/0035-9203(86)90142-2
   JUNGMANN P, 1992, J TROP MED HYG, V95, P114
   JUNGMANN P, 1991, AM J TROP MED HYG, V45, P325
   KLIKHAMER AC, 1967, TROP GEOGR MED, V201, P297
   KOBAYASHI MR, 1987, CLIN PLAST SURG, V14, P303
   KOEHLER PR, 1968, AMER J ROENTGENOL RA, V102, P455
   MARQUES R, 1964, J BRAS MED, V81, P1067
   O'Connor FW, 1930, AM J ROENTGENOL RADI, V23, P494
   OCONNOR FW, 1935, J PUBLIC HLTH TROP M, V11, P167
   Ottesen EA, 1992, PARASITOLOGY, V104, P571
   POLTERA AA, 1987, LANCET, V1, P505
   SEN SB, 1968, INDIAN J MED RES, V56, P1535
   TURIAF J., 1962, BULL SOC PATHOL EXOT, V55, P855
   VICENT AL, 1984, J PARASITOL, V70, P48
   WITTE M, 1988, LYMPHOLOGY, V21, P251
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   1992, WHO TECH REP SER, V821
NR 23
TC 110
Z9 116
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DRIVE SUITE 130, MCLEAN, VA 22101
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUN
PY 1994
VL 50
IS 6
BP 753
EP 757
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA NX126
UT WOS:A1994NX12600015
PM 8024070
ER

PT J
AU Lamy, A
   Devereaux, PJ
   Prabhakaran, D
   Taggart, DP
   Hu, SS
   Paolasso, E
   Straka, Z
   Piegas, LS
   Akar, AR
   Jain, AR
   Noiseux, N
   Padmanabhan, C
   Bahamondes, JC
   Novick, RJ
   Vaijyanath, P
   Reddy, S
   Tao, L
   Olavegogeascoechea, PA
   Airan, B
   Sulling, TA
   Whitlock, RP
   Ou, YN
   Ng, J
   Chrolavicius, S
   Yusuf, S
AF Lamy, Andre
   Devereaux, P. J.
   Prabhakaran, Dorairaj
   Taggart, David P.
   Hu, Shengshou
   Paolasso, Ernesto
   Straka, Zbynek
   Piegas, Leopoldo S.
   Akar, Ahmet Ruchan
   Jain, Anil R.
   Noiseux, Nicolas
   Padmanabhan, Chandrasekar
   Bahamondes, Juan-Carlos
   Novick, Richard J.
   Vaijyanath, Prashant
   Reddy, Sukesh
   Tao, Liang
   Olavegogeascoechea, Pablo A.
   Airan, Balram
   Sulling, Toomas-Andres
   Whitlock, Richard P.
   Ou, Yongning
   Ng, Jennifer
   Chrolavicius, Susan
   Yusuf, Salim
CA CORONARY Investigators
TI Off-Pump or On-Pump Coronary-Artery Bypass Grafting at 30 Days
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID ACUTE KIDNEY INJURY; RANDOMIZED-TRIALS; CARDIAC-SURGERY; OUTCOMES;
   MORBIDITY; COLLABORATION; METAANALYSIS; DESIGN
AB Background
   The relative benefits and risks of performing coronary-artery bypass grafting (CABG) with a beating-heart technique (off-pump CABG), as compared with cardiopulmonary bypass (on-pump CABG), are not clearly established.
   Methods
   At 79 centers in 19 countries, we randomly assigned 4752 patients in whom CABG was planned to undergo the procedure off-pump or on-pump. The first coprimary outcome was a composite of death, nonfatal stroke, nonfatal myocardial infarction, or new renal failure requiring dialysis at 30 days after randomization.
   Results
   There was no significant difference in the rate of the primary composite outcome between off-pump and on-pump CABG (9.8% vs. 10.3%; hazard ratio for the off-pump group, 0.95; 95% confidence interval [CI], 0.79 to 1.14; P = 0.59) or in any of its individual components. The use of off-pump CABG, as compared with on-pump CABG, significantly reduced the rates of blood-product transfusion (50.7% vs. 63.3%; relative risk, 0.80; 95% CI, 0.75 to 0.85; P<0.001), reoperation for perioperative bleeding (1.4% vs. 2.4%; relative risk, 0.61; 95% CI, 0.40 to 0.93; P = 0.02), acute kidney injury (28.0% vs. 32.1%; relative risk, 0.87; 95% CI, 0.80 to 0.96; P = 0.01), and respiratory complications (5.9% vs. 7.5%; relative risk, 0.79; 95% CI, 0.63 to 0.98; P = 0.03) but increased the rate of early repeat revascularizations (0.7% vs. 0.2%; hazard ratio, 4.01; 95% CI, 1.34 to 12.0; P = 0.01).
   Conclusions
   There was no significant difference between off-pump and on-pump CABG with respect to the 30-day rate of death, myocardial infarction, stroke, or renal failure requiring dialysis. The use of off-pump CABG resulted in reduced rates of transfusion, reoperation for perioperative bleeding, respiratory complications, and acute kidney injury but also resulted in an increased risk of early revascularization. (Funded by the Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov number, NCT00463294.)
C1 [Lamy, Andre; Devereaux, P. J.; Whitlock, Richard P.; Ou, Yongning; Ng, Jennifer; Chrolavicius, Susan; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.
   [Novick, Richard J.] London Hlth Sci Ctr, London, ON, Canada.
   [Taggart, David P.] Ctr Chron Dis Control, New Delhi, India.
   [Airan, Balram] All India Inst Med Sci, New Delhi, India.
   [Jain, Anil R.] SAL Hosp & Med Inst, Ahmadabad, Gujarat, India.
   [Padmanabhan, Chandrasekar] G Kuppuswamy Naidu Mem Hosp, Coimbatore, Tamil Nadu, India.
   [Vaijyanath, Prashant] Dr KM Cherian Heart Fdn, Madras, Tamil Nadu, India.
   [Reddy, Sukesh] Mediciti Hosp, Hyderabad, Andhra Pradesh, India.
   [Taggart, David P.] Univ Oxford, Oxford, England.
   [Hu, Shengshou] Fu Wai Cardiovasc Hosp, Beijing, Peoples R China.
   [Paolasso, Ernesto] Inst Invest Clin Rosario, Rosario, Argentina.
   [Straka, Zbynek] Charles Univ Prague, Fac Med 3, Prague, Czech Republic.
   [Piegas, Leopoldo S.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil.
   Ankara Univ, Sch Med, TR-06100 Ankara, Turkey.
   [Noiseux, Nicolas] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada.
   [Bahamondes, Juan-Carlos] Hosp Reg Temuco, Temuco, Chile.
   [Tao, Liang] Wuhan Asia Heart Hosp, Wuhan, Peoples R China.
   [Olavegogeascoechea, Pablo A.] Fdn Med Rio Negro & Neuguen, Rio Negro, Argentina.
   [Sulling, Toomas-Andres] N Estonia Med Ctr, Tallinn, Estonia.
RP Lamy, A (reprint author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.
EM lamya@mcmaster.ca
FU Canadian Institutes of Health Research
FX Supported by the Canadian Institutes of Health Research.Funded by the
   Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov
   number, NCT00463294.
CR Afilalo J, 2011, EUR HEART J     1010
   Brown PP, 2001, ANN THORAC SURG, V72, pS1009, DOI 10.1016/S0003-4975(01)02937-X
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   deGuzman BJ, 2004, NEW ENGL J MED, V350, P1791
   Devereaux PJ, 2005, BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88
   Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913
   Lamy A, 2012, AM HEART J, V163, P1, DOI 10.1016/j.ahj.2011.10.007
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6
   Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Song HK, 2003, EUR J CARDIO-THORAC, V24, P947, DOI 10.1016/S1010-7940(03)00616-X
   Spiess Bruce D, 2004, Semin Cardiothorac Vasc Anesth, V8, P267, DOI 10.1177/108925320400800402
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   The Society of Thoracic Surgeons, STS AD CARD SURG DAT
   VANDERLINDEN W, 1980, SURGERY, V87, P258
   Venkataraman Ramesh, 2007, J Intensive Care Med, V22, P187, DOI 10.1177/0885066607299510
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Yusuf S, 1994, LANCET, V344, P446
NR 24
TC 109
Z9 112
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 19
PY 2012
VL 366
IS 16
BP 1489
EP 1497
DI 10.1056/NEJMoa1200388
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA 927UE
UT WOS:000302934800006
PM 22449296
ER

PT J
AU Hoeve, M
   Dubas, JS
   Eichelsheim, VI
   van der Laan, PH
   Smeenk, W
   Gerris, JRM
AF Hoeve, Machteld
   Dubas, Judith Semon
   Eichelsheim, Veroni I.
   van der Laan, Peter H.
   Smeenk, Wilma
   Gerris, Jan R. M.
TI The Relationship Between Parenting and Delinquency: A Meta-analysis
SO JOURNAL OF ABNORMAL CHILD PSYCHOLOGY
LA English
DT Review
DE Child-rearing; Delinquency; Meta-analysis; Moderators; Development
ID SELF-REPORTED DELINQUENCY; AFRICAN-AMERICAN ADOLESCENTS; SERIOUS
   JUVENILE-OFFENDERS; LIFE-COURSE-PERSISTENT; PSYCHOLOGICAL CONTROL;
   ANTISOCIAL-BEHAVIOR; FAMILY INFLUENCES; VIOLENT BEHAVIOR; DEVIANT PEERS;
   RISK-FACTORS
AB This meta-analysis of 161 published and unpublished manuscripts was conducted to determine whether the association between parenting and delinquency exists and what the magnitude of this linkage is. The strongest links were found for parental monitoring, psychological control, and negative aspects of support such as rejection and hostility, accounting for up to 11% of the variance in delinquency. Several effect sizes were moderated by parent and child gender, child age, informant on parenting, and delinquency type, indicating that some parenting behaviors are more important for particular contexts or subsamples. Although both dimensions of warmth and support seem to be important, surprisingly very few studies focused on parenting styles. Furthermore, fewer than 20% of the studies focused on parenting behavior of fathers, despite the fact that the effect of poor support by fathers was larger than poor maternal support, particularly for sons. Implications for theory and parenting are discussed.
C1 [Hoeve, Machteld; van der Laan, Peter H.] Univ Amsterdam, Dept Educ Sci, NL-1090 GE Amsterdam, Netherlands.
   [Hoeve, Machteld; Eichelsheim, Veroni I.; van der Laan, Peter H.; Smeenk, Wilma] Netherlands Inst Study Crime & Law Enforcement NS, Amsterdam, Netherlands.
   [Dubas, Judith Semon] Univ Utrecht, Dept Dev Psychol, Utrecht, Netherlands.
   [Eichelsheim, Veroni I.] Univ Utrecht, Dept Pedag & Educ Sci, Utrecht, Netherlands.
   [Smeenk, Wilma] Res & Documentat Ctr, Minist Justice, The Hague, Netherlands.
   [Gerris, Jan R. M.] Radboud Univ Nijmegen, Inst Family & Child Care Studies, NL-6525 ED Nijmegen, Netherlands.
RP Hoeve, M (reprint author), Univ Amsterdam, Dept Educ Sci, POB 94208, NL-1090 GE Amsterdam, Netherlands.
EM m.hoeve@uva.nl
CR ADAMS JB, 2001, DISS ABSTR INT A, V62, P1595
   ANDRY R, 1962, SOCIOLOGY CRIME DELI
   ASELTINE RH, 1995, J HEALTH SOC BEHAV, V36, P103, DOI 10.2307/2137219
   Babinski LM, 2001, AGGRESSIVE BEHAV, V27, P44, DOI 10.1002/1098-2337(20010101/31)27:1<44::AID-AB4>3.0.CO;2-O
   BAILEY B. N., 2006, J ABNORM PSYCHOL, V34, P54, DOI 10.1007/s10802-005-9002-y
   Baldry AC, 2000, J COMMUNITY APPL SOC, V10, P17, DOI 10.1002/(SICI)1099-1298(200001/02)10:1<17::AID-CASP526>3.0.CO;2-M
   Banyard VL, 2006, J INTERPERS VIOLENCE, V21, P1314, DOI 10.1177/0886260506291657
   Barber BK, 2005, NEW DIR CHILD ADOLES, V108, P5, DOI 10.1002/cd.124
   Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.1111/j.1467-8624.1996.tb01915.x
   BARBER BK, 1994, CHILD DEV, V65, P1120, DOI 10.1111/j.1467-8624.1994.tb00807.x
   Barberet R., 1994, DELINQUENT BEHAV YOU
   BARNES GM, 1992, J MARRIAGE FAM, V54, P763, DOI 10.2307/353159
   BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x
   BAUMRIND D, 1968, ADOLESCENCE, V3, P255
   BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372
   Bean RA, 2006, J FAM ISSUES, V27, P1335, DOI 10.1177/0192513X06289649
   Becker KD, 2004, J AM ACAD CHILD PSY, V43, P905, DOI 10.1097/01.chi.0000128786.70990.9b
   Bessant J, 1998, J CRIM JUST, V26, P145, DOI 10.1016/S0047-2352(97)00076-7
   Bonett DG, 2007, AM PSYCHOL, V62, P254, DOI 10.1037/0003-066X.62.3.254
   Borduin C. M., 1985, CHILD FAMILY BEHAV T, V7, P51, DOI 10.1300/J019v07n02_04
   BORDUIN CM, 1986, J GENET PSYCHOL, V147, P333
   Born M., 1994, DELINQUENT BEHAV YOU, P130
   Bowman MA, 2007, J YOUTH ADOLESCENCE, V36, P517, DOI 10.1007/s10964-006-9117-7
   Brendgen M, 2001, J ABNORM CHILD PSYCH, V29, P293, DOI 10.1023/A:1010305828208
   Burt CH, 2006, CRIMINOLOGY, V44, P353, DOI 10.1111/j.1745-9125.2006.00052.x
   BURTON VS, 1995, J CRIM JUST, V23, P111, DOI 10.1016/0047-2352(95)00009-F
   Caldwell RM, 2006, J ADOLESCENCE, V29, P459, DOI 10.1016/j.adolescence.2005.07.005
   CAMPBELL A, 1987, J YOUTH ADOLESCENCE, V16, P167, DOI 10.1007/BF02138918
   Capaldi DM, 2003, J ABNORM CHILD PSYCH, V31, P127, DOI 10.1023/A:1022518123387
   Carlson C. I., 1991, NEW DIR CHILD ADOLES, V51, P13, DOI DOI 10.1002/CD.23219915103
   CERNKOVICH SA, 1987, CRIMINOLOGY, V25, P295, DOI 10.1111/j.1745-9125.1987.tb00799.x
   Chapple Constance L, 2003, Violence Vict, V18, P143, DOI 10.1891/vivi.2003.18.2.143
   Chung HL, 2006, DEV PSYCHOL, V42, P319, DOI 10.1037/0012-1649.42.2.319
   Cohen J, 1988, STAT POWER ANAL BEHA
   COLPIN H, 1999, GEZINSPEDAGOGIEK ACT, P53
   COOK ET, 1996, THESIS U WASHINGTON
   Cooper HM, 1989, INTEGRATING RES GUID
   Cota-Robles S, 2006, YOUTH SOC, V37, P375, DOI 10.1177/0044118X05282362
   Cottle CC, 2001, CRIM JUSTICE BEHAV, V28, P367, DOI 10.1177/0093854801028003005
   Coughlin C, 1996, J MARRIAGE FAM, V58, P491, DOI 10.2307/353512
   CRISS MM, 2002, DISS ABSTR INT B, V63, P1082
   Crouter A. C., 2003, CHILDRENS INFLUENCE
   DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487
   DEKEMP RAT, 2004, PEDAGOGIEK, V24, P262
   DEKKERS ME, 1998, THESIS U LEIDEN LEID
   Dekovic M., 2001, ERNSTIGE GEWELDDADIG, P225
   DISHION TJ, 1991, DEV PSYCHOL, V27, P172, DOI 10.1037/0012-1649.27.1.172
   DRAKEFORD M, 1996, HOWARD J, V35, P242
   DUNDES L, 1994, AM J POLICE, V13, P113
   Estevez E, 2005, ADOLESCENCE, V40, P183
   Farrington D P, 1989, Violence Vict, V4, P79
   FARRINGTON DP, 1991, CRIMINAL BEHAVIOR ME, V0001
   Farrington DP, 2005, ADV CRIM THEOR, V14, P1
   Farrington David P., 2003, VIOLENT CRIME ASSESS, P213, DOI 10.1017/CBO9780511499456.014
   Farrington David P, 2002, Crim Behav Ment Health, V12, P53, DOI 10.1002/cbm.486
   Farrington DP, 2001, J ADOLESCENCE, V24, P579, DOI 10.1006/jado.2001.0424
   Farrington D.P., 1999, HIST GEOGRAPHICAL IN, P299
   FARRINGTON DP, 1990, J ADOLESCENCE, V13, P93, DOI 10.1016/0140-1971(90)90001-N
   FARRINGTON DP, 2002, MULTI PROBLEM VIOLEN, V324, P23
   FELDMAN SS, 1994, CHILD DEV, V65, P195, DOI 10.1111/j.1467-8624.1994.tb00744.x
   Finkenauer C, 2005, INT J BEHAV DEV, V29, P58, DOI 10.1080/01650250444000333
   FISCHER DG, 1983, PERCEPT MOTOR SKILL, V56, P635
   Flannery DJ, 1999, AM J ORTHOPSYCHIAT, V69, P247, DOI 10.1037/h0080426
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Gainey RR, 1997, DEVIANT BEHAV, V18, P143
   Gendreau P, 1996, CRIMINOLOGY, V34, P575, DOI 10.1111/j.1745-9125.1996.tb01220.x
   Gersao E., 1994, DELINQUENT BEHAV YOU, P212
   GIEVER DM, 1996, THESIS INDIANA U PEN
   GLUECK E, 1968, DELINQUENTS NONDELIN
   Glueck S, 1950, UNRAVELING JUVENILE
   Gottfredson M. R., 1990, GEN THEORY CRIME
   GOVE WR, 1982, SOCIOL QUART, V23, P301, DOI 10.1111/j.1533-8525.1982.tb01014.x
   GRAHAM J, 1995, NO HOME OFFICE RES S, V145
   Granic I., 2000, EMOTION DEV SELF ORG, P267, DOI 10.1017/CBO9780511527883.012
   GRAYRAY P, 1990, YOUTH SOC, V22, P67, DOI 10.1177/0044118X90022001005
   Griffin KW, 2000, PSYCHOL ADDICT BEHAV, V14, P174, DOI 10.1037//0893-164X.14.2.174
   Hay C, 2003, SOCIOL PERSPECT, V46, P107, DOI 10.1525/sop.2003.46.1.107
   Hay C, 2006, J RES CRIME DELINQ, V43, P326, DOI 10.1177/0022427806291262
   Haynie DL, 2003, SOC FORCES, V82, P355, DOI 10.1353/sof.2003.0093
   Heaven PCL, 2001, PERS INDIV DIFFER, V30, P321, DOI 10.1016/S0191-8869(00)00049-0
   Heaven PCL, 2004, PERS INDIV DIFFER, V36, P173, DOI 10.1016/S0191-8869(03)00077-1
   Hedges L.V., 1985, STAT METHODS METAANA
   Herman MR, 1997, J ADOLESCENT RES, V12, P34
   Herrenkohl TI, 2000, J ADOLESCENT HEALTH, V26, P176, DOI 10.1016/S1054-139X(99)00065-8
   Avenevoli S, 1999, COPING WITH DIVORCE, SINGLE PARENTING, AND REMARRIAGE, P65
   HETHERIN.EM, 1971, J ABNORM PSYCHOL, V78, P160, DOI 10.1037/h0031988
   HILL GD, 1988, CRIMINOLOGY, V26, P127, DOI 10.1111/j.1745-9125.1988.tb00835.x
   Hirschi T., 2001, LIFE COURSE CRIMINAL, P229
   Hirschi T., 1969, CAUSES DELINQUENCY
   Hodgins S, 2001, ARCH GEN PSYCHIAT, V58, P746, DOI 10.1001/archpsyc.58.8.746
   Hoeve M, 2008, J ABNORM CHILD PSYCH, V36, P223, DOI 10.1007/s10802-007-9172-x
   Hoeve M., 2007, EUROPEAN J CRIMINOLO, V4, P116
   Holden GW, 1997, PARENTS DYNAMICS CHI
   Holden GW, 1999, PSYCHOL BULL, V125, P223, DOI 10.1037/0033-2909.125.2.223
   HOOPER RM, 1989, THESIS NEW YORK U
   Hubbard D. J., 2002, J OFFENDER REHABILIT, V34, P1, DOI DOI 10.1300/J076V34N03_
   Jacobson KC, 2000, J RES ADOLESCENCE, V10, P65, DOI 10.1207/SJRA1001_4
   Jaffee SR, 2003, CHILD DEV, V74, P109, DOI 10.1111/1467-8624.t01-1-00524
   JENSEN GF, 1972, AM J SOCIOL, V78, P562, DOI 10.1086/225364
   Johnson JG, 2004, BRIT J CRIMINOL, V44, P915, DOI 10.1093/bjc/azh041
   JOHNSON RE, 1987, ADOLESCENCE, V22, P305
   Jones DJ, 2000, ADOLESCENCE, V35, P513
   JONSSON G, 1967, ACTA PSYCHIAT S S195, V43, P264
   Juang LP, 1999, J ADOLESCENCE, V22, P719, DOI 10.1006/jado.1999.0267
   JURAS JL, 2004, DISS ABSTR INT B, V65, P2126
   Kazdin AE, 2001, J CLIN CHILD PSYCHOL, V30, P59, DOI 10.1207/S15374424JCCP3001_7
   Kerr M, 1999, J ADOLESCENCE, V22, P737, DOI 10.1006/jado.1999.0266
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   KOLVIN I, 1988, BRIT J PSYCHIAT, V152, P80, DOI 10.1192/bjp.152.1.80
   Kosterman R, 2001, Violence Vict, V16, P355
   Krohn M. D., 1992, J QUANTITATIVE CRIMI, V8, P287, DOI 10.1007/BF01064550
   KROHN MD, 1980, SOCIOL QUART, V21, P529, DOI 10.1111/j.1533-8525.1980.tb00634.x
   KROUPA SE, 1988, ADOLESCENCE, V23, P171
   KRUTTSCHNITT C, 1991, CRIM JUSTICE BEHAV, V18, P448, DOI 10.1177/0093854891018004006
   KUPANOFF KM, 2002, DISS ABSTR INT B, V63, P2621
   Laible DJ, 2004, J ADOLESCENT RES, V19, P759, DOI 10.1177/0743558402360094
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   Lanz M, 2001, INT J BEHAV DEV, V25, P133
   LARZELERE RE, 1990, CRIMINOLOGY, V28, P301, DOI 10.1111/j.1745-9125.1990.tb01327.x
   Lavoie F, 2002, J ADOLESCENT HEALTH, V30, P375, DOI 10.1016/S1054-139X(02)00347-6
   LeBlanc M., 1998, EARLY CHILD DEV CARE, V142, P63
   Lefkowitz M. M., 1977, GROWING BE VIOLENT L
   LEMPERS JD, 1989, CHILD DEV, V60, P25, DOI 10.1111/j.1467-8624.1989.tb02692.x
   Lipsey M. W., 2001, PRACTICAL METAANALYS
   Lipsey M. W., 1998, SERIOUS VIOLENT JUVE, P86
   LOEBER R, 1983, PSYCHOL BULL, V94, P68, DOI 10.1037/0033-2909.94.1.68
   Loeber R, 2008, VIOLENCE AND SERIOUS THEFT: DEVELOPMENT AND PREDICTION FROM CHILDHOOD TO ADULTHOOD, P1
   Loeber R., 1996, DELINQUENCY CRIME CU, P1
   Loukas A, 2007, J YOUTH ADOLESCENCE, V36, P489, DOI 10.1007/s10964-006-9124-8
   Lundahl BW, 2008, RES SOCIAL WORK PRAC, V18, P97, DOI 10.1177/1049731507309828
   LUO Q, 2000, THESIS WAYNE STATE U
   Maccoby E. E., 1983, HDB CHILD PSYCHOL, VIV, P1
   MACIE KM, 2003, INFLUENCE COPARENTIN
   MADOFF JM, 1959, OURNAL CONSULTING PS, V23, P518
   MAK AS, 1994, AUST J PSYCHOL, V46, P107, DOI 10.1080/00049539408259481
   Mason CA, 1996, CHILD DEV, V67, P2115, DOI 10.1111/j.1467-8624.1996.tb01847.x
   McCart MR, 2006, J ABNORM CHILD PSYCH, V34, P527, DOI 10.1007/s10802-006-9031-1
   McCartney K, 2000, CHILD DEV, V71, P173, DOI 10.1111/1467-8624.00131
   MCCORD J, 1991, CRIMINOLOGY, V29, P397, DOI 10.1111/j.1745-9125.1991.tb01072.x
   MCCORD J, 1991, J CRIM LAW CRIM, V82, P211, DOI 10.2307/1143796
   McCord J, 1996, J FAM PSYCHOL, V10, P147
   McCord J., 1990, STRAIGHT DEVIOUS PAT, P116
   McCord W., 1959, ORIGINS CRIME NEW EV
   MEDINNUS GR, 1965, J CONSULT PSYCHOL, V29, P592, DOI 10.1037/h0022776
   Moffitt T. E., 2001, SEX DIFFERENCES ANTI
   Moffitt T. E., 2006, DEV PSYCHOPATHOL, V3, P570
   Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097
   MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674
   MOJALLALI S, 1972, THESIS N TEXAS STATE
   Mounts NS, 2001, J EARLY ADOLESCENCE, V21, P92, DOI 10.1177/0272431601021001005
   Mulford CF, 2008, J CHILD FAM STUD, V17, P629, DOI 10.1007/s10826-007-9178-6
   Mullen B., 1989, ADV BASIC METAANALYS
   NOLLER P, 1988, DEV PSYCHOL, V24, P707, DOI 10.1037//0012-1649.24.5.707
   Nye F, 1958, FAMILY RELATIONSHIPS
   O'Connor BP, 2001, J RES PERS, V35, P1, DOI 10.1006/jrpe.2000.2295
   O'Connor TG, 2002, J CHILD PSYCHOL PSYC, V43, P555, DOI 10.1111/1469-7610.00046
   Paschall MJ, 2003, ADOLESCENCE, V38, P15
   Patterson G. R., 1985, CRIMINOLOGY, V23, P63, DOI 10.1111/j.1745-9125.1985.tb00326.x
   Patterson G. R., 2002, ANTISOCIAL BEHAV CHI, P147, DOI [10.1037/10468-007, DOI 10.1037/10468-007]
   Patterson G. R., 1993, MENTAL DISORDER CRIM, P140
   PATTERSON GR, 1995, CRIM BEHAV MENT HEAL, V5, P411
   Pedersen Willy, 2000, J SCANDINAVIAN STUDI, V1, P87, DOI 10.1080/14043850050116282
   Peiser NC, 1996, J ADOLESCENCE, V19, P557, DOI 10.1006/jado.1996.0054
   PETERSON D, 2002, THESIS U NEBRASKA
   Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298
   Piquero AR, 2005, J RES CRIME DELINQ, V42, P27, DOI 10.1177/0022427804266559
   RANKIN JH, 1994, CRIMINOLOGY, V32, P495, DOI 10.1111/j.1745-9125.1994.tb01163.x
   RASMUSSEN KS, 1995, PARENTAL CONTROL ADO
   Reitz E, 2007, J YOUTH ADOLESCENCE, V36, P623, DOI 10.1007/s10964-006-9150-6
   Riley D., 1985, HOME OFFICE RES STUD, P83
   Roche KM, 2007, J FAM ISSUES, V28, P882, DOI 10.1177/0192513X07299617
   Rohner RP, 2004, AM PSYCHOL, V59, P830, DOI 10.1037/0003-066X.59.8.830
   Rollins B.C., 1979, CONT THEORIES FAMILY, P317
   ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037//0033-2909.118.2.183
   Rosenthal R., 1991, METAANALYTIC PROCEDU, V86
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037//0033-2909.86.3.638
   ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55
   Samaniego RY, 1999, AM J COMMUN PSYCHOL, V27, P189, DOI 10.1023/A:1022883601126
   SAMPSON R, 2001, LIFECOURSE CRIMINOLO, P146
   Sampson R. J., 1993, CRIME MAKING PATHWAY
   SAMPSON RJ, 1994, CHILD DEV, V65, P523, DOI 10.2307/1131400
   Sampson RJ, 2005, ADV CRIM THEOR, V14, P165
   Scholte EM, 1999, J ADOLESCENCE, V22, P3, DOI 10.1006/jado.1998.0197
   SEYDLITZ R, 1993, YOUTH SOC, V24, P243, DOI 10.1177/0044118X93024003001
   SHAW JM, 1991, AUST J PSYCHOL, V43, P61, DOI 10.1080/00049539108259101
   SHELINE JL, 1994, AM J PUBLIC HEALTH, V84, P661, DOI 10.2105/AJPH.84.4.661
   Simons RL, 1998, CRIMINOLOGY, V36, P217, DOI 10.1111/j.1745-9125.1998.tb01247.x
   SIMONS RL, 1991, J YOUTH ADOLESCENCE, V20, P645, DOI 10.1007/BF01537367
   Simons RL, 2005, CRIMINOLOGY, V43, P989, DOI 10.1111/j.1745-9125.2005.00031.x
   Simons RL, 1998, J MARRIAGE FAM, V60, P467, DOI 10.2307/353862
   SIMONS RL, 1989, J YOUTH ADOLESCENCE, V18, P297
   SIMONS RL, 1994, J MARRIAGE FAM, V56, P591, DOI 10.2307/352870
   Singer MI, 1999, PEDIATRICS, V104, P878, DOI 10.1542/peds.104.4.878
   SKINNER KB, 2000, THESIS BRIGHAM YOUNG
   Smith DJ, 2003, BRIT J CRIMINOL, V43, P169, DOI 10.1093/bjc/43.1.169
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Kerr M, 2003, CHILDREN'S INFLUENCE ON FAMILY DYNAMICS: THE NEGLECTED SIDE OF FAMILY RELATIONSHIPS, P121
   Steinberg L, 2001, J RES ADOLESCENCE, V11, P1, DOI 10.1111/1532-7795.00001
   Steinberg L., 1991, J RES ADOLESCENCE, V1, P19, DOI DOI 10.1111/1532-7795.EP11522650
   Steinberg L, 2006, J RES ADOLESCENCE, V16, P47, DOI 10.1111/j.1532-7795.2006.00119.x
   STEINBERG L, 1994, CHILD DEV, V65, P754, DOI 10.1111/j.1467-8624.1994.tb00781.x
   Stewart EA, 2002, J RES CRIME DELINQ, V39, P36
   LOEBER R, 1986, CRIME JUSTICE, V7, P29, DOI 10.1086/449112
   Stouthamer-Loeber M, 2002, J CONSULT CLIN PSYCH, V70, P111, DOI 10.1037//0022-006X.70.1.111
   STUEWIG J, 2001, THESIS U ARIZONA
   Tabachnick BG, 1989, USING MULTIVARIATE S
   Tavecchio LWC, 1999, J MORAL EDUC, V28, P63, DOI 10.1080/030572499103313
   Ten Haaf P. G. J., 1993, OPVOEDINGSDIMENSIES
   TENHAAF PGJ, 1994, EUROPEAN J PSYCHOL A, V10, P111
   Terlouw G.-J., 1994, DELINQUENT BEHAV YOU
   TREMBLAY RE, 1995, COERCION PUNISHMENT
   Unnever J. D., 2006, YOUTH VIOLENCE JUV J, V4, P3, DOI 10.1177/1541204005282310
   VANVOORHIS P, 1988, CRIMINOLOGY, V26, P235
   Vazsonyi A. T, 1996, EUROPEAN J CRIMINAL, V4, P81, DOI 10.1007/BF02731603
   Vazsonyi AT, 1997, J EARLY ADOLESCENCE, V17, P271, DOI 10.1177/0272431697017003002
   VEGA WA, 1993, AM J COMMUN PSYCHOL, V21, P113, DOI 10.1007/BF00938210
   Videon TM, 2005, J FAM ISSUES, V26, P55, DOI 10.1177/0192513X04270262
   VISSING YM, 1991, CHILD ABUSE NEGLECT, V15, P223, DOI 10.1016/0145-2134(91)90067-N
   Vitaro F, 2000, J ABNORM CHILD PSYCH, V28, P313, DOI 10.1023/A:1005188108461
   Voss K, 2001, DISS ABSTR INT B, V61, P6725
   Walker-Barnes CJ, 2001, CHILD DEV, V72, P1814, DOI 10.1111/1467-8624.00380
   WARR M, 1993, SOC FORCES, V72, P247, DOI 10.2307/2580168
   WEINTRAUB KJ, 1991, CRIMINAL BEHAV MENTA, V0001
   WELLS LE, 1988, CRIMINOLOGY, V26, P263, DOI 10.1111/j.1745-9125.1988.tb00841.x
   Werner NE, 2003, J ADOLESCENT RES, V18, P454, DOI 10.1177/0743558403255063
   West D., 1977, DELINQUENT WAY LIFE
   West D. J., 1973, WHO BECOMES DELINQUE
   Williams A. J, 2004, DISS ABSTR INT B, V65, P1602
   Williams SK, 2005, J EARLY ADOLESCENCE, V25, P168, DOI 10.1177/0272431604274178
   WILSON H, 1980, NEW STATESMAN SOC, V54, P456
   WILSON H, 1987, BRIT J CRIMINOL, V27, P275
   WINDHAM AM, 2003, DISS ABSTR INT B, V63, P4632
   Wissink IB, 2006, J EARLY ADOLESCENCE, V26, P133, DOI 10.1177/0272431605285718
   Wright JP, 2000, CONT PERSP FAM RES, V2, P139
   Wright JP, 2001, CRIMINOLOGY, V39, P677, DOI 10.1111/j.1745-9125.2001.tb00937.x
NR 235
TC 108
Z9 112
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0091-0627
EI 1573-2835
J9 J ABNORM CHILD PSYCH
JI J. Abnorm. Child Psychol.
PD AUG
PY 2009
VL 37
IS 6
BP 749
EP 775
DI 10.1007/s10802-009-9310-8
PG 27
WC Psychology, Clinical; Psychology, Developmental
SC Psychology
GA 469RF
UT WOS:000267917100001
PM 19263213
ER

PT J
AU Burgess, DC
   Kilborn, MJ
   Keech, AC
AF Burgess, David C.
   Kilborn, Michael J.
   Keech, Anthony C.
TI Interventions for prevention of post-operative atrial fibrillation and
   its complications after cardiac surgery: a meta-analysis
SO EUROPEAN HEART JOURNAL
LA English
DT Review
DE atrial fibrillation; cardiothoracic surgery; meta-analysis; prevention
ID ARTERY-BYPASS-SURGERY; LOW-DOSE PROPRANOLOL; RANDOMIZED
   CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; OPEN-HEART-SURGERY;
   LENGTH-OF-STAY; INTRAVENOUS MAGNESIUM-SULFATE; PROPHYLACTIC ORAL
   AMIODARONE; CORONARY-BYPASS; SUPRAVENTRICULAR TACHYARRHYTHMIAS
AB Aims Atrial fibrillation (AF) is the most common complication after cardiac surgery. We aimed to evaluate, by meta-analysis, all randomized trials testing interventions for preventing AF.
   Methods and results Ninety-four trials of prevention of post-operative AF were identified, by standard search methods, and analysed by standard meta-analysis techniques. All five commonly tested interventions, beta-blockers (BBs), sotalol, amiodarone, magnesium, and atrial pacing, were effective in preventing AF. The odds ratio (OR) for the effect of BB on the incidence of AF was 0.36 (95% CI 0.28-0.47, P < 0.001), but after trials confounded by post-operative non-study BB withdrawal were excluded was 0.69 (95% CI 0.54-0.87, P=0.002). Sotalol reduced AF, compared with placebo (OR 0.34, 95% CI 0.26-0.45, P < 0.001) and compared with conventional BB (OR 0.42, 95% CI 0.26-0.65, P < 0.001). Amiodarone reduced AF (OR 0.48, 95% CI 0.40-0.57, P < 0.001). Magnesium (Mg) also had an effect (OR 0.57 95% CI 0.42-0.77) but there was significant heterogeneity (P < 0.001), partly explained by concomitant BB. The effect of Mg with BB was less (OR 0.83, 95% CI 0.60-1.16). Pacing reduced AF (OR 0.60, 95% CI 0.47-0.77, P < 0.001), despite wide variations in techniques. Only amiodarone and pacing significantly reduced length of stay, average -0.60 days (95% CI -0.92 to -0.29) and -1.3 days (95% CI -2.55 to -0.08), respectively. Collectively, all treatments analysed together reduced stroke (OR 0.63, 95% CI 0.41-0.98). Amiodarone was the only intervention that alone significantly reduced stroke rate (OR 0.54, 95% CI 0.30-0.95).
   Conclusion All five interventions reduced the incidence of AF, though the effect of BBs is less than previously thought. The significant reductions in length of stay and stroke in meta-analysis suggest that there are worthwhile benefits from aggressive prevention. Larger studies to confirm these clinical benefits and evaluate their cost-effectiveness would be worthwhile.
C1 Univ Sydney, Natl Hlth & Med Res Council Clin Trials, Sydney, NSW 2050, Australia.
   Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia.
RP Burgess, DC (reprint author), Univ Sydney, Natl Hlth & Med Res Council Clin Trials, Level 5,Bldg F,88 Mallett St, Sydney, NSW 2050, Australia.
EM startup@ctc.usyd.edu.au
CR Aasbo JD, 2005, ANN INTERN MED, V143, P327
   ABEL RM, 1983, ARCH SURG-CHICAGO, V118, P727
   Ali IM, 1997, EUR J CARDIO-THORAC, V11, P1154, DOI 10.1016/S1010-7940(97)01215-3
   Alwan K, 2004, ANN THORAC SURG, V77, P2051, DOI 10.1016/j.athoracsur.2003.11.004
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Aranki SF, 1996, CIRCULATION, V94, P390
   Auer J, 2004, AM HEART J, V147, P636, DOI 10.1016/j.ahj.2003.10.041
   BabinEball J, 1996, EUR J CARDIO-THORAC, V10, P412, DOI 10.1016/S1010-7940(96)80107-2
   Bert AA, 2001, J CARDIOTHOR VASC AN, V15, P204, DOI 10.1053/jcan.2001.21959
   Borzak S, 1998, CHEST, V113, P1489, DOI 10.1378/chest.113.6.1489
   Bradley D, 2005, CHEST, V128, p39S, DOI 10.1378/chest.128.2_suppl.39S
   Bucerius J, 2004, J THORAC CARDIOV SUR, V127, P57, DOI 10.1016/S0022-5223(03)01281-9
   BUTLER J, 1993, BRIT HEART J, V70, P56
   Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079
   CASPI J, 1995, ANN THORAC SURG, V59, P942, DOI 10.1016/0003-4975(95)00050-U
   Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Chung MK, 2000, ANN THORAC SURG, V69, P1057, DOI 10.1016/S0003-4975(99)01338-7
   COLQUHOUN IW, 1993, EUR J CARDIO-THORAC, V7, P520, DOI 10.1016/1010-7940(93)90049-H
   CRESWELL LL, 1993, ANN THORAC SURG, V56, P539
   Crystal E, 2004, HEART, V90, P941, DOI 10.1136/hrt.2003.016048
   Crystal E, 2002, CIRCULATION, V106, P75, DOI 10.1161/01.CIR.0000021113.44111.3E
   Cummings JE, 2004, J AM COLL CARDIOL, V43, P994, DOI 10.1016/j.jacc.2003.07.055
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Dagdelen S, 2002, ANN NONINVAS ELECTRO, V7, P211, DOI 10.1111/j.1542-474X.2002.tb00165.x
   Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501
   Daoud EG, 2000, CIRCULATION, V102, P761
   DAUDON P, 1986, AM J CARDIOL, V58, P933, DOI 10.1016/S0002-9149(86)80014-5
   Debrunner M, 2004, EUR J CARDIO-THORAC, V25, P16, DOI 10.1016/S1010-7940(03)00644-4
   Dorge H, 2000, ANN THORAC SURG, V69, P1358, DOI 10.1016/S0003-4975(00)01081-X
   Eagle Kim A, 2004, Circulation, V110, pe340
   EDE AL, 2004, ARQ BRAS CARDIOL, V82, P37
   Ege T, 2004, CHEST, V126, P1559, DOI 10.1378/chest.126.5.1559
   ENGLAND MR, 1992, JAMA-J AM MED ASSOC, V268, P2395, DOI 10.1001/jama.268.17.2395
   Evrard P, 2000, ANN THORAC SURG, V70, P151, DOI 10.1016/S0003-4975(00)01351-5
   Fan K, 2000, CIRCULATION, V102, P755
   FANNING WJ, 1991, ANN THORAC SURG, V52, P529
   Forlani S, 2002, ANN THORAC SURG, V74, P720, DOI 10.1016/S0003-4975(02)03773-6
   Fuster V, 2001, EUR HEART J, V22, P1852, DOI 10.1053/euhj.2001.2983
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Gerstenfeld EP, 2001, J INTERV CARD ELECTR, V5, P275, DOI 10.1023/A:1011412715439
   Gerstenfeld EP, 1999, J AM COLL CARDIOL, V33, P1981, DOI 10.1016/S0735-1097(99)00115-1
   Giri S, 2001, LANCET, V357, P830, DOI 10.1016/S0140-6736(00)04196-9
   Goette A, 2002, PACE, V25, P1072, DOI 10.1046/j.1460-9592.2002.01072.x
   Gold MR, 1996, AM J CARDIOL, V78, P975, DOI 10.1016/S0002-9149(96)00519-X
   Gomes JA, 1999, J AM COLL CARDIOL, V34, P334, DOI 10.1016/S0735-1097(99)00213-2
   Greenberg MD, 2000, J AM COLL CARDIOL, V35, P1416, DOI 10.1016/S0735-1097(00)00610-0
   Guarnieri T, 1999, J AM COLL CARDIOL, V34, P343, DOI 10.1016/S0735-1097(99)00212-0
   GUN C, 1998, J AM COLL CARD SC, P31
   Hakala T, 2005, EUROPACE, V7, P170, DOI 10.1016/j.eupc.2004.12.006
   HARRIS MNE, 1988, BRIT J ANAESTH, V60, P779, DOI 10.1093/bja/60.7.779
   Hazelrigg SR, 2004, ANN THORAC SURG, V77, P824, DOI 10.1016/j.athoracsur.2003.08.027
   HECKER BR, 1985, AM J CARDIOL, V55, P61, DOI 10.1016/0002-9149(85)90300-5
   HOHNLOSER SH, 1991, AM HEART J, V121, P89, DOI 10.1016/0002-8703(91)90960-P
   Holden MP, 1982, NUTR HEART DIS, P273
   IVEY MF, 1983, J THORAC CARDIOV SUR, V85, P214
   Jacquet L, 1994, J Cardiothorac Vasc Anesth, V8, P431, DOI 10.1016/1053-0770(94)90283-6
   JANSSEN J, 1986, ANGIOLOGY, V37, P601, DOI 10.1177/000331978603700807
   Jensen BM, 1997, SCAND CARDIOVASC J, V31, P265, DOI 10.3109/14017439709069546
   Johansson-Synnergren M, 2004, SCAND CARDIOVASC J, V38, P53, DOI 10.1080/14017430410024847
   Kaplan M, 2003, J THORAC CARDIOV SUR, V125, P344, DOI 10.1067/mtc.2003.108
   KARMYJONES R, 1995, ANN THORAC SURG, V59, P502, DOI 10.1016/0003-4975(94)00895-E
   KHURI SF, 1987, AM J CARDIOL, V60, pD51
   KLEINPETER U-M, 1987, European Heart Journal, V8, P137
   Klemperer JD, 1996, ANN THORAC SURG, V61, P1323, DOI 10.1016/0003-4975(96)00102-6
   Kobayashi J, 2005, CIRCULATION, V112, pI338, DOI 10.1161/CIRCULATIONAHA.104.524504
   Kochamba GS, 2000, ANN THORAC SURG, V69, P1466, DOI 10.1016/S0003-4975(00)01142-5
   Kowey PR, 2004, AM J CARDIOL, V94, P663, DOI 10.1016/j.amjcard.2004.05.038
   KOWEY PR, 1992, AM J CARDIOL, V69, P963, DOI 10.1016/0002-9149(92)90802-6
   Kurz DJ, 1999, PACE, V22, P721, DOI 10.1111/j.1540-8159.1999.tb00535.x
   LAMB RK, 1988, EUR HEART J, V9, P32
   LAUB GW, 1993, CRIT CARE MED, V21, P1474, DOI 10.1097/00003246-199310000-00014
   Lazar HL, 1997, J THORAC CARDIOV SUR, V113, P354, DOI 10.1016/S0022-5223(97)70333-7
   Lazar HL, 2000, ANN THORAC SURG, V70, P145, DOI 10.1016/S0003-4975(00)01317-5
   Lee SH, 2000, ANN THORAC SURG, V70, P157, DOI 10.1016/S0003-4975(00)01308-4
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Levy T, 2000, CIRCULATION, V102, P1382
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Lucio Ede A, 2004, ARQ BRAS CARDIOL, V82, P42
   Maras D, 2001, Am Heart J, V141, pE8, DOI 10.1067/mhj.2001.114201
   MARTINUSSEN HJ, 1988, THORAC CARDIOV SURG, V36, P206, DOI 10.1055/s-2007-1020079
   MATANGI MF, 1985, J THORAC CARDIOV SUR, V89, P439
   MATANGI MF, 1989, CAN J CARDIOL, V5, P229
   MATERNE P, 1985, INT J CARDIOL, V8, P275, DOI 10.1016/0167-5273(85)90219-0
   Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720
   Matsuura K, 2001, Jpn J Thorac Cardiovasc Surg, V49, P614
   MCCARTY RJ, 1966, CIRCULATION, V34, P792
   Melo J, 2004, J THORAC CARDIOV SUR, V127, P511, DOI 10.1016/S0022-5223(03)01283-2
   MERRICK AF, 1995, EUR J CARDIO-THORAC, V9, P146, DOI 10.1016/S1010-7940(05)80062-4
   Mitchell LB, 2005, JAMA-J AM MED ASSOC, V294, P3093, DOI 10.1001/jama.294.24.3093
   MOHR R, 1981, J THORAC CARDIOV SUR, V81, P840
   Mullis-Jansson SL, 1999, J THORAC CARDIOV SUR, V117, P1128, DOI 10.1016/S0022-5223(99)70249-7
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   MYHRE ESP, 1984, J CARDIOVASC SURG, V25, P348
   NEWMAN T, 2001, EUROSPACE S, V2, pB202
   Nurozler F, 1996, J CARDIAC SURG, V11, P421, DOI 10.1111/j.1540-8191.1996.tb00076.x
   Nygard E, 2004, J CARDIOTHOR VASC AN, V18, P709, DOI 10.1053/j.jvca.2004.08.006
   NYSTROM U, 1993, THORAC CARDIOV SURG, V41, P34, DOI 10.1055/s-2007-1013817
   OKA Y, 1980, AM HEART J, V99, P255, DOI 10.1016/0002-8703(80)90774-7
   ORMEROD OJM, 1984, BRIT HEART J, V51, P618
   ORR WP, 1999, PACE, V22, P755
   Paparella D, 2006, J THORAC CARDIOV SUR, V131, P290, DOI 10.1016/j.jtcvs.2005.10.018
   PARIKKA H, 1993, EUR HEART J, V14, P251
   Parikka H, 1998, J CARDIOVASC PHARM, V31, P67, DOI 10.1097/00005344-199801000-00010
   PATTI G, 2006, J AM COLL CARDIOL S, V47, pD29
   Paull DL, 1997, AM J SURG, V173, P419, DOI 10.1016/S0002-9610(97)00077-9
   Pfisterer ME, 1997, ANN THORAC SURG, V64, P1113, DOI 10.1016/S0003-4975(97)00804-7
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Quader MA, 2004, ANN THORAC SURG, V77, P1514, DOI 10.1016/j.athoracsur.2003.09.069
   Rastan AJ, 2005, EUR J CARDIO-THORAC, V27, P1057, DOI 10.1016/j.ejcts.2005.03.007
   Redle JD, 1999, AM HEART J, V138, P144, DOI 10.1016/S0002-8703(99)70260-7
   REED GL, 1988, NEW ENGL J MED, V319, P1246, DOI 10.1056/NEJM198811103191903
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   RUBIN DA, 1987, J THORAC CARDIOV SUR, V94, P331
   SALAZAR C, 1979, ANGIOLOGY, V30, P816, DOI 10.1177/000331977903001204
   Sanjuan R, 2004, ANN THORAC SURG, V77, P838, DOI 10.1016/j.athoracsur.2003.06.014
   Schwieger I M, 1989, J Cardiothorac Anesth, V3, P18, DOI 10.1016/0888-6296(89)90761-8
   Shakerinia T, 1996, CAN J SURG, V39, P397
   SILVERMAN NA, 1982, ANN SURG, V196, P194, DOI 10.1097/00000658-198208000-00012
   Solomon AJ, 2001, AM HEART J, V142, P811, DOI 10.1067/mhj.2001.118738
   Solomon AJ, 2000, ANN THORAC SURG, V69, P126, DOI 10.1016/S0003-4975(99)01187-X
   Speziale G, 2000, THORAC CARDIOV SURG, V48, P22, DOI 10.1055/s-2000-12141
   STEPHENSON LW, 1980, ANN THORAC SURG, V29, P113
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   SUTTORP MJ, 1990, J THORAC CARDIOV SUR, V100, P921
   SUTTORP MJ, 1991, AM J CARDIOL, V68, P1163, DOI 10.1016/0002-9149(91)90188-Q
   Tamis JE, 2000, CLIN CARDIOL, V23, P155
   Tokmakoglu H, 2002, EUR J CARDIO-THORAC, V21, P401, DOI 10.1016/S1010-7940(02)00006-4
   Toraman F, 2001, ANN THORAC SURG, V72, P1256, DOI 10.1016/S0003-4975(01)02898-3
   Treggiari-Venzi MM, 2000, BRIT J ANAESTH, V85, P690, DOI 10.1093/bja/85.5.690
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   VECHT RJ, 1986, INT J CARDIOL, V13, P125, DOI 10.1016/0167-5273(86)90137-3
   Velissaris T, 2003, EUR J CARDIO-THORAC, V23, P917, DOI 10.1016/S1010-7940(03)00167-2
   Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023
   Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043
   Weber UK, 1998, J CARDIOVASC PHARM T, V3, P209
   Wenke K, 1999, Z KARDIOL, V88, P647, DOI 10.1007/s003920050340
   White CM, 2003, CIRCULATION, V108, P200, DOI 10.1161/01.cir.0000087445.59819.6f
   WHITE HD, 1984, CIRCULATION, V70, P479
   Wijeysundera DN, 2003, J AM COLL CARDIOL, V41, P1496, DOI 10.1016/S0735-1097(03)00191-8
   WILLIAMS JB, 1982, ANN THORAC SURG, V34, P435
   Wistbacka J O, 1992, J Cardiothorac Vasc Anesth, V6, P521, DOI 10.1016/1053-0770(92)90093-M
   Wollert HG, 1997, THORAC CARDIOV SURG, V45, P213, DOI 10.1055/s-2007-1013729
   Yagdi T, 2003, J THORAC CARDIOV SUR, V125, P1420, DOI 10.1016/S0022-5223(02)73292-3
   Yared JP, 2000, ANN THORAC SURG, V69, P1420, DOI 10.1016/S0003-4975(00)01180-2
   Yazigi A, 2002, J CARDIOTHOR VASC AN, V16, P603, DOI 10.1053/jcan.2002.126956
   Yeatman M, 2002, ANN THORAC SURG, V73, P112, DOI 10.1016/S0003-4975(01)03270-2
   YILMAZ C, 2000, BR J ANAESTH S1, V84, P37
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 148
TC 107
Z9 110
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
J9 EUR HEART J
JI Eur. Heart J.
PD DEC
PY 2006
VL 27
IS 23
BP 2846
EP 2857
DI 10.1093/eurheartj/ehl272
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 111RN
UT WOS:000242472100018
PM 17015402
ER

PT J
AU Vicini, FA
   Kestin, LL
   Martinez, AA
AF Vicini, FA
   Kestin, LL
   Martinez, AA
TI The importance of adequate follow-up in defining treatment success after
   external beam irradiation for prostate cancer
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate; prostatic neoplasms; prostate-specific antigen; radiotherapy;
   biochemical failure
ID DISEASE-FREE SURVIVAL; RADIATION-THERAPY; POSTTREATMENT EVALUATION;
   BIOCHEMICAL FAILURE; ANTIGEN NADIR; DOUBLING TIME; PSA NADIR;
   RADIOTHERAPY; KINETICS; LEVEL
AB Purpose: We reviewed our institution's experience treating patients with localized prostate cancer with external beam radiation therapy (RT) to determine how differences in the length of follow-up affect the determination of treatment outcome using the American Society for Therapeutic Radiology and Oncology (ASTRO) Consensus Panel Definition of biochemical failure (BF).
   Methods and Materials: From January 1987 through December 1997, 1109 patients with localized prostate cancer were treated with definitive external beam RT at William Beaumont Hospital, Royal Oak, Michigan. All patients received external beam RT to a median total prostate dose of 66.6 Gy (range: 59.4-70.4 Gy). A total of 1096 patients (99%) had sufficient prostate-specific antigen (PSA) follow-up to determine their biochemical status. To test the impact of differences in follow-up on the calculation of BF, 389 patients with at least 5 years of PSA follow-up were selected as the reference group for the initial analysis. BF was then retrospectively determined using the Consensus Panel definition at yearly intervals, ignoring the remainder of each patient's follow-up. The median follow-up for this group of patients was 6.6 years (range: 5.0-11.6 years). In a second analysis, patient cohorts were randomly selected with varying median PSA follow-up intervals in order to more accurately represent a population whose follow-up is distributed continuously over a defined range. Seven cohorts were randomly selected with 200 patients in each cohort. Cohorts were individually identified such that half of the patients (100) had 2 years or less follow-up than the stated time point for analysis and half (100) had up to 2 years more follow-up than the time point chosen for analysis. For example, in the cohort with a median follow-up of 3 years, 100 patients with a PSA follow-up from 1 to 3 years were randomly selected, and 100 patients with a follow-up from 3 to 5 years were randomly selected, thus generating a median follow-up of 3 years for this cohort (range: 1 to 5 years). This process was repeated five times for five random samples of seven cohorts each. Biochemical failure was calculated according to the Consensus Panel definition.
   Results: In the first analysis, significantly different rates of biochemical control (varying by 6-21%) were calculated for the same actuarial year chosen for analysis depending only upon the length of follow-up used. For example, the 3-year actuarial rate of biochemical control (BC) varied from 71% when calculated with 3 years of follow-up versus 50.4% with 7 years (p < 0.01). These differences in actuarial rates of BC were observed in all subsets of patients analyzed (e.g., PSA < 10, Gleason less than or equal to 6, n = 132,p < 0.001; PSA < 10, Gleason greater than or equal to 7, n = 33, p = 0.03; PSA greater than or equal to 10, Gleason less than or equal to 6, n = 109, p < 0.001; and PSA greater than or equal to 10, Gleason greater than or equal to 7, n = 72, p = 0.002). The absolute magnitude of the difference in actuarial rates of BC was greatest during years 2 (range 18-30%), 3 (range 16-25%), and 4 (range 15-24%) after treatment. In the second analysis using median PSA follow-ups las defined above), statistically significant differences in actuarial rates of BC were again observed. For example, the 3-year actuarial rate of BC varied from 74.8% with a median follow-up of 2 years versus 49.2% with a median follow-up of 6 years. These dramatic differences in BC were still observed beyond 5 years.
   Conclusion: When the ASTRO Consensus Panel definition of BF is used to calculate treatment success with external beam RT for prostate cancer, adequate follow-up is critical. Depending upon the length of time after treatment, significantly different rates of BC (varying by 15% to 30%) can be calculated for the same time interval chosen for analysis. These results suggest that data should only be reported if the length of follow-up extends at least beyond the time point at which actuarial results are examined for the majority of patients. (C) 1999 Elsevier Science Inc.
C1 William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
RP Vicini, FA (reprint author), William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Aref I, 1998, RADIOTHER ONCOL, V48, P203, DOI 10.1016/S0167-8140(98)00061-9
   CHODAK GW, 1990, UROLOGY, V35, P288, DOI 10.1016/0090-4295(90)80147-F
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   DAMICO AV, 1993, CANCER, V72, P2638, DOI 10.1002/1097-0142(19931101)72:9<2638::AID-CNCR2820720919>3.0.CO;2-N
   DAMICO AV, 1995, INT J RADIAT ONCOL, V32, P473, DOI 10.1016/0360-3016(94)00606-L
   Ennis RD, 1998, INT J RADIAT ONCOL, V41, P511, DOI 10.1016/S0360-3016(98)00104-7
   FLEMING ID, 1998, AJCC CANC STAGING MA, P203
   GOAD JR, 1993, UROL CLIN N AM, V20, P727
   HANCOCK SL, 1995, J UROLOGY, V154, P1412, DOI 10.1016/S0022-5347(01)66879-4
   HANKS GE, 1993, INT J RADIAT ONCOL, V27, P125
   Hanlon AL, 1998, CANCER, V83, P130, DOI 10.1002/(SICI)1097-0142(19980701)83:1<130::AID-CNCR17>3.3.CO;2-M
   Horwitz EM, 1998, INT J RADIAT ONCOL, V41, P267, DOI 10.1016/S0360-3016(98)00078-9
   Horwitz EM, 1996, INT J RADIAT ONCOL, V36, P565, DOI 10.1016/S0360-3016(96)00360-4
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KAPLAN ID, 1993, J UROLOGY, V149, P519
   Kuban DA, 1998, SEMIN RADIAT ONCOL, V8, P72, DOI 10.1016/S1053-4296(98)80002-7
   KUBAN DA, 1995, INT J RADIAT ONCOL, V32, P307, DOI 10.1016/0360-3016(95)00137-N
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   McLaughlin PW, 1996, J CLIN ONCOL, V14, P2889
   RITTER MA, 1992, J CLIN ONCOL, V10, P1208
   RUSSELL KJ, 1991, J UROLOGY, V146, P1046
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Schellhammer PF, 1997, UROL CLIN N AM, V24, P407, DOI 10.1016/S0094-0143(05)70387-6
   STAMEY TA, 1994, J UROLOGY, V152, P492
   WILLETT CG, 1994, J UROLOGY, V151, P1579
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   ZAGARS GK, 1993, CANCER, V72, P538, DOI 10.1002/1097-0142(19930715)72:2<538::AID-CNCR2820720234>3.0.CO;2-S
   ZEITMAN AL, 1993, CANCER, V71, P959
   ZEITMAN AL, 1999, INT J RADIAT ONCOL, V43, P715
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
NR 38
TC 106
Z9 108
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD OCT 1
PY 1999
VL 45
IS 3
BP 553
EP 561
DI 10.1016/S0360-3016(99)00235-7
PG 9
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 243EA
UT WOS:000082983000006
PM 10524405
ER

PT J
AU PINCHES, GE
   MINGO, KA
AF PINCHES, GE
   MINGO, KA
TI MULTIVARIATE ANALYSIS OF INDUSTRIAL BOND RATINGS
SO JOURNAL OF FINANCE
LA English
DT Article
C1 UNIV MISSOURI,COLUMBIA,MO 65201.
   OKLAHOMA STATE UNIV,STILLWATER,OK 74074.
CR ALTMAN EI, 1968, J FINANC, V23, P589, DOI 10.2307/2978933
   Anderson T.W., 1958, INTRO MULTIVARIATE S
   Atkinson T. R., 1967, TRENDS CORPORATE BON
   Bruning J. L., 1968, COMPUTATIONAL HDB ST
   CARLETON WT, 1969, J MONEY CREDIT BANK, V1, P750, DOI 10.2307/1991449
   COOLEY WW, 1971, MULTIVARIATE DATA AN
   DIXON WJ, 1971, BMD BIOMEDICAL COMPU
   EDMISTER RO, 1972, J FINANC QUANT ANAL, V7, P1477, DOI 10.2307/2329929
   ESOKAIT AC, 1970, FORBES          0901, V106, P19
   FISHER L, 1959, J POLIT ECON, V67, P217, DOI 10.1086/258172
   FRANK RE, 1965, J MARKETING RES, V2, P250, DOI 10.2307/3150183
   GILBERT ES, 1968, J AM STAT ASSOC, V63, P1399, DOI 10.2307/2285893
   Goodman R. M., 1968, FINANCIAL ANAL J, V24, P59, DOI 10.2469/faj.v24.n3.59
   Harold G, 1938, BOND RATINGS INVESTM
   HICKMAN WB, 1958, CORPORATE BONDS QUAL
   HILLS M, 1967, APPLIED STATISTICS, V16, P237, DOI 10.2307/2985920
   HORRIGAN JO, 1966, J ACCOUNTING RES, V4, P44, DOI 10.2307/2490168
   HORTON JH, 1970, J BANK RES, V1, P29
   LINHART H, 1959, METRIKA, V2, P138, DOI 10.1007/BF02613730
   MOODY, 1970, WALL STREET J   1001, P2
   MOODY, 1968, MOODYS BOND SURVEY
   MOODY, 1969, MOODYS INDUSTRIAL MA
   MOODY, 1967, MOODYS BOND SURVEY
   MOODY, 1969, MOODYS BOND SURVEY
   MORRISON DG, 1969, J MARKETING RES, V6, P156, DOI 10.2307/3149666
   Mosteller F., 1954, HDB SOCIAL PSYCHOL, VI, P289
   PACKER SB, 1968, FINANCIAL ANAL J, V24, P93, DOI 10.2469/faj.v24.n4.93
   PINCHES GE, TO BE PUBLISHED
   POGUE TF, 1969, J FINANC QUANT ANAL, V4, P201, DOI 10.2307/2329840
   RADHAKISHNARAO C, 1952, ADVANCED STATISTICAL
   Rummel R. J., 1970, APPLIED FACTOR ANALY
   SIMKOWITZ M, 1971, SO J BUSINESS, V6, P1
   SMITH KV, 1965, 101 PURD U I RES BEH
   TATSUOKA MM, 1971, MULTIVARIATE ANALYSI
   West R, 1970, J ACCOUNT RES, P118
   WILLIAMS WH, 1971, J FINANC QUANT ANAL, V6, P1095, DOI 10.2307/2329608
   1966, BUSINESS MANAGEMENT, V29, P38
   1971, WALL STREET J   0813, P15
NR 38
TC 106
Z9 107
PU BLACKWELL PUBL LTD
PI OXFORD
PA 108 COWLEY RD, OXFORD, OXON, ENGLAND OX4 1JF
SN 0022-1082
J9 J FINANC
JI J. Financ.
PY 1973
VL 28
IS 1
BP 1
EP 18
DI 10.2307/2978164
PG 18
WC Business, Finance
SC Business & Economics
GA P2477
UT WOS:A1973P247700001
ER

PT J
AU Bigler, ED
AF Bigler, Erin D.
TI Neuropsychology and clinical neuroscience of persistent post-concussive
   syndrome
SO JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
LA English
DT Review
DE concussion; mild TBI; biomechanics; neuroimaging. neuropathology;
   neuropsychology
ID TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; DIFFUSE AXONAL INJURY;
   POSTTRAUMATIC-STRESS-DISORDER; CONTROLLED CORTICAL IMPACT; AMYLOID
   PRECURSOR PROTEIN; SPORTS-RELATED CONCUSSION; NEURON-SPECIFIC ENOLASE;
   MILD HEAD; POSTCONCUSSION SYNDROME
AB On the mild end of the acquired brain injury spectrum, the terms concussion and mild traumatic brain injury (mTBI) have been used interchangeably, where persistent post-concussive syndrome (PPCS) has been a label given when symptoms persist for more than three months post-concussion. Whereas it brief history Of Concussion research is overviewed, the focus of this review is on the Current status of PPCS as a clinical entity from the perspective of recent advances in the biomechanical modeling of concussion in human and animal studies, particularly directed at a better understanding of the neuropathology associated with concussion. These studies implicate common regions of injury, including the upper brainstem, base of the frontal lobe, hypothalamic-pituitary axis, medial temporal lobe, fornix, and corpus callosum. Limitations of Current neuropsychological techniques for the clinical assessment of memory and executive function are explored and recommendations for improved research designs offered, that may enhance the Study of long-term neuropsychological sequelae of concussion.
C1 [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.
   [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA.
   [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA.
   [Bigler, Erin D.] Univ Utah, Utah Brain Inst, Salt Lake City, UT USA.
RP Bigler, ED (reprint author), Brigham Young Univ, Dept Psychol, 1190D SWKT, Provo, UT 84602 USA.
EM erin_bigler@byu.edu
FU National institutes of Health [I R01 HD048946-01A2]; Ira Fulton
   Foundation
FX The information in this manuscript and the manuscript itself is new and
   original and has never been published whether electronically or in
   print. The author also acknowledges the support in part by the National
   institutes of Health federal grant I R01 HD048946-01A2 and the Ira
   Fulton Foundation. The technical assistance of Tracy Abildskov and Craig
   Vickers and the editorial assistance of Jo Ann Petrie are also
   gratefully acknowledged.
CR Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284
   Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu/2006.0133
   Alfano DP, 2006, BRAIN COGNITION, V60, P194
   Allet JL, 2006, CURR OPIN PSYCHIATR, V19, P413, DOI 10.1097/01.yco.0000228764.25732.21
   American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010
   ANDERSEN R, 2006, HIPPOCAMPUS BOOK
   Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812
   Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583]
   Ashman TA, 2006, MT SINAI J MED, V73, P999
   Ashwal S, 2006, ARCH PHYS MED REHAB, V87, P50, DOI 10.1016/j.apmr.2006.07.275
   Atmaca M, 2006, PROG NEURO-PSYCHOPH, V30, P708, DOI 10.1016/j.pnpbp.2006.01.011
   Bach-y-Rita Paul, 2004, Journal of Integrative Neuroscience, V3, P3, DOI 10.1142/S0219635204000336
   Barrow IM, 2006, J TRAUMA, V61, P1142, DOI 10.1097/01.ta.0000241238.70269.c1
   Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445
   Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102
   Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845
   Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163
   Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207
   Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158
   Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277
   Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546
   Berker E, 1996, INT J NEUROSCI, V85, P195, DOI 10.3109/00207459608986683
   Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400
   Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7
   Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1
   BIGLER ED, 2005, STRUCTURAL IMAGING
   Bigler ED, 2006, ARCH CLIN NEUROPSYCH, V21, P503, DOI 10.1016/j.acn.2006.03.008
   Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515
   Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870
   BLINKOV SM, 1992, J NEUROSURG, V76, P973, DOI 10.3171/jns.1992.76.6.0973
   Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D
   BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565
   BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4
   Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350
   Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4
   Broglio SP, 2007, NEUROSURGERY, V60, P1057
   Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0
   Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024
   Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4
   Buki A, 2006, ACTA NEUROCHIR WIEN, V148, P193
   Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9
   Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B
   Carroll L, 2004, J REHABIL MED S, V43, P113, DOI DOI 10.1080/16501960410023877
   CARROLL LJ, 2004, J REHABIL MED S, V43, P84, DOI DOI 10.1080/16501960410023859
   Casanueva F F, 2006, J Endocrinol Invest, V29, P764
   Casson Ira R, 2006, Neurosurgery, V59, pE1152
   Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795
   CERNICH A, 2007, ARCH CLIN NEUROPS S1, V14, pS101
   Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33
   Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296
   Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050150209156
   Chan RCK, 2005, BRAIN INJURY, V19, P1117, DOI 10.1080/026990500150088
   Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656
   Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002
   Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326
   Cheng TO, 2007, INT J CARDIOL, V123, P1, DOI 10.1016/j.ijcard.2006.12.023
   Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212
   Cohen BA, 2007, AM J NEURORADIOL, V28, P907
   Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155
   Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003
   Crawford MA, 2007, J INT NEUROPSYCH SOC, V13, P178, DOI 10.1017/S135561770707021X
   Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001
   Crosby EC, 1982, COMP CORRELATIVE NEU
   Das RR, 2005, NEW ENGL J MED, V353, P633
   de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727
   Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020
   de Lange FP, 2004, BRAIN, V127, P1948, DOI 10.1093/brain/awh225
   De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766
   Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300
   Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007
   Dockree PM, 2006, BRAIN, V129, P128, DOI 10.1093/brain/awh664
   Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x
   Duff D, 2001, Axone, V23, P18
   Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045
   Elliott MR, 2006, J TRAUMA, V61, P1244, DOI 10.1097/01.ta.0000195983.48529.0d
   EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056
   Fijalkowski RJ, 2006, BIOMED SCI INSTRUM, V42, P108
   Frater CJ, 2003, CLIN NUCL MED, V28, P699, DOI 10.1097/01.RLU.0000079435.08459.93
   Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328
   Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X
   Gale S D, 1995, J Int Neuropsychol Soc, V1, P17
   Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1
   Ghaffar O, 2006, NEUROLOGY, V67, P2036, DOI 10.1212/01.wnl.0000247275.68402.fc
   Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163
   Gowda NK, 2006, AM J NEURORADIOL, V27, P447
   GRONWALL D, 1975, LANCET, V2, P995
   Guigon E, 2007, J NEUROPHYSIOL, V97, P331, DOI 10.1152/jn.00290.2006
   Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011
   Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280
   Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5
   Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252
   Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195
   Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095
   Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066
   Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354
   Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013
   Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x
   HOLM LW, 2006, J RHEUMATOL, V34, P193
   Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607
   Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x
   HOVDA DA, 2004, TRAUMATIC BRAIN INJU
   Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072
   Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030
   Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298
   Inglese M, 2005, AM J NEURORADIOL, V26, P719
   Ivarsson J, 2002, J BIOMECH ENG-T ASME, V124, P422, DOI 10.1115/1.1485752
   IVERSON GI, 2007, POSTCONCUSSION DISOR
   Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651
   Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139
   Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae
   Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008
   Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910
   Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1080/13803390490918435
   Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006
   Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd
   Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738
   Johansen VA, 2006, NORD J PSYCHIAT, V60, P452, DOI 10.1080/08039480601021886
   Johansson Bengt H, 2006, Pain Res Manag, V11, P197
   Karp JF, 2006, PAIN MED, V7, P444, DOI 10.1111/j.1526-4637.2006.00212.x
   KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567
   Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036
   KEANE JR, 1992, NEUROL CLIN, V10, P849
   Keleştimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3
   Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928
   Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989
   Kennedy RE, 2006, J HEAD TRAUMA REHAB, V21, P260
   Kent D, 2007, AM SCI, V95, P60, DOI 10.1511/2007.63.1016
   Kercel Stephen W., 2005, Journal of Integrative Neuroscience, V4, P551, DOI 10.1142/S021963520500094X
   KERTESZ AG, 2003, RECOVERY COGNITION
   Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012
   King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276
   Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043
   Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7
   Kozora E, 2006, ARTHRIT RHEUM-ARTHR, V55, P628, DOI 10.1002/art.22101
   Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196
   Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859
   Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007
   Leker RR, 2002, ACT NEUR S, V83, P49
   Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396
   LEVY A, 1992, Brain Injury, V6, P401, DOI 10.3109/02699059209008136
   Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0
   Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27
   Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44
   Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384
   Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327
   MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509
   Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c
   Mai J.K., 2004, ATLAS HUMAN BRAIN
   Manville J, 2007, J MOL NEUROSCI, V31, P95, DOI 10.1385/JMN/31:02:95
   de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2
   Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702004570
   McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775
   McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450
   McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016
   McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71
   McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556
   McCrory P, 2005, BRIT J SPORT MED, V39, P196, DOI 10.1136/bjsm.2005.018614
   McCrory PR, 2000, NEUROLOGY, V54, P1488
   McCrory PR, 2001, NEUROLOGY, V57, P2283
   McDonald TJ, 2006, EXP NEUROL, V200, P532, DOI 10.1016/j.expneurol.2006.02.114
   McHugh T, 2006, BRAIN COGNITION, V60, P209
   MEARES S, J NEUROLOGY IN PRESS
   Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978
   Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297
   MILLER H, 1961, BRIT MED J, V1, P919
   Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003
   Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286
   Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264
   Moritz S, 2004, J INT NEUROPSYCH SOC, V10, P623, DOI 10.1017/S1355617704104153
   Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4
   Moucha R, 2006, PROG BRAIN RES, V157, P111, DOI 10.1016/S0079-6123(06)57007-4
   Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040
   O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075
   Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279
   Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431
   O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9
   Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102
   Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED
   Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f
   PAGE JD, 1947, ABNORMAL PSYCHOL CLI
   Park E, 2006, J NEUROPATH EXP NEUR, V65, P226
   Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761
   Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D
   Pellman EJ, 2004, NEUROSURGERY, V55, P873
   Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44
   Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76
   Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/Neurocrit.Care2006;05:61-70
   Priestley JV, 2007, BRAIN, V130, P895, DOI 10.1093/brain/awm041
   Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P359
   Racette BA, 2006, NEUROLOGY, V67, P2124, DOI 10.1212/01.wnl.0000249306.85048.86
   Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379
   Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001
   Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014
   Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645
   Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477
   Ross SR, 2006, J CLIN EXP NEUROPSYC, V28, P111, DOI 10.1080/13803390590929270
   Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104
   Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x
   Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124
   Ruff RM, 1999, BRAIN INJURY, V13, P943
   Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009
   Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692
   Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870
   Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x
   Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2
   Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730
   Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418
   Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85
   Schonfeldt-Lecuona C, 2006, J CLIN NEUROPHYSIOL, V23, P472
   Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728
   Schweinhardt P, 2006, CURR OPIN NEUROL, V19, P392, DOI 10.1097/01.wco.0000236620.89710.63
   Shaw K, 2002, LOCAL GOV STUD, V28, P1
   Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864
   Silver J. M., 2005, TXB TRAUMATIC BRAIN
   Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004
   Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188
   SMITH DH, 2006, PSYCHOSOMATICS, V47, P272
   Smith DH, 2006, PSYCHOSOMATICS, V47, P271, DOI 10.1176/appi.psy.47.3.271
   Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982
   Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910
   Stern Y., 2007, COGNITIVE RESERVE TH
   Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7
   Stonnington CM, 2006, AM J PSYCHIAT, V163, P1510, DOI 10.1176/appi.ajp.163.9.1510
   Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5
   Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001
   Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y
   Tagliaferri F, 2006, ACTA NEUROCHIR WIEN, P148
   Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851
   Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x
   Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032
   Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25
   Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000
   Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046
   Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db
   Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5
   Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5
   Van Hoesen GW, 1999, ANN NY ACAD SCI, V877, P575
   Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519
   Vasterling JJ, 2006, PHILOS T ROY SOC B, V361, P593, DOI 10.1098/rstb.2006.1819
   Veltmeyer Melinda D., 2005, Journal of Integrative Neuroscience, V4, P145, DOI 10.1142/S0219635205000719
   Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9
   Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B
   VICK NA, 1976, GRINKERS NEUROLOGY
   Vorst MV, 2007, J TRAUMA, V62, P199, DOI 10.1097/01.ta.0000238665.09611.4b
   Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   Ward N S, 2003, Cogn Neuropsychiatry, V8, P295, DOI 10.1080/13546800344000200
   Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398
   Warden DL, 2005, NEW ENGL J MED, V353, P633
   WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x
   Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105
   Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294
   Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079
   WILDE EA, NEUROLOGY IN PRESS
   Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412
   Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.2310/7010.2006.00152
   Williams ED, 2006, EJC SUPPL, V4, P15, DOI 10.1016/S1359-6349(06)70042-8
   Wood PB, 2005, INT REV NEUROBIOL, V67, P119, DOI 10.1016/S0074-7742(05)67005-5
   Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014
   WOOD RL, 2007, J NEUROL NEUROSUR PS, V78, P522
   Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906
   Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118
   Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134
   Zasler N.D., 2007, BRAIN INJURY MED
   Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277
   Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501
   Zhang L, 2006, AM J NEURORADIOL, V27, P2000
   Zhu Q, 2006, DEV NEUROSCI-BASEL, V28, P388, DOI 10.1159/000094165
   Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383
   Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099
   Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4
   ZUMSTEG D, 2006, SCIENCE, V33, P379
NR 275
TC 105
Z9 106
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1355-6177
J9 J INT NEUROPSYCH SOC
JI J. Int. Neuropsychol. Soc.
PD JAN
PY 2008
VL 14
IS 1
BP 1
EP 22
DI 10.1017/S135561770808017X
PG 22
WC Clinical Neurology; Neurosciences; Psychiatry; Psychology
SC Neurosciences & Neurology; Psychiatry; Psychology
GA 338VI
UT WOS:000258537100001
PM 18078527
ER

PT J
AU Sellke, FW
   Dimaio, JM
   Caplan, LR
   Ferguson, TB
   Gardner, TJ
   Hiratzka, LF
   Isselbacher, EM
   Lytle, BW
   Mack, MJ
   Murkin, JM
   Robbins, RC
AF Sellke, FW
   Dimaio, JM
   Caplan, LR
   Ferguson, TB
   Gardner, TJ
   Hiratzka, LF
   Isselbacher, EM
   Lytle, BW
   Mack, MJ
   Murkin, JM
   Robbins, RC
TI Comparing on-pump and off-pump coronary artery bypass grafting -
   Numerous studies but few conclusions - A scientific statement from the
   American Heart Association Council on Cardiovascular Surgery and
   Anesthesia in Collaboration with the Interdisciplinary Working Group on
   Quality of Care and Outcomes Research
SO CIRCULATION
LA English
DT Article
DE AHA Scientific Statements; grafting; trials; morbidity; mortality
ID HIGH-RISK PATIENTS; LEFT-VENTRICULAR DYSFUNCTION; CARDIOPULMONARY
   BYPASS; RANDOMIZED-TRIAL; MYOCARDIAL REVASCULARIZATION; MIDTERM
   OUTCOMES; SHORT-TERM; MORTALITY; DISEASE; METAANALYSIS
AB One of the most hotly debated and polarizing issues in cardiac surgery has been whether coronary artery bypass grafting (CABG) without the use of cardiopulmonary bypass or cardioplegia (off-pump CABG, or OPCAB) is superior to that performed with the heart-lung machine and the heart's being chemically arrested (standard CABG). Various clinical trials are reviewed comparing the 2 surgical strategies, including several large retrospective analyses, meta-analyses, and the randomized trials that address different aspects of standard CABG and OPCAB. Although definitive conclusions about the relative merits of standard CABG and OPCAB are difficult to reach from these varied randomized and nonrandomized studies, several generalizations may be possible. Patients may achieve an excellent outcome with either type of procedure, and individuals' outcomes likely depend more on factors other than whether they underwent standard CABG or OPCAB. Nevertheless, there appear to be trends in most studies. These trends include less blood loss and need for transfusion after OPCAB, less myocardial enzyme release after OPCAB up to 24 hours, less early neurocognitive dysfunction after OPCAB, and less renal insufficiency after OPCAB. Fewer grafts tend to be performed with OPCAB than with standard CABG. Length of hospital stay, mortality rate, and long-term neurological function and cardiac outcome appear to be similar in the 2 groups. To definitively answer the remaining questions of whether either strategy is superior and in which patients, a large-scale prospective randomized trial is required.
EM kgray@lww.com
CR Al-Ruzzeh S, 2003, ANN THORAC SURG, V76, P444, DOI 10.1016/S0003-4975(03)00348-5
   Ascione R, 2003, ANN THORAC SURG, V76, P793, DOI 10.1016/S0003-4975(03)00664-7
   Bittner HB, 2002, ANN THORAC SURG, V74, P115, DOI 10.1016/S0003-4975(02)03646-9
   Chamberlain MH, 2002, ANN THORAC SURG, V73, P1866, DOI 10.1016/S0003-4975(02)03550-6
   Edgerton JR, 2003, ANN THORAC SURG, V76, P1138, DOI 10.1016/S0003-4975(03)00747-1
   Gaudino M, 2004, ANN THORAC SURG, V77, P574, DOI 10.1016/S0003-4975(03)01534-0
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Hirose H, 2001, ANN THORAC SURG, V72, P2013, DOI 10.1016/S0003-4975(01)03147-2
   Hoff SJ, 2002, ANN THORAC SURG, V74, pS1340
   JIN R, IN PRESS CIRCULATION
   Keizer AMA, 2003, ANN THORAC SURG, V75, P835, DOI 10.1016/S0003-4975(02)04541-1
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Locker C, 2003, ANN THORAC SURG, V76, P771, DOI 10.1016/S0003-4975(03)00732-X
   Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9
   Mack MJ, 2004, J THORAC CARDIOV SUR, V127, P167, DOI 10.1016/j.jtcvs.2003.08.032
   Meharwal ZS, 2002, ANN THORAC SURG, V74, pS1353
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Racz MJ, 2004, J AM COLL CARDIOL, V43, P557, DOI 10.1016/j.jacc.2003.09.045
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Sabik JF, 2004, J THORAC CARDIOV SUR, V127, P142, DOI 10.1016/j.jtcvs.2003.08.046
   Sharony R, 2004, J THORAC CARDIOV SUR, V127, P406, DOI 10.1016/j.jtcvs.2003.08.011
   Sharony R, 2003, CIRCULATION, V108, P15, DOI 10.1161/01.cir.0000087448.65888.21
   Shennib H, 2002, ANN THORAC SURG, V74, pS1344
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
NR 29
TC 105
Z9 113
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD MAY 31
PY 2005
VL 111
IS 21
BP 2858
EP 2864
DI 10.1161/CIRCULATIONAHA.105.165030
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 931DE
UT WOS:000229465200022
PM 15927994
ER

PT J
AU LETTE, J
   TATUM, JL
   FRASER, S
   MILLER, DD
   WATERS, DD
   HELLER, G
   STANTON, EB
   BOM, HS
   LEPPO, J
   NATTEL, S
AF LETTE, J
   TATUM, JL
   FRASER, S
   MILLER, DD
   WATERS, DD
   HELLER, G
   STANTON, EB
   BOM, HS
   LEPPO, J
   NATTEL, S
TI SAFETY OF DIPYRIDAMOLE TESTING IN 73,806 PATIENTS - THE MULTICENTER
   DIPYRIDAMOLE SAFETY STUDY
SO JOURNAL OF NUCLEAR CARDIOLOGY
LA English
DT Article
DE DIPYRIDAMOLE; STRESS TESTING; RADIONUCLIDE IMAGING; CORONARY HEART
   DISEASE; CORONARY HYPEREMIA VASODILATION; ASTHMA
ID CORONARY-ARTERY DISEASE; MYOCARDIAL PERFUSION TOMOGRAPHY; CEREBRAL
   BLOOD-FLOW; INTRAVENOUS DIPYRIDAMOLE; CHEST PAIN; HEMODYNAMIC-RESPONSE;
   TL-201 SCINTIGRAPHY; SEVERE BRONCHOSPASM; ORAL DIPYRIDAMOLE; ADENOSINE
AB Background. Dipyridamole imaging is widely used as an alternative to exercise testing to identify and risk stratify patients with coronary artery disease. Safety data on intravenous dipyridamole stress testing has been derived largely from individual institutional data.
   Methods and Results. Data were collected retrospectively by 85 coinvestigators from 73,806 patients who underwent intravenous dipyridamole stress imaging in 59 hospitals and 19 countries to determine the incidence of major adverse reactions during testing. The dose of dipyridamole infused was 0.56 mg/kg in 64,740 patients, 0.74 mg/kg in 6551 patients, and 0.84 mg/kg in 2515 patients. Combined major adverse events among the entire 73,806 patients included seven cardiac deaths (0.95 per 10,000), 13 nonfatal myocardial infarctions (1.76 per 10,000), six nonfatal sustained ventricular arrhythmias (0.81 per 10,000) (ventricular tachycardia in two and ventricular fibrillation in four), nine transient cerebral ischemic attacks (1.22 per 10,000), (with speech or motor deficit), one stroke, and nine severe bronchospasms (1.22 per 10,000) (one intubation and eight near intubations). In addition to the safety data, detailed demographic, peripheral hemodynamic, side effect, and concomitant drug data were examined in a subgroup of 3751 patients. End points from subsets of patients were compared with those of the group as a whole. Multivariate analysis revealed that dipyridamole-induced chest pain was more common in patients less than 70 years old (p = 0.0017), those with a history of coronary revascularization (p = 0.002), or patients taking aspirin (p = 0.0001). Minor noncardiac side effects were less frequent among the elderly (p = 0.0053) and more frequent in women (p = 0.0001) and patients taking maintenance aspirin (p = 0.0034). When a patient was judged on the basis of the adequacy of hemodynamic response to be a dipyridamole ''nonresponder'' (<10 mm Hg drop in systolic blood pressure and 10 beats/min increase in heart rate), the only significant predictor was angiotensin-converting enzyme inhibitor intake (p = 0.0025). Inferoposterior hypoperfusion was significantly more frequent in patients with dipyridamole-induced hypotension: 57% (44/77) (p < 0.0001) of those who had hypotension and 89% (8/9) (p = 0.0076) who had severe symptomatic bradyarrhythmias displayed inferoposterior defects on thallium scanning. Caffeine levels were determined in 391 consecutive patients: levels greater than 5 mg/L were observed in only eight patients (2%), suggesting that methylxanthine levels sufficient to alter the hemodynamic response to dipyridamole resulting in suboptimal hyperemic stress are unlikely when patients take nothing by mouth after midnight.
   Conclusion. The risk of serious dipyridamole-induced side effects is very low and is comparable to that reported for exercise testing in a similar patient population.
C1 MAISONNEUVE HOSP,MONTREAL,PQ,CANADA.
   VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298.
   ST LOUIS UNIV,MED CTR,ST LOUIS,MO.
   HARTFORD HOSP,HARTFORD,CT 06115.
   ST JOSEPHS HOSP,HAMILTON,ON,CANADA.
   CHONNAM UNIV HOSP,KWANGJU,SOUTH KOREA.
   UNIV MASSACHUSETTS,MED CTR,WORCESTER,MA.
RP LETTE, J (reprint author), MONTREAL HEART INST,5000 BELANGER ST E,MONTREAL,PQ H1T 1C8,CANADA.
CR ALBRO PC, 1978, AM J CARDIOL, V42, P751, DOI 10.1016/0002-9149(78)90094-2
   ARRIGO F, 1992, INT J CARDIOL, V37, P415, DOI 10.1016/0167-5273(92)90275-8
   BAYLISS J, 1983, BRIT J RADIOL, V56, P686
   BIDDLE P, 1989, DICP ANN PHARMAC, V23, P665
   BLUMENTHAL MS, 1988, CHEST, V93, P1103, DOI 10.1378/chest.93.5.1103
   BOARINI DJ, 1982, STROKE, V13, P842
   BROWN KA, 1989, AM J CARDIOL, V64, P1017, DOI 10.1016/0002-9149(89)90800-X
   CERQUEIRA MD, 1994, J AM COLL CARDIOL, V23, P384
   CREAGER MA, 1994, J AM COLL CARDIOL, V23, P401
   DEMANGEAT JL, 1981, EUR J NUCL MED, V6, P491
   DEPUEY EG, 1990, CORONARY ARTERY DIS, V1, P75, DOI 10.1097/00019501-199001000-00011
   EAGLE KA, 1989, CHEST, V95, P258, DOI 10.1378/chest.95.2.258
   EGLOFF P, 1991, ARCH MAL COEUR VAISS, V84, P861
   FLETCHER GF, 1990, CIRCULATION, V82, P2286
   FRIEDMAN HZ, 1988, ANN INTERN MED, V109, P990
   GERSON MC, 1987, AM J CARDIOL, V60, P1399, DOI 10.1016/0002-9149(87)90629-1
   GRANATO JE, 1990, J AM COLL CARDIOL, V16, P1760
   HEIKELA A, 1982, PROSTAGLANDINS, V23, P147, DOI 10.1016/0090-6980(82)90042-9
   HEISTAD DD, 1981, AM J PHYSIOL, V240, pH775
   HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401
   HOUBEN JJG, 1990, CHEST, V98, P253
   Irace L, 1990, Minerva Cardioangiol, V38, P293
   ISKANDRIAN AS, 1994, J NUCL CARDIOL, V1, P94, DOI 10.1007/BF02940016
   JOHN RM, 1992, BRIT HEART J, V68, P21
   KAHN D, 1990, CLIN NUCL MED, V15, P678, DOI 10.1097/00003072-199015100-00004
   KASSELL NF, 1983, J NEUROSURG, V58, P69, DOI 10.3171/jns.1983.58.1.0069
   KERN MJ, 1993, CATHETER CARDIO DIAG, V29, P329, DOI 10.1002/ccd.1810290419
   KLEIN HO, 1992, AM J CARDIOL, V69, P482, DOI 10.1016/0002-9149(92)90990-G
   KO KR, 1990, AM J PHYSIOL, V259, pH1703
   KWAI AH, 1990, EUR J NUCL MED, V16, P745, DOI 10.1007/BF00998182
   LAARMAN G, 1988, INT J CARDIOL, V20, P231, DOI 10.1016/0167-5273(88)90267-7
   LAARMAN GJ, 1987, INT J CARDIOL, V14, P384, DOI 10.1016/0167-5273(87)90215-4
   LAM JYT, 1988, J AM COLL CARDIOL, V11, P585
   LETTE J, 1989, CHEST, V95, P1345, DOI 10.1378/chest.95.6.1345
   LETTE J, 1990, CHEST, V98, P253
   LETTE J, 1993, J NUCL MED, V34, P1389
   LEWEN MK, 1987, CHEST, V92, P1102, DOI 10.1378/chest.92.6.1102
   MARWICK TH, 1990, CLIN CARDIOL, V13, P230
   MILLER DD, 1994, J AM COLL CARDIOL, V23, P390
   PEARLMAN JD, 1988, AM J CARDIOL, V61, P43, DOI 10.1016/0002-9149(88)91301-X
   PENNELL DJ, 1993, NUCL MED COMMUN, V14, P262, DOI 10.1097/00006231-199304000-00029
   PENNELL DJ, 1993, NUCL MED COMMUN, V14, P939, DOI 10.1097/00006231-199311000-00002
   PENNELL DJ, 1990, INT J CARDIOL, V27, P272, DOI 10.1016/0167-5273(90)90170-A
   PENNELL DJ, 1993, AM J CARDIOL, V71, P1346, DOI 10.1016/0002-9149(93)90553-O
   PICANO E, 1989, AM J CARDIOL, V63, P429, DOI 10.1016/0002-9149(89)90313-5
   PICANO E, 1992, AM J CARDIOL, V70, P252, DOI 10.1016/0002-9149(92)91284-B
   PUIROUD S, 1988, BRAIN RES, V453, P287, DOI 10.1016/0006-8993(88)90169-2
   RANHOSKY A, 1990, CIRCULATION, V81, P1205
   SMITS P, 1991, J NUCL MED, V32, P1538
   SMITS P, 1989, J NUCL MED, V30, P1723
   SMITS P, 1991, CLIN PHARMACOL THER, V50, P529
   SMITS P, 1990, CLIN PHARMACOL THER, V48, P410
   SONE T, 1981, JPN HEART J, V22, P763
   SUN JW, 1992, CHINESE MED J-PEKING, V105, P883
   SYLVEN C, 1986, BRIT MED J, V293, P227
   TAILLEFER R, 1986, J AM COLL CARDIOL, V8, P76
   TAKEISHI Y, 1991, JPN CIRC J, V55, P465
   VILLANUEVA FS, 1992, AM J CARDIOL, V69, P445, DOI 10.1016/0002-9149(92)90982-5
   WANG T, 1992, AM J PHYSIOL, V263, pH552
   WHITING JH, 1993, J NUCL MED, V34, P128
   ZHU YY, 1988, AM HEART J, V116, P1071, DOI 10.1016/0002-8703(88)90162-7
   ZIEGLER MG, 1993, PSYCHOSOM MED, V55, P339
NR 62
TC 104
Z9 108
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 1071-3581
J9 J NUCL CARDIOL
JI J. Nucl. Cardiol.
PD JAN-FEB
PY 1995
VL 2
IS 1
BP 3
EP 17
DI 10.1016/S1071-3581(05)80003-0
PG 15
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine &
   Medical Imaging
GA QG220
UT WOS:A1995QG22000002
PM 9420757
ER

PT J
AU Han, KR
   Cohen, JK
   Miller, RJ
   Pantuck, AJ
   Freitas, DG
   Cuevas, CA
   Kim, HL
   Lugg, J
   Childs, SJ
   Shuman, B
   Jayson, MA
   Shore, ND
   Moore, Y
   Zisman, A
   Lee, JY
   Ugarte, R
   Mynderse, LA
   Wilson, TM
   Sweat, SD
   Zincke, H
   Belldegrun, AS
AF Han, KR
   Cohen, JK
   Miller, RJ
   Pantuck, AJ
   Freitas, DG
   Cuevas, CA
   Kim, HL
   Lugg, J
   Childs, SJ
   Shuman, B
   Jayson, MA
   Shore, ND
   Moore, Y
   Zisman, A
   Lee, JY
   Ugarte, R
   Mynderse, LA
   Wilson, TM
   Sweat, SD
   Zincke, H
   Belldegrun, AS
TI Treatment of organ confined prostate cancer with third generation
   cryosurgery: Preliminary multicenter experience
SO JOURNAL OF UROLOGY
LA English
DT Article
DE cryosurgery; prostatic neoplasms; salvage therapy
ID EXTERNAL-BEAM RADIATION; CRYOABLATION; COMPLICATIONS; CARCINOMA;
   EFFICACY; ABLATION; THERAPY
AB Purpose: Cryosurgical ablation of the prostate is 1 approach to the treatment of localized prostate cancer. Third generation cryosurgery uses gas driven probes that allow for a decrease in probe diameter to 17 gauge (1.5 mm). The safety, morbidity and preliminary prostate specific antigen (PSA) results of 122 cases are reported.
   Materials and Methods: A total of 106 patients have undergone percutaneous cryosurgery using a brachytherapy template with at least 12 months of PSA followup. Immediate and delayed morbidities were evaluated. PSA results at 3 and 12 months were recorded, and failure was defined as the inability to reach a nadir of 0.4 ng/ml or less.
   Results: Complications in patients undergoing primary cryosurgery included tissue sloughing (5%), incontinence (pads, 3%), urge incontinence/no pads (5%), transient urinary retention (3.3%) and rectal discomfort (2.6%). There were no cases of fistulas or infections. Postoperative impotence was 87% in previously potent patients. For patients who underwent salvage cryosurgery there were no fistulas reported and 2 (11%) patients required pads after salvage cryosurgery. A total of 96 (81%) patients achieved a PSA nadir of 0.4 ng/ml or less at 3 months of followup, while 79 of 106 (75%) remained free from biochemical recurrence at 12 months. A total of 42 (78%) low risk patients (Gleason score 7 or less and PSA 10 or less) remained with a PSA of 0.4 ng/ml or less at 12 months of followup, compared to 37 (71%) high risk patients. All patients were discharged within 24 hours.
   Conclusions: After a followup of 1 year 3rd generation cryosurgery appears to be well tolerated and minimally invasive. The use of ultrathin needles through a brachytherapy template allows for a simple percutaneous procedure and a relatively short learning curve. A prospective multicenter trial is ongoing to determine the long-term efficacy of this technique.
C1 Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Div Urol Oncol, Los Angeles, CA USA.
   Allegheny Gen Hosp, Div Urol, Pittsburgh, PA 15212 USA.
   Allegheny Prostate Ctr, Pittsburgh, PA USA.
   Boston Med Ctr, Boston, MA USA.
   Univ Colorado Hlth Sci, Cheyenne, WY USA.
   Albany Mem Hosp, Albany, NY USA.
   Southside Hosp, Urol Sect, Bay Shore, NY USA.
   Galil Med, Uniondale, NY USA.
   Grand Strand Urol, Myrtle Beach, SC USA.
   Univ Minnesota, Dept Urol Surg, Minneapolis, MN USA.
   Mayo Clin, Dept Urol, Rochester, MN USA.
   Assaf Harofeh Med Ctr, Tel Aviv, Israel.
RP Belldegrun, AS (reprint author), Univ Calif Los Angeles, Dept Urol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
CR Chin JL, 1998, J UROLOGY, V159, P910, DOI 10.1016/S0022-5347(01)63769-8
   COHEN JK, 1995, UROLOGY, V45, P861, DOI 10.1016/S0090-4295(99)80095-8
   COHEN JK, 1994, CRYOBIOLOGY, V31, P313, DOI 10.1006/cryo.1994.1037
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   De la Taille A, 2000, BJU INT, V85, P281, DOI 10.1046/j.1464-410x.2000.00456.x
   Fleming ID, 1997, AJCC CANC STAGING MA
   Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   Koppie TM, 1999, J UROLOGY, V162, P427, DOI 10.1016/S0022-5347(05)68576-X
   Long JP, 2001, UROLOGY, V57, P518, DOI 10.1016/S0090-4295(00)01060-8
   ONIK G, 1988, RADIOLOGY, V168, P629
   Pisters LL, 1997, J UROLOGY, V157, P921, DOI 10.1016/S0022-5347(01)65084-5
   Wong WS, 1997, CANCER, V79, P963
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
   Zisman A, 2001, UROLOGY, V58, P988, DOI 10.1016/S0090-4295(01)01422-4
NR 16
TC 103
Z9 105
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 2003
VL 170
IS 4
BP 1126
EP 1130
DI 10.1097/01.ju.0000087860.52991.a8
PN 1
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 722WN
UT WOS:000185401200012
PM 14501706
ER

PT J
AU FILDES, R
AF FILDES, R
TI THE EVALUATION OF EXTRAPOLATIVE FORECASTING METHODS
SO INTERNATIONAL JOURNAL OF FORECASTING
LA English
DT Article
DE EVALUATION TIME SERIES METHODS; EVALUATION METHODOLOGY; COMPARATIVE
   METHODS TIME SERIES; ROBUST ESTIMATION; OUTLIERS EFFECT OF; LOSS
   FUNCTIONS; EVALUATION; EX-ANTE
ID TIME-SERIES; COMPETITION; EXPERIENCE; ACCURACY
AB Extrapolative forecasting methods are widely used in production and inventory decisions. Typically many hundreds of series are forecast and the cost-effectiveness of the decisions depends on the accuracy of the forecasting method(s) used. This paper examines how a forecasting method should be chosen based on analyzing alternative loss functions. It is argued that a population of time series must be evaluated by time period and by series. Of the alternative loss functions considered, only the geometric root mean squared error is well-behaved and has a straightforward interpretation. The paper concludes that exponential smoothing and 'naive' models, previously thought to be 'robust' performers, forecast poorly for the particular set of time series under analysis, whatever error measure is used. As a consequence, forecasters should carry out a detailed evaluation of the data series, as described in the paper, rather than relying on a priori analysis developed from earlier forecasting competitions.
RP FILDES, R (reprint author), UNIV LANCASTER,SCH MANAGEMENT,DEPT OPERAT RES & OPERAT MANAGEMENT,LANCASTER LA1 4YX,ENGLAND.
CR ARMSTRONG JS, 1984, INTERFACES, V14, P52, DOI 10.1287/inte.14.6.52
   CARBONE R, 1982, J FORECASTING, V1, P215, DOI 10.1002/for.3980010207
   CHATFIELD C, 1988, INT J FORECASTING, V4, P515, DOI 10.1016/0169-2070(88)90127-6
   DEGOOIJER JG, 1985, INT STAT REV, V53, P379
   FILDES R, 1989, 184 MANCH BUS SCH WO
   FILDES R, 1989, MANAGE SCI, V35, P1056, DOI 10.1287/mnsc.35.9.1056
   FILDES R, 1984, OMEGA-INT J MANAGE S, V12, P427, DOI 10.1016/0305-0483(84)90042-2
   FILDES R, 1983, J FORECASTING, V2, P289
   Gardner E.S., 1984, J FORECASTING, V4, P1
   GARDNER ES, 1983, J FORECASTING, V2, P263
   GARDNER ES, 1985, MANAGE SCI, V31, P1237, DOI 10.1287/mnsc.31.10.1237
   GRAMBSCH P, 1990, INT J FORECASTING, V6, P53, DOI 10.1016/0169-2070(90)90097-U
   IONESCUGRAFF A, 1982, BELL SYST TECH J, V61, P34
   JENKINS GM, 1982, J FORECASTING, V1, P3, DOI 10.1002/for.3980010103
   MAKRIDAKIS S, 1982, J FORECASTING, V1, P111, DOI 10.1002/for.3980010202
   MAKRIDAKIS S, 1983, J FORECASTING, V2, P295
   MAKRIDAKIS S, 1989, APPL STAT-J ROY ST C, V38, P331, DOI 10.2307/2348063
   NEWBOLD P, 1974, J ROY STAT SOC A STA, V137, P131, DOI 10.2307/2344546
   NEWBOLD P, 1983, J FORECASTING, V2, P276
   PACK CD, 1982, AT&T TECH J, V61, P1
   PRICE DHR, 1986, INT J FORECASTING, V2, P313
   THOMPSON PA, 1990, INT J FORECASTING, V6, P219, DOI 10.1016/0169-2070(90)90007-X
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
NR 23
TC 102
Z9 102
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-2070
J9 INT J FORECASTING
JI Int. J. Forecast.
PD JUN
PY 1992
VL 8
IS 1
BP 81
EP 98
DI 10.1016/0169-2070(92)90009-X
PG 18
WC Economics; Management
SC Business & Economics
GA HZ830
UT WOS:A1992HZ83000008
ER

PT J
AU Boyer, TW
AF Boyer, Ty W.
TI The development of risk-taking: A multi-perspective review
SO DEVELOPMENTAL REVIEW
LA English
DT Review
DE risk-taking; development; cross-perspective review; decision-making;
   emotional regulation; psychobiology; socialization
ID VENTROMEDIAL PREFRONTAL CORTEX; ADOLESCENT PROBLEM BEHAVIOR; SOMATIC
   MARKER HYPOTHESIS; SELF-REPORTED DELINQUENCY; LINEAR UTILITY-MODELS;
   IOWA GAMBLING TASK; FUZZY-TRACE THEORY; DECISION-MAKING; SENSATION
   SEEKING; ANTISOCIAL-BEHAVIOR
AB The current paper reviews four research perspectives that have been used to investigate the development of risk-taking. Cognitive developmental research has investigated the development of decision-making capacities that potentially underlie risk-taking development, including sensitivity to risk, probability estimation, and perceptions of vulnerability. Emotional development research has found that affective decision-making and emotional regulation skills improve with development through adolescence. Psychobiological research has analyzed the cognitive and affective neurological and biochemical bases of risk-taking, and their development. Social developmental research has explored the effects of parent-child relationship quality, parenting strategies, and peer influences on the emergence of risk-taking tendencies. Although they have remained largely independent, it is argued throughout that factors within each of these perspectives interact to influence the probability that an individual will engage in risky activities, which should be the topic of future research. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Chicago, Dept Psychol, Chicago, IL 60637 USA.
RP Boyer, TW (reprint author), Univ Chicago, Dept Psychol, Chicago, IL 60637 USA.
EM tboyer@uchicago.edu
CR ACREDOLO C, 1989, CHILD DEV, V60, P933, DOI 10.1111/j.1467-8624.1989.tb03525.x
   ALLAN AC, 1953, CANCER, V6, P1
   Allen JP, 1996, J CONSULT CLIN PSYCH, V64, P254
   Allen JP, 2002, J CONSULT CLIN PSYCH, V70, P56, DOI 10.1037//0022-006X.70.1.56
   Allen JP, 1998, CHILD DEV, V69, P1406, DOI 10.2307/1132274
   Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5
   Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083
   Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson
   ARNETT J, 1990, PERS INDIV DIFFER, V11, P541, DOI 10.1016/0191-8869(90)90035-P
   ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R
   Arnett JJ, 1996, PERS INDIV DIFFER, V20, P693, DOI 10.1016/0191-8869(96)00027-X
   ARNETT J, 1995, CURR DIR PSYCHOL SCI, V4, P67, DOI 10.1111/1467-8721.ep10772304
   ARNETT JJ, 1999, AM PSYCHOL, V54
   Ary DV, 1999, BEHAV RES THER, V37, P217, DOI 10.1016/S0005-7967(98)00133-8
   Ayduk O., 2002, SELF IDENTITY, V1, P113, DOI DOI 10.1080/152988602317319285
   BARON J, 1993, MERRILL PALMER QUART, V39, P22
   Baron J., 2000, THINKING DECIDING
   Bauer LO, 1999, BIOL PSYCHIAT, V46, P263, DOI 10.1016/S0006-3223(98)00335-7
   Bauman KE, 1996, ADDICTION, V91, P185, DOI 10.1111/j.1360-0443.1996.tb03175.x
   BAUMRIND D, 1971, DEV PSYCHOL MONOGRAP, V75, P1
   Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002
   Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295
   Bechara A, 1999, J NEUROSCI, V19, P5473
   BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3
   Bechara A, 2003, ANN NY ACAD SCI, V985, P356
   BENTHIN A, 1993, J ADOLESCENCE, V16, P153, DOI 10.1006/jado.1993.1014
   Berger LE, 2005, DEV PSYCHOPATHOL, V17, P509, DOI 10.1017/S0954579405050248
   Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829
   BEYTHMAROM R, 1993, DEV PSYCHOL, V29, P549, DOI 10.1037/0012-1649.29.3.549
   BEYTHMAROM R, 1997, HLTH RISKS DEV TRANS
   Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901
   Blanton H, 1997, J FAM PSYCHOL, V11, P271, DOI 10.1037/0893-3200.11.3.271
   Bowlby J., 1969, ATTACHMENT
   BRAINERD CJ, 1990, DEV REV, V10, P3, DOI 10.1016/0273-2297(90)90003-M
   BRAINERD CJ, 1981, PSYCHOL REV, V88, P463, DOI 10.1037//0033-295X.88.6.463
   Bronfenbrenner U., 1998, HDB CHILD PSYCHOL TH
   Buchel C, 1999, J NEUROSCI, V19, P10869
   Byrnes J. P., 1998, NATURE DEV DECISION
   BYRNES JP, 1994, J EXP CHILD PSYCHOL, V58, P359, DOI 10.1006/jecp.1994.1040
   Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367
   Byrnes JP, 1999, CHILD DEV, V70, P1121, DOI 10.1111/1467-8624.00082
   BYRNES JP, 2003, 70 BIENN M SOC RES C
   Caffray CM, 2000, COGNITION EMOTION, V14, P543
   CASPI A, 1993, DEV PSYCHOL, V29, P19, DOI 10.1037/0012-1649.29.1.19
   Catanzaro SJ, 2004, ADDICT BEHAV, V29, P1779, DOI 10.1016/j.addbeh.2004.04.001
   Cauffman E, 2000, BEHAV SCI LAW, V18, P741, DOI 10.1002/bsl.416
   *CDCP, 2004, 53 CDCP
   *CDCP, 2005, MIDL SCH YOUTH RISK
   Chien YC, 1996, PERCEPT MOTOR SKILL, V83, P811
   COHN LD, 1995, HEALTH PSYCHOL, V14, P217, DOI 10.1037/0278-6133.14.3.217
   Colder CR, 1998, J YOUTH ADOLESCENCE, V27, P255, DOI 10.1023/A:1022889202419
   COLLAER ML, 1995, PSYCHOL BULL, V118, P55, DOI 10.1037//0033-2909.118.1.55
   Cooper M. L., 1992, PSYCHOL ASSESSMENT, V4, P123, DOI [10.1037/1040-3590.4.2.123, DOI 10.1037/1040-3590.4.2.123]
   Cooper ML, 2000, J PERS, V68, P1059, DOI 10.1111/1467-6494.00126
   Cooper ML, 2003, J PERS SOC PSYCHOL, V84, P390, DOI 10.1037/0022-3514.84.2.390
   COOPER ML, 1995, J PERS SOC PSYCHOL, V69, P990, DOI 10.1037/0022-3514.69.5.990
   CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74
   Crone EA, 2003, PERS INDIV DIFFER, V35, P1625, DOI 10.1016/S0191-8869(02)00386-0
   Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2
   CUFFMAN E, 2000, YOUTH TRIAL DEV PERS, P325
   DAHL RE, 2003, 70 BIENN M SOC RES C
   DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217
   Damasio Antonio R., 1994, DESCARTES ERROR EMOT
   DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487
   Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2
   Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812
   DELOACHE JS, 1998, HDB CHILD PSYCHOL CO
   Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380
   Dishion TJ, 2004, J ADOLESCENCE, V27, P515, DOI 10.1016/j.adolescence.2004.06.005
   DISHION TJ, 1991, DEV PSYCHOL, V27, P172, DOI 10.1037/0012-1649.27.1.172
   Dodge KA, 2003, DEV PSYCHOL, V39, P349, DOI 10.1037/0012-1649.39.2.349
   Donohew L, 2000, PERS INDIV DIFFER, V28, P1079, DOI 10.1016/S0191-8869(99)00158-0
   DONOVAN JE, 1988, J CONSULT CLIN PSYCH, V56, P762, DOI 10.1037/0022-006X.56.5.762
   DONOVAN JE, 1985, J CONSULT CLIN PSYCH, V53, P890, DOI 10.1037//0022-006X.53.6.890
   DUNCAN PD, 1985, J YOUTH ADOLESCENCE, V14, P227, DOI 10.1007/BF02090320
   Eisenberg N, 2005, DEV PSYCHOL, V41, P193, DOI 10.1037/0012-1649.41.1.193
   Eisenberg N, 2000, CHILD DEV, V71, P1367, DOI 10.1111/1467-8624.00233
   Eisenberg N, 2001, CHILD DEV, V72, P1112, DOI 10.1111/1467-8624.00337
   ELKIND D, 1967, CHILD DEV, V38, P1025, DOI 10.1111/j.1467-8624.1967.tb04378.x
   ELKIND D, 1985, DEV REV, V5, P218, DOI 10.1016/0273-2297(85)90010-3
   Elliott R, 1999, NEUROPSYCHOLOGIA, V37, P403, DOI 10.1016/S0028-3932(98)00107-9
   Elliott R, 2000, J NEUROSCI, V20, P6159
   ELLIS S, 1981, DEV PSYCHOL, V17, P399
   EPSTEIN S, 1998, ADV PERSONALITY
   Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6
   Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011
   Ernst M, 2003, AM J PSYCHIAT, V160, P33, DOI 10.1176/appi.ajp.160.1.33
   ERNST M, 2003, 70 BIENN M SOC RES C
   EVANS JSBT, 1984, BRIT J PSYCHOL, V75, P451
   Evans JSBT, 2002, BRIT J PSYCHOL, V93, P31, DOI 10.1348/000712602162436
   EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57
   FAGLEY NS, 1993, PSYCHOL BULL, V113, P451, DOI 10.1037//0033-2909.113.3.451
   Falk R., 1998, DEV PSYCHOL, V34, P1240
   Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108
   Flannery DJ, 1999, AM J ORTHOPSYCHIAT, V69, P247, DOI 10.1037/h0080426
   Flavell JH, 1999, ANNU REV PSYCHOL, V50, P21, DOI 10.1146/annurev.psych.50.1.21
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Fried CS, 2001, LAW HUMAN BEHAV, V25, P45, DOI 10.1023/A:1005639909226
   Fromme K, 1997, COGNITIVE THER RES, V21, P421, DOI 10.1023/A:1021932326716
   FURBY L, 1992, DEV REV, V12, P1, DOI 10.1016/0273-2297(92)90002-J
   Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625
   Garon N, 2004, BRAIN COGNITION, V55, P158, DOI 10.1016/s0278-2626(03)00272-0
   Gerrard M, 1996, HEALTH PSYCHOL, V15, P344, DOI 10.1037/0278-6133.15.5.344
   GERRARD M, 2003, SOCIAL PSYCHOL HLTH
   Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158
   Gigerenzer G., 2001, BOUNDED RATIONALITY
   Goldberg JH, 2002, HEALTH PSYCHOL, V21, P477, DOI 10.1037//0278-6133.21.5.477
   Goldstein M, 2000, PERS INDIV DIFFER, V29, P1169, DOI 10.1016/S0191-8869(99)00264-0
   Gottfredson M. R., 1990, GEN THEORY CRIME
   Gross JJ, 1999, COGNITION EMOTION, V13, P551, DOI 10.1080/026999399379186
   Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95
   Gullone E, 2000, J ADOLESCENT RES, V15, P231, DOI 10.1177/0743558400152003
   Halpern-Felsher BL, 2001, J APPL DEV PSYCHOL, V22, P257, DOI 10.1016/S0193-3973(01)00083-1
   HARBAUGH WT, 2001, EXPT EC, V5, P53
   HOEMANN HW, 1971, CHILD DEV, V42, P221, DOI 10.1111/j.1467-8624.1971.tb03631.x
   Hoffrage U, 2003, J EXP PSYCHOL-APPL, V9, P249, DOI 10.1037/1076-898X.9.4.249
   HORVATH P, 1993, PERS INDIV DIFFER, V14, P41, DOI 10.1016/0191-8869(93)90173-Z
   IRWIN CE, 1997, ADOLESCENT NUTR DISO
   IRWIN CE, 1993, ADOLESCENT RISK TAKI
   Jaccard J, 2005, DEV PSYCHOL, V41, P135, DOI 10.1037/0012-1649.41.1.135
   Jacobs JE, 2002, CURR DIR PSYCHOL SCI, V11, P145, DOI 10.1111/1467-8721.00188
   Jessor R, 1998, J PERS SOC PSYCHOL, V75, P788, DOI 10.1037//0022-3514.75.3.788
   JESSOR R, 1991, J ADOLESCENT HEALTH, V12, P597, DOI 10.1016/1054-139X(91)90007-K
   Jessor R., 1977, PROBLEM BEHAV PSYCHO
   JESSOR R, 1993, AM PSYCHOL, V48, P117, DOI 10.1037//0003-066X.48.2.117
   Kaheman D.X., 1979, ECONOMETRICA, V47, P263
   KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747
   KAHNEMAN D, 1972, COGNITIVE PSYCHOL, V3, P430, DOI 10.1016/0010-0285(72)90016-3
   KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037//0003-066X.39.4.341
   KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5
   Kandel DB, 1996, J DRUG ISSUES, V26, P289
   Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Kim JE, 1999, CHILD DEV, V70, P1209, DOI 10.1111/1467-8624.00088
   KIRKPATRICK LA, 1992, J PERS SOC PSYCHOL, V63, P534, DOI 10.1037/0022-3514.63.4.534
   Klaczynski PA, 2001, CHILD DEV, V72, P844, DOI 10.1111/1467-8624.00319
   Klaczynski PA, 2001, J APPL DEV PSYCHOL, V22, P225, DOI 10.1016/S0193-3973(01)00081-8
   KREITLER S, 1986, COGNITIVE DEV, V1, P365, DOI 10.1016/S0885-2014(86)80009-0
   Kuhn D., 1995, MONOGRAPHS SOC RES C, V60
   Kuhn D., 1998, HDB CHILD PSYCHOL CO
   KUZMAK SD, 1986, CHILD DEV, V57, P559
   La Greca AM, 2001, J PEDIATR PSYCHOL, V26, P131, DOI 10.1093/jpepsy/26.3.131
   Laird RD, 2001, DEV PSYCHOPATHOL, V13, P337, DOI 10.1017/S0954579401002085
   Laird RD, 2003, SOC DEV, V12, P401, DOI 10.1111/1467-9507.00240
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   LAMBORN SD, 1991, CHILD DEV, V62, P1049, DOI 10.1111/j.1467-8624.1991.tb01588.x
   Lansford JE, 2003, J RES ADOLESCENCE, V13, P161
   Larson CL, 2000, PSYCHOPHYSIOLOGY, V37, P92, DOI 10.1017/S0048577200981344
   LARSON R, 1989, CHILD DEV, V60, P1250, DOI 10.1111/j.1467-8624.1989.tb03555.x
   LAVERY B, 1993, J EXP CHILD PSYCHOL, V55, P277, DOI 10.1006/jecp.1993.1016
   LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.psych.46.1.209
   Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8
   Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75
   Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26
   Lemery KS, 2002, CHILD DEV, V73, P867, DOI 10.1111/1467-8624.00444
   Levin IP, 2003, J BEHAV DECIS MAKING, V16, P397, DOI 10.1002/bdm.453
   Lewis DA, 1997, NEUROPSYCHOPHARMACOL, V16, P385, DOI 10.1016/S0893-133X(96)00277-1
   LEWIS M, 1989, CHILD DEV, V60, P146, DOI 10.1111/j.1467-8624.1989.tb02704.x
   LICHTENS.S, 1971, J EXP PSYCHOL, V89, P46, DOI 10.1037/h0031207
   LOEBER R, 1983, PSYCHOL BULL, V94, P68, DOI 10.1037/0033-2909.94.1.68
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   LOPES LL, 1993, ADOLESCENT RISK TAKI
   Lopes LL, 1999, J MATH PSYCHOL, V43, P286, DOI 10.1006/jmps.1999.1259
   LOPES LL, 1994, ANNU REV PSYCHOL, V45, P197, DOI 10.1146/annurev.psych.45.1.197
   LUCE RD, 1991, J ECON THEORY, V53, P75, DOI 10.1016/0022-0531(91)90143-R
   LUCE RD, 1957, GAMES DECISIONS INTR
   LUCE RD, 1995, J RISK UNCERTAINTY, V11, P5, DOI 10.1007/BF01132728
   LUCE RD, 1991, J RISK UNCERTAINTY, V4, P29, DOI 10.1007/BF00057885
   Maccoby E. E., 1983, HDB CHILD PSYCHOL, VIV, P1
   MacCrimmon K. R., 1979, EXPECTED UTILITY HYP, P333
   Magnusson D, 1998, HDB CHILD PSYCHOL TH
   Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101
   Maia TV, 2005, TRENDS COGN SCI, V9, P162, DOI 10.1016/j.tics.2005.02.006
   Mandler J, 1998, HDB CHILD PSYCHOL CO
   MANN L, 1989, J ADOLESCENCE, V12, P265, DOI 10.1016/0140-1971(89)90077-8
   Marsh P, 2003, DEV PSYCHOPATHOL, V15, P451, DOI 10.1017/S0954579403000245
   May JC, 2004, BIOL PSYCHIAT, V55, P359, DOI 10.1016/j.biopsych.2003.11.008
   Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x
   Mellers BA, 1998, ANNU REV PSYCHOL, V49, P447, DOI 10.1146/annurev.psych.49.1.447
   Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037//0033-295X.106.1.3
   Miller DC, 1997, DEV PSYCHOL, V33, P814, DOI 10.1037/0012-1649.33.5.814
   MILLER L, 1985, NEUROPSYCHOLOGIA, V23, P371, DOI 10.1016/0028-3932(85)90023-5
   MILLER L, 1985, NEUROPSYCHOLOGIA, V23, P359, DOI 10.1016/0028-3932(85)90022-3
   MILLER LA, 1992, NEUROPSYCHOLOGIA, V30, P69, DOI 10.1016/0028-3932(92)90015-E
   Miller-Johnson S, 1999, J EMOT BEHAV DISORD, V7, P137, DOI 10.1177/106342669900700302
   Millstein SG, 2002, J RES ADOLESCENCE, V12, P399
   MISCHEL HN, 1983, CHILD DEV, V54, P603, DOI 10.2307/1130047
   MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056
   MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037//0022-3514.54.4.687
   MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674
   Moore S, 1996, J YOUTH ADOLESCENCE, V25, P343, DOI 10.1007/BF01537389
   Nelson CA, 2002, DEV PSYCHOPATHOL, V14, P499, DOI 10.1017/S0954579402003069
   Ornstein PA, 2004, DEV REV, V24, P374, DOI 10.1016/j.dr.2004.08.004
   Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014
   OZER EM, 2002, CHANGING ADOLESCENT
   PATTERSON GR, 1984, CHILD DEV, V55, P1299, DOI 10.2307/1129999
   Peiser NC, 1996, J ADOLESCENCE, V19, P557, DOI 10.1006/jado.1996.0054
   Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298
   Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110
   Piaget J., 1951, ORIGIN IDEA CHANCE C
   Prinstein MJ, 2001, J PEDIATR PSYCHOL, V26, P287, DOI 10.1093/jpepsy/26.5.287
   PROIMOS J, 1998, PEDIATRICS, V102
   QUADREL MJ, 1993, AM PSYCHOL, V48, P102, DOI 10.1037//0003-066X.48.2.102
   Rai AA, 2003, J ADOLESCENT HEALTH, V33, P108, DOI 10.1016/S1054-139X(03)00179-4
   Reyna V. F., 1996, ANN CHILD DEV, V12, P87
   REYNA VF, 1994, PSYCHOL SCI, V5, P275, DOI 10.1111/j.1467-9280.1994.tb00625.x
   Reyna VF, 2004, CURR DIR PSYCHOL SCI, V13, P60, DOI 10.1111/j.0963-7214.2004.00275.x
   Robbins RN, 2004, J ADOLESCENT RES, V19, P428, DOI 10.1177/074355840328860
   ROGOFF B, 1998, HDB CHILD PSYCHOL CO
   Rolison MR, 2002, ADOLESCENCE, V37, P585
   Rolison MR, 2003, ADOLESCENCE, V38, P689
   Rothbart MK, 1998, HDB CHILD PSYCHOL SO
   RUBIN KH, 1998, HDB CHILD PSYCHOL SO
   SAARNI C, 1998, HDB CHILD PSYCHOL SO
   Santor DA, 2000, J YOUTH ADOLESCENCE, V29, P163, DOI 10.1023/A:1005152515264
   Savage LJ, 1954, FDN STAT
   Schlottmann A, 2001, CHILD DEV, V72, P103, DOI 10.1111/1467-8624.00268
   Schwarz N, 2000, COGNITION EMOTION, V14, P433, DOI 10.1080/026999300402745
   SCNEIDER W, 1998, HDB CHILD PSYCHOL CO
   Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5
   Sethi A, 2000, DEV PSYCHOL, V36, P767, DOI 10.1037//0012-1649.36.6.767
   Siegler R., 1996, EMERGING MINDS PROCE
   Silk JS, 2003, CHILD DEV, V74, P1869, DOI 10.1046/j.1467-8624.2003.00643.x
   Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037//0033-2909.119.1.3
   SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x
   Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194
   Spear LP, 2000, CURR DIR PSYCHOL SCI, V9, P111, DOI 10.1111/1467-8721.00072
   Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2
   Stanford MS, 1996, PERS INDIV DIFFER, V21, P1073, DOI 10.1016/S0191-8869(96)00151-1
   STANFORD MS, 1992, PERS INDIV DIFFER, V13, P831, DOI 10.1016/0191-8869(92)90057-V
   Stanovich KE, 2003, PERS INDIV DIFFER, V35, P1061, DOI 10.1016/S0191-8869(03)00318-5
   Stanovich K. E., 2004, ROBOTS REBELLION FIN
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Steinberg L, 2004, ANN NY ACAD SCI, V1021, P51, DOI 10.1196/annals.1308.005
   Steinberg L., 1987, J ADOLESCENT RES, V2, P255, DOI 10.1177/074355488723006
   Steinberg L, 1996, LAW HUMAN BEHAV, V20, P249, DOI 10.1007/BF01499023
   Steinberg L, 2003, AM PSYCHOL, V58, P1009, DOI 10.1037/0003-066X.58.12.1009
   STEINBERG L, 1994, CHILD DEV, V65, P754, DOI 10.1111/j.1467-8624.1994.tb00781.x
   STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349
   Thomas KM, 2001, ARCH GEN PSYCHIAT, V58, P1057, DOI 10.1001/archpsyc.58.11.1057
   TINSLEY BJ, 1995, HEALTH EDUC QUART, V22, P244
   TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574
   TVERSKY A, 1969, J MATH PSYCHOL, V6, P1, DOI 10.1016/0022-2496(69)90027-3
   TVERSKY A, 1990, AM ECON REV, V80, P204
   TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683
   TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124
   Tversky A., 1986, J BUS, V59, P252
   TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750
   UDRY JR, 1988, AM SOCIOL REV, V53, P709, DOI 10.2307/2095817
   Vartanian LR, 2000, ADOLESCENCE, V35, P639
   Vazsonyi AT, 1997, J EARLY ADOLESCENCE, V17, P271, DOI 10.1177/0272431697017003002
   von Neumann J., 1944, THEORY GAMES EC BEHA
   Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912
   WILCOX BL, 1993, ADOLESCENT RISK TAKI
   Williams JM, 1999, J ADOLESCENCE, V22, P157, DOI 10.1006/jado.1998.0208
   Wright G., 1994, SUBJECTIVE PROBABILI, P239
   Zuckerman M., 1994, BEHAV EXPRESSION BIO
   ZUCKERMAN M, 1990, ADDICT BEHAV, V15, P209, DOI 10.1016/0306-4603(90)90064-5
   Zuckerman M., 1979, SENSATION SEEKING OP
   ZUCKERMAN M, 1984, BEHAV BRAIN SCI, V7, P413
   Zuckerman M., 1983, BIOL BASES SENSATION
NR 261
TC 100
Z9 106
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0273-2297
J9 DEV REV
JI Dev. Rev.
PD SEP
PY 2006
VL 26
IS 3
BP 291
EP 345
DI 10.1016/j.dr.2006.05.002
PG 55
WC Psychology, Developmental
SC Psychology
GA 088UF
UT WOS:000240835900002
ER

PT J
AU Kollmeier, MA
   Stock, RG
   Stone, N
AF Kollmeier, MA
   Stock, RG
   Stone, N
TI Biochemical outcomes after prostate brachytherapy with 5-year minimal
   follow-up: Importance of patient selection and implant quality
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT 44th Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology
CY OCT 06-10, 2002
CL NEW ORLEANS, LOUISIANA
SP Amer Soc Therapeut Radiol & Oncol
DE prostate cancer; brachytherapy; prostate-specific antigen; biochemical
   outcome
ID EXTERNAL-BEAM RADIATION; (125)IODINE IMPLANTATION; RADICAL
   PROSTATECTOMY; ANTIGEN NADIR; FREE SURVIVAL; CANCER; THERAPY; DOSIMETRY;
   DISEASE; RECOMMENDATIONS
AB Purpose: A prostate brachytherapy program was initiated in 1990, when comparatively little was known of the relative importance of disease- and treatment-related factors on outcome. Patients treated during the first 6 years of the program were analyzed to determine the value of patient selection and implant quality on biochemical control.
   Methods and Materials: We treated 243 patients with clinically localized prostate cancer with radioactive seed implantation and underwent 1-month CT-based dosimetric analysis. Follow-up ranged from 61 to 135 months (median 75). The Gleason score was less than or equal to6 in 78% (n = 189),7 in 14% (n = 35), and 8-10 in 8% (n = 19). The initial prostate-specific antigen (PSA) level was less than or equal to10 ng/mL in 61% (n = 149),10.1-20 ng/mL in 26%,(n = 63), and >20 ng/mL in 13% (n = 31). The disease stage was T2a or less in 49% (n = 120), and Stage T2b-T2c in 51% (n = 123). A real-time ultrasound-guided technique was used with I-125 (n = 138) and Pd-103 (n = 105) isotopes. No patient underwent external beam radiotherapy as part of their primary treatment. Of the 243 patients, 60% also received hormonal ablation for at least 3 months before and 2-3 months after seed implantation. All patients included underwent a 1-month CT-based dosimetric analysis. The implant dose was defined as the dose delivered to 90% of the prostate volume on postimplant dosimetry (D-90). On the basis of prior dose-response analyses, patients were retrospectively grouped into optimal D-90 (I-125 greater than or equal to 140 Gy Task Group 43 or Pd-103 greater than or equal to100 Gy) and suboptimal D-90 (I-125 < 140 Gy or Pd-103 < 100 Gy) dose groups. Biochemical failure was defined using the American Society for Therapeutic Radiology Oncology definition.
   Results: Disease-related factors, including initial PSA level, Gleason score, and stage, were significant predictors of biochemical failure. The actuarial 8-year freedom from biochemical failure (bFFF) rate was 80% for those with a PSA level less than or equal to10 ng/mL, 86% for PSA 10.1-20 ng/mL, and 45% for PSA >20 ng/mL (p = 0.0019). Patients with a Gleason score of:56 had an 8-year bFFF rate of 81% vs. 67% for those with Gleason score 7 and 53% for those with Gleason score 8-10 (p = 0.0003). Patients with Stage T2a or less had an 8-year bFFF rate of 85% compared with 69% for those with Stage T2b-T2c (p = 0.013). The 8-year bFFF rate was 88% for low-risk patients (Stage T2a or less, Gleason score less than or equal to6, and initial PSA level less than or equal to10 ng/mL; n = 75),81% for moderate-risk patients (Stage T2b or Gleason score 7 or initial PSA level >10.1-20 ng/mL; n = 70), and 65% for high-risk patients (two or more moderate-risk features or Gleason score greater than or equal to8 or initial PSA level >20 ng/mL; n = 98; p = 0.0009). Patients with optimal dose implants (n = 145) had an 8-year bFFF rate of 82% compared with 68% for those with suboptimal dose implants (n = 98; p = 0.007). Hormonal therapy did not significantly affect biochemical failure (p = 0.27). In multivariate analysis, the statistically significant variables included initial PSA level (p < 0.0001), Gleason score (p = 0.024), and dose group (p = 0.046). Because our current practice limits implantation alone to low-risk patients, an analysis of this subgroup was undertaken to validate the importance of dose. In the optimal dose group, low-risk patients had an 8-year bFFF rate of 94% vs. 75% for the low-risk patients in the suboptimal dose group (p = 0.02).
   Conclusion: With minimal follow-up of 5 years, these data continue to support the use of implantation alone in low-risk prostate cancer patients and demonstrate the importance of implant quality (dose) in achieving optimal outcomes. Low-risk patients who receive an optimal dose implant have a 94% bFFF rate at 8 years. (C) 2003 Elsevier Inc.
C1 Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY 10029 USA.
   Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA.
RP Stock, RG (reprint author), Mt Sinai Sch Med, Dept Radiat Oncol, 1184 5th Ave, New York, NY 10029 USA.
CR ADOLFSSON J, 1994, EUR UROL, V26, P207
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko JC, 1987, ENDOCURIETHER HYPERT, V3, P131
   Connell PP, 1999, UROLOGY, V54, P875, DOI 10.1016/S0090-4295(99)00253-8
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 2002, J UROLOGY, V168, P2434, DOI 10.1097/01.ju.0000030581.57555.04
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Kupelian PA, 2002, INT J RADIAT ONCOL, V52, P704, DOI 10.1016/S0360-3016(01)02778-X
   LEE LN, 2001, INT J RADIAT ONCOL, V52, P444
   Merrick GS, 2002, INT J RADIAT ONCOL, V54, P450, DOI 10.1016/S0360-3016(02)02948-6
   Nag S, 2000, Semin Urol Oncol, V18, P133
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   Potters Louis, 2002, Brachytherapy, V1, P36, DOI 10.1016/S1538-4721(02)00008-9
   SCHELLHAMMER PF, 1993, UROLOGY, V42, P13, DOI 10.1016/0090-4295(93)90325-5
   Schellhammer PF, 2000, UROLOGY, V56, P436, DOI 10.1016/S0090-4295(00)00711-1
   Stamey TA, 1998, J UROLOGY, V159, P2009, DOI 10.1016/S0022-5347(01)63229-4
   Stock RG, 1997, SEMIN SURG ONCOL, V13, P454, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<454::AID-SSU10>3.0.CO;2-T
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 2000, CANCER, V89, P1829, DOI 10.1002/1097-0142(20001015)89:8<1829::AID-CNCR25>3.0.CO;2-9
   Stock RG, 2000, INT J RADIAT ONCOL, V48, P899, DOI 10.1016/S0360-3016(00)00707-0
   STONE NN, 1995, RADIAT ONCOL INVEST, V3, P185, DOI 10.1002/roi.2970030407
   Storey MR, 1999, INT J RADIAT ONCOL, V43, P565, DOI 10.1016/S0360-3016(98)00451-9
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
   Vicini FA, 1997, J UROLOGY, V158, P319, DOI 10.1016/S0022-5347(01)64471-9
   Williamson JF, 2000, MED PHYS, V27, P634, DOI 10.1118/1.598923
   Zelefsky MJ, 1999, J CLIN ONCOL, V17, P517
   Zelefsky MJ, 2000, INT J RADIAT ONCOL, V47, P1261, DOI 10.1016/S0360-3016(00)00550-2
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
   ZELEFSKY MJ, 1995, J CLIN ONCOL, V13, P459
NR 34
TC 100
Z9 104
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD NOV 1
PY 2003
VL 57
IS 3
BP 645
EP 653
DI 10.1016/S0360-3016(03)00627-8
PG 9
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 730GQ
UT WOS:000185821200006
PM 14529768
ER

PT J
AU Jackson, BP
   Bertsch, PM
AF Jackson, BP
   Bertsch, PM
TI Determination of arsenic speciation in poultry wastes by IC-ICP-MS
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID PLASMA-MASS SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; ION
   CHROMATOGRAPHY; FLY-ASH; LAND APPLICATION; SOIL SOLUTION; GROUNDWATER;
   SOLUBILITY; BANGLADESH; LITTER
AB The aromatic organoarsenic compounds 4-hydroxy 3-nitrobenzenearsenic acid (Roxarsone, ROX) or 4-aminobenzenearsenic acid (p-arsanilic acid, p-ASA) are used as feed additives in the poultry industry for disease control and enhanced feed efficiency. While federal regulations govern acceptable As concentrations in edible tissue, elevated As concentrations occur in poultry litter, which raises concerns over repeated land application of poultry litter in agriculture. As a precursor to studying the fate of these organoarsenic compounds in soils, three speciation methodologies were developed to separate ROX and p-ASA from the more common and more toxic As species arsenate, arsenite, dimethyl arsenic acid (DMA), and monomethyl arsenic acid (MMA). The six arsenic species were separated on a Dionex AS14 column using a PO4 eluant, an AS16 column using a OH- eluant, and an AS7 column using a HNO3 eluant. While all three methods provided detection limits below 0.5 mug L-1 for all species, detection limits were lowest for the AS16 and AS7 columns, where all detection limits were generally < 0.05 mug L-1. The major arsenic species in a water extract of a poultry litter sample was identified as ROX by all three methods with trace concentrations of DMA and As(V) also detected. The AS14 and AS16 separations also revealed a number of unidentified As species present at low concentrations, presumably metabolites of ROX. This methodology should prove useful in identifying organoarsenic compounds and the more toxic inorganic species in soils subject to poultry litter application.
C1 Univ Georgia, Savannah River Ecol Lab, Adv Analyt Ctr Environm Sci, Aiken, SC 29802 USA.
RP Jackson, BP (reprint author), Univ Georgia, Savannah River Ecol Lab, Adv Analyt Ctr Environm Sci, Aiken, SC 29802 USA.
CR Alloway B. J., 1995, HEAVY METALS SOILS, P38
   Andreae M.O., 1986, ORGANOMETALLIC COMPO, P198
   BOWELL RJ, 1994, APPL GEOCHEM, V9, P15, DOI 10.1016/0883-2927(94)90048-5
   CHERRY JA, 1979, J HYDROL, V43, P373, DOI 10.1016/0022-1694(79)90182-3
   DEAN JR, 1994, J ANAL ATOM SPECTROM, V9, P615, DOI 10.1039/ja9940900615
   Gao S, 1997, J ENVIRON QUAL, V26, P753
   INOUE Y, 1994, J CHROMATOGR A, V675, P149, DOI 10.1016/0021-9673(94)85269-3
   Jackson BP, 1998, J ANAL ATOM SPECTROM, V13, P1107, DOI 10.1039/a806159i
   Jackson BP, 2000, SOIL SCI SOC AM J, V64, P1616
   Jackson BP, 1999, J ENVIRON QUAL, V28, P639
   Jackson BP, 1999, ENVIRON SCI TECHNOL, V33, P270, DOI 10.1021/es980409c
   Jackson BP, 2000, J ENVIRON QUAL, V29, P430
   Karim M, 2000, WATER RES, V34, P304, DOI 10.1016/S0043-1354(99)00128-1
   KINGERY WL, 1994, J ENVIRON QUAL, V23, P139
   LARSEN EH, 1994, J ANAL ATOM SPECTROM, V9, P1099, DOI 10.1039/ja9940901099
   Manning BA, 1997, ENVIRON SCI TECHNOL, V31, P2005, DOI 10.1021/es9608104
   MASSCHELEYN PH, 1991, ENVIRON SCI TECHNOL, V25, P1414, DOI 10.1021/es00020a008
   Mattusch J, 1998, ANAL CHEM, V70, P3649, DOI 10.1021/ac9802574
   MOORE PA, 1998, AGR USES MUNICIPAL A
   Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387
   Onken BM, 1996, SOIL SCI SOC AM J, V60, P1385
   Pergantis SA, 1997, ANALYST, V122, P1063, DOI 10.1039/a702691i
   SHEPPARD BS, 1992, ANALYST, V117, P971, DOI 10.1039/an9921700971
   STRINGER CE, 1979, ANAL CHEM, V51, P731, DOI 10.1021/ac50042a035
   United States Environmental Protection Agency (USEPA), 1993, FED REG, V58, P9387
   Webster GK, 1996, J AOAC INT, V79, P1012
   WOOLSON EA, 1973, ENVIRON SCI TECHNOL, V7, P47, DOI 10.1021/es60073a008
NR 27
TC 100
Z9 110
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD DEC 15
PY 2001
VL 35
IS 24
BP 4868
EP 4873
DI 10.1021/es0107172
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 502UF
UT WOS:000172760600023
PM 11775163
ER

PT J
AU Taylor, AM
   Thorne, SA
   Rubens, MB
   Jhooti, P
   Keegan, J
   Gatehouse, PD
   Wiesmann, F
   Grothues, F
   Somerville, J
   Pennell, DJ
AF Taylor, AM
   Thorne, SA
   Rubens, MB
   Jhooti, P
   Keegan, J
   Gatehouse, PD
   Wiesmann, F
   Grothues, F
   Somerville, J
   Pennell, DJ
TI Coronary artery imaging in grown up congenital heart disease -
   Complementary role of magnetic resonance and X-ray coronary angiography
SO CIRCULATION
LA English
DT Article
DE magnetic resonance imaging; arteries; heart disease, congenital;
   angiography
ID TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ANOMALOUS ORIGIN; MR-ANGIOGRAPHY;
   PULMONARY TRUNK; IDENTIFICATION; ADULTS; TETRALOGY; FALLOT; DIAGNOSIS;
   CONTRAST
AB Background-There is a high incidence of anomalous coronary arteries in subjects with congenital heart disease. These abnormalities can be responsible for myocardial ischemia and sudden death or be damaged during surgical intervention. It can be difficult to define the proximal course of anomalous coronary arteries with the use of conventional x-ray coronary angiography. Magnetic resonance coronary angiography (MRCA) has been shown to be useful in the assessment of the 3-dimensional relationship between the coronary arteries and the great vessels in subjects with normal cardiac morphology but has not been used in patients with congenital heart disease.
   Methods and Results-Twenty-five adults with various congenital heart abnormalities were studied. X-ray coronary angiography and respiratory-gated MRCA were performed in all subjects. Coronary artery origin and proximal course were assessed for each imaging modality by separate, blinded investigators, images were then compared, and a consensus diagnosis was reached. With the consensus readings for both magnetic resonance and x-ray coronary angiography, it was possible to identify the origin and course of the proximal coronary arteries in all 25 subjects: 16 with coronary anomalies and 9 with normal coronary arteries. Respiratory-gated MRCA had an accuracy of 92%, a sensitivity of 88%, and a specificity of 100% for the detection of abnormal coronary arteries. The MRCA results were more likely to agree with the consensus for definition of the proximal course of the coronary arteries (P<0.02).
   Conclusions-For the assessment of anomalous coronary artery anatomy in patients with congenital heart discase, the use of the combination of MRCA with x-ray coronary angiography improves the definition of the proximal coronary artery course. MRCA provides correct spatial relationships, whereas x-ray angiography provides a view of the entire coronary length and its peripheral run-off. Further more, respiratory-gated MRCA can be performed without breath holding and with only limited subject cooperation.
C1 Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England.
   Royal Brompton Hosp, Jane Somerville Grown Up Congenit Heart Unit, London SW3 6LY, England.
   Royal Brompton Hosp, Dept Radiol, London SW3 6LY, England.
RP Pennell, DJ (reprint author), Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, Sydney St, London SW3 6NP, England.
RI Taylor, Andrew/C-4311-2008
CR BITTL JA, 1997, HEART DIS TXB CARDIO, P259
   BRITTAIN JH, 1995, MAGNET RESON MED, V33, P689, DOI 10.1002/mrm.1910330515
   CARVALHO JS, 1993, BRIT HEART J, V70, P75
   CHEITLIN MD, 1974, CIRCULATION, V50, P780
   CLICK RL, 1989, J AM COLL CARDIOL, V13, P531
   DABIZZI RP, 1990, EUR HEART J, V11, P692
   Danias PG, 1997, RADIOLOGY, V203, P733
   DONALDSON RM, 1982, THORAC CARDIOV SURG, V30, P7, DOI 10.1055/s-2007-1022198
   DONALDSON RM, 1983, CATHETER CARDIO DIAG, V9, P237, DOI 10.1002/ccd.1810090303
   GAITHER NS, 1991, AM HEART J, V122, P69, DOI 10.1016/0002-8703(91)90760-F
   Hardy CJ, 1998, MAGNET RESON MED, V40, P105, DOI 10.1002/mrm.1910400115
   HIRSCH R, 1994, CIRCULATION, V90, P2937
   HOFFMAN JIE, 1995, HEART DIS INFANTS CH, P769
   ISHIKAWA T, 1985, AM J CARDIOL, V55, P770, DOI 10.1016/0002-9149(85)90154-7
   Jhooti P, 1998, JMRI-J MAGN RESON IM, V8, P968, DOI 10.1002/jmri.1880080428
   Jhooti P, 1999, MAGNET RESON MED, V41, P555, DOI 10.1002/(SICI)1522-2594(199903)41:3<555::AID-MRM19>3.0.CO;2-I
   Kasprzak JD, 1998, INT J CARDIAC IMAG, V14, P89, DOI 10.1023/A:1006093401010
   KRAGEL AH, 1988, AM J CARDIOL, V62, P771, DOI 10.1016/0002-9149(88)91220-9
   LANDOLT CC, 1986, ANN THORAC SURG, V41, P351
   Li DB, 1998, MAGNET RESON MED, V39, P1014, DOI 10.1002/mrm.1910390621
   LIU YL, 1993, MAGNET RESON MED, V30, P507, DOI 10.1002/mrm.1910300416
   MARSHALL J, 1990, AM HEART J, V119, P677, DOI 10.1016/S0002-8703(05)80296-0
   MCCONNELL MV, 1995, CIRCULATION, V92, P3158
   MEYER J, 1975, J CARDIOVASC SURG, V16, P500
   Oshinski JN, 1996, RADIOLOGY, V201, P737
   OSULLIVAN J, 1994, BRIT HEART J, V71, P102
   POST JC, 1995, CIRCULATION, V92, P3163
   SACHS TS, 1994, MAGNET RESON MED, V32, P639, DOI 10.1002/mrm.1910320513
   SANDERS SP, 1989, J AM COLL CARDIOL, V13, P922
   SEROTA H, 1990, AM J CARDIOL, V65, P891, DOI 10.1016/0002-9149(90)91432-6
   Taylor AM, 1999, JMRI-J MAGN RESON IM, V9, P220, DOI 10.1002/(SICI)1522-2586(199902)9:2<220::AID-JMRI11>3.0.CO;2-A
   Taylor AM, 1997, JMRI-J MAGN RESON IM, V7, P629, DOI 10.1002/jmri.1880070404
   THOMAS D, 1991, EUR HEART J, V12, P832
   TOPAZ O, 1992, INT J CARDIOL, V34, P129, DOI 10.1016/0167-5273(92)90148-V
   Vliegen HW, 1997, AM J CARDIOL, V79, P773
   Weinberg Paul M., 1998, Cardiology Clinics, V16, P315, DOI 10.1016/S0733-8651(05)70015-1
   Yang GZ, 1998, MAGNET RESON MED, V39, P833, DOI 10.1002/mrm.1910390521
   Zeppilli P, 1998, CHEST, V114, P89, DOI 10.1378/chest.114.1.89
NR 38
TC 99
Z9 110
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD APR 11
PY 2000
VL 101
IS 14
BP 1670
EP 1678
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 302MB
UT WOS:000086367900019
PM 10758049
ER

PT J
AU Moses, EI
   Boyd, RN
   Remington, BA
   Keane, CJ
   Al-Ayat, R
AF Moses, E. I.
   Boyd, R. N.
   Remington, B. A.
   Keane, C. J.
   Al-Ayat, R.
TI The National Ignition Facility: Ushering in a new age for high energy
   density science
SO PHYSICS OF PLASMAS
LA English
DT Article; Proceedings Paper
CT Meeting of the American-Physical-Society
CY APR, 2008
CL St Louis, MO
SP Amer Phys Soc
ID INERTIAL-CONFINEMENT FUSION; ULTRA-INTENSE LASERS; EQUATION-OF-STATE;
   X-RAY-DIFFRACTION; SUPERNOVA HYDRODYNAMICS; ABSORPTION-MEASUREMENTS;
   VOYAGER MEASUREMENTS; GLOBULAR-CLUSTERS; HELIUM ABUNDANCE; DRIVEN SHOCKS
AB The National Ignition Facility (NIF) [E. I. Moses, J. Phys.: Conf. Ser. 112, 012003 (2008); https://lasers.llnl.gov/], completed in March 2009, is the highest energy laser ever constructed. The high temperatures and densities achievable at NIF will enable a number of experiments in inertial confinement fusion and stockpile stewardship, as well as access to new regimes in a variety of experiments relevant to x-ray astronomy, laser-plasma interactions, hydrodynamic instabilities, nuclear astrophysics, and planetary science. The experiments will impact research on black holes and other accreting objects, the understanding of stellar evolution and explosions, nuclear reactions in dense plasmas relevant to stellar nucleosynthesis, properties of warm dense matter in planetary interiors, molecular cloud dynamics and star formation, and fusion energy generation. (C) 2009 American Institute of Physics. [DOI: 10.1063/1.3116505]
C1 [Moses, E. I.; Boyd, R. N.; Remington, B. A.; Keane, C. J.; Al-Ayat, R.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Moses, EI (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
CR AHUJA R, 1994, PHYS REV B, V50, P14690, DOI 10.1103/PhysRevB.50.14690
   Azechi H, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/1/012002
   BAHCALL JN, 1982, REV MOD PHYS, V54, P767, DOI 10.1103/RevModPhys.54.767
   Bailey JE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.265002
   Bao ZY, 2000, ATOM DATA NUCL DATA, V76, P70, DOI 10.1006/adnd.2000.0838
   Barty CPJ, 2004, NUCL FUSION, V44, pS266, DOI 10.1088/0029-5515/44/12/S18
   Bazan G, 2003, ASTR SOC P, V293, P1
   Bazan G, 1998, ASTROPHYS J, V496, P316, DOI 10.1086/305346
   BEER H, 1984, ASTROPHYS J, V278, P388, DOI 10.1086/161804
   Besnard D, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/1/012004
   Bettinger A, 1999, FUSION ENG DES, V46, P457, DOI 10.1016/S0920-3796(99)00037-X
   Boehly TR, 1999, FUSION ENG DES, V44, P35, DOI 10.1016/S0920-3796(98)00276-2
   BOYD RN, 2008, INTRO NUCL ASTROPHYS, P62308
   Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239
   Campbell EM, 1997, LASER PART BEAMS, V15, P607
   Celliers PM, 2000, PHYS REV LETT, V84, P5564, DOI 10.1103/PhysRevLett.84.5564
   Celliers PM, 2004, PHYS PLASMAS, V11, pL41, DOI 10.1063/1.1758944
   CELLIERS PM, 2004, PHYS REV LETT, V69, P2308
   Conrath BJ, 2000, ICARUS, V144, P124, DOI 10.1006/icar.1999.6265
   CONRATH BJ, 1984, ASTROPHYS J, V282, P807, DOI 10.1086/162267
   Dappen W, 2007, AIP CONF PROC, V948, P179, DOI 10.1063/1.2818968
   Dappen W, 2006, J PHYS A-MATH GEN, V39, P4441, DOI 10.1088/0305-4470/39/17/S19
   DASILVA LB, 1992, PHYS REV LETT, V69, P438, DOI 10.1103/PhysRevLett.69.438
   Dearborn DSP, 2006, ASTROPHYS J, V639, P405, DOI 10.1086/499263
   Dimonte G, 1996, PHYS PLASMAS, V3, P614, DOI 10.1063/1.871889
   Drake RP, 1999, J GEOPHYS RES-SPACE, V104, P14505, DOI 10.1029/98JA02829
   Dunne M, 2006, NAT PHYS, V2, P2, DOI 10.1038/nphys208
   Ebrardt J, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/3/032005
   Edwards J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.075002
   Eggert J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.124503
   Eggleton PP, 2006, SCIENCE, V314, P1580, DOI 10.1126/science.1133065
   Ferrarese L, 1996, ASTROPHYS J, V470, P444, DOI 10.1086/177876
   Foord ME, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.055002
   Fortney JJ, 2003, ICARUS, V164, P228, DOI 10.1016/S0019-1035(03)00130-1
   GROSSMAN AS, 1980, ICARUS, V42, P358, DOI 10.1016/0019-1035(80)90102-5
   HAAN SW, 1989, PHYS REV A, V39, P5812, DOI 10.1103/PhysRevA.39.5812
   Haan SW, 2006, FUSION SCI TECHNOL, V49, P553
   HAWRELIAK J, 2007, PHYS REV B, V74, P2308
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   Heeter RF, 2001, REV SCI INSTRUM, V72, P1224, DOI 10.1063/1.1324749
   Imbriani G, 2004, ASTRON ASTROPHYS, V420, P625, DOI 10.1051/0004-6361:20040981
   Jimenez-Garate MA, 2002, ASTROPHYS J, V581, P1297
   JOHNSON RP, J PHYS CONF SE UNPUB, P62308
   Kalantar DH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.075502
   Key MH, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2719178
   Kifonidis K, 2006, ASTRON ASTROPHYS, V453, P661, DOI 10.1051/0004-6361:20054512
   Knudson MD, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.035505
   Koch JA, 2008, HIGH ENERG DENS PHYS, V4, P1, DOI 10.1016/j.hedp.2007.09.001
   Koenig M, 2004, NUCL FUSION, V44, pS208, DOI 10.1088/0029-5515/44/12/S11
   Lemut A, 2006, PHYS LETT B, V634, P483, DOI 10.1016/j.physletb.2006.02.021
   LIBBY SB, 2004, INERTIAL FUSION SCI, P935
   Liedahl DA, 1996, ASTROPHYS J, V468, pL33, DOI 10.1086/310217
   Lin CH, 2005, ASTROPHYS J, V623, P556, DOI 10.1086/428447
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   LINDL JD, 1998, INERTIAL CONFINEMENT, P62308
   Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638
   Lorenz K. T., 2006, High Energy Density Physics, V2, DOI 10.1016/j.hedp.2006.08.001
   Marinak MM, 1998, PHYS REV LETT, V80, P4426, DOI 10.1103/PhysRevLett.80.4426
   Matzen MK, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1891746
   MATZEN MK, 2007, 2007 IEEE PULS UNPUB, V1, P1
   Maywar DN, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/3/032007
   McCrory RL, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2837048
   Miller GH, 2004, OPT ENG, V43, P2841, DOI [10.1117/1.1814767, 10.1117/1.1814787]
   Mima K, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/1/012005
   MONCUR NK, 1995, APPL OPTICS, V34, P4274, DOI 10.1364/AO.34.004274
   Moses EI, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/1/012003
   *NAT AC SCI NAT RE, 2003, CONN QUARKS COSM 11, P62308
   *NAT IGN CAMP EX P, 2006, UCRLAR213718 LLNL NA, P62308
   *NAT IGN CAMP EX P, 2006, NIF0111975AB LLNL NA, P62308
   *NAT SCI TECHN COU, 2007, REP INT TASK FORC HI, P62308
   NG A, 2007, UCRLTR520000712 LLNL, P62308
   Niemeyer JC, 1999, ASTROPHYS J, V524, P290, DOI 10.1086/307813
   Paerels F, 2000, ASTROPHYS J, V533, pL135, DOI 10.1086/312608
   Park H, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/4/042024
   Park HS, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2957918
   PERRY TS, 1991, PHYS REV LETT, V67, P3784, DOI 10.1103/PhysRevLett.67.3784
   POLLACK JB, 1977, ICARUS, V30, P111, DOI 10.1016/0019-1035(77)90126-9
   Pols OR, 1998, MON NOT R ASTRON SOC, V298, P525, DOI 10.1046/j.1365-8711.1998.01658.x
   Remington BA, 2006, REV MOD PHYS, V78, P755, DOI 10.1103/RevModPhys.78.755
   REMINGTON BA, 1997, SCI TECHNOLOGY REV, P4
   REMINGTON BA, 1995, PHYS PLASMAS, V2, P241, DOI 10.1063/1.871096
   REMINGTON BA, HIGH ENERGY DE UNPUB, P62308
   Remington BA, 1997, PHYS PLASMAS, V4, P1994, DOI 10.1063/1.872341
   RENZINI A, 1988, ANNU REV ASTRON ASTR, V26, P199
   RHODES MA, 1995, APPL OPTICS, V34, P5312, DOI 10.1364/AO.34.005312
   RIPIN BH, 1990, LASER PART BEAMS, V8, P183
   Rose SJ, 2004, J PHYS B-AT MOL OPT, V37, pL337, DOI 10.1088/0953-4075/37/17/L05
   ROSE SJ, 1991, LASER PART BEAMS, V9, P869
   Ryutov D, 1999, ASTROPHYS J, V518, P821, DOI 10.1086/307293
   Saumon D, 2004, ASTROPHYS J, V609, P1170, DOI 10.1086/421257
   Scott HA, 2001, J QUANT SPECTROSC RA, V71, P689, DOI 10.1016/S0022-4073(01)00109-1
   Smalyuk VA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.025002
   SODERLIND P, 1994, PHYS REV B, V49, P9365, DOI 10.1103/PhysRevB.49.9365
   SPRINGER PT, 1992, PHYS REV LETT, V69, P3735, DOI 10.1103/PhysRevLett.69.3735
   STEVENSON DJ, 1977, ASTROPHYS J SUPPL S, V35, P239, DOI 10.1086/190479
   Suter LJ, 2004, PHYS PLASMAS, V11, P2738, DOI 10.1063/1.1687725
   TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664
   Takabe H, 2001, PROG THEOR PHYS SUPP, P202
   TAKAHASHI K, 1987, ATOM DATA NUCL DATA, V36, P375, DOI 10.1016/0092-640X(87)90010-6
   Tommasini R, 2007, AIP CONF PROC, V926, P248, DOI 10.1063/1.2768857
   Wark J, 2007, AIP CONF PROC, V955, P1345, DOI 10.1063/1.2832973
   WARK JS, 1992, APPL PHYS LETT, V61, P651, DOI 10.1063/1.107811
   WARK JS, 2005, SHOCK COMPRESSION CO, P62308
   WARK JS, 1989, PHYS REV B, V40, P5705, DOI 10.1103/PhysRevB.40.5705
   Waxer LJ, 2005, OPT PHOTONICS NEWS, V16, P30, DOI 10.1364/OPN.16.7.000030
   Wheeler JC, 2008, ASTROPHYS J, V677, P1091, DOI 10.1086/528366
   Wisshak K, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.015802
   Wisshak K, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.065801
   Yaakobi B, 2004, PHYS PLASMAS, V11, P2688, DOI [10.1063/1.1646673, 10.1063/1.1644673]
   Yaakobi B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.075501
   Yaakobi B, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095504
   Yaakobi B, 2005, PHYS PLASMAS, V12, DOI [10.1063/1.1928193, 10.1063/1.2036887]
   Yaakobi B, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2938749
   Yaakobi B, 2003, J OPT SOC AM B, V20, P238, DOI 10.1364/JOSAB.20.000238
   YOUNG DA, 1991, PHASE DIAGRAMS ELEME, P62308
   ZHANG WY, 2008, J PHYS C SER, V112, P62308
   Zheng WG, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/3/032009
   2002, SAUUL WORKSH W UNPUB, P62308
   2003, FRONTIERS HIGH ENERG, P62308
NR 119
TC 98
Z9 101
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 1070-664X
J9 PHYS PLASMAS
JI Phys. Plasmas
PD APR
PY 2009
VL 16
IS 4
AR 041006
DI 10.1063/1.3116505
PG 13
WC Physics, Fluids & Plasmas
SC Physics
GA 456XI
UT WOS:000266885800009
ER

PT J
AU Malsam, J
   Kreye, S
   Sollner, TH
AF Malsam, J.
   Kreye, S.
   Soellner, T. H.
TI Membrane fusion: SNAREs and regulation
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Review
DE exocytosis; fusion; vesicle; tether; synaptotagmin; SM protein; Munc13;
   complexin
ID SYNAPTIC-VESICLE FUSION; N-TERMINAL DOMAIN; DENSE-CORE VESICLE;
   KISS-AND-RUN; NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN-I;
   CAENORHABDITIS-ELEGANS; ACTIVE ZONE; T-SNARE; 3-DIMENSIONAL STRUCTURE
AB SNARE (SNAP receptor) proteins drive intracellular membrane fusion and contribute specificity to membrane trafficking. The formation of SNAREpins between membranes is spatially and temporally controlled by a network of sequentially acting accessory components. These regulators add an additional layer of specificity, arrest SNAREpin intermediates, lower the energy required for fusion, and couple membrane fusion to triggering signals. The functional activity of some of these regulators determines the plasticity of regulated exocytosis.
C1 [Malsam, J.; Kreye, S.; Soellner, T. H.] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany.
RP Sollner, TH (reprint author), Univ Heidelberg, Biochem Ctr, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.
EM thomas.soellner@bzh.uni-heidelberg.de
RI Wunder, Stephanie/B-5066-2012; Zdilla, Michael/B-4145-2011
FU US National Institutes of Health
FX We thank M. Franke-Schaub for editorial assistance. T. H. S. is
   supported by a grant from the US National Institutes of Health.
CR Ales E, 1999, NAT CELL BIOL, V1, P40
   Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746
   Antonin W, 2002, J BIOL CHEM, V277, P36449, DOI 10.1074/jbc.M204369200
   Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200
   Arac D, 2005, J MOL BIOL, V346, P589, DOI 10.1016/j.jmb.2004.12.004
   Aravamudan B, 1999, NAT NEUROSCI, V2, P965
   Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200
   Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662
   Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768
   Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055
   Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199
   Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709
   Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258
   Basu J, 2007, J NEUROSCI, V27, P1200, DOI 10.1523/JNEUROSCI.4908-06.2007
   BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498
   Bethani I, 2007, EMBO J, V26, P3981, DOI 10.1038/sj.emboj.7601820
   Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6
   Betz A, 1997, J BIOL CHEM, V272, P2520
   Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076
   BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852
   Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608
   Braun S, 2007, EMBO REP, V8, P1176, DOI 10.1038/sj.embor.7401105
   BRENNER S, 1974, GENETICS, V77, P71
   BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771
   Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7
   Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380
   Bryant NJ, 2003, J CELL BIOL, V161, P691, DOI 10.1083/jcb.200212078
   Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37
   Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005
   Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024
   Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333
   Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a
   Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591
   Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000
   Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4
   Coe JGS, 1999, MOL BIOL CELL, V10, P2407
   Conibear E, 2000, MOL BIOL CELL, V11, P305
   Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200
   Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43
   D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200
   Danglot L, 2007, BIOL CELL, V99, P349, DOI 10.1042/BC20070029
   Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8
   Davletov B, 2007, CELL MOL LIFE SCI, V64, P1597, DOI 10.1007/s00018-007-6557-5
   DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5
   Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104
   Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381
   Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372
   Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753
   Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012
   Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002
   Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781
   Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0
   Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004
   Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438
   Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9
   Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200
   Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084
   Gao ZY, 2000, J BIOL CHEM, V275, P36079, DOI 10.1074/jbc.M004284200
   GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8
   Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328
   Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450
   Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200
   Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261
   Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321
   Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007
   Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x
   Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103
   Grote E, 2000, J CELL BIOL, V151, P453, DOI 10.1083/jcb.151.2.453
   Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m
   Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071
   Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198
   Hammarlund M, 2008, J CELL BIOL, V180, P483, DOI [10.1083/jcb.200708018, 10.1083/icb.200708018]
   Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801
   Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7
   Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8
   HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0
   Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200
   HAYASHI T, 1994, EMBO J, V13, P5051
   Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j
   Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0
   Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077
   Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7
   Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493
   Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909
   Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104
   Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005
   Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798
   Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102
   Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980
   Inoue E, 2006, GENES CELLS, V11, P659, DOI 10.1111/j.1365-2443.2006.00970.x
   ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241
   Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756
   Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002
   Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007
   Kim D. Kyle, 1997, Proceedings of the National Academy of Sciences of the United States of America, V94, P14782, DOI 10.1073/pnas.94.26.14782
   Kohn RE, 2000, MOL BIOL CELL, V11, P3441
   Kosodo Y, 2002, J CELL SCI, V115, P3683, DOI 10.1242/jcs.00027
   Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732
   Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072
   Lang T, 2007, J PHYSIOL-LONDON, V585, P693, DOI 10.1113/jphysiol.2007.134346
   Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088
   Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x
   LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0
   Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310
   LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888
   Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198
   LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109
   Lu XB, 2005, J BIOL CHEM, V280, P30538, DOI 10.1074/jbc.M506862200
   Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846
   Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200
   Margittai M, 2003, BIOCHEMISTRY-US, V42, P4009, DOI 10.1021/bi027437z
   Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614
   Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141
   MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729
   Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1
   MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257
   Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3
   McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2
   MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2
   McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105
   McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3
   McNew JA, 2000, NATURE, V407, P153
   Melia TJ, 2007, FEBS LETT, V581, P2131, DOI 10.1016/j.febslet.2007.02.066
   Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081
   Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120
   Munson M, 2000, NAT STRUCT BIOL, V7, P894
   Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097
   Nielsen E, 2000, J CELL BIOL, V151, P601
   Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004
   NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2
   Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083
   Oka T, 2005, J BIOCHEM, V137, P109, DOI 10.1093/jb/mvi024
   Ozaki N, 2000, NAT CELL BIOL, V2, P805
   Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200
   Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103
   Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006
   Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899
   Parlati F, 2000, NATURE, V407, P194
   Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006
   Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006
   PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0
   PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445
   Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486
   Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200
   Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1
   Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231
   Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722
   Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1
   Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115
   Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583
   Richmond JE, 1999, NAT NEUROSCI, V2, P959
   Rieder SE, 1997, MOL BIOL CELL, V8, P2307
   Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915
   Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002
   Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494
   Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002
   Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755
   Sassa T, 1999, J NEUROSCI, V19, P4772
   Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2
   Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124
   Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327
   Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a
   Schultz J, 2000, NAT GENET, V25, P201
   Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018
   Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402
   Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0
   Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016
   Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200
   Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127
   Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727
   Simonsen A, 1998, NATURE, V394, P494
   Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857
   SINIOSSOGLOU S, 2002, J BIOL CHEM, V107, P1
   SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0
   SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2
   Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013
   Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007
   Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055
   Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270
   Sun L, 2001, J BIOL CHEM, V276, P12911, DOI 10.1074/jbc.M011110200
   Sutton RB, 1998, NATURE, V395, P347
   Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005
   Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030
   Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030
   TerBush DR, 1996, EMBO J, V15, P6483
   Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950
   Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103
   Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x
   Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008
   Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196
   Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004
   van Weering JRT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000616
   VanRheenen SM, 1999, J CELL BIOL, V147, P729, DOI 10.1083/jcb.147.4.729
   Varlamov O, 2004, J CELL BIOL, V164, P79, DOI 10.1083/jcb.200307066
   Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799
   Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864
   Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3
   Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9
   Wang CT, 2006, J PHYSIOL-LONDON, V570, P295, DOI 10.1113/jphysiol.2005.097378
   Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857
   Wang Y, 2001, J BIOL CHEM, V276, P28598, DOI 10.1074/jbc.M101644200
   Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199
   Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1
   Wang Y, 1997, NATURE, V388, P593
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999
   Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063
   Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X
   Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010
   WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0
   Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6
   Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200
   Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551
   Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4
   Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921
   Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292
   Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9
   Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015
   Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032
   Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467
NR 219
TC 97
Z9 99
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1420-682X
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD SEP
PY 2008
VL 65
IS 18
BP 2814
EP 2832
DI 10.1007/s00018-008-8352-3
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 351WX
UT WOS:000259457700005
PM 18726177
ER

PT J
AU Widimsky, P
   Straka, Z
   Stros, P
   Jirasek, K
   Dvorak, J
   Votava, J
   Lisa, L
   Budesinsky, T
   Kolesar, M
   Vanek, T
   Brucek, P
AF Widimsky, P
   Straka, Z
   Stros, P
   Jirasek, K
   Dvorak, J
   Votava, J
   Lisa, L
   Budesinsky, T
   Kolesar, M
   Vanek, T
   Brucek, P
TI One-year coronary bypass graft patency - A randomized comparison between
   off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial
SO CIRCULATION
LA English
DT Article
DE angiography; coronary artery bypass; heart; surgery
ID INTERNAL MAMMARY ARTERY; SAPHENOUS-VEIN GRAFTS; CARDIOPULMONARY BYPASS;
   CLINICAL OUTCOMES; BEATING HEART; RISK-FACTORS; ASPIRIN;
   REVASCULARIZATION; LIPOPROTEIN(A); DIPYRIDAMOLE
AB Background - Off-pump coronary bypass surgery has become a widely used technique during recent years. However, limited data are available with regard to 1-year patency of bypass grafts implanted on the beating heart in unselected consecutive bypass surgery candidates. The aim of this study was to compare 1-year angiographic patency of bypass grafts done on the beating heart ( off pump) with those done classically ( on pump).
   Methods and Results - The PRAGUE-4 trial randomized 400 consecutive nonselected cardiac surgery candidates into group A ( on pump; n = 192) and group B ( off pump; n = 208). One-year follow-up coronary angiography was done in 255 patients. The arterial graft patency after 1 year was 91% in both groups. Saphenous graft patency was 59% ( on pump) versus 49% ( off pump; P = NS). Saphenous graft patency per patient was lower in the off-pump group: 0.7 patent anastomosis per patient versus 1.1 patent anastomosis in the on-pump group ( P < 0.01). There were 46% on- pump patients with all grafts patent versus 52% off-pump patients ( P = NS). Grafts anastomosed distally to collateralized chronic total occlusions of native coronary arteries remained patent in 100% on the left anterior descending artery compared with 23% on other arteries ( P < 0.0001).
   Conclusions - The patency of arterial coronary bypass grafts done on the beating heart is excellent and equal to grafts done on pump. The off-pump procedure in the unselected patient population results in fewer patent saphenous grafts per patient.
C1 Charles Univ, Hosp Kralovske Vinohrady, Med Sch 3, Cardioctr, Prague, Czech Republic.
RP Widimsky, P (reprint author), Univ Hosp Vinohrady, Cardioctr, Srobarova 50, Prague 10034 10, Czech Republic.
EM widim@fnkv.cz
CR Alderman EL, 1996, ANN THORAC SURG, V62, pS22, DOI 10.1016/0003-4975(96)00824-7
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6
   Berger PB, 1999, CIRCULATION, V100, P2353
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   CATALDO G, 1993, CIRCULATION, V88, P93
   CHOW MST, 1994, CIRCULATION, V90, P129
   Christenson JT, 1998, CARDIOVASC SURG, V6, P389, DOI 10.1016/S0967-2109(98)00024-6
   Diegeler A, 1999, THORAC CARDIOV SURG, V47, P14, DOI 10.1055/s-2007-1013101
   ERITSLAND J, 1994, AM J CARDIOL, V74, P1099, DOI 10.1016/0002-9149(94)90459-6
   Farsak B, 2002, HEART SURG FORUM, V5, P358
   GAVAGHAN TP, 1991, CIRCULATION, V83, P1526
   GOLDMAN S, 1994, CIRCULATION, V89, P1138
   GOLDMAN S, 1991, CIRCULATION, V84, P520
   Hernandez F, 2001, ANN THORAC SURG, V72, P1528, DOI 10.1016/S0003-4975(01)03202-7
   HOCKINGS BEF, 1993, MED J AUSTRALIA, V159, P376
   IAFFALDANO RA, 1995, CHEST, V108, P725, DOI 10.1378/chest.108.3.725
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kim KB, 2001, ANN THORAC SURG, V72, P1033
   LAWRIE GM, 1991, ANN SURG, V213, P377, DOI 10.1097/00000658-199105000-00001
   Lund O, 2001, EUR J CARDIO-THORAC, V20, P901, DOI 10.1016/S1010-7940(01)00972-1
   Mack MJ, 1998, ANN THORAC SURG, V66, P1055, DOI 10.1016/S0003-4975(98)00815-7
   McKay R G, 2001, Conn Med, V65, P515
   NWASOKWA ON, 1995, ANN INTERN MED, V123, P528
   Omeroglu SN, 2000, ANN THORAC SURG, V70, P844, DOI 10.1016/S0003-4975(00)01567-8
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Pokrovsky SN, 2003, J THORAC CARDIOV SUR, V126, P1071, DOI 10.1016/S0022-5223(03)00365-9
   Puskas J D, 1999, Heart Surg Forum, V2, P216
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   RAJAH SM, 1994, J THORAC CARDIOV SUR, V107, P1146
   Schwartz L, 2002, CIRCULATION, V106, P2652, DOI 10.1161/01.CIR.0000038885.94771.43
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Straka Z, 2002, ANN THORAC SURG, V74, P1544, DOI 10.1016/S0003-4975(02)03934-6
   Straka Z, 1998, Rozhl Chir, V77, P139
   Tan ES, 1999, J AM COLL CARDIOL, V34, P1760, DOI 10.1016/S0735-1097(99)00404-0
   VANDERMEER J, 1994, J AM COLL CARDIOL, V24, P1181
   VANDERMEER J, 1994, CIRCULATION, V90, P2367
   van Dijk D, 2000, CONTROL CLIN TRIALS, V21, P595, DOI 10.1016/S0197-2456(00)00103-3
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Vanek T, 2002, EUR J CARDIO-THORAC, V21, P369, DOI 10.1016/S1010-7940(01)01085-5
   Vural KM, 2001, EUR J CARDIO-THORAC, V19, P140, DOI 10.1016/S1010-7940(00)00629-1
NR 42
TC 96
Z9 100
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD NOV 30
PY 2004
VL 110
IS 22
BP 3418
EP 3423
DI 10.1161/01.CIR.0000148139.79580.36
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 875CT
UT WOS:000225398000005
PM 15557371
ER

PT J
AU Gordon, WA
   Zafonte, R
   Cicerone, K
   Cantor, J
   Brown, M
   Lombard, L
   Goldsmith, R
   Chandna, T
AF Gordon, WA
   Zafonte, R
   Cicerone, K
   Cantor, J
   Brown, M
   Lombard, L
   Goldsmith, R
   Chandna, T
TI Traumatic brain injury rehabilitation - State of the science
SO AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
LA English
DT Review
DE traumatic brain injury; rehabilitation research; outcomes
ID POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; RANDOMIZED
   CONTROLLED-TRIAL; SEVERE HEAD-INJURY; PLACEBO-CONTROLLED TRIAL;
   MOTOR-VEHICLE ACCIDENTS; DEEP VENOUS THROMBOSIS; INTRACRANIAL
   HEMORRHAGIC INJURIES; MAGNETIC-RESONANCE-SPECTROSCOPY; INFUSED
   INTRATHECAL BACLOFEN
C1 Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA.
   Univ Pittsburgh, Sch Med, Dept Rehabil Med, Pittsburgh, PA 15260 USA.
   JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ USA.
RP Gordon, WA (reprint author), Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave L Levy,Box 1240, New York, NY 10029 USA.
CR Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204
   Akman MN, 2004, ARCH PHYS MED REHAB, V85, P1091, DOI 10.1016/j.apmr.2003.10.023
   Alaranta H, 2000, Wien Med Wochenschr, V150, P444
   Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007
   Alderman N, 1999, BRAIN INJURY, V13, P669
   Anderson MC, 2004, J ORTHOP TRAUMA, V18, P190, DOI 10.1097/00005131-200403000-00013
   Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906
   Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x
   Angelino E, 2002, BRAIN INJURY, V16, P269, DOI 10.1080/02699050110103968
   Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104
   Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77
   Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213
   Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117
   Asikainen I, 1999, EUR J NEUROL, V6, P179, DOI 10.1111/j.1468-1331.1999.tb00011.x
   Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737
   Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39
   Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775
   Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x
   Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227
   Berg I, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384
   Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389
   Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135
   Bloom KK, 1998, AM J PHYS MED REHAB, V77, P157, DOI 10.1097/00002060-199803000-00017
   Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753
   Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91
   Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002
   Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.21967
   Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002
   Bounds TA, 2003, NEUROREHABILITATION, V18, P189
   Bowen A, 2001, BRAIN INJURY, V15, P29, DOI 10.1080/02699050150209101
   Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656
   Boyle GJ, 2002, PSYCHOL REP, V90, P415, DOI 10.2466/PR0.90.2.415-425
   *BRAIN TRAUM FDN, 1995, GUID MAN SEV HEAD IN
   *BRIAN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597
   Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266
   Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1
   Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899
   Bryant RA, 1998, AM J PSYCHIAT, V155, P625
   Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024
   Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836
   Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588
   Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629
   Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931
   Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006
   BRYANT RA, 2001, J NERV MENT DIS, V158, P440
   Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826
   Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/01.CCM.0000020747.28996.3B
   Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001
   Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091
   Bush BA, 2004, J CLIN PSYCHOL MED S, V11, P195, DOI 10.1023/B:JOCS.0000037613.69367.d4
   Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8
   Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092
   Canning CG, 2003, CLIN REHABIL, V17, P355, DOI 10.1191/0269215503cr620oa
   Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821
   Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285
   Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395
   Chiang MF, 2003, ACTA NEUROCHIR WIEN, V145
   Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3
   Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019
   Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1053/S0003-9993(03)00272-7
   Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864
   Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751
   Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803
   Coetzer B R, 2002, Aust J Rural Health, V10, P229, DOI 10.1046/j.1440-1584.2002.00425.x
   Coetzer BR, 2002, J COGN REHABIL, V20, P20
   Colantonio A, 2000, BRAIN COGNITION, V44, P19
   Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350
   Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433
   Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543
   Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07
   Crawford FC, 2002, NEUROLOGY, V58, P1115
   Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277
   Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA
   Danish SF, 2005, NEUROSURGERY, V56
   Dario A, 2002, ACTA NEUROL SCAND, V105, P83, DOI 10.1034/j.1600-0404.2002.1o042.x
   Denormandie P, 1999, Chir Main, V18, P99
   Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818
   Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041
   Dikmen SS, 2000, NEUROLOGY, V54, P895
   Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832
   Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343
   Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943
   Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103
   Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032
   Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010
   Edlund W., 2004, CLIN PRACTICE GUIDEL
   Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829
   Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022
   Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094
   Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006
   Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539
   Ezrachi O, 1991, J HEAD TRAUMA REHAB, V6, P71
   Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/01.wco.0000044767.39452.bf
   Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66
   Fakhry SM, 2004, J TRAUMA, V56, P499
   Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48
   Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47
   Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008
   Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25
   Feinstein A, 2000, BRAIN COGNITION, V44, P78
   Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985
   Fleming J, 1999, BRAIN INJURY, V13, P417
   Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354
   Francisco GE, 2002, AM J PHYS MED REHAB, V81, P355, DOI 10.1097/00002060-200205000-00007
   Francois B, 2001, J TRAUMA, V50, P158, DOI 10.1097/00005373-200101000-00035
   Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515
   Franulic A, 2000, BRAIN INJURY, V14, P431
   Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003
   Friedman SD, 1999, NEUROLOGY, V52, P1384
   Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306
   Gamble D, 2003, J REHABIL, V69, P31
   GAMBLE D, 2002, J APPL REHABILITATIO, V33, P41
   Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403
   Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341
   Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96
   Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004
   Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777
   Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115
   Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028
   Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557
   Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513
   Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187
   Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003
   Greve KW, 2001, BRAIN INJURY, V15, P255
   Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545
   Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835
   Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005
   Hammond FM, 2004, NEUROREHABILITATION, V19, P25
   Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4
   Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096
   Hanlon RE, 1999, BRAIN INJURY, V13, P873
   Harker WF, 2002, INT J REHABIL RES, V25, P93, DOI 10.1097/00004356-200206000-00003
   Harris JKJ, 2001, BRAIN INJURY, V15, P223
   Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3
   Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626
   Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069
   Harvey AG, 1998, BRAIN INJURY, V12, P147
   Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002
   Hattori N, 2003, J NUCL MED, V44, P1709
   Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156
   Hellawell DJ, 1999, BRAIN INJURY, V13, P489
   Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2
   Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24
   Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004
   Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116
   Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925
   Hicken BL, 2002, J REHABIL RES DEV, V39, P359
   Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227
   Hoofien D, 2001, BRAIN INJURY, V15, P189
   Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337
   Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290
   Huebner RA, 2003, AM J OCCUP THER, V57, P177
   Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370
   Iorio A, 2000, ARCH INTERN MED, V160, P2327, DOI 10.1001/archinte.160.15.2327
   Ippolito E, 1999, CLIN ORTHOP RELAT R, P130
   Ippolito E, 1999, J HAND SURG-AM, V24A, P546
   Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x
   Jang SH, 2000, YONSEI MED J, V41, P536
   Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6
   Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007
   Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098
   Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097
   Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003
   Jong CN, 1999, BRAIN INJURY, V13, P1017
   Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700
   Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42
   Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372
   Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4
   Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C
   Kant R, 1998, BRAIN INJURY, V12, P661, DOI 10.1080/026990598122223
   Karman N, 2003, J HEAD TRAUMA REHAB, V18, P259, DOI 10.1097/00001199-200305000-00004
   Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211
   Kendall E, 2003, J VOCATIONAL REHABIL, V19, P31
   Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605
   Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008
   Kim J, 2002, J TRAUMA, V53, P43
   KISHI Y, 2001, J NERV MENT DIS, V189, P923
   Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382
   Klein E, 2003, CAN J PSYCHIAT, V48, P28
   Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370
   Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4
   Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430
   Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009
   Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007
   Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27
   Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315
   Kosciulek JF, 1999, BRAIN INJURY, V13, P245, DOI 10.1080/026990599121610
   Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108
   Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128
   Lazaro F, 2000, PSYCHIAT B, V24, P264, DOI 10.1192/pb.24.7.264
   Leasure JL, 2004, BEHAV BRAIN RES, V150, P83, DOI 10.1016/S0166-4328(03)00254-7
   Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407
   Lepeintre JF, 2004, NEUROCHIRURGIE, V50, P83
   Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052
   Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004
   Lew HL, 1999, AM J PHYS MED REHAB, V78, P367, DOI 10.1097/00002060-199907000-00014
   Lichtman SW, 2000, NEUROLOGY, V55, P1536
   Lima JE, 2004, BRAZ J MED BIOL RES, V37, P19, DOI 10.1590/S0100-879X2004000100003
   Linan E, 2001, AM J PHYS MED REHAB, V80, P614, DOI 10.1097/00002060-200108000-00013
   Lippert-Gruner M, 2002, ACT NEUR S, V79, P21
   LUSTIG D. C., 2003, J APPL REHABILITATIO, V34, P30
   Maas AIR, 2004, ACT NEUR S, V89, P113
   Macdonald RL, 2003, SURG NEUROL, V59, P363, DOI 10.1016/S0090-3019(03)00111-3
   Macdonald RL, 2003, SURG NEUROL, V59, P372
   Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420
   Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812
   Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440
   Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980
   Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895
   Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55
   Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143
   Marion Donald W, 2002, Curr Opin Crit Care, V8, P111, DOI 10.1097/00075198-200204000-00004
   Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16
   Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030
   Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519
   Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002
   Maryniak O, 2001, BRAIN INJURY, V15, P167, DOI 10.1080/026990501458399
   Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833
   Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805
   Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010
   Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930
   Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540
   Mazaux JM, 2002, ACT NEUR S, V79, P49
   Mazaux JM, 2001, J REHABIL MED, V33, P99
   Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9
   Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076
   McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270
   McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353
   McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992
   McLeod A, 2004, OCCUP ENVIRON MED, V61, P414, DOI 10.1136/oem.2003.007336
   Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159
   Merchant RE, 1999, ANN NY ACAD SCI, V890, P42, DOI 10.1111/j.1749-6632.1999.tb07979.x
   Meythaler JA, 2001, ARCH PHYS MED REHAB, V82, P1155, DOI 10.1053/apmr.2001.25141
   Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P285, DOI 10.1053/apmr.2003.50116
   Meythaler JM, 1999, AM J PHYS MED REHAB, V78, P247, DOI 10.1097/00002060-199905000-00012
   Meythaler JM, 2004, J HEAD TRAUMA REHAB, V19, P101, DOI 10.1097/00001199-200403000-00003
   Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5
   MEYTHALER JM, 1908, J HEAD TRAUMA REHAB, V17, P300
   Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274
   MILDERS MV, 1995, NEUROPSYCHOL REHABIL, V5, P223, DOI 10.1080/09602019508401468
   Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005
   Minnes P, 2001, NEUROREHABILITATION, V16, P3
   Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286
   Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586
   Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068
   Mossberg KA, 2002, BRAIN INJURY, V16, P789, DOI 10.1080/02699050210131894
   Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41
   Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285
   Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037
   Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696
   Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701
   Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222
   O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212
   O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68
   O'Neill JH, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2003.08.114
   Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b
   Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700
   Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445
   Page S, 2003, BRAIN INJURY, V17, P675, DOI 10.1080/0269905031000107160
   Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010
   Paniak C, 2000, BRAIN INJURY, V14, P219
   Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927
   Paniak C, 2000, J MUSCULOSKELET PAIN, V8, P193, DOI 10.1300/J094v08n01_16
   Parente R, 1999, NEUROREHABILITATION, V13, P13
   Pavesi G, 1998, J NEUROL NEUROSUR PS, V64, P419, DOI 10.1136/jnnp.64.3.419
   Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371
   Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005
   Phuenpathom Nakornchai, 1999, Journal of the Medical Association of Thailand, V82, P46
   Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416
   Ptak T, 2003, AM J ROENTGENOL, V181, P1401
   Raabe A, 2001, ACTA NEUROCHIR, V143, P1, DOI 10.1007/s007010170131
   Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944
   Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159
   Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974
   Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303
   Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365
   Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039
   Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733
   Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139
   Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204
   Muzha I, 2004, LANCET, V364, P1321
   Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X
   Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7
   Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812
   Sachdev P, 2001, PSYCHOL MED, V31, P231
   Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075
   Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4
   Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017
   Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313
   Scheid R, 2003, AM J NEURORADIOL, V24, P1049
   Schierhout G, 2001, COCHRANE DB SYST REV, V4
   SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484
   Schneider WN, 1999, BRAIN INJURY, V13, P863
   Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258
   SECADES JJ, 1995, METHOD FIND EXP CLIN, V17, P1
   Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3
   Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106
   Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939
   Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009
   Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52
   Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802
   Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003
   Sherer M, 1999, BRAIN INJURY, V13, P973
   Silver BV, 2003, BRAIN INJURY, V17, P237, DOI 10.1080/0269905021000013192
   Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295
   Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103
   SKEEL RL, 2003, REHABIL PSYCHOL, V48, P154
   Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577
   Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40
   Smith A M, 1998, Rehabil Nurs, V23, P252
   Smith J, 1998, CANADIAN J REHABILIT, V11, P131
   Snead SL, 2002, BRAIN INJURY, V16, P947, DOI 10.1080/02699050210147211
   Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656
   Stanislav SW, 2000, BRAIN INJURY, V14, P261
   Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004
   Stebbins P, 2001, REHABIL PSYCHOL, V46, P178, DOI 10.1037/0090-5550.46.2.178
   Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279
   Stemmer B, 2000, BRAIN COGNITION, V44, P25
   Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088
   Talbot LR, 2000, BRAIN COGNITION, V44, P39
   Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155
   Taverni JP, 1998, BRAIN INJURY, V12, P77
   Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410
   Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033
   Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436
   Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593
   Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x
   Teng CJ, 2001, BRAIN INJURY, V15, P463, DOI 10.1080/02699050010005931
   Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006
   Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X
   Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542
   Tribl G, 2000, BRAIN INJURY, V14, P345
   Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418
   Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33
   VANDIVER VL, 2000, J COGN REHABIL, V18, P22
   VANREEKUM R, 2001, EVID BASED MENT HLTH, V4, P58
   van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316
   Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750
   Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x
   Vos PE, 2004, NEUROLOGY, V62, P1303
   Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006
   WAGNER AK, 2004, J NEUROTRAUM, V2, P125
   Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470
   Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004
   Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005
   Wagner RH, 1999, J HEAD TRAUMA REHAB, V14, P558
   Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343
   Watson NF, 2004, EPILEPSIA, V45, P690, DOI 10.1111/j.0013-9580.2004.59403.x
   Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027
   Wen DY, 1998, SURG NEUROL, V50, P521, DOI 10.1016/S0090-3019(98)00083-4
   Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107
   Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001
   Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3
   Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002
   Williams WH, 2002, BRAIN INJURY, V16, P673
   Wilson DJ, 2002, BRAIN INJURY, V16, P259, DOI 10.1080/02699050110103922
   Yablon SA, 2004, NEUROLOGY, V63, P485
   Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016
   Zafonte RD, 1998, BRAIN INJURY, V12, P617
   Zafonte RD, 2002, J HEAD TRAUMA REHAB, V17, P322, DOI 10.1097/00001199-200208000-00006
   ZHANG L, 2004, ARCH PHYS MED REHAB, V96, P1050
   Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr2003.10.014
   Zhu XL, 2001, BRIT J NEUROSURG, V15, P464, DOI 10.1080/02688690120097688
NR 363
TC 94
Z9 94
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0894-9115
J9 AM J PHYS MED REHAB
JI Am. J. Phys. Med. Rehabil.
PD APR
PY 2006
VL 85
IS 4
BP 343
EP 382
DI 10.1097/01.phm.0000202106.01654.61
PG 40
WC Rehabilitation; Sport Sciences
SC Rehabilitation; Sport Sciences
GA 026XI
UT WOS:000236376200004
PM 16554685
ER

PT J
AU Bowling, TE
   Galbraith, SM
   Hatfield, ARW
   Solano, J
   Spittle, MF
AF Bowling, TE
   Galbraith, SM
   Hatfield, ARW
   Solano, J
   Spittle, MF
TI A retrospective comparison of endoscopic stenting alone with stenting
   and radiotherapy in non-resectable cholangiocarcinoma
SO GUT
LA English
DT Article
DE cholangiocarcinoma; retrospective analysis; stenting; radiotherapy;
   survival
ID BILE-DUCT CARCINOMA; INTRAOPERATIVE RADIATION-THERAPY; MALIGNANT BILIARY
   OBSTRUCTION; HILAR CHOLANGIOCARCINOMA; IR-192 WIRE; INTERNAL
   RADIOTHERAPY; CONSECUTIVE PATIENTS; TRACT CARCINOMA; CANCER; MANAGEMENT
AB Background and Aims-Radiotherapy has been reported to be of benefit in prolonging the survival of patients with cholangiocarcinoma. This study examined whether radiotherapy in addition to endoscopic stenting improved survival,
   Subjects-56 patients with obstructive jaundice due to histologically confirmed non-resectable cholangiocarcinoma.
   Methods-A retrospective analysis of these patients who were treated either with endoscopic biliary stenting followed by external beam radiotherapy and internal iridium-192 brachytherapy (n=28) or with stenting alone (control group; n=28).
   Results-The two groups were well matched in age, sex, acid stricture type. Eighteen patients had a type I stricture (control group: 11; radiotherapy group: 7) at the time of diagnosis and 38 had a type II or III stricture (control group: 17; radiotherapy group: 21). The median (range) overall survival from diagnosis was seven (1-29) and 10 (4-75) months in the control and radiotherapy groups respectively: This difference did not reach statistical significance (p=0 . 06), but survival plots indicated a survival advantage in the radiotherapy group in the first nine months after diagnosis. Approximately one third survived longer than one year in both groups, More patients in the radiotherapy group required a stent change (1 . 9 v 0 . 9: p=0 . 05), and also had a longer overall inpatient stay (42 days v 19: p<0 . 001). When examined on the basis of stricture type, there was a survival advantage in the first 10 months after diagnosis in those with a type II/III stricture (seven and 11 months in the radiotherapy and control groups respectively: 0 . 01<p<0 . 05). There was no difference in survival between the groups in those with a type I stricture. Numbers surviving longer than one year, stent survival, and number of stent changes were all similar between the two groups when examined on the basis of stricture type, but length of hospital stay remained considerably longer in all patients receiving radiotherapy.
   Conclusion-The survival advantage of radiotherapy in those with a type II/III stricture is seen only in the first 10 months after diagnosis. The costs of radiotherapy and significantly increased time spent in hospital, however, raise doubts over Its routine use in the management of non-resectable cholangiocarcinoma
C1 UCL HOSP NHS TRUST, MIDDLESEX HOSP, DEPT GASTROENTEROL, LONDON W1N 8AA, ENGLAND.
   UCL HOSP NHS TRUST, MIDDLESEX HOSP, DEPT ONCOL, LONDON W1N 8AA, ENGLAND.
CR ALEXANDER F, 1984, AM J SURG, V147, P503, DOI 10.1016/0002-9610(84)90013-8
   BISMUTH H, 1988, WORLD J SURG, V12, P39
   BISMUTH H, 1992, ANN SURG, V215, P31
   BLUMGART LH, 1984, LANCET, V1, P66
   Broe P J, 1981, Adv Surg, V15, P47
   BUSSE PM, 1989, SURGERY, V105, P724
   CHITWOOD WR, 1982, AM J SURG, V143, P99, DOI 10.1016/0002-9610(82)90137-4
   CONROY RM, 1982, CANCER, V49, P1321, DOI 10.1002/1097-0142(19820401)49:7<1321::AID-CNCR2820490702>3.0.CO;2-S
   EDE RJ, 1989, BRIT J SURG, V76, P867, DOI 10.1002/bjs.1800760834
   FIELDS JN, 1987, INT J RADIAT ONCOL, V13, P331
   FLETCHER MS, 1981, LANCET, V2, P172
   FLETCHER MS, 1983, BRIT J SURG, V70, P733, DOI 10.1002/bjs.1800701213
   FORTNER JG, 1989, ARCH SURG-CHICAGO, V124, P1275
   GIBSON RN, 1988, AM J SURG, V156, P363, DOI 10.1016/S0002-9610(88)80187-9
   HADJIS NS, 1989, AM J SURG, V157, P395, DOI 10.1016/0002-9610(89)90583-7
   HAYES JK, 1988, INT J RADIAT ONCOL, V15, P735
   HERSKOVIC A, 1981, RADIOLOGY, V139, P219
   INOUYE AA, 1978, AM J SURG, V136, P90, DOI 10.1016/0002-9610(78)90206-4
   IWASAKI Y, 1988, WORLD J SURG, V12, P91
   JOHNSON DW, 1985, INT J RADIAT ONCOL, V11, P411
   KARANI J, 1985, CLIN RADIOL, V36, P603, DOI 10.1016/S0009-9260(85)80242-7
   KLATSKIN G, 1965, AM J MED, V38, P241, DOI 10.1016/0002-9343(65)90178-6
   KOYAMA K, 1989, SURG GYNECOL OBSTET, V168, P523
   KUVSHINOFF BW, 1995, BRIT J SURG, V82, P1522, DOI 10.1002/bjs.1800821122
   LANGER JC, 1985, SURGERY, V98, P752
   LEVITT MD, 1988, GUT, V29, P149, DOI 10.1136/gut.29.2.149
   MEYERS WC, 1988, WORLD J SURG, V12, P99
   MOLT P, 1986, CANCER, V57, P536, DOI 10.1002/1097-0142(19860201)57:3<536::AID-CNCR2820570322>3.0.CO;2-L
   MORNEX F, 1981, LANCET, V2, P479
   MURRAY PA, 1991, BRIT J CANCER, V64, pP57
   OHNISHI H, 1995, HEPATO-GASTROENTEROL, V42, P265
   OTTOW RT, 1985, SURGERY, V97, P251
   PILEPICH MV, 1978, RADIOLOGY, V127, P767
   POLYDOROU AA, 1991, GUT, V32, P685, DOI 10.1136/gut.32.6.685
   TODOROKI T, 1980, CANCER, V46, P2179, DOI 10.1002/1097-0142(19801115)46:10<2179::AID-CNCR2820461014>3.0.CO;2-Y
   TSUJINO K, 1995, RADIOLOGY, V196, P275
   WHEELER PG, 1981, Q J MED, V50, P247
NR 37
TC 94
Z9 96
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
J9 GUT
JI Gut
PD DEC
PY 1996
VL 39
IS 6
BP 852
EP 855
DI 10.1136/gut.39.6.852
PG 4
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA WD466
UT WOS:A1996WD46600013
PM 9038668
ER

PT J
AU Ishwaran, H
   Kogalur, UB
   Blackstone, EH
   Lauer, MS
AF Ishwaran, Hemant
   Kogalur, Udaya B.
   Blackstone, Eugene H.
   Lauer, Michael S.
TI RANDOM SURVIVAL FORESTS
SO ANNALS OF APPLIED STATISTICS
LA English
DT Article
DE Conservation of events; cumulative hazard function; ensemble;
   out-of-bag; prediction error; survival tree
ID CENSORED-DATA; OBESITY; REGRESSION; OVERWEIGHT; TREES; UNDERWEIGHT;
   MORTALITY
AB We introduce random survival forests, a random forests method for the analysis of right-censored survival data. New survival splitting rules for growing survival trees are introduced, as is a new missing data algorithm for imputing missing data. A conservation-of-events principle for survival forests is introduced and used to define ensemble mortality, a simple interpretable measure of mortality that can be used as a predicted outcome. Several illustrative examples are given, including a case study of the prognostic implications of body mass for individuals with coronary artery disease. Computations for all examples were implemented using the freely available R-software package. randomSurvivalForest.
C1 [Ishwaran, Hemant] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA.
   [Kogalur, Udaya B.] Columbia Univ, Dept Stat, New York, NY 10027 USA.
   [Blackstone, Eugene H.] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA.
   [Lauer, Michael S.] NHLBI, Div Prevent & Populat Sci, Rockledge Ctr 2, Bethesda, MD 20892 USA.
RP Ishwaran, H (reprint author), Cleveland Clin, Dept Quantitat Hlth Sci, 9500 Euclid Ave, Cleveland, OH 44195 USA.
EM hemant.ishwaran@gmail.com; ubk2101@columbia.edu; blackse@ccf.org;
   lauerm@nhlbi.nih.gov
RI Lauer, Michael/L-9656-2013
OI Lauer, Michael/0000-0002-9217-8177
FU National Institutes of Health [HL-072771]
FX Supported in part by National Institutes of Health RO1 Grant HL-072771.
CR Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1023/A:1018054314350
   Breiman L., 2003, MANUAL SETTING USING
   Breiman L., 1984, CLASSIFICATION REGRE
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   BREIMAN L, 2002, WALD LECT M I MATH S
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411
   Eagle KA, 2004, J AM COLL CARDIOL, V44, P213
   Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.2009.2014
   Fleming T. R., 1991, COUNTING PROCESSES S
   Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187
   HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543
   Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x
   Hothorn T, 2003, COMPUT STAT DATA AN, V43, P121
   Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011
   ISHWARAN H, NOVEL DATA DRIVER AP
   ISHWARAN H, 2008, RANDOMSURVIVALFOREST
   Ishwaran H, 2007, R NEWS, V7, P25
   Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039
   Ishwaran H, 2004, J AM STAT ASSOC, V99, P591, DOI 10.1198/016214504000000638
   Kalbfleisch J, 1980, STAT ANAL FAILURE TI
   Kattan MW, 2003, J UROLOGY, V170, pS6, DOI 10.1097/01.ju0000094764.56269.2d
   LEBLANC M, 1993, J AM STAT ASSOC, V88, P457, DOI 10.2307/2290325
   LEBLANC M, 1992, BIOMETRICS, V48, P411, DOI 10.2307/2532300
   LIAW A, 2007, RANDOMFOREST 4 5 18
   Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1016/J.MEMSCI.2010.02.036
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Molinaro AM, 2004, J MULTIVARIATE ANAL, V90, P154, DOI 10.1016/j.jmva.2004.02.003
   Naftel D., 1985, CONSERVATION E UNPUB
   Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Rossi P. H., 1980, MONEY WORK CRIME EXP
   Schapire RE, 1998, ANN STAT, V26, P1651
   SEGAL MR, 1988, BIOMETRICS, V44, P35, DOI 10.2307/2531894
   Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
NR 37
TC 93
Z9 94
PU INST MATHEMATICAL STATISTICS
PI CLEVELAND
PA 3163 SOMERSET DR, CLEVELAND, OH 44122 USA
SN 1932-6157
J9 ANN APPL STAT
JI Ann. Appl. Stat.
PD SEP
PY 2008
VL 2
IS 3
BP 841
EP 860
DI 10.1214/08-AOAS169
PG 20
WC Statistics & Probability
SC Mathematics
GA 374QD
UT WOS:000261057900003
ER

PT J
AU Newman, MF
   Mathew, JP
   Grocott, HP
   Mackensen, GB
   Monk, T
   Welsh-Bohmer, KA
   Blumenthal, JA
   Laskowitz, DT
   Mark, DB
AF Newman, Mark F.
   Mathew, Joseph P.
   Grocott, Hilary P.
   Mackensen, G. Burkhard
   Monk, Terri
   Welsh-Bohmer, Kathleen A.
   Blumenthal, James A.
   Laskowitz, Daniel T.
   Mark, Daniel B.
TI Central nervous system injury associated with cardiac surgery
SO LANCET
LA English
DT Review
ID CORONARY-ARTERY-BYPASS; CARDIOPULMONARY BYPASS; GRAFT-SURGERY;
   ATRIAL-FIBRILLATION; COGNITIVE DECLINE; RANDOMIZED-TRIAL; RISK-FACTOR;
   OFF-PUMP; NEUROCOGNITIVE FUNCTION; NONSURGICAL CONTROLS
AB Millions of individuals with coronary artery or valvular heart disease have been given a new chance at life by heart surgery, but the potential for neurological injury is an Achilles heel. Technological advancements and innovations in surgical and anaesthetic technique have allowed us to offer surgical treatment to patients at the extremes of age and infirmity-the group at greatest risk for neurological injury. Neurocognitive dysfunction is a complication of cardiac surgery that can restrict the improved quality of life that patients usually experience after heart surgery. With a broader understanding of the frequency and effects of neurological injury from cardiac surgery and its implications for patients in both the short term and the long term, we should be able to give personalised treatments and thus preserve both their quantity and quality of life. We describe these issues and the controversies that merit continued investigation.
C1 Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
RP Newman, MF (reprint author), Duke Univ, Med Ctr, Dept Anesthesiol, Box 3094, Durham, NC 27710 USA.
EM newma005@mc.duke.edu
CR Ahlgren E, 2003, EUR J CARDIO-THORAC, V23, P334, DOI 10.1016/S1010-7940(02)00807-2
   Ancelin ML, 2001, BRIT J PSYCHIAT, V178, P360, DOI 10.1192/bjp.178.4.360
   Aranki SF, 1996, CIRCULATION, V94, P390
   Arrowsmith JE, 2000, BRIT J ANAESTH, V84, P378
   Bar-Yosef S, 2004, ANN THORAC SURG, V78, P1556, DOI 10.1016/j.athoracsur.2004.05.002
   Blackstone EH, 2000, J THORAC CARDIOV SUR, V120, P629, DOI 10.1067/mtc.2000.110252
   Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6
   Boeken U, 2005, THORAC CARDIOV SURG, V53, P33, DOI 10.1055/s-2004-830426
   Brooker RF, 1998, ANN THORAC SURG, V65, P1651, DOI 10.1016/S0003-4975(98)00289-6
   Brown WR, 2000, STROKE, V31, P707
   Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9
   Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475
   CHALLA VR, 1993, J NEUROL SCI, V117, P224, DOI 10.1016/0022-510X(93)90177-Z
   Challa VR, 1998, J NEUROPATH EXP NEUR, V57, P140, DOI 10.1097/00005072-199802000-00005
   CHENG DC, 2005, ANESTHESIOLOGY, V102, P3
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   COSGROVE DM, 1984, J THORAC CARDIOV SUR, V88, P673
   Creswell L L, 1999, Semin Thorac Cardiovasc Surg, V11, P303
   CRESWELL LL, 1993, ANN THORAC SURG, V56, P539
   CROSBY LH, 1990, AM J CARDIOL, V66, P1520, DOI 10.1016/0002-9149(90)90550-K
   DeRose JJ, 2005, J THORAC CARDIOV SUR, V129, P314, DOI 10.1016/j.jtcvs.2004.05.022
   Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019
   Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2
   Fitch JCK, 1999, CIRCULATION, V100, P2499
   Friday G, 2005, HEART SURG FORUM, V8, pE105, DOI 10.1532/HSF98.20041146
   FULLER JA, 1989, J THORAC CARDIOV SUR, V97, P821
   GILMAN S, 1965, NEW ENGL J MED, V272, P489, DOI 10.1056/NEJM196503112721001
   GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6
   Goto T, 2001, ANN THORAC SURG, V72, P137, DOI 10.1016/S0003-4975(01)02676-5
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   HAMMERMEISTER KE, 1990, CIRCULATION, V82, P380
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hanning CD, 2003, EUR J ANAESTH, V20, P93
   Hartman GS, 1996, ANESTH ANALG, V83, P701, DOI 10.1097/00000539-199610000-00007
   HINEMAN BJ, 2002, HEART SURG FORUM, V5, P249
   HLATKY MA, 1997, CIRCULATION S9, V96, P1
   Hogue CW, 1999, CIRCULATION, V100, P642
   Hogue CW, 2001, CIRCULATION, V103, P2133
   Iglesias I, 2001, Semin Thorac Cardiovasc Surg, V13, P158, DOI 10.1053/stcs.2001.24076
   JONES EL, 1991, J THORAC CARDIOV SUR, V101, P108
   Jones TJ, 2002, ANN THORAC SURG, V74, P2132, DOI 10.1016/S0003-4975(02)04081-X
   Knipp SC, 2004, EUR J CARDIO-THORAC, V25, P791, DOI 10.1016/j.ejcts.2004.02.012
   LEITCH JW, 1990, J THORAC CARDIOV SUR, V100, P338
   Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0
   Lyketsos CG, 2006, INT J GERIATR PSYCH, V21, P509, DOI 10.1002/gps.1502
   Mack MJ, 2004, ANN THORAC SURG, V77, P761, DOI 10.1016/j.athoracsur.2003.06.019
   Mahanna EP, 1996, ANN THORAC SURG, V61, P1342, DOI 10.1016/0003-4975(95)01095-5
   MALENKA DJ, 2005, CIRCULATION, V112, P1371
   MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025
   MARK DB, 2002, JAMA-J AM MED ASSOC, P1448
   Mathew JP, 2004, STROKE, V35, P2335, DOI 10.1161/01.STR.0000141938.00524.83
   Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300
   MATHEW JP, 2004, ANESTHESIOLOGY
   Mathew JP, 2001, ANN THORAC SURG, V71, P663, DOI 10.1016/S0003-4975(00)02335-3
   Mathew JP, 2003, STROKE, V34, P508, DOI 10.1161/01.STR.0000053844.09493.58
   McKhann GM, 1997, LANCET, V349, P1282, DOI 10.1016/S0140-6736(96)09466-4
   McKhann GM, 2005, NEUROLOGY, V65, P991, DOI 10.1212/01.wnl.0000175220.78475.99
   MOHAN R, 1992, CARDIOLOGY, V80, P215, DOI 10.1159/000175005
   Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0
   MONK TG, 2004, ANESTHESIOLOGY, V101, pA62
   MOODY DM, 1990, ANN NEUROL, V28, P477, DOI 10.1002/ana.410280403
   MOODY DM, 1995, ANN THORAC SURG, V59, P1304, DOI 10.1016/0003-4975(95)00057-R
   Murkin JM, 1997, ANN THORAC SURG, V64, P904, DOI 10.1016/S0003-4975(97)00743-1
   MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U
   MURKIN JM, 1995, J THORAC CARDIOV SUR, V110, P340, DOI 10.1016/S0022-5223(95)70229-6
   Neville MJ, 2001, J THORAC CARDIOV SUR, V121, P125, DOI 10.1067/mtc.2001.111378
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Newman MF, 2004, CIRCULATION, V110, P3402, DOI 10.1161/01.CIR.0000150860.91937.ED
   Newman MF, 1996, CIRCULATION, V94, P74
   Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803
   Phillips-Bute B, 2006, PSYCHOSOM MED, V68, P369, DOI 10.1097/01.psy.0000221272.77984.e2
   Potter GG, 2004, NEUROLOGY, V63, P2245
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Ridker PM, 1997, LANCET, V349, P385, DOI 10.1016/S0140-6736(97)80010-4
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   Selnes OA, 2005, ANN THORAC SURG, V79, P1201, DOI 10.1016/j.athoracsur.2004.10.011
   Selnes OA, 1999, LANCET, V353, P1601, DOI 10.1016/S0140-6736(98)07576-X
   Stamou SC, 2001, STROKE, V32, P1508
   Stanley TO, 2002, ANESTH ANALG, V94, P290, DOI 10.1097/00000539-200202000-00011
   Steed L, 2001, ANN THORAC SURG, V71, P823, DOI 10.1016/S0003-4975(00)02511-X
   Stygall J, 2003, HEALTH PSYCHOL, V22, P579, DOI 10.1037/0278-6133.22.6.579
   Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1
   TUMAN KJ, 1992, J THORAC CARDIOV SUR, V104, P1510
   van der Linden J, 2001, J AM COLL CARDIOL, V38, P131, DOI 10.1016/S0735-1097(01)01328-6
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901
   Wahrborg P, 2004, CIRCULATION, V110, P3411, DOI 10.1161/01.CIR.0000148366.80443.2B
   WAREING TH, 1993, ANN THORAC SURG, V55, P1400
   WAREING TH, 1992, J THORAC CARDIOV SUR, V103, P453
   WEINTRAUB WS, 1989, CIRCULATION, V80, P276
   Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703
   Westaby S, 2001, ANN THORAC SURG, V71, P667, DOI 10.1016/S0003-4975(00)02405-X
   Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002
   WILLIAMSRUSSO P, 1995, JAMA-J AM MED ASSOC, V274, P44, DOI 10.1001/jama.274.1.44
   Wolman RL, 1999, STROKE, V30, P514
   YOUSIF H, 1990, INT J CARDIOL, V26, P313, DOI 10.1016/0167-5273(90)90087-L
NR 96
TC 92
Z9 102
PU LANCET LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0140-6736
J9 LANCET
JI Lancet
PD AUG 19
PY 2006
VL 368
IS 9536
BP 694
EP 703
DI 10.1016/S0140-6736(06)69254-4
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 074YT
UT WOS:000239849200037
PM 16920475
ER

PT J
AU Glass, EC
   Essner, R
   Morton, DL
AF Glass, EC
   Essner, R
   Morton, DL
TI Kinetics of three lymphoscintigraphic agents in patients with cutaneous
   melanoma
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Article
DE lymphoscintigraphy; melanoma; technetium-99m-sulfur colloid;
   technetium-99m-human serum albumin; technetium-99m-albumin colloid;
   sentinel lymphadenectomy
ID SENTINEL NODE BIOPSY; EARLY-STAGE MELANOMA; HUMAN SERUM-ALBUMIN;
   MALIGNANT-MELANOMA; BREAST-CANCER; QUANTITATIVE LYMPHOSCINTIGRAPHY;
   DYNAMIC LYMPHOSCINTIGRAPHY; LYMPHATIC-SYSTEM; MANAGEMENT;
   LYMPHADENECTOMY
AB Although lymphoscintigraphy is commonly used for the preoperative evaluation of patients with cutaneous melanoma and for intraoperative identification of sentinel lymph nodes, there is no consensus regarding the most useful radiopharmaceuticals or imaging times. Methods: Fifty-one consecutive patients with clinical American Joint Committee on Cancer Stage I or II melanoma were assigned to one of three groups of 17 for lymphoscintigraphy with one of three radiopharmaceuticals: Tc-99m-albumin colloid (AC), Tc-99m-human serum albumin (HSA) or Tc-99m-sulfur colloid (SC), Colloidal agents were filtered through 0.2 mu m filters. After injecting 18.5-30 MBq (500-800 mu Ci) of the radiopharmaceutical, dynamic monitoring over injection sites and node basins was performed to identify draining lymphatic channels and sentinel nodes, In addition, Static digital and analog images were acquired from the injection site and draining node basins immediately after injection and at 30 min (early) and 2 to 4 hr (delayed) after injection. Dynamic and static images were analyzed to determine transit times to the sentinel node, the number of nodes visualized in early and delayed images, the quality of lymph node and lymph channel visualization, the sentinel-to-nonsentinel uptake ratios and the washout rates from injection sites. Results: Early images with all three agents provided reliable identification of sentinel lymph nodes. Technetium-99m-HSA demonstrated faster washout rates from injection sites and better definition of lymph channels than either particulate agent, whereas particulate agents were retained longer in nodes and demonstrated more nodes in delayed images than in early images. All agents demonstrated lymph channels better in early images than in delayed images. In general, variations between patients exceeded differences between agents. Sentinel nodes could not be distinguished reliably from nonsentinel nodes in delayed images alone. Conclusion: All three agents are acceptable for cutaneous lymphoscintigraphy, but reliable identification of sentinel nodes and their afferent lymph channels requires early imaging. Delayed imaging or localization alone is unreliable and may lead to incorrect identification of the sentinel node.
C1 St Johns Hlth Ctr, Dept Nucl Med, Div Surg Oncol, John Wayne Canc Inst, Santa Monica, CA 90404 USA.
RP Glass, EC (reprint author), St Johns Hlth Ctr, Dept Nucl Med, Div Surg Oncol, John Wayne Canc Inst, 1328 22nd St, Santa Monica, CA 90404 USA.
CR ALAVI A, 1978, J NUCL MED, V19, P422
   Albertini JJ, 1996, ANN SURG, V223, P217, DOI 10.1097/00000658-199602000-00016
   Albertini JJ, 1996, JAMA-J AM MED ASSOC, V276, P1818, DOI 10.1001/jama.276.22.1818
   AVERY M, 1992, RADIAT RES, V132, P50, DOI 10.2307/3578332
   BENNETT LR, 1983, SEMIN NUCL MED, V13, P61, DOI 10.1016/S0001-2998(83)80037-3
   BERMAN CG, 1992, ANN PLAS SURG, V28, P29, DOI 10.1097/00000637-199201000-00010
   COCHRAN AJ, 1988, AM J SURG PATHOL, V12, P612, DOI 10.1097/00000478-198808000-00002
   ESATO K, 1991, J CARDIOVASC SURG, V32, P741
   ESSNER R, 1997, SEMIN ONCOL, V24
   FEE HJ, 1978, SURGERY, V84, P626
   GIULIANO AE, 1995, ANN SURG, V222, P394, DOI 10.1097/00000658-199509000-00016
   HOLMES EC, 1977, ANN SURG, V186, P481, DOI 10.1097/00000658-197710000-00010
   HUNG JC, 1995, J NUCL MED, V36, P1895
   IKOMI F, 1995, RADIOLOGY, V196, P107
   Kapteijn BAE, 1997, J NUCL MED, V38, P362
   KATAOKA M, 1991, BRIT J RADIOL, V64, P1119
   Kirkwood JM, 1996, J CLIN ONCOL, V14, P7
   KRAG DN, 1995, ARCH SURG-CHICAGO, V130, P654
   LAMKI L M, 1989, Journal of Nuclear Medicine, V30, P844
   LOCKANDERSEN J, 1989, CANCER, V63, P77, DOI 10.1002/1097-0142(19890101)63:1<77::AID-CNCR2820630113>3.0.CO;2-2
   MCCARTHY WH, 1995, ARCH SURG-CHICAGO, V130, P569
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
   MUDUN A, 1996, RADIOLOGY, V199, P177
   NORMAN J, 1991, AM J SURG, V162, P432, DOI 10.1016/0002-9610(91)90255-C
   NORMAN J, 1989, AM SURGEON, V55, P689
   PERSSON RBR, 1970, ACTA RADIOL THER PHY, V9, P567
   Pijpers R, 1997, J NUCL MED, V38, P366
   PIJPERS R, 1995, EUR J NUCL MED, V22, P1238, DOI 10.1007/BF00801606
   ROSS MI, 1993, SEMIN SURG ONCOL, V9, P219
   SADEK S, 1989, LYMPHOLOGY, V22, P157
   SAHA G B, 1986, Journal of Nuclear Medicine Technology, V14, P149
   STRAND SE, 1979, J NUCL MED, V20, P1038
   SULLIVAN DC, 1981, AM J ROENTGENOL, V137, P847
   Taylor A, 1996, CLIN NUCL MED, V21, P755, DOI 10.1097/00003072-199610000-00001
   UREN RF, 1993, J NUCL MED, V34, P1435
   UREN RF, 1995, J NUCL MED, V36, P1775
   Vera DR, 1997, J NUCL MED, V38, P530
   ZANZONICO PB, 1995, PRINCIPLES NUCL MED, P107
NR 39
TC 92
Z9 94
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA
SN 0161-5505
J9 J NUCL MED
JI J. Nucl. Med.
PD JUL
PY 1998
VL 39
IS 7
BP 1185
EP 1190
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA ZZ059
UT WOS:000074691600018
PM 9669391
ER

PT J
AU Wiesenack, C
   Liebold, A
   Philipp, A
   Ritzka, M
   Koppenberg, J
   Birnbaum, DE
   Keyl, C
AF Wiesenack, C
   Liebold, A
   Philipp, A
   Ritzka, M
   Koppenberg, J
   Birnbaum, DE
   Keyl, C
TI Four years' experience with a miniaturized extracorporeal circulation
   system and its influence on clinical outcome
SO ARTIFICIAL ORGANS
LA English
DT Article
DE extracorporeal circulation; minimized extracorporeal circulation;
   cardiac surgery; postoperative complications; anesthetic management
ID BYPASS GRAFT-SURGERY; CARDIOPULMONARY BYPASS; OFF-PUMP; INFLAMMATORY
   RESPONSE; MEMBRANE-OXYGENATORS; VENOUS RESERVOIRS; BIOCOMPATIBILITY;
   ACTIVATION; CIRCUITS; RISK
AB It has been suggested that the morbidity associated with cardiopulmonary bypass can be attributed in part to the blood-material and blood-air interactions in the extracorporeal circulation (ECC). A recently introduced minimized ECC-system (MECC System) should be able to reduce these negative effects associated with ECC. A retrospective analysis was performed comprising 485 patients who were operated on for elective coronary artery bypass grafting (CABG) using the MECC System with intermittent antegrade warm blood cardioplegia (group 1) from January 2000 to February 2004. A control group consisted of 485 patients (group 2) undergoing elective CABG in the same period using a conventional ECC and cold crystalloid cardioplegia. There were no significant differences between the two groups in terms of the duration of intubation following surgery, the length of intensive care unit-stay and the total hospital stay. Although the 30-day mortality was similar between the two groups, the incidence of postoperative complications and the perioperative use of blood products were significantly higher in the control group compared to the MECC group. The MECC System may serve as an alternative and less invasive approach to conventional ECC.
C1 Univ Hosp Regensburg, Dept Anesthesia, D-93052 Regensburg, Germany.
   Univ Hosp Rostock, Dept Cardiac Surg, Rostock, Germany.
   Univ Hosp Regensburg, Dept Cardiothorac Surg, D-93052 Regensburg, Germany.
   Heart Ctr Bad Krozingen, Dept Anesthesia, Bad Krozingen, Germany.
RP Wiesenack, C (reprint author), Univ Hosp Regensburg, Dept Anesthesia, Franz Josef Strauss Allee 11, D-93052 Regensburg, Germany.
EM christoph.wiesenack@klinik.uni-regensburg.de
CR Arom KV, 2000, ANN THORAC SURG, V69, P704, DOI 10.1016/S0003-4975(99)01510-6
   Borst C, 1999, CIRCULATION, V99, P1400
   Mahoney CB, 2000, PERFUSION-UK, V15, P467
   CALAFIORE AM, 1995, ANN THORAC SURG, V59, P398, DOI 10.1016/0003-4975(94)00843-V
   EDWARDS FH, 1994, ANN THORAC SURG, V57, P12
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X
   Hsu LC, 1997, J CARDIOTHOR VASC AN, V11, P376, DOI 10.1016/S1053-0770(97)90108-7
   Julier K, 2003, ANESTHESIOLOGY, V98, P1315, DOI 10.1097/00000542-200306000-00004
   Kalmár P, 2002, Thorac Cardiovasc Surg, V50, P30, DOI 10.1055/s-2002-35742
   Moen O, 1996, ANN THORAC SURG, V62, P1134, DOI 10.1016/0003-4975(96)00492-4
   Muehrcke DD, 1996, J THORAC CARDIOV SUR, V112, P472, DOI 10.1016/S0022-5223(96)70275-1
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   OVRUM E, 1995, CIRCULATION, V92, P2579
   OVRUM E, 1995, J THORAC CARDIOV SUR, V110, P1623, DOI 10.1016/S0022-5223(95)70023-4
   PALATIANOS GM, 2003, ANN THORAC SURG, V761, P129
   Philipp A, 2002, PERFUSION-UK, V17, P175, DOI 10.1191/0267659102pf566oa
   Phillips R, 2002, AREA, V34, P215
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Royston D, 1997, J CARDIOTHOR VASC AN, V11, P341, DOI 10.1016/S1053-0770(97)90105-1
   SCHONBERGER JPAM, 1995, ANN THORAC SURG, V59, P1549, DOI 10.1016/0003-4975(95)00241-C
   Takala J, 1996, New Horiz, V4, P483
   Vassiliades TA, 2002, ANN THORAC SURG, V73, P1874, DOI 10.1016/S0003-4975(02)03592-0
   Wiesenack C, 2002, ANESTHESIOLOGY, V97, P133, DOI 10.1097/00000542-200207000-00019
   WILDEVUUR CR, 1997, EUR J CARDIO-THORAC, V114, P616
NR 25
TC 91
Z9 92
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD DEC
PY 2004
VL 28
IS 12
BP 1082
EP 1088
DI 10.1111/j.1525-1594.2004.00030.x
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 872DO
UT WOS:000225187700005
PM 15554936
ER

PT J
AU Legare, JF
   Buth, KJ
   King, S
   Wood, J
   Sullivan, JA
   Friesen, CH
   Lee, J
   Stewart, K
   Hirsch, GM
AF Legare, JF
   Buth, KJ
   King, S
   Wood, J
   Sullivan, JA
   Friesen, CH
   Lee, J
   Stewart, K
   Hirsch, GM
TI Coronary bypass surgery performed off pump does not result in lower
   in-hospital morbidity than coronary artery bypass grafting performed on
   pump
SO CIRCULATION
LA English
DT Article
DE coronary disease; revascularization; cardiopulmonary bypass
ID OFF-PUMP; CARDIOPULMONARY BYPASS; BEATING-HEART; MYOCARDIAL
   REVASCULARIZATION; EXTRACORPOREAL-CIRCULATION; CARDIAC-SURGERY;
   TRANSFUSION; OUTCOMES; MORTALITY
AB Background - There is increasing evidence that cardiopulmonary bypass (CPB) may be responsible for the morbidity associated with coronary artery bypass grafting (CABG) surgery. Recent developments in cardiac stabilization devices have made CABG without CPB feasible. However, there is conflicting evidence to date from published trials comparing outcomes between CABG performed with and without CPB, with some trials indicating an advantage to the avoidance of CPB and others showing little benefit.
   Methods and Results - In a single-center randomized trial, 300 patients requiring CABG surgery at a single institution were prospectively randomized to have the procedure performed with CPB ( n = 150) or on the beating heart ( n = 150). Exclusion criteria for the trial included emergency procedure, concomitant major cardiac procedures, ejection fraction < 30%, and reoperation. In-hospital outcomes were analyzed on an intention-to-treat basis. A mean of 3.0 +/- 0.9 grafts were performed in the CPB group compared with 2.8 +/- 0.9 grafts in the beating-heart group ( P = 0.06). There were no significant differences between the CPB group and the beating- heart group in mortality (0.7% versus 1.3%; P = 1.0), transfusion (8.7% versus 9.3%), perioperative myocardial infarction ( 0.7% versus 2.7%; P = 0.37), permanent stroke (0% versus 1.3%; P = 0.50), new atrial fibrillation (32% versus 25%; P = 0.20), and deep sternal wound infection ( 0.7% versus 0%; P = 1.0). The mean time to extubation was 4 hours, the mean stay in the intensive care unit was 22 hours, and the median length of hospitalization was 5 days in both groups ( P = NS).
   Conclusions - In contrast to published trials, we were unable to demonstrate any advantage with CABG performed without CPB in terms of patient morbidity. Excellent results can be obtained with either surgical approach.
C1 Dalhousie Univ, New Halifax Infirm, Div Cardiovasc Surg, Halifax, NS B3H 3A7, Canada.
RP Legare, JF (reprint author), Dalhousie Univ, New Halifax Infirm, Div Cardiovasc Surg, 1796 Summer St,Room 2006, Halifax, NS B3H 3A7, Canada.
EM jean.legare@cdha.nshealth.ca
CR AUDET AM, 1992, ANN INTERN MED, V116, P403
   WESTABY S, 1987, INTENS CARE MED, V13, P89
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 2000, CIRCULATION, V102, P1530
   BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312
   BLAUTH CI, 1992, J THORAC CARDIOV SUR, V103, P1104
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   BUTLER J, 1993, ANN THORAC SURG, V55, P552
   Calafiore AM, 2001, ANN THORAC SURG, V72, P456, DOI 10.1016/S0003-4975(01)02810-7
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Ghali WA, 2003, CAN J CARDIOL, V19, P774
   GOODNOUGH LT, 1995, ANN THORAC SURG, V60, P473, DOI 10.1016/0003-4975(95)98960-3
   Hart James C, 2002, Semin Thorac Cardiovasc Surg, V14, P70, DOI 10.1053/stcs.2002.31897
   Hart JC, 2000, ANN THORAC SURG, V70, P1017, DOI 10.1016/S0003-4975(00)01799-9
   HASLEY PB, 1995, MED CARE, V33, P1145
   Hoff SJ, 2002, ANN THORAC SURG, V74, pS1340
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Ray A. Andrew, 2001, Circulation, V104, pI, DOI 10.1161/hc37t1.094904
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Tasdemir O, 1998, J THORAC CARDIOV SUR, V116, P68, DOI 10.1016/S0022-5223(98)70244-2
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 25
TC 91
Z9 95
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD FEB 24
PY 2004
VL 109
IS 7
BP 887
EP 892
DI 10.1161/01.CIR.0000115943.41814.7D
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 777FR
UT WOS:000189165800016
PM 14757693
ER

PT J
AU Todoroki, T
   Ohara, K
   Kawamoto, T
   Koike, N
   Yoshida, S
   Kashiwagi, H
   Otsuka, M
   Fukao, K
AF Todoroki, T
   Ohara, K
   Kawamoto, T
   Koike, N
   Yoshida, S
   Kashiwagi, H
   Otsuka, M
   Fukao, K
TI Benefits of adjuvant radiotherapy after radical resection of locally
   advanced main hepatic duct carcinoma
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE main hepatic duct carcinoma; radical resection; tumor residue;
   intraoperative radiation therapy; postoperative radiotherapy
ID INTRAOPERATIVE RADIATION-THERAPY; BILIARY-TRACT CARCINOMA; HILAR
   CHOLANGIOCARCINOMA; MURINE FIBROSARCOMAS; CANCER; SURGERY; IRRADIATION;
   PROGNOSIS; PATTERNS; SURVIVAL
AB Purpose: The objective of this study was to determine the benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma (Klatskin tumor),
   Methods and Materials: We conducted a retrospective review of 63 patients who underwent surgical resection of Stage IVA Klatskin tumor. Of the 63 patients, 47 had microscopic tumor residue (RT1), Twenty-eight of the 47 patients with RT1 were treated by adjuvant radiotherapy and the remaining 19 patients were treated exclusively by surgical resection, Seventeen of the 28 patients with RT1 were treated by both intraoperative radiotherapy (IORT) and postoperative radiotherapy (PORT); of the remaining 11 patients with RT1, 6 underwent resection and IORT, and 5 underwent resection and PORT.
   Results: The major complication and 30-day operative death rates were significantly lower in the radiation group (9.5% and 0.0%, respectively) than in the resection alone group (28.5% and 9.5%, respectively). Of the eight 5-year survivors with RT1, 6 had adjuvant radiotherapy and the remaining 2 had resection alone. Adjuvant radiotherapy for patients with RT1 yielded significantly (p = 0.0141) higher 5-year survival rates (33.9%) than in the resection alone group (13.5%), The best 5-year survival rate (39.2%) was found in patients who underwent a combination of IORT and PORT after resection, The local-regional control rate was significantly higher in the adjuvant radiation group than in the resection alone group (79.2% vs. 31.2%).
   Conclusion: Our data clearly suggest the improved prognosis of patients with locally advanced Klatskin tumor by integrated adjuvant radiotherapy with IORT and PORT to complete gross tumor resection with acceptable treatment mortality and morbidity, (C) 2000 Elsevier Science Inc.
C1 Univ Tsukuba, Inst Clin Med, Dept Surg, Tsukuba, Ibaraki 305, Japan.
   Univ Tsukuba, Inst Clin Med, Dept Radiol, Tsukuba, Ibaraki 305, Japan.
RP Todoroki, T (reprint author), Univ Tsukuba, Inst Clin Med, Dept Surg, Tsukuba, Ibaraki 305, Japan.
CR Ahrendt S A, 1996, Adv Surg, V30, P427
   BISMUTH H, 1975, SURG GYNECOL OBSTET, V140, P170
   Burke EC, 1998, ANN SURG, V228, P385, DOI 10.1097/00000658-199809000-00011
   BUSKIRK SJ, 1992, ANN SURG, V215, P125, DOI 10.1097/00000658-199202000-00006
   BUSSE PM, 1989, SURGERY, V105, P724
   CAMERON JL, 1990, AM J SURG, V159, P91, DOI 10.1016/S0002-9610(05)80612-9
   Chung C, 1998, AM SURGEON, V64, P921
   ELLIS F, 1969, Clinical Radiology, V20, P1, DOI 10.1016/S0009-9260(69)80043-7
   Fleming ID, 1997, AJCC CANC STAGING MA
   GONZALEZ DG, 1990, SEMIN LIVER DIS, V10, P131, DOI 10.1055/s-2008-1040466
   GROVE MK, 1991, AM J SURG, V161, P454, DOI 10.1016/0002-9610(91)91111-U
   GUNDERSON LL, 1999, ANN ONCOL          S, V4, pS221
   GUNDERSON LL, 1999, ANN ONCOL          S, V4, pS291
   Ishiyama S, 1998, J Hepatobiliary Pancreat Surg, V5, P429, DOI 10.1007/s005340050068
   IWASAKI Y, 1988, WORLD J SURG, V12, P91
   Klempnauer J, 1997, CANCER, V79, P26, DOI 10.1002/(SICI)1097-0142(19970101)79:1<26::AID-CNCR5>3.0.CO;2-K
   KOPELSON G, 1981, INT J RADIAT ONCOL, V7, P413
   Kusano T, 1998, INT SURG, V83, P119
   Madariaga JR, 1998, ANN SURG, V227, P70, DOI 10.1097/00000658-199801000-00011
   MEYERS WC, 1988, WORLD J SURG, V12, P99
   MINSKY BD, 1990, INT J RADIAT ONCOL, V18, P1157
   Miyazaki M, 1998, SURGERY, V123, P131, DOI 10.1067/msy.1998.85440
   Moon Y, 1997, INT J ONCOL, V10, P545
   Nimura Y, 1998, J Hepatobiliary Pancreat Surg, V5, P52, DOI 10.1007/PL00009951
   Ogura Y, 1998, BRIT J SURG, V85, P20
   PITT HA, 1995, ANN SURG, V221, P788, DOI 10.1097/00000658-199506000-00017
   SHIINA T, 1992, CANCER CHEMOTH PHARM, V31, pS115, DOI 10.1007/BF00687120
   TODOROKI T, 1980, SURG GYNECOL OBSTET, V150, P33
   TODOROKI T, 1986, J SURG ONCOL, V31, P279, DOI 10.1002/jso.2930310412
   TODOROKI T, 1999, INTRAOPERATIVE IRRAD, P223
   TODOROKI T, 1985, J SURG ONCOL, V29, P207, DOI 10.1002/jso.2930290402
   TODOROKI T, 1992, J SURG ONCOL, V51, P126, DOI 10.1002/jso.2930510213
   TODOROKI T, 2000, IN PRESS BR J SURG
   TSUJINO K, 1995, RADIOLOGY, V196, P275
   TSUZUKI T, 1991, CANCER, V67, P3010, DOI 10.1002/1097-0142(19910615)67:12<3010::AID-CNCR2820671214>3.0.CO;2-8
   VERBEEK PC, 1991, ANN CHIR, V5, P350
   YUASA N, 1994, BRIT J SURG, V81, P591, DOI 10.1002/bjs.1800810437
NR 37
TC 91
Z9 101
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD FEB 1
PY 2000
VL 46
IS 3
BP 581
EP 587
DI 10.1016/S0360-3016(99)00472-1
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 285WY
UT WOS:000085412400009
PM 10701737
ER

PT J
AU PAIROLERO, PC
   ARNOLD, PG
   HARRIS, JB
AF PAIROLERO, PC
   ARNOLD, PG
   HARRIS, JB
TI LONG-TERM RESULTS OF PECTORALIS MAJOR MUSCLE TRANSPOSITION FOR INFECTED
   STERNOTOMY WOUNDS
SO ANNALS OF SURGERY
LA English
DT Article; Proceedings Paper
CT 102ND ANNUAL MEETING OF THE SOUTHERN SURGICAL ASSOC
CY DEC 03-06, 1990
CL BOCA RATON, FL
SP SO SURG ASSOC
ID OPEN-HEART SURGERY; MEDIAN STERNOTOMY; MEDIASTINAL INFECTION; CHEST
   WALL; SURGICAL-MANAGEMENT; CARDIAC-SURGERY; COMPLICATIONS; FLAPS;
   EXPERIENCE; RECONSTRUCTION
AB During an 11.5-year period, 100 consecutive patients (79 male, 21 female) underwent repair of an infected sternotomy wound.  Sixty-five patients had failed attempts at wound closure by other physicians.  Median age was 61.5 years (range, 5 to 85 years).  Reconstruction included muscle in 79 patients, omentum in 4, and both in 15.  A total of 175 muscles were transposed, including 169 pectoralis major, 3 rectus abdominis, 2 external oblique, and 1 latissimus dorsi.  Median number of operations was four (range, 1 to 11).  Mechanical ventilation was required in 30 patients.  Two perioperative deaths occurred, one related to sepsis.  Median follow-up was 4.2 years (range, 1.3 to 13.5 years).  Twenty-six patients had recurrent infection.  Median time from our closure to recurrence was 5.5 months (range, 0.3 to 27.6 months).  Cause of recurrence was inadequate removal of cartilage in 16 patients, bone in 6, and retained foreign body in 4.  Eighteen patients had the wound reopened with further resection; 10 had another muscle or omentum transposition.  There were 30 late deaths, only one related to recurrent infection.  At the time of death or last followup, 92 patients had a healed chest wall.  Transposition of the pectoralis major muscle remains an excellent method of management for infected sternotomy wounds.  Failure is directly related to persistent infection of cartilage, bone, or retained foreign bodies.
C1 MAYO CLIN & MAYO FDN,PLAST & RECONSTRUCT SURG SECT,ROCHESTER,MN 55905.
RP PAIROLERO, PC (reprint author), MAYO CLIN & MAYO FDN,GEN THORAC SURG SECT,200 1ST ST SW,ROCHESTER,MN 55905, USA.
CR ARNOLD PG, 1986, PLAST RECONSTR SURG, V77, P605, DOI 10.1097/00006534-198604000-00016
   ARNOLD PG, 1984, ANN SURG, V199, P725, DOI 10.1097/00000658-198406000-00011
   ARNOLD PG, 1979, PLAST RECONSTR SURG, V63, P205, DOI 10.1097/00006534-197902000-00008
   ARNOLD PG, 1988, PLAST RECONSTR SURG, V81, P831, DOI 10.1097/00006534-198806000-00001
   ARNOLD PG, 1984, PLAST RECONSTR SURG, V73, P240, DOI 10.1097/00006534-198402000-00015
   BARNHORS.DA, 1973, SURG CLIN N AM, V53, P937
   BRYANT LR, 1969, ANN SURG, V169, P914, DOI 10.1097/00000658-196906000-00011
   CULLIFORD AT, 1976, J THORAC CARDIOV SUR, V72, P714
   DEMMY TL, 1990, ANN THORAC SURG, V49, P458
   ENGELMAN RM, 1973, ARCH SURG-CHICAGO, V107, P772
   GROSSI EA, 1985, ANN THORAC SURG, V40, P214
   HAZELRIGG SR, 1989, J THORAC CARDIOV SUR, V98, P1096
   JEEVANANDAM V, 1990, J THORAC CARDIOV SUR, V99, P256
   JOHNSON J A, 1989, Annals of Thoracic Surgery, V47, P270
   JULIAN OC, 1957, SURGERY, V42, P753
   JURKIEWICZ MJ, 1980, ANN SURG, V191, P738, DOI 10.1097/00000658-198006000-00012
   JURKIEWICZ MJ, 1977, ANN SURG, V185, P548, DOI 10.1097/00000658-197705000-00007
   LEE AB, 1976, SURGERY, V80, P433
   LOOP FD, 1990, ANN THORAC SURG, V49, P179
   MAJURE JA, 1986, ANN THORAC SURG, V42, P9
   MCCRAW JB, 1986, MCCRAW ARNOLDS ATLAS
   MEADOWS JA, 1985, MAYO CLIN PROC, V60, P604
   NAHAI F, 1989, PLAST RECONSTR SURG, V84, P434, DOI 10.1097/00006534-198909000-00009
   PAIROLERO PC, 1984, J THORAC CARDIOV SUR, V88, P357
   PAIROLERO PC, 1986, ANN THORAC SURG, V42, P1
   PAIROLERO PC, 1980, J THORAC CARDIOV SUR, V79, P142
   SANFELIP.PM, 1972, J THORAC CARDIOV SUR, V63, P419
   SARR MG, 1984, ANN THORAC SURG, V38, P415
   SERRY C, 1980, J THORAC CARDIOV SUR, V80, P861
   SHUMACKER HB, 1963, ARCH SURG-CHICAGO, V86, P384
   STIEGEL RM, 1988, ANN THORAC SURG, V46, P45
   THURER RJ, 1974, J THORAC CARDIOV SUR, V68, P962
   TRELSTAD A, 1990, PLASTIC SURG NURSING, V9, P117
   WILLIAMS CD, 1973, J THORAC CARDIOV SUR, V66, P592
NR 34
TC 91
Z9 91
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0003-4932
J9 ANN SURG
JI Ann. Surg.
PD JUN
PY 1991
VL 213
IS 6
BP 583
EP 590
PG 8
WC Surgery
SC Surgery
GA FQ682
UT WOS:A1991FQ68200008
PM 2039289
ER

PT J
AU Viner, RM
   Ozer, EM
   Denny, S
   Marmot, M
   Resnick, M
   Fatusi, A
   Currie, C
AF Viner, Russell M.
   Ozer, Elizabeth M.
   Denny, Simon
   Marmot, Michael
   Resnick, Michael
   Fatusi, Adesegun
   Currie, Candace
TI Adolescent Health 2 Adolescence and the social determinants of health
SO LANCET
LA English
DT Article
ID POSITIVE YOUTH DEVELOPMENT; PROTECTIVE FACTORS; RISK BEHAVIORS; INCOME
   INEQUALITY; MENTAL-HEALTH; EDUCATIONAL-ATTAINMENT; AMERICAN ADOLESCENTS;
   SOCIOECONOMIC-STATUS; PEER INFLUENCES; URBAN CHILDREN
AB The health of adolescents is strongly affected by social factors at personal, family, community, and national levels. Nations present young people with structures of opportunity as they grow up. Since health and health behaviours correspond strongly from adolescence into adult life, the way that these social determinants affect adolescent health are crucial to the health of the whole population and the economic development of nations. During adolescence, developmental effects related to puberty and brain development lead to new sets of behaviours and capacities that enable transitions in family, peer, and educational domains, and in health behaviours. These transitions modify childhood trajectories towards health and wellbeing and are modified by economic and social factors within countries, leading to inequalities. We review existing data on the effects of social determinants on health in adolescence, and present findings from country-level ecological analyses on the health of young people aged 10-24 years. The strongest determinants of adolescent health world wide are structural factors such as national wealth, income inequality, and access to education. Furthermore, safe and supportive families, safe and supportive schools, together with positive and supportive peers are crucial to helping young people develop to their full potential and attain the best health in the transition to adulthood. Improving adolescent health worldwide requires improving young people's daily life with families and peers and in schools, addressing risk and protective factors in the social environment at a population level, and focusing on factors that are protective across various health outcomes. The most effective interventions are probably structural changes to improve access to education and employment for young people and to reduce the risk of transport-related injury.
C1 [Viner, Russell M.] UCL, UCL Inst Child Hlth, London WC1N 1EH, England.
   [Ozer, Elizabeth M.] Univ Calif San Francisco, Off Divers & Outreach, San Francisco, CA 94143 USA.
   [Denny, Simon] Univ Auckland, Dept Paediat, Auckland, New Zealand.
   [Marmot, Michael] UCL, UCL Res Dept Epidemiol & Publ Hlth, London WC1N 1EH, England.
   [Resnick, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.
   [Fatusi, Adesegun] Obafemi Awolowo Univ, Coll Hlth Sci, Dept Commu Hlth, Ife, Nigeria.
   [Currie, Candace] Univ St Andrews, Child & Adolescent Hlth Res Unit, St Andrews KY16 9AJ, Fife, Scotland.
RP Viner, RM (reprint author), UCL, UCL Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.
EM rviner@ich.ucl.ac.uk
CR Ajdacic-Gross V, 2006, AM J PUBLIC HEALTH, V96, P1752, DOI 10.2105/AJPH.2005.075812
   Anderson DR, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00121
   Aneshensel CS, 1996, J HEALTH SOC BEHAV, V37, P293, DOI 10.2307/2137258
   Anteghini M, 2001, J ADOLESCENT HEALTH, V28, P295, DOI 10.1016/S1054-139X(00)00197-X
   BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122
   Bandura A., 1986, SOCIAL FDN THOUGHT A
   Barber Brian K, 2005, Monogr Soc Res Child Dev, V70, P1
   Bartlett S, 2008, ENVIRON URBAN, V20, P501, DOI 10.1177/0956247808096125
   Bauman KE, 2001, ADDICT BEHAV, V26, P349, DOI 10.1016/S0306-4603(00)00110-6
   Baumrind D., 1991, FAMILY TRANSITIONS, P111
   Beal AC, 2001, J ADOLESCENT HEALTH, V28, P474, DOI 10.1016/S1054-139X(01)00194-X
   Bhui K, 2005, SOC PSYCH PSYCH EPID, V40, P259, DOI 10.1007/s00127-005-0890-5
   Bhui K, 2005, J EPIDEMIOL COMMUN H, V59, P296, DOI 10.1136/jech.2003.014456
   Blum RW, 2000, AM J PUBLIC HEALTH, V90, P1879, DOI 10.2105/AJPH.90.12.1879
   Blum RW, 2003, AM J PUBLIC HEALTH, V93, P456, DOI 10.2105/AJPH.93.3.456
   Bond L, 2004, J EPIDEMIOL COMMUN H, V58, P997, DOI 10.1136/jech.2003.009449
   Bonnie R. J., 2004, REDUCING UNDERAGE DR
   Borges Carolina M, 2010, BMC Res Notes, V3, P338, DOI 10.1186/1756-0500-3-338
   Borowsky IW, 2002, AMBUL PEDIATR, V2, P475, DOI 10.1367/1539-4409(2002)002<0475:VRAPFA>2.0.CO;2
   Boyle MH, 2007, CHILD DEV, V78, P168, DOI 10.1111/j.1467-8624.2007.00991.x
   Bruneforth M, 2010, OUT OF SCH ADOLESCEN
   Catalano R. F., 1996, DELINQUENCY CRIME CU, P149
   Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4
   Catalano RF, 2002, J ADOLESCENT HEALTH, V31, P230, DOI 10.1016/S1054-139X(02)00496-2
   CATANIA JA, 1989, J SEX RES, V26, P514
   Chao RK, 2001, CHILD DEV, V72, P1832, DOI 10.1111/1467-8624.00381
   COIE JD, 1993, AM PSYCHOL, V48, P1013, DOI 10.1037/0003-066X.48.10.1013
   Collins W. A., 2006, HDB CHILD PSYCHOL
   Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ
   Crosby RA, 2003, ARCH PEDIAT ADOL MED, V157, P169
   Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024
   Currie C., 2008, INEQUALITIES YOUNG P
   Donovan JE, 2004, J ADOLESCENT HEALTH, V35, P7
   Dorling D, 2007, BRIT MED J, V335, P873, DOI 10.1136/bmj.39349.507315.DE
   Due P, 2009, INT J OBESITY, V33, P1084, DOI 10.1038/ijo.2009.128
   Erbaydar T, 2005, EUR J PUBLIC HEALTH, V15, P404, DOI 10.1093/eurpub/cki040
   Flay BR, 2004, ARCH PEDIAT ADOL MED, V158, P377, DOI 10.1001/archpedi.158.4.377
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Ford CA, 2005, ARCH PEDIAT ADOL MED, V159, P657, DOI 10.1001/archpedi.159.7.657
   Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3
   Gavin LE, 2010, J ADOLESCENT HEALTH, V46, pS75, DOI 10.1016/j.jadohealth.2009.11.215
   Gold R, 2001, Matern Child Health J, V5, P161, DOI 10.1023/A:1011343817153
   Gold R, 2002, HEALTH PLACE, V8, P77, DOI 10.1016/S1353-8292(01)00027-2
   Gordon-Larsen P, 2003, SOC SCI MED, V57, P2023, DOI 10.1016/S0277-9536(03)00072-8
   Gunnell D, 1999, BRIT J PSYCHIAT, V175, P263, DOI 10.1192/bjp.175.3.263
   Gutman LM, 2002, AM J COMMUN PSYCHOL, V30, P367, DOI 10.1023/A:1015389103911
   Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3
   Harding DJ, 2003, AM J SOCIOL, V109, P676, DOI 10.1086/379217
   Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9
   Hawkins JD, 2002, ADDICT BEHAV, V27, P951, DOI 10.1016/S0306-4603(02)00298-8
   Hawkins JD, 2005, ARCH PEDIAT ADOL MED, V159, P25, DOI 10.1001/archpedi.159.1.25
   HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64
   Herrenkohl TI, 2000, J ADOLESCENT HEALTH, V26, P176, DOI 10.1016/S1054-139X(99)00065-8
   Hertzman C., 2007, EARLY CHILD DEV POWE
   Hertzman C, 1999, ANN NY ACAD SCI, V896, P85, DOI 10.1111/j.1749-6632.1999.tb08107.x
   Holland T, 2011, INT J EDUC DEV, V31, P149, DOI 10.1016/j.ijedudev.2010.07.002
   Jaccard J, 2005, DEV PSYCHOL, V41, P135, DOI 10.1037/0012-1649.41.1.135
   Jayakody A, 2011, J ADOLESCENT HEALTH, V48, P499, DOI 10.1016/j.jadohealth.2010.08.010
   Jessor R, 1998, J PERS SOC PSYCHOL, V75, P788, DOI 10.1037//0022-3514.75.3.788
   Kaplan CP, 2001, ADDICT BEHAV, V26, P531, DOI 10.1016/S0306-4603(00)00143-X
   Khawaja M, 2006, SOC SCI MED, V63, P1304, DOI 10.1016/j.socscimed.2006.03.047
   Klasen F, 2010, CHILD DEV, V81, P1096, DOI 10.1111/j.1467-8624.2010.01456.x
   Knoester C, 2005, J MARRIAGE FAM, V67, P767, DOI 10.1111/j.1741-3737.2005.00168.x
   Kohrt BA, 2010, TRANSCULT PSYCHIATRY, V47, P727, DOI 10.1177/1363461510381290
   Kravdal O, 2002, DEMOGRAPHY, V39, P233, DOI 10.2307/3088337
   Kretman S. E., 2009, ADOLESCENT HLTH UNDE, P213
   Laursen B., 2009, HDB ADOLESCENT PSYCH, P3
   Legare F, 2010, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD006732.PUB2
   Leventhal T., 2009, HDB ADOLESCENT PSYCH, P451
   Li JH, 2009, HEALTH SOCIOL REV, V18, P3
   Little AW, 2009, INT J EDUC DEV, V29, P166, DOI 10.1016/j.ijedudev.2008.09.011
   Lohaus A, 2009, J EARLY ADOLESCENCE, V29, P449, DOI 10.1177/0272431608322954
   Machel G., 2001, IMPACT WAR CHILDREN
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519
   Marmot M, 1999, ANN NY ACAD SCI, V896, P16, DOI 10.1111/j.1749-6632.1999.tb08102.x
   Montgomery MR, 2009, POPUL B, V64, P2
   Morgan A, 2009, HEALTH PROMOT INT, V24, P363, DOI 10.1093/heapro/dap028
   Morrell SL, 1998, MED J AUSTRALIA, V168, P236
   OZER EM, 1990, J PERS SOC PSYCHOL, V58, P472, DOI 10.1037//0022-3514.58.3.472
   Patton George C, 2007, Lancet, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3
   Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7
   Peden M, 2008, WORLD REPORT CHILD I
   Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298
   Pitel L, 2010, PUBLIC HEALTH, V124, P512, DOI 10.1016/j.puhe.2010.05.005
   Raphael D, 1996, J ADOLESCENT HEALTH, V19, P6, DOI 10.1016/1054-139X(95)00233-I
   Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037//0033-2909.128.2.330
   Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823
   Richter M, 2007, EUR J PUBLIC HEALTH, V17, P565, DOI 10.1093/eurpub/ckm010
   Salazar LF, 2009, ADOLESCENT HLTH UNDE, P274
   Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918
   Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5
   Sethi D, 2010, EUROPEAN REPORT PREV
   Sinha S, 2007, ETHNIC HEALTH, V12, P423, DOI 10.1080/13557850701616839
   Spencer N, 2004, CHILD CARE HLTH DEV, V30, P699, DOI 10.1111/j.1365-2214.2004.00485.x
   Ssewamala FM, 2010, J ADOLESCENT HEALTH, V46, P372, DOI 10.1016/j.jadohealth.2009.08.010
   Stahl T, 2006, HLTH ALL POLICIES PR
   Steinberg L, 2001, J RES ADOLESCENCE, V11, P1, DOI 10.1111/1532-7795.00001
   Strasburger VC, 2010, PEDIATRICS, V125, P756, DOI 10.1542/peds.2009-2563
   Swift R, 2011, HEALTH ECON, V20, P306, DOI 10.1002/hec.1590
   Szreter S, 2002, AM J PUBLIC HEALTH, V92, P722, DOI 10.2105/AJPH.92.5.722
   Taffa N, 2002, INT J STD AIDS, V13, P714, DOI 10.1258/095646202760326480
   The World Bank, 2007, WORLD DEV REP DEV NE
   Torsheim T, 2004, SOC SCI MED, V59, P1, DOI 10.1016/j.socscimed.2003.09.032
   United Nations Population Division, 2008, WORLD URB PROSP 2007
   Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032
   Vesely SK, 2004, J ADOLESCENT HEALTH, V34, P356, DOI 10.1016/j.jadohealth.2003.08.008
   Viner Russell M, 2006, J Adolesc Health, V38, P55
   WANG MQ, 1995, J ADOLESCENT HEALTH, V16, P200, DOI 10.1016/1054-139X(94)00097-X
NR 108
TC 90
Z9 90
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
J9 LANCET
JI Lancet
PD APR 28
PY 2012
VL 379
IS 9826
BP 1641
EP 1652
DI 10.1016/S0140-6736(12)60149-4
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA 934OB
UT WOS:000303452600038
PM 22538179
ER

PT J
AU Moore, SA
   Zoellner, LA
AF Moore, Sally A.
   Zoellner, Lori A.
TI Overgeneral autobiographical memory and traumatic events: An evaluative
   review
SO PSYCHOLOGICAL BULLETIN
LA English
DT Review
DE autobiographical memory; trauma; depression; posttraumatic stress
   disorder
ID POSTTRAUMATIC-STRESS-DISORDER; BORDERLINE PERSONALITY-DISORDER; NATIONAL
   COMORBIDITY SURVEY; MAJOR DEPRESSIVE DISORDER; CHILDHOOD SEXUAL-ABUSE;
   SELF-FOCUS; FALSE MEMORIES; RISK-FACTORS; SPECIFICITY; MOOD
AB Does trauma exposure impair retrieval of autobiographical memories? Many theorists have suggested that the reduced ability to access specific memories of life events, termed overgenerality, is a protective mechanism helping attenuate painful emotions associated with trauma. The authors addressed this question by reviewing 24 studies that assessed trauma exposure and overgenerality, examining samples with posttraumatic stress disorder, acute stress disorder, depression, traumatic event exposure, and other clinical disorders. Limitations are discussed, including variations in assessment of events, depression, and overgenerality and the need for additional comparison groups. Across studies, there was no consistent association between trauma exposure and overgenerality, suggesting that trauma exposure is unlikely to be the primary mechanism leading to overgenerality. Instead, psychopathology factors such as depression and posttraumatic stress appear to be more consistently associated with overgenerality. Alternative overgenerality theories may help identify key overgenerality mechanisms, improving current understanding of autobiographical memory processes underlying psychopathology.
C1 Univ Washington, Dept Psychol, Seattle, WA 98195 USA.
RP Moore, SA (reprint author), Univ Washington, Dept Psychol, Box 351525, Seattle, WA 98195 USA.
EM samoore@u.washington.edu
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Arntz A, 2002, BEHAV RES THER, V40, P1063, DOI 10.1016/S0005-7967(01)00121-8
   BECK AT, 1979, COGNITIVE THERAPY DE
   Bremner JD, 2000, PSYCHOL SCI, V11, P333, DOI 10.1111/1467-9280.00266
   BRESLAU N, 1995, AM J PSYCHIAT, V152, P529
   Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748
   Brewin CR, 1998, BEHAV RES THER, V36, P1131, DOI 10.1016/S0005-7967(98)00084-9
   Brewin CR, 1999, J ABNORM PSYCHOL, V108, P511, DOI 10.1037/0021-843X.108.3.511
   Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5
   BRITTLEBANK AD, 1993, BRIT J PSYCHIAT, V162, P118, DOI 10.1192/bjp.162.1.118
   BURKE M, 1992, COGNITION EMOTION, V6, P23, DOI 10.1080/02699939208411056
   Burnside E, 2004, BRIT J CLIN PSYCHOL, V43, P365, DOI 10.1348/0144665042388991
   Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261
   Corsini R.J., 2000, CURRENT PSYCHOTHERAP
   Dalgleish T, 2003, EMOTION, V3, P211, DOI 10.1037/1528-3542.3.3.211
   Dalgleish T, 2001, J ABNORM PSYCHOL, V110, P335, DOI 10.1037//0021-843X.110.2.335
   Davies M. I., 1998, BEHAV COGN PSYCHOTH, V26, P303
   de Decker A, 2003, J CLIN CHILD ADOLESC, V32, P22, DOI 10.1207/15374420360533031
   Drummond LE, 2006, COGNITION EMOTION, V20, P488, DOI 10.1080/02699930500341342
   Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0
   Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037//0021-843X.107.3.508
   Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445
   Francis WN, 1982, FREQUENCY ANAL ENGLI
   Goodman M, 2002, PSYCHIAT ANN, V32, P337
   Harrison CL, 2004, J NERV MENT DIS, V192, P745, DOI 10.1097/01.nmd.0000144693.12282.11
   Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P500, DOI 10.1037/0022-006X.66.3.500
   Henderson D, 2002, BRIT J CLIN PSYCHOL, V41, P129, DOI 10.1348/014466502163921
   Hermans D, 2004, BEHAV RES THER, V42, P775, DOI 10.1016/S0005-7967(03)00197-9
   HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209
   Johnson RJ, 2005, J CLIN CHILD ADOLESC, V34, P235, DOI 10.1207/s15374424jccp3402_3
   Kaney S, 1999, BRIT J CLIN PSYCHOL, V38, P97, DOI 10.1348/014466599162692
   Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P293, DOI 10.1037/0022-006X.73.2.293
   KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   KILPATRICK DG, 1992, POSTTRAUMATIC STRESS, P113
   Kremers IP, 2004, BRIT J CLIN PSYCHOL, V43, P17, DOI 10.1348/014466504772812940
   KUYKEN W, 1995, J ABNORM PSYCHOL, V104, P585, DOI 10.1037//0021-843X.104.4.585
   Maccallum F, 2000, INT J CLIN EXP HYP, V48, P361, DOI 10.1080/00207140008410366
   Marx BP, 2005, REV GEN PSYCHOL, V9, P67, DOI 10.1037/1089-2680.9.1.67
   McGlashan TH, 2000, ACTA PSYCHIAT SCAND, V102, P256, DOI 10.1034/j.1600-0447.2000.102004256.x
   MCNALLY RJ, 1995, BEHAV RES THER, V33, P619, DOI 10.1016/0005-7967(95)00007-K
   MCNALLY RJ, 1994, COGNITION EMOTION, V8, P351, DOI 10.1080/02699939408408946
   Moses A, 2004, BRIT J CLIN PSYCHOL, V43, P377, DOI 10.1348/0144665042388964
   Nijenhuis E.R.S., 1999, SOMATOFORM DISSOCIAT, P188
   Nilsson-Ihrfelt E, 2004, J PSYCHOSOM RES, V57, P363, DOI 10.1016/j.jpsychores.2004.01.009
   Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504
   Orbach Y, 2001, CHILD ABUSE NEGLECT, V25, P1427, DOI 10.1016/S0145-2134(01)00283-6
   Park RJ, 2004, J CHILD PSYCHOL PSYC, V45, P996, DOI 10.1111/j.1469-7610.2004.t01-1-00291.x
   Peeters F, 2002, COMPR PSYCHIAT, V43, P344, DOI 10.1053/comp.2002.34635
   Philippot P, 2003, EMOTION, V3, P270, DOI 10.1037/1528-3542.3.3.270
   Raes F, 2005, BRIT J CLIN PSYCHOL, V44, P133, DOI 10.1348/014466504X20080
   Ramponi C, 2004, MEMORY, V12, P655, DOI 10.1080/09658210344000189
   RAPEE RM, 1994, BEHAV RES THER, V32, P89, DOI 10.1016/0005-7967(94)90087-6
   Renneberg B, 2005, COGNITIVE THER RES, V29, P343, DOI 10.1007/s10608-005-4267-4
   Rimes KA, 2005, BEHAV RES THER, V43, P1673, DOI 10.1016/j.brat.2004.12.002
   Shipherd JC, 1999, BEHAV RES THER, V37, P99, DOI 10.1016/S0005-7967(98)00136-3
   Stokes DJ, 2004, BEHAV RES THER, V42, P1357, DOI 10.1016/j.brat.2003.10.003
   VANDERKOLK BA, 1994, HARVARD REV PSYCHIAT, V1, P253, DOI 10.3109/10673229409017088
   van Minnen A, 2005, BRIT J CLIN PSYCHOL, V44, P405, DOI 10.1348/014466505X29648
   van Vreeswijk MF, 2004, BEHAV RES THER, V42, P731, DOI 10.1016/S0005-7967(03)00194-3
   Watkins E, 2004, J AFFECT DISORDERS, V82, P1, DOI 10.1016/j.jad.2003.10.006
   Watkins E, 2005, EMOTION, V5, P319, DOI 10.1037/1528-3542.5.3.319
   Watkins E, 2001, J ABNORM PSYCHOL, V110, P353, DOI 10.1037//0021-843X.110.2.353
   Watkins E, 2000, PSYCHOL MED, V30, P911, DOI 10.1017/S0033291799002263
   WEGNER DM, 1992, J PERS SOC PSYCHOL, V63, P903, DOI 10.1037/0022-3514.63.6.903
   Wessel I, 2001, BEHAV RES THER, V39, P409, DOI 10.1016/S0005-7967(00)00011-5
   Wessel I, 2002, J TRAUMA STRESS, V15, P227, DOI 10.1023/A:1015207428675
   Wilhelm S, 1997, BRIT J CLIN PSYCHOL, V36, P21
   Willebrand M, 2002, BURNS, V28, P465, DOI 10.1016/S0305-4179(02)00052-9
   WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144
   Williams J. M. G., 1996, REMEMBERING OUR PAST, P244, DOI [10.1017/CBO9780511527913.010, DOI 10.1017/CB09780511527913.010]
   Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278
   Williams JMG, 1988, COGNITION EMOTION, V2, P221, DOI 10.1080/02699938808410925
   Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551
   Yen S, 2002, J NERV MENT DIS, V190, P510, DOI 10.1097/01.NMD.0000026620.66764.78
   Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733
   Zoellner LA, 2000, J ABNORM PSYCHOL, V109, P517, DOI 10.1037//0021-843X.109.3.517
NR 77
TC 90
Z9 92
PU AMER PSYCHOLOGICAL ASSOC/EDUCATIONAL PUBLISHING FOUNDATION
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0033-2909
J9 PSYCHOL BULL
JI Psychol. Bull.
PD MAY
PY 2007
VL 133
IS 3
BP 419
EP 437
DI 10.1037/0033-2909.133.3.419
PG 19
WC Psychology; Psychology, Multidisciplinary
SC Psychology
GA 163AQ
UT WOS:000246131200003
PM 17469985
ER

PT J
AU Hillis, LD
   Smith, PK
   Anderson, JL
   Bittl, JA
   Bridges, CR
   Byrne, JG
   Cigarroa, JE
   DiSesa, VJ
   Hiratzka, LF
   Hutter, AM
   Jessen, ME
   Keeley, EC
   Lahey, SJ
   Lange, RA
   London, MJ
   Mack, MJ
   Patel, MR
   Puskas, JD
   Sabik, JF
   Selnes, O
   Shahian, DM
   Trost, JC
   Winniford, MD
AF Hillis, L. David
   Smith, Peter K.
   Anderson, Jeffrey L.
   Bittl, John A.
   Bridges, Charles R.
   Byrne, John G.
   Cigarroa, Joaquin E.
   DiSesa, Verdi J.
   Hiratzka, Loren F.
   Hutter, Adolph M., Jr.
   Jessen, Michael E.
   Keeley, Ellen C.
   Lahey, Stephen J.
   Lange, Richard A.
   London, Martin J.
   Mack, Michael J.
   Patel, Manesh R.
   Puskas, John D.
   Sabik, Joseph F.
   Selnes, Ola
   Shahian, David M.
   Trost, Jeffrey C.
   Winniford, Michael D.
TI 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery A
   Report of the American College of Cardiology Foundation/American Heart
   Association Task Force on Practice Guidelines Developed in Collaboration
   With the American Association for Thoracic Surgery, Society of
   Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE ACCF/AHA Practice Guidelines; acute coronary syndromes; anticoagulants;
   antiplatelet agents; arrhythmias, cardiac; coronary angiography;
   coronary artery revascularization interventions: stents; drug therapy;
   heart diseases; myocardial revasularization; platelet aggregation
   inhibitor; ultrasound
ID ACUTE MYOCARDIAL-INFARCTION; INTERNAL-MAMMARY-ARTERY; LONG-TERM
   SURVIVAL; RANDOMIZED-CONTROLLED-TRIAL; HIGH-RISK PATIENTS;
   ACUTE-RENAL-FAILURE; DRUG-ELUTING STENTS; NEW-YORK-STATE; STERNAL
   WOUND-INFECTION; ST-SEGMENT ELEVATION
AB The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
   The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have jointly produced guidelines in the area of cardiovascular disease since 1980. The ACCF/AHA Task Force on Practice Guidelines (Task Force), charged with developing, updating, and revising practice guidelines for cardiovascular diseases and procedures, directs and oversees this effort. Writing committees are charged with regularly reviewing and evaluating all available evidence to develop balanced, patient-centric recommendations for clinical practice.
   Experts in the subject under consideration are selected by the ACCF and AHA to examine subject-specific data and write guidelines in partnership with representatives from other medical organizations and specialty groups. Writing committees are asked to perform a formal literature review; weigh the strength of evidence for or against particular tests, treatments, or procedures; and include estimates of expected outcomes where such data exist. Patient-specific modifiers, comorbidities, and issues of patient preference that may influence the choice of tests or therapies are considered. When available, information from studies on cost is considered, but data on efficacy and outcomes constitute the primary basis for the recommendations contained herein.
   In analyzing the data and developing recommendations and supporting text, the writing committee uses evidence-based methodologies developed by the Task Force (1). The Class of Recommendation (COR) is an estimate of the size of the treatment effect considering risks versus benefits in addition to evidence and/or agreement that a given treatment or procedure is or is not useful/effective or in some situations may cause harm. The Level of Evidence (LOE) is an estimate of the certainty or precision of the treatment effect. The writing committee reviews and ranks evidence supporting each recommendation with the weight of evidence ranked as LOE A, B, or C according to specific definitions that are included in Table 1. Studies are identified as observational, retrospective, prospective, or randomized where appropriate. For certain conditions for which inadequate data are available, recommendations are based on expert consensus and clinical experience and are ranked as LOE C. When recommendations at LOE C are supported by historical clinical data, appropriate references (including clinical reviews) are cited if available. For issues for which sparse data are available, a survey of current
   [GRAPHICS]
   practice among the clinicians on the writing committee is the basis for LOE C recommendations, and no references are cited. The schema for COR and LOE is summarized in Table 1, which also provides suggested phrases for writing recommendations within each COR. A new addition to this methodology is separation of the Class III recommendations to delineate if the recommendation is determined to be of "no benefit" or is associated with "harm" to the patient. In addition, in view of the increasing number of comparative effectiveness studies, comparator verbs and suggested phrases for writing recommendations for the comparative effectiveness of one treatment or strategy versus another have been added for COR I and IIa, LOE A or B only.
   In view of the advances in medical therapy across the spectrum of cardiovascular diseases, the Task Force has designated the term guideline-directed medical therapy (GDMT) to represent optimal medical therapy as defined by ACCF/AHA guideline-recommended therapies (primarily Class I). This new term, GDMT, will be used herein and throughout all future guidelines.
   Because the ACCF/AHA practice guidelines address patient populations (and healthcare providers) residing in North America, drugs that are not currently available in North America are discussed in the text without a specific COR. For studies performed in large numbers of subjects outside North America, each writing committee reviews the potential influence of different practice patterns and patient populations on the treatment effect and relevance to the ACCF/AHA target population to determine whether the findings should inform a specific recommendation.
   The ACCF/AHA practice guidelines are intended to assist healthcare providers in clinical decision making by describing a range of generally acceptable approaches to the diagnosis, management, and prevention of specific diseases or conditions. The guidelines attempt to define practices that meet the needs of most patients in most circumstances. The ultimate judgment regarding the care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient. As a result, situations may arise for which deviations from these guidelines may be appropriate. Clinical decision making should involve consideration of the quality and availability of expertise in the area where care is provided. When these guidelines are used as the basis for regulatory or payer decisions, the goal should be improvement in quality of care. The Task Force recognizes that situations arise in which additional data are needed to inform patient care more effectively; these areas will be identified within each respective guideline when appropriate.
   Prescribed courses of treatment in accordance with these recommendations are effective only if followed. Because lack of patient understanding and adherence may adversely affect outcomes, physicians and other healthcare providers should make every effort to engage the patient's active participation in prescribed medical regimens and lifestyles. In addition, patients should be informed of the risks, benefits, and alternatives to a particular treatment and be involved in shared decision making whenever feasible, particularly for COR IIa and IIb, where the benefit-to-risk ratio may be lower.
   The Task Force makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of industry relationships or personal interests among the members of the writing committee. All writing committee members and peer reviewers of the guideline are required to disclose all such current relationships, as well as those existing 12 months previously. In December 2009, the ACCF and AHA implemented a new policy for relationships with industry and other entities (RWI) that requires the writing committee chair plus a minimum of 50% of the writing committee to have no relevant RWI (Appendix 1 for the ACCF/AHA definition of relevance). These statements are reviewed by the Task Force and all members during each conference call and meeting of the writing committee and are updated as changes occur. All guideline recommendations require a confidential vote by the writing committee and must be approved by a consensus of the voting members. Members are not permitted to write, and must recuse themselves from voting on, any recommendation or section to which their RWI apply. Members who recused themselves from voting are indicated in the list of writing committee members, and section recusals are noted in Appendix 1. Authors' and peer reviewers' RWI pertinent to this guideline are disclosed in Appendixes 1 and 2, respectively. Additionally, to ensure complete transparency, writing committee members' comprehensive disclosure information-including RWI not pertinent to this document-is available as an online supplement. Comprehensive disclosure information for the Task Force is also available online at www.cardiosource.org/ACC/About-ACC/Leadership/Guidelinesand-Documents-Task-Forces.aspx. The work of the writing committee was supported exclusively by the ACCF and AHA without commercial support. Writing committee members volunteered their time for this activity.
   In an effort to maintain relevance at the point of care for practicing physicians, the Task Force continues to oversee an ongoing process improvement initiative. As a result, in response to pilot projects, evidence tables (with references linked to abstracts in PubMed) have been added.
   In April 2011, the Institute of Medicine released 2 reports: Finding What Works in Health Care: Standards for Systematic Reviews and Clinical Practice Guidelines We Can Trust (2,3). It is noteworthy that the ACCF/AHA guidelines are cited as being compliant with many of the proposed standards. A thorough review of these reports and of our current methodology is under way, with further enhancements anticipated.
   The recommendations in this guideline are considered current until they are superseded by a focused update or the full-text guideline is revised. Guidelines are official policy of both the ACCF and AHA.
C1 [Hillis, L. David; Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
   [Smith, Peter K.] Duke Univ, Med Ctr, Private Diagnost Clin, Durham, NC 27706 USA.
   [Bridges, Charles R.] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA.
   [Byrne, John G.] Vanderbilt Univ, Med Ctr, Div Cardiac Surg, Nashville, TN 37203 USA.
   [Cigarroa, Joaquin E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [DiSesa, Verdi J.] Johns Hopkins Univ Hosp, Div Cardiac Surg, Baltimore, MD 21287 USA.
   [Hutter, Adolph M., Jr.; Shahian, David M.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Jessen, Michael E.] UT SW Med Ctr, Dallas, TX 75390 USA.
   [Keeley, Ellen C.] Univ Virginia, Charlottesville, VA 22903 USA.
   [Lahey, Stephen J.] Univ Connecticut, Storrs, CT 06269 USA.
   [London, Martin J.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA.
   [Puskas, John D.] Emory Univ, Atlanta, GA 30322 USA.
   [Sabik, Joseph F.] Cleveland Clin Fdn, Cleveland, OH USA.
   [Selnes, Ola] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA.
   [Winniford, Michael D.] Univ Mississippi, Med Ctr, University, MS 38677 USA.
RP Hillis, LD (reprint author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
CR Aaberge L, 2002, J AM COLL CARDIOL, V39, P1588, DOI 10.1016/S0735-1097(02)01828-4
   Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Abbaszadeh M, 2008, REV BRAS CIR CARDIOV, V23, P317, DOI 10.1590/S0102-76382008000300006
   Abboud CS, 2004, ANN THORAC SURG, V77, P676, DOI 10.1016/S0003-4975(03)01523-6
   Abizaid A, 2001, CIRCULATION, V104, P533, DOI 10.1161/hc3101.093700
   Aboyans V, 2006, EUR J CARDIO-THORAC, V30, P300, DOI 10.1016/j.ejcts.2006.03.066
   Abraham VS, 2000, CARDIOPULMONARY BYPA, P382
   Abramov D, 2000, ANN THORAC SURG, V70, P800, DOI 10.1016/S0003-4975(00)01563-0
   Acar C, 1998, J THORAC CARDIOV SUR, V116, P981, DOI 10.1016/S0022-5223(98)70050-9
   ACCF/AHA Task Force on Practice Guidelines, METH POL ACCF AHA TA
   Adabag AS, 2009, EUR HEART J, V30, P1910, DOI 10.1093/eurheartj/ehp053
   ADES PA, 1992, AM HEART J, V123, P916, DOI 10.1016/0002-8703(92)90696-S
   Agarwal S, 2010, AM J CARDIOL, V105, P1549, DOI 10.1016/j.amjcard.2010.01.012
   Aklog L, 2001, CIRCULATION, V104, pI68
   Alderman E, 1997, CIRCULATION, V96, P1761
   Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446
   Alexander KP, 2000, J AM COLL CARDIOL, V35, P731, DOI 10.1016/S0735-1097(99)00606-3
   Alexiou K, 2008, CLIN RES CARDIOL, V97, P601, DOI 10.1007/s00392-008-0657-6
   Alghamdi AA, 2006, J CARDIAC SURG, V21, P320, DOI 10.1111/j.1540-8191.2006.00241.x
   Ali IM, 1997, EUR J CARDIO-THORAC, V11, P1154, DOI 10.1016/S1010-7940(97)01215-3
   Al-Khatib SM, 2009, AM HEART J, V158, P792, DOI 10.1016/j.ahj.2009.09.003
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Allen KB, 1999, NEW ENGL J MED, V341, P1029, DOI 10.1056/NEJM199909303411403
   Al-Sarraf N, 2008, ANN THORAC SURG, V86, P517, DOI 10.1016/j.athoracsur.2008.03.070
   Alserius T, 2009, J THORAC CARDIOV SUR, V138, P1115, DOI 10.1016/j.jtcvs.2009.03.013
   Al Suwaidi J, 2004, AM HEART J, V147, P815, DOI 10.1016/j.ahj.2003.11.025
   Amar D, 2001, CHEST, V119, P1476, DOI 10.1378/chest.119.5.1476
   American Society of Anesthesiologists, STAND BAS AN PAR
   American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography, 2010, ANESTHESIOLOGY, V112, P1084
   American Society of Anesthesiologists Task Force on pulmonary artery catheterization, 2003, ANESTHESIOLOGY, V99, P988
   Amin AP, 2009, J INVASIVE CARDIOL, V21, P305
   Amoroso G, 2001, Ital Heart J, V2, P139
   Anand SS, 2005, J AM COLL CARDIOL, V46, P1845, DOI 10.1016/j.jacc.2005.05.091
   Anderson RE, 2005, EUR HEART J, V26, P1513, DOI 10.1093/eurheartj/ehi182
   Anderson RJ, 1999, KIDNEY INT, V55, P1057, DOI 10.1046/j.1523-1755.1999.0550031057.x
   ANDERSSON LG, 1993, THORAC CARDIOV SURG, V41, P237, DOI 10.1055/s-2007-1013861
   Andreasen JJ, 2000, SCAND CARDIOVASC J, V34, P242, DOI 10.1080/713783120
   Andrew MJ, 2001, J CARDIOTHOR VASC AN, V15, P9, DOI 10.1053/jcan.2001.20210
   ANDREWS TC, 1991, CIRCULATION, V84, P236
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   Angouras DC, 2010, ANN THORAC SURG, V89, P1112, DOI 10.1016/j.athoracsur.2010.01.009
   [Anonymous], 2006, ANESTHESIOLOGY, V104, P864
   [Anonymous], 2002, LANCET, V360, P965
   [Anonymous], 1996, J THORAC CARDIOVASC, V111, P1200
   [Anonymous], 1993, LANCET, V341, P573
   [Anonymous], 2002, LANCET, V360, P7
   [Anonymous], 2002, CIRCULATION, V106, P3143
   Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178
   [Anonymous], 2002, BMJ, V324, P141
   [Anonymous], 2011, FDA SAF AL ZOC SIMV
   Anthonisen NR, 2005, ANN INTERN MED, V142, P233
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424
   Arabaci U, 2003, JPN HEART J, V44, P61, DOI 10.1536/jhj.44.61
   Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002
   Argenziano M, 2006, ANN THORAC SURG, V81, P1666, DOI 10.1016/j.athoracsur.2005.11.007
   ARIANO RE, 1991, DICP ANN PHARMAC, V25, P478
   Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S040-6736(07)60716-8
   Aronson S, 2010, ANESTHESIOLOGY, V113, P305, DOI 10.1097/ALN.0b013e3181e07ee9
   Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107
   Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7
   Ashley ESD, 2004, CLIN INFECT DIS, V38, P1555
   AstraZeneca, 22433 NDA
   Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athorascur.2003.07.002
   Augoustides JGT, 2006, J CARDIOTHOR VASC AN, V20, P379, DOI 10.1053/j.jvca.2005.10.011
   Austin PC, 2003, MED DECIS MAKING, V23, P526, DOI 10.1177/0272989X03258443
   AUSTIN TW, 1980, CAN J SURG, V23, P483
   AUTSCHBACH R, 1994, PACE, V17, P552, DOI 10.1111/j.1540-8159.1994.tb01425.x
   Avidan MS, 2004, BRIT J ANAESTH, V92, P178, DOI 10.1093/bja/aeh037
   Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361
   Aziz O, 2007, BRIT MED J, V334, P617, DOI 10.1136/bmj.39106.476215.BE
   Badreldin A, 2010, INTERACT CARDIOV TH, V10, P48, DOI 10.1510/icvts.2009.211805
   Bae Ki Sun, 2007, Korean Journal of Internal Medicine, V22, P139
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baillot R, 2010, EUR J CARDIO-THORAC, V37, P880, DOI 10.1016/j.ejcts.2009.09.023
   Bainbridge D, 2006, CAN J ANAESTH, V53, P46
   Bainbridge D, 2006, CAN J ANAESTH, V53, P492
   Bair TL, 2007, CIRCULATION, V116, pI226, DOI 10.1161/CIRCULATIONAHA.106.681346
   Balacumaraswami L, 2007, ANN THORAC SURG, V83, P2251, DOI 10.1016/j.athoracsur.2006.12.025
   Banbury MK, 2006, J AM COLL SURGEONS, V202, P131, DOI 10.1016/j.jamcollsurg.2005.08.028
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Bapoje SR, 2007, CHEST, V132, P1637, DOI 10.1378/chest.07-0347
   Barakate MS, 2003, ANN THORAC SURG, V75, P1400, DOI 10.1016/S0003-4975(02)05026-9
   Bardakci H, 2007, ANN THORAC SURG, V83, P483, DOI 10.1016/j.athoracsur.2006.09.047
   BARNER HB, 1994, ANN THORAC SURG, V57, P1526
   BARNER HB, 1974, ARCH SURG-CHICAGO, V109, P627
   BARNER HB, 1985, J THORAC CARDIOV SUR, V90, P668
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   Becker ER, 2006, J NATL MED ASSOC, V98, P1729
   BELL MR, 1990, J AM COLL CARDIOL, V16, P553
   Beller GA, 2010, JACC-CARDIOVASC INTE, V3, P315, DOI 10.1016/j.jcin.2010.01.007
   Benedetto U, 2008, ANN THORAC SURG, V86, P1160, DOI 10.1016/j.athoracsur.2008.06.018
   Benedetto U, 2009, EUR J CARDIO-THORAC, V36, P611, DOI 10.1016/j.ejcts.2009.03.012
   Ben-Gal Y, 2006, ANN THORAC SURG, V82, P2067, DOI 10.1016/j.athoracsur.2006.06.041
   BENNETT B, 1991, OBSTET GYNECOL, V78, P1019
   BennettGuerrero E, 1996, JAMA-J AM MED ASSOC, V275, P687, DOI 10.1001/jama.275.9.687
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berendes E, 2003, ARCH SURG-CHICAGO, V138, P1283, DOI 10.1001/archsurg.138.12.1283
   Berger JS, 2008, J AM COLL CARDIOL, V52, P1693, DOI 10.1016/j.jacc.2008.08.031
   BERGER PB, 1995, AM J CARDIOL, V76, P565, DOI 10.1016/S0002-9149(99)80156-8
   Berger PB, 2001, J AM COLL CARDIOL, V38, P1440, DOI 10.1016/S0735-1097(01)01571-6
   Bergquist BD, 1996, ANESTH ANALG, V82, P1139, DOI 10.1097/00000539-199606000-00007
   Berkowitz SD, 2001, AM J CARDIOL, V88, P1230, DOI 10.1016/S0002-9149(01)02082-3
   Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568
   BERNTSEN RF, 1993, EUR HEART J, V14, P1297
   Berridge DC, 1998, J ROY COLL SURG EDIN, V43, P9
   Berry PD, 1998, BRIT J ANAESTH, V80, P20
   Biancari F, 2007, ANN THORAC SURG, V84, P254, DOI 10.1016/j.athoracsur.2007.02.022
   Bignami E, 2010, J CARDIOTHOR VASC AN, V24, P586, DOI 10.1053/j.jvca.2009.09.015
   Bijker JB, 2007, ANESTHESIOLOGY, V107, P213, DOI 10.1097/01.anes.0000270724.40897.8e
   Bilgin YM, 2010, CRIT CARE MED, V38, P546, DOI 10.1097/CCM.0b013e3181c0de7b
   Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21
   Bingol H, 2005, J CARDIAC SURG, V20, P252, DOI 10.1111/j.1540-8191.2005.200392.x
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   BIRKMEYER JD, 1995, J VASC SURG, V21, P445, DOI 10.1016/S0741-5214(95)70286-5
   Birkmeyer J D, 1999, Eff Clin Pract, V2, P277
   Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205
   Birkmeyer JD, 1999, SURGERY, V125, P250, DOI 10.1067/msy.1999.95211
   Birkmeyer JD, 2006, CANCER, V106, P2476, DOI 10.1002/cncr.21888
   Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139
   Birkmeyer JD, 2000, J AM COLL SURGEONS, V190, P341, DOI 10.1016/S1072-7515(99)00270-7
   Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741
   Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337
   Birkmeyer JD, 2000, JAMA-J AM MED ASSOC, V283, P1191, DOI 10.1001/jama.283.9.1191
   Bizzarri F, 2001, J THORAC CARDIOV SUR, V122, P1181, DOI 10.1067/mtc.2001.117838
   BJORK VO, 1981, SCAND J THORAC CARD, V15, P23, DOI 10.3109/14017438109101021
   BLANCHARD A, 1995, EUR J CARDIO-THORAC, V9, P153, DOI 10.1016/S1010-7940(05)80064-8
   Blankstein R, 2005, CIRCULATION, V112, pI323, DOI 10.1161/CIRCULATIONAHA.104.525139
   Blumberg N, 2002, AM J CLIN PATHOL, V118, P376
   Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Bolon MK, 2004, CLIN INFECT DIS, V38, P1357, DOI 10.1086/383318
   Bonaros N, 2009, J THORAC CARDIOV SUR, V137, P846, DOI 10.1016/j.jtcvs.2008.09.041
   Bonaros N, 2009, CARDIOLOGY, V114, P59, DOI 10.1159/000212115
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonatti J, 2006, J THORAC CARDIOV SUR, V131, P146, DOI 10.1016/j.jtcvs.2005.07.064
   Bonow RO, 2011, NEW ENGL J MED, V364, P1625
   Boodhwani M, 2009, ANN THORAC SURG, V87, P489, DOI 10.1016/j.athoracsur.2008.10.078
   Borger MA, 1998, ANN THORAC SURG, V65, P1050, DOI 10.1016/S0003-4975(98)00063-0
   Borowicz L, 2002, PSYCHOSOMATICS, V43, P464, DOI 10.1176/appi.psy.43.6.464
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Bourassa M G, 1985, Circulation, V72, pV71
   Bourassa MG, 1998, EUR HEART J, V19, P103, DOI 10.1053/euhj.1997.0574
   BOYLAN MJ, 1994, J THORAC CARDIOV SUR, V107, P657
   Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159
   BrandrupWognsen G, 1996, EUR HEART J, V17, P1426
   Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220
   Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7
   Bravata DM, 2007, ANN INTERN MED, V147, P703
   Braxton John H, 2004, Semin Thorac Cardiovasc Surg, V16, P70, DOI 10.1053/j.semtcvs.2004.01.006
   BREISBLATT WM, 1990, J AM COLL CARDIOL, V15, P1261
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55
   Bridges CR, 2004, ANN THORAC SURG, V77, P1494, DOI 10.1016/j.athoracsur.2004.01.007
   Briguori C, 2007, AM J CARDIOL, V99, P779, DOI 10.1016/j.amjcara.2006.10.031
   BROOKS N, 1979, BRIT HEART J, V42, P333
   Brophy JM, 2003, ANN INTERN MED, V138, P777
   Brown PP, 2008, ANN THORAC SURG, V85, P1980, DOI 10.1016/j.athoracsur.2008.01.053
   Bucerius J, 2004, J THORAC CARDIOV SUR, V127, P57, DOI 10.1016/S0022-5223(03)01281-9
   Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9
   BUCHE M, 1995, J THORAC CARDIOV SUR, V109, P553, DOI 10.1016/S0022-5223(95)70288-1
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Buckberg GD, 2010, J THORAC CARDIOV SUR, V140, P12, DOI 10.1016/j.jtcvs.2010.02.014
   Budeus M, 2006, INT J CARDIOL, V113, P201, DOI 10.1016/j.ijcard.2005.11.014
   Bukkapatnam RN, 2010, AM J CARDIOL, V105, P339, DOI 10.1016/j.amjcard.2009.09.035
   Bundy JK, 2006, AM J INFECT CONTROL, V34, P114, DOI 10.1016/j.ajic.2005.10.003
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   Butterworth J, 2005, J THORAC CARDIOV SUR, V130, P1319, DOI 10.1016/j.jtcvs.2005.02.049
   Butterworth J, 1998, ANESTHESIOLOGY, V88, P1437, DOI 10.1097/00000542-199806000-00005
   Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805
   CABRI Trial Participants, 1995, LANCET, V346, P1179
   Cahalan MK, 2002, J AM SOC ECHOCARDIOG, V15, P647, DOI 10.1067/mje.2002.123956
   Cai Tung H, 2007, Innovations (Phila), V2, P245, DOI 10.1097/IMI.0b013e31815cd976
   Caimmi PP, 2003, J CARDIOTHOR VASC AN, V17, P491, DOI 10.1016/S1053-0770(03)00155-1
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Campeau L, 1997, NEW ENGL J MED, V336, P153
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Canver CC, 1998, ANN THORAC SURG, V66, P144, DOI 10.1016/S0003-4975(98)00322-1
   Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   CAREY JA, 1994, BRIT HEART J, V72, P428
   Carrie D, 1997, CIRCULATION, V96, pII6
   Cartier R, 2008, EUR J CARDIO-THORAC, V34, P826, DOI 10.1016/j.ejcts.2008.07.024
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   Castellheim A, 2008, ANN THORAC SURG, V85, P1994, DOI 10.1016/j.athoracsur.2008.03.012
   CAVENDER JB, 1992, J AM COLL CARDIOL, V20, P287
   Cecil WT, 2008, AM J MANAG CARE, V14, P521
   Centers for Diseases Control and Prevention, 2010, MMWR-MORBID MORTAL W, V44, P1
   Chaitman BR, 2009, CIRCULATION, V120, P2529, DOI 10.1161/CIRCULATIONAHA.109.913111
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Chamchad D, 2010, J CARDIOTHOR VASC AN, V24, P780, DOI 10.1053/j.jvca.2010.04.002
   Chan AYM, 2010, J THORAC CARDIOV SUR, V140, P182, DOI 10.1016/j.jtcvs.2010.03.015
   Chaney MA, 2000, ANESTHESIOLOGY, V92, P1637, DOI 10.1097/00000542-200006000-00022
   Chang Andrew C, 2006, Thorac Surg Clin, V16, P87, DOI 10.1016/j.thorsurg.2006.01.008
   Charrot F, 2010, INTERACT CARDIOV TH, V10, P346, DOI 10.1510/icvts.2009.219352
   Chassin MR, 2002, HEALTH AFFAIR, V21, P40, DOI 10.1377/hlthaff.21.4.40
   Chatterjee K, 2009, CIRCULATION, V119, P147, DOI 10.1161/CIRCULATIONAHA.108.811141
   Cheitlin MD, 2003, J AM COLL CARDIOL, V42, P954, DOI 10.1016/S0735-1097(03)01065-9
   CHEITLIN MD, 1974, CIRCULATION, V50, P780
   Chelemer SB, 2002, ANN THORAC SURG, V73, P138, DOI 10.1016/S0003-4975(01)03308-2
   Chen J, 2000, ARCH INTERN MED, V160, P947, DOI 10.1001/archinte.160.7.947
   Chen YF, 2004, ANN THORAC SURG, V78, P634, DOI 10.1016/j.athoracsur.2004.02.091
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cheng DCH, 1996, J THORAC CARDIOV SUR, V112, P755, DOI 10.1016/S0022-5223(96)70062-4
   Cheng DCH, 1996, ANESTHESIOLOGY, V85, P1300, DOI 10.1097/00000542-199612000-00011
   Chertow GM, 1997, CIRCULATION, V95, P878
   CHESEBRO JH, 1984, NEW ENGL J MED, V310, P209, DOI 10.1056/NEJM198401263100401
   CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201
   CHEUNG AT, 1994, ANESTHESIOLOGY, V81, P376, DOI 10.1097/00000542-199408000-00016
   Chevalier P, 2004, EUR J CARDIO-THORAC, V26, P330, DOI 10.1016/j.ejcts.2004.04.027
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chiu FC, 2009, J THORAC CARDIOV SUR, V138, P1326, DOI 10.1016/j.jtcvs.2009.03.038
   Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Choudhry NK, 2005, AM J MED, V118, P465, DOI 10.1016/j.amjmed.2005.02.016
   Chowdhury UK, 2008, J THORAC CARDIOV SUR, V135, P1110, DOI 10.1016/j.jtcvs.2007.12.029
   CHRISTAKIS GT, 1995, J THORAC CARDIOV SUR, V110, P1344, DOI 10.1016/S0022-5223(95)70058-7
   Christenson JT, 1999, EUR J CARDIO-THORAC, V15, P394, DOI 10.1016/S1010-7940(99)00034-2
   Christenson JT, 2003, J CARDIAC SURG, V18, P286, DOI 10.1046/j.1540-8191.2003.02030.x
   Christenson J T, 1996, Cardiovasc Surg, V4, P801, DOI 10.1016/S0967-2109(96)00052-X
   Christenson JT, 1999, ANN THORAC SURG, V68, P934, DOI 10.1016/S0003-4975(99)00687-6
   Christenson JT, 2002, ANN THORAC SURG, V74, P1086, DOI 10.1016/S0003-4975(02)03854-7
   Christenson JT, 2001, CARDIOVASC SURG, V9, P383, DOI 10.1016/S0967-2109(00)00151-4
   Christiansen CL, 1997, ANN INTERN MED, V127, P764
   Chu MWA, 2004, ANN THORAC SURG, V78, P1536, DOI 10.1016/j.athoracsur.2004.03.028
   Chukwuemeka A, 2005, ANN THORAC SURG, V80, P2148, DOI 10.1016/j.athoracsur.2005.06.015
   CHUNG F, 1988, ANESTHESIOLOGY, V69, P343, DOI 10.1097/00000542-198809000-00010
   Cisowski M, 2002, ANN THORAC SURG, V74, pS1334
   Cisowski Marek, 2004, Kardiol Pol, V61, P253
   Clark AM, 2005, ANN INTERN MED, V143, P659
   Clark R E, 1996, Best Pract Benchmarking Healthc, V1, P62
   Clark RE, 1996, ANN THORAC SURG, V61, P21, DOI 10.1016/0003-4975(95)00734-2
   Cogliati AA, 2007, J CARDIOTHOR VASC AN, V21, P847, DOI 10.1053/j.jvca.2007.02.022
   Cole JH, 2002, J AM COLL CARDIOL, V40, P1968, DOI 10.1016/S0735-1097(02)02561-5
   Coleman CI, 2007, CURR MED RES OPIN, V23, P1783, DOI 10.1185/030079907X210570
   Collard CD, 2006, J THORAC CARDIOV SUR, V132, P392, DOI 10.1016/j.jtcvs.2006.04.009
   Conaway DG, 2003, J AM COLL CARDIOL, V42, P1421, DOI 10.1016/S0735-1097(03)01052-0
   Connerney I, 2001, LANCET, V358, P1766, DOI 10.1016/S0140-6736(01)06803-9
   Connolly SJ, 2003, AM HEART J, V145, P226, DOI 10.1067/mhj.2003.147
   Cook JR, 2002, AM HEART J, V143, P821, DOI 10.1067/mhj.2002.121732
   Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084
   CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E
   Coskun KO, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-3
   Cowan KN, 2005, ANN THORAC SURG, V80, P2205, DOI 10.1016/j.athoracsur.2005.04.005
   Crabtree Traves D, 2004, Semin Thorac Cardiovasc Surg, V16, P53, DOI 10.1053/j.semtcvs.2004.01.009
   CRAVER JM, 1992, ANN SURG, V215, P425, DOI 10.1097/00000658-199205000-00004
   CRESWELL LL, 1995, ANN THORAC SURG, V60, P19
   Crystal E, 2004, COCHRANE DB SYST REV, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2005.12.015
   Cywinski JB, 2006, J CARDIOTHOR VASC AN, V20, P796, DOI 10.1053/j.jvca.2006.01.022
   Czech B, 2007, KARDIOL POL, V65, P627
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0
   D'Ambra MN, 1997, ANN THORAC SURG, V64, P1686, DOI 10.1016/S0003-4975(97)00839-4
   Danner BC, 2009, ANN THORAC SURG, V88, P1433, DOI 10.1016/j.athoracsur.2009.06.059
   DAOUD EG, 1995, AM HEART J, V130, P277, DOI 10.1016/0002-8703(95)90440-9
   Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501
   Davies JE, 2009, ANN THORAC SURG, V88, P844, DOI 10.1016/j.athoracsur.2009.06.007
   Davies RF, 1997, CIRCULATION, V95, P2037
   Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0
   DAVIS KB, 1995, J AM COLL CARDIOL, V25, P1000, DOI 10.1016/0735-1097(94)00518-U
   Davis RF, 2000, CARDIOPULMONARY BYPA, P186, DOI DOI 10.1053/J.JVCA.2007.02.022
   DAVISON R, 1985, ANN THORAC SURG, V39, P336
   DeBois William, 2005, J Extra Corpor Technol, V37, P15
   DeFoe GR, 2001, ANN THORAC SURG, V71, P769, DOI 10.1016/S0003-4975(00)02393-6
   De Hert SG, 2002, ANESTHESIOLOGY, V97, P42, DOI 10.1097/00000542-200207000-00007
   De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009
   De Hert SG, 2004, ANESTHESIOLOGY, V101, P9, DOI 10.1097/00000542-200407000-00005
   Del Duca D, 2007, ANN THORAC SURG, V84, P1264, DOI 10.1016/j.athoracsur.2007.05.016
   DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914
   Dempsey C M, 2004, Crit Care Resusc, V6, P248
   De Paulis R, 2005, J THORAC CARDIOV SUR, V129, P536, DOI 10.1016/j.jtcvs.2004.07.059
   Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982
   DESPOTIS GJ, 1994, TRANSFUSION, V34, P290, DOI 10.1046/j.1537-2995.1994.34494233575.x
   DEWOOD MA, 1983, CIRCULATION, V68, P8
   Dial S, 2005, J THORAC CARDIOV SUR, V130, P654, DOI 10.1016/j.jtcvs.2005.02.025
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563
   Di Mauro M, 2007, ANN THORAC SURG, V84, P1496, DOI 10.1016/j.athoracsur.2007.05.054
   Di Mauro M, 2005, ANN THORAC SURG, V79, P81, DOI 10.1016/j.athoracsur.2004.06.058
   Djaiani G, 2007, CIRCULATION, V116, P1888, DOI 10.1161/CIRCULATIONAHA.107.698001
   Doenst T, 2005, J THORAC CARDIOV SUR, V130, P1144, DOI 10.1016/j.jtcvs.2005.05.049
   Donatelli F, 1997, EUR J CARDIO-THORAC, V11, P228, DOI 10.1016/S1010-7940(96)01050-0
   Doss M, 2002, EUR J CARDIO-THORAC, V22, P934, DOI 10.1016/S1010-7940(02)00594-8
   Dotani MI, 2000, AM J CARDIOL, V86, P1128, DOI 10.1016/S0002-9149(00)01172-3
   Dowd NP, 1998, ANESTHESIOLOGY, V89, P1068, DOI 10.1097/00000542-199811000-00006
   Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180
   Drenth DJ, 2004, AM J CARDIOL, V94, P1414, DOI 10.1016/j.amjcard.2004.08.016
   Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6
   Drew BJ, 2004, CIRCULATION, V110, P2721, DOI 10.1161/01.CIR.0000145144.56673.59
   Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159
   Duncan AE, 2010, ANESTHESIOLOGY, V112, P860, DOI 10.1097/ALN.0b013e3181d3d4b4
   Durand DJ, 2004, ANN THORAC SURG, V78, P159, DOI 10.1016/j.athorascur.2004.02.024
   Dyke CM, 2000, ANN THORAC SURG, V70, P866, DOI 10.1016/S0003-4975(00)01654-4
   Dyub AM, 2008, J CARDIAC SURG, V23, P79, DOI 10.1111/j.1540-8191.2007.00499.x
   Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Eagle Kim A, 2004, J Am Coll Cardiol, V44, pe213
   Ebrahimi R, 2009, J AM COLL CARDIOL, V53, P1965, DOI 10.1016/j.jacc.2009.03.006
   Echahidi N, 2008, J AM COLL CARDIOL, V51, P793, DOI 10.1016/j.jacc.2007.10.043
   Edmonds HL, 2011, J NEUROIMAGING, V21, P177, DOI 10.1111/j.1552-6569.2010.00471.x
   Edmonds HL, 2010, J CARDIOTHOR VASC AN, V24, P541, DOI 10.1053/j.jvca.2010.04.003
   Edwards FH, 2006, ANN THORAC SURG, V81, P397, DOI 10.1016/j.athoracsur.2005.06.034
   Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C
   Eifert S, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-90
   Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179
   Eisenstein EL, 2009, J MED SYST, V33, P287, DOI 10.1007/s10916-008-9190-4
   Ekery DL, 2003, AM HEART J, V145, P896, DOI 10.1016/S0002-8703(02)00077-7
   El-Hamamsy I, 2007, J THORAC CARDIOV SUR, V133, P7, DOI 10.1016/j.jtcvs.2006.05.070
   Ellis SG, 1997, CIRCULATION, V96, P3867
   Eltzschig HK, 2008, ANN THORAC SURG, V85, P845, DOI 10.1016/j.athoracsur.2007.11.015
   Engblom E, 1997, J Cardiopulm Rehabil, V17, P29, DOI 10.1097/00008483-199701000-00004
   Englberger L, 2004, EUR J CARDIO-THORAC, V26, P96, DOI 10.1016/j.ejcts.2004.03.030
   Engoren M, 2002, CHEST, V122, P1309, DOI 10.1378/chest.122.4.1309
   Ennker Ina C, 2009, Asian Cardiovasc Thorac Ann, V17, P253, DOI 10.1177/0218492309104746
   Ennker IC, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-5
   Erickson LC, 2000, JAMA-J AM MED ASSOC, V283, P1976, DOI 10.1001/jama.283.15.1976
   Evans BA, 2001, NEUROLOGY, V57, P1328
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   Fansa I., 2003, MED SCI MONITOR, V9, pP130
   Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012
   Fattouch K, 2009, J THORAC CARDIOV SUR, V138, P278, DOI 10.1016/j.jtcvs.2008.11.010
   Fattouch K, 2010, ANN THORAC SURG, V90, P1187, DOI 10.1016/j.athoracsur.2010.03.103
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   FAXON DP, 1992, AM HEART J, V123, P854, DOI 10.1016/0002-8703(92)90687-Q
   Fearn SJ, 2001, J THORAC CARDIOV SUR, V121, P1150, DOI 10.1067/mtc.2001.114099
   Fedoruk LM, 2007, J THORAC CARDIOV SUR, V133, P456, DOI 10.1016/j.jtcvs.2006.10.011
   Feit F, 2000, CIRCULATION, V101, P2795
   FEKETY FR, 1969, J THORAC CARDIOV SUR, V57, P757
   Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221
   Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49
   Ferguson TB, 2000, ANN THORAC SURG, V69, P680, DOI 10.1016/S0003-4975(99)01538-6
   Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395
   Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099
   Ferraris VA, 2002, ANN SURG, V235, P820, DOI 10.1097/00000658-200206000-00009
   FERRARIS VA, 1988, ANN THORAC SURG, V45, P71
   Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008
   FERRARIS VA, 1989, J THORAC CARDIOV SUR, V98, P492
   FERRARIS VA, 1995, TEX HEART I J, V22, P216
   Filizcan U, 2011, ANGIOLOGY, V62, P68, DOI 10.1177/0003319710369103
   Fillinger MP, 2002, ANESTH ANALG, V95, P1483, DOI 10.1213/01.ANE.0000034720.36481.21
   Filsoufi F, 2009, J CARDIOTHOR VASC AN, V23, P488, DOI 10.1053/j.jvca.2009.02.007
   Filsoufi F, 2008, ANN THORAC SURG, V85, P862, DOI 10.1016/j.athoracsur.2007.10.060
   Filsoufi F, 2007, J CARDIOTHOR VASC AN, V21, P784, DOI 10.1053/j.jvca.2007.08.007
   Filsoufi F, 2008, J CARDIOTHOR VASC AN, V22, P60, DOI 10.1053/j.jvca.2007.10.009
   Filsoufi F, 2002, J HEART VALVE DIS, V11, pS45
   Finkelstein R, 2002, J THORAC CARDIOV SUR, V123, P326, DOI 10.1067/mtc.2002.119698
   FIORE AC, 1990, ANN THORAC SURG, V49, P202
   Firanescu CE, 2009, EUR J CARDIO-THORAC, V36, P856, DOI 10.1016/j.ejcts.2009.05.032
   Fischer UM, 2005, CURR MED RES OPIN, V21, P1161, DOI 10.1185/030079905X53289
   FitzGibbon G, 1996, CAN J CARDIOL, V12, P893
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   FITZGIBBON GM, 1987, CAN MED ASSOC J, V136, P45
   Fleck Tatjana, 2006, Interact Cardiovasc Thorac Surg, V5, P145, DOI 10.1510/icvts.2005.122804
   Fleck TM, 2002, ANN THORAC SURG, V74, P1596, DOI 10.1016/S0003-4975(02)03948-6
   Fleisher LA, 2009, J AM COLL CARDIOL, V54, pe13
   Fletcher N, 2007, J BONE JOINT SURG AM, V89A, P1605, DOI 10.2106/JBJS.F.00901
   FLOOD AB, 1984, MED CARE, V22, P98, DOI 10.1097/00005650-198402000-00002
   FONG IW, 1979, J THORAC CARDIOV SUR, V78, P908
   Fontes ML, 1999, J CARDIOTHOR VASC AN, V13, P521, DOI 10.1016/S1053-0770(99)90001-0
   Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x
   Fox Amanda A, 2004, Semin Cardiothorac Vasc Anesth, V8, P283, DOI 10.1177/108925320400800403
   Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X
   Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B
   Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007
   Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X
   Fox KM, 2007, AM HEART J, V153, P629, DOI 10.1016/j.ahj.2007.01.032
   Frassdorf J, 2009, BRIT J ANAESTH, V103, P89, DOI 10.1093/bja/aep141
   FRASURESMITH N, 1985, PSYCHOSOM MED, V47, P431
   Fraund S, 2005, ANN THORAC SURG, V79, P1225, DOI 10.1016/j.arthoracsur.2004.08.082
   Frazier OH, 1999, NEW ENGL J MED, V341, P1021, DOI 10.1056/NEJM199909303411402
   Freedland KE, 2009, ARCH GEN PSYCHIAT, V66, P387, DOI 10.1001/archgenpsychiatry.2009.7
   Friedman DB, 1997, AM J CARDIOL, V79, P281
   Friedrich JO, 2005, ANN INTERN MED, V142, P510
   Frommelt PC, 2011, J THORAC CARDIOVASC
   Frutkin AD, 2008, AM J CARDIOL, V101, P53, DOI 10.1016/j.amjcard.2007.07.047
   Frye RL, 2009, NEW ENGL J MED, V360, P2503
   FULLER JK, 1985, VASCULAR SURG, V19, P174, DOI 10.1177/153857448501900305
   Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181
   Furnary Anthony P, 2006, Semin Thorac Cardiovasc Surg, V18, P302, DOI 10.1053/j.semtcvs.2006.04.005
   Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4
   Fuster RG, 2006, EUR J CARDIO-THORAC, V29, P202, DOI 10.1016/j.ejcts.2005.11.015
   Fuster V, 1997, NEW ENGL J MED, V336, P212, DOI 10.1056/NEJM199701163360309
   FUSTER V, 1979, CIRCULATION, V60, P1508
   Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013
   GALBUT DL, 1990, ANN THORAC SURG, V49, P195
   Gallagher R, 2009, J ADV NURS, V65, P2386, DOI 10.1111/j.1365-2648.2009.05101.x
   Gandhi GY, 2005, MAYO CLIN PROC, V80, P862
   Gandhi GY, 2007, ANN INTERN MED, V146, P233
   GANI JS, 1990, AUST NZ J SURG, V60, P171
   Gansera B, 2003, THORAC CARDIOV SURG, V51, P185
   Gansera B, 2004, THORAC CARDIOV SURG, V52, P261, DOI 10.1055/s-2004-821154
   Garcia C, 2005, BRIT J ANAESTH, V94, P159, DOI 10.1093/bja/aei026
   GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450
   GAUDIANI VA, 1991, ANN THORAC SURG, V51, P823
   GEELHOED GW, 1983, SURG GYNECOL OBSTET, V157, P265
   GEHA AS, 1979, AM J SURG, V137, P456, DOI 10.1016/0002-9610(79)90114-4
   Gengo FM, 2008, J CLIN PHARMACOL, V48, P117, DOI 10.1177/0091270007310379
   Geraci JM, 2005, MED CARE, V43, P149, DOI 10.1097/00005650-200502000-00008
   Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015
   Ghali WA, 1997, JAMA-J AM MED ASSOC, V277, P379, DOI 10.1001/jama.277.5.379
   Ghanta RK, 2010, J THORAC CARDIOV SUR, V140, P103, DOI 10.1016/j.jtcvs.2009.10.001
   Ghorbel MT, 2010, PHYSIOL GENOMICS, V42, P67, DOI 10.1152/physiolgenomics.00174.2009
   Ghosh S, 2003, J THORAC CARDIOV SUR, V126, P133, DOI 10.1016/S0022-5223(02)73293-5
   Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Gillinov A Marc, 2005, Curr Cardiol Rep, V7, P101, DOI 10.1007/s11886-005-0020-8
   Gioia G, 2007, CATHETER CARDIO INTE, V70, P26, DOI 10.1002/ccd.21072
   Glas KE, 2008, ANESTH ANALG, V106, P1376, DOI 10.1213/ane.0b013e31816a6b4c
   Glineur D, 2008, J AM COLL CARDIOL, V51, P120, DOI 10.1016/j.jacc.2007.09.030
   Gold JP, 2004, ANN THORAC SURG, V78, P1579, DOI 10.1016/j.athoracsur.2004.05.051
   Goldenberg I, 2003, ARCH INTERN MED, V163, P2301, DOI 10.1001/archinte.163.19.2301
   GOLDMAN S, 1990, CIRCULATION, V82, P237
   GOLDMAN S, 1991, CIRCULATION, V84, P520
   Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325
   Gombotz H, 1996, SEMIN HEMATOL, V33, P69
   GOODMAN JS, 1968, NEW ENGL J MED, V278, P117, DOI 10.1056/NEJM196801182780301
   GORDON MA, 1991, ANESTHESIOLOGY, V74, P848, DOI 10.1097/00000542-199105000-00008
   Goto T, 2001, ANN THORAC SURG, V72, P137, DOI 10.1016/S0003-4975(01)02676-5
   Goto T, 2003, ANN THORAC SURG, V75, P1912, DOI 10.1016/S0003-4975(03)00029-8
   Gottesman RF, 2010, ANN NEUROL, V67, P338, DOI 10.1002/ana.21899
   Gottesman RF, 2006, STROKE, V37, P2306, DOI 10.1161/01.STR.0000236024.68020.3a
   Goy JJ, 2008, J AM COLL CARDIOL, V52, P815, DOI 10.1016/j.jacc.2008.05.037
   GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8
   Goy JJ, 1999, CIRCULATION, V99, P3255
   Goy JJ, 2000, MAYO CLIN PROC, V75, P1116
   Goyal A, 2007, ANN THORAC SURG, V83, P993, DOI 10.1016/j.athoracsur.2006.10.046
   Goyal TM, 2005, PSYCHOSOM MED, V67, P759, DOI 10.1097/01.psy.0000174046.40566.80
   Graves EJ, 1993, VITAL HLTH STAT, V13, P1
   GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812
   Greilich PE, 2009, ANESTH ANALG, V109, P15, DOI 10.1213/ane.0b013e3181a40b5d
   Grigg OA, 2003, STAT METHODS MED RES, V12, P147, DOI 10.1191/0962280203sm323ra
   Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jace.2007.01.003
   Groesdonk HV, 2010, J CARDIOTHOR VASC AN, V24, P785, DOI 10.1053/j.jvca.2010.03.018
   GRONDIN CM, 1984, CIRCULATION, V70, P208
   Groom Robert C, 2010, J Extra Corpor Technol, V42, P40
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Grover FL, 1996, ANN THORAC SURG, V62, pS6, DOI 10.1016/0003-4975(96)00821-1
   GROVER FL, 1993, ANN THORAC SURG, V56, P1296
   GROVER FL, 1994, ANN THORAC SURG, V58, P1845
   GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Gummert JF, 2006, ANN THORAC SURG, V81, P90, DOI 10.1016/j.athoracsur.2005.06.035
   Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550
   Gurbuz AT, 2007, ANN THORAC SURG, V83, P1035, DOI 10.1016/j.athoracsur.2006.10.019
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   GURNE O, 1994, CIRCULATION, V90, P148
   Guru V, 2005, J THORAC CARDIOV SUR, V130, P1257, DOI 10.1016/j.jtcvs.2005.07.041
   Guru V, 2006, CIRCULATION, V113, P507, DOI 10.1161/CIRCULATIONAHA.105.576652
   Guru V, 2006, AM HEART J, V152, P573, DOI 10.1016/j.ahj.2005.10.026
   Haase M, 2007, CRIT CARE MED, V35, P1324, DOI 10.1097/01.CCM.0000261887.69976.12
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Haeffener MP, 2008, AM HEART J, V156, P900
   Hake U, 1989, Eur J Cardiothorac Surg, V3, P162, DOI 10.1016/1010-7940(89)90096-1
   Halkos ME, 2008, J THORAC CARDIOV SUR, V136, P631, DOI 10.1016/j.jtcvs.2008.02.091
   Halm E, 2000, INTERPRETING VOLUME
   Halm EA, 2002, ANN INTERN MED, V137, P511
   Halonen J, 2006, CIRCULATION, V114, pI1, DOI 10.1161/CIRCULATIONAHA.105.000851
   Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F
   HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601
   Hammar N, 1997, J AM COLL CARDIOL, V29, P659
   HAMMERMEISTER KE, 1994, ANN SURG, V219, P281, DOI 10.1097/00000658-199403000-00008
   HAMMERMEISTER KE, 1994, ANN THORAC SURG, V58, P1809
   Hangler HB, 2003, J THORAC CARDIOV SUR, V126, P391, DOI 10.1016/S0022-5223(03)00395-7
   Hannan EL, 1998, STROKE, V29, P2292
   Hannan EL, 2003, MED CARE, V41, P1164, DOI 10.1097/01.MLR.0000088452.82637.40
   Hannan EL, 1999, NEW ENGL J MED, V340, P1677, DOI 10.1056/NEJM199905273402112
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 1997, HEALTH SERV RES, V31, P659
   HANNAN EL, 1994, ANN THORAC SURG, V58, P1852
   Hannan EL, 1997, AM HEART J, V134, P55, DOI 10.1016/S0002-8703(97)70106-6
   Hannan EL, 2002, SURGERY, V131, P6, DOI 10.1067/msy.2002.120238
   Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATONAHA.104.528455
   HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768
   Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595
   HANNAN EL, 1992, HEALTH SERV RES, V27, P517
   HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761
   Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892
   Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B
   HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209
   HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003
   HANNAN EL, 1992, MED CARE, V30, P892, DOI 10.1097/00005650-199210000-00002
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hansen D, 2009, ACTA CARDIOL, V64, P639, DOI 10.2143/AC.64.5.2042694
   Harker LA, 1999, DRUG SAFETY, V21, P325, DOI 10.2165/00002018-199921040-00007
   Harrington Kathleen F, 2009, Expert Rev Respir Med, V3, P475, DOI 10.1586/ers.09.42
   Harrington OB, 1998, ANN THORAC SURG, V65, P1599, DOI 10.1016/S0003-4975(98)00239-2
   HARTZ AJ, 1994, AM J PUBLIC HEALTH, V84, P1609, DOI 10.2105/AJPH.84.10.1609
   Hashimoto H, 1996, J THORAC CARDIOV SUR, V111, P399, DOI 10.1016/S0022-5223(96)70449-X
   Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3
   Hawkes CA, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003587
   HAYASHI J, 1994, TRANSFUSION, V34, P142, DOI 10.1046/j.1537-2995.1994.34294143943.x
   Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119
   HE GW, 1995, J THORAC CARDIOV SUR, V110, P971, DOI 10.1016/S0022-5223(05)80164-3
   Hedges C, 2008, AM J CRIT CARE, V17, P133
   Held C, 2010, J AM COLL CARDIOL, V57, P672
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Hemmerling TM, 2005, ANESTH ANALG, V100, P354, DOI 10.1213/01.ANE.0000140245.44494.12
   Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3
   Henry D, 2009, CAN MED ASSOC J, V180, P183, DOI 10.1503/cmaj.081109
   Heringlake M, 2010, ANESTHESIOLOGY, V114, P12
   Herman CR, 2010, ANN THORAC SURG, V89, P397, DOI 10.1016/j.athoracsur.2009.10.051
   Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB
   Heusch G, 2008, BRIT J PHARMACOL, V153, P1589, DOI 10.1038/sj.bjp.0707673
   Hewitt M, 2000, INTERPRETING VOLUME
   Hibbard JH, 1996, HEALTH CARE FINANC R, V18, P95
   Hibbard J H, 2001, Jt Comm J Qual Improv, V27, P591
   Hibbard JH, 1997, MILBANK Q, V75, P395, DOI 10.1111/1468-0009.00061
   Hibbard JH, 1997, HEALTH AFFAIR, V16, P218, DOI 10.1377/hlthaff.16.3.218
   Hibbard JH, 2003, ANNU REV PUBL HEALTH, V24, P413, DOI 10.1146/annurev.publhealth.24.100901.141005
   Hilleman DE, 2004, CHEST, V125, P435, DOI 10.1378/chest.125.2.435
   Hirai Shinji, 2003, Ann Thorac Cardiovasc Surg, V9, P365
   Hix JK, 2006, CRIT CARE MED, V34, P2979, DOI 10.1097/01.CCM.0000248905.67352.BA
   Hlatky MA, 2004, CIRCULATION, V110, P1960, DOI 10.1161/01.CIR.0000143379.26342.5C
   Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203
   Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
   Ho PM, 2004, ANN THORAC SURG, V77, P597, DOI 10.1016/S0003-4975(03)01358-4
   Hochman JS, 1997, J AM COLL CARDIOL, V30, P141
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2
   HOCKINGS BEF, 1993, MED J AUSTRALIA, V159, P376
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   HOGUE CW, 1995, J THORAC CARDIOV SUR, V110, P517, DOI 10.1016/S0022-5223(95)70249-0
   Hollenbeck BK, 2007, UROLOGY, V69, P871, DOI 10.1016/j.urology.2007.01.040
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   Hong SJ, 2005, CATHETER CARDIO INTE, V64, P75, DOI 10.1002/ccd.20238
   Hongo RH, 2002, J AM COLL CARDIOL, V40, P231, DOI 10.1016/S0735-1097(02)01954-X
   Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70
   Horswell JL, 2005, J CARDIOTHOR VASC AN, V19, P282, DOI 10.1053/j.jvca.2005.03.002
   Hruska LA, 2005, J CARDIAC SURG, V20, P403, DOI 10.1111/j.1540-8191.2005.200472.x
   Hu SS, 2010, CIRCULATION, V121, P1800, DOI 10.1161/CIRCULATIONAHA.109.894543
   Hubbard R, 2005, TOB CONTROL, V14, P416, DOI 10.1136/tc.2005.011387
   Huber CH, 2007, EUR J CARDIO-THORAC, V31, P1099, DOI 10.1016/j.ejcts.2007.01.055
   Hudetz JA, 2011, J CARDIOTHOR VASC AN, V25, P811, DOI 10.1053/j.jvca.2010.05.003
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065
   Hueb WA, 1999, CIRCULATION, V100, P107
   Hughes CM, 1999, JAMA-J AM MED ASSOC, V281, P1375
   HUGHES RG, 1987, MED CARE, V25, P489, DOI 10.1097/00005650-198706000-00004
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851
   Humphries KH, 2007, J AM COLL CARDIOL, V49, P1552, DOI 10.1016/j.jacc.2006.08.068
   Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703
   Iezzoni LI, 2003, RISK ADJUSTMENT MEAS
   Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855
   Institute of Medicine, 2011, FIND WHAR WORKS HLTH
   Institute of Medicine, 2011, CLIN PRACT GUID WE C
   Institute of Medicine, 2006, PERF MEAS ACC IMP WA
   IPYAM PC, 1994, ANESTH ANALG, V78, P842
   Isley MR, 2009, J CLIN MONIT COMPUT, V23, P369, DOI 10.1007/s10877-009-9191-y
   IVERT T, 1988, J THORAC CARDIOV SUR, V96, P1
   Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010
   Jacka MF, 2002, ANESTH ANALG, V94, P1065, DOI 10.1097/00000539-200205000-00003
   Jacobs AK, 1998, CIRCULATION, V98, P1279
   Jaffery Z, 2007, EUR J CARDIO-THORAC, V31, P691, DOI 10.1016/j.ejcts.2007.01.018
   Jain U, 1997, ANESTHESIOLOGY, V86, P576, DOI 10.1097/00000542-199703000-00009
   Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148
   Jenkins C, 2009, EUR HEART J, V30, P98, DOI 10.1093/eurheartj/ehn484
   Jenkins DP, 1997, HEART, V77, P314
   Jensen BO, 2008, EUR J CARDIO-THORAC, V34, P1016, DOI 10.1016/j.ejcts.2008.07.053
   Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931
   Jha AK, 2006, HEALTH AFFAIR, V25, P844, DOI 10.1377/hlthaff.25.3.844
   JOHNSON LW, 1976, CIRCULATION, V53, P819
   Johnson T, 2002, ANESTHESIOLOGY, V96, P1351, DOI 10.1097/00000542-200206000-00014
   Johnson WC, 2002, J VASC SURG, V35, P413, DOI 10.1067/mva.2002.121847
   JONES EL, 1983, AM J CARDIOL, V51, P7, DOI 10.1016/S0002-9149(83)80003-4
   Jones G, 1997, ANN SURG, V225, P766, DOI 10.1097/00000658-199706000-00014
   Jones HU, 2002, CIRCULATION, V106, pI19, DOI 10.1161/01.cir.0000032917.33237.e0
   Jones KW, 2008, J DIABETES COMPLICAT, V22, P365, DOI 10.1016/j.jdiacomp.2007.05.006
   JONES RH, 1989, CIRCULATION, V79, P132
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   Jones RH, 1996, J AM COLL CARDIOL, V28, P1478, DOI 10.1016/S0735-1097(96)00359-2
   Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56
   Julier K, 2003, ANESTHESIOLOGY, V98, P1315, DOI 10.1097/00000542-200306000-00004
   JURKIEWICZ MJ, 1980, ANN SURG, V191, P738, DOI 10.1097/00000658-198006000-00012
   Kachroo S, 2006, ANN PHARMACOTHER, V40, P381, DOI 10.1345/aph.1G565
   KAISER AB, 1988, ANN THORAC SURG, V45, P35
   KAISER AB, 1987, ANN SURG, V206, P791, DOI 10.1097/00000658-198712000-00018
   KAISER GA, 1975, SURGERY, V78, P749
   Kalant N, 2004, CAN J CARDIOL, V20, P81
   KALLIS P, 1994, EUR J CARDIO-THORAC, V8, P404, DOI 10.1016/1010-7940(94)90081-7
   Kallmeyer IJ, 2001, ANESTH ANALG, V92, P1126
   Kamohara Keiji, 2006, Jpn J Thorac Cardiovasc Surg, V54, P95, DOI 10.1007/BF02744870
   Kapetanakis EI, 2006, CIRCULATION, V113, P1667, DOI 10.1161/CIRCULATIONAHA.105.571828
   Kapoor JR, 2008, JACC-CARDIOVASC INTE, V1, P483, DOI 10.1016/j.jcin.2008.07.001
   Kappetein AP, 2011, EUR HEART J, V17, P2125
   Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
   Karkouti K, 2001, TRANSFUSION, V41, P1193, DOI 10.1046/j.1537-2995.2001.41101193.x
   Karthik S, 2003, EUR J CARDIO-THORAC, V24, P66, DOI 10.1016/S1010-7940(03)00255-0
   KARWANDE SV, 1987, ANN THORAC SURG, V43, P318
   KASSIRER JP, 1994, NEW ENGL J MED, V330, P634, DOI 10.1056/NEJM199403033300910
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Kato M, 1993, J Cardiothorac Vasc Anesth, V7, P285, DOI 10.1016/1053-0770(93)90006-7
   Katritsis DG, 2007, NEW ENGL J MED, V357, P414
   Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864
   Katznelson R, 2009, ANESTHESIOLOGY, V110, P67, DOI 10.1097/ALN.0b013e318190b4d9
   KELLY P, 1990, J AM COLL CARDIOL, V15, P267
   Kempfert J, 2008, ANN THORAC SURG, V85, P1579, DOI 10.1016/j.athoracsur.2008.01.074
   Kertai MD, 2010, ANESTHESIOLOGY, V112, P1116, DOI 10.1097/ALN.0b013e3181d5e0a3
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Khanna MP, 2003, TRANSFUS MED REV, V17, P110, DOI 10.1053/tmrv.2003.50008
   Kihara C, 2009, J CARDIOL, V54, P282, DOI 10.1016/j.jjcc.2009.06.001
   Kikura M, 2006, J AM COLL SURGEONS, V202, P216, DOI 10.1016/j.jamcollsurg.2005.10.001
   Kim C, 2007, CLIN CARDIOL, V30, P491, DOI 10.1002/clc.20000
   Kim JHJ, 2008, AM HEART J, V156, P886, DOI 10.1016/j.ahj.2008.06.034
   Kim JW, 2005, INT J CARDIOL, V99, P437, DOI 10.1016/j.ijcard.2004.08.045
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   Kincaid EH, 2003, ANN THORAC SURG, V76, P124, DOI 10.1016/S0003-4975(03)00190-5
   King K B, 1992, Am J Crit Care, V1, P28
   KING KB, 1992, AM J CARDIOL, V69, P179, DOI 10.1016/0002-9149(92)91301-J
   King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602
   Kirdemir P, 2008, J CARDIOTHOR VASC AN, V22, P383, DOI 10.1053/j.jvca.2007.09.015
   Kiyama H, 1999, ANN THORAC SURG, V68, P1652, DOI 10.1016/S0003-4975(99)00755-9
   Kjaergard HK, 2004, SCAND CARDIOVASC J, V38, P143, DOI 10.1080/14017430410031119
   Kjaergard HK, 2006, SCAND CARDIOVASC J, V40, P25, DOI 10.1080/14017430500243614
   Kjoller-Hansen L, 2000, J AM COLL CARDIOL, V35, P881, DOI 10.1016/S0735-1097(99)00634-8
   Klemperer JD, 1996, ANN THORAC SURG, V61, P1323, DOI 10.1016/0003-4975(96)00102-6
   KLEMPERER JD, 1995, NEW ENGL J MED, V333, P1522, DOI 10.1056/NEJM199512073332302
   KLEPZIG H, 1991, EUR HEART J, V12, P946
   Knatterud GL, 2000, CIRCULATION, V102, P157
   KNIGHT AA, 1988, ANESTHESIOLOGY, V68, P681, DOI 10.1097/00000542-198805000-00005
   KO W, 1992, ANN THORAC SURG, V53, P301
   Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037
   Koch CG, 2003, J CARDIOTHOR VASC AN, V17, P585, DOI 10.1053/S1053-0770(03)00201-5
   Koch CG, 2006, ANN THORAC SURG, V82, P13, DOI 10.1016/j.athoracsur.2005.07.075
   Koch CG, 1996, J CARDIOTHOR VASC AN, V10, P839, DOI 10.1016/S1053-0770(96)80042-5
   Kofidis T, 2008, PERFUSION-UK, V23, P147, DOI 10.1177/0267659108097880
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Konvalinka A, 2006, J HOSP INFECT, V64, P162, DOI 10.1016/j.jhin.2006.06.010
   KOUCHOUKOS NT, 1988, ANN THORAC SURG, V45, P348
   Kourliouros A, 2010, EUR J CARDIO-THORAC, V37, P704, DOI 10.1016/j.ejcts.2009.08.020
   Koyanagi T, 1996, ANN THORAC SURG, V61, P1793, DOI 10.1016/0003-4975(96)00170-1
   Krasuski RA, 2009, JAMA-J AM MED ASSOC, V302, P290, DOI 10.1001/jama.2009.1012
   Krasuski RA, 2011, CIRCULATION, V123, P154, DOI 10.1161/CIRCULATIONAHA.109.921106
   KRETER B, 1992, J THORAC CARDIOV SUR, V104, P590
   Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769
   Kubal C, 2005, ANN THORAC SURG, V79, P1570, DOI 10.1016/j.athorascur.2004.10.035
   KULIER AH, 1993, ANESTH ANALG, V76, P102
   Kulik A, 2009, EXPERT OPIN DRUG SAF, V8, P559, DOI 10.1517/14740330903188413
   Kulik A, 2008, CIRCULATION, V118, P1785, DOI 10.1161/CIRCULATIONAHA.108.799445
   Kurlansky PA, 1996, ANN THORAC SURG, V62, P63, DOI 10.1016/0003-4975(96)00275-5
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Kuss O, 2010, J THORAC CARDIOVASC, V140, p[829, e1]
   LADENSON PW, 1984, AM J MED, V77, P261, DOI 10.1016/0002-9343(84)90701-0
   Ladowski J S, 1996, Cardiovasc Surg, V4, P23, DOI 10.1016/0967-2109(96)83779-3
   Laham RJ, 1999, CIRCULATION, V100, P1865
   Lahtinen P, 2006, ANESTHESIOLOGY, V105, P794, DOI 10.1097/00000542-200610000-00026
   Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013
   Landoni G, 2008, J CARDIOTHOR VASC AN, V22, P27, DOI 10.1053/j.jvca.2007.07.015
   Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.200610.013
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Laurikka J, 2002, CHEST, V121, P1183, DOI 10.1378/chest.121.4.1183
   Lavana JD, 2010, J THORAC CARDIOV SUR, V140, P80, DOI 10.1016/j.jtcvs.2009.09.033
   Lazar HL, 2009, ANN THORAC SURG, V87, P663, DOI 10.1016/j.athoracsur.2008.11.011
   Leacche Marzia, 2009, Semin Thorac Cardiovasc Surg, V21, P207, DOI 10.1053/j.semtcvs.2009.08.007
   Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461
   Leavitt BJ, 2004, CIRCULATION S1, V110, pII41, DOI 10.1161/01.CIR.0000138197.07051.e7
   Lee AH, 2007, CRIT CARE MED, V35, P1517, DOI 10.1097/CCM.0000266537.86437.38
   Lee D C, 2001, Ann Thorac Surg, V71, P1197
   Lee JH, 1997, SURGERY, V122, P675, DOI 10.1016/S0039-6060(97)90073-8
   Lee LY, 2002, PERFUSION-UK, V17, P33, DOI 10.1191/0267659102pf532oa
   Lee MS, 2007, INT J CARDIOL, V123, P34, DOI 10.1016/j.ijcard.2006.11.103
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   LEMERY R, 1992, AM J CARDIOL, V70, P147, DOI 10.1016/0002-9149(92)91266-7
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Levin MA, 2009, CIRCULATION, V120, P1664, DOI 10.1161/CIRCULATIONAHA.108.814533
   Levin R, 2010, J CARDIOTHOR VASC AN, V24, P568, DOI 10.1053/j.jvca.2010.01.002
   Lev-Ran O, 2004, ANN THORAC SURG, V77, P102, DOI 10.1016/S0003-4975(03)01334-1
   Li Y, 2008, J THORAC CARDIOV SUR, V136, P657, DOI 10.1016/j.jtcvs.2007.12.069
   Liakopoulos OJ, 2008, EUR HEART J, V29, P1548, DOI 10.1093/eurheartj/ehn198
   Lim E, 2003, BRIT MED J, V327, P1309, DOI 10.1136/bmj.327.7427.1309
   Lim HS, 2009, JACC-CARDIOVASC INTE, V2, P146, DOI 10.1016/j.jcin.2008.11.006
   LIMET R, 1987, J THORAC CARDIOV SUR, V94, P773
   Lin Terence, 2010, Congest Heart Fail, V16, P170, DOI 10.1111/j.1751-7133.2010.00146.x
   Lincoff AM, 2000, ANN THORAC SURG, V70, P516, DOI 10.1016/S0003-4975(00)01343-6
   Liu JY, 2000, CIRCULATION, V102, P2973
   Liu SS, 2004, ANESTHESIOLOGY, V101, P153, DOI 10.1097/00000542-200407000-00024
   Liu YH, 2009, ANESTH ANALG, V109, P1013, DOI 10.1213/ane.0b013e3181aed2bb
   Lloyd-Jones D, 2010, CIRCULATION, P121
   Localio AR, 1997, MED CARE, V35, P272, DOI 10.1097/00005650-199703000-00007
   London MJ, 2002, ANESTHESIOLOGY, V96, P860, DOI 10.1097/00000542-200204000-00013
   London MJ, 1999, ANESTHESIOLOGY, V91, P911, DOI 10.1097/00000542-199910000-00007
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   LOOP FD, 1990, ANN THORAC SURG, V49, P179
   LORENZ RL, 1984, LANCET, V1, P1261
   Losanoff JE, 2002, EUR J CARDIO-THORAC, V21, P831, DOI 10.1016/S1010-7940(02)00124-0
   Loubani M, 2003, J THORAC CARDIOV SUR, V126, P143, DOI 10.1016/S0022-5223(02)73601-5
   LOWENSTE.E, 1969, NEW ENGL J MED, V281, P1389, DOI 10.1056/NEJM196912182812503
   Lucchinetti E, 2007, ANESTHESIOLOGY, V106, P444, DOI 10.1097/00000542-200703000-00008
   Luckraz H, 2003, J THORAC CARDIOV SUR, V125, P301, DOI 10.1067/mtc.2003.74
   Luft H, 1990, ANN HARBOR
   Luft HS, 2001, J AM COLL CARDIOL, V38, P1931, DOI 10.1016/S0735-1097(01)01636-9
   LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503
   Luo WJ, 2008, EUR J CARDIO-THORAC, V33, P203, DOI 10.1016/j.ejcts.2007.11.010
   LUSCHER TF, 1988, NEW ENGL J MED, V319, P462, DOI 10.1056/NEJM198808253190802
   LYTLE BW, 1992, J THORAC CARDIOV SUR, V103, P831
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X
   LYTLE BW, 1980, CIRCULATION, V61, P869
   Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070
   Mack MJ, 2005, J THORAC CARDIOV SUR, V129, P1309, DOI 10.1016/j.jtcvs.2004.10.036
   Mack MJ, 2004, CIRCULATION, V110, pII1, DOI 10.1161/01.CIR.0000138198.62961.41
   Magovern JA, 1996, ANN THORAC SURG, V61, P27, DOI 10.1016/0003-4975(95)00808-X
   Mainwaring RD, 2011, ANN THORAC SURG, V92, P691, DOI 10.1016/j.athoracsur.2011.03.127
   MAKI DG, 1992, J THORAC CARDIOV SUR, V104, P1423
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Maltais S, 2008, EUR J CARDIO-THORAC, V34, P127, DOI 10.1016/j.ejcts.2008.03.052
   Mangano CM, 1998, ANN INTERN MED, V128, P194
   Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798
   Mangano DT, 1997, JAMA-J AM MED ASSOC, V277, P325, DOI 10.1001/jama.277.4.325
   Mangano DT, 2006, J AM COLL CARDIOL, V48, P206, DOI 10.1016/j.jacc.2006.04.044
   MANGANO DT, 1992, ANESTHESIOLOGY, V76, P342, DOI 10.1097/00000542-199203000-00004
   Maniar HS, 2002, J THORAC CARDIOV SUR, V123, P45, DOI 10.1067/mtc.2002.118686
   Mannacio VA, 2008, J THORAC CARDIOV SUR, V136, P1541, DOI 10.1016/j.jtcvs.2008.06.038
   Marasco SF, 2008, EUR J CARDIO-THORAC, V33, P961, DOI 10.1016/j.ejcts.2008.03.022
   Maree AO, 2005, J AM COLL CARDIOL, V46, P1258, DOI 10.1016/j.jacc.2005.06.058
   Marin F, 2006, AM J CARDIOL, V97, P55, DOI 10.1016/j.amjcard.2005.07.124
   Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789
   MARON BJ, 1986, J AM COLL CARDIOL, V7, P204
   Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199
   Martin Fiona, 2006, Br J Nurs, V15, P703
   Martinez EA, 2010, ANESTH ANALG, V110, P307, DOI 10.1213/ANE.0b013e3181c92b9c
   Martorell C, 2004, AM J INFECT CONTROL, V32, P63, DOI 10.1016/j.ajic.2003.09.005
   Mathew JP, 2006, J AM SOC ECHOCARDIOG, V19, P1303, DOI 10.1016/j.echo.2006.08.039
   Matros E, 2010, J THORAC CARDIOV SUR, V139, P680, DOI 10.1016/j.jtcvs.2009.10.006
   Matschke KE, 2005, J THORAC CARDIOV SUR, V130, P1645, DOI 10.1016/j.jtcvs.2005.08.033
   Matsuzaki K, 1997, Nihon Kyobu Geka Gakkai Zasshi, V45, P1710
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   McDonald SB, 2005, ANESTH ANALG, V100, P25, DOI 10.1213/01.ANE.0000139652.84897.BD
   McDonald SB, 2005, J CARDIOTHOR VASC AN, V19, P4, DOI 10.1053/j.jvca.2004.11.002
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McKhann GM, 1997, ANN THORAC SURG, V63, P516
   Medalion B, 2010, J THORAC CARDIOV SUR, V139, P1539, DOI 10.1016/j.jtcvs.2009.08.042
   Medalion B, 2003, J THORAC CARDIOV SUR, V126, P1875, DOI 10.1016/S0022-5223(03)01324-2
   Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P285
   Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P49
   Mehta RH, 2009, CIRC-CARDIOVASC QUAL, V2, P583, DOI 10.1161/CIRCOUTCOMES.109.858811
   Mehta RH, 2010, AM HEART J, V159, P141, DOI 10.1016/j.ahj.2009.10.035
   Mehta RH, 2006, J AM COLL CARDIOL, V48, P281, DOI 10.1016/j.jacc.2006.04.029
   Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573
   Alexander JH, 2008, JAMA-J AM MED ASSOC, V299, P1777
   Mentzer RM, 2008, ANN THORAC SURG, V85, P1261, DOI 10.1016/j.athoracsur.2007.10.054
   MERRY AF, 1992, BRIT J ANAESTH, V68, P6, DOI 10.1093/bja/68.1.6
   METKE MP, 1979, AM J CARDIOL, V43, P1144, DOI 10.1016/0002-9149(79)90145-0
   Miceli A, 2009, J AM COLL CARDIOL, V54, P1778, DOI 10.1016/j.jacc.2009.07.008
   Mierdl S, 2002, ANESTH ANALG, V94, P774, DOI 10.1097/00000539-200204000-00002
   Migliorini A, 2006, AM HEART J, V152, P903, DOI 10.1016/j.ahj.2005.12.030
   Milani RV, 1998, CHEST, V113, P599, DOI 10.1378/chest.113.3.599
   MILANO CA, 1995, CIRCULATION, V92, P2245
   Min JK, 2005, J AM SOC ECHOCARDIOG, V18, P925, DOI 10.1016/j.echo.2005.01.034
   Misfeld M, 2010, THORAC CARDIOV SURG, V58, P408, DOI 10.1055/s-0030-1249831
   Mohammed AA, 2009, CIRCULATION, V120, P843, DOI 10.1161/CIRCULATIONAHA.108.837278
   Moholdt TT, 2009, AM HEART J, V158, P1031, DOI 10.1016/j.ahj.2009.10.003
   Moises VA, 1998, J AM SOC ECHOCARDIOG, V11, P1139, DOI 10.1016/S0894-7317(98)80009-6
   Moller CH, 2010, CIRCULATION, V121, P498, DOI 10.1161/CIRCULATIONAHA.109.880443
   Monk TG, 2005, ANESTH ANALG, V100, P4, DOI 10.1213/01.ANE.0000147519.82841.5E
   Monk TG, 2008, ANESTHESIOLOGY, V108, P18
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Moran SV, 2001, ANN THORAC SURG, V72, P1552, DOI 10.1016/S0003-4975(01)03090-9
   Morawski W, 2005, J THORAC CARDIOV SUR, V130, P791, DOI 10.1016/j.jtcvs.2005.02.041
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Mortaz H, 2009, COCHRANE DB SYST REV
   Motallebzadeh R, 2007, ANN THORAC SURG, V83, P475, DOI 10.1016/j.athoracsur.2006.09.024
   Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002
   Mukamel D B, 2001, Jt Comm J Qual Improv, V27, P20
   Mukamel DB, 2007, MED CARE, V45, P1227
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Murkin J, 2009, BRIT J ANAESTH, V103, pi3
   Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4
   Murphy GJ, 2006, J THORAC CARDIOVASC, V132, pe1
   Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977
   Murphy GJ, 2006, J THORAC CARDIOV SUR, V132, P475, DOI 10.1016/j.jctvs.2006.01.064
   Murphy GS, 2006, J CARDIOTHOR VASC AN, V20, P493, DOI 10.1053/j.jvca.2005.07.036
   Murphy GS, 2009, ANESTH ANALG, V109, P311, DOI 10.1213/ane.0b013e3181a90adc
   Murphy GS, 2003, ANESTH ANALG, V96, P1301, DOI 10.1213/01.ANE.0000057602.27031.C8
   Murphy MB, 2001, NEW ENGL J MED, V345, P1548
   MUSTAFA I, 1981, J THORAC CARDIOV SUR, V82, P297
   Myers WO, 1999, J AM COLL CARDIOL, V33, P488, DOI 10.1016/S0735-1097(98)00563-4
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Myles PS, 2003, ANESTHESIOLOGY, V99, P982
   Myles PS, 2004, LANCET, V363, P1757, DOI 10.1016/S0140-6736(04)16300-9
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Nakamura M, 2008, ANN THORAC SURG, V85, P513, DOI 10.1016/j.athoracsur.2007.08.056
   Nallamothu BK, 2001, J AM COLL CARDIOL, V38, P1923, DOI 10.1016/S0735-1097(01)01647-3
   NASU M, 1995, ANN THORAC SURG, V59, P154, DOI 10.1016/0003-4975(94)00795-9
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Naylor AR, 2002, EUR J VASC ENDOVASC, V23, P283, DOI 10.1053/ejvs.2002.1609
   Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506
   NELSON DR, 1990, J THORAC CARDIOV SUR, V99, P977
   Nesher N, 2006, J CARDIAC SURG, V21, P395, DOI 10.1111/j.1540-8191.2006.00272.x
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Ngaage DL, 2008, ANN THORAC SURG, V85, P1278, DOI 10.1016/j.athoracsur.2007.12.035
   Nguyen JT, 2008, AM HEART J, V155, P862, DOI 10.1016/j.ahj.2007.11.036
   Nigwekar SU, 2009, J CARDIOTHOR VASC AN, V23, P151, DOI 10.1053/j.jvca.2008.11.007
   Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267
   Nikolov NM, 2010, ANESTH ANALG, V110, P335, DOI 10.1213/ANE.0b013e3181c76f87
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   NISHIDA H, 1991, J THORAC CARDIOV SUR, V101, P488
   Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545
   Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096
   Noyez L, 2004, EUR J CARDIO-THORAC, V25, P59, DOI 10.1016/S1010-7940(03)00656-0
   Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330
   Nuttall GA, 2001, ANESTHESIOLOGY, V94, P773, DOI 10.1097/00000542-200105000-00014
   Nygard E, 2005, CIRCULATION, V111, P2165, DOI 10.1161/01.CIR.0000163551.33812.1A
   OCONNOR GT, 1991, JAMA-J AM MED ASSOC, V266, P803, DOI 10.1001/jama.266.6.803
   O'Brien SM, 2007, ANN THORAC SURG, V83, pS13, DOI 10.1016/j.athoracsur.2007.01.055
   OCKENE JK, 1990, AM J PUBLIC HEALTH, V80, P954, DOI 10.2105/AJPH.80.8.954
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   OCONNOR GT, 1989, CIRCULATION, V80, P234
   OCONNOR GT, 1992, CIRCULATION, V85, P2110
   OCONNOR GT, 1993, CIRCULATION, V88, P2104
   OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841
   OGLIETTI J, 1976, J THORAC CARDIOV SUR, V71, P736
   OKEEFE JH, 1993, AM J CARDIOL, V71, P897, DOI 10.1016/0002-9149(93)90903-P
   OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945
   OLIVA PB, 1993, J AM COLL CARDIOL, V22, P720
   Olsen MA, 2002, J THORAC CARDIOV SUR, V124, P136, DOI 10.1067/mtc.2002.122306
   Olsson C, 2006, INFECT CONT HOSP EP, V27, P83, DOI 10.1086/500283
   Omoigui NA, 1996, CIRCULATION, V93, P27
   Oosterga M, 2001, AM J CARDIOL, V87, P542, DOI 10.1016/S0002-9149(00)01428-4
   Ostermann ME, 2000, INTENS CARE MED, V26, P565, DOI 10.1007/s001340051205
   Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(3)00125-9
   Ouattara A, 2005, ANESTHESIOLOGY, V103, P687, DOI 10.1097/00000542-200510000-00006
   Ouyang P, 2006, ATHEROSCLEROSIS, V189, P375, DOI 10.1016/j.atherosclerosis.2005.12.015
   Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129
   OXMAN TE, 1995, PSYCHOSOM MED, V57, P5
   Paciullo CA, 2009, ANN PHARMACOTHER, V43, P1197, DOI 10.1345/aph.1L423
   Pagni S, 1997, EUR J CARDIO-THORAC, V11, P1086, DOI 10.1016/S1010-7940(97)01214-1
   Pagni S, 1997, J SURG RES, V71, P172, DOI 10.1006/jsre.1997.5150
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Pan W, 2004, CIRCULATION, V110, P1145
   Panesar SS, 2006, HEART, V92, P1808, DOI 10.1136/hrt.2006.088450
   PAONE G, 1994, SURGERY, V116, P672
   Parikh SV, 2010, JACC-CARDIOVASC INTE, V3, P419, DOI 10.1016/j.jcin.2010.01.012
   Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2011, NEW ENGL J MED, V364, P1727
   Park YJ, 2009, ANN THORAC SURG, V87, P1846, DOI 10.1016/j.athoracsur.2009.03.032
   Parolari A, 2007, ANN THORAC SURG, V84, P823, DOI 10.1016/j.athoracsur.2007.04.048
   Parr KG, 2003, J CARDIOTHOR VASC AN, V17, P176, DOI 10.1053/jcan.2003.44
   Partik BL, 2003, AM J ROENTGENOL, V180, P987
   Pascual DA, 2006, ANN THORAC SURG, V81, P78, DOI 10.1016/j.athoracsur.2005.07.038
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603
   Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2
   Patel S, 2006, AM SURGEON, V72, P310
   Patti G, 2006, CIRCULATION, V114, P1455, DOI 10.1161/CIRCULATIONAHA.106.621763
   Paulitsch FS, 2009, CORONARY ARTERY DIS, V20, P100, DOI 10.1097/MCA.0b013e3283219e8b
   PEARSON KS, 1989, ANESTH ANALG, V69, P336
   PEARSON PJ, 1992, ANN THORAC SURG, V54, P1078
   Peart JN, 2006, AM J PHYSIOL-HEART C, V291, pH1746, DOI 10.1152/ajpheart.00233.2006
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Penttila HJ, 2003, ANN THORAC SURG, V75, P1246, DOI 10.1016/S0003-4975(02)04659-3
   Pereira JJ, 2005, AM J MED, V118, P735, DOI 10.1016/j.amjmed.2005.01.072
   Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195
   Peterson ED, 2003, J AM COLL CARDIOL, V42, P1611, DOI 10.1016/S0735-1097(03)01121-5
   Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   Pick AW, 1997, ANN THORAC SURG, V64, P599, DOI 10.1016/S0003-4975(97)00620-6
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Piper SN, 2003, CAN J ANAESTH, V50, P285
   Pires LA, 2002, J CARDIOVASC ELECTR, V13, P757, DOI 10.1046/j.1540-8167.2002.00757.x
   Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   PODESSER BK, 1995, J THORAC CARDIOV SUR, V110, P1461, DOI 10.1016/S0022-5223(95)70069-2
   Podestà A, 2000, Minerva Cardioangiol, V48, P341
   Podgoreanu MV, 2005, J AM COLL CARDIOL, V46, P1965, DOI 10.1016/j.jacc.2005.08.040
   Pohl T, 2004, CATHETER CARDIO INTE, V62, P323, DOI 10.1002/ccd.20060
   Possati G, 1998, J THORAC CARDIOV SUR, V116, P1015, DOI 10.1016/S0022-5223(98)70054-6
   Purcaro A, 1997, AM J CARDIOL, V80, P397
   Puskas JD, 2007, CIRCULATION, V116, pI192, DOI 10.1161/CIRCULATIONAHA.106.678979
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2007, ANN THORAC SURG, V84, P1447, DOI 10.1016/j.athoracsur.2007.06.104
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Puskas JD, 2009, ANN THORAC SURG, V88, P1142, DOI 10.1016/j.athoracsur.2009.04.135
   Qaddoura FE, 2004, ANN THORAC SURG, V78, P1586, DOI 10.1016/j.athoracsur.2004.05.001
   Quist-Paulsen P, 2005, EUR J CARDIOV PREV R, V12, P472, DOI 10.1097/01.hjr.0000183914.90236.01
   Rabi Doreen, 2010, Can J Cardiol, V26, P178
   Rader F, 2010, AM HEART J, V160, P329, DOI 10.1016/j.ahj.2010.05.033
   Ragosta M, 2006, CATHETER CARDIO INTE, V68, P357, DOI 10.1002/ccd.20709
   Rahimi K, 2009, HEART, V95, P1937, DOI 10.1136/hrt.2009.173302
   Rahimi K, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1250
   Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667
   Raja SG, 2006, J CARDIAC SURG, V21, P35, DOI 10.1111/j.1540-8191.2006.00164.x
   Raja Shahzad G, 2008, Interact Cardiovasc Thorac Surg, V7, P470, DOI 10.1510/icvts.2007.174698
   Ramadan ASE, 2007, ANN THORAC SURG, V84, P1034, DOI 10.1016/j.athoracsur.2007.04.047
   Ramphal PS, 2005, EUR J CARDIO-THORAC, V27, P910, DOI 10.1016/j.ejcts.2004.12.049
   Ramsay J, 2005, J THORAC CARDIOV SUR, V129, P300, DOI 10.1016/j.jtcvs.2004.06.005
   RAMSTROM J, 1993, EUR HEART J, V14, P634
   Rand RP, 1998, ANN THORAC SURG, V65, P1046, DOI 10.1016/S0003-4975(98)00087-3
   Ranucci M, 2010, MINERVA ANESTESIOL, V76, P249
   Ranucci Marco, 2008, Am J Cardiol, V101, P1112, DOI 10.1016/j.amjcard.2007.12.011
   Ranucci M, 2004, ANN THORAC SURG, V78, P1332, DOI 10.1016/j.athorcsur.2004.02.065
   Ranucci M, 2008, ANN THORAC SURG, V85, P481, DOI 10.1016/j.athoracsur.2007.10.014
   Rasmussen L S, 2000, Anesthesiol Clin North America, V18, P59, DOI 10.1016/S0889-8537(05)70149-8
   Rathore SS, 2004, ANN SURG, V239, P110, DOI 10.1097/01.sla.0000103066.22732.b8
   Ray JG, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-3
   Raymond PD, 2006, EUR J CARDIO-THORAC, V29, P82, DOI 10.1016/j.ejcts.2005.10.016
   Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5
   Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1
   Reeves ST, 2007, J AM SOC ECHOCARDIOG, V20, P427, DOI 10.1016/j.echo.2007.01.011
   REGRAGUI IA, 1995, ANN THORAC SURG, V60, P160
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Reinecke H, 2001, Z KARDIOL, V90, P729, DOI 10.1007/s003920170092
   REIZ S, 1983, ANESTHESIOLOGY, V59, P91, DOI 10.1097/00000542-198308000-00004
   Renda G, 2007, HAEMATOL-HEMATOL J, V92, P366, DOI 10.3324/haematol.10913
   Resano FG, 2006, J CARDIOTHOR VASC AN, V20, P300, DOI 10.1053/j.jvca.2006.01.017
   Rexius H, 2004, EUR J CARDIO-THORAC, V26, P521, DOI 10.1016/j.ejcts.2004.04.039
   Ridderstolpe L, 2001, EUR J CARDIO-THORAC, V20, P1168, DOI 10.1016/S1010-7940(01)00991-5
   Rigatelli G, 2008, J CARDIOVASC MED, V9, P113, DOI 10.2459/JCM.0b013e32813e3cd1
   Rigotti NA, 2008, ARCH INTERN MED, V168, P1950, DOI 10.1001/archinte.168.18.1950
   RIGOTTI NA, 1994, ANN INTERN MED, V120, P287
   Rinder CS, 2003, ANN THORAC SURG, V75, P899, DOI 10.1016/S0003-4975(02)04490-9
   Risnes I, 2010, ANN THORAC SURG, V89, P1502, DOI 10.1016/j.athoracsur.2010.02.038
   Risum O, 1997, EUR J CARDIO-THORAC, V11, P539, DOI 10.1016/S1010-7940(96)01107-4
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   ROBERTS WC, 1982, AM J CARDIOL, V49, P863, DOI 10.1016/0002-9149(82)91970-1
   ROBERTS WC, 1986, AM HEART J, V111, P941, DOI 10.1016/0002-8703(86)90646-0
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361
   Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7
   Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4
   RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060
   Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670
   Rollman BL, 2009, PSYCHOSOM MED, V71, P217, DOI 10.1097/PSY.0b013e3181970c1c
   Romano G, 2010, J THORAC CARDIOV SUR, V140, P188, DOI 10.1016/j.jtcvs.2010.03.022
   Romano PS, 2004, MED CARE, V42, P367, DOI 10.1097/01.mlr.0000118872.33251.11
   Rosenberger P, 2008, ANN THORAC SURG, V85, P548, DOI 10.1016/j.athoracsur.2007.08.061
   ROSENGART TK, 1994, ANN THORAC SURG, V58, P1397
   Rosengart TK, 2006, ANN THORAC SURG, V82, P597, DOI 10.1016/j.athoracsur.2006.03.026
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   Rouleau JL, 2008, CIRCULATION, V117, P24, DOI 10.1161/CIRCULATIONAHA.106.685073
   Rousou JA, 2000, ANN THORAC SURG, V69, P486, DOI 10.1016/S0003-4975(99)01086-3
   Roy P, 2009, AM J CARDIOL, V103, P950, DOI 10.1016/j.amjcard.2008.12.025
   Royse AG, 2000, EUR J CARDIO-THORAC, V17, P294, DOI 10.1016/S1010-7940(99)00364-4
   Royse CF, 1999, ANN THORAC SURG, V68, P1326, DOI 10.1016/S0003-4975(99)00829-2
   Royston D, 2001, BRIT J ANAESTH, V86, P575, DOI 10.1093/bja/86.4.575
   Rubens FD, 2007, CIRCULATION, V116, pI89, DOI 10.1161/CIRCULATIONAHA.106.678987
   RUBERMAN W, 1984, NEW ENGL J MED, V311, P552, DOI 10.1056/NEJM198408303110902
   Rudolph JL, 2007, AM J MED, V120, P807, DOI 10.1016/j.amjmed.2007.02.026
   Rudolph JL, 2009, PERFUSION-UK, V24, P409, DOI 10.1177/0267659109358207
   Rudolph JL, 2010, J AM GERIATR SOC, V58, P643, DOI 10.1111/j.1532-5415.2010.02762.x
   Russo A, 2008, CIRCULATION, V118, P1528, DOI 10.1161/CIRCULATIONAHA.107.747949
   Sabik JF, 2006, J THORAC CARDIOV SUR, V131, P90, DOI 10.1016/j.jtcvs.2005.05.024
   Sabik JF, 2003, ANN THORAC SURG, V76, P1490, DOI 10.1016/S0003-4975(03)01022-1
   Sabik JF, 2005, ANN THORAC SURG, V80, P1719, DOI 10.1016/j.athoracsur.2005.04.033
   Sabik JF, 2008, CIRCULATION, V118, pS210, DOI 10.1161/CIRCULATIONAHA.107.760827
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Safley DM, 2004, AM J CARDIOL, V94, P494, DOI 10.1016/j.amjcard.2004.05.008
   Saginur R, 2000, J THORAC CARDIOV SUR, V120, P1120, DOI 10.1067/mtc.2000.110384
   Sajja LR, 2007, J THORAC CARDIOV SUR, V133, P378, DOI 10.1016/j.jtcvs.2006.09.028
   Saleh SS, 2009, ANN SURG, V249, P335, DOI 10.1097/SLA.0b013e318195e475
   Salehi OA, 2007, BMC INFECT DIS, V7, P112
   Salminen US, 1999, J ANTIMICROB CHEMOTH, V44, P287, DOI 10.1093/jac/44.2.287
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Santa-Cruz RA, 2006, CATHETER CARDIO INTE, V67, P68, DOI 10.1002/ccd.20552
   Santos ATL, 2006, BRAZ J MED BIOL RES, V39, P63, DOI 10.1590/S0100-879X2006000100007
   Sarma AK, 2005, ANN THORAC SURG, V80, P714, DOI 10.1016/j.athoracsur.2004.01.020
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Saso S, 2010, ANN THORAC SURG, V89, P661, DOI 10.1016/j.athoracsur.2009.08.018
   Savage EB, 2007, ANN THORAC SURG, V83, P1002, DOI 10.1016/j.athoracsur.2006.09.094
   Savage RM, 1997, ANN THORAC SURG, V64, P368, DOI 10.1016/S0003-4975(97)00612-7
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Schachner T, 2004, ANN THORAC SURG, V78, P2028, DOI 10.1016/j.athoracsur.2004.04.078
   Schauffler HH, 2001, ANNU REV PUBL HEALTH, V22, P69, DOI 10.1146/annurev.publhealth.22.1.69
   SCHMOECKEL M, 1993, THORAC CARDIOV SURG, V41, P364, DOI 10.1055/s-2007-1013891
   Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051
   Schurr UP, 2001, ANN THORAC SURG, V72, P1316, DOI 10.1016/S0003-4975(01)03062-4
   Schwann TA, 2002, ANN THORAC SURG, V73, P1394, DOI 10.1016/S0003-4975(02)03422-7
   Scott BH, 2005, J CARDIOTHOR VASC AN, V19, P583, DOI 10.1053/j.jvca.2005.03.030
   Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043
   SEKI T, 1992, J THORAC CARDIOV SUR, V104, P1532
   Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668
   SELKER HP, 1993, ANN INTERN MED, V118, P820
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   Selnes OA, 2008, ANN NEUROL, V63, P581, DOI 10.1002/ana.21382
   Selnes OA, 2006, ANN THORAC SURG, V82, P388, DOI 10.1016/j.athoracsur.2006.02.060
   Selnes OA, 2003, ANN THORAC SURG, V75, P1377, DOI 10.1016/S0003-4975(03)00021-3
   Selnes OA, 1999, ANN THORAC SURG, V67, P1669, DOI 10.1016/S0003-4975(99)00258-1
   Serfontein L, 2010, CURR OPIN ANESTHESIO, V23, P103, DOI 10.1097/ACO.0b013e328334cb75
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Sergeant P, 1998, J THORAC CARDIOV SUR, V116, P440, DOI 10.1016/S0022-5223(98)70010-8
   Serrano CV, 2010, J CRIT CARE, V25, P305, DOI 10.1016/j.jcrc.2009.06.009
   Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
   SETHI GK, 1990, J AM COLL CARDIOL, V15, P15
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2004, ANN THORAC SURG, V78, P1868, DOI 10.1016/j.athorascur.2004.05.054
   Shahian DM, 2001, ANN THORAC SURG, V72, P2155, DOI 10.1016/S0003-4975(01)03222-2
   Shahian DM, 2000, J THORAC CARDIOV SUR, V120, P978, DOI 10.1067/mtc.2000.110461
   Shahian DM, 2004, JAMA-J AM MED ASSOC, V291, P246, DOI 10.1001/jama.291.2.246
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Shahian DM, 2008, J THORAC CARDIOV SUR, V135, P1202, DOI 10.1016/j.jtcvs.2007.12.037
   Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008
   Shahian DM, 2005, ANN THORAC SURG, V80, P1146, DOI 10.1016/j.athoracsur.2004.10.046
   Shahian DM, 2008, CIRCULATION, V117, P1955, DOI 10.1161/CIRCULATIONAHA.107.747873
   Shahian DM, 2003, ANN THORAC SURG, V75, P1048, DOI 10.1016/S0003-4975(02)04308-4
   Shahian DM, 2007, ANN THORAC SURG, V83, pS3, DOI 10.1016/j.athoracsur.2007.01.053
   Shamshad F, 2010, AM HEART J, V160, P145, DOI 10.1016/j.ahj.2010.02.037
   Shanewise JS, 1999, ANESTH ANALG, V89, P870, DOI 10.1097/00000539-199910000-00010
   SHARMA GVRK, 1983, CIRCULATION, V68, P218
   Sharoni E, 2009, THORAC CARDIOV SURG, V57, P204, DOI 10.1055/s-0029-1185367
   Sharony R, 2003, CIRCULATION, V108, P15, DOI 10.1161/01.cir.0000087448.65888.21
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Sheiman RG, 2007, AM J ROENTGENOL, V188, pW475, DOI 10.2214/AJR.06.1024
   Shernan SK, 2004, ANN THORAC SURG, V77, P942, DOI 10.1016/j.athoracsur.2003.08.054
   Shim JK, 2007, J THORAC CARDIOV SUR, V134, P59, DOI 10.1016/j.jtcvs.2007.03.013
   Shimizu T, 2000, J THORAC CARDIOV SUR, V120, P459, DOI 10.1067/mtc.2000.108166
   Shimizu T, 2010, CIRC J, V74, P449, DOI 10.1253/circj.CJ-09-0586
   Shiran A, 1997, CARDIOLOGY, V88, P207, DOI 10.1159/000177331
   Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016
   SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Shroyer ALW, 1996, ANN THORAC SURG, V61, P17, DOI 10.1016/0003-4975(95)00830-6
   SILVERMAN NA, 1982, ANN SURG, V196, P194, DOI 10.1097/00000658-198208000-00012
   Simchen E, 1997, EUR J EPIDEMIOL, V13, P503, DOI 10.1023/A:1007349230374
   Simons M, 2000, BIODRUGS, V14, P13, DOI 10.2165/00063030-200014010-00002
   Simoons ML, 1996, NEW ENGL J MED, V335, P275, DOI 10.1056/NEJM199607253350409
   SIMS FH, 1983, AM HEART J, V105, P560, DOI 10.1016/0002-8703(83)90478-7
   Singh M, 2009, MAYO CLIN PROC, V84, P501, DOI 10.1016/S0025-6196(11)60581-8
   Singh SK, 2008, CIRCULATION, V118, pS222, DOI 10.1161/CIRCULATIONAHA.107.757161
   Sirivella S, 2000, ANN THORAC SURG, V69, P501, DOI 10.1016/S0003-4975(99)01298-9
   SISTO T, 1989, ANN THORAC SURG, V47, P884
   Sjogren J, 2006, EUR J CARDIO-THORAC, V30, P898, DOI 10.1016/j.ejcts.2006.09.020
   Sjogren J, 2005, ANN THORAC SURG, V80, P1270, DOI 10.1016/j.athoracsur.2005.04.010
   Sjogren J, 2005, ANN THORAC SURG, V79, P2049, DOI 10.1016/j.athorascur.2004.12.048
   SJOLAND H, 1995, BRIT HEART J, V74, P235
   Skubas N, 2009, ANESTH ANALG, V108, P48, DOI 10.1213/ane.0b013e31818a6c4c
   Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070
   SLOGOFF S, 1988, ANESTHESIOLOGY, V68, P676, DOI 10.1097/00000542-198805000-00004
   SLOGOFF S, 1978, JAMA-J AM MED ASSOC, V240, P1487, DOI 10.1001/jama.240.14.1487
   SLOGOFF S, 1985, ANESTHESIOLOGY, V62, P107, DOI 10.1097/00000542-198502000-00002
   Smith Jr SC, 2006, J AM COLL CARDIOL, V47, P1
   Smith Jr. SC, 2011, CIRCULATION, DOI [10.1161/CIR.0b013e318235eb4d, DOI 10.1161/CIR.0B013E318235EB4D.]
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith PK, 2010, J THORAC CARDIOVASC, V142, P89
   Smith PM, 2009, CAN MED ASSOC J, V180, P1297, DOI 10.1503/cmaj.080862
   Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026
   Smith WT, 2004, J AM COLL CARDIOL, V44, P1241, DOI 10.1016/j.jacc.2004.06.031
   Song HK, 2009, J THORAC CARDIOV SUR, V137, P65, DOI 10.1016/j.jtcvs.2008.09.053
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   Sowade O, 1997, BLOOD, V89, P411
   SOWDEN AJ, 1995, BRIT MED J, V311, P151
   Spelman D, 2002, INFECT CONT HOSP EP, V23, P402, DOI 10.1086/502074
   Spiegelhalter D, 2003, INT J QUAL HEALTH C, V15, P7, DOI 10.1093/intqhc/15.1.7
   Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970
   Srinivasan AK, 2003, ANN THORAC SURG, V76, P41, DOI 10.1016/S0003-4975(03)00182-6
   Stahle E, 1997, EUR J CARDIO-THORAC, V11, P1146, DOI 10.1016/S1010-7940(97)01210-4
   Stamou SC, 2006, J THORAC CARDIOV SUR, V131, P28, DOI 10.1016/j.jtcvs.2005.08.059
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   Starobin D, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-25
   Staton GA, 2005, CHEST, V127, P892, DOI 10.1378/chest.127.3.892
   Stein PD, 2004, CHEST, V126, P600
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stevens LM, 2004, J THORAC CARDIOV SUR, V127, P1408, DOI 10.1016/j.jtcvs.2003.10.006
   Stewart RD, 1998, ANN THORAC SURG, V66, P1306, DOI 10.1016/S0003-4975(98)00760-7
   Stone GW, 2000, AM J CARDIOL, V85, P1292, DOI 10.1016/S0002-9149(00)00758-X
   Straka Z, 2002, ANN THORAC SURG, V74, P1544, DOI 10.1016/S0003-4975(02)03934-6
   Stroupe KT, 2006, CIRCULATION, V114, P1251, DOI 10.1161/CIRCULATIONAHA.105.570838
   Stygall J, 2003, HEALTH PSYCHOL, V22, P579, DOI 10.1037/0278-6133.22.6.579
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   Sukernik MR, 2007, ANESTH ANALG, V105, P602, DOI 10.1213/01.ane.0000278735.06194.0c
   Suma H, 2000, J THORAC CARDIOV SUR, V120, P496, DOI 10.1067/mtc.2000.108690
   Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104
   Surgenor SD, 2006, CIRCULATION, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271
   Suvarna S, 2007, J CARDIOTHOR VASC AN, V21, P805, DOI 10.1053/j.jvca.2007.05.014
   Svensson LG, 2010, J THORAC CARDIOV SUR, V139, P926, DOI 10.1016/j.jtcvs.2009.09.038
   Svircevic V, 2010, ANESTHESIOLOGY, V114, P271
   Swaminathan M, 2007, ANESTHESIOLOGY, V107, P739
   Swaminathan M, 2003, ANN THORAC SURG, V76, P784, DOI 10.1016/S0003-4975(03)00558-7
   Sweet JJ, 2008, ANN THORAC SURG, V85, P1571, DOI 10.1016/j.athoracsur.2008.01.090
   Sylivris S, 1997, J CARDIOTHOR VASC AN, V11, P704, DOI 10.1016/S1053-0770(97)90161-0
   Szczech LA, 2002, CIRCULATION, V105, P2253, DOI 10.1161/01.CIR.0000016051.33225.33
   Szczech LA, 2001, KIDNEY INT, V60, P292, DOI 10.1046/j.1523-1755.2001.00799.x
   Tabata M, 2007, AM J CARDIOL, V100, P442, DOI 10.1016/j.amjcard.2007.03.071
   Taghaddomi RJ, 2009, J CARDIOTHOR VASC AN, V23, P312, DOI 10.1053/j.jvca.2008.09.018
   Taillefer MC, 2006, J THORAC CARDIOV SUR, V131, P1274, DOI 10.1016/j.jtcvs.2006.02.001
   Takagi H, 2007, J THORAC CARDIOV SUR, V134, P548, DOI 10.1016/j.jtcvs.2007.03.047
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   TALLEY JD, 1990, CIRCULATION, V82, P1203
   Tamburino C, 2010, JACC-CARDIOVASC INTE, V3, P624, DOI 10.1016/j.jcin.2010.03.016
   Tanaka K, 2004, ANESTHESIOLOGY, V100, P707, DOI 10.1097/00000542-200403000-00035
   Tanner J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004122.pub3
   Tarakji KG, 2011, JAMA-J AM MED ASSOC, V305, P381, DOI 10.1001/jama.2011.37
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Tarantini G, 2009, CATHETER CARDIO INTE, V73, P50, DOI 10.1002/ccd.21757
   Tavakoli R, 2002, EUR J CARDIO-THORAC, V21, P818, DOI 10.1016/S1010-7940(02)00065-9
   Taylor AJ, 1997, AM HEART J, V133, P428, DOI 10.1016/S0002-8703(97)70184-4
   TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   Tector A J, 1996, Semin Thorac Cardiovasc Surg, V8, P29
   ten Broecke PWC, 2003, BRIT J ANAESTH, V90, P27, DOI 10.1093/bja/aeg013
   Tenenbein PK, 2008, CAN J ANAESTH, V55, P344, DOI 10.1007/BF03021489
   Testa L, 2008, J THORAC CARDIOV SUR, V136, P884, DOI 10.1016/j.jtcvs.2007.12.062
   Thakar CV, 2005, J AM SOC NEPHROL, V16, P162
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   Alderman EL, 1996, NEW ENGL J MED, V335, P217
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   De Giorgio L, 2000, NEW ENGL J MED, V342, P1376
   Talbot P, 2000, NEW ENGL J MED, V342, P748
   Herlitz J, 1995, EUR HEART J, V16, P1825
   PEDUZZI P, 1992, CIRCULATION, V86, P121
   Theologou T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004472.pub3
   Thiele H, 2009, J AM COLL CARDIOL, V53, P2324, DOI 10.1016/j.jacc.2009.03.032
   Thiele H, 2005, CIRCULATION, V112, P3445, DOI 10.1161/CIRCULATIONHA.105.578492
   Thielmann M, 2007, J THORAC CARDIOV SUR, V134, P1143, DOI 10.1016/j.jtcvs.2007.07.029
   Thielmann M, 2006, CIRCULATION, V114, pI448, DOI 10.1161/CIRCULATIONAHA.105.001057
   Thielmann M, 2007, ANN THORAC SURG, V84, P17, DOI 10.1016/j.athoracsur.2007.03.086
   THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301
   THOMAS D, 1991, EUR HEART J, V12, P832
   Thomas RJ, 2007, J AM COLL CARDIOL, V50, P1400, DOI 10.1016/j.jac.2007.04.033
   Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011
   Thys DM, 2009, ANESTH ANALG, V109, P1782, DOI 10.1213/ANE.0b013e3181be4002
   TIME Investigators, 2001, Lancet, V358, P951
   Ting HH, 2006, J AM COLL CARDIOL, V47, P1713, DOI 10.1016/j.jacc.2006.02.039
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   Toor Iqbal, 2009, Interact Cardiovasc Thorac Surg, V9, P827, DOI 10.1510/icvts.2009.210872
   Toumpoulis IK, 2005, CHEST, V127, P464, DOI 10.1378/chest.127.2.464
   TOWNSEND TR, 1993, J THORAC CARDIOV SUR, V106, P664
   Trichon BH, 2003, CIRCULATION, V108, P103, DOI 10.1161/01.cir.0000087656.10829.df
   Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Tu JV, 1997, J AM COLL CARDIOL, V30, P1317, DOI 10.1016/S0735-1097(97)00295-7
   Tully PJ, 2008, J PSYCHOSOM RES, V64, P285, DOI 10.1016/j.jpsychores.2007.09.007
   TUMAN KJ, 1989, ANESTHESIOLOGY, V70, P199, DOI 10.1097/00000542-198902000-00004
   Tumlin JA, 2005, AM J KIDNEY DIS, V46, P26, DOI 10.1053/j.ajkd.2005.04.002
   Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032
   Turner William F Jr, 2006, Ann Thorac Surg, V82, P790, DOI 10.1016/j.athoracsur.2006.03.112
   TYRAS DH, 1979, J THORAC CARDIOV SUR, V77, P310
   United States Renal Data System, 2009, NIH PUBL
   Urbach DR, 2005, J CLIN EPIDEMIOL, V58, P391, DOI 10.1016/j.jclinepi.2004.12.001
   Urban PM, 2004, AM J CARDIOL, V94, P181, DOI 10.1016/j.amjcard.2004.03.058
   UTLEY JR, 1995, ANN THORAC SURG, V60, P570, DOI 10.1016/0003-4975(95)00416-I
   Vaccarino GN, 2009, J THORAC CARDIOV SUR, V137, P309, DOI 10.1016/j.jtcvs.2008.08.002
   van DD, 2007, JAMA-J AM MED ASSOC, V297, P701
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van der Linden J, 2001, J AM COLL CARDIOL, V38, P131, DOI 10.1016/S0735-1097(01)01328-6
   van de Watering LMG, 1998, CIRCULATION, V97, P562
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   van Domburg RT, 2000, J AM COLL CARDIOL, V36, P878, DOI 10.1016/S0735-1097(00)00810-X
   van Domburg RT, 2008, AM HEART J, V156, P473, DOI 10.1016/j.ahj.2008.04.007
   van Eck FM, 2002, EUR J CARDIO-THORAC, V21, P205, DOI 10.1016/S1010-7940(01)01106-X
   van Mastrigt GAPG, 2006, CRIT CARE MED, V34, P1624, DOI 10.1097/01.CCM.0000217963.87227.7B
   van Mastrigt GAPG, 2010, QUAL LIFE RES, V19, P631, DOI 10.1007/s11136-010-9625-5
   van Mastrigt GAPG, 2006, CRIT CARE MED, V34, P65, DOI 10.1097/01.CCM.0000191266.72652.FA
   van Straten AHM, 2010, INTERACT CARDIOV TH, V10, P37, DOI 10.1510/icvts.2009.214551
   van Straten AHM, 2010, J CARDIOTHOR VASC AN, V24, P413, DOI 10.1053/j.jvca.2010.01.001
   Varani Elisabetta, 2007, J Invasive Cardiol, V19, P469
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades Thomas Jr, 2009, Semin Thorac Cardiovasc Surg, V21, P237, DOI 10.1053/j.semtcvs.2009.08.008
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Veeger NJGM, 2010, ANN THORAC SURG, V90, P1515, DOI 10.1016/j.athoracsur.2010.06.007
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1616
   Veliz-Reissmuller G, 2007, AGING CLIN EXP RES, V19, P172
   Venge P, 2009, J AM COLL CARDIOL, V54, P1165, DOI 10.1016/j.jacc.2009.05.051
   Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770
   Vesely DL, 2003, AM J PHYSIOL-RENAL, V285, pF167, DOI 10.1152/ajprenal.00259.2002
   Vincent JL, 2008, CRIT CARE MED, V36, P3093, DOI 10.1097/CCM.0b013e31818c10c7
   VINEBERG AM, 1946, CAN MED ASSOC J, V55, P117
   VLIETSTRA RE, 1986, JAMA-J AM MED ASSOC, V255, P1023, DOI 10.1001/jama.255.8.1023
   VONSEGESSER LK, 1994, EUR J CARDIO-THORAC, V8, P363, DOI 10.1016/1010-7940(94)90030-2
   Voors AA, 1996, CIRCULATION, V93, P42
   Vuorisalo S, 1998, INFECT CONT HOSP EP, V19, P234
   Wadhera RK, 2010, J THORAC CARDIOV SUR, V139, P312, DOI 10.1016/j.jtcvs.2009.10.048
   Wahrborg P, 1999, EUR HEART J, V20, P653, DOI 10.1053/euhj.1998.1237
   WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421
   Walpoth B, 1996, SEMIN HEMATOL, V33, P75
   WALSH EE, 2010, ARCH INTERN MED, V171, P68
   Walsh SR, 2007, BRIT J ANAESTH, V99, P611, DOI 10.1093/bja/aem273
   Walsh SR, 2008, EUR J CARDIO-THORAC, V34, P985, DOI 10.1016/j.ejcts.2008.07.062
   Walsh SR, 2010, EUR J VASC ENDOVASC, V39, P719, DOI 10.1016/j.ejvs.2010.02.004
   Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6
   Wang BH, 2009, BIOCHEM BIOPH RES CO, V389, P105, DOI 10.1016/j.bbrc.2009.08.097
   Wang G, 2010, J CARDIOTHOR VASC AN, V2, P268, DOI DOI 10.1152/AJPRENAL.00259.2002
   Wang JW, 2004, ANESTH ANALG, V99, P965, DOI 10.1213/01.ane.0000130614.45647.81
   WANG N, 1995, J THORAC CARDIOV SUR, V110, P214, DOI 10.1016/S0022-5223(05)80028-5
   Wasvary H, 1997, AM SURGEON, V63, P710
   WATANABE Y, 1992, ANN THORAC SURG, V54, P479
   WEBB JM, 1993, ANN ROY COLL SURG, V75, P291
   Weightman WM, 1999, ANESTH ANALG, V88, P286, DOI 10.1097/00000539-199902000-00011
   WEINER B, 1986, CLIN PHARMACY, V5, P55
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Weiss ES, 2008, J THORAC CARDIOV SUR, V135, P503, DOI 10.1016/j.jtcvs.2007.10.042
   Weiss ES, 2008, J THORAC CARDIOVASC, V135, pe1
   Welke KF, 2005, ANN THORAC SURG, V80, P2114, DOI 10.1016/j.athoracsur.2005.05.017
   Welke KF, 2007, ANN THORAC SURG, V84, P1538, DOI 10.1016/j.athoracsur.2007.06.022
   Welsby I, 2010, TRANSFUSION, V50, P2343
   Weltert L, 2010, J THORAC CARDIOV SUR, V139, P621, DOI 10.1016/j.jtcvs.2009.10.012
   Wenger NK, 1998, REHABILITATION CORON
   Werdan K, 2008, CRIT CARE MED, V36, P716, DOI 10.1097/01.CCM.0B013E3181611F62F
   Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   White CM, 2007, EUR J CARDIO-THORAC, V31, P817, DOI 10.1016/j.ejcts.2007.02.010
   White HD, 2005, CIRCULATION, V112, P1992, DOI 10.1161/CIRCULATIONAHA.105.540948
   Wiesbauer F, 2007, ANESTH ANALG, V104, P27, DOI 10.1213/01.ane.0000247805.00342.21
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   WILLIAMS DB, 1985, J THORAC CARDIOV SUR, V90, P592
   WILSON APR, 1988, J ANTIMICROB CHEMOTH, V21, P213, DOI 10.1093/jac/21.2.213
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wong CHK, 2006, EUR J CARDIO-THORAC, V30, P148, DOI 10.1016/j.ejcts.2006.03.049
   WONG PS, 1993, ANN THORAC SURG, V56, P108
   Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011
   Wu CT, 2004, CIRCULATION, V110, P784, DOI 10.1161/01.CIR.0000138744.13516.B5
   Wu ZK, 2002, CIRCULATION, V106, P3091, DOI 10.1161/01.CIR.0000041430.32233.5B
   Xia ZY, 2006, ANESTH ANALG, V103, P527, DOI 10.1213/01.ane.0000230612.29452.a6
   Yamaguchi A, 2009, ANN THORAC CARDIOVAS, V15, P98
   Yang JH, 2008, ANN THORAC SURG, V85, P65, DOI 10.1016/j.athoracsur.2007.06.027
   Yang Zhen Kun, 2007, J Interv Cardiol, V20, P10, DOI 10.1111/j.1540-8183.2007.00222.x
   Yao Yun-tai, 2009, Chinese Medical Sciences Journal, V24, P133
   Yap CH, 2009, ANN THORAC SURG, V87, P1386, DOI 10.1016/j.athoracsur.2009.02.006
   Yau JM, 2008, AM J CARDIOL, V102, P546, DOI 10.1016/j.amjcard.2008.04.069
   Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667
   Yende S, 2001, CRIT CARE MED, V29, P2271, DOI 10.1097/00003246-200112000-00006
   Yeung-Lai-Wah JA, 2004, ANN THORAC SURG, V77, P2083, DOI 10.1016/j.athoracsur.2003.12.020
   YLIMAYRY S, 1992, EUR HEART J, V13, P1259
   Young EW, 1998, ANN THORAC SURG, V65, P1316, DOI 10.1016/S0003-4975(98)00157-X
   Yu CH, 2006, CAN J ANAESTH, V53, P906
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489
   Zarbock A, 2009, CHEST, V135, P1252, DOI 10.1378/chest.08-1602
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   Zimarino M, 2004, ANN THORAC SURG, V78, P135, DOI 10.1016/j.athorascur.2003.12.030
   Zingone B, 2006, EUR J CARDIO-THORAC, V29, P720, DOI 10.1016/j.ejcts.2006.02.001
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
   Zvara DA, 2000, J CARDIOTHOR VASC AN, V14, P571, DOI 10.1053/jcan.2000.9445
NR 1259
TC 89
Z9 100
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD DEC
PY 2011
VL 58
IS 24
BP E123
EP E210
DI 10.1016/j.jacc.2011.08.009
PG 88
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 862ZJ
UT WOS:000298132300003
PM 22070836
ER

PT J
AU Sedrakyan, A
   Wu, AW
   Parashar, A
   Bass, EB
   Treasure, T
AF Sedrakyan, Artyom
   Wu, Albert W.
   Parashar, Amish
   Bass, Eric B.
   Treasure, Tom
TI Off-pump surgery is associated with reduced occurrence of stroke and
   other morbidity as compared with traditional coronary artery bypass
   grafting - A meta-analysis of systematically reviewed trials
SO STROKE
LA English
DT Article
DE atrial fibrillation; CABG; cardiac surgery; off-pump surgery; outcomes;
   stroke; systematic review
ID ON-PUMP; BEATING-HEART; INFLAMMATORY RESPONSE; ATRIAL-FIBRILLATION;
   CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; MYOCARDIAL INJURY;
   RANDOMIZED-TRIAL; REVASCULARIZATION; PREDICTORS
AB Background and Purpose-There is growing enthusiasm for coronary artery bypass grafting (CABG) without cardiopulmonary bypass (CPB). Although deleterious effects of CPB are known, it remains to be proven that avoiding CPB will result in reduction in morbidity. We sought to determine whether off-pump surgery is associated with reduced occurrence of adverse outcomes as compared with CABG with CPB.
   Methods-Studies were identified by searching the MEDLINE, EMBASE and the Cochrane Register 1980 to 2006 (February). We also searched the reference lists of randomized clinical trials (RCT) and reviews to look for additional studies. Study selection: RCTs comparing off-pump surgery to CABG with CPB. No restriction applied on the size of the trial or end point reports. Data extraction: 2 reviewers independently searched for studies, read abstracts and abstracted all data. Data synthesis: combined estimates were obtained using fixed or random effect meta-analyses. Relative risks and risk differences were calculated. Heterogeneity was assessed using X, and V values.
   Results-There were 3996 patients enrolled in 41 RCTs (mean age 62, 22% female). No study reported information on race. Off-pump CABG was associated with a 50% reduction in the relative risk of stroke (95% CI, 7% to 73%), 30% reduction in atrial fibrillation (AF; 95% CI, 16% to 43%) and 48% reduction in wound infection (95% CI, 26% to 63%) with no heterogeneity among RCTs. This translated into avoidance of 10 strokes, 80 cases of AF and 40 infections per 1000 CABG. Fewer distal grafts were performed and there was evidence for > 10 reinterventions per 1000 with off-pump CABG. Long-term follow-up is not yet reported in the trials.
   Conclusions-Off-pump CABG is associated with reduced risk of stroke, AF and infections as compared with CABG with CPB. Evidence should be generalized taking into account RCT enrollment limitations, drawbacks related to training requirements, propensity to perform fewer grafts and likely reinterventions after off-pump surgery.
C1 Ctr Outcomes & Evidence, Agcy Healthcare Res & Qual, Rockville, MD 20850 USA.
   London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England.
   Yale Sch Med, Dept Surg, New Haven, CT USA.
   Johns Hopkins Univ, Hlth Serv Res & Dev Ctr, Baltimore, MD USA.
   Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.
   Johns Hopkins Univ, Evidence Based Practice Ctr, Baltimore, MD USA.
   Guys Hosp, Cardiothorac Unit, London SE1 9RT, England.
RP Sedrakyan, A (reprint author), Ctr Outcomes & Evidence, Agcy Healthcare Res & Qual, 540 Gaither Rd, Rockville, MD 20850 USA.
EM asedraky@ahrq.gov
CR Al-Ruzzeh S, 2003, HEART SURG FORUM, V6, P89
   *AM HEART ASS, 2006, HEART STROK STAT UPD
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Aranki SF, 1996, CIRCULATION, V94, P390
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6
   Ascione R, 2003, J THORAC CARDIOV SUR, V125, P779, DOI 10.1067/mtc.2003.11
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Ascione R, 2000, CIRCULATION, V102, P1530
   BUFFOLO E, 1990, EUR J CARDIO-THORAC, V4, P504, DOI 10.1016/1010-7940(90)90174-X
   Czerny M, 2000, EUR J CARDIO-THORAC, V17, P737, DOI 10.1016/S1010-7940(00)00420-6
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   EFFLER DB, 1970, J THORAC CARDIOV SUR, V59, P147
   FAVALORO RG, 1994, AORTOCORONARY BYPASS, P94
   Favaloro R G, 1970, Ann Thorac Surg, V10, P97
   Giri S, 2001, LANCET, V357, P830, DOI 10.1016/S0140-6736(00)04196-9
   Gu YJ, 1998, ANN THORAC SURG, V65, P420
   Hogue CW, 1999, CIRCULATION, V100, P642
   Kapetanakis EI, 2004, ANN THORAC SURG, V78, P1564, DOI 10.1016/j.athoracsur.2004.05.019
   Keizer AMA, 2003, ANN THORAC SURG, V75, P835, DOI 10.1016/S0003-4975(02)04541-1
   KOLESSOV VI, 1967, J THORAC CARDIOV SUR, V54, P535
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Legare JF, 2005, EUR J CARDIO-THORAC, V27, P296, DOI 10.1016/j.ejcts.2004.11.009
   Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300
   McKhann GM, 2006, STROKE, V37, P562, DOI 10.1161/01.STR.0000199032.78782.6c
   Mitka M, 2004, JAMA-J AM MED ASSOC, V291, P1821, DOI 10.1001/jama.291.15.1821
   Motallebzadeh R, 2004, EUR J CARDIO-THORAC, V25, P409, DOI 10.1016/j.ejcts.2003.12.018
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P1897, DOI 10.1001/jama.291.15.1897
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Raja SG, 2003, SURG J R COLL SURG E, V1, P221
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   Sedrakyan A, 2004, BRIT MED J, V329, P1008, DOI 10.1136/bmj.38243.440486.55
   Stamou SC, 2006, STROKE, V37, P284, DOI 10.1161/01.STR.0000199048.87363.aa
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043
   Wandschneider W, 2000, ANN THORAC SURG, V70, P1577, DOI 10.1016/S0003-4975(00)01843-9
   Wehlin L, 2004, EUR J CARDIO-THORAC, V25, P35, DOI 10.1016/S1010-7940(03)00652-3
   2004, CLINTONS HEART  0907
NR 43
TC 89
Z9 90
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0039-2499
J9 STROKE
JI Stroke
PD NOV
PY 2006
VL 37
IS 11
BP 2759
EP 2769
DI 10.1161/01.STR.0000245081.52877.f2
PG 11
WC Clinical Neurology; Peripheral Vascular Disease
SC Neurosciences & Neurology; Cardiovascular System & Cardiology
GA 102GK
UT WOS:000241798800029
PM 17008617
ER

PT J
AU Lee, LN
   Stock, RG
   Stone, NN
AF Lee, LN
   Stock, RG
   Stone, NN
TI Role of hormonal therapy in the management of intermediate- to high-risk
   prostate cancer treated with permanent radioactive seed implantation
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT 42nd Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology (ASTRO)
CY OCT 21-26, 2000
CL BOSTON, MASSACHUSETTS
SP Amer Soc Therapeut Radiol & Oncol
DE prostate cancer; hormone therapy; brachytherapy
ID EXTERNAL-BEAM RADIATION; LYMPH-NODE DISSECTION; ANDROGEN SUPPRESSION;
   COMBINATION RADIOTHERAPY; RADICAL PROSTATECTOMY; CLINICAL STAGE;
   ONCOLOGY GROUP; DOSE-RESPONSE; BRACHYTHERAPY; ANTIGEN
AB Purpose: To study the impact of hormonal therapy (HTx) on intermediate- to high-risk prostate cancer treated With-permanent radioactive seed implantation.
   Methods and Materials: Patients with Stage T1b-T3bN0 prostate cancer, and Gleason score greater than or equal to7 or prostate-specific antigen (PSA) level >10 ng/mL were treated with seed implantation with or without HTx. Their disease was defined as intermediate risk (PSA 10-20, Gleason score 7, or Stage T2b) or high risk (two or more intermediate criteria, or PSA >20 ng/mL, Gleason score 8-10, or Stage T2c-T3). The median follow-up for 201 eligible patients was 42 months (range 18-110). Biochemical failure was defined as a rising PSA >1.0 ng/mL. Pretreatment disease characteristics, implant dose, and HTx were evaluated using univariate and multivariate analyses.
   Results: HTx significantly improved 5-year actuarial freedom from biochemical failure rate, 79% vs. 54% without HTx. In addition, high-dose, PSA :515 ng/mL, intermediate risk, and Stage T2a or lower significantly improved outcome in the univariate analyses. HTx was the most significant predictor of 5-year actuarial freedom from biochemical failure (p <0.0001) in a multivariate analysis. The best outcome was in the intermediate-risk patients treated with a high implant dose and HTx, resulting in a 4-year actuarial freedom from biochemical failure rate of 94%.
   Conclusion: In this retrospective review, HTx improved outcome in intermediate- to high-risk prostate cancer patients treated with brachytherapy. HTx was the most important prognostic factor in the univariate and multivariate analyses. (C) 2002 Elsevier Science Inc.
C1 Mt Sinai Med Ctr, Dept Radiat Oncol, New York, NY 10029 USA.
   Mt Sinai Med Ctr, Dept Urol, New York, NY 10029 USA.
RP Stock, RG (reprint author), Mt Sinai Med Ctr, Dept Radiat Oncol, 1 Gustave Levy Pl,Box 1236, New York, NY 10029 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Anderson PR, 1997, INT J RADIAT ONCOL, V39, P1025, DOI 10.1016/S0360-3016(97)00388-X
   BEARHS OH, 1992, MANUAL STAGING CANC, P181
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Bolla M., 1999, International Journal of Radiation Oncology Biology Physics, V45, P147, DOI 10.1016/S0360-3016(99)90023-8
   Cox D, 1984, ANAL SURVIVAL DATA, DOI Boca Raton, FL
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   D'Amico AV, 2000, JAMA-J AM MED ASSOC, V284, P1280, DOI 10.1001/jama.284.10.1280
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Davis BJ, 1999, CANCER, V85, P2630
   DeWeese TL, 2000, UROLOGY, V55, P169, DOI 10.1016/S0090-4295(99)00419-7
   Duchesne GM, 1996, RADIOTHER ONCOL, V38, P7, DOI 10.1016/0167-8140(95)01645-7
   Hanks G. E., 2000, International Journal of Radiation Oncology Biology Physics, V48, P112, DOI 10.1016/S0360-3016(00)80021-8
   Hanks GE, 1997, INT J RADIAT ONCOL, V37, P543, DOI 10.1016/S0360-3016(96)00602-5
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KOPROWSKI CD, 1995, INT J RADIAT ONCOL, V21, P995
   Kupelian P, 1997, CANCER J SCI AM, V3, P78
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445
   Pilepich MV, 1997, J CLIN ONCOL, V15, P1013
   PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3
   Pilepich M. V., 2000, International Journal of Radiation Oncology Biology Physics, V48, P169, DOI 10.1016/S0360-3016(00)80131-5
   Pollack A, 1997, INT J RADIAT ONCOL, V39, P1011, DOI 10.1016/S0360-3016(97)00508-7
   Potters L, 2000, J CLIN ONCOL, V18, P1187
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Roach M, 1999, J STEROID BIOCHEM, V69, P239, DOI 10.1016/S0960-0760(99)00040-0
   Roach M, 1996, J UROLOGY, V156, P1719, DOI 10.1016/S0022-5347(01)65490-9
   Roach M, 2000, INT J RADIAT ONCOL, V47, P617, DOI 10.1016/S0360-3016(00)00577-0
   Stock R. G., 1999, International Journal of Radiation Oncology Biology Physics, V45, P258, DOI 10.1016/S0360-3016(99)90229-8
   Stock RG, 1997, SEMIN SURG ONCOL, V13, P454, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<454::AID-SSU10>3.0.CO;2-T
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   STOCK RG, 1995, INT J RADIAT ONCOL, V33, P815, DOI 10.1016/0360-3016(95)02007-4
   Stock RG, 2000, INT J RADIAT ONCOL, V48, P899, DOI 10.1016/S0360-3016(00)00707-0
   Stone NN, 1999, J UROLOGY, V162, P421, DOI 10.1016/S0022-5347(05)68574-6
   STONE NN, 1995, J UROLOGY, V153, P1555, DOI 10.1016/S0022-5347(01)67460-3
   Vicini FA, 1997, J UROLOGY, V158, P319, DOI 10.1016/S0022-5347(01)64471-9
   ZAGARS GK, 1995, UROLOGY, V45, P476, DOI 10.1016/S0090-4295(99)80019-3
   Zeitlin SI, 1998, J UROLOGY, V160, P91, DOI 10.1016/S0022-5347(01)63042-8
   ZEITMAN A, 1997, UROLOGY, V49, P74
   Zelefsky MJ, 1999, J CLIN ONCOL, V17, P517
NR 50
TC 89
Z9 98
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD FEB 1
PY 2002
VL 52
IS 2
BP 444
EP 452
DI 10.1016/S0360-3016(01)02598-6
PG 9
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 512TR
UT WOS:000173340100020
PM 11872291
ER

PT J
AU FLECKENSTEIN, JL
   BURNS, DK
   MURPHY, FK
   JAYSON, HT
   BONTE, FJ
AF FLECKENSTEIN, JL
   BURNS, DK
   MURPHY, FK
   JAYSON, HT
   BONTE, FJ
TI DIFFERENTIAL-DIAGNOSIS OF BACTERIAL MYOSITIS IN AIDS - EVALUATION WITH
   MR-IMAGING
SO RADIOLOGY
LA English
DT Article
DE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS); LYMPHEDEMA; MAGNETIC
   RESONANCE (MR), TISSUE CHARACTERIZATION; MUSCLES, ABNORMALITIES;
   MUSCLES, ABSCESS; MUSCLES, MR-STUDIES; MYCOBACTERIA
ID ACQUIRED IMMUNODEFICIENCY SYNDROME; PYOMYOSITIS; PATIENT; POLYMYOSITIS;
   INFECTION; TOMOGRAPHY; LYMPHEDEMA; ABSCESSES; ARC
AB Magnetic resonance (MR) imaging was used to assess for the presence of bacterial myositis, rare outside the tropics, in 13 patients with either the acquired immunodeficiency syndrome (AIDS) (n = 11) or positive results of serologic tests for the human immunodeficiency virus but without other evidence of AIDS (n = 2).  Bacterial myositis was diagnosed in six patients: in five it was caused by pyogenic bacteria, and in the other, by Mycobacterium tuberculosis; in each patient, little or no subcutaneous tissue alteration occurred.  On T1-weighted images in three patients, muscle abscesses showed a rim of increased signal intensity corresponding to margins between drainable pus and edematous muscle.  Subcutaneous tissues appeared normal in patients with bacterial myositis but was not in the others, in whom muscle abnormalities tended to be less prominent.  The latter group included patients with lymphoma (n = 1), Kaposi sarcoma (n = 2), and carbunculosis (n = 1), and three patients in whom no diagnosis was made; lymphedema was presumed to account for imaging abnormalities in four of the latter group.
C1 UNIV TEXAS,SW MED CTR,DEPT PATHOL,DALLAS,TX 75235.
   UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235.
RP FLECKENSTEIN, JL (reprint author), UNIV TEXAS,SW MED CTR,DEPT RADIOL,5801 FOREST PK,DALLAS,TX 75235, USA.
CR BESSEN LJ, 1988, NEW ENGL J MED, V318, P708
   BLUEFARB SM, 1957, KAPOSIS SARCOMA MULT, P72
   CHIEDOZI LC, 1979, AM J SURG, V137, P255, DOI 10.1016/0002-9610(79)90158-2
   DALAKAS MC, 1986, JAMA-J AM MED ASSOC, V256, P2381, DOI 10.1001/jama.256.17.2381
   ELVINLEW.M, 1973, LYMPHOLOGY, V6, P113
   Fujii K, 1990, Rinsho Hoshasen, V35, P77
   GABBAI AA, 1990, MUSCLE NERVE, V13, P541, DOI 10.1002/mus.880130611
   GAUT P, 1988, ARCH INTERN MED, V148, P1608, DOI 10.1001/archinte.148.7.1608
   GOLTNER E, 1988, LYMPHOLOGY, V21, P134
   HADJIS NS, 1985, AM J ROENTGENOL, V144, P361
   KAUFMAN LD, 1987, ANN RHEUM DIS, V46, P569, DOI 10.1136/ard.46.8.569
   KAYE BR, 1989, ANN INTERN MED, V111, P158
   LACHIEWICZ PF, 1986, SOUTHERN MED J, V79, P1047, DOI 10.1097/00007611-198608000-00038
   MUSUMECI R, 1988, PROGR LYMPHOLOGY, V11, P387
   PAAJANEN H, 1987, MAGN RESON IMAGING, V5, P109, DOI 10.1016/0730-725X(87)90040-3
   PROKES B, 1988, PROGR LYMPHOLOGY, V11, P365
   RAPHAEL SA, 1989, AM J DIS CHILD, V143, P779
   SENSAKOVIC JW, 1985, ARCH INTERN MED, V145, P2247
   SIRINAVIN S, 1979, AM J DIS CHILD, V133, P263
   VARTIAN C, 1988, ARCH INTERN MED, V148, P2689
   VICTOR G, 1989, ARCH INTERN MED, V149, P705
   WALL SD, 1985, AM J ROENTGENOL, V144, P1217
   WATTS RA, 1987, BRIT MED J, V294, P1524
   WITTE MH, 1990, AM J ROENTGENOL, V155, P311
   WRZOLEK MA, 1990, MUSCLE NERVE, V13, P508, DOI 10.1002/mus.880130607
   YUH WTC, 1988, SKELETAL RADIOL, V17, P190
NR 26
TC 89
Z9 89
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JUN
PY 1991
VL 179
IS 3
BP 653
EP 658
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA FM910
UT WOS:A1991FM91000014
PM 2027969
ER

PT J
AU Orth, CD
   Payne, SA
   Krupke, WF
AF Orth, CD
   Payne, SA
   Krupke, WF
TI A diode pumped solid state laser driver for inertial fusion energy
SO NUCLEAR FUSION
LA English
DT Review
ID INDUCED SPATIAL INCOHERENCE; POWER-PLANT DESIGN; CONFINEMENT FUSION;
   HYLIFE-II; REACTOR; PERFORMANCE; AMPLIFIER; CRYSTALS; CONVERSION;
   PROGRESS
AB A comprehensive conceptual design for a diode pumped solid state laser (DPSSL) as a driver for an inertial fusion energy (IFE) power plant is presented. This design is based on recent technical advances that offer potential solutions to difficulties previously associated with the use of a laser for IFE applications. The design was selected by using a systems analysis code that optimizes a DPSSL configuration by minimizing the calculated cost of electricity (COE). The code contains the significant physics relevant to the DPSSL driver, bur treats the target chamber and balance of plant costs generically using scaling relations published for the Sombrero KrF laser concept. The authors describe the physics incorporated in the code, predict DPSSL performance and its variations with changes in the major parameters, discuss IFE economics and technical risk, and identify the high leverage development efforts that can make DPSSL driven IFE plants more economically competitive. It is believed that this study is a significant advance over previous conceptual studies of DPSSLs for IFE because it incorporates a new cost effective gain medium, applies a potential solution to the 'final optics' problem, and considers me laser physics in substantially greater detail. The result is the introduction of an option for an IFE driver that has relatively low development costs and that builds upon the mature laser technology base already developed for Nova and being developed for the proposed National Ignition Facility. The baseline design of the paper has a product of laser efficiency and target gain of eta G similar to 6.6 and a COE of 8.6 cents/kW.h for a 1 GW(e) plant with a target gain of 76 at 3.7 MJ. Higher eta G (greater than or similar to 11) and lower COEs (less than or similar to 6.6 cents/kW.h) can be achieved with target gains twice as high.
RP Orth, CD (reprint author), LAWRENCE LIVERMORE NATL LAB, LIVERMORE, CA USA.
CR Albrecht G. F., 1989, Proceedings of the SPIE - The International Society for Optical Engineering, V1040
   ALBRECHT GF, 1990, APPL OPTICS, V29, P3079, DOI 10.1364/AO.29.003079
   ALBRECHT GF, 1988, UCRL5200885 LAWR LIV, P25
   ALFEROV ZI, 1988, SOV PHYS SEMICOND+, V22, P650
   Antonishkis N. Yu., 1988, Soviet Technical Physics Letters, V14
   *ASS SECR DEF PROG, 1988, DOEDP0069 US DEP EN
   ATHERTON J, 1993, COMMUNICATION
   AVIZONIS PV, 1966, J APPL PHYS, V37, P687, DOI 10.1063/1.1708238
   BEACH R, 1992, OPT LETT, V17, P124, DOI 10.1364/OL.17.000124
   BEACH R, 1992, IEEE J QUANTUM ELECT, V28, P966, DOI 10.1109/3.135215
   BEACH RJ, 1994, COMMUNICATION
   BEACH RJ, 1994, LASER TECH BRIEF WIN, P32
   BENETT W, 1992, SPIE, V1634, P453
   BENETT WJ, 1993, SPIE P, V1865, P144
   BIERI R, 1993, FUSION TECHNOL, V21, P1583
   BIERI RL, 1991, FUSION TECHNOL, V19, P673
   BODNER S, 1994, COMMUNICATION
   BORN M, 1980, PRINCIPLES OPTICS, P393
   BROWN DC, 1981, HIGH PEAK POWER ND G, P128
   CAMPBELL EM, 1992, PHYS FLUIDS B-PLASMA, V4, P3781, DOI 10.1063/1.860333
   Carlson N.W, 1994, MONOLITHIC DIODE LAS
   COMASKEY B, 1993, P SOC PHOTO-OPT INS, V1865, P9, DOI 10.1117/12.146945
   COMASKEY BJ, 1992, IEEE J QUANTUM ELECT, V28, P992, DOI 10.1109/3.135218
   CUNNINGHAM JA, 1980, IEEE SPECTRUM, V17, P45
   DELENE J, 1993, COMMUNICATION
   DELENE JG, 1991, FUSION TECHNOL, V19, P807
   DELOACH LD, 1993, IEEE J QUANTUM ELECT, V29, P1179, DOI 10.1109/3.214504
   DELOACH LD, 1994, J OPT SOC AM B, V11, P269, DOI 10.1364/JOSAB.11.000269
   DELOACH LD, 1993, OSA PROC, V15, P188
   DIXIT SN, 1993, COMMUNICATION
   DIXIT SN, 1994, OPT LETT, V19, P417
   EIMERL D, 1987, IEEE J QUANTUM ELECT, V23, P575, DOI 10.1109/JQE.1987.1073391
   EIMERL D, 1987, IEEE J QUANTUM ELECT, V23, P2238, DOI 10.1109/JQE.1987.1073290
   EMANUEL MA, 1994, COMMUNICATION
   Emmett J. L., 1983, Soviet Journal of Quantum Electronics, V13, DOI 10.1070/QE1983v013n01ABEH004004
   ERLANDSON AC, 1992, UCRLLR105821923 LAWR, V2, P105
   GOLDHAR J, 1986, IEEE J QUANTUM ELECT, V22, P1137, DOI 10.1109/JQE.1986.1073098
   Hackel L A, 1993, Appl Opt, V32, P6914, DOI 10.1364/AO.32.006914
   HARRIS DB, 1993, LASER PART BEAMS, V11, P323
   HECHT J, 1991, LASERS OPTRONICS, P54
   HOFFMAN MA, 1992, FUSION TECHNOL, V21, P1557
   HOGAN WJ, 1992, PHYS TODAY, V45, P42, DOI 10.1063/1.881319
   HOLZRICHTER JF, 1978, UCRL5002177 LAWR LIV, V1
   HOUSE PA, 1992, FUSION TECHNOL, V21, P1487
   *ICF PROGR, 1977, UCRL5002176 LAWR LIV
   KITAGAWA Y, 1992, FUSION TECHNOL, V21, P1460
   KOSLOWSKI M, 1994, COMMUNICATION
   KRUPKE WF, 1989, FUSION TECHNOL, V15, P377
   KRUPKE WF, 1993, IEEE LEOS ANN MTG, P40, DOI 10.1109/LEOS.1993.379139
   KRUPKE WF, 1990, OPT QUANT ELECTRON, V22, pS1, DOI 10.1007/BF02088996
   LEHMBERG RH, 1987, J APPL PHYS, V62, P2680, DOI 10.1063/1.339419
   LINDL JD, 1993, COMMUNICATION
   LINDL JD, 1992, PHYS TODAY, V45, P32, DOI 10.1063/1.881318
   MARION JE, 1991, EUR J SOL STATE INOR, V28, P271
   MARION JE, 1986, J APPL PHYS, V60, P69, DOI 10.1063/1.337630
   MARSHALL CD, 1995, IEEE J SEL TOP QUANT, V1, P67, DOI 10.1109/2944.468369
   MARSHALL CD, 1994, COMMUNICATION
   MARSHALL CD, 1995, IN PRESS ADV SOLID S, V24
   MAYER A, 1994, LASER MAT PROCESSING
   MEIER WR, 1994, COMMUNICATION
   MEIER WR, 1993, COMMUNICATION
   MEIER WR, 1992, FUSION TECHNOL, V21, P1552
   MERRITT BT, 1993, COMMUNICATION
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   MOIR RW, 1992, FUSION TECHNOL, V21, P1475
   MUNDINGER D, 1988, APPL PHYS LETT, V53, P1030, DOI 10.1063/1.100055
   MURRAY JE, 1981, APPL OPTICS, V20, P826, DOI 10.1364/AO.20.000826
   MURRAY JR, 1991, UCRLLR105821913 LAWR, V1, P89
   MURRAY JR, 1989, J OPT SOC AM B, V6, P2402, DOI 10.1364/JOSAB.6.002402
   MURRAY JR, 1994, COMMUNICATION
   MURRAY KE, 1993, COMMUNICATION
   NAITO K, 1992, ILE Q PROGR REP, V3
   NAITO K, 1992, JPN J APPL PHYS 1, V31, P259, DOI 10.1143/JJAP.31.259
   *NIF TEAM, 1994, UCRLPROP117093 NIF T, V2
   *NIF TEAM, 1994, UCRLPROP117093 LAWR, V3
   OBENSCHAIN SP, 1986, PHYS REV LETT, V56, P2807, DOI 10.1103/PhysRevLett.56.2807
   ORTH CD, 1994, UCRLID117096 LAWR LI
   PATTON H, 1993, COMMUNICATION
   PAYNE SA, 1994, IEEE J QUANTUM ELECT, V30, P170, DOI 10.1109/3.272077
   PAYNE SA, 1992, IEEE J QUANTUM ELECT, V28, P2619, DOI 10.1109/3.161321
   PAYNE SA, 1992, UCRLLR105821922 LAWR, V2, P51
   PAYNE SA, 1994, J APPL PHYS, V76, P497, DOI 10.1063/1.357101
   PETERSON RR, 1992, FUSION ENG, V1, P400
   PLECHATY EF, 1976, UCRL50400 LAWR LIV N, V14
   RAINER F, 1994, P SOC PHOTO-OPT INS, V2114, P9, DOI 10.1117/12.180882
   REMINGTON BA, 1992, PHYS FLUIDS B-PLASMA, V4, P967, DOI 10.1063/1.860113
   REMINGTON BA, 1993, PHYS FLUIDS B-PLASMA, V5, P2589, DOI 10.1063/1.860695
   RHODES MA, 1992, UCRLLR105821921 LAWR, V2, P23
   RICE R, 1993, COMMUNICATION
   ROSEN MD, 1984, 83 LAWR LIV NAT LAB, P3
   SACKS RA, 1992, UCRLLR105821924 LAWR, V2, P179
   SASNETT MW, 1991, P SOC PHOTO-OPT INS, V1414, P21, DOI 10.1117/12.43661
   SEIFRITZ W, 1991, FUSION TECHNOL, V20, P295
   SEPPALA L, 1993, COMMUNICATION
   SIEGMAN AE, 1990, P SOC PHOTO-OPT INS, V1224, P2, DOI 10.1117/12.18425
   SKUPSKY S, 1989, J APPL PHYS, V66, P3456, DOI 10.1063/1.344101
   SOLARZ R, 1994, DIODE LASER ARRAYS
   STOKOWSKI SE, 1981, M095 LAWR LIV NAT LA, V1
   STORM E, 1993, COMMUNICATION
   SUTTON SB, 1991, J APPL PHYS, V69, P1183, DOI 10.1063/1.347302
   SUTTON SB, 1992, AIAA J, V30, P431, DOI 10.2514/3.10934
   TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664
   TABAK M, 1993, COMMUNICATION
   THIJS PJA, 1994, IEEE J QUANTUM ELECT, V30, P477
   TOBIN MT, 1989, FUSION TECHNOL, V15, P583
   TRENHOLME J, 1993, COMMUNICATION
   VANN C, 1994, COMMUNICATION
   VANWONTERGHEM BM, 1994, FUSION TECHNOL, V26, P702
   WATERS RG, 1987, APPL PHYS LETT, V51, P1318, DOI 10.1063/1.98715
   WEGNER PJ, 1992, APPL OPTICS, V31, P6414, DOI 10.1364/AO.31.006414
   WILLIAMSON RC, 1993, SURFACE EMITTING SEM
   WOODWORTH J, 1993, COMMUNICATION
   WOODWORTH JG, 1992, FUSION ENG, V2, P895
NR 113
TC 88
Z9 89
PU INT ATOMIC ENERGY AGENCY
PI VIENNA
PA WAGRAMERSTRASSE 5, PO BOX 100, A-1400 VIENNA, AUSTRIA
SN 0029-5515
J9 NUCL FUSION
JI Nucl. Fusion
PD JAN
PY 1996
VL 36
IS 1
BP 75
EP 116
DI 10.1088/0029-5515/36/1/I06
PG 42
WC Physics, Fluids & Plasmas; Physics, Nuclear
SC Physics
GA XV150
UT WOS:A1996XV15000006
ER

PT J
AU Mack, MJ
   Pfister, A
   Bachand, D
   Emery, R
   Magee, MJ
   Connolly, M
   Subramanian, V
AF Mack, MJ
   Pfister, A
   Bachand, D
   Emery, R
   Magee, MJ
   Connolly, M
   Subramanian, V
TI Comparison of coronary bypass surgery with and without cardiopulmonary
   bypass in patients with multivessel disease
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID OFF-PUMP; TRIALS
AB Background: Coronary artery bypass grafting can now be performed with or without cardiopulmonary bypass. Our objective was to determine whether off-pump coronary artery bypass grafting is associated with better early outcomes compared with conventional coronary artery bypass grafting.
   Methods: In 4 centers with off-pump coronary surgery experience, a retrospective analysis of all coronary artery bypass grafting in a 3-year period was performed. Groups were compared to determine selection criteria, mortality, and morbidity, then computer-matched by propensity score to control for selection bias. Multivariate logistic regression identified risk factors predictive of mortality. Specific subgroups most likely to benefit were identified.
   Results: In all, 17,401 isolated coronary artery bypass grafts were performed, 7283 (41.9%) off-pump coronary artery bypass grafts and 10,118 (58.1%) conventional coronary artery bypass with cardiopulmonary bypass. Factors determining selection of patients for off-pump coronary artery bypass grafting included female gender (55.5% vs 44.5%), preexisting renal failure (57.0% vs 43.0%), and reoperations (52.6% vs 47.4%). Operative mortality was 2.8%; off-pump coronary artery bypass grafting versus conventional coronary artery bypass with cardiopulmonary bypass (1.9% vs 3.5%, P < .001) had the same predicted risk. Of the patients with multivessel disease, 11,548 were matched by propensity scoring. Mortality was significantly less in the off-pump coronary artery bypass grafting group (2.8% vs 3.7%, P < .001). By multivariate logistic regression analysis of the matched sample, predictors for mortality were female gender (odds ratio 1.83, confidence interval 1.37-2.44), preexisting renal failure (odds ratio 2.85, confidence interval 2.64-4.95), history of stroke (odds ratio 1.74, confidence interval 1.08-2.80), previous coronary artery bypass grafting surgery (odds ratio 4.22, confidence interval 2.92-6.09), use of cardiopulmonary bypass (odds ratio 2.08, confidence interval 1.52-2.83), and recent myocardial infarction (odds ratio 2.31, confidence interval 1.68-3.22). Cardiopulmonary bypass was predictive of mortality in reoperations, female patients, and patients aged greater than or equal to 75 years. Off-pump coronary artery bypass grafting was associated with less morbidity, including reductions in blood transfusion (32.6% vs 40.6%, P < .001), stroke (1.4% vs 2.1%, P = .002), renal failure (2.6% vs 5.2%, P < .001), pulmonary complications (4.1% vs 9.5%, P < .001), reoperation (1.7% vs 3.2%, P < .001), atrial fibrillation (21.1% vs 24.99%, P < .001), and gastrointestinal complications (3.6% vs 4.8%, P = .02).
   Conclusion: In 4 centers with beating-heart operation experience, there is an overall early benefit in off-pump surgery, especially in patients traditionally considered at high risk for coronary artery bypass grafting.
C1 Med City Dallas Hosp, CRSTI, Dallas, TX USA.
   Lenox Hill Hosp, New York, NY 10021 USA.
   Cardiac Surg Associates PA, Minneapolis, MN USA.
   Washington Hosp Ctr, Washington, DC 20010 USA.
RP Mack, MJ (reprint author), 7777 Forest Lane,Suite A323, Dallas, TX 75230 USA.
EM mjmack@earthlink.net
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Bernstein AD, 2000, ANN THORAC SURG, V69, P823, DOI 10.1016/S0003-4975(99)01424-1
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   CAIRNS J, 1998, BMJ BOOKS, P17
   CONACTO J, 2000, NEW ENGL J MED, V342, P1887
   D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   Favaloro R G, 1970, Ann Thorac Surg, V10, P97
   Jansen EWL, 1998, J THORAC CARDIOV SUR, V116, P60, DOI 10.1016/S0022-5223(98)70243-0
   KOLESSOV VI, 1967, J THORAC CARDIOV SUR, V54, P535
   Omeroglu SN, 2000, ANN THORAC SURG, V70, P844, DOI 10.1016/S0003-4975(00)01567-8
   PFISTER AJ, 1992, ANN THORAC SURG, V54, P3085
   Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Rubin DB, 1997, ANN INTERN MED, V127, P757
   Subramanian V, 1995, CIRCULATION S, V92, P645
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
NR 17
TC 87
Z9 94
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD JAN
PY 2004
VL 127
IS 1
BP 167
EP 173
DI 10.1016/j.jtcvs.2003.08.032
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 770EG
UT WOS:000188709800025
PM 14752427
ER

PT J
AU Wilhelm, AJ
   Mijnhout, GS
   Franssen, EJF
AF Wilhelm, AJ
   Mijnhout, GS
   Franssen, EJF
TI Radiopharmaceuticals in sentinel lymph-node detection - an overview
SO EUROPEAN JOURNAL OF NUCLEAR MEDICINE
LA English
DT Article; Proceedings Paper
CT 1st International Congress on the Sentinel Node in Diagnosis and
   Treatment of Cancer
CY APR 07-10, 1999
CL AMSTERDAM, NETHERLANDS
DE sentinel node; Tc-99m-sulfur colloid; Tc-99m-antimony trisulfide
   colloid; Tc-99m-colloidal albumin; radiocolloids
ID INTRAOPERATIVE GAMMA-PROBE; INTERNAL MAMMARY LYMPHOSCINTIGRAPHY;
   BREAST-CANCER; DYNAMIC LYMPHOSCINTIGRAPHY; CUTANEOUS MELANOMA;
   QUANTITATIVE LYMPHOSCINTIGRAPHY; MALIGNANT-MELANOMA; BIOPSY;
   IDENTIFICATION; SYSTEM
AB Biopsy of the first tumour-draining lymph node (sentinel node, SN) is bound to become the procedure of choice in regional staging of melanoma and breast cancer patients. Several radiopharmaceuticals have been developed for lymphoscintigraphy. In this paper we review the most frequently used radiopharmaceuticals for their appropriateness in the sentinel-node procedure. We conclude that accurate localization of SNs is demonstrated using technetium-99m-sulfur colloid (Tc-99m-SC), Tc-99m antimony trisulfide colloid (Tc-99m-ATC) [10] and Tc-99m nanocolloidal albumin (Tc-99m-CA). Tc-99m-Ca and Tc-99m-SC are both available in Europe. In the United States Tc-99m-SC is the only registered tracer for lymphoscintigraphy.
C1 Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Hosp Pharm, NL-1007 MB Amsterdam, Netherlands.
   Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Nucl Med, NL-1007 MB Amsterdam, Netherlands.
RP Wilhelm, AJ (reprint author), Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Hosp Pharm, POB 7057, NL-1007 MB Amsterdam, Netherlands.
RI Wilhelm, A.J./C-4521-2008
CR ALAVI A, 1978, J NUCL MED, V19, P422
   Alazraki NP, 1997, SEMIN NUCL MED, V27, P55, DOI 10.1016/S0001-2998(97)80036-0
   Albertini JJ, 1996, ANN SURG, V223, P217, DOI 10.1097/00000658-199602000-00016
   Albertini JJ, 1996, JAMA-J AM MED ASSOC, V276, P1818, DOI 10.1001/jama.276.22.1818
   BENNETT LR, 1983, SEMIN NUCL MED, V13, P61, DOI 10.1016/S0001-2998(83)80037-3
   BERGQVIST L, 1983, SEMIN NUCL MED, V12, P9
   BERGQVIST L, 1982, J NUCL MED, V23, P698
   Borgstein P, 1998, J AM COLL SURGEONS, V186, P275, DOI 10.1016/S1072-7515(98)00011-8
   CYGNE A, 1996, SOLCO NANOCOLL KIT P
   CYGNE A, 1996, ALBU RES KIT PREPARA
   DRAGOTAKES SC, 1995, J NUCL MED S, V36, P80
   EGE GN, 1976, RADIOLOGY, V118, P101
   Eshima D, 1996, J NUCL MED, V37, P1575
   FEE HJ, 1978, SURGERY, V84, P626
   Glass EC, 1998, J NUCL MED, V39, P1185
   Goldfarb LR, 1998, RADIOLOGY, V208, P505
   HENZE E, 1982, J NUCL MED, V23, P923
   HUNG JC, 1995, J NUCL MED, V36, P1895
   IKOMI F, 1995, RADIOLOGY, V196, P107
   JAGER PL, 1998, EUR J NUCL MED, V25, P838
   KAPLAN WD, 1985, J NUCL MED, V26, P1382
   Kapteijn BAE, 1996, J NUCL MED, V37, P972
   Kapteijn BAE, 1997, J NUCL MED, V38, P362
   KATAOKA M, 1991, BRIT J RADIOL, V64, P1119
   KEELING DH, 1987, NUKLEARMED, V23, P478
   Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401
   LAMKI L M, 1989, Journal of Nuclear Medicine, V30, P844
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MEYER CM, 1979, RADIOLOGY, V131, P205
   Mudun A, 1996, RADIOLOGY, V199, P171
   OBRIEN CJ, 1995, AM J SURG, V170, P461, DOI 10.1016/S0002-9610(99)80330-4
   Paganelli G, 1998, Q J NUCL MED, V42, P49
   Pijpers R, 1997, WORLD J SURG, V21, P788
   Pijpers R, 1997, J NUCL MED, V38, P366
   PIJPERS R, 1995, EUR J NUCL MED, V22, P1238, DOI 10.1007/BF00801606
   Pijpers R, 1998, MELANOMA RES, V8, P413, DOI 10.1097/00008390-199810000-00005
   PONTO JA, 1987, J NUCL MED, V28, P1781
   SADEK S, 1989, LYMPHOLOGY, V22, P844
   SAHA G B, 1986, Journal of Nuclear Medicine Technology, V14, P149
   SMITH EM, 1967, J NUCL MED, V8, P896
   STEIGMAN J, CHEM TECHNETIUM MED
   STRAND SE, 1979, J NUCL MED, V20, P1038
   STRAND SE, 1989, CRIT REV THER DRUG, V6, P211
   Taylor A, 1996, CLIN NUCL MED, V21, P755, DOI 10.1097/00003072-199610000-00001
   UREN R, 1994, MED J AUSTRALIA, V161, P226
   UREN RF, 1993, J NUCL MED, V34, P1435
   UREN RF, 1995, J NUCL MED, V36, P1775
   Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0
   WANEBO HJ, 1985, CANCER, V55, P1403, DOI 10.1002/1097-0142(19850315)55:6<1403::AID-CNCR2820550640>3.0.CO;2-K
   Wong JH, 1998, ANN SURG ONCOL, V5, P77, DOI 10.1007/BF02303767
NR 50
TC 87
Z9 92
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0340-6997
J9 EUR J NUCL MED
JI Eur. J. Nucl. Med.
PD APR
PY 1999
VL 26
IS 4
SU S
BP S36
EP S42
DI 10.1007/PL00014793
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 185XJ
UT WOS:000079696000007
PM 10199931
ER

PT J
AU LAKS, H
   PEARL, JM
   HAAS, GS
   DRINKWATER, DC
   MILGALTER, E
   JARMAKANI, JM
   ISABELJONES, J
   GEORGE, BL
   WILLIAMS, RG
AF LAKS, H
   PEARL, JM
   HAAS, GS
   DRINKWATER, DC
   MILGALTER, E
   JARMAKANI, JM
   ISABELJONES, J
   GEORGE, BL
   WILLIAMS, RG
TI PARTIAL FONTAN - ADVANTAGES OF AN ADJUSTABLE INTERATRIAL COMMUNICATION
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 27TH ANNUAL MEETING OF THE SOC OF THORACIC SURGEONS
CY FEB 18-20, 1991
CL SAN FRANCISCO, CA
SP SOC THORAC SURGEONS
ID TRICUSPID ATRESIA; OPERATION; REPAIR; HEART; LESIONS
AB Systemic venous hypertension after the Fontan procedure is a major cause of mortality and morbidity, accounting for 11 of 16 deaths in our series of 228 Fontan procedures.  A partial Fontan with a residual atrial septal defect (ASD) would allow controlled right-to-left shunting to reduce venous pressure and improve cardiac output while maintaining a reduced but acceptable arterial oxygen saturation.  This allows complete or graded closure of the ASD after the discontinuation of cardiopulmonary bypass in the operating room or at any time in the postoperative period by exposing the snare under local anesthesia.  From 1987 to 1990, 36 patients undergoing the modified Fontan procedure had placement of an adjustable interatrial communication.  Indications for placement of an adjustable ASD included increased pulmonary artery pressures, increased pulmonary vascular resistance, reactive airway disease, previously increased or unknown pulmonary vascular resistance, small pulmonary arteries, and borderline ventricular function.  Fourteen patients had the adjustable ASD closed at the time of operation, 8 patients underwent narrowing, and 12 underwent closure of the ASD in the postoperative period.  Eight patients were discharged with the ASD partially open, and 2 patients underwent delayed closure.  The partial Fontan with an adjustable ASD may increase the safety of the Fontan procedure for high-risk groups such as those with increased pulmonary vascular resistance, pulmonary hypertension, and impaired left ventricular function and for infants, who tolerate venous hypertension poorly.  The ability to adjust the ASD in stages depending on the hemodynamic response increases flexibility and safety.
C1 UNIV CALIF LOS ANGELES,MED CTR,DIV PEDIAT CARDIOL,LOS ANGELES,CA 90024.
RP LAKS, H (reprint author), UNIV CALIF LOS ANGELES,MED CTR,DEPT SURG,DIV CARDIOTHORAC SURG,CHS 62-151,10833 LECONTE AVE,LOS ANGELES,CA 90024, USA.
CR ANNECCHINO FP, 1988, ANN THORAC SURG, V45, P430
   BILLINGSLEY AM, 1989, J THORAC CARDIOV SUR, V97, P746
   BRIDGES ND, 1990, CIRCULATION, V82, P1681
   Choussat A, 1978, PEDIAT CARDIOLOGY, P559
   CLEVELAND DC, 1984, ANN THORAC SURG, V38, P447
   DANIELSON GK, 1983, J THORAC CARDIOVASC, V85, P647
   DEBRUX JL, 1983, J THORAC CARDIOV SUR, V85, P440
   DELARIVIERE AB, 1983, J THORAC CARDIOV SUR, V85, P809
   DELEON SY, 1986, J THORAC CARDIOV SUR, V92, P402
   DELEON SY, 1986, J THORAC CARDIOV SUR, V92, P1029
   DEVIVIE ER, 1986, J THORAC CARDIOV SUR, V91, P690
   FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240
   FONTAN F, 1983, J THORAC CARDIOV SUR, V85, P647
   GALE AW, 1979, J THORAC CARDIOV SUR, V78, P831
   GALE AW, 1980, CIRCULATION, V62, P91
   GIROD DA, 1987, CIRCULATION, V75, P605
   GUYTON RA, 1985, CIRCULATION, V72, P97
   HAAS GS, 1990, ADV CARDIAC SURGERY, V1
   HECK HA, 1981, CIRCULATION, V64, P118
   HELGASON H, 1985, AM HEART J, V110, P705, DOI 10.1016/0002-8703(85)90117-6
   LAKS H, 1989, PERSPECTIVES PEDIATR
   Laks H, 1988, CIRCULATION S2, V78, P357
   LAKS H, 1980, J THORAC CARDIOVASC, V192, P382
   MAIR DD, 1985, CIRCULATION, V72, P1188
   MARCELLETTI C, 1980, J THORAC CARDIOV SUR, V80, P764
   MAYER JE, 1986, J THORAC CARDIOV SUR, V92, P1021
   MAYER JE, 1985, MODERN TECHNICS SURG
   MCAVOY MR, 1988, DIMENS CRIT CARE NUR, V7, P19
   SADE RM, 1983, J THORAC CARDIOVASC, V85, P809
   SANDERS SP, 1982, AM J CARDIOL, V49, P1733, DOI 10.1016/0002-9149(82)90253-3
   STEIN DG, 1991, J THORAC CARDIOV SUR, V102, P280
NR 31
TC 87
Z9 89
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD NOV
PY 1991
VL 52
IS 5
BP 1084
EP 1095
PG 12
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA GP868
UT WOS:A1991GP86800011
PM 1953128
ER

PT J
AU Decety, J
AF Decety, Jean
TI The Neurodevelopment of Empathy in Humans
SO DEVELOPMENTAL NEUROSCIENCE
LA English
DT Review
DE Affective neuroscience; Amygdala; Empathy; Theory of mind;
   Neurodevelopment; Orbitofrontal cortex; Ventromedial prefrontal cortex
ID FACIAL EXPRESSIONS; EMOTION REGULATION; COGNITIVE-DEVELOPMENT;
   PERSPECTIVE-TAKING; EXECUTIVE FUNCTION; DEVELOPING BRAIN; NEURAL BASES;
   CHILDREN; FEELINGS; BEHAVIOR
AB Empathy, which implies a shared interpersonal experience, is implicated in many aspects of social cognition, notably prosocial behavior, morality and the regulation of aggression. The purpose of this paper is to critically examine the current knowledge in developmental and affective neuroscience with an emphasis on the perception of pain in others. It will be argued that human empathy involves several components: affective arousal, emotion understanding and emotion regulation, each with different developmental trajectories. These components are implemented by a complex network of distributed, often recursively connected, interacting neural regions including the superior temporal sulcus, insula, medial and orbitofrontal cortices, amygdala and anterior cingulate cortex, as well as autonomic and neuroendocrine processes implicated in social behaviors and emotional states. Decomposing the construct of empathy into subcomponents that operate in conjunction in the healthy brain and examining their developmental trajectory provides added value to our current approaches to understanding human development. It can also benefit our understanding of both typical and atypical development. Copyright (c) 2010 S. Karger AG, Basel
C1 [Decety, Jean] Univ Chicago, Dept Psychol, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA.
   [Decety, Jean] Univ Chicago, Dept Psychiat, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA.
RP Decety, J (reprint author), Univ Chicago, Dept Psychol, Ctr Cognit & Social Neurosci, 5848 S Univ Ave, Chicago, IL 60637 USA.
EM decety@uchicago.edu
FU National Science Foundation [BCS-0718480]; NIH/National Institute of
   Mental Health [MH84934-01A1]
FX The writing of this paper was supported by a grant (BCS-0718480) from
   the National Science Foundation and a grant from the NIH/National
   Institute of Mental Health (MH84934-01A1).
CR Akitsuki Y, 2009, NEUROIMAGE, V47, P722, DOI 10.1016/j.neuroimage.2009.04.091
   Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709
   Bell M., 2007, SOCIOEMOTIONAL DEV T, P345
   Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525
   Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9
   Calkins SD, 2002, DEV PSYCHOPATHOL, V14, P477, DOI 10.1017/S0954579402003057
   Carlson SM, 2004, DEV PSYCHOL, V40, P1105, DOI 10.1037/0012-1649.40.6.1105
   CARROLL JJ, 1984, CHILD DEV, V55, P1486, DOI 10.2307/1130018
   Carter S. S., 2009, SOCIAL NEUROSCIENCE, P169
   Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011
   Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)0090-4
   Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/S1364-6613(04)00103-2
   Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187
   DECETY J, 2010, DEV SCI
   Decety J, 2008, NEUROPSYCHOLOGIA, V46, P2607, DOI 10.1016/j.neuropsychologia.2008.05.026
   Decety J., 2005, OTHER MINDS HUMANS B, P135
   Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503
   Decety J, 2010, EMOT REV, V2, P204, DOI 10.1177/1754073910361981
   de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003
   Dondi M, 1999, DEV PSYCHOL, V35, P418, DOI 10.1037//0012-1649.35.2.418
   Duncan S, 2007, COGNITION EMOTION, V21, P1184, DOI 10.1080/02699930701437931
   Eggum Natalie D., 2009, SOCIAL NEUROSCIENCE, P71
   Eisenberg N., 1991, HDB MORAL BEHAVIOR D, V2, P63
   FOX NA, 1994, MONOGR SOC RES CHILD, V59, pR5
   GROSS AL, 1991, DEV REV, V11, P368, DOI 10.1016/0273-2297(91)90019-K
   Gunnar M. R., 2009, HDB DEV SOCIAL NEURO, P3
   Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI DOI 10.1007/S11211-007-0034-Z
   HARRIS PL, 1981, J CHILD PSYCHOL PSYC, V22, P247, DOI 10.1111/j.1469-7610.1981.tb00550.x
   HARRIS PL, 1994, J CHILD PSYCHOL PSYC, V35, P3, DOI 10.1111/j.1469-7610.1994.tb01131.x
   HAVILAND JM, 1987, DEV PSYCHOL, V23, P97, DOI 10.1037/0012-1649.23.1.97
   Hodges S.D., 2001, J SOCIO EC, V30, P437, DOI DOI 10.1016/S1053-535(01)00112-3
   Hughes C, 1998, DEV PSYCHOL, V34, P1026, DOI 10.1037/0012-1649.34.5.1026
   Hurliman E, 2005, J NEUROSCI, V25, P4641, DOI 10.1523/JNEUROSCI.2563-04.2005
   Izard C. E., 1982, MEASURING EMOTIONS I
   Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013
   Killgore WDS, 2007, SOC NEUROSCI, V2, P28, DOI 10.1080/17470910701214186
   Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179
   Knight R. T., 2002, PRINCIPLES FRONTAL L, P446
   Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42
   Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554
   Lewis M., 2000, HDB EMOTIONS, P623
   Lewis MD, 2006, J COGNITIVE NEUROSCI, V18, P430, DOI 10.1162/089892906775990633
   LUDEMANN PM, 1988, DEV PSYCHOL, V24, P492, DOI 10.1037//0012-1649.24.4.492
   MacLean E D., 1987, FRONTAL LOBES REVISI, P121
   More B. S., 1990, MOTIV EMOTION, V14, P75
   Moriguchi Y, 2007, PSYCHIAT CLIN NEUROS, V61, pS10
   Nielsen L., 2002, Phenomenology and the Cognitive Sciences, V1, DOI 10.1023/A:1021359916894
   Nystrom P, 2008, SOC NEUROSCI, V3, P334, DOI 10.1080/17470910701563665
   Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212
   Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032
   Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65
   ROTHBART MK, 1994, MERRILL PALMER QUART, V40, P21
   Sabbagh MA, 2009, CHILD DEV, V80, P1147, DOI 10.1111/j.1467-8624.2009.01322.x
   Saxe RR, 2009, CHILD DEV, V80, P1197, DOI 10.1111/j.1467-8624.2009.01325.x
   Strum V. E., 2006, BRAIN, V129, P2508
   Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102
   Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013
   Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865
   Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322
   Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061
   Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009
   Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106
   Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005
NR 63
TC 86
Z9 88
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0378-5866
J9 DEV NEUROSCI-BASEL
JI Dev. Neurosci.
PY 2010
VL 32
IS 4
BP 257
EP 267
DI 10.1159/000317771
PG 11
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 694KS
UT WOS:000285297300001
PM 20805682
ER

PT J
AU Puskas, JD
   Thourani, VH
   Kilgo, P
   Cooper, W
   Vassiliades, T
   Vega, JD
   Morris, C
   Chen, E
   Schmotzer, BJ
   Guyton, RA
   Lattouf, OM
AF Puskas, John D.
   Thourani, Vinod H.
   Kilgo, Patrick
   Cooper, William
   Vassiliades, Thomas
   Vega, J. David
   Morris, Cullen
   Chen, Edward
   Schmotzer, Brian J.
   Guyton, Robert A.
   Lattouf, Omar M.
TI Off-Pump Coronary Artery Bypass Disproportionately Benefits High-Risk
   Patients
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 45th Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 26-28, 2009
CL San Francisco, CA
SP Soc Thorac Surg
ID ON-PUMP; SURGERY; MORTALITY; REVASCULARIZATION; MORBIDITY; OUTCOMES
AB Background. It is not known which patient subgroups may benefit most from off-pump coronary artery bypass grafting (OPCAB) rather than coronary artery bypass grafting on cardiopulmonary bypass (CPB).
   Methods. The Society of Thoracic Surgeons database was queried for all isolated, primary coronary artery bypass graft cases between January 1, 1997, and December 31, 2007, at a US academic center. The Society of Thoracic Surgeons Predicted Risk of Mortality (PROM) was calculated by a formula based on 30 preoperative risk factors. It was used in three ways to compare 30-day operative mortality between patients treated with OPCAB versus CPB. First, patients were divided into quartiles based on their PROM, and mortality rates were compared between OPCAB and CPB patients within each PROM quartile. Second, a logistic regression model tested for an interaction between surgery type and PROM; a significant interaction would indicate that the relative mortality risk of OPCAB versus CPB varied with different PROM levels. Finally, locally smoothed kernel regression curves were used to visually estimate a threshold PROM point at which mortality rates diverge for the surgery types.
   Results. There were 14,766 consecutive patients, 7,083 OPCAB (48.0%) and 7,683 CPB (52.0%). There was no difference in operative mortality between OPCAB and CPB for patients in the lower two risk quartiles. In the higher risk quartiles there was a mortality benefit for OPCAB (odds ratio, 0.62 and 0.45 for OPCAB in the third and fourth risk quartiles). Logistic regression analysis confirmed a significant interaction between surgery type and PROM (p = 0.005) meaning that OPCAB is especially beneficial to patients with higher PROM. This benefit is most significant for patients with PROM values above 2.5% to 3%, where mortality curves sharply diverge.
   Conclusions. Off-pump coronary artery bypass grafting is associated with lower operative mortality than coronary artery bypass grafting on CPB for higher risk patients. This mortality benefit increases with increasing PROM. (Ann Thorac Surg 2009;88:1142-7) (C) 2009 by The Society of Thoracic Surgeons
C1 Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30308 USA.
   Emory Univ, Clin Res Unit, Div Cardiothorac Surg, Atlanta, GA 30308 USA.
RP Puskas, JD (reprint author), Emory Univ, Emory Crawford Long Hosp, Div Cardiothorac Surg, 550 Peachtree St,6th Floor Med Off Tower, Atlanta, GA 30308 USA.
EM john.puskas@emoryhealthcare.org
CR Al-Ruzzeh S, 2003, EUR J CARDIO-THORAC, V23, P50, DOI 10.1016/S1010-7940(02)00654-1
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   *DUK CLIN RES I, 2008, SOC THOR SURG NAT AD
   Lattouf OM, 2007, ANN THORAC SURG, V84, P1485, DOI 10.1016/j.athoracsur.2007.06.035
   Magee MJ, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.cir.0000089187.51855.77
   Palmer G, 2007, ANN THORAC SURG, V83, P986, DOI 10.1016/j.athoracsur.2006.10.057
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas John, 2005, Innovations (Phila), V1, P3, DOI 10.1097/01243895-200500110-00002
   Puskas JD, 2007, CIRCULATION S11, V116, P192
   Puskas JD, 2007, ANN THORAC SURG, V84, P1447, DOI 10.1016/j.athoracsur.2007.06.104
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Sharoni E, 2006, HEART, V92, P499, DOI 10.1136/hrt.2005.062778
   Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6
   Song HK, 2003, EUR J CARDIO-THORAC, V24, P947, DOI 10.1016/S1010-7940(03)00616-X
   TREHAN N, 2001, ANN THORAC SURG, V72, P1026
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
NR 17
TC 86
Z9 88
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD OCT
PY 2009
VL 88
IS 4
BP 1142
EP 1147
DI 10.1016/j.athoracsur.2009.04.135
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 501NL
UT WOS:000270388500014
PM 19766798
ER

PT J
AU Al-Ruzzeh, S
   George, S
   Bustami, M
   Wray, J
   Ilsley, C
   Athanasiou, T
   Amrani, M
AF Al-Ruzzeh, S
   George, S
   Bustami, M
   Wray, J
   Ilsley, C
   Athanasiou, T
   Amrani, M
TI Effect of off-pump coronary artery bypass surgery on clinical,
   angiographic, neurocognitive, and quality of life outcomes: randomised
   controlled trial
SO BRITISH MEDICAL JOURNAL
LA English
DT Article
ID CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; GRAFT-SURGERY;
   REVASCULARIZATION; MORBIDITY; OPERATION; RISK
AB Objective To compare the clinical, angiographic, neurocognitive, and quality of life outcomes of off-pump coronary artery bypass surgery with conventional coronary artery bypass grafting surgery using cardiopulmonary bypass.
   Design Randomised controlled clinical trial.
   Setting Tertiary cardiothoracic centre in Middlesex, England.
   Participants 168 patients (27 women) requiring primary isolated coronary artery bypass grafting surgery.
   Interventions Patients were randomised to conventional coronary artery bypass grafting surgery using cardiopulmonary bypass (n = 84) or off-pump coronary artery bypass surgery (n = 84), carried out by one surgeon. Angiographic examination was carried out at three months postoperatively. Neurocognitive tests were carried out at baseline and at six weeks and six months postoperatievely.
   Main outcome measures Clinical outcome, graft patency at three months, neurocognitive function at six weeks and six months, and health related quality of life.
   Results Graft patency was evaluated by angiography in 151 (89.9%) patients and was similar between the cardiopulmonary bypass and off-pump groups (risk difference - 1%, 95% confidence interval - 5% to 4% with the off-pump group considered the treatment group. Patients in the off-pump group required fewer blood transfusions (1.7 units v 1.0 unit, P = 0.02), shorter duration of mechanical ventilation (7.7 hours v 3.9 hours, P = 0.03), and shorter hospital stay (10.8 days v 8.9 days). Scores for neurocognitive function showed * significant difference in three memory subtests at six weeks and two memory subtests at six months in favour of the off-pump group.
   Conclusions Patients who underwent off-pump coronary artery bypass surgery showed similar patency of grafts, better clinical outcome, shorter hospital stay, and better neurocognitive function than patients who underwent conventional coronary artery bypass grafting surgery using cardiopulmonary bypass.
C1 Harefield Hosp, Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield UB9 6JH, Middx, England.
RP Amrani, M (reprint author), Harefield Hosp, Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield UB9 6JH, Middx, England.
EM mohamedamrani@hotmail.co.uk
CR Al-Ruzzeh S, 2002, ANN THORAC SURG, V73, P1431, DOI 10.1016/S0003-4975(02)03399-4
   Al-Ruzzeh S, 2002, J THORAC CARDIOV SUR, V123, P525, DOI 10.1067/mtc.2002.119059
   Al-Ruzzeh S, 2005, J CARDIAC SURG, V20, P1, DOI 10.1111/j.0886-0440.2005.05003.x
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Anyanwu AC, 2002, ANN THORAC SURG, V73, P798, DOI 10.1016/S0003-4975(01)03415-4
   Browne SM, 1999, J THORAC CARDIOV SUR, V117, P481, DOI 10.1016/S0022-5223(99)70327-2
   BUCHER H, 2002, USERS GUIDE MED LIT, P393
   Collie A, 2002, ANN THORAC SURG, V73, P2005, DOI 10.1016/S0003-4975(01)03375-6
   Cox CM, 2000, ANN THORAC SURG, V69, P140, DOI 10.1016/S0003-4975(99)01196-0
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Grigore AM, 2001, ANESTHESIOLOGY, V95, P1110, DOI 10.1097/00000542-200111000-00014
   Grigore AM, 2002, ANESTH ANALG, V94, P4, DOI 10.1097/00000539-200201000-00002
   Gundry SR, 1998, J THORAC CARDIOV SUR, V115, P1273, DOI 10.1016/S0022-5223(98)70209-0
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   McKhann GM, 1997, ANN THORAC SURG, V63, P516
   MOODY DM, 1990, ANN NEUROL, V28, P477, DOI 10.1002/ana.410280403
   MURKIN JM, 1995, J THORAC CARDIOV SUR, V110, P349, DOI 10.1016/S0022-5223(95)70230-X
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Omeroglu SN, 2000, ANN THORAC SURG, V70, P844, DOI 10.1016/S0003-4975(00)01567-8
   Onorati F, 2005, ANN THORAC SURG, V79, P837, DOI 10.1016/j.athorascur.2004.07.060
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Snapinn SM, 2000, CURR CONTR TRIALS C, V1, P19, DOI 10.1186/CVM-1-1-019
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Taggart DP, 2001, CURR OPIN CARDIOL, V16, P271, DOI 10.1097/00001573-200109000-00003
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   van Dijk D, 2004, HEART, V90, P431, DOI 10.1136/hrt.2003.010173
   Power M, 1998, SOC SCI MED, V46, P1569
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 32
TC 85
Z9 94
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0959-8146
J9 BRIT MED J
JI Br. Med. J.
PD JUN 10
PY 2006
VL 332
IS 7554
BP 1365
EP 1368
DI 10.1136/bmj.38852.479907.7C
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA 057HN
UT WOS:000238587000018
PM 16740529
ER

PT J
AU Kerr, M
   Stattin, H
   Burk, WJ
AF Kerr, Margaret
   Stattin, Hakan
   Burk, William J.
TI A Reinterpretation of Parental Monitoring in Longitudinal Perspective
SO JOURNAL OF RESEARCH ON ADOLESCENCE
LA English
DT Article
ID ADOLESCENT PROBLEM BEHAVIOR; SUBSTANCE USE; YOUNG ADOLESCENTS;
   ANTISOCIAL-BEHAVIOR; DELINQUENT-BEHAVIOR; SELF-DISCLOSURE; RISK
   BEHAVIORS; ALCOHOL-USE; KNOWLEDGE; ADJUSTMENT
AB A commonly used measure of parental monitoring is parents' knowledge of adolescents' daily activities. This measure has been criticized on the grounds that parents get more knowledge about teenagers' daily activities through willing youth disclosure than through their own active monitoring efforts, but this claim was based on cross-sectional data. In the present study, we reexamine this claim with longitudinal data over 2 years from 938 seventh and eighth graders and their parents. Youth disclosure was a significant longitudinal predictor of parental knowledge in single- and cross-rater models. Neither measure of parents' monitoring efforts-control or solicitation-was a significant predictor. In analyses involving delinquency, parental monitoring efforts did not predict changes in delinquency over time, but youth disclosure did. We conclude that because knowledge measures do not seem to represent parental monitoring efforts, the conclusions from studies using these measures should be reinterpreted.
C1 [Kerr, Margaret] Univ Orebro, Res Dev Ctr, JPS Psychol, S-70182 Orebro, Sweden.
RP Kerr, M (reprint author), Univ Orebro, Res Dev Ctr, JPS Psychol, S-70182 Orebro, Sweden.
EM margaret.kerr@oru.se
RI Burk, William/D-6521-2012
CR Barnes GA, 2005, PSYCHOL ADDICT BEHAV, V19, P165, DOI 10.1037/0893-164X.19.2.165
   Barnes GM, 2006, J MARRIAGE FAM, V68, P1084, DOI 10.1111/j.1741-3737.2006.00315.x
   BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238
   Borawski EA, 2003, J ADOLESCENT HEALTH, V33, P60, DOI 10.1016/S1054-139X(03)00100-9
   Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002001
   Chamberlain P, 1998, J CONSULT CLIN PSYCH, V66, P624, DOI 10.1037/0022-006X.66.4.624
   COLLINS NL, 1994, PSYCHOL BULL, V116, P457, DOI 10.1037/0033-2909.116.3.457
   Crouter AC, 2005, CHILD DEV, V76, P869, DOI 10.1111/j.1467-8624.2005.00883.x
   Crouter A.C., 2002, HDB PARENTING, V3, P461
   DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363
   Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380
   Dishion TJ, 1999, AM PSYCHOL, V54, P755, DOI 10.1037//0003-066X.54.9.755
   Dishion TJ, 2003, BEHAV THER, V34, P553, DOI 10.1016/S0005-7894(03)80035-7
   Dishion TJ, 2004, J ADOLESCENCE, V27, P515, DOI 10.1016/j.adolescence.2004.06.005
   Eamon MK, 2005, AM J ORTHOPSYCHIAT, V75, P117, DOI 10.1037/0002-9432.75.1.117
   Eddy JM, 2000, J CONSULT CLIN PSYCH, V68, P857, DOI 10.1037/0022-006X.68.5.857
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Forgatch M. S., 1999, TIDSSKRIFT NORSK PSY, V10, P923
   Harakeh Z, 2004, PREV MED, V39, P951, DOI 10.1016/j.ypmed.2004.03.036
   Hirschi T., 1969, CAUSES DELINQUENCY
   Hu L, 1999, STRUCTURAL EQUATION, V6, P55
   Huey SJ, 2000, J CONSULT CLIN PSYCH, V68, P451, DOI 10.1037//0022-006X.68.3.451
   Kerr M., 2008, WHAT CAN PARENTS DO, P91, DOI DOI 10.1002/9780470774113.CH4
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   Marshall SK, 2005, J ADOLESCENCE, V28, P633, DOI 10.1016/j.adolescence.2005.08.008
   MCCORD J, 1994, INT J BEHAV DEV, V17, P739
   Muthen LK, 2006, MPLUS USERS GUIDE
   Nash SG, 2005, J ADOLESCENT HEALTH, V37, P19, DOI 10.1016/j.jadohealth.2004.06.004
   PIKO BF, 2005, EUROPEAN CHILD ADOLE, V14, P65
   Ramirez JR, 2004, PSYCHOL ADDICT BEHAV, V18, P3, DOI 10.1037/0893-164X.18.1.3
   Richards MH, 2004, J YOUTH ADOLESCENCE, V33, P221, DOI 10.1023/B:JOYO.0000025321.27416.f6
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037//0033-2909.86.3.638
   Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Siebenbruner J, 2006, DEV PSYCHOPATHOL, V18, P551, DOI 10.1017/S0954579406060287
   Soenens B, 2006, DEV PSYCHOL, V42, P305, DOI 10.1073/0012-1649.42.2.305
   Stanton BF, 2000, J ADOLESCENT HEALTH, V26, P18, DOI 10.1016/S1054-139X(99)00022-1
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Kerr M, 2003, CHILDREN'S INFLUENCE ON FAMILY DYNAMICS: THE NEGLECTED SIDE OF FAMILY RELATIONSHIPS, P121
   TUCKER HH, 1973, BRIT MED J, V1, P10
   Waizenhofer RN, 2004, J FAM PSYCHOL, V18, P348, DOI 10.1037/0893-3200.18.2.348
   Webb JA, 2002, AM J ORTHOPSYCHIAT, V72, P392, DOI 10.1037//0002-9432.72.3.392
NR 43
TC 84
Z9 84
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1050-8392
J9 J RES ADOLESCENCE
JI J. Res. Adolesc.
PY 2010
VL 20
IS 1
BP 39
EP 64
DI 10.1111/j.1532-7795.2009.00623.x
PG 26
WC Family Studies; Psychology, Developmental
SC Family Studies; Psychology
GA 557WO
UT WOS:000274701000004
ER

PT J
AU Pollack, A
   Zagars, GK
   Antolak, JA
   Kuban, DA
   Rosen, II
AF Pollack, A
   Zagars, GK
   Antolak, JA
   Kuban, DA
   Rosen, II
TI Prostate biopsy status and PSA nadir level as early surrogates for
   treatment failure: Analysis of a prostate cancer randomized radiation
   dose escalation trial
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE radiation dose; prostate-specific antigen nadir; prostate biopsy
ID EXTERNAL-BEAM RADIATION; DEFINES DISEASE FREEDOM; BIOCHEMICAL FAILURE;
   FOLLOW-UP; CONFORMAL RADIOTHERAPY; RADICAL PROSTATECTOMY; ANTIGEN NADIR;
   FREE SURVIVAL; THERAPY; CARCINOMA
AB Purpose: A positive biopsy after external beam radiotherapy in patients free of any evidence of treatment failure is not synonymous with eventual recurrence. Although biopsy positivity is a predictor of outcome, the utility of biopsy status as a surrogate end point, the effect of radiation dose on biopsy status, and the interrelationships of these associations to prostate-specific antigen (PSA) nadir level are not well-defined. These issues were investigated in a cohort of men with Stage T1-T3 prostate cancer who were randomized to receive between 70 Gy and 78 Gy and were prospectively biopsied at about 2 years after the completion of radiotherapy (RT).
   Methods and Materials: Of the 301 assessable patients in the trial, 168 underwent planned sextant or greater prostate post-RT biopsies in the absence of biochemical or clinical failure; this group constituted the study cohort. Of the 168 patients, 87 were in the 70-Gy arm and 81 in the 78-Gy arm. Biopsies were classified into four groups: negative (no tumor), atypical/suspicious cells (not diagnostic of carcinoma), carcinoma with treatment effect (CaTxEffect), and carcinoma without treatment effect (CaNoTxEffect). Any diagnosis of carcinoma in the specimen was classified as biopsy positive. Freedom from failure (FFF) included biochemical failure and/or clinical failure. Kaplan-Meier curves were calculated from the completion of RT. For those alive in the study cohort, the median follow-up was 65 months.
   Results: The rate of biopsy without tumor was 42%; with atypical cells, it was 28%, with CaTxEffect 21%, and with CaNoTxEffect 9%. The overall biopsy positivity rate (CaTxEffect + CaNoTxEffect) was 30%; 28% in the 70-Gy group and 32% in the 78-Gy group (p = 0.52). The distribution of PSA nadir levels was 73% less than or equal to 0.5, 20% > 0.5-1.0, 5% > 1.0 -2.0, and 1% > 2.0 ng/mL. Significantly more patients randomized to 78 Gy had a PSA nadir of less than or equal to 0.5 ng/mL (80 % vs. 67 %; p = 0.02). No relationship was found between PSA nadir level and prostate biopsy status. The 5-year FFF rate for those classified as biopsy negative was 84 % and for those biopsy positive was 60 % (p = 0.0002). Radiation dose did not significantly alter FFF rates by prostate biopsy status. Nadir PSA level correlated with FFF, although this was dependent on the inclusion of the 2 patients with a PSA nadir > 2.0 ng/mL.
   Conclusion: For patients free of treatment failure at the time of prostate biopsy 2 years after RT, the prognosis of no tumor cells was the same as that of atypical/suspicious cells and CaTxEffect was the same as CaNoTxEffect. The biopsy positivity rate was not altered by dose, suggesting that most of the outcome differences between the 70-Gy and 78-Gy groups were due to events occurring before prostate biopsy at 2 years and/or were not entirely dependent on biopsy status. Biopsy status,is a strong prognostic factor, but, as an early end point, it may be misleading. PSA nadir appears to have little clinical value in patients treated to doses of 2:70 Gy who are failure free 2 years after RT. (C) 2002 Elsevier Science Inc.
C1 Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.
RP Pollack, A (reprint author), Fox Chase Canc Ctr, Dept Radiat Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 1998, MAYO CLIN PROC, V73, P401
   Connell PP, 1999, UROLOGY, V54, P875, DOI 10.1016/S0090-4295(99)00253-8
   COX DR, 1984, ANAL SURVIVAL DATA, P110
   COX JD, 1983, INT J RADIAT ONCOL, V9, P299
   Cox JD, 1999, J CLIN ONCOL, V17, P1155
   Cox J D, 1983, Semin Urol, V1, P237
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I
   CROOK JM, 1995, UROLOGY, V45, P624, DOI 10.1016/S0090-4295(99)80054-5
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   DUGAN TC, 1991, J UROLOGY, V146, P1313
   Flemming ID, 1997, AJCC CANC STAGING MA, P219
   Hankey BF, 1999, J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Hanlon AL, 2000, INT J RADIAT ONCOL, V46, P559, DOI 10.1016/S0360-3016(99)00450-2
   HARRIS EK, 1991, SURVIVORSHIP ANAL CL, P5
   HERR HW, 1982, PROSTATE, V3, P339, DOI 10.1002/pros.2990030404
   Jhaveri FM, 1999, J CLIN ONCOL, V17, P3167
   Kattan MW, 2000, INT J RADIAT ONCOL, V48, P1469, DOI 10.1016/S0360-3016(00)01359-6
   KAVADI VS, 1994, INT J RADIAT ONCOL, V30, P279
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   KUBAN DA, 1992, INT J RADIAT ONCOL, V24, P409
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   Martinez AA, 2000, INT J RADIAT ONCOL, V47, P343, DOI 10.1016/S0360-3016(00)00436-3
   Perez CA, 2001, INT J RADIAT ONCOL, V49, P1287, DOI 10.1016/S0360-3016(00)01492-9
   Pollack A, 2000, J CLIN ONCOL, V18, P3904
   Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8
   Pollack A, 1996, INT J RADIAT ONCOL, V34, P555, DOI 10.1016/0360-3016(95)02103-5
   PRESTIDGE BR, 1992, INT J RADIAT ONCOL, V24, P403
   Ragde H, 2001, Arch Esp Urol, V54, P739
   RHAMY RK, 1972, J UROLOGY, V107, P627
   Scardino PT, 1988, NATL CANCER I MONOGR, V7, P95
   SCHELLHAMMER PF, 1987, J UROLOGY, V137, P897
   Taylor JMG, 2001, INT J RADIAT ONCOL, V50, P1212, DOI 10.1016/S0360-3016(01)01571-1
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
   Vicini FA, 2000, CANCER, V88, P2305, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2305::AID-CNCR15>3.0.CO;2-3
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P21, DOI 10.1016/0360-3016(95)00566-H
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   ZAGARS GK, 1992, INT J RADIAT ONCOL, V23, P47
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V33, P23, DOI 10.1016/0360-3016(95)00154-Q
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
NR 46
TC 84
Z9 86
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD NOV 1
PY 2002
VL 54
IS 3
BP 677
EP 685
DI 10.1016/S0360-3016(02)02977-2
PG 9
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 606CG
UT WOS:000178715200010
PM 12377318
ER

PT J
AU Wessel, I
   Meeren, M
   Peeters, F
   Arntz, A
   Merckelbach, H
AF Wessel, I
   Meeren, M
   Peeters, F
   Arntz, A
   Merckelbach, H
TI Correlates of autobiographical memory specificity: the role of
   depression, anxiety and childhood trauma
SO BEHAVIOUR RESEARCH AND THERAPY
LA English
DT Article
DE autobiographical memory specificity; mood disorders; trauma
ID POSTTRAUMATIC-STRESS-DISORDER; INTELLIGENCE; ABUSE
AB The present study examined the role of childhood trauma, major depressive disorder (MDD), and anxiety disorder (AD) in overgeneral autobiographical memory. Ninety-three outpatients and 24 healthy controls completed a childhood trauma questionnaire and an autobiographical memory test (AMT), Results showed that MDD diagnosis rather than trauma history predicted AMT-performance. Memory specificity was not related to AD diagnosis, recovered MDD, or self-rated depression severity. The present findings cast doubts on theories that emphasize the role of childhood trauma in overgeneral autobiographical memory. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Maastricht Univ, Dept Psychol, NL-6200 MD Maastricht, Netherlands.
   Maastricht Univ, Dept Med Clin & Expt Psychol, NL-6200 MD Maastricht, Netherlands.
   Maastricht Univ, Dept Psychiat & Neuropsychiat, NL-6200 MD Maastricht, Netherlands.
RP Wessel, I (reprint author), Maastricht Univ, Dept Psychol, POB 616, NL-6200 MD Maastricht, Netherlands.
RI Arntz, Arnoud/M-3011-2013
OI Arntz, Arnoud/0000-0002-7992-2272
CR Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012
   BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132
   BERNSTEIN DP, 1995, MANUAL CHILDHOOD TRA
   Brewin CR, 1999, J ABNORM PSYCHOL, V108, P511, DOI 10.1037/0021-843X.108.3.511
   BRITTLEBANK AD, 1993, BRIT J PSYCHIAT, V162, P118, DOI 10.1192/bjp.162.1.118
   BURKE M, 1992, COGNITION EMOTION, V6, P23, DOI 10.1080/02699939208411056
   First M. B., 1997, STRUCTURED CLIN INTE
   Fleiss J. L., 1986, DESIGN ANAL CLIN EXP
   Goddard L, 1996, J ABNORM PSYCHOL, V105, P609, DOI 10.1037/0021-843X.105.4.609
   Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P500, DOI 10.1037/0022-006X.66.3.500
   Kupka R. W., 1999, GESTRUCTUREERD KLIN
   KUYKEN W, 1995, BRIT J CLIN PSYCHOL, V34, P89
   KUYKEN W, 1995, J ABNORM PSYCHOL, V104, P585, DOI 10.1037//0021-843X.104.4.585
   Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323
   MCNALLY RJ, 1995, BEHAV RES THER, V33, P629
   MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936
   MCNALLY RJ, 1994, COGNITION EMOTION, V8, P351, DOI 10.1080/02699939408408946
   MERCKELBACH H, 1996, BEHAV COGN PSYCHOTH, V24, P109
   MOORE RG, 1988, BRIT J CLIN PSYCHOL, V27, P275
   Phillips S, 1997, BRIT J CLIN PSYCHOL, V36, P341
   Reynolds M, 1999, BEHAV RES THER, V37, P201, DOI 10.1016/S0005-7967(98)00132-6
   SIDLEY GL, 1997, BEHAV COGN PSYCHOTH, V25, P195
   Spitzer RL, 1986, STRUCTURED CLIN INTE
   Wilhelm S, 1997, BRIT J CLIN PSYCHOL, V36, P21
   WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144
   Williams J. M. G., 1996, REMEMBERING OUR STUD
   Williams JMG, 1988, COGNITION EMOTION, V2, P221, DOI 10.1080/02699938808410925
   WILLIAMS JMG, 1988, PSYCHOL MED, V18, P689
   Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
NR 30
TC 83
Z9 85
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0005-7967
J9 BEHAV RES THER
JI Behav. Res. Ther.
PD APR
PY 2001
VL 39
IS 4
BP 409
EP 421
DI 10.1016/S0005-7967(00)00011-5
PG 13
WC Psychology, Clinical
SC Psychology
GA 411DT
UT WOS:000167483400003
PM 11280340
ER

PT J
AU Kennedy, JE
   Jaffee, MS
   Leskin, GA
   Stokes, JW
   Leal, FO
   Fitzpatrick, PJ
AF Kennedy, Jan E.
   Jaffee, Michael S.
   Leskin, Gregory A.
   Stokes, James W.
   Leal, Felix O.
   Fitzpatrick, Pamela J.
TI Posttraumatic stress disorder and posttraumatic stress disorder-like
   symptoms and mild traumatic brain injury
SO JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT
LA English
DT Review
DE biological factors; blast concussion; clinical course; comorbidity;
   concussion; incidence; mild traumatic brain injury; rehabilitation;
   posttraumatic stress disorder; traumatic brain injury; treatment
ID MOTOR-VEHICLE ACCIDENTS; NATIONAL COMORBIDITY SURVEY; EYE-MOVEMENT
   DESENSITIZATION; RANDOMIZED CLINICAL-TRIAL; VIETNAM COMBAT VETERANS;
   FLUID-PERCUSSION INJURY; ROAD TRAFFIC ACCIDENTS; MENTAL-HEALTH PROBLEMS;
   CLOSED-HEAD INJURY; GULF-WAR VETERANS
AB In this article, we review the literature on posttraumatic stress disorder (PTSD) and PTSD-like symptoms that can occur along with mild traumatic brain injury (TBI) and concussion, with specific reference to concussive injuries in the military. We address four major areas: (1) clinical aspects of TBI and PTSD, including diagnostic criteria, incidence, predictive factors, and course; (2) biological interface between PTSD and TBI; (3) comorbidity between PTSD and other mental disorders that can occur after mild TBI; and (4) current treatments for PTSD, with specific considerations related to treatment for patients with mild TBI or concussive injuries.
C1 [Kennedy, Jan E.; Jaffee, Michael S.; Stokes, James W.; Leal, Felix O.; Fitzpatrick, Pamela J.] Wilford Hall USAF Med Ctr, Def & Vet Brain Injury Ctr, Lackland AFB, TX 78236 USA.
   [Leskin, Gregory A.] Vet Affairs Palo Alto Hlth Care Syst, Educ & Clin Lab, Natl Ctr Posttraumat Stress Disorder, Palo Alto, CA USA.
   Brooke Army Med Ctr, Dept Behav Med, Psychiat Serv, Ft Sam Houston, TX 78234 USA.
RP Kennedy, JE (reprint author), Wilford Hall USAF Med Ctr, Def & Vet Brain Injury Ctr, 59MHS SGON,2200 Berguist Dr,Suite 1, Lackland AFB, TX 78236 USA.
EM janlizkennedy@yahoo.com
CR ADLER AB, 1994, POST TRAUMATIC STRES
   Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x
   *AM PSYCHIAT ASS, 1980, DSM 3 DIAGN STAT MAN
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P463
   Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9
   Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5
   Beckham JC, 1996, J TRAUMA STRESS, V9, P335, DOI 10.1007/BF02110665
   Beckham JC, 2002, ANN BEHAV MED, V24, P219, DOI 10.1207/S15324796ABM2403_07
   Benight CC, 2002, J TRAUMA STRESS, V15, P177, DOI 10.1023/A:1015295025950
   Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353
   Bernat JA, 1998, J TRAUMA STRESS, V11, P645, DOI 10.1023/A:1024485130934
   Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683
   Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402
   Black DW, 2006, CNS SPECTRUMS, V11, P29
   BLEIBERG J, 1991, HDB CLIN PSYCHOL MED, P375
   Boehnlein James K, 2007, J Psychiatr Pract, V13, P72, DOI 10.1097/01.pra.0000265763.79753.c1
   Brady KT, 2000, J CLIN PSYCHIAT, V61, P22
   Bremner JD, 1996, AM J PSYCHIAT, V153, P369
   Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2
   BREMNER JD, 1995, AM J PSYCHIAT, V152, P973
   Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626
   Breslau N, 2001, J CLIN PSYCHIAT, V62, P16
   Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044
   Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748
   Brewin CR, 1999, AM J PSYCHIAT, V156, P360
   Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295
   Bromet E, 1998, AM J EPIDEMIOL, V147, P353
   Bruns John Jr., 2003, Epilepsia, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x
   Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006
   Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836
   Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4
   Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585
   Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629
   BRYANT RA, 1995, PSYCHOL MED, V25, P869
   Bryant RA, 2005, PSYCHOL SCI, V16, P749, DOI 10.1111/j.1467-9280.2005.01608.x
   Butterfield MI, 2000, J TRAUMA STRESS, V13, P735, DOI 10.1023/A:1007874620024
   Cahill SP, 2006, J TRAUMA STRESS, V19, P597, DOI 10.1002/jts.20173
   Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017
   Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195
   Chilcoat HD, 1998, ARCH GEN PSYCHIAT, V55, P913, DOI 10.1001/archpsyc.55.10.913
   CZEH B, 2005, NEUROPSYCHOPHARMACOL, V31, P1616
   Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135
   Davidson PR, 2001, J CONSULT CLIN PSYCH, V69, P305, DOI 10.1037//0022-006X.69.2.305
   Davis JL, 2007, J TRAUMA STRESS, V20, P123, DOI 10.1002/jts.20199
   *DEP VET AFF OFF Q, 2006, POST TRAUM STRESS DI
   *DEP VET AFF VHA O, 2007, VET HLTH IN
   Devilly GJ, 2005, AUST NZ J PSYCHIAT, V39, P437, DOI 10.1080/j.1440-1614.2005.01601.x
   Dikel TN, 2005, J TRAUMA STRESS, V18, P69, DOI 10.1002/jts.20002
   DIKEMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80
   Dirkzwager AJE, 2001, J NERV MENT DIS, V189, P846, DOI 10.1097/00005053-200112000-00006
   DJW McMinn, 2003, HIP INT S2, V13, P1
   Dougall AL, 2001, PSYCHOSOM MED, V63, P402
   ELOFSSON UO, 2007, J ANXIETY DISORD
   Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2
   Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25
   Feinstein A, 2000, BRAIN COGNITION, V44, P78
   Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005
   Friedman MJ, 2000, J CLIN PSYCHIAT, V61, P44
   Frommberger UH, 1998, EUR ARCH PSY CLIN N, V248, P316, DOI 10.1007/s004060050057
   Frueh BC, 1997, J CLIN PSYCHOL, V53, P871
   Fuchs E, 2006, FRONT BIOSCI, V11, P2746, DOI 10.2741/2004
   Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317
   Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963
   Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5
   Gray MJ, 2004, J CONSULT CLIN PSYCH, V72, P909, DOI 10.1037/0022-006X.72.5.909
   Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011
   Hageman I, 2001, ACTA PSYCHIAT SCAND, V104, P411, DOI 10.1034/j.1600-0447.2001.00237.x
   Harvey AG, 1999, J TRAUMA STRESS, V12, P519, DOI 10.1023/A:1024723205259
   Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626
   Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069
   Heinrichs M, 2005, AM J PSYCHIAT, V162, P2276, DOI 10.1176/appi.ajp.162.12.2276
   Hickling EJ, 1998, BRAIN INJURY, V12, P265
   Hiott DW, 2002, NEUROREHABILITATION, V17, P345
   Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023
   Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603
   Holbourn AHS, 1943, LANCET, V2, P438
   HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243
   HOVLAND D, 2000, NEUROPSYCHOLOGICAL M, P9
   Huppert JD, 2005, J ANXIETY DISORD, V19, P127, DOI 10.1016/j.janxdis.2004.01.001
   Johnson DR, 2004, J NERV MENT DIS, V192, P35, DOI 10.1097/01.nmd.0000105998.90425.6a
   Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136
   Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372
   Karakucuk EI, 1997, NEUROPEPTIDES, V31, P259, DOI 10.1016/S0143-4179(97)90057-3
   Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86
   Kessler RC, 1994, ARCH GEN PSYCHIAT, V1, P8
   KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048
   Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617
   Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4
   Kessler RC., 2000, J CLIN PSYCHIAT S5, V61, P13
   King NS, 2002, BRAIN INJURY, V16, P65, DOI 10.1080/02699050110088263
   King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82
   Klein E, 2003, CAN J PSYCHIAT, V48, P28
   Koenen KC, 2003, J CONSULT CLIN PSYCH, V71, P980, DOI 10.1037/0022-006X.71.6.980
   Koenen KC, 2002, J NERV MENT DIS, V190, P209, DOI 10.1097/01.NMD.0000012868.95340.32
   Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276
   Koren D, 1999, AM J PSYCHIAT, V156, P367
   Koren D, 2001, BEHAV RES THER, V39, P1449, DOI 10.1016/S0005-7967(01)00025-0
   Kulka R. A., 1990, TRAUMA VIETNAM WAR G
   Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920
   Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754
   Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465
   Malt U F, 1992, Psychiatr Med, V10, P117
   Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045
   MAYOU R, 1993, BRIT MED J, V307, P647
   Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540
   McFarlane AC, 1997, ANN NY ACAD SCI, V821, P437, DOI 10.1111/j.1749-6632.1997.tb48299.x
   McFarlane AC, 2000, J CLIN PSYCHIAT, V61, P15
   McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532
   McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016
   McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030
   Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047
   MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9
   North Carol S, 2004, Ann Clin Psychiatry, V16, P209, DOI 10.1080/10401230490522034
   North CS, 2004, J NERV MENT DIS, V192, P823, DOI 10.1097/01.nmd.0000146911.52616.22
   Novaco RW, 2002, J TRAUMA STRESS, V15, P123, DOI 10.1023/A:1014855924072
   Nutt DJ, 2004, J CLIN PSYCHIAT, V65, P11
   Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106
   Orcutt HK, 2004, J TRAUMA STRESS, V17, P195, DOI 10.1023/B:JOTS.0000029262.42865.c2
   Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52
   Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467
   Pearlstein T, 2000, J CLIN PSYCHIAT, V61, P40
   Perkonigg A, 2005, AM J PSYCHIAT, V162, P1320, DOI 10.1176/appi.ajp.162.7.1320
   Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213
   PITMAN RK, 1989, AM J PSYCHIAT, V146, P667
   Pitman RK, 2001, J CLIN PSYCHIAT, V62, P47
   Price K. P., 1994, DEF LAW J, V43, P113
   Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005
   Rabe S, 2006, APPL PSYCHOPHYS BIOF, V31, P315, DOI 10.1007/s10484-006-9027-1
   Radant A, 2001, PSYCHIAT RES, V102, P203, DOI 10.1016/S0165-1781(01)00252-9
   Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2
   Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032
   RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675
   RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984
   Ruff RM, 1999, BRAIN INJURY, V13, P943
   Ruzich MJ, 2005, AM J GERIAT PSYCHIAT, V13, P424, DOI 10.1176/appi.ajgp.13.5.424
   SAIGH PA, 1995, BEHAV RES THER, V33, P701, DOI 10.1016/0005-7967(94)00092-X
   SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780
   Schell TL, 2004, J ABNORM PSYCHOL, V113, P189, DOI 10.1037/0021-843X.113.2.189
   SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496
   Schnurr PP, 2004, J TRAUMA STRESS, V17, P85, DOI 10.1023/B:JOTS.0000022614.21794.f4
   Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594
   Seckl JR, 2006, ANN NY ACAD SCI, V1071, P351, DOI 10.1196/annals.1364.027
   Seedat S, 2001, MOL PSYCHIATR, V6, P360, DOI 10.1038/sj.mp.4000867
   Seedat S, 2005, CNS DRUGS, V19, P411, DOI 10.2165/00023210-200519050-00004
   Segman RH, 2003, CNS SPECTR, V8, P693
   Seidler GH, 2006, PSYCHOL MED, V36, P1515, DOI 10.1017/S0033291706007963
   Shalev AY, 1997, BRIT J PSYCHIAT, V170, P558, DOI 10.1192/bjp.170.6.558
   Shalev AY, 2001, J CLIN PSYCHIAT, V62, P4
   Shephard B., 2001, WAR NERVES SOLDIERS
   Shepherd J, 2000, PSYCHOL MED, V30, P863, DOI 10.1017/S0033291799002366
   Silver J. M., 2005, TXB TRAUMATIC BRAIN
   Simon RI, 1999, HARVARD REV PSYCHIAT, V6, P304
   Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659
   Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6
   Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141
   Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595
   TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257
   Ursano Robert J, 2004, Am J Psychiatry, V161, P3
   Uzzell BP, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P1
   van der Kolk BA, 2007, J CLIN PSYCHIAT, V68, P37
   van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316
   Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398
   Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18
   Williams W H, 2003, Cogn Neuropsychiatry, V8, P1, DOI 10.1080/713752238
   Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026
   Wolfe J, 1999, J CONSULT CLIN PSYCH, V67, P520, DOI 10.1037/0022-006X.67.4.520
   Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29
   Yehuda R, 2001, DEV PSYCHOPATHOL, V13, P733, DOI 10.1017/S0954579401003170
   Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41
   Yehuda R, 2000, J CLIN PSYCHIAT, V61, P14
   Yehuda R, 1998, AM J PSYCHIAT, V155, P841
   Zlotnick C, 2004, J NERV MENT DIS, V192, P153, DOI 10.1097/01.nmd.0000110287.16635.8e
   Zlotnick C, 1999, J TRAUMA STRESS, V12, P89, DOI 10.1023/A:1024746316245
NR 173
TC 82
Z9 84
PU JOURNAL REHAB RES & DEV
PI BALTIMORE
PA DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET,
   BALTIMORE, MD 21202-4051 USA
SN 0748-7711
J9 J REHABIL RES DEV
JI J. Rehabil. Res. Dev.
PY 2007
VL 44
IS 7
BP 895
EP 919
DI 10.1682/JRRD.2006.12.0166
PG 25
WC Rehabilitation
SC Rehabilitation
GA 253NL
UT WOS:000252524800004
PM 18075948
ER

PT J
AU Ownsworth, T
   McKenna, K
AF Ownsworth, T
   McKenna, K
TI Investigation of factors related to employment outcome following
   traumatic brain injury: a critical review and conceptual model
SO DISABILITY AND REHABILITATION
LA English
DT Review
ID FACTORS PREDICTING RETURN; MOTOR-VEHICLE ACCIDENTS; CLOSED-HEAD INJURY;
   COMMUNITY INTEGRATION; ECOLOGICAL VALIDITY; SELF-AWARENESS;
   POSTTRAUMATIC-STRESS; IMPAIRED AWARENESS; WORK; REHABILITATION
AB Purpose : The purpose of this article is to critically review the literature to examine factors that are most consistently related to employment outcome following traumatic brain injury (TBI), with a particular focus on metacognitive skills. It also aims to develop a conceptual model of factors related to employment outcome.
   Method : The first stage of the review considered 85 studies published between 1980 and December 2003 which investigated factors associated with employment outcome following TBI. English-language studies were identified through searches of Medline and PsycINFO, as well as manual searches of journals and reference lists. The studies were evaluated and rated by two independent raters (Kappa = 0.835) according to the quality of their methodology based upon nine criteria. Fifty studies met the criteria for inclusion in the second stage of the review, which examined the relationship between a broad range of variables and employment outcome.
   Results : The factors most consistently associated with employment outcome included pre-injury occupational status, functional status at discharge, global cognitive functioning, perceptual ability, executive functioning, involvement in vocational rehabilitation services and emotional status.
   Conclusions : A conceptual model is presented which emphasises the importance of metacognitive, emotional and social environment factors for improving employment outcome.
C1 Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, St Lucia, Qld 4072, Australia.
RP Ownsworth, T (reprint author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, St Lucia, Qld 4072, Australia.
EM t.ownsworth@shrs.uq.edu.au
CR Asikainen I, 1996, BRAIN INJURY, V10, P883
   Barco PP, 1991, COGNITIVE REHABILITA, P129
   BENJAMIN T, 2000, PLAINTIFF, V42, P16
   Ben-Yishay Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI 10.1097/00001199-198703000-00007
   Berglind H, 2002, DISABIL REHABIL, V24, P719, DOI 10.1080/09638280210124301
   Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005
   Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753
   Bogan AM, 1997, BRAIN INJURY, V11, P431
   Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52
   Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699
   BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208
   Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439
   Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547
   Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008
   Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821
   Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007
   Cicerone K. D., 2000, TRAUMATIC BRAIN INJU, P95
   Cicerone K. D., 1986, CLIN NEUROPSYCHOLOGY, P59
   Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5
   Crepeau F., 1993, NEUROPSYCHOL REHABIL, V3, P5, DOI 10.1080/09602019308401421
   DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177
   Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103
   Ezrachi O, 1991, J HEAD TRAUMA REHAB, V6, P71
   Fabiano R. J., 1995, J APPL REHABILITATIO, V26, P17
   FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037//0090-5550.40.3.223
   Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985
   Fleming J, 1999, BRAIN INJURY, V13, P417
   Fleming JM, 1996, BRAIN INJURY, V10, P1
   Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354
   FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217
   FRASER R, 1988, REHABIL COUNS BULL, V31, P276
   Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003
   GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574
   Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557
   Goran DA, 1997, ARCH CLIN NEUROPSYCH, V12, P691, DOI 10.1016/S0887-6177(97)00004-8
   Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520
   Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835
   Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005
   Hanlon RE, 1999, BRAIN INJURY, V13, P873
   Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227
   IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211
   Johansson U, 2001, DISABIL REHABIL, V23, P474
   Johnson R, 1987, Int Disabil Stud, V9, P49
   Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098
   KARSZMARK P, 1995, BRAIN INJURY, V9, P21
   Katz Noomi, 2002, Can J Occup Ther, V69, P281
   Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605
   Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318
   Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3
   Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128
   Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947
   LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022
   LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959
   Luria AR, 1963, RESTORATION FUNCTION
   Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980
   Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895
   McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353
   Nybo T, 1999, BRAIN INJURY, V13, P759
   O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212
   Ownsworth TL, 1999, BRAIN INJURY, V13, P605
   Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465
   Ownsworth TL, 1998, BRAIN INJURY, V12, P735
   Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076
   Paniak C, 2000, J MUSCULOSKELET PAIN, V8, P193, DOI 10.1300/J094v08n01_16
   Pengel LHM, 2003, BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323
   Pepping M, 1991, NEUROPSYCHOLOGY EVER, P215
   PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566
   Possl O, 2001, BRAIN INJURY, V15, P15
   PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414
   PRIGATANO GP, 1999, COGNITIVE NEUROREHAB, P240
   Prigatano GP, 1986, NEUROPSYCHOLOGICAL R
   RAO N, 1992, ARCH PHYS MED REHAB, V73, P911
   Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139
   Robertson I. H., 1994, TEST EVERYDAY ATTENT
   Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005
   RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164
   Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7
   Sale P., 1991, J HEAD TRAUMA REHAB, V6, P1
   Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007
   Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52
   Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045
   Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802
   Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238
   Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003
   Sherer M, 1999, BRAIN INJURY, V13, P973
   Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380
   SHERRON P, 2000, VOCATIONAL REHABILIT, P119
   Simmond M, 2003, BRIT J OCCUPATIONAL, V66, P447
   Simpson A, 2002, BRAIN INJURY, V16, P1075, DOI 10.1080/02699050210155249
   SMIGIELSKI JS, 1992, MAYO CLIN PROC, V67, P767
   Spreen O., 1998, COMPENDIUM NEUROPSYC
   STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164
   STAPLETON M, 2000, VOCATIONAL REHABILIT, P269
   RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148
   Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372
   UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3
   VELDHEER L, 2000, VOCATIONAL REHABILIT, P19
   VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643
   Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561
   Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470
   WEHMAN P, 2000, VOCATIONAL REHABILIT, P1
   WEHMAN P, 2001, NEUROREHABILITATION, V15, P71
   Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949
   WEST M, 2000, VOCATIONAL REHABILIT, P201
   WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200
   Westmorland MG, 2002, DISABIL REHABIL, V24, P802, DOI 10.1080/09638280110113421
   Whishaw I. Q., 1990, FUNDAMENTALS HUMAN N
   Williams WH, 2002, BRAIN INJURY, V16, P673
   Wilson B. A., 1996, BEHAV ASSESSMENT DYS
   WILSON BA, 1996, MEMORY, V4, P456
   World Health Organisation, 2001, INT CLASS FUNCT DIS
   Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002
NR 112
TC 82
Z9 84
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0963-8288
J9 DISABIL REHABIL
JI Disabil. Rehabil.
PD JUL 8
PY 2004
VL 26
IS 13
BP 765
EP 784
DI 10.1080/09638280410001696700
PG 20
WC Rehabilitation
SC Rehabilitation
GA 833PP
UT WOS:000222350800001
PM 15371049
ER

PT J
AU Peschel, RE
   Colberg, JW
AF Peschel, RE
   Colberg, JW
TI Surgery, brachytherapy, and external-beam radiotherapy for early
   prostate cancer
SO LANCET ONCOLOGY
LA English
DT Review
ID CONFORMAL RADIATION-THERAPY; RADICAL RETROPUBIC PROSTATECTOMY; COMPETING
   RISK ANALYSIS; DISEASE-FREE SURVIVAL; BIOCHEMICAL FAILURE; RANDOMIZED
   TRIAL; DOSE-ESCALATION; SEED IMPLANTATION; HORMONAL-THERAPY; ANTIGEN ERA
AB Patients diagnosed with early prostate cancer after 2000 can expect better outcomes from treatment than patients who were diagnosed in the 1980s and early 1990s. These improved outcomes are the result of stage migration, new technologies such as three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated external-beam radiotherapy (IMRT), better implant techniques, and optimum use of hormone therapy. We review the outcomes for radical prostatectomy, permanent seed implant, 3DCRT, and IMRT. For patients with clinical stage T1c or T2 disease and a Gleason score of less than 8, 5-year biochemical disease-free survival is remarkably similar for all the above treatments. Furthermore, complication rates are acceptable for all these modalities. For patients with bulky T2-3 disease or a Gleason score of 8-10, hormone therapy plus 3DCRT or IMRT is an excellent treatment choice. Studies of radical prostatectomy show the most reliable long-term results, and the studies of external-beam radiotherapy have used the best scientific methods to assess efficacy. On the basis of current data, we recommend specific treatment options.
C1 Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA.
   Yale Univ, Sch Med, Urol Sect, New Haven, CT USA.
RP Peschel, RE (reprint author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.
CR Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975
   Benoit RM, 2000, UROLOGY, V55, P91, DOI 10.1016/S0090-4295(99)00122-3
   Beyer DC, 2000, RADIOTHER ONCOL, V57, P263, DOI 10.1016/S0167-8140(00)00286-3
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   Blasko JC, 1998, PROSTATE CANCER, P137
   Blasko JC, 2000, RADIOTHER ONCOL, V57, P273, DOI 10.1016/S0167-8140(00)00288-7
   Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Catalona WJ, 1999, J UROLOGY, V162, P433, DOI 10.1016/S0022-5347(05)68578-3
   CHEN CT, 2002, INT J CANCER, V96, P83
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   Crook J, 2002, INT J RADIAT ONCOL, V52, P453, DOI 10.1016/S0360-3016(01)02658-X
   D'Amico AV, 2002, INT J RADIAT ONCOL, V54, P436, DOI 10.1016/S0360-3016(02)02940-1
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0
   Ennis RD, 1998, INT J RADIAT ONCOL, V41, P511, DOI 10.1016/S0360-3016(98)00104-7
   Epstein JI, 1998, J UROLOGY, V160, P97, DOI 10.1016/S0022-5347(01)63045-3
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Han M, 2001, J UROLOGY, V166, P416, DOI 10.1016/S0022-5347(05)65955-1
   Hanks GE, 2000, INT J RADIAT ONCOL, V46, P823, DOI 10.1016/S0360-3016(99)00498-8
   Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7
   Incrocci L, 2002, INT J RADIAT ONCOL, V52, P681, DOI 10.1016/S0360-3016(01)02727-4
   Jani AB, 1999, UROLOGY, V54, P700, DOI 10.1016/S0090-4295(99)00229-0
   Jhaveri FM, 1999, UROLOGY, V54, P884, DOI 10.1016/S0090-4295(99)00252-6
   Kattan MW, 2000, INT J RADIAT ONCOL, V48, P1469, DOI 10.1016/S0360-3016(00)01359-6
   KEELEY FX, 1998, PROSTATE CANC, P1
   Kestin LL, 2002, INT J RADIAT ONCOL, V53, P304, DOI 10.1016/S0360-3016(02)02707-4
   Keyser D, 1997, INT J RADIAT ONCOL, V38, P723, DOI 10.1016/S0360-3016(97)00123-5
   KING CR, 1998, J BRACHYTHERAPY INT, V14, P169
   Kupelian P, 1997, CANCER J SCI AM, V3, P78
   Kupelian PA, 2002, J CLIN ONCOL, V20, P3376, DOI 10.1200/JCO.2002.01.150
   Kupelian PA, 2002, INT J RADIAT ONCOL, V52, P704, DOI 10.1016/S0360-3016(01)02778-X
   Lau WK, 2002, J UROLOGY, V167, P117, DOI 10.1016/S0022-5347(05)65394-3
   Lee LN, 2002, INT J RADIAT ONCOL, V52, P444, DOI 10.1016/S0360-3016(01)02598-6
   Lepor H, 2001, J UROLOGY, V166, P1729, DOI 10.1016/S0022-5347(05)65662-5
   Mantz CA, 1999, CANCER J SCI AM, V5, P230
   Martinez AA, 2000, INT J RADIAT ONCOL, V47, P343, DOI 10.1016/S0360-3016(00)00436-3
   Merrick GS, 2002, INT J RADIAT ONCOL, V52, P461, DOI 10.1016/S0360-3016(01)01811-9
   PESCHEL RE, 1997, UROLOGIC CANC, P126
   Peschel R. E., 2001, International Journal of Radiation Oncology Biology Physics, V51, P292, DOI 10.1016/S0360-3016(01)02359-8
   Peschel RE, 1999, CANCER J SCI AM, V5, P145
   Peschel RE, 2000, INT J CANCER, V90, P29
   Peschel RE, 1999, RADIAT ONCOL INVESTI, V7, P278, DOI 10.1002/(SICI)1520-6823(1999)7:5<278::AID-ROI3>3.0.CO;2-3
   Pollack A, 2000, J CLIN ONCOL, V18, P3904
   Pollack A, 2000, INT J RADIAT ONCOL, V48, P507, DOI 10.1016/S0360-3016(00)00620-9
   Potters L, 1999, CANCER J SCI AM, V5, P301
   Potters L, 2000, ONCOLOGY-NY, V14, P981
   Potters L, 2001, INT J RADIAT ONCOL, V50, P1235, DOI 10.1016/S0360-3016(01)01578-4
   Pound CR, 1997, WORLD J UROL, V15, P373, DOI 10.1007/BF01300186
   Boyer AL, 2001, INT J RADIAT ONCOL, V51, P880
   Puthawala AA, 2001, CANCER, V92, P2084, DOI 10.1002/1097-0142(20011015)92:8<2084::AID-CNCR1549>3.0.CO;2-C
   Ragde H, 2000, CANCER, V89, P135, DOI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
   Ramos CG, 1999, J UROLOGY, V161, P1212, DOI 10.1016/S0022-5347(01)61636-7
   Roach M. III, 2001, International Journal of Radiation Oncology Biology Physics, V51, P3, DOI 10.1016/S0360-3016(01)01829-6
   Roach M, 2000, INT J RADIAT ONCOL, V47, P617, DOI 10.1016/S0360-3016(00)00577-0
   Rosser CJ, 2002, J UROLOGY, V168, P536, DOI 10.1016/S0022-5347(05)64674-5
   Schellhammer PF, 1998, INT J RADIAT ONCOL, V41, P489
   Sobin LH, 1997, TNM CLASSIFICATION M, P170
   Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483
   Storey MR, 2000, INT J RADIAT ONCOL, V48, P635, DOI 10.1016/S0360-3016(00)00700-8
   Sweat SD, 2002, J UROLOGY, V168, P525, DOI 10.1016/S0022-5347(05)64672-1
   Taylor JMG, 2001, INT J RADIAT ONCOL, V50, P1212, DOI 10.1016/S0360-3016(01)01571-1
   Wallner K, 2002, CANCER J, V8, P67
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   Zelefsky MJ, 1999, CANCER, V85, P2460, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2460::AID-CNCR23>3.0.CO;2-N
NR 66
TC 82
Z9 84
PU LANCET LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1470-2045
J9 LANCET ONCOL
JI Lancet Oncol.
PD APR
PY 2003
VL 4
IS 4
BP 233
EP 241
DI 10.1016/S1470-2045(03)01035-0
PG 9
WC Oncology
SC Oncology
GA 666VK
UT WOS:000182197000021
PM 12681267
ER

PT S
AU Umberson, D
   Crosnoe, R
   Reczek, C
AF Umberson, Debra
   Crosnoe, Robert
   Reczek, Corinne
BE Cook, KS
   Massey, DS
TI Social Relationships and Health Behavior Across the Life Course
SO ANNUAL REVIEW OF SOCIOLOGY, VOL 36
SE Annual Review of Sociology
LA English
DT Article; Book Chapter
DE social integration; social support; social control; stress; social
   networks
ID ADOLESCENT PROBLEM BEHAVIOR; MARITAL-STATUS; SUBSTANCE USE; ALCOHOL-USE;
   ALLOSTATIC LOAD; PHYSICAL HEALTH; UNITED-STATES; MENTAL-HEALTH;
   BODY-WEIGHT; PARENTING PRACTICES
AB Sociological theory and research point to the importance of social relationships in affecting health behavior. This work tends to focus on specific stages of the life course, with a division between research on childhood/adolescent and adult populations. Yet recent advances demonstrate that early life course experiences shape health outcomes well into adulthood. We synthesize disparate bodies of research on social ties and health behavior throughout the life course, with attention to explaining how various social ties influence health behaviors at different life stages and how these processes accumulate and reverberate throughout the life course.
C1 [Umberson, Debra; Crosnoe, Robert; Reczek, Corinne] Univ Texas Austin, Dept Sociol, Populat Res Ctr, Austin, TX 78712 USA.
RP Umberson, D (reprint author), Univ Texas Austin, Dept Sociol, Populat Res Ctr, Austin, TX 78712 USA.
EM Umberson@prc.utexas.edu; Crosnoe@austin.utexas.edu;
   Reczek@prc.utexas.edu
RI Reczek, Corinne/G-2547-2013
OI Reczek, Corinne/0000-0001-5309-3632
CR Ackard DM, 2006, AM J PREV MED, V30, P59, DOI 10.1016/j.amepre.2005.09.013
   Allen JP, 2005, CHILD DEV, V76, P747, DOI 10.1111/j.1467-8624.2005.00875.x
   Bachman J. G., 2002, DECLINE SUBSTANCE US
   Baker TB, 2004, ANNU REV PSYCHOL, V55, P463, DOI 10.1146/annurev.psych.55.090902.142054
   Barnes GM, 2000, J MARRIAGE FAM, V62, P175, DOI 10.1111/j.1741-3737.2000.00175.x
   Ennet ST, 2001, J MARRIAGE FAM, V63, P48, DOI 10.1111/j.1741-3737.2001.00048.x
   Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89
   Bearman PS, 2001, AM J SOCIOL, V106, P859, DOI 10.1086/320295
   Bellows-Riecken KH, 2008, PREV MED, V46, P99, DOI 10.1016/j.ypmed.2007.08.003
   BERG MM, 1994, ANN BEHAV MED, V16, P109
   Berkman L. F., 1983, HLTH WAYS LIVING ALA
   Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4
   Biblarz TJ, 2000, J MARRIAGE FAM, V62, P533, DOI 10.1111/j.1741-3737.2000.00533.x
   Boardman JD, 2008, BEHAV GENET, V38, P234, DOI 10.1007/s10519-008-9197-0
   Borawski EA, 2003, J ADOLESCENT HEALTH, V33, P60, DOI 10.1016/S1054-139X(03)00100-9
   Brummett BH, 2001, PSYCHOSOM MED, V63, P267
   Call Kathleen T., 2001, ARENAS COMFORT ADOLE
   Carr D, 2006, SOC PSYCHOL QUART, V69, P127
   Cherlin Andrew J., 2009, MARRIAGE GO ROUND
   Chilcoat HD, 1996, J HEALTH SOC BEHAV, V37, P339, DOI 10.2307/2137261
   Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082
   Chuang YC, 2005, J HEALTH SOC BEHAV, V46, P187
   Cleveland HH, 2003, CHILD DEV, V74, P279, DOI 10.1111/1467-8624.00535
   COHEN S, 1991, PREV MED, V20, P306, DOI 10.1016/0091-7435(91)90029-4
   Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676
   Coleman James, 1961, ADOLESCENT SOC SOCIA
   Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1
   Crockett L. J., 1993, PROMOTING HLTH ADOLE, P13
   Crosnoe R, 2006, SOCIOL EDUC, V79, P44
   Crosnoe R, 2004, SOC PROBL, V51, P288, DOI 10.1525/sp.2004.51.2.288
   Duncan G. J., 2004, RES HUMAN DEV, VI, P59, DOI DOI 10.1080/15427609.2004.9683330
   Duncan GJ, 2006, DEMOGRAPHY, V43, P691, DOI 10.1353/dem.2006.0032
   Durkheim E., 1897, SUICIDE STUDY SOCIOL
   Elder G., 2003, HDB LIFE COURSE, P369
   Eng PM, 2005, J EPIDEMIOL COMMUN H, V59, P56, DOI 10.1136/jech.2004.020073
   Ennett ST, 2006, J RES ADOLESCENCE, V16, P159, DOI 10.1111/j.1532-7795.2006.00127.x
   Ensel WM, 2004, J COMMUNITY PSYCHOL, V32, P81, DOI 10.1002/jcop.10079
   Eyler AA, 2003, MED SCI SPORT EXER, V35, P1529, DOI 10.1249/01.MSS.0000084622.39122.0C
   FEKETE E, 2008, PSYCHOL HEALTH, V24, P501
   Ferrari S, 2003, THORAX, V58, P19
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Franks MM, 2002, J AGING HEALTH, V14, P336, DOI 10.1177/08964302014003002
   FRIEDMAN HS, 1995, J PERS SOC PSYCHOL, V68, P696, DOI 10.1037/0022-3514.68.4.696
   Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127
   Gaughan M, 2006, J HEALTH SOC BEHAV, V47, P47
   Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749
   Gorman BK, 2006, J HEALTH SOC BEHAV, V47, P95
   Grzywacz JG, 1999, J FAM ISSUES, V20, P243, DOI 10.1177/019251399020002004
   GULLIVER SB, 1995, ADDICTION, V90, P767, DOI 10.1046/j.1360-0443.1995.9067673.x
   Guo G, 2008, AM SOCIOL REV, V73, P543
   Haas S, 2008, SOC SCI MED, V66, P849, DOI 10.1016/j.socscimed.2007.11.004
   Harden KP, 2008, BEHAV GENET, V38, P339, DOI 10.1007/s10519-008-9202-7
   Harris KM, 2006, TWIN RES HUM GENET, V9, P988, DOI 10.1375/183242706779462787
   Hayward MD, 2000, AM SOCIOL REV, V65, P910, DOI 10.2307/2657519
   HAYWARD MD, 2004, DEMOGRAPHY, V241, P540
   Helgeson VS, 2004, J SOC PERS RELAT, V21, P53, DOI 10.1177/0265407504039840
   Hernandez L. M., 2006, GENES BEHAV SOCIAL E
   Hetherington E.M, 2002, BETTER WORSE DIVORCE
   Hoffmann JP, 2006, J HEALTH SOC BEHAV, V47, P275
   HORWITZ AV, 1991, J HEALTH SOC BEHAV, V32, P221, DOI 10.2307/2136805
   HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277
   House JS, 2001, PSYCHOSOM MED, V63, P273
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889
   Idler EL, 1997, J GERONTOL B-PSYCHOL, V52, pS294
   Jaccard J, 2005, DEV PSYCHOL, V41, P135, DOI 10.1037/0012-1649.41.1.135
   Jeffery RW, 2002, OBES RES, V10, P809, DOI 10.1038/oby.2002.109
   Johnson RA, 2000, J HEALTH SOC BEHAV, V41, P392, DOI 10.2307/2676293
   KAPLAN GA, 1991, AGING HLTH BEHAV HLT, P69
   Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2
   Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270
   Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472
   Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4
   Kirby JB, 2002, J HEALTH SOC BEHAV, V43, P56, DOI 10.2307/3090245
   Knoester C, 2006, J MARRIAGE FAM, V68, P1247, DOI 10.1111/j.1741-3737.2006.00326.x
   KRAUSE N, 2008, SOCIAL STRUCTURES AG, P73
   Lewis MA, 2005, PERS SOC PSYCHOL B, V31, P416, DOI 10.1177/0146167204271600
   Lewis MA, 2007, J APPL SOC PSYCHOL, V37, P298, DOI 10.1111/j.0021-9029.2007.00161.x
   Lewis MA, 2004, J SOC PERS RELAT, V21, P669, DOI 10.1177/0265404045893
   Lundborg P, 2006, J HEALTH ECON, V25, P214, DOI 10.1016/j.jhealeco.2005.02.001
   Marshal M. P., 2000, APPL DEV SCI, V4, P80, DOI [10.1207/S1532480XADS0402_3, DOI 10.1207/S1532480XADS0402_3]
   MCCAFFREY DR, 2008, W14102 NBER
   MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093
   McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78
   Meadows SO, 2007, SOC FORCES, V85, P1143, DOI 10.1353/sof.2007.0048
   Miller KE, 2003, J DRUG EDUC, V33, P445, DOI 10.2190/XPV5-JD5L-RYLK-UMJA
   Mirowsky J., 2003, SOCIAL CAUSES PSYCHO
   Musick M. A., 2007, VOLUNTEERS SOCIAL PR
   Nock S., 1998, MARRIAGE MENS LIVES
   Nomaguchi KM, 2004, J MARRIAGE FAM, V66, P413, DOI 10.1111/j.1741-3737.2004.00029.x
   Palloni A, 2006, DEMOGRAPHY, V43, P587, DOI 10.1353/dem.2006.0036
   Paton-Simpson G., 2001, CONTEMP DRUG PROBL, V28, P133
   Pearlin LI, 2005, J HEALTH SOC BEHAV, V46, P205
   Pears K, 2007, PSYCHOL ADDICT BEHAV, V21, P373, DOI 10.1037/0893-164X.21.3.373
   Peck SC, 2008, ADDICTION, V103, P69, DOI 10.1111/j.1360-0443.2008.02177.x
   Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126
   Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037//0033-2909.128.2.330
   Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823
   ROGERS RG, 1995, J MARRIAGE FAM, V57, P515, DOI 10.2307/353703
   ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319
   Schnittker J, 2005, ANNU REV SOCIOL, V31, P75, DOI 10.1146/annurev.soc.30.012703.110622
   Seeman TE, 2002, PSYCHOSOM MED, V64, P395
   SMITH B, 2001, HDB HLTH PSYCHOL, P139
   Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601
   Sobal J, 2003, APPETITE, V41, P181, DOI 10.1016/S0195-6663(03)00078-3
   Sobal J, 2003, SOC SCI MED, V56, P1543, DOI 10.1016/S0277-9536(02)00155-7
   Soenens B, 2006, DEV PSYCHOL, V42, P305, DOI 10.1073/0012-1649.42.2.305
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Steinberg L, 2001, ANNU REV PSYCHOL, V52, P83, DOI 10.1146/annurev.psych.52.1.83
   Strawbridge WJ, 2001, ANN BEHAV MED, V23, P68, DOI 10.1207/S15324796ABM2301_10
   Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5
   Taylor SE, 1997, ANNU REV PSYCHOL, V48, P411, DOI 10.1146/annurev.psych.48.1.411
   Taylor DH, 2002, AM J PUBLIC HEALTH, V92, P990, DOI 10.2105/AJPH.92.6.990
   The NS, 2009, OBESITY, V17, P1441, DOI 10.1038/oby.2009.97
   THOITS PA, 1995, J HEALTH SOC BEHAV, V35, P53, DOI 10.2307/2626957
   Tucker JS, 2006, HEALTH PSYCHOL, V25, P715, DOI 10.1037/0278-6133.25.6.715
   Tucker JS, 2002, J GERONTOL B-PSYCHOL, V57, pP387
   Tucker JS, 2004, J GERONTOL B-PSYCHOL, V59, pP147
   Uchino BN, 2004, SOCIAL SUPPORT PHYS
   Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5
   Umberson D, 2009, J HEALTH SOC BEHAV, V50, P327
   UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S
   Umberson Debra, 2008, ADV LIFE COURSE RES, P19
   *US DEP HHS, 2009, HLTH PEOPL 2010 NAT
   Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946
   Waite L. J., 2000, CASE MARRIAGE WHY MA
   Waite L. J., 2010, ICPSR20541V5, DOI [10.3886/ICPSR20541, DOI 10.3886/ICPSR20541]
   Walen HR, 2000, J SOC PERS RELAT, V17, P5, DOI 10.1177/0265407500171001
   Weng HLH, 2004, J WOMENS HEALTH, V13, P85, DOI 10.1089/154099904322836492
   Wilcox S, 2003, HEALTH PSYCHOL, V22, P513, DOI 10.1037/0278-6133.22.5.513
   WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025
   Williams DR, 2002, AM J PUBLIC HEALTH, V92, P588, DOI 10.2105/AJPH.92.4.588
   Williams K, 2004, J HEALTH SOC BEHAV, V45, P81
   Williams K, 2004, J GERONTOL B-PSYCHOL, V59, pS343
   Williams RB, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P661
   Winkleby M. A., 2004, CRIT PERSPECT, P450
   Wu Z, 2003, J FAM ISSUES, V24, P811, DOI 10.1177/0192513X03254519
NR 136
TC 81
Z9 81
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0360-0572
BN 978-0-8243-2236-6
J9 ANNU REV SOCIOL
JI Annu. Rev. Sociol.
PY 2010
VL 36
BP 139
EP 157
DI 10.1146/annurev-soc-070308-120011
PG 19
WC Sociology
SC Sociology
GA BQL62
UT WOS:000281254500007
ER

PT J
AU Magee, AG
   Brzezinska-Rajszys, G
   Qureshi, SA
   Rosenthal, E
   Zubrzycka, M
   Ksiazyk, J
   Tynan, M
AF Magee, AG
   Brzezinska-Rajszys, G
   Qureshi, SA
   Rosenthal, E
   Zubrzycka, M
   Ksiazyk, J
   Tynan, M
TI Stent implantation for aortic coarctation and recoarctation
SO HEART
LA English
DT Article
DE coarctation; aortic recoarctation; stents
ID CONGENITAL-ANOMALIES REGISTRY; PATCH AORTOPLASTY REPAIR; BALLOON
   ANGIOPLASTY; NATIVE COARCTATION; FOLLOW-UP; INTRAVASCULAR ULTRASOUND;
   ARTERY-STENOSIS; BLOOD-PRESSURE; HEART-DISEASE; CHILDREN
AB Objective-To determine the early results of balloon expandable stent implantation for aortic coarctation or recoarctation.
   Design-Prospective observational study.
   Setting-Two paediatric cardiology tertiary referral centres.
   Patients-17 patients, median age 17 years (range 4.4 to 45) and median weight 61 kg (17 to 92). Six had native aortic coarctation and 11 had aortic recoarctation; 14 had upper limb systolic hypertension. Of those with recoarctation, eight had had at least one previous balloon dilatation attempt and two of these patients also had further surgical interventions.
   Intervention-Balloon expandable Palmaz iliac stent implantation.
   Main outcome measures-Systolic pressures gradients, minimum aortic diameter, upper limb blood pressures, and incidence of aneurysm formation.
   Results-18 stents were implanted during 18 procedures in the 17 patients. Mean peak systolic pressure gradient fell from 26 mm Hg (95% confidence interval (CI), 21 to 31 mm Hg) before to 5 mm Hg (2 to 8 mm Hg) after stent implantation (p < 0.001), and mean minimum aortic diameter increased from 7 mm (95% CI, 6 to 8 mm) before to 11.3 mm (10 to 12.6 mm) after implantation (p < 0.001). Complications occurred in five patients (bleeding in two, stent migration in two, and aneurysm formation in one). Two patients remained borderline hypertensive and eight were receiving antihypertensive treatment at most recent assessment.
   Conclusions-Stent implantation for aortic recoarctation and native coarctation gives good immediate results. Careful follow up is necessary to evaluate complications and the long term effect on blood pressure.
C1 Guys Hosp, Dept Paediat Cardiol, London SE1 9RT, England.
   Childrens Mem Hosp, Warsaw, Poland.
RP Qureshi, SA (reprint author), Guys Hosp, Dept Paediat Cardiol, 11th Floor Guys Tower,St Thomas St, London SE1 9RT, England.
RI Rosenthal, Eric/I-7469-2012
OI Rosenthal, Eric/0000-0003-3030-9749
CR ANJOS R, 1992, AM J CARDIOL, V69, P665, DOI 10.1016/0002-9149(92)90161-Q
   AYDOGAN U, 1995, CATHETER CARDIO DIAG, V36, P226, DOI 10.1002/ccd.1810360307
   BALAJI S, 1991, BRIT HEART J, V65, P100
   Blum U, 1996, RADIOLOGY, V198, P25
   BROMBERG BI, 1989, J AM COLL CARDIOL, V14, P734
   Bulbul ZR, 1996, CATHETER CARDIO DIAG, V39, P36, DOI 10.1002/(SICI)1097-0304(199609)39:1<36::AID-CCD7>3.0.CO;2-3
   CHEATHAM J, 1998, CARDIOLOGY YOUNG S1, V9, P11
   FLETCHER SE, 1995, J AM COLL CARDIOL, V25, P730, DOI 10.1016/0735-1097(94)00437-U
   HARRISON JK, 1990, J AM COLL CARDIOL, V15, P906
   HELLENBRAND WE, 1990, AM J CARDIOL, V65, P793, DOI 10.1016/0002-9149(90)91390-R
   HIJAZI ZM, 1991, CIRCULATION, V84, P1150
   HO SY, 1988, INT J CARDIOL, V19, P99, DOI 10.1016/0167-5273(88)90195-7
   HUGGON IC, 1994, AM J CARDIOL, V73, P799, DOI 10.1016/0002-9149(94)90884-2
   Ino T, 1998, CARDIOVASC INTER RAD, V21, P102, DOI 10.1007/s002709900224
   Knyshov GV, 1996, ANN THORAC SURG, V61, P935, DOI 10.1016/0003-4975(95)01189-7
   LOCK JE, 1982, RADIOLOGY, V143, P689
   McCrindle BW, 1996, J AM COLL CARDIOL, V28, P1810
   MENDELSOHN AM, 1994, AM J CARDIOL, V74, P696, DOI 10.1016/0002-9149(94)90312-3
   Mendelsohn AM, 1996, CATHETER CARDIO DIAG, V38, P430, DOI 10.1002/(SICI)1097-0304(199608)38:4<430::AID-CCD24>3.0.CO;2-H
   MORROW WR, 1994, CIRCULATION, V89, P2677
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923
   PALMAZ JC, 1988, RADIOLOGY, V168, P727
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   Pethig K, 1996, ANN THORAC SURG, V61, P1724, DOI 10.1016/0003-4975(96)00140-3
   PINZON JL, 1991, RADIOLOGY, V180, P199
   Rao PS, 1996, J AM COLL CARDIOL, V27, P462, DOI 10.1016/0735-1097(95)00479-3
   ROSENTHAL E, 1995, AM HEART J, V129, P1220, DOI 10.1016/0002-8703(95)90408-5
   SCHATZ RA, 1987, CIRCULATION, V76, P450
   SCHRADER R, 1995, CATHETER CARDIO DIAG, V36, P220, DOI 10.1002/ccd.1810360306
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   TYNAN M, 1990, AM J CARDIOL, V65, P790, DOI 10.1016/0002-9149(90)91389-N
   WITSENBURG M, 1993, BRIT HEART J, V70, P170
   Xu JP, 1997, AM HEART J, V134, P93, DOI 10.1016/S0002-8703(97)70111-X
NR 33
TC 81
Z9 84
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
J9 HEART
JI Heart
PD NOV
PY 1999
VL 82
IS 5
BP 600
EP 606
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 253BK
UT WOS:000083536600018
PM 10525517
ER

PT J
AU Stein, MB
   McAllister, TW
AF Stein, Murray B.
   McAllister, Thomas W.
TI Exploring the Convergence of Posttraumatic Stress Disorder and Mild
   Traumatic Brain Injury
SO AMERICAN JOURNAL OF PSYCHIATRY
LA English
DT Review
ID COMORBIDITY SURVEY REPLICATION; OF-VETERANS-AFFAIRS; POSTCONCUSSIVE
   SYMPTOMS; PSYCHIATRIC-DISORDERS; CLINICAL MANAGEMENT; COGNITIVE-ABILITY;
   MENTAL-DISORDERS; IRAQ-WAR; COMBAT; US
AB The authors examine the relationship of the two signature injuries experienced by military personnel serving in Afghanistan and Iraq: posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mild TBI). Studies show that a substantial minority of those serving develop persistent emotional sequelae (such as PTSD and other psychological health problems) and/or somatic or cognitive sequelae (postconcussive symptoms) of traumatic exposure. Remarkably, the mechanism (emotional versus biomechanical) and locus (head versus other regions) of injury are weak determinants of whether an individual develops PTSD, persistent postconcussive symptoms, or both. Preexisting or traumatically acquired cognitive dysfunction can increase the risk for these syndromes, probably by reducing cognitive reserve. Structural and functional neuroimaging studies can be interpreted to explain part of the shared symptomatic and functional variance in these syndromes, but this literature is far from consistent and serves mainly to raise new, challenging questions about mutual pathophysiology. The frequent confluence of PTSD and persistent postconcussive symptoms in military personnel strains the bounds of these constructs. New studies are needed to improve our understanding of how emotional and biomechanical stressors can yield these adverse outcomes and how such outcomes can be prevented and treated.
C1 [Stein, Murray B.] Univ Calif San Diego 0855, Dept Psychiat, La Jolla, CA 92093 USA.
   Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA.
   VA San Diego Healthcare Syst, San Diego, CA USA.
   Dartmouth Med Sch, Sect Neuropsychiat, Dept Psychiat, Lebanon, NH USA.
RP Stein, MB (reprint author), Univ Calif San Diego 0855, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM mstein@ucsd.edu
FU Department of Defense
FX Supported by a grant from the Department of Defense.
CR Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004
   Adler AB, 2008, J TRAUMA STRESS, V21, P301, DOI 10.1002/jts.20336
   ALEXANDER MP, 1995, NEUROLOGY, V45, P1253
   Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5
   BENEDEK D, 2004, COMPREHENSIVE TXB PS, P2426
   Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X
   Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501
   Bremner J Douglas, 2008, Prog Brain Res, V167, P171
   Breslau N, 2006, ARCH GEN PSYCHIAT, V63, P1238, DOI 10.1001/archpsyc.63.11.1238
   Breslau N, 2004, PSYCHOL MED, V34, P889, DOI 10.1017/S0033291703001612
   Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2
   Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931
   Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235
   Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326
   Desai RA, 2008, MIL MED, V173, P721
   Elhai JD, 2008, J CLIN PSYCHIAT, V69, P597
   Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504
   Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53
   FEAR NT, PSYCHOL MED
   Gale CR, 2008, ARCH GEN PSYCHIAT, V65, P1410, DOI 10.1001/archpsyc.65.12.1410
   Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210
   Galea S, 2008, EPIDEMIOLOGY, V19, P47, DOI 10.1097/EDE.0b013e31815cIdbf
   Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029
   Gutierrez PM, 2008, ARCH SUICIDE RES, V12, P336, DOI 10.1080/13811110802324961
   Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195
   Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069
   Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972
   Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606
   Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370
   *I MED COMM GULF W, 2006, POSTTR STRESS DIS DI
   *I MED COMM TREATM, 2008, GULF WAR HLTH, V7
   Institute of Medicine Committee on Treatment of Posttraumatic Stress Disorder, 2007, TREATM POSTTR STRESS
   Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031
   Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022
   Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106
   Koenen KC, 2007, PSYCHOL MED, V37, P181, DOI 10.1017/S0033291706009019
   Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343
   Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008
   Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032
   Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315
   Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216
   Kremen WS, 2007, ARCH GEN PSYCHIAT, V64, P361, DOI 10.1001/archpsyc.64.3.361
   Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375
   Liberzon Israel, 2008, Prog Brain Res, V167, P151
   Mathew SJ, 2008, AM J MED GENET C, V148C, P89, DOI 10.1002/ajmg.c.30172
   McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450
   McAllister TW, 2002, NEUROREHABILITATION, V17, P265
   McCrea M. A., 2008, MILD TRAUMATIC BRAIN
   Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141
   Mills K. L., 2006, AM J PSYCHIAT, V163, P651, DOI DOI 10.1176/APPLAJP.163.4.652
   MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200
   Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558
   Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711
   Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389
   Norman SB, 2007, J NERV MENT DIS, V195, P48, DOI 10.1097/01.nmd.0000252135.25114.02
   North CS, 2009, AM J PSYCHIAT, V166, P34, DOI 10.1176/appi.ajp.2008.08050644
   Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035
   Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004
   RAVINDRAN LN, 2009, BRAIN RES
   Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856
   Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843
   Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068
   Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476
   Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027
   Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542
   Smith TC, 2008, BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE
   Spitzer RL, 2008, COMPR PSYCHIAT, V49, P319, DOI 10.1016/j.comppsych.2008.01.006
   SUUMPTER RE, 2006, BRAIN INJURY, V20, P93
   Tanielian T., 2008, INVISIBLE WOUNDS WAR
   Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8
   Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519
   VASTERLING JJ, 2005, NEUROPSYCHOLOGICAL F
   Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398
   Warden DL, 2005, NEW ENGL J MED, V353, P633
   Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54
   Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026
   Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943
NR 79
TC 80
Z9 80
PU AMER PSYCHIATRIC PUBLISHING, INC
PI ARLINGTON
PA 1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA
SN 0002-953X
J9 AM J PSYCHIAT
JI Am. J. Psychiat.
PD JUL
PY 2009
VL 166
IS 7
BP 768
EP 776
DI 10.1176/appi.ajp.2009.08101604
PG 9
WC Psychiatry
SC Psychiatry
GA 465RF
UT WOS:000267603800008
PM 19448186
ER

PT J
AU Merrick, GS
   Wallner, KE
   Butler, WM
AF Merrick, GS
   Wallner, KE
   Butler, WM
TI Permanent interstitial brachytherapy for the management of carcinoma of
   the prostate gland
SO JOURNAL OF UROLOGY
LA English
DT Review
DE prostate; prostatic neoplasms; brachytherapy; morbidity
ID RADIOACTIVE SEED IMPLANTATION; EXTERNAL-BEAM RADIATION; HORMONE-NAIVE
   PATIENTS; PERINEURAL INVASION; EXTRAPROSTATIC EXTENSION; RADICAL
   PROSTATECTOMY; ERECTILE DYSFUNCTION; URINARY MORBIDITY; CLINICAL
   UTILITY; FREE SURVIVAL
AB Purpose: We summarize the permanent prostate brachytherapy literature, including biochemical outcomes, quality of life parameters and areas of controversy.
   Materials and Methods: The permanent prostate brachytherapy literature was reviewed using MEDLINE searches to ensure completeness.
   Results: Using various planning and intraoperative techniques the majority of the brachytherapy literature demonstrates durable biochemical outcomes for patients with low, intermediate and high risk features. For low risk patients there is no advantage to combining supplemental external beam radiation therapy with brachytherapy. In addition, supplemental external beam radiation therapy may not improve biochemical outcomes for patients at intermediate and high risk if the target volume consists of the prostate with a generous periprostatic margin. There is no defined role for adjuvant hormonal manipulation. Although a reliable set of pretreatment criteria to predict implant related morbidity is not available, severe urinary and rectal morbidity is rare. The incidence of brachytherapy induced erectile dysfunction is significantly greater than initially reported but the majority of patients respond favorably to sildenafil.
   Conclusions: Continued refinements in brachytherapy planning and implementation techniques, postimplantation evaluation and continued elucidation of the etiology of urinary, bowel and sexual dysfunction should result in further improvements in biochemical and quality of life outcomes.
C1 Wheeling Hosp, Schiffler Canc Ctr, Wheeling, WV 26003 USA.
   George Washington Univ, Med Ctr, Div Radiat Oncol & Biophys, Washington, DC 20037 USA.
   Dept Vet Affairs, Puget Sound Hlth Care Syst, Seattle, WA USA.
RP Merrick, GS (reprint author), Wheeling Hosp, Schiffler Canc Ctr, Wheeling, WV 26003 USA.
CR Badiozamani KR, 1999, INT J RADIAT ONCOL, V43, P375, DOI 10.1016/S0360-3016(98)00418-0
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko JC, 2000, RADIOTHER ONCOL, V57, P273, DOI 10.1016/S0167-8140(00)00288-7
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Brachman DG, 2000, INT J RADIAT ONCOL, V48, P111, DOI 10.1016/S0360-3016(00)00598-8
   Carter HB, 1999, UROLOGY, V53, P126, DOI 10.1016/S0090-4295(98)00466-X
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   D'Amico AV, 2001, INT J RADIAT ONCOL, V49, P679, DOI 10.1016/S0360-3016(00)01423-1
   D'Amico AV, 2000, J CLIN ONCOL, V18, P1164
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Dattoli M, 1999, INT J RADIAT ONCOL, V45, P853, DOI 10.1016/S0360-3016(99)00259-X
   Davis BJ, 1999, CANCER, V85, P2630
   DAWSON JE, 1994, RADIOTHER ONCOL, V32, P268, DOI 10.1016/0167-8140(94)90027-2
   Desai J, 1998, Radiat Oncol Investig, V6, P135, DOI 10.1002/(SICI)1520-6823(1998)6:3<135::AID-ROI4>3.0.CO;2-Z
   Egan AJM, 1997, AM J SURG PATHOL, V21, P1496, DOI 10.1097/00000478-199712000-00013
   Gelblum DY, 2000, INT J RADIAT ONCOL, V48, P119, DOI 10.1016/S0360-3016(00)00632-5
   Grann A, 1998, INT J RADIAT ONCOL, V40, P135, DOI 10.1016/S0360-3016(97)00583-X
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Herold DM, 1998, UROLOGY, V51, P985, DOI 10.1016/S0090-4295(98)00029-6
   HUGHES S, 2002, RAD ONCOL INVESTIG S, V96, P79
   Jackson A, 2001, INT J RADIAT ONCOL, V49, P685, DOI 10.1016/S0360-3016(00)01414-0
   Landis Daniel, 2002, Brachytherapy, V1, P21, DOI 10.1016/S1538-4721(02)00004-1
   Lee LN, 2002, INT J RADIAT ONCOL, V52, P444, DOI 10.1016/S0360-3016(01)02598-6
   Leibovich BC, 2000, UROLOGY, V56, P726, DOI 10.1016/S0090-4295(00)00792-5
   Merrick GS, 2002, INT J RADIAT ONCOL, V52, P893, DOI 10.1016/S0360-3016(01)02675-X
   Merrick GS, 2002, UROLOGY, V60, P104, DOI 10.1016/S0090-4295(02)01638-2
   Merrick GS, 1999, UROLOGY, V53, P1112, DOI 10.1016/S0090-4295(99)00048-5
   Merrick GS, 2002, INT J RADIAT ONCOL, V52, P664, DOI 10.1016/S0360-3016(01)02670-0
   Merrick GS, 2003, ONCOLOGY-NY, V17, P52
   MERRICK GS, 2001, J BRACHYTHERAPY INT, V17, P189
   Merrick GS, 2001, UROLOGY, V57, P524, DOI 10.1016/S0090-4295(00)01017-7
   Merrick GS, 2000, INT J RADIAT ONCOL, V46, P215, DOI 10.1016/S0360-3016(99)00405-8
   Merrick GS, 2001, INT J RADIAT ONCOL, V51, P41, DOI 10.1016/S0360-3016(01)01594-2
   Merrick GS, 2002, UROLOGY, V60, P650, DOI 10.1016/S0090-4295(02)01840-X
   Merrick G S, 2000, Med Dosim, V25, P237, DOI 10.1016/S0958-3947(00)00047-9
   Merrick GS, 2000, INT J RADIAT ONCOL, V47, P121, DOI 10.1016/S0360-3016(99)00525-8
   Merrick GS, 2001, CANCER J, V7, P404
   Merrick GS, 2002, INT J RADIAT ONCOL, V54, P1055, DOI 10.1016/S0360-3016(02)03031-6
   Merrick GS, 2002, INT J RADIAT ONCOL, V52, P461, DOI 10.1016/S0360-3016(01)01811-9
   Merrick GS, 2002, INT J RADIAT ONCOL, V54, P450, DOI 10.1016/S0360-3016(02)02948-6
   Merrick GS, 1999, INT J RADIAT ONCOL, V44, P1111, DOI 10.1016/S0360-3016(99)00137-6
   Merrick Gregory S, 2002, Brachytherapy, V1, P95, DOI 10.1016/S1538-4721(02)00016-8
   Merrick GS, 2000, INT J RADIAT ONCOL, V48, P667, DOI 10.1016/S0360-3016(00)00698-2
   MERRICK GS, UNPUB RAD ONCOL INVE
   Merrick G S, 2000, Tech Urol, V6, P78
   Merrick GS, 2001, INT J RADIAT ONCOL, V50, P1253, DOI 10.1016/S0360-3016(01)01539-5
   Merrick GS, 2002, CANCER J, V8, P322, DOI 10.1097/00130404-200207000-00008
   Merrick GS, 2002, UROLOGY, V60, P98, DOI 10.1016/S0090-4295(02)01640-0
   Merrick GS, 1999, INT J RADIAT ONCOL, V43, P1021, DOI 10.1016/S0360-3016(98)00486-6
   Merrick G S, 2001, Tech Urol, V7, P233
   Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3
   Do TM, 2001, UROLOGY, V57, P1121, DOI 10.1016/S0090-4295(01)01051-2
   Potters L, 1999, CANCER J SCI AM, V5, P301
   Potters L, 2000, J CLIN ONCOL, V18, P1187
   Potters L, 2001, INT J RADIAT ONCOL, V50, P1235, DOI 10.1016/S0360-3016(01)01578-4
   Prete JJ, 1998, INT J RADIAT ONCOL, V40, P1001, DOI 10.1016/S0360-3016(97)00901-2
   RADGE H, 1998, CANCER, V83, P989
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Roberson PL, 1997, MED PHYS, V24, P251, DOI 10.1118/1.598058
   Smathers S, 2001, INT J RADIAT ONCOL, V50, P1207, DOI 10.1016/S0360-3016(01)01568-1
   Snyder KM, 2001, INT J RADIAT ONCOL, V50, P335, DOI 10.1016/S0360-3016(01)01442-0
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   Stock RG, 2001, J UROLOGY, V165, P436, DOI 10.1097/00005392-200102000-00020
   Stone NN, 2000, INT J RADIAT ONCOL, V46, P1199, DOI 10.1016/S0360-3016(99)00516-7
   Stone NN, 1998, J UROLOGY, V160, P1722, DOI 10.1016/S0022-5347(01)62393-0
   Terk MD, 1998, J UROLOGY, V160, P1379, DOI 10.1016/S0022-5347(01)62542-4
   Valicenti R, 2000, J CLIN ONCOL, V18, P2740
   Wallner K, 1997, INT J RADIAT ONCOL, V37, P565, DOI 10.1016/S0360-3016(96)00570-6
   WALLNER K, 1995, INT J RADIAT ONCOL, V32, P465, DOI 10.1016/0360-3016(94)00599-G
   Wallner K, 2001, PROSTATE BRACHYTHERA
   Wallner K, 2002, CANCER J, V8, P67
   WU CS, 1998, MED PHYS, V25, P2186
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   Zelefsky MJ, 2000, INT J RADIAT ONCOL, V47, P1261, DOI 10.1016/S0360-3016(00)00550-2
NR 75
TC 80
Z9 86
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAY
PY 2003
VL 169
IS 5
BP 1643
EP 1652
DI 10.1097/01.ju.0000035544.25483.61
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA 667WM
UT WOS:000182257600002
PM 12686802
ER

PT J
AU Swartz, MA
   Skobe, M
AF Swartz, MA
   Skobe, M
TI Lymphatic function, lymphangiogenesis, and cancer metastasis
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE lymphangiogenesis; lymphatic function; cancer; VEGF-C; VEGF-D; lymphatic
   metastasis
ID ENDOTHELIAL GROWTH-FACTOR; INTERSTITIAL FLUID VOLUME; FACTOR-C
   EXPRESSION; VEGF-C; INITIAL LYMPHATICS; CAPILLARY-PRESSURE; PRIMARY
   LYMPHEDEMA; FACTOR RECEPTOR-3; TRANSGENIC MICE; NODE METASTASIS
AB The lymphatic system serves as the primary route for the metastasis of many cancers and the extent of lymph node involvement is the most important indicator of tumor aggressiveness. Despite the apparent importance of the lymphatic vessels for tumor dissemination, it has remained unclear whether activation of lymphatic endothelial cells may affect tumor progression and metastasis and the molecular mechanisms of lymphangiogenesis are just beginning to be elucidated. This overview describes the unique structural and functional characteristics of the lymphatic vessels that render them particularly suitable for invasion by tumor cells and for their efficient transport to lymph nodes. Recent evidence indicates occurrence of tumor lymphangiogenesis and its correlation with metastasis. Molecular regulation of tumor lymphangiogenesis, its significance for tumor metastasis, and implications for cancer therapy are discussed. (C) 2001 Wiley-Liss, Inc.
C1 Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA.
   Northwestern Univ, Dept Biomed, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
RP Skobe, M (reprint author), Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, 1 Gustave L Levy Pl,1425 Madison Ave,Box 1130, New York, NY 10029 USA.
EM mihaela.skobe@mssm.edu
RI Swartz, Melody/B-7633-2009; Swartz, Melody/F-9563-2011
CR Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548
   Akagi K, 2000, BRIT J CANCER, V83, P887, DOI 10.1054/bjoc.2000.1396
   Andre T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.0.CO;2-E
   AUKLAND K, 1981, PHYSIOL REV, V61, P556
   AUKLAND K, 1993, PHYSIOL REV, V73, P1
   Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   BATES DO, 1994, J PHYSIOL-LONDON, V477, P355
   Berk DA, 1996, AM J PHYSIOL-HEART C, V270, pH330
   BERT JL, 1988, AM J PHYSIOL, V254, pH384
   BOLLINGER A, 1981, CIRCULATION, V64, P1195
   Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6
   Bunone G, 1999, AM J PATHOL, V155, P1967, DOI 10.1016/S0002-9440(10)65515-0
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   CASLEYS.J, 1961, Q J EXP PHYSIOL CMS, V46, P101
   COLANTUONI A, 1984, INT J MICROCIRC, V3, P13
   CORNFORD ME, 1993, LYMPHOLOGY, V26, P67
   DAROCZY J, 1988, DERMAL LYMPHATIC CAP
   Eggert A, 2000, CLIN CANCER RES, V6, P1900
   EVANS HM, 1908, J HOPKINS MED J, V19, P232
   Fellmer PT, 1999, SURGERY, V126, P1056, DOI 10.1067/msy.2099.101432
   FISCHER M, 1994, 18TH ANN EUR C MICR
   FISHER B, 1968, LYMPH LYMPHOTIC SYST, P324
   Folkman J, 1996, NEW ENGL J MED, V334, P921
   GERLI R, 1990, ANAT EMBRYOL, V181, P281
   GERLI R, 1991, LYMPHOLOGY, V24, P105
   GILCHRIST RK, 1950, AMA ARCH SURG, V61, P913
   GUYTON ARTHUR C., 1965, INVEST OPHTHALMOL, V4, P1075
   HALL J. G., 1965, J PHYSIOL [LONDON], V180, P336
   HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0
   HARGENS AR, 1977, AM J PHYSIOL, V233, pH57
   HOGAN RD, 1986, MICROVASC RES, V31, P317, DOI 10.1016/0026-2862(86)90020-8
   Ikomi F, 1996, AM J PHYSIOL-HEART C, V271, pH173
   JAIN RK, 1987, CANCER RES, V47, P3039
   Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423
   Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898
   Joukov V, 1996, EMBO J, V15, P1751
   Jussila L, 1998, CANCER RES, V58, P1599
   KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566
   Kurebayashi J, 1999, JPN J CANCER RES, V90, P977
   LAUWERYNS JM, 1976, J CELL BIOL, V68, P163, DOI 10.1083/jcb.68.1.163
   LEAK L V, 1970, Microvascular Research, V2, P361, DOI 10.1016/0026-2862(70)90031-2
   LEAK LV, 1976, FED PROC, V35, P1863
   LEAK LV, 1966, AM J ANAT, V118, P785, DOI 10.1002/aja.1001180308
   Lee FC, 1933, ARCH SURG-CHICAGO, V26, P602
   Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988
   Leu AJ, 2000, CANCER RES, V60, P4324
   LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C
   Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672
   MARCHETTI C, 1991, LYMPHOLOGY, V24, P26
   MCGEOWN JG, 1988, J PHYSIOL-LONDON, V397, P449
   MCHALE NG, 1989, MICROVASC RES, V37, P70, DOI 10.1016/0026-2862(89)90073-3
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MISLIN H, 1976, EXPERIENTIA, V32, P820, DOI 10.1007/BF02003701
   MORTIMER PS, 1990, J INVEST DERMATOL, V95, P677, DOI 10.1111/1523-1747.ep12514347
   NEGRINI D, 1994, J APPL PHYSIOL, V76, P2267
   Negrini D, 1996, AM J PHYSIOL-HEART C, V270, pH2000
   Niki T, 2000, CLIN CANCER RES, V6, P2431
   Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639
   OHHASHI T, 1980, AM J PHYSIOL, V239, pH88
   Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650
   Ohta Y, 2000, J THORAC CARDIOV SUR, V119, P804, DOI 10.1016/S0022-5223(00)70017-1
   OLSZEWSKI W, 1977, ACTA PHYSIOL SCAND, V99, P149, DOI 10.1111/j.1748-1716.1977.tb10365.x
   Olszewski WL, 1980, AM J PHYSIOL, V239, P775
   Papoutsi M, 2000, HISTOCHEM CELL BIOL, V114, P373
   Parsons RJ, 1938, J EXP MED, V68, P353, DOI 10.1084/jem.68.3.353
   Pullinger BD, 1935, BRIT J EXP PATHOL, V16, P49
   REDDY NP, 1981, MICROVASC RES, V21, P183, DOI 10.1016/0026-2862(81)90031-5
   Reichert FL, 1926, ARCH SURG-CHICAGO, V13, P871
   RENKIN EM, 1994, MICROVASC RES, V47, P318, DOI 10.1006/mvre.1994.1025
   Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2
   SCHAD H, 1976, ERGEB ANGIOL, V12, P185
   SCHAD H, 1978, PFLUG ARCH EUR J PHY, V378, P121, DOI 10.1007/BF00584444
   SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987
   SCHMIDSCHONBEIN GW, 1990, ARCH HISTOL CYTOL, V53, P107, DOI 10.1679/aohc.53.Suppl_107
   Shushanov S, 2000, INT J CANCER, V86, P47, DOI 10.1002/(SICI)1097-0215(20000401)86:1<47::AID-IJC7>3.0.CO;2-R
   SKOBE M, 2000, REV J INVEST DERMATO, V5, P14
   Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643
   SKOBE M, IN PRESS AM J PATHOL
   Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635
   Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324
   TANIGAWA N, 1981, LYMPHOLOGY, V14, P149
   TAYLOR AE, 1973, LYMPHOLOGY, V6, P192
   Tsurusaki T, 1999, BRIT J CANCER, V80, P309, DOI 10.1038/sj.bjc.6690356
   Veikkola T, 2000, CANCER RES, V60, P203
   WEISS L, 1989, CELL BIOPHYS, V14, P187
   WEN S, 1994, INT J MICROCIRC, V14, P139, DOI 10.1159/000178821
   Weninger W, 1999, LAB INVEST, V79, P243
   Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1
   Witte M H, 1997, EXS, V79, P65
   Witzenbichler B, 1998, AM J PATHOL, V153, P381, DOI 10.1016/S0002-9440(10)65582-4
   Yoffey JM, 1970, LYMPHATICS LYMPH LYM
   Yonemura Y, 1999, CLIN CANCER RES, V5, P1823
   ZAUGGVESTI B, 1993, MICROVASC RES, V46, P128, DOI 10.1006/mvre.1993.1041
   ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283
   ZEIDMAN I, 1955, CANCER, V8, P123, DOI 10.1002/1097-0142(1955)8:1<123::AID-CNCR2820080116>3.0.CO;2-A
   ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219
NR 96
TC 80
Z9 90
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD OCT 15
PY 2001
VL 55
IS 2
BP 92
EP 99
DI 10.1002/jemt.1160
PG 8
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 484TH
UT WOS:000171705300005
PM 11596154
ER

PT J
AU Ord, JK
   Koehler, AB
   Snyder, RD
AF Ord, JK
   Koehler, AB
   Snyder, RD
TI Estimation and prediction for a class of dynamic nonlinear statistical
   models
SO JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
LA English
DT Article
DE forecasting; Holt-Winters method; maximum likelihood estimation;
   state-space models
ID HOLT-WINTERS; FORECASTS; STATE; SPACE
AB A class of nonlinear state-space models, characterized by a single source of randomness, is introduced. A special case, the model underpinning the multiplicative Holt-Winters method of forecasting, is identified. Maximum likelihood estimation based on exponential smoothing instead of a Kalman filter, and with the potential to be applied in contexts involving non-Gaussian disturbances, is considered. A method for computing prediction intervals is proposed and evaluated on both simulated and real data.
C1 Penn State Univ, Dept Management Sci & Informat Syst, University Pk, PA 16802 USA.
   Penn State Univ, Dept Stat, University Pk, PA 16802 USA.
   Miami Univ, Dept Decis Sci & Management Informat Syst, Oxford, OH 45056 USA.
   Monash Univ, Dept Econometr, Clayton, Vic 3168, Australia.
RP Ord, JK (reprint author), Penn State Univ, Dept Management Sci & Informat Syst, University Pk, PA 16802 USA.
CR AKAIKE H, 1974, ANN I STAT MATH, V26, P363, DOI 10.1007/BF02479833
   ANSLEY CF, 1985, ANN STAT, V13, P1286, DOI 10.1214/aos/1176349739
   Aoki M, 1991, ECONOMET REV, V10, P1, DOI 10.1080/07474939108800194
   ARCHIBALD BC, 1990, INT J FORECASTING, V6, P199, DOI 10.1016/0169-2070(90)90005-V
   Bowerman B., 1993, FORECASTING TIME SER
   Box G. E. P., 1994, TIME SERIES ANAL
   CHATFIELD C, 1993, J BUS ECON STAT, V11, P121
   CHATFIELD C, 1991, INT J FORECASTING, V7, P31, DOI 10.1016/0169-2070(91)90030-Y
   GARDNER ES, 1985, J FORECASTING, V4, P1, DOI 10.1002/for.3980040103
   GARDNER ES, 1988, MANAGE SCI, V34, P542
   Harvey AC, 1983, J BUS ECON STAT, V1, P299, DOI 10.2307/1391661
   Harvey A.C., 1990, FORECASTING STRUCTUR
   Holt C. C., 1957, 52 ONR CARN I TECHN, V52
   MAKRIDAKIS S, 1982, J FORECASTING, V1, P111, DOI 10.1002/for.3980010202
   MCKENZIE E, 1976, STATISTICIAN, V25, P3, DOI 10.2307/2988127
   ORD JK, 1990, P DEC SCI I, P555
   ROBERTS SA, 1982, MANAGE SCI, V28, P808, DOI 10.1287/mnsc.28.7.808
   SCHWEPPE FC, 1965, IEEE T INFORM THEORY, V11, P61, DOI 10.1109/TIT.1965.1053737
   SNYDER RD, 1996, PREDICTION INTERVALS
   SNYDER RD, 1985, J ROY STAT SOC B MET, V47, P272
   SWEET AL, 1985, J FORECASTING, V4, P235, DOI 10.1002/for.3980040210
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
   WINTERS PR, 1960, MANAGE SCI, V6, P324, DOI 10.1287/mnsc.6.3.324
NR 23
TC 80
Z9 82
PU AMER STATISTICAL ASSOC
PI ALEXANDRIA
PA 1429 DUKE ST, ALEXANDRIA, VA 22314 USA
SN 0162-1459
J9 J AM STAT ASSOC
JI J. Am. Stat. Assoc.
PD DEC
PY 1997
VL 92
IS 440
BP 1621
EP 1629
DI 10.2307/2965433
PG 9
WC Statistics & Probability
SC Mathematics
GA YN091
UT WOS:000071132200044
ER

PT J
AU Hillis, LD
   Smith, PK
   Anderson, JL
   Bittl, JA
   Bridges, CR
   Byrne, JG
   Cigarroa, JE
   DiSesa, VJ
   Hiratzka, LF
   Hutter, AM
   Jessen, ME
   Keeley, EC
   Lahey, SJ
   Lange, RA
   London, MJ
   Mack, MJ
   Patel, MR
   Puskas, JD
   Sabik, JF
   Selnes, O
   Shahian, DM
   Trost, JC
   Winniford, MD
AF Hillis, L. David
   Smith, Peter K.
   Anderson, Jeffrey L.
   Bittl, John A.
   Bridges, Charles R.
   Byrne, John G.
   Cigarroa, Joaquin E.
   DiSesa, Verdi J.
   Hiratzka, Loren F.
   Hutter, Adolph M., Jr.
   Jessen, Michael E.
   Keeley, Ellen C.
   Lahey, Stephen J.
   Lange, Richard A.
   London, Martin J.
   Mack, Michael J.
   Patel, Manesh R.
   Puskas, John D.
   Sabik, Joseph F.
   Selnes, Ola
   Shahian, David M.
   Trost, Jeffrey C.
   Winniford, Michael D.
TI 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery A
   Report of the American College of Cardiology Foundation/American Heart
   Association Task Force on Practice Guidelines
SO CIRCULATION
LA English
DT Article
DE AHA Scientific Statements; acute coronary syndromes; anticoagulants;
   antiplatelet agents; arrhythmias, cardiac; coronary angiography;
   coronary artery revascularization interventions: stents; drug therapy;
   heart diseases; myocardial revascularization; platelet aggregation
   inhibitor; ultrasound
ID ACUTE MYOCARDIAL-INFARCTION; INTERNAL-MAMMARY-ARTERY; LONG-TERM
   SURVIVAL; RANDOMIZED-CONTROLLED-TRIAL; HIGH-RISK PATIENTS; IN-HOSPITAL
   MORTALITY; ACUTE-RENAL-FAILURE; DRUG-ELUTING STENTS; NEW-YORK-STATE;
   STERNAL WOUND-INFECTION
C1 [Hillis, L. David; Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
   [Smith, Peter K.] Duke Univ, Med Ctr Private Diagnost Clin, Durham, NC 27706 USA.
   [Bridges, Charles R.] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA.
   [Byrne, John G.] Vanderbilt Univ, Med Ctr Div Cardiac Surg, Nashville, TN 37235 USA.
   [Cigarroa, Joaquin E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [DiSesa, Verdi J.] Johns Hopkins Univ Hosp, Div Cardiac Surg, Baltimore, MD 21287 USA.
   [Hutter, Adolph M., Jr.; Shahian, David M.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Jessen, Michael E.] UT SW Med Ctr, Dallas, TX USA.
   [Keeley, Ellen C.] Univ Virginia, Charlottesville, VA 22903 USA.
   [Lahey, Stephen J.] Univ Connecticut, Storrs, CT USA.
   [London, Martin J.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA.
   [Patel, Manesh R.] Duke Univ, Med Ctr, Durham, NC 27706 USA.
   [Puskas, John D.] Emory Univ Emory Healthcare, Atlanta, GA USA.
   [Sabik, Joseph F.] Cleveland Clin Fdn, Cleveland, OH USA.
   [Selnes, Ola] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA.
   [Trost, Jeffrey C.] Johns Hopkins Sch Med, Baltimore, MD USA.
   [Winniford, Michael D.] Univ Mississippi, Med Ctr, University, MS 38677 USA.
RP Hillis, LD (reprint author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
CR Aaberge L, 2002, J AM COLL CARDIOL, V39, P1588, DOI 10.1016/S0735-1097(02)01828-4
   Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Abbaszadeh M, 2008, REV BRAS CIR CARDIOV, V23, P317, DOI 10.1590/S0102-76382008000300006
   Abboud CS, 2004, ANN THORAC SURG, V77, P676, DOI 10.1016/S0003-4975(03)01523-6
   Abizaid A, 2001, CIRCULATION, V104, P533, DOI 10.1161/hc3101.093700
   Aboyans V, 2006, EUR J CARDIO-THORAC, V30, P300, DOI 10.1016/j.ejcts.2006.03.066
   Abraham VS, 2000, CARDIOPULMONARY BYPA, P382
   Abramov D, 2000, ANN THORAC SURG, V70, P800, DOI 10.1016/S0003-4975(00)01563-0
   Acar C, 1998, J THORAC CARDIOV SUR, V116, P981, DOI 10.1016/S0022-5223(98)70050-9
   ACCF/AHA Task Force on Practice Guidelines, METH POL ACCF AHA TA
   Adabag AS, 2009, EUR HEART J, V30, P1910, DOI 10.1093/eurheartj/ehp053
   ADES PA, 1992, AM HEART J, V123, P916, DOI 10.1016/0002-8703(92)90696-S
   Agarwal S, 2010, AM J CARDIOL, V105, P1549, DOI 10.1016/j.amjcard.2010.01.012
   Aklog L, 2001, CIRCULATION, V104, pI68
   Alderman E, 1997, CIRCULATION, V96, P1761
   Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446
   Alexander KP, 2000, J AM COLL CARDIOL, V35, P731, DOI 10.1016/S0735-1097(99)00606-3
   Alexiou K, 2008, CLIN RES CARDIOL, V97, P601, DOI 10.1007/s00392-008-0657-6
   Alghamdi AA, 2006, J CARDIAC SURG, V21, P320, DOI 10.1111/j.1540-8191.2006.00241.x
   Ali IM, 1997, EUR J CARDIO-THORAC, V11, P1154, DOI 10.1016/S1010-7940(97)01215-3
   Al-Khatib SM, 2009, AM HEART J, V158, P792, DOI 10.1016/j.ahj.2009.09.003
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Allen KB, 1999, NEW ENGL J MED, V341, P1029, DOI 10.1056/NEJM199909303411403
   Al-Sarraf N, 2008, ANN THORAC SURG, V86, P517, DOI 10.1016/j.athoracsur.2008.03.070
   Alserius T, 2009, J THORAC CARDIOV SUR, V138, P1115, DOI 10.1016/j.jtcvs.2009.03.013
   Al Suwaidi J, 2004, AM HEART J, V147, P815, DOI 10.1016/j.ahj.2003.11.025
   *AM SOC AN, STAND BAS AN MON COM
   Amar D, 2001, CHEST, V119, P1476, DOI 10.1378/chest.119.5.1476
   American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography, 2010, ANESTHESIOLOGY, V112, P1084
   American Society of Anesthesiologists Task Force on pulmonary artery catheterization, 2003, ANESTHESIOLOGY, V99, P988
   Amin AP, 2009, J INVASIVE CARDIOL, V21, P305
   Amoroso G, 2001, Ital Heart J, V2, P139
   Anand SS, 2005, J AM COLL CARDIOL, V46, P1845, DOI 10.1016/j.jacc.2005.05.091
   Anderson JL, 2007, CIRCULATION, V116, pe148
   Anderson RE, 2005, EUR HEART J, V26, P1513, DOI 10.1093/eurheartj/ehi182
   Anderson RJ, 1999, KIDNEY INT, V55, P1057, DOI 10.1046/j.1523-1755.1999.0550031057.x
   ANDERSSON LG, 1993, THORAC CARDIOV SURG, V41, P237, DOI 10.1055/s-2007-1013861
   Andreasen JJ, 2000, SCAND CARDIOVASC J, V34, P242, DOI 10.1080/713783120
   Andrew MJ, 2001, J CARDIOTHOR VASC AN, V15, P9, DOI 10.1053/jcan.2001.20210
   ANDREWS TC, 1991, CIRCULATION, V84, P236
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   Angouras DC, 2010, ANN THORAC SURG, V89, P1112, DOI 10.1016/j.athoracsur.2010.01.009
   [Anonymous], 2006, ANESTHESIOLOGY, V104, P864
   [Anonymous], 2002, LANCET, V360, P965
   [Anonymous], 1996, J THORAC CARDIOVASC, V111, P1200
   [Anonymous], 1993, LANCET, V341, P573
   [Anonymous], 2002, LANCET, V360, P7
   [Anonymous], 2002, CIRCULATION, V106, P3143
   Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178
   [Anonymous], 2002, BMJ, V324, P141
   [Anonymous], 2011, FDA SAF AL ZOC SIMV
   Anthonisen NR, 2005, ANN INTERN MED, V142, P233
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424
   Arabaci U, 2003, JPN HEART J, V44, P61, DOI 10.1536/jhj.44.61
   Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002
   Argenziano M, 2006, ANN THORAC SURG, V81, P1666, DOI 10.1016/j.athoracsur.2005.11.007
   ARIANO RE, 1991, DICP ANN PHARMAC, V25, P478
   Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S040-6736(07)60716-8
   Aronson S, 2010, ANESTHESIOLOGY, V113, P305, DOI 10.1097/ALN.0b013e3181e07ee9
   Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107
   Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7
   Ashley ESD, 2004, CLIN INFECT DIS, V38, P1555
   *ASTRAZENECA, 22433 REMS NDA ASTRA
   Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athorascur.2003.07.002
   Augoustides JGT, 2006, J CARDIOTHOR VASC AN, V20, P379, DOI 10.1053/j.jvca.2005.10.011
   Austin PC, 2003, MED DECIS MAKING, V23, P526, DOI 10.1177/0272989X03258443
   AUSTIN TW, 1980, CAN J SURG, V23, P483
   AUTSCHBACH R, 1994, PACE, V17, P552, DOI 10.1111/j.1540-8159.1994.tb01425.x
   Avidan MS, 2004, BRIT J ANAESTH, V92, P178, DOI 10.1093/bja/aeh037
   Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361
   Aziz O, 2007, BRIT MED J, V334, P617, DOI 10.1136/bmj.39106.476215.BE
   Badreldin A, 2010, INTERACT CARDIOV TH, V10, P48, DOI 10.1510/icvts.2009.211805
   Bae Ki Sun, 2007, Korean Journal of Internal Medicine, V22, P139
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baillot R, 2010, EUR J CARDIO-THORAC, V37, P880, DOI 10.1016/j.ejcts.2009.09.023
   Bainbridge D, 2006, CAN J ANAESTH, V53, P46
   Bainbridge D, 2006, CAN J ANAESTH, V53, P492
   Bair TL, 2007, CIRCULATION, V116, pI226, DOI 10.1161/CIRCULATIONAHA.106.681346
   Balacumaraswami L, 2007, ANN THORAC SURG, V83, P2251, DOI 10.1016/j.athoracsur.2006.12.025
   Banbury MK, 2006, J AM COLL SURGEONS, V202, P131, DOI 10.1016/j.jamcollsurg.2005.08.028
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Bapoje SR, 2007, CHEST, V132, P1637, DOI 10.1378/chest.07-0347
   Barakate MS, 2003, ANN THORAC SURG, V75, P1400, DOI 10.1016/S0003-4975(02)05026-9
   Bardakci H, 2007, ANN THORAC SURG, V83, P483, DOI 10.1016/j.athoracsur.2006.09.047
   BARNER HB, 1994, ANN THORAC SURG, V57, P1526
   BARNER HB, 1974, ARCH SURG-CHICAGO, V109, P627
   BARNER HB, 1985, J THORAC CARDIOV SUR, V90, P668
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   Becker ER, 2006, J NATL MED ASSOC, V98, P1729
   BELL MR, 1990, J AM COLL CARDIOL, V16, P553
   Beller GA, 2010, JACC-CARDIOVASC INTE, V3, P315, DOI 10.1016/j.jcin.2010.01.007
   Benedetto U, 2008, ANN THORAC SURG, V86, P1160, DOI 10.1016/j.athoracsur.2008.06.018
   Benedetto U, 2009, EUR J CARDIO-THORAC, V36, P611, DOI 10.1016/j.ejcts.2009.03.012
   Ben-Gal Y, 2006, ANN THORAC SURG, V82, P2067, DOI 10.1016/j.athoracsur.2006.06.041
   BENNETT B, 1991, OBSTET GYNECOL, V78, P1019
   BennettGuerrero E, 1996, JAMA-J AM MED ASSOC, V275, P687, DOI 10.1001/jama.275.9.687
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berendes E, 2003, ARCH SURG-CHICAGO, V138, P1283, DOI 10.1001/archsurg.138.12.1283
   Berger JS, 2008, J AM COLL CARDIOL, V52, P1693, DOI 10.1016/j.jacc.2008.08.031
   BERGER PB, 1995, AM J CARDIOL, V76, P565, DOI 10.1016/S0002-9149(99)80156-8
   Berger PB, 2001, J AM COLL CARDIOL, V38, P1440, DOI 10.1016/S0735-1097(01)01571-6
   Bergquist BD, 1996, ANESTH ANALG, V82, P1139, DOI 10.1097/00000539-199606000-00007
   Berkowitz SD, 2001, AM J CARDIOL, V88, P1230, DOI 10.1016/S0002-9149(01)02082-3
   Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568
   BERNTSEN RF, 1993, EUR HEART J, V14, P1297
   Berridge DC, 1998, J ROY COLL SURG EDIN, V43, P9
   Berry PD, 1998, BRIT J ANAESTH, V80, P20
   Biancari F, 2007, ANN THORAC SURG, V84, P254, DOI 10.1016/j.athoracsur.2007.02.022
   Bignami E, 2010, J CARDIOTHOR VASC AN, V24, P586, DOI 10.1053/j.jvca.2009.09.015
   Bijker JB, 2007, ANESTHESIOLOGY, V107, P213, DOI 10.1097/01.anes.0000270724.40897.8e
   Bilgin YM, 2010, CRIT CARE MED, V38, P546, DOI 10.1097/CCM.0b013e3181c0de7b
   Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21
   Bingol H, 2005, J CARDIAC SURG, V20, P252, DOI 10.1111/j.1540-8191.2005.200392.x
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   BIRKMEYER JD, 1995, J VASC SURG, V21, P445, DOI 10.1016/S0741-5214(95)70286-5
   Birkmeyer J D, 1999, Eff Clin Pract, V2, P277
   Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205
   Birkmeyer JD, 1999, SURGERY, V125, P250, DOI 10.1067/msy.1999.95211
   Birkmeyer JD, 2006, CANCER, V106, P2476, DOI 10.1002/cncr.21888
   Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139
   Birkmeyer JD, 2000, J AM COLL SURGEONS, V190, P341, DOI 10.1016/S1072-7515(99)00270-7
   Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741
   Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337
   Birkmeyer JD, 2000, JAMA-J AM MED ASSOC, V283, P1191, DOI 10.1001/jama.283.9.1191
   Bizzarri F, 2001, J THORAC CARDIOV SUR, V122, P1181, DOI 10.1067/mtc.2001.117838
   BJORK VO, 1981, SCAND J THORAC CARD, V15, P23, DOI 10.3109/14017438109101021
   BLANCHARD A, 1995, EUR J CARDIO-THORAC, V9, P153, DOI 10.1016/S1010-7940(05)80064-8
   Blankstein R, 2005, CIRCULATION, V112, pI323, DOI 10.1161/CIRCULATIONAHA.104.525139
   Blumberg N, 2002, AM J CLIN PATHOL, V118, P376
   Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Bolon MK, 2004, CLIN INFECT DIS, V38, P1357, DOI 10.1086/383318
   Bonaros N, 2009, J THORAC CARDIOV SUR, V137, P846, DOI 10.1016/j.jtcvs.2008.09.041
   Bonaros N, 2009, CARDIOLOGY, V114, P59, DOI 10.1159/000212115
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonatti J, 2006, J THORAC CARDIOV SUR, V131, P146, DOI 10.1016/j.jtcvs.2005.07.064
   Bonow RO, 2011, NEW ENGL J MED, V364, P1625
   Boodhwani M, 2009, ANN THORAC SURG, V87, P489, DOI 10.1016/j.athoracsur.2008.10.078
   Borger MA, 1998, ANN THORAC SURG, V65, P1050, DOI 10.1016/S0003-4975(98)00063-0
   Borowicz L, 2002, PSYCHOSOMATICS, V43, P464, DOI 10.1176/appi.psy.43.6.464
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   BOURASSA MG, 1985, CIRCULATION, V72, P71
   Bourassa MG, 1998, EUR HEART J, V19, P103, DOI 10.1053/euhj.1997.0574
   BOYLAN MJ, 1994, J THORAC CARDIOV SUR, V107, P657
   Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159
   BrandrupWognsen G, 1996, EUR HEART J, V17, P1426
   Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220
   Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53
   Bravata DM, 2007, ANN INTERN MED, V147, P703
   Braxton John H, 2004, Semin Thorac Cardiovasc Surg, V16, P70, DOI 10.1053/j.semtcvs.2004.01.006
   BREISBLATT WM, 1990, J AM COLL CARDIOL, V15, P1261
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55
   Bridges CR, 2004, ANN THORAC SURG, V77, P1494, DOI 10.1016/j.athoracsur.2004.01.007
   Briguori C, 2007, AM J CARDIOL, V99, P779, DOI 10.1016/j.amjcara.2006.10.031
   BROOKS N, 1979, BRIT HEART J, V42, P333
   Brophy JM, 2003, ANN INTERN MED, V138, P777
   Brown PP, 2008, ANN THORAC SURG, V85, P1980, DOI 10.1016/j.athoracsur.2008.01.053
   Bucerius J, 2004, J THORAC CARDIOV SUR, V127, P57, DOI 10.1016/S0022-5223(03)01281-9
   Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9
   BUCHE M, 1995, J THORAC CARDIOV SUR, V109, P553, DOI 10.1016/S0022-5223(95)70288-1
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Buckberg GD, 2010, J THORAC CARDIOV SUR, V140, P12, DOI 10.1016/j.jtcvs.2010.02.014
   Budeus M, 2006, INT J CARDIOL, V113, P201, DOI 10.1016/j.ijcard.2005.11.014
   Bukkapatnam RN, 2010, AM J CARDIOL, V105, P339, DOI 10.1016/j.amjcard.2009.09.035
   Bundy JK, 2006, AM J INFECT CONTROL, V34, P114, DOI 10.1016/j.ajic.2005.10.003
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   Butterworth J, 2005, J THORAC CARDIOV SUR, V130, P1319, DOI 10.1016/j.jtcvs.2005.02.049
   Butterworth J, 1998, ANESTHESIOLOGY, V88, P1437, DOI 10.1097/00000542-199806000-00005
   Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805
   CABRI Trial Participants, 1995, LANCET, V346, P1179
   Cahalan MK, 2002, J AM SOC ECHOCARDIOG, V15, P647, DOI 10.1067/mje.2002.123956
   Cai Tung H, 2007, Innovations (Phila), V2, P245, DOI 10.1097/IMI.0b013e31815cd976
   Caimmi PP, 2003, J CARDIOTHOR VASC AN, V17, P491, DOI 10.1016/S1053-0770(03)00155-1
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Campeau L, 1997, NEW ENGL J MED, V336, P153
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Canver CC, 1998, ANN THORAC SURG, V66, P144, DOI 10.1016/S0003-4975(98)00322-1
   Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   CAREY JA, 1994, BRIT HEART J, V72, P428
   Carrie D, 1997, CIRCULATION, V96, pII6
   Cartier R, 2008, EUR J CARDIO-THORAC, V34, P826, DOI 10.1016/j.ejcts.2008.07.024
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   Castellheim A, 2008, ANN THORAC SURG, V85, P1994, DOI 10.1016/j.athoracsur.2008.03.012
   CAVENDER JB, 1992, J AM COLL CARDIOL, V20, P287
   Cecil WT, 2008, AM J MANAG CARE, V14, P521
   Centers for Diseases Control and Prevention, 2010, MMWR-MORBID MORTAL W, V44, P1
   Chaitman BR, 2009, CIRCULATION, V120, P2529, DOI 10.1161/CIRCULATIONAHA.109.913111
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Chamchad D, 2010, J CARDIOTHOR VASC AN, V24, P780, DOI 10.1053/j.jvca.2010.04.002
   Chan AYM, 2010, J THORAC CARDIOV SUR, V140, P182, DOI 10.1016/j.jtcvs.2010.03.015
   Chaney MA, 2000, ANESTHESIOLOGY, V92, P1637, DOI 10.1097/00000542-200006000-00022
   Chang Andrew C, 2006, Thorac Surg Clin, V16, P87, DOI 10.1016/j.thorsurg.2006.01.008
   Charrot F, 2010, INTERACT CARDIOV TH, V10, P346, DOI 10.1510/icvts.2009.219352
   Chassin MR, 2002, HEALTH AFFAIR, V21, P40, DOI 10.1377/hlthaff.21.4.40
   Chatterjee K, 2009, CIRCULATION, V119, P147, DOI 10.1161/CIRCULATIONAHA.108.811141
   Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9
   CHEITLIN MD, 1974, CIRCULATION, V50, P780
   Chelemer SB, 2002, ANN THORAC SURG, V73, P138, DOI 10.1016/S0003-4975(01)03308-2
   Chen J, 2000, ARCH INTERN MED, V160, P947, DOI 10.1001/archinte.160.7.947
   Chen YF, 2004, ANN THORAC SURG, V78, P634, DOI 10.1016/j.athoracsur.2004.02.091
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cheng DCH, 1996, J THORAC CARDIOV SUR, V112, P755, DOI 10.1016/S0022-5223(96)70062-4
   Cheng DCH, 1996, ANESTHESIOLOGY, V85, P1300, DOI 10.1097/00000542-199612000-00011
   Chertow GM, 1997, CIRCULATION, V95, P878
   CHESEBRO JH, 1984, NEW ENGL J MED, V310, P209, DOI 10.1056/NEJM198401263100401
   CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201
   CHEUNG AT, 1994, ANESTHESIOLOGY, V81, P376, DOI 10.1097/00000542-199408000-00016
   Chevalier P, 2004, EUR J CARDIO-THORAC, V26, P330, DOI 10.1016/j.ejcts.2004.04.027
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chiu FC, 2009, J THORAC CARDIOV SUR, V138, P1326, DOI 10.1016/j.jtcvs.2009.03.038
   Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Choudhry NK, 2005, AM J MED, V118, P465, DOI 10.1016/j.amjmed.2005.02.016
   Chowdhury UK, 2008, J THORAC CARDIOV SUR, V135, P1110, DOI 10.1016/j.jtcvs.2007.12.029
   CHRISTAKIS GT, 1995, J THORAC CARDIOV SUR, V110, P1344, DOI 10.1016/S0022-5223(95)70058-7
   Christenson JT, 1999, EUR J CARDIO-THORAC, V15, P394, DOI 10.1016/S1010-7940(99)00034-2
   Christenson JT, 2003, J CARDIAC SURG, V18, P286, DOI 10.1046/j.1540-8191.2003.02030.x
   Christenson J T, 1996, Cardiovasc Surg, V4, P801, DOI 10.1016/S0967-2109(96)00052-X
   Christenson JT, 1999, ANN THORAC SURG, V68, P934, DOI 10.1016/S0003-4975(99)00687-6
   Christenson JT, 2002, ANN THORAC SURG, V74, P1086, DOI 10.1016/S0003-4975(02)03854-7
   Christenson JT, 2001, CARDIOVASC SURG, V9, P383, DOI 10.1016/S0967-2109(00)00151-4
   Christiansen CL, 1997, ANN INTERN MED, V127, P764
   Chu MWA, 2004, ANN THORAC SURG, V78, P1536, DOI 10.1016/j.athoracsur.2004.03.028
   Chukwuemeka A, 2005, ANN THORAC SURG, V80, P2148, DOI 10.1016/j.athoracsur.2005.06.015
   CHUNG F, 1988, ANESTHESIOLOGY, V69, P343, DOI 10.1097/00000542-198809000-00010
   Cisowski M, 2002, ANN THORAC SURG, V74, pS1334
   Cisowski Marek, 2004, Kardiol Pol, V61, P253
   Clark AM, 2005, ANN INTERN MED, V143, P659
   Clark R E, 1996, Best Pract Benchmarking Healthc, V1, P62
   Clark RE, 1996, ANN THORAC SURG, V61, P21, DOI 10.1016/0003-4975(95)00734-2
   Cogliati AA, 2007, J CARDIOTHOR VASC AN, V21, P847, DOI 10.1053/j.jvca.2007.02.022
   Cole JH, 2002, J AM COLL CARDIOL, V40, P1968, DOI 10.1016/S0735-1097(02)02561-5
   Coleman CI, 2007, CURR MED RES OPIN, V23, P1783, DOI 10.1185/030079907X210570
   Collard CD, 2006, J THORAC CARDIOV SUR, V132, P392, DOI 10.1016/j.jtcvs.2006.04.009
   Conaway DG, 2003, J AM COLL CARDIOL, V42, P1421, DOI 10.1016/S0735-1097(03)01052-0
   Connerney I, 2001, LANCET, V358, P1766, DOI 10.1016/S0140-6736(01)06803-9
   Connolly SJ, 2003, AM HEART J, V145, P226, DOI 10.1067/mhj.2003.147
   Cook JR, 2002, AM HEART J, V143, P821, DOI 10.1067/mhj.2002.121732
   Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084
   CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E
   Coskun KO, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-3
   Cowan KN, 2005, ANN THORAC SURG, V80, P2205, DOI 10.1016/j.athoracsur.2005.04.005
   Crabtree Traves D, 2004, Semin Thorac Cardiovasc Surg, V16, P53, DOI 10.1053/j.semtcvs.2004.01.009
   CRAVER JM, 1992, ANN SURG, V215, P425, DOI 10.1097/00000658-199205000-00004
   CRESWELL LL, 1995, ANN THORAC SURG, V60, P19
   Crystal E, 2004, COCHRANE DB SYST REV, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2005.12.015
   Cywinski JB, 2006, J CARDIOTHOR VASC AN, V20, P796, DOI 10.1053/j.jvca.2006.01.022
   Czech B, 2007, KARDIOL POL, V65, P627
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0
   D'Ambra MN, 1997, ANN THORAC SURG, V64, P1686, DOI 10.1016/S0003-4975(97)00839-4
   Danner BC, 2009, ANN THORAC SURG, V88, P1433, DOI 10.1016/j.athoracsur.2009.06.059
   DAOUD EG, 1995, AM HEART J, V130, P277, DOI 10.1016/0002-8703(95)90440-9
   Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501
   Davies JE, 2009, ANN THORAC SURG, V88, P844, DOI 10.1016/j.athoracsur.2009.06.007
   Davies RF, 1997, CIRCULATION, V95, P2037
   Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0
   DAVIS KB, 1995, J AM COLL CARDIOL, V25, P1000, DOI 10.1016/0735-1097(94)00518-U
   Davis RF, 2000, CARDIOPULMONARY BYPA, P186, DOI DOI 10.1053/J.JVCA.2007.02.022
   DAVISON R, 1985, ANN THORAC SURG, V39, P336
   DeBois William, 2005, J Extra Corpor Technol, V37, P15
   DeFoe GR, 2001, ANN THORAC SURG, V71, P769, DOI 10.1016/S0003-4975(00)02393-6
   De Hert SG, 2002, ANESTHESIOLOGY, V97, P42, DOI 10.1097/00000542-200207000-00007
   De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009
   De Hert SG, 2004, ANESTHESIOLOGY, V101, P9, DOI 10.1097/00000542-200407000-00005
   Del Duca D, 2007, ANN THORAC SURG, V84, P1264, DOI 10.1016/j.athoracsur.2007.05.016
   DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914
   Dempsey C M, 2004, Crit Care Resusc, V6, P248
   De Paulis R, 2005, J THORAC CARDIOV SUR, V129, P536, DOI 10.1016/j.jtcvs.2004.07.059
   Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982
   DESPOTIS GJ, 1994, TRANSFUSION, V34, P290, DOI 10.1046/j.1537-2995.1994.34494233575.x
   DEWOOD MA, 1983, CIRCULATION, V68, P8
   Dial S, 2005, J THORAC CARDIOV SUR, V130, P654, DOI 10.1016/j.jtcvs.2005.02.025
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563
   Di Mauro M, 2007, ANN THORAC SURG, V84, P1496, DOI 10.1016/j.athoracsur.2007.05.054
   Di Mauro M, 2005, ANN THORAC SURG, V79, P81, DOI 10.1016/j.athoracsur.2004.06.058
   Djaiani G, 2007, CIRCULATION, V116, P1888, DOI 10.1161/CIRCULATIONAHA.107.698001
   Doenst T, 2005, J THORAC CARDIOV SUR, V130, P1144, DOI 10.1016/j.jtcvs.2005.05.049
   Donatelli F, 1997, EUR J CARDIO-THORAC, V11, P228, DOI 10.1016/S1010-7940(96)01050-0
   Doss M, 2002, EUR J CARDIO-THORAC, V22, P934, DOI 10.1016/S1010-7940(02)00594-8
   Dotani MI, 2000, AM J CARDIOL, V86, P1128, DOI 10.1016/S0002-9149(00)01172-3
   Dowd NP, 1998, ANESTHESIOLOGY, V89, P1068, DOI 10.1097/00000542-199811000-00006
   Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180
   Drenth DJ, 2004, AM J CARDIOL, V94, P1414, DOI 10.1016/j.amjcard.2004.08.016
   Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6
   Drew BJ, 2004, CIRCULATION, V110, P2721, DOI 10.1161/01.CIR.0000145144.56673.59
   Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159
   Duncan AE, 2010, ANESTHESIOLOGY, V112, P860, DOI 10.1097/ALN.0b013e3181d3d4b4
   Durand DJ, 2004, ANN THORAC SURG, V78, P159, DOI 10.1016/j.athorascur.2004.02.024
   Dyke CM, 2000, ANN THORAC SURG, V70, P866, DOI 10.1016/S0003-4975(00)01654-4
   Dyub AM, 2008, J CARDIAC SURG, V23, P79, DOI 10.1111/j.1540-8191.2007.00499.x
   Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Eagle KA, 2004, CIRCULATION, V110, P340
   Ebrahimi R, 2009, J AM COLL CARDIOL, V53, P1965, DOI 10.1016/j.jacc.2009.03.006
   Echahidi N, 2008, J AM COLL CARDIOL, V51, P793, DOI 10.1016/j.jacc.2007.10.043
   Edmonds HL, 2011, J NEUROIMAGING, V21, P177, DOI 10.1111/j.1552-6569.2010.00471.x
   Edmonds HL, 2010, J CARDIOTHOR VASC AN, V24, P541, DOI 10.1053/j.jvca.2010.04.003
   Edwards FH, 2006, ANN THORAC SURG, V81, P397, DOI 10.1016/j.athoracsur.2005.06.034
   Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C
   Eifert S, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-90
   Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179
   Eisenstein EL, 2009, J MED SYST, V33, P287, DOI 10.1007/s10916-008-9190-4
   Ekery DL, 2003, AM HEART J, V145, P896, DOI 10.1016/S0002-8703(02)00077-7
   El-Hamamsy I, 2007, J THORAC CARDIOV SUR, V133, P7, DOI 10.1016/j.jtcvs.2006.05.070
   Ellis SG, 1997, CIRCULATION, V96, P3867
   Eltzschig HK, 2008, ANN THORAC SURG, V85, P845, DOI 10.1016/j.athoracsur.2007.11.015
   Engblom E, 1997, J Cardiopulm Rehabil, V17, P29, DOI 10.1097/00008483-199701000-00004
   Englberger L, 2004, EUR J CARDIO-THORAC, V26, P96, DOI 10.1016/j.ejcts.2004.03.030
   Engoren M, 2002, CHEST, V122, P1309, DOI 10.1378/chest.122.4.1309
   Ennker Ina C, 2009, Asian Cardiovasc Thorac Ann, V17, P253, DOI 10.1177/0218492309104746
   Ennker IC, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-5
   Erickson LC, 2000, JAMA-J AM MED ASSOC, V283, P1976, DOI 10.1001/jama.283.15.1976
   Evans BA, 2001, NEUROLOGY, V57, P1328
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   Fansa Iyad, 2003, Med Sci Monit, V9, pPI30
   Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012
   Fattouch K, 2009, J THORAC CARDIOV SUR, V138, P278, DOI 10.1016/j.jtcvs.2008.11.010
   Fattouch K, 2010, ANN THORAC SURG, V90, P1187, DOI 10.1016/j.athoracsur.2010.03.103
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   FAXON DP, 1992, AM HEART J, V123, P854, DOI 10.1016/0002-8703(92)90687-Q
   Fearn SJ, 2001, J THORAC CARDIOV SUR, V121, P1150, DOI 10.1067/mtc.2001.114099
   Fedoruk LM, 2007, J THORAC CARDIOV SUR, V133, P456, DOI 10.1016/j.jtcvs.2006.10.011
   Feit F, 2000, CIRCULATION, V101, P2795
   FEKETY FR, 1969, J THORAC CARDIOV SUR, V57, P757
   Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221
   Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49
   Ferguson TB, 2000, ANN THORAC SURG, V69, P680, DOI 10.1016/S0003-4975(99)01538-6
   Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395
   Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099
   Ferraris VA, 2002, ANN SURG, V235, P820, DOI 10.1097/00000658-200206000-00009
   FERRARIS VA, 1988, ANN THORAC SURG, V45, P71
   Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008
   FERRARIS VA, 1989, J THORAC CARDIOV SUR, V98, P492
   FERRARIS VA, 1995, TEX HEART I J, V22, P216
   Filizcan U, 2011, ANGIOLOGY, V62, P68, DOI 10.1177/0003319710369103
   Fillinger MP, 2002, ANESTH ANALG, V95, P1483, DOI 10.1213/01.ANE.0000034720.36481.21
   Filsoufi F, 2009, J CARDIOTHOR VASC AN, V23, P488, DOI 10.1053/j.jvca.2009.02.007
   Filsoufi F, 2008, ANN THORAC SURG, V85, P862, DOI 10.1016/j.athoracsur.2007.10.060
   Filsoufi F, 2007, J CARDIOTHOR VASC AN, V21, P784, DOI 10.1053/j.jvca.2007.08.007
   Filsoufi F, 2008, J CARDIOTHOR VASC AN, V22, P60, DOI 10.1053/j.jvca.2007.10.009
   Filsoufi F, 2002, J HEART VALVE DIS, V11, pS45
   Finkelstein R, 2002, J THORAC CARDIOV SUR, V123, P326, DOI 10.1067/mtc.2002.119698
   FIORE AC, 1990, ANN THORAC SURG, V49, P202
   Firanescu CE, 2009, EUR J CARDIO-THORAC, V36, P856, DOI 10.1016/j.ejcts.2009.05.032
   Fischer UM, 2005, CURR MED RES OPIN, V21, P1161, DOI 10.1185/030079905X53289
   FitzGibbon G, 1996, CAN J CARDIOL, V12, P893
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   FITZGIBBON GM, 1987, CAN MED ASSOC J, V136, P45
   Fleck Tatjana, 2006, Interact Cardiovasc Thorac Surg, V5, P145, DOI 10.1510/icvts.2005.122804
   Fleck TM, 2002, ANN THORAC SURG, V74, P1596, DOI 10.1016/S0003-4975(02)03948-6
   Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690
   Fletcher N, 2007, J BONE JOINT SURG AM, V89A, P1605, DOI 10.2106/JBJS.F.00901
   FLOOD AB, 1984, MED CARE, V22, P98, DOI 10.1097/00005650-198402000-00002
   FONG IW, 1979, J THORAC CARDIOV SUR, V78, P908
   Fontes ML, 1999, J CARDIOTHOR VASC AN, V13, P521, DOI 10.1016/S1053-0770(99)90001-0
   Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x
   Fox Amanda A, 2004, Semin Cardiothorac Vasc Anesth, V8, P283, DOI 10.1177/108925320400800403
   Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X
   Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B
   Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007
   Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X
   Fox KM, 2007, AM HEART J, V153, P629, DOI 10.1016/j.ahj.2007.01.032
   Frassdorf J, 2009, BRIT J ANAESTH, V103, P89, DOI 10.1093/bja/aep141
   FRASURESMITH N, 1985, PSYCHOSOM MED, V47, P431
   Fraund S, 2005, ANN THORAC SURG, V79, P1225, DOI 10.1016/j.arthoracsur.2004.08.082
   Frazier OH, 1999, NEW ENGL J MED, V341, P1021, DOI 10.1056/NEJM199909303411402
   Freedland KE, 2009, ARCH GEN PSYCHIAT, V66, P387, DOI 10.1001/archgenpsychiatry.2009.7
   Friedman DB, 1997, AM J CARDIOL, V79, P281
   Friedrich JO, 2005, ANN INTERN MED, V142, P510
   Frommelt PC, 2011, J THORAC CARDIOVASC
   Frutkin AD, 2008, AM J CARDIOL, V101, P53, DOI 10.1016/j.amjcard.2007.07.047
   Frye RL, 2009, NEW ENGL J MED, V360, P2503
   FULLER JK, 1985, VASCULAR SURG, V19, P174, DOI 10.1177/153857448501900305
   Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181
   Furnary Anthony P, 2006, Semin Thorac Cardiovasc Surg, V18, P302, DOI 10.1053/j.semtcvs.2006.04.005
   Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4
   Fuster RG, 2006, EUR J CARDIO-THORAC, V29, P202, DOI 10.1016/j.ejcts.2005.11.015
   Fuster V, 1997, NEW ENGL J MED, V336, P212, DOI 10.1056/NEJM199701163360309
   FUSTER V, 1979, CIRCULATION, V60, P1508
   Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d
   GALBUT DL, 1990, ANN THORAC SURG, V49, P195
   Gallagher R, 2009, J ADV NURS, V65, P2386, DOI 10.1111/j.1365-2648.2009.05101.x
   Gandhi GY, 2005, MAYO CLIN PROC, V80, P862
   Gandhi GY, 2007, ANN INTERN MED, V146, P233
   GANI JS, 1990, AUST NZ J SURG, V60, P171
   Gansera B, 2003, THORAC CARDIOV SURG, V51, P185
   Gansera B, 2004, THORAC CARDIOV SURG, V52, P261, DOI 10.1055/s-2004-821154
   Garcia C, 2005, BRIT J ANAESTH, V94, P159, DOI 10.1093/bja/aei026
   GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450
   GAUDIANI VA, 1991, ANN THORAC SURG, V51, P823
   GEELHOED GW, 1983, SURG GYNECOL OBSTET, V157, P265
   GEHA AS, 1979, AM J SURG, V137, P456, DOI 10.1016/0002-9610(79)90114-4
   Gengo FM, 2008, J CLIN PHARMACOL, V48, P117, DOI 10.1177/0091270007310379
   Geraci JM, 2005, MED CARE, V43, P149, DOI 10.1097/00005650-200502000-00008
   Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015
   Ghali WA, 1997, JAMA-J AM MED ASSOC, V277, P379, DOI 10.1001/jama.277.5.379
   Ghanta RK, 2010, J THORAC CARDIOV SUR, V140, P103, DOI 10.1016/j.jtcvs.2009.10.001
   Ghorbel MT, 2010, PHYSIOL GENOMICS, V42, P67, DOI 10.1152/physiolgenomics.00174.2009
   Ghosh S, 2003, J THORAC CARDIOV SUR, V126, P133, DOI 10.1016/S0022-5223(02)73293-5
   Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Gillinov A Marc, 2005, Curr Cardiol Rep, V7, P101, DOI 10.1007/s11886-005-0020-8
   Gioia G, 2007, CATHETER CARDIO INTE, V70, P26, DOI 10.1002/ccd.21072
   Glas KE, 2008, ANESTH ANALG, V106, P1376, DOI 10.1213/ane.0b013e31816a6b4c
   Glineur D, 2008, J AM COLL CARDIOL, V51, P120, DOI 10.1016/j.jacc.2007.09.030
   Gold JP, 2004, ANN THORAC SURG, V78, P1579, DOI 10.1016/j.athoracsur.2004.05.051
   Goldenberg I, 2003, ARCH INTERN MED, V163, P2301, DOI 10.1001/archinte.163.19.2301
   GOLDMAN S, 1990, CIRCULATION, V82, P237
   GOLDMAN S, 1991, CIRCULATION, V84, P520
   Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325
   Gombotz H, 1996, SEMIN HEMATOL, V33, P69
   GOODMAN JS, 1968, NEW ENGL J MED, V278, P117, DOI 10.1056/NEJM196801182780301
   GORDON MA, 1991, ANESTHESIOLOGY, V74, P848, DOI 10.1097/00000542-199105000-00008
   Goto T, 2001, ANN THORAC SURG, V72, P137, DOI 10.1016/S0003-4975(01)02676-5
   Goto T, 2003, ANN THORAC SURG, V75, P1912, DOI 10.1016/S0003-4975(03)00029-8
   Gottesman RF, 2010, ANN NEUROL, V67, P338, DOI 10.1002/ana.21899
   Gottesman RF, 2006, STROKE, V37, P2306, DOI 10.1161/01.STR.0000236024.68020.3a
   Goy JJ, 2008, J AM COLL CARDIOL, V52, P815, DOI 10.1016/j.jacc.2008.05.037
   GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8
   Goy JJ, 1999, CIRCULATION, V99, P3255
   Goy JJ, 2000, MAYO CLIN PROC, V75, P1116
   Goyal A, 2007, ANN THORAC SURG, V83, P993, DOI 10.1016/j.athoracsur.2006.10.046
   Goyal TM, 2005, PSYCHOSOM MED, V67, P759, DOI 10.1097/01.psy.0000174046.40566.80
   Graves EJ, 1993, VITAL HLTH STAT, V13, P1
   GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812
   Greilich PE, 2009, ANESTH ANALG, V109, P15, DOI 10.1213/ane.0b013e3181a40b5d
   Grigg OA, 2003, STAT METHODS MED RES, V12, P147, DOI 10.1191/0962280203sm323ra
   Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jace.2007.01.003
   Groesdonk HV, 2010, J CARDIOTHOR VASC AN, V24, P785, DOI 10.1053/j.jvca.2010.03.018
   GRONDIN CM, 1984, CIRCULATION, V70, P208
   Groom Robert C, 2010, J Extra Corpor Technol, V42, P40
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Grover FL, 1996, ANN THORAC SURG, V62, pS6, DOI 10.1016/0003-4975(96)00821-1
   GROVER FL, 1993, ANN THORAC SURG, V56, P1296
   GROVER FL, 1994, ANN THORAC SURG, V58, P1845
   GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Gummert JF, 2006, ANN THORAC SURG, V81, P90, DOI 10.1016/j.athoracsur.2005.06.035
   Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550
   Gurbuz AT, 2007, ANN THORAC SURG, V83, P1035, DOI 10.1016/j.athoracsur.2006.10.019
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   GURNE O, 1994, CIRCULATION, V90, P148
   Guru V, 2005, J THORAC CARDIOV SUR, V130, P1257, DOI 10.1016/j.jtcvs.2005.07.041
   Guru V, 2006, CIRCULATION, V113, P507, DOI 10.1161/CIRCULATIONAHA.105.576652
   Guru V, 2006, AM HEART J, V152, P573, DOI 10.1016/j.ahj.2005.10.026
   Haase M, 2007, CRIT CARE MED, V35, P1324, DOI 10.1097/01.CCM.0000261887.69976.12
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Haeffener MP, 2008, AM HEART J, V156, P900
   Hake U, 1989, Eur J Cardiothorac Surg, V3, P162, DOI 10.1016/1010-7940(89)90096-1
   Halkos ME, 2008, J THORAC CARDIOV SUR, V136, P631, DOI 10.1016/j.jtcvs.2008.02.091
   Halm E, 2000, INTERPRETING VOLUME
   Halm EA, 2002, ANN INTERN MED, V137, P511
   Halonen J, 2006, CIRCULATION, V114, pI1, DOI 10.1161/CIRCULATIONAHA.105.000851
   Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F
   HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601
   Hammar N, 1997, J AM COLL CARDIOL, V29, P659
   HAMMERMEISTER KE, 1994, ANN SURG, V219, P281, DOI 10.1097/00000658-199403000-00008
   HAMMERMEISTER KE, 1994, ANN THORAC SURG, V58, P1809
   Hangler HB, 2003, J THORAC CARDIOV SUR, V126, P391, DOI 10.1016/S0022-5223(03)00395-7
   Hannan EL, 1998, STROKE, V29, P2292
   Hannan EL, 2003, MED CARE, V41, P1164, DOI 10.1097/01.MLR.0000088452.82637.40
   Hannan EL, 1999, NEW ENGL J MED, V340, P1677, DOI 10.1056/NEJM199905273402112
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 1997, HEALTH SERV RES, V31, P659
   HANNAN EL, 1994, ANN THORAC SURG, V58, P1852
   Hannan EL, 1997, AM HEART J, V134, P55, DOI 10.1016/S0002-8703(97)70106-6
   Hannan EL, 2002, SURGERY, V131, P6, DOI 10.1067/msy.2002.120238
   Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATONAHA.104.528455
   HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768
   Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595
   HANNAN EL, 1992, HEALTH SERV RES, V27, P517
   HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761
   Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892
   Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B
   HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209
   HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003
   HANNAN EL, 1992, MED CARE, V30, P892, DOI 10.1097/00005650-199210000-00002
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hansen D, 2009, ACTA CARDIOL, V64, P639, DOI 10.2143/AC.64.5.2042694
   Harker LA, 1999, DRUG SAFETY, V21, P325, DOI 10.2165/00002018-199921040-00007
   Harrington Kathleen F, 2009, Expert Rev Respir Med, V3, P475, DOI 10.1586/ers.09.42
   Harrington OB, 1998, ANN THORAC SURG, V65, P1599, DOI 10.1016/S0003-4975(98)00239-2
   HARTZ AJ, 1994, AM J PUBLIC HEALTH, V84, P1609, DOI 10.2105/AJPH.84.10.1609
   Hashimoto H, 1996, J THORAC CARDIOV SUR, V111, P399, DOI 10.1016/S0022-5223(96)70449-X
   Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3
   Hawkes CA, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003587
   HAYASHI J, 1994, TRANSFUSION, V34, P142, DOI 10.1046/j.1537-2995.1994.34294143943.x
   Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119
   HE GW, 1995, J THORAC CARDIOV SUR, V110, P971, DOI 10.1016/S0022-5223(05)80164-3
   Hedges C, 2008, AM J CRIT CARE, V17, P133
   Held C, 2010, J AM COLL CARDIOL, V57, P672
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Hemmerling TM, 2005, ANESTH ANALG, V100, P354, DOI 10.1213/01.ANE.0000140245.44494.12
   Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3
   Henry D, 2009, CAN MED ASSOC J, V180, P183, DOI 10.1503/cmaj.081109
   Heringlake M, 2010, ANESTHESIOLOGY, V114, P12
   Herman CR, 2010, ANN THORAC SURG, V89, P397, DOI 10.1016/j.athoracsur.2009.10.051
   Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB
   Heusch G, 2008, BRIT J PHARMACOL, V153, P1589, DOI 10.1038/sj.bjp.0707673
   Hewitt M, 2000, INTERPRETING VOLUME
   Hibbard JH, 1996, HEALTH CARE FINANC R, V18, P95
   Hibbard J H, 2001, Jt Comm J Qual Improv, V27, P591
   Hibbard JH, 1997, MILBANK Q, V75, P395, DOI 10.1111/1468-0009.00061
   Hibbard JH, 1997, HEALTH AFFAIR, V16, P218, DOI 10.1377/hlthaff.16.3.218
   Hibbard JH, 2003, ANNU REV PUBL HEALTH, V24, P413, DOI 10.1146/annurev.publhealth.24.100901.141005
   Hilleman DE, 2004, CHEST, V125, P435, DOI 10.1378/chest.125.2.435
   Hirai Shinji, 2003, Ann Thorac Cardiovasc Surg, V9, P365
   Hix JK, 2006, CRIT CARE MED, V34, P2979, DOI 10.1097/01.CCM.0000248905.67352.BA
   Hlatky MA, 2004, CIRCULATION, V110, P1960, DOI 10.1161/01.CIR.0000143379.26342.5C
   Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203
   Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
   Ho PM, 2004, ANN THORAC SURG, V77, P597, DOI 10.1016/S0003-4975(03)01358-4
   Hochman JS, 1997, J AM COLL CARDIOL, V30, P141
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2
   HOCKINGS BEF, 1993, MED J AUSTRALIA, V159, P376
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   HOGUE CW, 1995, J THORAC CARDIOV SUR, V110, P517, DOI 10.1016/S0022-5223(95)70249-0
   Hollenbeck BK, 2007, UROLOGY, V69, P871, DOI 10.1016/j.urology.2007.01.040
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   Hong SJ, 2005, CATHETER CARDIO INTE, V64, P75, DOI 10.1002/ccd.20238
   Hongo RH, 2002, J AM COLL CARDIOL, V40, P231, DOI 10.1016/S0735-1097(02)01954-X
   Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70
   Horswell JL, 2005, J CARDIOTHOR VASC AN, V19, P282, DOI 10.1053/j.jvca.2005.03.002
   Hruska LA, 2005, J CARDIAC SURG, V20, P403, DOI 10.1111/j.1540-8191.2005.200472.x
   Hu SS, 2010, CIRCULATION, V121, P1800, DOI 10.1161/CIRCULATIONAHA.109.894543
   Hubbard R, 2005, TOB CONTROL, V14, P416, DOI 10.1136/tc.2005.011387
   Huber CH, 2007, EUR J CARDIO-THORAC, V31, P1099, DOI 10.1016/j.ejcts.2007.01.055
   Hudetz JA, 2011, J CARDIOTHOR VASC AN, V25, P811, DOI 10.1053/j.jvca.2010.05.003
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065
   Hueb WA, 1999, CIRCULATION, V100, P107
   Hughes CM, 1999, JAMA-J AM MED ASSOC, V281, P1375
   HUGHES RG, 1987, MED CARE, V25, P489, DOI 10.1097/00005650-198706000-00004
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851
   Humphries KH, 2007, J AM COLL CARDIOL, V49, P1552, DOI 10.1016/j.jacc.2006.08.068
   Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703
   Iezzoni LI, 2003, RISK ADJUSTMENT MEAS
   Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855
   Institute of Medicine, 2006, PERF MEAS ACC IMPR
   Institute of Medicine, 2011, CLIN PRACT GUID WE C
   Institute of Medicine, 2011, FIND WHAT WORKS HLTH
   IPYAM PC, 1994, ANESTH ANALG, V78, P842
   Isley MR, 2009, J CLIN MONIT COMPUT, V23, P369, DOI 10.1007/s10877-009-9191-y
   IVERT T, 1988, J THORAC CARDIOV SUR, V96, P1
   Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010
   Jacka MF, 2002, ANESTH ANALG, V94, P1065, DOI 10.1097/00000539-200205000-00003
   Jacobs AK, 1998, CIRCULATION, V98, P1279
   Jaffery Z, 2007, EUR J CARDIO-THORAC, V31, P691, DOI 10.1016/j.ejcts.2007.01.018
   Jain U, 1997, ANESTHESIOLOGY, V86, P576, DOI 10.1097/00000542-199703000-00009
   Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148
   Jenkins C, 2009, EUR HEART J, V30, P98, DOI 10.1093/eurheartj/ehn484
   Jenkins DP, 1997, HEART, V77, P314
   Jensen BO, 2008, EUR J CARDIO-THORAC, V34, P1016, DOI 10.1016/j.ejcts.2008.07.053
   Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931
   Jha AK, 2006, HEALTH AFFAIR, V25, P844, DOI 10.1377/hlthaff.25.3.844
   JOHNSON LW, 1976, CIRCULATION, V53, P819
   Johnson T, 2002, ANESTHESIOLOGY, V96, P1351, DOI 10.1097/00000542-200206000-00014
   Johnson WC, 2002, J VASC SURG, V35, P413, DOI 10.1067/mva.2002.121847
   JONES EL, 1983, AM J CARDIOL, V51, P7, DOI 10.1016/S0002-9149(83)80003-4
   Jones G, 1997, ANN SURG, V225, P766, DOI 10.1097/00000658-199706000-00014
   Jones HU, 2002, CIRCULATION, V106, pI19, DOI 10.1161/01.cir.0000032917.33237.e0
   Jones KW, 2008, J DIABETES COMPLICAT, V22, P365, DOI 10.1016/j.jdiacomp.2007.05.006
   JONES RH, 1989, CIRCULATION, V79, P132
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   Jones RH, 1996, J AM COLL CARDIOL, V28, P1478, DOI 10.1016/S0735-1097(96)00359-2
   Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56
   Julier K, 2003, ANESTHESIOLOGY, V98, P1315, DOI 10.1097/00000542-200306000-00004
   JURKIEWICZ MJ, 1980, ANN SURG, V191, P738, DOI 10.1097/00000658-198006000-00012
   Kachroo S, 2006, ANN PHARMACOTHER, V40, P381, DOI 10.1345/aph.1G565
   KAISER AB, 1988, ANN THORAC SURG, V45, P35
   KAISER AB, 1987, ANN SURG, V206, P791, DOI 10.1097/00000658-198712000-00018
   KAISER GA, 1975, SURGERY, V78, P749
   Kalant N, 2004, CAN J CARDIOL, V20, P81
   KALLIS P, 1994, EUR J CARDIO-THORAC, V8, P404, DOI 10.1016/1010-7940(94)90081-7
   Kallmeyer IJ, 2001, ANESTH ANALG, V92, P1126
   Kamohara Keiji, 2006, Jpn J Thorac Cardiovasc Surg, V54, P95, DOI 10.1007/BF02744870
   Kapetanakis EI, 2006, CIRCULATION, V113, P1667, DOI 10.1161/CIRCULATIONAHA.105.571828
   Kapoor JR, 2008, JACC-CARDIOVASC INTE, V1, P483, DOI 10.1016/j.jcin.2008.07.001
   Kappetein AP, 2011, EUR HEART J, V17, P2125
   Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
   Karkouti K, 2001, TRANSFUSION, V41, P1193, DOI 10.1046/j.1537-2995.2001.41101193.x
   Karthik S, 2003, EUR J CARDIO-THORAC, V24, P66, DOI 10.1016/S1010-7940(03)00255-0
   KARWANDE SV, 1987, ANN THORAC SURG, V43, P318
   KASSIRER JP, 1994, NEW ENGL J MED, V330, P634, DOI 10.1056/NEJM199403033300910
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Kato M, 1993, J Cardiothorac Vasc Anesth, V7, P285, DOI 10.1016/1053-0770(93)90006-7
   Katritsis DG, 2007, NEW ENGL J MED, V357, P414
   Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864
   Katznelson R, 2009, ANESTHESIOLOGY, V110, P67, DOI 10.1097/ALN.0b013e318190b4d9
   KELLY P, 1990, J AM COLL CARDIOL, V15, P267
   Kempfert J, 2008, ANN THORAC SURG, V85, P1579, DOI 10.1016/j.athoracsur.2008.01.074
   Kertai MD, 2010, ANESTHESIOLOGY, V112, P1116, DOI 10.1097/ALN.0b013e3181d5e0a3
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Khanna MP, 2003, TRANSFUS MED REV, V17, P110, DOI 10.1053/tmrv.2003.50008
   Kihara C, 2009, J CARDIOL, V54, P282, DOI 10.1016/j.jjcc.2009.06.001
   Kikura M, 2006, J AM COLL SURGEONS, V202, P216, DOI 10.1016/j.jamcollsurg.2005.10.001
   Kim C, 2007, CLIN CARDIOL, V30, P491, DOI 10.1002/clc.20000
   Kim JHJ, 2008, AM HEART J, V156, P886, DOI 10.1016/j.ahj.2008.06.034
   Kim JW, 2005, INT J CARDIOL, V99, P437, DOI 10.1016/j.ijcard.2004.08.045
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   Kincaid EH, 2003, ANN THORAC SURG, V76, P124, DOI 10.1016/S0003-4975(03)00190-5
   King K B, 1992, Am J Crit Care, V1, P28
   KING KB, 1992, AM J CARDIOL, V69, P179, DOI 10.1016/0002-9149(92)91301-J
   King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602
   Kirdemir P, 2008, J CARDIOTHOR VASC AN, V22, P383, DOI 10.1053/j.jvca.2007.09.015
   Kiyama H, 1999, ANN THORAC SURG, V68, P1652, DOI 10.1016/S0003-4975(99)00755-9
   Kjaergard HK, 2004, SCAND CARDIOVASC J, V38, P143, DOI 10.1080/14017430410031119
   Kjaergard HK, 2006, SCAND CARDIOVASC J, V40, P25, DOI 10.1080/14017430500243614
   Kjoller-Hansen L, 2000, J AM COLL CARDIOL, V35, P881, DOI 10.1016/S0735-1097(99)00634-8
   Klemperer JD, 1996, ANN THORAC SURG, V61, P1323, DOI 10.1016/0003-4975(96)00102-6
   KLEMPERER JD, 1995, NEW ENGL J MED, V333, P1522, DOI 10.1056/NEJM199512073332302
   KLEPZIG H, 1991, EUR HEART J, V12, P946
   Knatterud GL, 2000, CIRCULATION, V102, P157
   KNIGHT AA, 1988, ANESTHESIOLOGY, V68, P681, DOI 10.1097/00000542-198805000-00005
   KO W, 1992, ANN THORAC SURG, V53, P301
   Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037
   Koch CG, 2003, J CARDIOTHOR VASC AN, V17, P585, DOI 10.1053/S1053-0770(03)00201-5
   Koch CG, 2006, ANN THORAC SURG, V82, P13, DOI 10.1016/j.athoracsur.2005.07.075
   Koch CG, 1996, J CARDIOTHOR VASC AN, V10, P839, DOI 10.1016/S1053-0770(96)80042-5
   Kofidis T, 2008, PERFUSION-UK, V23, P147, DOI 10.1177/0267659108097880
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Konvalinka A, 2006, J HOSP INFECT, V64, P162, DOI 10.1016/j.jhin.2006.06.010
   KOUCHOUKOS NT, 1988, ANN THORAC SURG, V45, P348
   Kourliouros A, 2010, EUR J CARDIO-THORAC, V37, P704, DOI 10.1016/j.ejcts.2009.08.020
   Koyanagi T, 1996, ANN THORAC SURG, V61, P1793, DOI 10.1016/0003-4975(96)00170-1
   Krasuski RA, 2009, JAMA-J AM MED ASSOC, V302, P290, DOI 10.1001/jama.2009.1012
   Krasuski RA, 2011, CIRCULATION, V123, P154, DOI 10.1161/CIRCULATIONAHA.109.921106
   KRETER B, 1992, J THORAC CARDIOV SUR, V104, P590
   Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769
   Kubal C, 2005, ANN THORAC SURG, V79, P1570, DOI 10.1016/j.athorascur.2004.10.035
   KULIER AH, 1993, ANESTH ANALG, V76, P102
   Kulik A, 2009, EXPERT OPIN DRUG SAF, V8, P559, DOI 10.1517/14740330903188413
   Kulik A, 2008, CIRCULATION, V118, P1785, DOI 10.1161/CIRCULATIONAHA.108.799445
   Kurlansky PA, 1996, ANN THORAC SURG, V62, P63, DOI 10.1016/0003-4975(96)00275-5
   Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663
   Kuss O, 2010, J THORAC CARDIOVASC, V140, pe1
   Kuss O, 2010, J THORAC CARDIOV SUR, V140, P829, DOI 10.1016/j.jtcvs.2009.12.022
   LADENSON PW, 1984, AM J MED, V77, P261, DOI 10.1016/0002-9343(84)90701-0
   Ladowski J S, 1996, Cardiovasc Surg, V4, P23, DOI 10.1016/0967-2109(96)83779-3
   Laham RJ, 1999, CIRCULATION, V100, P1865
   Lahtinen P, 2006, ANESTHESIOLOGY, V105, P794, DOI 10.1097/00000542-200610000-00026
   Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013
   Landoni G, 2008, J CARDIOTHOR VASC AN, V22, P27, DOI 10.1053/j.jvca.2007.07.015
   Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.200610.013
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Laurikka J, 2002, CHEST, V121, P1183, DOI 10.1378/chest.121.4.1183
   Lavana JD, 2010, J THORAC CARDIOV SUR, V140, P80, DOI 10.1016/j.jtcvs.2009.09.033
   Lazar HL, 2009, ANN THORAC SURG, V87, P663, DOI 10.1016/j.athoracsur.2008.11.011
   Leacche Marzia, 2009, Semin Thorac Cardiovasc Surg, V21, P207, DOI 10.1053/j.semtcvs.2009.08.007
   Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461
   Leavitt BJ, 2004, CIRCULATION S1, V110, pII41, DOI 10.1161/01.CIR.0000138197.07051.e7
   Lee AH, 2007, CRIT CARE MED, V35, P1517, DOI 10.1097/CCM.0000266537.86437.38
   Lee D C, 2001, Ann Thorac Surg, V71, P1197
   Lee JH, 1997, SURGERY, V122, P675, DOI 10.1016/S0039-6060(97)90073-8
   Lee LY, 2002, PERFUSION-UK, V17, P33, DOI 10.1191/0267659102pf532oa
   Lee MS, 2007, INT J CARDIOL, V123, P34, DOI 10.1016/j.ijcard.2006.11.103
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   LEMERY R, 1992, AM J CARDIOL, V70, P147, DOI 10.1016/0002-9149(92)91266-7
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Levin MA, 2009, CIRCULATION, V120, P1664, DOI 10.1161/CIRCULATIONAHA.108.814533
   Levin R, 2010, J CARDIOTHOR VASC AN, V24, P568, DOI 10.1053/j.jvca.2010.01.002
   Lev-Ran O, 2004, ANN THORAC SURG, V77, P102, DOI 10.1016/S0003-4975(03)01334-1
   Li Y, 2008, J THORAC CARDIOV SUR, V136, P657, DOI 10.1016/j.jtcvs.2007.12.069
   Liakopoulos OJ, 2008, EUR HEART J, V29, P1548, DOI 10.1093/eurheartj/ehn198
   Lim E, 2003, BRIT MED J, V327, P1309, DOI 10.1136/bmj.327.7427.1309
   Lim HS, 2009, JACC-CARDIOVASC INTE, V2, P146, DOI 10.1016/j.jcin.2008.11.006
   LIMET R, 1987, J THORAC CARDIOV SUR, V94, P773
   Lin Terence, 2010, Congest Heart Fail, V16, P170, DOI 10.1111/j.1751-7133.2010.00146.x
   Lincoff AM, 2000, ANN THORAC SURG, V70, P516, DOI 10.1016/S0003-4975(00)01343-6
   Liu JY, 2000, CIRCULATION, V102, P2973
   Liu SS, 2004, ANESTHESIOLOGY, V101, P153, DOI 10.1097/00000542-200407000-00024
   Liu YH, 2009, ANESTH ANALG, V109, P1013, DOI 10.1213/ane.0b013e3181aed2bb
   Lloyd-Jones D, 2010, CIRCULATION, P121
   Localio AR, 1997, MED CARE, V35, P272, DOI 10.1097/00005650-199703000-00007
   London MJ, 2002, ANESTHESIOLOGY, V96, P860, DOI 10.1097/00000542-200204000-00013
   London MJ, 1999, ANESTHESIOLOGY, V91, P911, DOI 10.1097/00000542-199910000-00007
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   LOOP FD, 1990, ANN THORAC SURG, V49, P179
   LORENZ RL, 1984, LANCET, V1, P1261
   Losanoff JE, 2002, EUR J CARDIO-THORAC, V21, P831, DOI 10.1016/S1010-7940(02)00124-0
   Loubani M, 2003, J THORAC CARDIOV SUR, V126, P143, DOI 10.1016/S0022-5223(02)73601-5
   LOWENSTE.E, 1969, NEW ENGL J MED, V281, P1389, DOI 10.1056/NEJM196912182812503
   Lucchinetti E, 2007, ANESTHESIOLOGY, V106, P444, DOI 10.1097/00000542-200703000-00008
   Luckraz H, 2003, J THORAC CARDIOV SUR, V125, P301, DOI 10.1067/mtc.2003.74
   Luft HS, 2001, J AM COLL CARDIOL, V38, P1931, DOI 10.1016/S0735-1097(01)01636-9
   Luft HS, 1990, HOSP VOLUME PHYS VOL
   LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503
   Luo WJ, 2008, EUR J CARDIO-THORAC, V33, P203, DOI 10.1016/j.ejcts.2007.11.010
   LUSCHER TF, 1988, NEW ENGL J MED, V319, P462, DOI 10.1056/NEJM198808253190802
   LYTLE BW, 1992, J THORAC CARDIOV SUR, V103, P831
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X
   LYTLE BW, 1980, CIRCULATION, V61, P869
   Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070
   Mack MJ, 2005, J THORAC CARDIOV SUR, V129, P1309, DOI 10.1016/j.jtcvs.2004.10.036
   Mack MJ, 2004, CIRCULATION, V110, pII1, DOI 10.1161/01.CIR.0000138198.62961.41
   Magovern JA, 1996, ANN THORAC SURG, V61, P27, DOI 10.1016/0003-4975(95)00808-X
   Mainwaring RD, 2011, ANN THORAC SURG, V92, P691, DOI 10.1016/j.athoracsur.2011.03.127
   MAKI DG, 1992, J THORAC CARDIOV SUR, V104, P1423
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Maltais S, 2008, EUR J CARDIO-THORAC, V34, P127, DOI 10.1016/j.ejcts.2008.03.052
   Mangano CM, 1998, ANN INTERN MED, V128, P194
   Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798
   MANGANO DT, 1997, GROUP, V277, P325
   Mangano DT, 2006, J AM COLL CARDIOL, V48, P206, DOI 10.1016/j.jacc.2006.04.044
   MANGANO DT, 1992, ANESTHESIOLOGY, V76, P342, DOI 10.1097/00000542-199203000-00004
   Maniar HS, 2002, J THORAC CARDIOV SUR, V123, P45, DOI 10.1067/mtc.2002.118686
   Mannacio VA, 2008, J THORAC CARDIOV SUR, V136, P1541, DOI 10.1016/j.jtcvs.2008.06.038
   Marasco SF, 2008, EUR J CARDIO-THORAC, V33, P961, DOI 10.1016/j.ejcts.2008.03.022
   Maree AO, 2005, J AM COLL CARDIOL, V46, P1258, DOI 10.1016/j.jacc.2005.06.058
   Marin F, 2006, AM J CARDIOL, V97, P55, DOI 10.1016/j.amjcard.2005.07.124
   Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789
   MARON BJ, 1986, J AM COLL CARDIOL, V7, P204
   Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199
   Martin Fiona, 2006, Br J Nurs, V15, P703
   Martinez EA, 2010, ANESTH ANALG, V110, P307, DOI 10.1213/ANE.0b013e3181c92b9c
   Martorell C, 2004, AM J INFECT CONTROL, V32, P63, DOI 10.1016/j.ajic.2003.09.005
   Mathew JP, 2006, J AM SOC ECHOCARDIOG, V19, P1303, DOI 10.1016/j.echo.2006.08.039
   Matros E, 2010, J THORAC CARDIOV SUR, V139, P680, DOI 10.1016/j.jtcvs.2009.10.006
   Matschke KE, 2005, J THORAC CARDIOV SUR, V130, P1645, DOI 10.1016/j.jtcvs.2005.08.033
   Matsuzaki K, 1997, Nihon Kyobu Geka Gakkai Zasshi, V45, P1710
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   McDonald SB, 2005, ANESTH ANALG, V100, P25, DOI 10.1213/01.ANE.0000139652.84897.BD
   McDonald SB, 2005, J CARDIOTHOR VASC AN, V19, P4, DOI 10.1053/j.jvca.2004.11.002
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McKhann GM, 1997, ANN THORAC SURG, V63, P516
   Medalion B, 2010, J THORAC CARDIOV SUR, V139, P1539, DOI 10.1016/j.jtcvs.2009.08.042
   Medalion B, 2003, J THORAC CARDIOV SUR, V126, P1875, DOI 10.1016/S0022-5223(03)01324-2
   Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P285
   Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P49
   Mehta RH, 2009, CIRC-CARDIOVASC QUAL, V2, P583, DOI 10.1161/CIRCOUTCOMES.109.858811
   Mehta RH, 2010, AM HEART J, V159, P141, DOI 10.1016/j.ahj.2009.10.035
   Mehta RH, 2006, J AM COLL CARDIOL, V48, P281, DOI 10.1016/j.jacc.2006.04.029
   Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573
   Alexander JH, 2008, JAMA-J AM MED ASSOC, V299, P1777
   Mentzer RM, 2008, ANN THORAC SURG, V85, P1261, DOI 10.1016/j.athoracsur.2007.10.054
   MERRY AF, 1992, BRIT J ANAESTH, V68, P6, DOI 10.1093/bja/68.1.6
   METKE MP, 1979, AM J CARDIOL, V43, P1144, DOI 10.1016/0002-9149(79)90145-0
   Miceli A, 2009, J AM COLL CARDIOL, V54, P1778, DOI 10.1016/j.jacc.2009.07.008
   Mierdl S, 2002, ANESTH ANALG, V94, P774, DOI 10.1097/00000539-200204000-00002
   Migliorini A, 2006, AM HEART J, V152, P903, DOI 10.1016/j.ahj.2005.12.030
   Milani RV, 1998, CHEST, V113, P599, DOI 10.1378/chest.113.3.599
   MILANO CA, 1995, CIRCULATION, V92, P2245
   Min JK, 2005, J AM SOC ECHOCARDIOG, V18, P925, DOI 10.1016/j.echo.2005.01.034
   Misfeld M, 2010, THORAC CARDIOV SURG, V58, P408, DOI 10.1055/s-0030-1249831
   Mohammed AA, 2009, CIRCULATION, V120, P843, DOI 10.1161/CIRCULATIONAHA.108.837278
   Moholdt TT, 2009, AM HEART J, V158, P1031, DOI 10.1016/j.ahj.2009.10.003
   Moises VA, 1998, J AM SOC ECHOCARDIOG, V11, P1139, DOI 10.1016/S0894-7317(98)80009-6
   Moller CH, 2010, CIRCULATION, V121, P498, DOI 10.1161/CIRCULATIONAHA.109.880443
   Monk TG, 2005, ANESTH ANALG, V100, P4, DOI 10.1213/01.ANE.0000147519.82841.5E
   Monk TG, 2008, ANESTHESIOLOGY, V108, P18
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Moran SV, 2001, ANN THORAC SURG, V72, P1552, DOI 10.1016/S0003-4975(01)03090-9
   Morawski W, 2005, J THORAC CARDIOV SUR, V130, P791, DOI 10.1016/j.jtcvs.2005.02.041
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Mortaz H, 2009, COCHRANE DB SYST REV
   Motallebzadeh R, 2007, ANN THORAC SURG, V83, P475, DOI 10.1016/j.athoracsur.2006.09.024
   Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002
   Mukamel D B, 2001, Jt Comm J Qual Improv, V27, P20
   Mukamel DB, 2007, MED CARE, V45, P1227
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Murkin JM, 2009, BR J ANAESTH S1, V103, pi3, DOI [DOI 10.1093/BJA/AEP299), 10.1093/bja/aep299]
   Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4
   Murphy GJ, 2006, J THORAC CARDIOVASC, V132, pe1
   Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977
   Murphy GJ, 2006, J THORAC CARDIOV SUR, V132, P475, DOI 10.1016/j.jctvs.2006.01.064
   Murphy GS, 2006, J CARDIOTHOR VASC AN, V20, P493, DOI 10.1053/j.jvca.2005.07.036
   Murphy GS, 2009, ANESTH ANALG, V109, P311, DOI 10.1213/ane.0b013e3181a90adc
   Murphy GS, 2003, ANESTH ANALG, V96, P1301, DOI 10.1213/01.ANE.0000057602.27031.C8
   Murphy MB, 2001, NEW ENGL J MED, V345, P1548
   MUSTAFA I, 1981, J THORAC CARDIOV SUR, V82, P297
   Myers WO, 1999, J AM COLL CARDIOL, V33, P488, DOI 10.1016/S0735-1097(98)00563-4
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Myles PS, 2003, ANESTHESIOLOGY, V99, P982
   Myles PS, 2004, LANCET, V363, P1757, DOI 10.1016/S0140-6736(04)16300-9
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Nakamura M, 2008, ANN THORAC SURG, V85, P513, DOI 10.1016/j.athoracsur.2007.08.056
   Nallamothu BK, 2001, J AM COLL CARDIOL, V38, P1923, DOI 10.1016/S0735-1097(01)01647-3
   NASU M, 1995, ANN THORAC SURG, V59, P154, DOI 10.1016/0003-4975(94)00795-9
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Naylor AR, 2002, EUR J VASC ENDOVASC, V23, P283, DOI 10.1053/ejvs.2002.1609
   Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506
   NELSON DR, 1990, J THORAC CARDIOV SUR, V99, P977
   Nesher N, 2006, J CARDIAC SURG, V21, P395, DOI 10.1111/j.1540-8191.2006.00272.x
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Ngaage DL, 2008, ANN THORAC SURG, V85, P1278, DOI 10.1016/j.athoracsur.2007.12.035
   Nguyen JT, 2008, AM HEART J, V155, P862, DOI 10.1016/j.ahj.2007.11.036
   Nigwekar SU, 2009, J CARDIOTHOR VASC AN, V23, P151, DOI 10.1053/j.jvca.2008.11.007
   Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267
   Nikolov NM, 2010, ANESTH ANALG, V110, P335, DOI 10.1213/ANE.0b013e3181c76f87
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   NISHIDA H, 1991, J THORAC CARDIOV SUR, V101, P488
   Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545
   Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096
   Noyez L, 2004, EUR J CARDIO-THORAC, V25, P59, DOI 10.1016/S1010-7940(03)00656-0
   Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330
   Nuttall GA, 2001, ANESTHESIOLOGY, V94, P773, DOI 10.1097/00000542-200105000-00014
   Nygard E, 2005, CIRCULATION, V111, P2165, DOI 10.1161/01.CIR.0000163551.33812.1A
   OCONNOR GT, 1991, JAMA-J AM MED ASSOC, V266, P803, DOI 10.1001/jama.266.6.803
   O'Brien SM, 2007, ANN THORAC SURG, V83, pS13, DOI 10.1016/j.athoracsur.2007.01.055
   OCKENE JK, 1990, AM J PUBLIC HEALTH, V80, P954, DOI 10.2105/AJPH.80.8.954
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   OCONNOR GT, 1989, CIRCULATION, V80, P234
   OCONNOR GT, 1992, CIRCULATION, V85, P2110
   OCONNOR GT, 1993, CIRCULATION, V88, P2104
   OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841
   OGLIETTI J, 1976, J THORAC CARDIOV SUR, V71, P736
   OKEEFE JH, 1993, AM J CARDIOL, V71, P897, DOI 10.1016/0002-9149(93)90903-P
   OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945
   OLIVA PB, 1993, J AM COLL CARDIOL, V22, P720
   Olsen MA, 2002, J THORAC CARDIOV SUR, V124, P136, DOI 10.1067/mtc.2002.122306
   Olsson C, 2006, INFECT CONT HOSP EP, V27, P83, DOI 10.1086/500283
   Omoigui NA, 1996, CIRCULATION, V93, P27
   Oosterga M, 2001, AM J CARDIOL, V87, P542, DOI 10.1016/S0002-9149(00)01428-4
   Ostermann ME, 2000, INTENS CARE MED, V26, P565, DOI 10.1007/s001340051205
   Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(3)00125-9
   Ouattara A, 2005, ANESTHESIOLOGY, V103, P687, DOI 10.1097/00000542-200510000-00006
   Ouyang P, 2006, ATHEROSCLEROSIS, V189, P375, DOI 10.1016/j.atherosclerosis.2005.12.015
   Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129
   OXMAN TE, 1995, PSYCHOSOM MED, V57, P5
   Paciullo CA, 2009, ANN PHARMACOTHER, V43, P1197, DOI 10.1345/aph.1L423
   Pagni S, 1997, EUR J CARDIO-THORAC, V11, P1086, DOI 10.1016/S1010-7940(97)01214-1
   Pagni S, 1997, J SURG RES, V71, P172, DOI 10.1006/jsre.1997.5150
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Pan W, 2004, CIRCULATION S, V110, pII45, DOI DOI 10.1016/J.ATHORACSUR.2005.07.038
   Panesar SS, 2006, HEART, V92, P1808, DOI 10.1136/hrt.2006.088450
   PAONE G, 1994, SURGERY, V116, P672
   Parikh SV, 2010, JACC-CARDIOVASC INTE, V3, P419, DOI 10.1016/j.jcin.2010.01.012
   Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2011, NEW ENGL J MED, V364, P1727
   Park YJ, 2009, ANN THORAC SURG, V87, P1846, DOI 10.1016/j.athoracsur.2009.03.032
   Parolari A, 2007, ANN THORAC SURG, V84, P823, DOI 10.1016/j.athoracsur.2007.04.048
   Parr KG, 2003, J CARDIOTHOR VASC AN, V17, P176, DOI 10.1053/jcan.2003.44
   Partik BL, 2003, AM J ROENTGENOL, V180, P987
   Pascual DA, 2006, ANN THORAC SURG, V81, P78, DOI 10.1016/j.athoracsur.2005.07.038
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603
   Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44
   Patel S, 2006, AM SURGEON, V72, P310
   Patti G, 2006, CIRCULATION, V114, P1455, DOI 10.1161/CIRCULATIONAHA.106.621763
   Paulitsch FS, 2009, CORONARY ARTERY DIS, V20, P100, DOI 10.1097/MCA.0b013e3283219e8b
   PEARSON KS, 1989, ANESTH ANALG, V69, P336
   PEARSON PJ, 1992, ANN THORAC SURG, V54, P1078
   Peart JN, 2006, AM J PHYSIOL-HEART C, V291, pH1746, DOI 10.1152/ajpheart.00233.2006
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Penttila HJ, 2003, ANN THORAC SURG, V75, P1246, DOI 10.1016/S0003-4975(02)04659-3
   Pereira JJ, 2005, AM J MED, V118, P735, DOI 10.1016/j.amjmed.2005.01.072
   Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195
   Peterson ED, 2003, J AM COLL CARDIOL, V42, P1611, DOI 10.1016/S0735-1097(03)01121-5
   Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   Pick AW, 1997, ANN THORAC SURG, V64, P599, DOI 10.1016/S0003-4975(97)00620-6
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Piper SN, 2003, CAN J ANAESTH, V50, P285
   Pires LA, 2002, J CARDIOVASC ELECTR, V13, P757, DOI 10.1046/j.1540-8167.2002.00757.x
   Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   PODESSER BK, 1995, J THORAC CARDIOV SUR, V110, P1461, DOI 10.1016/S0022-5223(95)70069-2
   Podestà A, 2000, Minerva Cardioangiol, V48, P341
   Podgoreanu MV, 2005, J AM COLL CARDIOL, V46, P1965, DOI 10.1016/j.jacc.2005.08.040
   Pohl T, 2004, CATHETER CARDIO INTE, V62, P323, DOI 10.1002/ccd.20060
   Possati G, 1998, J THORAC CARDIOV SUR, V116, P1015, DOI 10.1016/S0022-5223(98)70054-6
   Purcaro A, 1997, AM J CARDIOL, V80, P397
   Puskas JD, 2007, CIRCULATION, V116, pI192, DOI 10.1161/CIRCULATIONAHA.106.678979
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2007, ANN THORAC SURG, V84, P1447, DOI 10.1016/j.athoracsur.2007.06.104
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Puskas JD, 2009, ANN THORAC SURG, V88, P1142, DOI 10.1016/j.athoracsur.2009.04.135
   Qaddoura FE, 2004, ANN THORAC SURG, V78, P1586, DOI 10.1016/j.athoracsur.2004.05.001
   Quist-Paulsen P, 2005, EUR J CARDIOV PREV R, V12, P472, DOI 10.1097/01.hjr.0000183914.90236.01
   Rabi Doreen, 2010, Can J Cardiol, V26, P178
   Rader F, 2010, AM HEART J, V160, P329, DOI 10.1016/j.ahj.2010.05.033
   Ragosta M, 2006, CATHETER CARDIO INTE, V68, P357, DOI 10.1002/ccd.20709
   Rahimi K, 2009, HEART, V95, P1937, DOI 10.1136/hrt.2009.173302
   Rahimi K, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1250
   Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667
   Raja SG, 2006, J CARDIAC SURG, V21, P35, DOI 10.1111/j.1540-8191.2006.00164.x
   Raja Shahzad G, 2008, Interact Cardiovasc Thorac Surg, V7, P470, DOI 10.1510/icvts.2007.174698
   Ramadan ASE, 2007, ANN THORAC SURG, V84, P1034, DOI 10.1016/j.athoracsur.2007.04.047
   Ramphal PS, 2005, EUR J CARDIO-THORAC, V27, P910, DOI 10.1016/j.ejcts.2004.12.049
   Ramsay J, 2005, J THORAC CARDIOV SUR, V129, P300, DOI 10.1016/j.jtcvs.2004.06.005
   RAMSTROM J, 1993, EUR HEART J, V14, P634
   Rand RP, 1998, ANN THORAC SURG, V65, P1046, DOI 10.1016/S0003-4975(98)00087-3
   Ranucci M, 2010, MINERVA ANESTESIOL, V76, P249
   Ranucci Marco, 2008, Am J Cardiol, V101, P1112, DOI 10.1016/j.amjcard.2007.12.011
   Ranucci M, 2004, ANN THORAC SURG, V78, P1332, DOI 10.1016/j.athorcsur.2004.02.065
   Ranucci M, 2008, ANN THORAC SURG, V85, P481, DOI 10.1016/j.athoracsur.2007.10.014
   Rasmussen L S, 2000, Anesthesiol Clin North America, V18, P59, DOI 10.1016/S0889-8537(05)70149-8
   Rathore SS, 2004, ANN SURG, V239, P110, DOI 10.1097/01.sla.0000103066.22732.b8
   Ray JG, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-3
   Raymond PD, 2006, EUR J CARDIO-THORAC, V29, P82, DOI 10.1016/j.ejcts.2005.10.016
   Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5
   Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1
   Reeves ST, 2007, J AM SOC ECHOCARDIOG, V20, P427, DOI 10.1016/j.echo.2007.01.011
   REGRAGUI IA, 1995, ANN THORAC SURG, V60, P160
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Reinecke H, 2001, Z KARDIOL, V90, P729, DOI 10.1007/s003920170092
   REIZ S, 1983, ANESTHESIOLOGY, V59, P91, DOI 10.1097/00000542-198308000-00004
   Renda G, 2007, HAEMATOL-HEMATOL J, V92, P366, DOI 10.3324/haematol.10913
   Resano FG, 2006, J CARDIOTHOR VASC AN, V20, P300, DOI 10.1053/j.jvca.2006.01.017
   Rexius H, 2004, EUR J CARDIO-THORAC, V26, P521, DOI 10.1016/j.ejcts.2004.04.039
   Ridderstolpe L, 2001, EUR J CARDIO-THORAC, V20, P1168, DOI 10.1016/S1010-7940(01)00991-5
   Rigatelli G, 2008, J CARDIOVASC MED, V9, P113, DOI 10.2459/JCM.0b013e32813e3cd1
   Rigotti NA, 2008, ARCH INTERN MED, V168, P1950, DOI 10.1001/archinte.168.18.1950
   RIGOTTI NA, 1994, ANN INTERN MED, V120, P287
   Rinder CS, 2003, ANN THORAC SURG, V75, P899, DOI 10.1016/S0003-4975(02)04490-9
   Risnes I, 2010, ANN THORAC SURG, V89, P1502, DOI 10.1016/j.athoracsur.2010.02.038
   Risum O, 1997, EUR J CARDIO-THORAC, V11, P539, DOI 10.1016/S1010-7940(96)01107-4
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   ROBERTS WC, 1982, AM J CARDIOL, V49, P863, DOI 10.1016/0002-9149(82)91970-1
   ROBERTS WC, 1986, AM HEART J, V111, P941, DOI 10.1016/0002-8703(86)90646-0
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361
   Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7
   Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4
   RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060
   Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670
   Rollman BL, 2009, PSYCHOSOM MED, V71, P217, DOI 10.1097/PSY.0b013e3181970c1c
   Romano G, 2010, J THORAC CARDIOV SUR, V140, P188, DOI 10.1016/j.jtcvs.2010.03.022
   Romano PS, 2004, MED CARE, V42, P367, DOI 10.1097/01.mlr.0000118872.33251.11
   Rosenberger P, 2008, ANN THORAC SURG, V85, P548, DOI 10.1016/j.athoracsur.2007.08.061
   ROSENGART TK, 1994, ANN THORAC SURG, V58, P1397
   Rosengart TK, 2006, ANN THORAC SURG, V82, P597, DOI 10.1016/j.athoracsur.2006.03.026
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   Rouleau JL, 2008, CIRCULATION, V117, P24, DOI 10.1161/CIRCULATIONAHA.106.685073
   Rousou JA, 2000, ANN THORAC SURG, V69, P486, DOI 10.1016/S0003-4975(99)01086-3
   Roy P, 2009, AM J CARDIOL, V103, P950, DOI 10.1016/j.amjcard.2008.12.025
   Royse AG, 2000, EUR J CARDIO-THORAC, V17, P294, DOI 10.1016/S1010-7940(99)00364-4
   Royse CF, 1999, ANN THORAC SURG, V68, P1326, DOI 10.1016/S0003-4975(99)00829-2
   Royston D, 2001, BRIT J ANAESTH, V86, P575, DOI 10.1093/bja/86.4.575
   Rubens FD, 2007, CIRCULATION, V116, pI89, DOI 10.1161/CIRCULATIONAHA.106.678987
   RUBERMAN W, 1984, NEW ENGL J MED, V311, P552, DOI 10.1056/NEJM198408303110902
   Rudolph JL, 2007, AM J MED, V120, P807, DOI 10.1016/j.amjmed.2007.02.026
   Rudolph JL, 2009, PERFUSION-UK, V24, P409, DOI 10.1177/0267659109358207
   Rudolph JL, 2010, J AM GERIATR SOC, V58, P643, DOI 10.1111/j.1532-5415.2010.02762.x
   Russo A, 2008, CIRCULATION, V118, P1528, DOI 10.1161/CIRCULATIONAHA.107.747949
   Sabik JF, 2006, J THORAC CARDIOV SUR, V131, P90, DOI 10.1016/j.jtcvs.2005.05.024
   Sabik JF, 2003, ANN THORAC SURG, V76, P1490, DOI 10.1016/S0003-4975(03)01022-1
   Sabik JF, 2005, ANN THORAC SURG, V80, P1719, DOI 10.1016/j.athoracsur.2005.04.033
   Sabik JF, 2008, CIRCULATION, V118, pS210, DOI 10.1161/CIRCULATIONAHA.107.760827
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Safley DM, 2004, AM J CARDIOL, V94, P494, DOI 10.1016/j.amjcard.2004.05.008
   Saginur R, 2000, J THORAC CARDIOV SUR, V120, P1120, DOI 10.1067/mtc.2000.110384
   Sajja LR, 2007, J THORAC CARDIOV SUR, V133, P378, DOI 10.1016/j.jtcvs.2006.09.028
   Saleh SS, 2009, ANN SURG, V249, P335, DOI 10.1097/SLA.0b013e318195e475
   Salehi OA, 2007, BMC INFECT DIS, V7, P112
   Salminen US, 1999, J ANTIMICROB CHEMOTH, V44, P287, DOI 10.1093/jac/44.2.287
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Santa-Cruz RA, 2006, CATHETER CARDIO INTE, V67, P68, DOI 10.1002/ccd.20552
   Santos ATL, 2006, BRAZ J MED BIOL RES, V39, P63, DOI 10.1590/S0100-879X2006000100007
   Sarma AK, 2005, ANN THORAC SURG, V80, P714, DOI 10.1016/j.athoracsur.2004.01.020
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Saso S, 2010, ANN THORAC SURG, V89, P661, DOI 10.1016/j.athoracsur.2009.08.018
   Savage EB, 2007, ANN THORAC SURG, V83, P1002, DOI 10.1016/j.athoracsur.2006.09.094
   Savage RM, 1997, ANN THORAC SURG, V64, P368, DOI 10.1016/S0003-4975(97)00612-7
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Schachner T, 2004, ANN THORAC SURG, V78, P2028, DOI 10.1016/j.athoracsur.2004.04.078
   Schauffler HH, 2001, ANNU REV PUBL HEALTH, V22, P69, DOI 10.1146/annurev.publhealth.22.1.69
   SCHMOECKEL M, 1993, THORAC CARDIOV SURG, V41, P364, DOI 10.1055/s-2007-1013891
   Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051
   Schurr UP, 2001, ANN THORAC SURG, V72, P1316, DOI 10.1016/S0003-4975(01)03062-4
   Schwann TA, 2002, ANN THORAC SURG, V73, P1394, DOI 10.1016/S0003-4975(02)03422-7
   Scott BH, 2005, J CARDIOTHOR VASC AN, V19, P583, DOI 10.1053/j.jvca.2005.03.030
   Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043
   SEKI T, 1992, J THORAC CARDIOV SUR, V104, P1532
   Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668
   SELKER HP, 1993, ANN INTERN MED, V118, P820
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   Selnes OA, 2008, ANN NEUROL, V63, P581, DOI 10.1002/ana.21382
   Selnes OA, 2006, ANN THORAC SURG, V82, P388, DOI 10.1016/j.athoracsur.2006.02.060
   Selnes OA, 2003, ANN THORAC SURG, V75, P1377, DOI 10.1016/S0003-4975(03)00021-3
   Selnes OA, 1999, ANN THORAC SURG, V67, P1669, DOI 10.1016/S0003-4975(99)00258-1
   Serfontein L, 2010, CURR OPIN ANESTHESIO, V23, P103, DOI 10.1097/ACO.0b013e328334cb75
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Sergeant P, 1998, J THORAC CARDIOV SUR, V116, P440, DOI 10.1016/S0022-5223(98)70010-8
   Serrano CV, 2010, J CRIT CARE, V25, P305, DOI 10.1016/j.jcrc.2009.06.009
   Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
   SETHI GK, 1990, J AM COLL CARDIOL, V15, P15
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2004, ANN THORAC SURG, V78, P1868, DOI 10.1016/j.athorascur.2004.05.054
   Shahian DM, 2001, ANN THORAC SURG, V72, P2155, DOI 10.1016/S0003-4975(01)03222-2
   Shahian DM, 2000, J THORAC CARDIOV SUR, V120, P978, DOI 10.1067/mtc.2000.110461
   Shahian DM, 2004, JAMA-J AM MED ASSOC, V291, P246, DOI 10.1001/jama.291.2.246
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Shahian DM, 2008, J THORAC CARDIOV SUR, V135, P1202, DOI 10.1016/j.jtcvs.2007.12.037
   Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008
   Shahian DM, 2005, ANN THORAC SURG, V80, P1146, DOI 10.1016/j.athoracsur.2004.10.046
   Shahian DM, 2008, CIRCULATION, V117, P1955, DOI 10.1161/CIRCULATIONAHA.107.747873
   Shahian DM, 2003, ANN THORAC SURG, V75, P1048, DOI 10.1016/S0003-4975(02)04308-4
   Shahian DM, 2007, ANN THORAC SURG, V83, pS3, DOI 10.1016/j.athoracsur.2007.01.053
   Shamshad F, 2010, AM HEART J, V160, P145, DOI 10.1016/j.ahj.2010.02.037
   Shanewise JS, 1999, ANESTH ANALG, V89, P870, DOI 10.1097/00000539-199910000-00010
   SHARMA GVRK, 1983, CIRCULATION, V68, P218
   Sharoni E, 2009, THORAC CARDIOV SURG, V57, P204, DOI 10.1055/s-0029-1185367
   Sharony R, 2003, CIRCULATION, V108, P15, DOI 10.1161/01.cir.0000087448.65888.21
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Sheiman RG, 2007, AM J ROENTGENOL, V188, pW475, DOI 10.2214/AJR.06.1024
   Shernan SK, 2004, ANN THORAC SURG, V77, P942, DOI 10.1016/j.athoracsur.2003.08.054
   Shim JK, 2007, J THORAC CARDIOV SUR, V134, P59, DOI 10.1016/j.jtcvs.2007.03.013
   Shimizu T, 2000, J THORAC CARDIOV SUR, V120, P459, DOI 10.1067/mtc.2000.108166
   Shimizu T, 2010, CIRC J, V74, P449, DOI 10.1253/circj.CJ-09-0586
   Shiran A, 1997, CARDIOLOGY, V88, P207, DOI 10.1159/000177331
   Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016
   SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Shroyer ALW, 1996, ANN THORAC SURG, V61, P17, DOI 10.1016/0003-4975(95)00830-6
   SILVERMAN NA, 1982, ANN SURG, V196, P194, DOI 10.1097/00000658-198208000-00012
   Simchen E, 1997, EUR J EPIDEMIOL, V13, P503, DOI 10.1023/A:1007349230374
   Simons M, 2000, BIODRUGS, V14, P13, DOI 10.2165/00063030-200014010-00002
   Simoons ML, 1996, NEW ENGL J MED, V335, P275, DOI 10.1056/NEJM199607253350409
   SIMS FH, 1983, AM HEART J, V105, P560, DOI 10.1016/0002-8703(83)90478-7
   Singh M, 2009, MAYO CLIN PROC, V84, P501, DOI 10.1016/S0025-6196(11)60581-8
   Singh SK, 2008, CIRCULATION, V118, pS222, DOI 10.1161/CIRCULATIONAHA.107.757161
   Sirivella S, 2000, ANN THORAC SURG, V69, P501, DOI 10.1016/S0003-4975(99)01298-9
   SISTO T, 1989, ANN THORAC SURG, V47, P884
   Sjogren J, 2006, EUR J CARDIO-THORAC, V30, P898, DOI 10.1016/j.ejcts.2006.09.020
   Sjogren J, 2005, ANN THORAC SURG, V80, P1270, DOI 10.1016/j.athoracsur.2005.04.010
   Sjogren J, 2005, ANN THORAC SURG, V79, P2049, DOI 10.1016/j.athorascur.2004.12.048
   SJOLAND H, 1995, BRIT HEART J, V74, P235
   Skubas N, 2009, ANESTH ANALG, V108, P48, DOI 10.1213/ane.0b013e31818a6c4c
   Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070
   SLOGOFF S, 1988, ANESTHESIOLOGY, V68, P676, DOI 10.1097/00000542-198805000-00004
   SLOGOFF S, 1978, JAMA-J AM MED ASSOC, V240, P1487, DOI 10.1001/jama.240.14.1487
   SLOGOFF S, 1985, ANESTHESIOLOGY, V62, P107, DOI 10.1097/00000542-198502000-00002
   Smith Jr. SC, 2011, CIRCULATION, DOI [10.1161/CIR.0b013e318235eb4d, DOI 10.1161/CIR.0B013E318235EB4D]
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith PK, 2010, J THORAC CARDIOVASC, V142, P89
   Smith PM, 2009, CAN MED ASSOC J, V180, P1297, DOI 10.1503/cmaj.080862
   Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815
   Smith WT, 2004, J AM COLL CARDIOL, V44, P1241, DOI 10.1016/j.jacc.2004.06.031
   Song HK, 2009, J THORAC CARDIOV SUR, V137, P65, DOI 10.1016/j.jtcvs.2008.09.053
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   Sowade O, 1997, BLOOD, V89, P411
   SOWDEN AJ, 1995, BRIT MED J, V311, P151
   Spelman D, 2002, INFECT CONT HOSP EP, V23, P402, DOI 10.1086/502074
   Spiegelhalter D, 2003, INT J QUAL HEALTH C, V15, P7, DOI 10.1093/intqhc/15.1.7
   Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970
   Srinivasan AK, 2003, ANN THORAC SURG, V76, P41, DOI 10.1016/S0003-4975(03)00182-6
   Stahle E, 1997, EUR J CARDIO-THORAC, V11, P1146, DOI 10.1016/S1010-7940(97)01210-4
   Stamou SC, 2006, J THORAC CARDIOV SUR, V131, P28, DOI 10.1016/j.jtcvs.2005.08.059
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   Starobin D, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-25
   Staton GA, 2005, CHEST, V127, P892, DOI 10.1378/chest.127.3.892
   Stein PD, 2004, CHEST, V126, P600
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stevens LM, 2004, J THORAC CARDIOV SUR, V127, P1408, DOI 10.1016/j.jtcvs.2003.10.006
   Stewart RD, 1998, ANN THORAC SURG, V66, P1306, DOI 10.1016/S0003-4975(98)00760-7
   Stone GW, 2000, AM J CARDIOL, V85, P1292, DOI 10.1016/S0002-9149(00)00758-X
   Straka Z, 2002, ANN THORAC SURG, V74, P1544, DOI 10.1016/S0003-4975(02)03934-6
   Stroupe KT, 2006, CIRCULATION, V114, P1251, DOI 10.1161/CIRCULATIONAHA.105.570838
   Stygall J, 2003, HEALTH PSYCHOL, V22, P579, DOI 10.1037/0278-6133.22.6.579
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   Sukernik MR, 2007, ANESTH ANALG, V105, P602, DOI 10.1213/01.ane.0000278735.06194.0c
   Suma H, 2000, J THORAC CARDIOV SUR, V120, P496, DOI 10.1067/mtc.2000.108690
   Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104
   Surgenor SD, 2006, CIRCULATION, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271
   Suvarna S, 2007, J CARDIOTHOR VASC AN, V21, P805, DOI 10.1053/j.jvca.2007.05.014
   Svensson LG, 2010, J THORAC CARDIOV SUR, V139, P926, DOI 10.1016/j.jtcvs.2009.09.038
   Svircevic V, 2010, ANESTHESIOLOGY, V114, P271
   Swaminathan M, 2007, ANESTHESIOLOGY, V107, P739
   Swaminathan M, 2003, ANN THORAC SURG, V76, P784, DOI 10.1016/S0003-4975(03)00558-7
   Sweet JJ, 2008, ANN THORAC SURG, V85, P1571, DOI 10.1016/j.athoracsur.2008.01.090
   Sylivris S, 1997, J CARDIOTHOR VASC AN, V11, P704, DOI 10.1016/S1053-0770(97)90161-0
   Szczech LA, 2002, CIRCULATION, V105, P2253, DOI 10.1161/01.CIR.0000016051.33225.33
   Szczech LA, 2001, KIDNEY INT, V60, P292, DOI 10.1046/j.1523-1755.2001.00799.x
   Tabata M, 2007, AM J CARDIOL, V100, P442, DOI 10.1016/j.amjcard.2007.03.071
   Taghaddomi RJ, 2009, J CARDIOTHOR VASC AN, V23, P312, DOI 10.1053/j.jvca.2008.09.018
   Taillefer MC, 2006, J THORAC CARDIOV SUR, V131, P1274, DOI 10.1016/j.jtcvs.2006.02.001
   Takagi H, 2007, J THORAC CARDIOV SUR, V134, P548, DOI 10.1016/j.jtcvs.2007.03.047
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   TALLEY JD, 1990, CIRCULATION, V82, P1203
   Tamburino C, 2010, JACC-CARDIOVASC INTE, V3, P624, DOI 10.1016/j.jcin.2010.03.016
   Tanaka K, 2004, ANESTHESIOLOGY, V100, P707, DOI 10.1097/00000542-200403000-00035
   Tanner J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004122.pub3
   Tarakji KG, 2011, JAMA-J AM MED ASSOC, V305, P381, DOI 10.1001/jama.2011.37
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Tarantini G, 2009, CATHETER CARDIO INTE, V73, P50, DOI 10.1002/ccd.21757
   Tavakoli R, 2002, EUR J CARDIO-THORAC, V21, P818, DOI 10.1016/S1010-7940(02)00065-9
   Taylor AJ, 1997, AM HEART J, V133, P428, DOI 10.1016/S0002-8703(97)70184-4
   TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   Tector A J, 1996, Semin Thorac Cardiovasc Surg, V8, P29
   ten Broecke PWC, 2003, BRIT J ANAESTH, V90, P27, DOI 10.1093/bja/aeg013
   Tenenbein PK, 2008, CAN J ANAESTH, V55, P344, DOI 10.1007/BF03021489
   Testa L, 2008, J THORAC CARDIOV SUR, V136, P884, DOI 10.1016/j.jtcvs.2007.12.062
   Thakar CV, 2005, J AM SOC NEPHROL, V16, P162
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   Alderman EL, 1996, NEW ENGL J MED, V335, P217
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   De Giorgio L, 2000, NEW ENGL J MED, V342, P1376
   Talbot P, 2000, NEW ENGL J MED, V342, P748
   Herlitz J, 1995, EUR HEART J, V16, P1825
   PEDUZZI P, 1992, CIRCULATION, V86, P121
   Theologou T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004472.pub3
   Thiele H, 2009, J AM COLL CARDIOL, V53, P2324, DOI 10.1016/j.jacc.2009.03.032
   Thiele H, 2005, CIRCULATION, V112, P3445, DOI 10.1161/CIRCULATIONHA.105.578492
   Thielmann M, 2007, J THORAC CARDIOV SUR, V134, P1143, DOI 10.1016/j.jtcvs.2007.07.029
   Thielmann M, 2006, CIRCULATION, V114, pI448, DOI 10.1161/CIRCULATIONAHA.105.001057
   Thielmann M, 2007, ANN THORAC SURG, V84, P17, DOI 10.1016/j.athoracsur.2007.03.086
   THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301
   THOMAS D, 1991, EUR HEART J, V12, P832
   Thomas RJ, 2007, CIRCULATION, V116, P1611, DOI 10.1161/CIRCULATIONAHA.107.185734
   Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011
   Thys DM, 2009, ANESTH ANALG, V109, P1782, DOI 10.1213/ANE.0b013e3181be4002
   TIME Investigators, 2001, Lancet, V358, P951
   Ting HH, 2006, J AM COLL CARDIOL, V47, P1713, DOI 10.1016/j.jacc.2006.02.039
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   Toor Iqbal, 2009, Interact Cardiovasc Thorac Surg, V9, P827, DOI 10.1510/icvts.2009.210872
   Toumpoulis IK, 2005, CHEST, V127, P464, DOI 10.1378/chest.127.2.464
   TOWNSEND TR, 1993, J THORAC CARDIOV SUR, V106, P664
   Trichon BH, 2003, CIRCULATION, V108, P103, DOI 10.1161/01.cir.0000087656.10829.df
   Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Tu JV, 1997, J AM COLL CARDIOL, V30, P1317, DOI 10.1016/S0735-1097(97)00295-7
   Tully PJ, 2008, J PSYCHOSOM RES, V64, P285, DOI 10.1016/j.jpsychores.2007.09.007
   TUMAN KJ, 1989, ANESTHESIOLOGY, V70, P199, DOI 10.1097/00000542-198902000-00004
   Tumlin JA, 2005, AM J KIDNEY DIS, V46, P26, DOI 10.1053/j.ajkd.2005.04.002
   Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032
   Turner William F Jr, 2006, Ann Thorac Surg, V82, P790, DOI 10.1016/j.athoracsur.2006.03.112
   TYRAS DH, 1979, J THORAC CARDIOV SUR, V77, P310
   United States Renal Data System, 2009, NIH PUBL
   Urbach DR, 2005, J CLIN EPIDEMIOL, V58, P391, DOI 10.1016/j.jclinepi.2004.12.001
   Urban PM, 2004, AM J CARDIOL, V94, P181, DOI 10.1016/j.amjcard.2004.03.058
   UTLEY JR, 1995, ANN THORAC SURG, V60, P570, DOI 10.1016/0003-4975(95)00416-I
   Vaccarino GN, 2009, J THORAC CARDIOV SUR, V137, P309, DOI 10.1016/j.jtcvs.2008.08.002
   van DD, 2007, JAMA-J AM MED ASSOC, V297, P701
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van der Linden J, 2001, J AM COLL CARDIOL, V38, P131, DOI 10.1016/S0735-1097(01)01328-6
   van de Watering LMG, 1998, CIRCULATION, V97, P562
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   van Domburg RT, 2000, J AM COLL CARDIOL, V36, P878, DOI 10.1016/S0735-1097(00)00810-X
   van Domburg RT, 2008, AM HEART J, V156, P473, DOI 10.1016/j.ahj.2008.04.007
   van Eck FM, 2002, EUR J CARDIO-THORAC, V21, P205, DOI 10.1016/S1010-7940(01)01106-X
   van Mastrigt GAPG, 2006, CRIT CARE MED, V34, P1624, DOI 10.1097/01.CCM.0000217963.87227.7B
   van Mastrigt GAPG, 2010, QUAL LIFE RES, V19, P631, DOI 10.1007/s11136-010-9625-5
   van Mastrigt GAPG, 2006, CRIT CARE MED, V34, P65, DOI 10.1097/01.CCM.0000191266.72652.FA
   van Straten AHM, 2010, INTERACT CARDIOV TH, V10, P37, DOI 10.1510/icvts.2009.214551
   van Straten AHM, 2010, J CARDIOTHOR VASC AN, V24, P413, DOI 10.1053/j.jvca.2010.01.001
   Varani Elisabetta, 2007, J Invasive Cardiol, V19, P469
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades Thomas Jr, 2009, Semin Thorac Cardiovasc Surg, V21, P237, DOI 10.1053/j.semtcvs.2009.08.008
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Veeger NJGM, 2010, ANN THORAC SURG, V90, P1515, DOI 10.1016/j.athoracsur.2010.06.007
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1616
   Veliz-Reissmuller G, 2007, AGING CLIN EXP RES, V19, P172
   Venge P, 2009, J AM COLL CARDIOL, V54, P1165, DOI 10.1016/j.jacc.2009.05.051
   Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770
   Vesely DL, 2003, AM J PHYSIOL-RENAL, V285, pF167, DOI 10.1152/ajprenal.00259.2002
   Vincent JL, 2008, CRIT CARE MED, V36, P3093, DOI 10.1097/CCM.0b013e31818c10c7
   VINEBERG AM, 1946, CAN MED ASSOC J, V55, P117
   VLIETSTRA RE, 1986, JAMA-J AM MED ASSOC, V255, P1023, DOI 10.1001/jama.255.8.1023
   VONSEGESSER LK, 1994, EUR J CARDIO-THORAC, V8, P363, DOI 10.1016/1010-7940(94)90030-2
   Voors AA, 1996, CIRCULATION, V93, P42
   Vuorisalo S, 1998, INFECT CONT HOSP EP, V19, P234
   Wadhera RK, 2010, J THORAC CARDIOV SUR, V139, P312, DOI 10.1016/j.jtcvs.2009.10.048
   Wahrborg P, 1999, EUR HEART J, V20, P653, DOI 10.1053/euhj.1998.1237
   WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421
   Walpoth B, 1996, SEMIN HEMATOL, V33, P75
   WALSH EE, 2010, ARCH INTERN MED, V171, P68
   Walsh SR, 2007, BRIT J ANAESTH, V99, P611, DOI 10.1093/bja/aem273
   Walsh SR, 2008, EUR J CARDIO-THORAC, V34, P985, DOI 10.1016/j.ejcts.2008.07.062
   Walsh SR, 2010, EUR J VASC ENDOVASC, V39, P719, DOI 10.1016/j.ejvs.2010.02.004
   Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6
   Wang BH, 2009, BIOCHEM BIOPH RES CO, V389, P105, DOI 10.1016/j.bbrc.2009.08.097
   Wang G, 2010, J CARDIOTHOR VASC AN, V2, P268, DOI DOI 10.1152/AJPRENAL.00259.2002
   Wang JW, 2004, ANESTH ANALG, V99, P965, DOI 10.1213/01.ane.0000130614.45647.81
   WANG N, 1995, J THORAC CARDIOV SUR, V110, P214, DOI 10.1016/S0022-5223(05)80028-5
   Wasvary H, 1997, AM SURGEON, V63, P710
   WATANABE Y, 1992, ANN THORAC SURG, V54, P479
   WEBB JM, 1993, ANN ROY COLL SURG, V75, P291
   Weightman WM, 1999, ANESTH ANALG, V88, P286, DOI 10.1097/00000539-199902000-00011
   WEINER B, 1986, CLIN PHARMACY, V5, P55
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Weiss ES, 2008, J THORAC CARDIOV SUR, V135, P503, DOI 10.1016/j.jtcvs.2007.10.042
   Weiss ES, 2008, J THORAC CARDIOVASC, V135, pe1
   Welke KF, 2005, ANN THORAC SURG, V80, P2114, DOI 10.1016/j.athoracsur.2005.05.017
   Welke KF, 2007, ANN THORAC SURG, V84, P1538, DOI 10.1016/j.athoracsur.2007.06.022
   Welsby I, 2010, TRANSFUSION, V50, P2343
   Weltert L, 2010, J THORAC CARDIOV SUR, V139, P621, DOI 10.1016/j.jtcvs.2009.10.012
   WENGER NK, 1998, REHABILITATION CORON
   Werdan K, 2008, CRIT CARE MED, V36, P716, DOI 10.1097/01.CCM.0B013E3181611F62F
   Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   White CM, 2007, EUR J CARDIO-THORAC, V31, P817, DOI 10.1016/j.ejcts.2007.02.010
   White HD, 2005, CIRCULATION, V112, P1992, DOI 10.1161/CIRCULATIONAHA.105.540948
   Wiesbauer F, 2007, ANESTH ANALG, V104, P27, DOI 10.1213/01.ane.0000247805.00342.21
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   WILLIAMS DB, 1985, J THORAC CARDIOV SUR, V90, P592
   WILSON APR, 1988, J ANTIMICROB CHEMOTH, V21, P213, DOI 10.1093/jac/21.2.213
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wong CHK, 2006, EUR J CARDIO-THORAC, V30, P148, DOI 10.1016/j.ejcts.2006.03.049
   WONG PS, 1993, ANN THORAC SURG, V56, P108
   Wu CT, 2004, CIRCULATION, V110, P784, DOI 10.1161/01.CIR.0000138744.13516.B5
   Wu ZK, 2002, CIRCULATION, V106, P3091, DOI 10.1161/01.CIR.0000041430.32233.5B
   Xia ZY, 2006, ANESTH ANALG, V103, P527, DOI 10.1213/01.ane.0000230612.29452.a6
   Yamaguchi A, 2009, ANN THORAC CARDIOVAS, V15, P98
   Yang JH, 2008, ANN THORAC SURG, V85, P65, DOI 10.1016/j.athoracsur.2007.06.027
   Yang Zhen Kun, 2007, J Interv Cardiol, V20, P10, DOI 10.1111/j.1540-8183.2007.00222.x
   Yao Yun-tai, 2009, Chinese Medical Sciences Journal, V24, P133
   Yap CH, 2009, ANN THORAC SURG, V87, P1386, DOI 10.1016/j.athoracsur.2009.02.006
   Yau JM, 2008, AM J CARDIOL, V102, P546, DOI 10.1016/j.amjcard.2008.04.069
   Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667
   Yende S, 2001, CRIT CARE MED, V29, P2271, DOI 10.1097/00003246-200112000-00006
   Yeung-Lai-Wah JA, 2004, ANN THORAC SURG, V77, P2083, DOI 10.1016/j.athoracsur.2003.12.020
   YLIMAYRY S, 1992, EUR HEART J, V13, P1259
   Young EW, 1998, ANN THORAC SURG, V65, P1316, DOI 10.1016/S0003-4975(98)00157-X
   Yu CH, 2006, CAN J ANAESTH, V53, P906
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489
   Zarbock A, 2009, CHEST, V135, P1252, DOI 10.1378/chest.08-1602
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   Zimarino M, 2004, ANN THORAC SURG, V78, P135, DOI 10.1016/j.athorascur.2003.12.030
   Zingone B, 2006, EUR J CARDIO-THORAC, V29, P720, DOI 10.1016/j.ejcts.2006.02.001
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
   Zvara DA, 2000, J CARDIOTHOR VASC AN, V14, P571, DOI 10.1053/jcan.2000.9445
   2011, CIRCULATION, V123, pE269
NR 1260
TC 79
Z9 82
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD DEC 6
PY 2011
VL 124
IS 23
BP E652
EP U267
DI 10.1161/CIR.0b013e31823c074e
PG 176
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 863QW
UT WOS:000298183300002
PM 22064599
ER

PT J
AU Ruocco, V
   Schwartz, RA
   Ruocco, E
AF Ruocco, V
   Schwartz, RA
   Ruocco, E
TI Lymphedema: An immunologically vulnerable site for development of
   neoplasms
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Article
ID PEMPHIGOID FOLLOWING RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA;
   KAPOSIS-SARCOMA; POSTMASTECTOMY LYMPHEDEMA; AMPUTATION STUMP;
   MALIGNANT-LYMPHOMA; ANGIOSARCOMA; LEG; SKIN; ASSOCIATION
AB Lymphedema is the result of accumulation of protein-rich interstitial fluid (lymph stasis') caused by a failure of lymph drainage in the face of a normal capillary filtration. Whether the origin is congenital or acquired from infection, radiation, trauma, or surgery, chronic lymph stasis impairs local immune surveillance by disrupting trafficking of the immunocompetent cells in the lymphedematous district and stimulates vicarious angiogenesis by promoting development of a collateral lymphatic and hematic network in the lymphedematous district. When the local mechanisms Of immune surveillance begin to fail, the lymphedematous region becomes an immunologically vulnerable area, predisposed to malignancy, chiefly vascular tumors such as Stewart-Treves syndrome and Kaposi's sarcoma, because of the continual angiogenic stimulus.
C1 Univ Med & Dent New Jersey, Dept Dermatol, Newark, NJ 07103 USA.
   Univ Naples 2, Dept Dermatol, Naples, Italy.
RP Schwartz, RA (reprint author), Univ Med & Dent New Jersey, Dept Dermatol, 185 S Orange Ave, Newark, NJ 07103 USA.
CR ALBANESE A, 1991, DERMATOLOGIA OGGI, V5, P13
   ALLAN A, 1998, J CUTAN PATHOL, V25, P485
   Azurdia RM, 1999, CLIN EXP DERMATOL, V24, P270
   BARTAL AH, 1985, J SURG ONCOL, V30, P16, DOI 10.1002/jso.2930300106
   BENSON PM, 1988, J DERMATOL SURG ONC, V14, P781
   BEYLOTBARRY M, 1995, DERMATOLOGY, V190, P77
   CALLENS A, 1993, ACTA DERM-VENEREOL, V73, P461
   Cliff S, 1996, ACTA DERM-VENEREOL, V76, P330
   DAMORE ESG, 1990, AM J SURG PATHOL, V14, P456, DOI 10.1097/00000478-199005000-00005
   DEMITSU T, 1991, DERMATOLOGICA, V183, P230
   Dragan LR, 2000, J AM ACAD DERMATOL, V42, P872, DOI 10.1016/S0190-9622(00)90258-5
   FEI L, 1987, PRESSE MED, V16, P1188
   FERGUSSON CM, 1985, J ROY SOC MED, V78, P497
   Hengge UR, 2000, BRIT J DERMATOL, V142, P501, DOI 10.1046/j.1365-2133.2000.03364.x
   HILLS RJ, 1993, BRIT J DERMATOL, V129, P186, DOI 10.1111/j.1365-2133.1993.tb03526.x
   HODL S, 1988, HAUTARZT, V39, P302
   Karkkainen MJ, 2000, NAT GENET, V25, P153
   KIRCHMANN TTT, 1994, J AM ACAD DERMATOL, V31, P861, DOI 10.1016/S0190-9622(94)70247-0
   Klein E, 1980, CLIN IMMUNOTHER, P31
   KOLDE G, 1989, BRIT J DERMATOL, V120, P575, DOI 10.1111/j.1365-2133.1989.tb01334.x
   KRYWONIS N, 1990, INT J DERMATOL, V29, P41, DOI 10.1111/j.1365-4362.1990.tb03754.x
   LAMBERT PB, 1965, TRANSPLANTATION, V36, P62
   LAOR Y, 1979, J SURG ONCOL, V12, P299, DOI 10.1002/jso.2930120403
   Leconte-Boulard C, 2000, ANN DERMATOL VENER, V127, P70
   Lister RK, 1997, BRIT J DERMATOL, V136, P384, DOI 10.1111/j.1365-2133.1997.tb14950.x
   LOTEM M, 1994, J AM ACAD DERMATOL, V31, P812
   Lukas M, 1996, J INVEST DERMATOL, V106, P1293, DOI 10.1111/1523-1747.ep12349010
   Mallon E, 1997, BRIT J DERMATOL, V137, P928, DOI 10.1111/j.1365-2133.1997.tb01553.x
   MORTIMER PS, 1995, CLIN EXP DERMATOL, V20, P98, DOI 10.1111/j.1365-2230.1995.tb02665.x
   OFFORI TW, 1993, CLIN EXP DERMATOL, V18, P174, DOI 10.1111/j.1365-2230.1993.tb01008.x
   OLSZEWSKI WL, 1990, LYMPHOLOGY, V23, P23
   ROSSO R, 1995, J CUTAN PATHOL, V22, P164, DOI 10.1111/j.1600-0560.1995.tb01401.x
   RUOCCO V, 1985, ANN DERMATOL VENER, V112, P283
   RUOCCO V, 1982, ANN DERMATOL VENER, V109, P489
   Ruocco V, 1992, ANN ITAL DERMATOL CL, V46, P153
   RUOCCO V, 1991, B DERMATOL ALLERGOL, V6, P173
   RUOCCO V, 1986, INT J DERMATOL, V25, P594, DOI 10.1111/j.1365-4362.1986.tb04711.x
   RUOCCO V, 1984, INT J DERMATOL, V23, P56, DOI 10.1111/j.1365-4362.1984.tb05664.x
   RYTTER BM, 1972, DTSCH GESUNDHEITSW, V27, P118
   SARKANY I, 1972, P ROY SOC MED, V65, P253
   SCHWARTZ RA, 1991, DERMATOLOGICA, V182, P193
   Schwartz RA, 1996, J AM ACAD DERMATOL, V34, P804, DOI 10.1016/S0190-9622(96)90018-3
   Schwartz RA, 2000, BRIT J DERMATOL, V142, P153, DOI 10.1046/j.1365-2133.2000.03259.x
   SHELLEY WB, 1981, CANCER, V48, P820, DOI 10.1002/1097-0142(19810801)48:3<820::AID-CNCR2820480325>3.0.CO;2-H
   Sinclair SA, 1998, BRIT J DERMATOL, V138, P692
   STARK RB, 1960, ANN NY ACAD SCI, V87, P140, DOI 10.1111/j.1749-6632.1960.tb23186.x
   TATNALL FM, 1985, BRIT J DERMATOL, V113, P751, DOI 10.1111/j.1365-2133.1985.tb02412.x
   Torres-Paoli D, 2000, AM J DERMATOPATH, V22, P257, DOI 10.1097/00000372-200006000-00009
   WAXMAN M, 1984, ARCH PATHOL LAB MED, V108, P206
   WILKINSON SM, 1992, CLIN EXP DERMATOL, V17, P456, DOI 10.1111/j.1365-2230.1992.tb00260.x
   WITTE MH, 1990, AM J ROENTGENOL, V155, P311
   WITTE MH, 1989, INT J DERMATOL, V28, P561, DOI 10.1111/j.1365-4362.1989.tb02529.x
   Ziegler JL, 2001, J CLIN VIROL, V20, P127, DOI 10.1016/S1386-6532(00)00137-2
   ZIEGLER JL, 1993, LANCET, V342, P1348, DOI 10.1016/0140-6736(93)92252-O
NR 54
TC 79
Z9 81
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD JUL
PY 2002
VL 47
IS 1
BP 124
EP 127
DI 10.1067/mjd.2002.120909
PG 4
WC Dermatology
SC Dermatology
GA 568TR
UT WOS:000176560400015
PM 12077591
ER

PT J
AU Wilting, J
   Papoutsi, M
   Christ, B
   Nicolaides, KH
   von Kaisenberg, CS
   Borges, J
   Stark, GB
   Alitalo, K
   Tomarev, SI
   Niemeyer, C
   Rossler, J
AF Wilting, J
   Papoutsi, M
   Christ, B
   Nicolaides, KH
   von Kaisenberg, CS
   Borges, J
   Stark, GB
   Alitalo, K
   Tomarev, SI
   Niemeyer, C
   Rossler, J
TI The transcription factor Prox1 is a marker for lymphatic endothelial
   cells in normal and diseased human tissues
SO FASEB JOURNAL
LA English
DT Article
DE human fetus; lymphedema; lymphangioma; hemangioma; lymphangiogenesis
ID GROWTH-FACTOR RECEPTOR-3; VASCULAR TUMORS; VEGF-C; EXPRESSION; BLOOD;
   GENE; LYMPHANGIOGENESIS; PROMOTES; ANTIGEN; SYSTEM
AB Detection of lymphatic endothelal cells (LECs) has been problematic because of the lack of specific markers. The homeobox transcription factor Prox1 is expressed in LECs of murine and avian embryos. We have studied expression of Prox1 in human tissues with immunofluorescence. In 19-wk-old human fetuses, Prox1 and vascular endothelial growth factor receptor-3 (VEGFR-3) are coexpressed in LECs of lymphatic trunks and lymphatic capillaries. Prox1 is located in the nucleus, and its expression is mutually exclusive with that of the blood vascular marker PAL-E. Prox1 is a constitutive marker of LECs and is found in tissues of healthy adults and lymphedema patients. Blood vascular endothelial cells (BECs) of hemangiomas express CD31 and CD34, but not Prox1. A subset of these cells is positive for VEGFR-3. Lymphatics in the periphery of hemangiomas express Prox1 and CD31, but not CD34. In lymphangiomas, LECs express Prox1, CD31, and VEGFR-3, but rarely CD34. In the stroma, spindle-shaped CD34-positive cells are present. We show that Prox1 is a reliable marker for LECs in normal and pathologic human tissues, coexpressed with VEGFR-3 and CD31. VEGFR-3 and CD34 are less reliable markers for LECs and BECs, respectively, because exceptions from their normal expression patterns are found in pathologic tissues.
C1 Univ Freiburg, Inst Anat, D-79104 Freiburg, Germany.
   Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England.
   Univ Kiel, Frauenklin, D-24105 Kiel, Germany.
   Univ Freiburg, Abt Plast & Handchirurg, D-79104 Freiburg, Germany.
   Univ Helsinki, Mol & Canc Biol Lab, FIN-00014 Helsinki, Finland.
   NEI, Mol & Dev Biol Lab, NIH, Bethesda, MD 20892 USA.
   Univ Freiburg, Zentrum Kinderheilkunde & Jugendmed, D-79104 Freiburg, Germany.
RP Wilting, J (reprint author), Univ Freiburg, Inst Anat, Albertstr 17, D-79104 Freiburg, Germany.
EM Joerg.Wilting@anat.uni-freiburg.de
RI Alitalo, Kari/J-5013-2014
OI Alitalo, Kari/0000-0002-7331-0902
CR Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6
   BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141
   Carreira CM, 2001, CANCER RES, V61, P8079
   Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946
   Duncan GS, 1999, J IMMUNOL, V162, P3022
   FOLKMAN J, 1974, CANCER RES, V34, P2109
   Folpe AL, 2000, MODERN PATHOL, V13, P180, DOI 10.1038/modpathol.3880033
   KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566
   KATO S, 1990, ACTA HISTOCHEM CYTOC, V23, P613
   KINMONTH JB, 1972, LYMPHATICS DIS LYMPH
   KRIEHUBER E, 2001, J EXP MED, V194, pF37
   Lymboussaki A, 1998, AM J PATHOL, V153, P395, DOI 10.1016/S0002-9440(10)65583-6
   Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MIETTINEN M, 1994, MODERN PATHOL, V7, P82
   NOSE K, 1990, CELL GROWTH DIFFER, V1, P511
   OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M
   Paal E, 1998, CANCER, V82, P2150, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2150::AID-CNCR9>3.0.CO;2-Z
   Papoutsi M, 2001, DEV DYNAM, V222, P238, DOI 10.1002/dvdy.1187
   Papoutsi M, 2000, HISTOCHEM CELL BIOL, V114, P373
   Papoutsi M, 2000, HISTOCHEM CELL BIOL, V113, P105, DOI 10.1007/s004180050013
   Partanen TA, 1999, CANCER, V86, P2406, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2406::AID-CNCR31>3.0.CO;2-E
   Partanen TA, 2000, FASEB J, V14, P2087, DOI 10.1096/fj.99-1049com
   Polkinghorne J., 1989, CM762
   Rodriguez-Niedenfuhr M, 2001, ANAT EMBRYOL, V204, P399, DOI 10.1007/s00429-001-0214-9
   Sauter B, 1998, J HISTOCHEM CYTOCHEM, V46, P165
   SCHLINGEMANN RO, 1985, LAB INVEST, V52, P71
   SIMMONS DL, 1990, J EXP MED, V171, P2147, DOI 10.1084/jem.171.6.2147
   Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643
   Sleeman JP, 2001, MICROSC RES TECHNIQ, V55, P61, DOI 10.1002/jemt.1157
   SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4
   Sosa-Pineda B, 2000, NAT GENET, V25, P254
   Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635
   Tomarev SI, 1996, DEV DYNAM, V206, P354, DOI 10.1002/(SICI)1097-0177(199608)206:4<354::AID-AJA2>3.0.CO;2-H
   Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V248, P684, DOI 10.1006/bbrc.1998.8989
   Vikkula M, 1998, TRENDS CARDIOVAS MED, V8, P281, DOI 10.1016/S1050-1738(98)00024-3
   von Kaisenberg CS, 1999, HUM REPROD, V14, P823, DOI 10.1093/humrep/14.3.823
   Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2
   Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1
   Wilting J, 1997, CELL TISSUE RES, V288, P207, DOI 10.1007/s004410050807
   Wilting J, 2001, MICROSC RES TECHNIQ, V55, P81, DOI 10.1002/jemt.1159
   Witte MH, 2001, MICROSC RES TECHNIQ, V55, P122, DOI 10.1002/jemt.1163
   Zinovieva RD, 1996, GENOMICS, V35, P517, DOI 10.1006/geno.1996.0392
NR 44
TC 79
Z9 87
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JUN
PY 2002
VL 16
IS 8
BP 1271
EP +
DI 10.1096/fj.01-1010fje
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 570WR
UT WOS:000176683900038
PM 12060670
ER

PT J
AU von Kodolitsch, Y
   Aydin, MA
   Koschyk, DH
   Loose, R
   Schalwat, I
   Karck, M
   Cremer, J
   Haverich, A
   Berger, J
   Meinertz, T
   Nienaber, CA
AF von Kodolitsch, Y
   Aydin, MA
   Koschyk, DH
   Loose, R
   Schalwat, I
   Karck, M
   Cremer, J
   Haverich, A
   Berger, J
   Meinertz, T
   Nienaber, CA
TI Predictors of aneurysmal formation after surgical correction of aortic
   coarctation
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID PATCH AORTOPLASTY REPAIR; TERM FOLLOW-UP; GRAFT AORTOPLASTY;
   ANGIOPLASTY; EXPERIENCE; DISSECTION; VALVE; SITE
AB OBJECTIVES We sought to identify the predictors of aneurysmal formation after surgical correction of aortic coarctation.
   BACKGROUND In 9% of patients, aneurysms develop late after corrective surgery of coarctation of the aorta, with a 36% mortality rate if left untreated. However, the predictors of postsurgical aneurysmal formation are unknown.
   METHODS Of 25 aortic aneurysms requiring corrective surgery 152 +/- 78 months after the initial coarctation repair, 8 were located in the ascending aorta (type A) and 17 at the site of previous repair (local type). Seventy-four patients without progression of the aortic diameter within 189 +/- 71 months after coarctation repair were used for categorical data analysis in an attempt to identify the predictors of postsurgical aneurysmal formation.
   RESULTS Advanced age at coarctation repair (p = 0.004) and patch graft technique (p < 0.0005) independently predicted local aneurysmal formation. Type A aneurysm was univariately associated with the presence of a bicuspid aortic valve (p = 0.02), advanced age at coarctation repair (p = 0.044) and a high preoperative peak systolic pressure gradient of 74 +/- 21 mm Hg (p = 0.041). Conversely, multivariate analysis confirmed only the presence of a bicuspid aortic valve (p = 0.015) as an independent predictor of type A aneurysm. Receiver operating characteristic curve analysis revealed that 72% of patients with a postsurgical aneurysm had an operation at age 13.5 years or more, whereas 69% with no postsurgical aneurysm had an operation at a younger age.
   CONCLUSIONS Use of the patch graft technique and late correction of coarctation can predict aneurysmal formation at the site of coarctation repair, whereas patients with a bicuspid aortic valve may be at risk for an aneurysm developing in the ascending aorta, particularly after late repair of aortic coarctation with high preoperative pressure gradients. (C) 2002 by the American College of Cardiology.
C1 Univ Hosp Hamburg Eppendorf, Dept Internal Med, Div Cardiol, D-20246 Hamburg, Germany.
   Univ Hosp Hamburg Eppendorf, Inst Math & Comp Sci Med, D-20246 Hamburg, Germany.
   Hannover Med Sch, Dept Cardiovasc Surg, D-3000 Hannover, Germany.
   Univ Kiel, Dept Cardiovasc Surg, Kiel, Germany.
RP von Kodolitsch, Y (reprint author), Univ Hosp Hamburg Eppendorf, Dept Internal Med, Div Cardiol, Martinistr 52, D-20246 Hamburg, Germany.
CR ALAKULJU K, 1989, ANN THORAC SURG, V47, P853
   BOGAERT J, 1995, J AM COLL CARDIOL, V26, P521, DOI 10.1016/0735-1097(95)80032-C
   BROMBERG BI, 1989, J AM COLL CARDIOL, V14, P734
   CARVALHO JS, 1990, BRIT HEART J, V64, P133
   CLARKSON PM, 1985, AM J CARDIOL, V56, P342, DOI 10.1016/0002-9149(85)90861-6
   DELNIDO PJ, 1986, CIRCULATION, V74, P32
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   EDWARDS JE, 1948, P STAFF M MAYO CLIN, V23, P324
   FORFANG K, 1979, ACTA MED SCAND, V206, P375
   Heger M, 1997, Z KARDIOL, V86, P50, DOI 10.1007/s003920050033
   HEHRLEIN FW, 1986, J THORAC CARDIOV SUR, V92, P226
   Ingelfinger JR, 1982, PEDIAT HYPERTENSION, P229
   KAPPETEIN AP, 1991, J THORAC CARDIOV SUR, V102, P830
   Knyshov GV, 1996, ANN THORAC SURG, V61, P935, DOI 10.1016/0003-4975(95)01189-7
   KOLLER M, 1987, EUR HEART J, V8, P670
   KRON IL, 1990, ANN THORAC SURG, V49, P920
   NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   PENNINGTON DG, 1979, J THORAC CARDIOV SUR, V77, P217
   PINZON JL, 1991, RADIOLOGY, V180, P199
   RHEUBAN KS, 1986, AM J CARDIOL, V58, P178, DOI 10.1016/0002-9149(86)90270-5
   SORLAND SJ, 1980, ACTA PAEDIATR SCAND, V69, P113, DOI 10.1111/j.1651-2227.1980.tb07041.x
   Task Force on Blood Pressure Control in Children, 1987, PEDIATRICS, V79, P1
   von Kodolitsch Y, 1999, CIRCULATION, V100, P287
NR 24
TC 79
Z9 80
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD FEB 20
PY 2002
VL 39
IS 4
BP 617
EP 624
DI 10.1016/S0735-1097(01)01784-3
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 522PB
UT WOS:000173904800010
PM 11849860
ER

PT J
AU Martinez, AA
   Kestin, LL
   Stromberg, JS
   Gonzalez, JA
   Wallace, M
   Gustafson, GS
   Edmundson, GK
   Spencer, W
   Vicini, FA
AF Martinez, AA
   Kestin, LL
   Stromberg, JS
   Gonzalez, JA
   Wallace, M
   Gustafson, GS
   Edmundson, GK
   Spencer, W
   Vicini, FA
TI Interim report of image-guided conformal high-dose-rate brachytherapy
   for patients with unfavorable prostate cancer: The William Beaumont
   Phase II dose-escalating trial
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate; prostatic neoplasms; radiotherapy; brachytherapy; image
   guided; prostate-specific antigen
ID EXTERNAL-BEAM RADIOTHERAPY; RATE IR-192 BRACHYTHERAPY;
   RADIATION-THERAPY; DEFINITIVE RADIOTHERAPY; PELVIC LYMPHADENECTOMY;
   RADICAL PROSTATECTOMY; TUMOR-CONTROL; FOLLOW-UP; CARCINOMA; IRRADIATION
AB Purpose: We analyzed our institution's experience treating patients with unfavorable prostate cancer in a prospective Phase II dose-escalating trial of external beam radiation therapy (EBRT) integrated with conformal high-dose-rate (HDR) brachytherapy boosts. This interim report discusses treatment outcome and prognostic factors using this treatment approach.
   Methods and Materials: From November 1991 through February 1998, 142 patients with unfavorable prostate cancer were prospectively treated in a dose-escalating trial with pelvic EBRT in combination with outpatient HDR brachytherapy at William Beaumont Hospital. Patients with any of the following characteristics were eligible: pretreatment prostate-specific antigen (PSA) greater than or equal to 10.0 ng/ml, Gleason score greater than or equal to 7, or clinical stage T2b or higher. All patients received pelvic EBRT to a median total dose of 46.0 Gy. Pelvic EBRT was integrated with ultrasound-guided transperineal conformal interstitial iridium-192 HDR implants. From 1991 to 1995, 58 patients underwent three conformal interstitial HDR implants during the first, second, and third weeks of pelvic EBRT. After October 1995, 84 patients received two interstitial implants during the first and third weeks of pelvic EBRT. The dose delivered via interstitial brachytherapy was escalated from 5.50 Gy to 6.50 Gy for each implant in those patients receiving three implants, and subsequently, from 8.25 Gy to 9.50 Gy per fraction in those patients receiving two implants. To improve implant quality and reduce operator dependency, an on-line, image-guided interactive dose optimization program was utilized during each HDR implant. No patient received hormonal therapy unless treatment failure was documented. The median follow-up was 2.1 years (range: 0.2-7.2 years). Biochemical failure was defined according to the American Society for Therapeutic Radiology and Oncology Consensus Panel definition.
   Results: The pretreatment PSA level was greater than or equal to 10.0 ng/ml in 51% of patients. The biopsy Gleason score was greater than or equal to 7 in 58% of cases, and 75% of cases were clinical stage T2b or higher. Despite the high frequency of these poor prognostic factors, the actuarial biochemical control rate was 89% at 2 years and 63% at 5 years. On multivariate analysis, a higher pretreatment PSA level, higher Gleason score, higher PSA nadir level, and shorter time to nadir were associated with biochemical failure. In the entire population, 14 patients (10%) experienced clinical failure at a median interval of 1.7 years (range: 0.2-4.5 years) after completing RT. The 5-year actuarial clinical failure rate was 22%. The 5-year actuarial rates of local failure and distant metastasis were 16% and 14%, respectively. For all patients, the 5-year disease-free survival, overall survival, and cause-specific survival rates were 89%, 95%, and 96%, respectively. The 5-year actuarial rate of RTOG Grade 3 late complications was 9% with no patient experiencing Grade 4 or 5 acute or late toxicity.
   Conclusion: Pelvic FBRT in combination with image-guided conformal HDR brachytherapy boosts appears to be an effective treatment for patients with unfavorable prostate cancer with minimal associated morbidity. Our dose-escalating trial will continue. (C) 2000 Elsevier Science Inc.
C1 William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
   William Beaumont Hosp, Dept Urol, Royal Oak, MI 48072 USA.
RP Martinez, AA (reprint author), William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.
CR *AM JOINT COMM CAN, 1993, AJCC CANC STAG MAN, P189
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981
   Beard CJ, 1996, INT J RADIAT ONCOL, V34, P451, DOI 10.1016/0360-3016(95)02081-0
   BLACKARD CE, 1975, CANCER CHEMOTH REP 1, V59, P225
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Borghede G, 1997, RADIOTHER ONCOL, V44, P245, DOI 10.1016/S0167-8140(97)00122-9
   Borghede G, 1997, RADIOTHER ONCOL, V44, P237, DOI 10.1016/S0167-8140(97)00121-7
   BRABBINS DS, 1998, RADIOTHER ONCOL S1, V48, P23
   Brenner DJ, 1999, INT J RADIAT ONCOL, V43, P1095, DOI 10.1016/S0360-3016(98)00438-6
   COX DR, 1972, J ROY STAT SOC B, V34, P1
   COX JD, 1983, INT J RADIAT ONCOL, V9, P299
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Edmundson GK, 1995, INT J RADIAT ONCOL, V33, P1257, DOI 10.1016/0360-3016(95)00276-6
   EDMUNDSON GK, 1990, BRACHYTHERAPY, P184
   EDMUNDSON GK, 1993, INT J RADIAT ONCOL, V27, P1215
   Forman J D, 1997, Semin Urol Oncol, V15, P239
   Forman JD, 1996, INT J RADIAT ONCOL, V35, P259, DOI 10.1016/0360-3016(96)00020-X
   FORMAN JD, 1993, RADIOTHER ONCOL, V27, P203, DOI 10.1016/0167-8140(93)90075-J
   FukunagaJohnson N, 1997, INT J RADIAT ONCOL, V38, P311, DOI 10.1016/S0360-3016(97)82499-6
   GEORGE NJR, 1988, LANCET, V1, P494
   Gustafson Gary, 1995, International Journal of Radiation Oncology Biology Physics, V32, P199, DOI 10.1016/0360-3016(95)97781-U
   Hanks GE, 1996, INT J RADIAT ONCOL, V35, P861, DOI 10.1016/0360-3016(96)00207-6
   Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3
   Hanks GE, 1999, CANCER J SCI AM, V5, P152
   HANKS GE, 1987, INT J RADIAT ONCOL, V13, P499, DOI 10.1016/0360-3016(87)90063-0
   HANKS GE, 1988, INT J RADIAT ONCOL, V15, P1299
   Hanks GE, 1997, INT J RADIAT ONCOL, V37, P543, DOI 10.1016/S0360-3016(96)00602-5
   HARAF DJ, 1995, INT J RADIAT ONCOL, V33, P3, DOI 10.1016/0360-3016(95)00181-W
   HENDRY JH, 1984, BRIT J RADIOL, V57, P1045
   HOLM HH, 1983, J UROLOGY, V130, P283
   KABALIN JN, 1989, J UROLOGY, V142, P326
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KAYE KW, 1995, J UROLOGY, V153, P1020, DOI 10.1016/S0022-5347(01)67626-2
   Kini VR, 1999, INT J RADIAT ONCOL, V43, P571, DOI 10.1016/S0360-3016(98)00420-9
   KOVACS G, 1997, P 9 INT BRACH C PALM, P84
   Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8
   LEACH GE, 1982, J UROLOGY, V128, P505
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   MARTINEZ A, 1985, INT J RADIAT ONCOL, V11, P841
   Martinez A, 1995, INT J RADIAT ONCOL, V33, P1019, DOI 10.1016/0360-3016(95)00254-5
   MARTINEZ AA, IN PRESS CANC
   Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2
   Melian E, 1997, INT J RADIAT ONCOL, V38, P73, DOI 10.1016/S0360-3016(97)00221-6
   Paul R, 1997, WORLD J UROL, V15, P252, DOI 10.1007/BF01367663
   PAULSON DF, 1990, J UROLOGY, V144, P1180
   PAULSON DF, 1982, J UROLOGY, V128, P502
   Perez C, 1997, PRINCIPLES PRACTICE, P1583
   PEREZ CA, 1986, INT J RADIAT ONCOL, V12, P523
   PILEPICH MV, 1987, UROLOGY, V30, P18, DOI 10.1016/0090-4295(87)90563-2
   Pilepich MV, 1997, J CLIN ONCOL, V15, P1013
   PILEPICH MV, 1987, INT J RADIAT ONCOL, V13, P659
   Pollack A, 1998, UROLOGY, V51, P258, DOI 10.1016/S0090-4295(97)00621-3
   PRIESTLY JB, 1992, UROLOGY, V40, P27, DOI 10.1016/0090-4295(92)90431-U
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Roach M, 1996, J UROLOGY, V156, P1719, DOI 10.1016/S0022-5347(01)65490-9
   SCARDINO PT, 1986, J UROLOGY, V135, P510
   SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5
   SMITH JA, 1987, J UROLOGY, V137, P1
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   STROMBERG J, 1995, INT J RADIAT ONCOL, V33, P161, DOI 10.1016/0360-3016(95)00035-W
   STROMBERG J, 1994, INT J RADIAT ONCOL, V28, P171
   Stromberg JS, 1997, CANCER J SCI AM, V3, P346
   Yan D, 1998, INT J RADIAT ONCOL, V41, P715, DOI 10.1016/S0360-3016(97)00567-1
   Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2
   Zeitlin SI, 1998, J UROLOGY, V160, P91, DOI 10.1016/S0022-5347(01)63042-8
   Zelefsky MJ, 1998, RADIOLOGY, V209, P169
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
   ZINCKE H, 1981, CANCER, V47, P1901, DOI 10.1002/1097-0142(19810401)47:7<1901::AID-CNCR2820470731>3.0.CO;2-N
NR 72
TC 79
Z9 80
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD MAY 1
PY 2000
VL 47
IS 2
BP 343
EP 352
DI 10.1016/S0360-3016(00)00436-3
PG 10
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 314AH
UT WOS:000087031600011
PM 10802358
ER

PT J
AU Horwitz, EM
   Vicini, FA
   Ziaja, EL
   Dmuchowski, CF
   Stromberg, JS
   Martinez, AA
AF Horwitz, EM
   Vicini, FA
   Ziaja, EL
   Dmuchowski, CF
   Stromberg, JS
   Martinez, AA
TI The correlation between the astro consensus panel definition of
   biochemical failure and clinical outcome for patients with prostate
   cancer treated with external beam irradiation
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT 39th Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology
CY OCT 18-23, 1997
CL ORLANDO, FLORIDA
SP Amer Soc Therapeut Radiol & Oncol
DE prostate cancer; prostate specific antigen; biochemical control;
   radiation therapy
ID RADIATION-THERAPY; METASTATIC DISSEMINATION; DOSE-ESCALATION; ANTIGEN
   NADIR; RADIOTHERAPY; CARCINOMA; NEUTRON; PHOTON; TRIAL; SERUM
AB Purpose: We reviewed our institution's experience treating patients with external beam irradiation (RT) to determine if the ASTRO Consensus Panel definition of biochemical failure (BF) following radiation therapy correlates with clinical distant metastases free survival (DMFS), disease-free survival (DFS), cause-specific survival (CSS), and local control (LC).
   Methods and Materials: Between 1/1/87 and 12/31/92, 568 patients with clinically localized prostate cancer received external beam irradiation (RT) using localized prostate fields at William Beaumont Hospital (median total dose 66.6 Gy; range: 60-70.4 Gy). Biochemical failure was defined as three consecutive increases in post-treatment prostate specific: antigen (PSA) after achieving a nadir. Biochemical failure was recorded as the time midway between the nadin and the first rising PSA. Five-year actuarial rates of clinical DMFS, DFS, CSS, and LC were calculated for patients who were biochemically controlled (BC) versus those who failed biochemically. Median follow-up was 56 months (range: 24-118 months).
   Results: Five-year actuarial rates of DMFS, DFS, CSS, and LC were significantly greater in patients who were biochemically controlled versus those who were not (p < 0.001). In patients who were BC, the 5-year actuarial rates of DMFS, DFS, CSS, and LC were 99%, 99%, 98%, and 99% respectively. For patients who failed biochemically, the 5-year actuarial rates of DMFS, DFS, CSS, and LC were 74%, 64%, 89%, and 86% respectively. When stratifying by pretreatment PSA, Gleason score, and T stage these differences remained significant for DMFS, DFS, and CSS. The Cox proportional hazards model demonstrated that BC was the single most important predictor of clinical outcome for DMFS, DFS, CSS, and LC. Pretreatment PSA and Gleason score were also independent predictors of outcome for DMFS and DFS.
   Conclusions: The ASTRO Consensus Panel definition of BF following radiation therapy correlates well with clinical DMFS, DFS, and CSS. These findings suggest that the Consensus Panel definition may be a surrogate for clinical progression and survival and should be considered a valid endpoint for separating successful versus unsuccessful treatment. Additional studies with longer follow-up will be needed to corroborate these findings. (C) 1998 Elsevier Science Inc.
C1 William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
   William Beaumont Hosp, Dept Biostat, Royal Oak, MI 48073 USA.
RP Vicini, FA (reprint author), William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Beahrs OH, 1992, MANUAL STAGING CANC, P181
   CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I
   Forman JD, 1996, INT J RADIAT ONCOL, V35, P259, DOI 10.1016/0360-3016(96)00020-X
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537
   FukunagaJohnson N, 1997, INT J RADIAT ONCOL, V38, P311, DOI 10.1016/S0360-3016(97)82499-6
   Hanks GE, 1996, INT J RADIAT ONCOL, V35, P861, DOI 10.1016/0360-3016(96)00207-6
   Hanks G E, 1992, Oncology (Williston Park), V6, P79
   HANKS GE, 1995, J UROLOGY, V154, P456, DOI 10.1016/S0022-5347(01)67073-3
   Horwitz EM, 1996, INT J RADIAT ONCOL, V36, P565, DOI 10.1016/S0360-3016(96)00360-4
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KUBAN DA, 1995, INT J RADIAT ONCOL, V32, P307, DOI 10.1016/0360-3016(95)00137-N
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   LEE WR, 1995, J CLIN ONCOL, V13, P464
   Lehmann E.L., 1975, NONPARAMETRICS STAT
   LEIBEL SA, 1994, J UROLOGY, V152, P1792
   LEIBEL SA, 1991, INT J RADIAT ONCOL, V21, P549
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   McLaughlin PW, 1996, J CLIN ONCOL, V14, P2889
   Roach M, 1996, J UROLOGY, V156, P1719, DOI 10.1016/S0022-5347(01)65490-9
   RUSSELL KJ, 1994, INT J RADIAT ONCOL, V28, P47
   STROMBERG J, 1995, INT J RADIAT ONCOL, V33, P161, DOI 10.1016/0360-3016(95)00035-W
   Stromberg JS, 1997, CANCER J SCI AM, V3, P346
   WOOLF SH, 1995, NEW ENGL J MED, V333, P1401, DOI 10.1056/NEJM199511233332107
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   ZAGARS GK, 1995, UROLOGY, V45, P476, DOI 10.1016/S0090-4295(99)80019-3
   ZIETMAN AL, 1995, INT J RADIAT ONCOL, V32, P287, DOI 10.1016/0360-3016(95)00123-G
   ZIETMAN AL, 1996, RADIOTHER ONCOL, V40, P151
NR 31
TC 79
Z9 80
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD MAY 1
PY 1998
VL 41
IS 2
BP 267
EP 272
DI 10.1016/S0360-3016(98)00078-9
PG 6
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA ZP346
UT WOS:000073743100005
PM 9607340
ER

PT J
AU Rasmussen, JC
   Tan, IC
   Marshall, MV
   Fife, CE
   Sevick-Muraca, EM
AF Rasmussen, John C.
   Tan, I-Chih
   Marshall, Milton V.
   Fife, Caroline E.
   Sevick-Muraca, Eva M.
TI Lymphatic imaging in humans with near-infrared fluorescence
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID INDOCYANINE GREEN-DYE; BREAST-CANCER; INTRAOPERATIVE IDENTIFICATION;
   OPTICAL TOMOGRAPHY; INVISIBLE LIGHT; NODE BIOPSY; LYMPHOGRAPHY;
   LYMPHEDEMA; MELANOMA; DRAINAGE
AB While the lymphatic system is increasingly associated with diseases of prevalence, study of these diseases is difficult owing to the paucity of imaging techniques with the sensitivity and temporal resolution to discriminate lymphatic function. Herein, we review the known, pertinent features of the human lymphatic system in health and disease and set the context for a number of emerging studies that use near-infrared fluorescence imaging to non-invasively assess tumor draining lymphatic basins in cancer patients, intraoperatively guide resection of first draining lymph nodes, and to interrogate the difference between normal and aberrant lymphatic structure and function.
C1 [Rasmussen, John C.; Tan, I-Chih; Marshall, Milton V.; Sevick-Muraca, Eva M.] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Ctr Mol Imaging, Houston, TX 77030 USA.
   [Fife, Caroline E.] Mem Hermann Hosp, Div Cardiol, Houston, TX 77030 USA.
   [Fife, Caroline E.] Mem Hermann Hosp, Ctr Wound Healing & Lymphedema Therapy, Houston, TX 77030 USA.
RP Sevick-Muraca, EM (reprint author), Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Ctr Mol Imaging, 1825 Pressler St SRB 330A, Houston, TX 77030 USA.
EM eva.sevick@uth.tmc.edu
FU National Institutes of Health [R01 CA112679]; Longaberger Foundation
   through American Cancer Society [RSG-06-213-01-LR]
FX We would like to acknowledge Kristen E Adams, Ruchi Sharma, Erik A Maus,
   Latisha A Smith, Juliet A Wendt, Glenn Wilson.and Nallely Connoly for
   their clinical assistance. This work is supported partly by the National
   Institutes of Health (R01 CA112679) and the Longaberger Foundation
   through the American Cancer Society Research Scholar Grant
   (RSG-06-213-01-LR).
CR Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480
   Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037
   Fujiwara M, 2009, J PLAST RECONSTR AES, V62, pE373, DOI 10.1016/j.bjps.2007.12.074
   Ge JJ, 2008, MED PHYS, V35, P3354, DOI 10.1118/1.2940603
   Godavarty A, 2005, MED PHYS, V32, P992, DOI 10.1118/1.1861160
   Gurfinkel M, 2000, PHOTOCHEM PHOTOBIOL, V72, P94, DOI 10.1562/0031-8655(2000)072<0094:POIAHC>2.0.CO;2
   Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642
   Houston JP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2114748
   Ji RC, 2005, HISTOL HISTOPATHOL, V20, P155
   Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211
   Kwon Sunkuk, 2007, Lymphatic Research and Biology, V5, P219, DOI 10.1089/lrb.2007.1013
   Lee AC, 2002, EUR J CANCER, V38, P784, DOI 10.1016/S0959-8049(01)00471-3
   Li C, 2006, NUCL MED BIOL, V33, P349, DOI 10.1016/j.nucmedbio.2006.01.001
   Liang XP, 2008, ACAD RADIOL, V15, P859, DOI 10.1016/j.acra.2008.01.028
   Mariani G, 2002, J NUCL MED, V43, P811
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x
   Ogasawara Y, 2008, WORLD J SURG, V32, P1924, DOI 10.1007/s00268-008-9519-7
   Ogata F, 2007, ANN PLAS SURG, V59, P180, DOI 10.1097/01.sap.0000253341.70866.54
   Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2
   Parungo CP, 2005, J THORAC CARDIOV SUR, V129, P844, DOI 10.1016/j.jtcvs.2004.08.001
   Reynolds JS, 1999, PHOTOCHEM PHOTOBIOL, V70, P87, DOI 10.1562/0031-8655(1999)070<0087:IOSCMT>2.3.CO;2
   ROCKSON SG, 2008, LYMPHATIC CONTINUUM, P1131
   Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234
   Sampath L, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2953498
   Sevick-Muraca EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2953185
   Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962
   Sharma R, 2007, AM J PHYSIOL-HEART C, V292, pH3109, DOI 10.1152/ajpheart.01223.2006
   Sharma R, 2008, ANN NY ACAD SCI, V1131, P13, DOI 10.1196/annals.1413.002
   Soltesz EG, 2006, ANN SURG ONCOL, V13, P386, DOI 10.1245/ASO.2006.04.025
   Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032
   Tanaka E, 2006, ANN SURG ONCOL, V13, P1671, DOI 10.1245/s10434-006-9194-6
   Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023
   Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013
   Uren RF, 2003, J NUCL MED, V44, P570
   Uren RF, 2004, ANN SURG ONCOL, V11, p179S, DOI 10.1245/ASO.2004.11.916
   WEINSTEIN JN, 1983, SCIENCE, V222, P423, DOI 10.1126/science.6623082
   Wunderbaldinger P, 2006, EUR J RADIOL, V58, P390, DOI 10.1016/j.ejrad.2005.12.043
   Yuan ZB, 2006, ANN NUCL MED, V20, P341, DOI 10.1007/BF02987244
NR 39
TC 78
Z9 79
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD FEB
PY 2009
VL 20
IS 1
BP 74
EP 82
DI 10.1016/j.copbio.2009.01.009
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 452JB
UT WOS:000266535200010
PM 19233639
ER

PT J
AU Scherr, DS
   Vaughan, D
   Wei, J
   Chung, M
   Felsen, D
   Allbright, R
   Knudsen, BS
AF Scherr, DS
   Vaughan, D
   Wei, J
   Chung, M
   Felsen, D
   Allbright, R
   Knudsen, BS
TI Bcl-2 and p53 expression in clinically localized prostate cancer
   predicts response to external beam radiotherapy
SO JOURNAL OF UROLOGY
LA English
DT Article
DE apoptosis; prostate; radiotherapy; prostate-specific antigen; tumor
   markers, biological
ID RADIATION-THERAPY; PROGNOSTIC BIOMARKERS; RADICAL PROSTATECTOMY;
   IONIZING-RADIATION; CELL-DEATH; APOPTOSIS; ANTIGEN; CARCINOMA;
   ADENOCARCINOMA; PROGRESSION
AB Purpose: Clinicians have long been hampered by the inability to distinguish patients with localized prostate cancer who will and will not respond to radiotherapy. In a significant proportion of patients therapy fails as determined by increasing posttreatment serum prostate specific antigen (PSA). We evaluated the expression of 2 key regulators of apoptosis, bcl-2 and p53, relative to treatment outcomes in patients who received external beam radiotherapy for clinically organ confined carcinoma of the prostate.
   Materials and Methods: Immunohistochemical staining for bcl-2 and p53 on pretreatment needle biopsies was performed in 54 patients who were treated with radiotherapy for localized prostate cancer. Expression was scored using strict criteria. Nadir PSA less than 1 ng./ml. after therapy was considered a successful treatment response.
   Results: There was a predominance of stage Tie cancer (74%) with a mean Gleason score of 6.9 and an average pretreatment PSA of 25.3 ng./ml. Overall 54% of the, patients did not have a nadir PSA of less; than 1 ng./ml. Of the bcl-2 positive cases therapy ultimately failed in 85%. Similarly 88% of the patients with p53 positive biopsies had treatment failure and in all with bcl-2 as well as p53 expression radiotherapy failed. Expression of bcl-2 and p53 was an independent prognostic variable for treatment failure with odds ratios (95% confidence interval) of 7.3 and 10.8, respectively.
   Conclusions: Expression of bcl-2 and p53 was associated with treatment failure after external beam radiation therapy. These findings suggest that bcl-2 and p53 expression in pretreatment biopsies may be helpful for predicting response to definitive radiotherapy.
C1 Johns Hopkins Med Inst, Dept Urol, James Buchanan Brady Fdn, Baltimore, MD 21205 USA.
   Amer Fdn Urol Dis, Robert Wood Johnson Clin Scholars Program, Baltimore, MD USA.
   Cornell Univ, Med Ctr, New York Presbyterian Hosp, Dept Pathol,Stich Dept Radiat Oncol, New York, NY 10021 USA.
   Univ Michigan, Med Ctr, Urol Sect, Ann Arbor, MI USA.
RP Scherr, DS (reprint author), Johns Hopkins Med Inst, Dept Urol, James Buchanan Brady Fdn, Baltimore, MD 21205 USA.
CR Ahmed MM, 1997, J BIOL CHEM, V272, P33056, DOI 10.1074/jbc.272.52.33056
   *AM CANC SOC, 1998, CANC FACT FIG
   Bauer JJ, 1996, J UROLOGY, V156, P1511, DOI 10.1016/S0022-5347(01)65641-6
   CHEN M, 1995, CANCER RES, V55, P991
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   De Marzo AM, 1998, AM J PATHOL, V153, P911, DOI 10.1016/S0002-9440(10)65632-5
   Denmeade SR, 1996, PROSTATE, V28, P251
   ENNIS RD, 1993, CANCER, V72, P2644, DOI 10.1002/1097-0142(19931101)72:9<2644::AID-CNCR2820720920>3.0.CO;2-N
   Grignon DJ, 1997, J NATL CANCER I, V89, P158, DOI 10.1093/jnci/89.2.158
   Grossfeld GD, 1998, J UROLOGY, V159, P1437, DOI 10.1097/00005392-199805000-00004
   HANCOCK SL, 1995, J UROLOGY, V154, P1412, DOI 10.1016/S0022-5347(01)66879-4
   Huang A, 1998, UROLOGY, V51, P346, DOI 10.1016/S0090-4295(97)00636-5
   Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358
   Krajewska M, 1996, AM J PATHOL, V148, P1567
   Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614
   Matsushima H, 1997, J UROLOGY, V158, P2278, DOI 10.1016/S0022-5347(01)68235-1
   MILLER GJ, 1994, J UROLOGY, V152, P1709
   Moul JW, 1996, SURGERY, V120, P159, DOI 10.1016/S0039-6060(96)80283-2
   Myers RB, 1997, BIOTECH HISTOCHEM, V72, P86, DOI 10.3109/10520299709082217
   Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445
   PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   Prendergast NJ, 1996, J UROLOGY, V155, P1685, DOI 10.1016/S0022-5347(01)66165-2
   REED JC, 1996, MECH LYMPHOCYTE ACTI, V6, P99
   SCHELLHAMMER PF, 1993, UROLOGY, V42, P13, DOI 10.1016/0090-4295(93)90325-5
   SHURBAJI MS, 1995, HUM PATHOL, V26, P106, DOI 10.1016/0046-8177(95)90122-1
   STAMEY TA, 1993, J UROLOGY, V150, P1856
   VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8
   WALLACE DM, 1975, BRIT J UROL, V47, P1, DOI 10.1111/j.1464-410X.1975.tb03911.x
   Woloschak GE, 1997, INT J RADIAT ONCOL, V39, P951, DOI 10.1016/S0360-3016(97)00357-X
   ZINCKE H, 1991, J UROLOGY, V146, P1053
NR 31
TC 78
Z9 83
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD JUL
PY 1999
VL 162
IS 1
BP 12
EP 16
DI 10.1097/00005392-199907000-00003
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 204FP
UT WOS:000080753700002
PM 10379729
ER

PT J
AU Kleisli, T
   Cheng, W
   Jacobs, MJ
   Mirocha, J
   DeRobertis, MA
   Kass, RM
   Blanche, C
   Fontana, GP
   Raissi, SS
   Magliato, KE
   Trento, A
AF Kleisli, T
   Cheng, W
   Jacobs, MJ
   Mirocha, J
   DeRobertis, MA
   Kass, RM
   Blanche, C
   Fontana, GP
   Raissi, SS
   Magliato, KE
   Trento, A
TI In the current era, complete revascularization improves survival after
   coronary artery bypass surgery
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article; Proceedings Paper
CT 30th Annual Meeting of the Western-Thoracic-Surgical-Association
CY JUN 23-26, 2004
CL Maui, HI
SP Western Thorac Surg Assoc
ID OFF-PUMP; MORTALITY
AB Background: Complete revascularization has been the standard for coronary bypass grafting. However, surgical intervention has evolved with increasing use of arterial conduits and off-pump techniques.
   Methods: Patients undergoing non-redo bypass surgery from January 1998 through December 2000 were followed up with questionnaires and telephone contact. Incomplete revascularization was defined as absence of bypass grafts placed to a coronary territory supplied by a vessel with 50% or greater stenosis.
   Results: One thousand thirty-four patients were followed for a mean of 3.3 +/- 1.6 years. Complete revascularization was found in 937 (90.6%) patients, and incomplete revascularization was found in 97 (9.4%) patients. Eight hundred twenty-seven (80.4%) patients underwent on-pump operations, and 207 (19.6%) underwent off-pump operations. Incomplete revascularization was more prevalent in off-pump versus on-pump operations (21.7% vs 6.3%, P < .001). Multivariable Cox regression analysis indicated that in-hospital cerebrovascular accidents (hazard ratio, 5.49; P < .001), chronic obstructive pulmonary disease (hazard ratio, 1.97; P =.019), and incomplete revascularization (hazard ratio, 1.85; P =.040) predicted an increased hazard (risk) of cardiac death. Left internal thoracic artery (hazard ratio, 0.38; P =.047), right internal thoracic artery (hazard ratio, 0.25; P =.019), and radial artery (hazard ratio, 0.36; P <.001) grafting reduced the risk of cardiac death. The 5-year unadjusted survival rate was 52.6% versus 82.4% in patients undergoing incomplete and complete revascularization (P <.001), with cardiac survival rates of 74.5% versus 93.1%, respectively (P <.001). However, this difference in cardiac survival was smaller in octogenarians with incomplete versus complete revascularizations (77.4% vs 87.6%, P = .101) and was essentially absent in off-pump versus on-pump operations if complete revascularization was achieved in both cases (93.6% vs 93.1%, P >.200).
   Conclusions: Complete revascularization and arterial grafting improve 5-year survival. Off-pump techniques do not affect survival. Complete revascularization should be performed whenever possible.
C1 Cedars Sinai Med Ctr, Div Cardiothorac Surg, Los Angeles, CA 90048 USA.
RP Cheng, W (reprint author), Cedars Sinai Med Ctr, Div Cardiothorac Surg, 8700 Beverly Blvd,N Tower,Suite 6215, Los Angeles, CA 90048 USA.
EM chengw@cshs.org
CR BELL MR, 1992, CIRCULATION, V86, P446
   Cheng W, 2002, J THORAC CARDIOV SUR, V124, P313, DOI 10.1067/mtc.2002.122304
   Jones EL, 1996, J THORAC CARDIOV SUR, V112, P227, DOI 10.1016/S0022-5223(96)70243-X
   Moon MR, 2001, ANN THORAC SURG, V72, P2003, DOI 10.1016/S0003-4975(01)03144-7
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Vander Salm TJ, 2002, J AM COLL CARDIOL, V39, P565, DOI 10.1016/S0735-1097(01)01806-X
NR 7
TC 77
Z9 78
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD JUN
PY 2005
VL 129
IS 6
BP 1283
EP 1291
DI 10.1016/j.jtcvs.2004.12.034
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 935NQ
UT WOS:000229789400009
PM 15942568
ER

PT J
AU Dikmen, SS
   Corrigan, JD
   Levin, HS
   Machamer, J
   Stiers, W
   Weisskopf, MG
AF Dikmen, Sureyya S.
   Corrigan, John D.
   Levin, Harvey S.
   Machamer, Joan
   Stiers, William
   Weisskopf, Marc G.
TI Cognitive Outcome Following Traumatic Brain Injury
SO JOURNAL OF HEAD TRAUMA REHABILITATION
LA English
DT Article
DE closed head injury; cognitive outcome; neuropsychological outcome;
   penetrating TBI; traumatic brain injury
ID PENETRATING HEAD-INJURY; PROFESSIONAL SOCCER PLAYERS; UNITED-STATES;
   NEUROPSYCHOLOGICAL IMPAIRMENT; VIETNAM VETERANS; TEST-PERFORMANCE;
   CONCUSSION; RECOVERY; MEMORY; HOSPITALIZATION
AB Objective: To determine whether an association exists between traumatic brain Injury (TBI) sustained in adulthood and cognitive impairment 6 months or longer after injury. Design: Systematic review of the published, peer-reviewed literature. Results: From 430 articles, we identified 11 primary and 22 secondary studies that examined cognitive impairment by using performance measures for adults who were at least 6 months post-TBI. There was clear evidence of an association between penetrating brain injury and impaired cognitive function. Factors that modified this association included preinjury intelligence, volume of brain tissue lost, and brain region injured. There was also suggestive evidence that penetrating brain injury may exacerbate the cognitive effects of normal aging. We found clear evidence for long-term cognitive deficits associated with severe TBI. There was suggestive evidence that moderately severe brain injuries are associated with cognitive impairments. There was inadequate/insufficient evidence to determine whether an association exists between a single, mild TBI and cognitive deficits 6 months or longer postinjury. Conclusion: In adults, penetrating, moderate, and severe TBIs are associated with cognitive deficits 6 months or longer postinjury. There is insufficient evidence to determine whether mild TBI is associated with cognitive deficits 6 months or longer postinjury.
C1 [Dikmen, Sureyya S.; Machamer, Joan] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA.
   [Dikmen, Sureyya S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.
   [Dikmen, Sureyya S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
   [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.
   [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA.
   [Stiers, William] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA.
   [Weisskopf, Marc G.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   [Weisskopf, Marc G.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
RP Dikmen, SS (reprint author), Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA.
EM dikmen@u.washington.edu
RI Corrigan, John/E-2921-2011
FU US Department of Veterans Affairs
FX The study was supported by a contract from the US Department of Veterans
   Affairs to the National Academy of Sciences, Institute of Medicine.
CR Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190
   Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277
   BUTLER RJ, 1993, J NEUROL NEUROSUR PS, V56, P1055, DOI 10.1136/jnnp.56.10.1055
   CORKIN S, 1989, J NEUROSCI, V9, P3876
   DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227
   DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613
   Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019
   DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80
   Finkelstein E., 2006, INCIDENCE EC BURDEN
   GRAFMAN J, 1986, INT J NEUROSCI, V29, P125
   GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169
   GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.8.1120-1122
   Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD
   Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354
   Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9
   Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426
   Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091
   LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234
   Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971
   Matser JT, 1998, NEUROLOGY, V51, P791
   Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029
   Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4
   MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9
   Novack TA, 2000, BRAIN INJURY, V14, P987
   Porter MD, 1996, CLIN J SPORT MED, V6, P90, DOI 10.1097/00042752-199604000-00005
   Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002
   Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300
   Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0
   Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009
   Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586
   SALAZAR AM, 1986, NEUROLOGY, V36, P459
   Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39
   Straume-Naesheim T. M., 2005, BR J SPORTS MED S1, V39, P70
   TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001
   TEASDALE G, 1974, LANCET, V2, P81
   Teuber HL, 1954, J PSYCHOL, V38, P177
   Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954
   Thurman DJ, 2001, HEAD TRAUMA BASIC PR
   Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   WEINSTEIN S, 1957, J COMP PHYSIOL PSYCH, V50, P535, DOI 10.1037/h0047738
   WEINSTEIN S, 1956, J PSYCHOL, V42, P249
   WEINSTEIN S, 1957, SCIENCE, V125, P1036, DOI 10.1126/science.125.3256.1036
   Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247
NR 46
TC 76
Z9 79
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0885-9701
J9 J HEAD TRAUMA REHAB
JI J. Head Trauma Rehabil.
PD NOV-DEC
PY 2009
VL 24
IS 6
BP 430
EP 438
PG 9
WC Clinical Neurology; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA 528VW
UT WOS:000272476100003
PM 19940676
ER

PT J
AU Puskas, JD
   Kilgo, PD
   Lattouf, OM
   Thourani, VH
   Cooper, WA
   Vassiliades, TA
   Chen, EP
   Vega, JD
   Guyton, RA
AF Puskas, John D.
   Kilgo, Patrick D.
   Lattouf, Omar M.
   Thourani, Vinod H.
   Cooper, William A.
   Vassiliades, Thomas A.
   Chen, Edward P.
   Vega, J. David
   Guyton, Robert A.
TI Off-pump coronary bypass provides reduced mortality and morbidity and
   equivalent 10-year survival
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 44th Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 28-30, 2008
CL Ft Lauderdale, FL
SP Soc Thorac Surg
ID ARTERY-BYPASS; ON-PUMP; OPERATIVE MORTALITY; SEX-DIFFERENCES; SURGERY;
   WOMEN; OUTCOMES; RISK; REVASCULARIZATION; GENDER
AB Background. This study compared in-hospital major adverse cardiac events (MACE) and long-term survival after off-pump (OPCAB) vs on-pump (CPB) coronary artery bypass grafting (CABG).
   Methods. Reviewed were 12,812 consecutive isolated CABG patients from 1997 to 2006. A propensity score (PS), including 40 preoperative risk factors, balanced characteristics between OPCAB and CPB groups. Multiple logistic regression models tested whether gender or surgery type, or their interaction, were associated with in-hospital mortality and MACE. A proportional hazards regression model and Kaplan-Meier curves related longterm survival with gender, surgery type, and their interaction, adjusted for PS and age.
   Results. OPCAB was associated with a significant reduction in operative mortality (adjusted odds ratio [AOR], 0.68; p = 0.045), stroke (AOR, 0.48; p < 0.001), and MACE (AOR, 0.66; p = 0.018). Female gender was associated with higher rates of death (AOR, 1.93), stroke (AOR, 1.82), myocardial infarction (AOR, 2.19), and MACE (AOR, 1.97; each p < 0.001). Women disproportionately benefited from OPCAB in operative mortality (p = 0.04). Odds of death for women on CPB were higher than for women treated with OPCAB (AOR, 2.07, p = 0.005). Odds of death for men on CPB were not significantly higher than for men treated with OPCAB (AOR, 1.16, p = 0.51). Male gender was associated with longer-term survival (p = .011), but surgery type (OPCAB vs CPB) was not (p = 0.23).
   Conclusions. OPCAB provides significant early mortality and morbidity advantages, especially for women. During the 10-year follow-up, OPCAB and CPB result in similar survival, regardless of gender.
C1 Emory Univ, Sch Med, Clin Res Unit, Div Cardiothorac Surg, Atlanta, GA 30308 USA.
   Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30308 USA.
RP Puskas, JD (reprint author), Emory Univ, Sch Med, Emory Crawford Long Hosp, 6th Floor Med Off Tower,550 Peachtree St NE, Atlanta, GA 30308 USA.
EM john.puskas@emoryhealthcare.org
CR Aldea GS, 1999, ANN THORAC SURG, V67, P1097, DOI 10.1016/S0003-4975(99)00055-7
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2001.120329
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   COSGROVE DM, 1984, J THORAC CARDIOV SUR, V88, P673
   D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   EDMUNDS LH, 1998, ANN THORAC SURG, V66, P12
   Edwards FH, 1998, ANN THORAC SURG, V66, P125, DOI 10.1016/S0003-4975(98)00358-0
   Hogue CW, 2001, CIRCULATION, V103, P2133
   Jacobs AK, 1998, CIRCULATION, V98, P1279
   Koch CG, 2003, J THORAC CARDIOV SUR, V126, P932, DOI 10.1016/S0022-5223(03)01304-7
   Koch CG, 2003, J CARDIOTHOR VASC AN, V17, P585, DOI 10.1053/S1053-0770(03)00201-5
   Koch CG, 1996, J CARDIOTHOR VASC AN, V10, P839, DOI 10.1016/S1053-0770(96)80042-5
   Magee MJ, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.cir.0000089187.51855.77
   Molenberghs G, 2007, MISSING DATA CLIN ST, P105
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Nussmeier NA, 2002, J THORAC CARDIOV SUR, V124, P1225, DOI 10.1067/2002.126225
   Palmer G, 2007, ANN THORAC SURG, V83, P986, DOI 10.1016/j.athoracsur.2006.10.057
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas JD, 2007, CIRCULATION S11, V116, P192
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2007, ANN THORAC SURG, V84, P1447, DOI 10.1016/j.athoracsur.2007.06.104
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6
   *SOC THOR SURG NAT, 2007, SPRING THOR 2007
   Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133
   Vaccarino V, 2003, J THORAC CARDIOV SUR, V126, P1707, DOI 10.1016/j.jtcvs.2003.10.007
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   WEINTRAUB WS, 1993, CIRCULATION, V88, P79
   Wenger NK, 2003, J THORAC CARDIOV SUR, V126, P929, DOI 10.1016/S0022-5223(03)00883-3
NR 32
TC 76
Z9 80
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD OCT
PY 2008
VL 86
IS 4
BP 1139
EP 1146
DI 10.1016/j.athoracsur.2008.05.073
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 357LT
UT WOS:000259848000013
PM 18805149
ER

PT J
AU Yun, KL
   Wu, YX
   Aharonian, V
   Mansukhani, P
   Pfeffer, TA
   Sintek, CF
   Kochamba, GS
   Grunkemeier, G
   Khonsari, S
AF Yun, KL
   Wu, YX
   Aharonian, V
   Mansukhani, P
   Pfeffer, TA
   Sintek, CF
   Kochamba, GS
   Grunkemeier, G
   Khonsari, S
TI Randomized trial of endoscopic versus open vein harvest for coronary
   artery bypass grafting: Six-month patency rates
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article; Proceedings Paper
CT 30th Annual Meeting of the Western-Thoracic-Surgical-Association
CY JUN 23-26, 2004
CL Maui, HI
SP Western Thorac Surg Assoc
ID SAPHENOUS-VEIN; ENDOTHELIAL INTEGRITY; WOUND COMPLICATIONS;
   RISK-FACTORS; SAPHENECTOMY; SURGERY; QUALITY; FATE
AB Objective: We sought to compare the 6-month angiographic patency rates of greater saphenous veins removed during artery bypass grafting with the endoscopic vein harvest or open vein harvest techniques.
   Methods: Two hundred patients undergoing nonemergency on-pump coronary artery bypass grafting were prospectively randomized to either endoscopic vein harvest or open vein harvest. Follow-up angiography of all vein grafts was scheduled at 6 months. Graft patency and disease grades were assigned independently by 2 interventional cardiologists. Leg wound healing was evaluated at discharge, 1 month, and 6 months for evidence of complications.
   Results: There were 3 conversions from endoscopic vein harvest to open vein harvest because of vein factors. Leg wound cornplications were significantly lower in the endoscopic vein harvest group (7.4% vs 19.4%, P = .014). On multivariable analysis, endoscopic vein harvest emerged as the only factor affecting wound complications (odds ratio, 0.33). Three deaths (2 perioperative and 1 late) occurred in the endoscopic vein harvest group that were unrelated to vein graft Closure. Twenty-four and 29 patients in the endoscopic vein harvest and open vein harvest cohorts, respectively, refused the follow-up 6-month angiography. Therefore a total of 144 angiograms (73 endoscopic vein harvests and 71 open vein harvests) and 336 vein grafts (166 endoscopic vein harvests and 170 open vein harvests) were available for analysis. The overall occlusion rates at 6 months were 21.7% for endoscopic vein harvest and 17.6% for open vein harvest. Additionally, there was evidence of significant disease (>50% stenosis) in 10.2% and 12.4% of endoscopic vein harvest and open vein harvest,rafts, respectively. By means of ordinal hierarchic logistic regression, endoscopic vein harvest was not found to be a risk factor for vein graft occlusion or disease (odds ratio, 1.15). Significant predictors were congestive heart failure (odds ratio. 2.87), graft to the diaconal artery territory (odds ratio, 1.76), larger vein conduit size (odds ratio, 1.32), and graft flow (odds ratio, 0.90).
   Conclusion: Endoscopic vein harvest reduces leg Wound complications compared with open vein harvest without compromising the 6-month patency rate. The overall patency rate depends on target and vein-related variables and patient characteristics rather than the method of vein harvesting.
C1 Kaiser Permanente Med Ctr, Dept Cardiac Surg, Los Angeles, CA USA.
   Providence Hlth Syst, Portland, OR USA.
RP Yun, KL (reprint author), So Calif Permanente Med Grp, Dept Cardiac Surg, 1526 N Edgemont St,3rd Floor, Los Angeles, CA 90027 USA.
EM Kwok.L.Yun@kp.org
CR Allen KB, 1998, ANN THORAC SURG, V66, P26, DOI 10.1016/S0003-4975(98)00392-0
   Athanasiou T, 2003, ANN THORAC SURG, V76, P2141, DOI 10.1016/S0003-4975(03)01435-8
   Bitondo JM, 2002, ANN THORAC SURG, V73, P523, DOI 10.1016/S0003-4975(01)03334-3
   BJORK VO, 1981, SCAND J THORAC CARD, V15, P11, DOI 10.3109/14017438109101020
   Black EA, 2001, ANN THORAC SURG, V71, P1503, DOI 10.1016/S0003-4975(01)02463-8
   Cable DG, 1998, ANN THORAC SURG, V66, P139, DOI 10.1016/S0003-4975(98)00344-0
   Carpino PA, 2000, J THORAC CARDIOV SUR, V119, P69, DOI 10.1016/S0022-5223(00)70219-4
   Cook RC, 2004, J THORAC CARDIOV SUR, V127, P65, DOI 10.1016/S0022-5223(03)01024-9
   Crouch JD, 1999, ANN THORAC SURG, V68, P1513, DOI 10.1016/S0003-4975(99)00947-9
   Davis Z, 2004, J THORAC CARDIOV SUR, V127, P823, DOI 10.1016/j.jtcvs.2003.10.051
   Fabricius AM, 2000, ANN THORAC SURG, V70, P473, DOI 10.1016/S0003-4975(00)01370-9
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   FITZGIBBON GM, 1986, J THORAC CARDIOV SUR, V91, P773
   GOLDMAN S, 1989, CIRCULATION, V80, P1990
   Griffith GL, 2000, ANN THORAC SURG, V69, P520, DOI 10.1016/S0003-4975(99)01364-8
   Kiaii B, 2002, J THORAC CARDIOV SUR, V123, P204, DOI 10.1067/mtc.2002.118682
   Korpilahti K, 1998, SCAND CARDIOVASC J, V32, P343
   Meyer DM, 2000, ANN THORAC SURG, V70, P487, DOI 10.1016/S0003-4975(00)01503-4
   Perrault LP, 2004, J THORAC CARDIOV SUR, V127, P1402, DOI 10.1016/j.jtcvs.2003.10.040
   Puskas JD, 1999, ANN THORAC SURG, V68, P1509, DOI 10.1016/S0003-4975(99)00952-2
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Rinia-Feenstra M, 2000, ANN THORAC SURG, V69, P1116, DOI 10.1016/S0003-4975(99)01571-4
   Shah PJ, 2003, J THORAC CARDIOV SUR, V126, P1972, DOI 10.1016/S0022-5223(03)01276-5
   Souza DSR, 2002, ANN THORAC SURG, V73, P1189, DOI 10.1016/S0003-4975(02)03425-2
   Tsui JCS, 2001, BRIT J SURG, V88, P1209, DOI 10.1046/j.0007-1323.2001.01855.x
   UTLEY JR, 1989, J THORAC CARDIOV SUR, V98, P147
NR 26
TC 76
Z9 82
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD MAR
PY 2005
VL 129
IS 3
BP 496
EP 503
DI 10.1016/j.jtcvs.2004.08.054
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 904AC
UT WOS:000227466300004
PM 15746730
ER

PT J
AU Choure, AJ
   Garcia, MJ
   Hesse, B
   Sevensma, M
   Maly, G
   Greenberg, NL
   Borzi, L
   Ellis, S
   Tuzcu, EM
   Kapadia, SR
AF Choure, Arti J.
   Garcia, Mario J.
   Hesse, Barbara
   Sevensma, Matthew
   Maly, George
   Greenberg, Nell L.
   Borzi, Lynn
   Ellis, Stephen
   Tuzcu, E. Murat
   Kapadia, Samir R.
TI In vivo analysis of the anatomical relationship of coronary sinus to
   mitral annulus and left circumflex coronary artery using cardiac
   multidetector computed tomography - Implications for percutaneous
   coronary sinus mitral annuloplasty
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID LONG-TERM SURVIVAL; VALVE REPAIR; HEART-FAILURE; OVINE MODEL;
   REGURGITATION; REPLACEMENT; SURGERY; FEASIBILITY; PREVALENCE; REDUCTION
AB OBJECTIVES We sought to determine the in vivo anatomical relationships between mitral annulus (MA) and coronary sinus (CS) as well as CS and left circumflex coronary artery using cardiac computed tomography.
   BACKGROUND Percutaneous treatment of mitral regurgitation (MR) by annuloplasty via CS is under development. Success of such treatment depends on the close anatomical proximity of the MA to the CS. The in vivo data regarding this anatomical relationship in humans are scant. We investigated this relationship using contrast multidetector computed tomography.
   METHODS We studied 25 normal individuals and 11 patients with severe MR (3 to 4+) due to mitral valve prolapse. Separation between MA and CS was measured in standard planes, in 4-chamber (4C), 2-chamber (2C), and 3-chamber views. Distance from ostium of CS to the intersection with left circumflex (LCX), and anatomical relation of LCX and CS were determined using 3-dimensional mapping (Philips Brilliance, Philips Medical Systems, Amsterdam, the Netherlands).
   RESULTS There was significant variance of CS to MA separation at all planes. Separation of CS and MA was increased in lateral location (4C) and decreased in posterior location (2C) in the MR group with increase in MA size. Left circumflex artery crossed between CS and MA in 80% of patients. The LCX crossed CS at a variable distance from the ostium of CS (86.5 +/- 21 mm, range 37 to 123 mm)
   CONCLUSIONS There is significant variability in the relation of CS to MA in humans. Coronary sinus to MA distance increases in patients with severe MR and annular dilation, mainly in the posterolateral location. The left circumflex crosses under the CS the majority of times, but with a significant variability in the location where it crosses the CS. These anatomical features should be taken into consideration while selecting percutaneous treatment strategies for mitral valve repair.
C1 Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA.
   Cleveland Clin, Dept Radiol, Cleveland, OH 44195 USA.
RP Kapadia, SR (reprint author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave,F25, Cleveland, OH 44195 USA.
EM kapadis@ccf.org
CR Alfieri O, 2004, EUR J CARDIO-THORAC, V26, pS36, DOI 10.1016/j.ejctsup.2004.11.010
   Block PC, 2005, CIRCULATION, V111, P2154, DOI 10.1161/01.CIR.0000165266.57397.B2
   Casserly Ivan P, 2005, Expert Rev Cardiovasc Ther, V3, P143, DOI 10.1586/14779072.3.1.143
   Cohn LH, 2002, ADV CARDIOL, V39, P153
   Dahlberg PS, 2003, ANN THORAC SURG, V76, P1539, DOI 10.1016/S0003-4975(03)01071-3
   Daimon M, 2005, CIRCULATION, V111, P2183, DOI 10.1161/01.CIR.0000163547.03188.AC
   El-Maasarany S, 2005, EUROPACE, V7, P475, DOI 10.1016/j.eupc.2005.05.013
   Enriquez-Sarano M, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.CIR.0000083831.17708.25
   Gerber TC, 2001, INT J CARDIAC IMAG, V17, P65, DOI 10.1023/A:1010692103831
   Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4
   GOLDMAN ME, 1987, J AM COLL CARDIOL, V10, P568
   Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945
   Hayek E, 2005, LANCET, V365, P507
   Jamieson WRE, 1999, ANN THORAC SURG, V67, P943, DOI 10.1016/S0003-4975(99)00175-7
   Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X
   Kaye DM, 2003, CIRCULATION, V108, P1795, DOI 10.1161/01.CIR.0000096051.23734.28
   Liddicoat JR, 2003, CATHETER CARDIO INTE, V60, P410, DOI 10.1002/ccd.10662
   Maniu CV, 2004, J AM COLL CARDIOL, V44, P1652, DOI 10.1016/j.jacc.2004.03.085
   Romano MA, 2004, J CARDIAC SURG, V19, P396, DOI 10.1111/j.0886-0440.2004.04079.x
   Salgo IS, 2002, CIRCULATION, V106, P711, DOI 10.1161/01.CIR.0000025426.39426.83
   Savage EB, 2003, ANN THORAC SURG, V75, P820, DOI 10.1016/S0003-4975(02)04645-3
   Shinbane JS, 1998, AM HEART J, V135, P93, DOI 10.1016/S0002-8703(98)70348-5
   Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Vassiliades TA, 2005, J AM COLL CARDIOL, V45, P1554, DOI 10.1016/j.jacc.2004.12.024
   Yamanouchi Y, 1998, PACE, V21, P2522, DOI 10.1111/j.1540-8159.1998.tb01212.x
   YUN K L, 1991, Cardiology Clinics, V9, P315
NR 27
TC 75
Z9 77
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD NOV 21
PY 2006
VL 48
IS 10
BP 1938
EP 1945
DI 10.1016/j.jacc.2006.07.043
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 108NX
UT WOS:000242247600004
PM 17112981
ER

PT J
AU Moghimi, SM
   Bonnemain, B
AF Moghimi, SM
   Bonnemain, B
TI Subcutaneous and intravenous delivery of diagnostic agents to the
   lymphatic system: applications in lymphoscintigraphy and indirect
   lymphography
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE imaging; lymph nodes; lymphatic system; lymphography; macrophage;
   magnetic resonance; computer tomography; gamma scintigraphy; positron
   emission tomography; superparamagnetic iron oxide particles; contrast
   agents; radiopharmaceuticals
ID SUPERPARAMAGNETIC IRON-OXIDE; MR CONTRAST AGENT; MAGNETIC-RESONANCE
   LYMPHOGRAPHY; POSITRON EMISSION TOMOGRAPHY; INITIAL CLINICAL-EXPERIENCE;
   NODE METASTASES; COMPUTED-TOMOGRAPHY; MONOCLONAL-ANTIBODY;
   BREAST-CANCER; IODINATED NANOPARTICLES
AB Lymph node status is important in the staging of many malignancies. Although tissue characterization by histologic analysis of biopsy samples may improve staging, noninvasive staging is more acceptable to both patients and clinicians. Several imaging techniques may serve this goal. Modern noninvasive techniques such as computed tomography and magnetic resonance detect lymph node abnormality by nodal enlargement, but that does not always imply malignant involvement. On the other hand, many nodes are infiltrated or replaced by tumour without change in size. This becomes a serious diagnostic defect by these modalities. Consequently, attention has been focused to develop contrast agents and radiolabelled complexes for better cancer detection as well as characterization of individual tumours in lymph nodes. For delivery of such materials to regional lymph nodes one can take advantage from the distinct physiological function of the lymphatic capillaries. The thin-walled and fenestrated lymphatic microvessel is easily penetrated by particulate and macromolecular agents after injection into the extracellular space. Once inside the vessel, materials that are transported with the lymph either specifically target certain nodal elements (e.g. neoplastic cells) or become cleared by macrophages located in the lymph nodes. Indeed, interstitial delivery of diagnostic agents have been of benefit in determining regional spread of cancer and assessing lymphatic function either by lymphoscintigraphy or indirect lymphography. On the other hand, development of contrast materials that can reach lymph nodes after a single intravenous injection is highly desirable because of the large number of lymph nodes in the body and access being difficult to most of them. Today, a number of contrast agents exist that can reach a vast array of lymph nodes in the body, particularly those that are not readily accessible for histologic evaluation, after a single intravascular injection to help distinguish between normal and tumour-bearing nodes or reactive and metastatic nodes with magnetic resonance. In this article we critically examine advantages and limitations of both subcutaneous and intravenous routes of injection for the delivery of diagnostic agents to the lymphatic system. (C) 1999 Elsevier Science BN. All rights reserved.
C1 Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
   Lab Guerbet, F-95943 Roissy, France.
RP Moghimi, SM (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
CR ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7
   ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5
   ALLEN TM, 1993, BIOCHIM BIOPHYS ACTA, V1150, P9, DOI 10.1016/0005-2736(93)90115-G
   ANDERSON AO, 1975, AM J PATHOL, V80, P387
   ANDERSON ND, 1976, IMMUNOLOGY, V31, P455
   Anzai Y, 1997, JMRI-J MAGN RESON IM, V7, P75, DOI 10.1002/jmri.1880070111
   ANZAI Y, 1994, AM J NEURORADIOL, V15, P87
   ANZAI Y, 1994, RADIOLOGY, V192, P709
   BAILET JW, 1992, LARYNGOSCOPE, V102, P281
   BENGELE HH, 1994, MAGN RESON IMAGING, V12, P433, DOI 10.1016/0730-725X(94)92537-2
   Berger DH, 1997, ANN SURG ONCOL, V4, P247, DOI 10.1007/BF02306617
   BOGDANOV AA, 1994, BBA-BIOMEMBRANES, V1193, P212, DOI 10.1016/0005-2736(94)90350-6
   BOTTOMLEY PA, 1987, MED PHYS, V14, P1, DOI 10.1118/1.596111
   CAMBRIA RA, 1993, J VASC SURG, V18, P773
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   CLAESSON MH, 1971, Z ZELLFORSCH MIKROSK, V119, P95
   CROLL MN, 1983, SEMIN NUCL MED, V13, P4, DOI 10.1016/S0001-2998(83)80030-0
   DASS RS, 1993, NUCL MED BIOL, V20, P701, DOI 10.1016/0969-8051(93)90041-R
   DIDOLKAR MS, 1977, ANN SURG, V186, P625, DOI 10.1097/00000658-197711000-00014
   DOOMS GC, 1985, RADIOLOGY, V155, P691
   EGE GN, 1983, SEMIN NUCL MED, V13, P26, DOI 10.1016/S0001-2998(83)80033-6
   Elste V, 1996, ACAD RADIOL, V3, P660, DOI 10.1016/S1076-6332(96)80193-0
   ERCAN MT, 1992, NUCL MED BIOL, V19, P101
   Fasano A, 1998, TRENDS BIOTECHNOL, V16, P152, DOI 10.1016/S0167-7799(97)01170-0
   FRIEDMAN M, 1990, LARYNGOSCOPE, V100, P54
   Frija G, 1996, ACAD RADIOL, V3, pS299, DOI 10.1016/S1076-6332(96)80563-0
   GERLOWSKI LE, 1986, MICROVASC RES, V31, P288, DOI 10.1016/0026-2862(86)90018-X
   GUIMARAES R, 1994, AM J ROENTGENOL, V162, P201
   HANNA G, 1994, INVEST RADIOL, V29, pS33, DOI 10.1097/00004424-199406001-00012
   Harika L, 1996, RADIOLOGY, V198, P365
   HARIKA L, 1995, MAGNET RESON MED, V33, P88, DOI 10.1002/mrm.1910330113
   Harisinghani MG, 1997, JMRI-J MAGN RESON IM, V7, P161, DOI 10.1002/jmri.1880070124
   Hawley AE, 1997, PHARMACEUT RES, V14, P657, DOI 10.1023/A:1012117531448
   Hawley AE, 1997, FEBS LETT, V400, P319, DOI 10.1016/S0014-5793(96)01408-1
   IKOMI F, 1995, RADIOLOGY, V196, P107
   INGVAR C, 1990, ACTA ONCOL, V29, P1047
   JAMIESON DG, 1989, COMPUT MED IMAG GRAP, V13, P61, DOI 10.1016/0895-6111(89)90079-7
   KABALKA GW, 1991, MAGN RESON IMAGING, V9, P373, DOI 10.1016/0730-725X(91)90425-L
   Kapteijn BAE, 1996, J NUCL MED, V37, P972
   KIMMOUTH JB, 1952, CLIN SCI, V11, P13
   LAISSY JP, 1994, RADIOLOGY, V191, P263
   Lamer S, 1996, INVEST RADIOL, V31, P673, DOI 10.1097/00004424-199611000-00001
   LEE J, 1989, J COLLOID INTERF SCI, V131, P252, DOI 10.1016/0021-9797(89)90166-5
   LOSSEF SV, 1994, SEMIN INTERVENT RAD, V11, P107, DOI 10.1055/s-2008-1074746
   LUNDGREN O, 1964, ANGIOLOGICA, V1, P284
   MCLACHLAN SJ, 1994, JMRI-J MAGN RESON IM, V4, P301, DOI 10.1002/jmri.1880040313
   Misselwitz B, 1997, ACTA RADIOL, V38, P51
   MOGHIMI SM, 1991, INT J PHARM, V68, P121, DOI 10.1016/0378-5173(91)90134-A
   MOGHIMI SM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P157, DOI 10.1016/0167-4889(93)90137-E
   Moghimi SM, 1996, PROG BIOPHYS MOL BIO, V65, P221, DOI 10.1016/S0079-6107(96)00012-0
   MOGHIMI SM, IN PRESS TARGETING D, V6
   MOGHIMI SM, 1998, IN PRESS ADV DRUG DE
   MOGHIMI SM, 1994, FEBS LETT, V344, P25, DOI 10.1016/0014-5793(94)00351-3
   Moore A, 1997, JMRI-J MAGN RESON IM, V7, P1140, DOI 10.1002/jmri.1880070629
   MOREHOUSE HT, 1986, CRIT REV DIAGN IMAG, V25, P177
   MULLER A, 1995, INVEST RADIOL, V30, P98
   Nabi HA, 1997, SEMIN NUCL MED, V27, P30, DOI 10.1016/S0001-2998(97)80034-7
   Nathanson SD, 1996, ANN SURG ONCOL, V3, P329, DOI 10.1007/BF02305661
   NAWAZ MK, 1990, CLIN NUCL MED, V15, P794, DOI 10.1097/00003072-199011000-00004
   OREILLY BJ, 1989, CLIN OTOLARYNGOL, V14, P67, DOI 10.1111/j.1365-2273.1989.tb00339.x
   Oussoren C, 1997, PHARMACEUT RES, V14, P1479, DOI 10.1023/A:1012145410859
   OYEN RH, 1994, RADIOLOGY, V190, P315
   Papisov M, 1996, CRIT REV THER DRUG, V13, P57
   PARSONS C, 1986, DIAGNOSTIC RADIOLOGY, V3, P2167
   Pecking AP, 1996, INT J ONCOL, V9, P659
   Pecking AP, 1997, MED NUCL, V21, P77
   PEREZ CA, 1989, CANC PRINCIPLES PRAC, P1023
   Perrymore WD, 1996, J NUCL MED, V37, P1517
   Pijpers R, 1997, J NUCL MED, V38, P366
   PITTET JC, 1995, NUCL MED BIOL, V22, P355, DOI 10.1016/0969-8051(94)00100-X
   ROBINSON GD, 1986, J NUCL MED, V27, P239
   ROGERS JM, 1994, MAGN RESON IMAGING, V12, P1161, DOI 10.1016/0730-725X(94)90081-2
   Rosenecker J, 1996, P NATL ACAD SCI USA, V93, P7236, DOI 10.1073/pnas.93.14.7236
   RUTGERS EJT, 1995, BREAST, V4, P221
   SANT SM, 1995, CLIN RHEUMATOL, V14, P445, DOI 10.1007/BF02207680
   SAWCZUK IS, 1983, UROLOGY, V21, P81, DOI 10.1016/0090-4295(83)90136-X
   SCHATTEN C, 1994, NUCL MED COMMUN, V15, P422, DOI 10.1097/00006231-199406000-00005
   SCHATTEN C, 1991, LANCET, V337, P395, DOI 10.1016/0140-6736(91)91169-U
   SHERMAN AI, 1953, CANCER, V6, P1238, DOI 10.1002/1097-0142(195311)6:6<1238::AID-CNCR2820060618>3.0.CO;2-6
   SHERVE PD, 1996, RADIOLOGY, V199, P751
   SOMBECK MD, 1993, INT J RADIAT ONCOL, V25, P425
   STOMPER PC, 1993, RADIOLOGY, V187, P381
   STRAND SE, 1989, CRIT REV THER DRUG, V6, P211
   TANOURA T, 1992, AM J ROENTGENOL, V159, P875
   TAUPITZ M, 1993, ACTA RADIOL, V34, P10
   TILCOCK C, 1989, RADIOLOGY, V171, P77
   Torchilin VP, 1996, MOL MED TODAY, V2, P242, DOI 10.1016/1357-4310(96)88805-8
   TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P181, DOI 10.1016/0005-2736(94)90025-6
   Trubetskoy VS, 1996, ACAD RADIOL, V3, P232, DOI 10.1016/S1076-6332(96)80448-X
   UNGER EC, 1985, INVEST RADIOL, V20, P693, DOI 10.1097/00004424-198510000-00008
   VASSALLO P, 1994, RADIOLOGY, V193, P501
   Victor J, 1935, AM J PHYSIOL, V111, P477
   VOGEL TJ, 1997, ACTA RADIOL, V38, P47
   WAGNER S, 1994, INVEST RADIOL, V29, P364, DOI 10.1097/00004424-199403000-00021
   WAHL RL, 1987, J NUCL MED, V28, P1736
   WEINSTEIN JN, 1984, CANCER TREAT REP, V68, P257
   WEINSTEIN JN, 1983, SCIENCE, V222, P423, DOI 10.1126/science.6623082
   Weiss M, 1996, NUKLEARMED, V35, P236
   WEISSLEDER H, 1989, RADIOLOGY, V170, P371
   WEISSLEDER R, 1995, ADV DRUG DELIVER REV, V16, P321, DOI 10.1016/0169-409X(95)00033-4
   WEISSLEDER R, 1990, RADIOLOGY, V175, P494
   WEISSLEDER R, 1989, RADIOLOGY, V171, P835
   WELLS KE, 1994, PLAST RECONSTR SURG, V93, P757, DOI 10.1097/00006534-199404000-00016
   Werner GT, 1997, VASA-J VASCULAR DIS, V26, P25
   WIESSLEDER R, 1994, RADIOLOGY, V191, P225
   Wisner E R, 1994, Acad Radiol, V1, P377
   Wisner ER, 1996, ACAD RADIOL, V3, P40, DOI 10.1016/S1076-6332(96)80331-X
   WISNER ER, 1995, ACAD RADIOL, V2, P985, DOI 10.1016/S1076-6332(05)80701-9
   Wisner ER, 1997, J MED CHEM, V40, P3992, DOI 10.1021/jm970665k
   Wisner ER, 1996, ACAD RADIOL, V3, pS257, DOI 10.1016/S1076-6332(96)80551-4
   WOLF GL, 1994, RADIOLOGY, V191, P501
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   YEH TC, 1995, MAGNET RESON MED, V33, P200, DOI 10.1002/mrm.1910330209
   YEH TC, 1993, MAGNET RESON MED, V30, P617, DOI 10.1002/mrm.1910300513
NR 114
TC 75
Z9 78
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD MAY 4
PY 1999
VL 37
IS 1-3
BP 295
EP 312
DI 10.1016/S0169-409X(98)00099-4
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 190RW
UT WOS:000079979400019
ER

PT J
AU NEWSOM, BD
   KUKORA, JS
AF NEWSOM, BD
   KUKORA, JS
TI CONGENITAL AND ACQUIRED INTERNAL HERNIAS - UNUSUAL CAUSES OF SMALL-BOWEL
   OBSTRUCTION
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
C1 UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT SURG,JACKSON,MS 39216.
CR ANDRENSANDBERG A, 1981, ACTA CHIR SCAND, V147, P381
   Andrews E, 1923, SURG GYNECOL OBSTET, V37, P740
   BARTLETT MK, 1968, ANN SURG, V168, P249, DOI 10.1097/00000658-196808000-00010
   BERARDI RS, 1981, SURG GYNECOL OBSTET, V152, P99
   BIZER LS, 1981, SURGERY, V89, P407
   Blunt A, 1968, Aust N Z J Surg, V37, P310, DOI 10.1111/j.1445-2197.1968.tb03180.x
   COHEN DJ, 1982, DIS COLON RECTUM, V25, P820, DOI 10.1007/BF02553325
   DAHLGREN SVEN, 1961, ACTA CHIR SCAND, V120, P402
   DAVIS R, 1975, AM J SURG, V129, P570, DOI 10.1016/0002-9610(75)90318-9
   ERSKINE JM, 1967, SURG GYNECOL OBSTET, P1093
   FILTZER H, 1973, SURG CLIN N AM, V53, P371
   Garden O J, 1980, J R Coll Surg Edinb, V25, P198
   GUBA AM, 1978, ANN SURG, V188, P49, DOI 10.1097/00000658-197807000-00008
   Hansmann GH, 1939, ARCH SURG-CHICAGO, V39, P973
   HARBIN WP, 1982, RADIOLOGY, V143, P736
   HARMON JW, 1976, ARCH SURG-CHICAGO, V111, P953
   IUCHTMAN M, 1978, J PEDIATR SURG, V13, P439
   JANIN Y, 1980, SURG GYNECOL OBSTET, V150, P747
   LAMPHIER TA, 1982, AM J PROCTOL GASTRO, V33, P12
   LEFFALL LD, 1965, ARCH SURG-CHICAGO, V91, P592
   LEISSNER KH, 1976, ACTA CHIR SCAND, V142, P483
   Mayo CH, 1922, ARCH SURG-CHICAGO, V4, P324
   Mayo CW, 1941, ANN SURG, V114, P875, DOI 10.1097/00000658-194111000-00008
   MCALLISTER FF, 1948, ANN SURG, V128, P1194, DOI 10.1097/00000658-194812000-00015
   MILLER BJ, 1981, CAN J SURG, V24, P401
   MORTON CB, 1955, ANN SURG, V141, P759
   MURPHY DA, 1964, SURGERY, V55, P311
   Ohkuma R, 1977, Jpn J Surg, V7, P151, DOI 10.1007/BF02469346
   Pal J C, 1980, J Indian Med Assoc, V74, P109
   PETTERSON G, 1979, BRIT J SURG, V66, P665, DOI 10.1002/bjs.1800660923
   RICHARDSON JB, 1981, MARYLAND STATE MED J, V30, P56
   Shannon R, 1968, Aust N Z J Surg, V38, P21
   SHATILA AH, 1976, AM J SURG, V132, P299, DOI 10.1016/0002-9610(76)90379-2
   STAMMERS FAR, 1951, ANN ROY COLL SURG, V9, P189
   TAGORE NK, 1974, INT SURG, V59, P53
   TURLEY K, 1979, ARCH SURG-CHICAGO, V114, P1072
   WANG HH, 1972, AM J SURG, V124, P587, DOI 10.1016/0002-9610(72)90093-1
NR 37
TC 75
Z9 77
PU CAHNERS PUBL CO
PI NEW YORK
PA 249 WEST 17 STREET, NEW YORK, NY 10011
SN 0002-9610
J9 AM J SURG
JI Am. J. Surg.
PD SEP
PY 1986
VL 152
IS 3
BP 279
EP 285
DI 10.1016/0002-9610(86)90258-8
PG 7
WC Surgery
SC Surgery
GA D9594
UT WOS:A1986D959400009
PM 3752377
ER

PT J
AU Levine, GN
   Bates, ER
   Blankenship, JC
   Bailey, SR
   Bittl, JA
   Cercek, B
   Chambers, CE
   Ellis, SG
   Guyton, RA
   Hollenberg, SM
   Khot, UN
   Lange, RA
   Mauri, L
   Mehran, R
   Moussa, ID
   Mukherjee, D
   Nallamothu, BK
   Ting, HH
AF Levine, Glenn N.
   Bates, Eric R.
   Blankenship, James C.
   Bailey, Steven R.
   Bittl, John A.
   Cercek, Bojan
   Chambers, Charles E.
   Ellis, Stephen G.
   Guyton, Robert A.
   Hollenberg, Steven M.
   Khot, Umesh N.
   Lange, Richard A.
   Mauri, Laura
   Mehran, Roxana
   Moussa, Issam D.
   Mukherjee, Debabrata
   Nallamothu, Brahmajee K.
   Ting, Henry H.
TI 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention:
   Executive Summary A Report of the American College of Cardiology
   Foundation/American Heart Association Task Force on Practice Guidelines
   and the Society for Cardiovascular Angiography and Interventions
SO CIRCULATION
LA English
DT Article
DE AHA Scientific Statements; acute coronary syndromes; anticoagulants;
   antiplatelet agents, arrhythmias, cardiac; coronary angiography;
   coronary artery revascularization interventions: stents; drug therapy;
   heart diseases; myocardial revascularization; platelet aggregation
   inhibitor; ultrasound
ID ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; RANDOMIZED
   CONTROLLED-TRIAL; DRUG-ELUTING STENTS; LONG-TERM SURVIVAL; GLYCOPROTEIN
   IIB/IIIA RECEPTOR; FRACTIONAL FLOW RESERVE; CONTRAST-INDUCED
   NEPHROPATHY; ARTERY-BYPASS SURGERY; BARE-METAL STENTS
AB The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
C1 [Levine, Glenn N.] Baylor Coll Med, Houston, TX 77030 USA.
   [Bates, Eric R.; Nallamothu, Brahmajee K.] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Blankenship, James C.] Geisinger Med Ctr, Cardiol & Cardiac Catheterizat Labs, Danville, PA USA.
   [Bailey, Steven R.] Univ Texas Med Ctr, Dallas, TX USA.
   [Cercek, Bojan] Cedars Sinai Med Ctr, Coronary Care Unit, Los Angeles, CA USA.
   [Chambers, Charles E.] Penn State Milton S Hershey Med Ctr, Hershey, PA USA.
   [Ellis, Stephen G.] Cleveland Clin Fdn, Cleveland, OH USA.
   [Guyton, Robert A.] Emory Clin Inc, Div Cardiothorac Surg, Atlanta, GA USA.
   [Hollenberg, Steven M.] Cooper Univ Hosp, Coronary Care Unit, Camden, NJ USA.
   [Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA.
   [Mauri, Laura] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02138 USA.
   [Mehran, Roxana] Columbia Univ, Med Ctr, New York, NY 10027 USA.
   [Moussa, Issam D.; Ting, Henry H.] Mayo Clin, Rochester, MN 55905 USA.
   [Mukherjee, Debabrata] Texas Tech Univ, Lubbock, TX 79409 USA.
RP Levine, GN (reprint author), Baylor Coll Med, Houston, TX 77030 USA.
CR Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Abraham NS, 2010, CIRCULATION, V122, P2619, DOI 10.1161/CIR.0b013e318202f701
   ACCF/AHA Task Force on Practice Guidelines, METH POL ACCF AHA TA
   Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943
   Aguirre FV, 2008, CIRCULATION, V117, P1145, DOI 10.1161/CIRCULATIONAHA.107.728519
   Albiero R, 2004, J AM COLL CARDIOL, V43, P943, DOI 10.1016/j.jacc.2003.09.054
   Alderman E, 1997, CIRCULATION, V96, P1761
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   Aliabadi D, 1997, AM J CARDIOL, V80, P994, DOI 10.1016/S0002-9149(97)00591-2
   Al-Lamee R, 2010, AM J CARDIOL, V106, P1721, DOI 10.1016/j.amjcard.2010.08.013
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Nestico PF, 2004, JAMA-J AM MED ASSOC, V291, P2196
   Griffith JL, 2003, JAMA-J AM MED ASSOC, V289, P178
   Alter DA, 2003, J AM COLL CARDIOL, V42, P410, DOI 10.1016/S0735-1097(03)00640-5
   Amit G, 2006, AM HEART J, V152
   [Anonymous], 2002, LANCET, V360, P7
   [Anonymous], 2002, CIRCULATION, V106, P3143
   [Anonymous], 1999, LANCET, V354, P708
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   Antoniucci D, 2004, CIRCULATION, V109, P1704, DOI 10.1161/01.CIR.0000126284.40075.98
   Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Assali AR, 2000, CATHETER CARDIO INTE, V51, P27, DOI 10.1002/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO;2-0
   Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943
   Bader BD, 2004, CLIN NEPHROL, V62, P1
   Collins R, 2009, LANCET, V373, P1849
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baim DS, 2002, CIRCULATION, V105, P1285, DOI 10.1161/01.CIR.0000012783.63093.0C
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Barcin C, 2004, CATHETER CARDIO INTE, V61, P484, DOI 10.1002/ccd.20010
   BARNATHAN ES, 1987, CIRCULATION, V76, P125
   Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295
   Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050
   Bavry AA, 2008, EUR HEART J, V29, P2989, DOI 10.1093/eurheartj/ehn421
   Bellandi F, 2004, CATHETER CARDIO INTE, V62, P186, DOI 10.1002/ccd.20041
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berger PB, 1999, CIRCULATION, V99, P248
   Bertrand OF, 2010, AM J CARDIOL, V105, P1520, DOI 10.1016/j.amjcard.2010.01.006
   Biancari F, 2010, AM HEART J, V159, P518, DOI 10.1016/j.ahj.2009.12.027
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   Bittl JA, 2004, J AM COLL CARDIOL, V43, P936, DOI 10.1016/j.jacc.2003.10.039
   Blankenship JC, 2011, J AM COLL CARDIOL, V57, P272, DOI 10.1016/j.jacc.2010.06.056
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Boersma E, 1999, CIRCULATION, V100, P2045
   Bohmer E, 2010, J AM COLL CARDIOL, V55, P102, DOI 10.1016/j.jacc.2009.08.007
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   Borgia F, 2010, EUR HEART J, V31, P2156, DOI 10.1093/eurheartj/ehq204
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Brieger D, 2011, CATHETER CARDIO INTE, V77, P182, DOI 10.1002/ccd.22674
   Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005
   Briguori C, 2001, AM J CARDIOL, V87, P136, DOI 10.1016/S0002-9149(00)01304-7
   Briguori C, 2004, EUR HEART J, V25, P1822, DOI 10.1016/j.ehj.2004.07.017
   BROGAN WC, 1993, AM J CARDIOL, V71, P794, DOI 10.1016/0002-9149(93)90826-X
   Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501
   Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941
   Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106
   Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Chen EW, 2003, CIRCULATION, V108, P951, DOI 10.1161/01.CIR.000008508.59734.E4
   Chen SL, 2011, J AM COLL CARDIOL, V57, P914, DOI 10.1016/j.jacc.2010.10.023
   Chen ZM, 2005, LANCET, V366, P1607
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Choussat R, 2002, J AM COLL CARDIOL, V40, P1943, DOI 10.1016/S0735-1097(02)02531-7
   Clark AM, 2005, ANN INTERN MED, V143, P659
   Cohen M, 2010, CATHETER CARDIO INTE, V75, P928, DOI 10.1002/ccd.22340
   Collet JP, 2004, AM HEART J, V147, P655, DOI 10.1016/j.ahj.2003.10.019
   Collet JP, 2001, CIRCULATION, V103, P658
   Colombo A, 2009, CIRCULATION, V119, P71, DOI 10.1161/CIRCULATIONAHA.108.808402
   Coolong A, 2008, CIRCULATION, V117, P790, DOI 10.1161/CIRCULATIONAHA.106.651232
   Cornuz J, 2002, ANN INTERN MED, V136, P429
   Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034
   Cruden NLM, 2010, CIRC-CARDIOVASC INTE, V3, P236, DOI 10.1161/CIRCINTERVENTIONS.109.934703
   CUMMINGS SR, 1989, J GEN INTERN MED, V4, P482, DOI 10.1007/BF02599545
   Dangas G, 2009, J AM COLL CARDIOL, V54, P1438, DOI 10.1016/j.jacc.2009.06.021
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320
   Dauerman HL, 2007, J AM COLL CARDIOL, V50, P1617, DOI 10.1016/j.jacc.2007.07.028
   Davies RF, 1997, CIRCULATION, V95, P2037
   DEFEYTER PIMJ, 1993, J AM COLL CARDIOL, V21, P1539
   DEFEYTER PJ, 1989, AM J CARDIOL, V64, P88, DOI 10.1016/0002-9149(89)90658-9
   Dehmer GJ, 2007, CATHETER CARDIO INTE, V69, P471, DOI 10.1002/ccd.21097
   Deibele AJ, 2006, J THROMB THROMBOLYS, V22, P47, DOI 10.1007/s11239-006-7454-8
   Deibele AJ, 2010, CIRCULATION, V121, P784, DOI 10.1161/CIRCULATIONAHA.109.882746
   de Labriolle A, 2008, AM J CARDIOL, V102, P1175, DOI 10.1016/j.amjcard.2008.06.059
   De Luca G, 2009, THROMB HAEMOSTASIS, V102, P428, DOI 10.1160/TH09-05-0287
   De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759
   De Luca G, 2009, EUR HEART J, V30, P2705, DOI 10.1093/eurheartj/ehp118
   Dibra A, 2007, J AM COLL CARDIOL, V49, P616, DOI 10.1016/j.jacc.2006.10.049
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8
   Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028
   Drouet L, 2009, AM HEART J, V158, P177, DOI 10.1016/j.ahj.2009.05.022
   DUNCAN C, 1991, AM J PUBLIC HEALTH, V81, P899, DOI 10.2105/AJPH.81.7.899
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Eisenberg MJ, 2004, AM J CARDIOL, V93, P744, DOI 10.1016/j.amjcard.2003.11.071
   Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179
   El Khoury C, 2010, ARCH CARDIOVASC DIS, V103, P287, DOI 10.1016/j.acvd.2010.04.005
   Ellis SG, 2009, JACC-CARDIOVASC INTE, V2, P909, DOI 10.1016/j.jcin.2009.07.009
   Ellis SG, 1997, CIRCULATION, V96, P3867
   Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816
   Ellis SG, 1998, J AM COLL CARDIOL, V32, P1619, DOI 10.1016/S0735-1097(98)00403-3
   CALIFF RM, 1994, NEW ENGL J MED, V330, P956
   Topol EJ, 1997, NEW ENGL J MED, V336, P1689
   EPISTENT Investigators, 1998, Lancet, V352, P87
   Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304
   Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985
   Tcheng JE, 2000, LANCET, V356, P2037
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   Fassa AA, 2005, J AM COLL CARDIOL, V45, P204, DOI 10.1016/j.jacc.2004.09.066
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   Feit F, 2000, CIRCULATION, V101, P2795
   Ferenc M, 2008, EUR HEART J, V29, P2859, DOI 10.1093/eurheartj/ehn455
   Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45
   Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1
   APPLEBY P, 1994, LANCET, V343, P311
   Fischell Tim A, 2008, Cardiovasc Revasc Med, V9, P224, DOI 10.1016/j.carrev.2008.03.002
   Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699
   Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690
   Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960
   Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007
   Galassi AR, 2009, JACC-CARDIOVASC INTE, V2, P185, DOI 10.1016/j.jcin.2008.12.005
   Gershlick AH, 2005, NEW ENGL J MED, V353, P2758, DOI 10.1056/NEJMoa050849
   Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194
   Gibson CM, 2003, J AM COLL CARDIOL, V42, P7, DOI 10.1016/S0735-1097(03)00506-0
   Gierlotka M, 2011, AM J CARDIOL, V107, P501, DOI 10.1016/j.amjcard.2010.10.008
   Gil Robert J, 2005, Kardiol Pol, V63, P223
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gill BV, 2009, J ALLERGY CLIN IMMUN, V124, P1055, DOI 10.1016/j.jaci.2009.06.030
   Goel K, 2011, CIRCULATION, V123, P2344, DOI 10.1161/CIRCULATIONAHA.110.983536
   Gonzales DA, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-32
   GREENBERGER PA, 1985, ARCH INTERN MED, V145, P2197, DOI 10.1001/archinte.145.12.2197
   Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jace.2007.01.003
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Grzybowski M, 2003, JAMA-J AM MED ASSOC, V290, P1891, DOI 10.1001/jama.290.14.1891
   Gupta M, 2003, EUR HEART J, V24, P1640, DOI 10.1016/S0195-668X(03)00433-0
   Gurbel PA, 2005, CIRCULATION, V111, P1153, DOI 10.1161/01.CIR.0000157138.02645.11
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073
   Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103
   Hamon M, 2009, EUROINTERVENTION, V5, P115
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATONAHA.104.528455
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hansen PR, 2010, J INVASIVE CARDIOL, V22, P278
   Hao PP, 2010, TEX HEART I J, V37, P516
   Hassan Y, 2009, ANN PHARMACOTHER, V43, P1598, DOI 10.1345/aph.1M187
   Hausleiter J, 2004, J INTERN MED, V256, P388, DOI 10.1111/j.1365-2796.2004.01398.x
   Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141
   Hildick-Smith D, 2010, CIRCULATION, V121, P1235, DOI 10.1161/CIRCULATIONAHA.109.888297
   Hillegass WB, 2001, J AM COLL CARDIOL, V37, P1335, DOI 10.1016/S0735-1097(01)01138-X
   Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139
   Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190
   Hoffer EK, 2003, J VASC INTERV RADIOL, V14, P865, DOI 10.1097/01.RVI.0000071086.764348.8E
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264
   Holmes DR, 2010, CIRCULATION, V122, P537, DOI 10.1161/CIR.0b013e3181ee08ed
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   Huang RI, 2006, CATHETER CARDIO INTE, V68, P671, DOI 10.1002/ccd.20885
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Iakovou I, 2004, J AM COLL CARDIOL, V44, P967, DOI 10.1016/j.jacc.2004.05.058
   Institute of Medicine, 2011, CLIN PRACT GUID WE C
   Institute of Medicine, 2011, FIND WHAT WORKS HLTH
   Ioannidis JPA, 2007, AM HEART J, V154, P1065, DOI 10.1016/j.ahj.2007.07.049
   Ito H, 1999, J AM COLL CARDIOL, V33, P654, DOI 10.1016/S0735-1097(98)00604-4
   Jaffe R, 2007, CATHETER CARDIO INTE, V69, P815, DOI 10.1002/ccd.21021
   Iversen Allan, 2008, Curr Cardiol Rev, V4, P293, DOI 10.2174/157340308786349480
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Jolly SS, 2009, EUR HEART J, V30, P900, DOI 10.1093/eurheartj/ehn417
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   KAISER GA, 1975, SURGERY, V78, P749
   Kakkar AK, 2004, CATHETER CARDIO INTE, V61, P31, DOI 10.1002/ccd.10730
   Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P65, DOI 10.1161/CIRCINTERVENTIONS.110.959148
   Kapadia SR, 1998, CIRCULATION, V98, P2672
   Kaplan BM, 1996, CATHETER CARDIO DIAG, V39, P113, DOI 10.1002/(SICI)1097-0304(199610)39:2<113::AID-CCD1>3.0.CO;2-I
   Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213
   Kappetein AP, 2011, EUR HEART J, V17, P2125
   Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859
   Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034
   Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944
   Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165
   Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503
   Keeley EC, 2004, JAMA-J AM MED ASSOC, V291, P736, DOI 10.1001/jama.291.6.736
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   Klein LW, 2009, CATHETER CARDIO INTE, V74, P728, DOI 10.1002/ccd.22113
   Kobashigawa JA, 2005, J AM COLL CARDIOL, V45, P1532, DOI 10.1016/j.jacc.2005.02.035
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Levey AS, 2006, ANN INTERN MED, V145, P247
   Levine GN, 2004, J THROMB THROMBOLYS, V17, P167, DOI 10.1023/B:THRO.0000040484.99422.77
   LEVINE GN, CIRCULATION, DOI DOI 10.1016/CIR.0B013E31823BA622
   Levine GN, 2003, ANN INTERN MED, V139, P123
   Lewis BE, 2002, CATHETER CARDIO INTE, V57, P177, DOI 10.1002/ccd.10276
   Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853
   Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696
   Lincoff AM, 2008, JACC-CARDIOVASC INTE, V1, P639, DOI 10.1016/j.jcin.2008.10.004
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Louvard Y, 2004, AM J CARDIOL, V94, P1177, DOI 10.1016/j.amjcard.2004.07.089
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   Madsen JK, 1997, CIRCULATION, V96, P748
   Magni V, 2009, CATHETER CARDIO INTE, V73, P441, DOI 10.1002/ccd.21812
   Mahaffey Kenneth W, 2003, J Invasive Cardiol, V15, P611
   Maioli M, 2007, J AM COLL CARDIOL, V49, P1517, DOI 10.1016/j.jacc.2006.12.036
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Marciniak SJ, 2002, THROMB HAEMOSTASIS, V87, P1020
   Marenzi G, 2009, ANN INTERN MED, V150, P170
   Martin JL, 2004, CATHETER CARDIO INTE, V61, P163, DOI 10.1002/ccd.10726
   Marzilli M, 2000, CIRCULATION, V101, P2154
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Mauri L, 2003, AM HEART J, V145, P847, DOI 10.1016/S0002-8703(03)00080-2
   Mauri L, 2002, AM J CARDIOL, V90, P1079, DOI 10.1016/S0002-9149(02)02773-X
   Mauri L, 2007, J AM COLL CARDIOL, V50, P1442, DOI 10.1016/j.jacc.2007.06.039
   Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485
   McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905
   Mehilli J, 2009, CIRCULATION, V119, P1933, DOI 10.1161/CIRCULATIONAHA.108.818617
   Mehilli J, 2004, CIRCULATION, V110, P3627, DOI 10.1161/01.CIR.0000148956.93631.4D
   Mehilli J, 2011, LANCET, V378, P1071, DOI 10.1016/S0140-6736(11)61255-5
   Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068
   Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7
   Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986
   Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4
   Melberg T, 2006, AM HEART J, V152, P888, DOI 10.1016/j.ahj.2006.06.026
   Montalescot G, 2004, JAMA-J AM MED ASSOC, V292, P362, DOI 10.1001/jama.292.3.362
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Montalescot G, 2009, JACC-CARDIOVASC INTE, V2, P1083, DOI 10.1016/j.jcin.2009.08.016
   Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Moussa I, 1997, CIRCULATION, V96, P128
   Moussa ID, 2011, CATHETER CARDIO INTE, V77, P537, DOI 10.1002/ccd.22865
   Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Nasser M, 2005, CATHETER CARDIO INTE, V65, P516, DOI 10.1002/ccd.20391
   Neumann FJ, 2000, J AM COLL CARDIOL, V35, P915, DOI 10.1016/S0735-1097(99)00635-X
   Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Noble S, 2008, CATHETER CARDIO INTE, V71, P803, DOI 10.1002/ccd.21490
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7
   Ono H, 2004, AM HEART J, V148, P611, DOI 10.1016/j.ahj.2004.05.014
   Osuna JGG, 2006, REV ESP CARDIOL, V59, P567
   Ozcan EE, 2007, AM HEART J, V154, P539, DOI 10.1016/j.ohi.2007.05.012
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Pan XH, 2010, J ZHEJIANG UNIV-SC B, V11, P754, DOI 10.1631/jzus.B0900302
   Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039
   Park DW, 2007, AM J CARDIOL, V99, P760, DOI 10.1016/j.amjcard.2006.10.028
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87
   Patel MR, 2010, CIRCULATION, V122, P1882, DOI 10.1161/CIR.0b013e3181f9b345
   Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   PIANA RN, 1994, CIRCULATION, V89, P2514
   Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162
   Popma JJ, 2004, CHEST, V126, p576S
   Post Piet N, 2010, Eur Heart J, V31, P1985, DOI 10.1093/eurheartj/ehq151
   Pristipino C, 2009, HEART, V95, P476, DOI 10.1136/hrt.2008.150714
   Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007
   Rao SV, 2010, J AM COLL CARDIOL, V55, P2187, DOI 10.1016/j.jacc.2010.01.039
   Rathore S, 2009, JACC-CARDIOVASC INTE, V2, P489, DOI 10.1016/j.jcin.2009.04.008
   Reddy PR, 2005, AM J CARDIOL, V95, P755, DOI 10.1016/j.amjcard.2004.11.029
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Reifart N, 1997, CIRCULATION, V96, P91
   Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081
   Roffi M, 2001, CIRCULATION, V104, P2767, DOI 10.1161/hc4801.100029
   Roffi M, 2002, CIRCULATION, V106, P3063, DOI 10.1161/01.CIR.0000041250.89627.A9
   Romagnoli E, 2005, INT J CARDIOL, V105, P250, DOI 10.1016/j.ijcard.2004.11.037
   Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061
   ROSSER W, 1992, CAN FAM PHYSICIAN, V38, P1623
   RUSSO D, 1995, J AM SOC NEPHROL, V6, P1451
   Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Sanborn TA, 2000, J AM COLL CARDIOL, V36, P1123, DOI 10.1016/S0735-1097(00)00875-5
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Sano K, 2007, AM HEART J, V154, P983, DOI 10.1016/j.ahj.2007.07.001
   Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Schouten O, 2009, AM J CARDIOL, V103, P897, DOI 10.1016/j.amjcard.2008.12.018
   Schulz S, 2010, EUR HEART J, V31, P582, DOI 10.1093/eurheartj/ehq008
   SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603
   Sdringola S, 2000, CATHETER CARDIO INTE, V51, P394, DOI 10.1002/1522-726X(200012)51:4<394::AID-CCD4>3.0.CO;2-G
   Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Sharma AK, 2004, CATHETER CARDIO INTE, V63, P141, DOI 10.1002/ccd.20124
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   SHEHADI WH, 1975, AM J ROENTGENOL, V124, P145
   Singh PP, 2011, AM J THER, V18, pE22, DOI 10.1097/MJT.0b013e3181bc0f5a
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   SMITH SC, CIRCULATION, DOI DOI 10.1016/CIR.0B013E318235EB4D
   Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516
   SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066
   Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   Steg PG, 2004, EUR HEART J, V25, P2187, DOI 10.1016/j.ehj.2004.10.019
   Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920
   Steinhubl SR, 2009, ANN INTERN MED, V150, P379
   Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411
   Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stevens LA, 2009, AM J KIDNEY DIS, V54, P33, DOI 10.1053/j.ajkd.2009.03.008
   Stoel MG, 2008, CATHETER CARDIO INTE, V71, P283, DOI 10.1002/ccd.21334
   Stone GW, 1997, J AM COLL CARDIOL, V30, P1714, DOI 10.1016/S0735-1097(97)00387-2
   Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437
   Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116
   Stone GW, 2005, CIRCULATION, V112, P2530, DOI 10.1161/CIRCULATIONAHA.105.583716
   Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191
   Stone GW, 2003, CIRCULATION, V108, P548, DOI 10.1161/01.CIR.0000080894.51311.0A
   Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404
   Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   Suero JA, 2001, J AM COLL CARDIOL, V38, P409, DOI 10.1016/S0735-1097(01)01349-3
   Suh HS, 2011, INT J TECHNOL ASSESS, V27, P11, DOI 10.1017/S0266462310001340
   Swoboda I, 2002, J IMMUNOL, V168, P4576
   Takagi A, 1999, CIRCULATION, V100, P250
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   ten Berg JM, 2010, J AM COLL CARDIOL, V55, P2446, DOI 10.1016/j.jacc.2009.11.091
   Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139
   Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255
   Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091
   Thomas RJ, 2007, CIRCULATION, V116, P1611, DOI 10.1161/CIRCULATIONAHA.107.185734
   Thompson PD, 2003, ARTERIOSCL THROM VAS, V23, P1319, DOI 10.1161/01.ATV.0000087143.33998/F2
   TIME Investigators, 2001, LANCET, V358, P951
   Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   Tramer MR, 2006, BRIT MED J, V333, P675, DOI 10.1136/bmj.38905.634132.AE
   Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Urban P, 1999, EUR HEART J, V20, P1030, DOI 10.1053/euhj.1998.1353
   Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668
   Valgimigli M, 2004, J AM COLL CARDIOL, V44, P14, DOI 10.1016/j.jacc.2004.03.042
   Valgimigli M, 2007, J AM COLL CARDIOL, V49, P431, DOI 10.1016/j.jacc.2006.06.081
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van der Heijden DJ, 2004, J AM COLL CARDIOL, V44, P20, DOI 10.1016/j.jacc.2004.02.056
   van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0
   Vaquerizo B, 2010, J INTERV CARDIOL, V23, P240, DOI 10.1111/j.1540-8183.2010.00547.x
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
   Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8
   vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6
   Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Welke KF, 2007, ANN THORAC SURG, V84, P1538, DOI 10.1016/j.athoracsur.2007.06.022
   Werner GS, 2002, CATHETER CARDIO INTE, V57, P444, DOI 10.1002/ccd.10375
   WEYRENS FJ, 1995, AM J CARDIOL, V75, P849, DOI 10.1016/S0002-9149(99)80430-5
   Whelton SP, 2002, ANN INTERN MED, V136, P493
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   Widimsky P, 2011, EUR HEART J, V32, P396, DOI 10.1093/eurheartj/ehq410
   Wijeysundera HC, 2007, J AM COLL CARDIOL, V49, P422, DOI 10.1016/j.jacc.2006.09.033
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   Wilson SH, 2003, J AM COLL CARDIOL, V42, P234, DOI 10.1016/S0735-1097(03)00622-3
   Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001
   Winchester DE, 2010, J AM COLL CARDIOL, V56, P1099, DOI 10.1016/j.jacc.2010.04.023
   Witt BJ, 2004, J AM COLL CARDIOL, V44, P988, DOI 10.1016/j.jacc.2004.05.062
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wohrle J, 2003, CIRCULATION, V107, P1840, DOI 10.1161/01.CIR.0000066852.98038.D1
   Wöhrle Jochen, 2008, EuroIntervention, V3, P465, DOI 10.4244/EIJV3I4A83
   Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3
   Wu TG, 2008, CIRC J, V72, P1605, DOI 10.1253/circj.CJ-08-0357
   Yang Xin-chun, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P517
   Yun KH, 2009, INT J CARDIOL, V137, P246, DOI 10.1016/j.ijcard.2008.06.055
   Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519
   Yusuf S, 2006, NEW ENGL J MED, V354, P1464
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Zahn R, 1999, CATHETER CARDIO INTE, V46, P127, DOI 10.1002/(SICI)1522-726X(199902)46:2<127::AID-CCD2>3.0.CO;2-G
   Zeymer U, 2003, CIRCULATION, V108, P1324, DOI 10.1161/01.CIR.0000087605.09362.0E
   Zhang F, 2010, ANN MED, V42, P171, DOI 10.3109/07853890903463976
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002
NR 443
TC 74
Z9 84
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD DEC 6
PY 2011
VL 124
IS 23
BP 2574
EP 2609
DI 10.1161/CIR.0b013e31823a5596
PG 36
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 863QW
UT WOS:000298183300022
PM 22064598
ER

PT J
AU Vagnozzi, R
   Tavazzi, B
   Signoretti, S
   Amorini, AM
   Belli, A
   Cimatti, M
   Delfini, R
   Di Pietro, V
   Finocchiaro, A
   Lazzarino, G
AF Vagnozzi, Roberto
   Tavazzi, Barbara
   Signoretti, Stefano
   Amorini, Angela M.
   Belli, Antonio
   Cimatti, Marco
   Delfini, Roberto
   Di Pietro, Valentina
   Finocchiaro, Antonino
   Lazzarino, Giuseppe
TI Temporal window of metabolic brain vulnerability to concussions:
   Mitochondrial-related impairment - Part I
SO NEUROSURGERY
LA English
DT Article
DE brain vulnerability; concussion; energy metabolism; N-acetylaspartate
   metabolism; repeat or multiple concussions; second impact syndrome
ID MILD HEAD-INJURY; SPORT-RELATED CONCUSSION; DIFFUSE AXONAL INJURY;
   N-ACETYLASPARTATE; MAGNETIC-RESONANCE; GLUCOSE-METABOLISM;
   ENERGY-METABOLISM; NAAG PEPTIDASE; NITRIC-OXIDE; RATS
AB OBJECTIVE: In the present study, we investigate the existence of a temporal window of brain vulnerability in rats undergoing repeat mild traumatic brain injury (mTBI) delivered at increasing time intervals.
   METHODS: Rats were subjected to two diffuse mTBIs (450 g/1 m height) with the second mTBI delivered after 1 (n = 6), 2 (n = 6), 3 (n = 6), 4 (n = 6), and 5 days (n = 6) and sacrificed 48 hours after the last impact. Sham-operated animals were used as controls (n = 6). Two further groups of six rats each received a second mTBI after 3 days and were sacrificed at 120 and 168 hours postinjury. Concentrations of adenine nucleotides, N-acetylated amino acids, oxypurines, nucleosides, free coenzyme A, acetyl CoA, and oxidized and reduced nicotinamide adenine dinucleotides, oxidized nicotinamide adenine dinucleotide phosphate, and reduced nicotinamide adenine dinucleotide, reduced nicotinamide adenine dinucleotide phosphate nicotinic coenzymes were measured in deproteinized cerebral tissue extracts (three right and three left hemispheres), whereas the gene expression of N-acetylaspartate acylase, the enzyme responsible for N-acetylaspartate (NAA) degradation, was evaluated in extracts of three left and three right hemispheres.
   RESULTS: A decrease of adenosine triphosphate, adenosine triphosphate /adenosine diphosphate ratio, NAA, N-acetylaspartylglutamate, oxidized and reduced nicotinamide adenine dinucleotide, reduced nicotinamide adenine dinucleotide, and acetyl CoA and increase of N-acetylaspartate acylase expression were related to the interval between impacts with maximal changes recorded when mTBIs were spaced by 3 days. In these animals, protracting the time of sacrifice after the second mTBI up to 1 week failed to show cerebral metabolic recovery, indicating that this type of damage is difficult to reverse. A metabolic pattern similar to controls was observed only in animals receiving mTBIs 5 days apart.
   CONCLUSION: This study shows the existence of a temporal window of brain vulnerability after mTBI. A second concussive event failing within this time range had profound consequences on mitochondrial-related metabolism. Furthermore, because NAA recovery coincided with normalization of ail other metabolites, it is conceivable to hypothesize that NAA measurement by H-1-NMR spectroscopy might be a valid tool in assessing full cerebral metabolic recovery in the clinical setting and with particular reference to sports medicine in establishing when to return mTBI-affected athletes to play. This study also shows, for the first time, the influence of TBI on acetyl-CoA, N-acetylaspartate acylase gene expression, and N-acetylaspartylglutamate, thus providing novel data on cerebral biochemical changes occurring in head injury.
C1 Univ Catania, Biochem Lab, Dept Chem Sci, I-95125 Catania, Italy.
   Univ Roma Tor Vergata, Dept Neurosci, I-00173 Rome, Italy.
   Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Rome, Italy.
   San Camillo Hosp, Div Neurosurg, Rome, Italy.
   Univ Southampton, Div Clin Neurosci, Southampton SO9 5NH, Hants, England.
   Univ Roma La Sapienza, Dept Neurol Sci Neurosurg, I-00185 Rome, Italy.
RP Lazzarino, G (reprint author), Univ Catania, Biochem Lab, Dept Chem Sci, Viale A Doria 6, I-95125 Catania, Italy.
EM lazzarig@mbox.unict.it
CR Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x
   Baslow MH, 2003, J MOL NEUROSCI, V21, P185, DOI 10.1385/JMN:21:3:185
   Baslow MH, 2006, DRUG NEWS PERSPECT, V19, P145, DOI 10.1358/dnp.2006.19.3.985930
   Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x
   Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389
   BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4
   Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9
   Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4
   Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674
   Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P224
   Cherian L, 2004, BRAIN PATHOL, V14, P195
   Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155
   Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843
   FODA MAA, 1994, J NEUROSURG, V80, P301
   Giza CC, 2001, J ATHL TRAINING, V36, P228
   Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA
   Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549
   Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3
   Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276
   HOVDA DA, 1983, INTRACRANIAL PRESSUR, P469
   Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12
   Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994
   Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b
   Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x
   Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859
   Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013
   Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03
   Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44
   Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004
   MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291
   Marmarou A, 2005, ACT NEUR S, V95, P149
   Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027
   McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817
   McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004
   Moreno A, 2001, J NEUROCHEM, V77, P347, DOI 10.1046/j.1471-4159.2001.00282.x
   Movsesyan VA, 2006, J NEUROTRAUM, V23, P117, DOI 10.1089/neu.2006.23.117
   Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004
   Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D
   Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44
   Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283
   Putukian Margot, 2006, Curr Sports Med Rep, V5, P15
   Randolph C, 2005, J ATHL TRAINING, V40, P139
   Rose ME, 2002, BRAIN RES, V935, P40, DOI 10.1016/S0006-8993(02)02445-9
   Santos A, 2005, NEUROCHEM RES, V30, P625, DOI 10.1007/s11064-005-2750-9
   Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001
   Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7
   Sheline CT, 2006, NEUROSCIENCE, V140, P235, DOI 10.1016/j.neuroscience.2006.02.019
   Signoretti S, 2004, J NEUROTRAUM, V21, P1154
   Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683
   Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971
   Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002
   Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6
   Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903
   Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85
   Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   Wroblewska B, 2006, ADV EXP MED BIOL, V576, P317
   Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266
   2005, BR J SPORT MED, V39, P78
NR 59
TC 74
Z9 74
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-396X
J9 NEUROSURGERY
JI Neurosurgery
PD AUG
PY 2007
VL 61
IS 2
BP 379
EP 388
DI 10.1227/01.NEU.0000280002.41696.D8
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 197AN
UT WOS:000248525400036
PM 17762751
ER

PT J
AU Parolari, A
   Alamanni, F
   Polvani, G
   Agrifoglio, M
   Chen, YB
   Kassem, S
   Veglia, F
   Tremoli, E
   Biglioli, P
AF Parolari, A
   Alamanni, F
   Polvani, G
   Agrifoglio, M
   Chen, YB
   Kassem, S
   Veglia, F
   Tremoli, E
   Biglioli, P
TI Meta-analysis of randomized trials comparing off-pump with on-pump
   coronary artery bypass graft patency
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID RESOURCE UTILIZATION; SHORT-TERM; SURGERY; OUTCOMES; REVASCULARIZATION;
   QUALITY; STATE; LONG
AB Background. Off-pump coronary artery bypass graft surgery (OPCAB) is increasingly becoming a widely used technique and challenges conventional on-pump coronary artery bypass grafting as the standard surgical therapy for coronary artery disease. Little information, however, is available concerning postoperative performance of bypass grafts done with this new technique. The aim of this study is to assess differences in graft patency between OPCAB and coronary artery bypass grafting by meta-analysis of data published in randomized trials.
   Methods. A literature search for the period beginning January 1990 until December 2004 supplemented with manual bibliographic review was performed for all peer-reviewed English-language publications. A systematic overview (meta-analysis) of randomized trials was conducted to assess differences between OPCAB and coronary artery bypass grafting in graft occlusion rates.
   Results. Literature search yielded five comparable randomized studies, for a total of 872 and 998 grafts performed during OPCAB and coronary artery bypass grafting procedures, respectively. Meta-analysis of these studies showed an increased risk of graft occlusion in the OPCAB group of patients, both when all the studies were analyzed together (odds ratio, 1.51; 95% confidence intervals, 1.15 to 1.99; p = 0.003), and when low-quality (odds ratio, 1.46; 95% confidence intervals, 1.05 to 2.03; p = 0.02) and high-quality (odds ratio, 1.65; 95% confidence intervals, 0.99 to 2.75; p = 0.05) studies were analyzed separately.
   Conclusions. Cumulative analysis of the few prospective randomized studies currently available in the literature documents a reduction in postoperative patency of coronary artery bypass grafts performed during OPCAB procedures. The risk of reduced graft patency needs to be considered when choosing OPCAB as tailored strategy for selected patients.
C1 Univ Milan, IRCCS, Ctr Cardiol Monzino, Dept Cardiac Surg, I-20138 Milan, Italy.
   Univ Milan, IRCCS, Ctr Cardiol Monzino, Biostat Unit, I-20138 Milan, Italy.
RP Parolari, A (reprint author), Univ Milan, IRCCS, Ctr Cardiol Monzino, Dept Cardiac Surg, Via Parea 4, I-20138 Milan, Italy.
EM aparolari@cardiologicomonzino.it
RI tremoli, elena/C-1035-2011
CR Amano A, 2001, Jpn J Thorac Cardiovasc Surg, V49, P67, DOI 10.1007/BF02913127
   Balacumaraswami L, 2004, J THORAC CARDIOV SUR, V128, P238, DOI 10.1016/j.jtcvs.2003.11.072
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Farsak B, 2002, HEART SURG FORUM, V5, P358
   Hirose H, 2000, Ann Thorac Cardiovasc Surg, V6, P110
   Ishida Michiko, 2004, Jpn J Thorac Cardiovasc Surg, V52, P240
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kim KB, 2001, ANN THORAC SURG, V72, P1033
   Kurlansky PA, 2003, J THORAC CARDIOV SUR, V126, P7, DOI 10.1016/S0022-5223(02)73472-7
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Lund O, 2001, EUR J CARDIO-THORAC, V20, P901, DOI 10.1016/S1010-7940(01)00972-1
   Lytle BW, 2004, CIRCULATION, V109, P810, DOI 10.1161/01.CIR.0000118642.28474.D2
   Motwani JG, 1998, CIRCULATION, V97, P916
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Ochi Masami, 2003, Journal of Nippon Medical School, V70, P157
   Omeroglu SN, 2000, ANN THORAC SURG, V70, P844, DOI 10.1016/S0003-4975(00)01567-8
   Parolari A, 2005, J THORAC CARDIOV SUR, V130, P303, DOI 10.1016/j.jtcvs.2004.11.002
   Parolari A, 2003, J THORAC CARDIOV SUR, V125, P336, DOI 10.1067/mtc.2003.2
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Puskas J D, 1999, Heart Surg Forum, V2, P216
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Racz MJ, 2004, J AM COLL CARDIOL, V43, P557, DOI 10.1016/j.jacc.2003.09.045
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Tagusari O, 2004, ANN THORAC SURG, V78, P1304, DOI 10.1016/j.athoracsur.2004.03.094
   Takahashi K, 2000, Jpn J Thorac Cardiovasc Surg, V48, P789
   van der Heijden GJMG, 2004, EUR J CARDIO-THORAC, V26, P81, DOI 10.1016/j.ejcts.2004.03.032
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
NR 31
TC 74
Z9 77
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD DEC
PY 2005
VL 80
IS 6
BP 2121
EP 2125
DI 10.1016/j.athoracsur.2005.05.007
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 993BD
UT WOS:000233926800023
PM 16305856
ER

PT J
AU Touma, NJ
   Izawa, JI
   Chin, JL
AF Touma, NJ
   Izawa, JI
   Chin, JL
TI Current status of local salvage therapies following radiation failure
   for prostate cancer
SO JOURNAL OF UROLOGY
LA English
DT Review
DE prostate; prostatic neoplasms; prostatectomy; salvage therapy; treatment
   failure
ID EXTERNAL-BEAM RADIOTHERAPY; RADICAL RETROPUBIC PROSTATECTOMY;
   ARGON-BASED SYSTEM; QUALITY-OF-LIFE; CRYOSURGICAL ABLATION; CONFORMAL
   RADIOTHERAPY; ANDROGEN DEPRIVATION; COMPLICATION RATES; GLANDULAR
   ABLATION; DOSE-ESCALATION
AB Purpose: We reviewed the curative options available to patients with local failure after radical radiotherapy for prostate cancer and identified the patients best suited for such salvage therapies.
   Materials and Methods: A literature search of English language publications was done using. C, the key terms salvage, prostatectomy, cryosurgery, brachytherapy and radiation failure.
   Results: Salvage radical prostatectomy offers 5-year biochemical relapse-free rates between 55 and 69%. Higher complication rates are reported with salvage compared to primary radical prostatectomy, including rectal injuries, bladder neck contracture and urinary, incontinence. Cryosurgery biochemical response rates vary according to the definition of failure but, they are generally lower than those of salvage radical prostatectomy. The local control rates of cryosurgery are acceptable. Major complications related to cryotherapy are urinary incontinence, impotence, pelvic pain and urinary retention. Experience with salvage brachytherapy has been limited but some success has been reported in terms of biochemical control.
   Conclusions: Salvage prostatectomy for localized radiation failure is a good option in the patient with a life expectancy of at least 10 years, preradiation and preoperative prostate specific antigen less than 10 ng/ml, and localized preoperative stage with the understanding that complication risks are higher. Salvage cryotherapy is a valid option in patients with preoperative prostate specific antigen less than 10 ng/ml and Gleason score less than 8, clinical stage less than T3 who are hormonally naive. Salvage cryotherapy is especially suited for older patients with some comorbidities who are still considered to be at reasonable anesthetic risk. The study of brachytherapy remains in its infancy and the efficacy of this modality remains to be determined.
C1 Univ Western Ontario, Div Urol, London, ON N6A 3K7, Canada.
   Univ Western Ontario, Dept Oncol, London, ON N6A 3K7, Canada.
RP Izawa, JI (reprint author), Suite 3250,800 Commissioners Rd E, London, ON N6A 4G5, Canada.
EM jchin@lhsc.on.ca
CR AHLERING TE, 1992, J UROLOGY, V147, P900
   Amling CL, 1999, J UROLOGY, V161, P857, DOI 10.1016/S0022-5347(01)61790-7
   Anastasiadis AG, 2003, J CANCER RES CLIN, V129, P676, DOI 10.1007/s00432-003-0472-4
   BALES GT, 1995, UROLOGY, V46, P676, DOI 10.1016/S0090-4295(99)80300-8
   Beyer DC, 1999, UROLOGY, V54, P880, DOI 10.1016/S0090-4295(99)00241-1
   Bochner BH, 1998, J UROLOGY, V160, P29, DOI 10.1016/S0022-5347(01)63018-0
   Borghede G, 1997, BRIT J UROL, V80, P247, DOI 10.1046/j.1464-410X.1997.00260.x
   BORLAND RN, 1992, J UROLOGY, V147, P905
   CARSON CC, 1980, J UROLOGY, V124, P237
   Catalona WJ, 1999, J UROLOGY, V162, P433, DOI 10.1016/S0022-5347(05)68578-3
   Catton Charles, 2002, Can J Urol, V9, P1444
   Cespedes RD, 1997, J UROLOGY, V157, P237, DOI 10.1016/S0022-5347(01)65335-7
   Cheng L, 1998, CANCER, V83, P2164, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2164::AID-CNCR15>3.0.CO;2-I
   Chin JL, 2001, J UROLOGY, V165, P1937, DOI 10.1016/S0022-5347(05)66246-5
   Chin JL, 1998, J UROLOGY, V159, P910, DOI 10.1016/S0022-5347(01)63769-8
   Chin JL, 2003, J UROLOGY, V170, P1199, DOI 10.1097/01.ju.0000085620.28141.40
   Chin J L, 1996, Tech Urol, V2, P187
   Coen JJ, 2002, J CLIN ONCOL, V20, P3199, DOI 10.1200/JCO.2002.01.086
   COOGAN CL, 1995, J UROLOGY, V154, P1813, DOI 10.1016/S0022-5347(01)66791-0
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   de la Taille A, 2000, UROLOGY, V55, P79, DOI 10.1016/S0090-4295(99)00390-8
   De la Taille A, 2000, BJU INT, V85, P281, DOI 10.1046/j.1464-410x.2000.00456.x
   FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E
   FukunagaJohnson N, 1997, INT J RADIAT ONCOL, V38, P311, DOI 10.1016/S0360-3016(97)82499-6
   Garzotto M, 1998, J UROLOGY, V159, P950, DOI 10.1016/S0022-5347(01)63778-9
   GEARY ES, 1995, UROLOGY, V45, P1000
   Ghafar MA, 2001, J UROLOGY, V166, P1333, DOI 10.1016/S0022-5347(05)65763-1
   Gheiler EL, 1998, UROLOGY, V51, P789, DOI 10.1016/S0090-4295(98)00096-X
   Grado GL, 1999, UROLOGY, V53, P2, DOI 10.1016/S0090-4295(98)00492-0
   Greene GF, 1998, J UROLOGY, V160, P86, DOI 10.1016/S0022-5347(01)63040-4
   Han KR, 2003, J UROLOGY, V170, P1126, DOI 10.1097/01.ju.0000087860.52991.a8
   Izawa JI, 2002, J CLIN ONCOL, V20, P2664, DOI 10.1200/JCO.2002.06.086
   Izawa JI, 2003, INT J RADIAT ONCOL, V56, P468, DOI 10.1016/S0360-3016(02)04574-1
   Izawa JI, 2001, J UROLOGY, V165, P867, DOI 10.1016/S0022-5347(05)66546-9
   KABALIN JN, 1989, J UROLOGY, V142, P326
   Kupelian PA, 2002, INT J RADIAT ONCOL, V53, P904, DOI 10.1016/S0360-3016(02)02836-5
   Lee F, 1999, UROLOGY, V54, P135, DOI 10.1016/S0090-4295(99)00039-4
   Lee WR, 1997, J CLIN ONCOL, V15, P230
   LERNER SE, 1995, J UROLOGY, V154, P1103, DOI 10.1016/S0022-5347(01)66988-X
   LINK P, 1991, UROLOGY, V37, P189, DOI 10.1016/0090-4295(91)80282-C
   Long JP, 1998, J UROLOGY, V159, P477, DOI 10.1016/S0022-5347(01)63953-3
   MADOR DR, 1985, J UROLOGY, V133, P58
   Miller RJ, 1996, CANCER, V77, P1510, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1510::AID-CNCR13>3.0.CO;2-2
   MOUL JW, 1991, CANCER, V68, P1265, DOI 10.1002/1097-0142(19910915)68:6<1265::AID-CNCR2820680615>3.0.CO;2-G
   MURPHY GP, 1994, J UROLOGY, V152, P1817
   NEERHUT GJ, 1988, J UROLOGY, V140, P544
   ONIK G, 1984, CRYOBIOLOGY, V21, P321, DOI 10.1016/0011-2240(84)90327-4
   ONIK GM, 1993, CANCER, V72, P1291, DOI 10.1002/1097-0142(19930815)72:4<1291::AID-CNCR2820720423>3.0.CO;2-I
   Perrotte P, 1999, J UROLOGY, V162, P398, DOI 10.1016/S0022-5347(05)68569-2
   Pinover WH, 2000, INT J RADIAT ONCOL, V47, P649, DOI 10.1016/S0360-3016(00)00465-X
   Pisters LL, 1997, J UROLOGY, V157, P921, DOI 10.1016/S0022-5347(01)65084-5
   Pisters LL, 1999, J CLIN ONCOL, V17, P2514
   Pisters LL, 2000, J UROLOGY, V163, P1771, DOI 10.1016/S0022-5347(05)67539-8
   Pollack A, 1998, UROLOGY, V51, P258, DOI 10.1016/S0090-4295(97)00621-3
   Pollack A, 2002, INT J RADIAT ONCOL, V54, P677, DOI 10.1016/S0360-3016(02)02977-2
   PONTES JE, 1993, CANCER, V71, P976, DOI 10.1002/1097-0142(19930201)71:3+<976::AID-CNCR2820711413>3.0.CO;2-M
   RAINWATER LM, 1988, J UROLOGY, V140, P1455
   ROGERS E, 1995, J UROLOGY, V153, P104, DOI 10.1097/00005392-199501000-00037
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Scardino PT, 1988, NATL CANCER I MONOGR, V7, P95
   Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354
   STEIN A, 1992, UROLOGY, V40, P197, DOI 10.1016/0090-4295(92)90473-A
   THOMPSON IM, 1988, CANCER, V61, P1464, DOI 10.1002/1097-0142(19880401)61:7<1464::AID-CNCR2820610732>3.0.CO;2-F
   Vaidya A, 2000, J UROLOGY, V164, P1998, DOI 10.1016/S0022-5347(05)66937-6
   Vallancien G, 2003, J UROLOGY, V170, P1838, DOI 10.1097/01.ju.0000091875.24816.6b
   Zagars GK, 1999, INT J RADIAT ONCOL, V44, P809, DOI 10.1016/S0360-3016(99)00089-9
   Zelefsky MJ, 2002, INT J RADIAT ONCOL, V53, P1111, DOI 10.1016/S0360-3016(02)02857-2
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
   ZIETMAN AL, 1995, INT J RADIAT ONCOL, V32, P287, DOI 10.1016/0360-3016(95)00123-G
   ZINCKE H, 1994, J UROLOGY, V152, P1850
   ZINCKE H, 1992, J UROLOGY, V147, P894
NR 74
TC 74
Z9 79
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD FEB
PY 2005
VL 173
IS 2
BP 373
EP 379
DI 10.1097/01.ju.0000150627.68410.4d
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 889NX
UT WOS:000226450800007
PM 15643174
ER

PT J
AU Stock, RG
   Stone, NN
   Cesaretti, JA
AF Stock, RG
   Stone, NN
   Cesaretti, JA
TI Prostate-specific antigen bounce after prostate seed implantation for
   localized prostate cancer: Descriptions and implications
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; brachytherapy; PSA bounce
ID RADIATION-THERAPY; BRACHYTHERAPY; RECOMMENDATIONS; DOSIMETRY
AB Purpose: To calculate the actuarial risk of developing a prostate-specific antigen (PSA) bounce after prostate brachytherapy alone, using three definitions of bounce mentioned in the literature, and to explore the relationship between disease and treatment variables and the risk of developing a bounce. The impact of PSA bounce on PSA failure was also explored.
   Methods and Materials: A total of 373 patients with T1-T2 prostate cancer underwent radioactive seed implant Using I-125 (n = 337) or Pd-103 (n = 36) without hormonal therapy or external beam RT. All patients had a minimum of I year (median 4, maximum 11) of follow-up and at least three follow-up PSA values. PSA bounce was defined by a rise of one or two PSA values with a subsequent fall. Three definitions of bounce were used: definition 1, rise greater than or equal to0.1 ng/mL; definition 2, rise greater than or equal to0.4 ng/mL; and definition 3, rise >35% of previous value.
   Results: The actuarial likelihood of experiencing a PSA bounce at 5 years was 31% for definition 1, 17% for definition 2, and 20% for definition 3. The median time to develop a bounce was 19.5 months for definitions 1 and 2 and 20.5 months for definition 3. Gleason score, initial PSA level, and clinical stage did not predict for bounce using any definition. Using definition 1, younger patients (565 years) had a bounce rate at 5 years of 38% vs. 24% for older patients (p = 0.009). I-125 patients receiving an implant dose of less than or equal to160 Gy had a bounce rate (definition 1) at 5 years of 24% vs. 38% for those receiving a dose delivered to 90% of the gland on the 1 month postimplant dose-volume histogram (D-90) >160 Gy (p = 0.04). Using definition 2, prostate volume significantly affected the incidence of bounce. Patients with larger glands (>35 cm(3)) were more likely to experience a bounce (23% at 5 years) than those with smaller glands (less than or equal to35 cm(3)) who had a bounce rate of 11% at 5 years (P = 0.01). In a multivariate analysis of factors predicting for PSA failure, PSA bounce was not found to be significant.
   Conclusion: PSA bounce is a common phenomenon after prostate brachytherapy and occurs at a rate of 17-31 %, depending on the definition used. It is more common in younger patients, those receiving higher implant doses, and those with larger glands. PSA bounce does not predict for future PSA failure. (C) 2003 Elsevier Inc.
C1 CUNY Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY 10029 USA.
   CUNY Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA.
RP Stock, RG (reprint author), CUNY Mt Sinai Sch Med, Dept Radiat Oncol, 1184 5th Ave, New York, NY 10029 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Beyer D, 2000, INT J RADIAT ONCOL, V47, P273, DOI 10.1016/S0360-3016(00)00555-1
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   IANNUZZI C, 1999, RADIAT ONCOL INVEST, V70, P30
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   NORUSIS MJ, 2000, SPSS 10 0 GUIDE DATA, P1
   Prestigiacomo AF, 1996, J UROLOGY, V155, P1977, DOI 10.1016/S0022-5347(01)66067-1
   Pruthi RS, 2000, J UROLOGY, V164, P2031, DOI 10.1016/S0022-5347(05)66958-3
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 2001, J UROLOGY, V165, P436, DOI 10.1097/00005392-200102000-00020
   Stock RG, 2000, INT J RADIAT ONCOL, V48, P899, DOI 10.1016/S0360-3016(00)00707-0
   STONE NN, 1995, RADIAT ONCOL INVEST, V3, P185, DOI 10.1002/roi.2970030407
   SYNDER KM, 2001, INT J RADIAT ONCOL, V50, P335
NR 17
TC 74
Z9 74
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUN 1
PY 2003
VL 56
IS 2
BP 448
EP 453
DI 10.1016/S0360-3016(02)04470-X
PG 6
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 678HP
UT WOS:000182861500017
PM 12738319
ER

PT J
AU Hanlon, AL
   Diratzouian, H
   Hanks, GE
AF Hanlon, AL
   Diratzouian, H
   Hanks, GE
TI Posttreatment prostate-specific antigen nadir highly predictive of
   distant failure and death from prostate cancer
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; PSA nadir; conformal radiotherapy; distant metastasis;
   cause-specific survival
ID RADIATION-THERAPY; DOUBLING TIMES; RADIOTHERAPY; CARCINOMA
AB Purpose: To link posttreatment biochemical profiles to distant failure and cause-specific survival by assessing the relationship between posttreatment prostate-specific antigen (PSA) nadir and PSA doubling time (PSADT) with these outcome measures.
   Methods and Materials: A total of 615 men were treated at the Fox Chase Cancer Center between April 1989 and December 1995 with three-dimensional conformal radiotherapy alone (median dose 73 Gy). The median follow-up was 64 months (range 2-135). Kaplan-Meier methods were used to estimate the rates of biochemical control, freedom from distant metastasis (FDM), and cause-specific survival. Multivariate predictors of outcome were assessed using stepwise Cox regression analysis.
   Results: Multivariate analyses demonstrated that the predictors of improved biochemical control were a lower PSA nadir (p < 0.0001), lower pretreatment PSA level (p < 0.0001), Gleason score of 2-6 (p = 0.001), Stage T1-T2a tumors (p = 0.03), and higher RT dose (p = 0.02). The predictors of improved FDM were a lower PSA nadir (p < 0.0001), longer interval to nadir from start of treatment (p = 0.0002), Gleason score of 2-6 (p = 0.005), androgen deprivation for biochemical failure (p = 0.001), and Stage T1-T2a tumors (p = 0.01). The predictors of improved cause-specific survival were a lower PSA nadir (p = 0.006) and longer interval to nadir from the start of treatment (p = 0.03). The 8-year FDM rate was 96%, 89%, and 61% for PSA nadir values of less than or equal to 1.0, 1.1-2.0, and > 2.0 ng/mL (p < 0.0001), respectively. The 8-year cause-specific survival rate was 97%, 96%, and 78% for posttreatment PSA nadir values of less than or equal to 1.0, 1.1-2.0, and > 2.0 ng/mL (p < 0.0001), respectively. For patients with sufficient PSA follow-up for PSADT calculations (n = 136), multivariate analysis of FDM from the time of biochemical failure demonstrated that androgen deprivation (p = 0.001), longer PSADT (p = 0.003), lower PSA nadir (p = 0.02), and longer interval to nadir from start of treatment (p = 0.04) were independent predictors of improved FDM.
   Conclusion: This is the first study, to our knowledge, to demonstrate the overwhelming predictive power of posttreatment PSA nadir for distant failure and death from prostate cancer. It is also the first study, to our knowledge, to demonstrate a strong association between posttreatment PSADT and distant failure. The results provide new information regarding disease progression as a function of posttreatment PSA profiles (time to achieve nadir from start of treatment, nadir, and PSADT) and the timing of androgen deprivation for biochemical relapse. This study may be used for the early identification of patients at high risk of distant metastasis and who may be directed to applicable systemic treatment clinical trials. (C) 2002 Elsevier Science Inc.
C1 Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA.
   Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA.
RP Hanlon, AL (reprint author), Fox Chase Canc Ctr, Dept Biostat, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I
   DAMICO AV, 1993, CANCER, V72, P2638, DOI 10.1002/1097-0142(19931101)72:9<2638::AID-CNCR2820720919>3.0.CO;2-N
   Davis JW, 1999, J UROLOGY, V162, P758, DOI 10.1097/00005392-199909010-00036
   Flemming ID, 1997, AJCC CANC STAGING MA, P219
   Greene GF, 1998, J UROLOGY, V160, P86, DOI 10.1016/S0022-5347(01)63040-4
   HANKS GE, 1993, INT J RADIAT ONCOL, V27, P125
   Hanks GE, 1996, INT J RADIAT ONCOL, V34, P549, DOI 10.1016/0360-3016(95)02154-X
   International Commission on Radiation Units and Measurements, 1993, 50 ICRU
   Iyer RV, 1999, CANCER, V85, P1816, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1816::AID-CNCR23>3.0.CO;2-U
   Kalbfleisch J, 1980, STAT ANAL FAILURE TI
   Kaplan EL, 1958, J AM STAT ASSOC, V53, P447
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   Pinover W. H., 2000, International Journal of Radiation Oncology Biology Physics, V48, P206, DOI 10.1016/S0360-3016(00)80206-0
   Pinover WH, 2000, INT J RADIAT ONCOL, V47, P649, DOI 10.1016/S0360-3016(00)00465-X
   STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501
NR 17
TC 74
Z9 76
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUN 1
PY 2002
VL 53
IS 2
BP 297
EP 303
DI 10.1016/S0360-3016(02)02717-7
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 557TC
UT WOS:000175923400006
PM 12023133
ER

PT J
AU Nilsson, S
   Norlen, BJ
   Widmark, A
AF Nilsson, S
   Norlen, BJ
   Widmark, A
TI A systematic overview of radiation therapy effects in prostate cancer
SO ACTA ONCOLOGICA
LA English
DT Review
ID EXTERNAL-BEAM RADIOTHERAPY; QUALITY-OF-LIFE; DOSE-RATE BRACHYTHERAPY;
   3-DIMENSIONAL CONFORMAL RADIOTHERAPY; RADIOACTIVE SEED IMPLANTATION;
   DISEASE-FREE SURVIVAL; FAILURE-FREE SURVIVAL; LONG-TERM SURVIVAL;
   NEOADJUVANT HORMONAL-THERAPY; LOCALLY ADVANCED-CARCINOMA
AB A systematic review of radiation therapy trials in prostate cancer has been performed according to principles adopted by the Swedish Council of Technology Assessment in Health Care (SBU). This synthesis of the literature is based on data from one meta-analysis, 30 randomized trials, many dealing with hormonal therapy, 55 prospective trials, and 210 retrospective studies. Totally the studies included 152 614 patients. There is a lack of properly controlled clinical trials in most important aspects of radiation therapy in prostate cancer. The conclusions reached can be summarized as follows:
   - There are no randomized studies that compare the outcome of surgery (radical prostatectomy) with either external beam radiotherapy or brachytherapy for patients with clinically localized low-risk prostate cancer. However, with the advent of widely accepted prognostic markers for prostate cancer (pre-treatment PSA, Gleason score, and T-stage), such comparisons have been made possible. There is substantial documentation from large single-institutional and multi-institutional series on patients with this disease category (PSA<10, GSless than or equal to6, less than or equal toT2b) showing that the outcome of external beam radiotherapy and brachytherapy is similar to those of surgery.
   - There is fairly strong evidence that patients with localized, intermediate risk, and high risk (pre-treatment PSAgreater than or equal to10 and/or GSgreater than or equal to7 and/or>T2) disease, i.e. patients normally not suited for surgery, benefit from higher than conventional total dose. No overall survival benefit has yet been shown.
   - Dose escalation to patients with intermediate-risk or high-risk disease can be performed with 3D conformal radiotherapy (photon or proton) boost, with Ir-192 high dose rate brachytherapy boost, or brachytherapy boost with permanent seed implantation. Despite an increased risk of urinary tract and/or rectal side effects, dose-escalated therapy can generally be safely delivered with all three techniques. \
   - There is some evidence that 3D conformal radiotherapy results in reduced late rectal toxicity and acute anal toxicity compared with radiotherapy administered with non-conformal treatment volumes.
   - There is some evidence that postoperative external beam radiotherapy after radical prostatectomy in patients with pT3 disease prolongs biochemical disease-free survival and that the likelihood of achieving long-term DFS is higher when treatment is given in an adjuvant rather than a salvage setting. A breakpoint seems to exist around a PSA level of 1.0 ng/mL, above which the likelihood for eradication of the recurrence of cancer diminishes.
   - After prostatectomy, endocrine therapy prior to and during adjuvant radiotherapy may result in longer biochemical disease-free survival than if only adjuvant radiotherapy is given. No impact on overall survival has been shown. There is fairly strong evidence that short-term endocrine therapy prior to and during radiotherapy results in increased disease-free survival, increased local control, reduced incidence of distant metastases, and reduced cause-specific mortality in patients with locally advanced disease.
   - There is some evidence that short-term endocrine therapy prior to and during radiotherapy results in increased overall survival in a subset (GS 2-6) of patients with locally advanced disease.
   - There is strong evidence that adjuvant endocrine treatment after curative radiotherapy results in improved local control, increased freedom from distant metastases, and increased disease-free survival in patients with loco-regionally advanced and/or high-risk disease.
   - There is moderately strong evidence that adjuvant endocrine treatment after radiotherapy results in longer overall survival compared with radiotherapy alone in patients with loco-regionally advanced disease.
C1 Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden.
   Univ Uppsala, Dept Urol, Uppsala, Sweden.
   Umea Univ, Dept Oncol, Umea, Sweden.
RP Nilsson, S (reprint author), Karolinska Hosp, Radiumhemmet, SE-17176 Stockholm, Sweden.
EM sten.nilsson@ks.se
CR ADOLFSSON J, 1993, CANCER, V72, P310, DOI 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T
   ADOLFSSON J, 1994, EUR UROL, V26, P207
   Akakura K, 1999, UROLOGY, V54, P313, DOI 10.1016/S0090-4295(99)00106-5
   Algan O, 1999, RADIAT ONCOL INVESTI, V7, P106, DOI 10.1002/(SICI)1520-6823(1999)7:2<106::AID-ROI6>3.0.CO;2-J
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Anderson PR, 1998, INT J RADIAT ONCOL, V41, P1087, DOI 10.1016/S0360-3016(98)00167-9
   Anderson PR, 2000, CANCER, V89, P2565, DOI 10.1002/1097-0142(20001215)89:12<2565::AID-CNCR8>3.0.CO;2-I
   Anderson PR, 1997, INT J RADIAT ONCOL, V39, P1025, DOI 10.1016/S0360-3016(97)00388-X
   Anscher MS, 2000, INT J RADIAT ONCOL, V48, P369, DOI 10.1016/S0360-3016(00)00645-3
   ANSCHER MS, 1995, INT J RADIAT ONCOL, V33, P37, DOI 10.1016/0360-3016(95)00038-Z
   Arcangeli G, 1998, AM J CLIN ONCOL-CANC, V21, P1, DOI 10.1097/00000421-199802000-00001
   Aref I, 1998, RADIOTHER ONCOL, V48, P203, DOI 10.1016/S0167-8140(98)00061-9
   Armstrong J, 1998, IRISH J MED SCI, V167, P138, DOI 10.1007/BF02937924
   Asbell SO, 1998, INT J RADIAT ONCOL, V40, P769, DOI 10.1016/S0360-3016(97)00926-7
   AYGUN C, 1995, MARYLAND MED J, V44, P363
   Bacon CG, 2001, J UROLOGY, V166, P1804, DOI 10.1016/S0022-5347(05)65679-0
   Barry MJ, 2001, CANCER, V91, P2302, DOI 10.1002/1097-0142(20010615)91:12<2302::AID-CNCR1262>3.0.CO;2-P
   Battermann JJ, 2000, RADIOTHER ONCOL, V57, P269, DOI 10.1016/S0167-8140(00)00287-5
   Beard CJ, 1997, J CLIN ONCOL, V15, P223
   Beard CJ, 1998, INT J RADIAT ONCOL, V41, P257, DOI 10.1016/S0360-3016(98)00054-6
   Bergstrom P, 1998, INT J RADIAT ONCOL, V42, P305, DOI 10.1016/S0360-3016(98)00229-6
   Bey P, 2000, INT J RADIAT ONCOL, V48, P513, DOI 10.1016/S0360-3016(00)00691-X
   Beyer DC, 2000, RADIOTHER ONCOL, V57, P263, DOI 10.1016/S0167-8140(00)00286-3
   Blank LECM, 2000, RADIOTHER ONCOL, V57, P307, DOI 10.1016/S0167-8140(00)00231-0
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   Blasko JC, 2000, RADIOTHER ONCOL, V57, P273, DOI 10.1016/S0167-8140(00)00288-7
   Boersma LJ, 1998, INT J RADIAT ONCOL, V41, P83, DOI 10.1016/S0360-3016(98)00037-6
   Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Borghede G, 1997, RADIOTHER ONCOL, V43, P139, DOI 10.1016/S0167-8140(96)01871-3
   Borghede G, 1997, RADIOTHER ONCOL, V44, P245, DOI 10.1016/S0167-8140(97)00122-9
   Borghede G, 1997, RADIOTHER ONCOL, V44, P237, DOI 10.1016/S0167-8140(97)00121-7
   Brachman DG, 2000, INT J RADIAT ONCOL, V48, P111, DOI 10.1016/S0360-3016(00)00598-8
   Brandeis JM, 2000, J UROLOGY, V163, P851, DOI 10.1016/S0022-5347(05)67818-4
   Brundage M, 2002, RADIOTHER ONCOL, V64, P239, DOI 10.1016/S0167-8140(02)00184-6
   Buskirk SJ, 2001, MAYO CLIN PROC, V76, P702
   Buskirk SJ, 1996, MAYO CLIN PROC, V71, P242
   Butler EB, 1997, SEMIN SURG ONCOL, V13, P406, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<406::AID-SSU4>3.0.CO;2-E
   Cadeddu JA, 1998, J UROLOGY, V159, P173, DOI 10.1016/S0022-5347(01)64047-3
   Catton C, 2001, RADIOTHER ONCOL, V59, P51, DOI 10.1016/S0167-8140(01)00302-4
   Catton Charles, 2002, Can J Urol, V9, P1444
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Cellini N, 2002, INT J RADIAT ONCOL, V53, P595, DOI 10.1016/S0360-3016(02)02795-5
   Chawla AK, 2002, UROLOGY, V59, P726, DOI 10.1016/S0090-4295(02)01540-6
   Chen CT, 2001, INT J RADIAT ONCOL, V50, P591, DOI 10.1016/S0360-3016(01)01504-8
   Cheng L, 1999, CANCER, V85, P1293, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1293::AID-CNCR11>3.0.CO;2-O
   CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403
   Choo R, 2002, INT J RADIAT ONCOL, V52, P674, DOI 10.1016/S0360-3016(01)02677-3
   Choo R, 2002, INT J RADIAT ONCOL, V53, P269, DOI 10.1016/S0360-3016(02)02730-X
   Chou RH, 2000, INT J RADIAT ONCOL, V47, P115, DOI 10.1016/S0360-3016(00)00422-3
   Chuba PJ, 2001, INT J RADIAT ONCOL, V50, P325, DOI 10.1016/S0360-3016(01)01478-X
   Coen JJ, 2002, J CLIN ONCOL, V20, P3199, DOI 10.1200/JCO.2002.01.086
   Corn BW, 1999, UROLOGY, V54, P495, DOI 10.1016/S0090-4295(99)00186-7
   Crane CH, 1997, INT J RADIAT ONCOL, V39, P681, DOI 10.1016/S0360-3016(97)00361-1
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   Crook J, 1996, UROLOGY, V47, P387, DOI 10.1016/S0090-4295(99)80458-0
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   Crook J, 2001, CAN MED ASSOC J, V164, P975
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   Curran MJ, 2000, J ENDOUROL, V14, P351, DOI 10.1089/end.2000.14.351
   DAmico AV, 1997, INT J RADIAT ONCOL, V39, P335, DOI 10.1016/S0360-3016(97)00320-9
   D'Amico AV, 2000, JAMA-J AM MED ASSOC, V284, P1280, DOI 10.1001/jama.284.10.1280
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   DAmico AV, 1997, INT J RADIAT ONCOL, V37, P1053, DOI 10.1016/S0360-3016(96)00633-5
   Das P, 2002, INT J RADIAT ONCOL, V54, P698, DOI 10.1016/S0360-3016(02)03036-5
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0
   Deger S, 2002, EUR UROL, V41, P420, DOI 10.1016/S0302-2838(02)00016-7
   Demanes DJ, 2000, RADIOTHER ONCOL, V57, P289, DOI 10.1016/S0167-8140(00)00291-7
   DeWeese TL, 2000, UROLOGY, V55, P169, DOI 10.1016/S0090-4295(99)00419-7
   Dinges S, 1998, RADIOTHER ONCOL, V48, P197, DOI 10.1016/S0167-8140(98)00054-1
   Do LV, 2002, AM J CLIN ONCOL-CANC, V25, P1, DOI 10.1097/00000421-200202000-00001
   DONNELLY BJ, 1991, UROL CLIN N AM, V18, P481
   Duchesne G M, 2001, Lancet Oncol, V2, P73, DOI 10.1016/S1470-2045(00)00223-0
   Eastham JA, 1997, J CLIN ONCOL, V15, P3214
   Edgren M, 2001, ANTICANCER RES, V21, P2231
   Egawa S, 2001, JPN J CLIN ONCOL, V31, P541, DOI 10.1093/jjco/hye115
   Egawa S, 1999, UROLOGY, V53, P148, DOI 10.1016/S0090-4295(98)00442-7
   Egawa S, 1999, BJU INT, V84, P815
   Ennis RD, 1998, UROLOGY, V51, P265, DOI 10.1016/S0090-4295(97)00503-7
   Eulau SM, 1998, INT J RADIAT ONCOL, V41, P735, DOI 10.1016/S0360-3016(98)00127-8
   Fiveash JB, 2000, INT J RADIAT ONCOL, V47, P335, DOI 10.1016/S0360-3016(00)00441-7
   Forman JD, 1996, INT J RADIAT ONCOL, V34, P655, DOI 10.1016/0360-3016(95)02202-3
   Forman JD, 1997, J UROLOGY, V158, P1439
   Forman JD, 1997, J UROLOGY, V158, P1436, DOI 10.1016/S0022-5347(01)64235-6
   Formenti SC, 2000, UROLOGY, V56, P453, DOI 10.1016/S0090-4295(00)00677-4
   Fowler FJ, 1996, J CLIN ONCOL, V14, P2258
   Franklin C I, 1998, Australas Radiol, V42, P58, DOI 10.1111/j.1440-1673.1998.tb00566.x
   Fransson P, 2002, RADIOTHER ONCOL, V63, P239, DOI 10.1016/S0167-8140(02)00107-X
   Fransson P, 1996, CANCER, V78, P1066, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1066::AID-CNCR17>3.0.CO;2-0
   Fransson P, 1999, CANCER, V85, P678, DOI 10.1002/(SICI)1097-0142(19990201)85:3<678::AID-CNCR18>3.0.CO;2-E
   Fransson P, 2001, CANCER, V92, P3111, DOI 10.1002/1097-0142(20011215)92:12<3111::AID-CNCR10160>3.0.CO;2-E
   Fritjofsson A, 1988, Scand J Urol Nephrol Suppl, V110, P177
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537
   FukunagaJohnson N, 1997, INT J RADIAT ONCOL, V38, P311, DOI 10.1016/S0360-3016(97)82499-6
   Fulmer BR, 2001, CANCER, V91, P2046, DOI 10.1002/1097-0142(20010601)91:11<2046::AID-CNCR1231>3.0.CO;2-W
   Galalae RM, 2002, INT J RADIAT ONCOL, V52, P81, DOI 10.1016/S0360-3016(01)01758-8
   Gardner BG, 2002, J UROLOGY, V167, P123, DOI 10.1016/S0022-5347(05)65395-5
   Garg MK, 1998, UROLOGY, V51, P998, DOI 10.1016/S0090-4295(98)00023-5
   Gelblum DY, 1999, INT J RADIAT ONCOL, V45, P59, DOI 10.1016/S0360-3016(99)00176-5
   Gelblum DY, 2000, INT J RADIAT ONCOL, V48, P119, DOI 10.1016/S0360-3016(00)00632-5
   Gerard JP, 1999, AUST NZ J SURG, V69, P707, DOI 10.1046/j.1440-1622.1999.01690.x
   Grado GL, 1998, INT J RADIAT ONCOL, V42, P289, DOI 10.1016/S0360-3016(98)00209-0
   Granfors T, 1998, J UROLOGY, V159, P2030, DOI 10.1016/S0022-5347(01)63235-X
   Granfors T, 1997, INT J RADIAT ONCOL, V39, P1031, DOI 10.1016/S0360-3016(97)00559-2
   Gray CL, 2001, J UROLOGY, V166, P116, DOI 10.1016/S0022-5347(05)66088-0
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   GUERRIERO WG, 1980, CANCER, V45, P1922
   HAAB F, 1995, UROLOGY, V45, P1022, DOI 10.1016/S0090-4295(99)80124-1
   Hamilton AS, 2001, J CLIN ONCOL, V19, P2517
   Hanks GE, 1996, INT J RADIAT ONCOL, V35, P861, DOI 10.1016/0360-3016(96)00207-6
   Hanks GE, 1998, INT J RADIAT ONCOL, V40, P765, DOI 10.1016/S0360-3016(97)00921-8
   Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3
   Hanks GE, 1999, CANCER J SCI AM, V5, P152
   Hanks GE, 2000, INT J RADIAT ONCOL, V46, P823, DOI 10.1016/S0360-3016(99)00498-8
   Hanks GE, 2002, INT J RADIAT ONCOL, V54, P427, DOI 10.1016/S0360-3016(02)02954-1
   Hanks GE, 1997, INT J RADIAT ONCOL, V37, P543, DOI 10.1016/S0360-3016(96)00602-5
   Hanks GE, 2000, ANN MED, V32, P57, DOI 10.3109/07853890008995911
   Hanlon AL, 2001, INT J RADIAT ONCOL, V49, P51, DOI 10.1016/S0360-3016(00)01365-1
   Hanlon AL, 2000, CANCER J, V6, pS193
   Hanlon AL, 2002, INT J RADIAT ONCOL, V53, P297, DOI 10.1016/S0360-3016(02)02717-7
   Hanus MC, 1999, INT J RADIAT ONCOL, V43, P379, DOI 10.1016/S0360-3016(98)00408-8
   HARAF DJ, 1995, INT J RADIAT ONCOL, V33, P3, DOI 10.1016/0360-3016(95)00181-W
   HELGASON AR, 1995, INT J RADIAT ONCOL, V32, P33, DOI 10.1016/0360-3016(95)00542-7
   HENRIKSSON R, 1992, J CLIN ONCOL, V10, P969
   Herold D, 1997, Radiat Oncol Investig, V5, P15, DOI 10.1002/(SICI)1520-6823(1997)5:1<15::AID-ROI3>3.0.CO;2-N
   HOCHSTETLER JA, 1995, PROSTATE, V26, P316, DOI 10.1002/pros.2990260607
   Hodgson DC, 2001, INT J RADIAT ONCOL, V49, P957, DOI 10.1016/S0360-3016(00)01431-0
   HOLLAND GN, 1980, J COMPUT ASSIST TOMO, V4, P1, DOI 10.1097/00004728-198002000-00001
   Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794
   Horwitz EM, 2001, CANCER, V92, P1281, DOI 10.1002/1097-0142(20010901)92:5<1281::AID-CNCR1449>3.0.CO;2-9
   Horwitz EM, 1996, INT J RADIAT ONCOL, V36, P565, DOI 10.1016/S0360-3016(96)00360-4
   Horwitz EM, 2001, INT J RADIAT ONCOL, V49, P947, DOI 10.1016/S0360-3016(00)01443-7
   Huguenin PU, 1999, STRAHLENTHER ONKOL, V175, P554, DOI 10.1007/s000660050040
   Incrocci L, 2002, INT J RADIAT ONCOL, V52, P681, DOI 10.1016/S0360-3016(01)02727-4
   Incrocci L, 2002, UROLOGY, V60, P1, DOI 10.1016/S0090-4295(02)01659-X
   ISAKA S, 1994, JPN J CLIN ONCOL, V24, P218
   Iversen P, 1991, Scand J Urol Nephrol Suppl, V138, P109
   Jackson A, 2001, INT J RADIAT ONCOL, V49, P685, DOI 10.1016/S0360-3016(00)01414-0
   Janda M, 2000, CANCER, V89, P1322, DOI 10.1002/1097-0142(20000915)89:6<1322::AID-CNCR18>3.0.CO;2-D
   Johansson JE, 1997, JAMA-J AM MED ASSOC, V277, P467, DOI 10.1001/jama.277.6.467
   Johansson KA, 2003, ACTA ONCOL, V42, P85, DOI 10.1080/02841860310004922
   Johnstone P A, 1998, Radiat Oncol Investig, V6, P103, DOI 10.1002/(SICI)1520-6823(1998)6:2<103::AID-ROI6>3.0.CO;2-1
   Joly F, 1998, ANN ONCOL, V9, P751, DOI 10.1023/A:1008276632623
   Jones S, 2002, INT J RADIAT ONCOL, V53, P328, DOI 10.1016/S0360-3016(02)02741-4
   Kang SK, 2002, INT J RADIAT ONCOL, V53, P99, DOI 10.1016/S0360-3016(01)02811-5
   Kang SK, 2001, INT J RADIAT ONCOL, V50, P937, DOI 10.1016/S0360-3016(01)01530-9
   KAPLAN ID, 1993, J UROLOGY, V149, P519
   KAPLAN ID, 1992, UROLOGY, V39, P401, DOI 10.1016/0090-4295(92)90233-M
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   Kestin LL, 2000, J CLIN ONCOL, V18, P2869
   Kestin LL, 2002, INT J RADIAT ONCOL, V54, P107, DOI 10.1016/S0360-3016(02)02925-5
   Keyser D, 1997, INT J RADIAT ONCOL, V38, P723, DOI 10.1016/S0360-3016(97)00123-5
   KHAN K, 1992, INT J RADIAT ONCOL, V22, P935
   King CR, 2000, INT J RADIAT ONCOL, V47, P1165, DOI 10.1016/S0360-3016(00)00543-5
   KLEIN FA, 1988, SOUTHERN MED J, V81, P27, DOI 10.1097/00007611-198801000-00006
   Kneebone A, 2001, INT J RADIAT ONCOL, V51, P628, DOI 10.1016/S0360-3016(01)01660-1
   Koper PCM, 1999, INT J RADIAT ONCOL, V43, P727, DOI 10.1016/S0360-3016(98)00406-4
   Koppie TM, 2001, J UROLOGY, V166, P111, DOI 10.1016/S0022-5347(05)66087-9
   Koutrouvelis P, 2000, J ENDOUROL, V14, P357, DOI 10.1089/end.2000.14.357
   Koutrouvelis P, 2001, RADIOTHER ONCOL, V60, P31, DOI 10.1016/S0167-8140(01)00372-3
   Kovacs G, 1999, STRAHLENTHER ONKOL, V175, P87
   Kramer NM, 2002, INT J RADIAT ONCOL, V53, P277, DOI 10.1016/S0360-3016(02)02706-2
   Krupski T, 2000, UROLOGY, V55, P736, DOI 10.1016/S0090-4295(99)00597-X
   KUBAN DA, 1995, INT J RADIAT ONCOL, V32, P307, DOI 10.1016/0360-3016(95)00137-N
   Kupelian PA, 2002, INT J RADIAT ONCOL, V53, P904, DOI 10.1016/S0360-3016(02)02836-5
   Kupelian PA, 2000, INT J RADIAT ONCOL, V46, P567, DOI 10.1016/S0360-3016(99)00455-1
   Kupelian PA, 2002, J CLIN ONCOL, V20, P3376, DOI 10.1200/JCO.2002.01.150
   Kupelian PA, 2001, INT J RADIAT ONCOL, V51, P988, DOI 10.1016/S0360-3016(01)01730-8
   Kupelian PA, 2002, INT J RADIAT ONCOL, V52, P704, DOI 10.1016/S0360-3016(01)02778-X
   Kupelian PA, 2001, INT J RADIAT ONCOL, V50, P621, DOI 10.1016/S0360-3016(01)01466-3
   KWON ED, 1991, J UROLOGY, V145, P524
   Langley SEM, 2002, BJU INT, V89, P241, DOI 10.1046/j.1464-4096.2001.01610.x
   LARAMORE GE, 1993, AM J CLIN ONCOL-CANC, V16, P164, DOI 10.1097/00000421-199304000-00018
   Larson G, 2000, J Okla State Med Assoc, V93, P391
   Laverdiere J, 1997, INT J RADIAT ONCOL, V37, P247, DOI 10.1016/S0360-3016(96)00513-5
   Lawton CA, 2001, INT J RADIAT ONCOL, V49, P937, DOI 10.1016/S0360-3016(00)01516-9
   Lawton CA, 1997, INT J RADIAT ONCOL, V38, P931, DOI 10.1016/S0360-3016(97)00288-5
   Lederman GS, 2001, INT J RADIAT ONCOL, V49, P1297, DOI 10.1016/S0360-3016(00)01442-5
   Lee LN, 2002, INT J RADIAT ONCOL, V52, P444, DOI 10.1016/S0360-3016(01)02598-6
   Lee LY, 2000, ADSORPT SCI TECHNOL, V18, P147, DOI 10.1260/0263617001493350
   Lee WR, 1997, J CLIN ONCOL, V15, P230
   Lee WR, 2000, INT J RADIAT ONCOL, V46, P77, DOI 10.1016/S0360-3016(99)00355-7
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   Lee WR, 2001, INT J RADIAT ONCOL, V51, P614, DOI 10.1016/S0360-3016(01)01707-2
   Lee WR, 1999, J UROLOGY, V162, P403, DOI 10.1016/S0022-5347(05)68570-9
   Leibovich BC, 2000, J UROLOGY, V163, P1178, DOI 10.1016/S0022-5347(05)67717-8
   LENNERNAS B, 1995, ACTA ONCOL, V34, P959
   Lennernas B, 2002, STRAHLENTHER ONKOL, V178, P537, DOI 10.1007/s00066-002-0920-0
   LENNERNAS B, 1995, ACTA ONCOL, V34, P953
   Leventis AK, 2001, J CLIN ONCOL, V19, P1030
   Levitt SH, 2001, INT J RADIAT ONCOL, V51, P871, DOI 10.1016/S0360-3016(01)01720-5
   Lilleby W, 1999, INT J RADIAT ONCOL, V43, P735, DOI 10.1016/S0360-3016(98)00475-1
   LIM AJ, 1995, J UROLOGY, V154, P1420, DOI 10.1016/S0022-5347(01)66881-2
   LITWIN MS, 1995, CANCER, V75, P2000, DOI 10.1002/1097-0142(19950401)75:7+<2000::AID-CNCR2820751641>3.0.CO;2-4
   Litwin MS, 2000, J UROLOGY, V164, P1973, DOI 10.1016/S0022-5347(05)66931-5
   Ljung G, 1997, PROSTATE, V32, P99, DOI 10.1002/(SICI)1097-0045(19970701)32:2<99::AID-PROS4>3.0.CO;2-A
   LJUNG G, 1995, ACTA ONCOL, V34, P945
   Loening SA, 1997, SEMIN SURG ONCOL, V13, P419, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<419::AID-SSU5>3.0.CO;2-D
   Ludgate C M, 2000, Can J Urol, V7, P937
   LuYao GL, 1997, LANCET, V349, P906, DOI 10.1016/S0140-6736(96)09380-4
   Lyons JA, 2000, UROLOGY, V55, P85, DOI 10.1016/S0090-4295(99)00380-5
   Maartense S, 2000, CLIN ONCOL-UK, V12, P222, DOI 10.1007/s001740070040
   Magrini S M, 1998, Cancer Radiother, V2, P351, DOI 10.1016/S1278-3218(98)80346-6
   Magrini SM, 2002, INT J RADIAT ONCOL, V52, P1310, DOI 10.1016/S0360-3016(01)02783-3
   Malone S, 2000, INT J RADIAT ONCOL, V48, P105, DOI 10.1016/S0360-3016(00)00603-9
   Mansfield J T, 1996, Semin Urol Oncol, V14, P174
   Martin T, 2000, STRAHLENTHER ONKOL, V176, P361, DOI 10.1007/PL00002344
   Martinez AA, 2000, CANCER, V88, P425, DOI 10.1002/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z
   Martinez AA, 2000, INT J RADIAT ONCOL, V47, P343, DOI 10.1016/S0360-3016(00)00436-3
   Martinez AA, 2001, INT J RADIAT ONCOL, V49, P61, DOI 10.1016/S0360-3016(00)01463-2
   Martinez AA, 2002, INT J RADIAT ONCOL, V53, P316, DOI 10.1016/S0360-3016(02)02733-5
   Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2
   Mayer R, 2002, UROLOGY, V59, P732, DOI 10.1016/S0090-4295(02)01502-9
   McCammon KA, 1999, UROLOGY, V54, P509, DOI 10.1016/S0090-4295(99)00163-6
   MCCARTHY JF, 1994, J UROLOGY, V151, P1575
   McLean M, 1997, Clin Oncol (R Coll Radiol), V9, P226, DOI 10.1016/S0936-6555(97)80006-4
   Medini E, 1996, CANCER, V78, P1254, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1254::AID-CNCR13>3.0.CO;2-#
   Merrick GS, 2001, INT J RADIAT ONCOL, V51, P41, DOI 10.1016/S0360-3016(01)01594-2
   Merrick GS, 2002, INT J RADIAT ONCOL, V54, P450, DOI 10.1016/S0360-3016(02)02948-6
   Merrick GS, 2001, INT J CANCER, V96, P313, DOI 10.1002/ijc.1028
   Merrick GS, 2001, INT J RADIAT ONCOL, V50, P1253, DOI 10.1016/S0360-3016(01)01539-5
   Merrick GS, 2002, UROLOGY, V60, P98, DOI 10.1016/S0090-4295(02)01640-0
   Michalski JM, 2000, INT J RADIAT ONCOL, V46, P391, DOI 10.1016/S0360-3016(99)00443-5
   Mohideen MN, 1998, AM J CLIN ONCOL-CANC, V21, P6, DOI 10.1097/00000421-199802000-00002
   Morris MM, 1997, INT J RADIAT ONCOL, V38, P731, DOI 10.1016/S0360-3016(97)00080-1
   Nguyen LN, 1998, UROLOGY, V51, P991, DOI 10.1016/S0090-4295(98)00028-4
   Nickers P, 2000, RADIOTHER ONCOL, V55, P41, DOI 10.1016/S0167-8140(00)00142-0
   Nickers P, 2001, STRAHLENTHER ONKOL, V177, P90, DOI 10.1007/PL00002389
   Nudell DM, 1999, UROLOGY, V54, P1049, DOI 10.1016/S0090-4295(99)00299-X
   Nygren P, 2001, ACTA ONCOL, V40, P155
   OBrien PC, 1997, RADIOTHER ONCOL, V45, P117, DOI 10.1016/S0167-8140(97)00146-1
   OHORI M, 1995, J UROLOGY, V154, P1818, DOI 10.1016/S0022-5347(01)66792-2
   O'Sullivan JM, 2000, CLIN ONCOL-UK, V12, P217
   Pan CC, 2002, INT J RADIAT ONCOL, V53, P1139, DOI 10.1016/S0360-3016(02)02818-3
   Parker C, 2001, RADIOTHER ONCOL, V61, P107, DOI 10.1016/S0167-8140(01)00439-X
   Paul R, 1997, WORLD J UROL, V15, P252, DOI 10.1007/BF01367663
   PAULSON DF, 1994, J UROLOGY, V152, P1826
   PAULSON DF, 1982, J UROLOGY, V128, P502
   Perez C A, 2000, Radiology, V215 Suppl, P1449
   Perez C A, 2000, Radiology, V215 Suppl, P1419
   Perez CA, 2000, INT J RADIAT ONCOL, V47, P629, DOI 10.1016/S0360-3016(00)00479-X
   Perez CA, 1996, INT J RADIAT ONCOL, V36, P573, DOI 10.1016/S0360-3016(96)00378-1
   Perez C A, 1995, Mo Med, V92, P696
   Peschel RE, 2000, INT J CANCER, V90, P29
   Peschel RE, 1999, RADIAT ONCOL INVESTI, V7, P278, DOI 10.1002/(SICI)1520-6823(1999)7:5<278::AID-ROI3>3.0.CO;2-3
   Petrovich Z, 2002, BJU INT, V89, P604, DOI 10.1046/j.1464-410X.2002.02698.x
   Petrovich Z, 2002, INT J RADIAT ONCOL, V53, P600, DOI 10.1016/S0360-3016(02)02766-9
   Petrovich Z, 2001, AM J CLIN ONCOL-CANC, V24, P537, DOI 10.1097/00000421-200112000-00002
   PICKLES T, 1991, INT J RADIAT ONCOL, V21, P1005
   Pickles T, 1999, INT J RADIAT ONCOL, V43, P47, DOI 10.1016/S0360-3016(98)00371-X
   PILEPICH MV, 1995, INT J RADIAT ONCOL, V32, P175, DOI 10.1016/0360-3016(95)00536-8
   Pilepich MV, 1997, J CLIN ONCOL, V15, P1013
   PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3
   Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6
   PILEPICH MV, 1987, INT J RADIAT ONCOL, V13, P339
   PILEPICH MV, 1990, AM J CLIN ONCOL-CANC, V13, P461, DOI 10.1097/00000421-199012000-00001
   Pinover WH, 2000, INT J RADIAT ONCOL, V47, P649, DOI 10.1016/S0360-3016(00)00465-X
   PISANSKY TM, 1993, J CLIN ONCOL, V11, P2158
   Pisansky TM, 2000, J UROLOGY, V163, P845, DOI 10.1016/S0022-5347(05)67817-2
   Pollack A, 2000, INT J RADIAT ONCOL, V46, P153, DOI 10.1016/S0360-3016(99)00387-9
   Pollack A, 2000, J CLIN ONCOL, V18, P3904
   Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8
   Pollack A, 1997, INT J RADIAT ONCOL, V39, P1011, DOI 10.1016/S0360-3016(97)00508-7
   Pollack A, 2000, INT J RADIAT ONCOL, V48, P507, DOI 10.1016/S0360-3016(00)00620-9
   Pollack A, 1996, INT J RADIAT ONCOL, V34, P555, DOI 10.1016/0360-3016(95)02103-5
   Potosky AL, 2000, J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582
   Potters L, 2000, J CLIN ONCOL, V18, P1187
   Potters L, 2001, INT J RADIAT ONCOL, V50, P1235, DOI 10.1016/S0360-3016(01)01578-4
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Powell CR, 1997, J UROLOGY, V157, P1754, DOI 10.1016/S0022-5347(01)64854-7
   Puthawala AA, 2001, CANCER, V92, P2084, DOI 10.1002/1097-0142(20011015)92:8<2084::AID-CNCR1549>3.0.CO;2-C
   Ragde H, 2001, Arch Esp Urol, V54, P739
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Ramos CG, 1999, J UROLOGY, V161, P1212, DOI 10.1016/S0022-5347(01)61636-7
   Raymond JF, 1998, INT J RADIAT ONCOL, V41, P93, DOI 10.1016/S0360-3016(98)00033-9
   Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826
   Roach M, 2000, INT J RADIAT ONCOL, V47, P609, DOI 10.1016/S0360-3016(00)00578-2
   Roach M, 1996, J UROLOGY, V156, P1719, DOI 10.1016/S0022-5347(01)65490-9
   Roach M, 1999, J UROLOGY, V161, P864, DOI 10.1016/S0022-5347(01)61793-2
   Roach M, 2000, INT J RADIAT ONCOL, V47, P617, DOI 10.1016/S0360-3016(00)00577-0
   Robinson JW, 1997, CANCER, V79, P538, DOI 10.1002/(SICI)1097-0142(19970201)79:3<538::AID-CNCR16>3.0.CO;2-4
   Robinson JW, 2002, INT J RADIAT ONCOL, V54, P1063, DOI 10.1016/S0360-3016(02)03030-4
   Rogers R, 1998, J UROLOGY, V160, P1748, DOI 10.1016/S0022-5347(01)62398-X
   ROSENBERG SJ, 1985, J UROLOGY, V133, P225
   Rosser CJ, 2002, J UROLOGY, V168, P2001, DOI 10.1097/01.ju.0000034351.97426.fe
   Rosser CJ, 2002, J UROLOGY, V168, P536, DOI 10.1016/S0022-5347(05)64674-5
   Rossi CJ, 1999, STRAHLENTHER ONKOL, V175, P82
   RUSSELL KJ, 1994, INT J RADIAT ONCOL, V28, P47
   Ryu JK, 2002, INT J RADIAT ONCOL, V54, P1036, DOI 10.1016/S0360-3016(02)03006-7
   Sanchez-Ortiz RF, 2000, INT J IMPOT RES, V12, pS18, DOI 10.1038/sj.ijir.3900557
   Sandhu AS, 2000, INT J RADIAT ONCOL, V48, P643, DOI 10.1016/S0360-3016(00)00714-8
   SANDLER HM, 1995, INT J RADIAT ONCOL, V33, P797, DOI 10.1016/0360-3016(95)00219-7
   Sandler HM, 2000, INT J RADIAT ONCOL, V48, P629, DOI 10.1016/S0360-3016(00)00717-3
   SANDS ME, 1995, INT J RADIAT ONCOL, V31, P13, DOI 10.1016/0360-3016(94)00324-E
   Sanguineti G, 2002, BRIT J CANCER, V86, P1843, DOI 10.1038/sj.bjc.6600266
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Schellhammer PF, 2000, UROLOGY, V56, P436, DOI 10.1016/S0090-4295(00)00711-1
   Schild SE, 2001, INT J CANCER, V96, P94, DOI 10.1002/ijc.1012
   Schild SE, 1996, J UROLOGY, V156, P1725, DOI 10.1016/S0022-5347(01)65492-2
   Schultheiss TE, 1997, INT J RADIAT ONCOL, V37, P3, DOI 10.1016/S0360-3016(96)00468-3
   Seaward SA, 1998, INT J RADIAT ONCOL, V42, P1055, DOI 10.1016/S0360-3016(98)00282-X
   Seung SK, 1998, CANCER J SCI AM, V4, P168
   Sharkey J, 2000, J ENDOUROL, V14, P343, DOI 10.1089/end.2000.14.343
   Sherertz T, 2001, INT J RADIAT ONCOL, V51, P1241, DOI 10.1016/S0360-3016(01)01738-2
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5
   ShraderBogen CL, 1997, CANCER, V79, P1977, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1977::AID-CNCR20>3.0.CO;2-R
   Siegel T, 2001, J UROLOGY, V165, P430, DOI 10.1097/00005392-200102000-00019
   Singh A, 2000, INT J CANCER, V90, P275
   Skwarchuk MW, 2000, INT J RADIAT ONCOL, V47, P103, DOI 10.1016/S0360-3016(99)00560-X
   Slater JD, 1998, INT J RADIAT ONCOL, V42, P299, DOI 10.1016/S0360-3016(98)00225-9
   Slater JD, 1999, UROLOGY, V53, P978, DOI 10.1016/S0090-4295(99)00014-X
   Smith DS, 2000, CANCER, V88, P1454, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1454::AID-CNCR25>3.3.CO;2-J
   Smith RC, 1996, J UROLOGY, V156, P454, DOI 10.1016/S0022-5347(01)65877-4
   SMITH RC, 1996, J UROLOGY, V156, P457
   STAMEY TA, 1993, J UROLOGY, V150, P1856
   STEIN A, 1992, UROLOGY, V40, P197, DOI 10.1016/0090-4295(92)90473-A
   Stock RG, 1996, INT J RADIAT ONCOL, V35, P267, DOI 10.1016/0360-3016(95)02050-0
   Stock RG, 2001, J UROLOGY, V165, P436, DOI 10.1097/00005392-200102000-00020
   Stokes SH, 1997, INT J RADIAT ONCOL, V37, P337, DOI 10.1016/S0360-3016(96)00508-1
   Stokes SH, 2000, INT J RADIAT ONCOL, V47, P129, DOI 10.1016/S0360-3016(99)00526-X
   Stone NN, 1999, MOL UROL, V3, P239
   Stone NN, 2000, J ENDOUROL, V14, P375, DOI 10.1089/end.2000.14.375
   Stone NN, 2000, MOL UROL, V4, P163
   Storey MR, 2000, INT J RADIAT ONCOL, V48, P635, DOI 10.1016/S0360-3016(00)00700-8
   Storey MR, 1999, INT J RADIAT ONCOL, V43, P565, DOI 10.1016/S0360-3016(98)00451-9
   Suit H, 2003, ACTA ONCOL, V42, P800, DOI 10.1080/02841860310017676
   Svensson H, 2003, ACTA ONCOL, V42, P430, DOI 10.1080/0284180310011159
   Syed A M, 2001, Cancer Control, V8, P511
   SYED AMN, 1992, CANCER, V69, P2515, DOI 10.1002/1097-0142(19920515)69:10<2515::AID-CNCR2820691022>3.0.CO;2-H
   Sylvester J, 2000, MOL UROL, V4, P169
   Sylvester J, 2000, MOL UROL, V4, P155
   Syndikus I, 1996, J UROLOGY, V155, P1983, DOI 10.1016/S0022-5347(01)66069-5
   Tait DM, 1997, RADIOTHER ONCOL, V42, P121, DOI 10.1016/S0167-8140(96)01870-1
   Talcott JA, 2001, J UROLOGY, V166, P494, DOI 10.1016/S0022-5347(05)65970-8
   Talcott JA, 1998, J CLIN ONCOL, V16, P275
   Teh BS, 2002, CANCER INVEST, V20, P437, DOI 10.1081/CNV-120002143
   Teshima T, 1997, INT J RADIAT ONCOL, V39, P77, DOI 10.1016/S0360-3016(97)00301-5
   Tiguert R, 1999, Semin Urol Oncol, V17, P141
   Turesson I, 2003, ACTA ONCOL, V42, P107, DOI 10.1080/12841860310004968
   Turner SL, 1999, UROLOGY, V54, P124, DOI 10.1016/S0090-4295(99)00032-1
   Valicenti R, 2000, J CLIN ONCOL, V18, P2740
   Valicenti RK, 1998, CANCER, V82, P1909, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1909::AID-CNCR14>3.0.CO;2-X
   Valicenti RK, 1998, INT J RADIAT ONCOL, V42, P501, DOI 10.1016/S0360-3016(98)00270-3
   Valicenti RK, 1999, INT J RADIAT ONCOL, V45, P53, DOI 10.1016/S0360-3016(99)00169-8
   Valicenti R K, 2000, Semin Urol Oncol, V18, P115
   VanCangh PJ, 1998, J UROLOGY, V159, P164, DOI 10.1016/S0022-5347(01)64044-8
   VanderKooy MJ, 1997, UROLOGY, V49, P65, DOI 10.1016/S0090-4295(96)00371-8
   Vicini FA, 2000, CANCER, V88, P2305, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2305::AID-CNCR15>3.0.CO;2-3
   Vicini F A, 2000, Tech Urol, V6, P135
   Vicini FA, 1999, INT J RADIAT ONCOL, V44, P483, DOI 10.1016/S0360-3016(99)00047-4
   Vicini FA, 1999, UROLOGY, V54, P111, DOI 10.1016/S0090-4295(99)00219-8
   Vicini FA, 1999, INT J RADIAT ONCOL, V43, P707, DOI 10.1016/S0360-3016(98)00513-6
   Vicini FA, 1998, INT J RADIAT ONCOL, V40, P1101, DOI 10.1016/S0360-3016(97)00942-5
   Wachter-Gerstner N, 2002, STRAHLENTHER ONKOL, V178, P542, DOI 10.1007/s00066-002-0963-2
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   WATKINSBRUNER D, 1995, INT J RADIAT ONCOL, V33, P901, DOI 10.1016/0360-3016(95)02002-5
   Watson RB, 1996, UROLOGY, V48, P80, DOI 10.1016/S0090-4295(96)00092-1
   WHEELER JA, 1993, CANCER, V71, P3783, DOI 10.1002/1097-0142(19930601)71:11<3783::AID-CNCR2820711149>3.0.CO;2-X
   WHITTINGTON R, 1995, UROLOGY, V46, P213, DOI 10.1016/S0090-4295(99)80196-4
   Widmark A, 1997, ACTA ONCOL, V36, P499
   WIDMARK A, 1994, CANCER, V74, P2520, DOI 10.1002/1097-0142(19941101)74:9<2520::AID-CNCR2820740921>3.0.CO;2-Q
   WIEGEL T, 1995, EUR J CANCER, V1, P5
   Wiegel T, 2002, STRAHLENTHER ONKOL, V178, P422, DOI 10.1007/s0066-002-0917-8
   Wilder RB, 2000, AM J CLIN ONCOL-CANC, V23, P176, DOI 10.1097/00000421-200004000-00014
   Wilson K S, 2000, Can J Urol, V7, P1099
   WU JJ, 1995, INT J RADIAT ONCOL, V32, P317, DOI 10.1016/0360-3016(95)00083-B
   Yarbro C H, 1998, Oncol Nurs Forum, V25, P685
   Yock TI, 2002, INT J RADIAT ONCOL, V54, P420, DOI 10.1016/S0360-3016(02)02957-7
   Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2
   Young C D, 2000, Semin Urol Oncol, V18, P121
   Zagars GK, 1997, CANCER, V80, P764
   Zagars GK, 1997, CANCER, V79, P1370, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X
   ZAGARS GK, 1988, INT J RADIAT ONCOL, V14, P1085
   Zagars GK, 1999, INT J RADIAT ONCOL, V44, P809, DOI 10.1016/S0360-3016(99)00089-9
   Zagars GK, 2001, UROLOGY, V58, P233, DOI 10.1016/S0090-4295(01)01168-2
   Zeitlin SI, 1998, J UROLOGY, V160, P91, DOI 10.1016/S0022-5347(01)63042-8
   Zelefsky MJ, 2002, INT J RADIAT ONCOL, V53, P1111, DOI 10.1016/S0360-3016(02)02857-2
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
   Zelefsky MJ, 1999, J CLIN ONCOL, V17, P517
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   Zelefsky MJ, 1997, J UROLOGY, V158, P29
   Zelefsky MJ, 1999, CANCER, V85, P2460, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2460::AID-CNCR23>3.0.CO;2-N
   Zelefsky MJ, 2000, INT J RADIAT ONCOL, V47, P1261, DOI 10.1016/S0360-3016(00)00550-2
   Zelefsky MJ, 1997, INT J RADIAT ONCOL, V39, P327, DOI 10.1016/S0360-3016(97)00056-4
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
   ZELEFSKY MJ, 1995, J CLIN ONCOL, V13, P459
   Zietman AL, 1997, CANCER J SCI AM, V3, P31
   ZIETMAN AL, 1995, INT J RADIAT ONCOL, V32, P287, DOI 10.1016/0360-3016(95)00123-G
   Zietman AL, 1997, UROLOGY, V49, P74, DOI 10.1016/S0090-4295(97)00173-8
NR 394
TC 73
Z9 73
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0284-186X
J9 ACTA ONCOL
JI Acta Oncol.
PD JUN
PY 2004
VL 43
IS 4
BP 316
EP 381
DI 10.1080/02841860410030661
PG 66
WC Oncology
SC Oncology
GA 826WS
UT WOS:000221860800002
PM 15303499
ER

PT J
AU Merrick, GS
   Butler, WM
   Dorsey, AT
   Lief, JH
   Walbert, HL
   Blatt, HJ
AF Merrick, GS
   Butler, WM
   Dorsey, AT
   Lief, JH
   Walbert, HL
   Blatt, HJ
TI Rectal dosimetric analysis following prostate brachytherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate brachytherapy; rectal dosimetry; tolerance; complication;
   I-125; Pd-103
ID ANTIGEN NADIR; I-125; CARCINOMA; IMPLANTATION; IRRADIATION; FREEDOM;
   CANCER
AB Purpose: To retrospectively assess the rectal tolerance dose in transperineal ultrasound-guided prostate brachytherapy using easily measured point doses.
   Methods and Materials: Forty-five consecutive patients who underwent prostate seed implantation from January 1996 to October 1996, using either I-125 or Pd-103 as monotherapy or as a boost following 45 Gy of external beam radiotherapy (XRT), were evaluated. For monotherapy using I-125, the minimal peripheral dose (mPD) was 160 Gy, utilizing dosimetry parameters which are equivalent to 144 Gy under the American Association of Physicists in Medicine Task Group 43 (AAPM TG43) recommendations. Computed tomography (CT)-based dosimetry was performed within 9 days of the implant, with a urinary catheter in place for identification of the urethra, and a rectal obturator positioned prior to the CT scan for identification of the anterior rectal mucosa. Dosimetric parameters relevant to this study were the average, maximal and minimal anterior rectal mucosal dose, and the surface area and length of the anterior rectal mucosa irradiated to 50%, 75%, 90%, 100%, and 120% of the prescribed dose. Rectal complications were determined by patient reporting during office visits and telephone follow-up. Follow-up ranged from 19 to 28 months (median 23).
   Results: Among the four cohorts, the average anterior rectal mucosal dose as a percent of the prescribed mPD was 82.5% +/- 14.1% (standard deviation, SD), and the average maximum was 120% +/- 35%. The length of the rectum receiving a given dose was found to be correlated with the rectal surface area receiving that dose (r(2) = 0.82 - 0.93 over the dose range 0.5-1.2 mPD). Rectal complications occurred in only four patients, and consisted of mild, self-limited proctitis. Three of the four were in the top quartile of average and maximal rectal dose and length of rectum receiving greater than or equal to 100% of mPD, while the fourth was In the bottom quartile of these parameters. In terms of surface area, all four patients were in the upper half of the study group, with greater than or equal to 90 mm(2) at dose levels greater than or equal to 100% of mPD.
   Conclusion: Our results indicate that in an implant program which maintains the anterior rectal mucosa point dose averages to about 85% of the prescribed dose (regardless of the choice of isotope or the treatment approach), the average maximum to 120% of mPD, and the length of the anterior rectal mucosa receiving 100% and 120% of the prescribed dose at approximately 10 mm and 5 mm, respectively, the incidence of mild self-limited proctitis will be in the range of approximately 9%, without incidence of rectal ulceration and/or fistula formation. (C) 1999 Elsevier Science Inc.
C1 Wheeling Hosp, Schiffler Oncol Ctr, Wheeling, WV 26003 USA.
   George Washington Univ, Med Ctr, Div Radiat Oncol & Biophys, Washington, DC 20037 USA.
RP Merrick, GS (reprint author), Wheeling Hosp, Schiffler Oncol Ctr, 1 Med Pk, Wheeling, WV 26003 USA.
CR Albert Peter, 1997, Journal of Urology, V157, P290
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko JC, 1987, ENDOCURIETHER HYPERT, V3, P131
   Blasko JC, 1993, SEMIN RADIAT ONCOL, V3, P240, DOI 10.1053/SRAO00300240
   Blasko John, 1996, International Journal of Radiation Oncology Biology Physics, V36, P198, DOI 10.1016/S0360-3016(97)85421-1
   Butler WM, 1998, INT J RADIAT ONCOL, V41, P217, DOI 10.1016/S0360-3016(97)00951-6
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Grimm PD, 1994, ATLAS UROL CLIN N AM, V2, P113
   Li SD, 1997, MED PHYS, V24, P1107, DOI 10.1118/1.598014
   Merrick G S, 1997, Radiat Oncol Investig, V5, P305, DOI 10.1002/(SICI)1520-6823(1997)5:6<305::AID-ROI7>3.0.CO;2-1
   Merrick G S, 1998, Radiat Oncol Investig, V6, P182, DOI 10.1002/(SICI)1520-6823(1998)6:4<182::AID-ROI6>3.0.CO;2-U
   Prestidge BR, 1997, INT J RADIAT ONCOL, V39, P289, DOI 10.1016/S0360-3016(97)80864-4
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   Stone N N, 1995, Tech Urol, V1, P72
   WALLNER K, 1994, INT J RADIAT ONCOL, V30, P405
   WALLNER K, 1995, INT J RADIAT ONCOL, V32, P465, DOI 10.1016/0360-3016(94)00599-G
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Waterman FM, 1997, INT J RADIAT ONCOL, V39, P220, DOI 10.1016/S0360-3016(97)80729-8
   Willins J, 1997, INT J RADIAT ONCOL, V39, P347, DOI 10.1016/S0360-3016(97)00322-2
NR 23
TC 72
Z9 73
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD MAR 15
PY 1999
VL 43
IS 5
BP 1021
EP 1027
DI 10.1016/S0360-3016(98)00486-6
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 178RD
UT WOS:000079279100013
PM 10192350
ER

PT J
AU Grado, GL
   Larson, TR
   Balch, CS
   Grado, MM
   Collins, JM
   Kriegshauser, JS
   Swanson, GP
   Navickis, RJ
   Wilkes, MM
AF Grado, GL
   Larson, TR
   Balch, CS
   Grado, MM
   Collins, JM
   Kriegshauser, JS
   Swanson, GP
   Navickis, RJ
   Wilkes, MM
TI Actuarial disease-free survival after prostate cancer brachytherapy
   using interactive techniques with biplane ultrasound and fluoroscopic
   guidance
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate carcinoma; brachytherapy; iodine; palladium; prostate-specific
   antigen
ID EXTERNAL-BEAM RADIATION; SEED IMPLANTATION; FOLLOW-UP; (125)IODINE
   IMPLANTATION; I-125 IMPLANTATION; PROGNOSTIC FACTOR; ANTIGEN; CARCINOMA;
   RADIOTHERAPY; THERAPY
AB Purpose: To evaluate the effectiveness and safety of interactive transperineal brachytherapy under biplane ultrasound and fluoroscopic guidance in patients with localized prostate cancer.
   Methods and Materials: Brachytherapy using I-125 or Pd-103 radioactive seeds either alone or in combination with adjunctive external beam radiotherapy (XRT) was administered to 490 patients at a single institution. Posttreatment follow-up included clinical assessment of disease status, assays of serum prostate-specific antigen (PSA) levels and documentation of treatment-related symptoms and complications.
   Results: Actuarial disease-free survival at 5 yr was 79% (95% CI, 71-85%), and the 5-yr actuarial rate of local control was 98% (95% CI, 94-99%). Post-treatment PSA nadir and pretreatment PSA level were found to be significant predictors of disease-free survival. In patients with a PSA nadir < 0.5 ng/ml, 5-yr disease-free survival was 93% (95% CI, 84-97%), compared with 25% (95% CI, 5-53%) in patients whose PSA nadir was 0.5-1.0 ng/ml and 15% (95% CI, 3-38) in patients with a PSA nadir > 1.0 ng/ml. Brachytherapy was well tolerated with few post-treatment complications.
   Conclusion: A broad range of patients with localized prostate cancer can benefit from transperineal brachytherapy with minimal morbidity. A post-treatment PSA nadir below 0.5 ng/ml provides a useful prognostic indicator of favorable long-term outcome. (C) 1998 Elsevier Science Inc.
C1 Mayo Clin, Dept Radiat Oncol, Scottsdale, AZ USA.
   Mayo Clin, Dept Urol, Scottsdale, AZ USA.
   Mayo Clin, Dept Diagnost Radiol, Scottsdale, AZ USA.
   Hygeia Associates, Grass Valley, CA USA.
   Scott & White Clin, Temple, TX USA.
RP Grado, GL (reprint author), 10040 E Windrose Dr, Scottsdale, AZ 85260 USA.
CR ADOLFSSON J, 1994, EUR UROL, V26, P207
   Althof VGM, 1996, INT J RADIAT ONCOL, V34, P709, DOI 10.1016/0360-3016(95)02162-0
   ANDERSON LL, 1993, INT J RADIAT ONCOL, V27, P129
   ARTERBERY VE, 1993, INT J RADIAT ONCOL, V25, P661
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko J C, 1991, Scand J Urol Nephrol Suppl, V137, P113
   Blasko JC, 1993, SEMIN RADIAT ONCOL, V3, P240, DOI 10.1053/SRAO00300240
   Blasko John C., 1994, International Journal of Radiation Oncology Biology Physics, V30, P219, DOI 10.1016/0360-3016(94)90738-2
   CHAUVET B, 1994, J CLIN ONCOL, V12, P1402
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   DAmico AV, 1996, J CLIN ONCOL, V14, P304
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Gleason DF, 1997, UROLOGIC PATHOLOGY P, P171
   GOTTESMAN JE, 1991, J UROLOGY, V146, P1317
   Hanks G E, 1994, Important Adv Oncol, P225
   HOLM HH, 1983, J UROLOGY, V130, P283
   HOLTGREWE HL, 1989, J UROLOGY, V141, P248
   KAPLAN ID, 1993, J UROLOGY, V149, P519
   KAYE KW, 1995, J UROLOGY, V153, P1020, DOI 10.1016/S0022-5347(01)67626-2
   KAYE KW, 1995, AUST NZ J SURG, V65, P658, DOI 10.1111/j.1445-2197.1995.tb00676.x
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   Luse RW, 1997, INT J RADIAT ONCOL, V37, P737, DOI 10.1016/S0360-3016(96)00576-7
   Nag S, 1985, ENDOCURIE HYPERTHERM, V1, P207
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   PISANSKY TM, 1993, J CLIN ONCOL, V11, P2158
   POLLACK A, 1994, CANCER, V74, P670, DOI 10.1002/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8
   RADGE H, 1989, J ENDOUROL, V3, P209
   RADGE H, 1997, CANCER, V80, P442
   ROSENZWEIG KE, 1995, J UROLOGY, V153, P1561, DOI 10.1016/S0022-5347(01)67461-5
   SCHELLHAMMER PF, 1993, UROLOGY, V42, P13, DOI 10.1016/0090-4295(93)90325-5
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   Stokes SH, 1997, INT J RADIAT ONCOL, V37, P337, DOI 10.1016/S0360-3016(96)00508-1
   Stone N N, 1995, Tech Urol, V1, P72
   SWANSON GP, 1994, BRIT J RADIOL, V67, P877
   UTZ DC, 1969, J AMER MED ASSOC, V209, P1701, DOI 10.1001/jama.209.11.1701
   VIJVERBERG PLM, 1992, EUR UROL, V21, P35
   WALLNER K, 1994, INT J RADIAT ONCOL, V30, P405
   Wallner K, 1997, INT J RADIAT ONCOL, V37, P565, DOI 10.1016/S0360-3016(96)00570-6
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   WEYRICH TP, 1993, UROLOGY, V41, P122, DOI 10.1016/0090-4295(93)90160-C
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
   ZIETMAN AL, 1994, J UROLOGY, V151, P640
NR 44
TC 72
Z9 72
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD SEP 1
PY 1998
VL 42
IS 2
BP 289
EP 298
DI 10.1016/S0360-3016(98)00209-0
PG 10
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 129JM
UT WOS:000076460100008
PM 9788406
ER

PT J
AU Guth, PS
   Perin, P
   Norris, CH
   Valli, P
AF Guth, PS
   Perin, P
   Norris, CH
   Valli, P
TI The vestibular hair cells: Post-transductional signal processing
SO PROGRESS IN NEUROBIOLOGY
LA English
DT Review
ID GENE-RELATED PEPTIDE; GUINEA-PIG COCHLEA; FROG CRISTA-AMPULLARIS;
   NICOTINIC ACETYLCHOLINE-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; LATERAL-LINE
   ORGAN; METABOTROPIC GLUTAMATE RECEPTORS; SEMICIRCULAR CANAL AFFERENTS;
   CALCIUM-BINDING PROTEIN; VOLTAGE-CLAMP ANALYSIS
AB Hair cells in mechanosensory systems transduce mechanical stimuli into biological signals to be presented to and analyzed by the brain. Vestibular hair cells transduce stimuli primarily associated with the organism's orientation and motion in space. When examined superficially it may appear that the hair cells act as passive transducers whereby mechanical stimulation of their hair bundle results in transmitter release at their afferent synapses. In fact, hair cell functions are more complicated, and the mechanical signals are heavily processed even before being encoded in afferent nerve activity. Hair cells are different from one another in morphology, biophysics, transmitter and transmitter receptor complements, not only across different organs (as one might expect), but even in the same organ. This review focuses on hair cell morpho-physiological properties, ionic conductances, neurotransmitters/modulators and their receptors, second messengers and effecters. Special features of hair cell neurotransmission, as the synaptic body and the presence of autoreceptors and local circuits, are also discussed, as is the possibility of a differential modulation of hair cell transmitter release in the resting and mechanically-stimulated states. (C) 1997 Elsevier Science Ltd.
C1 Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.
   Univ Pavia, Ist Fisiol Gen, I-27100 Pavia, Italy.
RP Guth, PS (reprint author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.
CR ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4
   ADAMS JC, 1987, BRAIN RES, V419, P347, DOI 10.1016/0006-8993(87)90606-8
   ADRIAN ED, 1943, J PHYSIOL-LONDON, V101, P369
   AHLSTROM P, 1975, LARYNGOSCOPE, V85, P1241, DOI 10.1288/00005537-197507000-00016
   AMARO J, 1966, BRIT J PHARM CHEMOTH, V28, P207
   AMBACHE N, 1955, PHARMACOL REV, V7, P467
   ANASTASIO TJ, 1985, J NEUROPHYSIOL, V54, P335
   ANNIKO M, 1991, ACTA OTO-LARYNGOL, V111, P491, DOI 10.3109/00016489109138374
   ANNONI JM, 1984, J NEUROSCI, V4, P2106
   ANSON LC, 1994, 1 INT S INN EAR NEUR, V1, P3
   ANTHONY PF, 1991, AM J OTOL, V12, P388
   ART JJ, 1993, J PHYSIOL-LONDON, V470, P109
   ART JJ, 1985, J PHYSIOL-LONDON, V360, P397
   Art JJ, 1996, ANN NY ACAD SCI, V781, P103, DOI 10.1111/j.1749-6632.1996.tb15696.x
   ART JJ, 1987, J PHYSIOL-LONDON, V385, P207
   ART JJ, 1995, J GEN PHYSIOL, V105, P49, DOI 10.1085/jgp.105.1.49
   ART JJ, 1984, J PHYSIOL-LONDON, V356, P525
   ART JJ, 1982, PROC R SOC SER B-BIO, V216, P377, DOI 10.1098/rspb.1982.0081
   ASHCROFT DW, 1934, J LARYNG, V49, P450, DOI 10.1017/S002221510004041X
   ASHMORE JF, 1990, J PHYSIOL-LONDON, V428, P109
   ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323
   ASHMORE JF, 1983, NATURE, V304, P536, DOI 10.1038/304536a0
   ASHMORE JF, 1982, J PHYSIOL-LONDON, V329, pP25
   ASSAD JA, 1992, J NEUROSCI, V12, P3291
   ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X
   ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918
   ATHAS GB, 1997, 20 ARO MIDW RES M, V66
   ATHAS GB, 1997, 20 ARO MIDW RES M, P148
   AUBERT A, 1994, NEUROSCIENCE, V62, P963, DOI 10.1016/0306-4522(94)90487-1
   AUBERT A, 1995, NEUROSCIENCE, V64, P1153, DOI 10.1016/0306-4522(94)00434-7
   AUBERT A, 1993, BRAIN RES, V607, P301, DOI 10.1016/0006-8993(93)91520-3
   BAGGERSJOBACK D, 1980, ARCH OTO-RHINO-LARYN, V228, P217, DOI 10.1007/BF00454231
   BAIRD RA, 1986, BRAIN RES, V369, P48, DOI 10.1016/0006-8993(86)90512-3
   Baird RA, 1997, HEARING RES, V103, P85, DOI 10.1016/S0378-5955(96)00167-0
   BAIRD RA, 1992, ANN NY ACAD SCI, V656, P12, DOI 10.1111/j.1749-6632.1992.tb25197.x
   BAIRD RA, 1988, J NEUROPHYSIOL, V60, P182
   BAIRD RA, 1994, J NEUROPHYSIOL, V71, P666
   BAIRD RA, 1994, J COMP NEUROL, V342, P279, DOI 10.1002/cne.903420210
   BAIRD RA, 1994, J NEUROPHYSIOL, V71, P685
   BARRIE AP, 1991, J NEUROCHEM, V57, P1398, DOI 10.1111/j.1471-4159.1991.tb08306.x
   BARTOLAMI S, 1990, HEARING RES, V47, P229, DOI 10.1016/0378-5955(90)90154-H
   BERNARD C, 1985, BRAIN RES, V338, P225, DOI 10.1016/0006-8993(85)90151-9
   BERNARD C, 1983, ACTA OTO-LARYNGOL, V96, P21, DOI 10.3109/00016488309132871
   BETZ H, 1979, NATURE, V278, P749, DOI 10.1038/278749a0
   BIFFO S, 1990, NEUROSCIENCE, V35, P637, DOI 10.1016/0306-4522(90)90335-2
   BLANKS RHI, 1975, J NEUROPHYSIOL, V38, P1250
   BLASCHKO H, 1956, J PHYSIOL-LONDON, V133, P548
   Bledsoe Jr S.C., 1988, PHYSL HEARING, P385
   BLEDSOE SC, 1989, HEARING RES, V38, P81, DOI 10.1016/0378-5955(89)90130-5
   BLEDSOE S C JR, 1983, Comparative Biochemistry and Physiology C Pharmacology Toxicology and Endocrinology, V75, P199, DOI 10.1016/0742-8413(83)90180-9
   BLONDEL O, 1995, TRENDS NEUROSCI, V18, P157, DOI 10.1016/0166-2236(95)93894-4
   BLOSSER JC, 1980, J BIOL CHEM, V255, P1235
   BOBBIN RP, 1985, AUDITORY BIOCH, P102
   BOBBIN RP, 1978, ANN OTO RHINOL LARYN, V87, P185
   BOBBIN RP, 1990, HEARING RES, V46, P83, DOI 10.1016/0378-5955(90)90141-B
   BOBBIN RP, 1970, NEUROPHARMACOLOGY, V9, P567, DOI 10.1016/0028-3908(70)90007-9
   Bowen RE, 1931, P NATL ACAD SCI USA, V17, P192, DOI 10.1073/pnas.17.4.192
   BOYLE R, 1990, J NEUROSCI, V10, P1570
   BOYLE R, 1991, J NEUROPHYSIOL, V66, P1504
   BRAIN SD, 1985, NATURE, V298, P240
   BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0
   BRANTLEY RK, 1988, J COMP NEUROL, V275, P87, DOI 10.1002/cne.902750108
   BRICHTA AM, 1994, J COMP NEUROL, V344, P481, DOI 10.1002/cne.903440402
   BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153
   BRYANT GM, 1987, HEARING RES, V30, P231, DOI 10.1016/0378-5955(87)90139-0
   BULLOCK TH, 1966, STRUCTURE FUNCTION N
   BURGEN ASV, 1974, BRIT J PHARMACOL, V50, P145
   BURNHAM JA, 1984, J NEUROCYTOL, V13, P617, DOI 10.1007/BF01148082
   BURNHAM JA, 1984, HEARING RES, V13, P261, DOI 10.1016/0378-5955(84)90079-0
   BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1
   CAMPBELL V, 1995, J PHYSIOL-LONDON, V485, P365
   CARPENTER MB, 1987, BRAIN RES, V408, P275, DOI 10.1016/0006-8993(87)90387-8
   CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B
   CAZALS Y, 1980, SCIENCE, V210, P83, DOI 10.1126/science.6968092
   CAZALS Y, 1982, BRAIN RES, V231, P197, DOI 10.1016/0006-8993(82)90019-1
   CHABBERT C, 1994, PFLUG ARCH EUR J PHY, V427, P162, DOI 10.1007/BF00585956
   CHANG JSY, 1992, J COMP NEUROL, V324, P621, DOI 10.1002/cne.903240413
   CHEN C, 1995, HEARING RES, V86, P25, DOI 10.1016/0378-5955(95)00050-E
   CHEN WY, 1994, BIOPHYS J, V66, pA430
   CHURCHILL J. A., 1956, LARYNGOSCOPE, V66, P1
   CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5
   COCHRAN SL, 1987, SYNAPSE, V1, P102, DOI 10.1002/syn.890010114
   COCHRAN SL, 1995, BRAIN RES, V670, P321, DOI 10.1016/0006-8993(94)01357-N
   COHEN AI, 1963, EXP EYE RES, V2, P88, DOI 10.1016/S0014-4835(63)80028-7
   COHEN GM, 1987, HEARING RES, V28, P57, DOI 10.1016/0378-5955(87)90153-5
   COLTON CK, 1975, COMP BIOCHEM PHYS C, V51, P275, DOI 10.1016/0306-4492(75)90074-X
   COREY DP, 1979, BIOPHYS J, V26, P499
   COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0
   COREY DP, 1983, J NEUROSCI, V3, P962
   Correia MJ, 1996, ANN NY ACAD SCI, V781, P138, DOI 10.1111/j.1749-6632.1996.tb15698.x
   COTMAN CW, 1986, J PHYSIOL-LONDON, V378, P403
   COUSILLAS H, 1988, HEARING RES, V36, P213, DOI 10.1016/0378-5955(88)90063-9
   CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79
   CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405
   CURTIS DR, 1974, ERG PHYSIOL BIOL CH, V69, P97
   DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0
   DANI JA, 1995, CURR OPIN NEUROBIOL, V5, P310, DOI 10.1016/0959-4388(95)80043-3
   DANIELSON PD, 1983, BRAIN RES, V448, P158
   DAVIS KG, 1997, ABSTR ASS RES OT, V20, P231
   DECHESNE C, 1984, ANN OTO RHINOL LARYN, V93, P163
   DECHESNE CJ, 1991, BRAIN RES, V545, P223, DOI 10.1016/0006-8993(91)91290-H
   Dechesne CJ, 1997, DEV BRAIN RES, V99, P103, DOI 10.1016/S0165-3806(96)00216-7
   Dechesne C J, 1988, Brain Res, V469, P221
   DECHESNE CJ, 1988, HEARING RES, V33, P273, DOI 10.1016/0378-5955(88)90157-8
   DEMEMES D, 1993, CELL TISSUE RES, V274, P487, DOI 10.1007/BF00314545
   DEMEMES D, 1991, MOL BRAIN RES, V9, P153, DOI 10.1016/0169-328X(91)90141-J
   DEMEMES D, 1995, BRAIN RES, V671, P83, DOI 10.1016/0006-8993(94)01322-9
   DEMEMES D, 1990, HEARING RES, V46, P261, DOI 10.1016/0378-5955(90)90007-C
   DEMEMES D, 1984, BRAIN RES, V304, P188, DOI 10.1016/0006-8993(84)90880-1
   DEMEMES D, 1983, NEUROSCIENCE, V8, P285, DOI 10.1016/0306-4522(83)90066-0
   Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1
   DESMEDT JE, 1975, J PHYSIOL-LONDON, V247, P407
   DEVAU G, 1993, EUR J NEUROSCI, V5, P1210, DOI 10.1111/j.1460-9568.1993.tb00975.x
   DEVRIES SH, 1993, CELL, V72, P139, DOI 10.1016/S0092-8674(05)80033-9
   DEWAELE C, 1995, BRAIN RES REV, V20, P24, DOI 10.1016/0165-0173(94)00004-9
   DICKMAN JD, 1989, J NEUROPHYSIOL, V62, P1102
   DICKMAN JD, 1993, NEUROSCIENCE, V57, P1097, DOI 10.1016/0306-4522(93)90052-H
   DIDIER A, 1990, HEARING RES, V46, P171, DOI 10.1016/0378-5955(90)90147-H
   DIDIER A, 1990, CELL TISSUE RES, V260, P415, DOI 10.1007/BF00318645
   DIDIER A, 1989, HEARING RES, V37, P123, DOI 10.1016/0378-5955(89)90034-8
   DIENER HC, 1988, VESTIBULOSPINAL CONT, P253
   DODD J, 1981, BRAIN RES, V207, P109, DOI 10.1016/0006-8993(81)90682-X
   DOI K, 1990, HEARING RES, V45, P157, DOI 10.1016/0378-5955(90)90192-R
   DOI K, 1992, HEARING RES, V58, P221, DOI 10.1016/0378-5955(92)90131-6
   Dolezal V, 1997, BRAIN RES BULL, V42, P71, DOI 10.1016/S0361-9230(96)00208-0
   DOLPHIN AC, 1995, EXP PHYSIOL, V80, P1
   DONOGHUE JP, 1985, J NEUROSCI, V5, P2597
   DOUGLAS W, 1965, PHARMACOL BASIS THER, P615
   DOWDALL MJ, 1974, BIOCHEM J, V140, P1
   DOWLING JE, 1968, PROC R SOC SER B-BIO, V170, P205, DOI 10.1098/rspb.1968.0034
   DOWLING JE, 1974, SOC GEN PHYSL SERIES, V28, P87
   DOWLING JE, 1965, COLD SPRING HARB SYM, V30, P393
   DRENCKHAHN D, 1985, AUDITORY BIOCH, P317
   DRESCHER DG, 1987, COMP BIOCHEM PHYS A, V87, P305, DOI 10.1016/0300-9629(87)90126-5
   DRESCHER MJ, 1995, NEUROSCI LETT, V196, P145, DOI 10.1016/0304-3940(95)11764-N
   DRESCHER MJ, 1987, COMP BIOCHEM PHYS A, V86, P553, DOI 10.1016/0300-9629(87)90540-8
   DRESCHER MJ, 1992, J NEUROCHEM, V59, P93, DOI 10.1111/j.1471-4159.1992.tb08879.x
   DRESCHER MJ, 1995, P ASS RES OTOLARYNGO, V18
   DRESCHER MJ, 1991, J NEUROCHEM, V56, P658, DOI 10.1111/j.1471-4159.1991.tb08200.x
   DULON D, 1991, NEUROREPORT, V2, P69, DOI 10.1097/00001756-199102000-00001
   DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X
   DUNN RF, 1980, J COMP NEUROL, V193, P255, DOI 10.1002/cne.901930117
   DURHAM D, 1989, HEARING RES, V43, P39, DOI 10.1016/0378-5955(89)90057-9
   EATOCK RA, 1987, J NEUROSCI, V7, P2821
   EDMONDS B, 1997, BIOPHYS J, V72, P285
   EHRENBERGER K, 1982, ACTA OTO-LARYNGOL, V93, P269, DOI 10.3109/00016488209130882
   ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X
   ENGSTROM H, 1972, ACTA OTO-LARYNGOL, P75
   EROSTEGUI C, 1994, HEARING RES, V74, P135, DOI 10.1016/0378-5955(94)90182-1
   EROSTEGUI C, 1994, HEARING RES, V81, P119, DOI 10.1016/0378-5955(94)90159-7
   ERSPAMER V, 1965, J NEUROCHEM, V12, P123, DOI 10.1111/j.1471-4159.1965.tb11947.x
   ESTES MS, 1975, J NEUROPHYSIOL, V38, P1232
   EVANS MG, 1987, BIOPHYS J, V52, P649
   EYBALIN M, 1993, PHYSIOL REV, V73, P309
   FAVRE D, 1977, ARCH OTO-RHINO-LARYN, V215, P183, DOI 10.1007/BF00455865
   Favre D, 1986, Brain Res, V390, P137
   FELDER CC, 1995, FASEB J, V9, P619
   FELIX D, 1982, ACTA OTO-LARYNGOL, V93, P101, DOI 10.3109/00016488209130858
   FERNANDE.C, 1971, J NEUROPHYSIOL, V34, P661
   FERRARY E, 1988, ACTA OTO-LARYNGOL, P13
   FETTIPLACE R, 1987, TRENDS NEUROSCI, V10, P421, DOI 10.1016/0166-2236(87)90013-0
   FEX J, 1978, BRAIN RES, V159, P440, DOI 10.1016/0006-8993(78)90555-3
   FINE BS, 1963, J NEUROPATH EXP NEUR, V22, P255, DOI 10.1097/00005072-196304000-00004
   FINKEL AS, 1983, J PHYSIOL-LONDON, V344, P119
   FLOCK A, 1974, RHEINISCHER WESTFAEL, V53, P347
   FLOCK A, 1980, HEARING RES, V2, P411, DOI 10.1016/0378-5955(80)90076-3
   FLOCK A, 1973, J PHYSIOL-LONDON, V235, P591
   FLOCK A, 1965, ACTA OTO-LARYNGOL, V333, P1
   FLOCK A, 1976, J PHYSIOL-LONDON, V257, P45
   FLOCK A, 1977, J CELL BIOL, V75, P339, DOI 10.1083/jcb.75.2.339
   FLOCK A, 1965, J CELL BIOL, V25, P1, DOI 10.1083/jcb.25.1.1
   FLOCK A, 1978, BRAIN RES, V157, P11, DOI 10.1016/0006-8993(78)90992-7
   FLOREY E, 1967, FED PROC, V26, P1164
   FLOREY E, 1972, J EVOLUT BIOCH PHYSL, V7, P3
   FONTAINE B, 1986, NEUROSCI LETT, V71, P59, DOI 10.1016/0304-3940(86)90257-0
   FOSTER JD, 1995, HEARING RES, V83, P203, DOI 10.1016/0378-5955(95)00006-P
   FREDHOLM BB, 1980, BIOCHEM PHARMACOL, V29, P1635, DOI 10.1016/0006-2952(80)90117-3
   FREDHOLM BB, 1994, PHARMACOL REV, V46, P143
   FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553
   FUCHS PA, 1988, J NEUROSCI, V8, P2460
   FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039
   FUCHS PA, 1988, J COMP PHYSIOL A, V164, P151, DOI 10.1007/BF00603947
   FUCHS PA, 1992, J NEUROSCI, V12, P800
   Fuchs PA, 1996, CURR OPIN NEUROBIOL, V6, P514, DOI 10.1016/S0959-4388(96)80058-4
   FUJITA S, 1994, NEUROREPORT, V5, P862, DOI 10.1097/00001756-199404000-00002
   FURUKAWA T, 1981, J PHYSIOL-LONDON, V315, P203
   Fykse EM, 1996, NEUROCHEM RES, V21, P1053, DOI 10.1007/BF02532415
   GACEK R R, 1965, Acta Otolaryngol, V59, P541, DOI 10.3109/00016486509124585
   GACEK RR, 1974, ACTA OTO-LARYNGOL, V77, P92, DOI 10.3109/00016487409124603
   Gacek R R, 1969, Acta Otolaryngol Suppl, V254, P1
   GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567
   Garrison JC, 1990, PHARMACOL BASIS THER, P575
   GIBSON SJ, 1984, J NEUROSCI, V4, P3101
   GILLESPIE PG, 1995, CURR OPIN NEUROBIOL, V5, P449, DOI 10.1016/0959-4388(95)80004-2
   GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625
   GIOGLIO L, 1995, ARCH HISTOL CYTOL, V58, P1, DOI 10.1679/aohc.58.1
   GISSELSSON LENNART, 1952, ACTA OTOLARYNGOL, V42, P208, DOI 10.3109/00016485209120348
   GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454
   GLEICH O, 1990, HEARING RES, V45, P295, DOI 10.1016/0378-5955(90)90128-C
   GLEISNER L, 1973, ACTA OTO-LARYNGOL, V76, P199, DOI 10.3109/00016487309121500
   GLEOC G, 1997, P ROY SOC LOND B BIO, V264, P611
   GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V261, P251, DOI 10.1098/rspb.1995.0145
   GODFREY DA, 1984, HEARING RES, V14, P93, DOI 10.1016/0378-5955(84)90072-8
   GODFREY DA, 1986, NEUROBIOLOGY HEARING, P149
   Goldberg J M, 1979, Prog Brain Res, V50, P355
   GOLDBERG JM, 1980, J NEUROPHYSIOL, V43, P986
   Goldberg JM, 1996, ANN NY ACAD SCI, V781, P474, DOI 10.1111/j.1749-6632.1996.tb15721.x
   Goldberg J.M., 1984, HDB PHYSL 1, VIII, P977
   GONZALEZ A, 1993, J COMP NEUROL, V332, P258, DOI 10.1002/cne.903320209
   Goodman MB, 1996, BIOPHYS J, V71, P430
   Goodman MB, 1996, J PHYSIOL-LONDON, V497, P395
   GORDON JL, 1986, BIOCHEM J, V233, P309
   GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9
   Green GE, 1996, J NEUROCHEM, V67, P37
   GRENNINGLOH G, 1990, EMBO J, V9, P771
   GRIGUER C, 1994, PFLUG ARCH EUR J PHY, V427, P193, DOI 10.1007/BF00585963
   GRIGUER C, 1995, CELL CALCIUM, V17, P327, DOI 10.1016/0143-4160(95)90106-X
   GRIGUER C, 1993, PFLUG ARCH EUR J PHY, V425, P344, DOI 10.1007/BF00374185
   GUIRAMAND J, 1990, BIOCHEM PHARMACOL, V39, P1913, DOI 10.1016/0006-2952(90)90609-O
   GUTH P, 1993, HEARING RES, V66, P143, DOI 10.1016/0378-5955(93)90135-N
   GUTH PS, 1988, HEARING RES, V33, P223, DOI 10.1016/0378-5955(88)90152-9
   GUTH PS, 1976, PHARMACOL REV, V28, P95
   GUTH PS, 1986, ACTA OTO-LARYNGOL, V102, P194, DOI 10.3109/00016488609108666
   GUTH PS, 1985, PRIMARY AFFERENT TRA, P42
   GUTH PS, 1996, P ASS RES OTOLARYNGO, V19, P398
   GUTH PS, 1969, INT J NEUROPHARMACOL, V8, P49
   GUTH PS, 1994, HEARING RES, V75, P225, DOI 10.1016/0378-5955(94)90073-6
   GUTH PS, 1977, J NEUROCHEM, V28, P263, DOI 10.1111/j.1471-4159.1977.tb07741.x
   GUTH PS, 1991, HEARING RES, V56, P69, DOI 10.1016/0378-5955(91)90155-3
   GUTH PS, 1994, HEARING RES, V73, P109, DOI 10.1016/0378-5955(94)90288-7
   GUTH SL, 1984, EXP BRAIN RES, V56, P72
   HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1
   HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4
   HAMA K, 1965, J CELL BIOL, V24, P193, DOI 10.1083/jcb.24.2.193
   HAMILTON DW, 1969, ANAT REC, V164, P253, DOI 10.1002/ar.1091640301
   HARPER A, 1995, HEARING RES, V86, P171, DOI 10.1016/0378-5955(95)00068-F
   HARTMANN R, 1980, PFLUG ARCH EUR J PHY, V388, P123, DOI 10.1007/BF00584117
   HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0
   HERRERO I, 1992, NATURE, V360, P163, DOI 10.1038/360163a0
   Hiel H, 1996, BRAIN RES, V738, P347, DOI 10.1016/S0006-8993(96)01046-3
   Highstein SM, 1996, J NEUROPHYSIOL, V75, P575
   HIGHSTEIN SM, 1991, NEUROSCI RES, V12, P13, DOI 10.1016/0168-0102(91)90096-H
   HIGHSTEIN SM, 1986, J COMP NEUROL, V243, P309, DOI 10.1002/cne.902430303
   HIGHSTEIN SM, 1992, ANN NY ACAD SCI, V656, P108, DOI 10.1111/j.1749-6632.1992.tb25203.x
   HIGHSTEIN SM, 1985, J NEUROPHYSIOL, V54, P370
   HILDING D, 1962, Acta Otolaryngol, V55, P205, DOI 10.3109/00016486209127354
   HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0
   Hille B, 1992, IONIC CHANNELS EXCIT
   HILLMAN DE, 1974, BRAIN BEHAV EVOLUT, V10, P52, DOI 10.1159/000124302
   HILLMAN DE, 1971, SCIENCE, V174, P416, DOI 10.1126/science.174.4007.416
   Hillman D.E., 1976, P452
   HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335
   HOLT JR, 1995, J NEUROPHYSIOL, V73, P1484
   HOLTON FA, 1954, J PHYSIOL-LONDON, V126, P124
   HOLTON P, 1959, J PHYSIOL-LONDON, V145, P494
   HONRUBIA V, 1984, LARYNGOSCOPE, V94, P464, DOI 10.1288/00005537-198404000-00004
   HONRUBIA V, 1989, J NEUROPHYSIOL, V61, P688
   HOSHINO T, 1975, ACTA OTO-LARYNGOL, V80, P43, DOI 10.3109/00016487509121299
   HOUSLEY GD, 1992, P ROY SOC B-BIOL SCI, V249, P265, DOI 10.1098/rspb.1992.0113
   HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065
   Housley GD, 1997, AUDIOL NEURO-OTOL, V2, P92
   HOUSLEY GD, 1994, HEARING RES, V75, P47, DOI 10.1016/0378-5955(94)90054-X
   HOUSLEY GD, 1990, HEARING RES, V43, P121, DOI 10.1016/0378-5955(90)90221-A
   HOUSLEY GD, 1989, HEARING RES, V38, P259, DOI 10.1016/0378-5955(89)90070-1
   HOUSLEY GD, 1988, HEARING RES, V35, P87, DOI 10.1016/0378-5955(88)90043-3
   HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064
   HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99
   HU GY, 1991, BRAIN RES, V568, P339, DOI 10.1016/0006-8993(91)91423-X
   HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407
   HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3
   HUDSPETH AJ, 1983, ANNU REV NEUROSCI, V6, P187, DOI 10.1146/annurev.ne.06.030183.001155
   HUDSPETH AJ, 1979, P NATL ACAD SCI USA, V76, P1506, DOI 10.1073/pnas.76.3.1506
   HUDSPETH AJ, 1986, HEARING RES, V22, P21, DOI 10.1016/0378-5955(86)90070-5
   HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0
   HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237
   HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0
   HUNTERDUVAR IM, 1984, ULTRASTRUCTURAL ATLA, P211
   ICHIMIYA I, 1994, ACTA OTO-LARYNGOL, V114, P167, DOI 10.3109/00016489409126037
   IKEDA K, 1991, ORL J OTO-RHINO-LARY, V53, P78
   ISHIYAMA A, 1994, OTOLARYNG HEAD NECK, V111, P385
   ISHIYAMA A, 1994, CELL BIOL INT, V18, P979, DOI 10.1006/cbir.1994.1019
   ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578
   Iurato S, 1972, Prog Brain Res, V37, P429, DOI 10.1016/S0079-6123(08)63917-5
   IURATO S, 1971, ACTA OTO-LARYNGOL, V71, P147, DOI 10.3109/00016487109125343
   IURATO S, 1971, ACTA OTO-LARYNGOL, P1
   JACKSON RT, 1987, ARCH OTOLARYNGOL, V113, P536
   JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9
   JASSER A, 1973, J NEUROCHEM, V20, P45, DOI 10.1111/j.1471-4159.1973.tb12103.x
   Jastrow H, 1997, CELL TISSUE RES, V287, P255, DOI 10.1007/s004410050750
   Jin H, 1992, Nihon Jibiinkoka Gakkai Kaiho, V95, P391
   JONES PQ, 1990, NEUROSCI LETT, V111, P228, DOI 10.1016/0304-3940(90)90373-H
   JORGENSEN F, 1994, ACTA PHYSIOL SCAND, V151, P7, DOI 10.1111/j.1748-1716.1994.tb09716.x
   JORGENSEN J M, 1974, Acta Zoologica (Stockholm), V55, P289
   Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X
   KAKEHATA S, 1993, J PHYSIOL-LONDON, V463, P227
   KANAI Y, 1993, TRENDS NEUROSCI, V16, P365, DOI 10.1016/0166-2236(93)90094-3
   Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7
   KARLSEN HE, 1992, J EXP BIOL, V171, P173
   Kataoka Y, 1996, J NEUROPHYSIOL, V76, P1870
   KAWASAKI K, 1992, HEARING RES, V60, P64, DOI 10.1016/0378-5955(92)90059-V
   KEHOE J, 1972, J PHYSIOL-LONDON, V225, P115
   KELLOG RS, 1965, AEROSPACE MED, V36, P313
   KLINKE R, 1974, PHYSIOL REV, V54, P316
   KLINKE R, 1977, EXP BRAIN RES, V28, P311
   KOCH T, 1988, ARCH OTO-RHINO-LARYN, V245, P82, DOI 10.1007/BF00481441
   KOLESNIKOV SS, 1991, FEBS LETT, V290, P167, DOI 10.1016/0014-5793(91)81251-3
   KONG WJ, 1994, HEARING RES, V75, P191, DOI 10.1016/0378-5955(94)90070-1
   KONGRGA I, 1990, J NEUROSCI, V10, P2026
   KOYAMA H, 1982, BRAIN RES, V250, P168, DOI 10.1016/0006-8993(82)90964-7
   KRNJEVIC K, 1993, PROG BRAIN RES, V98, P285
   KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102
   KUJAWA SG, 1994, HEARING RES, V78, P181, DOI 10.1016/0378-5955(94)90024-8
   KUJAWA SG, 1994, HEARING RES, V76, P87, DOI 10.1016/0378-5955(94)90091-4
   KURUVILLA A, 1985, LARYNGOSCOPE, V95, P692
   Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3
   LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268
   LANDOLT JP, 1980, J NEUROPHYSIOL, V43, P1746
   LANFORD PJ, 1995, P ASS RES OTOLARYNGO, V18, P100
   LANG DG, 1989, J NEUROPHYSIOL, V62, P935
   LAPEYRE PNM, 1993, BRAIN RES, V609, P269, DOI 10.1016/0006-8993(93)90882-N
   LAUFER R, 1987, EMBO J, V6, P901
   Lenzi David, 1994, Current Opinion in Neurobiology, V4, P496, DOI 10.1016/0959-4388(94)90049-3
   LEWIS ER, 1975, BRAIN RES, V83, P35, DOI 10.1016/0006-8993(75)90856-2
   LEWIS ER, 1992, J COMP PHYSIOL A, V171, P421
   LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0
   LIM DJ, 1979, SCANNING ELECTRON MI, V3, P929
   LIU J, 1997, 20 ARO MIDW RES M, V688
   LLINAS R, 1969, EXP BRAIN RES, V9, P16
   LOCKE RE, 1989, P ASS RES OTOLARYNGO, P99
   LOCKE R E, 1990, Society for Neuroscience Abstracts, V16, P735
   Loewi O, 1921, PFLUGERS ARCH, V193, P201
   Loewi O, 1921, PFLUG ARCH GES PHYS, V189, P239, DOI 10.1007/BF01738910
   LOPEZ I, 1990, COMP BIOCHEM PHYS B, V95, P375, DOI 10.1016/0305-0491(90)90090-G
   LOPEZ I, 1988, NEUROSCIENCE, V25, P13
   LOPEZ I, 1992, BRAIN RES, V589, P341, DOI 10.1016/0006-8993(92)91297-R
   LOPEZ I, 1990, BRAIN RES, V530, P170, DOI 10.1016/0006-8993(90)90677-4
   Lorente de No R., 1926, TRAV LAB INVEST BIOL, V24, P53
   LOWENSTEIN O, 1959, NATURE, V184, P1807, DOI 10.1038/1841807a0
   LUES G, 1971, Z ZELLFORSCH MIK ANA, V114, P38, DOI 10.1007/BF00339464
   LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113
   MADISON DV, 1987, J NEUROSCI, V7, P733
   MAGGIO E, 1966, ACTA OTOLARYNGOL S, V218, P1
   MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J
   MARTIN AR, 1992, P ROY SOC B-BIOL SCI, V250, P71, DOI 10.1098/rspb.1992.0132
   MASETTO S, 1994, J NEUROPHYSIOL, V72, P443
   MASETTO S, 1995, PRIMARY SENSORY NEUR, V1, P129
   Masetto S, 1997, J NEUROPHYSIOL, V78, P1913
   Masetto S, 1995, NEUROREPORT, V7, P230, DOI 10.1097/00001756-199512000-00055
   MATSUBARA A, 1995, ACTA OTO-LARYNGOL, P248
   MATSUSAK.T, 1967, J ULTRA MOL STRUCT R, V18, P55, DOI 10.1016/S0022-5320(67)80231-4
   MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19
   MBIENE JP, 1986, J COMP NEUROL, V254, P271, DOI 10.1002/cne.902540210
   MCAFEE DA, 1986, VERTEBRATE NERVOUS S, P481
   MCCUE MP, 1995, J NEUROPHYSIOL, V74, P1563
   MEES K, 1984, ARCH OTO-RHINO-LARYN, V240, P55, DOI 10.1007/BF00464345
   Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8
   MEREDITH GE, 1986, NEUROSCIENCE, V17, P225, DOI 10.1016/0306-4522(86)90238-1
   MEUNIER FM, 1975, NATURE, V257, P407, DOI 10.1038/257407a0
   MEZA G, 1981, SOC NEUR ABSTR, V7, P147
   MEZA G, 1984, NEUROSCI LETT, V49, P93, DOI 10.1016/0304-3940(84)90142-3
   MEZA G, 1992, INT J DEV NEUROSCI, V10, P407, DOI 10.1016/0736-5748(92)90030-4
   MEZA G, 1981, T AM SOC NEUROCHEM, V12, P256
   MEZA G, 1985, BRAIN RES, V337, P179, DOI 10.1016/0006-8993(85)91628-2
   MEZA G, 1989, ACTA OTO-LARYNGOL, V107, P406, DOI 10.3109/00016488909127530
   MICHELSO.MJ, 1974, BIOCHEM PHARMACOL, V23, P2211, DOI 10.1016/0006-2952(74)90551-6
   MILLER AM, 1983, J PHYSIOL-LONDON, V334, P325
   MISSOTTEN L, 1960, Ophthalmologica, V140, P200
   Mizuta K, 1995, NEUROSCI LETT, V201, P147, DOI 10.1016/0304-3940(95)12149-8
   MOKRASCH LC, 1973, BIOL DATA BOOK, P1206
   MONAGHAN P, 1975, CELL TISSUE RES, V163, P239
   MONS N, 1995, TRENDS NEUROSCI, V18, P536, DOI 10.1016/0166-2236(95)98375-9
   Morgans CW, 1996, J NEUROSCI, V16, P6713
   MROZ EA, 1993, HEARING RES, V70, P22, DOI 10.1016/0378-5955(93)90049-7
   MROZ EA, 1989, HEARING RES, V38, P141, DOI 10.1016/0378-5955(89)90136-6
   MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728
   MUROFUSHI T, 1995, EXP BRAIN RES, V103, P174
   MURROW B, 1995, J PHYSL LOND 2, V480, P247
   MURROW B, 1995, J PHYSL LOND    0201
   MURROW BW, 1995, J PHYSIOL-LONDON, V482, P725
   MYERS SF, 1990, BRAIN RES, V534, P15, DOI 10.1016/0006-8993(90)90107-M
   Myers SF, 1997, J NEUROPHYSIOL, V77, P2061
   NADOL JB, 1988, HEARING RES, V34, P253, DOI 10.1016/0378-5955(88)90006-8
   NAKAGAWA T, 1990, J NEUROPHYSIOL, V63, P1068
   NAKAGAWA T, 1991, J NEUROPHYSIOL, V65, P715
   NAKAGAWA T, 1994, BRAIN RES, V661, P293, DOI 10.1016/0006-8993(94)91207-6
   NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185
   NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7
   NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0
   NIEDZIELSKI AS, 1995, J NEUROSCI, V15, P2338
   NIEDZIELSKI AS, 1992, NEUROREPORT, V3, P273, DOI 10.1097/00001756-199203000-00015
   NIEDZIELSKI AS, 1991, HEARING RES, V57, P107, DOI 10.1016/0378-5955(91)90079-O
   NILLSON SEG, 1970, J ULTRASTRUCT RES, V30, P87
   NORRIS CH, 1992, J NEUROPHYSIOL, V68, P1642
   NORRIS CH, 1974, ACTA OTO-LARYNGOL, V77, P318, DOI 10.3109/00016487409124631
   NORRIS CH, 1987, ARCH OTOLARYNGOL, V113, P981
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   NORRIS CH, 1994, ENIERES DIS PERSPECT, P485
   OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387
   OCONNOR SE, 1991, TRENDS PHARMACOL SCI, V12, P137, DOI 10.1016/0165-6147(91)90530-6
   ODOWD JJ, 1988, BIOCHIM BIOPHYS ACTA, V967, P241, DOI 10.1016/0304-4165(88)90015-3
   OGAWA K, 1993, HEARING RES, V69, P207, DOI 10.1016/0378-5955(93)90109-E
   Ohmori H, 1990, Neurosci Res Suppl, V12, pS51, DOI 10.1016/0921-8696(90)90008-Q
   Ohmori H, 1996, NEWS PHYSIOL SCI, V11, P161
   OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189
   OHMORI H, 1984, J PHYSIOL-LONDON, V350, P561
   OHNO K, 1993, ACTA OTO-LARYNGOL, P16
   OHNO K, 1993, MOL BRAIN RES, V18, P343, DOI 10.1016/0169-328X(93)90100-4
   OSBORNE MP, 1966, J INSECT PHYSIOL, V12, P1503, DOI 10.1016/0022-1910(66)90040-0
   OSBORNE MP, 1972, Z ZELLFORSCHUNG, V127, P3247
   OSBORNE MP, 1977, SYNAPSES, P40
   OUDAR O, 1990, CELL TISSUE RES, V262, P579, DOI 10.1007/BF00305255
   PALOHEIMO S, 1977, ARCH OTO-RHINO-LARYN, V217, P347, DOI 10.1007/BF00465552
   PANZANELLI P, 1994, BRAIN RES, V662, P293, DOI 10.1016/0006-8993(94)90829-X
   PARK JC, 1987, HEARING RES, V28, P87, DOI 10.1016/0378-5955(87)90156-0
   PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4
   Pemberton KE, 1997, PFLUG ARCH EUR J PHY, V433, P505, DOI 10.1007/s004240050306
   PENINGTON NJ, 1995, J NEUROSCI, V15, P5719
   PERACHIO AA, 1989, EXP BRAIN RES, V78, P315
   PEREZ ME, 1991, BRAIN RES, V563, P221, DOI 10.1016/0006-8993(91)91537-B
   PERIN P, 1997, IN PRESS PFLUGERS AR
   PERIN P, 1997, IN PRESS SOC NEUR AB, V23
   Peterson EH, 1996, ANN NY ACAD SCI, V781, P85, DOI 10.1111/j.1749-6632.1996.tb15695.x
   PICKLES JO, 1992, TRENDS NEUROSCI, V15, P254, DOI 10.1016/0166-2236(92)90066-H
   PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G
   Platt C., 1981, HEARING SOUND COMMUN, P3
   POPPER A, 1990, EVOLUTIONARY BIOL HE, P49
   POPPER AN, 1993, HEARING RES, V64, P211, DOI 10.1016/0378-5955(93)90008-O
   POTTER AJ, 1986, COMP BIOCHEM PHYS A, V84, P265, DOI 10.1016/0300-9629(86)90611-0
   PRECHT W, 1978, NEURONAL OPERATION V
   Precht W., 1976, P481
   PRIGIONI I, 1994, NEUROREPORT, V5, P516, DOI 10.1097/00001756-199401120-00038
   Prigioni I, 1996, NEUROREPORT, V7, P1841, DOI 10.1097/00001756-199607290-00031
   Prigioni I, 1992, J Vestib Res, V2, P31
   PRIGIONI I, 1983, BRAIN RES, V269, P83, DOI 10.1016/0006-8993(83)90964-2
   PRIGIONI I, 1990, HEARING RES, V46, P253, DOI 10.1016/0378-5955(90)90006-B
   PUEL JL, 1989, COMP BIOCHEM PHYS C, V93, P73, DOI 10.1016/0742-8413(89)90013-3
   PUJOL R, 1994, BRIT J AUDIOL, V28, P185, DOI 10.3109/03005369409086567
   Pujol R., 1986, NEUROBIOLOGY HEARING, P161
   PULL I, 1972, BIOCHEM J, V130, P975
   PURCELL I, 1995, 18 MIDW M ARO
   Purcell I. M., 1995, Society for Neuroscience Abstracts, V21, P399
   PURCELL I, 1996, 19 MIDW M ARO, P174
   Purcell IM, 1996, ANN NY ACAD SCI, V781, P680, DOI 10.1111/j.1749-6632.1996.tb15758.x
   Rabejac D, 1997, EUR J NEUROSCI, V9, P221, DOI 10.1111/j.1460-9568.1997.tb01393.x
   RATHOUZ MM, 1995, J BIOL CHEM, V270, P14366
   RAYMOND J, 1984, EXP BRAIN RES, V56, P523
   REBILLARD G, 1989, BRAIN RES, V494, P379, DOI 10.1016/0006-8993(89)90608-2
   Rennie KJ, 1996, J NEUROPHYSIOL, V75, P2117
   RENNIE KJ, 1991, HEARING RES, V51, P279, DOI 10.1016/0378-5955(91)90044-A
   RENNIE KJ, 1994, J NEUROPHYSIOL, V71, P317
   RENNIE KJ, 1994, 1 INT S INN EAR NEUR, V1, P12
   RENNIE KJ, 1993, NEUROSCI LETT, V160, P185, DOI 10.1016/0304-3940(93)90409-E
   RICCI A, 1991, P ASS RES OTOLARYNGO, V14, P95
   RICCI A, 1991, BRAIN RES, V565, P78, DOI 10.1016/0006-8993(91)91738-M
   Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x
   Ricci AJ, 1996, ANN NY ACAD SCI, V781, P690, DOI 10.1111/j.1749-6632.1996.tb15761.x
   RICHARDS DM, 1984, DRUGS, V28, P38, DOI 10.2165/00003495-198428010-00003
   ROBERTS BL, 1971, PROC R SOC SER B-BIO, V179, P157, DOI 10.1098/rspb.1971.0087
   ROBERTS BL, 1994, HEARING RES, V74, P231, DOI 10.1016/0378-5955(94)90191-0
   ROBERTS WM, 1994, J NEUROSCI, V14, P3246
   ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0
   ROBERTS WM, 1991, ANN NY ACAD SCI, V635, P221, DOI 10.1111/j.1749-6632.1991.tb36494.x
   ROBERTS WM, 1990, J NEUROSCI, V10, P3664
   ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0
   ROSS M, 1995, P ASS RES OTOLARYNGO, V18, P3
   ROSS MD, 1990, ACTA OTO-LARYNGOL, V109, P83, DOI 10.3109/00016489009107418
   Ross MD, 1997, J COMP NEUROL, V379, P333, DOI 10.1002/(SICI)1096-9861(19970317)379:3<333::AID-CNE2>3.0.CO;2-4
   ROSSI ML, 1982, BRAIN RES, V233, P181, DOI 10.1016/0006-8993(82)90939-8
   ROSSI ML, 1991, BRAIN RES, V555, P123, DOI 10.1016/0006-8993(91)90868-V
   ROSSI ML, 1980, BRAIN RES, V185, P125, DOI 10.1016/0006-8993(80)90677-0
   RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4
   RUSCH A, 1991, J PHYSIOL-LONDON, V434, P52
   Rusch A, 1996, ANN NY ACAD SCI, V781, P71, DOI 10.1111/j.1749-6632.1996.tb15694.x
   RUSCH A, 1989, PFLUG ARCH EUR J PHY, V413, P533, DOI 10.1007/BF00594186
   Rusch A, 1996, J NEUROPHYSIOL, V76, P995
   RUSSELL IJ, 1972, J EXP BIOL, V57, P77
   Russo G, 1996, NEUROREPORT, V7, P2143, DOI 10.1097/00001756-199609020-00016
   RUSSO G, 1995, NEUROREPORT, V6, P425, DOI 10.1097/00001756-199502000-00005
   SAFIEDDINE S, 1992, P WORKSH INN EAR BIO, V29, P113
   SAFIEDDINE S, 1992, NEUROREPORT, V3, P1145, DOI 10.1097/00001756-199212000-00029
   Safieddine S, 1996, MOL BRAIN RES, V40, P127
   Saidel WM, 1995, BRAIN BEHAV EVOLUT, V46, P362, DOI 10.1159/000113286
   SAITO A, 1986, AM J PHYSIOL, V250, pH693
   Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1
   SANS A, 1984, BRAIN RES, V308, P191, DOI 10.1016/0006-8993(84)90936-3
   SANS A, 1994, ACTA OTO-LARYNGOL, P11
   SANS A, 1987, BRAIN RES, V435, P293, DOI 10.1016/0006-8993(87)91612-X
   SANS A, 1986, BRAIN RES, V364, P190, DOI 10.1016/0006-8993(86)91003-6
   SANS A, 1989, HEARING RES, V40, P117, DOI 10.1016/0378-5955(89)90105-6
   SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155
   SARIA A, 1986, NEUROSCI LETT, V63, P310, DOI 10.1016/0304-3940(86)90376-9
   SASSOEPOGNETTO M, 1995, J COMP NEUROL, V357, P1, DOI 10.1002/cne.903570102
   SATOH Y, 1988, J PINEAL RES, V5, P13, DOI 10.1111/j.1600-079X.1988.tb00764.x
   SCARFONE E, 1988, J NEUROSCI, V8, P4640
   SCARFONE E, 1991, J NEUROSCI, V11, P1173
   SCHACHT J, 1987, HEARING RES, V31, P155, DOI 10.1016/0378-5955(87)90121-3
   SCHERMULY L, 1990, J COMP PHYSIOL A, V166, P355
   SCHESSEL DA, 1991, BRAIN RES, V544, P1, DOI 10.1016/0006-8993(91)90879-Z
   SCHESSEL DA, 1981, ANN NY ACAD SCI, V374, P210, DOI 10.1111/j.1749-6632.1981.tb30871.x
   Schmitz F, 1996, J NEUROSCI, V16, P7109
   SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1
   SELLICK PM, 1972, PFLUG ARCH EUR J PHY, V336, P21, DOI 10.1007/BF00589138
   SELLICK PM, 1972, PFLUG ARCH EUR J PHY, V336, P28, DOI 10.1007/BF00589139
   SEWELL WF, 1991, J NEUROPHYSIOL, V65, P1158
   SEWELL WF, 1990, HEARING RES, V50, P127, DOI 10.1016/0378-5955(90)90039-R
   SEWELL WF, 1987, J NEUROSCI, V7, P2465
   SEWELL WF, 1990, HEARING RES, V44, P71, DOI 10.1016/0378-5955(90)90023-I
   SEWELL WF, 1978, SCIENCE, V202, P910, DOI 10.1126/science.30998
   Shepherd G., 1990, SYNAPTIC ORG BRAIN
   SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973
   SHIGEMOTO T, 1990, J PHYSIOL-LONDON, V420, P127
   SHIGEMOTO T, 1991, J PHYSIOL-LONDON, V442, P669
   SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x
   SIEGEL JH, 1987, HEARING RES, V28, P131, DOI 10.1016/0378-5955(87)90044-X
   SIEGEL JH, 1986, J NEUROCYTOL, V15, P311, DOI 10.1007/BF01611434
   SILINSKY EM, 1973, NATURE, V243, P327
   SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9
   SKOFITSCH G, 1985, PEPTIDES, V4, P975
   SNYDER SH, 1985, ANNU REV NEUROSCI, V8, P103
   SOBIN A, 1983, ACTA OTO-LARYNGOL, V96, P407, DOI 10.3109/00016488309132726
   SOBKOWICZ HM, 1993, ACTA OTO-LARYNGOL, P3
   SOBKOWICZ HM, 1986, J NEUROCYTOL, V15, P693, DOI 10.1007/BF01625188
   SOBKOWICZ HM, 1975, J NEUROCYTOL, V4, P543, DOI 10.1007/BF01351537
   SOBKOWICZ HM, 1982, J NEUROSCI, V2, P942
   SOTO E, 1988, BRAIN RES, V462, P104, DOI 10.1016/0006-8993(88)90591-4
   SOTO E, 1994, BRAIN RES, V633, P289, DOI 10.1016/0006-8993(94)91551-2
   SOTO E, 1988, Society for Neuroscience Abstracts, V14, P331
   SPOENDLIN H, 1970, ULTRASTRUCTURE PERIP, P263
   Sridhar TS, 1997, J NEUROSCI, V17, P428
   SRIDHAR TS, 1995, J NEUROSCI, V15, P3667
   STALLCUP WB, 1980, P NATL ACAD SCI-BIOL, V77, P634, DOI 10.1073/pnas.77.1.634
   STARR PA, 1990, SOC NEUR ABSTR, V14, P331
   STARR PA, 1991, HEARING RES, V52, P23, DOI 10.1016/0378-5955(91)90185-C
   Steinacker A, 1996, ANN NY ACAD SCI, V781, P150, DOI 10.1111/j.1749-6632.1996.tb15699.x
   STEINACKER A, 1991, BRAIN RES, V556, P22, DOI 10.1016/0006-8993(91)90543-5
   STEINACKER A, 1992, ANN NY ACAD SCI, V656, P27, DOI 10.1111/j.1749-6632.1992.tb25198.x
   STEINACKER A, 1988, HEARING RES, V35, P265, DOI 10.1016/0378-5955(88)90123-2
   STERKERS O, 1988, PHYSIOL REV, V68, P1083
   STERKERS O, 1988, ACTA OTO-LARYNGOL, P28
   STRUTZ J, 1980, BRAIN RES, V215, P323
   SU ZL, 1995, HEARING RES, V87, P62, DOI 10.1016/0378-5955(95)00079-J
   SUGAI T, 1992, HEARING RES, V61, P56, DOI 10.1016/0378-5955(92)90036-M
   Sugihara I, 1996, J PHYSIOL-LONDON, V495, P665
   SUGIHARA I, 1994, J PHYSIOL-LONDON, V476, P373
   Sugihara I, 1995, J PHYSIOL-LONDON, V489, P443
   SUGIHARA I, 1989, J NEUROPHYSIOL, V62, P1330
   SURPRENANT A, 1995, TRENDS NEUROSCI, V18, P224, DOI 10.1016/0166-2236(95)93907-F
   TACHIBANA M, 1994, MOL BRAIN RES, V21, P355, DOI 10.1016/0169-328X(94)90267-4
   TAGLIETTI V, 1977, BRAIN RES, V123, P41, DOI 10.1016/0006-8993(77)90642-4
   TAKAHASHI T, 1990, J PHYSIOL-LONDON, V423, P47
   TAKEDA N, 1986, EXP BRAIN RES, V61, P575
   TANAKA K, 1978, AM J ANAT, V153, P251, DOI 10.1002/aja.1001530206
   TANAKA M, 1989, BRAIN RES, V504, P31, DOI 10.1016/0006-8993(89)91593-X
   Tanaka M, 1989, Acta Otolaryngol Suppl, V468, P31
   TAXI J, 1976, FROG NEUROBIOLOGY, P92
   THACH JS, 1968, AEROSPACE MED, V39, P734
   THIEFFRY M, 1978, BRAIN RES, V156, P402, DOI 10.1016/0006-8993(78)90528-0
   THORN L, 1972, Experientia (Basel), V28, P835, DOI 10.1007/BF01923160
   THORNHIL.RA, 1972, COMPARATIVE, V3, P89, DOI 10.1016/0010-4035(72)90045-6
   Torre V, 1995, J NEUROSCI, V15, P7757
   TOWER DB, 1960, NEUROCHEMISTRY NUCLE, P173
   TSCHOPP FA, 1985, P NATL ACAD SCI USA, V82, P248, DOI 10.1073/pnas.82.1.248
   Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X
   Tucker TR, 1996, J PHYSIOL-LONDON, V494, P613
   TURNER JS, 1983, LARYNGOSCOPE, V93, P898
   UPADHYAY S, 1997, 20 ARO MIDW RES M
   USAMI S, 1991, BRAIN RES, V555, P153, DOI 10.1016/0006-8993(91)90872-S
   USAMI S, 1995, BRAIN RES, V676, P285, DOI 10.1016/0006-8993(95)00099-C
   USAMI S, 1995, NEUROREPORT, V6, P1161, DOI 10.1097/00001756-199505300-00022
   USAMI SI, 1991, ACTA OTO-LARYNGOL, P166
   USHERWOO.PN, 1966, NATURE, V210, P634, DOI 10.1038/210634a0
   Valat J, 1995, J NEUROCYTOL, V24, P916, DOI 10.1007/BF01215642
   VALAT J, 1991, NEUROSCI LETT, V127, P231, DOI 10.1016/0304-3940(91)90801-Y
   VALERA S, 1994, NATURE, V373, P112
   VALLI P, 1986, BRAIN RES, V362, P92, DOI 10.1016/0006-8993(86)91402-2
   VALLI P, 1990, J PHYSIOL-LONDON, V430, P585
   VALLI P, 1985, BRAIN RES, V330, P1, DOI 10.1016/0006-8993(85)90002-2
   VALLI P, 1988, J COMP PHYSIOL A, V162, P173, DOI 10.1007/BF00606082
   VALLI P, 1974, ACTA OTO-LARYNGOL, V78, P51, DOI 10.3109/00016487409126325
   VALLI P, 1976, ACTA OTO-LARYNGOL, V81, P395, DOI 10.3109/00016487609107493
   VALVERDE MA, 1995, FASEB J, V9, P509
   VAZQUEZ E, 1995, NEUROSCIENCE, V68, P117, DOI 10.1016/0306-4522(95)00121-X
   VEGA R, 1991, Society for Neuroscience Abstracts, V17, P317
   VEGA R, 1987, HEARING RES, V29, P163, DOI 10.1016/0378-5955(87)90164-X
   VETTER DE, 1991, SYNAPSE, V7, P21, DOI 10.1002/syn.890070104
   Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X
   VIZI ES, 1979, PROG NEUROBIOL, V12, P181, DOI 10.1016/0301-0082(79)90011-X
   VOLLRATH L, 1973, Z ZELLFORSCH MIK ANA, V145, P171, DOI 10.1007/BF00307386
   WACKYM PA, 1995, CELL BIOL INT, V19, P291, DOI 10.1006/cbir.1995.1071
   WACKYM PA, 1991, OTOLARYNG HEAD NECK, V105, P493
   WAGNER HJ, 1973, NATURE-NEW BIOL, V246, P53
   Walker RG, 1996, P NATL ACAD SCI USA, V93, P2203, DOI 10.1073/pnas.93.5.2203
   WANG JJ, 1995, EXP BRAIN RES, V105, P18
   Wang X, 1997, J NEUROCHEM, V68, P443
   Warr W.B., 1986, NEUROBIOLOGY HEARING, P333
   WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I
   WEISLEDER P, 1995, HEARING RES, V82, P125
   WENTHOLD RJ, 1983, GLUTAMINE GLUTAMATE, P33
   WERSALL J, 1965, COLD SPRING HARB SYM, V30, P115
   WERSALL J, 1956, Acta Otolaryngol Suppl, V126, P1
   WERSALL J, 1974, HDB SENSORY PHYSL I, V6, P53
   WHIM MD, 1990, J NEUROSCI, V10, P3313
   WHITLON DS, 1989, J NEUROCYTOL, V18, P505, DOI 10.1007/BF01474546
   WICKMAN K, 1995, PHYSIOL REV, V75, P865
   Wilson VJ, 1979, MAMMALIAN VESTIBULAR
   WITT CM, 1994, J NEUROPHYSIOL, V72, P1037
   WOLFE D E, 1965, Prog Brain Res, V10, P332
   Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4
   WOOD MR, 1977, BRAIN RES, V130, P24
   WOODS AD, 1987, ACTA OTO-LARYNGOL, V104, P193, DOI 10.3109/00016488709107318
   WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5
   Wu YC, 1996, BIOPHYS J, V70, P2557
   Wu YC, 1996, BIOPHYS J, V71, P2256
   YAMAGUCHI K, 1993, J PHYSIOL-LONDON, V464, P213
   YAMASHITA M, 1990, EXP BRAIN RES, V80, P475
   YAMASHITA T, 1993, ACTA OTO-LARYNGOL, P26
   YLIKOSKI J, 1984, ACTA OTO-LARYNGOL, V97, P523, DOI 10.3109/00016488409132930
   YLIKOSKI J, 1984, J LARYNGOL OTOL, V98, P759, DOI 10.1017/S0022215100147413
   YOSHIDA N, 1994, BRAIN RES, V644, P90, DOI 10.1016/0006-8993(94)90351-4
   YOUNG ED, 1977, ACTA OTO-LARYNGOL, V84, P352, DOI 10.3109/00016487709123977
   ZAJIC G, 1983, HEARING RES, V10, P249, DOI 10.1016/0378-5955(83)90090-4
   ZENNER HP, 1991, ACTA OTO-LARYNGOL, V111, P291, DOI 10.3109/00016489109137390
   Zenner H P, 1992, J Vestib Res, V2, P181
   ZENNER HP, 1990, HEARING RES, V50, P289, DOI 10.1016/0378-5955(90)90052-Q
   ZIDANIC M, 1995, BIOPHYS J, V68, P1323
   ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7
   ZUCCA G, 1993, HEARING RES, V68, P238, DOI 10.1016/0378-5955(93)90127-M
   ZUCCA G, 1992, ACTA PHYSIOL SCAND, V145, P423, DOI 10.1111/j.1748-1716.1992.tb09384.x
   ZUCCA G, 1992, HEARING RES, V63, P52, DOI 10.1016/0378-5955(92)90073-V
   ZUCCA G, 1995, ACTA OTO-LARYNGOL, V115, P34, DOI 10.3109/00016489509133343
   ZUCCA G, 1993, NEUROREPORT, V4, P403, DOI 10.1097/00001756-199304000-00015
NR 631
TC 72
Z9 87
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0301-0082
J9 PROG NEUROBIOL
JI Prog. Neurobiol.
PD FEB
PY 1998
VL 54
IS 2
BP 193
EP 247
DI 10.1016/S0301-0082(97)00068-3
PG 55
WC Neurosciences
SC Neurosciences & Neurology
GA YR682
UT WOS:000071519700004
PM 9481798
ER

PT J
AU MERRITT, TA
   DISESSA, TG
   FELDMAN, BH
   KIRKPATRICK, SE
   GLUCK, L
   FRIEDMAN, WF
AF MERRITT, TA
   DISESSA, TG
   FELDMAN, BH
   KIRKPATRICK, SE
   GLUCK, L
   FRIEDMAN, WF
TI CLOSURE OF PATENT DUCTUS-ARTERIOSUS WITH LIGATION AND INDOMETHACIN -
   CONSECUTIVE EXPERIENCE
SO JOURNAL OF PEDIATRICS
LA English
DT Article
C1 UNIV CALIF SAN DIEGO,DEPT PEDIAT,DIV PEDIAT CARDIOL,SAN DIEGO,CA 92103.
   UNIV CALIF SAN DIEGO,DEPT PEDIAT,DIV PERINATAL MED,SAN DIEGO,CA 92103.
   SUNRISE HOSP,SW NEONATAL CTR,SAN DIEGO,CA.
CR AMIELTISON C, 1977, INTRAUTERINE ASPHYXI, P423
   BENSON D, CIRCULATION
   CLARKE DR, 1976, ANN THORAC SURG, V22, P138
   EDWARDS D, J ROENTGENOLOGY
   FELDMAN BH, 1975, 44TH ANN M AM AC PED
   FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003
   FRIEDMAN WF, ADV PEDIATR
   HALL GS, 1976, ANN THORAC SURG, V22, P146
   HARNICK E, 1977, LANCET, V2, P245
   HEYMANN MA, 1976, NEW ENGL J MED, V295, P530, DOI 10.1056/NEJM197609022951004
   HIGGINS CB, 1977, RADIOLOGY, V124, P189
   HIRSCHKLAU MJ, 1978, J PEDIATR, V92, P474, DOI 10.1016/S0022-3476(78)80452-1
   JONES MD, 1977, PEDIATR ANN, V6, P61
   KILMAN JW, 1974, J PEDIATR SURG, V9, P277, DOI 10.1016/S0022-3468(74)80280-0
   KIRKPATRICK SE, 1977, PEDIATR RES, V11, P394
   LEVITSKY S, 1976, ANN THORAC SURG, V22, P131
   LUBCHENC.LO, 1966, PEDIATRICS, V37, P403
   MERRITT TA, 1978, WESTERN J MED, V128, P212
   MURPHY DA, 1974, J THORAC CARDIOV SUR, V67, P221
   NEAL WA, 1975, J PEDIATR, V86, P127, DOI 10.1016/S0022-3476(75)80723-2
   NEAL WA, 1977, J PEDIATR, V91, P621, DOI 10.1016/S0022-3476(77)80519-2
   NELSON RJ, 1976, J THORAC CARDIOV SUR, V71, P169
   OPPERMANN HC, 1977, PEDIATR RADIOL, V5, P137, DOI 10.1007/BF00973978
   OXNARD SC, 1976, CLIN RES, pA164
   PARKER BR, 1976, CLIN RES, V24, pA194
   PHILIP AGS, 1975, PEDIATRICS, V55, P44
   POWELL ML, 1963, MED J AUSTRALIA, V2, P58
   RASMUSSEN LF, 1977, CLIN RES, V25, P2
   RHODES PG, 1975, PEDIATRICS, V55, P788
   RITTENHOUSE EA, 1976, J THORAC CARDIOV SUR, V71, P187
   SAHN DJ, 1976, AM J CARDIOL, V38, P73, DOI 10.1016/0002-9149(76)90065-5
   SHANKARAN S, 1977, J PEDIATR, V90, P642, DOI 10.1016/S0022-3476(77)80392-2
   THIBEAULT DW, 1975, J PEDIATR, V86, P120, DOI 10.1016/S0022-3476(75)80722-0
   WENNBERG RP, 1977, J PEDIATR, V90, P647, DOI 10.1016/S0022-3476(77)80393-4
   WILLIAMS WH, 1976, ANN THORAC SURG, V22, P151
   WINTHER J, 1977, PEDIATR RES, V11, P402, DOI 10.1203/00006450-197704000-00200
   ZACHMAN RD, 1974, AM HEART J, V87, P697, DOI 10.1016/0002-8703(74)90413-X
   1977, OCT P M JOHNS HOPK S
NR 38
TC 72
Z9 72
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-3476
J9 J PEDIATR
JI J. Pediatr.
PY 1978
VL 93
IS 4
BP 639
EP 646
PG 8
WC Pediatrics
SC Pediatrics
GA FQ867
UT WOS:A1978FQ86700023
PM 279657
ER

PT J
AU LONGMIRE, WP
   ROSE, AS
AF LONGMIRE, WP
   ROSE, AS
TI HEMODUCTAL PANCREATITIS
SO SURGERY GYNECOLOGY & OBSTETRICS
LA English
DT Article
C1 UNIV CALIF,SCH MED,DEPT SURG,LOS ANGELES,CA 90024.
   UNIV CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90024.
CR AKERS DR, 1972, SURGERY, V71, P817
   BRADBEER JW, 1959, BRIT J SURG, V46, P603, DOI 10.1002/bjs.18004620011
   MELLISH RW, 1961, PEDIATRICS, V27, P397
   Nicholoson GW, 1923, J PATHOL BACTERIOL, V26, P399, DOI 10.1002/path.1700260310
   PARKER BC, 1972, J PEDIATR SURG, V7, P294, DOI 10.1016/0022-3468(72)90128-5
   SANDBLOM P, 1969, T AM SURG ASSOC, V87, P506
   WELCH KJ, 1969, PEDIATRIC SURGERY, P750
   WILLIAMS WH, 1971, SURGERY, V69, P708
   1964, N ENGL J MED, V270, P736
NR 9
TC 71
Z9 71
PU FRANKLIN H MARTIN FOUNDATION
PI CHICAGO
PA 55 E ERIE ST, CHICAGO, IL 60611
SN 0039-6087
J9 SURG GYNECOL OBSTET
JI Surg. Gynecol. Obstet.
PY 1973
VL 136
IS 2
BP 246
EP 250
PG 5
WC Obstetrics & Gynecology; Surgery
SC Obstetrics & Gynecology; Surgery
GA O6374
UT WOS:A1973O637400021
PM 4686768
ER

PT J
AU Shuhaiber, J
   Anderson, RJ
AF Shuhaiber, Jeffrey
   Anderson, Robert J.
TI Meta-analysis of clinical outcomes following surgical mitral valve
   repair or replacement
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Review
DE mitral valve repair; mitral valve replacement; meta-analysis
ID CORONARY-ARTERY-DISEASE; LONG-TERM SURVIVAL; REGURGITATION; SURGERY;
   RECONSTRUCTION; CHORDAE; AGE
AB Although the use of mitral valve surgery has been successful at alleviating mitral valve disease, published studies on either replacement or repair have yielded mixed clinical outcomes regarding differences between repair and replacement. Meta-anatysis of various outcomes from 29 published studies was conducted. Studies were separated into four groups by etiology of disease: ischemic; degenerative/myxomatous; rheumatic and mixed. The summary odds ratio for early mortality, comparing replacement to repair, was 2.24 (1.78-2.80), while the summary total survival hazard ratio was 1.58 (1.41-1.78), replacement compared to repair, indicating worse outcomes among those undergoing mitral valve replacement. The risk of thromboembotism was tower in the repair group (summary hazard ratio = 1.86, replacement vs. repair), while there was no statistical difference in time to re-operation between the two treatment groups (hazard ratio = 0.88 [95% confidence interval: 0.48, 1.62]). Analysis stratified by etiologic classification was able to detect strong evidence of differences in 30-day and total survival outcomes favoring repair for three disease groups (rheumatic, mixed and degenerative). Surgery for ischemic mitral valve had lower 30-day mortality for repair than replacement, but no statistically significant difference in the overall survival was detected. The reported information in the published studies used in the current work tacks sufficient detail to allow summary determination of outcomes by mitral valve repair techniques and by type of mitrat valve replacement. (c) 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
C1 Loyola Univ, Stritch Sch Med, Dept Thorac & Cardiovasc Surg, Maywood, IL 60153 USA.
   Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60612 USA.
RP Shuhaiber, J (reprint author), 42 Hamdenway Papworth Everard, Cambridge CB3 8UG, England.
EM jeffrey01@mac.com
CR ADEBO OA, 1984, THORAC CARDIOV SURG, V32, P139, DOI 10.1055/s-2007-1023370
   AKINS CW, 1994, ANN THORAC SURG, V58, P668
   ANGELL WW, 1987, J THORAC CARDIOV SUR, V93, P665
   ANTUNES MJ, 1990, EUR J CARDIO-THORAC, V4, P257, DOI 10.1016/1010-7940(90)90249-Y
   BOLLING SF, 2001, HEART FAIL REV, V6, P161
   BORENSTEIN M, 2005, COMPRHENSIVE META AN
   Calafiore AM, 2004, ANN THORAC SURG, V77, P1989, DOI 10.1016/j.athoracsur.2003.11.017
   CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323
   COHN LH, 1995, EUR J CARDIO-THORAC, V9, P568, DOI 10.1016/S1010-7940(05)80008-9
   CRAVER JM, 1990, ANN THORAC SURG, V49, P964
   Dahlberg PS, 2003, ANN THORAC SURG, V76, P1539, DOI 10.1016/S0003-4975(03)01071-3
   DION R, 1993, J HEART VALVE DIS, V2, P243
   Enriquez-Sarano M, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.CIR.0000083831.17708.25
   ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022
   GALLOWAY A C, 1989, Annals of Thoracic Surgery, V47, P655
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Gillinov AM, 2003, J THORAC CARDIOV SUR, V125, P1350, DOI 10.1016/S0022-5223(02)73274-1
   Gometza B, 1996, J HEART VALVE DIS, V5, P294
   Gramaglia B, 1999, J CARDIOVASC SURG, V40, P93
   Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945
   Harris KM, 2002, ANN THORAC SURG, V74, P1468, DOI 10.1016/S0003-4975(02)03920-6
   Hausmann H, 1999, J HEART VALVE DIS, V8, P536
   Izhar U, 1999, CIRCULATION, V100, P84
   KAWACHI Y, 1991, JPN CIRC J, V55, P443
   Kim YH, 2005, ANN THORAC SURG, V79, P1895, DOI 10.1016/j.athoracsur.2004.11.005
   Lee EM, 1997, EUR HEART J, V18, P655
   Mantovani V, 2004, J HEART VALVE DIS, V13, P421
   Mohty D, 2001, CIRCULATION S1, V104, P1
   Okita Y, 1993, J Heart Valve Dis, V2, P159
   OLIVEIRA DBG, 1983, BRIT HEART J, V50, P318
   Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
   PERIER P, 1984, CIRCULATION, V70, P187
   RANKIN JS, 1988, J THORAC CARDIOV SUR, V95, P165
   Reece TB, 2004, ANN SURG, V239, P671, DOI 10.1097/sla.0000124297.40815.86
   SAND ME, 1987, J THORAC CARDIOV SUR, V94, P208
   SARRIS GE, 1988, J THORAC CARDIOV SUR, V95, P969
   Seipelt RG, 2001, EUR J CARDIO-THORAC, V20, P270, DOI 10.1016/S1010-7940(01)00817-X
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303
   YACOUB M, 1981, CIRCULATION S2, V64, P11
   Yau TM, 2000, J THORAC CARDIOV SUR, V119, P53, DOI 10.1016/S0022-5223(00)70217-0
NR 41
TC 70
Z9 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD FEB
PY 2007
VL 31
IS 2
BP 267
EP 275
DI 10.1016/j.ejcts.2006.11.014
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 137VO
UT WOS:000244320900028
PM 17175161
ER

PT J
AU Pate, GE
   Al Zubaidi, A
   Chandavimol, M
   Thompson, CR
   Munt, BI
   Webb, JG
AF Pate, Gordon E.
   Al Zubaidi, Abdul
   Chandavimol, Mann
   Thompson, Christopher R.
   Munt, Bradley I.
   Webb, John G.
TI Percutaneous closure of prosthetic paravalvular leaks: Case series and
   review
SO CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
LA English
DT Article
DE prosthetic; valve; aortic; mitral; perivalvular
ID AORTIC-VALVE-REPLACEMENT; AMPLATZER DUCT OCCLUDER; MITRAL-VALVE;
   TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HEMOLYTIC-ANEMIA; FOLLOW-UP;
   PERIVALVULAR LEAK; MECHANICAL VALVES; SURGERY; REGURGITATION
AB Background: Paravalvular leaks (PVLs) are a well-recognized complication of prosthetic valve replacement. Most are asymptomatic and benign, but some may cause symptoms due to a large regurgitant volume or hemolysis. Medical therapy is palliative, while reoperation carries significant morbidity and mortality. Percutaneous transcatheter closure techniques, now routinely applied in the management of pathological cardiac and vascular communications, may be adaptable to PVL closure, potentially offer symptomatic relief. Methods: We reviewed our experience with attempted percutaneous closure of PVLs, using data from medical and procedural records. Results: Between 2001 and 2004, 14 procedures were performed in 10 patients, all under general anesthesia, with transesophageal and radiographic guidance. Mitral (9) and aortic (1) valve replacements were involved, both mechanical and bioprosthetic. A variety of devices were used, including atrial septal occluders, patent ductus arteriosus occluders, and coils (all of label use). Six had a single procedure, which was technically successful in four: in two, the PVL could not be crossed. Four underwent a second procedure, which was technically successful in three; in one the previously deployed device was dislodged necessitating urgent, but ultimately uneventful, surgical removal and leak repair. One patient had transient severe hemolysis, which resolved after 1 week. At 1-year follow-up (9/10 pts) three had died, five had sustained symptomatic improvement while 1 patient with a residual leak still required regular blood transfusions. Conclusions: Percutaneous closure of PVLs is time-consuming but feasible in selected patients, with a reasonable degree of technical and clinical success. A second procedure may be necessary and a variety of complications can occur. (c) 2006 Wiley-Liss, Inc.
C1 St Pauls Hosp, Div Cardiol, Vancouver, BC V6Z 1Y6, Canada.
   Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
RP Webb, JG (reprint author), St Pauls Hosp, Div Cardiol, Room 5002,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.
EM webb@providencehealth.bc.ca
CR ALONSOLEJ F, 1975, ANN THORAC SURG, V19, P571
   Autschbach R, 2000, CIRCULATION, V102, P1
   Azevedo J E, 1992, Rev Port Cardiol, V11, P759
   BARGIGGIA GS, 1990, AM HEART J, V120, P1137, DOI 10.1016/0002-8703(90)90127-J
   BERNAL JM, 1991, J THORAC CARDIOV SUR, V101, P871
   Bortolotti U, 1988, J Card Surg, V3, P459, DOI 10.1111/j.1540-8191.1988.tb00438.x
   Boudjemline Y, 2002, ARCH MAL COEUR VAISS, V95, P483
   Braxton JH, 1996, J HEART VALVE DIS, V5, P169
   CHEN YT, 1990, J CLIN ULTRASOUND, V18, P557, DOI 10.1002/jcu.1870180706
   COHN LH, 1982, CIRCULATION 2, V66, P53
   Condado Jóse Antonio, 2003, J Interv Cardiol, V16, P523, DOI 10.1046/j.1540-8183.2003.01052.x
   DUVERNOY WFC, 1975, CHEST, V68, P102, DOI 10.1378/chest.68.1.102
   ECHEVARRIA JR, 1991, EUR J CARDIO-THORAC, V5, P523, DOI 10.1016/1010-7940(91)90105-S
   Eisenhauer AC, 2001, CATHETER CARDIO INTE, V54, P234, DOI 10.1002/ccd.1274
   Erez E, 2001, EUR J CARDIO-THORAC, V19, P793, DOI 10.1016/S1010-7940(01)00677-7
   Faletra F, 1996, HEART, V75, P609, DOI 10.1136/hrt.75.6.609
   Fischer V, 1991, Bratisl Lek Listy, V92, P451
   Flachskampf F A, 1995, J Am Soc Echocardiogr, V8, P70, DOI 10.1016/S0894-7317(05)80360-8
   FORMOLO JM, 1995, J CLIN ULTRASOUND, V23, P185, DOI 10.1002/jcu.1870230307
   Genoni M, 2000, EUR J CARDIO-THORAC, V17, P14, DOI 10.1016/S1010-7940(99)00358-9
   Genoni M, 2001, J HEART VALVE DIS, V10, P426
   Grunkemeier G L, 2000, Curr Probl Cardiol, V25, P73
   HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801
   HAMMOND GL, 1987, J THORAC CARDIOV SUR, V93, P182
   Hassan A, 2004, CAN J CARDIOL, V20, P149
   Schaff HV, 2002, ANN THORAC SURG, V73, P785, DOI 10.1016/S0003-4975(01)03442-7
   Hijazi ZM, 2004, CATHETER CARDIO INTE, V61, P552, DOI 10.1002/ccd.20022
   HORSTKOTTE D, 1983, Z KARDIOL, V72, P119
   HOURIHAN M, 1992, J AM COLL CARDIOL, V20, P1371
   Hussain ST, 2003, J THORAC CARDIOV SUR, V126, P879, DOI 10.1016/S0022-5223(03)00725-6
   JINDANI A, 1991, J CARDIOVASC SURG, V32, P503
   Jones JM, 2001, J THORAC CARDIOV SUR, V122, P913, DOI 10.1067/mtc.2001.116470
   Kawachi Y, 2002, ARTIF ORGANS, V26, P706, DOI 10.1046/j.1525-1594.2002.06931_2.x
   Kirali K, 2001, J HEART VALVE DIS, V10, P418
   Koch A, 2003, PEDIATR CARDIOL, V24, P576, DOI 10.1007/s00246-003-0403-9
   Kort HW, 2004, CATHETER CARDIO INTE, V61, P548, DOI 10.1002/ccd.10785
   Kort S, 2001, AM HEART J, V142, P476, DOI 10.1067/mhj.2001.117773
   LAKS H, 1993, J CARDIAC SURG, V8, P459, DOI 10.1111/j.1540-8191.1993.tb00394.x
   Lam BK, 2004, ANN THORAC SURG, V77, P191, DOI 10.1016/S0003-4975(03)01455-3
   LEHRER E, 1983, AM HEART J, V106, P762, DOI 10.1016/0002-8703(83)90102-3
   Lengyel M, 1997, J HEART VALVE DIS, V6, P204
   Linden BC, 2003, J HEART VALVE DIS, V12, P400
   LOCK J, 2001, 4 INT WORKSH CATH IN
   MASRI Z, 1990, TEX HEART I J, V17, P106
   MELACINI P, 1992, AM J CARDIOL, V70, P1157, DOI 10.1016/0002-9149(92)90048-4
   Miller D L, 1995, J Heart Valve Dis, V4, P160
   Misawa Yoshio, 2003, Jpn J Thorac Cardiovasc Surg, V51, P355, DOI 10.1007/BF02719467
   Moneta A, 2003, EUR J CARDIO-THORAC, V23, P1074, DOI 10.1016/S1010-7940(03)00163-5
   Moscucci M, 2001, CIRCULATION, V104, pE85, DOI 10.1161/hc4101.096829
   Movsowitz H D, 1994, J Am Soc Echocardiogr, V7, P488
   Pate G, 2004, CAN J CARDIOL, V20, P452
   Peterseim DS, 1999, J THORAC CARDIOV SUR, V117, P890, DOI 10.1016/S0022-5223(99)70368-5
   Piéchaud Jean-François, 2003, J Interv Cardiol, V16, P153, DOI 10.1046/j.1540-8183.2003.08028.x
   Potter DD, 2004, ANN THORAC SURG, V78, P67, DOI 10.1016/j.athorascur.2004.02.014
   Rallidis LS, 1999, AM HEART J, V138, P351, DOI 10.1016/S0002-8703(99)70124-9
   Safi AM, 2000, ANGIOLOGY, V51, P479, DOI 10.1177/000331970005100605
   SCHOEN FJ, 1992, EUR J CARDIO-THORAC, V6, P50
   SCHON HR, 1986, Z KARDIOL, V75, P286
   Schroeyers P, 2001, ANN THORAC SURG, V72, pS1050, DOI 10.1016/S0003-4975(01)02974-5
   Shapira Y, 2004, ANN THORAC SURG, V78, P579, DOI 10.1016/j.athroracsur.2004.02.075
   Shapira Y, 2001, J HEART VALVE DIS, V10, P431
   Sinha D P, 1996, J Assoc Physicians India, V44, P525
   SMITH RE, 1991, J CARDIOVASC SURG, V32, P56
   Taggart D P, 1988, Eur J Cardiothorac Surg, V2, P137, DOI 10.1016/1010-7940(88)90060-7
   Taylor K M, 1992, J Heart Valve Dis, V1, P152
   Vanermen H, 2000, J CARDIAC SURG, V15, P51, DOI 10.1111/j.1540-8191.2000.tb00444.x
   Webb JG, 2005, CATHETER CARDIO INTE, V65, P69, DOI 10.1002/ccd.20337
   WILLIAMS TE, 1995, ANN THORAC SURG, V59, P243, DOI 10.1016/0003-4975(94)00872-5
NR 68
TC 70
Z9 71
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1522-1946
J9 CATHETER CARDIO INTE
JI Catheter. Cardiovasc. Interv.
PD OCT
PY 2006
VL 68
IS 4
BP 528
EP 533
DI 10.1002/ccd.20795
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 091SG
UT WOS:000241048000006
PM 16969856
ER

PT J
AU Sachweh, JS
   Vazquez-Jimenez, JF
   Schondube, FA
   Daebritz, SH
   Dorge, H
   Muhler, EG
   Messmer, BJ
AF Sachweh, JS
   Vazquez-Jimenez, JF
   Schondube, FA
   Daebritz, SH
   Dorge, H
   Muhler, EG
   Messmer, BJ
TI Twenty years experience with pediatric pacing: epicardial and
   transvenous stimulation
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 13th Annual Meeting of the
   European-Association-for-Cardio-Thoracic-Surgery
CY SEP 05-08, 1999
CL GLASGOW, SCOTLAND
SP European Assoc Cardio Thoracic Surg
DE cardiac pacemaker; heart surgery; congenital heart disease
ID TERM FOLLOW-UP; CHILDREN; ELECTRODES; PACEMAKER; LEADS
AB Objective: Permanent cardiac pacing in children and adolescents is rare and often occurs by means of epicardial pacing. Based on two decades of experience, operative and postoperative data of patients with epicardial and transvenous pacing were analyzed retrospectively. Methods: Between October 1979 and December 1998, 71 patients (mean age, 5.3 +/- 4.2, range, 1 day-16.2 years; mean body weight, 18 +/- 12; range, 8-56 kg) underwent permanent pacemaker implantation. Indications were sinus node dysfunction and atrio-ventricular block following surgery for congenital heart disease (69%), or congenital atrioventricular block (31%). Pacing was purely atrial (1.4%), purely ventricular (73%), ventricular with atrial synchronization (5.6%), or atrioventricular synchronized (20%). Epicardial pacing was established in 49 (69%), transvenous in 22 (31%) patients. Follow-up was 3.4 +/- 3.8 years (epicardial) and 3.0 +/- 4.0 years (transvenous). Results: Epicardial leads were implanted in younger patients (mean age: 4.5 vs. 7.0 years, P < 0.05) and preferably after surgery induced atrioventricular block (78 vs. 46%, P < 0.05). The youngest patient with transvenous pacing was 1.3 years old (weight, 8.5 kg). At implantation epicardial ventricular stimulation threshold at 1.0 ms was 1.07 +/- 0.46 vs. 0.53 +/- 0.31 V (transvenous) (P < 0.05). The age-adjusted rate of lead-related reoperations was significantly higher in patients with epicardial leads (P < 0.05), mainly due to increasing chronic stimulation thresholds resulting in early battery depletion. In three patients who received steroid-eluting epicardial leads initial low thresholds persisted after five month to one years. In two patients with recurrent epicardial threshold increase, steroid-eluting epicardial leads led to good acute and chronic thresholds after nine to 15 month. Two post-operative death (2.8%) were probably due to a dysfunction of the (epicardial) pacing system. Conclusions: Transvenous pacing in the pediatric population is associated with a lower acute stimulation threshold and a lower rate of lead-related complications. If epicardial pacing is necessary (e.g. small body weight, special intracardiac anatomy (e.g. Fontan), impossible access to superior caval vein), steroid-eluting leads may be considered. (C) 2000 Elsevier Science B.V. Ail rights reserved.
C1 Univ Hosp, Dept Thorac & Cardiovasc Surg, D-52057 Aachen, Germany.
   Univ Hosp, Dept Pediat Cardiol, D-52057 Aachen, Germany.
RP Sachweh, JS (reprint author), Univ Hosp, Dept Thorac & Cardiovasc Surg, Pauwelsstr 30, D-52057 Aachen, Germany.
CR Bauersfeld U, 1999, ANN THORAC SURG, V68, P1380, DOI 10.1016/S0003-4975(99)00695-5
   BEUFORTKROL GC, 1999, J THORAC CARDIOVASC, V117, P523
   Bonatti V, 1998, Pediatr Med Chir, V20, P181
   BYRD CL, 1990, PACE, V13, P1856, DOI 10.1111/j.1540-8159.1990.tb06903.x
   Cutler NG, 1997, PACE, V20, P2943, DOI 10.1111/j.1540-8159.1997.tb05464.x
   DELEON SY, 1990, J THORAC CARDIOV SUR, V99, P905
   ESPERER HD, 1993, THORAC CARDIOV SURG, V41, P21, DOI 10.1055/s-2007-1013815
   GILETTE PC, 1983, AM HEART J, V105, P843
   GILETTE PC, 1988, PACE, V11, P1935
   HENGLEIN D, 1984, PACE, V7, P203, DOI 10.1111/j.1540-8159.1984.tb04887.x
   KERSTJENSFREDERIKSE MWS, 1991, INT J CARDIOL, V33, P207, DOI 10.1016/0167-5273(91)90348-S
   MICHALIK RE, 1984, PACE, V7, P831, DOI 10.1111/j.1540-8159.1984.tb05624.x
   NORDLANDER R, 1992, SCAND J THORAC CARD, V26, P69, DOI 10.3109/14017439209099056
   ROSENTHAL E, 1995, PACE, V18, P2103, DOI 10.1111/j.1540-8159.1995.tb03874.x
   SPITTELL PC, 1992, MAYO CLIN PROC, V67, P258
   TILL JA, 1990, PACE, V13, P1385, DOI 10.1111/j.1540-8159.1990.tb04013.x
   WARD DE, 1985, CLIN PROG ELECTROPHY, V3, P133
   WARD DE, 1983, PEDIAT CARDIOLOGY, P34
   WEBER H, 1983, PACE, V6, P95
   Williams WG, 1983, CLIN PROG ELECTROPHY, V4, P478
NR 20
TC 70
Z9 72
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD APR
PY 2000
VL 17
IS 4
BP 455
EP 461
DI 10.1016/S1010-7940(00)00364-X
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 311WT
UT WOS:000086909700030
PM 10773570
ER

PT J
AU Stone, NN
   Stock, RG
AF Stone, NN
   Stock, RG
TI Prostate brachytherapy: Treatment strategies
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT 93rd Annual Meeting of the American-Urological-Association
CY MAY 30-JUN 04, 1998
CL SAN DIEGO, CALIFORNIA
SP Amer Urol Assoc
DE prostatic neoplasms; brachytherapy; radiation
ID EXTERNAL-BEAM RADIOTHERAPY; SEMINAL-VESICLE BIOPSY; LYMPH-NODE
   DISSECTION; RADICAL PROSTATECTOMY; RADIATION-THERAPY; ANTIGEN LEVELS;
   PATHOLOGICAL FACTORS; CANCER; CARCINOMA; IRRADIATION
AB Purpose: Patients who present with localized and locally advanced prostate cancer may be candidates for prostate brachytherapy. We evaluated the treatment outcomes in a diverse group of prostate cancer patients who presented with low, moderate and high risk features.
   Materials and Methods: A total of 301 patients who presented with T1 to T3 prostate cancer were treated with brachytherapy alone or combined with hormonal therapy and/or external beam irradiation. Of these patients 109 at low risk with prostate specific antigen (PSA) 10 ng/ml. or less, Gleason score 6 or less and clinical stage T2a or less were treated with iodine alone, 152 at moderate risk with PSA greater than 10 ng/ml., Gleason score greater than 6 or stage T2b or greater were treated with (125)iodine or (103)palladium or combined implant alone with 5 months of hormonal therapy, and 40 at high risk with PSA greater than 15 ng./ml., Gleason 8 or greater, clinical stage T2c to T3 or positive seminal vesicle biopsy (20) were treated with combination brachytherapy, external beam irradiation and 9 months of hormonal therapy. Patients with a positive seminal vesicle biopsy (T3c disease) and negative pelvic lymph nodes were included in the high risk group, and the walls of the seminal vesicles were also treated with implantation. Followup was performed every 6 months with digital rectal examination and ultrasound evaluation. Prostate biopsy was routinely recommended 2 years after completion of the radiation. Failure was defined as PSA increase on 2 consecutive determinations above 1 ng./ml. or evidence of local recurrence on digital rectal examination, transrectal ultrasound or biopsy. Kaplan-Meier projections were used to calculate progression-free survival rates.
   Results: Of the 109 patients at low risk followed from 1 to 7 years (median 18 months) 91% were free of PSA failure at 4 years. No patient experienced urinary incontinence following implantation, although grade 1 to 2 radiation proctitis occurred in 5 (4.5%). Of the 152 patients at moderate risk 73 received implantation and 79 received implantation combined with hormonal therapy. The 4-year biochemical freedom from failure rate for the hormone group was 85% versus 58% for the no hormone group (p = 0.08). The difference was more significant for those with Gleason score 7 or greater (90 versus 43%, p = 0.01) and for those with PSA greater than 10 ng./ml. (87 versus 59%, p = 0.04). Grade 1 to 2 radiation proctitis occurred in 1 of the 79 patients (1.3%) receiving hormonal therapy and in 3 (4%) treated with implantation only. There were no cases of urinary incontinence. Of the 40 patients at high risk 71% were free of biochemical failure at 3 years. Of the 4 patients with failure (10%) 3 (75%) originally had positive seminal vesicle biopsies. Five patients experienced gastrointestinal complications, although none was grade 3 or 4. The actuarial freedom from grade 2 proctitis was 82%. No patient experienced urinary incontinence. Prostate biopsies were negative in 87% of the low risk, 96.8 (hormone group) versus 68.6% (no hormone group) of the moderate risk (p = 0.0023) and 86% of the high risk patients,
   Conclusions: Brachytherapy appears to offer comparable results to external beam irradiation and radical prostatectomy when patients are stratified by disease extent. adopting a strategy of implant alone, implant with hormonal therapy or implant with hormonal therapy and external beam irradiation in patients who present with low to high risk features can improve the overall results in the more advanced cases.
C1 Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA.
   Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY 10029 USA.
RP Stone, NN (reprint author), Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA.
CR BLASKO JC, 1997, MOL UROL, V1, P207
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko John, 1996, International Journal of Radiation Oncology Biology Physics, V36, P198, DOI 10.1016/S0360-3016(97)85421-1
   CATALONA WJ, 1990, J UROLOGY, V143, P538
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   DAMICO AV, 1995, J UROLOGY, V154, P131, DOI 10.1016/S0022-5347(01)67248-3
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Hanks GE, 1996, J CLIN ONCOL, V14, P1093
   HANKS GE, 1988, INT J RADIAT ONCOL, V15, P1299
   HANKS GE, 1995, J UROLOGY, V154, P456, DOI 10.1016/S0022-5347(01)67073-3
   HOLM HH, 1983, J UROLOGY, V130, P283
   KUBAN DA, 1995, INT J RADIAT ONCOL, V32, P307, DOI 10.1016/0360-3016(95)00137-N
   Kupelian P, 1996, UROLOGY, V48, P249, DOI 10.1016/S0090-4295(96)00167-7
   Kupelian P, 1997, CANCER J SCI AM, V3, P78
   Laverdiere J, 1997, INT J RADIAT ONCOL, V37, P247, DOI 10.1016/S0360-3016(96)00513-5
   LEE WR, 1995, J CLIN ONCOL, V13, P464
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   Paterson R., 1934, British Journal of Radiology, V7
   PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3
   Quimby EH, 1932, AM J ROENTGENOL RADI, V27, P18
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Stock RG, 1997, SEMIN SURG ONCOL, V13, P454, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<454::AID-SSU10>3.0.CO;2-T
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   STOCK RG, 1995, INT J RADIAT ONCOL, V33, P815, DOI 10.1016/0360-3016(95)02007-4
   STONE NN, 1995, RADIAT ONCOL INVEST, V3, P185, DOI 10.1002/roi.2970030407
   STONE NN, 1995, J UROLOGY, V154, P1392, DOI 10.1016/S0022-5347(01)66874-5
   Vicini FA, 1997, J UROLOGY, V158, P319, DOI 10.1016/S0022-5347(01)64471-9
   Vicini FA, 1998, INT J RADIAT ONCOL, V40, P1101, DOI 10.1016/S0360-3016(97)00942-5
   ZAGARS GK, 1994, J UROLOGY, V152, P1786
   ZAGARS GK, 1995, UROLOGY, V45, P476, DOI 10.1016/S0090-4295(99)80019-3
   Zeitman AL, 1994, UROLOGY, V43, P828
   ZEITMAN AL, 1994, J UROLOGY, V151, P640
NR 35
TC 70
Z9 73
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD AUG
PY 1999
VL 162
IS 2
BP 421
EP 426
DI 10.1016/S0022-5347(05)68574-6
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 214UA
UT WOS:000081344900033
PM 10411050
ER

PT J
AU Wang, Q
   Pomerantz, EM
   Chen, HC
AF Wang, Qian
   Pomerantz, Eva M.
   Chen, Huichang
TI The role of parents' control in early adolescents' psychological
   functioning: A longitudinal investigation in the united states and china
SO CHILD DEVELOPMENT
LA English
DT Article
ID CROSS-CULTURAL RESEARCH; PERCEIVED CONTROL; AUTONOMY; ACHIEVEMENT;
   CHILDREN; VALIDATION; CONSTRUCT; BEHAVIOR; FAMILY; DOMAIN
AB This research compared the effects over time of parents' control and autonomy support on children's functioning in the United States and China. American and Chinese (N = 806) seventh graders (mean age = 12.73 years) participated in a 6-month longitudinal study. Children reported on their parents' psychological control, psychological autonomy support, behavioral control, and their own emotional and academic functioning. Children's grades were obtained. Supporting cultural similarities, in both countries over time, parents' psychological control predicted children's dampened emotional functioning, parents' psychological autonomy support predicted children's enhanced emotional and academic functioning, and parents' behavioral control predicted children's enhanced academic functioning. Supporting cultural differences, the beneficial effects of parents' psychological autonomy support were generally stronger in the United States than in China.
C1 Univ Illinois, Dept Psychol, Champaign, IL 61820 USA.
   Chinese Univ Hong Kong, Sha Tin 100083, Peoples R China.
   Beijing Normal Univ, Beijing 100875, Peoples R China.
RP Wang, Q (reprint author), Univ Illinois, Dept Psychol, 603 E Daniel St, Champaign, IL 61820 USA.
EM qianwang@psy.cuhk.edu.hk; pomerntz@uiuc.edu
RI Wang, Qian/J-1412-2012
CR ARBUCKLE J. L., 2005, AMOS 6 0 USERS GUIDE
   Arbuckle J. L., 1996, ADV STRUCTURAL EQUAT, P243
   Barber B. K, 2002, INTRUSIVE PARENTING
   Barber B. K., 2006, MONOGRAPH SOC RES CH, V70, P1
   Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.1111/j.1467-8624.1996.tb01915.x
   Bollen K. A., 1989, STRUCTURAL EQUATIONS
   Brislin R. W., 1980, HDB CROSS CULTURAL P, P389
   Chao R., 2002, HDB PARENTING, V4, P59
   Chao R. K, 1994, CHILD DEV, V65, P111
   Chen CS, 1998, DEV PSYCHOL, V34, P770, DOI 10.1037//0012-1649.34.4.770
   Chen XY, 2000, J FAM PSYCHOL, V14, P401, DOI 10.1037//0893-3200.14.3.401
   Cheung GW, 2000, J CROSS CULT PSYCHOL, V31, P187, DOI 10.1177/0022022100031002003
   Chirkov VI, 2001, J CROSS CULT PSYCHOL, V32, P618, DOI 10.1177/0022022101032005006
   d'Ailly H, 2003, J EDUC PSYCHOL, V95, P84, DOI 10.1037/0022-0663.95.1.84
   de Bary Wm. Theodore, 1983, LIBERAL TRADITION CH
   DIENER E, 1995, J PERS SOC PSYCHOL, V69, P130, DOI 10.1037//0022-3514.69.1.130
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Dowson M, 2004, EDUC PSYCHOL MEAS, V64, P290, DOI 10.1177/0013164403251335
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Fuligni AJ, 1999, CHILD DEV, V70, P1030, DOI 10.1111/1467-8624.00075
   Fung H, 1999, ETHOS, V27, P180, DOI 10.1525/eth.1999.27.2.180
   Gonzales NA, 1996, CHILD DEV, V67, P1483, DOI 10.1111/j.1467-8624.1996.tb01809.x
   Gray MR, 1999, J MARRIAGE FAM, V61, P574, DOI 10.2307/353561
   Greenfield PM, 2003, ANNU REV PSYCHOL, V54, P461, DOI 10.1146/annurev.psych.54.101601.145221
   GROLNICK, 2003, PSYCHOL PARENTAL CON
   GROLNICK, 1989, J ED PSYCHOL, V81, P143
   GROLNICK WS, 1991, J EDUC PSYCHOL, V83, P508, DOI 10.1037/0022-0663.83.4.508
   GROLNICK WS, 1994, CHILD DEV, V65, P237, DOI 10.1111/j.1467-8624.1994.tb00747.x
   Hasebe Y, 2004, CHILD DEV, V75, P815, DOI 10.1111/j.1467-8624.2004.00708.x
   Helwig CC, 2003, CHILD DEV, V74, P783, DOI 10.1111/1467-8624.00568
   Ho D. Y. F, 1996, HDB CHINESE PSYCHOL, P155
   Hoffman M., 2000, EMPATHY MORAL DEV
   Keith T. Z., 2006, MULTIPLE REGRESSION
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   KISHTON JM, 1994, EDUC PSYCHOL MEAS, V54, P757, DOI 10.1177/0013164494054003022
   Kline R. B., 2005, PRINCIPLES PRACTICE
   LAU S, 1987, DEV PSYCHOL, V23, P726, DOI 10.1037/0012-1649.23.5.726
   Little TD, 2000, J CROSS CULT PSYCHOL, V31, P213, DOI 10.1177/0022022100031002004
   Maccoby E. E., 1983, HDB CHILD PSYCHOL, VIV, P1
   MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224
   McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64
   MCPARTLAND JM, 1977, SOCIOL EDUC, V50, P133, DOI 10.2307/2112375
   Olsen S. F., 2002, INTRUSIVE PARENTING, P235, DOI DOI 10.1037/10422-008
   Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3
   PATRICK BC, 1993, J PERS SOC PSYCHOL, V65, P781, DOI 10.1037/0022-3514.65.4.781
   Pomerantz EM, 2000, J PERS SOC PSYCHOL, V79, P617, DOI 10.1037//0022-3514.79.4.617
   Pomerantz EM, 2001, J FAM PSYCHOL, V15, P510, DOI 10.1037//0893-3200.15.3.510
   Robbins R. J., 1994, THESIS U ROCHESTER, P1994
   Rosenberg M., 1965, SOC ADOLESCENT SELF
   ROWE DC, 1994, PSYCHOL REV, V101, P396, DOI 10.1037/0033-295X.101.3.396
   RYAN R. M., 2002, HDB SELF DETERMINATI, P3
   Sessa FM, 2001, J FAM PSYCHOL, V15, P53, DOI 10.1037/0893-3200.15.1.53
   Shweder R. A., 1998, HDB CHILD PSYCHOL, VI, P865
   SHWEDER RA, 1993, ANNU REV PSYCHOL, V44, P497, DOI 10.1146/annurev.psych.44.1.497
   Silk JS, 2003, J RES ADOLESCENCE, V13, P113, DOI 10.1111/1532-7795.1301004
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528
   Steinberg L, 2001, J RES ADOLESCENCE, V11, P1, DOI 10.1111/1532-7795.00001
   STEINBERG L, 1992, CHILD DEV, V63, P1266, DOI 10.1111/j.1467-8624.1992.tb01694.x
   Steinberg L., 2005, NEW DIRECTIONS CHILD, P71
   Steinberg L., 1990, THRESHOLD DEV ADOLES, P255
   Stewart SM, 2002, INT J PSYCHOL, V37, P74, DOI 10.1080/00207590413000162
   STICE E, 1995, DEV PSYCHOL, V31, P322, DOI 10.1037//0012-1649.31.2.322
   TAFARODI RW, 1995, J PERS ASSESS, V65, P322, DOI 10.1207/s15327752jpa6502_8
   TERRY T, 1995, SOC INDIC RES, V35, P39, DOI 10.1007/BF01079237
   Vansteenkiste M, 2005, J EDUC PSYCHOL, V97, P468, DOI 10.1037/0022-0663.97.3.468
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
NR 67
TC 69
Z9 75
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0009-3920
J9 CHILD DEV
JI Child Dev.
PD SEP-OCT
PY 2007
VL 78
IS 5
BP 1592
EP 1610
DI 10.1111/j.1467-8624.2007.01085.x
PG 19
WC Psychology, Educational; Psychology, Developmental
SC Psychology
GA 213IC
UT WOS:000249659100012
PM 17883450
ER

PT J
AU Chen, JS
   Ko, WJ
   Yu, HY
   Lai, LP
   Huang, SC
   Chi, NH
   Tsai, CH
   Wang, SS
   Lin, FY
   Chen, YS
AF Chen, JS
   Ko, WJ
   Yu, HY
   Lai, LP
   Huang, SC
   Chi, NH
   Tsai, CH
   Wang, SS
   Lin, FY
   Chen, YS
TI Analysis of the outcome for patients experiencing myocardial infarction
   and cardiopulmonary resuscitation refractory to conventional therapies
   necessitating extracorporeal life support rescue
SO CRITICAL CARE MEDICINE
LA English
DT Article; Proceedings Paper
CT 13th World Congress of the Society-of-Cardiothoracic-Surgeons
CY NOV 01-05, 2003
CL San Diego, CA
SP Soc Cardiothorac Surg
DE extracorporeal life support; acute myocardial infarction; cardiogenic
   shock; beating heart; coronary bypass grafting
ID VENTRICULAR ASSIST DEVICE; FAILURE ASSESSMENT SCORE; CARDIOGENIC-SHOCK;
   MEMBRANE-OXYGENATION; CARDIAC-ARREST; ORGAN DYSFUNCTION/FAILURE;
   IMPROVED SURVIVAL; TEMPORAL TRENDS; SOFA SCORE; OFF-PUMP
AB Objective. To analyze the results of acute myocardial infarction (AMI) complicated with refractory shock necessitating extracorporeal life support (ECLS) rescue and to search for associated risk factors.
   Design: Retrospective review of our 9-yr experience with patients initially presenting with AN with shock necessitating ECLS rescue; analysis of patient outcomes.
   Setting. A university-affiliated tertiary referral medical center.
   Patients: Between 1994 and 2003 inclusively, 36 consecutive patients (age [mean +/- So], 57 +/- 10 yrs) with AMI complicated by refractory shock and undergoing cardiopulmonary resuscitation (CPR) necessitating emergent ECLS rescue were enrolled in this study.
   Intervention: All patients underwent CPR before ECLS, although 30 patients (83.3%) received ECLS during CPR because spontaneous circulation failed to return. All patients underwent intraaortic counterpulsation either before or following rescue. Seven patients underwent angioplasty only, and one underwent heart transplantation without any intervention. Twenty-eight patients underwent coronary artery bypass grafting (CABG), in which the beating-heart technique was used for 20 patients.
   Measurements and Main Results: The pre-ECLS blood lactate level was high (13.4 +/- 8.5 mmol/L), as was the inotropic score (121.4 +/- 117.3 mu g/kg/min). Twenty-five patients (69.4%) were successfully weaned off ECLS, and 12 (48%) survived to discharge (one had a neurologic deficit). The overall mortality rate was 66.7%. A lower inotropic score, reduced blood lactate level, shorter CPR duration, surgical revascularization, and a reduced total maximal Sepsis-related Organ Failure Assessment (SOFA) score were noted among survivors. Liver failure, central nervous system failure, and renal failure mainly occurred in nonsurvivors after ECLS. The technique used for surgical revascularization (beating heart or arrested heart) did not influence the outcome. ECLS is associated with a lower mortality rate than that expected (> 90%) from the resultant total maximal SOFA score (16.6 +/- 3.0).
   Conclusions: AN complicated with refractory shock remains associated with a high mortality rate, even following ECLS rescue, although ECLS might afford a better chance of survival. The SOFA score can be applied to ECLS condition as a reference point for predicting outcome.
C1 Far Eastern Mem Hosp, Ctr Cardiovasc, Div Cardiovasc Surg, Taipei, Taiwan.
   Natl Taiwan Univ Hosp, Dept Cardiol, Taipei, Taiwan.
   Natl Taiwan Univ Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan.
   Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan.
   Natl Taiwan Univ Hosp, Dept Surg, Yunlin, Taiwan.
RP Chen, JS (reprint author), Far Eastern Mem Hosp, Ctr Cardiovasc, Div Cardiovasc Surg, Taipei, Taiwan.
CR Alwan K, 2004, ANN THORAC SURG, V77, P2051, DOI 10.1016/j.athoracsur.2003.11.004
   Bertrand ME, 2003, J AM COLL CARDIOL, V42, P1387, DOI 10.1016/S0735-1097(03)01049-0
   Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3
   Ceriani R, 2003, CHEST, V123, P1229, DOI 10.1378/chest.123.4.1229
   Chen JM, 1999, J AM COLL CARDIOL, V33, P1903, DOI 10.1016/S0735-1097(99)00132-1
   Chen YS, 2001, J HEART LUNG TRANSPL, V20, P850, DOI 10.1016/S1053-2498(01)00267-4
   CHEN YS, 2004, AM J TRANSPLANT, V4, P181
   Chen YS, 2003, J AM COLL CARDIOL, V41, P197, DOI 10.1016/S0735-1097(02)02716-X
   Dauerman HL, 2002, AM J CARDIOL, V90, P838, DOI 10.1016/S0002-9149(02)02704-2
   Entwistle JWC, 2003, HEART SURG FORUM, V6, P316
   GOLDBERG RJ, 1991, NEW ENGL J MED, V325, P1117, DOI 10.1056/NEJM199110173251601
   Goldberg RJ, 1999, NEW ENGL J MED, V340, P1162, DOI 10.1056/NEJM199904153401504
   Goldberg RJ, 2001, AM HEART J, V141, P65, DOI 10.1067/mhj.2001.111405
   HANDS ME, 1989, J AM COLL CARDIOL, V14, P40
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2
   Huang SC, 2004, J THORAC CARDIOV SUR, V128, P776, DOI 10.1016/j.jtcvs.2004.03.042
   KOICHI F, 2001, ARTIF ORGANS, V25, P1000
   LANDRY FJ, 1992, ARCH INTERN MED, V152, P2305, DOI 10.1001/archinte.152.11.2305
   Massetti M, 2005, ANN THORAC SURG, V79, P178, DOI 10.1016/j.athoracsur.2004.06.095
   Menon V, 2002, HEART, V88, P531, DOI 10.1136/heart.88.5.531
   MITSURO K, 1994, CLIN CARDIOL, V17, P552
   Ngaage DL, 2003, EUR J CARDIO-THORAC, V24, P557, DOI 10.1016/S1010-7940(03)00381-6
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Rhodes JF, 1999, CIRCULATION, V100, P194
   Schultz SC, 1996, RESUSCITATION, V33, P13, DOI 10.1016/S0300-9572(96)00986-0
   Schwarz B, 2003, CRIT CARE MED, V31, P758, DOI 10.1097/01.CCM.0000053522.55711.E3
   Stone GW, 2003, J AM COLL CARDIOL, V41, P1940, DOI 10.1016/S0735-1097(03)00400-5
   van den Brand MJBM, 2002, J AM COLL CARDIOL, V39, P559, DOI 10.1016/S0735-1097(01)01785-5
   Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751
   Vincent JL, 1998, CRIT CARE MED, V26, P1793
   Wang SS, 2001, ARTIF ORGANS, V25, P599, DOI 10.1046/j.1525-1594.2001.025008599.x
   WEB JG, 2001, AM HEART J, V141, P964
NR 33
TC 69
Z9 76
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PD APR
PY 2006
VL 34
IS 4
BP 950
EP 957
DI 10.1097/01.CCM.0000206103.35460.1F
PG 8
WC Critical Care Medicine
SC General & Internal Medicine
GA 025YH
UT WOS:000236303000003
PM 16484889
ER

PT J
AU DeVore, ER
   Ginsburg, KR
AF DeVore, ER
   Ginsburg, KR
TI The protective effects of good parenting on adolescents
SO CURRENT OPINION IN PEDIATRICS
LA English
DT Review
DE adolescent; parental communication; parental monitoring; parenting;
   parenting style; risk behaviors
ID HEALTH-RISK BEHAVIORS; OF-SCHOOL CARE; YOUNG ADOLESCENTS; FEMALE
   ADOLESCENTS; SEXUAL INTERCOURSE; INVOLVEMENT; INTERVENTION; PERCEPTIONS;
   INITIATION; KNOWLEDGE
AB Purpose of review To explore recent developments in the literature regarding parenting practices and adolescent development, with a focus on parenting style, parental monitoring, communication, and supervision.
   Recent findings There have been significant recent advances in the study of the relationship between parenting and adolescent development. Several recent intervention studies with a parenting component demonstrated immediate and long-term protective effects on adolescent risk behavior. Parent-child connectedness and authoritative parenting style are protective for teens. Parental monitoring has a protective effect on many adolescent risk behaviors in both middle-class populations and poor urban environments and has been shown both to moderate the effect of peer influence and to persist into late adolescence. Whereas unsupervised time, exposure to sexual possibility situations, and out-of-home care increase sexual behavior, improved parent-child communication reduces sexual risk behaviors.
   Summary Recent scholarship demonstrates the significant, enduring, and protective influence of positive parenting practices on adolescent development. In particular, parental monitoring, open parent-child communication, supervision, and high quality of the parent-child relationship deter involvement in high-risk behavior. Authoritative parenting generally leads to the best outcomes for teens. Clinicians should find opportunities to discuss evidence-based parenting practices with families. Future research should focus on the development and long-term evaluation of effective parenting interventions.
C1 Childrens Hosp, Div Adolescent Young Adult Med, Dept Med, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Childrens Hosp Philadelphia, Craig Dalsimer Div Adolescent Med, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Med, Philadelphia, PA 19104 USA.
RP DeVore, ER (reprint author), Childrens Hosp, Div Adolescent Young Adult Med, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.
EM Elise.devore@childrens.harvard.edu
RI Berlan, Elise/E-2744-2011
CR Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1
   Beck KH, 2004, AM J HEALTH BEHAV, V28, P272
   Bettinger JA, 2004, ARCH PEDIAT ADOL MED, V158, P666, DOI 10.1001/archpedi.158.7.666
   Bingham CR, 2004, J STUD ALCOHOL, V65, P84
   Blake SM, 2001, FAM PLANN PERSPECT, V33, P52, DOI 10.2307/2673750
   Borawski EA, 2003, J ADOLESCENT HEALTH, V33, P60, DOI 10.1016/S1054-139X(03)00100-9
   Buckner JC, 2003, DEV PSYCHOPATHOL, V15, P139, DOI 10.1017/S0954579403000087
   *CDC, 2005, NATL CTR CHRON DIS P
   COHEN DA, 2002, PEDIATRICS, V100, pE66
   Coley RL, 2004, CHILD DEV, V75, P948
   COTTON S, 2004, J ADOLESCENT HEALTH, V34, P4553
   Crosby RA, 2003, ARCH PEDIAT ADOL MED, V157, P169
   Crosby RA, 2001, PREV MED, V33, P175, DOI 10.1006/pmed.2001.0868
   DiClemente RJ, 2001, J PEDIATR, V139, P407, DOI 10.1067/mpd.2001.117075
   DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363
   DILORIO C, 2004, J ADOLESCENT HEALTH, V35, pE511
   DORNBUSCH SM, 1987, CHILD DEV, V58, P1244, DOI 10.1111/j.1467-8624.1987.tb01455.x
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Hawkins JD, 2005, ARCH PEDIAT ADOL MED, V159, P25, DOI 10.1001/archpedi.159.1.25
   Huebner AJ, 2003, J ADOLESCENT HEALTH, V33, P71, DOI 10.1016/S1054-139X(03)00141-1
   Juang LP, 2002, J ADOLESCENCE, V25, P3, DOI 10.1006/jado.2001.0445
   Lammers C, 2000, J ADOLESCENT HEALTH, V26, P42, DOI 10.1016/S1054-139X(99)00041-5
   Li XM, 2000, J ADOLESCENT HEALTH, V27, P49, DOI 10.1016/S1054-139X(00)00092-6
   Li XM, 2000, J ADOLESCENT HEALTH, V27, P43, DOI 10.1016/S1054-139X(99)00077-4
   Lloyd JJ, 2003, J URBAN HEALTH, V80, P383, DOI 10.1093/jurban/jtg043
   Meschke LL, 2002, J ADOLESCENT HEALTH, V31, P264, DOI 10.1016/S1054-139X(02)00499-8
   Parker JS, 2004, ADOLESCENCE, V39, P519
   Pearce MJ, 2003, CHILD DEV, V74, P1682, DOI 10.1046/j.1467-8624.2003.00631.x
   Pittman LD, 2001, J RES ADOLESCENCE, V11, P199, DOI 10.1111/1532-7795.00010
   Rai AA, 2003, J ADOLESCENT HEALTH, V33, P108, DOI 10.1016/S1054-139X(03)00179-4
   Ramirez JR, 2004, PSYCHOL ADDICT BEHAV, V18, P3, DOI 10.1037/0893-164X.18.1.3
   Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823
   Richards MH, 2004, J CLIN CHILD ADOLESC, V33, P138, DOI 10.1207/S15374424JCCP3301_13
   Roche KM, 2005, ARCH PEDIAT ADOL MED, V159, P68, DOI 10.1001/archpedi.159.1.68
   Simons-Morton BG, 2004, HEALTH EDUC RES, V19, P561, DOI 10.1093/her/cyg071
   Stanton B, 2004, ARCH PEDIAT ADOL MED, V158, P947, DOI 10.1001/archpedi.158.10.947
   Stanton B, 2002, J URBAN HEALTH, V79, P536, DOI 10.1093/jurban/79.4.536
   Stanton BF, 2000, J ADOLESCENT HEALTH, V26, P18, DOI 10.1016/S1054-139X(99)00022-1
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   STEINBERG L, 1992, CHILD DEV, V63, P1266, DOI 10.1111/j.1467-8624.1992.tb01694.x
   Sullivan TN, 2004, J CLIN CHILD ADOLESC, V33, P488, DOI 10.1207/s15374424jccp3303_6
   Tilson EC, 2004, J ADOLESCENT HEALTH, V35, P182, DOI 10.1016/j.jadohealth.2003.09.014
   Tolan P, 2004, J CONSULT CLIN PSYCH, V72, P855, DOI 10.1037/0022-006X.72.5.855
   Ungar M, 2004, FAM PROCESS, V43, P23, DOI 10.1111/j.1545-5300.2004.04301004.x
   Waizenhofer RN, 2004, J FAM PSYCHOL, V18, P348, DOI 10.1037/0893-3200.18.2.348
   Wilder EI, 2002, MILBANK Q, V80, P481, DOI 10.1111/1468-0009.00020
   Williams KM, 2002, PREV MED, V35, P593, DOI 10.1006/pmed.2002.1112
   Wood MD, 2004, PSYCHOL ADDICT BEHAV, V18, P19, DOI 10.1037/0893-164X.18.1.19
NR 48
TC 69
Z9 69
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1040-8703
J9 CURR OPIN PEDIATR
JI CURR. OPIN. PEDIATR.
PD AUG
PY 2005
VL 17
IS 4
BP 460
EP 465
DI 10.1097/01.mop.0000170514.27649.c9
PG 6
WC Pediatrics
SC Pediatrics
GA 947AD
UT WOS:000230613500003
PM 16012256
ER

PT J
AU Stokes, SH
AF Stokes, SH
TI Comparison of biochemical disease-free survival of patients with
   localized carcinoma of the prostate undergoing radical prostatectomy,
   transperineal ultrasound-guided radioactive seed implantation, or
   definitive external beam irradiation
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT Meeting of the American-Brachytherapy-Society
CY MAY   07, 1999
CL SAN DIEGO, CALIFORNIA
SP Amer Brachytherapy Soc
DE prostate cancer; radiotherapy; prostatectomy; biochemical disease-free
   survival
ID RADIATION-THERAPY; CANCER; ANTIGEN; RADIOTHERAPY
AB Purpose: This retrospective study compares the long-term biochemical disease-free survival for patients undergoing radical prostatectomy, transperineal ultrasound-guided (125)Iodine implantation, or external beam irradiation alone in a tertiary referral community-based hospital.
   Methods and Materials: Five hundred forty patients were available for evaluation, which included: external beam, 132; I-125, 186; and radical prostatectomy, 222, For the 318 patients referred to the Department of Radiation Oncology, those with T3 disease underwent external beam irradiation while patients with T1 or T2 underwent I-125 implantation or external beam irradiation as definitive treatment. No patient received androgen ablation. Patients undergoing irradiation were considered a biochemical failure if their PSA nadir was > 1 at 1 year or, if following a nadir PSA < 1, the patient subsequently experienced three consecutive rising PSA values obtained at a minimum 3-month interval. Patients undergoing prostatectomy were considered a biochemical failure if their postop PSA remained detectable > 0.2 ng/mL or if they had three consecutive increases in their PSA or an increase in their postoperative PSA warranting intervention with androgen ablation or external beam irradiation to the pelvis.
   Results: Patients were stratified by pretreatment risk groups predicting for post-treatment PSA recurrence, Patients were considered to be at a low or intermediate risk for recurrence if their clinical stage was T1c, T2a, T2b, pretreatment PSA level was less than or equal to 20, or their biopsy Gleason score was less than or equal to 6. Patients were considered to be at high risk for failure if they were clinically stage T2c, T3, PSA at diagnosis > 20, or Gleason score was greater than or equal to 7. For 132 patients undergoing external beam irradiation, 28 of 37 low or intermediate risk obtained a 1 year nadir PSA of < 1 (76%) while 40% of high risk patients obtained nadir < 1. Of 186 patients undergoing I-125, 112 of 147 low or intermediate risk (76%) obtained a nadir PSA < 1, Twenty of 39 (51%) high risk obtained a nadir PSA < 1, Of the 222 patients undergoing prostatectomy, 83 of 88 (94%) low or intermediate risk had undetectable levels of PSA at 1 year. One hundred seventeen of 134 (86%) were high risk and had undetectable levels of PSA at 1 year, The biochemical disease-free survival for patients with low or intermediate risk at 5 years is approximately 70% with no significant difference between those patients treated with radical prostatectomy, external beam, or I-125. For those patients with high risk factors for recurrence, there is no significant difference between ultrasound-guided implant or external beam, but there is a significant improvement in biochemical disease-free survival with radical prostatectomy.
   Conclusion: For patients with low or intermediate risk disease, external beam, ultrasound-guided I-125, Or a radical prostatectomy give comparable long-term biochemical disease-free survival, For patients with high risk disease, a radical prostatectomy provides a significantly improved biochemical disease-free survival, Our current protocols utilize androgen ablation in combination with conformal three-dimensional external beam irradiation or androgen ablation in conjunction with external beam irradiation and Pd-103 seed implantation for patients at high risk for extra capsular disease. It is too early to determine if this combination therapy will give results comparable to radical prostatectomy, For patients who obtain a 1 year nadir PSA of < 1, the biochemical disease-free survival is durable with little risk of subsequent recurrence. (C) 2000 Elsevier Science Inc.
C1 SE Reg Radiat Oncol Ctr, Dept Radiat Oncol, Dothan, AL 36302 USA.
RP Stokes, SH (reprint author), SE Reg Radiat Oncol Ctr, Dept Radiat Oncol, POB 5526, Dothan, AL 36302 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   DATTOLI M, 1997, J BRACHYTHER INT, V13, P347
   Keyser D, 1997, INT J RADIAT ONCOL, V38, P723, DOI 10.1016/S0360-3016(97)00123-5
   Kupelian P, 1996, UROLOGY, V48, P249, DOI 10.1016/S0090-4295(96)00167-7
   Kupelian P, 1997, CANCER J SCI AM, V3, P78
   Kupelian PA, 1997, INT J RADIAT ONCOL, V37, P1043, DOI 10.1016/S0360-3016(96)00590-1
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Stokes SH, 1997, INT J RADIAT ONCOL, V37, P337, DOI 10.1016/S0360-3016(96)00508-1
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
NR 13
TC 69
Z9 72
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD APR 1
PY 2000
VL 47
IS 1
BP 129
EP 136
DI 10.1016/S0360-3016(99)00526-X
PG 8
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 303MW
UT WOS:000086426500013
PM 10758314
ER

PT J
AU FREEDMAN, DO
   DEALMEIDA, PJ
   BESH, S
   SILVA, MCME
   BRAGA, C
   MACIEL, A
AF FREEDMAN, DO
   DEALMEIDA, PJ
   BESH, S
   SILVA, MCME
   BRAGA, C
   MACIEL, A
TI LYMPHOSCINTIGRAPHIC ANALYSIS OF LYMPHATIC ABNORMALITIES IN SYMPTOMATIC
   AND ASYMPTOMATIC HUMAN FILARIASIS
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID WHOLE-BODY LYMPHANGIOSCINTIGRAPHY; BANCROFTIAN FILARIASIS;
   BRUGIA-MALAYI; TC-99M-LABELED DEXTRAN; LYMPHEDEMA; SYSTEM
AB To obtain high-resolution radionuclide lymphoscintigraphic images of affected limbs in persons with both symptomatic and asymptomatic filarial infection, 36 volunteers were recruited from a Wuchereria bancrofti-endemic area of Recife, Brazil, for a prospective, controlled analysis. Subjects were stratified after determination of serologic and clinical determinants of filarial infection status. Widespread lymphatic abnormalities were found in clinically asymptomatic microfilaremic persons, who had been assumed to have infection but not disease. All patients with clinical manifestations of lymphatic pathology had marked abnormalities. No correlation was found between clinical findings and actual lymphatic function as demonstrated by lymphoscintigraphy. The initial diagnosis of lymphatic filariasis, whether asymptomatic or symptomatic, is based an nonimaging laboratory criteria. After diagnosis, lymphoscintigraphy is a valuable tool for initial assessment of any lymphatic damage. Changes in strategies for therapeutic interventions in asymptomatic microfilaremic persons, who are not usually aggressively treated, may be warranted.
C1 LABS CERPE, NUCL MED UNIT, RECIFE, PE, BRAZIL.
   CTR PESQUISAS AGGEU MAGALHAES, RECIFE, PE, BRAZIL.
RP FREEDMAN, DO (reprint author), UNIV ALABAMA, DIV GEOG MED, UAB STN, BBRB 206, BIRMINGHAM, AL 35294 USA.
RI Braga, Cynthia/A-8204-2013
OI Braga, Cynthia/0000-0002-7862-6455
CR ALBUQUERQUE M, 1990, LYMPHOLOGY, V23, P215
   CAHILL KEVIN M., 1964, TRANS ROY SOC TROP MED HYG, V58, P356
   CASE TC, 1992, ANN TROP MED PARASIT, V86, P435
   COHEN LB, 1961, AM J TROP MED HYG, V10, P843
   COLWELL EJ, 1970, AM J TROP MED HYG, V19, P227
   FREEDMAN DO, 1989, J CLIN INVEST, V83, P14, DOI 10.1172/JCI113850
   FREEDMAN DO, 1989, J IMMUNOL, V142, P653
   FREEDMAN DO, 1992, AM J TROP MED HYG, V47, P787
   GLOVICZKI P, 1989, J VASC SURG, V9, P683, DOI 10.1067/mva.1989.vs0090683
   HENZE E, 1982, J NUCL MED, V23, P923
   HINES SA, 1985, LYMPHOLOGY, V18, P173
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   NAWAZ MK, 1989, CLIN NUCL MED, V15, P794
   OLDFIELD EC, 1993, CLIN INFECT DIS, V16, pS132
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   PFLUG JJ, 1971, BRIT J SURG, V58, P925, DOI 10.1002/bjs.1800581216
   SADEK S, 1989, LYMPHOLOGY, V22, P157
   SAMUELS LD, 1987, LYMPHOLOGY, V20, P4
   SNOWDEN K, 1986, LYMPHOLOGY, V19, P77
   VAQUEIRO M, 1986, J NUCL MED, V27, P1125
   VINCENT AL, 1984, J PARASITOL, V70, P48, DOI 10.2307/3281924
   WARTMAN WB, 1947, MEDICINE, V26, P333
   WEIL GJ, 1987, J INFECT DIS, V156, P350
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729
   WEISSLEDER R, 1989, RADIOLOGY, V172, P315
   WITTE M, 1988, LYMPHOLOGY, V21, P251
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   YANG KTA, 1989, EUR J NUCL MED, V15, P171, DOI 10.1007/BF00253788
   1992, WHO TECH REP SER, V821, P14
NR 29
TC 69
Z9 72
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 S WOODLAWN AVE, CHICAGO, IL 60637
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD OCT
PY 1994
VL 170
IS 4
BP 927
EP 933
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA PJ694
UT WOS:A1994PJ69400027
PM 7523538
ER

PT J
AU MASSON, RG
   KRIKORIAN, J
   LUKL, P
   EVANS, GL
   MCGRATH, J
AF MASSON, RG
   KRIKORIAN, J
   LUKL, P
   EVANS, GL
   MCGRATH, J
TI PULMONARY MICROVASCULAR CYTOLOGY IN THE DIAGNOSIS OF LYMPHANGITIC
   CARCINOMATOSIS
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
C1 FRAMINGHAM UNION HOSP,DEPT PATHOL,FRAMINGTON,MA 01701.
   BOSTON UNIV,SCH MED,BOSTON,MA 02118.
RP MASSON, RG (reprint author), FRAMINGHAM UNION HOSP,DEPT MED,115 LINCOLN ST,FRAMINGTON,MA 01701, USA.
CR ALLEN WG, 1983, CRIT CARE MED, V11, P261, DOI 10.1097/00003246-198304000-00001
   ARANDA C, 1978, CANCER, V42, P1995, DOI 10.1002/1097-0142(197810)42:4<1995::AID-CNCR2820420446>3.0.CO;2-C
   BLOCK ER, 1982, CHEST, V81, P215, DOI 10.1378/chest.81.2.215
   CAREY RW, 1976, AM J MED, V60, P273, DOI 10.1016/0002-9343(76)90437-X
   CHRISTOP.WM, 1965, ACTA CYTOL, V9, P169
   DURHAM JR, 1961, JAMA-J AM MED ASSOC, V175, P757
   HAUSER TE, 1951, ANN INTERN MED, V34, P881
   HOTCHKISS RS, 1986, AM REV RESPIR DIS, V133, P1019
   JANOWER ML, 1971, RADIOLOGY, V101, P267
   LEVY H, 1988, CHEST, V94, P1028, DOI 10.1378/chest.94.5.1028
   MASSON RG, 1985, CHEST, V88, P908, DOI 10.1378/chest.88.6.908
   MASSON RG, 1988, NEW ENGL J MED, V318, P324
   MASSON RG, 1979, AM REV RESPIR DIS, V120, P187
   MCGREW EA, 1965, ACTA CYTOL, V9, P58
   MELAMED MR, 1979, DIAGNOSTIC CYTOLOGY, V2, P1105
   PRUITT JC, 1958, NEW ENGL J MED, V259, P1161, DOI 10.1056/NEJM195812112592404
   RAKER JW, 1960, NEW ENGL J MED, V263, P993, DOI 10.1056/NEJM196011172632003
   RAPAPORT E, 1958, Methods Med Res, V7, P85
   SCHEININ TM, 1963, BLOOD, V22, P82
   SCHEININ TM, 1962, SURGERY, V51, P652
   SCOGGINS WG, 1977, ANN THORAC SURG, V24, P474
   SPENCER H, 1978, PTHOLOGY LUNG EXCLUD, V2, P999
   Suter P M, 1975, Crit Care Med, V3, P175, DOI 10.1097/00003246-197509000-00001
   WILLIAMS WH, 1982, CRIT CARE MED, V10, P636, DOI 10.1097/00003246-198210000-00003
   1983, NEW ENGL J MED, V309, P477
   1984, NEW ENGL J MED, V310, P1728
   1971, NEW ENGL J MED, V285, P793
   1980, NEW ENGL J MED, V303, P1049
   1972, NEW ENGL J MED, V287, P604
   1987, NEW ENGL J MED, V317, P225
NR 30
TC 69
Z9 69
PU MASS MEDICAL SOC
PI BOSTON
PA 10 SHATTUCK, BOSTON, MA 02115
SN 0028-4793
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 13
PY 1989
VL 321
IS 2
BP 71
EP 76
DI 10.1056/NEJM198907133210202
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA AE676
UT WOS:A1989AE67600002
PM 2471933
ER

PT J
AU Hanlon, AL
   Pinover, WH
   Horwitz, EM
   Hanks, GE
AF Hanlon, AL
   Pinover, WH
   Horwitz, EM
   Hanks, GE
TI Patterns and fate of PSA bouncing following 3D-CRT
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate-specific antigen; radiation therapy; conformal; prostatic
   neoplasms
ID PROSTATE-SPECIFIC ANTIGEN; RADIATION; CANCER
AB Purpose: The goals of this study were to quantify the frequency of post-treatment prostate-specific antigen (PSA)-level bouncing following three-dimensional conformal radiation therapy (3D-CRT) for prostate cancer and to identify any relationships that may exist between bouncing activity and biochemical control (bNED).
   Methods: Between May 1989 and July 1995, 306 patients were treated with 3D-CRT alone. All patients had 6 or more post-treatment PSA levels and at least 5 years of PSA follow-up. The median total follow-up and total dose to the center of prostate was 79 months and 74 Gy, respectively. A bounce was defined by a minimum rise in PSA of 0.4 ng/mL over a 6-month period, followed by a drop in PSA of any magnitude. Estimates of bNED control rates were made using Kaplan-Meier methodology and comparisons were made using the log-rank test. Multivariate analysis of bNED control predictors was accomplished using a stepwise Cox proportional hazards model.
   Results: Nearly one third of the patients experienced at least one bounce. Bouncers were found to present with higher pretreatment PSA levels and were treated with lower dose levels to the center of prostate. Five-year bNED control estimates for nonbouncers vs. bouncers were 69% and 52%, respectively (p = 0.0024). After controlling for dose and pretreatment PSA level, total number of bounces emerged as a significant predictor of bNED control (p = 0.02).
   Conclusions: pouncing PSA levels occur in approximately one third of the patients treated with 3D-CRT alone, with bouncing occurring at a constant rate from 2 to 5 years post-treatment. Bouncing is associated with lower radiation dose levels, higher pretreatment PSA levels, and decreased bNED control. Nearly half of the bouncers are bNED controlled; thus, clinicians should not use bouncing as a sole indicator of relapse. (C) 2001 Elsevier Science Inc.
C1 Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA.
   Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA.
RP Hanlon, AL (reprint author), Fox Chase Canc Ctr, Dept Biostat, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   [Anonymous], 1993, 50 ICRU INT COMM RAD
   ARMITAGE P, 1973, STAT METHODS MED RES, P212
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Flemming ID, 1997, AJCC CANC STAGING MA, P219
   Kalbfleisch J, 1980, STAT ANAL FAILURE TI
   Kaplan EL, 1958, J AM STAT ASSOC, V53, P447
   KILLIAN CS, 1985, CANCER RES, V45, P886
   Lehmann E.L., 1975, NONPARAMETRICS STAT
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   Pinover WH, 2000, INT J RADIAT ONCOL, V47, P649, DOI 10.1016/S0360-3016(00)00465-X
NR 12
TC 68
Z9 70
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUL 15
PY 2001
VL 50
IS 4
BP 845
EP 849
DI 10.1016/S0360-3016(01)01557-7
PG 5
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 448EZ
UT WOS:000169615100001
PM 11429210
ER

PT J
AU Meezan, NB
   Atherton, LJ
   Callahan, DA
   Dewald, EL
   Dixit, S
   Dzenitis, EG
   Edwards, MJ
   Haynam, CA
   Hinkel, DE
   Jones, OS
   Landen, O
   London, RA
   Michel, PA
   Moody, JD
   Milovich, JL
   Schneider, MB
   Thomas, CA
   Town, RPJ
   Warrick, AL
   Weber, SV
   Widmann, K
   Glenzer, SH
   Suter, LJ
   MacGowan, BJ
   Kline, JL
   Kyrala, GA
   Nikroo, A
AF Meezan, N. B.
   Atherton, L. J.
   Callahan, D. A.
   Dewald, E. L.
   Dixit, S.
   Dzenitis, E. G.
   Edwards, M. J.
   Haynam, C. A.
   Hinkel, D. E.
   Jones, O. S.
   Landen, O.
   London, R. A.
   Michel, P. A.
   Moody, J. D.
   Milovich, J. L.
   Schneider, M. B.
   Thomas, C. A.
   Town, R. P. J.
   Warrick, A. L.
   Weber, S. V.
   Widmann, K.
   Glenzer, S. H.
   Suter, L. J.
   MacGowan, B. J.
   Kline, J. L.
   Kyrala, G. A.
   Nikroo, A.
TI National Ignition Campaign Hohlraum energetics
SO PHYSICS OF PLASMAS
LA English
DT Article; Proceedings Paper
CT 51st Annual Meeting of the Division-of-Plasma-Physics of the
   American-Physics-Society
CY NOV 02-06, 2009
CL Atlanta, GA
SP Amer Phys Soc, Div Plasma Phys
DE plasma production by laser
ID INERTIAL CONFINEMENT FUSION; PHYSICS BASIS; FACILITY; TARGETS;
   SIMULATIONS; PLASMAS; DESIGN; NIF
AB The first series of experiments of the National Ignition Facility (NIF) [E. I. Moses , Phys. Plasmas 16, 041006 (2009)] tested ignition Hohlraum "energetics," a term described by four broad goals: (1) measurement of laser absorption by the Hohlraum; (2) measurement of the x-ray radiation flux (T(RAD)(4)) on the surrogate ignition capsule; (3) quantitative understanding of the laser absorption and resultant x-ray flux; and (4) determining whether initial Hohlraum performance is consistent with requirements for ignition. This paper summarizes the status of NIF Hohlraum energetics experiments. The Hohlraum targets and experimental design are described, as well as the results of the initial experiments. The data demonstrate low backscattered energy (< 10%) for Hohlraums filled with helium gas. A discussion of our current understanding of NIF Hohlraum x-ray drive follows, including an overview of the computational tools, i.e., radiation-hydrodynamics codes that have been used to design the Hohlraums. The performance of the codes is compared to x-ray drive and capsule implosion data from the first NIF experiments. These results bode well for future NIF ignition Hohlraum experiments. (C) 2010 American Institute of Physics. [doi:10.1063/1.3354110]
C1 [Meezan, N. B.; Atherton, L. J.; Callahan, D. A.; Dewald, E. L.; Dixit, S.; Dzenitis, E. G.; Edwards, M. J.; Haynam, C. A.; Hinkel, D. E.; Jones, O. S.; Landen, O.; London, R. A.; Michel, P. A.; Moody, J. D.; Milovich, J. L.; Schneider, M. B.; Thomas, C. A.; Town, R. P. J.; Warrick, A. L.; Weber, S. V.; Widmann, K.; Glenzer, S. H.; Suter, L. J.; MacGowan, B. J.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
   [Kline, J. L.; Kyrala, G. A.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
   [Nikroo, A.] Gen Atom Co, San Diego, CA 93286 USA.
RP Meezan, NB (reprint author), Lawrence Livermore Natl Lab, POB 808, Livermore, CA 94551 USA.
EM meezan1@llnl.gov
RI Michel, Pierre/J-9947-2012
CR Boehly TR, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3334998
   Callahan DA, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022021
   Dewald EL, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2178783
   Dewald EL, 2004, REV SCI INSTRUM, V75, P3759, DOI 10.1063/1.1788872
   Divol L, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2844361
   DJAOUI A, 1992, J PHYS B-AT MOL OPT, V25, P2745, DOI 10.1088/0953-4075/25/11/026
   DRAKE JF, 1974, PHYS FLUIDS, V17, P778, DOI 10.1063/1.1694789
   FORSLUND DW, 1975, PHYS FLUIDS, V18, P1017, DOI 10.1063/1.861249
   Froula DH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045006
   Froula DH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.115002
   Glenzer SH, 2010, SCIENCE, V327, P1228, DOI 10.1126/science.1185634
   Haan SW, 2004, NUCL FUSION, V44, pS171, DOI 10.1088/0029-5515/44/12/S06
   Haan SW, 2009, FUSION SCI TECHNOL, V55, P227
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   Landon MD, 2001, REV SCI INSTRUM, V72, P698, DOI 10.1063/1.1318255
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638
   Lokke W. A., 1977, UCRL52276 NAT TECHN
   Mackinnon AJ, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336466
   Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740
   McDonald JW, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2186927
   Michel P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025004
   Michel P, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3325733
   MORE RM, 1988, PHYS FLUIDS, V31, P3059, DOI 10.1063/1.866963
   Moses EI, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3116505
   Neumayer P, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2953413
   Neumayer P, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2890126
   Neumayer P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.105001
   Nobile A, 2006, LASER PART BEAMS, V24, P567, DOI 10.1017/S0263034606060757
   Spears B, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022003
   Zimmerman G. B., 1975, Comments on Plasma Physics and Controlled Fusion, V2
NR 31
TC 67
Z9 68
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 1070-664X
J9 PHYS PLASMAS
JI Phys. Plasmas
PD MAY
PY 2010
VL 17
IS 5
AR 056304
DI 10.1063/1.3354110
PG 8
WC Physics, Fluids & Plasmas
SC Physics
GA 603BM
UT WOS:000278182900117
ER

PT J
AU Sarosdy, MF
AF Sarosdy, Michael F.
TI Testosterone replacement for hypogonadism after treatment of early
   prostate cancer with brachytherapy
SO CANCER
LA English
DT Article; Proceedings Paper
CT 101st Annual Meeting of the American-Urological-Association
CY MAY 20-25, 2006
CL Atlanta, GA
SP Amer Urol Assoc
DE testosterone replacement; prostate cancer; hypogonadism; brachytherapy
ID RADICAL PROSTATECTOMY; I-125 BRACHYTHERAPY; MEN; ANTIGEN; CARCINOMA;
   THERAPY; RADIOTHERAPY; IRRADIATION
AB BACKGROUND. Controversy and a notable paucity of published clinical data best characterize the current knowledge of testosterone-replacement therapy (TRT) for hypogonadism after treatment for early, localized prostate cancer. The objective of this study was to assess the risk of biochemical failure with TRT after treatment of early prostate cancer with permanent transperineal brachytherapy with or without external beam therapy in patients with low serum levels of testosterone and clinical symptoms of hypogonadism.
   METHODS. Patients who underwent prostate brachytherapy from 1996 to 2004 and received subsequent TRT for symptomatic hypogonadism were reviewed to detail cancer characteristics and treatment as well as pre- and post-TRT serum testosterone and prostate-specific antigen (PSA) values.
   RESULTS. Thirty-one men received TRT after prostate brachytherapy for 0.5 to 8.5 years (median, 4.5 years), with a follow-up that ranged from 1.5 years to 9.0 years (median, 5.0 years) postbrachytherapy, TRT was started from 0.5 years to 4.5 years (median, 2.0 years) after brachytherapy. Serum total testosterone levels ranged from 30 ng/dL to 255 ng/dL (median, 188 ng/dL) before TRT and rose to 365 ng/dL to 1373 ng/dL (median, 498 ng/dL) on TRT. Transient rises in PSA were observed in 1 patient. The most recent PSA level was < 0.1 ng/mL in 23 patients (74.2%), < 0.5 ng/mL in 30 patients (96.7%), and < 1 ng/mL in 31 patients (100%). No patients stopped TRT because of cancer recurrence or documented cancer progression.
   CONCLUSIONS. For patients with low serum testosterone levels and symptoms of hypogonadism, TRT may be used with caution and close follow-up after prostate brachytherapy.
C1 S Texas Urol & Urol Oncol, San Antonio, TX 78229 USA.
RP Sarosdy, MF (reprint author), S Texas Urol & Urol Oncol, 4499 Med Dr,Suite 218, San Antonio, TX 78229 USA.
EM urodoc@satx.rr.com
CR Agarwal PK, 2005, J UROLOGY, V173, P533, DOI 10.1097/01.ju.0000143942.55896.64
   Akyol F, 2005, EUR UROL, V48, P40, DOI 10.1016/j.eururo.2005.04.007
   Bianco FJ, 2005, UROLOGY, V66, P83, DOI 10.1016/j.urology.2005.06.116
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   Calof OM, 2005, J GERONTOL A-BIOL, V60, P1451
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   Critz FA, 2003, J UROLOGY, V170, P1864, DOI 10.1097/01.ju.0000091644.41330.2a
   El-Sakka AI, 2005, J SEX MED, V2, P235, DOI 10.1111/j.1743-6109.2005.20233.x
   FLEMING ID, 1998, AJCC CANC STAGING MA, P219
   Gaylis FD, 2005, J UROLOGY, V174, P534, DOI 10.1097/01.ju.0000165166.36280.60
   Gerstenbluth RE, 2002, J ANDROL, V23, P922
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Huggins C, 1941, CANCER RES, V1, P293
   Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7
   Jemal A, 2006, CA-CANCER J CLIN, V56, P106
   Kaufman JM, 2004, J UROLOGY, V172, P920, DOI 10.1097/01.ju.0000136269.10161.32
   Klotz L, 2006, UROL CLIN N AM, V33, P161, DOI 10.1016/j.ucl.2005.12.001
   Liverman C, 2004, TESTOSTERONE AGING C
   Morgentaler Abraham, 2006, Can J Urol, V13 Suppl 1, P40
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Rhoden EL, 2003, J UROLOGY, V170, P2348, DOI 10.1097/01.ju.0000091104.71869.8e
   Rhoden EL, 2004, NEW ENGL J MED, V350, P482, DOI 10.1056/NEJMra022251
   Sarosdy MF, 1999, BJU INT, V83, P801
   Snyder PJ, 2004, NEW ENGL J MED, V350, P440, DOI 10.1056/NEJMp038207
   Wang C, 2004, J CLIN ENDOCR METAB, V89, P2085, DOI 10.1210/jc.2003-032006
NR 25
TC 67
Z9 71
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0008-543X
J9 CANCER
JI Cancer
PD FEB 1
PY 2007
VL 109
IS 3
BP 536
EP 541
DI 10.1002/cncr.22438
PG 6
WC Oncology
SC Oncology
GA 131LF
UT WOS:000243869700010
PM 17183557
ER

PT J
AU Bean, RA
   Barber, BK
   Crane, DR
AF Bean, Roy A.
   Barber, Brian K.
   Crane, D. Russell
TI Parental support, behavioral control, and psychological control among
   African American youth - The relationships to academic grades,
   delinquency, and depression
SO JOURNAL OF FAMILY ISSUES
LA English
DT Article
DE African Americans; parenting; adolescents; depression; delinquency
ID ECOLOGICAL PERSPECTIVE; ETHNIC EQUIVALENCE; PROTECTIVE FACTORS;
   EUROPEAN-AMERICAN; ADOLESCENTS; ACHIEVEMENT; FAMILY; CONNECTION;
   COMPETENCE; AUTONOMY
AB Associations among three dimensions of parenting (support, behavioral control, psychological control) and measures of adolescent depression, delinquency, and academic achievement were assessed in a sample of African American youth. All data were adolescent self-reports by way of school-administered questionnaires in random samples of classrooms in southeastern U.S. metropolitan areas. Path analysis revealed several associations between parenting dimensions and youth outcomes, including negative relationships between paternal support and depression and between parental behavioral control and delinquency. Group comparisons (by youth grade level, gender, and family socioeconomic status [SES]) were also conducted, and no age or SES differences were noted.
C1 Texas Tech Univ, Lubbock, TX 79409 USA.
   Univ Tennessee, Knoxville, TN USA.
   Brigham Young Univ, Provo, UT 84602 USA.
RP Bean, RA (reprint author), Texas Tech Univ, Lubbock, TX 79409 USA.
CR Achenbach T., 1987, MANUAL YOUTH SELF RE
   Achenbach TM, 1991, MANUAL YOUTH SELF RE
   Arbuckle J. L., 2003, AMOS 5 0 USERS GUIDE
   Barber B. K., 2003, MARRIAGE FAM REV, V35, P107
   Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.1111/j.1467-8624.1996.tb01915.x
   BARBER BK, 1994, CHILD DEV, V65, P1120, DOI 10.1111/j.1467-8624.1994.tb00807.x
   Barber BK, 1997, J ADOLESCENT RES, V12, P5, DOI 10.1177/0743554897121002
   BARBER BK, 2002, PARENTAL PSYCHOL CON
   BARBER BK, 2004, UNPUB PARENTAL SUPPO
   BartleHaring S, 1997, J ADOLESCENCE, V20, P553, DOI 10.1006/jado.1997.0109
   Beale Spencer M., 1990, THRESHOLD DEV ADOLES, P123
   Bean RA, 2003, J ADOLESCENT RES, V18, P523, DOI 10.1177/0743558403255070
   BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004
   Bollen K. A., 1989, STRUCTURAL EQUATIONS
   Brody GH, 2003, CHILDREN'S INFLUENCE ON FAMILY DYNAMICS: THE NEGLECTED SIDE OF FAMILY RELATIONSHIPS, P163
   Brody GH, 1998, CHILD DEV, V69, P803, DOI 10.1111/j.1467-8624.1998.tb06244.x
   Brook JS, 1995, J GENET PSYCHOL, V156, P393
   Brown B. B., 1993, CHILD DEV, V63, P391
   Chao RK, 2001, CHILD DEV, V72, P1832, DOI 10.1111/1467-8624.00381
   Day RD, 2004, CONCEPTUALIZING AND MEASURING FATHER INVOLVEMENT, P273
   DORNBUSCH SM, 1987, CHILD DEV, V58, P1244, DOI 10.1111/j.1467-8624.1987.tb01455.x
   Eccles JS, 1997, J ADOLESCENT RES, V12, P263, DOI 10.1177/0743554897122007
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Garber J, 1997, J ADOLESCENT RES, V12, P12, DOI 10.1177/0743554897121003
   Garnefski N, 1997, J YOUTH ADOLESCENCE, V26, P321, DOI 10.1007/s10964-005-0005-3
   Grant KE, 2000, J EARLY ADOLESCENCE, V20, P388, DOI 10.1177/0272431600020004002
   Gray MR, 1999, J MARRIAGE FAM, V61, P574, DOI 10.2307/353561
   Herman MR, 1997, J ADOLESCENT RES, V12, P34
   Hrabowski III F. A., 1998, BEATING ODDS RAISING
   Kerr M., 2000, DEV PSYCHOL, V36, P1
   Kim K, 2002, J CROSS CULT PSYCHOL, V33, P127, DOI 10.1177/0022022102033002001
   Kim S., 2003, J BLACK PSYCHOL, V29, P359, DOI [10.1177/0095798403256887, DOI 10.1177/0095798403256887]
   Krishnakumar A, 2004, J MARRIAGE FAM, V66, P809, DOI 10.1111/j.0022-2445.2004.00054.x
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   LAMBORN SD, 1991, CHILD DEV, V62, P1049, DOI 10.1111/j.1467-8624.1991.tb01588.x
   Lamborn SD, 2003, J ADOLESCENCE, V26, P605, DOI 10.1016/S0140-1971(03)00059-9
   Loehlin J. C., 1992, LATENT VARIABLE MODE
   Loehlin J. C., 1998, LATENT VARIABLE MODE
   Maccoby E. E., 1983, HDB CHILD PSYCHOL, VIV, P1
   Mason CA, 1996, CHILD DEV, V67, P2115, DOI 10.1111/j.1467-8624.1996.tb01847.x
   MCADOO JL, 1997, BLACK FAMILIES, P183
   McCabe KM, 1999, J CLIN CHILD PSYCHOL, V28, P137, DOI 10.1207/s15374424jccp2802_2
   Mounts NS, 2004, J ADOLESCENT RES, V19, P468, DOI 10.1177/0743558403258862
   NUCCI L, 1994, NEW DIRECTIONS CHILD, V66, P81
   OGBU JU, 1981, CHILD DEV, V52, P413, DOI 10.1111/j.1467-8624.1981.tb03064.x
   PHARES V, 1992, PSYCHOL BULL, V111, P387, DOI 10.1037/0033-2909.111.3.387
   SCHAEFER ES, 1965, J CONSULT PSYCHOL, V29, P552, DOI 10.1037/h0022702
   SMITH C, 1995, J YOUTH ADOLESCENCE, V24, P69, DOI 10.1007/BF01537561
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Steinberg L., 1991, J RES ADOLESCENCE, V1, P19, DOI DOI 10.1111/1532-7795.EP11522650
   STEINBERG L, 1989, CHILD DEV, V60, P1424, DOI 10.1111/j.1467-8624.1989.tb04014.x
   STEINBERG L, 1992, AM PSYCHOL, V47, P723, DOI 10.1037//0003-066X.47.6.723
   Sussman MB, 1987, HDB MARRIAGE FAMILY, P471
   Tanner J, 1999, SOC PROBL, V46, P250, DOI 10.1525/sp.1999.46.2.03x0188f
   Zimmerman MA, 2000, J COMMUNITY PSYCHOL, V28, P17
NR 55
TC 67
Z9 68
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-513X
J9 J FAM ISSUES
JI J. Fam. Issues
PD OCT
PY 2006
VL 27
IS 10
BP 1335
EP 1355
DI 10.1177/0192513X06289649
PG 21
WC Family Studies
SC Family Studies
GA 085QK
UT WOS:000240618400001
ER

PT J
AU Poston, RS
   Gu, JY
   Brown, JM
   Gammie, JS
   White, C
   Nie, L
   Pierson, RN
   Griffith, BP
AF Poston, RS
   Gu, JY
   Brown, JM
   Gammie, JS
   White, C
   Nie, L
   Pierson, RN
   Griffith, BP
TI Endothelial injury and acquired-aspirin resistance as promoters of
   regional thrombin formation and early vein graft failure after coronary
   artery bypass grafting
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article; Proceedings Paper
CT 85th Annual Meeting of the American-Association-for-Thoracic-Surgery
CY APR 10-13, 2005
CL San Francisco, CA
SP Amer Assoc Thorac Surg
ID TIME FLOW MEASUREMENT; OFF-PUMP; RANDOMIZED-TRIAL; SURGERY; PATENCY;
   ACTIVATION; EXPRESSION; HEPARIN; SURFACE
AB Objective: The predominant mechanism of early graft failure after coronary artery bypass grafting remains in doubt. Aspirin administered in the initial hours after coronary artery bypass grafting improves graft patency, implicating prostanoid synthesis in the pathogenesis. We hypothesized that synergy between endothelial disruption in the venous conduit and aspirin resistance would cause vein graft failure.
   Methods: Aspirin resistance, defined by diagnostic findings on at least two of three separate assays, was serially assessed in 225 patients undergoing off-pump coronary artery bypass grafting: Endothelial cell integrity was determined in surplus segments obtained from 408 vein grafts. The deposition of intraluminal thrombin within the vein was determined by comparing serum F1.2 levels between the coronary sinus and the aorta after grafting. Intraoperative blood flow in the grafts was measured with transit-time technology, and patency was assessed with electrocardiographically gated multichannel computed tomographic coronary angiography on day 5. Aspirin was the sole antithrombotic agent used during the study.
   Results: Thrombosed grafts (16/408) showed more endothelial cell loss at the time of grafting than did those grafts that remained patent (10.8% +/- 21.5% vs 51.4% +/- 39.1% integrity, P < .01). Aspirin resistance occurred in 67 patients (30%). Graft thrombosis was associated with aspirin resistance (P < .04) and reduced endothelial integrity (P < .01). These factors coexisted in 14 of 16 grafts that failed and were associated with elevated coronary sinus F1.2 levels.
   Conclusion: Aspirin resistance and relatively compromised venous endothelial cell integrity together marked patients whose vein grafts failed within days after offpump coronary artery bypass grafting. These observations form a basis for identifying patients at risk and developing approaches to prevent vein injury or to selectively intervene in high-risk circumstances.
C1 Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA.
   Univ Maryland, Sch Med, Dept Radiol, Baltimore, MD 21201 USA.
   Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA.
   Baltimore VAMC, Baltimore, MD USA.
RP Poston, RS (reprint author), Univ Maryland, Sch Med, Dept Surg, N4W94 22 S Greene St, Baltimore, MD 21201 USA.
EM rposton@smail.umaryland.edu
CR Alberio L, 2000, BLOOD, V95, P1694
   Ascione R, 2005, ANN THORAC SURG, V79, P1210, DOI 10.1016/j.arthoracsur.2004.09.046
   Craft RM, 2004, J LAB CLIN MED, V143, P301, DOI 10.1016/j.lab.2004.01.011
   D'Ancona G, 2000, EUR J CARDIO-THORAC, V17, P287, DOI 10.1016/S1010-7940(00)00332-8
   Ehsan A, 2002, CIRCULATION, V105, P1686, DOI 10.1161/01.CIR.0000013775.02396.93
   Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07
   Frazier AA, 2005, RADIOGRAPHICS, V25, P881, DOI 10.1148/RG.25405151
   Friend M, 2003, BRIT MED J, V326, P82, DOI 10.1136/bmj.326.7380.82
   HATTON MWC, 1989, AM J PATHOL, V135, P499
   Jackson ZS, 2001, J VASC SURG, V34, P300, DOI 10.1067/mva.2001.115815
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Koster A, 2002, ANESTHESIOLOGY, V97, P837, DOI 10.1097/00000542-200210000-00014
   Leong DKH, 2005, ANN THORAC SURG, V79, P854, DOI 10.1016/j.athorascur.2004.06.010
   Manchio JV, 2005, ANN THORAC SURG, V79, P1991, DOI 10.1016/j.athorascur.2004.12.054
   Merry AF, 2004, ANN THORAC SURG, V77, P925, DOI 10.1016/j.athoracsur.2003.09.061
   Mizuno O, 2000, AM J CARDIOL, V85, P154, DOI 10.1016/S0002-9149(99)00651-7
   MOOR E, 1994, THROMB HAEMOSTASIS, V72, P335
   Morota T, 2002, ANN THORAC SURG, V73, P1446, DOI 10.1016/S0003-4975(02)03505-1
   Muluk SC, 1998, J VASC SURG, V27, P521, DOI 10.1016/S0741-5214(98)70327-1
   Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P1897, DOI 10.1001/jama.291.15.1897
   POSTON R, 2005, IN PRESS ANN THORAC
   POSTON RS, 2004, HEART SURG FORUM, V7, P123
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655
   STEIN PD, 1995, CHEST S, V108, P424
   Thatte HS, 2001, ANN THORAC SURG, V72, pS2245, DOI 10.1016/S0003-4975(01)03272-6
   Thatte HS, 2001, ANN THORAC SURG, V72, pS2267
   Turitto V. T., 1998, THROMB RES, V92, P25
   VANSCHOONBEEK K, 2004, J THROMB HAEMOST, V23, P476
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Yun KL, 2005, J THORAC CARDIOV SUR, V129, P496, DOI 10.1016/j.jtcvs.2004.08.054
   Zimmermann N, 2003, CIRCULATION, V108, P542, DOI 10.1161/01.CIR.0000081770.51929.5A
NR 32
TC 67
Z9 69
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD JAN
PY 2006
VL 131
IS 1
BP 122
EP 130
DI 10.1016/j.jtcvs.2005.08.058
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 003CY
UT WOS:000234660400021
PM 16399303
ER

PT J
AU Thompson, IM
   Coltman, CA
   Crowley, J
AF Thompson, IM
   Coltman, CA
   Crowley, J
TI Chemoprevention of prostate cancer: The Prostate Cancer Prevention Trial
SO PROSTATE
LA English
DT Editorial Material
DE prostate neoplasms; chemoprevention; finasteride
ID UNITED-STATES; MORTALITY; ANTIGEN; MEN
AB BACKGROUND. A variety of innovative approaches to the prevention of prostate cancer are now available, including selenium, alpha tocopherol, dietary interventions, and vitamin D. Perhaps the most promising opportunity is based upon considerable evidence that cumulative androgen exposure of the prostate contributes to the age-related risk of prostate cancer.
   METHODS. The Prostate Cancer Prevention Trial has completed randomization of over 18,000 healthy men to either finasteride or placebo.
   CONCLUSIONS. While the primary objective of this study is to determine whether finasteride can reduce the period prevalence of prostate cancer over a 7-year period, the biologic and data resources of this study will provide multiple opportunities to better understand this most common cancer in U.S. men. (C) 1997 Wiley-Liss, Inc.
C1 SW ONCOL GRP,SAN ANTONIO,TX 78229.
   FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104.
RP Thompson, IM (reprint author), BROOKE ARMY MED CTR,DEPT SURG,3851 ROGER BROOKE DR,SAN ANTONIO,TX 78234, USA.
CR BERGES RR, 1993, P NATL ACAD SCI USA, V90, P8910, DOI 10.1073/pnas.90.19.8910
   Bosland M C, 1992, J Cell Biochem Suppl, V16H, P89
   BRAWLEY OW, 1994, CANCER EPIDEM BIOMAR, V3, P177
   Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957
   Cole P, 1996, CANCER, V78, P2045, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2045::AID-CNCR3>3.0.CO;2-N
   COONER WH, 1988, J UROLOGY, V139, P758
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   FELDMAN D, 1995, ADV EXP MED BIOL, V375, P53
   GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571
   GOLDENBERG SL, 1995, UROLOGY, V45, P839
   GORMLEY GJ, 1992, NEW ENGL J MED, V327, P1185, DOI 10.1056/NEJM199210223271701
   HANCHETTE CL, 1992, CANCER, V70, P2861, DOI 10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G
   HENDERSON BE, 1988, BRIT J CANCER, V57, P216, DOI 10.1038/bjc.1988.46
   HOVENANIAN MS, 1948, SURG GYNECOL OBSTET, V86, P29
   IMPERATOMCGINLEY J, 1992, J CLIN ENDOCR METAB, V75, P1022, DOI 10.1210/jc.75.4.1022
   Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166
   Lerner S E, 1996, Semin Urol Oncol, V14, P12
   LUBKE WL, 1994, J NATL CANCER I, V86, P1790, DOI 10.1093/jnci/86.23.1790
   Morton MS, 1996, BRIT J UROL, V77, P481, DOI 10.1046/j.1464-410X.1996.09361.x
   *PROST CANC TRIAL, 1995, LANCET, V346, P265
   Rosen PJ, 1996, J CLIN ONCOL, V14, P1626
   ROSS R, 1986, J NATL CANCER I, V76, P45
   SCHWARTZ GG, 1990, ANTICANCER RES, V10, P107
   Tannock IF, 1996, J CLIN ONCOL, V14, P1756
   The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, NEW ENGL J MED, V14, P1029
   *US BUR CENS, 1996, STAT ABSTR US 1996, P21
NR 26
TC 67
Z9 70
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0270-4137
J9 PROSTATE
JI Prostate
PD NOV 1
PY 1997
VL 33
IS 3
BP 217
EP 221
DI 10.1002/(SICI)1097-0045(19971101)33:3<217::AID-PROS11>3.0.CO;2-N
PG 5
WC Endocrinology & Metabolism; Urology & Nephrology
SC Endocrinology & Metabolism; Urology & Nephrology
GA YE723
UT WOS:A1997YE72300011
PM 9365551
ER

PT J
AU HUNG, JC
   WISEMAN, GA
   WAHNER, HW
   MULLAN, BP
   TAGGART, TR
   DUNN, WL
AF HUNG, JC
   WISEMAN, GA
   WAHNER, HW
   MULLAN, BP
   TAGGART, TR
   DUNN, WL
TI FILTERED TECHNETIUM-99M-SULFUR COLLOID EVALUATED FOR LYMPHOSCINTIGRAPHY
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Article
DE FILTERED TECHNETIUM-99M-SULFUR COLLOID; LYMPHOSCINTIGRAPHY; MEMBRANE
   FILTRATION; RADIOCOLLOID SIZE DETERMINATION
ID ANTIMONY
AB Several Tc-99m-labeled radiopharmaceuticals have been developed for lymphoscintigraphy of the extremities. In the United States, however, these agents are not widely used clinically. This study evaluates the use of smaller particle sizes (< 0.1 mu m) of Tc-99m-sulfur colloid (Tc-99m-SC) for lymphoscintigraphy. Methods: The Tc-99m-SC was prepared by kit, and the final preparation was filtered through a sterile 0.1-mu m filter. The radiochemical purity (RCP) of the filtered Tc-99m-SC was determined before administration. Nineteen patients with suspected lymphedema were injected with 18.5 MBq (500 mu Ci) filtered Tc-99m-SC intradermally in each foot, and whole-body images were obtained immediately and 1, 3, 6 and 24 hr later. Local views over the inguinal or axillary lymph nodes were also obtained every 5 min for the first hour. Results: The average RCP value was 93.4% +/- 4.2% (n = 19), and the RCP difference pre-and postfiltration of the Tc-99m-SC preparation was -1.7% +/- 1.4% (n = 40). Evaluation of the particle size with the polycarbonate filter showed that 89.9% +/- 4.5% (n = 28) of particles were less than 50 nm, and the particle size was further determined by electron microscopy to be 38.0 +/- 3.3 nm (n = 202). The mean particle sizes of two peaks measured by laser light scattering techniques were 7.5 and 53.9 nm (major peak). Clinical studies with filtered Tc-99m-SC demonstrated similar lymphoscintigrams compared with those obtained with Tc-99m antimony sulfide colloid (Tc-99m-ATC). Filtered Tc-99m-SC Showed a faster transport rate to the inguinal lymph nodes and lower radiation dosimetry for liver, spleen and whole body compared with Tc-99m-ATC. Conclusion: Filtered Tc-99m-SC can be easily prepared and is readily available for routine clinical use in lymphoscintigraphic studies.
RP HUNG, JC (reprint author), MAYO CLIN & MAYO FDN,DEPT DIAGNOST RADIOL,200 1ST ST SW,ROCHESTER,MN 55905, USA.
CR BERGQVIST L, 1982, J NUCL MED, V23, P698
   DAVIS MA, 1974, J NUCL MED, V15, P923
   DUNSON GL, 1973, RADIOLOGY, V109, P387
   EGE GN, 1979, BRIT J RADIOL, V52, P124
   EGE GN, 1976, RADIOLOGY, V118, P101
   KAPLAN WD, 1979, J NUCL MED, V20, P933
   KOWALSKI RJ, 1987, RADIOPHARMACEUTICALS, P271
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   OCONNOR MK, 1988, EUR J NUCL MED, V14, P562
   Richards T B, 1990, Ann Vasc Surg, V4, P255, DOI 10.1007/BF02009453
   SACKS GA, 1983, CLIN NUCL MED, V8, P309, DOI 10.1097/00003072-198307000-00006
   VANREENEN O, 1982, EUR J NUCL MED, V7, P80
   WARBICK A, 1977, J NUCL MED, V18, P827
   1995, US PHARMACOPEIA, P1480
   1985, MIRDOSE2 COMPUTER PR
   1988, AN SULFUR COLLOID KI
NR 16
TC 67
Z9 71
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 22090-5316
SN 0161-5505
J9 J NUCL MED
JI J. Nucl. Med.
PD OCT
PY 1995
VL 36
IS 10
BP 1895
EP 1901
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA RZ318
UT WOS:A1995RZ31800036
PM 7562061
ER

PT J
AU BUNTAIN, WL
   WOOD, JB
   WOOLLEY, MM
AF BUNTAIN, WL
   WOOD, JB
   WOOLLEY, MM
TI PANCREATITIS IN CHILDHOOD
SO JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
C1 CHILDRENS HOSP,DEPT PEDIAT,BIRMINGHAM,AL 35233.
RP BUNTAIN, WL (reprint author), CHILDRENS HOSP,DEPT SURG,BIRMINGHAM,AL 35233, USA.
CR ANCES IG, 1971, SOUTHERN MED J, V64, P267
   ANDERSON MC, 1967, SURG CLIN N AM, V47, P127
   ANDERSON MC, 1963, JAMA-J AM MED ASSOC, V183, P534
   ANDERSON MC, 1968, AM J SURG, V115, P118, DOI 10.1016/0002-9610(68)90139-6
   ARTZ CP, 1962, ANN SURG, V155, P756, DOI 10.1097/00000658-196205000-00015
   BAGGENSTOSS AH, 1948, AM J PATHOL, V24, P1003
   BALSLOV JORGEN T., 1962, ACTA CHIR SCAND, V124, P348
   BEISEL WR, 1959, ARCH INTERN MED, V104, P589
   BLOCK MB, 1970, NEW ENGL J MED, V282, P380, DOI 10.1056/NEJM197002122820710
   CARONE FA, 1957, NEW ENGL J MED, V257, P690, DOI 10.1056/NEJM195710102571502
   COLLINS JJ, 1968, ANN SURG, V167, P433, DOI 10.1097/00000658-196803000-00019
   DUBOIS EL, 1963, ANN INTERN MED, V38, P1265
   FONKALSR.EW, 1968, AM J SURG, V116, P198, DOI 10.1016/0002-9610(68)90493-5
   FREY C, 1963, PEDIATRICS, V32, P93
   GEOKAS MC, 1972, CALIF MED, V117, P25
   GEOKAS MC, 1972, ANN INTERN MED, V76, P105
   GERBER BC, 1963, ARCH SURG-CHICAGO, V87, P70
   GILBERT MG, 1964, PEDIATRICS, V33, P589
   GLOVER JL, 1969, J SURG RES, V9, P531, DOI 10.1016/0022-4804(69)90130-9
   HASKELL CM, 1969, NEW ENGL J MED, V281, P1028, DOI 10.1056/NEJM196911062811902
   HENDREN WH, 1965, ARCH DIS CHILD, V40, P132
   HENDRY WS, 1966, EXP MED SURG, V24, P303
   JAFFE N, 1972, PEDIATRICS, V49, P590
   KATTWINK.J, 1973, PEDIATRICS, V51, P55
   LAND VJ, 1972, CANCER, V30, P339, DOI 10.1002/1097-0142(197208)30:2<339::AID-CNCR2820300206>3.0.CO;2-P
   LEVITT MD, 1969, ANN INTERN MED, V71, P919
   MCCUTCHE.AD, 1968, GUT, V9, P296, DOI 10.1136/gut.9.3.296
   Moossa A R, 1972, Prog Pediatr Surg, V4, P111
   MULHAUSE.R, 1969, METABOLIS, V18, P669, DOI 10.1016/0026-0495(69)90080-8
   NARDI GL, 1966, ANN SURG, V164, P611
   OPPENHEIMER EH, 1960, B JOHNS HOPKINS HOSP, V107, P297
   PALOYAN E, 1967, CURR PROBL SURG  JUN, P3
   PFEFFER RB, 1970, HOSP MED, P79
   POLLAK VE, 1958, NEW ENGL J MED, V259, P258, DOI 10.1056/NEJM195808072590602
   RIEMENSC.TA, 1968, PEDIATRICS, V41, P428
   ROBECHEK PJ, 1967, AM J SURG, V113, P819, DOI 10.1016/0002-9610(67)90354-6
   ROSATO EF, 1973, ANN SURG, V175, P384
   SARLES H, 1963, S MARSEILLES, P7
   SAUVAGE LR, 1968, AM J SURG, V116, P198
   SCHUMER W, 1964, SURGERY, V55, P841
   SLEEMAN HK, 1969, SURGERY, V66, P1060
   STUMPF HH, 1956, LAB INVEST, V5, P224
   TOFFLER AH, 1962, ANN INTERN MED, V57, P655
   WATERMAN NG, 1968, SURG GYNECOL OBSTETR, V126, P963
   WILLIAMS WH, 1971, SURGERY, V69, P708
   WRIGHT PW, 1970, ARCH SURG-CHICAGO, V100, P42
   1964, N ENGL J MED, V270, P736
NR 47
TC 67
Z9 67
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0022-3468
J9 J PEDIATR SURG
JI J. Pediatr. Surg.
PY 1978
VL 13
IS 2
BP 143
EP 149
DI 10.1016/S0022-3468(78)80008-6
PG 7
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA EU410
UT WOS:A1978EU41000008
PM 650364
ER

PT J
AU Kon, ZN
   Brown, EN
   Tran, R
   Joshi, A
   Reicher, B
   Grant, MC
   Kallam, S
   Burris, N
   Connerney, I
   Zimrin, D
   Poston, RS
AF Kon, Zachary N.
   Brown, Emile N.
   Tran, Richard
   Joshi, Ashish
   Reicher, Barry
   Grant, Michael C.
   Kallam, Seeta
   Burris, Nicholas
   Connerney, Ingrid
   Zimrin, David
   Poston, Robert S.
TI Simultaneous hybrid coronary revascularization reduces postoperative
   morbidity compared with results from conventional off-pump coronary
   artery bypass
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article; Proceedings Paper
CT 87th Annual Meeting of the American-Association-for-Thoracic-Surgery
CY MAY 05-09, 2007
CL Washington, DC
SP Amer Assoc Thorac Surg
ID RANDOMIZED-TRIAL; RADIAL-ARTERY; GRAFTS; ANGIOPLASTY; SURGERY; SINGLE;
   COST; COMPLICATIONS; OCCLUSION; STENOSIS
AB Objectives: Less- invasive options are available for surgical treatment of multivessel coronary artery disease. We hypothesized that stenting combined with grafting of the left anterior descending artery with the left internal thoracic artery through a minithoracotomy (hybrid procedure) would provide the best outcome.
   Methods: Patients with equivalent numbers of coronary lesions (2.8 +/- 0.4) underwent either hybrid (n = 15) or off-pump coronary artery bypass through a sternotomy (n = 30). Early and 1-year outcomes were compared. Blood drawn from the aorta and coronary sinus immediately postoperatively was analyzed for activation of coagulation (prothrombin fragment 1.2 and activated Factor XII), myocardial injury (myoglobin), and inflammation (interleukin 8) by using an enzyme-linked immunosorbent assay. Target-vessel patency was determined by means of computed tomographic angiographic analysis.
   Results: The hybrid procedure was associated with significantly shorter lengths of intubation and stays in the intensive care unit and hospital and perioperative morbidity (P < .05). Intraoperative costs were increased but postoperative costs were reduced for the hybrid procedure compared with off-pump coronary artery bypass through a sternotomy. As a result, overall total costs were not significantly different between the groups. After adjusting for potential confounders, assignment to the hybrid group was an independent predictor of shortened time to return to work (t = -2.12, P = .04). Patient satisfaction after the hybrid procedure, as judged on a 6-point scale, was greater versus that after off-pump coronary artery bypass through a sternotomy. Finally, the hybrid procedure showed significantly reduced transcardiac gradients of markers of coagulation, myocardial injury, and inflammation and a trend toward significant improvement in target-vessel patency.
   Conclusions: Perhaps because of reduced myocardial injury, inflammation, and activation of coagulation, patients undergoing the hybrid procedure had better perioperative outcomes and satisfaction, with excellent patency at 1 year's follow-up. These promising preliminary findings warrant further investigation of this procedure.
C1 [Kon, Zachary N.; Brown, Emile N.; Tran, Richard; Grant, Michael C.; Kallam, Seeta; Burris, Nicholas; Poston, Robert S.] Univ Maryland, Sch Med, Div Cardiac Surg, Dept Surg, Baltimore, MD 21201 USA.
   [Reicher, Barry; Zimrin, David] Univ Maryland, Dept Cardiol, Baltimore, MD 21201 USA.
   [Connerney, Ingrid] Univ Maryland, Med Syst, Baltimore, MD 21201 USA.
   [Joshi, Ashish] Univ Maryland Baltimore Cty, Dept Informat Syst, Baltimore, MD 21228 USA.
RP Poston, RS (reprint author), Univ Maryland, Sch Med, Div Cardiac Surg, Dept Surg, N4W94 22 S Greene St, Baltimore, MD 21201 USA.
EM rposton@smail.umaryland.edu
CR Arom KV, 1999, ANN THORAC SURG, V68, P1562, DOI 10.1016/S0003-4975(99)00962-5
   Cohen HA, 1998, CIRCULATION, V98, P1048
   Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982
   Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563
   Frazier AA, 2005, RADIOGRAPHICS, V25, P881, DOI 10.1148/RG.25405151
   GALBUT DL, 1993, J THORAC CARDIOV SUR, V106, P128
   GROSSI EA, 1991, J THORAC CARDIOV SUR, V102, P342
   HUEB WA, 1995, J AM COLL CARDIOL, V26, P1600, DOI 10.1016/0735-1097(95)00384-3
   Khot UN, 2004, CIRCULATION, V109, P2086, DOI 10.1161/01.CIR.0000127570.20508.5C
   Kon ZN, 2006, INNOVATIONS, V1, P232, DOI 10.1097/01.IMI.0000242160.21278.b7
   LOOP FD, 1990, ANN THORAC SURG, V49, P179
   Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X
   MOOR E, 1994, THROMB HAEMOSTASIS, V72, P335
   NEUMANN FJ, 1995, CIRCULATION, V92, P748
   Neumann FJ, 1996, J AM COLL CARDIOL, V27, P15, DOI 10.1016/0735-1097(95)00433-5
   Oltrona L, 1996, CIRCULATION, V94, P2064
   Pick AW, 1997, ANN THORAC SURG, V64, P599, DOI 10.1016/S0003-4975(97)00620-6
   Poston RS, 2006, J THORAC CARDIOV SUR, V131, P122, DOI 10.1016/j.jtcvs.2005.08.058
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Riess FC, 2002, ANN THORAC SURG, V73, P1849, DOI 10.1016/S0003-4975(02)03519-1
   SCHARF RE, 1992, ARTERIOSCLER THROMB, V12, P1475
   Subramanian VA, 1997, ANN THORAC SURG, V64, P1648, DOI 10.1016/S0003-4975(97)01099-0
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
NR 23
TC 66
Z9 70
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 2008
VL 135
IS 2
BP 367
EP 375
DI 10.1016/j.jtcvs.2007.09.025
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 257WU
UT WOS:000252830400020
PM 18242270
ER

PT J
AU Nakai, S
   Mima, K
AF Nakai, S
   Mima, K
TI Laser driven inertial fusion energy: present and prospective
SO REPORTS ON PROGRESS IN PHYSICS
LA English
DT Review
ID CONFINEMENT FUSION; FAST IGNITION; CONCEPTUAL DESIGN; HIGH-GAIN;
   COMPRESSION; PHYSICS; REACTOR; DENSITY; PLASMA; PERFORMANCE
AB Recent progress in laser driven implosion is reviewed. Improvements in the uniformity of irradiation by laser beams on fuel pellets have achieved quantitative progress in implosion performance. The recent results of the direct drive-central ignition experiments give us confidence in achieving fusion ignition, burning and energy gain using a multi-beam megajoule laser with full implementation of beam smoothing techniques. Fast ignition research is also reviewed, which could give us a higher energy gain with lower laser energy. The science and technology of laser fusion power plants are beginning to attract wider attention, as forming the road map to achieve commercial power plants for cleaner,. safer and abundant fusion energy.
C1 Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan.
   Kochi Natl Coll Technol, Nanko Ku, Kochi 7838508, Japan.
RP Nakai, S (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 5650871, Japan.
CR Atzeni S, 1999, PHYS PLASMAS, V6, P3316, DOI 10.1063/1.873571
   ATZENI S, 1995, JPN J APPL PHYS 1, V34, P1980
   AZECHI H, 1991, LASER PART BEAMS, V9, P193
   BAYRAMIAN AJ, 2002, INERTIAL FUSION SCI, P459
   Betti R, 1998, PHYS PLASMAS, V5, P1446, DOI 10.1063/1.872802
   Bodner SE, 2000, PHYS PLASMAS, V7, P2298, DOI 10.1063/1.874063
   BODNER SE, 1998, NRLMR6730988113
   BOOTH LA, 1972, CENTRAL STATION POWE, V1
   Deutsch C, 1996, PHYS REV LETT, V77, P2483, DOI 10.1103/PhysRevLett.77.2483
   FUJIMOTO Y, 2002, INERTIAL FUSION SCI, P524
   Hogan W.J., 1995, ENERGY INERTIAL FUSI
   IZAWA Y, 2002, 19 IAEA FUS EN C LYO
   Johzaki T, 2003, FUSION SCI TECHNOL, V43, P428
   Kawashima T, 2001, JPN J APPL PHYS 1, V40, P6415, DOI 10.1143/JJAP.40.6415
   Kitagawa Y, 2002, PHYS PLASMAS, V9, P2202, DOI 10.1063/1.1458588
   KODAMA R, 2002, NATURE, V418, P993
   Kodama R, 2001, NATURE, V412, P798, DOI 10.1038/35090525
   KODAMA R, 2000, 18 IAEA FUS EN C SOR
   KOZAKI Y, 2002, 19 IAEA FUS EN C LYO
   KRUPKE WF, 1989, FUSION TECHNOL, V15, P377
   Krupke WF, 2000, P SOC PHOTO-OPT INS, V3889, P21, DOI 10.1117/12.380885
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   LiNDL J. D., 1998, INERTIAL CONFINEMENT
   LU J, 2002, INTERTIAL FUSION SCI, P576
   MAHADY AI, 1999, NUCL FUSION, V39, P467
   Matsui H., 2000, Review of Laser Engineering, V28
   Matsui H, 1999, FUSION ENG DES, V44, P401, DOI 10.1016/S0920-3796(98)00317-2
   MAYERTERVEHN J, 1982, NUCL FUSION, V22, P561
   MCCRORY RL, 19 IAEA FUS EN C LYO
   McKenty PW, 2001, PHYS PLASMAS, V8, P2315, DOI 10.1063/1.1350571
   MIMA K, 2000, 18 IAEA FUS EN C SOR
   MIMA K, 1992, 14 IAEA FUS EN C WUR
   MIMA K, 2002, 19 FUS EN C LYON FRA
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   NAITO K, 1992, JPN J APPL PHYS 1, V31, P259, DOI 10.1143/JJAP.31.259
   NAKAI S, 1989, B AM PHYS SOC, V34, P2040
   NAKAI S, 1990, 13 IAEA FUS EN C WAS
   Nakai S, 1996, REP PROG PHYS, V59, P1071, DOI 10.1088/0034-4885/59/9/002
   Nakamura S., 2000, AAPPS B, V10, P2
   NISHIMURA H, 1998, 17 IAEA FUS EN C YOK
   NORIMATSU T, 2002, 19 IAEA FUS EN C LYO
   NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0
   Orth CD, 1996, NUCL FUSION, V36, P75, DOI 10.1088/0029-5515/36/1/I06
   Piriz AR, 1998, PHYS PLASMAS, V5, P2721, DOI 10.1063/1.872960
   Regan SP, 2000, J OPT SOC AM B, V17, P1483, DOI 10.1364/JOSAB.17.001483
   Sentoku Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.155001
   SHIGEMORI K, 2002, 19 IAEA FUS EN C LYO
   SHIGEMORI K, 2001, B AM PHYS SOC, V46, P286
   SKUPSKY S, 1989, J APPL PHYS, V66, P3456, DOI 10.1063/1.344101
   STRICKLAND D, 1985, OPT COMMUN, V56, P219, DOI 10.1016/0030-4018(85)90120-8
   SVIATOSLAVSKY IN, 1992, FUSION TECHNOL, V21, P1470
   TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664
   TAKABE H, 1985, PHYS FLUIDS, V28, P3679
   Tanaka KA, 2000, PHYS PLASMAS, V7, P2014, DOI 10.1063/1.874023
   Yamaguchi M, 2000, J BONE MINER METAB, V18, P77, DOI 10.1007/s007740050015
   YAMANAKA C, 1986, NATURE, V319, P757, DOI 10.1038/319757a0
   YAMANAKA C, 1981, ILE8127P
   YAMANAKA T, 2002, 19 IAEA FUS EN C LYO
   1999, P SPIE, V3885
NR 59
TC 66
Z9 71
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0034-4885
J9 REP PROG PHYS
JI Rep. Prog. Phys.
PD MAR
PY 2004
VL 67
IS 3
BP 321
EP 349
DI 10.1088/0034-4885/67/3/R04
PG 29
WC Physics, Multidisciplinary
SC Physics
GA 813FF
UT WOS:000220892300004
ER

PT J
AU Kestin, LL
   Martinez, AA
   Stromberg, JS
   Edmundson, GK
   Gustafson, GS
   Brabbins, DS
   Chen, PY
   Vicini, FA
AF Kestin, LL
   Martinez, AA
   Stromberg, JS
   Edmundson, GK
   Gustafson, GS
   Brabbins, DS
   Chen, PY
   Vicini, FA
TI Matched-pair analysis of conformal high-dose-rate brachytherapy boost
   versus external-beam radiation therapy alone for locally advanced
   prostate cancer
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Article
ID RANDOMIZED COMPARATIVE TRIAL; RATE IR-192 BRACHYTHERAPY; WHOLE-PELVIC
   IRRADIATION; DISEASE-FREE SURVIVAL; DEFINITIVE RADIOTHERAPY; RADICAL
   PROSTATECTOMY; ANTIGEN NADIR; BIOCHEMICAL FAILURE; LOCALIZED CARCINOMA;
   ONCOLOGY GROUP
AB Purpose: We performed a matched-pair analysis to compare our institution's experience in treating locally advanced prostate cancer with external-beam radiation therapy (EBRT) alone to EBRT in combination with conformal interstitial high-dose-rate (HDR) brachytherapy boosts (EBRT + HDR),
   Materials and Methods: From 1991 to 1998, 161 patients with locally advanced prostate cancer were prospectively treated with EBRT + HDR at William Beaumont Hospital, Royal Oak, Michigan. Patients with any of the following characteristics were eligible for study entry: pretreatment prostate-specific antigen (PSA) level of greater than or equal to 10.0 ng/mL, Gleason score greater than or equal to 7, or clinical stage T2b to T3c, Pelvic EBRT (46.0 Gy) was supplemented with three (1991 through 1995) or two (1995 through 1998) ultrasound-guided transperineal interstitial iridium-192 HDR implants, The brachytherapy dose was escalated from 5.50 to 10.50 Gy per implant,
   Each of the 161 EBRT + HDR patients wets randomly matched with a unique EBRT-alone patient. Patients were matched according to PSA level, Gleason score, T stage, and follow-up duration. The median PSA fallow-up was 2.5 years for both EBRT + HDR and EBRT alone.
   Results: EBRT + HDR patients demonstrated significantly lower PSA nadir levels (median, 0.4 ng/mL) compared with those receiving EBRT alone (median, 1.1 ng/mL), The 5-year biochemical control rater for EBRT + HDR versus EBRT-alone patients were 67% versus 44%, respectively (P < .001), On multivariate analyses, pretreatment PSA, Gleason score, T stage, and the use of EBRT alone were significantly associated with biochemical failure, Those patients in both treatment groups who experienced biochemical failure had a lower 5-year cause-specific survival rate than patients who were biochemically controlled (84% v 100%; P < .001).
   Conclusion: Locally advanced prostate cancer patients treated with EBRT + HDR demonstrate improved biochemical control compared with those who are treated with conventional doses of EBRT alone, J Clin Oncol 18:2869-2880, (C) 2000 by American Society of Clinical Oncology.
C1 William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
RP Martinez, AA (reprint author), William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.
CR Algan O, 1996, RADIAT RES, V146, P267, DOI 10.2307/3579456
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Aref I, 1998, RADIOTHER ONCOL, V48, P203, DOI 10.1016/S0167-8140(98)00061-9
   ARISTIZABAL S A, 1984, Radiotherapy and Oncology, V1, P309, DOI 10.1016/S0167-8140(84)80018-3
   Asbell SO, 1998, INT J RADIAT ONCOL, V40, P769, DOI 10.1016/S0360-3016(97)00926-7
   ASBELL SO, 1988, INT J RADIAT ONCOL, V15, P1307
   Bagshaw MA, 1988, NATL CANCER I MONOGR, V7, P47
   BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981
   BEAHRS OH, 1993, AJCC CANC STAGING MA, P189
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Borghede G, 1997, RADIOTHER ONCOL, V44, P245, DOI 10.1016/S0167-8140(97)00122-9
   Borghede G, 1997, RADIOTHER ONCOL, V44, P237, DOI 10.1016/S0167-8140(97)00121-7
   BRABBINS DS, 1998, RADIOTHER ONCOL S1, V48, P23
   Brenner DJ, 1999, INT J RADIAT ONCOL, V43, P1095, DOI 10.1016/S0360-3016(98)00438-6
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Dinges S, 1998, RADIOTHER ONCOL, V48, P197, DOI 10.1016/S0167-8140(98)00054-1
   Duchesne GM, 1999, INT J RADIAT ONCOL, V44, P747
   Edmundson GK, 1995, INT J RADIAT ONCOL, V33, P1257, DOI 10.1016/0360-3016(95)00276-6
   EDMUNDSON GK, 1990, BRACHYTHERAPY, P184
   EDMUNDSON GK, 1993, INT J RADIAT ONCOL, V27, P1215
   Forman J D, 1997, Semin Urol Oncol, V15, P239
   Forman JD, 1996, INT J RADIAT ONCOL, V35, P259, DOI 10.1016/0360-3016(96)00020-X
   FORMAN JD, 1993, RADIOTHER ONCOL, V27, P203, DOI 10.1016/0167-8140(93)90075-J
   FukunagaJohnson N, 1997, INT J RADIAT ONCOL, V38, P311, DOI 10.1016/S0360-3016(97)82499-6
   Gerber GS, 1997, EUR UROL, V32, P385
   GOAD JR, 1993, UROL CLIN N AM, V20, P727
   Goto Y, 1998, Int J Urol, V5, P337, DOI 10.1111/j.1442-2042.1998.tb00363.x
   Hanks GE, 1996, INT J RADIAT ONCOL, V35, P861, DOI 10.1016/0360-3016(96)00207-6
   Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3
   Hanks GE, 1999, CANCER J SCI AM, V5, P152
   Hanks GE, 1997, INT J RADIAT ONCOL, V37, P543, DOI 10.1016/S0360-3016(96)00602-5
   HARAF DJ, 1995, INT J RADIAT ONCOL, V33, P3, DOI 10.1016/0360-3016(95)00181-W
   HARISIADIS L, 1978, CANCER, V41, P2131, DOI 10.1002/1097-0142(197806)41:6<2131::AID-CNCR2820410609>3.0.CO;2-R
   HILL DR, 1974, CANCER, V34, P156, DOI 10.1002/1097-0142(197407)34:1<156::AID-CNCR2820340123>3.0.CO;2-Q
   Horwitz EM, 1998, INT J RADIAT ONCOL, V41, P267, DOI 10.1016/S0360-3016(98)00078-9
   Horwitz EM, 1996, INT J RADIAT ONCOL, V36, P565, DOI 10.1016/S0360-3016(96)00360-4
   Jaffray DA, 1999, SEMIN RADIAT ONCOL, V9, P4, DOI 10.1016/S1053-4296(99)80051-4
   JOHNSON D E, 1972, Journal of Surgical Oncology, V4, P207, DOI 10.1002/jso.2930040305
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   Kestin LL, 1999, RADIOLOGY, V213P, P154
   KOVACS G, 1997, P 9 INT BRACH C PALM, P84
   Kupelian P, 1997, CANCER J SCI AM, V3, P78
   Laverdiere J, 1997, INT J RADIAT ONCOL, V37, P247, DOI 10.1016/S0360-3016(96)00513-5
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   LEIBEL SA, 1984, INT J RADIAT ONCOL, V10, P401
   LEITH JT, 1994, PROSTATE, V24, P119, DOI 10.1002/pros.2990240304
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   Martinez A, 1995, INT J RADIAT ONCOL, V33, P1019, DOI 10.1016/0360-3016(95)00254-5
   Martinez AA, 2000, CANCER, V88, P425, DOI 10.1002/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z
   Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2
   MCGOWAN DG, 1981, INT J RADIAT ONCOL, V7, P1333
   NEGLIA WJ, 1977, INT J RADIAT ONCOL, V2, P873
   Oefelein MG, 1997, J UROLOGY, V158, P1460, DOI 10.1016/S0022-5347(01)64243-5
   Paul R, 1997, WORLD J UROL, V15, P252, DOI 10.1007/BF01367663
   PEREZ CA, 1989, RADIOTHER ONCOL, V16, P1, DOI 10.1016/0167-8140(89)90066-2
   Perez CA, 1996, INT J RADIAT ONCOL, V36, P573, DOI 10.1016/S0360-3016(96)00378-1
   Pickles T, 1999, INT J RADIAT ONCOL, V43, P699
   Pilepich MV, 1997, J CLIN ONCOL, V15, P1013
   PILEPICH MV, 1995, UROLOGY, V45, P616, DOI 10.1016/S0090-4295(99)80053-3
   PILEPICH MV, 1987, INT J RADIAT ONCOL, V13, P339
   PLOYSONGSANG S, 1986, UROLOGY, V27, P10, DOI 10.1016/0090-4295(86)90197-4
   Pollack A, 1998, UROLOGY, V51, P258, DOI 10.1016/S0090-4295(97)00621-3
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   RANGALA N, 1982, INT J RADIAT ONCOL, V8, P1909
   Rasp G. M., 1996, International Journal of Radiation Oncology Biology Physics, V36, P245, DOI 10.1016/S0360-3016(97)85514-9
   Roach M, 1996, J UROLOGY, V156, P1719, DOI 10.1016/S0022-5347(01)65490-9
   Rosen E, 1985, Int J Radiat Oncol Biol Phys, V11, P723
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Seaward SA, 1998, INT J RADIAT ONCOL, V42, P1055, DOI 10.1016/S0360-3016(98)00282-X
   Seaward SA, 1998, CANCER J SCI AM, V4, P370
   SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   Stock RG, 1998, ONCOLOGY-NY, V12, P1467
   STROMBERG J, 1995, INT J RADIAT ONCOL, V33, P161, DOI 10.1016/0360-3016(95)00035-W
   Stromberg JS, 1997, CANCER J SCI AM, V3, P346
   VANDERLAARSE R, 1994, BRACHYTHERAPY RADIUM, P331
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
   Vicini FA, 2000, CANCER, V88, P2305, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2305::AID-CNCR15>3.0.CO;2-3
   Vicini FA, 1997, NEW ENGL J MED, V337, P1693
   Vicini FA, 1999, ONCOLOGY-NY, V13, P491
   Wills ML, 1998, UROLOGY, V51, P759, DOI 10.1016/S0090-4295(98)00011-9
   Yan D, 1998, INT J RADIAT ONCOL, V41, P715, DOI 10.1016/S0360-3016(97)00567-1
   Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   ZAGARS GK, 1987, CANCER, V60, P1489, DOI 10.1002/1097-0142(19871001)60:7<1489::AID-CNCR2820600715>3.0.CO;2-9
   Zeitlin SI, 1998, J UROLOGY, V160, P91, DOI 10.1016/S0022-5347(01)63042-8
   Zelefsky MJ, 1998, RADIOLOGY, V209, P169
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
NR 98
TC 66
Z9 67
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0732-183X
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD AUG
PY 2000
VL 18
IS 15
BP 2869
EP 2880
PG 12
WC Oncology
SC Oncology
GA 340EU
UT WOS:000088520800011
PM 10920135
ER

PT J
AU Tzifa, A
   Ewert, P
   Brzezinska-Rajszys, G
   Peters, B
   Zubrzycka, M
   Rosenthal, E
   Berger, F
   Qureshi, SA
AF Tzifa, A
   Ewert, P
   Brzezinska-Rajszys, G
   Peters, B
   Zubrzycka, M
   Rosenthal, E
   Berger, F
   Qureshi, SA
TI Covered Cheatham-platinum stents for aortic coarctation - Early and
   intermediate-term results
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID CONGENITAL-ANOMALIES REGISTRY; PATCH AORTOPLASTY REPAIR; BALLOON
   ANGIOPLASTY; FOLLOW-UP; NATIVE COARCTATION; COEXISTENT COARCTATION;
   ENDOVASCULAR STENTS; PEDIATRIC-PATIENT; RECOARCTATION; ANEURYSM
AB OBJECTIVES This study sought to evaluate the use of covered Cheatham-platinum (CP) stents in the treatment of aortic coarctation (CoA).
   BACKGROUND Aortic aneurysms and stent fractures have been encountered after surgical and transcatheter treatment for CoA. Covered stents have previously been used in the treatment of abdominal and thoracic aneurysms in adults. We implanted covered CP stents as a rescue treatment in patients with CoA aneurysms or previous stent-related complications and in patients at risk of developing complications because of complex CoA anatomy or advanced age.
   METHODS Thirty-three covered CP stents were implanted in 30 patients; 16 patients had had previous procedures. The remaining patients had complex or near-atretic CoA.
   RESULTS The mean patient age and weight were 28 (+/- 17.5) years (range 8 to 65 years), and 62 (+/- 13) kg (range 28 to 86 kg), respectively. The systolic gradient across the CoA decreased from a mean (+/- SD) of 36 +/- 20 mm Hg before to a mean of 4 +/- 4 mm Hg after the procedure (p < 0.0001), and the diameter of the CoA increased from 6.4 +/- 3.8 min to 17.1 +/- 3.1 mm (p < 0.0001). The follow-up period was up to 40 months (mean, 11 months). All stents were patent and in good position on computed tomography or magnetic resonance imaging performed three to six months later. In 43% of the patients antihypertensive medication was either decreased or stopped.
   CONCLUSIONS Covered CP stents may be used as the therapy of choice in patients with complications after CoA repairs, whereas they provide a safe alternative to conventional stenting in patients with severe and complex CoA lesions or advanced age.
C1 Guys & St Thomas Hosp, Dept Congenital Heart Dis, London SE1 9RT, England.
   German Heart Inst, Dept Congenital Heart Dis, Berlin, Germany.
   Childrens Mem Hosp, Dept Pediat Cardiol, Warsaw, Poland.
RP Qureshi, SA (reprint author), St Thomas Hosp, Evelina Childrens Hosp, Dept Congenital Heart Dis, Lambeth Palace Rd, London SE1 7EH, England.
EM shakeel.qureshi@gstt.nhs.uk
RI Rosenthal, Eric/I-7469-2012
OI Rosenthal, Eric/0000-0003-3030-9749
CR BROMBERG BI, 1989, J AM COLL CARDIOL, V14, P734
   Cheatham JP, 2001, CATHETER CARDIO INTE, V54, P112, DOI 10.1002/ccd.1249
   COHEN M, 1989, CIRCULATION, V80, P840
   Connolly JE, 1998, AM J SURG, V176, P92, DOI 10.1016/S0002-9610(98)00133-0
   CRAFOORD C, 1945, J THORAC SURG, V14, P347
   de Giovanni J V, 2001, J Interv Cardiol, V14, P187
   de Lezo JS, 1999, AM J CARDIOL, V83, P400
   Ebeid MR, 1997, J AM COLL CARDIOL, V30, P1847, DOI 10.1016/S0735-1097(97)00408-7
   Ewert P, 2004, CATHETER CARDIO INTE, V63, P236, DOI 10.1002/ccd.20119
   FLETCHER SE, 1995, J AM COLL CARDIOL, V25, P730, DOI 10.1016/0735-1097(94)00437-U
   Forbes T, 2003, PEDIATR CARDIOL, V24, P289, DOI 10.1007/s00246-002-0262-9
   Gunn J, 1999, HEART, V82, P351
   Hamdan MA, 2001, J AM COLL CARDIOL, V38, P1518, DOI 10.1016/S0735-1097(01)01572-8
   HELLENBRAND WE, 1990, AM J CARDIOL, V65, P793, DOI 10.1016/0002-9149(90)91390-R
   Hijazi ZM, 2003, CATHETER CARDIO INTE, V59, P391, DOI 10.1002/ccd.10561
   HIJAZI ZM, 1991, CIRCULATION, V84, P1150
   Ino T, 1997, ACTA PAEDIATR, V86, P367, DOI 10.1111/j.1651-2227.1997.tb09024.x
   ISNER JM, 1987, CIRCULATION, V75, P689
   Khan MS, 2000, CATHETER CARDIO INTE, V50, P445, DOI 10.1002/1522-726X(200008)50:4<445::AID-CCD17>3.0.CO;2-1
   Magee AG, 1999, HEART, V82, P600
   Maheshwari S, 2000, J AM COLL CARDIOL, V35, P209, DOI 10.1016/S0735-1097(99)00527-6
   Marshall AC, 2000, AM HEART J, V139, P1054, DOI 10.1067/mhj.2000.106616
   McCrindle BW, 1996, J AM COLL CARDIOL, V28, P1810
   MENDELSOHN AM, 1994, AM J CARDIOL, V74, P696, DOI 10.1016/0002-9149(94)90312-3
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923
   Ovaert C, 1998, PEDIATR CARDIOL, V19, P27, DOI 10.1007/s002469900243
   PALMAZ JC, 1988, AM J ROENTGENOL, V150, P1263
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   Pedra CAC, 2005, PEDIATR CARDIOL, V26, P431, DOI 10.1007/s00246-004-0814-2
   Qureshi SA, 2004, CARDIOL YOUNG, V14, P50
   Rao PS, 1996, J AM COLL CARDIOL, V27, P462, DOI 10.1016/0735-1097(95)00479-3
   Rao PS, 1998, HEART, V79, P407
   Rehders TC, 2004, J ENDOVASC THER, V11, P659, DOI 10.1583/04-1311R.1
   Sadiq M, 2003, CATHETER CARDIO INTE, V59, P387, DOI 10.1002/ccd.10501
   SINGER MI, 1982, AM HEART J, V103, P131, DOI 10.1016/0002-8703(82)90539-7
   Taylor PR, 2001, EUR J VASC ENDOVASC, V22, P70, DOI 10.1053/ejvs.2001.1407
   Thanopoulos BD, 2000, HEART, V84, P65, DOI 10.1136/heart.84.1.65
   TYNAN M, 1990, AM J CARDIOL, V65, P790, DOI 10.1016/0002-9149(90)91389-N
   Varma C, 2003, CATHETER CARDIO INTE, V59, P528, DOI 10.1002/ccd.10548
   Wada T, 2001, ANN THORAC SURG, V72, P80, DOI 10.1016/S0003-4975(01)02639-X
   WHITE GH, 2003, CATHETER BASED DEVIC, P427
NR 41
TC 65
Z9 72
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD APR 4
PY 2006
VL 47
IS 7
BP 1457
EP 1463
DI 10.1016/j.jacc.2005.11.061
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 030PQ
UT WOS:000236647200021
PM 16580536
ER

PT J
AU TAMISIER, D
   VOUHE, PR
   VERNANT, F
   LECA, F
   MASSOT, C
   NEVEUX, JY
AF TAMISIER, D
   VOUHE, PR
   VERNANT, F
   LECA, F
   MASSOT, C
   NEVEUX, JY
TI MODIFIED BLALOCK-TAUSSIG SHUNTS - RESULTS IN INFANTS LESS THAN 3 MONTHS
   OF AGE
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
C1 HOP LAENNEC,SERV CHIRURG THORAC & CARDIOVASC,42 RUE SEVRES,F-75340 PARIS 07,FRANCE.
CR AMATO JJ, 1988, J THORAC CARDIOV SUR, V95, P62
   ARCINIEGAS E, 1982, J THORAC CARDIOV SUR, V84, P88
   BARRAGRY TP, 1987, J THORAC CARDIOV SUR, V93, P767
   BOVE EL, 1987, CIRCULATION, V76, P19
   DELEVAL MR, 1981, J THORAC CARDIOV SUR, V81, P112
   GUYTON RA, 1983, J THORAC CARDIOV SUR, V85, P917
   ILBAWI M N, 1984, Journal of Thoracic and Cardiovascular Surgery, V88, P770
   LAMBERTI JJ, 1984, J THORAC CARDIOV SUR, V88, P76
   MOULTON AL, 1985, CIRCULATION, V72, P35
   STEWART S, 1988, J THORAC CARDIOV SUR, V96, P117
   ULLOM RL, 1987, ANN THORAC SURG, V44, P539
   VOUHE PR, 1989, P BIOFLOW SMALL DIAM, P23
   WOOLF PK, 1984, ANN THORAC SURG, V38, P26
   1985, BMDP STATISTICAL SOF
NR 14
TC 65
Z9 67
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAY
PY 1990
VL 49
IS 5
BP 797
EP 801
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA DE320
UT WOS:A1990DE32000021
PM 1692681
ER

PT J
AU Angelini, GD
   Culliford, L
   Smith, DK
   Hamilton, MCK
   Murphy, GJ
   Ascione, R
   Baumbach, A
   Reeves, BC
AF Angelini, Gianni D.
   Culliford, Lucy
   Smith, David K.
   Hamilton, Mark C. K.
   Murphy, Gavin J.
   Ascione, Raimondo
   Baumbach, Andreas
   Reeves, Barnaby C.
TI Effects of on-and off-pump coronary artery surgery on graft patency,
   survival, and health-related quality of life: Long-term follow-up of 2
   randomized controlled trials
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article; Proceedings Paper
CT 88th Annual Meeting of the American-Association-for-Thoracic-Surgery
CY MAY 10-14, 2008
CL San Diego, CA
SP Amer Assoc Thorac Surg
ID BYPASS SURGERY; BEATING HEART; CARDIOPLEGIC ARREST; MORBIDITY;
   MORTALITY; QUESTIONNAIRE; METAANALYSIS; BHACAS-2
AB Objective: Off-pump coronary artery bypass grafting reduces postoperative morbidity and uses fewer resources than conventional surgical intervention with cardiopulmonary bypass. However, only 15% to 20% of coronary artery bypass grafting operations use off-pump coronary artery bypass. One reason for not using off-pump coronary artery bypass might be the surgeon's concern about the long-term patency of grafts performed with this technique. Therefore our objective was to compare long-term outcomes in patients randomized to off-pump coronary artery bypass or coronary artery bypass grafting with cardiopulmonary bypass.
   Methods: Participants in 2 randomized trials comparing off-pump coronary artery bypass and coronary artery bypass grafting with cardiopulmonary bypass were followed up for 6 to 8 years after surgical intervention to assess graft patency, major adverse cardiac-related events, and health-related quality of life. Patency was assessed by using multidetector computed tomographic coronary angiographic analysis with a 16-slice scanner. Two blinded observers classified proximal, body, and distal segments of each graft as occluded or not. Major adverse cardiac-related events and health-related quality of life were obtained from questionnaires given to participants and family practitioners.
   Results: Patency was studied in 199 and health-related quality of life was studied in 299 of 349 survivors. There was no evidence of attrition bias. The likelihood of graft occlusion was no different between off-pump coronary artery bypass (10.6%) and coronary artery bypass grafting with cardiopulmonary bypass (11.0%) groups (odds ratio, 1.00; 95% confidence interval, 0.55-1.81; P >. 99). Graft occlusion was more likely at the distal than the proximal anastomosis (odds ratio, 1.11; 95% confidence interval, 1.02-1.20). There were also no differences between the off-pump coronary artery bypass and coronary artery bypass grafting with cardiopulmonary bypass groups in the hazard of death (hazard ratio, 1.24; 95% confidence interval, 0.72-2.15) or major adverse cardiacrelated events or death (hazard ratio, 0.84; 95% confidence interval, 0.58-1.24), or mean health-related quality of life across a range of domains and instruments.
   Conclusions: Long-term health outcomes with off-pump coronary artery bypass are similar to those with coronary artery bypass grafting with cardiopulmonary bypass when both operations are performed by experienced surgeons.
C1 [Angelini, Gianni D.; Culliford, Lucy; Smith, David K.; Murphy, Gavin J.; Ascione, Raimondo; Reeves, Barnaby C.] Univ Bristol, Bristol Heart Inst, Bristol Royal Infirm, Bristol BS2 8HW, Avon, England.
   [Angelini, Gianni D.; Culliford, Lucy; Smith, David K.; Murphy, Gavin J.; Ascione, Raimondo; Reeves, Barnaby C.] United Bristol Healthcare NHS Trust, Bristol, Avon, England.
   [Hamilton, Mark C. K.; Baumbach, Andreas] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England.
RP Angelini, GD (reprint author), Univ Bristol, Bristol Heart Inst, Bristol Royal Infirm, Level 7, Bristol BS2 8HW, Avon, England.
EM g.d.angelini@bristol.ac.uk
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 2004, EUR HEART J, V25, P765, DOI 10.1016/j.ehj.2003.11.015
   Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6
   Ascione R, 2000, CIRCULATION, V102, P1530
   Austen W G, 1975, Circulation, V51, P5
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   EuroQol Group, 1990, HLTH POLICY, V16, P119
   Keogh BE, 2004, 5 NATL ADULT CARDIAC
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Lim E, 2006, J THORAC CARDIOV SUR, V132, P1409, DOI 10.1016/j.jtcvs.2006.08.012
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Schlosser T, 2004, J AM COLL CARDIOL, V44, P1224, DOI 10.1016/j.jacc.2003.09.075
   Schroter S, 2004, HEART, V90, P1460, DOI 10.1136/hrt.2003.021899
   SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9
   Taylor F, 2003, HEART, V89, P331, DOI 10.1136/heart.89.3.331
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   Ware J, 2000, SF 36 HLTH SURVEY MA
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Watters MPR, 2001, EUR J CARDIO-THORAC, V19, P34, DOI 10.1016/S1010-7940(00)00603-5
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
NR 23
TC 64
Z9 67
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 2009
VL 137
IS 2
BP 295
EP 303
DI 10.1016/j.jtcvs.2008.09.046
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 401DN
UT WOS:000262919000006
PM 19185140
ER

PT J
AU Moppett, IK
AF Moppett, I. K.
TI Traumatic brain injury: assessment, resuscitation and early management
SO BRITISH JOURNAL OF ANAESTHESIA
LA English
DT Review
DE complications, hypotension; head, injury; hypoxia; risk
ID SEVERE HEAD-INJURY; GLASGOW-COMA-SCALE; 7.5-PERCENT SODIUM-CHLORIDE;
   CERVICAL-SPINE INJURY; REACTION-LEVEL-SCALE; CEREBRAL BLOOD-FLOW;
   INTENSIVE INSULIN THERAPY; RAPID-SEQUENCE INTUBATION; ACUTE
   SUBDURAL-HEMATOMA; CLINICAL-TRIAL
AB This review examines the evidence base for the early management of head-injured patients. Traumatic brain injury (TBI) is common, carries a high morbidity and mortality, and has no specific treatment The pathology of head injury is increasingly well understood. Mechanical forces result in shearing and compression of neuronal and vascular tissue at the time of impact. A series of pathological events may then ensue leading to further brain injury. This secondary injury may be amenable to intervention and is worsened by secondary physiological insults. Various risk factors for poor outcome after TBI have been identified. Most of these are fixed at the time of injury such as age, gender, mechanism of injury, and presenting signs (Glasgow Coma Scale and pupillary signs), but some such as hypotension and hypoxia are potential areas for medical intervention. There is very little evidence positively in favour of any treatments or packages of early care; however, prompt, specialist neurocritical care is associated with improved outcome. Various drugs that target specific pathways in the pathophysiology of brain injury have been the subject of animal and human research, but, to date, none has been proved to be successful in improving outcome.
C1 Univ Nottingham, Nottingham Univ Hosp NHS Trust, Queens Med Ctr Campus, Div Anaesthesia & Intens Care, Nottingham NG7 2UH, England.
RP Moppett, IK (reprint author), Univ Nottingham, Nottingham Univ Hosp NHS Trust, Queens Med Ctr Campus, Div Anaesthesia & Intens Care, Nottingham NG7 2UH, England.
EM iain.moppett@nottingham.ac.uk
RI Moppett, Iain/B-1756-2008
OI Moppett, Iain/0000-0003-3750-6067
CR ACHESON MB, 1987, AM J ROENTGENOL, V148, P1179
   ADAMS A, 2001, PEOPLE COMPUTERS, V15, P49
   Alderson P, 1997, BRIT MED J, V314, P1855
   ANDREWS BT, 1987, SURG NEUROL, V28, P419, DOI 10.1016/0090-3019(87)90223-0
   ARANGO MF, 2006, COCHRANE DATABASE SY, V4
   Association of Anaesthetists of Great Britain and Ireland, 2006, REC SAF TRANSF PAT B
   Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161
   Bernard F, 2006, CRIT CARE MED, V34, P583, DOI 10.1097/01.CCM.0000199042.80034.A8
   Berne JD, 1999, J TRAUMA, V47, P896, DOI 10.1097/00005373-199911000-00014
   BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701
   BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838
   Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056
   BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685
   BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360
   BRAAKMAN R, 1980, NEUROSURGERY, V6, P362
   Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM
   Brain Trauma Foundation American Association of Neurological Surgeons, 2000, MAN PROGN SEV TRAUM
   Canavero S, 2003, SURG NEUROL, V60, P165, DOI 10.1016/S0090-3019(03)00159-9
   Chesnut R M, 1993, Acta Neurochir Suppl (Wien), V59, P121
   CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006
   CHESNUT RM, 1994, NEUROSURGERY, V34, P840
   CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381
   CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169
   CLIFTON GL, 1981, NEUROSURGERY, V8, P10
   Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48
   Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7
   Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C
   Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87
   Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.lc
   Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/Nerocrit.Care2005;2:165-171
   Davis Daniel P, 2005, J Trauma, V59, P486, DOI 10.1097/00005373-200508000-00037
   Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58
   Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066
   DeWitt D S, 1995, New Horiz, V3, P376
   Diringer MN, 2006, CRIT CARE MED, V34, P930, DOI 10.1097/01.CCM.0000202433-99341.D6
   EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688
   Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032
   FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809
   FORSYTH RJ, 2006, COCHRANE DATABASE SY, V4
   GALE JL, 1983, NEUROSURGERY, V12, P487
   Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783
   GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026
   GENTRY LR, 1988, AM J ROENTGENOL, V150, P673
   Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/mem.2004.421
   Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776
   GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016
   GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346
   GRAHAM DI, 1985, BRIT J ANAESTH, V57, P3, DOI 10.1093/bja/57.1.3
   *GROUP ALS, 2005, ADV PAED LIF SUPP PR
   Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082
   Hare GMT, 2003, CAN J ANAESTH, V50, P1061
   Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d
   Havill J H, 2001, Crit Care Resusc, V3, P15
   Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204
   Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D
   HEIDEN JS, 1983, PHYS THER, V63, P1946
   Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139
   Hodgkinson D W, 1994, Eur J Emerg Med, V1, P9, DOI 10.1097/00063110-199403000-00003
   Hogan GJ, 2005, RADIOLOGY, V237, P106, DOI 10.1148/radiol.2371040697
   Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285
   Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666
   Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018
   Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3
   Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362
   JENNETT B, 1976, LANCET, V1, P1031
   JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291
   Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6
   JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177
   JONES PA, 1994, J NEUROSURG ANESTH, V6, P4
   KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864
   KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500
   KLAUBER MR, 1989, NEUROSURGERY, V24, P31
   Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009
   KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5
   KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613
   Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F
   LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545
   LANGHAM J, 2000, COCHRANE DATABASE SY
   Larner AJ, 2003, J NEUROL NEUROSUR PS, V74, P415, DOI 10.1136/jnnp.74.4.415
   LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885
   LINK TM, 1995, RADIOLOGY, V196, P741
   LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048
   LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254
   Lu J, 2005, ACT NEUR S, V95, P281
   Luber SD, 1996, AM J EMERG MED, V14, P543, DOI 10.1016/S0735-6757(96)90094-7
   Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823
   Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/51474-4422(05)70253-2
   Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668
   Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118
   MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014
   MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407
   Marmarou A, 1991, J NEUROSURG, V75, P159
   MARSHALL LF, 1991, J NEUROSURG, V75, pS25
   Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519
   MARSHALL LF, 1991, J NEUROSURG, V75, pS14
   Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2
   MAXWELL WL, 1994, ACT NEUR S, V60, P465
   MENDELOW AD, 1979, BRIT MED J, V2, P134
   MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008
   MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439
   Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737
   MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731
   Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292
   Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015
   Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567
   NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751
   *NAT I CLIN, 2003, HEAD INJ TRAG ASS IN, V4
   *NETW SCOTT INT GU, 2000, EAR MAN PAT HEAD INJ
   Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259
   OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241
   Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4
   Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768
   PFENNINGER E, 1987, ANAESTHESIST, V36, P570
   PHONPRASERT C, 1980, J TRAUMA, V20, P679, DOI 10.1097/00005373-198008000-00008
   PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V
   PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011
   PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8
   POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1
   Ransom GH, 2003, CHILD ABUSE NEGLECT, V27, P381, DOI 10.1016/S0145-2134(03)00025-5
   REILLY PL, 1988, CHILD NERV SYST, V4, P30
   Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916
   RIVAS JJ, 1988, NEUROSURGERY, V23, P44
   ROBERTS I, 2007, BRIT MED J, V334, P292
   Roberts I, 1999, COCHRANE DATABASE SY, P3
   Muzha I, 2004, LANCET, V364, P1321
   ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076
   Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022
   SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961
   Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004
   Schierhout G, 2001, COCHRANE DATABASE SY, V4
   SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503
   SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372
   Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021
   Servadei F, 2000, NEUROSURGERY, V46, P70
   SHARPLES PM, 1990, BRIT MED J, V301, P1193
   SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212
   SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I
   SIMPSON DA, 1991, CHILD NERV SYST, V7, P183
   SIMPSON DA, 1997, HEAD INJURY PATHOPHY, P145
   STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699
   STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521
   Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707
   Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X
   Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14
   Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353
   Tatman A, 1997, ARCH DIS CHILD, V77, P519
   TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603
   TEASDALE G, 1974, LANCET, V2, P81
   TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862
   TEASDALE G, 1990, ACT NEUR S, V51, P315
   TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801
   Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458.-5-21
   TENNANT A, 1996, TRAUMATIC BRAIN INJU
   BRAAKMAN R, 1994, J NEUROSURG, V80, P797
   Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631
   Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568
   *TRAUM COMM AM COL, 2004, ADV TRAUM LIF SUPP P
   Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Van den Berghe G, 2005, NEUROLOGY, V64, P1348
   van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207
   VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951
   Van Putten HP, 2005, J NEUROTRAUM, V22, P857
   VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003
   VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003
   VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065
   VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309
   Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F
   VOLLMER DG, 1991, J NEUROSURG, V75, pS37
   Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x
   Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591
   WAKAI A, 2007, COCHRANE DATABASE SY, V1
   Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188
   Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91
   Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131
   Wilson M, 2007, BRIT J ANAESTH, V99, P43, DOI 10.1093/bja/aem142
   Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592
   Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901
   YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007
NR 179
TC 64
Z9 71
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-0912
J9 BRIT J ANAESTH
JI Br. J. Anaesth.
PD JUL
PY 2007
VL 99
IS 1
BP 18
EP 31
DI 10.1093/bja/aem128
PG 14
WC Anesthesiology
SC Anesthesiology
GA 190UR
UT WOS:000248086600004
PM 17545555
ER

PT J
AU Ashman, TA
   Spielman, LA
   Hibbard, MR
   Silver, JM
   Chandna, T
   Gordon, WA
AF Ashman, TA
   Spielman, LA
   Hibbard, MR
   Silver, JM
   Chandna, T
   Gordon, WA
TI Psychiatric challenges in the first 6 years after traumatic brain
   injury: Cross-sequential analyses of axis I disorders
SO ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
LA English
DT Article; Proceedings Paper
CT State of the Science Conference
CY APR, 2002
CL Washington, DC
SP Rehabilitat Res & Training Ctr, NIDRR
HO Geroge Washington Univ
DE brain injuries; psychiatry; rehabilitation; research design
ID POSTTRAUMATIC-STRESS-DISORDER; STRUCTURED CLINICAL INTERVIEW; DSM-III;
   DEPRESSION; PREVALENCE; SYMPTOMS; EXTENT; 2-YEAR; RISK
AB Objective: To examine the preinjury rates of Axis I disorders and the prospective rates within the first 6 years after traumatic brain injury (TBI).
   Design: Cross-sectional, longitudinal, and cross-sequential.
   Setting: Community-based research and training center.
   Participants: Persons (N = 188) who had sustained TBI within 4 years of enrollment into the project were interviewed at either 2 and 3 assessments. Each assessment was approximately I year apart. Several Axis I diagnoses were analyzed to detect cross-sectional differences (by age and time postinjury) and average individual changes over the multiple measurement time points.
   Interventions: Not applicable.
   Main Outcome Measure: Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders.
   Results: The odds ratios changed longitudinally within each subject, indicating a decreased probability of having an Axis I diagnosis over time. There were few cross-sectional differences in age; therefore, age at the time of injury had little impact on Axis I diagnoses. Cross-sectional time since injury was not associated with more psychiatric disorders, whereas cross-sectional preinjury history of psychiatric disorders was predictive of postinjury psychiatric disorders. After controlling for cross-sectional effects, the frequencies of Axis I disorders increased in depression, anxiety, and posttraumatic stress disorders in the first assessment postinjury and declined in subsequent assessments.
   Conclusions: Cross-sequential analyses that control for cross-sectional and longitudinal differences produced a more complete description of psychiatric disorders after TBI.
C1 Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA.
   Lenox Hill Hosp, Dept Psychiat, New York, NY USA.
RP Ashman, TA (reprint author), Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave Levy Pl Box 1240, New York, NY 10029 USA.
EM teresa.ashman@mssm.edu
RI Ashman, Teresa/B-1621-2013
CR American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010
   BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663
   Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656
   Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629
   Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006
   Deb S, 1999, AM J PSYCHIAT, V156, P374
   Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67
   FALLON BA, 1991, J CLIN PSYCHIAT, V52, P272
   FANN JR, 1995, AM J PSYCHIAT, V152, P493
   Federoff JP, 1992, AM J PSYCHIAT, V149, P918
   First MB, 1997, USERS GUIDE STRUCTUR
   GLENN MB, 2001, BRIAN INJ, V15, P81118
   GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X
   GRIECO E, 2001, CENSUS 2000 BRIEF OV
   Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626
   Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24
   Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17
   Hoofien D, 2001, BRAIN INJURY, V15, P189
   JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N
   JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369
   Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315
   Kraus Jess F., 1994, P3
   Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108
   KURTZKE JF, 1984, ANN NEUROL, V16, P265, DOI 10.1002/ana.410160302
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754
   Max W, 1991, J HEAD TRAUMA REHAB, V6, P76, DOI 10.1097/00001199-199106000-00010
   Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770
   Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082
   Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974
   RISKIND JH, 1987, ARCH GEN PSYCHIAT, V44, P817
   ROBINS LN, 1991, PSYCHIAT DISORDERS A
   SPITZER R L, 1988, Journal of Psychiatric Research, V22, P55, DOI 10.1016/0022-3956(88)90069-6
   STEINBERG M, 1990, AM J PSYCHIAT, V147, P76
   VanReekum R, 1996, BRAIN INJURY, V10, P319
   Varney N. R., 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7
   Wallace CA, 2000, BRAIN INJURY, V14, P549
   Weitzenkamp DA, 2001, SPINAL CORD, V39, P301, DOI 10.1038/sj.sc.3101146
   Williams WH, 2002, BRAIN INJURY, V16, P673
NR 39
TC 64
Z9 64
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0003-9993
J9 ARCH PHYS MED REHAB
JI Arch. Phys. Med. Rehabil.
PD APR
PY 2004
VL 85
IS 4
SU 2
BP S36
EP S42
DI 10.1016/j.apmr.2003.08.117
PG 7
WC Rehabilitation; Sport Sciences
SC Rehabilitation; Sport Sciences
GA 812FL
UT WOS:000220825300005
PM 15083420
ER

PT J
AU Tiwari, A
   Cheng, KS
   Button, M
   Myint, F
   Hamilton, G
AF Tiwari, A
   Cheng, KS
   Button, M
   Myint, F
   Hamilton, G
TI Differential diagnosis, investigation, and current treatment of lower
   limb lymphedema
SO ARCHIVES OF SURGERY
LA English
DT Review
ID OBESITY SIMULATING LYMPHEDEMA; LOWER-EXTREMITY LYMPHEDEMA; LEG EDEMA;
   PERIPHERAL LYMPHEDEMA; ARTERIAL RECONSTRUCTION; OBSTRUCTIVE LYMPHEDEMA;
   NONINVASIVE EVALUATION; ISOTOPE LYMPHOGRAPHY; PHYSICAL THERAPY; VENOUS
   DYNAMICS
AB Hypothesis: The causes and management of lower limb lymphedema in the Western population are different from those in the developing world.
   Objective: To look at the differential diagnosis, methods of investigation, and available treatments for lower limb lymphedema in the West.
   Data Source: A PubMed search was conducted for the years 1980-2002 with the keyword "lymphedema." English language and human subject abstracts only were analyzed, and only those articles dealing with lower limb lymphedema were further reviewed. Other articles were extracted from cross-referencing.
   Results: Four hundred twenty-five review articles pertaining to lymphedema were initially examined. This review summarizes the findings of relevant articles along with our own practice regarding the management of lymphedema.
   Conclusions: The common differential diagnosis in Western patients with lower limb swelling is secondary lymphedema, venous disease, lipedema, and adverse reaction to ipsilateral limb surgery. Lymphedema can be confirmed by a lymphoscintigram, computed tomography, magnetic resonance imaging, or ultrasound. The lymphatic anatomy is demonstrated with lymphoscintigraphy, which is particularly indicated if surgical intervention is being considered. The treatment of choice for lymphedema is multidisciplinary. in the first instance, combined physical therapy should be commenced (complete decongestive therapy), with surgery reserved for a small number of cases.
C1 Royal Free Hosp, Dept Surg, NHS Trust, London, England.
   N Middlesex Univ Hosp, NHS Trust, London, England.
RP Hamilton, G (reprint author), Royal Free Hosp & Univ Coll Med Sch, Dept Surg, Pond St, London NW3 2QG, England.
CR Allen EV, 1934, ARCH INTERN MED, V54, P606
   Badger CMA, 2000, CANCER, V88, P2832, DOI 10.1002/1097-0142(20000615)88:12<2832::AID-CNCR24>3.0.CO;2-U
   Bardare M, 1997, J RHEUMATOL, V24, P384
   BAULIEU F, 1990, LYMPHOLOGY, V23, P15
   BAUMEISTER RG, 1986, SCAND J PLAST RECONS, V20, P141
   BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012
   Berard A, 2000, ANGIOLOGY, V51, P711
   BILANCINI S, 1995, ANGIOLOGY, V46, P333, DOI 10.1177/000331979504600408
   Boris M, 1997, Oncology (Williston Park), V11, P99
   Boris M, 1998, LYMPHOLOGY, V31, P15
   Brautigam P, 1998, LYMPHOLOGY, V31, P43
   BRAUTIGAM P, 1993, ANGIOLOGY, V44, P464, DOI 10.1177/000331979304400606
   BROSTROM LA, 1989, ANN CHIR GYNAECOL FE, V78, P320
   BROWSE NL, 1985, J CARDIOVASC SURG, V26, P91
   BULL RH, 1993, J AM ACAD DERMATOL, V28, P585
   BURNAND K, 1980, BRIT MED J, V5, P7
   Burnand KG, 2002, BRIT J SURG, V89, P74, DOI 10.1046/j.0007-1323.2001.01964.x
   CAMBRIA RA, 1993, J VASC SURG, V18, P773
   CAMPISI C, 1995, MICROSURG, V16, P161, DOI 10.1002/micr.1920160309
   CAMPISI C, 1995, MICROSURG, V16, P463, DOI 10.1002/micr.1920160706
   CAMPISI C, 1991, LYMPHOLOGY, V24, P71
   CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604
   CASLEYSMITH JR, 1988, LYMPHOLOGY, V21, P190
   CasleySmith JR, 1996, LYMPHOLOGY, V29, P76
   CASLEYSMITH JR, 1994, LYMPHOLOGY, V27, P56
   Casley-Smith J R, 1992, Australas J Dermatol, V33, P69, DOI 10.1111/j.1440-0960.1992.tb00082.x
   Casley-Smith J R, 1992, Australas J Dermatol, V33, P61, DOI 10.1111/j.1440-0960.1992.tb00081.x
   Cesarone MR, 1999, PANMINERVA MED, V41, P10
   CHANG TS, 1989, LYMPHOLOGY, V22, P20
   Chang TS, 1996, LYMPHOLOGY, V29, P106
   CHEN KTK, 1979, ARCH PATHOL LAB MED, V103, P86
   CIOCON JO, 1995, ANGIOLOGY, V46, P19, DOI 10.1177/000331979504600103
   DEGNI M, 1992, LYMPHOLOGY, V25, P182
   DOLDI SB, 1992, LYMPHOLOGY, V25, P129
   DUEWELL S, 1992, RADIOLOGY, V184, P227
   Dumanian GA, 1996, LYMPHOLOGY, V29, P20
   EGOROV YS, 1994, LYMPHOLOGY, V27, P137
   EICKHOFF JH, 1982, ANN SURG, V195, P474, DOI 10.1097/00000658-198204000-00015
   ELISKA O, 1995, LYMPHOLOGY, V28, P21
   ESATO K, 1991, J CARDIOVASC SURG, V32, P741
   Foldi M, 2000, LYMPHOLOGY, V33, P167
   Franzeck UK, 1997, J VASC RES, V34, P306, DOI 10.1159/000159238
   GLOVICZKI P, 1989, J VASC SURG, V9, P683, DOI 10.1067/mva.1989.vs0090683
   GONG-KANG H, 1981, Journal of Microsurgery, V3, P32
   HAAVERSTAD R, 1994, INT ANGIOL, V13, P115
   HAAVERSTAD R, 1995, EUR J VASC ENDOVASC, V10, P316, DOI 10.1016/S1078-5884(05)80049-8
   HAAVERSTAD R, 1992, EUR J VASCULAR SURG, V6, P124, DOI 10.1016/S0950-821X(05)80228-2
   HADJIS NS, 1985, AM J ROENTGENOL, V144, P361
   HAMER JD, 1972, BRIT J SURG, V59, P979, DOI 10.1002/bjs.1800591212
   Harwood CA, 1996, BRIT J DERMATOL, V134, P1
   HEYN R, 1992, J CLIN ONCOL, V10, P614
   Howarth DM, 1997, MAYO CLIN PROC, V72, P423
   HUANG GK, 1985, PLAST RECONSTR SURG, V76, P671
   Idy-Peretti I, 1998, J INVEST DERMATOL, V110, P782, DOI 10.1046/j.1523-1747.1998.00184.x
   IPSEN T, 1988, SCAND J PLAST RECONS, V22, P233
   KARAKOUSIS CP, 1994, BRIT J SURG, V81, P1771, DOI 10.1002/bjs.1800811221
   Kim DI, 1999, LYMPHOLOGY, V32, P11
   KLEIN MJ, 1988, ARCH PHYS MED REHAB, V69, P202
   Ko DSC, 1998, ARCH SURG-CHICAGO, V133, P452, DOI 10.1001/archsurg.133.4.452
   LARCOS G, 1995, NUCL MED COMMUN, V16, P683, DOI 10.1097/00006231-199508000-00010
   LEWIS JM, 1984, J PEDIATR, V104, P641, DOI 10.1016/S0022-3476(84)80937-3
   LIU NF, 1992, LYMPHOLOGY, V25, P155
   LIU NF, 1993, LYMPHOLOGY, V26, P28
   Logmans A, 1999, GYNECOL ONCOL, V75, P323, DOI 10.1006/gyno.1999.5624
   LOUGHLIN V, 1993, NEW ENGL J MED, V328, P1496
   Marotel M, 1998, LYMPHOLOGY, V31, P180
   Miller TA, 1998, PLAST RECONSTR SURG, V102, P1486, DOI 10.1097/00006534-199810000-00022
   Milroy WF, 1928, J AMER MED ASSOC, V91, P1172
   Mortimer PS, 2000, BRIT MED J, V320, P1527, DOI 10.1136/bmj.320.7248.1527
   Mortimer PS, 1995, INT ANGIOL, V14, P32
   MYINT F, 2001, VASCULAR ENDOVASCULA, P415
   Nakazono T, 2000, SKELETAL RADIOL, V29, P413
   NAWAZ MK, 1992, ANGIOLOGY, V43, P147, DOI 10.1177/000331979204300209
   NIELUBOW.J, 1968, J CARDIOVASC SURG, V9, P262
   OBRIEN BMC, 1989, BRIT J PLAST SURG, V42, P530, DOI 10.1016/0007-1226(89)90039-8
   Olszewski W, 2000, ANGIOLOGY, V51, P25, DOI 10.1177/000331970005100106
   OREFICE S, 1988, TUMORI, V74, P347
   PILLER NB, 1988, BRIT J PLAST SURG, V41, P20, DOI 10.1016/0007-1226(88)90139-7
   PROBY CM, 1990, BRIT J DERMATOL, V123, P29, DOI 10.1111/j.1365-2133.1990.tb01821.x
   Richards T B, 1990, Ann Vasc Surg, V4, P255, DOI 10.1007/BF02009453
   RICHMAND DM, 1985, ARCH SURG-CHICAGO, V120, P1116
   RIJKE AM, 1990, J NUCL MED, V31, P990
   RUDKIN GH, 1994, PLAST RECONSTR SURG, V94, P841, DOI 10.1097/00006534-199411000-00014
   Salem A H, 1986, J R Coll Surg Edinb, V31, P143
   Schirger A, 1983, Cardiovasc Clin, V13, P293
   SERVELLE M, 1987, SURGERY, V101, P485
   SONG RY, 1982, CLIN PLAST SURG, V9, P113
   STEWART FW, 1948, CANCER, V1, P64, DOI 10.1002/1097-0142(194805)1:1<64::AID-CNCR2820010105>3.0.CO;2-W
   STEWART G, 1985, BRIT J SURG, V72, P906, DOI 10.1002/bjs.1800721120
   SUGA K, 1991, NUCL MED COMMUN, V12, P907
   Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209
   Tanaka Y, 1996, MICROSURG, V17, P209
   TER SE, 1993, CLIN NUCL MED, V18, P646, DOI 10.1097/00003072-199308000-00003
   THIBAUT G, 1992, ANGIOLOGY, V43, P567, DOI 10.1177/000331979204300704
   TIWARI A, 2002, PATHWAYS VASCULAR SU, P71
   Valentin LI, 1999, ANGIOLOGY, V50, P721, DOI 10.1177/000331979905000905
   VANBEMMELEN SPS, 1988, NETH J SURG, V40, P64
   van der Veen P, 2000, LYMPHOLOGY, V33, P12
   VAQUEIRO M, 1986, J NUCL MED, V27, P1125
   VAUGHAN BF, 1990, CLIN RADIOL, V41, P24, DOI 10.1016/S0009-9260(05)80927-4
   VROUENRAETS BC, 1995, ARCH SURG-CHICAGO, V130, P43
   Ward LC, 2000, ANGIOLOGY, V51, P615, DOI 10.1177/000331970005100712
   WEISSLEDER H, 1989, RADIOLOGY, V170, P371
   Werner GT, 1998, LYMPHOLOGY, V31, P34
   Wheatley DC, 1996, BRIT J RADIOL, V69, P1117
   Williams WH, 2000, CLIN NUCL MED, V25, P451, DOI 10.1097/00003072-200006000-00013
   WITTE MH, 1992, NEW ENGL J MED, V327, P1927
   WOLFE JH, 1992, NEW AIRDS COMPANION, P415
   WOLFE JHN, 1981, ARCH SURG-CHICAGO, V116, P1157
   WRIGHT NB, 1994, ARCH DIS CHILD, V71, P44
   Yasuhara H, 1996, INT ANGIOL, V15, P272
   ZELIKOVSKI A, 1980, LYMPHOLOGY, V13, P68
   ZELIKOVSKI A, 1986, LYMPHOLOGY, V19, P106
   2002, AUST ADVERSE DRUG RE, V14, P3
NR 114
TC 64
Z9 67
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0004-0010
J9 ARCH SURG-CHICAGO
JI Arch. Surg.
PD FEB
PY 2003
VL 138
IS 2
BP 152
EP 161
DI 10.1001/archsurg.138.2.152
PG 10
WC Surgery
SC Surgery
GA 644AG
UT WOS:000180895300008
PM 12578410
ER

PT J
AU Kestin, LL
   Vicini, FA
   Martinez, AA
AF Kestin, LL
   Vicini, FA
   Martinez, AA
TI Practical application of biochemical failure definitions: What to do and
   when to do it
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate; prostatic neoplasms; prostate-specific antigen; radiotherapy;
   biochemical failure
ID PROSTATE-SPECIFIC-ANTIGEN; EXTERNAL-BEAM RADIATION; RADICAL
   PROSTATECTOMY; DOUBLING TIMES; ANDROGEN SUPPRESSION; FOLLOW-UP; CANCER;
   THERAPY; RADIOTHERAPY; CARCINOMA
AB Purpose: The posttreatment prostate-specific antigen (PSA) profile can often be difficult to interpret after external beam radiotherapy for prostate cancer. We performed an extensive analysis of post-radiotherapy PSA measurements to determine the clinical significance of biochemical failure (BF) and the correlation of BF with clinical failure (CF) and cause-specific death (CSD).
   Materials and Methods: Between 1987 and 1997, 727 patients with clinical stage T1-T3 N0 M0 prostate cancer were treated with definitive external beam radiotherapy at William Beaumont Hospital and had at least five post-radiotherapy PSA levels and did not receive hormonal therapy for post-radiotherapy PSA elevations only (before evidence of CF). All patients received external beam radiotherapy alone (no adjuvant hormonal therapy) to a median total prostate dose of 66.6 Gy. More than 20 BF definitions were tested for their correlation with CF (any local failure or distant metastasis) and CSD. All BF definitions were tested for sensitivity, specificity, accuracy, and positive and negative value of predicting subsequent CF and CSD. The median follow-up was 5.0 years.
   Results: Three consecutive PSA rises yielded a 73% sensitivity, 76% specificity, and 75% overall accuracy for predicting CF. The 10-year CF rate (from the completion of radiotherapy) for those 251 patients demonstrating three consecutive rises (BF) was 64% vs. 14% for those patients who did not have three rises (biochemically controlled). Defining BF as a post-nadir increase to greater than or equal to 3 ng/ml above the nadir yielded the highest accuracy of 87%. In addition, this definition also seemed to pro-tide the greatest separation in CF rates: 82% for BF vs. 5% for biochemically controlled at 10 years after radiotherapy. CF rates were also calculated from the date of BF (e.g., date of third rise). The CF rates at 6 months and 2 years after the third PSA rise were 9% and 27%, respectively. The CF rates at 6 months and 2 years after an increase to 2:3 ng/ml above the nadir were 23% and 54%, respectively. Once a patient was classified as a BF, regardless of the BF definition, the CF rate varied markedly, depending on the pretreatment characteristics. For each BF definition, younger age at diagnosis, higher pretreatment PSA, and higher Gleason score independently predicted for CF after BF on Cox multiple regression analysis. For instance, patients with a pretreatment PSA < 4.0 ng/ml demonstrated an 11% CF rate at 2 years after the third PSA rise vs. 46% after three rises with a pretreatment PSA greater than or equal to 20.0 ng/ml. Similarly, patients with Gleason 2-4 had a 2-year CF rate of only 3% after a nadir greater than or equal to 1.0 ng/ml vs. 47% for Gleason 8-10 at 2 years after a nadir greater than or equal to 1.0 ng/ml. Although the CF rate also coincided with pretreatment characteristics when using greater than or equal to 3 ng/ml above the nadir, CF rates remained high even for low-risk patients (e.g., 2-year CF of 48% for PSA < 10.0 ng/ml, 41% for Gleason 2-4). In addition, a shorter time interval from nadir to nadir + 1 ng/ml or from nadir to nadir + 3 ng/ml (corresponding to a steeper slope in the PSA profile) independently predicted for CF.
   Conclusion: Once the post-radiotherapy PSA profile reaches greater than or equal to 3 ng/ml above the nadir, there is a high risk of clinical allure within a relatively short time period, for which treatment intervention may be considered, regardless of pretreatment characteristics. After a nadir greater than or equal to 1.0 ng/ml or three consecutive rises, some patients (especially with low-risk pretreatment characteristics) may be considered for further PSA observation before treatment intervention. (C) 2002 Elsevier Science Inc.
C1 William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
RP Kestin, LL (reprint author), William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   ARONSON N, 1999, AGENCY HLTH CARE POL
   Baert LV, 1998, J UROLOGY, V159, P61
   BEAHRS OH, 1993, AJCC CANC STAGING MA, P189
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C
   Byar D P, 1980, Scand J Urol Nephrol Suppl, V55, P99
   Connell PP, 1999, UROLOGY, V54, P875, DOI 10.1016/S0090-4295(99)00253-8
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   DAMICO AV, 1995, INT J RADIAT ONCOL, V32, P473, DOI 10.1016/0360-3016(94)00606-L
   Ennis RD, 1998, INT J RADIAT ONCOL, V41, P511, DOI 10.1016/S0360-3016(98)00104-7
   Granfors T, 1998, J UROLOGY, V159, P2030, DOI 10.1016/S0022-5347(01)63235-X
   HANKS GE, 1993, INT J RADIAT ONCOL, V27, P125
   HANKS GE, 2000, P AN M AM SOC CLIN, V19, pA327
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Hanlon AL, 2000, INT J RADIAT ONCOL, V46, P559, DOI 10.1016/S0360-3016(99)00450-2
   Hanlon AL, 1998, CANCER, V83, P130, DOI 10.1002/(SICI)1097-0142(19980701)83:1<130::AID-CNCR17>3.3.CO;2-M
   Hodgson DC, 2001, INT J RADIAT ONCOL, V49, P957, DOI 10.1016/S0360-3016(00)01431-0
   Horwitz EM, 1996, INT J RADIAT ONCOL, V36, P565, DOI 10.1016/S0360-3016(96)00360-4
   Horwitz EM, 2001, INT J RADIAT ONCOL, V49, P947, DOI 10.1016/S0360-3016(00)01443-7
   IVERSEN P, 1999, EUR UROL S, V36, P220
   Jani AB, 1999, UROLOGY, V54, P700, DOI 10.1016/S0090-4295(99)00229-0
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kattan MW, 2000, INT J RADIAT ONCOL, V48, P1469, DOI 10.1016/S0360-3016(00)01359-6
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   Kirk D, 2000, BJU INT, V86, P220
   Klotz L, 2000, MOL UROL, V4, P233
   Laverdiere J, 1997, INT J RADIAT ONCOL, V37, P247, DOI 10.1016/S0360-3016(96)00513-5
   Lawton CA, 2001, INT J RADIAT ONCOL, V49, P937, DOI 10.1016/S0360-3016(00)01516-9
   Lu J, 2000, Semin Urol Oncol, V18, P83
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401
   MRC Prostate Cancer Working Party Investigator's Group, 1997, BR J UROL, V72, P235
   Nixon RG, 1997, J UROLOGY, V157, P2183, DOI 10.1016/S0022-5347(01)64711-6
   Patel A, 1997, J UROLOGY, V158, P1441, DOI 10.1016/S0022-5347(01)64238-1
   Pickles T, 1999, INT J RADIAT ONCOL, V43, P699
   Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6
   POLLACK A, 1994, CANCER, V74, P670, DOI 10.1002/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Pruthi RS, 1997, UROLOGY, V49, P737, DOI 10.1016/S0090-4295(97)00231-8
   *PSA, 2000, ONCOLOGY, V14, P267
   *PSA AUA, 2000, ONCOLOGY HUNTINGT, V14, P280
   Roberts SG, 2001, MAYO CLIN PROC, V76, P576
   Sandler HM, 2000, INT J RADIAT ONCOL, V48, P629, DOI 10.1016/S0360-3016(00)00717-3
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Schroder FH, 1999, BJU INT, V83, P161
   SOLOWAY MS, 1997, BR J UROL S2, V80, P259
   Taylor JMG, 2001, INT J RADIAT ONCOL, V50, P1212, DOI 10.1016/S0360-3016(01)01571-1
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
   Vicini FA, 2000, CANCER, V88, P2305, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2305::AID-CNCR15>3.0.CO;2-3
   Vollmer RT, 1999, CLIN CANCER RES, V5, P4119
   Walsh PC, 2001, J UROLOGY, V166, P508, DOI 10.1016/S0022-5347(05)65972-1
   WILLETT CG, 1994, J UROLOGY, V151, P1579
   Wirth M, 2001, UROLOGY, V58, P146, DOI 10.1016/S0090-4295(01)01213-4
   Witjes WPJ, 1998, J UROLOGY, V159, P254
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   ZAGARS GK, 1988, INT J RADIAT ONCOL, V14, P1085
   Zietman AL, 1999, INT J RADIAT ONCOL, V43, P715, DOI 10.1016/S0360-3016(98)00484-2
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
NR 62
TC 64
Z9 64
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUN 1
PY 2002
VL 53
IS 2
BP 304
EP 315
DI 10.1016/S0360-3016(02)02707-4
PG 12
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 557TC
UT WOS:000175923400007
PM 12023134
ER

PT J
AU Kattan, MW
   Fearn, PA
   Leibel, S
   Potters, L
AF Kattan, MW
   Fearn, PA
   Leibel, S
   Potters, L
TI The definition of biochemical failure in patients treated with
   definitive radiotherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; radiotherapy; brachytherapy
ID EXTERNAL-BEAM IRRADIATION; PROSTATE-CANCER; ANTIGEN NADIR; FOLLOW-UP;
   PREDICT
AB Purpose: The American Society for Therapeutic Radiology and Oncology (ASTRO) published a definition for biochemical failure following treatment of prostate cancer. Others have noted difficulties with interpreting this definition and recommended modifications to accommodate special recurrence patterns. We have compared various modifications to the original ASTRO definition on our series of 1213 patients treated with transperineal permanent prostate brachytherapy.
   Methods and Materials: The ASTRO modifications we considered adjusted for (I) early censoring of nonrecurrent patients with rising prostate-specific antigen levels (PSA), (2) cumulative rather than consecutive rises (without a decrease) as evidence of recurrence, (3) both of the above, and (4) waiting 2 years before data analysis, The Kaplan-Meier method was used to compute the effects on recurrence rate for patients treated with and without neoadjuvant hormones.
   Results: With the original ASTRO definition, freedom from recurrence in our series of men who did not receive neoadjuvant hormones was 83% at 4 years. All of the modifications considered had statistically insignificant effects on freedom from recurrence rates, varying from 80% to 83% at 4 years. Patients treated with neoadjuvant hormones also showed very little sensitivity to the recurrence definition employed.
   Conclusion: Early censoring of equivocal patients and counting cumulative rather than consecutive rises in PSA (without a decrease) had little empiric effect on the ASTRO recurrence rates. However, we favor the addition of both these modifications to the ASTRO definition on conceptual grounds for evaluating patients following any modality (radiation or surgery), whereby a trend over multiple PSA values is used to judge failure, (C) 2000 Elsevier Science Inc.
C1 Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA.
   St Johns Mercy Med Ctr, Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, Rockville Ctr, NY USA.
RP Kattan, MW (reprint author), Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave,C1076A, New York, NY 10021 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Connell PP, 1999, UROLOGY, V54, P875, DOI 10.1016/S0090-4295(99)00253-8
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Hanlon AL, 2000, INT J RADIAT ONCOL, V46, P559, DOI 10.1016/S0360-3016(99)00450-2
   Horwitz EM, 1998, INT J RADIAT ONCOL, V41, P267, DOI 10.1016/S0360-3016(98)00078-9
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kattan MW, 1997, CANCER, V79, P528, DOI 10.1002/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.0.CO;2-5
   Potters L, 1999, CANCER J SCI AM, V5, P301
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
NR 11
TC 64
Z9 64
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD DEC 1
PY 2000
VL 48
IS 5
BP 1469
EP 1474
DI 10.1016/S0360-3016(00)01359-6
PG 6
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 378VC
UT WOS:000165604600028
PM 11121650
ER

PT J
AU Grossfeld, GD
   Stier, DM
   Flanders, SC
   Henning, JM
   Schonfeld, W
   Warolin, K
   Carroll, PR
AF Grossfeld, GD
   Stier, DM
   Flanders, SC
   Henning, JM
   Schonfeld, W
   Warolin, K
   Carroll, PR
TI Use of second treatment following definitive local therapy for prostate
   cancer: Data from the CaPSURE database
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostatic neoplasms; prostatectomy; radiation; cryosurgery
ID BEAM RADIATION-THERAPY; RADICAL RETROPUBIC PROSTATECTOMY; ANTIGEN NADIR;
   CARCINOMA; ADENOCARCINOMA; RECURRENCE; SURVIVAL; MEN
AB Purpose: We compare secondary cancer treatment use in patients who underwent definitive local treatment for prostate cancer.
   Materials and Methods: The rate of second cancer treatment was determined in patients who underwent radical prostatectomy (1,254), radiotherapy (499) or cryosurgery (141) using data from the CaPSURE database, a longitudinal disease registry of patients with prostate cancer. Second treatments started within 3 months after initial treatment were defined as adjuvant and those started more than 3 months were defined as nonadjuvant. Using a parametric regression model of survival analysis, second treatment rates were adjusted for differences in clinical and demographic characteristics, and duration of followup among groups.
   Results: Of the patients 4% received a second adjuvant treatment and 1746 received a second nonadjuvant treatment within 3 years of initial therapy. Adjusted rates of nonadjuvant second treatment were lowest after radical prostatectomy, and 34 and 88% higher after radiation and cryosurgery, respectively (p = 0.01). This finding was most evident in patients with pretreatment prostate specific antigen 10.0 ng./ml. or less, clinical stage T2N0M0 disease, or Gleason score 6 or less on diagnostic biopsy, and in those classified as low risk for recurrence based on a combination of these parameters (p = 0.004).
   Conclusions: Approximately 1 in 5 patients receive second cancer treatment within a mean of 3 years following initial local treatment for prostate cancer. Our data suggest that the likelihood of receiving second treatment was lowest in patients initially treated with radical prostatectomy.
C1 Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Mt Zion Med Ctr, San Francisco, CA 94120 USA.
   Technol Assessment Grp, San Francisco, CA USA.
   TAP Holdings Inc, Deerfield, IL USA.
RP Grossfeld, GD (reprint author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.
CR Albertsen PC, 1996, UROL CLIN N AM, V23, P521, DOI 10.1016/S0094-0143(05)70332-3
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   BARRY MJ, 1994, J UROLOGY, V152, P1903
   Bauer JJ, 1997, CANCER, V79, P952, DOI 10.1002/(SICI)1097-0142(19970301)79:5<952::AID-CNCR12>3.0.CO;2-1
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948
   Connolly JA, 1997, UROL CLIN N AM, V24, P415, DOI 10.1016/S0094-0143(05)70388-8
   COOGAN CL, 1995, J UROLOGY, V154, P1813, DOI 10.1016/S0022-5347(01)66791-0
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   DAGOSTINO RB, 1995, MED CARE, V33, pAS95
   Fowler FJ, 1996, J CLIN ONCOL, V14, P2258
   FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E
   GEIST RW, 1995, UROLOGY, V45, P1016, DOI 10.1016/S0090-4295(99)80123-X
   Gerber GS, 1996, JAMA-J AM MED ASSOC, V276, P615
   Hanks GE, 1997, INT J RADIAT ONCOL, V37, P543, DOI 10.1016/S0360-3016(96)00602-5
   Krongrad A, 1997, JAMA-J AM MED ASSOC, V278, P44
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   LITWIN M, 1997, CONT UROL, V9, P43
   Lubeck DP, 1996, UROLOGY, V48, P773, DOI 10.1016/S0090-4295(96)00226-9
   LuYao GL, 1996, J NATL CANCER I, V88, P166, DOI 10.1093/jnci/88.3-4.166
   OHORI M, 1994, J UROLOGY, V152, P1843
   Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445
   Pisansky TM, 1997, CANCER-AM CANCER SOC, V79, P337, DOI 10.1002/(SICI)1097-0142(19970115)79:2<337::AID-CNCR17>3.0.CO;2-1
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   SAS Institute Inc, 1990, SAS STAT US GUID VER
   VARENHORST E, 1994, PHARMACOECONOMICS, V6, P127, DOI 10.2165/00019053-199406020-00005
   WALSH PC, 1994, J UROLOGY, V152, P1831
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   ZIETMAN AL, 1994, J UROLOGY, V152, P1806
NR 29
TC 64
Z9 67
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 1998
VL 160
IS 4
BP 1398
EP 1404
DI 10.1016/S0022-5347(01)62548-5
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 120YZ
UT WOS:000075986600049
PM 9751363
ER

PT J
AU Kestin, LL
   Vicini, FA
   Ziaja, EL
   Stromberg, JS
   Frazier, RC
   Martinez, AA
AF Kestin, LL
   Vicini, FA
   Ziaja, EL
   Stromberg, JS
   Frazier, RC
   Martinez, AA
TI Defining biochemical cure for prostate carcinoma patients treated with
   external beam radiation therapy
SO CANCER
LA English
DT Article
DE prostate; prostatic neoplasms; prostate specific antigen; radiotherapy;
   prostatectomy
ID DISEASE-FREE SURVIVAL; POSTTREATMENT EVALUATION; ANTIGEN NADIR; DOUBLING
   TIME; PSA NADIR; CANCER; RADIOTHERAPY; KINETICS; LEVEL; IRRADIATION
AB BACKGROUND. The authors retrospectively reviewed their institution's long term experience with conventional external beam radiation therapy (RT) for localized prostate carcinoma to identify criteria associated with long term biochemical cure.
   METHODS, Between January 1987 and December 1994, 871 patients were treated with external beam RT alone for clinically localized prostate carcinoma at William Beaumont Hospital, Royal Oak, Michigan. Ail patients received only external beam RT to a median total dose of 66.6 grays (Gy) (range, 59.4-70.4 Gy). No patient received hormonal therapy unless treatment failure was documented. The median follow-up was 5.0 years (range, 0.2-11.8 years). Biochemical failure was defined according to the American Society for Therapeutic Radiology and Oncology Consensus Panel definition.
   RESULTS. In the entire study group, 380 patients experienced biochemical failure at a median interval of 1.5 years after the completion of RT. The 5-year and 7-year actuarial rates of biochemical control were 50% and 48%, respectively. On multivariate analysis, a higher pretreatment prostate specific antigen (PSA) level, higher Gleason score, higher clinical T classification, higher nadir level, and shorter time interval to nadir all were associated significantly with biochemical failure (P < 0.001). The median intervals to biochemical failure for patients with pretreatment PSA levels less than or equal to 3.9 ng/mL, 4.0-19.9 ng/mL, and greater than or equal to 20.0 ng/mL were 2.2 years, 1.5 years, and 1.2 years, respectively (P < 0.001). The median intervals to biochemical failure for patients with Gleason scores of 2-4, 5-7, and 8-10 were 1.8 years, 1.5 years, and 1.1 years, respectively (P < 0.001). Only 6 patients failed beyond 5 years after treatment even though 136 patients were at risk for failure beyond this point. When restricting analysis to 643 patients (74%) with greater than or equal to 3 years of PSA follow-up, the median nadir level for biochemically controlled patients was 0.6 ng/mL and occurred at a median interval of 1.9 years after RT versus a median nadir level of 1.3 ng/mL (P = 0.002) occurring at a median interval of 1.0 years (P < 0.001) in those patients who experienced biochemical failure. Patients were divided into subgroups based on their PSA nadir level and time to nadir. The 5-year actuarial biochemical control rates for patients with nadir values of less than or equal to 0.4 ng/mL, 0.5-0.9 ng/mL, 1.0-1.9 ng/mL, 2.0-3.9 ng/mL, and greater than or equal to 4.0 ng/mL were 78%, 60%, 50%, 20%, and 9%, respectively (P < 0.001). The 5-year actuarial biochemical control rates for patients who reached their nadir at < 1.0 years, 1.0-1.9 years, 2.0-2.9 years, and greater than or equal to 3.0 years were 30%, 52%, 64%, and 92%, respectively (P < 0.001). All 52 patients who achieved a nadir of less than or equal to 0.4 ng/mL and required greater than or equal to 2.0 years to reach this nadir had biochemically controlled disease.
   CONCLUSIONS. These results suggest that a patient has a high likelihood of biochemical cure after treatment for prostate carcinoma with conventional doses of external beam RT if he has not demonstrated biochemical failure within 5 years of treatment. Patients with lower pretreatment PSA levels and lower Gleason scores may require longer follow-up than those with less favorable characteristics to achieve the same certainty of cure. Patients who achieve a PSA nadir less than or equal to 0.4 ng/mL and require greater than or equal to 2.0 years to reach this nadir have the highest probability of cure. (C) 1999 American Cancer Society.
C1 William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
RP Vicini, FA (reprint author), William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.
CR *AM JOINT COMM CAN, 1998, AJCC CANC STAG MAN, P203
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Aref I, 1998, RADIOTHER ONCOL, V48, P203, DOI 10.1016/S0167-8140(98)00061-9
   CHODAK GW, 1990, UROLOGY, V35, P288, DOI 10.1016/0090-4295(90)80147-F
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   DAMICO AV, 1993, CANCER, V72, P2638, DOI 10.1002/1097-0142(19931101)72:9<2638::AID-CNCR2820720919>3.0.CO;2-N
   DAMICO AV, 1995, INT J RADIAT ONCOL, V32, P473, DOI 10.1016/0360-3016(94)00606-L
   Ennis RD, 1998, INT J RADIAT ONCOL, V41, P511, DOI 10.1016/S0360-3016(98)00104-7
   GOAD JR, 1993, UROL CLIN N AM, V20, P727
   HANCOCK SL, 1995, J UROLOGY, V154, P1412, DOI 10.1016/S0022-5347(01)66879-4
   HANKS GE, 1993, INT J RADIAT ONCOL, V27, P125
   Hanlon AL, 1998, CANCER, V83, P130, DOI 10.1002/(SICI)1097-0142(19980701)83:1<130::AID-CNCR17>3.3.CO;2-M
   Horwitz EM, 1996, INT J RADIAT ONCOL, V36, P565, DOI 10.1016/S0360-3016(96)00360-4
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KAPLAN ID, 1993, J UROLOGY, V149, P519
   Kuban DA, 1998, SEMIN RADIAT ONCOL, V8, P72, DOI 10.1016/S1053-4296(98)80002-7
   KUBAN DA, 1995, INT J RADIAT ONCOL, V32, P307, DOI 10.1016/0360-3016(95)00137-N
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   McLaughlin PW, 1996, J CLIN ONCOL, V14, P2889
   *PSA NAD LEV RAD P, 1997, ONCOLOGY, V11, P1236
   RITTER MA, 1992, J CLIN ONCOL, V10, P1208
   RUSSELL KJ, 1991, J UROLOGY, V146, P1046
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Schellhammer PF, 1997, UROL CLIN N AM, V24, P407, DOI 10.1016/S0094-0143(05)70387-6
   STAMEY TA, 1994, J UROLOGY, V152, P492
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   ZAGARS GK, 1993, CANCER, V72, P538, DOI 10.1002/1097-0142(19930715)72:2<538::AID-CNCR2820720234>3.0.CO;2-S
   ZEITMAN AL, 1993, CANCER, V71, P959
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
NR 36
TC 63
Z9 63
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0008-543X
J9 CANCER
JI Cancer
PD OCT 15
PY 1999
VL 86
IS 8
BP 1557
EP 1566
DI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
PG 10
WC Oncology
SC Oncology
GA 245WJ
UT WOS:000083130900024
PM 10526285
ER

PT J
AU Potters, L
   Cha, C
   Oshinsky, G
   Venkatraman, E
   Zelefsky, M
   Leibel, S
AF Potters, L
   Cha, C
   Oshinsky, G
   Venkatraman, E
   Zelefsky, M
   Leibel, S
TI Risk profiles to predict PSA relapse-free survival for patients
   undergoing permanent prostate brachytherapy
SO CANCER JOURNAL FROM SCIENTIFIC AMERICAN
LA English
DT Article; Proceedings Paper
CT Meeting of the American-Brachytherapy-Society
CY JUL   07, 1999
CL SAN DIEGO, CALIFORNIA
SP Amer Brachytherapy Soc
DE prostate cancer; brachytherapy; radiotherapy; palladium; iodine
ID DISEASE-FREE SURVIVAL; RADICAL RETROPUBIC PROSTATECTOMY; EXTERNAL-BEAM
   IRRADIATION; RADIATION-THERAPY; CONFORMAL RADIOTHERAPY; DOSE-ESCALATION;
   CANCER; ANTIGEN; CARCINOMA; IMPLANTATION
AB PURPOSE
   Combined risk profiles are helpful in assessing the likelihood of prostate-specific antigen relapse-free survival (PSA-RFS) for patients with localized prostate cancer. This retrospective analysis reports the 5-year biochemical outcome of a large cohort of patients according to prognostic factors and risk profiles for patients undergoing ultrasound-guided transperineal interstitial permanent prostate brachytherapy (TIPPB).
   PATIENTS AND METHODS
   Seven hundred seventeen consecutive patients with clinically localized prostate cancer treated between June 1992 and November 1997 underwent TIPPB. Palladium-103 (Pd-103) (n = 539) or iodine-125 (I-125) (n = 178) sources were utilized to a prescribed dose of 120 Gy and 144 Gy, respectively. One hundred eleven patients received combined external-beam irradiation (41.4 or 45 Gy) and TIPPB (Pd-103, 90 Gy, and I-125, 108 Gy) One hundred twelve patients received androgen ablation therapy in advance of TIPPB. Patients were grouped into risk profiles based on pretreatment factors that consisted of PSA less than or equal to 10 and Gleason score less than or equal to 6. Patients meeting both criteria were classified as favorable (n = 334). Those not fulfilling one criteria were classified as intermediate risk (n = 261), and those not fulfilling two criteria were classified as unfavorable risk (n = 261). PSA-RFS was calculated based on the American Society of Therapeutic Radiology and Oncology consensus conference definition of PSA failure. The median follow-up was 41 months (range, 14-82 months).
   RESULTS
   The actuarial PSA-RFS survival at 5 years was 82%, Multivariate Cox regression analysis identified PSA and Gleason score as highly significant factors predicting for biochemical outcome. Hazard risk ratios using a nadir definition of the PSA as less than or equal to 1.0 ng/mL and less than or equal to 0.5 ng/mL were each significant predictors of outcome with the 0.5 ng/mL nadir level only slightly better (risk ratio for nadir less than or equal to 1.0 = 2.78; risk ratio for nadir less than or equal to 0.5 = 3.57). Favorable-risk patients had a 5-year actuarial PSA-RFS of 93%, whereas intermediate-risk and unfavorable-risk groups had 5-year PSA-RFSs of 77% and 62%, respectively. Four hundred ninety-three patients underwent brachytherapy without external-beam irradiation or androgen ablation, From this group, the 5-year PSA-RFSs for the favorable-risk, intermediate-risk, and unfavorable-risk patients were 92%, 74%, and 55%, respectively.
   DISCUSSION
   This retrospective study examining TIPPB demonstrated excellent 5-year actuarial PSA-RFS rates. The assignment of risk profiles based on the results of multivariate analysis of prognostic factors identifies the expected PSA-RFS for patients undergoing TIPPB.
C1 Mercy Med Ctr, Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 11570 USA.
   Virginia Mason Med Ctr, Dept Radiat Oncol, Seattle, WA 98101 USA.
   Mercy Med Ctr, Rockville Ctr, Dept Urol, New York, NY USA.
   Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA.
RP Potters, L (reprint author), Mercy Med Ctr, Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1000 N Village Ave,Rockville Ctr, New York, NY 11570 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   ANDERSON LL, 1993, INT J RADIAT ONCOL, V27, P129
   Bauer JJ, 1998, J UROLOGY, V159, P929, DOI 10.1016/S0022-5347(01)63773-X
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   Blasko J C, 1991, Scand J Urol Nephrol Suppl, V137, P113
   Butler EB, 1997, SEMIN SURG ONCOL, V13, P406, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<406::AID-SSU4>3.0.CO;2-E
   COX DR, 1972, J R STAT SOC B, V34, P187
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   D'Amico AV, 1998, CANCER, V83, P2172, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2172::AID-CNCR16>3.0.CO;2-K
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Fleming ID, 1997, AJCC CANC STAGING MA
   GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125
   Grado GL, 1998, INT J RADIAT ONCOL, V42, P289, DOI 10.1016/S0360-3016(98)00209-0
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kupelian P, 1997, CANCER J SCI AM, V3, P78
   Lattanzi JP, 1997, INT J RADIAT ONCOL, V38, P569, DOI 10.1016/S0360-3016(97)00100-4
   Leibel S A, 1996, Front Radiat Ther Oncol, V29, P229
   Lerner SE, 1996, J UROLOGY, V156, P137, DOI 10.1016/S0022-5347(01)65967-6
   Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2
   Nath R, 1997, MED PHYS, V24, P1557, DOI 10.1118/1.597966
   PISANSKY TM, 1993, J CLIN ONCOL, V11, P2158
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   UNGER PD, 1995, ANAL QUANT CYTOL, V17, P100
   Zelefsky MJ, 1999, J CLIN ONCOL, V17, P517
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   ZELEFSKY MJ, 1995, J CLIN ONCOL, V13, P459
   Zelefsky MJ, 1998, SEMIN RADIAT ONCOL, V8, P107, DOI 10.1016/S1053-4296(98)80006-4
NR 31
TC 63
Z9 64
PU SCI AMERICAN INC
PI NEW YORK
PA 415 MADISON AVE, NEW YORK, NY 10017 USA
SN 1081-4442
J9 CANCER J SCI AM
JI Cancer J. Sci. Am.
PD SEP-OCT
PY 1999
VL 5
IS 5
BP 301
EP 306
PG 6
WC Oncology
SC Oncology
GA 247CL
UT WOS:000083203000009
PM 10526671
ER

PT J
AU Tang, Q
   Zhou, Z
   Chen, ZF
AF Tang, Qing
   Zhou, Zhen
   Chen, Zhongfang
TI Graphene-related nanomaterials: tuning properties by functionalization
SO NANOSCALE
LA English
DT Review
ID NITROGEN-DOPED GRAPHENE; CHEMICAL-VAPOR-DEPOSITION; EXFOLIATED GRAPHITE
   OXIDE; MOLECULAR CHARGE-TRANSFER; SOLID-STATE NMR; PARTIALLY
   HYDROGENATED GRAPHENE; MULTIWALLED CARBON NANOTUBES; BORON-NITRIDE
   NANORIBBONS; FIELD-EFFECT TRANSISTORS; CATALYST-FREE SYNTHESIS
AB In this review, we discuss the most recent progress on graphene-related nanomaterials, including doped graphene and derived graphene nanoribbons, graphene oxide, graphane, fluorographene, graphyne, graphdiyne, and porous graphene, from both experimental and theoretical perspectives, and emphasize tuning their stability, electronic and magnetic properties by chemical functionalization.
C1 [Tang, Qing; Zhou, Zhen] Nankai Univ, Tianjin Key Lab Met & Mol Based Mat Chem, Key Lab Adv Energy Mat Chem,Minist Educ, Inst New Energy Mat Chem,Computat Ctr Mol Sci, Tianjin 300071, Peoples R China.
   [Chen, Zhongfang] Univ Puerto Rico, Dept Chem, Inst Funct Nanomat, San Juan, PR 00936 USA.
RP Zhou, Z (reprint author), Nankai Univ, Tianjin Key Lab Met & Mol Based Mat Chem, Key Lab Adv Energy Mat Chem,Minist Educ, Inst New Energy Mat Chem,Computat Ctr Mol Sci, Tianjin 300071, Peoples R China.
EM zhouzhen@nankai.edu.cn
RI Tang, Qing/F-9830-2013; Zhou, Zhen/C-4517-2008; Chen,
   Zhongfang/A-3397-2008
OI Zhou, Zhen/0000-0003-3232-9903; 
FU NSFC, China [21273118]; 111 Project, China [B12015]; Department of
   Defense, USA [W911NF-12-1-0083]; NSF, USA [EPS-1010094]
FX Support in China by NSFC (21273118) and 111 Project (B12015), and in USA
   by Department of Defense (Grant W911NF-12-1-0083) and partially by NSF
   (Grant EPS-1010094) is gratefully acknowledged. The authors thank Mr
   Pengtao Xu for his help in the application for copyright permission and
   the design of cover picture.
CR Abdelsayed V, 2010, J PHYS CHEM LETT, V1, P2804, DOI 10.1021/jz1011143
   Akhavan O, 2009, J PHYS CHEM C, V113, P20214, DOI 10.1021/jp906325q
   Allen MJ, 2010, CHEM REV, V110, P132, DOI 10.1021/cr900070d
   Ambrosi A, 2012, CHEM MATER, V24, P2292, DOI 10.1021/cm300382b
   Andriotis AN, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2839373
   Ao ZM, 2009, J APPL PHYS, V105, DOI 10.1063/1.3103327
   Attaccalite C, 2010, NANO LETT, V10, P1172, DOI 10.1021/nl9034626
   Babarao R, 2012, J PHYS CHEM C, V116, P7106, DOI 10.1021/jp301450m
   Bagri A, 2010, NAT CHEM, V2, P581, DOI [10.1038/nchem.686, 10.1038/NCHEM.686]
   Bai H, 2009, CHEM COMMUN, P1667, DOI 10.1039/b821805f
   Bai HC, 2011, RSC ADV, V1, P768, DOI 10.1039/c1ra00481f
   Bai JW, 2009, NANO LETT, V9, P2083, DOI 10.1021/nl900531n
   Balog R, 2009, J AM CHEM SOC, V131, P8744, DOI 10.1021/ja902714h
   Balog R, 2010, NAT MATER, V9, P315, DOI [10.1038/nmat2710, 10.1038/NMAT2710]
   Banhart F, 2011, ACS NANO, V5, P26, DOI 10.1021/nn102598m
   Banhart F, 2000, PHYS REV LETT, V84, P686, DOI 10.1103/PhysRevLett.84.686
   Baraket M, 2010, CARBON, V48, P3382, DOI 10.1016/j.carbon.2010.05.031
   Barone V, 2006, NANO LETT, V6, P2748, DOI 10.1021/nl0617033
   BAUGHMAN RH, 1987, J CHEM PHYS, V87, P6687, DOI 10.1063/1.453405
   Becerril HA, 2008, ACS NANO, V2, P463, DOI 10.1021/nn700375n
   Bekyarova E, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/15/154009
   Berashevich J, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/35/355201
   Bhattacharya A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.033404
   Bhowrnick S, 2011, J PHYS CHEM C, V115, P9889, DOI 10.1021/jp200671p
   Bi S, 2012, CHEM COMMUN, V48, P106, DOI 10.1039/c1cc15443e
   Biel B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096803
   Bieri M, 2009, CHEM COMMUN, P6919, DOI 10.1039/b915190g
   Blake P, 2008, NANO LETT, V8, P1704, DOI 10.1021/nl080649i
   Blankenburg S, 2010, SMALL, V6, P2266, DOI 10.1002/smll.201001126
   Botello-Mendez AR, 2009, ACS NANO, V3, P3606, DOI 10.1021/nn900614x
   Boukhvalov DW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/5/055708
   Boukhvalov DW, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/17/175302
   Boukhvalov DW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035427
   Boukhvalov DW, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/34/344205
   Boukhvalov DW, 2012, CHEMPHYSCHEM, V13, P1463, DOI 10.1002/cphc.201100847
   Boukhvalov DW, 2008, J AM CHEM SOC, V130, P10697, DOI 10.1021/ja8021686
   Boukhvalov DW, 2008, NANO LETT, V8, P4373, DOI 10.1021/nl802098g
   Bourlinos AB, 2012, CARBON, V50, P1425, DOI 10.1016/j.carbon.2011.10.012
   Brito WH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045417
   Brodie B., 1855, ANN CHIM PHYS, V45, P351
   BRODIE B.C, 1859, PHILOS T R SOC LONDO, V149, P249, DOI DOI 10.1098/RSTL.1859.0013
   Bulusheva LG, 2012, CHEM MATER, V24, P2708, DOI 10.1021/cm3006309
   Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b
   Burress JW, 2010, ANGEW CHEM INT EDIT, V49, P8902, DOI 10.1002/anie.201003328
   Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211
   Cai WW, 2008, SCIENCE, V321, P1815, DOI 10.1126/science.1162369
   Calandra M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.161406
   Cambedouzou J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.235422
   Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d
   Cano-Marquez AG, 2009, NANO LETT, V9, P1527, DOI 10.1021/nl803585s
   Cantele G, 2009, NANO LETT, V9, P3425, DOI 10.1021/nl901557x
   Casabianca LB, 2010, J AM CHEM SOC, V132, P5672, DOI 10.1021/ja9030243
   Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802
   Cervantes-Sodi F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165427
   Chan KT, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235430
   Chang CH, 2012, J PHYS CHEM C, V116, P13788, DOI 10.1021/jp302293p
   Chang HX, 2011, CHEM-EUR J, V17, P8896, DOI 10.1002/chem.201100699
   CHARLIER JC, 1993, PHYS REV B, V47, P16162, DOI 10.1103/PhysRevB.47.16162
   Chen D, 2010, CHEM SOC REV, V39, P3157, DOI 10.1039/b923596e
   Chen D, 2012, CHEM REV, V112, P6027, DOI 10.1021/cr300115g
   Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757
   Chen L, 2012, ANGEW CHEM INT EDIT, V51, P7640, DOI 10.1002/anie.201201084
   Chen L, 2010, J AM CHEM SOC, V132, P6742, DOI 10.1021/ja100327h
   Chen S, 2010, ACS NANO, V4, P2822, DOI 10.1021/nn901311t
   Chen W, 2007, J AM CHEM SOC, V129, P10418, DOI 10.1021/ja071658g
   Chen WF, 2010, CARBON, V48, P1146, DOI 10.1016/j.carbon.2009.11.037
   Chen WF, 2010, J PHYS CHEM C, V114, P19885, DOI 10.1021/jp107131v
   Chen Y, 2009, CHEM COMMUN, P4527, DOI 10.1039/b907723e
   Chen YP, 2008, J APPL PHYS, V103, DOI 10.1063/1.2894910
   Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020
   Cheng SH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205435
   Cheng YC, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4746261
   Chernozatonskii LA, 2012, J PHYS CHEM C, V116, P20035, DOI 10.1021/jp304596y
   Chien CT, 2012, ANGEW CHEM INT EDIT, V51, P6662, DOI 10.1002/anie.201200474
   Cho YJ, 2011, J PHYS CHEM C, V115, P3737, DOI 10.1021/jp112141f
   Choi J, 2009, J PHYS CHEM C, V113, P9433, DOI 10.1021/jp9010444
   Choi W, 2010, CRIT REV SOLID STATE, V35, P52, DOI 10.1080/10408430903505036
   Choudhury D, 2010, CHEM PHYS LETT, V497, P66, DOI 10.1016/j.cplett.2010.07.089
   Chu S. W., 2012, SYNTHETIC MET, V161, P1689
   Ci L, 2010, NAT MATER, V9, P430, DOI 10.1038/nmat2711
   Cohen-Tanugi D, 2012, NANO LETT, V12, P3602, DOI 10.1021/nl3012853
   Coletti C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235401
   Compton OC, 2010, SMALL, V6, P711, DOI 10.1002/smll.200901934
   Cote LJ, 2009, J AM CHEM SOC, V131, P11027, DOI 10.1021/ja902348k
   Cranford SW, 2012, NANOSCALE, V4, P4587, DOI 10.1039/c2nr30921a
   Cranford SW, 2011, CARBON, V49, P4111, DOI 10.1016/j.carbon.2011.05.024
   Cretu O, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.196102
   Crowther AC, 2012, ACS NANO, V6, P1865, DOI 10.1021/nn300252a
   Cudazzo P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.226804
   Cui X, 2011, NANOSCALE, V3, P2118, DOI 10.1039/c1nr10127g
   Da HX, 2011, J PHYS CHEM C, V115, P22701, DOI 10.1021/jp203506z
   Dai JY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165414
   Dalosto SD, 2008, J PHYS CHEM C, V112, P8196, DOI 10.1021/jp711524y
   Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67
   Das B, 2008, CHEM COMMUN, P5155, DOI 10.1039/b808955h
   Deifallah M, 2008, J PHYS CHEM C, V112, P5447, DOI 10.1021/jp711483t
   Deng DH, 2011, CHEM MATER, V23, P1188, DOI 10.1021/cm102666r
   Denis PA, 2011, J PHYS CHEM C, V115, P195, DOI 10.1021/jp107057e
   de Vos RM, 1998, SCIENCE, V279, P1710, DOI 10.1126/science.279.5357.1710
   Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016
   Ding Y, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3234374
   Ding Y, 2011, J PHYS CHEM C, V115, P5334, DOI 10.1021/jp110336r
   do Nascimento GM, 2009, J PHYS CHEM C, V113, P3934, DOI 10.1021/jp808382p
   Dong JC, 2012, J PHYS CHEM C, V116, P17259, DOI 10.1021/jp304189w
   Dong XC, 2009, SMALL, V5, P1422, DOI 10.1002/smll.200801711
   Dong XC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.135501
   Dossel L, 2011, ANGEW CHEM INT EDIT, V50, P2540, DOI 10.1002/anie.201006593
   Dresselhaus MS, 2010, ACS NANO, V4, P6297, DOI 10.1021/nn1029789
   Dreyer DR, 2011, J MATER CHEM, V21, P3443, DOI 10.1039/c0jm02704a
   Dreyer DR, 2010, ANGEW CHEM INT EDIT, V49, P6813, DOI 10.1002/anie.201002160
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Du AJ, 2010, J AM CHEM SOC, V132, P2876, DOI 10.1021/ja100156d
   Duan HG, 2008, ADV MATER, V20, P3284, DOI 10.1002/adma.200702149
   Dubin S, 2010, ACS NANO, V4, P3845, DOI 10.1021/nn100511a
   Dutta S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096601
   Dutta S, 2008, J PHYS CHEM B, V112, P1333, DOI 10.1021/jp710637c
   Dutta S, 2010, J MATER CHEM, V20, P8207, DOI 10.1039/c0jm00261e
   Dzhurakhalov AA, 2011, CARBON, V49, P3258, DOI 10.1016/j.carbon.2011.03.052
   Eda G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937846
   Eda G, 2010, ADV MATER, V22, P2392, DOI 10.1002/adma.200903689
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Eda G, 2009, J PHYS CHEM C, V113, P15768, DOI 10.1021/jp9051402
   Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130
   Elias AL, 2010, NANO LETT, V10, P366, DOI 10.1021/nl901631z
   Englert JM, 2011, NAT CHEM, V3, P279, DOI [10.1038/nchem.1010, 10.1038/NCHEM.1010]
   Enyashin AN, 2011, PHYS STATUS SOLIDI B, V248, P1879, DOI 10.1002/pssb.201046583
   Erickson K, 2010, ADV MATER, V22, P4467, DOI 10.1002/adma.201000732
   Fampiou I, 2012, J PHYS CHEM C, V116, P6543, DOI 10.1021/jp2110117
   Fan XB, 2008, ADV MATER, V20, P4490, DOI 10.1002/adma.200801306
   Fan XF, 2010, J PHYS CHEM C, V114, P14939, DOI 10.1021/jp1041537
   Fan XF, 2012, ACS APPL MATER INTER, V4, P2432, DOI 10.1021/am3000962
   Fan ZJ, 2011, ACS NANO, V5, P191, DOI 10.1021/nn102339t
   Fan ZJ, 2010, CARBON, V48, P1686, DOI 10.1016/j.carbon.2009.12.063
   Fang M, 2009, J MATER CHEM, V19, P7098, DOI 10.1039/b908220d
   Feng LY, 2011, ACS NANO, V5, P9611, DOI 10.1021/nn202906f
   Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h
   FERRARA JD, 1988, J AM CHEM SOC, V110, P647, DOI 10.1021/ja00210a082
   FERRARA JD, 1987, ORGANOMETALLICS, V6, P676, DOI 10.1021/om00146a041
   FERRARA JD, 1988, INORG CHEM, V27, P2201, DOI 10.1021/ic00286a001
   FERRARA JD, 1985, J AM CHEM SOC, V107, P6719, DOI 10.1021/ja00309a056
   Fiori G, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153404
   Fischbein MD, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2980518
   Fowler JD, 2009, ACS NANO, V3, P301, DOI 10.1021/nn800593m
   FUSARO RL, 1970, ASLE TRANS, V13, P56
   Gan YJ, 2008, SMALL, V4, P587, DOI 10.1002/smll.200700929
   Gao HL, 2011, J PHYS CHEM C, V115, P3236, DOI 10.1021/jp1094454
   Gao W, 2009, NAT CHEM, V1, P403, DOI [10.1038/nchem.281, 10.1038/NCHEM.281]
   Gao XF, 2010, J PHYS CHEM C, V114, P832, DOI 10.1021/jp909284g
   Gao XF, 2009, J AM CHEM SOC, V131, P9663, DOI 10.1021/ja902878w
   Gava P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.165431
   Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Georgakilas V, 2012, CHEM REV, V112, P6156, DOI 10.1021/cr3000412
   Georgakilas V, 2010, CHEM COMMUN, V46, P1766, DOI 10.1039/b922081j
   Ghosh A, 2009, J EXP NANOSCI, V4, P313, DOI 10.1080/17458080903115379
   Gierz I, 2008, NANO LETT, V8, P4603, DOI 10.1021/nl802996s
   Gilje S, 2010, ADV MATER, V22, P419, DOI 10.1002/adma.200901902
   Gilje S, 2007, NANO LETT, V7, P3394, DOI 10.1021/nl0717715
   Giovannetti G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026803
   Gomez-Navarro C, 2010, NANO LETT, V10, P1144, DOI 10.1021/nl9031617
   Gomez-Navarro C, 2008, NANO LETT, V8, P2045, DOI 10.1021/nl801384y
   Gomez-Navarro C, 2009, NANO LETT, V9, DOI 10.1021/nl901209z
   Gopalakrishnan K, 2012, RSC ADV, V2, P1605, DOI 10.1039/c1ra00403d
   Grassi R, 2011, NANO LETT, V11, P4574, DOI 10.1021/nl2017338
   Guisinger NP, 2009, NANO LETT, V9, P1462, DOI 10.1021/nl803331q
   Gunlycke D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2783196
   Guo BD, 2010, NANO LETT, V10, P4975, DOI 10.1021/nl103079j
   Guo SJ, 2011, CHEM SOC REV, V40, P2644, DOI 10.1039/c0cs00079e
   Guo YF, 2010, J PHYS CHEM C, V114, P13098, DOI 10.1021/jp102147a
   Guo YH, 2012, J PHYS CHEM C, V116, P13837, DOI 10.1021/jp302062c
   Haberer D, 2010, NANO LETT, V10, P3360, DOI 10.1021/nl101066m
   Haberer D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165433
   Haberer D, 2011, ADV MATER, V23, P4497, DOI 10.1002/adma.201102019
   Haley MM, 1997, ANGEW CHEM INT EDIT, V36, P836, DOI 10.1002/anie.199708361
   Haley MM, 2008, PURE APPL CHEM, V80, P519, DOI 10.1351/pac200880030519
   Han MY, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056801
   Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805
   Hankel M, 2012, J PHYS CHEM C, V116, P6672, DOI 10.1021/jp211930a
   Hao R, 2008, CHEM COMMUN, P6576, DOI 10.1039/b816971c
   Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817
   Hatanaka M, 2010, CHEM PHYS LETT, V488, P187, DOI 10.1016/j.cplett.2010.02.014
   Hauser AW, 2012, J PHYS CHEM C, V116, P10819, DOI 10.1021/jp302498d
   Hauser AW, 2012, J PHYS CHEM LETT, V3, P209, DOI 10.1021/jz201504k
   He HK, 2010, CHEM MATER, V22, P5054, DOI 10.1021/cm101634k
   He HY, 1996, J PHYS CHEM-US, V100, P19954, DOI 10.1021/jp961563t
   He HY, 1998, CHEM PHYS LETT, V287, P53, DOI 10.1016/S0009-2614(98)00144-4
   He QY, 2012, CHEM SCI, V3, P1764, DOI 10.1039/c2sc20205k
   He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639
   Herbig C, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/31/314208
   Hernandez-Nieves AD, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165412
   Hicks J, 2013, NAT PHYS, V9, P49, DOI [10.1038/nphys2487, 10.1038/NPHYS2487]
   Higginbotham AL, 2010, ACS NANO, V4, P2059, DOI 10.1021/nn100118m
   Hirsch A, 2009, ANGEW CHEM INT EDIT, V48, P6594, DOI 10.1002/anie.200902534
   Hirsch A, 2010, NAT MATER, V9, P868, DOI 10.1038/nmat2885
   Hod O, 2007, NANO LETT, V7, P2295, DOI 10.1021/nI0708922
   Hoffman U., 1939, BER DTSCH CHEM GES, V72, P754
   Holby EF, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4742890
   Hong JM, 2011, SMALL, V7, P1175, DOI 10.1002/smll.201002244
   HONTORIALUCAS C, 1995, CARBON, V33, P1585, DOI 10.1016/0008-6223(95)00120-3
   Hossain MZ, 2012, NAT CHEM, V4, P305, DOI 10.1038/nchem.1269
   Huang B, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.161405
   Huang B, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075415
   Huang B, 2008, J PHYS CHEM C, V112, P13442, DOI 10.1021/jp8021024
   Huang H, 2009, ACS NANO, V3, P3431, DOI 10.1021/nn9008615
   Huang L, 2011, CARBON, V49, P2431, DOI 10.1016/j.carbon.2011.01.067
   Huang X, 2011, SMALL, V7, P1876, DOI 10.1002/smll.201002009
   Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   HUNGER HF, 1973, J ELECTROCHEM SOC, V120, P1161, DOI 10.1149/1.2403654
   Ijas M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.035440
   Imamura G, 2011, J PHYS CHEM C, V115, P10000, DOI 10.1021/jp202128f
   Itkis ME, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3562316
   Jafri RI, 2010, J MATER CHEM, V20, P7114, DOI 10.1039/c0jm00467g
   Jaiswal M, 2011, ACS NANO, V5, P888, DOI 10.1021/nn102034y
   Jaiswal NK, 2012, SOLID STATE COMMUN, V152, P1489, DOI 10.1016/j.ssc.2012.04.047
   Jalili S, 2011, MOL PHYS, V109, P687, DOI 10.1080/00268976.2010.547523
   Jayasekera T, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/42/424033
   Jeon KJ, 2011, ACS NANO, V5, P1042, DOI 10.1021/nn1025274
   Jeong HK, 2008, J AM CHEM SOC, V130, P1362, DOI 10.1021/ja076473o
   Jeong HM, 2011, NANO LETT, V11, P2472, DOI 10.1021/nl2009058
   Jia XT, 2009, SCIENCE, V323, P1701, DOI 10.1126/science.1166862
   Jia XT, 2011, NANOSCALE, V3, P86, DOI 10.1039/c0nr00600a
   Jiang DE, 2006, J PHYS CHEM B, V110, P23628, DOI 10.1021/jp065980+
   Jiang DE, 2009, NANO LETT, V9, P4019, DOI 10.1021/nl9021946
   Jiang DE, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715558
   Jiao LY, 2010, NAT NANOTECHNOL, V5, P321, DOI [10.1038/nnano.2010.54, 10.1038/NNANO.2010.54]
   Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919
   Jiao Y, 2011, CHEM COMMUN, V47, P11843, DOI 10.1039/c1cc15129k
   Jin Z, 2011, ACS NANO, V5, P4112, DOI 10.1021/nn200766e
   Jing L, 2010, NANO LETT, V10, P4000, DOI 10.1021/nl101901g
   Jo K, 2011, LANGMUIR, V27, P2014, DOI 10.1021/la104420p
   Johari P, 2011, ACS NANO, V5, P7640, DOI 10.1021/nn202732t
   Johns JE, 2013, ACCOUNTS CHEM RES, V46, P77, DOI 10.1021/ar300143e
   Jones JD, 2010, CARBON, V48, P2335, DOI 10.1016/j.carbon.2010.03.010
   Jung I, 2007, NANO LETT, V7, P3569, DOI 10.1021/nl0714177
   Jung I, 2008, J PHYS CHEM C, V112, P8499, DOI 10.1021/jp802173m
   Jung I, 2008, NANO LETT, V8, P4283, DOI 10.1021/nl8019938
   Jung I, 2008, J PHYS CHEM C, V112, P20264, DOI 10.1021/jp807525d
   Jung JH, 2010, ANGEW CHEM INT EDIT, V49, P5708, DOI 10.1002/anie.201001428
   Jung N, 2010, ACS NANO, V4, P7005, DOI 10.1021/nn102227u
   Jung N, 2009, NANO LETT, V9, P4133, DOI 10.1021/nl902362q
   Juselus J, 2001, PHYS CHEM CHEM PHYS, V3, P2433, DOI 10.1039/b101179k
   KAMARCHIK P, 1978, ACCOUNTS CHEM RES, V11, P296, DOI 10.1021/ar50128a002
   Kan E, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3327884
   Kan EJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2821112
   Kan EJ, 2008, J AM CHEM SOC, V130, P4224, DOI 10.1021/ja710407t
   Kan EJ, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2971187
   Kang J, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/34/346001
   Kang J, 2011, J PHYS CHEM C, V115, P20466, DOI 10.1021/jp206751m
   Kang YJ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.115404
   Karlicky F, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4736998
   Kasry A, 2010, ACS NANO, V4, P3839, DOI 10.1021/nn100508g
   Kattel S, 2012, J PHYS CHEM C, V116, P8161, DOI 10.1021/jp2121609
   Kehoe JM, 2000, ORG LETT, V2, P969, DOI 10.1021/ol005623w
   Khan SUM, 2002, SCIENCE, V297, P2243, DOI 10.1126/science.1077386
   Kim G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2828976
   Kim HJ, 2012, J PHYS CHEM C, V116, P13795, DOI 10.1021/jp302733p
   Kim J, 2012, ACCOUNTS CHEM RES, V45, P1356, DOI 10.1021/ar300047s
   Kim JE, 2011, ANGEW CHEM INT EDIT, V50, P3043, DOI 10.1002/anie.201004692
   Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719
   Kim MC, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3197007
   Kim WY, 2008, NAT NANOTECHNOL, V3, P408, DOI 10.1038/nnano.2008.163
   Kim YA, 2012, ACS NANO, V6, P6293, DOI 10.1021/nn301728j
   KITA Y, 1979, J AM CHEM SOC, V101, P3832, DOI 10.1021/ja00508a020
   Klintenberg M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.085433
   Kobayashi Y, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.193406
   Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/nnano.2012.162, 10.1038/NNANO.2012.162]
   Kondo M, 2005, CHEM PHYS, V312, P289, DOI 10.1016/j.chemphys.2004.11.029
   Kopylov S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3487782
   Koskinen P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.115502
   Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872
   Kosynkin DV, 2011, ACS NANO, V5, P968, DOI 10.1021/nn102326c
   Kozlov SM, 2011, ADV MATER, V23, P2638, DOI 10.1002/adma.201100171
   Krasheninnikov AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.126807
   Krishnamoorthy K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3599453
   Krishnan D, 2012, NANO TODAY, V7, P137, DOI 10.1016/j.nantod.2012.02.003
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   Kuhn P, 2008, J AM CHEM SOC, V130, P13333, DOI 10.1021/ja803708s
   Kuila T, 2012, PROG MATER SCI, V57, P1061, DOI 10.1016/j.pmatsci.2012.03.002
   Lahaye RJWE, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125435
   Lebegue S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245117
   Lee B, 2010, NANO LETT, V10, P2427, DOI 10.1021/nl100587e
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee G, 2009, J PHYS CHEM C, V113, P14225, DOI 10.1021/jp904321n
   Lee G, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.165440
   Lee H, 2011, J PHYS CHEM C, V115, P18736, DOI 10.1021/jp205840v
   Lee JH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3495771
   Lee YL, 2010, ACS NANO, V4, P1345, DOI 10.1021/nn9019064
   Leenaerts O, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195436
   Leenaerts O, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125416
   Leenaerts O, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245422
   Lei ZB, 2012, ENERG ENVIRON SCI, V5, P6391, DOI 10.1039/c1ee02478g
   Lerf A, 1998, J PHYS CHEM B, V102, P4477, DOI 10.1021/jp9731821
   Lerf A, 1997, SOLID STATE IONICS, V101, P857, DOI 10.1016/S0167-2738(97)00319-6
   Lherbier A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.036808
   Li B, 2011, ACS NANO, V5, P5957, DOI 10.1021/nn201731t
   Li C, 2011, J PHYS CHEM C, V115, P23221, DOI 10.1021/jp208423y
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Li F, 2012, NANOSCALE, V4, P1254, DOI 10.1039/c2nr11350c
   Li FY, 2012, J PHYS CHEM C, V116, P2507, DOI 10.1021/jp209572d
   Li GX, 2011, J PHYS CHEM C, V115, P2611, DOI 10.1021/jp107996f
   Li GX, 2010, CHEM COMMUN, V46, P3256, DOI 10.1039/b922733d
   Li JL, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.176101
   Li N, 2012, NANOSCALE, V4, P6205, DOI 10.1039/c2nr31750h
   Li N, 2010, CARBON, V48, P255, DOI 10.1016/j.carbon.2009.09.013
   Li XL, 2009, J AM CHEM SOC, V131, P15939, DOI 10.1021/ja907098f
   Li XL, 2008, NAT NANOTECHNOL, V3, P538, DOI 10.1038/nnano.2008.210
   Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878
   Li YF, 2012, J PHYS CHEM C, V116, P208, DOI 10.1021/jp207788t
   Li YF, 2010, J PHYS CHEM C, V114, P6250, DOI 10.1021/jp911535v
   Li YF, 2010, CHEM COMMUN, V46, P3672, DOI 10.1039/b926313f
   Li YF, 2009, ACS NANO, V3, P1952, DOI 10.1021/nn9003428
   Li YF, 2012, J PHYS CHEM C, V116, P4526, DOI 10.1021/jp212499h
   Li YF, 2012, J AM CHEM SOC, V134, P11269, DOI 10.1021/ja3040416
   Li YF, 2009, J PHYS CHEM C, V113, P15043, DOI 10.1021/jp9053499
   Li ZY, 2009, J AM CHEM SOC, V131, P6320, DOI 10.1021/ja8094729
   Liang J, 2012, ANGEW CHEM INT EDIT, V51, P11496, DOI 10.1002/anie.201206720
   Liao L, 2010, NANO LETT, V10, P1917, DOI 10.1021/nl100840z
   Lisenkov S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187208
   Liu GX, 2012, ACS NANO, V6, P6786, DOI 10.1021/nn301515a
   Liu H, 2009, LANGMUIR, V25, P12006, DOI 10.1021/la9029613
   Liu HB, 2010, ACCOUNTS CHEM RES, V43, P1496, DOI 10.1021/ar100084y
   Liu HT, 2011, J MATER CHEM, V21, P3335, DOI 10.1039/c0jm02922j
   Liu HT, 2009, J AM CHEM SOC, V131, P17099, DOI 10.1021/ja9043906
   Liu JB, 2010, J AM CHEM SOC, V132, P7279, DOI 10.1021/ja100938r
   Liu L, 2008, NANO LETT, V8, P1965, DOI 10.1021/nl0808684
   Liu LH, 2011, J MATER CHEM, V21, P3273, DOI 10.1039/c0jm02765k
   Liu LH, 2010, NANO LETT, V10, P3754, DOI 10.1021/nl1024744
   Liu LZ, 2012, CARBON, V50, P1690, DOI 10.1016/j.carbon.2011.12.014
   Liu YL, 2011, J PHYS CHEM C, V115, P9442, DOI 10.1021/jp201350e
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Liu ZB, 2009, J PHYS CHEM B, V113, P9681, DOI 10.1021/jp9004357
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI [10.1038/nchem.907, 10.1038/NCHEM.907]
   Loh KP, 2010, J MATER CHEM, V20, P2277, DOI 10.1039/b920539j
   Long DH, 2010, LANGMUIR, V26, P16096, DOI 10.1021/la102425a
   Long MQ, 2011, ACS NANO, V5, P2593, DOI 10.1021/nn102472s
   Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479
   Lu CL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.144427
   Lu N, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3455715
   Lu N, 2011, J PHYS CHEM C, V115, P11991, DOI 10.1021/jp204476q
   Lu YH, 2009, J PHYS CHEM B, V113, P2, DOI 10.1021/jp806905e
   Lu YH, 2009, J PHYS CHEM C, V113, P20156, DOI 10.1021/jp908829m
   Lu YH, 2009, J PHYS CHEM C, V113, P20841, DOI 10.1021/jp9067284
   Luo ZQ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524217
   Luo ZQ, 2009, ACS NANO, V3, P1781, DOI 10.1021/nn900371t
   Luo ZQ, 2011, J MATER CHEM, V21, P8038, DOI 10.1039/c1jm10845j
   Luo ZT, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3098358
   Ma CC, 2012, J MATER CHEM, V22, P8911, DOI 10.1039/c2jm00166g
   Ma DW, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123018
   Ma L, 2012, ANGEW CHEM INT EDIT, V51, P1161, DOI 10.1002/anie.201105920
   Ma XW, 2012, CHEM-ASIAN J, V7, P2547, DOI 10.1002/asia.201200520
   Malola S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3075216
   Manna AK, 2009, CHEM-ASIAN J, V4, P855, DOI 10.1002/asia.200800486
   Manna AK, 2011, J PHYS CHEM C, V115, P10842, DOI 10.1021/jp202195b
   Mao S, 2012, RSC ADV, V2, P2643, DOI 10.1039/c2ra00663d
   Mao S, 2011, NANOSCALE, V3, P2849, DOI 10.1039/c1nr10270b
   Markevich A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115439
   Martins TB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196803
   Mas-Balleste R, 2011, NANOSCALE, V3, P20, DOI 10.1039/c0nr00323a
   Masubuchi S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3089693
   Mattausch A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.076802
   Mattevi C, 2009, ADV FUNCT MATER, V19, P2577, DOI 10.1002/adfm.200900166
   McAllister MJ, 2007, CHEM MATER, V19, P4396, DOI 10.1021/cm0630800
   McCann E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161403
   Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t
   MERMOUX M, 1991, CARBON, V29, P469, DOI 10.1016/0008-6223(91)90216-6
   Mkhoyan KA, 2009, NANO LETT, V9, P1058, DOI 10.1021/nl8034256
   Mohanty N, 2010, SMALL, V6, P226, DOI 10.1002/smll.200901505
   Moon IK, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1067
   Morales-Narvaez E, 2012, ADV MATER, V24, P3298, DOI 10.1002/adma.201200373
   Munoz E, 2010, DIAM RELAT MATER, V19, P368, DOI 10.1016/j.diamond.2010.01.007
   Nair RR, 2010, SMALL, V6, P2877, DOI 10.1002/smll.201001555
   NAKAJIMA T, 1988, CARBON, V26, P357, DOI 10.1016/0008-6223(88)90227-8
   NAKAJIMA T, 1994, CARBON, V32, P469, DOI 10.1016/0008-6223(94)90168-6
   Narita N, 2000, PHYS REV B, V62, P11146, DOI 10.1103/PhysRevB.62.11146
   Narita N, 1998, PHYS REV B, V58, P11009, DOI 10.1103/PhysRevB.58.11009
   Narita N, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.245408
   Nduwimana A, 2009, ACS NANO, V3, P1995, DOI 10.1021/nn9004268
   Ng ML, 2010, J PHYS CHEM C, V114, P18559, DOI 10.1021/jp106361y
   Ni XX, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3264087
   Niimi Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085421
   Ning GQ, 2012, CHEM COMMUN, V48, P6815, DOI 10.1039/c2cc31785k
   Niyogi S, 2010, NANO LETT, V10, P4061, DOI 10.1021/nl1021128
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681
   Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082
   Oyama ST, 2004, J MEMBRANE SCI, V244, P45, DOI 10.1016/j.memsci.2004.06.046
   Paci JT, 2007, J PHYS CHEM C, V111, P18099, DOI 10.1021/jp075799g
   Palnitkar UA, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3464168
   Pan LD, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3583507
   Panchokarla LS, 2009, ADV MATER, V21, P4726, DOI 10.1002/adma.200901285
   Parashar UK, 2011, NANOSCALE, V3, P3876, DOI 10.1039/c1nr10483g
   Paredes JI, 2008, LANGMUIR, V24, P10560, DOI 10.1021/la801744a
   Park J, 2013, ACCOUNTS CHEM RES, V46, P181, DOI 10.1021/ar300172h
   Park J, 2012, ADV MATER, V24, P407, DOI 10.1002/adma.201103411
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]
   Park S, 2008, CHEM MATER, V20, P6592, DOI 10.1021/cm801932u
   Pei SF, 2010, CARBON, V48, P4466, DOI 10.1016/j.carbon.2010.08.006
   Pei SF, 2012, CARBON, V50, P3210, DOI 10.1016/j.carbon.2011.11.010
   Peng C, 2010, SMALL, V6, P1686, DOI 10.1002/smll.201000560
   Peng Q, 2012, PHYS CHEM CHEM PHYS, V14, P13385, DOI 10.1039/c2cp42387a
   Pinto H, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/40/402001
   Plachinda P, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3613649
   Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663
   Pontes RB, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.033412
   Prado MC, 2011, ACS NANO, V5, P394, DOI 10.1021/nn102211n
   Pujari BS, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.041402
   Pujari BS, 2009, J PHYS CHEM C, V113, P21063, DOI 10.1021/jp907640t
   Pumera M, 2011, ENERG ENVIRON SCI, V4, P668, DOI 10.1039/c0ee00295j
   Pyun J, 2011, ANGEW CHEM INT EDIT, V50, P46, DOI 10.1002/anie.201003897
   Qian XM, 2012, DALTON T, V41, P730, DOI 10.1039/c1dt11641j
   Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u
   Quintana M, 2010, ACS NANO, V4, P3527, DOI 10.1021/nn100883p
   Ramasse QM, 2012, ACS NANO, V6, P4063, DOI 10.1021/nn300452y
   Ramasubramaniam A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245413
   Ramesh P, 2010, J AM CHEM SOC, V132, P14429, DOI 10.1021/ja101706j
   Ramesha GK, 2009, J PHYS CHEM C, V113, P7985, DOI 10.1021/jp811377n
   Ranjbar A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165446
   Rao CNR, 2009, J MATER CHEM, V19, P2457, DOI 10.1039/b815239j
   Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678
   Rao CNR, 2010, J PHYS CHEM LETT, V1, P572, DOI 10.1021/jz9004174
   Reddy ALM, 2010, ACS NANO, V4, P6337, DOI 10.1021/nn101926g
   Reunchan P, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560468
   Rigo VA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075435
   Robinson JT, 2008, NANO LETT, V8, P3137, DOI 10.1021/nl8013007
   Robinson JT, 2008, NANO LETT, V8, P3441, DOI 10.1021/nl8023092
   Robinson JT, 2010, NANO LETT, V10, P3001, DOI 10.1021/nl101437p
   Rodriguez-Manzo JA, 2010, ACS NANO, V4, P3422, DOI 10.1021/nn100356q
   Romero HE, 2008, ACS NANO, V2, P2037, DOI 10.1021/nn800354m
   Rudenko AN, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035427
   Ruess G, 1947, MONATSH CHEM, V76, P381
   Ruff O, 1934, Z ANORG ALLG CHEM, V217, P1, DOI 10.1002/zaac.19342170102
   Rummeli MH, 2011, ADV MATER, V23, P4471, DOI 10.1002/adma.201101855
   Ryu S, 2008, NANO LETT, V8, P4597, DOI 10.1021/nl802940s
   Saha SK, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155414
   Sahin H, 2012, J PHYS CHEM C, V116, P24075, DOI 10.1021/jp307006c
   Sahin H, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3268792
   Salas EC, 2010, ACS NANO, V4, P4852, DOI 10.1021/nn101081t
   Salavagione HJ, 2011, MACROMOL RAPID COMM, V32, P1771, DOI 10.1002/marc.201100527
   Samarakoon DK, 2011, SMALL, V7, P965, DOI 10.1002/smll.201002058
   Samarakoon DK, 2009, ACS NANO, V3, P4017, DOI 10.1021/nn901317d
   Samarakoon DK, 2010, ACS NANO, V4, P4126, DOI 10.1021/nn1007868
   Santos EJG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195420
   Santos EJG, 2012, J PHYS CHEM C, V116, P1174, DOI 10.1021/jp2077374
   Santos EJG, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125433
   Santos EJG, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053012
   Savini G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.037002
   Saxena S, 2010, J PHYS CHEM LETT, V1, P3433, DOI 10.1021/jz1014339
   Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967
   Scheffler M, 2012, ACS NANO, V6, P10590, DOI 10.1021/nn303485c
   Schiros T, 2012, NANO LETT, V12, P4025, DOI 10.1021/nl301409h
   Schmidt MJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165439
   Schmidt MJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.085422
   Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f
   SCHOLZ W, 1969, Z ANORG ALLG CHEM, V369, P327, DOI 10.1002/zaac.19693690322
   Schrier J, 2010, J PHYS CHEM LETT, V1, P2284, DOI 10.1021/jz100748x
   Schrier J, 2012, CHEM PHYS LETT, V521, P118, DOI 10.1016/j.cplett.2011.11.069
   Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458
   Sevincli H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195434
   Shao YY, 2010, J MATER CHEM, V20, P743, DOI 10.1039/b917975e
   Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571
   Sheng ZH, 2011, ACS NANO, V5, P4350, DOI 10.1021/nn103584t
   Shi YM, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115402
   Shiflett MB, 1999, SCIENCE, V285, P1902, DOI 10.1126/science.285.5435.1902
   Shim SH, 2012, ACS APPL MATER INTER, V4, P4184, DOI 10.1021/am300906z
   Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167
   Shinde DB, 2011, J AM CHEM SOC, V133, P4168, DOI 10.1021/ja1101739
   Si Y, 2008, NANO LETT, V8, P1679, DOI 10.1021/nl080604h
   Singh AK, 2010, ACS NANO, V4, P3510, DOI 10.1021/nn1006072
   Singh AK, 2009, NANO LETT, V9, P1540, DOI 10.1021/nl803622c
   Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003
   Sinitskii A, 2010, ACS NANO, V4, P5405, DOI 10.1021/nn101019h
   Sinitskii A, 2010, ACS NANO, V4, P1949, DOI 10.1021/nn901899j
   Sint K, 2008, J AM CHEM SOC, V130, P16448, DOI 10.1021/ja804409f
   Sofo JO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153401
   Soin N, 2011, J PHYS CHEM C, V115, P5366, DOI 10.1021/jp110476m
   Sokolov DA, 2010, J PHYS CHEM LETT, V1, P2633, DOI 10.1021/jz100790y
   Soldano C, 2010, CARBON, V48, P2127, DOI 10.1016/j.carbon.2010.01.058
   Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803
   Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180
   Song EH, 2012, J PHYS CHEM C, V116, P20342, DOI 10.1021/jp304757f
   Song EH, 2011, J PHYS CHEM C, V115, P3678, DOI 10.1021/jp108978c
   Song P, 2012, RSC ADV, V2, P1168, DOI 10.1039/c1ra00934f
   Srinivasu K, 2012, J PHYS CHEM C, V116, P5951, DOI 10.1021/jp212181h
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969
   Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h
   Starodub E, 2010, J PHYS CHEM C, V114, P5134, DOI 10.1021/jp912139e
   STAUDENMAIER L., 1898, BER DTSCH CHEM GES, V31, P1481, DOI 10.1002/cber.18980310237
   Strom TA, 2010, CHEM COMMUN, V46, P4097, DOI 10.1039/c001488e
   Su CY, 2010, ACS NANO, V4, P5285, DOI 10.1021/nn101691m
   Su Q, 2009, ADV MATER, V21, P3191, DOI 10.1002/adma.200803808
   Suggs K, 2011, J PHYS CHEM C, V115, P3313, DOI 10.1021/jp111637b
   Suk JW, 2010, ACS NANO, V4, P6557, DOI 10.1021/nn101781v
   Suk ME, 2010, J PHYS CHEM LETT, V1, P1590, DOI 10.1021/jz100240r
   Sun CH, 2012, J PHYS CHEM C, V116, P26222, DOI 10.1021/jp309638z
   Sun JT, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155403
   Sun T, 2012, NANO LETT, V12, P17, DOI 10.1021/nl202656c
   Sun ZZ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1577
   Sun ZZ, 2011, J PHYS CHEM LETT, V2, P2425, DOI 10.1021/jz201000a
   Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579
   Surwade SP, 2012, J PHYS CHEM C, V116, P20600, DOI 10.1021/jp306537y
   Sxahin H., 2010, PHYS REV B, V81
   Szabo T, 2006, CHEM MATER, V18, P2740, DOI 10.1021/cm060258
   Tahara K, 2007, J ORG CHEM, V72, P1437, DOI 10.1021/jo0622781
   Takagi Y, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.121103
   Talyzin AV, 2011, ACS NANO, V5, P5132, DOI 10.1021/nn201224k
   Tang SB, 2011, J PHYS CHEM C, V115, P16644, DOI 10.1021/jp204880f
   Tang YA, 2012, PHYS CHEM CHEM PHYS, V14, P16566, DOI 10.1039/c2cp41441d
   Tang YB, 2012, ACS NANO, V6, P1970, DOI 10.1021/nn3005262
   Tapaszto L, 2008, NAT NANOTECHNOL, V3, P397, DOI 10.1038/nnano.2008.149
   Taychatanapat T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166601
   Terrones M, 2010, ACS NANO, V4, P1775, DOI 10.1021/nn1006607
   Terrones M, 2010, NANO TODAY, V5, P351, DOI 10.1016/j.nantod.2010.06.010
   Tian XQ, 2010, J PHYS CHEM B, V114, P11377, DOI 10.1021/jp102800v
   Tongay S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115428
   Tozzini V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.113404
   Tung V C, 2008, NAT NANOTECHNOL, V4, P25
   Uchoa B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.146801
   Uchoa B, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035420
   Ugeda MM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.096804
   Unarunotai S, 2010, ADV MATER, V22, P1072, DOI 10.1002/adma.200904095
   Usachov D, 2011, NANO LETT, V11, P5401, DOI 10.1021/nl2031037
   Vadukumpully S, 2011, NANOSCALE, V3, P303, DOI 10.1039/c0nr00547a
   Varchon F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.126805
   Varghese N, 2009, J PHYS CHEM C, V113, P16855, DOI 10.1021/jp9075355
   Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459
   Veca LM, 2009, CHEM COMMUN, P2565, DOI 10.1039/b900590k
   Vinogradov NA, 2011, J PHYS CHEM C, V115, P9568, DOI 10.1021/jp111962k
   Voggu R, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/47/472204
   Wakeland S, 2010, CARBON, V48, P3463, DOI 10.1016/j.carbon.2010.05.043
   Wang GX, 2008, J PHYS CHEM C, V112, P8192, DOI 10.1021/jp710931h
   Wang H, 2011, IND ENG CHEM RES, V50, P6132, DOI 10.1021/ie102572q
   Wang HB, 2011, J MATER CHEM, V21, P5430, DOI 10.1039/c1jm00049g
   Wang HB, 2011, ANGEW CHEM INT EDIT, V50, P7065, DOI 10.1002/anie.201101351
   Wang HT, 2012, NANO LETT, V12, P141, DOI 10.1021/nl2031629
   Wang HT, 2012, NANOSCALE, V4, P2920, DOI 10.1039/c2nr00059h
   Wang L, 2009, ACS NANO, V3, P2995, DOI 10.1021/nn900667s
   Wang L, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.161406
   Wang Q, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085404
   Wang QH, 2009, NAT CHEM, V1, P206, DOI [10.1038/nchem.212, 10.1038/NCHEM.212]
   Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r
   Wang X., 2008, NAT MATER, V8, P76
   Wang XM, 2011, J PHYS CHEM C, V115, P7596, DOI 10.1021/jp200386z
   Wang XR, 2009, SCIENCE, V324, P768, DOI 10.1126/science.1170335
   Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803
   Wang Y, 2010, J AM CHEM SOC, V132, P9274, DOI 10.1021/ja103169v
   Wang Y, 2010, ACS NANO, V4, P6146, DOI 10.1021/nn1017389
   Wang Y, 2011, ACS APPL MATER INTER, V3, P1127, DOI 10.1021/am1012613
   Wang Y, 2010, ACS NANO, V4, P1790, DOI 10.1021/nn100315s
   Wang YL, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3574906
   Wang ZF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2906631
   Wang ZY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3455884
   Wannakao S, 2012, J PHYS CHEM C, V116, P16992, DOI 10.1021/jp3035192
   Watanabe N., 1980, Solid State Ionics, V1, DOI 10.1016/0167-2738(80)90025-9
   Wehling TO, 2008, NANO LETT, V8, P173, DOI [10.1021/nl072364w, 10.1021/nL072364w]
   Wei DC, 2009, J AM CHEM SOC, V131, P11147, DOI 10.1021/ja903092k
   Wei DC, 2013, ACCOUNTS CHEM RES, V46, P106, DOI [10.1021/ar300103f, 10.1021/ar3001031]
   Wei DC, 2010, ADV MATER, V22, P3225, DOI 10.1002/adma.200904144
   Wei DC, 2009, NANO LETT, V9, P1752, DOI 10.1021/nl803279t
   Wei ZQ, 2010, SCIENCE, V328, P1373, DOI 10.1126/science.1188119
   Westervelt RM, 2008, SCIENCE, V320, P324, DOI 10.1126/science.1156936
   Widenkvist E, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/11/112003
   Williams G, 2008, ACS NANO, V2, P1487, DOI 10.1021/nn800251f
   Wilson NR, 2009, ACS NANO, V3, P2547, DOI 10.1021/nn900694t
   Withers F, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.073403
   Wu HY, 2011, J PHYS CHEM C, V115, P9241, DOI 10.1021/jp200038b
   Wu J, 2011, J AM CHEM SOC, V133, P19668, DOI 10.1021/ja2091068
   Wu JS, 2007, CHEM REV, V107, P718, DOI 10.1021/cr068010r
   Wu MH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3143611
   Wu M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/063020
   Wu MH, 2010, J PHYS CHEM C, V114, P3937, DOI 10.1021/jp100027w
   Wu XJ, 2008, NANO RES, V1, P40, DOI 10.1007/s12274-008-8001-z
   Wu ZS, 2010, NANO RES, V3, P16, DOI 10.1007/s12274-010-1003-7
   Xia FN, 2010, NANO LETT, V10, P715, DOI 10.1021/nl9039636
   Xiang HJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035416
   Xiang QJ, 2012, CHEM SOC REV, V41, P782, DOI 10.1039/c1cs15172j
   Xu B, 2010, J APPL PHYS, V108, DOI 10.1063/1.3487959
   Xu PT, 2012, CHINESE SCI BULL, V57, P2948, DOI 10.1007/s11434-012-5121-3
   Xu XJ, 2012, RSC ADV, V2, P7042, DOI 10.1039/c2ra20460f
   Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y
   Xu ZP, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/4/045704
   Xue YZ, 2012, J AM CHEM SOC, V134, P11060, DOI 10.1021/ja302483t
   Yamamoto M, 2012, ACS NANO, V6, P8335, DOI 10.1021/nn303082a
   Yan J, 2010, NANO LETT, V10, P4521, DOI 10.1021/nl102459t
   Yan JA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.086802
   Yan JA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125403
   Yan L, 2012, CHEM SOC REV, V41, P97, DOI 10.1039/c1cs15193b
   Yan QM, 2007, NANO LETT, V7, P1469, DOI 10.1021/nl070133j
   Yang CK, 2010, CARBON, V48, P3901, DOI 10.1016/j.carbon.2010.06.056
   Yang D, 2009, CARBON, V47, P145, DOI 10.1016/j.carbon.2008.09.045
   Yang HF, 2009, CHEM COMMUN, P3880, DOI 10.1039/b905085j
   Yang HF, 2009, J MATER CHEM, V19, P4632, DOI 10.1039/b901421g
   Yang M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3425664
   Yang MM, 2012, J PHYS CHEM C, V116, P844, DOI 10.1021/jp2088143
   Yang Q, 2010, J PHYS CHEM C, V114, P3811, DOI 10.1021/jp910232x
   Yang XY, 2008, J AM CHEM SOC, V130, P4216, DOI 10.1021/ja710234t
   Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k
   Yang Z, 2012, ACS NANO, V6, P205, DOI 10.1021/nn203393d
   Yao PP, 2010, ADV MATER, V22, P5008, DOI 10.1002/adma.201002312
   Yao Z, 2012, CHEM COMMUN, V48, P1027, DOI 10.1039/c2cc16192c
   Yavari F, 2012, J PHYS CHEM LETT, V3, P1746, DOI 10.1021/jz300358t
   Yaya A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.045411
   Yeh TF, 2010, ADV FUNCT MATER, V20, P2255, DOI 10.1002/adfm.201000274
   Yoon Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2769764
   Yoshimura T, 2006, ORG LETT, V8, P2933, DOI 10.1021/ol060781u
   Yu SS, 2010, ACS NANO, V4, P7619, DOI 10.1021/nn102369r
   Yu WJ, 2010, ACS NANO, V4, P5480, DOI 10.1021/nn101581k
   Yu WJ, 2011, NANO LETT, V11, P4759, DOI 10.1021/nl2025739
   Yu ZZ, 2011, J PHYS CHEM C, V115, P10836, DOI 10.1021/jp200870t
   Zajac A, 2000, J SOLID STATE CHEM, V150, P286, DOI 10.1006/jssc.1999.8593
   Zboril R, 2010, SMALL, V6, P2885, DOI 10.1002/smll.201001401
   Zeng QO, 2010, ADV FUNCT MATER, V20, P3366, DOI 10.1002/adfm.201000540
   Zhan D, 2011, CARBON, V49, P1362, DOI 10.1016/j.carbon.2010.12.002
   Zhang CH, 2011, ADV MATER, V23, P1020, DOI 10.1002/adma.201004110
   Zhang H, 2010, ACS NANO, V4, P380, DOI 10.1021/nn901221k
   Zhang HY, 2012, J PHYS CHEM C, V116, P16634, DOI 10.1021/jp304908p
   Zhang HY, 2011, J PHYS CHEM C, V115, P8845, DOI 10.1021/jp201062m
   Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a
   Zhang LL, 2010, LANGMUIR, V26, P17624, DOI 10.1021/la103413s
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang LP, 2011, J PHYS CHEM C, V115, P11170, DOI 10.1021/jp201991j
   Zhang WH, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3276339
   Zhang WJ, 2011, ACS NANO, V5, P7517, DOI 10.1021/nn202463g
   Zhang XY, 2011, CHEM-EUR J, V17, P8957, DOI 10.1002/chem.201100980
   Zhang Y, 2012, J PHYS CHEM C, V116, P9356, DOI 10.1021/jp301691z
   Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105
   Zhang YL, 2010, NANO TODAY, V5, P15, DOI 10.1016/j.nantod.2009.12.009
   Zhang ZX, 2011, J PHYS CHEM LETT, V2, P2897, DOI 10.1021/jz201273r
   Zhao JP, 2010, ACS NANO, V4, P5245, DOI 10.1021/nn1015506
   Zhao LY, 2011, SCIENCE, V333, P999, DOI 10.1126/science.1208759
   Zhao SC, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/35/355703
   Zheng B, 2010, ACS NANO, V4, P4165, DOI 10.1021/nn1002425
   Zhong X, 2010, CHEM COMMUN, V46, P7340, DOI 10.1039/c0cc02389b
   Zhou J, 2009, NANO LETT, V9, P3867, DOI 10.1021/nl9020733
   Zhou J, 2010, CARBON, V48, P1405, DOI 10.1016/j.carbon.2009.12.031
   Zhou J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3225154
   Zhou LJ, 2012, J PHYS CHEM C, V116, P21780, DOI 10.1021/jp304861d
   Zhou M, 2009, CHEM-EUR J, V15, P6116, DOI 10.1002/chem.200900596
   Zhou SY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.086402
   Zhou SY, 2007, NAT MATER, V6, P770, DOI 10.1038/nmat2003
   Zhou Y, 2009, CHEM MATER, V21, P2950, DOI 10.1021/cm9006603
   Zhou Y, 2010, ADV MATER, V22, P67, DOI 10.1002/adma.200901942
   Zhu CZ, 2010, ACS NANO, V4, P2429, DOI 10.1021/nn1002387
   Zhu LY, 2010, NANO LETT, V10, P494, DOI 10.1021/nl903278w
   Zhu Y, 2010, NANO LETT, V10, P4356, DOI 10.1021/nl101695g
   Zhu YW, 2010, ACS NANO, V4, P1227, DOI 10.1021/nn901689k
   Zhu YW, 2010, CARBON, V48, P2118, DOI 10.1016/j.carbon.2010.02.001
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
NR 649
TC 62
Z9 62
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
J9 NANOSCALE
JI Nanoscale
PY 2013
VL 5
IS 11
BP 4541
EP 4583
DI 10.1039/c3nr33218g
PG 43
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 145IL
UT WOS:000319008700001
PM 23443470
ER

PT J
AU Viano, DC
   Casson, IR
   Pellman, EJ
AF Viano, David C.
   Casson, Ira R.
   Pellman, Elliot J.
TI Concussion in professional football: Biomechanics of the struck player -
   Part 14
SO NEUROSURGERY
LA English
DT Article
DE biomechanics; concussion; football; impact tolerances; neck injury;
   sport injury prevention
ID HIGH-SCHOOL; AMERICAN FOOTBALL; GAME IMPACTS; BRAIN-INJURY; RECOVERY;
   PERFORMANCE; HELMETS
AB OBJECTIVE: Impacts Causing concussion in professional football were simulated in laboratory tests to determine collision mechanics. This study focuses on the biomechanics of concussion in the struck player.
   METHODS: Twenty-five helmet impacts were reconstructed using Hybrid III dummies. Head impact velocity, direction, and helmet kinematics-matched game video. Translational and rotational accelerations were measured in both players' heads; 6-axis upper neck responses were measured in all striking and five struck players. Head kinematics and biomechanics were determined for concussed players. Head displacement, rotation, and neck loads were determined because finite element analysis showed maximum strains occurring in the midbrain after the high impact forces. A model was developed of the helmet impact to study the influence of neck strength and other parameters on head responses.
   RESULTS: The impact response of the concussed player's head includes peak accelerations of 94 +/- 28 g and 6432 +/- 1813 r/s(2), and velocity changes of 7.2 +/- 1.8 m/s and 34.8 +/- 15.2 r/s. Near the end of impact (10 ms), head movement is only 20.2 +/- 6.8 mm and 6.9 +/- 2.5 degrees. After impact, there is rapid head displacement involving a fourfold increase to 87.6 +/- 21.2 mm and 29.9 +/- 9.5 degrees with neck tension and bending at 20 ms. Impacts to the front of the helmet, the source of the majority of National Football League concussions, cause rotation primarily around the z axis (superior-inferior axis) because the force is forward of the neck centerline. This twists the head to the right or left an average of 17.6 +/- 12.7 degrees, causing a moment of 17.7 +/- 3.3 Nm and neck tension of 1704 +/- 432 N at 20 ms. The head injury criterion correlates with concussion risk and is proportional to Delta V-4/d(1.5) for half-sine acceleration. Stronger necks reduce head acceleration, AV, and displacement. Even relatively small reductions in AV have a large effect on head injury criterion that may reduce concussion risks because changes in AV change head injury criterion through the 4th power.
   CONCLUSION: This study addresses head responses causing concussion in National Football League players. Although efforts are underway to reduce impact acceleration through helmet padding, further study is needed of head kinematics after impact and their contribution to concussion, including rapid head displacement, z-axis rotation, and neck tension up to the time of maximum strain in the midbrain. Neck strength influences head AV and head injury criterion and may help explain different concussion risks in professional and youth athletes, women, and children.
C1 ProBiomech LLC, Bloomfield Hills, MI 48304 USA.
   Long Isl Jewish Med Ctr, Dept Neurol, New Hyde Pk, NY 11042 USA.
   Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA.
   ProHlth Care Associates LLP, Lake Success, NY USA.
RP Viano, DC (reprint author), ProBiomech LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.
EM dviano@comcast.net
CR Backaitis S. H., 1994, HYBRID, pPT
   Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4
   CHOU CC, 1974, ANAL STUDIES HEAD IN
   Denny-Brown D, 1941, BRAIN, V64, P7
   Field M, 2003, J PEDIATR, V142, P546, DOI 10.1067/mpd.2003.190
   GURDJIAN ES, 1964, J TRAUMA, V171, P309
   GURDJIAN ES, 1975, IMPACT HEAD INJURY M, P181
   Gurdjian E S, 1964, Clin Neurosurg, V12, P112
   Hilker Christopher E, 2002, Stapp Car Crash J, V46, P417
   Hodgson V. R., 1985, UTILITY HEAD INJURY
   Hodgson VR, 1972, 16 STAPP CAR CRASH C
   HODGSON VR, 1980, REDUCING SERIOUS INJ, V7
   Irwin A., 1997, 41 STAPP CAR CRASH C
   Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X
   Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296
   LOVELL MR, 2004, AM J SPORTS MED, V32, P1
   McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817
   McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556
   MERTZ HJ, 2001, STAPP CAR CRASH J, V45
   MERTZ HJ, 1996, HEAD INJURY RISK ASS
   Mertz HJ, 1989, 890756 SAE
   Mertz HJ, 2003, STAPP CAR CRASH J, V47, P155
   Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1
   Myers B.S., 1989
   NEWMAN JA, 1993, BIOMECHANICS HUMAN T, P292
   Newman JA, 1975, 19 STAPP CAR CRASH C
   Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025
   Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D
   Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21
   Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54
   Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C
   Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62
   Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1227/01.NEU.0000083559.68424.3F
   UNTERHARNSCHEID.F, 1970, TEX REP BIOL MED, V28, P447
   Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2
   Viano David C, 2003, Traffic Inj Prev, V4, P214, DOI 10.1080/15389580309877
   Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9
   Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C
   Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   WISMANS J, 1996, 30 STAPP CAR CRASH C
   Zhang L, 2001, RECENT ADV BRAIN INJ
NR 42
TC 62
Z9 62
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-396X
J9 NEUROSURGERY
JI Neurosurgery
PD AUG
PY 2007
VL 61
IS 2
BP 313
EP 327
DI 10.1227/01.NEU.0000279969.02685.D0
PG 15
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 197AN
UT WOS:000248525400022
PM 17762744
ER

PT J
AU Nordmeyer, J
   Khambadkone, S
   Coats, L
   Schievano, S
   Lurz, P
   Parenzan, G
   Taylor, AM
   Lock, JE
   Bonhoeffer, P
AF Nordmeyer, Johannes
   Khambadkone, Sachin
   Coats, Louise
   Schievano, Silvia
   Lurz, Philipp
   Parenzan, Giovanni
   Taylor, Andrew M.
   Lock, James E.
   Bonhoeffer, Philipp
TI Risk stratification, systematic classification, and anticipatory
   management strategies for stent fracture after percutaneous pulmonary
   valve implantation
SO CIRCULATION
LA English
DT Article
DE catheterization; echocardiography; heart defects, congenital; pulmonary
   valve
ID OUTFLOW TRACT OBSTRUCTION; RIGHT-VENTRICLE; ARTERY; IMPACT
AB Background-We analyzed the incidence, risk factors and treatment options for stent fracture after percutaneous pulmonary valve (PPV) implantation (PPVI).
   Methods and Results-After PPVI, 123 patients had chest x-ray in anteroposterior and lateral projection, echocardiography, and clinical evaluation during structured follow-up. Of these 123 patients, 26 (21.1%) developed stent fracture 0 to 843 days after PPVI (stent fracture-free survival at 1 year, 85.1%; at 2 years, 74.5%; and at 3 years, 69.2%). Stent fracture was classified as type I: no loss of stent integrity (n=17); type II: loss of integrity with restenosis on echocardiography (n=8); and type III: separation of fragments or embolization (n=1). In a multivariate Cox regression, we analyzed various factors, of which 3 were associated with a higher risk of stent fracture: implantation into "native" right ventricular outflow tract (P = 0.04), no calcification along the right ventricular outflow tract (judged with fluoroscopy, P = 0.02), recoil of PPV (qualitatively, PPV diameter in frontal or lateral plane with fully inflated balloon > diameter after balloon deflation, P=0.03). Substernal PPV location, high-pressure post-PPVI dilatation of PPV, pre-PPVI right ventricular outflow tract gradients, and other indicators of PPV compression or asymmetry did not pose increased risk. Patients with type I fracture remain under follow-up. Patients with type II fracture had 2nd PPVI or are awaiting such procedure, and 1 patient with type III fracture required surgical explantation.
   Conclusion-Stent fracture after PPVI can be managed effectively by risk stratification, systematic classification, and anticipatory management strategies. Serial x-ray and echocardiography are recommended for surveillance.
C1 Great Ormond St Hosp Sick Children, Cardiothorac Unit, London WC1N 3JH, England.
   UCL, Inst Child Hlth, London WC1E 6BT, England.
   Childrens Hosp, Dept Cardiol, Boston, MA USA.
RP Bonhoeffer, P (reprint author), Great Ormond St Hosp Sick Children, Cardiothorac Unit, Great Ormond St, London WC1N 3JH, England.
EM bonhop@gosh.nhs.uk
RI Taylor, Andrew/C-4311-2008; Lurz, Philipp/B-6558-2009; Schievano,
   Silvia/B-6803-2009
CR Bonhoeffer P, 2000, CIRCULATION, V102, P813
   Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   Cheatham JP, 2001, CATHETER CARDIO INTE, V54, P112, DOI 10.1002/ccd.1249
   Coats L, 2005, EUR J CARDIO-THORAC, V27, P536, DOI 10.1016/j.ejcts.2004.12.053
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Khambadkone S, 2005, CIRCULATION, V112, P1189, DOI 10.1161/CIRCULATIONAHA.104.523266
   Knirsch W, 2003, CATHETER CARDIO INTE, V58, P116, DOI 10.1002/ccd.10379
   Murugan S J, 2005, Heart, V91, P1441, DOI 10.1136/hrt.2005.064808
   OLAUGHLIN MP, 1993, CIRCULATION, V88, P605
   Ovaert C, 1999, J THORAC CARDIOV SUR, V118, P886, DOI 10.1016/S0022-5223(99)70058-9
   Peng LF, 2006, CIRCULATION, V113, P2598, DOI 10.1161/CIRCULATIONAHA.105.607127
   Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026
NR 12
TC 62
Z9 63
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD MAR 20
PY 2007
VL 115
IS 11
BP 1392
EP 1397
DI 10.1161/CIRCULATIONAHA.106.674259
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 147WK
UT WOS:000245034300010
PM 17339542
ER

PT J
AU Dunning, J
   Treasure, T
   Versteegh, M
   Nashef, SAM
AF Dunning, Joel
   Treasure, Tom
   Versteegh, Michael
   Nashef, Samer A. M.
CA EACTS Audit Guidelines Comm
TI Guidelines on the prevention and management of de novo atrial
   fibrillation after cardiac and thoracic surgery
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Review
ID CORONARY-ARTERY-BYPASS; PLACEBO-CONTROLLED TRIAL; OPEN-HEART-SURGERY;
   INTRAVENOUS MAGNESIUM-SULFATE; RANDOMIZED CONTROLLED-TRIALS;
   LENGTH-OF-STAY; GRAFT-SURGERY; SUPRAVENTRICULAR TACHYARRHYTHMIAS;
   DOUBLE-BLIND; MYOCARDIAL REVASCULARIZATION
C1 Papworth Hosp, Cambridge CB3 8RE, England.
   James Cook Univ Hosp, Middlesbrough, Cleveland, England.
   Guys Hosp, London SE1 9RT, England.
   Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands.
RP Nashef, SAM (reprint author), Papworth Hosp, Cambridge CB3 8RE, England.
EM sam.nashef@papworth.nhs.uk
CR Abdulrahman O., 1999, European Heart Journal, V20, P372
   Alex J, 2005, ANN THORAC SURG, V79, P517, DOI 10.1016/j.athoracsur.2004.08.011
   Alghamdi AA, 2005, J CARDIAC SURG, V20, P293, DOI 10.1111/j.1540-8191.2005.200447.x
   Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011
   *AM COLL CARD, 2001, J AM COLL CARDIOL, V38, P1266
   Amar D, 1997, ANN THORAC SURG, V63, P1374
   ANDREWS TC, 1991, CIRCULATION, V84, P236
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Aranki SF, 1996, CIRCULATION, V94, P390
   Auer J, 2004, AM HEART J, V147, P636, DOI 10.1016/j.ahj.2003.10.041
   Bayliff CD, 1999, ANN THORAC SURG, V67, P182, DOI 10.1016/S0003-4975(98)01226-0
   Bernard EO, 2003, CRIT CARE MED, V31, P1031, DOI 10.1097/01.CCM.0000053555.78624.0F
   Bert AA, 2001, J CARDIOTHOR VASC AN, V15, P204, DOI 10.1053/jcan.2001.21959
   BHARUCHA DB, 2000, AM J CARDIOL S1, V85, P20, DOI 10.1016/S0002-9149(00)00903-6
   BORGEAT A, 1991, ANN THORAC SURG, V51, P964
   BORGEAT A, 1989, ANN THORAC SURG, V48, P232
   BRODSKY MA, 1994, AM J CARDIOL, V73, P1227, DOI 10.1016/0002-9149(94)90190-2
   BUTLER J, 1993, BRIT HEART J, V70, P56
   CAMPBELL TJ, 1985, BRIT HEART J, V54, P86
   Chiladakis JA, 2001, INT J CARDIOL, V79, P287, DOI 10.1016/S0167-5273(01)00450-8
   COCHRANE AD, 1994, EUR J CARDIO-THORAC, V8, P194, DOI 10.1016/1010-7940(94)90114-7
   COLQUHOUN IW, 1993, EUR J CARDIO-THORAC, V7, P520, DOI 10.1016/1010-7940(93)90049-H
   CONNOLLY SJ, 1987, J AM COLL CARDIOL, V10, P1145
   COOK RJ, 1995, PLANT PHYSIOL, V108, P4
   Creswell LL, 2001, J THORAC CARDIOV SUR, V121, P638, DOI 10.1067/mtc.2001.114347
   CRESWELL LL, 1993, ANN THORAC SURG, V56, P539
   Crombie I. K., 1996, POCKET GUIDE CRITICA
   CRYSTAL E, 2004, COCHRANE DB SYST REV, P4
   Crystal E, 2002, CIRCULATION, V106, P75, DOI 10.1161/01.CIR.0000021113.44111.3E
   Daoud EG, 2004, CARDIOL CLIN, V22, P159, DOI 10.1016/S0733-8651(03)00136-X
   Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501
   Davis Zev, 2003, Card Electrophysiol Rev, V7, P185, DOI 10.1023/A:1027480020448
   DIBIASI P, 1995, EUR J CARDIO-THORAC, V9, P587, DOI 10.1016/S1010-7940(05)80011-9
   DUNNING J, 2004, INTERACTIVE CARDIOVA, P46
   DUNNING J, 2004, INTERACTIVE CARDIOVA, P503
   DUNNING J, 2003, INTERACTIVE CARDIOVA, P405
   DUNNING J, 2004, INTERACTIVE CARDIOVA, P510
   Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7
   Farsak B, 2002, EUR J CARDIO-THORAC, V22, P278, DOI 10.1016/S1010-7940(02)00259-2
   Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221
   Forlani S, 2002, ANN THORAC SURG, V74, P720, DOI 10.1016/S0003-4975(02)03773-6
   Frick M, 1999, AM J CARDIOL, V84, P104, DOI 10.1016/S0002-9149(99)00204-0
   Frost L, 1997, INT J CARDIOL, V58, P135, DOI 10.1016/S0167-5273(96)02856-2
   GAVAGHAN TP, 1985, AUST NZ J MED, V15, P27, DOI 10.1111/j.1445-5994.1985.tb02726.x
   Geelen P, 1999, AM J CARDIOL, V84, P345, DOI 10.1016/S0002-9149(99)00292-1
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Giri S, 2001, LANCET, V357, P830, DOI 10.1016/S0140-6736(00)04196-9
   GLIKSON M, 1995, ANN INTERN MED, V123, P443
   Groh MA, 1999, ANN THORAC SURG, V68, P1506, DOI 10.1016/S0003-4975(99)00949-2
   GULLESTAD L, 1993, CLIN CARDIOL, V16, P429
   Hart RG, 1999, ANN INTERN MED, V131, P492
   HAYS JV, 1994, ANN EMERG MED, V24, P61, DOI 10.1016/S0196-0644(94)70163-6
   Hazelrigg SR, 2004, ANN THORAC SURG, V77, P824, DOI 10.1016/j.athoracsur.2003.08.027
   Hill LL, 2002, J CARDIOTHOR VASC AN, V16, P626, DOI 10.1053/jcan.2002.126931
   Hilleman DE, 2003, CURR MED RES OPIN, V19, P376, DOI 10.1185/030079903125001929
   HJELMS E, 1992, SCAND J THORAC CARD, V26, P193, DOI 10.3109/14017439209099077
   Hogue CW, 2000, ANN THORAC SURG, V69, P300, DOI 10.1016/S0003-4975(99)01267-9
   HOHNLOSER SH, 1991, AM HEART J, V121, P89, DOI 10.1016/0002-8703(91)90960-P
   Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913
   Jacquet L, 1994, J Cardiothorac Vasc Anesth, V8, P431, DOI 10.1016/1053-0770(94)90283-6
   Jakobsen CJ, 1997, J CARDIOTHOR VASC AN, V11, P746, DOI 10.1016/S1053-0770(97)90169-5
   JANSSEN J, 1986, ANGIOLOGY, V37, P601, DOI 10.1177/000331978603700807
   Jayam VKS, 2002, CARDIOVASC SURG, V10, P351, DOI 10.1016/S0967-2109(02)00023-6
   Jideus L, 2001, SCAND CARDIOVASC J, V35, P238
   Kalus JS, 2003, AM J HEALTH-SYST PH, V60, P2308
   Kaplan M, 2003, J THORAC CARDIOV SUR, V125, P344, DOI 10.1067/mtc.2003.108
   Karthik S, 2004, ANN THORAC SURG, V77, P1245, DOI 10.1016/j.athoracsur.2003.09.054
   Kerstein J, 2004, CHEST, V126, P716, DOI 10.1378/chest.126.3.716
   Kilger E, 2001, INTENS CARE MED, V27, P534, DOI 10.1007/s001340000788
   KING KB, 1992, AM J CARDIOL, V69, P179, DOI 10.1016/0002-9149(92)91301-J
   KOWEY PR, 1992, AM J CARDIOL, V69, P963, DOI 10.1016/0002-9149(92)90802-6
   Larbuisson R, 1996, J CARDIOTHOR VASC AN, V10, P229, DOI 10.1016/S1053-0770(96)80243-6
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Lee John K, 2003, Card Electrophysiol Rev, V7, P178, DOI 10.1023/A:1027428003609
   Lee JK, 2000, AM HEART J, V140, P871, DOI 10.1067/mhj.2000.111104
   Maisel WH, 2001, ANN INTERN MED, V135, P1061
   MALOUF JF, 1993, EUR HEART J, V14, P1451
   Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300
   MCALISTER HF, 1990, J THORAC CARDIOV SUR, V99, P911
   Melo J, 2004, J THORAC CARDIOV SUR, V127, P511, DOI 10.1016/S0022-5223(03)01283-2
   Miller S, 2005, HEART, V91, P618, DOI 10.1136/hrt.2004.033811
   Mooe T, 1996, CORONARY ARTERY DIS, V7, P475, DOI 10.1097/00019501-199606000-00011
   Mooss AN, 2000, AM HEART J, V140, P176, DOI 10.1067/mhj.2000.106917
   MORAN JL, 1995, CRIT CARE MED, V23, P1816, DOI 10.1097/00003246-199511000-00005
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   NAGARAJAN DV, 2004, INTERACTIVE CARDIOVA, P386
   *NAT COLL CTR CHRO, 2006, MAN ATR FIBR
   NYSTROM U, 1993, THORAC CARDIOV SURG, V41, P34, DOI 10.1055/s-2007-1013817
   Oka T, 2001, ANESTH ANALG, V93, P253, DOI 10.1097/00000539-200108000-00003
   Olshansky B, 1996, Am J Cardiol, V78, P27, DOI 10.1016/S0002-9149(96)00563-2
   OMORPHOS S, 2004, INTERACTIVE CARDIOVA, P641
   ORSZULAK TA, 1995, EUR J CARDIO-THORAC, V9, P615, DOI 10.1016/S1010-7940(05)80106-X
   Parikka H, 1998, J CARDIOVASC PHARM, V31, P67, DOI 10.1097/00005344-199801000-00010
   Patel Anish, 2005, Interact Cardiovasc Thorac Surg, V4, P147, DOI 10.1510/icvts.2004.102152
   Patel Anish, 2005, Interact Cardiovasc Thorac Surg, V4, P193, DOI 10.1510/icvts.2005.106419
   PIRES LA, 1995, AM HEART J, V129, P799, DOI 10.1016/0002-8703(95)90332-1
   PRYSTOWSKY EN, 2000, AM J CARDIOL S1, V85, P3, DOI 10.1016/S0002-9149(00)00908-5
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   RAJA SG, 2004, INTERACTIVE CARDIOVA, P647
   Reiffel JA, 2000, AM J CARDIOL, V85, p12D
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Ronald Andrew, 2005, Interact Cardiovasc Thorac Surg, V4, P33, DOI 10.1510/icvts.2004.097121
   Rostron Anthony, 2005, Interact Cardiovasc Thorac Surg, V4, P52, DOI 10.1510/icvts.2004.100339
   SALERNO DM, 1989, AM J CARDIOL, V63, P1046, DOI 10.1016/0002-9149(89)90076-3
   Sanjuan R, 2004, ANN THORAC SURG, V77, P838, DOI 10.1016/j.athoracsur.2003.06.014
   Seguin P, 2004, CRIT CARE MED, V32, P722, DOI 10.1097/01.CCM.0000114579.56430.E0
   Shiga T, 2004, AM J MED, V117, P325, DOI 10.1016/j.amjmed.2004.03.030
   SHRIVASTAVA V, 2004, INTERACTIVE CARDIOVA, P656
   SOUCIER R, 2003, MED SCI MONITOR, V9, pI19
   Stamou SC, 2001, STROKE, V32, P1508
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   SUTTORP MJ, 1990, J THORAC CARDIOV SUR, V100, P921
   SUTTORP MJ, 1991, AM J CARDIOL, V68, P1163, DOI 10.1016/0002-9149(91)90188-Q
   Terzi A, 1996, THORAC CARDIOV SURG, V44, P300, DOI 10.1055/s-2007-1012041
   Thompson AE, 2002, J CLIN PHARM THER, V27, P21, DOI 10.1046/j.1365-2710.2002.00383.x
   Tisdale JE, 1998, AM HEART J, V135, P739, DOI 10.1016/S0002-8703(98)70031-6
   Toraman F, 2001, ANN THORAC SURG, V72, P1256, DOI 10.1016/S0003-4975(01)02898-3
   van der Heijden GJMG, 2004, EUR J CARDIO-THORAC, V26, P81, DOI 10.1016/j.ejcts.2004.03.032
   VanderLugt JT, 1999, CIRCULATION, V100, P369
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   VANMIEGHEM W, 1994, CHEST, V105, P1642, DOI 10.1378/chest.105.6.1642
   VanMieghem W, 1996, ANN THORAC SURG, V61, P1083, DOI 10.1016/0003-4975(96)00073-2
   Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023
   WAFA SS, 1989, AM J CARDIOL, V63, P1058, DOI 10.1016/0002-9149(89)90078-7
   WISTBACKA JOM, 1995, J CARDIOTHOR VASC AN, V9, P140, DOI 10.1016/S1053-0770(05)80184-3
   Wurdeman RL, 2002, CHEST, V121, P1203, DOI 10.1378/chest.121.4.1203
   Yeatman M, 2002, ANN THORAC SURG, V73, P112, DOI 10.1016/S0003-4975(01)03270-2
   Zaman AG, 2000, CIRCULATION, V101, P1403
   Zimmer J, 2003, AM J CARDIOL, V91, P1137, DOI 10.1016/S0002-9149(03)00168-1
NR 130
TC 62
Z9 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD DEC
PY 2006
VL 30
IS 6
BP 852
EP 872
DI 10.1016/j.ejcts.2006.09.003
PG 21
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 117WU
UT WOS:000242904800008
PM 17070065
ER

PT J
AU Mangi, AA
   Christison-Lagay, ER
   Torchiana, DF
   Warshaw, AL
   Berger, DL
AF Mangi, AA
   Christison-Lagay, ER
   Torchiana, DF
   Warshaw, AL
   Berger, DL
TI Gastrointestinal complications in patients undergoing heart operation -
   An analysis of 8709 consecutive cardiac surgical patients
SO ANNALS OF SURGERY
LA English
DT Article; Proceedings Paper
CT 116th Annual Meeting of the Southern-Surgical-Association
CY DEC 05-08, 2004
CL Palm Beach, FL
SP SE Surg Assoc
ID CARDIOPULMONARY BYPASS-SURGERY; INTRAABDOMINAL COMPLICATIONS;
   BLOOD-FLOW; OFF-PUMP; ABDOMINAL COMPLICATIONS; MUCOSAL PH; OUTCOMES;
   INJURY
AB Introduction: Gastrointestinal (GI) complications following heart operation may be life-threatening. Systematic analysis of risk factors to allow early identification of patients at risk for GI complication may lead to the development of strategies to mitigate this complication as well as to optimize management after its occurrence.
   Methods: Of 8709 consecutive patients undergoing heart operation during 7 years (1997-2003), 46 (0.53%) developed GI complications requiring surgical consultation. Preoperative, intraoperative, and postoperative predictors of complication and death were identified and compared with a control group.
   Results: Significant (P < 0.05) preoperative predictors of complication were prior cerebrovascular accident (CVA), chronic obstructive pulmonary disease (COPD), type II heparin-induced thrombocytopenia, atrial fibrillation, prior myocardial infarction, renal insufficiency, hypertension, and need for intra-aortic balloon counter-pulsation. The most frequent serious GI complication was mesenteric ischemia, which developed in 31 (67%) patients. Twenty-two (71%) of these patients were explored, and 14 (64%) died within 2 days of heart operation. Of the 9 patients with mesenteric ischemia who were not explored, 7 (78%) died within 3 days of heart operation. Other complications included diverticulitis (5), pancreatitis (4), peptic ulcer disease (4), and cholecystitis (2). The mortality rate in this group of other diagnoses was lower (40%), and death occurred later (32 days) after heart operation (P = 0.03 compared with mesenteric ischemia). Predictors of death from GI complication included New York Heart Association (NYHA) class III and IV heart failure, smoking, chronic obstructive pulmonary disease, history of syncope, aspartate aminotransferase (AST) > 600U/L, direct bilirubin > 2.4mg/dL, pH < 7.30, and the need for > 2 pressors.
   Conclusions: The most common catastrophic GI complication after cardiac surgery is mesenteric ischemia, which is frequently fatal. This complication may be a result of atheroembolization, heparin-induced thrombocytopenia, or hypoperfusion. Techniques to reduce the occurrence of and/or preemptively diagnosis postcardio to my mesenteric ischemia are necessary to decrease its associated mortality.
C1 Harvard Univ, Div Gen Surg, Dept Surg, Massachusetts Gen Hosp,Sch Med, Boston, MA 02114 USA.
   Harvard Univ, Div Gastrointestinal Surg, Dept Surg, Massachusetts Gen Hosp,Sch Med, Boston, MA 02114 USA.
   Harvard Univ, Div Cardiac Surg, Dept Surg, Massachusetts Gen Hosp,Sch Med, Boston, MA 02114 USA.
RP Berger, DL (reprint author), Harvard Univ, Div Gen Surg, Dept Surg, Massachusetts Gen Hosp,Sch Med, 15 Parkman St,WAC465, Boston, MA 02114 USA.
EM dberger@partners.org
CR Andersson B, 2005, BRIT J SURG, V92, P326, DOI 10.1002/bjs.4823
   Antoniou T, 2002, HEART SURG FORUM, V5, P354
   BRODMAN R, 1981, ANN THORAC SURG, V31, P370
   CHRISTENSON JT, 1994, J THORAC CARDIOV SUR, V108, P899
   CLAVIEN PA, 1987, BRIT J SURG, V74, P500, DOI 10.1002/bjs.1800740628
   Dewey TM, 2004, ANN THORAC SURG, V77, P1542, DOI 10.1016/j.athoracsur.2003.09.047
   Doguet F, 2004, ANN THORAC SURG, V77, P2130, DOI 10.1016/j.arthoracsur.2003.10.034
   FIDDIANGREEN RG, 1987, CRIT CARE MED, V15, P153, DOI 10.1097/00003246-198702000-00015
   Flynn M, 2004, EUR J CARDIO-THORAC, V25, P116, DOI 10.1016/S1010-7940(03)00608-0
   HANKS JB, 1982, SURGERY, V92, P394
   HUDDY SPJ, 1991, BRIT J SURG, V78, P293, DOI 10.1002/bjs.1800780309
   JOHNSTON G, 1992, AM J SURG, V163, P529
   KRASNA MJ, 1988, SURGERY, V104, P773
   LAWTHORNE TW, 1976, AM J SURG, V126, P254
   LEITMAN IM, 1987, SURG GYNECOL OBSTET, V165, P251
   LISBON A, 2003, CHEST, V123, P460
   Meier-Hellmann A, 1999, CRIT CARE MED, V27, P2166, DOI 10.1097/00003246-199910000-00015
   MERCADO PD, 1994, AM SURGEON, V60, P789
   MONETA GL, 1985, AM J SURG, V149, P648, DOI 10.1016/S0002-9610(85)80148-3
   Musleh GS, 2003, EUR J CARDIO-THORAC, V23, P170, DOI 10.1016/S1010-7940(02)00762-5
   OHRI SK, 1994, ANN THORAC SURG, V57, P1193
   OHRI SK, 1991, ANN THORAC SURG, V52, P826
   OTT MJ, 1995, ANN THORAC SURG, V59, P1210, DOI 10.1016/0003-4975(95)00133-6
   Perugini RA, 1997, ARCH SURG-CHICAGO, V132, P352
   PISON CW, 1983, AM J SURG, V146, P133
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Recht MH, 2004, J AM COLL SURGEONS, V198, P742, DOI 10.1016/j.jamcollsurg.2004.01.007
   Sack FU, 2002, BRIT J ANAESTH, V88, P841, DOI 10.1093/bja/88.6.841
   Sakorafas GH, 1999, EUR J SURG, V165, P820
   Sanisoglu I, 2004, ANN THORAC SURG, V77, P619, DOI 10.1016/j.athoracsur.2003.08.006
   TAO WK, 1995, J THORAC CARDIOV SUR, V110, P819, DOI 10.1016/S0022-5223(95)70116-8
   TEMMESFELDWOLLBRUC, 1998, AM J RESP CRIT CARE, V157, P1586
   TSIOTOS GG, 1994, AM J SURG, V167, P553, DOI 10.1016/0002-9610(94)90096-5
   WALLWORK J, 1980, BRIT J SURG, V67, P410, DOI 10.1002/bjs.1800670609
   WELLING RE, 1986, ARCH SURG-CHICAGO, V121, P1178
   Winter DC, 1999, J SURG RES, V83, P62, DOI 10.1006/jsre.1998.5561
   Yilmaz AT, 1996, EUR J CARDIO-THORAC, V10, P763, DOI 10.1016/S1010-7940(96)80337-X
NR 37
TC 62
Z9 67
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-4932
J9 ANN SURG
JI Ann. Surg.
PD JUN
PY 2005
VL 241
IS 6
BP 895
EP 901
DI 10.1097/01.sla.0000164173.05762.32
PG 7
WC Surgery
SC Surgery
GA 929MD
UT WOS:000229349300013
PM 15912039
ER

PT J
AU Geva, T
AF Geva, Tal
TI Repaired tetralogy of Fallot: the roles of cardiovascular magnetic
   resonance in evaluating pathophysiology and for pulmonary valve
   replacement decision support
SO JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
LA English
DT Review
ID VENTRICULAR OUTFLOW TRACT; CONGENITAL HEART-DISEASE; ATRIAL
   SEPTAL-DEFECT; SUDDEN CARDIAC DEATH; SYSTOLIC FUNCTION IMPROVEMENT; LATE
   GADOLINIUM ENHANCEMENT; LONG-TERM; DIASTOLIC FUNCTION; AORTIC
   REGURGITATION; FOLLOW-UP
AB Surgical management of tetralogy of Fallot (TOF) results in anatomic and functional abnormalities in the majority of patients. Although right ventricular volume load due to severe pulmonary regurgitation can be tolerated for many years, there is now evidence that the compensatory mechanisms of the right ventricular myocardium ultimately fail and that if the volume load is not eliminated or reduced by pulmonary valve replacement the dysfunction might be irreversible. Cardiovascular magnetic resonance (CMR) has evolved during the last 2 decades as the reference standard imaging modality to assess the anatomic and functional sequelae in patients with repaired TOF. This article reviews the pathophysiology of chronic right ventricular volume load after TOF repair and the risks and benefits of pulmonary valve replacement. The CMR techniques used to comprehensively evaluate the patient with repaired TOF are reviewed and the role of CMR in supporting clinical decisions regarding pulmonary valve replacement is discussed.
C1 Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp Boston,Dept Cardiol, Boston, MA 02115 USA.
RP Geva, T (reprint author), Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp Boston,Dept Cardiol, Boston, MA 02115 USA.
EM tal.geva@cardio.chboston.org
FU National Institutes of Health [NIH/NHLBI 1 R01 HL089269-01A2]; Higgins
   Family Noninvasive Cardiac Imaging Research Fund
FX This work was supported in part by the National Institutes of Health
   (NIH/NHLBI 1 R01 HL089269-01A2) and by the Higgins Family Noninvasive
   Cardiac Imaging Research Fund.
CR Abd El Rahman MY, 2005, J AM COLL CARDIOL, V45, P915, DOI 10.1016/j.jacc.2004.11.049
   Abd El Rahman MY, 2000, HEART, V84, P416
   ADAMS CW, 1966, DIS CHEST, V50, P641
   Alexiou C, 2001, ANN THORAC SURG, V71, P494, DOI 10.1016/S0003-4975(00)02444-9
   Alfakih K, 2003, J MAGN RESON IMAGING, V17, P323, DOI 10.1002/jmri.10262
   Alfakih K, 2002, J MAGN RESON IMAGING, V16, P253, DOI 10.1002/jmri.10164
   Alfakih K, 2003, J MAGN RESON IMAGING, V18, P25, DOI 10.1002/jmri.10329
   Ammash Naser M, 2007, Congenit Heart Dis, V2, P386, DOI 10.1111/j.1747-0803.2007.00131.x
   Babu-Narayan SV, 2006, CIRCULATION, V113, P405, DOI 10.1161/CIRCULATIONAHA.105.548727
   Babu-Narayan SV, 2003, CURR TREAT OPTION CA, V5, P389, DOI 10.1007/s11936-003-0045-5
   Babu-Narayan SV, 2005, CIRCULATION, V111, P2091, DOI 10.1161/01.CIR.0000162463.61626.3B
   Bacha EA, 2001, J THORAC CARDIOV SUR, V122, P154, DOI 10.1067/mtc.2001.115156
   Bekeredjian R, 2005, CIRCULATION, V112, P125, DOI 10.1161/CIRCULATIONAHA.104.488825
   Berul CI, 1997, J CARDIOVASC ELECTR, V8, P1349, DOI 10.1111/j.1540-8167.1997.tb01031.x
   Beygui F, 2004, INT J CARDIOVAS IMAG, V20, P509, DOI 10.1007/s10554-004-1097-7
   BLALOCK A, 1945, JAMA-J AM MED ASSOC, V128, P189
   Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3
   Borer JS, 2002, CIRCULATION, V105, P1837, DOI 10.1161/01.CIR.0000014419.71706.85
   BOVE EL, 1985, J THORAC CARDIOV SUR, V90, P50
   BRICKER JT, 1995, CIRCULATION, V92, P158
   Buechel ERV, 2005, EUR HEART J, V26, P2721, DOI 10.1093/eurheartj/ehi581
   Buechel EV, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-19
   Caldarone CA, 2000, J THORAC CARDIOV SUR, V120, P1022, DOI 10.1067/mtc.2000.110684
   Carr JC, 2001, RADIOLOGY, V219, P828
   Celik S, 2004, JPN HEART J, V45, P265, DOI 10.1536/jhj.45.265
   Chaliki HP, 2002, CIRCULATION, V106, P2687, DOI 10.1161/01.CIR.0000038498.59829.38
   Cheung EWY, 2010, AM J CARDIOL, V106, P552, DOI 10.1016/j.amjcard.2010.03.065
   Choe YH, 2001, KOREAN J RADIOL, V2, P121
   CLOAN SD, 2010, HEMODYNAMIC MEASUREM, P63
   DARSEE JR, 1981, CIRC RES, V49, P1017
   Dave HH, 2005, ANN THORAC SURG, V80, P1615, DOI 10.1016/j.athoracsur.2005.04.058
   Dave HH, 2005, ANN THORAC SURG, V80, P1620
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   Dell'Italia L J, 1991, Curr Probl Cardiol, V16, P653
   de Roos A, 2000, EUR RADIOL, V10, P2, DOI 10.1007/s003300050002
   Discigil B, 2001, J THORAC CARDIOV SUR, V121, P344, DOI 10.1067/mtc.2001.111209
   Doughan AR, 2005, AM J CARDIOL, V95, P1511, DOI 10.1016/j.amjcard.2005.01.100
   Eroglu AG, 1999, CARDIOL YOUNG, V9, P384
   Eyskens B, 2000, AM J CARDIOL, V85, P221, DOI 10.1016/S0002-9149(99)00640-2
   Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   Gatzoulis MA, 2000, HEART, V84, P409, DOI 10.1136/heart.84.4.409
   GATZOULIS MA, 1995, CIRCULATION, V92, P231
   GATZOULIS MA, 1995, CIRCULATION, V91, P1775
   Gengsakul A, 2007, EUR J CARDIO-THORAC, V32, P462, DOI 10.1016/j.ejcts.2007.06.009
   Geva Tal, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P11
   Geva T, 1998, CIRCULATION, V98, P339
   Geva T, 2010, CIRCULATION, V122, pS201, DOI 10.1161/CIRCULATIONAHA.110.951178
   Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045
   Ghai A, 2002, J AM COLL CARDIOL, V40, P1675, DOI 10.1016/S0735-1097(02)02344-6
   Giardini A, 2005, AM J CARDIOL, V95, P1255, DOI 10.1016/j.amjcard.2005.01.062
   Gottlieb D, 2010, J THORAC CARDIOV SUR, V139, P723, DOI 10.1016/j.jtcvs.2009.11.006
   Graham Thomas P Jr, 2008, Congenit Heart Dis, V3, P162, DOI 10.1111/j.1747-0803.2008.00189.x
   Greenberg SB, 1997, PEDIATR RADIOL, V27, P932, DOI 10.1007/s002470050275
   Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005
   GRUVER EJ, 1994, BASIC RES CARDIOL, V89, P139
   Harrild DM, 2009, CIRCULATION, V119, P445, DOI 10.1161/CIRCULATIONAHA.108.775221
   Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1
   HAUSDORF G, 1990, PEDIATR CARDIOL, V11, P61, DOI 10.1007/BF02239563
   Helbing WA, 2000, PEDIATR CARDIOL, V21, P70, DOI 10.1007/s002469910009
   Helbing WA, 1996, J AM COLL CARDIOL, V28, P1827
   Henkens IR, 2007, ANN THORAC SURG, V83, P907, DOI 10.1016/j.athoracsur.2006.09.090
   Hergan K, 2008, EUR J RADIOL, V65, P270, DOI 10.1016/j.ejrad.2007.03.031
   HORVATH KA, 1992, J AM COLL CARDIOL, V20, P1156
   Hudsmith LE, 2005, J CARDIOVASC MAGN R, V7, P775, DOI 10.1080/10976640500295516
   ILBAWI MN, 1986, ANN THORAC SURG, V41, P478
   Iriart X, 2009, EUR J ECHOCARDIOGR, V10, P784, DOI 10.1093/ejechocard/jep071
   Jategaonkar S, 2009, CIRC-CARDIOVASC INTE, V2, P85, DOI 10.1161/CIRCINTERVENTIONS.108.814046
   Kang IS, 2003, CIRCULATION, V107, P2938, DOI 10.1161/01.CIR.0000077064.67790.5B
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Mavroudis C, 2002, ANN THORAC SURG, V73, P1806
   Karamiltsos TD, 2007, J CARDIOVASC MAGN R, V9, P777, DOI 10.1080/10976640701545073
   KATZ NM, 1982, CIRCULATION, V65, P403
   Khairy P, 2006, CIRCULATION, V113, P517, DOI 10.1161/CIRCULATIONAHA.105.589655
   Khairy P, 2004, CIRCULATION, V109, P1994, DOI 10.1161/01.CIR.0000126495.11040.BD
   Khairy P, 2010, CIRCULATION, V122, P868, DOI 10.1161/CIRCULATIONAHA.109.928481
   Kilner PJ, 2010, EUR HEART J, V31, P794, DOI 10.1093/eurheartj/ehp586
   Kilner PJ, 2009, INT J CARDIOL, V133, P157, DOI 10.1016/j.ijcard.2008.06.078
   Kiriazis Helen, 1992, Heart and Vessels, V7, P175, DOI 10.1007/BF01744602
   KIRKLIN JOHN W., 1965, ANN SURG, V162, P578, DOI 10.1097/00000658-196510000-00004
   Knauth AL, 2008, HEART, V94, P211, DOI 10.1136/hrt.2006.104745
   Kogon B, 2009, J THORAC CARDIOV SUR, V138, P103, DOI 10.1016/j.jtcvs.2009.02.020
   KONDO C, 1995, CIRCULATION, V92, P250
   Kuehne T, 2001, CIRCULATION, V104, P2363, DOI 10.1161/hc4401.098472
   Kuehne T, 2003, CIRCULATION, V108, P2007, DOI 10.1161/01.CIR.0000092887.84425.09
   Kugler JD, 1998, J CARDIOVASC ELECTR, V9, P103, DOI 10.1111/j.1540-8167.1998.tb00873.x
   Kurotobi S, 2005, AM J CARDIOL, V95, P1344, DOI 10.1016/j.amjcard.2005.01.080
   Lee C, 2006, J CARDIOVASC SURG, V47, P65
   LILLEHEI CW, 1955, ANN SURG, V142, P418, DOI 10.1097/00000658-195509000-00010
   LILLEHEI CW, 1955, SURGERY, V38, P11
   Lindsey CW, 2010, ANN THORAC SURG, V89, P147, DOI 10.1016/j.athoracsur.2009.07.039
   Lurz P, 2010, AM J CARDIOL, V105, P721, DOI 10.1016/j.amjcard.2009.10.054
   Lytrivi ID, 2004, AM J CARDIOL, V94, P970, DOI 10.1016/j.amjcard.2004.06.045
   McElhinney DB, 2010, CIRCULATION, V122, P507, DOI 10.1161/CIRCULATIONAHA.109.921692
   Meijboom FJ, 2008, J THORAC CARDIOV SUR, V135, P50, DOI 10.1016/j.jtcvs.2007.07.030
   Mooij CF, 2008, J MAGN RESON IMAGING, V28, P67, DOI 10.1002/jmri.21407
   Moroseos T, 2010, AM J CARDIOL, V105, P1603, DOI 10.1016/j.amjcard.2010.01.025
   Mueller M, 2010, EUR J ECHOCARDIOGR, V11, P786, DOI 10.1093/ejechocard/jeq067
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Niezen RA, 1996, RADIOLOGY, V201, P135
   Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5
   Nordmeyer J, 2009, J THORAC CARDIOV SUR, V138, P84, DOI 10.1016/j.jtcvs.2008.08.072
   NORGARD G, 1993, SCAND J THORAC CARD, V27, P41, DOI 10.3109/14017439309099092
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   Ooi A, 2006, EUR J CARDIO-THORAC, V30, P917, DOI 10.1016/j.ejcts.2006.08.022
   Oosterhof T, 2006, EUR HEART J, V27, P1478, DOI 10.1093/eurheartj/ehl033
   Oosterhof T, 2005, RADIOLOGY, V237, P868, DOI 10.1148/radiol.2373041324
   Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664
   Ortega M, 2009, CIRCULATION, V120, pS575
   Owen AR, 2000, SEMIN THORAC CARDIOV, V3, P216
   Parry AJ, 2000, J AM COLL CARDIOL, V36, P2279, DOI 10.1016/S0735-1097(00)00989-X
   Pascotto M, 2005, AM J CARDIOL, V96, P439, DOI 10.1016/j.amjcard.2005.03.096
   Pigula FA, 1999, CIRCULATION, V100, P157
   Prakash A, 2010, CIRC-CARDIOVASC IMAG, V3, P112, DOI 10.1161/CIRCIMAGING.109.875021
   Raman SV, 2005, AM J CARDIOL, V95, P683, DOI 10.1016/j.amjcard.2004.11.014
   REBERGEN SA, 1993, CIRCULATION, V88, P2257
   Redington Andrew N., 1993, Current Opinion in Pediatrics, V5, P619, DOI 10.1097/00008480-199310000-00017
   Renella P, 2010, J AM SOC ECHOCARDIOG, V23, P880, DOI 10.1016/j.echo.2010.05.019
   Roos-Hesselink JW, 2003, EUR HEART J, V24, P190, DOI 10.1016/S0195-668X(03)00383-4
   Salehian O, 2005, J AM COLL CARDIOL, V45, P499, DOI 10.1016/j.jacc.2004.10.052
   Samyn MM, 2007, J MAGN RESON IMAGING, V26, P934, DOI 10.1002/jmri.21094
   SanchezQuintana D, 1996, HEART, V76, P280, DOI 10.1136/hrt.76.3.280
   SANDOR GGS, 1987, AM J CARDIOL, V60, P1148, DOI 10.1016/0002-9149(87)90408-5
   Saul JP, 1999, J CARDIOVASC ELECTR, V10, P1271, DOI 10.1111/j.1540-8167.1999.tb00305.x
   Sheehan FH, 2010, AM J CARDIOL, V105, P993, DOI 10.1016/j.amjcard.2009.11.032
   SHIMAZAKI Y, 1984, THORAC CARDIOV SURG, V32, P257, DOI 10.1055/s-2007-1023399
   Silka MJ, 1998, J AM COLL CARDIOL, V32, P245, DOI 10.1016/S0735-1097(98)00187-9
   SIWEK LG, 1985, J THORAC CARDIOV SUR, V90, P404
   Sparrow Patrick, 2006, AJR Am J Roentgenol, V187, pW630, DOI 10.2214/AJR.05.1264
   Strugnell WE, 2005, J CARDIOV MAGN RESON, V7, P769, DOI 10.1080/10976640500295433
   Tang D., 2010, PROG PEDIATR CARDIOL, V30, P51, DOI 10.1016/j.ppedcard.2010.09.007
   Tang DL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913339
   Therrien J, 2001, CIRCULATION, V103, P2489
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Tornos MP, 1998, AM HEART J, V136, P681, DOI 10.1016/S0002-8703(98)70016-X
   Tverskaya MS, 2004, B EXP BIOL MED+, V138, P616, DOI 10.1007/s10517-005-0140-6
   Tzemos N, 2009, AM J CARDIOL, V103, P420, DOI 10.1016/j.amjcard.2008.09.101
   van der Hulst AE, 2010, RADIOLOGY, V256, P724, DOI 10.1148/radiol.10092269
   van der Wall EE, 2005, EUR HEART J, V26, P2614, DOI 10.1093/eurheartj/ehi613
   van Straten A, 2005, J AM COLL CARDIOL, V46, P1559, DOI 10.1016/j.jacc.2005.07.030
   van Straten A, 2005, EUR RADIOL, V15, P702, DOI 10.1007/s00330-004-2574-z
   van Straten A, 2003, J AM COLL CARDIOL, V41, p487A
   Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8
   Wald RM, 2009, CIRCULATION, V119, P1370, DOI 10.1161/CIRCULATIONAHA.108.816546
   Wald RM, 2009, EUR HEART J, V30, P356, DOI 10.1093/eurheartj/ehn595
   Wald RM, 2009, CONGENIT HEART DIS, V4, P231, DOI 10.1111/j.1747-0803.2009.00311.x
   Walker RE, 2004, AM J CARDIOL, V93, P1374, DOI 10.1016/j.amjcard.2004.02.033
   Warner KG, 2003, ANN THORAC SURG, V76, P1066, DOI 10.1016/S0003-4975(03)00748-3
   Warner KG, 2003, ANN THORAC SURG, V76, P1071
   Yemets IM, 1997, ANN THORAC SURG, V64, P526, DOI 10.1016/S0003-4975(97)00577-8
NR 151
TC 61
Z9 64
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1097-6647
J9 J CARDIOVASC MAGN R
JI J. Cardiov. Magn. Reson.
PD JAN 20
PY 2011
VL 13
AR 9
DI 10.1186/1532-429X-13-9
PG 24
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 718QY
UT WOS:000287142200001
PM 21251297
ER

PT J
AU Unno, N
   Inuzuka, K
   Suzuki, M
   Yamamoto, N
   Sagara, D
   Nishiyama, M
   Konno, H
AF Unno, Naoki
   Inuzuka, Kazunori
   Suzuki, Minoru
   Yamamoto, Naoto
   Sagara, Daisuke
   Nishiyama, Motohiro
   Konno, Hiroyuki
TI Preliminary experience with a novel fluorescence lymphography using
   indocyanine green in patients with secondary lymphedema
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID NONINVASIVE EVALUATION; LYMPHOSCINTIGRAPHY; MANAGEMENT
AB Background: Lymphoscintigraphy has largely been performed to diagnose lymphedema. It is, however a time-consuming and expensive technique, which has not been covered by Japanese medical insurance since the year 2002. In this report we introduce a new imaging technique of fluorescent lymphography to diagnose lymphedema.
   Methods. Fluorescence images of subcutaneous lymphatic drainage after subcutaneous injection of indocyanine green (ICG) at the foot were obtained using a newly developed near-infrared camera system. ICG fluorescent lymphography was performed in 12 patient; with secondary lymphedema and 10 healthy volunteers. The 12 patients were diagnosed with secondary lymphedema according to the medical history and lymphoscintigram, of which 11 had a history of hysterectomy with extended. lymph node dissection and local radiation therapy for uterine cancer. Lymphedema developed in one patient after femorotibial artery bypass for peripheral artery occlusive disease.
   Results. Four abnormal fluorescent patterns of the lymph drainage were observed in lymphedema: dermal backflow (an abnormal filling of the lymph capillaries), extended fluorescent signal at the dorsum and plantar region of the foot, dilated lymph channels with proximal obliteration, and diffuse glittering of fluorescent signals with scattered twinkling of the dye. Continuous lymph channels from the injection site of the foot to the groin were observed along the medial aspect of thigh in healthy subjects.
   Conclusion: ICG fluorescence lymphography is safe, simple, and minimally invasive. The device is portable and easy to use. The technique may be useful in clinical practice to identify presence of lymphatic disorder.
C1 Hamamatsu Univ Sch Med, Dept Surg 2, Div Vasc Surg, Hamamatsu, Shizuoka 4313192, Japan.
   Hamamatsu Univ Sch Med, Dept Surg, Hamamatsu, Shizuoka 4313192, Japan.
RP Unno, N (reprint author), Hamamatsu Univ Sch Med, Dept Surg 2, Div Vasc Surg, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
EM unno@hama-med.ac.jp
CR Astrom KGO, 2001, ACTA RADIOL, V42, P409, DOI 10.1080/028418501127346909
   Becker C, 2006, ANN SURG, V243, P313, DOI 10.1097/01.sla.0000201258.10304.16
   BENSON RC, 1978, PHYS MED BIOL, V23, P159, DOI 10.1088/0031-9155/23/1/017
   BOLLINGER A, 1981, CIRCULATION, V64, P1195
   BROWSE NL, 1985, J CARDIOVASC SURG, V26, P91
   CAMBRIA RA, 1993, J VASC SURG, V18, P773
   Dimakakos PB, 1997, INT SURG, V82, P411
   GLOVICZKI P, 1989, J VASC SURG, V9, P683, DOI 10.1067/mva.1989.vs0090683
   Holm C, 2002, BRIT J PLAST SURG, V55, P635, DOI 10.1054/bjps.2002.3969
   JAGER K, 1983, INT ANGIOL, V2, P129
   KINMONTH JB, 1957, BRIT J SURG, V189, P1
   KINMONTH JB, 1952, CLIN SCI, V11, P13
   Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211
   KLEINHANS E, 1985, EUR J NUCL MED, V10, P349
   Lee BB, 2005, LYMPHOLOGY, V38, P122
   Mellor RH, 2000, J VASC RES, V37, P501, DOI 10.1159/000054083
   Monnin-Delhom ED, 2002, LYMPHOLOGY, V35, P121
   MOTOMURA K, 1999, JPN J CLIN ONCOL, V15, P2345
   OBRIEN BM, 1990, PLAST RECONSTR SURG, V85, P562, DOI 10.1097/00006534-199004000-00011
   Still JM, 2001, BURNS, V27, P364, DOI 10.1016/S0305-4179(00)00140-6
   Taggart DP, 2003, ANN THORAC SURG, V75, P870, DOI 10.1016/S0003-4975(02)04669-6
   Tiwari A, 2006, EUR J VASC ENDOVASC, V31, P311, DOI 10.1016/j.ejvs.2005.09.017
   VAQUEIRO M, 1986, J NUCL MED, V27, P1125
   Williams WH, 2000, CLIN NUCL MED, V25, P451, DOI 10.1097/00003072-200006000-00013
   Witte CL, 1999, INT ANGIOL, V18, P25
NR 25
TC 61
Z9 62
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD MAY
PY 2007
VL 45
IS 5
BP 1016
EP 1021
DI 10.1016/j.jvs.2007.01.023
PG 6
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 163CA
UT WOS:000246135000031
PM 17391894
ER

PT J
AU Chukwuemeka, A
   Weisel, A
   Maganti, M
   Nette, AF
   Wijeysundera, DN
   Beattie, WS
   Borger, MA
AF Chukwuemeka, A
   Weisel, A
   Maganti, M
   Nette, AF
   Wijeysundera, DN
   Beattie, WS
   Borger, MA
TI Renal dysfunction in high-risk patients after on-pump and off-pump
   coronary artery bypass surgery: A propensity score analysis
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID CARDIOPULMONARY BYPASS; MYOCARDIAL REVASCULARIZATION; CARDIAC-SURGERY;
   RESOURCE UTILIZATION; FAILURE; REDUCE; MORBIDITY; MORTALITY;
   STRATIFICATION; MULTIVESSEL
AB Background. Cardiopulmonary bypass may be a causal factor in the development of renal impairment after cardiac surgery. When acute renal failure requiring dialysis occurs after cardiac surgery, it is associated with high mortality. We attempted to determine whether off-pump coronary artery bypass grafting surgery prevents postoperative renal dysfunction in patients at high risk for renal failure.
   Methods. Retrospective analysis identified 2,869 patients who had preexisting renal dysfunction (preoperative creatinine clearance less than 60 mL/min) and who underwent isolated coronary artery bypass grafting between 1995 and 2003. Patients who required preoperative dialysis were excluded. Propensity scores were computed to match off-pump coronary artery bypass surgery patients 3:1 with those who underwent conventional coronary artery bypass grafting surgery, and the independent predictors of postoperative renal dysfunction were determined.
   Results. Two thousand seven hundred eleven patients with preexisting renal dysfunction underwent conventional coronary artery bypass grafting surgery, and 158 patients underwent coronary artery bypass grafting surgery without cardiopulmonary bypass (off-pump coronary artery bypass grafting surgery group). The matched groups showed no differences in any of the preoperative or postoperative variables examined. Diabetes (odds ratio, 1.96; p = 0.01), peripheral vascular disease (odds ratio, 2.50; p < 0.001), and reduced preoperative creatinine clearance (odds ratio, 1.02; p = 0.02) were independent risk factors for the development of postoperative renal dysfunction. Off-pump coronary artery bypass grafting surgery was not associated with a decreased risk of renal dysfunction by univariate or multivariable analysis.
   Conclusions. Off-pump coronary artery bypass grafting surgery did not reduce the risk of postoperative renal dysfunction in this large, unselected, sequential series of patients at high risk for renal failure after coronary artery bypass grafting surgery. Our results suggest that renal function should not be a deciding factor when determining whether or not a patient undergoes off-pump coronary artery bypass grafting surgery.
C1 Toronto Gen Hosp, Dept Surg, Div Cardiovasc Surg, Toronto, ON M5G 2C4, Canada.
   Toronto Gen Hosp, Dept Anesthesia, Toronto, ON M5G 2C4, Canada.
   Univ Toronto, Toronto, ON, Canada.
RP Borger, MA (reprint author), Toronto Gen Hosp, Dept Surg, Div Cardiovasc Surg, 200 Elizabeth St,4N-451, Toronto, ON M5G 2C4, Canada.
EM michael.borger@uhn.on.ca
RI Beattie, William /A-4352-2008
CR Anderson RJ, 1999, KIDNEY INT, V55, P1057, DOI 10.1046/j.1523-1755.1999.0550031057.x
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Arom KV, 2000, ANN THORAC SURG, V69, P704, DOI 10.1016/S0003-4975(99)01510-6
   Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2003, ANN THORAC SURG, V75, P306, DOI 10.1016/S0003-4975(02)04020-1
   Bucerius J, 2004, ANN THORAC SURG, V77, P1250, DOI 10.1016/S0003-4975(03)01346-8
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Chertow GM, 1997, CIRCULATION, V95, P878
   Chukwuemeka A, 2005, ANN THORAC SURG, V80, P2148, DOI 10.1016/j.athoracsur.2005.06.015
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x
   GAILIUNAS P, 1980, J THORAC CARDIOV SUR, V79, P241
   Gamoso MG, 2000, ANESTH ANALG, V91, P1080, DOI 10.1097/00000539-200011000-00007
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Hall RI, 1997, ANESTH ANALG, V85, P766, DOI 10.1097/00000539-199710000-00011
   HIBERMAN M, 1980, J THORAC CARDIOVASC, V79, P838
   IPYAM PC, 1994, ANESTH ANALG, V78, P842
   Kshettry VR, 2000, ANN THORAC SURG, V69, P1725, DOI 10.1016/S0003-4975(00)01419-3
   Lema G, 1998, Curr Opin Anaesthesiol, V11, P9, DOI 10.1097/00001503-199802000-00003
   MacGillivray TE, 2004, NEW ENGL J MED, V350, P3, DOI 10.1056/NEJMp038185
   Mangano CM, 1998, ANN INTERN MED, V128, P194
   MAZZARELLA V, 1992, J THORAC CARDIOV SUR, V104, P1625
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parsons LS, 2001, P 26 ANN SAS US GROU, P214
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Rao V, 1996, J THORAC CARDIOV SUR, V112, P38, DOI 10.1016/S0022-5223(96)70176-9
   Rose EA, 2003, NEW ENGL J MED, V348, P379, DOI 10.1056/NEJMp020171
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Schwann NM, 2004, ANESTH ANALG, V99, P959, DOI 10.1213/01.ane.0000132978.32215.2c
   SEARGENT P, 2004, EUR J CARDIO-THORAC, V25, P779
   Sirivella S, 2000, ANN THORAC SURG, V69, P501, DOI 10.1016/S0003-4975(99)01298-9
   Suen WS, 1998, ANGIOLOGY, V49, P789, DOI 10.1177/000331979804900902
   van de Wal RMA, 2005, J THORAC CARDIOV SUR, V129, P330, DOI 10.1016/j.jtcvs.2004.06.038
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Vural KM, 1995, THORAC CARDIOV SURG, V43, P320, DOI 10.1055/s-2007-1013803
   Wijeysundera DN, 2003, ANESTH ANALG, V96, P1265, DOI 10.1213/01.ANE.0000056824.69668.33
   Yokoyama T, 2000, ANN THORAC SURG, V70, P1546, DOI 10.1016/S0003-4975(00)01922-6
   Zamvar VY, 2002, HEART SURG FORUM, V5, P109
   ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489
NR 40
TC 61
Z9 62
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD DEC
PY 2005
VL 80
IS 6
BP 2148
EP 2154
DI 10.1016/j.athoracsur.2005.06.015
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 993BD
UT WOS:000233926800027
PM 16305860
ER

PT J
AU Oliver, JM
   Gallego, P
   Gonzalez, A
   Aroca, A
   Bret, M
   Mesa, JM
AF Oliver, JM
   Gallego, P
   Gonzalez, A
   Aroca, A
   Bret, M
   Mesa, JM
TI Risk factors for aortic complications in adults with coarctation of the
   aorta
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID PATCH AORTOPLASTY REPAIR; TERM FOLLOW-UP; ANEURYSM FORMATION;
   SURGICAL-CORRECTION; DILATATION; VALVE; ANGIOPLASTY; PROGRESSION;
   DISSECTION; MANAGEMENT
AB OBJECTIVES We sought to determine the prevalence and predisposing condition for aortic wall complications in adults with either repaired or non-repaired coarctation of the aorta.
   BACKGROUND Aortic wall complications may develop in adults with coarctation of the aorta, despite successful surgical repair in childhood.
   METHODS A total of 235 adults with coarctation (mean age 27 +/- 13 years) were retrospectively reviewed. Treatment had been performed by surgery in 181 patients (group I) or by balloon angioplasty or stenting in 28 patients (group II). No previous intervention had been carried out in 26 patients with mild coarctation at diagnosis (group III).
   RESULTS Forty-four aortic wall complications were found in 37 patients (16%). There were no differences among the three groups with respect to total complications (15%, 18%, and 15%, respectively), ascending aortic aneurysms (9%, 11%, and 12%), or descending aortic aneurysms (4% in all three groups). Multivariate analysis did not show a significant relationship between previous repair, type of repair, age at repair, residual Doppler pressure gradient, or systemic hypertension and the occurrence of aortic complications. Only aging (risk ratio [RR] 1.4 per decade of age, 95% confidence interval [CI] 1.1 to 1.8, p = 0.002) and bicuspid aortic valve (RR 3.2, 95% CI 1.3 to 7.5, p = 0.005) were significantly related to these complications.
   CONCLUSIONS Aortic wall complications are frequent in adults with coarctation of the aorta beyond that attributable to associated hemodynamic derangement or previous repair. The only independent risk factors appear to be advanced age and bicuspid aortic valve. (C) 2004 by the American College of Cardiology Foundation.
C1 Hosp Univ La Paz, Unidad Med Quirurg Cardiol, Adult Congenital Heart Dis Unit, Madrid 28046, Spain.
   Hosp Univ La Paz, Dept Radiol, Madrid 28046, Spain.
   Virgen Macarena Univ Hosp, Seville, Spain.
RP Oliver, JM (reprint author), Hosp Univ La Paz, Unidad Med Quirurg Cardiol, Adult Congenital Heart Dis Unit, Castellana 261, Madrid 28046, Spain.
EM pepeoliver@jet.es
CR AEBERT H, 1993, EUR J CARDIO-THORAC, V7, P200, DOI 10.1016/1010-7940(93)90159-9
   Bauer M, 2002, ANN THORAC SURG, V74, P58, DOI 10.1016/S0003-4975(02)03650-0
   Bonderman D, 1999, CIRCULATION, V99, P2138
   BROMBERG BI, 1989, J AM COLL CARDIOL, V14, P734
   COHEN M, 1989, CIRCULATION, V80, P840
   Daniels SR, 2001, LANCET, V358, P89, DOI 10.1016/S0140-6736(01)05378-8
   DAY CMP, 1986, REV ESP CARDIOL, V39, P68
   DELNIDO PJ, 1986, CIRCULATION, V74, P32
   Dodge-Khatami A, 2000, J CARDIAC SURG, V15, P369
   ERBEL R, 1990, CIRCULATION, V81, P805
   FAVRE JP, 1994, SURGERY, V115, P264
   Fujita T, 1996, ANN THORAC SURG, V62, P1511, DOI 10.1016/0003-4975(96)00483-3
   Galeote G, 2000, REV ESP CARDIOL, V53, P287
   Harrison DA, 2001, HEART, V85, P561, DOI 10.1136/heart.85.5.561
   HEHRLEIN FW, 1986, J THORAC CARDIOV SUR, V92, P226
   Jost CHA, 2002, MAYO CLIN PROC, V77, P646
   Keane MG, 2000, CIRCULATION, V102, P35
   KIRSH MM, 1977, J THORAC CARDIOV SUR, V74, P636
   MENDELSOHN AM, 1992, J AM COLL CARDIOL, V20, P381
   MOODIE DS, 1990, CURR OPIN CARDIOL, V5, P649, DOI 10.1097/00001573-199010000-00014
   Nguyen DM, 1999, ANN THORAC SURG, V68, P1392, DOI 10.1016/S0003-4975(99)00710-9
   Nistri S, 1999, HEART, V82, P19
   PARIKH SR, 1991, J AM COLL CARDIOL, V17, P1367
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   Schmid FX, 2003, EUR J CARDIO-THORAC, V23, P537, DOI 10.1016/S1010-7940(02)00833-3
   SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902
   STEWART AB, 1993, BRIT HEART J, V69, P65
   Therrien J, 2000, J AM COLL CARDIOL, V35, P997, DOI 10.1016/S0735-1097(99)00653-1
   Toro-Salazar OH, 2002, AM J CARDIOL, V89, P541, DOI 10.1016/S0002-9149(01)02293-7
   UNGER EL, 1977, AM J ROENTGENOL, V129, P329
   von Kodolitsch Y, 2002, J AM COLL CARDIOL, V39, P617, DOI 10.1016/S0735-1097(01)01784-3
   Warnes CA, 2003, HEART, V89, P965, DOI 10.1136/heart.89.9.965
NR 32
TC 61
Z9 65
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD OCT 19
PY 2004
VL 44
IS 8
BP 1641
EP 1647
DI 10.1016/j.jacc.2004.07.037
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 863PJ
UT WOS:000224573700015
PM 15489097
ER

PT J
AU Gouleau, D
   Jouanneau, JM
   Weber, O
   Sauriau, PG
AF Gouleau, D
   Jouanneau, JM
   Weber, O
   Sauriau, PG
TI Short- and long-term sedimentation on Montportail-Brouage intertidal
   mudflat, Marennes-Oleron Bay (France)
SO CONTINENTAL SHELF RESEARCH
LA English
DT Article
DE tidal mudflats; fluid mud; ridge; runnel; sedimentation rate;
   Marennes-Oleron Bay
ID STABILITY
AB The intertidal mudflat of Montportail-Brouage is 4 km wide and er;tends over about 30% of intertidal area of the Bay of Marennes-Oleron. The sampling area was a cross-shore transect (east-west) in the mid-part of the mudflat, so as to overlap the different geomorphological features, from the shore to the central channel. Particularly distinctive were zones of shore-oblique ridges and runnels, and small channels. The short-term erosion-sedimentation processes related to these bedforms, and their effects on the long-term stability of these structures are poorly known. Thus, sediment budget is difficult to assess in the long term, due to temporal variations. Monthly sedimentological surveys were performed from March 1997 to May 1998. Six stations were sampled by coring for determination of water content, dry density, grain size and carbonate content of the sandy fraction, measured on the topmost 5 cm. Within the ridge and runnel zone, this sampling was done on both structures along with the determination of depth profiles of macrofauna species. Radiographic profiles to a depth of 50 cm were made at each of the 6 stations for description of the sedimentary facies, and radioisotope profiles (Be-7, Pb-210(exc)) were made at four stations. Wet bulk density appeared to be roughly constant (1.39-1.44 kg m(-3)) over the whole mudflat below 2 or 3 cm. For the levels 0-1 and 1-2 cm, the bulk density showed much more variation, in particular in the runnels. These variations were due to episodic deposits of fluid mud (wet bulk density < 1.25 kg m(-3)). The sand content decreased from the lower part of the mudflat to the upper part, particularly in the fluid mud. On the contrary, the carbonate content of the sand fraction increased in the upper part by accumulation of foraminifera associated with shell lag deposits. Be-7 measurements revealed a short-term sedimentation of fluid mud (up to 21.04 cm yr(-1)), particularly in runnels from the upper mudflat, thus indicating a temporary deposit, easily resuspended by wave action.
C1 IFREMER, CNRS, UMR 10, CREMA LHoumeau, F-17137 LHoumeau, France.
   CNRS, EPOC, UMR 5805, Dpt Geol & Oceanog, F-33405 Talence, France.
RP Gouleau, D (reprint author), IFREMER, CNRS, UMR 10, CREMA LHoumeau, BP 5, F-17137 LHoumeau, France.
RI Sauriau, Pierre-Guy/N-6307-2014
OI Sauriau, Pierre-Guy/0000-0002-5360-8728
CR ALEXANDER CR, 1991, J SEDIMENT PETROL, V61, P805
   BASSOULLET P, 2000, SEDIMENT TRANSPORT I
   Blanchard GF, 1997, MAR ECOL PROG SER, V151, P17, DOI 10.3354/meps151017
   BLANCHARD GF, 2000, EFFECT GEOMORPHOLOGI
   DAVEY J, 1998, LONDON GEOLOGICAL SO, V139, P123
   DORBIGNY CMD, 1921, J PHYSIQUE CHIM HIST, V28, P194
   GERMANEAU J, 1996, B SOC SCI NATURELLES, V18, P53
   GOLDBERG ED, 1963, GEOCHRONOLOGY LEAD, V210, P121
   GONZALEZ JL, 1991, ENVIRON TECHNOL, V12, P209
   GOULEAU D, 1979, SCI GEOLOGIQUES MEMO, V53, P49
   GOULEAU D, 1976, CR ACAD SCI D NAT, V283, P21
   Graf G, 1997, J MARINE SYST, V11, P269, DOI 10.1016/S0924-7963(96)00126-1
   Gruet Yves, 1994, Quaternaire, V5, P85
   Heral M., 1989, HOMME RESSOURCES HAL, P225
   HERAL M, 1983, REV TRAV I PECHES, V46, P97
   Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x
   KRISHNAS.S, 1971, EARTH PLANET SC LETT, V11, P407, DOI 10.1016/0012-821X(71)90202-0
   Le Hir P, 2000, CONT SHELF RES, V20, P1433, DOI 10.1016/S0278-4343(00)00031-5
   MCCAVE IN, 1986, J SEDIMENT PETROL, V56, P561
   Migeon S, 1999, GEO-MAR LETT, V18, P251, DOI 10.1007/s003670050076
   NITTROUER CA, 1984, MAR GEOL, V54, P201, DOI 10.1016/0025-3227(84)90038-0
   PATERSON DM, 1990, ESTUAR COAST SHELF S, V30, P541, DOI 10.1016/0272-7714(90)90091-5
   POULIQUEN M, 1975, THESIS BORDEUX 1 U F
   Reise K., 1985, TIDAL FLAT ECOLOGY
   RHOADS DC, 1970, J MAR RES, V28, P150
   SAURIAU PG, 1989, OCEANOL ACTA, V12, P193
   Shi Z, 1996, CONT SHELF RES, V16, P1909, DOI 10.1016/0278-4343(95)00059-3
   Sornin J.-M., 1983, J MOLLUSC STUD A S, V12A, P185
   VERGER F, 1968, BISCAYE FERES IMPRIM, V1
   VISSET L, 1988, BOREAS, V17, P3229
   WHITEHOUSE RJS, 2000, INFLUENCE BEDFORMS F, V20, P1099
   Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551
NR 32
TC 61
Z9 65
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-4343
J9 CONT SHELF RES
JI Cont. Shelf Res.
PD SEP
PY 2000
VL 20
IS 12-13
BP 1513
EP 1530
DI 10.1016/S0278-4343(00)00035-2
PG 18
WC Oceanography
SC Oceanography
GA 348FX
UT WOS:000088975800006
ER

PT J
AU Slater, JD
   Yonemoto, LT
   Rossi, CJ
   Reyes-Molyneux, NJ
   Bush, DA
   Antoine, JE
   Loredo, LN
   Schulte, RWM
   Teichman, SL
   Slater, JM
AF Slater, JD
   Yonemoto, LT
   Rossi, CJ
   Reyes-Molyneux, NJ
   Bush, DA
   Antoine, JE
   Loredo, LN
   Schulte, RWM
   Teichman, SL
   Slater, JM
TI Conformal proton therapy for prostate carcinoma
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE radiotherapy; proton; prostate; PSA; prognostic factors
ID LOCALLY ADVANCED-CARCINOMA; EXTERNAL-BEAM RADIATION; HIGH-DOSE
   IRRADIATION; RADICAL PROSTATECTOMY; CANCER; ANTIGEN; ADENOCARCINOMA;
   ESCALATION; PSA; IMPLANTATION
AB Background: The role and optimum dose of radiation to eradicate prostate cancer continues to be evaluated. Protons offer an opportunity to increase the radiation dose to the prostate while minimizing treatment toxicity.
   Methods: Six hundred forty-three patients with localized prostate cancer were treated with protons, with or without photons. Treatments were planned with a 3D planning system; patients received 74-75 CGE (Cobalt Gray Equivalent) at 1.8-2.0 CGE per fraction. Patients were evaluated for response to therapy and treatment-related toxicity.
   Results: The overall clinical disease-free survival rate was 89% at 5 years. When post-treatment prostate-specific antigen (PSA) was used as an endpoint for disease control, the 4.5-year disease-free survival rate was 100% for patients with an initial PSA of < 4.0 ng/ml, and 89%, 72%, and 53% for patients with initial PSA levels of 4.1-10.0, 10.1-20.0, and > 20.0, respectively. Patients in whom the post-treatment PSA nadir was below 0.5 ng/ml did significantly better than those whose nadir values were between 0.51-1.0 or > 1.0 ng/ml: the corresponding 5-year disease-free survival rates were 91%, 79%, and 40%, respectively. Minimal radiation proctitis was seen in 21% of patients; toxicity of greater severity was seen in less than 1%.
   Conclusion: Proton therapy to 74-75 CGE produced minimal treatment-related toxicity and excellent PSA normalization and disease-free survival in patients with low initial PSA levels. A prospective randomized dose-escalation trial is now underway to help define the optimum dose of radiation for patients with early stage prostate cancer. (C) 1998 Elsevier Science Inc.
C1 Loma Linda Univ, Med Ctr, Dept Radiat Med, Loma Linda, CA 92354 USA.
RP Slater, JM (reprint author), Loma Linda Univ, Med Ctr, Dept Radiat Med, POB 2000, Loma Linda, CA 92354 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   ARCHAMBE.JO, 1974, RADIOLOGY, V110, P445
   BENK VA, 1993, INT J RADIAT ONCOL, V26, P551
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   CORN BW, 1995, INT J RADIAT ONCOL, V32, P325, DOI 10.1016/0360-3016(94)00618-U
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   CROOK J, 1996, CANCER, V79, P328
   FORMAN JD, 1995, AM J CLIN ONCOL-CANC, V18, P231, DOI 10.1097/00000421-199506000-00010
   HANKS GE, 1994, J UROLOGY, V152, P1775
   HANKS GE, 1988, INT J RADIAT ONCOL, V15, P1299
   Hanks GE, 1997, INT J RADIAT ONCOL, V37, P543, DOI 10.1016/S0360-3016(96)00602-5
   HANKS GE, 1995, J UROLOGY, V154, P456, DOI 10.1016/S0022-5347(01)67073-3
   KUBAN DA, 1995, INT J RADIAT ONCOL, V32, P307, DOI 10.1016/0360-3016(95)00137-N
   LEE WR, 1995, J CLIN ONCOL, V13, P464
   LEIBEL SA, 1994, J UROLOGY, V152, P1792
   LEIBEL SA, 1994, INT J RADIAT ONCOL, V28, P55
   MURPHY GP, 1994, J UROLOGY, V152, P1817
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   SANDLER HM, 1995, INT J RADIAT ONCOL, V33, P797, DOI 10.1016/0360-3016(95)00219-7
   SANDLER HM, 1992, INT J RADIAT ONCOL, V22, P361
   Schultheiss TE, 1997, INT J RADIAT ONCOL, V37, P3, DOI 10.1016/S0360-3016(96)00468-3
   SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5
   SHIPLEY WU, 1979, JAMA-J AM MED ASSOC, V241, P1912, DOI 10.1001/jama.241.18.1912
   SLATER JM, 1992, INT J RADIAT ONCOL, V22, P383
   WILSON RR, 1946, RADIOLOGY, V47, P487
   Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   Zagars GK, 1997, CANCER, V79, P1370, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X
   ZAGARS GK, 1995, UROLOGY, V45, P476, DOI 10.1016/S0090-4295(99)80019-3
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
   ZIETMAN AL, 1995, INT J RADIAT ONCOL, V32, P287, DOI 10.1016/0360-3016(95)00123-G
   ZIETMAN AL, 1994, J UROLOGY, V151, P640
NR 33
TC 61
Z9 65
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD SEP 1
PY 1998
VL 42
IS 2
BP 299
EP 304
DI 10.1016/S0360-3016(98)00225-9
PG 6
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 129JM
UT WOS:000076460100009
PM 9788407
ER

PT J
AU Mayer, AR
   Mannell, MV
   Ling, J
   Gasparovic, C
   Yeo, RA
AF Mayer, Andrew R.
   Mannell, Maggie V.
   Ling, Josef
   Gasparovic, Charles
   Yeo, Ronald A.
TI Functional Connectivity in Mild Traumatic Brain Injury
SO HUMAN BRAIN MAPPING
LA English
DT Article
DE mild TBI; attention; connectivity; fMRI; DTI
ID DIFFUSE AXONAL INJURY; RESTING-STATE; DEFAULT NETWORK; WORKING-MEMORY;
   GLOBAL SIGNAL; MRI; DYSFUNCTION; FMRI; ACTIVATION; MODE
AB Objectives: Research suggests that the majority of mild traumatic brain injury (mTBI) patients exhibit both cognitive and emotional dysfunction within the first weeks of injury, followed by symptom resolution 36 months postinjury. The neuronal correlates of said dysfunction are difficult to detect with standard clinical neuroimaging, complicating differential diagnosis and early identification of patients who may not recover. This study examined whether resting state functional magnetic resonance imaging (fMRI) provides objective markers of injury and predicts cognitive, emotional, and somatic complaints in mTBI patients semiacutely (<3 weeks postinjury) and in late recovery (3-5 month) phases. Methods: Twenty-seven semiacute mTBI patients and 26 gender, age, and education-matched controls were studied. Fifteen of 27 patients returned for a follow-up visit 3-5 months postinjury. The main dependent variables were spontaneous fluctuations (temporal correlation) in the default-mode (DMN) and fronto-parietal task-related networks as measured by fMRI. Results: Significant differences in self-reported cognitive, emotional, and somatic complaints were observed (all P < 0.05), despite normal clinical (T1 and T2) imaging and neuropsychological testing results. Mild TBI patients demonstrated decreased functional connectivity within the DMN and hyper-connectivity between the DMN and lateral prefrontal cortex. Measures of functional connectivity exhibited high levels of sensitivity and specificity for patient classification and predicted cognitive complaints in the semi-acute injury stage. However, no changes in functional connectivity were observed across a 4-month recovery period. Conclusions: Abnormal connectivity between the DMN and frontal cortex may provide objective biomarkers of mTBI and underlie cognitive impairment. Hum Brain Mapp 32:1825-1835, 2011. (C) 2011 Wiley Periodicals, Inc.
C1 [Mayer, Andrew R.; Mannell, Maggie V.; Ling, Josef; Gasparovic, Charles; Yeo, Ronald A.] Mind Res Network, Albuquerque, NM 87106 USA.
   [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA.
   [Mayer, Andrew R.; Gasparovic, Charles; Yeo, Ronald A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.
RP Mayer, AR (reprint author), Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd, Albuquerque, NM 87106 USA.
EM amayer@mrn.org
FU Department of Energy (The Mind Research Network) [DE-FG02-99ER62764];
   National Institutes of Health [R24-HD050836, R21-NS064464-01A1, 3 R21
   NS064464-01S1]; NCRR (Center on Neural Mechanisms of Schizophrenia) [P20
   RR021938]
FX Contract grant sponsor: Department of Energy (The Mind Research
   Network); Contract grant number: DE-FG02-99ER62764; Contract grant
   sponsor: National Institutes of Health; Contract grant number:
   R24-HD050836, R21-NS064464-01A1, 3 R21 NS064464-01S1; Contract grant
   sponsor: NCRR (Center on Neural Mechanisms of Schizophrenia); Contract
   grant number: P20 RR021938.
CR Aralasmak A, 2006, J COMPUT ASSIST TOMO, V30, P695, DOI 10.1097/01.rct.0000226397.43235.8b
   Arfanakis K, 2002, AM J NEURORADIOL, V23, P794
   Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068
   Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241
   Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277
   Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X
   Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265
   Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220
   Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672
   Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015
   Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624
   Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002
   Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011
   Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585
   Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704
   Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025
   Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650
   Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032
   Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014
   Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105
   FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508
   Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102
   Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008
   Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201
   Franco AR, 2008, IEEE J-STSP, V2, P986, DOI 10.1109/JSTSP.2008.2006718
   Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI 10.1089/neu.2009-0896
   Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101
   Hua KG, 2009, CEREB CORTEX, V19, P1889, DOI 10.1093/cercor/bhn215
   Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672
   Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298
   Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735
   Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672
   Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216
   Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030
   Lehericy S, 2000, NEUROLOGY, V54, P1625
   Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27
   Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584
   Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976
   Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295
   Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836
   Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd
   McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450
   McAllister TW, 1999, NEUROLOGY, V53, P1300
   McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899
   Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816
   Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036
   Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247
   Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151
   Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054
   Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787
   Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76
   Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819
   Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676
   Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965
   Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017
   Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106
   Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709
   Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786
   Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017
   Talairach J, 1988, COPLANAR STERIOTAXIC
   Tijssen RHN, 2009, HUM BRAIN MAPP, V30, P2641, DOI 10.1002/hbm.20695
   Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531
   Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5
   van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737
   Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313
   Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727
   Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54
NR 70
TC 60
Z9 60
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1065-9471
J9 HUM BRAIN MAPP
JI Hum. Brain Mapp.
PD NOV
PY 2011
VL 32
IS 11
BP 1825
EP 1835
DI 10.1002/hbm.21151
PG 11
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 845VA
UT WOS:000296850700005
PM 21259381
ER

PT J
AU Heidarsdottir, R
   Arnar, DO
   Skuladottir, GV
   Torfason, B
   Edvardsson, V
   Gottskalksson, G
   Palsson, R
   Indridason, OS
AF Heidarsdottir, Ragnhildur
   Arnar, David O.
   Skuladottir, Gudrun V.
   Torfason, Bjarni
   Edvardsson, Vidar
   Gottskalksson, Gizur
   Palsson, Runolfur
   Indridason, Olafur S.
TI Does treatment with n-3 polyunsaturated fatty acids prevent atrial
   fibrillation after open heart surgery?
SO EUROPACE
LA English
DT Article
DE Atrial fibrillation; Post-operative; Open heart surgery; n-3
   Polyunsaturated fatty acids; Randomized controlled trial
ID ARTERY-BYPASS-SURGERY; FISH-OIL SUPPLEMENTATION; TUMOR-NECROSIS-FACTOR;
   C-REACTIVE PROTEIN; CARDIAC-SURGERY; VENTRICULAR-FIBRILLATION; DIETARY
   SUPPLEMENTATION; CYTOKINE PRODUCTION; CONTROLLED-TRIAL; OFF-PUMP
AB Aims To examine the effect of n-3 polyunsaturated fatty acid (PUFA) treatment on the incidence of post-operative atrial fibrillation (POAF).
   Methods and results A prospective, randomized, double-blinded, placebo-controlled trial was conducted in patients admitted for coronary artery bypass grafting and/or valvular repair surgery. The patients received either n-3 PUFA capsules, containing a daily dose of 1240 mg eicosapentaenoic acid and 1000 mg docosahexaenoic acid, or olive oil capsules for 5-7 days prior to surgery and post-operatively until hospital discharge. The endpoint was POAF, defined as an episode detected by continuous electrocardiographic monitoring, lasting >5 min. A total of 170 patients were enrolled in the study, and 168 patients underwent surgery. Their median age was 67 (range 43-82) years, and 79.2% were males. There was no difference in baseline characteristics between the n-3 PUFA group (n = 83) and the placebo group (n = 85), and the incidence of POAF was 54.2 and 54.1% (P = 0.99), respectively. Factors associated with POAF included advanced age, peak post-operative C-reactive protein level, valvular surgery, lower body mass index, and non-smoking, but n-3 PUFA concentration in plasma lipids was not associated with POAF.
   Conclusion There is no evidence for a beneficial effect of treatment with n-3 PUFA on the occurrence of POAF in patients undergoing open heart surgery.
C1 [Arnar, David O.; Gottskalksson, Gizur; Palsson, Runolfur; Indridason, Olafur S.] Landspitali Univ Hosp, Div Nephrol, Dept Med, IS-101 Reykjavik, Iceland.
   [Heidarsdottir, Ragnhildur; Skuladottir, Gudrun V.] Univ Iceland, Dept Physiol, Sch Hlth Sci, Reykjavik, Iceland.
   [Heidarsdottir, Ragnhildur; Arnar, David O.; Skuladottir, Gudrun V.; Torfason, Bjarni; Edvardsson, Vidar; Palsson, Runolfur] Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland.
   [Arnar, David O.; Gottskalksson, Gizur] Landspitali Univ Hosp, Cardiovasc Res Ctr, IS-101 Reykjavik, Iceland.
   [Torfason, Bjarni] Landspitali Univ Hosp, Dept Cardiothorac Surg, IS-101 Reykjavik, Iceland.
   [Edvardsson, Vidar] Landspitali Univ Hosp, Childrens Med Ctr, IS-101 Reykjavik, Iceland.
RP Indridason, OS (reprint author), Landspitali Univ Hosp, Div Nephrol, Dept Med, Off 14-F, IS-101 Reykjavik, Iceland.
EM olasi@landspitali.is
FU Icelandic Centre for Research (RANNIS) [080411021]; University of
   Iceland Research Fund; Landspitali University Hospital Research Fund
FX This work was supported by grants from the Icelandic Centre for Research
   (RANNIS, 080411021); the University of Iceland Research Fund; and the
   Landspitali University Hospital Research Fund.
CR Abbatecola AM, 2009, REJUV RES, V12, P25, DOI 10.1089/rej.2008.0799
   Aranki SF, 1996, CIRCULATION, V94, P390
   Auer J, 2005, J CARDIOVASC SURG, V46, P583
   Blok WL, 1996, J NUTR, V126, P1515
   BROUARD C, 1990, BIOCHIM BIOPHYS ACTA, V1047, P19, DOI 10.1016/0005-2760(90)90255-V
   Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079
   Caughey GE, 1996, AM J CLIN NUTR, V63, P116
   CRESWELL LL, 1993, ANN THORAC SURG, V56, P539
   da Cunha DNQ, 2007, BRIT J PHARMACOL, V150, P281, DOI 10.1038/sj.njp.0706977
   ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Heidt MC, 2009, THORAC CARDIOV SURG, V57, P276, DOI 10.1055/s-0029-1185301
   Ishida K, 2006, EUR J CARDIO-THORAC, V29, P501, DOI 10.1016/j.ejcts.2005.12.028
   Ishii Y, 2005, CIRCULATION, V111, P2881, DOI 10.1161/CIRCULATIONAHA.104.475194
   Jahangiri A, 2000, MOL CELL BIOCHEM, V206, P33, DOI 10.1023/A:1007025007403
   Kaireviciute D, 2009, EUR HEART J, V30, P410, DOI 10.1093/eurheartj/ehn609
   Karthik S, 2003, EUR J CARDIO-THORAC, V24, P66, DOI 10.1016/S1010-7940(03)00255-0
   LAUER MS, 1989, PROG CARDIOVASC DIS, V31, P367, DOI 10.1016/0033-0620(89)90031-5
   LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903
   Li GR, 2009, CARDIOVASC RES, V81, P286, DOI 10.1093/cvr/cvn322
   Lo B, 2005, ANN THORAC SURG, V79, P1530, DOI 10.1016/j.athoracsur.2004.10.004
   Lombardi F, 2007, CURR MED CHEM, V14, P2070
   Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720
   MCLENNAN PL, 1988, AM HEART J, V116, P709, DOI 10.1016/0002-8703(88)90328-6
   MCLENNAN PL, 1993, AM J CLIN NUTR, V58, P666
   Metcalf RG, 2007, AM J CLIN NUTR, V85, P1222
   MEYDANI SN, 1991, J NUTR, V121, P547
   Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5
   Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5
   Pignier C, 2007, BASIC RES CARDIOL, V102, P553, DOI 10.1007/s00395-007-0676-x
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884
   Sarrazin JF, 2007, J AM COLL CARDIOL, V50, P1505, DOI 10.1016/j.jacc.2007.05.046
   Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6
   SKULADOTTIR GV, 1995, LIPIDS, V30, P649, DOI 10.1007/BF02537002
   Tselentakis EV, 2006, J SURG RES, V135, P68, DOI 10.1016/j.jss.2006.03.024
   Ucar HI, 2007, HEART SURG FORUM, V10, pE131, DOI 10.1532/HSF98.20061175
   Valagussa F, 1999, LANCET, V354, P447
   VENKATRAMAN JT, 1992, LIPIDS, V27, P94, DOI 10.1007/BF02535806
   Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023
   Wigfield CH, 2006, EUR J CARDIO-THORAC, V29, P434, DOI 10.1016/j.ejcts.2006.01.016
   Yap Cheng-Hon, 2007, Heart Lung Circ, V16, P31, DOI 10.1016/j.hlc.2006.09.007
NR 42
TC 60
Z9 61
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1099-5129
J9 EUROPACE
JI Europace
PD MAR
PY 2010
VL 12
IS 3
BP 356
EP 363
DI 10.1093/europace/eup429
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 575ER
UT WOS:000276050200015
PM 20061328
ER

PT J
AU Detaint, D
   Sundt, TM
   Nkomo, VT
   Scott, CG
   Tajik, AJ
   Schaff, HV
   Enriquez-Sarano, M
AF Detaint, Delphine
   Sundt, Thoralf M.
   Nkomo, Vuyisile T.
   Scott, Christopher G.
   Tajik, A. Jamil
   Schaff, Hartzell V.
   Enriquez-Sarano, Maurice
TI Surgical correction of mitral regurgitation in the elderly - Outcomes
   and recent improvements
SO CIRCULATION
LA English
DT Article
DE aging; echocardiography; mitral valve; prognosis; surgery; survival;
   valves
ID VALVE REPAIR; CARDIAC-SURGERY; ATRIAL-FIBRILLATION; ECHOCARDIOGRAPHIC
   PREDICTION; RISK-FACTORS; REPLACEMENT; SURVIVAL; AGE; DETERMINANTS;
   PROLAPSE
AB Background - In the elderly, mitral regurgitation (MR) is frequent, but surgery risks are considered high. Benefits and indications of MR surgery are uncertain in the elderly.
   Methods and Results - Baseline characteristics, outcome, and trends for surgical results improvement were analyzed in elderly patients (>= 75 years of age; n = 284) operated on for MR in 1980 to 1995 compared with younger patients ( 65 to 74 years of age, n = 504; and < 65 years of age, n = 556). Preoperatively, class III to IV symptoms, atrial fibrillation, coronary disease, creatinine, and comorbidity index were more severe in elderly patients ( all P < 0.002). In the long term after surgery, observed survival stratified by age (>= 75, 65 to 74, < 65 years) was lower in elderly than in younger patients ( at 5 years, 57 +/- 3%, 73 +/- 2%, and 85 +/- 2%, respectively; P < 0.001), but ratios of observed to expected survival were similar ( 83%, 85%, and 88%, respectively). In multivariate analysis adjusted to expected survival, elderly patients showed no difference in life expectancy restoration compared with younger patients ( adjusted hazard ratio, 0.89; 95% confidence interval, 0.73 to 1.30; P = 0.54). Temporal trends showed that risk of operative mortality, although higher in elderly patients ( P < 0.001), declined markedly for all ages (27% to 5% in those >= 75 years of age, P < 0.01; 21% to 4% in those 65 to 74 years of age, P < 0.01; and 7% to 2% in those < 65 years of age, P = 0.06), with a parallel decline in low cardiac output and length of hospital stay. Over time, valve repair feasibility increased in all age groups ( 30% to 84% overall and 31% to 93% in degenerative MR; P < 0.0001).
   Conclusions - Elderly patients undergoing MR surgery display more severe preoperative characteristics and incur higher operative risks than younger patients. However, restoration of life expectancy after surgery is similar in elderly and younger patients, and outstanding recent surgical improvements particularly benefited elderly patients. Thus, elderly patients with MR can now carefully be considered for surgery before refractory heart failure is present.
C1 Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA.
   Mayo Clin, Div Cardiovasc Surg, Rochester, MN 55905 USA.
   Mayo Clin, Biostat Sect, Rochester, MN 55905 USA.
RP Enriquez-Sarano, M (reprint author), Mayo Clin, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.
EM sarano.maurice@mayo.edu
CR Alexander KP, 2000, J AM COLL CARDIOL, V35, P731, DOI 10.1016/S0735-1097(99)00606-3
   Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF
   Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840
   Bonow RO, 1998, CIRCULATION, V98, P1949
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   CHRISTAKIS GT, 1985, CIRCULATION, V72, P120
   CHUA YL, 1994, J THORAC CARDIOV SUR, V107, P408
   COHN LH, 1989, J THORAC CARDIOV SUR, V98, P987
   COSGROVE DM, 1986, CIRCULATION, V74, P82
   Craver JM, 1999, ANN THORAC SURG, V67, P1104, DOI 10.1016/S0003-4975(99)00154-X
   David TE, 1993, ANN THORAC SURG, V56, P13
   DAVID TE, 1993, ANN THORAC SURG, V56, P7
   DIGREGORIO V, 2004, ANN THORAC SURG, V78, P813
   DiGregorio V, 2004, ANN THORAC SURG, V78, P807, DOI 10.1016/j.athoracsur.2004.03.041
   ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536
   EnriquezSarano M, 1996, NEW ENGL J MED, V335, P316, DOI 10.1056/NEJM199608013350504
   Enriquez-Sarano M, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.CIR.0000083831.17708.25
   Enriquez-Sarano M, 1995, CIRCULATION, V91, P1264
   ENRIQUEZSARANO M, 1994, CIRCULATION, V90, P830
   Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451
   FREEMAN WK, 1991, J AM COLL CARDIOL, V18, P29
   FREMES SE, 1989, CIRCULATION, V80, P77
   Grigioni F, 2002, J AM COLL CARDIOL, V40, P84, DOI 10.1016/S0735-1097(02)01922-8
   Grigioni F, 2001, CIRCULATION, V103, P1759
   HAMMERMEISTER KE, 1978, CIRCULATION, V57, P341
   IZUMI S, 1987, CIRCULATION, V76, P777
   Lee EM, 1997, J HEART VALVE DIS, V6, P22
   Lee EM, 1997, EUR HEART J, V18, P655
   Ling H, 1996, NEW ENGL J MED, V335, P1417
   Ling LH, 1997, CIRCULATION, V96, P1819
   Mehta RH, 2002, ANN THORAC SURG, V74, P1459, DOI 10.1016/S0003-4975(02)03928-0
   PENKOSKE PA, 1985, AM J CARDIOL, V55, P735, DOI 10.1016/0002-9149(85)90147-X
   QUINONES MA, 1978, CHEST, V74, P59, DOI 10.1378/chest.74.1.59
   RAMSDALE DR, 1984, EUR HEART J, V5, P716
   SETHI GK, 1987, J THORAC CARDIOV SUR, V93, P884
   Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9
   SPENCER G, 1989, CENSUS USBOT PROJECT
   TAJIK AJ, 1978, MAYO CLIN PROC, V53, P271
   TEOH KH, 1990, ANN THORAC SURG, V49, P643
   THOMPSON R, 1985, NEW ZEAL MED J, V98, P944
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Tribouilloy CM, 1999, CIRCULATION, V99, P400
   TRIBOUILLOY CM, 1998, CIRCULATION, V98, P108
   TSAI TP, 1994, ANN THORAC SURG, V58, P445
   Tsai TP, 1994, ANN THORAC SURG, V58, P450
   WALLER BF, 1982, AM HEART J, V104, P276, DOI 10.1016/0002-8703(82)90204-6
NR 47
TC 60
Z9 61
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD JUL 25
PY 2006
VL 114
IS 4
BP 265
EP 272
DI 10.1161/CIRCULATIONAHA.106.619239
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 066NS
UT WOS:000239237200006
PM 16847151
ER

PT J
AU Ishida, K
   Kimura, F
   Imamaki, M
   Ishida, A
   Shimura, H
   Kohno, H
   Sakurai, M
   Miyazaki, M
AF Ishida, K
   Kimura, F
   Imamaki, M
   Ishida, A
   Shimura, H
   Kohno, H
   Sakurai, M
   Miyazaki, M
TI Relation of inflammatory cytokines to atrial fibrillation after off-pump
   coronary artery bypass grafting
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE arrhythmia; coronary artery bypass grafts; inflammation
ID AVOIDING CARDIOPULMONARY BYPASS; MYOCARDIAL INJURY; CARDIAC-SURGERY;
   INTERLEUKIN-6; REVASCULARIZATION; ACTIVATION; HUMANS; LENGTH
AB Objective: It has been observed that a systemic inflammatory response after on-pump coronary artery bypass grafting (CABG) participates in the pathogenesis of postoperative atrial fibrillation (AF). In patients undergoing off-pump CABG, it is plausible that inflammation is associated with the development of postoperative AF The present study examined relation of proinflammatory cytokines, which play an important role in the upstream of inflammatory cascade, to the development of AF after off-pump CABG. Methods: The present study included 39 patients undergoing off-pump CABG. Tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, and IL-8, were measured by enzyme-linked immunosorbent assay, on anesthetic induction, after sternotomy before anastomoses, at the completion of anastomoses, 3 and 6 h thereafter, and on postoperative days (POD) 1-4. C-reactive protein (CRP) was also measured by turbidimetric immunoassay, preoperatively, and on POD 1, 2, 3, 6, 9, and 13. Results: Eleven patients (28%) developed postoperative AF. Patients with postoperative AF were older (70 +/- 6.4 years vs 60 +/- 8.8 years, P = 0.001); however, there was no difference in other pre- and perioperative variables. TNF-a level did not change during the study period. However, IL-8 and CRP levels significantly increased after the surgery, although there was no significant difference between the two groups. IL-6 level also increased after the surgery with its peak at 6 h after the completion of anastomoses. IL-6 levels of 3 and 6 h after anastomoses were significantly higher in patients with postoperative AF (360 +/- 143 pg/ml vs 230 +/- 94 pg/ml, P = 0.0047, 435 +/- 175 pg/ml vs 247 +/- 102 pg/ml, P = 0.0005, respectively). Logistic regression analysis indicated that the highest quartile of IL-6 level immediately after the surgery (odds ratio 7.63; 95% CI, 1.06-54.9; P = 0.04) and age (odds ratio 1.18; 95% CI, 1.01 -1.39; P = 0.04) independently predict postoperative AF. Furthermore, the maximum level of IL-6 immediately after the surgery significantly correlated to age and intraoperative blood loss (r = 0.04, P = 0.01, and r = 0.47, P = 0.04, respectively). Conclusions: Advanced age was a major risk factor for postoperative AF Furthermore, inflammatory response induced by surgical trauma was also associated with the development of AF after off-pump CABG. (c) 2006 Published by Elsevier B.V.
C1 Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, Chiba 2600856, Japan.
RP Ishida, K (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, Inohana 1-8-1, Chiba 2600856, Japan.
EM keiichi-ishida@pro.odn.ne.jp
CR Abdelhadi RH, 2004, AM J CARDIOL, V93, P1176, DOI 10.1016/j.amjcard.2004.01.053
   Bruins P, 1997, CIRCULATION, V96, P3542
   Burzotta F, 2001, AM J CARDIOL, V88, P1125, DOI 10.1016/S0002-9149(01)02046-X
   Calafiore AM, 2003, EUR J CARDIO-THORAC, V24, P953, DOI 10.1016/S1010-7940(03)00572-4
   CRESWELL LL, 1993, ANN THORAC SURG, V56, P539
   Dimmer C, 1998, AM J CARDIOL, V82, P22, DOI 10.1016/S0002-9149(98)00231-8
   Gaudino M, 2003, CIRCULATION S1, V108, pII195
   Kalman JM, 1995, ANN THORAC SURG, V60, P1709, DOI 10.1016/0003-4975(95)00718-0
   Karthik S, 2003, EUR J CARDIO-THORAC, V24, P66, DOI 10.1016/S1010-7940(03)00255-0
   Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009
   LEITCH JW, 1990, J THORAC CARDIOV SUR, V100, P338
   Maisel WH, 2001, ANN INTERN MED, V135, P1061
   MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690
   Papanicolaou DA, 1998, ANN INTERN MED, V128, P127
   Prondzinsky R, 2005, J THORAC CARDIOV SUR, V129, P760, DOI 10.1016/j.jtcvs.2004.07.052
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Rubens FD, 2005, ANN THORAC SURG, V79, P655, DOI 10.1016/j.athoracsur.2004.07.044
   Sawa Y, 1998, J THORAC CARDIOV SUR, V116, P511, DOI 10.1016/S0022-5223(98)70018-2
   STOUTHARD JML, 1995, AM J PHYSIOL-ENDOC M, V268, pE813
   Wan S, 1999, ANN THORAC SURG, V68, P52, DOI 10.1016/S0003-4975(99)00315-X
   Wan S, 1999, EUR J CARDIO-THORAC, V16, pS107, DOI 10.1016/S1010-7940(99)00200-6
   Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051
   Yared JP, 2000, ANN THORAC SURG, V69, P1420, DOI 10.1016/S0003-4975(00)01180-2
   Zaman AG, 2000, CIRCULATION, V101, P1403
NR 24
TC 60
Z9 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD APR
PY 2006
VL 29
IS 4
BP 501
EP 505
DI 10.1016/j.ejcts.2005.12.028
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 036BW
UT WOS:000237046900017
PM 16439145
ER

PT J
AU Desch, MC
AF Desch, MC
TI Democracy and victory - Why regime type hardly matters
SO INTERNATIONAL SECURITY
LA English
DT Review
ID ECONOMIC-GROWTH; INTERNATIONAL-RELATIONS; ALLIANCE DURATION; WAR;
   COMMITMENT; STATES; POLICY; INSTITUTIONS; INITIATORS; SIMILARITY
C1 Univ Kentucky, Sch Diplomacy & Int Commerce, Patterson Sch, Lexington, KY 40506 USA.
RP Desch, MC (reprint author), Univ Kentucky, Sch Diplomacy & Int Commerce, Patterson Sch, Lexington, KY 40506 USA.
CR ARREGUINTOFT I, 2001, INT SECURITY, V26, P97
   BASINGER B, 1980, THEORY RENT SEEKING, P235
   BENGURION D, 1975, MOSHE DYAN STORY MY, P92
   BENHORIN Y, 1981, 2845NA RAND, P9
   Bennett DS, 1997, AM J POLIT SCI, V41, P846, DOI 10.2307/2111677
   BENNETT DS, 1996, J CONFLICT RESOLUT, V42, P246
   BRAWLEY MR, 1993, COMP POLIT STUD, V26, P178, DOI 10.1177/0010414093026002002
   BURKHART RE, 1994, AM POLIT SCI REV, V88, P903, DOI 10.2307/2082715
   CHEIBUB JA, 1998, WORLD POLIT, V50, P372
   Christensen TJ, 2001, INT SECURITY, V25, P5, DOI 10.1162/01622880151091880
   CLARK A, 1965, BARBARROSSA RUSSIAN
   CUSHMAN JH, 1988, MILITARY EFFECTIVENE, V3, P320
   de Mesquita BB, 1999, J CONFLICT RESOLUT, V43, P147, DOI 10.1177/0022002799043002002
   DEMESQUITA BB, 1995, AM POLIT SCI REV, V89, P841, DOI 10.2307/2082512
   DESSLER D, 1991, INT STUD QUART, V35, P337, DOI 10.2307/2600703
   DETOCQUEVILLE A, 1945, DEMOCRACY AM, V1, P243
   DIAMOND L, 1992, AM BEHAV SCI, V35, P450, DOI 10.1177/0002764292035004007
   DOWNING BM, 1992, MILITARY REVOLUTION, P78
   Ellingsen Tanja, 2001, AM POLIT SCI REV, V95, P34
   ELMAN MF, 1997, PATHS PEACE IS DEMOC, P329
   Eyerman J, 1996, J CONFLICT RESOLUT, V40, P597, DOI 10.1177/0022002796040004004
   FARBER HS, 1995, INT SECURITY, V20, P239
   FEARON JD, 1994, AM POLIT SCI REV, V88, P577, DOI 10.2307/2944796
   FEIGENBAUM EA, 1999, INT SECURITY, V24, P119
   Feng Y, 1997, BRIT J POLIT SCI, V27, P391, DOI 10.1017/S0007123497000197
   FRIEDBERG AL, 1992, INT SECURITY, V16, P109, DOI 10.2307/2539189
   FRIEDBERG AL, 2000, SHADOW GARRISON STAT, P340
   Gasiorowski MJ, 2000, COMP POLIT STUD, V33, P319, DOI 10.1177/0010414000033003002
   GAUBATZ KT, 1996, INT ORGAN, V50, P110
   GAUBATZ KT, 1995, WORLD POLIT, V47, P538
   GILBERT F, 1975, HIST ESSAYS O HINTZE, P178
   GILBERT M, 1998, ISRAEL HIST, P504
   GLAIN SJ, 2000, WALL STREET J   1026, pA23
   Gleditsch KS, 1997, J CONFLICT RESOLUT, V41, P361, DOI 10.1177/0022002797041003002
   GOEMANS HE, 2000, WAR PUNISHMENT CAUSE, P39
   Green DP, 2001, INT ORGAN, V55, P441, DOI 10.1162/00208180151140630
   Hanson V. D., 1999, SOUL BATTLE ANCIENT
   HARKAVI Y, 1967, ORBIS, V11, P680
   HELLIWELL JF, 1994, BRIT J POLIT SCI, V24, P225
   HERSH S, 1991, SAMSON OPTION ISRAEL, P271
   HERZOG C, 1975, WAR ATONEMENT OCT 19, P31
   HOLSTI O, 1992, INT STUDIES Q, V36, P447
   HORNE A, 1988, LOSE BATTLE FRANCE 1
   HOWARD M, 1976, WAR EUROPEAN HIST, P110
   HUNTINGTON SP, 1991, 3 WAVE DEMOCRATIZATI, P37
   Isaacson Jeffrey, 1999, PREDICTING MILITARY
   JAGGERS K, 1996, 6695 ICPSR
   KAGAN D, 2000, WHILE AM SLEEPS SELF, P307
   KAGAN D, 1991, PERICLES ATHENS BIRT, P16
   KAGAN R, 2001, WEEKLY STANDARD 1119
   Kant I., 1983, PERPETUAL PEACE OTHE, P107
   King G, 2001, INT ORGAN, V55, P497, DOI 10.1162/00208180151140667
   KING G, 1994, DESIGNING SOCIAL INQ, P158
   KUGLER J, 1986, COMP POLITICS STUDIE, V19, P50
   KUGLER J, 1986, COMP POLIT STUD, V19, P39, DOI 10.1177/0010414086019001002
   Lai B, 2000, J CONFLICT RESOLUT, V44, P203, DOI 10.1177/0022002700044002003
   LAKE DA, 1992, AM POLIT SCI REV, V86, P24, DOI 10.2307/1964013
   LANE FC, 1996, VENICE HIST COLLECTE, P389
   LEVY J, 1989, BEHAV SOC NUCLEAR WA, V1, P270
   LEVY JS, 1988, J INTERDISCIPLINARY, V18, P669
   LONDREGEN JB, 1996, WORLD POLIT, V49, P2
   Lupfer Timothy T., 1981, DYNAMICS DOCTRINE CH
   Lynn John A., 1996, BAYONETS REPUBLIC MO
   MACK A, 1975, WORLD POLIT, V27, P175, DOI 10.2307/2009880
   MADEJ WV, 1978, J POLIT MIL SOCIOL, V6, P233
   MANSFIELD ED, 1995, INT SECURITY, V20, P35
   MEARSHEIMER JJ, 1989, INT SECURITY, V13, P54, DOI 10.2307/2538780
   MEARSHEIMER John J, 2001, TRAGEDY GREAT POWER
   MEIR G, 1975, MY LIFE, P230
   MILLETT AR, 1986, INT SECURITY, V11, P37, DOI 10.2307/2538875
   MILWARD AS, 1977, WAR EC SOC 1939 1945, P99
   MORRIS B, 1999, RIGHTEOUS VICTIMS HI, P192
   MUELLER J, 1991, ANNU M AM POLIT SCI, P50
   MUELLER J, 1985, WAR PRESIDENTS PUBLI, P2
   Mueller John, 1995, QUIET CATACLYSM REFL
   NEUBAUER DE, 1967, AM POLIT SCI REV, V61, P1002, DOI 10.2307/1953402
   NINCIC DJ, 1995, J PEACE RES, V32, P413, DOI 10.1177/0022343395032004003
   NORTH DC, 1989, J ECON HIST, V49, P803
   OLSON M, 1993, AM POLIT SCI REV, V87, P567, DOI 10.2307/2938736
   OLSON M, 1970, ALLIANCE INT POLITIC, P186
   OLSON M, 1982, RISE DECLINE NATIONS, P77
   Olson Mancur, 1986, INT POLITICAL SCI RE, V7, P165, DOI 10.1177/019251218600700205
   ONEAL JR, 2001, INT ORGAN, V55, P471
   OREN I, 1995, INT SECURITY, V20, P266
   OVERY R, 1995, ALLIES WON, P63
   Overy Richard, 1997, RUSSIAS WAR HIST SOV
   Palmer R. R., 1986, MAKERS MODERN STRATE, P91
   PARET P, 1970, MIL AFF, V34, P2, DOI 10.2307/1984544
   PERLMUTTER A, 1975, ORBIS-J WORLD AFF, V19, P434
   Pollack Kenneth, 1996, THESIS MIT
   Porter Bruce D., 1994, WAR RISE STATE MILIT
   POSEN BR, 1993, INT SECURITY, V18, P80, DOI 10.2307/2539098
   PRZEWORSKI A, 1993, J ECON PERSPECT, V7, P51
   RASLER K, 1999, J CONFLICT RESOLUT, V43, P7
   Rasler K. A., 1989, WAR STATE MAKING SHA
   Reed W, 1997, AM J POLIT SCI, V41, P1072, DOI 10.2307/2111689
   Reed W, 2000, J CONFLICT RESOLUT, V44, P378, DOI 10.1177/0022002700044003005
   REITER D, 1998, AM POLIT SCI REV, V92, P378
   Reiter D, 1998, J CONFLICT RESOLUT, V42, P259, DOI 10.1177/0022002798042003003
   Resende-Santos Joao, 1996, SECURITY STUDIES, V5, P193
   REVEL JF, 1984, DEMOCRACIES PERISH, P3
   ROPP T, 1962, WAR MODERN WORLD, P98
   RUSSETT BM, 1990, CONTROLLING SWORD DE, P106
   SCHULTZ KA, 1998, AM POLIT SCI REV, V92, P830
   SCHULTZ KA, 1999, INT ORGAN, V53, P237
   Schultz Kenneth A., 1998, STRATEGIC POLITICIAN, P15
   SEGEV T, 1993, 7 MILLION ISRAELIS H, P191
   SHIRER WL, 1994, COLLAPSE THIRD REPUB
   Simon MW, 1996, J CONFLICT RESOLUT, V40, P617, DOI 10.1177/0022002796040004005
   Singer J. D., 1994, 9905 ICPSR, P1816
   SIVERSON RM, 1991, J CONFLICT RESOLUT, V35, P285, DOI 10.1177/0022002791035002007
   SMALL M, 1996, DEMOCRACY DIPLOMACY, pR8
   SNYDER J, 1991, MYTHS EMPIRE DOMESTI, P18
   Stam Allan C., 2002, DEMOCRACIES WAR
   Stam III Allan C., 1996, WIN LOSE DRAW DOMEST
   STINCHCOMBE AL, 1968, CONSTRUCTING SOCIAL, P24
   TARLTON CD, 1965, WORLD POLIT, V17, P584, DOI 10.2307/2009323
   TELLIS AJ, 1999, 1818A RAND
   THOMPSON WR, 1996, INT ORGAN, V50, P149
   TOLLISON RD, 1982, KYKLOS, V35, P575, DOI 10.1111/j.1467-6435.1982.tb00174.x
   van Creveld M., 1982, FIGHTING POWER GERMA
   VANCREVELD M, 1998, SWORD OLIVE CRITICAL, P215
   VANEVERA, 1997, GUIDE METHODS STUDEN, P31
   VANEVERA S, 1990, INT SECURITY, V15, P27
   VANEVERA S, 1994, INT SECURITY, V18, P30
   VONCLAUSEWITZ CM, 1968, WAR, P384
   WALT SM, 1999, INT SECURITY, V23, P33
   WALTZ K, 1979, THEORY INT POLITICS, P76
   WANG K, 1994, INT STUD QUART, V38, P139, DOI 10.2307/2600875
   Weber Eugene, 1994, HOLLOW YEARS FRANCE
   WEEDE E, 1983, KYKLOS, V36, P35
   WEHATCROFT G, 1996, CONTROVERSY ZION JEW, P241
   WILLIAMS WH, 1978, AM STAT, V32, P61, DOI 10.2307/2683617
   1974, NY TIMES        0403, P1
   1994, ECONOMIST       0827, P15
NR 135
TC 60
Z9 60
PU M I T PRESS
PI CAMBRIDGE
PA FIVE CAMBRIDGE CENTER, CAMBRIDGE, MA 02142 USA
SN 0162-2889
J9 INT SECURITY
JI Int. Secur.
PD FAL
PY 2002
VL 27
IS 2
BP 5
EP 47
DI 10.1162/016228802760987815
PG 43
WC International Relations
SC International Relations
GA 629MR
UT WOS:000180053900002
ER

PT J
AU Merrick, GS
   Butler, WM
   Galbreath, RW
   Lief, JH
AF Merrick, GS
   Butler, WM
   Galbreath, RW
   Lief, JH
TI Five-year biochemical outcome following permanent interstitial
   brachytherapy for clinical T1-T3 prostate cancer
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; brachytherapy; biochemical outcome; Pd-103; I-125
ID RADIATION-THERAPY; CARCINOMA; SURVIVAL; ANTIGEN; DISEASE; AGE;
   IMPLANTATION; MEN
AB Purpose: To evaluate 5-year biochemical disease-free outcome for men with clinical T1b-T3a NxM0 1977 American Joint Committee on Cancer (1997 AJCC) adenocarcinoma of the prostate gland who underwent transperineal ultrasound-guided permanent prostate brachytherapy.
   Methods and Materials: Four hundred twenty-five patients underwent transperineal ultrasound-guided prostate brachytherapy using either Pd-103 or I-125, for clinical T1b-T3a NxMO (1997 AJCC) adenocarcinoma of the prostate gland, from April 1995 to October 1999. No patient underwent pathologic lymph-node staging. One hundred ninety patients were implanted with either Pd-103 or I-125 monotherapy; 235 patients received moderate-dose external beam radiation therapy (EBRT), followed by a prostate brachytherapy boost; 163 patients received neoadjuvant hormonal manipulation, in conjunction with either Pd-103 or I-125 monotherapy (77 patients) or in conjunction with moderate-dose EBRT and a prostate brachytherapy boost (86 patients). The median patient age was 68.0 years (range, 48.2-81.3 years). The median follow-up was 31 months (range, 11-69 months). Follow-up was calculated from the day of implantation. No patient was lost to follow-up. Biochemical disease-free survival was defined by the American Society of Therapeutic Radiation and Oncology (ASTRO) consensus definition.
   Results: For the entire cohort, the 5-year actuarial biochemical no evidence of disease (bNED) survival rate was 94%. For patients with low-, intermediate-, and high-risk disease, the 5-year biochemical disease-free rates were 97.1%, 97.5%, and 84.4%, respectively. For hormone-naive patients, 95.7%, 96.4%, and 79.9% of patients with low-, intermediate-, and high-risk disease were free of biochemical failure. Clinical and treatment parameters predictive of biochemical outcome included: clinical stage, pretreatment prostate-specific antigen (PSA), Gleason score, risk group, age > 65 years, and neoadjuvant hormonal therapy. Isotope choice was not a statistically significant predictor of disease-free survival for any risk group. The median postimplant PSA was less than or equal to 0.2 for all risk groups, regardless of hormonal status. The mean posttreatment PSA, however, was significantly lower for men implanted with Pd-103 (0.14 ng/mL) than for those implanted with I-125 (0.25 ng/mL), p less than or equal to 0.001.
   Conclusion: With a median follow-up of 31 months, permanent prostate brachytherapy results in a high probability of actuarial 5-year biochemical disease-free survival (DFS) for patients with clinical T1b-T3a (1997 AJCC) adenocarcinoma of the prostate gland, with an apparent plateau on the PSA survival curve. (C) 2001 Elsevier Science Inc.
C1 Wheeling Hosp, Schiffler Canc Ctr, Wheeling, WV 26003 USA.
   George Washington Univ, Med Ctr, Div Radiat Oncol & Biophys, Washington, DC 20037 USA.
   Wheeling Jesuit Univ, Wheeling, WV USA.
RP Merrick, GS (reprint author), Wheeling Hosp, Schiffler Canc Ctr, 1 Med Pk, Wheeling, WV 26003 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Butler WM, 1998, INT J RADIAT ONCOL, V41, P217, DOI 10.1016/S0360-3016(97)00951-6
   Butler WM, 2000, MED PHYS, V27, P381, DOI 10.1118/1.598842
   Carter HB, 1999, UROLOGY, V53, P126, DOI 10.1016/S0090-4295(98)00466-X
   Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   Dattoli M, 1999, INT J RADIAT ONCOL, V45, P853, DOI 10.1016/S0360-3016(99)00259-X
   Fleming ID, 1998, AJCC CANC STAGING HD
   Herold DM, 1998, UROLOGY, V51, P985, DOI 10.1016/S0090-4295(98)00029-6
   Merrick G S, 2000, Tech Urol, V6, P117
   Merrick GS, 1998, J BRACHYTHERAPY INT, V14, P113
   MERRICK GS, IN PRESS INT J RAD O
   Merrick GS, 2000, INT J RADIAT ONCOL, V46, P215, DOI 10.1016/S0360-3016(99)00405-8
   Merrick GS, 1999, INT J RADIAT ONCOL, V44, P717, DOI 10.1016/S0360-3016(99)00067-X
   MERRICK GS, IN PRESS TECH UROL
   Merrick G S, 1998, Radiat Oncol Investig, V6, P182, DOI 10.1002/(SICI)1520-6823(1998)6:4<182::AID-ROI6>3.0.CO;2-U
   Merrick G S, 2001, Tech Urol, V7, P12
   Merrick GS, 1999, INT J RADIAT ONCOL, V43, P1021, DOI 10.1016/S0360-3016(98)00486-6
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   Potters L, 1999, CANCER J SCI AM, V5, P301
   Ragde H, 2000, CANCER, V89, P135, DOI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
   Smith CV, 2000, J UROLOGY, V164, P1964, DOI 10.1016/S0022-5347(05)66929-7
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   Valicenti R, 2000, J CLIN ONCOL, V18, P2740
   Waterman FM, 1998, INT J RADIAT ONCOL, V41, P1069, DOI 10.1016/S0360-3016(98)00152-7
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   Zelefsky MJ, 2000, INT J RADIAT ONCOL, V47, P1261, DOI 10.1016/S0360-3016(00)00550-2
NR 29
TC 60
Z9 75
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD SEP 1
PY 2001
VL 51
IS 1
BP 41
EP 48
DI 10.1016/S0360-3016(01)01594-2
PG 8
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 468EM
UT WOS:000170745200007
PM 11516849
ER

PT J
AU Landen, OL
   Edwards, J
   Haan, SW
   Robey, HF
   Milovich, J
   Spears, BK
   Weber, SV
   Clark, DS
   Lindl, JD
   MacGowan, BJ
   Moses, EI
   Atherton, J
   Amendt, PA
   Boehly, TR
   Bradley, DK
   Braun, DG
   Callahan, DA
   Celliers, PM
   Collins, GW
   Dewald, EL
   Divol, L
   Frenje, JA
   Glenzer, SH
   Hamza, A
   Hammel, BA
   Hicks, DG
   Hoffman, N
   Izumi, N
   Jones, OS
   Kilkenny, JD
   Kirkwood, RK
   Kline, JL
   Kyrala, GA
   Marinak, MM
   Meezan, N
   Meyerhofer, DD
   Michel, P
   Munro, DH
   Olson, RE
   Nikroo, A
   Regan, SP
   Suter, LJ
   Thomas, CA
   Wilson, DC
AF Landen, O. L.
   Edwards, J.
   Haan, S. W.
   Robey, H. F.
   Milovich, J.
   Spears, B. K.
   Weber, S. V.
   Clark, D. S.
   Lindl, J. D.
   MacGowan, B. J.
   Moses, E. I.
   Atherton, J.
   Amendt, P. A.
   Boehly, T. R.
   Bradley, D. K.
   Braun, D. G.
   Callahan, D. A.
   Celliers, P. M.
   Collins, G. W.
   Dewald, E. L.
   Divol, L.
   Frenje, J. A.
   Glenzer, S. H.
   Hamza, A.
   Hammel, B. A.
   Hicks, D. G.
   Hoffman, N.
   Izumi, N.
   Jones, O. S.
   Kilkenny, J. D.
   Kirkwood, R. K.
   Kline, J. L.
   Kyrala, G. A.
   Marinak, M. M.
   Meezan, N.
   Meyerhofer, D. D.
   Michel, P.
   Munro, D. H.
   Olson, R. E.
   Nikroo, A.
   Regan, S. P.
   Suter, L. J.
   Thomas, C. A.
   Wilson, D. C.
TI Capsule implosion optimization during the indirect-drive National
   Ignition Campaign
SO PHYSICS OF PLASMAS
LA English
DT Article
ID INERTIAL CONFINEMENT FUSION; HOHLRAUM SYMMETRY EXPERIMENTS; LASER-HEATED
   HOHLRAUMS; X-RAY BURNTHROUGH; HYDRA SIMULATIONS; PHYSICS BASIS; ERROR
   BUDGET; CH CAPSULES; FACILITY; TARGETS
AB Capsule performance optimization campaigns will be conducted at the National Ignition Facility [G. H. Miller, E. I. Moses, and C. R. Wuest, Nucl. Fusion 44, 228 (2004)] to substantially increase the probability of ignition. The campaigns will experimentally correct for residual uncertainties in the implosion and hohlraum physics used in our radiation-hydrodynamic computational models using a variety of ignition capsule surrogates before proceeding to cryogenic-layered implosions and ignition experiments. The quantitative goals and technique options and down selections for the tuning campaigns are first explained. The computationally derived sensitivities to key laser and target parameters are compared to simple analytic models to gain further insight into the physics of the tuning techniques. The results of the validation of the tuning techniques at the OMEGA facility [J. M. Soures et al., Phys. Plasmas 3, 2108 (1996)] under scaled hohlraum and capsule conditions relevant to the ignition design are shown to meet the required sensitivity and accuracy. A roll-up of all expected random and systematic uncertainties in setting the key ignition laser and target parameters due to residual measurement, calibration, cross-coupling, surrogacy, and scale-up errors has been derived that meets the required budget. Finally, we show how the tuning precision will be improved after a number of shots and iterations to meet an acceptable level of residual uncertainty. (C) 2011 American Institute of Physics. [doi: 10.1063/1.3592170]
C1 [Landen, O. L.; Edwards, J.; Haan, S. W.; Robey, H. F.; Milovich, J.; Spears, B. K.; Weber, S. V.; Clark, D. S.; Lindl, J. D.; MacGowan, B. J.; Moses, E. I.; Atherton, J.; Amendt, P. A.; Bradley, D. K.; Braun, D. G.; Callahan, D. A.; Celliers, P. M.; Collins, G. W.; Dewald, E. L.; Divol, L.; Glenzer, S. H.; Hamza, A.; Hammel, B. A.; Hicks, D. G.; Izumi, N.; Jones, O. S.; Kirkwood, R. K.; Marinak, M. M.; Meezan, N.; Michel, P.; Munro, D. H.; Suter, L. J.; Thomas, C. A.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
   [Boehly, T. R.; Meyerhofer, D. D.; Regan, S. P.] Univ Rochester, Laser Energet Lab, Rochester, NY USA.
   [Frenje, J. A.] MIT, Plasma Sci & Fus Ctr, Cambridge, MA 02139 USA.
   [Hoffman, N.; Kline, J. L.; Kyrala, G. A.; Wilson, D. C.] Los Alamos Natl Lab, Los Alamos, NM USA.
   [Kilkenny, J. D.; Nikroo, A.] Gen Atom Co, San Diego, CA USA.
   [Olson, R. E.] Sandia Natl Labs, Albuquerque, NM USA.
RP Landen, OL (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RI Collins, Gilbert/G-1009-2011; Michel, Pierre/J-9947-2012
FU U.S. Department of Energy by Lawrence Livermore National Laboratory
   [DE-AC52-07NA27344]
FX This work was performed under the auspices of the U.S. Department of
   Energy by Lawrence Livermore National Laboratory under Contract
   DE-AC52-07NA27344.
CR Amendt P, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2825662
   Amendt P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.165001
   Amendt P, 2001, PHYS PLASMAS, V8, P2908, DOI 10.1063/1.1369412
   Atherton LJ, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/3/032063
   Babonneau D, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2973480
   Bennett GR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.205003
   Bennett GR, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336433
   Besnard D, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/1/012004
   Biener J, 2006, FUSION SCI TECHNOL, V49, P737
   Boehly TR, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3078422
   Boehly TR, 2004, PHYS PLASMAS, V11, pL49, DOI 10.1063/1.1778164
   Boehly TR, 1997, OPT COMMUN, V133, P495, DOI 10.1016/S0030-4018(96)00325-2
   Bourgade JL, 2001, REV SCI INSTRUM, V72, P1173, DOI 10.1063/1.1324744
   BOURGADE JL, J INSTRUM UNPUB
   Bradley DK, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2721971
   Bullock AB, 2006, J APPL PHYS, V100, DOI 10.1063/1.2229737
   Callahan DA, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022021
   CAMPBELL EM, 1986, REV SCI INSTRUM, V57, P2101, DOI 10.1063/1.1138755
   Campbell KM, 2004, REV SCI INSTRUM, V75, P3768, DOI 10.1063/1.1789603
   Celliers PM, 2004, REV SCI INSTRUM, V75, P4916, DOI 10.1063/1.1807008
   Chen KC, 2006, FUSION SCI TECHNOL, V49, P750
   Chen KC, 2007, FUSION SCI TECHNOL, V51, P593
   Clark DS, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2890123
   Clark DS, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3403293
   Cohen DH, 2004, PHYS PLASMAS, V11, P2702, DOI 10.1063/1.1647135
   Cohen DH, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2146863
   Dattolo E, 2001, PHYS PLASMAS, V8, P260, DOI 10.1063/1.1324659
   DELAMATER N, 2006, REV SCI INSTRUM, V10
   Delamater ND, 1996, PHYS REV E, V53, P5240, DOI 10.1103/PhysRevE.53.5240
   Delamater ND, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2978198
   Delamater ND, 2000, PHYS PLASMAS, V7, P1609, DOI 10.1063/1.873982
   DEWALD E, 2009, B AM PHYS SOC, V54, P28
   Dewald EL, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2970041
   Dewald EL, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2216991
   Dewald EL, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478683
   Dewald EL, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2178783
   Dewald EL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.215004
   Dewald EL, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2943700
   DEWALD EL, PHYS PLASMAS UNPUB
   Dewald EL, 2004, REV SCI INSTRUM, V75, P3759, DOI 10.1063/1.1788872
   Dittrich TR, 1999, PHYS PLASMAS, V6, P2164, DOI 10.1063/1.873467
   Dixit SN, 1996, OPT LETT, V21, P1715, DOI 10.1364/OL.21.001715
   Dixit SN, 2006, J PHYS IV, V133, P717, DOI 10.1051/jp4:2006133145
   Eder DC, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/3/032023
   Edwards J, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1914809
   Edwards MJ, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592173
   EIDMANN K, 1995, PHYS REV E, V52, P6703, DOI 10.1103/PhysRevE.52.6703
   Fernandez JC, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2183907
   FOLDES IB, 1994, PHYS REV E, V50, pR690, DOI 10.1103/PhysRevE.50.R690
   Frenje JA, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3098540
   Frenje JA, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.2965829
   Frenje JA, 2004, PHYS PLASMAS, V11, P2798, DOI 10.1063/1.1695359
   Froula DH, 2004, REV SCI INSTRUM, V75, P4168, DOI 10.1063/1.1789592
   Girard F, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2032167
   Girard F, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3155006
   Glenzer SH, 2010, SCIENCE, V327, P1228, DOI 10.1126/science.1185634
   GLENZER SH, 2007, NAT PHYS, V3, P709
   Glenzer SH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.109903
   Glenzer SH, 2004, NUCL FUSION, V44, pS185, DOI 10.1088/0029-5515/44/12/S08
   Glenzer SH, 1998, PHYS REV LETT, V80, P2845, DOI 10.1103/PhysRevLett.80.2845
   Haan SW, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592169
   Haan SW, 2007, FUSION SCI TECHNOL, V51, P509
   Haan SW, 2009, FUSION SCI TECHNOL, V55, P227
   Haan SW, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1885003
   Haan SW, 2006, FUSION SCI TECHNOL, V49, P553
   Haan SW, 2007, EUR PHYS J D, V44, P249, DOI 10.1140/epjd/e2007-00163-0
   Hammel BA, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022007
   Hammel BA, 2010, HIGH ENERG DENS PHYS, V6, P171, DOI 10.1016/j.hedp.2009.12.005
   HAMMEL BA, 1993, PHYS REV LETT, V70, P1263, DOI 10.1103/PhysRevLett.70.1263
   HAMMEL BA, 1993, PHYS FLUIDS B-PLASMA, V5, P2259, DOI 10.1063/1.860759
   HAUER AA, 1995, PHYS PLASMAS, V2, P672
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   Hicks DG, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3475727
   Hicks DG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014112
   Hicks DG, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3486536
   Hoffman NM, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022075
   Hoffman NM, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2221930
   HUANG H, 2009, FUSION SCI TECHNOL, V55, P536
   JAANIMAGI PA, 1986, REV SCI INSTRUM, V57, P2189, DOI 10.1063/1.1138727
   Jaanimagi PA, 2005, P SOC PHOTO-OPT INS, V5580, P408, DOI 10.1117/12.602565
   Jones OS, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2712426
   Jones OS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.065002
   KAUFFMAN RL, 1994, PHYS REV LETT, V73, P2320, DOI 10.1103/PhysRevLett.73.2320
   Kauffman RL, 1998, PHYS PLASMAS, V5, P1927, DOI 10.1063/1.872822
   Keiter PA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3432116
   Kilkenny JD, 1999, PHILOS T R SOC A, V357, P533
   Kilkenny JD, 1999, LASER PART BEAMS, V17, P159
   Kimbrough JR, 2004, REV SCI INSTRUM, V75, P4060, DOI 10.1063/1.1789261
   Kirkwood RK, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3041160
   Kline JL, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491032
   Kline JL, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.085003
   KNUDSON MA, 2006, B AM PHYS SOC, V51, P340
   Knudson MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.225501
   Koch JA, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1940614
   KOCH JA, 2009, J APPL PHYS, V105, P1
   Kozioziemski BJ, 2007, NUCL FUSION, V47, P1, DOI 10.1088/0029-5515/47/1/001
   KRITCHER A, 2009, B AM PHYS SOC, V54, P354
   KRITCHER AL, PHYS REV LETT UNPUB
   KRITCHER AL, HIGH ENERGY IN PRESS
   Kritcher AL, 2008, SCIENCE, V322, P69, DOI 10.1126/science.1161466
   Kyrala GA, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3481028
   KYRALA GA, 2008, B AM PHYS SOC, V53, P247
   Landen OL, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022004
   Landen OL, 1999, PHYS PLASMAS, V6, P2137, DOI 10.1063/1.873465
   LANDEN OL, 2010, PHYS PLASMAS, V17
   Landen OL, 2007, EUR PHYS J D, V44, P273, DOI 10.1140/epjd/e2006-00111-6
   Landon MD, 2001, REV SCI INSTRUM, V72, P698, DOI 10.1063/1.1318255
   Langer SH, 2001, J QUANT SPECTROSC RA, V71, P479, DOI 10.1016/S0022-4073(01)00091-7
   Langer SH, 2007, HIGH ENERG DENS PHYS, V3, P169, DOI 10.1016/j.hedp.2007.02.017
   Lee HJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.115001
   LEE YT, 1984, PHYS FLUIDS, V27, P1273, DOI 10.1063/1.864744
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638
   Mackinnon AJ, 2004, REV SCI INSTRUM, V75, P4183, DOI 10.1063/1.1789594
   Maddox BR, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3531979
   Magelssen GR, 1998, PHYS REV E, V57, P4663, DOI 10.1103/PhysRevE.57.4663
   Malone RM, 2004, PROC SPIE, V5523, P148, DOI 10.1117/12.561773
   Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740
   Marinak MM, 1998, PHYS PLASMAS, V5, P1125, DOI 10.1063/1.872643
   McDonald JW, 2004, REV SCI INSTRUM, V75, P3753, DOI 10.1063/1.1788871
   Meadowcroft AL, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3013123
   Meezan NB, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022022
   Meezan NB, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2710782
   MEEZAN NB, 2010, PHYS PLASMAS, V18
   Michel P, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3103788
   Michel P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046409
   Michel P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025004
   Miller G.H., 2004, NUCL FUSION, V44, P228
   Moses EI, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/1/012003
   Munro DH, 2001, PHYS PLASMAS, V8, P2245, DOI 10.1063/1.1347037
   Murphy TJ, 1998, PHYS REV LETT, V81, P108, DOI 10.1103/PhysRevLett.81.108
   Nikroo A, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2179054
   Oertel JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2227439
   Okishev AV, 2006, P SOC PHOTO-OPT INS, V6053, pJ530, DOI 10.1117/21.660311
   Olson RE, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2965021
   Olson RE, 2004, PHYS PLASMAS, V11, P2778, DOI 10.1063/1.1691032
   Olson RE, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3566009
   Olson RE, 2003, REV SCI INSTRUM, V74, P2186, DOI 10.1063/1.1537866
   Olson RE, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.235002
   Park HS, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478682
   Pollaine SM, 2001, PHYS PLASMAS, V8, P2357, DOI 10.1063/1.1364514
   Regan SP, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3309481
   Regan SP, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022077
   REMINGTON BA, 1992, REV SCI INSTRUM, V63, P5083, DOI 10.1063/1.1143499
   Robey HF, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022078
   ROBEY HF, 2009, PHYS PLASMAS, V17
   Robey HF, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1927543
   Rogers FJ, 2000, PHYS PLASMAS, V7, P51, DOI 10.1063/1.873815
   Rosen MD, 1996, PHYS PLASMAS, V3, P1803, DOI 10.1063/1.871683
   Sangster TC, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2671844
   Sangster TC, 2007, NUCL FUSION, V47, pS686, DOI 10.1088/0029-5515/47/10/S17
   Sawada H, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2819675
   Schein J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175003
   Schneider MB, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491316
   SIMON A, 1983, PHYS FLUIDS, V26, P3107, DOI 10.1063/1.864037
   Soures JM, 1996, PHYS PLASMAS, V3, P2108, DOI 10.1063/1.871662
   Spears B, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022003
   Sterne PA, 2007, HIGH ENERG DENS PHYS, V3, P278, DOI 10.1016/j.hedp.2007.02.037
   SUTER LJ, 1994, PHYS REV LETT, V73, P2328, DOI 10.1103/PhysRevLett.73.2328
   Theobald W, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2397581
   Thomas CA, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036413
   TRAINOR RJ, 1979, PHYS REV LETT, V42, P1154, DOI 10.1103/PhysRevLett.42.1154
   Turner RE, 2003, PHYS PLASMAS, V10, P2429, DOI 10.1063/1.1576762
   Turner RE, 2000, PHYS PLASMAS, V7, P333, DOI 10.1063/1.873801
   Wilson B, 2006, J QUANT SPECTROSC RA, V99, P658, DOI 10.1016/j.jqsrt.2005.05.053
   Wilson DC, 1998, PHYS PLASMAS, V5, P1953, DOI 10.1063/1.872865
   Wilson DC, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2229268
   Wilson DC, 2003, PHYS PLASMAS, V10, P4427, DOI 10.1063/1.1613653
   Workman J, 2001, P SOC PHOTO-OPT INS, V4504, P168, DOI 10.1117/12.448463
   YU V, 2006, REV SCI INSTRUM, V77
   ZE F, 1992, REV SCI INSTRUM, V63, P5124, DOI 10.1063/1.1143460
   Ze F, 1997, PHYS PLASMAS, V4, P778, DOI 10.1063/1.872172
   Zimmerman G. B., 1975, Comments on Plasma Physics and Controlled Fusion, V2
NR 173
TC 59
Z9 64
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 1070-664X
J9 PHYS PLASMAS
JI Phys. Plasmas
PD MAY
PY 2011
VL 18
IS 5
AR 051002
DI 10.1063/1.3592170
PG 32
WC Physics, Fluids & Plasmas
SC Physics
GA 785EF
UT WOS:000292209500006
ER

PT J
AU Grolnick, WS
   Pomerantz, EM
AF Grolnick, Wendy S.
   Pomerantz, Eva M.
TI Issues and Challenges in Studying Parental Control: Toward a New
   Conceptualization
SO CHILD DEVELOPMENT PERSPECTIVES
LA English
DT Article
DE parenting; control; structure
ID ADOLESCENT ADJUSTMENT; COMPETENCE; BEHAVIOR; SOCIALIZATION; FAMILIES;
   IMPACT; SCHOOL; CHILD; CONNECTION; DIMENSIONS
AB Although investigators have long considered parents' exertion of control over children as a central part of the socialization process, the study of control has been marked by conceptual and empirical confusion. This article outlines some of the history of the construct of control in the context of parenting, delineating the development of the contemporary approach that distinguishes among multiple forms of control. It proposes a refinement of this approach such that only parenting characterized by pressure, intrusion, and domination should be considered control, whereas parenting frequently labeled control but characterized mainly by guidance should be considered structure. This article highlights the benefits of distinguishing between these two dimensions of parenting rather than multiple forms of control.
C1 [Grolnick, Wendy S.] Clark Univ, Dept Psychol, Worcester, MA 01610 USA.
   [Pomerantz, Eva M.] Univ Illinois, Urbana, IL 61801 USA.
RP Grolnick, WS (reprint author), Clark Univ, Dept Psychol, Worcester, MA 01610 USA.
EM wgrolnick@clarku.edu; pomerntz@uiuc.edu
CR Baldwin A., 1990, RISK PROTECTIVE FACT, P257, DOI 10.1017/CBO9780511752872.016
   Baldwin A. L., 1955, BEHAV DEV CHILDHOOD
   Barber B. K., 2005, MONOGRAPHS SOC RES C, V70
   Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.1111/j.1467-8624.1996.tb01915.x
   BARBER BK, 1994, CHILD DEV, V65, P1120, DOI 10.1111/j.1467-8624.1994.tb00807.x
   Barber BK, 1997, J ADOLESCENT RES, V12, P287, DOI 10.1177/0743554897122008
   BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x
   BAUMRIND D, 1971, DEV PSYCHOL MONOGR 2, V2
   BAUMRIND D, 1967, CHILD DEV, V38, P291, DOI 10.1111/j.1467-8624.1967.tb04348.x
   Brown B. B., 1993, CHILD DEV, V63, P391
   BUSEMEYER JR, 1983, PSYCHOL BULL, V93, P549, DOI 10.1037/0033-2909.93.3.549
   Chao RK, 2001, CHILD DEV, V72, P1832, DOI 10.1111/1467-8624.00381
   Coley RL, 1996, J APPL DEV PSYCHOL, V17, P51, DOI 10.1016/S0193-3973(96)90005-2
   Deci E., 2002, HDB SELF DETERMINATI, P361
   Deci E. L., 1985, INTRINSIC MOTIVATION
   Eccles JS, 1997, J ADOLESCENT RES, V12, P263, DOI 10.1177/0743554897122007
   FARKAS M, 2008, M AM ED RES ASS NEW
   FAUBER R, 1990, CHILD DEV, V61, P1112, DOI 10.1111/j.1467-8624.1990.tb02845.x
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Gray MR, 1999, J MARRIAGE FAM, V61, P574, DOI 10.2307/353561
   GROLNICK WS, 1991, J EDUC PSYCHOL, V83, P508, DOI 10.1037/0022-0663.83.4.508
   Grolnick W. S., 1997, PARENTING CHILDRENS, P135
   Grolnick W. S., 2003, PSYCHOL PARENTAL CON
   GROLNICK WS, 1989, J EDUC PSYCHOL, V81, P143, DOI 10.1037/0022-0663.81.2.143
   GRUSEC JE, 1994, DEV PSYCHOL, V30, P4, DOI 10.1037/0012-1649.30.1.4
   HOFFMAN ML, 1960, CHILD DEV, V31, P129
   Ispa JM, 2004, CHILD DEV, V75, P1613, DOI 10.1111/j.1467-8624.2004.00806.x
   Kenney-Benson GA, 2005, J PERS, V73, P23, DOI 10.1111/j.1467-6494.2004.00303.x
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Kochanska G, 2004, CHILD DEV, V75, P1229, DOI 10.1111/j.1467-8624.2004.00735.x
   LAMBORN SD, 1991, CHILD DEV, V62, P1049, DOI 10.1111/j.1467-8624.1991.tb01588.x
   Maccoby E. E., 1983, HDB CHILD PSYCHOL, VIV, P1
   MARTIN JA, 1981, CHILD DEV, V52, P1064, DOI 10.1111/j.1467-8624.1981.tb03149.x
   Masten AS, 1995, CHILD DEV, V66, P1635, DOI 10.2307/1131901
   MCCARTHY KA, 1993, BIENN M SOC RES CHIL
   Pomerantz EM, 2005, ADV CHILD DEV BEHAV, V33, P193, DOI 10.1016/S0065-2407(05)80008-4
   Rollins B.C., 1979, CONT THEORIES FAMILY, P317
   ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55
   ROWE DC, 1981, DEV PSYCHOL, V17, P203, DOI 10.1037/0012-1649.17.2.203
   SCHAEFER ES, 1965, CHILD DEV, V36, P413, DOI 10.1111/j.1467-8624.1965.tb05305.x
   SCHAEFER ES, 1965, J CONSULT PSYCHOL, V16, P54
   Skinner E, 2005, PARENT-SCI PRACT, V5, P175, DOI 10.1207/s15327922par0502_3
   STEINBERG L, 1989, CHILD DEV, V60, P1424, DOI 10.1111/j.1467-8624.1989.tb04014.x
   Steinberg L., 1990, THRESHOLD DEV ADOLES, P255
   Symonds P. M., 1939, DYNAMICS PARENT CHIL
   Wang Q, 2007, CHILD DEV, V78, P1592, DOI 10.1111/j.1467-8624.2007.01085.x
   WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934
NR 47
TC 59
Z9 60
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1750-8592
J9 CHILD DEV PERSPECT
JI Child Develop. Perspect.
PD DEC
PY 2009
VL 3
IS 3
BP 165
EP 170
PG 6
WC Psychology, Developmental
SC Psychology
GA 524LB
UT WOS:000272143700007
ER

PT J
AU Dixon, JB
   Greiner, ST
   Gashev, AA
   Cote, GL
   Moore, JE
   Zawieja, DC
AF Dixon, J. Brandon
   Greiner, Steven T.
   Gashev, Anatoliy A.
   Cote, Gerard L.
   Moore, James E., Jr.
   Zawieja, David C.
TI Lymph flow, shear stress, and lymphocyte velocity in rat mesenteric
   prenodal lymphatics
SO MICROCIRCULATION
LA English
DT Article
DE lymphatic; lymph pump; lymph flow; lymph shear stress; lymphocyte
   trafficking
ID NITRIC-OXIDE; BLOOD-FLOW; IN-VIVO; CONTRACTILE ACTIVITY; VESSELS; PUMP;
   MICROVESSELS; CAPILLARIES; TRANSPORT; MICROLYMPHATICS
AB Objective: To measure lymphocyte velocity, lymphatic contraction, and shear stress in physically contracting lymphatics in situ.
   Methods: A high-speed video system was used to capture multiple contraction cycles in rat mesenteric lymphatic preparations. The images were analyzed to determine fluid velocity, volume flow rate, wall shear stress, and retrograde flow.
   Results: Lymphocyte density and flux varied from 326 to 35,500 cells/mu L and 206 to 2030 cells/min, respectively. Lymphatics contracted physically, with a mean diameter 91 +/- 9.0 mu m and amplitudes of 39%. Lymph velocity varied with the phasic contractions in both direction and magnitude with an average of 0.87 +/- 0.18 and peaks of 2.2-9.0 mm/s. The velocity was similar to 180 degrees out of phase with the contraction cycle. The average lymph flow was 13.95 +/- 5.27 mu L/h with transient periods of flow reversal. This resulted in an average shear of 0.64 +/- 0.14 with peaks of 4-12 dynes/cm(2).
   Conclusions: High-speed lymphocyte tracking provided the spatial and temporal resolution to measure lymphocyte flux throughout the phasic contraction. Poiseuille flow was a reasonable model for estimating wall shear stress through most of the phasic contraction cycle of the intervalvular lymphatic segments. Shear rate was low but had large variations in magnitude compared to that seen in blood vessels.
C1 Texas A&M Univ, Coll Med, Hlth Sci Ctr,Dept Syst Biol & Translat Med, Div Lymphat Biol,Cardiovasc Res Inst,Assoc Head, College Stn, TX 77843 USA.
   Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
   Texas A&M Univ, Coll Med, TAMUS Hlth Sci Ctr, Dept Syst Biol & Translat Med, College Stn, TX 77843 USA.
RP Zawieja, DC (reprint author), Texas A&M Univ, Coll Med, Hlth Sci Ctr,Dept Syst Biol & Translat Med, Div Lymphat Biol,Cardiovasc Res Inst,Assoc Head, College Stn, TX 77843 USA.
EM dcz@tamu.edu
RI Dixon, J. Brandon/A-5973-2009
CR ASOKAN SK, 1975, BRIT HEART J, V37, P604
   AUKLAND K, 1967, ACTA PHYSIOL SCAND, V70, P99, DOI 10.1111/j.1748-1716.1967.tb03604.x
   BENCHIMO.A, 1972, AM J MED, V52, P467, DOI 10.1016/0002-9343(72)90037-X
   BENOIT JN, 1989, AM J PHYSIOL, V257, pH2059
   Berk DA, 1996, AM J PHYSIOL-HEART C, V270, pH330
   BIEWENER AA, 1994, J APPL PHYSIOL, V76, P946
   BUGA GM, 1991, HYPERTENSION, V17, P187
   Burton-Opitz R, 1917, AM J PHYSIOL, V45, P25
   Cliff S, 1999, BRIT J DERMATOL, V140, P61
   COLE JS, 1977, CIRCULATION, V56, P18
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   DIXON JB, 2005, J BIOMEDICAL OPTICS, V10, P7
   Fedosov IV, 2002, TECH PHYS LETT+, V28, P690, DOI 10.1134/1.1505552
   Fedosov IV, 2002, QUANTUM ELECTRON+, V32, P970, DOI 10.1070/QE2002v032n11ABEH002330
   Fischer M, 1996, AM J PHYSIOL-HEART C, V270, pH358
   Fischer M, 1997, INT J MICROCIRC, V17, P143, DOI 10.1159/000179222
   Fox R., 1998, INTRO FLUID MECH
   Galanzha EI, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2060567
   Gashev AA, 2006, AM J PHYSIOL-HEART C, V290, pH2295, DOI 10.1152/ajpheart.00260.2005
   Gashev AA, 2004, MICROCIRCULATION, V11, P477, DOI 10.1080/10739680490476033
   GASHEV AA, 1989, DOKL AKAD NAUK SSSR+, V308, P1261
   Gashev AA, 2002, J PHYSIOL-LONDON, V540, P1023, DOI 10.1113/jphysiol.2002.016642
   Guyton A. C., 1996, TXB MED PHYSL
   HARGENS AR, 1977, AM J PHYSIOL, V233, pH57
   Havas E, 1997, J PHYSIOL-LONDON, V504, P233, DOI 10.1111/j.1469-7793.1997.233bf.x
   Koller A, 1999, AM J PHYSIOL-REG I, V277, pR1683
   Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966
   MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796
   MCHALE NG, 1976, J PHYSIOL-LONDON, V261, P255
   MIURA S, 1987, AM J PHYSIOL, V253, pG596
   Mizuno R, 1998, AM J PHYSIOL-REG I, V274, pR790
   Muthuchamy M, 2003, FASEB J, V17, P920, DOI 10.1096/fj.02-0626fje
   NAKAMURA T, 1968, TOHOKU J EXP MED, V95, P135
   NEILD TO, 1989, BLOOD VESSELS, V26, P48
   OLSZEWSKI WL, 1980, AM J PHYSIOL, V239, pH775
   REDDY NP, 1986, CRIT REV BIOMED ENG, V14, P45
   Sakai H, 1999, AM J PHYSIOL-HEART C, V277, pH459
   SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987
   Shirasawa Y, 2000, AM J PHYSIOL-GASTR L, V278, pG551
   Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324
   UlYanov SS, 1996, LASER MED SCI, V11, P97, DOI 10.1007/BF02133206
   von der Weid PY, 2001, AM J PHYSIOL-HEART C, V280, pH2707
   WHANG CJ, 1975, STROKE, V6, P445
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283
   ZUROVSKY Y, 1995, EXP PHYSIOL, V80, P203
   ZWICKER E, 1974, ACTA OTO-LARYNGOL, V78, P65, DOI 10.3109/00016487409126327
NR 47
TC 59
Z9 61
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1073-9688
J9 MICROCIRCULATION
JI Microcirculation
PD OCT-NOV
PY 2006
VL 13
IS 7
BP 597
EP 610
DI 10.1080/10739680600893909
PG 14
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 095RT
UT WOS:000241326300006
PM 16990218
ER

PT J
AU Ray, ME
   Thames, HD
   Levy, LB
   Horwitz, EM
   Kupelian, PA
   Martinez, AA
   Michalski, JM
   Pisansky, TM
   Shipley, WU
   Zelefsky, MJ
   Zietman, AL
   Kuban, DA
AF Ray, ME
   Thames, HD
   Levy, LB
   Horwitz, EM
   Kupelian, PA
   Martinez, AA
   Michalski, JM
   Pisansky, TM
   Shipley, WU
   Zelefsky, MJ
   Zietman, AL
   Kuban, DA
TI PSA nadir predicts biochemical and distant failures after external beam
   radiotherapy for prostate cancer: A multi-institutional analysis
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT 46th Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology
CY OCT 17-20, 2004
CL Atlanta, GA
SP Amer Soc Therapeut Radiol & Oncol
DE prostate cancer; PSA nadir; external beam radiotherapy
ID DISEASE-FREE SURVIVAL; RADIATION-THERAPY; ANTIGEN NADIR; DOSE-RESPONSE;
   CONFORMAL RADIOTHERAPY; PRETREATMENT NOMOGRAM; LOCALIZED CARCINOMA;
   STAGE T1-T2; IRRADIATION; ESCALATION
AB Purpose: To determine the significance of prostate-specific antigen (PSA) nadir (nPSA) and the time to nPSA (T-nPSA) in predicting biochemical or clinical disease-free survival (PSA-DFS) and distant metastasis-free survival (DMFS) in patients treated with definitive external beam radiotherapy (RT) for clinical Stage T1b-T2 prostate cancer.
   Methods and Materials: Nine participating institutions submitted data on 4839 patients treated between 1986 and 1995 for Stage T1b-T2cN0-NxM0 prostate cancer. All patients were treated definitively with RT alone to doses >= 60 Gy, without neoadjuvant or planned adjuvant androgen suppression. A total of 4833 patients with a median follow-up of 6.3 years met the criteria for analysis. Two endpoints were considered: (1) PSA-DFS, defined as freedom from PSA failure (American Society for Therapeutic Radiology and Oncology definition), initiation of androgen suppression after completion of RT, or documented local or distant failure; and (2) DMFS, defined as freedom from clinically apparent distant failure. In patients with failure, nPSA was defined as the lowest PSA measurement before any failure. In patients without failure, nPSA was the lowest PSA measurement during the entire follow-up period. T-nPSA was calculated from the completion of RT to the nPSA date.
   Results: A greater nPSA level and shorter T-nPSA were associated with decreased PSA-DFS and DMFS in all patients and in all risk categories (low [Stage T1b, T1c, or T2a, Gleason score <= 6, and PSA level <= 10 ng/mL], intermediate [Stage T1b, T1c, or T2a, Gleason score <= 6, and PSA level >10 but <= 20 ng/mL, or Stage T2b or T2c, Gleason score <= 6, and PSA level <= 20 ng/mL, or Gleason score 7 and PSA level <= 20 ng/mL], and high [Gleason score 8-10 or PSA level >20 ng/mL]), regardless of RT dose. The 8-year PSA-DFS and DMFS rate for patients with nPSA <0.5 ng/mL was 75% and 97%; nPSA >= 0.5 but <1.0 ng/mL, 52% and 96%; nPSA >= 1.0 but <2.0 ng/mL, 40% and 91%; and nPSA >= 2.0 ng/mL, 17% and 73%, respectively. The 8-year PSA-DFS and DMFS rate for patients with T-nPSA <6 months was 27% and 66%; T-nPSA >= 6 but <12 months, 31% and 85%; T-nPSA >= 12 but <24 months, 42% and 94%; and T-nPSA >= 24 months, 75% and 99%, respectively. A shorter T-nPSA was associated with decreased PSA-DFS and DMFS, regardless of the nPSA. Both nPSA and T-nPSA were significant predictors of PSA-DFS and DMFS in multivariate models incorporating clinical stage, Gleason score, initial PSA level, and RT dose. The significance of nPSA and T-nPSA was supported by landmark analysis, as well as by analysis of nPSA and T-nPSA as time-dependent covariates. A dose >= 70 Gy was associated with a lower nPSA level and longer T-nPSA in all risk categories, and a greater dose was significantly associated with greater PSA-DFS and DMFS in multivariate analysis. Regression analysis confirmed that higher clinical stage, Gleason score, and initial PSA were associated with a greater nPSA level.
   Conclusion: The results of this large, multi-institutional analysis of 4833 patients have provided important evidence that nPSA and T-nPSA after definitive external beam RT are not only predictive of a predominantly PSA endpoint (PSA-DFS), but are also predictive of distant metastasis in all clinical risk categories. Greater RT doses were associated with lower nPSA, longer T-nPSA, and improved PSA-DFS and DMFS. (C) 2006 Elsevier Inc.
C1 Univ Michigan, Med Ctr, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA.
   Univ Texas, MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA.
   Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA.
   Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA.
   William Beaumont Hosp, Royal Oak, MI 48072 USA.
   Edward Mallinckrodt Inst Radiol, Dept Radiat Oncol, St Louis, MO 63110 USA.
   Mayo Clin, Coll Med, Div Radiat Oncol, Rochester, MN USA.
   Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA.
   Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA.
RP Ray, ME (reprint author), Univ Michigan, Med Ctr, Dept Radiat Oncol, UH-B2C490,Box 0010,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.
EM mray@umich.edu
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Aref I, 1998, RADIOTHER ONCOL, V48, P203, DOI 10.1016/S0167-8140(98)00061-9
   Breiman L., 1984, CLASSIFICATION REGRE
   Cavanaugh SX, 2004, CANCER, V101, P96, DOI 10.1002/cncr.20328
   Cheung R, 2003, INT J RADIAT ONCOL, V56, P1234, DOI 10.1016/S0360-3016(03)00278-5
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   Critz FA, 2002, J UROLOGY, V168, P2434, DOI 10.1097/01.ju.0000030581.57555.04
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   D'Amico AV, 1999, J CLIN ONCOL, V17, P168
   DeWitt KD, 2003, UROLOGY, V62, P492, DOI 10.1016/S0090-4295(03)00460-6
   Hanlon AL, 2002, INT J RADIAT ONCOL, V53, P297, DOI 10.1016/S0360-3016(02)02717-7
   Kaminski JM, 2002, INT J RADIAT ONCOL, V52, P888, DOI 10.1016/S0360-3016(01)02764-X
   Kattan MW, 2000, J CLIN ONCOL, V18, P3352
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   Kuban DA, 2003, INT J RADIAT ONCOL, V57, P915, DOI 10.1016/S0360-3016(03)00632-1
   Kupelian PA, 2001, INT J RADIAT ONCOL, V50, P621, DOI 10.1016/S0360-3016(01)01466-3
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   McLaughlin PW, 1996, J CLIN ONCOL, V14, P2889
   Perez CA, 2001, INT J RADIAT ONCOL, V49, P1287, DOI 10.1016/S0360-3016(00)01492-9
   Pisansky TM, 1997, CANCER, V79, P2154, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2154::AID-CNCR13>3.0.CO;2-V
   Pollack A, 2004, J UROLOGY, V171, P1132, DOI 10.1097/01.ju.0000111844.95024.74
   Pollack A, 2000, J CLIN ONCOL, V18, P3904
   Pollack A, 2002, INT J RADIAT ONCOL, V54, P677, DOI 10.1016/S0360-3016(02)02977-2
   Pollack A, 2000, INT J RADIAT ONCOL, V48, P507, DOI 10.1016/S0360-3016(00)00620-9
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Symon Z, 2003, INT J RADIAT ONCOL, V57, P384, DOI 10.1016/S0360-3016(03)00569-8
   Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
   Zietman A, 2004, INT J RADIAT ONCOL, V60, pS131, DOI 10.1016/S0360-3016(04)01087-9
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
NR 36
TC 59
Z9 60
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD MAR 15
PY 2006
VL 64
IS 4
BP 1140
EP 1150
DI 10.1016/j.ijrobp.2005.07.006
PG 11
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 020GQ
UT WOS:000235897100022
PM 16198506
ER

PT J
AU Wilting, J
   Neeff, H
   Christ, B
AF Wilting, J
   Neeff, H
   Christ, B
TI Embryonic lymphangiogenesis
SO CELL AND TISSUE RESEARCH
LA English
DT Review
DE lymphatic endothelial cell; lymph heart; lymphangiogenesis; VEGF-C;
   chick embryo
ID ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; RECEPTOR
   TYROSINE KINASES; VEGF-C; LYMPHATIC VESSELS; CHORIOALLANTOIC MEMBRANE;
   MONOCLONAL-ANTIBODY; CELL GROWTH; IN-VIVO; ANGIOGENESIS
AB About 8-9 decades ago the development of embryonic lymphatics was studied intensively. Since then our knowledge has not considerably increased in this field, and it is still unknown whether lymphatics are derived by sprouting from veins, de novo from lymphangioblasts, or by both mechanisms. However, very recent studies have shown that the vascular endothelial growth factor-C (VEGF-C) is a highly specific lymphangiogenic growth factor. This raises new questions and perspectives. Here we will review the literature on embryonic lymphangiogenesis and lymphangiogenic growth factors. We also present a description of the pattern of the lymphatics of avian embryos with emphasis on lymph hearts. The avian embryo is highly suited for studies on lymphatics, because these can be demonstrated by injection methods, serial sectioning and in situ hybridization with VEGF-receptor-2 and -3 probes. The greatest advantage resides in the fact that the lymphatics of the chorioallantoic membrane are easily accessible for experimental studies.
C1 Univ Freiburg, Inst Anat, D-79104 Freiburg, Germany.
RP Wilting, J (reprint author), Univ Freiburg, Inst Anat, Albertstr 17, D-79104 Freiburg, Germany.
CR Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548
   ALLEN EV, 1946, PERIPHERAL VASCULAR
   BARSKY SH, 1983, AM J SURG PATHOL, V7, P667, DOI 10.1097/00000478-198310000-00007
   BAUM H, 1930, LYMPHGEFASSSYSTEM HU
   BELLMAN S, 1958, ACTA CHIR SCAND, V116, P99
   BOLLINGER A, 1981, CIRCULATION, V64, P1195
   Budge Albrecht, 1880, Archiv fuer Anatomie und Physiologie, P320
   BUDGE A, 1882, ARCH ANAT ENTWICKL G, P350
   Budge A., 1887, Archiv fuer Anatomie und Physiologie (Anat), P59
   BUDRAS KD, 1987, J MORPHOL, V191, P77, DOI 10.1002/jmor.1051910108
   CARMELIET P, 1996, NATURE, V380, P439
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   CASLEYSMITH JR, 1980, LYMPHOLOGY, V12, P177
   Clark EL, 1912, ANAT REC, V6, P247, DOI 10.1002/ar.1090060604
   CLARK EL, 1914, ANAT REC, V8, P80
   CLARK ER, 1920, CONTR EMBRYOL, V9, P447
   Clark ER, 1909, ANAT REC, V3, P183, DOI 10.1002/ar.1090030407
   CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322
   DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657
   DUMONT AE, 1993, J NATL CANCER I, V85, P74
   Eichmann A, 1998, DEVELOPMENT, V125, P743
   EICHMANN A, 1993, MECH DEVELOP, V42, P33, DOI 10.1016/0925-4773(93)90096-G
   Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090
   EZAKI T, 1990, ARCH HISTOL CYTOL, V53, P77, DOI 10.1679/aohc.53.Suppl_77
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Feucht M, 1997, AM J PATHOL, V151, P1407
   FOLKMAN J, 1985, ADV CANCER RES, V43, P175
   Folkman J, 1996, NEW ENGL J MED, V334, P921
   FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0
   FULLEBORN F, 1895, BEITRAGE ENTWICKLUNG, P1
   HOYER H, 1922, GEGENBAURS MORPHOL J, V51, P1
   Huntington GS, 1908, ANAT REC, V2, P19, DOI 10.1002/ar.1090020103
   Isner JM, 1996, HUM GENE THER, V7, P959, DOI 10.1089/hum.1996.7.8-959
   Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423
   Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898
   Joukov V, 1996, EMBO J, V15, P290
   KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566
   Kampmeier OF, 1912, ANAT REC, V6, P223, DOI 10.1002/ar.1090060602
   Korpelainen EI, 1998, CURR OPIN CELL BIOL, V10, P159, DOI 10.1016/S0955-0674(98)80137-3
   Kukk E, 1996, DEVELOPMENT, V122, P3829
   LEE J, 1996, P NATL ACAD SCI USA, V88, P9267
   Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Lewis FT, 1905, AM J ANAT, V5, P95, DOI 10.1002/aja.1000050107
   MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9
   Miller AM, 1913, AM J ANAT, V15, P131, DOI 10.1002/aja.1000150202
   MULLER KHG, 1995, LYMPHGEFASSSYSTEM LY
   NICKEL R, 1992, LEHRBUCH ANATOMIE HA, V5
   Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639
   Olofsson B, 1996, J BIOL CHEM, V271, P19310
   Orlandini M, 1996, P NATL ACAD SCI USA, V93, P11675, DOI 10.1073/pnas.93.21.11675
   PARDANAUD L, 1987, DEVELOPMENT, V100, P339
   PARDANAUD L, 1989, DEVELOPMENT, V105, P473
   PARK JE, 1994, J BIOL CHEM, V269, P25646
   PURI MC, 1995, EMBO J, V14, P5884
   RANVIER L, 1895, CR HEBD ACAD SCI, V121, P1105
   RUSZNYAK I, 1969, LYMPHOLOGIE PHYSL PA
   Sabin FR, 1909, AM J ANAT, V9, P43, DOI 10.1002/aja.1000090104
   SALA L, 1900, RIC LAB ANAT NORM, V7, P899
   SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0
   Sawa Y, 1997, MICROVASC RES, V53, P142, DOI 10.1006/mvre.1996.2000
   SCHMELZ M, 1994, DIFFERENTIATION, V57, P97, DOI 10.1046/j.1432-0436.1994.5720097.x
   SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   SURI C, 1998, VASCULAR MORPHOGENES, P65
   Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9
   TANIGAWA N, 1981, LYMPHOLOGY, V14, P149
   TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2
   Tondury G, 1972, HDB ALLGEMEINEN PATH, V3, P1
   vanNetten JP, 1996, NEW ENGL J MED, V334, P920
   Van der Jagt ER, 1932, Q J MICROSC SCI, V75, P151
   VANDERPUTTE SCJ, 1975, ADV ANAT EMBRYOL CEL, V51, P1
   VONRAUTENFELD DB, 1993, LEHRBUCH LYMPHOLOGIE, P202
   VONRAUTENFELD DB, 1981, LYMPHOLOGY, V14, P186
   VONRAUTENFELD DB, 1994, BENNINGHOFF A ANATOM, P756
   WERNER JA, 1989, ACTA HISTOCHEM, V85, P15
   Wilting J, 1996, NATURWISSENSCHAFTEN, V83, P153, DOI 10.1007/s001140050265
   Wilting J, 1997, CELL TISSUE RES, V288, P207, DOI 10.1007/s004410050807
   WILTING J, 1992, ANAT EMBRYOL, V186, P251
   WILTING J, 1998, VASCULAR MORPHOGENES, P21
   Wilting J, 1996, DEV BIOL, V176, P76, DOI 10.1006/dbio.1996.9993
   Witte MH, 1997, REGULATION ANGIOGENE, P65
   Yamada Y, 1997, GENOMICS, V42, P483, DOI 10.1006/geno.1997.4774
   ZEIDMAN I, 1955, CANCER, V8, P123, DOI 10.1002/1097-0142(1955)8:1<123::AID-CNCR2820080116>3.0.CO;2-A
NR 86
TC 59
Z9 64
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD JUL
PY 1999
VL 297
IS 1
BP 1
EP 11
DI 10.1007/s004410051328
PG 11
WC Cell Biology
SC Cell Biology
GA 210DA
UT WOS:000081088800001
PM 10398878
ER

PT J
AU Zeitlin, SI
   Sherman, J
   Raboy, A
   Lederman, G
   Albert, P
AF Zeitlin, SI
   Sherman, J
   Raboy, A
   Lederman, G
   Albert, P
TI High dose combination radiotherapy for the treatment of localized
   prostate cancer
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate neoplasms; brachytherapy; radiotherapy
ID EXTERNAL-BEAM RADIOTHERAPY; RADICAL PROSTATECTOMY; I-125 IMPLANTATION;
   ANTIGEN; CARCINOMA; IRRADIATION; BRACHYTHERAPY; RADIATION
AB Purpose: We evaluate the efficacy of high dose combination radiotherapy for the treatment of localized prostate cancer.
   Materials and Methods: A total of 212 patients with localized prostate cancer (T1-T3) were treated with transperineal radioactive seed implantation followed by 45 Gy. external beam radiation therapy. Patients with Gleason scores of 2-5 were treated with (125)iodine at a minimum peripheral dose of 120 Gy., while (103)palladium at a minimum peripheral dose of 90 Gy. was used for those with Gleason scores of 7-10. Patients with Gleason 6 diploid tumors were treated with (125)iodine and those with aneuploid tumors were treated with (103)palladium. Biochemical failure was defined as inability to achieve a prostate specific antigen nadir value of 0.5 ng./ml. or less. No patient was treated with androgen deprivation therapy.
   Results: The 212 patients have a minimum of 24 months of followup (mean 33 months). Prostate specific antigen 0.5 ng./ml. or less was reached by 72% of the patients (152 of 212) and positive biopsies were detected in 13.9% (20 of 144), Using life table survivorship analysis the probability of initial biochemical success at 5 years was 91% (95% confidence interval, 83 to 97). The probability of subsequent failure following an initial success was 11% (95% confidence interval, 6 to 20) at 24 months. The complications of combination therapy included proctitis in 21.4% (47 of 212 men), impotence in 38% (38 of 100), urinary retention in 1.5%, incontinence in 2.8%, rectoprostate fistula in 2.4%, rectal wall breakdown in 0.5% and urethral stricture in 0.5%. Six patients (2.8%) required colostomy and urinary diversion.
   Conclusions: Short-term responses to high dose combination radiotherapy for localized prostate cancer are promising. The morbidity is acceptable. Further long-term followup is warranted to assess this treatment.
C1 Staten Isl Univ Hosp, Dept Urol, Staten Isl, NY 10305 USA.
   Staten Isl Univ Hosp, Dept Radiat Oncol, Staten Isl, NY USA.
   SUNY Hlth Sci Ctr, Dept Urol, Brooklyn, NY 11203 USA.
RP Zeitlin, SI (reprint author), Staten Isl Univ Hosp, Dept Urol, Staten Isl, NY 10305 USA.
CR Blasko J C, 1991, Scand J Urol Nephrol Suppl, V137, P113
   Blasko John C., 1994, International Journal of Radiation Oncology Biology Physics, V30, P219, DOI 10.1016/0360-3016(94)90738-2
   CATALONA WJ, 1990, J UROLOGY, V143, P538
   COX JD, 1977, CANCER, V40, P156, DOI 10.1002/1097-0142(197707)40:1<156::AID-CNCR2820400126>3.0.CO;2-#
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537
   HOLM HH, 1983, J UROLOGY, V130, P283
   Iversen P, 1991, Scand J Urol Nephrol Suppl, V138, P109
   KAYE KW, 1995, J UROLOGY, V153, P1020, DOI 10.1016/S0022-5347(01)67626-2
   LEE WR, 1995, J CLIN ONCOL, V13, P464
   Mettlin CJ, 1996, CANCER, V77, P2162
   PATEL J, 1990, UROLOGY, V36, P27, DOI 10.1016/0090-4295(90)80307-9
   PORTER AT, 1995, CA-CANCER J CLIN, V45, P165, DOI 10.3322/canjclin.45.3.165
   Raboy A, 1997, J UROLOGY, V158, P2202, DOI 10.1016/S0022-5347(01)68195-3
   SCHELLHAMMER PF, 1980, J UROLOGY, V123, P700
   STAMEY TA, 1993, J UROLOGY, V150, P1856
   STEINER MS, 1991, J UROLOGY, V145, P512
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   WHITMORE WF, 1972, J UROLOGY, V108, P918
   ZELEFSKY MJ, 1995, J CLIN ONCOL, V13, P459
NR 22
TC 59
Z9 59
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD JUL
PY 1998
VL 160
IS 1
BP 91
EP 94
DI 10.1016/S0022-5347(01)63042-8
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA ZT003
UT WOS:000074037800035
PM 9628612
ER

PT J
AU Polascik, TJ
   Pound, CR
   DeWeese, TL
   Walsh, PC
AF Polascik, TJ
   Pound, CR
   DeWeese, TL
   Walsh, PC
TI Comparison of radical prostatectomy and iodine 125 interstitial
   radiotherapy for the treatment of clinically localized prostate cancer:
   A 7-year biochemical (PSA) progression analysis
SO UROLOGY
LA English
DT Article
ID RETROPUBIC PROSTATECTOMY
AB Objectives. To evaluate the relative efficacy of brachytherapy to radical prostatectomy, we compared biochemical progression rates from a published series of men who underwent iodine 125 (I-125) interstitial radiotherapy for localized prostate cancer to a similar group of men who underwent anatomic radical prostatectomy using appropriate end points.
   Methods. Seventy-six men who underwent anatomic radical prostatectomy between 1988 and 1990 were carefully matched for Gleason score and clinical stage to a recently reported contemporary series of patients treated at another institution with I-125 brachytherapy without adjuvant treatment. The definition of biochemical progression was a serum PSA level greater than 0.2 ng/mL after anatomic radical prostatectomy and greater than 0.5 ng/mL for brachytherapy-treated patients.
   Results. The 7-year actuarial PSA progression-free survival following anatomic radical prostatectomy was 97.8% (95% confidence interval [CI], 85.6% to 99.7%) for this group of men selected to match the brachytherapy group, compared to 79% (95% CI not published) for men treated with I-125 interstitial radiotherapy.
   Conclusions. Using comparative end points for biochemical-free progression, failure rates may be higher following I-125 interstitial radiotherapy compared to anatomic radical prostatectomy. These data provide a better comparison of biochemical progression than previously published studies and emphasize the need for caution in interpreting the relative efficacy of brachytherapy in controlling localized prostate cancer. (C) 1998, Elsevier Science Inc. All rights reserved.
C1 Johns Hopkins Hosp, Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21287 USA.
   Johns Hopkins Hosp, Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Radiat Oncol, Baltimore, MD 21287 USA.
RP Walsh, PC (reprint author), Johns Hopkins Hosp, Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, 600 N Wolfe St, Baltimore, MD 21287 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   BASTACKY SI, 1995, J UROLOGY, V153, P987, DOI 10.1016/S0022-5347(01)67619-5
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   Cadeddu JA, 1997, UROLOGY, V50, P251, DOI 10.1016/S0090-4295(97)00186-6
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   DAmico AV, 1996, J CLIN ONCOL, V14, P304
   Epstein JI, 1996, AM J SURG PATHOL, V20, P286, DOI 10.1097/00000478-199603000-00004
   Epstein JI, 1996, UROL CLIN N AM, V23, P651, DOI 10.1016/S0094-0143(05)70343-8
   EPSTEIN JI, 1993, CANCER, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y
   Grimm PD, 1996, HEMATOL ONCOL CLIN N, V10, P653, DOI 10.1016/S0889-8588(05)70359-2
   Hanks GE, 1997, UROLOGY, V50, P87, DOI 10.1016/S0090-4295(97)00226-4
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
NR 18
TC 59
Z9 64
PU CAHNERS PUBL CO
PI NEW YORK
PA 249 WEST 17 STREET, NEW YORK, NY 10011 USA
SN 0090-4295
J9 UROLOGY
JI UROLOGY
PD JUN
PY 1998
VL 51
IS 6
BP 884
EP 889
DI 10.1016/S0090-4295(98)00153-8
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA ZP380
UT WOS:000073746500006
PM 9609622
ER

PT J
AU Callahan, DA
AF Callahan, DA
TI Chamber propagation physics for heavy ion fusion
SO FUSION ENGINEERING AND DESIGN
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Heavy Ion Inertial Fusion
CY SEP 06-09, 1995
CL PRINCETON, NJ
HO PRINCETON PLASMA PHYS LAB
ID INERTIAL FUSION
AB Chamber transport is a key area of study for heavy ion fusion. Final focus and chamber transport are high leverage areas providing opportunities to decrease significantly the cost of electricity from a heavy ion fusion power plant. Chamber transport in two basic regimes is under consideration. In the low chamber density regime (below about 0.003 Torr), ballistic or nearly ballistic transport is used. Partial beam neutralization has been studied to offset the effects of beam stripping. In the high chamber density regime (above about 0.1 Torr), two transport modes (pinched transport and channel transport) are under investigation. Both involve focusing the beam outside the chamber and then transporting it at small radius (about 2 mm). Both high chamber density modes relax the constraints on the beam quality needed from the accelerator which will reduce the driver cost and the cost of electricity.
RP Callahan, DA (reprint author), LAWRENCE LIVERMORE NATL LAB, POB 808 L-440, LIVERMORE, CA 94551 USA.
CR BADGER B, 1984, UWFDM625
   BARBOZA N, 1994, COMMUNICATION
   BARLETTA WA, 1984, P INT S HEAV ION ACC
   Birdsall C. K., 1985, PLASMA PHYSICS VIA C
   BOGGASCH E, 1992, APPL PHYS LETT, V60, P2475, DOI 10.1063/1.107443
   BOYD JK, 1984, P INT S HEAV ION ACC
   BRADY VO, 1987, LBL23040
   BUCHANAN HL, 1979, P 3 TOP C HIGH POW E
   CALLAHAN DA, 1995, P 1995 PART ACC C DA
   CALLAHAN DA, 1995, APPL PHYS LETT, V67, P27
   CHEN P, 1990, PHYS REV LETT, V64, P1231, DOI 10.1103/PhysRevLett.64.1231
   Hahn K, 1996, FUSION ENG DES, V32-33, P417, DOI 10.1016/S0920-3796(96)00497-8
   HAHN KD, 1996, COMMUNICATION, V32, P417
   HAHN KD, 1995, COMMUNICATION
   Ho DDM, 1996, NUCL FUSION, V36, P769, DOI 10.1088/0029-5515/36/6/I08
   Ho D. D.-M., 1991, Particle Accelerators, V36
   HO DDM, 1995, 7 INT S HEAV ION IN
   HOFMANN I, 1993, J APPL PHYS, V73, P7061, DOI 10.1063/1.352374
   LANGDON AB, 1991, B AM PHYS SOC, V35, P2415
   Langdon A. B., 1992, Particle Accelerators, V37-38
   LANGDON AB, 1992, COMPUT PHYS COMMUN, V70, P447
   LEE EP, 1986, HEAVY ION INERTIAL F, P461
   LEE EP, 1993, NUOVO CIMENTO A, V106, P1679, DOI 10.1007/BF02821267
   LEMONS DS, 1986, HEAVY ION INERTIAL F, P287
   MAGELSSEN GR, 1986, HEAVY ION INERTIAL F, P330
   Meier W. R., 1992, WJSA9201
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   OLSON CL, 1994, SAND950116 SNL
   PETZOLDT RW, 1995, THESIS U CALIFORNIA
   TAUCHWITZ A, 1995, P 1995 PART ACC C DA
   Tauschwitz A, 1996, FUSION ENG DES, V32-33, P493, DOI 10.1016/S0920-3796(96)00505-4
   Vay JL, 1996, FUSION ENG DES, V32-33, P467, DOI 10.1016/S0920-3796(96)00502-9
   Yu SS, 1996, FUSION ENG DES, V32-33, P309, DOI 10.1016/S0920-3796(96)00483-8
NR 33
TC 59
Z9 59
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0920-3796
J9 FUSION ENG DES
JI Fusion Eng. Des.
PD NOV
PY 1996
VL 32-33
BP 441
EP 452
DI 10.1016/S0920-3796(96)00500-5
PG 12
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA WC005
UT WOS:A1996WC00500059
ER

PT J
AU Tomic, V
   Russwurm, S
   Moller, E
   Claus, RA
   Blaess, M
   Brunkhorst, F
   Bruegel, M
   Bode, K
   Bloos, F
   Wippermann, J
   Wahlers, T
   Deigner, HP
   Thiery, J
   Reinhart, K
   Bauer, M
AF Tomic, V
   Russwurm, S
   Moller, E
   Claus, RA
   Blaess, M
   Brunkhorst, F
   Bruegel, M
   Bode, K
   Bloos, F
   Wippermann, J
   Wahlers, T
   Deigner, HP
   Thiery, J
   Reinhart, K
   Bauer, M
TI Transcriptomic and proteomic patterns of systemic inflammation in
   on-pump and off-pump coronary artery bypass grafting
SO CIRCULATION
LA English
DT Article
DE immunology; cardiopulmonary bypass; inflammation; leukocytes; molecular
   biology
ID CARDIOPULMONARY BYPASS; SURGERY; EXPRESSION; REVASCULARIZATION;
   CIRCULATION
AB Background-Coronary artery bypass grafting (CABG) using cardiopulmonary bypass (CPB) provides controlled operative conditions but induces a whole-body inflammatory response capable of initiating devastating morbidity and mortality. Although technically more demanding, deliberate avoidance of CPB in off-pump surgery attenuates the physiological insult associated with CABG.
   Methods and Results-To systematically assess the molecular mechanisms underlying the better-preserved remote organ function, we studied gene expression patterns in leukocytes and plasma proteomic response to on-pump and off-pump CABG. Proteomic analysis confirmed ( tumor necrosis factor-alpha, interleukin [IL]-6, IL-10) and expanded (eg, interferon [ IFN]-gamma, granulocyte colony - stimulating factor [G-CSF], monocyte chemotactic protein-1, macrophage inflammatory protein-1 beta)the mediators released on CPB, whereas blood leukocyte transcriptomics suggested that circulating leukocytes are not primarily responsible for this response. Interestingly, release of some cytokines (eg, IL-6, IFN-gamma, G-CSF) was observed on off-pump surgery to a similar extent but with delayed kinetics. A total of 45 of 4868 transcripts were identified to be significantly altered as a result of initiation of CPB. Systematic analysis of transcriptional activation by CPB revealed primarily genes involved in inflammation-related cell - cell communication ( such as L-selectin or intercellular adhesion molecule-2)and signaling ( such as IL-1, IL-8, or IL-18 receptors and toll-like receptors 4, 5, and 6), thus confirming a "primed" phenotype of circulating peripheral blood mononuclear cells.
   Conclusions-Gene array and multiplex protein analysis, only in concert, can illuminate the molecular mechanisms responsible for systemic sequelae of CPB and indicate that circulating leukocytes overexpress adhesion and signaling factors after contact with CPB, which potentially facilitates their trapping, eg, in the lungs and may promote a subsequent tissue-associated inflammatory response.
C1 Univ Jena, Dept Anesthesiol & Intens Care Med, D-07740 Jena, Germany.
   Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.
   Univ Jena, Dept Cardiothorac & Vasc Surg, D-07740 Jena, Germany.
   SIRS Lab GmbH, Jena, Germany.
RP Bauer, M (reprint author), Univ Jena, Dept Anesthesiol & Intens Care Med, Erlanger Allee 101, D-07740 Jena, Germany.
EM michael.bauer@med.uni-jena.de
CR Al-Ruzzeh S, 2003, EUR J CARDIO-THORAC, V23, P50, DOI 10.1016/S1010-7940(02)00654-1
   Badolato R, 2004, J LEUKOCYTE BIOL, V76, P1, DOI 10.1189/jlb.1103529
   BEUTLER BA, 1985, J IMMUNOL, V135, P3972
   Bonchek LI, 1998, CIRCULATION, V98, P495
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046
   Comerford Iain, 2005, Immunology Letters, V96, P163, DOI 10.1016/j.imlet.2004.08.018
   *COMM RES DEV I ST, 1998, CONTR CARD DIS DEV C
   Feezor RJ, 2004, J IMMUNOL, V172, P7103
   Gregersen PK, 2003, GENES IMMUN, V4, P175, DOI 10.1038/sj.gene.6363976
   Grundmann U, 2000, ANESTHESIOLOGY, V93, P359, DOI 10.1097/00000542-200008000-00013
   Huber W., 2003, STAT APPL GENET MOL, V2, DOI 10.2202/1544-6115.1008
   Laffey JG, 2002, ANESTHESIOLOGY, V97, P215
   Lauter J, 1996, BIOMETRICS, V52, P964, DOI 10.2307/2533057
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Linscheid P, 2004, CRIT CARE MED, V32, P1715, DOI 10.1097/01.CCM.0000134404.63292.71
   Massoudy P, 2001, CHEST, V119, P31, DOI 10.1378/chest.119.1.31
   Massoudy P, 1999, Eur J Med Res, V4, P178
   Meldrum DR, 1997, ANN SURG, V226, P587, DOI 10.1097/00000658-199711000-00003
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Okubo Naoko, 2003, Ann Thorac Cardiovasc Surg, V9, P43
   Prucha M, 2004, SHOCK, V22, P29, DOI 10.1097/01.shk.0000129199.30965.02
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Sabiston DC, 1997, ANN SURG, V226, P153, DOI 10.1097/00000658-199708000-00006
   Sharif MN, 2004, J IMMUNOL, V172, P6476
   Simon RM, 2003, DESIGN ANAL DNA MICR
   STOREY JD, 2003, P NATL ACAD SCI USA, V16, P9440
   Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520
   Verma S, 2004, CIRCULATION, V109, P1206, DOI 10.1161/01.CIR.0000120292.65143.F5
   WHITNEY AR, 2003, P NATL ACAD SCI USA, V100, P896
   Wildhirt SM, 2001, SHOCK, V16, P55
   Yacoub M, 2001, CIRCULATION, V104, P1743
NR 32
TC 58
Z9 59
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD NOV 8
PY 2005
VL 112
IS 19
BP 2912
EP 2920
DI 10.1161/CIRCULATIONAHA.104.531152
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 981UT
UT WOS:000233114200006
PM 16275880
ER

PT J
AU Knowles, R
   Griebsch, I
   Dezateux, C
   Brown, J
   Bull, C
   Wren, C
AF Knowles, R
   Griebsch, I
   Dezateux, C
   Brown, J
   Bull, C
   Wren, C
TI Newborn screening for congenital heart defects: a systematic review and
   cost-effectiveness analysis
SO HEALTH TECHNOLOGY ASSESSMENT
LA English
DT Review
ID VENTRICULAR SEPTAL-DEFECT; QUALITY-OF-LIFE; ARTERIAL-SWITCH OPERATION;
   TERM-FOLLOW-UP; DUCHENNE MUSCULAR-DYSTROPHY; LOW-BIRTH-WEIGHT;
   HYPOTHERMIC CIRCULATORY ARREST; PULMONARY VENOUS CONNECTION; RANDOMIZED
   CONTROLLED-TRIAL; AORTOPULMONARY COLLATERAL ARTERIES
AB Objectives: To provide evidence to inform policy decisions about the most appropriate newborn screening strategy for congenital heart defects, identifying priorities for future research that might reduce important uncertainties in the evidence base for such decisions.
   Data sources: Electronic databases. Groups of parents and health professionals.
   Review methods: A systematic review of the published medical literature concerning outcomes for children with congenital heart defects was carried out. A decision analytic model was developed to assess the cost-effectiveness of alternative screening strategies for congenital heart defects relevant to the UK. A further study was then carried out using a self-administered anonymous questionnaire to explore the perspectives of parents and health professionals towards the quality of life of children with congenital heart defects. The findings from a structured review of the medical literature regarding parental experiences were linked with those from a focus group of parents of children with congenital heart defects.
   Results: Current newborn screening policy comprises a clinical examination at birth and 6 weeks, with specific cardiac investigations for specified high-risk children. Routine data are lacking, but under half of affected babies, not previously identified antenatally or because of symptoms, are identified by current newborn screening. There is evidence that screen-positive infants do not receive timely management. Pulse oximetry and echocardiography, in addition to clinical examination, are alternative newborn screening strategies but their cost-effectiveness has not been adequately evaluated in a UK setting. In a population of 100,000 live-born infants, the model predicts 121 infants with life-threatening congenital heart defects undiagnosed at screening, of whom 82 (68%) and 83 (69%) are detected by pulse oximetry and screening echocardiography, respectively, but only 39 (32%) by clinical examination alone. Of these, 71, 71 and 34, respectively, receive a timely diagnosis. The model predicts 46 (0.5%) false-positive screening diagnoses per 100,000 infants with clinical examination, 1168 (1.3%) with pulse oximetry and 4857 (5.4%) with screening echocardiography. The latter includes infants with clinically non-significant defects. Total programme costs are predicted of pound 300,000 for clinical examination, pound 480,000 for pulse oximetry and pound 3.54 million for screening echocardiography. The additional cost per additional timely diagnosis of life-threatening congenital heart defects ranges from pound 4900 for pulse oximetry to pound 4.5 million for screening echocardiography. Including clinically significant congenital heart defects gives an additional cost per additional diagnosis of pound 1500 for pulse oximetry and pound 36,000 for screening echocardiography. Key determinants for cost-effectiveness are detection rates for pulse oximetry and screening echocardiography. Parents and health professionals place similar values on the quality of life outcomes of children with congenital heart defects and both are more averse to neurological than to cardiac disability. Adverse psychosocial effects for parents are focused around poor management and/or false test results.
   Conclusions: Early detection through newborn screening potentially can improve the outcome of congenital heart defects; however the current programme performs poorly, and lacks monitoring of quality assurance, performance management and longer term outcomes. Pulse oximetry is a promising alternative newborn screening strategy but further evaluation is needed to obtain more precise estimates of test performance and to inform optimal timing, diagnostic and management strategies. Although screening echocardiography is associated with the highest detection rate, it is the most costly strategy and has a 5% false-positive rate. Improving antenatal detection of congenital heart defects increases the cost per timely postnatal diagnosis afforded by any newborn screening strategy but does not alter the relative effects of the strategies. An improvement of timely management of screen positive infants is essential. Further research is required to refine the detection rate and other aspects of pulse oximetry, to evaluate antenatal screening strategies more directly, and to investigate the psychosocial effects of newborn screening for congenital heart defects.
C1 Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England.
   Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 1TH, Avon, England.
   Great Ormond St Hosp Children NHS Trust, London WC1N 3JH, England.
   Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.
RP Dezateux, C (reprint author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England.
RI Dezateux, Carol/A-3416-2009
CR ABUHARB M, 1994, ARCH DIS CHILD, V71, pF179, DOI 10.1136/fn.71.3.F179
   ABUHARB M, 1994, ARCH DIS CHILD, V71, P3
   ABUHARB M, 1995, BRIT HEART J, V74, P192
   Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162
   AHARON AS, 1994, J THORAC CARDIOV SUR, V107, P1262
   Ainsworth SB, 1999, ARCH DIS CHILD, V80, pF43
   Alberman E, 2002, J MED SCREEN, V9, P97, DOI 10.1136/jms.9.3.97
   Alden B, 1998, ACTA PAEDIATR, V87, P405
   Alexiou C, 2000, EUR J CARDIO-THORAC, V17, P125, DOI 10.1016/S1010-7940(00)00324-9
   Alexiou C, 2001, ANN THORAC SURG, V71, P494, DOI 10.1016/S0003-4975(00)02444-9
   Al-Halees Z, 2002, J THORAC CARDIOV SUR, V123, P437, DOI 10.1067/mtc.2002.119705
   ALJADER LN, 1990, CLIN GENET, V38, P460
   Allan L, 2000, HEART, V83, P367, DOI 10.1136/heart.83.3.367
   ALLAN LD, 1991, LANCET, V337, P959, DOI 10.1016/0140-6736(91)91582-F
   Allan LD, 2000, SEMIN PERINATOL, V24, P380, DOI 10.1053/sper.2000.16550
   Amaral F, 1997, Arq Bras Cardiol, V68, P421
   Andrews R, 2001, ARCH DIS CHILD, V85, P474, DOI 10.1136/adc.85.6.474
   [Anonymous], 1992, INT CLASSIFICATION D
   ANTA MZ, 1993, AN ESP PEDIATR, V38, P213
   ASHRAF MH, 1993, ANN THORAC SURG, V55, P347
   Atkin K, 1998, SOC SCI MED, V46, P445, DOI 10.1016/S0277-9536(97)00189-5
   Axworthy D, 1996, LANCET, V347, P1443
   Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6
   AYLIN P, 2001, ANAL HOSP EPISODE ST
   Bacha EA, 2001, J THORAC CARDIOV SUR, V122, P154, DOI 10.1067/mtc.2001.115156
   Bache Annette, 2002, Ugeskr Laeger, V164, P4169
   BALDERSTON SM, 1992, J AM COLL CARDIOL, V19, P154
   Ballard C, 1996, INT REV PSYCHIATR, V8, P65, DOI 10.3109/09540269609037818
   BANDO K, 1995, J THORAC CARDIOV SUR, V110, P1543, DOI 10.1016/S0022-5223(95)70078-1
   Baroni M A, 1997, Pediatr Nurs, V23, P143
   BARR JT, 1996, MED DECIS MAKING, V16, P470
   Bassett M, 2001, GENET TEST, V5, P317, DOI 10.1089/109065701753617453
   BAUER EP, 1992, THORAC CARDIOV SURG, V40, P334, DOI 10.1055/s-2007-1020176
   BEITZKE A, 1990, WIEN MED WOCHENSCHR, V140, P266
   BEKKER H, 1994, J MED GENET, V31, P364, DOI 10.1136/jmg.31.5.364
   BELL S, 1994, PEDIATR HEMAT ONCOL, V11, P433, DOI 10.3109/08880019409140544
   BELL S, 1994, PEDIATR HEMAT ONCOL, V11, P157, DOI 10.3109/08880019409141651
   Belli E, 1998, CIRCULATION, V98, P360
   BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901
   Bellinger DC, 1999, CIRCULATION, V100, P526
   BENATAR A, 1995, EUR J CARDIO-THORAC, V9, P320, DOI 10.1016/S1010-7940(05)80190-3
   Bennett JE, 2000, ARCH PEDIAT ADOL MED, V154, P43
   Bennett KJ, 1996, QUALITY LIFE PHARMAC, P253
   Berdjis F, 1996, HERZ, V21, P330
   Berry DA, 1996, BAYESIAN BIOSTATISTI
   BEWLEY S, 1995, BRIT J OBSTET GYNAEC, V102, P386, DOI 10.1111/j.1471-0528.1995.tb11290.x
   Bloomfield L, 2003, J MED SCREEN, V10, P176, DOI 10.1258/096914103771773267
   Bodegård G, 1983, Acta Paediatr Scand Suppl, V304, P1
   Boening A, 2002, EUR J CARDIO-THORAC, V22, P167, DOI 10.1016/S1010-7940(02)00272-5
   Bogers AJJC, 1999, EUR J CARDIO-THORAC, V16, P296, DOI 10.1016/S1010-7940(99)00236-5
   Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F
   Bolger AP, 2003, EUR HEART J, V24, P970, DOI 10.1016/S0195-668X(03)00005-8
   Bonnet D, 1999, CIRCULATION, V99, P916
   BOUGHMAN JA, 1987, AM J MED GENET, V26, P839, DOI 10.1002/ajmg.1320260411
   Bove EL, 1998, PEDIATR CARDIOL, V19, P308, DOI 10.1007/s002469900314
   BOVE EL, 1983, ARCH DIS CHILD, V58, P137
   BOWLING A, 2001, QUAL HLTH CARE S1, V10, P2
   BOWYER JJ, 1990, ARCH DIS CHILD, V65, P865
   Brackley KJ, 2000, LANCET, V356, P1143, DOI 10.1016/S0140-6736(00)02756-2
   BRADLEY DM, 1993, BRIT MED J, V306, P357
   Bradley SM, 2002, ANN THORAC SURG, V74, P805, DOI 10.1016/S0003-4975(02)03836-5
   Braun J, 1998, J HEART VALVE DIS, V7, P615
   Brazier J, 1999, HLTH TECHNOL ASSESS, V3
   Breymann T, 1999, EUR J CARDIO-THORAC, V16, P117, DOI 10.1016/S1010-7940(99)00155-4
   Bricker L, 2000, HLTH TECHNOL ASSESS, V4
   Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922
   Briggs AH, 2001, EC EVALUATION HLTH C, P172
   *BRIT PAED ASS, 1979, CLASS DIS S
   *BRIT ROYAL INF IN, 2001, CM5207
   Brizard CP, 1997, EUR J CARDIO-THORAC, V11, P687, DOI 10.1016/S1010-7940(97)01155-X
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Brown JW, 2001, ANN THORAC SURG, V71, P1978, DOI 10.1016/S0003-4975(01)02529-2
   Brown KL, 2003, CRIT CARE MED, V31, P28, DOI 10.1097/01.CCM.0000046068.19048.86
   Bull C., 2000, BRIT MED J, V320, P168
   Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8
   Bull C, 2001, KEY ISSUES RETROSPEC
   Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6
   CAMPBELL M, 1968, BRIT HEART J, V30, P4
   Campion P, 1998, PREV MED, V27, P590, DOI 10.1006/pmed.1998.0330
   Carano N, 1999, Pediatr Med Chir, V21, P105
   CARLGREN LE, 1987, PEDIATR CARDIOL, V8, P247, DOI 10.1007/BF02427537
   Carvalho JS, 2002, HEART, V88, P387, DOI 10.1136/heart.88.4.387
   CASEY F, 1994, J PEDIATR PSYCHOL, V21, P335
   CASEY FA, 1994, ARCH DIS CHILD, V70, P382
   CHAN HC, 1998, T HONG KONG I ENG, V5, P6
   CHANG AC, 1991, J THORAC CARDIOV SUR, V102, P841
   Cheng AK, 2000, JAMA-J AM MED ASSOC, V284, P850, DOI 10.1001/jama.284.7.850
   CHILCOTT J, 2003, HLTH TECHNOL ASSESS, V7
   Cho JM, 2002, J THORAC CARDIOV SUR, V124, P70, DOI 10.1067/mtc.2002.120711
   CIOFFI D, 1991, J PERS SOC PSYCHOL, V61, P969, DOI 10.1037/0022-3514.61.6.969
   Clancy RR, 2003, PEDIATRICS, V111, P592, DOI 10.1542/peds.111.3.592
   CLAPP SK, 1987, AM J CARDIOL, V59, P454, DOI 10.1016/0002-9149(87)90955-6
   Clark S M, 1999, J Soc Pediatr Nurs, V4, P7, DOI 10.1111/j.1744-6155.1999.tb00075.x
   Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X
   Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3
   Claxton K, 2001, INT J TECHNOL ASSESS, V17, P38, DOI 10.1017/S0266462301104058
   Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560
   Clemens CJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e7
   Cobanoglu A, 2002, ANN THORAC SURG, V74, P133, DOI 10.1016/S0003-4975(02)03619-6
   COBB E, 1991, J MED GENET, V28, P322, DOI 10.1136/jmg.28.5.322
   COHEN AJ, 1991, ANN THORAC SURG, V52, P1266
   COHEN M, 1989, CIRCULATION, V80, P840
   Cooper PJ, 1998, BRIT MED J, V316, P1884
   CORREAVILLASENOR A, 1991, AM J EPIDEMIOL, V134, P393
   CORREAVILLASENOR A, 1993, J EXPO ANAL ENV EPID, V3, P173
   Crepaz R, 1993, G Ital Cardiol, V23, P767
   CUTRONA CE, 1986, CHILD DEV, V57, P1507, DOI 10.1111/j.1467-8624.1986.tb00475.x
   Daebritz SH, 2000, ANN THORAC SURG, V69, P1880, DOI 10.1016/S0003-4975(00)01241-8
   Dajani AS, 1997, CLIN INFECT DIS, V25, P1448, DOI 10.1086/516156
   Dastgiri S, 2003, ARCH DIS CHILD, V88, P391, DOI 10.1136/adc.88.5.391
   Davies S, 2000, HLTH TECHNOL ASSESS, V4
   Davis A, 1997, HLTH TECHNOL ASSESS, V1
   Dearani JA, 2003, ANN THORAC SURG, V75, P399, DOI 10.1016/S0003-4975(02)04547-2
   DEBOER DA, 1990, ANN THORAC SURG, V50, P69
   DELAHAYE JP, 1988, EUR HEART J, V9, P43
   DELAMATER AM, 2001, QUALITY LIFE CHILD A, P297
   de Leval MR, 2001, LANCET, V357, P1814, DOI 10.1016/S0140-6736(00)05006-6
   Delius RE, 1997, EUR J CARDIO-THORAC, V12, P171, DOI 10.1016/S1010-7940(97)00165-6
   Delius RE, 1996, J THORAC CARDIOV SUR, V112, P1581, DOI 10.1016/S0022-5223(96)70017-X
   DEMASO DR, 1991, J PEDIATR PSYCHOL, V16, P137, DOI 10.1093/jpepsy/16.2.137
   DENNIS J, 1999, DSMIG SURVEILLANCE E
   de Ruijter FTH, 2002, ANN THORAC SURG, V73, P1794, DOI 10.1016/S0003-4975(02)03586-5
   De Vore GR, 1998, ANN NY ACAD SCI, V847, P46, DOI 10.1111/j.1749-6632.1998.tb08925.x
   Dezateux C, 1996, ARCH DIS CHILD, V74, P445
   Di Filippo S, 1997, ARCH MAL COEUR VAISS, V90, P1723
   Dobrovoljski G, 2003, J PEDIAT HEMATOL ONC, V25, P14, DOI 10.1097/00043426-200301000-00005
   Dormandy E, 2002, J MED SCREEN, V9, P109, DOI 10.1136/jms.9.3.109
   Drummond M. F., 1997, METHODS EC EVALUATIO
   Dudley M, 2001, J REPROD INFANT PSYC, V19, P187
   Eiser C, 2001, ARCH DIS CHILD, V84, P205, DOI 10.1136/adc.84.3.205
   Eiser C, 1997, ARCH DIS CHILD, V77, P350
   Eiser C, 2001, HLTH TECHNOL ASSESS, V5
   Elgamal MA, 2002, ANN THORAC SURG, V73, P1267, DOI 10.1016/S0003-4975(01)03622-0
   Elkins RC, 2001, J HEART VALVE DIS, V10, P736
   ELKINS RC, 1994, ANN THORAC SURG, V57, P826
   Elwyn G, 2001, Lancet, V358, P571, DOI 10.1016/S0140-6736(01)05709-9
   Elwyn G, 2001, J EVAL CLIN PRACT, V7, P211, DOI 10.1046/j.1365-2753.2001.00286.x
   *EUROCAT, 1996, B3 EUR
   Evans JR, 1998, INTRO SIMULATION RIS
   FALLON P, 1995, ARCH DIS CHILD, V72, P418
   Farrell MH, 2001, ARCH PEDIAT ADOL MED, V155, P120
   Farrer KFM, 2003, ARCH DIS CHILD, V88, pF147, DOI 10.1136/fn.88.2.F147
   Feeny D, 1998, MEASURING HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS, P171
   Feeny D, 1998, Med Pediatr Oncol, VSuppl 1, P54
   Feeny D, 2000, MED CARE, V38, P151
   Felli JC, 1998, MED DECIS MAKING, V18, P95, DOI 10.1177/0272989X9801800117
   FENWICK E, 2000, 179 U YORK
   FERENC C, 1990, Acta Paediatrica Hungarica, V30, P169
   FERENCZ C, 1989, J AM COLL CARDIOL, V14, P756
   FERENCZ C, 1987, TERATOLOGY, V35, P367, DOI 10.1002/tera.1420350311
   FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31
   FERENCZ C, 1990, TERATOLOGY, V41, P319, DOI 10.1002/tera.1420410309
   Ferrieri P, 2002, CIRCULATION, V105, P2115, DOI 10.1161/01.CIR.0000013073.22415.90
   Fesslova' V, 1999, HEART, V82, P594
   FIRTH M, 1983, DEV MED CHILD NEUROL, V25, P466
   FIRTH MA, 1983, BRIT MED J, V286, P1933
   Fitzpatrick R, 1998, HEALTH TECHNOL ASSES, V2, P14
   Forbess JM, 2002, J THORAC CARDIOV SUR, V123, P631, DOI 10.1067/mtc.2002.119342
   Forbess JM, 2002, CIRCULATION S1, V106, pI
   FORBESS JM, 1995, CIRCULATION, V92, P262
   Forbess Joseph M., 2001, Circulation, V104, pI, DOI 10.1161/hc37t1.094816
   Franklin O, 2002, HEART, V87, P67, DOI 10.1136/heart.87.1.67
   FRANKLIN RCG, 1991, J THORAC CARDIOV SUR, V101, P924
   FRANKLIN RCG, 1993, CIRCULATION, V87, P427
   Fulton JO, 1999, ANN THORAC SURG, V67, P177, DOI 10.1016/S0003-4975(98)01193-X
   FURLONG W, 1990, WORKING PAPER SERIES, V909
   Fyler DC, 1980, PEDIATRICS S, V65, P375
   FYRO K, 1987, ACTA PAEDIATR SCAND, V76, P107, DOI 10.1111/j.1651-2227.1987.tb10424.x
   Gabriel HM, 2002, J AM COLL CARDIOL, V39, P1066, DOI 10.1016/S0735-1097(02)01706-0
   Garcia J, 2002, BIRTH-ISS PERINAT C, V29, P225, DOI 10.1046/j.1523-536X.2002.00198.x
   Gaynor JW, 2002, EUR J CARDIO-THORAC, V22, P82, DOI 10.1016/S1010-7940(02)00198-7
   Gaynor JW, 1999, J THORAC CARDIOV SUR, V117, P506, DOI 10.1016/S0022-5223(99)70330-2
   Gaynor JW, 2002, J THORAC CARDIOV SUR, V123, P237, DOI 10.1067/mtc.2002.119337
   Genoni M, 1996, Swiss Surg Suppl, VSuppl 1, P32
   GEWILLIG M, 1991, CIRCULATION, V84, P87
   Gibson PJ, 1997, ACTA PAEDIATR, V86, P72, DOI 10.1111/j.1651-2227.1997.tb08835.x
   GILDEIN P, 1994, AM J CARDIOL, V74, P166, DOI 10.1016/0002-9149(94)90091-4
   Glazener CMA, 1999, BRIT MED J, V318, P627
   Gomelsky A, 1998, CARDIOL YOUNG, V8, P352
   Goodship J, 1998, ARCH DIS CHILD, V79, P348
   Green JM, 1996, CHILD CARE HLTH DEV, V22, P113, DOI 10.1046/j.1365-2214.1996.776776.x
   GREEN JM, 1995, BRIT J OBSTET GYNAEC, V102, P228, DOI 10.1111/j.1471-0528.1995.tb09099.x
   Gregory J, 1999, ARCH DIS CHILD, V80, pF46
   Griffiths R, 1984, ABILITIES YOUNG CHIL
   GROW JA, 1988, GEOLOGY N AM, V1, P1
   Haas F, 1999, ANN THORAC SURG, V68, P1692, DOI 10.1016/S0003-4975(99)01039-5
   Hall D., 2003, HLTH ALL CHILDREN
   Hall S, 2000, BRIT MED J, V320, P407, DOI 10.1136/bmj.320.7232.407
   Hamada H, 2002, CARDIOL YOUNG, V12, P345
   Hampton K, 1998, BRIT MED J, V317, P748
   HANEDA K, 1990, TOHOKU J EXP MED, V161, P319, DOI 10.1620/tjem.161.319
   HANEDA K, 1992, TOHOKU J EXP MED, V166, P201, DOI 10.1620/tjem.166.201
   Harding LJ, 1999, PRENATAL DIAG, V19, P701, DOI 10.1002/(SICI)1097-0223(199908)19:8<701::AID-PD621>3.0.CO;2-5
   Hauser M, 2000, CARDIOL YOUNG, V10, P353
   Hawkins JA, 1998, ANN THORAC SURG, V65, P1758, DOI 10.1016/S0003-4975(98)00268-9
   Heger M, 1997, Z KARDIOL, V86, P50, DOI 10.1007/s003920050033
   Henneman L, 2002, AM J MED GENET, V110, P324, DOI 10.1002/ajmg.10464
   Hergils L, 2000, BRIT J AUDIOL, V34, P321
   HERNANDEZ JAG, 1994, REV ESP CARDIOL, V47, P97
   HERNANDEZ JAG, 1995, REV ESP CARDIOL, V48, P333
   Hertling-Schaal E, 2001, Gynecol Obstet Fertil, V29, P440, DOI 10.1016/S1297-9589(01)00158-8
   Heying R, 1999, ACTA PAEDIATR, V88, P1238, DOI 10.1080/080352599750030356
   HISATOMI K, 1991, Kurume Medical Journal, V38, P149
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   HOFFMAN JIE, 1987, PAEDIATRIC CARDIOLOG, V1, P3
   Hokanson J S, 1999, Cardiol Rev, V7, P149, DOI 10.1097/00045415-199905000-00012
   Hoke TR, 2002, PEDIATR CARDIOL, V23, P403, DOI 10.1007/s00246-002-1482-8
   HOLTZMAN NA, 1983, PEDIATRICS, V72, P807
   HORSTKOTTE D, 1993, Z KARDIOL, V82, P552
   Hoshino K, 1999, AM HEART J, V137, P535, DOI 10.1016/S0002-8703(99)70503-X
   Hovels-Gurich HH, 2001, ANN THORAC SURG, V71, P881, DOI 10.1016/S0003-4975(00)02515-7
   Hovels-Gurich HH, 2002, J THORAC CARDIOV SUR, V124, P448, DOI 10.1067/mtc.2002.122307
   HovelsGurich HH, 1997, J THORAC CARDIOV SUR, V114, P578, DOI 10.1016/S0022-5223(97)70047-3
   Hovels-Gurich HH, 2002, ARCH DIS CHILD, V87, P506, DOI 10.1136/adc.87.6.506
   Hovels-Gurich HH, 2003, ACTA PAEDIATR, V92, P190
   Hraska V, 1999, Bratisl Lek Listy, V100, P286
   Hucin B, 2000, J CARDIOVASC SURG, V41, P233
   HUERTA GC, 1990, REV ESP CARDIOL, V43, P93
   Hunink MGM, 2001, DECISION MAKING HLTH
   HUYSMANS HA, 1989, Z KARDIOL, V78, P39
   Hyde JAJ, 1999, EUR J CARDIO-THORAC, V15, P735, DOI 10.1016/S1010-7940(99)00104-9
   Hyett JA, 2002, PRENATAL DIAG, V22, P864, DOI 10.1002/pd.413
   Ishino K, 1999, J THORAC CARDIOV SUR, V117, P920, DOI 10.1016/S0022-5223(99)70373-9
   Isomatsu Y, 2001, J THORAC CARDIOV SUR, V122, P524, DOI 10.1067/mtc.2001.115425
   IZQUIERDO PF, 1990, REV ESP CARDIOL, V43, P381
   Jackson M, 1996, CARDIOL YOUNG, V6, P272
   Jarvinen O, 1999, J MED GENET, V36, P615
   Jenney MEM, 1997, ARCH DIS CHILD, V77, P347
   Joelsson BME, 2001, SCAND CARDIOVASC J, V35, P192
   JONAS RA, 1994, J THORAC CARDIOV SUR, V107, P1121
   JONES C, 2002, PARENTS EXPERIENCES
   Juniper EF, 1997, EUR RESPIR J, V10, P2285, DOI 10.1183/09031936.97.10102285
   Juttmann RE, 2002, EUR J PUBLIC HEALTH, V12, P198, DOI 10.1093/eurpub/12.3.198
   Juttmann RE, 2001, J EPIDEMIOL COMMUN H, V55, P126, DOI 10.1136/jech.55.2.126
   KADEN GG, 1985, AM J DIS CHILD, V139, P995
   KAPPETEIN PA, 1993, ANN THORAC SURG, V55, P1153
   KARL TR, 1992, ANN THORAC SURG, V54, P903
   Karlsson G, 1996, PHARMACOECONOMICS, V9, P113
   Karnon J, 2002, PHARMACOECONOMICS, V20, P119, DOI 10.2165/00019053-200220020-00005
   Kawashima Y, 1990, Kyobu Geka, V43, P660
   KEANE JF, 1993, CIRCULATION S, V874, P16
   Kelson M., 1999, HLTH EXPECT, V2, P129, DOI 10.1046/j.1369-6513.1999.00042.x
   KERDANIELARICHE I, 1999, ARCH MAL COEUR VAISS, V92, P607
   Kirjavainen M, 1999, J THORAC CARDIOV SUR, V117, P488, DOI 10.1016/S0022-5223(99)70329-6
   Kirkham FJ, 1998, PEDIATR CARDIOL, V19, P331, DOI 10.1007/s002469900318
   Kirshbom PM, 2002, ANN THORAC SURG, V74, P1616, DOI 10.1016/S0003-4975(02)03935-8
   KONSTANTINIDES S, 1991, KLIN WOCHENSCHR, V69, P506, DOI 10.1007/BF01649286
   KOOT HM, 2001, QUALITY LIFE CHILD A, P431
   Koppel RI, 2003, PEDIATRICS, V111, P451, DOI 10.1542/peds.111.3.451
   KRAMER HH, 1989, J CHILD PSYCHOL PSYC, V30, P299, DOI 10.1111/j.1469-7610.1989.tb00242.x
   KRAMER MS, 1994, PEDIATRICS, V93, P697
   Kumar RK, 1999, AM J CARDIOL, V83, P1649, DOI 10.1016/S0002-9149(99)00172-1
   Kuppermann M, 2000, PEDIATR INFECT DIS J, V19, P129, DOI 10.1097/00006454-200002000-00010
   Kwon C, 2000, ARCH PEDIAT ADOL MED, V154, P714
   Laane KM, 1997, ACTA PAEDIATR, V86, P975, DOI 10.1111/j.1651-2227.1997.tb15182.x
   Laane KM, 1997, SCAND CARDIOVASC J, V31, P213, DOI 10.3109/14017439709041748
   Laird L, 1996, BRIT MED J, V313, P407
   Last JM, 1995, DICT EPIDEMIOLOGY
   Lenert L, 2000, MED CARE S, V38, pIII38
   Leonard H, 2000, HEART, V84, P499, DOI 10.1136/heart.84.5.499
   Leung MP, 1999, PRENATAL DIAG, V19, P305, DOI 10.1002/(SICI)1097-0223(199904)19:4<305::AID-PD535>3.3.CO;2-2
   Limperopoulos C, 2001, PEDIATRICS, V108, P1325, DOI 10.1542/peds.108.6.1325
   Limperopoulos C, 1999, PEDIATRICS, V103, P402, DOI 10.1542/peds.103.2.402
   Lupton D, 1995, IMPERATIVE HLTH PUBL
   Luterman D, 1999, Am J Audiol, V8, P13, DOI 10.1044/1059-0889(1999/006)
   Macfarlane A, 1998, BRIT MED J, V316, P566
   Magnuson M, 1999, SCAND AUDIOL, V28, P47, DOI 10.1080/010503999424905
   Magnuson M, 2000, PATIENT EDUC COUNS, V41, P285, DOI 10.1016/S0738-3991(99)00117-2
   Mahle W, 2002, CIRCULATION S1, V106, P109, DOI DOI 10.1161/01.CIR.000003208.33237.B1
   Mahle WT, 2002, PEDIATR CARDIOL, V23, P224, DOI 10.1007/s00246-001-0054-7
   Mahle WT, 2001, CLIN PERINATOL, V28, P235, DOI 10.1016/S0095-5108(05)70077-4
   Mahle WT, 2000, PEDIATRICS, V105, P1082, DOI 10.1542/peds.105.5.1082
   Mahle WT, 2000, CIRCULATION, V102, P136
   MAHONY L, 1982, CIRCULATION, V66, P253
   Mair DD, 1997, J AM COLL CARDIOL, V29, P1359
   Majnemer A, 1999, Semin Pediatr Neurol, V6, P12, DOI 10.1016/S1071-9091(99)80042-4
   MALAN JE, 1991, INT J CARDIOL, V30, P23, DOI 10.1016/0167-5273(91)90120-E
   Malec E, 2000, EUR J CARDIO-THORAC, V18, P202, DOI 10.1016/S1010-7940(00)00495-4
   Malec E, 1999, PEDIATR CARDIOL, V20, P351, DOI 10.1007/s002469900483
   MANDELIK J, 1994, CLEV CLIN J MED, V61, P29
   Marino B, 1999, GENET COUNSEL, V10, P25
   Marteau TM, 1998, BRIT MED J, V316, P693
   MARTEAU TM, 1994, BRIT J CLIN PSYCHOL, V33, P1
   MARTEAU TM, 1992, J MED GENET, V29, P24, DOI 10.1136/jmg.29.1.24
   MARTIN GR, 1989, PEDIATRICS, V83, P200
   Masi G, 1996, Minerva Cardioangiol, V44, P479
   Masi G, 1999, ADOLESCENCE, V34, P185
   Masuda M, 2001, Jpn J Thorac Cardiovasc Surg, V49, P497, DOI 10.1007/BF02919544
   Masuda M, 1999, EUR J CARDIO-THORAC, V15, P283, DOI 10.1016/S1010-7940(99)00002-0
   MATTHYS D, 1990, ARCH MAL COEUR VAISS, V83, P697
   McCarthy JF, 1996, EUR J CARDIO-THORAC, V10, P534, DOI 10.1016/S1010-7940(96)80420-9
   MCCRINDLE BW, 1995, CLIN PEDIATR, V34, P25, DOI 10.1177/000992289503400105
   McDonald IG, 1996, BRIT MED J, V313, P329
   McElhinney DB, 1997, ANN THORAC SURG, V63, P1676, DOI 10.1016/S0003-4975(97)00364-0
   Mehta A V, 2000, Tenn Med, V93, P136
   MEIJBOOM F, 1994, J AM COLL CARDIOL, V24, P1358
   Menahem S, 1998, CARDIOL YOUNG, V8, P400
   Menzel P, 2002, SOC SCI MED, V55, P2149, DOI 10.1016/S0277-9536(01)00358-6
   MERELLE ME, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001402
   Merelle ME, 2003, PEDIATRICS, V111, P346, DOI 10.1542/peds.111.2.346
   MERLO M, 1991, ANN THORAC SURG, V51, P227
   MESSMER BJ, 1991, EUR J CARDIO-THORAC, V5, P378, DOI 10.1016/1010-7940(91)90056-P
   Michie S, 2001, J MED GENET, V38, P519, DOI 10.1136/jmg.38.8.519
   Michie S, 1999, PRENATAL DIAG, V19, P743, DOI 10.1002/(SICI)1097-0223(199908)19:8<743::AID-PD636>3.0.CO;2-C
   Michie S, 2002, J BEHAV MED, V25, P33, DOI 10.1023/A:1013537701374
   Miller G, 1996, J CHILD NEUROL, V11, P49
   Miller G, 1999, Semin Pediatr Neurol, V6, P20, DOI 10.1016/S1071-9091(99)80043-6
   MILLER G, 1995, ARCH PEDIAT ADOL MED, V149, P764
   Mischler EH, 1998, PEDIATRICS, V102, P44, DOI 10.1542/peds.102.1.44
   MOLLER JH, 1995, PEDIATR CARDIOL, V16, P216, DOI 10.1007/BF00795710
   MORRIS CD, 1991, JAMA-J AM MED ASSOC, V266, P3447, DOI 10.1001/jama.266.24.3447
   Mosca RS, 1997, ANN THORAC SURG, V64, P1126, DOI 10.1016/S0003-4975(97)00848-5
   Mosca RS, 2000, J THORAC CARDIOV SUR, V119, P1110, DOI 10.1067/mtc.2000.106656
   Moulin A, 2001, ARCH PEDIATRIE, V8, P929, DOI 10.1016/S0929-693X(01)00557-7
   Mukherjee S, 2000, EDUC RES, V42, P59
   MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401
   MURRAY G, 2001, REPORT UK CARDIAC SU
   MURRAY J, 1999, HEALTH TECHNOL ASSES, V3, P8
   Murray L, 1996, DEV MED CHILD NEUROL, V38, P109
   Murray L, 1997, ARCH DIS CHILD, V77, P99
   Murray L, 1997, PSYCHOL MED, V27, P253, DOI 10.1017/S0033291796004564
   MYRIDAKIS DJ, 1994, AM J CARDIOL, V74, P1030, DOI 10.1016/0002-9149(94)90854-0
   Najm HK, 1997, ANN THORAC SURG, V63, P669, DOI 10.1016/S0003-4975(96)01366-5
   Najm HK, 1998, ANN THORAC SURG, V66, P829, DOI 10.1016/S0003-4975(98)00607-9
   Najm HK, 1997, CIRCULATION S, V96, pII
   Naraine VS, 2002, HAEMOPHILIA, V8, P112, DOI 10.1046/j.1365-2516.2002.00591.x
   Netten A, 2001, UNIT COSTS HLTH SOCI
   New York Heart Association. New York Heart Association (NYHA) functional classification: the criteria committee of the New York heart association, 1994, NOM CRIT DIAGN DIS H
   Newburger JW, 2003, J PEDIATR, V143, P67, DOI 10.1016/S0022-3476(03)00183-5
   *NHS CTR REV DISS, 2001, 4 NHS U YORK CTR REV
   NIEDERHAUSER U, 1992, THORAC CARDIOV SURG, V40, P130, DOI 10.1055/s-2007-1020130
   NIEMINEN HP, 2003, CIRCULATION, V104, P570
   Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5
   Norgaard MA, 1999, EUR J CARDIO-THORAC, V16, P125, DOI 10.1016/S1010-7940(99)00137-2
   O'Connor AM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001431
   Oechslin E, 2001, Ther Umsch, V58, P111, DOI 10.1024/0040-5930.58.2.111
   Oechslin E, 2000, THORAC CARDIOV SURG, V48, P233, DOI 10.1055/s-2000-6901
   Oechslin EN, 2000, AM J CARDIOL, V86, P1111, DOI 10.1016/S0002-9149(00)01169-3
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   Office for National Statistics, 2003, HLTH STAT Q, V18, P57
   Office of Population Censuses and Surveys, 1987, CLASS SURG OP PROC 4
   Oliver S, 2001, Health Expect, V4, P18, DOI 10.1046/j.1369-6513.2001.00113.x
   Oliver S, 1996, BRIT MED J, V313, P1251
   Oliver S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003859.PUB2
   Onat T, 1998, PEDIATR CARDIOL, V19, P230, DOI 10.1007/s002469900291
   ONG CM, 1992, AM HEART J, V123, P1594, DOI 10.1016/0002-8703(92)90815-D
   Oostenbrink R, 2002, J CLIN EPIDEMIOL, V55, P791, DOI 10.1016/S0895-4356(02)00448-1
   OTTERSTAD JE, 1985, SCAND J THORAC CARD, V19, P221, DOI 10.3109/14017438509102723
   Owen M, 2001, ARCH DIS CHILD, V84, pF157, DOI 10.1136/fn.84.3.F157
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   Parsons EP, 2002, ARCH DIS CHILD, V86, P91
   Pass KA, 2003, PEDIATRICS, V111, P670, DOI 10.1542/peds.111.3.670
   PAWADE A, 1993, J CARDIAC SURG, V8, P371, DOI 10.1111/j.1540-8191.1993.tb00379.x
   Pearson GA, 2001, ARCH DIS CHILD, V84, P125, DOI 10.1136/adc.84.2.125
   Pelchat D, 1999, CHILD CARE HLTH DEV, V25, P377, DOI 10.1046/j.1365-2214.1999.00107.x
   PERRY LW, 1993, PERSPECTIVES PEDIAT, V4, P33
   Petticrew M, 2000, HLTH TECHNOL ASSESS, V4
   Pigula FA, 1999, CIRCULATION, V100, P157
   PLACKETT P, 2001, COMMUNICATION
   PLANCHE C, 1993, J THORAC CARDIOV SUR, V105, P925
   Pollitt RJ, 1997, HLTH TECHNOL ASSESS, V1
   Powell CB, 1997, AM J CARDIOL, V79, P1147
   PRADAT P, 1992, J EPIDEMIOL COMMUN H, V46, P211, DOI 10.1136/jech.46.3.211
   PRADAT P, 1992, EUR J EPIDEMIOL, V8, P789, DOI 10.1007/BF00145321
   Pretre R, 2001, LANCET, V357, P1826, DOI 10.1016/S0140-6736(00)04957-6
   PRIDJIAN AK, 1993, AM J CARDIOL, V71, P959, DOI 10.1016/0002-9149(93)90914-X
   RADZIK D, 1993, J AM COLL CARDIOL, V22, P851
   Rakow T, 2003, ARCH DIS CHILD, V88, P497, DOI 10.1136/adc.88.6.497
   *RCPCH, 2000, CHART PAED
   Read CY, 2002, CLIN GENET, V61, P268, DOI 10.1034/j.1399-0004.2002.610405.x
   Reddy V, 1996, EUR J CARDIO-THORAC, V10, P546, DOI 10.1016/S1010-7940(96)80422-2
   Reddy VM, 2000, CIRCULATION, V101, P1826
   Reich JD, 2003, J PEDIATR, V142, P268, DOI 10.1067/mpd.2003.87
   Reller MD, 1998, J PEDIATR, V132, P738, DOI 10.1016/S0022-3476(98)70372-5
   REYBROUCK T, 1995, EUR J PEDIATR, V154, P801, DOI 10.1007/BF01959785
   Reybrouck T, 2001, CARDIOL YOUNG, V11, P17
   Richmond S, 2002, ARCH DIS CHILD, V87, pF83, DOI 10.1136/fn.87.2.F83
   RITTENHOUSE B, 1996, USES MODELS EC EVALU, P1
   Roberts T, 1998, BRIT J OBSTET GYNAEC, V105, P960, DOI 10.1111/j.1471-0528.1998.tb10258.x
   Roberts TE, 1998, BRIT MED J, V317, P911
   Robinson BV, 2000, CARDIOL YOUNG, V10, P225
   ROGERS BT, 1995, J PEDIATR, V126, P496, DOI 10.1016/S0022-3476(95)70478-7
   ROGERS R, 1994, ACTA PAEDIATR, V83, P866, DOI 10.1111/j.1651-2227.1994.tb13159.x
   ROGUIN N, 1995, J AM COLL CARDIOL, V26, P1545, DOI 10.1016/0735-1097(95)00358-4
   Rona RJ, 1998, ACTA PAEDIATR, V87, P201, DOI 10.1080/08035259850157679
   RORDAM S, 1994, SCAND J THORAC CARD, V28, P55, DOI 10.3109/14017439409100163
   Rosenbaum PJ, 1996, QUALITY LIFE PHARMAC, P785
   ROSENTHAL GL, 1991, AM J EPIDEMIOL, V133, P1273
   ROSS DA, 1991, J CARDIAC SURG, V6, P367, DOI 10.1111/j.1540-8191.1991.tb00332.x
   Rubay JE, 1999, ANN THORAC SURG, V67, P1355, DOI 10.1016/S0003-4975(99)00256-8
   RUBAY JE, 1992, J CARDIOVASC SURG, V33, P216
   RUBIN JD, 1985, PEDIATRICS, V76, P371
   RUSTICO MA, 1995, ULTRASOUND OBST GYN, V6, P313, DOI 10.1046/j.1469-0705.1995.06050313.x
   Ruttenberg HD, 1999, PEDIATR CARDIOL, V20, P33, DOI 10.1007/s002469900391
   SADIQ M, 1995, BRIT HEART J, V73, P173
   Saigal S, 2000, PEDIATRICS, V105, P569, DOI 10.1542/peds.105.3.569
   Saigal S, 1998, MEASURING HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS, P151
   Saigal S, 2003, ARCH PEDIAT ADOL MED, V157, P261
   SAIGAL S, 1994, J PEDIATR, V125, P418, DOI 10.1016/S0022-3476(05)83289-5
   Saigal S, 1999, JAMA-J AM MED ASSOC, V281, P1991, DOI 10.1001/jama.281.21.1991
   SAIGAL S, 1994, J PEDIATR, V125, P411, DOI 10.1016/S0022-3476(05)83288-3
   Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453
   Salyer John W, 2003, Respir Care, V48, P386
   Samanek M, 2000, CARDIOL YOUNG, V10, P179
   SAMANEK M, 1992, PEDIATR CARDIOL, V13, P152
   SAMANEK M, 1988, BRIT HEART J, V59, P581
   SAMANEK M, 1986, INT J CARDIOL, V11, P63
   Samanek M, 1999, PEDIATR CARDIOL, V20, P411
   SamangoSprouse C, 1997, CURR OPIN CARDIOL, V12, P91
   Sands A, 2002, J PERINAT MED, V30, P307, DOI 10.1515/JPM.2002.045
   Sands AJ, 1999, ARCH DIS CHILD, V81, pF61
   SANO T, 1995, CIRCULATION, V92, P272
   Saw SM, 2003, BRIT J OPHTHALMOL, V87, P341, DOI 10.1136/bjo.87.3.341
   Schmid FX, 1999, HERZ, V24, P307
   *SCOTT PROGR CLIN, 2001, BAB AN SCOTT OV
   Seirafi PA, 1998, ANN THORAC SURG, V66, P1378, DOI 10.1016/S0003-4975(98)00595-5
   Senior V, 1999, SOC SCI MED, V48, P1857, DOI 10.1016/S0277-9536(99)00099-4
   SERRAF A, 1991, CIRCULATION, V84, P200
   SERRAF A, 1991, J THORAC CARDIOV SUR, V102, P140
   Serraf A, 1999, J THORAC CARDIOV SUR, V117, P669, DOI 10.1016/S0022-5223(99)70286-2
   SHINEBOURNE EA, 1976, BRIT HEART J, V38, P327
   Shinoka T, 1993, Nihon Kyobu Geka Gakkai Zasshi, V41, P1298
   Silka MJ, 1998, J AM COLL CARDIOL, V32, P245, DOI 10.1016/S0735-1097(98)00187-9
   SMITH RA, 1990, BRIT MED J, V300, P1112
   SOCOL ML, 1994, AM J OBSTET GYNECOL, V170, P991
   Sohn S, 2000, J KOREAN MED SCI, V15, P37
   SORENSON JR, 1984, PEDIATRICS, V73, P183
   SOUSA UM, 1993, ARCH MAL COEUR, V86, P593
   SPARLING JW, 1988, OBSTET GYNECOL, V72, P902
   SPIEGELHALTER DJ, 2001, INITIAL SYNTHESIS ST
   SPIEGELHALTER DJ, 2000, HLTH TECHNOL ASSESS, V4
   SPIEGELHALTER DJ, 1994, J AM STAT ASSOC, V89, P435, DOI 10.2307/2290843
   SPIETH LE, 2001, QUALITY LIFE CHILD A, P49
   STATHAM H, 1993, BRIT MED J, V307, P174
   STEIN A, 1991, BRIT J PSYCHIAT, V158, P46, DOI 10.1192/bjp.158.1.46
   Stellin G, 2000, EUR J CARDIO-THORAC, V18, P74, DOI 10.1016/S1010-7940(00)00457-7
   Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X9801800209
   Stuart A, 2000, Am J Audiol, V9, P135, DOI 10.1044/1059-0889(2000/016)
   Suominen P, 2001, EUR J CARDIO-THORAC, V19, P127, DOI 10.1016/S1010-7940(00)00650-3
   Sveger T, 1999, ACTA PAEDIATR, V88, P315, DOI 10.1080/08035259950170097
   Tchervenkov CI, 1998, J THORAC CARDIOV SUR, V116, P897, DOI 10.1016/S0022-5223(98)70039-X
   Tennstedt C, 1999, HEART, V82, P34
   THEKEKARA AG, 1994, IRISH MED J, V87, P80
   THELIN T, 1985, ACTA PAEDIATR SCAND, V74, P841, DOI 10.1111/j.1651-2227.1985.tb10046.x
   THIES WR, 1991, EUR J CARDIO-THORAC, V5, P571, DOI 10.1016/1010-7940(91)90221-5
   Thompson LD, 2001, ANN THORAC SURG, V72, P391, DOI 10.1016/S0003-4975(01)02796-5
   Thu Kjartan, 1999, Tidsskrift for den Norske Laegeforening, V119, P2162
   Tilford JM, 2002, AMBUL PEDIATR, V2, P330, DOI 10.1367/1539-4409(2002)002<0330:CEAAEM>2.0.CO;2
   Tlaskal T, 1998, EUR J CARDIO-THORAC, V14, P235, DOI 10.1016/S1010-7940(98)00184-5
   Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004
   TRINQUET F, 1988, ANN THORAC SURG, V45, P186
   TULLOH RMR, 1994, ARCH DIS CHILD, V70, pF206, DOI 10.1136/fn.70.3.F206
   Turner SW, 1999, ARCH DIS CHILD, V81, P413
   Tweddell JS, 1996, ANN THORAC SURG, V62, P419, DOI 10.1016/0003-4975(96)00250-0
   Tworetzky W, 2001, CIRCULATION, V103, P1269
   TYNAN MJ, 1979, BRIT HEART J, V41, P544
   Umans-Eckenhausen M A W, 2002, J Med Genet, V39, pe49, DOI 10.1136/jmg.39.9.e49
   Urban AE, 1998, ANN THORAC SURG, V66, pS183, DOI 10.1016/S0003-4975(98)01103-5
   Utens EM, 1998, EUR HEART J, V19, P801, DOI 10.1053/euhj.1997.0855
   Utens EM, 2000, CARDIOL YOUNG, V10, P239
   UTENS EMWJ, 1993, PSYCHOL MED, V23, P415
   UTENS EMWJ, 1994, J PSYCHOSOM RES, V38, P745, DOI 10.1016/0022-3999(94)90027-2
   Van Arsdell GS, 2000, CIRCULATION, V102, P123
   Vandvik IH, 2000, ACTA PAEDIATR, V89, P1129, DOI 10.1080/713794571
   VANPRAAGH R, 1964, AM J CARDIOL, V13, P367, DOI 10.1016/0002-9149(64)90453-9
   VARDULAKI K, 2001, SYSTEMATIC REV OUTCO
   Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812
   Veldtman GR, 2000, HEART, V84, P395, DOI 10.1136/heart.84.4.395
   Verheijen PM, 2001, J THORAC CARDIOV SUR, V121, P798, DOI 10.1067/mtc.2001.112825
   VESTERBY A, 1987, BRIT HEART J, V58, P653
   Visconti KJ, 1999, CIRCULATION, V100, P145
   Vohr B R, 2001, J Perinatol, V21, P15, DOI 10.1038/sj.jp.7200475
   von Bernuth G, 2000, THORAC CARDIOV SURG, V48, P228, DOI 10.1055/s-2000-6896
   Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133
   Wald NJ, 1998, HEALTH TECHNOL ASSES, V2, P1
   WALD NJ, 1994, J MED SCREEN, V1, P76
   Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4
   WARREN NS, 1982, J PEDIATR, V100, P373, DOI 10.1016/S0022-3476(82)80432-0
   Watkin PM, 1998, BRIT J AUDIOL, V32, P27, DOI 10.3109/03005364000000048
   WATKIN PM, 1995, BRIT J AUDIOL, V29, P259, DOI 10.3109/03005369509076740
   Webb CL, 2002, CIRCULATION, V105, P2318, DOI 10.1161/01.CIR.0000017557.24261.A7
   Weichbold V, 2001, BRIT J AUDIOL, V35, P59
   Wernovsky G, 2003, J PEDIATR, V142, P6, DOI 10.1067/mpd.2003.54
   Wetter J, 2001, EUR J CARDIO-THORAC, V20, P816, DOI 10.1016/S1010-7940(01)00912-5
   Whitelaw S, 1996, J MED GENET, V33, P540, DOI 10.1136/jmg.33.7.540
   Williams DL, 2000, J THORAC CARDIOV SUR, V119, P720, DOI 10.1016/S0022-5223(00)70007-9
   WILLIAMS WG, 1980, J THORAC CARDIOV SUR, V79, P603
   Wilson NJ, 1998, J AM COLL CARDIOL, V32, P758, DOI 10.1016/S0735-1097(98)00309-X
   Wilson PD, 1998, AM J EPIDEMIOL, V148, P414
   Wolke D, 2002, MIDWIFERY, V18, P145, DOI 10.1054/ymidw.0305
   Wolke D, 2002, ARCH DIS CHILD, V86, P155
   Wray J, 1999, ARCH DIS CHILD, V80, P511
   Wray J, 2001, HEART, V85, P687, DOI 10.1136/heart.85.6.687
   Wren C, 2002, HEART, V88, P426, DOI 10.1136/heart.88.4.426
   Wren C, 1999, ARCH DIS CHILD, V80, pF49
   Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414
   Wren C, 2003, HEART, V89, P1217, DOI 10.1136/heart.89.10.1217
   Wren C, 2000, HEART, V83, P410, DOI 10.1136/heart.83.4.410
   Wren C, 2001, HEART, V85, P438, DOI 10.1136/heart.85.4.438
   WRIGHT M, 1985, ARCH PHYS MED REHAB, V66, P289
   Wyllie JP, 1997, ARCH DIS CHILD, V76, pF26
   Yi MS, 2002, J PEDIATR, V141, P504, DOI 10.1067/mpd.2002.127502
   Yi MS, 2003, J PEDIATR, V142, P133, DOI 10.1067/mpd.2003.51
   Young A., 2001, J DEAF STUD DEAF EDU, V6, P149, DOI DOI 10.1093/DEAFED/6.3.149
   Yu MS, 1999, AM J MED GENET, V86, P219, DOI 10.1002/(SICI)1096-8628(19990917)86:3<219::AID-AJMG5>3.0.CO;2-7
   ZEHR KJ, 1995, ANN THORAC SURG, V59, P33, DOI 10.1016/0003-4975(94)00825-R
   ZEUNER D, 1999, HLTH TECHNOL ASSESS, V3
   ZOBEL G, 1993, J CARDIOVASC SURG, V34, P333
   Zosmer N, 1999, BRIT J OBSTET GYNAEC, V106, P829, DOI 10.1111/j.1471-0528.1999.tb08405.x
   2001, BRIST ROYAL INF 0304
   1999, ONLINE MED DICT
NR 511
TC 58
Z9 58
PU GRAY PUBLISHING
PI TUNBRIDGE WELLS
PA RUSSELL HOUSE, GROVE HILL RD, TUNBRIDGE WELLS, TN1 1RZ, ENGLAND
SN 1366-5278
J9 HEALTH TECHNOL ASSES
JI Health Technol. Assess.
PD NOV
PY 2005
VL 9
IS 44
BP 1
EP +
PG 150
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA 988OT
UT WOS:000233611200001
PM 16297355
ER

PT J
AU Lev-Ran, O
   Braunstein, R
   Sharony, R
   Kramer, A
   Paz, Y
   Mohr, R
   Uretzky, G
AF Lev-Ran, O
   Braunstein, R
   Sharony, R
   Kramer, A
   Paz, Y
   Mohr, R
   Uretzky, G
TI No-touch aorta off-pump coronary surgery: The effect on stroke
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID ARTERY-BYPASS; ASCENDING AORTA; OUTCOMES; RISK; REVASCULARIZATION;
   MANAGEMENT; MORTALITY; EMBOLI; GRAFT
AB Objective: Studies examining the neuroprotective effects of off-pump coronary artery bypass grafting have shown inconsistent results. Most studies, however, have not differentiated between clampless and clamp off-pump techniques. The aim of this study was to evaluate the effect of avoiding aortic manipulation on major neurologic outcomes after off-pump coronary artery bypass grafting.
   Methods: A total of 700 consecutive patients undergoing multiple-vessel off-pump coronary artery bypass grafting between 2000 and 2003 were included. The 429 patients undergoing aortic no-touch technique were compared with 271 patients in whom partial aortic clamps were applied. The aorta was screened by manual palpation, and epiaortic ultrasonography was used selectively.
   Results: The frequency of detected atherosclerotic aortic disease was higher in the no-touch group (17.4% vs 5.1%, P < .0001). No-touch revascularization was achieved with arterial conduits, arranged in T-graft or in situ configurations (50%). The respective graft/patient ratios were 2.5 +/- 0.6 and 2.6 +/- 0.6 in the side-clamp and no-touch groups (P = .009); however, revascularization of the posterolateral myocardial territory was comparable (87% vs 90%, difference not significant). The incidence of stroke (0.2% vs 2.2%, P = .01) was significantly lower in the no-touch group (1/429). Logistic regression identified partial aortic clamping as the only independent predictor of stroke (odds ratio 28.5, confidence interval 0.22-333, P = .009), increasing this risk 28-fold. Peripheral vascular disease (P = .068), diabetes (P = .072), and history of stroke (P = .074) trended toward stroke.
   Conclusions: Avoiding partial aortic clamping during off-pump coronary artery bypass grafting provides superior neurologic outcome. The results are reproducible and irrespective of the severity of aortic disease or the method of aortic screening. This technique is recommended whenever technically feasible.
C1 Tel Aviv Sourasky Med Ctr, Dept Cardiothorac Surg, IL-64239 Tel Aviv, Israel.
   Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol, IL-69978 Tel Aviv, Israel.
RP Lev-Ran, O (reprint author), Tel Aviv Sourasky Med Ctr, Dept Cardiothorac Surg, 6 Weizmann St, IL-64239 Tel Aviv, Israel.
EM orenlevran@hotmail.com
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Arom KV, 2000, ANN THORAC SURG, V69, P704, DOI 10.1016/S0003-4975(99)01510-6
   BARBUT D, 1994, STROKE, V25, P2398
   Barbut D, 1997, ANN THORAC SURG, V63, P1262
   Calafiore AM, 2002, ANN THORAC SURG, V73, P1387, DOI 10.1016/S0003-4975(02)03470-7
   Cheng W, 2002, J THORAC CARDIOV SUR, V124, P313, DOI 10.1067/mtc.2002.122304
   DEMARIA RG, 2002, CIRCULATION, V106, P15
   ECKSTEIN FS, 2002, J THORAC CARDIOVASC, V123, P778
   Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2
   Katariya K, 2004, ANN THORAC SURG, V77, P563, DOI 10.1016/S0003-4975(03)01587-X
   KOBAYASHI S, 2002, HEART SURG FORUM, V5, P114
   Leacche M, 2003, HEART SURG FORUM, V6, P169
   Lev-Ran O, 2002, ANN THORAC SURG, V74, P704, DOI 10.1016/S0003-4975(02)03791-8
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   MILLS NL, 1991, J THORAC CARDIOV SUR, V102, P546
   Patel NC, 2002, ANN THORAC SURG, V74, P400, DOI 10.1016/S0003-4975(02)03755-4
   Patel NC, 2002, HEART SURG FORUM, V5, P28
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   RORICK MB, 1990, NEUROLOGY, V40, P835
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Shimokawa T, 2002, ANN THORAC SURG, V74, P2097, DOI 10.1016/S0003-4975(02)04089-4
   Stamou SC, 2002, ANN THORAC SURG, V74, P394, DOI 10.1016/S0003-4975(02)03636-6
   Stamou SC, 2001, STROKE, V32, P1508
   Strandgaard S, 1996, J HYPERTENS, V14, pS23, DOI 10.1097/00004872-199610003-00005
   Van Boven W J, 2002, Heart Surg Forum, V5 Suppl 4, pS461
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   WAREING TH, 1992, J THORAC CARDIOV SUR, V103, P453
   Wilson MJ, 2000, ANN THORAC SURG, V70, P25, DOI 10.1016/S0003-4975(00)01256-X
   Yokoyama T, 2000, ANN THORAC SURG, V70, P1546, DOI 10.1016/S0003-4975(00)01922-6
NR 30
TC 58
Z9 63
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 2005
VL 129
IS 2
BP 307
EP 313
DI 10.1016/j.jtcvs.2004.06.013
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 893QQ
UT WOS:000226734700011
PM 15678040
ER

PT J
AU BROCKETT, PL
   COOPER, WW
   GOLDEN, LL
   PITAKTONG, U
AF BROCKETT, PL
   COOPER, WW
   GOLDEN, LL
   PITAKTONG, U
TI A NEURAL-NETWORK METHOD FOR OBTAINING AN EARLY WARNING OF INSURER
   INSOLVENCY
SO JOURNAL OF RISK AND INSURANCE
LA English
DT Article
ID INSURANCE INDUSTRY; FINANCIAL DISTRESS
AB This article introduces a neural network artificial intelligence model as an early warning system for predicting insurer insolvency.  In order to investigate a firm's propensity toward insolvency, a feed forward, back-propagation methodology is applied to financial data two years prior to insolvency for a sample of U.S. property-liability insurers that became insolvent in 1991 or 1992 and a size-matched sample of solvent insurers.  The results of the neural network method are compared with those of discriminant analysis, A. M. Best ratings, and the National Association of Insurance Commissioners' Insurance Regulatory Information System ratings.  The neural network results show high predictability and generalizability, suggesting the usefulness of this method for predicting future insurer insolvency.
C1 UNIV TEXAS,INST IC2,AUSTIN,TX 78712.
   UNIV TEXAS,TEXAS STATE DEPT INSURANCE,RES UNIT,AUSTIN,TX 78712.
RP BROCKETT, PL (reprint author), UNIV TEXAS,CTR CYBERNET STUDIES,AUSTIN,TX 78712, USA.
CR ALTMAN EI, 1968, J FINANC, V23, P589, DOI 10.2307/2978933
   Altman E. I., 1977, J BANK FINANC, V1, P29, DOI 10.1016/0378-4266(77)90017-6
   AMBROSE JM, 1988, J RISK INSUR, V55, P229, DOI 10.2307/253325
   BARNIV R, 1990, J RISK INSUR, V57, P110, DOI 10.2307/252927
   BARNIV R, 1992, J RISK INSUR, V59, P543, DOI 10.2307/253344
   BARNOFF E, 1993, THESIS U TEXAS AUSTI
   BARRESE J, 1990, CPCU J, V43, P37
   BIERMAN H, 1960, ACCOUNT REV, V35, P628
   BORCH K, 1970, ASTIN B, V6, P66
   BROCKETT PL, 1993, METHODOLOGICAL CONTR
   CHARNES A, 1963, J MATH ANAL APPL, V7, P475, DOI 10.1016/0022-247X(63)90069-6
   CUMMINS J, 1994, IN PRESS J BANKING F
   EBERHART RC, 1990, NEURAL NETWORK PC TO
   GOLDEN LL, 1993, USING ARTIFICIAL INT
   GRACE M, 1993, 1993 ANN M AM RISK I
   HARRINGTON SE, 1986, J RISK INSUR, V53, P583, DOI 10.2307/252965
   HEBB DO, 1949, ORG BEHAVIOR
   HECHTNIELSEN R, 1988, IEEE SPECTRUM, V25, P36, DOI 10.1109/6.4520
   Hertz J., 1991, INTRO THEORY NEURAL
   HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554
   LIPPMANN RP, 1987, IEEE ASSP MAGAZINE, V1, P4
   Lorentz G. G., 1976, MATH DEV ARISING HIL
   Minsky M.L., 1969, PERCEPTRONS
   NETI C, 1992, IEEE T NEURAL NETWOR, V30, P12
   QUIRK JP, 1961, INT ECON REV, V2, P210, DOI 10.2307/2525446
   ROBERTS JA, 1988, NEURAL NETWORKS, V1, P295
   Rosenblatt F., 1962, PRINCIPLES NEURODYNA
   Rosenblatt F., 1959, P S MECH THOUGHT PRO, P421
   RUMELHART DE, 1985, ICS8506 U CAL I COGN
   SALCHENBERGER LM, 1990, 9009 LOY U SCH BUS W
   Santomero A., 1977, J BANK FINANC, V1, P185, DOI 10.1016/0378-4266(77)90006-1
   SINKEY JF, 1975, J FINANC, V30, P21, DOI 10.2307/2978429
   TINSLEY PA, 1970, J FINANC QUANT ANAL, V5, P33, DOI 10.2307/2979006
   VINSO JD, 1979, J FINANC QUANT ANAL, V14, P77, DOI 10.2307/2330656
   Widrow B., 1962, SELF ORG SYSTEMS, P435
   WILLIAMS WH, 1971, J FINANC QUANT ANAL, V6, P1095, DOI 10.2307/2329608
NR 36
TC 58
Z9 60
PU AMER RISK INSURANCE ASSOC, INC
PI MT VERNON
PA C/O CHASE COMMUNICATIONS, STEVE ACUNTO, BOX 9001, MT VERNON, NY 10552
SN 0022-4367
J9 J RISK INSUR
JI J. Risk Insur.
PD SEP
PY 1994
VL 61
IS 3
BP 402
EP 424
DI 10.2307/253568
PG 23
WC Business, Finance; Economics
SC Business & Economics
GA PQ446
UT WOS:A1994PQ44600002
ER

PT J
AU CHATFIELD, C
AF CHATFIELD, C
TI CALCULATING INTERVAL FORECASTS
SO JOURNAL OF BUSINESS & ECONOMIC STATISTICS
LA English
DT Article
DE BAYESIAN FORECASTING; BOOTSTRAPPING; BOX-JENKINS METHOD; FORECASTING;
   HOLT-WINTERS METHOD; PREDICTION INTERVALS; RESAMPLING; SIMULATION
ID BOOTSTRAP PREDICTION INTERVALS; UNIVARIATE TIME-SERIES;
   CONFIDENCE-INTERVALS; ESTIMATED PARAMETERS; M-COMPETITION; MODELS;
   ERRORS; ACCURACY; SAMPLE; UNCERTAINTY
AB The importance of interval forecasts is reviewed. Several general approaches to calculating such forecasts are described and compared. They include the use of theoretical formulas based on a fitted probability model (with or without a correction for parameter uncertainty), various ''approximate'' formulas (which should be avoided), and empirically based, simulation resampling procedures. The latter are useful when theoretical formulas are not available or there are doubts about some model assumptions. The distinction between a forecasting method and a forecasting model is expounded. For large groups of series, a forecasting method may be chosen in a fairly ad hoc way. With appropriate checks, it may be possible to base interval forecasts on the model for which the method is optimal. It is certainly unsound to use a model for which the method is not optimal, but, strangely, this is sometimes done. Some general comments are made as to why prediction intervals tend to be too narrow in practice to encompass the required proportion of future observations. An example demonstrates the overriding importance of careful model specification. In particular, when data are ''nearly nonstationary,'' the difference between fitting a stationary and a nonstationary model is critical.
RP CHATFIELD, C (reprint author), UNIV BATH,SCH MATH SCI,BATH BA2 7AY,AVON,ENGLAND.
CR Abraham B, 1983, STATISTICAL METHODS
   Armstrong J., 1985, LONG RANGE FORECASTI
   ASHLEY R, 1988, INT J FORECASTING, V4, P363, DOI 10.1016/0169-2070(88)90104-5
   BAILLIE RT, 1979, BIOMETRIKA, V66, P675
   BIANCHI C, 1987, INT J FORECASTING, V3, P211, DOI 10.1016/0169-2070(87)90003-3
   BOWERMAN BL, 1987, TIME SERIES FORECAST
   BOWERMAN BL, 1989, UNPUB 9TH INT S FOR
   Box GEP, 1976, TIME SERIES ANAL
   Brockwell PJ, 1987, TIME SERIES THEORY M
   Brown R. G., 1967, DECISION RULES INVEN
   Brown RG, 1963, SMOOTHING FORECASTIN
   BUTLER R, 1980, J AM STAT ASSOC, V75, P881, DOI 10.2307/2287176
   CHATFIELD C, 1988, STATISTICIAN, V37, P129, DOI 10.2307/2348687
   Chatfield C, 1988, J APPLIED STATISTICS, V15, P19, DOI 10.1080/02664768800000003
   CHATFIEL.C, 1973, J ROY STAT SOC A STA, V136, P295, DOI 10.2307/2344994
   CHATFIELD C, 1991, STATISTICIAN, V7, P31
   CHATFIELD C, 1991, INT J FORECASTING, V7, P239, DOI 10.1016/0169-2070(91)90057-3
   CHATFIELD C, 1991, INT J FORECASTING, V7, P31, DOI 10.1016/0169-2070(91)90030-Y
   Chatfield C., 1989, ANAL TIME SERIES
   COLLINS S, 1991, J BUS ECON STAT, V9, P267, DOI 10.2307/1391291
   CORKER RJ, 1986, INT J FORECASTING, V2, P53, DOI 10.1016/0169-2070(86)90030-0
   DALRYMPLE DJ, 1987, INT J FORECASTING, V3, P379, DOI 10.1016/0169-2070(87)90031-8
   ENGLE RF, 1987, J ECONOMETRICS, V35, P143, DOI 10.1016/0304-4076(87)90085-6
   FAIR RC, 1980, INT ECON REV, V21, P355, DOI 10.2307/2526186
   FILDES R, 1992, INT J FORECASTING, V8, P81, DOI 10.1016/0169-2070(92)90009-X
   Findley D. F., 1986, Computer Science and Statistics. Proceedings of the Seventeenth Symposium on the Interface
   Freedman D. A., 1984, J BUS ECON STAT, V2, P150, DOI 10.2307/1391259
   FREEDMAN DA, 1984, J AM STAT ASSOC, V79, P97, DOI 10.2307/2288341
   FULLER WA, 1981, J AM STAT ASSOC, V76, P155, DOI 10.2307/2287061
   GARDNER ES, 1988, MANAGE SCI, V34, P541, DOI 10.1287/mnsc.34.4.541
   GILCHRIST W, 1976, STATISTICAL FORECAST
   Granger C. W. J., 1986, FORECASTING EC TIME
   HAHN GJ, 1991, STATISTICAL INTERVAL, P77671
   Harrison P., 1967, MANAGE SCI, V13, P821, DOI 10.1287/mnsc.13.11.821
   Harvey AC, 1989, FORECASTING STRUCTUR
   JOHNSTON FR, 1986, J OPER RES SOC, V37, P303, DOI 10.2307/2582210
   Kendall M., 1990, TIME SERIES
   KOEHLER AB, 1990, INT J FORECASTING, V6, P557, DOI 10.1016/0169-2070(90)90034-9
   ANSLEY CF, 1986, BIOMETRIKA, V73, P467, DOI 10.2307/2336224
   LEDOLTER J, 1989, INT J FORECASTING, V5, P231, DOI 10.1016/0169-2070(89)90090-3
   LEFRANCOIS P, 1990, INT J FORECASTING, V6, P561, DOI 10.1016/0169-2070(90)90036-B
   LEFRANCOIS P, 1989, INT J FORECASTING, V5, P553, DOI 10.1016/0169-2070(89)90011-3
   Lutkepohl H., 1991, INTRO MULTIPLE TIME
   MAKRIDAKIS S, 1987, INT J FORECASTING, V3, P489, DOI 10.1016/0169-2070(87)90045-8
   MAKRIDAKIS S, 1988, INT J FORECASTING, V4, P467, DOI 10.1016/0169-2070(88)90112-4
   MAKRIDAKIS S, 1989, APPL STAT-J ROY ST C, V38, P331, DOI 10.2307/2348063
   MASAROTTO G, 1990, INT J FORECASTING, V6, P229, DOI 10.1016/0169-2070(90)90008-Y
   MCKENZIE E, 1986, INT J FORECASTING, V2, P373, DOI 10.1016/0169-2070(86)90055-5
   Miller AJ, 1990, SUBSET SELECTION REG
   THOMPSON PA, 1986, J BUS ECON STAT, V4, P427, DOI 10.2307/1391498
   Montgomery D. C., 1976, FORECASTING TIME SER
   NEWBOLD P, 1974, J ROY STAT SOC A STA, V137, P131, DOI 10.2307/2344546
   NEWBOLD P, 1988, STATISTICIAN, V37, P111, DOI 10.2307/2348686
   OCONNOR M, 1989, J FORECASTING, V8, P141, DOI 10.1002/for.3980080207
   OCONNOR M, 1992, INT J FORECASTING, V7, P413, DOI 10.1016/0169-2070(92)90026-6
   PETERS SC, 1985, J FORECASTING, V4, P251, DOI 10.1002/for.3980040302
   PFLAUMER P, 1988, INT J FORECASTING, V4, P135, DOI 10.1016/0169-2070(88)90015-5
   Phillips P. C. B, 1979, J ECONOMETRICS, V9, P241, DOI 10.1016/0304-4076(79)90073-3
   RAVISHANKER N, 1987, TECHNOMETRICS, V29, P371, DOI 10.2307/1269346
   RAVISHANKER N, 1991, J FORECASTING, V10, P445, DOI 10.1002/for.3980100502
   REINSEL G, 1980, J ROY STAT SOC B MET, V42, P328
   SCHMIDT P, 1977, ECONOMETRICA, V45, P997, DOI 10.2307/1912687
   STINE RA, 1987, J AM STAT ASSOC, V82, P1072, DOI 10.2307/2289383
   STOICA P, 1989, J FORECASTING, V8, P357, DOI 10.1002/for.3980080402
   THOMBS LA, 1990, J AM STAT ASSOC, V85, P486, DOI 10.2307/2289788
   Tong H., 1990, NONLINEAR TIME SERIE
   VEALL MR, 1989, B ISI, P75
   WALLIS KF, 1974, J R STAT SOC A STAT, V137, P155
   Weisberg S., 1985, APPLIED LINEAR REGRE
   West M., 1989, BAYESIAN FORECASTING
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
   WINKLER RL, 1972, J AM STAT ASSOC, V67, P187
   WWS Wei, 1990, TIME SERIES ANAL
   YAMAMOTO T, 1976, APPL STAT, V25, P123, DOI 10.2307/2346680
   YAMAMOTO T, 1981, BIOMETRIKA, V68, P485, DOI 10.1093/biomet/68.2.485
   YAR M, 1990, INT J FORECASTING, V6, P1
NR 76
TC 58
Z9 58
PU AMER STATISTICAL ASSOC
PI ALEXANDRIA
PA 1429 DUKE ST, ALEXANDRIA, VA 22314
SN 0735-0015
J9 J BUS ECON STAT
JI J. Bus. Econ. Stat.
PD APR
PY 1993
VL 11
IS 2
BP 121
EP 135
PG 15
WC Economics; Social Sciences, Mathematical Methods; Statistics &
   Probability
SC Business & Economics; Mathematical Methods In Social Sciences;
   Mathematics
GA KU474
UT WOS:A1993KU47400001
ER

PT J
AU HOUSLEY, GD
   NORRIS, CH
   GUTH, PS
AF HOUSLEY, GD
   NORRIS, CH
   GUTH, PS
TI ELECTROPHYSIOLOGICAL PROPERTIES AND MORPHOLOGY OF HAIR-CELLS ISOLATED
   FROM THE SEMICIRCULAR CANAL OF THE FROG
SO HEARING RESEARCH
LA English
DT Article
C1 TULANE UNIV,SCH MED,DEPT OTOLARYNGOL,NEW ORLEANS,LA 70112.
RP HOUSLEY, GD (reprint author), TULANE UNIV,SCH MED,DEPT PHARMACOL,1430 TULANE AVE,NEW ORLEANS,LA 70112, USA.
CR ALDRICH RW, 1981, BIOPHYS J, V36, P519
   ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P507
   ART JJ, 1986, HEARING RES, V22, P31, DOI 10.1016/0378-5955(86)90073-0
   ART JJ, 1987, J PHYSIOL-LONDON, V385, P207
   ASHMORE JF, 1988, PROG BRAIN RES, V74, P1
   ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323
   ASHMORE JF, 1985, PROC R SOC SER B-BIO, V226, P325, DOI 10.1098/rspb.1985.0098
   ASHMORE JF, 1988, SCI PROG, V72, P139
   ASHMORE JF, 1983, NATURE, V304, P539
   Brownell W. E., 1986, NEUROBIOLOGY HEARING, P91
   BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153
   BRYANT GM, 1987, HEARING RES, V30, P231, DOI 10.1016/0378-5955(87)90139-0
   CODY AR, 1987, J PHYSIOL-LONDON, V383, P551
   Cole K.S., 1968, MEMBRANE IONS IMPULS
   COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0
   CORREIA M J, 1987, Society for Neuroscience Abstracts, V13, P635
   CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377
   CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79
   DALLOS P, 1985, J NEUROSCI, V5, P1591
   EATOCK RA, 1987, J NEUROSCI, V7, P2821
   EVANS MG, 1987, BIOPHYS J, V52, P649
   FERNANDE.C, 1971, J NEUROPHYSIOL, V34, P661
   FETTIPLACE R, 1987, TRENDS NEUROSCI, V10, P421, DOI 10.1016/0166-2236(87)90013-0
   FLOCK A, 1977, ACTA OTO-LARYNGOL, V83, P85, DOI 10.3109/00016487709128817
   FLOCK A, 1976, J PHYSIOL-LONDON, V257, P45
   FUCHS PA, 1986, J PHYSIOL-LONDON, V371, pP31
   FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P193
   GITTER AH, 1986, ORL J OTO-RHINO-LARY, V48, P68
   GOLDBERG JM, 1975, ANNU REV PHYSIOL, V37, P129, DOI 10.1146/annurev.ph.37.030175.001021
   GUTH PS, 1988, HEARING RES, V33, P223, DOI 10.1016/0378-5955(88)90152-9
   HAGIWARA S, 1982, J PHYSIOL-LONDON, V331, P231
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   Hille B., 1984, IONIC CHANNELS EXCIT
   HILLMAN DE, 1974, BRAIN BEHAV EVOLUT, V10, P52, DOI 10.1159/000124302
   HOLLEY MC, 1987, CELL BIOL INT REP, V11, P239, DOI 10.1016/0309-1651(87)90053-1
   HOUSLEY GD, 1988, HEARING RES, V35, P87, DOI 10.1016/0378-5955(88)90043-3
   HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407
   HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275
   HUDSPETH AJ, 1983, ANNU REV NEUROSCI, V6, P187, DOI 10.1146/annurev.ne.06.030183.001155
   HUDSPETH AJ, 1979, P NATL ACAD SCI USA, V76, P1506, DOI 10.1073/pnas.76.3.1506
   HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237
   HUDSPETH AJ, 1983, TRENDS NEUROSCI, V6, P366, DOI 10.1016/0166-2236(83)90166-2
   IRISAWA H, 1987, ELECTROPHYSIOLOGY SI, P167
   LANDOLT JP, 1972, ANAT REC, V174, P311, DOI 10.1002/ar.1091740304
   LEWIS ER, 1975, BRAIN RES, V83, P35, DOI 10.1016/0006-8993(75)90856-2
   LEWIS ER, 1976, BRAIN BEHAV EVOLUT, V13, P196, DOI 10.1159/000123810
   LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0
   LI CW, 1979, ANN OTO RHINOL LARYN, V88, P427
   LIM DJ, 1985, ACTA OTO-LARYNGOL, V99, P478, DOI 10.3109/00016488509108941
   MEECH RW, 1978, ANNU REV BIOPHYS BIO, V7, P1, DOI 10.1146/annurev.bb.07.060178.000245
   MOFFAT AJM, 1976, J COMP PHYSIOL, V105, P1
   NAKAJIMA Y, 1986, P NATL ACAD SCI USA, V83, P3022, DOI 10.1073/pnas.83.9.3022
   NORRIS CH, 1985, TRENDS PHARMACOL SCI, V6, P15
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189
   OHMORI H, 1984, J PHYSIOL-LONDON, V350, P561
   OHMORI H, 1986, BIOMED RES-TOKYO, V7, P103
   PITCHFORD S, 1987, HEARING RES, V27, P75, DOI 10.1016/0378-5955(87)90027-X
   Ramprashad F, 1986, Acta Otolaryngol Suppl, V427, P1
   RUSSELL IJ, 1979, NEURONES IMPULSES, P117
   RUSSELL IJ, 1978, J PHYSIOL-LONDON, V284, P261
   RUSSELL IJ, 1987, HEARING RES, V31, P9, DOI 10.1016/0378-5955(87)90210-3
   SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X
   SATO H, 1977, INNER EAR BIOL INSER, V68, P179
   SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996
   STEINACKER A, 1988, HEARING RES, V35, P265, DOI 10.1016/0378-5955(88)90123-2
   STERKERS O, 1988, PHYSIOL REV, V68, P1083
   VALLI P, 1985, BRAIN RES, V330, P1, DOI 10.1016/0006-8993(85)90002-2
   von Bekesy G., 1960, EXPT HEARING
   WEISS TF, 1978, EVOKED ELECTRICAL AC, P91
   WERSALL J, 1965, COLD SPRING HARB SYM, V30, P115
   ZAJIC G, 1987, HEARING RES, V26, P249, DOI 10.1016/0378-5955(87)90061-X
NR 72
TC 58
Z9 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5955
J9 HEARING RES
JI Hear. Res.
PD APR
PY 1989
VL 38
IS 3
BP 259
EP 276
DI 10.1016/0378-5955(89)90070-1
PG 18
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA U1690
UT WOS:A1989U169000007
PM 2468636
ER

PT J
AU DUNCAN, GJ
   KALTON, G
AF DUNCAN, GJ
   KALTON, G
TI ISSUES OF DESIGN AND ANALYSIS OF SURVEYS ACROSS TIME
SO INTERNATIONAL STATISTICAL REVIEW
LA English
DT Article
RP DUNCAN, GJ (reprint author), UNIV MICHIGAN,SURVEY RES CTR,ANN ARBOR,MI 48106, USA.
CR Allison PD, 1982, SOCIOL METHODOL, P61
   ASHENFELTER O, 1986, 23 WORLD BANK WORK P
   ATKINS E, 1981, PROSPECTIVE LONGITUD, P25
   BACHMAN JG, 1983, MONITORING FUTURE QU
   BAILAR BA, 1975, J AM STAT ASSOC, V70, P23, DOI 10.2307/2285370
   BAILAR BA, 1979, B INT STAT I, V48, P385
   BECKETTI S, 1983, ATTRITION PSID
   BENUS J, 1974, 5000 AM FAMILIES PAT, V1, P277
   BENUS J, 1976, REV ECON STAT, V58, P129, DOI 10.2307/1924018
   BIELBY WT, 1977, J AM STAT ASSOC, V72, P723, DOI 10.2307/2286452
   BIORN E, 1981, J ECONOMETRICS, V16, P221, DOI 10.1016/0304-4076(81)90109-3
   BOHRNSTEDT GW, 1969, SOCIOL METHODOL, P113
   BOOTH A, 1985, SOCIOL METHOD RES, V14, P53, DOI 10.1177/0049124185014001003
   Call V. R. A., 1982, TRACKING RESPONDENTS
   CHAMBERLAIN G, 1982, J ECONOMETRICS, V18, P5, DOI 10.1016/0304-4076(82)90094-X
   CLARRIDGE BR, 1978, SOCIOL METHODOL, P185
   CORCORAN M, 1985, J HUM RESOUR, V20, P165, DOI 10.2307/146006
   CRIDER DM, 1971, PUBLIC OPIN QUART, V35, P613, DOI 10.1086/267959
   DAVIS JA, 1985, GENERAL SOCIAL SURVE
   DAYMONT TN, 1983, REV PUBLIC DATA USE, V11, P203
   DOUGLAS JWB, 1956, MILBANK FUND Q, V34, P227, DOI 10.2307/3348526
   DUNCAN GJ, 1984, COLLECTION ANAL EC C, P301
   DUNCAN GJ, 1985, J LABOR ECON, V3, P508, DOI 10.1086/298067
   DUNCAN GJ, 1985, J ECON SOC MEAS, V13, P361
   DUNCAN GJ, 1983, J LABOR ECON, V1, P366, DOI 10.1086/298018
   Duncan Greg J., 1984, YEARS POVERTY YEARS
   DUNCAN OD, 1969, PSYCHOL BULL, V72, P177, DOI 10.1037/h0027876
   ECKLAND BK, 1968, PUBLIC OPIN QUART, V32, P51, DOI 10.1086/267578
   FERBER R, 1966, RELIABILITY CONSUMER
   FIENBERG SE, 1986, SURVEY RES DESIGNS B, P60
   Fogelman K., 1983, GROWING GREAT BRITAI
   FREEDMAN DS, 1980, SOCIOL METHOD RES, V9, P87, DOI 10.1177/004912418000900104
   Ghangurde PD, 1982, SURV METHODOL, V8, P86
   GURNEY M, 1965, P SOC STAT SECT AM S, P242
   HANEFELD U, 1984, P SOCIAL STATIST SEC, P117
   HAUSE JC, 1980, ECONOMETRICA, V48, P1013, DOI 10.2307/1912945
   HECKMAN J, 1984, ECONOMETRICA, V52, P271, DOI 10.2307/1911491
   HECKMAN J, 1981, STRUCTURAL ANAL DISC, P144
   Heckman James J., 1985, LONGITUDINAL ANAL LA, P156, DOI 10.1017/CCOL0521304539.004
   HERRIOT R, 1984, P SECT SURV RES METH, P107
   HOLMES J, 1977, 5000 AM FAMILIES PAT, P147
   Huang E.T., 1981, P SECT SURV RES METH, P303
   HUANG H, 1984, P SURVEY RES METH SE, P670
   Hymans S. H., 1976, Journal of Econometrics, V4, P167, DOI 10.1016/0304-4076(76)90011-7
   Jowell R, 1984, BRIT SOCIAL ATTITUDE
   JOWELL R, 1985, BRIT SOCIAL ATTITUDE
   Judge G. G., 1980, THEORY PRACTICE ECON
   KALTON G, 1985, J ECON SOC MEAS, V13, P319
   Kalton G., 1986, J OFF STAT, V2, P303
   KALTON G, 1983, TECHNICAL CONCEPTUAL, P171
   KASPRZYK D, 1983, TECHNICAL CONCEPTUAL, P155
   KESSLER R, 1981, LINEAR PANEL MODELS
   KISH L, 1983, STAT METHODS IMPROVE, P73
   KISH L, 1986, AUSTR J STAT, V28, P1
   KLEVMARKEN NA, 1984, P SOCIAL STATIST SEC, P125
   Kmenta J., 1971, ELEMENTS ECONOMETRIC
   Kumar S., 1983, SURV METHODOL, V9, P178
   Leinhardt S., 1981, SOCIOL METHODOL, P389
   LIEVESLEY D, 1985, BRIT SOCIAL ATTITUDE, P177
   LIKER JK, 1985, SOC SCI RES, V14, P80, DOI 10.1016/0049-089X(85)90013-4
   LILLARD LA, 1978, ECONOMETRICA, V46, P985, DOI 10.2307/1911432
   LITTLE R, 1983, WEIGHTING ADJUSTMENT
   LITTLE RJA, 1982, J AM STAT ASSOC, V77, P237, DOI 10.2307/2287227
   Maddala GS, 1977, ECONOMETRICS
   MASON KO, 1973, AM SOCIOL REV, V38, P242, DOI 10.2307/2094398
   MATHIOWETZ NA, 1984, P AM STAT ASSOC, P652
   MCALLIST.RJ, 1973, PUBLIC OPIN QUART, V37, P413, DOI 10.1086/268103
   MCCALL JJ, 1973, INCOME MOBILITY RACI
   MCMILLEN DB, 1985, J ECON SOC MEAS, V13, P349
   MEYER RH, 1983, J LABOR ECON, V1, P66, DOI 10.1086/298005
   MINCER J, 1982, J HUM RESOUR, V17, P3, DOI 10.2307/145520
   Moss L. B., 1979, RECALL METHOD SOCIAL
   MURPHY L, 1976, P SOC STAT SECT AM S, P633
   NETER J, 1964, J AM STAT ASSOC, V59, P18, DOI 10.2307/2282857
   PATTERSON HD, 1950, J ROY STAT SOC B, V12, P241
   PELZ DC, 1964, AM SOCIOL REV, V29, P836, DOI 10.2307/2090866
   SCOTT AJ, 1977, INT STAT REV, V45, P13, DOI 10.2307/1403000
   SOBOL MG, 1959, J AM STAT ASSOC, V54, P52, DOI 10.2307/2282139
   STAFFORD F, 1987, IN PRESS HDB LABOR E
   Stafford FP, 1985, TIME GOODS WELL BEIN
   SUDMAN S, 1984, COLLECTION ANAL EC C, P329
   TRAUGOTT M, 1979, PUB OPIN Q, V79, P359
   Tuma NB, 1984, SOCIAL DYNAMICS MODE
   WILCOX NE, 1965, AM J PUBLIC HEALTH N, V55, P1741, DOI 10.2105/AJPH.55.11.1741
   WILLIAMS WH, 1970, J AM STAT ASSOC, V65, P1338
   WOLTMAN H, 1975, P SOC STATIST SECT A, P159
   1978, 40 US BUR CENS TECHN
   1977, 71526 STAT CAN CAT
   1984, USER GUIDE PANEL STU
   1984, GENERAL HOUSEHOLD SU
   1985, P C GROSS FLOWS LABO
   1975, HLTH INTERVIEW SURVE
NR 92
TC 58
Z9 58
PU INT STATISTICAL INST
PI VOORBURG
PA 428 PRINSES BEATRIXLAAN, 2270 AZ VOORBURG, NETHERLANDS
SN 0306-7734
J9 INT STAT REV
JI Int. Stat. Rev.
PD APR
PY 1987
VL 55
IS 1
BP 97
EP 117
DI 10.2307/1403273
PG 21
WC Statistics & Probability
SC Mathematics
GA G9385
UT WOS:A1987G938500007
ER

PT J
AU MORRIS, AH
   CHAPMAN, RH
   GARDNER, RM
AF MORRIS, AH
   CHAPMAN, RH
   GARDNER, RM
TI FREQUENCY OF TECHNICAL PROBLEMS ENCOUNTERED IN THE MEASUREMENT OF
   PULMONARY-ARTERY WEDGE PRESSURE
SO CRITICAL CARE MEDICINE
LA English
DT Article
C1 UNIV UTAH,SCH MED,DEPT MED,DIV RESP CRIT CARE & OCCUPAT PULM MED,SALT LAKE CITY,UT 84112.
   UNIV UTAH,SCH MED,DEPT MED BIOPHYS & COMP,SALT LAKE CITY,UT 84112.
RP MORRIS, AH (reprint author), LATTER DAY ST HOSP,DEPT MED,DIV PULM,INTERMT RESP INTENS CARE UNIT,SALT LAKE CITY,UT 84143, USA.
CR ARCHER G, 1974, ANN SURG, V180, P747, DOI 10.1097/00000658-197411000-00007
   BREWSTER H, 1973, J APPL PHYSIOL, V34, P413
   CENGIZ M, 1983, CRIT CARE MED, V11, P502, DOI 10.1097/00003246-198307000-00004
   CHLUP J, 1975, CLIN SCI MOL MED, V48, P47
   CONNORS AF, 1983, NEW ENGL J MED, V308, P263, DOI 10.1056/NEJM198302033080508
   DEXTER L, 1947, J CLIN INVEST, V26, P554, DOI 10.1172/JCI101840
   FRY DL, 1960, PHYSIOL REV, V40, P753
   GARDNER RM, 1970, IEEE T BIOMED ENG, V18, P60
   GARDNER RM, 1981, ANESTHESIOLOGY, V54, P227, DOI 10.1097/00000542-198103000-00010
   GARDNER RM, 1977, ANN THORAC SURG, V23, P534
   GREENE R, 1981, AM REV RESPIR DIS, V124, P593
   HOAR PF, 1978, ANESTHESIOLOGY, V48, P445, DOI 10.1097/00000542-197806000-00014
   HOAR PF, 1981, NEW ENGL J MED, V305, P993, DOI 10.1056/NEJM198110223051707
   KANE PB, 1978, CRIT CARE MED, V6, P36, DOI 10.1097/00003246-197801000-00009
   LANGERLOF H, 1947, SCAND J CLIN LAB INV, V1, P147
   LEFCOE MS, 1979, CRIT CARE MED, V7, P449, DOI 10.1097/00003246-197910000-00001
   MALMSTROM G, 1954, ACTA MED SCAND, V149, P431
   MALMSTROM G, 1953, ACTA MED SCAND, V145, P91
   MANKTELO.RT, 1969, J THORAC CARDIOV SUR, V58, P122
   MENDEL A, 1968, PRACTICE CARDIAC CAT, P234
   MOSER KM, 1983, ANN INTERN MED, V98, P53
   PACE NL, 1977, ANESTHESIOLOGY, V47, P455, DOI 10.1097/00000542-197711000-00014
   RAPAPORT E, 1958, METHOD MED RES, P85
   SHAPIRO HM, 1974, ANESTHESIOLOGY, V40, P291, DOI 10.1097/00000542-197403000-00017
   Suter P M, 1975, Crit Care Med, V3, P175, DOI 10.1097/00003246-197509000-00001
   SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902
   TODD TRJ, 1978, AM REV RESPIR DIS, V118, P613
   TOOKER J, 1978, AM REV RESPIR DIS, V117, P721
   WILLIAMS WH, 1982, CRIT CARE MED, V10, P636, DOI 10.1097/00003246-198210000-00003
   WOODS M, 1976, SURGERY, V79, P469
NR 30
TC 58
Z9 59
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PY 1984
VL 12
IS 3
BP 164
EP 170
DI 10.1097/00003246-198403000-00003
PG 7
WC Critical Care Medicine
SC General & Internal Medicine
GA SK111
UT WOS:A1984SK11100003
PM 6697740
ER

PT J
AU Gaul, EW
   Martinez, M
   Blakeney, J
   Jochmann, A
   Ringuette, M
   Hammond, D
   Borger, T
   Escamilla, R
   Douglas, S
   Henderson, W
   Dyer, G
   Erlandson, A
   Cross, R
   Caird, J
   Ebbers, C
   Ditmire, T
AF Gaul, Erhard W.
   Martinez, Mikael
   Blakeney, Joel
   Jochmann, Axel
   Ringuette, Martin
   Hammond, Doug
   Borger, Ted
   Escamilla, Ramiro
   Douglas, Skylar
   Henderson, Watson
   Dyer, Gilliss
   Erlandson, Alvin
   Cross, Rick
   Caird, John
   Ebbers, Christopher
   Ditmire, Todd
TI Demonstration of a 1.1 petawatt laser based on a hybrid optical
   parametric chirped pulse amplification/mixed Nd:glass amplifier
SO APPLIED OPTICS
LA English
DT Article
ID PLASMA ACCELERATORS; ENERGY; FUSION; OPTIMIZATION; GENERATION; BEAMS
AB We present the design and performance of the Texas Petawatt Laser, which produces a 186 J 167 fs pulse based on the combination of optical parametric chirped pulse amplification (OPCPA) and mixed Nd:glass amplification. OPCPA provides the majority of the gain and is used to broaden and shape the seed spectrum, while amplification in Nd: glass accounts for >99% of the final pulse energy. Compression is achieved with highly efficient multilayer dielectric gratings. (C) 2010 Optical Society of America
C1 [Gaul, Erhard W.; Martinez, Mikael; Blakeney, Joel; Jochmann, Axel; Ringuette, Martin; Hammond, Doug; Borger, Ted; Escamilla, Ramiro; Douglas, Skylar; Henderson, Watson; Dyer, Gilliss; Ditmire, Todd] Univ Texas Austin, Texas Ctr High Intens Laser Sci, Austin, TX 78712 USA.
   [Erlandson, Alvin; Cross, Rick; Caird, John; Ebbers, Christopher] Lawrence Livermore Natl Lab, Natl Ignit Facil Directorate, Livermore, CA 94550 USA.
RP Gaul, EW (reprint author), Univ Texas Austin, Texas Ctr High Intens Laser Sci, 1 Univ Stn,Mail Stop C1510, Austin, TX 78712 USA.
EM gaul@physics.utexas.edu
RI Jochmann, Axel/B-7616-2013
FU National Nuclear Security Administration [DE-FC52-03NA00156]
FX This work was supported by the National Nuclear Security Administration
   under cooperative agreement DE-FC52-03NA00156.
CR Aoyama M, 2003, OPT LETT, V28, P1594, DOI 10.1364/OL.28.001594
   Banks PS, 2000, IEEE J QUANTUM ELECT, V36, P268, DOI 10.1109/3.825872
   Bayramian AJ, 2009, FUSION SCI TECHNOL, V56, P295
   BOR Z, 1989, OPT LETT, V14, P119, DOI 10.1364/OL.14.000119
   Danson CN, 2005, LASER PART BEAMS, V23, P87, DOI 10.1017/S0263034605050159
   Ditmire T, 2008, LASER PHOTONICS REV, V2, P400, DOI 10.1002/lpor.200810005
   Ditmire T, 1999, NATURE, V398, P489, DOI 10.1038/19037
   Dubietis A, 2006, IEEE J SEL TOP QUANT, V12, P163, DOI 10.1109/JSTQE.2006.871962
   DUBIETIS A, 1992, OPT COMMUN, V88, P437, DOI 10.1016/0030-4018(92)90070-8
   Evans RG, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1920422
   Fleurot N, 2005, FUSION ENG DES, V74, P147, DOI 10.1016/j.fusengdes.2005.06.251
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   Hays GR, 2007, APPL OPTICS, V46, P4813, DOI 10.1364/AO.46.004813
   Kitagawa Y, 2004, IEEE J QUANTUM ELECT, V40, P281, DOI 10.1109/JQE.2003.823043
   Leemans W, 2006, PHILOS T ROY SOC A, V364, P585, DOI 10.1098/rsta.2005.1724
   Leemans WP, 2006, NAT PHYS, V2, P696, DOI 10.1038/nphys418
   Liao ZM, 2006, OPT LETT, V31, P1277, DOI 10.1364/OL.31.001277
   Lozhkarev VV, 2007, LASER PHYS LETT, V4, P421, DOI 10.1002/lapl.200710008
   MAINE P, 1988, IEEE J QUANTUM ELECT, V24, P398, DOI 10.1109/3.137
   Malka V, 2008, NAT PHYS, V4, P447, DOI 10.1038/nphys966
   PERRY MD, 1994, SCIENCE, V264, P917, DOI 10.1126/science.264.5161.917
   Perry MD, 1999, OPT LETT, V24, P160, DOI 10.1364/OL.24.000160
   Remington BA, 1999, SCIENCE, V284, P1488, DOI 10.1126/science.284.5419.1488
   Ross IN, 2002, J OPT SOC AM B, V19, P2945, DOI 10.1364/JOSAB.19.002945
   Ross IN, 1997, APPL OPTICS, V36, P9348, DOI 10.1364/AO.36.009348
   Schwoerer H, 2008, S AFR J SCI, V104, P299
   Snavely RA, 2000, PHYS REV LETT, V85, P2945, DOI 10.1103/PhysRevLett.85.2945
   STRICKLAND D, 1985, OPT COMMUN, V56, P219, DOI 10.1016/0030-4018(85)90120-8
NR 28
TC 57
Z9 59
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1559-128X
EI 2155-3165
J9 APPL OPTICS
JI Appl. Optics
PD MAR 20
PY 2010
VL 49
IS 9
BP 1676
EP 1681
DI 10.1364/AO.49.001676
PG 6
WC Optics
SC Optics
GA 571HS
UT WOS:000275743500027
PM 20300167
ER

PT J
AU Puskas, JD
   Edwards, FH
   Pappas, PA
   O'Brien, S
   Peterson, ED
   Kilgo, P
   Ferguson, TB
AF Puskas, John D.
   Edwards, Fred H.
   Pappas, Paul A.
   O'Brien, Sean
   Peterson, Eric D.
   Kilgo, Patrick
   Ferguson, T. Bruce, Jr.
TI Off-pump techniques benefit men and women and narrow the disparity in
   mortality after coronary bypass grafting
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 43rd Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 29-31, 2007
CL San Diego, CA
SP Soc Thorac Surg
ID IN-HOSPITAL MORTALITY; ARTERY-BYPASS; SEX-DIFFERENCES; SURGERY;
   OUTCOMES; GENDER; RISK; REVASCULARIZATION; SURVIVAL; SOCIETY
AB Background. Women have historically had greater morbidity and mortality than men after conventional coronary artery bypass grafting (CABG) on cardiopulmonary bypass (ONCAB). It is controversial whether off-pump CABG (OPCAB) alters this gender-based disparity.
   Methods. The Society of Thoracic Surgeons National Cardiac Database was reviewed for risk factors and clinical outcomes of 42,477 consecutive, nonemergency, isolated, primary ONCAB or OPCAB cases performed at 63 North American centers that performed more than 100 OPCAB cases between January 1, 2004, and December 31, 2005. Odds ratios for adverse events, adjusted for 32 clinical and demographic co-variates, were compared by multiple logistic regression models between women and men who had OPCAB versus ONCAB. All analyses were by intention-to-treat; 355 (2.2%) patients converted from OPCAB to ONCAB intraoperatively were included in the OPCAB group.
   Results. Women (n = 11,785) and those treated with OPCAB (n = 16,245) were older and had more comorbidities than men (n = 30,662) and those treated with conventional ONCAB (n = 26,202). Overall, adjusted odds ratios for death and most major complications in both men and women were significantly lower with OPCAB than with ONCAB. Among ONCAB cases only, women had a significantly greater adjusted risk of death, prolonged ventilation, and long length of stay than men. In contrast, among OPCAB cases, women had lower risk of reexploration than men and similar risks for death, myocardial infarction, and prolonged ventilation and hospital stay.
   Conclusions. OPCAB is associated with lower adjusted risk of death and major adverse events than ONCAB. OPCAB benefits both men and women and reduces the gender disparity in clinical outcomes after CABG.
C1 Emory Univ, Sch Med, Emory Crawford Long Hosp, Atlanta, GA 30308 USA.
   Univ Florida, Jacksonville, FL USA.
   Duke Univ, Duke Clin Res Inst, Durham, NC 27706 USA.
   E Carolina Univ, Greenville, NC USA.
RP Puskas, JD (reprint author), Emory Univ, Sch Med, Emory Crawford Long Hosp, 550 Peachtree St,NE,6th Floor Med Off Tower, Atlanta, GA 30308 USA.
EM john.puskas@emoryhealthcare.org
CR Abramov D, 2000, ANN THORAC SURG, V70, P800, DOI 10.1016/S0003-4975(00)01563-0
   Aldea GS, 1999, ANN THORAC SURG, V67, P1097, DOI 10.1016/S0003-4975(99)00055-7
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   COSGROVE DM, 1984, J THORAC CARDIOV SUR, V88, P673
   Edgerton JR, 2003, ANN THORAC SURG, V76, P1138, DOI 10.1016/S0003-4975(03)00747-1
   EDMUNDS LH, 1998, ANN THORAC SURG, V66, P12
   Edwards FH, 2005, ANN THORAC SURG, V79, P2189, DOI 10.1016/j.athoracsur.2005.02.065
   EDWARDS FH, 1998, ANN THORAC SURG, V66, P123
   Hogue CW, 2001, CIRCULATION, V103, P2133
   Jacobs AK, 1998, CIRCULATION, V98, P1279
   Koch CG, 2003, J THORAC CARDIOV SUR, V126, P932, DOI 10.1016/S0022-5223(03)01304-7
   Koch CG, 2003, J CARDIOTHOR VASC AN, V17, P585, DOI 10.1053/S1053-0770(03)00201-5
   Koch CG, 1996, J CARDIOTHOR VASC AN, V10, P839, DOI 10.1016/S1053-0770(96)80042-5
   Lawton JS, 2003, J THORAC CARDIOV SUR, V126, P936, DOI 10.1016/S0022-5223(03)00805-5
   Leavitt BJ, 1998, CIRCULATION, V98, P130
   Magee MJ, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.cir.0000089187.51855.77
   *NAT SOC THOR SURG, 2005, AD CARD DAT
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Nussmeier NA, 2002, J THORAC CARDIOV SUR, V124, P1225, DOI 10.1067/2002.126225
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas John, 2005, Innovations (Phila), V1, P3, DOI 10.1097/01243895-200500110-00002
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6
   Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133
   Vaccarino V, 2003, J THORAC CARDIOV SUR, V126, P1707, DOI 10.1016/j.jtcvs.2003.10.007
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   WEINTRAUB WS, 1993, CIRCULATION, V88, P79
   Wenger NK, 2003, J THORAC CARDIOV SUR, V126, P929, DOI 10.1016/S0022-5223(03)00883-3
NR 31
TC 57
Z9 57
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD NOV
PY 2007
VL 84
IS 5
BP 1447
EP 1456
DI 10.1016/j.athoracsur.2007.06.104
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 229DF
UT WOS:000250782500004
PM 17954045
ER

PT J
AU Boethig, D
   Thies, WR
   Hecker, H
   Breymann, T
AF Boethig, D
   Thies, WR
   Hecker, H
   Breymann, T
TI Mid term course after pediatric right ventricular outflow tract
   reconstruction: a comparison of homografts, porcine xenografts and
   Contegras
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE right ventricular outflow tract; conduit durability; congenital cardiac
   surgery; Contegra
ID CONGENITAL HEART-DISEASE; INTERMEDIATE FOLLOW-UP; PULMONIC VALVE
   CONDUIT; FAILURE; ARTERY; INFANTS; CIRCULATION; EXPERIENCE; ALLOGRAFTS;
   LONGEVITY
AB Objective: Homografts and porcine xenografts are valved conduits for pediatric RVOT reconstruction. They lack availability and durability. The Contegra, a glutaraldehyde fixed bovine jugular vein, was developed as an alternative. In this article, we compare single center results of 190 RVOT conduit implantations. Methods: 52 homografts, 30 porcine xenografts, 108 Contegras were implanted since 1992. Since 1999, data collection was prospective, for Contegras within a controlled clinical trial. Follow-up is complete for all evaluated items. We stratified reoperations by problem zone (sub-, intra-, and supravalvular) and analyzed the rote of patient age, diagnosis, graft type, graft size, previous operations and year of operation on freedom from explantation or reoperation related to supravalvular reasons. Results: Porcine xenografts were inferior concerning freedom from explantation and reoperation (P < 0.0001). They gave erlier reason for explantation in each zone (P < 0.001). At 4 years, homograft valve related reoperation need reached 20%, Contegras 0% (P = 0.002). Supravalvular reoperation reasons developed about equally in homografts and Contegras. Multivariabte Cox' regression analysis showed porcine xenografts and age < 1 year as independent risk factors for explantation due to supravalvular reasons. We found no reason to assume that supravalvular reoperation reasons occured more frequently after Contegra than after homograft implantation. Conclusion: After 12 years RVOT reconstruction with 190 valved conduits, Contegras remain our device of choice. At 4 years, they show no subvalvular or valvular reason for explantation or reoperation. Contegras have the advantages of easy handling and availability, and they compare well with homografts regarding freedom from explantation and freedom from reoperation. (C) 2004 Elsevier B.V. All rights reserved.
C1 Hannover Med Sch, Dept Surg Congenital Heart Dis, D-30625 Hannover, Germany.
   Hannover Med Sch, Dept Pediat Cardiol & Intens Care, D-30625 Hannover, Germany.
   Pediat Cardiol Practice, D-30159 Hannover, Germany.
   Hannover Med Sch, Inst Biomet, D-30625 Hannover, Germany.
RP Breymann, T (reprint author), Hannover Med Sch, Dept Surg Congenital Heart Dis, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM breymann@thg.mh-hannover.de
CR Aupecle B, 2002, ANN THORAC SURG, V74, P127, DOI 10.1016/S0003-4975(02)03639-1
   BANDO K, 1995, J THORAC CARDIOV SUR, V109, P509, DOI 10.1016/S0022-5223(95)70282-2
   Boudjemline Y, 2003, EUR J CARDIO-THORAC, V23, P122, DOI 10.1016/S1010-7940(02)00660-7
   Breymann T, 2002, EUR J CARDIO-THORAC, V21, P703, DOI 10.1016/S1010-7940(02)00049-0
   Caldarone CA, 2000, J THORAC CARDIOV SUR, V120, P1022, DOI 10.1067/mtc.2000.110684
   Champsaur G, 1998, J THORAC CARDIOV SUR, V116, P793, DOI 10.1016/S0022-5223(98)00443-7
   CLEVELAND DC, 1992, CIRCULATION, V86, P150
   ELZENGA NJ, 1990, J THORAC CARDIOV SUR, V100, P416
   Forbess JM, 2001, ANN THORAC SURG, V71, P54, DOI 10.1016/S0003-4975(00)01788-4
   Gerestein CG, 2001, ANN THORAC SURG, V71, P911, DOI 10.1016/S0003-4975(00)02440-1
   Goffin YA, 2000, J HEART VALVE DIS, V9, P207
   Homann M, 2000, EUR J CARDIO-THORAC, V17, P624, DOI 10.1016/S1010-7940(00)00414-0
   Ishizaka T, 2003, EUR J CARDIO-THORAC, V23, P715, DOI 10.1016/S1010-7940(03)00080-0
   Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Lange R, 2001, ANN THORAC SURG, V71, pS365, DOI 10.1016/S0003-4975(01)02552-8
   LeBlanc JG, 1998, ANN THORAC SURG, V66, pS174, DOI 10.1016/S0003-4975(98)01032-7
   Levine AJ, 2001, EUR J CARDIO-THORAC, V19, P122, DOI 10.1016/S1010-7940(00)00628-X
   Marianeschi SM, 2001, ANN THORAC SURG, V71, P619, DOI 10.1016/S0003-4975(00)02456-5
   Pearl JM, 2002, ANN THORAC SURG, V74, P542, DOI 10.1016/S0003-4975(02)03644-5
   Sinzobahamvya N, 2001, ANN THORAC SURG, V72, P2070, DOI 10.1016/S0003-4975(01)03178-2
   Tatebe S, 2003, CIRC J, V67, P906, DOI 10.1253/circj.67.906
   Tweddell JS, 2000, CIRCULATION, V102, P130
   Urban AE, 1998, ANN THORAC SURG, V66, pS183, DOI 10.1016/S0003-4975(98)01103-5
   Wells WJ, 2002, J THORAC CARDIOV SUR, V124, P88, DOI 10.1067/mtc.2002.121158
NR 25
TC 57
Z9 65
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD JAN
PY 2005
VL 27
IS 1
BP 58
EP 66
DI 10.1016/j.ejcts.2004.09.009
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 897SW
UT WOS:000227026400012
PM 15621472
ER

PT J
AU Moller, CH
   Penninga, L
   Wetterslev, J
   Steinbruchel, DA
   Gluud, C
AF Moller, Christian H.
   Penninga, Luit
   Wetterslev, Jorn
   Steinbruechel, Daniel A.
   Gluud, Christian
TI Clinical outcomes in randomized trials of off- vs. on-pump coronary
   artery bypass surgery: systematic review with meta-analyses and trial
   sequential analyses
SO EUROPEAN HEART JOURNAL
LA English
DT Review
ID QUALITY-OF-LIFE; LOW-RISK PATIENTS; CARDIOPULMONARY BYPASS;
   BEATING-HEART; GRAFT-SURGERY; MYOCARDIAL INJURY; INFLAMMATORY RESPONSE;
   OXIDATIVE STRESS; CARDIAC-SURGERY; COMPLETE REVASCULARIZATION
AB To assess the clinical outcomes of off- vs. on-pump coronary artery bypass surgery in randomized trials.
   We searched electronic databases and bibliographies until June 2007. Trials were assessed for risk of bias. Outcome measures were all-cause mortality, myocardial infarction, stroke, atrial fibrillation, and renewed coronary revascularization at maximum follow-up. We applied trial sequential analysis to estimate the strength of evidence. We found 66 randomized trials. There was no statistically significant differences regarding mortality [relative risk (RR) 0.98; 95% confidence interval (CI) 0.66-1.44], myocardial infarction (RR 0.95; 95% CI 0.65-1.37), or renewed coronary revascularization (RR 1.34; 95% CI 0.83-2.18). We found a significant reduced risk of atrial fibrillation (RR 0.69; 95% CI 0.57-0.83) and stroke (RR 0.53; 95% CI 0.31-0.91) in off-pump patients. However, when continuity correction for zero-event trials was included, the reduction in stroke became insignificant (RR 0.62; 95% CI 0.32-1.19). Trial sequential analysis demonstrated overwhelming evidence supporting that off-pump bypass surgery reduces atrial fibrillation.
   Off-pump surgery reduces the risks of postoperative atrial fibrillation compared with on-pump surgery. For death, myocardial infarction, stroke, and renewed coronary revascularization, the evidence is still weak and more low-bias risk trials are needed.
C1 [Moller, Christian H.; Penninga, Luit; Steinbruechel, Daniel A.] Univ Copenhagen Hosp, Rigshosp, Dept Cardiothorac Surg, DK-2100 Copenhagen, Denmark.
   [Moller, Christian H.; Wetterslev, Jorn; Gluud, Christian] Univ Copenhagen Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2100 Copenhagen, Denmark.
RP Moller, CH (reprint author), Univ Copenhagen Hosp, Rigshosp, Dept Cardiothorac Surg, Blegdamvej 9, DK-2100 Copenhagen, Denmark.
EM chm@ctu.rh.dk
RI Gluud, Christian/K-2561-2013
FU The Danish Heart Foundation [08-4-R64A2029-B948-22480]; The Danish
   Medical Research Council; The Copenhagen Hospital Corporations Medical
   Research Council; The Rigshospitalet Research Council; The Copenhagen
   Trial Unit
FX Funding was received from The Danish Heart Foundation: (08-4-R64A2029-
   B948-22480), The Danish Medical Research Council, The Copenhagen
   Hospital Corporations Medical Research Council, The Rigshospitalet
   Research Council, and The Copenhagen Trial Unit. The funding sources had
   no role in the conduct of the study, collection of data, management,
   analysis, interpretation of the data, or preparation of the manuscript.
CR Al-Ruzzeh S, 2006, BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C
   Al-Ruzzeh S, 2003, HEART SURG FORUM, V6, P89
   Altman DG, 2003, BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219
   Alwan K, 2004, ANN THORAC SURG, V77, P2051, DOI 10.1016/j.athoracsur.2003.11.004
   Anderson RE, 2005, EUR J CARDIO-THORAC, V28, P425, DOI 10.1016/j.ejcts.2005.05.025
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 2004, EUR HEART J, V25, P765, DOI 10.1016/j.ehj.2003.11.015
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2003, Indian Heart J, V55, P275
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Ascione R, 2005, CIRCULATION, V112, P3833, DOI 10.1161/CIRCULATIONAHA.105.557462
   Ascione R, 2006, ANN THORAC SURG, V81, P97, DOI 10.1016/j.athoracsur.2005.06.038
   Ascione R, 2000, CIRCULATION, V102, P1530
   Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X
   Baker RA, 2001, HEART SURG FORUM, V4, pS19
   Blacher C, 2005, INT J CARDIOL, V101, P473, DOI 10.1016/j.ijcard.2004.07.006
   Caputo M, 2002, ANN THORAC SURG, V74, P2088, DOI 10.1016/S0003-4975(02)04025-0
   Cardon D, 2005, SOC NETWORKS, V27, P301, DOI 10.1016/j.socnet.2004.11.005
   Carrier M, 2003, HEART SURG FORUM, V6, pE89
   Cavalca V, 2006, ANN THORAC SURG, V81, P562, DOI 10.1016/j.athoracsur.2005.08.019
   Celik JB, 2005, RENAL FAILURE, V27, P183, DOI 10.1081/JDI-200048219
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Covino E, 2001, J CARDIOVASC SURG, V42, P23
   Cox CM, 2000, ANN THORAC SURG, V69, P140, DOI 10.1016/S0003-4975(99)01196-0
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Czerny M, 2000, EUR J CARDIO-THORAC, V17, P737, DOI 10.1016/S1010-7940(00)00420-6
   Devereaux PJ, 2005, BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Diephuis JC, 2005, BRIT J ANAESTH, V94, P715, DOI 10.1093/bja/aei118
   Dorman BH, 2004, J CARDIOTHOR VASC AN, V18, P25, DOI 10.1053/j.jvca.2003.10.005
   ELDIN BMN, 2004, EGYPT J ANAESTH, V20, P351
   Ernest CS, 2006, ANN THORAC SURG, V81, P2105, DOI 10.1016/j.athoracsur.2006.01.008
   Ernest CS, 2006, ANN THORAC SURG, V82, P812, DOI 10.1016/j.athoracsur.2006.04.005
   Fergusson D, 2002, BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652
   Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5
   Gasz Balázs, 2004, Exp Clin Cardiol, V9, P26
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Gonenc A, 2006, J BIOCHEM MOL BIOL, V39, P377
   Gu YJ, 1998, ANN THORAC SURG, V65, P420
   Guler M, 2001, ANN THORAC SURG, V71, P152, DOI 10.1016/S0003-4975(00)02250-5
   Gulielmos V, 1999, EUR J CARDIO-THORAC, V16, pS34, DOI 10.1016/S1010-7940(99)00266-3
   Gulielmos V, 2000, EUR J CARDIO-THORAC, V18, P594, DOI 10.1016/S1010-7940(00)00553-4
   Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290
   Higgins J. P. T., 2006, COCHRANE HDB SYSTEMA
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   HOULIND KC, 2006, SATS C REYKJ ISL 16
   Jares M, 2007, INT HEART J, V48, P57, DOI 10.1536/ihj.48.57
   Johansson-Synnergren M, 2004, SCAND CARDIOVASC J, V38, P53, DOI 10.1080/14017430410024847
   Karolak W, 2007, AM HEART J, V153, P689, DOI 10.1016/j.ahj.2007.01.033
   Keizer AMA, 2003, ANN THORAC SURG, V75, P835, DOI 10.1016/S0003-4975(02)04541-1
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kherani A, 2003, 83 ANN M AM ASS THOR, P4
   Kjaergard LL, 2001, ANN INTERN MED, V135, P982
   Kobayashi J, 2005, CIRCULATION, V112, P1338
   Kochamba GS, 2000, ANN THORAC SURG, V69, P1466, DOI 10.1016/S0003-4975(00)01142-5
   Kunes P, 2007, SCAND CARDIOVASC J, V41, P171, DOI 10.1080/14017430701324262
   Laine C, 2007, BRIT MED J, V334, P1177, DOI 10.1136/bmj.39233.510810.80
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Legare JF, 2005, EUR J CARDIO-THORAC, V27, P296, DOI 10.1016/j.ejcts.2004.11.009
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Lingaas PS, 2006, ANN THORAC SURG, V81, P2089, DOI 10.1016/j.athoracsur.2005.12.003
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Lloyd CT, 2000, J THORAC CARDIOV SUR, V119, P148, DOI 10.1016/S0022-5223(00)70230-3
   Lo B, 2004, ANESTH ANALG, V99, P634, DOI 10.1213/ANE.0000130257.64006.5C
   Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9
   Lund C, 2005, ANN THORAC SURG, V80, P2126, DOI 10.1016/j.athoracsur.2005.06.012
   Malheiros SMF, 2001, ARQ NEURO-PSIQUIAT, V59, P1
   Malik V, 2006, TEX HEART I J, V33, P321
   Mariscalco G, 2006, J THORAC CARDIOV SUR, V131, P1364, DOI 10.1016/j.jtcvs.2006.01.040
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Mathisen L, 2005, J THORAC CARDIOV SUR, V130, P1691, DOI 10.1016/j.jtcvs.2005.08.008
   Mathisen L, 2005, ANN THORAC SURG, V79, P1584, DOI 10.1016/j.athorascur.2004.10.019
   Michaux I, 2006, J THORAC CARDIOV SUR, V131, P1281, DOI 10.1016/j.jtcvs.2006.01.035
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Moller CH, 2007, CONTEMP CLIN TRIALS, V28, P540, DOI 10.1016/j.cct.2006.11.002
   Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203
   Motallebzadeh R, 2007, ANN THORAC SURG, V83, P475, DOI 10.1016/j.athoracsur.2006.09.024
   Motallebzadeh R, 2004, EUR J CARDIO-THORAC, V25, P409, DOI 10.1016/j.ejcts.2003.12.018
   Motallebzadeh R, 2006, ANN THORAC SURG, V82, P615, DOI 10.1016/j.athoracsur.2006.03.081
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Narayan P, 2005, CLIN RADIOL, V60, P693, DOI 10.1016/j.crad.2004.10.012
   Nathoe HM, 2006, AM J CARDIOL, V97, P1482, DOI 10.1016/j.amjcard.2005.12.038
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Nathoe HM, 2004, CIRCULATION, V110, P1738, DOI 10.1161/01.CIR.0000143105.42988.FD
   Nesher N, 2006, J CARDIAC SURG, V21, P395, DOI 10.1111/j.1540-8191.2006.00272.x
   Niranjan G, 2006, EUR J CARDIO-THORAC, V30, P271, DOI 10.1016/j.ejcts.2006.04.042
   *NORD COCHR CTR CO, 2003, COMP PROGR VERS 4 2
   Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859
   Ozkara C, 2007, INT J CLIN PRACT, V61, P763, DOI 10.1111/j.1742-1241.2006.00952.x
   Paparella D, 2006, J THORAC CARDIOV SUR, V131, P290, DOI 10.1016/j.jtcvs.2005.10.018
   Parolari A, 2003, ANN THORAC SURG, V76, P737, DOI 10.1016/S0003-4975(03)00683-0
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Penttila HJ, 2001, ANN THORAC SURG, V71, P565, DOI 10.1016/S0003-4975(00)02002-6
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2003, HEART SURG FORUM, V6, pE103
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Quaniers JM, 2006, ANN THORAC SURG, V81, P1683, DOI 10.1016/j.athoracsur.2005.11.059
   RACHWALICH M, 2006, ANAESTH INTENSIVE TH, V1, P4
   Raja SG, 2003, SURG J R COLL SURG E, V1, P221
   Sahlman A, 2003, SCAND CARDIOVASC J, V37, P211, DOI 10.1080/14017430310001726
   Schmid FX, 2006, EUR J CARDIO-THORAC, V29, P496, DOI 10.1016/j.ejcts.2006.01.029
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Schulze C, 2000, THORAC CARDIOV SURG, V48, P364, DOI 10.1055/s-2000-8352
   Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2
   Selvanayagam JB, 2004, CIRCULATION, V110, P1535, DOI 10.1161/01.CIR.0000142045.22628.74
   Selvanayagam JB, 2006, HEART, V92, P1329, DOI 10.1136/hrt.2005.080796
   Selvanayagam JB, 2004, CIRCULATION, V109, P345, DOI 10.1161/01.CIR.0000109489.71945.BD
   Staton GA, 2005, CHEST, V127, P892, DOI 10.1378/chest.127.3.892
   STATON GW, 2005, CHEST, V124, pS104
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761
   Tang ATM, 2002, EUR J CARDIO-THORAC, V22, P118, DOI 10.1016/S1010-7940(02)00220-8
   Tatoulis J, 2006, ANN THORAC SURG, V82, P1436, DOI 10.1016/j.athoracsur.2006.04.053
   Tobe Tom J., 2001, Journal of the American Society of Nephrology, V12, p184A
   van Stel HF, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-20
   van der Heijden GJMG, 2004, EUR J CARDIO-THORAC, V26, P81, DOI 10.1016/j.ejcts.2004.03.032
   van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701
   van Dijk D, 2000, CONTROL CLIN TRIALS, V21, P595, DOI 10.1016/S0197-2456(00)00103-3
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2002, CIRCULATION, V105, pE179, DOI 10.1161/01.CIR.0000017211.69397.BE
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   van Dijk D, 2004, HEART, V90, P431, DOI 10.1136/hrt.2003.010173
   Vedin Jenny, 2003, Interact Cardiovasc Thorac Surg, V2, P489, DOI 10.1016/S1569-9293(03)00119-1
   Vedin J, 2005, INTERACT CARDIOVASC, V4, P497
   Vedin J, 2006, EUR J CARDIO-THORAC, V30, P305, DOI 10.1016/j.ejcts.2006.03.037
   Vedin J, 2005, ANN THORAC SURG, V80, P586, DOI 10.1016/j.athoracsur.2005.02.036
   Velissaris T, 2004, ANN THORAC SURG, V78, P506, DOI 10.1016/S0003-4975(03)01360-2
   Velissaris T, 2003, EUR J CARDIO-THORAC, V23, P917, DOI 10.1016/S1010-7940(03)00167-2
   Vural KM, 1995, THORAC CARDIOV SURG, V43, P320, DOI 10.1055/s-2007-1013803
   Wandschneider W, 2000, ANN THORAC SURG, V70, P1577, DOI 10.1016/S0003-4975(00)01843-9
   Wehlin L, 2005, SCAND CARDIOVASC J, V39, P78, DOI 10.1080/14017430410004623
   Wehlin L, 2004, EUR J CARDIO-THORAC, V25, P35, DOI 10.1016/S1010-7940(03)00652-3
   Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
   Wildhirt S M, 2000, Eur J Med Res, V5, P222
   WILDHIRT SM, 2001, HERZ THORAX GEFASSCH, V15, P7
   Wildhirt SM, 2001, SHOCK, V16, P55
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 141
TC 56
Z9 59
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
J9 EUR HEART J
JI Eur. Heart J.
PD NOV
PY 2008
VL 29
IS 21
BP 2601
EP 2616
DI 10.1093/eurheartj/ehn335
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 373NS
UT WOS:000260979300005
PM 18628261
ER

PT J
AU Cleveland, MJ
   Feinberg, ME
   Bontempo, DE
   Greenberg, MT
AF Cleveland, Michael J.
   Feinberg, Mark E.
   Bontempo, Daniel E.
   Greenberg, Mark T.
TI The role of risk and protective factors in substance use across
   adolescence
SO JOURNAL OF ADOLESCENT HEALTH
LA English
DT Article
DE adolescence; age differences; risk factors; protective factors;
   substance use
ID SOCIAL-DEVELOPMENT MODEL; CARE YOUTH SURVEY; PROBLEM BEHAVIORS;
   ALCOHOL-USE; DRUG-USE; SMOKING; COMMUNITIES; PREDICTORS; PEER;
   PERCEPTIONS
AB Purpose: To compare the relative influence of risk and protective factors across several domains on adolescent substance use in a large sample of youth.
   Methods: Cross-sectional survey data were collected from students in grades 6, 8, 10, and 12 in Pennsylvania (N = 91,778). Generalized linear mixed models were estimated for each grade level to examine associations among indices of three risk factors (individual, peer, and family) and three protective factors (family, school, and community) and both recent and lifetime substance use.
   Results: The risk factors were stronger predictors of substance use outcomes compared with the protective factors, regardless of grade level or Substance use type. In particular, the individual and peer risk factors were strongly related to lifetime and recent use of cigarettes, alcohol, and marijuana. Amon-, the protective factors, the strongest associations with substance use were found in the community domain. Several age-related differences in the associations were also found, suggesting that family and community factors were more salient among younger adolescents whereas peer and school factors were stronger among older adolescents.
   Conclusions: These findings provide support for the social development model (SDM), which proposes that adolescent substance use is associated with factors across multiple spheres of influence. Age-related differences in these associations suggest that effective interventions to reduce adolescent Substance use may need to emphasize different domains of risk and protective factors at different stages of adolescent development. (c) 2008 Society for Adolescent Medicine. All rights reserved.
C1 [Cleveland, Michael J.; Feinberg, Mark E.; Bontempo, Daniel E.; Greenberg, Mark T.] Penn State Univ, Prevent Res Ctr, University Pk, PA 16802 USA.
   [Cleveland, Michael J.] Penn State Univ, Methodol Ctr, State Coll, PA 16801 USA.
RP Cleveland, MJ (reprint author), Penn State Univ, Methodol Ctr, 204 E Calder Way,Suite 400, State Coll, PA 16801 USA.
EM mjc37@psu.edu
RI Price, Katie/H-1931-2012
CR Allen M, 2003, CRIM JUSTICE BEHAV, V30, P163, DOI 10.1177/0093854802251002
   Arthur MW, 2002, EVALUATION REV, V26, P575, DOI 10.1177/019384102237850
   Atzaba-Poria N, 2004, J CHILD PSYCHOL PSYC, V45, P707, DOI 10.1111/j.1469-7610.2004.00265.x
   Bond L, 2007, J ADOLESC HLTH, V40
   Brook D. W., 1992, FAMILY THERAPY DRUG, P15
   Bursik Jr R. J., 1996, DELINQUENCY CRIME CU, P236
   Case S, 2007, SUBST USE MISUSE, V42, P89, DOI 10.1080/10826080601094280
   Catalano R. F., 1999, CRIM BEHAV MENT HEAL, V9, P39, DOI [10.1002/cbm.290, DOI 10.1002/CBM.290]
   Catalano R. F., 1996, DELINQUENCY CRIME CU, P149
   Catalano RF, 1996, J DRUG ISSUES, V26, P429
   Cooper ML, 2003, J PERS SOC PSYCHOL, V84, P390, DOI 10.1037/0022-3514.84.2.390
   Delbert Elliott, 1985, EXPLAINING DELINQUEN
   Dierker LC, 2004, PREV SCI, V5, P169, DOI 10.1023/B:PREV.0000037640.66607.6b
   Feinberg ME, 2007, J ADOLESCENT HEALTH, V40, P506, DOI 10.1016/j.jadohealth.2006.09.002
   Feinberg ME, 2007, PREV SCI, V8, P261, DOI 10.1007/s11121-007-0073-6
   Flay BR, 1998, PREV MED, V27, pA9, DOI 10.1006/pmed.1998.0380
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Flory K, 2004, DEV PSYCHOPATHOL, V16, P193, DOI 10.1017/S0954579404044475
   FURMAN W, 1992, CHILD DEV, V63, P103, DOI 10.1111/j.1467-8624.1992.tb03599.x
   Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008
   Gerard JM, 2004, CHILD DEV, V75, P1832, DOI 10.1111/j.1467-8624.2004.00820.x
   Glaser RR, 2005, J QUANT CRIMINOL, V21, P73, DOI 10.1007/s10940-004-1788-1
   HAWKINS JD, 1992, PSYCHOL BULL, V112, P105
   Hays S. P., 2003, J PRIM PREV, V24, P125, DOI 10.1023/A:1025940311556
   Hill KG, 2005, J ADOLESCENT HEALTH, V37, P202, DOI 10.1016/j.jadohealth.2004.08.014
   Jackson C, 1997, ADDICT BEHAV, V22, P685, DOI 10.1016/S0306-4603(97)00005-1
   JOHNSTON LD, TEEN DRUG USE CONTIN
   JOHNSTON LD, DECLINE DAILY SMOKIN
   Kliewer W, 2007, J ADOLESCENT HEALTH, V40, P448, DOI 10.1016/j.jadohealth.2006.11.148
   Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309
   Lochman J., 2002, J PRIM PREV, V23, P49, DOI 10.1023/A:1016591216363
   Lonczak HS, 2001, J STUD ALCOHOL, V62, P179
   NEWCOMB MD, 1992, J PERS SOC PSYCHOL, V63, P280, DOI 10.1037//0022-3514.63.2.280
   Ostaszewski K, 2006, AM J COMMUN PSYCHOL, V38, P237, DOI 10.1007/s10464-006-9076-x
   PRENTICE DA, 1993, J PERS SOC PSYCHOL, V64, P243, DOI 10.1037/0022-3514.64.2.243
   Prinstein MJ, 2005, J ABNORM CHILD PSYCH, V33, P293, DOI 10.1007/s10802-005-3566-4
   Spoth RL, 2005, AM J COMMUN PSYCHOL, V35, P107, DOI 10.1007/s10464-005-3388-0
   Tragesser SL, 2006, SOC DEV, V15, P311, DOI 10.1111/j.1467-9507.2006.00343.x
   van den Bree MBM, 2005, ARCH GEN PSYCHIAT, V62, P311, DOI 10.1001/archpsyc.62.3.311
   WRIGHT D, 1999, DHHS PUBLICATION
NR 40
TC 56
Z9 56
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-139X
J9 J ADOLESCENT HEALTH
JI J. Adolesc. Health
PD AUG
PY 2008
VL 43
IS 2
BP 157
EP 164
DI 10.1016/j.jadohealth.2008.01-015
PG 8
WC Psychology, Developmental; Public, Environmental & Occupational Health;
   Pediatrics
SC Psychology; Public, Environmental & Occupational Health; Pediatrics
GA 330PU
UT WOS:000257956100009
PM 18639789
ER

PT J
AU Cleveland, MJ
   Gibbons, FX
   Gerrard, M
   Pomery, EA
   Brody, GH
AF Cleveland, MJ
   Gibbons, FX
   Gerrard, M
   Pomery, EA
   Brody, GH
TI The impact of parenting on risk cognitions and risk behavior: A study of
   mediation and moderation in a panel of African American adolescents
SO CHILD DEVELOPMENT
LA English
   Estonian
DT Article
ID SUBSTANCE USE; DRUG-USE; HEALTH-RISK; EARLY-ONSET; ALCOHOL-USE;
   INTERGENERATIONAL TRANSMISSION; NEIGHBORHOOD DISADVANTAGE; PROTOTYPE
   PERCEPTION; CIGARETTE-SMOKING; YOUNG-ADULTS
AB Hypotheses concerning the extent to which adolescents' cognitions mediate the relation between parenting behaviors and adolescent substance use were examined in a panel of African American adolescents (N = 714, M age at Time 1 = 10.51 years) and their primary caregivers. A nested-model approach indicated that effective parenting (i. e., monitoring of the child's activities, communication about substances, and parental warmth) was related to adolescent substance use more than 5 years later. The parenting behaviors protected the adolescent from subsequent alcohol, tobacco, and marijuana use through associations with two cognitive elements from the prototype/willingness model: favorable risk images (prototypes) and behavioral willingness. Additional analyses indicated that these protective effects were strongest among families residing in high-risk neighborhoods.
C1 Iowa State Univ, Ames, IA 50011 USA.
   Univ Georgia, Athens, GA 30602 USA.
RP Cleveland, MJ (reprint author), Univ Massachusetts, Dept Psychol, 285 Old Westport Rd, N Dartmouth, MA 02747 USA.
EM mcleveland@umassd.edu
CR ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037//0033-2909.101.2.213
   Aiken L. S., 1991, MULTIPLE REGRESSION
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I, 1985, ACTION CONTROL COGNI, P11
   ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3
   ASELTINE RH, 1995, J HEALTH SOC BEHAV, V36, P103, DOI 10.2307/2137219
   BACHMAN JC, 1991, AM J PUBLIC HEALTH, V81, P371
   Barnes GM, 2000, J MARRIAGE FAM, V62, P175, DOI 10.1111/j.1741-3737.2000.00175.x
   Barnow S, 2002, J STUD ALCOHOL, V63, P305
   Ennet ST, 2001, J MARRIAGE FAM, V63, P48, DOI 10.1111/j.1741-3737.2001.00048.x
   Bauman KE, 1996, ADDICTION, V91, P185, DOI 10.1111/j.1360-0443.1996.tb03175.x
   Bentler P. M., 1988, P AM STAT ASS, P308
   Bentler P. M., 1990, PSYCHOL BULL, V107, P588, DOI 10.1037/0033-2909.107.2.238
   Beyth-Marom R., 1997, HLTH RISKS DEV TRANS, P110
   BIAFORA F, 1998, DRUG USE ETHNICITY E, P149
   Blanton H, 1997, J FAM PSYCHOL, V11, P271, DOI 10.1037/0893-3200.11.3.271
   Brody G. H., 2000, APPL DEV SCI, V4, P71, DOI DOI 10.1207/S
   Brody GH, 2003, J CONSULT CLIN PSYCH, V71, P211, DOI 10.1037/0022-006X.71.2.211
   Brody GH, 2001, CHILD DEV, V72, P1231, DOI 10.1111/1467-8624.00344
   Brody GH, 1998, J FAM PSYCHOL, V12, P209, DOI 10.1037//0893-3200.12.2.209
   BRODY GH, 1990, RES METHODS STUDYING
   BROOK J S, 1989, Genetic Social and General Psychology Monographs, V115, P125
   Brook JS, 1997, J GENET PSYCHOL, V158, P172
   BROWN BB, 1993, CHILD DEV, V64, P467, DOI 10.2307/1131263
   Brown L K, 1991, AIDS Educ Prev, V3, P50
   Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002001
   BURTON LM, 1996, NEIGHBORHOOD POVERTY, P132
   Carroll A, 1997, J EDUC PSYCHOL, V89, P441
   Chassin L, 1998, DEV PSYCHOL, V34, P1189, DOI 10.1037//0012-1649.34.6.1189
   CHASSIN L, 1981, PERS SOC PSYCHOL B, V7, P670, DOI 10.1177/014616728174025
   CONGER RD, 1992, CHILD DEV, V63, P526, DOI 10.1111/j.1467-8624.1992.tb01644.x
   Cutrona CE, 2000, J PERS SOC PSYCHOL, V79, P1088, DOI 10.1037/0022-3514.79.6.1088
   DISHION TJ, 1995, DEV PSYCHOPATHOL, V7, P803
   Elkind D, 1978, ADOLESCENCE, V13, P127
   Ellickson PL, 1999, J ADOLESCENT HEALTH, V25, P382, DOI 10.1016/S1054-139X(98)00144-X
   EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Gerrard M, 2005, J PEDIATR PSYCHOL, V30, P305, DOI 10.1093/jpepsy/jsi026
   GERRARD M, IN PRESS THOERY BASE
   Gerrard M, 1996, HEALTH PSYCHOL, V15, P344, DOI 10.1037/0278-6133.15.5.344
   Gibbons F., 1997, HLTH COPING WELL BEI, P63
   Gibbons FX, 2004, PERS SOC PSYCHOL B, V30, P1048, DOI 10.1177/0146167204264788
   GIBBONS FX, 1995, J PERS SOC PSYCHOL, V69, P505, DOI 10.1037/0022-3514.69.3.505
   Gibbons FX, 1998, J PERS SOC PSYCHOL, V74, P1164, DOI 10.1037//0022-3514.74.5.1164
   GIBBONS FX, 2003, SOCIAL PSYCHOL FDN H, P107, DOI 10.1002/9780470753552.ch5
   GIBBONS FX, 1995, PERS SOC PSYCHOL B, V21, P85
   Gibbons FX, 2004, J PERS SOC PSYCHOL, V86, P517, DOI 10.1037/0022-3514.86.4.517
   GIORDANO PC, 1993, J MARRIAGE FAM, V55, P277, DOI 10.2307/352801
   GOCHMAN DS, 1992, EMOTION COGNITION HL, P9
   Gonzales NA, 1996, AM J COMMUN PSYCHOL, V24, P365, DOI 10.1007/BF02512027
   GUY SM, 1994, J DRUG EDUC, V24, P109, DOI 10.2190/X4WU-BV3X-Q483-Y5BT
   Hartos JL, 2000, J YOUTH ADOLESCENCE, V29, P441, DOI 10.1023/A:1005158425861
   HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64
   Jackson C, 1997, ADDICT BEHAV, V22, P107, DOI 10.1016/0306-4603(95)00108-5
   Johnston L. D., 2000, MONITORING FUTURE NA
   JORESKOG KG, 2004, LISREL VERSION 8 70
   JORESKOG KG, 2004, PRELIS VERSION 2 70
   Kandel DB, 1996, J DRUG ISSUES, V26, P289
   Kaplow JB, 2002, J ABNORM CHILD PSYCH, V30, P199
   KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
   Kline R. B., 1998, PRINCIPLES PRACTICE
   Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309
   Li XM, 2000, J ADOLESCENT HEALTH, V27, P49, DOI 10.1016/S1054-139X(00)00092-6
   Lloyd B. B., 1998, SMOKING ADOLESCENCE
   Oxford M., 2000, AM J DRUG ALCOHOL AB, V27, P599
   PEEPLES F, 1994, J QUANT CRIMINOL, V10, P141, DOI 10.1007/BF02221156
   Peterson P. L., 1994, J RES ADOLESCENCE, V4, P203, DOI 10.1207/s15327795jra0402_3
   Rankin BH, 2002, SOC PROBL, V49, P79, DOI 10.1525/sp.2002.49.1.79
   Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918
   Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192
   SHAFFER JL, 1993, J AM ACAD CHILD ADOL, V32, P643
   Shen S, 2001, J STUD ALCOHOL, V62, P763
   Sieving RE, 2000, J RES ADOLESCENCE, V10, P489, DOI 10.1207/SJRA1004_06
   Simons R., 1996, UNDERSTANDING DIFFER
   Simons RL, 2002, J MARRIAGE FAM, V64, P331, DOI 10.1111/j.1741-3737.2002.00331.x
   Simons-Morton Bruce G, 2002, Prev Sci, V3, P275, DOI 10.1023/A:1020876625045
   Smart R.G., 1994, J CHILD ADOLES SUBST, V3, P37, DOI 10.1300/J029v03n01_04
   Smetana JG, 2002, J RES ADOLESCENCE, V12, P275, DOI 10.1111/1532-7795.00034
   STONEROMERO EF, 1994, J APPL PSYCHOL, V79, P354, DOI 10.1037/0021-9010.79.3.354
   Substance Abuse and Mental Health Services Administration, 2002, NAT SURV DRUG US HLT, DOI 10.3886/ICPSR03903
   Thornton B, 2002, PERS SOC PSYCHOL B, V28, P986, DOI 10.1177/01467202028007011
   Vaccaro D, 1998, J DRUG EDUC, V28, P257, DOI 10.2190/TEPB-PTW4-A2PG-43FJ
   WALLACE JM, 2002, J PRIM PREVENT, V0022
   WARSHAW PR, 1985, J EXP SOC PSYCHOL, V21, P213, DOI 10.1016/0022-1031(85)90017-4
   West S. G., 1995, STRUCTURAL EQUATION, P56
   Whitbeck LB, 1999, SUBST USE MISUSE, V34, P1025, DOI 10.3109/10826089909039394
   Wickrama KAS, 1999, J HEALTH SOC BEHAV, V40, P258, DOI 10.2307/2676351
   Wills T A, 1994, J Subst Abuse, V6, P1, DOI 10.1016/S0899-3289(94)90039-6
   Wills T A, 2001, Prev Sci, V2, P145, DOI 10.1023/A:1011558807062
   Wills TA, 2000, HEALTH PSYCHOL, V19, P253, DOI 10.1037/0278-6133.19.3.253
   Wills TA, 1998, J PERS SOC PSYCHOL, V74, P387, DOI 10.1037//0022-3514.74.2.387
NR 91
TC 56
Z9 57
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0009-3920
J9 CHILD DEV
JI Child Dev.
PD JUL-AUG
PY 2005
VL 76
IS 4
BP 900
EP 916
DI 10.1111/j.1467-8624.2005.00885.x
PG 17
WC Psychology, Educational; Psychology, Developmental
SC Psychology
GA 945HK
UT WOS:000230493400010
PM 16026504
ER

PT J
AU Boccon-Gibod, L
   Djavan, B
   Hammerer, P
   Hoeltl, W
   Kattan, MW
   Prayer-Galetti, T
   Teillac, P
   Tunn, UW
AF Boccon-Gibod, L
   Djavan, B
   Hammerer, P
   Hoeltl, W
   Kattan, MW
   Prayer-Galetti, T
   Teillac, P
   Tunn, UW
TI Management of prostate-specific antigen relapse in prostate cancer: A
   European consensus
SO INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
LA English
DT Review
DE European consensus; Prostate Specific Antigen (PSA); PSA relapse; total
   PSA
ID MULTICENTER CLINICAL-TRIAL; SARCOMA-SPECIFIC DEATH; PHASE-III TRIAL;
   RADICAL PROSTATECTOMY; RADIATION-THERAPY; SEED IMPLANTATION; LOCAL
   RECURRENCE; HORMONAL-THERAPY; DOUBLING TIME; POSTOPERATIVE NOMOGRAM
AB A European Consensus on the management of prostate-specific antigen (PSA) relapse in patients with prostate cancer has been formulated. The key recommendations proposed are that total PSA is the best detection tool for prostate cancer, with free and complexed PSA having a role in the PSA range 1-4 ng/ml. PSA relapse after radical prostatectomy (RP) has been defined as a value of 0.2 ng/ml with one subsequent rise, while the ASTRO definition should be used after radiotherapy. A PSA level of less than 0.4 ng/ml after hormonal therapy can be considered an indicator of a positive response. Continuous assessment using nomograms or artificial neural networks will help to determine whether progression after local therapy is distant or local, which is the basis for treatment decisions. Secondary treatment after local failure of RP should be initiated when PSA levels reach 1.0-1.5 ng/ml and salvage radiotherapy can be considered with or without hormonal therapy. Local failure after radiotherapy can be treated with a choice of high-intensity-focused ultrasound, salvage RP (only in highly selected patients), cryotherapy or external beam radiation. Treatment of distant failure involves hormonal manipulation, the type and the timing of which is based on both physician and patient preferences.
C1 CHU Bichat, Dept Urol, F-75818 Paris 18, France.
   Univ Vienna, A-1010 Vienna, Austria.
   Braunschweig Acad Hosp, Braunschweig, Germany.
   Kaiser Franz Josef Hosp, Vienna, Austria.
   Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA.
   Univ Padua, Azienda Osped, Padua, Italy.
   St Louis Acad Hosp, Paris, France.
   Akad Stad Kliniken, Offenbach, Germany.
RP Boccon-Gibod, L (reprint author), CHU Bichat, Dept Urol, 46 Rue Henri Huchard, F-75818 Paris 18, France.
EM laurent.boccon-gibod@bch.ap-hop-paris.fr
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Ash D, 2000, RADIOTHER ONCOL, V57, P315, DOI 10.1016/S0167-8140(00)00306-6
   Auclerc G, 2000, Oncologist, V5, P36, DOI 10.1634/theoncologist.5-1-36
   Bach PB, 2003, J NATL CANCER I, V95, P470
   BERRY W, 2001, PHASE 2 RANDOMISED T
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   BRAWER MK, 2000, 2 INT CONS PROST CAN
   Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542
   Catalona WJ, 2003, J UROLOGY, V169, P290
   Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Ciatto S, 2002, INT J BIOL MARKER, V17, P79
   Coleman RE, 2001, SEMIN ONCOL, V28, P35, DOI 10.1053/sonc.2001.25427
   Corral DA, 1996, UROL CLIN N AM, V23, P677, DOI 10.1016/S0094-0143(05)70345-1
   Cox JD, 1999, J CLIN ONCOL, V17, P1155
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   CROOK JM, 1995, UROLOGY, V45, P624, DOI 10.1016/S0090-4295(99)80054-5
   DAMICO AV, 1995, J UROLOGY, V154, P131, DOI 10.1016/S0022-5347(01)67248-3
   Djavan B, 2002, UROLOGY, V60, P4, DOI 10.1016/S0090-4295(02)01896-4
   Djavan B, 1999, UROLOGY, V54, P517, DOI 10.1016/S0090-4295(99)00153-3
   EISENBERGER MA, 2003, P AN M AM SOC CLIN, V22, P380
   Gancarczyk KJ, 2003, UROLOGY, V61, P589, DOI 10.1016/S0090-4925(02)02287-2
   Gann PH, 2002, J UROLOGY, V167, P2427, DOI 10.1016/S0022-5347(05)64998-1
   Garg MK, 1998, UROLOGY, V51, P998, DOI 10.1016/S0090-4295(98)00023-5
   Grossfeld GD, 1998, J UROLOGY, V160, P1398, DOI 10.1016/S0022-5347(01)62548-5
   HAAB F, 1995, UROLOGY, V45, P1022, DOI 10.1016/S0090-4295(99)80124-1
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Hanlon AL, 2002, INT J RADIAT ONCOL, V53, P297, DOI 10.1016/S0360-3016(02)02717-7
   HOLZMAN M, 1991, J UROLOGY, V146, P1578
   Hudes G, 1999, J CLIN ONCOL, V17, P3160
   HUDSON MA, 1989, J UROLOGY, V142, P1011
   Johnstone P A, 1997, Urol Oncol, V3, P108, DOI 10.1016/S1078-1439(98)00007-6
   Kattan MW, 2001, J UROLOGY, V166, P63, DOI 10.1016/S0022-5347(05)66077-6
   Kattan MW, 2003, J CLIN ONCOL, V21, P3647, DOI 10.1200/JCO.2003.01.240
   Kattan MW, 2003, STAT MED, V22, P3515, DOI 10.1002/sim.1574
   Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.20.3.791
   Kattan MW, 2000, J CLIN ONCOL, V18, P3352
   Khan MA, 2003, J UROLOGY, V170, P723, DOI 10.1097/01.ju.0000086940.10392.93
   Kramer S, 1997, BRIT J RADIOL, V70, P995
   LANGE PH, 1989, J UROLOGY, V141, P873
   Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401
   Mikolajczyk SD, 2002, UROLOGY, V59, P797, DOI 10.1016/S0090-4295(01)01605-3
   MILLER JI, 1992, J UROLOGY, V147, P956
   Nudell DM, 1999, UROLOGY, V54, P1049, DOI 10.1016/S0090-4295(99)00299-X
   Osoba D, 1999, J CLIN ONCOL, V17, P1654
   Partin AW, 2003, J UROLOGY, V170, P1787, DOI 10.1097/01.ju.0000092695.55705.dd
   PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5
   Pisansky T M, 2000, Semin Urol Oncol, V18, P93
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Pruthi RS, 1997, UROLOGY, V49, P404, DOI 10.1016/S0090-4295(96)00500-6
   Roberts SG, 2001, MAYO CLIN PROC, V76, P576
   Roehl KA, 2002, J UROLOGY, V168, P922, DOI 10.1097/01.ju.0000024660.18328.2d
   Ross RW, 2002, J UROLOGY, V167, P1952, DOI 10.1016/S0022-5347(05)65060-4
   Saad F, 2002, SEMIN ONCOL, V29, P19, DOI 10.1053/sonc.2002.37418
   Saleem MD, 1998, UROLOGY, V51, P283, DOI 10.1016/S0090-4295(97)00509-8
   Sanz G, 1999, BJU INT, V84, P1028
   SCHER HI, 1995, UROLOGY, V46, P142, DOI 10.1016/S0090-4295(99)80182-4
   SCHMID HP, 1993, CANCER, V71, P2031, DOI 10.1002/1097-0142(19930315)71:6<2031::AID-CNCR2820710618>3.0.CO;2-Q
   Schmid HP, 1999, J CLIN ONCOL, V17, P1645
   See W, 2003, EUR UROL, V44, P512, DOI 10.1016/S0302-2838(03)00366-X
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Smith DC, 1998, J CLIN ONCOL, V16, P1835
   Smith JA, 1997, J UROLOGY, V157, P1329, DOI 10.1016/S0022-5347(01)64963-2
   STEPHENSON J, 2003, P AN M AM SOC CLIN, V22, P392
   Sternberg CN, 2002, CRIT REV ONCOL HEMAT, V43, P105, DOI 10.1016/S1040-8428(02)00023-9
   Stock RG, 2003, INT J RADIAT ONCOL, V56, P448, DOI 10.1016/S0360-3016(02)04470-X
   Tannock IF, 1996, J CLIN ONCOL, V14, P1756
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
NR 72
TC 56
Z9 58
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1368-5031
J9 INT J CLIN PRACT
JI Int. J. Clin. Pract.
PD APR
PY 2004
VL 58
IS 4
BP 382
EP 390
DI 10.1111/j.1368-5031.2004.00184.x
PG 9
WC Medicine, General & Internal; Pharmacology & Pharmacy
SC General & Internal Medicine; Pharmacology & Pharmacy
GA 821PM
UT WOS:000221474300012
PM 15161124
ER

PT J
AU Slavin, SA
   Van den Abeele, AD
   Losken, A
   Swartz, MA
   Jain, RK
AF Slavin, SA
   Van den Abeele, AD
   Losken, A
   Swartz, MA
   Jain, RK
TI Return of lymphatic function after flap transfer for acute lymphedema
SO ANNALS OF SURGERY
LA English
DT Article
ID DISSECTION
AB Objective
   The goats of this work were to develop animal models of lymphedema and tissue flap transfer, and to observe physiologic changes in lymphatic function that occur in these models over time, both systemically with lymphoscintigraphy (LS) and locally using fluorescence microlymphangiography (FM).
   Summary Background Data
   Although lymphedema has been managed by a combination of medical and surgical approaches, no effective long-term cure exists. Surgical attempts aimed at reconnecting impaired lymphatic channels or bypassing obstructed areas have failed.
   Methods
   The tails of rats (A groups) and mice (B groups) were used because of their different features. Lymphedema was created by ligation of the lymphatics at the tail base and quantified by diameter measurements there. In the experimental group, rectus abdominis myocutaneous flap was transferred across the ligation, In addition to the ligation (A1 and B1) and ligation + flap (A2 and B2) groups, three control groups were included: sham flap with ligation (B4), sham flap alone (B5), and normal (A3 and B3) animals. Observations were made at weekly time points for lymphatic function and continuity.
   Results
   Lymphedema was successfully created in the mouse ligation groups (B1 and B4) and sustained for the entire length of observation (up to 14 weeks). Lymphatic continuity was restored in those animals with transferred flaps across the ligation site (A2 and B2), as seen both by LS and FM. Sham flaps did not visibly affect lymphatic function nor did they cause any visible swelling in the tail.
   Conclusions
   Acute lymphedema developing after ligation of tail lymphatics in mice can be prevented by myocutaneous flap transfer. Restored lymphatic continuity and function were demonstrable using lymphoscintigraphy and fluorescence microlymphangiography.
C1 Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Beth Israel Deaconess Med Ctr, Div Plast Surg, Boston, MA USA.
   Dana Farber Canc Inst, Div Oncol Nucl Med, Boston, MA 02115 USA.
RP Swartz, MA (reprint author), Massachusetts Gen Hosp, Dept Radiat Oncol, Cox 7, Boston, MA 02114 USA.
RI Swartz, Melody/B-7633-2009; Swartz, Melody/F-9563-2011
CR BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012
   BOLLINGER A, 1993, INT J MICROCIRC, V12, P1
   CAMPISI C, 1995, MICROSURG, V16, P463, DOI 10.1002/micr.1920160706
   ENGESET A, 1960, CANCER RES, V20, P613
   HUANG GK, 1985, PLAST RECONSTR SURG, V76, P671
   IVENS D, 1992, BRIT J CANCER, V66, P136, DOI 10.1038/bjc.1992.230
   KANTER MA, 1990, PLAST RECONSTR SURG, V85, P573, DOI 10.1097/00006534-199004000-00012
   LEU AJ, 1994, AM J PHYSIOL-HEART C, V267, pH1507
   MANDELL GA, 1993, SEMIN NUCL MED, V23, P334, DOI 10.1016/S0001-2998(05)80112-6
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   Mortimer PS, 1997, ANGIOLOGY, V48, P87, DOI 10.1177/000331979704800114
   PEZNER RD, 1986, INT J RADIAT ONCOL, V12, P2079
   SAVAGE RC, 1984, SURG GYNECOL OBSTET, V159, P501
   Slavin SA, 1997, PLAST RECONSTR SURG, V99, P730, DOI 10.1097/00006534-199703000-00020
   SMITH AR, 1987, PLAST RECONSTR SURG, V79, P163, DOI 10.1097/00006534-198702000-00001
   Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324
NR 16
TC 56
Z9 63
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-4932
J9 ANN SURG
JI Ann. Surg.
PD MAR
PY 1999
VL 229
IS 3
BP 421
EP 427
DI 10.1097/00000658-199903000-00017
PG 7
WC Surgery
SC Surgery
GA 174ER
UT WOS:000079021600018
PM 10077056
ER

PT J
AU LASSER, EC
   LANG, J
   SOVAK, M
   KOLB, W
   LYON, S
   HAMLIN, AE
AF LASSER, EC
   LANG, J
   SOVAK, M
   KOLB, W
   LYON, S
   HAMLIN, AE
TI STEROIDS - THEORETICAL AND EXPERIMENTAL BASIS FOR UTILIZATION IN
   PREVENTION OF CONTRAST-MEDIA REACTIONS
SO RADIOLOGY
LA English
DT Article
C1 UNIV HOSP SAN DIEGO,MED CTR,DEPT RADIOL,SAN DIEGO,CA 92103.
CR AGARWAL KN, 1964, ACTA ENDOCRINOL-COP, V47, P3
   ANSELL G, 1970, INVEST RADIOL, V5, P374, DOI 10.1097/00004424-197011000-00002
   ATKINSON JP, 1974, J IMMUNOL, V113, P1085
   ATKINSON JP, 1973, J IMMUNOL, V111, P1061
   BRASCH RC, 1976, INVEST RADIOL, V11, P1, DOI 10.1097/00004424-197601000-00001
   BRASCH RC, 1970, INVEST RADIOL, V6, P510
   COHEN LS, 1969, RADIOLOGY, V92, P329
   COLEMAN WP, 1964, SOUTHERN MED J, V57, P1401
   COLLINS JV, 1970, LANCET, V2, P1047
   DIETZMAN RH, 1971, SEPTIC SHOCK MAN, P231
   DISANTO AR, 1975, J PHARM SCI, V64, P109, DOI 10.1002/jps.2600640122
   GREAVES MW, 1974, IMMUNOLOGY, V27, P359
   GRIGGS RC, 1972, J ALLERGY CLIN IMMUN, V49, P267, DOI 10.1016/0091-6749(72)90094-2
   JENNINGS JF, 1966, J IMMUNOL, V96, P409
   KABAT EA, 1971, EXPT IMMUNOCHEMISTRY, P130
   KOLB W, TO BE PUBLISHED
   LALLI AF, 1975, AM J ROENTGENOL, V125, P264
   LANG JH, 1976, INVEST RADIOL, V11, P303, DOI 10.1097/00004424-197607000-00007
   LANG JH, 1974, INVEST RADIOL, V9, P51, DOI 10.1097/00004424-197403000-00001
   LASSER EC, 1976, RADIOLOGY, V119, P91
   LASSER EC, 1971, RADIOLOGY, V100, P683
   LECLERCQ R, 1974, J PHARMACOKINET BIOP, V2, P175, DOI 10.1007/BF01061507
   MORLEY AA, 1967, BRIT J HAEMATOL, V13, P310, DOI 10.1111/j.1365-2141.1967.tb08745.x
   PETERS GA, 1966, J ALLERGY, V38, P74, DOI 10.1016/0021-8707(66)90046-3
   SANDBERG DH, 1970, BIOCHEM MED METAB B, V4, P383, DOI 10.1016/0006-2944(70)90066-9
   SCHATZ M, 1975, J ALLERGY CLIN IMMUN, V55, P358, DOI 10.1016/0091-6749(75)90007-X
   SCHREIBER AD, 1975, J CLIN INVEST, V56, P1189, DOI 10.1172/JCI108196
   SHEHADI WH, 1975, AM J ROENTGENOL, V124, P145
   WEISSMANN G, 1961, EXP CELL RES, V25, P207, DOI 10.1016/0014-4827(61)90328-7
   WITTEN DM, 1973, AM J ROENTGENOL, V119, P832
   ZWEIMAN B, 1975, ANN INTERN MED, V83, P159
NR 31
TC 56
Z9 56
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PY 1977
VL 125
IS 1
BP 1
EP 9
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA DV468
UT WOS:A1977DV46800001
PM 897151
ER

PT J
AU BRZICA, SM
   PINEDA, AA
   TASWELL, HF
AF BRZICA, SM
   PINEDA, AA
   TASWELL, HF
TI AUTOLOGOUS BLOOD-TRANSFUSION
SO MAYO CLINIC PROCEEDINGS
LA English
DT Review
C1 MAYO CLIN & MAYO FDN,DEPT ANESTHESIOL,ROCHESTER,MN 55901.
   MAYO CLIN & MAYO FDN,DEPT LAB MED,BLOOD BANK & TRANSF SERV,ROCHESTER,MN 55901.
CR AARON RK, 1974, ARCH SURG-CHICAGO, V108, P831
   ADAMSON J, 1968, J AMER MED ASSOC, V205, P609, DOI 10.1001/jama.205.9.609
   AKERBLOM O, 1972, ACTA CHIR SCAND, V138, P79
   AKERBLOM O, 1970, LANCET, V2, P385
   ALLARDYC.DB, 1966, J THORAC CARDIOV SUR, V52, P706
   ALLEN C, 1972, ANESTH ANALG CLEVE, V51, P287
   ALLEN JG, 1962, JAMA-J AM MED ASSOC, V180, P1079
   ALTER HJ, 1972, ANN INTERN MED, V77, P691
   ANDERSEN MN, 1969, J THORAC CARDIOV SUR, V57, P238
   ANDERSON NORMAN G., 1966, NAT CANCER INST MONOGR, V21, P9
   APELO R, 1951, Philipp J Surg, V6, P166
   Appleby LH, 1925, CAN MED ASSOC J, V15, P36
   ASCARI WQ, 1968, TRANSFUSION, V8, P111
   ASHMORE PG, 1968, J THORAC CARDIOV SUR, V55, P691
   ASHMORE PG, 1972, J THORAC CARDIOV SUR, V63, P240
   AVIADO DM, 1968, J TRAUM, V8, P880, DOI 10.1097/00005373-196809000-00037
   BACKERGRONDAHL N, 1953, ACTA CHIR SCAND, V105, P3
   BAKER JBC, 1964, J PATH BACT, V87, P49
   BANKOFF GA, 1961, MILESTONES MEDICINE, P94
   BECKER CE, 1966, ANN INTERN MED, V65, P745
   BELLER FK, 1968, AM J OBSTET GYNECOL, V102, P1121
   BENNETT SH, 1973, AM J SURG, V125, P696, DOI 10.1016/0002-9610(73)90167-0
   BENNETT SH, 1972, J SURG RES, V13, P295, DOI 10.1016/0022-4804(72)90080-7
   BENNETT SH, 1973, AM J SURG, V125, P273, DOI 10.1016/0002-9610(73)90040-8
   Bing RJ, 1944, B JOHNS HOPKINS HOSP, V74, P161
   BIRNDORF NI, 1970, J APPL PHYSIOL, V29, P573
   YOSHIKAW.H, 1973, AM J CARDIOL, V32, P670, DOI 10.1016/S0002-9149(73)80061-X
   Blundell J, 1818, Med Chir Trans, V9, P56
   BOURNE G, 1955, BRIT MED J, V2, P305
   Bregman D, 1974, Ann Thorac Surg, V18, P590
   BRENER BJ, 1973, ARCH SURG-CHICAGO, V107, P78
   Brener B J, 1973, Surg Forum, V24, P255
   BUCKLEY M J, 1971, Surgical Forum (Chicago), V22, P160
   BUNN HF, 1969, J CLIN INVEST, V48, P311, DOI 10.1172/JCI105987
   BURCH LE, 1923, SURG GYNECOL OBSTET, V36, P811
   BURCH LE, 1922, T S SURG ASSOC, V35, P25
   Butler H B, 1929, Br Med J, V2, P1006
   CARTY MJ, 1972, J OBSTET GYN BR COMM, V79, P1137
   CARTY MJ, 1973, J OBSTET GYN BR COMM, V80, P701
   CHAPLIN H, 1974, NEW ENGL J MED, V291, P68, DOI 10.1056/NEJM197407112910204
   CHAPLIN H, 1973, PRESERVATION RED BLO
   COLEMAN DH, 1953, ARCH INTERN MED, V92, P341
   COLMAN RW, 1972, AM J MED, V52, P679, DOI 10.1016/0002-9343(72)90058-7
   CONELL RS, 1973, ANNALS SURGERY, V177, P40
   COPE W, 1956, BR MED J, V2, P638
   CORPE RF, 1966, J ABDOMINAL SURG, V8, P45
   COWELL HR, 1974, J BONE JOINT SURG AM, VA 56, P908
   CROWELL JW, 1958, AM J PHYSIOL, V192, P171
   CUELLO L, 1967, SURGERY, V62, P814
   CUELLO L, 1967, TRANSFUSION, V7, P309
   CULLEN DJ, 1970, ANESTHESIOLOGY, V32, P46, DOI 10.1097/00000542-197001000-00011
   DAANE JA, 1969, AM J OBSTET GYNECOL, V105, P394
   DAGGETT WM, 1970, J THORAC CARDIOV SUR, V59, P546
   DAVIS LE, 1925, SURG GYNECOL OBSTET, V40, P310
   DAVIS MB, 1922, J TENN MED ASS, V15, P292
   DHALL DP, 1969, CARDIOVASC RES, V3, P147, DOI 10.1093/cvr/3.2.147
   DORANG LA, 1972, AM J SURG, V123, P686, DOI 10.1016/0002-9610(72)90354-6
   DOWLING J, 1973, 1ST ANN BENTL AUT SE, P11
   DUNCAN SE, 1974, ANN SURG, V180, P296, DOI 10.1097/00000658-197409000-00007
   Duncan S E, 1974, Rev Surg, V31, P121
   DUNCAN SE, 1974, SURGERY, V76, P1024
   DYER RH, 1972, AM J SURG, V123, P510, DOI 10.1016/0002-9610(72)90211-5
   DYER RH, 1966, AM J SURG, V112, P874, DOI 10.1016/0002-9610(66)90142-5
   Ebert RV, 1941, ARCH INTERN MED, V68, P578
   FADALI AMA, 1972, SURGERY, V71, P738
   FARRAR LKP, 1929, SURG GYNECOL OBSTET, V49, P454
   FINCH S, 1950, J CLIN INVEST, V29, P1078, DOI 10.1172/JCI102339
   GARCIA E, 1964, Philipp J Surg Surg Spec, V19, P33
   GERST PH, 1967, NEW YORK STATE J MED, V67, P830
   GILCHER RO, 1975, TRANSFUSION, V15, P520
   GOLDFINGER D, 1974, NEW APPROACHES TRANS, P15
   GOLDINER PL, 1972, ANESTH ANAL CURR RES, V51, P717
   GRANT FC, 1921, ANN SURG, V74, P253
   Graves C L, 1970, Rocky Mt Med J, V67, P35
   Griswold RA, 1943, SURG GYNECOL OBSTET, V77, P167
   HALLOWEL.P, 1972, J THORAC CARDIOV SUR, V64, P941
   HAMSTRA RD, 1969, J APPL PHYSIOL, V27, P503
   HARDAWAY RM, 1965, AM J SURG, V110, P298, DOI 10.1016/0002-9610(65)90060-7
   HARDESTY RL, 1968, J THORAC CARDIOV SUR, V56, P683
   HAVERBUSH JJ, 1973, 1ST ANN BENTL AUT SE, P53
   HENDERSO.PA, 1969, BLOOD-J HEMATOL, V34, P357
   Hendry WB, 1925, AM J OBSTET GYNECOL, V10, P386
   Highmore W, 1874, LANCET, V1, P89
   Hill J D, 1969, Ann Thorac Surg, V7, P409
   HILLMAN RS, 1969, J CLIN INVEST, V48, P454, DOI 10.1172/JCI106002
   HILLMAN RS, 1969, J CLIN INVEST, V48, P443, DOI 10.1172/JCI106001
   HILLMAN RS, 1972, HEMATOLOGY, P521
   HILLMAN ROBERT S., 1967, SEMINAR HEMATOL, V4, P327
   HOWARTH HC, 1973, J ORAL SURG, V31, P40
   HUGGINS CE, 1972, TRANSPLANT P, V4, P575
   JACOBS J, 1969, SOUTHERN MED J, V62, P216
   Johansen S H, 1966, Acta Anaesthesiol Scand Suppl, V24, P63
   KAHN RA, 1975, TRANSFUSION, V15, P516
   KALLOS T, 1974, ANESTHESIOLOGY, V41, P293, DOI 10.1097/00000542-197409000-00017
   Kingsley J R, 1973, Surg Forum, V24, P258
   KLEBANOFF G, 1972, 13 INT C INT SOC BLO
   KLEBANOF.G, 1968, AM J SURG, V116, P475, DOI 10.1016/0002-9610(68)90250-X
   KLEBANOFF G, 1970, American Journal of Surgery, V120, P718
   KLEBANOF.G, 1972, J TRAUM, V12, P422, DOI 10.1097/00005373-197205000-00013
   KLEBANOF.G, 1970, AM J SURG, V120, P351
   LAKS H, 1973, CLIN RES, V21, P431
   Langston H T, 1972, Bull Soc Int Chir, V31, P514
   LANGSTON HT, 1963, ANN SURG, V158, P333, DOI 10.1097/00000658-196315830-00002
   LEE WH, 1961, SURGERY, V50, P29
   LINMAN JW, 1968, NEW ENGL J MED, V279, P812, DOI 10.1056/NEJM196810102791508
   LISTER J, 1963, ANN SURG, V158, P698, DOI 10.1097/00000658-196310000-00016
   LITWIN MS, 1960, ANNALS SURGERY, V152, P1016
   LJUNGQVI.U, 1973, J SURG RES, V15, P132, DOI 10.1016/0022-4804(73)90154-6
   LOGAN FP, 1948, S AFR MED J, V22, P793
   LUBIN J, 1974, TRANSFUSION, V14, P602
   MACCORMACK K, 1926, NZ MED J, V25, P7
   MACFEE WF, 1931, SURG CLIN N AM, V11, P691
   MATI JKG, 1973, J OBSTET GYN BR COMM, V80, P932
   MATTOX KL, 1975, J TRAUMA, V15, P663, DOI 10.1097/00005373-197508000-00007
   MAY GE, 1930, NEW ENGL J MED, V203, P1197, DOI 10.1056/NEJM193012112032406
   MAYNARD RL, 1929, JAMA-J AM MED ASSOC, V92, P1758
   MCCURDY PR, 1965, J AMER MED ASSOC, V191, P859
   MCKITTRI.JE, 1974, AM J SURG, V128, P137
   McMANUS T. J., 1961, FED PROC, V20, P65
   MICHALSKI AH, 1966, ANN SURG, V168, P946
   MILLER RD, 1973, ANESTHESIOLOGY, V39, P82, DOI 10.1097/00000542-197307000-00012
   MILLER WV, 1973, TRANSFUSION REACTION, P1
   MILLER WV, 1974, TECHNICAL METHODS PR, P310
   MILLES G, 1962, SURG GYNECOL OBSTET, V115, P689
   MILLES G, 1971, AUTOLOGOUS TRANSFUSI
   MILLES G, 1969, AM J OBSTET GYNECOL, V103, P1166
   Miya F, 1971, Transfusion, V11, P390
   MOIR JC, 1960, LANCET, V1, P60
   MOORE FD, 1965, NEW ENGL J MED, V273, P567, DOI 10.1056/NEJM196509092731101
   Nahas R A, 1972, Surg Forum, V23, P149
   NEWMAN MM, 1971, J AMER MED ASSOC, V218, P861, DOI 10.1001/jama.218.6.861
   NOONE RB, 1973, PLAST RECONSTR SURG, V51, P559, DOI 10.1097/00006534-197305000-00012
   NUNN JF, 1964, ANAESTHESIA, V19, P206, DOI 10.1111/j.1365-2044.1964.tb00367.x
   OBERMAN HA, 1974, SEMINAR CURRENT TECH, P73
   OCHSNER JL, 1973, ANN SURG, V177, P811, DOI 10.1097/00000658-197306000-00022
   OPELZ G, 1972, TRANSPLANT P, V4, P433
   OSBORN JJ, 1962, J THORAC CARDIOV SUR, V43, P459
   OSKI FA, 1971, BLOOD-J HEMATOL, V37, P52
   PAVEK K, 1974, AM J PHYSIOL, V226, P1172
   PEDDLE LJ, 1970, VOX SANG, V18, P547
   RABINER SF, 1968, BRIT J HAEMATOL, V14, P105, DOI 10.1111/j.1365-2141.1968.tb01480.x
   RABINER SF, 1967, J EXP MED, V126, P1127, DOI 10.1084/jem.126.6.1127
   RAKOWER SR, 1973, 1ST P ANN BENTL AUT, P27
   RAKOWER SR, 1973, SURG GYNECOL OBSTET, V137, P633
   RAKOWER SR, 1973, J TRAUMA, V13, P573, DOI 10.1097/00005373-197306000-00024
   RAMIREZ AT, 1971, AM J SURG, V122, P101, DOI 10.1016/0002-9610(71)90358-8
   RELIHAN M, 1972, ANN SURG, V176, P700, DOI 10.1097/00000658-197212000-00003
   RELIHAN M, 1972, SURGERY, V71, P395
   REPLOGLE RL, 1967, SURG FORUM, V18, P157
   RESTALL CJ, 1969, ANESTH ANALG CLEVELA, V48, P617
   REUL GJ, 1974, SURGERY, V76, P546
   REUL GJ, 1973, ARCH SURG-CHICAGO, V106, P386
   Ricci JV, 1931, AM J OBSTET GYNECOL, V22, P857
   RUMBAUGH MC, 1931, PENN MED, V34, P710
   RUNCK AH, 1972, TRANSFUSION, V12, P237
   RUSH B, 1967, ANN SURG, V165, P977, DOI 10.1097/00000658-196706000-00013
   RUSH BF, 1969, ARCH SURG-CHICAGO, V98, P49
   SANDS CJ, 1968, ARCH OTOLARYNGOL, V88, P423
   SEAGER OA, 1974, JAMA-J AM MED ASSOC, V229, P790, DOI 10.1001/jama.229.7.790
   SHAFER AW, 1959, NEW ENGL J MED, V260, P180, DOI 10.1056/NEJM195901222600408
   SKILLMAN JJ, 1967, ANN SURG, V166, P865, DOI 10.1097/00000658-196712000-00001
   Smith W W, 1975, Ohio State Med J, V71, P83
   SOLIS RT, 1972, TRANSFUSION, V12, P245
   SPURLING CL, 1974, NEW APPROACHES TRANS, P53
   STABLER F, 1934, J OBSTET GYNAECOL BR, V41, P768
   STAGER WR, 1951, AMA ARCH SURG, V63, P78
   SUKHNAND.R, 1965, SURGERY, V58, P185
   SWANK RL, 1961, NEW ENGL J MED, V265, P728, DOI 10.1056/NEJM196110122651503
   SWANK RL, 1964, J APPL PHYSIOL, V19, P340
   SWANK RL, 1968, J TRAUM, V8, P872, DOI 10.1097/00005373-196809000-00036
   SWANK RL, 1962, AM J PHYSIOL, V202, P261
   SYMBAS PN, 1969, SOUTHERN MED J, V62, P671
   SYMBAS PN, 1972, J TRAUM, V12, P689
   SYMBAS PN, 1969, CURRENT TOPICS SURGI, V1, P387
   TERASAKI PI, 1971, POSTGRAD MED J, V47, P89
   THIES J, 1914, ZANTRALBL GYNAK, V38, P1191
   Tiber L J, 1934, Cal West Med, V41, P16
   TURNER RS, 1968, J BONE JOINT SURG AM, VA 50, P834
   Tyras D H, 1973, Am Surg, V39, P652
   VALERI CR, 1972, NEW ENGL J MED, V287, P1307, DOI 10.1056/NEJM197212282872601
   VALERI CR, 1971, NEW ENGL J MED, V284, P81, DOI 10.1056/NEJM197101142840205
   VASSALLI P, 1963, AM J PATHOL, V43, P579
   VERSKA JJ, 1973, TRANSFUSION, V13, P219
   WADSWORTH GR, 1955, J PHYSIOL-LONDON, V129, P583
   WAGSTAFF.JG, 1972, THORAX, V27, P410, DOI 10.1136/thx.27.4.410
   WALLINGFORD AJ, 1937, NEW YORK STATE J MED, V37, P1922
   WALSH JH, 1970, J AMER MED ASSOC, V211, P261, DOI 10.1001/jama.211.2.261
   WATSONWILLIAMS EJ, 1975, TRANSFUSION, V15, P520
   WEEKES LR, 1960, OBSTET GYNECOL, V16, P715
   Weil AM, 1938, AM J OBSTET GYNECOL, V35, P602
   WILLIAMS WH, 1968, ARCH SURG-CHICAGO, V96, P317
   WILLIAMS WJ, 1972, HEMATOLOGY, P1120
   WILSON JD, 1968, MAYO CLIN PROC, V43, P26
   WILSON JD, 1971, J UROLOGY, V105, P873
   WILSON JD, 1969, MAYO CLIN PROC, V44, P374
   WISE W, 1957, Surg Forum, V8, P18
   WRIGHT CB, 1973, AM J SURG, V126, P25, DOI 10.1016/S0002-9610(73)80088-1
   WRIGHT CB, 1974, AM J SURG, V128, P49, DOI 10.1016/0002-9610(74)90233-5
   WYLIE WD, 1972, PRACTICE ANAESTHESIA, P741
   YAW PB, 1975, JAMA-J AM MED ASSOC, V231, P490, DOI 10.1001/jama.231.5.490
   YOUNG LE, 1964, ANN INTERN MED, V61, P136
   ZUCK TF, 1972, 13 INT TRANSF C WASH, P53
   1975, LANCET, V2, P959
   1974, FED REG 32702, V39
   1972, JAMA, V220, P692
   1974, STANDARDS BLOOD BANK, P17
NR 206
TC 56
Z9 56
PU MAYO CLINIC PROCEEDINGS
PI ROCHESTER
PA 660 SIEBENS BLDG MAYO CLINIC, ROCHESTER, MN 55905
SN 0025-6196
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PY 1976
VL 51
IS 11
BP 723
EP 737
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA CM883
UT WOS:A1976CM88300006
PM 994552
ER

PT J
AU Sharma, R
   Wendt, JA
   Rasmussen, JC
   Adams, KE
   Marshall, MV
   Sevick-Muraca, EM
AF Sharma, Ruchi
   Wendt, Juliet A.
   Rasmussen, John C.
   Adams, Kristen E.
   Marshall, Milton V.
   Sevick-Muraca, Eva M.
TI New horizons for imaging lymphatic function
SO LYMPHATIC CONTINUUM REVISITED
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article
DE lymph flow; NIR optical imaging; fluorescence; indocyanine green
ID MAGNETIC-RESONANCE LYMPHANGIOGRAPHY; SENTINEL NODE DETECTION;
   BREAST-CANCER PATIENTS; POSITRON-EMISSION-TOMOGRAPHY;
   COMPUTED-TOMOGRAPHY; RADIONUCLIDE LYMPHOSCINTIGRAPHY; CONTRAST AGENT;
   QUANTUM DOTS; LOWER-LIMB; DIFFERENTIAL-DIAGNOSIS
AB In this review, we provide a comprehensive summary of noninvasive imaging modalities used clinically for the diagnosis of lymphatic diseases, new imaging agents for assessing lymphatic architecture and cancer status of lymph nodes, and emerging near-infrared (NIR) fluorescent optical imaging technologies and agents for functional lymphatic imaging. Given the promise of NIR optical imaging, we provide example results of functional. lymphatic imaging in mice, swine, and humans, showing the ability of this technology to quantify lymph velocity and frequencies of propulsion resulting from the contractility of lymphatic structures.
C1 [Sharma, Ruchi; Wendt, Juliet A.; Rasmussen, John C.; Adams, Kristen E.; Marshall, Milton V.; Sevick-Muraca, Eva M.] Baylor Coll Med, Div Mol Imaging, Dept Radiol, Houston, TX 77030 USA.
RP Sevick-Muraca, EM (reprint author), Baylor Coll Med, Div Mol Imaging, Dept Radiol, 1 Baylor Plaza,BCM 360, Houston, TX 77030 USA.
EM evas@bcm.edu
CR Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480
   Armstrong SE, 2002, AM J PHYSIOL-HEART C, V283, pH2485, DOI 10.1152/ajpheart.00385.2002
   Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j
   Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037
   Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   Barrett T, 2006, CONTRAST MEDIA MOL I, V1, P230, DOI 10.1002/cmmi.116
   Bar-Shalom R, 2003, J NUCL MED, V44, P1200
   Bedrosian I, 2003, ANN SURG ONCOL, V10, P1025, DOI 10.1245/ASO.2003.12.017
   Bellin MF, 1998, RADIOLOGY, V207, P799
   Blacker HA, 2007, ANAT REC, V290, P108, DOI 10.1002/ar.a.20410
   Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173
   Clement O, 2004, EUR RADIOL, V14, P1498, DOI 10.1007/s00330-004-2265-9
   Cueni LN, 2006, J INVEST DERMATOL, V126, P2167, DOI 10.1038/sj.jid.5700464
   Delbeke D, 1999, J NUCL MED, V40, P591
   Ellner SJ, 2003, NUCL MED BIOL, V30, P805, DOI 10.1016/j.nucmedbio.2003.10.001
   Enderle JD, 2000, INTRO BIOMEDICAL ENG
   ENGESET A, 1960, CANCER RES, V20, P613
   Fischer M, 1997, INT J MICROCIRC, V17, P143, DOI 10.1159/000179222
   Goldberg BB, 2004, RADIOLOGY, V230, P727, DOI 10.1148/radiol.2303021440
   Gurfinkel M, 2000, PHOTOCHEM PHOTOBIOL, V72, P94, DOI 10.1562/0031-8655(2000)072<0094:POIAHC>2.0.CO;2
   Hama Y, 2007, CONTRAST MEDIA MOL I, V2, P82, DOI 10.1002/cmmi.129
   HAMMER JB, 2007, ANN SURG ONCOL, V14, P1904
   Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642
   Hauff P, 2004, RADIOLOGY, V231, P667, DOI 10.1148/radiol.2313030425
   Hoffman JM, 2007, RADIOLOGY, V244, P39, DOI 10.1148/radiol.2441060773
   Houston JP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2114748
   Hultén L, 1966, Acta Chir Scand, V132, P261
   HUTCHINS GD, 1990, J AM COLL CARDIOL, V15, P1032
   Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x
   Ji RC, 2005, HISTOL HISTOPATHOL, V20, P155
   Karkkainen MJ, 2002, NAT CELL BIOL, V4, pE2, DOI 10.1038/ncb0102-e2
   Kersey TW, 2001, J SURG RES, V96, P255, DOI 10.1006/jsre.2000.6075
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   KINMONTH JB, 1972, LYMPHATICS DIS LYMPH
   KINMONTH JB, 1952, CLIN SCI, V11, P13
   Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211
   Kitayama J, 2007, SURGERY, V141, P815, DOI 10.1016/j.surg.2007.01.026
   Kobayashi H, 2005, NEOPLASIA, V7, P984, DOI 10.1593/neo.05454
   Kobayashi H, 2004, J NATL CANCER I, V96, P703, DOI 10.1093/jnci/djh124
   Kobayashi H, 2003, CANCER RES, V63, P271
   Kos S, 2007, CARDIOVASC INTER RAD, V30, P968, DOI 10.1007/s00270-007-9026-5
   Koukourakis MI, 2005, J CLIN PATHOL, V58, P202, DOI 10.1136/jcp.2004.019174
   Kwon Sunkuk, 2007, Lymphatic Research and Biology, V5, P219, DOI 10.1089/lrb.2007.1013
   Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136
   LAURENT TC, 1992, FASEB J, V6, P2397
   Leu AJ, 2000, CANCER RES, V60, P4324
   LEU AJ, 1994, AM J PHYSIOL-HEART C, V267, pH1507
   Lim HW, 1993, CLIN PHOTOMEDICINE
   Lindqvist U, 2000, EUR J CLIN INVEST, V30, P600
   Liu NF, 2004, LYMPHOLOGY, V37, P6
   Liu NF, 1998, LYMPHOLOGY, V31, P173
   Lohrmann C, 2007, BRIT J RADIOL, V80, P569, DOI 10.1259/bjr/95414884
   Lohrmann C, 2006, AM J ROENTGENOL, V187, P556, DOI 10.2214/AJR.05.1750
   Lohrmann C, 2006, EUR J RADIOL, V59, P401, DOI 10.1016/j.ejrad.2006.02.012
   Matsushima S, 2007, J COMPUT ASSIST TOMO, V31, P299, DOI 10.1097/01.rct.0000236415.97642.58
   McGreevy JM, 2003, J SURG RES, V111, P38, DOI 10.1016/S0022-4804(03)00000-0
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348
   Mellor RH, 2000, J VASC RES, V37, P501, DOI 10.1159/000054083
   Mettler F. A., 2006, ESSENTIALS NUCL MED
   Misselwitz B, 2006, EUR J RADIOL, V58, P375, DOI 10.1016/j.ejrad.2005.12.044
   Moghimi SM, 1996, PROG BIOPHYS MOL BIO, V65, P221, DOI 10.1016/S0079-6107(96)00012-0
   Motomura K, 1999, JPN J CLIN ONCOL, V29, P604, DOI 10.1093/jjco/29.12.604
   Motomura K, 2001, EUR J SURG ONCOL, V27, P141, DOI 10.1053/ejso.2000.1059
   Nathanson SD, 2003, CANCER, V98, P413, DOI 10.1002/cncr.11464
   O'Mahony S, 2006, AM J ROENTGENOL, V186, P1349, DOI 10.2214/AJR.04.1341
   O'Mahony S, 2007, EJSO-EUR J SURG ONC, V33, P1052, DOI 10.1016/j.ejso.2007.03.012
   Pan Da, 2006, Lymphatic Research and Biology, V4, P211, DOI 10.1089/lrb.2006.4405
   PARTSCH H, 1983, LYMPHOLOGY, V16, P12
   PARTSCH H, 1984, BRIT J DERMATOL, V110, P431, DOI 10.1111/j.1365-2133.1984.tb04658.x
   Parungo CP, 2005, J THORAC CARDIOV SUR, V129, P844, DOI 10.1016/j.jtcvs.2004.08.001
   Parungo CP, 2005, CHEST, V127, P1799, DOI 10.1378/chest.127.5.1799
   PECKING AP, 2002, REV MED INTERNE, V23
   Peer FI, 2007, INT J DERMATOL, V46, P166
   Rabin O, 2006, NAT MATER, V5, P118, DOI 10.1038/nmat1571
   Rety F, 2000, J MAGN RESON IMAGING, V12, P734, DOI 10.1002/1522-2586(200011)12:5<734::AID-JMRI10>3.0.CO;2-R
   Ruehm SG, 2001, RADIOLOGY, V220, P816, DOI 10.1148/radiol.2203010090
   Saaristo A, 2004, FASEB J, V18, P1707, DOI 10.1096/fj.04-1592fje
   Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234
   SATO T, 2000, ORAL SURG ORAL MED O, V90, P526
   Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942
   Schoder H, 2006, CANCER METAST REV, V25, P185, DOI 10.1007/s10555-006-8498-0
   Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962
   Sharma R, 2007, AM J PHYSIOL-HEART C, V292, pH3109, DOI 10.1152/ajpheart.01223.2006
   SILVESTRI RC, 1980, AM REV RESPIR DIS, V122, P543
   Slavin SA, 1999, ANN SURG, V229, P421, DOI 10.1097/00000658-199903000-00017
   Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055
   Suga K, 2005, RADIOLOGY, V237, P952, DOI 10.1148/radiol.2373041578
   Suga K, 2003, INVEST RADIOL, V38, P73, DOI 10.1097/00004424-200302000-00002
   Suresh S, 1997, J ULTRAS MED, V16, P45
   SUTTON D, 1998, RADIOLOGY IMAGING ME
   Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8
   Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324
   Szuba A, 2003, J NUCL MED, V44, P43
   Szuba A, 2002, FASEB J, V16, P1985, DOI 10.1096/fj.02-0401fje
   Szuba A, 2002, NUCL MED COMMUN, V23, P1171, DOI 10.1097/01.mnm.0000046208.83338.da
   Thompson M, 2007, ANN SURG ONCOL, V14, P1890, DOI 10.1245/s10434-007-9412-x
   Tiwari A, 2003, ARCH SURG-CHICAGO, V138, P152, DOI 10.1001/archsurg.138.2.152
   Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023
   Vogl T J, 1997, Acta Radiol Suppl, V412, P47
   Wallace AM, 2003, ANN SURG ONCOL, V10, P531, DOI 10.1245/ASO.2003.07.012
   Weiss M, 2003, EUR J NUCL MED MOL I, V30, P202, DOI 10.1007/s00259-002-1020-1
   Weiss M, 2002, CLIN NUCL MED, V27, P788, DOI 10.1097/01.RLU.0000033613.05410.34
   Wisner ER, 2003, INVEST RADIOL, V38, P358, DOI 10.1097/01.rli.0000065423.05038.88
   Wisner ER, 1996, ACAD RADIOL, V3, P40, DOI 10.1016/S1076-6332(96)80331-X
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   Wunderbaldinger P, 2003, EUR RADIOL, V13, P2206, DOI 10.1007/s00330-003-1932-6
   Yuan ZB, 2006, ANN NUCL MED, V20, P341, DOI 10.1007/BF02987244
NR 108
TC 55
Z9 58
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXEN, ENGLAND
SN 0077-8923
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2008
VL 1131
BP 13
EP 36
DI 10.1196/annals.1413.002
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA BHV94
UT WOS:000256902600003
PM 18519956
ER

PT J
AU Wilson, BA
AF Wilson, Barbara A.
TI Neuropsychological rehabilitation
SO ANNUAL REVIEW OF CLINICAL PSYCHOLOGY
SE Annual Review of Clinical Psychology
LA English
DT Review; Book Chapter
DE brain injury; cognition; emotion; psychosocial; holistic programs
ID TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE
   REHABILITATION; COMMUNITY INTEGRATION; SUSTAINED ATTENTION; EVERYDAY
   MEMORY; ALZHEIMER-TYPE; HEAD-INJURY; INTERVENTION; DEMENTIA
AB Neuropsychological rehabilitation (NR) is concerned with the amelioration of cognitive, emotional, psychosocial, and behavioral deficits caused by an insult to the brain. Major changes in NR have occurred over the past decade or so. NR is now mostly centered on a goal-planning approach in a partnership of survivors of brain injury, their families, and professional staff who negotiate and select goals to be achieved. There is widespread recognition that cognition, emotion, and psychosocial functioning are interlinked, and all should be targeted in rehabilitation. This is the basis of the holistic approach. Technology is increasingly used to compensate for cognitive deficits, and some technological aids are discussed. Evidence for effective treatment of cognitive, emotional, and psychosocial difficulties is presented, models that have been most influential in NR are described, and the review concludes with guidelines for good practice.
C1 Addenbrookes Hosp, Cognit & Brain Sci Unit, Med Res Council, Cambridge CB2 2QQ, England.
RP Wilson, BA (reprint author), Addenbrookes Hosp, Cognit & Brain Sci Unit, Med Res Council, Hills Rd, Cambridge CB2 2QQ, England.
EM barbara.wilson@mrc-cbu.cam.ac.uk
CR ALDERMAN N, 2003, NEUROPSYCHOL REHABIL, P171
   [Anonymous], 1999, CONCISE OXFORD DICT
   Austin JT, 1996, PSYCHOL BULL, V120, P338, DOI 10.1037//0033-2909.120.3.338
   BADDELEY A, 1992, CONSCIOUS COGN, V1, P3, DOI 10.1016/1053-8100(92)90037-B
   BADDELEY M, 2007, QUEENS EC SEM CAMBR
   BATEMAN A, 2005, BRAIN IMPAIR, V6, P132
   Beck A. J., 1976, COGNITIVE THERAPY EM
   BECT AT, 1996, FRONTIERS COGNITIVE, P1
   BENYISHAY Y, 1978, REHABIL MONOGR, V59
   BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514
   BOAKE C, 2003, NEUROPSYCHOL REHABIL, P11
   Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656
   Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037//0033-295X.103.4.670
   BRUCE V, 1986, BRIT J PSYCHOL, V77, P305
   Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931
   Butler G, 1998, COMPREHENSIVE CLIN P, P1
   CARAMAZZA A, 1993, NEUROPSYCHOL REHABIL, V3, P217, DOI 10.1080/09602019308401437
   Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008
   Chesnut RM, 1999, 2 AG HLTH CAR POL RE
   Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024
   Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240
   Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019
   CICERONE KD, 2007, BRAIN IMPAIR, V8, P169
   Clare L, 2001, NEUROPSYCHOL REHABIL, V11, P477
   Clare L, 2006, NEUROPSYCHOL REHABIL, V16, P353, DOI 10.1080/09602010500465366
   Clare L, 2000, J CLIN EXP NEUROPSYC, V22, P132, DOI 10.1076/1380-3395(200002)22:1;1-8;FT132
   Clare L, 1999, NEUROCASE, V5, P37, DOI 10.1080/13554799908404063
   Clare L, 2008, NEUROPSYCHOLOG REHAB, P1
   Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540
   *DEP HLTH, 2004, NAT SERV FRAM LONG T
   Diller L., 1976, CLIN PSYCHOL, V29, P13
   DILLER L, 2002, CLIN NEUROPSYCHOL, P293
   Engberg AW, 2004, ACTA NEUROL SCAND, V110, P281, DOI 10.1111/j.1600-0404.2004.00323.x
   EYSENCK HJ, 1964, EXPT BEHAV THERAPY, P1
   Feeney T., 2000, BRAIN IMPAIR, V1, P12, DOI [10.1375/brim.1.1.12, DOI 10.1375/BRIM.1.1.12]
   Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015
   FISH J, 2007, UNPUB J NEUROL NEURO
   GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440
   GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5
   Goldstein K., 1942, AFTEREFFECTS BRAIN I
   Halligan P. W., 2005, EFFECTIVENESS REHABI
   HASLAM C, 2007, IN PRESS NEUROPSYCHO
   Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309
   Hoofien D, 2001, BRAIN INJURY, V15, P189
   HOWARD D, 2005, EFFECTIVENESS REHABI, P155
   Johnson K, 1998, BEHAV MODIF, V22, P502, DOI 10.1177/01454455980224004
   Karlovits T, 1999, BRAIN INJURY, V13, P845
   Kendall E, 2006, J VOCAT REHABIL, V25, P149
   Khan F, 2003, MED J AUSTRALIA, V178, P290
   Kirsch N. L., 1987, J HEAD TRAUMA REHAB, V2, P77
   Kopelman M, 1996, NEUROPSYCHOL REHABIL, V6, P187, DOI 10.1080/713755504
   KURLYCHEK RT, 1983, CLIN GERONTOLOGIST, V1, P93
   Luria A. R., 1969, HDB CLIN NEUROLOGY, V3, P368
   Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4
   MANLY T, 2003, NEUROPSYCHOL REHABIL, P23
   Markowitsch HJ, 1998, NEUROCASE, V4, P429, DOI 10.1080/13554799808410636
   Martin P. R., 1991, HDB BEHAV THERAPY PS
   Mateer CA, 2006, NEUROREHABILITATION, V21, P315
   MCDONALD S, 2003, BRAIN IMPAIRMENT, V4, P36, DOI 10.1375/brim.4.1.36.27032
   McLellan D. L., 1991, CLIN NEUROLOGY, P768
   McMillan TM, 1999, NEUROPSYCHOL REHABIL, V9, P241, DOI 10.1080/096020199389356
   McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016
   McNeil J E, 1996, Cogn Neuropsychiatry, V1, P239, DOI 10.1080/135468096396532
   MITCHUM CC, 1995, NEUROPSYCHOL REHABIL, V5, P1, DOI 10.1080/09602019508520173
   MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185
   MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574
   Nair KPS, 2003, ARCH PHYS MED REHAB, V84, P1710, DOI 10.1053/S0003-9993(03)00313-7
   Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315
   Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465
   Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874
   POPPELREUTER W, 1991, DISTURBANCES LOWER H
   Poser U, 1996, NEUROPSYCHOL REHABIL, V6, P257, DOI 10.1080/713755510
   Prigatano G, 2005, EFFECTIVENESS REHABI, P3
   Prigatano G. P., 1994, BRAIN INJURY NEUROPS, P173
   Prigatano GP, 1991, AWARENESS DEFICIT BR
   Prigatano GP, 1999, PRINCIPLES NEUROPSYC
   Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P29
   Quintard B., 2002, Annales de Readaptation et de Medecine Physique, V45, P456, DOI 10.1016/S0168-6054(02)00296-9
   Robertson IH, 1999, ATTENTION PERFORM, V17, P677
   Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290
   ROBINSON R G, 1989, Journal of Geriatric Psychiatry, V22, P1
   ROSE FD, 2005, CYBER PSYCHOL BEHAV, V8, P243
   Salkovskis P., 1996, FRONTIERS COGNITIVE
   SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780
   Sohlberg MM, 2001, COGNITIVE REHABILITA
   SOPENA S, 2007, BRAIN IMPAIR, V8, P70
   TATE RL, 2003, NEUROPSYCHOL REHABIL, P137
   Tate RL, 1998, NEUROPSYCHOL REHABIL, V8, P1, DOI 10.1080/713755554
   Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013
   Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004170.PUB2
   Wade D. T., 2005, EFFECTIVENESS REHABI, P31
   Wade DT, 1999, TOP STROKE REHABIL, V6, P1, DOI 10.1310/MTQV-NCRV-50T0-R5T3
   Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335
   Williams W. H., 2003, BIOPSYCHOSOCIAL APPR
   Williams WH, 1999, NEUROPSYCHOL REHABIL, V9, P421, DOI 10.1080/096020199389482
   Williams W H, 2003, Cogn Neuropsychiatry, V8, P1, DOI 10.1080/713752238
   WILLIAMS WH, 2003, NEUROPSYCHOL REHABIL, P115
   Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026
   Wilson B., 1999, CASE STUDIES NEUROPS
   Wilson BA, 2003, NEUROPSYCHOLOG REHAB, P1
   Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477
   Wilson BA, 2002, J HEAD TRAUMA REHAB, V17, P542, DOI 10.1097/00001199-200212000-00006
   Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020
   Wilson BA, 2000, INT HDB NEUROPSYCHOL, P231
   Wood R. L, 1990, COGNITIVE REHABILITA, P3
   Wood R. L., 1987, BRAIN INJURY REHABIL
   WOOD RL, 2005, J NEUROL NEUROSUR PS, V77, P1
   World Health Organisation, 2001, INT CLASS FUNCT DIS
   Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408
   Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104
   Zangwill OL, 1947, B J PSYCHOL-GEN SECT, V37, P60
NR 111
TC 55
Z9 55
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1548-5943
J9 ANNU REV CLIN PSYCHO
JI Annu. Rev. Clin. Psychol.
PY 2008
VL 4
BP 141
EP 162
DI 10.1146/annurev.clinpsy.4.022007.141212
PG 22
WC Psychology, Clinical; Psychology
SC Psychology
GA 297WW
UT WOS:000255649100007
PM 17716045
ER

PT J
AU Vriend, JWJ
   Mulder, BJM
AF Vriend, JWJ
   Mulder, BJM
TI Late complications in patients after repair of aortic coarctation:
   implications for management
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Review
DE aortic coarctation; complications; clinical management; hypertension
ID TERM-FOLLOW-UP; EXERCISE-INDUCED HYPERTENSION; AMBULATORY
   BLOOD-PRESSURE; CONGENITAL HEART-DISEASE; LEFT-VENTRICULAR MASS; PATCH
   AORTOPLASTY REPAIR; BALLOON ANGIOPLASTY; NATIVE COARCTATION; SURGICAL
   REPAIR; SYSTOLIC HYPERTENSION
AB Survival of patients with aortic coarctation has dramatically improved after surgical repair became available and the number of patients who were operated and reach adulthood is steadily increasing. However, life expectancy is still not as normal as in unaffected peers. Cardiovascular complications are frequent and require indefinite follow-up. Concern falls chiefly in seven categories: recoarctation, aortic aneurysm formation or aortic dissection, coexisting bicuspid aortic valve, endocarditis, premature coronary atherosclerosis, cerebrovascular accidents and systemic hypertension. In this review, these complications, with particular reference to late hypertension, are discussed and strategies for the clinical management of post-coarctectomy patients are described. &COPY; 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands.
RP Mulder, BJM (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Room B2-239,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM B.J.Mulder@amc.uva.nl
CR Allison TG, 1999, AM J CARDIOL, V83, P371, DOI 10.1016/S0002-9149(98)00871-6
   ANYANWU E, 1981, ATHEROSCLEROSIS, V39, P367, DOI 10.1016/0021-9150(81)90023-X
   Aris A, 1999, ANN THORAC SURG, V67, P1376, DOI 10.1016/S0003-4975(99)00266-0
   ATTENHOFFER JCH, 2002, MAYO CLIN P, V77, P646
   Bacha EA, 2001, ANN THORAC SURG, V71, P1260, DOI 10.1016/S0003-4975(00)02664-3
   Bauer M, 2001, ANN THORAC SURG, V72, P2060, DOI 10.1016/S0003-4975(01)03094-6
   Bauer M, 2002, ANN THORAC SURG, V74, P58, DOI 10.1016/S0003-4975(02)03650-0
   BEAUCHESNE LM, 2001, CIRCULATION, V50, P456
   Beauchesne LM, 2001, J AM COLL CARDIOL, V38, P1728, DOI 10.1016/S0735-1097(01)01617-5
   BEEKMAN RH, 1983, AM J CARDIOL, V52, P112, DOI 10.1016/0002-9149(83)90080-2
   Bhat MA, 2001, BRIT J SURG, V88, P536, DOI 10.1046/j.1365-2168.2001.01745.x
   Bjork VO, 1978, ADV CARDIOL, V22, P205
   BOGAERT J, 1995, J AM COLL CARDIOL, V26, P521, DOI 10.1016/0735-1097(95)80032-C
   Bonderman D, 1999, CIRCULATION, V99, P2138
   Bouchart F, 2000, ANN THORAC SURG, V70, P1483, DOI 10.1016/S0003-4975(00)01999-8
   British Cardiac Society Working Cardiac Party, 2002, HEART, V88, pi1
   BROMBERG BI, 1989, J AM COLL CARDIOL, V14, P734
   BROUWER RMHJ, 1994, J THORAC CARDIOV SUR, V108, P525
   CAMPBELL M, 1970, BRIT HEART J, V32, P633
   CHAN KC, 1992, BRIT HEART J, V68, P192
   CLARKSON PM, 1985, AM J CARDIOL, V56, P342, DOI 10.1016/0002-9149(85)90861-6
   COHEN M, 1989, CIRCULATION, V80, P840
   COKKINOS DV, 1979, J THORAC CARDIOV SUR, V77, P315
   Connelly MS, 1998, CAN J CARDIOL, V14, P395
   CORONE P, 1989, ARCH MAL COEUR VAISS, V82, P779
   CRAFOORD C, 1945, J THORAC SURG, V14, P347
   Cyran Stephen E., 1993, American Journal of Cardiology, V71, P963, DOI 10.1016/0002-9149(93)90915-Y
   Daniels SR, 2001, LANCET, V358, P89, DOI 10.1016/S0140-6736(01)05378-8
   de Divitiis M, 2003, J AM COLL CARDIOL, V41, P2259, DOI 10.1016/S0735-1097(03)00480-7
   de Divitiis M, 2001, CIRCULATION, V104, pI165
   DEGEVIGNEY G, 1995, EUR HEART J, V16, P7
   deGiovanni JV, 1996, AM J CARDIOL, V77, P435, DOI 10.1016/S0002-9149(97)89381-2
   De Mey S, 2001, J BIOMECH, V34, P951, DOI 10.1016/S0021-9290(01)00043-4
   Dodge-Khatami A, 2000, J CARDIAC SURG, V15, P369
   EDWARDS WD, 1978, CIRCULATION, V57, P1022
   Ergin MA, 1999, ANN THORAC SURG, V67, P1834, DOI 10.1016/S0003-4975(99)00439-7
   Fawzy ME, 1997, J AM COLL CARDIOL, V30, P1542, DOI 10.1016/S0735-1097(97)00350-1
   Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8
   FLETCHER SE, 1995, J AM COLL CARDIOL, V25, P730, DOI 10.1016/0735-1097(94)00437-U
   Franklin SS, 1997, CIRCULATION, V96, P308
   FREED MD, 1979, AM J CARDIOL, V43, P253, DOI 10.1016/S0002-9149(79)80012-0
   GARDINER HM, 1994, CIRCULATION, V89, P1745
   GIDDING SS, 1985, CIRCULATION, V71, P495
   Greenberg SB, 1997, PEDIATR CARDIOL, V18, P345, DOI 10.1007/s002469900196
   GUENTHARD J, 1995, AM J CARDIOL, V75, P814, DOI 10.1016/S0002-9149(99)80418-4
   Hamdan MA, 2001, J AM COLL CARDIOL, V38, P1518, DOI 10.1016/S0735-1097(01)01572-8
   Hauser M, 2003, HEART, V89, P125, DOI 10.1136/heart.89.2.125
   Ho S Y, 1979, Br Heart J, V41, P268
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   Hornung T S, 2002, Cardiol Rev, V10, P139, DOI 10.1097/00045415-200205000-00002
   Ing FF, 1996, PEDIATRICS, V98, P378
   KAPPETEIN AP, 1991, SURG CORRECTION COAR
   KIRKLIN JW, 1992, CARDIAC SURGERY COAR
   Knyshov GV, 1996, ANN THORAC SURG, V61, P935, DOI 10.1016/0003-4975(95)01189-7
   KOLLER M, 1987, EUR HEART J, V8, P670
   KROGMANN ON, 1993, J AM COLL CARDIOL, V21, P1454
   LABABIDI Z, 1983, AM HEART J, V106, P752, DOI 10.1016/0002-8703(83)90098-4
   LEANDRO J, 1992, J AM COLL CARDIOL, V20, P197
   Liddicoat J E, 1975, Circulation, V52, pI202
   Lim DS, 2002, ECHOCARDIOGR-J CARD, V19, P55, DOI 10.1046/j.1540-8175.2002.00055.x
   MARKEL H, 1986, J AM COLL CARDIOL, V8, P165
   McCrindle BW, 1996, J AM COLL CARDIOL, V28, P1810
   MENDELSOHN AM, 1994, AM J CARDIOL, V74, P696, DOI 10.1016/0002-9149(94)90312-3
   MOLLER JH, 1992, AM J CARDIOL, V70, P661, DOI 10.1016/0002-9149(92)90209-H
   Morris CD, 1998, JAMA-J AM MED ASSOC, V279, P599, DOI 10.1001/jama.279.8.599
   Mullen MJ, 2003, HEART, V89, P3, DOI 10.1136/heart.89.1.3
   Nistri S, 2002, J HEART VALVE DIS, V11, P369
   Nkomo VT, 2003, ARTERIOSCL THROM VAS, V23, P351, DOI 10.1161/01.ATV.0000055441.28842.0A
   ONG CM, 1992, AM HEART J, V123, P1594, DOI 10.1016/0002-8703(92)90815-D
   O'Sullivan JJ, 2002, HEART, V88, P163, DOI 10.1136/heart.88.2.163
   Ovaert C, 1998, PEDIATR CARDIOL, V19, P27, DOI 10.1007/s002469900243
   Papademetriou V, 2003, AM J CARDIOL, V91, P433, DOI 10.1016/S0002-9149(02)03239-3
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   PELECH AN, 1986, AM HEART J, V112, P1263, DOI 10.1016/0002-8703(86)90358-3
   PRESBITERO P, 1987, BRIT HEART J, V57, P462
   Rao PS, 1996, J AM COLL CARDIOL, V27, P462, DOI 10.1016/0735-1097(95)00479-3
   REDINGTON AN, 1993, BRIT HEART J, V69, P80
   Rosenthal E, 2001, J AM COLL CARDIOL, V38, P1524, DOI 10.1016/S0735-1097(01)01573-X
   Russo CF, 2002, ANN THORAC SURG, V74, pS1773, DOI 10.1016/S0003-4975(02)04261-3
   SEHESTED J, 1982, CIRCULATION, V65, P1060
   Seirafi PA, 1998, ANN THORAC SURG, V66, P1378, DOI 10.1016/S0003-4975(98)00595-5
   SERIZAWA T, 1992, Neurologia Medico-Chirurgica, V32, P342, DOI 10.2176/nmc.32.342
   SHADDY RE, 1993, CIRCULATION, V87, P793
   Sharabi Y, 2001, J HUM HYPERTENS, V15, P353, DOI 10.1038/sj.jhh.1001157
   Siblini G, 1998, AM J CARDIOL, V81, P61, DOI 10.1016/S0002-9149(97)00805-9
   Sigurdardottir LY, 1996, PEDIATR CARDIOL, V17, P301, DOI 10.1007/s002469900066
   SIMON AB, 1974, CIRCULATION, V50, P456
   SIMSOLO R, 1988, AM HEART J, V115, P1268, DOI 10.1016/0002-8703(88)90020-8
   Singh JP, 1999, CIRCULATION, V99, P1831
   Siu SC, 2001, HEART, V85, P710, DOI 10.1136/heart.85.6.710
   Spaanderman MEA, 2000, AM J OBSTET GYNECOL, V183, P1278, DOI 10.1067/mob.2000.106750
   Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539
   Staessen J A, 1999, Blood Press Monit, V4, P319, DOI 10.1097/00126097-199912000-00005
   Swan L, 2003, HEART, V89, P189, DOI 10.1136/heart.89.2.189
   Swan L, 1998, EUR HEART J, V19, P382, DOI 10.1053/euhj.1997.0557
   Swan L, 2002, LANCET, V359, P977, DOI 10.1016/S0140-6736(02)08000-5
   Tantengco MVT, 1997, AM HEART J, V134, P1082, DOI 10.1016/S0002-8703(97)70029-2
   Therrien J, 2000, J AM COLL CARDIOL, V35, P997, DOI 10.1016/S0735-1097(99)00653-1
   Therrien J, 2001, CAN J CARDIOL, V17, P1029
   Toro-Salazar OH, 2002, AM J CARDIOL, V89, P541, DOI 10.1016/S0002-9149(01)02293-7
   Towbin JA, 2000, AM J MED GENET, V97, P297, DOI 10.1002/1096-8628(200024)97:4<297::AID-AJMG1280>3.0.CO;2-O
   von Kodolitsch Y, 2002, J AM COLL CARDIOL, V39, P617, DOI 10.1016/S0735-1097(01)01784-3
   Walhout RJ, 2002, AM HEART J, V144, P180, DOI 10.1067/mhj.2002.123109
   Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81
   WARD KE, 1990, PEDIATRICS, V86, P972
   WEBER HS, 1993, J AM COLL CARDIOL, V21, P1002
   Wells WJ, 1996, ANN THORAC SURG, V61, P1168, DOI 10.1016/0003-4975(96)00008-2
   Yetman AT, 1997, J AM COLL CARDIOL, V30, P811, DOI 10.1016/S0735-1097(97)00228-3
   Younoszai AK, 2002, ANN THORAC SURG, V74, P1631, DOI 10.1016/S0003-4975(02)03902-4
   Zabal C, 2003, HEART, V89, P77, DOI 10.1136/heart.89.1.77
NR 110
TC 55
Z9 56
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD JUN 8
PY 2005
VL 101
IS 3
BP 399
EP 406
DI 10.1016/j.ijcard.2004.03.056
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 932LD
UT WOS:000229554300009
PM 15907407
ER

PT J
AU Storey, MR
   Landgren, RC
   Cottone, JL
   Stallings, JW
   Logan, CW
   Fraiser, LP
   Ross, CS
   Kock, RJ
   Berkley, LW
   Hauer-Jensen, M
AF Storey, MR
   Landgren, RC
   Cottone, JL
   Stallings, JW
   Logan, CW
   Fraiser, LP
   Ross, CS
   Kock, RJ
   Berkley, LW
   Hauer-Jensen, M
TI Transperineal (125)iodine implantation for treatment of clinically
   localized prostate cancer: 5-year tumor control and morbidity
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; transperineal implants; community results
ID RADICAL PROSTATECTOMY; ANTIGEN; ADENOCARCINOMA; EXPERIENCE; CARCINOMA;
   PSA
AB Purpose: To evaluate the efficacy and toxicity of transperineal I-125 implants for clinically localized prostate cancer in elderly men in a community cancer setting.
   Methods and Materials: From 1988 to 1993, 206 patients, median age 77 years, with localized (Stage T1 and T2), low-grade (Gleason score less than or equal to 7) prostate cancer were treated using pre-planned I-125 transperineal implants. Patients were followed for biochemical freedom from disease, overall survival, and treatment-associated morbidity.
   Results: The 5-year actuarial biochemical freedom from failure rate for all patients available for follow-up was 63%. Specifically, biochemical freedom from failure was 76% in patients with pretreatment PSA less than or equal to 10 ng/ml, compared to 51% of patients with values > 10 ng/ml (median observation time 35 months). Actuarial freedom from failure for patients with PSA less than or equal to 4 ng/ml was 84%. Stage and Gleason score did not predict outcome. PSA nadir was the strongest predictor of long-term biochemical disease-free survival (p < 0.001) with only 2 failures in 62 patients who achieved a posttreatment PSA nadir less than or equal to 0.5 ng/ml.
   Conclusion: Transperineal 125I implants for early prostate cancer are efficacious and feasible for certain populations of elderly patients with favorable prognostic indicators in the community canter setting. Patients with poor prognostic indicators at diagnosis do not appear to be candidates for treatment with implant alone. (C) 1999 Elsevier Science Inc.
C1 Univ Texas, MD Anderson Cancer Ctr, Div Radiotherapy, Houston, TX 77030 USA.
   Radiat Oncol Associates PA, Little Rock, AR USA.
   Urol Associates, Little Rock, AR USA.
   Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
   Cent Arkansas Radiat Therapy Inst, Little Rock, AR USA.
RP Storey, MR (reprint author), Univ Texas, MD Anderson Cancer Ctr, Div Radiotherapy, Box 97,1515 Holcombe Blvd, Houston, TX 77030 USA.
EM mstorey@wans.net
CR Altman DG, 1991, PRACTICAL STAT MED R, P179
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko JC, 1987, ENDOCURIETHER HYPERT, V3, P131
   COX DR, 1984, ANAL SURVIVAL DATA, P110
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E
   HARRIS EK, 1991, SURVIVORSHIP ANAL CL, P5
   JONLER M, 1994, BRIT J UROL, V74, P352, DOI 10.1111/j.1464-410X.1994.tb16626.x
   KILLIAN CS, 1985, CANCER RES, V45, P886
   KUPELIAN P, 1996, P ANN M AM SOC CLIN, V15, pA16
   Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6
   MURPHY GP, 1995, J UROLOGY, V154, P1100
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   Prestidge BR, 1998, INT J RADIAT ONCOL, V40, P1111, DOI 10.1016/S0360-3016(97)00947-4
   RAINWATER LM, 1990, MAYO CLIN PROC, V65, P1118
   Roach Mack Iii, 1996, International Journal of Radiation Oncology Biology Physics, V36, P248, DOI 10.1016/S0360-3016(97)85520-4
   RUSSELL KJ, 1993, PROBLEMS UROLOGY, V7, P260
   STAMEY TA, 1989, J UROLOGY, V141, P1070
   STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Willins J, 1997, INT J RADIAT ONCOL, V39, P347, DOI 10.1016/S0360-3016(97)00322-2
   ZAGARS GK, 1995, UROLOGY, V45, P476, DOI 10.1016/S0090-4295(99)80019-3
NR 24
TC 55
Z9 58
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD FEB 1
PY 1999
VL 43
IS 3
BP 565
EP 570
DI 10.1016/S0360-3016(98)00451-9
PG 6
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 172FA
UT WOS:000078911600015
PM 10078638
ER

PT J
AU Ovaert, C
   Benson, LN
   Nykanen, D
   Freedom, RM
AF Ovaert, C
   Benson, LN
   Nykanen, D
   Freedom, RM
TI Transcatheter treatment of coarctation of the aorta: A review
SO PEDIATRIC CARDIOLOGY
LA English
DT Review
ID BALLOON DILATION ANGIOPLASTY; TRANS-LUMINAL ANGIOPLASTY; CONGENITAL
   HEART-DISEASE; TERM FOLLOW-UP; PATCH AORTOPLASTY REPAIR; 1ST 3 MONTHS;
   NATIVE COARCTATION; SURGICAL REPAIR; PERCUTANEOUS ANGIOPLASTY; RECURRENT
   COARCTATION
C1 Univ Toronto, Hosp Sick Children, Sch Med, Div Cardiol, Toronto, ON M5G 1X8, Canada.
RP Benson, LN (reprint author), Univ Toronto, Hosp Sick Children, Sch Med, Div Cardiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
CR ALAKULJU K, 1989, ANN THORAC SURG, V47, P853
   ALEXANDER B, 1769, SEATS CAUSES DIS INV
   ALLEN HD, 1986, AM J CARDIOL, V57, P828, DOI 10.1016/0002-9149(86)90622-3
   ANJOS R, 1992, AM J CARDIOL, V69, P665, DOI 10.1016/0002-9149(92)90161-Q
   ATTIA IM, 1988, AM HEART J, V116, P1623, DOI 10.1016/0002-8703(88)90752-1
   ATTIA IM, 1988, AM J CARDIOL, V61, P930, DOI 10.1016/0002-9149(88)90379-7
   AYDOGAN U, 1995, CATHETER CARDIO DIAG, V36, P226, DOI 10.1002/ccd.1810360307
   BALAJI S, 1991, BRIT HEART J, V65, P100
   BANK ER, 1987, RADIOLOGY, V162, P235
   Beekman R, 1988, J INTERV CARDIOL, V1, P137, DOI 10.1111/j.1540-8183.1988.tb00398.x
   BEEKMAN RH, 1986, J AM COLL CARDIOL, V8, P1406
   BEEKMAN RH, 1987, J AM COLL CARDIOL, V10, P1078
   BEEKMAN RH, 1981, AM J CARDIOL, V48, P1108, DOI 10.1016/0002-9149(81)90328-3
   BENSON LN, 1986, CARDIOVASC INTER RAD, V9, P184, DOI 10.1007/BF02577937
   BRANDT B, 1987, J THORAC CARDIOV SUR, V94, P715
   BREWER LA, 1972, J THORAC CARDIOV SUR, V64, P368
   BROMBERG BI, 1989, J AM COLL CARDIOL, V14, P734
   BROUWER RMHJ, 1994, J THORAC CARDIOV SUR, V108, P525
   Bulbul ZR, 1996, CATHETER CARDIO DIAG, V39, P36, DOI 10.1002/(SICI)1097-0304(199609)39:1<36::AID-CCD7>3.0.CO;2-3
   BURROWS PE, 1990, CIRCULATION, V82, P1868
   BURROWS PE, 1994, CIRCULATION, V90, P915
   CAMPBELL M, 1970, BRIT HEART J, V32, P633
   CASTANEDAZUNIGA WR, 1982, RADIOLOGY, V143, P693
   CHOY M, 1987, CIRCULATION, V75, P1186
   CLARKSON PM, 1983, AM J CARDIOL, V51, P1481, DOI 10.1016/0002-9149(83)90661-6
   COHEN M, 1989, CIRCULATION, V80, P840
   COLES JG, 1995, J THORAC CARDIOV SUR, V110, P1513, DOI 10.1016/S0022-5223(95)70075-7
   CONTE S, 1995, J THORAC CARDIOV SUR, V109, P663, DOI 10.1016/S0022-5223(95)70347-0
   COOPER RS, 1987, CIRCULATION, V75, P600
   COOPER RS, 1984, CIRCULATION, V70, P903
   COOPER SG, 1989, J AM COLL CARDIOL, V14, P413, DOI 10.1016/0735-1097(89)90195-2
   CRAFOORD C, 1945, J THORAC SURG, V14, P347
   deGiovanni JV, 1996, AM J CARDIOL, V77, P435, DOI 10.1016/S0002-9149(97)89381-2
   DELEZO JS, 1995, AM HEART J, V129, P1002
   DELEZO JS, 1989, J AM COLL CARDIOL, V13, P689
   DELEZO JS, 1984, AM J CARDIOL, V54, P1147
   DSOUZA VJ, 1984, AM J CARDIOL, V54, P457, DOI 10.1016/0002-9149(84)90224-8
   EDWARDS JE, 1948, P STAFF M MAYO CLIN, V23, P324
   ERBEL R, 1990, CIRCULATION, V81, P805
   ERGINA PL, 1992, ANN THORAC SURG, V54, P599
   FAWZY ME, 1992, AM HEART J, V124, P167, DOI 10.1016/0002-8703(92)90936-P
   FINLEY JP, 1983, BRIT HEART J, V50, P411
   FLETCHER SE, 1995, J AM COLL CARDIOL, V25, P730, DOI 10.1016/0735-1097(94)00437-U
   FOGELMAN R, 1995, CIRCULATION, V92, P881
   FONTES VF, 1990, INT J CARDIOL, V27, P311, DOI 10.1016/0167-5273(90)90286-E
   GARDINER HM, 1994, CIRCULATION, V89, P1745
   GIDDING SS, 1985, CIRCULATION, V71, P495
   GOODALL M, 1969, CIRCULATION, V39, P345
   Guerit JM, 1996, EUR J CARDIO-THORAC, V10, P93, DOI 10.1016/S1010-7940(96)80130-8
   Hanley FL, 1996, J AM COLL CARDIOL, V27, P471, DOI 10.1016/0735-1097(95)00547-1
   Harrison DA, 1996, CAN J CARDIOL, V12, P965
   HARRISON JK, 1990, J AM COLL CARDIOL, V15, P906
   HELLENBRAND WE, 1990, AM J CARDIOL, V65, P793, DOI 10.1016/0002-9149(90)91390-R
   HESS J, 1986, BRIT HEART J, V55, P459
   HIJAZI ZM, 1991, CIRCULATION, V84, P1150
   HIJAZI ZM, 1995, J INTERV CARDIOL, V8, P509, DOI 10.1111/j.1540-8183.1995.tb00579.x
   HO SY, 1995, COLOR ATLAS CONGENIT
   Ho S Y, 1979, Br Heart J, V41, P268
   HO SY, 1988, INT J CARDIOL, V19, P99, DOI 10.1016/0167-5273(88)90195-7
   HUGGON IC, 1994, PEDIATR CARDIOL, V15, P313, DOI 10.1007/BF00798127
   HUGGON IC, 1994, AM J CARDIOL, V73, P799, DOI 10.1016/0002-9149(94)90884-2
   ISNER JM, 1987, CIRCULATION, V75, P689
   JAIN A, 1992, AM HEART J, V123, P514, DOI 10.1016/0002-8703(92)90668-L
   JOHNSON MC, 1993, AM HEART J, V125, P464, DOI 10.1016/0002-8703(93)90027-7
   JOHNSON MC, 1994, J AM COLL CARDIOL, V24, P1589
   JONAS RA, 1991, ANN THORAC SURG, V52, P604
   Kaine SF, 1996, CIRCULATION, V94, P1056
   Kale P A, 1992, Indian Heart J, V44, P207
   KAN JS, 1983, CIRCULATION, V68, P1087
   KAPPETEIN AP, 1994, J THORAC CARDIOV SUR, V107, P87
   Kashani IA, 1996, CATHETER CARDIO DIAG, V38, P406, DOI 10.1002/(SICI)1097-0304(199608)38:4<406::AID-CCD18>3.0.CO;2-C
   KIRKLIN JW, 1992, CARDIAC SURG, P1263
   KOCIS KC, 1995, AM J CARDIOL, V75, P642, DOI 10.1016/S0002-9149(99)80640-7
   KRABILL KA, 1987, PEDIATR CARDIOL, V8, P39, DOI 10.1007/BF02308383
   Lababidi Z, 1992, J Interv Cardiol, V5, P57, DOI 10.1111/j.1540-8183.1992.tb00825.x
   LABABIDI Z, 1984, AM J CARDIOL, V53, P350, DOI 10.1016/0002-9149(84)90461-2
   LABABIDI Z, 1983, AM HEART J, V106, P752, DOI 10.1016/0002-8703(83)90098-4
   LABABIDI ZA, 1984, AM J CARDIOL, V54, P1288, DOI 10.1016/S0002-9149(84)80083-1
   LEANDRO J, 1992, CHILD NEPHROL UROL, V12, P124
   LEANDRO J, 1992, J AM COLL CARDIOL, V20, P197
   LEWIS AB, 1988, AM J CARDIOL, V62, P649, DOI 10.1016/0002-9149(88)90675-3
   LINDSAY J, 1988, AM J CARDIOL, V61, P182, DOI 10.1016/0002-9149(88)91327-6
   LO RNS, 1989, AM HEART J, V117, P1157, DOI 10.1016/0002-8703(89)90878-8
   LOCK JE, 1983, CIRCULATION, V68, P109
   LOCK JE, 1982, CIRCULATION, V66, P1280
   LOCK JE, 1984, AM J CARDIOL, V54, P1360, DOI 10.1016/S0002-9149(84)80098-3
   LOCK JE, 1982, RADIOLOGY, V143, P689
   MANALOES.P, 1967, ARCH PATHOL, V83, P336
   MARTIN MM, 1988, AM J CARDIOL, V61, P951, DOI 10.1016/0002-9149(88)90390-6
   MCCRINDLE BW, 1996, J AM COLL CARDIOL, V28
   MENDELSOHN AM, 1994, AM J CARDIOL, V74, P696, DOI 10.1016/0002-9149(94)90312-3
   Mendelsohn AM, 1996, CATHETER CARDIO DIAG, V38, P430, DOI 10.1002/(SICI)1097-0304(199608)38:4<430::AID-CCD24>3.0.CO;2-H
   MENDELSON AM, 1995, J INTERV CARDIOL, V8, P487, DOI 10.1111/j.1540-8183.1995.tb00578.x
   MERRILL WH, 1994, ANN THORAC SURG, V58, P399
   MINICH LL, 1992, J AM COLL CARDIOL, V19, P389
   MOHIADDIN RH, 1993, CIRCULATION, V88, P264
   MORROW WR, 1993, J AM COLL CARDIOL, V22, P2007
   MORROW WR, 1994, CIRCULATION, V89, P2677
   MORROW WR, 1988, J AM COLL CARDIOL, V11, P133
   NANTON MA, 1976, AM J CARDIOL, V37, P769, DOI 10.1016/0002-9149(76)90373-8
   OLAUGHLIN MP, 1993, CIRCULATION, V88, P605
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923
   Ozdil E, 1996, CIRCULATION, V93, P1940
   PALMAZ JC, 1988, AM J ROENTGENOL, V150, P1263
   PARKER F B JR, 1982, Circulation, V66, P513
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   PELECH AN, 1986, AM HEART J, V112, P1263, DOI 10.1016/0002-8703(86)90358-3
   PELLEGRINO A, 1985, J THORAC CARDIOV SUR, V89, P121
   PHADKE K, 1993, BRIT HEART J, V69, P36
   PIECHAUD JF, 1995, ARCH MAL COEUR VAISS, V88, P711
   PINZON JL, 1991, RADIOLOGY, V180, P199
   POLLACK P, 1983, AM J CARDIOL, V51, P1690, DOI 10.1016/0002-9149(83)90211-4
   QUAEGEBEUR JM, 1994, J THORAC CARDIOV SUR, V108, P841
   RALPHEDWARDS AC, 1995, ANN THORAC SURG, V60, P1303, DOI 10.1016/0003-4975(95)00619-V
   RAO PS, 1988, AM HEART J, V116, P1558, DOI 10.1016/0002-8703(88)90743-0
   Rao PS, 1996, AM HEART J, V132, P403
   RAO PS, 1995, BRIT HEART J, V74, P578
   RAO PS, 1994, J AM COLL CARDIOL, V23, P1479
   RAO PS, 1993, AM HEART J, V125, P1205, DOI 10.1016/0002-8703(93)90150-8
   Rao PS, 1996, J AM COLL CARDIOL, V27, P462, DOI 10.1016/0735-1097(95)00479-3
   RAO PS, 1989, J AM COLL CARDIOL, V14, P1312
   RAO PS, 1990, AM HEART J, V120, P1315, DOI 10.1016/0002-8703(90)90242-P
   RAO PS, 1995, AM HEART J, V130, P116, DOI 10.1016/0002-8703(95)90245-7
   RAO PS, 1991, ANN THORAC SURG, V52, P621
   RAO PS, 1986, BRIT HEART J, V56, P250
   RAO PS, 1990, AM HEART J, V120, P1310, DOI 10.1016/0002-8703(90)90241-O
   RAO PS, 1992, AM HEART J, V124, P1622, DOI 10.1016/0002-8703(92)90082-7
   Rao PS, 1996, J INVASIVE CARDIOL, V8, P301
   RAO PS, 1989, J AM COLL CARDIOL, V13, P109
   RAO PS, 1989, AM HEART J, V117, P987, DOI 10.1016/0002-8703(89)90645-5
   RAO PS, 1988, AM HEART J, V115, P657, DOI 10.1016/0002-8703(88)90817-4
   REDINGTON A, 1993, AM HEART J, V126, P1492, DOI 10.1016/0002-8703(93)90566-R
   REDINGTON AN, 1990, INT J CARDIOL, V27, P317, DOI 10.1016/0167-5273(90)90287-F
   REDINGTON AN, 1990, BRIT HEART J, V64, P277
   REDINGTON AN, 1993, BRIT HEART J, V69, P80
   RITTER SB, 1989, J AM COLL CARDIOL, V13, P696
   ROBERTS DH, 1993, AM HEART J, V125, P1181, DOI 10.1016/0002-8703(93)90139-Z
   Rocchini Albert P., 1993, Current Opinion in Pediatrics, V5, P611, DOI 10.1097/00008480-199310000-00016
   ROCCHINI AP, 1976, CIRCULATION, V54, P382
   ROTHMAN A, 1992, CIRCULATION, V85, P2291
   RUBAY JE, 1992, J CARDIOVASC SURG, V33, P216
   Ruiz CE, 1996, CATHETER CARDIO DIAG, V39, P43
   RUSSELL GA, 1991, J THORAC CARDIOV SUR, V102, P596
   SALAHUDDIN N, 1991, AM HEART J, V122, P1772, DOI 10.1016/0002-8703(91)90300-7
   SAUL JP, 1987, AM J CARDIOL, V59, P943, DOI 10.1016/0002-9149(87)91130-1
   SAWADA S, 1994, CARDIOVASC INTER RAD, V17, P102
   SCHATZ RA, 1987, CIRCULATION, V76, P450
   SHADDY RE, 1993, CIRCULATION, V87, P793
   SHRADER R, 1995, CATHET CARDIOVASC DI, V36, P220
   SINGER MI, 1982, AM HEART J, V103, P131, DOI 10.1016/0002-8703(82)90539-7
   SOHN SJ, 1994, CIRCULATION, V90, P340
   SOS T, 1979, LANCET, V2, P970
   SOULEN RL, 1987, AM J CARDIOL, V60, P343, DOI 10.1016/0002-9149(87)90239-6
   SPERLING DR, 1983, AM J CARDIOL, V51, P562, DOI 10.1016/S0002-9149(83)80097-6
   STEWART GW, 1994, ARCH PHYS MED REHAB, V75, P921, DOI 10.1016/0003-9993(94)90119-8
   TYAGI S, 1992, AM HEART J, V123, P674, DOI 10.1016/0002-8703(92)90505-P
   TYAGI S, 1993, AM HEART J, V125, P1386, DOI 10.1016/0002-8703(93)91012-4
   TYNAN M, 1990, AM J CARDIOL, V65, P790, DOI 10.1016/0002-9149(90)91389-N
   VANHEURN LWE, 1994, J THORAC CARDIOV SUR, V107, P74
   VERMILION RP, 1993, PEDIATR CARDIOL, V14, P13
   VEYRE P, 1994, ARCH MAL COEUR, V86, P581
   WALDMAN JD, 1993, CIRCULATION, V87, P1043
   Weber HS, 1996, PEDIATR CARDIOL, V17, P184, DOI 10.1007/BF02505210
   WITSENBURG M, 1993, BRIT HEART J, V70, P170
   WORMS AM, 1993, ARCH MAL COEUR VAISS, V86, P573
   WREN C, 1987, BRIT HEART J, V58, P369
   YETMAN A, 1996, IN PRESS J AM COLL C
   ZEHR KJ, 1995, ANN THORAC SURG, V59, P33, DOI 10.1016/0003-4975(94)00825-R
NR 168
TC 55
Z9 56
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0172-0643
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD JAN-FEB
PY 1998
VL 19
IS 1
BP 27
EP 44
DI 10.1007/s002469900243
PG 18
WC Cardiac & Cardiovascular Systems; Pediatrics
SC Cardiovascular System & Cardiology; Pediatrics
GA YL769
UT WOS:000070991000009
PM 9396847
ER

PT J
AU Witte, MH
   Jones, K
   Wilting, J
   Dictor, M
   Selg, M
   McHale, N
   Gershenwald, JE
   Jackson, DG
AF Witte, MH
   Jones, K
   Wilting, J
   Dictor, M
   Selg, M
   McHale, N
   Gershenwald, JE
   Jackson, DG
TI Structure function relationships in the lymphatic system and
   implications for cancer biology
SO CANCER AND METASTASIS REVIEWS
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Cancer Metastasis and the Lymphovascular
   System
CY APR 28-30, 2005
CL San Francisco, CA
DE lymphatic system; structure-function; cancer biology; metastasis;
   lymphatic embryology; stem cells; lymphatic contractility; lymphatic
   endothelium; sentinel nodes; lymphatic markers; tumor lymphangiogenesis
ID ENDOTHELIAL GROWTH-FACTOR; LYMPHEDEMA-DISTICHIASIS SYNDROME; BOVINE
   MESENTERIC LYMPHATICS; TRANSCRIPTION FACTOR; FACTOR-C; TUMOR
   LYMPHANGIOGENESIS; HEREDITARY LYMPHEDEMA; ANESTHETIZED SHEEP;
   BREAST-CANCER; THORACIC-DUCT
AB The lymphatic system, composed of lymphatic vessels, lymph, lymph nodes, and lymphocytes, is a distinctive vasculature (discontinuous basement membrane, open endothelial junctions, anchoring filaments, valves, and intrinsic contractility), different yet similar to the blood vasculature; an integral component of the plasma-tissue fluid-lymph circulation (the "blood-lymph loop"); and the center of the immunoregulatory network. Lymphatics are involved in diverse developmental, growth, repair, and pathologic processes both analogous to and distinct from those affecting the blood vasculature. Interference with the blood-lymph loop produces swelling [an imbalance between lymph formation (regulated by Starling's law of transcapillary fluid exchange) and lymph absorption], scarring, nutritional and immunodysregulatory disorders, as well as disturbances in lymph(hem)angiogenesis (lymphedema-angiodysplasia syndromes). The lymphatic system is also the stage on which key events during cancer development and progression are played out, and historically, also forms the basis for current evaluation, prognostication, and/or both operative and non-operative treatment of most cancers. Recent advances in molecular lymphology (e.g., discovery of lymphatic growth factors, endothelial receptors, transcription factors, genes, and highly specific immunohistochemical markers) and growing interest in lymphangiogenesis, combined with fresh insights and refined tools in clinical lymphology, including non-invasive lymphatic imaging, are opening up a window for translation to the clinical arena. Therefore, in cancer biology, attention to the multifaceted structure-function relationships within this vast, relatively unexplored system is long overdue.
C1 Univ Arizona, Dept Surg, Tucson, AZ 85721 USA.
   Univ Utah, Dept Med Oncol, Salt Lake City, UT USA.
   Univ Gottingen, Dept Pediat, D-3400 Gottingen, Germany.
   Univ Lund Hosp, Dept Pathol, S-22185 Lund, Sweden.
   Univ Lund Hosp, Dept Expt Pathol, S-22185 Lund, Sweden.
   Dundalk Inst Technol, Smooth Muscle Res Ctr, Dundalk, Ireland.
   Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.
   Univ Oxford, John Radcliffe Hosp, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England.
RP Witte, MH (reprint author), Univ Arizona, Dept Surg, Tucson, AZ 85721 USA.
EM lymph@u.arizona.edu; kimberlyannejones@yahoo.com;
   joerg.wilting@med.uni-goettingen.de; michael.dictor@med.lu.se;
   m.self@fh-weks.at; n.mchale@qub.ac.uk; jgershen@mdanderson.org;
   djackson@hammer.imm.ox.ac.uk
CR Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017
   Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548
   Adair TH, 1985, EXPT BIOL LYMPHATIC, P13
   ADAIR TH, 1982, AM J PHYSIOL, V243, pH351
   ALESSANDRINI C, 1981, LYMPHOLOGY, V14, P1
   Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X
   ALLEN JM, 1988, PFLUG ARCH EUR J PHY, V411, P167, DOI 10.1007/BF00582310
   ASELLIUS G, 1927, LACTIBUS SIVE LACTEI
   Azzali G, 2003, INT REV CYTOL, V230, P41, DOI 10.1016/S0074-7696(03)30002-6
   Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   Beasley NJP, 2002, CANCER RES, V62, P1315
   Bono P, 2004, CLIN CANCER RES, V10, P7144, DOI 10.1158/1078-0432.CCR-03-0826
   BOWMAN CA, 1984, LYMPHOLOGY, V17, P15
   Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6
   Breiteneder-Geleff S, 1999, Verh Dtsch Ges Pathol, V83, P270
   Carleton HM, 1927, P R SOC LOND B-CONTA, V102, P110, DOI 10.1098/rspb.1927.0042
   CASLEYSMITH JR, 1978, TISSUE CELL, V10, P571
   CLARK ER, 1920, CONTR EMBRYOL, V9, P447
   COURTICE FC, 1954, PHYSIOL REV, V34, P419
   Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3
   DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23
   DRINKER CK, 1941, LYMPHATICS LYMPH LYM, P112
   ELIAS RM, 1990, J APPL PHYSIOL, V68, P199
   Evans AL, 1999, AM J HUM GENET, V64, P547, DOI 10.1086/302248
   Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915
   Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073
   Florey H, 1927, J PHYSIOL-LONDON, V63, P1
   FOLDI M, 2003, TXB LYMPHOLOGY PHYS, P689
   FOLDI M, 1972, HDB ALLGEMEINER PA 6, V3, P239
   FOY WL, 1989, PEPTIDES, V10, P533, DOI 10.1016/0196-9781(89)90138-1
   FURUKAWA H, 2004, 2 INT MEL RES C PHOE
   Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4
   GALLAND F, 1992, GENOMICS, V13, P475, DOI 10.1016/0888-7543(92)90277-Y
   GENERISH H, 1971, ARBEITEN P HYSL ANST, V5, P53
   GIRON LT, 1980, ANN NEUROL, V8, P520, DOI 10.1002/ana.410080509
   GNEPP DR, 1985, IN VITRO CELL DEV B, V21, P200
   HEIDENHAIN R, 1891, PFLUGERS ARCH, V49, P209, DOI 10.1007/BF01664719
   HEWSON W, 1774, EXPT ENQUIRIES 2, P126
   Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5
   HOLLYWOOD MA, 1994, J PHYSIOL-LONDON, V481, P415
   Hong YK, 2004, DEV DYNAM, V231, P462, DOI 10.1002/dvdy.20179
   Horstmann E, 1952, MORPHOLOGISCHES JB, V91, P483
   HORSTMANN E, 1959, PFLUG ARCH GES PHYS, V269, P511, DOI 10.1007/BF00362409
   Huntington GS, 1908, ANAT REC, V2, P19, DOI 10.1002/ar.1090020103
   Iida K, 1997, DEVELOPMENT, V124, P4627
   Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614
   Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x
   Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6
   JACOBSSON S, 1964, ACTA PHYSIOL SCAND, V60, P278, DOI 10.1111/j.1748-1716.1964.tb02889.x
   Jain RK, 2002, J NATL CANCER I, V94, P417
   Jeltsch M, 2003, CELL TISSUE RES, V314, P69, DOI 10.1007/s00441-003-0777-2
   JOHNSTON MG, 1984, IN VITRO CELL DEV B, V20, P566
   Joukov V, 1996, EMBO J, V15, P290
   Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599
   KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566
   KAMPMEIER O F, 1969, P620
   Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013
   Karkkainen MJ, 2000, NAT GENET, V25, P153
   KINMONTH JB, 1972, LYMPHATICS DIS LYMPH, P420
   Kriederman BM, 2003, HUM MOL GENET, V12, P1179, DOI 10.1093/hmg/ddg123
   Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797
   LEAK LV, 1994, IN VITRO CELL DEV-AN, V30A, P512
   Leu AJ, 2000, CANCER RES, V60, P4324
   Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762
   Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672
   MAWHINNE.HJ, 1973, J PHYSIOL-LONDON, V229, P339
   McCarrell JD, 1939, AM J PHYSIOL, V127, P154
   McCloskey KD, 1999, J PHYSIOL-LONDON, V521, P201, DOI 10.1111/j.1469-7793.1999.00201.x
   McCloskey KD, 2002, CELL TISSUE RES, V310, P77, DOI 10.1007/s00441-002-0623-y
   MCCULLOUGH JS, 1988, J PHYSIOL-LONDON, V396, pP177
   MCGEOWN JG, 1987, J PHYSIOL-LONDON, V393, P123
   MCGEOWN JG, 1987, J PHYSIOL-LONDON, V387, P83
   MCHALE NG, 1989, CIRC RES, V64, P1165
   MCHALE NG, 1990, EXP PHYSIOL, V75, P847
   McHale NG., 1985, EXPT BIOL LYMPHATIC, P121
   MCHALE NG, 1986, J PHYSIOL-LONDON, V378, P109
   MCHALE NG, 1992, J PHYSIOL-LONDON, V450, P503
   MCHALE NG, 1976, J PHYSIOL-LONDON, V261, P255
   McMaster PD, 1937, J EXP MED, V65, P373, DOI 10.1084/jem.65.3.373
   MORRIS B, 1970, PROGR LYMPHOLOGY, V2, P60
   Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078
   Northup KA, 2003, LYMPHOLOGY, V36, P162
   Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258
   Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420
   PAJUSOLA K, 1994, ONCOGENE, V9, P3545
   PARDANAUD L, 1987, DEVELOPMENT, V100, P339
   PASQUI D, 2005, LYMPHOLOGY, V28, P50
   Pawlik TM, 2004, ANN SURG ONCOL, V11, P362, DOI 10.1245/ASO.2004.08.016
   Pepper MS, 2003, J CELL BIOL, V163, P209, DOI 10.1083/jcb.200308082
   Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470
   Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399
   POPPER P, 1988, PEPTIDES, V9, P257, DOI 10.1016/0196-9781(88)90258-6
   Rousseau DL, 2003, ANN SURG ONCOL, V10, P569, DOI 10.1245/ASO.2003.09.016
   Rubbia-Brandt L, 2004, CLIN CANCER RES, V10, P6919, DOI 10.1158/1078-0432.CCR-04-0397
   RUSZNYAK I, 1960, LYMPHATICS LYMPH CIR, P853
   Sabin FR, 1909, AM J ANAT, V9, P43, DOI 10.1002/aja.1000090104
   Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310
   Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216
   Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342
   SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987
   Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220
   Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013
   Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643
   SMITH RO, 1949, J EXP MED, V90, P497, DOI 10.1084/jem.90.5.497
   Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635
   STARLING EH, 1909, FLUIDS BODY, P81
   Starling EH, 1896, LANCET, Vi, P1267
   THORNBURY KD, 1990, J PHYSIOL-LONDON, V422, P513
   THORNBURY KD, 1990, EXP PHYSIOL, V75, P75
   THUNEBERG L, 1982, MOTILITY DIGESTIVE T, P115
   TODD GL, 1973, ANAT REC, V177, P303, DOI 10.1002/ar.1091770210
   TRIOLO VA, 1965, CANCER RES, V25, P75
   Trojan L, 2004, J UROLOGY, V172, P103, DOI 10.1097/01.ju.0000128860.00639.9c
   VANDERPUTTE SCJ, 1975, ADV ANAT EMBRYOL CEL, V51, P1
   Van Trappen PO, 2003, J PATHOL, V201, P544, DOI 10.1002/path.1467
   Von Marschall Z, 2005, INT J ONCOL, V27, P669
   Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094
   Weninger W, 1999, LAB INVEST, V79, P243
   White JC, 1933, AM J PHYSIOL, V103, P34
   Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1
   Williams CSM, 2003, J PATHOL, V200, P195, DOI 10.1002/path.1343
   WILTING J, 2005, IN PRESS CURR MED CH
   Wilting J, 2001, MICROSC RES TECHNIQ, V55, P59, DOI 10.1002/jemt.1156
   WITTE CL, 1980, GASTROENTEROLOGY, V78, P1059
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   WITTE CL, 2005, VASCULAR SURG, P2379
   Witte MH, 2001, MICROSC RES TECHNIQ, V55, P122, DOI 10.1002/jemt.1163
   Witte MH, 1998, LYMPHOLOGY, V31, P145
   WITTE MH, 1990, WESTERN J MED, V153, P17
   WITTE MH, 2003, TXB LYMPHOLOGY, P471
   Witte MH, 1999, ANTICANCER RES, V19, P4919
   WITTE MH, 1986, LYMPHOLOGY, V19, P21
   WITTE MH, 1969, CIRCULATION, V39, P723
   Witte MH, 1997, REGULATION ANGIOGENE, P65
   WITTE MH, 1997, PROGR LYMPHOLOGY, V16
   YOFFEY J M, 1970, P942
   ZANG ET, 1992, ACTA NEUROPATHOL BER, V83, P233
   ZWEIFACH BW, 1975, AM J PHYSIOL, V228, P1326
   1967, PROGR LYMPHOLOGY
NR 139
TC 54
Z9 61
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-7659
J9 CANCER METAST REV
JI Cancer Metastasis Rev.
PD JUN
PY 2006
VL 25
IS 2
BP 159
EP 184
DI 10.1007/s10555-006-8496-2
PG 26
WC Oncology
SC Oncology
GA 052YA
UT WOS:000238268800002
PM 16770531
ER

PT J
AU D'Souza, WD
   Thames, HD
AF D'Souza, WD
   Thames, HD
TI Is the alpha/beta ratio for prostate cancer low?
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Editorial Material
ID DOSE-RATE BRACHYTHERAPY; RADIOTHERAPY; IRRADIATION; CARCINOMA; I-125
C1 Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA.
RP D'Souza, WD (reprint author), Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, 1515 Holcombe Blvd, Houston, TX 77030 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Brenner DJ, 1999, INT J RADIAT ONCOL, V43, P1095, DOI 10.1016/S0360-3016(98)00438-6
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   DALE RG, 1985, BRIT J RADIOL, V58, P515
   DALE RG, 1989, BRIT J RADIOL, V62, P241
   Duchesne GM, 1999, INT J RADIAT ONCOL, V44, P747
   King CR, 2001, INT J RADIAT ONCOL, V51, P213, DOI 10.1016/S0360-3016(01)01651-0
   LING CC, 1995, INT J RADIAT ONCOL, V32, P373, DOI 10.1016/0360-3016(95)00530-C
   MARCHESE MJ, 1990, INT J RADIAT ONCOL, V18, P1407
   Martinez AA, 2000, INT J RADIAT ONCOL, V47, P343, DOI 10.1016/S0360-3016(00)00436-3
   Mohan DS, 2000, INT J RADIAT ONCOL, V46, P575, DOI 10.1016/S0360-3016(99)00454-X
   POLLACK A, 2001, COMMUNICATION    MAY
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
NR 14
TC 54
Z9 55
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD SEP 1
PY 2001
VL 51
IS 1
BP 1
EP 3
DI 10.1016/S0360-3016(01)01650-9
PG 3
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 468EM
UT WOS:000170745200001
PM 11516843
ER

PT J
AU Merrick, GS
   Butler, WM
   Dorsey, AT
   Lief, JH
AF Merrick, GS
   Butler, WM
   Dorsey, AT
   Lief, JH
TI Potential role of various dosimetric quality indicators in prostate
   brachytherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate brachytherapy; quality indicators; dosimetry
ID POSTIMPLANT DOSIMETRY; PD-103 BRACHYTHERAPY; PERMANENT IMPLANTS; ANTIGEN
   NADIR; DOSE-RESPONSE; I-125; CARCINOMA; THERAPY; CANCER; IRRADIATION
AB Purpose: Postoperative CT-based dosimetric analysis provides detailed information regarding the coverage and uniformity of an implant, but the assessment of implant quality remains an unanswered and controversial issue. There is no disagreement that a good implant should cover the target volume with an adequate dose, but there is no consensus as to what represents an adequate dose.
   Materials and Methods: The American Brachytherapy Society has recently proposed that prostate brachytherapy quality be measured in terms of the following parameters: D90, V100, and V150 where D90 is defined as the minimal dose covering 90% of the prostate volume and V100 and V150 are defined as the percent volume of the prostate receiving at least 100% or 150% of the prescribed minimal peripheral dose (mPD), respectively. We report detailed day 0 dosimetric evaluation for 60 consecutive prostate brachytherapy patients implanted via a standard transperineal ultrasound guided approach in terms of D90, D100, V90, V100, and V150 and also the maximal and average rectal and urethral dose.
   Results: Dosimetric evaluation resulted in a V100 greater than 80% of the prostate volume and a D90 greater than 90% of the mPD in the entire patient population. There was a statistically significant difference between the quality scores of I-125 implants and Pd-103 implants with the I-125 mean V100 and D90 at 95.3% volume and 109.9% mPD, respectively, vs. Pd-103 at 91.8% volume and 103.7% mPD. Likewise, the rectal and urethral doses as a fraction of mPD were significantly lower in Pd-103 than in I-125 implants. This occurred despite the fact that palladium implants were typically preplanned with significantly better coverage and hotter V150 than iodine implants. We consider V150 to be an important parameter for determining dose homogeneity although the clinical utility of dose homogeneity remains unknown. The mean V150 was 45.6 +/- 9.6% volume. There was no additional dosimetric utility from a determination of V90 while D100 was found to be overly sensitive to steep dose gradients at the periphery of the prostate.
   Conclusions: This report represents the first detailed postimplant day 0 dosimetric evaluation comparing ABS recommended quality parameters used to evaluate prostate brachytherapy. At the present time, no long-term clinical outcomes are available because of short follow-up. As PSA based follow-up data becomes available, however, this report may help define what represents an adequate implant. (C) 1999 Elsevier Science Inc.
C1 Wheeling Hosp, Schiffler Oncol Ctr, Wheeling, WV 26003 USA.
   George Washington Univ, Med Ctr, Div Radiat Oncol & Biophys, Washington, DC 20037 USA.
   Wheeling Jesuit Univ, Wheeling, WV USA.
RP Merrick, GS (reprint author), Wheeling Hosp, Schiffler Oncol Ctr, 1 Med Pk, Wheeling, WV 26003 USA.
CR BICE WS, 1997, J BRACHYTHER INT, V13, P297
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko JC, 1993, SEMIN RADIAT ONCOL, V3, P240, DOI 10.1053/SRAO00300240
   Blasko John, 1996, International Journal of Radiation Oncology Biology Physics, V36, P198, DOI 10.1016/S0360-3016(97)85421-1
   BUTLER WM, UNPUB ISOTOPE CHOICE
   Butler WM, 1998, INT J RADIAT ONCOL, V41, P217, DOI 10.1016/S0360-3016(97)00951-6
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Dattoli MJ, 1997, INT J RADIAT ONCOL, V39, P221
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537
   LING CC, 1992, INT J RADIAT ONCOL, V23, P81
   Merrick GS, 1998, J BRACHYTHERAPY INT, V14, P113
   Merrick G S, 1997, Radiat Oncol Investig, V5, P305, DOI 10.1002/(SICI)1520-6823(1997)5:6<305::AID-ROI7>3.0.CO;2-1
   Merrick G S, 1998, Radiat Oncol Investig, V6, P182, DOI 10.1002/(SICI)1520-6823(1998)6:4<182::AID-ROI6>3.0.CO;2-U
   Merrick GS, 1999, INT J RADIAT ONCOL, V43, P1021, DOI 10.1016/S0360-3016(98)00486-6
   Moerland MA, 1997, INT J RADIAT ONCOL, V37, P927, DOI 10.1016/S0360-3016(96)00575-5
   MORTON JD, 1988, INT J RADIAT ONCOL, V14, P1153
   NAG S, 1998, AM BRACH SOC ANN M A
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   PRESTIDGE BR, 1997, INT J RADIAT ONCOL, V39, P238
   Prestidge BR, 1998, INT J RADIAT ONCOL, V40, P1111, DOI 10.1016/S0360-3016(97)00947-4
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   ROY JN, 1993, INT J RADIAT ONCOL, V26, P163, DOI 10.1016/0360-3016(93)90188-2
   SAW CB, 1991, INT J RADIAT ONCOL, V20, P135
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   Stock RG, 1997, INT J RADIAT ONCOL, V39, P221, DOI 10.1016/S0360-3016(97)80730-4
   Stokes SH, 1997, INT J RADIAT ONCOL, V37, P337, DOI 10.1016/S0360-3016(96)00508-1
   WALLNER K, 1994, INT J RADIAT ONCOL, V30, P405
   WALLNER K, 1995, INT J RADIAT ONCOL, V32, P465, DOI 10.1016/0360-3016(94)00599-G
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Waterman FM, 1997, INT J RADIAT ONCOL, V39, P220, DOI 10.1016/S0360-3016(97)80729-8
   Waterman FM, 1997, INT J RADIAT ONCOL, V38, P335, DOI 10.1016/S0360-3016(97)00114-4
   Willins J, 1997, INT J RADIAT ONCOL, V39, P347, DOI 10.1016/S0360-3016(97)00322-2
   Yu Y, 1996, INT J RADIAT ONCOL, V34, P717, DOI 10.1016/0360-3016(95)02153-1
NR 36
TC 54
Z9 54
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUN 1
PY 1999
VL 44
IS 3
BP 717
EP 724
DI 10.1016/S0360-3016(99)00067-X
PG 8
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 199YF
UT WOS:000080511100032
PM 10348304
ER

PT J
AU Pui, MH
   Yueh, TC
AF Pui, MH
   Yueh, TC
TI Lymphoscintigraphy in chyluria, chyloperitoneum and chylothorax
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Article
DE chyluria; chyloperitoneum; chylothorax; lymphoscintigraphy
ID LYMPHATIC ABNORMALITIES; HUMAN FILARIASIS; CHYLOUS ASCITES; TC-99M
   DEXTRAN; LYMPHANGIOSCINTIGRAPHY; COMMUNICATION; EFFUSION; SYSTEM
AB Lymphoscintigraphy allows functional assessment of lymphatic transport and depiction of regional lymph nodes, is fast and nontraumatic and has no known side effects. We retrospectively analyzed lymphoscintigraphic studies to determine their efficacy in the investigation of chyluria, chyloperitoneum and chylothorax. Methods: Twenty-one whole-body lymphoscintigrams using Tc-99m-antimony sulfide colloid or dextran were acquired in 18 patients with chyluria, chyloperitoneum and/or chylothorax. The images were reviewed to assess the rate of tracer transport and number, size and distribution of lymph vessels and nodes as well as the presence of collateral, fistula or lymph reflux. Results: Lymphoscintigraphy was normal (5 of 11 patients) or showed lymphatic obstruction (6 of 11 patients) in chyluria associated with filariasis. Lymphatic obstruction was demonstrated in chyloperitoneum and/or chylothorax associated with liver cirrhosis (2 patients), postoperative (1 patient) or congenital (1 patient) lymphatic dysplasia, inferior vena cava obstruction (1 patient) and nephrotic syndrome(1 patient). Enhanced lymph flow was seen in systemic lupus erythematosus (1 patient). Follow-up lymphoscintigrams showed patency of lymphovenous anastomosis (1 patient), improvement (1 patient) or no change (1 patient) in lymphatic drainage after treatment. Conclusion: Lymphoscintigraphy can demonstrate abnormal lymphatic drainage in chyluria, chyloperitoneum and chylothorax. It is useful for selecting patients for surgery and assessing the effect of treatment.
C1 Sun Yat Sen Univ Med Sci, Affiliated Hosp 1, Dept Nucl Med, Guangzhou, Peoples R China.
RP Pui, MH (reprint author), Aga Khan Univ, Med Ctr, Dept Radiol, Stadium Rd,POB 3500, Karachi 74800, Pakistan.
CR ABLAN CJ, 1990, ARCH SURG-CHICAGO, V125, P270
   AKISADA M, 1968, RADIOLOGY, V90, P311
   Biswas G, 1996, CLIN NUCL MED, V21, P341, DOI 10.1097/00003072-199604000-00027
   BROWSE NL, 1992, BRIT J SURG, V79, P1145, DOI 10.1002/bjs.1800791110
   CAMIEL MR, 1964, GASTROENTEROLOGY, V47, P188
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927
   GATES GF, 1972, RADIOLOGY, V105, P619
   GLOVICZKI P, 1988, J VASC SURG, V7, P647
   GREGG DC, 1988, CLIN NUCL MED, V13, P300, DOI 10.1097/00003072-198804000-00019
   HADDAD MC, 1994, CLIN RADIOL, V49, P137, DOI 10.1016/S0009-9260(05)83458-0
   HEYMAN S, 1986, J NUCL MED, V27, P1783
   JUMA N, 1985, BRIT J RADIOL, V58, P325
   LINDENBA.J, 1968, AM J MED, V44, P830, DOI 10.1016/0002-9343(68)90262-3
   LOPEZ OL, 1986, CLIN NUCL MED, V11, P479
   LU G, 1995, CLIN NUCL MED, V20, P706, DOI 10.1097/00003072-199508000-00010
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MOSS R, 1989, AM REV RESPIR DIS, V140, P1436
   SABNIS RB, 1992, BRIT J UROL, V70, P660, DOI 10.1111/j.1464-410X.1992.tb15839.x
   STY JR, 1978, CLIN NUCL MED, V4, P412
   VERREAULT J, 1986, J NUCL MED, V27, P1706
   WEISSLEDER R, 1989, RADIOLOGY, V172, P315
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   YU HHY, 1978, BRIT J UROL, V50, P126, DOI 10.1111/j.1464-410X.1978.tb03042.x
NR 23
TC 54
Z9 59
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA
SN 0161-5505
J9 J NUCL MED
JI J. Nucl. Med.
PD JUL
PY 1998
VL 39
IS 7
BP 1292
EP 1296
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA ZZ059
UT WOS:000074691600040
PM 9669413
ER

PT J
AU GARAN, H
   RUSKIN, JN
   DIMARCO, JP
   DERKAC, WM
   AKINS, CW
   DAGGETT, WM
   AUSTEN, WG
   BUCKLEY, MJ
AF GARAN, H
   RUSKIN, JN
   DIMARCO, JP
   DERKAC, WM
   AKINS, CW
   DAGGETT, WM
   AUSTEN, WG
   BUCKLEY, MJ
TI ELECTROPHYSIOLOGIC STUDIES BEFORE AND AFTER MYOCARDIAL REVASCULARIZATION
   IN PATIENTS WITH LIFE-THREATENING VENTRICULAR ARRHYTHMIAS
SO AMERICAN JOURNAL OF CARDIOLOGY
LA English
DT Article
C1 MASSACHUSETTS GEN HOSP,SURG UNIT,BOSTON,MA 02114.
   MASSACHUSETTS GEN HOSP,DIV CARDIOL,BOSTON,MA 02114.
RP GARAN, H (reprint author), MASSACHUSETTS GEN HOSP,CARDIAC UNIT,BOSTON,MA 02114, USA.
CR BONCHEK LI, 1977, ANN THORAC SURG, V24, P337
   de Soyza N, 1978, Ann Intern Med, V89, P10
   FENOGLIO JJ, 1976, HUM PATHOL, V7, P547, DOI 10.1016/S0046-8177(76)80102-5
   GUINN GA, 1977, AM J CARDIOL, V39, P270
   JOSEPHSON ME, 1980, AM J CARDIOL, V46, P948, DOI 10.1016/0002-9149(80)90350-1
   JOSEPHSON ME, 1978, CIRCULATION, V57, P431
   KAISER GA, 1975, SURGERY, V78, P749
   KEHOE R, 1980, AM J CARDIOL, V45, P444, DOI 10.1016/0002-9149(80)90883-8
   LEUTENEGGER F, 1979, AM HEART J, V98, P15, DOI 10.1016/0002-8703(79)90315-6
   RUSKIN JN, 1980, NEW ENGL J MED, V303, P607, DOI 10.1056/NEJM198009113031103
   SANDLER H, 1968, AM HEART J, V75, P325, DOI 10.1016/0002-8703(68)90089-6
   TRESCH DD, 1981, CIRCULATION, V64, P1
   WEAVER WD, 1976, CIRCULATION, V54, P895
NR 13
TC 54
Z9 54
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 245 WEST 17TH STREET, NEW YORK, NY 10011
SN 0002-9149
J9 AM J CARDIOL
JI Am. J. Cardiol.
PY 1983
VL 51
IS 3
BP 519
EP 524
DI 10.1016/S0002-9149(83)80091-5
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QB101
UT WOS:A1983QB10100028
PM 6600577
ER

PT J
AU Rogers, JM
   Read, CA
AF Rogers, Jeffrey M.
   Read, Christina A.
TI Psychiatric comorbidity following traumatic brain injury
SO BRAIN INJURY
LA English
DT Review
DE traumatic brain injury; psychiatric; outcome
ID POSTTRAUMATIC-STRESS-DISORDER; EPIDEMIOLOGIC CATCHMENT-AREA;
   SPINAL-CORD-INJURY; SUBSTANCE-ABUSE; AXIS-I; ORBITOFRONTAL CORTEX;
   UNIPOLAR DEPRESSION; BIPOLAR-DISORDER; MAJOR DEPRESSION; MOOD DISORDERS
AB Primary objective: Survivors of traumatic brain injury (TBI) are at increased risk for development of severe, long-term psychiatric disorders. However, the aetiology of these disorders remains unclear. This article systematically reviews the most current prevalence rates and evidence for causality, in terms of established criteria.
   Main outcome and results: Psychiatric syndromes are consistently present at an elevated rate following TBI. Survivors of TBI are particularly susceptible to major depression, generalized anxiety disorder and post-traumatic stress disorder. Evidence for a biological gradient is generally lacking, although this criterion may not be appropriate in the case of TBI. The temporal pattern of onset is variable and reliable critical periods for the post-injury development of a psychiatric disorder remain to be identified; however, individuals appear to remain at risk for years following injury.
   Conclusions: Non-organic factors, including pre-morbid personality traits and post-injury psychological reactions to disability and trauma, are implicated in the generation and maintenance of post-TBI psychiatric disorder. There remains insufficient evidence to conclude what role the neuropathological consequences of TBI play in the development of post-TBI psychiatric disorder.
C1 [Rogers, Jeffrey M.] NSW Brain Injury Rehabil Directorate, Liverpool BC, NSW 1871, Australia.
   [Read, Christina A.] Graylands Hosp, Ctr Clin Res Neuropsychiat, Mt Claremont, WA, Australia.
   [Read, Christina A.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA, Australia.
RP Rogers, JM (reprint author), NSW Brain Injury Rehabil Directorate, Locked Bag 7103, Liverpool BC, NSW 1871, Australia.
EM jeffrey.rogers@sswahs.nsw.gov.au
CR Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011
   Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117
   Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23
   BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0
   Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.21967
   BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663
   Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1
   Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629
   Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296
   CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7
   Deb S, 1999, AM J PSYCHIAT, V156, P374
   Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041
   Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370
   Drubach D A, 1993, Md Med J, V42, P989
   Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53
   Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615
   Freeman HL, 1999, BRIT J PSYCHIAT, V174, P79
   GETHING L, 1994, DISABILITY AWARENESS
   Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5
   Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276
   Harlow J.M., 1868, PUBLICATIONS MASSACH, V2, P327
   Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24
   Hill AB, 1965, P ROY SOC MED, V58, P293
   Hiott DW, 2002, NEUROREHABILITATION, V17, P345
   Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17
   Hoofien D, 2001, BRAIN INJURY, V15, P189
   Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42
   JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N
   KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567
   KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
   Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571
   Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475
   Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315
   Koponen S, 2004, NEUROLOGY, V63, P749
   Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108
   Lacerda ALT, 2004, BIOL PSYCHIAT, V55, P353, DOI 10.1016/j.biopsych.2003.08.021
   Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754
   LEZAK MD, 1995, NEUROPSYCHOLOGICAL A
   LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460
   Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440
   Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286
   National Institute of Health Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury, 1998, JAMA-J AM MED ASSOC, V282, P974
   Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5
   Osterman JE, 2001, GEN HOSP PSYCHIAT, V23, P198, DOI 10.1016/S0163-8343(01)00142-6
   Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066
   PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058
   Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003
   Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5
   Sagduyu K, 2002, J CLIN PSYCHIAT, V63, P594
   SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780
   Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3
   Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106
   Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295
   Soares JC, 1997, J PSYCHIAT RES, V31, P393, DOI 10.1016/S0022-3956(97)00016-2
   Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982
   Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436
   Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2
   van der Kolk BA, 2001, HUM PSYCHOPHARM CLIN, V16, pS49, DOI 10.1002/hup.270
   van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316
   van Reekum R, 2001, J NEUROPSYCH CLIN N, V13, P318, DOI 10.1176/appi.neuropsych.13.3.318
   Williams WH, 2002, BRAIN INJURY, V16, P673
   Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026
NR 62
TC 53
Z9 57
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0269-9052
J9 BRAIN INJURY
JI Brain Inj.
PD DEC
PY 2007
VL 21
IS 13-14
BP 1321
EP 1333
DI 10.1080/02699050701765700
PG 13
WC Neurosciences; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA 253AA
UT WOS:000252488200001
PM 18066935
ER

PT J
AU Staton, GA
   Williams, IH
   Mahoney, EA
   Hu, J
   Chu, HT
   Duke, PG
   Puskas, JD
AF Staton, GA
   Williams, IH
   Mahoney, EA
   Hu, J
   Chu, HT
   Duke, PG
   Puskas, JD
TI Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery
   in a randomized trial
SO CHEST
LA English
DT Article
DE cardiopulmonary bypass; coronary artery surgery; off-pump coronary
   artery bypass; off-pump coronary arterial surgery; pulmonary surgical
   complications
ID RESPIRATORY-DISTRESS-SYNDROME; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY;
   GAS-EXCHANGE; EXTRACORPOREAL-CIRCULATION; FUNCTION ABNORMALITIES;
   INFLAMMATORY RESPONSE; GRAFT-SURGERY; MECHANICS; REVASCULARIZATION
AB Study objectives: Comparison of pulmonary outcomes after off-pump coronary artery bypass (OPCAB) vs on-pump coronary artery grafting with cardiopulmonary bypass (CABG/CPB). Study design: We examined preoperative and postoperative respiratory compliance, fluid balance, hemodynamics, arterial blood gases, chest radiographs, spirometry, pulmonary complications, and time to extubation in a prospective trial of 200 patients randomized to OPCAB vs CABG/CPB performed by one surgeon.
   Results: One CABG/CPB patient and two OPCAB patients required mitral valve repair or replacement and were withdrawn. After three crossovers from CABG/CBP to OPCAB and one crossover from OPCAB to CABG, 97 CABG/CPB patients and 100 OPCAB patients remained. There were no significant preoperative demographic differences between groups. Postoperative compliance was reduced more after OPCAB than after CABG/CPB (-15.4 +/- 10.7 mL/cm H2O vs -11.2 +/- 10.1 mL/cm H2O [mean +/- SD]; p = 0.007), associated with rotation of the heart into the right chest to perform posterolateral bypasses (p < 0.001) and the concomitant increased fluid requirements necessary to maintain hemodynamic stability during rotation of the heart. In addition to higher intraoperative fluid intake (4,541 +/- 1,311 mL vs 3,585 +/- 1,033 mL, p < 0.0001), OPCAB patients had higher intraoperative fluid balance (3,903 +/- 1,315 mL vs 1,772 +/- 1,373 mL, p < 0.0001), and higher postoperative pulmonary arterial diastolic pressure (15.0 +/- 5.5 mm Hg vs 11.8 +/- 5.2 mm Hg, p < 0.0001) and central venous pressure (10.4 +/- 4.5 mm Hg vs 8.4 +/- 4.7 mm Hg, p < 0.0001). Despite lower compliance, immediate postoperative PaO2 on fraction of inspired oxygen of 1.0 (275 +/- 97 torr vs 221 +/- 92 torr, p = 0.001) was higher after OPCAB and extubation was earlier (p = 0.001). Postoperative chest radiographs, spirometry, mortality, reintubation, or readmission for pulmonary complications were not different between groups.
   Conclusions: Compared to CABG/CPB, OPCAB was associated with a greater reduction in postoperative respiratory compliance associated with increased fluid administration and rotation of the heart into the right chest to perform posterolateral grafts. OPCAB yielded better gas exchange and earlier extubation but no difference in chest radiographs, spirometry, or rates of death, pneumonia, pleural effusion, or pulmonary edema.
C1 Emory Univ, Sch Med, Dept Med,Div Pulm & Crit Care Med, Atlanta, GA 30329 USA.
   Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30329 USA.
   Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30329 USA.
   Emory Univ, Sch Med, Dept Surg, Div Cardiothorac Surg,Emory Ctr Outcomes Res, Atlanta, GA 30329 USA.
   Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   New England Res Inst, Watertown, MA 02172 USA.
RP Staton, GA (reprint author), Emory Univ, Sch Med, Dept Med,Div Pulm & Crit Care Med, 1821 Clifton Rd NE, Atlanta, GA 30329 USA.
EM gerald_staton@emoryhealthcare.org
RI Chu, Haitao /J-7576-2012
CR Al-Ruzzeh S, 2003, EUR J CARDIO-THORAC, V23, P50, DOI 10.1016/S1010-7940(02)00654-1
   ANJOULINDSKOG E, 1983, ACTA ANAESTH SCAND, V27, P378
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X
   AULER JOC, 1987, CHEST, V92, P984, DOI 10.1378/chest.92.6.984
   Auler JOC, 2000, BRAZ J MED BIOL RES, V33, P31
   Babik B, 2003, ANESTH ANALG, V96, P1280, DOI 10.1213/01.ANE.0000055363.23715.40
   Baumgartner FJ, 2000, AM J CARDIOL, V86, P1021, DOI 10.1016/S0002-9149(00)01142-5
   Brasil LA, 1998, ANN THORAC SURG, V66, P56, DOI 10.1016/S0003-4975(98)00181-7
   BRAUN SR, 1978, CHEST, V73, P316, DOI 10.1378/chest.73.3.316
   Bredee JJ, 1998, CURR OPIN CARDIOL, V13, P476, DOI 10.1097/00001573-199811000-00014
   Cimen S, 2003, EUR J CARDIO-THORAC, V23, P589, DOI 10.1016/S1010-7940(03)00023-X
   Cox CM, 2000, ANN THORAC SURG, V69, P140, DOI 10.1016/S0003-4975(99)01196-0
   Fransen E, 1998, CHEST, V113, P1290, DOI 10.1378/chest.113.5.1290
   Frass OM, 2001, CHEST, V120, P1599, DOI 10.1378/chest.120.5.1599
   Guler M, 2001, ANN THORAC SURG, V71, P152, DOI 10.1016/S0003-4975(00)02250-5
   Hart James C, 2002, Semin Thorac Cardiovasc Surg, V14, P70, DOI 10.1053/stcs.2002.31897
   Kaul TK, 1998, J CARDIOVASC SURG, V39, P777
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Macguire B, 2000, Ann Thorac Cardiovasc Surg, V6, P13
   MACNAUGHTON PD, 1992, CRIT CARE MED, V20, P1289, DOI 10.1097/00003246-199209000-00016
   Magee MJ, 2002, ANN THORAC SURG, V73, P1196, DOI 10.1016/S0003-4975(01)03587-1
   Messent M, 1997, CRIT CARE MED, V25, P425, DOI 10.1097/00003246-199703000-00009
   Milot J, 2001, CHEST, V119, P884, DOI 10.1378/chest.119.3.884
   Nicholson DJ, 2002, J CARDIOTHOR VASC AN, V16, P27, DOI 10.1053/jcan.2002.29648
   Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5
   PINILLA JC, 1990, CRIT CARE MED, V18, P836, DOI 10.1097/00003246-199008000-00008
   Polese G, 1999, INTENS CARE MED, V25, P1092, DOI 10.1007/s001340051017
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Quinlan GJ, 2000, CRIT CARE MED, V28, P2271
   Ranieri VM, 1999, CRIT CARE MED, V27, P1454, DOI 10.1097/00003246-199908000-00008
   Roosens C, 2002, CRIT CARE MED, V30, P2430, DOI 10.1097/01.CCM.0000034680.46256.1B
   Shenkman Z, 1997, ACTA ANAESTH SCAND, V41, P1193
   Staton GW, 2003, CHEST, V124, p104S
   Tenling A, 1998, ANESTHESIOLOGY, V89, P371, DOI 10.1097/00000542-199808000-00013
   Tschernko EM, 2002, J THORAC CARDIOV SUR, V124, P732, DOI 10.1067/mtc.2002.124798
   VANBELLE AF, 1992, RESP MED, V86, P195, DOI 10.1016/S0954-6111(06)80054-5
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Vargas FS, 1997, RESP MED, V91, P629, DOI 10.1016/S0954-6111(97)90010-X
   Yokoyama T, 2000, ANN THORAC SURG, V70, P1546, DOI 10.1016/S0003-4975(00)01922-6
NR 44
TC 53
Z9 57
PU AMER COLL CHEST PHYSICIANS
PI NORTHBROOK
PA 3300 DUNDEE ROAD, NORTHBROOK, IL 60062-2348 USA
SN 0012-3692
J9 CHEST
JI Chest
PD MAR
PY 2005
VL 127
IS 3
BP 892
EP 901
DI 10.1378/chest.127.3.892
PG 10
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA 908HG
UT WOS:000227777500035
PM 15764773
ER

PT J
AU Critz, FA
AF Critz, FA
TI A standard definition of disease freedom is needed for prostate cancer:
   Undetectable prostate specific antigen compared with the American
   Society of Therapeutic Radiology and Oncology Consensus Definition
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate; prostate-specific antigen; prostatic neoplasms; disease-free
   survival
ID RADICAL RETROPUBIC PROSTATECTOMY; RECURRENCE; BRACHYTHERAPY; SURVIVAL;
   PATTERNS
AB Purpose: Freedom from prostate cancer is defined by undetectable prostate specific antigen (PSA) after surgery and the American Society of Therapeutic Radiology and Oncology (ASTRO) criteria are recommended for irradiation. Whether these definitions of disease freedom are comparable was evaluated in this study.
   Materials and Methods: From August 1992 to August 1996 simultaneous irradiation with prostate 125 iodine implantation followed by external beam irradiation was performed in 591 consecutive men with stage T1T2NX prostate cancer. All patients had a transperineal implant and none received neoadjuvant hormones. Disease freedom was defined by a PSA cutoff of 0.2 ng./ml. and the ASTRO consensus definition. Median followup was 6 years (range 5 to 8).
   Results: Of the 591 men in this study 65 had recurrence by ASTRO criteria and 93 had recurrence by a PSA cutoff of 0.2 ng./ml., which was a significant difference (p = 0.001). On multivariate analysis of the factors related to disease-free status the definition of disease freedom, pretreatment PSA and Gleason score were highly significant. Of the 528 men with a minimum 5-year PSA followup the 8-year disease-free survival rate by ASTRO criteria was 99% in those who achieved a PSA nadir of 0.2 ng./ml. and 16% in those with a nadir of 0.3 to 1 ng./ml. Of the 469 disease-free patients by ASTRO criteria with a minimum 5-year followup 455 (97%) achieved a PSA nadir of 0.2 ng./ml. or less.
   Conclusions: The definition of freedom from prostate cancer significantly affects treatment results. A standard definition is needed and a PSA cutoff of 0.2 ng./ml. is suggested as the standard for all curative treatments for localized prostate cancer.
C1 Radiotherapy Clin Georgia, Decatur, GA USA.
RP Critz, FA (reprint author), Radiotherapy Clin Georgia, Decatur, GA USA.
CR *AM SOC THER RAD O, 1997, INT J RADIAT ONCOL, V37, P1035
   Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   Iselin CE, 1999, J UROLOGY, V161, P163, DOI 10.1016/S0022-5347(01)62088-3
   Kattan MW, 1998, J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766
   KLEE GG, 1994, J UROLOGY, V151, P94
   LEE EW, 1992, NATO ADV SCI I E-APP, V211, P237
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   Ragde H, 2000, CANCER, V89, P135, DOI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Shah R, 2000, UROLOGY, V56, P721, DOI 10.1016/S0090-4295(00)00775-5
   Shinohara K, 1997, J UROLOGY, V158, P2206, DOI 10.1016/S0022-5347(01)68198-9
   TAKAYAMA TK, 1993, J UROLOGY, V150, P374
   ZINCKE H, 1991, J UROLOGY, V146, P1053
NR 14
TC 53
Z9 53
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAR
PY 2002
VL 167
IS 3
BP 1310
EP 1313
DI 10.1016/S0022-5347(05)65288-3
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 519YK
UT WOS:000173752900022
PM 11832720
ER

PT J
AU FAULDS, D
   CHRISP, P
   BUCKLEY, MMT
AF FAULDS, D
   CHRISP, P
   BUCKLEY, MMT
TI ADENOSINE - AN EVALUATION OF ITS USE IN CARDIAC DIAGNOSTIC PROCEDURES,
   AND IN THE TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
SO DRUGS
LA English
DT Review
ID PECTORIS-LIKE PAIN; ATRIOVENTRICULAR NODAL CONDUCTION; SUPRA-VENTRICULAR
   TACHYCARDIA; CORONARY BLOOD-FLOW; ANGINA-PECTORIS; INTRAVENOUS
   ADENOSINE; INTRACORONARY ADENOSINE; INFUSED ADENOSINE; THERAPEUTIC USE;
   JUNCTIONAL TACHYCARDIA
AB Adenosine (adenine riboside), administered either as the free base or as the 5'-triphosphate (ATP) by rapid intravenous bolus, depresses atrioventricular (AV) nodal conduction, resulting in transient AV block.  Adenosine is the active agent and ATP is rapidly converted to adenosine after exogenous administration.  By blocking the anterograde AV nodal limb of a re-entrant circuit, adenosine 6 to 12mg (or ATP 10 to 20mg) converts almost all episodes of paroxysmal supraventricular tachycardia (PSVT) involving the AV node within 30 seconds of administration.  This is at least equivalent in efficacy to verapamil in adults, and superior to lanatoside C in children, with a considerably more rapid onset of action.  Furthermore, if a dose of adenosine is ineffective, the exceptionally short plasma half-life of the adenyl nucleosides (< 10 sec) allows rapid upward dosage titration until PSVT is terminated.
   Because the induced conduction block primarily affects the AV node, adenosine is a useful diagnostic tool in patients with broad or narrow QRS complex tachycardia; it terminates arrhythmias dependent on the AV node, unmasks other supraventricular mechanisms during transient AV block, but almost always has no effect on ventricular tachycardia.  Noncardiac adverse effects, i.e. flushing, dyspnoea and chest pain, may occur during acute arrhythmia termination or diagnosis with adenosine, and arrhythmias may develop; however, these effects are usually transient (lasting less than 1 minute).
   Adenosine has also been used to induce coronary vasodilation in patients undergoing thallium-201 single photon emission computed tomography (Tl-201 SPECT), 2-dimensional echocardiography or positron emission tomography to evaluate suspected coronary artery disease.  Intravenous infusion of adenosine 140-mu-g/kg/min for 6 minutes was generally associated with only mild adverse effects.  These usually resolved within 1 to 2 minutes of discontinuing adenosine, although occasionally patients required aminophylline and/or nitroglycerin (glyceryl trinitrate).  Diagnoses based on the results of scintigraphy were of a sensitivity, specificity and predictive accuracy comparable to those achieved with exercise- or dipyridamole-Tl-201 SPECT.
   Adenosine is therefore particularly suitable for the diagnosis of tachycardias and the acute management of PSVT involving the AV node in all age groups, without the risks of cardiac arrest and hypotension associated with verapamil.  Furthermore, intravenous adenosine infusion may be used to induce coronary vasodilation in patients unable to perform exercise stress tests for Tl-201 scintigraphy, and is well tolerated.
RP FAULDS, D (reprint author), ADIS INT LTD,41 CENTORIAN DR,AUCKLAND 10,NEW ZEALAND.
CR ALAZRAKI N, 1990, Journal of Nuclear Medicine, V31, P837
   BABBITT DG, 1989, CIRCULATION, V80, P1388
   BABBITT DG, 1990, CIRCULATION, V82, P287
   BABBITT DG, 1990, AM HEART J, V120, P808, DOI 10.1016/0002-8703(90)90196-5
   BAUMAN JL, 1983, CLIN PHARMACY, V2, P312
   BELARDINELLI L, 1989, PROG CARDIOVASC DIS, V32, P73, DOI 10.1016/0033-0620(89)90015-7
   BELARDINELLI L, 1983, AM J PHYSIOL, V244, pH734
   BELARDINELLI L, 1988, J PHYSIOL-LONDON, V405, P615
   BELHASSEN B, 1984, J AM COLL CARDIOL, V4, P414
   BELHASSEN B, 1984, AM J CARDIOL, V54, P225, DOI 10.1016/0002-9149(84)90334-5
   BELHASSEN B, 1984, AM J CARDIOL, V53, P1405, DOI 10.1016/0002-9149(84)90104-8
   BELHASSEN B, 1983, CIRCULATION, V68, P827
   BELHASSEN B, 1988, CIRCULATION, V77, P795
   BELHASSEN B, 1989, AM HEART J, V118, P634, DOI 10.1016/0002-8703(89)90289-5
   BIAGGIONI I, 1987, J AM COLL CARDIOL, V9, pA137
   BIAGGIONI I, 1986, LIFE SCI, V39, P2292
   BIAGGIONI I, 1987, CIRC RES, V61, P779
   BLUMENTHAL MS, 1988, CHEST, V93, P1103, DOI 10.1378/chest.93.5.1103
   BOLLING SF, 1990, J THORAC CARDIOV SUR, V99, P469
   BUSH A, 1989, BRIT J CLIN PHARMACO, V27, P165
   BUXTON AE, 1987, AM J CARDIOL, V59, P1107, DOI 10.1016/0002-9149(87)90857-5
   CAIRNS CB, 1990, ANN EMERG MED, V19, P957
   CLARKE B, 1988, EUR J CLIN PHARMACOL, V35, P309, DOI 10.1007/BF00558270
   CLARKE B, 1989, INT J CARDIOL, V23, P1, DOI 10.1016/0167-5273(89)90322-7
   CLEMO HF, 1986, CIRC RES, V59, P427
   COADE SB, 1989, CIRC RES, V65, P531
   COLLIS MG, 1989, PHARMACOL THERAPEUT, V41, P143, DOI 10.1016/0163-7258(89)90104-6
   CONRADSON TBG, 1987, ACTA PHYSIOL SCAND, V129, P387, DOI 10.1111/j.1748-1716.1987.tb08082.x
   COYNE E, 1990, EUR J NUCL MED, V16, pS194
   CREA F, 1990, CIRCULATION, V81, P164
   CREA F, 1989, BRIT HEART J, V61, P455
   DANCY M, 1985, LANCET, V2, P320
   DIMARCO JP, 1983, CIRCULATION, V68, P1254
   DIMARCO JP, 1987, CIRCULATION, V76, P67
   DIMARCO J P, 1988, Journal of the American College of Cardiology, V11, p227A
   DIMARCO JP, 1990, ANN INTERN MED, V113, P104
   DIMARCO JP, 1985, J AM COLL CARDIOL, V6, P417
   DOBSON JG, 1983, AM J PHYSIOL, V245, pH468
   DOBSON JG, 1978, CIRC RES, V43, P785
   DOLE WP, 1985, CIRC RES, V56, P517
   DOWNING SE, 1986, AM J PHYSIOL, V251, pH40
   ELISEEV VV, 1988, KARDIOLOGIYA, V28, P103
   ELLENBOGEN KA, 1990, CIRCULATION, V81, P821
   ELY SW, 1985, J THORAC CARDIOV SUR, V90, P549
   FAGBEMI O, 1984, EUR J PHARMACOL, V100, P243, DOI 10.1016/0014-2999(84)90231-0
   FAVALE S, 1985, J AM COLL CARDIOL, V5, P1212
   FENTON RA, 1982, AM J PHYSIOL, V242, pH797
   FORMAN MB, 1989, J AM COLL CARDIOL, V13, P450
   FRIEDMAN HZ, 1988, ANN INTERN MED, V109, P990
   GARRATT C, 1989, AM J CARDIOL, V64, P1310, DOI 10.1016/0002-9149(89)90573-0
   GARRATT C, 1990, Journal of the American College of Cardiology, V15, p173A
   GEWIRTZ H, 1986, AM J PHYSIOL, V250, P1030
   GRECO R, 1982, CIRCULATION, V66, P504
   GRIFFITH MJ, 1990, LANCET, P670
   GRIFFITH MJ, 1988, LANCET, V1, P672
   GUPTA N, 1989, Journal of Nuclear Medicine, V30, P730
   GUPTA N, 1990, Journal of Nuclear Medicine, V31, P733
   GUPTA NC, 1990, RADIOLOGY, V177, P234
   HANLEY FL, 1986, AM J PHYSIOL, V250, pH558
   HOMEISTER JW, 1990, CIRCULATION, V82, P595
   HOOD MA, 1988, AUST NZ J MED, V18, P381
   HORI M, 1986, AM J PHYSIOL, V250, pH509
   ISKANDRIAN AS, 1990, AM J CARDIOL, V66, P807, DOI 10.1016/0002-9149(90)90356-6
   JOSEPHSON ME, 1987, HARRISONS PRINCIPLES, V1, P923
   KERN MJ, 1990, CIRCULATION, V82, P300
   KLABUNDE RE, 1983, EUR J PHARMACOL, V93, P21, DOI 10.1016/0014-2999(83)90026-2
   KNOBB RM, 1984, AM J PHYSIOL, V247, pH804
   KOLASSA N, 1970, EUR J PHARMACOL, V9, P265, DOI 10.1016/0014-2999(70)90221-9
   KOMOR K, 1955, LANCET, V2, P93
   KROLL K, 1985, AM J PHYSIOL, V249, P1176
   KUJACIC V, 1990, CIRCULATION, V82, P192
   KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301
   KUTTESCH JF, 1982, CANCER CHEMOTH PHARM, V8, P221
   KWAI AH, 1990, EUR J NUCL MED, V16, P745, DOI 10.1007/BF00998182
   LEDINGHAM S, 1990, CARDIOVASC RES, V24, P247, DOI 10.1093/cvr/24.3.247
   LEDINGHAM SJM, 1990, BRIT HEART J, V64, P89
   LERMAN BB, 1987, CIRCULATION, V76, P21
   LERMAN BB, 1989, CIRCULATION, V80, P1536
   LERMAN BB, 1988, J CLIN INVEST, V82, P2127, DOI 10.1172/JCI113834
   LERMAN BB, 1986, CIRCULATION, V74, P270
   LEWEN MK, 1987, CHEST, V92, P1102, DOI 10.1378/chest.92.6.1102
   LOHSE MJ, 1985, N-S ARCH PHARMACOL, V328, P310, DOI 10.1007/BF00515559
   MAHMARIAN JJ, 1989, CIRCULATION S2, V80, P308
   MAHMARIAN JJ, 1989, CIRCULATION S2, V80, P521
   MAXWELL DL, 1987, ACTA PHYSIOL SCAND, V131, P459, DOI 10.1111/j.1748-1716.1987.tb08262.x
   MOSER GH, 1989, AM J PHYSIOL, V256, pC799
   MUNOZ A, 1985, CIRCULATION, V72, P241
   MUNOZ A, 1984, EUR HEART J, V5, P735
   MURAKAMI H, 1990, JAPANESE HEART J, V54, P365
   NGUYEN T, 1990, J AM COLL CARDIOL, V16, P1375
   NISHIMURA S, 1990, CIRCULATION, V82, P731
   NORTON ED, 1989, CIRCULATION S2, V80, P238
   OLAFSSON B, 1987, CIRCULATION, V76, P1135
   OVERHOLT ED, 1988, AM J CARDIOL, V61, P336, DOI 10.1016/0002-9149(88)90940-X
   OWALL A, 1988, ANESTHESIOLOGY, V68, P416
   OWALL A, 1987, ANESTH ANALG, V66, P229
   OWALL A, 1988, ANESTH ANALG, V67, P228
   PARKER RB, 1990, CLIN PHARMACY, V9, P261
   PELLEG A, 1990, PHARMACOTHERAPY, V10, P157
   PERROT B, 1984, EUR HEART J, V5, P382
   PITARYS CJ, 1991, IN PRESS CIRCULATION
   PITARYS CJ, 1990, CIRCULATION, V82, P263
   PITT B, 1990, CIRCULATION, V82, P308
   PLATIA E V, 1990, Chest, V98, p4S
   POLOSA R, 1990, IMMUNOL ALLERGY CLIN, V10, P363
   PORTER RS, 1990, CLIN PHARMACY, V9, P271
   RADFORD D, 1983, ARCH DIS CHILD, V58, P465
   RANKIN AC, 1990, AM HEART J, V119, P316, DOI 10.1016/S0002-8703(05)80022-5
   RANKIN AC, 1987, LANCET, V2, P472
   RANKIN AC, 1989, BRIT HEART J, V62, P195
   RANKIN AC, 1990, Q J MED, V74, P203
   REID PG, 1987, BRIT J CLIN PHARMACO, V23, P331
   REID PG, 1990, EUR HEART J, V11, P1018
   RINNE C, 1988, AM HEART J, V115, P1042, DOI 10.1016/0002-8703(88)90074-9
   RONCATESTONI S, 1982, J MOL CELL CARDIOL, V14, P177, DOI 10.1016/0022-2828(82)90116-X
   ROSSEN JD, 1990, CIRCULATION, V82, P731
   SAITO D, 1986, BRIT HEART J, V55, P291
   SCHRADER BJ, 1990, CIRCULATION S3, V92, P23
   SCHRADER J, 1972, AM J PHYSIOL, V223, P159
   SELLERS T, 1987, CARDIAC ELECTROPHYSI, P283
   SHARMA AD, 1988, AM J CARDIOL, V61, P330, DOI 10.1016/0002-9149(88)90939-3
   SHARMA AD, 1990, AM J MED, V88, P337, DOI 10.1016/0002-9343(90)90486-W
   SIFFRING PA, 1989, RADIOLOGY, V173, P769
   SINGH BN, 1983, DRUGS, V25, P125
   SOLLEVI A, 1985, SCAND J THORAC CARD, V19, P155, DOI 10.3109/14017438509102711
   SOLLEVI A, 1986, PROG NEUROBIOL, V27, P319, DOI 10.1016/0301-0082(86)90005-5
   SOMLO E, 1955, LANCET, V1, P1125
   SPARKS HV, 1985, FED PROC, V44, P2620
   SREERAM N, 1990, ARCH DIS CHILD, V65, P127
   STEWART RB, 1986, ANN INTERN MED, V104, P766
   SYLVEN C, 1989, EUR HEART J, V10, P48
   SYLVEN C, 1986, BRIT MED J, V293, P227
   SYLVEN C, 1989, LANCET, V1, P1328
   SYLVEN C, 1988, EUR HEART J, V9, P87
   SYLVEN C, 1988, European Heart Journal, V9, P6
   SYLVEN C, 1986, BRIT MED J, V293, P1027
   TADOKORO H, 1990, CIRCULATION, V82, P287
   TAJIMA T, 1986, PACE, V9, P401, DOI 10.1111/j.1540-8159.1986.tb04495.x
   TAVIOT B, 1986, PRESSE MED, V15, P1103
   THORNTON JD, 1990, CIRCULATION, V82, P464
   TILL J, 1989, BRIT HEART J, V62, P204
   TORSSELL I, 1985, ANESTHESIOLOGY, V63, pA34
   TRAKHTENBROIT AD, 1990, CIRCULATION, V82, P193
   TRAKHTENBROIT A D, 1990, Journal of the American College of Cardiology, V15, p234A
   VELASCO C E, 1990, Journal of the American College of Cardiology, V15, p88A
   VELASCO CE, 1990, CIRCULATION, V82, P287
   VERANI MS, 1990, JUN NUCL CARD IM M S
   VERANI M S, 1990, Journal of Nuclear Medicine, V31, P722
   VERANI MS, 1990, CIRCULATION, V82, P80
   VISENTIN S, 1988, PHARMACOLOGIST, V30, pA179
   VISKIN S, 1990, AM HEART J, V120, P180, DOI 10.1016/0002-8703(90)90176-X
   WATT AH, 1985, BRIT J CLIN PHARMACO, V20, P503
   WATT AH, 1986, BRIT J CLIN PHARMACO, V21, P227
   WATT AH, 1987, BRIT J CLIN PHARMACO, V24, P665
   WATT AH, 1986, BRIT J CLIN PHARMACO, V21, P533
   WATT AH, 1989, BRIT J CLIN PHARMACO, V27, P265
   WATT AH, 1986, BRIT MED J, V293, P504
   WEST GA, 1985, PFLUG ARCH EUR J PHY, V403, P75, DOI 10.1007/BF00583285
   WEST GA, 1985, PFLUG ARCH EUR J PHY, V403, P66, DOI 10.1007/BF00583284
   WILSON RF, 1990, CIRCULATION, V82, P1593
   WU D, 1978, AM J CARDIOL, V41, P1045, DOI 10.1016/0002-9149(78)90856-1
   YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0
   ZIFFER JA, 1990, RADIOLOGY, V177, P98
   ZIJLSTRA F, 1988, CATHETER CARDIO DIAG, V15, P76, DOI 10.1002/ccd.1810150203
NR 164
TC 53
Z9 55
PU ADIS INTERNATIONAL LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW
   ZEALAND
SN 0012-6667
J9 DRUGS
JI Drugs
PD APR
PY 1991
VL 41
IS 4
BP 596
EP 624
DI 10.2165/00003495-199141040-00007
PG 29
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA FK410
UT WOS:A1991FK41000010
PM 1711962
ER

PT J
AU Hillis, LD
   Smith, PK
   Anderson, JL
   Bittl, JA
   Bridges, CR
   Byrne, JG
   Cigarroa, JE
   DiSesa, VJ
   Hiratzka, LF
   Hutter, AM
   Jessen, ME
   Keeley, EC
   Lahey, SJ
   Lange, RA
   London, MJ
   Mack, MJ
   Patel, MR
   Puskas, JD
   Sabik, JF
   Selnes, O
   Shahian, DM
   Trost, JC
   Winniford, MD
AF Hillis, L. David
   Smith, Peter K.
   Anderson, Jeffrey L.
   Bittl, John A.
   Bridges, Charles R.
   Byrne, John G.
   Cigarroa, Joaquin E.
   DiSesa, Verdi J.
   Hiratzka, Loren F.
   Hutter, Adolph M., Jr.
   Jessen, Michael E.
   Keeley, Ellen C.
   Lahey, Stephen J.
   Lange, Richard A.
   London, Martin J.
   Mack, Michael J.
   Patel, Manesh R.
   Puskas, John D.
   Sabik, Joseph F.
   Selnes, Ola
   Shahian, David M.
   Trost, Jeffrey C.
   Winniford, Michael D.
TI 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery:
   Executive Summary A Report of the American College of Cardiology
   Foundation/American Heart Association Task Force on Practice Guidelines
SO CIRCULATION
LA English
DT Article
DE AHA Scientific Statements; acute coronary syndromes; anticoagulants;
   antiplatelet agents; arrhythmias, cardiac; coronary angiography;
   coronary artery revascularization; interventions: stents; drug therapy;
   heart diseases; myocardial revascularization; platelet aggregation
   inhibitor; ultrasound
ID ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL;
   RANDOMIZED-CONTROLLED-TRIAL; VACUUM-ASSISTED CLOSURE;
   ACUTE-RENAL-FAILURE; HIGH-RISK PATIENTS; LEFT-VENTRICULAR DYSFUNCTION;
   PREOPERATIVE STATIN THERAPY; DRUG-ELUTING STENTS; TRANSMYOCARDIAL LASER
   REVASCULARIZATION
AB The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
C1 [Hillis, L. David; Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
   [Smith, Peter K.] Duke Univ, Med Ctr Private Diagnost Clin, Durham, NC 27706 USA.
   [Bridges, Charles R.] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA.
   [Byrne, John G.] Vanderbilt Univ, Med Ctr Div Cardiac Surg, Nashville, TN 37235 USA.
   [Cigarroa, Joaquin E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [DiSesa, Verdi J.] Johns Hopkins Univ Hosp, Div Cardiac Surg, Baltimore, MD 21287 USA.
   [Hutter, Adolph M., Jr.; Shahian, David M.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Keeley, Ellen C.] Univ Virginia, Charlottesville, VA 22903 USA.
   [Lahey, Stephen J.] Univ Connecticut, Storrs, CT USA.
   [London, Martin J.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA.
   [Mack, Michael J.] Heart Hosp Baylor Plano Cardiovasc Surg, Plano, TX USA.
   [Patel, Manesh R.] Duke Univ, Med Ctr, Durham, NC 27706 USA.
   [Puskas, John D.] Emory Univ Emory Healthcare, Atlanta, GA USA.
   [Sabik, Joseph F.] Cleveland Clin Fdn, Cleveland, OH USA.
   [Selnes, Ola] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA.
   [Trost, Jeffrey C.] Johns Hopkins Sch Med, Baltimore, MD USA.
   [Winniford, Michael D.] Univ Mississippi, Med Ctr, University, MS 38677 USA.
RP Hillis, LD (reprint author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
CR Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Acar C, 1998, J THORAC CARDIOV SUR, V116, P981, DOI 10.1016/S0022-5223(98)70050-9
   ACCF/AHA Task Force on Practice Guidelines, METH POL ACCF AHA TA
   Adabag AS, 2009, EUR HEART J, V30, P1910, DOI 10.1093/eurheartj/ehp053
   Aklog L, 2001, CIRCULATION, V104, pI68
   Alderman E, 1997, CIRCULATION, V96, P1761
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   Alexiou K, 2008, CLIN RES CARDIOL, V97, P601, DOI 10.1007/s00392-008-0657-6
   Ali IM, 1997, EUR J CARDIO-THORAC, V11, P1154, DOI 10.1016/S1010-7940(97)01215-3
   Al-Khatib SM, 2009, AM HEART J, V158, P792, DOI 10.1016/j.ahj.2009.09.003
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Amar D, 2001, CHEST, V119, P1476, DOI 10.1378/chest.119.5.1476
   American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography, 2010, ANESTHESIOLOGY, V112, P1084
   American Society of Anesthesiologists Task Force on pulmonary artery catheterization, 2003, ANESTHESIOLOGY, V99, P988
   Amin AP, 2009, J INVASIVE CARDIOL, V21, P305
   ANDREWS TC, 1991, CIRCULATION, V84, P236
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   [Anonymous], 2002, CIRCULATION, V106, P3143
   [Anonymous], 2002, BMJ, V324, P141
   [Anonymous], 2011, FDA SAF AL ZOC SIMV
   Anthonisen NR, 2005, ANN INTERN MED, V142, P233
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002
   Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107
   Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7
   AUSTIN TW, 1980, CAN J SURG, V23, P483
   Avidan MS, 2004, BRIT J ANAESTH, V92, P178, DOI 10.1093/bja/aeh037
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baillot R, 2010, EUR J CARDIO-THORAC, V37, P880, DOI 10.1016/j.ejcts.2009.09.023
   Bainbridge D, 2006, CAN J ANAESTH, V53, P492
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Barakate MS, 2003, ANN THORAC SURG, V75, P1400, DOI 10.1016/S0003-4975(02)05026-9
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   Benedetto U, 2008, ANN THORAC SURG, V86, P1160, DOI 10.1016/j.athoracsur.2008.06.018
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berger JS, 2008, J AM COLL CARDIOL, V52, P1693, DOI 10.1016/j.jacc.2008.08.031
   Bergquist BD, 1996, ANESTH ANALG, V82, P1139, DOI 10.1097/00000539-199606000-00007
   Berry PD, 1998, BRIT J ANAESTH, V80, P20
   Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   Bizzarri F, 2001, J THORAC CARDIOV SUR, V122, P1181, DOI 10.1067/mtc.2001.117838
   Blumberg N, 2002, AM J CLIN PATHOL, V118, P376
   Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Bolon MK, 2004, CLIN INFECT DIS, V38, P1357, DOI 10.1086/383318
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   BOYLAN MJ, 1994, J THORAC CARDIOV SUR, V107, P657
   Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Buckberg GD, 2010, J THORAC CARDIOV SUR, V140, P12, DOI 10.1016/j.jtcvs.2010.02.014
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   Butterworth J, 2005, J THORAC CARDIOV SUR, V130, P1319, DOI 10.1016/j.jtcvs.2005.02.049
   Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805
   Cahalan MK, 2002, J AM SOC ECHOCARDIOG, V15, P647, DOI 10.1067/mje.2002.123956
   Caimmi PP, 2003, J CARDIOTHOR VASC AN, V17, P491, DOI 10.1016/S1053-0770(03)00155-1
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Campeau L, 1997, NEW ENGL J MED, V336, P153
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   Centers for Diseases Control and Prevention, 2010, MMWR-MORBID MORTAL W, V44, P1
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cheng DCH, 1996, J THORAC CARDIOV SUR, V112, P755, DOI 10.1016/S0022-5223(96)70062-4
   Cheng DCH, 1996, ANESTHESIOLOGY, V85, P1300, DOI 10.1097/00000542-199612000-00011
   Chevalier P, 2004, EUR J CARDIO-THORAC, V26, P330, DOI 10.1016/j.ejcts.2004.04.027
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chiu FC, 2009, J THORAC CARDIOV SUR, V138, P1326, DOI 10.1016/j.jtcvs.2009.03.038
   Christenson JT, 1999, EUR J CARDIO-THORAC, V15, P394, DOI 10.1016/S1010-7940(99)00034-2
   Christenson JT, 2003, J CARDIAC SURG, V18, P286, DOI 10.1046/j.1540-8191.2003.02030.x
   Christenson JT, 1999, ANN THORAC SURG, V68, P934, DOI 10.1016/S0003-4975(99)00687-6
   Christenson JT, 2002, ANN THORAC SURG, V74, P1086, DOI 10.1016/S0003-4975(02)03854-7
   Christenson JT, 2001, CARDIOVASC SURG, V9, P383, DOI 10.1016/S0967-2109(00)00151-4
   Chu MWA, 2004, ANN THORAC SURG, V78, P1536, DOI 10.1016/j.athoracsur.2004.03.028
   Chukwuemeka A, 2005, ANN THORAC SURG, V80, P2148, DOI 10.1016/j.athoracsur.2005.06.015
   CHUNG F, 1988, ANESTHESIOLOGY, V69, P343, DOI 10.1097/00000542-198809000-00010
   Clark AM, 2005, ANN INTERN MED, V143, P659
   Clark RE, 1996, ANN THORAC SURG, V61, P21, DOI 10.1016/0003-4975(95)00734-2
   Cogliati AA, 2007, J CARDIOTHOR VASC AN, V21, P847, DOI 10.1053/j.jvca.2007.02.022
   Collard CD, 2006, J THORAC CARDIOV SUR, V132, P392, DOI 10.1016/j.jtcvs.2006.04.009
   Connerney I, 2001, LANCET, V358, P1766, DOI 10.1016/S0140-6736(01)06803-9
   Connolly SJ, 2003, AM HEART J, V145, P226, DOI 10.1067/mhj.2003.147
   Cowan KN, 2005, ANN THORAC SURG, V80, P2205, DOI 10.1016/j.athoracsur.2005.04.005
   CRAVER JM, 1992, ANN SURG, V215, P425, DOI 10.1097/00000658-199205000-00004
   Crystal E, 2004, COCHRANE DB SYST REV, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2005.12.015
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0
   Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501
   Davies RF, 1997, CIRCULATION, V95, P2037
   Davis RF, 2000, CARDIOPULMONARY BYPA, P186, DOI DOI 10.1053/J.JVCA.2007.02.022
   Del Duca D, 2007, ANN THORAC SURG, V84, P1264, DOI 10.1016/j.athoracsur.2007.05.016
   Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982
   DESPOTIS GJ, 1994, TRANSFUSION, V34, P290, DOI 10.1046/j.1537-2995.1994.34494233575.x
   DEWOOD MA, 1983, CIRCULATION, V68, P8
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Di Mauro M, 2007, ANN THORAC SURG, V84, P1496, DOI 10.1016/j.athoracsur.2007.05.054
   Doenst T, 2005, J THORAC CARDIOV SUR, V130, P1144, DOI 10.1016/j.jtcvs.2005.05.049
   Donatelli F, 1997, EUR J CARDIO-THORAC, V11, P228, DOI 10.1016/S1010-7940(96)01050-0
   Doss M, 2002, EUR J CARDIO-THORAC, V22, P934, DOI 10.1016/S1010-7940(02)00594-8
   Dotani MI, 2000, AM J CARDIOL, V86, P1128, DOI 10.1016/S0002-9149(00)01172-3
   Dowd NP, 1998, ANESTHESIOLOGY, V89, P1068, DOI 10.1097/00000542-199811000-00006
   Drew BJ, 2004, CIRCULATION, V110, P2721, DOI 10.1161/01.CIR.0000145144.56673.59
   Duncan AE, 2010, ANESTHESIOLOGY, V112, P860, DOI 10.1097/ALN.0b013e3181d3d4b4
   Durand DJ, 2004, ANN THORAC SURG, V78, P159, DOI 10.1016/j.athorascur.2004.02.024
   Dyke CM, 2000, ANN THORAC SURG, V70, P866, DOI 10.1016/S0003-4975(00)01654-4
   Dyub AM, 2008, J CARDIAC SURG, V23, P79, DOI 10.1111/j.1540-8191.2007.00499.x
   Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Eagle Kim A, 2004, Circulation, V110, pe340
   EAGLE KA, 2005, CIRCULATION, V111, P2014
   Echahidi N, 2008, J AM COLL CARDIOL, V51, P793, DOI 10.1016/j.jacc.2007.10.043
   El-Hamamsy I, 2007, J THORAC CARDIOV SUR, V133, P7, DOI 10.1016/j.jtcvs.2006.05.070
   Ellis SG, 1997, CIRCULATION, V96, P3867
   Eltzschig HK, 2008, ANN THORAC SURG, V85, P845, DOI 10.1016/j.athoracsur.2007.11.015
   Engblom E, 1997, J Cardiopulm Rehabil, V17, P29, DOI 10.1097/00008483-199701000-00004
   Englberger L, 2004, EUR J CARDIO-THORAC, V26, P96, DOI 10.1016/j.ejcts.2004.03.030
   Ennker IC, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-5
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   Fansa Iyad, 2003, Med Sci Monit, V9, pPI30
   Fattouch K, 2009, J THORAC CARDIOV SUR, V138, P278, DOI 10.1016/j.jtcvs.2008.11.010
   Fattouch K, 2010, ANN THORAC SURG, V90, P1187, DOI 10.1016/j.athoracsur.2010.03.103
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   Feit F, 2000, CIRCULATION, V101, P2795
   FEKETY FR, 1969, J THORAC CARDIOV SUR, V57, P757
   Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221
   Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395
   Filizcan U, 2011, ANGIOLOGY, V62, P68, DOI 10.1177/0003319710369103
   Filsoufi F, 2002, J HEART VALVE DIS, V11, pS45
   Finkelstein R, 2002, J THORAC CARDIOV SUR, V123, P326, DOI 10.1067/mtc.2002.119698
   Firanescu CE, 2009, EUR J CARDIO-THORAC, V36, P856, DOI 10.1016/j.ejcts.2009.05.032
   Fischer UM, 2005, CURR MED RES OPIN, V21, P1161, DOI 10.1185/030079905X53289
   Fleck Tatjana, 2006, Interact Cardiovasc Thorac Surg, V5, P145, DOI 10.1510/icvts.2005.122804
   Fleck TM, 2002, ANN THORAC SURG, V74, P1596, DOI 10.1016/S0003-4975(02)03948-6
   FONG IW, 1979, J THORAC CARDIOV SUR, V78, P908
   Fox KM, 2007, AM HEART J, V153, P629, DOI 10.1016/j.ahj.2007.01.032
   Freedland KE, 2009, ARCH GEN PSYCHIAT, V66, P387, DOI 10.1001/archgenpsychiatry.2009.7
   Friedrich JO, 2005, ANN INTERN MED, V142, P510
   FROMMELT PC, 2011, J THORAC CARDIO 0323
   Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181
   Furnary Anthony P, 2006, Semin Thorac Cardiovasc Surg, V18, P302, DOI 10.1053/j.semtcvs.2006.04.005
   Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d
   Gandhi GY, 2007, ANN INTERN MED, V146, P233
   GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450
   Geraci JM, 2005, MED CARE, V43, P149, DOI 10.1097/00005650-200502000-00008
   Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Gillinov A Marc, 2005, Curr Cardiol Rep, V7, P101, DOI 10.1007/s11886-005-0020-8
   GOODMAN JS, 1968, NEW ENGL J MED, V278, P117, DOI 10.1056/NEJM196801182780301
   GORDON MA, 1991, ANESTHESIOLOGY, V74, P848, DOI 10.1097/00000542-199105000-00008
   Goyal A, 2007, ANN THORAC SURG, V83, P993, DOI 10.1016/j.athoracsur.2006.10.046
   Greilich PE, 2009, ANESTH ANALG, V109, P15, DOI 10.1213/ane.0b013e3181a40b5d
   Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944
   Groesdonk HV, 2010, J CARDIOTHOR VASC AN, V24, P785, DOI 10.1053/j.jvca.2010.03.018
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   Haase M, 2007, CRIT CARE MED, V35, P1324, DOI 10.1097/01.CCM.0000261887.69976.12
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Haeffener MP, 2008, AM HEART J, V156, P900
   Halonen J, 2006, CIRCULATION, V114, pI1, DOI 10.1161/CIRCULATIONAHA.105.000851
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 1997, HEALTH SERV RES, V31, P659
   Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B
   HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209
   HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003
   HANNAN EL, 1992, MED CARE, V30, P892, DOI 10.1097/00005650-199210000-00002
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hansen D, 2009, ACTA CARDIOL, V64, P639, DOI 10.2143/AC.64.5.2042694
   HARTZ AJ, 1994, AM J PUBLIC HEALTH, V84, P1609, DOI 10.2105/AJPH.84.10.1609
   Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3
   Hawkes CA, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003587
   Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119
   Collins R, 2002, LANCET, V360, P7
   Held C, 2010, J AM COLL CARDIOL, V57, P672
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Herman CR, 2010, ANN THORAC SURG, V89, P397, DOI 10.1016/j.athoracsur.2009.10.051
   Heusch G, 2008, BRIT J PHARMACOL, V153, P1589, DOI 10.1038/sj.bjp.0707673
   Hilleman DE, 2004, CHEST, V125, P435, DOI 10.1378/chest.125.2.435
   Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   Hongo RH, 2002, J AM COLL CARDIOL, V40, P231, DOI 10.1016/S0735-1097(02)01954-X
   Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851
   Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568
   Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855
   Institute of Medicine, 2011, CLIN PRACT GUID WE C
   Institute of Medicine, 2011, FIND WHAT WORKS HLTH
   IPYAM PC, 1994, ANESTH ANALG, V78, P842
   Jain U, 1997, ANESTHESIOLOGY, V86, P576, DOI 10.1097/00000542-199703000-00009
   Jones HU, 2002, CIRCULATION, V106, pI19, DOI 10.1161/01.cir.0000032917.33237.e0
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   Jones RH, 1996, J AM COLL CARDIOL, V28, P1478, DOI 10.1016/S0735-1097(96)00359-2
   JURKIEWICZ MJ, 1980, ANN SURG, V191, P738, DOI 10.1097/00000658-198006000-00012
   KAISER AB, 1987, ANN SURG, V206, P791, DOI 10.1097/00000658-198712000-00018
   KAISER GA, 1975, SURGERY, V78, P749
   Kalant N, 2004, CAN J CARDIOL, V20, P81
   Kapetanakis EI, 2006, CIRCULATION, V113, P1667, DOI 10.1161/CIRCULATIONAHA.105.571828
   Kappetein AP, 2011, EUR HEART J, V17, P2125
   KELLY P, 1990, J AM COLL CARDIOL, V15, P267
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kikura M, 2006, J AM COLL SURGEONS, V202, P216, DOI 10.1016/j.jamcollsurg.2005.10.001
   Kim JHJ, 2008, AM HEART J, V156, P886, DOI 10.1016/j.ahj.2008.06.034
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   Kincaid EH, 2003, ANN THORAC SURG, V76, P124, DOI 10.1016/S0003-4975(03)00190-5
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   Kirdemir P, 2008, J CARDIOTHOR VASC AN, V22, P383, DOI 10.1053/j.jvca.2007.09.015
   Kjoller-Hansen L, 2000, J AM COLL CARDIOL, V35, P881, DOI 10.1016/S0735-1097(99)00634-8
   Knatterud GL, 2000, CIRCULATION, V102, P157
   KNIGHT AA, 1988, ANESTHESIOLOGY, V68, P681, DOI 10.1097/00000542-198805000-00005
   Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037
   Kofidis T, 2008, PERFUSION-UK, V23, P147, DOI 10.1177/0267659108097880
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Konvalinka A, 2006, J HOSP INFECT, V64, P162, DOI 10.1016/j.jhin.2006.06.010
   Krasuski RA, 2011, CIRCULATION, V123, P154, DOI 10.1161/CIRCULATIONAHA.109.921106
   KRETER B, 1992, J THORAC CARDIOV SUR, V104, P590
   Kulik A, 2008, CIRCULATION, V118, P1785, DOI 10.1161/CIRCULATIONAHA.108.799445
   Lahtinen P, 2006, ANESTHESIOLOGY, V105, P794, DOI 10.1097/00000542-200610000-00026
   Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013
   Landoni G, 2008, J CARDIOTHOR VASC AN, V22, P27, DOI 10.1053/j.jvca.2007.07.015
   Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.200610.013
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Laurikka J, 2002, CHEST, V121, P1183, DOI 10.1378/chest.121.4.1183
   Lavana JD, 2010, J THORAC CARDIOV SUR, V140, P80, DOI 10.1016/j.jtcvs.2009.09.033
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   LEMERY R, 1992, AM J CARDIOL, V70, P147, DOI 10.1016/0002-9149(92)91266-7
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Levin MA, 2009, CIRCULATION, V120, P1664, DOI 10.1161/CIRCULATIONAHA.108.814533
   Liakopoulos OJ, 2008, EUR HEART J, V29, P1548, DOI 10.1093/eurheartj/ehn198
   Lim HS, 2009, JACC-CARDIOVASC INTE, V2, P146, DOI 10.1016/j.jcin.2008.11.006
   Lin Terence, 2010, Congest Heart Fail, V16, P170, DOI 10.1111/j.1751-7133.2010.00146.x
   Lincoff AM, 2000, ANN THORAC SURG, V70, P516, DOI 10.1016/S0003-4975(00)01343-6
   Liu JY, 2000, CIRCULATION, V102, P2973
   Liu SS, 2004, ANESTHESIOLOGY, V101, P153, DOI 10.1097/00000542-200407000-00024
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Lucchinetti E, 2007, ANESTHESIOLOGY, V106, P444, DOI 10.1097/00000542-200703000-00008
   Luckraz H, 2003, J THORAC CARDIOV SUR, V125, P301, DOI 10.1067/mtc.2003.74
   Luo WJ, 2008, EUR J CARDIO-THORAC, V33, P203, DOI 10.1016/j.ejcts.2007.11.010
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X
   Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070
   Mack MJ, 2005, J THORAC CARDIOV SUR, V129, P1309, DOI 10.1016/j.jtcvs.2004.10.036
   MAKI DG, 1992, J THORAC CARDIOV SUR, V104, P1423
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Maltais S, 2008, EUR J CARDIO-THORAC, V34, P127, DOI 10.1016/j.ejcts.2008.03.052
   Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798
   MANGANO DT, 1997, GROUP, V277, P325
   Mangano DT, 2006, J AM COLL CARDIOL, V48, P206, DOI 10.1016/j.jacc.2006.04.044
   MANGANO DT, 1992, ANESTHESIOLOGY, V76, P342, DOI 10.1097/00000542-199203000-00004
   Maniar HS, 2002, J THORAC CARDIOV SUR, V123, P45, DOI 10.1067/mtc.2002.118686
   Mannacio VA, 2008, J THORAC CARDIOV SUR, V136, P1541, DOI 10.1016/j.jtcvs.2008.06.038
   Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789
   Martinez EA, 2010, ANESTH ANALG, V110, P307, DOI 10.1213/ANE.0b013e3181c92b9c
   Mathew JP, 2006, J AM SOC ECHOCARDIOG, V19, P1303, DOI 10.1016/j.echo.2006.08.039
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   McDonald SB, 2005, J CARDIOTHOR VASC AN, V19, P4, DOI 10.1053/j.jvca.2004.11.002
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   Medalion B, 2010, J THORAC CARDIOV SUR, V139, P1539, DOI 10.1016/j.jtcvs.2009.08.042
   Medalion B, 2003, J THORAC CARDIOV SUR, V126, P1875, DOI 10.1016/S0022-5223(03)01324-2
   Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P285
   Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P49
   Mehta RH, 2009, CIRC-CARDIOVASC QUAL, V2, P583, DOI 10.1161/CIRCOUTCOMES.109.858811
   Mehta RH, 2010, AM HEART J, V159, P141, DOI 10.1016/j.ahj.2009.10.035
   Alexander JH, 2008, JAMA-J AM MED ASSOC, V299, P1777
   Miceli A, 2009, J AM COLL CARDIOL, V54, P1778, DOI 10.1016/j.jacc.2009.07.008
   Migliorini A, 2006, AM HEART J, V152, P903, DOI 10.1016/j.ahj.2005.12.030
   Milani RV, 1998, CHEST, V113, P599, DOI 10.1378/chest.113.3.599
   Moises VA, 1998, J AM SOC ECHOCARDIOG, V11, P1139, DOI 10.1016/S0894-7317(98)80009-6
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Moran SV, 2001, ANN THORAC SURG, V72, P1552, DOI 10.1016/S0003-4975(01)03090-9
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4
   Murphy GJ, 2006, J THORAC CARDIOVASC, V132, pe1
   Murphy GJ, 2006, J THORAC CARDIOV SUR, V132, P475, DOI 10.1016/j.jctvs.2006.01.064
   Murphy GS, 2003, ANESTH ANALG, V96, P1301, DOI 10.1213/01.ANE.0000057602.27031.C8
   Murphy MB, 2001, NEW ENGL J MED, V345, P1548
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Myles PS, 2003, ANESTHESIOLOGY, V99, P982
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Nakamura M, 2008, ANN THORAC SURG, V85, P513, DOI 10.1016/j.athoracsur.2007.08.056
   Nallamothu BK, 2001, J AM COLL CARDIOL, V38, P1923, DOI 10.1016/S0735-1097(01)01647-3
   Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506
   Ngaage DL, 2008, ANN THORAC SURG, V85, P1278, DOI 10.1016/j.athoracsur.2007.12.035
   Nigwekar SU, 2009, J CARDIOTHOR VASC AN, V23, P151, DOI 10.1053/j.jvca.2008.11.007
   Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330
   Nuttall GA, 2001, ANESTHESIOLOGY, V94, P773, DOI 10.1097/00000542-200105000-00014
   Nygard E, 2005, CIRCULATION, V111, P2165, DOI 10.1161/01.CIR.0000163551.33812.1A
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   Oosterga M, 2001, AM J CARDIOL, V87, P542, DOI 10.1016/S0002-9149(00)01428-4
   Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(3)00125-9
   Ouattara A, 2005, ANESTHESIOLOGY, V103, P687, DOI 10.1097/00000542-200510000-00006
   Ouyang P, 2006, ATHEROSCLEROSIS, V189, P375, DOI 10.1016/j.atherosclerosis.2005.12.015
   Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Pan W, 2004, CIRCULATION S, V110, pII45, DOI DOI 10.1016/J.ATHORACSUR.2005.07.038
   PAONE G, 1994, SURGERY, V116, P672
   Parikh SV, 2010, JACC-CARDIOVASC INTE, V3, P419, DOI 10.1016/j.jcin.2010.01.012
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Pascual DA, 2006, ANN THORAC SURG, V81, P78, DOI 10.1016/j.athoracsur.2005.07.038
   PEARSON KS, 1989, ANESTH ANALG, V69, P336
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Penttila HJ, 2003, ANN THORAC SURG, V75, P1246, DOI 10.1016/S0003-4975(02)04659-3
   Pereira JJ, 2005, AM J MED, V118, P735, DOI 10.1016/j.amjmed.2005.01.072
   Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Piper SN, 2003, CAN J ANAESTH, V50, P285
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   PODESSER BK, 1995, J THORAC CARDIOV SUR, V110, P1461, DOI 10.1016/S0022-5223(95)70069-2
   Possati G, 1998, J THORAC CARDIOV SUR, V116, P1015, DOI 10.1016/S0022-5223(98)70054-6
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Qaddoura FE, 2004, ANN THORAC SURG, V78, P1586, DOI 10.1016/j.athoracsur.2004.05.001
   Rabi Doreen, 2010, Can J Cardiol, V26, P178
   Rader F, 2010, AM HEART J, V160, P329, DOI 10.1016/j.ahj.2010.05.033
   Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667
   Raja SG, 2006, J CARDIAC SURG, V21, P35, DOI 10.1111/j.1540-8191.2006.00164.x
   Rand RP, 1998, ANN THORAC SURG, V65, P1046, DOI 10.1016/S0003-4975(98)00087-3
   Ranucci M, 2010, MINERVA ANESTESIOL, V76, P249
   Ranucci Marco, 2008, Am J Cardiol, V101, P1112, DOI 10.1016/j.amjcard.2007.12.011
   Ranucci M, 2004, ANN THORAC SURG, V78, P1332, DOI 10.1016/j.athorcsur.2004.02.065
   Rathore SS, 2004, ANN SURG, V239, P110, DOI 10.1097/01.sla.0000103066.22732.b8
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Renda G, 2007, HAEMATOL-HEMATOL J, V92, P366, DOI 10.3324/haematol.10913
   Resano FG, 2006, J CARDIOTHOR VASC AN, V20, P300, DOI 10.1053/j.jvca.2006.01.017
   Rigotti NA, 2008, ARCH INTERN MED, V168, P1950, DOI 10.1001/archinte.168.18.1950
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670
   Rollman BL, 2009, PSYCHOSOM MED, V71, P217, DOI 10.1097/PSY.0b013e3181970c1c
   Romano G, 2010, J THORAC CARDIOV SUR, V140, P188, DOI 10.1016/j.jtcvs.2010.03.022
   Rosenberger P, 2008, ANN THORAC SURG, V85, P548, DOI 10.1016/j.athoracsur.2007.08.061
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   Rouleau JL, 2008, CIRCULATION, V117, P24, DOI 10.1161/CIRCULATIONAHA.106.685073
   Roy P, 2009, AM J CARDIOL, V103, P950, DOI 10.1016/j.amjcard.2008.12.025
   Royse AG, 2000, EUR J CARDIO-THORAC, V17, P294, DOI 10.1016/S1010-7940(99)00364-4
   Royston D, 2001, BRIT J ANAESTH, V86, P575, DOI 10.1093/bja/86.4.575
   Russo A, 2008, CIRCULATION, V118, P1528, DOI 10.1161/CIRCULATIONAHA.107.747949
   Sabik JF, 2006, J THORAC CARDIOV SUR, V131, P90, DOI 10.1016/j.jtcvs.2005.05.024
   Sabik JF, 2003, ANN THORAC SURG, V76, P1490, DOI 10.1016/S0003-4975(03)01022-1
   Sabik JF, 2008, CIRCULATION, V118, pS210, DOI 10.1161/CIRCULATIONAHA.107.760827
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Saginur R, 2000, J THORAC CARDIOV SUR, V120, P1120, DOI 10.1067/mtc.2000.110384
   Sajja LR, 2007, J THORAC CARDIOV SUR, V133, P378, DOI 10.1016/j.jtcvs.2006.09.028
   Salminen US, 1999, J ANTIMICROB CHEMOTH, V44, P287, DOI 10.1093/jac/44.2.287
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Santa-Cruz RA, 2006, CATHETER CARDIO INTE, V67, P68, DOI 10.1002/ccd.20552
   Santos ATL, 2006, BRAZ J MED BIOL RES, V39, P63, DOI 10.1590/S0100-879X2006000100007
   Savage RM, 1997, ANN THORAC SURG, V64, P368, DOI 10.1016/S0003-4975(97)00612-7
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schwann TA, 2002, ANN THORAC SURG, V73, P1394, DOI 10.1016/S0003-4975(02)03422-7
   Serfontein L, 2010, CURR OPIN ANESTHESIO, V23, P103, DOI 10.1097/ACO.0b013e328334cb75
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Sergeant P, 1998, J THORAC CARDIOV SUR, V116, P440, DOI 10.1016/S0022-5223(98)70010-8
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   SETHI GK, 1990, J AM COLL CARDIOL, V15, P15
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008
   Shamshad F, 2010, AM HEART J, V160, P145, DOI 10.1016/j.ahj.2010.02.037
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Sheiman RG, 2007, AM J ROENTGENOL, V188, pW475, DOI 10.2214/AJR.06.1024
   Shernan SK, 2004, ANN THORAC SURG, V77, P942, DOI 10.1016/j.athoracsur.2003.08.054
   Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016
   SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785
   Shroyer ALW, 1996, ANN THORAC SURG, V61, P17, DOI 10.1016/0003-4975(95)00830-6
   SILVERMAN NA, 1982, ANN SURG, V196, P194, DOI 10.1097/00000658-198208000-00012
   Simoons ML, 1996, NEW ENGL J MED, V335, P275, DOI 10.1056/NEJM199607253350409
   Sirivella S, 2000, ANN THORAC SURG, V69, P501, DOI 10.1016/S0003-4975(99)01298-9
   Sjogren J, 2005, ANN THORAC SURG, V80, P1270, DOI 10.1016/j.athoracsur.2005.04.010
   Sjogren J, 2005, ANN THORAC SURG, V79, P2049, DOI 10.1016/j.athorascur.2004.12.048
   Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070
   SLOGOFF S, 1988, ANESTHESIOLOGY, V68, P676, DOI 10.1097/00000542-198805000-00004
   SLOGOFF S, 1985, ANESTHESIOLOGY, V62, P107, DOI 10.1097/00000542-198502000-00002
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith PK, 2010, J THORAC CARDIOVASC, V142, P89
   Smith PM, 2009, CAN MED ASSOC J, V180, P1297, DOI 10.1503/cmaj.080862
   Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516
   Smith WT, 2004, J AM COLL CARDIOL, V44, P1241, DOI 10.1016/j.jacc.2004.06.031
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   SOWDEN AJ, 1995, BRIT MED J, V311, P151
   Spelman D, 2002, INFECT CONT HOSP EP, V23, P402, DOI 10.1086/502074
   Stamou SC, 2006, J THORAC CARDIOV SUR, V131, P28, DOI 10.1016/j.jtcvs.2005.08.059
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stevens LM, 2004, J THORAC CARDIOV SUR, V127, P1408, DOI 10.1016/j.jtcvs.2003.10.006
   Stewart RD, 1998, ANN THORAC SURG, V66, P1306, DOI 10.1016/S0003-4975(98)00760-7
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   Surgenor SD, 2006, CIRCULATION, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271
   Swaminathan M, 2007, ANESTHESIOLOGY, V107, P739
   Taghaddomi RJ, 2009, J CARDIOTHOR VASC AN, V23, P312, DOI 10.1053/j.jvca.2008.09.018
   Taillefer MC, 2006, J THORAC CARDIOV SUR, V131, P1274, DOI 10.1016/j.jtcvs.2006.02.001
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Tavakoli R, 2002, EUR J CARDIO-THORAC, V21, P818, DOI 10.1016/S1010-7940(02)00065-9
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   ten Broecke PWC, 2003, BRIT J ANAESTH, V90, P27, DOI 10.1093/bja/aeg013
   Tenenbein PK, 2008, CAN J ANAESTH, V55, P344, DOI 10.1007/BF03021489
   Testa L, 2008, J THORAC CARDIOV SUR, V136, P884, DOI 10.1016/j.jtcvs.2007.12.062
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   De Giorgio L, 2000, NEW ENGL J MED, V342, P1376
   Talbot P, 2000, NEW ENGL J MED, V342, P748
   Thielmann M, 2007, J THORAC CARDIOV SUR, V134, P1143, DOI 10.1016/j.jtcvs.2007.07.029
   THOMAS D, 1991, EUR HEART J, V12, P832
   Thomas RJ, 2007, CIRCULATION, V116, P1611, DOI 10.1161/CIRCULATIONAHA.107.185734
   Thys DM, 2009, ANESTH ANALG, V109, P1782, DOI 10.1213/ANE.0b013e3181be4002
   TIME Investigators, 2001, Lancet, V358, P951
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   TOWNSEND TR, 1993, J THORAC CARDIOV SUR, V106, P664
   Trichon BH, 2003, CIRCULATION, V108, P103, DOI 10.1161/01.cir.0000087656.10829.df
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Tu JV, 1997, J AM COLL CARDIOL, V30, P1317, DOI 10.1016/S0735-1097(97)00295-7
   TUMAN KJ, 1989, ANESTHESIOLOGY, V70, P199, DOI 10.1097/00000542-198902000-00004
   Tumlin JA, 2005, AM J KIDNEY DIS, V46, P26, DOI 10.1053/j.ajkd.2005.04.002
   Urban PM, 2004, AM J CARDIOL, V94, P181, DOI 10.1016/j.amjcard.2004.03.058
   Vaccarino GN, 2009, J THORAC CARDIOV SUR, V137, P309, DOI 10.1016/j.jtcvs.2008.08.002
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van de Watering LMG, 1998, CIRCULATION, V97, P562
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   van Mastrigt GAPG, 2006, CRIT CARE MED, V34, P1624, DOI 10.1097/01.CCM.0000217963.87227.7B
   van Straten AHM, 2010, INTERACT CARDIOV TH, V10, P37, DOI 10.1510/icvts.2009.214551
   van Straten AHM, 2010, J CARDIOTHOR VASC AN, V24, P413, DOI 10.1053/j.jvca.2010.01.001
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770
   Vesely DL, 2003, AM J PHYSIOL-RENAL, V285, pF167, DOI 10.1152/ajprenal.00259.2002
   Vuorisalo S, 1998, INFECT CONT HOSP EP, V19, P234
   Wadhera RK, 2010, J THORAC CARDIOV SUR, V139, P312, DOI 10.1016/j.jtcvs.2009.10.048
   WALSH EE, 2010, ARCH INTERN MED, V171, P68
   Walsh SR, 2008, EUR J CARDIO-THORAC, V34, P985, DOI 10.1016/j.ejcts.2008.07.062
   Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6
   Wang G, 2010, J CARDIOTHOR VASC AN, V2, P268, DOI DOI 10.1152/AJPRENAL.00259.2002
   Wang JW, 2004, ANESTH ANALG, V99, P965, DOI 10.1213/01.ane.0000130614.45647.81
   Weightman WM, 1999, ANESTH ANALG, V88, P286, DOI 10.1097/00000539-199902000-00011
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Welke KF, 2005, ANN THORAC SURG, V80, P2114, DOI 10.1016/j.athoracsur.2005.05.017
   Welke KF, 2007, ANN THORAC SURG, V84, P1538, DOI 10.1016/j.athoracsur.2007.06.022
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   White CM, 2007, EUR J CARDIO-THORAC, V31, P817, DOI 10.1016/j.ejcts.2007.02.010
   White HD, 2005, CIRCULATION, V112, P1992, DOI 10.1161/CIRCULATIONAHA.105.540948
   Wiesbauer F, 2007, ANESTH ANALG, V104, P27, DOI 10.1213/01.ane.0000247805.00342.21
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   WILSON APR, 1988, J ANTIMICROB CHEMOTH, V21, P213, DOI 10.1093/jac/21.2.213
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wong CHK, 2006, EUR J CARDIO-THORAC, V30, P148, DOI 10.1016/j.ejcts.2006.03.049
   Wu CT, 2004, CIRCULATION, V110, P784, DOI 10.1161/01.CIR.0000138744.13516.B5
   Yamaguchi A, 2009, ANN THORAC CARDIOVAS, V15, P98
   Yao Yun-tai, 2009, Chinese Medical Sciences Journal, V24, P133
   Yau JM, 2008, AM J CARDIOL, V102, P546, DOI 10.1016/j.amjcard.2008.04.069
   Young EW, 1998, ANN THORAC SURG, V65, P1316, DOI 10.1016/S0003-4975(98)00157-X
   Yu CH, 2006, CAN J ANAESTH, V53, P906
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Zarbock A, 2009, CHEST, V135, P1252, DOI 10.1378/chest.08-1602
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   Zimarino M, 2004, ANN THORAC SURG, V78, P135, DOI 10.1016/j.athorascur.2003.12.030
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
   Zvara DA, 2000, J CARDIOTHOR VASC AN, V14, P571, DOI 10.1053/jcan.2000.9445
NR 495
TC 52
Z9 55
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD DEC 6
PY 2011
VL 124
IS 23
BP 2610
EP 2642
DI 10.1161/CIR.0b013e31823b5fee
PG 33
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 863QW
UT WOS:000298183300023
PM 22064600
ER

PT J
AU Sharma, R
   Wang, W
   Rasmussen, JC
   Joshi, A
   Houston, JP
   Adams, KE
   Cameron, A
   Ke, S
   Kwon, S
   Mawad, ME
   Sevick-Muraca, EM
AF Sharma, Ruchi
   Wang, Wei
   Rasmussen, John C.
   Joshi, Amit
   Houston, Jessica P.
   Adams, Kristen E.
   Cameron, Arlin
   Ke, Shi
   Kwon, Sunkuk
   Mawad, Michel E.
   Sevick-Muraca, Eva M.
TI Quantitative imaging of lymph function
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article
DE optical imaging; indocyanine green; hyaluronan; lymphedema
ID NEAR-INFRARED FLUORESCENCE; SENTINEL NODE DETECTION; BREAST-CANCER;
   CONTRAST AGENTS; QUANTUM DOTS; IN-VIVO; LYMPHANGIOGRAPHY; HYALURONAN;
   LYVE-1; ENDOTHELIUM
AB Functional lymphatic imaging, was demonstrated in the abdomen and anterior hindlimb of anesthetized. intact Yorkshire swine by using near-infrared (NIR) fluorescence imaging following intradermal administration of 100-200 mu l of 32 mu M indocyanine green (ICG) and 64 mu M hyaluronan NIR imaging conjugate to target the lymph vacular endothelial receptor (LYVE)-1 on the lymph endothelium. NIR fluorescence imaging employed illumination of 780 nm excitation light (similar to 2 nW/cm(2)) and collection of 830 nm fluorescence generated from the ima imaging agents. Our results show the ability to image the immediate trafficking, of ICG from the plexus, through the vessels and lymph-angions, and to the superficial mammary. subiliac. and middle iliac lymph nodes. which were located as (Jeep as 3 cin beneath the tissue Surface. "Packets" of ICG-transited lymph vessels of 2-16 cin length propelled at frequencies of 0.5-3.3 pulses/min and velocities of 0.23-0.75 cm/s. Lymph propulsion Was independent of respiration rate. In the case of the hyaluronan imaging agent. lymph propulsion was absent as the dye progressed immediately through the plexus and stained the lymph vessels and nodes. Lymph imaging required 5.0 and 11.9 mu g of ICG and hyaluronan conjugate, respectively. Our results Suggest that mnicrogram quantities of NIR optical imaging agents and their conjugates have a potential to image lymph function in patients suffering from lymph-related disorders.
C1 Baylor Coll Med, Dept Radiol, Div Mol Imaging, Houston, TX 77030 USA.
RP Sevick-Muraca, EM (reprint author), Baylor Coll Med, Dept Radiol, Div Mol Imaging, Houston, TX 77030 USA.
EM evas@bcm.edu
CR Armer JM, 2005, CANCER INVEST, V23, P76, DOI 10.1081/CNV-200048707
   Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037
   Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   Bergmark K, 2006, INT J GYNECOL CANCER, V16, P1130, DOI 10.1111/j.1525-1438.2006.00601.x
   Carreira CM, 2001, CANCER RES, V61, P8079
   Clement O, 2004, EUR RADIOL, V14, P1498, DOI 10.1007/s00330-004-2265-9
   DEVRIES M, 2006, SURG ONCOL, V32, P785
   Ellner SJ, 2003, NUCL MED BIOL, V30, P805, DOI 10.1016/j.nucmedbio.2003.10.001
   Ferrell RE, 2002, ANN NY ACAD SCI, V979, P39
   Gurfinkel M, 2000, PHOTOCHEM PHOTOBIOL, V72, P94, DOI 10.1562/0031-8655(2000)072<0094:POIAHC>2.0.CO;2
   Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642
   Houston JP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2114748
   Hultén L, 1966, Acta Chir Scand, V132, P261
   Ji RC, 2005, HISTOL HISTOPATHOL, V20, P155
   Karkkainen MJ, 2002, NAT CELL BIOL, V4, pE2, DOI 10.1038/ncb0102-e2
   Keberle M, 2000, EUR RADIOL, V10, P1591, DOI 10.1007/s003300000384
   Kersey TW, 2001, J SURG RES, V96, P255, DOI 10.1006/jsre.2000.6075
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   KINMONTH JB, 1972, LYMPHATICS DIS LYMPH, P420
   Kobayashi H, 2003, MAGNET RESON MED, V50, P758, DOI 10.1002/mrm.10583
   LAURENT TC, 1992, FASEB J, V6, P2397
   LIU N, 2005, J VASC SURG, V41, P70
   Luciani A, 2006, EUR J RADIOL, V58, P338, DOI 10.1016/j.ejrad.2005.12.038
   Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158
   McGreevy JM, 2003, J SURG RES, V111, P38, DOI 10.1016/S0022-4804(03)00000-0
   MCINNES RR, 2003, CLIN GENET, V64, P282
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   Mellor RH, 2000, J VASC RES, V37, P501, DOI 10.1159/000054083
   Misselwitz B, 2006, EUR J RADIOL, V58, P375, DOI 10.1016/j.ejrad.2005.12.044
   Moghimi SM, 1996, PROG BIOPHYS MOL BIO, V65, P221, DOI 10.1016/S0079-6107(96)00012-0
   Oliver G, 2005, ANNU REV CELL DEV BI, V21, P457, DOI 10.1146/annurev.cellbio.21.012704.132338
   O'Mahony S, 2004, EUR J NUCL MED MOL I, V31, P555, DOI 10.1007/s00259-003-1399-3
   Parungo CP, 2005, J THORAC CARDIOV SUR, V129, P844, DOI 10.1016/j.jtcvs.2004.08.001
   Parungo CP, 2005, CHEST, V127, P1799, DOI 10.1378/chest.127.5.1799
   Reynolds JS, 1997, BIOTECHNOL PROGR, V13, P669, DOI 10.1021/bp970085g
   Reynolds JS, 1999, PHOTOCHEM PHOTOBIOL, V70, P87, DOI 10.1562/0031-8655(1999)070<0087:IOSCMT>2.3.CO;2
   Ridner SH, 2006, PATIENT EDUC COUNS, V61, P72, DOI 10.1016/j.pec.2005.02.009
   Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942
   SILVESTRI RC, 1980, AM REV RESPIR DIS, V122, P543
   Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055
   Soltesz EG, 2006, ANN SURG ONCOL, V13, P386, DOI 10.1245/ASO.2006.04.025
   Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8
   Szuba A, 2003, J NUCL MED, V44, P43
   Tiwari A, 2003, ARCH SURG-CHICAGO, V138, P152, DOI 10.1001/archsurg.138.2.152
   Vogl T J, 1997, Acta Radiol Suppl, V412, P47
   Wallace AM, 2003, ANN SURG ONCOL, V10, P531, DOI 10.1245/ASO.2003.07.012
   Wisner ER, 2003, INVEST RADIOL, V38, P358, DOI 10.1097/01.rli.0000065423.05038.88
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
NR 48
TC 52
Z9 54
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6135
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD JUN
PY 2007
VL 292
IS 6
BP H3109
EP H3118
DI 10.1152/ajpheart.01223.2006
PG 10
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular
   Disease
SC Cardiovascular System & Cardiology; Physiology
GA 186KJ
UT WOS:000247777300067
PM 17307997
ER

PT J
AU Swindle, PW
   Kattan, MW
   Scardino, PT
AF Swindle, PW
   Kattan, MW
   Scardino, PT
TI Markers and meaning of primary treatment failure
SO UROLOGIC CLINICS OF NORTH AMERICA
LA English
DT Review
ID PROSTATE-SPECIFIC ANTIGEN; RADICAL RETROPUBIC PROSTATECTOMY;
   EXTERNAL-BEAM RADIATION; POSITRON-EMISSION-TOMOGRAPHY; DIGITAL RECTAL
   EXAMINATION; JOHNS-HOPKINS EXPERIENCE; TERM FOLLOW-UP; LOCAL RECURRENCE;
   BIOCHEMICAL FAILURE; DISEASE RECURRENCE
AB This article reviews the various endpoints used to assess the efficacy of therapy for carcinoma of the prostate. The most common clinically used endpoint for determining failure following therapy for localized carcinoma of the prostate is biochemical recurrence (BCR). Until recently, the true meaning and implications of BCR were not well understood. This article briefly reviews the factors that predict BCR and discusses the natural history of BCR following radical prostatectomy and radiotherapy. It also outlines the clinicopathologic factors that allow for prediction of disease recurrence, and reviews the utility of investigations used to identify local recurrence and metastatic disease. Presently, there are no validated recommendations for the treatment of BCR. This information provides the framework on which patients can be stratified according to their risk for developing local and metastatic disease, and thereby be appropriately selected for adjuvant, local, or systemic therapy trials.
C1 Mem Sloan Kettering Canc Ctr, Dept Urol, Sidney Kimmel Ctr Prostate, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Urol Ctr, New York, NY 10021 USA.
RP Scardino, PT (reprint author), Mem Sloan Kettering Canc Ctr, Dept Urol, Sidney Kimmel Ctr Prostate, 1275 York Ave, New York, NY 10021 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5
   Bauer JJ, 1997, CANCER, V79, P952, DOI 10.1002/(SICI)1097-0142(19970301)79:5<952::AID-CNCR12>3.0.CO;2-1
   BRAWER MK, 1995, PROSTATE, V27, P1, DOI 10.1002/pros.2990270102
   Cadeddu JA, 1998, J UROLOGY, V159, P173, DOI 10.1016/S0022-5347(01)64047-3
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   CATALONA WJ, 1994, J UROLOGY, V151, P1283
   Cheng L, 1999, AM J SURG PATHOL, V23, P1173, DOI 10.1097/00000478-199910000-00002
   Cher ML, 1998, J UROLOGY, V160, P1387, DOI 10.1016/S0022-5347(01)62545-X
   CHODAK GW, 1990, UROLOGY, V35, P288, DOI 10.1016/0090-4295(90)80147-F
   Coakley FV, 2001, RADIOLOGY, V219, P817
   Connell PP, 1999, UROLOGY, V54, P875, DOI 10.1016/S0090-4295(99)00253-8
   Connolly JA, 1996, UROLOGY, V47, P225, DOI 10.1016/S0090-4295(99)80421-X
   Cookson M M, 2001, Cancer Control, V8, P133
   Cox JD, 1999, J CLIN ONCOL, V17, P1155
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   CROOK J, 1993, INT J RADIAT ONCOL, V27, P31
   Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I
   CROOK JM, 1995, UROLOGY, V45, P624, DOI 10.1016/S0090-4295(99)80054-5
   D'Amico AV, 1999, J CLIN ONCOL, V17, P168
   D'Amico AV, 1998, J UROLOGY, V160, P2096, DOI 10.1016/S0022-5347(01)62251-1
   DAMICO AV, 1995, J UROLOGY, V154, P131, DOI 10.1016/S0022-5347(01)67248-3
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Diamandis EP, 1997, UROL CLIN N AM, V24, P275, DOI 10.1016/S0094-0143(05)70373-6
   Do T, 1998, CANCER J SCI AM, V4, P324
   EGAWA S, 1992, UROLOGY, V39, P358, DOI 10.1016/0090-4295(92)90213-G
   Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504
   Ellis WJ, 1997, UROLOGY, V50, P573, DOI 10.1016/S0090-4295(97)00251-3
   Epstein JI, 1996, AM J SURG PATHOL, V20, P286, DOI 10.1097/00000478-199603000-00004
   Epstein JI, 2001, UROL CLIN N AM, V28, P567, DOI 10.1016/S0094-0143(05)70164-6
   EPSTEIN JI, 1993, CANCER, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y
   FERGUSON JK, 1994, UROL CLIN N AM, V21, P677
   FIJUTH J, 1992, RADIOTHER ONCOL, V23, P236
   FOSTER LS, 1993, J UROLOGY, V149, P1024
   FOWLER JE, 1995, J UROLOGY, V153, P1011, DOI 10.1016/S0022-5347(01)67624-9
   FRAZIER HA, 1993, J UROLOGY, V149, P516
   Freedman GM, 1999, UROLOGY, V54, P118, DOI 10.1016/S0090-4295(99)00090-4
   FUJII Y, 1995, BRIT J UROL, V75, P54, DOI 10.1111/j.1464-410X.1995.tb07232.x
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537
   GOSFIELD E, 1993, J NUCL MED, V34, P2191
   Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4
   Hanks GE, 1996, INT J RADIAT ONCOL, V34, P549, DOI 10.1016/0360-3016(95)02154-X
   Hanlon AL, 2000, INT J RADIAT ONCOL, V46, P559, DOI 10.1016/S0360-3016(99)00450-2
   Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923
   Hoh CK, 1998, J UROLOGY, V159, P347, DOI 10.1016/S0022-5347(01)63916-8
   Horwitz EM, 1998, INT J RADIAT ONCOL, V41, P267, DOI 10.1016/S0360-3016(98)00078-9
   Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7
   Jemal A, 2002, CA-CANCER J CLIN, V52, P23
   Jhaveri FM, 1999, UROLOGY, V54, P884, DOI 10.1016/S0090-4295(99)00252-6
   Johnstone P A, 1997, Urol Oncol, V3, P108, DOI 10.1016/S1078-1439(98)00007-6
   Johnstone PAS, 2001, J UROLOGY, V166, P1684, DOI 10.1016/S0022-5347(05)65653-4
   Kahn D, 1998, J UROLOGY, V159, P2041, DOI 10.1016/S0022-5347(01)63239-7
   Kattan MW, 1997, CANCER, V79, P528, DOI 10.1002/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.0.CO;2-5
   Kattan MW, 2000, INT J RADIAT ONCOL, V48, P1469, DOI 10.1016/S0360-3016(00)01359-6
   Kattan MW, 1998, J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766
   Kattan MW, 1999, J CLIN ONCOL, V17, P1499
   Kattan MW, 2000, J CLIN ONCOL, V18, P3352
   KELLY WK, 1993, J CLIN ONCOL, V11, P607
   Koppie TM, 2001, J UROLOGY, V166, P111, DOI 10.1016/S0022-5347(05)66087-9
   Kramer S, 1997, BRIT J RADIOL, V70, P995
   Kupelian P, 1996, UROLOGY, V48, P249, DOI 10.1016/S0090-4295(96)00167-7
   Kurhanewicz J, 1996, RADIOLOGY, V200, P489
   Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8
   Lange PH, 2001, UROLOGY, V57, P402, DOI 10.1016/S0090-4295(00)01109-2
   Laufer M, 2000, UROLOGY, V55, P309, DOI 10.1016/S0090-4295(99)00465-3
   Lee CT, 1997, UROL CLIN N AM, V24, P389, DOI 10.1016/S0094-0143(05)70385-2
   Lee WR, 1997, J CLIN ONCOL, V15, P230
   LEIBMAN BD, 1995, CANCER, V76, P2530, DOI 10.1002/1097-0142(19951215)76:12<2530::AID-CNCR2820761219>3.0.CO;2-F
   Leibman BD, 1998, J CLIN ONCOL, V16, P2267
   Leventis AK, 2001, RADIOLOGY, V219, P432
   Leventis AK, 2001, J CLIN ONCOL, V19, P1030
   Levesque PE, 1998, UROLOGY, V51, P978, DOI 10.1016/S0090-4295(98)00025-9
   LIGHTNER DJ, 1990, J UROLOGY, V144, P921
   LINK P, 1991, J UROLOGY, V145, P532
   Lowe BA, 1997, J UROLOGY, V158, P1452, DOI 10.1016/S0022-5347(01)64240-X
   MOSTOFI FK, 1993, CANCER, V71, P906, DOI 10.1002/1097-0142(19930201)71:3+<906::AID-CNCR2820711407>3.0.CO;2-I
   Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8
   Moul JW, 1999, ONCOLOGY-NY, V13, P985
   Murphy GP, 1998, CANCER, V83, P2259, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2259::AID-CNCR5>3.0.CO;2-T
   Nudell DM, 2000, RADIOL CLIN N AM, V38, P213, DOI 10.1016/S0033-8389(05)70157-3
   Nudell DM, 1999, UROLOGY, V54, P1049, DOI 10.1016/S0090-4295(99)00299-X
   OESTERLING JE, 1991, J UROLOGY, V145, P907
   OESTERLING JE, 1988, J UROLOGY, V139, P766
   Oh J, 1999, J UROLOGY, V161, P520, DOI 10.1016/S0022-5347(01)61939-6
   OHORI M, 1995, J UROLOGY, V154, P1818, DOI 10.1016/S0022-5347(01)66792-2
   Ohori M, 1999, J UROLOGY, V161, P500, DOI 10.1016/S0022-5347(01)61935-9
   Ornstein DK, 1998, UROL CLIN N AM, V25, P591, DOI 10.1016/S0094-0143(05)70050-1
   Ornstein DK, 1998, UROLOGY, V52, P1047, DOI 10.1016/S0090-4295(98)00403-8
   PARRA RO, 1990, J UROLOGY, V144, P707
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   PARTIN AW, 1995, UROLOGY, V45, P831, DOI 10.1016/S0090-4295(99)80091-0
   PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5
   PARTIN AW, 1994, J UROLOGY, V152, P1358
   PARTIN AW, 1993, J UROLOGY, V150, P110
   Patel A, 1997, J UROLOGY, V158, P1441, DOI 10.1016/S0022-5347(01)64238-1
   Petronis JD, 1998, CLIN NUCL MED, V23, P672, DOI 10.1097/00003072-199810000-00005
   POLLACK A, 1994, CANCER, V74, P670, DOI 10.1002/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407
   Ravery V, 1999, Semin Urol Oncol, V17, P127
   Ripple MG, 2000, MODERN PATHOL, V13, P521, DOI 10.1038/modpathol.3880091
   RITTER MA, 1992, J CLIN ONCOL, V10, P1208
   Roach M, 2001, ONCOLOGY-NY, V15, P1399
   Roberts SG, 2001, MAYO CLIN PROC, V76, P576
   Saleem MD, 1998, UROLOGY, V51, P283, DOI 10.1016/S0090-4295(97)00509-8
   SALOMON CG, 1993, RADIOLOGY, V189, P713
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Scardino P T, 1983, Semin Urol, V1, P243
   Schellhammer P, 1997, UROLOGY, V49, P27, DOI 10.1016/S0090-4295(99)80321-5
   Scher HI, 1996, J NATL CANCER I, V88, P1623, DOI 10.1093/jnci/88.22.1623
   Scher HI, 1999, JAMA-J AM MED ASSOC, V281, P1642, DOI 10.1001/jama.281.17.1642
   Seckin B, 1996, WORLD J UROL, V14, pS26
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Silverman JM, 1997, AM J ROENTGENOL, V168, P379
   Slovin S F, 1999, Semin Urol Oncol, V17, P164
   Smith-Jones PM, 2000, CANCER RES, V60, P5237
   Steineck G, 1991, Scand J Urol Nephrol Suppl, V138, P121
   Stephenson RA, 1997, WORLD J UROL, V15, P331, DOI 10.1007/BF01300179
   TAKAYAMA TK, 1993, J UROLOGY, V150, P374
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   Troyer JK, 1997, PROSTATE, V30, P232, DOI 10.1002/(SICI)1097-0045(19970301)30:4<232::AID-PROS2>3.0.CO;2-N
   TURNER JW, 1993, J UROLOGY, V149, P1482
   VANDENOUDEN D, 1993, BRIT J UROL, V72, P489
   vanIersel MP, 1996, BRIT J UROL, V77, P418, DOI 10.1046/j.1464-410X.1996.91017.x
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
   Wheeler TM, 1998, HUM PATHOL, V29, P856, DOI 10.1016/S0046-8177(98)90457-9
   YU H, 1995, CLIN CHEM, V41, P430
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V31, P237, DOI 10.1016/0360-3016(94)00323-D
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   Zagars GK, 1997, CANCER, V79, P1370, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X
   ZAGARS GK, 1993, CANCER, V72, P538, DOI 10.1002/1097-0142(19930715)72:2<538::AID-CNCR2820720234>3.0.CO;2-S
   ZAGARS GK, 1991, CANCER, V68, P2370, DOI 10.1002/1097-0142(19911201)68:11<2370::AID-CNCR2820681107>3.0.CO;2-T
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
   ZELEFSKY MJ, 1995, J CLIN ONCOL, V13, P459
   ZIETMAN AL, 1995, INT J RADIAT ONCOL, V32, P287, DOI 10.1016/0360-3016(95)00123-G
   ZIETMAN AL, 1994, J UROLOGY, V151, P640
   ZIETMAN AL, 1993, CANCER, V71, P959, DOI 10.1002/1097-0142(19930201)71:3+<959::AID-CNCR2820711411>3.0.CO;2-L
   ZINCKE H, 1994, J UROLOGY, V152, P1850
NR 142
TC 52
Z9 54
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0094-0143
J9 UROL CLIN N AM
JI Urol. Clin. N. Am.
PD MAY
PY 2003
VL 30
IS 2
BP 377
EP +
DI 10.1016/S0094-0143(02)00176-3
PG 26
WC Urology & Nephrology
SC Urology & Nephrology
GA 671UR
UT WOS:000182482900018
PM 12735513
ER

PT J
AU Witte, MH
   Erickson, R
   Bernas, M
   Andrade, M
   Reiser, F
   Conlon, W
   Hoyme, HE
   Witte, CL
AF Witte, MH
   Erickson, R
   Bernas, M
   Andrade, M
   Reiser, F
   Conlon, W
   Hoyme, HE
   Witte, CL
TI Phenotypic and genotypic heterogeneity in familial Milroy lymphedema
SO LYMPHOLOGY
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE; VEGF-C; LYMPHATIC-SYSTEM;
   RECEPTOR; FLT4; HEREDITARY; EXPRESSION; DISEASE; LINKAGE
AB Familial Milroy lymphedema (ML) is classified as an autosomal dominant disorder characterized by peripheral edema of the lower extremities at birth or in early childhood. The variety of phenotypes are not well described, and the genomic location and functional expression of the gene or genes underlying this and related familial lymphedema syndromes remain largely unknown. In this collaborative study between the University of Arizona and the University of Sao Paulo, we collected clinical pedigrees on 6 ML families, carried out clinical examination of affected and unaffected individuals, and in representative affected members of two of the families performed dynamic lymphangioscintigraphy (LAS) of the lower and upper limbs to delineate further the ML lymphangiodysplastic phenotype. To localize the gene for ML, we conducted a genome-wide search in 4 of the families using 387 polymorphic dinucleotide-repeat markers at approximate 10 cM spacing in 54 subjects (affected, unaffected bloodline relatives, and spouses). In all 6 families (86 subjects), we specifically examined the suggested linkage to the vascular endothelial growth factor (VEGF)-C receptor (Flt4) gene localized to the chromosome region 5q34-q35, The findings provide evidence for a spectrum of ML clinical and LAS phenotypes and also suggest ML locus heterogeneity.
C1 Univ Arizona, Coll Med, Dept Surg, Tucson, AZ 85724 USA.
   Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ 85724 USA.
   Univ Sao Paulo, Dept Surg, Sao Paulo, Brazil.
RP Witte, MH (reprint author), Univ Arizona, Coll Med, Dept Surg GS&T, POB 245063, Tucson, AZ 85724 USA.
EM lymph@u.arizona.edu
CR AAGAENAES O, 1970, ARCH DIS CHILD, V45, P690
   APRELIKOVA O, 1992, CANCER RES, V52, P746
   Boehnke M, 1997, SIMLINK PROGRAM ESTI
   BOLLINGER A, 1983, LYMPHOLOGY, V16, P27
   DALE R, 1985, J MED GENET, V2, P274
   Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946
   ERICKSON R, D SMITH MORPH MALF C
   ERSEK RA, 1966, SURGERY, V60, P1098
   ESTERLY J R, 1965, J Med Genet, V2, P93, DOI 10.1136/jmg.2.2.93
   GALLAND F, 1992, GENOMICS, V13, P475, DOI 10.1016/0888-7543(92)90277-Y
   GREENLEE R, 1993, LYMPHOLOGY, V26, P156
   Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48
   HEINISCH HM, 1983, LYMPHANGIOLOGY, P777
   HOYME HE, D SMITH MORPH MALF C
   JACKSON FI, 1978, CLIN NUCL MED, V3, P296, DOI 10.1097/00003072-197807000-00009
   Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423
   Joukov V, 1996, EMBO J, V15, P290
   KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566
   KIMAK MA, 1998, AM J HUM GENET, V63, pA34
   KINMONTH JB, 1972, LYMPHATICS DIS LYMPH, P143
   Kukk E, 1996, DEVELOPMENT, V122, P3829
   LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443
   Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988
   LETESSIER EE, 1865, THESIS FM STRASBOURG
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   Meige H, 1898, PRESSE MED, V6, P341
   Milroy W F, 1892, NY MED J, V56, P505
   Nonne M, 1891, VIRCHOWS ARCH, V125, P189, DOI 10.1007/BF01970303
   PAPENDIECK CM, 1992, ATLAS COLOR TEMAS AN
   PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543
   WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M
   WITTE CL, 1987, LYMPHOLOGY, V20, P171
   Witte MH, 1998, LYMPHOLOGY, V31, P37
   WITTE MH, 1986, LYMPHOLOGY, V19, P21
   Witte MH, 1997, REGULATION ANGIOGENE, P65
   WITTE MH, 1998, PHLEBOLYMPHOLOGY, V16, P19
NR 36
TC 52
Z9 58
PU LYMPHOLOGY
PI TUCSON
PA C/O C L WITTE MD 1501 N CAMPBELL AVE DEPT SURGERY, TUCSON, AZ 85724 USA
SN 0024-7766
J9 LYMPHOLOGY
JI Lymphology
PD DEC
PY 1998
VL 31
IS 4
BP 145
EP 155
PG 11
WC Immunology; Physiology
SC Immunology; Physiology
GA 160KB
UT WOS:000078228400001
PM 9949386
ER

PT J
AU Oshinski, JN
   Parks, WJ
   Markou, CP
   Bergman, HL
   Larson, BE
   Ku, DN
   Mukundan, S
   Pettigrew, RI
AF Oshinski, JN
   Parks, WJ
   Markou, CP
   Bergman, HL
   Larson, BE
   Ku, DN
   Mukundan, S
   Pettigrew, RI
TI Improved measurement of pressure gradients in aortic coarctation by
   magnetic resonance imaging
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID DOPPLER ECHOCARDIOGRAPHY; ARTERIAL-STENOSIS; NONINVASIVE QUANTIFICATION;
   VALVE STENOSIS; PULSATILE FLOW; ANGIOGRAPHY; VELOCITY; CHILDREN;
   ACCURACY; INVIVO
AB Objectives. This study evaluated whether magnetic resonance imaging (MRI) and magnetic resonance (MR) phase velocity mapping could provide accurate estimates of stenosis severity and pressure gradients in aortic coarctation.
   Background. Clinical management of aortic coarctation re quires determination of lesion location and severity and quantification of the pressure gradient across the constricted area,
   Methods. Using a series of anatomically accurate models of aortic coarctation, the laboratory portion of this study found that the loss coefficient (K), commonly taken to be 4.0 in the simplified Bernoulli equation Delta P = KV2, was a function of stenosis severity. The values of the loss coefficient ranged from 2.8 for a 50% stenosis to 4.9 for a 90% stenosis, Magnetic resonance imaging and MR phase velocity mapping were then used to determine coarctation severity and pressure gradient in 32 patients.
   Results. Application of the new severity-dependent loss coefficients found that pressure gradients deviated from 1 to 17 mm Hg compared with calculations made with the commonly used value of 4.0, Comparison of MR estimates of pressure gradient with Doppler ultrasound estimates (in 22 of 32 patients) and with catheter pressure measurements (in 6 of 32 patients) supports the conclusion that the severity based loss coefficient provides improved estimates of pressure gradients.
   Conclusions. This study suggests that MRI could he used as a complete diagnostic toot for accurate evaluation of aortic coarctation, by determining stenosis location and severity and by accurately estimating pressure gradients. (C) 1996 by the American College of Cardiology
C1 EMORY UNIV, SCH MED, DEPT HEMATOL, ATLANTA, GA 30322 USA.
   GEORGIA INST TECHNOL, SCH MECH ENGN, ATLANTA, GA 30332 USA.
   EGLESTON CHILDRENS HOSP, CHILDRENS HEART CTR, ATLANTA, GA USA.
RP Oshinski, JN (reprint author), EMORY UNIV, SCH MED, DEPT RADIOL, FREDERIK PHILIPS MR RES CTR, 1364 CLIFTON RD, ATLANTA, GA 30322 USA.
CR ANSON JA, 1993, NEUROSURGERY, V32, P335
   BERGER M, 1984, J AM COLL CARDIOL, V3, P150
   BOXER RA, 1986, J AM COLL CARDIOL, V7, P1095
   BUONOCORE MH, 1992, MAGNET RESON MED, V26, P141, DOI 10.1002/mrm.1910260115
   CAMPBELL M, 1970, BRIT HEART J, V32, P633
   CAPE EG, 1990, J BIOMECH, V23, P27, DOI 10.1016/0021-9290(90)90366-B
   CURRIE PJ, 1985, CIRCULATION, V71, P1162
   DEGRAAF RG, 1992, MAGN RESON IMAGING, V10, P25, DOI 10.1016/0730-725X(92)90369-B
   FACCENDA F, 1985, ANGIOLOGY, V36, P899, DOI 10.1177/000331978503601211
   FIRMIN DN, 1990, MAGNET RESON MED, V14, P230, DOI 10.1002/mrm.1910140209
   FUNG YC, 1988, BIOMECHANICS, P63
   Guyton A.C., 1991, TXB MED PHYSL
   HATTLE L, 1981, CIRCULATION, V64, P381
   KENT KC, 1991, J VASC SURG, V13, P311
   KILNER PJ, 1993, CIRCULATION, V87, P1239
   KOSTURAKIS D, 1984, J AM COLL CARDIOL, V3, P1256
   Ku D N, 1987, J Vasc Surg, V6, P274, DOI 10.1067/mva.1987.avs0060274
   LEVINE RA, 1989, J AM COLL CARDIOL, V13, P706
   MARX GR, 1986, J AM COLL CARDIOL, V7, P1379
   MOORE JE, 1992, J BIOMECH ENG-T ASME, V114, P391, DOI 10.1115/1.2891400
   MULIGAN SA, 1993, J MAGN RESON IMAGING, V3, P829
   NYMAN R, 1989, ACTA RADIOL, V30, P481
   OSHINSKI JN, 1995, MAGNET RESON MED, V33, P193, DOI 10.1002/mrm.1910330208
   OSHINSKI JN, 1992, JMRI-J MAGN RESON IM, V2, P665, DOI 10.1002/jmri.1880020610
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   PETTIGREW RI, 1987, AM J ROENTGENOL, V148, P411
   PUCILLO AL, 1989, AM HEART J, V117, P482, DOI 10.1016/0002-8703(89)90798-9
   Rao PS, 1996, J AM COLL CARDIOL, V27, P462, DOI 10.1016/0735-1097(95)00479-3
   REES S, 1989, RADIOLOGY, V173, P499
   RIJSTERBORGH H, 1987, ULTRASOUND MED BIOL, V13, P241, DOI 10.1016/0301-5629(87)90096-2
   SIMPSON IA, 1988, CIRCULATION, V78, P142
   SONDERGAARD L, 1993, AM HEART J, V126, P1156, DOI 10.1016/0002-8703(93)90669-Z
   STERN HC, 1991, PEDIATR CARDIOL, V12, P1, DOI 10.1007/BF02238489
   STEVENSON JG, 1984, J AM COLL CARDIOL, V3, P179
   VANDIJK P, 1984, J COMPUT ASSIST TOMO, V8, P429, DOI 10.1097/00004728-198406000-00012
   WEBER G, 1992, J VASC SURG, V16, P10
   YEAGER M, 1986, AM J CARDIOL, V57, P644, DOI 10.1016/0002-9149(86)90851-9
   YOGANATHAN AP, 1987, CIRCULATION, V76, P657
   YOUNG DF, 1973, J BIOMECH, V6, P395, DOI 10.1016/0021-9290(73)90099-7
   ZHANG Y, 1986, INT J CARDIOL, V10, P197, DOI 10.1016/0167-5273(86)90002-1
NR 40
TC 52
Z9 52
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD DEC
PY 1996
VL 28
IS 7
BP 1818
EP 1826
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA VY325
UT WOS:A1996VY32500026
PM 8962572
ER

PT J
AU DELEON, SY
   ILBAWI, MN
   IDRISS, FS
   MUSTER, AJ
   GIDDING, SS
   BERRY, TE
   PAUL, MH
AF DELEON, SY
   ILBAWI, MN
   IDRISS, FS
   MUSTER, AJ
   GIDDING, SS
   BERRY, TE
   PAUL, MH
TI FONTAN TYPE OPERATION FOR COMPLEX LESIONS - SURGICAL CONSIDERATIONS TO
   IMPROVE SURVIVAL
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
C1 CHILDRENS MEM HOSP,DIV CARDIOL,CHICAGO,IL 60614.
   NORTHWESTERN UNIV,SCH MED,DEPT SURG,CHICAGO,IL 60611.
   NORTHWESTERN UNIV,SCH MED,DEPT PEDIAT,CHICAGO,IL 60611.
RP DELEON, SY (reprint author), CHILDRENS MEM HOSP,DIV CARDIOVASC THORAC SURG,2300 CHILDRENS PLAZA,CHICAGO,IL 60614, USA.
CR BARBER G, 1984, J AM COLL CARDIOL, V4, P771
   BARGERON LM, 1972, AM J CARDIOL, V30, P211, DOI 10.1016/0002-9149(72)90060-4
   BJORK VO, 1979, J THORAC CARDIOV SUR, V77, P452
   BORUCHOW IB, 1970, J THORAC CARDIOV SUR, V60, P531
   Choussat A, 1978, PEDIAT CARDIOLOGY, P559
   CLEVELAND DC, 1984, ANN THORAC SURG, V38, P447
   CLOUTIER A, 1985, CIRCULATION, V72, P471
   DANIELSON GK, COMMUNICATION
   DEBRUX JL, 1983, J THORAC CARDIOV SUR, V85, P440
   DELEON SY, 1984, J THORAC CARDIOV SUR, V88, P601
   DELEON SY, 1986, J THORAC CARDIOV SUR, V92, P402
   DELEON SY, 1983, J THORAC CARDIOV SUR, V85, P669
   DICARLO D, 1982, J THORAC CARDIOV SUR, V83, P437
   DIDONATO R, 1985, ANN THORAC SURG, V39, P283
   DOTY DB, 1981, J THORAC CARDIOV SUR, V81, P470
   FONTAN F, 1983, J THORAC CARDIOV SUR, V85, P647
   GALE AW, 1979, J THORAC CARDIOV SUR, V78, P831
   GUYTON RA, 1985, CIRCULATION, V72, P97
   HECK HA, 1981, CIRCULATION, V64, P118
   HELGASON H, 1985, AM HEART J, V110, P705, DOI 10.1016/0002-8703(85)90117-6
   HOPKINS RA, 1985, J THORAC CARDIOV SUR, V90, P391
   ILBAWI MN, 1986, J THORAC CARDIOV SUR, V92, P231
   JUANEDA E, 1985, BRIT HEART J, V53, P515
   JUANEDA E, 1984, BRIT HEART J, V52, P575
   KREUTZER GO, 1982, J THORAC CARDIOV SUR, V83, P427
   LAKS H, 1984, J THORAC CARDIOV SUR, V88, P939
   LAKS H, 1980, ANN SURG, V192, P382, DOI 10.1097/00000658-198009000-00014
   LAKS H, 1977, J THORAC CARDIOV SUR, V74, P253
   LAMBERTI JJ, 1976, J THORAC CARDIOV SUR, V71, P386
   MAIR DD, 1978, MAYO CLIN PROC, V53, P397
   MAIR DD, 1985, CIRCULATION, V72, P1188
   MARCELLETTI C, 1980, J THORAC CARDIOV SUR, V80, P764
   MCFAUL RC, 1977, CIRCULATION, V55, P212
   MOLINA JE, 1985, ANN THORAC SURG, V39, P371
   OELERT H, 1984, THORAC CARDIOV SURG, V32, P392, DOI 10.1055/s-2007-1023433
   OTTENKAMP J, 1982, THORAX, V37, P718, DOI 10.1136/thx.37.10.718
   PENKOSKE PA, 1984, J THORAC CARDIOV SUR, V87, P767
   PENNINGTON DG, 1981, ANN THORAC SURG, V31, P532
   SAMANEK M, 1969, BRIT HEART J, V31, P511
   SANDERS SP, 1982, AM J CARDIOL, V49, P1733, DOI 10.1016/0002-9149(82)90253-3
   TATOOLES CJ, 1976, ANN THORAC SURG, V21, P499
   TRUSLER GA, 1980, ANN THORAC SURG, V29, P312
   WILLMAN VL, 1974, J THORAC CARDIOV SUR, V67, P380
NR 43
TC 52
Z9 52
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD DEC
PY 1986
VL 92
IS 6
BP 1029
EP 1037
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA F1286
UT WOS:A1986F128600009
PM 2431228
ER

PT J
AU Yu, SS
   Meier, WR
   Abbott, RP
   Barnard, JJ
   Brown, T
   Callahan, DA
   Debonnel, C
   Heitzenroeder, P
   Latkowski, JF
   Logan, BG
   Pemberton, SJ
   Peterson, PF
   Rose, DV
   Sabbi, GL
   Sharp, WM
   Welch, DR
AF Yu, SS
   Meier, WR
   Abbott, RP
   Barnard, JJ
   Brown, T
   Callahan, DA
   Debonnel, C
   Heitzenroeder, P
   Latkowski, JF
   Logan, BG
   Pemberton, SJ
   Peterson, PF
   Rose, DV
   Sabbi, GL
   Sharp, WM
   Welch, DR
TI An updated point design for heavy ion fusion
SO FUSION SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 15th Topical Meeting on the Technology of Fusion Energy
CY NOV 17-21, 2002
CL WASHINGTON, D.C.
ID DISTRIBUTED RADIATOR; TARGET; DRIVEN; PROTECTION; PROGRESS; CHAMBERS;
   BEAMS
AB An updated, self-consistent point design for a heavy ion fusion (HIF) power plant based on an induction linac driver, indirect-drive targets, and a thick liquid wall chamber has been completed. Conservative parameters were selected to allow each design area to meet its functional requirements in a robust manner, and thus this design is referred to as the Robust Point Design (RPD-2002). This paper provides a top-level summary of the major characteristics and design parameters for the target, driver, final focus magnet layout and shielding, chamber, beam propagation to the target, and overall power plant.
C1 Univ Calif Berkeley, Berkeley, CA 94720 USA.
   Lawrence Livermore Natl Lab, Livermore, CA USA.
   Princeton Plasma Phys Lab, Princeton, NJ 08543 USA.
   Univ Calif Berkeley, Berkeley, CA 94720 USA.
   Miss Res Corp, Albuquerque, NM USA.
RP Yu, SS (reprint author), Univ Calif Berkeley, 1 Cyclotron Rd,Bldg 47, Berkeley, CA 94720 USA.
CR Abbott R, 2001, FUSION TECHNOL, V39, P732
   Callahan-Miller DA, 2000, PHYS PLASMAS, V7, P2083, DOI 10.1063/1.874031
   Callahan DA, 2002, LASER PART BEAMS, V20, P405, DOI 10.1017/S0263034602203079
   Callahan-Miller DA, 1999, NUCL FUSION, V39, P883, DOI 10.1088/0029-5515/39/7/305
   DEBONNEL CS, UNPUB FUSION SCI TEC
   Meier WR, 2001, NUCL INSTRUM METH A, V464, P433, DOI 10.1016/S0168-9002(01)00101-2
   Meier WR, 1998, NUCL INSTRUM METH A, V415, P249, DOI 10.1016/S0168-9002(98)00392-1
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   Olander DR, 2002, FUSION SCI TECHNOL, V41, P141
   Pemberton S, 2001, FUSION TECHNOL, V39, P726
   Peterson PF, 2001, FUSION TECHNOL, V39, P702
   Sabbi GL, 2002, IEEE T APPL SUPERCON, V12, P236, DOI 10.1109/TASC.2002.1018390
   SHARP WM, 2002, P 19 IAEA FUS EN C L
   Tabak M, 1998, NUCL FUSION, V38, P509, DOI 10.1088/0029-5515/38/4/303
   Weber M, 1998, NUCL INSTRUM METH A, V415, P339, DOI 10.1016/S0168-9002(98)00534-8
   WELCH DR, 2002, IN PRESS LASERS PART
   Welch DR, 2001, NUCL INSTRUM METH A, V464, P134, DOI 10.1016/S0168-9002(01)00024-9
NR 17
TC 51
Z9 51
PU AMER NUCLEAR SOCIETY
PI LA GRANGE PK
PA 555 N KENSINGTON AVENUE, LA GRANGE PK, IL 60526 USA
SN 1536-1055
J9 FUSION SCI TECHNOL
JI Fusion Sci. Technol.
PD SEP
PY 2003
VL 44
IS 2
BP 266
EP 273
PG 8
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 713XM
UT WOS:000184883300006
ER

PT J
AU Nieminen, HP
   Jokinen, EV
   Sairanen, HI
AF Nieminen, HP
   Jokinen, EV
   Sairanen, HI
TI Late results of pediatric cardiac surgery in Finland - A
   population-based study with 96% follow-up
SO CIRCULATION
LA English
DT Article
DE heart defects, congenital; surgery; follow-up studies; survival;
   population
ID ATRIAL SEPTAL-DEFECT; SURGICAL REPAIR; GREAT-ARTERIES; TETRALOGY;
   FALLOT; COARCTATION; SURVIVAL; TRANSPOSITION; OPERATION; MUSTARD
AB Background-This population-based study characterizes the history and progress of pediatric cardiac surgery in Finland. For the first time, all defects and procedures are included in an outcome study, reflecting the true effectiveness of operative treatment.
   Methods and Results-All data relating to the operations were collected retrospectively from hospital records. Current patient status was obtained from the population registry. Survival was evaluated with the Kaplan-Meier method applied to all patients and separately to subgroups of patients with the most common defects. The survival rates were compared with those of an age- and sex-matched general population. During the 37 years (1953 to 1989), 6461 patients underwent surgery; 96% of them were traced. The number of operations and the constellation of defects treated increased dramatically over time. Actuarial survival for the 45 years ended October 28, 1998 (the ending date of this study) was 78% for patients versus 93% for the general population. Survival and the number of operations per patient varied widely with the defect. The survival of patients with a surgically closed atrial septal defect was comparable to that of the general population, and such patients rarely needed a reoperation, whereas only 15% of patients with univentricular heart survived for 34 years, and almost all needed at least 2 operations.
   Conclusions-The overall survival of patients with cardiac defects corrected surgically in childhood is good compared with their estimated natural course. The increasing number of surgically treatable defects and the growing number of operations per patient reflect the increasing ability to treat more difficult cases.
C1 Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland.
   Univ Helsinki, Cent Hosp, Dept Cardiol, Hosp Children & Adolescents, Helsinki, Finland.
RP Sairanen, HI (reprint author), HUS HYKS, Hosp Children & Adolescents, POB 281, FIN-00029 Hus, Finland.
EM heikki.sairanen@hus.fi
CR CARLGREN LE, 1987, PEDIATR CARDIOL, V8, P247, DOI 10.1007/BF02427537
   COHEN M, 1989, CIRCULATION, V80, P840
   FONTAN F, 1990, CIRCULATION, V81, P1520
   Fyler DC, 1980, PEDIATRICS S, V65, P375
   HAKULINEN T, 1982, BIOMETRICS, V38, P933, DOI 10.2307/2529873
   HAKULINEN T, 1985, COMPUT PROG BIOMED, V19, P197, DOI 10.1016/0010-468X(85)90011-X
   HELBING WA, 1994, J THORAC CARDIOV SUR, V108, P363
   JONSSON H, 1995, SCAND J THORAC CARD, V29, P43, DOI 10.3109/14017439509107201
   KAPPETEIN AP, 1994, J THORAC CARDIOV SUR, V107, P87
   Kirjavainen M, 1999, J THORAC CARDIOV SUR, V117, P488, DOI 10.1016/S0022-5223(99)70329-6
   KIRKLIN JW, 1993, CARDIAC SURG, P749
   Knott-Craig CJ, 1998, ANN THORAC SURG, V66, P506, DOI 10.1016/S0003-4975(98)00493-7
   LILLEHEI CW, 1992, QUALITY LIFE OPEN HE, P253
   Louhimo I, 1979, Duodecim, V95, P1201
   MEIJBOOM F, 1993, AM J CARDIOL, V72, P1431, DOI 10.1016/0002-9149(93)90192-F
   MEIJBOOM F, 1994, J AM COLL CARDIOL, V24, P1358
   Meijboom F, 1996, J THORAC CARDIOV SUR, V111, P1158, DOI 10.1016/S0022-5223(96)70217-9
   MIYAMURA H, 1993, SURG TODAY, V23, P1049
   MORRIS CD, 1991, JAMA-J AM MED ASSOC, V266, P3447, DOI 10.1001/jama.266.24.3447
   MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   MYRIDAKIS DJ, 1994, AM J CARDIOL, V74, P1030, DOI 10.1016/0002-9149(94)90854-0
   Norgaard MA, 1999, EUR J CARDIO-THORAC, V16, P125, DOI 10.1016/S1010-7940(99)00137-2
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   RIZZOLI G, 1990, EUR J CARDIO-THORAC, V4, P371, DOI 10.1016/1010-7940(90)90045-2
   SAMANEK M, 1992, PEDIATR CARDIOL, V13, P152
   SNAKAR D, 1999, CIRCULATION S2, V100, P176
   STEWART AB, 1993, BRIT HEART J, V69, P65
   TURINA M, 1992, QUALITY LIFE OPEN HE, P267
NR 29
TC 51
Z9 51
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD JUL 31
PY 2001
VL 104
IS 5
BP 570
EP 575
DI 10.1161/hc3101.093968
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 460NE
UT WOS:000170313000022
PM 11479255
ER

PT J
AU BETHENCOURT, DM
   LAKS, H
AF BETHENCOURT, DM
   LAKS, H
TI IMPORTANCE OF EDEMA AND COMPLIANCE CHANGES DURING 24 HOURS OF
   PRESERVATION OF THE DOG HEART
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
C1 YALE UNIV,SCH MED,DEPT SURG,CARDIOTHORAC SECT,NEW HAVEN,CT 06510.
CR Adam H, 1965, METHOD ENZYMAT AN, P573
   ANGELL WW, 1968, ORGAN PERFUSION PRES, P363
   BAUMGARTNER WA, 1978, J THORAC CARDIOV SUR, V75, P525
   BELL PRF, 1974, TRANSPLANT P, V6, P245
   BUJA LM, 1971, CIRCULATION       S1, V44, P44
   COPELAND JG, 1973, ANN SURG, V178, P687, DOI 10.1097/00000658-197312000-00002
   COPELAND JG, 1974, TRANSPLANT P, V6, P311
   DOWNES GL, 1972, SURG FORUM, V23, P256
   FERRANS VJ, 1971, LAB INVEST, V24, P265
   Holdefer W F, 1968, Surg Forum, V19, P225
   JYNGE P, 1978, J THORAC CARDIOV SUR, V76, P2
   LAKS H, 1977, J THORAC CARDIOV SUR, V73, P129
   LAKS H, 1977, SURG FORUM, V28, P231
   LAMPRECHT W, 1965, METHOD ENZYMAT AN, P543
   LAZAR HL, 1978, SURG FORUM, V29, P276
   LEVITSKY S, 1970, J THORAC CARDIOV SUR, V60, P625
   LEVITSKY S, 1971, CIRCULATION       S1, V44, P124
   PHILLIPS DS, 1978, BASIC STATISTICS HLT
   PROCTOR E, 1973, ORGAN PRESERVATION, P216
   PROCTOR E, 1969, Guy's Hospital Reports, V118, P75
   PROCTOR E, 1971, THORAX, V26, P99, DOI 10.1136/thx.26.1.99
   REITZ B A, 1974, Surgical Forum (Chicago), V25, P149
   SPRAY TL, 1977, J THORAC CARDIOV SUR, V73, P880
   Starling E H, 1896, J Physiol, V19, P312
   STUBBS J, 1959, J PHYSIOL-LONDON, V148, P393
   THOMAS FT, 1978, ANN THORAC SURG, V26, P344
   TRUNKEY D, 1969, CRYOBIOLOGY, V6, P515
   WARNICK CT, 1977, TRANSPLANT P, V9, P1575
   WATSON DC, 1977, TRANSPLANT P, V9, P297
NR 29
TC 51
Z9 51
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PY 1981
VL 81
IS 3
BP 440
EP 449
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA LG784
UT WOS:A1981LG78400020
PM 7464205
ER

PT J
AU Fihn, SD
   Gardin, JM
   Abrams, J
   Berra, K
   Blankenship, JC
   Dallas, AP
   Douglas, PS
   Foody, JM
   Gerber, TC
   Hinderliter, AL
   King, SB
   Kligfield, PD
   Krumholz, HM
   Kwong, RYK
   Lim, MJ
   Linderbaum, JA
   Mack, MJ
   Munger, MA
   Prager, RL
   Sabik, JF
   Shaw, LJ
   Sikkema, JD
   Smith, CR
   Smith, SC
   Spertus, JA
   Williams, SV
AF Fihn, Stephan D.
   Gardin, Julius M.
   Abrams, Jonathan
   Berra, Kathleen
   Blankenship, James C.
   Dallas, Apostolos P.
   Douglas, Pamela S.
   Foody, JoAnne M.
   Gerber, Thomas C.
   Hinderliter, Alan L.
   King, Spencer B., III
   Kligfield, Paul D.
   Krumholz, Harlan M.
   Kwong, Raymond Y. K.
   Lim, Michael J.
   Linderbaum, Jane A.
   Mack, Michael J.
   Munger, Mark A.
   Prager, Richard L.
   Sabik, Joseph F.
   Shaw, Leslee J.
   Sikkema, Joanna D.
   Smith, Craig R., Jr.
   Smith, Sidney C.
   Spertus, John A.
   Williams, Sankey V.
TI 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and
   Management of Patients With Stable Ischemic Heart Disease A Report of
   the American College of Cardiology Foundation/American Heart Association
   Task Force on Practice Guidelines, and the American College of
   Physicians, American Association for Thoracic Surgery, Preventive
   Cardiovascular Nurses Association, Society for Cardiovascular
   Angiography and Interventions, and Society of Thoracic Surgeons
SO CIRCULATION
LA English
DT Article
DE AHA Scientific Statements; cardiovascular diagnostic techniques;
   coronary artery disease; coronary stenosis; minimally invasive surgical
   procedures; myocardial ischemia; myocardial revascularization; risk
   factors; stable angina
ID CORONARY-ARTERY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; EMISSION
   COMPUTED-TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR
   DYSFUNCTION; LONG-TERM SURVIVAL; ELUTING STENT IMPLANTATION; CARDIAC
   MAGNETIC-RESONANCE; TRANSMYOCARDIAL LASER REVASCULARIZATION; DOBUTAMINE
   STRESS ECHOCARDIOGRAPHY
CR Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Abdelmoneim SS, 2010, ECHOCARDIOGR-J CARD, V27, P421, DOI 10.1111/j.1540-8175.2009.01026.x
   Abernethy DR, 1999, NEW ENGL J MED, V341, P1447
   Abidov A, 2003, J AM COLL CARDIOL, V42, P1818, DOI 10.1016/j.jacc.2003.07.010
   Abizaid A, 2001, CIRCULATION, V104, P533, DOI 10.1161/hc3101.093700
   ABRAMS J, 1987, DRUGS, V34, P391
   Abrams J, 2005, NEW ENGL J MED, V352, P2524, DOI 10.1056/NEJMcp042317
   AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827
   Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1
   Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1
   Akhtar M, 2006, AM J CARDIOL, V98, P28, DOI 10.1016/j.amjcard.2006.01.053
   Akram K, 2009, ATHEROSCLEROSIS, V203, P533, DOI 10.1016/j.atherosclerosis.2008.07.008
   Albert MA, 2003, CIRCULATION, V107, P443, DOI 10.1161/01.CIR.0000045669.16499.EC
   ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   ALDERMAN EL, 1990, CIRCULATION, V82, P1629
   Alderman MH, 1997, LANCET, V349, P594, DOI 10.1016/S0140-6736(96)08359-6
   Alexander KP, 1998, J AM COLL CARDIOL, V32, P1657, DOI 10.1016/S0735-1097(98)00451-3
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Allen KB, 2004, ANN THORAC SURG, V77, P1228, DOI 10.1016/j.athoracsur.2004.01.008
   Allen KB, 1999, NEW ENGL J MED, V341, P1029, DOI 10.1056/NEJM199909303411403
   Al-Mallah MH, 2006, J AM COLL CARDIOL, V47, P1576, DOI 10.1016/j.jacc.2005.11.073
   Al Suwaidi J, 2004, AM HEART J, V147, P815, DOI 10.1016/j.ahj.2003.11.025
   Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100
   AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56
   America YGCJ, 2009, J NUCL CARDIOL, V16, P10, DOI 10.1007/s12350-008-9012-6
   America YGCJ, 2007, J NUCL CARDIOL, V14, P75, DOI 10.1016/j.nuclcard.2006.10.018
   American Academy of Family Physicians, 2000, AM FAM PHYS, V62, P1712
   American Heart Association, 2008, AHA CHOOS MOV
   Amin F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007219.pub2
   Anand SS, 2003, J AM COLL CARDIOL, V41, p62S, DOI 10.1016/S0735-1097(02)02776-6
   Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
   Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701
   Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   [Anonymous], 1997, ARCH INTERN MED, V157, P657
   [Anonymous], 1985, BR MED J CLIN RES ED, V291, P97
   [Anonymous], 1998, N ENGL J MED, V339, P1349
   [Anonymous], 2007, RAN PACK INS
   [Anonymous], 1984, JAMA, V251, P351
   [Anonymous], 1999, LANCET, V354, P447
   [Anonymous], 2002, LANCET, V360, P965
   [Anonymous], 2001, J AM COLL CARDIOL, V37, P51
   [Anonymous], 1994, LANCET, V344, P1383
   [Anonymous], 1984, JAMA, V251, P365
   [Anonymous], 1993, LANCET, V341, P573
   [Anonymous], 1998, LANCET, V352, P854
   [Anonymous], 2002, JAMA, V288, P2998
   [Anonymous], 2004, N S W PUBLIC HLTH B, V15, P107
   [Anonymous], 1997, CIRCULATION, V96, P1761
   [Anonymous], 1982, JAMA, V247, P1707
   [Anonymous], 2002, LANCET, V360, P743
   [Anonymous], 1998, EUR J CARDIOTHORAC S, V14, P480
   [Anonymous], 2002, LANCET, V360, P7
   [Anonymous], 1997, LANCET, V350, P461
   [Anonymous], 1994, CIRCULATION, V90, P1765
   [Anonymous], 1988, N ENGL J MED, V319, P385
   [Anonymous], 1995, JAMA, V273, P199
   [Anonymous], 1980, CIRCULATION, V62, pV85
   [Anonymous], 1992, BMJ, V304, P405
   [Anonymous], 2005, WKLY EPIDEMIOL REC, V80, P277
   [Anonymous], 2002, LANCET, V359, P1269
   [Anonymous], 1991, JAMA, V265, P3255
   [Anonymous], 1997, CIRCULATION, V95, P265
   [Anonymous], 1997, LANCET, V349, P1857
   [Anonymous], 1980, LANCET, V2, P491
   [Anonymous], 2012, METH MAN POL ACCF AH
   [Anonymous], 2002, JAMA, V288, P2981
   [Anonymous], 1996, N ENGL J MED, V335, P217
   [Anonymous], 1979, JAMA, V242, P2562
   [Anonymous], 1982, N ENGL J MED, V307, P976
   [Anonymous], 1998, LANCET, V352, P837
   [Anonymous], 1990, AM J CARDIOL, V66, P779
   [Anonymous], 1995, LANCET, V346, P1179
   [Anonymous], 2011, DIABETES CARE S1, V34, pS11
   [Anonymous], 1984, N ENGL J MED, V311, P1333
   Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178
   [Anonymous], 1993, WHO TECH REP SER, V831, P1
   [Anonymous], 2009, CIRCULATION, V119, P1883
   [Anonymous], 1997, JAMA, V277, P715
   [Anonymous], 1984, HYPERTENSION, V6, pI198
   [Anonymous], 2002, JAMA, V288, P2015
   [Anonymous], 2006, MED MED STAT SUPPL
   [Anonymous], 1998, CLIN GUID ID EV TREA
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   ANTMAN E, 1980, NEW ENGL J MED, V302, P1269, DOI 10.1056/NEJM198006053022301
   Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209
   Antman Elliott M, 2004, Circulation, V110, pe82
   Antman EM, 2009, CIRCULATION, V119, P1180, DOI 10.1161/CIRCULATIONAHA.109.856757
   Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793
   Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083
   ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704
   Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521
   Arnold SV, 2009, CIRC-CARDIOVASC QUAL, V2, P344, DOI 10.1161/CIRCOUTCOMES.108.829523
   Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P107, DOI 10.1161/CIRCOUTCOMES.108.798009
   Arora RR, 1999, J AM COLL CARDIOL, V33, P1833, DOI 10.1016/S0735-1097(99)00140-0
   Atherosclerosis Thrombosis and Vascular Biology Italian Study Group, 2003, CIRCULATION, V107, P1117
   Aubry MC, 2007, J RHEUMATOL, V34, P937
   Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532
   Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003
   Azevedo ER, 2001, J AM COLL CARDIOL, V37, P505, DOI 10.1016/S0735-1097(00)01140-2
   Aziz O, 2007, BRIT MED J, V334, P617, DOI 10.1136/bmj.39106.476215.BE
   Badran HM, 2007, J AM SOC ECHOCARDIOG, V20, P820, DOI 10.1016/j.echo.2007.01.007
   Bae Ki Sun, 2007, Korean Journal of Internal Medicine, V22, P139
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2
   BALLEGAARD S, 1990, J INTERN MED, V227, P25
   BALLEGAARD S, 1986, ACTA MED SCAND, V220, P307
   BALSANO F, 1990, CIRCULATION, V82, P17
   BANDURA A, 1983, J PERS SOC PSYCHOL, V45, P1017, DOI 10.1037//0022-3514.45.5.1017
   Bangalore S, 2007, AM J CARDIOL, V100, P536, DOI 10.1016/j.amjcard.2007.03.057
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Barsness G, 2001, CLIN CARDIOL, V24, P435
   Bateman TM, 2006, J NUCL CARDIOL, V13, P24, DOI 10.1016/j.nuclcard.2005.12.004
   Baumhakel M, 2011, INT J CLIN PRACT, V65, P289, DOI 10.1111/j.1742-1241.2010.02563.x
   Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720
   Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369
   BELL MR, 1990, J AM COLL CARDIOL, V16, P553
   Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60
   Beltrame JF, 2009, ARCH INTERN MED, V169, P1491, DOI 10.1001/archinternmed.2009.295
   Benedetto U, 2009, EUR J CARDIO-THORAC, V36, P611, DOI 10.1016/j.ejcts.2009.03.012
   Ben-Gal Y, 2006, ANN THORAC SURG, V82, P2067, DOI 10.1016/j.athoracsur.2006.06.041
   Beniamini Y, 1999, J Cardiopulm Rehabil, V19, P8, DOI 10.1097/00008483-199901000-00001
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berger PB, 2001, J AM COLL CARDIOL, V38, P1440, DOI 10.1016/S0735-1097(01)01571-6
   Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106
   Berman D, 2004, HURSTS HEART, P563
   Berman DS, 2009, JACC-CARDIOVASC IMAG, V2, P273, DOI 10.1016/j.jcmg.2008.12.012
   BERMAN DS, 1995, J AM COLL CARDIOL, V26, P639, DOI 10.1016/0735-1097(95)00218-S
   Berman DS, 2006, J NUCL CARDIOL, V13, P191, DOI 10.1016/j.nuclcard.2006.01.020
   Bernheim AM, 2011, AM HEART J, V161, P740, DOI 10.1016/j.ahj.2010.12.017
   Bernstein SJ, 1999, HEART, V81, P470
   Berrington de Gonzalez A, 2010, CIRCULATION, V122, P2403
   Berrington de Gonzalez A, 2009, ARCH INTERN MED, V169, P2071
   Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964
   Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025
   Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989
   Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096
   Biagini E, 2006, EUR J NUCL MED MOL I, V33, P1442, DOI 10.1007/s00259-006-0156-9
   Bingham SE, 2011, CIRCULATION, V123, P1509, DOI 10.1161/CIRCULATIONAHA.109.907659
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Bjork Ingul C, 2007, CIRCULATION, V115, P1252
   Blankstein R, 2009, J AM COLL CARDIOL, V54, P1072, DOI 10.1016/j.jacc.2009.06.014
   Blendea Mihaela C, 2003, Curr Diab Rep, V3, P223, DOI 10.1007/s11892-003-0068-z
   BLOCK WJ, 1952, JAMA-J AM MED ASSOC, V150, P259
   Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055
   Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626
   BOBERG J, 1992, CLIN CARDIOL, V15, P591
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Bodi V, 2007, J AM COLL CARDIOL, V50, P1174, DOI 10.1016/j.jacc.2007.06.016
   Boekholdt SM, 2001, CIRCULATION, V104, P3063, DOI 10.1161/hc5001.100793
   Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720
   BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745
   BOMAN K, 1995, EUR J CLIN PHARMACOL, V49, P27
   Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atgersclerosis.2004.08.035
   Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   Bonow RO, 2008, JACC-CARDIOVASC IMAG, V1, P164, DOI 10.1016/j.jcmg.2008.01.004
   Borer JS, 2003, CIRCULATION, V107, P817, DOI 10.1161/01.CIR.0000048143.25023.87
   Borjesson M, 2000, EUR HEART J, V21, P1853, DOI 10.1053/euhj.1999.1994
   Bosworth HB, 2007, CONTEMP CLIN TRIALS, V28, P33, DOI 10.1016/j.cct.2006.08.006
   Bottcher M, 2002, AM J CARDIOL, V89, P1019, DOI 10.1016/S0002-9149(02)02268-3
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Bourassa MG, 1998, EUR HEART J, V19, P103, DOI 10.1053/euhj.1997.0574
   Bouzas-Mosquera A, 2010, EUR J CLIN INVEST, V40, P1122, DOI 10.1111/j.1365-2362.2010.02365.x
   Bouzas-Mosquera A, 2009, J AM COLL CARDIOL, V53, P1981, DOI 10.1016/j.jacc.2009.01.067
   Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048
   Braunwald E, 1994, CLIN PRACTICE GUIDEL
   BRAUNWALD E, 1989, CIRCULATION, V80, P410
   Braunwald E, 2006, J AM COLL CARDIOL, V47, pC101, DOI 10.1016/j.jacc.2005.10.072
   Bravata DM, 2007, ANN INTERN MED, V147, P703
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161
   Bridges CR, 2004, ANN THORAC SURG, V77, P1494, DOI 10.1016/j.athoracsur.2004.01.007
   Briguori C, 2007, AM J CARDIOL, V99, P779, DOI 10.1016/j.amjcara.2006.10.031
   Brogden RN, 1996, DRUGS, V51, P792, DOI 10.2165/00003495-199651050-00007
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brophy JM, 2003, ANN INTERN MED, V138, P777
   Brorsson B, 2002, HEART, V87, P140, DOI 10.1136/heart.87.2.140
   Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321
   Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090
   BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901
   Bruder O, 2009, J AM COLL CARDIOL, V54, P1457, DOI 10.1016/j.jacc.2009.07.003
   BRUNELLI C, 1989, EUR HEART J, V10, P292
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Buckley BS, 2009, BRIT MED J, V339, pb3058
   Buckley DI, 2009, ANN INTERN MED, V151, P483
   Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031
   Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   Byzova TV, 1997, J BIOL CHEM, V272, P27183, DOI 10.1074/jbc.272.43.27183
   Cademartiri F, 2010, EUR RADIOL, V20, P81, DOI 10.1007/s00330-009-1529-9
   CALIFF RM, 1985, J AM COLL CARDIOL, V5, P1055
   Califf RM, 1996, J AM COLL CARDIOL, V27, P1007, DOI 10.1016/0735-1097(96)87733-3
   CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501
   Calnon DA, 2001, J AM COLL CARDIOL, V38, P1511, DOI 10.1016/S0735-1097(01)01565-0
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   CAMERON A, 1983, CIRCULATION, V68, P484
   Camm A John, 2003, Drugs R D, V4, P83, DOI 10.2165/00126839-200304020-00001
   CAMPEAU L, 1978, CIRCULATION, V57, P1111
   CAMPEAU L, 1976, CIRCULATION, V54, P522
   CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   Cardinal B J, 1996, J Epidemiol, V6, P31
   Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981
   CARNEY RM, 1995, HEALTH PSYCHOL, V14, P88, DOI 10.1037//0278-6133.14.1.88
   CARNEY RM, 1987, AM J CARDIOL, V60, P1273, DOI 10.1016/0002-9149(87)90607-2
   Carney RM, 2001, CIRCULATION, V104, P2024, DOI 10.1161/hc4201.097834
   Carrabba N, 2010, J NUCL CARDIOL, V17, P470, DOI 10.1007/s12350-010-9218-2
   Carrie D, 1997, CIRCULATION, V96, pII6
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   Caulin-Glaser Teresa, 2007, Prev Cardiol, V10, P15, DOI 10.1111/j.1520-037.2007.05666.x
   Cecil MP, 1996, J CLIN EPIDEMIOL, V49, P735, DOI 10.1016/0895-4356(96)00014-5
   Cecil WT, 2008, AM J MANAG CARE, V14, P521
   Centers for Disease Control and Prevention, 2008, 2008 PHYS ACT GUID
   Cerqueira MD, 2010, J NUCL CARDIOL, V17, P709, DOI 10.1007/s12350-010-9244-0
   Chaitman BR, 2009, CIRCULATION, V120, P2529, DOI 10.1161/CIRCULATIONAHA.109.913111
   Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309
   CHAITMAN BR, 1981, CIRCULATION, V64, P360
   Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916
   Chaowalit N, 2006, EUR HEART J, V27, P3039, DOI 10.1093/eurheartj/ehl393
   Charatan F, 2003, BRIT MED J, V326, P1055, DOI 10.1136/bmj.326.7398.1055
   Chatterjee K, 1998, PRIMARY CARDIOLOGY, P234
   Chatziioannou SN, 1999, CIRCULATION, V99, P867
   Cheezum MK, 2011, J CARDIOVASC COMPUT, V5, P101, DOI 10.1016/j.jcct.2010.11.005
   Cheitlin MD, 2005, AM J CARDIOL, V96, p24M, DOI 10.1016/j.amjcard.2005.07.007
   Chen JT, 2005, PHARMACOTHERAPY, V25, P171, DOI 10.1592/phco.25.2.171.56942
   Cheng ASH, 2007, J AM COLL CARDIOL, V49, P2440, DOI 10.1016/j.jacc.2007.03.028
   Cheng Victor Y, 2011, Circulation, V124, P2423, DOI 10.1161/CIRCULATIONAHA.111.039255
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chirinos JA, 2007, INT J CARDIOL, V117, P97, DOI 10.1016/j.ijcard.2006.06.005
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Choudhry NK, 2005, AM J MED, V118, P465, DOI 10.1016/j.amjmed.2005.02.016
   Chow BJW, 2011, JACC-CARDIOVASC IMAG, V4, P496, DOI 10.1016/j.jcmg.2011.01.015
   Chow BJW, 2010, J AM COLL CARDIOL, V55, P1017, DOI 10.1016/j.jacc.2009.10.039
   CHRISTIAN TF, 1994, ANN INTERN MED, V121, P825
   CHRYSANT SG, 1993, AM J CARDIOL, V72, P1249, DOI 10.1016/0002-9149(93)90292-K
   Chuah SC, 1998, CIRCULATION, V97, P1474
   Ciapponi A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14681858.CD003614.pub2
   Cisowski M, 2002, ANN THORAC SURG, V74, pS1334
   Cisowski Marek, 2004, Kardiol Pol, V61, P253
   Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163
   Clark AM, 2010, EUR J CARDIOV PREV R, V17, P261, DOI 10.1097/HJR.0b013e32833090ef
   Clayton TC, 2005, BRIT MED J, V331, P869, DOI 10.1136/bmj.38603.656076.63
   Coelho OR, 2011, JACC-CARDIOVASC IMAG, V4, P850, DOI 10.1016/j.jcmg.2011.04.015
   Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713
   Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804
   Cole JH, 2002, J AM COLL CARDIOL, V40, P1968, DOI 10.1016/S0735-1097(02)02561-5
   Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75
   Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0
   Collins R, 1994, TXB HYPERTENSION
   CONLEY MJ, 1978, CIRCULATION, V57, P947
   Cortigiani L, 2001, AM J MED, V110, P361, DOI 10.1016/S0002-9343(01)00630-1
   Couch RB, 2007, VACCINE, V25, P7656, DOI 10.1016/j.vaccine.2007.08.042
   Critchfield TS, 2001, J APPL BEHAV ANAL, V34, P101, DOI 10.1901/jaba.2001.34-101
   Critchley J, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003041.PUB2
   Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86
   Cromwell J, 2005, MED CARE, V43, P330, DOI 10.1097/01.mlr.0000156864.80880.aa
   Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413
   Cuisset T, 2009, J AM COLL CARDIOL, V54, P1149, DOI 10.1016/j.jacc.2009.05.050
   Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3
   Cury RC, 2010, AM J CARDIOL, V106, P310, DOI 10.1016/j.amjcard.2010.03.025
   D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180
   Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P1225, DOI 10.1001/jama.2011.336
   Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X
   Daly C., 2003, European Heart Journal, V24, P532, DOI 10.1016/S0195-668X(02)00820-5
   Daly C, 2006, CIRCULATION, V113, P490, DOI 10.1161/CIRCULATIONAHA.105.561647
   Daly CA, 2006, BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE
   Danchin N, 2006, ARCH INTERN MED, V166, P787, DOI 10.1001/archinte.166.7.787
   Danias PG, 2004, J AM COLL CARDIOL, V44, P1867, DOI 10.1016/j.jacc.2004.07.051
   Dargie HJ, 2001, LANCET, V357, P1385
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320
   Daugherty SL, 2011, AM HEART J, V161, P908, DOI 10.1016/j.ahj.2011.01.021
   Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559
   Davies RF, 1997, CIRCULATION, V95, P2037
   Davis AM, 2007, MED CARE RES REV, V64, p29S, DOI 10.1177/1077558707305416
   DAVIS JW, 1985, J LAB CLIN MED, V105, P479
   Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004
   Dawn B, 2002, ANN NY ACAD SCI, V962, P18
   Tognoni G, 2001, LANCET, V357, P89
   de Azevedo CF, 2011, JACC-CARDIOVASC IMAG, V4, P740, DOI 10.1016/j.jcmg.2011.02.017
   DEBUSK RF, 1994, ANN INTERN MED, V120, P721
   de Diego C, 2009, EUR HEART J, V30, P209, DOI 10.1093/eurheartj/ehn498
   Defoor J, 2006, EUR HEART J, V27, P808, DOI 10.1093/eurheartj/ehi737
   DEJONGSTE MJL, 1994, BRIT HEART J, V71, P413
   DELANDSHEERE C, 1992, AM J CARDIOL, V69, P1143, DOI 10.1016/0002-9149(92)90926-P
   DEMOTS H, 1989, J AM COLL CARDIOL, V13, P786
   Denollet J, 2006, AM J CARDIOL, V97, P970, DOI 10.1016/j.amjcard.2005.10.035
   de Peuter OR, 2009, NETH J MED, V67, P284
   DETRE K, 1981, CIRCULATION, V63, P1329
   Dey D, 2010, RADIOLOGY, V257, P516, DOI 10.1148/radiol.10100681
   Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537
   DIAMOND GA, 1986, AM J CARDIOL, V57, P1175, DOI 10.1016/0002-9149(86)90694-6
   Diamond GA, 2010, NEW ENGL J MED, V363, P93
   DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402
   DIAMOND GA, 1980, J CLIN INVEST, V65, P1210, DOI 10.1172/JCI109776
   Diamond GA, 2007, J AM COLL CARDIOL, V50, P1604, DOI 10.1016/j.jacc.2007.08.010
   Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190
   Di Carli MF, 2007, J NUCL CARDIOL, V14, P799, DOI 10.1016/j.nuclcard.2007.07.012
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01
   Diegeler A, 2002, NEW ENGL J MED, V347, P561, DOI 10.1056/NEJMoa013563
   DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003
   DIGENIO AG, 1991, S AFR MED J, V79, P188
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   Di Pede F, 2003, AM J CARDIOL, V91, P951, DOI 10.1016/S0002-9149(03)00110-3
   DISOMMA S, 1993, CARDIOVASC DRUG THER, V7, P119
   Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182
   DOBSON AJ, 1991, J CLIN EPIDEMIOL, V44, P1247, DOI 10.1016/0895-4356(91)90157-5
   Doesch C, 2009, JACC-CARDIOVASC IMAG, V2, P424, DOI 10.1016/j.jcmg.2008.11.017
   DOLL R, 1976, BRIT MED J, V2, P1525
   Domanski MJ, 2003, J CARD FAIL, V9, P354, DOI 10.1054/S1071-9164(03)00133-7
   Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765
   DORING G, 1992, J CARDIOVASC PHARM, V20, pS74
   Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9
   Dorr DA, 2008, J AM GERIATR SOC, V56, P2195, DOI 10.1111/j.1532-5415.2008.02005.x
   Douglas PS, 1997, CIRCULATION, V95, P299
   Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002
   Dowling RD, 1998, CIRCULATION S2, V98, pII73
   Drenth DJ, 2004, AM J CARDIOL, V94, P1414, DOI 10.1016/j.amjcard.2004.08.016
   Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6
   Drozda J, 2011, CIRCULATION, V124, P248, DOI 10.1161/CIR.0b013e31821d9ef2
   Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131
   Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431
   Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544
   Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002
   Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002
   Dusing R, 2005, DRUGS, V65, P773
   Duvall WL, 2006, J NUCL CARDIOL, V13, P202, DOI 10.1016/j.nuclcard.2006.01.003
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Ebrahim S, 2002, J EPIDEMIOL COMMUN H, V56, P99, DOI 10.1136/jech.56.2.99
   Edwards FH, 1998, ANN THORAC SURG, V66, P125, DOI 10.1016/S0003-4975(98)00358-0
   Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C
   Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317
   Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179
   El Fakhri G, 2009, J NUCL MED, V50, P1062, DOI 10.2967/jnumed.104.007831
   Elhendy A, 2002, J AM COLL CARDIOL, V40, P1623, DOI 10.1016/S0735-1097(02)02338-0
   Ellis SG, 1997, CIRCULATION, V96, P3867
   ELVEBACK LR, 1985, MAYO CLIN PROC, V60, P305
   Emanuelsson H, 1999, AM HEART J, V137, P854, DOI 10.1016/S0002-8703(99)70409-6
   EMOND M, 1994, CIRCULATION, V90, P2645
   Epstein FH, 2007, J NUCL CARDIOL, V14, P729, DOI 10.1016/j.nuelcard.2007.07.006
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   EZEKOWITZ MD, 1995, AM HEART J, V129, P527, DOI 10.1016/0002-8703(95)90281-3
   Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   FAXON DP, 1992, AM HEART J, V123, P854, DOI 10.1016/0002-8703(92)90687-Q
   Fazel R, 2011, J NUCL CARDIOL, V18, P562, DOI 10.1007/s12350-011-9403-y
   Feit F, 2000, CIRCULATION, V101, P2795
   Feldman DN, 2006, AM J CARDIOL, V98, P1334, DOI 10.1016/j.amjcard.2006.06.026
   FESMIRE FM, 1991, SOUTHERN MED J, V84, P841
   Feuchtner G, 2011, CIRC-CARDIOVASC IMAG, V4, P540, DOI 10.1161/CIRCIMAGING.110.961250
   Fiechter M, 2011, EUR J NUCL MED MOL I, V39, P430
   Fisher E, 2009, HLTH CARE SPENDING Q
   FISHER L, 1983, CIRCULATION, V68, P951
   Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913
   Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690
   Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935
   Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056
   Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8
   Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001
   Fox KA, INTERVENTIONAL VERSU
   Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007
   Fraker TD, 2007, CIRCULATION, V116, P2762, DOI 10.1161/CIRCULATIONAHA.107.187930
   FRANK CW, 1973, CIRCULATION, V47, P509
   Franklin BA, 1998, CHEST, V114, P902, DOI 10.1378/chest.114.3.902
   Franzen D, 2001, INT J IMPOT RES, V13, P348, DOI 10.1038/sj.ijir.3900787
   FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819
   Frattaroli J, 2008, AM J CARDIOL, V101, P911, DOI 10.1016/j.amjcard.2007.11.039
   Fraund S, 2005, ANN THORAC SURG, V79, P1225, DOI 10.1016/j.arthoracsur.2004.08.082
   Frazier OH, 1999, NEW ENGL J MED, V341, P1021, DOI 10.1056/NEJM199909303411402
   Fred HL, 2008, TEX HEART I J, V35, P6
   FREEMAN WK, 1991, J AM COLL CARDIOL, V18, P29
   Freemantle N, 1999, BRIT MED J, V318, P1730
   Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723
   FRISHMAN WH, 1991, AM J CARDIOL, V67, P665, DOI 10.1016/0002-9149(91)90518-P
   Frishman WH, 2003, CARDIOVASCULAR PHARM
   FROELICHER V, 1984, JAMA-J AM MED ASSOC, V252, P1291, DOI 10.1001/jama.252.10.1291
   Frosch DL, 1999, AM J PREV MED, V17, P285, DOI 10.1016/S0749-3797(99)00097-5
   FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203
   Frye RL, 2009, NEW ENGL J MED, V360, P2503
   Fukushima K, 2011, J NUCL MED, V52, P726, DOI 10.2967/jnumed.110.081828
   Gaede P, 2003, NEW ENGL J MED, V348, P383
   Galinanes M, 2004, ANN THORAC SURG, V78, P122, DOI 10.1016/j.athorascur.2003.12.032
   Garber AM, 1999, ANN INTERN MED, V130, P719
   GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450
   Gebker R, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-46
   Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508
   Gehi AK, 2008, ARCH INTERN MED, V168, P1423, DOI 10.1001/archinte.168.13.1423
   Geleijnse ML, 2007, AM J CARDIOL, V99, P714, DOI 10.1016/j.amjcard.2006.09.124
   George RT, 2011, AM J ROENTGENOL, V197, P829, DOI 10.2214/AJR.10.5689
   Gerber TC, 2010, JACC-CARDIOVASC IMAG, V3, P528, DOI 10.1016/j.jcmg.2010.03.003
   Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650
   GERSH BJ, 1989, CIRCULATION, V79, P46
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545
   GETZ GS, 1993, ARTERIOSCLER THROMB, V13, P459
   GIANROSSI R, 1989, CIRCULATION, V80, P87
   Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29
   Gibbons RJ, 1999, CIRCULATION, V100, P2140
   GIBBONS RJ, 1990, ANN INTERN MED, V112, P743
   GIBBONS RJ, 1991, CATHETER CARDIO DIAG, V22, P14, DOI 10.1002/ccd.1810220104
   Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15
   Gil VM, 1998, J NUCL CARDIOL, V5, P414, DOI 10.1016/S1071-3581(98)90147-7
   Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x
   Gimelli A, 2009, J NUCL MED, V50, P546, DOI 10.2967/jnumed.108.055954
   Ginsberg HN, 1998, ARTERIOSCL THROM VAS, V18, P441
   Gioia G, 2007, CATHETER CARDIO INTE, V70, P26, DOI 10.1002/ccd.21072
   Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701
   Glynn L. G., 2010, COCHRANE DB SYST REV, V3
   Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012
   GOGIA H, 1995, J AM COLL CARDIOL, V26, P1575, DOI 10.1016/0735-1097(95)00368-1
   Goldberg AC, 2006, AM J CARDIOL, V97, P376, DOI 10.1016/j.amjcard.2005.08.056
   GOLDMAN L, 1982, CIRCULATION, V66, P945
   Goldsmith RL, 2000, CORONARY ARTERY DIS, V11, P129, DOI 10.1097/00019501-200003000-00007
   Goldstein S, 1997, CARDIOVASC DRUG THER, V11, P219, DOI 10.1023/A:1007711025487
   Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47
   GORDON T, 1974, LANCET, V2, P1345
   Gori T, 2007, BRIT J CLIN PHARMACO, V64, P145, DOI 10.1111/j.1365-2125.2007.02864.x
   Gori T, 2002, CIRCULATION, V106, P2404, DOI 10.1161/01.CIR.0000036742.52907.91
   Gorin SS, 2004, CANCER EPIDEM BIOMAR, V13, P2012
   Gorman J M, 2000, Am Heart J, V140, P77, DOI 10.1067/mhj.2000.109981
   Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801
   Goy JJ, 2008, J AM COLL CARDIOL, V52, P815, DOI 10.1016/j.jacc.2008.05.037
   GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8
   Goy JJ, 1999, CIRCULATION, V99, P3255
   Goy JJ, 2000, MAYO CLIN PROC, V75, P1116
   Goyal D, 2009, CARDIOVASC THER, V27, P10, DOI 10.1111/j.1755-5922.2008.00067.x
   GRADY D, 1992, ANN INTERN MED, V117, P1016
   Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49
   Greenfield JR, 2005, J CLIN ENDOCR METAB, V90, P661, DOI 10.1210/jc.2004-1511
   Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c
   Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4
   Grimm RH, 1997, HYPERTENSION, V29, P8
   Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291
   Guadagnoli E, 2004, AM J MED, V117, P371, DOI 10.1016/j.amjmed.2004.04.013
   Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50
   Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249
   Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154
   GULDAGER B, 1992, J INTERN MED, V231, P261
   Guleserian KJ, 2003, ANN THORAC SURG, V75, P1842, DOI 10.1016/S0003-4975(03)00178-4
   Gupta S, 2011, CIRCULATION, V123, P1377, DOI 10.1161/CIRCULATIONAHA.110.003236
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   Gurm HS, 2011, J AM COLL CARDIOL, V58, P907, DOI 10.1016/j.jacc.2011.05.023
   Haberl R, 2005, AM HEART J, V149, P1112, DOI 10.1016/j.ahj.2005.02.048
   Hachamovitch R, 2006, J NUCL CARDIOL, V13, P768, DOI 10.1016/j.nuclcard.2006.08.017
   Hachamovitch R, 1998, CIRCULATION, V97, P535
   Hachamovitch R, 2009, J NUCL CARDIOL, V16, P935, DOI 10.1007/s12350-009-9140-7
   Hachamovitch R, 2003, J AM COLL CARDIOL, V41, P1329, DOI 10.1016/S0735-1097(03)00125-6
   Hachamovitch R, 1996, CIRCULATION, V93, P905
   Hachamovitch R, 2007, J NUCL CARDIOL, V14, P634, DOI 10.1016/j.nuclcard.2007.06.118
   Hachamovitch R, 2004, J AM COLL CARDIOL, V43, P200, DOI 10.1016/j.jacc.2003.07.043
   Hachamovitch R, 2005, J AM COLL CARDIOL, V45, P722, DOI 10.1016/j.jacc.2004.08.069
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Hachamovitch R, 1997, AM J CARDIOL, V80, P426
   Hachamovitch R, 2000, Rev Cardiovasc Med, V1, P91
   Hachamovitch R, 2012, J AM COLL CARDIOL, V59, P462, DOI 10.1016/j.jacc.2011.09.066
   Hachamovitch R, 2002, CIRCULATION, V105, P823, DOI 10.1161/hc0702.103973
   Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500
   Hacker M, 2007, NUKLEARMED-NUCL MED, V46, P29
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Haffner SM, 2000, NEW ENGL J MED, V342, P1040, DOI 10.1056/NEJM200004063421408
   Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001
   Hallikainen MA, 2000, J NUTR, V130, P767
   Halpern EJ, 2010, ACAD RADIOL, V17, P577, DOI 10.1016/j.acra.2009.12.015
   Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F
   Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C
   Hambrecht Rainer, 1993, Journal of the American College of Cardiology, V22, P468
   Hamdan A, 2011, JACC-CARDIOVASC IMAG, V4, P50, DOI 10.1016/j.jcmg.2010.10.007
   HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601
   HAMMERMEISTER KE, 1979, CIRCULATION, V59, P421
   Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29
   Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028
   Hamon M, 2008, RADIOLOGY, V247, P679, DOI 10.1148/radiol.2473071132
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 2006, J AM COLL CARDIOL, V47, P661, DOI 10.1016/j.jacc.2005.10.057
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   HARRIS PJ, 1979, CIRCULATION, V60, P1259
   Hashimoto A, 2009, CIRC J, V73, P2288
   HASKELL WL, 1994, CIRCULATION, V89, P975
   Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649
   HaufZachariou U, 1997, EUR J CLIN PHARMACOL, V52, P95, DOI 10.1007/s002280050256
   Hautvast RWM, 1996, AM J CARDIOL, V77, P462, DOI 10.1016/S0002-9149(97)89338-1
   Hautvast RWM, 1998, AM HEART J, V136, P1114, DOI 10.1016/S0002-8703(98)70171-1
   He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459
   Heart Outcomes Prevention Evaluation (HOPE) Study investigators, 2000, LANCET, V355, P253
   HEBERT PR, 1993, ARCH INTERN MED, V153, P578, DOI 10.1001/archinte.153.5.578
   Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927
   Heitzer T, 1998, J AM COLL CARDIOL, V31, P83, DOI 10.1016/S0735-1097(97)00431-2
   Held C, 1997, CIRCULATION, V95, P2380
   Helton TJ, 2007, AM J CARDIOVASC DRUG, V7, P289, DOI 10.2165/00129784-200707040-00006
   Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Hendel RC, 2009, CIRCULATION, V119, pE561, DOI 10.1161/CIRCULATIONAHA.109.192519
   Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003
   Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3
   Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3
   Henneman MM, 2008, J AM COLL CARDIOL, V52, P216, DOI 10.1016/j.jacc.2008.04.012
   Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB
   Heslop CL, 2010, J AM COLL CARDIOL, V55, P1102, DOI 10.1016/j.jacc.2009.11.050
   Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e
   HIRSH J, 1995, CHEST, V108, pS247, DOI 10.1378/chest.108.4_Supplement.247S
   Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278
   Hlatky MA, 2004, J AM COLL CARDIOL, V43, P583, DOI 10.1016/j.jacc.2003.11.021
   Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203
   Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3
   Ho KT, 2002, MAYO CLIN PROC, V77, P515
   Ho PM, 2007, AM HEART J, V154, P489, DOI 10.1016/j.ohi.2007.05.018
   Hochholzer W, 2005, CIRCULATION, V111, P2560, DOI 10.1161/01.CIR.0000160869.75810.98
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   HOLLANDER JE, 1995, NEW ENGL J MED, V333, P1267, DOI 10.1056/NEJM199511093331907
   Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470
   Holmboe ES, 2000, J GEN INTERN MED, V15, P632, DOI 10.1046/j.1525-1497.2000.90823.x
   Holmes DR, 2008, JACC-CARDIOVASC INTE, V1, P34, DOI 10.1016/j.jcin.2007.10.001
   Holubkov R, 2002, AM HEART J, V144, P826, DOI 10.1067/mhj.2002.125505
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   HOMCY CJ, 1982, AM J CARDIOL, V49, P478, DOI 10.1016/0002-9149(82)90528-8
   HONG MK, 1992, AM J CARDIOL, V69, P176, DOI 10.1016/0002-9149(92)91300-S
   Hong SJ, 2005, CATHETER CARDIO INTE, V64, P75, DOI 10.1002/ccd.20238
   Honig A, 2007, PSYCHOSOM MED, V69, P606, DOI 10.1097/PSY.0b013e31814b260d
   Horne BD, 2004, ANN EPIDEMIOL, V14, P143, DOI 10.1016/S1047-2797(03)00125-X
   Hosokawa S, 2003, CIRC J, V67, P221
   HSIEH SD, 1995, INT J OBESITY, V19, P585
   HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2007, ANN THORAC SURG, V83, P93, DOI 10.1016/j.athoracsur.2006.08.050
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065
   Hughes JR, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2
   Hughes JR, 2003, J GEN INTERN MED, V18, P1053, DOI 10.1111/j.1525-1497.2003.20640.x
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Hundley WG, 1999, CIRCULATION, V100, P1697
   Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065
   Iafrate R P Jr, 1983, Pharmacotherapy, V3, P118
   Imran MB, 2003, INT J CARDIOVAS IMAG, V19, P23, DOI 10.1023/A:1021746515555
   Ingkanisorn WP, 2006, J AM COLL CARDIOL, V47, P1427, DOI 10.1016/j.jacc.2005.11.059
   Innocenti F, 2011, INT J CARDIOVAS IMAG, V27, P65, DOI 10.1007/s10554-010-9655-7
   Ishikawa K, 1997, CIRCULATION, V95, P2368
   ISNER JM, 1981, CIRCULATION, V63, P1056
   Ix JH, 2005, AM HEART J, V149, P512, DOI 10.1016/j.ahj.2004.10.010
   Jacobs AK, 2002, J AM COLL CARDIOL, V39, P1608, DOI 10.1016/S0735-1097(02)01835-1
   Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201
   Jaffery Z, 2007, EUR J CARDIO-THORAC, V31, P691, DOI 10.1016/j.ejcts.2007.01.018
   Jagathesan R, 2006, J CARDIOVASC PHARM, V48, P110, DOI 10.1097/01.fjc.0000245404.20922.9f
   Jahnke C, 2007, CIRCULATION, V115, P1769, DOI 10.1161/CIRCULATIONAHA.106.652016
   Janne d'Othee B, 2008, EUR J RADIOL, V65, P449
   JANOSI A, 1991, CHEST, V100, P227, DOI 10.1378/chest.100.1.227
   Javaid A, 2007, CIRCULATION, V116, pI200, DOI 10.1161/CIRCULATIONAHA.106.681148
   Javitz HS, 2004, AM J MANAG CARE, V10, pS358
   Jensen MK, 2008, CIRCULATION, V117, P3062, DOI 10.1161/CIRCULATIONAHA.107.759951
   Jerling M, 2005, CLIN PHARMACOL THER, V78, P288, DOI 10.1016/j.clpt.2005.05.004
   Jneid H, 2005, CIRCULATION, V111, P2565, DOI 10.1161/CIRCULATIONAHA.104.515445
   Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0
   Joannides R, 2006, BRIT J CLIN PHARMACO, V61, P127, DOI 10.1111/j.1365-2125.2005.02544.x
   Johansen A, 2006, CLIN PHYSIOL FUNCT I, V26, P288, DOI 10.1111/j.1475-097X.2006.00690.x
   Johnson JA, 2003, CLIN PHARMACOL THER, V74, P44, DOI 10.1016/S0009-9236(03)00068-7
   JOHNSON SM, 1981, JAMA-J AM MED ASSOC, V245, P1849, DOI 10.1001/jama.245.18.1849
   Joint Commission, 2007, JT COMM PERSPECT, V27, P1
   Jones CM, 2007, ANN THORAC SURG, V83, P341, DOI 10.1016/j.athoracsur.2006.08.018
   JONES EL, 1983, AM J CARDIOL, V51, P7, DOI 10.1016/S0002-9149(83)80003-4
   Jones JW, 1999, ANN THORAC SURG, V67, P1596, DOI 10.1016/S0003-4975(99)00368-9
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P5
   Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012
   Julius S, 2006, HYPERTENSION, V48, P385, DOI 10.1161/01.HYP.0000236119.96301.f2
   Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004
   JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q
   Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001
   KAISER GA, 1975, SURGERY, V78, P749
   Kamalesh M, 2002, AM HEART J, V143, P163, DOI 10.1067/mhj.2002.119377
   Kang XP, 2006, J AM COLL CARDIOL, V47, P1418, DOI 10.1016/j.jacc.2005.11.062
   KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035
   KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8
   KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9
   Kantor PF, 2000, CIRC RES, V86, P580
   Kapoor JR, 2008, JACC-CARDIOVASC INTE, V1, P483, DOI 10.1016/j.jcin.2008.07.001
   Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213
   Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
   Kardas Przemyslaw, 2007, Vasc Health Risk Manag, V3, P235, DOI 10.2147/vhrm.2007.3.2.235
   KARLSON BW, 1993, CLIN CARDIOL, V16, P397
   Karlsson J, 2004, CLIN CARDIOL, V27, P347, DOI 10.1002/clc.4960270610
   Kasper J F, 1992, QRB Qual Rev Bull, V18, P183
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Katritsis DG, 2007, NEW ENGL J MED, V357, P414
   Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864
   Katzel LI, 1999, J AM GERIATR SOC, V47, P923
   KAUL S, 1995, AM J CARDIOL, V75, pD18
   Keitel WA, 2006, ARCH INTERN MED, V166, P1121, DOI 10.1001/archinte.166.10.1121
   Kelle S, 2011, JACC-CARDIOVASC IMAG, V4, P161, DOI 10.1016/j.jcmg.2010.11.012
   Kelly TN, 2009, ANN INTERN MED, V151, P394
   Ken-Dror Gie, 2004, Harefuah, V143, P566
   Kernis SJ, 2004, J AM COLL CARDIOL, V43, P1773, DOI 10.1016/j.jacc.2003.09.071
   Khunnawat C, 2008, AM J CARDIOL, V102, P635, DOI 10.1016/j.amjcard.2008.04.035
   Kim JW, 2005, INT J CARDIOL, V99, P437, DOI 10.1016/j.ijcard.2004.08.045
   Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602
   Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E
   Kleisli T, 2005, J THORAC CARDIOV SUR, V129, P1283, DOI 10.1016/j.jtcvs.2004.12.034
   Klem I, 2006, J AM COLL CARDIOL, V47, P1630, DOI 10.1016/j.jacc.2005.10.074
   Kloner RA, 2004, J UROLOGY, V172, P1935, DOI 10.1097/01.ju.0000142687.75577.e4
   KNOCHEL JP, 1961, AM J MED, V30, P299, DOI 10.1016/0002-9343(61)90101-2
   Knudtson ML, 2002, JAMA-J AM MED ASSOC, V287, P481, DOI 10.1001/jama.287.4.481
   Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039
   Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351
   KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503
   Koh KK, 2002, CARDIOVASC RES, V55, P714, DOI 10.1016/S0008-6363(02)00487-X
   Kok G, 1997, PATIENT EDUC COUNS, V30, P19, DOI 10.1016/S0738-3991(96)00953-6
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066
   Kop WJ, 2002, AM J CARDIOL, V89, P419, DOI 10.1016/S0002-9149(01)02264-0
   Korosoglou G, 2010, J AM COLL CARDIOL, V56, P1225, DOI 10.1016/j.jacc.2010.06.020
   Koyanagi T, 1996, ANN THORAC SURG, V61, P1793, DOI 10.1016/0003-4975(96)00170-1
   Kozower BD, 2005, ANN THORAC SURG, V80, P112, DOI 10.1016/j.athoracsur.2005.02.017
   KREPP HP, 1991, CARDIOLOGY, V79, P14, DOI 10.1159/000174919
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1
   Kronish IM, 2006, J GEN INTERN MED, V21, P1178, DOI 10.1111/j.1525-1497.2006.00586.x
   Krumholz HM, 2010, JAMA-J AM MED ASSOC, V303, P1190, DOI 10.1001/jama.2010.309
   Kuntz KM, 1999, ANN INTERN MED, V130, P709
   Kunz R, 2008, ANN INTERN MED, V148, P30
   Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663
   Kwok JMF, 2002, J AM COLL CARDIOL, V39, P1475, DOI 10.1016/S0735-1097(02)01769-2
   Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1
   Kwong RY, 2003, CIRCULATION, V107, P531, DOI 10.1161/01.CIR.0000047527.11221.29
   Kwong RY, 2011, JACC-CARDIOVASC IMAG, V4, P157, DOI 10.1016/j.jcmg.2010.12.004
   LACOSTE LL, 1994, AM J CARDIOL, V73, P1058
   Ladapo JA, 2009, J AM COLL CARDIOL, V54, P2409, DOI 10.1016/j.jacc.2009.10.012
   LADENHEIM ML, 1987, AM J CARDIOL, V59, P270, DOI 10.1016/0002-9149(87)90798-3
   LADENHEIM ML, 1986, J AM COLL CARDIOL, V7, P464
   LaghrissiThode F, 1997, BIOL PSYCHIAT, V42, P290, DOI 10.1016/S0006-3223(96)00345-9
   Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6
   Lancaster T, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001292.PUB2
   Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197
   Lapenna E, 2006, ANN THORAC SURG, V82, P1704, DOI 10.1016/j.athoracsur.2006.05.096
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754
   Lauer MS, 2011, CIRCULATION, V123, P1364, DOI 10.1161/CIRCULATIONAHA.111.023218
   Lauer MS, 2007, ANN INTERN MED, V147, P821
   Lauer MS, 1998, LANCET, V351, P615, DOI 10.1016/S0140-6736(97)07062-1
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Leape LL, 2000, AM HEART J, V139, P106, DOI 10.1016/S0002-8703(00)90316-8
   Lee AB, 2006, INTERN MED J, V36, P237, DOI 10.1111/j.1445-5994.2006.01044.x
   Lee MS, 2007, INT J CARDIOL, V123, P34, DOI 10.1016/j.ijcard.2006.11.103
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   LEE TH, 1990, J GEN INTERN MED, V5, P381, DOI 10.1007/BF02599421
   Leischik R, 2007, INT J CARDIOL, V119, P297, DOI 10.1016/j.ijcard.2006.07.190
   Leizorovicz A, 2002, AM HEART J, V143, P301, DOI 10.1067/mhj.2002.120768
   Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Lerakis S, 2010, AM J MED SCI, V339, P216, DOI 10.1097/MAJ.0b013e3181c6bfcc
   Lertsburapa K, 2008, J NUCL CARDIOL, V15, P745, DOI 10.1007/BF03007355
   Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367
   Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622
   LEVY D, 1989, ANN INTERN MED, V110, P101
   LEVY D, 1994, CIRCULATION, V90, P1786
   LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
   Lewington S, 2002, LANCET, V360, P1903
   Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303
   Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821
   Liao L, 2005, AM J CARDIOL, V95, P1243, DOI 10.1016/j.amjcard.2005.01.057
   Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257
   Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
   Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769
   Lima RSL, 2004, INT J CARDIOL, V93, P137, DOI 10.1016/S0167-5273(03)00149-9
   Lin FY, 2011, J AM COLL CARDIOL, V58, P510, DOI 10.1016/j.jacc.2010.11.078
   Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604
   LITTLE WC, 1988, CIRCULATION, V78, P1157
   Liu J, 2006, CLIN PHARMACOL THER, V80, P23, DOI 10.1016/j.clpt.2006.03.004
   Liu J, 2003, CLIN PHARMACOL THER, V74, P372, DOI 10.1067/S0009-9236(03)00224-8
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Loke YK, 2011, BRIT MED J, V342, P1309
   Lonn E, 2006, NEW ENGL J MED, V354, P1567
   LONN EM, 1994, CIRCULATION, V90, P2056
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Lopez-Jimenez F, 2005, MAYO CLIN PROC, V80, P1157
   Lorenzoni R, 2003, J AM SOC ECHOCARDIOG, V16, P1287, DOI 10.1067/j.echo.2003.07.007
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   MACGREGOR GA, 1989, LANCET, V2, P1244
   Maddox TM, 2008, ARCH INTERN MED, V168, P1310, DOI 10.1001/archinte.168.12.1310
   Mahajan N, 2010, HEART, V96, P956, DOI 10.1136/hrt.2009.182295
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Malfatto Gabriella, 2005, Ital Heart J, V6, P21
   Mannheimer C, 1998, CIRCULATION, V97, P1157
   MANOLIO TA, 1993, CIRCULATION, V88, P2163
   MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141
   Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808
   Manz M, 2003, CARDIOLOGY, V100, P149, DOI 10.1159/000073933
   Manzi S, 1997, AM J EPIDEMIOL, V145, P408
   Maqbool A, 1999, LANCET, V353, P897, DOI 10.1016/S0140-6736(99)00549-8
   Marcassa C, 2008, EUR HEART J, V29, P557, DOI 10.1093/eurheartj/ehm607
   MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204
   MARK DB, 1994, CIRCULATION, V89, P2015
   MARK DB, 1987, ANN INTERN MED, V106, P793
   Mark DB, 2010, CIRCULATION, V121, P2509, DOI 10.1161/CIR.0b013e3181d4b618
   Markham A, 2000, DRUGS, V60, P955, DOI 10.2165/00003495-200060040-00007
   Maron DJ, 2009, AM J CARDIOL, V104, P1055, DOI 10.1016/j.amjcard.2009.05.056
   Martini CH, 2005, J THROMB HAEMOST, V3, P177, DOI 10.1111/j.1538-7836.2004.01080.x
   Martuscelli E, 2008, EUR J CARDIO-THORAC, V33, P4, DOI 10.1016/j.ejcts.2007.09.029
   Marwick TH, 1997, J AM COLL CARDIOL, V30, P83
   Marwick TH, 2001, CIRCULATION, V103, P2566
   Marwick TH, 2003, EUR HEART J, V24, P1153, DOI 10.1016/S0195-668X(03)00113-1
   Marwick TH, 2001, J AM COLL CARDIOL, V37, P754, DOI 10.1016/S0735-1097(00)01191-8
   Marzilli M, 2003, CORONARY ARTERY DIS, V14, P171, DOI 10.1097/01.mca.0000062799.53287.82
   Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670
   Matetzky S, 2003, ARCH INTERN MED, V163, P457, DOI 10.1001/archinte.163.4.457
   Mattera JA, 1998, J NUCL CARDIOL, V5, P498, DOI 10.1016/S1071-3581(98)90181-7
   Matzkies FK, 2001, NEPHRON, V89, P10, DOI 10.1159/000046036
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   MAY GA, 1984, PHYS THER, V64, P1361
   MCCARTNEY N, 1991, AM J CARDIOL, V67, P939, DOI 10.1016/0002-9149(91)90164-G
   McCord J, 2008, CIRCULATION, V117, P1897, DOI 10.1161/CIRCULATIONAHA.107.188950
   McCormack J, 2000, BRIT MED J, V320, P1720, DOI 10.1136/bmj.320.7251.1720
   McCully RB, 2002, J AM COLL CARDIOL, V39, P1345, DOI 10.1016/S0735-1097(02)01778-3
   McCully RB, 1998, J AM COLL CARDIOL, V31, P144, DOI 10.1016/S0735-1097(97)00427-0
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McGillion Michael, 2007, Can J Nurs Res, V39, P48
   McKellar JD, 2004, DIABETES EDUCATOR, V30, P485, DOI 10.1177/014572170403000320
   McLellan CS, 2005, AM HEART J, V150, P800, DOI 10.1016/j.ahj.2004.10.037
   McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037
   McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3
   McNulty PH, 2002, CATHETER CARDIO INTE, V56, P174, DOI 10.1002/ccd.10186
   McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79
   Mega JL, 2010, CIRCULATION, V121, P1809, DOI 10.1161/CIRCULATIONAHA.109.897231
   Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171
   Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068
   Mehta NJ, 2003, ANGIOLOGY, V54, P269, DOI 10.1177/000331970305400302
   Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058
   MELIN JA, 1985, CIRCULATION, V71, P535
   Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38
   Merz N B, 2001, Am J Manag Care, V7, P959
   Messerli FH, 2006, ANN INTERN MED, V144, P884
   Metz LD, 2007, J AM COLL CARDIOL, V49, P227, DOI 10.1016/j.jace.2006.08.048
   Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60
   Milani RV, 2004, J AM COLL CARDIOL, V43, P1056, DOI 10.1016/j.jacc.2003.10.041
   Miller JM, 2008, NEW ENGL J MED, V359, P232
   Miller NH, 1995, MONOGRAPH HUMAN KINE, V2
   MILLER TD, 1994, MAYO CLIN PROC, V69, P626
   Miller TD, 2002, AM J MED, V112, P290, DOI 10.1016/S0002-9343(01)01111-1
   Miller TD, 2005, AM J MED, V118, P866, DOI 10.1016/j.amjmed.2005.03.013
   Miller WR, 2002, MOTIVATIONAL INTERVI
   Min JK, 2010, J AM COLL CARDIOL, V55, P957, DOI 10.1016/j.jacc.2009.08.087
   Min JK, 2008, RADIOLOGY, V249, P62, DOI 10.1148/radiol.2483071453
   Min JK, 2010, RADIOLOGY, V254, P801, DOI 10.1148/radiol.09090349
   Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067
   Min JK, 2008, AM J CARDIOL, V102, P672, DOI 10.1016/j.amjcard.2008.04.045
   Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074
   MOCK MB, 1982, CIRCULATION, V66, P562
   MOE G, 1986, AM J MED, V81, P765, DOI 10.1016/0002-9343(86)90341-4
   Moller J, 2001, HEART, V86, P387, DOI 10.1136/heart.86.4.387
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Montorsi F, 2004, EUR UROL, V45, P339, DOI 10.1016/j.eururo.2003.11.010
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morise AP, 2003, J AM COLL CARDIOL, V42, P842, DOI 10.1016/S0735-1097(03)00837-4
   MORRIS SN, 1978, AM J CARDIOL, V41, P221, DOI 10.1016/0002-9149(78)90160-1
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775
   Morrow DA, 2009, CIRCULATION, V119, P2032, DOI 10.1161/CIRCULATIONAHA.107.763912
   MORROW K, 1993, ANN INTERN MED, V118, P689
   Mosca Lori, 2011, Circulation, V123, P1243, DOI 10.1161/CIR.0b013e31820faaf8
   Moscucci M, 2001, CIRCULATION, V104, P263
   Moss AJ, 2008, J CARDIOVASC ELECTR, V19, P1289, DOI 10.1111/j.1540-8167.2008.01246.x
   Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068
   Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, piii
   Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292
   Mozaffarian D, 2003, AM HEART J, V146, P1015, DOI 10.1016/S0002-8703(03)00436-8
   Mukamal KJ, 2007, J CLIN ENDOCR METAB, V92, P2559, DOI 10.1210/jc.2006-2422
   Mukamal KJ, 2001, JAMA-J AM MED ASSOC, V285, P1965, DOI 10.1001/jama.285.15.1965
   Mukherjee D, 1999, AM J CARDIOL, V84, P598, DOI 10.1016/S0002-9149(99)00387-2
   Muller JE, 2000, AM J CARDIOL, V86, p14F
   Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462
   Muntwyler J, 1998, LANCET, V352, P1882, DOI 10.1016/S0140-6736(98)06351-X
   Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d
   Munzel T, 2002, CIRCULATION, V106, P170, DOI 10.1161/01.CIR.0000021663.39699.30
   MURPHY ML, 1977, NEW ENGL J MED, V297, P621, DOI 10.1056/NEJM197709222971201
   Murphy SL, 2012, NATL VITAL STAT REPO, P60
   Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8
   Murthy VL, 2011, CIRCULATION, V124, P2215, DOI 10.1161/CIRCULATIONAHA.111.050427
   Musselman DL, 1996, AM J PSYCHIAT, V153, P1313
   Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x
   Myers J, 2009, CIRCULATION, V119, P3144, DOI 10.1161/CIRCULATIONAHA.109.192520
   Myers J, 2002, AM HEART J, V143, P1052, DOI 10.1067/mhj.2002.122287
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   MYERS WO, 1987, ANN THORAC SURG, V44, P471
   Nagao T, 2007, CIRC J, V71, P1029, DOI 10.1253/circj.71.1029
   Nagata M, 2011, RADIOLOGY, V259, P384, DOI 10.1148/radiol.11101323
   Nagel E, 1999, CIRCULATION, V99, P763
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011
   Nakagomi A, 1996, AM J CARDIOL, V78, P516, DOI 10.1016/S0002-9149(96)00355-4
   Nakata T, 2009, JACC-CARDIOVASC IMAG, V2, P1393, DOI 10.1016/j.jcmg.2009.09.010
   Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962
   Nallamothu N, 1997, J NUCL CARDIOL, V4, P487, DOI 10.1016/S1071-3581(97)90006-4
   NALLAMOTHU N, 1995, J AM COLL CARDIOL, V25, P830, DOI 10.1016/0735-1097(94)00471-2
   Nandalur KR, 2007, J AM COLL CARDIOL, V50, P1343, DOI 10.1016/j.jacc.2007.06.030
   Nandalur KR, 2008, ACAD RADIOL, V15, P444, DOI 10.1016/j.acra.2007.08.012
   NARAHARA KA, 1990, AM J CARDIOL, V65, P577, DOI 10.1016/0002-9149(90)91033-3
   Nathan DM, 2005, NEW ENGL J MED, V353, P2643
   National Heart Lung and Blood Institute, 2006, INC PREV 2006 CHART
   Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865
   Navare SM, 2004, J NUCL CARDIOL, V11, P551, DOI 10.1016/j.nuclcard.2004.06.128
   National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treat-ment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, CIRCULATION, V106, P3143
   Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE
   Ng ACT, 2009, AM HEART J, V158, P836, DOI 10.1016/j.ahj.2009.09.010
   Nguyen TT, 1999, MAYO CLIN PROC, V74, P1198
   Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338
   Nicorandil study ivestigators, 2003, DRUG THER B, V41, P86
   Nieman K, 2009, AM J CARDIOL, V104, P1499, DOI 10.1016/j.amjcard.2009.07.011
   Nieminen T, 2006, J APPL PHYSIOL, V100, P507, DOI 10.1152/japplphysiol.00899.2005
   Nigam A, 1998, J NUCL MED, V39, P579
   Nikolsky Eugenia, 2004, J Invasive Cardiol, V16, P102
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217
   Nowak Z, 2010, KARDIOL POL, V68, P32
   Nucifora G, 2011, INT J CARDIOVAS IMAG, V27, P777, DOI 10.1007/s10554-010-9725-x
   Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   O'Donoghue M, 2006, CIRCULATION, V113, P1745, DOI 10.1161/CIRCULATIONAHA.105.612630
   O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7
   Oesterle SN, 2000, LANCET, V356, P1705, DOI 10.1016/S0140-6736(00)03203-7
   Oka R, 2008, DIABETES RES CLIN PR, V79, P474, DOI 10.1016/j.diabres.2007.10.016
   OKEEFE JH, 1993, AM J CARDIOL, V71, P897, DOI 10.1016/0002-9149(93)90903-P
   Okin PM, 2003, CIRCULATION, V108, P684, DOI 10.1161/01.CIR.0000083724.28630.C3
   Okin PM, PROGNOSTIC VALUE CHA
   OLDRIDGE NB, 1989, MED SCI SPORT EXER, V21, P308
   Oremus M, 2008, CLIN BIOCHEM, V41, P260, DOI 10.1016/j.clinbiochem.2007.09.011
   ORNISH D, 1983, JAMA-J AM MED ASSOC, V249, P54, DOI 10.1001/jama.249.1.54
   O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7
   O'Shaughnessy KM, 2000, CLIN SCI, V99, P233, DOI 10.1042/CS20000030
   Osswald BR, 2001, THORAC CARDIOV SURG, V49, P373, DOI 10.1055/s-2001-19017
   Otero HJ, 2010, INT J CARDIOVAS IMAG, V26, P605, DOI 10.1007/s10554-010-9634-z
   Ovrehus KA, 2010, AM J CARDIOL, V105, P773, DOI 10.1016/j.amjcard.2009.11.006
   Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201
   Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101
   Padma-Nathan H, 2002, UROLOGY, V60, P67, DOI 10.1016/S0090-4295(02)01752-1
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410
   Paridon SM, 2006, CIRCULATION, V113, P1905, DOI 10.1161/CIRCULATIONAHA.106.174375
   Parisi AF, 1997, J AM COLL CARDIOL, V30, P1256, DOI 10.1016/S0735-1097(97)00293-3
   Park DW, 2008, CIRCULATION, V117, P2079, DOI 10.1161/CIRCULATIONAHA.107.750109
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Parker JD, 1998, NEW ENGL J MED, V338, P520
   PARKER JO, 1995, CIRCULATION, V91, P1368
   PARMLEY WW, 1992, J AM COLL CARDIOL, V19, P1380
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603
   Patel A, 2008, NEW ENGL J MED, V358, P2560
   Patel MR, 2005, J AM COLL CARDIOL, V46, P1606, DOI 10.1016/j.jacc.2005.08.030
   Pazhenkottil AP, 2011, J NUCL MED, V52, P196, DOI 10.2967/jnumed.110.080580
   Pazhenkottil AP, 2011, EUR HEART J, V32, P1465, DOI 10.1093/eurheartj/ehr047
   Pazhenkottil AP, 2010, HEART, V96, P2050, DOI 10.1136/hrt.2010.201996
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403
   Pennell DJ, 2004, EUR HEART J, V25, P1940, DOI 10.1016/j.ehj.2004.06.040
   Pepine CJ, 2004, CIRCULATION, V109, pE44, DOI 10.1161/01.CIR.0000116206.77324.5B
   PEPINE CJ, 1981, AM HEART J, V101, P719, DOI 10.1016/0002-8703(81)90606-2
   Perrone-Filardi P, 2010, J NUCL CARDIOL, V17, P310, DOI 10.1007/s12350-009-9182-x
   Peteiro J, 2006, AM HEART J, V151
   Peteiro J, 2010, EUR HEART J, V31, P187, DOI 10.1093/eurheartj/ehp427
   Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB
   Peterson ED, 2003, J AM COLL CARDIOL, V42, P1611, DOI 10.1016/S0735-1097(03)01121-5
   PETERSON ED, 1994, ANN INTERN MED, V121, P919
   Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
   Pfisterer M, 2004, CIRCULATION, V110, P1213, DOI 10.1161/01.CIR.0000140983.69571.BA
   Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   Philpott S, 2001, SOC SCI MED, V52, P1565, DOI 10.1016/S0277-9536(00)00269-0
   Picano E, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-30
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pilz G, 2010, J MAGN RESON IMAGING, V32, P615, DOI 10.1002/jmri.22289
   Pilz G, 2008, AM J CARDIOL, V101, P1408, DOI 10.1016/j.amjcard.2008.01.019
   Pinkstaff S, 2010, MAYO CLIN PROC, V85, P1095, DOI 10.4065/mcp.2010.0357
   Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202
   Pitt B, 2001, AM J CARDIOL, V87, P1058, DOI 10.1016/S0002-9149(01)01461-8
   Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202
   Pittman M A, 2001, Trustee, V54, P30
   PLOTNICK GD, 1979, ANN INTERN MED, V91, P149
   Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   Pohl T, 2004, CATHETER CARDIO INTE, V62, P323, DOI 10.1002/ccd.20060
   Poldermans D, 1999, CIRCULATION, V99, P757
   Poldermans D, 1997, EUR HEART J, V18, pD86
   Pollock BG, 2000, J CLIN PSYCHOPHARM, V20, P137, DOI 10.1097/00004714-200004000-00004
   Poole-Wilson PA, 2007, EUR HEART J, V28, P1928, DOI 10.1093/eurheartj/ehm198
   Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7
   Poornima IG, 2004, J AM COLL CARDIOL, V43, P194, DOI 10.1016/j.jacc.2003.09.029
   Pope CA, 2007, INHAL TOXICOL, V19, P33, DOI 10.1080/08958370701492961
   Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Porter TR, 2011, CIRC-CARDIOVASC IMAG, V4, P628, DOI 10.1161/CIRCIMAGING.111.966341
   Poses RM, 2002, CHEST, V122, P122, DOI 10.1378/chest.122.1.122
   Pothier CE, 2004, AM J MED, V117, P380
   Prasad A, 1999, J AM COLL CARDIOL, V33, P796, DOI 10.1016/S0735-1097(98)00611-1
   Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165
   Prochaska J, 1984, CHANGING GOOD REVOLU
   PROUDFIT WJ, 1983, CIRCULATION, V68, P986
   PRYOR DB, 1991, AM J MED, V90, P553
   PRYOR DB, 1993, ANN INTERN MED, V118, P81
   Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534
   Pundziute G, 2008, HEART, V94, P48, DOI 10.1136/hrt.2007.116715
   Qureshi MA, 2003, J AM COLL CARDIOL, V42, P1890, DOI 10.1016/j.jacc.2003.06.014
   Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056
   Raftery EB, 1996, EUR HEART J, V17, P30
   Ragosta M, 2006, CATHETER CARDIO INTE, V68, P357, DOI 10.1002/ccd.20709
   Rajaratnam R, 1999, AM J CARDIOL, V83, P1120, DOI 10.1016/S0002-9149(99)00025-9
   randomized A, 1996, LANCET, V348, P1329
   Rao SV, 2004, ARCH INTERN MED, V164, P1128, DOI 10.1001/archinte.164.10.1128
   Rauramaa R, 2001, MED SCI SPORT EXER, V33, pS516, DOI 10.1097/00005768-200106001-00022
   Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8
   Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5
   Rees K, 2004, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD002902.pub2, DOI 10.1002/14651858.CD002902.PUB2]
   Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1
   Rehnqvist N, 1995, Cardiologia, V40, P301
   REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Reid RJ, 2009, AM J MANAG CARE, V15, pE71
   Resnic FS, 2001, AM J CARDIOL, V88, P5, DOI 10.1016/S0002-9149(01)01576-4
   RICHTER A, 1991, EUR HEART J, V12, P175
   Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978
   Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378
   Rieckmann N, 2006, AM HEART J, V152, P922, DOI 10.1016/j.ahj.2006.05.014
   Rieckmann N, 2006, J AM COLL CARDIOL, V48, P2218, DOI 10.1016/j.jacc.2006.07.063
   Rigotti NA, 2009, CAN MED ASSOC J, V180, P1283, DOI 10.1503/cmaj.090729
   Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744
   RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117
   RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004
   RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941
   Rocha JA, 2010, RADIOLOGY, V254, P410, DOI 10.1148/radiol.09091014
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7
   RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060
   Rodriguez A, ARGENTINE RANDOMIZED
   Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081
   Roger VL, 1997, CIRCULATION, V95, P405
   Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9
   Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONHA.107.183885
   Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0
   ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   Rouleau JL, 2008, CIRCULATION, V117, P24, DOI 10.1161/CIRCULATIONAHA.106.685073
   Rousseau MF, 2005, AM J CARDIOL, V95, P311, DOI 10.1016/j.amjcard.2004.09.025
   Rozanski A, 2010, J NUCL CARDIOL, V17, P999, DOI 10.1007/s12350-010-9300-9
   ROZANSKI A, 1983, NEW ENGL J MED, V309, P518, DOI 10.1056/NEJM198309013090902
   Rozanski A, 1999, CIRCULATION, V99, P2192
   RUBERMAN W, 1980, CIRCULATION, V61, P1172
   Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604
   Rubinshtein R, 2007, AM J CARDIOL, V99, P472, DOI 10.1016/j.amjcard.2006.08.060
   Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0
   Rumsfeld JS, 2003, AM HEART J, V145, P493, DOI 10.1067/mhj.2003.177
   Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298
   Rumsfeld JS, 2005, CIRCULATION, V111, P250, DOI 10.1161/01.CIR.0000154573.62822.89
   Rumsfeld JS, 2003, J AM COLL CARDIOL, V41, P1732, DOI 10.1016/S0735-1097(03)00330-9
   Rumsfeld JS, 2005, AM HEART J, V150, P961, DOI 10.1016/j.ahj.2005.02.036
   Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215
   Rutledge T, 2004, PSYCHOSOM MED, V66, P882, DOI 10.1097/01.psy.0000145819.94041.52
   RYDEN L, 1992, J INTERN MED, V231, P7
   Sabharwal NK, 2007, J NUCL CARDIOL, V14, P174, DOI 10.1016/j.nuclcard.2006.12.324
   Sachdev M, 2004, J AM COLL CARDIOL, V43, P576, DOI 10.1016/j.jacc.2003.10.031
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   Sakuma H, 2011, RADIOLOGY, V258, P340, DOI 10.1148/radiol.10100116
   Sakuma H, 2006, J AM COLL CARDIOL, V48, P1946, DOI 10.1016/j.jacc.2006.07.055
   Sampson UK, 2007, J AM COLL CARDIOL, V49, P1052, DOI 10.1016/j.jacc.2006.12.015
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Santana-Boado C, 1998, J NUCL MED, V39, P751
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031
   Savonitto S, 1996, J AM COLL CARDIOL, V27, P311, DOI 10.1016/0735-1097(95)00489-0
   Saw J, 2007, J AM COLL CARDIOL, V50, P291, DOI 10.1016/j.jacc.2007.01.097
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Sawada SG, 2007, ECHOCARDIOGR-J CARD, V24, P739, DOI 10.1111/j.1540-8175.2007.00471.x
   Schaefer EJ, 1997, AM J CLIN NUTR, V65, P823
   SCHAEFER EJ, 1995, ARTERIOSCL THROM VAS, V15, P1079
   Schappert SM, 2006, VITAL HLTH STAT, V13, P1
   Schinkel AFL, 2005, J NUCL MED, V46, P12
   SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051
   Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008
   Schuijf JD, 2006, AM HEART J, V151, P404, DOI 10.1016/j.ahj.2005.03.022
   SCHULER G, 1992, CIRCULATION, V86, P1
   Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617
   Scirica BM, 2007, CIRCULATION, V116, P1647, DOI 10.1161/CIRCULATIONAHA.107.724880
   SEBRECHTS CP, 1986, AM HEART J, V112, P1217, DOI 10.1016/0002-8703(86)90351-0
   Sedlis SP, 2009, AM J CARDIOL, V104, P1647, DOI 10.1016/j.amjcard.2009.07.043
   Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070
   Sergeant P, 1 CARDIOLOGICAL CARD
   Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0
   Shah SA, 2010, PHARMACOTHERAPY, V30, P639, DOI 10.1592/phco.30.7.639
   Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Sharaf BL, 2001, AM J CARDIOL, V87, P937, DOI 10.1016/S0002-9149(01)01424-2
   Sharir T, 2010, J AM COLL CARDIOL, V55, P1965, DOI 10.1016/j.jacc.2010.01.028
   Sharir T, 2008, JACC-CARDIOVASC IMAG, V1, P156, DOI 10.1016/j.jcmg.2007.12.004
   Shark T, 2006, J NUCL CARDIOL, V13, P495, DOI 10.1016/j.nuclcard.2006.03.019
   Sharir T, 1999, CIRCULATION, V100, P1035
   Shaw L, 2012, J NUCL CARDIOL
   Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004
   Shaw LJ, 2005, EUR HEART J, V26, P447, DOI 10.1093/eurheartj/ehi102
   Shaw LJ, 1998, CIRCULATION, V98, P1622
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Shaw LJ, 2005, J AM COLL CARDIOL, V45, P1494, DOI 10.1016/j.jacc.2005.01.036
   Shaw LJ, 2010, CIRC-CARDIOVASC IMAG, V3, P473, DOI 10.1161/CIRCIMAGING.109.860981
   Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990
   Shaw LJ, 2009, CARDIOL CLIN, V27, P597, DOI 10.1016/j.ccl.2009.06.009
   Shaw LJ, 2008, J NUCL CARDIOL, V15, P762, DOI 10.1007/BF03007357
   Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098
   Shaw LJ, 1996, J AM COLL CARDIOL, V27, P787, DOI 10.1016/0735-1097(95)00549-8
   Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072
   Shaw LJ, 2006, EUR HEART J, V27, P2448, DOI 10.1093/eurheartj/ehl204
   Shaw LJ, 2011, CIRCULATION, V124, P1239, DOI 10.1161/CIRCULATIONAHA.111.029660
   Shaw LJ, 2003, J NUCL MED, V44, P134
   Shaw LJ, 2000, AM J CARDIOL, V86, P1, DOI 10.1016/S0002-9149(00)00819-5
   Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X
   Shaw Richard E, 2003, J Invasive Cardiol, V15, P578
   Shechter M, 2003, J AM COLL CARDIOL, V42, P2090, DOI 10.1016/j.jacc.2003.05.013
   Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X
   Sherwood A, 2005, J AM COLL CARDIOL, V46, P656, DOI 10.1016/j.jacc.2005.05.041
   Shimbo D, 2002, AM J CARDIOL, V89, P331, DOI 10.1016/S0002-9149(01)02236-6
   Shmilovich H, 2011, ATHEROSCLEROSIS, V219, P588, DOI 10.1016/j.atherosclerosis.2011.07.128
   Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652
   Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6
   Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232
   Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459
   Sievers B, 2007, CIRCULATION, V115, P236, DOI 10.1161/CIRCULATIONAHA.106.635409
   Silagy C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000146.PUB2
   SILBER S, 1990, EUR J CLIN PHARMACOL, V38, pS35, DOI 10.1007/BF01417564
   Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017
   SIMARI RD, 1991, AM J CARDIOL, V67, P573, DOI 10.1016/0002-9149(91)90894-Q
   Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227
   Simoons ML, 1996, NEW ENGL J MED, V335, P275, DOI 10.1056/NEJM199607253350409
   Singh M, 2008, J AM COLL CARDIOL, V51, P2313, DOI 10.1016/j.jacc.2008.01.066
   Singh M, 2002, J AM COLL CARDIOL, V40, P387, DOI 10.1016/S0735-1097(02)01980-0
   Singh M, 2005, AM J CARDIOL, V96, P907, DOI 10.1016/j.amjcard.2005.05.045
   Sirois C, 2008, INT J CARDIOL, V129, P172, DOI 10.1016/j.ijcard.2008.01.030
   Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254
   Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305
   Slomka PJ, 2005, J NUCL CARDIOL, V12, P66, DOI 10.1016/j.nuclcard.2004.10.006
   Slomka PJ, 2007, J NUCL CARDIOL, V14, P44, DOI 10.1016/j.nuclcard.2006.10.021
   SLOTHNIELSEN J, 1991, AM J SURG, V162, P122, DOI 10.1016/0002-9610(91)90172-A
   Small GR, 2011, J AM COLL CARDIOL, V58, P2389, DOI 10.1016/j.jacc.2011.08.047
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith PM, 2009, CAN MED ASSOC J, V180, P1297, DOI 10.1503/cmaj.080862
   Smith P.M., 2006, IMPLEMENTING INPATIE
   Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d
   Soejima H, 2004, CIRC J, V68, P367, DOI 10.1253/circj.68.367
   Sofowora GG, 2003, CLIN PHARMACOL THER, V73, P366, DOI 10.1016/S0009-9236(02)17734-4
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   Sowers JR, 2001, HYPERTENSION, V37, P1053
   Sox Jr HC, 1990, AM J MED, V89, P7
   Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302
   SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X
   SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9
   Spertus JA, 2005, J AM COLL CARDIOL, V45, P1147, DOI 10.1016/j.jacc.2005.03.011
   Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90
   Spertus JA, 2001, AM J MED, V111, P341, DOI 10.1016/S0002-9343(01)00878-6
   Spertus JA, 2000, AM HEART J, V140, P105, DOI 10.1067/mhj.2000.106600
   Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
   STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102
   STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P
   STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003
   Stead LF, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001007.PUB2
   Stead LF, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002850
   Steel K, 2009, CIRCULATION, V120, P1390, DOI 10.1161/CIRCULATIONAHA.108.812503
   Stein PD, 2006, AM J MED, V119, P203, DOI 10.1016/j.amjmed.2005.06.071
   Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1
   Stevens VJ, 2001, ANN INTERN MED, V134, P1
   STEVENS VJ, 1993, ARCH INTERN MED, V153, P849, DOI 10.1001/archinte.153.7.849
   Stone GW, 2002, J AM COLL CARDIOL, V39, P1581, DOI 10.1016/S0735-1097(02)01829-6
   Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044
   STRATMANN HG, 1994, CIRCULATION, V89, P615
   Stroupe KT, 2006, CIRCULATION, V114, P1251, DOI 10.1161/CIRCULATIONAHA.105.570838
   Stys TP, 2002, AM J CARDIOL, V89, P822, DOI 10.1016/S0002-9149(02)02191-4
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   SULLIVAN AK, 1994, BRIT MED J, V308, P883
   Sun ZH, 2006, EUR J RADIOL, V60, P279, DOI 10.1016/j.ejrad.2006.06.009
   Sun ZH, 2010, EUR J RADIOL, V73, P266, DOI 10.1016/j.ejrad.2008.10.025
   Szczech LA, 2001, KIDNEY INT, V60, P292, DOI 10.1046/j.1523-1755.2001.00799.x
   Tabib A, 2000, CORONARY ARTERY DIS, V11, P41, DOI 10.1097/00019501-200002000-00008
   Taillefer R, 1997, J AM COLL CARDIOL, V29, P69
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   Tamaki N, 2011, J NUCL CARDIOL, V18, P135, DOI 10.1007/s12350-010-9305-4
   Tamburino C, 2010, JACC-CARDIOVASC INTE, V3, P624, DOI 10.1016/j.jcin.2010.03.016
   Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182
   Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8
   Tandogan I, 2001, INT J CARDIOVAS IMAG, V17, P339, DOI 10.1023/A:1011973530231
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Tarantini G, 2009, CATHETER CARDIO INTE, V73, P50, DOI 10.1002/ccd.21757
   Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586
   Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597
   TAYLOR AE, 1992, CIRCULATION, V86, P699
   Taylor AJ, 2010, CIRCULATION, V122, pE525, DOI 10.1161/CIR.0b013e3181fcae66
   Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934
   Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   Taylor RS, 2010, COCHRANE DB SYST REV
   Tepper D, 1999, CONGEST HEART FAIL, V5, P184
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators, 1993, LANCET, V342, P821
   The Criteria Committee of the New York Heart Association I, 1964, DIS HEART BLOOD VESS
   The Diabetes Control and Complications Trial Research Group, 1993, N ENGL J MED, V329, P977
   Fox KM, 2003, LANCET, V362, P782
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   Braunwald E, 2004, NEW ENGL J MED, V351, P2058
   The SOLVD Investigators, 1991, N ENGL J MED, V325, P293
   Thiele H, 2009, J AM COLL CARDIOL, V53, P2324, DOI 10.1016/j.jacc.2009.03.032
   Thiele H, 2005, CIRCULATION, V112, P3445, DOI 10.1161/CIRCULATIONHA.105.578492
   Thomas RJ, 2010, CIRCULATION, V122, P1342, DOI 10.1161/CIR.0b013e3181f5185b
   Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485
   Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77
   TIME Investigators, 2001, LANCET, V358, P951
   Timmis AD, 2006, EUR HEART J, V27, P42, DOI 10.1093/eurheartj/ehi495
   Tobacco Use and Dependence Guideline Panel, 2008, TREATING TOBACCO USE
   TODD IC, 1992, BRIT HEART J, V68, P560
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565
   TOPOL EJ, 1995, CIRCULATION, V92, P2333
   TREESE N, 1992, J CARDIOVASC PHARM, V20, pS52, DOI 10.1097/00005344-199206203-00010
   Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6
   Trikalinos Thomas A, 2009, Med Decis Making, V29, pE22, DOI 10.1177/0272989X09345022
   TSUYA T, 1990, AM J CARDIOL, V66, P275, DOI 10.1016/0002-9149(90)90835-O
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Tummala PE, 1999, CIRCULATION, V100, P1223
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Agodoa L, 2007, J HYPERTENS, V25, P951
   Turnbull F, 2003, LANCET, V362, P1527
   Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0
   Underwood SR, 1999, EUR HEART J, V20, P157, DOI 10.1053/euhj.1998.1196
   Underwood SR, 2004, EUR J NUCL MED MOL I, V31, P261, DOI 10.1007/s00259-003-1344-5
   Underwood SR, 2004, HEART, V90, pV34, DOI 10.1136/hrt.2003.019133
   Urano H, 2001, J AM COLL CARDIOL, V37, P93, DOI 10.1016/S0735-1097(00)01095-0
   U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A
   US Food and Drug Administration, 2008, INF HEALTHC PROF VAR
   US Food and Drug Administration. Public Health Advisory, 2008, IMP INF CHANT VAR
   Ussher M., 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002295.PUB2
   Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401
   Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133
   Valdiviezo C, 2010, J NUCL CARDIOL, V17, P1091, DOI 10.1007/s12350-010-9291-6
   VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160
   van der Bijl N, 2011, IMAGING MED, V2, P167
   VANRIJ AM, 1994, CIRCULATION, V90, P1194
   VANDENBURG MJ, 1986, BRIT J CLIN PRACT, V40, P524
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van der Sloot JAP, 2004, ANN THORAC SURG, V78, P875, DOI 10.1016/j.athoracsur.2004.02.073
   van Velzen JE, 2010, CIRC-CARDIOVASC IMAG, V3, P718, DOI 10.1161/CIRCIMAGING.109.913541
   van Werkhoven JM, 2009, J AM COLL CARDIOL, V53, P623, DOI 10.1016/j.jacc.2008.10.043
   Varani Elisabetta, 2007, J Invasive Cardiol, V19, P469
   Vardeny O, 2009, J CARD FAIL, V15, P368, DOI 10.1016/j.cardfail.2008.11.009
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Villarruz MV, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002785
   Villines TC, 2011, J AM COLL CARDIOL, V58, P2540
   VINEBERG AM, 1946, CAN MED ASSOC J, V55, P117
   Vitarelli A, 2003, HEART FAIL REV, V8, P181, DOI 10.1023/A:1023001104207
   Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9
   VONARNIM T, 1995, J AM COLL CARDIOL, V25, P231, DOI 10.1016/0735-1097(94)00345-Q
   von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088
   Vongvanich P, 1996, AM J CARDIOL, V77, P1383, DOI 10.1016/S0002-9149(96)00215-9
   Wagdy HM, 1998, CIRCULATION, V97, P1563
   Wahrborg P, 1999, EUR HEART J, V20, P653, DOI 10.1053/euhj.1998.1237
   Wallace EL, 2009, JACC-CARDIOVASC IMAG, V2, P299, DOI 10.1016/j.jcmg.2008.10.015
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432
   WAYSBORT J, 1991, CARDIOLOGY, V79, P19, DOI 10.1159/000174920
   WEINER DA, 1984, J AM COLL CARDIOL, V3, P772
   Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Wenaweser P, 2008, AM J CARDIOL, V101, P807, DOI 10.1016/j.amjcard.2007.10.046
   WEST JNW, 1991, INT J CARDIOL, V31, P102, DOI 10.1016/0167-5273(91)90275-T
   Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839
   Whelton SP, 2004, AM J CARDIOL, V93, P1119, DOI 10.1016/j.amjcard.2004.01.038
   Whelton SP, 2002, ANN INTERN MED, V136, P493
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874
   Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x
   Wiest FC, 2004, AM J MED, V117, P234, DOI 10.1016/j.amjmed.2004.02.044
   WIGHT LJ, 1992, EUR J CLIN PHARMACOL, V42, P341
   Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102
   Wilson PWF, 1998, CIRCULATION, V97, P1837
   Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427
   WINNIFORD MD, 1987, AM J CARDIOL, V59, P203, DOI 10.1016/0002-9149(87)90785-5
   Winter R, 2007, J AM SOC ECHOCARDIOG, V20, P974, DOI 10.1016/j.echo.2007.01.029
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   WONG ND, 1991, ANN INTERN MED, V115, P687
   Woodcock J, 2010, 021071 NDA CTR DRUG
   Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897
   Wright JT, 2002, ARCH INTERN MED, V162, P1636, DOI 10.1001/archinte.162.14.1636
   Wu CT, 2006, J AM COLL CARDIOL, V47, P654, DOI 10.1016/j.jacc.2005.09.071
   Xie HG, 2001, PHARMACOGENETICS, V11, P191, DOI 10.1097/00008571-200104000-00002
   Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424
   Yang JH, 2008, ANN THORAC SURG, V85, P65, DOI 10.1016/j.athoracsur.2007.06.027
   Yang Zhen Kun, 2007, J Interv Cardiol, V20, P10, DOI 10.1111/j.1540-8183.2007.00222.x
   Yao SS, 2012, AM J CARDIOL, V109, P153, DOI 10.1016/j.amjcard.2011.08.023
   Yao SS, 2010, J AM SOC ECHOCARDIOG, V23, P832, DOI 10.1016/j.echo.2010.05.004
   Yao SS, 2003, J AM COLL CARDIOL, V42, P1084, DOI 10.1016/S0735-1097(03)00923-9
   Yoshinaga K, 2006, J AM COLL CARDIOL, V48, P1029, DOI 10.1016/j.jacc.2006.06.025
   Yoshinaga K, 2011, CIRC J, V75, P2628, DOI 10.1253/circj.CJ-11-0502
   Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632
   Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Yusuf S, 2008, NEW ENGL J MED, V358, P1547
   ZEIHER AM, 1995, CIRCULATION, V92, P1094
   Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818
   1992, CIRCULATION, V86, P121
NR 1263
TC 50
Z9 52
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD DEC 18
PY 2012
VL 126
IS 25
BP E354
EP U191
DI 10.1161/CIR.0b013e318277d6a0
PG 167
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 057FW
UT WOS:000312549200002
PM 23166211
ER

PT J
AU Belanger, HG
   Spiegel, E
   Vanderploeg, RD
AF Belanger, Heather G.
   Spiegel, Eric
   Vanderploeg, Rodney D.
TI Neuropsychological performance following a history of multiple
   self-reported concussions: A meta-analysis
SO JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
LA English
DT Article
DE Brain concussion; Multiple concussions; Head injury; Minor;
   Neuropsychological; Traumatic brain injury; Cognition
ID TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; HEAD-INJURY;
   RELIABILITY; IMPAIRMENT; RECOVERY; OUTCOMES; SPORT
AB Debate continues about the long-term neuropsychological impact of multiple mild traumatic brain injuries (MTBI). A meta-analysis of the relevant literature was conducted to determine the impact of having a history of more than one self-reported MTBI (versus just One MTBI) across seven cognitive domains, as well as symptom complaints. The analysis was based on 8 studies, all conducted with athletes. involving 614 cases Of multiple MTBI and 926 control cases of a single MTBI The overall effect of multiple MTBI on neuropsychological functioning was minimal and not significant (d = 0.06). However. follow-up analyses revealed that Multiple self-reported MTBI was associated with poorer performance on measures of delayed memory and executive functioning. The implications and limitations of these findings are discussed. (JINS, 2010, 16 262-267.)
C1 [Belanger, Heather G.; Spiegel, Eric; Vanderploeg, Rodney D.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA.
   [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA.
   [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat, Tampa, FL USA.
   [Belanger, Heather G.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA.
RP Belanger, HG (reprint author), James A Haley Vet Hosp, Mental Hlth & Behav Sci 116B,13000 Bruce B Downs, Tampa, FL 33612 USA.
EM heather.belanger@va.gov
FU Department of Veterans Affairs, Veterans Health Administration (VHA);
   Defense and Veterans Brain Injury Center; James A. Haley Veterans'
   Hospital
FX The research reported here was Supported by the Department of Veterans
   Affairs, Veterans Health Administration (VHA). Further support was
   provided by the Defense and Veterans Brain Injury Center and the James
   A. Haley Veterans' Hospital. The views expressed herein are those of the
   authors and do not necessarily reflect the views of the Department of
   Veterans Affairs. There are no conflicts of interest.
CR Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175
   Baddeley A., 1992, SPEED CAPACITY LANGU
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277
   Benedict R. H., 1997, BRIEF VISUOSPATIAL M
   Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726
   Benton AL, 1976, MULTILINGUAL APHASIA
   Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3
   Borg J., 2004, J REHABIL MED S, V43, P61
   Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI DOI 10.1080/13854049108403297
   Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019
   Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8
   CAPRUSO DX, 1992, NEUROL CLIN, V10, P879
   CDC, 2003, REP C MILD TRAUM BRA
   CDC, 2007, NAT CTR INJ PREV CON
   Cohen J, 1988, STAT POWER ANAL BEHA
   Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802
   Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006
   Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964
   Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006
   De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931
   DELIA LF, 1989, COLOUR TRIALS 1 2
   DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017
   Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103
   DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6
   Erlanger D, 1999, CONCUSSION RESOLUTIO
   Gaetz M, 2000, BRAIN INJURY, V14, P1077
   Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950
   GRONWALL D, 1975, LANCET, V2, P995
   Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549
   Hunter J. E., 1990, METHODS METAANALYSIS
   Iverson G, 2007, CLIN J SPORT MED, V17, P31
   Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651
   Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910
   *LAF INSTR CO, INSTR GROOV PEGB
   Lezak M., 2004, NEUROPSYCHOLOGICAL A
   Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9
   Macciocchi SN, 2001, J ATHL TRAINING, V36, P303
   Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027
   Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503
   Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1
   Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4
   MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9
   Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102
   Randolph C., 1998, REPEATABLE BATTERY A
   Reitan RM, 1985, HALSTEADREITAN NEURO
   Schmidt F. L., 2003, HDB PSYCHOL, V2, P533
   Smith A, 1973, SYMBOL DIGIT MODALIT
   Strauss E., 2006, COMPENDIUM NEUROPSYC
   Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662
   Thurman DJ, 2001, HEAD TRAUMA BASIC PR
   Trenerry MR, 1989, STROOP NEUROPSYCHOLO
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   Wechsler D., 1997, WECHSLER ADULT INTEL
NR 54
TC 50
Z9 50
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1355-6177
J9 J INT NEUROPSYCH SOC
JI J. Int. Neuropsychol. Soc.
PD MAR
PY 2010
VL 16
IS 2
BP 262
EP 267
DI 10.1017/S1355617709991287
PG 6
WC Clinical Neurology; Neurosciences; Psychiatry; Psychology
SC Neurosciences & Neurology; Psychiatry; Psychology
GA 562DZ
UT WOS:000275030900006
PM 20003581
ER

PT J
AU Merrick, GS
   Butler, WM
   Wallner, KE
   Galbreath, RW
   Anderson, RL
AF Merrick, GS
   Butler, WM
   Wallner, KE
   Galbreath, RW
   Anderson, RL
TI Prostate-specific antigen spikes after permanent prostate brachytherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; brachytherapy; prostate-specific antigen; Pd-103; I-125
ID EXTERNAL-BEAM RADIATION; INTERSTITIAL BRACHYTHERAPY; CANCER; BIOPSIES;
   KINETICS
AB Purpose: To evaluate whether any clinical, treatment, or dosimetric parameters correlated with the development of a prostate-specific antigen (PSA) spike after permanent prostate brachytherapy.
   Methods and Materials: The evaluated population consisted of 218 hormone-naive patients free of biochemical or clinical failure who underwent permanent prostate brachytherapy with or without supplemental external beam radiotherapy for clinical Stage T1b-T3a adenocarcinoma of the prostate gland (1997 AJCC) between August 1995 and November 1999. No patient underwent pre- or postimplant hormonal manipulation, pretreatment seminal vesicle biopsy, or pathologic lymph node staging. In addition, none of the 218 patients possessed equivocal biochemical results (one or two consecutive PSA rises or a declining PSA> 1.0 ng/mL). The median patient follow-up was 46.2 months. A PSA spike was defined as a rise of greater than or equal to0.2 ng/mL, followed by a durable decline. The clinical parameters evaluated included patient age, clinical T stage, Gleason score, pretreatment PSA level, prostate volume, brachytherapy planning volume, and patient follow-up in months. The evaluated treatment parameters included isotope and use of supplemental external beam radiotherapy. The dosimetric parameters evaluated included the minimal dose received by 90% of the prostate gland (D-90), the percentage of the prostate volume receiving 100% (V-100), 150%, and 200% (V-200) of the prescribed minimal peripheral dose, and the mean, median, maximal, and minimal urethral doses. Biochemical disease-free survival was defined by the American Society for Therapeutic Radiology and Oncology consensus definition with the additional constraint that the most recent PSA level was less than or equal to1.0 ng/mL.
   Results: Fifty-two patients (23.9%) developed a PSA spike at a mean and median of 19.5 +/- 9.4 months and 16.3 months (range 6.5-59.9), respectively. The median serum PSA before the PSA spike was 0.50 ng/mL, and the median PSA at the time of the spike was 0.90 ng/mL (range 0.3-3.0). On average, patients experiencing a PSA spike were 3.4 years younger (63.9 vs. 67.3 years, p = 0.002) than patients not experiencing a spike and were more likely to have been implanted with I-125 than with Pd-103 (32.7% vs. 16.7%,p = 0.006). In addition, the mean first postimplant PSA level was significantly higher in the spike than in the nonspike patients (1.2 vs. 0.7 ng/mL, p <0.001). By 66 months, the mean and median serum PSA levels for the spike and nonspike patients were all less than or equal to0.1 ng/mL. Stratified into three nadir PSA groups, patients with a nadir PSA less than or equal to0.2 ng/mL were significantly less likely to develop a PSA spike than those patients with a PSA nadir >0.2 to less than or equal to0.5 ng/mL or >0.5 to 1.0 ng/mL (20%, 50%, and 80%, respectively, p <0.001). In Cox multivariate regression analysis, patient age, clinical stage, first postimplant PSA level, and V-150 were predictive for the development of a PSA spike. A postimplant dosimetric threshold of either <115% of the minimal peripheral dose for D-90 or <55% of the prostate volume for V150 was strongly predictive of a spike. When the variables only determinable after the occurrence of the PSA spike were included in the multivariate analysis, V-150, preimplant PSA level, and nadir PSA were the significant predictors.
   Conclusion: Of the patients, 23.9% developed a PSA spike with a median time to development of 16.3 months and a median prespike and median postspike PSA of 0.50 ng/mL and 0.90 ng/mL, respectively. In multivariate analysis, patient age, clinical stage, first postimplant PSA level, and V-150 were predictive for the development of a PSA spike. At approximately 66 months after implantation, the PSA curves converged for spike and nonspike patients, with a median PSA level &LT;0.1 ng/mL. &COPY; 2002 Elsevier Science Inc.
C1 Wheeling Hosp, Schiffler Canc Ctr, Wheeling, WV 26003 USA.
   George Washington Univ, Ctr Med, Div Radiat Oncol & Biophys, Washington, DC USA.
   Puget Sound Hlth Care Syst, Seattle, WA USA.
   Wheeling Jesuit Univ, Wheeling, WV USA.
RP Merrick, GS (reprint author), Wheeling Hosp, Schiffler Canc Ctr, 1 Med Pk, Wheeling, WV 26003 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Butler WM, 2000, INT J RADIAT ONCOL, V48, P1575, DOI 10.1016/S0360-3016(00)01380-8
   Butler WM, 2000, MED PHYS, V27, P381, DOI 10.1118/1.598842
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   CROOK JM, 1995, UROLOGY, V45, P624, DOI 10.1016/S0090-4295(99)80054-5
   HANLON AL, 2001, INT J RADIAT ONCOL, V50, P1207
   Hanlon AL, 1998, CANCER, V83, P130, DOI 10.1002/(SICI)1097-0142(19980701)83:1<130::AID-CNCR17>3.3.CO;2-M
   KUBAN DA, 1992, INT J RADIAT ONCOL, V24, P409
   Merrick GS, 1998, J BRACHYTHERAPY INT, V14, P113
   Merrick GS, 2000, INT J RADIAT ONCOL, V46, P215, DOI 10.1016/S0360-3016(99)00405-8
   Merrick GS, 1999, INT J RADIAT ONCOL, V44, P717, DOI 10.1016/S0360-3016(99)00067-X
   Merrick G S, 2000, Tech Urol, V6, P78
   Merrick G S, 2001, Tech Urol, V7, P12
   MERRICK GS, IN PRESS INT J CANC
   Merrick G S, 2001, Tech Urol, V7, P233
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   Prestidge BR, 1997, INT J RADIAT ONCOL, V37, P31, DOI 10.1016/S0360-3016(96)00390-2
   Smathers S, 2001, INT J RADIAT ONCOL, V50, P1207, DOI 10.1016/S0360-3016(01)01568-1
   Wallner KE BJ, 1997, PROSTATE BRACHYTHERA
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
NR 21
TC 50
Z9 51
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD OCT 1
PY 2002
VL 54
IS 2
BP 450
EP 456
DI 10.1016/S0360-3016(02)02948-6
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 596ZE
UT WOS:000178196200022
PM 12243821
ER

PT J
AU Callahan-Miller, DA
   Tabak, M
AF Callahan-Miller, DA
   Tabak, M
TI Progress in target physics and design for heavy ion fusion
SO PHYSICS OF PLASMAS
LA English
DT Article; Proceedings Paper
CT 41st Annual Meeting of the Division of Plasma Physics of the
   American-Physical-Society
CY NOV 15-19, 1999
CL SEATTLE, WASHINGTON
SP Amer Phys Soc, Div Plasma Phys
ID NATIONAL-IGNITION-FACILITY; PLASMA; ENERGY; POWER; GAIN
AB Two-dimensional, integrated calculations of a close-coupled version of the distributed radiator, heavy ion target predict gain 130 from 3.3 MJ of beam energy. To achieve these results, the case-to-capsule ratio was decreased by about 25% from the previous heavy ion targets [M. Tabak and D. Callahan-Miller, Phys. Plasmas 5, 1895 (1998)]. These targets are robust to changes in the ion stopping model because changes in the ion stopping model can be accommodated by changes to the target. The capsule is also insensitive to changes in the deuterium-tritium (DT) gas fill in the center of the capsule over the range that is of interest for target fabrication and target injection. Single-mode Rayleigh-Taylor growth rates for this capsule are smaller than those for at least one National Ignition Facility (NIF) [J. A. Paisner et al., Laser Focus World 30, 75 (1994)] design. As a result, stability issues for the heavy ion capsule can be settled on NIF. The close-coupled target also opens up the possibility of a high gain engineering test facility from a 1.5-2 MJ driver; calculations predict that gain 90 is achievable from 1.75 MJ of beam energy. Finally, the choice of hohlraum wall material, which must satisfy constraints from target physics, environment and safety, chamber design, and target fabrication, is discussed. (C) 2000 American Institute of Physics. [S1070-664X(00)90805-X].
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Callahan-Miller, DA (reprint author), Univ Calif Lawrence Livermore Natl Lab, L-015,POB 808, Livermore, CA 94550 USA.
CR BITTNER DN, 1998, DE00008491 NAT TECHN, P131
   Callahan-Miller DA, 1999, NUCL FUSION, V39, P883, DOI 10.1088/0029-5515/39/7/305
   CAMPBELL EM, 1998, COMMUNICATION
   Dittrich TR, 1997, FUSION TECHNOL, V31, P402
   HAAN SW, 1995, PHYS PLASMAS, V2, P2480, DOI 10.1063/1.871209
   HO DDM, 1994, NUCL FUSION, V34, P1081, DOI 10.1088/0029-5515/34/8/I03
   Krauser WJ, 1996, PHYS PLASMAS, V3, P2084, DOI 10.1063/1.872006
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   Meier WR, 1998, FUSION TECHNOL, V34, P326
   MEIER WR, 1994, P 15 IEEE NPSS S FUS, P1001
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   Neuner U, 1998, NUCL INSTRUM METH A, V415, P586, DOI 10.1016/S0168-9002(98)00388-X
   Orzechowski TJ, 1997, PHYS REV LETT, V78, P2273, DOI 10.1103/PhysRevLett.78.2273
   PAISNER JA, 1994, LASER FOCUS WORLD, V30, P75
   PETZOLDT RW, 1995, THESIS U CALIFORNIA
   Stockl C, 1998, NUCL INSTRUM METH A, V415, P558, DOI 10.1016/S0168-9002(98)00370-2
   SUTER LJ, 1998, B AM PHYS SOC, V43, P1736
   SUTER LJ, 1999, B AM PHYS SOC, V44, P282
   Tabak M, 1998, NUCL FUSION, V38, P509, DOI 10.1088/0029-5515/38/4/303
   TABAK M, 1998, PHYS PLASMAS, V5, P1896
   Wang P, 1998, PHYS PLASMAS, V5, P2977, DOI 10.1063/1.873022
   Zimmerman G. B., 1975, Comments on Plasma Physics and Controlled Fusion, V2
   1999, BULL AM PHYS SOC, V44, P283
NR 23
TC 50
Z9 50
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 1070-664X
J9 PHYS PLASMAS
JI Phys. Plasmas
PD MAY
PY 2000
VL 7
IS 5
BP 2083
EP 2091
DI 10.1063/1.874031
PN 2
PG 9
WC Physics, Fluids & Plasmas
SC Physics
GA 304XZ
UT WOS:000086511000060
ER

PT J
AU Morton, DL
   Chan, AD
AF Morton, DL
   Chan, AD
TI Current status of intraoperative lymphatic mapping and sentinel
   lymphadenectomy for melanoma: Is it standard of care?
SO JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
LA English
DT Article; Proceedings Paper
CT American-College-of-Surgeons 84th Annual Clinical Congress
CY OCT, 1998
CL ORLANDO, FLORIDA
SP Amer Coll Surgeons
ID EARLY-STAGE MELANOMA; CUTANEOUS MALIGNANT-MELANOMA; HMB-45
   MONOCLONAL-ANTIBODY; POLYMERASE-CHAIN-REACTION; MINIMAL-ACCESS SURGERY;
   GAMMA-PROBE; BREAST-CANCER; NODE BIOPSY; S-100 PROTEIN;
   SURGICAL-MANAGEMENT
C1 St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA 90404 USA.
RP Morton, DL (reprint author), St Johns Hlth Ctr, John Wayne Canc Inst, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.
CR Alazraki NP, 1997, SEMIN NUCL MED, V27, P55, DOI 10.1016/S0001-2998(97)80036-0
   Albertini JJ, 1996, ANN SURG, V223, P217, DOI 10.1097/00000658-199602000-00016
   Albertini JJ, 1996, JAMA-J AM MED ASSOC, V276, P1818, DOI 10.1001/jama.276.22.1818
   ALEX JC, 1993, SURG ONCOL, V2, P303, DOI 10.1016/S0960-7404(06)80006-X
   *AM JOINT COMM CAN, 1998, AJCC CANC STAG HDB
   *AM SOC BREAST SUR, 1998, CONS STAT GUID PERF
   Bachter D, 1998, INT J DERMATOL, V37, P278, DOI 10.1046/j.1365-4362.1998.00358.x
   Balch CM, 1996, ANN SURG, V224, P255, DOI 10.1097/00000658-199609000-00002
   Bertil R, 1970, Acta Radiol Ther Phys Biol, V9, P567
   Bilchik AJ, 1998, CANCER J SCI AM, V4, P351
   Bostick P, 1999, ARCH SURG-CHICAGO, V134, P43, DOI 10.1001/archsurg.134.1.43
   Bostick P, 1997, AM J SURG, V174, P536, DOI 10.1016/S0002-9610(97)00150-5
   Brobeil A, 1997, J Fla Med Assoc, V84, P157
   Cascinelli N, 1998, LANCET, V351, P793, DOI 10.1016/S0140-6736(97)08260-3
   COCHRAN AJ, 1992, WORLD J SURG, V16, P214
   COCHRAN AJ, 1988, AM J SURG PATHOL, V12, P612, DOI 10.1097/00000478-198808000-00002
   COCHRAN AJ, 1993, MELANOMA RES, V3, P325, DOI 10.1097/00008390-199310000-00004
   Coit D, 1997, Oncology (Williston Park), V11, P1317
   Dale PS, 1997, ANN SURG ONCOL, V4, P13, DOI 10.1007/BF02316805
   Doi F, 1996, INT J CANCER, V65, P454
   DURAY PH, 1988, CANCER, V61, P2460, DOI 10.1002/1097-0142(19880615)61:12<2460::AID-CNCR2820611213>3.0.CO;2-R
   EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101
   ESATO K, 1991, J CARDIOVASC SURG, V32, P741
   Essner R, 1997, SEMIN ONCOL, V24, pS8
   FEE HJ, 1978, SURGERY, V84, P626
   FERNANDO SSE, 1994, PATHOLOGY, V26, P16
   GAYNOR R, 1981, LANCET, V1, P869
   Gershenwald JE, 1999, J CLIN ONCOL, V17, P976
   Gershenwald JE, 1998, J CLIN ONCOL, V16, P2253
   GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015
   Giuliano AE, 1997, J CLIN ONCOL, V15, P2345
   GIULIANO AE, 1995, ANN SURG, V222, P394, DOI 10.1097/00000658-199509000-00016
   Glass EC, 1998, J NUCL MED, V39, P1185
   Glass LF, 1996, DERMATOL SURG, V22, P715
   GOWN AM, 1986, AM J PATHOL, V123, P195
   Goydos JS, 1998, J AM COLL SURGEONS, V187, P182, DOI 10.1016/S1072-7515(98)00138-0
   HELLER R, 1991, ARCH SURG-CHICAGO, V126, P1455
   HELLER R, 1993, SEMIN SURG ONCOL, V9, P285
   HOLMES EC, 1977, ANN SURG, V186, P481, DOI 10.1097/00000658-197710000-00010
   Houghton A, 1998, ONCOLOGY-NY, V12, P153
   Joseph E, 1997, CANCER J SCI AM, V3, P341
   Kapteijn BAE, 1997, J NUCL MED, V38, P362
   KARAKOUSIS CP, 1994, BRIT J SURG, V81, P1771, DOI 10.1002/bjs.1800811221
   KATAOKA M, 1991, BRIT J RADIOL, V64, P1119
   Kelemen PR, 1998, ARCH SURG-CHICAGO, V133, P288, DOI 10.1001/archsurg.133.3.288
   Kelley MC, 1998, SEMIN SURG ONCOL, V14, P283, DOI 10.1002/(SICI)1098-2388(199806)14:4<283::AID-SSU4>3.0.CO;2-Z
   Kirkwood JM, 1996, J CLIN ONCOL, V14, P7
   KIRKWOOD JM, 1998, S ADV BIOL TREATM CU
   KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6
   KRAG DN, 1995, ARCH SURG-CHICAGO, V130, P654
   Kuo CT, 1998, CLIN CANCER RES, V4, P411
   LAMKI L M, 1989, Journal of Nuclear Medicine, V30, P844
   Leong SPL, 1997, ARCH SURG-CHICAGO, V132, P666
   LEVENBACK C, 1994, OBSTET GYNECOL, V84, P163
   Lieber KA, 1998, SURGERY, V124, P757, DOI 10.1067/msy.1998.90943
   Lingam MK, 1997, BRIT J CANCER, V75, P1505, DOI 10.1038/bjc.1997.257
   MCCARTHY WH, 1995, ARCH SURG-CHICAGO, V130, P659
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   Morton DL, 1997, CANCER J SCI AM, V3, P328
   MORTON DL, 1990, SOC SURG ONC WASH DC
   MORTON DL, 1998, CONTEMP SURG, V53, P281
   MORTON DL, 1998, CONTEMP SURG, V53, P353
   MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
   Morton DL, 1997, J SURG ONCOL, V66, P267, DOI 10.1002/(SICI)1096-9098(199712)66:4<267::AID-JSO9>3.0.CO;2-9
   MORTON DL, 1993, J CLIN ONCOL, V11, P1751
   Mudun A, 1996, RADIOLOGY, V199, P171
   OBRIEN CJ, 1995, AM J SURG, V170, P461, DOI 10.1016/S0002-9610(99)80330-4
   ORDONEZ NG, 1988, AM J CLIN PATHOL, V90, P385
   ORDONEZ NG, 1988, ACTA CYTOL, V32, P684
   PIJPERS R, 1995, EUR J NUCL MED, V22, P1238, DOI 10.1007/BF00801606
   Poelman M, 1998, Ned Tijdschr Geneeskd, V142, P905
   PRITCHARD DJ, 1989, MAYO CLIN PROC, V64, P846
   REINTGEN D, 1994, ANN SURG, V220, P759, DOI 10.1097/00000658-199412000-00009
   Reintgen D, 1997, J SURG ONCOL, V66, P277
   ROBINSON DS, 1977, SURG FORUM, V28, P147
   ROSS MI, 1993, SEMIN SURG ONCOL, V9, P219
   SAHA G B, 1986, Journal of Nuclear Medicine Technology, V14, P149
   Sarantou T, 1997, CANCER RES, V57, P1371
   Shivers SC, 1998, JAMA-J AM MED ASSOC, V280, P1410, DOI 10.1001/jama.280.16.1410
   SIM FH, 1978, CANCER, V41, P948, DOI 10.1002/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z
   Sim FH, 1997, MAYO CLIN PROC, V72, P565
   SIM FH, 1986, MAYO CLIN PROC, V61, P697
   STRAND SE, 1979, J NUCL MED, V20, P1038
   Taylor A, 1996, CLIN NUCL MED, V21, P755, DOI 10.1097/00003072-199610000-00001
   THOMPSON JF, 1995, MELANOMA RES, V5, P255, DOI 10.1097/00008390-199508000-00008
   Turner RR, 1997, ANN SURG, V226, P271, DOI 10.1097/00000658-199709000-00006
   URIST MM, 1983, CANCER, V51, P2152, DOI 10.1002/1097-0142(19830601)51:11<2152::AID-CNCR2820511134>3.0.CO;2-7
   VANDERVEEN H, 1994, BRIT J SURG, V81, P1769, DOI 10.1002/bjs.1800811220
   VanderVeldeZimmermann D, 1996, AM J PATHOL, V149, P759
   VERONESI U, 1982, CANCER, V49, P2420, DOI 10.1002/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2
   WANG XN, 1994, ANN SURG, V220, P768, DOI 10.1097/00000658-199412000-00010
   WATTS AE, 1988, AM J CLIN PATHOL, V90, P77
   Wong JH, 1996, SURGERY, V120, P114, DOI 10.1016/S0039-6060(96)80250-9
   WONG JH, 1991, ANN SURG, V214, P637, DOI 10.1097/00000658-199111000-00015
NR 94
TC 50
Z9 51
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 1072-7515
J9 J AM COLL SURGEONS
JI J. Am. Coll. Surg.
PD AUG
PY 1999
VL 189
IS 2
BP 214
EP 223
DI 10.1016/S1072-7515(99)00129-5
PG 10
WC Surgery
SC Surgery
GA 222CA
UT WOS:000081764800015
PM 10437845
ER

PT J
AU Vicini, FA
   Kini, VR
   Edmundson, G
   Gustafson, GS
   Stromberg, J
   Martinez, A
AF Vicini, FA
   Kini, VR
   Edmundson, G
   Gustafson, GS
   Stromberg, J
   Martinez, A
TI A comprehensive review of prostate cancer brachytherapy: Defining an
   optimal technique
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Review
DE prostatic neoplasms; brachytherapy; interstitial brachytherapy
ID TRANSPERINEAL SEED-IMPLANTATION; INTERSTITIAL RADIATION-THERAPY;
   EXTERNAL-BEAM RADIOTHERAPY; RATE IR-192 BRACHYTHERAPY; SERIAL CT
   ACQUISITION; DISEASE-FREE SURVIVAL; PERMANENT IMPLANTS; TRANSRECTAL
   ULTRASOUND; POSTIMPLANT DOSIMETRY; I-125 IMPLANTATION
AB Purpose: A comprehensive review of prostate cancer brachytherapy literature was performed to determine if an optimal method of implantation could be identified, and to compare and contrast techniques currently in use.
   Methods and Materials: A MEDLINE search was conducted to obtain all articles in the English language on prostate cancer brachytherapy from 1985 through 1998. Articles were reviewed and grouped to determine the primary technique of implantation, the method or philosophy of source placement and/or dose specification, the technique to evaluate implant quality, overall treatment results (based upon pretreatment prostate specific antigen, (PSA), and biochemical control) and clinical, pathological or biochemical outcome based upon implant quality.
   Results: A total of 178 articles were identified in the MEDLINE database. Of these, 53 studies discussed evaluable techniques of implantation and were used for this analysis. Of these studies, 52% used preoperative ultrasound to determine the target volume to be implanted, 16% used preoperative computerized tomography (CT) scans, and 18% placed seeds with an open surgical technique. An additional 11% of studies placed seeds or needles under ultrasound guidance using interactive real-time dosimetry. The number and distribution of radioactive sources to be implanted or the method used to prescribe dose was determined using nomograms in 27% of studies, a least squares optimization technique in 11%, or not stated in 35%. In the remaining 26%, sources were described as either uniformly, differentially, or peripherally placed in the gland. To evaluate implant quality, 28% of studies calculated some type of dose-volume histogram, 21% calculated the matched peripheral dose, 19% the minimum peripheral dose, 14% used some type of CT-based qualitative review and, in 18% of studies, no implant quality evaluation was mentioned. Six studies correlated outcome with implant dose. One study showed an association of implant dose with the achievement of a PSA nadir less than or equal to 0.5. Two studies showed an improvement in biochemical control with a D-90 (dose to 90% of the prostate volume) of 120 to 140 Gy or higher, and 2 additional studies found an association of clinical outcome with implant dose. One study correlated implant quality with biopsy results. Of the articles, 33 discussed evaluable treatment results, but only 16 reported findings based upon pretreatment PSA and biochemical control. Three- to 5-year biochemical control rates ranged from 48% to 100% for pretreatment PSAs less than or equal to 4, 55% to 90% for PSAs between 4 and 10, 30% to 89% for PSAs > 10, less than or equal to 20 and < 10% to 100% for PSAs > 20. Due to substantial differences in patient selection criteria (e.g., median Gleason score, clinical stage, pretreatment PSA), number of patients treated, median follow-up, definitions of biochemical control, and time points for analysis, no single technique consistently produced superior results.
   Conclusions: Our comprehensive review of prostate cancer brachytherapy literature failed to identify an optimal treatment approach when studies were analyzed for treatment outcome based upon pretreatment PSA and biochemical control. Although several well-designed studies showed an improvement in outcome with total dose or implant quality, the numerous techniques for implantation and the varied and inconsistent methods to specify dose or evaluate implant quality suggest that standardized protocols should be developed to objectively evaluate this treatment approach. These protocols have recently been suggested and, when implemented, should significantly improve the reporting of treatment data and, ultimately, the efficacy of prostate brachytherapy. (C) 1999 Elsevier Science Inc.
C1 William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
RP Vicini, FA (reprint author), William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13th Mile Rd, Royal Oak, MI 48073 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   ANDERSON LL, 1986, MED PHYS, V13, P898, DOI 10.1118/1.595815
   ANDERSON LL, 1993, INT J RADIAT ONCOL, V27, P129
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   Bice WS, 1998, INT J RADIAT ONCOL, V41, P921, DOI 10.1016/S0360-3016(98)90123-7
   Bice WS, 1998, INT J RADIAT ONCOL, V40, P1237, DOI 10.1016/S0360-3016(97)00949-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko JC, 1993, SEMIN RADIAT ONCOL, V3, P240, DOI 10.1053/SRAO00300240
   Blasko JC, 1996, UROL CLIN N AM, V23, P633, DOI 10.1016/S0094-0143(05)70342-6
   Borghede G, 1997, RADIOTHER ONCOL, V44, P245, DOI 10.1016/S0167-8140(97)00122-9
   Borghede G, 1997, RADIOTHER ONCOL, V44, P237, DOI 10.1016/S0167-8140(97)00121-7
   BROSMAN SA, 1991, UROLOGY, V38, P372, DOI 10.1016/0090-4295(91)80157-3
   CAREY PO, 1988, J UROLOGY, V139, P989
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   DAmico AV, 1996, J CLIN ONCOL, V14, P304
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   D'Addessi A, 1995, Minerva Urol Nefrol, V47, P105
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   DAWSON JE, 1994, RADIOTHER ONCOL, V32, P268, DOI 10.1016/0167-8140(94)90027-2
   DEGOR S, 1997, TECHNIQUES UROL, V3, P190
   DONNELLY BJ, 1991, UROL CLIN N AM, V18, P481
   Dubois DF, 1997, INT J RADIAT ONCOL, V39, P220, DOI 10.1016/S0360-3016(97)80728-6
   Dubois DF, 1997, INT J RADIAT ONCOL, V39, P1037, DOI 10.1016/S0360-3016(97)00501-4
   Dubois DF, 1998, RADIOLOGY, V207, P785
   Eastham JA, 1997, J CLIN ONCOL, V15, P3214
   Friedland J L, 1997, Med Dosim, V22, P17, DOI 10.1016/S0958-3947(96)00134-3
   GOAD JR, 1993, UROL CLIN N AM, V20, P727
   GOTTESMAN JE, 1991, J UROLOGY, V146, P1317
   Grimm PD, 1996, HEMATOL ONCOL CLIN N, V10, P653, DOI 10.1016/S0889-8588(05)70359-2
   HOLM HH, 1990, UROLOGY, V36, P249, DOI 10.1016/0090-4295(90)80266-P
   HOLM HH, 1983, J UROLOGY, V130, P283
   Horwitz EM, 1996, INT J RADIAT ONCOL, V36, P565, DOI 10.1016/S0360-3016(96)00360-4
   IVERSEN P, 1989, UROLOGY, V34, P181, DOI 10.1016/0090-4295(89)90368-3
   KAYE KW, 1995, J UROLOGY, V153, P1020, DOI 10.1016/S0022-5347(01)67626-2
   KAYE KW, 1995, AUST NZ J SURG, V65, P658, DOI 10.1111/j.1445-2197.1995.tb00676.x
   KAYE KW, 1992, J ENDOUROL, V6, P61, DOI 10.1089/end.1992.6.61
   Kota C, 1997, INT J RADIAT ONCOL, V39, P346, DOI 10.1016/S0360-3016(97)80978-9
   KUMAR PP, 1988, J NATL MED ASSOC, V82, P181
   LING CC, 1992, INT J RADIAT ONCOL, V23, P81
   Martinez A, 1995, INT J RADIAT ONCOL, V33, P1019, DOI 10.1016/0360-3016(95)00254-5
   Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2
   MIDDLETON RG, 1995, J UROLOGY, V154, P2144, DOI 10.1016/S0022-5347(01)66718-1
   Middleton RG, 1996, CA-CANCER J CLIN, V46, P249, DOI 10.3322/canjclin.46.4.249
   Moerland MA, 1997, INT J RADIAT ONCOL, V37, P927, DOI 10.1016/S0360-3016(96)00575-5
   MORTON JD, 1988, INT J RADIAT ONCOL, V14, P1153
   NAG S, 1997, INT J BRACHYTHER, V13, P243
   NAG S, 1995, UROLOGY, V45, P87, DOI 10.1016/S0090-4295(95)96950-0
   NARAYANA V, 1997, INT J RADIAT ONCOL, V39, P341
   Narayana V, 1996, RADIOLOGY, V199, P457
   Paul R, 1997, WORLD J UROL, V15, P252, DOI 10.1007/BF01367663
   PORTER AT, 1993, CANCER, V71, P953, DOI 10.1002/1097-0142(19930201)71:3+<953::AID-CNCR2820711410>3.0.CO;2-5
   PORTER AT, 1995, CA-CANCER J CLIN, V45, P165, DOI 10.3322/canjclin.45.3.165
   Pouliot J, 1996, INT J RADIAT ONCOL, V36, P711, DOI 10.1016/S0360-3016(96)00365-3
   Prestidge BR, 1998, INT J RADIAT ONCOL, V40, P461, DOI 10.1016/S0360-3016(97)00715-3
   Prestidge BR, 1998, INT J RADIAT ONCOL, V40, P1111, DOI 10.1016/S0360-3016(97)00947-4
   Prestidge BR, 1997, INT J RADIAT ONCOL, V37, P31, DOI 10.1016/S0360-3016(96)00390-2
   Prete J J, 1998, Radiat Oncol Investig, V6, P90, DOI 10.1002/(SICI)1520-6823(1998)6:2<90::AID-ROI4>3.0.CO;2-C
   Prete JJ, 1997, INT J RADIAT ONCOL, V39, P345, DOI 10.1016/S0360-3016(97)80976-5
   PRIESTLY JB, 1992, UROLOGY, V40, P27, DOI 10.1016/0090-4295(92)90431-U
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   RAGDE H, 1989, Journal of Endourology, V3, P209, DOI 10.1089/end.1989.3.209
   Roach M, 1996, INT J RADIAT ONCOL, V35, P1011, DOI 10.1016/0360-3016(96)00232-5
   Roberson PL, 1997, MED PHYS, V24, P251, DOI 10.1118/1.598058
   ROY JN, 1993, RADIOTHER ONCOL, V28, P72, DOI 10.1016/0167-8140(93)90189-F
   ROY JN, 1993, INT J RADIAT ONCOL, V26, P163, DOI 10.1016/0360-3016(93)90188-2
   Sharkey J, 1998, UROLOGY, V51, P796, DOI 10.1016/S0090-4295(98)00017-X
   Stock RG, 1998, INT J RADIAT ONCOL, V41, P101, DOI 10.1016/S0360-3016(98)00006-6
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   Stokes SH, 1997, INT J RADIAT ONCOL, V37, P337, DOI 10.1016/S0360-3016(96)00508-1
   Stokes S H, 1990, Ala Med, V60, P18
   STONE NN, 1995, J UROLOGY, V153, P1555, DOI 10.1016/S0022-5347(01)67460-3
   STROMBERG J, 1995, INT J RADIAT ONCOL, V33, P161, DOI 10.1016/0360-3016(95)00035-W
   Stromberg JS, 1997, CANCER J SCI AM, V3, P346
   VANTRIET A, 1992, INT J RADIAT ONCOL, V24, P555
   Vicini FA, 1997, J UROLOGY, V158, P319, DOI 10.1016/S0022-5347(01)64471-9
   Vicini FA, 1998, INT J RADIAT ONCOL, V40, P1101, DOI 10.1016/S0360-3016(97)00942-5
   VIJVERBERG PLM, 1993, BRIT J UROL, V72, P470, DOI 10.1111/j.1464-410X.1993.tb16180.x
   WALLNER K, 1994, INT J RADIAT ONCOL, V30, P405
   WALLNER K, 1991, J UROLOGY, V146, P90
   Wallner K, 1991, Oncology (Williston Park), V5, P115
   Wallner K, 1997, INT J RADIAT ONCOL, V37, P565, DOI 10.1016/S0360-3016(96)00570-6
   WALLNER K, 1991, INT J RADIAT ONCOL, V20, P1075
   WALLNER K, 1994, INT J RADIAT ONCOL, V29, P863
   WALLNER K, 1995, INT J RADIAT ONCOL, V32, P465, DOI 10.1016/0360-3016(94)00599-G
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Waterman FM, 1997, INT J RADIAT ONCOL, V39, P220, DOI 10.1016/S0360-3016(97)80729-8
   Waterman FM, 1998, INT J RADIAT ONCOL, V41, P1069, DOI 10.1016/S0360-3016(98)00152-7
   Waterman FM, 1997, INT J RADIAT ONCOL, V38, P335, DOI 10.1016/S0360-3016(97)00114-4
   Willins J, 1997, INT J RADIAT ONCOL, V39, P347, DOI 10.1016/S0360-3016(97)00322-2
   Yu Y, 1996, INT J RADIAT ONCOL, V34, P717, DOI 10.1016/0360-3016(95)02153-1
   Yue N, 1997, INT J RADIAT ONCOL, V39, P345, DOI 10.1016/S0360-3016(97)80975-3
   Zeitlin SI, 1998, J UROLOGY, V160, P91, DOI 10.1016/S0022-5347(01)63042-8
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
NR 97
TC 50
Z9 50
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUN 1
PY 1999
VL 44
IS 3
BP 483
EP 491
DI 10.1016/S0360-3016(99)00047-4
PG 9
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 199YF
UT WOS:000080511100003
PM 10348275
ER

PT J
AU GERHARDT, T
   BANCALARI, E
AF GERHARDT, T
   BANCALARI, E
TI LUNG COMPLIANCE IN NEWBORNS WITH PATENT DUCTUS-ARTERIOSUS BEFORE AND
   AFTER SURGICAL LIGATION
SO BIOLOGY OF THE NEONATE
LA English
DT Article
RP GERHARDT, T (reprint author), UNIV MIAMI,SCH MED,DEPT PEDIAT,DIV NEONATOL,MIAMI,FL 33101, USA.
CR BANCALARI E, 1977, J PEDIATR, V90, P192, DOI 10.1016/S0022-3476(77)80628-8
   BAYLEN BG, 1975, J PEDIATR, V86, P423
   COTTON RB, 1978, J PEDIATR, V92, P467, DOI 10.1016/S0022-3476(78)80451-X
   COTTON RB, 1978, J PEDIATR, V93, P647, DOI 10.1016/S0022-3476(78)80910-X
   EDMUNDS LH, 1973, CIRCULATION, V48, P856
   EDWARDS DK, 1977, PEDIATRICS, V59, P839
   FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003
   GAY JH, 1973, J PEDIATR SURG, V8, P677, DOI 10.1016/0022-3468(73)90406-5
   GUPTA JM, 1972, J THORAC CARDIOV SUR, V63, P642
   HEYMANN MA, 1976, NEW ENGL J MED, V295, P530, DOI 10.1056/NEJM197609022951004
   HIRSCHKLAU MJ, 1978, J PEDIATR, V92, P474, DOI 10.1016/S0022-3476(78)80452-1
   JONES RWA, 1977, ARCH DIS CHILD, V52, P274
   KITTERMA.JA, 1972, NEW ENGL J MED, V287, P473, DOI 10.1056/NEJM197209072871001
   NAULTY CM, 1978, J PEDIATR, V93, P682, DOI 10.1016/S0022-3476(78)80917-2
   NEAL WA, 1975, J PEDIATR, V86, P127, DOI 10.1016/S0022-3476(75)80723-2
   NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701
   PARVING HH, 1973, ACTA PAEDIATR SCAND, V62, P248, DOI 10.1111/j.1651-2227.1973.tb08100.x
   RITTENHOUSE EA, 1976, J THORAC CARDIOV SUR, V71, P187
   SIASSI B, 1969, J PEDIATR, V74, P11, DOI 10.1016/S0022-3476(69)80003-X
   SILVERMA.NH, 1974, CIRCULATION, V50, P821
   STAUB NC, 1974, AM REV RESPIR DIS, V109, P358
   THIBEAULT DW, 1975, J PEDIATR, V86, P120, DOI 10.1016/S0022-3476(75)80722-0
   WHITE RD, 1978, J PEDIATR, V92, P867, DOI 10.1016/S0022-3476(78)80208-X
   WILLIAMS WH, 1976, ANN THORAC SURG, V22, P151
NR 24
TC 50
Z9 53
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0006-3126
J9 BIOL NEONATE
JI Biol. Neonate
PY 1980
VL 38
IS 1-2
BP 96
EP 105
PG 10
WC Pediatrics
SC Pediatrics
GA JT078
UT WOS:A1980JT07800015
PM 7388095
ER

PT J
AU BROGDEN, RN
   SPEIGHT, TM
   AVERY, GS
AF BROGDEN, RN
   SPEIGHT, TM
   AVERY, GS
TI AMOXYCILLIN - REVIEW OF ITS ANTIBACTERIAL AND PHARMACOKINETIC PROPERTIES
   AND THERAPEUTIC USE
SO DRUGS
LA English
DT Review
C1 AUSTRALASIAN DRUG INFORMATION SERV,POB 34-030,BIRKENHEAD,AUCKLAND 10,NEW ZEALAND.
CR ACRED P, 1971, ANTMICROB AGENTS CHE, P416
   ADACHI T, 1973, CHEMOTHERAPY TOKYO, V21, P1747
   ALERGANT CD, 1973, BRIT J VENER DIS, V49, P274
   ARATA J, 1973, CHEMOTHERAPY TOKYO, V21, P1808
   ARIYOSHI M, 1973, CHEMOTHERAPY TOKYO, V21, P1812
   ARONOVITZ GH, 1974, J INFECTIOUS DISEA S, V129, P185
   AUVERGNA.JC, 1974, J INT MED RES, V2, P189
   BACH MC, 1973, ANTIMICROB AGENTS CH, V3, P1
   BARRETO M, 1974, J INFECTIOUS DISEA S, V129, P207
   BAYNE L, 1974, CAN MED ASSOC J, V111, P685
   BELL GA, 1974, BRIT J CLIN PRACT, V28, P89
   BODEY GP, 1972, ANT AG CHEM, P358
   BRAFF EH, 1974, J INFECTIOUS DISEA S, V129, P254
   Breese BB, 1974, J INFECT DIS S, V129, P178
   BRUSCH JL, 1974, AM J MED SCI, V267, P41, DOI 10.1097/00000441-197401000-00006
   BURGI H, 1973, CHEMOTHERAPY, V18, P19
   BURNS MW, 1974, J INFECT DIS S, V129, P194
   Caestaro B., 1983, J INFECT DIS, V133, P229
   CALDERON E, 1974, J INFECTIOUS DISEA S, V129, P219
   COLE M, 1973, ANTIMICROB AGENTS CH, V3, P463
   COX CE, 1974, J INFECT DIS, V129, P235
   CROYDON EAP, 1971, ANTIMICROB AGENTS CH, P427
   DEAL WB, 1974, J INFECTIOUS DISEA S, V129, P256
   DERLUYN JP, 1973, TIJDSCHRIFT GENEESKU, V19, P945
   DUBB S, 1973, S AFR MED J, V47, P1218
   DUVAL J, 1973, MED MALADIES INFECT, V3, P525, DOI 10.1016/S0399-077X(73)80014-9
   FARID Z, 1974, LANCET, V1, P350
   FIEGEL P, 1973, CHEMOTHERAPY, V18, P57
   FINLAND M, 1974, J INFECTIOUS DISEA S, V129, P132
   FUJII R, 1974, 1973 INT S AM LOND, P107
   FURUSAWA T, 1973, CHEMOTHERAPY JAPAN, V21, P1624
   FURUYA H, 1973, CHEMOTHERAPY TOKYO, V21, P1752
   GEDDES AM, 1974, 1973 INT S AM LOND, P116
   GILBERT DN, 1974, J INFECTIOUS DISEA S, V129, P231
   GOMEZLUS R, 1973, CHEMOTHERAPY, V18, P47
   GORDON RC, 1972, ANTIMICROB AGENTS CH, V1, P504
   GOTO T, 1973, CHEMOTHERAPY TOKYO, V21, P1767
   GUIBERT JMC, 1973, CHEMOTHERAPY, V18, P81
   GURWITH MJ, 1974, J INFECTIOUS DISEA S, V129, P258
   HANDSFIELD HH, 1973, ANTIMICROBIAL AGENTS, P262
   HARDING JW, 1972, PRACTITIONER, V209, P363
   HARIMA M, 1973, CHEMOTHERAPY TOKYO, V21, P1777
   HIGUCHI M, 1973, CHEMOTHERAPY TOKYO, V21, P1716
   HOWIE VM, 1974, J INFECTIOUS DISEA S, V129, P181
   HUNTER PA, 1973, ANTIMICROB AGENTS CH, V4, P285
   INGOLD A, 1974, IRCS, V2, P1463
   ISHIBE T, 1973, CHEMOTHERAPY TOKYO, V21, P1704
   ISHIGAMI J, 1974, 1973 INT S AM LOND, P56
   ISHII T, 1973, CHEMOTHERAPY TOKYO, V21, P1619
   ISHIYAMA S, 1974, 1973 INT S AM LOND, P94
   IWASAWA T, 1973, CHEMOTHERAPY TOKYO, V21, P1830
   JONES FD, 1974, J INFECT DIS S, V129, P187
   Jones G R, 1973, Br J Clin Pract, V27, P161
   KARNEY W, 1974, J INFECT DIS S, V129, P250
   KARNEY WW, 1974, ANTIMICROB AGENTS CH, V5, P114
   KERREBIJ.KF, 1973, CHEMOTHERAPY, V18, P92
   KIENITZ M, 1973, CHEMOTHERAPY, V18, P97
   KIRBY WMM, 1974, J INFECT DIS, V129, P154
   KNOTHE H, 1974, ARZNEIMITTEL-FORSCH, V24, P951
   KONDO S, 1973, CHEMOTHERAPY TOKYO, V21, P1638
   Kosmidis J, 1972, Br J Clin Pract, V26, P341
   KOZAKAI N, 1973, CHEMOTHERAPY TOKYO, V21, P1359
   KUROYANAGI K, 1973, CHEMOTHERAPY TOKYO, V21, P1658
   LAWSON DH, 1974, POSTGRAD MED J, V50, P500
   LEIGH DA, 1974, 1973 INT S AM LOND, P48
   Leigh D A, 1972, Curr Med Res Opin, V1, P10, DOI 10.1185/03007997209111140
   LITTLE PJ, 1974, MED J AUSTRALIA, V2, P598
   LITTLE PJ, 1974, J INFECT DIS S, V129, P241
   LODE H, 1974, J INFECT DIS       S, V129, P156
   LOPEZFRANCO RL, 1973, REV MEDICINA MEXICAN, V54, P461
   LUNASOLANO JL, 1974, REV MEDICINA MEXICAN, V54, P77
   LUTTECKE K, 1973, CHEMOTHERAPY, V18, P12
   MACLEOD C, 1973, CLINICAL RESEARCH, V21, P1018
   MASHIMO K, 1974, 1973 INT S AM LOND, P123
   MASUTANI M, 1973, CHEMOTHERAPY TOKYO, V21, P1793
   MAY JR, 1974, J INFECTIOUS DISEA S, V129, P189
   May J R, 1972, Br J Dis Chest, V66, P185, DOI 10.1016/0007-0971(72)90029-0
   MAY JR, 1974, 1973 INT S AM LOND, P132
   MAZZEI JA, 1974, J INFECT DIS, V129, P200
   MIDDLETO.FG, 1973, ANTIMICROB AGENTS CH, V4, P25
   MIDDLETO.RS, 1974, GERONTOL CLIN, V16, P92
   MIKI F, 1973, CHEMOTHER TOKYO, V21, P1504
   MIKI F, 1974, 1973 INT S AM LOND, P25
   MILLER GB, 1974, J INFECTIOUS DISEA S, V129, P237
   MINE Y, 1973, CHEMOTHERAPY TOKYO, V21, P1409
   MISHIMA K, 1973, CHEMOTHERAPY TOKYO, V21, P1825
   MITSUHASHI S, 1973, CHEMOTHERAPY TOKYO, V21, P1355
   MOLLA AL, 1974, PRACTITIONER, V212, P123
   MOMOSE S, 1973, CHEMOTHERAPY TOKYO, V21, P1711
   MONGEAU JG, 1974, J INFECTIOUS DISEA S, V129, P243
   MOTOHIRO T, 1973, CHEMOTHERAPY TOKYO, V21, P1603
   MULROY R, 1973, BRIT MED J, V1, P554
   MUNNICH D, 1974, CHEMOTHERAPY, V20, P29
   MURAKAWA T, 1973, CHEMOTHERAPY, V21, P1399
   NAKANO M, 1973, CHEMOTHERAPY TOKYO, V21, P1797
   NAKAZAWA S, 1974, 1973 COMM INT S AM L, P11
   NAKAZAWA S, 1973, CHEMOTHERAPY, V21, P1375
   NAKAZAWA S, 1973, CHEMOTHERAPY TOKYO, V21, P1572
   NAMBU H, 1973, CHEMOTHERAPY TOKYO, V21, P1564
   NEU HC, 1971, ANTIMICROB AGENTS CH, P423
   NEU HC, 1974, J INFECTIOUS DISEA S, V129, P123
   NEU HC, 1971, ANTIMICROB AGENTS CH, P407
   NISHIMURA T, 1973, CHEMOTHERAPY TOKYO, V21, P1597
   OE PL, 1973, CHEMOTHERAPY, V19, P279
   OHISHI M, 1973, CHEMOTHERAPY TOKYO, V21, P1817
   OHKOSHI M, 1974, 1973 INT S AM LOND, P39
   ORTEGA FF, 1973, REV MEDICINA MEXICAN, V53, P445
   PANKEY GA, 1974, J INFECT DIS S, V129, P202
   PEDDIE BA, 1973, NEW ZEALAND MEDICAL, V78, P299
   PEROMET K, 1973, CHEMOTHERAPY BASEL S, V18, P52
   POWSANG J, 1974, J INFECTIOUS DISEA S, V129, P246
   Price J D, 1973, Br J Clin Pract, V27, P165
   ROBERTS FL, 1974, J INFECTIOUS DISEA S, V129, P262
   RODRIGUEZ V, 1974, J INFECTIOUS DISEA S, V129, P209
   ROLINSON GN, 1974, 1973 INT S AM LOND, P1
   SABTO J, 1973, MED J AUSTRALIA, V2, P537
   SANTOSCOY G, 1974, J INFECTIOUS DISEA S, V129, P228
   SATO K, 1973, CHEMOTHERAPY, V21, P1383
   SEIGA K, 1973, CHEMOTHERAPY TOKYO, V21, P1780
   SELIGMAN SJ, 1974, J INFECT DIS S, V129, P213
   SHIBATA K, 1974, 1973 INT S AM LOND, P85
   SHIOTA K, 1974, 1973 INT S AM LOND, P135
   SIMON C, 1974, ARZNEIMITTEL-FORSCH, V24, P181
   SOTO RF, 1974, J INFECTIOUS DISEA S, V129, P216
   STAM J, 1973, CHEMOTHERAPY, V18, P27
   STEWART SM, 1970, THORAX, V25, P304, DOI 10.1136/thx.25.3.304
   STEWART SM, 1974, THORAX, V29, P110, DOI 10.1136/thx.29.1.110
   STILLERMAN M, 1974, J INFECT DIS S, V129, P169
   Sutherland R, 1972, Br Med J, V3, P13
   SUTHERLAND R, 1971, ANTIMICROBIAL AGENTS, P411
   TAKASU T, 1973, CHEMOTHERAPY TOKYO, V21, P1838
   TAN JS, 1974, J INFECTIOUS DISEA S, V129, P146
   TAN P, 1973, CHEMOTHERAPY, V18, P69
   TURCK M, 1974, J INFECTIOUS DISEA S, V129, P248
   UCHIDA S, 1973, CHEMOTHERAPY TOKYO, V21, P1392
   UEDA Y, 1973, CHEMOTHER TOKYO, V21, P1446
   VALLEJOS C, 1973, CLIN PHARMACOL THER, V14, P962
   VITTI TG, 1974, J INFECT DIS S, V129, P149
   VOLLHABE.HH, 1973, CHEMOTHERAPY, V18, P34
   WEINBERG EG, 1973, S AFR MED J, V47, P717
   WILLCOX RR, 1974, BRIT J VENER DIS, V50, P120
   WILLCOX RR, 1974, 1973 INT S AM LOND, P71
   WILLCOX RR, 1972, BRIT J VENER DIS, V48, P504
   WISE PJ, 1974, 1973 INT S AM LOND, P76
   WOLK E, 1974, J INFECT DIS S, V129, P264
   YAKUSHIJI M, 1973, CHEMOTHERAPY TOKYO, V21, P1787
   YAMASAKU F, 1973, CHEMOTHERAPY TOKYO, V21, P1477
NR 147
TC 50
Z9 51
PU ADIS INTERNATIONAL LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW
   ZEALAND
SN 0012-6667
J9 DRUGS
JI Drugs
PY 1975
VL 9
IS 2
BP 88
EP 140
DI 10.2165/00003495-197509020-00002
PG 53
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA V9461
UT WOS:A1975V946100002
PM 1126306
ER

PT J
AU Rohling, ML
   Binder, LM
   Demakis, GJ
   Larrabee, GJ
   Ploetz, DM
   Langhinrichsen-Rohling, J
AF Rohling, Martin L.
   Binder, Laurence M.
   Demakis, George J.
   Larrabee, Glenn J.
   Ploetz, Danielle M.
   Langhinrichsen-Rohling, Jennifer
TI A Meta-Analysis of Neuropsychological Outcome After Mild Traumatic Brain
   Injury: Re-analyses and Reconsiderations of Binder et al. (1997),
   Frencham et al. (2005), and Pertab et al. (2009)
SO CLINICAL NEUROPSYCHOLOGIST
LA English
DT Article
DE Traumatic brain injury; Meta-analysis; Post concussion; Effect size
   calculations
ID POSTCONCUSSION-SYNDROME; HEAD-INJURY; SYMPTOM REPORT; PERFORMANCE;
   CONCUSSION; DEPRESSION; SCORES; ADULTS
AB The meta-analytic findings of Binder etal. (1997) and Frencham etal. (2005) showed that the neuropsychological effect of mild traumatic brain injury (mTBI) was negligible in adults by 3 months post injury. Pertab etal. (2009) reported that verbal paired associates, coding tasks, and digit span yielded significant differences between mTBI and control groups. We re-analyzed data from the 25 studies used in the prior meta-analyses, correcting statistical and methodological limitations of previous efforts, and analyzed the chronicity data by discrete epochs. Three months post injury the effect size of -0.07 was not statistically different from zero and similar to that which has been found in several other meta-analyses (Belanger etal., 2005; Schretlen Shapiro, 2003). The effect size 7 days post injury was -0.39. The effect of mTBI immediately post injury was largest on Verbal and Visual Memory domains. However, 3 months post injury all domains improved to show non-significant effect sizes. These findings indicate that mTBI has an initial small effect on neuropsychological functioning that dissipates quickly. The evidence of recovery in the present meta-analysis is consistent with previous conclusions of both Binder etal. and Frencham etal. Our findings may not apply to people with a history of multiple concussions or complicated mTBIs.
C1 [Langhinrichsen-Rohling, Jennifer] Univ S Alabama, Dept Psychol, Mobile, AL 36688 USA.
   [Binder, Laurence M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Demakis, George J.] Univ N Carolina, Charlotte, NC 28223 USA.
RP Langhinrichsen-Rohling, J (reprint author), Univ S Alabama, Dept Psychol, 331 Life Sci Univ, Mobile, AL 36688 USA.
EM mrohling@usouthal.edu
CR Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277
   Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870
   Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001
   BOHNEN N, 1993, NEUROPSY NEUROPSY BE, P6193
   Boone K. B., 2007, ASSESSMENT FEIGNED C
   Bornstein R. A., 1993, NEUROPSYCHOLOGY, V7, P228, DOI [10.1037/0894-4105.7.2.228, DOI 10.1037/0894-4105.7.2.228]
   CARROLL LJ, 2004, J REHABIL MED S, V43, P84, DOI DOI 10.1080/16501960410023859
   Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187
   COLFORD JM, 2001, AM J EPIDEMIOL, V154, P972, DOI 10.1093/aje/154.10.972-a
   Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004
   Dikmen S., 1993, J HEAD TRAUMA REHAB, V8, P30, DOI 10.1097/00001199-199309000-00005
   DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80
   Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005
   Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328
   GLASZIOU PP, 2010, BMC MED RES METHODOL, V18, P10
   GOUVIER WD, 1998, DETECTION MALINGERIN
   GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G
   Greiffenstein M, 2009, CLIN NEUROPSYCHOL, V23, P286, DOI 10.1080/13854040802104873
   Greiffenstein MF, 2003, CLIN NEUROPSYCHOL, V17, P561, DOI 10.1076/clin.17.4.561.27937
   Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0087-6177(03)00073-8
   Hedges L. V., 1981, J EDUC STATIST, V6, P107, DOI [10.3102/10769986006002107, DOI 10.2307/1164588]
   Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486
   Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813
   HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853
   Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae
   Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008
   Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513
   Iverson G.L., 2001, J FORENSIC NEUROPSYC, V2, P19, DOI 10.1300/J151v02n01_02
   Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02
   Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3
   Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1
   Larrabee G.J., 2007, ASSESSMENT MALINGERE
   LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z
   Lipsey M. W., 2001, PRACTICAL METAANALYS
   Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327
   Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014
   Mapou R., 2008, ADULT LEARNING DISAB
   McCrea M. A., 2008, MILD TRAUMATIC BRAIN
   MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070
   Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984
   Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066
   Putnam S. H., 1996, NEUROPSYCHOLOGICAL A, P529
   Ruff RM, 2009, PSYCHOL INJURY LAW, V2, P34, DOI DOI 10.1007/S12207-009-9029-4
   Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9
   SCHMIDT FL, 1992, AM PSYCHOL, V47, P1173, DOI 10.1037/0003-066X.47.10.1173
   Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728
   Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   Wiggins J. S., 1973, PERSONALITY PREDICTI
   WILLIAMS DH, 1990, NEUROSURGERY, V27, P422
   Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7
NR 53
TC 49
Z9 49
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1385-4046
J9 CLIN NEUROPSYCHOL
JI Clin. Neuropsychol.
PY 2011
VL 25
IS 4
BP 608
EP 623
DI 10.1080/13854046.2011.565076
PG 16
WC Psychology, Clinical; Clinical Neurology; Psychology
SC Psychology; Neurosciences & Neurology
GA 761QD
UT WOS:000290411700175
PM 21512956
ER

PT J
AU Crook, J
   Gillan, C
   Yeung, I
   Austen, L
   McLean, M
   Lockwood, G
AF Crook, Juanita
   Gillan, Caitlin
   Yeung, Ivan
   Austen, Lynette
   McLean, Michael
   Lockwood, Gina
TI PSA kinetics and PSA bounce following permanent seed prostate
   brachytherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate-specific antigen (PSA) bounce; Prostate brachytherapy;
   biochemical failure
ID EXTERNAL-BEAM RADIOTHERAPY; BIOCHEMICAL FAILURE; ANTIGEN BOUNCE;
   RADIATION-THERAPY; ANDROGEN DEPRIVATION; AMERICAN SOCIETY; PATIENT AGE;
   CANCER; DEFINITIONS; IMPLANTATION
AB Purpose: To report the incidence, timing, and magnitude of the benign prostate-specific antigen (PSA) bounce after I-125 prostate brachytherapy and correlate the bounce with clinical and/or dosimetric factors. Methods and Materials: From March 1999 to August 2003, a total of 292 men received I-125 prostate brachytherapy without androgen deprivation or supplemental beam radiotherapy and have PSA follow-up > 30 months. Implants were preplanned using transrectal ultrasound (TRUS) and performed under transrectal ultrasound/fluoroscopy guidance using preloaded needles. A PSA bounce is defined as an increase >= 0.2 ng/ml with spontaneous return to prebounce level or lower. Results: Resolved PSA bounces were seen in 40% of men with follow-up > 30 months. Median onset was 15 months, and median magnitude was 0.76 ng/ml. Magnitude > 2 ng/ml was seen in 15%. The only clinical or dosimetric factor predictive of bounce in multivariate analysis was younger age. Median time to increasing PSA level indicative of failure was 30 months. Conclusions: Benign PSA bounces are common after I-125 prostate brachytherapy, especially in younger men. An increase > 2 ng/ml above the nadir was seen in 15%. Magnitude of increase does not distinguish bounce from failure. Time to the start of the PSA increase can be helpful, but is not absolute. The PSA bounce does not predict subsequent failure. Caution is advised in interpreting an early increasing PSA level in the first 30 months after I-125 brachytherapy in favorable-risk patients. (c) 2007 Elsevier Inc.
C1 Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada.
   Princess Margaret Hosp, Univ Hlth Network, Dept Radiat Med, Toronto, ON M4X 1K9, Canada.
   Princess Margaret Hosp, Dept Radiat Phys, Toronto, ON M4X 1K9, Canada.
   Univ Hlth Network, Dept Biostat, Toronto, ON, Canada.
RP Crook, J (reprint author), Princess Margaret Hosp, Dept Radiat Oncol, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.
EM juanita.crook@rmp.uhn.on.ca
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Cherullo EE, 2002, PROSTATE CANCER P D, V5, P54, DOI 10.1038/sj/pcan/450545
   Ciezki JP, 2006, INT J RADIAT ONCOL, V64, P512, DOI 10.1016/j.ijrobp.2005.07.960
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 2002, J UROLOGY, V167, P1310, DOI 10.1016/S0022-5347(05)65288-3
   Critz FA, 2003, J UROLOGY, V170, P1864, DOI 10.1097/01.ju.0000091644.41330.2a
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   Das P, 2002, INT J RADIAT ONCOL, V54, P698, DOI 10.1016/S0360-3016(02)03036-5
   Feigenberg SJ, 2006, AM J CLIN ONCOL-CANC, V29, P458, DOI 10.1097/01.coc.0000225410.37469.58
   Horwitz EM, 2006, CANCER, V107, P1496, DOI 10.1002/cncr.22183
   Horwitz EM, 2003, J UROLOGY, V169, P2153, DOI 10.1097/01.ju.0000067181.52741.09
   Kuban DA, 2004, ONCOLOGY-NY, V18, P595
   KUBAN DA, 2004, ONCOLOGY HUNTINGT, V18, P609
   KUBAN DA, 2004, ONCOLOGY HUNTINGT, V18, P608
   Merrick Gregory S, 2003, Brachytherapy, V2, P181, DOI 10.1016/S1538-4721(03)00130-2
   Merrick GS, 2002, INT J RADIAT ONCOL, V54, P450, DOI 10.1016/S0360-3016(02)02948-6
   MORITA M, 2004, NIPPON HINYOKIKA GAK, V65, P609
   Patel C, 2004, UROLOGY, V63, P110, DOI 10.1016/j.urology.2003.08.025
   Pickles T, 2006, INT J RADIAT ONCOL, V64, P1355, DOI 10.1016/j.ijrobp.2005.10.008
   Reed D, 2003, UROLOGY, V62, P683, DOI 10.1016/S0090-4295(03)00505-3
   Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029
   Rosser CJ, 2005, UROLOGY, V66, P327, DOI 10.1016/j.urology.2005.02.026
   Stock RG, 2003, INT J RADIAT ONCOL, V56, P448, DOI 10.1016/S0360-3016(02)04470-X
   Taussky D, 2005, INT J RADIAT ONCOL, V62, P974, DOI 10.1016/j.ijrobp.2004.12.012
   Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X
   Toledano A, 2006, BRACHYTHERAPY, V5, P122, DOI 10.1016/j.brachy.2006.02.003
   Zietman AL, 2005, INT J RADIAT ONCOL, V62, P714, DOI 10.1016/j.ijrobp.2004.11.020
NR 28
TC 49
Z9 49
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD OCT 1
PY 2007
VL 69
IS 2
BP 426
EP 433
DI 10.1016/j.ijrobp.2007.03.031
PG 8
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 215GK
UT WOS:000249796100016
PM 17869662
ER

PT J
AU Rastan, AJ
   Bittner, HB
   Gummert, JF
   Walther, T
   Schewick, CV
   Girdauskas, E
   Mohr, FW
AF Rastan, AJ
   Bittner, HB
   Gummert, JF
   Walther, T
   Schewick, CV
   Girdauskas, E
   Mohr, FW
TI On-pump beating heart versus off-pump coronary artery bypass
   surgery-evidence of pump-induced myocardiat injury
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE cardioplulmonary bypass; CPCAB; beating heart surgery; myocardial
   injury; biomarkers
ID HIGH-RISK PATIENTS; CARDIOPULMONARY BYPASS; COMPLETE REVASCULARIZATION;
   MORBIDITY
AB Objective: By maintaining native coronary blood flow in on-pump beating heart surgery (OnP-BH) and comparing with OPCAB strategy pump-related effects on myocardial injury and cardiac dysfunction could be specifically differentiated from ischemia/reperfusion-related consequences of surgical coronary revascularization. Methods: In a randomized-prospective design, 40 elective patients with normal EF and three vessels coronary artery disease (left main disease excluded) were assigned to OPCAB or OnP-BH surgery. Before coronary occlusion and 1, 30, 60, and 90 min after reperfusion with the LIMA graft, coronary sinus (CS) blood was sampled to determine intraoperative myocardial ischemia (pH, lactate, pO(2)) and oxidative stress (malondialdehyde, MDA). Additionally to CS blood arterial blood was analyzed 4, 12, and 24 h postoperatively to determine myocardial necrosis (CK-MB, cardiac troponin 1), myocardial dysfunction (NT-proBNP) and inflammation (C-reactive protein). Results: Groups were identical with regards to age and gender (OPCAB 63.0 +/- 6.0 versus OnP-BH 65.3 +/- 3.9 y, 20% female patients). Number of grafts were 3.0 +/- 0.5 in OPCAB versus 2.9 +/- 0.3 in OnP-BH (n.s.) with 44 versus 34% bilateral IMAs and 56 versus 50% complete arterial revascularization. Regarding ischemia, intraoperatively only lactate values increased significantly in the OnP-BH group. Significantly higher CK-MB and troponin I levels were found from LIMA-LAD flow release onwards to 4 h postoperatively in the OnP-BH group. NT-proBNP levels were significantly higher in the OnP-BH group during the entire study period. CRP levels were higher in the OnP-BH group 12 and 24 h postoperatively. Conclusions: In this randomized study on routine coronary patients with normal ventricular function, OPCAB revealed less myocardial injury than OnP-BH. These findings implicate that CPB slightly affects the myocardium. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Leipzig, Heart Ctr Leipzig, Dept Cardiac Surg, D-04289 Leipzig, Germany.
RP Rastan, AJ (reprint author), Univ Leipzig, Heart Ctr Leipzig, Dept Cardiac Surg, Struempellstr 39, D-04289 Leipzig, Germany.
EM rastan@rz.uni-leipzig.de
CR Alwan K, 2004, ANN THORAC SURG, V77, P2051, DOI 10.1016/j.athoracsur.2003.11.004
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Bail DHL, 2004, THORAC CARDIOV SURG, V52, P135, DOI 10.1005/s-2004-817875
   Bittner HB, 2002, ANN THORAC SURG, V74, P115, DOI 10.1016/S0003-4975(02)03646-9
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   D'Ancona G, 2001, J CARDIAC SURG, V16, P132, DOI 10.1111/j.1540-8191.2001.tb00498.x
   Diegeler A, 2000, CIRCULATION, V102, P95
   Dybdahl B, 2004, EUR J CARDIO-THORAC, V25, P985, DOI 10.1016/j.ejcts.2004.03.002
   Edgerton JR, 2004, HEART SURG FORUM, V7, P8
   Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje
   Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Langenbach MR, 2000, Z KARDIOL, V89, P1133, DOI 10.1007/s003920070141
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Peivandi AA, 2001, THORAC CARDIOV SURG, V49, P137, DOI 10.1055/s-2001-14289
   Perrault LP, 1997, ANN THORAC SURG, V64, P1368, DOI 10.1016/S0003-4975(97)00842-4
   Prifti E, 2000, J CARDIAC SURG, V15, P403
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Schulze C, 2000, THORAC CARDIOV SURG, V48, P364, DOI 10.1055/s-2000-8352
   Thiery J, 1996, ATHEROSCLEROSIS, V121, P63, DOI 10.1016/0021-9150(95)05700-5
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043
   Wan S, 1999, ANN THORAC SURG, V68, P52, DOI 10.1016/S0003-4975(99)00315-X
   Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994
   Wildhirt S M, 2000, Eur J Med Res, V5, P222
NR 25
TC 49
Z9 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD JUN
PY 2005
VL 27
IS 6
BP 1057
EP 1063
DI 10.1016/j.ejcts.2005.03.007
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 935YD
UT WOS:000229818400027
PM 15896617
ER

PT J
AU Crook, JM
   Choan, E
   Perry, GA
   Robertson, S
   Esche, BA
AF Crook, JM
   Choan, E
   Perry, GA
   Robertson, S
   Esche, BA
TI Serum prostate-specific antigen profile following radiotherapy for
   prostate cancer: Implications for patterns of failure and definition of
   cure
SO UROLOGY
LA English
DT Article
ID EXTERNAL-BEAM IRRADIATION; RADIATION-THERAPY; ADENOCARCINOMA; PREDICTOR;
   KINETICS
AB Objectives. A reference range of prostate-specific antigen (PSA) values compatible with cure following radiotherapy (RT) for prostate cancer (PCa) has yet to be established. Various thresholds, as low as 0.5 ng/mL, have been used to define biochemical disease-free status. We report PSA profiles in 118 patients who were systematically biopsied following standard RT, with a minimum 4-year follow-up.
   Methods. One hundred eighteen patients were treated with standard external beam RT from May 1987 to October 1991, and were followed prospectively with transrectal ultrasound (TRUS)-guided biopsies and measurement of serum PSA levels. Stage distribution was as follows: T1b: 25 patients, T2a: 27 patients, T2b/c: 42 patients, T3: 23 patients, T4: 1 patient. Median follow-up for patients without clinical failure is 68 months (range 48 to 108). Treatment failures were categorized as biochemical (biochemical failure [chemF]: PSA level of 2.0 ng/ml or more and greater than 1 ng/mL over nadir), local (local failure [LF]: positive biopsy and PSA level greater than 2.0), and distant Failure (DF).
   Results. PCa recurred in 55% of patients: 38% LF (n = 45; 30 isolated and 15 with DF), 25% DF (n = 30; 15 isolated and 15 with LF), and 4% chemF (n = 5). Mean PSA nadir was 0.4 for patients with no evidence of disease (NED) and occurred at 33 months, 3.2 for LF at 17 months, 7.7 for DF at 12 months, and 1.4 for chemF at 24 months, After reaching the nadir, PSA in patients with recurrence followed first-order kinetics, rising exponentially over time. The mean PSA doubling time was 12.6 months for LF, 5.2 months for DF, and 21.8 months for chemF (P = 0.004). At last follow-up, the median PSA for patients without evidence of disease is 0.5 ng/mL, Four such patients had PSA values that rose to between 1 and 2 ng/mL for 5 to 38 months, but these eventually fell again to less than 1 ng/mL. Three patients had PSA values between 2 and 3 ng/mL, but 2 now have decreasing levels and the third has a rising level. All patients whose PSA levels rose to greater than 3 ng/mL exhibited a persistently rising pattern and ultimate tumor recurrence.
   Conclusions. There is a range of PSA values following RT for PCa that is compatible with cure. A definition of biochemical disease-free status at any absolute threshold of PSA level less than 3 ng/mL will overdiagnose failure in a significant proportion of patients. Patients with a PSA level between 1.5 and 3 ng/mL should be observed until there is unequivocal evidence of disease recurrence. In the absence of known biopsy status, PSA doubling time can be a useful indicator of whether failure is local or distant. (C) 1998, Elsevier Science Inc. All rights reserved.
C1 Ottawa Reg Canc Ctr, Gen Div, Dept Radiat Oncol, Ottawa, ON K1H 8L6, Canada.
   Ottawa Gen Hosp, Dept Anat Pathol, Ottawa, ON K1H 8L6, Canada.
RP Crook, JM (reprint author), Ottawa Reg Canc Ctr, Gen Div, Dept Radiat Oncol, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.
CR BAGSHAW MA, 1994, J UROLOGY, V152, P1781
   BRAWER MK, 1989, CANCER, V63, P454, DOI 10.1002/1097-0142(19890201)63:3<454::AID-CNCR2820630311>3.0.CO;2-E
   COX RS, 1994, INT J RADIAT ONCOL, V28, P23
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I
   CROOK JM, 1995, UROLOGY, V45, P624, DOI 10.1016/S0090-4295(99)80054-5
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   CROOK M, 1993, CLIN BIOCHEM, V26, P31, DOI 10.1016/0009-9120(93)90014-W
   DAMICO AV, 1993, CANCER, V72, P2638, DOI 10.1002/1097-0142(19931101)72:9<2638::AID-CNCR2820720919>3.0.CO;2-N
   GEIST RW, 1995, UROLOGY, V45, P1016, DOI 10.1016/S0090-4295(99)80123-X
   HANKS GE, 1994, INT J RADIAT ONCOL, V30, P289
   HANKS GE, IN PRESS INT J RAD O
   HERMANEK P, 1992, INT UNION CANC TNM C
   KAPLAN ID, 1993, J UROLOGY, V149, P519
   Lee WR, 1997, J CLIN ONCOL, V15, P230
   Pisansky TM, 1997, CANCER-AM CANCER SOC, V79, P337, DOI 10.1002/(SICI)1097-0142(19970115)79:2<337::AID-CNCR17>3.0.CO;2-1
   RITTER MA, 1992, J CLIN ONCOL, V10, P1208
   ROSENZWEIG KE, 1995, J UROLOGY, V153, P1561, DOI 10.1016/S0022-5347(01)67461-5
   Scardino P T, 1983, Semin Urol, V1, P243
   STARNEY TA, 1993, J UROLOGY, V150, P1856
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   WILLETT CG, 1994, J UROLOGY, V151, P1579
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V33, P23, DOI 10.1016/0360-3016(95)00154-Q
   ZELEFSKY MJ, 1995, J CLIN ONCOL, V13, P459
   ZIETMAN AL, 1994, J UROLOGY, V151, P640
NR 26
TC 49
Z9 51
PU CAHNERS PUBL CO
PI NEW YORK
PA 249 WEST 17 STREET, NEW YORK, NY 10011 USA
SN 0090-4295
J9 UROLOGY
JI UROLOGY
PD APR
PY 1998
VL 51
IS 4
BP 566
EP 572
DI 10.1016/S0090-4295(97)00650-X
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA ZJ993
UT WOS:000073274300011
PM 9586608
ER

PT J
AU Powers, JH
AF Powers, JH
TI The abuse of rest as a therapeutic measure in surgery - Early
   postoperative activity and rehabilitation
SO JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
C1 Mary Imogene Bassett Hosp, Dept Surg, Cooperstown, NY USA.
CR Abel A L, 1937, Postgrad Med J, V13, P435
   BOLDT HJ, 1907, NEW YORK M J, V85, P145
   Claremont HE, 1922, LANCET, V1, P427
   Leithauser DJ, 1941, ARCH SURG-CHICAGO, V42, P1086
   Nelson EW, 1942, SURGERY, V12, P109
   Newburger B, 1943, SURGERY, V14, P142
   NEWBURGER B, SURGERY, V13, P692
   Powers JH, 1928, ARCH SURG-CHICAGO, V17, P304
   POWERS JH, 1944, 2 NAT RES COUNC
   Ries E., 1899, JAMA-J AM MED ASSOC, VXXXIII, P454
   ROBERTSON G, 1927, PRACTITIONER, V119, P162
   Smith LA, 1940, ARCH SURG-CHICAGO, V41, P1366
   Sparkman RS, 1942, SURGERY, V11, P698
NR 13
TC 49
Z9 49
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0002-9955
J9 J AMER MED ASSOC
JI J. Am. Med. Assoc.
PD MAY-AUG
PY 1944
VL 125
BP 1079
EP 1083
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA V24NU
UT WOS:000201658200201
ER

PT J
AU Lamy, A
   Devereaux, PJ
   Prabhakaran, D
   Taggart, DP
   Hu, SS
   Paolasso, E
   Straka, Z
   Piegas, LS
   Akar, AR
   Jain, AR
   Noiseux, N
   Padmanabhan, C
   Bahamondes, JC
   Novick, RJ
   Vaijyanath, P
   Reddy, SK
   Tao, L
   Olavegogeascoechea, PA
   Airan, B
   Sulling, TA
   Whitlock, RP
   Ou, YN
   Pogue, J
   Chrolavicius, S
   Yusuf, S
AF Lamy, Andre
   Devereaux, P. J.
   Prabhakaran, Dorairaj
   Taggart, David P.
   Hu, Shengshou
   Paolasso, Ernesto
   Straka, Zbynek
   Piegas, Leopoldo S.
   Akar, Ahmet Ruchan
   Jain, Anil R.
   Noiseux, Nicolas
   Padmanabhan, Chandrasekar
   Bahamondes, Juan-Carlos
   Novick, Richard J.
   Vaijyanath, Prashant
   Reddy, Sukesh Kumar
   Tao, Liang
   Olavegogeascoechea, Pablo A.
   Airan, Balram
   Sulling, Toomas-Andres
   Whitlock, Richard P.
   Ou, Yongning
   Pogue, Janice
   Chrolavicius, Susan
   Yusuf, Salim
CA CORONARY Investigators
TI Effects of Off-Pump and On-Pump Coronary-Artery Bypass Grafting at 1
   Year
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID AORTIC-VALVE-REPLACEMENT; COGNITIVE IMPAIRMENT; RANDOMIZED-TRIAL;
   ELDERLY-PATIENTS; RISK PATIENTS; SURGERY; OUTCOMES; LIFE; COLLABORATION;
   TRANSCATHETER
AB BACKGROUND
   Previously, we reported that there was no significant difference at 30 days in the rate of a primary composite outcome of death, myocardial infarction, stroke, or new renal failure requiring dialysis between patients who underwent coronary-artery bypass grafting (CABG) performed with a beating-heart technique (off-pump) and those who underwent CABG performed with cardiopulmonary bypass (on-pump). We now report results on quality of life and cognitive function and on clinical outcomes at 1 year.
   METHODS
   We enrolled 4752 patients with coronary artery disease who were scheduled to undergo CABG and randomly assigned them to undergo the procedure off-pump or on-pump. Patients were enrolled at 79 centers in 19 countries. We assessed quality of life and cognitive function at discharge, at 30 days, and at 1 year and clinical outcomes at 1 year.
   RESULTS
   At 1 year, there was no significant difference in the rate of the primary composite outcome between off-pump and on-pump CABG (12.1% and 13.3%, respectively; hazard ratio with off-pump CABG, 0.91; 95% confidence interval [CI], 0.77 to 1.07; P = 0.24). The rate of the primary outcome was also similar in the two groups in the period between 31 days and 1 year (hazard ratio, 0.79; 95% CI, 0.55 to 1.13; P = 0.19). The rate of repeat coronary revascularization at 1 year was 1.4% in the off-pump group and 0.8% in the on-pump group (hazard ratio, 1.66; 95% CI, 0.95 to 2.89; P = 0.07). There were no significant differences between the two groups at 1 year in measures of quality of life or neurocognitive function.
   CONCLUSIONS
   At 1 year after CABG, there was no significant difference between off-pump and on-pump CABG with respect to the primary composite outcome, the rate of repeat coronary revascularization, quality of life, or neurocognitive function. (Funded by the Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov number, NCT00463294.)
C1 [Lamy, Andre; Devereaux, P. J.; Whitlock, Richard P.; Ou, Yongning; Pogue, Janice; Chrolavicius, Susan; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada.
   [Noiseux, Nicolas] Ctr Hosp Univ Montreal, Montreal, PQ, Canada.
   [Novick, Richard J.] London Hlth Sci Ctr, London, ON, Canada.
   [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India.
   [Jain, Anil R.] SAL Hosp & Med Inst, Ahmadabad, Gujarat, India.
   [Padmanabhan, Chandrasekar] G Kuppuswamy Naidu Mem Hosp, Coimbatore, Tamil Nadu, India.
   [Vaijyanath, Prashant] Frontier Lifeline, Dr KM Cherian Heart Fdn, Chennai, Tamil Nadu, India.
   [Reddy, Sukesh Kumar] Mediciti Hosp, Hyderabad, Andhra Pradesh, India.
   [Airan, Balram] All India Inst Med Sci, New Delhi, India.
   [Taggart, David P.] Univ Oxford, Oxford, England.
   [Hu, Shengshou] Fu Wai Cardiovasc Hosp, Beijing, Peoples R China.
   [Paolasso, Ernesto] Inst Invest Clin Rosario, Rosario, Santa Fe, Argentina.
   [Straka, Zbynek] Charles Univ Prague, Fac Med 3, Prague, Czech Republic.
   [Piegas, Leopoldo S.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil.
   [Akar, Ahmet Ruchan] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey.
   [Bahamondes, Juan-Carlos] Hosp Reg Temuco, Temuco, Chile.
   [Tao, Liang] Wuhan Asia Heart Hosp, Wuhan, Hubei, Peoples R China.
   [Sulling, Toomas-Andres] North Estonia Med Ctr, Tallinn, Estonia.
RP Lamy, A (reprint author), McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada.
EM lamya@mcmaster.ca
FU Canadian Institutes of Health Research
FX Supported by the Canadian Institutes of Health Research.
CR [Anonymous], 2004, N ENGL J MED, V350, P1791
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Brown PP, 2001, ANN THORAC SURG, V72, pS1009, DOI 10.1016/S0003-4975(01)02937-X
   Devereaux PJ, 2005, BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88
   DHAWAN J, 1995, INT J CARDIOL, V49, P267, DOI 10.1016/0167-5273(95)02315-N
   EuroQol Group, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9
   Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366
   Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47
   Hachinski V, 2007, STROKE, V38, P1118, DOI 10.1161/01.STR.0000259385.54832.e4
   Hochstenbach JB, 2001, ARCH PHYS MED REHAB, V82, P1360, DOI 10.1053/apmr.2001.25970
   Houlind K, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-47
   Houlind K, 2012, CIRCULATION, V125, P2431, DOI 10.1161/CIRCULATIONAHA.111.052571
   Kaplan E., 1991, WAIS R NEUROPSYCHOLO
   Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384
   Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388
   Lamy A, 2012, AM HEART J, V163, P1, DOI 10.1016/j.ahj.2011.10.007
   LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Lip GYH, 1999, POSTGRAD MED J, V75, P463
   Makaryus AN, 2005, AM J CARDIOL, V96, P778, DOI 10.1016/j.amjcard.2005.05.018
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   Song HK, 2003, EUR J CARDIO-THORAC, V24, P947, DOI 10.1016/S1010-7940(03)00616-X
   STORANDT M, 1984, ARCH NEUROL-CHICAGO, V41, P497
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   VANDERLINDEN W, 1980, SURGERY, V87, P258
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Yusuf S, 1994, LANCET, V344, P446
NR 34
TC 48
Z9 49
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 28
PY 2013
VL 368
IS 13
BP 1179
EP 1188
DI 10.1056/NEJMoa1301228
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 116FU
UT WOS:000316869000005
PM 23477676
ER

PT J
AU Mirsadraee, S
   Wilcox, HE
   Korossis, SA
   Kearney, JN
   Watterson, KG
   Fisher, J
   Ingham, E
AF Mirsadraee, S
   Wilcox, HE
   Korossis, SA
   Kearney, JN
   Watterson, KG
   Fisher, J
   Ingham, E
TI Development and characterization of an acellular human pericardial
   matrix for tissue engineering
SO TISSUE ENGINEERING
LA English
DT Article
ID HEART-VALVES; PORCINE; RECELLULARIZATION; EXTRACTION; FATE
AB This study aimed to produce an acellular human tissue scaffold with a view to recellularization with autologous cells to produce a tissue-engineered pericardium that can be used as a patch for cardiovascular repair. Human pericardia from cadaveric donors were treated sequentially with hypotonic buffer, SDS in hypotonic buffer, and a nuclease solution. Histological analysis of decellularized matrices showed that the human pericardial tissue retained its histioarchitecture and major structural proteins. There were no whole cells or cell fragments. There were no significant differences in the hydroxyproline (normal and denatured collagen) and glycosaminoglycan content of the tissue before and after decellularization (p > 0.05). There were no significant changes in the ultimate tensile strength after decellularization (p > 0.05). However, there was an increased extensibility when the tissue strips were cut parallel to the visualized collagen bundles (p = 0.005). No indication of contact or extract cytotoxicity was found when using human dermal fibroblasts and A549 cells. In summary, successful decellularization of the human pericardium was achieved producing a biocompatible matrix that retained the major structural components and strength of the native tissue.
C1 Univ Leeds, Inst Med & Biol Engn, Leeds, W Yorkshire, England.
   Yorkshire Heart Ctr, Leeds, W Yorkshire, England.
   NBS Tissue Serv R&D, Sheffield, S Yorkshire, England.
RP Ingham, E (reprint author), Univ Leeds, Sch Biochesistry & Microbiol, Leeds LS2 9JT, W Yorkshire, England.
EM e.ingham@leeds.ac.uk
CR Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3
   BODNAR E, 1986, THORAC CARDIOV SURG, V34, P82, DOI 10.1055/s-2007-1020381
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   CLARKE CP, 1968, THORAX, V23, P111, DOI 10.1136/thx.23.2.111
   COURTMAN DW, 1995, J BIOMED MATER RES, V29, P1507, DOI 10.1002/jbm.820291207
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Daniels JT, 1997, BURNS, V23, P26, DOI 10.1016/S0305-4179(96)00061-7
   DURAN CG, 1993, CASA EDIT SCI INT, V69
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Ehler W J, 1990, J Invest Surg, V3, P119, DOI 10.3109/08941939009140342
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   GUYTON RA, 1984, J THORAC CARDIOV SUR, V87, P619
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   KIM KM, 1994, CELL MATER, V4, P247
   Korossis SA, 2002, J HEART VALVE DIS, V11, P463
   Lomas RJ, 2003, BURNS, V29, P515, DOI 10.1016/S0305-4179(03)00137-2
   Maranto A R, 1988, ASAIO Trans, V34, P827
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Voet D., 1995, BIOCHEMISTRY
   Wilcox HE, 2005, J HEART VALVE DIS, V14, P228
NR 24
TC 48
Z9 52
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 2006
VL 12
IS 4
BP 763
EP 773
DI 10.1089/ten.2006.12.763
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 041YV
UT WOS:000237494400013
PM 16674290
ER

PT J
AU Nollert, G
   Schwabenland, I
   Maktav, D
   Kur, F
   Christ, F
   Fraunberger, P
   Reichart, B
   Vicol, C
AF Nollert, G
   Schwabenland, I
   Maktav, D
   Kur, F
   Christ, F
   Fraunberger, P
   Reichart, B
   Vicol, C
TI Miniaturized cardiopulmonary bypass in coronary artery bypass surgery:
   Marginal impact on inflammation and coagulation but loss of safety
   margins - Invited commentary
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID PERICARDIAL SUCTION BLOOD; CARDIAC-SURGERY; OFF-PUMP;
   EXTRACORPOREAL-CIRCULATION; CARDIOTOMY SUCTION; HEPARIN; REDUCTION;
   OUTCOMES; PATENCY
AB Purpose. Inflammation and coagulation disturbances are common consequences of cardiopulmonary bypass (CPB). Recently, miniaturized closed CPB circuits without cardiotomy suction and venous reservoir have been proposed to reduce complication rates. We compared outcomes with conventional (CCPB) and miniaturized cardiopulmonary bypass (MCPB) after coronary artery bypass operations (CABG) with respect to inflammation and coagulation.
   Description. Thirty patients (23% female; aged 67.9 +/- 9.0 years) were prospectively randomly assigned to undergo isolated CABG with CCPB or MCPB. Conventional CPB had a pump prime of 1, 600 mL. Miniaturized CPB consisted of a centrifugal pump, arterial filter, heparinized tubing, and oxygenator with a priming volume of 800 mL. Shed blood was removed by a cell-saving device and reinfused. Measurements included interleukin (IL)-2 receptor, IL-6, IL-10, tumor necrosis factor receptor 55 and 75, C reactive protein, leukocyte differentiation, d-dimers, fibrinogen, and thrombocytes at six time points.
   Evaluation. In both groups no major complication occurred. However, two dangerous air leaks occurred in the closed MCPB circuit, demonstrating the narrow safety margins. Operative handling was also more difficult owing to limitations in venting and fluid management. International normalized ratio (p = 0.03) and antithrombin III (p = 0.04) levels were elevated during CPB in the CCPB group, most likely owing to differences of the intraoperative anticoagulation management. Repeated measures analysis revealed that not a single parameter of inflammation or clinical outcome showed significant differences among groups.
   Conclusions. Use of a MCPB affected inflammation and coagulation variables only marginally and did not lead to clinical relevant changes as assessed by blood loss, need for blood products, and intensive care unit and clinical stays. However, safety margins for volume loss, air emboli, and weaning from CPB decrease, because of the closed MCPB circuit.
C1 Univ Munich, Anesthesiol Clin, Munich, Germany.
   Chinese Univ Hong Kong, Prince Wales Hosp, Div Cardiothorac Surg, Hong Kong, Hong Kong, Peoples R China.
RP Nollert, G (reprint author), Univ Clin Munich, Clin Cardiac Surg, Clin Grosshadern, Marchioninistr 15, D-81366 Munich, Germany.
EM georg.nollert@med.uni-muenchen.de
CR Aldea GS, 2002, J THORAC CARDIOV SUR, V123, P742, DOI 10.1067/mtc.2002.120347
   Appelblad M, 2002, J THORAC CARDIOV SUR, V124, P377, DOI 10.1067/mtc.2002.122303
   Asimakopoulos G, 2001, PERFUSION-UK, V16, P353
   Caputo M, 1998, EUR J CARDIO-THORAC, V14, P596, DOI 10.1016/S1010-7940(98)00247-4
   Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X
   Gummert JF, 2004, THORAC CARDIOV SURG, V52, P70, DOI 10.1055/s-2004-817806
   Jewell AE, 2003, EUR J CARDIO-THORAC, V23, P633, DOI 10.1016/S1010-7940(02)00834-5
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Moen O, 1996, ANN THORAC SURG, V62, P1134, DOI 10.1016/0003-4975(96)00492-4
   Nollert G, 2005, ANN THORAC SURG, V80, P2326, DOI 10.1016/j.athoracsur.2005.05.080
   OVRUM E, 1995, ANN THORAC SURG, V60, P365, DOI 10.1016/0003-4975(95)00366-S
   Peschon JJ, 1998, J IMMUNOL, V160, P943
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Shapira OM, 1998, ANN THORAC SURG, V65, P724, DOI 10.1016/S0003-4975(97)01431-8
   Svenmarker S, 2003, SCAND CARDIOVASC J, V37, P158, DOI 10.1090/14017430310001465
   Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043
   Wiesenack C, 2004, ARTIF ORGANS, V28, P1082, DOI 10.1111/j.1525-1594.2004.00030.x
NR 18
TC 48
Z9 48
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD DEC
PY 2005
VL 80
IS 6
BP 2326
EP 2332
DI 10.1016/j.athoracsur.2005.05.080
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 993BD
UT WOS:000233926800053
PM 16305899
ER

PT J
AU Byrne, JG
   Leacche, M
   Unic, D
   Rawn, JD
   Simon, DI
   Rogers, CD
   Cohn, LH
AF Byrne, JG
   Leacche, M
   Unic, D
   Rawn, JD
   Simon, DI
   Rogers, CD
   Cohn, LH
TI Staged initial percutaneous coronary intervention followed by valve
   surgery ("hybrid approach") for patients with complex coronary and valve
   disease
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID CARDIAC-SURGERY; REPLACEMENT; STERNOTOMY; MORTALITY; REPAIR
AB OBJECTIVES The goal of this study was to determine if a "hybrid" approach to the treatment of complex combined coronary and valve disease is superior to the results predicted by a Society of Thoracic Surgeons' (STS) algorithm with conventional coronary artery bypass graft (CAB G)/ valve surgery in high-risk patients.
   BACKGROUND With advancements in percutaneous coronary interventions (PCIs), some patients requiring coronary revascularization and valve surgery may benefit from a hybrid approach involving initial planned PCT followed by valve surgery, rather than conventional CABG/valve surgery.
   METHODS We retrospectively analyzed 26 consecutive patients with coronary artery and valve disease who underwent planned initial PCI followed by valve surgery during the same hospital stay between September 1997 and August 2003. We calculated the predicted mortality at the time of PCI and compared it with the observed mortality.
   RESULTS There were 12 male and 14 female patients with a median age of 72 years (range 53 to 91 years). Balloon angioplasty was performed in all patients, followed by stenting in 22 (85%) patients. Within a median of 5 days (range 0 to 14 days), 15 patients (58%) underwent primary and 11 patients (42%) underwent re-operative valve surgery. Operative mortality was 1 of 26 patients (3.8%), dramatically lower than the STS-predicted mortality of 22%. Median blood loss was 900 ml, and 22 patients (85%) required blood transfusions. Survival at 1, 3, and 5 years was 78%, 56%, and 44%, respectively.
   CONCLUSIONS Hybrid initial PCI followed by staged valve surgery represents an excellent alternative to conventional CABG/valve surgery in some high-risk patients, particularly those who present in shock after myocardial infarction. Lower mortality rates come at the cost of more bleeding and transfusion requirements. (C) 2005 by the American College of Cardiology Foundation.
C1 Brigham & Womens Hosp, Div Cardiac Surg, Boston, MA 02115 USA.
   Brigham & Womens Hosp, Cardiovasc Div, Boston, MA 02115 USA.
RP Byrne, JG (reprint author), Vanderbilt Univ, Ctr Med, Dept Cardiac Surg, 221 Kirkland Hall, Nashville, TN 37232 USA.
EM john.byrne@vanderbilt.edu
CR Byrne JG, 2000, EUR J CARDIO-THORAC, V18, P282, DOI 10.1016/S1010-7940(00)00528-5
   Byrne JG, 1999, J THORAC CARDIOV SUR, V118, P991, DOI 10.1016/S0022-5223(99)70092-9
   Byrne JG, 2001, J HEART VALVE DIS, V10, P584
   Cohn LH, 1997, ANN SURG, V226, P421, DOI 10.1097/00000658-199710000-00003
   Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X
   Hasdai D, 2003, EUR HEART J, V24, P623, DOI 10.1016/S0195-668X(02)00742X
   Herlitz J, 1997, EUR J CARDIO-THORAC, V12, P836, DOI 10.1016/S1010-7940(97)00278-9
   Jamieson WRE, 1999, ANN THORAC SURG, V67, P943, DOI 10.1016/S0003-4975(99)00175-7
   Karamanoukian HL, 2002, HEART SURG FORUM, V5, pE24
   Saia F, 2003, CIRCULATION, V108, P1927, DOI 10.1161/01.CIR.0000096053.87580.CD
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Wilson SH, 2003, J AM COLL CARDIOL, V42, P234, DOI 10.1016/S0735-1097(03)00622-3
NR 12
TC 48
Z9 50
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD JAN 4
PY 2005
VL 45
IS 1
BP 14
EP 18
DI 10.1016/j.jacc.2004.09.050
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 883LF
UT WOS:000226012600003
PM 15629366
ER

PT J
AU Fleminger, S
   Oliver, DL
   Williams, WH
   Evans, J
AF Fleminger, S
   Oliver, DL
   Williams, WH
   Evans, J
TI The neuropsychiatry of depression after brain injury
SO NEUROPSYCHOLOGICAL REHABILITATION
LA English
DT Review
ID CLOSED-HEAD INJURY; POSTSTROKE DEPRESSION; MOOD DISORDERS; LESION
   LOCATION; STROKE PATIENTS; COGNITIVE IMPAIRMENT; FOLLOW-UP; INSIGHT;
   APATHY; SCHIZOPHRENIA
AB Biological aspects of depression after brain injury, in particular traumatic brain injury (TBI) and stroke, are reviewed. Symptoms of depression after brain injury are found to be rather non-specific with no good evidence of a clear pattern distinguishing it from depression in those without brain injury. Nevertheless symptoms of disturbances of interest and concentration are particularly prevalent, and guilt is less evident. Variabilitiy of mood is characteristic. The prevalence of depression is similar after both stroke and TBI with the order of 20-40% affected at any point in time in the first year, and about 50% of people experience depression at some stage. There is no good evidence for areas of specific vulnerability in terms of lesion location, and early suggestions of a specific association with injury to the left hemisphere have not been confirmed.
   Insight appears to be related to depressed mood with studies of TBI indicating that greater insight over time post-injury may be associated with greater depression. We consider that this relationship may be due to depression appearing as people gain more awareness of their disability, but also suggest that changes in mood may result in altered awareness.
   The risk of suicide after TBI is reviewed. There appears to be about a three to fourfold increased risk of suicide after TBI, although much of this increased risk may be due to pre-injury factors in terms of the characteristics of people who suffer TBI. About 1% of people who have suffered TBI will commit suicide over a 15-year follow-up.
   Drug management of depression is reviewed. There is little specific evidence to guide the choice of antidepressant medication and most psychiatrists would start with a selective serotonin reuptake inhibitor (SSRI). It is important that the drug management of depression after brain injury is part of a full package of care that can address biological as well as psychosocial factors in management.
C1 Maudsley Hosp & Inst Psychiat, Lishman Brain Injury Unit, London SE5 8AZ, England.
   Univ Exeter, Sch Psychol, Exeter, Devon, England.
   Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, England.
RP Fleminger, S (reprint author), Maudsley Hosp & Inst Psychiat, Lishman Brain Injury Unit, Denmark Hill, London SE5 8AZ, England.
CR Aben I, 2001, PROG NEURO-PSYCHOPH, V25, P671, DOI 10.1016/S0278-5846(01)00158-0
   ABRAMS D, 1992, ELECETROCONVULSIVE T
   ACHTE KA, 1970, PHYSICAT FENNICA, V1, P231
   ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441
   ALOIA MS, 1995, BRAIN INJURY, V9, P575, DOI 10.3109/02699059509008216
   ANDERSEN G, 1994, ACTA PSYCHIAT SCAND, V90, P190, DOI 10.1111/j.1600-0447.1994.tb01576.x
   BECK AT, 1963, ARCH GEN PSYCHIAT, V9, P324
   Berg A, 2001, CEREBROVASC DIS, V12, P14, DOI 10.1159/000047675
   BHAT M, 2000, ANN M ROYAL COLL PSY
   BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198
   Bowen A, 1999, BRAIN INJURY, V13, P547
   Brown KW, 1998, ACTA PSYCHIAT SCAND, V98, P455, DOI 10.1111/j.1600-0447.1998.tb10119.x
   Carroll A, 1999, SCHIZOPHR RES, V35, P247, DOI 10.1016/S0920-9964(98)00142-X
   Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X
   COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313
   Dam H, 2001, ACTA PSYCHIAT SCAND, V103, P287, DOI 10.1034/j.1600-0447.2001.103004287.x
   DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x
   Dixon M, 1998, BRIT J MED PSYCHOL, V71, P85
   Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943
   DOWNHILL JE, 1994, J NERV MENT DIS, V182, P425, DOI 10.1097/00005053-199408000-00001
   EVANS JJ, 2002, NEUROPSYCHOL REHABIL, V12, P167, DOI 10.1080/09602010143000185
   FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918
   Finset A, 2000, BRAIN INJURY, V14, P887
   Flashman L. A., 1998, SEMINARS CLIN NEUROP, V3, P201
   Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39
   FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037//0022-3514.50.5.992
   Forgas JP, 1998, J PERS SOC PSYCHOL, V75, P318, DOI 10.1037/0022-3514.75.2.318
   FORGAS JP, 1990, J PERS SOC PSYCHOL, V59, P809, DOI 10.1037//0022-3514.59.4.809
   Freeland J., 1996, MAGAZINE, V4, P32
   FREELAND J, 1995, ECT HDB
   Gainotti G, 2001, J NEUROL NEUROSUR PS, V71, P258, DOI 10.1136/jnnp.71.2.258
   GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440
   Gainotti G, 1999, BRIT J PSYCHIAT, V175, P163, DOI 10.1192/bjp.175.2.163
   Gall A, 2001, HOSP MED, V62, P268
   GHAEMI SN, 1995, J NERV MENT DIS, V183, P464, DOI 10.1097/00005053-199507000-00007
   Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777
   GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574
   GORDON WA, 1991, REHABIL PSYCHOL, V36, P71, DOI 10.1037//0090-5550.36.2.71
   Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205
   Herrmann N, 1998, STROKE, V29, P618
   HERRMANN M, 1995, STROKE, V26, P850
   Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24
   Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925
   Hoofien D, 2001, BRAIN INJURY, V15, P189
   HOUSE A, 1991, BRIT J PSYCHIAT, V158, P83, DOI 10.1192/bjp.158.1.83
   HOUSE A, 1990, BRAIN, V113, P1113, DOI 10.1093/brain/113.4.1113
   Iqbal Z, 2000, BRIT J PSYCHIAT, V177, P522
   JACKSON HF, 1988, APHASIOLOGY, V2, P89, DOI 10.1080/02687038808248891
   JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N
   JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004
   Kant R, 1999, J NEUROPSYCH CLIN N, V11, P32
   Kant R, 1998, BRAIN INJURY, V12, P87
   Kauhanen ML, 1999, STROKE, V30, P1875
   Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502
   Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662
   Kim JS, 2000, NEUROLOGY, V54, P1805
   KLONOFF PS, 1995, J HEAD TRAUMA REHAB, V10, P16, DOI 10.1097/00001199-199512000-00005
   Kotila M, 1998, STROKE, V29, P368
   Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108
   MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219
   MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243
   MARIN RS, 1990, AM J PSYCHIAT, V147, P22
   Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954
   MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882
   MICHALAKEAS A, 1994, ACTA PSYCHIAT SCAND, V90, P46, DOI 10.1111/j.1600-0447.1994.tb01554.x
   MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185
   Moore O, 1999, EUR PSYCHIAT, V14, P264, DOI 10.1016/S0924-9338(99)00172-8
   MOOREY P, 1996, FRONTIERS COGNITIVE
   MOOS RH, 1984, COPING PHYSICAL ILLN
   MORRIS PLP, 1992, AUST NZ J PSYCHIAT, V26, P208, DOI 10.3109/00048679209072029
   MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574
   Ownsworth TL, 1998, BRAIN INJURY, V12, P735
   Pacini R, 1998, J PERS SOC PSYCHOL, V74, P1056, DOI 10.1037/0022-3514.74.4.1056
   Peralta V, 1998, J AFFECT DISORDERS, V49, P55, DOI 10.1016/S0165-0327(97)00198-5
   Ponsford J, 1995, TRAUMATIC BRAIN INJU
   PRIGATANO GP, 1997, NEUROPSYCHOLOGICAL R
   Ramadhan RH, 1998, J MATER CIVIL ENG, V10, P26, DOI 10.1061/(ASCE)0899-1561(1998)10:1(26)
   ROBINSON RG, 1987, STROKE, V18, P837
   ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81
   ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506
   Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5
   Roth A., 1996, WHAT WORKS WHOM CRIT
   Sanz M, 1998, PSYCHOL MED, V28, P437, DOI 10.1017/S0033291797006296
   Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313
   SCHIFF HB, 1982, AM J PSYCHIAT, V139, P1346
   SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303
   SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945
   Smith TE, 2000, SCHIZOPHRENIA BULL, V26, P193
   STARKSTEIN SE, 1993, STROKE, V24, P1625
   STREETER CC, 1995, J NERV MENT DIS, V183, P577, DOI 10.1097/00005053-199509000-00003
   Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003
   Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436
   Turner-Stokes L, 2002, CLIN REHABIL, V16, P248, DOI 10.1191/0269215502cr488oa
   Vataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925
   WADE DT, 1987, BRIT J PSYCHIAT, V151, P200, DOI 10.1192/bjp.151.2.200
   Wallace CA, 2000, BRAIN INJURY, V14, P549
   Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551
   WILLIAMS WH, IN PRESS J TRAUMATIC
   WILLIAMS WH, IN PRESS NEUROPSYCHO
   WILLIAMS WH, 1997, COGNITIVE THERAPY PE
   YAO SM, 2000, CHINESE MENTAL HLTH, V14, P388
NR 101
TC 48
Z9 48
PU PSYCHOLOGY PRESS
PI HOVE
PA 27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND
SN 0960-2011
J9 NEUROPSYCHOL REHABIL
JI Neuropsychol. Rehabil.
PD MAR-MAY
PY 2003
VL 13
IS 1-2
SI SI
BP 65
EP 87
DI 10.1080/09602010244000354
PG 23
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA 665EK
UT WOS:000182106500005
PM 21854328
ER

PT J
AU Wessel, I
   Merckelbach, H
   Dekkers, T
AF Wessel, I
   Merckelbach, H
   Dekkers, T
TI Autobiographical memory specificity, intrusive memory, and general
   memory skills in Dutch-Indonesian survivors of the World War II era
SO JOURNAL OF TRAUMATIC STRESS
LA English
DT Article
DE autobiographical memory specificity; overgeneral memories; intrusive
   memory; general memory skills; war survivors
ID POSTTRAUMATIC-STRESS-DISORDER; DEPRESSION; RETRIEVAL; INTELLIGENCE;
   ASSOCIATION; MOOD
AB A lack of specific autobiographical memory may result from exposure to psychological trauma, intrusive memories of adverse events, and/or a general memory deficit. This study explored the role of these variables in 25 patients with various psychiatric diagnoses and 15 healthy controls. All participants had been exposed to war atrocities during their childhood in Indonesia. Patients produced significantly less specific memories than did controls. In addition, rather than performance on general neuropsychological memory tests, the frequent occurrence of intrusive memories and the avoidance of reminders of trauma predicted less autobiographical memory specificity. These results replicate and extend earlier findings on intrusive and nonspecific autobiographical memory in depressed samples to a group of people who experienced war atrocities in childhood.
C1 Maastricht Univ, Dept Psychol, NL-6200 MD Maastricht, Netherlands.
   Ctr Victims War & Violence, Heeze, Netherlands.
RP Wessel, I (reprint author), Maastricht Univ, Dept Psychol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM i.wessel@psychology.unimaas.nl
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68
   Arrindell W. A., 1986, SCL 90 HANDLEIDING B
   Bramsen I., 1995, LONG TERM PSYCHOL AD
   BRAND N, 1985, J GEN PSYCHOL, V112, P201
   Brewin CR, 1998, BEHAV RES THER, V36, P1131, DOI 10.1016/S0005-7967(98)00084-9
   Brewin CR, 1999, J ABNORM PSYCHOL, V108, P511, DOI 10.1037/0021-843X.108.3.511
   Brewin CR, 1996, COGNITION EMOTION, V10, P107, DOI 10.1080/026999396380411
   BRITTLEBANK AD, 1993, BRIT J PSYCHIAT, V162, P118, DOI 10.1192/bjp.162.1.118
   BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037//0033-2909.117.2.285
   Dalgleish T, 2001, J ABNORM PSYCHOL, V110, P335, DOI 10.1037//0021-843X.110.2.335
   First M. B., 1997, STRUCTURED CLIN INTE
   FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405
   Goddard L, 1996, J ABNORM PSYCHOL, V105, P609, DOI 10.1037/0021-843X.105.4.609
   Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P500, DOI 10.1037/0022-006X.66.3.500
   HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209
   Jones B, 1999, PSYCHOL MED, V29, P1397, DOI 10.1017/S0033291799001208
   Kaney S, 1999, BRIT J CLIN PSYCHOL, V38, P97, DOI 10.1348/014466599162692
   Kupka R. W., 1999, GESTRUCTUREERD KLIN
   KUYKEN W, 1995, J ABNORM PSYCHOL, V104, P585, DOI 10.1037//0021-843X.104.4.585
   Lara ME, 1999, CLIN PSYCHOL REV, V19, P553, DOI 10.1016/S0272-7358(98)00066-X
   Luteijn F, 1983, HANDLEIDING GRONINGE
   Lyubomirsky S, 1998, J PERS SOC PSYCHOL, V75, P166, DOI 10.1037/0022-3514.75.1.166
   Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323
   MCNALLY RJ, 1995, BEHAV RES THER, V33, P629
   MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936
   MCNALLY RJ, 1994, COGNITION EMOTION, V8, P351, DOI 10.1080/02699939408408946
   Reynolds M, 1999, BEHAV RES THER, V37, P201, DOI 10.1016/S0005-7967(98)00132-6
   Watkins E, 2000, PSYCHOL MED, V30, P911, DOI 10.1017/S0033291799002263
   Wessel I, 2001, BEHAV RES THER, V39, P409, DOI 10.1016/S0005-7967(00)00011-5
   Wilhelm S, 1997, BRIT J CLIN PSYCHOL, V36, P21
   WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144
   Williams J. M. G., 1996, REMEMBERING OUR STUD
   WILLIAMS JMG, 1992, NATO ADV SCI INST SE, V65, P391
   Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551
NR 35
TC 48
Z9 48
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0894-9867
J9 J TRAUMA STRESS
JI J. Trauma Stress
PD JUN
PY 2002
VL 15
IS 3
BP 227
EP 234
DI 10.1023/A:1015207428675
PG 8
WC Psychology, Clinical; Psychiatry
SC Psychology; Psychiatry
GA 549QR
UT WOS:000175456300008
PM 12092915
ER

PT J
AU Bartynski, WS
   Grabb, BC
   Zeigler, Z
   Lin, L
   Andrews, DF
AF Bartynski, WS
   Grabb, BC
   Zeigler, Z
   Lin, L
   Andrews, DF
TI Watershed imaging features and clinical vascular injury in cyclosporin A
   neurotoxicity
SO JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
LA English
DT Article
ID LYMPHEDEMA; DIAGNOSIS; CT
AB Purpose: The purpose of our study was to assess whether the imaging and clinical features of cyclosporin A (CsA) neurotoxicity support a vascular ''watershed'' cause for the brain lesions observed.
   Method: Fourteen patients receiving CsA after allogeneic bone marrow transplantation or with marrow aplastic disorders developed neurotoxicity and MR or CT imaging abnormalities. The locations of brain lesions were analyzed, and clinical features, in particular bone marrow transplant thrombotic microangiopathy (BMT-TM), were assessed.
   Results: Sixty-six lesions had consistent locations in watershed zones between major cerebral vessels or their main branches, including the parietal area (19), occipital poles (18), frontoparietal junction (15), inferior temporooccipital junction (10), and cerebellum (3). BMT-TM was identified in 10 of 10 marrow transplant patients studied.
   Conclusion: Vascular injury, suggested from watershed location and BMT-TM, likely establishes the location of the brain lesions in CsA neurotoxicity. Secondary toxicity in these vulnerable regions may cause the white matter lesions.
C1 WESTERN PENN HOSP,DEPT MED,DIV HEMATOL & ONCOL,PITTSBURGH,PA 15224.
RP Bartynski, WS (reprint author), WESTERN PENN HOSP,DEPT RADIOL,4800 FRIENDSHIP AVE,PITTSBURGH,PA 15224, USA.
CR CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   DUEWELL S, 1992, RADIOLOGY, V184, P227
   FLECKENSTEIN JL, 1991, RADIOLOGY, V179, P653
   FUJII K, 1994, ACTA RADIOL, V35, P262
   HADJIS NS, 1985, AM J ROENTGENOL, V144, P361
   KALIMA TV, 1985, PROGR LYMPHOLOGY, V10, P116
   KOSSMAN CE, 1964, NOMENCLATURE CRITERI
   Landis EM, 1927, AM J PHYSIOL, V82, P217
   RAHMOUNI A, 1994, RADIOLOGY, V2, P493
   Starling E H, 1896, J Physiol, V19, P312
   STEINBACH LS, 1993, RADIOLOGY, V186, P833
   VAUGHAN BF, 1990, CLIN RADIOL, V41, P24, DOI 10.1016/S0009-9260(05)80927-4
NR 12
TC 48
Z9 48
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0363-8715
J9 J COMPUT ASSIST TOMO
JI J. Comput. Assist. Tomogr.
PD NOV-DEC
PY 1997
VL 21
IS 6
BP 872
EP 880
DI 10.1097/00004728-199711000-00005
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA YF694
UT WOS:A1997YF69400006
PM 9386275
ER

PT J
AU Kazura, JW
   Bockarie, M
   Alexander, N
   Perry, R
   Bockarie, F
   Dagoro, H
   Dimber, Z
   Hyun, P
   Alpers, MP
AF Kazura, JW
   Bockarie, M
   Alexander, N
   Perry, R
   Bockarie, F
   Dagoro, H
   Dimber, Z
   Hyun, P
   Alpers, MP
TI Transmission intensity and its relationship to infection and disease due
   to Wuchereria bancrofti in Papua New Guinea
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC, 1995
CL SAN ANTONIO, TX
SP Amer Soc Trop Med & Hyg
ID LYMPHATIC FILARIASIS; FREQUENCY-DISTRIBUTION; HUMAN-POPULATIONS;
   MICROFILAREMIA; ABNORMALITIES; MODEL; SEX
AB This study describes the relationship between transmission intensity and infection and disease due to Wuchereria bancrofti in an endemic area of Papua New Guinea. The prevalence of microfilaremia in the entire study population was 66%. Of 1892 persons examined, 6.2% and 12.3% had lymphedema of the legs and hydroceles, respectively. The prevalences of microfilaremia and clinical morbidity were lowest in persons <20 years old and increased progressively with age. Annual transmission potential and annual infective biting were monitored in five villages where Anopheles punctulatus and Anopheles koliensis are the only vectors of W. bancrofti. Both measures of the entomologic inoculation rate were positively associated with the village-specific microfilarial rate, mean intensity of microfilaremia, and prevalence of leg edema. These data indicate that transmission intensity is a major determinant of patent infection and morbidity rates in bancroftian filariasis.
C1 PAPUA NEW GUINEA INST MED RES,GOROKA,PAPUA N GUINEA.
   PAPUA NEW GUINEA INST MED RES,MAPRIK,PAPUA N GUINEA.
   PAPUA NEW GUINEA INST MED RES,MADANG,PAPUA N GUINEA.
RP Kazura, JW (reprint author), CASE WESTERN RESERVE UNIV,SCH MED,DIV GEOG MED,W137,2109 ADELBERT RD,CLEVELAND,OH 44106, USA.
CR ANDERSON RM, 1976, ADV PARASIT, V24, P1
   Belkin JN, 1962, MOSQUITOES S PACIFIC, V1
   Bockarie Moses, 1996, American Journal of Tropical Medicine and Hygiene, V54, P577
   BRABIN L, 1990, EPIDEMIOL INFECT, V105, P335
   BRYAN JH, 1986, T ROY SOC TROP MED H, V80, P123, DOI 10.1016/0035-9203(86)90210-5
   BUNDY DAP, 1991, FILED91WP26 WHO
   BURKOT TR, 1990, T ROY SOC TROP MED H, V84, P773, DOI 10.1016/0035-9203(90)90073-N
   Centers for Disease Control and Prevention, 1993, MMWR-MORBID MORTAL W, V2, P1
   CHANTEAU S, 1994, J INFECT DIS, V170, P247
   DAS PK, 1990, PARASITOLOGY, V101, P429
   DESOWITZ RS, 1974, AM J TROP MED HYG, V23, P877
   EDWARDS AL, 1979, MULTIPLE REGRESSION, P7
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927
   GRENFELL BT, 1990, PARASITOLOGY, V101, P417
   GRENFELL BT, 1992, PARASITOLOGY, V104, pS81
   GUBHER DJ, 1974, AM J TROP MED HYG, V23, P1027
   HAIRSTON NG, 1968, B WORLD HEALTH ORGAN, V38, P935
   KAZURA JW, 1984, AM J TROP MED HYG, V33, P1119
   King C. L., 1991, IMMUNOL TODAY, V12, pA54
   LAMMIE PJ, 1991, LANCET, V337, P1005, DOI 10.1016/0140-6736(91)92661-K
   MAIZELS RM, 1991, PARASITOL TODAY, V7, P271, DOI 10.1016/0169-4758(91)90093-4
   MCMAHON JE, 1981, ANN TROP MED PARASIT, V75, P415
   MICHAEL E, 1994, P ROY SOC B-BIOL SCI, V256, P33, DOI 10.1098/rspb.1994.0045
   NELSON FK, 1991, J EXP MED, V173, P659, DOI 10.1084/jem.173.3.659
   NELSON G. S., 1959, JOUR HEL MINTHOL, V33, P233
   NELSON G S, 1958, Bull World Health Organ, V19, P204
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   OTTESEN EA, 1995, PARASITOL TODAY, V11, P129, DOI 10.1016/0169-4758(95)80128-6
   Ottesen EA, 1992, PARASITOLOGY, V104, P571
   PLAISIER AP, 1990, COMPUT METH PROG BIO, V31, P43, DOI 10.1016/0169-2607(90)90030-D
   SASA M, 1976, HUMAN FILARIASIS
   SELF LS, 1978, T R SOC TROP MED HYG, P581
   SOUTHGATE BA, 1992, J TROP MED HYG, V95, P1
   STEEL C, 1994, LANCET, V343, P890, DOI 10.1016/S0140-6736(94)90009-4
   SVRIDYA A, 1991, T R SOC TROP MED HYG, V85, P255
   *U SAINS MAL, 1994, CONS M PEN MAL U SAI
   WALSH JF, 1986, T R SOC TROP MED HYG, V72, P675
   WARTMAN WB, 1947, MEDICINE, V26, P334
   WEIL GJ, 1987, J INFECT DIS, V156, P350
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   World Health Organization, 1984, WHO TECH REP SER, V702, P3
NR 41
TC 48
Z9 49
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 S WOODLAWN AVE, CHICAGO, IL 60637
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL
PY 1997
VL 176
IS 1
BP 242
EP 246
DI 10.1086/514030
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA XH275
UT WOS:A1997XH27500031
PM 9207373
ER

PT J
AU COHEN, JE
AF COHEN, JE
TI POPULATION FORECASTS AND CONFIDENCE-INTERVALS FOR SWEDEN - A COMPARISON
   OF MODEL-BASED AND EMPIRICAL APPROACHES
SO DEMOGRAPHY
LA English
DT Article
RP COHEN, JE (reprint author), ROCKEFELLER UNIV,1230 YORK AVE,NEW YORK,NY 10021, USA.
CR ALHO JM, 1985, J AM STAT ASSOC, V80, P306, DOI 10.2307/2287887
   Ascher W., 1978, FORECASTING APPRAISA
   Charlesworth B., 1980, EVOLUTION AGE STRUCT
   Coale A., 1972, GROWTH STRUCTURE HUM
   COHEN JE, 1979, THEOR POPUL BIOL, V16, P159, DOI 10.1016/0040-5809(79)90011-X
   COHEN JE, 1979, J MATH ANAL APPL, V69, P243, DOI 10.1016/0022-247X(79)90191-4
   COHEN JE, 1976, J AM STAT ASSOC, V71, P335, DOI 10.2307/2285308
   COHEN JE, 1977, ADV APPL PROBAB, V9, P18, DOI 10.2307/1425814
   COHEN JE, 1977, ADV APPL PROBAB, V9, P462, DOI 10.2307/1426109
   COHEN JE, 1976, BIOSCIENCE, V26, P391, DOI 10.2307/1297412
   COHEN JE, 1983, 1982 CTR ADV STUD BE, P59
   COHEN JE, 1979, B AM MATH SOC, V1, P275, DOI 10.1090/S0273-0979-1979-14594-4
   COHEN JE, 1983, CAN J FISH AQUAT SCI, V40, P2170, DOI 10.1139/f83-251
   COHEN JE, AM STATISTICIAN
   COHEN JE, 1982, MULTIREGIONAL MATH D, P477
   COHEN JE, 1980, P NATL ACAD SCI USA, V77, P3749, DOI 10.1073/pnas.77.7.3749
   COHEN JE, 1985, ENCY STATISTICAL SCI
   COHEN JE, 1979, MATH P CAMBRIDGE PHI, V86, P351, DOI 10.1017/S0305004100056176
   FURSTENBERG H, 1960, ANN MATH STAT, V31, P457, DOI 10.1214/aoms/1177705909
   GOODYEAR CP, 1985, T AM FISH SOC, V114, P146, DOI 10.1577/1548-8659(1985)114<146:MSB>2.0.CO;2
   HAJNAL J, 1957, COLD SPRING HARB SYM, V22, P97
   HALL P, 1980, MARTINGALE LIMIT THE
   HENRY L, 1977, POPULATION, V32, P625, DOI 10.2307/1531465
   HEYDE CC, 1985, THEOR POPUL BIOL, V27, P120, DOI 10.1016/0040-5809(85)90007-3
   HEYDE CC, 1985, P BERKELEY C HONOR J, V1, P215
   HOFSTEN E, 1972, SWEDISH POPULATION 1
   Keyfitz N., 1971, POPULATION FACTS MET
   Keyfitz N., 1968, INTRO MATH POPULATIO
   KEYFITZ N, 1982, POPULATION CHANGE SO, pCH13
   Keyfitz N., 1968, WORLD POPULATION ANA
   LAND KC, 1985, 7001 U TEX AUST POP
   LANGE K, 1979, J APPL PROBAB, V16, P496, DOI 10.2307/3213079
   LANGE K, 1981, J APPL PROBAB, V18, P325, DOI 10.2307/3213280
   LANGE K, 1980, MATH BIOSCI, V52, P289, DOI 10.1016/0025-5564(80)90073-5
   LEE RD, 1974, J AM STAT ASSOC, V69, P607, DOI 10.2307/2285990
   SABOIA JLM, 1974, DEMOGRAPHY, V11, P483, DOI 10.2307/2060440
   SIEGEL JS, 1972, DEMOGRAPHY, V9, P51, DOI 10.2307/2060545
   SLADE NA, 1982, THEOR POPUL BIOL, V22, P299, DOI 10.1016/0040-5809(82)90047-8
   SMITH SK, 1985, UNPUB POPULATION PRO
   STOTO MA, 1982, 117D HARV U JF KENN
   STOTO MA, 1983, J AM STAT ASSOC, V78, P13, DOI 10.2307/2287094
   TULJAPURKAR SD, CONT MATH AM MATH SO, V50
   TULJAPURKAR SD, 1980, THEOR POPUL BIOL, V18, P314, DOI 10.1016/0040-5809(80)90057-X
   TULJAPURKAR SD, 1982, THEOR POPUL BIOL, V21, P114, DOI 10.1016/0040-5809(82)90009-0
   *UN, 1983, 1981 DEM YB
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
NR 46
TC 48
Z9 50
PU POPULATION ASSN AMER
PI WASHINGTON
PA 1722 N ST NW, WASHINGTON, DC 20036
SN 0070-3370
J9 DEMOGRAPHY
JI Demography
PD FEB
PY 1986
VL 23
IS 1
BP 105
EP 126
DI 10.2307/2061412
PG 22
WC Demography
SC Demography
GA A1254
UT WOS:A1986A125400010
PM 3484356
ER

PT J
AU BERARDI, RS
AF BERARDI, RS
TI PARADUODENAL HERNIAS
SO SURGERY GYNECOLOGY & OBSTETRICS
LA English
DT Review
RP BERARDI, RS (reprint author), VET ADM MED CTR,SURG SERV,DES MOINES,IA, USA.
CR Achour H, 1975, Chirurgie, V101, P954
   ALEXANDER FK, 1976, PA MED, V79, P76
   Andrews E, 1923, SURG GYNECOL OBSTET, V37, P740
   Azouz E M, 1976, J Can Assoc Radiol, V27, P108
   BARTLETT JD, 1971, SURG GYNECOL OBSTETR, V132, P443
   BARTLETT MK, 1968, ANN SURG, V168, P249, DOI 10.1097/00000658-196808000-00010
   BATSON OV, 1955, SURG CLIN N AM, V35, P1527
   Baumeister C, 1938, ARCH SURG-CHICAGO, V37, P327
   BELLTHOMSON J, 1977, AM J GASTROENTEROL, V68, P254
   BERENS JJ, 1963, ARCH SURG-CHICAGO, V86, P726
   BOTTOMS R, 1965, Med J Aust, V1, P467
   BURNHAM P J, 1953, J Int Coll Surg, V20, P753
   Callander CL, 1935, SURG GYNECOL OBSTET, V60, P1052
   Camprodon R, 1973, Rev Esp Enferm Apar Dig, V39, P449
   Cappiello R, 1967, Ann Ital Chir, V43, P527
   Cardoen G, 1975, Tijdschr Gastroenterol, V18, P197
   Case JT, 1926, J AMER MED ASSOC, V87, P891
   CHAURASIA BD, 1975, ACTA ANAT, V91, P305
   CISZEWSK.E, 1971, POL REV RADIOL NUCL, V35, P563
   Cogswell HD, 1941, ANN SURG, V114, P1035
   COOPER A, CITED INDIRECTLY
   COOPWOOD TB, 1972, SOUTHERN MED J, V65, P1138
   Dacka E, 1977, Pol Przegl Chir, V49, P69
   DAVIS R, 1975, AM J SURG, V129, P570, DOI 10.1016/0002-9610(75)90318-9
   Deffrenne P, 1969, Minerva Pediatr, V21, P1288
   Desjardins AU, 1918, ANN SURG, V67, P195, DOI 10.1097/00000658-191802000-00011
   Dott NM, 1923, BRIT J SURG, V11, P251, DOI 10.1002/bjs.1800114207
   Dutkiewicz A, 1976, Pol Przegl Chir, V48, P1431
   EPPINGER H, 1870, HERNIA RETROPERITONE, P127
   ESTRADA RL, 1958, ANOMALIES INTESTINAL
   Exner FB, 1933, AM J ROENTGENOL RADI, V29, P585
   FILTZER H, 1973, SURG CLIN N AM, V53, P371
   FINDLAY C W Jr, 1956, Surg Gynecol Obstet, V103, P417
   FRAZER JE, 1915, J ANAT PHYSL, V57, P75
   FREUND H, 1977, ARCH SURG-CHICAGO, V112, P1180
   GARDINER GA, 1959, AMER J ROENTGENOL RA, V82, P1038
   GARDNER CE, 1950, ANN SURG, V131, P879, DOI 10.1097/00000658-195006000-00009
   Garza R, 1968, Tex Med, V64, P46
   Gillet M, 1970, Chirurgie, V96, P431
   GRUBER W, 1863, OESTERR Z PRAKT HEIL, V9, P18
   Guibé J P, 1966, Ann Chir, V20, P736
   GUIVARCH M, 1972, CHIRURGIE, V98, P788
   Hansmann GH, 1939, ARCH SURG-CHICAGO, V39, P973
   HARDOUIN J P, 1968, Semaine des Hopitaux de Paris, V44, P1949
   HAYMOND HE, 1931, SURG GYNECOL OBSTET, V53, P316
   Houghton PW, 1942, BRIT J SURG, V29, P360, DOI 10.1002/bjs.18002911519
   Hudson HW, 1941, NEW ENGL J MED, V225, P4, DOI 10.1056/NEJM194107032250102
   Inberg M V, 1970, Duodecim, V86, P680
   JONES TW, 1964, HERNIA, P577
   JONNESCO T, 1889, ANATOMIE TOPOGRAPHIQ
   JONNESCO T, 1890, HERNIES INTERNES RET
   KLOB JM, 1861, WBL Z KK GESELLSCH A, V24
   KONDI ES, 1975, ANN SURG, V181, P442, DOI 10.1097/00000658-197504000-00013
   KRISS N, 1965, NEW YORK STATE J MED, V65, P2482
   KUMMER E, 1921, J RADIOL ELECT, V5, P362
   KYOSOLA K, 1973, ANN CHIR GYNAECOL FE, V62, P98
   LAHEY FH, 1945, ANN SURG, V122, P436, DOI 10.1097/00000658-194509000-00008
   LAMPHIER TA, 1961, NEW YORK STATE J MED, V61, P3332
   LANDZERT T, 1871, MED Z NEUE FOLGE, V2, P350
   Lebel M, 1965, Mem Acad Chir (Paris), V91, P1102
   Longacre JJ, 1934, SURG GYNECOL OBSTET, V59, P165
   LUOSTO R, 1978, ACTA CHIR SCAND, V144, P263
   MALL FP, 1898, B J HOPKINS HOSP, V9, P197
   MARCHAND M, 1974, J CHIR-PARIS, V108, P435
   MAWUPEVOVOR V, 1959, LYON CHIR, V55, P701
   Mayo CW, 1941, ANN SURG, V114, P875, DOI 10.1097/00000658-194111000-00008
   MECKEL JF, 1816, HDB PATHOL ANAT, V2, P470
   MEYERS MA, 1969, RADIOLOGY, V92, P1035
   MEYERS MA, 1970, RADIOLOGY, V95, P29
   MICHIELS G, 1978, ACTA CHIR BELG, V77, P171
   Mikhail L W, 1975, J Egypt Med Assoc, V58, P593
   Miller Joseph M., 1942, AMER JOUR DIGEST DIS, V9, P383
   MOYNIHAN BGA, 1889, BRIT MED J
   Nagel GW, 1923, J AMER MED ASSOC, V81, P907
   Naqvi M A, 1970, N S Med Bull, V49, P37
   NEUBAUER JE, 1786, OPERA ANATOMICA COLL
   OLEARCHYK AS, 1979, MIL MED, V144, P192
   Papez JW, 1932, ANAT REC, V54, P197, DOI 10.1002/ar.1090540209
   PELTOKAL.P, 1968, AM J SURG, V115, P367, DOI 10.1016/0002-9610(68)90162-1
   Pistacchi E, 1967, Minerva Chir, V22, P511
   POPKY GL, 1966, RADIOLOGY, V86, P327
   RANSLEY PG, 1973, BRIT J SURG, V60, P323, DOI 10.1002/bjs.1800600416
   ROBERTS HW, 1966, ANAT REC, V155, P279
   RUBIN SZ, 1976, J PEDIATR SURG, V11, P205, DOI 10.1016/0022-3468(76)90288-8
   Sahariah S, 1976, J Indian Med Assoc, V66, P184
   SCHAEFER CE, 1968, AM J SURG, V116, P847, DOI 10.1016/0002-9610(68)90454-6
   Shaffner L de S, 1971, Surg Clin North Am, V51, P1355
   Sims W G, 1971, J Med Assoc Ga, V60, P105
   SINGH S, 1971, CAN J SURG, V14, P148
   SNYDER WH, 1956, SURG CLIN N AM, V36, P1479
   Sokolić J, 1973, Lijec Vjesn, V95, P141
   Steinke CR, 1932, ARCH SURG-CHICAGO, V25, P909
   TANNY A J, 1961, J Int Coll Surg, V35, P176
   Taylor J, 1930, BRIT J SURG, V17, P639, DOI 10.1002/bjs.1800176808
   TESSON JA, 1957, AM J SURG, V93, P470, DOI 10.1016/0002-9610(57)90844-9
   THOREN L, 1978, ACTA CHIR SCAND, V144, P267
   TOLDT C, 1879, MED WCHNSCHR, V4, P225
   Treitz W, 1857, HERNIA RETROPERITONE
   TREVES F, 1885, ANATOMY INTESTINAL C
   WALDEYER H, 1868, HERNIA RETROPERITONE
   WILKINSO.GW, 1971, CAN J SURG, V14, P151
   WILLIAMS A. JUSTIN, 1951, CALIFORNIA MED, V74, P22
   WILLIAMS AJ, 1952, RADIOLOGY, V59, P817
   WILLWERT.BM, 1974, AM J SURG, V128, P358, DOI 10.1016/0002-9610(74)90173-1
   Yadav S N, 1977, J Indian Med Assoc, V68, P36
   ZIMMERMAN LM, 1953, ANN SURG, V138, P82, DOI 10.1097/00000658-195307000-00010
   ZISKIND J, 1940, SO SURG, V9, P175
   ZOLLINGER RM, 1978, HERNIA, P488
NR 108
TC 48
Z9 48
PU FRANKLIN H MARTIN FOUNDATION
PI CHICAGO
PA 55 E ERIE ST, CHICAGO, IL 60611
SN 0039-6087
J9 SURG GYNECOL OBSTET
JI Surg. Gynecol. Obstet.
PY 1981
VL 152
IS 1
BP 99
EP 110
PG 12
WC Obstetrics & Gynecology; Surgery
SC Obstetrics & Gynecology; Surgery
GA KY199
UT WOS:A1981KY19900025
PM 7006131
ER

PT J
AU Lee, BB
   Bergan, J
   Gloviczki, P
   Laredo, J
   Loose, DA
   Mattassi, R
   Parsi, K
   Villavicencio, JL
   Zamboni, P
AF Lee, B. B.
   Bergan, J.
   Gloviczki, P.
   Laredo, J.
   Loose, D. A.
   Mattassi, R.
   Parsi, K.
   Villavicencio, J. L.
   Zamboni, P.
TI Diagnosis and treatment of venous malformations Consensus Document of
   the International Union of Phlebology (IUP)-2009
SO INTERNATIONAL ANGIOLOGY
LA English
DT Article
ID KLIPPEL-TRENAUNAY-SYNDROME; CONGENITAL VASCULAR MALFORMATIONS;
   BUDD-CHIARI-SYNDROME; INFERIOR VENA-CAVA; ARTERIOVENOUS SHUNTING
   MALFORMATION; SODIUM TETRADECYL SULFATE; SOFT-TISSUE HEMANGIOMAS;
   BLOOD-POOL SCINTIGRAPHY; JUGULAR-VEIN ANEURYSM; PERCUTANEOUS
   SCLEROTHERAPY
C1 [Lee, B. B.; Laredo, J.] Georgetown Univ, Sch Med, Ctr Vein Lymphat & Vasc Malformat, Div Vasc Surg,Dept Surg, Washington, DC USA.
   [Bergan, J.] Univ Calif San Diego, Dept Surg, UCSD Sch Med, San Diego, CA 92103 USA.
   [Gloviczki, P.] Mayo Clin, Div Vasc & Endovasc Surg, Coll Med, Dept Surg, Rochester, MN USA.
   [Gloviczki, P.] Mayo Clin, Gonda Vasc Ctr, Rochester, MN USA.
   [Loose, D. A.] Facharztklin Hamburg, Dept Vasc Surg, European Ctr Diag & Treatment Vasc Malformat, Hamburg, Germany.
   [Mattassi, R.] G Salvini Hosp, Dept Vasc Surg, Stefan Belov Ctr Vasc Malformat, Milan, Italy.
   [Parsi, K.] Australian Coll Phlebol, Sydney, NSW, Australia.
   [Parsi, K.] Univ New S Wales, Sydney, NSW 2052, Australia.
   [Villavicencio, J. L.] Uniformed Serv Univ Hlth Sci, Dept Surg, Sch Med, Bethesda, MD 20814 USA.
   [Villavicencio, J. L.] Walter Reed Army Med Ctr, Venous & Lymphat Teaching Clin, Bethesda, MD USA.
   [Zamboni, P.] Univ Ferrara, Vasc Dis Ctr, I-44100 Ferrara, Italy.
RP Lee, BB (reprint author), Georgetown Univ, Sch Med, Ctr Vein Lymphat & Vasc Malformat, Div Vasc Surg,Dept Surg, Washington, DC USA.
EM bblee38@comcast.net
RI Parsi, Kurosh/D-2060-2012
CR ACSADY G, 1986, WHAT IS NEW ANGIOLOG, P457
   Allegra C, 2002, LYMPHOLOGY, V35, P114
   Andreev A, 1998, INT ANGIOL, V17, P272
   Avram J, 1966, Phlebologie, V19, P157
   BAKER LL, 1993, AM J NEURORADIOL, V14, P307
   BARTON DJ, 1992, PLAST RECONSTR SURG, V89, P53
   BARTON DJ, 1992, PLAST RECONSTR SURG, V89, P46, DOI 10.1097/00006534-199289010-00008
   Bastide G, 1989, VASCULAR MALFORMATIO, P20
   BAULIEU F, 1989, LYMPHOLOGY, V22, P178
   BELOV S, 1990, INT ANGIOL, V9, P155
   BELOV S, 1990, INT ANGIOL, V9, P175
   Belov S, 1993, Semin Vasc Surg, V6, P245
   BELOV S, 1972, J CARDIOVASC SURG, V13, P594
   BELOV S, 1990, INT ANGIOL, V9, P141
   Belov S., 1989, VASCULAR MALFORMATIO, P25
   BELOV ST, 1989, PERIODICA ANGIOLOGIC, V16, P138
   BELOV ST, 1986, WHAT IS NEW ANGIOLOG, P249
   Belov S, 1993, Semin Vasc Surg, V6, P219
   BELOV ST, TXB ANGIOLOGY, P1284
   BELOV ST, 1989, ADV VASCULAR PATHOLO, V2, P1355
   Belov St, 1992, PROGR ANGIOLOGY, P379
   Bergan J, 2006, J CARDIOVASC SURG, V47, P9
   Bergan J, 2007, PHLEBOLOGY, V22, P299, DOI 10.1258/026835507782655281
   Berwald C, 2006, Ann Chir Plast Esthet, V51, P369, DOI 10.1016/j.anplas.2006.07.020
   BLEI F, 2009, ANN NY ACAD SCI, V1131, P185
   Boon LM, 1996, J PEDIATR, V128, P329, DOI 10.1016/S0022-3476(96)70276-7
   Bush S, 1999, EUR J PEDIATR SURG, V9, P47, DOI 10.1055/s-2008-1072212
   BYARD RW, 1991, EUR J PEDIATR, V150, P224, DOI 10.1007/BF01955516
   Cabrera J, 2003, ARCH DERMATOL, V139, P1409, DOI 10.1001/archderm.139.11.1409
   Choi JY, 1997, KOREAN J NUCL MED, V31, P262
   Choi JY, 1999, KOREAN J NUCL MED, V33, P143
   Coleridge Smith P., 2005, SEMIN VASC SURG, V18, P19, DOI 10.1053/j.semvascsurg.2004.12.007
   CONAWAY CW, 1989, SURG MANAGEMENT KLIP
   de Takats G, 1932, SURG GYNECOL OBSTET, V55, P227
   DICKINSON PHILIP H., 1953, EXPTL MED AND SURG, V11, P49
   Do YS, 2005, RADIOLOGY, V235, P674, DOI 10.1148/radiol.2352040449
   Dobson MJ, 1997, CLIN RADIOL, V52, P595, DOI 10.1016/S0009-9260(97)80251-6
   Donnelly LF, 1999, AM J ROENTGENOL, V173, P655
   Dragieva G, 2003, VASA-J VASCULAR DIS, V32, P159, DOI 10.1024/0301-1526.32.3.159
   Dubois J, 1998, AM J ROENTGENOL, V171, P247
   DUBOIS JM, 1991, RADIOLOGY, V180, P195
   Eifert Sandra, 2000, Journal of Vascular Surgery, V31, P462, DOI 10.1016/S0741-5214(00)90306-9
   Elsayes KM, 2008, AM J ROENTGENOL, V190, P1291, DOI 10.2214/AJR.07.2779
   Enjolras O, 2000, TXB PEDIAT DERMATOLO, P975
   ENJOLRAS O, 1990, PEDIATRICS, V85, P491
   Enjolras O, 1997, J PEDIATR, V130, P631, DOI 10.1016/S0022-3476(97)70249-X
   FINN MC, 1983, J PEDIATR SURG, V18, P894
   Fishman G, 2004, BRIT J PLAST SURG, V57, P165, DOI 10.1016/j.bjps.2003.11.032
   Franzeck UK, 1997, J VASC RES, V34, P306, DOI 10.1159/000159238
   FRIEDMAN SG, 1990, SURGERY, V108, P92
   FRONT D, 1984, SEMIN NUCL MED, V14, P226, DOI 10.1016/S0001-2998(84)80017-3
   Fukuda Y, 1999, CLIN NUCL MED, V24, P232, DOI 10.1097/00003072-199904000-00002
   Gelbert F, 2000, NEURORADIOLOGY, V42, P692
   GELBERT F, 1991, JMRI-J MAGN RESON IM, V1, P579, DOI 10.1002/jmri.1880010511
   Gillespie DL, 1997, J VASC SURG, V26, P845, DOI 10.1016/S0741-5214(97)70099-5
   Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409
   GLOVICZKI P, 1983, ANN SURG, V197, P353, DOI 10.1097/00000658-198303000-00017
   GLOVICZKI P, 2008, HDB VENOUS DISORDERS, P702
   GLOVICZKI P, 2009, VASCULAR MALFORMATIO, V21, P133
   Gloviczki P, 2007, PHLEBOLOGY, V22, P291, DOI 10.1258/026835507782655209
   GLOVICZKI P, 1991, SURGERY, V110, P469
   Hancock BJ, 1992, J PEDIATR SURG, V27, P224
   HANCOCK BJ, 1992, J PEDIATR SURG, V27, P220, DOI 10.1016/0022-3468(92)90316-Y
   Harisinghani MG, 2004, RADIOGRAPHICS, V24, P867, DOI 10.1148/rg.243035190
   Herborn CU, 2003, AM J ROENTGENOL, V181, P729
   Hirooka K, 2008, INTERNAL MED, V47, P91, DOI 10.2169/internalmedicine.47.0501
   HOLLERMAN JJ, 1986, CLIN NUCL MED, V11, P716, DOI 10.1097/00003072-198610000-00012
   HUBSCH P, 1991, ULTRASCHALL MED, V12, P87, DOI 10.1055/s-2007-1003976
   Hulsmanns RFJ, 1995, SCOPE PHLEBOL LYMPHO, V2, P8
   Hyodoh H, 2005, RADIOGRAPHICS, V25, pS159, DOI 10.1148/rg.25si055509
   Ilijevski NS, 2006, VASC MED, V11, P51, DOI 10.1191/1358863x06vm638xx
   Ilijevski NS, 2008, VASCULAR, V16, P291, DOI 10.2310/6670.2008.00022
   Inoue Y, 1996, CLIN NUCL MED, V21, P958, DOI 10.1097/00003072-199612000-00008
   JACKSON IT, 1993, PLAST RECONSTR SURG, V91, P1216, DOI 10.1097/00006534-199306000-00006
   Jacob AG, 1998, MAYO CLIN PROC, V73, P28
   JEON YH, 2003, J KOR RADIOL SOC, V49, P263
   Kern S, 2000, ACTA RADIOL, V41, P453, DOI 10.1080/028418500127345677
   Kersting S, 2008, VASA-J VASCULAR DIS, V37, P371, DOI [10.1024/0301-1526.37.4.371, 10.1024/0301.1526.37.4.371]
   KIM KH, 2001, J KOREAN ASS PEDIAT, V7, P142
   Kim YW, 2007, EUR J VASC ENDOVASC, V33, P122, DOI 10.1016/j.ejvs.2006.06.025
   Kim YW, 2006, J VASC SURG, V44, P545, DOI 10.1016/j.jvs.2006.05.035
   Klippel M, 1900, ARCHIVES GENERALES M, V3, P641
   Laor T, 1998, Magn Reson Imaging Clin N Am, V6, P497
   Lee A, 2005, PEDIATRICS, V115, P744, DOI 10.1542/peds.2004-0446
   Lee B B, 2005, Vasc Endovascular Surg, V39, P67, DOI 10.1177/153857440503900107
   LEE BB, 2005, J VASC SURG, V4, P821
   LEE BB, 2008, TXB PERIPHERAL VASCU, P712
   LEE BB, 2007, PHLEBOLOGY, P22258
   Lee BB, 2005, PHLEBOLOGY, V20, P28, DOI 10.1258/0268355053300875
   Lee BB, 2005, INT ANGIOL, V24, P173
   LEE BB, 2008, TXB PERIPHERAL VASCU, P725
   Lee BB, 2004, ANN VASC SURG, V18, P380, DOI 10.1007/s10016-004-0020-y
   Lee BB, 2007, PHLEBOLOGY, V22, P253, DOI 10.1258/026835507782655245
   Lee BB, 2004, INT J ANGIOL, V13, P182, DOI 10.1007/s00547-005-2009-y
   Lee BB, 2003, INT J ANGIOL, V12, P248
   Lee BB, 2005, EUR J VASC ENDOVASC, V30, P184, DOI 10.1016/j.ejvs.2004.10.006
   Lee BB, 2002, LYMPHOLOGY S, V35, P450
   Lee BB, 2005, LYMPHOLOGY, V38, P122
   LEE BB, 2003, CAPITOLO, V19, P116
   Lee BB, 2009, HDB VENOUS DISORDERS, P583
   LEE BB, 2003, VASCULAR SURG CASES, P315
   Lee BB, 2001, J VASC SURG, V33, P764, DOI 10.1067/mva.2001.112209
   Lee BB, 1999, ASIAN J SURG, V22, P152
   Lee BB, 2006, J VASC SURG, V43, P101, DOI 10.1016/j.jvs.2005.09.003
   Lee BB, 2004, J AM COLL SURGEONS, V198, P549, DOI 10.1016/j.jamcollsurg.2003.12.013
   Lee BB, 2003, PHLEBOLYMPHOLOGY, V43, P197
   Lee BB, 2003, ANGIOLOGIE, V55, P17
   Lee BB, 2005, PHLEBOLYMPHOLOGY, V47, P324
   Lee BB, 2003, J KOR SOC VASC SURG, V19, P121
   LEE BB, 2006, VASCULAR SURG, P377, DOI 10.1007/1-84628-211-X_42
   Lee BB, 2002, INT ANGIOL, V21, P209
   LEE BB, 2008, LYMPHATIC MALFORMATI, pCH4
   LEE BB, 1998, ADV PHLEBOLOGY, P59
   Lee BB, 2008, J VASC SURG, V48, P775, DOI 10.1016/j.jvs.2008.04.072
   LEE BB, 2004, ANGIOLOGIE, V56, P11
   Lee BB, 2007, PHLEBOLOGY, V22, P249, DOI 10.1258/026835507782655236
   Lee BB, 2003, J VASC SURG, V37, P533, DOI 10.1067/mva.2003.91
   Lee BB, 2005, J AM COLL SURGEONS, V200, P638, DOI 10.1016/j.jamcollsurg.2004.12.008
   Lee BB, 2004, INT ANGIOL, V23, P355
   Lee Byung-Boong Bb, 2008, Ann Vasc Dis, V1, P11, DOI 10.3400/avd.AVDsc00207
   LEE BB, 2002, J CARDIOVASC SURG, V10, P523
   Lee BB, 2007, FAST FACTS VASCULAR, P42
   Lee BB, 2003, INT ANGIOL, V22, P328
   Lee BB, 2006, ARTERIOVENOUS MALFOR, P597
   Lee HY, 2007, J CLIN ULTRASOUND, V35, P94, DOI 10.1002/jcu.20263
   Lee JI, 2009, LIVER INT, V29, P231, DOI 10.1111/j.1478-3231.2008.01815.x
   LERICHE A, 1976, ACTA RADIOL S, V347, P415
   Leu HJ, 1989, VASCULAR MALFORMATIO, P37
   LEU HJ, 1990, INT ANGIOL, V9, P147
   Leu H J, 1982, Morphol Med, V2, P99
   Lewis FT, 1906, AM J ANAT, V5, P113
   LIM SW, 1998, J KOREAN VASCULAR SU, V14, P304
   Lo Casto A, 2003, DENTOMAXILLOFAC RAD, V32, P333, DOI 10.1259/dmfr/73824372
   LOHRMANN C, 2008, MICROVASC RES, P42
   LOOSE DA, 2000, TXB ANGIOLOGY, P1278
   Loose DA, 1991, PROGR ANGIOLOGY, P373
   Loose D A, 1993, Semin Vasc Surg, V6, P260
   LOOSE DA, 2001, CHIR PIEDE, V25, P1
   LOOSE DA, 1993, PERIPHERAL ARTERIAL, P1025
   Loose DA, 2007, PHLEBOLOGY, V22, P276, DOI 10.1258/026835507782655254
   LOOSE DA, 2000, TXB ANGIOLOGY, P1248
   LOOSE DA, 1997, SURGERY, V15, P39
   LOOSE DA, 1997, FORUM FL, V2, P101
   LOOSE DA, 1994, GEFASSKRANKHEITEN
   Mahesh B, 2003, CLIN IMAG, V27, P171, DOI 10.1016/S0899-7071(02)00503-X
   MALAN E, 1974, VASCULAR MALFORMATIO, P30
   MALAN E, 1965, J CARDIOVASC SURG, V6, P255
   Mattassi R, 1993, Semin Vasc Surg, V6, P233
   MATTASSI R, 2009, HEMANGIOMAS VASCULAR, P9, DOI 10.1007/978-88-470-0569-3_2
   MATTASSI R, 2009, VASCULAR MALFORMATIO
   MATTASSI R, 2005, PRZEGLAD FLEBOLOGICZ, V13, P145
   Mattassi R, 1992, PROGR ANGIOLOGY, P383
   MATTASSI R, 1990, INT ANGIOL, V9, P196
   MATTASSI R, 1993, VASCULAR SURG, P397
   Mattassi R, 2007, PHLEBOLOGY, V22, P283, DOI 10.1258/026835507782655218
   Mattassi R, 2009, HEMANGIOMAS VASCULAR
   Mattassi R, 2007, PHLEBOLOGY, V22, P287, DOI 10.1258/026835507782655263
   MATTASSI R, 1989, VASCULAR MALFORMATIO, P202
   Mattassi R, 2009, HEMANGIOMAS VASCULAR, P223, DOI 10.1007/978-88-470-0569-3_28
   MCNEILL GC, 2002, LYMPHOLOGY S, V35, P219
   Menegatti E, 2008, CURR NEUROVASC RES, V5, P260, DOI 10.2174/156720208786413442
   Mimura H, 2003, ACTA MED OKAYAMA, V57, P227
   Mulliken J B, 1993, Semin Vasc Surg, V6, P204
   MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002
   Mulliken JB, 1988, VASCULAR BIRTHMARKS, P24
   MULLIKEN JB, 1982, SURGERY, V92, P348
   Napoli A, 2004, J COMPUT ASSIST TOMO, V28, pS32, DOI 10.1097/01.rct.0000120859.80935.10
   NEDELMANN M, 2009, J NEUROL
   Noel AA, 2000, J VASC SURG, V32, P840, DOI 10.1067/mva.2000.110343
   ODonovan JC, 1997, AM J ROENTGENOL, V169, P723
   Offergeld C, 1998, LARYNGO RHINO OTOL, V77, P342, DOI 10.1055/s-2007-996985
   Orvidas LJ, 2000, ANN OTO RHINOL LARYN, V109, P411
   Paltiel HJ, 2000, RADIOLOGY, V214, P747
   PARK JH, 1998, J KOREAN VASCULAR SU, V14, P300
   Weber FP, 1907, BRIT J DERMATOL, V19, P231
   PARSI K, 2006, 16 INT WORKSH VASC A, P66
   Pascarella L, 2005, ANN VASC SURG, V19, P457, DOI 10.1007/s10016-005-4656-z
   Puig S, 2005, EUR J RADIOL, V53, P35, DOI 10.1016/j.ejrad.2004.07.023
   Raju S, 2006, J VASC SURG, V44, P820, DOI 10.1016/j.jvs.2006.05.054
   RAK KM, 1992, AM J ROENTGENOL, V159, P107
   RICHE MC, 1983, PLAST RECONSTR SURG, V71, P607, DOI 10.1097/00006534-198305000-00003
   Rimon U, 2004, EUR J RADIOL, V52, P283, DOI 10.1016/j.ejrad.2003.09.010
   Rosenblatt M, 2007, PHLEBOLOGY, V22, P264, DOI 10.1258/026835507782655290
   RUBIN PAD, 1995, AM J NEURORADIOL, V16, P1255
   Ruiz DS, 2002, AM J NEURORADIOL, V23, P1500
   Rutherford RB., 1995, CURRENT THERAPY VASC, P834
   Rutherford R B, 1993, Semin Vasc Surg, V6, P225
   RUTHERFORD RB, 1989, VASCULAR MALFORMATIO, V16, P60
   Schreiber SJ, 2003, J APPL PHYSIOL, V94, P1802, DOI 10.1152/japplphysiol.00782.2002
   SERVELLE M, 1985, ANN SURG, V201, P365, DOI 10.1097/00000658-198503000-00020
   Servelle M, 1980, Phlebologie, V33, P31
   Shin BS, 2005, RADIOLOGY, V235, P1072, DOI 10.1148/radiol.2353040903
   Sidhu MK, 2005, J VASC INTERV RADIOL, V16, P879, DOI 10.1097/01.RVI.0000163005.50283.62
   Siniluoto TMJ, 1997, SCAND J PLAST RECONS, V31, P145
   SLOAN GM, 1988, ANN PLAS SURG, V21, P236, DOI 10.1097/00000637-198809000-00008
   SMITH JK, 1995, CLIN IMAG, V19, P109
   SOLTESZ L, 1965, J CARDIOVAS SURG S, V5
   STAL S, 1986, OTOLARYNG CLIN N AM, V19, P769
   Stein Jennifer A, 2008, Dermatol Online J, V14, P7
   STILLO F, 1998, ANGIOLOGIE, V50, P30
   SZILAGYI DE, 1976, ARCH SURG-CHICAGO, V111, P423
   SZILAGYI DE, 1965, SURGERY, V57, P61
   TASNADI G, 1998, LYMPHOLOGY S, V31, P381
   Tasnádi G, 1993, Semin Vasc Surg, V6, P200
   Timmerman D, 2003, ULTRASOUND OBST GYN, V21, P529
   Trop I, 1999, RADIOLOGY, V212, P841
   Tzuladze II, 1999, ZH VOPR NEIROKHIR N, V2, P8
   Valdueza JM, 2000, LANCET, V355, P200
   Valla DC, 2009, J HEPATOL, V50, P195, DOI 10.1016/j.jhep.2008.10.007
   van der Linden E, 2005, J VASC INTERV RADIOL, V16, P747, DOI 10.1097/01.RVI.0000157245.60426.7B
   VANDERSTRICHT J, 1989, VASCULAR MALFORMATIO, P23
   Vargel I, 2004, BRIT J RADIOL, V77, P197, DOI 10.1259/bjr/88438281
   VILLAVICENCIO IL, 2008, SURG MANAGEMENT VENO
   VILLAVICENCIO JL, 2001, J VASC SURG, V33, P1
   Villavicencio J Leonel, 2002, Semin Vasc Surg, V15, P65, DOI 10.1053/svas.2002.30450
   VILLAVICENCIO JL, 1993, COMPLEX PROBLEMS INV, P329
   Villavicencio JL, 2007, PHLEBOLOGY, V22, P247, DOI 10.1258/026835507782655191
   Villavicencio JL, 2000, SCOPE PHLEBOLOGY LYM, V71, P116
   VILLAVICENCIO JL, 2006, VENOUS ARTERIAL MALF, P28
   VILLAVICENCIO JL, 1997, SURG MANAGEMENT VENO, P445
   VILLAVICENCIO JL, 2000, CIRCULATION, V102
   VILLAVICENCIO JL, 1999, CURRENT THERAPY VASC
   VOLLMAR J, 1976, CHIRURG, V47, P205
   VOLLMAR J, 1979, VASA-J VASCULAR DIS, V8, P192
   WANER M, 1999, HEMANGIOMAS VASCULAR, P13
   Weber J, 2006, VASA-J VASCULAR DIS, V35, P67, DOI 10.1024/0301-1526.35.2.67
   WILLIAMS WH, 2002, LYMPHOLOGY S, V35, P223
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   Woolard HH, 1922, CONTRIBUTIONS EMBRYO, V14, P139
   Xu K, 1996, CARDIOVASC INTER RAD, V19, P32, DOI 10.1007/s002709900006
   Yamaki T, 2002, DERMATOL SURG, V28, P619, DOI 10.1046/j.1524-4725.2002.01311.x
   YONETSU K, 1993, ORAL SURG ORAL MED O, V76, P783, DOI 10.1016/0030-4220(93)90052-6
   ZAMBONI P, 2009, J NEUROL SCI
   Zamboni P, 1990, PHLEBOLOGY, V5, P45
   Zamboni P, 1996, J CARDIOVASC SURG, V37, P583
   Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164
   Zamboni P, 2009, VASCULAR ENDOVASCULA, P71
   Ziyeh S, 2004, EUR RADIOL, V14, P2025, DOI 10.1007/s00330-004-2274-8
NR 238
TC 47
Z9 49
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0392-9590
J9 INT ANGIOL
JI Int. Angiol.
PD DEC
PY 2009
VL 28
IS 6
BP 434
EP 451
PG 18
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 582QK
UT WOS:000276612600003
PM 20087280
ER

PT J
AU Kuusikko, S
   Haapsamo, H
   Jansson-Verkasalo, E
   Hurtig, T
   Mattila, ML
   Ebeling, H
   Jussila, K
   Bolte, S
   Moilanen, I
AF Kuusikko, Sanna
   Haapsamo, Helena
   Jansson-Verkasalo, Eira
   Hurtig, Tuula
   Mattila, Marja-Leena
   Ebeling, Hanna
   Jussila, Katja
   Boelte, Sven
   Moilanen, Irma
TI Emotion Recognition in Children and Adolescents with Autism Spectrum
   Disorders
SO JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
LA English
DT Article
DE Asperger syndrome; Development; Eye region; High-functioning autism;
   Interpretation; Self-esteem
ID HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; FACIAL EXPRESSIONS; SOCIAL
   COMPETENCE; FACES; PERCEPTION; RESPONSES; PROSODY; MIND; GESTURES
AB We examined upper facial basic emotion recognition in 57 subjects with autism spectrum disorders (ASD) (M = 13.5 years) and 33 typically developing controls (M = 14.3 years) by using a standardized computer-aided measure (The Frankfurt Test and Training of Facial Affect Recognition, FEFA). The ASD group scored lower than controls on the total scores of FEFA and perceived ambiguous stimuli more often as a negative emotion. The older ASD group (a parts per thousand yen12 years) performed better than the younger ASD group (< 12 years) on the blended emotions of FEFA. The results support the findings that individuals with ASD have difficulties in emotion recognition. However, older subjects with ASD seem to have better skills than younger subjects with ASD.
C1 [Kuusikko, Sanna; Haapsamo, Helena; Hurtig, Tuula; Mattila, Marja-Leena; Ebeling, Hanna; Jussila, Katja; Moilanen, Irma] Univ & Univ Hosp Oulu, Dept Child Psychiat, Inst Clin Med, Oys Oulu 90029, Finland.
   [Jansson-Verkasalo, Eira] Univ Oulu, Fac Humanities, Oulu, Finland.
   [Jansson-Verkasalo, Eira] Univ Hosp Oulu, Dept Clin Neurophysiol, Oulu, Finland.
   [Hurtig, Tuula] Univ Oulu, Inst Hlth Sci, Oulu, Finland.
   [Boelte, Sven] Univ Frankfurt, Dept Child & Adolescent Psychiat, D-60528 Frankfurt, Germany.
RP Kuusikko, S (reprint author), Univ & Univ Hosp Oulu, Dept Child Psychiat, Inst Clin Med, POB 26, Oys Oulu 90029, Finland.
EM kuusisan@paju.oulu.fi
CR ALBERTOWSKI K, 2007, 1 WISS TAG AUT SPEKT, P35
   Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014
   ATTWOOD A, 1988, J AUTISM DEV DISORD, V18, P241, DOI 10.1007/BF02211950
   Back E, 2007, CHILD DEV, V78, P397, DOI 10.1111/j.1467-8624.2007.01005.x
   BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8
   Beck A. J., 1976, COGNITIVE THERAPY EM
   Bolte S., 2003, FRANKFURTER TEST TRA
   Bolte S, 2003, PSYCHOL MED, V33, P907, DOI 10.1017/S0033291703007438
   Bolte S, 2008, J AUTISM DEV DISORD, V38, P776, DOI 10.1007/s10803-007-0443-8
   Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211
   Boraston Z, 2007, NEUROPSYCHOLOGIA, V45, P1501, DOI 10.1016/j.neuropsychologia.2006.11.010
   Buitelaar JK, 1999, DEV PSYCHOPATHOL, V11, P39, DOI 10.1017/S0954579499001947
   Castelli F, 2005, AUTISM, V9, P428, DOI 10.1177/1362361305056082
   CUSTRINI RJ, 1989, J CLIN CHILD PSYCHOL, V18, P336, DOI 10.1207/s15374424jccp1804_7
   Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271
   Dawson G, 2004, DEVELOPMENTAL SCI, V7, P340, DOI 10.1111/j.1467-7687.2004.00352.x
   Ehlers S, 1999, J AUTISM DEV DISORD, V29, P129, DOI 10.1023/A:1023040610384
   Ekman P, 1976, PICTURES FACIAL AFFE
   EYSENK MW, 1992, ANXIETY COGNITIVE PE
   Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305
   Gross TF, 2004, J ABNORM CHILD PSYCH, V32, P469, DOI 10.1023/B:JACP.0000037777.17698.01
   Grossman JB, 2000, J CHILD PSYCHOL PSYC, V41, P369, DOI 10.1017/S0021963099005466
   Howlin P, 1999, DEV MED CHILD NEUROL, V41, P834, DOI 10.1017/S0012162299001656
   Kaland N, 2007, J AUTISM DEV DISORD, V37, P197, DOI 10.1007/s10803-006-0152-8
   Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809
   Klucharev V, 2004, NEUROREPORT, V15, P621, DOI 10.1097/01.wnr.0000116052.55437c1
   Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003
   Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2
   Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048
   KUUSIKKO S, 2008, PSYCHOMETRIC EVALUAT
   KUUSIKKO S, 2008, J AUTISM DEV DISORDE
   LAIHAIE A, 2006, NEUROPSYCHOLOGY, V20, P30, DOI DOI 10.1037/0894-4105.20.1.30
   Lindner JL, 2006, J AUTISM DEV DISORD, V36, P769, DOI 10.1007/s10803-006-0105-2
   Lord C., 2000, AUTISM DIAGNOSTIC OB
   LORD C, 1995, AUTISM DIAGNOSTIC IN
   MACDONALD H, 1989, J CHILD PSYCHOL PSYC, V30, P865, DOI 10.1111/j.1469-7610.1989.tb00288.x
   Mattila ML, 2007, J AM ACAD CHILD PSY, V46, P636, DOI 10.1097/chi.0b013e318033ff42
   Melfsen S, 2006, EUR CHILD ADOLES PSY, V15, P111, DOI 10.1007/s00787-006-0510-2
   MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75
   Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598
   Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369
   Rutherford MD, 2007, J AUTISM DEV DISORD, V37, P187, DOI 10.1007/s10803-006-0151-9
   SIGMAN MD, 1992, CHILD DEV, V63, P796, DOI 10.1111/j.1467-8624.1992.tb01662.x
   Silver M, 2001, AUTISM, V5, P299, DOI 10.1177/1362361301005003007
   Smith LS, 2007, DEV PSYCHOBIOL, V49, P543, DOI 10.1002/dev.20229
   Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865
   van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055
   Wechsler D, 1991, WECHSLER INTELLIGENC
   *WHO, 1993, 10 REV INT CLASS DIS
   WOODHEAD M, 1995, PERSONAL SOCIAL EMOT, P136
NR 50
TC 47
Z9 49
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0162-3257
J9 J AUTISM DEV DISORD
JI J. Autism Dev. Disord.
PD JUN
PY 2009
VL 39
IS 6
BP 938
EP 945
DI 10.1007/s10803-009-0700-0
PG 8
WC Psychology, Developmental
SC Psychology
GA 445ZL
UT WOS:000266089900012
PM 19205857
ER

PT J
AU Falagas, ME
   Vergidis, PI
AF Falagas, ME
   Vergidis, PI
TI Narrative review: Diseases that masquerade as infectious cellulitis
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Review
ID FAMILIAL MEDITERRANEAN FEVER; CUTANEOUS LUPUS-ERYTHEMATOSUS; DEEP VENOUS
   THROMBOSIS; FIXED DRUG ERUPTION; PERIFOLLICULITIS-CAPITIS-ABSCEDENS;
   NECROLYTIC MIGRATORY ERYTHEMA; INFLAMMATORY BREAST-CARCINOMA; CELL
   PROLYMPHOCYTIC LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; RELAPSING
   POLYCHONDRITIS
AB For cellulitis that does not respond to conventional antimicrobial treatment, clinicians should consider, among other explanations, several noninfectious disorders that might masquerade as infectious cellulitis. Diseases that commonly masquerade as this condition include thrombophlebitis, contact dermatitis, insect stings, drug reactions, eosinophilic cellulitis (the Wells syndrome), gouty arthritis, carcinoma erysipelatoides, familial Mediterranean fever, and foreign-body reactions. Diseases that uncommonly masquerade as infectious cellulitis include urticaria, lymphedema, lupus erythematosus, sarcoidosis, lymphoma, leukemia, Paget disease, and panniculitis. Clinicians should do an initial diagnostic work-up directed by the findings from a detailed history and complete physical examination. In many cases, skin biopsy is the only tool that helps identify the correct diagnosis. Special tests may also be needed.
C1 Alfa Healthcare, Athens 15123, Greece.
   Tufts Univ, Sch Med, Boston, MA 02111 USA.
RP Falagas, ME (reprint author), Alfa Healthcare, 9 Neapoleos St, Athens 15123, Greece.
EM matthew.falagas@tufts.edu
CR ALANKO K, 1994, CONTACT DERMATITIS, V31, P25, DOI 10.1111/j.1600-0536.1994.tb01900.x
   Alexander EK, 2002, CLIN ENDOCRINOL, V57, P827, DOI 10.1046/j.1365-2265.2002.01660.x
   [Anonymous], 2003, LYMPHOLOGY, V36, P84
   Antezana M, 2003, IMMUNOL ALLERGY CLIN, V23, P269, DOI 10.1016/S0889-8561(03)00027-4
   Arch-Ferrer JE, 2003, SURGERY, V134, P941, DOI 10.1016/S0039-6060(03)00430-6
   Ascher Enrico, 2003, Vasc Endovascular Surg, V37, P421, DOI 10.1177/153857440303700606
   Baddour LM, 2001, CUTIS, V68, P223
   Baker WF, 1998, MED CLIN N AM, V82, P459, DOI 10.1016/S0025-7125(05)70005-5
   Barzilai A, 2000, J AM ACAD DERMATOL, V42, P791, DOI 10.1067/mjd.2000.103048
   Bogenrieder T, 1997, BRIT J DERMATOL, V137, P978, DOI 10.1111/j.1365-2133.1997.tb01563.x
   Brook I, 2002, J MED MICROBIOL, V51, P808
   Bruce AJ, 2002, J AM ACAD DERMATOL, V46, P187, DOI 10.1067/mjd.2002.119101
   Burrall B, 1999, Dermatol Online J, V5, P8
   Callen JP, 2002, BEST PRACT RES CL RH, V16, P245, DOI 10.1053/berh.2001.0224
   Carrasco L, 2001, AM J DERMATOPATH, V23, P283, DOI 10.1097/00000372-200108000-00001
   Cavalli F, 1998, Ann Oncol, V9 Suppl 5, pS109
   CHEN K-R, 1989, Journal of Dermatology (Tokyo), V16, P429
   CHICARILLI ZN, 1987, ANN PLAS SURG, V18, P230, DOI 10.1097/00000637-198703000-00009
   Cohen JB, 2002, INT J DERMATOL, V41, P182, DOI 10.1046/j.1365-4362.2002.01409.x
   Cohen Philip R, 2002, Am J Clin Dermatol, V3, P117, DOI 10.2165/00128071-200203020-00005
   Cohen PR, 2003, INT J DERMATOL, V42, P761, DOI 10.1046/j.1365-4362.2003.01891.x
   COPEMAN PWM, 1985, J ROY SOC MED, V78, P43
   COPPOLA M, 1992, ANN EMERG MED, V21, P81, DOI 10.1016/S0196-0644(05)82246-2
   Crum NF, 2003, CUTIS, V71, P469
   CURTIN JP, 1990, GYNECOL ONCOL, V39, P374, DOI 10.1016/0090-8258(90)90269-Q
   Davis MDP, 2000, ARCH DERMATOL, V136, P330, DOI 10.1001/archderm.136.3.330
   DINARELL.CA, 1974, NEW ENGL J MED, V291, P934, DOI 10.1056/NEJM197410312911804
   DOMPMARTIN A, 1991, INT J DERMATOL, V30, P644, DOI 10.1111/j.1365-4362.1991.tb03491.x
   Erdmann SM, 2003, HAUTARZT, V54, P331, DOI 10.1007/s00105-003-0517-2
   Erhardt A, 2000, J HEPATOL, V33, P677, DOI 10.1034/j.1600-0641.2000.033004677.x
   Fabbri P, 2003, AM J CLIN DERMATOL, V4, P449, DOI 10.2165/00128071-200304070-00002
   Falagas ME, 2004, INT J CLIN PRACT, V58, P720, DOI 10.1111/j.1368-5031.2004.00269.x
   FALAGAS ME, IN PRESS CLIN MICROB
   FALANGA V, 1990, ARCH DERMATOL, V126, P609, DOI 10.1001/archderm.126.5.609
   Fanning J, 1999, AM J OBSTET GYNECOL, V180, P24, DOI 10.1016/S0002-9378(99)70143-2
   Fine A, 2002, KIDNEY INT, V61, P2210, DOI 10.1046/j.1523-1755.2002.00375.x
   FITZPATRICK BT, 2000, COLOR ATLAS SYNOPSIS
   Fonacier L, 2003, CURR ALLERGY ASTHM R, V3, P283, DOI 10.1007/s11882-003-0088-4
   Frazee BW, 1999, AM J EMERG MED, V17, P271, DOI 10.1016/S0735-6757(99)90123-7
   Fu W, 2001, AM J CLIN ONCOL-CANC, V24, P397, DOI 10.1097/00000421-200108000-00019
   Gniadecka M, 1998, J AM ACAD DERMATOL, V39, P966, DOI 10.1016/S0190-9622(98)70271-3
   GREEN AW, 1980, J ALLERGY CLIN IMMUN, V66, P186, DOI 10.1016/0091-6749(80)90037-8
   Guillevin L, 1998, ARTHRITIS RHEUM, V41, P2100, DOI 10.1002/1529-0131(199812)41:12<2100::AID-ART3>3.0.CO;2-J
   Gushi A, 2000, J Dermatol, V27, P778
   Hassink RI, 1997, EUR J PEDIATR, V156, P851, DOI 10.1007/s004310050728
   HAZELRIGG D E, 1977, Archives of Dermatology, V113, P69, DOI 10.1001/archderm.113.1.69
   Hope MJ, 2004, J ORTHOP TRAUMA, V18, P220, DOI 10.1097/00005131-200404000-00005
   Hughes Laura B, 2002, Curr Rheumatol Rep, V4, P75, DOI 10.1007/s11926-002-0027-8
   Johnson SM, 2003, J AM ACAD DERMATOL, V49, P325, DOI 10.1067/S0190-9622(02)61774-8
   Kacinski BM, 2001, ANN NY ACAD SCI, V941, P194
   Katta R, 2002, AM FAM PHYSICIAN, V65, P1581
   Kennedy D, 2001, EMERG MED CLIN N AM, V19, P869, DOI 10.1016/S0733-8627(05)70223-6
   KHAN AJ, 1994, CUTIS, V54, P98
   Khan JH, 1999, J AM ACAD DERMATOL, V41, P299, DOI 10.1016/S0190-9622(99)70369-5
   King R, 2001, ARCH DERMATOL, V137, P969
   KIRSNER RS, 1993, J AM ACAD DERMATOL, V28, P623
   Kjus T, 2003, ACTA DERM-VENEREOL, V83, P462, DOI 10.1080/00015550310015004
   Klosterhalfen B, 2003, EUR SURG, V35, P16, DOI 10.1046/j.1563-2563.2003.03011.x
   KURZROCK R, 1991, AM J MED, V91, P416, DOI 10.1016/0002-9343(91)90160-Y
   Langevitz P, 1999, ISRAEL MED ASSOC J, V1, P31
   LEDO A, 1985, J AM ACAD DERMATOL, V13, P1058, DOI 10.1016/S0190-9622(85)80504-1
   Letko E, 2002, SEMIN ARTHRITIS RHEU, V31, P384, DOI 10.1053/sarh.2002.32586
   Levin C, 2000, CONTACT DERMATITIS, V43, P317, DOI 10.1034/j.1600-0536.2000.043006317.x
   Loprinzi CL, 1996, MAYO CLIN PROC, V71, P552
   LUDWIG RJ, 2003, J AM ACAD DERMATOL, V48, pS
   Mahboob A, 1998, INT J DERMATOL, V37, P833, DOI 10.1046/j.1365-4362.1998.00451.x
   MAJEED HA, 1990, Q J MED, V75, P607
   MALLETT RB, 1995, BRIT J DERMATOL, V132, P263
   Marshall JK, 2003, CANCER, V97, P2142, DOI 10.1002/cncr.11337
   Martens PB, 1999, J RHEUMATOL, V26, P68
   Martin B G, 1999, J Am Osteopath Assoc, V99, pS11
   Matthews BD, 2002, AM SURGEON, V68, P660
   McBean J, 2003, CUTIS, V71, P205
   McCarthy L, 2002, TRANSFUSION, V42, P1245, DOI 10.1046/j.1537-2995.2002.00210.x
   McDermott EM, 1997, MAYO CLIN PROC, V72, P806
   Mert A, 2004, SCAND J INFECT DIS, V36, P424, DOI 10.1080/00365540410027184
   Michiels JJ, 1997, SEMIN THROMB HEMOST, V23, P441, DOI 10.1055/s-2007-996121
   Moossavi M, 2003, INT J DERMATOL, V42, P62, DOI 10.1046/j.1365-4362.2003.01705.x
   Naschitz J E, 1993, Cardiovasc Surg, V1, P524
   O'Neill J H Jr, 1991, Del Med J, V63, P683
   Ozkaya-Bayazit E, 2003, J AM ACAD DERMATOL, V49, P1003, DOI 10.1016/S0190-9622(03)01588-3
   Ozkaya-Bayazit E, 1999, CONTACT DERMATITIS, V41, P185
   Patel P, 2002, DERMATOL CLIN, V20, P373, DOI 10.1016/S0733-8635(02)00016-5
   PETERS MS, 1989, MED CLIN N AM, V73, P1113
   Petit A, 1996, J AM ACAD DERMATOL, V34, P521, DOI 10.1016/S0190-9622(96)90466-1
   Preiss JC, 2002, DIGESTION, V66, P193, DOI 10.1159/000066758
   Psychos DN, 2000, CLIN RHEUMATOL, V19, P212, DOI 10.1007/s100670050159
   Raake W, 2002, Hamostaseologie, V22, P149
   Ramzi DW, 2004, AM FAM PHYSICIAN, V69, P2841
   REISMAN RE, 1994, NEW ENGL J MED, V331, P523, DOI 10.1056/NEJM199408253310808
   Requena Luis, 2002, Dermatol Online J, V8, P4
   Russell-Jones R, 2000, SEMIN CUTAN MED SURG, V19, P100, DOI 10.1016/S1085-5629(00)80006-1
   Russo Glenn, 1994, Comprehensive Therapy, V20, P418
   Scheinfeld Noah S, 2003, Dermatol Online J, V9, P8
   SCHEWACHMILLET M, 1986, J AM ACAD DERMATOL, V15, P1291, DOI 10.1016/S0190-9622(86)80042-1
   Seckin D, 2001, INT J DERMATOL, V40, P138, DOI 10.1046/j.1365-4362.2001.01177-3.x
   Sehgal VN, 2002, INT J DERMATOL, V41, P467, DOI 10.1046/j.1365-4362.2002.01469.x
   Serra A, 1998, ACTA DERM-VENEREOL, V78, P198
   SHAFFER N, 1992, ARCH DERMATOL, V128, P1329, DOI 10.1001/archderm.128.10.1329
   Sheahan P, 2001, J LARYNGOL OTOL, V115, P1032
   SIEGELMAN ES, 1993, NEW ENGL J MED, V328, P885
   Siva C, 2003, AM FAM PHYSICIAN, V68, P83
   Soto-Romero I, 2002, PEDIATR DERMATOL, V19, P60, DOI 10.1046/j.1525-1470.2002.00014.x
   Stawiski M A, 1985, Emerg Med Clin North Am, V3, P785
   Swan A, 2002, ANN RHEUM DIS, V61, P493, DOI 10.1136/ard.61.6.493
   Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209
   Tagalakis V, 2002, AM J MED, V113, P146, DOI 10.1016/S0002-9343(02)01163-4
   TERCEDOR J, 1992, INT J DERMATOL, V31, P598, DOI 10.1111/j.1365-4362.1992.tb02731.x
   Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733
   Tiwari A, 2002, BRIT J SURG, V89, P397, DOI 10.1046/j.0007-1323.2002.02063.x
   Vigan M, 1996, ANN DERMATOL VENER, V123, P686
   Watabe H, 2002, J DERMATOL, V29, P748
   Weiss G, 2001, INT J DERMATOL, V40, P148, DOI 10.1046/j.1365-4362.2001.01177-6.x
   WILLIAMSON LM, 1982, Q J MED, V51, P469
   Wilmer WA, 2002, SEMIN DIALYSIS, V15, P172, DOI 10.1046/j.1525-139X.2002.00052.x
   WINKELMANN RK, 1993, MAYO CLIN PROC, V68, P122
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   Wozniacka A, 2002, LUPUS, V11, P71, DOI 10.1191/0961203302lu147rr
   Yim JH, 1997, ANN SURG ONCOL, V4, P287, DOI 10.1007/BF02303576
   Young RJ, 2001, INT J DERMATOL, V40, P249, DOI 10.1046/j.1365-4362.2001.01151.x
   ZEMER D, 1974, NEW ENGL J MED, V291, P932, DOI 10.1056/NEJM197410312911803
NR 121
TC 47
Z9 47
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD JAN 4
PY 2005
VL 142
IS 1
BP 47
EP 55
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA 916DS
UT WOS:000228366200005
PM 15630108
ER

PT J
AU Hricak, H
   Schoder, H
   Pucar, D
   Lis, E
   Eberhardt, SC
   Onyebuchi, CN
   Scher, HI
AF Hricak, H
   Schoder, H
   Pucar, D
   Lis, E
   Eberhardt, SC
   Onyebuchi, CN
   Scher, HI
TI Advances in imaging in the postoperative patient with a rising
   prostate-specific antigen level
SO SEMINARS IN ONCOLOGY
LA English
DT Review
ID POSITRON-EMISSION-TOMOGRAPHY; RADICAL RETROPUBIC PROSTATECTOMY;
   HORMONE-DEPRIVATION THERAPY; CAPROMAB PENDETIDE SCAN; RADIONUCLIDE
   BONE-SCAN; LYMPH-NODE METASTASES; LOCAL RECURRENCE; TRANSRECTAL
   ULTRASOUND; MEMBRANE ANTIGEN; (111)INDIUM-CAPROMAB PENDETIDE
C1 Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA.
RP Hricak, H (reprint author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave,C278, New York, NY 10021 USA.
CR ALGRA PR, 1991, RADIOGRAPHICS, V11, P219
   Bellin MF, 1998, RADIOLOGY, V207, P799
   Boni RAH, 1996, ABDOM IMAGING, V21, P345, DOI 10.1007/s002619900079
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3
   Chen M, 1996, AM J ROENTGENOL, V166, P1157
   Cher ML, 1998, J UROLOGY, V160, P1387, DOI 10.1016/S0022-5347(01)62545-X
   Costello LC, 1997, UROLOGY, V50, P3, DOI 10.1016/S0090-4295(97)00124-6
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   D'Amico AV, 1998, J UROLOGY, V160, P2096, DOI 10.1016/S0022-5347(01)62251-1
   DeGrado TR, 2001, CANCER RES, V61, P110
   DELPASSAND ES, 1995, CLIN NUCL MED, V20, P1047, DOI 10.1097/00003072-199512000-00001
   Effert PJ, 1996, J UROLOGY, V155, P994, DOI 10.1016/S0022-5347(01)66366-3
   Elgamal AAA, 1998, PROSTATE, V37, P261, DOI 10.1002/(SICI)1097-0045(19981201)37:4<261::AID-PROS8>3.0.CO;2-#
   EVENSAPIR E, 1993, RADIOLOGY, V187, P193
   FLOCKS RH, 1959, J UROLOGY, V81, P194
   FOSTER LS, 1993, J UROLOGY, V149, P1024
   Fricke E, 2003, EUR J NUCL MED MOL I, V30, P607, DOI 10.1007/s00259-002-1104-y
   GOLDENBERG SL, 1992, J UROLOGY, V147, P1307
   Hara Toshihiko, 2002, Mol Imaging Biol, V4, P267, DOI 10.1016/S1536-1632(02)00015-X
   Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923
   HRICAK H, 1994, RADIOLOGY, V193, P703
   Imbriaco M, 1998, CLIN CANCER RES, V4, P1765
   Jager PL, 2001, J NUCL MED, V42, P432
   Jemal A, 2002, CA-CANCER J CLIN, V52, P23
   Jhaveri F M, 1999, Semin Urol Oncol, V17, P130
   Kahn D, 1998, J CLIN ONCOL, V16, P284
   KAHN D, 1994, J UROLOGY, V152, P1490
   Kahn D, 1998, J UROLOGY, V159, P2041, DOI 10.1016/S0022-5347(01)63239-7
   Kalbhen CL, 1996, RADIOLOGY, V198, P807
   Kato T, 2002, EUR J NUCL MED MOL I, V29, P1492, DOI 10.1007/s00259-002-0885-3
   Kattan MW, 1999, J CLIN ONCOL, V17, P1499
   Khan A, 2000, Urology, V56, P154, DOI 10.1016/S0090-4295(00)00531-8
   Kotzerke J, 2002, EUR J NUCL MED MOL I, V29, P1380, DOI 10.1007/s00259-002-0882-6
   Kramer S, 1997, BRIT J RADIOL, V70, P995
   Kurhanewicz J, 1996, RADIOLOGY, V198, P795
   Kurhanewicz J, 2000, RADIOL CLIN N AM, V38, P115, DOI 10.1016/S0033-8389(05)70152-4
   Kurhanewicz J, 1996, RADIOLOGY, V200, P489
   Laufer M, 2000, UROLOGY, V55, P309, DOI 10.1016/S0090-4295(99)00465-3
   Lee CT, 1997, UROL CLIN N AM, V24, P389, DOI 10.1016/S0094-0143(05)70385-2
   Leventis AK, 2001, RADIOLOGY, V219, P432
   Levesque PE, 1998, UROLOGY, V51, P978, DOI 10.1016/S0090-4295(98)00025-9
   LIGHTNER DJ, 1990, J UROLOGY, V144, P921
   Liu IJ, 2001, UROLOGY, V57, P108, DOI 10.1016/S0090-4295(00)00896-7
   Males RG, 2000, MAGNET RESON MED, V43, P17, DOI 10.1002/(SICI)1522-2594(200001)43:1<17::AID-MRM3>3.0.CO;2-6
   Michaels EK, 1999, J UROLOGY, V161, P597, DOI 10.1016/S0022-5347(01)61960-8
   Morris MJ, 2002, UROLOGY, V59, P913, DOI 10.1016/S0090-4295(02)01509-1
   MORTON RA, 1991, J UROLOGY, V145, P1197
   Mueller-Lisse UG, 2001, RADIOLOGY, V221, P380, DOI 10.1148/radiol.2211001582
   Mueller-Lisse UG, 2001, MAGNET RESON MED, V46, P49, DOI 10.1002/mrm.1159
   Nash PA, 1996, J UROLOGY, V155, P607, DOI 10.1016/S0022-5347(01)66464-4
   Noguchi M, 2003, BRIT J CANCER, V88, P195, DOI 10.1038/sj.bjc.6600715
   Nudell DM, 2000, RADIOL CLIN N AM, V38, P213, DOI 10.1016/S0033-8389(05)70157-3
   Nunez R, 2002, J NUCL MED, V43, P46
   Oyama N, 2003, J NUCL MED, V44, P549
   OYEN RH, 1994, RADIOLOGY, V190, P315
   PALMER E, 1988, ACTA RADIOL, V29, P445
   Parivar F, 1996, UROLOGY, V48, P594, DOI 10.1016/S0090-4295(96)00250-6
   PARRA RO, 1990, J UROLOGY, V144, P707
   PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5
   PARTIN AW, 1994, J UROLOGY, V152, P1358
   Picchio M, 2003, J UROLOGY, V169, P1337, DOI 10.1097/01.ju.0000056901.95996.43
   Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U
   POLLEN JJ, 1984, AM J ROENTGENOL, V142, P773
   POMERANZ SJ, 1994, SEMIN NUCL MED, V24, P188, DOI 10.1016/S0001-2998(05)80010-8
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Raj GV, 2002, CANCER, V94, P987, DOI 10.1002/cncr.10337
   Sabbatini P, 1999, J CLIN ONCOL, V17, P948
   Savelli G, 2001, Q J NUCL MED, V45, P27
   Scheidler J, 1999, RADIOLOGY, V213, P473
   Schirrmeister H, 2001, J NUCL MED, V42, P1800
   SCHNEIDER JA, 1994, J NUCL MED, V35, P1748
   Scott DL, 2001, J UROLOGY, V165, P910, DOI 10.1016/S0022-5347(05)66566-4
   SELLA T, 2002, RAD SOC N AM DEC 6 2, V225
   Seltzer MA, 1999, J UROLOGY, V162, P1322, DOI 10.1016/S0022-5347(05)68277-8
   Silverman JM, 1997, AM J ROENTGENOL, V168, P379
   Smith-Jones PM, 2003, J NUCL MED, V44, P610
   Sodee DB, 2000, UROLOGY, V56, P988, DOI 10.1016/S0090-4295(00)00824-4
   SPENCER JA, 1994, CLIN RADIOL, V49, P404, DOI 10.1016/S0009-9260(05)81826-4
   Taoka T, 2001, AM J ROENTGENOL, V176, P1525
   TERRIS MK, 1991, J NUCL MED, V32, P1713
   Thomas CT, 2003, J CLIN ONCOL, V21, P1715, DOI 10.1200/JCO.2003.05.138
   Traill ZC, 1999, CLIN RADIOL, V54, P448, DOI 10.1016/S0009-9260(99)90830-9
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   Troyer JK, 1997, PROSTATE, V30, P232, DOI 10.1002/(SICI)1097-0045(19970301)30:4<232::AID-PROS2>3.0.CO;2-N
   TROYER JK, 1995, INT J CANCER, V62, P552
   Turlakow A, 2001, Q J NUCL MED, V45, P235
   TURNER JW, 1993, J UROLOGY, V149, P1482
   Valliappan S, 1999, CLIN NUCL MED, V24, P984, DOI 10.1097/00003072-199912000-00020
   VANDERWALL H, 1998, NUCL MED CLIN DIAGNO, V2, P1169
   Wefer AE, 2000, J UROLOGY, V164, P400, DOI 10.1016/S0022-5347(05)67370-3
   Yeung HW, 2002, J NUCL MED, V43, p32P
   Yu KK, 1999, RADIOLOGY, V213, P481
   ZAKIAN KL, 2002, P RADIOL SOC M AM, V1525
   ZAKIAN KL, 2000, P INT SOC MAGN RESON, V1894
   ZANZI I, 2002, UROLOGY, V60, P517
   ZINCKE H, 1994, J UROLOGY, V152, P1850
   Zucker RJ, 2001, CLIN NUCL MED, V26, P568, DOI 10.1097/00003072-200106000-00026
NR 98
TC 47
Z9 47
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0093-7754
J9 SEMIN ONCOL
JI Semin. Oncol.
PD OCT
PY 2003
VL 30
IS 5
BP 616
EP 634
DI 10.1053/S00093-7754(03)00359-2
PG 19
WC Oncology
SC Oncology
GA 735VE
UT WOS:000186134600006
PM 14571410
ER

PT J
AU Rosser, CJ
   Kuban, DA
   Levy, LB
   Chichakli, R
   Pollack, A
   Lee, AK
   Pisters, LL
AF Rosser, CJ
   Kuban, DA
   Levy, LB
   Chichakli, R
   Pollack, A
   Lee, AK
   Pisters, LL
TI The prostate specific antigen bounce phenomenon after external beam
   radiation for clinically localized prostate cancer
SO JOURNAL OF UROLOGY
LA English
DT Article
DE radiotherapy; prostatic neoplasms; prostate-specific antigen
ID DOUBLING TIME; THERAPY
AB Purpose: We characterize the prostate-specific antigen (PSA) bounce in patients who underwent external beam radiation therapy for prostate cancer and correlate the PSA bounce with the development of biochemical disease progression.
   Materials and Methods: In this study 964 patients received full dose radiation therapy alone. Followup PSA values were obtained 3 months after completion of radiotherapy and every 3 to 6 months thereafter. Median followup of the entire study group was 48 months. All time intervals were calculated from the completion date of radiation therapy. PSA bounce was defined as an initial increase in serum PSA of at least 0.5 ng./ml., followed by a decrease to pre-bounce baseline serum PSA values no more than 60 months after external beam radiation therapy.
   Results: Of the 964 patients 119 (12%) had a PSA bounce. PSA bounce was unrelated to age, race, pretreatment PSA, Gleason score, clinical T stage or radiation dose. Mean time to PSA bounce was 9 months from the time of therapy. The respective 1 and 5-year biochemical disease-free survival rates were 100% and 82.1% for patients with PSA bounce and 93.9% and 57.7% for those without PSA bounce (p = 0.0001).
   Conclusions: Of men with prostate cancer treated with external beam radiation therapy 12% experienced a transient increase in PSA (PSA bounce) followed by a return to pre-bounce levels after radiation. The PSA bounce phenomenon was not predictive of time to biochemical recurrence.
C1 Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA.
RP Pisters, LL (reprint author), Univ Texas, MD Anderson Canc Ctr, Dept Urol, Box 446,1515 Holcombe Blvd, Houston, TX 77030 USA.
CR American Joint Commission on Cancer, 1992, MAN STAG CANC
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   HANKS GE, 1993, INT J RADIAT ONCOL, V27, P125
   Hanks GE, 1997, UROLOGY, V50, P87, DOI 10.1016/S0090-4295(97)00226-4
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   POLLACK A, 1994, CANCER, V74, P670, DOI 10.1002/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   ZAGARS GK, 1991, CANCER, V67, P412, DOI 10.1002/1097-0142(19910115)67:2<412::AID-CNCR2820670216>3.0.CO;2-R
NR 11
TC 47
Z9 48
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD NOV
PY 2002
VL 168
IS 5
BP 2001
EP 2005
DI 10.1097/01.ju.0000034351.97426.fe
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 603LX
UT WOS:000178562100027
PM 12394695
ER

PT J
AU Eicken, A
   Ewert, P
   Hager, A
   Peters, B
   Fratz, S
   Kuehne, T
   Busch, R
   Hess, J
   Berger, F
AF Eicken, Andreas
   Ewert, Peter
   Hager, Alfred
   Peters, Bjoern
   Fratz, Sohrab
   Kuehne, Titus
   Busch, Raymonde
   Hess, John
   Berger, Felix
TI Percutaneous pulmonary valve implantation: two-centre experience with
   more than 100 patients
SO EUROPEAN HEART JOURNAL
LA English
DT Article
DE Right ventricular outflow tract dysfunction; Percutaneous pulmonary
   valve implantation
ID CARDIOVASCULAR MAGNETIC-RESONANCE; RIGHT-VENTRICULAR FUNCTION; OUTFLOW
   TRACT OBSTRUCTION; REPAIRED TETRALOGY; ADULTS LATE; FALLOT; REPLACEMENT;
   DYSFUNCTION; CHILDREN; RISK
AB Aims Dysfunction of valved conduits in the right ventricular outflow tract (RVOT) limits durability and enforces repeated surgical interventions. We report on our combined two-centre experience with percutaneous pulmonary valve implantation (PPVI).
   Methods and results One hundred and two patients with RVOT dysfunction [median weight: 63 kg (54.2-75.9 kg), median age: 21.5 years (16.2-30.1 years), diagnoses: TOF/PA 61, TAC 14, TGA 9, other 10, AoS post-Ross-OP 8] were scheduled for PPVI since December 2006. Percutaneous pulmonary valve implantation was performed in all patients. Pre-stenting of the RVOT was done in 97 patients (95%). The median peak systolic RVOT gradient decreased from 37 mmHg (29-46 mmHg) to 14 mmHg (9-17 mmHg, P < 0.001) and the ratio RV pressure/AoP decreased from 62% (53-76%) to 36% (30-42%, P < 0.0001). The median end-diastolic RV-volume index (MRI) decreased from 106 mL/m(2) (93-133 mL/m(2)) to 90 mL/m(2) (71-108 mL/m(2), P < 0.001). Pulmonary regurgitation was significantly reduced in all patients. One patient died due to compression of the left coronary artery. The incidence of stent fractures was 5 of 102 (5%). During follow-up [median: 352 days (99-390 days)] one percutaneous valve had to be removed surgically 6 months after implantation due to bacterial endocarditis. In 8 of 102 patients, a repeated dilatation of the valve was done due to a significant residual systolic pressure gradient, which resulted in a valve-in-valve procedure in four.
   Conclusion This study shows that PPVI is feasible and it improves the haemodynamics in a selected patient collective. Apart from one coronary compression, the rate of complications at short-term follow-up was low. Percutaneous pulmonary valve implantation can be performed by experienced interventionalists with similar results as originally published. The intervention is technically challenging and longer clinical follow-up is needed.
C1 [Eicken, Andreas; Hager, Alfred; Fratz, Sohrab; Hess, John] Tech Univ Munich, Klin Kinderkardiol & Angeboren Herzfehler, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany.
   [Ewert, Peter; Peters, Bjoern; Kuehne, Titus; Berger, Felix] Deutsch Herzzentrum Berlin, Abt Angeborene Herzfehler Kinderkardiol, Berlin, Germany.
   [Busch, Raymonde] Tech Univ Munich, Inst Med Stat IMSE, D-80636 Munich, Germany.
RP Eicken, A (reprint author), Tech Univ Munich, Klin Kinderkardiol & Angeboren Herzfehler, Deutsch Herzzentrum Munchen, Lazarettstr 36, D-80636 Munich, Germany.
EM eicken@dhm.mhn.de
CR Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   Buechel ERV, 2005, EUR HEART J, V26, P2721, DOI 10.1093/eurheartj/ehi581
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   Eicken A, 2003, J AM COLL CARDIOL, V42, P1061, DOI 10.1016/S0735-1097(03)00986-0
   Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   GATZOULIS MA, 1995, CIRCULATION, V92, P231
   Harrild DM, 2009, CIRCULATION, V119, P445, DOI 10.1161/CIRCULATIONAHA.108.775221
   Homann M, 2000, EUR J CARDIO-THORAC, V17, P624, DOI 10.1016/S1010-7940(00)00414-0
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Mavroudis C, 2002, ANN THORAC SURG, V73, P1806
   Khambadkone S, 2004, CATHETER CARDIO INTE, V62, P401, DOI 10.1002/ccd.20122
   Khambadkone S, 2005, CIRCULATION, V112, P1189, DOI 10.1161/CIRCULATIONAHA.104.523266
   Kostolny M, 2008, EUR J CARDIO-THORAC, V33, P607, DOI 10.1016/j.ejcts.2007.12.034
   Lange R, 2001, ANN THORAC SURG, V71, pS365, DOI 10.1016/S0003-4975(01)02552-8
   Lurz P, 2008, CIRCULATION, V117, P1964, DOI 10.1161/CIRCULATIONAHA.107.735779
   Momenah TS, 2009, J AM COLL CARDIOL, V53, P1859, DOI 10.1016/j.jacc.2008.08.061
   Nordmeyer J, 2008, EUR HEART J, V29, P810, DOI 10.1093/eurheartj/ehn073
   Nordmeyer J, 2007, CIRCULATION, V115, P1392, DOI 10.1161/CIRCULATIONAHA.106.674259
   Oosterhof T, 2005, CIRCULATION, V111, pE112, DOI 10.1161/01.CIR.0000156455.52299.82
   Schreiber C, 2000, EUR J CARDIO-THORAC, V18, P68, DOI 10.1016/S1010-7940(00)00449-8
   SHIMAZAKI Y, 1984, THORAC CARDIOV SURG, V32, P257, DOI 10.1055/s-2007-1023399
   Singh GK, 1998, AM J CARDIOL, V81, P1378, DOI 10.1016/S0002-9149(98)00171-4
   Sridharan S, 2006, CIRCULATION, V113, pE934, DOI 10.1161/CIRCULATIONAHA.105.599514
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8
   Zahn EM, 2009, J AM COLL CARDIOL, V54, P1722, DOI 10.1016/j.jacc.2009.06.034
NR 27
TC 46
Z9 48
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
J9 EUR HEART J
JI Eur. Heart J.
PD MAY
PY 2011
VL 32
IS 10
BP 1260
EP 1265
DI 10.1093/eurheartj/ehq520
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 766UM
UT WOS:000290812000018
PM 21273201
ER

PT J
AU Keijsers, L
   Branje, SJT
   VanderValk, IE
   Meeus, W
AF Keijsers, Loes
   Branje, Susan J. T.
   VanderValk, Inge E.
   Meeus, Wim
TI Reciprocal Effects Between Parental Solicitation, Parental Control,
   Adolescent Disclosure, and Adolescent Delinquency
SO JOURNAL OF RESEARCH ON ADOLESCENCE
LA English
DT Article
ID PROBLEM BEHAVIOR; YOUNG ADULTHOOD; SELF-DISCLOSURE; KNOWLEDGE;
   ADJUSTMENT; REINTERPRETATION; CHILD; SOCIALIZATION; LINKS; INFORMATION
AB This two-wave multi-informant study examined the bidirectional associations of parental control and solicitation with adolescent disclosure and delinquency. Participants were 289 adolescents (150 females and 139 males, modal age 14) and both parents. Parental solicitation and control did not predict adolescent delinquency, but adolescents' self-reported disclosure was a negative predictor of delinquency. In addition, delinquency predicted less disclosure. Furthermore, maternal solicitation predicted disclosure and adolescent disclosure predicted parental solicitation. All relations held after controlling for leisure time spent with parents and with peers. These longitudinal findings show an overlap in the development of parental solicitation and the development of adolescent disclosure, but also show that only adolescent disclosure is negatively related to delinquency over time.
C1 [Keijsers, Loes] Univ Utrecht, Res Ctr Adolescent Dev, NL-3508 TC Utrecht, Netherlands.
RP Keijsers, L (reprint author), Univ Utrecht, Res Ctr Adolescent Dev, POB 80-140, NL-3508 TC Utrecht, Netherlands.
EM l.keijsers@uu.nl
RI Branje, Susan/A-7813-2010; Meeus, Wim/H-8099-2013
OI Branje, Susan/0000-0002-9999-5313; 
CR Baerveldt C., 2003, NETHERLANDS J SOCIAL, V39, P107
   Bechger T. M., 1998, FAMILY SCI REV, V11, P354, DOI DOI 10.1234/12345678
   BELL RQ, 1986, DEV PSYCHOL, V22, P595, DOI 10.1037/0012-1649.22.5.595
   BELL RQ, 1968, PSYCHOL REV, V75, P81, DOI 10.1037/h0025583
   Beyers W, 1999, J ADOLESCENCE, V22, P753, DOI 10.1006/jado.1999.0268
   Bosmans G, 2006, J YOUTH ADOLESCENCE, V35, P373, DOI 10.1007/s10964-005-9026-1
   Brody GH, 2003, CHILDREN'S INFLUENCE ON FAMILY DYNAMICS: THE NEGLECTED SIDE OF FAMILY RELATIONSHIPS, P163
   Buhrmester D., 1995, DISCLOSURE PROCESSES, P10, DOI 10.1017/CBO9780511527746.002
   Bumpus MF, 2001, DEV PSYCHOL, V37, P163, DOI 10.1037//0012-1649.37.2.163
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   COLLINS NL, 1994, PSYCHOL BULL, V116, P457, DOI 10.1037/0033-2909.116.3.457
   Crouter AC, 2005, CHILD DEV, V76, P869, DOI 10.1111/j.1467-8624.2005.00883.x
   Crouter A.C., 2002, HDB PARENTING, V3, P461
   Crouter AC, 1999, CHILD DEV, V70, P246, DOI 10.1111/1467-8624.00018
   Darling N, 2006, J YOUTH ADOLESCENCE, V35, P667, DOI 10.1007/s10964-006-9058-1
   Engels RCME, 2006, J YOUTH ADOLESCENCE, V35, P949, DOI 10.1007/s10964-006-9082-1
   FAGOT B, 1995, DISCLOSURE PROCESSES, P148, DOI 10.1017/CBO9780511527746.008
   Finkenauer C, 2004, J MARRIAGE FAM, V66, P195, DOI 10.1111/j.0022-2445.2004.00014.x
   Finkenauer C, 2005, PERS RELATIONSHIP, V12, P387, DOI 10.1111/j.1475-6811.2005.00122.x
   Finkenauer C, 2002, J YOUTH ADOLESCENCE, V31, P123, DOI 10.1023/A:1014069926507
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   FULIGNI AJ, 1993, DEV PSYCHOL, V29, P622, DOI 10.1037/0012-1649.29.4.622
   FURMAN W, 1985, DEV PSYCHOL, V21, P1016, DOI 10.1037//0012-1649.21.6.1016
   HARRIS KM, 1991, J MARRIAGE FAM, V53, P531, DOI 10.2307/352730
   Hoyle R. H., 1995, STRUCTURAL EQUATION, P158
   HOYLE RH, 1994, J CONSULT CLIN PSYCH, V62, P429, DOI 10.1037/0022-006X.62.3.429
   Huh D, 2006, J ADOLESCENT RES, V21, P185, DOI 10.1177/0743558405285462
   Kandel D. B., 1995, COERCION PUNISHMENT, P106, DOI DOI 10.1017/CBO9780511527906.006
   Kerr M, 1999, J ADOLESCENCE, V22, P737, DOI 10.1006/jado.1999.0266
   Kerr M., 2003, HDB PSYCHOL, V6, P395, DOI 10.1002/0471264385.wei0616
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Kline R. B., 2005, PRINCIPLES PRACTICE
   Larson RW, 1996, DEV PSYCHOL, V32, P744, DOI 10.1037/0012-1649.32.4.744
   Laursen B, 1997, INT J BEHAV DEV, V21, P747
   LYTTON H, 1990, DEV PSYCHOL, V26, P683, DOI 10.1037/0012-1649.26.5.683
   Mahoney JL, 2000, J ADOLESCENCE, V23, P113, DOI 10.1006/jado.2000.0302
   Marshall SK, 2005, J ADOLESCENCE, V28, P633, DOI 10.1016/j.adolescence.2005.08.008
   Meeus W, 2004, J CHILD PSYCHOL PSYC, V45, P1288, DOI 10.1111/j.1469-7610.2004.00312.x
   MEEUS W, 2004, CODEBOOK RES PROJECT, V2
   Muthen B. O., 2006, MPLUS USERS GUIDE
   NOLLER P, 1985, J ADOLESCENCE, V8, P125, DOI 10.1016/S0140-1971(85)80042-7
   NOLLER P, 1978, DEV PSYCHOL, V14, P317
   Raaijmakers QAW, 2005, INT J BEHAV DEV, V29, P247, DOI 10.1080/01650250544000035
   Rogers KN, 2003, J EARLY ADOLESCENCE, V23, P349, DOI 10.1177/0272431603258344
   Satorra A., 1994, LATENT VARIABLES ANA, P399
   Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192
   Smetana JG, 2006, ANNU REV PSYCHOL, V57, P255, DOI 10.1146/annurev.psych.57.102904.190124
   Smetana JG, 2006, CHILD DEV, V77, P201, DOI 10.1111/j.1467-8624.2006.00865.x
   Soenens B, 2006, DEV PSYCHOL, V42, P305, DOI 10.1073/0012-1649.42.2.305
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Kerr M, 2003, CHILDREN'S INFLUENCE ON FAMILY DYNAMICS: THE NEGLECTED SIDE OF FAMILY RELATIONSHIPS, P121
   Steinberg L., 1990, THRESHOLD DEV ADOLES, P255
   STICE E, 1995, DEV PSYCHOL, V31, P322, DOI 10.1037//0012-1649.31.2.322
   Tilton-Weaver LC, 2003, J RES ADOLESCENCE, V13, P269, DOI 10.1111/1532-7795.1303002
   Waizenhofer RN, 2004, J FAM PSYCHOL, V18, P348, DOI 10.1037/0893-3200.18.2.348
NR 55
TC 46
Z9 46
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1050-8392
J9 J RES ADOLESCENCE
JI J. Res. Adolesc.
PY 2010
VL 20
IS 1
BP 88
EP 113
DI 10.1111/j.1532-7795.2009.00631.x
PG 26
WC Family Studies; Psychology, Developmental
SC Family Studies; Psychology
GA 557WO
UT WOS:000274701000006
ER

PT J
AU Pickles, T
AF Pickles, T
CA British Columbia Canc Agcy Prostat
TI Prostate-specific antigen (PSA) bounce and other fluctuations: Which
   biochemical relapse definition is least prone to PSA false calls? An
   analysis of 2030 men treated for prostate cancer with external beam or
   brachytherapy with or without adjuvant androgen deprivation therapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT 47th Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology
CY OCT 16-20, 2005
CL Denver, CO
SP Amer Soc Therapeut Radiol & Oncol
DE prostate neoplasms; biochemical relapse; PSA kinetics; radiation
   therapy; brachytherapy
ID RADIATION-THERAPY; NEOADJUVANT; FAILURE
AB Purpose: To determine the false call (FC) rate for prostate-specific antigen (PSA) relapse according to nine different PSA relapse definitions after a PSA fluctuation (bounce) has occurred after external beam radiation therapy (EBRT) or brachytherapy, with or without adjuvant androgen deprivation therapy.
   Methods and Materials: An analysis of a prospective database of 2030 patients was conducted. Prostate-specific antigen relapse was scored according to the American Society for Therapeutic Radiology and Oncology (ASTRO), Vancouver, threshold + n, and nadir + n definitions for the complete data set and then compared against a truncated data set, with data subsequent to the height of the bounce deleted. The FC rate was calculated for each definition.
   Results: The bounce rate, with this very liberal definition of bounce, was 58% with EBRT and 84% with brachytherapy. The FC rate was lowest with nadir + 2 and + 3 definitions (2.2% and 1.6%, respectively) and greatest with low-threshold and ASTRO definitions (32% and 18%, respectively). The ASTRO definition was particularly susceptible to FC when androgen deprivation therapy was used with radiation (24%).
   Discussion: New definitions of biochemical non-evidence of disease that are more robust than the ASTRO definition have been identified. Those with the least FC rates are the nadir + 2 and nadir + 3 definitions, both of which are being considered to replace the ASTRO definition by the 2005 meeting of the Radiation Therapy Oncology Group-ASTRO consensus panel. (c) 2006 Elsevier Inc.
C1 British Columbia Canc Agcy, Vancouver, BC V6R 2T9, Canada.
RP Pickles, T (reprint author), British Columbia Canc Agcy, 600 W 10th Ave, Vancouver, BC V6R 2T9, Canada.
EM tpickles@bccancer.bc.ca
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Coen JJ, 2004, INT J RADIAT ONCOL, V60, pS444
   Critz FA, 2003, J UROLOGY, V170, P1864, DOI 10.1097/01.ju.0000091644.41330.2a
   Horwitz EM, 2004, INT J RADIAT ONCOL, V60, pS235
   MERRICK GS, 2005, BRACHYTHERAPY, V3, P141
   PICKLES T, 2005, SEM M RAD THER ONC G
   Pickles T, 2003, INT J RADIAT ONCOL, V57, P11, DOI 10.1016/S0360-3016(03)00439-5
   Pickles T, 1999, INT J RADIAT ONCOL, V43, P699
   Rosser CJ, 2002, J UROLOGY, V168, P2001, DOI 10.1097/01.ju.0000034351.97426.fe
   Sengoz M, 2003, EUR UROL, V43, P473, DOI 10.1016/S0302-2838(03)00138-6
   Stock RG, 2003, INT J RADIAT ONCOL, V56, P448, DOI 10.1016/S0360-3016(02)04470-X
   Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X
   Zietman AL, 2005, INT J RADIAT ONCOL, V62, P714, DOI 10.1016/j.ijrobp.2004.11.020
NR 13
TC 46
Z9 46
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD APR 1
PY 2006
VL 64
IS 5
BP 1355
EP 1359
DI 10.1016/j.ijrobp.2005.10.008
PG 5
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 028HG
UT WOS:000236477200009
PM 16406391
ER

PT J
AU Aarsvold, JN
   Alazraki, NP
AF Aarsvold, JN
   Alazraki, NP
TI Update on detection of sentinel lymph nodes in patients with breast
   cancer
SO SEMINARS IN NUCLEAR MEDICINE
LA English
DT Review
ID INTERNAL MAMMARY LYMPHOSCINTIGRAPHY; POSITRON-EMISSION-TOMOGRAPHY;
   INTRAOPERATIVE GAMMA PROBES; TERM-FOLLOW-UP; RADIATION SAFETY; IMAGING
   PROBE; HAND-HELD; PATHOLOGICAL EXAMINATION; RADIOGUIDED SURGERY;
   CLINICAL-EVALUATION
AB Sentinel lymph node biopsy is now the practice of choice for the management of many patients with breast cancer. This was not true in the early 1990s, when the first such procedures were performed and protocols for such were refined often. This was also not true in the first years of the 21st century, when a decade of collective experience and information acquired from numerous clinical investigations dictated additional subtle and not-so-subtle refinements of the procedures. However, it is true today; reports of the latest round of clinical investigations indicate that there are several breast cancer sentinel node procedures that result in successful identification of potential sentinel nodes in nearly all patients who are eligible for such procedures. A significant component of many of these successful sentinel node procedures is a detection and localization protocol that involves radiotracer methodologies, including radiopharmaceutical administration, preoperative nuclear medicine imaging, and intraoperative gamma counting. The present state and roles of nuclear medicine protocols used in breast cancer sentinel lymph node biopsy procedures is reviewed with emphasis on discussion of recent results, unresolved issues, and future considerations. Included are brief reviews of present radiotracer and blue-dye techniques for node localization, including remarks about injection strategies, counting probe technology, and radiation safety. Included also are discussions of on-going investigations of the implications of the presence of micrometastases; of the management value of detection, localization, and excision of extra-axillary nodes such as internal mammary nodes; and of the broad range of recurrence rates presently being reported. Remarks on the present and possible near- and long-term roles for nuclear medicine in the staging of breast cancer patients including comments on positron emission tomography and intraoperative imaging conclude the article.
C1 Vet Affairs Med Ctr, Nucl Med Serv, Atlanta, GA 30033 USA.
   Emory Univ, Atlanta, GA 30322 USA.
RP Aarsvold, JN (reprint author), Vet Affairs Med Ctr, Nucl Med Serv, 115,1670 Clairmont Rd, Atlanta, GA 30033 USA.
EM john.aarsvold@med.va.gov
CR AARSVOLD JN, 2002, C REC 2002 IEEE NSS, P1172
   Abe A, 2003, EUR J NUCL MED MOL I, V30, P805, DOI 10.1007/s00259-002-1067-z
   Alazraki NP, 2000, SEMIN NUCL MED, V30, P56, DOI 10.1016/S0001-2998(00)80062-8
   Alazraki NP, 2001, RADIOL CLIN N AM, V39, P947, DOI 10.1016/S0033-8389(05)70322-5
   ALEX JC, 1993, SURG ONCOL, V2, P137, DOI 10.1016/0960-7404(93)90001-F
   American Cancer Society, 2003, BREAST CANC FACTS FI
   Avril N, 1996, J NATL CANCER I, V88, P1204, DOI 10.1093/jnci/88.17.1204
   BARRANGER E, 2004, ANNA SURG ONCOL, V10, P622
   BELVIS IM, 2005, C REC 2004 IEEE NSS, pM9
   BELVIS IM, 2002, J NUCL MED, V43, pP232
   Benda RK, 2004, CANCER, V100, P518, DOI 10.1002/cncr.11918
   BEVILACQUA JL, 2002, J SURG ONCOL, V28, P603
   Borgstein PJ, 2000, ANN SURG, V232, P81, DOI 10.1097/00000658-200007000-00012
   Britten AJ, 1999, EUR J NUCL MED, V26, P76, DOI 10.1007/s002590050362
   CABANAS RM, 1977, CANCER, V39, P456, DOI 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I
   Campisi C, 2002, TUMORI, V88, pS56
   Chu KU, 1999, ANN SURG, V229, P536, DOI 10.1097/00000658-199904000-00013
   Cohen C, 2002, APPL IMMUNOHISTO M M, V10, P296, DOI 10.1097/00022744-200212000-00002
   Colgan TJ, 2001, CAN MED ASSOC J, V164, P1868
   de Kanter AY, 2003, EUR J SURG ONCOL, V29, P396, DOI 10.1053/ejso.2002.1424
   Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H
   Dragotakes S. C., 1995, Journal of Nuclear Medicine, V36, p80P
   Edreira MM, 2001, NUCL MED COMMUN, V22, P499, DOI 10.1097/00006231-200105000-00006
   EGE GN, 1976, RADIOLOGY, V118, P101
   Eshima D, 1996, J NUCL MED, V37, P1575
   Fabry HFJ, 2004, J SURG ONCOL, V87, P13, DOI 10.1002/jso.20073
   Fehr Mathias K, 2004, Breast J, V10, P89, DOI 10.1111/j.1075-122X.2004.21455.x
   Fitzgibbons PL, 2000, AM J SURG PATHOL, V24, P1549, DOI 10.1097/00000478-200011000-00012
   Galimberti V, 2002, ANN SURG ONCOL, V9, P924, DOI 10.1245/ASO.2002.02.016
   Gentilini O, 2004, ANN ONCOL, V15, P1348, DOI 10.1093/annonc/mdh355
   Glass EC, 1999, ANN SURG ONCOL, V6, P10, DOI 10.1007/s10434-999-0010-y
   Goldfarb LR, 1998, RADIOLOGY, V208, P505
   Hampton T, 2003, JAMA-J AM MED ASSOC, V290, P3053, DOI 10.1001/jama.290.23.3053
   Hoffman EJ, 2004, EMISSION TOMOGRAPHY, P335
   Hoffman EJ, 1999, EUR J NUCL MED, V26, P913, DOI 10.1007/s002590050468
   Jakub JW, 2004, SEMIN ONCOL, V31, P324, DOI 10.1053/j.seminoncol.2004.03.014
   KAPLAN WD, 1994, FRONT RADIAT THER ON, V28, P25
   Kim CK, 2004, J NUCL MED, V45, P1597
   Kitagawa Y, 2001, ANN SURG ONCOL S, V8, P86
   Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401
   Krynyckyi BR, 2003, CLIN NUCL MED, V28, P97, DOI 10.1097/00003072-200302000-00002
   Lara JF, 2003, CANCER, V98, P2105, DOI 10.1002/cncr.11761
   Law M, 2004, SEMIN ONCOL, V31, P298, DOI 10.1053/j.seminoncol.2004.03.002
   Levin C, 2004, EMISSION TOMOGRAPHY, P293
   Lin KM, 2004, J AM COLL SURGEONS, V199, P561, DOI 10.1016/j.jamcollsurg.2004.06.018
   Lovrics PJ, 2004, ANN SURG ONCOL, V11, P846, DOI 10.1245/ASO.2004.11.033
   MacDonald LR, 2000, P SOC PHOTO-OPT INS, V4142, P242, DOI 10.1117/12.410569
   MACDONALD LR, 2001, C REC 2000 IEEE NSS
   Mansel RE, 2004, SEMIN ONCOL, V31, P304, DOI 10.1053/j.seminoncol.2004.03.003
   Mariani G, 2001, J NUCL MED, V42, P1198
   Menard L, 1999, IEEE T NUCL SCI, V46, P2068, DOI 10.1109/23.819284
   Michel R, 2004, HEALTH PHYS, V86, pS35, DOI 10.1097/00004032-200402001-00011
   Miner TJ, 1999, ANN SURG ONCOL, V6, P75, DOI 10.1007/s10434-999-0075-7
   MORTON DL, 1991, ANN SURG, V214, P491, DOI 10.1097/00000658-199110000-00013
   Morton DL, 1999, SURGERY, V126, P815, DOI 10.1016/S0039-6060(99)70019-X
   Morton R, 2003, BRIT J RADIOL, V76, P117, DOI 10.1259/bjr/91805723
   Motta C, 2000, TUMORI, V86, P372
   *NEMA, 2004, 32004 NU NEMA
   Nieweg OE, 2004, J SURG ONCOL, V87, P105, DOI 10.1002/jso.20092
   Nieweg OE, 1999, EUR J NUCL MED, V26, pS11, DOI 10.1007/s002590050572
   Nieweg OE, 2004, J SURG ONCOL, V87, P153, DOI 10.1002/jso.20108
   Nugent N, 2001, IRISH J MED SCI, V170, P236
   Patel NA, 2004, AM SURGEON, V70, P696
   Pelosi E, 2003, NUCL MED COMMUN, V24, P519, DOI 10.1097/01.mnh.0000071245.54690.7a
   Pelosi E, 2004, J NUCL MED, V45, P220
   Perkins AC, 1999, NUCL MED COMMUN, V20, P309, DOI 10.1097/00006231-199904000-00005
   Pitre S, 2003, EUR J NUCL MED MOL I, V30, P339, DOI 10.1007/s00259-002-1064-2
   Posther KE, 2004, SEMIN ONCOL, V31, P426, DOI 10.1053/j.seminoncol.2004.03.019
   Quan ML, 2004, SEMIN ONCOL, V31, P311, DOI 10.1056/j.seminoncol.2004.03.012
   Radovanovic Z, 2004, EJSO, V30, P913, DOI 10.1016/j.ejso.2004.08.003
   RECHT A, 1988, INT J RADIAT ONCOL, V14, P477
   Reynolds C, 1999, J CLIN ONCOL, V17, P1720
   Rose C, 2002, NUCL MED COMMUN, V23, P613, DOI 10.1097/00006231-200207000-00004
   Sakorafas GH, 2004, EJSO, V30, P807, DOI 10.1016/j.ejso.2004.06.020
   SAPHIR O, 1948, CANCER, V1, P238, DOI 10.1002/1097-0142(194807)1:2<238::AID-CNCR2820010208>3.0.CO;2-U
   Schillaci O, 2002, TUMORI, V88, pS32
   Scopinaro F, 2000, TUMORI, V86, P329
   Shen J, 2004, CANCER, V101, P1330, DOI 10.1002/cncr.20515
   Stratmann SL, 1999, AM J SURG, V178, P454, DOI 10.1016/S0002-9610(99)00230-5
   Strzelczyk I, 2004, Health Phys, V86, pS31
   Styblo T, 2001, SEMIN ROENTGENOL, V36, P261, DOI 10.1053/sroe.2001.25115
   Susnik B, 2004, ANN SURG ONCOL, V11, P568, DOI 10.1245/ASO.2004.10.021
   Tiourina T, 1998, EUR J NUCL MED, V25, P1224, DOI 10.1007/s002590050288
   Torrenga H, 2004, J SURG ONCOL, V88, P4, DOI 10.1002/jso.20101
   Tsuchimochi M, 2003, EUR J NUCL MED MOL I, V30, P1605, DOI 10.1007/s00259-003-1301-3
   Turner RR, 1997, ANN SURG, V226, P271, DOI 10.1097/00000658-199709000-00006
   Turner RR, 2001, WORLD J SURG, V25, P798
   Turner RR, 2000, CANCER, V89, P574, DOI 10.1002/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y
   van Lingen A, 1999, EUR J NUCL MED, V26, P183
   Vargas HI, 2003, AM SURGEON, V69, P886
   Vidal-Sicart S, 2003, EUR J NUCL MED MOL I, V30, P362, DOI 10.1007/s00259-002-1051-7
   Waddington W A, 2000, Eur J Nucl Med, V27, P377, DOI 10.1007/s002590050520
   Wawroschek F, 2003, UROL INT, V71, P129, DOI 10.1159/000071833
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   Wood TF, 2002, J GASTROINTEST SURG, V6, P322, DOI 10.1016/S1091-255X(02)00013-6
   Yamaguchi Y, 2002, P SOC PHOTO-OPT INS, V4786, P103, DOI 10.1117/12.456318
   Zanzonico P, 2000, SEMIN NUCL MED, V30, P33, DOI 10.1016/S0001-2998(00)80060-4
   Zornoza G, 2004, EUR J SURG ONCOL, V30, P15, DOI 10.1016/j.ejso.2003.10.010
NR 98
TC 46
Z9 47
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0001-2998
J9 SEMIN NUCL MED
JI Semin. Nucl. Med.
PD APR
PY 2005
VL 35
IS 2
BP 116
EP 128
DI 10.1053/j.semnuclmed.2004.11.003
PG 13
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 908GH
UT WOS:000227775000004
PM 15765374
ER

PT J
AU Straka, H
   Dieringer, N
AF Straka, H
   Dieringer, N
TI Basic organization principles of the VOR: lessons from frogs
SO PROGRESS IN NEUROBIOLOGY
LA English
DT Review
ID CENTRAL-NERVOUS-SYSTEM; 2ND-ORDER VESTIBULAR NEURONS;
   METHYL-D-ASPARTATE; PIGEON COLUMBA-LIVIA; SEMICIRCULAR CANAL AFFERENTS;
   HEN GALLUS-DOMESTICUS; COMPARATIVE TRANSDUCTION MECHANISMS; METABOTROPIC
   GLUTAMATE RECEPTORS; INNERVATING OTOLITH ORGANS; COMPENSATORY
   EYE-MOVEMENTS
AB Locomotion is associated with a number of optical consequences that degrade visual information processing in the absence of appropriate compensatory movements. The resulting retinal image flow is counteracted by coordinated eye-head reflexes that are initiated by optokinetic and vestibular inputs. The contribution of the vestibulo-ocular reflex (VOR) for stabilizing retinal images is relatively small in amplitude in frogs but important in function by compensating for the non-linearities of the neck motor system. The spatial tuning of the VOR networks underlying the angular (AVOR) and linear (LVOR) with respect to canal and extraocular motor coordinates is organized in a common, canal-related reference frame. Thereby, the axes of head and eye rotation are aligned, principle and auxiliary VOR connections transform vestibular into motor signals and parallel AVOR and LVOR circuits mediate vergence and version signals separately. Comparison of these results with data from other vertebrates demonstrates a number of fundamental organization principles common to most vertebrates. However, the fewer degrees of behavioral freedom of frogs are reflected by the absence of, e.g. a functioning velocity storage network or of a fixation suppression of the VOR. In vitro experiments with the isolated brainstem and branches of N.VIII attached were used to study the putative transmitters of vestibular nerve afferent inputs, the postsynaptic receptor subtypes of second-order vestibular neurons and their dynamic response properties. Evidence is presented that suggests that afferent vestibular nerve fibers with different dynamic response properties activate different subtypes of glutamate receptors. The convergence pattern of monosynaptic afferent nerve inputs from different labyrinthine organs onto second-order vestibular neurons is remarkably specific. As a rule, second-order vestibular neurons receive converging afferent nerve inputs from one semicircular canal and from a specific sector of hair cells on one otolith organ. This convergence pattern remains malleable even in adulthood and reorganization is initiated by activity-related changes in vestibular nerve afferent fibers. The output of second-order vestibular neurons is modified by at least three inhibitory control loops. Uncrossed inhibitory vestibular side loops appear to control specifically the dynamic response tuning, whereas coplanar commissural inhibitory inputs improve mainly the spatial tuning and the cerebellar feedback loop controls the response gain. Among the targets of second-order vestibular projection neurons are extraocular motoneurons and internuclear neurons. Extraocular motoneurons differ among each other by the presence of very different response dynamics. These differences may represent a co-adaptation to the response dynamics of twitch and non-twitch extraocular muscle fibers. Different dynamical properties are required for a rapid acceleration of the globe at the one end and for the maintenance of a stable eccentric eye position over long periods of time at the other end of a continuum of variations in dynamic response properties. The maintenance of a given eccentric eye position over long periods of time is especially well developed in frogs and assists visual surveillance during lurking in the absence of saccades. (C) 2004 Elsevier Ltd. All rights reserved.
C1 LMU Munchen, Inst Physiol, D-80336 Munich, Germany.
   Univ Paris 05, CNRS, UMR 7060, LNRS, F-75270 Paris 06, France.
RP Dieringer, N (reprint author), LMU Munchen, Inst Physiol, Pettenkoferstr 12, D-80336 Munich, Germany.
EM norbert.dieringer@med.uni-muenchen.de
CR ABEND WK, 1978, EXP BRAIN RES, V31, P459
   ABEND WK, 1977, BRAIN RES, V132, P65, DOI 10.1016/0006-8993(77)90706-5
   ADANINA VO, 1976, EVOL BIOCH PHYSL, V11, P282
   AGOSTI R, 1986, EXP BRAIN RES, V61, P291
   AMAT J, 1984, NEUROSCIENCE, V11, P885, DOI 10.1016/0306-4522(84)90199-4
   Andrianov GN, 2000, NEUROREPORT, V11, P183, DOI 10.1097/00001756-200001170-00036
   ANGELAKI DE, 1993, J NEUROPHYSIOL, V69, P996
   ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1729
   ANNONI JM, 1984, J NEUROSCI, V4, P2106
   ARENDS JJA, 1991, J COMP NEUROL, V306, P273, DOI 10.1002/cne.903060205
   ARENDS JJA, 1991, J COMP NEUROL, V306, P221, DOI 10.1002/cne.903060203
   ASCHER P, 1994, NMDA RECEPTOR, P177
   ASHCROFT DW, 1934, J LARYNG, V49, P450, DOI 10.1017/S002221510004041X
   Auclair F, 1999, J COMP NEUROL, V411, P288, DOI 10.1002/(SICI)1096-9861(19990823)411:2<288::AID-CNE9>3.0.CO;2-U
   AUTRUM H, 1959, NATURWISSENSCHAFTEN, V46, P435
   Babalian A, 1997, NEUROSCIENCE, V81, P405, DOI 10.1016/S0306-4522(97)00069-9
   BABALIAN AL, 1984, BRAIN RES, V309, P163, DOI 10.1016/0006-8993(84)91023-0
   Bacskai T, 2002, BRAIN RES BULL, V57, P317, DOI 10.1016/S0361-9230(01)00707-9
   BAIRD RA, 1986, BRAIN RES, V369, P48, DOI 10.1016/0006-8993(86)90512-3
   BAIRD RA, 1992, ANN NY ACAD SCI, V656, P12, DOI 10.1111/j.1749-6632.1992.tb25197.x
   BAIRD RA, 1994, J NEUROPHYSIOL, V71, P666
   BAIRD RA, 1994, J COMP NEUROL, V342, P279, DOI 10.1002/cne.903420210
   BAIRD RA, 1994, J NEUROPHYSIOL, V71, P685
   Baker R, 1998, OTOLARYNG HEAD NECK, V119, P263, DOI 10.1016/S0194-5998(98)70061-0
   BANGMA GC, 1983, J COMP NEUROL, V220, P453
   Baurle J, 1997, NEUROREPORT, V8, P2443
   BAURMANN M, 1921, KLIN MBL AUGENHEILK, V56, P393
   BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0
   Bennett M.V.L., 1972, P221
   BERNARD C, 1985, BRAIN RES, V338, P225, DOI 10.1016/0006-8993(85)90151-9
   Birinyi A, 2001, BRAIN RES, V921, P44, DOI 10.1016/S0006-8993(01)03075-X
   BIRUKOW G, 1937, Z VERGL PHYSIOL, V25, P92, DOI 10.1007/BF00348495
   BIRUKOW G, 1952, Z VERGL PHYSIOL, V34, P448, DOI 10.1007/BF00297878
   Blair EA, 1933, AM J PHYSIOL, V106, P524
   BLANKS RHI, 1976, EXP BRAIN RES, V25, P369
   BLANKS RHI, 1978, BRAIN RES, V150, P295, DOI 10.1016/0006-8993(78)90281-0
   BLANKS RHI, 1988, NEUROANATOMY OCULOMO, P225
   BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648
   BROUSSARD DM, 1992, J NEUROPHYSIOL, V68, P1906
   Bruce LL, 1997, INT J DEV NEUROSCI, V15, P671, DOI 10.1016/S0736-5748(96)00120-7
   Buttner-Ennever JA, 2001, J COMP NEUROL, V438, P318, DOI 10.1002/cne.1318
   BUTTNERENNEVER JA, 1992, ANN NY ACAD SCI, V656, P363, DOI 10.1111/j.1749-6632.1992.tb25222.x
   Buttner-Ennever JA, 1999, ANN NY ACAD SCI, V871, P51, DOI 10.1111/j.1749-6632.1999.tb09175.x
   Cambronero F, 2000, J COMP NEUROL, V427, P522, DOI 10.1002/1096-9861(20001127)427:4<522::AID-CNE3>3.0.CO;2-Y
   CARPENTER DO, 1992, ANN NY ACAD SCI, V656, P668, DOI 10.1111/j.1749-6632.1992.tb25244.x
   CARPENTER MB, 1990, J HIRNFORSCH, V31, P585
   CASTON J, 1977, J COMP PHYSIOL, V118, P273
   ChenHuang C, 1997, EXP BRAIN RES, V114, P405, DOI 10.1007/PL00005650
   CHRISTENSENDALSGAARD J, 1993, J COMP PHYSIOL A, V172, P653
   CHRISTENSENDALSGAARD J, 1988, J COMP PHYSIOL A, V162, P633, DOI 10.1007/BF01342638
   CHUN KS, 1978, BIOL CYBERN, V28, P209, DOI 10.1007/BF00344268
   COCHRAN SL, 1987, SYNAPSE, V1, P102, DOI 10.1002/syn.890010114
   COCHRAN SL, 1995, BRAIN RES, V670, P321, DOI 10.1016/0006-8993(94)01357-N
   COCHRAN SL, 1992, SOC NEUR ABSTR, V18
   COCHRAN SL, 1984, J NEUROSCI, V4, P43
   COCHRAN SL, 1980, NEUROSCIENCE, V5, P1629, DOI 10.1016/0306-4522(80)90027-5
   COCHRAN SL, 1977, BRAIN RES, V121, P362, DOI 10.1016/0006-8993(77)90160-3
   COLLEWIJN H, 1989, PROG BRAIN RES, V80, P197
   Cortopassi KA, 1998, BRAIN BEHAV EVOLUT, V51, P331, DOI 10.1159/000006546
   Cortopassi KA, 1996, J VESTIBUL RES-EQUIL, V6, P105
   CROMMELINCK M, 1982, DOCUMENTA OPHTALMOLO, V34, P379
   CUENOD M, 1983, METHODS CHEM NEUROAN, V1, P365
   CURTHOYS IS, 1977, ACTA OTO-LARYNGOL, V83, P258, DOI 10.3109/00016487709128843
   DAUNICHT WJ, 1986, EXP BRAIN RES, V64, P535, DOI 10.1007/BF00340491
   de No RL, 1933, ARCH NEURO PSYCHIATR, V30, P245
   de Burlet HM, 1929, J COMP NEUROL, V47, P155, DOI 10.1002/cne.900470202
   DEMEMES D, 1990, HEARING RES, V46, P261, DOI 10.1016/0378-5955(90)90007-C
   DEMEMES D, 1984, BRAIN RES, V304, P188, DOI 10.1016/0006-8993(84)90880-1
   DEWAELE C, 1995, BRAIN RES REV, V20, P24, DOI 10.1016/0165-0173(94)00004-9
   Diaz C, 2002, BRAIN RES BULL, V57, P307, DOI 10.1016/S0361-9230(01)00673-6
   Diaz C, 1998, DEV BIOL, V202, P14, DOI 10.1006/dbio.1998.8986
   Dickman JD, 2002, J NEUROPHYSIOL, V88, P3518, DOI 10.1152/jn.00518.2002
   Dickman JD, 1996, J COMP NEUROL, V367, P110
   Dieringer N, 2003, ANN NY ACAD SCI, V1004, P50, DOI 10.1196/annals.1303.006
   DIERINGER N, 1992, BRAIN BEHAV EVOLUT, V39, P289, DOI 10.1159/000114126
   DIERINGER N, 1986, NATURWISSENSCHAFTEN, V73, P330, DOI 10.1007/BF00451484
   DIERINGER N, 1994, INFORMATION PROCESSI, P151
   DIERINGER N, 1982, EXP BRAIN RES, V47, P394
   DIERINGER N, 1983, J COMP PHYSIOL, V153, P495
   DIERINGER N, 1979, EXP BRAIN RES, V36, P311, DOI 10.1007/BF00238914
   DIERINGER N, 1982, EXP BRAIN RES, V47, P407
   DIERINGER N, 1977, NATURE, V269, P431, DOI 10.1038/269431a0
   DIERINGER N, 1995, PROG NEUROBIOL, V46, P97, DOI 10.1016/0301-0082(94)00063-N
   DIERINGER N, 1987, BRAIN RES, V404, P33, DOI 10.1016/0006-8993(87)91352-7
   DIERINGER N, 1986, J COMP PHYSIOL A, V158, P179, DOI 10.1007/BF01338561
   DIERINGER N, 1984, J PHYSL, V353, P50
   DOI K, 1990, EXP BRAIN RES, V82, P254
   DUNN RF, 1978, J COMP NEUROL, V182, P621, DOI 10.1002/cne.901820405
   EPEMA AH, 1988, EXP BRAIN RES, V71, P129
   ESTES MS, 1975, J NEUROPHYSIOL, V38, P1232
   EVINGER C, 1991, LIFE SCI R, V50, P23
   Evinger C, 1988, Rev Oculomot Res, V2, P81
   Ewald JR, 1892, PHYSL UNTERSUCHUNGEN
   FABER DS, 1980, NEUROSCIENCE, V5, P433, DOI 10.1016/0306-4522(80)90118-9
   FERNANDE.C, 1971, J NEUROPHYSIOL, V34, P661
   FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P996
   FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970
   FINCH DJ, 1983, PROC R SOC SER B-BIO, V217, P491, DOI 10.1098/rspb.1983.0022
   FITE KV, 1973, BEHAV BIOL, V9, P707, DOI 10.1016/S0091-6773(73)80131-2
   FLOCK A, 1983, HEARING RES, V11, P249, DOI 10.1016/0378-5955(83)90060-6
   Fritzsch B, 1999, SING AUDIOL TEXTBK, P31
   Furuya N, 1998, ACTA OTO-LARYNGOL, V118, P64
   Gacek R R, 1969, Acta Otolaryngol Suppl, V254, P1
   GAILLARD F, 1985, J COMP PHYSIOL A, V157, P47, DOI 10.1007/BF00611094
   GALLE H, 1973, EQUILIB RES, V3, P33
   Galvani L., 1791, VIRIBUS ELECT MOTU M
   GILLAND E, 1993, ACTA ANAT, V148, P110
   GIOANNI H, 1993, VISUAL NEUROSCI, V10, P947
   GIOANNI H, 1988, EXP BRAIN RES, V69, P583, DOI 10.1007/BF00247311
   GIOANNI H, 1988, EXP BRAIN RES, V69, P567, DOI 10.1007/BF00247310
   GIOGLIO L, 1995, ARCH HISTOL CYTOL, V58, P1, DOI 10.1679/aohc.58.1
   GLEISNER L, 1973, ACTA OTO-LARYNGOL, V76, P199, DOI 10.3109/00016487309121500
   Glover JC, 2001, BRAIN RES BULL, V55, P683, DOI 10.1016/S0361-9230(01)00562-7
   Glover JC, 2000, PROG BRAIN RES, V124, P3
   GLOVER JC, 1991, J NEUROBIOL, V22, P353, DOI 10.1002/neu.480220405
   Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033
   GOLDBERG JM, 1987, J NEUROPHYSIOL, V58, P700
   GOLDBERG JM, 1980, J NEUROPHYSIOL, V43, P986
   GOLDBERG JM, 1990, J NEUROPHYSIOL, V63, P781
   Goldberg JM, 1998, OTOLARYNG HEAD NECK, V119, P165, DOI 10.1016/S0194-5998(98)70051-8
   GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236
   GONZALEZ A, 1984, ANAT EMBRYOL, V169, P167, DOI 10.1007/BF00303146
   Goto F, 2001, J NEUROPHYSIOL, V85, P2643
   Goto F, 2000, J NEUROPHYSIOL, V84, P581
   Goto F, 2002, EXP BRAIN RES, V147, P374, DOI 10.1007/s00221-002-1266-7
   GRAF W, 1983, SCIENCE, V221, P777, DOI 10.1126/science.6603656
   GRAF W, 1981, DEV NEUROSCIENCE, V12, P411
   GREGORY KM, 1972, BRAIN BEHAV EVOLUT, V5, P70, DOI 10.1159/000123738
   GROBSTEIN P, 1977, NATURE, V269, P54, DOI 10.1038/269054a0
   GROFOVA I, 1972, BRAIN RES, V42, P189, DOI 10.1016/0006-8993(72)90052-2
   GROVER BG, 1984, CELL TISSUE RES, V237, P259, DOI 10.1007/BF00217144
   GUTH PS, 1988, HEARING RES, V33, P223, DOI 10.1016/0378-5955(88)90152-9
   Guth PS, 1998, PROG NEUROBIOL, V54, P193, DOI 10.1016/S0301-0082(97)00068-3
   Guth PS, 1998, HEARING RES, V125, P154, DOI 10.1016/S0378-5955(98)00145-2
   GUTH PS, 1994, HEARING RES, V75, P225, DOI 10.1016/0378-5955(94)90073-6
   GUTH PS, 1991, HEARING RES, V56, P69, DOI 10.1016/0378-5955(91)90155-3
   GUTH PS, 1994, HEARING RES, V73, P109, DOI 10.1016/0378-5955(94)90288-7
   HACKETT JT, 1972, BRAIN RES, V48, P385, DOI 10.1016/0006-8993(72)90195-3
   HACKETT JT, 1974, BRAIN RES, V80, P527, DOI 10.1016/0006-8993(74)91038-5
   Harada Y, 2001, ACTA OTO-LARYNGOL, V121, P355
   HARRIS AJ, 1965, J EXP BIOL, V43, P107
   Hellmann B, 1996, BRAIN BEHAV EVOLUT, V47, P185, DOI 10.1159/000113238
   Hendricson AW, 2002, HEARING RES, V172, P99, DOI 10.1016/S0378-5955(02)00519-1
   Hendricson AW, 2002, NEUROREPORT, V13, P1765, DOI 10.1097/00001756-200210070-00014
   HESS BJM, 1984, NEUROSCIENCE, V11, P645, DOI 10.1016/0306-4522(84)90050-2
   HESS BJM, 1984, EXP BRAIN RES, V55, P570
   HESS BJM, 1990, EUR J NEUROSCI, V2, P909, DOI 10.1111/j.1460-9568.1990.tb00003.x
   HESS BJM, 1991, J NEUROPHYSIOL, V66, P1805
   HIGHSTEIN SM, 1981, ANN NY ACAD SCI, V374, P102, DOI 10.1111/j.1749-6632.1981.tb30864.x
   HIGHSTEI.SM, 1971, BRAIN RES, V29, P358, DOI 10.1016/0006-8993(71)90043-6
   HIGHSTEIN SM, 1992, J COMP NEUROL, V319, P501, DOI 10.1002/cne.903190404
   HIGHSTEIN SM, 1991, NEUROSCI RES, V12, P13, DOI 10.1016/0168-0102(91)90096-H
   Hillman D.E., 1976, P452
   HIRAOKA I, 1995, ACTA OTO-LARYNGOL, P253
   Holler S, 2001, EXP BRAIN RES, V137, P190, DOI 10.1007/s002210000670
   Holt JC, 2000, HEARING RES, V146, P17, DOI 10.1016/S0378-5955(00)00092-7
   HONRUBIA V, 1981, INT J NEUROSCI, V15, P197, DOI 10.3109/00207458108985857
   HONRUBIA V, 1985, LARYNGOSCOPE, V95, P1526
   HONRUBIA V, 1989, J NEUROPHYSIOL, V61, P688
   HORN E, 1986, J COMP PHYSIOL A, V159, P869, DOI 10.1007/BF00603740
   HOUSLEY GD, 1990, HEARING RES, V43, P121, DOI 10.1016/0378-5955(90)90221-A
   HOUSLEY GD, 1989, HEARING RES, V38, P259, DOI 10.1016/0378-5955(89)90070-1
   Hursh JB, 1939, AM J PHYSIOL, V127, P131
   Ishiyama G, 2002, BRAIN RES, V935, P16, DOI 10.1016/S0006-8993(02)02419-8
   Isu N, 2000, EXP BRAIN RES, V131, P262, DOI 10.1007/s002219900292
   ITO M, 1969, EXP BRAIN RES, V7, P214
   JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0
   JONES GM, 1963, PROC R SOC SER B-BIO, V157, P403, DOI 10.1098/rspb.1963.0019
   JORGENSEN MB, 1991, J COMP PHYSIOL A, V169, P341
   Kaas J., 2000, NEW COGNITIVE NEUROS, P223
   Kaiser A, 1996, J COMP NEUROL, V374, P108
   KASAHARA M, 1971, BRAIN RES, V34, P366, DOI 10.1016/0006-8993(71)90288-5
   KASAHARA M, 1974, EXP BRAIN RES, V20, P285
   KEVETTER GA, 1995, SOC NEUR ABSTR, V20
   KEVETTER GA, 1989, BRAIN BEHAV EVOLUT, V34, P193, DOI 10.1159/000116505
   KILARSKI W, 1969, Z ZELLFORSCH MIK ANA, V94, P194, DOI 10.1007/BF00339356
   KINNEY GA, 1994, J NEUROPHYSIOL, V72, P1588
   KLINKE R, 1974, PHYSIOL REV, V54, P316
   KNOPFEL T, 1984, J COMP PHYSIOL, V154, P233, DOI 10.1007/BF00604988
   KNOPFEL T, 1987, BRAIN RES, V426, P212, DOI 10.1016/0006-8993(87)90875-4
   Knöpfel T, 1988, Adv Otorhinolaryngol, V42, P229
   KOPP J, 1984, BRAIN BEHAV EVOLUT, V25, P187, DOI 10.1159/000118864
   KORN H, 1977, NEUROSCIENCE, V2, P851, DOI 10.1016/0306-4522(77)90111-7
   KORN H, 1973, EXP BRAIN RES, V16, P255
   KOYAMA H, 1982, BRAIN RES, V250, P168, DOI 10.1016/0006-8993(82)90964-7
   KUFFLER SW, 1947, J NEUROPHYSIOL, V10, P395
   KULIK A, 1994, ACTA BIOL HUNG, V45, P323
   Kumar SS, 1999, J NEUROSCI, V19, P1620
   KUNKEL AW, 1994, J COMP PHYSIOL A, V174, P621
   KURUVILLA A, 1985, LARYNGOSCOPE, V95, P692
   Kushiro K, 2000, EXP BRAIN RES, V131, P406, DOI 10.1007/s002219900312
   LABANDEIRA-GARCIA JL, 1989, J COMP NEUROL, V282, P523, DOI 10.1002/cne.902820405
   LACOUR M, 1987, EXP BRAIN RES, V65, P559
   Ladhams A, 1996, J COMP NEUROL, V366, P335, DOI 10.1002/(SICI)1096-9861(19960304)366:2<335::AID-CNE11>3.0.CO;2-O
   LANNOU J, 1976, PFLUG ARCH EUR J PHY, V366, P143, DOI 10.1007/BF00585869
   Larsell O, 1967, COMP ANATOMY HISTOLO
   LEWIS ER, 1975, BRAIN RES, V83, P35, DOI 10.1016/0006-8993(75)90856-2
   LEWIS ER, 1982, SCIENCE, V215, P1641, DOI 10.1126/science.6978525
   Lewis ER, 1999, COMP HEARING FISH AM, P101
   LEWIS MR, 1989, SYNAPSE, V3, P149, DOI 10.1002/syn.890030206
   Li H, 1997, NEUROSCIENCE, V77, P473, DOI 10.1016/S0306-4522(96)00468-X
   LIN JW, 1988, J NEUROSCI, V8, P1302
   LIN JW, 1988, J NEUROSCI, V8, P1313
   LISBERGER SG, 1984, J NEUROPHYSIOL, V52, P1140
   Llinas R., 1976, P892
   Luksch H, 1996, J NEUROSCI METH, V70, P91, DOI 10.1016/S0165-0270(96)00107-0
   MACKAY WA, 1979, PROG NEUROBIOL, V13, P361, DOI 10.1016/0301-0082(79)90004-2
   MacNAUGHTAN I P J, 1946, J Laryngol Otol, V61, P204, DOI 10.1017/S0022215100007842
   MAGHERIN.PC, 1974, PFLUG ARCH EUR J PHY, V349, P149, DOI 10.1007/BF00586625
   MAGHERINI PC, 1975, PFLUG ARCH EUR J PHY, V356, P99, DOI 10.1007/BF00584290
   MANLEY GA, 1991, HEARING RES, V6, P211
   MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x
   MARKHAM CH, 1977, BRAIN RES, V138, P99, DOI 10.1016/0006-8993(77)90786-7
   Matesz C, 2002, J COMP NEUROL, V444, P115, DOI 10.1002/cne.10137
   MATESZ C, 1988, ACTA BIOL HUNG, V39, P267
   MATESZ C, 1977, ACTA BIOL ACAD SCI H, V28, P461
   MATESZ C, 1979, NEUROSCIENCE, V4, P2061, DOI 10.1016/0306-4522(79)90078-2
   MATESZ C, 1996, ACTA BIOL HUNG, V47, P323
   MATESZ C, 1990, DEV BRAIN RES, V51, P179, DOI 10.1016/0165-3806(90)90274-3
   MATESZ C, 1990, NEUROSCI LETT, V116, P1, DOI 10.1016/0304-3940(90)90376-K
   MCCORMICK CA, 1994, BRAIN BEHAV EVOLUT, V43, P189, DOI 10.1159/000113634
   MCCUE MP, 1994, J NEUROSCI, V14, P6058
   McNally WJ, 1933, Q J EXP PHYSIOL, V23, P147
   McNally WJ, 1925, AM J PHYSIOL, V75, P155
   MEIER RK, 1993, EXP BRAIN RES, V96, P54
   METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202
   MINOR LB, 1991, J NEUROSCI, V11, P1636
   MOFFAT AJM, 1976, J COMP PHYSIOL, V105, P1
   MONAGHAN DT, 1985, J NEUROSCI, V5, P2909
   MONTGOMERY NM, 1988, BRAIN BEHAV EVOLUT, V31, P82, DOI 10.1159/000116577
   MUGNAINI E, 1967, EXP BRAIN RES, V4, P146
   MUNOZ M, 1995, BRAIN RES BULL, V36, P433, DOI 10.1016/0361-9230(94)00233-Q
   MYERS SF, 1990, BRAIN RES, V534, P15, DOI 10.1016/0006-8993(90)90107-M
   Myers SF, 1997, J NEUROPHYSIOL, V77, P2061
   NAITO Y, 1995, HEARING RES, V87, P141, DOI 10.1016/0378-5955(95)00085-I
   NAKAJIMA Y, 1974, J COMP NEUROL, V156, P375, DOI 10.1002/cne.901560402
   Newlands SD, 2003, BRAIN RES BULL, V60, P475, DOI 10.1016/S0361-9230(03)00051-0
   Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0
   ORREGO F, 1979, NEUROSCIENCE, V4, P1037, DOI 10.1016/0306-4522(79)90186-6
   Ottersen OP, 1998, PROG NEUROBIOL, V54, P127, DOI 10.1016/S0301-0082(97)00054-3
   OZAWA S, 1974, EXP BRAIN RES, V19, P394
   PANTLE C, 1995, EXP BRAIN RES, V106, P28
   Pantle C, 1998, J COMP PHYSIOL A, V182, P475, DOI 10.1007/s003590050195
   PANZANELLI P, 1994, BRAIN RES, V662, P293, DOI 10.1016/0006-8993(94)90829-X
   PAPALOPULU N, 1991, DEVELOPMENT, V113, P1145
   PELLEGRINI M, 1985, BRAIN RES, V344, P1, DOI 10.1016/0006-8993(85)91183-7
   Pereda AE, 1996, J NEUROSCI, V16, P983
   PETRALIA RS, 1994, J NEUROSCI, V14, P667
   PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107
   PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309
   PEUSNER KD, 1994, NEUROSCIENCE, V58, P99, DOI 10.1016/0306-4522(94)90158-9
   PEUSNER KD, 1992, DEV AUDITORY VESTIBU, V2, P489
   Popper P, 1997, MOL BRAIN RES, V44, P21, DOI 10.1016/S0169-328X(96)00210-0
   PRECHT W, 1974, EXP BRAIN RES, V19, P377
   PRECHT W, 1973, BRAIN RES, V62, P222, DOI 10.1016/0006-8993(73)90631-8
   PRIGIONI I, 1990, HEARING RES, V46, P253, DOI 10.1016/0378-5955(90)90006-B
   RAMPRASHAD F, 1986, ACTA OTO-LARYNGOL, P1
   RAMPRASHAD F, 1984, AM J ANAT, V169, P295, DOI 10.1002/aja.1001690306
   Reichenberger I, 1997, J COMP NEUROL, V377, P149
   REICHENBERGER I, 1993, NEUROSCI LETT, V154, P89, DOI 10.1016/0304-3940(93)90178-N
   REICHENBERGER I, 1994, J COMP NEUROL, V349, P603, DOI 10.1002/cne.903490408
   Retzius G., 1881, GEHORORGAN WIRBELTIE
   Robbins R. G., 1967, Acta Oto-laryngologica, V64, P436, DOI 10.3109/00016486709139130
   Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x
   ROBINSON DA, 1985, ADAPTIVE MECH GAZE C, P297
   ROCK MK, 1980, J NEUROPHYSIOL, V44, P135
   Rohregger M, 2002, J NEUROPHYSIOL, V87, P385
   ROSSI ML, 1991, BRAIN RES, V555, P123, DOI 10.1016/0006-8993(91)90868-V
   ROSSI ML, 1980, BRAIN RES, V185, P125, DOI 10.1016/0006-8993(80)90677-0
   SANS A, 1972, BRAIN RES, V44, P337, DOI 10.1016/0006-8993(72)90307-1
   Sato H, 2000, EXP BRAIN RES, V131, P253
   SATO K, 1995, NEUROSCIENCE, V64, P459, DOI 10.1016/0306-4522(94)00335-3
   SCHNEIDER D, 1954, Z VERGL PHYSIOL, V36, P147, DOI 10.1007/BF00297744
   SCHWARZ DWF, 1986, ACTA OTO-LARYNGOL, V102, P463, DOI 10.3109/00016488609119432
   SCHWEIGART G, 1988, BEHAV BRAIN RES, V31, P121, DOI 10.1016/0166-4328(88)90015-0
   SERAFIN M, 1992, EXP BRAIN RES, V88, P187, DOI 10.1007/BF02259140
   SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110
   SHIMAZU H, 1966, J NEUROPHYSIOL, V29, P467
   Shimazu H, 1972, Prog Brain Res, V37, P177, DOI 10.1016/S0079-6123(08)63902-3
   SIMON H, 1993, NEURON, V11, P209, DOI 10.1016/0896-6273(93)90179-U
   SIMPSON JI, 1981, ANN NY ACAD SCI, V374, P20, DOI 10.1111/j.1749-6632.1981.tb30856.x
   Simpson JI, 1985, ADAPTIVE MECH GAZE C, P3
   SOLOMON D, 1992, J NEUROPHYSIOL, V67, P1146
   SOMMERKAMP HERMANN, 1928, ARCH EXT PATH U PHARMAKOL, V128, P99, DOI 10.1007/BF01863244
   SONNTAG R, 1987, NEUROSCI LETT, V77, P143, DOI 10.1016/0304-3940(87)90576-3
   Sotelo C, 1978, Int Rev Cytol, V55, P67
   Sotelo C, 1977, NEURON CONCEPT TODAY, P17
   SPENCER RF, 1989, J NEUROSCI, V9, P2718
   STARR PA, 1991, HEARING RES, V52, P23, DOI 10.1016/0378-5955(91)90185-C
   STEHOUWER DJ, 1987, BRAIN RES, V410, P264, DOI 10.1016/0006-8993(87)90323-4
   STEHOUWER DJ, 1988, DEV PSYCHOBIOL, V21, P383, DOI 10.1002/dev.420210409
   STEIN BM, 1967, AM J ANAT, V120, P281, DOI 10.1002/aja.1001200205
   STRAKA H, 1999, NEUROCHEMISTRY VESTI, P47
   Straka H, 1996, NEUROSCIENCE, V70, P697, DOI 10.1016/S0306-4522(96)83008-9
   Straka H, 1997, J NEUROPHYSIOL, V78, P1363
   STRAKA H, 2002, SOC NEUR ABSTR, V28
   STRAKA H, 2000, SOC NEUR ABSTR, V26, P310
   Straka H, 2002, BRAIN RES BULL, V57, P301, DOI 10.1016/S0361-9230(01)00670-0
   Straka H, 1998, BIOL BULL, V195, P220, DOI 10.2307/1542849
   Straka H, 2000, EXP BRAIN RES, V135, P462, DOI 10.1007/s002210000544
   Straka H, 2001, J COMP NEUROL, V437, P42, DOI 10.1002/cne.1268
   Straka H, 2003, J NEUROPHYSIOL, V90, P3501, DOI 10.1152/jn.00372.2003
   STRAKA H, 1993, EUR J NEUROSCI, V5, P251, DOI 10.1111/j.1460-9568.1993.tb00491.x
   STRAKA H, 1991, J COMP NEUROL, V312, P537, DOI 10.1002/cne.903120405
   Straka H, 1996, NEUROSCIENCE, V70, P685, DOI 10.1016/S0306-4522(96)83007-7
   Straka H, 1996, J NEUROPHYSIOL, V76, P3087
   Straka H, 2002, J NEUROPHYSIOL, V88, P2287, DOI 10.1152/jn.00370.2002
   STRAKA H, 1992, NEUROSCI LETT, V140, P67, DOI 10.1016/0304-3940(92)90683-X
   Straka H, 2000, BRAIN RES, V880, P70, DOI 10.1016/S0006-8993(00)02768-2
   Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0
   SUAREZ C, 1985, LARYNGOSCOPE, V95, P1238
   SUGAI T, 1991, JPN J PHYSIOL, V41, P217, DOI 10.2170/jjphysiol.41.217
   Suwa H, 1999, ANN NY ACAD SCI, V871, P1, DOI 10.1111/j.1749-6632.1999.tb09171.x
   Suwa H., 1998, Society for Neuroscience Abstracts, V24, P1411
   Suzuki J., 1988, ADV AUDIOL, V4, P1
   SUZUKI M, 1987, ARCH OTO-RHINO-LARYN, V244, P215, DOI 10.1007/BF00455308
   SZENTAGOTHAI J, 1950, J NEUROPHYSIOL, V13, P395
   Szentagothar J, 1943, ARCH PSYCHIAT NERVEN, V116, P721, DOI 10.1007/BF01873687
   Tait J, 1934, PHILOS T ROY SOC B, V224, P241, DOI 10.1098/rstb.1934.0019
   TAKAHASHI Y, 1994, BRAIN RES, V659, P287, DOI 10.1016/0006-8993(94)90895-8
   TENDONKELAAR HJ, 1987, ADV ANAT EMBRYOL CEL, V107, P1
   UCHINO Y, 1981, BRAIN RES, V223, P273, DOI 10.1016/0006-8993(81)91141-0
   Uchino Y, 2001, Biol Sci Space, V15, P375, DOI 10.2187/bss.15.375
   Uchino Y, 1997, J NEUROPHYSIOL, V77, P3003
   Uchino Y, 2001, EXP BRAIN RES, V136, P421, DOI 10.1007/s002210000611
   UCHINO Y, 1986, NEUROSCI LETT, V70, P210, DOI 10.1016/0304-3940(86)90465-9
   USAMI S, 1991, BRAIN RES, V555, P153, DOI 10.1016/0006-8993(91)90872-S
   USAMI S, 1995, BRAIN RES, V676, P285, DOI 10.1016/0006-8993(95)00099-C
   Usami S I, 2001, Biol Sci Space, V15, P367, DOI 10.2187/bss.15.367
   VALLI P, 1986, BRAIN RES, V362, P92, DOI 10.1016/0006-8993(86)91402-2
   VALLI P, 1985, BRAIN RES, V330, P1, DOI 10.1016/0006-8993(85)90002-2
   VALLI P, 1974, ACTA OTO-LARYNGOL, V78, P51, DOI 10.3109/00016487409126325
   VANDERLINDEN JAM, 1987, ANAT EMBRYOL, V176, P431
   Vidal PP, 1999, ADV OTO-RHINO-LARYNG, V55, P26
   VIDAL PP, 1982, EXP BRAIN RES, V46, P448
   Vidal PP, 1996, BRAIN RES BULL, V40, P347, DOI 10.1016/0361-9230(96)00123-2
   WADAN K, 1994, BIOL CYBERN, V70, P533
   WALBERG F, 1990, EXP BRAIN RES, V79, P547
   WERMAN R, 1966, COMP BIOCHEM PHYSIOL, V18, P745, DOI 10.1016/0010-406X(66)90209-X
   Wersall J., 1974, HDB SENSORY PHYSIOLO, V6, P123
   WERSALL J, 1965, COLD SPRING HARB SYM, V30, P115
   WERSALL J, 1956, Acta Otolaryngol Suppl, V126, P1
   WILCZYNSKI W, 1981, J COMP NEUROL, V198, P421, DOI 10.1002/cne.901980304
   WILL U, 1982, CELL TISSUE RES, V225, P673
   WILL U, 1991, BRAIN BEHAV EVOLUT, V37, P317, DOI 10.1159/000114368
   WILLIS KG, 1985, J RURAL STUD, V1, P147, DOI 10.1016/0743-0167(85)90067-1
   WILSON VJ, 1968, J NEUROPHYSIOL, V31, P176
   WILSON VJ, 1972, J NEUROPHYSIOL, V35, P253
   WOLD JE, 1978, J COMP NEUROL, V179, P393, DOI 10.1002/cne.901790209
   WOLD JE, 1979, EXP BRAIN RES, V34, P217
   WOLD JE, 1978, BRAIN BEHAV EVOLUT, V15, P41, DOI 10.1159/000123771
   Won MH, 1996, NEUROSCI LETT, V217, P129, DOI 10.1016/0304-3940(96)13088-3
   WULLIMANN MF, 1989, J COMP NEUROL, V289, P554, DOI 10.1002/cne.902890403
   WYLIE RM, 1973, BRAIN RES, V50, P179, DOI 10.1016/0006-8993(73)90605-7
   YANG XD, 1991, P NATL ACAD SCI USA, V88, P4299, DOI 10.1073/pnas.88.10.4299
   YLIKOSKI J, 1984, ACTA OTO-LARYNGOL, V97, P523, DOI 10.3109/00016488409132930
   Zakir M, 2000, EXP BRAIN RES, V132, P139, DOI 10.1007/s002210000336
   Zhang X, 2002, EXP BRAIN RES, V147, P407, DOI 10.1007/s00221-002-1273-8
   Zhang X, 2001, EXP BRAIN RES, V140, P1, DOI 10.1007/s002210100764
   ZUCCA G, 1992, HEARING RES, V63, P52, DOI 10.1016/0378-5955(92)90073-V
NR 362
TC 46
Z9 47
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0301-0082
J9 PROG NEUROBIOL
JI Prog. Neurobiol.
PD JUL
PY 2004
VL 73
IS 4
BP 259
EP 309
DI 10.1016/j.pneurobio.2004.05.003
PG 51
WC Neurosciences
SC Neurosciences & Neurology
GA 842MI
UT WOS:000223008000002
PM 15261395
ER

PT J
AU Warner, KG
   O'Brien, PKH
   Rhodes, J
   Kaur, A
   Robinson, DA
   Payne, DD
AF Warner, KG
   O'Brien, PKH
   Rhodes, J
   Kaur, A
   Robinson, DA
   Payne, DD
TI Expanding the indications for pulmonary valve replacement after repair
   of tetralogy of Fallot
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID RIGHT-VENTRICULAR-FUNCTION; OUTFLOW TRACT OBSTRUCTION; EXERCISE
   CAPACITY; TRANSANNULAR PATCH; ADULTS LATE; REGURGITATION; INSERTION;
   INSUFFICIENCY; PERFORMANCE; ARRHYTHMIA
AB Background. Insertion of a competent pulmonary valve has been advocated to reduce right ventricular volume overload associated with pulmonary regurgitation (PR) after repair of tetralogy of Fallot. However the indications, proper timing, and long-term benefits of restoring pulmonary valve function remain controversial.
   Methods. Thirty-six patients (aged 15.2 +/- 9.2 years) underwent pulmonary valve implantation (31 homografts, 5 heterografts) 12.2 +/- 6.9 years after tetralogy repair. Additional surgical procedures included pulmonary artery augmentation (n = 14), closure of septal defects (n = 10), and cryoablation and endocardial resection of ventricular tachycardia (n = 2).
   Results. All patients have had clinical improvement in their exercise capacity. Preoperative and postoperative bicycle ergometry tests in 6 patients demonstrated significant improvement in the percent of predicted peak workload (68.5% +/- 19.8% to 80.7% +/- 17.4%, p < 0.015). One midterm death occurred in a 38-year-old patient with a history of ventricular tachycardia who died suddenly 2 years after pulmonary valve insertion. Postoperative echocardiographic measurements were available in 34 patients at a mean follow-up of 5 years. There was a 30% reduction in right ventricular end-diastolic diameter indexed to body surface area after surgery (30.1 +/- 10.2 to 18.6 +/- 6.0 mm/m(2), p < 0.0001). Two patients required conduit replacements at 1 and 9 years postoperatively.
   Conclusions. Timely insertion of a competent pulmonary valve in children, adolescents, and young adults with significant PR after tetralogy of Fallot repair results in subjective and objective improvement in exercise capacity and is associated with reduction in right ventricle size. (C) 2003 by The Society of Thoracic Surgeons.
C1 Tufts Univ, New England Med Ctr, Div Cardiothorac Surg, Boston, MA 02111 USA.
   Tufts Univ, New England Med Ctr, Div Pediat Cardiol, Boston, MA 02111 USA.
   Tufts Univ, Sch Med, Boston Floating Hosp, Boston, MA 02111 USA.
RP Warner, KG (reprint author), Tufts Univ, New England Med Ctr, Div Cardiothorac Surg, Box 266,750 Washington St, Boston, MA 02111 USA.
CR BOVE EL, 1985, J THORAC CARDIOV SUR, V90, P50
   CARVALHO JS, 1992, BRIT HEART J, V67, P470
   Conte S, 1999, EUR J CARDIO-THORAC, V15, P143, DOI 10.1016/S1010-7940(98)00306-6
   de Ruijter FTH, 2002, ANN THORAC SURG, V73, P1794, DOI 10.1016/S0003-4975(02)03586-5
   Discigil B, 2001, J THORAC CARDIOV SUR, V121, P344, DOI 10.1067/mtc.2001.111209
   d'Udekem Y, 1998, J HEART VALVE DIS, V7, P450
   Eyskens B, 2000, AM J CARDIOL, V85, P221, DOI 10.1016/S0002-9149(99)00640-2
   Frater RWM, 1998, J HEART VALVE DIS, V7, P48
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1
   Hazekamp MG, 2001, EUR J CARDIO-THORAC, V19, P667, DOI 10.1016/S1010-7940(01)00656-X
   Helbing WA, 2002, HEART, V88, P515, DOI 10.1136/heart.88.5.515
   ILBAWI MN, 1987, J THORAC CARDIOV SUR, V93, P36
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   KONDO C, 1995, CIRCULATION S, V2, P250
   MARX GR, 1988, AM J CARDIOL, V61, P595, DOI 10.1016/0002-9149(88)90771-0
   Rhodes J, 1998, AM J CARDIOL, V81, P1217, DOI 10.1016/S0002-9149(98)00095-2
   ROWE SA, 1991, J AM COLL CARDIOL, V17, P461
   SAUL JP, 2001, ADULT TETRALOGY FALL, P61
   Schamberger MS, 2000, PEDIATR CARDIOL, V21, P244, DOI 10.1007/s002460010050
   Singh GK, 1998, AM J CARDIOL, V81, P1378, DOI 10.1016/S0002-9149(98)00171-4
   Therrien J, 2001, CIRCULATION, V103, P2489
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8
   WARNER KG, 1993, CIRCULATION, V88, P189
   WASSERMAN K, 1994, PRINCIPLES EXERCISE, P112
   WEI L, 2001, CIRCULATION S, V17, P431
   Yetman AT, 2001, AM J CARDIOL, V87, P1021, DOI 10.1016/S0002-9149(01)01443-6
NR 28
TC 46
Z9 47
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD OCT
PY 2003
VL 76
IS 4
BP 1066
EP 1071
DI 10.1016/S0003-4975(03)00748-3
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 728LD
UT WOS:000185717900021
PM 14529986
ER

PT J
AU Cheville, AL
   McGarvey, CL
   Petrek, JA
   Russo, SA
   Thiadens, SRJ
   Taylor, ME
AF Cheville, AL
   McGarvey, CL
   Petrek, JA
   Russo, SA
   Thiadens, SRJ
   Taylor, ME
TI The grading of lymphedema in oncology clinical trials
SO SEMINARS IN RADIATION ONCOLOGY
LA English
DT Article
ID BREAST-CANCER PATIENTS; AXILLARY DISSECTION; MAGNETIC-RESONANCE; ARM
   EDEMA; BIOELECTRICAL-IMPEDANCE; PSYCHOLOGICAL DISTRESS; EXTREMITY
   LYMPHEDEMA; NODE DISSECTION; SOMA SCALE; DIAGNOSIS
C1 Univ Penn, Hlth Syst, Dept Rehabil Med, Philadelphia, PA 19104 USA.
   NIH, Dept Rehabil Med, Warren Magnuson Clin Ctr, Bethesda, MD 20892 USA.
   Mem Sloan Kettering Canc Ctr, Evelyn H Lauder Breast Ctr, New York, NY 10021 USA.
   Columbia Presbyterian Med Ctr, Dept Radiat Oncol, New York, NY 10032 USA.
   Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA.
   Natl Lymphedema Network, Oakland, CA USA.
RP Cheville, AL (reprint author), Univ Penn, Hlth Syst, Dept Rehabil Med, 5 West Gates,3400 Spruce St, Philadelphia, PA 19104 USA.
CR American Physical Therapy Association, 2001, GUID PHYS THER PRACT
   Astrom KGO, 2001, ACTA RADIOL, V42, P409, DOI 10.1080/028418501127346909
   Balzarini A, 2001, LYMPHOLOGY, V34, P152
   BATES DO, 1994, LYMPHOLOGY, V27, P159
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604
   CASLEYSMITH JR, 1994, LYMPHOLOGY, V27, P56
   CasleySmith JR, 1995, LYMPHOLOGY, V28, P174
   CHEVILLE A, 2002, AC PHYS MED MED REH
   CHEVILLE A, 2002, AC PHYS MED REH ANN
   CLODIUS L, 1996, LYMPHOLOGY, V9, P1
   Cornish BH, 1996, BREAST CANCER RES TR, V38, P169, DOI 10.1007/BF01806671
   Cornish BH, 1998, APPL RADIAT ISOTOPES, V49, P651, DOI 10.1016/S0969-8043(97)00266-2
   Cornish BH, 2001, LYMPHOLOGY, V34, P2
   DOLDI SB, 1992, LYMPHOLOGY, V25, P129
   DUEWELL S, 1992, RADIOLOGY, V184, P227
   FUJII K, 1994, ACTA RADIOL, V35, P262
   GERBER L, 1992, BREAST CANCER RES TR, V21, P139, DOI 10.1007/BF01836960
   Gniadecka M, 1996, BRIT J DERMATOL, V135, P218, DOI 10.1111/j.1365-2133.1996.tb01150.x
   GOLTNER E, 1985, DEUT MED WOCHENSCHR, V110, P949, DOI 10.1055/s-2008-1068937
   Harwood CA, 1995, CLIN DERMATOL, V13, P459, DOI 10.1016/0738-081X(95)00096-X
   HUANG A, 1994, SKELETAL RADIOL, V23, P483
   Johansson S, 2002, INT J RADIAT ONCOL, V52, P1207, DOI 10.1016/S0360-3016(01)02743-2
   KERAMOPOULOS A, 1993, ONCOLOGY, V50, P445
   Kiel KD, 1996, RADIOLOGY, V198, P279
   LACTCHFORD S, 1997, LYMPHOLOGY, V30, P161
   Liljegren G, 1997, EUR J CANCER, V33, P193, DOI 10.1016/S0959-8049(96)00375-9
   LIN PP, 1993, J CLIN ONCOL, V11, P1536
   LINDAHL OA, 1995, PHYSIOL MEAS, V16, P17, DOI 10.1088/0967-3334/16/1/002
   Liu NF, 1998, LYMPHOLOGY, V31, P119
   Loprinzi CL, 1999, NEW ENGL J MED, V340, P346, DOI 10.1056/NEJM199902043400503
   MAUNSELL E, 1993, CAN J SURG, V36, P315
   Meek AG, 1998, CANCER, V83, P2788, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2788::AID-CNCR27>3.0.CO;2-I
   Misselwitz B, 2002, INVEST RADIOL, V37, P146, DOI 10.1097/00004424-200203000-00007
   NORMAN SA, 1981, PHYS THER, V6, P1192
   Paci E, 1996, TUMORI, V82, P321
   Passik SD, 1995, PSYCHO-ONCOL, V4, P255, DOI 10.1002/pon.2960040402
   PAVY JJ, 1995, INT J RADIAT ONCOL, V31, P1043, DOI 10.1016/0360-3016(95)00059-8
   PAVY JJ, 1995, RADIOTHER ONCOL, V35, P11, DOI 10.1016/0167-8140(95)97448-M
   Petrek JA, 2001, CANCER, V92, P1368, DOI 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9
   Ramaiah KD, 1997, TROP MED INT HEALTH, V2, P832, DOI 10.1046/j.1365-3156.1997.d01-406.x
   SANDER AP, 2002, J APTA, V82, P1201
   Schrenk P, 2000, CANCER, V88, P608, DOI 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K
   SEGERSTROM K, 1991, SCAND J PLAST RECONS, V25, P241
   SENOFSKY GM, 1991, ARCH SURG-CHICAGO, V126, P1336
   Stanton AWB, 1997, LYMPHOLOGY, V30, P77
   TOBIN M, 1993, CANCER, V172, P3248
   WARD LC, 1992, EUR J CLIN INVEST, V22, P751, DOI 10.1111/j.1365-2362.1992.tb01440.x
   WERNER RS, 1991, RADIOLOGY, V180, P177
NR 49
TC 46
Z9 49
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 1053-4296
J9 SEMIN RADIAT ONCOL
JI Semin. Radiat. Oncol.
PD JUL
PY 2003
VL 13
IS 3
BP 214
EP 225
DI 10.1016/S1053-4296(03)00038-9
PG 12
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 710FN
UT WOS:000184670300006
PM 12903011
ER

PT J
AU Rossi, CR
   Foletto, M
   Di Filippo, F
   Vaglini, M
   Anza, M
   Azzarelli, A
   Pilati, P
   Mocellin, S
   Lise, M
AF Rossi, CR
   Foletto, M
   Di Filippo, F
   Vaglini, M
   Anza, M
   Azzarelli, A
   Pilati, P
   Mocellin, S
   Lise, M
TI Soft tissue limb sarcomas - Italian clinical trials with hyperthermic
   antiblastic perfusion
SO CANCER
LA English
DT Article
DE soft tissue sarcoma; hyperthermic perfusion; doxorubicin; tumor necrosis
   factor-alpha
ID LOCALIZED PROSTATE-CANCER; RADICAL PROSTATECTOMY; THERAPY
AB BACKGROUND. Of the different options for limb-sparing treatment for patients with soft tissue limb sarcomas (STLS), hyperthermic antiblastic perfusion (HAP) combined with surgery might be the most effective in terms of tumor resectability, local control, and aesthetic and functional results. The aim of this study was to identify the most safe, active, and effective perfusional regimen in order to improve multidisciplinary treatment for patients with advanced STLS.
   METHODS. The first trial undertaken (which involved 18 patients) was a Phase I study to assess the maximum tolerable dose of doxorubicin, the second (with 29 patients) was a Phase II study of HAP with doxorubicin, and the third (with 20 patients) was a Phase I-II study to assess the maximum tolerable dose and tumor response to doxorubicin combined with tumor necrosis factor (TNF). Statistical tests were performed on the whole series to evaluate the factors influencing local toxicity, tumor response, and local disease free and overall survival.
   RESULTS. Grade IV systemic toxicity was observed in only 2 cases (TNF >1 mg). Muscle temperature (>41.5 degrees C) was the limiting factor for locoregional toxicity. Limb-sparing surgery was feasible for 60 patients (92.3%). The highest tumor response was observed in the third trial, with complete histologic necrosis in 26.3% of cases. Muscle and tumor temperature (>41.5 degrees C) and the type of trial had a statistically significant influence on response. The local recurrence rate was influenced by tumor site, type of trial, maximum tumor temperature, and local toxicity, whereas the overall survival was influenced by the presence of metastasis, tumor grade, and response to treatment.
   CONCLUSIONS. These findings show that HAP with doxorubicin and TNF (less than or equal to 1 mg) at a muscle temperature of less than or equal to 41.5 degrees C is a safe, active, and effective perfusional regimen for the multidisciplinary treatment of patients with advanced STLS. (C) 1999 American Cancer Society.
C1 Univ Padua, Clin Chirurg 2, I-35128 Padua, Italy.
   Ist Regina Elena, I-00161 Rome, Italy.
   Ist Tumori, Milan, Italy.
RP Rossi, CR (reprint author), Univ Padua, Clin Chirurg 2, Via Giustiniani 2, I-35128 Padua, Italy.
CR BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   D'Amico AV, 1998, INT J RADIAT ONCOL, V42, P507, DOI 10.1016/S0360-3016(98)00271-5
   MCNEAL JE, 1986, LANCET, V1, P60
   Presti JC, 1998, UROLOGY, V52, P1079, DOI 10.1016/S0090-4295(98)00373-2
   ROY JN, 1993, INT J RADIAT ONCOL, V26, P163, DOI 10.1016/0360-3016(93)90188-2
   SCHENCK JF, 1995, RADIOLOGY, V195, P805
   SCHIEBLER ML, 1993, RADIOLOGY, V189, P339
NR 9
TC 46
Z9 47
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0008-543X
J9 CANCER
JI Cancer
PD NOV 1
PY 1999
VL 86
IS 9
BP 1742
EP 1749
DI 10.1002/(SICI)1097-0142(19991101)86:9<1742::AID-CNCR16>3.0.CO;2-G
PG 8
WC Oncology
SC Oncology
GA 251EB
UT WOS:000083430700016
PM 10547547
ER

PT J
AU KHAR, A
AF KHAR, A
TI CHARACTERIZATION OF SPONTANEOUS IMMUNOLOGICAL REGRESSION IN A
   HISTIOCYTOMA .1. ROLE OF NK CELLS AND ANTITUMOR ANTIBODIES
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE SPONTANEOUS TUMOR REJECTION; NATURAL KILLER CELLS; ADCC
ID NATURAL-KILLER CELLS; TUMOR REJECTION; SUPPRESSOR CELLS; T-CELLS;
   LYMPHOCYTES; INTERFERON; MECHANISM; IMMUNITY; ANTIGENS; GAMMA
AB The mechanism of regression of a rat macrophage-like tumor, AK-5 in syngeneic hosts is studied. Tumor rejecting animals produce antitumor antibodies which are cytotoxic to AK-5 cells in the presence of complement. About 30-50% of the animals do not develop the tumor when immune spleen cells are used in adoptive transfer of immunity assays. The cytotoxicity of immune spleen cells is totally lost on treating the effector cell fraction with anti-Thy. 1 and complement, indicating the involvement of thy. 1 positive cells in the rejection of AK-5. OX-8 (CD8) positive subset of natural killer cells is cytotoxic to AK-5 cells in vitro in the presence of anti-AK-5. Effector cells, when treated with either OX-8 or SH-34 (anti-asialo-GM1) monoclonals and complement, lost the cytotoxic activity against AK-5 cells suggesting the role for OX-8+ NK cells in the tumor regression. Effector cells were CD, negative since anti CD3 antibody, did not stain these cells. The animals which have rejected the tumor are immune to the subsequent tumor challenges with AK-5, however, other tumors do grow in these animals. This study demonstrates the efficiency of a multipronged attack launched by the host to overcome a rapidly growing tumor and therefore suggests a similar line of treatment for cancer immunotherapy.
RP KHAR, A (reprint author), CTR CELLULAR & MOLEC BIOL,HYDERABAD 500007,INDIA.
CR Baldwin R W, 1978, Adv Cancer Res, V28, P91, DOI 10.1016/S0065-230X(08)60647-8
   BARTH RJ, 1991, J EXP MED, V173, P647, DOI 10.1084/jem.173.3.647
   Cerottini J C, 1974, Adv Immunol, V18, P67, DOI 10.1016/S0065-2776(08)60308-9
   CHEN YH, 1985, CANCER RES, V45, P5473
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   EVANS R, 1986, BIOCHIM BIOPHYS ACTA, V865, P1, DOI 10.1016/0304-419X(86)90009-0
   FERNANDEZCRUZ E, 1980, J EXP MED, V152, P823, DOI 10.1084/jem.152.4.823
   FLOOD PM, 1980, P NATL ACAD SCI-BIOL, V77, P2209, DOI 10.1073/pnas.77.4.2209
   Fotino M, 1971, Ann Clin Lab Sci, V1, P131
   FUIJAMA S, 1985, CANCER RES, V45, P4103
   FUJIWARA H, 1986, BIOESSAYS, V4, P19, DOI 10.1002/bies.950040106
   FUST G, 1980, J IMMUNOL METHODS, V38, P281, DOI 10.1016/0022-1759(80)90276-8
   GUTIERREZ C, 1979, J IMMUNOL METHODS, V29, P57, DOI 10.1016/0022-1759(79)90125-X
   Herberman R B, 1978, Adv Cancer Res, V27, P305
   Herberman R B, 1980, Contemp Top Immunobiol, V10, P61
   HERBERMA.RB, 1973, J NATL CANCER I, V51, P1509
   HERBERMAN RB, 1986, ANNU REV IMMUNOL, V4, P651, DOI 10.1146/annurev.immunol.4.1.651
   KHAR A, 1990, INDIAN J EXP BIOL, V28, P1101
   KHAR A, 1987, IND J CANCER CHEMOTH, V9, P97
   KHAR A, 1986, J BIOCHEM BIOPH METH, V13, P161, DOI 10.1016/0165-022X(86)90089-8
   KHAR A, 1986, J NATL CANCER I, V76, P871
   KHAR A, 1993, INT J ONCOL, V2, P399
   KLEIN G, 1960, CANCER RES, V20, P1561
   Levy J P, 1977, Adv Cancer Res, V24, P1, DOI 10.1016/S0065-230X(08)61012-X
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASON DW, 1983, IMMUNOL REV, V74, P57, DOI 10.1111/j.1600-065X.1983.tb01084.x
   MOORE M, 1973, INT J CANCER, V12, P428, DOI 10.1002/ijc.2910120214
   MORTON DL, 1968, SURGERY, V64, P233
   Naor D, 1979, Adv Cancer Res, V29, P45, DOI 10.1016/S0065-230X(08)60846-5
   NELSON M, 1981, CELL IMMUNOL, V60, P34, DOI 10.1016/0008-8749(81)90245-8
   NORTH RJ, 1985, ADV CANCER RES, V45, P1, DOI 10.1016/S0065-230X(08)60265-1
   OLD LJ, 1962, ANN NY ACAD SCI, V101, P80, DOI 10.1111/j.1749-6632.1962.tb26446.x
   SOLOMON FR, 1987, MOL IMMUNOL, V24, P57, DOI 10.1016/0161-5890(87)90111-8
   THOMSON DMP, 1973, BRIT J CANCER, V28, P6, DOI 10.1038/bjc.1973.65
   TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187
   VANREIS R, 1984, J IMMUNOL, V133, P758
   WILLIAMS WH, 1972, J NATL CANCER I, V49, P1613
   WOOD GW, 1974, J NATL CANCER I, V53, P309
   WOODRUFF MFA, 1986, BIOCHIM BIOPHYS ACTA, V865, P43, DOI 10.1016/0304-419X(86)90012-0
   Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X
NR 40
TC 46
Z9 46
PU INT JOURNAL ONCOLOGY
PI ATHENS
PA C/O PROFESSOR D A SPANDIDOS, EDITORIAL OFFICE, 1, S MERKOURI ST, ATHENS
   116 35, GREECE
SN 1019-6439
J9 INT J ONCOL
JI Int. J. Oncol.
PD MAR
PY 1993
VL 2
IS 3
BP 393
EP 398
PG 6
WC Oncology
SC Oncology
GA KL816
UT WOS:A1993KL81600008
PM 21573567
ER

PT J
AU FILDES, R
AF FILDES, R
TI QUANTITATIVE FORECASTING - THE STATE OF THE ART - ECONOMETRIC-MODELS
SO JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY
LA English
DT Review
C1 BELL COMMUN RES,HOLMDEL,NJ.
RP FILDES, R (reprint author), MANCHESTER BUSINESS SCH,MANCHESTER M15 6PB,LANCS,ENGLAND.
RI Weller, Matt/E-8421-2010
CR AITKIN M, 1982, BIOMETRICS, V38, P511, DOI 10.2307/2530465
   AMEMIYA T, 1980, INT ECON REV, V21, P331, DOI 10.2307/2526185
   ANSLEY CF, 1980, J ECONOMETRICS, V13, P159, DOI 10.1016/0304-4076(80)90013-5
   Armstrong J., 1985, LONG RANGE FORECASTI
   ARMSTRON.JS, 1972, MANAGE SCI B-APPL, V19, P211, DOI 10.1287/mnsc.19.2.211
   ARMSTRONG JS, 1978, J BUSIN, V51, P547
   ASHLEY R, 1983, J FORECASTING, V2, P211, DOI 10.1002/for.3980020304
   ASKIN RG, 1982, J FORECASTING, V1, P281, DOI 10.1002/for.3980010307
   BAILLIE RT, 1979, J AM STAT ASSOC, V74, P175, DOI 10.2307/2286748
   BELSLEY DA, 1984, J FORECASTING, V3, P183, DOI 10.1002/for.3980030206
   BENDEL RB, 1976, AM STAT, V30, P85, DOI 10.2307/2683800
   BOX GEP, 1980, J ROY STAT SOC A STA, V143, P383, DOI 10.2307/2982063
   Box GEP, 1976, TIME SERIES ANAL
   BRANDT JA, 1983, J FORECASTING, V2, P243
   BRODIE R, 1984, J MARKETING RES, V21, P194, DOI 10.2307/3151701
   BROWN RL, 1974, R STATIST SOC B, V37, P149
   BUNN DW, 1983, J OPER RES SOC, V34, P17, DOI 10.2307/2581599
   CARROLL RJ, 1982, J AM STAT ASSOC, V77, P878, DOI 10.2307/2287321
   CHANG HS, 1979, ANN REGIONAL SCI, V13, P8, DOI 10.1007/BF01284776
   CLEARY J, 1982, PROFESSIONAL FORECAS
   Cook R.D., 1982, RESIDUALS INFLUENCE
   COOPER RL, 1972, ECONOMETRIC MODELS C
   CORKER RJ, 1983, 98 CTR EC FOR LOND B
   COURAKIS AS, 1983, EC J, V88, P537
   COVERDALE I, 1980, J OPER RES SOC, V31, P801
   CURRIE D, 1981, ECON J, V91, P704, DOI 10.2307/2232834
   CWJ Granger, 1969, ECONOMETRICA, V37, P424, DOI DOI 10.2307/1912791
   DAVIDSON JEH, 1978, ECON J, V88, P661, DOI 10.2307/2231972
   DAVIES N, 1979, BIOMETRIKA, V66, P153, DOI 10.1093/biomet/66.1.153
   DENBUTTER FAG, 1982, INT STAT REV, V50, P267, DOI 10.2307/1402497
   DOYLE P, 1979, J OPER RES SOC, V30, P105, DOI 10.2307/3009291
   EDLUND PO, 1984, J FORECASTING, V3, P297, DOI 10.1002/for.3980030307
   ENGLE RF, 1984, SHORT RUN FORECASTIN
   EVANS GBA, 1981, ECONOMETRICA, V49, P753, DOI 10.2307/1911521
   EVANS GBA, 1984, ECONOMETRICA, V52, P1241, DOI 10.2307/1910998
   Fair R. C., 1984, SPECIFICATION ESTIMA
   FAIR RC, 1979, J POLIT ECON, V87, P701, DOI 10.1086/260789
   FAIR RC, 1980, INT ECON REV, V21, P355, DOI 10.2307/2526186
   FEARN T, 1983, J R STAT SOC C-APPL, V32, P73
   FILDES R, 1981, BIBLIO BUSINESS EC F
   FILDES R, 1979, J OPER RES SOC, V30, P691, DOI 10.2307/3009312
   FILDES R, 1984, BIBLIO BUSINESS EC F
   FILDES R, 1979, STUDIES MANAGEMENT S, P296
   FREUND RJ, 1975, AM J AGR ECON, V57, P721, DOI 10.2307/1238895
   GEMMILL G, 1980, REV ECON STAT, V62, P147, DOI 10.2307/1924286
   GEWEKE J, 1983, J ECONOMETRICS, V21, P161, DOI 10.1016/0304-4076(83)90012-X
   GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238
   GHOSH A, 1984, J MARKETING RES, V21, P202, DOI 10.2307/3151702
   GODFREY LG, 1981, REV ECON STUD, V48, P487, DOI 10.2307/2297160
   Granger C. W. J., 1978, INTRO BILINEAR TIME
   GRANGER CWJ, 1984, J FORECASTING, V3, P197, DOI 10.1002/for.3980030207
   GRANGER CWJ, 1979, FORECASTING EC TIME
   Harvey A. C., 1981, ECONOMETRIC ANAL TIM
   HARVEY AC, 1980, INT ECON REV, V21, P707, DOI 10.2307/2526363
   HARVEY AC, 1984, J AM STAT ASSOC, V79, P125, DOI 10.2307/2288346
   HATJOULLIS G, 1979, BUSIN EC         SPR
   HAUGH LD, 1977, J AM STAT ASSOC, V72, P121, DOI 10.2307/2286919
   HELMER RM, 1977, J MARKETING RES, V14, P227, DOI 10.2307/3150472
   HENDERSON HV, 1982, BIOMETRICS, V38, P511
   HENDERSON HV, 1981, BIOMETRICS, V37, P391, DOI 10.2307/2530428
   Hendry D. F., 1980, ECON MODEL, P217
   HENDRY DF, 1982, J ECONOMETRICS, V20, P3, DOI 10.1016/0304-4076(82)90101-4
   HENDRY DF, 1983, INT STAT REV, V51, P111, DOI 10.2307/1402738
   HENDRY DF, 1978, ECON J, V88, P549, DOI 10.2307/2232053
   HENDRY DF, 1974, ECONOMETRICA, V42, P559, DOI 10.2307/1911791
   Hendry D.F., 1984, HDB ECONOMETRICS, V2
   HILL CI, 1981, J OPER RES SOC, V32, P125
   HILLMER S, 1984, J FORECASTING, V3, P205, DOI 10.1002/for.3980030208
   HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336
   Intriligator M.D., 1978, ECONOMETRIC MODELS T
   IZAN HY, 1980, J ECONOMETRICS, V13, P391, DOI 10.1016/0304-4076(80)90086-X
   JENKINS GM, 1983, CASE STUDIES TIME SE
   JOHNSTON FR, 1980, J OPER RES SOC, V31, P699, DOI 10.2307/2581687
   Judge G. G., 1980, THEORY PRACTICE ECON
   KENWARD LR, 1976, CAN J ECON, V9, P517, DOI 10.2307/134498
   KLING JL, 1984, INT J FORECASTING, V1, P5
   KOENKER R, 1982, ECONOMET REV, V1, P213
   Leamer E., 1978, SPECIFICATION SEARCH
   LEAMER EE, 1983, AM ECON REV, V73, P31
   LEAMER EE, 1984, HDB ECONOMETRICS, V1
   LEEFLANG PSH, 1984, J MARKETING RES, V21, P211, DOI 10.2307/3151703
   Legasto A. A., 1980, System Dynamics
   LEVENBACH H, 1982, BEGINNING FORECASTER
   Litterman R., 1983, J BUS ECON STAT, V1, P169, DOI 10.2307/1391858
   Little J. D. C., 1970, MANAGE SCI, V16, P466, DOI 10.1287/mnsc.16.8.B466
   LIU LM, 1982, COMMUN STATIST THEOR, V11, P293
   LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.1093/biomet/65.2.297
   LONGBOTTOM JA, 1985, INT J FORECASTING, V4, P75
   LOVELL MC, 1983, REV ECON STAT, V64, P1
   MacKinnon J. G., 1983, ECONOMET REV, V2, P85, DOI 10.1080/07311768308800031
   MAYER T, 1975, ECON J, V85, P877, DOI 10.2307/2230630
   McCabe B. P. M., 1980, Applied Statistics, V29, DOI 10.2307/2986299
   MCDONALD J, 1981, J AM STAT ASSOC, V76, P782, DOI 10.2307/2287568
   MCINTYRE SH, 1983, J MARKETING RES, V20, P1, DOI 10.2307/3151406
   MCNEES SK, 1982, J FORECASTING, V1, P37, DOI 10.1002/for.3980010105
   Meese R., 1984, J BUS ECON STAT, V2, P191, DOI 10.2307/1391702
   MENDENHALL W, 1982, STATISTICS MANAGEMEN
   MIZON GE, 1977, STUDIES MODERN EC AN
   MOSKOWITZ H, 1982, OMEGA-INT J MANAGE S, V10, P647, DOI 10.1016/0305-0483(82)90067-6
   Naert P. A., 1978, BUILDING IMPLEMENTAB
   NAERT P, 1981, J MARKETING RES, V18, P146, DOI 10.2307/3150949
   NELSON CR, 1984, J BUS ECON STAT, V2, P73
   NELSON CR, 1982, J AM STAT ASSOC, V77, P1
   NEWBOLD P, 1975, OPER RES QUART, V26, P397, DOI 10.2307/3007750
   OHTANI K, 1981, REV ECON STAT, V63, P627, DOI 10.2307/1935861
   OSBORN DR, 1979, NATL I ECON REV, V27, P50
   PACK DJ, 1977, DECISION SCI, V8, P377, DOI 10.1111/j.1540-5915.1977.tb01090.x
   Pagan A. R., 1983, ECONOMET REV, V2, P159, DOI 10.1080/07311768308800039
   PESARAN MH, 1982, J ECONOMETRICS, V18, P263, DOI 10.1016/0304-4076(82)90040-9
   PETERS SC, 1985, INT J FORECASTING
   Pierce D. A., 1977, J ECONOMETRICS, V5, P265, DOI 10.1016/0304-4076(77)90039-2
   Pindyck R. S., 1981, ECONOMETRIC MODELS E
   Plosser C. I., 1977, J ECONOMETRICS, V6, P199, DOI 10.1016/0304-4076(77)90015-X
   QUADE ES, 1980, PITFALLS ANAL
   RAVEH A, 1985, INT J FORECASTING
   SARGAN JD, 1980, REV ECON STUD, V47, P113, DOI 10.2307/2297106
   SARGAN JD, 1983, ECONOMETRICA, V51, P153, DOI 10.2307/1912252
   SARGAN JD, 1975, A2 LOND SCH EC DISC
   SCHMIDT P, 1973, J AM STAT ASSOC, V68, P11, DOI 10.2307/2284132
   SCHULTZ RL, 1984, J FORECASTING, V3, P43, DOI 10.1002/for.3980030106
   SCHWERT GW, 1979, J MONETARY EC S, V10, P55
   SHARP JA, 1982, OMEGA-INT J MANAGE S, V10, P237, DOI 10.1016/0305-0483(82)90094-9
   SIMS C, 1979, CARNEGIE ROCHESTER C, V10, P1
   SPARKES JR, 1984, J FORECASTING, V3, P37, DOI 10.1002/for.3980030105
   SPITZER JJ, 1978, J AM STAT ASSOC, V73, P488, DOI 10.2307/2286587
   STAINTON R, 1983, J OPER RES SOC, V34, P657, DOI 10.1057/jors.1983.159
   STARK T, 1978, REV UK STATISTICAL S, V10
   STOTO MA, 1983, J AM STAT ASSOC, V78, P13, DOI 10.2307/2287094
   THISTED RA, 1981, J AM STAT ASSOC, V76, P516, DOI 10.2307/2287504
   THOMPSON ML, 1978, INT STAT REV, V46, P1, DOI 10.2307/1402505
   THOMPSON ML, 1978, INT STAT REV, V46, P129, DOI 10.2307/1402809
   URI ND, 1977, OMEGA-INT J MANAGE S, V5, P463, DOI 10.1016/0305-0483(77)90008-1
   WALLIS KF, 1974, J AM STAT ASSOC, V69, P18, DOI 10.2307/2285495
   Wilcox J.A., 1983, J BUSINESS EC STAT, V1, P187, DOI 10.2307/1391336
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
   WINKLER RL, 1983, J ROY STAT SOC A STA, V146, P150, DOI 10.2307/2982011
   YOUNG RM, 1982, J FORECASTING, V1, P189, DOI 10.1002/for.3980010205
   ZARNOWITZ V, 1984, J FORECASTING, V3, P11, DOI 10.1002/for.3980030103
   ZELLNER A, 1979, CARNEGIE ROCHESTER C, V10, P1
NR 139
TC 46
Z9 46
PU STOCKTON PRESS
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS
SN 0160-5682
J9 J OPER RES SOC
JI J. Oper. Res. Soc.
PY 1985
VL 36
IS 7
BP 549
EP 580
DI 10.2307/2582473
PG 32
WC Management; Operations Research & Management Science
SC Business & Economics; Operations Research & Management Science
GA AMG32
UT WOS:A1985AMG3200001
ER

PT J
AU ANDERSON, DW
   MANTEL, N
AF ANDERSON, DW
   MANTEL, N
TI ON EPIDEMIOLOGIC SURVEYS
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Letter
C1 AMER UNIV,DEPT MATH STAT & COMP SCI,BETHESDA,MD.
RP ANDERSON, DW (reprint author), NINCDS,OFF BIOMETRY & FIELD STUDIES,FED BLDG,ROOM 7C14,BETHESDA,MD 20205, USA.
CR DEMING W, 1968, INT ENCY SOCIAL SCI
   Deming WE, 1960, SAMPLE DESIGN BUSINE
   EISENHART C, 1969, PRECISION MEASUREMEN
   KESSLER II, 1970, COMMUNITY EPIDEMIOLO
   Kish L, 1965, SURVEY SAMPLING
   KURLAND LT, 1973, USES EPIDEMIOLOGY PL
   Lewis C. I., 1929, MIND WORLD ORDER OUT
   MACMAHON B, 1967, PREVENTIVE MED
   MANTEL N, 1976, AM STAT, V30, P201
   MITCHELL RG, 1961, CEREBRAL PALSY CHILD
   Moser C., 1971, SURVEY METHODS SOCIA
   Shewhart W.A., 1931, EC CONTROL QUALITY M
   SHEWHART WA, 1939, STATISTICAL METHOD V
   WILLIAMS B, 1978, SAMPLER SAMPLING
   WILLIAMS WH, 1978, AM STAT, V32, P61, DOI 10.2307/2683617
   Wilson Edgar Bright., 1952, INTRO SCI RES
   Yates F., 1981, SAMPLING METHODS CEN
NR 17
TC 46
Z9 46
PU JOHNS HOPKINS UNIV SCHOOL HYGIENE PUB HEALTH
PI BALTIMORE
PA 111 MARKET PLACE, STE 840, BALTIMORE, MD 21202-6709
SN 0002-9262
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PY 1983
VL 118
IS 5
BP 613
EP 619
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA RQ421
UT WOS:A1983RQ42100001
PM 6356888
ER

PT J
AU POTTER, M
   WALTERS, JL
AF POTTER, M
   WALTERS, JL
TI EFFECT OF INTRAPERITONEAL PRISTENE ON ESTABLISHED IMMUNITY TO ADJ-PC-5
   PLASMACYTOMA
SO JOURNAL OF THE NATIONAL CANCER INSTITUTE
LA English
DT Article
C1 NCI,LAB CELL BIOL,BETHESDA,MD 20014.
   LITTON BIONETICS INC,KENSINGTON,MD 20795.
CR ANDERSON PN, 1969, NATURE, V222, P994, DOI 10.1038/222994a0
   AOKI T, 1972, J EXP MED, V135, P443, DOI 10.1084/jem.135.3.443
   GISLER RH, 1972, CELL IMMUNOL, V4, P341, DOI 10.1016/0008-8749(72)90037-8
   HERBERMA.RB, 1972, J NATL CANCER I, V48, P265
   HERBERMA.RB, 1972, J EXP MED, V136, P94, DOI 10.1084/jem.136.1.94
   HOFFMANN M, 1971, SCIENCE, V172, P1047, DOI 10.1126/science.172.3987.1047
   HYMAN R, 1972, J NATL CANCER I, V48, P173
   LESPINAT.G, 1969, EUR J CANCER, V5, P421, DOI 10.1016/0014-2964(69)90095-4
   LYNCH RG, 1972, P NATL ACAD SCI USA, V69, P1540, DOI 10.1073/pnas.69.6.1540
   MERWIN RM, 1963, J NAT CANC, V31, P998
   MERWIN RM, 1959, P SOC EXP BIOL MED, V101, P437
   NAMBA Y, 1972, J IMMUNOL, V109, P1193
   POTTER M, 1972, J NATL CANCER I, V49, P305
   POTTER M, 1966, J MOL BIOL, V16, P334
   POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0
   POTTER M, 1964, J NATL CANCER I, V33, P497
   POTTER M, 1972, PHYSIOL REV, V52, P631
   POTTER M, 1960, J NATL CANCER I, V25, P847
   ROLLINGH.M, 1973, J NATL CANCER I, V50, P159
   SIRISINH.S, 1971, P NATL ACAD SCI USA, V68, P3130, DOI 10.1073/pnas.68.12.3130
   STOCKERT E, 1971, J EXP MED, V133, P1334, DOI 10.1084/jem.133.6.1334
   WHISSON ME, 1965, NATURE, V206, P689, DOI 10.1038/206689a0
   WHISSON ME, 1965, NATURE, V205, P406, DOI 10.1038/205406a0
   WILLIAMS WH, 1972, J NATL CANCER I, V49, P1613
NR 24
TC 46
Z9 46
PU NATL CANCER INSTITUTE
PI BETHESDA
PA 9030 OLD GEORGETOWN RD, BETHESDA, MD 20814
SN 0027-8874
J9 J NATL CANCER I
JI J. Natl. Cancer Inst.
PY 1973
VL 51
IS 3
BP 875
EP 881
PG 7
WC Oncology
SC Oncology
GA R0941
UT WOS:A1973R094100018
PM 4743559
ER

PT J
AU AKERS, DR
   FAVARA, BE
   FRANCIOS.RA
   NELSON, JM
AF AKERS, DR
   FAVARA, BE
   FRANCIOS.RA
   NELSON, JM
TI DUPLICATIONS OF ALIMENTARY-TRACT - REPORT OF 3 UNUSUAL CASES ASSOCIATED
   WITH BILE AND PANCREATIC DUCTS
SO SURGERY
LA English
DT Article
CR BASU R, 1960, BR J SURG, V47, P447
   BRADBEER JW, 1958, BRIT J SURG, V46, P603
   Brooks B, 1943, ANN SURG, V117, P728
   CHRISTEN.AH, 1970, ARCH PATHOL, V90, P423
   DONOVAN EJ, 1947, ANN SURG, V126, P289, DOI 10.1097/00000658-194709000-00004
   GITLITZ A J, 1957, J Mt Sinai Hosp N Y, V24, P875
   GORDIMER H, 1950, ANN SURG, V132, P1149, DOI 10.1097/00000658-195012000-00015
   Gross RE, 1953, SURG INFANCY CHILDHO, P221
   GROSS RE, 1952, PEDIATRICS, V9, P449
   Hudson HW, 1935, NEW ENGL J MED, V213, P1123, DOI 10.1056/NEJM193512052132302
   INOUYE WY, 1965, ANN SURG, V162, P910
   JELENKO G, 1962, AM SURG, V28, P120
   Ladd WE, 1937, SOUTH MED J, V30, P363, DOI 10.1097/00007611-193704000-00002
   LADD WE, 1941, ABDOMINAL SURG INFAN, P83
   Ladd WEGR, 1940, SURG GYNECOL OBSTET, V70, P295
   LEE CM, 1957, NEW ENGL J MED, V256, P927, DOI 10.1056/NEJM195705162562003
   MELLISH RW, 1961, PEDIATRICS, V27, P397
   MOORE TC, 1952, SURG GYNECOL OBSTET, V95, P557
   Nicholoson GW, 1923, J PATHOL BACTERIOL, V26, P399, DOI 10.1002/path.1700260310
   POLSON RA, 1953, GASTROENTEROLOGY, V25, P431
   RAVITCH MM, 1969, PEDIATRIC SURGERY, P833
   SEEL DJ, 1969, SURGERY, V66, P821
   SUMMERS FH, 1970, J AMER MED ASSOC, V214, P597
   WELCH KJ, 1969, PEDIATRIC SURGERY, P751
   WELLING RE, 1970, ARCH SURG-CHICAGO, V101, P626
   WHITTAKE.LD, 1967, SURGERY, V62, P382
   WILLIAMS WH, 1971, SURGERY, V69, P708
   WRENN EL, 1971, SURGERY, V69, P858
   1964, N ENGL J MED, V270, P736
NR 29
TC 46
Z9 46
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0039-6060
J9 SURGERY
JI Surgery
PY 1972
VL 71
IS 6
BP 817
EP &
PG 0
WC Surgery
SC Surgery
GA M6331
UT WOS:A1972M633100004
PM 5030497
ER

PT J
AU Yamamoto, T
   Narushima, M
   Doi, K
   Oshima, A
   Ogata, F
   Mihara, M
   Koshima, I
   Mundinger, GS
AF Yamamoto, Takumi
   Narushima, Mitsunaga
   Doi, Kentaro
   Oshima, Azusa
   Ogata, Fusa
   Mihara, Makoto
   Koshima, Isao
   Mundinger, Gerhard S.
TI Characteristic Indocyanine Green Lymphography Findings in Lower
   Extremity Lymphedema: The Generation of a Novel Lymphedema Severity
   Staging System Using Dermal Backflow Patterns
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID ULTRASTRUCTURAL OBSERVATIONS; FLUORESCENCE LYMPHOGRAPHY; LYMPHATIC
   VESSELS; OBSTRUCTION; RELIEF; VOLUME; DYE
AB Background: Indocyanine green lymphography has been a highly useful modality in the clinical examination and surgical management of patients with lymphedema. No formal classification system of indocyanine green imaging findings according to the severity of lymphedema exists, however. The purpose of this study was to describe, analyze, and classify characteristic indocyanine green lymphography findings to uniformly guide surgical management of lymphedema using this modality.
   Methods: Forty-five patients (78 limbs) with lower extremity lymphedema underwent indocyanine green lymphography. All lymphography images were recorded in photographs and videos. Images were reviewed and analyzed to classify characteristic findings according to clinical severity as determined by Campisi clinical lymphedema staging.
   Results: Lymphography findings were classifiable into two patterns. Mild cases of lymphedema were characterized by a linear lymphatic channel pattern (linear pattern). In more severe cases, lymphatic channels demonstrated retrograde lymphatic flow (dermal backflow pattern) and diminution or absence of linear channel patterning. Three dermal backflow patterns, splash, stardust, and diffuse, were identified and correlated with the progression of lymphedema severity. These findings supported the generation of a novel anatomical lymphedema severity staging system, the dermal backflow staging system.
   Conclusions: Indocyanine green lymphography is a safe, minimally invasive, and useful tool for the surgical evaluation of extremity lymphedema. Characteristic indocyanine green lymphography patterns are consistent and correlate with clinical severity. The dermal backflow staging system can facilitate patient stratification, discussion between referring parties, and surgical planning. (Plast. Reconstr. Surg. 127: 1979, 2011.)
C1 [Yamamoto, Takumi] Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan.
   Johns Hopkins Univ Hosp, Div Plast Reconstruct & Maxillofacial Surg, Baltimore, MD 21287 USA.
RP Yamamoto, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
EM tyamamoto-tky@umin.ac.jp
FU Princess Takamatsu Cancer Research Fund [09-24120]
FX This study was supported in part by Princess Takamatsu Cancer Research
   Fund grant 09-24120 (to T.Y.). The authors thank all members of the
   Tokyo University Department of Plastic and Reconstructive Surgery for
   their help in data collection.
CR Armer JM, 2005, CANCER INVEST, V23, P76, DOI 10.1081/CNV-200048707
   BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012
   Baumeister RG, 1990, PLAST RECONSTR SURG, V85, P75
   Campisi C, 2004, WORLD J SURG, V28, P609, DOI 10.1007/s00268-004-7252-4
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   DOLDI SB, 1992, LYMPHOLOGY, V25, P129
   Foldi M, 1996, PLAST RECONSTR SURG, V97, P406
   GAMBA JL, 1983, RADIOLOGY, V149, P218
   GOLDSMIT.HS, 1967, ANN SURG, V166, P573, DOI 10.1097/00000658-196710000-00006
   Karges JR, 2003, PHYS THER, V83, P134
   KINMONTH JB, 1978, BRIT J SURG, V65, P829, DOI 10.1002/bjs.1800651202
   Koshima I, 1996, PLAST RECONSTR SURG, V97, P397, DOI 10.1097/00006534-199602000-00018
   Narushima M, 2010, PLAST RECONSTR SURG, V125, P935, DOI 10.1097/PRS.0b013e3181cb64da
   OBRIEN BM, 1977, AUST NZ J SURG, V47, P284, DOI 10.1111/j.1445-2197.1977.tb04291.x
   Ogata F, 2007, ANN PLAS SURG, V59, P180, DOI 10.1097/01.sap.0000253341.70866.54
   Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2
   PANI SP, 1995, LYMPHOLOGY, V28, P57
   Sistrunk WE, 1918, J AMER MED ASSOC, V71, P800
   STY JR, 1979, J NUCL MED, V20, P905
   Tartaglione G, 2010, NUCL MED COMMUN, V31, P547, DOI 10.1097/MNM.0b013e328338277d
   THOMPSON N, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P54
   Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023
   Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013
   Zhibin Y, 2006, ANN NUCL MED, V20, P341
NR 24
TC 45
Z9 45
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD MAY
PY 2011
VL 127
IS 5
BP 1979
EP 1986
DI 10.1097/PRS.0b013e31820cf5df
PG 8
WC Surgery
SC Surgery
GA 758FT
UT WOS:000290148100028
PM 21532424
ER

PT J
AU Broglio, SP
   Ferrara, MS
   Piland, SG
   Anderson, RB
AF Broglio, S. P.
   Ferrara, M. S.
   Piland, S. G.
   Anderson, R. B.
TI Concussion history is not a predictor of computerised neurocognitive
   performance
SO BRITISH JOURNAL OF SPORTS MEDICINE
LA English
DT Article
ID NEUROPSYCHOLOGICAL TEST PROTOCOL; SPORT-RELATED CONCUSSION; FOOTBALL
   PLAYERS; STABILITY; RECOVERY
AB Background: The long term effects of self reported concussion on neurocognitive functioning have been found to be variable.
   Objectives: To evaluate cognitive performance on the Headminder concussion resolution index (CRI) and ImPACT assessment tests of subjects with and without a history of self reported concussion.
   Methods: A retrospective analysis was completed on 235 Headminder CRI baseline assessments and 264 ImPACT baseline assessments. Participants were divided into four groups on the basis of reported number of concussions (zero, one, two, or three). Multivariate analysis of variance was used to evaluate differences between the concussion history groups on the two computer based concussion assessment programs.
   Results: Multivariate analysis of variance indicated no significant difference between those with and without a history of concussion on the CRI (Lambda = 0.963, F-(15,F- 627.05) = 0.57, p = 0.898). It also revealed no significant differences between groups on the ImPACT test (Lambda = 0.951, F-(12,F- (672.31)) = 1.07, p = 0.381).
   Conclusions: The results suggest that either long term cognitive decrements may not be associated with a history of concussion or the decrements may be subtle and undetectable by these computer programs.
C1 Univ Georgia, Dept Kinesiol, St Marys Res Lab, Athens, GA 30602 USA.
   Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL 61820 USA.
   Univ So Mississippi, Sch Human Performance & Recreat, Hattiesburg, MS 39406 USA.
   Florida Atlantic Univ, Boca Raton, FL 33431 USA.
RP Ferrara, MS (reprint author), Univ Georgia, Dept Kinesiol, St Marys Res Lab, 330 River Rd, Athens, GA 30602 USA.
EM mferrara@uga.edu
CR Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556
   Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802
   Collins MW, 2003, AM J SPORT MED, V31, P168
   Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964
   Erlanger D, 2001, J ATHL TRAINING, V36, P280
   Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5
   Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477
   Giza CC, 2001, J ATHL TRAINING, V36, P228
   Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003
   Guskiewicz K. M., 2004, J ATHL TRAINING, V29, P280
   Guskiewicz KM, 2002, AM J SPORT MED, V30, P157
   Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263
   Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651
   Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910
   KESSELMAN HJ, 1998, PSYCHOPHYSIOLOGY, V35, P470
   Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723
   McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003
   McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58
   McCrory P, 2005, BRIT J SPORT MED, V39, P196, DOI 10.1136/bjsm.2005.018614
   Pellman EJ, 2004, NEUROSURGERY, V55, P1290
   Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006
   Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
NR 23
TC 45
Z9 45
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-3674
J9 BRIT J SPORT MED
JI Br. J. Sports Med.
PD SEP
PY 2006
VL 40
IS 9
BP 802
EP 805
DI 10.1136/bjsm.2006.028019
PG 4
WC Sport Sciences
SC Sport Sciences
GA 076ZS
UT WOS:000239998100013
PM 16929049
ER

PT J
AU Desai, ND
   Miwa, S
   Kodama, D
   Koyama, T
   Cohen, G
   Pelletier, MP
   Cohen, EA
   Christakis, GT
   Goldman, BS
   Fremes, SE
AF Desai, Nimesh D.
   Miwa, Senri
   Kodama, David
   Koyama, Taadaki
   Cohen, Gideon
   Pelletier, Marc P.
   Cohen, Eric A.
   Christakis, George T.
   Goldman, Bernard S.
   Fremes, Stephen E.
TI A randomized comparison of intraoperative indocyanine green angiography
   and transit-time flow measurement to detect technical errors in coronary
   bypass grafts
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article; Proceedings Paper
CT 85th Annual Meeting of the American-Association-for-Thoracic-Surgery
CY APR 10-13, 2005
CL San Francisco, CA
SP Amer Assoc Thorac Surg
ID OFF-PUMP; ASPIRIN THERAPY; ARTERY; PATENCY; TRIAL; SURGERY; FLOWMETER;
   OPERATION
AB Background: Early coronary bypass graft failures may be preventable if identified intraoperatively. The purpose of this investigation was to compare the diagnostic accuracy of two intraoperative graft assessment techniques, transit-time ultrasound flow measurement and indocyanine green fluorescent-dye graft angiography.
   Methods: Patents undergoing isolated coronary artery bypass grafting with no contraindications for postoperative angiography were enrolled in the study. Patients were randomly assigned to be evaluated with either indocyanine green angiography (Novadaq Spy angiography system; Novadaq Technologies Inc, Concord, Ontario, Canada) and then transit-time ultrasonic flow measurement (Medtronic Medi-Stim Butterfly Flowmeter TTF measurement system; Medtronic Inc, Minneapolis, Minn) or transit-time flow then indocyanine green angiography. Patients underwent x-ray angiography on postoperative day 4. The primary end point of the trial was to determine the sensitivity and specificity of the two techniques versus reference standard x-ray angiography to detect graft occlusion or greater than 50% stenosis in the graft or perianastomotic area.
   Results: Between February 2004 and March 2005, 106 patients were enrolled and x-ray angiography was performed in 46 patients. In total, 139 grafts were reviewed with all three techniques and 12 grafts (8.2%) were demonstrated to have greater than 50% stenosis or occlusion by the reference standard. The sensitivity and specificity of indocyanine green angiography to detect greater than 50% stenosis or occlusion was 83.3% and 100%, respectively. The sensitivity and specificity of transit-time ultrasonic flow measurement to detect greater than 50% stenosis or occlusion was 25% and 98.4%, respectively. The P value for the overall comparison of sensitivity and specificity between indocyanine green angiography and transit-time flow ultrasonography was .011. The difference between sensitivity for indocyanine green angiography and transit-time flow measurement was 58% with a 95% confidence interval of 30% to 86%, P = .023.
   Conclusion: Indocyanine green angiography provides better diagnostic accuracy for detecting clinically significant graft errors than does transit-time ultrasound flow measurement.
C1 Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada.
RP Desai, ND (reprint author), 2075 Bayview Ave,Room H410, Toronto, ON M4N 3M5, Canada.
EM nimesh.desai@utoronto.ca
CR Alderman EL, 1998, J THORAC CARDIOV SUR, V116, P716, DOI 10.1016/S0022-5223(98)00431-0
   Campeau L, 1999, CIRCULATION, V99, P3241
   Canver CC, 1997, J CARDIOVASC SURG, V38, P211
   CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201
   DANCONA G, 2001, INTRAOPERATIVE GRAFT, P105
   D'Ancona G, 2000, EUR J CARDIO-THORAC, V17, P287, DOI 10.1016/S1010-7940(00)00332-8
   Desai N, 2005, J AM COLL CARDIOL, V45, p78A
   DESAI ND, 2004, NEW ENGL J MED, DOI UNSP 3512302-9
   DONNER A, 1994, AM J EPIDEMIOL, V140, P279
   Elbeery JR, 1998, ANN THORAC SURG, V66, P51, DOI 10.1016/S0003-4975(98)00377-4
   Fabricius AM, 2001, EUR J CARDIO-THORAC, V19, P853, DOI 10.1016/S1010-7940(01)00692-3
   FITZGIBBON GM, 1978, CIRCULATION, V57, P1070
   FREMES SE, 1993, EUR J CARDIO-THORAC, V7, P169, DOI 10.1016/1010-7940(93)90155-5
   GOLDMAN S, 1991, CIRCULATION, V84, P520
   Hawass NED, 1997, BRIT J RADIOL, V70, P360
   Hol PK, 2001, HEART SURG FORUM, V4, P254
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   LOUAGIE YAG, 1994, ANN THORAC SURG, V58, P742
   LOUAGIE YAG, 1994, ANN THORAC SURG, V57, P357
   MOHR FW, 1991, EUR J CARDIO-THORAC, V5, P534, DOI 10.1016/1010-7940(91)90107-U
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Rubens FD, 2002, HEART SURG FORUM, V5, P141
   Walporth BH, 2005, ANN THORAC SURG, V79, P857, DOI 10.1016/j.athoracsur.2004.07.051
NR 24
TC 45
Z9 45
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD SEP
PY 2006
VL 132
IS 3
BP 585
EP 594
DI 10.1016/j.jtcvs.2005.09.061
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 077NY
UT WOS:000240037700026
PM 16935114
ER

PT J
AU Hoffman, LA
   Tasota, FJ
   Zullo, TG
   Scharfenberg, C
   Donahoe, MP
AF Hoffman, LA
   Tasota, FJ
   Zullo, TG
   Scharfenberg, C
   Donahoe, MP
TI Outcomes of care managed by an acute care nurse practitioner/attending
   physician team in a subacute medical intensive care unit
SO AMERICAN JOURNAL OF CRITICAL CARE
LA English
DT Article
ID CHRONICALLY CRITICALLY ILL; PROLONGED MECHANICAL VENTILATION; ACUTE
   CARENURSE PRACTITIONERS; TIME-AND-MOTION; ILLNESS; COST; FACILITIES;
   IMPACT; EXPERIENCE; MORTALITY
AB BACKGROUND Many academic medical centers emploly nurse practitioners as substitutes to provide care normally supplied by house staff.
   OBJECTIVE To compare outcomes in a subacute medical intensive care unit of patients managed by a team consisting of either an acute care nurse practitioner and an attending physician or an attending physician and critical care/pulmonary follows.
   METHODS During a 31-month period, in 7-month blocks of time, 526 consecutive patients admitted to the unit for more than 24 hours were managed by one or the other of the teams. Patients managed by the 2 teams were compared for a variety of outcomes.
   RESULTS Patients managed by the 2 teams did not differ sign ificantly for any workload, demographic, or medical condition variable. The patients also did not clef,fer in readmission to the high acuity unit (P = .25) or subacute unit (P = .44) within 72 hours qf discharge or in mortaliiy with (P = .25) or without (P = .89) treatment limitations. Among patients who had multiple weaning trials, patients managed by the 2 teams did not differ in length of stay in the subacute unit (P = .42), duration of mechanical ventilation (P = .18), weaning status at time of discharge from the unit (P = .80), or disposition (P = .28). A cute Physiology Scores were significantly dif ferent over time (P = .046). Patients managed by the fellows had more reintubations (P =.02).
   CONCLUSIONS In a subacute intensive care unit, management by the 2 teams produced equivalent outcomes. (American Journal of Critical Care. 2005; 14: 121-132)
C1 Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, Sch Nursing, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA.
RP Hoffman, LA (reprint author), Univ Pittsburgh, Sch Nursing, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA.
CR Accreditation Council for Graduate Medical Education, 2012, ACGME DUT HOURS STAN
   Brilli RJ, 2001, CRIT CARE MED, V29, P2007, DOI 10.1097/00003246-200110000-00026
   Burke TA, 2000, J NURS ADMIN, V30, P118, DOI 10.1097/00005110-200003000-00003
   Burns S M, 1998, Am J Crit Care, V7, P45
   Burns SM, 2003, CRIT CARE MED, V31, P2752, DOI 10.1097/01.CCM.0000094217.07170.75
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Dahle KL, 1998, AM J CARDIOL, V82, P686, DOI 10.1016/S0002-9149(98)00389-0
   DALY BJ, 1991, HEART LUNG, V20, P45
   Dasgupta A, 1999, CHEST, V116, P447, DOI 10.1378/chest.116.2.447
   Douglas S, 1996, NURS RES, V45, P73, DOI 10.1097/00006199-199603000-00003
   Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502
   Ewart GW, 2004, CHEST, V125, P1518, DOI 10.1378/chest.125.4.1518
   FINKLER SA, 1993, HEALTH SERV RES, V28, P577
   Gracey DR, 2000, MAYO CLIN PROC, V75, P445
   Hoffman LA, 2003, AM J CRIT CARE, V12, P436
   Howie JN, 2002, AM J CRIT CARE, V11, P448
   Hravnak M, 1998, AACN Clin Issues, V9, P283, DOI 10.1097/00044067-199805000-00012
   Hravnak M, 1995, Am J Crit Care, V4, P179
   Junker C, 2002, CHEST, V121, P1253, DOI 10.1378/chest.121.4.1253
   Kelley MA, 2004, CHEST, V125, P1514, DOI 10.1378/chest.125.4.1514
   Kersten A, 2003, CRIT CARE MED, V31, pA8
   KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619
   Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004
   KRISHNAN JA, 2004, AM J RESP CRIT CARE, V169, P973
   Manthous CA, 1997, MAYO CLIN PROC, V72, P391
   Marelich GP, 2000, CHEST, V118, P459, DOI 10.1378/chest.118.2.459
   MCCARTHY TP, 1998, RESP CARE, V43, P114
   McCusker ME, 2002, AM J INFECT CONTROL, V30, P139, DOI 10.1067/mic.2002.121662
   McMullen M, 2001, Dimens Crit Care Nurs, V20, P30, DOI 10.1097/00003465-200109000-00008
   Nasraway SA, 2000, CRIT CARE MED, V28, P19, DOI 10.1097/00003246-200001000-00004
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Chelluri L, 2002, CHEST, V121, P549
   Rosenthal GE, 1998, ARCH INTERN MED, V158, P1144, DOI 10.1001/archinte.158.10.1144
   Rudy E B, 1998, Am J Crit Care, V7, P267
   Rudy EB, 1995, NURS RES, V44, P324
   Russell D, 2002, AM J CRIT CARE, V11, P353
   SCHEINHORN DJ, 2002, CHEST, V122, pS37
   Scheinhorn DJ, 2001, CHEST, V120, p482S, DOI 10.1378/chest.120.6_suppl.482S
   Seneff MG, 2000, CRIT CARE MED, V28, P342, DOI 10.1097/00003246-200002000-00009
   SPISSO J, 1990, J TRAUMA, V30, P660, DOI 10.1097/00005373-199006000-00001
   Swoboda SM, 2002, AM J CRIT CARE, V11, P459
   van Soeren M H, 2001, AACN Clin Issues, V12, P424, DOI 10.1097/00044067-200108000-00010
NR 42
TC 45
Z9 47
PU AMER ASSOC CRITICAL CARE NURSES
PI ALISO VIEJO
PA 101 COLUMBIA, ALISO VIEJO, CA 92656 USA
SN 1062-3264
J9 AM J CRIT CARE
JI Am. J. Crit. Care
PD MAR
PY 2005
VL 14
IS 2
BP 121
EP 130
PG 10
WC Critical Care Medicine; Nursing
SC General & Internal Medicine; Nursing
GA 904DX
UT WOS:000227477400006
PM 15728954
ER

PT J
AU Chassot, PG
   van der Linden, P
   Zaugg, M
   Mueller, XM
   Spahn, DR
AF Chassot, PG
   van der Linden, P
   Zaugg, M
   Mueller, XM
   Spahn, DR
TI Off-pump coronary artery bypass surgery: physiology and anaesthetic
   management
SO BRITISH JOURNAL OF ANAESTHESIA
LA English
DT Review
DE anaesthesia, cardiovascular; complications, intraoperative myocardial
   ischaemia; heart, manipulation technique; monitoring; outcome studies;
   surgery, off-pump coronary artery bypass
ID BEATING-HEART-SURGERY; LEFT-VENTRICULAR FUNCTION; HIGH-RISK PATIENTS;
   INTRAOPERATIVE TRANSESOPHAGEAL ECHOCARDIOGRAPHY; THORACIC
   EPIDURAL-ANESTHESIA; ACUTE MYOCARDIAL-INFARCTION; OCTOPUS TISSUE
   STABILIZER; CARDIOPULMONARY BYPASS; ON-PUMP; CARDIAC-SURGERY
AB Increasing interest is being shown in beating heart (off-pump) coronary artery surgery (OPCAB) because, compared with operations performed with cardiopulmonary bypass, OPCAB surgery may be associated with decreased postoperative morbidity and reduced total costs. Its appears to produce better results than conventional surgery in high-risk patient populations, elderly patients, and those with compromised cardiac function or coagulation disorders. Recent improvements in the technique have resulted in the possibility of multiple-vessel grafting in all coronary territories, with a graft patency comparable with conventional surgery. During beating-heart surgery, anaesthetists face two problems: first, the maintenance of haemodynamic stability during heart enucleation necessary for accessing each coronary artery; and second, the management of intraoperative myocardial ischaemia when coronary flow must be interrupted during grafting. The anaesthetic technique is less important than adequate management of these two major constraints. However, experimental and recent clinical data suggest that volatile anaesthetics have a marked cardioprotective effect against ischaemia, and might be specifically indicated. OPCAB surgery requires team work between anaesthetists and surgeons, who must be aware of each other's constraints. Some surgical aspects of the operation are reviewed along with physiological and anaesthetic data.
C1 CHU Vaudois, Univ Lausanne Hosp, Dept Anaesthesiol, CH-1011 Lausanne, Switzerland.
   CHU Vaudois, Univ Lausanne Hosp, Dept Cardiovasc Surg, CH-1011 Lausanne, Switzerland.
   CHU Brugmann, Dept Cardiac Anaesthesiol, B-1020 Brussels, Belgium.
   Univ Zurich Hosp USZ, Inst Anasthesiol, CH-8091 Zurich, Switzerland.
RP Spahn, DR (reprint author), CHU Vaudois, Univ Lausanne Hosp, Dept Anaesthesiol, CH-1011 Lausanne, Switzerland.
EM donat.spahn@chuv.hospvd.ch
CR Akpinar B, 2001, HEART SURG FORUM, V4, P236
   Akpinar B, 2001, HEART SURG FORUM, V4, P231
   Al-Ruzzeh S, 2001, EUR J CARDIO-THORAC, V20, P1152, DOI 10.1016/S1010-7940(01)00978-2
   Al-Ruzzeh S, 2003, CIRCULATION, V108, P1, DOI 10.1161/01.cir.0000087440.59920.a1
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Arom KV, 2000, ANN THORAC SURG, V69, P704, DOI 10.1016/S0003-4975(99)01510-6
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X
   Bams JL, 1999, BRIT J ANAESTH, V82, P33
   Belhomme D, 1999, CIRCULATION, V100, P340
   BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312
   Bergsland J, 1999, ANN THORAC SURG, V68, P1428, DOI 10.1016/S0003-4975(99)00935-2
   Bettex DA, 2002, CAN J ANAESTH, V49, P711
   Bouchard D, 1998, EUR J CARDIO-THORAC, V14, pS20
   Bowles BJ, 2001, CHEST, V119, P25, DOI 10.1378/chest.119.1.25
   Boyd WD, 1999, ANN THORAC SURG, V68, P1490, DOI 10.1016/S0003-4975(99)00951-0
   Brown PM, 1999, CIRCULATION, V100, P125
   BUFFINGTON CW, 1985, ANESTHESIOLOGY, V63, P651, DOI 10.1097/00000542-198512000-00016
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   Bull DA, 2001, ANN THORAC SURG, V71, P173
   Bull DA, 2001, ANN THORAC SURG, V71, P170, DOI 10.1016/S0003-4975(00)02205-0
   Calafiore AM, 2001, ANN THORAC SURG, V72, P456, DOI 10.1016/S0003-4975(01)02810-7
   Calafiore AM, 2001, ANN THORAC SURG, V72, P462
   Calafiore AM, 1999, ANN THORAC SURG, V67, P450, DOI 10.1016/S0003-4975(98)01194-1
   Calafiore AM, 1998, ANN THORAC SURG, V66, P998, DOI 10.1016/S0003-4975(98)00708-5
   Calafiore AM, 2002, ANN THORAC SURG, V73, P1387, DOI 10.1016/S0003-4975(02)03470-7
   Cartier R, 2000, J THORAC CARDIOV SUR, V119, P221, DOI 10.1016/S0022-5223(00)70176-0
   Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023
   Chauhan SE, 1999, INDIAN J MED RES, V110, P174
   Cheng W, 2002, J THORAC CARDIOV SUR, V124, P313, DOI 10.1067/mtc.2002.122304
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Arom I, 2001, ANN THORAC SURG, V72, P1288
   Conzen PF, 2003, ANESTHESIOLOGY, V99, P826, DOI 10.1097/00000542-200310000-00013
   Corbalan R, 2001, AM J CARDIOL, V88, P342, DOI 10.1016/S0002-9149(01)01676-9
   Cox CM, 2000, ANN THORAC SURG, V69, P140, DOI 10.1016/S0003-4975(99)01196-0
   Czerny M, 2000, EUR J CARDIO-THORAC, V17, P737, DOI 10.1016/S1010-7940(00)00420-6
   D'Ancona G, 2000, ANGIOLOGY, V51, P725, DOI 10.1177/000331970005100904
   De Hert SG, 2002, ANESTHESIOLOGY, V97, P42, DOI 10.1097/00000542-200207000-00007
   Demaria RG, 2002, CIRCULATION, V106
   Diegeler A, 1999, Heart Surg Forum, V2, P290
   Diegeler A, 2000, CIRCULATION, V102, P95
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Diegeler A, 1999, HEART SURG FORUM, V2, P295
   Djaiani GN, 2001, J CARDIOTHOR VASC AN, V15, P152, DOI 10.1053/jcan.2001.21936
   Do QB, 2002, EUR J CARDIO-THORAC, V21, P385, DOI 10.1016/S1010-7940(02)00009-X
   Elliott P, 2000, ANESTH ANALG, V91, P58, DOI 10.1097/00000539-200007000-00011
   FANNING WJ, 1991, ANN THORAC SURG, V52, P529
   Fawcett WJ, 1999, BRIT J ANAESTH, V83, P302
   Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221
   Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127
   GALLAGHER JD, 1986, ANESTHESIOLOGY, V64, P785, DOI 10.1097/00000542-198606000-00018
   Gamoso MG, 2000, ANESTH ANALG, V91, P1080, DOI 10.1097/00000539-200011000-00007
   George SJ, 2002, ANN THORAC SURG, V73, P1424, DOI 10.1016/S0003-4975(02)03406-9
   Grundeman PF, 1998, ANN THORAC SURG, V65, P1348, DOI 10.1016/S0003-4975(98)00226-4
   Grundeman PF, 1999, J THORAC CARDIOV SUR, V118, P316, DOI 10.1016/S0022-5223(99)70222-9
   Haroun-Bizri S, 2001, J CARDIOTHOR VASC AN, V15, P418, DOI 10.1053/jcan.2001.24954
   Hernandez F, 2001, ANN THORAC SURG, V72, P1528, DOI 10.1016/S0003-4975(01)03202-7
   Iaco AL, 1999, ANN THORAC SURG, V68, P1486, DOI 10.1016/S0003-4975(99)00957-1
   Julier K, 2003, ANESTHESIOLOGY, V98, P1315, DOI 10.1097/00000542-200306000-00004
   Kallmeyer IJ, 2001, ANESTH ANALG, V92, P1126
   Kehl F, 2002, ANESTHESIOLOGY, V96, P675, DOI 10.1097/00000542-200203000-00025
   Kilger E, 2001, INTENS CARE MED, V27, P534, DOI 10.1007/s001340000788
   Kim KB, 2001, ANN THORAC SURG, V71, P1964, DOI 10.1016/S0003-4975(01)02638-8
   KIRNO K, 1994, ANESTH ANALG, V79, P1075
   Koh TW, 1999, HEART, V81, P285
   KOLESSOV VI, 1967, J THORAC CARDIOV SUR, V54, P535
   Koutlas TC, 2000, ANN THORAC SURG, V69, P1042, DOI 10.1016/S0003-4975(00)01154-1
   Kshettry VR, 2000, ANN THORAC SURG, V69, P1725, DOI 10.1016/S0003-4975(00)01419-3
   KSHETTRY VR, 2000, ANN THORAC SURG, V69, P1730
   Lancey RA, 2000, HEART SURG FORUM, V3, P277
   Laurikka J, 2002, CHEST, V121, P1183, DOI 10.1378/chest.121.4.1183
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Lee JH, 2000, SURGERY, V128, P548, DOI 10.1067/msy.2000.108223
   Lee JH, 2002, J CARDIOTHOR VASC AN, V16, P139, DOI 10.1053/jcan.2002.31053
   LIEBERMAN RW, 1983, ANESTHESIOLOGY, V59, P36, DOI 10.1097/00000542-198307000-00007
   Loef BG, 2002, CHEST, V121, P1190, DOI 10.1378/chest.121.4.1190
   Lonn U, 1999, ANN THORAC SURG, V67, P99, DOI 10.1016/S0003-4975(98)01158-8
   LOUAGIE YA, 1998, ANN THORAC SURG, V66, P1288
   Louagie YAG, 1998, ANN THORAC SURG, V66, P1282, DOI 10.1016/S0003-4975(98)00777-2
   Lucchetti V, 1999, EUR J CARDIO-THORAC, V15, P255, DOI 10.1016/S1010-7940(99)00005-6
   Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798
   Mariani MA, 1999, ANN THORAC SURG, V67, P1370, DOI 10.1016/S0003-4975(99)00265-9
   Maslow AD, 2000, J CARDIOTHOR VASC AN, V14, P524, DOI 10.1053/jcan.2000.9485
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Mathison M, 2000, ANN THORAC SURG, V70, P1355, DOI 10.1016/S0003-4975(00)01590-3
   Mathison M, 2000, ANN THORAC SURG, V70, P60
   Menasche P, 2001, ANN THORAC SURG, V72, pS2265
   Menasche P, 2001, ANN THORAC SURG, V72, pS2260, DOI 10.1016/S0003-4975(01)03286-6
   Mishra Yugal, 2002, Indian Heart J, V54, P159
   Moises VA, 1998, J AM SOC ECHOCARDIOG, V11, P1139, DOI 10.1016/S0894-7317(98)80009-6
   Montes FR, 2000, ANESTH ANALG, V91, P776, DOI 10.1097/00000539-200010000-00003
   Moshkovitz Y, 1997, ANN THORAC SURG, V63, pS44, DOI 10.1016/S0003-4975(97)00432-3
   Mueller XM, 2002, EUR J CARDIO-THORAC, V22, P249, DOI 10.1016/S1010-7940(02)00270-1
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Murkin JM, 1999, ANN THORAC SURG, V68, P1498, DOI 10.1016/S0003-4975(99)00953-4
   Myles PS, 1999, ANAESTH INTENS CARE, V27, P137
   Nader ND, 1999, ANN THORAC SURG, V68, P1640, DOI 10.1016/S0003-4975(99)00827-9
   Nakajima Y, 2002, ANESTH ANALG, V94, P221, DOI 10.1097/00000539-200201000-00043
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Nierich AP, 1999, J CARDIOTHOR VASC AN, V13, P123, DOI 10.1016/S1053-0770(99)90073-3
   Nierich AP, 2000, ANN THORAC SURG, V70, P466, DOI 10.1016/S0003-4975(00)01561-7
   OROURKE MF, 1984, ANN BIOMED ENG, V12, P119, DOI 10.1007/BF02584226
   Patel NC, 2002, ANN THORAC SURG, V74, P400, DOI 10.1016/S0003-4975(02)03755-4
   Patel NC, 2002, EUR J CARDIO-THORAC, V22, P255, DOI 10.1016/S1010-7940(02)00301-9
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   PUSKAS JD, 2003, ANN THORAC SURG, V125, P797
   PUSKAS JD, 2001, ANN THORAC SURG, V71, P1483
   Reuter DA, 2003, EUR J ANAESTH, V20, P17
   Ricci M, 2000, ANN THORAC SURG, V69, P1471, DOI 10.1016/S0003-4975(00)01238-8
   Riha M, 2002, EUR J CARDIO-THORAC, V21, P193, DOI 10.1016/S1010-7940(01)01100-9
   ROWELL LB, 1968, CIRCULATION, V37, P954
   Ruesch S, 2002, ANESTH ANALG, V95, P316, DOI 10.1213/01.ANE.0000018527.77358.0B
   Schmidt C, 1999, ANESTHESIOLOGY, V91, P58, DOI 10.1097/00000542-199907000-00012
   Scott NB, 2001, ANESTH ANALG, V93, P528, DOI 10.1097/00000539-200109000-00003
   SEITELBERGER R, 1994, J THORAC CARDIOV SUR, V107, P811
   Sergeant P, 2001, EUR J CARDIO-THORAC, V20, P538, DOI 10.1016/S1010-7940(01)00852-1
   Shapira OM, 1999, J THORAC CARDIOV SUR, V117, P906, DOI 10.1016/S0022-5223(99)70370-3
   Sharony R, 2003, CIRCULATION, V108, P15, DOI 10.1161/01.cir.0000087448.65888.21
   Smith A, 2002, J CARDIOTHOR VASC AN, V16, P413, DOI 10.1053/jcan.2002.125151
   Spooner TH, 1999, ANN THORAC SURG, V68, P1478, DOI 10.1016/S0003-4975(99)00966-2
   STAMOU SC, 2000, J AM COLL CARDIOL, V35, P1017
   Stamou SC, 2000, AM J CARDIOL, V86, P64, DOI 10.1016/S0002-9149(00)00829-8
   Sternik L, 1997, EUR J CARDIO-THORAC, V11, P123, DOI 10.1016/S1010-7940(96)01011-1
   Taggart DP, 1999, J THORAC CARDIOV SUR, V118, P414, DOI 10.1016/S0022-5223(99)70177-7
   TAGGART DP, 1999, J THORAC CARDIOVASC, V118, P420
   Tasdemir O, 1998, J THORAC CARDIOV SUR, V116, P68, DOI 10.1016/S0022-5223(98)70244-2
   Te Velthuis Henk, 1995, Journal of Thoracic and Cardiovascular Surgery, V110, P1663, DOI 10.1016/S0022-5223(95)70028-5
   TREHAN N, 2001, ANN THORAC SURG, V72, P1026
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Daicoff G, 2002, ANN THORAC SURG, V73, P1879
   Vassiliades TA, 2002, ANN THORAC SURG, V73, P1874, DOI 10.1016/S0003-4975(02)03592-0
   Vaturi M, 2000, J THROMB THROMBOLYS, V10, P5
   Watters MPR, 2000, BRIT J ANAESTH, V84, P629
   Watters MPR, 2001, EUR J CARDIO-THORAC, V19, P34, DOI 10.1016/S1010-7940(00)00603-5
   WISTBACKA JOM, 1995, J CARDIOTHOR VASC AN, V9, P140, DOI 10.1016/S1053-0770(05)80184-3
   Yeatman M, 2001, EUR J CARDIO-THORAC, V19, P239, DOI 10.1016/S1010-7940(01)00572-3
   Yeatman M, 2002, ANN THORAC SURG, V73, P1411, DOI 10.1016/S0003-4975(02)03407-0
   Yokoyama T, 2000, ANN THORAC SURG, V70, P1546, DOI 10.1016/S0003-4975(00)01922-6
   Zaugg M, 2003, BRIT J ANAESTH, V91, P566, DOI 10.1093/bja/aeg206
   Zaugg M, 2002, ANESTHESIOLOGY, V97, P4, DOI 10.1097/00000542-200207000-00003
NR 146
TC 45
Z9 61
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-0912
J9 BRIT J ANAESTH
JI Br. J. Anaesth.
PD MAR
PY 2004
VL 92
IS 3
BP 400
EP 413
DI 10.1093/bja/aeh064
PG 14
WC Anesthesiology
SC Anesthesiology
GA 776VP
UT WOS:000189140300015
PM 14970136
ER

PT J
AU Ince, H
   Petzsch, M
   Rehders, T
   Kische, S
   Korber, T
   Weber, F
   Nienaber, CA
AF Ince, H
   Petzsch, M
   Rehders, T
   Kische, S
   Korber, T
   Weber, F
   Nienaber, CA
TI Percutaneous endovascular repair of aneurysm after previous coarctation
   surgery
SO CIRCULATION
LA English
DT Article
DE coarctation; aneurysm; grafting; stents; aorta
ID RECURRENT AORTIC COARCTATION; TERM-FOLLOW-UP; BALLOON ANGIOPLASTY;
   SUBCLAVIAN ARTERY; ADULTS; AORTOPLASTY
AB Background - Formation of aortic aneurysm late after surgical repair of coarctation carries a significant risk of rupture and lethal outcome, and repeat surgery is associated with a 14% in-hospital mortality rate and morbidity from paraplegia, injury to the central nervous system, or from bleeding. The potential of nonsurgical endovascular repair by the use of stent-grafts in lieu of repeat surgery for postcoarctation aneurysm is unknown.
   Methods and Results - The concept of postsurgical endovascular stent-graft placement was evaluated with respect to feasibility and safety in 6 consecutive patients with late aneurysm formation after coarctation repair. All patients had aneurysm formation late after patch aortoplasty; placement of an elephant trunk during surgical repair of secondary type I dissection preceded formation of a local aneurysm in 2 cases. Patient age was 49 +/- 12 years, ranging from 31 to 68 years. Transluminal placement of customized stent-grafts was successful, with no 30-day or 1-year intervention-related mortality or morbidity. Follow-up survey of 11 to 47 months revealed optimal reconstruction of the thoracic aorta; 1 patient died 11 months after endovascular repair from cancer.
   Conclusions - Nonsurgical aortic reconstruction of postsurgical thoracic aneurysms forming late after coarctation repair is safe and feasible; interventional stent-graft placement has the potential to avoid repeat surgery of postsurgical aortic aneurysm.
C1 Univ Hosp Rostock, Rostock Sch Med, Div Cardiol, D-18057 Rostock, Germany.
RP Nienaber, CA (reprint author), Univ Hosp Rostock, Rostock Sch Med, Div Cardiol, Ernst Heydemann Str 6, D-18057 Rostock, Germany.
CR AEBERT H, 1993, EUR J CARDIO-THORAC, V7, P200, DOI 10.1016/1010-7940(93)90159-9
   ALAKULJU K, 1989, ANN THORAC SURG, V47, P853
   Aris A, 1999, ANN THORAC SURG, V67, P1376, DOI 10.1016/S0003-4975(99)00266-0
   Bouchart F, 2000, ANN THORAC SURG, V70, P1483, DOI 10.1016/S0003-4975(00)01999-8
   CLARKSON PM, 1985, AM J CARDIOL, V56, P342, DOI 10.1016/0002-9149(85)90861-6
   EBHEID MR, 1997, J AM COLL CARDIOL, V30, P1847
   Fawzy ME, 1997, J AM COLL CARDIOL, V30, P1542, DOI 10.1016/S0735-1097(97)00350-1
   Fujita T, 1996, ANN THORAC SURG, V62, P1511, DOI 10.1016/0003-4975(96)00483-3
   Gorich J, 2002, J ENDOVASC THER, V9, P39
   Ince H, 2002, J CARDIAC SURG, V17, P135, DOI 10.1111/j.1540-8191.2002.tb01188.x
   Jahangiri M, 2000, J THORAC CARDIOV SUR, V120, P224, DOI 10.1067/mtc.2000.107687
   KIEFFER E, 1994, J VASC SURG, V19, P100
   Knyshov GV, 1996, ANN THORAC SURG, V61, P935, DOI 10.1016/0003-4975(95)01189-7
   Marshall AC, 2000, AM HEART J, V139, P1054, DOI 10.1067/mhj.2000.106616
   Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003
   Owens WA, 1997, ANN THORAC SURG, V64, P1072, DOI 10.1016/S0003-4975(97)00855-2
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   Sakopoulos AG, 1998, J THORAC CARDIOV SUR, V116, P560, DOI 10.1016/S0022-5223(98)70161-8
   von Kodolitsch Y, 2002, J AM COLL CARDIOL, V39, P617, DOI 10.1016/S0735-1097(01)01784-3
   Yetman AT, 1997, J AM COLL CARDIOL, V30, P811, DOI 10.1016/S0735-1097(97)00228-3
NR 20
TC 45
Z9 47
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD DEC 16
PY 2003
VL 108
IS 24
BP 2967
EP 2970
DI 10.1161/01.CIR.0000106902.51626.AF
PG 4
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 754CZ
UT WOS:000187286300005
PM 14662704
ER

PT J
AU Pollack, A
   Hanlon, A
   Horwitz, EM
   Feigenberg, S
   Uzzo, RG
   Price, RA
AF Pollack, A
   Hanlon, A
   Horwitz, EM
   Feigenberg, S
   Uzzo, RG
   Price, RA
TI Radiation therapy dose escalation for prostate cancer: a rationale for
   IMRT
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE prostate cancer; dose escalation; intensity modulated radiotherapy
ID INTENSITY-MODULATED RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; LATE
   RECTAL TOXICITY; CONFORMAL RADIOTHERAPY; RADICAL PROSTATECTOMY;
   BIOCHEMICAL FAILURE; ALPHA/BETA RATIO; AMERICAN-SOCIETY;
   COMPUTED-TOMOGRAPHY; TREATMENT POSITIONS
AB The response of prostate cancer to radiation was well-documented in the pre-PSA era. Large palpable tumors resolved within months of treatment with relatively modest radiation doses of 64-70 Gy. The use of PSA-based failure as an endpoint, however, has made it clear that cure rates were much lower than appreciated. While doses in this range are still widely used today, data from retrospective, sequential prospective and now randomized studies indicate that for patients with intermediate-to-high risk disease, doses above 70 Gy are associated with a significant reduction in biochemical failure. The use of 3D-conformal radiotherapy to escalate radiation dose has resulted in modest increases in rectal and bladder toxicity. The application of intensity modulated radiotherapy methods allows for greater sparing of the surrounding normal tissues and, hence, the potential to further escalate dose. The results of dose escalation, the ability of IMRT to reduce rectal and bladder exposure to high radiation doses and the use of new imaging methods to more accurately target the prostate are described.
C1 Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA.
   Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA.
   Fox Chase Canc Ctr, Dept Urol, Philadelphia, PA 19111 USA.
   Fox Chase Canc Ctr, Dept Radiat Phys, Philadelphia, PA 19111 USA.
RP Pollack, A (reprint author), Fox Chase Canc Ctr, Dept Radiat Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 1998, MAYO CLIN PROC, V73, P401
   Antolak JA, 1998, INT J RADIAT ONCOL, V42, P661, DOI 10.1016/S0360-3016(98)00248-X
   Armour EP, 2002, INT J RADIAT ONCOL, V52, P6
   BENK VA, 1993, INT J RADIAT ONCOL, V26, P551
   Boersma LJ, 1998, INT J RADIAT ONCOL, V41, P83, DOI 10.1016/S0360-3016(98)00037-6
   Brenner DJ, 1999, INT J RADIAT ONCOL, V43, P1095, DOI 10.1016/S0360-3016(98)00438-6
   Chandra A, 2003, INT J RADIAT ONCOL, V56, P436, DOI 10.1016/S063003016(02)04612-6
   Chism DB, 2003, INT J RADIAT ONCOL, V56, P1241, DOI 10.1016/S0360-3016(03)00268-2
   Critz FA, 2002, J UROLOGY, V167, P1310, DOI 10.1016/S0022-5347(05)65288-3
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   CROOK JM, 1995, RADIOTHER ONCOL, V37, P35, DOI 10.1016/0167-8140(95)01613-L
   D'Amico AV, 2002, INT J RADIAT ONCOL, V54, P436, DOI 10.1016/S0360-3016(02)02940-1
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Dawson LA, 2000, INT J RADIAT ONCOL, V48, P319, DOI 10.1016/S0360-3016(00)00751-3
   Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0
   D'Souza WD, 2001, INT J RADIAT ONCOL, V51, P1, DOI 10.1016/S0360-3016(01)01650-9
   Fowler J, 2001, INT J RADIAT ONCOL, V50, P1021, DOI 10.1016/S0360-3016(01)01607-8
   Gardner BG, 2002, J UROLOGY, V167, P123, DOI 10.1016/S0022-5347(05)65395-5
   Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3
   Hanks GE, 1999, CANCER J SCI AM, V5, P152
   Hanks GE., 1988, NATL CANCER I MONOGR, V7, P75
   HANKS GE, 1988, INT J RADIAT ONCOL, V15, P1299
   HANKS GE, 1985, INT J RADIAT ONCOL, V11, P153
   Hanks GE, 2002, INT J RADIAT ONCOL, V54, P427, DOI 10.1016/S0360-3016(02)02954-1
   Hanlon AL, 2002, INT J RADIAT ONCOL, V53, P297, DOI 10.1016/S0360-3016(02)02717-7
   Horwitz EM, 2003, J UROLOGY, V169, P2153, DOI 10.1097/01.ju.0000067181.52741.09
   Hua CH, 2003, INT J RADIAT ONCOL, V55, P811, DOI 10.1016/S0360-3016(02)04207-4
   Huang E, 2002, INT J RADIAT ONCOL, V53, P261, DOI 10.1016/S0360-3016(02)02738-4
   Huang EH, 2002, INT J RADIAT ONCOL, V54, P1314, DOI 10.1016/S0360-3016(02)03742-2
   Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5
   Jhaveri FM, 1999, J CLIN ONCOL, V17, P3167
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   Kestin LL, 2002, INT J RADIAT ONCOL, V53, P304, DOI 10.1016/S0360-3016(02)02707-4
   Keyser D, 1997, INT J RADIAT ONCOL, V38, P723, DOI 10.1016/S0360-3016(97)00123-5
   King CR, 2001, INT J RADIAT ONCOL, V51, P213, DOI 10.1016/S0360-3016(01)01651-0
   Kitamura K, 2002, RADIOTHER ONCOL, V62, P275, DOI 10.1016/S0167-8140(02)00017-8
   Kitamura K, 2002, INT J RADIAT ONCOL, V53, P1117, DOI 10.1016/S0360-3016(02)02882-1
   Kupelian PA, 2002, CANCER J, V8, P62, DOI 10.1097/00130404-200201000-00011
   Kupelian PA, 2001, CANCER J, V7, P421
   Kupelian PA, 2001, INT J RADIAT ONCOL, V51, P988, DOI 10.1016/S0360-3016(01)01730-8
   Kupelian PA, 2002, INT J RADIAT ONCOL, V52, P704, DOI 10.1016/S0360-3016(01)02778-X
   Langen KM, 2001, INT J RADIAT ONCOL, V50, P265, DOI 10.1016/S0360-3016(01)01453-5
   Lattanzi J, 1999, INT J RADIAT ONCOL, V43, P719, DOI 10.1016/S0360-3016(98)00496-9
   Lee WR, 1996, INT J RADIAT ONCOL, V35, P251, DOI 10.1016/0360-3016(96)00064-8
   Lyons JA, 2000, UROLOGY, V55, P85, DOI 10.1016/S0090-4295(99)00380-5
   Mah D, 2002, INT J RADIAT ONCOL, V54, P568, DOI 10.1016/S0360-3016(02)03008-0
   Malone S, 2000, INT J RADIAT ONCOL, V48, P105, DOI 10.1016/S0360-3016(00)00603-9
   Martinez AA, 2002, INT J RADIAT ONCOL, V53, P316, DOI 10.1016/S0360-3016(02)02733-5
   Nederveen AJ, 2002, INT J RADIAT ONCOL, V53, P206, DOI 10.1016/S0360-3016(01)02823-1
   Nederveen AJ, 2001, PHYS MED BIOL, V46, P1219, DOI 10.1088/0031-9155/46/4/321
   PEREZ CA, 1988, NATL CANCER I MONOGR, V7, P85
   Perez CA, 2001, INT J RADIAT ONCOL, V49, P1287, DOI 10.1016/S0360-3016(00)01492-9
   Pinover WH, 2000, INT J RADIAT ONCOL, V47, P649, DOI 10.1016/S0360-3016(00)00465-X
   Pollack A, 2002, INT J RADIAT ONCOL, V54, P677, DOI 10.1016/S0360-3016(02)02977-2
   Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8
   Pollack A, 2002, UROLOGY, V60, P22, DOI 10.1016/S0090-4295(02)01564-9
   Pollack A, 2000, INT J RADIAT ONCOL, V48, P507, DOI 10.1016/S0360-3016(00)00620-9
   POLLACK A, 2003, IN PRESS INT J RAD O
   SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5
   Sidhu K, 2003, INT J RADIAT ONCOL, V55, P757, DOI 10.1016/S0360-3016(02)04152-4
   Skwarchuk MW, 2000, INT J RADIAT ONCOL, V47, P103, DOI 10.1016/S0360-3016(99)00560-X
   Teh BS, 2002, CANCER J, V8, P476, DOI 10.1097/00130404-200211000-00012
   Uematsu M, 2001, INT J RADIAT ONCOL, V51, P666, DOI 10.1016/S0360-3016(01)01703-5
   Wu J, 2001, RADIOTHER ONCOL, V61, P127, DOI 10.1016/S0167-8140(01)00452-2
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   Zelefsky MJ, 2002, INT J RADIAT ONCOL, V53, P1111, DOI 10.1016/S0360-3016(02)02857-2
   Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
NR 70
TC 45
Z9 46
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD SEP
PY 2003
VL 21
IS 4
BP 200
EP 208
DI 10.1007/s00345-003-0356-x
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA 726ML
UT WOS:000185602800003
PM 12961097
ER

PT J
AU Brorson, H
   Svensson, H
   Norrgren, K
   Thorsson, O
AF Brorson, H
   Svensson, H
   Norrgren, K
   Thorsson, O
TI Liposuction reduces arm lymphedema without significantly altering the
   already impaired lymph transport
SO LYMPHOLOGY
LA English
DT Article
ID QUANTITATIVE LYMPHOSCINTIGRAPHY; NONINVASIVE EVALUATION; PERIPHERAL
   LYMPHEDEMA; BREAST-CANCER; SYSTEM; LYMPHANGIOGRAPHY; EXTREMITIES; EDEMA
AB In a prospective study, 20 patients with arm lymphedema after breast cancer treatment underwent liposuction combined with Controlled Compression Therapy (CCT) or CCT alone. Indirect lymphoscintigraphy (ILS) was used to study lymph kinetics before and after intervention. Lymphoscintigrams from the contralateral, non-edematous arm were characterized by prompt transit of the radiotracer (Tc-99m-albumin nanocolloid) to the axillary nodes, whereas tracer accumulation as dermal backflow characterized tracer transport in the lymphedematous arm. Neither liposuction with CCT nor CCT alone, changed this ILS profile. Liposuction combined with CCT reduced arm edema volume by (median) 115% (range 92-179%), whereas CCT alone decreased arm edema volume by only 54% (range 7-81%) (p=0.008). Because liposuction in conjunction with CCT was not associated with further impairment to an already restricted lymph transport, we recommend this therapy (liposuction with external compression) for chronic arm lymphedema, as it reduces edema volume safely, rapidly, and more efficiently than external compression alone. Moreover, it does not worsen an already impaired lymph transport in the lymphedematous upper extremity.
C1 Malmo Univ Hosp, Dept Plast & Reconstruct Surg, SE-20502 Malmo, Sweden.
   Malmo Univ Hosp, Dept Radiat Phys, SE-20502 Malmo, Sweden.
   Malmo Univ Hosp, Dept Clin Physiol, SE-20502 Malmo, Sweden.
RP Brorson, H (reprint author), Malmo Univ Hosp, Dept Plast & Reconstruct Surg, SE-20502 Malmo, Sweden.
CR Brorson H, 1998, PLAST RECONSTR SURG, V102, P1058, DOI 10.1097/00006534-199809040-00021
   Brorson H, 1997, LYMPHOLOGY, V30, P165
   Brorson H, 1997, SCAND J PLAST RECONS, V31, P137
   CAMBRIA RA, 1993, J VASC SURG, V18, P773
   CARENA M, 1988, EUR J NUCL MED, V14, P88
   GLOVICZKI P, 1989, J VASC SURG, V9, P683, DOI 10.1067/mva.1989.vs0090683
   GOLTNER E, 1988, LYMPHOLOGY, V21, P134
   Ketterings C, 1997, LYMPHOLOGY, V30, P49
   KISSIN MW, 1986, BRIT J SURG, V73, P580, DOI 10.1002/bjs.1800730723
   KLEINHANS E, 1985, EUR J NUCL MED, V10, P349
   Koehler P R, 1968, Lymphology, V1, P116
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MOSTBECK A, 1985, INITIAL LYMPHATICS, P123
   OHTAKE E, 1986, CLIN NUCL MED, V11, P474, DOI 10.1097/00003072-198607000-00002
   PECKING A, 1984, IMMUNOLOGY HEMATOLOG, V2, P201
   RIJKE AM, 1990, J NUCL MED, V31, P990
   STECKEL RJ, 1975, AM J ROENTGENOL, V124, P600
   STEWART G, 1985, BRIT J SURG, V72, P906, DOI 10.1002/bjs.1800721120
   VAQUEIRO M, 1986, J NUCL MED, V27, P1125
   WEISSLEDER H, 1989, RADIOLOGY, V170, P371
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729
   WEISSLEDER R, 1989, RADIOLOGY, V172, P315
   Williams W, 1996, LYMPHOLOGY, V29, P134
NR 23
TC 45
Z9 47
PU LYMPHOLOGY
PI TUCSON
PA C/O C L WITTE MD 1501 N CAMPBELL AVE DEPT SURGERY, TUCSON, AZ 85724 USA
SN 0024-7766
J9 LYMPHOLOGY
JI Lymphology
PD DEC
PY 1998
VL 31
IS 4
BP 156
EP 172
PG 17
WC Immunology; Physiology
SC Immunology; Physiology
GA 160KB
UT WOS:000078228400002
PM 9949387
ER

PT J
AU ULLRICH, S
   ZOLLAPAZNER, S
AF ULLRICH, S
   ZOLLAPAZNER, S
TI IMMUNOREGULATORY CIRCUITS IN MYELOMA
SO CLINICS IN HAEMATOLOGY
LA English
DT Article
C1 NEW YORK VET ADM MED CTR, CLIN IMMUNOL LAB, NEW YORK, NY 10010 USA.
RP ULLRICH, S (reprint author), NYU, MED CTR, DEPT PATHOL, NEW YORK, NY 10016 USA.
CR ABBAS AK, 1980, J EXP MED, V152, P306, DOI 10.1084/jem.152.2.306
   ABBAS AK, 1980, J EXP MED, V152, P969, DOI 10.1084/jem.152.4.969
   ABBAS AK, 1980, J IMMUNOL, V124, P1160
   ABBAS AK, 1979, IMMUNOL REV, V48, P245, DOI 10.1111/j.1600-065X.1979.tb00305.x
   ANDERSSO.J, 1974, J EXP MED, V140, P742, DOI 10.1084/jem.140.3.742
   AZAR HA, 1973, MULTIPLE MYELOMA REL, V1, P1
   BHOOPALA.N, 1972, BLOOD-J HEMATOL, V39, P465
   BOYER PJJ, 1976, J IMMUNOL, V116, P202
   BRIDGES SH, 1978, J IMMUNOL, V121, P479
   BRODER S, 1975, NEW ENGL J MED, V293, P887, DOI 10.1056/NEJM197510302931801
   BRUS I, 1978, BRIT J CANCER, V37, P545, DOI 10.1038/bjc.1978.83
   CALKINS CE, 1972, CELL IMMUNOL, V5, P579, DOI 10.1016/0008-8749(72)90108-6
   CAMPBELL AE, 1975, BRIT J HAEMATOL, V29, P178
   COHEN HJ, 1975, ARCH INTERN MED, V135, P177, DOI 10.1001/archinte.135.1.177
   COHN M, 1977, SCAND J IMMUNOL, V6, P39, DOI 10.1111/j.1365-3083.1977.tb00321.x
   CONE L, 1964, J CLIN INVEST, V43, P2241, DOI 10.1172/JCI105098
   DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U
   EPSTEIN LB, 1974, J IMMUNOL, V112, P1131
   FAHEY JL, 1962, IMMUNOLOGY, V5, P110
   FAHEY JL, 1963, AM J MED, V35, P698, DOI 10.1016/0002-9343(63)90140-2
   FRIKKE MJ, 1977, J IMMUNOL, V118, P2206
   GLENCHUR H, 1959, ARCH INTERN MED, V103, P173
   GOOD RA, 1962, PROG ALLERGY, V6, P187, DOI 10.1159/000313800
   HAMBURGER AW, 1980, J NATL CANCER I, V65, P1337
   HARRIS TN, 1978, J RETICULOENDOTH SOC, V23, pI35
   HAVAS HF, 1978, IMMUNOLOGY, V34, P1
   HIRANO S, 1968, BLOOD, V31, P252
   HOOVER RG, 1981, FED PROC, V40, P361
   HOOVER RG, 1980, J IMMUNOL, V125, P1280
   JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373
   JERNE NK, 1963, SCIENCE, V140, P405, DOI 10.1126/science.140.3565.405
   KATZMAN J, 1978, CANCER RES, V38, P2555
   KATZMANN JA, 1978, J IMMUNOL, V121, P1405
   KENNARD J, 1980, J IMMUNOL, V124, P268
   KNAPP W, 1978, J IMMUNOL, V121, P1177
   KOLB JP, 1977, J IMMUNOL, V118, P702
   KRAKAUER RS, 1977, J IMMUNOL, V118, P1385
   KRIPKE ML, 1970, INT J CANCER, V6, P422, DOI 10.1002/ijc.2910060313
   KYLE RA, 1976, MONOCLONAL GAMMOPATH, P156
   LASKOV R, 1970, Journal of Experimental Medicine, V131, P515, DOI 10.1084/jem.131.3.515
   LAZARUS HM, 1980, AM J MED, V69, P419, DOI 10.1016/0002-9343(80)90014-5
   LESPINAT.G, 1969, EUR J CANCER, V5, P421, DOI 10.1016/0014-2964(69)90095-4
   LYNCH RG, 1972, P NATL ACAD SCI USA, V69, P1540, DOI 10.1073/pnas.69.6.1540
   LYNCH RG, 1979, IMMUNOL REV, V48, P45, DOI 10.1111/j.1600-065X.1979.tb00298.x
   MCCOY JL, 1974, INT J CANCER, V14, P264, DOI 10.1002/ijc.2910140216
   MEYERS BR, 1972, AM J MED, V52, P87, DOI 10.1016/0002-9343(72)90010-1
   MILLBURN GL, 1981, FED PROC, V40, P1008
   MISHELL RI, 1967, J EXP MED, V126, P423, DOI 10.1084/jem.126.3.423
   MORIWAKI K, 1971, J NATL CANCER I, V47, P623
   MUNDY GR, 1974, NEW ENGL J MED, V291, P1041, DOI 10.1056/NEJM197411142912001
   PADARATHSINGH ML, 1977, J NATL CANCER I, V58, P1701
   PAGLIERONI T, 1979, BLOOD, V54, P226
   PAGLIERONI T, 1977, J CLIN INVEST, V59, P1120, DOI 10.1172/JCI108736
   PAGLIERONI T, 1980, J IMMUNOL, V124, P2563
   PENNY R, 1966, BRIT J HAEMATOL, V12, P633, DOI 10.1111/j.1365-2141.1966.tb00146.x
   POTTER M, 1972, PHYSIOL REV, V52, P631
   PRUZANSKI W, 1980, CLIN IMMUNOL IMMUNOP, V17, P280, DOI 10.1016/0090-1229(80)90097-5
   REBUCK JW, 1955, ANN NY ACAD SCI, V59, P757, DOI 10.1111/j.1749-6632.1955.tb45983.x
   ROHRER JW, 1977, J IMMUNOL, V119, P2045
   ROHRER JW, 1977, J IMMUNOL, V119, P861
   ROHRER JW, 1978, J IMMUNOL, V121, P1066
   ROHRER JW, 1978, J IMMUNOL, V121, P1799
   ROHRER JW, 1979, J IMMUNOL, V122, P2011
   ROHRER JW, 1979, J IMMUNOL, V123, P1083
   ROLLINGH.M, 1973, EUR J IMMUNOL, V3, P471, DOI 10.1002/eji.1830030804
   ROLLINGHOFF M, 1973, J NATL CANCER I, V50, P158
   ROUSE BT, 1973, EUR J IMMUNOL, V3, P218, DOI 10.1002/eji.1830030408
   ROUSE BT, 1972, NATURE-NEW BIOL, V238, P116
   SALMON SE, 1969, BLOOD-J HEMATOL, V33, P300
   SCHMID G, 1979, INTERSCIENCE C ANTIM
   SMITH F, 1960, J NATL CANCER I, V25, P803
   SNAPPER I, 1971, MYELOMATOSIS FUNDAME, P215
   SPITLER LE, 1975, BRIT J HAEMATOL, V29, P279, DOI 10.1111/j.1365-2141.1975.tb01822.x
   TANAPATC.P, 1974, SCIENCE, V186, P748, DOI 10.1126/science.186.4165.748
   ULLRICH SE, 1980, J IMMUNOL METHODS, V39, P147, DOI 10.1016/0022-1759(80)90303-8
   WAGNER H, 1973, J EXP MED, V138, P1, DOI 10.1084/jem.138.1.1
   WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491
   WALDMANN TA, 1978, ANN INTERN MED, V88, P226
   WILLIAMS WH, 1972, J NATL CANCER I, V49, P1613
   YAKULIS V, 1973, IMMUNOL COMMUN, V2, P129, DOI 10.3109/08820137309022786
   ZIEGLER JB, 1975, AUST NZ J MED, V5, P39, DOI 10.1111/j.1445-5994.1975.tb03253.x
   ZINNEMAN HH, 1954, ANN INTERN MED, V41, P1152
   ZOLLA S, 1972, J IMMUNOL, V108, P1039
   ZOLLA S, 1974, J IMMUNOL, V112, P2068
   ZOLLAPAZNER S, 1980, PROGR IMMUNOLOGY, P171
   ZOLLAPAZNER S, 1981, CELL IMMUNOL, V62, P149, DOI 10.1016/0008-8749(81)90308-7
   ZOLLAPAZNER S, 1981, B LYMPHOCYTES IMMUNE, P493
   ZOLLAPAZNER S, 1976, J IMMUNOL, V117, P563
NR 88
TC 45
Z9 45
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0308-2261
J9 CLIN HAEMATOL
PY 1982
VL 11
IS 1
BP 87
EP 111
PG 25
WC Hematology
SC Hematology
GA NJ041
UT WOS:A1982NJ04100006
PM 7042151
ER

PT J
AU Steer, AC
   Danchin, MH
   Carapetis, JR
AF Steer, Andrew C.
   Danchin, Margaret H.
   Carapetis, Jonathan R.
TI Group A streptococcal infections in children
SO JOURNAL OF PAEDIATRICS AND CHILD HEALTH
LA English
DT Review
DE acute rheumatic fever; epidemiology; group A streptococcus; impetigo;
   pharyngitis; post-streptococcal glomerulonephritis
ID ACUTE RHEUMATIC-FEVER; TOXIC-SHOCK-SYNDROME; ACUTE POSTSTREPTOCOCCAL
   GLOMERULONEPHRITIS; EPIDEMIOLOGIC FEATURES; HEART-DISEASE; DOUBLE-BLIND;
   SORE THROAT; NECROTIZING FASCIITIS; ABORIGINAL CHILDREN;
   NORTHERN-TERRITORY
AB The group A streptococcus causes the widest range of disease in humans of all bacterial pathogens. Group A streptococcal diseases are more common in children than adults with diseases ranging from pharyngitis and impetigo to invasive infections and the post-streptococcal sequelae - acute rheumatic fever and acute post-streptococcal glomerulonephritis. The global burden of severe group A streptococcal disease is concentrated largely in developing countries and Indigenous populations such as Aboriginal Australians. Control of group A streptococcal disease is poor in these settings and the need for a vaccine has been argued. With an ever-increasing understanding of the group A streptococcus at a molecular level, new and sophisticated vaccines are currently in human trials and the next decade holds exciting prospects for curbing group A streptococcal diseases.
C1 Menzies Sch Hlth Res, Casuarina, NT 0811, Australia.
   Univ Melbourne, Ctr Int Child Hlth, Dept Paediat,Murdoch Childrens Res Inst, Royal Childrens Hosp, Melbourne, Vic, Australia.
RP Carapetis, JR (reprint author), Menzies Sch Hlth Res, POB 41096, Casuarina, NT 0811, Australia.
EM jonathan.carapetis@menzies.edu.au
CR Akesson P, 1996, J BIOL CHEM, V271, P1081
   Batzloff M, 2004, INDIAN J MED RES, V119, P104
   Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275
   Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842
   Bilton BD, 1998, AM SURGEON, V64, P397
   Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949
   Bisno AL, 2004, CLIN INFECT DIS, V38, P1535, DOI 10.1086/392520
   BOHLE A, 1992, PATHOL RES PRACT, V188, P908
   BYWATERS EG, 1961, BRIT MED J, V1, P1628
   CARAPETIS J, 1995, CLIN INFECT DIS, V21, P1220, DOI 10.1093/clinids/21.5.1220
   Carapetis JR, 1995, J PAEDIATR CHILD H, V31, P563, DOI 10.1111/j.1440-1754.1995.tb00886.x
   Carapetis JR, 1999, ASIA PACIFIC HEART J, V8, P138, DOI 10.1016/S1328-0163(99)90050-7
   Carapetis JR, 1999, EPIDEMIOL INFECT, V122, P59, DOI 10.1017/S0950268898001952
   CARAPETIS JR, 2004, REV WHO ACTIVITIES B, P1
   CARAPETIS JR, 2000, ASIA PACIFIC HEART J, V8, P138
   Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X
   Carapetis JR, 1996, MED J AUSTRALIA, V164, P146
   Casey JR, 2004, CLIN INFECT DIS, V38, P1526, DOI 10.1086/392496
   CHELSOM J, 1994, LANCET, V344, P1111, DOI 10.1016/S0140-6736(94)90629-7
   CHOW JW, 1992, CLIN INFECT DIS, V14, P418
   Cilliers AM, 2003, COCHRANE DB SYST REV
   CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305
   Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000
   Curtis N, 1996, CURR OPIN INFECT DIS, V9, P191, DOI 10.1097/00001432-199606000-00012
   DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069
   Danchin MH, 2004, INDIAN J MED RES, V119, P144
   Danchin MH, 2002, MED J AUSTRALIA, V177, P512
   Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630
   Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803
   Del Mar CB, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000023.PUB3
   DELMAR C, 1992, MED J AUSTRALIA, V156, P572
   DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151
   DILLON HC, 1979, REV INFECT DIS, V1, P935
   EAGLE H, 1952, AM J MED, V13, P389, DOI 10.1016/0002-9343(52)90293-3
   Edmond KM, 1996, MED J AUSTRALIA, V165, P420
   Eriksson BKG, 2003, CLIN INFECT DIS, V37, P1189, DOI 10.1086/379013
   Evans C, 2001, NO TERRITORY DIS CON, V8, P1
   FEINSTEIN AR, 1964, AM HEART J, V68, P817, DOI 10.1016/0002-8703(64)90132-2
   Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398
   FERRIERI P, 1974, J INFECT DIS, V129, P429
   FERRIERI P, 1972, J CLIN INVEST, V51, P2851, DOI 10.1172/JCI107108
   FINLAND M, 1959, JAMA-J AM MED ASSOC, V170, P2188
   GEMMELL CG, 1981, J CLIN INVEST, V67, P1249, DOI 10.1172/JCI110152
   GERBER MA, 1989, PEDIATR INFECT DIS J, V8, P820, DOI 10.1097/00006454-198911000-00032
   Gerber MA, 1997, JAMA-J AM MED ASSOC, V277, P899, DOI 10.1001/jama.277.11.899
   GOOD MF, 1997, MICROBIOL AUST, V18, P30
   HOGE CW, 1993, JAMA-J AM MED ASSOC, V269, P384, DOI 10.1001/jama.269.3.384
   Ji YD, 1996, INFECT IMMUN, V64, P503
   Johnston F, 1999, PEDIATR INFECT DIS J, V18, P327, DOI 10.1097/00006454-199904000-00003
   JORDAN SC, 1982, PEDIATR CLIN N AM, V29, P857
   Kaplan EL, 2001, LANCET, V358, P1334, DOI 10.1016/S0140-6736(01)06415-7
   KATZ AR, 1992, CLIN INFECT DIS, V14, P298
   Kaul R, 1999, CLIN INFECT DIS, V28, P800, DOI 10.1086/515199
   Kearns T, 2000, NO TERRITORY DIS CON, V8, P6
   Kelly A, 2003, NT DIS CONTROL B, V10, P9
   KEVY SV, 1961, NEW ENGL J MED, V264, P738, DOI 10.1056/NEJM196104132641502
   Koning S., 2004, COCHRANE DB SYST REV, V2
   Kotloff KL, 2004, PEDIATR INFECT DIS J, V23, P765, DOI 10.1097/01.inf.0000136296.98686.c5
   KROBER MS, 1985, JAMA-J AM MED ASSOC, V253, P1271, DOI 10.1001/jama.253.9.1271
   Kurlan R, 2004, PEDIATRICS, V113, P883, DOI 10.1542/peds.113.4.883
   LANCEFIELD RC, 1928, J EXP MED, V47, P9
   Laupland KB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.5.e60
   Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34
   Maguire GP, 1996, MED J AUSTRALIA, V164, P721
   MARKOWITZ M, 1993, J PEDIATR, V123, P679, DOI 10.1016/S0022-3476(05)80840-6
   MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115
   McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2
   McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587
   MCNEIL S, 2005, 16 LANC INT S STREPT
   MCSHAN WM, 2005, 16 LANC INT S STREPT
   MORTIMER EA, 1959, NEW ENGL J MED, V260, P101, DOI 10.1056/NEJM195901152600301
   Muller MP, 2003, ARCH INTERN MED, V163, P467, DOI 10.1001/archinte.163.4.467
   Muller MP, 2001, 41 INT C ANT AG CHEM
   Nandi S, 2001, B WORLD HEALTH ORGAN, V79, P528
   Narula J, 2001, LANCET, V358, P2000, DOI 10.1016/S0140-6736(01)06993-8
   National Heart Foundation of Australia (RF/RHD Guideline Development Working Group) and the Cardiac Society of Australia and New Zealand, 2006, DIAGN MAN AC RHEUM F
   NorrbyTeglund A, 1996, INFECT IMMUN, V64, P5395
   Norton R, 2004, INDIAN J MED RES, V119, P148
   Pena J, 2002, ARQ NEURO-PSIQUIAT, V60, P374, DOI 10.1590/S0004-282X2002000300006
   PICHICHERO ME, 1991, PEDIATR INFECT DIS J, V10, P275, DOI 10.1097/00006454-199104000-00002
   POTTER EV, 1982, NEW ENGL J MED, V307, P725, DOI 10.1056/NEJM198209163071205
   REINGOLD AL, 1982, ANN INTERN MED, V96, P871
   ROGERS M, 1987, MED J AUSTRALIA, V147, P63
   Shetty AK, 2001, PEDIATR EMERG CARE, V17, P430, DOI 10.1097/00006565-200112000-00007
   Shulman ST, 2002, CURR OPIN RHEUMATOL, V14, P562, DOI 10.1097/01.BOR.0000025208.15831.03
   Shulman ST, 2004, CLIN INFECT DIS, V39, P325, DOI 10.1086/421949
   Snitcowsky R, 1996, PEDIATRICS, V97, P996
   Steer A C, 1999, Arch Dis Child, V81, P372
   STEVENS DL, 1992, CLIN INFECT DIS, V14, P2
   STEVENS DL, 2003, INFECT DIS, P133
   STILL JG, 1995, PEDIAT INFECT DIS S, V14, P57
   STREETON CL, 1995, J PAEDIATR CHILD H, V31, P245, DOI 10.1111/j.1440-1754.1995.tb00795.x
   Thakur JS, 1996, J EPIDEMIOL COMMUN H, V50, P62, DOI 10.1136/jech.50.1.62
   BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Veasy LG, 2001, LANCET, V357, P1994, DOI 10.1016/S0140-6736(00)05134-5
   VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801
   White AV, 2001, MED J AUSTRALIA, V174, P492
   *WHO, 2004, WORLD HLTH REP, P122
   WHO, 1999, PEDIATR INFECT DIS J, V18, pS17, DOI DOI 10.1097/00006454-199910001-00004
   WYATT RJ, 1988, PEDIATR NEPHROL, V2, P219
   Zimbelman J, 1999, PEDIATR INFECT DIS J, V18, P1096, DOI 10.1097/00006454-199912000-00014
   Zwart S, 2003, BRIT MED J, V327, P1324, DOI 10.1136/bmj.327.7427.1324
   2003, CARPA STANDARD TREAT, P322
NR 104
TC 44
Z9 46
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1034-4810
J9 J PAEDIATR CHILD H
JI J. Paediatr. Child Health
PD APR
PY 2007
VL 43
IS 4
BP 203
EP 213
DI 10.1111/j.1440-1754.2007.01051.x
PG 11
WC Pediatrics
SC Pediatrics
GA 153DL
UT WOS:000245411800002
PM 17444820
ER

PT J
AU Lim, E
   Drain, A
   Davies, W
   Edmonds, L
   Rosengard, BR
AF Lim, Eric
   Drain, Andrew
   Davies, William
   Edmonds, Lyn
   Rosengard, Bruce R.
TI A systematic review of randomized trials comparing revascularization
   rate and graft patency of off-pump and conventional coronary surgery
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the of the
   Society-of-Cardiothoracic-Surgeons-of-Great-Britain-and-Ireland
CY AUG   08, 2006
CL Dublin, IRELAND
SP Soc Cardiothorac Surg Great Britain & Ireland
ID ARTERY-BYPASS SURGERY; ON-PUMP; MYOCARDIAL REVASCULARIZATION;
   METAANALYSIS; OUTCOMES; MORBIDITY; MORTALITY
AB Objective: Although many trials have been conducted to evaluate the benefits of off-pump coronary surgery, few have concentrated on graft patency. We sought to evaluate the impact of off-pump surgery on completeness of revascularization and graft patency compared with conventional surgery.
   Methods: A systematic literature search was undertaken of all randomized trials of off-pump coronary surgery in MEDLINE, EMBASE, the Cochrane Library Controlled Trials Register, the National Research Register, and abstracts from major conferences.
   Results: In total, 132 publications were identified. From this number, we excluded 43 without a conventional surgery arm and 80 that did not evaluate graft patency. One trial was excluded for selective angiography and one abstract was excluded because of insufficient information. A total of 7 trials were eligible for overview. On initial analysis, the relative risk of graft patency in off-pump coronary surgery compared with conventional surgery was 0.959 (95% confidence interval 0.936-0.983; P = .001). The analysis was repeated after excluding one specific trial because of clinical and statistical heterogeneity (x(6)(2) = 27.78; P < .001), and a relative risk of 0.953 (95% confidence interval 0.927-0.980; P = .001) was obtained with no further evidence of heterogeneity (x(5)(2) = 5.35; P = .374). In 5 trials that included the mean number of grafts performed per arm, the standardized mean difference in revascularization comparing off-pump with conventional surgery was -0.164 (-0.286 to -0.043; P = .008).
   Conclusion: In a meta-analysis of randomized trials, patients undergoing off-pump coronary surgery had a lower rate of revascularization and lower graft patency than did patients undergoing conventional coronary surgery.
C1 Papworth Hosp, Dept Cardiothorac Surg, Cambridge CB3 8RE, England.
   Papworth Hosp, Lib Serv, Cambridge CB3 8RE, England.
   Papworth Hosp, Knowledge Serv, Cambridge CB3 8RE, England.
RP Lim, E (reprint author), Papworth Hosp, Dept Cardiothorac Surg, Cambridge CB3 8RE, England.
EM eric.lim@cvsnet.org
CR ALRUZZEH S, 2004, CIRCULATION S, V110
   Bradley SM, 2003, ANN THORAC SURG, V76, P783
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   KEOGH BE, 2004, 5 NAT AD CARD SURG
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   KOBAYASHI J, 2005, CIRCULATION S, V112
   Liao L, 2005, J AM COLL CARDIOL, V46, P1684, DOI 10.1016/j.jacc.2005.06.074
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
NR 18
TC 44
Z9 45
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD DEC
PY 2006
VL 132
IS 6
BP 1409
EP 1413
DI 10.1016/j.jtcvs.2006.08.012
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 113VN
UT WOS:000242626200026
PM 17140968
ER

PT J
AU Poston, R
   Gu, JY
   Manchio, J
   Lee, A
   Brown, J
   Gammie, J
   White, C
   Griffith, BP
AF Poston, R
   Gu, JY
   Manchio, J
   Lee, A
   Brown, J
   Gammie, J
   White, C
   Griffith, BP
TI Platelet function tests predict bleeding and thrombotic events after
   off-pump coronary bypass grafting
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 18th Annual Meeting of the
   European-Association-for-Cardiothoracic-Surgery/12th Annual Meeting of
   the European-Society-of-Thoracic-Surgeons
CY SEP 12-15, 2004
CL Leipzig, GERMANY
SP European Assoc Cardiothorac Surg, European Soc Thorac Surg
DE platelet; saphenous vein; coronary artery bypass grafting; thrombosis
ID CARDIAC SURGICAL PATIENTS; SAPHENOUS-VEIN; TRANSFUSION REQUIREMENTS;
   SURGERY; THERAPY; ANTICOAGULATION; AGGREGATION; ASPIRIN
AB Objective: A balanced coagulation system after cardiac surgery minimizes bleeding and thrombotic events. However, the best method to monitor this balance has not been established. We used a series of tests of coagulation and platelet function to define the risk of bleeding and thrombotic events after OPCAB. Methods: In 76 patients, routine coagulation tests (i.e. prothrombin time, fibrinogen level, d-dimer, and platelet count), thrombelastography, and whole blood aggregometry were obtained perioperatively and on days 1 and 3 after OPCAB. Intra- and postoperative blood toss was determined. Early patency of venous bypass grafts was determined using CT angiography (Philips Medical, Corp.). Results: Chest tube output and red cell volume loss at 24 h were 952 +/- 475 and 190 +/- 115 ml, respectively. Early graft failure developed in eight patients. Perioperative changes in routine coagulation tests showed no correlation with either bleeding or thrombosis. However, perioperative decline in platelet function as assessed by the area under the impedance curve for whole blood aggregometry correlated with intraoperative blood loss (R=0.42, P < 0.05). A perioperative decline in the maximum amplitude of the thrombelastography trace showed a significant correlation with 24h hemoglobin loss (R=0.45, P < 0.05). Compared to those with all patent grafts, patients with early graft failure demonstrated a reduction in platelet sensitivity to aspirin by both thrombelastography and aggregometry on day 3. Conclusions: In contrast to standard coagulation testing, platelet function predicted both bleeding and thrombosis after OPCAB. Titration of perioperative platelet function according to these tests may minimize thrombosis without increasing bleeding. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Maryland, Sch Med, Dept Surg, Div Cardiac Surg, Baltimore, MD 21201 USA.
   Univ Maryland, Sch Med, Dept Radiol, Baltimore, MD 21201 USA.
RP Poston, R (reprint author), Univ Maryland, Sch Med, Dept Surg, Div Cardiac Surg, N4W94 22 S Greene St, Baltimore, MD 21201 USA.
EM rposton@smail.umaryland.edu
CR Avidan MS, 2004, BRIT J ANAESTH, V92, P178, DOI 10.1093/bja/aeh037
   Campeau L, 1997, NEW ENGL J MED, V336, P153
   Cartier R, 2001, J THORAC CARDIOV SUR, V121, P920, DOI 10.1067/mtc.2001.113177
   Craft RM, 2004, J LAB CLIN MED, V143, P301, DOI 10.1016/j.lab.2004.01.011
   D'Ancona G, 2001, HEART SURG FORUM, V4, P354
   Despotis GJ, 1996, ANESTH ANALG, V82, P13, DOI 10.1097/00000539-199601000-00004
   DIETRICH W, 1995, J CARDIOTHOR VASC AN, V9, P250, DOI 10.1016/S1053-0770(05)80316-7
   Essell J H, 1993, J Cardiothorac Vasc Anesth, V7, P410, DOI 10.1016/1053-0770(93)90161-D
   Friend M, 2003, BRIT MED J, V326, P82, DOI 10.1136/bmj.326.7380.82
   GRAVLEE GP, 1994, ANN THORAC SURG, V58, P216
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Mariani MA, 1999, ANN THORAC SURG, V67, P1370, DOI 10.1016/S0003-4975(99)00265-9
   Moor E, 2000, THROMB RES, V98, P39, DOI 10.1016/S0049-3848(99)00221-2
   Morota T, 2002, ANN THORAC SURG, V73, P1446, DOI 10.1016/S0003-4975(02)03505-1
   POSTON RS, 2004, HEART SURG FORUM, V7, P1
   Potapov EV, 2004, ANN THORAC SURG, V77, P869, DOI 10.1016/j.athoracsur.2003.08.013
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   RAY MJ, 1994, ANN THORAC SURG, V57, P981
   Salama ME, 2004, TRANSFUS APHER SCI, V30, P93, DOI 10.1016/j.transci.2003.10.005
   Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016
   Spiess Bruce D, 2004, Int Anesthesiol Clin, V42, P55, DOI 10.1097/00004311-200404220-00006
   STEIN PD, 1995, CHEST, V108, pS424, DOI 10.1378/chest.108.4_Supplement.424S
   TUMAN KJ, 1991, ANESTH ANALG, V73, P696
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Yoo KJ, 2003, EUR J CARDIO-THORAC, V24, P86, DOI 10.1016/S1010-7940(03)00192-1
NR 25
TC 44
Z9 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD APR
PY 2005
VL 27
IS 4
BP 584
EP 590
DI 10.1016/j.ejcts.2004.12.061
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 915QS
UT WOS:000228319600013
PM 15784355
ER

PT J
AU Das, P
   Chen, MH
   Valentine, K
   Lopes, L
   Cormack, RA
   Renshaw, AA
   Tempany, CM
   Kumar, S
   D'Amico, AV
AF Das, P
   Chen, MH
   Valentine, K
   Lopes, L
   Cormack, RA
   Renshaw, AA
   Tempany, CM
   Kumar, S
   D'Amico, AV
TI Using the magnitude of PSA bounce after MRI-guided prostate
   brachytherapy to distinguish recurrence, benign precipitating factors,
   and idiopathic bounce
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; prostate-specific antigen; brachytherapy; PSA bounce;
   recurrence
ID EXTERNAL-BEAM RADIATION; RADICAL PROSTATECTOMY; ANTIGEN CONCENTRATION;
   CANCER; THERAPY
AB Purpose: To identify events that precipitated a prostate-specific antigen (PSA) bounce and characterize the magnitude, duration, and time to PSA bounce after MRI-guided prostate brachytherapy.
   Methods and Materials: Between 1997 and 2001, 186 patients with low-risk prostate cancer underwent MRI-guided permanent 1251 source implantation, with or without external beam radiotherapy. A PSA bounce was defined as a greater than or equal to 15% elevation in PSA compared with the most recent value, followed by a decline to a level at or less than the prebounce value. At the time of PSA measurement, data were prospectively collected on whether the patient had recent ejaculation, ongoing radiation proctitis, or recent instrumentation.
   Results: A total of 115 patients (61.8%) had a total of 156 PSA bounces. Of these, 36 patients had PSA bounces associated with ejaculation, proctitis, or instrumentation, and 79 experienced idiopathic PSA bounces (not associated with a precipitating event). The magnitude of the PSA bounce was significantly lower for the idiopathic PSA bounce (0.6 ng/mL) compared with that associated with ejaculation (p = 0.003), proctitis (p < 0.0001), or instrumentation (p = 0.007). Patients with biopsy-proven local recurrence had a median PSA elevation of 1.2 ng/mL, significantly higher (p = 0.006) than the magnitude of the idiopathic PSA bounce, but not significantly different from the magnitude of the PSA bounce due to ejaculation, proctitis, or instrumentation.
   Conclusion: In patients treated with MRI-guided prostate brachytherapy, recent ejaculation, instrumentation, or ongoing radiation proctitis can cause a transient increase in PSA, the magnitude of which is significantly higher than that for idiopathic PSA bounce, but is similar to that in patients with recurrent disease. (C) 2002 Elsevier Science Inc.
C1 Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA 02115 USA.
   Univ Connecticut, Dept Stat, Storrs, CT 06269 USA.
   Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA.
   Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA.
   Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Urol, Boston, MA 02115 USA.
RP Das, P (reprint author), Brigham & Womens Hosp, Dept Radiat Oncol, Joint Ctr Radiat Therapy, 75 Francis St, Boston, MA 02115 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   D'Amico AV, 1998, INT J RADIAT ONCOL, V42, P507, DOI 10.1016/S0360-3016(98)00271-5
   Dew T, 1999, ANN CLIN BIOCHEM, V36, P340
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Patel C., 2001, International Journal of Radiation Oncology Biology Physics, V51, P277, DOI 10.1016/S0360-3016(01)02332-X
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Prestigiacomo AF, 1996, J UROLOGY, V155, P1977, DOI 10.1016/S0022-5347(01)66067-1
   Pruthi RS, 2000, J UROLOGY, V164, P2031, DOI 10.1016/S0022-5347(05)66958-3
   Ragde H, 2000, CANCER, V89, P135, DOI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
   Safford HR, 1996, J UROLOGY, V156, P103, DOI 10.1016/S0022-5347(01)65954-8
   Tchetgen MB, 1996, UROLOGY, V47, P511, DOI 10.1016/S0090-4295(99)80486-5
NR 14
TC 44
Z9 45
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD NOV 1
PY 2002
VL 54
IS 3
BP 698
EP 702
DI 10.1016/S0360-3016(02)03036-5
PG 5
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 606CG
UT WOS:000178715200012
PM 12377320
ER

PT J
AU Deeg, DJH
AF Deeg, DJH
TI Attrition in longitudinal population studies: Does it affect the
   generalizability of the findings? An introduction to the series
SO JOURNAL OF CLINICAL EPIDEMIOLOGY
LA English
DT Article
ID OLDER ADULTS; PANEL; PARTICIPATION; INCOME
C1 LASA, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands.
   LASA, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands.
RP Deeg, DJH (reprint author), LASA, Dept Psychiat, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
CR Brayne C, 1999, J AM GERIATR SOC, V47, P1283
   Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302
   CRIDER DM, 1973, SOCIOL METHOD RES, V2, P3, DOI 10.1177/004912417300200101
   de Heer W, 1999, J OFF STAT, V15, P129
   Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9
   Fitzgerald J, 1998, J HUM RESOUR, V33, P251, DOI 10.2307/146433
   Groves Robert M., 1998, NONRESPONSE HOUSEHOL
   HAUSMAN JA, 1979, ECONOMETRICA, P47
   Heitjan DF, 1997, AM J PUBLIC HEALTH, V87, P548, DOI 10.2105/AJPH.87.4.548
   HOX JJ, 1994, QUAL QUANT, V28, P329, DOI 10.1007/BF01097014
   Kempen GIJM, 2002, J CLIN EPIDEMIOL, V55, P224, DOI 10.1016/S0895-4356(01)00474-7
   LEBOWITZ BD, 1989, SPECIAL RES METHODS, P309
   LITTLE RJA, 1989, SOCIOL METHOD RES, V18, P292, DOI 10.1177/0049124189018002004
   Markides K S, 1986, J Gerontol, V41, P806
   MCALLIST.RJ, 1973, PUBLIC OPIN QUART, V37, P413, DOI 10.1086/268103
   NORRIS FH, 1987, J GERONTOL, V42, P597
   NORRIS FH, 1986, J GERONTOL, V41, P806
   Portrait F, 1999, HEALTH ECON, V8, P441, DOI 10.1002/(SICI)1099-1050(199908)8:5<441::AID-HEC452>3.0.CO;2-O
   RENDTEL U, 1990, KOLNER Z SOZIOL SOZ, V42, P280
   RIEGEL KF, 1967, J PERS SOC PSYCHOL, V5, P342, DOI 10.1037/h0024298
   SCHAIE KW, 1973, J GERONTOL, V28, P328
   SIEGLER IC, 1979, J GERONTOL, V34, P242
   STREIB GF, 1966, J GERONTOL, V21, P200
   Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0
   Van Beijsterveldt CEM, 2002, J CLIN EPIDEMIOL, V55, P216, DOI 10.1016/S0895-4356(01)00473-5
   WILLIAMS WH, 1970, J AM STAT ASSOC, V65, P1338
   Zabel JE, 1998, J HUM RESOUR, V33, P479, DOI 10.2307/146438
NR 27
TC 44
Z9 44
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-4356
J9 J CLIN EPIDEMIOL
JI J. Clin. Epidemiol.
PD MAR
PY 2002
VL 55
IS 3
BP 213
EP 215
DI 10.1016/S0895-4356(01)00472-3
PG 3
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 526FT
UT WOS:000174119900001
ER

PT J
AU HANLEY, PC
   HOLMES, DR
   JULSRUD, PR
   SMITH, HC
AF HANLEY, PC
   HOLMES, DR
   JULSRUD, PR
   SMITH, HC
TI USE OF CONVENTIONAL AND NEWER RADIOGRAPHIC CONTRAST AGENTS IN CARDIAC
   ANGIOGRAPHY
SO PROGRESS IN CARDIOVASCULAR DISEASES
LA English
DT Review
C1 MAYO CLIN & MAYO FDN,DIV CARDIOVASC DIS & INTERNAL MED,200 1ST ST SW,ROCHESTER,MN 55905.
   MAYO CLIN & MAYO FDN,DEPT DIAGNOST RADIOL,ROCHESTER,MN 55905.
CR Aakhus T, 1980, Acta Radiol Suppl, V362, P131
   ALEXANDER RD, 1978, ARCH INTERN MED, V138, P381
   AMIEL M, 1982, CONTRAST MEDIA RADIO
   ANSELL G, 1980, INVEST RADIOL, V15, pS32, DOI 10.1097/00004424-198011001-00010
   BAILEY LE, 1968, J GEN PHYSIOL, V52, P969, DOI 10.1085/jgp.52.6.969
   BALTAXE HA, 1976, INVEST RADIOL, V11, P172, DOI 10.1097/00004424-197605000-00004
   BASSAN M, 1975, CIRCULATION, V51, P442
   BENCHIMO.A, 1966, NEW ENGL J MED, V274, P1217, DOI 10.1056/NEJM196606022742201
   BERGER RE, 1982, AM J ROENTGENOL, V138, P283
   BERKSETH RO, 1984, MED CLIN N AM, V68, P351
   BERNSTEIN EF, 1968, INVEST RADIOL, V1, P162
   BETTMANN MA, 1982, AM J ROENTGENOL, V139, P787
   BROWN TG, 1967, ANGIOLOGY, V18, P273, DOI 10.1177/000331976701800503
   BROWN TG, 1967, ACTA RADIOL        S, V270, P58
   BRUNDAGE BH, 1974, AM HEART J, V88, P281, DOI 10.1016/0002-8703(74)90460-8
   BYRD L, 1979, MEDICINE, V58, P270, DOI 10.1097/00005792-197905000-00006
   CARSON RP, 1970, AM J CARDIOL, V25, P571, DOI 10.1016/0002-9149(70)90596-5
   CARVALLO A, 1978, AM J MED, V65, P38, DOI 10.1016/0002-9343(78)90690-3
   COHEN LS, 1969, RADIOLOGY, V92, P329
   CUMBERLAND DC, 1981, BRIT HEART J, V45, P698
   CUMBERLAND DC, 1981, BRIT J RADIOL, V54, P203
   DAWSON P, 1983, CLIN RADIOL, V34, P221, DOI 10.1016/S0009-9260(83)80312-2
   DELIA JA, 1982, AM J MED, V72, P719, DOI 10.1016/0002-9343(82)90536-8
   DISESSA TG, 1983, RADIOLOGY, V148, P687
   ECKBERG DL, 1974, J CLIN INVEST, V54, P1455, DOI 10.1172/JCI107893
   ENDRICH B, 1979, RADIOLOGY, V132, P331
   ERIKSON U, 1982, CONTRAST MEDIA RADIO, P340
   EVILL CA, 1977, INVEST RADIOL, V12, P169, DOI 10.1097/00004424-197703000-00012
   FIERRO D, 1982, CONTRAST MEDIA RADIO, P302
   FISCHER HW, 1977, J THEOR BIOL, V67, P653, DOI 10.1016/0022-5193(77)90252-1
   FISCHER HW, 1978, INVEST RADIOL, V13, P450, DOI 10.1097/00004424-197809000-00010
   FRINK RJ, 1975, AM J CARDIOL, V35, P17, DOI 10.1016/0002-9149(75)90553-6
   GAFTER U, 1979, RADIOLOGY, V132, P341
   GENSINI GG, 1964, RADIOLOGY, V82, P24
   GERBER KH, 1982, INVEST RADIOL, V17, P292, DOI 10.1097/00004424-198201730-00018
   GERBER KH, 1982, CIRCULATION, V65, P1307
   GOLDBERG M, 1984, ANESTHESIOLOGY, V60, P46, DOI 10.1097/00000542-198401000-00010
   GOOTMAN N, 1970, AM J CARDIOL, V25, P59, DOI 10.1016/0002-9149(70)90815-5
   GRAINGER RG, 1982, BRIT J RADIOL, V55, P1
   GRAINGER RG, 1979, BRIT J RADIOL, V52, P781
   GREEN CE, 1981, CARDIOVASC INTER RAD, V4, P110, DOI 10.1007/BF02552389
   GREHN S, 1982, RADIOLOGY, V143, P825
   GRENDAHL H, 1972, ACTA MED SCAND, V191, P493
   GRIGGS DM, 1966, CLIN RES, V14, P247
   GROSSMAN W, 1980, CARDIAC CATHETERIZAT
   HADDY FJ, 1960, CIRC RES, V8, P57
   HAMBY RI, 1977, AM HEART J, V93, P9, DOI 10.1016/S0002-8703(77)80166-X
   HAMMERME.KE, 1973, AM J CARDIOL, V31, P307, DOI 10.1016/0002-9149(73)90260-9
   HARKONEN S, 1977, AM J MED, V63, P939, DOI 10.1016/0002-9343(77)90549-6
   HESSEL SJ, 1981, RADIOLOGY, V138, P273
   HIGGINS CB, 1983, CIRCULATION, V68, P628
   HIGGINS CB, 1977, RADIOLOGY, V124, P599
   HIGGINS CB, 1982, RADIOLOGY, V142, P681
   HIGGINS CB, 1976, RADIOLOGY, V121, P205
   HIGGINS CB, 1978, CIRCULATION, V58, P512
   HIGGINS CB, 1980, INVEST RADIOL, V15, pS220, DOI 10.1097/00004424-198011001-00048
   HIGGINS CB, 1980, INVEST RADIOL, V15, P39, DOI 10.1097/00004424-198001000-00007
   HIGGINS CB, 1978, INVEST RADIOL, V13, P205, DOI 10.1097/00004424-197805000-00006
   HILAL SK, 1966, RADIOLOGY, V86, P615
   HILDNER FJ, 1971, RADIOLOGY, V100, P329
   HIRSHFELD JW, 1983, J AM COLL CARDIOL, V2, P954
   ISERI LT, 1965, AM HEART J, V69, P154, DOI 10.1016/0002-8703(65)90032-3
   JACOBSSON B, 1967, ACTA RADIOL STOCKH S, V270, P103
   JOHNSON JH, 1962, NEUROLOGY, V12, P560
   KATZBERG RW, 1977, INVEST RADIOL, V12, P381, DOI 10.1097/00004424-197709000-00002
   KLOSTER FE, 1972, CIRCULATION, V46, P438
   Kloster F E, 1966, Invest Radiol, V1, P398, DOI 10.1097/00004424-196609000-00029
   KOHRI K, 1977, RADIOLOGY, V122, P654
   KROVETZ LJ, 1967, AM HEART J, V74, P453, DOI 10.1016/0002-8703(67)90003-8
   LALLI AF, 1981, RADIOLOGY, V138, P47
   LANGER GA, 1973, ANNU REV PHYSIOL, V35, P55, DOI 10.1146/annurev.ph.35.030173.000415
   LASSER EC, 1973, INVEST RADIOL, V8, P189, DOI 10.1097/00004424-197307000-00001
   LASSER EC, 1979, AM J ROENTGENOL, V132, P171
   LASSER EC, 1980, INVEST RADIOL, V15, pS2, DOI 10.1097/00004424-198011001-00003
   LEHAN PATRICK H., 1963, JOUR CLIN INVEST, V42, P950
   LEVITAN H, 1976, ACTA RADIOL DIAGN, V17, P81
   LIPTON MJ, 1978, INVEST RADIOL, V13, P519, DOI 10.1097/00004424-197811000-00007
   LUDWIG JW, 1979, DIAGN IMAGING, V48, P223
   MACALPIN RN, 1966, CIRCULATION, V34, P627
   MAHER JF, 1979, STRAUSS WELTS DISEAS, V2, P1431
   MALLETTE LE, 1983, RADIOLOGY, V147, P677
   MANCINI GBJ, 1983, AM J CARDIOL, V51, P1218
   MANCINI GBJ, 1984, AM J CARDIOL, V53, P228, DOI 10.1016/0002-9149(84)90717-3
   MANDAL AK, 1983, CIRC SHOCK, V11, P245
   MARTINPAREDERO V, 1983, ARCH SURG-CHICAGO, V118, P1417
   MILLER D, 1976, INVEST RADIOL, V11, P577, DOI 10.1097/00004424-197611000-00014
   MOREAU JF, 1980, INVEST RADIOL, V15, pS54, DOI 10.1097/00004424-198011001-00014
   MOREAU JF, 1982, CONTRAST MEDIA RADIO, P195
   MORRIS TW, 1979, INVEST RADIOL, V14, P217
   MORRIS TW, 1983, RADIOLOGY, V148, P55
   MYERS GE, 1981, CATHETER CARDIO DIAG, V7, P65, DOI 10.1002/ccd.1810070109
   NAKHJAVA.FK, 1974, J ELECTROCARDIOL, V7, P101, DOI 10.1016/S0022-0736(74)80018-X
   NEWELL JD, 1980, INVEST RADIOL, V15, P363, DOI 10.1097/00004424-198009000-00003
   NISHIMURA RA, 1984, AM J CARDIOL, V53, P1496
   PARVEZ Z, 1983, INVEST RADIOL, V18, P279, DOI 10.1097/00004424-198305000-00012
   PAULIN S, 1971, RADIOLOGY, V101, P45
   PEREZGOMEZ F, 1977, BRIT HEART J, V39, P967
   POPIO KA, 1978, CIRCULATION, V58, P520
   RAHIMTOO.SH, 1967, CIRCULATION, V35, P70
   RAND PW, 1965, RADIOLOGY, V85, P1022
   RAO VM, 1983, RADIOLOGY, V147, P601
   RAO VM, 1982, RADIOLOGY, V144, P291
   RAPOPORT S, 1982, RADIOLOGY, V143, P321
   REYNOLDS G, 1953, BRIT HEART J, V15, P74
   RUDOLPH AM, 1968, CIRCULATION S3, V37, P59
   SALEM DN, 1983, CLIN RES, V31, pA216
   SCHIANTA.P, 1973, INVEST RADIOL, V8, P199, DOI 10.1097/00004424-197307000-00003
   Schräder R, 1983, Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd, V118, P67
   SELIN K, 1983, ACTA RADIOL DIAGN, V24, P37
   SERUR JR, 1982, CARDIOVASC INTER RAD, V5, P211, DOI 10.1007/BF02552312
   SHEHADI WH, 1980, RADIOLOGY, V137, P299
   SHEHADI WH, 1982, RADIOLOGY, V143, P11
   SHEHADI WH, 1975, AM J ROENTGENOL, V124, P145
   SIMON AL, 1972, AM J ROENTGENOL, V114, P810
   SLUTSKY R, 1983, AM HEART J, V106, P107, DOI 10.1016/0002-8703(83)90447-7
   SMITH RF, 1967, CIRCULATION, V36, P63
   SNYDER CF, 1971, AMER J ROENTGENOL RA, V113, P567
   Speck U, 1983, Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd, V118, P2
   SPECK U, 1982, CONTRAST MEDIA RADIO, P335
   STEINER RM, 1980, CLIN RADIOL, V31, P621, DOI 10.1016/S0009-9260(80)80001-8
   STRAIN WH, 1983, ABRAMS ANGIOGRAPHY V, V1
   SWARTZ RD, 1978, AM J MED, V65, P31, DOI 10.1016/0002-9343(78)90689-7
   TALNER LB, 1972, INVEST RADIOL, V7, P311, DOI 10.1097/00004424-197207000-00014
   TALNER LB, 1972, RADIOL CLIN N AM, V10, P421
   TAY DJ, 1976, ACTA RADIOL DIAGN, V17, P449
   THOMSON KR, 1980, INVEST RADIOL, V15, P234, DOI 10.1097/00004424-198005000-00010
   THOMSON KR, 1978, INVEST RADIOL, V13, P238, DOI 10.1097/00004424-197805000-00010
   TRAGARDH B, 1976, ACTA RADIOL DIAGN, V17, P69
   Trägårdh B, 1980, Acta Radiol Suppl, V362, P25
   TRAGARDH B, 1975, RADIOLOGY, V115, P59
   TRAGARDH B, 1976, INVEST RADIOL, V11, P563
   TRAGARDH B, 1976, INVEST RADIOL, V11, P569
   TRAGARDH B, 1974, INVEST RADIOL, V9, P340
   TRAGARDH B, 1975, INVEST RADIOL, V10, P231
   TZIVONI D, 1977, BASIC RES CARDIOL, V72, P1, DOI 10.1007/BF01906296
   VINE DL, 1977, CIRCULATION, V56, P379
   VIOLANTE MR, 1978, RADIOLOGY, V128, P497
   WEIKL A, 1982, CARDIOVASC INTER RAD, V5, P202, DOI 10.1007/BF02552311
   WEIKL A, 1981, RADIOL MED TORINO, V61, P398
   WEIKL A, 1975, FORTSCHR RONTG NEUEN, V123, P218
   WHITE CW, 1973, CIRCULATION S4, V48, P38
   WHITE CW, 1976, CARDIOVASC RES, V10, P214, DOI 10.1093/cvr/10.2.214
   WHITE CW, 1972, CIRCULATION, V46, P38
   WIDRICH WC, 1983, RADIOLOGY, V148, P61
   WILDENTH.K, 1969, AM J PHYSIOL, V217, P302
   WINDING O, 1980, RADIOLOGY, V134, P317
   WINDING O, 1980, RADIOLOGY, V134, P321
   Wink K, 1983, Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd, V118, P120
   WOLF GL, 1978, RADIOLOGY, V129, P215
   WOLF GL, 1980, INVEST RADIOL, V15, pS208, DOI 10.1097/00004424-198011001-00046
   WOLF GL, 1981, INVEST RADIOL, V16, P320, DOI 10.1097/00004424-198107000-00013
   WOLF GL, 1981, CARDIOVASC INTER RAD, V4, P145, DOI 10.1007/BF02552414
   WOLF GL, 1973, RADIOLOGY, V107, P655
   YAMAZAKI H, 1975, JPN HEART J, V16, P57
   ZELIS R, 1976, CIRCULATION, V53, P490
NR 155
TC 44
Z9 44
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0033-0620
J9 PROG CARDIOVASC DIS
JI Prog. Cardiovasc. Dis.
PD MAY-JUN
PY 1986
VL 28
IS 6
BP 435
EP 448
DI 10.1016/0033-0620(86)90026-5
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA C3167
UT WOS:A1986C316700003
PM 3517963
ER

PT J
AU TRESCH, DD
   WETHERBEE, JN
   SIEGEL, R
   TROUP, PJ
   KEELAN, MH
   OLINGER, GN
   BROOKS, HL
AF TRESCH, DD
   WETHERBEE, JN
   SIEGEL, R
   TROUP, PJ
   KEELAN, MH
   OLINGER, GN
   BROOKS, HL
TI LONG-TERM FOLLOW-UP OF SURVIVORS OF PREHOSPITAL SUDDEN CARDIAC DEATH
   TREATED WITH CORONARY-BYPASS SURGERY
SO AMERICAN HEART JOURNAL
LA English
DT Article
C1 MED COLL WISCONSIN,DEPT MED,DIV CARDIOTHORAC SURG,MILWAUKEE,WI 53226.
RP TRESCH, DD (reprint author), MED COLL WISCONSIN,DEPT MED,DIV CARDIOL,8700 W WISCONSIN AVE,MILWAUKEE,WI 53226, USA.
CR BAUM RS, 1974, CIRCULATION, V50, P1231
   Blackburn H, 1976, Adv Cardiol, V18, P208
   BOINEAU JP, 1982, AM J CARDIOL, V49, P381, DOI 10.1016/0002-9149(82)90516-1
   BONCHEK LI, 1977, ANN THORAC SURG, V24, P337
   COBB LA, 1980, MOD CONC CARDIOV DIS, V49, P31
   COBB LA, 1983, J AM COLL CARDIOL, V1, P688
   DETRE K, 1977, LANCET, V2, P1243
   EISENBERG MS, 1982, NEW ENGL J MED, V306, P1340, DOI 10.1056/NEJM198206033062206
   GARAN H, 1983, AM J CARDIOL, V51, P519, DOI 10.1016/S0002-9149(83)80091-5
   GUINN GA, 1977, AM J CARDIOL, V39, P270
   HAMMERMEISTER KE, 1977, AM J CARDIOL, V39, P925, DOI 10.1016/S0002-9149(77)80048-9
   HOROWITZ LN, 1980, N ENGL J MED, V302, P591
   JUDKINS MP, 1968, RADIOL CLIN N AM, V6, P467
   KAISER GA, 1975, SURGERY, V78, P749
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KEHOE R, 1980, AM J CARDIOL, V45, P444, DOI 10.1016/0002-9149(80)90883-8
   LIBERTHS.RR, 1974, NEW ENGL J MED, V291, P317, DOI 10.1056/NEJM197408152910701
   MORADY F, 1983, AM J CARDIOL, V51, P85, DOI 10.1016/S0002-9149(83)80016-2
   MYERBURG RJ, 1975, CIRCULATION S3, V51, P219
   MYERBURG RJ, 1982, JAMA-J AM MED ASSOC, V247, P1485, DOI 10.1001/jama.247.10.1485
   MYERBURG RJ, 1984, CIRCULATION, V70, P538
   ROY D, 1983, AM J CARDIOL, V52, P969, DOI 10.1016/0002-9149(83)90514-3
   SANDLER H, 1968, AM HEART J, V75, P325, DOI 10.1016/0002-8703(68)90089-6
   SHAFFER WA, 1975, NEW ENGL J MED, V293, P259
   SONES F M Jr, 1962, Mod Concepts Cardiovasc Dis, V31, P735
   SWERDLOW CD, 1982, AM HEART J, V104, P1004, DOI 10.1016/0002-8703(82)90432-X
   TRESCH DD, 1984, AM HEART J, V108, P1, DOI 10.1016/0002-8703(84)90536-2
   TRESCH DD, 1981, ARCH INTERN MED, V141, P1154
   TRESCH DD, 1981, CIRCULATION, V64, P1
   VISMARA LA, 1977, AM J CARDIOL, V39, P919, DOI 10.1016/S0002-9149(77)80047-7
   WEAVER WD, 1976, CIRCULATION, V54, P895
NR 31
TC 44
Z9 45
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0002-8703
J9 AM HEART J
JI Am. Heart J.
PY 1985
VL 110
IS 6
BP 1139
EP 1145
DI 10.1016/0002-8703(85)90003-1
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AVP26
UT WOS:A1985AVP2600002
PM 4072871
ER

PT J
AU ARMSTRONG, JS
AF ARMSTRONG, JS
TI FORECASTING BY EXTRAPOLATION - CONCLUSIONS FROM 25 YEARS OF RESEARCH
SO INTERFACES
LA English
DT Article
RP ARMSTRONG, JS (reprint author), UNIV PENN,WHARTON SCH,PHILADELPHIA,PA 19104, USA.
CR Adam E. E., 1973, DECISION SCI, V4, P458, DOI 10.1111/j.1540-5915.1973.tb00573.x
   ALBRECHT WS, 1977, J ACCOUNTING RES, V15, P226, DOI 10.2307/2490350
   Armstrong J. S., 1978, LONG RANGE FORECASTI
   ARMSTRONG JS, 1983, J FORECASTING, V2, P259
   ARMSTRONG JS, 1975, PUBLIC OPIN QUART, V39, P111, DOI 10.1086/268203
   BATES JM, 1969, OPER RES QUART, V20, P451, DOI 10.2307/3008764
   Box GEP, 1976, TIME SERIES ANAL
   BRANDON CH, 1983, MANAGE SCI, V29, P256, DOI 10.1287/mnsc.29.2.256
   BROWN LD, 1978, J FINANC, V33, P1, DOI 10.2307/2326346
   BROWN RG, 1959, STATISTICAL FORECAST
   BUNN DW, 1979, J MARKETING RES, V16, P280, DOI 10.2307/3150692
   CARBONE R, 1983, MANAGE SCI, V29, P559, DOI 10.1287/mnsc.29.5.559
   CAREY KJ, 1978, J ECON BUS, V30, P182
   CHATFIEL.C, 1973, J ROY STAT SOC A STA, V136, P295, DOI 10.2307/2344994
   Chatfield C., 1978, APPLIED STATISTICS, P264, DOI 10.2307/2347162
   CHOW WM, 1965, J IND ENGINEERING, V16, P314
   COGGIN TD, 1982, J BUSINESS FORECASTI, V1, P20
   COOPER HM, 1980, PSYCHOL BULL, V87, P442, DOI 10.1037/0033-2909.87.3.442
   DALRYMPLE DJ, 1978, J BUS RES, V6, P133, DOI 10.1016/0148-2963(78)90004-8
   DANCER R, 1977, DECISION SCI, V8, P228, DOI 10.1111/j.1540-5915.1977.tb01079.x
   Dennis J. D., 1978, PRODUCTION INVENTORY, V19, P43
   DORN HF, 1950, J AM STAT ASSOC, V45, P311, DOI 10.2307/2280290
   EKERN S, 1981, J OPER RES SOC, V32, P775, DOI 10.2307/2581393
   ELTON EJ, 1972, MANAGE SCI B-APPL, V18, pB409
   FRANK W, 1969, J ACCOUNTING RES, V7, P123, DOI 10.2307/2490271
   Gardner E. S., 1980, Decision Sciences, V11, DOI 10.1111/j.1540-5915.1980.tb01145.x
   GARDNER ES, 1979, INTERFACES, V9, P49, DOI 10.1287/inte.9.4.49
   GARDNER ES, 1983, OMEGA-INT J MANAGE S, V11, P621, DOI 10.1016/0305-0483(83)90023-3
   GARDNER ES, 1984, J FORECASTING
   GEURTS MD, 1975, J MARKETING RES, V12, P182, DOI 10.2307/3150441
   GROFF GK, 1973, MANAGE SCI, V20, P22, DOI 10.1287/mnsc.20.1.22
   HAGERMAN RL, 1979, J ECON BUS, V31, P172
   HAJNAL J, 1955, J AM STAT ASSOC, V50, P309, DOI 10.2307/2280963
   HILL G, 1984, UNPUB J FORECASTING
   JOHNSON TE, 1974, FINANC MANAGE, V3, P64, DOI 10.2307/3665292
   KAHL DR, 1983, MANAGE SCI, V29, P1325, DOI 10.1287/mnsc.29.11.1325
   KENNY PB, 1982, J ROY STAT SOC A STA, V145, P1, DOI 10.2307/2981420
   KIRBY RM, 1966, MANAGEMENT SCI, V13, pB202
   LAWRENCE MJ, 1985, UNPUB J FORECASTING
   LAWRENCE MJ, 1983, J FORECASTING, V2, P169, DOI 10.1002/for.3980020207
   LEOLTER J, 1981, TECHNOMETRICS, V23, P411
   MABERT VA, 1976, DECISION SCI, V7, P310, DOI 10.1111/j.1540-5915.1976.tb00678.x
   MABERT VA, 1978, DECISION SCI, V9, P285, DOI 10.1111/j.1540-5915.1978.tb01385.x
   MAKRIDAKIS S, 1979, J ROY STAT SOC A STA, V142, P97, DOI 10.2307/2345077
   MAKRIDAKIS S, 1982, J FORECASTING, V1, P111, DOI 10.1002/for.3980010202
   MAKRIDAKIS S, 1983, MANAGE SCI, V29, P987, DOI 10.1287/mnsc.29.9.987
   MARKLAND RE, 1970, NAV RES LOGIST Q, V17, P103, DOI 10.1002/nav.3800170110
   MCLEAVEY DW, 1981, DECISION SCI, V12, P708, DOI 10.1111/j.1540-5915.1981.tb00122.x
   MORRIS MJ, 1977, J ROY STAT SOC A STA, V140, P437, DOI 10.2307/2345279
   NEWBOLD P, 1974, J ROY STAT SOC A STA, V137, P131, DOI 10.2307/2344546
   Ogburn WF, 1934, SOC FORCES, V13, P224, DOI 10.2307/2570338
   RAINE JE, 1971, DECISION SCI, V2, P181, DOI 10.1111/j.1540-5915.1971.tb01453.x
   REID DJ, 1975, PRACTICAL ASPECTS FO
   REINMUTH JE, 1979, FORECASTING
   RULAND W, 1980, FINANC MANAGE, V9, P30, DOI 10.2307/3665165
   SHISKIN J, 1958, SCIENCE, V128, P1539, DOI 10.1126/science.128.3338.1539
   SMITH DE, 1974, OPER RES QUART, V25, P421, DOI 10.2307/3007929
   TORFIN GP, 1968, PRODUCTION INVENTORY, V9, P72
   Whybark D. C., 1972, Logistics and Transportation Review, V8
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
   WINKLER RL, 1983, J ROY STAT SOC A STA, V146, P150, DOI 10.2307/2982011
   WINTERS PR, 1960, MANAGE SCI, V6, P324, DOI 10.1287/mnsc.6.3.324
NR 62
TC 44
Z9 44
PU INST OPERATIONS RESEARCH  MANAGEMENT SCIENCES
PI LINTHICUM HTS
PA 901 ELKRIDGE LANDING RD, STE 400, LINTHICUM HTS, MD 21090-2909
SN 0092-2102
J9 INTERFACES
JI Interfaces
PY 1984
VL 14
IS 6
BP 52
EP 61
DI 10.1287/inte.14.6.52
PG 10
WC Management; Operations Research & Management Science
SC Business & Economics; Operations Research & Management Science
GA TX450
UT WOS:A1984TX45000008
ER

PT J
AU Carlson, KF
   Kehle, SM
   Meis, LA
   Greer, N
   MacDonald, R
   Rutks, I
   Sayer, NA
   Dobscha, SK
   Wilt, TJ
AF Carlson, Kathleen F.
   Kehle, Shannon M.
   Meis, Laura A.
   Greer, Nancy
   MacDonald, Roderick
   Rutks, Indulis
   Sayer, Nina A.
   Dobscha, Steven K.
   Wilt, Timothy J.
TI Prevalence, Assessment, and Treatment of Mild Traumatic Brain Injury and
   Posttraumatic Stress Disorder: A Systematic Review of the Evidence
SO JOURNAL OF HEAD TRAUMA REHABILITATION
LA English
DT Article
DE blast-related injury; comorbidity; military; postconcussive syndrome;
   posttraumatic stress disorder; systematic review; traumatic brain
   injury; veterans
ID MINOR HEAD-INJURY; MOTOR-VEHICLE ACCIDENTS; WAR VETERANS; SELF-REPORT;
   POSTCONCUSSIVE SYMPTOMS; ENDURING FREEDOM; SERVICE MEMBERS; COMBAT
   VETERANS; TERROR VICTIMS; PTSD
AB Background: Iraq and Afghanistan war veterans are returning from combat having sustained traumatic brain injury, most commonly mild traumatic brain injury (mTBI), and experiencing posttraumatic stress disorder (PTSD). Clinical guidelines for mTBI and PTSD do not focus on the co-occurrence of these conditions (mTBI/PTSD). A synthesis of the evidence on prevalence, diagnostic accuracy, and treatment effectiveness for mTBI/PTSD would be of use to clinicians, researchers, and policymakers. Methods: We conducted a systematic review of studies identified through PubMed, PsycINFO, REHABDATA, Cochrane Library, pearling, and expert recommendations. Peer-reviewed English language studies published between 1980 and June, 2009 were included if they reported frequencies of traumatic brain injury and PTSD, or diagnostic accuracy or treatment effectiveness specific to mTBI/PTSD. Results: Thirty-four studies met inclusion criteria. None evaluated diagnostic accuracy or treatment effectiveness. Studies varied considerably in design. Frequency of mTBI/PTSD ranged from 0% to 89%. However, in 3 large studies evaluating Iraq and Afghanistan war veterans, frequencies of probable mTBI/PTSD were from 5% to 7%; among those with probable mTBI, frequencies of probable PTSD were from 33% to 39%. Discussion: The wide range of mTBI/PTSD frequency levels was likely due to variation across study parameters, including aims and assessment methods. Studies using consistent, validated methods to define and measure mTBI history and PTSD are needed.
C1 [Carlson, Kathleen F.] Minneapolis VA Med Ctr 152 2E, VA Hlth Serv Res & Dev Serv, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA.
   [Carlson, Kathleen F.; Kehle, Shannon M.; Meis, Laura A.; Sayer, Nina A.; Wilt, Timothy J.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.
   [Sayer, Nina A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA.
   [Dobscha, Steven K.] Portland VA Med Ctr, Portland Ctr Study Chron ComorbidMental & Phys Di, Portland, OR USA.
RP Carlson, KF (reprint author), Minneapolis VA Med Ctr 152 2E, VA Hlth Serv Res & Dev Serv, Ctr Chron Dis Outcomes Res, 1 Vet Dr, Minneapolis, MN 55417 USA.
EM kathleen.carlson@va.gov
RI Schueter, nicos/A-3625-2014
FU Department of Veterans Affairs, Veterans Health Administration, Office
   of Research and Development [ESP 09-009]; Postdoctoral Training Program
   [TPP 67-005]; Career Development Award Program [CDA 08-025]
FX This work was supported by Department of Veterans Affairs, Veterans
   Health Administration, Office of Research and Development Evidence-based
   Synthesis Pilot Program (ESP 09-009), Postdoctoral Training Program (TPP
   67-005), and Career Development Award Program (CDA 08-025) grants.
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   American Psychiatric Association, 1987, DIAGN STAT MAN MENT
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   American Psychiatric Association, 1980, DIAGN STAT MAN MENT
   Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117
   Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084
   Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513
   Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23
   Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501
   Bossuyt Patrick M, 2003, Ann Intern Med, V138, pW1
   Brenner LA, 2009, MIL MED, V174, P347
   Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007
   Bryant RA, 2004, PSYCHOSOM MED, V66, P760, DOI 10.1097/01.psy.0000138121.13198.84
   Bryant RA, 1998, AM J PSYCHIAT, V155, P625
   Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006
   Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836
   Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585
   Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629
   Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931
   Bryant RA, 2006, COGN BEHAV PRACT, V13, P17, DOI 10.1016/j.cbpra.2005.03.002
   Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006
   Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826
   Carlson K, 2009, ASSESSMENT TREATMENT
   Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483
   Carroll L, 2004, J REHABIL MED S, V43, P113, DOI DOI 10.1080/16501960410023877
   Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R
   Chalton LD, 2009, BRAIN INJURY, V23, P77, DOI 10.1080/02699050802635273
   Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001
   DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083
   Foa E. B., 2008, EFFECTIVE TREATMENTS
   Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42
   Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963
   Golding H, 2009, J REHABIL RES DEV, V46, pVII, DOI 10.1682/JRRD.2009.06.0081
   Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276
   Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626
   Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24
   Hickling EJ, 1998, BRAIN INJURY, V12, P265
   Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972
   Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606
   Hoofien D, 2001, BRAIN INJURY, V15, P189
   Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928
   Institute of Medicine, 2009, GULF WAR HLTH, V7
   Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031
   KANG HK, 2009, VHA ENV EPIDEMIOLOGY
   Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166
   Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4
   Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106
   King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696
   Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032
   *MAN COUC M TBI WO, 2009, VA DOD CLIN PRACT GU
   McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289
   McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016
   McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652
   McCrea M., 2007, MILD TRAUMATIC BRAIN
   McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532
   MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5
   Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558
   Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6
   Powell TJ, 1996, DISABIL REHABIL, V18, P231
   *PRES COMM CAR AM, 2007, SERV SUPP SIMPL
   Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5
   Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028
   Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008
   SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780
   Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068
   Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707
   Schwab KA, 2006, NEUROLOGY, V66, pA235
   Schwartz I, 2007, ARCH PHYS MED REHAB, V88, P440, DOI 10.1016/j.apmr.2007.01.001
   Schwartz I, 2008, BRAIN INJURY, V22, P255, DOI 10.1080/02699050801941763
   Sigford B, 2009, NEW ENGL J MED, V361, P536, DOI 10.1056/NEJMc096180
   Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604
   Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090
   Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423
   Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791
   Tanielian T., 2008, INVISIBLE WOUNDS WAR
   *TASK FORC RET GLO, 2007, TASK FORC REP
   Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341
   Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8
   Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308
   Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334
   *US DEP VET AFF HL, VA EV SYNTH PROG ESP
   *USA MED RES MAT C, 2006, MAPP LANDS DEPL REL
   *VET HLTH ADM, 2004, VA DOD CLIN PRACT GU
   Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398
   Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18
   Williams WH, 2002, BRAIN INJURY, V16, P673
NR 86
TC 43
Z9 43
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0885-9701
J9 J HEAD TRAUMA REHAB
JI J. Head Trauma Rehabil.
PD MAR-APR
PY 2011
VL 26
IS 2
BP 103
EP 115
DI 10.1097/HTR.0b013e3181e50ef1
PG 13
WC Clinical Neurology; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA 732OR
UT WOS:000288197200001
PM 20631631
ER

PT J
AU Pinson, P
   Kariniotakis, G
AF Pinson, Pierre
   Kariniotakis, George
TI Conditional Prediction Intervals of Wind Power Generation
SO IEEE TRANSACTIONS ON POWER SYSTEMS
LA English
DT Article
DE Forecasting; fuzzy inference; nonlinear; nonstationary; resampling;
   uncertainty; wind power
ID SHORT-TERM PREDICTION; PROBABILISTIC FORECASTS; QUANTILE REGRESSION;
   RISK
AB A generic method for the providing of prediction intervals of wind power generation is described. Prediction intervals complement the more common wind power point forecasts, by giving a range of potential outcomes for a given probability, their so-called nominal coverage rate. Ideally they inform of the situation-specific uncertainty of point forecasts. In order to avoid a restrictive assumption on the shape of forecast error distributions, focus is given to an empirical and nonparametric approach named adapted resampling. This approach employs a fuzzy inference model that permits to integrate expertise on the characteristics of prediction errors for providing conditional interval forecasts. By simultaneously generating prediction intervals with various nominal coverage rates, one obtains full predictive distributions of wind generation. Adapted resampling is applied here to the case of an onshore Danish wind farm, for which three point forecasting methods are considered as input. The probabilistic forecasts generated are evaluated based on their reliability and sharpness, while compared to forecasts based on quantile regression and the climatology benchmark. The operational application of adapted resampling to the case of a large number of wind farms in Europe and Australia among others is finally discussed.
C1 [Pinson, Pierre] Tech Univ Denmark, Dept Informat & Math Modeling, DK-2800 Lyngby, Denmark.
   [Kariniotakis, George] Ecole Mines Paris, Ctr Energy & Proc, F-06904 Sophia Antipolis, France.
RP Pinson, P (reprint author), Tech Univ Denmark, Dept Informat & Math Modeling, 2800 Kgs, DK-2800 Lyngby, Denmark.
EM pp@imm.dtu.dk; georges.kariniotakis@mines-paristech.fr
RI Pinson, Pierre/C-1601-2009
OI Pinson, Pierre/0000-0002-1480-0282
FU European Commission [ENK5-CT2002-00665]
FX Manuscript received August 02, 2009; revised December 04, 2009. First
   published April 19, 2010; current version published October 20, 2010.
   This work was supported in part by the European Commission via the
   ANEMOS Project (ENK5-CT2002-00665). Paper no. TPWRS-00601-2009.
CR Bremnes JB, 2006, WIND ENERGY, V9, P3, DOI 10.1002/we.182
   Castronuovo ED, 2004, IEEE T POWER SYST, V19, P1599, DOI 10.1109/TPWRS.2004.831707
   Chatfield C, 2003, ANAL TIME SERIES INT
   Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560
   Costa A, 2008, RENEW SUST ENERG REV, V12, P1725, DOI 10.1016/j.rser.2007.01.015
   da Silva AP, 2000, IEEE T POWER SYST, V15, P1191, DOI 10.1109/59.898089
   Doherty R, 2005, IEEE T POWER SYST, V20, P587, DOI 10.1109/TPWRS.2005.846206
   ENFRON B, 2007, INTRO BOOTSTRAP
   GENEST C, 1990, J FORECASTING, V9, P53, DOI 10.1002/for.3980090106
   GIEBEL G, 2003, STATE ART SHORT TERM
   GIEBEL G, 2005, RISOR1527EN
   Gneiting T, 2007, J ROY STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x
   Gneiting T, 2006, J AM STAT ASSOC, V101, P968, DOI 10.1198/016214506000000456
   JUBAN JN, 2007, P IEEE POW TECH 2007, P683
   KARINIOTAKIS G, 2002, P IEEE MEDPOWER 02 C
   Lange M, 2005, J SOL ENERG-T ASME, V127, P177, DOI 10.1115/1.1862266
   MATOS MA, 2009, P IEEE POW TECH C BU
   Moller JK, 2008, COMPUT STAT DATA AN, V52, P1292, DOI 10.1016/j.csda.2007.06.027
   Nielsen HA, 2006, WIND ENERGY, V9, P95, DOI 10.1002/we.180
   Nielsen T. S., 2002, P 15 IFAC WORLD C BA
   Pinson P, 2004, WIND ENERGY, V7, P119, DOI 10.1002/we.114
   Pinson P, 2009, WIND ENERGY, V12, P51, DOI 10.1002/we.284
   Pinson P, 2010, Q J ROY METEOR SOC, V136, P77, DOI 10.1002/qj.559
   Pinson P, 2007, IEEE T POWER SYST, V22, P1148, DOI 10.1109/TPWRS.2007.901117
   PINSON P, 2009, APPL ENERG, V186, P1326
   Pinson P., 2006, THESIS ECOLE MINES P
   Pinson P, 2007, WIND ENERGY, V10, P497, DOI 10.1002/we.230
   Pinson P, 2009, WIND ENERGY, V12, P137, DOI 10.1002/we.309
   Sanchez I, 2006, INT J FORECASTING, V22, P43, DOI 10.1016/j.ijforecast.2005.05.003
   Stewart T. R., 2000, PREDICTION SCI DECIS, P41
   TAYLOR JR, 1999, J NEUROSCI, V19, P1
   Thor S-E, 2002, WIND ENERGY, V5, P73, DOI 10.1002/we.65
   Thorarinsdottir TL, 2010, J R STAT SOC A STAT, V173, P371
   Wang L.-X., 1994, ADAPTIVE FUZZY SYSTE
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
NR 35
TC 43
Z9 45
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0885-8950
J9 IEEE T POWER SYST
JI IEEE Trans. Power Syst.
PD NOV
PY 2010
VL 25
IS 4
BP 1845
EP 1856
DI 10.1109/TPWRS.2010.2045774
PG 12
WC Engineering, Electrical & Electronic
SC Engineering
GA 670UD
UT WOS:000283451900009
ER

PT J
AU Moller, CH
   Perko, MJ
   Lund, JT
   Andersen, LW
   Kelbaek, H
   Madsen, JK
   Winkel, P
   Gluud, C
   Steinbruchel, DA
AF Moller, Christian H.
   Perko, Mario J.
   Lund, Jens T.
   Andersen, Lars W.
   Kelbaek, Henning
   Madsen, Jan K.
   Winkel, Per
   Gluud, Christian
   Steinbruechel, Daniel A.
TI No Major Differences in 30-Day Outcomes in High-Risk Patients Randomized
   to Off-Pump Versus On-Pump Coronary Bypass Surgery The Best Bypass
   Surgery Trial
SO CIRCULATION
LA English
DT Article
DE cardiopulmonary bypass; high-risk patients; off-pump; OPCAB;
   revascularization
ID ARTERY-BYPASS; CARDIOPULMONARY BYPASS; LIFE OUTCOMES; REVASCULARIZATION;
   QUALITY; STRATEGIES
AB Background-Off-pump coronary artery bypass grafting compared with coronary revascularization with cardiopulmonary bypass seems safe and results in about the same outcome in low-risk patients. Observational studies indicate that off-pump surgery may provide more benefit in high-risk patients. Our objective was to compare 30-day outcomes in high-risk patients randomized to coronary artery bypass grafting without or with cardiopulmonary bypass.
   Methods and Results-We randomly assigned 341 patients with a EuroSCORE >= 5 and 3-vessel coronary disease to undergo coronary artery bypass grafting without or with cardiopulmonary bypass. Patients were followed through the Danish National Patient Registry. The primary outcome was a composite of adverse cardiac and cerebrovascular events (ie, all-cause mortality, acute myocardial infarction, cardiac arrest with successful resuscitation, low cardiac output syndrome/cardiogenic shock, stroke, and coronary reintervention). An independent adjudication committee blinded to treatment allocation assessed the outcomes. Baseline characteristics were well balanced between groups. The mean number of grafts per patient did not differ significantly between groups (3.22 in off-pump group and 3.34 in on-pump group; P=0.11). Fewer grafts were performed to the lateral part of the left ventricle territory during off-pump surgery (0.97 versus 1.14 after on-pump surgery; P=0.01). No significant differences in the composite primary outcome (15% versus 17%; P=0.48) or the individual components were found at 30-day follow-up.
   Conclusions-Both off- and on-pump coronary artery bypass grafting can be performed in high-risk patients with low short-term complications.
   Clinical Trial Registration-clinicaltrials.gov. Identifier: NCT00120991. (Circulation. 2010;121:498-504.)
C1 [Moller, Christian H.] Copenhagen Univ Hosp, Rigshosp, Dept Cardiothorac Surg, Dept 2152, DK-2100 Copenhagen, Denmark.
   [Andersen, Lars W.] Copenhagen Univ Hosp, Rigshosp, Dept Cardiothorac Anesthesiol, DK-2100 Copenhagen, Denmark.
   [Kelbaek, Henning] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark.
   [Madsen, Jan K.] Copenhagen Univ Hosp, Gentofte Hosp, Dept Cardiol, DK-2100 Copenhagen, Denmark.
   [Moller, Christian H.; Winkel, Per; Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, DK-2100 Copenhagen, Denmark.
RP Moller, CH (reprint author), Copenhagen Univ Hosp, Rigshosp, Dept Cardiothorac Surg, Dept 2152, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM chm@ctu.rh.dk
FU Danish Heart Foundation [08-4-R64-A2029-B948-22480]; Danish Medical
   Research Council; Copenhagen Hospital Corporations Medical Research
   Council; Rigshospitalet Research Council; Aase and Ejnar Danielsens
   Foundation; Gangsted Foundation; Danish Agency for Science, Technology,
   and Innovation
FX This study was funded by the Danish Heart Foundation
   (08-4-R64-A2029-B948-22480), Danish Medical Research Council, Copenhagen
   Hospital Corporations Medical Research Council, Rigshospitalet Research
   Council, Aase and Ejnar Danielsens Foundation, Gangsted Foundation, and
   Danish Agency for Science, Technology, and Innovation.
CR Al-Ruzzeh S, 2003, EUR J CARDIO-THORAC, V23, P50, DOI 10.1016/S1010-7940(02)00654-1
   Al-Ruzzeh S, 2006, BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C
   Amar D, 2004, J AM COLL CARDIOL, V44, P1248, DOI 10.1016/j.jacc.2004.05.078
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Briffa N, 2008, EUR HEART J, V29, P1346, DOI 10.1093/eurheartj/ehn128
   Calafiore AM, 2003, EUR J CARDIO-THORAC, V23, P360, DOI 10.1016/S1010-7940(02)00800-X
   *DUK CLIN RES I, 2007, SOC THOR SURG NAT AD
   Fergusson D, 2002, BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652
   Filsoufi F, 2007, HEART SURG FORUM, V10, pE349, DOI 10.1532/HSF98.20071067
   Gaudino M, 2004, ANN THORAC SURG, V77, P574, DOI 10.1016/S0003-4975(03)01534-0
   Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4
   Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931
   Kjaergard LL, 2001, ANN INTERN MED, V135, P982
   Kobayashi J, 2005, CIRCULATION S1, V112, pI338
   Mack MJ, 2004, J THORAC CARDIOV SUR, V127, P167, DOI 10.1016/j.jtcvs.2003.08.032
   Moller CH, 2008, EUR HEART J, V29, P2601, DOI 10.1093/eurheartj/ehn335
   Moller CH, 2007, CONTEMP CLIN TRIALS, V28, P540, DOI 10.1016/j.cct.2006.11.002
   Nalysnyk L, 2003, HEART, V89, P767, DOI 10.1136/heart.89.7.767
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Ohata T, 2005, ANN THORAC SURG, V80, P131, DOI 10.1016/j.athoracsur.2005.02.031
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Stamou SC, 2005, ANN THORAC SURG, V79, P552, DOI 10.1016/j.athoracsur.2004.07.075
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   TUMAN KJ, 1992, J THORAC CARDIOV SUR, V104, P1510
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Wood L, 2008, BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD
NR 27
TC 43
Z9 46
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD FEB 2
PY 2010
VL 121
IS 4
BP 498
EP U41
DI 10.1161/CIRCULATIONAHA.109.880443
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 550TY
UT WOS:000274154300007
PM 20083683
ER

PT J
AU Ellena, JF
   Liang, BY
   Wiktor, M
   Stein, A
   Cafiso, DS
   Jahn, R
   Tamm, LK
AF Ellena, Jeffrey F.
   Liang, Binyong
   Wiktor, Maciej
   Stein, Alexander
   Cafiso, David S.
   Jahn, Reinhard
   Tamm, Lukas K.
TI Dynamic structure of lipid-bound synaptobrevin suggests a
   nucleation-propagation mechanism for trans-SNARE complex formation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE structure; dynamics; membrane fusion; SNARE proteins; NMR
ID MEMBRANE-FUSION; NMR-SPECTROSCOPY; TRANSMEMBRANE DOMAIN; BACKBONE
   DYNAMICS; CRYSTAL-STRUCTURE; EXOCYTOSIS; PROTEINS; DETERMINANTS;
   VESICLES; SYNTAXIN
AB The synaptic vesicle protein synaptobrevin engages with syntaxin and SNAP-25 to form the SNARE complex, which drives membrane fusion in neuronal exocytosis. In the SNARE complex, the SNARE motif of synaptobrevin forms a 55-residue helix, but it has been assumed to be mostly unstructured in its prefusion form. NMR data for full-length synaptobrevin in dodecylphosphocholine micelles reveals two transient helical segments flanked by natively disordered regions and a third more stable helix. Transient helix I comprises the most N-terminal part of the SNARE motif, transient helix II extends the SNARE motif into the juxtamembrane region, and the more stable helix III is the transmembrane domain. These helices may have important consequences for SNARE complex folding and fusion: helix I likely forms a nucleation site, the C-terminal disordered SNARE motif may act as a folding arrest signal, and helix II likely couples SNARE complex folding and fusion.
C1 [Liang, Binyong; Wiktor, Maciej; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA.
   [Liang, Binyong; Wiktor, Maciej; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.
   [Wiktor, Maciej] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   [Stein, Alexander; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.
   [Cafiso, David S.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.
RP Tamm, LK (reprint author), Univ Virginia, Ctr Membrane Biol, POB 800886, Charlottesville, VA 22908 USA.
EM lkt2e@virginia.edu
RI Stein, Alexander/I-4950-2012
OI Stein, Alexander/0000-0002-2696-0611
FU National Institutes of Health [GM72694]
FX This work was supported by National Institutes of Health grant P01
   GM72694.
CR Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l
   Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746
   Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214
   Bowen M, 2006, P NATL ACAD SCI USA, V103, P8378, DOI 10.1073/pnas.0602644103
   Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4
   Columbus L, 2004, BIOCHEMISTRY-US, V43, P7273, DOI 10.1021/bi0497906
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381
   EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0
   Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200
   Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h
   Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036
   Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117
   Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500
   Goddard T. D., 2008, SPARKY NMR ASSIGNMEN, V3
   Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065
   Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o
   Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875
   Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002
   JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.neuro.17.1.219
   Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p
   KALLICK DA, 1995, J MAGN RESON SER B, V109, P60, DOI 10.1006/jmrb.1995.1146
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025
   Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928
   Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072
   Langosch D, 2001, J MOL BIOL, V311, P709, DOI 10.1006/jmbi.2001.4889
   Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104
   Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306
   McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3
   Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081
   Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102
   Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486
   Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049
   Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003
   Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156
   Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104
   Sutton RB, 1998, NATURE, V395, P347
   Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716
   Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200
   Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003
   Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292
   Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028
NR 47
TC 43
Z9 44
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 1
PY 2009
VL 106
IS 48
BP 20306
EP 20311
DI 10.1073/pnas.0908317106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 525YQ
UT WOS:000272254400033
PM 19918058
ER

PT J
AU Smedira, NG
   Dyke, CM
   Koster, A
   Jurmann, M
   Bhatia, DS
   Hu, TF
   McCarthy, HL
   Lincoff, AM
   Spiess, BD
   Aronson, S
AF Smedira, NG
   Dyke, CM
   Koster, A
   Jurmann, M
   Bhatia, DS
   Hu, TF
   McCarthy, HL
   Lincoff, AM
   Spiess, BD
   Aronson, S
TI Anticoagulation with bivalirudin for off-pump coronary artery bypass
   grafting: The results of the EVOLUTION-OFF study
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article; Proceedings Paper
CT 31st Annual Meeting of the Western-Thoracic-Surgical-Association
CY JUN 22-25, 2005
CL Victoria, CANADA
SP Western Thorac Surg Assoc
ID ON-PUMP; SURGERY; HEPARIN; REVASCULARIZATION; PROTAMINE; HEART
AB Objectives: Unfractionated heparin has many shortcomings, including indirect and partial inhibition of thrombin, antibody formation, and platelet activation. Bivalirudin, a short- acting direct thrombin inhibitor, avoids these limitations and has superior outcomes during percutaneous revascularization. This trial was performed to evaluate the safety and efficacy of bivalirudin in off- pump coronary artery bypass grafting.
   Methods: An open- label, multicenter randomized trial compared heparin with protamine reversal to bivalirudin in patients undergoing off- pump coronary artery bypass. The primary objective was safety as demonstrated by similar rates of procedural success defined as freedom from a composite of death, myocardial infarction, stroke, and repeat revascularization. Twenty- one institutions randomized 105 patients to receive bivalirudin and 52 patients to receive heparin.
   Results: The mean age was 65 years for both groups. The bivalirudin group had more grafts: 3.0 +/- 1 versus 2.5 +/- 1. Procedural success rates at 30 days were identical in bivalirudin- and heparin- treated patients ( 93%). Operative times, total blood loss, reoperations for bleeding, and major adverse events were not significantly different. Strokes were more frequent in the heparin group: 5.5% versus 0; P = .05. Mortality was 2% in each group. Repeat revascularization was required in 3% of bivalirudin- and 2% of the heparin- treated patients.
   Conclusions: For patients undergoing off- pump coronary artery bypass grafting, bivalirudin was an effective anticoagulant, without excessive bleeding and with a safety profile similar to that of heparin. Further trials are warranted to assess whether anticoagulation with bivalirudin improves clinical outcomes.
C1 Cleveland Clin Fdn, Cleveland, OH 44195 USA.
   Duke Univ, Med Ctr, Durham, NC USA.
   Houston NW Med Ctr, Houston, TX USA.
   Gaston Mem Hosp, Gastonia, NC USA.
   Deutsch Herzzentrum, Berlin, Germany.
   Virginia Commonwealth Univ, Med Ctr, VCURES, Richmond, VA USA.
RP Smedira, NG (reprint author), Cleveland Clin Fdn, 9500 Euclid Ave,Desk F24, Cleveland, OH 44195 USA.
EM smedirn@ccf.org
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Bott JN, 2003, ANN THORAC SURG, V76, P273, DOI 10.1016/S0003-4975(03)00144-9
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Koster A, 2004, AM J CARDIOL, V93, P356, DOI 10.1016/j.amjcard.2003.10.021
   LINCOFF MA, 2003, JAMA-J AM MED ASSOC, V289, P853
   Merry AF, 2004, ANN THORAC SURG, V77, P925, DOI 10.1016/j.athoracsur.2003.09.061
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Warkentin TE, 2004, ANN THORAC SURG, V77, P931, DOI 10.1016/j.athoracsur.2003.10.113
NR 10
TC 43
Z9 45
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD MAR
PY 2006
VL 131
IS 3
BP 686
EP 692
DI 10.1016/j.jtcvs.2005.10.049
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 020VI
UT WOS:000235940600028
PM 16515924
ER

PT J
AU Desai, ND
   Miwa, S
   Kodama, D
   Cohen, G
   Christakis, GT
   Goldman, BS
   Baerlocher, MO
   Pelletier, MP
   Fremes, SE
AF Desai, ND
   Miwa, S
   Kodama, D
   Cohen, G
   Christakis, GT
   Goldman, BS
   Baerlocher, MO
   Pelletier, MP
   Fremes, SE
TI Improving the quality of coronary bypass surgery with intraoperative
   angiography - Validation of a new technique
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID GRAFT PATENCY; OFF-PUMP; ARTERY; TRIAL; EXPERIENCE; FLOWMETER
AB OBJECTIVES We report a comprehensive assessment and validation of a new intraoperative angiography technique.
   BACKGROUND Technical problems at the site of the distal anastomosis compromise an underappreciated proportion of coronary bypass grafts. The absence of a systematic, validated technique to verify graft patency in the operating room represents a significant breach in quality assurance.
   METHODS Fluorescent indocyanine green (ICG) dye is excited with dispersed laser light to create an angiographic depiction of the graft, native vessel, and anastomosis. One-hundred twenty patients underwent ICG angiography. Angiograms were reviewed for reliability and validity studies.
   RESULTS A total of 348 coronary bypass grafts were studied. Each ICG angiogram took 2.2 +/- 1.1 min to perform. The ICG angiography found 4.2% of patients had significant graft problems requiring major revision. Quality of visualization was rated according to a seven-point Likert scale (1 = worst, 7 = best). Among conduits, saphenous veins were best visualized (mean score standard deviation), 6.4 +/- 1.5 versus 5.5 +/- 1.9 for internal mammary arteries and 4.4 +/- 2.3 for radial arteries (p = 0.02). Location of distal anastomosis did not influence quality of visualization. There was high inter-rater reliability for graft revision (kappa = 1.0) and graft patency (kappa = 0.97) between surgeons. Sensitivity and specificity of the ICG angiograms for graft stenosis > 50% was 100% among 22 grafts also studied with X-ray angiography.
   CONCLUSIONS Information from ICG angiograms led to graft revisions for technical problems in 4.2% of patients that would have otherwise gone unrecognized. Intraoperative angiography is an emerging tool for improving the quality of coronary bypass surgery.
C1 Univ Toronto, Sunnybrook & Womens Coll HSC, Toronto, ON M4N 3M5, Canada.
RP Desai, ND (reprint author), Univ Toronto, Sunnybrook & Womens Coll HSC, 2075 Bayview Ave,Room H410, Toronto, ON M4N 3M5, Canada.
EM nimesh.desai@utoronto.ca
CR Alderman EL, 1998, J THORAC CARDIOV SUR, V116, P716, DOI 10.1016/S0022-5223(98)00431-0
   CHESEBRO JH, 1987, CIRCULATION, V76, P142
   Elbeery JR, 1998, ANN THORAC SURG, V66, P51, DOI 10.1016/S0003-4975(98)00377-4
   Fabricius AM, 2001, EUR J CARDIO-THORAC, V19, P853, DOI 10.1016/S1010-7940(01)00692-3
   FALK V, 1995, J CARDIAC SURG, V10, P147
   GOLDMAN S, 1991, CIRCULATION, V84, P520
   Hol PK, 2001, HEART SURG FORUM, V4, P254
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   LOUAGIE YAG, 1994, ANN THORAC SURG, V58, P742
   LOUAGIE YAG, 1994, ANN THORAC SURG, V57, P357
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Reuthebuch O, 2004, CHEST, V125, P418, DOI 10.1378/chest.125.2.418
   Rubens FD, 2002, HEART SURG FORUM, V5, P141
   Taggart DP, 2003, ANN THORAC SURG, V75, P870, DOI 10.1016/S0003-4975(02)04669-6
NR 14
TC 43
Z9 44
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD OCT 18
PY 2005
VL 46
IS 8
BP 1521
EP 1525
DI 10.1016/j.jacc.2005.05.081
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 974GN
UT WOS:000232579400017
PM 16226178
ER

PT J
AU Guermazi, A
   Brice, P
   Hennequin, C
   Sarfati, E
AF Guermazi, A
   Brice, P
   Hennequin, C
   Sarfati, E
TI Lymphography: An old technique retains its usefulness
SO RADIOGRAPHICS
LA English
DT Article
DE chyloperitoneum; chylothorax; chyluria; lymphatic system, diseases;
   lymphography; lymphoma, staging; testis, neoplasms; uterine neoplasms,
   staging
ID NON-HODGKIN-LYMPHOMA; NONSEMINOMATOUS TESTICULAR-TUMORS;
   COMPUTED-TOMOGRAPHY; MALIGNANT-LYMPHOMA; CHYLOUS ASCITES;
   RETROPERITONEAL METASTASES; STAGING LYMPHOMAS; FILARIAL CHYLURIA;
   DISEASE; LYMPHANGIOGRAPHY
AB Conventional lymphography has long been the method of choice for imaging the lymphatic system. However, the number of lymphographic studies performed in oncology centers has declined markedly since the introduction of cross-sectional imaging techniques, especially computed tomography (CT). Therefore, levels of expertise in both performing lymphography and interpreting lymphograms are falling. The unique ability of lymphography to demonstrate derangements of the internal architecture of normal-sized lymph nodes can be valuable and makes it more accurate than CT in evaluation of some lymphomas (especially Hodgkin disease) and genitourinary malignancies. In fact, lymphography and CT are complementary rather than mutually exclusive techniques for the staging of some lymphomas and genitourinary malignancies. In addition, lymphography opacifies the lymphatic channels and therefore may be a valuable tool for detection of lymphatic fistulas or lymphatic leakage. Finally, lymphography helps guide subsequent therapy in patients with lymphomas, genitourinary malignancies, or disorders of lymphatic flow.
C1 St Louis Univ Hosp, AP HP, Dept Hematol, Paris, France.
   St Louis Univ Hosp, AP HP, Dept Radiat Therapy, Paris, France.
   St Louis Univ Hosp, AP HP, Dept Surg, Paris, France.
   St Louis Univ Hosp, AP HP, Dept Radiol, Paris, France.
RP Guermazi, A (reprint author), Univ San Francisco, Dept Radiol, 350 Parnassus Ave,Suite 150, San Francisco, CA 94117 USA.
CR ABLAN CJ, 1990, ARCH SURG-CHICAGO, V125, P270
   ALLEN W, 1986, J UROLOGY, V135, P797
   ASHRAF M, 1982, GYNECOL ONCOL, V14, P96, DOI 10.1016/0090-8258(82)90055-5
   BENSON WJ, 1987, AUST NZ J MED, V17, P253, DOI 10.1111/j.1445-5994.1987.tb00056.x
   BESA PC, 1995, CANCER, V75, P2361, DOI 10.1002/1097-0142(19950501)75:9<2361::AID-CNCR2820750928>3.0.CO;2-N
   Beyersdorff D., 1995, European Journal of Gynaecological Oncology, V16, P274
   Campieri C, 1996, NEPHRON, V72, P705
   Carde P, 1996, BAILLIERE CLIN HAEM, V9, P479, DOI 10.1016/S0950-3536(96)80022-9
   CASTELLINO RA, 1990, RADIOLOGY, V175, P687
   CASTELLINO RA, 1984, AM J ROENTGENOL, V143, P37
   CASTELLINO RA, 1990, INVEST RADIOL, V25, P412, DOI 10.1097/00004424-199004000-00019
   CASTELLINO RA, 1986, RADIOLOGY, V159, P305
   DIAMOND E, 1985, UROLOGY, V26, P427, DOI 10.1016/0090-4295(85)90147-5
   DIXON AK, 1985, CLIN RADIOL, V36, P287, DOI 10.1016/S0009-9260(85)80066-0
   DUNNICK NR, 1981, AM J ROENTGENOL, V136, P1093
   Dupont H, 1996, INTENS CARE MED, V22, P614, DOI 10.1007/BF01708114
   Fein DA, 1996, INT J RADIAT ONCOL, V36, P13, DOI 10.1016/S0360-3016(96)00249-0
   Fuller LM, 1998, INT J RADIAT ONCOL, V40, P377, DOI 10.1016/S0360-3016(97)00712-8
   GARRIDO P, 1995, ANN THORAC SURG, V60, P687, DOI 10.1016/0003-4975(95)00333-G
   GLATSTEIN E, 1993, INT J RADIAT ONCOL, V25, P567
   Guermazi A, 2001, LEUKEMIA LYMPHOMA, V42, P655, DOI 10.3109/10428190109099326
   HADDAD MC, 1994, CLIN RADIOL, V49, P137, DOI 10.1016/S0009-9260(05)83458-0
   HALLOUL Z, 1995, VASA-J VASCULAR DIS, V24, P377
   HARDING M, 1990, CLIN RADIOL, V41, P392, DOI 10.1016/S0009-9260(05)80598-7
   Henry-Amar M, 1992, Ann Oncol, V3 Suppl 4, P117
   IYER RB, 1995, LYMPHOLOGY, V28, P89
   JANSEN TTH, 1984, UROLOGY, V23, P565, DOI 10.1016/0090-4295(84)90071-2
   JARMAN PR, 1995, THORAX, V50, P1324, DOI 10.1136/thx.50.12.1324
   JONSSON K, 1983, ACTA RADIOL DIAGN, V24, P153
   KAPLAN HS, 1971, CANCER RES, V31, P1811
   KLUINNELEMANS HC, 1990, LEUKEMIA, V4, P132
   Koga S, 2000, BJU INT, V85, P222, DOI 10.1046/j.1464-410x.2000.00400.x
   KUSUMOTO S, 1991, CLIN RADIOL, V44, P279, DOI 10.1016/S0009-9260(05)80199-0
   LENZ M, 1995, ROFO FORTSCHR RONTG, V162, P178, DOI 10.1055/s-2007-1015857
   LIBSON E, 1994, RADIOLOGY, V193, P757
   LIEN HH, 1983, RADIOLOGY, V146, P129
   LISTER TA, 1989, J CLIN ONCOL, V7, P1630
   MACHER MS, 1985, UROLOGY, V26, P193, DOI 10.1016/0090-4295(85)90063-9
   MAGNUSSON A, 1982, ACTA RADIOL DIAGN, V23, P29
   MANSFIELD CM, 1990, CANCER, V66, P2295, DOI 10.1002/1097-0142(19901201)66:11<2295::AID-CNCR2820661107>3.0.CO;2-S
   MARGLIN S, 1981, RADIOLOGY, V140, P351
   MENDENHALL NP, 1994, INT J RADIAT ONCOL, V30, P993
   MORTAZAVI S H, 1971, Clinical Radiology, V22, P389, DOI 10.1016/S0009-9260(71)80090-9
   MOSKOVIC E, 1991, BRIT J RADIOL, V64, P422
   MURRELL HJ, 1995, SEMIN ONCOL, V22, P15
   NGAN H, 1988, BRIT J RADIOL, V61, P1032
   NORTH LB, 1992, AM J ROENTGENOL, V158, P725
   NORTH LB, 1993, AM J ROENTGENOL, V161, P867
   PAGE JE, 1988, CLIN RADIOL, V39, P273, DOI 10.1016/S0009-9260(88)80529-4
   PEH WC, 1996, RADIOLOGY, V40, P463
   PERA A, 1987, RADIOLOGY, V164, P631
   POND GD, 1989, RADIOLOGY, V170, P159
   SACHS PB, 1991, AM J ROENTGENOL, V157, P703
   SMALES E, 1986, CLIN RADIOL, V37, P19, DOI 10.1016/S0009-9260(86)80156-8
   SOMBECK MD, 1993, INT J RADIAT ONCOL, V25, P425
   Stephenson N J, 1995, Australas Radiol, V39, P54, DOI 10.1111/j.1440-1673.1995.tb00232.x
   STOMPER PC, 1993, RADIOLOGY, V187, P381
   Strijk S P, 1987, Rofo, V146, P312, DOI 10.1055/s-2008-1048489
   SULLIVAN KL, 1984, J COMPUT ASSIST TOMO, V8, P1005, DOI 10.1097/00004728-198410000-00042
   SWART E, 1989, European Journal of Gynaecological Oncology, V10, P85
   VINNICOMBE SJ, 1995, RADIOLOGY, V194, P349
   Vogl T J, 1997, Acta Radiol Suppl, V412, P47
   VONESCHENBACH AC, 1985, UROL CLIN N AM, V12, P715
   Winterer JT, 1999, RADIOLOGY, V210, P381
   WISHNOW KI, 1989, J UROLOGY, V141, P1133
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   Yagi S, 1998, J UROLOGY, V159, P1615, DOI 10.1097/00005392-199805000-00055
NR 67
TC 43
Z9 51
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0271-5333
J9 RADIOGRAPHICS
JI Radiographics
PD NOV-DEC
PY 2003
VL 23
IS 6
BP 1541
EP 1558
DI 10.1148/rg.236035704
PG 18
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 741FG
UT WOS:000186447600016
PM 14615563
ER

PT J
AU Gretzer, MB
   Trock, BJ
   Han, M
   Walsh, PC
AF Gretzer, MB
   Trock, BJ
   Han, M
   Walsh, PC
TI A critical analysis of the interpretation of biochemical failure in
   surgically treated patients using the american society for therapeutic
   radiation and oncology criteria
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate-specific antigen; prostatic neoplasms; recurrence;
   prostatectomy; radiotherapy
ID PROSTATE-SPECIFIC ANTIGEN; EXTERNAL-BEAM RADIATION; DISEASE-FREE
   SURVIVAL; RADICAL PROSTATECTOMY; FOLLOW-UP; CANCER; BRACHYTHERAPY;
   RADIOTHERAPY; PROGRESSION; IRRADIATION
AB Purpose: The use of prostate specific antigen (PSA) to indicate biochemical failure has become an accepted procedure to measure the effectiveness of therapy. Because long-term randomized studies comparing radiation modalities to radical prostatectomy are not available, use of biochemical recurrence as a surrogate measure of efficacy is increasing. Unfortunately, the definition of failure is not uniform among therapies. We evaluate how the American Society for Therapeutic Radiation and Oncology (ASTRO) criteria affect the interpretation of failure when applied to radical prostatectomy.
   Materials and Methods: We retrospectively reviewed data from 2,691 men who underwent anatomical radical prostatectomy for localized disease between 1985 and 2000. All patients had regular followup visits ranging from 6 months to 15 years (mean 6). No patients were treated with radiation or hormonal therapy preoperatively or postoperatively until clinical recurrence. Biochemical failure was defined as any measurable PSA 0.2 ng./ml. or greater. We evaluated how elements of the ASTRO criteria affected the failure rate when applied to this series. We looked at 1) backdating the failure date to the midpoint between nadir and first PSA greater than 0.2 ng./ml., 2) early censoring if only 1 or 2 increasing values were available and 3) defining failure after 3 consecutive PSA increases and backdating failure time (midpoint of nadir and first PSA increase).
   Results: Using actuarial analysis of the data defining failure as the first PSA 0.2 ng./ml. or greater, biochemical freedom from failure at 5, 10 and 15 years was 85%, 77% and 68%, respectively. In contrast, when backdating was used in this series, almost all failures occurred early with rare late failures (freedom from failure 82%, 80% and 80% at 5, 10 and 15 years, respectively). The difference in failure became even more pronounced when ASTRO criteria were applied requiring 3 consecutive increases, and backdating failure to the midpoint between nadir and first PSA (freedom from failure 90%, 90% and 90% at 5, 10 and 15 years, respectively).
   Conclusions: The application of ASTRO criteria to a mature series of surgically treated patients with localized prostate cancer produced an apparent improvement in the probability of being biochemically free of disease at 15 years from 68% to 90%. Until prospective trials comparing these different therapies become available, caution should be exercised when interpreting outcomes between series due to the inherent differences in definition of biochemical failure.
C1 Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA.
RP Gretzer, MB (reprint author), Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Connell PP, 1999, UROLOGY, V54, P875, DOI 10.1016/S0090-4295(99)00253-8
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 2002, J UROLOGY, V167, P1310, DOI 10.1016/S0022-5347(05)65288-3
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   FRAZIER HA, 1993, J UROLOGY, V149, P516
   Han M, 2001, J UROLOGY, V166, P416, DOI 10.1016/S0022-5347(05)65955-1
   Hanlon AL, 2000, INT J RADIAT ONCOL, V46, P559, DOI 10.1016/S0360-3016(99)00450-2
   Kattan MW, 2000, INT J RADIAT ONCOL, V48, P1469, DOI 10.1016/S0360-3016(00)01359-6
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   LANGE PH, 1989, J UROLOGY, V141, P873
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   Lu J, 2000, Semin Urol Oncol, V18, P83
   Polascik TJ, 1998, UROLOGY, V51, P884, DOI 10.1016/S0090-4295(98)00153-8
   Ragde H, 2000, CANCER, V89, P135, DOI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
   Ragde H, 2000, SEMIN SURG ONCOL, V18, P45, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<45::AID-SSU7>3.0.CO;2-1
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Smathers S, 2001, INT J RADIAT ONCOL, V50, P1207, DOI 10.1016/S0360-3016(01)01568-1
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
NR 23
TC 43
Z9 44
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 2002
VL 168
IS 4
BP 1419
EP 1422
DI 10.1097/ju.0000029729.26315.fd
PN 1
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 596VU
UT WOS:000178187800027
PM 12352408
ER

PT J
AU Morton, DL
   Chan, AD
AF Morton, DL
   Chan, AD
TI The concept of sentinel node localization: How it started
SO SEMINARS IN NUCLEAR MEDICINE
LA English
DT Review
ID PRIMARY MALIGNANT-MELANOMA; LYMPH-NODE; QUANTITATIVE LYMPHOSCINTIGRAPHY;
   PROGNOSTIC FACTORS; REGIONAL NODES; S-100 PROTEIN; LYMPHADENECTOMY;
   DISSECTION; IDENTIFICATION; CANCER
AB Intraoperative lymphatic mapping and sentinel lymphadenectomy (LM/SL) followed by selective complete lymphadenectomy (SCLND) has revolutionized the management of the regional lymph node basin in patients with solid tumors. Many investigators over the centuries have contributed to the understanding of the progression of tumor cells through the lymphatic system. This article discusses the conceptual background for the development of LM/SL in the original model of melanoma, The sentinel node hypothesis has been validated by a multicenter clinical trial showing that LM/SL in melanoma can be accurately performed in a uniform manner by multidisciplinary teams at cancer centers worldwide. Although the diagnostic and prognostic accuracy of LM/SL has been established, demonstration of the therapeutic use of this procedure awaits analysis of survival data from the multicenter randomized trial of wide excision alone versus wide excision plus LM/SL/SCLND, Copyright (C) 2000 by W. B. Saunders Company.
C1 St Johns Hlth Ctr, John Wayne Canc Inst, Roy E Coats Res Labs, Santa Monica, CA 90404 USA.
RP Morton, DL (reprint author), St Johns Hlth Ctr, John Wayne Canc Inst, Roy E Coats Res Labs, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.
CR Albertini JJ, 1996, ANN SURG, V223, P217, DOI 10.1097/00000658-199602000-00016
   ALEX JC, 1993, SURG ONCOL, V2, P303, DOI 10.1016/S0960-7404(06)80006-X
   Bachter D, 1998, INT J DERMATOL, V37, P278, DOI 10.1046/j.1365-4362.1998.00358.x
   BALCH CM, 1981, ANN SURG, V193, P377, DOI 10.1097/00000658-198103000-00023
   Balch CM, 1996, ANN SURG, V224, P255, DOI 10.1097/00000658-199609000-00002
   Bertil R, 1970, Acta Radiol Ther Phys Biol, V9, P567
   Bilchik AJ, 1998, CANCER J SCI AM, V4, P351
   Bostick P, 1999, ARCH SURG-CHICAGO, V134, P43, DOI 10.1001/archsurg.134.1.43
   Boxen I, 1999, CLIN NUCL MED, V24, P390, DOI 10.1097/00003072-199906000-00003
   Buchels HK, 1997, CHIRURG, V68, P45, DOI 10.1007/s001040050148
   CABANAS RM, 1977, CANCER, V39, P456, DOI 10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I
   Cascinelli N, 1998, LANCET, V351, P793, DOI 10.1016/S0140-6736(97)08260-3
   COCHRAN AJ, 1982, INT J CANCER, V30, P295, DOI 10.1002/ijc.2910300307
   COCHRAN AJ, 1984, INT J CANCER, V34, P159, DOI 10.1002/ijc.2910340204
   COCHRAN AJ, 1988, AM J SURG PATHOL, V12, P612, DOI 10.1097/00000478-198808000-00002
   COCHRAN AJ, 1989, ANTICANCER RES, V9, P859
   ESATO K, 1991, J CARDIOVASC SURG, V32, P741
   ESSNER R, 1994, ANN M SOC SURG ONC M
   Essner R, 1999, ANN SURG ONCOL, V6, P442, DOI 10.1007/s10434-999-0442-4
   FEE HJ, 1978, SURGERY, V84, P626
   GAYNOR R, 1981, LANCET, V1, P869
   Giuliano AE, 1997, J CLIN ONCOL, V15, P2345
   Glass EC, 1998, J NUCL MED, V39, P1185
   Haagensen C, 1972, LYMPHATICS CANC
   Handley WS, 1907, LANCET, V1, P996
   HELLER R, 1993, SEMIN SURG ONCOL, V9, P285
   HILL GJ, 1979, SEMIN ONCOL, V6, P409
   HOLMES EC, 1977, ANN SURG, V186, P481, DOI 10.1097/00000658-197710000-00010
   Houghton A, 1998, ONCOLOGY-NY, V12, P153
   KARDINAL CG, 1979, SEMIN ONCOL, V6, P396
   KATAOKA M, 1991, BRIT J RADIOL, V64, P1119
   Kelemen PR, 1998, ARCH SURG-CHICAGO, V133, P288, DOI 10.1001/archsurg.133.3.288
   KRAG DN, 1995, ARCH SURG-CHICAGO, V130, P654
   LAMKI L M, 1989, Journal of Nuclear Medicine, V30, P844
   Leong SPL, 1997, ARCH SURG-CHICAGO, V132, P666
   LEVENBACK C, 1994, OBSTET GYNECOL, V84, P163
   Lingam MK, 1997, BRIT J CANCER, V75, P1505, DOI 10.1038/bjc.1997.257
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MILTON GW, 1982, BRIT J SURG, V69, P108, DOI 10.1002/bjs.1800690217
   MORTON D, 1990, ANN M SOC SURG ONC W
   MORTON DL, 1991, ANN SURG, V214, P491, DOI 10.1097/00000658-199110000-00013
   MORTON DL, 1998, CONTEMP SURG, V53, P281
   Morton DL, 1999, J AM COLL SURGEONS, V189, P214, DOI 10.1016/S1072-7515(99)00129-5
   MORTON DL, IN PRESS ANN SURG
   MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
   MORTON DL, 1993, J CLIN ONCOL, V11, P1751
   MORTON LT, 1970, MED BIBLIO ANNOTATED
   PIJPERS R, 1995, EUR J NUCL MED, V22, P1238, DOI 10.1007/BF00801606
   PRINGLE JH, 1908, EDINBURGH MED J, V23, P496
   REINTGEN D, 1994, ANN SURG, V220, P759, DOI 10.1097/00000658-199412000-00009
   ROBINSON DS, 1977, SURG FORUM, V28, P147
   Sabiston DCJ, 1997, TXB SURG BIOL BASIS
   Shivers SC, 1998, JAMA-J AM MED ASSOC, V280, P1410, DOI 10.1001/jama.280.16.1410
   SIM FH, 1978, CANCER, V41, P948, DOI 10.1002/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z
   Snow H, 1892, LANCET, V2, P872
   STRAND SE, 1979, J NUCL MED, V20, P1038
   THOMPSON JF, 1995, MELANOMA RES, V5, P255, DOI 10.1097/00008390-199508000-00008
   VERONESI U, 1982, CANCER, V49, P2420, DOI 10.1002/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2
   WEISS L, 1980, LYMPHATIC SYSTEM MET
   Wilhelm AJ, 1999, EUR J NUCL MED, V26, pS36, DOI 10.1007/PL00014793
   WONG JH, 1991, ANN SURG, V214, P637, DOI 10.1097/00000658-199111000-00015
NR 61
TC 43
Z9 44
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0001-2998
J9 SEMIN NUCL MED
JI Semin. Nucl. Med.
PD JAN
PY 2000
VL 30
IS 1
BP 4
EP 10
DI 10.1016/S0001-2998(00)80056-2
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 276QJ
UT WOS:000084888600003
PM 10656238
ER

PT J
AU Callahan-Miller, DA
   Tabak, M
AF Callahan-Miller, DA
   Tabak, M
TI A distributed radiator, heavy ion target driven by Gaussian beams in a
   multibeam illumination geometry
SO NUCLEAR FUSION
LA English
DT Article
ID INERTIAL CONFINEMENT FUSION; DESIGN
AB An inertial confinement fusion target driven by ion beams in a multibeam illumination geometry is presented. Two dimensional integrated LASNEX calculations (ion beam deposition to fusion burn in one computer simulation) predict a gain of greater than 65 for this target. Each beam has a Gaussian density profile and is focused to an elliptically shaped spot. Multiple beam ellipses are overlayed to form an annulus on the end of the cylindrical hohlraum. The beams enter at angles relative to the cylindrical axis of the hohlraum that are consistent with both liquid wall chamber protection and the space required for a final focusing system upstream. For an accelerator that is 25% efficient (eta = 0.25), a gain G of 65 leads to eta G greater than 16; a reactor with a reasonably small recirculating power fraction requires eta G greater than 8-10.
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Callahan-Miller, DA (reprint author), Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
CR Allshouse GO, 1999, NUCL FUSION, V39, P893, DOI 10.1088/0029-5515/39/7/306
   BANGERTER RO, 1998, COMMUNICATION
   BASKO MM, 1993, NUCL FUSION, V33, P601, DOI 10.1088/0029-5515/33/4/I07
   Bluhm HJ, 1996, LASER PART BEAMS, V14, P655
   Callahan DA, 1996, FUSION ENG DES, V32-33, P441, DOI 10.1016/S0920-3796(96)00500-5
   CALLAHAN DA, 1995, PRACTICLE ACCELERATO
   Derzon MS, 1996, PHYS REV LETT, V76, P435, DOI 10.1103/PhysRevLett.76.435
   Ho DDM, 1996, NUCL FUSION, V36, P769, DOI 10.1088/0029-5515/36/6/I08
   Ho DDM, 1998, NUCL FUSION, V38, P701, DOI 10.1088/0029-5515/38/5/305
   LANGDON AB, 1992, COMPUT PHYS COMMUN, V70, P447
   MARK JWK, 1983, COMMUNICATION
   Meier WR, 1998, NUCL INSTRUM METH A, V415, P249, DOI 10.1016/S0168-9002(98)00392-1
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   Olson RE, 1997, LASER PART BEAMS, V15, P461
   PIRIZ AR, 1993, NUOVO CIMENTO A, V106, P1893, DOI 10.1007/BF02780592
   Tabak M, 1998, NUCL FUSION, V38, P509, DOI 10.1088/0029-5515/38/4/303
   TABAK M, 1998, PHYS PLASMAS, V5, P1896
   Zimmerman G. B., 1975, Comments on Plasma Physics and Controlled Fusion, V2
NR 18
TC 43
Z9 43
PU INT ATOMIC ENERGY AGENCY
PI VIENNA
PA WAGRAMERSTRASSE 5, PO BOX 100, A-1400 VIENNA, AUSTRIA
SN 0029-5515
J9 NUCL FUSION
JI Nucl. Fusion
PD JUL
PY 1999
VL 39
IS 7
BP 883
EP 891
DI 10.1088/0029-5515/39/7/305
PG 9
WC Physics, Fluids & Plasmas; Physics, Nuclear
SC Physics
GA 224JB
UT WOS:000081893300005
ER

PT J
AU SUGAI, T
   YANO, J
   SUGITANI, M
   OOYAMA, H
AF SUGAI, T
   YANO, J
   SUGITANI, M
   OOYAMA, H
TI ACTIONS OF CHOLINERGIC AGONISTS AND ANTAGONISTS ON THE EFFERENT SYNAPSE
   IN THE FROG SACCULUS
SO HEARING RESEARCH
LA English
DT Article
DE VESTIBULAR EFFERENT SYNAPSE; HAIR CELL; ACETYLCHOLINE RECEPTOR; FROG;
   SACCULUS
ID COCHLEAR HAIR-CELLS; LATERAL LINE ORGAN; BURBOT LOTA-LOTA;
   ACETYLCHOLINE-RECEPTORS; NERVE-FIBERS; STIMULATION; INHIBITION;
   TRANSMISSION; ORGANIZATION; TURTLE
AB Intracellular recordings were made from hair cells in the frog saccular epithelium isolated with its innervating nerves. Inhibitory post-synaptic potentials (IPSPs) were recorded from hair cells when the efferent fibers were activated by electrical stimulation. The effects of acetylcholine (ACh), cholinomimetics, and cholinergic antagonists on the efferent synapse were studied in a preparation where the IPSPs can be observed directly. ACh or carbachol (CCh) produced a transient membrane hyperpolarization with a decrease in input resistance followed by an abolition or reduction of the IPSP. In a low Ca2+ medium where efferent synaptic activity was abolished, ACh or CCh still induced hyperpolarization, though the response appeared to be smaller than that in normal medium. Neither nicotinic (dimethyl-4-phenyl-piperazinium (DMPP), phenyltrimethylammonium (PTMA) and nicotine) nor muscarinic (muscarine, methacholine, bethanechol and oxotremorine) agonists induced the membrane hyperpolarization, but the former drugs inhibited the IPSPs while the latter drugs did not. Both d-tubocurarine and atropine inhibited the IPSP, but the d-tubocurarine was more potent, causing inhibition even at a dose of 0.5-mu-M while 2-mu-M or more atropine was needed. The ACh- or CCh-induced hyperpolarization was inhibited completely by d-tubocurarine (5-mu-M), but only slightly by atropine (5-mu-M).
   These results may indicate that the IPSP and the effects of ACh or CCh are based on a direct interaction between ACh or CCh and ACh receptors on the hair cells.
RP SUGAI, T (reprint author), KANAZAWA MED UNIV,DEPT PHYSIOL,UCHINADA,ISHIKAWA 92002,JAPAN.
CR ART JJ, 1985, J PHYSIOL-LONDON, V360, P397
   ART JJ, 1984, J PHYSIOL-LONDON, V356, P525
   ART JJ, 1982, PROC R SOC SER B-BIO, V216, P377, DOI 10.1098/rspb.1982.0081
   ASHMORE JF, 1982, J PHYSIOL-LONDON, V329, pP25
   BERNARD C, 1985, BRAIN RES, V338, P225, DOI 10.1016/0006-8993(85)90151-9
   DESMEDT JE, 1963, NATURE, V200, P472, DOI 10.1038/200472b0
   FLOCK A, 1973, J PHYSIOL-LONDON, V235, P591
   FLOCK A, 1976, J PHYSIOL-LONDON, V257, P45
   FURUKAWA T, 1981, J PHYSIOL-LONDON, V315, P203
   GUTH PS, 1986, ACTA OTOLARYNGOL, V102, P186
   HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065
   HOUSLEY GD, 1990, HEARING RES, V43, P121, DOI 10.1016/0378-5955(90)90221-A
   HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407
   KEHOE J, 1972, J PHYSIOL-LONDON, V225, P115
   KLINKE R, 1974, PHYSIOL REV, V54, P316
   KOKETSU K, 1958, AM J PHYSIOL, V193, P213
   LINDMAR R, 1967, EXPERIENTIA, V23, P933, DOI 10.1007/BF02136230
   NORRIS CH, 1985, TRENDS PHARMACOL SCI, V6, P15
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   PRIGIONI I, 1983, BRAIN RES, V269, P83, DOI 10.1016/0006-8993(83)90964-2
   ROSSI ML, 1980, BRAIN RES, V185, P984
   SEWELL WF, 1991, J NEUROPHYSIOL, V65, P1158
   SHIGEMOTO T, 1990, J PHYSIOL-LONDON, V420, P127
   STEINACKER A, 1988, HEARING RES, V35, P265, DOI 10.1016/0378-5955(88)90123-2
   SUGAI T, 1989, JPN J PHYSL S, V39, P168
   SUGAI T, 1990, JPN J PHYSL S, V40, P186
   SUGAI T, 1991, JPN J PHYSIOL, V41, P217, DOI 10.2170/jjphysiol.41.217
   VALLI P, 1986, BRAIN RES, V362, P92, DOI 10.1016/0006-8993(86)91402-2
   WIEDERHO.ML, 1970, J ACOUST SOC AM, V48, P950, DOI 10.1121/1.1912234
   WONG LA, 1989, NATURE, V341, P439, DOI 10.1038/341439a0
NR 30
TC 43
Z9 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5955
J9 HEARING RES
JI Hear. Res.
PD AUG
PY 1992
VL 61
IS 1-2
BP 56
EP 64
DI 10.1016/0378-5955(92)90036-M
PG 9
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA JJ938
UT WOS:A1992JJ93800008
PM 1526894
ER

PT J
AU GUTH, PS
   AUBERT, A
   RICCI, AJ
   NORRIS, CH
AF GUTH, PS
   AUBERT, A
   RICCI, AJ
   NORRIS, CH
TI DIFFERENTIAL MODULATION OF SPONTANEOUS AND EVOKED NEUROTRANSMITTER
   RELEASE FROM HAIR-CELLS - SOME NOVEL HYPOTHESES
SO HEARING RESEARCH
LA English
DT Article
DE HAIR CELL; NEUROTRANSMITTER; OCTAVOLATERALIS; SEMICIRCULAR CANAL;
   GLUTAMATE; CALCIUM
ID GUINEA-PIG COCHLEA; AMINO-ACID AGONISTS; LATERAL-LINE ORGAN;
   XENOPUS-LAEVIS; GLUTAMATE; FROG; RECEPTORS; TRANSDUCTION; POTENTIALS;
   CALCIUM
AB It has been generally accepted that even in the absence of mechanical stimulation of the transductional elements, a resting depolarizing current exists which is ultimately responsible for the spontaneous release of neurotransmitter. Movement of the transductional elements modulates this resting current and thereby the evoked release of neurotransmitter occurs. Recent data from our laboratory and others have led us to question whether the relationship between spontaneous and evoked neurotransmitter release is as simple as stated. Indeed, a variety of experimental manipulations appear to influence the two modes of release differently. Examination of our results and the results of others has led us to four hypotheses: 1. the two modes of neurotransmitter release are processed differently by the hair cells: 2. cyclic AMP is involved in spontaneous but not evoked neurotransmitter release; 3. there is a positive feedback step involving an excitatory amino acid and its receptor on the hair cell in evoked neurotransmitter release and; 4. different pools of calcium are involved according to the mode of release.
   Accordingly, there may be several biochemical steps between the transductional movement of the stereocilia at the apex of the hair cells and the ultimate release of the neurotransmitter at the base of these cells. Some of these biochemical steps are different depending on whether the mode of release is spontaneous or evoked. These biochemical steps may amplify or at least interact with the biophysical processes previously described in the hair cells.
C1 TULANE UNIV,SCH MED,DEPT OTOLARYNGOL,NEW ORLEANS,LA 70112.
   TULANE UNIV,SCH MED,NEUROSCI PROGRAM,NEW ORLEANS,LA 70112.
RP GUTH, PS (reprint author), TULANE UNIV,SCH MED,DEPT PHARMACOL,1430 TULANE AVE,NEW ORLEANS,LA 70112, USA.
CR ANNONI JM, 1984, J NEUROSCI, V4, P2106
   AUBERT A, 1991, IN PESS BRAIN RES
   BERNARD C, 1980, PFLUG ARCH EUR J PHY, V388, P93, DOI 10.1007/BF00584114
   BERNARD C, 1983, ACTA OTO-LARYNGOL, V96, P21, DOI 10.3109/00016488309132871
   BLEDSOE SC, 1988, NEUROTRANSMISSION IN, P385
   BOBBIN RP, 1978, FED PROC, V37, P613
   COLTON CK, 1975, COMP BIOCHEM PHYS C, V51, P275, DOI 10.1016/0306-4492(75)90074-X
   COTMAN CW, 1986, J PHYSIOL-LONDON, V378, P403
   COUSILLAS H, 1988, HEARING RES, V36, P213, DOI 10.1016/0378-5955(88)90063-9
   DRESCHER DG, 1987, COMP BIOCHEM PHYS A, V87, P305, DOI 10.1016/0300-9629(87)90126-5
   DRESCHER MJ, 1987, BRAIN RES, V417, P39, DOI 10.1016/0006-8993(87)90177-6
   DURHAM D, 1989, HEARING RES, V43, P39, DOI 10.1016/0378-5955(89)90057-9
   FLOREY E, 1986, COMP BIOCH PHYSL, V26, P651
   FORSYTHE I D, 1988, Society for Neuroscience Abstracts, V14, P791
   GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454
   GLEICH O, 1990, HEARING RES, V45, P295, DOI 10.1016/0378-5955(90)90128-C
   GUTH PS, 1988, HEARING RES, V33, P223, DOI 10.1016/0378-5955(88)90152-9
   HOUSLEY GD, 1990, HEARING RES, V43, P121, DOI 10.1016/0378-5955(90)90221-A
   HUDSPETH AJ, 1983, ANNU REV NEUROSCI, V6, P187, DOI 10.1146/annurev.ne.06.030183.001155
   JENISON GL, 1986, COMP BIOCHEM PHYS C, V84, P385, DOI 10.1016/0742-8413(86)90110-6
   JENISON GL, 1985, J NEUROCHEM, V44, P1845, DOI 10.1111/j.1471-4159.1985.tb07178.x
   MAYER ML, 1990, TRENDS PHARMACOL SCI, V11, P254, DOI 10.1016/0165-6147(90)90254-6
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   OHMORI H, 1989, JPN J PHYSIOL, V39, P643, DOI 10.2170/jjphysiol.39.643
   Precht W., 1976, P481
   PRIGIONI I, 1990, HEARING RES, V46, P253, DOI 10.1016/0378-5955(90)90006-B
   PUEL JL, 1989, COMP BIOCHEM PHYS C, V93, P73, DOI 10.1016/0742-8413(89)90013-3
   REBILLARD G, 1989, BRAIN RES, V494, P379, DOI 10.1016/0006-8993(89)90608-2
   RICCI A, 1991, UNPUB ABSTR ASS RES, P52
   RICCI A, 1991, UNPUB EFFECTS 4 AMIN
   RICCI A, 1991, ABSTR ASS RES OT, P95
   RUSSELL IJ, 1972, J EXP BIOL, V57, P77
   SEWELL WF, 1990, HEARING RES, V44, P71, DOI 10.1016/0378-5955(90)90023-I
   SIEGEL JH, 1987, HEARING RES, V28, P131, DOI 10.1016/0378-5955(87)90044-X
   SOTO E, 1988, BRAIN RES, V462, P104, DOI 10.1016/0006-8993(88)90591-4
   STARR PA, 1990, SOC NEUR ABSTR, V14, P331
   THIEFFRY M, 1978, BRAIN RES, V156, P402, DOI 10.1016/0006-8993(78)90528-0
   USHERWOO.PN, 1966, NATURE, V210, P634, DOI 10.1038/210634a0
   VALLI P, 1986, BRAIN RES, V361, P92
   VALLI P, 1979, ACTA OTO-LARYNGOL, V87, P466, DOI 10.3109/00016487909126453
   VALLI P, 1985, BRAIN RES, V330, P1, DOI 10.1016/0006-8993(85)90002-2
   VALLI P, 1974, ACTA OTO-LARYNGOL, V78, P51, DOI 10.3109/00016487409126325
   VIZI ES, 1979, PROG NEUROBIOL, V12, P181, DOI 10.1016/0301-0082(79)90011-X
   YAMAMOTO H, 1990, GEN PHARMACOL, V21, P387, DOI 10.1016/0306-3623(90)90686-G
NR 44
TC 43
Z9 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5955
J9 HEARING RES
JI Hear. Res.
PD NOV
PY 1991
VL 56
IS 1-2
BP 69
EP 78
DI 10.1016/0378-5955(91)90155-3
PG 10
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA GR403
UT WOS:A1991GR40300009
PM 1685158
ER

PT J
AU GUSTAFSON, RA
   WARDEN, HE
   MURRAY, GF
   HILL, RC
   ROZAR, GE
AF GUSTAFSON, RA
   WARDEN, HE
   MURRAY, GF
   HILL, RC
   ROZAR, GE
TI PARTIAL ANOMALOUS PULMONARY VENOUS CONNECTION TO THE RIGHT SIDE OF THE
   HEART
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
RP GUSTAFSON, RA (reprint author), W VIRGINIA UNIV,MED CTR,SCH MED,DEPT SURG,MORGANTOWN,WV 26506, USA.
CR BABB JD, 1980, ANN THORAC SURG, V31, P540
   BAHNSON HT, 1958, J THORAC SURG, V36, P777
   BAILEY CP, 1953, J THORAC SURG, V26, P184
   BENVENUTO R, 1959, SURGERY, V45, P173
   BRAIS M, 1973, J THORAC CARDIOV SUR, V65, P296
   Brody H, 1942, ARCH PATHOL, V33, P221
   CHARTRAND C, 1976, J THORAC CARDIOV SUR, V71, P29
   CLARK DA, 1975, AM J CARDIOL, V35, P127, DOI 10.1016/0002-9149(75)90613-X
   DOTTER CT, 1949, AM J MED SCI, V218, P31, DOI 10.1097/00000441-194907000-00004
   EDWARDS JE, 1953, P STAFF M MAYO CLIN, V28, P441
   EHRENHAFT JL, 1958, ANN SURG, V148, P249, DOI 10.1097/00000658-195808000-00014
   FRIEDLI B, 1972, CIRCULATION, V45, P159
   FRYE RL, 1968, AM J CARDIOL, V22, P242, DOI 10.1016/0002-9149(68)90230-0
   GERBODE F, 1949, SURGERY, V25, P556
   GOTSMAN MS, 1965, BRIT HEART J, V27, P566
   Groves L K, 1967, Ann Thorac Surg, V4, P301
   HAWE A, 1969, CIRCULATION S1, V39, P185
   Hughes CW, 1944, ARCH PATHOL, V37, P0364
   KALKE BR, 1967, AM J CARDIOL, V20, P91, DOI 10.1016/0002-9149(67)90114-2
   KIRKLIN JW, 1956, SURGERY, V39, P389
   Kirklin JW, 1986, CARDIAC SURG, P463
   KIRKLIN JW, 1955, J THORAC SURG, V29, P37
   KYGER ER, 1978, ANN THORAC SURG, V25, P44
   LAWRANCE K, 1962, J THORAC CARDIOV SUR, V43, P622
   LEWIN AN, 1978, ANN THORAC SURG, V26, P185
   LEWIS FJ, 1958, J THORAC SURG, V36, P1
   LEWIS FJ, 1955, ANN SURG, V142, P401, DOI 10.1097/00000658-195509000-00009
   LONG DM, 1974, ANN THORAC SURG, V18, P466
   PACIFICO AD, 1975, J THORAC CARDIOV SUR, V70, P272
   PUIGMASS.M, 1972, J THORAC CARDIOV SUR, V64, P108
   RADFORD DJ, 1975, ARCH DIS CHILD, V50, P879
   ROBICSEK F, 1979, J THORAC CARDIOV SUR, V78, P559
   STEWART S, 1986, ANN THORAC SURG, V41, P498
   TRUSLER GA, 1980, J THORAC CARDIOV SUR, V79, P776
   TUNG KSK, 1967, J THORAC CARDIOV SUR, V53, P814
   WARDEN HE, 1984, ANN THORAC SURG, V38, P601
   WILLIAMS WH, 1984, ANN THORAC SURG, V38, P345
   YOUNG D, 1973, AM J CARDIOL, V31, P14, DOI 10.1016/0002-9149(73)90804-7
NR 38
TC 43
Z9 44
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD NOV
PY 1989
VL 98
IS 5
BP 861
EP 868
PN 2
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA CB652
UT WOS:A1989CB65200010
PM 2682021
ER

PT J
AU SMITH, SK
AF SMITH, SK
TI TESTS OF FORECAST ACCURACY AND BIAS FOR COUNTY POPULATION PROJECTIONS
SO JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
LA English
DT Article
RP SMITH, SK (reprint author), UNIV FLORIDA,COLL BUSINESS ADM,BUR ECON & BUSINESS RES,GAINESVILLE,FL 32611, USA.
CR ALHO J, 1984, SCANDINAVIAN HOUSING, V1, P99
   Ascher W., 1978, FORECASTING APPRAISA
   BIRCH DL, 1977, COMMENTS LONG TERM P, P148
   Borts GH, 1964, EC GROWTH FREE MARKE
   COHEN JE, 1986, DEMOGRAPHY, V23, P105, DOI 10.2307/2061412
   ELDRIDGE HT, 1965, DEMOGRAPHY, V2, P444, DOI 10.2307/2060130
   GREENBER.MR, 1972, ECON GEOGR, V48, P179, DOI 10.2307/142873
   GREENBERG MR, 1978, LOCAL POPULATION EMP
   HAJNAL J, 1955, J AM STAT ASSOC, V50, P309, DOI 10.2307/2280963
   IRWIN R, 1977, 39 US BUR CENS TECHN
   ISSERMAN AM, 1977, J AM I PLANNERS, V43, P247, DOI 10.1080/01944367708977786
   ISSERMAN AM, 1984, POPUL RES POLICY REV, V3, P27, DOI 10.1007/BF00123008
   KALE B, 1981, UNPUB ANN M POPULATI
   KEYFITZ N, 1981, POPUL DEV REV, V7, P579, DOI 10.2307/1972799
   KEYFITZ N, 1972, J AM STAT ASSOC, V67, P347, DOI 10.2307/2284381
   LEE RD, 1974, J AM STAT ASSOC, V69, P607, DOI 10.2307/2285990
   MILLER AR, 1967, J AM STAT ASSOC, V62, P1418, DOI 10.2307/2283787
   MORRISON P, 1977, POPULATION FORECASTI, P3
   PITTENGER DB, 1978, SOCIO ECON PLAN SCI, V12, P271, DOI 10.1016/0038-0121(78)90030-7
   PITTENGER DB, 1980, AM STAT, V34, P135, DOI 10.2307/2683869
   SABOIA JLM, 1974, DEMOGRAPHY, V11, P483, DOI 10.2307/2060440
   Schmitt RC, 1952, LAND ECON, V28, P183, DOI 10.2307/3159547
   Schmitt R., 1953, J MARKETING, V17, P417, DOI 10.2307/1247019
   Schmitt RC, 1951, LAND ECON, V27, P346, DOI 10.2307/3159671
   SHRYOCK HS, 1973, METHODS MATERIALS DE
   Siegel JS, 1953, LAND ECON, V29, P72, DOI 10.2307/3144286
   SIEGEL JS, 1972, DEMOGRAPHY, V9, P51, DOI 10.2307/2060545
   SMITH SK, 1986, UNPUB ANN M POPULATI
   SMITH SK, 1986, DEMOGRAPHY, V23, P127, DOI 10.2307/2061413
   SMITH SK, 1984, MONOGRAPH U FLORIDA, V1
   STOTO MA, 1983, J AM STAT ASSOC, V78, P13, DOI 10.2307/2287094
   VOSS PR, 1985, UNPUB ANN M POPULATI
   WHITE HR, 1954, J AM STAT ASSOC, V49, P480, DOI 10.2307/2281125
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
   1965, CURRENT POPULATI P25, V301
   1972, CURRENT POPULATI P25, V477
   1984, STATE SURVEY POPULAT
NR 37
TC 43
Z9 44
PU AMER STATISTICAL ASSOC
PI ALEXANDRIA
PA 1429 DUKE ST, ALEXANDRIA, VA 22314
SN 0162-1459
J9 J AM STAT ASSOC
JI J. Am. Stat. Assoc.
PD DEC
PY 1987
VL 82
IS 400
BP 991
EP 1003
DI 10.2307/2289369
PG 13
WC Statistics & Probability
SC Mathematics
GA L4502
UT WOS:A1987L450200006
PM 12155376
ER

PT J
AU LASSER, EC
   LANG, JH
AF LASSER, EC
   LANG, JH
TI CONTRAST-PROTEIN INTERACTIONS
SO INVESTIGATIVE RADIOLOGY
LA English
DT Article
CR BANG HO, 1948, ACTA PHARMACOL TOX, V4, P87
   BENTLEY PE, 1968, THESIS U LOUISVILLE
   BERDON WE, 1969, RADIOLOGY, V92, P714
   BERNSTEIN EF, 1960, JAMA-J AM MED ASSOC, V174, P1417
   BERNSTEIN EF, 1964, ACTA RADIOL DIAGN, V2, P401
   Bernstein E F, 1966, Invest Radiol, V1, P162, DOI 10.1097/00004424-196603000-00030
   BISHOP C, 1964, RED BLOOD CELL, P147
   BJORK L, 1968, AMER J ROENTGENOL RA, V102, P441
   BRODIE BB, 1965, SCIENCE, V148, P1547, DOI 10.1126/science.148.3677.1547
   CHAPLIN H, 1961, AMER J ROENTGENOL RA, V86, P1127
   CHOREMIS C, 1965, ACTA PAEDIATR SCAND, V54, P218, DOI 10.1111/j.1651-2227.1965.tb06365.x
   COHEN G, 1964, BIOCHEMISTRY-US, V3, P895, DOI 10.1021/bi00895a006
   COHEN LS, 1969, RADIOLOGY, V92, P329
   CROSBY DJ, 1966, ARCH INTERN MED, V118, P79
   CWYMARSKI MT, 1969, BR MED J, V1, P486
   DEAN RICHARD E., 1963, JOUR AMER MED ASSOC, V184, P201
   GREIG ME, 1949, ARCH BIOCHEM, V23, P370
   HELMER S, 1968, BIOCHEM, V7, P28
   JACKSON DM, 1968, LANCET, V1, P1286
   KIEHS K, 1966, BIOCHEMISTRY-US, V5, P2602, DOI 10.1021/bi00872a018
   KNOEFEL TK, 1956, J PHARMACOL EXP THER, V117, P307
   Lasser E C, 1966, Invest Radiol, V1, P237, DOI 10.1097/00004424-196605000-00020
   LASSER EC, UNPUBLISHED DATA
   LASSER EC, 1966, RADIOL CLIN N AM, V4, P511
   LASSER EC, 1962, AMER J ROENTGENOL RA, V87, P338
   LASSER EC, 1968, J CANAD ASS RADIOL, V19, P110
   LASSER EC, 1965, 11 P INT C RAD ROM, P437
   LASSER EC, 1966, J AMER MED ASSOC, V198, P945, DOI 10.1001/jama.198.8.945
   LASSER EC, 1967, DYNAMIC FACTORS ROEN, P105
   LASSER ES, 1967, INVEST RADIOL, V2, P396
   PODLESKI T, 1967, SCIENCE, V157, P1579, DOI 10.1126/science.157.3796.1579
   PUTNAM FW, PLASMA PROTEINS, V1, P189
   PUTNAM FW, PLASMA PROTEINS, V1, P182
   READ RC, 1959, CARDIOVASC SURG, V38, P685
   SHEA TE, 1969, AMER J ROENTGENOL RA, V107, P763
   STEIN HL, 1968, AMER J ROENTGENOL RA, V104, P458
   THOREN A, 1960, ACTA ENDOCRINOL-COP, V35, P351
   THOREN A, 1960, ACTA ENDOCRINOL-COP, V35, P359
   VEREBELY K, 1969, BLOOD-J HEMATOL, V33, P468
NR 39
TC 43
Z9 43
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0020-9996
J9 INVEST RADIOL
JI Invest. Radiol.
PY 1970
VL 5
IS 6
BP 446
EP &
PG 0
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA I5763
UT WOS:A1970I576300005
PM 5501849
ER

PT J
AU Diegeler, A
   Borgermann, J
   Kappert, U
   Breuer, M
   Boning, A
   Ursulescu, A
   Rastan, A
   Holzhey, D
   Treede, H
   Riess, FC
   Veeckmann, P
   Asfoor, A
   Reents, W
   Zacher, M
   Hilker, M
AF Diegeler, Anno
   Boergermann, Jochen
   Kappert, Utz
   Breuer, Martin
   Boening, Andreas
   Ursulescu, Adrian
   Rastan, Ardawan
   Holzhey, David
   Treede, Hendrik
   Riess, Friedrich-Christian
   Veeckmann, Philippe
   Asfoor, Amjad
   Reents, Wilko
   Zacher, Michael
   Hilker, Michael
CA GOPCABE Study Grp
TI Off-Pump versus On-Pump Coronary-Artery Bypass Grafting in Elderly
   Patients
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID RISK PATIENTS; CARDIOPULMONARY BYPASS; LOGISTIC EUROSCORE; SURGERY;
   OUTCOMES; TRIAL; PATENCY; REVASCULARIZATION
AB BACKGROUND
   The benefits of coronary-artery bypass grafting (CABG) without cardiopulmonary bypass in the elderly are still undetermined.
   METHODS
   We randomly assigned patients 75 years of age or older who were scheduled for elective first-time CABG to undergo the procedure either without cardiopulmonary bypass (off-pump CABG) or with it (on-pump CABG). The primary end point was a composite of death, stroke, myocardial infarction, repeat revascularization, or new renal-replacement therapy at 30 days and at 12 months after surgery.
   RESULTS
   A total of 2539 patients underwent randomization. At 30 days after surgery, there was no significant difference between patients who underwent off-pump surgery and those who underwent on-pump surgery in terms of the composite outcome (7.8% vs. 8.2%; odds ratio, 0.95; 95% confidence interval [CI], 0.71 to 1.28; P = 0.74) or four of the components (death, stroke, myocardial infarction, or new renal-replacement therapy). Repeat revascularization occurred more frequently after off-pump CABG than after on-pump CABG (1.3% vs. 0.4%; odds ratio, 2.42; 95% CI, 1.03 to 5.72; P = 0.04). At 12 months, there was no significant between-group difference in the composite end point (13.1% vs. 14.0%; hazard ratio, 0.93; 95% CI, 0.76 to 1.16; P = 0.48) or in any of the individual components. Similar results were obtained in a per-protocol analysis that excluded the 177 patients who crossed over from the assigned treatment to the other treatment.
   CONCLUSIONS
   In patients 75 years of age or older, there was no significant difference between on-pump and off-pump CABG with regard to the composite outcome of death, stroke, myocardial infarction, repeat revascularization, or new renal-replacement therapy within 30 days and within 12 months after surgery. (Funded by Maquet; GOPCABE ClinicalTrials.gov number, NCT00719667.)
C1 [Diegeler, Anno; Reents, Wilko; Zacher, Michael] Herz & Gefass Klin Bad Neustadt, Bad Neustadt an der Saale, Germany.
   [Boergermann, Jochen] Herz & Diabet Zentrum Bad Oeynhausen, Bad Oeynhausen, Germany.
   [Kappert, Utz] Herzzentrum Dresden, Dresden, Germany.
   [Breuer, Martin] Univ Klin Jena, Jena, Germany.
   [Boening, Andreas] Univ Klin Giessen, Giessen, Germany.
   [Ursulescu, Adrian] Robert Bosch Krankenhaus Stuttgart, Stuttgart, Germany.
   [Rastan, Ardawan; Holzhey, David] Herzzentrum Univ Leipzig, Leipzig, Germany.
   [Treede, Hendrik] Univ Klin Hamburg Eppendorf, Hamburg, Germany.
   [Riess, Friedrich-Christian] Albertinen Krankenhaus Hamburg, Hamburg, Germany.
   [Veeckmann, Philippe] Klinikum Herzchirurg Karlsruhe, Karlsruhe, Germany.
   [Asfoor, Amjad] Ruhr Univ Bochum, Bochum, Germany.
   [Hilker, Michael] Univ Klin Regensburg, Regensburg, Germany.
RP Diegeler, A (reprint author), Cardiovasc Clin Bad Neustadt, Salzburger Leite 1, D-97616 Bad Neustadt an der Saale, Germany.
EM cachir@herzchirurgie.de
FU Maquet
FX Supported by Maquet.
CR Badreldin AMA, 2011, THORAC CARDIOV SURG, V59, P399, DOI 10.1055/s-0030-1270944
   Diegeler A, 2000, CIRCULATION, V102, P95
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595
   Hattler B, 2012, CIRCULATION, V125, P2827, DOI 10.1161/CIRCULATIONAHA.111.069260
   Houlind K, 2012, CIRCULATION, V125, P2431, DOI 10.1161/CIRCULATIONAHA.111.052571
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kuss O, 2011, J THORAC CARDIOV SUR, V142, pE117, DOI 10.1016/j.jtcvs.2011.04.032
   Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388
   Moller CH, 2010, CIRCULATION, V121, P498, DOI 10.1161/CIRCULATIONAHA.109.880443
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Pintar Tatjana, 2003, Anesthesiol Clin North America, V21, P453, DOI 10.1016/S0889-8537(03)00039-7
   Puskas John, 2005, Innovations (Phila), V1, P3, DOI 10.1097/01243895-200500110-00002
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
NR 19
TC 42
Z9 42
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 28
PY 2013
VL 368
IS 13
BP 1189
EP 1198
DI 10.1056/NEJMoa1211666
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 116FU
UT WOS:000316869000006
PM 23477657
ER

PT J
AU Prins, ML
   Hales, A
   Reger, M
   Giza, CC
   Hovda, DA
AF Prins, M. L.
   Hales, A.
   Reger, M.
   Giza, C. C.
   Hovda, D. A.
TI Repeat Traumatic Brain Injury in the Juvenile Rat Is Associated with
   Increased Axonal Injury and Cognitive Impairments
SO DEVELOPMENTAL NEUROSCIENCE
LA English
DT Article
DE Traumatic brain injury; Concussion; Repeat brain injury; Age; Axonal
   injury
ID SCHOOL FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; HEAD-INJURY; RECURRENT
   CONCUSSION; RECOVERY; ADOLESCENTS; DEFICITS; DTI; ENCEPHALOPATHY;
   POPULATION
AB Among the enormous population of head-injured children and young adults are a growing subpopulation who experience repeat traumatic brain injury (RTBI). The most common cause of RTBI in this age group is sports-related concussions, and athletes who have experienced a head injury are at greater risk for subsequent TBI, with consequent long-term cognitive dysfunction. While several animal models have been proposed to study RTBI, they have been shown to either produce injuries too severe, were conducted in adults, involved craniotomy, or failed to show behavioral deficits. A closed head injury model for postnatal day 35 rats was established, and single and repeat TBI (1-day interval) were examined histologically for axonal injury and behaviorally by the novel object recognition (NOR) task. The results from the current study demonstrate that an experimental closed head injury in the rodent with low mortality rates and absence of gross pathology can produce measurable cognitive deficits in a juvenile age group. The introduction of a second injury 24 h after the first impact resulted in increased axonal injury, astrocytic reactivity and increased memory impairment in the NOR task. The histological evidence demonstrates the potential usefulness of this RTBI model for studying the impact and time course of RTBI as it relates to the pediatric and young adult population. This study marks the first critical step in experimentally addressing the consequences of concussions and the cumulative effects of RTBI in the developing brain. Copyright (C) 2010 S. Karger AG, Basel
C1 [Prins, M. L.; Hales, A.; Reger, M.; Giza, C. C.; Hovda, D. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.
   [Giza, C. C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Neurol, Los Angeles, CA 90095 USA.
   [Hovda, D. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Prins, M. L.; Giza, C. C.; Hovda, D. A.] Univ Calif Los Angeles, David Geffen Sch Med, Interdept Program Neurosci, Los Angeles, CA 90095 USA.
   [Giza, C. C.; Hovda, D. A.] Univ Calif Los Angeles, David Geffen Sch Med, Interdept Program Biomed Engn, Los Angeles, CA 90095 USA.
   [Hales, A.; Reger, M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychol, Los Angeles, CA 90095 USA.
RP Prins, ML (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, NPI 18-228, Los Angeles, CA 90095 USA.
EM mprins@mednet.ucla.edu
FU UCLA Brain Injury Research Institute; UCLA Faculty Research Grant; Child
   Neurology Foundation/Winokur Family Foundation [NS058489, NS027544,
   NS057420]
FX The authors would like to thank for the support from the UCLA Brain
   Injury Research Institute, the UCLA Faculty Research Grant and the Child
   Neurology Foundation/Winokur Family Foundation (NS058489, NS027544 and
   NS057420).
CR ANNEGERS JF, 1980, NEUROLOGY, V30, P912
   Baldwin SA, 1996, GLIA, V16, P266
   Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241
   Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101
   Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143
   Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566
   Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46
   Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1227/01.NEU.0000031572.99927.93
   Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964
   Copeland SA, 2008, ANN NEUROL, V64, pS128
   ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X
   Field M, 2003, J PEDIATR, V142, P546, DOI 10.1067/mpd.2003.190
   Gaetz M, 2000, BRAIN INJURY, V14, P1077
   GRONWALL D, 1975, LANCET, V2, P995
   Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549
   Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD
   Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A
   Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672
   Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072
   JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006
   Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994
   KRAUS JF, 1990, AM J DIS CHILD, V144, P684
   Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216
   Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203
   Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547
   Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117
   McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817
   McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004
   Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503
   Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4
   Müller E, 1967, Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed, V70, P422
   NEHLIG A, 1988, J NEUROSCI, V8, P2321
   Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970
   Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.6945127
   Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D
   Povlishock JT, 1996, ACT NEUR S, V66, P81
   Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402
   Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148
   ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4
   Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511
   Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF
   Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518
   Wakade C, 2010, J NEUROSURG
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54
   Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004
NR 46
TC 42
Z9 42
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0378-5866
J9 DEV NEUROSCI-BASEL
JI Dev. Neurosci.
PY 2010
VL 32
IS 5-6
BP 510
EP 518
DI 10.1159/000316800
PG 9
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 725RO
UT WOS:000287663900019
PM 20829578
ER

PT J
AU Diblasio, CJ
   Kattan, MW
AF Diblasio, CJ
   Kattan, MW
TI Use of nomograms to predict the risk of disease recurrence after
   definitive local therapy for prostate cancer
SO UROLOGY
LA English
DT Article
ID MULTIINSTITUTIONAL POOLED ANALYSIS; RADICAL RETROPUBIC PROSTATECTOMY;
   EXTERNAL-BEAM RADIATION; POSTOPERATIVE NOMOGRAM; CLINICAL STAGE;
   PROGNOSTIC-SIGNIFICANCE; PRETREATMENT NOMOGRAM; PREOPERATIVE NOMOGRAM;
   PATHOLOGICAL STAGE; ANTIGEN FAILURE
AB The generally indolent nature of prostate cancer, as well as the impact that treatment can have on quality of life (QOL) and cancer control, makes the decision analysis difficult for patients facing the task of selecting a treatment for clinically localized disease. Instruments to aid patients and their physicians in this decision analysis are needed. Nomograms are instruments that predict outcomes using specific clinical parameters. Nomograms use algorithms that incorporate several variables to calculate the predicted probability that a patient will achieve a particular clinical end point. Nomograms tend to outperform both clinical experts and predictive models using methods of risk grouping. We briefly outline the uses and limitations of nomograms, principles of nomogram construction, and the available models for predicting the progression-free probability after local definitive therapy with radical prostatectomy, external-beam radiotherapy, or brachytherapy. There is a need for additional nomograms that predict outcomes after salvage therapy, as well other clinical end points, including QOL-adjusted survival. (C) 2003 Elsevier Inc.
C1 Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY 10021 USA.
RP Kattan, MW (reprint author), Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA.
EM kattanm@mskcc.org
CR *AJCC, 1992, CANC STAG MAN
   ALBERTSEN PC, 1995, JAMA-J AM MED ASSOC, V274, P626, DOI 10.1001/jama.274.8.626
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   ANTMAN EM, 2000, JAMA-J AM MED ASSOC, V284, P876
   BAGSHAW MA, 1994, J UROLOGY, V152, P1781
   Begg CB, 2000, STAT MED, V19, P1997, DOI 10.1002/1097-0258(20000815)19:15<1997::AID-SIM511>3.0.CO;2-C
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   Chan TY, 2000, UROLOGY, V56, P823, DOI 10.1016/S0090-4295(00)00753-6
   CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403
   Cowen ME, 1998, MED DECIS MAKING, V18, P376, DOI 10.1177/0272989X9801800404
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   D'Amico AV, 2003, J UROLOGY, V169, P1320, DOI 10.1097/01.ju.0000049200.30192.d1
   DAMICO AV, 1995, J UROLOGY, V154, P131, DOI 10.1016/S0022-5347(01)67248-3
   D'Amico AV, 1999, CANCER, V86, P1632, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1632::AID-CNCR2>3.0.CO;2-5
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844
   Fleming ID, 1997, AJCC CANC STAGING MA
   Gerber GS, 1996, JAMA-J AM MED ASSOC, V276, P615
   Graefen M, 2002, J CLIN ONCOL, V20, P951, DOI 10.1200/JCO.20.4.951
   Graefen M, 2002, J CLIN ONCOL, V20, P3206, DOI 10.1200/JCO.2002.12.019
   Graefen M, 2002, UROL ONCOL, V7, P141, DOI 10.1016/S1078-1439(02)00177-1
   Halabi S, 2003, J CLIN ONCOL, V21, P1232, DOI 10.1200/JCO.2003.06.100
   Han M, 2001, J UROLOGY, V166, P416, DOI 10.1016/S0022-5347(05)65955-1
   Hanks GE, 1997, UROLOGY, V50, P87, DOI 10.1016/S0090-4295(97)00226-4
   HANKS GE, 1995, J UROLOGY, V154, P456, DOI 10.1016/S0022-5347(01)67073-3
   Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
   Harrell FE, 1998, STAT MED, V17, P909, DOI 10.1002/(SICI)1097-0258(19980430)17:8<909::AID-SIM753>3.3.CO;2-F
   HOGARTH R, 1987, JUDGMENT CHOICE PSYC, P311
   Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169
   Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7
   Jemal A, 2003, CA-CANCER J CLIN, V53, P5
   Kattan MW, 2001, J UROLOGY, V166, P63, DOI 10.1016/S0022-5347(05)66077-6
   Kattan MW, 2001, UROLOGY, V58, P393, DOI 10.1016/S0090-4295(01)01233-X
   Kattan MW, 2001, INT ENCY SOCIAL BEHA, P5135
   Kattan Michael W, 2002, Clin Prostate Cancer, V1, P90, DOI 10.3816/CGC.2002.n.010
   Kattan MW, 1998, J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766
   Kattan MW, 1999, J CLIN ONCOL, V17, P1499
   Kattan MW, 2003, CURR OPIN UROL, V13, P111, DOI 10.1097/01.mou.0000058631.64616.54
   Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.20.3.791
   Kattan MW, 2000, J CLIN ONCOL, V18, P3352
   Kattan Michael W, 2003, Clin Prostate Cancer, V1, P221, DOI 10.3816/CGC.2003.n.003
   Mazumdar M, 2001, STAT MED, V20, P883, DOI 10.1002/sim.706
   MEEHL PE, 1986, J PERS ASSESS, V50, P370, DOI 10.1207/s15327752jpa5003_6
   Mitchell JA, 2003, J UROLOGY, V169, P459
   OHORI M, 1995, J UROLOGY, V154, P1818, DOI 10.1016/S0022-5347(01)66792-2
   Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445
   Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8
   PARTIN AW, 1993, J UROLOGY, V150, P110
   Perez Carlos A., 2000, Rays (Rome), V25, P331
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   Ragde H, 2000, CANCER, V89, P135, DOI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Ross PL, 2001, J UROLOGY, V165, P1562, DOI 10.1016/S0022-5347(05)66349-5
   Ross Phillip L, 2002, Semin Urol Oncol, V20, P82, DOI 10.1053/suro.2002.32490
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021
   Stokes SH, 1997, INT J RADIAT ONCOL, V37, P337, DOI 10.1016/S0360-3016(96)00508-1
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   Wheeler TM, 1998, HUM PATHOL, V29, P856, DOI 10.1016/S0046-8177(98)90457-9
   WILT TJ, 1994, J UROLOGY, V152, P1910
   Yan Y, 2000, CANCER, V88, P1122, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1122::AID-CNCR24>3.0.CO;2-Q
   ZAGARS GK, 1994, CANCER, V73, P1904, DOI 10.1002/1097-0142(19940401)73:7<1904::AID-CNCR2820730722>3.0.CO;2-6
   Zelefsky MJ, 2000, INT J RADIAT ONCOL, V47, P1261, DOI 10.1016/S0360-3016(00)00550-2
   ZINCKE H, 1994, J UROLOGY, V152, P1850
NR 66
TC 42
Z9 43
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-4295
J9 UROLOGY
JI Urology
PD DEC 29
PY 2003
VL 62
IS 6B
SU S
BP 9
EP 18
DI 10.1016/j.urology.2003.09.029
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA 808TR
UT WOS:000220591900003
PM 14747038
ER

PT J
AU Stock, RG
   Stone, NN
AF Stock, RG
   Stone, NN
TI The effect of prognostic factors on therapeutic outcome following
   transperineal prostate brachytherapy
SO SEMINARS IN SURGICAL ONCOLOGY
LA English
DT Review
DE brachytherapy; interventional ultrasonography; prostate; prostatic
   neoplasms; prostate-specific antigen; palladium; radioisotopes; iodine
   radioisotopes; patient selection; neoplasm staging
ID PREDICT PATHOLOGICAL STAGE; SEMINAL-VESICLE BIOPSY; LYMPH-NODE
   DISSECTION; CLINICAL STAGE; GLEASON SCORE; CANCER; ANTIGEN; CARCINOMA;
   IMPLANTATION; MEN
AB The objectives of this study were to examine the effect of both disease and treatment related prognostic factors on biochemical control and post-treatment biopsy. Two-hundred fifty-eight patients underwent interactive ultrasound guided transperineal prostate implantation for T1-T2 prostate cancer using Iodine-125 (139 patients) and Palladium-103 (119 patients) and were followed from 6-67 months (median, 19). Hormonal therapy with 3 months of leuprolide and flutamide prior to implantation and two months given after the implant was used in 96 patients. Pre-treatment prostate-specific antigen (PSA) had the most significant effect on biochemical failure. Freedom from biochemical failure (FFBF) rates at 4 years were 75% for patients with PSA 1.3 - 10 ng/ml (144), 74% for patients with PSA 10.1-20 ng/ml (73), and 34% for patients with PSA > 20 ng/ml (41) (P = 0.0004). Gleason score also had a significant effect on FFBF rates. Four-year rates were 81%, 65% and 47% for patients with scores of 2-4 (68), 5-6 (130), and greater than or equal to 7 respectively (60) (P = 0.01). These two factors were also significant in multivariate analysis (P = 0.002, 0.007, respectively). Gleason score was the only factor to significantly affect post-treatment biopsy results. Patients with scores of 2-6 had 85% (63/ 74) negative 2-year biopsies versus 62% (13/21) for patients with scores greater than or equal to 7 (P = 0.02). Low-risk patients (PSA less than or equal to 10 ng/ml, scores <7 and stage <T2a) had a 4-year FFBF rate of 88% as compared to 60% for high-risk patients (PSA > 10 ng/ml, score > 6 or stage greater than or equal to T2b) (P = 0.02) and had a 95% negative biopsy rate versus 76% for high-risk patients (P = 0.06). Low-risk patients demonstrate high FFBF and negative biopsy rates following implantation. Patients presenting with higher risk prognostic factors such as PSA > 20 ng/ml or Gleason scores greater than or equal to 7 may require more aggressive treatment regimens. Semin. Surg. Oncol. 13:454-460, 1997. (C) 1997 Wiley-Liss, Inc.
RP Stock, RG (reprint author), MT SINAI MED CTR,DEPT RADIAT ONCOL,1 GUSTAVE L LEVY PL,BOS 1236,NEW YORK,NY 10029, USA.
CR Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko John, 1996, International Journal of Radiation Oncology Biology Physics, V36, P198, DOI 10.1016/S0360-3016(97)85421-1
   Cox D, 1984, ANAL SURVIVAL DATA, DOI Boca Raton, FL
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Fienberg S. E., 1980, ANAL CROSS CLASSIFIE
   HANKS GE, 1995, J UROLOGY, V154, P456, DOI 10.1016/S0022-5347(01)67073-3
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kupelian P, 1996, UROLOGY, V48, P249, DOI 10.1016/S0090-4295(96)00167-7
   Kupelian P, 1997, CANCER J SCI AM, V3, P78
   Laverdiere J, 1997, INT J RADIAT ONCOL, V37, P247, DOI 10.1016/S0360-3016(96)00513-5
   LAVERDIERE J, 1997, INT J RADIAT ONCOL, V37, P245
   LEE WR, 1995, J CLIN ONCOL, V13, P464
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   PARTIN AW, 1993, J UROLOGY, V150, P1923
   PARTIN AW, 1994, J UROLOGY, V152, P172
   PARTIN AW, 1993, J UROLOGY, V150, P110
   Roach M, 1996, J UROLOGY, V156, P1719, DOI 10.1016/S0022-5347(01)65490-9
   ROACH M, 1996, J UROLOGY, V156, P1724
   Stock RG, 1996, INT J RADIAT ONCOL, V35, P267, DOI 10.1016/0360-3016(95)02050-0
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   STOCK RG, 1995, INT J RADIAT ONCOL, V33, P815, DOI 10.1016/0360-3016(95)02007-4
   STONE NN, 1995, RADIAT ONCOL INVEST, V3, P185, DOI 10.1002/roi.2970030407
   STONE NN, 1995, J UROLOGY, V154, P1392, DOI 10.1016/S0022-5347(01)66874-5
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   ZAGARS GK, 1994, J UROL 2, V152, P1773
   ZAGARS GK, 1994, J UROL 2, V152, P1791
   ZAGARS GK, 1995, UROLOGY, V45, P476, DOI 10.1016/S0090-4295(99)80019-3
   Zeitman AL, 1994, UROLOGY, V43, P828
   ZEITMAN AL, 1997, CANCER J SCI AM, V3, P31
   ZEITMAN AL, 1994, J UROLOGY, V151, P640
NR 34
TC 42
Z9 42
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 8756-0437
J9 SEMIN SURG ONCOL
JI Semin. Surg. Oncol.
PD NOV-DEC
PY 1997
VL 13
IS 6
BP 454
EP 460
DI 10.1002/(SICI)1098-2388(199711/12)13:6<454::AID-SSU10>3.0.CO;2-T
PG 7
WC Oncology; Surgery
SC Oncology; Surgery
GA YD540
UT WOS:A1997YD54000010
PM 9358593
ER

PT J
AU FAN, LL
   CAMPBELL, DN
   CLARKE, DR
   WASHINGTON, RL
   FIX, EJ
   WHITE, CW
AF FAN, LL
   CAMPBELL, DN
   CLARKE, DR
   WASHINGTON, RL
   FIX, EJ
   WHITE, CW
TI PARALYZED LEFT VOCAL CORD ASSOCIATED WITH LIGATION OF PATENT
   DUCTUS-ARTERIOSUS
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
C1 UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT,DENVER,CO 80262.
   UNIV COLORADO,HLTH SCI CTR,DEPT SURG,DENVER,CO 80262.
   CHILDRENS HOSP,DEPT CARDIOL,DENVER,CO 80218.
   CHILDRENS HOSP,DEPT CARDIOVASC SURG,DENVER,CO 80218.
   CHILDRENS HOSP,DEPT RESP THERAPY,DENVER,CO 80218.
RP FAN, LL (reprint author), CHILDRENS HOSP,DEPT PEDIAT PULMONOL,1056 E 19TH AVE,DENVER,CO 80218, USA.
CR CLARKE DR, 1976, ANN THORAC SURG, V22, P138
   FAN LL, 1981, LARYNGOSCOPE, V91, P451
   FAN LL, 1988, CHEST, V93, P556, DOI 10.1378/chest.93.3.556
   FAN LL, 1986, CHEST, V89, P673, DOI 10.1378/chest.89.5.673
   HALL GS, 1976, ANN THORAC SURG, V22, P146
   HARDY JD, 1966, ANN SURG, V164, P877, DOI 10.1097/00000658-196611000-00015
   JONES JC, 1965, J THORAC CARDIOV SUR, V50, P149
   KITTERMA.JA, 1972, NEW ENGL J MED, V287, P473, DOI 10.1056/NEJM197209072871001
   LEVITSKY S, 1976, ANN THORAC SURG, V22, P131
   NELSON RJ, 1976, J THORAC CARDIOV SUR, V71, P169
   PANAGOPO.PG, 1971, THORAX, V26, P137, DOI 10.1136/thx.26.2.137
   WILLIAMS WH, 1976, ANN THORAC SURG, V22, P151
NR 12
TC 42
Z9 43
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD OCT
PY 1989
VL 98
IS 4
BP 611
EP 613
PG 3
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA AU114
UT WOS:A1989AU11400018
PM 2796367
ER

PT J
AU Hattler, B
   Messenger, JC
   Shroyer, AL
   Collins, JF
   Haugen, SJ
   Garcia, JA
   Baltz, JH
   Cleveland, JC
   Novitzky, D
   Grover, FL
AF Hattler, Brack
   Messenger, John C.
   Shroyer, A. Laurie
   Collins, Joseph F.
   Haugen, Scott J.
   Garcia, Joel A.
   Baltz, Janet H.
   Cleveland, Joseph C., Jr.
   Novitzky, Dimitri
   Grover, Frederick L.
CA Vet Affairs Randomized On Off
TI Off-Pump Coronary Artery Bypass Surgery Is Associated With Worse
   Arterial and Saphenous Vein Graft Patency and Less Effective
   Revascularization Results From the Veterans Affairs Randomized On/Off
   Bypass (ROOBY) Trial
SO CIRCULATION
LA English
DT Article
DE coronary artery bypass; coronary artery bypass; off-pump
ID TERM-FOLLOW-UP; ON-PUMP; LIFE OUTCOMES; HEART; MORTALITY; SURVIVAL;
   PRAGUE-4; FATE
AB Background-The Department of Veterans Affairs Randomized On/Off Bypass (ROOBY) trial compared clinical and angiographic outcomes in off-pump versus on-pump coronary artery bypass graft (CABG) surgery to ascertain the relative efficacy of the 2 techniques.
   Methods and Results-From February 2002 to May 2007, the ROOBY trial randomized 2203 patients to off-pump versus on-pump CABG. Follow-up angiography was obtained in 685 off-pump (62%) and 685 on-pump (62%) patients. Angiograms were analyzed (blinded to treatment) for FitzGibbon classification (A=widely patent, B=flow limited, O=occluded) and effective revascularization. Effective revascularization was defined as follows: All 3 major coronary territories with significant disease were revascularized by a FitzGibbon A-quality graft to the major diseased artery, and there were no new postanastomotic lesions. Off-pump CABG resulted in lower FitzGibbon A patency rates than on-pump CABG for arterial conduits (85.8% versus 91.4%; P=0.003) and saphenous vein grafts (72.7% versus 80.4%; P<0.001). Fewer off-pump patients were effectively revascularized (50.1% versus 63.9% on-pump; P<0.001). Within each major coronary territory, effective revascularization was worse off pump than on pump (all P<0.001). The 1-year adverse cardiac event rate was 16.4% in patients with ineffective revascularization versus 5.9% in patients with effective revascularization (P<0.001).
   Conclusions-Off-pump CABG resulted in significantly lower FitzGibbon A patency for arterial and saphenous vein graft conduits and less effective revascularization than on-pump CABG. At 1 year, patients with less effective revascularization had higher adverse event rates.
C1 [Hattler, Brack; Shroyer, A. Laurie; Baltz, Janet H.; Cleveland, Joseph C., Jr.; Grover, Frederick L.] Eastern Colorado Hlth Care Syst, Dept Vet Affairs, Denver, CO USA.
   [Hattler, Brack; Messenger, John C.; Garcia, Joel A.] Univ Colorado Hosp Denver, Dept Med, Aurora, CO USA.
   [Hattler, Brack; Messenger, John C.; Garcia, Joel A.; Cleveland, Joseph C., Jr.; Grover, Frederick L.] Hlth Sci Ctr, Aurora, CO USA.
   [Shroyer, A. Laurie] Northport Vet Affairs Med Ctr, Northport, NY USA.
   [Collins, Joseph F.] Vet Affairs Med Ctr, Cooperat Studies Program Coordinating Ctr, Perry Point, MD USA.
   [Haugen, Scott J.] Bellevue Med Ctr, Grp Hlth Cooperat, Bellevue, WA USA.
   [Cleveland, Joseph C., Jr.; Grover, Frederick L.] Univ Colorado Hosp Denver, Dept Surg, Aurora, CO USA.
   [Novitzky, Dimitri] James A Haley Vet Hosp, Tampa, FL 33612 USA.
RP Hattler, B (reprint author), Denver VAMC, 1055 Clermont St,111B, Denver, CO 80220 USA.
EM brack.hattler@va.gov
FU VA Office of Research and Development; VA Central Office, Office of
   Patient Care Services; Office of Research and Development at the Eastern
   Colorado Health Care System; Office of Denver VA Medical Center; Office
   of Northport VA Medical Center
FX This work was supported by the Cooperative Studies Program of the VA
   Office of Research and Development and the VA Central Office, Office of
   Patient Care Services, and in part by the Offices of Research and
   Development at the Eastern Colorado Health Care System, Denver VA
   Medical Center, and the Northport VA Medical Center.
CR ALDERMAN EL, 1992, CORONARY ARTERY DIS, V3, P1189
   Al-Ruzzeh S, 2006, BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C
   Angelini GD, 2009, J THORAC CARDIOV SUR, V137, P295, DOI 10.1016/j.jtcvs.2008.09.046
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   FITZGIBBON GM, 1978, CIRCULATION, V57, P1070
   GOLDMAN S, 1989, CIRCULATION, V80, P1190
   Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595
   Hu SS, 2010, CIRCULATION, V121, P1800, DOI 10.1161/CIRCULATIONAHA.109.894543
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Lingaas PS, 2006, ANN THORAC SURG, V81, P2089, DOI 10.1016/j.athoracsur.2005.12.003
   Mohr FW, 2010, EUR HEART J, V31, P2441, DOI 10.1093/eurheartj/ehq257
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Novitzky D, 2007, CLIN TRIALS, V4, P81, DOI 10.1177/1740774506075859
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas JD, 2011, ANN THORAC SURG, V91, P1836, DOI 10.1016/j.athoracsur.2010.12.043
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
NR 25
TC 41
Z9 43
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD JUN 12
PY 2012
VL 125
IS 23
BP 2827
EP 2835
DI 10.1161/CIRCULATIONAHA.111.069260
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 981NM
UT WOS:000306975100022
PM 22592900
ER

PT J
AU Glenzer, SH
   Callahan, DA
   MacKinnon, AJ
   Kline, JL
   Grim, G
   Alger, ET
   Berger, RL
   Bernstein, LA
   Betti, R
   Bleuel, DL
   Boehly, TR
   Bradley, DK
   Burkhart, SC
   Burr, R
   Caggiano, JA
   Castro, C
   Casey, DT
   Choate, C
   Clark, DS
   Celliers, P
   Cerjan, CJ
   Collins, GW
   Dewald, EL
   DiNicola, P
   DiNicola, JM
   Divol, L
   Dixit, S
   Doppner, T
   Dylla-Spears, R
   Dzenitis, E
   Eckart, M
   Erbert, G
   Farley, D
   Fair, J
   Fittinghoff, D
   Frank, M
   Frenje, LJA
   Friedrich, S
   Casey, DT
   Johnson, MG
   Gibson, C
   Giraldez, E
   Glebov, V
   Glenn, S
   Guler, N
   Haan, SW
   Haid, BJ
   Hammel, BA
   Hamza, AV
   Haynam, CA
   Heestand, GM
   Hermann, M
   Hermann, HW
   Hicks, DG
   Hinkel, DE
   Holder, JP
   Holunda, DM
   Horner, JB
   Hsing, WW
   Huang, H
   Izumi, N
   Jackson, M
   Jones, OS
   Kalantar, DH
   Kauffman, R
   Kilkenny, JD
   Kirkwood, RK
   Klingmann, J
   Kohut, T
   Knauer, JP
   Koch, JA
   Kozioziemki, B
   Kyrala, GA
   Kritcher, AL
   Kroll, J
   La Fortune, K
   Lagin, L
   Landen, OL
   Larson, DW
   LaTray, D
   Leeper, RJ
   Le Pape, S
   Lindl, JD
   Lowe-Webb, R
   Ma, T
   McNaney, J
   MacPhee, AG
   Malsbury, TN
   Mapoles, E
   Marshall, CD
   Meezan, NB
   Merrill, F
   Michel, P
   Moody, JD
   Moore, AS
   Moran, M
   Moreno, KA
   Munro, DH
   Nathan, BR
   Nikroo, A
   Olson, RE
   Orth, CD
   Pak, AE
   Patel, PK
   Parham, T
   Petrasso, R
   Ralph, JE
   Rinderknecht, H
   Regan, SP
   Robey, HF
   Ross, JS
   Rosen, MD
   Sacks, R
   Salmonson, JD
   Saunders, R
   Sater, J
   Sangster, C
   Schneider, MB
   Seguin, FH
   Shaw, MJ
   Spears, BK
   Springer, PT
   Stoeffl, W
   Suter, LJ
   Thomas, CA
   Tommasini, R
   Town, RPJ
   Walters, C
   Weaver, S
   Weber, SV
   Wegner, PJ
   Whitman, PK
   Widmann, K
   Widmayer, CC
   Wilde, CH
   Wilson, DC
   Van Wonterghem, B
   MacGowan, BJ
   Atherton, LJ
   Edwards, MJ
   Moses, EI
AF Glenzer, S. H.
   Callahan, D. A.
   MacKinnon, A. J.
   Kline, J. L.
   Grim, G.
   Alger, E. T.
   Berger, R. L.
   Bernstein, L. A.
   Betti, R.
   Bleuel, D. L.
   Boehly, T. R.
   Bradley, D. K.
   Burkhart, S. C.
   Burr, R.
   Caggiano, J. A.
   Castro, C.
   Casey, D. T.
   Choate, C.
   Clark, D. S.
   Celliers, P.
   Cerjan, C. J.
   Collins, G. W.
   Dewald, E. L.
   DiNicola, P.
   DiNicola, J. M.
   Divol, L.
   Dixit, S.
   Doeppner, T.
   Dylla-Spears, R.
   Dzenitis, E.
   Eckart, M.
   Erbert, G.
   Farley, D.
   Fair, J.
   Fittinghoff, D.
   Frank, M.
   Frenje, L. J. A.
   Friedrich, S.
   Casey, D. T.
   Johnson, M. Gatu
   Gibson, C.
   Giraldez, E.
   Glebov, V.
   Glenn, S.
   Guler, N.
   Haan, S. W.
   Haid, B. J.
   Hammel, B. A.
   Hamza, A. V.
   Haynam, C. A.
   Heestand, G. M.
   Hermann, M.
   Hermann, H. W.
   Hicks, D. G.
   Hinkel, D. E.
   Holder, J. P.
   Holunda, D. M.
   Horner, J. B.
   Hsing, W. W.
   Huang, H.
   Izumi, N.
   Jackson, M.
   Jones, O. S.
   Kalantar, D. H.
   Kauffman, R.
   Kilkenny, J. D.
   Kirkwood, R. K.
   Klingmann, J.
   Kohut, T.
   Knauer, J. P.
   Koch, J. A.
   Kozioziemki, B.
   Kyrala, G. A.
   Kritcher, A. L.
   Kroll, J.
   La Fortune, K.
   Lagin, L.
   Landen, O. L.
   Larson, D. W.
   LaTray, D.
   Leeper, R. J.
   Le Pape, S.
   Lindl, J. D.
   Lowe-Webb, R.
   Ma, T.
   McNaney, J.
   MacPhee, A. G.
   Malsbury, T. N.
   Mapoles, E.
   Marshall, C. D.
   Meezan, N. B.
   Merrill, F.
   Michel, P.
   Moody, J. D.
   Moore, A. S.
   Moran, M.
   Moreno, K. A.
   Munro, D. H.
   Nathan, B. R.
   Nikroo, A.
   Olson, R. E.
   Orth, C. D.
   Pak, A. E.
   Patel, P. K.
   Parham, T.
   Petrasso, R.
   Ralph, J. E.
   Rinderknecht, H.
   Regan, S. P.
   Robey, H. F.
   Ross, J. S.
   Rosen, M. D.
   Sacks, R.
   Salmonson, J. D.
   Saunders, R.
   Sater, J.
   Sangster, C.
   Schneider, M. B.
   Seguin, F. H.
   Shaw, M. J.
   Spears, B. K.
   Springer, P. T.
   Stoeffl, W.
   Suter, L. J.
   Thomas, C. A.
   Tommasini, R.
   Town, R. P. J.
   Walters, C.
   Weaver, S.
   Weber, S. V.
   Wegner, P. J.
   Whitman, P. K.
   Widmann, K.
   Widmayer, C. C.
   Wilde, C. H.
   Wilson, D. C.
   Van Wonterghem, B.
   MacGowan, B. J.
   Atherton, L. J.
   Edwards, M. J.
   Moses, E. I.
TI Cryogenic thermonuclear fuel implosions on the National Ignition
   Facility
SO PHYSICS OF PLASMAS
LA English
DT Article
ID INERTIAL CONFINEMENT FUSION; D TOKAMAK PLASMAS; LASER PERFORMANCE;
   STIMULATED RAMAN; HOHLRAUM PLASMAS; PROFILE CONTROL; PHYSICS BASIS;
   POWER LASERS; TARGETS; TRITIUM
AB The first inertial confinement fusion implosion experiments with equimolar deuterium-tritium thermonuclear fuel have been performed on the National Ignition Facility. These experiments use 0.17 mg of fuel with the potential for ignition and significant fusion yield conditions. The thermonuclear fuel has been fielded as a cryogenic layer on the inside of a spherical plastic capsule that is mounted in the center of a cylindrical gold hohlraum. Heating the hohlraum with 192 laser beams for a total laser energy of 1.6 MJ produces a soft x-ray field with 300 eV temperature. The ablation pressure produced by the radiation field compresses the initially 2.2-mm diameter capsule by a factor of 30 to a spherical dense fuel shell that surrounds a central hot-spot plasma of 50 mu m diameter. While an extensive set of x-ray and neutron diagnostics has been applied to characterize hot spot formation from the x-ray emission and 14.1 MeV deuterium-tritium primary fusion neutrons, thermonuclear fuel assembly is studied by measuring the down-scattered neutrons with energies in the range of 10 to 12 MeV. X-ray and neutron imaging of the compressed core and fuel indicate a fuel thickness of (14 +/- 3) mu m, which combined with magnetic recoil spectrometer measurements of the fuel areal density of (1 +/- 0.09) g cm(-2) result in fuel densities approaching 600 g cm(-3). The fuel surrounds a hot-spot plasma with average ion temperatures of (3.5 +/- 0.1) keV that is measured with neutron time of flight spectra. The hot-spot plasma produces a total fusion neutron yield of 10 15 that is measured with the magnetic recoil spectrometer and nuclear activation diagnostics that indicate a 14.1 MeV yield of (7.5 +/- 0.1) x 10(14) which is 70% to 75% of the total fusion yield due to the high areal density. Gamma ray measurements provide the duration of nuclear activity of (170 +/- 30) ps. These indirect-drive implosions result in the highest areal densities and neutron yields achieved on laser facilities to date. This achievement is the result of the first hohlraum and capsule tuning experiments where the stagnation pressures have been systematically increased by more than a factor of 10 by fielding low-entropy implosions through the control of radiation symmetry, small hot electron production, and proper shock timing. The stagnation pressure is above 100 Gbars resulting in high Lawson-type confinement parameters of P tau similar or equal to 10 atm s. Comparisons with radiation-hydrodynamic simulations indicate that the pressure is within a factor of three required for reaching ignition and high yield. This will be the focus of future higher-velocity implosions that will employ additional optimizations of hohlraum, capsule and laser pulse shape conditions. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4719686]
C1 [Glenzer, S. H.; Callahan, D. A.; MacKinnon, A. J.; Alger, E. T.; Berger, R. L.; Bernstein, L. A.; Bleuel, D. L.; Bradley, D. K.; Burkhart, S. C.; Burr, R.; Caggiano, J. A.; Castro, C.; Choate, C.; Clark, D. S.; Celliers, P.; Cerjan, C. J.; Collins, G. W.; Dewald, E. L.; DiNicola, P.; DiNicola, J. M.; Divol, L.; Dixit, S.; Doeppner, T.; Dylla-Spears, R.; Dzenitis, E.; Eckart, M.; Erbert, G.; Farley, D.; Fair, J.; Frank, M.; Friedrich, S.; Gibson, C.; Giraldez, E.; Glenn, S.; Haan, S. W.; Haid, B. J.; Hammel, B. A.; Hamza, A. V.; Haynam, C. A.; Heestand, G. M.; Hermann, M.; Hermann, H. W.; Hicks, D. G.; Hinkel, D. E.; Holder, J. P.; Holunda, D. M.; Horner, J. B.; Hsing, W. W.; Huang, H.; Izumi, N.; Jackson, M.; Jones, O. S.; Kalantar, D. H.; Kauffman, R.; Kirkwood, R. K.; Klingmann, J.; Kohut, T.; Koch, J. A.; Kozioziemki, B.; Kritcher, A. L.; Kroll, J.; La Fortune, K.; Lagin, L.; Landen, O. L.; Larson, D. W.; LaTray, D.; Le Pape, S.; Lindl, J. D.; Lowe-Webb, R.; Ma, T.; McNaney, J.; MacPhee, A. G.; Malsbury, T. N.; Mapoles, E.; Marshall, C. D.; Meezan, N. B.; Michel, P.; Moody, J. D.; Moran, M.; Moreno, K. A.; Munro, D. H.; Nathan, B. R.; Orth, C. D.; Pak, A. E.; Patel, P. K.; Parham, T.; Ralph, J. E.; Robey, H. F.; Ross, J. S.; Rosen, M. D.; Sacks, R.; Salmonson, J. D.; Saunders, R.; Sater, J.; Schneider, M. B.; Shaw, M. J.; Spears, B. K.; Springer, P. T.; Stoeffl, W.; Suter, L. J.; Thomas, C. A.; Tommasini, R.; Town, R. P. J.; Walters, C.; Weaver, S.; Weber, S. V.; Wegner, P. J.; Whitman, P. K.; Widmann, K.; Widmayer, C. C.; Van Wonterghem, B.; MacGowan, B. J.; Atherton, L. J.; Edwards, M. J.; Moses, E. I.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
   [Kline, J. L.; Grim, G.; Fittinghoff, D.; Guler, N.; Kyrala, G. A.; Merrill, F.; Wilde, C. H.; Wilson, D. C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
   [Betti, R.; Boehly, T. R.; Glebov, V.; Knauer, J. P.; Regan, S. P.; Sangster, C.] Univ Rochester, Laser Energet Lab, Rochester, NY 14623 USA.
   [Casey, D. T.; Frenje, L. J. A.; Casey, D. T.; Johnson, M. Gatu; Petrasso, R.; Rinderknecht, H.; Seguin, F. H.] MIT, Plasma Sci & Fus Ctr, Cambridge, MA 02139 USA.
   [Kilkenny, J. D.; Nikroo, A.] Gen Atom Co, San Diego, CA 92121 USA.
   [Leeper, R. J.; Olson, R. E.] Sandia Natl Labs, Sandia, NM 87185 USA.
   [Moore, A. S.] Atom Weap Estab, Aldermaston RG7, England.
RP Glenzer, SH (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RI Dylla-Spears, Rebecca/H-5605-2012; Patel, Pravesh/E-1400-2011; Whitman,
   Pamela/B-2336-2013; Ma, Tammy/F-3133-2013; McNaney, James/F-5258-2013;
   Michel, Pierre/J-9947-2012
OI Ma, Tammy/0000-0002-6657-9604; 
FU U.S. Department of Energy by Lawrence Livermore National Laboratory
   [DE-AC52-07NA27344]; U.S. Department of Energy Office of Inertial
   Confinement Fusion [DE-FC52-08NA28302]
FX The authors like to acknowledge valuable discussions with H. S. McLean
   and D. L. Correll. This work performed under the auspices of the U.S.
   Department of Energy by Lawrence Livermore National Laboratory under
   Contract DE-AC52-07NA27344. This work was also supported by the U.S.
   Department of Energy Office of Inertial Confinement Fusion under
   Cooperative Agreement No. DE-FC52-08NA28302.
CR [Anonymous], 1987, U.S. patent, Patent No. [4,292,340, 4292340]
   Atzeni S, 2004, PHYS INERTIAL FUSION
   Berger RL, 1998, PHYS PLASMAS, V5, P4337, DOI 10.1063/1.873171
   Betti R, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3380857
   Boehly TR, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3640805
   BRYSK H, 1973, PLASMA PHYS CONTR F, V15, P611, DOI 10.1088/0032-1028/15/7/001
   Callahan DA, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694840
   Celliers PM, 2004, REV SCI INSTRUM, V75, P4916, DOI 10.1063/1.1807008
   Chang Py., 2010, PHYS REV LETT, V104
   Dattolo E, 2001, PHYS PLASMAS, V8, P260, DOI 10.1063/1.1324659
   Dewald E. L., 2005, PLASMA PHYS CONTROL, V47, P405
   Dewald EL, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2943700
   Dewald EL, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3624497
   Dewald EL, 2004, REV SCI INSTRUM, V75, P3759, DOI 10.1063/1.1788872
   Doppner T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.135006
   DRAKE RP, 1984, PHYS REV LETT, V53, P1739, DOI 10.1103/PhysRevLett.53.1739
   Edwards MJ, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592173
   Frenje JA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3304475
   Froula DH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045006
   Froula DH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.115002
   Glebov VY, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3492351
   Glebov VY, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2236281
   Glenzer SH, 2010, SCIENCE, V327, P1228, DOI 10.1126/science.1185634
   Glenzer SH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.085004
   Glenzer SH, 2001, PHYS REV LETT, V86, P2565, DOI 10.1103/PhysRevLett.86.2565
   Glenzer SH, 1998, PHYS REV LETT, V80, P2845, DOI 10.1103/PhysRevLett.80.2845
   Glenzer SH, 2007, NAT PHYS, V3, P716, DOI 10.1038/nphys709
   Glenzer SH, 1998, PHYS REV LETT, V81, P365, DOI 10.1103/PhysRevLett.81.365
   Glenzer SH, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/4/045013
   Goncharov VN, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.165001
   Haan SW, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592169
   HAAN SW, 1995, PHYS PLASMAS, V2, P2480, DOI 10.1063/1.871209
   HAUER AA, 1995, PHYS PLASMAS, V2, P2488, DOI 10.1063/1.871210
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   Herrmann HW, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3495770
   Hicks DG, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3486536
   HOFFER JK, 1988, PHYS REV LETT, V60, P1310, DOI 10.1103/PhysRevLett.60.1310
   Jones OS, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4718595
   KATO Y, 1984, PHYS REV LETT, V53, P1057, DOI 10.1103/PhysRevLett.53.1057
   Kauffman R. L., 1994, PHYS REV LETT, V73, P2328
   Keilhacker M, 1999, NUCL FUSION, V39, P209, DOI 10.1088/0029-5515/39/2/306
   Keilhacker M., 1999, PLASMA PHYS CONTROLL, V41, pB1B23
   KILKENNY JD, 1995, REV SCI INSTRUM, V66, P288, DOI 10.1063/1.1146387
   Kline JL, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.085003
   Kozioziemski BJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1862764
   Kritcher AL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.015002
   Kucheyev SO, 2010, J APPL PHYS, V108, DOI 10.1063/1.3489943
   Kyrala GA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3574504
   Landen O. L., 1999, PHYS PLASMAS, V6, P2488
   Landen OL, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592170
   LAWSON JD, 1957, P PHYS SOC LOND B, V70, P6, DOI 10.1088/0370-1301/70/1/303
   Lazarus EA, 1996, PHYS REV LETT, V77, P2714, DOI 10.1103/PhysRevLett.77.2714
   Lazarus EA, 1997, NUCL FUSION, V37, P7, DOI 10.1088/0029-5515/37/1/I11
   Lefebvre E, 1998, PHYS PLASMAS, V5, P2701, DOI 10.1063/1.872957
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638
   MacGowan B. J., 1995, PHYS PLASMAS, V3, P2029
   MacKinnon A. J., PHYS REV LETT UNPUB
   Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740
   MARSHAK RE, 1958, PHYS FLUIDS, V1, P24, DOI 10.1063/1.1724332
   MARTIN AJ, 1988, J VAC SCI TECHNOL A, V6, P1885, DOI 10.1116/1.575234
   Meezan N. B., 2011, IN FUS SCI APPL C BO
   Meezan NB, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3354110
   Michel P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046409
   Michel P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025004
   Michel P, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3325733
   Miller J. R., 1975, LA6245PR, P82
   Moody JD, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491035
   Moody JD, 2012, NAT PHYS, V8, P344, DOI [10.1038/nphys2239, 10.1038/NPHYS2239]
   Moody JD, 2001, PHYS REV LETT, V86, P2810, DOI 10.1103/PhysRevLett.86.2810
   Moses EI, 2005, FUSION SCI TECHNOL, V47, P314
   Niemann C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.045002
   OFFENBERGER AA, 1982, PHYS REV LETT, V49, P371, DOI 10.1103/PhysRevLett.49.371
   Regan SP, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694057
   Regan SP, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3309481
   Robey HF, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694122
   Sangster, 2008, PHY REV LETT, V100
   Schneider MB, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491316
   SIGEL R, 1990, PHYS REV LETT, V65, P587, DOI 10.1103/PhysRevLett.65.587
   Spears BK, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3696743
   Springer P. T., J PHYS UNPUB
   STRACHAN JD, 1994, PHYS REV LETT, V72, P3526, DOI 10.1103/PhysRevLett.72.3526
   Suter LJ, 2004, PHYS PLASMAS, V11, P2738, DOI 10.1063/1.1687725
   Thomas PR, 1998, PHYS REV LETT, V80, P5548, DOI 10.1103/PhysRevLett.80.5548
   Town RPJ, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3562552
   Turner RE, 2000, PHYS PLASMAS, V7, P333, DOI 10.1063/1.873801
   Zhou CD, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2998604
   Zhou CD, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3152994
NR 88
TC 41
Z9 41
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 1070-664X
J9 PHYS PLASMAS
JI Phys. Plasmas
PD MAY
PY 2012
VL 19
IS 5
AR 056318
DI 10.1063/1.4719686
PG 15
WC Physics, Fluids & Plasmas
SC Physics
GA 952YB
UT WOS:000304831100104
ER

PT J
AU Pieters, BR
   de Back, DZ
   Koning, CCE
   Zwinderman, AH
AF Pieters, Bradley R.
   de Back, Djuna Z.
   Koning, Caro C. E.
   Zwinderman, Aeilko H.
TI Comparison of three radiotherapy modalities on biochemical control and
   overall survival for the treatment of prostate cancer: A systematic
   review
SO RADIOTHERAPY AND ONCOLOGY
LA English
DT Review
DE Prostate neoplasms; Systematic review; Meta-analysis; Dose-escalated
   radiotherapy; Brachytherapy
ID EXTERNAL-BEAM RADIOTHERAPY; DOSE-RATE BRACHYTHERAPY; DISEASE-FREE
   SURVIVAL; CONFORMAL RADIATION-THERAPY; RATE IR-192 BRACHYTHERAPY;
   RELAPSE-FREE SURVIVAL; PD-103 BRACHYTHERAPY; ANDROGEN DEPRIVATION; HDR
   BRACHYTHERAPY; PHASE-II
AB Background and Purpose: For the radiation treatment of prostate cancer high dose should be delivered for optimal biochemical control. Treatment can be given by dose-escalated external beam radiotherapy (EBRT) or external beam radiotherapy combined with a radioactive seed implantation (EBSeeds) or high-dose rate (HDR) brachytherapy (EBTI). Differences in outcome between the modalities were assessed by a systematic review.
   Materials and methods: A systematic search was performed resulting in 40 articles to be used. Data were extracted on biochemical control and overall survival at 3, 5, and 8 years and other time points mentioned in the articles. Also known prognostic parameters were noted. Comparison of the modalities was done by a Weibull survival analysis and estimation of Hazard Ratio's (HR) was done with 95% confidence intervals (95% CIs).
   Results: The HR for biochemical recurrence was 1.40 (95% CI 1.31-1.51) for EBRT relative to EBTI, and was 1.37 (95% CI 1.26-1.49) for EBSeeds relative to EBTI. The HR for overall survival was 1.50 (95% CI 1.29-1.73) for EBRT relative to EBTI, and was 2.33 (95% CI 2.04-2.66) for EBSeeds relative to EBTI.
   Conclusion: The combination of external beam radiotherapy and HDR brachytherapy results in a superior biochemical control and overall survival found in a systematic review on radiotherapy for prostate cancer. (C) 2009 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 93 (2009) 168-173
C1 [Pieters, Bradley R.; de Back, Djuna Z.; Koning, Caro C. E.] Univ Amsterdam, Acad Med Ctr, Dept Radiat Oncol, NL-1100 DD Amsterdam, Netherlands.
   [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DD Amsterdam, Netherlands.
RP Pieters, BR (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Radiat Oncol, POB 22660,ZO-416, NL-1100 DD Amsterdam, Netherlands.
EM b.r.pieters@amc.uva.nl
RI koning, caro/A-5339-2008
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Astrom L, 2005, RADIOTHER ONCOL, V74, P157, DOI 10.1016/j.radonc.2004.10.014
   Chen YC, 2007, UROLOGY, V70, P101, DOI 10.1016/j.urology.2007.03.008
   Chin YS, 2006, CLIN ONCOL-UK, V18, P474, DOI 10.1016/j.clon.2006.04.005
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   Dattoli M, 2007, UROLOGY, V69, P334, DOI 10.1016/j.urology.2006.09.045
   Deger S, 2005, EUR UROL, V47, P441, DOI 10.1016/j.eururo.2004.11.014
   Demanes DJ, 2005, INT J RADIAT ONCOL, V61, P1306, DOI 10.1016/j.ijrobp.2004.08.014
   Eade TN, 2007, INT J RADIAT ONCOL, V68, P682, DOI 10.1016/j.ijrobp.2007.01.008
   Ellis RJ, 2007, BRACHYTHERAPY, V6, P16, DOI 10.1016/j.brachy.2006.11.002
   Galalae RM, 2002, INT J RADIAT ONCOL, V52, P81, DOI 10.1016/S0360-3016(01)01758-8
   GUIX B, 2007, RADIOTHER ONCOL, V83, pS39
   Hiratsuka J, 2004, INT J RADIAT ONCOL, V59, P684, DOI 10.1016/j.ijrobp.2003.11.035
   Hoskin PJ, 2007, RADIOTHER ONCOL, V84, P114, DOI 10.1016/j.radonc.2007.04.011
   Hsu I-Chow J, 2005, Brachytherapy, V4, P202, DOI 10.1016/j.brachy.2005.03.005
   IVERSEN P, 1989, UROLOGY, V34, P181, DOI 10.1016/0090-4295(89)90368-3
   Izard MA, 2006, INT J RADIAT ONCOL, V66, P38, DOI 10.1016/j.ijrobp.2006.04.002
   Jani AB, 2006, UROLOGY, V67, P1007, DOI 10.1016/j.urology.2005.11.008
   Kalkner KM, 2007, ACTA ONCOL, V46, P909, DOI 10.1080/02841860601156140
   KAYE KW, 1995, J UROLOGY, V153, P1020, DOI 10.1016/S0022-5347(01)67626-2
   Kupelian PA, 2002, INT J RADIAT ONCOL, V53, P904, DOI 10.1016/S0360-3016(02)02836-5
   Lederman GS, 2001, INT J RADIAT ONCOL, V49, P1297, DOI 10.1016/S0360-3016(00)01442-5
   Lee WR, 2007, CANCER, V109, P1506, DOI 10.1002/cncr.22560
   Martin T, 2004, RADIOTHER ONCOL, V71, P35, DOI 10.1016/j.radonc.2003.10.004
   Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2
   Merrick GS, 2007, INT J RADIAT ONCOL, V68, P34, DOI 10.1016/j.ijrobp.2006.11.046
   Nichol A, 2005, RADIOTHER ONCOL, V76, P11, DOI 10.1016/j.radonc.2005.06.002
   Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530
   Pellizzon ACA, 2003, RADIOTHER ONCOL, V66, P167, DOI 10.1016/S0167-8140(02)00408-5
   Phan TP, 2007, J UROLOGY, V177, P123, DOI 10.1016/j.juro.2006.08.109
   Pieters BR, 2008, RADIOTHER ONCOL, V88, P46, DOI 10.1016/j.radonc.2008.02.023
   Pollack A, 2004, J UROLOGY, V171, P1132, DOI 10.1097/01.ju.0000111844.95024.74
   Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8
   Pollack A, 2000, INT J RADIAT ONCOL, V48, P507, DOI 10.1016/S0360-3016(00)00620-9
   Potters L, 2002, PROSTATE CANCER P D, V5, P47, DOI 10.1038/sj/pcan/450552
   Rades D, 2007, STRAHLENTHER ONKOL, V183, P398, DOI 10.1007/s00066-007-1643-z
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5
   Singh AM, 2005, PROSTATE, V62, P54, DOI 10.1002/pros.20118
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sylvester JE, 2007, INT J RADIAT ONCOL, V67, P57, DOI 10.1016/j.ijrobp.2006.07.1382
   Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X
   Vargas CE, 2006, INT J RADIAT ONCOL, V66, P416, DOI 10.1016/j.ijrobp.2006.04.045
   Vicini FA, 1998, INT J RADIAT ONCOL, V40, P1101, DOI 10.1016/S0360-3016(97)00942-5
   Yamada Y, 2006, BRACHYTHERAPY, V5, P157, DOI 10.1016/j.brachy.2006.03.004
   Zelefsky MJ, 2003, J UROLOGY, V170, P1828, DOI 10.1097/01.JU.0000093720.46502.24
   Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233
NR 47
TC 41
Z9 42
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-8140
J9 RADIOTHER ONCOL
JI Radiother. Oncol.
PD NOV
PY 2009
VL 93
IS 2
BP 168
EP 173
DI 10.1016/j.radonc.2009.08.033
PG 6
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 523RT
UT WOS:000272092900002
PM 19748692
ER

PT J
AU Elwood, LS
   Hahn, KS
   Olatunji, BO
   Williams, NL
AF Elwood, Lisa S.
   Hahn, Kathryn S.
   Olatunji, Bunmi O.
   Williams, Nathan L.
TI Cognitive vulnerabilities to the development of PTSD: A review of four
   vulnerabilities and the proposal of an integrative vulnerability model
SO CLINICAL PSYCHOLOGY REVIEW
LA English
DT Review
DE Vulnerability; PTSD; Diathesis-stress; Attribution; Rumination; Anxiety
   sensitivity; Looming cognitive style
ID POSTTRAUMATIC-STRESS-DISORDER; ATTRIBUTIONAL STYLE QUESTIONNAIRE;
   MOTOR-VEHICLE ACCIDENTS; TRAUMA-EXPOSED ADULTS; ANXIETY SENSITIVITY
   INDEX; LOOMING MALADAPTIVE STYLE; SEXUAL-ABUSE SURVIVORS; DSM-IV
   ANXIETY; PANIC-ATTACKS; DEPRESSIVE SYMPTOMS
AB While some individuals develop PTSD Subsequent to traumatic experiences, many individuals resume prior functioning naturally. Diathesis-stress models Suggest that stable individual differences present in individuals prior to trauma may serve as Vulnerability factors to symptom development. The high levels of comorbidity and symptom similarity Suggest that established Vulnerability factors for anxiety and depression may also serve as vulnerability factors for PTSD. The examination Of Multiple Vulnerability factors simultaneously may increase understanding of the etiology of PTSD and comorbid post-trauma symptomatology and account for a greater percentage of variance in PTSD symptoms. In addition, the Vulnerability factors may be related to distinct sets of symptoms, with vulnerabilities predicting the PTSD symptoms most similar to their associated disorders. Research examining the relations between attributional style, rumination, anxiety sensitivity, and the looming cognitive style and the development of PTSD after trauma exposure is reviewed and Suggestions for future research are provided. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Elwood, Lisa S.] Univ Missouri, Ctr Trauma Recovery, St Louis, MO 63121 USA.
   [Hahn, Kathryn S.] Univ Mississippi, Med Ctr, GV Sonny Montgomery VAMC, University, MS 38677 USA.
   [Olatunji, Bunmi O.] Vanderbilt Univ, Nashville, TN USA.
   [Williams, Nathan L.] Univ Arkansas, Fayetteville, AR 72701 USA.
RP Elwood, LS (reprint author), Univ Missouri, Ctr Trauma Recovery, 1 Univ Blvd, St Louis, MO 63121 USA.
EM elwoodls@umsl.edu
RI Mavoa, Suzanne/B-5372-2010
CR Abramson L. Y., 1999, J COGNITIVE PSYCHOTH, V13, P5
   ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037//0033-295X.96.2.358
   Alloy LB, 2000, J ABNORM PSYCHOL, V109, P403, DOI 10.1037//0021-843X.109.3.403
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   American Psychiatric Association, 1980, DIAGN STAT MAN MENT
   Asmundson Gordon J. G., 2008, Cognitive Behaviour Therapy, V37, P66, DOI 10.1080/16506070801969005
   Asmundson GJG, 1998, J ANXIETY DISORD, V12, P57, DOI 10.1016/S0887-6185(97)00049-2
   ASMUNDSON GJG, 2005, COGNITIVE BEHAV THER, V34, P245
   Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4
   Beck A. T., 1967, DEPRESSION CLIN EXPT
   Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1
   Beck JG, 2004, PSYCHOL ASSESSMENT, V16, P289, DOI 10.1037/1040-3590.16.3.289
   Bernstein A, 2005, DEPRESS ANXIETY, V22, P138, DOI 10.1002/da.20091
   Bernstein Amit, 2005, Cognitive Behaviour Therapy, V34, P229, DOI 10.1080/16506070510041176
   Blais MA, 2001, J PERS ASSESS, V77, P272, DOI 10.1207/S15327752JPA7702_10
   BLOOM SL, 2000, INT HDB HUMAN RESPON, P27
   Bonin MF, 2000, J BEHAV THER EXP PSY, V31, P55, DOI 10.1016/S0005-7916(00)00008-2
   Bowman ML, 2004, POSTTRAUMATIC STRESS, P15, DOI 10.1002/9780470713570
   Brady KT, 2000, J CLIN PSYCHIAT, V61, P22
   Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748
   Broman-Fulks JJ, 2008, ASSESSMENT, V15, P188, DOI 10.1177/1073191107311284
   Brown EJ, 1999, J ABNORM CHILD PSYCH, V27, P311, DOI 10.1023/A:1022610709748
   Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037/0021-843X.110.4.585
   Brown TA, 1998, J ABNORM PSYCHOL, V107, P179, DOI 10.1037/0021-843X.107.2.179
   Bryant RA, 2001, BEHAV RES THER, V39, P961, DOI 10.1016/S0005-7967(00)00086-3
   Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6
   Calmes C. A., 2007, COGNITIVE THERAPY RE, V30, P343, DOI DOI 10.1007/S10608-006-9026-9
   CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316
   Clohessy S, 1999, BRIT J CLIN PSYCHOL, V38, P251, DOI 10.1348/014466599162836
   Collimore KC, 2008, J ANXIETY DISORD, V22, P1021, DOI 10.1016/j.janxdis.2007.11.002
   Conley CS, 2001, J ABNORM CHILD PSYCH, V29, P445, DOI 10.1023/A:1010451604161
   Conway M, 2000, J PERS ASSESS, V75, P404, DOI 10.1207/S15327752JPA7503_04
   Corr PJ, 1996, J PSYCHOL, V130, P645
   Taylor S, 1998, BEHAV RES THER, V36, P37, DOI 10.1016/S0005-7967(97)00071-5
   Cutrona C. E., 1985, J PERS SOC PSYCHOL, V47, P1043
   Dalgleish T, 2004, BEHAV RES THER, V42, P1069, DOI 10.1016/j.brat.2004.05.001
   Davis RN, 2000, COGNITIVE THER RES, V24, P699, DOI 10.1023/A:1005591412406
   Dixon A, 2005, J AM ACAD CHILD PSY, V44, P798, DOI 10.1097/01.chi.0000164590.48318.9c
   Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0
   Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037//0021-843X.107.3.508
   Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X
   Ehlers A, 2003, BEHAV RES THER, V41, P1, DOI 10.1016/S0005-7967(01)00126-7
   Ehring T, 2006, BEHAV RES THER, V44, P1699, DOI 10.1016/j.brat.2005.11.013
   Elklit A, 2004, J INTERPERS VIOLENCE, V19, P709, DOI 10.1177/0886260504263872
   Elwood LS, 2007, J ANXIETY DISORD, V21, P554, DOI 10.1016/j.janxdis.2006.08.006
   Engelhard IM, 2007, BEHAV RES THER, V45, P2317, DOI 10.1016/j.brat.2007.04.005
   Engelhard IM, 2006, GEN HOSP PSYCHIAT, V28, P414, DOI 10.1016/j.genhosppsych.2006.07.001
   Engelhard IM, 2003, PERS INDIV DIFFER, V35, P381, DOI 10.1016/S0191-8869(02)00200-3
   Engelhard IM, 2007, CAN J PSYCHIAT, V52, P505
   Epstein S., 1991, SELF REGULATORY BEHA, P273
   EYSENCK HJ, 1967, ADDEDTHE BIOL BASIS
   Fairbrother N, 2004, BEHAV RES THER, V42, P173, DOI 10.1016/S0005-7967(03)00108-6
   FALSETTI SA, 1995, J APPL SOC PSYCHOL, V25, P1027, DOI 10.1111/j.1559-1816.1995.tb00615.x
   FAO EB, 1993, AM PSYCHIAT PRESS RE, V12, P273
   Fedoroff I. C., 2000, BEHAV COGN PSYCHOTH, V28, P5
   Feiring C., 1998, CHILD MALTREATMENT, V3, P129, DOI 10.1177/1077559598003002007
   Feiring C, 2002, DEV PSYCHOL, V38, P79, DOI 10.1037//0012-1649.38.1.79
   Feiring Candice, 2002, Child Maltreat, V7, P26
   Feldner M. T., 2006, J COGNITIVE PSYCHOTH, V20, P201, DOI [10.1891/jcop.20.2.201, DOI 10.1891/JC0P.20.2.201]
   Feldner MT, 2008, ADDICT BEHAV, V33, P1470, DOI 10.1016/j.addbeh.2008.02.015
   Feldner MT, 2004, CLIN PSYCHOL-SCI PR, V11, P405, DOI 10.1093/clipsy/bph098
   Feldner MT, 2008, DEPRESS ANXIETY, V25, P190, DOI 10.1002/da.20281
   Feldner MT, 2008, COGNITIVE THER RES, V32, P116, DOI 10.1007/s10608-007-9138-x
   Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303
   FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X
   Friedman Matthew J., 1995, P429
   GLADSTONE TRG, 1995, J ABNORM CHILD PSYCH, V23, P597, DOI 10.1007/BF01447664
   GOLIN S, 1981, J ABNORM PSYCHOL, V90, P14, DOI 10.1037/0021-843X.90.1.14
   Grant DM, 2007, BEHAV RES THER, V45, P2247, DOI 10.1016/j.brat.2007.02.008
   Gray MJ, 2004, J LOSS TRAUMA, V9, P59, DOI 10.1080/15325020490255313
   Gray MJ, 2003, J ANXIETY DISORD, V17, P289, DOI 10.1016/S0887-6185(02)00205-0
   Greening L, 2002, COGNITIVE THER RES, V26, P261, DOI 10.1023/A:1014530021675
   Hankin BL, 2002, J CLIN CHILD ADOLESC, V31, P491, DOI 10.1207/153744202320802160
   Harada K, 2008, PHARMACOL BIOCHEM BE, V89, P11, DOI 10.1016/j.pbb.2007.10.016
   Harris PW, 2008, PERS INDIV DIFFER, V44, P150, DOI 10.1016/j.paid.2007.07.011
   Harvey AG, 2000, J NERV MENT DIS, V188, P602, DOI 10.1097/00005053-200009000-00007
   Hewitt AK, 2004, PERS INDIV DIFFER, V37, P1483, DOI 10.1016/j.paid.2004.02.005
   Hickling EJ, 1999, J TRAUMA STRESS, V12, P345, DOI 10.1023/A:1024784711484
   Hinton DE, 2005, BEHAV RES THER, V43, P1631, DOI 10.1016/j.brat.2005.01.001
   Ingram R. E., 1998, COGNITIVE VULNERABIL
   Ingram RE, 2001, VULNERABILITY PSYCHO
   Janoff-Bulman Ronny, 1992, SHATTERED ASSUMPTION
   Joiner TE, 1999, COGNITIVE THER RES, V23, P105, DOI 10.1023/A:1018766825706
   Joiner TE, 1995, CLIN PSYCHOL REV, V15, P777, DOI 10.1016/0272-7358(95)00046-1
   JOSEPH SA, 1991, BRIT J PSYCHIAT, V159, P542, DOI 10.1192/bjp.159.4.542
   Just N, 1997, J ABNORM PSYCHOL, V106, P221, DOI 10.1037/0021-843X.106.2.221
   Kasch KL, 2001, PSYCHOL ASSESSMENT, V13, P375, DOI 10.1037//1040-3590.13.3.375
   Kashdan TB, 2006, BEHAV RES THER, V44, P1609, DOI 10.1016/j.brat.2005.12.003
   Keane TM, 1997, ANN NY ACAD SCI, V821, P24, DOI 10.1111/j.1749-6632.1997.tb48266.x
   Keogh Edmund, 2002, Cognitive Behaviour Therapy, V31, P145, DOI 10.1080/165060702321138546
   KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048
   Kilic EZ, 2008, J PSYCHOSOM RES, V65, P81, DOI 10.1016/j.jpsychores.2008.02.013
   Kleim B, 2008, J CONSULT CLIN PSYCH, V76, P231, DOI 10.1037/0022-006X.76.2.231
   Kleim B, 2007, PSYCHOL MED, V37, P1457, DOI 10.1017/S0033291707001006
   Kozlovsky N, 2008, EUR NEUROPSYCHOPHARM, V18, P107, DOI 10.1016/j.euroneuro.2007.04.009
   Kuyken W, 1999, COGNITIVE THER RES, V23, P665, DOI 10.1023/A:1018793026132
   Lang AJ, 2002, DEPRESS ANXIETY, V16, P77, DOI 10.1002/da.10062
   Leen-Feldner EW, 2008, BEHAV RES THER, V46, P548, DOI 10.1016/j.brat.2008.01.014
   MALLER RG, 1992, J ANXIETY DISORD, V6, P241, DOI 10.1016/0887-6185(92)90036-7
   Marcus DK, 2008, J PSYCHOSOM RES, V64, P495, DOI 10.1016/j.jpsychores.2008.02.004
   Marshall GN, 2002, J ABNORM PSYCHOL, V111, P626, DOI 10.1037//0021-843X.111.4.626
   Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9
   McCann I. L., 1990, PSYCHOL TRAUMA ADULT
   McKee Laura, 2007, Cognitive Behaviour Therapy, V36, P91, DOI 10.1080/16506070601119314
   McKeever VM, 2003, REV GEN PSYCHOL, V7, P237, DOI 10.1037/1089-2680.7.3.237
   McNally RJ, 1998, CLIN PSYCHOL REV, V18, P971, DOI 10.1016/S0272-7358(98)00036-1
   McNally RJ, 2001, VULNERABILITY TO PSYCHOPATHOLOGY, P304
   MEEHL PE, 1977, J MED PHILOS, V2, P33
   MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029
   METALSKY GI, 1992, J PERS SOC PSYCHOL, V63, P667, DOI 10.1037/0022-3514.63.4.667
   Michael T, 2007, DEPRESS ANXIETY, V24, P307, DOI 10.1002/da.20228
   MIKULINCER M, 1988, J ABNORM PSYCHOL, V97, P308, DOI 10.1037/0021-843X.97.3.308
   Miller MW, 2007, BEHAV THER, V38, P58, DOI 10.1016/j.beth.2006.04.003
   Miller MW, 2003, CLIN PSYCHOL-SCI PR, V10, P373, DOI 10.1093/clipsy/bpg040
   Miller MW, 2004, J ABNORM PSYCHOL, V113, P636, DOI 10.1037/0021-843X.113.4.636
   Miranda R, 2007, BEHAV RES THER, V45, P3088, DOI 10.1016/j.brat.2007.07.015
   Moulds ML, 2007, BEHAV RES THER, V45, P251, DOI 10.1016/j.brat.2006.03.003
   Muris P, 2005, PERS INDIV DIFFER, V39, P1105, DOI 10.1016/j.paid.2005.04.005
   Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363
   Nixon RDV, 2003, BEHAV RES THER, V41, P1237, DOI 10.1016/S0005-7967(03)00150-5
   Nixon RDV, 2005, BEHAV CHANGE, V22, P22, DOI 10.1375/bech.22.1.22.66783
   Nolen-Hoeksema S, 2007, J ABNORM PSYCHOL, V116, P198, DOI 10.1037/0021-843X.116.1.198
   Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P801, DOI 10.1037/0022-3514.77.4.801
   Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037//0022-3514.77.5.1061
   NOLENHOEKSEMA S, 1993, COGNITION EMOTION, V7, P561, DOI 10.1080/02699939308409206
   NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569
   NOLENHOEKSEMA S, 1994, J PERS SOC PSYCHOL, V67, P92, DOI 10.1037/0022-3514.67.1.92
   Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504
   OLATUNJI BO, 2008, INT Q, V22, P37
   Orth U, 2008, J CONSULT CLIN PSYCH, V76, P208, DOI 10.1037/0022-006X.76.2.208
   Owens GP, 2001, J INTERPERS VIOLENCE, V16, P178, DOI 10.1177/088626001016002006
   Owens GP, 2001, BEHAV THER, V32, P413, DOI 10.1016/S0005-7894(01)80028-9
   Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52
   Palker-Corell A, 2004, J SOC CLIN PSYCHOL, V23, P445, DOI 10.1521/jscp.23.4.445.40311
   PETERSON C, 1984, PSYCHOL REV, V91, P347, DOI 10.1037/0033-295X.91.3.347
   PETERSON C, 1982, COGNITIVE THER RES, V6, P287, DOI 10.1007/BF01173577
   PETERSON C, 1988, J ABNORM PSYCHOL, V97, P87, DOI 10.1037//0021-843X.97.1.87
   Peterson R. A., 1993, ANXIETY SENSITIVITY
   PETERSON RC, 1999, SENSITIVITY THEORY R, P61
   Plehn K, 2002, J ANXIETY DISORD, V16, P455, DOI 10.1016/S0887-6185(02)00129-9
   Power M. J., 1999, BEHAV COGN PSYCHOTH, V27, P129
   Reardon JA, 2007, J ANXIETY DISORD, V21, P625, DOI 10.1016/j.janxdis.2006.09.013
   Reijntjes A, 2008, COGNITIVE THER RES, V32, P247, DOI 10.1007/s10608-007-9124-3
   REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9
   REISS S, 1991, CLIN PSYCHOL REV, V11, P141, DOI 10.1016/0272-7358(91)90092-9
   Resick P. A., 1996, COGNITIVE PROCESSING
   Riskind J. H., 1999, J COGNITIVE PSYCHOTH, V13, P41
   Riskind JH, 2006, J SOC CLIN PSYCHOL, V25, P705, DOI 10.1521/jscp.2006.25.7.705
   Riskind JH, 2005, COGNITIVE THER RES, V29, P7, DOI 10.1007/s10608-005-1645-z
   RISKIND JH, 1997, BEHAV RES THER, V35, P793
   Riskind JH, 2000, J PERS SOC PSYCHOL, V79, P837, DOI 10.1037/0022-3514.79.5.837
   Roelofs J, 2006, J BEHAV THER EXP PSY, V37, P299, DOI 10.1016/j.jbtep.2006.03.002
   ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1002/jts.2490050309
   Rueger SY, 2007, J CLIN CHILD ADOLESC, V36, P476
   Runyon Melissa K, 2002, Child Maltreat, V7, P254, DOI 10.1177/1077559502007003007
   Sanjuan P, 2008, PERS INDIV DIFFER, V45, P187, DOI 10.1016/j.paid.2008.03.004
   Schmidt NB, 2006, J PSYCHIAT RES, V40, P691, DOI 10.1016/j.jpsychires.2006.07.009
   Schmidt NB, 2007, J ANXIETY DISORD, V21, P302, DOI 10.1016/j.janxdis.2006.06.002
   Schmidt NB, 1997, J ABNORM PSYCHOL, V106, P355, DOI 10.1037/0021-843X.106.3.355
   Schonfeld S, 2006, EMOTION, V6, P611, DOI 10.1037/1528-3542.6.4.611
   Smari J, 2003, ANXIETY STRESS COPIN, V16, P375, DOI 10.1080/1061580031000107791
   SOLOMON Z, 1991, SOC PSYCH PSYCH EPID, V26, P8, DOI 10.1007/BF00783574
   Steil R, 2000, BEHAV RES THER, V38, P537, DOI 10.1016/S0005-7967(99)00069-8
   Stewart S., 2000, ALCOHOLISM TREATMENT, V18, P31, DOI 10.1300/J020v18n03_04
   SWEENEY PD, 1986, J PERS SOC PSYCHOL, V50, P974, DOI 10.1037/0022-3514.50.5.974
   Taylor S., 2004, ADV TREATMENT POSTTR
   Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176.supp
   TAYLOR S, 1992, J ANXIETY DISORD, V6, P249, DOI 10.1016/0887-6185(92)90037-8
   Taylor S., 2003, J COGNITIVE PSYCHOTH, V17, P179, DOI 10.1891/088983903780906147
   Taylor S, 1998, J ANXIETY DISORD, V12, P463, DOI 10.1016/S0887-6185(98)00028-0
   TENNEN H, 1987, J PERS SOC PSYCHOL, V52, P72, DOI 10.1037//0022-3514.52.1.72
   Thompson M, 1998, PSYCHOL ASSESSMENT, V10, P166, DOI 10.1037/1040-3590.10.2.166
   Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561
   TRULL TJ, 1994, J ABNORM PSYCHOL, V103, P350, DOI 10.1037//0021-843X.103.2.350
   Tull MT, 2007, BEHAV THER, V38, P303, DOI 10.1016/j.beth.2006.10.001
   van den Hout MA, 2004, J PSYCHOPATHOL BEHAV, V26, P181, DOI 10.1023/B:JOBA.0000022110.17639.60
   Vujanovic Anka A., 2008, Cognitive Behaviour Therapy, V37, P76, DOI 10.1080/16506070801969039
   Wald Jaye, 2008, Cognitive Behaviour Therapy, V37, P90, DOI 10.1080/16506070801969054
   WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465
   Weems CF, 2002, J ABNORM PSYCHOL, V111, P471, DOI 10.1037//0021-843X.111.3.471
   Wenninger K, 1998, J TRAUMA STRESS, V11, P281, DOI 10.1023/A:1024451103931
   Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331
   Williams AD, 2007, BEHAV RES THER, V45, P1141, DOI 10.1016/j.brat.2006.09.005
   Williams NL, 2005, J ANXIETY DISORD, V19, P157, DOI 10.1016/j.janxdis.2004.01.003
   Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026
   ZINBARG RE, 1999, ANXIETY SENSITIVITY, P83
   Zoellner LA, 2001, BEHAV RES THER, V39, P697, DOI 10.1016/S0005-7967(00)00050-4
   ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037//0021-843X.86.2.103
   Zvolensky MJ, 2003, BEHAV RES THER, V41, P841, DOI 10.1016/S0005-7967(02)00187-0
   Zvolensky MJ, 2006, BEHAV RES THER, V44, P1219, DOI 10.1016/j.brat.2006.06.001
NR 190
TC 41
Z9 44
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0272-7358
J9 CLIN PSYCHOL REV
JI Clin. Psychol. Rev.
PD FEB
PY 2009
VL 29
IS 1
BP 87
EP 100
DI 10.1016/j.cpr.2008.10.002
PG 14
WC Psychology, Clinical
SC Psychology
GA 399TD
UT WOS:000262821300008
PM 19008028
ER

PT J
AU Unno, N
   Nishiyama, M
   Suzuki, M
   Yamamoto, N
   Inuzuka, K
   Sagara, D
   Tanaka, H
   Konno, H
AF Unno, N.
   Nishiyama, M.
   Suzuki, M.
   Yamamoto, N.
   Inuzuka, K.
   Sagara, D.
   Tanaka, H.
   Konno, H.
TI Quantitative lymph imaging for assessment of lymph function using
   indocyanine green fluorescence lymphography
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE indocyanine green; lymphography; lymphedema; exercise; transit time
ID LOWER-LIMB LYMPHEDEMA; HUMAN-SERUM-ALBUMIN; NONINVASIVE EVALUATION;
   ISOTOPE LYMPHOGRAPHY; LYMPHOSCINTIGRAPHY; EXTREMITY; DIAGNOSIS; EDEMA
AB Objectives: A new diagnostic imaging technique that can assess lymph function is needed as a screening test in daily practice. This study assessed the use of indocyanine green (ICG) fluorescence lymphography in subjects without leg oedema.
   Methods: 0.3 ml of ICG (0.5 %) was injected subcutaneously at the dorsum of the foot. Subsequently, the movement of ICG dye from the injection site to the groin was traced by visualizing its fluorescence signal with an infrared light camera. The time for the dye to reach the knee and groin were measured (Transit time to knee: TT(K), Transit time to groin: TT(G)). TTG was measured while standing, lying at a supine position, standing with massage, and sitting while using a cycle ergometer exercise at an intensity of 50 W at 50 rpm in ten healthy volunteers at intervals of 14 days.
   Results: Mean TTG during standing was 357 289 and 653 564 seconds for the right and left legs respectively. Compared to TTG in the standing position, all other conditions shortened TTG. In another seventeen subjects without leg oedema, we compared transit time obtained with ICG fluorescence lymphography to that with dynamic lymphoscintigraphy. A significant correlation between transit time measured with ICG lymphography and dynamic lymphoscintigraphy was identified (r(2) = 0.64, p < 0.01).
   Conclusions: ICG fluorescence lymphography has the potential to become an alternative lymphatic imaging technique to assess lymph function. (C) 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Unno, N.; Nishiyama, M.; Suzuki, M.; Yamamoto, N.; Inuzuka, K.; Sagara, D.; Tanaka, H.] Hamamatsu Univ Sch Med, Dept Surg 2, Div Vasc Surg, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan.
RP Unno, N (reprint author), Hamamatsu Univ Sch Med, Dept Surg 2, Div Vasc Surg, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.
EM unno@hama-med.ac.jp
CR BENSON RC, 1978, PHYS MED BIOL, V23, P159, DOI 10.1088/0031-9155/23/1/017
   Burnand KG, 2002, BRIT J SURG, V89, P74, DOI 10.1046/j.0007-1323.2001.01964.x
   CAMBRIA RA, 1993, J VASC SURG, V18, P773
   GLOVICZKI P, 1989, J VASC SURG, V9, P683, DOI 10.1067/mva.1989.vs0090683
   JACKSON FI, 1978, CLIN NUCL MED, V3, P296, DOI 10.1097/00003072-197807000-00009
   KINMONTH JB, 1955, BRIT MED J, V1, P940
   KINMONTH JB, 1952, CLIN SCI, V11, P13
   KLEINHANS E, 1985, EUR J NUCL MED, V10, P349
   Lane KN, 2007, J APPL PHYSIOL, V103, P917, DOI 10.1152/japplphysiol.00077.2007
   MANDELL GA, 1993, SEMIN NUCL MED, V23, P334, DOI 10.1016/S0001-2998(05)80112-6
   NAWAZ MK, 1990, CLIN NUCL MED, V15, P794, DOI 10.1097/00003072-199011000-00004
   NCNEILL GC, 1989, RADIOLOGY, V172, P492
   Ogata F, 2007, ANN PLAS SURG, V59, P180, DOI 10.1097/01.sap.0000253341.70866.54
   OHTAKE E, 1986, CLIN NUCL MED, V11, P474, DOI 10.1097/00003072-198607000-00002
   SAGE HH, 1958, CANCER, V11, P200, DOI 10.1002/1097-0142(195801/02)11:1<200::AID-CNCR2820110131>3.0.CO;2-N
   Sharma R, 2007, AM J PHYSIOL-HEART C, V292, pH3109, DOI 10.1152/ajpheart.01223.2006
   SMITH RO, 1949, J EXP MED, V90, P497, DOI 10.1084/jem.90.5.497
   STEWART G, 1985, BRIT J SURG, V72, P906, DOI 10.1002/bjs.1800721120
   Tiwari A, 2003, ARCH SURG-CHICAGO, V138, P152, DOI 10.1001/archsurg.138.2.152
   Tiwari A, 2006, EUR J VASC ENDOVASC, V31, P311, DOI 10.1016/j.ejvs.2005.09.017
   Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023
   VAQUEIRO M, 1986, J NUCL MED, V27, P1125
   Weiss M, 2003, EUR J NUCL MED MOL I, V30, P202, DOI 10.1007/s00259-002-1020-1
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729
   Williams WH, 2000, CLIN NUCL MED, V25, P451, DOI 10.1097/00003072-200006000-00013
   WITTE CL, 1987, LYMPHOLOGY, V20, P171
NR 26
TC 41
Z9 41
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1078-5884
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD AUG
PY 2008
VL 36
IS 2
BP 230
EP 236
DI 10.1016/j.ejvs.2008.04.013
PG 7
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 338IY
UT WOS:000258502100022
PM 18534875
ER

PT J
AU Coats, L
   Tsang, V
   Khambadkone, S
   van Doorn, C
   Cullen, S
   Deanfield, J
   de Leval, MR
   Bonhoeffer, P
AF Coats, L
   Tsang, V
   Khambadkone, S
   van Doorn, C
   Cullen, S
   Deanfield, J
   de Leval, MR
   Bonhoeffer, P
TI The potential impact of percutaneous pulmonary valve stent implantation
   on right ventricular outflow tract re-intervention
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 18th Annual Meeting of the
   European-Association-for-Cardiothoracic-Surgery/12th Annual Meeting of
   the European-Society-of-Thoracic-Surgeons
CY SEP 12-15, 2004
CL Leipzig, GERMANY
SP European Assoc Cardiothorac Surg, European Soc Thorac Surg
DE congenital heart disease; re-intervention; right ventricular outflow
   tract surgery; percutaneous pulmonary valve
ID REPLACEMENT; TETRALOGY; FALLOT; REPAIR
AB Objective: To assess the impact of a percutaneous technique for pulmonary valve implantation on the conventional surgical valve/conduit approach to right ventricular outflow tract re-intervention. Methods: We have retrospectively reviewed our results following surgical or percutaneous re-intervention to the right ventricular outflow tract in both paediatric and adult groups. Between November 1998 and March 2004, 94 patients underwent surgical re-intervention to the right ventricular outflow tract. Percutaneous pulmonary valve implantation was introduced in October 2002 and 35 procedures were performed to March 2004. The median age was 26 years (6-65 years) in the surgical group and 16 years (9-39 years) in the percutaneous group. Tetralogy of Fallot was the commonest original diagnosis (64.9 and 62.9%, respectively). The predominant indication for re-intervention in the surgical group was pulmonary regurgitation (64.9%) compared to the percutaneous group in which it was homograft/conduit stenosis or a mixed lesion (68.6%). Results: There has been one (1.1%) early death reported in the surgical series and none in the percutaneous group. In the surgical group 9 (9.6%) experienced a procedural complication whilst 3 (8.5%) of those undergoing a percutaneous valve experienced a significant procedural event necessitating urgent surgery. Important early morbidity was 8 (8.5%) in the surgical group and 2 (5.7%) in the percutaneous group. Freedom from re-operation at 1 year was 100% in the surgical group and 86.1% in the percutaneous group due to late restenosis. Median hospital stay in the surgical group was 7 (4-114) days and 2 (2-22) days in the percutaneous group. Conclusions: Preliminary data suggests that percutaneous pulmonary valve implantation provides a promising additional and complementary approach to a successful surgical programme. Both approaches are safe with acceptable levels of morbidity and low mortality. With current technology the aneurysmal outflow tract remains a problem for the percutaneous approach. Follow-up remains too short, at present, to prove longevity of the percutaneous conduit. (c) 2005 Elsevier B.V. All rights reserved.
C1 Great Ormond St Hosp Children, London WC1N 3JH, England.
   Inst Child Hlth, London, England.
   Heart Hosp, London, England.
RP Tsang, V (reprint author), Great Ormond St Hosp Children, Great Ormond St, London WC1N 3JH, England.
EM tsangv@gosh.nhs.uk
CR Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   Boudjemline Y, 2004, J AM COLL CARDIOL, V43, P1082, DOI 10.1016/j.jacc.2003.10.037
   Discigil B, 2001, J THORAC CARDIOV SUR, V121, P344, DOI 10.1067/mtc.2001.111209
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Stark J, 1998, J THORAC CARDIOV SUR, V115, P506, DOI 10.1016/S0022-5223(98)70312-5
   Therrien J, 2001, CIRCULATION, V103, P2489
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Tweddell JS, 2000, CIRCULATION, V102, P130
   VRICELLA L, 2004, CARDIOL YOUNG, V14, P1
NR 9
TC 41
Z9 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD APR
PY 2005
VL 27
IS 4
BP 536
EP 542
DI 10.1016/j.ejcts.2004.12.053
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 915QS
UT WOS:000228319600001
PM 15784347
ER

PT J
AU Callahan-Miller, DA
   Tabak, M
AF Callahan-Miller, DA
   Tabak, M
TI Increasing the coupling efficiency in a heavy ion, inertial confinement
   fusion target
SO NUCLEAR FUSION
LA English
DT Article
ID NATIONAL-IGNITION-FACILITY; DESIGN; PHYSICS; DRIVEN; GAIN
AB A close coupled, distributed radiator heavy ion target is presented. Close coupled refers to a decrease in the distance between the hohlraum wall and the inertial confinement fusion capsule. In two dimensional, integrated, LASNEX calculations, this target produced 436 MJ of yield from 3.27 MJ of ion beam energy for a gain of 133. To achieve these results, the hohlraum dimensions were reduced by 27% from the previous distributed radiator, heavy ion target while driving the same capsule. This reduced the beam energy required from 5.9 to 3.27 MJ. Calculations of single mode Rayleigh-Taylor growth for this capsule show that this capsule is more stable than at least one of the NIF target designs (the PT design which uses a CH ablator doped with oxygen and bromine). This means that issues regarding the Rayleigh-Taylor instability for the heavy ion driven capsule can be settled on NIF. This close coupled target can also be scaled down in size for an Engineering Test Facility; LASNEX calculations predict that a gain of 94 can be achieved from 1.75 MJ of beam energy. In addition, gain curves for distributed radiator targets with the 'conventional' case to capsule ratio and the close coupled case to capsule ratio are presented.
C1 Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Callahan-Miller, DA (reprint author), Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
CR Bodner SE, 1998, PHYS PLASMAS, V5, P1901, DOI 10.1063/1.872861
   Callahan-Miller DA, 1999, NUCL FUSION, V39, P883, DOI 10.1088/0029-5515/39/7/305
   CAMPBELL EM, 1998, COMMUNICATION
   Dittrich TR, 1997, FUSION TECHNOL, V31, P402
   Gardner JH, 1998, PHYS PLASMAS, V5, P1935, DOI 10.1063/1.872863
   HAAN SW, 1995, PHYS PLASMAS, V2, P2480, DOI 10.1063/1.871209
   HO DDM, 1994, NUCL FUSION, V34, P1081, DOI 10.1088/0029-5515/34/8/I03
   Krauser WJ, 1996, PHYS PLASMAS, V3, P2084, DOI 10.1063/1.872006
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   MEIER WR, 1998, 13 AM NUCL SOC TOP M
   MEIER WR, 1994, FUSION ENG, P1001
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   SUTER LJ, 1998, B AM PHYS SOC, V43, P1736
   Tabak M, 1998, NUCL FUSION, V38, P509, DOI 10.1088/0029-5515/38/4/303
   TABAK M, 1998, PHYS PLASMAS, V5, P1896
   Zimmerman G. B., 1975, Comments on Plasma Physics and Controlled Fusion, V2
NR 16
TC 41
Z9 41
PU INT ATOMIC ENERGY AGENCY
PI VIENNA
PA WAGRAMERSTRASSE 5, PO BOX 100, A-1400 VIENNA, AUSTRIA
SN 0029-5515
J9 NUCL FUSION
JI Nucl. Fusion
PD NOV
PY 1999
VL 39
IS 11
BP 1547
EP 1556
DI 10.1088/0029-5515/39/11/306
PG 10
WC Physics, Fluids & Plasmas; Physics, Nuclear
SC Physics
GA 260GF
UT WOS:000083940600006
ER

PT J
AU MASON, JW
   STINSON, EB
   WINKLE, RA
   OYER, PE
   GRIFFIN, JC
   ROSS, DL
AF MASON, JW
   STINSON, EB
   WINKLE, RA
   OYER, PE
   GRIFFIN, JC
   ROSS, DL
TI RELATIVE EFFICACY OF BLIND LEFT-VENTRICULAR ANEURYSM RESECTION FOR THE
   TREATMENT OF RECURRENT VENTRICULAR-TACHYCARDIA
SO AMERICAN JOURNAL OF CARDIOLOGY
LA English
DT Article
RP MASON, JW (reprint author), STANFORD UNIV,MED CTR,CARDIAC ARRHYTHMIA STUDY UNIT,STANFORD,CA 94305, USA.
CR ALEXANDE.S, 1974, JAMA-J AM MED ASSOC, V228, P70, DOI 10.1001/jama.228.1.70
   ARMBRUST CA, 1950, CIRCULATION, V1, P28
   BARRY WH, 1972, AM HEART J, V84, P235, DOI 10.1016/0002-8703(72)90338-9
   BASTA LL, 1973, AM J CARDIOL, V32, P693, DOI 10.1016/S0002-9149(73)80064-5
   BRYSON AL, 1973, AM J CARDIOL, V32, P995
   BUDA AJ, 1979, AM J CARDIOL, V44, P1171, DOI 10.1016/0002-9149(79)90184-X
   COUCH OA, 1959, CIRCULATION, V20, P251
   ECKER RR, 1971, CIRCULATION, V44, P666
   Favaloro R G, 1968, Ann Thorac Surg, V6, P227
   FONTAINE G, 1975, ARCH MAL COEUR VAISS, V68, P113
   GALLAGHER JJ, 1978, CIRCULATION, V57, P190
   GRAHAM AF, 1973, AM J CARDIOL, V32, P909
   GUIRAUDON G, 1980, MED SURGICAL MANAGEM, P177
   GUIRAUDON G, 1978, ANN THORAC SURG, V26, P438
   HERRMANN GR, 1959, AM HEART J, V57, P166, DOI 10.1016/0002-8703(59)90064-X
   HOROWITZ LN, 1980, NEW ENGL J MED, V302, P589, DOI 10.1056/NEJM198003133021101
   HUNT D, 1969, BRIT HEART J, V31, P264
   HUTCHINSON JE, 1981, JAMA, V216, P1645
   KAISER GA, 1975, SURGERY, V78, P749
   KREMER R, 1969, Acta Cardiologica, V24, P523
   MAGIDSON O, 1969, DIS CHEST, V56, P211
   MASON JW, 1981, 1980 S CARD ARRH DEC, P533
   MASON JW, 1981, CIRCULATION, V63, P670
   MASON JW, 1981, AM J CARDIOL, V47, P497, DOI 10.1016/0002-9149(81)91063-8
   MASON JW, CIRCULATION
   MASON JW, 1980, CIRCULATION, V62, P263
   MASON JW, 1980, MED SURGICAL MANAGEM, P155
   NAKHJAVA.FK, 1971, J AMER MED ASSOC, V216, P2138, DOI 10.1001/jama.216.13.2138
   NORDSTROM LA, 1975, AM HEART J, V89, P236, DOI 10.1016/0002-8703(75)90053-8
   RICKS WB, 1977, CIRCULATION, V56, P38
   RITTER ER, 1969, ANN INTERN MED, V71, P1155
   SCHLESIN.Z, 1971, J THORAC CARDIOV SUR, V61, P602
   SPIELMAN SR, 1978, CIRCULATION, V57, P666
   STINSON EB, 1981, 1980 S CARD ARRH DEC, P447
   TABRY IF, 1978, CIRCULATION, V58, P166
   THIND GS, 1971, AM J CARDIOL, V27, P690, DOI 10.1016/0002-9149(71)90238-4
   WARDEKAR A, 1972, CHEST, V62, P505, DOI 10.1378/chest.62.4.505
   WINKLE RA, 1976, ANN INTERN MED, V85, P1
   YASHAR J, 1977, AM J SURG, V133, P453, DOI 10.1016/0002-9610(77)90130-1
NR 39
TC 41
Z9 41
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 245 WEST 17TH STREET, NEW YORK, NY 10011
SN 0002-9149
J9 AM J CARDIOL
JI Am. J. Cardiol.
PY 1982
VL 49
IS 1
BP 241
EP 248
DI 10.1016/0002-9149(82)90297-1
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MW922
UT WOS:A1982MW92200029
PM 6976115
ER

PT J
AU FERRANS, VJ
   ROBERTS, WC
AF FERRANS, VJ
   ROBERTS, WC
TI MYOCARDIAL ULTRASTRUCTURE IN ACUTE AND CHRONIC HYPOXIA
SO CARDIOLOGY
LA English
DT Review
CR ARCOS JC, 1968, EXP MOL PATHOL, V8, P49, DOI 10.1016/0014-4800(68)90005-1
   ARCOS JC, 1964, BIOCHEMISTRY-US, V3, P2041, DOI 10.1021/bi00900a045
   BELZER FO, 1968, ANN SURG, V168, P382, DOI 10.1097/00000658-196809000-00008
   BISCHOFF MB, 1969, FED PROC, V28, P1268
   BLACKSTO.EH, 1968, J THORAC CARDIOV SUR, V56, P689
   BOZNER A, 1969, VIRCHOWS ARCH B, V2, P125
   BOZNER A, 1968, EXP MED SURG, V26, P156
   BROWN AH, 1969, J THORAC CARDIOV SUR, V58, P655
   BRYANT RE, 1958, CIRC RES, V6, P699
   BUCHNER F, 1959, BEITR PATH ANAT, V121, P145
   Büchner F, 1967, Beitr Pathol Anat, V135, P153
   BUJA L M, 1971, Circulation Research Supplement, V43, P44
   BURDETTE WJ, 1963, ANN SURG, V158, P513, DOI 10.1097/00000658-196310000-00001
   CAULFIELD J, 1959, AM J PATHOL, V35, P489
   CHERPACHENKO N M, 1970, Arkhiv Patologii, V32, P23
   DAVID H, 1961, Zentralbl Allg Pathol, V103, P68
   DEGASPERIS C, 1970, J MOL CELL CARDIOL, V1, P169, DOI 10.1016/0022-2828(70)90050-7
   DENKER MW, 1969, JOHNS HOPKINS MED J, V124, P311
   DUSEK J, 1971, AM J PATHOL, V62, P321
   EPLING GP, 1968, AM J VET RES, V29, P97
   FERRANS VJ, 1965, AM HEART J, V69, P159, DOI 10.1016/0002-8703(65)90033-5
   FERRANS VJ, 1971, LAB INVEST, V24, P265
   Ferrans V J, 1970, J Mol Cell Cardiol, V1, P11, DOI 10.1016/0022-2828(70)90025-8
   FERRANS VJ, ADVANCES MYOCARDIOLO
   FERRANS VJ, 1970, CIRCULATION S5, V41, P104
   GOODMAN JR, 1970, PEDIATR RES, V4, P244, DOI 10.1203/00006450-197005000-00003
   Grosgogeat Y, 1966, Arch Mal Coeur Vaiss, V59, P203
   HATT P Y, 1970, Journal of Molecular and Cellular Cardiology, V1, P235, DOI 10.1016/0022-2828(70)90004-0
   HAUSAMEN TU, 1965, VIRCHOWS ARCH A, V339, P212, DOI 10.1007/BF00962886
   HECHT A, 1961, VIRCHOWS ARCH A, V334, P267, DOI 10.1007/BF00957745
   HENSON DE, 1969, ARCH PATHOL, V88, P423
   HERDSON PB, 1969, AM J PATHOL, V57, P539
   HERDSON PB, 1965, AM J PATHOL, V46, P367
   HIBBS RG, 1965, ANAT REC, V153, P173, DOI 10.1002/ar.1091530207
   HIBBS RICHARD G., 1965, BULL TULANE UNIV MED FAC, V24, P225
   HIBBS RG, 1963, ANAT REC, V147, P261, DOI 10.1002/ar.1091470209
   HIBBS RG, 1965, AM HEART J, V69, P766, DOI 10.1016/0002-8703(65)90450-3
   HOLSCHER B, 1961, SURGERY, V49, P492
   HUTTNER I, 1970, AM J PATHOL, V61, P395
   JENNINGS RB, 1969, ANN NY ACAD SCI, V156, P61, DOI 10.1111/j.1749-6632.1969.tb16718.x
   JENNINGS RB, 1965, ARCH PATHOL, V79, P135
   KEEN G, 1970, CARDIOVASC RES, V4, P348, DOI 10.1093/cvr/4.3.348
   KING DW, 1970, AM J PHYSIOL, V218, P1150
   KORB G, 1967, VIRCHOWS ARCH A, V342, P85, DOI 10.1007/BF00956851
   KORB G, 1969, ANN NY ACAD SCI, V156, P48, DOI 10.1111/j.1749-6632.1969.tb16717.x
   Langer G A, 1966, Prog Cardiovasc Dis, V9, P194, DOI 10.1016/S0033-0620(66)80005-1
   LAUGENS RP, 1966, EXPERIENTIA, V22, P244
   LEVITSKY S, 1970, J THORAC CARDIOV SUR, V60, P625
   LEVITSKY S, 1971, Circulation Research Supplement, V43, P124
   LOZADO BB, 1965, REV ARGENT CARDIOL, V32, P5
   Manasek F J, 1970, Am J Cardiol, V25, P149, DOI 10.1016/0002-9149(70)90576-X
   MEERSON FZ, 1964, EXP CELL RES, V36, P568, DOI 10.1016/0014-4827(64)90313-1
   MEESSEN H, 1964, Verh Dtsch Ges Kreislaufforsch, V30, P34
   MILLER DR, 1964, ANN SURG, V159, P208, DOI 10.1097/00000658-196402000-00005
   MILLER DR, 1961, ANN SURG, V154, P751
   Mitia E S, 1969, Arkh Patol, V31, P22
   MIWA A, 1969, JPN CIRCULATION J, V33, P1235
   MOLBERT E, 1957, Beitr Pathol Anat, V118, P421
   MUIR AR, 1967, J ANAT, V101, P239
   NOVI A. M., 1968, BEITR PATHOL ANAT ALLG PATHOL, V137, P19
   ONISHI S, 1969, Beitraege zur Pathologischen Anatomie und zur Allgemeinen Pathologie, V139, P94
   PAULUSSE.F, 1968, KLIN WOCHENSCHR, V46, P165, DOI 10.1007/BF01746228
   PELOSI G, 1968, LAB INVEST, V18, P86
   POCHE R, 1969, VIRCHOWS ARCH A, V346, P239, DOI 10.1007/BF00549203
   POCHE R, 1969, ANN NY ACAD SCI, V156, P34, DOI 10.1111/j.1749-6632.1969.tb16716.x
   Poche R, 1967, Beitr Pathol Anat, V136, P58
   PUCCI I, 1964, EXP CELL RES, V35, P412, DOI 10.1016/0014-4827(64)90107-7
   Reichenbach DD, 1970, HUM PATHOL, V1, P125, DOI 10.1016/S0046-8177(70)80007-7
   REIS RL, 1969, ARCH SURG-CHICAGO, V99, P815
   RONA G, 1967, METHODS ACHIEV EXP P, V3, P200
   SICKINGER K, 1961, Beitr Pathol Anat, V125, P256
   SULKIN NM, 1967, J GERONTOL, V22, P485
   SULKIN NM, 1965, LAB INVEST, V14, P1523
   SUN CN, 1969, EXPERIENTIA, V25, P763, DOI 10.1007/BF01897616
   SUZUKI T, 1967, TOHOKU J EXP MED, V91, P249
   SUZUKI T, 1968, TOHOKU J EXP MED, V95, P271
   SUZUKI T, 1969, TOHOKU J EXP MED, V97, P197
   SWYNGHED.B, 1968, REV FR ETUD CLIN BIO, V13, P666
   TAHERI SA, 1968, ANGIOLOGY, V19, P573, DOI 10.1177/000331976801901001
   TAKAKI F, 1956, ACTA PATH JAP, V6, P397
   VANNOORD.S, 1971, CARDIOVASC RES, V5, P118
   Vitali Mazza L, 1969, J Cardiovasc Surg (Torino), V10, P212
   VOGELL W, 1964, ACTA HISTOCHEM, V19, P234
   WEDELL J, 1965, VIRCHOWS ARCH A, V338, P355, DOI 10.1007/BF00957658
   WILCKEN DEL, 1970, LANCET, V2, P21
   WOLLENBERGER A, 1961, J BIOPHYS BIOCHEM CY, V10, P285, DOI 10.1083/jcb.10.2.285
   ZAPOL WM, 1969, CURR TOP SURG RES, V1, P449
NR 87
TC 41
Z9 40
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0008-6312
J9 CARDIOLOGY
JI Cardiology
PY 1971
VL 56
IS 1
BP 144
EP &
DI 10.1159/000169357
PG 0
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA M7911
UT WOS:A1971M791100020
PM 4949412
ER

PT J
AU Keijsers, L
   Frijns, T
   Branje, SJT
   Meeus, W
AF Keijsers, Loes
   Frijns, Tom
   Branje, Susan J. T.
   Meeus, Wim
TI Developmental Links of Adolescent Disclosure, Parental Solicitation, and
   Control With Delinquency: Moderation by Parental Support
SO DEVELOPMENTAL PSYCHOLOGY
LA English
DT Article
DE adolescent disclosure; parental control; parenting; adolescent
   delinquency; longitudinal
ID LIFE-COURSE-PERSISTENT; PROBLEM BEHAVIOR; ANTISOCIAL-BEHAVIOR; CHILD;
   REINTERPRETATION; PERCEPTIONS; KNOWLEDGE; AUTONOMY; MODEL; PREDICTORS
AB This 4-wave study among 309 Dutch adolescents and their parents examined changes in adolescent disclosure, parental solicitation, and parental control and their links with the development of delinquent activities. Annually, adolescents and both parents reported on adolescent disclosure, parental solicitation, and parental control, and adolescents reported on delinquent activities and parental support. Latent growth curve analyses revealed a linear decline in parental control between ages 13 and 16. Adolescent disclosure decreased gradually in adolescent reports and showed an L-shaped pattern in father reports and a V-shaped pattern in mother reports. A stronger increase in delinquent activities was related to a stronger decrease in disclosure in mother and adolescent reports and to lower levels of disclosure in father reports. The linkages between levels of disclosure and delinquent activities were stronger in families with high parental support than in families with lower support. Furthermore, in lower parental support families, a stronger decrease in paternal control was related to a stronger increase in delinquent activities. In high parental support families, however, a stronger decrease in adolescent-reported parental control was related to a less strong increase in delinquent activities.
C1 [Keijsers, Loes; Frijns, Tom; Branje, Susan J. T.; Meeus, Wim] Univ Utrecht, Res Ctr Adolescent Dev, NL-3508 TC Utrecht, Netherlands.
RP Keijsers, L (reprint author), Univ Utrecht, Res Ctr Adolescent Dev, POB 80140, NL-3508 TC Utrecht, Netherlands.
EM L.Keijsers@uu.nl
RI Branje, Susan/A-7813-2010; Meeus, Wim/H-8099-2013
OI Branje, Susan/0000-0002-9999-5313; 
CR Baerveldt C., 2003, NETHERLANDS J SOCIAL, V39, P107
   BELL RQ, 1968, PSYCHOL REV, V75, P81, DOI 10.1037/h0025583
   Beyers W, 1999, J ADOLESCENCE, V22, P753, DOI 10.1006/jado.1999.0268
   Buhrmester D., 1995, DISCLOSURE PROCESSES, P10, DOI 10.1017/CBO9780511527746.002
   Collins W. A., 2004, HDB ADOLESCENT PSYCH, P331
   Collins W. A., 1990, CHILDHOOD ADOLESCENC, P85
   Crouter A.C., 2002, HDB PARENTING, V3, P461
   Darling N, 2006, J YOUTH ADOLESCENCE, V35, P667, DOI 10.1007/s10964-006-9058-1
   DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487
   De Goede IHA, 2009, J YOUTH ADOLESCENCE, V38, P75, DOI 10.1007/s10964-008-9286-7
   Dubas JS, 2002, J FAM PSYCHOL, V16, P415, DOI 10.1037//0893-3200.16.4.415
   Duncan T. E., 1999, INTRO LATENT VARIABL
   Enders CK, 2001, STRUCT EQU MODELING, V8, P430, DOI 10.1207/S15328007SEM0803_5
   Farrington DP, 1996, CRIMINOLOGY, V34, P493, DOI 10.1111/j.1745-9125.1996.tb01217.x
   Finkenauer C, 2004, J MARRIAGE FAM, V66, P195, DOI 10.1111/j.0022-2445.2004.00014.x
   Finkenauer C, 2002, J YOUTH ADOLESCENCE, V31, P123, DOI 10.1023/A:1014069926507
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   FULIGNI AJ, 1993, DEV PSYCHOL, V29, P622, DOI 10.1037/0012-1649.29.4.622
   FURMAN W, 1985, DEV PSYCHOL, V21, P1016, DOI 10.1037//0012-1649.21.6.1016
   Gottfredson M. R., 1990, GEN THEORY CRIME
   Granic I, 2006, PSYCHOL REV, V113, P101, DOI 10.1037/0033-295X.113.1.101
   Hasebe Y, 2004, CHILD DEV, V75, P815, DOI 10.1111/j.1467-8624.2004.00708.x
   Hawk ST, 2008, J EARLY ADOLESCENCE, V28, P583, DOI 10.1177/0272431608317611
   HAWK ST, J FAMILY PS IN PRESS
   Hirschi T., 1969, CAUSES DELINQUENCY
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huh D, 2006, J ADOLESCENT RES, V21, P185, DOI 10.1177/0743558405285462
   Jolliffe Darrick, 2003, Crim Behav Ment Health, V13, P179, DOI 10.1002/cbm.541
   Keijsers L, 2010, J RES ADOLESCENCE, V20, P88, DOI 10.1111/j.1532-7795.2009.00631.x
   Kerr M, 1999, J ADOLESCENCE, V22, P737, DOI 10.1006/jado.1999.0266
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Kline R. B., 2005, PRINCIPLES PRACTICE
   Larson RW, 1996, DEV PSYCHOL, V32, P744, DOI 10.1037/0012-1649.32.4.744
   Laursen B, 1997, INT J BEHAV DEV, V21, P747
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   LOEBER R, 1983, PSYCHOL BULL, V94, P68, DOI 10.1037/0033-2909.94.1.68
   Lollis S, 1997, J SOC PERS RELAT, V14, P441
   LYTTON H, 1990, DEV PSYCHOL, V26, P683, DOI 10.1037/0012-1649.26.5.683
   Mahoney JL, 2000, J ADOLESCENCE, V23, P113, DOI 10.1006/jado.2000.0302
   Marshall SK, 2005, J ADOLESCENCE, V28, P633, DOI 10.1016/j.adolescence.2005.08.008
   MEEUS W, 2004, CODEBOOK RES P UNPUB, V2
   Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097
   MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674
   Mounts NS, 2002, J FAM PSYCHOL, V16, P58, DOI 10.1037/0893-3200.16.1.58
   Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x
   Muthen B. O., 2006, MPLUS USERS GUIDE
   Noller P., 1995, EXPLAINING FAMILY IN, P77
   NOLLER P, 1990, J YOUTH ADOLESCENCE, V19, P349, DOI 10.1007/BF01537077
   Patterson G R, 1997, Nebr Symp Motiv, V44, P119
   Piquero AR, 2008, LONG VIEW OF CRIME: A SYNTHESIS OF LONGITUDINAL RESEARCH, P23, DOI 10.1007/978-0-387-71165-2_2
   Satorra A., 1994, LATENT VARIABLES ANA, P399
   Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192
   SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360
   Smetana JG, 2009, J ADOLESCENCE, V32, P693, DOI 10.1016/j.adolescence.2008.06.010
   Smetana JG, 2002, CHILD DEV, V73, P563, DOI 10.1111/1467-8624.00424
   Smetana JG, 2004, CHILD DEV, V75, P1418, DOI 10.1111/j.1467-8624.2004.00749.x
   SMETANA JG, 1994, CHILD DEV, V65, P1147, DOI 10.1111/j.1467-8624.1994.tb00809.x
   Smollar J., 1985, ADOLESCENT RELATIONS
   Soenens B, 2006, DEV PSYCHOL, V42, P305, DOI 10.1073/0012-1649.42.2.305
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Kerr M, 2003, CHILDREN'S INFLUENCE ON FAMILY DYNAMICS: THE NEGLECTED SIDE OF FAMILY RELATIONSHIPS, P121
   STEINBERG L, 1986, CHILD DEV, V57, P841, DOI 10.1111/j.1467-8624.1986.tb00250.x
   Steinberg L., 1990, THRESHOLD DEV ADOLES, P255
   STICE E, 1995, DEV PSYCHOL, V31, P322, DOI 10.1037//0012-1649.31.2.322
   Van der Vorst H, 2006, PSYCHOL ADDICT BEHAV, V20, P107, DOI 10.1037/0893-164X.20.2.107
   Waizenhofer RN, 2004, J FAM PSYCHOL, V18, P348, DOI 10.1037/0893-3200.18.2.348
NR 66
TC 40
Z9 40
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0012-1649
J9 DEV PSYCHOL
JI Dev. Psychol.
PD SEP
PY 2009
VL 45
IS 5
BP 1314
EP 1327
DI 10.1037/a0016693
PG 14
WC Psychology, Developmental
SC Psychology
GA 488RG
UT WOS:000269366900010
PM 19702394
ER

PT J
AU Byrne, JG
   Leacche, M
   Vaughan, DE
   Zhao, DX
AF Byrne, John G.
   Leacche, Marzia
   Vaughan, Douglas E.
   Zhao, David X.
TI Hybrid Cardiovascular Procedures
SO JACC-CARDIOVASCULAR INTERVENTIONS
LA English
DT Article
DE hybrid procedures; minimally invasive cardiac surgery; percutaneous
   coronary intervention
AB A hybrid strategy combines the treatments traditionally available only in the catheterization laboratory with those traditionally available only in the operating room to offer patients the best available therapies for any given set of cardiovascular lesions. Examples include hybrid coronary revascularization (coronary artery bypass grafting [CABG]/percutaneous coronary intervention [PCI]) wherein a left internal mammary artery graft is placed on the left anterior descending artery (left anterior descending coronary artery [LAD]) either by minimally invasive or open technique and combined with PCI of non-LAD vessels. Other examples include minimally invasive valve surgery combined with PCI to coronary lesions (valve/PCI), to convert a high-risk valve/CABG into a lower-risk isolated minimally invasive valve procedure. Several questions remain unresolved, such as the order in which surgery and PCI should be performed, the duration of the staging of the 2 procedures, antiplatelet strategies, the costs, and the logistics. Other areas in which hybrid approaches are being developed include hybrid endomyocardial/epicardial atrial fibrillation procedures and hybrid aortic arch debranching combined with endovascular grafting for thoracic aortic procedures. The key requirement in all of these approaches is the need for collaboration between cardiac surgeons, vascular surgeons, and interventional cardiologists to obtain optimal patient outcomes. (J Am Coll Cardiol Intv 2008;1:459-68) (C) 2008 by the American College of Cardiology Foundation
C1 [Byrne, John G.; Leacche, Marzia; Vaughan, Douglas E.; Zhao, David X.] Vanderbilt Heart & Vasc Inst, Nashville, TN USA.
RP Byrne, JG (reprint author), Vanderbilt Univ, Med Ctr, Dept Cardiac Surg, Nashville, TN 37232 USA.
EM john.byrne@vanderbilt.edu
CR Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   Ascione R, 2003, ANN THORAC SURG, V76, P793, DOI 10.1016/S0003-4975(03)00664-7
   Ashby DT, 2002, AM J CARDIOL, V89, P1162, DOI 10.1016/S0002-9149(02)02297-X
   Bakir I, 2006, ANN THORAC SURG, V81, P1599, DOI 10.1016/j.athoracsur.2005.12.011
   Balacumaraswami L, 2007, ANN THORAC SURG, V83, P2251, DOI 10.1016/j.athoracsur.2006.12.025
   Bergeron P, 2006, EUR J VASC ENDOVASC, V32, P38, DOI 10.1016/j.ejvs.2005.12.023
   Bisleri G, 2005, HEART SURG FORUM, V8, pE326, DOI 10.1532/HSF98.20051125
   Black SA, 2006, J VASC SURG, V43, P1089
   Black SA, 2006, J VASC SURG, V43, P1081, DOI 10.1016/j.jvs.2005.12.071
   Böckler Dittmar, 2008, J Vasc Surg, V47, P724, DOI 10.1016/j.jvs.2007.12.009
   Bonatti J, 2007, CARDIOLOGY, V110, P92
   Bravata DM, 2007, ANN INTERN MED, V147, P703
   Brinster DR, 2006, AM J CARDIOL, V98, P1501, DOI 10.1016/j.amjcard.2006.08.010
   Byrne JG, 2005, J AM COLL CARDIOL, V45, P14, DOI 10.1016/j.jacc.2004.09.050
   Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800
   Camenzind E, 2007, CIRCULATION, V115, P1455
   Carpentier A, 2002, ANN THORAC SURG, V74, P663
   Cisowski M, 2002, EUR J CARDIO-THORAC, V22, P261, DOI 10.1016/S1010-7940(02)00262-2
   COLLINS JJ, 1994, J CARDIAC SURG, V9, P145, DOI 10.1111/j.1540-8191.1994.tb00914.x
   Cox JL, 2004, EUROPACE, V5, pS20, DOI 10.1016/j.eupc.2004.07.004
   Dangas G, 2005, J AM COLL CARDIOL, V45, P1186, DOI 10.1016/j.jacc.2004.10.077
   DAVIDAVICIUS G, 2005, CIRCULATION, V112, P1317
   de Canniere D, 2001, AM HEART J, V142, P563, DOI 10.1067/mhj.2001.118466
   DOBELL ARC, 1984, ANN THORAC SURG, V37, P273
   Dogan S, 2003, J HEART VALVE DIS, V12, P76
   Farhat F, 2000, HEART SURG FORUM, V3, P119
   Farhat F, 2000, HEART SURG FORUM, V3, P120
   Folliguet TA, 2005, EUR J CARDIO-THORAC, V28, P172, DOI 10.1016/j.ejcts.2005.03.021
   Friedrich GJ, 2007, HEART SURG FORUM, V10, pE292, DOI 10.1532/HSF98.20070708
   Gersbach P, 2001, EUR J CARDIO-THORAC, V20, P760, DOI 10.1016/S1010-7940(01)00826-0
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   GRONDIN CM, 1984, J THORAC CARDIOV SUR, V87, P379
   Grossi EA, 2002, ANN THORAC SURG, V74, P660, DOI 10.1016/S0003-4975(02)03754-2
   Grossi EA, 2001, J THORAC CARDIOV SUR, V121, P708, DOI 10.1067/mtc.2001.112626
   Hannan EL, 2007, ANN THORAC SURG, V83, P921, DOI 10.1016/j.athoracsur.2006.09.051
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hayward PAR, 2007, ANN THORAC SURG, V84, P795, DOI 10.1016/j.athoracsur.2007.04.028
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   Isomura T, 2000, ANN THORAC SURG, V70, P2017, DOI 10.1016/S0003-4975(00)01839-7
   Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3
   Katz MR, 2006, CIRCULATION S, V114, P1473
   Kiaii B, 2005, CHEST, V128, P4046, DOI 10.1378/chest.128.6.4046
   Kim KB, 2001, ANN THORAC SURG, V72, P1033
   Kim KB, 2008, J THORAC CARDIOV SUR, V135, P300, DOI 10.1016/j.jtcvs.2007.09.044
   King SB, 2008, JACC-CARDIOVASC INTE, V1, P109, DOI 10.1016/j.jcin.2008.01.001
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Lee Michael S, 2004, J Invasive Cardiol, V16, P419
   Lee WA, 2007, J AM COLL SURGEONS, V205, P420, DOI 10.1016/j.jamcolisurg.2007.04.016
   Lewis BS, 1999, AM J CARDIOL, V84, P1246, DOI 10.1016/S0002-9149(99)00538-X
   Lloyd CT, 1999, ANN THORAC SURG, V68, P911
   Lloyd CT, 1999, ANN THORAC SURG, V68, P908, DOI 10.1016/S0003-4975(99)00555-X
   Loulmet D, 1999, J THORAC CARDIOV SUR, V118, P4, DOI 10.1016/S0022-5223(99)70133-9
   LYTLE BW, 1986, ANN THORAC SURG, V42, P632
   Magee MJ, 2008, ANN THORAC SURG, V85, P494, DOI 10.1016/j.athoracsur.2007.10.008
   Magee MJ, 2008, ANN THORAC SURG, V85, P499
   Melissano G, 2007, J ENDOVASC THER, V14, P150, DOI 10.1583/1545-1550(2007)14[150:ROTEGI]2.0.CO;2
   Morice MC, 2007, J AM COLL CARDIOL, V50, P1299, DOI 10.1016/j.jacc.2007.06.029
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Nifong LW, 2005, J THORAC CARDIOV SUR, V129, P1395, DOI 10.1016/j.jtcvs.2004.07.050
   Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282
   Potter DD, 2005, J THORAC CARDIOV SUR, V129, P94, DOI 10.1016/j.jtcvs.2004.08.023
   Presbitero P, 2001, Ital Heart J, V2, P363
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Riess FC, 2002, ANN THORAC SURG, V73, P1849, DOI 10.1016/S0003-4975(02)03519-1
   Saksena S, 2003, J INTERV CARD ELECTR, V9, P235, DOI 10.1023/A:1026296710161
   Saleh HM, 2006, J VASC SURG, V44, P460, DOI 10.1016/j.jvs.2006.04.057
   Sawhney N, 2004, CIRCULATION, V110, P374, DOI 10.1161/01.CIR.0000136580.34604.B8
   Serruys PW, 1996, CIRCULATION, V93, P412
   Sharony R, 2004, J HEART VALVE DIS, V13, P887
   Skanes AC, 2003, J INTERV CARD ELECTR, V9, P289, DOI 10.1023/A:1026209212886
   Soltesz Edward G, 2007, Cardiol Rev, V15, P109, DOI 10.1097/01.crd.0000233769.92470.75
   STAHL KD, 2002, ANN THORAC SURG, V74, P1358, DOI 10.1016/S0003-4975(02)03889-4
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Svensson LG, 2007, J THORAC CARDIOV SUR, V134, P677, DOI 10.1016/j.jtcvs.2007.04.052
   Tabata M, 2008, EUR J CARDIO-THORAC, V33, P537, DOI 10.1016/j.ejcts.2007.12.037
   Tatoulis J, 2004, ANN THORAC SURG, V77, P93, DOI 10.1016/S0003-4975(03)01331-6
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   Umakanthan R, 2008, ANN THORAC SURG, V85, P1549
   Umakanthan R, 2008, ANN THORAC SURG, V85, P1544, DOI 10.1016/j.athoracsur.2008.01.099
   Us MH, 2006, TEX HEART I J, V33, P458
   van Gameren M, 2008, ANN THORAC SURG, V85, P921, DOI 10.1016/j.athoracsur.2007.11.074
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Versaci F, 1997, NEW ENGL J MED, V336, P817, DOI 10.1056/NEJM199703203361201
   Weisz G, 2006, J AM COLL CARDIOL, V47, P1350, DOI 10.1016/j.jacc.2005.11.077
   Wittwer T, 1999, J THORAC CARDIOV SUR, V118, P766
   Zenati M, 1999, J THORAC CARDIOV SUR, V117, P439, DOI 10.1016/S0022-5223(99)70322-3
   Zenati M, 1999, J THORAC CARDIOVASC, V117, P444
   Zhou W, 2006, J VASC SURG, V44, P688, DOI 10.1016/j.jvs.2006.06.013
NR 90
TC 40
Z9 45
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1936-8798
J9 JACC-CARDIOVASC INTE
JI JACC-Cardiovasc. Interv.
PD OCT
PY 2008
VL 1
IS 5
BP 459
EP 468
DI 10.1016/j.jcin.2008.07.002
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V12FY
UT WOS:000207586300001
PM 19463346
ER

PT J
AU Sahin, S
   Ubeyli, M
AF Sahin, S
   Ubeyli, M
TI Modified APEX reactor as a fusion breeder
SO ENERGY CONVERSION AND MANAGEMENT
LA English
DT Article
DE fusion breeder; liquid wall; molten salt; high power density; radiation
   damage
ID SPENT FUEL; HYLIFE-II; BLANKET; REJUVENATION; DESIGN; WASTE
AB An advanced fusion reactor project, called APEX, with improved effectiveness has been developed using a protective flowing liquid wall for tritium breeding and energy transfer. In the modified APEX concept, the flowing molten salt wall is composed of Flibe as the main constituent with increased mole fractions of heavy metal salt (ThF4 or UF4) for both fissile and fusile breeding purposes and to increase the energy multiplication. Neutron transport calculations are conducted with the help of the SCALE4.3 SYSTEM by solving the Boltzmann transport equation with the code XSDRNPM. By preserving a self sufficient tritium breeding ratio (TBR > 1.05) for a mole fraction up to 6% of ThF4 or 12% of UF4, the modified APEX reactor can produce up to similar to2800 kg of U-231/year or similar to4950 kg of Pu-239/year, assuming the same baseline fusion power production of 4000 MWth, as in the original APEX concept. With 6% ThF4 or 12% UF4 in the coolant, the total energy output will increase to 5560 MWth or 8440 MWth, respectively. For a plant operation period of 30 full power years, the atomic displacement and helium production rates remain well below the presumable limits. The additional benefits of fissionable metal salt in the flowing liquid in a fusion reactor can be summarized as breeding of high quality fissile fuel for external reactors and increase of total plant power output. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Gazi Univ, Tekn Egitim Fak, TR-06503 Ankara, Turkey.
RP Sahin, S (reprint author), Gazi Univ, Tekn Egitim Fak, TR-06503 Ankara, Turkey.
EM sumer@gazi.edu.tr
RI SAHIN, Sumer/C-6252-2013
OI SAHIN, Sumer/0000-0003-2844-8061
CR Abdou MA, 1999, FUSION ENG DES, V45, P145, DOI 10.1016/S0920-3796(99)00018-6
   Abdou MA, 2001, FUSION ENG DES, V54, P181, DOI 10.1016/S0920-3796(00)00433-6
   BLINK A, 1985, UCRL53559 LO LIV NAT
   CHRISTOFILOS NC, 1989, J FUSION ENERG, V8, P97, DOI 10.1007/BF01050784
   Duderstadt J. J., 1982, INERTIAL CONFINEMENT
   GREENE N, 1997, ORNLNUREGCSD2V2R5
   GREENE NM, 1997, NUREGCR0200 ORNL
   *INT THERM EXP REA, 1989, ITER DOC SER, V3
   JORDAN WC, 1997, ORNLNUREGCSD2V3R5
   Kayabali K, 1998, ENVIRON GEOL, V34, P95
   LANDERS NF, 1997, ORNLNUREGCSD2V1R5
   LEE JD, 1994, FUSION TECHNOL, V26, P74
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   MOIR RW, 1987, FUSION ENG DES, V5, P269, DOI 10.1016/S0920-3796(87)90024-X
   MOIR RW, 1995, FUSION ENG DES, V29, P34, DOI 10.1016/0920-3796(95)80003-G
   Moir RW, 1997, NUCL FUSION, V37, P557, DOI 10.1088/0029-5515/37/4/I13
   PERLADO JM, 1995, ENERGY INERTIAL FUSI
   Perlado M., 1995, INT ATOMIC ENERGY AG, P272
   Sahin S, 2003, ANN NUCL ENERGY, V30, P669, DOI 10.1016/S0306-4549(02)00109-3
   SAHIN S, 1983, 8 INT SUMM COLL PHYS
   Sahin S, 1998, ANN NUCL ENERGY, V25, P1317, DOI 10.1016/S0306-4549(98)00018-8
   Sahin S, 2002, ARAB J SCI ENG, V27, P173
   Sahin S., 1997, Transactions of the American Nuclear Society, V77
   Sahin S, 1996, FUSION TECHNOL, V30, P1027
   SAHIN S, 1991, PUBLICATION GAZI U F, V169
   SAHIN S, 1994, KERNTECHNIK, V59, P270
   Sahin S, 2003, ANN NUCL ENERGY, V30, P245, DOI 10.1016/S0306-4549(02)00049-X
   SAHIN S, 1991, FUSION TECHNOL, V20, P26
   TOBIN MT, 1991, FUSION TECHNOL, V19, P763
   YAPICI H, 2001, ERCIYES U KAYS TURK
   Yapici H, 2002, ANN NUCL ENERGY, V29, P1871, DOI 10.1016/S0306-4549(02)00016-6
   YING A, 1999, UCLAENG99206 APEX U
NR 32
TC 40
Z9 40
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0196-8904
J9 ENERG CONVERS MANAGE
JI Energy Conv. Manag.
PD JUN
PY 2004
VL 45
IS 9-10
BP 1497
EP 1512
DI 10.1016/j.enconman.2003.09.014
PG 16
WC Thermodynamics; Energy & Fuels; Mechanics; Physics, Nuclear
SC Thermodynamics; Energy & Fuels; Mechanics; Physics
GA 780MM
UT WOS:000189385000014
ER

PT J
AU Kanter, KR
   Fyfe, DA
   Mahle, WT
   Forbess, JM
   Kirshbom, PA
AF Kanter, KR
   Fyfe, DA
   Mahle, WT
   Forbess, JM
   Kirshbom, PA
TI Results with the freestyle porcine aortic root for right ventricular
   outflow tract reconstruction in children
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 39th Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 31-FEB 02, 2003
CL SAN DIEGO, CALIFORNIA
SP Soc Thorac Surg
ID PERICARDIAL VALVED CONDUITS; TERM FOLLOW-UP; PULMONARY-ARTERY; RIGHT
   SIDE; REPLACEMENT; EXPERIENCE; XENOGRAFTS; HOMOGRAFT; HEART;
   BIOPROSTHESIS
AB Background. The ideal choice for valved reconstruction of the right ventricular outflow tract (RVOT) in children is undetermined. This study explores the Freestyle porcine aortic root for these patients.
   Methods. From January 1998 to December 2002, 56 patients ages 1.6 to 29.9 years old (mean 11.8 years old) underwent RVOT reconstruction using a Freestyle porcine aortic root. The patients averaged 1.9 prior operations (range 0 to 5) for tetralogy of Fallot +/- pulmonary atresia (28 patients), critical pulmonary stenosis (10 patients), Ross procedure (5 patients), pulmonary atresia/ intact ventricular septum (4 patients), complete atrioventricular septal defect +/- tetralogy of Fallot (4 patients), and others (5 patients). At time of RVOT reconstruction, 42 patients (75%) had additional procedures including the following: tricuspid or mitral repair (24 patients), pulmonary arterioplasty +/- Glenn (12 patients), ventricular septal defect closure (5 patients), aortic valve replacement (3 patients), placement of a cardioverter/ defibrillator or pacemaker (3 patients), and others (8 patients).
   Results. One patient developed mediastinitis; another was treated for Candida endocarditis (his excised homograft unexpectedly grew Candida). All patients are well on follow-up from 2 to 60 months (mean 30 +/- 20 months) with no deaths. The patient with endocarditis underwent conduit replacement for recurrent pulmonary stenosis 3.5 years postoperatively. Echocardiography revealed mild or no pulmonary insufficiency in 93%. The calculated mean peak systolic RVOT gradient by echocardiography was 19.7 +/- 15.4 mm Hg.
   Conclusions. These data demonstrate excellent results with the Freestyle bioprosthesis for RVOT reconstruction in children. This valve may serve as a readily available alternative to homograft valves in RVOT reconstruction, particularly since early insufficiency seems to be less problematic. Questions of long-term durability and significance of echocardiographic stenosis remain unanswered. (Ann Thorac Surg 2003;76:1889-95) (C) 2003 by The Society of Thoracic Surgeons.
C1 Emory Univ, Sch Med, Div Cardiothorac Surg, Dept Surg, Atlanta, GA 30322 USA.
   Emory Univ, Sch Med, Div Pediat Cardiol, Atlanta, GA 30322 USA.
RP Kanter, KR (reprint author), Emory Univ, Sch Med, Div Cardiothorac Surg, Dept Surg, 1365 Clifton Rd, Atlanta, GA 30322 USA.
CR ALBERT JD, 1993, J THORAC CARDIOV SUR, V106, P228
   Baur LHB, 1999, J AM SOC ECHOCARDIOG, V12, P729, DOI 10.1016/S0894-7317(99)70023-4
   Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3
   Breymann T, 2002, EUR J CARDIO-THORAC, V21, P703, DOI 10.1016/S1010-7940(02)00049-0
   CHARD RB, 2001, ANN THORAC SURG S, V71, P361
   Corno AF, 2002, J HEART VALVE DIS, V11, P242
   CURRIE PJ, 1986, J AM COLL CARDIOL, V7, P800
   Dittrich S, 2000, ANN THORAC SURG, V70, P717, DOI 10.1016/S0003-4975(00)01532-0
   FLEMING WH, 1989, ANN THORAC SURG, V48, P404
   Goldstein S, 2000, ANN THORAC SURG, V70, P1962, DOI 10.1016/S0003-4975(00)01812-9
   GOTT JP, 1992, ANN THORAC SURG, V53, P207
   Homann M, 2000, EUR J CARDIO-THORAC, V17, P624, DOI 10.1016/S1010-7940(00)00414-0
   Kanter KR, 2001, ANN THORAC SURG, V72, P1344, DOI 10.1016/S0003-4975(01)02976-9
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Konertz W, 1996, J HEART VALVE DIS, V5, P418
   Levine AJ, 2001, EUR J CARDIO-THORAC, V19, P122, DOI 10.1016/S1010-7940(00)00628-X
   Marianeschi SM, 2001, ANN THORAC SURG, V71, P619, DOI 10.1016/S0003-4975(00)02456-5
   Melina G, 2002, J HEART VALVE DIS, V11, P54
   MIYAMURA H, 1987, J THORAC CARDIOV SUR, V94, P148
   NUROZLER F, 2002, ASIAN CARDIOVASC THO, V108, P181
   Pearl JM, 2002, ANN THORAC SURG, V74, P542, DOI 10.1016/S0003-4975(02)03644-5
   Riley RD, 2000, ANN THORAC SURG, V70, P48, DOI 10.1016/S0003-4975(00)01559-9
   Robin J, 1998, J THORAC CARDIOV SUR, V115, P898, DOI 10.1016/S0022-5223(98)70372-1
   SANO S, 1991, ANN THORAC SURG, V52, P285
   Schlichter AJ, 1996, ANN THORAC SURG, V62, P155, DOI 10.1016/0003-4975(96)00263-9
   Schlichter AJ, 2000, J THORAC CARDIOV SUR, V119, P869, DOI 10.1016/S0022-5223(00)70081-X
   Schoof PH, 1998, ANN THORAC SURG, V65, P1726, DOI 10.1016/S0003-4975(98)00263-X
   Stark J, 1998, J THORAC CARDIOV SUR, V115, P506, DOI 10.1016/S0022-5223(98)70312-5
   Tweddell JS, 2000, CIRCULATION, V102, P130
   Vrandecic MOP, 1998, ANN THORAC SURG, V66, pS179, DOI 10.1016/S0003-4975(98)00981-3
   WEIPERT J, 1995, ANN THORAC SURG, V60, pS101, DOI 10.1016/0003-4975(95)00260-R
NR 31
TC 40
Z9 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD DEC
PY 2003
VL 76
IS 6
BP 1889
EP 1895
DI 10.1016/S0003-4975(03)01304-3
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 750JA
UT WOS:000186986500024
PM 14667606
ER

PT J
AU Melrose, WD
AF Melrose, WD
TI Lymphatic filariasis: new insights into an old disease
SO INTERNATIONAL JOURNAL FOR PARASITOLOGY
LA English
DT Review
DE lymphatic filariasis; new insights; old disease
ID WUCHERERIA-BANCROFTI INFECTION; POLYMERASE-CHAIN-REACTION;
   PAPUA-NEW-GUINEA; MASS DIETHYLCARBAMAZINE CHEMOTHERAPY; TROPICAL
   PULMONARY EOSINOPHILIA; SINGLE-DOSE DIETHYLCARBAMAZINE; OG4C3
   CIRCULATING ANTIGEN; BRUGIA-MALAYI INFECTION; ANTIBODY-BASED ELISA;
   WOLBACHIA BACTERIA
AB Lymphatic filariasis has afflicted people in the tropical areas of the world for thousands of years but even up to comparatively recent times it has been poorly understood and its importance under recognised. In the last 2 decades or so there has been a flurry of activity in filariasis research, which has provided new insights into the global problem of filariasis, the pathogenesis of filarial disease, diagnosis and control. (C) 2002 Published by Elsevier Science Ltd. on behalf of Australian Society for Parasitology Inc.
C1 James Cook Univ N Queensland, Sch Publ Hlth & Trop Med, Lymphat Filariasis Support Ctr, Townsville, Qld 4811, Australia.
RP Melrose, WD (reprint author), James Cook Univ N Queensland, Sch Publ Hlth & Trop Med, Lymphat Filariasis Support Ctr, Townsville, Qld 4811, Australia.
CR Abbasi I, 1999, PARASITOL RES, V85, P844, DOI 10.1007/s004360050643
   Abbasi I, 1996, T ROY SOC TROP MED H, V90, P531, DOI 10.1016/S0035-9203(96)90308-9
   Addiss DG, 1997, LANCET, V350, P480, DOI 10.1016/S0140-6736(97)02231-9
   ADDISS DG, 1994, LANCET, V343, P597, DOI 10.1016/S0140-6736(94)91547-4
   ADDISS DG, 1993, AM J TROP MED HYG, V48, P178
   Adebajo Adewale O., 1996, Current Opinion in Rheumatology, V8, P85, DOI 10.1097/00002281-199601000-00015
   Albuquerque MF, 1995, REV INST MED TROP SP, V37, P225
   AMARAL F, 1994, AM J TROP MED HYG, V50, P753
   AZOUBEL E, 1996, LYMPHOLOGY S, V29, P12
   Bal M, 1999, ACTA TROP, V72, P259, DOI 10.1016/S0001-706X(98)00099-0
   Bal M, 1996, PARASITE IMMUNOL, V18, P473, DOI 10.1111/j.1365-3024.1996.tb01031.x
   BAL M, 1995, J BIOSCIENCE, V20, P157, DOI 10.1007/BF02703265
   Bandyopadhyay L, 1996, SOC SCI MED, V42, P1401, DOI 10.1016/0277-9536(95)00288-X
   Barsoum RS, 1999, NEPHROL DIAL TRANSPL, V14, P79, DOI 10.1093/ndt/14.suppl_3.79
   Beach MJ, 1999, AM J TROP MED HYG, V60, P479
   BEAN B, 1992, DIAGN MICR INFEC DIS, V15, P345, DOI 10.1016/0732-8893(92)90021-K
   BELL D, 1967, ANN TROP MED PARASIT, V61, P220
   BEURIA MK, 1995, J HELMINTHOL, V69, P181
   Bockarie MJ, 1999, MED VET ENTOMOL, V13, P120, DOI 10.1046/j.1365-2915.1999.00159.x
   Borkow G, 2000, B WORLD HEALTH ORGAN, V78, P1368
   BURKOT T, 1990, T R SOC TROP MED HYG, V84, P733
   CAMPBELL WC, 1991, ANNU REV MICROBIOL, V45, P445
   Cao WC, 1997, TROP MED INT HEALTH, V2, P393
   CHANDRASEKHARAN A, 1984, INDIAN J MED RES, V79, P600
   CHANG PR, 1995, IEEE T IMAGE PROCESS, V4, P81
   CHANTEAU S, 1994, J INFECT DIS, V170, P247
   CHANTEAU S, 1994, T ROY SOC TROP MED H, V88, P665, DOI 10.1016/0035-9203(94)90219-4
   CHARLWOOD JD, 1987, PAPUA NEW GUINEA MED, V30, P199
   Chaturvedi P., 1993, Indian Journal of Pediatrics, V60, P803, DOI 10.1007/BF02751052
   CHENTHAMARAKSHAN V, 1995, PARASITE IMMUNOL, V17, P277, DOI 10.1111/j.1365-3024.1995.tb00893.x
   CHODAKEWITZ J, 1995, PARASITOL TODAY, V11, P233, DOI 10.1016/0169-4758(95)80087-5
   CHULEREK P, 1970, J PARASITOL, V56, P23
   COUTINHO AD, 1994, AM J TROP MED HYG, V50, P339
   CRYZ SJ, 1991, EXPERIENTIA, V47, P146, DOI 10.1007/BF01945415
   Dasgupta A, 1984, Indian J Pathol Microbiol, V27, P273
   DAY KP, 1991, AM J TROP MED HYG, V44, P518
   de Sylva D S, 1990, Acta Paediatr Jpn, V32, P164
   DENHAM DA, 1971, T ROY SOC TROP MED H, V65, P521, DOI 10.1016/0035-9203(71)90163-5
   DESOWITZ R S, 1973, Southeast Asian Journal of Tropical Medicine and Public Health, V4, P329
   Devasia A, 1998, J UROLOGY, V159, P1637, DOI 10.1097/00005392-199805000-00062
   Dhanda V, 1996, INDIAN J MED RES, V103, P46
   Dissanayake S, 2000, T ROY SOC TROP MED H, V94, P526, DOI 10.1016/S0035-9203(00)90075-0
   DISSANAYAKE S, 1995, AM J TROP MED HYG, V53, P289
   DISSANAYAKE S, 1995, T ROY SOC TROP MED H, V89, P517, DOI 10.1016/0035-9203(95)90092-6
   DREYER G, 1992, AM J TROP MED HYG, V46, P745
   Dreyer G, 1999, BRAZ J MED BIOL RES, V32, P1467, DOI 10.1590/S0100-879X1999001200003
   Dreyer G, 1997, ACTA TROP, V63, P57, DOI 10.1016/S0001-706X(96)00604-3
   Dreyer G, 1996, BRAZ J MED BIOL RES, V29, P1005
   Dreyer G, 2000, T ROY SOC TROP MED H, V94, P594, DOI 10.1016/S0035-9203(00)90200-1
   Dreyer G, 1999, T ROY SOC TROP MED H, V93, P413, DOI 10.1016/S0035-9203(99)90140-2
   Dreyer G, 2000, PARASITOL TODAY, V16, P544, DOI 10.1016/S0169-4758(00)01778-6
   Dreyer G, 1996, TROP MED INT HEALTH, V1, P427, DOI 10.1046/j.1365-3156.1996.d01-79.x
   Dreyer G, 1996, T ROY SOC TROP MED H, V90, P288, DOI 10.1016/S0035-9203(96)90253-9
   Dunyo SK, 2000, T ROY SOC TROP MED H, V94, P437, DOI 10.1016/S0035-9203(00)90135-4
   Dzodzomenyo M, 1999, TROP MED INT HEALTH, V4, P13, DOI 10.1046/j.1365-3156.1999.00354.x
   Eberhard ML, 1997, AM J TROP MED HYG, V57, P483
   EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S
   Faris R, 1998, AM J TROP MED HYG, V59, P864
   FigueredoSilva J, 1996, T ROY SOC TROP MED H, V90, P192, DOI 10.1016/S0035-9203(96)90138-8
   FORSYTH K, 1987, PAPUA NEW GUINEA MED, V30, P189
   Freedman DO, 1998, PARASITOL TODAY, V14, P229, DOI 10.1016/S0169-4758(98)01244-7
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927
   FREEDMAN DO, 1995, J INFECT DIS, V171, P997
   Furtado AF, 1997, MEM I OSWALDO CRUZ, V92, P85, DOI 10.1590/S0074-02761997000100016
   GELBAND H, 1994, AM J TROP MED HYG, V50, P655
   Gilbert HM, 1996, AM J TROP MED HYG, V54, P596
   Gourlay WA, 1999, J UROLOGY, V161, P603, DOI 10.1016/S0022-5347(01)61963-3
   Grieve R B, 1995, Pharm Biotechnol, V6, P737
   GROVE DI, 1979, T ROY SOC TROP MED H, V73, P23, DOI 10.1016/0035-9203(79)90123-8
   Gyapong JO, 1998, T ROY SOC TROP MED H, V92, P407, DOI 10.1016/S0035-9203(98)91068-9
   Haarbrink M, 1999, TROP MED INT HEALTH, V4, P93, DOI 10.1046/j.1365-3156.1999.00367.x
   HAARBRINK M, 1995, LANCET, V346, P853, DOI 10.1016/S0140-6736(95)91676-8
   HIGHTOWER AW, 1993, PARASITOL TODAY, V9, P418, DOI 10.1016/0169-4758(93)90051-G
   HOERAUF A, 2000, LANCET, V355, P211
   Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768
   HUNTER JM, 1992, SOC SCI MED, V35, P627, DOI 10.1016/0277-9536(92)90001-7
   Ismail MM, 1996, T ROY SOC TROP MED H, V90, P684, DOI 10.1016/S0035-9203(96)90437-X
   Ismail MM, 1998, T ROY SOC TROP MED H, V92, P94, DOI 10.1016/S0035-9203(98)90972-5
   Ismail M. M., 1991, Tropical Biomedicine, V8, P71
   Itoh M, 1998, T ROY SOC TROP MED H, V92, P513, DOI 10.1016/S0035-9203(98)90896-3
   JINGYUAN L, 1992, J TROP MED HYG, V95, P132
   KAZURA J, 1993, IMMUNOLOGY MOL BIOL, pCH18
   KAZURA J, 1993, AM J TROP MED HYG, V49, P804
   KHAMBOONRUANG C, 1987, ASIAN J TROP MED PUB, V18, P218
   Kimura E, 1996, PARASITOL TODAY, V12, P240, DOI 10.1016/0169-4758(96)10014-4
   KNOTT J., 1935, Transactions of the Royal Society of Tropical Medicine and Hygiene., V29, P59, DOI 10.1016/S0035-9203(35)90018-9
   KRISHNARAO P, 1991, Journal of Communicable Diseases, V23, P128
   KWANLIM GE, 1990, J IMMUNOL, V145, P4298
   LAL RB, 1988, J INFECT DIS, V158, P1034
   Lalitha P, 1998, TROP MED INT HEALTH, V3, P41, DOI 10.1046/j.1365-3156.1998.00170.x
   LAMMIE PJ, 1991, LANCET, V337, P1005, DOI 10.1016/0140-6736(91)92661-K
   Langhammer J, 1997, TROP MED INT HEALTH, V2, P875, DOI 10.1046/j.1365-3156.1997.d01-404.x
   LIU JY, 1992, J TROP MED HYG, V95, P132
   LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314
   LOWMAN E, 1944, US NAVAL MED B, V52, P341
   LOWRIE RC, 1989, AM J TROP MED HYG, V41, P429
   Lucena WA, 1998, T ROY SOC TROP MED H, V92, P290, DOI 10.1016/S0035-9203(98)91016-1
   LUNDE MN, 1988, AM J TROP MED HYG, V38, P366
   LUTSCH C, 1988, CLIN EXP IMMUNOL, V71, P253
   Mackenzie C. D., 1985, Tropical Diseases Bulletin, V82, pR1
   MAHANTY S, 1994, J INFECT DIS, V170, P1339
   MAIZELS RM, 1995, PARASITOL TODAY, V11, P50, DOI 10.1016/0169-4758(95)80116-2
   MAK J W, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P479
   Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340
   Malhotra I, 1999, J IMMUNOL, V162, P6843
   Marchetti F, 1998, T ROY SOC TROP MED H, V92, P650, DOI 10.1016/S0035-9203(98)90797-0
   Mataika JU, 1998, B WORLD HEALTH ORGAN, V76, P575
   MCCARTHY J, 1996, J INFECT DIS, P1510
   McCarthy JS, 1996, J INFECT DIS, V174, P1384
   MCQUAY RM, 1967, AM J TROP MED HYG, V16, P161
   Melrose W, 2000, T ROY SOC TROP MED H, V94, P706, DOI 10.1016/S0035-9203(00)90242-6
   Melrose WD, 2000, T ROY SOC TROP MED H, V94, P176, DOI 10.1016/S0035-9203(00)90266-9
   Meyrowitsch DW, 1998, T ROY SOC TROP MED H, V92, P98, DOI 10.1016/S0035-9203(98)90973-7
   Meyrowitsch DW, 1996, T ROY SOC TROP MED H, V90, P74, DOI 10.1016/S0035-9203(96)90485-X
   Michael E, 1996, PARASITOLOGY, V112, P409
   Michael E, 1996, TROP MED INT HEALTH, V1, P414, DOI 10.1046/j.1365-3156.1996.d01-82.x
   Michael E, 1997, PARASITOL TODAY, V13, P472, DOI 10.1016/S0169-4758(97)01151-4
   MISRA S, 1993, TROP MED PARASITOL, V44, P75
   Mohamed N. H., 1992, Journal of the Egyptian Society of Parasitology, V22, P719
   Mohamed N H, 1983, J Egypt Soc Parasitol, V13, P403
   Molyneaux DH, 2000, T ROY SOC TROP MED H, V94, P589, DOI 10.1016/S0035-9203(00)90198-6
   MORE SJ, 1990, TROP MED PARASITOL, V41, P403
   MORE SJ, 1991, TROP MED PARASITOL, V42, P91
   MOULIAPELAT JP, 1992, TROP MED PARASITOL, V43, P146
   MOULIAPELAT JP, 1995, TROP MED PARASITOL, V46, P9
   MouliaPelat JP, 1996, PARASITE, V3, P45
   NANDURI J, 1989, CLIN MICROBIOL REV, V2, P39
   NARASIMHAM M V V L, 1989, Journal of Communicable Diseases, V21, P157
   Nasr Nabil T., 1996, Journal of the Egyptian Society of Parasitology, V26, P161
   NATHAN MB, 1982, ANN TROP MED PARASIT, V76, P339
   NGU JL, 1985, CLIN NEPHROL, V24, P128
   NGUYEN NL, 1994, T ROY SOC TROP MED H, V88, P461, DOI 10.1016/0035-9203(94)90434-0
   Nicolas L, 1996, T ROY SOC TROP MED H, V90, P136, DOI 10.1016/S0035-9203(96)90113-3
   Nicolas L, 1997, J INFECT DIS, V175, P489
   Noroes J, 1996, T ROY SOC TROP MED H, V90, P55, DOI 10.1016/S0035-9203(96)90478-2
   Noroes J, 1996, J UROLOGY, V156, P409, DOI 10.1016/S0022-5347(01)65862-2
   Olszewski WL, 1999, ACTA TROP, V73, P217, DOI 10.1016/S0001-706X(99)00029-7
   Olszewski WL, 1997, AM J TROP MED HYG, V57, P7
   Ong RKC, 1998, CHEST, V113, P1673, DOI 10.1378/chest.113.6.1673
   ORMEROD AD, 1983, POSTGRAD MED J, V59, P730
   OTTESEN EA, 1993, INFECT DIS CLIN N AM, V7, P619
   OTTESEN E A, 1989, American Journal of Tropical Medicine and Hygiene, V41, P9
   Ottesen EA, 1999, PARASITOL TODAY, V15, P382, DOI 10.1016/S0169-4758(99)01486-6
   OTTESEN EA, 1995, PARASITOL TODAY, V11, P129, DOI 10.1016/0169-4758(95)80128-6
   OTTESEN EA, 1994, CURR OPIN INFECT DIS, V7, P550, DOI 10.1097/00001432-199410000-00006
   OTTESEN EA, 1992, PARASITOLOGY, V104, pS71
   OTTESEN EA, 1985, REV INFECT DIS, V7, P341
   OTTESEN EA, 1990, NEW ENGL J MED, V322, P1113, DOI 10.1056/NEJM199004193221604
   Pani SP, 2000, TROP MED INT HEALTH, V5, P359, DOI 10.1046/j.1365-3156.2000.00559.x
   PANICKER K N, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P402
   PARTONO F, 1984, ACTA TROP, V38, P217
   PARTONO F, 1987, CIBA FDN S, V127
   PARTONO F, 1989, T ROY SOC TROP MED H, V83, P821, DOI 10.1016/0035-9203(89)90343-X
   Phantana Sirichai, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P47
   PHILIPP M, 1988, ANNU REV MICROBIOL, V42, P685
   PIESSENS WF, 1980, SEMIN INFECT DIS, V3, P131
   Plaisier AP, 1999, PARASITOLOGY, V119, P385, DOI 10.1017/S0031182099004783
   PODDAR SK, 1994, ACTA NEUROL SCAND, V89, P225
   PRASAD GBKS, 1988, DIAGN CLIN IMMUNOL, V5, P269
   Rahmah N, 1998, TROP MED INT HEALTH, V3, P184, DOI 10.1046/j.1365-3156.1998.00229.x
   Rahmah N, 2001, T ROY SOC TROP MED H, V95, P601, DOI 10.1016/S0035-9203(01)90091-4
   Rahmah N, 1998, T ROY SOC TROP MED H, V92, P404, DOI 10.1016/S0035-9203(98)91066-5
   RAMACHANDRAN C, 1997, FILARIAL LINKS, V2, P4
   RAO CK, 1981, INDIAN J MED RES, V73, P865
   RATHAUR S, 1987, MOL BIOCHEM PARASIT, V26, P257, DOI 10.1016/0166-6851(87)90078-8
   Ravindran B, 1998, T ROY SOC TROP MED H, V92, P21, DOI 10.1016/S0035-9203(98)90937-3
   ROBERTS LS, 1996, FDN PARASITOLOGY, pCH29
   ROCHA A, 1995, T ROY SOC TROP MED H, V89, P573, DOI 10.1016/0035-9203(95)90112-4
   ROUTH HB, 1993, INT J DERMATOL, V32, P913, DOI 10.1111/j.1365-4362.1993.tb01418.x
   SABRY M, 1992, J TROP MED HYG, V95, P260
   SANTIAGOSTEVENSON D, 1947, JAMA-J AM MED ASSOC, V135, P708
   SCHMIDT LH, 1981, AM J TROP MED HYG, V30, P5
   SCHULTZ G W, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P207
   SCHUURKAMP GJT, 1987, PAPUA NEW GUINEA MED, V30, P39
   SCHUURKAMP GJ, 1990, PAPUA NEW GUINEA MED, V33, P89
   SELKIRK ME, 1992, IMMUNOBIOLOGY, V184, P263
   SHAOQUING Z, 1994, T R SOC TROP MED HYG, V88, P510, DOI 10.1016/0035-9203(94)90140-6
   Sharma S, 1998, TROP MED INT HEALTH, V3, P46, DOI 10.1046/j.1365-3156.1998.00171.x
   Shenoy RK, 1999, ANN TROP MED PARASIT, V93, P367
   Shenoy RK, 1998, ANN TROP MED PARASIT, V92, P285
   SIDKY H A, 1987, Journal of the Egyptian Society of Parasitology, V17, P155
   Simonsen PE, 1999, T ROY SOC TROP MED H, V93, P278, DOI 10.1016/S0035-9203(99)90022-6
   Simonsen PE, 1997, PARASITOL TODAY, V13, P413, DOI 10.1016/S0169-4758(97)01139-3
   Sivam N. Subramania, 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P739
   SOUTHGATE B, 1973, T R SOC TROP MED HYG, V65, P521
   Srivastava SK, 1999, BIOORGAN MED CHEM, V7, P1223, DOI 10.1016/S0968-0896(99)00050-4
   STEEL C, 1994, LANCET, V343, P890, DOI 10.1016/S0140-6736(94)90009-4
   Sundaray N K, 1992, J Assoc Physicians India, V40, P693
   Suresh S, 1997, J ULTRAS MED, V16, P45
   Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429
   Taylor MJ, 1997, PARASITOL TODAY, V13, P85, DOI 10.1016/S0169-4758(97)01001-6
   Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1
   Taylor MJ, 2000, T ROY SOC TROP MED H, V94, P596, DOI 10.1016/S0035-9203(00)90201-3
   Terhell AJ, 1996, T ROY SOC TROP MED H, V90, P196, DOI 10.1016/S0035-9203(96)90140-6
   TESH RB, 1990, AM J TROP MED HYG, V43, P229
   TURNER P, 1993, TROP MED PARASITOL, V44, P45
   TURNER PF, 1997, MED J AUSTRALIA, V166, P233
   Wang SH, 1997, AM J TROP MED HYG, V56, P474
   WARTMAN WB, 1947, MEDICINE, V26, P333
   WEBBER RH, 1991, J TROP MED HYG, V94, P241
   Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7
   Weil GJ, 1996, AM J TROP MED HYG, V55, P333
   WEIL GJ, 1988, AM J TROP MED HYG, V38, P589
   *WHO, 2000, PROGR EL LYMPH FIL E
   *WHO, 1997, M PRINC FURTH ENH PU
   *WHO, 2000, PROGR EL LYMPH FIL T
   *WHO, 1994, CONS M HELD U SAINS
   WIJERS DJB, 1984, ANN TROP MED PARASIT, V78, P383
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   World Health Organization, 1997, LYMPH FIL REAS HOP
   Yan Y, 1997, PARASITOLOGY, V114, P333, DOI 10.1017/S0031182096008566
   Younis Tayseer A., 1997, Journal of the Egyptian Society of Parasitology, V27, P291
   Zang XX, 1999, BLOOD, V94, P1418
   ZHENG HJ, 1991, AM J TROP MED HYG, V45, P168
   ZHENG HJ, 1991, AM J TROP MED HYG, V45, P175
NR 216
TC 40
Z9 42
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7519
J9 INT J PARASITOL
JI Int. J. Parasit.
PD JUL
PY 2002
VL 32
IS 8
BP 947
EP 960
DI 10.1016/S0020-7519(02)00062-0
PG 14
WC Parasitology
SC Parasitology
GA 577XE
UT WOS:000177087500002
PM 12076624
ER

PT J
AU Woods, RK
   Sharp, RJ
   Holcomb, GW
   Snyder, CL
   Lofland, GK
   Ashcraft, KW
   Holder, TM
AF Woods, RK
   Sharp, RJ
   Holcomb, GW
   Snyder, CL
   Lofland, GK
   Ashcraft, KW
   Holder, TM
TI Vascular anomalies and tracheoesophageal compression: A single
   institution's 25-year experience
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID SURGICAL-CORRECTION; RINGS; DIAGNOSIS; CHILDREN; SYMPTOMS
AB Background. Vascular rings are uncommon anomalies in which preferred strategies for diagnosis and treatment may vary among institutions. In this report, we offer a description of our approach and a review of our 25-year experience.
   Methods. A retrospective review was conducted of all pediatric patients with symptomatic tracheoesophageal compression secondary to anomalies of the aortic arch and great vessels diagnosed from 1974 to 2000.
   Results. Thirty-one patients (38%) of eighty-two patients (mean age, 1.7 years), were identified with double aortic arch, 22 patients (27%) with right arch left ligamenturn, and 20 patients (24%) with innominate artery compression. Our diagnostic approach emphasized barium esophagram, along with echocardiography. This regimen was found to be reliable for all cases except those with innominate artery compression for which bronchoscopy was preferred, and except those with pulmonary artery sling for which computed tomography or magnetic resonance imaging, in addition to bronchoscopy, were preferred. Left thoracotomy was the most common operative approach (70 of 82; 85%). Ten patients (12%) had associated heart anomalies, and 6 (7%) patients underwent repair. Complications occurred in 9 (11%) patients and led to death in 3 (4%) patients.
   Conclusions. In our practice, barium swallow and echocardiography are sufficient in diagnosing and planning the operative strategy in the majority of cases, with notable exceptions. Definitive intraoperative delineation of arch anatomy minimizes the risk of misdiagnosis or inadequate treatment. (C) 2001 by The Society of Thoracic Surgeons.
C1 Univ Missouri, Childrens Mercy Hosp, Sch Med, Dept Surg, Kansas City, MO 64108 USA.
   Univ Missouri, Childrens Mercy Hosp, Sch Med, Div Cardiovasc Surg, Kansas City, MO 64108 USA.
RP Holcomb, GW (reprint author), Univ Missouri, Childrens Mercy Hosp, Sch Med, Dept Surg, 2401 Gillham Rd, Kansas City, MO 64108 USA.
CR ANAND R, 1994, PEDIATR CARDIOL, V15, P58
   BACKER CL, 1989, J THORAC CARDIOV SUR, V97, P725
   Bakker DAH, 1999, ACTA PAEDIATR, V88, P947, DOI 10.1080/08035259950168423
   Beekman RP, 1997, EUR J PEDIATR, V156, P516, DOI 10.1007/s004310050651
   BERTOLINI A, 1987, J CARDIOVASC SURG, V28, P301
   BERTRAND JM, 1986, PEDIATR PULM, V2, P378, DOI 10.1002/ppul.1950020611
   BURKE RP, 1995, J AM COLL CARDIOL, V25, P943, DOI 10.1016/0735-1097(94)00461-X
   CHUN K, 1992, ANN THORAC SURG, V53, P597
   GROSS RE, 1946, SURG GYNECOL OBSTET, V83, P435
   Hartyánszky I L, 1989, Eur J Cardiothorac Surg, V3, P250, DOI 10.1016/1010-7940(89)90074-2
   Horváth P, 1990, Rozhl Chir, V69, P504
   JULSRUD PR, 1986, MAYO CLIN PROC, V61, P181
   Kocis KC, 1997, PEDIATR CARDIOL, V18, P127, DOI 10.1007/s002469900130
   LEDWITH MV, 1994, IRAN MED J, V87, P2257
   Leijala M, 1989, Eur J Cardiothorac Surg, V3, P125, DOI 10.1016/1010-7940(89)90089-4
   LILLEHEI CW, 1992, J PEDIATR SURG, V27, P1118, DOI 10.1016/0022-3468(92)90571-N
   MAHONEY EB, 1964, SURGERY, V55, P1
   NEUHAUSER EBD, 1946, AM J ROENTGENOL, V56, P1
   Pickhardt PT, 1997, RADIOLOGY, V203, P423
   SAHN DJ, 1982, AM J CARDIOL, V50, P342, DOI 10.1016/0002-9149(82)90186-2
   SPIRIDONOV AA, 1990, GRUD SERDECHNOSOSUDI, V11, P3
   VANSON JAM, 1994, ANN THORAC SURG, V57, P604
   VANSON JAM, 1993, MAYO CLIN PROC, V68, P1056
NR 23
TC 40
Z9 45
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD AUG
PY 2001
VL 72
IS 2
BP 434
EP 438
DI 10.1016/S0003-4975(01)02806-5
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 462UC
UT WOS:000170437300029
PM 11515879
ER

PT J
AU Urego, M
   Flickinger, JC
   Carr, BI
AF Urego, M
   Flickinger, JC
   Carr, BI
TI Radiotherapy and multimodality management of cholangiocarcinoma
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE cholangiocarcinoma; biliary cancer; radiotherapy; chemotherapy
ID EXTRAHEPATIC BILE-DUCT; EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY;
   BILIARY CARCINOMA; PHASE-I; CANCER; BRACHYTHERAPY; IRRADIATION;
   PALLIATION
AB Purpose: To evaluate the results of radiotherapy in cholangiocarcinoma patients managed with various combinations of chemotherapy and surgical resection with selective liver transplantation.
   Methods and Materials: From January 1990 to December 1995, 61 patients with histologically confirmed biliary duct adenocarcinoma were seen in the Radiation Oncology Department of the University of Pittsburgh, Median follow-up was 22 months (1 to 91 months). The extent of surgery was complete resection in 23 patients (including 17 with orthotopic liver transplant), partial resection in 4, and biopsy in 34, All patients had radiotherapy; median dose was 49.5 Gy. Thirty patients received chemotherapy! 5-fluorouracil (5-FU)-leucovorin with interferon alpha (IFN alpha) in 27, and taxol in 3,
   Results: The median survival was 20 months (95% CI 15-25 months), The 5-year actuarial survival was 23.8 +/- 6.8%. The only significant variable in multivariate analysis was achieving a complete resection with negative margins through conventional surgery or liver transplantation (p = 0.001, hazard rate ratio [HRR] = 0.25, 95% CI 0.12-0.54). Patients with complete resections had a 5-year actuarial survival of 53.5 +/- 10.9%,
   Conclusion: Combined modality therapy that includes complete surgical resection with or without transplantation can be curative in the majority of patients with biliary duct carcinoma. Further study is needed to better define the roles of chemotherapy and radiotherapy in cholangiocarcinoma. (C) 1999 Elsevier Science Inc.
C1 Univ Pittsburgh, Sch Med, Dept Radiat Oncol, Div Transplant Surg, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Sch Med, Dept Surg, Div Transplant Surg, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA.
   Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA.
RP Flickinger, JC (reprint author), Joint Radiat Oncol Ctr, 200 Lothrop St, Pittsburgh, PA 15213 USA.
CR ALDEN ME, 1994, INT J RADIAT ONCOL, V28, P945
   BORIS WK, 1996, SURG ONCOL CLIN N AM, P317
   BUSKIRK SJ, 1992, ANN SURG, V215, P125, DOI 10.1097/00000658-199202000-00006
   CHEN MF, 1989, CANCER, V64, P2226, DOI 10.1002/1097-0142(19891201)64:11<2226::AID-CNCR2820641107>3.0.CO;2-1
   COX DR, 1972, J R STAT SOC B, V34, P187
   DOUGLASS HO, 1987, CANCER, V59, P2006
   FLICKINGER JC, 1991, CANCER, V68, P289, DOI 10.1002/1097-0142(19910715)68:2<289::AID-CNCR2820680213>3.0.CO;2-2
   FRITZ P, 1994, INT J RADIAT ONCOL, V29, P855
   *GASTR TUM STUD GR, 1985, NEW ENGL J MED, V336, P980
   GROVE MK, 1991, AM J SURG, V161, P454, DOI 10.1016/0002-9610(91)91111-U
   Hsue V, 1996, INT J RADIAT ONCOL, V34, P445, DOI 10.1016/0360-3016(95)02032-2
   Kamada T, 1996, INT J RADIAT ONCOL, V34, P767, DOI 10.1016/0360-3016(95)02132-9
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Lotze M.T., 1993, CANC PRINCIPLES PRAC, P883
   LOWENFELS AB, 1978, JAMA-J AM MED ASSOC, V240, P434
   MARCOS A, 1996, SURG ONCOL CLIN N AM, P301
   MOGAVERO GT, 1992, AM J ROENTGENOL, V159, P1001
   Montemaggi P, 1996, RADIOLOGY, V199, P861
   PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1
   PITT HA, 1995, ANN SURG, V221, P788, DOI 10.1097/00000658-199506000-00017
   SCHILINKERT RT, 1992, HPB SURG, V50, P101
   SCHOENTHALER R, 1993, INT J RADIAT ONCOL, V27, P75
   TOLLENAAR RAEM, 1991, ACTA CHIR-EUR J SURG, V157, P587
   TSUJINO K, 1995, RADIOLOGY, V196, P275
   VAUTHEY JN, 1994, SEMIN LIVER DIS, V14, P109, DOI 10.1055/s-2007-1007302
   WHITTINGTON R, 1995, J CLIN ONCOL, V13, P227
   WOLKOV HB, 1992, AM J CLIN ONCOL-CANC, V15, P323, DOI 10.1097/00000421-199208000-00010
   YEHUDA Z, 1996, J CLIN ONCOL, V14, P2311
NR 28
TC 40
Z9 44
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD APR 1
PY 1999
VL 44
IS 1
BP 121
EP 126
DI 10.1016/S0360-3016(98)00509-4
PG 6
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 187JQ
UT WOS:000079783800016
PM 10219804
ER

PT J
AU Freedman, DO
AF Freedman, DO
TI Immune dynamics in the pathogenesis of human lymphatic filariasis
SO PARASITOLOGY TODAY
LA English
DT Review
ID WUCHERERIA-BANCROFTI INFECTION; T-CELL ACTIVATION; BRUGIA-MALAYI;
   IMMUNOLOGICAL-TOLERANCE; PARASITE ANTIGENEMIA; CIRCULATING ANTIGEN;
   RESPONSES; LYMPHEDEMA; PATHOLOGY; MICE
AB Despite the longstanding recognition of the spectral nature of human disease due to lymphatic filariasis, immunologists interested in pathogenesis have mostly examined patients classified as being at either one extreme pole or the other. While the clinically asymptomatic individuals with microfilaremia who sit at one pole always have active infection, it has been difficult to define who else on the clinical spectrum is actively infected with living adult worms. In this review, David Freedman discusses how the ability to measure circulating filarial antigen in patient serum has advanced our ability to understand the immunopathogenesis of lymphatic filariasis by improving the precision of patient classification. Recent work suggests that the presence (or absence) of antigenemia, rather than overt clinical manifestations of disease, is closely associated with specific cytokine responses. A framework for patient classification based on these findings is proposed.
C1 Univ Alabama, Dept Med, Div Geog Med, Birmingham, AL 35294 USA.
RP Freedman, DO (reprint author), Univ Alabama, Dept Med, Div Geog Med, Birmingham, AL 35294 USA.
EM dfreedman@geomed.dom.uab.edu
CR ADDISS DG, 1995, J INFECT DIS, V171, P755
   BUNDY D A P, 1991, Immunology Today, V12, pA71, DOI 10.1016/S0167-5699(05)80021-0
   CHANTEAU S, 1994, TROP MED PARASITOL, V45, P255
   deAlmeida AB, 1996, J INFECT DIS, V173, P1453
   DIMOCK KA, 1994, J INFECT DIS, V170, P403
   Dimock KA, 1996, INFECT IMMUN, V64, P2962
   DISSANAYAKE S, 1995, T ROY SOC TROP MED H, V89, P517, DOI 10.1016/0035-9203(95)90092-6
   FARIS R, 1993, T ROY SOC TROP MED H, V87, P659, DOI 10.1016/0035-9203(93)90277-W
   FREEDMAN DO, 1997, LANCET, V350, P1675
   Freedman DO, 1996, J IMMUNOL, V156, P2901
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927
   FREEDMAN DO, 1995, J INFECT DIS, V171, P997
   Freedman DO, 1995, AM J TROP MED HYG, V53, P633
   GRENFELL BT, 1991, PARASITOL TODAY, V7, P318, DOI 10.1016/0169-4758(91)90270-X
   Gyapong JO, 1996, AM J TROP MED HYG, V54, P591
   JUNGMANN P, 1992, J TROP MED HYG, V95, P114
   Kazura JW, 1997, J INFECT DIS, V176, P242, DOI 10.1086/514030
   KING CL, 1992, J CLIN INVEST, V89, P1403, DOI 10.1172/JCI115729
   KING C L, 1991, Immunology Today, V12, pA54, DOI 10.1016/S0167-5699(05)80016-7
   KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752
   KURNIAWAN A, 1993, J IMMUNOL, V150, P3941
   LAMMIE PJ, 1993, J INFECT DIS, V167, P1178
   Lawrence RA, 1996, PARASITOL TODAY, V12, P267, DOI 10.1016/0169-4758(96)10025-9
   Mahanty S, 1996, EXP PARASITOL, V84, P282, DOI 10.1006/expr.1996.0114
   Mahanty S, 1997, INFECT IMMUN, V65, P1742
   MAIZELS RM, 1991, PARASITOL TODAY, V7, P271, DOI 10.1016/0169-4758(91)90093-4
   MAIZELS RM, 1995, PARASITOL TODAY, V11, P50, DOI 10.1016/0169-4758(95)80116-2
   MCCARTHY JS, 1995, J INFECT DIS, V172, P521
   Michael E, 1996, PARASITOLOGY, V112, P409
   MICHAEL E, 1994, P ROY SOC B-BIOL SCI, V256, P33, DOI 10.1098/rspb.1994.0045
   MORE SJ, 1990, TROP MED PARASITOL, V41, P403
   NELSON FK, 1991, J EXP MED, V173, P659, DOI 10.1084/jem.173.3.659
   Noroes J, 1996, J UROLOGY, V156, P409, DOI 10.1016/S0022-5347(01)65862-2
   OLSZEWSKI WL, 1994, LYMPHOLOGY, V27, P345
   OLSZEWSKI WL, 1993, TROP MED PARASITOL, V44, P40
   Olszewski WL, 1997, AM J TROP MED HYG, V57, P7
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   OTTESEN EA, 1977, IMMUNOLOGY, V33, P413
   OTTESEN EA, 1980, SPRINGER SEMIN IMMUN, V2, P373, DOI 10.1007/BF01857174
   PIESSENS WF, 1980, NEW ENGL J MED, V302, P833, DOI 10.1056/NEJM198004103021503
   Plier DA, 1997, CLIN IMMUNOL IMMUNOP, V82, P216, DOI 10.1006/clin.1996.4317
   RAJAN TV, 1997, CHEM IMMUNOL, V66, P125
   Ravichandran M, 1997, PARASITE IMMUNOL, V19, P69, DOI 10.1046/j.1365-3024.1997.d01-185.x
   Sartono E, 1995, PARASITE IMMUNOL, V17, P587, DOI 10.1111/j.1365-3024.1995.tb01002.x
   Shenoy R. K., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P301
   SNOWDEN KF, 1989, T ROY SOC TROP MED H, V83, P670, DOI 10.1016/0035-9203(89)90394-5
   Srividya A, 1996, EPIDEMIOL INFECT, V117, P195
   TURNER P, 1993, TROP MED PARASITOL, V44, P45
   VICKERY AC, 1991, ACTA TROP, V49, P45, DOI 10.1016/0001-706X(91)90029-J
   VINCENT AL, 1984, J PARASITOL, V70, P48, DOI 10.2307/3281924
   WARTMAN WB, 1947, MEDICINE, V26, P333
   Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7
   WEIL GJ, 1990, EXP PARASITOL, V71, P353, DOI 10.1016/0014-4894(90)90042-B
   WEIL GJ, 1987, J INFECT DIS, V156, P350
   WELLER PF, 1982, AM J TROP MED HYG, V31, P942
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   YAZDANBAKHSH M, 1993, EUR J IMMUNOL, V23, P3312, DOI 10.1002/eji.1830231238
   YAZDANBAKHSH M, 1993, J INFECT DIS, V167, P925
NR 58
TC 40
Z9 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0169-4758
J9 PARASITOL TODAY
JI Parasitol. Today
PD JUN
PY 1998
VL 14
IS 6
BP 229
EP 234
DI 10.1016/S0169-4758(98)01244-7
PG 6
WC Parasitology
SC Parasitology
GA ZQ374
UT WOS:000073854800008
PM 17040766
ER

PT J
AU Gunther, T
   Mazzitelli, D
   Haehnel, CJ
   Holper, K
   Sebening, F
   Meisner, H
AF Gunther, T
   Mazzitelli, D
   Haehnel, CJ
   Holper, K
   Sebening, F
   Meisner, H
TI Long-term results after repair of complete atrioventricular septal
   defects: Analysis of risk factors
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 33rd Annual Meeting of the Society-of-Thoracic-Surgeons
CY FEB 03-05, 1997
CL SAN DIEGO, CALIFORNIA
SP Soc Thorac Surgeons
ID CANAL DEFECTS; INFANCY
AB Background. We analyzed data from 320 patients to evaluate the impact of different preoperative, operative, and postoperative factors on We outcome after repair of complete atrioventricular septal defect.
   Methods. Between October 1974 and December 1995, 320 patients with complete atrioventricular septal defect not associated with major cardiac anomalies were operated on. Two hundred seventy-four patients underwent total repair. Sixty-three patients (23%) were less than 6 months old. One hundred ninety-eight (72.2%) underwent primary repair. Seventy-six patients (27.7%) had a previous palliative operation.
   Results. Operative mortality in patients who underwent primary repair decreased from 17.6% (1974 to 1979) to 5.0% (1990 to 1995) despite an increase in the number of patients younger than 6 months. In patients undergoing a two-stage procedure operative mortality was 3.9% (late mortality, 7.9%), Young age (<6 months) was an incremental risk factor (p = 0.008) for operative mortality in the early study period. Coarctation of the aorta (p = 0.02) and severe dysplastic left atrioventricular valve (p = 0.001) were associated with a higher risk for operative mortality. Freedom from reoperation at 10 years was 82.5% +/- 3.8%.
   Conclusions. In patients with complete atrioventricular septal defect, primary repair is the treatment of choice and can be accomplished with good results. in our experience over a period of more than 20 years, earlier date of operation, young age (<6 months), dysplastic left atrioventricular valve, and coexisting coarctation were incremental risk factors for hospital death. The presence of a previously placed pulmonary artery band did not alter the outcome of repair. The reconstructed atrioventricular valve shows a good and long-lasting performance. (C) 1998 by The Society of Thoracic Surgeons.
C1 German Heart Ctr, Dept Cardiovasc Surg, D-80636 Munich, Germany.
RP Gunther, T (reprint author), German Heart Ctr, Dept Cardiovasc Surg, Lazarettstr 36, D-80636 Munich, Germany.
CR ABBRUZZESE PA, 1983, J THORAC CARDIOV SUR, V85, P388
   AlexiMeskishvili V, 1996, ANN THORAC SURG, V62, P519, DOI 10.1016/0003-4975(96)00319-0
   BENDER HW, 1982, J THORAC CARDIOV SUR, V84, P515
   BERGER TJ, 1978, AM J CARDIOL, V41, P906, DOI 10.1016/0002-9149(78)90732-4
   BRETSCHNEIDER HJ, 1975, J CARDIOVASC SURG, V16, P241
   CARPENTIER A, 1978, PEDIAT CARDIOLOGY, P477
   CHIN AJ, 1982, J THORAC CARDIOV SUR, V84, P437
   CLAPP SK, 1987, AM J CARDIOL, V59, P454, DOI 10.1016/0002-9149(87)90955-6
   MCGRATH LB, 1987, J THORAC CARDIOV SUR, V94, P582
   METRAS D, 1989, ARCH MAL COEUR VAISS, V82, P719
   NEWFELD EA, 1977, AM J CARDIOL, V39, P721, DOI 10.1016/S0002-9149(77)80135-5
   PACIFICO AD, 1988, ANN THORAC SURG, V46, P645
   POZZI M, 1991, J THORAC CARDIOVASC, V101, P38
   RASTELLI GC, 1968, J THORAC CARDIOV SUR, V55, P299
   RASTELLI GC, 1966, MAYO CLIN PROC, V41, P296
   Rowlatt UF, 1963, PEDIATR CLIN N AM, V10, P499
   SANTOS A, 1986, J THORAC CARDIOV SUR, V91, P505
   SILVERMAN N, 1983, CIRCULATION, V68, P148
   STUDER M, 1982, J THORAC CARDIOV SUR, V84, P523
   THIES WR, 1991, EUR J CARDIO-THORAC, V5, P571, DOI 10.1016/1010-7940(91)90221-5
   Tweddell JS, 1996, ANN THORAC SURG, V62, P419, DOI 10.1016/0003-4975(96)00250-0
   VOGEL M, 1989, J CARDIOVASC SURG, V30, P34
   WILLIAMS WH, 1983, J THORAC CARDIOV SUR, V86, P838
   YASUI H, 1990, J CARDIOVASC SURG, V31, P498
NR 24
TC 40
Z9 43
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAR
PY 1998
VL 65
IS 3
BP 754
EP 759
DI 10.1016/S0003-4975(98)00028-9
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA ZC498
UT WOS:000072586100031
PM 9527207
ER

PT J
AU Dent, JM
   Spotnitz, WD
   Nolan, SP
   Jayaweera, AR
   Glasheen, WP
   Kaul, S
AF Dent, JM
   Spotnitz, WD
   Nolan, SP
   Jayaweera, AR
   Glasheen, WP
   Kaul, S
TI Mechanism of mitral leaflet excursion
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article
DE mitral leaflet opening; mitral leaflet closure; left ventricular
   systolic function
ID PAPILLARY-MUSCLE; SEPTAL SEPARATION; VALVE LEAFLETS; INTACT DOGS;
   E-POINT; CLOSURE; REGURGITATION; MOTION; DYSFUNCTION; VOLUME
AB The factors that influence the extent of mitral leaflet opening (MLO) and closure (MLC) have not been defined. We hypothesized that left ventricular (LV) systolic function determines the rate of increase of the early diastolic left atrial (LA)-LV pressure gradient, which is responsible for the extent of MLO, and also the rate of change of the early systolic LV-LA pressure gradient, which determines the degree of MLC. Accordingly, global LV function was changed by altering left main coronary artery flow with LA pressure held relatively constant. LV end-systolic dimension and peak positive LV rate of pressure development (dP/dt) correlated best with the degrees of MLO and MLC, with average correlation coefficients of 0.88 and 0.68, and 0.86 and 0.72, respectively. Although transsecting the submitral apparatus resulted in flailing of the mitral leaflets during normal LV systolic function, the extents of MLO and MLC during LV systolic dysfunction were still influenced by LV systolic function. It is concluded that LV systolic function determines the extent (both opening and closure) of mitral leaflet excursion.
C1 UNIV VIRGINIA, MED CTR, SCH MED, DIV CARDIOVASC, CHARLOTTESVILLE, VA 22908 USA.
   UNIV VIRGINIA, SCH MED, DIV THORAC & CARDIOVASC SURG, CHARLOTTESVILLE, VA 22908 USA.
CR AHMADPOUR H, 1983, AM HEART J, V106, P21, DOI 10.1016/0002-8703(83)90433-7
   BELLHOUS.BJ, 1972, CARDIOVASC RES, V6, P199, DOI 10.1093/cvr/6.2.199
   CHILD JS, 1981, AM HEART J, V101, P797, DOI 10.1016/0002-8703(81)90618-9
   COURTOIS M, 1992, CIRCULATION, V85, P1132
   DAVID D, 1983, CIRCULATION, V67, P640
   DENT JM, 1992, CIRCULATION, V86, P553
   ENGLE SJ, 1983, AM J CARDIOL, V52, P1084, DOI 10.1016/0002-9149(83)90537-4
   GODLEY RW, 1981, CIRCULATION, V63, P565
   KARAS S, 1970, CIRC RES, V26, P689
   KAUL S, 1991, CIRCULATION, V84, P2167
   KAUL S, 1989, AM HEART J, V118, P963, DOI 10.1016/0002-8703(89)90231-7
   KINNEY EL, 1985, AM HEART J, V109, P87, DOI 10.1016/0002-8703(85)90420-X
   LANIADO S, 1975, CIRCULATION, V51, P104
   LENGYEL M, 1981, ACTA CARDIOL, V1, P35
   LEVINE RA, 1987, CIRCULATION, V75, P756
   LITTLE RC, 1979, CIRCULATION, V59, P615
   MARZILLI M, 1980, AM J PHYSIOL, V238, pH348
   MASSIE BM, 1977, AM J CARDIOL, V39, P1008, DOI 10.1016/S0002-9149(77)80215-4
   MITTAL AK, 1971, CIRCULATION, V44, P174
   NIKOLIC SD, 1994, CIRCULATION, V90, P432
   NOLAN SP, 1970, AM HEART J, V79, P668, DOI 10.1016/0002-8703(70)90286-3
   ROSOFF MH, 1985, AM J CARDIOL, V56, P809, DOI 10.1016/0002-9149(85)91150-6
   TSAKIRIS AG, 1971, J APPL PHYSIOL, V30, P611
   TSAKIRIS AG, 1975, J APPL PHYSIOL, V39, P359
   TSAKIRIS AG, 1978, AM J PHYSIOL, V234, pH146
   TSAKIRIS AG, 1970, MAYO CLIN PROC, V45, P275
   YELLIN EL, 1983, ADV CARDIOVASCULAR P, V5, P137
   YELLIN EL, 1981, AM J PHYSIOL, V241, pH389
   YORAN C, 1983, AM J CARDIOL, V52, P1345, DOI 10.1016/0002-9149(83)90599-4
   ZAKY A, 1969, AM J PHYSIOL, V217, P1652
NR 30
TC 40
Z9 40
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0363-6135
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD DEC
PY 1995
VL 269
IS 6
BP H2100
EP H2108
PG 9
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular
   Disease
SC Cardiovascular System & Cardiology; Physiology
GA TM581
UT WOS:A1995TM58100033
ER

PT J
AU MOES, CAF
   FREEDOM, RM
AF MOES, CAF
   FREEDOM, RM
TI RARE TYPES OF AORTIC-ARCH ANOMALIES
SO PEDIATRIC CARDIOLOGY
LA English
DT Review
DE RARE AORTIC ARCH MALFORMATIONS; EMBRYOLOGY; ANGIOCARDIOGRAPHIC FEATURES
ID DIGITAL SUBTRACTION ANGIOGRAPHY; LEFT INNOMINATE-ARTERY; LEFT
   PULMONARY-ARTERY; SUBCLAVIAN ARTERY; VASCULAR RINGS; ABNORMALITIES
AB Rare types of aortic arch malformations include isolation of the right or left subclavian arteries in conjunction with a left or right aortic arch respectively. Isolation of the innominate or carotid arteries and an aberrant left innominate artery may exist in association with a right aortic arch. Other anomalies are persistent fifth aortic arch, subclavian artery as the first branch of the aortic arch, pulmonary artery, and ductus arteriosus sling. The angiocardiographic features and embryology of each of these malformations are discussed.
C1 HOSP SICK CHILDREN,DEPT CARDIOL,TORONTO M5G 1X8,ONTARIO,CANADA.
   UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA.
RP MOES, CAF (reprint author), HOSP SICK CHILDREN,DEPT RADIOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.
CR BARRY A, 1951, ANAT REC, V11, P221
   BAUMMAN JL, 1977, CHEST, V72, P67
   BERDON WE, 1984, RADIOLOGY, V152, P57
   BERDON WE, 1972, SEMIN ROENTGENOL, V7, P39, DOI 10.1016/0037-198X(72)90029-6
   BINET JP, 1978, THORAX, V33, P72, DOI 10.1136/thx.33.1.72
   BOECHAT MI, 1978, AM J ROENTGENOL, V131, P721
   CAPITANI.MA, 1971, AMER J ROENTGENOL RA, V112, P28
   COHEN SR, 1976, ANN OTO RHINOL LARYN, V85, P582
   Congdon ED, 1922, CONTRIB EMBRYOL CARN, V68, P47
   EDWARDS JE, 1953, LAB INVEST, V2, P56
   EDWARDS J E, 1948, Med Clin North Am, V32, P925
   Elliott L P, 1977, Circulation, V56, P1048
   FONG LV, 1987, BRIT HEART J, V57, P552
   FREEDOM RM, 1989, INT J CARDIOL, V24, P241, DOI 10.1016/0167-5273(89)90314-8
   Freedom RM, 1984, ANGIOCARDIOGRAPHY CO, P487
   GARTI IJ, 1982, CARDIOVASC INTER RAD, V5, P235, DOI 10.1007/BF02565402
   GARTI IJ, 1979, PEDIATR RADIOL, V8, P48, DOI 10.1007/BF00973679
   GERLIS LM, 1989, INT J CARDIOL, V23, P239, DOI 10.1016/0167-5273(89)90253-2
   GIKONYO BM, 1989, PEDIATR CARDIOL, V23, P239
   GROLLMAN JH, 1968, RADIOLOGY, V90, P782
   GROSS RE, 1951, PEDIATRICS, V7, P69
   GUMBINER CH, 1980, AM J CARDIOL, V45, P311, DOI 10.1016/0002-9149(80)90651-7
   HERRERA MA, 1987, PEDIATR CARDIOL, V8, P265, DOI 10.1007/BF02427540
   KEITH JD, 1978, HEART DISEASE INFANC, P856
   KLINKHAMER A, 1969, ESOPHAGOGRAPHY ANOMA
   LENOX CC, 1979, J THORAC CARDIOV SUR, V77, P748
   LEVINE S, 1966, AM J SURG, V111, P632, DOI 10.1016/0002-9610(66)90030-4
   LUBBERS W J, 1975, European Journal of Cardiology, V2, P477
   MARANHAO V, 1968, BRIT HEART J, V30, P875
   MARTIN EC, 1979, AM J ROENTGENOL, V132, P833
   MOES CAF, 1991, PEDIATR CARDIOL, V12, P39
   MOODIE DS, 1982, AM HEART J, V104, P628, DOI 10.1016/0002-8703(82)90238-1
   NATH PH, 1981, AM J ROENTGENOL, V137, P683
   PERTLE T, 1982, AJR, V140, P1111
   RODRIGUEZ L, 1975, BRIT HEART J, V37, P931
   SADE RM, 1975, J THORAC CARDIOV SUR, V69, P333
   SAHN DJ, 1982, AM J CARDIOL, V50, P342, DOI 10.1016/0002-9149(82)90186-2
   SHULFORD WH, 1974, AORTIC ARCH ITS MALF
   SHULFORD WH, 1970, AM J ROENTGENOL RADI, V109, P75
   Sprague P L, 1976, Pediatr Radiol, V4, P188, DOI 10.1007/BF00975355
   STEWART JR, 1964, ATLAS VASCULAR RINGS
   TONKIN IL, 1980, RADIOLOGY, V135, P69
   TONKIN ILD, 1984, AM J ROENTGENOL, V142, P1287
   TOZZI R, 1989, PEDIATR RADIOL, V19, P449, DOI 10.1007/BF02387653
   VANPRAAG.R, 1969, AM J CARDIOL, V24, P279, DOI 10.1016/0002-9149(69)90417-2
   VICTORIC.BE, 1970, AMER J ROENTGENOL RA, V108, P582
   VINCENT RN, 1989, AM J CARDIOL, V64, P687, DOI 10.1016/0002-9149(89)90508-0
   WALKINS E, 1961, MED CLIN N AM, V41, P821
   WITTENBO.MH, 1967, RADIOLOGY, V88, P653
   YOO SJ, 1989, ANGIOCARDIOGRAMS CON, P236
NR 50
TC 40
Z9 42
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0172-0643
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD MAR
PY 1993
VL 14
IS 2
BP 93
EP 101
PG 9
WC Cardiac & Cardiovascular Systems; Pediatrics
SC Cardiovascular System & Cardiology; Pediatrics
GA KU243
UT WOS:A1993KU24300006
PM 8469639
ER

PT J
AU Selnes, OA
   Gottesman, RF
   Grega, MA
   Baumgartner, WA
   Zeger, SL
   McKhann, GM
AF Selnes, Ola A.
   Gottesman, Rebecca F.
   Grega, Maura A.
   Baumgartner, William A.
   Zeger, Scott L.
   McKhann, Guy M.
TI CURRENT CONCEPTS Cognitive and Neurologic Outcomes after Coronary-Artery
   Bypass Surgery
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Review
ID HIGH-RISK PATIENTS; OFF-PUMP; CARDIAC-SURGERY; ON-PUMP; CARDIOPULMONARY
   BYPASS; GRAFT-SURGERY; RANDOMIZED-TRIAL; NONCARDIAC SURGERY; STROKE;
   DYSFUNCTION
C1 [Selnes, Ola A.; Gottesman, Rebecca F.; McKhann, Guy M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Cardiac Surg, Baltimore, MD 21205 USA.
   [Grega, Maura A.; Baumgartner, William A.] Johns Hopkins Univ, Sch Med, Dept Surg, Div Cardiac Surg, Baltimore, MD 21205 USA.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [McKhann, Guy M.] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21205 USA.
RP Selnes, OA (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurol, Div Cognit Neurosci, Reed Hall E2,1620 McElderry St, Baltimore, MD 21205 USA.
EM oselnes@jhmi.edu
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Belcher PR, 2002, J HUM HYPERTENS, V16, P691, DOI 10.1038/sj.jhh.1001469
   Bouchard D, 2011, ANN THORAC SURG, V91, P654, DOI 10.1016/j.athoracsur.2010.11.036
   Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159
   Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9
   Bybee K. A., 2005, CIRCULATION S1, V112, pI
   Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475
   Caplan LR, 2009, ARCH NEUROL-CHICAGO, V66, P1062, DOI 10.1001/archneurol.2009.181
   Dijkstra JB, 2002, NEUROPSYCHOL REV, V12, P1, DOI 10.1023/A:1015404122161
   Durand DJ, 2004, ANN THORAC SURG, V78, P159, DOI 10.1016/j.athorascur.2004.02.024
   Eagle Kim A, 2004, J Am Coll Cardiol, V44, pe213
   Eagle KA, 2005, J AM COLL CARDIOL, V45, P1377
   Fontes ML, 2008, ANESTH ANALG, V107, P1122, DOI 10.1213/ane.0b013e31816ba404
   GARDNER TJ, 1985, ANN THORAC SURG, V40, P574
   Gerriets T, 2010, AM J CARDIOL, V105, P1095, DOI 10.1016/j.amjcard.2009.12.009
   GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6
   Goto T, 2001, ANN THORAC SURG, V72, P137, DOI 10.1016/S0003-4975(01)02676-5
   Gottesman RF, 2006, STROKE, V37, P2306, DOI 10.1161/01.STR.0000236024.68020.3a
   Hedberg M, 2011, EUR J CARDIO-THORAC, V40, P379, DOI 10.1016/j.ejcts.2010.11.060
   Hernandez F, 2007, ANN THORAC SURG, V84, P1897, DOI 10.1016/j.athoracsur.2007.07.036
   Ho PM, 2004, ANN THORAC SURG, V77, P597, DOI 10.1016/S0003-4975(03)01358-4
   Hogue CW, 1999, CIRCULATION, V100, P642
   Hueb W, 2010, CIRCULATION, V122, pS48, DOI 10.1161/CIRCULATIONAHA.109.924258
   Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931
   Kapetanakis EI, 2004, ANN THORAC SURG, V78, P1564, DOI 10.1016/j.athoracsur.2004.05.019
   Karkouti K, 2005, ANN THORAC SURG, V80, P1381, DOI 10.1016/j.athoracsur.2005.03.137
   Knopman DS, 2005, NEUROLOGY, V65, P986, DOI 10.1212/01.WNL.0000171954.92119.c7
   Kozora E, 2010, ANN THORAC SURG, V90, P1134, DOI 10.1016/j.athoracsur.2010.05.076
   Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Li YB, 2009, ARCH NEUROL-CHICAGO, V66, P1091, DOI 10.1001/archneurol.2009.114
   Maekawa K, 2008, ANN THORAC SURG, V86, P1563, DOI 10.1016/j.athoracsur.2008.07.021
   Maganti M, 2009, CAN J CARDIOL, V25, pE32
   Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798
   McKhann GM, 2006, STROKE, V37, P562, DOI 10.1161/01.STR.0000199032.78782.6c
   Millar K, 2001, BRIT J ANAESTH, V86, P63, DOI 10.1093/bja/86.1.63
   Moller CH, 2010, CIRCULATION, V121, P498, DOI 10.1161/CIRCULATIONAHA.109.880443
   Monk TG, 2008, ANESTHESIOLOGY, V108, P18
   Moritz S, 2010, EUR J ANAESTH, V27, P542, DOI 10.1097/EJA.0b013e3283343ef8
   Mullges W, 2000, CRIT CARE MED, V28, P1808
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Mutch WAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017457
   Nakamura M, 2008, ANN THORAC SURG, V85, P513, DOI 10.1016/j.athoracsur.2007.08.056
   Nakamura Yoshitsugu, 2004, Ann Thorac Cardiovasc Surg, V10, P81
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Nishiyama K, 2009, ANN THORAC SURG, V87, P1839, DOI 10.1016/j.athoracsur.2009.02.061
   Price CC, 2008, ANESTHESIOLOGY, V108, P8
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Raja SG, 2007, J CARDIAC SURG, V22, P445, DOI 10.1111/j.1540-8191.2007.00447.x
   Rodriguez RA, 2010, STROKE, V41, P2229, DOI 10.1161/STROKEAHA.110.590513
   Selnes OA, 2009, ANN THORAC SURG, V88, P445, DOI 10.1016/j.athoracsur.2009.04.061
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070
   Stroobant N, 2008, EUR J CARDIO-THORAC, V34, P396, DOI 10.1016/j.ejcts.2008.05.001
   Sweet JJ, 2008, ANN THORAC SURG, V85, P1571, DOI 10.1016/j.athoracsur.2008.01.090
   Tarakji KG, 2011, JAMA-J AM MED ASSOC, V305, P381, DOI 10.1001/jama.2011.37
   Westaby S, 2001, ANN THORAC SURG, V71, P667, DOI 10.1016/S0003-4975(00)02405-X
NR 59
TC 39
Z9 41
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JAN 19
PY 2012
VL 366
IS 3
BP 250
EP 257
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 877RZ
UT WOS:000299201400011
PM 22256807
ER

PT J
AU Chu, D
   Bakaeen, FG
   Dao, TK
   LeMaire, SA
   Coselli, JS
   Huh, J
AF Chu, Danny
   Bakaeen, Faisal G.
   Dao, Tam K.
   LeMaire, Scott A.
   Coselli, Joseph S.
   Huh, Joseph
TI On-Pump Versus Off-Pump Coronary Artery Bypass Grafting in a Cohort of
   63,000 Patients
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 45th Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 26-28, 2009
CL San Francisco, CA
SP Soc Thorac Surg
ID CONTEMPORARY CLINICAL STANDARDS; NATIONAL ADMINISTRATIVE DATA; SURGICAL
   MORTALITY-RATES; RISK-ADJUSTED MORTALITY; CARDIOPULMONARY BYPASS;
   PERCUTANEOUS PROCEDURES; REVASCULARIZATION 1999; RESOURCE UTILIZATION;
   REDUCE MORBIDITY; RANDOMIZED-TRIAL
AB Background. The best approach to surgical myocardial revascularization remains controversial. We compared outcomes of conventional on-pump coronary artery bypass grafting (CABG) and off-pump coronary artery bypass (OPCAB) by using a nonvoluntary national database.
   Methods. In the 2004 Nationwide Inpatient Sample database, we identified 63,047 discharge records of patients who underwent CABG (n = 48,658) or OPCAB (n = 14,389). We analyzed seven preoperative variables, including the Deyo comorbidity index and five outcome measures. Multivariable logistic regression was used to identify independent predictors of outcomes.
   Results. CABG and OPCAB patients had similar demographics and comorbidities. They also had similar rates of in-hospital mortality (3.0% vs 3.2%; p = 0.14) and postoperative stroke (1.8% vs 1.7%; p = 0.53). However, OPCAB patients had longer hospital stays (10.2 +/- 9.4 vs 9.9 +/- 8.5 days; p < 0.0001) and higher hospital costs ($ 38,793 +/- $ 30,830 vs $ 37,806 +/- $ 28,705; p = 0.0005) than CABG patients. Multivariable regression analysis showed that OPCAB independently predicted 0.6 more days of hospital stay (95% confidence interval [CI], 0.4 to 0.8 day; R(2) = 0.09; p < 0.0001) and $ 1,497 more in hospital costs (95% CI, $ 779 to $ 2,216; R(2) = 0.09; p < 0.01) per patient.
   Conclusions. OPCAB does not produce lower postoperative mortality or stroke rates than CABG. Furthermore, OPCAB is associated with longer hospital stays and higher hospital costs. (Ann Thorac Surg 2009; 87: 1820-7) (C) 2009 by The Society of Thoracic Surgeons
C1 [Chu, Danny] Baylor Coll Med, Div Cardiothorac Surg, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.
   Univ Houston, St Lukes Episcopal Hosp, Texas Heart Inst, Sect Adult Cardiac Surg, Houston, TX USA.
RP Chu, D (reprint author), Baylor Coll Med, Div Cardiothorac Surg, 1 Baylor Plaza, Houston, TX 77030 USA.
EM dchumd@gmail.com
CR [Anonymous], 2001, HEALTHC COST UT PROJ
   [Anonymous], 1988, INT CLASS DIS 9 REV
   BENETTI FJ, 1995, J CARDIAC SURG, V10, P620, DOI 10.1111/j.1540-8191.1995.tb00651.x
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   Bull DA, 2001, ANN THORAC SURG, V71, P173
   Bull DA, 2001, ANN THORAC SURG, V71, P170, DOI 10.1016/S0003-4975(00)02205-0
   Calafiore AM, 1996, ANN THORAC SURG, V62, P1545, DOI 10.1016/0003-4975(96)00794-1
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cheng W, 2002, J THORAC CARDIOV SUR, V124, P313, DOI 10.1067/mtc.2002.122304
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Arom I, 2001, ANN THORAC SURG, V72, P1288
   Cohen J, 1988, STAT POWER ANAL BEHA
   Dewey TM, 2001, ANN THORAC SURG, V72, P788, DOI 10.1016/S0003-4975(01)02839-9
   DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8
   Edmunds Jr LH, 2003, CARDIAC SURG ADULT, P315
   Ghali WA, 2003, CAN J CARDIOL, V19, P774
   Guler M, 2001, ANN THORAC SURG, V71, P152, DOI 10.1016/S0003-4975(00)02250-5
   Guru V, 2007, CAN J CARDIOL, V23, P281
   Halkos ME, 2008, ANN THORAC SURG, V86, P504, DOI 10.1016/j.athoracsur.2008.04.011
   Jin R, 2005, CIRCULATION S, V112, pI332
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Lazar HL, 1997, AM J CARDIOL, V80, pA90, DOI 10.1016/S0002-9149(97)00462-1
   Lipsey M. W., 1990, DESIGN SENSITIVITY S
   Sundt T, 2004, ANN THORAC SURG, V77, P766
   Mack MJ, 2004, ANN THORAC SURG, V77, P761, DOI 10.1016/j.athoracsur.2003.06.019
   Magee MJ, 2001, ANN THORAC SURG, V72, P776, DOI 10.1016/S0003-4975(01)02840-5
   Cleveland JC, 2001, ANN THORAC SURG, V72, P780
   Marasco SF, 2008, EUR J CARDIO-THORAC, V33, P961, DOI 10.1016/j.ejcts.2008.03.022
   Morrow DA, 2008, BRAUNWALDS HEART DIS, P1353
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 1998, ANN THORAC SURG, V66, P1068, DOI 10.1016/S0003-4975(98)00657-2
   Puskas JD, 2008, ANN THORAC SURG, V86, P1139, DOI 10.1016/j.athoracsur.2008.05.073
   PUSKAS JD, 2001, ANN THORAC SURG, V71, P1483
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Rinne T, 1993, J Cardiothorac Vasc Anesth, V7, P679, DOI 10.1016/1053-0770(93)90052-M
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2
   Staton GA, 2005, CHEST, V127, P892, DOI 10.1378/chest.127.3.892
   Takagi H, 2007, J THORAC CARDIOV SUR, V134, P1059, DOI 10.1016/j.jtcvs.2007.07.006
   Trehan N, 2001, ANN THORAC SURG, V72, pS1026, DOI 10.1016/S0003-4975(01)02936-8
   Welke KF, 2009, ANN THORAC SURG, V87, P216, DOI 10.1016/j.athoracsur.2008.10.032
   Mayer JE, 2009, ANN THORAC SURG, V87, P222
   Wilson CT, 2007, HEALTH AFFAIR, V26, P162, DOI 10.1377/hlthaff.26.1.162
NR 46
TC 39
Z9 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUN
PY 2009
VL 87
IS 6
BP 1820
EP 1827
DI 10.1016/j.athoracsur.2009.03.052
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 448BA
UT WOS:000266234900028
PM 19463602
ER

PT J
AU Bashore, TM
AF Bashore, Thomas M.
TI Adult congenital heart disease - Right ventricular outflow tract lesions
SO CIRCULATION
LA English
DT Review
DE heart diseases; ventricles; heart defects, congenital; heart septal
   defects; pulmonary valve stenosis; tetralogy of Fallot; truncus
   arteriosis
ID PULMONARY VALVE-REPLACEMENT; CHAMBERED RIGHT VENTRICLE; TRUNCUS
   ARTERIOSUS COMMUNIS; TERM FOLLOW-UP; SEPTAL-DEFECT; SURGICAL REPAIR;
   NOONAN-SYNDROME; SUDDEN-DEATH; BALLOON VALVULOPLASTY; CORRECTED
   TETRALOGY
C1 Duke Univ, Med Ctr, Div Cardiovasc Med, Dept Med, Durham, NC 27710 USA.
RP Bashore, TM (reprint author), Duke Univ, Med Ctr, Div Cardiovasc Med, Dept Med, Durham, NC 27710 USA.
EM thomas.bashore@duke.edu
CR ABRAHAMS DG, 1951, BRIT HEART J, V13, P519
   ACIERNO LJ, 1999, CLIN CARDIOL, V22, P176
   Agarwal Saket, 2002, Indian Heart J, V54, P77
   ANDERSON KR, 1978, AM J CARDIOL, V41, P76, DOI 10.1016/0002-9149(78)90135-2
   Anderson Robert H, 2005, Cardiol Young, V15 Suppl 1, P38, DOI 10.1017/S1047951105001010
   ANDERSON RH, 2005, CARDIOL YOUNG S, P38
   ARVIDSSON H, 1961, ACTA RADIOL, V56, P466
   Bacha EA, 2004, ANN THORAC SURG, V77, P734, DOI 10.1016/S0003-4975(03)01053-1
   BERTRANOU EG, 1978, AM J CARDIOL, V42, P458, DOI 10.1016/0002-9149(78)90941-4
   BLOUNT SG, 1959, AM HEART J, V57, P684, DOI 10.1016/0002-8703(59)90178-4
   Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   Bonow R O, 1998, J Heart Valve Dis, V7, P672
   Boudjemline Y, 2001, J PEDIATR, V138, P520, DOI 10.1067/mpd.2001.112174
   CALDER L, 1976, AM HEART J, V92, P23, DOI 10.1016/S0002-8703(76)80400-0
   Canobbio MM, 1996, J AM COLL CARDIOL, V28, P763, DOI 10.1016/0735-1097(96)00234-3
   Carlson KM, 2005, CATHETER CARDIO INTE, V64, P507, DOI 10.1002/ccd.20319
   CHEATHAN JP, 1998, SCI PRACTICE PEDIAT, P1207
   CHEN JTT, 1969, AMER J ROENTGENOL RA, V107, P343
   CHESLER ELLIOT, 1968, AMER J CARDIOL, V21, P661, DOI 10.1016/0002-9149(68)90263-4
   Cheung Michael M H, 2005, Semin Thorac Cardiovasc Surg, V17, P155, DOI 10.1053/j.semtcvs.2005.02.006
   CHOU TC, 1996, ELECTROCARDIOGRAPHY, P296
   Coats L, 2005, EUR J CARDIO-THORAC, V27, P536, DOI 10.1016/j.ejcts.2004.12.053
   COLLETT RW, 1949, SURG CLIN N AM, V29, P1245
   CONNELLY MS, 2003, DIAGNOSIS MANAGEMENT, P265
   CORMODE EJ, 1986, AM J MED GENET, V24, P289, DOI 10.1002/ajmg.1320240209
   Corno AF, 2004, ANN THORAC SURG, V78, P1382, DOI 10.1016/j.athorscsur.2004.02.095
   CULLEN S, 1995, CIRCULATION, V91, P1782
   Daehnert I, 2005, ANN THORAC SURG, V79, P1754, DOI 10.1016/j.athoracsur.2003.11.059
   Dajani AS, 1997, CIRCULATION, V96, P358
   DAS SK, 1964, CIRCULATION, V30, P429
   Davos CH, 2002, CIRCULATION, V106, pI69, DOI 10.1161/01.cir.0000032886.55215.15
   Discigil B, 2001, J THORAC CARDIOV SUR, V121, P344, DOI 10.1067/mtc.2001.111209
   Dittrich S, 2000, ANN THORAC SURG, V70, P717, DOI 10.1016/S0003-4975(00)01532-0
   Dodge-Khatami A, 2001, CARDIOL YOUNG, V11, P484, DOI 10.1017/S1047951101000701
   DORE A, 2003, DIAGNOSIS MANAGEMENT, P299
   Dore A, 2004, PACE, V27, P47, DOI 10.1111/j.1540-8159.2004.00384.x
   Drenthen W, 2006, HEART, V92, P1290, DOI 10.1136/hrt.2005.085407
   DRISCOLL DJ, 1993, CIRCULATION, V87, P114
   Eldadah ZA, 2001, HUM MOL GENET, V10, P163, DOI 10.1093/hmg/10.2.163
   FEIGL A, 1980, ISRAEL J MED SCI, V16, P496
   Forbess JM, 2001, ANN THORAC SURG, V71, P54, DOI 10.1016/S0003-4975(00)01788-4
   Freedom RM, 2004, NATURAL MODIFIED HIS, P56
   FREEDOM RM, 2004, NATURAL MODIFIED HIS, P186
   FREEDOM RM, 2004, NATURAL MODIFIED HIS, P232
   FREEDOM RM, 2004, NATURAL MODIFIED HIS, P370
   FREIJ BJ, 1988, CLIN PERINATOL, V15, P247
   FRYNS J P, 1992, Genetic Counseling, V3, P19
   GATZOULIS MA, 2003, DIAGNOSIS MANAGEMENT, P315
   GATZOULIS MA, 1995, CIRCULATION, V92, P231
   Gerlis LM, 2004, CARDIOL YOUNG, V14, P664, DOI 10.1017/S1047951104006122
   Gersony W M, 1989, Cardiol Clin, V7, P915
   Ghai A, 2002, J AM COLL CARDIOL, V40, P1675, DOI 10.1016/S0735-1097(02)02344-6
   GOITEIN KJ, 1980, AM J CARDIOL, V45, P604, DOI 10.1016/S0002-9149(80)80011-7
   Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9
   Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427
   GUTGESELL HP, 1986, CIRCULATION, V74, P1195
   Hachiro Y, 2001, ANN THORAC SURG, V72, P1520, DOI 10.1016/S0003-4975(01)02982-4
   Hadchouel Michelle, 2002, Indian Journal of Pediatrics, V69, P815, DOI 10.1007/BF02723697
   Hamza N, 2004, INFECTION, V32, P170, DOI 10.1007/s15010-004-3022-3
   HAYES CJ, 1993, CIRCULATION, V87, P28
   HO SY, 1995, COLOR ATLAS CONGENIT, P7
   Huh J, 2001, J KOREAN MED SCI, V16, P25
   Ibrahim T, 2002, CIRCULATION, V105, P2692, DOI 10.1161/01.CIR.0000013206.40857.B6
   Jacobs M L, 2000, Ann Thorac Surg, V69, pS50
   Jarrar M, 1999, AM HEART J, V138, P950, DOI 10.1016/S0002-8703(99)70022-0
   JONES RN, 1968, CIRCULATION, V38, P468
   KAN JS, 1982, NEW ENGL J MED, V307, P510
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Khambadkone S, 2004, CATHETER CARDIO INTE, V62, P401, DOI 10.1002/ccd.20122
   Khambadkone S, 2005, CIRCULATION, V112, P1189, DOI 10.1161/CIRCULATIONAHA.104.523266
   Krasuski RA, 2000, J AM COLL CARDIOL, V36, P2204, DOI 10.1016/S0735-1097(00)00994-3
   LENOX CC, 1992, J THORAC CARDIOV SUR, V104, P1728
   LLOYD TR, 1987, AM HEART J, V114, P268, DOI 10.1016/0002-8703(87)90489-3
   Massin M, 1998, ANN CARDIOL ANGEIOL, V47, P579
   MCCRINDLE BW, 1991, CIRCULATION, V83, P1915
   McElhinney DB, 2000, J AM COLL CARDIOL, V35, P1317, DOI 10.1016/S0735-1097(00)00551-9
   McElhinney DB, 2003, DIAGNOSIS MANAGEMENT, P305
   MCGOON DC, 1968, J AMER MED ASSOC, V205, P69, DOI 10.1001/jama.205.2.69
   MCNAMARA DG, 1985, J AM COLL CARDIOL, V6, P1200
   MCNAMARA DG, 1982, AM J CARDIOL, V50, P560, DOI 10.1016/0002-9149(82)90325-3
   Meijer JM, 2005, HEART, V91, P801, DOI 10.1136/hrt.2004.034108
   MENDEZ HMM, 1985, AM J MED GENET, V21, P493, DOI 10.1002/ajmg.1320210312
   MILO S, 1988, BRIT HEART J, V60, P128
   MIROWITZ SA, 1989, RADIOLOGY, V171, P207
   Mohanakrishnan Laxmanan, 2003, Asian Cardiovasc Thorac Ann, V11, P74
   Momma K, 1997, J AM COLL CARDIOL, V30, P1067, DOI 10.1016/S0735-1097(97)00240-4
   Monro J, 2005, HEART, V91, P139, DOI 10.1136/hrt.2004.039057
   Moran AM, 1998, J AM COLL CARDIOL, V31, P1127, DOI 10.1016/S0735-1097(98)00034-5
   MURDOCH IA, 1991, PEDIATR CARDIOL, V12, P175, DOI 10.1007/BF02238526
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Neffke JGJ, 2002, HEART, V88, P266, DOI 10.1136/heart.88.3.266
   NEWFELD EA, 1977, AM J CARDIOL, V39, P715, DOI 10.1016/S0002-9149(77)80134-3
   Nishimura T, 1987, Ann Nucl Med, V1, P47
   Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5
   Nollert G, 1997, THORAC CARDIOV SURG, V45, P178, DOI 10.1055/s-2007-1013719
   Noonan J, 1999, CARDIOL YOUNG, V9, P545
   NORA JJ, 1976, CIRCULATION, V53, P701
   Norgaard MA, 1999, EUR J CARDIO-THORAC, V16, P125, DOI 10.1016/S1010-7940(99)00137-2
   OCONNOR BK, 1992, J AM COLL CARDIOL, V20, P169
   Ogata T, 1998, AM J MED GENET, V79, P153, DOI 10.1002/(SICI)1096-8628(19980901)79:2<153::AID-AJMG13>3.0.CO;2-I
   O'Laughlin MP, 1998, PEDIATR CARDIOL, V19, P48, DOI 10.1007/s002469900245
   Oliver JM, 2003, J THORAC CARDIOV SUR, V126, P711, DOI 10.1016/S0022-5223(03)00044-8
   Oosterhof T, 2005, RADIOLOGY, V237, P868, DOI 10.1148/radiol.2373041324
   Pan T C, 1992, J Tongji Med Univ, V12, P250
   PARSON AM, 2004, NETTERS CARDIOLOGY, P456
   Perloff JK, 2003, CLIN RECOGNITION CON, P348
   PERLOFF JK, 2003, CLIN RECOGNITION CON, P163
   Peterson C, 2003, ANN THORAC SURG, V76, P1078, DOI 10.1016/S0003-4975(03)00678-7
   PONGIGLIONE G, 1982, AM J CARDIOL, V50, P776, DOI 10.1016/0002-9149(82)91233-4
   POWELL AJ, 1995, CIRCULATION, V92, P3282
   Raff GW, 2000, J AM SOC ECHOCARDIOG, V13, P58, DOI 10.1016/S0894-7317(00)90043-9
   Rajasinghe HA, 1997, J THORAC CARDIOV SUR, V113, P869, DOI 10.1016/S0022-5223(97)70259-9
   Raman SV, 2005, AM J CARDIOL, V95, P683, DOI 10.1016/j.amjcard.2004.11.014
   ROOSHESSELINK J, 1995, CIRCULATION, V91, P2214
   ROSENQUIST GC, 1976, AM J CARDIOL, V37, P410, DOI 10.1016/0002-9149(76)90291-5
   Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798
   Sadr-Ameli MA, 1998, AM J CARDIOL, V82, P398, DOI 10.1016/S0002-9149(98)00302-6
   Samanek M, 1999, PEDIATR CARDIOL, V20, P411
   SHEN WK, 1990, CIRCULATION, V81, P128
   SHIRANI J, 1993, AM J CARDIOL, V72, P368, DOI 10.1016/0002-9149(93)90692-6
   Shuke N, 1998, CLIN NUCL MED, V23, P223, DOI 10.1097/00003072-199804000-00006
   Silversides CK, 2003, J AM SOC ECHOCARDIOG, V16, P1057, DOI 10.1016/S0894-7317(03)00553-4
   STEVENSON WG, 1991, CONGENITAL HEART DIS, P259
   TAUSSIG HB, 1949, AM HEART J, V37, P459
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Tramboo NA, 2002, J PAEDIATR CHILD H, V38, P521, DOI 10.1046/j.1440-1754.2002.00027.x
   VANPRAAG.R, 1965, AM J CARDIOL, V16, P406, DOI 10.1016/0002-9149(65)90732-0
   Van Praagh R, 1987, Eur J Cardiothorac Surg, V1, P65, DOI 10.1016/1010-7940(87)90014-5
   VANARSDELL GS, 2003, DIAGNOSIS MANAGEMENT, P389
   van der Wall EE, 2005, EUR HEART J, V26, P2614, DOI 10.1093/eurheartj/ehi613
   van Straten A, 2005, J AM COLL CARDIOL, V46, P1559, DOI 10.1016/j.jacc.2005.07.030
   van Straten A, 2005, EUR RADIOL, V15, P702, DOI 10.1007/s00330-004-2574-z
   Veldtman GR, 2004, J AM COLL CARDIOL, V44, P174, DOI 10.1016/j.jacc.2003.11.067
   VOGEL M, 1988, AM J CARDIOL, V61, P857, DOI 10.1016/0002-9149(88)91079-X
   Volpe P, 2003, HEART, V89, P1437, DOI 10.1136/heart.89.12.1437
   WARNES CA, 1984, AM J CARDIOL, V54, P1383, DOI 10.1016/S0002-9149(84)80111-3
   Warnes CA, 2002, CIRCULATION, V106, P1310, DOI 10.1161/01.CIR.0000032580.69198.A5
   WONG PC, 1991, AM J CARDIOL, V68, P1681, DOI 10.1016/0002-9149(91)90329-J
NR 139
TC 39
Z9 40
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD APR 10
PY 2007
VL 115
IS 14
BP 1933
EP 1947
DI 10.1161/CIRCULATIONAHA.105.592345
PG 15
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 155JY
UT WOS:000245574900014
PM 17420363
ER

PT J
AU Enriquez-Sarano, M
   Schaff, HV
   Frye, RL
AF Enriquez-Sarano, M
   Schaff, HV
   Frye, RL
TI Mitral regurgitation - What causes the leakage is fundamental to the
   outcome of valve repair
SO CIRCULATION
LA English
DT Editorial Material
ID REPLACEMENT; SURGERY; RECONSTRUCTION; PRESERVATION; HEART
C1 Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA.
   Mayo Clin & Mayo Fdn, Div Cardiovasc Surg, Rochester, MN 55905 USA.
RP Enriquez-Sarano, M (reprint author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.
CR Bolling SF, 2002, J HEART VALVE DIS, V11, pS26
   Braunberger E, 2001, CIRCULATION S1, V104
   CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323
   COHN LH, 1995, ANN THORAC SURG, V60, P1452, DOI 10.1016/0003-4975(95)00379-Y
   CRAVER JM, 1990, ANN THORAC SURG, V49, P964
   ENRIQUEZSARANO M, 1995, CIRCULATION, V92, P2496
   Enriquez-Sarano M, 1995, CIRCULATION, V91, P1264
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   GOLDMAN ME, 1987, J AM COLL CARDIOL, V10, P568
   Hung J, 2002, CIRCULATION, V106, P2594, DOI 10.1161/01.CIR.0000038363.83133.6D
   Lee EM, 1997, EUR HEART J, V18, P655
   Le Tourneau T, 2000, J AM COLL CARDIOL, V36, P2263, DOI 10.1016/S0735-1097(00)01015-9
   MOHTY D, 2001, CIRCULATION S2, V104, P17
   PERIER P, 1984, CIRCULATION, V70, P187
   Reul RM, 1997, PROG CARDIOVASC DIS, V39, P567, DOI 10.1016/S0033-0620(97)80015-1
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Yiu SF, 2000, CIRCULATION, V102, P1400
   Yun KL, 1999, CIRCULATION, V100, P90
NR 18
TC 39
Z9 41
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD JUL 22
PY 2003
VL 108
IS 3
BP 253
EP 256
DI 10.1161/01.CIR.0000083831.17708.25
PG 4
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 703MB
UT WOS:000184282200005
PM 12876134
ER

PT J
AU Al Jubair, KA
   Al Fagih, MR
   Al Jarallah, AS
   Al Yousef, S
   Ali Khan, MA
   Ashmeg, A
   Al Faraidi, Y
   Sawyer, W
AF Al Jubair, KA
   Al Fagih, MR
   Al Jarallah, AS
   Al Yousef, S
   Ali Khan, MA
   Ashmeg, A
   Al Faraidi, Y
   Sawyer, W
TI Results of 546 Blalock-Taussig shunts performed in 478 patients
SO CARDIOLOGY IN THE YOUNG
LA English
DT Article
DE Results of Blalock-Taussig shunt
ID INFANTS; AGE
AB Between 1983 and 1995, 546 Blalock-Taussig shunt procedures were performed in 472 patients: 128 (23.0%) were classical shunts, 90 of them on the same side as to the aortic arch, and 418 (77.0%) were modified shunts, 182 on the same side of the arch. At the time of surgery, 78 patients were aged below one week, 270 from one week to 12 months, and 198 patients were over one year of age. The mean pre-operative arterial saturation (71.7%+/-16.54%) was significantly increased to 83%+/-17.9% immediately after the procedure (p=0.017). The overall hospital mortality rate was 2.9% (16/546), with rates of 2.3% (3/128) for the classical, and 3.1% (13/418) for the modified shunts (p = not significant). The rate was significantly higher, however, for classical shunts when the pulmonary arterial diameter was less than 4 mm (15.4% versus zero; p=0.047), though this relationship was reversed for modified shunts (zero versus 3.6%; p=0.338). Early mortality was significantly influenced by the age at surgery, 5/78 (6.4%) in patients aged below 1 week, 3.7% between 1 week and 1 year, and 0.5% over 1 year (p=0.019). Early mortality was also significantly increased in patients weighing 3kg or less, 8/156 (5.1%), versus 3/303 (1.0%), p=0.037. Overall, 51 shunts failed (9.3%), 10 early and 41 late, Early failure was significantly increased in patients weighing 3kg or less, 8/156 (5.1%) versus 3/303 (1.0%), p=0.016. The overall early failure rate was 1.4% (3/215) when heparin was administered intra-operatively and for 48 hours postoperatively, in contrast to an early failure rate of 3.4% (7/203) when heparin was not used (p=0.294). Overall rates of failure during follow-up were 3.1% (17/188) in heparinized patients versus 13.6% (24/177), (p=0.173) in non-heparinized patients. Failure of classical shunts was 10.2% (13/128), compared with 6.7% (28/418) for modified shunts (p=0.195). Failure was more common overall if the pulmonary arterial diameter was less than 4 nun, 14.7% (9/61), as opposed to 8.7% (26/300) when the diameter was 4 mm or greater, (p=0.144). Administration of aspirin during follow-up after the modified shunt procedure reduced failure from 11% (18/163) to 6.7% (10/150), p=0.176. Classical or modified Blalock-Taussig shunts, either on the same side or opposite to the aortic arch, can be performed on patients of any age with minimum postoperative complications and low operative mortality. The use of intra- and post-operative heparin appears to reduce the overall rate of failure, and the administration of aspirin during follow-up appears to reduce failure of modified Blalock-Taussig shunts.
C1 Prince Sultan Cardiac Ctr, Riyadh 11159, Saudi Arabia.
RP Al Jubair, KA (reprint author), Prince Sultan Cardiac Ctr, POB 7897, Riyadh 11159, Saudi Arabia.
CR ARCINIEGAS E, 1979, ANN THORAC SURG, V27, P514
   AZIZ KU, 1975, PEDIATR CARDIOL, V36, P479
   BLALOCK A, 1945, JAMA-J AM MED ASSOC, V128, P189
   EDMUNDS LH, 1980, CIRCULATION, V62, P597
   GUYTON RA, 1983, J THORAC CARDIOV SUR, V85, P917
   LAKS H, 1973, ANN THORAC SURG, V19, P319
   NECHES WH, 1975, J THORAC CARDIOVASC, V70, P91
   ULLOM RL, 1987, ANN THORAC SURG, V44, P539
   WOOLF PK, 1984, ANN THORAC SURG, V38, P26
NR 9
TC 39
Z9 39
PU GREENWICH MEDICAL MEDIA LTD
PI LONDON
PA 219 LINEN HALL, 162-168 REGENT ST, LONDON W1R 5TB, ENGLAND
SN 1047-9511
J9 CARDIOL YOUNG
JI Cardiol. Young
PD OCT
PY 1998
VL 8
IS 4
BP 486
EP 490
PG 5
WC Cardiac & Cardiovascular Systems; Pediatrics
SC Cardiovascular System & Cardiology; Pediatrics
GA 143KJ
UT WOS:000077254300014
PM 9855103
ER

PT J
AU ANDERSON, TM
   MILLER, JI
AF ANDERSON, TM
   MILLER, JI
TI USE OF PLEURA, AZYGOS VEIN, PERICARDIUM, AND MUSCLE FLAPS IN
   TRACHEOBRONCHIAL SURGERY
SO ANNALS OF THORACIC SURGERY
LA English
DT Review
ID RECURRENT TRACHEOESOPHAGEAL FISTULA; REPLACEMENT; MANAGEMENT; RESECTION;
   PATCH; LUNG
AB Desmoplastic reactions secondary to adjuvant chemotherapy and radiation in stage IIIA lung cancer, plus advances in complex tracheobronchial surgery, have rejuvenated an interest for augmenting bronchial stump coverage and suture line reinforcement. We present the techniques and applications of harvesting pleural, azygos vein, pericardial naps, and fat pad grafts, and intrathoracic transposition of chest wall muscle naps.
C1 EMORY UNIV,SCH MED,EMORY CLIN,DEPT CARDIOTHORAC SURG,ATLANTA,GA 30308.
CR BOTHAM MJ, 1986, J PEDIATR SURG, V21, P164, DOI 10.1016/S0022-3468(86)80074-4
   BREWER LA, 1953, J THORAC SURG, V26, P507
   BRYANT LR, 1964, J THORAC CARDIOV SUR, V48, P733
   CORAN AG, 1973, AM J SURG, V125, P294, DOI 10.1016/0002-9610(73)90044-5
   GRAY H, 1973, ANATOMY HUMAN BODY, V542, P1137
   GUYTON RA, 1984, J THORAC CARDIOV SUR, V87, P619
   HASSE J, 1990, EUR J CARDIO-THORAC, V4, P412, DOI 10.1016/1010-7940(90)90069-C
   Haverich A, 1989, J Card Surg, V4, P136, DOI 10.1111/j.1540-8191.1989.tb00269.x
   HOOD RM, 1989, THORACIC TRAUMA, P307
   ICENOGLE TB, 1986, ANN THORAC SURG, V42, P216
   IDRISS FS, 1984, J THORAC CARDIOV SUR, V88, P527
   ISHIHARA T, 1977, J THORAC CARDIOV SUR, V73, P936
   JUSTICZ AG, 1991, AM SURGEON, V57, P4
   MANSOUR KA, 1994, ANN THORAC SURG, V57, P1120
   MILLER JI, 1992, CURRENT TOPICS GENER, V2, P355
   MOGHISSI K, 1975, J THORAC CARDIOV SUR, V69, P499
   PEARSON FG, 1974, ANN THORAC SURG, V18, P16
   REINHOFF WF, 1942, ANN SURG, V116, P481
   RUSCH VW, 1993, J THORAC CARDIOV SUR, V105, P97
   SANO T, 1989, JPN J CLIN ONCOL, V19, P402
   STROMBERG BV, 1989, LARYNGOSCOPE, V99, P339
   SWEET RH, 1945, SURGERY, V18, P82
   VIDNE B, 1970, SURGERY, V68, P389
   WEISEL RD, 1979, J THORAC CARDIOV SUR, V78, P839
   WHEATLEY MJ, 1992, J PEDIATR SURG, V27, P1122, DOI 10.1016/0022-3468(92)90572-O
NR 25
TC 39
Z9 40
PU ELSEVIER SCIENCE PUBL CO INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD SEP
PY 1995
VL 60
IS 3
BP 729
EP 733
DI 10.1016/0003-4975(95)00500-K
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA RU638
UT WOS:A1995RU63800063
PM 7677520
ER

PT J
AU AKHTAR, M
   GARAN, H
   LEHMANN, MH
   TROUP, PJ
AF AKHTAR, M
   GARAN, H
   LEHMANN, MH
   TROUP, PJ
TI SUDDEN CARDIAC DEATH - MANAGEMENT OF HIGH-RISK PATIENTS
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Review
ID IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; MALIGNANT VENTRICULAR
   ARRHYTHMIAS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE;
   AUTOMATIC DEFIBRILLATOR; PROGRAMMED STIMULATION; CLINICAL-EXPERIENCE;
   ACUTE-ISCHEMIA; FOLLOW-UP; ARREST
AB Sudden cardiac death remains a leading cause of death in the United States, accounting for more than 350 000 deaths each year, and the survival rate of victims remains low.  Most survivors face a significant risk for recurrence.  The typical substrate is chronic-abnormal myocardium with fibrosis (often from previous myocardial infarction) and left ventricular dysfunction.  Acute triggers for sudden cardiac death are primarily electrical, ischemic, metabolic, neurohormonal, and pharmacologic.  In most electrocardiographically documented cases of sudden cardiac death, the trigger-substrate interaction appears to result in ventricular tachycardia and fibrillation.  After initial resuscitation, survivors need a thorough cardiovascular evaluation, including definition of coronary anatomy, left ventricular function, and wall-motion abnormalities, as well as an electrophysiologic evaluation.  An attempt must be made to determine what each survivor's correctable triggers are.  Management should address all reversible triggers, such as acute ischemia and electrolyte abnormalities, and should include modifying or correcting the arrhythmogenic substrate.  Empiric antiarrhythmic therapy offers no advantage in such modification.  Pharmacologic therapy with antiarrhythmic drugs should be guided by an objective therapeutic endpoint, which is best accomplished through the use of programmed ventricular stimulation and serial electrophysiologic studies.  Other therapeutic options include surgical suppression of ventricular tachycardia and implantation of a cardioverter defibrillator.
C1 VET ADM MED CTR,MED SERV,MARTINEZ,CA 94553.
   UNIV CALIF DAVIS,SCH MED,DEPT MED,DAVIS,CA 95616.
CR ANDERSON KP, 1984, J CARDIOVASC PHARM, V6, pS498
   BABA N, 1975, CIRCULATION, V52, P53
   BACH S M JR, 1989, Journal of the American College of Cardiology, V13, p65A
   BAUM RS, 1974, CIRCULATION, V50, P1231
   BENDITT DG, 1983, J AM COLL CARDIOL, V2, P418
   BERGER MD, 1988, CIRCULATION, V78, P885
   BIGGER JT, 1984, CIRCULATION, V69, P250
   BIGGER JT, 1987, AM J CARDIOL, V59, pE2, DOI 10.1016/0002-9149(87)90195-0
   BRACHMANN J, 1983, CIRCULATION, V68, P846
   CECCHI F, 1989, J AM COLL CARDIOL, V13, P1283
   COBB LA, 1975, CIRCULATION, V52, P223
   COOPER DK, 1986, CLIN PROG ELECTROPHY, V4, P306
   COOPER WD, 1984, EUR HEART J, V5, P464
   COX JL, 1989, CIRCULATION, V79, P163
   DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801
   DIXON EG, 1987, CIRCULATION, V76, P1176
   ELSHERIF N, 1975, CIRCULATION, V51, P1003
   FOGOROS RN, 1989, PACE, V12, P1465, DOI 10.1111/j.1540-8159.1989.tb06151.x
   FRIEDMAN M, 1975, CIRCULATION, V52, P34
   FRIEDMAN M, 1973, JAMA-J AM MED ASSOC, V225, P1319
   FURUKAWA T, 1989, CIRCULATION, V80, P599
   GABRY MD, 1987, J AM COLL CARDIOL, V9, P1349
   GARAN H, 1988, J AM COLL CARDIOL, V11, P603
   GEDDES LA, 1971, MED BIOL ENG, V9, P185, DOI 10.1007/BF02474814
   GRABOYS TB, 1986, AM J CARDIOL, V58, P59, DOI 10.1016/0002-9149(86)90241-9
   HARGROVE WC, 1989, CIRCULATION, V79, P178
   HERRE JM, 1989, J AM COLL CARDIOL, V13, P442
   HORNING RJ, 1982, PROG BATTERIES SOLAR, V4, P97
   HOROWITZ LN, 1984, TACHYCARDIAS, P283
   HOROWITZ LN, 1988, PROGR CARDIOLOGY, P109
   JACKMAN WM, 1988, PROG CARDIOVASC DIS, V31, P115, DOI 10.1016/0033-0620(88)90014-X
   JOSEPHSON ME, 1980, AM J CARDIOL, V46, P948, DOI 10.1016/0002-9149(80)90350-1
   KAISER GA, 1975, SURGERY, V78, P749
   KALBFLEISCH KR, 1989, AM J CARDIOL, V64, P199, DOI 10.1016/0002-9149(89)90457-8
   KEHOE RF, 1987, J AM COLL CARDIOL, V9, pA108
   KELLY P, 1990, J AM COLL CARDIOL, V15, P267
   KELLY PA, 1988, J AM COLL CARDIOL, V11, P1278
   KEMPF FC, 1984, AM J CARDIOL, V53, P1577, DOI 10.1016/0002-9149(84)90582-4
   Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR, P96
   KULLER L, 1972, ARCH INTERN MED, V129, P714, DOI 10.1001/archinte.129.5.714
   KUPPERMANN M, 1990, CIRCULATION, V81, P91
   LAMPERT S, 1988, AM J CARDIOL, V61, P791, DOI 10.1016/0002-9149(88)91068-5
   LEHMANN MH, 1987, POSTGRAD MED, V82, P36
   LEHMANN MH, 1988, AM J CARDIOL, V62, P803, DOI 10.1016/0002-9149(88)91226-X
   LEHMANN MH, 1987, POSTGRAD MED, V82, P43
   LIBERTHSON RR, 1979, CIRCULATION, V59, P748
   LIBERTHS.RR, 1974, CIRCULATION, V49, P790
   LIE JT, 1975, CIRCULATION, V52, P41
   MANOLIS AS, 1989, AM HEART J, V118, P445, DOI 10.1016/0002-8703(89)90256-1
   MIROWSKI M, 1970, ARCH INTERN MED, V126, P158, DOI 10.1001/archinte.126.1.158
   MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607
   MORADY F, 1983, AM J CARDIOL, V51, P85, DOI 10.1016/S0002-9149(83)80016-2
   MORADY F, 1984, J AM COLL CARDIOL, V4, P39
   MYERBURG RJ, 1989, AM J CARDIOL, V63, P1512, DOI 10.1016/0002-9149(89)90017-9
   MYERBURG RJ, 1978, AM J CARDIOL, V41, P365, DOI 10.1016/0002-9149(78)90234-5
   MYERBURG RJ, 1989, J AM COLL CARDIOL, V14, P508, DOI 10.1016/0735-1097(89)90209-X
   MYERBURG RJ, 1988, HEART DISEASE TXB CA, P742
   MYERBURG RJ, 1984, CIRCULATION, V70, P538
   MYERBURG RJ, 1980, AM J MED, V68, P568, DOI 10.1016/0002-9343(80)90307-1
   NEWMAN D, 1989, Journal of the American College of Cardiology, V13, p65A
   NEWMAN WP, 1981, LAB INVEST, V44, P496
   NIAZI I, 1988, AM HEART J, V115, P830, DOI 10.1016/0002-8703(88)90886-1
   NIAZI I, 1988, CIRCULATION, V78, P71
   NORDREHAUG JE, 1985, CIRCULATION, V71, P645
   PACKER M, 1985, CIRCULATION, V72, P681
   PATTERSON E, 1982, AM J CARDIOL, V50, P1414, DOI 10.1016/0002-9149(82)90484-2
   POLL DS, 1986, AM J CARDIOL, V58, P992, DOI 10.1016/S0002-9149(86)80025-X
   PYCHA C, 1986, PSYCHOSOMATICS, V27, P841
   REICHENBACH DD, 1975, CIRCULATION, V52, P60
   RITCHIE JL, 1985, AM J CARDIOL, V55, P645, DOI 10.1016/0002-9149(85)90129-8
   RODEN DM, 1986, J AM COLL CARDIOL, V8, pA73
   ROY D, 1983, AM J CARDIOL, V52, P969, DOI 10.1016/0002-9149(83)90514-3
   RUSKIN JN, 1983, NEW ENGL J MED, V309, P1302, DOI 10.1056/NEJM198311243092107
   RUSKIN JN, 1980, NEW ENGL J MED, V303, P607, DOI 10.1056/NEJM198009113031103
   SAKSENA S, 1988, JAMA-J AM MED ASSOC, V259, P69, DOI 10.1001/jama.259.1.69
   SCHUDER JC, 1984, CARDIOVASC RES, V18, P419, DOI 10.1093/cvr/18.7.419
   SCHUDER JC, 1970, CARDIOVASC RES, V4, P497, DOI 10.1093/cvr/4.4.497
   SCHUGER CD, 1988, PACE, V11, P1456, DOI 10.1111/j.1540-8159.1988.tb04995.x
   SEBULSKY AM, 1989, RACE DEV IMPLANTABLE
   SKALE BT, 1986, AM J CARDIOL, V57, P113, DOI 10.1016/0002-9149(86)90962-8
   SONG SL, 1989, PACE, V12, P1555, DOI 10.1111/j.1540-8159.1989.tb06163.x
   TCHOU PJ, 1988, ANN INTERN MED, V109, P529
   The Cardiac Arrhythmia Suppression Trial (CAST) Investigators, 1989, NEW ENGL J MED, V321, P406
   THOMAS AC, 1988, PACE, V11, P2053, DOI 10.1111/j.1540-8159.1988.tb06349.x
   TRESCH DD, 1981, CIRCULATION, V64, P1
   TROUP P, 1989, PACE, V12, P688
   TROUP PJ, 1989, 24TH P AAMI ANN M EX, P92
   TZIVONI D, 1988, CIRCULATION, V77, P392
   VELTRI E, 1989, INTERVENTIONAL CARDI
   VISBISKY M, 1989, J POWER SOURCES, V26, P185, DOI 10.1016/0378-7753(89)80026-6
   WARREN J, 1986, PACE, V9, P1079, DOI 10.1111/j.1540-8159.1986.tb06673.x
   WEAVER WD, 1976, CIRCULATION, V54, P895
   WILBER DJ, 1988, NEW ENGL J MED, V318, P19, DOI 10.1056/NEJM198801073180105
   WINKLE RA, 1984, CIRCULATION, V69, P766
   WINKLE RA, 1989, J AM COLL CARDIOL, V13, P1353
   WIT AL, 1975, CIRCULATION       S3, V51, P96
   WOLF F, 1979, HEART DISEASE REHABI, P120
   ZHEUTLIN T, 1984, CIRCULATION, V70, P399
   ZIPES DP, 1984, NEW ENGL J MED, V311, P485, DOI 10.1056/NEJM198408233110801
NR 99
TC 39
Z9 39
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572
SN 0003-4819
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAR 15
PY 1991
VL 114
IS 6
BP 499
EP 512
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA FB640
UT WOS:A1991FB64000011
PM 1888350
ER

PT J
AU BURT, JM
   COPELAND, JG
AF BURT, JM
   COPELAND, JG
TI MYOCARDIAL-FUNCTION AFTER PRESERVATION FOR 24 HOURS
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
C1 UNIV ARIZONA,COLL MED,DEPT SURG,TUCSON,AZ 85724.
RP BURT, JM (reprint author), UNIV ARIZONA,COLL MED,DEPT PHYSIOL,TUCSON,AZ 85724, USA.
CR BELL PRF, 1974, TRANSPLANT P, V6, P245
   BETHENCOURT DM, 1981, J THORAC CARDIOV SUR, V81, P440
   BURT JM, HEART TRANSPLANT
   CHILDS J W, 1969, Progress in Cardiovascular Diseases, V12, P149, DOI 10.1016/0033-0620(69)90014-0
   COLLINS GM, 1969, TRANSPLANTATION, V8, P821
   COPELAND JG, 1973, ANN SURG, V178, P687, DOI 10.1097/00000658-197312000-00002
   FEEMSTER JA, 1969, TRANSPLANT P, V1, P138
   GUERRATY A, 1981, J THORAC CARDIOV SUR, V82, P531
   HEARSE DJ, 1981, PROTECTION ISCHEMIC, P410
   KONDO Y, 1965, J THORAC CARDIOV SUR, V50, P781
   Langendorff O., 1895, PFLUEGERS ARCH, V61, P291, DOI DOI 10.1007/BF01812150
   LEE BY, 1980, J SURG RES, V29, P50, DOI 10.1016/0022-4804(80)90008-6
   LEVITSKY S, 1970, J THORAC CARDIOV SUR, V60, P625
   LEVITSKY S, 1971, CIRCULATION S1, V43, P125
   Păuşescu E, 1978, World J Surg, V2, P109
   PITZELE S, 1971, SURGERY, V70, P569
   PROCTOR E, 1968, BRIT MED J, V4, P296
   ROSENFELDT FL, 1982, J THORAC CARDIOV SUR, V84, P656
   SNELL ME, 1972, BRIT J SURG, V59, P886, DOI 10.1002/bjs.1800591111
   SUAUDEAU J, 1982, J THORAC CARDIOV SUR, V84, P886
   TRUNKEY D, 1970, CRYOBIOLOGY, V6, P515, DOI 10.1016/S0011-2240(70)80002-5
   WARNER M, 1982, J THORAC CARDIOV SUR, V83, P290
   WATSON DC, 1977, TRANSPLANT P, V9, P297
   WICOMB W, 1982, J THORAC CARDIOV SUR, V83, P133
NR 24
TC 39
Z9 39
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD AUG
PY 1986
VL 92
IS 2
BP 238
EP 246
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA D5562
UT WOS:A1986D556200009
PM 3525995
ER

PT J
AU WAGNER, HR
   ELLISON, RC
   ZIERLER, S
   LANG, P
   PUROHIT, DM
   BEHRENDT, D
   WALDHAUSEN, JA
AF WAGNER, HR
   ELLISON, RC
   ZIERLER, S
   LANG, P
   PUROHIT, DM
   BEHRENDT, D
   WALDHAUSEN, JA
TI SURGICAL CLOSURE OF PATENT DUCTUS-ARTERIOSUS IN 268 PRETERM INFANTS
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
RP WAGNER, HR (reprint author), CHILDRENS HOSP,PHILADELPHIA,PA 19104, USA.
CR AULD PAM, 1966, J PEDIATR, V69, P61, DOI 10.1016/S0022-3476(66)80362-1
   CORAN AG, 1975, J PEDIATR SURG, V10, P399
   COTTON RB, 1978, J PEDIATR, V93, P647, DOI 10.1016/S0022-3476(78)80910-X
   DANILOWI.D, 1966, PEDIATRICS, V37, P74
   EDMUNDS LH, 1978, ANN THORAC SURG, V26, P586
   EDMUNDS LH, 1973, CIRCULATION, V48, P856
   ELLISON RC, 1983, PEDIATRICS, V71, P364
   FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003
   GAY JH, 1973, J PEDIATR SURG, V23, P564
   GERSONY WM, 1983, J PEDIATR, V102, P895, DOI 10.1016/S0022-3476(83)80022-5
   GUPTA JM, 1972, J THORAC CARDIOV SUR, V63, P642
   HEYMANN MA, 1976, NEW ENGL J MED, V295, P530, DOI 10.1056/NEJM197609022951004
   HORSLEY BL, 1973, ANN SURG, V177, P806, DOI 10.1097/00000658-197306000-00021
   KILMAN JW, 1974, J PEDIATR SURG, V9, P277, DOI 10.1016/S0022-3468(74)80280-0
   KITTERMA.JA, 1972, NEW ENGL J MED, V287, P473, DOI 10.1056/NEJM197209072871001
   MURPHY DA, 1974, J THORAC CARDIOV SUR, V67, P221
   NELSON RJ, 1976, J THORAC CARDIOV SUR, V71, P169
   OXNARD SC, 1977, ANN THORAC SURG, V23, P564
   RITTENHOUSE EA, 1976, J THORAC CARDIOV SUR, V71, P187
   SALOMON NW, 1979, CHEST, V75, P671, DOI 10.1378/chest.75.6.671
   THIBEAULT DW, 1975, J PEDIATR, V86, P120, DOI 10.1016/S0022-3476(75)80722-0
   WILLIAMS WH, 1976, ANN THORAC SURG, V22, P151
NR 22
TC 39
Z9 39
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PY 1984
VL 87
IS 6
BP 870
EP 875
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA SV986
UT WOS:A1984SV98600010
PM 6374300
ER

PT J
AU WILLWERT.BM
   ZOLLINGE.RM
   IZANT, RJ
AF WILLWERT.BM
   ZOLLINGE.RM
   IZANT, RJ
TI CONGENITAL MESOCOLIC (PARADUODENAL) HERNIA - EMBRYOLOGIC BASIS OF REPAIR
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
C1 CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH.
   UNIV HOSP CLEVELAND,DEPT SURG,CLEVELAND,OH.
CR Andrews E, 1923, SURG GYNECOL OBSTET, V37, P740
   BARTLETT MK, 1968, ANN SURG, V168, P249, DOI 10.1097/00000658-196808000-00010
   Callander CL, 1935, SURG GYNECOL OBSTET, V60, P1052
   HAYMOND HE, 1931, SURG GYNECOL OBSTET, V53, P316
   WILKINSO.GW, 1971, CAN J SURG, V14, P151
   ZIMMERMAN LM, 1953, ANN SURG, V138, P82, DOI 10.1097/00000658-195307000-00010
NR 6
TC 39
Z9 39
PU CAHNERS PUBL CO
PI NEW YORK
PA 249 WEST 17 STREET, NEW YORK, NY 10011
SN 0002-9610
J9 AM J SURG
JI Am. J. Surg.
PY 1974
VL 128
IS 3
BP 358
EP 361
DI 10.1016/0002-9610(74)90173-1
PG 4
WC Surgery
SC Surgery
GA U1273
UT WOS:A1974U127300010
PM 4412601
ER

PT J
AU Pei, QX
   Sha, ZD
   Zhang, YW
AF Pei, Qing-Xiang
   Sha, Zhen-Dong
   Zhang, Yong-Wei
TI A theoretical analysis of the thermal conductivity of hydrogenated
   graphene
SO CARBON
LA English
DT Article
ID MOLECULAR-DYNAMICS; NANORIBBONS; COMPOSITES; TRANSPORT; GRAPHANE
AB We investigate the thermal conductivity of hydrogenated graphene using non-equilibrium molecular dynamics simulations. It is found that the thermal conductivity greatly depends on the hydrogen distribution and coverage. For random hydrogenation, the thermal conductivity decreases rapidly with increasing coverage up to about 30%. Beyond this limit, however, the thermal conductivity is almost insensitive to the coverage. For patterned hydrogenation with stripes parallel to the heat flux, the thermal conductivity decreases gradually with increasing coverage from 0% to 100%. In contrast, when the stripe direction is perpendicular to the heat flux, a small (5%) coverage causes a sharp (60%) drop of thermal conductivity. The deterioration of thermal conductivity is due to the sp(2)-to-sp(3) bonding transition upon hydrogenation, which softens the G-band phonon modes. Percolation theory can be used to explain the variation of thermal conductivity at different hydrogenation distributions and coverages. The applicability of the rule of mixtures in predicting the thermal conductivity is also discussed. The work suggests that hydrogenation is a possible route to tune graphene thermal conductivity and manage heat dissipation in graphene-based nanoelectronic devices. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Pei, Qing-Xiang; Sha, Zhen-Dong; Zhang, Yong-Wei] Inst High Performance Comp, Singapore 138632, Singapore.
RP Pei, QX (reprint author), Inst High Performance Comp, Singapore 138632, Singapore.
EM peiqx@ihpc.a-star.edu.sg
RI Zhang, Yong-Wei/D-5191-2012; SHA, Zhendong/E-9463-2012
FU Agency for Science, Technology and Research (A*STAR), Singapore
FX This work was supported by the Agency for Science, Technology and
   Research (A*STAR), Singapore.
CR Ao ZM, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3525377
   Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872
   Balog R, 2010, NAT MATER, V9, P315, DOI [10.1038/nmat2710, 10.1038/NMAT2710]
   Boukhvalov DW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035427
   Boukhvalov DW, 2009, J PHYS CONDENS MATT, V21
   Boukhvalov DW, 2010, PHYS CHEM CHEM PHYS, V12, P15367, DOI 10.1039/c0cp01009j
   Brenner DW, 2000, PHYS STATUS SOLIDI B, V217, P23, DOI 10.1002/(SICI)1521-3951(200001)217:1<23::AID-PSSB23>3.0.CO;2-N
   Cahill DG, 2003, J APPL PHYS, V93, P793, DOI 10.1063/1.1524305
   Cai WW, 2010, NANO LETT, V10, P1645, DOI 10.1021/nl9041966
   Che JW, 2000, NANOTECHNOLOGY, V11, P65, DOI 10.1088/0957-4484/11/2/305
   Chien SK, 2011, APPL PHYS LETT, V98
   Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130
   Fiori G, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153404
   Gaier JR, 2003, CARBON, V41, P2187, DOI 10.1010/S0008-6223(03)00238-0
   Geim AK, 2008, SCI AM, V298, P90
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Ghosh S., 2008, APPL PHYS LETT, V92
   Guo ZX, 2009, APPL PHYS LETT, V95
   Hu JN, 2009, NANO LETT, V9, P2730, DOI 10.1021/nl901231s
   Jiang JW, 2010, J APPL PHYS, V108, DOI 10.1063/1.3481677
   Jiang JW, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205418
   Jones JD, 2010, CARBON, V48, P2335, DOI 10.1016/j.carbon.2010.03.010
   Kong L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165422
   Kong LT, 2011, COMPUT PHYS COMMUN, V182, P2201, DOI 10.1016/j.cpc.2011.04.019
   Lan JH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115401
   Lee YL, 2010, ACS NANO, V4, P1345, DOI 10.1021/nn9019064
   Loh KP, 2010, J MATER CHEM, V20, P2277, DOI 10.1039/b920539j
   Maruyama S, 2002, PHYSICA B, V323, P193, DOI 10.1016/S0921-4526(02)00898-0
   MullerPlathe F, 1997, J CHEM PHYS, V106, P6082, DOI 10.1063/1.473271
   Nayak R, 2010, COMP MATER SCI, V48, P576, DOI 10.1016/j.commatsci.2010.02.025
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Pan R, 2007, NANOTECHNOLOGY, V18
   Peelaers H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3551712
   Pei QX, 2010, CARBON, V48, P898, DOI 10.1016/j.carbon.2009.11.014
   Pei QX, 2010, NANOTECHNOLOGY, V21
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Pop E, 2006, NANO LETT, V6, P96, DOI 10.1021/nl052145f
   Roman T, 2007, CARBON, V45, P218, DOI 10.1016/j.carbon.2006.09.027
   Ryu S, 2008, NANO LETT, V8, P4597, DOI 10.1021/nl802940s
   Samarakoon DK, 2009, ACS NANO, V3, P4017, DOI 10.1021/nn901317d
   Sen D, 2010, SMALL, V6, P1108, DOI 10.1002/smll.201000097
   Singh AK, 2009, NANO LETT, V9, P1540, DOI 10.1021/nl803622c
   Sofo JO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153401
   Soldano C, 2010, CARBON, V48, P2127, DOI 10.1016/j.carbon.2010.01.058
   Strachan A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1831277
   Stuart SJ, 2000, J CHEM PHYS, V112, P6472, DOI 10.1063/1.481208
   Suding PN, 1999, PHYS REV E, V60, P275, DOI 10.1103/PhysRevE.60.275
   Varshney V, 2010, ACS NANO, V4, P1153, DOI 10.1021/nn901341r
   Wang Z, 2007, NANOTECHNOLOGY, V18
   Wang ZF, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.113406
   Wei N, 2011, NANOTECHNOLOGY, V22
   Wei ZY, 2011, CARBON, V49, P2653, DOI 10.1016/j.carbon.2011.02.051
   Xu Z, 2009, NANOTECHNOLOGY, V20
   Xu ZP, 2009, ACS NANO, V3, P2767, DOI 10.1021/nn9006237
   Zhang G, 2005, J CHEM PHYS, V123
NR 55
TC 38
Z9 38
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-6223
J9 CARBON
JI Carbon
PD NOV
PY 2011
VL 49
IS 14
BP 4752
EP 4759
DI 10.1016/j.carbon.2011.06.083
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 825UT
UT WOS:000295308300016
ER

PT J
AU Dyer, MTD
   Goldsmith, KA
   Sharples, LS
   Buxton, MJ
AF Dyer, Matthew T. D.
   Goldsmith, Kimberley A.
   Sharples, Linda S.
   Buxton, Martin J.
TI A review of health utilities using the EQ-5D in studies of
   cardiovascular disease
SO HEALTH AND QUALITY OF LIFE OUTCOMES
LA English
DT Review
ID QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE;
   PERIPHERAL ARTERIAL-DISEASE; COST-EFFECTIVENESS ANALYSIS;
   PREFERENCE-BASED MEASURE; BYPASS-GRAFTING SURGERY; CARDIAC
   REHABILITATION; UNITED-STATES; MYOCARDIAL-INFARCTION
AB Background: The EQ-5D has been extensively used to assess patient utility in trials of new treatments within the cardiovascular field. The aims of this study were to review evidence of the validity and reliability of the EQ-5D, and to summarise utility scores based on the use of the EQ-5D in clinical trials and in studies of patients with cardiovascular disease.
   Methods: A structured literature search was conducted using keywords related to cardiovascular disease and EQ-5D. Original research studies of patients with cardiovascular disease that reported EQ-5D results and its measurement properties were included.
   Results: Of 147 identified papers, 66 met the selection criteria, with 10 studies reporting evidence on validity or reliability and 60 reporting EQ-5D responses (VAS or self-classification). Mean EQ-5D index-based scores ranged from 0.24 (SD 0.39) to 0.90 (SD 0.16), while VAS scores ranged from 37 (SD 21) to 89 (no SD reported). Stratification of EQ-5D index scores by disease severity revealed that scores decreased from a mean of 0.78 (SD 0.18) to 0.51 (SD 0.21) for mild to severe disease in heart failure patients and from 0.80 (SD 0.05) to 0.45 (SD 0.22) for mild to severe disease in angina patients.
   Conclusions: The published evidence generally supports the validity and reliability of the EQ-5D as an outcome measure within the cardiovascular area. This review provides utility estimates across a range of cardiovascular subgroups and treatments that may be useful for future modelling of utilities and QALYs in economic evaluations within the cardiovascular area.
C1 [Dyer, Matthew T. D.; Buxton, Martin J.] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England.
   [Goldsmith, Kimberley A.; Sharples, Linda S.] Papworth Hosp NHS Trust, Cambridge, England.
   [Goldsmith, Kimberley A.; Sharples, Linda S.] Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England.
   [Dyer, Matthew T. D.] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London SW1X 8PG, England.
RP Dyer, MTD (reprint author), Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England.
EM mdyer@cru.rcpsych.ac.uk
RI Goldsmith, Kimberley/B-9107-2011
FU EuroQol Group
FX The authors are grateful for the funding support of the EuroQol Group
   (PI: Buxton). An earlier version of this paper was presented at the 2008
   EuroQol Plenary Meeting, Baveno, Italy, Sept 11-13, 2008. The authors
   thank Simon Pickard for helpful comments on an earlier version of the
   paper. MD is now employed at the National Collaborating Centre for
   Mental Health within the National Institute for Health and Clinical
   Excellence (NICE). However, the study was conducted whilst he was a
   researcher at Brunel University.
CR Almenar-Pertejo M, 2006, TRANSPLANT P, V38, P2524, DOI 10.1016/j.transproceed.2006.08.017
   Ascione R, 2004, EUR HEART J, V25, P765, DOI 10.1016/j.ehj.2003.11.015
   Austin J, 2008, EUR J CARDIOV PREV R, V15, P162, DOI 10.1097/HJR.0b013e3282f10e87
   Jaffray M, 2007, FAM PRACT, V24, P189, DOI 10.1093/fampra/cml075
   Borowiak E, 2006, QUAL LIFE RES, V15, P1281, DOI 10.1007/s11136-006-0058-0
   Bosch JL, 2000, QUAL LIFE RES, V9, P591, DOI 10.1023/A:1008929129537
   Bosch JL, 1999, CIRCULATION, V99, P3155
   Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8
   Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202
   Busschbach JJV, 1999, J VASC SURG, V30, P1162, DOI 10.1016/S0741-5214(99)70058-3
   Buxton M, 2006, HEALTH TECHNOL ASSES, V10, P1
   Calvert MJ, 2005, EUR J HEART FAIL, V7, P243, DOI 10.1016/j.ejheart.2005.01.012
   Campeau L, 2002, CAN J CARDIOL, V18, P439
   CLAES C, NEW GERMAN VERSION E, P1
   Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496
   Cook T A, 1997, Cardiovasc Surg, V5, P424, DOI 10.1016/S0967-2109(97)00037-9
   DANKOVA I, 2001, CZECH HLTH POLICY EC, P2
   Denvir MA, 2006, J EPIDEMIOL COMMUN H, V60, P1085, DOI 10.1136/jech.2005.044255
   de Vries M, 2006, RADIOLOGY, V240, P401, DOI 10.1148/radiol.2402050223
   de Vries M, 2005, J VASC SURG, V41, P261, DOI 10.1016/j.jvs.2004.11.022
   Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002
   Dorman P, 1998, STROKE, V29, P63
   Dunning J, 2008, ANN THORAC SURG, V85, P1988, DOI 10.1016/j.athoracsur.2008.02.024
   Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C
   Eurich DT, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-89
   Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092
   Granja C, 2002, RESUSCITATION, V55, P37, DOI 10.1016/S0300-9572(02)00203-4
   Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5
   Griffin SC, 2007, BRIT MED J, V334, P624, DOI 10.1136/bmj.39129.442164.55
   Groeneveld PW, 2007, PACE, V30, P463, DOI 10.1111/j.1540-8159.2007.00694.x
   GUYATT GH, 1993, J AM COLL CARDIOL, V22, pA185
   Haacke C, 2006, STROKE, V37, P193
   Hage Camilla, 2003, Physiother Res Int, V8, P13, DOI 10.1002/pri.268
   Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hofer S, 2006, WIEN KLIN WOCHENSCHR, V118, P744, DOI 10.1007/s00508-006-0727-6
   Höfer Stefan, 2004, Health Qual Life Outcomes, V2, P3, DOI 10.1186/1477-7525-2-3
   HOLLAND R, 2007, BRIT MED J, V334, P1098
   Sharples L, 2007, HEALTH TECHNOL ASSES, V11, P1
   Hung HF, 2007, CARDIOLOGY, V108, P252, DOI 10.1159/000096952
   INNOCENTI AD, 2002, BLOOD PRESSURE, V11, P157, DOI 10.1080/080370502760050395
   Jowett S, 2006, BRIT J HAEMATOL, V134, P632, DOI 10.1111/j.1365-2141.2006.06243.x
   Kiessling A, 2005, INT J TECHNOL ASSESS, V21, P180
   Kim J, 2005, J AM COLL CARDIOL, V45, P221, DOI 10.1016/j.jacc.2004.10.034
   Krijnen P, 2005, J HUM HYPERTENS, V19, P467, DOI 10.1038/sj.jhh.1001847
   Kruse M, 2006, INT J TECHNOL ASSESS, V22, P478
   Lacey E Anne, 2004, Eur J Cardiovasc Nurs, V3, P219, DOI 10.1016/j.ejcnurse.2004.06.005
   Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124
   Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733
   Legrand VMG, 2004, CIRCULATION, V109, P1114, DOI 10.1161/01.CIR.0000118504.61212.4B
   Lenzen Mattie, 2006, Eur J Cardiovasc Nurs, V5, P115, DOI 10.1016/j.ejcnurse.2006.01.003
   Lindgren P, 2007, EUR J HEALTH ECON, V8, P25, DOI 10.1007/s10198-006-0002-9
   Longworth Louise, 2005, Eur J Health Econ, V6, P347, DOI 10.1007/s10198-005-0309-y
   Lottman PEM, 2004, J ENDOVASC THER, V11, P323, DOI 10.1583/03-1141.1
   Maliwa MA, 2003, CARDIOVASC SURG, V11, P381, DOI 10.1016/S0967-2109(03)00030-9
   Nowels D, 2005, QUAL LIFE RES, V14, P95, DOI 10.1007/s11136-004-0614-4
   Park J, 2005, ARCH INTERN MED, V165, P2026, DOI 10.1001/archinte.165.17.2026
   Pickard AS, 2007, PHARMACOECONOMICS, V25, P365, DOI 10.2165/00019053-200725050-00002
   Pickard A Simon, 2005, Qual Life Res, V14, P207
   Pickard AS, 2008, RESP MED, V102, P519, DOI 10.1016/j.rmed.2007.11.016
   Pickard AS, 2004, STROKE, V35, P607, DOI 10.1161/01.STR.0000110984.91157.BD
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   Reeves BC, 2004, HEALTH TECHNOL ASSES, V8, P1
   ROCCA HPB, 2007, LANCET, V370, P1552, DOI 10.1016/S0140-6736(07)61660-2
   Ryan T, 2006, CLIN REHABIL, V20, P123, DOI 10.1191/0269215506cr933oa
   Safley DM, 2007, CIRCULATION, V115, P569, DOI 10.1161/CIRCULATIONAHA.106.643346
   Schweikert B, 2006, HEART, V92, P62, DOI 10.1136/hrt.2004.052787
   SHARPLES L, 2006, NCCHTA HLTH TECHNOL, V10, P1
   Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003
   Shrive FM, 2005, CAN MED ASSOC J, V172, P345, DOI 10.1503/cmaj.1041062
   Shrive FM, 2007, MED CARE, V45, P269, DOI 10.1097/01.mlr.0000250480.55578.45
   Slovacek L, 2007, SAO PAULO MED J, V125, P250, DOI 10.1590/S1516-31802007000400012
   Sollano JA, 1998, ANN SURG, V228, P297, DOI 10.1097/00000658-199809000-00003
   Spencer CA, 2004, ANZ J SURG, V74, P1069, DOI 10.1111/j.1445-1433.2004.03270.x
   Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010
   SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9
   Spiraki C, 2008, HELL J CARDIOL, V49, P241
   Sulch D, 2002, STROKE, V33, P1600, DOI 10.1161/01.STR.0000017144.04043.87
   Sullivan PW, 2005, MED CARE, V43, P736, DOI 10.1097/01.mlr.0000172050.67085.4f
   Swenson JR, 2000, J PSYCHOSOM RES, V48, P405, DOI 10.1016/S0022-3999(99)00092-6
   Tangelder MJD, 1999, J VASC SURG, V29, P913, DOI 10.1016/S0741-5214(99)70219-3
   Taylor RS, 2007, INT J CARDIOL, V119, P196, DOI 10.1016/j.ijcard.2006.07.218
   Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004
   The Criteria Committee for the New York Heart Association, 1994, NOM CRIT DIAGN DIS H
   van Stel HF, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-20
   van der Schaaf IC, 2006, J NEUROL NEUROSUR PS, V77, P748, DOI 10.1136/jnnp.2005.079194
   van Eck JWM, 2008, AM HEART J, V156, P491, DOI 10.1016/j.ahj.2008.04.029
   van Exel NJA, 2004, QUAL LIFE RES, V13, P427, DOI 10.1023/B:QURE.0000018496.02968.50
   WITTRUPJENSEN K, ESTIMATING DANISH EQ, P257
   World Health Organization, 2003, WORLD HLTH REP 2003
   World Health Organization, 2007, INT STAT CLASS DIS R
   Xie JP, 2006, STROKE, V37, P2567, DOI 10.1161/01.STR.0000240506.34616.10
   Xie JP, 2008, CIRCULATION, V118, P491, DOI 10.1161/CIRCULATIONAHA.107.752006
NR 95
TC 38
Z9 38
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-7525
J9 HEALTH QUAL LIFE OUT
JI Health Qual. Life Outcomes
PD JAN 28
PY 2010
VL 8
AR 13
DI 10.1186/1477-7525-8-13
PG 12
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA 558WQ
UT WOS:000274779700001
PM 20109189
ER

PT J
AU Poston, RS
   White, C
   Gu, JY
   Brown, J
   Gammie, J
   Pierson, RN
   Lee, A
   Connerney, I
   Avari, T
   Christenson, R
   Tandry, U
   Griffith, BP
AF Poston, RS
   White, C
   Gu, JY
   Brown, J
   Gammie, J
   Pierson, RN
   Lee, A
   Connerney, I
   Avari, T
   Christenson, R
   Tandry, U
   Griffith, BP
TI Aprotinin shows both hemostatic and antithrombotic effects during
   off-pump coronary artery bypass grafting
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 41st Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 24-26, 2005
CL Tampa, FL
SP Soc Thorac Surg
ID PLATELET-FUNCTION; CARDIOPULMONARY BYPASS; MYOCARDIAL-INFARCTION;
   PROCOAGULANT ACTIVITY; RANDOMIZED-TRIALS; CARDIAC-SURGERY; BLOOD-LOSS;
   ON-PUMP; ASPIRIN; THERAPY
AB Background. Hemostatic drugs are widely thought to be unnecessary and potentially detrimental in off-pump coronary artery bypass graft surgery (OPCABG), despite well-established use in on-pump surgery. In a randomized, prospective OPCABG trial, we assessed efficacy and safety of aprotinin through a comprehensive assessment of graft patency and hematologic function.
   Methods. Sixty patients were randomly assigned to full-dose aprotinin or placebo. Heparin was titrated to a kaolin-based activated clotting time of greater than 300 seconds. Exclusionary criteria included creatinine greater than 2 mg/dL, conversion to on-pump CABG, and preoperative GPIIb/IIIa inhibition. Hematologic assessments were obtained preoperatively, at the end of surgery, and on days 1 and 3: mean platelet volume, thrombin generation (prothrombin fragment 1.2 assay), and aspirin resistance using a modified thrombelastography, whole blood aggregometry, 11-dehydro-thromboxane B, levels, and flow cytometry. Thrombotic events were defined as postoperative myocardial infarction by electrocardiography or elevated troponin I, clinical stroke by examination and head computed tomography, and bypass graft failure by multichannel computed tomography angiography on day 5.
   Results. Aprotinin was associated with a significant reduction in intraoperative and postoperative blood loss compared with placebo but had no effect on transfusion rates. Patients treated with aprotinin had significantly fewer thrombotic events (3% versus 23%, p < 0.05, Fisher's exact test) and less postoperative aspirin resistance (20% versus 46%, respectively, p < 0.05, Fisher's exact test). Postoperative prothrombin fragment 1.2 level was reduced by aprotinin use.
   Conclusions. Aprotinin reduced perioperative bleeding after OPCABG. Preserved aspirin sensitivity in the aprotinin group may explain the observed reduction in thrombotic events and might be related to the suppression of perioperative and transmyocardial thrombin formation.
C1 Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA.
   Univ Maryland, Sch Med, Dept Radiol, Baltimore, MD 21201 USA.
   Univ Maryland, Sch Med, Dept Clin Effectiveness, Baltimore, MD 21201 USA.
   Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.
   Chronolog Corp, Havertown, PA USA.
   Sinai Ctr Thrombosis Res, Baltimore, MD USA.
RP Poston, RS (reprint author), Div Cardiac Surg, N4W94 22 S Greene St, Baltimore, MD 21201 USA.
EM rposton@smail.umaryland.edu
CR Alderman EL, 1999, J THORAC CARDIOV SUR, V118, P979
   ALTMAN R, 1994, BRIT MED J, V308, P81
   Bedirhan MA, 2001, EUR J CARDIO-THORAC, V20, P1122, DOI 10.1016/S1010-7940(01)01016-8
   Bhatt DL, 2001, CIRCULATION, V103, P363
   Burman JF, 2002, TRANSFUSION MED, V12, P173, DOI 10.1046/j.1365-3148.2002.00369.x
   Casati V, 2001, ANESTHESIOLOGY, V95, P1103, DOI 10.1097/00000542-200111000-00013
   COSGROVE DM, 1992, ANN THORAC SURG, V54, P1031
   Craft RM, 2004, J LAB CLIN MED, V143, P301, DOI 10.1016/j.lab.2004.01.011
   DIETRICH W, 1996, J CARDIOVASC PHARM, V27, P50, DOI 10.1097/00005344-199600001-00011
   Englberger L, 2002, EUR J CARDIO-THORAC, V22, P545, DOI 10.1016/S1010-7940(02)00433-5
   Friend M, 2003, BRIT MED J, V326, P82, DOI 10.1136/bmj.326.7380.82
   Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0
   Hongo RH, 2002, J AM COLL CARDIOL, V40, P231, DOI 10.1016/S0735-1097(02)01954-X
   Koster A, 2002, ANESTHESIOLOGY, V97, P837, DOI 10.1097/00000542-200210000-00014
   Landis RC, 2001, ANN THORAC SURG, V72, P2169, DOI 10.1016/S0003-4975(01)02821-1
   MAIR J, 1994, CLIN CHEM, V40, P2066
   Manchio JV, 2005, ANN THORAC SURG, V79, P1991, DOI 10.1016/j.athorascur.2004.12.054
   Mariani MA, 1999, ANN THORAC SURG, V67, P1370, DOI 10.1016/S0003-4975(99)00265-9
   Moller CH, 2003, SCAND CARDIOVASC J, V37, P149, DOI 10.1080/14017430310001456
   MOOR E, 1994, THROMB HAEMOSTASIS, V72, P335
   MURKIN JM, 1995, ANESTH ANALG, V80, P343, DOI 10.1097/00000539-199502000-00023
   PENG JP, 1994, BLOOD, V83, P161
   Poston R, 2005, EUR J CARDIO-THORAC, V27, P584, DOI 10.1016/j.ejcts.2004.12.061
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016
   Smith PK, 2004, ANN THORAC SURG, V77, P635, DOI 10.1016/j.athoracsur.2003.06.008
   STEIN PD, 1995, CHEST S, V108, P424
   VANOEVEREN W, 1990, J THORAC CARDIOV SUR, V99, P788
   Vanschoonbeek K, 2004, J THROMB HAEMOST, V2, P476, DOI 10.1111/j.1538-7933.2004.00618.x
   Weerwind PW, 2003, THROMB J, V1, P3, DOI 10.1186/1477-9560-1-3
   ZIMMERMANN N, 2003, CIRCULATION, V8, P542
NR 31
TC 38
Z9 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JAN
PY 2006
VL 81
IS 1
BP 104
EP 111
DI 10.1016/j.athoracsur.2005.05.085
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 002BC
UT WOS:000234585400014
PM 16368345
ER

PT J
AU Bruha, R
   Petrtyl, J
   Kubecova, M
   Marecek, Z
   Dufek, V
   Urbanek, P
   Kodadova, J
   Chodounsky, Z
AF Bruha, R
   Petrtyl, J
   Kubecova, M
   Marecek, Z
   Dufek, V
   Urbanek, P
   Kodadova, J
   Chodounsky, Z
TI Intraluminal brachytherapy and selfexpandable stents in nonresectable
   biliary malignancies - The question of long-term palliation
SO HEPATO-GASTROENTEROLOGY
LA English
DT Article
DE biliary tumor; percutaneous biliary drainage; metallic stent;
   intraluminal brachytherapy
ID BILE-DUCT CANCER; COMBINED EXTERNAL-BEAM; RADIATION-THERAPY; HILAR
   CHOLANGIOCARCINOMA; OBSTRUCTIVE-JAUNDICE; METALLIC STENTS; SURGICAL
   RESECTION; IR-192 WIRE; RADIOTHERAPY; ENDOPROSTHESIS
AB Background/Aims: To evaluate the effect of a combination of intraluminal brachytherapy and metallic stent implantation in the treatment of patients with nonresectable biliary tumors.
   Methodology: Thirty-two patients aged 41-80 years with nonresectable biliary malignancies - Klatskin's tumor (n = 17), gallbladder carcinoma (n = 11) and carcinoma of papilla Vateri (n = 4) - were treated with a combination of intraluminal brachytherapy (source Ir192, high-dose radiation regimen, total dose 30Gy) and metallic stent implantation. Intraluminal brachytherapy and stent insertion (metallic, spiral-Z stent) were performed percutaneously in all patients.
   Results: The mean survival in patients with Klatskin's tumor was 457 days (range: 64-1186; median: 358 days), in patients with gallbladder carcioma 237 days (range: 92-609; median: 210 days) and in patients with carcinoma of papilla Vateri 850 days (range: 48-1518; median: 1277 days). The rate of 2-year survival in these groups was 27, 0 and 50%, respectively. The survival time differed significantly at the 5% level. The mean time of stent patency was 418, 220 and 850 days, respectively. No complications related directly to intraluminal brachytherapy were observed.
   Conclusions: Intraluminal brachytherapy combined with stent implantation is a safe method and appears to prolong survival in inoperable patients with Klatskin's tumor and carcinoma of papilla Vateri compared with nontreated patients in previous studies. In contrast no similar effect should be expected in patients with gallbladder carcinoma.
C1 Charles Univ, Teaching Hosp, Dept Med 1, Prague 12808 2, Czech Republic.
   Charles Univ, Teaching Hosp, Dept Radiol, Prague 12808 2, Czech Republic.
   Charles Univ, Teaching Hosp, Dept Radiotherapy & Oncol, Prague 1, Czech Republic.
RP Bruha, R (reprint author), Charles Univ, Teaching Hosp, Dept Med 1, U Nemocnice 2, Prague 12808 2, Czech Republic.
RI Bruha, Radan/A-4432-2008
CR ALDEN ME, 1994, INT J RADIAT ONCOL, V28, P945
   BISMUTH H, 1988, WORLD J SURG, V12, P39
   CAMERON JL, 1990, AM J SURG, V159, P91, DOI 10.1016/S0002-9610(05)80612-9
   CLASSEN M, 1987, ENDOSCOPY, V19, P25, DOI 10.1055/s-2007-1018305
   CONROY RM, 1982, CANCER, V49, P1321, DOI 10.1002/1097-0142(19820401)49:7<1321::AID-CNCR2820490702>3.0.CO;2-S
   COONS H, 1992, CARDIOVASC INTER RAD, V15, P367, DOI 10.1007/BF02734120
   Dick B W, 1990, J Vasc Interv Radiol, V1, P97, DOI 10.1016/S1051-0443(90)72511-0
   DOBELBOWER RR, 1986, CANCER, V58, P2185, DOI 10.1002/1097-0142(19861115)58:10<2185::AID-CNCR2820581004>3.0.CO;2-Q
   Eschelman DJ, 1996, RADIOLOGY, V200, P717
   FALKSON G, 1984, CANCER, V54, P965, DOI 10.1002/1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X
   FLETCHER MS, 1983, BRIT J SURG, V70, P733, DOI 10.1002/bjs.1800701213
   FRITZ P, 1994, INT J RADIAT ONCOL, V29, P855
   GILLAMS A, 1990, RADIOLOGY, V174, P137
   GONZALEZ DG, 1990, SEMIN LIVER DIS, V10, P131, DOI 10.1055/s-2008-1040466
   HISHIKAWA Y, 1983, RADIOLOGY, V146, P787
   JOHNSON DW, 1985, INT J RADIAT ONCOL, V11, P411
   JOHNSON PJ, 1987, BAILLIERE CLIN GASTR, V1, P17, DOI 10.1016/0950-3528(87)90032-7
   KAMAD T, 1996, INT J RAD ONCOL BOIL, V3, P767
   KARANI J, 1985, CLIN RADIOL, V36, P603, DOI 10.1016/S0009-9260(85)80242-7
   KLATSKIN G, 1965, AM J MED, V38, P241, DOI 10.1016/0002-9343(65)90178-6
   KUVSHINOFF BW, 1995, BRIT J SURG, V82, P1522, DOI 10.1002/bjs.1800821122
   Lai E C, 1987, Ann Surg, V205, P111, DOI 10.1097/00000658-198702000-00001
   LAMERIS JS, 1991, RADIOLOGY, V179, P703
   LAMMER J, 1990, RADIOLOGY, V177, P789
   Lee BH, 1997, AM J ROENTGENOL, V168, P741
   Leung J, 1996, AUST NZ J SURG, V66, P74, DOI 10.1111/j.1445-2197.1996.tb01115.x
   Leung J T, 1997, Australas Radiol, V41, P151, DOI 10.1111/j.1440-1673.1997.tb00701.x
   MAHE M, 1991, RADIOTHER ONCOL, V21, P121, DOI 10.1016/0167-8140(91)90084-T
   MATHIESON JR, 1994, RADIOLOGY, V192, P663
   MEYERS WC, 1988, WORLD J SURG, V12, P99
   Montemaggi P, 1996, RADIOLOGY, V199, P861
   NUNNERLEY HB, 1990, RADIOL CLIN N AM, V28, P1237
   REDING R, 1991, ANN SURG, V213, P236, DOI 10.1097/00000658-199103000-00010
   ROSSI P, 1994, J VASC INTERV RADIOL, V5, P279, DOI 10.1016/S1051-0443(94)71483-4
   SALOMONOWITZ EK, 1992, CARDIOVASC INTER RAD, V15, P351, DOI 10.1007/BF02734117
   SIEGEL JH, 1988, GASTROINTEST ENDOSC, V34, P301, DOI 10.1016/S0016-5107(88)71360-7
   ANDERSEN JR, 1989, GUT, V30, P1132, DOI 10.1136/gut.30.8.1132
   STAIN SC, 1992, SURG GYNECOL OBSTET, V175, P579
   Tana S, 1995, Radiol Med, V90, P124
   TSUJINO K, 1995, RADIOLOGY, V196, P275
   Vallis KA, 1996, RADIOTHER ONCOL, V41, P61
   VEEZEKUIJPERS B, 1990, INT J RADIAT ONCOL, V18, P63
   VENU RP, 1987, GASTROINTEST ENDOSC, V33, P236, DOI 10.1016/S0016-5107(87)71567-3
   WASHBURN WK, 1995, ARCH SURG-CHICAGO, V130, P270
NR 44
TC 38
Z9 43
PU H G E UPDATE MEDICAL PUBL LTD.
PI ATHENS
PA PO BOX 17160, ATHENS GR-10024, GREECE
SN 0172-6390
J9 HEPATO-GASTROENTEROL
JI Hepato-Gastroenterol.
PD MAY-JUN
PY 2001
VL 48
IS 39
BP 631
EP 637
PG 7
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 448MX
UT WOS:000169631600009
PM 11462891
ER

PT J
AU Guth, PS
   Norris, CH
AF Guth, PS
   Norris, CH
TI The hair cell acetylcholine receptors: A synthesis
SO HEARING RESEARCH
LA English
DT Article
DE acetylcholine; receptor; hair cell; inner ear; auditory; vestibular
ID GUINEA-PIG COCHLEA; POLYMERASE CHAIN-REACTION; VOLTAGE-CLAMP ANALYSIS;
   HIPPOCAMPAL-NEURONS; PHOSPHOINOSITIDE HYDROLYSIS; CHOLINERGIC
   INHIBITION; MUSCARINIC RECEPTORS; OUTWARD CURRENTS; BINDING-SITE; RAT
   COCHLEA
AB In this article the evidence concerning the nature of the acetylcholine (ACh) receptors on hair cells is reviewed. A schematic organization of these receptors is offered, based on the evidence as follows. (1) There are two kinds of ACh receptors on hair cells: muscarinic-like and nicotinic-like. (2) The nicotinic-like receptor mediates a hyperpolarizing response to ACh and a consequent reduction in afferent firing. (3) The muscarinic-like receptors mediate both a depolarization and a hyperpolarization of hair cells. (4) The hyperpolarization results in a reduction in afferent firing and (5) the depolarization results in an increase in afferent firing.
C1 TULANE UNIV, SCH MED, DEPT OTOLARYNGOL, NEW ORLEANS, LA 70112 USA.
RP Guth, PS (reprint author), TULANE UNIV, SCH MED, DEPT PHARMACOL, 1430 TULANE AVE, NEW ORLEANS, LA 70112 USA.
CR AMARO J, 1966, BRIT J PHARM CHEMOTH, V28, P207
   AMBACHE N, 1955, PHARMACOL REV, V7, P413
   ANNIKO M, 1991, ACTA OTO-LARYNGOL, V111, P491, DOI 10.3109/00016489109138374
   ART JJ, 1984, J PHYSIOL-LONDON, V356, P525
   ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384
   BARTOLAMI S, 1993, NEUROREPORT, V4, P1003
   BERNARD C, 1985, BRAIN RES, V338, P225, DOI 10.1016/0006-8993(85)90151-9
   BOBBIN RP, 1985, AUDITORY BIOCH, P102
   BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763
   BURGEN ASV, 1974, BRIT J PHARMACOL, V50, P145
   BUTH PS, 1996, ASS RES OTOLARYNGOL, V19, P398
   CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B
   COMIS SD, 1974, NEUROPHARMACOLOGY, V13, P633, DOI 10.1016/0028-3908(74)90053-7
   COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F
   DODD J, 1981, BRAIN RES, V207, P109, DOI 10.1016/0006-8993(81)90682-X
   DRESCHER DG, 1992, J NEUROCHEM, V59, P765, DOI 10.1111/j.1471-4159.1992.tb09436.x
   DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9
   ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X
   EROSTEGUI C, 1994, HEARING RES, V74, P135, DOI 10.1016/0378-5955(94)90182-1
   FELDER CC, 1992, P NATL ACAD SCI USA, V89, P509, DOI 10.1073/pnas.89.2.509
   FEX J, 1978, BRAIN RES, V159, P440, DOI 10.1016/0006-8993(78)90555-3
   FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039
   FUCHS PA, 1992, J NEUROSCI, V12, P800
   GERZANICH V, 1994, MOL PHARMACOL, V45, P212
   GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0
   GUIRAMAND J, 1990, BIOCHEM PHARMACOL, V39, P1913, DOI 10.1016/0006-2952(90)90609-O
   GUTH PS, 1986, ACTA OTO-LARYNGOL, V102, P194, DOI 10.3109/00016488609108666
   GUTH PS, 1969, INT J NEUROPHARMACOL, V8, P49
   GUTH PS, 1994, HEARING RES, V75, P225, DOI 10.1016/0378-5955(94)90073-6
   HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4
   HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0
   HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065
   HOUSLEY GD, 1994, HEARING RES, V75, P47, DOI 10.1016/0378-5955(94)90054-X
   HOUSLEY GD, 1990, HEARING RES, V43, P121, DOI 10.1016/0378-5955(90)90221-A
   Hulme E. C., 1990, ANN REV PHARM TOXICO, V30, P663
   JAMES WM, 1983, HEARING RES, V9, P113, DOI 10.1016/0378-5955(83)90139-9
   JASSER A, 1973, J NEUROCHEM, V20, P45, DOI 10.1111/j.1471-4159.1973.tb12103.x
   KAKEHATA S, 1993, J PHYSIOL-LONDON, V463, P227
   KATZ A, 1992, NATURE, V360, P6887
   KRNJEVIC K, 1993, PROG BRAIN RES, V98, P285
   KUJAWA SG, 1994, HEARING RES, V74, P122, DOI 10.1016/0378-5955(94)90181-3
   LAI J, 1991, J PHARMACOL EXP THER, V258, P938
   LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268
   LUETJE CW, 1991, J NEUROSCI, V11, P837
   MADISON DV, 1987, J NEUROSCI, V7, P733
   MICHELSO.MJ, 1974, BIOCHEM PHARMACOL, V23, P2211, DOI 10.1016/0006-2952(74)90551-6
   MULLE C, 1992, NEURON, V8, P135, DOI 10.1016/0896-6273(92)90115-T
   NIEDZIELSKI AS, 1992, HEARING RES, V59, P250, DOI 10.1016/0378-5955(92)90121-3
   NORRIS CH, 1974, ACTA OTO-LARYNGOL, V77, P318, DOI 10.3109/00016487409124631
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   PINKASKRAMARSKI R, 1990, NEUROSCI LETT, V108, P335, DOI 10.1016/0304-3940(90)90663-T
   PLINKERT PK, 1991, HEARING RES, V53, P123, DOI 10.1016/0378-5955(91)90219-Y
   REEVE HL, 1995, NEUROPHARMACOLOGY, V34, P319, DOI 10.1016/0028-3908(94)00161-K
   RICCI A, 1991, BRAIN RES, V565, P78, DOI 10.1016/0006-8993(91)91738-M
   ROBERTS WM, 1994, J NEUROSCI, V14, P3246
   ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0
   ROBERTS WM, 1991, ANN NY ACAD SCI, V635, P221, DOI 10.1111/j.1749-6632.1991.tb36494.x
   ROSSI ML, 1980, BRAIN RES, V185, P125, DOI 10.1016/0006-8993(80)90677-0
   RUSSELL IJ, 1972, J EXP BIOL, V57, P77
   SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155
   SEGUELA P, 1993, J NEUROSCI, V13, P596
   SHIGEMOTO T, 1991, J PHYSIOL-LONDON, V442, P669
   STEINACKER A, 1988, HEARING RES, V35, P365
   SUGAI T, 1992, HEARING RES, V61, P56, DOI 10.1016/0378-5955(92)90036-M
   TAKASHIMA A, 1989, J BIOL CHEM, V264, P10654
   VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S
   WACKYM PA, 1992, OTOLARYNG CLIN N AM, V25, P1053
   YOSHIDA N, 1994, BRAIN RES, V644, P90, DOI 10.1016/0006-8993(94)90351-4
NR 68
TC 38
Z9 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5955
J9 HEARING RES
JI Hear. Res.
PD SEP 1
PY 1996
VL 98
IS 1-2
BP 1
EP 8
DI 10.1016/0378-5955(96)00031-7
PG 8
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA VH191
UT WOS:A1996VH19100001
PM 8880175
ER

PT J
AU LEE, JD
AF LEE, JD
TI WASTE-DISPOSAL ASSESSMENT OF HYLIFE-II STRUCTURE
SO FUSION TECHNOLOGY
LA English
DT Article
DE WASTE DISPOSAL; ICF; HYLIFE-II
AB Initial scoping analysis indicates that by using Type 304 stainless steel (SS), most of the vacuum vessel's structural mass in the HYLIFE-II inertial fusion energy power plant conceptual design could be disposed of by shallow burial. And, if all the structural components are mixed together and treated as one solid entity, all of it could be disposed of by shallow burial Two other types of SS assessed, manganese-modified Type 316 SS and prime candidate alloy (PCA), were found to require disposal by deep geologic burial of most of the structural mass. The presence of niobium and molybdenum in manganese-modified Type 316 SS and PCA was found to dominate the generation of long-term wastes that contribute to the shallow burial index, and their presence should be avoided.
RP LEE, JD (reprint author), LAWRENCE LIVERMORE NATL LAB,POB 808,LIVERMORE,CA 94550, USA.
CR BLINK JA, 1981, UCRL53262 LAWR LIV N
   BLINK JA, 1985, UCRL53633 LAWR LIV N
   EDWARDS A, 1992, UCID17026 LAWR LIV N
   FETTER S, 1988, FUSION ENG DES, V6, P123, DOI 10.1016/S0920-3796(88)80098-X
   GARDNER MA, 1978, UCRL50400 LAWR LIV N, V18
   HOUSE PA, 1992, FUSION TECHNOL, V21, P1487
   HOWERTON RJ, 1975, UCRL50400 LAWR LIV N, V15
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   PLEACHATY EF, 1976, UCRL50400 LAWR LIV N, V14
   1984, J NUCL MATER, V122, P472
   1971, MATERIALS ENG, P85
NR 11
TC 38
Z9 38
PU AMER NUCLEAR SOCIETY
PI LA GRANGE PK
PA 555 N KENSINGTON AVENUE, LA GRANGE PK, IL 60525
SN 0748-1896
J9 FUSION TECHNOL
JI Fusion Technol.
PD AUG
PY 1994
VL 26
IS 1
BP 74
EP 78
PG 5
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA NY713
UT WOS:A1994NY71300006
ER

PT J
AU DICKMAN, JD
   CORREIA, MJ
AF DICKMAN, JD
   CORREIA, MJ
TI BILATERAL COMMUNICATION BETWEEN VESTIBULAR LABYRINTHS IN PIGEONS
SO NEUROSCIENCE
LA English
DT Article
ID SEMICIRCULAR CANAL AFFERENTS; RETROGRADE TRACER METHODS; OPSANUS-TAU;
   EFFERENT NEURONS; SYSTEM; TOADFISH; FIBERS; FROG; RESPONSES;
   ORGANIZATION
AB Extracellular action potentials from single horizontal semicircular canal primary afferent fibers were recorded in paralysed decerebrate pigeons during pulse mechanical stimulation of the contralateral horizontal semicircular canal. Clear responses to the contralateral membranous duct displacement stimuli were observed in 51% of the tested 158 horizontal semicircular canal afferents. Generally, three different types of responses were obtained in the primary afferent fibers including excitation, inhibition, and a few complex type neural activity profiles. Inhibitory responses were of larger amplitude and had longer time constants than did excitatory responses. The few complex type responses observed were characterized by an initial excitatory discharge followed by a longer duration decrease in the fiber's firing rate. The sensitivity to stimulation and type of response obtained for each afferent was significantly correlated with the fiber's coefficient of variation value. Regular firing afferents were less sensitive and exhibited primarily excitatory responses (71%) to contralateral canal stimulation. Irregular firing afferents were more sensitive and exhibited mostly inhibitory responses (84%).
   The present results demonstrate that a communication network for information exchange between the bilateral labyrinths exists in pigeons. The observed responses in primary afferent fibers to contralateral horizontal semicircular canal stimulation are proposed to be mediated by the vestibular efferent system, which could provide an anatomical pathway for information exchange from vestibular receptors on opposite sides of the head.
C1 UNIV MISSISSIPPI,MED CTR,DEPT ANAT,JACKSON,MS 39216.
   UNIV TEXAS,MED BRANCH,DEPT OTOLARYNGOL,GALVESTON,TX 77550.
   UNIV TEXAS,MED BRANCH,DEPT PHYSIOL & BIOPHYS,GALVESTON,TX 77550.
RP DICKMAN, JD (reprint author), UNIV MISSISSIPPI,MED CTR,DEPT SURG OTOLARYNGOL,JACKSON,MS 39216, USA.
CR ANASTASIO TJ, 1985, J NEUROPHYSIOL, V54, P335
   ANNIKO M, 1991, ACTA OTO-LARYNGOL, V111, P491, DOI 10.3109/00016489109138374
   BOYLE R, 1990, J NEUROSCI, V10, P1570
   BOYLE R, 1991, J NEUROPHYSIOL, V66, P1504
   BRICHTA AM, 1992, SOC NEUR ABSTR, V18, P510
   BROWN RD, 1969, J PHARMACOL EXP THER, V165, P300
   DECHESNE C, 1977, NEUROSCIENCE, V2, P893
   DICKMAN JD, 1988, J NEUROSCI METH, V25, P111, DOI 10.1016/0165-0270(88)90147-1
   DICKMAN JD, 1989, J NEUROPHYSIOL, V62, P1090
   DICKMAN JD, 1992, ANN NY ACAD SCI, V656, P927, DOI 10.1111/j.1749-6632.1992.tb25297.x
   DIERINGER N, 1977, NEUROSCI LETT, V5, P285, DOI 10.1016/0304-3940(77)90080-5
   EDEN AR, 1982, BRAIN RES, V248, P210
   ESTES MS, 1975, J NEUROPHYSIOL, V38, P1232
   FAVRE D, 1977, ARCH OTO-RHINO-LARYN, V215, P183, DOI 10.1007/BF00455865
   GALLEY N, 1973, BRAIN RES, V64, P55, DOI 10.1016/0006-8993(73)90170-4
   GLEISNER L, 1963, ACTA OTO-LARYNGOL, V192, P90
   GOLDBERG JM, 1990, HEARING RES, V49, P89, DOI 10.1016/0378-5955(90)90097-9
   GOLDBERG JM, 1980, J NEUROPHYSIOL, V43, P986
   GRIBENSKI A, 1976, EXP BRAIN RES, V26, P275
   GUTH PS, 1986, ACTA OTOLARYNGOL, V102, P186
   HIGHSTEIN SM, 1986, J COMP NEUROL, V243, P309, DOI 10.1002/cne.902430303
   HIGHSTEIN SM, 1985, J NEUROPHYSIOL, V54, P370
   LLINAS R, 1969, EXP BRAIN RES, V9, P16
   MARCO J, 1990, ADV OTO-RHINO-LARYNG, V45, P82
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   PERACHIO AA, 1989, EXP BRAIN RES, V78, P315
   PERACHIO AA, 1988, BASIC APPLIED ASPECT
   PERACHIO AA, 1983, BRAIN RES, V280, P287, DOI 10.1016/0006-8993(83)90058-6
   PRECHT W, 1971, EXP BRAIN RES, V13, P378
   ROSSI ML, 1980, BRAIN RES, V185, P125, DOI 10.1016/0006-8993(80)90677-0
   SANS A, 1984, BRAIN RES, V308, P191, DOI 10.1016/0006-8993(84)90936-3
   SCHWARZ IE, 1981, J COMP NEUROL, V196, P1, DOI 10.1002/cne.901960102
   STRUTZ J, 1980, NEUROSCI LETT, V18, P5, DOI 10.1016/0304-3940(80)90205-0
   STRUTZ J, 1982, BRAIN RES, V244, P165, DOI 10.1016/0006-8993(82)90914-3
   TANAKA M, 1989, BRAIN RES, V504, P31, DOI 10.1016/0006-8993(89)91593-X
   THOMAS RC, 1965, NATURE, V206, P211, DOI 10.1038/206211b0
   VALLI P, 1986, BRAIN RES, V362, P92, DOI 10.1016/0006-8993(86)91402-2
   Wersall J., 1974, HDB SENSORY PHYSIOLO, V6, P123
   WILL U, 1982, CELL TISSUE RES, V225, P673
NR 39
TC 38
Z9 38
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0306-4522
J9 NEUROSCIENCE
JI Neuroscience
PD DEC
PY 1993
VL 57
IS 4
BP 1097
EP 1108
DI 10.1016/0306-4522(93)90052-H
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA ML366
UT WOS:A1993ML36600022
PM 8309545
ER

PT J
AU SREERAM, N
   SALEEM, M
   JACKSON, M
   PEART, I
   MCKAY, R
   ARNOLD, R
   WALSH, K
AF SREERAM, N
   SALEEM, M
   JACKSON, M
   PEART, I
   MCKAY, R
   ARNOLD, R
   WALSH, K
TI RESULTS OF BALLOON PULMONARY VALVULOPLASTY AS A PALLIATIVE PROCEDURE IN
   TETRALOGY OF FALLOT
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID VENTRICULAR OUTFLOW TRACT; BLALOCK-TAUSSIG SHUNT; VALVE STENOSIS;
   PRIMARY REPAIR; DILATATION; INFANCY; GROWTH; INSUFFICIENCY; MANAGEMENT;
   OPERATION
AB Balloon pulmonary valvuloplasty was attempted in 67 patients with tetralogy of Fallot at a median age of 5 months (range 0.03 to 52 months) for relief of cyanosis.  In three patients, the valve could not be crossed and an aortopulmonary shunt was performed.  In 35 patients, follow-up angiography was performed 3 to 30 months (average 12) after valvuloplasty.  In 24 of these 35 patients (group A), the stenosis had been adequately palliated by valvuloplasty; the other 11 patients (group B) had required an aortopulmonary shunt 1 month (range 0 to 3 months) after valvuloplasty.  The two groups were similar (p < 0.1) with respect to age at valvuloplasty, pulmonary anulus diameter, ratio of pulmonary artery to descending aorta diameter before valvuloplasty and interval to follow-up angiography.  In contrast to patients in group B, patients in group A had a significant immediate improvement in systemic arterial oxygen saturation (p < 0.01) and a significant increase in pulmonary anulus diameter at follow-up angiography (p < 0.001).  The growth of the branch pulmonary arteries was similar (p < 0.1) in the two groups.
   Among 42 patients who have had surgical correction, a transannular patch for right ventricular outflow tract reconstruction was used in 27 (64%); there was no difference between groups A and B with respect to its use.  Eight patients died (three after repair) and death could not be directly attributed to valvuloplasty in any.
   Balloon valvuloplasty promotes growth of the pulmonary valve anulus and pulmonary arteries and is a useful alternative to an aortopulmonary shunt in patients with small pulmonary arteries or associated complex intracardiac defects.
C1 UNIV LIVERPOOL,INST CHILD HLTH,LIVERPOOL L69 3BX,ENGLAND.
RP SREERAM, N (reprint author), ROYAL LIVERPOOL CHILDRENS HOSP,DEPT CARDIOL,HEART CLIN,EATON RD,LIVERPOOL L12 2AP,ENGLAND.
CR ALFIERI O, 1979, J THORAC CARDIOV SUR, V77, P826
   ALIFERI O, 1979, J THORAC CARDIOVASC, V78, P440
   BATTISTESSA SA, 1990, BRIT HEART J, V64, P321
   BOVE EL, 1983, J THORAC CARDIOV SUR, V85, P691
   CASTANEDA AR, 1977, J THORAC CARDIOV SUR, V74, P372
   FELLOWS KE, 1987, AM J CARDIOL, V60, P679, DOI 10.1016/0002-9149(87)90381-X
   GALE AW, 1979, J THORAC CARDIOV SUR, V77, P459
   GRAHAM TP, 1976, CIRCULATION, V54, P417
   GUSTAFSON RA, 1988, ANN THORAC SURG, V45, P235
   GUYTON RA, 1983, J THORAC CARDIOV SUR, V85, P917
   ILBAWI MN, 1987, J THORAC CARDIOV SUR, V93, P36
   KAN JS, 1982, NEW ENGL J MED, V307, P540, DOI 10.1056/NEJM198208263070907
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KAY PH, 1983, BRIT HEART J, V49, P359
   KIRKLIN JW, 1979, CIRCULATION, V60, P373
   MCGOON DC, 1975, CIRCULATION, V52, P109
   NEWFELD EA, 1977, AM J CARDIOL, V39, P715, DOI 10.1016/S0002-9149(77)80134-3
   PARSONS JM, 1989, BRIT HEART J, V62, P65
   QURESHI SA, 1988, BRIT HEART J, V60, P232
   RADTKE W, 1986, J AM COLL CARDIOL, V8, P909
   RAO PS, 1988, BRIT HEART J, V60, P507
   REY C, 1988, J AM COLL CARDIOL, V11, P815
   RING JC, 1984, AM J CARDIOL, V55, P210
   RITTENHOUSE EA, 1985, J THORAC CARDIOV SUR, V89, P772
   Rowlatt UF, 1963, PEDIATR CLIN N AM, V10, P499
   TOUATI GD, 1990, J THORAC CARDIOV SUR, V99, P396
   WALSH EP, 1988, CIRCULATION, V77, P1062
NR 27
TC 38
Z9 41
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD JUL
PY 1991
VL 18
IS 1
BP 159
EP 165
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FU815
UT WOS:A1991FU81500026
PM 1711062
ER

PT J
AU LUBET, RA
   CARLSON, DE
AF LUBET, RA
   CARLSON, DE
TI THERAPY OF MURINE PLASMACYTOMA MOPC 104E - ROLE OF IMMUNE-RESPONSE
SO JOURNAL OF THE NATIONAL CANCER INSTITUTE
LA English
DT Article
C1 UNIV TEXAS,HLTH SCI CTR,DEPT RADIOL,DALLAS,TX 75235.
CR ANDERSON RE, 1976, ADV IMMUNOL, V24, P214
   Burnet FM, 1964, BRIT MED B, V20, P154
   COX P J, 1976, Biochemical Pharmacology, V25, P993, DOI 10.1016/0006-2952(76)90331-2
   HIRAMOTO R, 1975, CANCER RES, V35, P1309
   HIRAMOTO RN, 1974, CANCER RES, V34, P1738
   HIRAMOTO RN, 1974, J IMMUNOL, V112, P266
   KAHAN BD, 1975, J SURG RES, V18, P263, DOI 10.1016/0022-4804(75)90150-X
   LAMON EW, 1973, J EXP MED, V137, P1472, DOI 10.1084/jem.137.6.1472
   LIN HS, 1973, CANCER RES, V33, P1716
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   LUBET RA, 1977, CANCER IMMUNOL IMMUN, V2, P67
   LUBET RA, 1978, J NATL CANCER I, V60, P1107
   MATHE G, 1977, CANCER IMMUNOL IMMUN, V2, P139
   MCCOY JL, 1974, INT J CANCER, V14, P264, DOI 10.1002/ijc.2910140216
   MOORE M, 1973, INT J CANCER, V11, P358, DOI 10.1002/ijc.2910110213
   OGAWA M, 1973, BLOOD, V41, P7
   PREHN RT, 1977, J NATL CANCER I, V59, P1043
   RADOV LA, 1976, INT J CANCER, V17, P773, DOI 10.1002/ijc.2910170613
   SLADEK NE, 1972, CANCER RES, V32, P535
   STEEL GG, 1975, CANCER RES, V35, P1530
   TELLER MN, 1974, J NATL CANCER I, V52, P667
   WARNER TFCS, 1977, J NATL CANCER I, V58, P983
   WILLIAMS WH, 1972, J NATL CANCER I, V49, P1613
NR 23
TC 38
Z9 38
PU NATL CANCER INSTITUTE
PI BETHESDA
PA 9030 OLD GEORGETOWN RD, BETHESDA, MD 20814
SN 0027-8874
J9 J NATL CANCER I
JI J. Natl. Cancer Inst.
PY 1978
VL 61
IS 3
BP 897
EP 903
PG 7
WC Oncology
SC Oncology
GA FS775
UT WOS:A1978FS77500038
PM 278867
ER

PT J
AU Afilalo, J
   Rasti, M
   Ohayon, SM
   Shimony, A
   Eisenberg, MJ
AF Afilalo, Jonathan
   Rasti, Mandana
   Ohayon, Samuel M.
   Shimony, Avi
   Eisenberg, Mark J.
TI Off-pump vs. on-pump coronary artery bypass surgery: an updated
   meta-analysis and meta-regression of randomized trials
SO EUROPEAN HEART JOURNAL
LA English
DT Article
DE Coronary artery bypass; Off-pump; Meta-analysis; Meta-regression;
   Mortality; Stroke
ID LOW-RISK PATIENTS; CARDIOPULMONARY BYPASS; BEATING-HEART; MYOCARDIAL
   REVASCULARIZATION; GRAFT-SURGERY; INFLAMMATORY RESPONSE;
   CARDIAC-SURGERY; TRANSFUSION REQUIREMENTS; PULMONARY-DISEASE; OXIDATIVE
   STRESS
AB The benefits of off-pump coronary artery bypass (OPCAB) continue to be debated, in part due to the fact that pooled effects fail to consider differences in trial and patient characteristics. We sought to analyse the contemporary evidence for OPCAB vs. conventional coronary artery bypass (CCAB), incorporating recent larger trials, and adjusting for differences in trials using a technique known as meta-regression.
   We systematically reviewed MEDLINE, EMBASE, and the Cochrane database for published and unpublished randomized trials of OPCAB vs. CCAB in which 30-day or in-hospital clinical outcomes were reported. The outcomes of interest were: all-cause mortality, stroke, and myocardial infarction. In addition to measuring the pooled treatment effects using a random effects meta-analysis model, we measured the effect of selected trial-level factors on the effects observed using the meta-regression technique. Fifty-nine trials were included, encompassing 8961 patients with a mean age of 63.4 and 16 females. There was a significant 30 reduction in the occurrence of post-operative stroke with OPCAB [risk ratio (RR) 0.70, 95 CI: 0.490.99]. There was no significant difference in mortality (RR: 0.90, 95 CI: 0.631.30) or myocardial infarction (pooled RR: 0.89, 95 CI: 0.691.13). In the meta-regression analysis, the effect of OPCAB on all of the clinical outcomes was similar regardless of mean age, proportion of females in the trial, number of grafts per patient, and trial publication date.
   Our meta-analysis incorporating recent trials suggests that there appears to be a beneficial effect of OPCAB on stroke. Moreover, our meta-regression does not support the hypothesis that differences in study populations are responsible for the observed outcomes, although pooled individual patient-data would be better suited to confirm these findings.
C1 [Afilalo, Jonathan; Rasti, Mandana; Ohayon, Samuel M.; Shimony, Avi; Eisenberg, Mark J.] McGill Univ, SMBD Jewish Gen Hosp, Div Cardiol, Dept Med, Montreal, PQ H3T 1E2, Canada.
   [Afilalo, Jonathan; Rasti, Mandana; Ohayon, Samuel M.; Shimony, Avi; Eisenberg, Mark J.] McGill Univ, SMBD Jewish Gen Hosp, Div Clin Epidemiol, Dept Med, Montreal, PQ H3T 1E2, Canada.
RP Afilalo, J (reprint author), McGill Univ, SMBD Jewish Gen Hosp, Div Cardiol, Dept Med, 3755 Cote Ste Catherine,Suite A-112, Montreal, PQ H3T 1E2, Canada.
EM jonathan@afilalo.com
FU Canadian Institutes of Health Research (CIHR); Fonds de la recherche en
   sante du Quebec (FRSQ)
FX M.J.E. is a National Researcher supported by the Canadian Institutes of
   Health Research (CIHR) and the Fonds de la recherche en sante du Quebec
   (FRSQ).
CR Abu-Omar Y, 2004, J THORAC CARDIOV SUR, V127, P1759, DOI 10.1016/j.jtves.2003.09.048
   Al-Ruzzeh S, 2006, BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C
   Alwan K, 2004, ANN THORAC SURG, V77, P2051, DOI 10.1016/j.athoracsur.2003.11.004
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Baker RA, 2001, HEART SURG FORUM, V4, pS19
   Bednar F, 2008, J THORAC CARDIOV SUR, V136, P1054, DOI 10.1016/j.jtcvs.2008.03.052
   Biglioli P, 2003, EUR J CARDIO-THORAC, V24, P260, DOI 10.1016/S1010-7940(03)00295-1
   Bradley SM, 2003, ANN THORAC SURG, V76, P783
   Brizzio ME, 2010, ANN THORAC SURG, V89, P19, DOI 10.1016/j.athoracsur.2009.07.076
   Caputo M, 2002, ANN THORAC SURG, V74, P2088, DOI 10.1016/S0003-4975(02)04025-0
   Caputo M, 2002, ANN THORAC SURG, V74, P2095
   Carrier M, 2003, HEART SURG FORUM, V6, pE89
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Covino E, 2001, J CARDIOVASC SURG, V42, P23
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Diegeler A, 2000, CIRCULATION, V102, P95
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Fattouch K, 2009, J THORAC CARDIOV SUR, V137, P650, DOI 10.1016/j.jtcvs.2008.11.033
   Fattouch K, 2009, J THORAC CARDIOVASC, V137, P656
   Feng ZZ, 2009, ANN THORAC SURG, V87, P757, DOI 10.1016/j.athoracsur.2008.11.042
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Guler M, 2001, ANN THORAC SURG, V71, P152, DOI 10.1016/S0003-4975(00)02250-5
   Gulielmos V, 2000, EUR J CARDIO-THORAC, V18, P594, DOI 10.1016/S1010-7940(00)00553-4
   Halkos ME, 2010, CURR OPIN CARDIOL, V25, P583, DOI 10.1097/HCO.0b013e32833f04b0
   Hernandez F, 2007, ANN THORAC SURG, V84, P1897, DOI 10.1016/j.athoracsur.2007.07.036
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Houlind K, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-47
   Hueb W, 2010, CIRCULATION, V122, pS48, DOI 10.1161/CIRCULATIONAHA.109.924258
   Johansson-Synnergren M, 2004, SCAND CARDIOVASC J, V38, P53, DOI 10.1080/14017430410024847
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kobayashi J, 2005, CIRCULATION S1, V112, pI338
   Kochamba GS, 2000, ANN THORAC SURG, V69, P1466, DOI 10.1016/S0003-4975(00)01142-5
   Krejca M, 1999, EUR J CARDIO-THORAC, V16, P337, DOI 10.1016/S1010-7940(99)00234-1
   Kuss O, 2008, J THORAC CARDIOV SUR, V136, P241, DOI 10.1016/j.jtcvs.2007.12.046
   Hammon JW, 2003, ANN THORAC SURG, V76, P25
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Lund C, 2003, ANN THORAC SURG, V76, P770
   Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Medved I, 2008, COLLEGIUM ANTROPOL, V32, P381
   Michaux I, 2006, J THORAC CARDIOV SUR, V131, P1281, DOI 10.1016/j.jtcvs.2006.01.035
   Mishra M, 2006, ANN THORAC SURG, V82, P608, DOI 10.1016/j.athoracsur.2006.03.071
   Moher D, 2009, ANN INTERN MED, V151, P264
   Moller CH, 2010, CIRCULATION, V121, P498, DOI 10.1161/CIRCULATIONAHA.109.880443
   Motallebzadeh R, 2007, ANN THORAC SURG, V83, P475, DOI 10.1016/j.athoracsur.2006.09.024
   Motallebzadeh R, 2004, EUR J CARDIO-THORAC, V25, P409, DOI 10.1016/j.ejcts.2003.12.018
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Nesher N, 2006, J CARDIAC SURG, V21, P395, DOI 10.1111/j.1540-8191.2006.00272.x
   Niranjan G, 2006, EUR J CARDIO-THORAC, V30, P271, DOI 10.1016/j.ejcts.2006.04.042
   Nishiyama K, 2009, ANN THORAC SURG, V87, P1839, DOI 10.1016/j.athoracsur.2009.02.061
   Onorati F, 2010, EUR J CARDIO-THORAC, V37, P897, DOI 10.1016/j.ejcts.2009.11.010
   Ozkara C, 2007, INT J CLIN PRACT, V61, P763, DOI 10.1111/j.1742-1241.2006.00952.x
   Paparella D, 2006, J THORAC CARDIOV SUR, V131, P290, DOI 10.1016/j.jtcvs.2005.10.018
   Parolari A, 2003, ANN THORAC SURG, V76, P737, DOI 10.1016/S0003-4975(03)00683-0
   Parolari A, 2003, ANN THORAC SURG, V76, P743
   Paulitsch FS, 2009, CORONARY ARTERY DIS, V20, P100, DOI 10.1097/MCA.0b013e3283219e8b
   Penttila HJ, 2001, ANN THORAC SURG, V71, P565, DOI 10.1016/S0003-4975(00)02002-6
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Rainio A, 2007, J CARDIOVASC SURG, V48, P773
   Rastan AJ, 2005, EUR J CARDIO-THORAC, V27, P1057, DOI 10.1016/j.ejcts.2005.03.007
   Sahlman A, 2003, SCAND CARDIOVASC J, V37, P211, DOI 10.1080/14017430310001726
   Sajja LR, 2007, J THORAC CARDIOV SUR, V133, P378, DOI 10.1016/j.jtcvs.2006.09.028
   Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2
   Selvanayagam JB, 2004, CIRCULATION, V109, P345, DOI 10.1161/01.CIR.0000109489.71945.BD
   Sharony R, 2003, CIRCULATION, V108, P15, DOI 10.1161/01.cir.0000087448.65888.21
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Takagi H, 2010, J THORAC CARDIOV SUR, V140, pE45, DOI 10.1016/j.jtcvs.2009.11.045
   Takagi H, 2007, J THORAC CARDIOV SUR, V134, P1059, DOI 10.1016/j.jtcvs.2007.07.006
   Tang ATM, 2002, EUR J CARDIO-THORAC, V22, P118, DOI 10.1016/S1010-7940(02)00220-8
   Tatoulis J, 2006, ANN THORAC SURG, V82, P1436, DOI 10.1016/j.athoracsur.2006.04.053
   Uva MS, 2010, EUR HEART J, V31, P2492, DOI 10.1093/eurheartj/ehq210
   Vedin J, 2006, EUR J CARDIO-THORAC, V30, P305, DOI 10.1016/j.ejcts.2006.03.037
   Velissaris T, 2003, EUR J CARDIO-THORAC, V23, P917, DOI 10.1016/S1010-7940(03)00167-2
   Velissaris T, 2003, EUR J CARDIO-THORAC, V23, P924
   Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043
   Wandschneider W, 2000, ANN THORAC SURG, V70, P1577, DOI 10.1016/S0003-4975(00)01843-9
   Wehlin L, 2004, EUR J CARDIO-THORAC, V25, P35, DOI 10.1016/S1010-7940(03)00652-3
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 83
TC 37
Z9 37
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
J9 EUR HEART J
JI Eur. Heart J.
PD MAY
PY 2012
VL 33
IS 10
BP 1257
EP 1267
DI 10.1093/eurheartj/ehr307
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 944IY
UT WOS:000304194400021
PM 21987177
ER

PT J
AU Verheugt, CL
   Uiterwaal, CSPM
   Grobbee, DE
   Mulder, BJM
AF Verheugt, Carianne L.
   Uiterwaal, Cuno S. P. M.
   Grobbee, Diederick E.
   Mulder, Barbara J. M.
TI Long-term prognosis of congenital heart defects: A systematic review
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Review
DE Congenital heart defects; Epidemiology; Long-term; Prognosis; Survival
ID VENTRICULAR SEPTAL-DEFECT; FOLLOW-UP; RISK-FACTORS; AORTIC COARCTATION;
   SURGICAL CLOSURE; GREAT-ARTERIES; BALLOON ANGIOPLASTY; PULMONARY
   STENOSIS; MUSTARD OPERATION; OUTFLOW TRACT
AB Background: In the large and expanding population of adults with congenital heart disease, little is known about their long-term outcome. By means of a systematic literature search, we aimed to assess the quantity and quality of data on long-term survival and morbidity in adults with common congenital heart defects.
   Methods: All literature on MEDLINE from January 1980 to January 2007 was searched, using a broad range of keywords for atrial septal defect, ventricular septal defect, pulmonary stenosis, tetralogy of Fallot, aortic coarctation, and transposition of the great arteries. After study selection using pre-specified criteria and quality assessment, data were extracted and weighed according to number of patients. Pooled estimates were obtained.
   Results: We identified 322 articles. Selection yielded 35 articles comprising 7894 patients. Data on survival were mainly available up until 40 years of age. In this young population, survival varied from 87.4% in aortic coarctation to 99.6% in atrial septal defect. Data on morbidity were sparse. Based on these data, morbidity was substantial.
   Conclusions: Until the age of 40 years, survival is decreased in patients with congenital heart defects, albeit most pronounced among patients with complex heart defects. Moreover, morbidity is considerable in all defects. Sufficient data on long-term survival and morbidity beyond the age of 40 years are lacking, yet crucial for optimal clinical care. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Verheugt, Carianne L.; Mulder, Barbara J. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands.
   [Verheugt, Carianne L.; Uiterwaal, Cuno S. P. M.; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Mulder, Barbara J. M.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.
RP Mulder, BJM (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM b.j.mulder@amc.uva.nl
RI Grobbee, Diederick/C-7651-2014
OI Grobbee, Diederick/0000-0003-4472-4468
CR ABRIL E, 1982, SCAND J THORAC CARD, V16, P33, DOI 10.3109/14017438209100606
   Agnetti A, 2004, CLIN CARDIOL, V27, P611, DOI 10.1002/clc.4960271107
   Bacha EA, 2001, J THORAC CARDIOV SUR, V122, P154, DOI 10.1067/mtc.2001.115156
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840
   BOGERS AJJC, 1994, THORAC CARDIOV SURG, V42, P337, DOI 10.1055/s-2007-1016518
   Bolz D, 2005, PEDIATR CARDIOL, V26, P614, DOI 10.1007/s00246-005-0838-2
   Bouchart F, 2000, ANN THORAC SURG, V70, P1483, DOI 10.1016/S0003-4975(00)01999-8
   CALZA G, 1989, ANN THORAC SURG, V47, P428
   Carr JA, 2005, ANN THORAC SURG, V79, P1950, DOI 10.1016/j.athoracsur.2005.01.004
   DUFFELS MG, 2007, NETH HEART J, V15, P357
   Engelfriet P, 2005, EUR HEART J, V26, P2325, DOI 10.1093/eurheartj/ehi396
   Fawzy ME, 2004, J AM COLL CARDIOL, V43, P1062, DOI 10.1016/j.jacc.2003.10.040
   Gabriel HM, 2002, J AM COLL CARDIOL, V39, P1066, DOI 10.1016/S0735-1097(02)01706-0
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   Hamada H, 2002, CARDIOL YOUNG, V12, P345
   HARJULA A, 1988, J CARDIOVASC SURG, V29, P134
   Harrison DA, 2001, AM J CARDIOL, V87, P584, DOI 10.1016/S0002-9149(00)01435-1
   HEIKKINEN L, 1990, ANN THORAC SURG, V49, P948
   Hisatomi K, 1995, J CARDIOVASC SURG, V36, P541
   HISATOMI K, 1991, Kurume Medical Journal, V38, P149
   Hoimyr H, 2006, EUR J CARDIO-THORAC, V30, P910, DOI 10.1016/j.ejcts.2006.09.016
   HORVATH KA, 1992, J AM COLL CARDIOL, V20, P1156
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   JONSSON H, 1995, SCAND J THORAC CARD, V29, P43, DOI 10.3109/14017439509107201
   Kaul T K, 1988, Eur J Cardiothorac Surg, V2, P405, DOI 10.1016/1010-7940(88)90042-5
   Lange R, 2006, CIRCULATION, V114, P1905, DOI 10.1161/CIRCULATIONAHA.105.606046
   Lu X, 2006, THORAC CARDIOV SURG, V54, P295, DOI 10.1055/s-2006-923959
   Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066
   MIYAMURA H, 1993, SURG TODAY, V23, P1049
   Moons P, 2006, EUR HEART J, V27, P1324, DOI 10.1093/eurheartj/ehi858
   Nieminen HP, 2001, CIRCULATION, V104, P570, DOI 10.1161/hc3101.093968
   Niwa K, 2002, CARDIOL YOUNG, V12, P453, DOI 10.1017/S104795110200077X
   Norgaard MA, 1999, EUR J CARDIO-THORAC, V16, P125, DOI 10.1016/S1010-7940(99)00137-2
   Oechslin EN, 2000, AM J CARDIOL, V86, P1111, DOI 10.1016/S0002-9149(00)01169-3
   Owens WA, 1997, ANN THORAC SURG, V64, P1072, DOI 10.1016/S0003-4975(97)00855-2
   Paddon AJ, 2000, CARDIOVASC INTER RAD, V23, P364, DOI 10.1007/s002700010086
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   PERLOFF JK, 1991, CIRCULATION, V84, P1881
   Roos-Hesselink JW, 2006, EUR HEART J, V27, P482, DOI 10.1093/eurheartj/ehi685
   Roos-Hesselink JW, 2003, EUR HEART J, V24, P190, DOI 10.1016/S0195-668X(03)00383-4
   Roos-Hesselink JW, 2004, EUR HEART J, V25, P1057, DOI 10.1016/j.ehj.2004.04.012
   SaginSaylam G, 1996, HEART, V75, P72, DOI 10.1136/hrt.75.1.72
   Van der Velde ET, 2005, EUR J EPIDEMIOL, V20, P549, DOI 10.1007/s10654-005-4264-9
   VOGEL M, 1990, PEDIATR CARDIOL, V11, P191, DOI 10.1007/BF02238365
   von Elm E, 2007, ANN INTERN MED, V147, P573
   Vriend JWJ, 2005, INT J CARDIOL, V101, P399, DOI 10.1016/j.ijcard.2004.03.056
   WARNES CA, 1987, BRIT HEART J, V58, P148
   Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4
   Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083
NR 49
TC 37
Z9 38
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD DEC 17
PY 2008
VL 131
IS 1
BP 25
EP 32
DI 10.1016/j.ijcard.2008.06.023
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 377KX
UT WOS:000261251200004
PM 18687485
ER

PT J
AU Frydrychowicz, A
   Arnold, R
   Hirtler, D
   Schlensak, C
   Stalder, AF
   Hennig, J
   Langer, M
   Markl, M
AF Frydrychowicz, Alex
   Arnold, Raoul
   Hirtler, Daniel
   Schlensak, Christian
   Stalder, Aurelien F.
   Hennig, Juergen
   Langer, Mathias
   Markl, Michael
TI Multidirectional flow analysis by cardiovascular magnetic resonance in
   aneurysm development following repair of aortic coarctation
SO JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
LA English
DT Article
ID DACRON PATCH AORTOPLASTY; BLOOD-FLOW; THORACIC AORTA; PATTERNS;
   STREAMLINES; ANGIOGRAPHY; PREDICTORS; RISK
AB Aneurysm formation is a life-threatening complication after operative therapy in coarctation. The identification of patients at risk for the development of such secondary pathologies is of high interest and requires a detailed understanding of the link between vascular malformation and altered hemodynamics. The routine morphometric follow-up by magnetic resonance angiography is a well-established technique. However, the intrinsic sensitivity of magnetic resonance (MR) towards motion offers the possibility to additionally investigate hemodynamic consequences of morphological changes of the aorta.
   We demonstrate two cases of aneurysm formation 13 and 35 years after coarctation surgery based on a Waldhausen repair with a subclavian patch and a Vosschulte repair with a Dacron patch, respectively. Comprehensive flow visualization by cardiovascular MR (CMR) was performed using a flow-sensitive, 3-dimensional, and 3-directional time-resolved gradient echo sequence at 3T. Subsequent analysis included the calculation of a phase contrast MR angiography and color-coded streamline and particle trace 3D visualization. Additional quantitative evaluation provided regional physiological information on blood flow and derived vessel wall parameters such as wall shear stress and oscillatory shear index.
   The results highlight the individual 3D blood-flow patterns associated with the different vascular pathologies following repair of aortic coarctation. In addition to known factors predisposing for aneurysm formation after surgical repair of coarctation these findings indicate the importance of flow sensitive CMR to follow up hemodynamic changes with respect to the development of vascular disease.
C1 [Frydrychowicz, Alex; Stalder, Aurelien F.; Hennig, Juergen; Langer, Mathias; Markl, Michael] Univ Hosp Freiburg, Dept Diagnost Radiol Med Phys, Freiburg, Germany.
   [Schlensak, Christian] Univ Hosp Freiburg, Dept Cardiovasc Surg, Freiburg, Germany.
   [Arnold, Raoul; Hirtler, Daniel] Univ Hosp Freiburg, Dept Pediat Cardiol, Freiburg, Germany.
RP Markl, M (reprint author), Univ Hosp Freiburg, Dept Diagnost Radiol Med Phys, Freiburg, Germany.
EM alex.frydrychowicz@uniklinik-freiburg.de;
   raoul.arnold@uniklinik-freiburg.de;
   daniel.hirtler@uniklinik-freiburg.de;
   christian.schlensak@uniklinik-freiburg.de;
   aurelien.stalder@uniklinik-freiburg.de;
   juergen.hennig@uniklinik-freiburg.de;
   mathias.langer@uniklinik-freiburg.de;
   michael.markl@uniklinik-freiburg.de
RI Hennig, Jurgen/F-2424-2010; Stalder, Aurelien/A-7071-2010; Markl,
   Michael/F-7436-2011
OI Stalder, Aurelien/0000-0002-0590-2746; 
CR Bogren HG, 2004, J MAGN RESON IMAGING, V19, P417, DOI 10.1002/jmri.20018
   BOGREN HG, 1995, J THORAC CARDIOV SUR, V110, P704, DOI 10.1016/S0022-5223(95)70102-8
   BROMBERG BI, 1989, J AM COLL CARDIOL, V14, P734
   Buonocore MH, 1998, MAGNET RESON MED, V40, P210, DOI 10.1002/mrm.1910400207
   de Divitiis M, 2001, CIRCULATION, V104, P1165
   Frydrychowicz A, 2007, J COMPUT ASSIST TOMO, V31, P9, DOI 10.1097/01.rct.0000232918.45158.c9
   GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204
   He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948
   KILNER PJ, 1993, CIRCULATION, V88, P2235
   KRON IL, 1990, ANN THORAC SURG, V49, P925
   KRON IL, 1990, ANN THORAC SURG, V49, P920
   LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904
   Markl M, 2007, J MAGN RESON IMAGING, V25, P824, DOI 10.1002/jmri.20871
   MARTIN MM, 1988, AM J CARDIOL, V61, P951, DOI 10.1016/0002-9149(88)90390-6
   NAPEL S, 1992, JMRI-J MAGN RESON IM, V2, P143, DOI 10.1002/jmri.1880020206
   Nielsen JC, 2005, CIRCULATION, V111, P622, DOI 10.1161/01.CIR.0000154549.53684.64
   Oliver JM, 2004, J AM COLL CARDIOL, V44, P1641, DOI 10.1016/j.jacc.2004.07.037
   Ou P, 2007, J AM COLL CARDIOL, V49, P883, DOI 10.1016/j.jacc.2006.10.057
   PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L
   Prince MR, 1996, AM J ROENTGENOL, V166, P1387
   Roth M, 1997, EUR J CARDIO-THORAC, V11, P997, DOI 10.1016/S1010-7940(97)01171-8
   STALDER AF, 2006, P ISMRM WORKSH FLOW
   von Kodolitsch Y, 2002, J AM COLL CARDIOL, V39, P617, DOI 10.1016/S0735-1097(01)01784-3
   VOSSSCHULTE K, 1957, Thoraxchirurgie, V4, P443
   VOSSSCHULTE K, 1961, Thorax, V16, P338, DOI 10.1136/thx.16.4.338
   WALDHAUS.JA, 1966, J THORAC CARDIOV SUR, V51, P532
   WEBB GD, 2008, BRAUNWALDS HEART DIS, P1605
   Wentzel JJ, 2005, J AM COLL CARDIOL, V45, P846, DOI 10.1016/j.jacc.2004.12.026
   Wigstrom L, 1996, MAGNET RESON MED, V36, P800, DOI 10.1002/mrm.1910360521
NR 29
TC 37
Z9 39
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1097-6647
J9 J CARDIOVASC MAGN R
JI J. Cardiov. Magn. Reson.
PD JUN 8
PY 2008
VL 10
AR 30
DI 10.1186/1532-429X-10-30
PG 8
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 320BF
UT WOS:000257208000001
PM 18538035
ER

PT J
AU Lingaas, PS
   Hol, PK
   Lundblad, R
   Rein, KA
   Mathisen, L
   Smith, HJ
   Andersen, R
   Thaulow, E
   Tonnesen, TI
   Svennevig, JL
   Hauge, SN
   Fredriksen, PM
   Andersen, M
   Fosse, E
AF Lingaas, PS
   Hol, PK
   Lundblad, R
   Rein, KA
   Mathisen, L
   Smith, HJ
   Andersen, R
   Thaulow, E
   Tonnesen, TI
   Svennevig, JL
   Hauge, SN
   Fredriksen, PM
   Andersen, M
   Fosse, E
TI Clinical and radiologic outcome of off-pump coronary surgery at 12
   months follow-up: A prospective randomized trial
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID ARTERY-BYPASS SURGERY; ON-PUMP; CARDIOPULMONARY BYPASS; BEATING-HEART;
   MYOCARDIAL INJURY; REVASCULARIZATION; OPERATIONS; PATENCY
AB Background. After more than a decade of experience with off-pump coronary bypass surgery, still no consensus exists concerning its benefit on clinical outcome compared to the on-pump technique. In this 12-month follow-up, we compare off-pump and on-pump surgery on the appearance of graft patency, myocardial function, and clinical outcome.
   Methods. One hundred twenty patients were randomized to off-pump or on-pump coronary surgery. Angiography was performed intraoperatively, at 3 and 12 months. Global myocardial function was estimated by magnetic resonance imaging (MRI) preoperatively and 12 months postoperatively, as well as functional class and stress testing.
   Results. After 12 months internal mammary artery patency was 94% in the off-pump group and 96% in the on-pump group. Vein graft patency was 80% and 87%, respectively. No statistically significant difference between the two groups existed. There were no differences in exercise capacity improvement and attenuation of symptoms between the groups.
   Conclusions. At 12-months follow-up, off-pump coronary bypass surgery provided the same angiographic graft patency as the on-pump technique. Improvement in functional class and exercise capacity was the same in both groups.
C1 Rikshosp Univ Hosp, Dept Thorac & Cardiovasc Surg, Intervent Ctr, Dept Radiol, N-0027 Oslo, Norway.
   Rikshosp Univ Hosp, Dept Pediat, N-0027 Oslo, Norway.
   Rikshosp Univ Hosp, Dept Anesthesiol, N-0027 Oslo, Norway.
   Rikshosp Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway.
   Rikshosp Univ Hosp, Dept Physiotherapy, N-0027 Oslo, Norway.
   Rikshosp Univ Hosp, Dept Surg, N-0027 Oslo, Norway.
RP Lingaas, PS (reprint author), Rikshosp Univ Hosp, Dept Thorac & Cardiovasc Surg, Intervent Ctr, Dept Radiol, N-0027 Oslo, Norway.
EM per.snorre.lingaas@rikshospitalet.no
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Bergsland J, 2004, J THORAC CARDIOV SUR, V128, P718, DOI 10.1016/j.jtcvs.2004.07.001
   CAMPEAU L, 1976, CIRCULATION, V54, P522
   Diegeler A, 2000, CIRCULATION, V102, P95
   FITZGIBBON GM, 1978, CIRCULATION, V57, P1070
   Fosse E, 2000, MINIM INVASIV THER, V9, P403
   Hol PK, 2002, ANN THORAC SURG, V73, P813, DOI 10.1016/S0003-4975(01)03459-2
   Hol PK, 2004, ANN THORAC SURG, V78, P502, DOI 10.1016/j.athoracsur.2004.03.004
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Lingaas PS, 2006, ANN THORAC SURG, V81, P2089, DOI 10.1016/j.athoracsur.2005.12.003
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Lo B, 2004, ANESTH ANALG, V99, P634, DOI 10.1213/ANE.0000130257.64006.5C
   Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 1998, ANN THORAC SURG, V66, P1068, DOI 10.1016/S0003-4975(98)00657-2
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Selvanayagam JB, 2004, CIRCULATION, V109, P345, DOI 10.1161/01.CIR.0000109489.71945.BD
   SIVERTSSEN E, 1980, SCAND J THORAC CARD, V14, P61, DOI 10.3109/14017438009109856
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   VISSER FC, 1993, INT J CARD IMAGIN S1, P41
   Wiklund L, 2000, EUR J CARDIO-THORAC, V17, P46, DOI 10.1016/S1010-7940(99)00365-6
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 26
TC 37
Z9 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUN
PY 2006
VL 81
IS 6
BP 2089
EP 2096
DI 10.1016/j.athoracsur.2005.12.003
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 049PD
UT WOS:000238027600022
PM 16731135
ER

PT J
AU Critz, FA
   Levinson, K
AF Critz, FA
   Levinson, K
TI 10-year disease-free survival rates after simultaneous irradiation for
   prostate cancer with a focus on calculation methodology
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT 98th Annual Meeting of the American-Urological-Association
CY APR 26-MAY 01, 2003
CL CHICAGO, IL
SP Amer Urol Assoc
DE prostatic neoplasms; brachytherapy; radiotherapy
ID RADICAL PROSTATECTOMY; FOLLOW-UP; AMERICAN SOCIETY; BRACHYTHERAPY;
   RADIOTHERAPY; RECURRENCE; RADIATION; FAILURE
AB Purpose: We documented the 10-year disease-free survival rate after simultaneous irradiation for prostate cancer and suggested standards for outcome calculation methodology.
   Materials and Methods: From 1992 to 1998, 1,469 consecutive men with clinical stage T1T2NxM0 prostate cancer who did not receive neoadjuvant hormones were treated with simultaneous irradiation, an ultrasound guided transperineal prostate I-125 seed implant followed by external irradiation. Median pretreatment prostate specific antigen (PSA) was 7.1 ng/ml (range 0.3 to 88). All men were treated 5 or more years ago. Median followup was 6 years (range 3 months to 11 years). Disease freedom was defined as the achievement and maintenance of PSA 0.2 ng/ml or less, and treatment failure was defined as a PSA nadir greater than 0.2 ng/ml or a subsequent PSA increase above this level.
   Results: The overall 10-year disease-free survival rate was 83%. Median time to recurrence was 30 months (range 3 months to 8 years) and 24% of recurrences were after 5-year followup. The 10-year outcome according to low, intermediate and high risk group was, 93%, 80% and 61%, respectively (p <0.0001). Multivariate analysis of factors related to disease freedom documents that pretreatment PSA, Gleason score and percent positive biopsies were significant but stage and age were not.
   Conclusions: By calculating outcome with PSA cut point 0.2 ng/ml and evaluation only of men treated 5 or more years ago, the 10-year disease-free survival rates from this study can be reasonably compared with the outcome of radical prostatectomy performed in the PSA era.
C1 Radiotherapy Clin Georgia, Decatur, GA 30033 USA.
   Georgia Urol, Decatur, GA USA.
RP Critz, FA (reprint author), Radiotherapy Clin Georgia, 2349 Lawrenceville Highway, Decatur, GA 30033 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Blasko JC, 1996, UROL CLIN N AM, V23, P633, DOI 10.1016/S0094-0143(05)70342-6
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Coen JJ, 2003, INT J RADIAT ONCOL, V57, P621, DOI 10.1016/S0360-3016(03)00722-3
   Connell PP, 1999, UROLOGY, V54, P875, DOI 10.1016/S0090-4295(99)00253-8
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   Critz FA, 2002, J UROLOGY, V167, P1310, DOI 10.1016/S0022-5347(05)65288-3
   Critz FA, 2002, J UROLOGY, V168, P2434, DOI 10.1097/01.ju.0000030581.57555.04
   Critz FA, 2003, J UROLOGY, V170, P1864, DOI 10.1097/01.ju.0000091644.41330.2a
   Freedland SJ, 2003, UROLOGY, V61, P365, DOI 10.1016/S0090-4295(02)02268-9
   Gelblum DY, 1999, INT J RADIAT ONCOL, V45, P59, DOI 10.1016/S0360-3016(99)00176-5
   Gretzer MB, 2002, J UROLOGY, V168, P1419, DOI 10.1097/ju.0000029729.26315.fd
   Grimm PD, 1996, HEMATOL ONCOL CLIN N, V10, P653, DOI 10.1016/S0889-8588(05)70359-2
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Howard A, 2001, J BRACHYTHER INT, V17, P37
   Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169
   Iversen P, 1991, Scand J Urol Nephrol Suppl, V138, P109
   Khan MA, 2003, UROLOGY, V62, P86, DOI 10.1016/S0090-4295(03)00404-7
   Steinberg DM, 1997, AM J SURG PATHOL, V21, P566, DOI 10.1097/00000478-199705000-00010
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
   Ward JF, 2003, J UROLOGY, V170, P1872, DOI 10.1097/01.ju.0000091876.13656.2e
   Zeitlin SI, 1998, J UROLOGY, V160, P91, DOI 10.1016/S0022-5347(01)63042-8
NR 23
TC 37
Z9 37
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD DEC
PY 2004
VL 172
IS 6
BP 2232
EP 2238
DI 10.1097/01.ju.0000144033.61661.31
PN 1
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 872GE
UT WOS:000225194900025
PM 15538238
ER

PT J
AU Khambadkone, S
   Bonhoeffer, P
AF Khambadkone, S
   Bonhoeffer, P
TI Nonsurgical pulmonary valve replacement: Why, when, and how?
SO CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
LA English
DT Article
DE transcatheter; pulmonary valve; regurgitation
ID VENTRICULAR OUTFLOW TRACT; PERCUTANEOUS STENT IMPLANTATION;
   AORTIC-VALVE; REPAIRED TETRALOGY; TRANSCATHETER IMPLANTATION; EXERCISE
   PERFORMANCE; DIASTOLIC FUNCTION; ADULTS LATE; FALLOT; RECONSTRUCTION
AB Percutaneous transcatheter interventions for valve replacement or implantation is one of the most exciting developments in the field of interventional cardiology. Valvular stenosis has been treated by balloon dilatation with early and late results; however, treatment for valvular regurgitation has remained surgical until now. Most new designs have been investigated for implantation of valves in the left or right ventricular outflow tracts. Patients with surgery on the right ventricular outflow tract for congenital heart disease constitute the most common group for reoperations during late follow-up. Surgical pulmonary valve replacement can be performed with low mortality; however, it sets up a substrate for future operations. Also, the risk of cardiopulmonary bypass, infection, bleeding, and ventricular dysfunction remains. A transcatheter technique is likely to have more acceptance and may expand the indications for early intervention for right ventricular outflow tract dysfunction. (C) 2004 Wiley-Liss, Inc.
C1 Great Ormond St Hosp Sick Children, Dept Cardiol, London, England.
RP Khambadkone, S (reprint author), Great Ormond St Hosp Sick Children, Dept Cardiol, Great Ormond St, London, England.
EM khambs@gosh.nhs.uk
CR ANDERSEN HR, 1992, EUR HEART J, V13, P704
   Bielefeld MR, 2001, ANN THORAC SURG, V71, P482, DOI 10.1016/S0003-4975(00)02521-2
   Bonhoeffer P, 2000, CIRCULATION, V102, P813
   Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3
   Boudjemline Y, 2003, J THORAC CARDIOV SUR, V125, P741, DOI 10.1067/mtc.2003.280
   Boudjemline Y, 2003, J THORAC CARDIOV SUR, V126, P490, DOI 10.1016/S0022-5223(03)00232-0
   BOVE EL, 1985, J THORAC CARDIOV SUR, V90, P50
   Breymann T, 2002, EUR J CARDIO-THORAC, V21, P703, DOI 10.1016/S1010-7940(02)00049-0
   Buheitel G, 2001, Z KARDIOL, V90, P503, DOI 10.1007/s003920170140
   CARVALHO JS, 1992, BRIT HEART J, V67, P470
   Conte S, 1999, EUR J CARDIO-THORAC, V15, P143, DOI 10.1016/S1010-7940(98)00306-6
   Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8
   CRIBIER A, 1993, CORONARY ARTERY DIS, V4, P943, DOI 10.1097/00019501-199310000-00015
   CRIBIER A, 2003, J AM COLL CARDIOL, V41, P508, DOI 10.1016/S0735-1097(03)82753-5
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   de Ruijter FTH, 2002, ANN THORAC SURG, V73, P1794, DOI 10.1016/S0003-4975(02)03586-5
   Discigil B, 2001, J THORAC CARDIOV SUR, V121, P344, DOI 10.1067/mtc.2001.111209
   Dohmen P M, 2001, Semin Thorac Cardiovasc Surg, V13, P24
   Eyskens B, 2000, AM J CARDIOL, V85, P221, DOI 10.1016/S0002-9149(99)00640-2
   Forbess JM, 2001, ANN THORAC SURG, V71, P54, DOI 10.1016/S0003-4975(00)01788-4
   Gatzoulis MA, 1997, CIRCULATION, V95, P401
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   GATZOULIS MA, 1995, CIRCULATION, V91, P1775
   Gatzoulis MA, 2000, AM J CARDIOL, V86, P1352, DOI 10.1016/S0002-9149(00)01241-8
   Gerestein CG, 2001, ANN THORAC SURG, V71, P911, DOI 10.1016/S0003-4975(00)02440-1
   GUNDRY SR, 1994, J THORAC CARDIOV SUR, V107, P908
   Helbing WA, 1996, J AM COLL CARDIOL, V28, P1827
   Homann M, 2000, EUR J CARDIO-THORAC, V17, P624, DOI 10.1016/S1010-7940(00)00414-0
   HUFNAGEL CA, 1951, B GEORGETOWN U MED C, V4, P1
   Kanter KR, 2003, ANN THORAC SURG, V76, P1889, DOI 10.1016/S0003-4975(03)01304-3
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Lange R, 2001, ANN THORAC SURG, V71, pS365, DOI 10.1016/S0003-4975(01)02552-8
   Li W, 2004, AM HEART J, V147, P165, DOI 10.1016/S0002-8703(03)00527-1
   Lip Gregory Y. H., 1999, Clinical Cardiology, V22, P733
   Lutter G, 2002, J THORAC CARDIOV SUR, V123, P768, DOI 10.1067/mtc.2002.121157
   MCGOON DC, 1982, AM J CARDIOL, V49, P1741, DOI 10.1016/0002-9149(82)90254-5
   MISAKI T, 1994, CIRCULATION, V90, P264
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   PAVCNIK D, 1992, RADIOLOGY, V183, P151
   Pedra CAC, 2002, J THORAC CARDIOV SUR, V124, P82, DOI 10.1067/mtc.2002.122309
   POWELL AJ, 1995, CIRCULATION, V92, P3282
   Rosti L, 1998, ANN THORAC SURG, V65, P889
   Roughneen PT, 1999, J CARDIAC SURG, V14, P370, DOI 10.1111/j.1540-8191.1999.tb01012.x
   Sanatani S, 2001, PEDIATR CARDIOL, V22, P228, DOI 10.1007/s002460010209
   Silversides CK, 2003, J AM SOC ECHOCARDIOG, V16, P1057, DOI 10.1016/S0894-7317(03)00553-4
   Stark J, 1998, PEDIATR CARDIOL, V19, P282, DOI 10.1007/s002469900311
   Therrien J, 2001, CIRCULATION, V103, P2489
   Therrien Judith, 2002, Cardiology Clinics, V20, P395, DOI 10.1016/S0733-8651(02)00010-3
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Turrentine MW, 2002, ANN THORAC SURG, V74, P2202, DOI 10.1016/S0003-4975(02)03844-4
   VANSTRATEN A, 2003, J AM COLL CARDIOL  S, V41, P487, DOI 10.1016/S0735-1097(03)82663-3
   VANSTRATEN A, 2003, J AM COLL CARDIOL  S, V41, P491, DOI 10.1016/S0735-1097(03)82679-7
   Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8
   WARNER KG, 1993, CIRCULATION, V88, P189
NR 54
TC 37
Z9 38
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1522-1946
J9 CATHETER CARDIO INTE
JI Catheter. Cardiovasc. Interv.
PD JUL
PY 2004
VL 62
IS 3
BP 401
EP 408
DI 10.1002/ccd.20122
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 834JR
UT WOS:000222407900025
PM 15224313
ER

PT J
AU van der Heijden, GJMG
   Nathoe, HM
   Jansen, EWL
   Grobbee, DE
AF van der Heijden, GJMG
   Nathoe, HM
   Jansen, EWL
   Grobbee, DE
TI Meta-analysis on the effect of off-pump coronary bypass surgery
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 17th Annual Meeting of the
   European-Association-for-Cardio-Thoracic-Surgery/11th Annual Meeting of
   the European-Society-of-Thoracic-Surgeons
CY OCT 12-15, 2003
CL VIENNA, AUSTRIA
SP European Assoc Cardio Thorac Surg, European Soc Thorac Surg
DE off-pump coronary bypass surgery; meta-analysis; randomised trials
ID LOW-RISK PATIENTS; BEATING-HEART; ON-PUMP; CARDIOPULMONARY BYPASS;
   COMPLETE REVASCULARIZATION; INFLAMMATORY RESPONSE; RANDOMIZED TRIALS;
   MYOCARDIAL INJURY; GRAFT-SURGERY; HETEROGENEITY
AB Objective: To assess the effect of conventional coronary artery bypass surgery (CABG) compared to the off-pump procedure (OPCAB). Methods: Based on randomised trials found in PubMed and Science Citation Index, an overall odds ratio and 95% confidence interval was calculated for the combined endpoint of mortality, stroke and myocardial infarction. Results: The 18 randomised trials included 1584 patients (783 OPCAB, 801 CABG). The odds ratio was 0.73 (95% CI = 0.26; 2.04) at 2-week post-surgery, 0.75 (0.39; 1.42) at 1-month post-surgery. 0.55 (0.28; 1.08) at 3-month post-surgery, and 0.66 (0.38; 1.15) at 1-year post-surgery. Conclusions: The outcome of this meta-analysis shows favourable results for OPCAB for the combined endpoint of mortality, stroke and myocardial infarction at short and long term follow-up. However, none of the risk reductions reach statistical significance at the conventional level. Based on our results OPCAB appears to be equivalent to CABG. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Utrecht, Ctr Med, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands.
   Univ Utrecht, Ctr Med, Heart Lung Ctr, Dept Cardiothorac Surg, Utrecht, Netherlands.
   Univ Utrecht, Ctr Med, Heart Lung Ctr, Dept Cardiol, Utrecht, Netherlands.
RP van der Heijden, GJMG (reprint author), Univ Utrecht, Ctr Med, Julius Ctr Hlth Sci & Primary Care, Str 6-131 POB 85500, NL-3508 GA Utrecht, Netherlands.
EM s.vanderheijden@umcutrecht.nl
RI Grobbee, Diederick/C-7651-2014
OI Grobbee, Diederick/0000-0003-4472-4468
CR Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Ascione R, 2000, CIRCULATION, V102, P1530
   Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X
   Baker RA, 2001, HEART SURG FORUM, V4, pS19
   BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202
   Cox CM, 2000, ANN THORAC SURG, V69, P140, DOI 10.1016/S0003-4975(99)01196-0
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Czerny M, 2000, EUR J CARDIO-THORAC, V17, P737, DOI 10.1016/S1010-7940(00)00420-6
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Gulielmos V, 1999, EUR J CARDIO-THORAC, V16, pS34, DOI 10.1016/S1010-7940(99)00266-3
   Gulielmos V, 2000, EUR J CARDIO-THORAC, V18, P594, DOI 10.1016/S1010-7940(00)00553-4
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Lloyd CT, 2000, J THORAC CARDIOV SUR, V119, P148, DOI 10.1016/S0022-5223(00)70230-3
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Penttila HJ, 2001, ANN THORAC SURG, V71, P565, DOI 10.1016/S0003-4975(00)02002-6
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K
   Tang ATM, 2002, EUR J CARDIO-THORAC, V22, P118, DOI 10.1016/S1010-7940(02)00220-8
   Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V
   Tramer MR, 1997, BRIT MED J, V315, P635
   van Dijk D, 2000, CONTROL CLIN TRIALS, V21, P595, DOI 10.1016/S0197-2456(00)00103-3
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Velissaris T, 2003, EUR J CARDIO-THORAC, V23, P917, DOI 10.1016/S1010-7940(03)00167-2
   Vural KM, 1995, THORAC CARDIOV SURG, V43, P320, DOI 10.1055/s-2007-1013803
   Wandschneider W, 2000, ANN THORAC SURG, V70, P1577, DOI 10.1016/S0003-4975(00)01843-9
   Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 37
TC 37
Z9 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD JUL
PY 2004
VL 26
IS 1
BP 81
EP 84
DI 10.1016/j.ejcts.2004.03.032
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 835KT
UT WOS:000222482500017
PM 15200983
ER

PT J
AU Patel, C
   Elshaikh, MA
   Angermeier, K
   Ulchaker, J
   Klein, EA
   Chehade, N
   Wilkinson, DA
   Reddy, CA
   Ciezki, JP
AF Patel, C
   Elshaikh, MA
   Angermeier, K
   Ulchaker, J
   Klein, EA
   Chehade, N
   Wilkinson, DA
   Reddy, CA
   Ciezki, JP
TI PSA bounce predicts early success in patients with permanent iodine-125
   prostate implant
SO UROLOGY
LA English
DT Article
ID BRACHYTHERAPY; ANTIGEN; RECOMMENDATIONS; RADIATION; CANCER
AB Objectives. To determine the clinical and dosimetric factors that predict prostate-specific antigen (PSA) bounce after iodine-125 prostate brachytherapy and to determine the predictive value of PSA bounce relative to biochemical relapse-free survival (bRFS).
   Methods. A multivariate analysis of factors thought to predict for PSA bounce was performed in 295 consecutive patients with T1-T2 prostate cancer treated by prostate brachytherapy as the sole radiotherapeutic modality and a minimum follow-up of 2 years. The variables examined included age, initial PSA level, biopsy Gleason score, use of androgen deprivation, occurrence of PSA bounce, dose received by 90% of the prostate gland, and volume of gland receiving 100% of the prescribed dose. A PSA bounce was defined as a rise of at least 0.2 ng/mL greater than a previous PSA level with a subsequent decline equal to, or less than, the initial nadir. A second analysis investigating the same factors and adding PSA bounce as a predictor of bRFS was also performed.
   Results. The median follow-up was 38 months. A PSA bounce was noted in 82 (28%) of 295 patients. On multivariate analysis, only younger age (younger than 65 years) significantly predicted for a PSA bounce. Patients who experienced a PSA bounce were less likely to have biochemical failure (P = 0.037). Overall, the bRFS rate at 5 years in those experiencing a PSA bounce was 100% versus 92% in those with no bounce.
   Conclusions. Immediate salvage therapy in patients with a rising PSA level after permanent prostate brachytherapy should not be initiated provided the PSA increase does not exceed the pretreatment PSA value. A PSA bounce may be associated with improved bRFS but was not associated with any of the pretreatment clinical and dosimetric factors examined. (C) 2004 Elsevier Inc.
C1 Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Glickman Urol Inst, Cleveland, OH 44195 USA.
   Kaiser Permanente, Dept Urol, Cleveland, OH USA.
RP Ciezki, JP (reprint author), Cleveland Clin Fdn, Dept Radiat Oncol, 9500 Euclid Ave,Desk T-28, Cleveland, OH 44195 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Das P, 2002, INT J RADIAT ONCOL, V54, P698, DOI 10.1016/S0360-3016(02)03036-5
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Merrick GS, 2002, INT J RADIAT ONCOL, V54, P450, DOI 10.1016/S0360-3016(02)02948-6
   Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3
   Nag S, 2000, INT J RADIAT ONCOL, V46, P221, DOI 10.1016/S0360-3016(99)00351-X
   Prestigiacomo AF, 1996, J UROLOGY, V155, P1977, DOI 10.1016/S0022-5347(01)66067-1
NR 9
TC 37
Z9 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-4295
J9 UROLOGY
JI Urology
PD JAN
PY 2004
VL 63
IS 1
BP 110
EP 113
DI 10.1016/j.urology.2003.08.025
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 807YZ
UT WOS:000220538100027
PM 14751360
ER

PT J
AU Cesaretti, JA
   Stone, NN
   Stock, RG
AF Cesaretti, JA
   Stone, NN
   Stock, RG
TI Urinary symptom flare following I-125 prostate brachytherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT 44th Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology
CY OCT 06-10, 2002
CL NEW ORLEANS, LOUISIANA
SP Amer Soc Therapeut Radiol & Oncol
DE prostate cancer; brachytherapy; IPSS; quality of life; QOL
ID QUALITY-OF-LIFE; POSTIMPLANT DOSIMETRY; SEED IMPLANTATION;
   TUMOR-CONTROL; CANCER; HYPERPLASIA; MORBIDITY; CARCINOMA; MEN;
   PARAMETERS
AB Purpose: Although acute urinary morbidity after prostate brachytherapy has been well-documented, long-term effects have not been fully characterized. We describe a late complication of I-125 prostate brachytherapy we have termed urinary symptom flare.
   Methods and Materials: A total of 172 patients who underwent I-125 prostate brachytherapy between 1991 and 1998 completed a pretreatment and at least four follow-up International Prostate Symptom Score (IPSS) forms. Follow-up visits were made 1 month after implant and at 3- to 6-month intervals thereafter. Follow-up periods ranged from 12 to 106 months (median 41.5 months). The number of IPSS forms per patient ranged from 4 to 17 (median 6). A total of 32.6% of patients received both 3 months of neoadjuvant and 3 months of adjuvant hormonal therapy. Postimplant dosimetry revealed D90 values of 5578-25692 cGy (median 17290 cGy). The peak voiding score, indicating the time of the most severe urinary morbidity after brachytherapy, was defined as the highest rise in IPSS recorded after implantation. The nadir score was the lowest IPSS attained after the peak score, generally indicating a return to the patient's preimplant urinary function. A "flare" was defined as a rise in IPSS from the nadir score of at least five points, denoting a late exacerbation of urinary symptoms. Patients with a transient rise in PSA of 0.1 ng/ml or greater were considered to have a PSA bounce.
   Results: The mean pretreatment IPSS for the study population was 7.5. The mean peak IPSS was 19.4 and occurred from 0.1 to 25 months (median 1.3 months) after the date of implant. The mean nadir IPSS was 6.7 and occurred from 1.6 to 61.6 months (median 14.3) after brachytherapy. A total of 35.5% of patients (61/172) have experienced a urinary flare of 5 or more points, as measured by the IPSS form. The mean "flare" IPSS was 16.4. The time to develop a flare ranged from 5.8 to 64 months (median 23.9 months). The actuarial risk of developing a flare was 21% by 2 years, 34% by 3 years, 38% by 4 years, and 47% by five years. In 72% of patients (44/61) who developed a flare, the flare subsided to baseline by the next follow-up visit. Of the remaining patients, 3% (2/61) reached a baseline value two follow-up visits later. In 25% of the patients (15/61) who experienced a flare, it occurred during their last follow-up visit. No single factor, including PSA (p = 0.9), stage (p = 0.9), use of hormone therapy (p = 0.9), implanted activity (p = 0.1), ultrasound volume (p = 0.4), dose (p = 0.4), seed number (p = 0.4), or needle number (p = 0.9), had a significant effect on the risk of developing a flare. There was a trend for younger patients (less than or equal to65 vs. > 65, p = 0.07) to experience the urinary flare.
   Conclusions: Acute symptoms after I-125 prostate brachytherapy appear to peak I month after a prostate implant and return to their baseline values at 1 year. A transient late exacerbation of urinary symptoms is common and can occur in up to half of all patients by 5 years. There appears to be no statistically significant association between a late exacerbation in urinary symptoms and clinical or implant parameters. (C) 2003 Elsevier Inc.
C1 CUNY Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY 10029 USA.
   CUNY Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA.
RP Stock, RG (reprint author), CUNY Mt Sinai Sch Med, Dept Radiat Oncol, Box 1236,1 Gustave L Levy Pl, New York, NY 10029 USA.
CR *AM JOINT COMM CAN, 1992, CANC STAG MAN
   Arterbery VE, 1997, SEMIN SURG ONCOL, V13, P461, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<461::AID-SSU11>3.0.CO;2-W
   Barry MJ, 1991, P INT CONS BEN PROST, P279
   BARRY MJ, 1993, J UROLOGY, V150, P351
   BARRY MJ, 1992, J UROLOGY, V148, P1549
   Blasko J C, 1991, Scand J Urol Nephrol Suppl, V137, P113
   Boyle P, 1996, UROLOGY, V48, P398, DOI 10.1016/S0090-4295(96)00353-6
   Brandeis JM, 2000, J UROLOGY, V163, P851, DOI 10.1016/S0022-5347(05)67818-4
   Bubolz T, 2001, UROLOGY, V58, P977, DOI 10.1016/S0090-4295(01)01434-0
   Cox D, 1984, ANAL SURVIVAL DATA, DOI Boca Raton, FL
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Davis JW, 2001, J UROLOGY, V166, P947, DOI 10.1016/S0022-5347(05)65870-3
   Desai J, 1998, Radiat Oncol Investig, V6, P135, DOI 10.1002/(SICI)1520-6823(1998)6:3<135::AID-ROI4>3.0.CO;2-Z
   Desgrandchamps F, 2001, EUR UROL, V40, P2, DOI 10.1159/000049884
   DIN KEE, 1996, UROLOGY, V48, P393
   Eckhardt MD, 2001, UROLOGY, V57, P695, DOI 10.1016/S0090-4295(00)01101-8
   Gelblum DY, 1999, INT J RADIAT ONCOL, V45, P59, DOI 10.1016/S0360-3016(99)00176-5
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KLEINBERG L, 1994, INT J RADIAT ONCOL, V28, P985
   Lee WR, 2001, INT J RADIAT ONCOL, V51, P614, DOI 10.1016/S0360-3016(01)01707-2
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   *MED DAT INT, 1999, OPP US PROST DIS DIA
   Merrick GS, 2000, INT J RADIAT ONCOL, V47, P121, DOI 10.1016/S0360-3016(99)00525-8
   Mettlin CJ, 1998, CANCER, V83, P1679, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1679::AID-CNCR24>3.0.CO;2-Y
   Penson D F, 2000, Curr Urol Rep, V1, P71, DOI 10.1007/s11934-000-0038-9
   Potters L, 2001, INT J RADIAT ONCOL, V50, P605, DOI 10.1016/S0360-3016(01)01473-0
   PRUTHI RS, 2001, J UROLOGY, V164, P2031
   Smathers S, 2001, INT J RADIAT ONCOL, V50, P1207, DOI 10.1016/S0360-3016(01)01568-1
   STOCK RG, 2000, J UROLOGY, V163, P1268
   STOCK RG, 1995, INT J RADIAT ONCOL, V32, P219, DOI 10.1016/0360-3016(95)00521-Y
   Stock RG, 2002, EUR UROL, V41, P434, DOI 10.1016/S0302-2838(02)00018-0
   Stock RG, 2000, INT J RADIAT ONCOL, V48, P899, DOI 10.1016/S0360-3016(00)00707-0
   Stone Nelson N, 2002, Curr Urol Rep, V3, P201, DOI 10.1007/s11934-002-0065-9
   Storey MR, 1999, INT J RADIAT ONCOL, V43, P565, DOI 10.1016/S0360-3016(98)00451-9
   Wallner K, 2001, HEMATOL ONCOL CLIN N, V15, P359, DOI 10.1016/S0889-8588(05)70217-3
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Wei JT, 2002, J CLIN ONCOL, V20, P557, DOI 10.1200/JCO.20.2.557
   YALLA SV, 1995, J UROLOGY, V153, P674, DOI 10.1016/S0022-5347(01)67682-1
NR 40
TC 37
Z9 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUL 15
PY 2003
VL 56
IS 4
BP 1085
EP 1092
DI 10.1016/S0630-3016(03)00210-4
PG 8
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 697HX
UT WOS:000183937500024
PM 12829146
ER

PT J
AU Vicini, FA
   Kestin, LL
   Martinez, AA
AF Vicini, FA
   Kestin, LL
   Martinez, AA
TI The correlation of serial prostate specific antigen measurements with
   clinical outcome after external beam radiation therapy of patients for
   prostate carcinoma
SO CANCER
LA English
DT Article
DE prostate; prostatic neoplasms; prostate specific antigen (PSA);
   radiotherapy; biochemical failure
ID BIOCHEMICAL FAILURE; END-POINTS; FOLLOW-UP; CANCER; RADIOTHERAPY; CURE;
   IRRADIATION; DEFINITION; CONSENSUS; KINETICS
AB BACKGROUND. The authors analyzed retrospectively their institution's experience in treating patients with localized prostate carcinoma with external beam radiation therapy (EBRT) to determine the correlation of various biochemical failure (BF) definitions with clinical failure and cause specific survival (CSS).
   METHODS. Between January 1987 and December 1997, 1094 patients with clinical T1-T3N0M0 prostate carcinoma were treated with definitive EBRT alone at William Beaumont Hospital, Royal Oak, Michigan. All patients received EBRT alone (no adjuvant hormones) to a median total prostate dose of 66.6 grays (Gy) (range, 59.4-70.4 Gy). Multiple BF definitions were tested for their correlation with clinical failure and cause specific death (CSD = 1-CSS). All BF definitions were tested for sensitivity, specificity, and accuracy of predicting subsequent clinical failure and CSD. Positive and negative predictive values were calculated in the form of 10-year actuarial clinical failure and CSD rates. Analyses were performed on all 1094 patients as well as for those 727 patients who had at least 5 post-RT prostate specific antigen (PSA) level measurements and who did not receive hormonal therapy for post-RT PSA elevations. The median PSA follow-up was 4.0 years for the entire population and 4.5 years for those 727 patients included in the second analysis.
   RESULTS. In the entire population, 167 patients (15%) experienced clinical failure corresponding to 5- and 10-year actuarial rates of 16% and 34%, respectively. The correlation of various BF definitions with outcome was calculated in those 727 patients who did not receive hormonal therapy. For these patients, BF (as defined by the American Society for Therapeutic Radiology and Oncology Consensus Panel) yielded a 73% sensitivity, 76% specificity, and 75% overall accuracy for predicting clinical failure and a 74% sensitivity, 69% specificity, and 69% overall accuracy for predicting CSD. The 10-year clinical failure rate for those 251 patients demonstrating 3 consecutive PSA rises (BF) was 64% versus 14% for those patients who did not meet these criteria (biochemically controlled [BC]). As expected, definitions requiring only two rises were more sensitive but less specific in predicting clinical failure than those definitions requiring three or four rises. Because there were dramatically more clinically controlled patients (85%) than clinical failures (15%), the overall accuracy for each definition more closely approximated its specificity. The definitions classifying BF as a postnadir increase of greater than or equal to 3 or greater than or equal to 4 ng/mL above the nadir yielded the highest accuracies of 87% and 88%, respectively. In addition, these definitions also appeared to provide the greatest separation in clinical failure rates between BC and BF patients, an absolute difference of 77% and 76%, respectively.
   CONCLUSIONS. The correlation between BF and clinical failure and CSD varies markedly depending on the BF definition used. Definitions incorporating a fixed baseline (the nadir level) and the postnadir PSA profile may have better correlation with clinical failure than definitions using the nadir only or a specific number of consecutive rises in which a variable baseline "resets" after a PSA decrease. Cancer 2000;88:2305-18. (C) 2000 American Cancer Society.
C1 William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA.
RP Vicini, FA (reprint author), William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.
CR *AM JOINT COMM CAN, 1993, AJCC CANC STAG MAN, P189
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Aref I, 1998, RADIOTHER ONCOL, V48, P203, DOI 10.1016/S0167-8140(98)00061-9
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   DAMICO AV, 1995, INT J RADIAT ONCOL, V32, P473, DOI 10.1016/0360-3016(94)00606-L
   Dawson NA, 1998, J CLIN ONCOL, V16, P3398
   Ennis RD, 1998, INT J RADIAT ONCOL, V41, P511, DOI 10.1016/S0360-3016(98)00104-7
   HANKS GE, 1993, INT J RADIAT ONCOL, V27, P125
   Hanlon AL, 1998, CANCER, V83, P130, DOI 10.1002/(SICI)1097-0142(19980701)83:1<130::AID-CNCR17>3.3.CO;2-M
   Horwitz EM, 1998, INT J RADIAT ONCOL, V41, P267, DOI 10.1016/S0360-3016(98)00078-9
   Horwitz EM, 1996, INT J RADIAT ONCOL, V36, P565, DOI 10.1016/S0360-3016(96)00360-4
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KAPLAN ID, 1993, J UROLOGY, V149, P519
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   McLaughlin PW, 1996, J CLIN ONCOL, V14, P2889
   Peschel RE, 1996, INT J RADIAT ONCOL, V36, P749, DOI 10.1016/S0360-3016(96)00397-5
   Pickles T, 1999, INT J RADIAT ONCOL, V43, P699
   RITTER MA, 1992, J CLIN ONCOL, V10, P1208
   RUSSELL KJ, 1991, J UROLOGY, V146, P1046
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   Schellhammer P, 1997, UROLOGY, V49, P27, DOI 10.1016/S0090-4295(99)80321-5
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Vicini FA, 1999, INT J RADIAT ONCOL, V45, P553, DOI 10.1016/S0360-3016(99)00235-7
   WILLETT CG, 1994, J UROLOGY, V151, P1579
   Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   ZEITMAN AL, 1993, CANCER, V71, P959
   ZEITMAN AL, 1999, INT J RADIAT ONCOL, V43, P715
   Zietman AL, 1996, UROLOGY, V47, P236, DOI 10.1016/S0090-4295(99)80423-3
NR 34
TC 37
Z9 37
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0008-543X
J9 CANCER
JI Cancer
PD MAY 15
PY 2000
VL 88
IS 10
BP 2305
EP 2318
DI 10.1002/(SICI)1097-0142(20000515)88:10<2305::AID-CNCR15>3.0.CO;2-3
PG 14
WC Oncology
SC Oncology
GA 310DD
UT WOS:000086810500015
PM 10820353
ER

PT J
AU Beerlage, HP
   Thuroff, S
   Madersbacher, S
   Zlotta, AR
   Aus, G
   de Reijke, TM
   de la Rosette, JJMCH
AF Beerlage, HP
   Thuroff, S
   Madersbacher, S
   Zlotta, AR
   Aus, G
   de Reijke, TM
   de la Rosette, JJMCH
TI Current status of minimally invasive treatment options for localized
   prostate carcinoma
SO EUROPEAN UROLOGY
LA English
DT Review
DE prostate carcinoma; brachytherapy; cryoablation; high-intensity focused
   ultrasound; radiofrequency
ID INTENSITY FOCUSED ULTRASOUND; TRANSURETHRAL NEEDLE ABLATION; SALVAGE
   RADICAL PROSTATECTOMY; INTERSTITIAL TUMOR ABLATION; EARLY
   CLINICAL-EXPERIENCE; TERM FOLLOW-UP; CRYOSURGICAL ABLATION; IN-VIVO;
   HISTOLOGIC-FINDINGS; I-125 IMPLANTATION
AB Introduction: Prostate cancer is the leading malignancy in men today and an increase in detected localized prostate cancers is expected in the years to come. Even though radical prostatectomy is an effective treatment, it is associated with a considerable morbidity in some cases and efforts are made to provide minimally invasive alternative treatment options with equal efficacy but fewer side effects.
   Methods: Cryosurgical ablation of the prostate (CSAP), brachytherapy, high-intensity focused ultrasound (HIFU) and radiofrequency interstitial tumor ablation (RITA) were evaluated after a literature review from a Medline Search (1966-1998). Furthermore, personal experience and latest data from the authors were taken into account.
   Results: All alternative treatments nowadays make use of sophisticated technology, including the latest ultrasound devices for exact planning and monitoring of treatment, leading to increased safety compared to treatments in the 1960s and 1970s. Five-year results of CSAP show a PSA < 1 ng/ml in 60% of cases whereas brachytherapy is able to achieve PSA < 1 ng/ml in 80% of cases in a selected group. Recent outcome data come close to results of radical prostatectomy series. HIFU and RITA are promising new technologies that proved to be able to induce extensive necrosis, but the follow-up is too short to determine their definite places in the treatment of prostate cancer.
   Conclusion: Two alternative treatment options for localized prostate carcinoma, CSAP and brachytherapy, have been studied with a sufficient number of patients and an adequate follow-up. The overall results of brachytherapy are favorable when compared to CSAP and are in the same range as the outcome after radical prostatectomy. HIFU and RITA are relatively new techniques based on sophisticated technology that are very promising at present, but a longer follow-up is mandatory. Copyright (C) 2000 S. Karger AG, Basel.
C1 Univ Nijmegen Hosp, Dept Urol, NL-6500 HB Nijmegen, Netherlands.
   Univ Hosp Amsterdam, Amsterdam, Netherlands.
   City Hosp Munchen Harlaching, Dept Urol, Munich, Germany.
   Univ Vienna, Dept Urol, A-1010 Vienna, Austria.
   Univ Hosp Brussels, Dept Urol, Brussels, Belgium.
   Cty Hosp Ryhov, Dept Urol, Jonkoping, Sweden.
RP Beerlage, HP (reprint author), Univ Nijmegen Hosp, Dept Urol, POB 9101, NL-6500 HB Nijmegen, Netherlands.
CR ADOLFSSON J, 1993, CANCER, V72, P310, DOI 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T
   Aus G, 1997, UROLOGY, V50, P615, DOI 10.1016/S0090-4295(97)00312-9
   BAHN DK, 1995, RADIOLOGY, V194, P551
   BALES GT, 1995, UROLOGY, V46, P676, DOI 10.1016/S0090-4295(99)80300-8
   Barringer BS, 1917, J AMER MED ASSOC, V68, P1227
   Beerlage HP, 1999, PROSTATE, V39, P41, DOI 10.1002/(SICI)1097-0045(19990401)39:1<41::AID-PROS7>3.0.CO;2-5
   Blasko J C, 1991, Scand J Urol Nephrol Suppl, V137, P113
   Blasko JC, 1996, UROL CLIN N AM, V23, P633, DOI 10.1016/S0094-0143(05)70342-6
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Borkowski P, 1996, MODERN PATHOL, V9, P807
   BRENNER PC, 1995, BRIT J UROL, V75, P44, DOI 10.1111/j.1464-410X.1995.tb07230.x
   BRIX F, 1988, STRAHLENTHER ONKOL, V164, P474
   Bruskewitz R, 1998, J UROLOGY, V159, P1588, DOI 10.1097/00005392-199805000-00048
   CATALONA WJ, 1990, J UROLOGY, V143, P538
   CHAPELON JY, 1992, CANCER RES, V52, P6353
   Cohen JK, 1996, UROLOGY, V47, P395, DOI 10.1016/S0090-4295(99)80459-2
   Cohen JK, 1998, J UROLOGY, V159, P252
   Connolly JA, 1997, UROL CLIN N AM, V24, P415, DOI 10.1016/S0094-0143(05)70388-8
   COX RL, 1995, UROLOGY, V45, P932
   Cozzi PJ, 1996, BRIT J UROL, V77, P89, DOI 10.1046/j.1464-410X.1996.80314.x
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   DEBERG JC, 1995, LANCET, V346, P350, DOI 10.1016/S0140-6736(95)92228-8
   Djavan B, 1997, UROLOGY, V50, P986, DOI 10.1016/S0090-4295(97)00540-2
   DONNELLY BJ, 1991, UROL CLIN N AM, V18, P481
   Falconieri G, 1996, PATHOL RES PRACT, V192, P579
   FLOCKS RH, 1972, J UROLOGY, V108, P933
   FLOCKS RH, 1952, J UROLOGY, V68, P510
   FOSTER RS, 1993, EUR UROL, V23, P330
   FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E
   FROHMULLER H, 1991, EUR UROL, V19, P279
   FRY F J, 1978, Ultrasound in Medicine and Biology, V4, P337, DOI 10.1016/0301-5629(78)90022-4
   FukunagaJohnson N, 1997, INT J RADIAT ONCOL, V38, P311, DOI 10.1016/S0360-3016(97)82499-6
   GELET A, 1998, EUR UROL S1, V33, P53
   GELET A, 1993, J ENDOUROL, V7, P249, DOI 10.1089/end.1993.7.249
   Gelet A, 1996, EUR UROL, V29, P174
   Gonder M J, 1966, Invest Urol, V3, P372
   GRAMPSAS SA, 1995, UROLOGY, V45, P936, DOI 10.1016/S0090-4295(99)80111-3
   Grimm PD, 1996, HEMATOL ONCOL CLIN N, V10, P653, DOI 10.1016/S0889-8588(05)70359-2
   HOCHSTETLER JA, 1995, PROSTATE, V26, P316, DOI 10.1002/pros.2990260607
   HOLM HH, 1983, J UROLOGY, V130, P283
   IVERSEN P, 1989, UROLOGY, V34, P181, DOI 10.1016/0090-4295(89)90368-3
   Jager GJ, 1997, RADIOLOGY, V203, P645
   Kincaide LF, 1996, AM J VET RES, V57, P1225
   Lee F, 1997, ANTICANCER RES, V17, P1511
   LITTRUP PJ, 1994, UROLOGY, V44, P175, DOI 10.1016/S0090-4295(94)80123-1
   LOVEROCK P, 1990, BRIT J RADIOL, V63, P542
   Mack D, 1997, EUR UROL, V32, P129
   MADERSBACHER S, 1995, CANCER RES, V55, P3346
   MADERSBACHER S, 1994, J UROLOGY, V152, P1956
   Madersbacher S, 1998, PROSTATE, V37, P174
   MEIKLE AW, 1990, UROL CLIN N AM, V17, P709
   MITCHELL JB, 1977, RADIAT RES, V71, P547, DOI 10.2307/3574623
   Moerland MA, 1997, INT J RADIAT ONCOL, V37, P927, DOI 10.1016/S0360-3016(96)00575-5
   MOORE WE, 1989, J PEDIATR SURG, V24, P30, DOI 10.1016/S0022-3468(89)80295-7
   MURPHY GP, 1994, J UROLOGY, V152, P1817
   ONIK G, 1988, RADIOLOGY, V168, P629
   ONIK G, 1991, UROLOGY, V37, P277, DOI 10.1016/0090-4295(91)80306-R
   OPTENBERG SA, 1990, UROL CLIN N AM, V17, P719
   PAULSON DF, 1987, UROL CLIN N AM, V14, P675
   Pisters LL, 1997, J UROLOGY, V157, P921, DOI 10.1016/S0022-5347(01)65084-5
   Polascik TJ, 1998, UROLOGY, V51, P884, DOI 10.1016/S0090-4295(98)00153-8
   Pollack A, 1998, UROLOGY, V51, P258, DOI 10.1016/S0090-4295(97)00621-3
   PORTER AT, 1995, CA-CANCER J CLIN, V45, P165, DOI 10.3322/canjclin.45.3.165
   PRIONAS SD, 1994, INT J RADIAT ONCOL, V28, P151
   Ragde H, 1997, SEMIN SURG ONCOL, V13, P438, DOI 10.1002/(SICI)1098-2388(199711/12)13:6<438::AID-SSU8>3.0.CO;2-B
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Rossi S, 1996, AM J ROENTGENOL, V167, P759
   ROY JN, 1993, INT J RADIAT ONCOL, V26, P163, DOI 10.1016/0360-3016(93)90188-2
   SCHULMAN CC, 1995, UROLOGY, V45, P28, DOI 10.1016/S0090-4295(95)96260-3
   Schulman C C, 1994, Prog Clin Biol Res, V386, P479
   Seigne JD, 1996, J UROLOGY, V156, P182, DOI 10.1016/S0022-5347(01)65986-X
   Shinohara K, 1997, J UROLOGY, V158, P2206, DOI 10.1016/S0022-5347(01)68198-9
   Steed J, 1997, CAN ASSOC RADIOL J, V48, P186
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   SUSANI M, 1993, EUR UROL, V23, P34
   Sylvester J, 1997, J SURG ONCOL, V66, P65, DOI 10.1002/(SICI)1096-9098(199709)66:1<65::AID-JSO13>3.0.CO;2-N
   THUOFF S, 1998, EUR UROL S1, V33, P54
   VIJVERBERG PLM, 1993, BRIT J UROL, V72, P470, DOI 10.1111/j.1464-410X.1993.tb16180.x
   VIJVERBERG PLM, 1992, EUR UROL, V21, P35
   Wake RW, 1996, J UROLOGY, V155, P1663, DOI 10.1016/S0022-5347(01)66158-5
   WALSH PC, 1994, J UROLOGY, V152, P1831
   WALSH PC, 1987, UROL CLIN N AM, V14, P663
   WHITMORE WF, 1972, J UROLOGY, V108, P918
   Wong WS, 1997, CANCER, V79, P963
   YANG R, 1991, ARCH SURG-CHICAGO, V126, P1002
   Young HH, 1922, SURG GYNECOL OBSTET, V34, P93
   Zelefsky MJ, 1997, J UROLOGY, V158, P23, DOI 10.1097/00005392-199707000-00005
   Zippe CD, 1996, UROL CLIN N AM, V23, P147, DOI 10.1016/S0094-0143(05)70300-1
   Zlotta AR, 1997, J ENDOUROL, V11, P251, DOI 10.1089/end.1997.11.251
   ZLOTTA AR, 1995, INT J ONCOL, V7, P863
   Zlotta AR, 1998, BRIT J UROL, V81, P265
NR 92
TC 37
Z9 38
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0302-2838
J9 EUR UROL
JI Eur. Urol.
PD JAN
PY 2000
VL 37
IS 1
BP 2
EP 13
DI 10.1159/000020091
PG 12
WC Urology & Nephrology
SC Urology & Nephrology
GA 284JM
UT WOS:000085328800002
PM 10671777
ER

PT J
AU HOUSLEY, GD
   NORRIS, CH
   GUTH, PS
AF HOUSLEY, GD
   NORRIS, CH
   GUTH, PS
TI CHOLINERGICALLY-INDUCED CHANGES IN OUTWARD CURRENTS IN HAIR-CELLS
   ISOLATED FROM THE SEMICIRCULAR CANAL OF THE FROG
SO HEARING RESEARCH
LA English
DT Article
C1 TULANE UNIV,SCH MED,DEPT OTOLARYNGOL,1430 TULANE AVE,NEW ORLEANS,LA 70112.
   TULANE UNIV,SCH MED,DEPT PHARMACOL,NEW ORLEANS,LA 70112.
CR ART JJ, 1985, J PHYSIOL-LONDON, V360, P397
   ART JJ, 1984, J PHYSIOL-LONDON, V356, P525
   ART JJ, 1982, PROC R SOC SER B-BIO, V216, P377, DOI 10.1098/rspb.1982.0081
   ART JJ, 1984, J PHYSIOL-LONDON, V356, P507
   ASHMORE JF, 1982, J PHYSIOL-LONDON, V329, pP25
   BERNARD C, 1985, BRAIN RES, V338, P225, DOI 10.1016/0006-8993(85)90151-9
   BOBBIN RP, 1985, COMP BIOCHEM PHYS C, V80, P313, DOI 10.1016/0742-8413(85)90062-3
   DECHESNE C, 1980, ACTA OTO-LARYNGOL, V90, P82, DOI 10.3109/00016488009131701
   DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0
   FINDLAY I, 1984, J PHYSIOL-LONDON, V350, P179
   FLOCK A, 1976, J PHYSIOL-LONDON, V257, P45
   FURUKAWA T, 1981, J PHYSIOL-LONDON, V315, P203
   GITTER AH, 1986, ORL J OTO-RHINO-LARY, V48, P68
   GOLDBERG JM, 1980, J NEUROPHYSIOL, V43, P986
   GORMAN ALF, 1982, BIOPHYS J, V38, P319
   GUTH PS, 1989, P ASS RES OTOLARYNGO, P325
   GUTH PS, 1986, ACTA OTOLARYNGOL, V102, P186
   HARTMANN R, 1980, PFLUG ARCH EUR J PHY, V388, P123, DOI 10.1007/BF00584117
   HOUSLEY G, 1988, P ASS RES OTOLARYNGO, P91
   HOUSLEY G D, 1988, Society for Neuroscience Abstracts, V14, P947
   HOUSLEY GD, 1989, HEARING RES, V38, P259, DOI 10.1016/0378-5955(89)90070-1
   HOUSLEY GD, 1988, HEARING RES, V35, P87, DOI 10.1016/0378-5955(88)90043-3
   HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237
   KEHOE J, 1985, J PHYSIOL-LONDON, V369, P399
   LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0
   MADISON DV, 1987, J NEUROSCI, V7, P733
   Marty A, 1983, SINGLE CHANNEL RECOR, P107
   MEECH RW, 1975, J PHYSIOL-LONDON, V249, P211
   NORRIS C, 1988, INNER EAR BIOL WORKS, V25, P65
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   PRIGIONI I, 1983, BRAIN RES, V269, P83, DOI 10.1016/0006-8993(83)90964-2
   ROSSI ML, 1980, BRAIN RES, V185, P984
   STEINACKER A, 1988, Society for Neuroscience Abstracts, V14, P799
   STEINACKER A, 1988, HEARING RES, V35, P265, DOI 10.1016/0378-5955(88)90123-2
   STEINACKER A, 1985, BIOPHYS J, V47, pA144
   VALLI P, 1986, BRAIN RES, V362, P92, DOI 10.1016/0006-8993(86)91402-2
NR 36
TC 37
Z9 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5955
J9 HEARING RES
JI Hear. Res.
PD JAN
PY 1990
VL 43
IS 2-3
BP 121
EP 134
DI 10.1016/0378-5955(90)90221-A
PG 14
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA CP732
UT WOS:A1990CP73200004
PM 2312408
ER

PT J
AU CANTER, CE
   GUTIERREZ, FR
   MIROWITZ, SA
   MARTIN, TC
   HARTMANN, AF
AF CANTER, CE
   GUTIERREZ, FR
   MIROWITZ, SA
   MARTIN, TC
   HARTMANN, AF
TI EVALUATION OF PULMONARY ARTERIAL MORPHOLOGY IN CYANOTIC CONGENITAL
   HEART-DISEASE BY MAGNETIC-RESONANCE IMAGING
SO AMERICAN HEART JOURNAL
LA English
DT Article
C1 JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110.
   WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT INST RADIOL,ST LOUIS,MO 63110.
   WASHINGTON UNIV,SCH MED,EDWARD J MALLINCKRODT DEPT PEDIAT,DIV CARDIOL,ST LOUIS,MO 63110.
RP CANTER, CE (reprint author), ST LOUIS CHILDRENS HOSP,400 S KINGSHIGHWAY BLVD,ST LOUIS,MO 63110, USA.
CR ALFIERI O, 1978, J THORAC CARDIOV SUR, V76, P321
   BARGERON LM, 1977, CIRCULATION, V56, P1075
   BARRAGRY TP, 1987, J THORAC CARDIOV SUR, V93, P767
   BOVE EL, 1987, CIRCULATION, V76, P19
   BOXER RA, 1986, J PEDIATR, V1109, P460
   CHEN DG, 1987, AM HEART J, V113, P767, DOI 10.1016/0002-8703(87)90718-6
   EMMANOUILIDES GC, 1983, PULMONARY STENOSIS H, P256
   FELLOWS KE, 1977, CIRCULATION, V56, P485
   FELLOWS KE, 1981, AM J CARDIOL, V47, P1279, DOI 10.1016/0002-9149(81)90259-9
   FLEISS JL, 1973, STAT METHODS RATES P, P145
   FLETCHER BD, 1986, AM J ROENTGENOL, V146, P941
   FREEDOM RM, 1983, AM J CARDIOL, V51, P936, DOI 10.1016/S0002-9149(83)80169-6
   GUYTON RA, 1983, J THORAC CARDIOV SUR, V85, P917
   HIGGINS CB, 1984, CIRCULATION, V70, P851
   HUHTA JC, 1982, AM J CARDIOL, V49, P1235, DOI 10.1016/0002-9149(82)90049-2
   ICHIDA F, 1987, BRIT HEART J, V58, P627
   ILBAWI MN, 1987, J THORAC CARDIOV SUR, V93, P36
   KERSTINGSOMMERHOFF BA, 1988, J AM COLL CARDIOL, V11, P166
   KIRKLIN JW, 1977, CIRCULATION, V56, P612
   LAPPEN RS, 1983, J AM COLL CARDIOL, V2, P121
   MAHLE S, 1979, ANN THORAC SURG, V27, P216
   MAYER JE, 1986, J THORAC CARDIOV SUR, V92, P1021
   MEITUSSNYDER M, 1987, CIRCULATION S3, V76, P39
   MOMMA K, 1987, BRIT HEART J, V57, P534
   MOMMA K, 1986, BRIT HEART J, V55, P39
   NAKATA S, 1984, J THORAC CARDIOV SUR, V88, P610
   NAKAZAWA M, 1987, CIRCULATION, V75, P1117
   REES RSO, 1987, BRIT HEART J, V58, P621
   SNIDER AR, 1984, AM J CARDIOL, V53, P218, DOI 10.1016/0002-9149(84)90715-X
   TUCKER WY, 1979, J THORAC CARDIOV SUR, V78, P494
   VONSCHULTHESS GK, 1986, RADIOLOGY, V158, P469
NR 31
TC 37
Z9 38
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0002-8703
J9 AM HEART J
JI Am. Heart J.
PD AUG
PY 1989
VL 118
IS 2
BP 347
EP 354
DI 10.1016/0002-8703(89)90196-8
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AH864
UT WOS:A1989AH86400020
PM 2750656
ER

PT J
AU KUGLER, JD
   DANFORD, DA
AF KUGLER, JD
   DANFORD, DA
TI PACEMAKERS IN CHILDREN - AN UPDATE
SO AMERICAN HEART JOURNAL
LA English
DT Review
RP KUGLER, JD (reprint author), UNIV NEBRASKA,MED CTR,DEPT PEDIAT CARDIOL,CARDIOL SECT,42ND & DEWEY AVE,OMAHA,NE 68105, USA.
CR BEDER SD, 1985, AM HEART J, V109, P152, DOI 10.1016/0002-8703(85)90427-2
   BEERMAN LB, 1983, AM J CARDIOL, V51, P1530, DOI 10.1016/0002-9149(83)90671-9
   BELLINDER G, 1986, EUR HEART J, V7, P105
   BENDITT DG, 1987, CIRCULATION, V76, P279
   BENDITT DG, 1987, CIRCULATION, V75, P184
   BENREY J, 1976, CIRCULATION, V56, P245
   BENSON DW, 1982, PEDIATR CARDIOL, V2, P39, DOI 10.1007/BF02265615
   BERNSTEIN AD, 1987, PACE, V10, P794, DOI 10.1111/j.1540-8159.1987.tb06035.x
   BINKBOELKENS MT, 1984, PACE, V7, P618, DOI 10.1111/j.1540-8159.1984.tb05587.x
   BINKBOELKENS MTE, 1983, AM HEART J, V106, P125, DOI 10.1016/0002-8703(83)90449-0
   BOGNOLO D, 1983, PACE, V6, P113, DOI 10.1111/j.1540-8159.1983.tb06588.x
   BREN GB, 1986, CIRCULATION, V74, P388
   BRENNER JI, 1988, AM J CARDIOL, V61, P654, DOI 10.1016/0002-9149(88)90786-2
   BRICKER JT, 1985, PACE, V8, P656, DOI 10.1111/j.1540-8159.1985.tb05877.x
   BRICKER JT, 1988, PACE, V11, P460, DOI 10.1111/j.1540-8159.1988.tb06007.x
   BUCKINGHAM TA, 1988, J AM COLL CARDIOL, V11, P1269
   CASE C, 1988, PACE, V11, P484
   CHARDACK WM, 1960, SURGERY, V4, P643
   DAICOFF GR, 1974, CHEST, V66, P639, DOI 10.1378/chest.66.6.639
   DASMAHAPATRA HK, 1986, THORAC CARDIOV SURG, V34, P230, DOI 10.1055/s-2007-1020418
   DELEON SY, 1982, ANN THORAC SURG, V33, P273
   DEWEY RC, 1987, NEW ENGL J MED, V316, P835, DOI 10.1056/NEJM198704023161403
   DISEGNI E, 1980, J ELECTROCARDIOL, V13, P189, DOI 10.1016/S0022-0736(80)80053-7
   DONAHOO JS, 1976, ANN THORAC SURG, V22, P584
   DREIFUS LS, 1986, PACE, V9, P371, DOI 10.1111/j.1540-8159.1986.tb04491.x
   DULK K D, 1988, American Journal of Cardiology, V61, P107, DOI 10.1016/0002-9149(88)91314-8
   ELDAR M, 1987, J AM COLL CARDIOL, V3, P600
   EPSTEIN ML, 1986, AM J CARDIOL, V57, P889, DOI 10.1016/0002-9149(86)90639-9
   EPSTEIN ML, 1984, J AM COLL CARDIOL, V3, P485
   ERLEBACHER JA, 1984, J AM COLL CARDIOL, V4, P550
   ESSCHER E, 1983, PEDIATR CARDIOL, V4, P121, DOI 10.1007/BF02076336
   FISHER JD, 1987, AM J CARDIOL, V60, P1311, DOI 10.1016/0002-9149(87)90613-8
   FISHER JD, 1988, PACE, V11, P2, DOI 10.1111/j.1540-8159.1988.tb03923.x
   FLEMING WH, 1981, ANN THORAC SURG, V31, P329
   FLEMING WH, 1983, ANN THORAC SURG, V35, P535
   FLINN CJ, 1984, NEW ENGL J MED, V310, P1635, DOI 10.1056/NEJM198406213102504
   FROHLIG G, 1988, PACE, V11, P47, DOI 10.1111/j.1540-8159.1988.tb03929.x
   Frye R L, 1984, Circulation, V70, p331A
   FURMAN S, 1977, AM J CARDIOL, V39, P550, DOI 10.1016/S0002-9149(77)80165-3
   GILLETTE PC, 1987, J AM COLL CARDIOL, V9, pA199
   GILLETTE PC, 1981, AM HEART J, V102, P920, DOI 10.1016/0002-8703(81)90044-2
   GILLETTE PC, 1985, MODERN CARDIAC PACIN, P483
   GILLETTE PC, 1983, AM HEART J, V105, P843, DOI 10.1016/0002-8703(83)90250-8
   GILLETTE PC, 1986, PRACTICAL CARDIAC PA
   GILLETTE PC, 1986, PRACTICAL CARDIAC PA, P45
   GILLETTE PC, 1986, J AM COLL CARDIOL, V7, P138
   GILLETTE PC, 1987, J AM COLL CARDIOL, V9, P811
   GILLETTE PC, 1988, PACE, V11, P483
   GLENN WWL, 1969, J THORAC CARDIOV SUR, V58, P361
   GLENN WWL, 1976, ANN THORAC SURG, V22, P605
   GLENN WWL, 1959, NEW ENGL J MED, V261, P948, DOI 10.1056/NEJM195911052611905
   GOLDMAN BS, 1985, PACE, V8, P732, DOI 10.1111/j.1540-8159.1985.tb05885.x
   GOLDMAN BS, 1984, CIRCULATION, V70, P208
   GRIFFIN JC, 1986, PRACTICAL CARDIAC PA, P38
   GRIFFIN JC, 1986, PACE, V9, P387, DOI 10.1111/j.1540-8159.1986.tb04493.x
   GRIFFITHS SP, 1975, AM J CARDIOL, V36, P921, DOI 10.1016/0002-9149(75)90083-1
   HANLEY PC, 1984, MAYO CLIN PROC, V59, P268
   HARRIS PD, 1966, J THORAC CARDIOV SUR, V52, P277
   HAYES CJ, 1986, J AM COLL CARDIOL, V7, P133
   HEINZ M, 1988, PACE, V11, P495
   HENGLEIN D, 1984, PACE, V7, P203, DOI 10.1111/j.1540-8159.1984.tb04887.x
   HESSLEIN PS, 1982, CIRCULATION, V66, P170
   HOFFMAN BF, 1975, AM HEART J, V90, P117, DOI 10.1016/0002-8703(75)90263-X
   JANOSIK DL, 1987, AM J CARDIOL, V60, P1030, DOI 10.1016/0002-9149(87)90347-X
   KANGOS JJ, 1967, AM J CARDIOL, V20, P632, DOI 10.1016/0002-9149(67)90004-5
   KARPAWICH PP, 1981, AM J CARDIOL, V48, P1098, DOI 10.1016/0002-9149(81)90326-X
   KARPAWICH PP, 1987, CIRCULATION, V76, P550
   KARPAWICH PP, 1987, AM HEART J, V113, P316, DOI 10.1016/0002-8703(87)90271-7
   KATO R, 1987, PACE, V10, P424
   KING DH, 1983, AM HEART J, V106, P1438, DOI 10.1016/0002-8703(83)90060-1
   KORHONEN U, 1984, PACE, V7, P678, DOI 10.1111/j.1540-8159.1984.tb05596.x
   KRUSE IM, 1985, PACE, V8, P45, DOI 10.1111/j.1540-8159.1985.tb05721.x
   KUGLER J, 1988, PACE, V11, P2216, DOI 10.1111/j.1540-8159.1988.tb05988.x
   KUGLER JD, IN PRESS PEDIATRIC A
   KUGLER JD, 1986, AM HEART J, V112, P650
   LANDZBERG JS, 1987, CIRCULATION, V76, P279
   LIDWILL MC, 1929, 3RD T SESS AUSTR MED, P160
   Lindesmith G G, 1968, Ann Thorac Surg, V6, P358
   LIPKIN DP, 1987, BRIT HEART J, V58, P613
   LIU L, 1967, AM J CARDIOL, V20, P639, DOI 10.1016/0002-9149(67)90005-7
   LUCERI RM, 1986, PACE, V9, P137, DOI 10.1111/j.1540-8159.1986.tb05372.x
   MARTIN MV, 1966, PEDIATRICS, V37, P323
   MEDINARAVELL V, 1983, PACE, V6, P333, DOI 10.1111/j.1540-8159.1983.tb04370.x
   Michaëlsson M, 1972, Cardiovasc Clin, V4, P85
   MICHALIK RE, 1984, PACE, V7, P831, DOI 10.1111/j.1540-8159.1984.tb05624.x
   MILLER GB, 1988, AM HEART J, V115, P1048, DOI 10.1016/0002-8703(88)90075-0
   MOND H, 1988, PACE, V11, P214, DOI 10.1111/j.1540-8159.1988.tb04543.x
   MOND HG, 1982, PACE, V5, P278, DOI 10.1111/j.1540-8159.1982.tb02226.x
   MOQUIN PM, 1962, ARCH MAL COEUR, V55, P241
   MORRISS JH, 1972, J PEDIATR, V81, P1167, DOI 10.1016/S0022-3476(72)80256-7
   OTT DA, 1982, TEX HEART I J, V9, P149
   OTT DA, 1982, PRACTICAL CARDIAC PA, P63
   PARSONNET V, 1983, CIRCULATION, V68, pA227
   PETERS RW, 1980, AM J CARDIOL, V45, P1088, DOI 10.1016/0002-9149(80)90179-4
   PINSKY WW, 1982, PEDIATRICS, V69, P728
   RADOVSKY AS, 1988, PACE, V11, P1085, DOI 10.1111/j.1540-8159.1988.tb03955.x
   REDIKER DE, 1988, AM J CARDIOL, V61, P323, DOI 10.1016/0002-9149(88)90938-1
   ROSENQVIST M, 1988, AM HEART J, V116, P16, DOI 10.1016/0002-8703(88)90244-X
   ROSS BA, 1987, J AM COLL CARDIOL, V9, pA32
   ROY PR, 1976, AM J CARDIOL, V37, P237, DOI 10.1016/0002-9149(76)90318-0
   SAKSENA S, 1988, PACE, V11, P93, DOI 10.1111/j.1540-8159.1988.tb03932.x
   SCAGLIOTTI D, 1984, PEDIATR CARDIOL, V5, P39, DOI 10.1007/BF02306747
   SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7
   SCOTT WA, 1987, AM J CARDIOL, V60, P1409, DOI 10.1016/0002-9149(87)90634-5
   SERWER G, 1988, PACE, V11, P484
   SERWER GA, 1987, AM J CARDIOL, V59, P824, DOI 10.1016/0002-9149(87)91099-X
   SERWER GA, 1988, AM J CARDIOL, V61, P104, DOI 10.1016/0002-9149(88)91313-6
   SHANNON CE, 1983, PACE, V6, P96
   SHANNON CE, 1983, PACE, V6, pA96
   SHEARIN RPN, 1978, ANN THORAC SURG, V25, P144
   SIMON AB, 1982, PACE, V5, P836, DOI 10.1111/j.1540-8159.1982.tb06565.x
   SMITH RT, IN PRESS PEDIATRIC A
   SMITH RT, 1987, PACE, V10, P441
   SMITH RT, 1986, CIRCULATION, V4, P120
   STANTON RE, 1975, AM J DIS CHILD, V129, P484
   TABER RE, 1964, CIRCULATION, V29, P182
   TALIERCIO CP, 1985, J THORAC CARDIOV SUR, V90, P414
   TALIERCIO CP, 1986, CLIN PROG ELECTROPHY, V4, P246
   TRUSLER GA, 1968, J THORAC CARDIOV SUR, V55, P105
   VALLARIO LE, 1988, AM HEART J, V116, P11, DOI 10.1016/0002-8703(88)90243-8
   VERA Z, 1982, AM HEART J, V103, P80, DOI 10.1016/0002-8703(82)90533-6
   VIDEEN JS, 1986, AM J CARDIOL, V57, P1035
   VINCE DJ, 1987, PEDIATR CARDIOL, V8, P121, DOI 10.1007/BF02079467
   WAELKENS JJJ, 1982, PEDIATR CARDIOL, V3, P337, DOI 10.1007/BF02427037
   WALLS JT, 1983, ANN THORAC SURG, V36, P328
   WALSH C, 1988, PACE, V11, P483
   WARD DE, 1985, CLIN PROG ELECTROPHY, V3, P133
   WARD DE, 1985, CIRCULATION, V72, P340
   WEBB CL, 1987, J AM COLL CARDIOL, V9, P1031
   White PD, 1929, J CLIN INVEST, V7, P387, DOI 10.1172/JCI100236
   WHITMAN V, 1978, J PEDIATR, V92, P722, DOI 10.1016/S0022-3476(78)80136-X
   WILLIAMS WG, 1978, PACE, V1, P439, DOI 10.1111/j.1540-8159.1978.tb03505.x
   Williams WG, 1983, CLIN PROG ELECTROPHY, V4, P478
   WILMER CI, 1987, AM J CARDIOL, V59, P171, DOI 10.1016/S0002-9149(87)80098-X
   WINKLE RA, 1988, PACE, V11, P109, DOI 10.1111/j.1540-8159.1988.tb03935.x
   WINKLER RB, 1980, AM HEART J, V99, P87, DOI 10.1016/0002-8703(80)90317-8
   WISH M, 1986, PACE, V9, P1089, DOI 10.1111/j.1540-8159.1986.tb06675.x
   YOUNG D, 1981, PACE, V4, P61, DOI 10.1111/j.1540-8159.1981.tb03675.x
   1984, HCFA PUBLICATION, V6
NR 139
TC 37
Z9 37
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0002-8703
J9 AM HEART J
JI Am. Heart J.
PD MAR
PY 1989
VL 117
IS 3
BP 665
EP 679
DI 10.1016/0002-8703(89)90743-6
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA T5211
UT WOS:A1989T521100022
PM 2645752
ER

PT J
AU DELLSPERGER, KC
   WIETING, DW
   BAEHR, DA
   BARD, RJ
   BRUGGER, JP
   HARRISON, EC
AF DELLSPERGER, KC
   WIETING, DW
   BAEHR, DA
   BARD, RJ
   BRUGGER, JP
   HARRISON, EC
TI REGURGITATION OF PROSTHETIC HEART-VALVES - DEPENDENCE ON HEART-RATE AND
   CARDIAC-OUTPUT
SO AMERICAN JOURNAL OF CARDIOLOGY
LA English
DT Article
C1 MITRAL MED INT,IRVINE,CA.
   FDN COEUR ARTIFICIEL,GENEVA,SWITZERLAND.
   LOUISIANA STATE UNIV,MED CTR,SCH MED,NEW ORLEANS,LA 70112.
   UNIV SO CALIF,LOS ANGELES CTY MED CTR,DEPT MED,CARDIOL SECT,LOS ANGELES,CA 90033.
RP DELLSPERGER, KC (reprint author), LOUISIANA STATE UNIV,MED CTR,DEPT PHYSIOL & BIOPHYS,SHREVEPORT,LA 71130, USA.
CR BELLHOUSE BJ, 1976, MITRAL VALVE PLURIDI, P247
   BJORK VO, 1976, MITRAL VALVE PLURIDI, P239
   BURTON AC, 1965, PHYSL BIOPHYSICS CIR, P123
   FOLTS JD, 1971, J THORAC CARDIOV SUR, V61, P235
   FRATER RWM, 1979, 14TH ANN M ASS ADV M, P246
   FRATER RWM, 1976, MITRAL VALVE PLURIDI, P300
   HARKEN DE, 1960, J THORAC CARDIOV SUR, V40, P744
   HARRISON EC, 1978, AM HEART J, V95, P483, DOI 10.1016/0002-8703(78)90240-5
   HUFNAGEL C A, 1953, Bull Georgetown Univ Med Cent, V6, P60
   LEFRAK EA, 1979, CARDIAC VALVE PROSTH, P3
   LEVANG OW, 1980, SCAND J THORAC CARD, V14, P7, DOI 10.3109/14017438009109850
   MAGILLIGAN DJ, 1980, ANN THORAC SURG, V30, P259
   MERENDIN.KA, 1973, ANN SURG, V177, P694, DOI 10.1097/00000658-197306000-00008
   MORROW AG, 1965, CIRCULATION S1, V32
   NOLAN SP, 1970, AM HEART J, V79, P668, DOI 10.1016/0002-8703(70)90286-3
   NOLAN SP, 1976, MITRAL VALVE PLURIDI, P291
   NOLAN SP, 1969, ANN SURG, V169, P551, DOI 10.1097/00000658-196904000-00011
   NOLAN SP, 1968, ARCH SURG-CHICAGO, V97, P969
   STARR A, 1961, ANN SURG, V154, P726, DOI 10.1097/00000658-196110000-00017
   Wieting D W, 1966, Cardiovasc Res Cent Bull, V5, P41
   WILLIAMS BT, 1970, J THORAC CARDIOV SUR, V59, P824
   WRIGHT JTM, 1977, THORAX, V32, P296, DOI 10.1136/thx.32.3.296
   WRIGHT JTM, 1971, THORAX, V26, P81, DOI 10.1136/thx.26.1.81
   YOGANATHAN AP, 1978, CIRCULATION, V58, P70
NR 24
TC 37
Z9 37
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 245 WEST 17TH STREET, NEW YORK, NY 10011
SN 0002-9149
J9 AM J CARDIOL
JI Am. J. Cardiol.
PY 1983
VL 51
IS 2
BP 321
EP 328
DI 10.1016/S0002-9149(83)80058-7
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QA363
UT WOS:A1983QA36300018
PM 6823845
ER

PT J
AU MCCOY, JL
   DEAN, JH
   LAW, LW
   WILLIAMS, J
   MCCOY, NT
   HOLIMAN, BJ
AF MCCOY, JL
   DEAN, JH
   LAW, LW
   WILLIAMS, J
   MCCOY, NT
   HOLIMAN, BJ
TI IMMUNOGENICITY, ANTIGENICITY AND MECHANISMS OF TUMOR REJECTION OF
   MINERAL-OIL-INDUCED PLASMACYTOMAS IN SYNGENEIC BALB-C MICE
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article
C1 LITTON BIONETICS INC,DEPT IMMUNOL,KENSINGTON,MD 20795.
   NCI,LAB CELL BIOL,BETHESDA,MD 20014.
CR ANDERSSO.J, 1973, J EXP MED, V137, P943, DOI 10.1084/jem.137.4.943
   AOKI T, 1972, J EXP MED, V135, P443, DOI 10.1084/jem.135.3.443
   DEAN J, 1974, P AM ASSOC CANC RES, V15, P85
   GLYNN JP, 1964, CANCER RES, V24, P502
   KIT S, 1969, INT J CANCER, V4, P384, DOI 10.1002/ijc.2910040403
   KLEIN G, 1966, ANNU REV MICROBIOL, V20, P223, DOI 10.1146/annurev.mi.20.100166.001255
   KRIPKE ML, 1970, INT J CANCER, V6, P422, DOI 10.1002/ijc.2910060313
   LESPINAT.G, 1970, J NATL CANCER I, V45, P845
   MORIWAKI K, 1971, J NATL CANCER I, V47, P623
   PARAF A, 1970, P NATL ACAD SCI USA, V67, P983, DOI 10.1073/pnas.67.2.983
   POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0
   POTTER M, 1973, J NATL CANCER I, V51, P875
   POTTER M, 1972, PHYSIOL REV, V52, P631
   REIF AE, 1964, J EXP MED, V120, P413, DOI 10.1084/jem.120.3.413
   ROLLINGH.M, 1973, J NATL CANCER I, V50, P159
   ROUSE BT, 1972, NATURE-NEW BIOL, V238, P116
   ANDERSSO.J, 1972, CELL IMMUNOL, V4, P381, DOI 10.1016/0008-8749(72)90040-8
   TAKAHASH.T, 1970, J EXP MED, V132, P1181, DOI 10.1084/jem.132.6.1181
   TAKAHASH.T, 1971, J EXP MED, V134, P815, DOI 10.1084/jem.134.4.815
   TAKAHASH.T, 1970, J EXP MED, V131, P1325, DOI 10.1084/jem.131.6.1325
   WAGNER H, 1973, NATURE-NEW BIOL, V241, P53
   WATANABE T, 1971, J IMMUNOL, V106, P1213
   WHISSON ME, 1965, NATURE, V206, P689, DOI 10.1038/206689a0
   WHISSON ME, 1965, NATURE, V205, P406, DOI 10.1038/205406a0
   WILLIAMS WH, 1972, J NATL CANCER I, V49, P1613
   WINN HJ, 1960, J IMMUNOL, V84, P530
NR 26
TC 37
Z9 37
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0020-7136
J9 INT J CANCER
JI Int. J. Cancer
PY 1974
VL 14
IS 2
BP 264
EP 276
DI 10.1002/ijc.2910140216
PG 13
WC Oncology
SC Oncology
GA T7660
UT WOS:A1974T766000015
PM 4142466
ER

PT J
AU MERCHANT, FJ
   FEINBERG, H
   LEVITSKY, S
AF MERCHANT, FJ
   FEINBERG, H
   LEVITSKY, S
TI SEQUENTIAL-ANALYSIS OF ALTERED MYOCARDIAL-METABOLISM AND CONTRACTILITY
   INDUCED BY NORMOTHERMIC ARREST AND REPERFUSION
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
C1 UNIV ILLINOIS,COLL MED,ABRAHAM LINCOLN SCH MED,DEPT PHARMACOL,CHICAGO,IL 60680.
   UNIV ILLINOIS,COLL MED,ABRAHAM LINCOLN SCH MED,DEPT SURG,CHICAGO,IL 60680.
CR ABEL R M, 1970, Circulation Research, V27, P961
   ADAM H, 1965, METHODS ENZYMATIC AN
   ARNOLD G, 1968, PFLUG ARCH EUR J PHY, V299, P339, DOI 10.1007/BF00602910
   BESTER AJ, 1962, CARDIOVASC RES, V6, P284
   BUJA L M, 1971, Circulation Research Supplement, V43, P44
   DEUTICKE B, 1966, PFLUG ARCH GES PHYS, V292, P239, DOI 10.1007/BF00362739
   GAY WA, 1973, SURGERY, V74, P284
   GELET TR, 1969, CIRCULATION       S4, V39, P60
   GERLACH E, 1963, ARZNEIMITTEL-FORSCH, V13, P48
   GUNDJARNASON S, 1970, J MOLEC CELL CARD, V1, P325
   HOCKERTS T, 1959, ARZNEIMITTEL-FORSCH, V9, P47
   HOLZEN H, 1965, METHODS ENZYMATIC AN
   ISSELHAR.W, 1970, PFLUG ARCH EUR J PHY, V316, P164, DOI 10.1007/BF00586484
   Isselhard W, 1968, Acta Anaesthesiol Scand Suppl, V29, P203
   KATORI M, 1966, CIRC RES, V19, P420
   KATZ AM, 1970, PHYSIOL REV, V50, P63
   KUBLER W, 1970, Journal of Molecular and Cellular Cardiology, V1, P351, DOI 10.1016/0022-2828(70)90034-9
   LAMPRECHT W, 1965, METHODS ENZYMATIC AN
   LEVITSKY S, 1970, J THORAC CARDIOV SUR, V60, P625
   LEVITSKY S, 1971, AM HEART J, V81, P381, DOI 10.1016/0002-8703(71)90108-6
   MCDONALD TF, 1971, PFLUG ARCH EUR J PHY, V322, P95, DOI 10.1007/BF00592292
   MERCHANT F, 1972, SURG FORUM, V23, P163
   POOL PE, 1966, CIRC RES, V19, P221
   RAABO E, 1960, SCAND J CLIN LAB INV, V12, P402
   ROSALKI SB, 1967, J LAB CLIN MED, V69, P696
   SARIN CL, 1968, J THORAC CARDIOV SUR, V56, P395
   SARNOFF SJ, 1954, CIRCULATION, V9, P706
   STONEY RJ, 1962, SURGERY, V52, P37
   TAYLOR RR, 1967, CIRC RES, V21, P99
   Van Slyke DD, 1924, J BIOL CHEM, V61, P523
   WOLLENBERGER A, 1960, PFLUGERS ARCH, V27, P339
   WOLLENBE.A, 1969, BIOCHEM BIOPH RES CO, V36, P664, DOI 10.1016/0006-291X(69)90357-X
NR 32
TC 37
Z9 37
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PY 1974
VL 16
IS 2
BP 153
EP 161
DI 10.1016/0022-4804(74)90023-7
PG 9
WC Surgery
SC Surgery
GA S5332
UT WOS:A1974S533200009
PM 4818340
ER

PT J
AU Hicks, DG
   Meezan, NB
   Dewald, EL
   Mackinnon, AJ
   Olson, RE
   Callahan, DA
   Doppner, T
   Benedetti, LR
   Bradley, DK
   Celliers, PM
   Clark, DS
   Di Nicola, P
   Dixit, SN
   Dzenitis, EG
   Eggert, JE
   Farley, DR
   Frenje, JA
   Glenn, SM
   Glenzer, SH
   Hamza, AV
   Heeter, RF
   Holder, JP
   Izumi, N
   Kalantar, DH
   Khan, SF
   Kline, JL
   Kroll, JJ
   Kyrala, GA
   Ma, T
   MacPhee, AG
   McNaney, JM
   Moody, JD
   Moran, MJ
   Nathan, BR
   Nikroo, A
   Opachich, YP
   Petrasso, RD
   Prasad, RR
   Ralph, JE
   Robey, HF
   Rinderknecht, HG
   Rygg, JR
   Salmonson, D
   Schneider, MB
   Simanovskaia, N
   Spears, BK
   Tommasini, R
   Widmann, K
   Zylstra, AB
   Collins, GW
   Landen, OL
   Kilkenny, JD
   Hsing, WW
   MacGowan, BJ
   Atherton, LJ
   Edwards, MJ
AF Hicks, D. G.
   Meezan, N. B.
   Dewald, E. L.
   Mackinnon, A. J.
   Olson, R. E.
   Callahan, D. A.
   Doeppner, T.
   Benedetti, L. R.
   Bradley, D. K.
   Celliers, P. M.
   Clark, D. S.
   Di Nicola, P.
   Dixit, S. N.
   Dzenitis, E. G.
   Eggert, J. E.
   Farley, D. R.
   Frenje, J. A.
   Glenn, S. M.
   Glenzer, S. H.
   Hamza, A. V.
   Heeter, R. F.
   Holder, J. P.
   Izumi, N.
   Kalantar, D. H.
   Khan, S. F.
   Kline, J. L.
   Kroll, J. J.
   Kyrala, G. A.
   Ma, T.
   MacPhee, A. G.
   McNaney, J. M.
   Moody, J. D.
   Moran, M. J.
   Nathan, B. R.
   Nikroo, A.
   Opachich, Y. P.
   Petrasso, R. D.
   Prasad, R. R.
   Ralph, J. E.
   Robey, H. F.
   Rinderknecht, H. G.
   Rygg, J. R.
   Salmonson, D.
   Schneider, M. B.
   Simanovskaia, N.
   Spears, B. K.
   Tommasini, R.
   Widmann, K.
   Zylstra, A. B.
   Collins, G. W.
   Landen, O. L.
   Kilkenny, J. D.
   Hsing, W. W.
   MacGowan, B. J.
   Atherton, L. J.
   Edwards, M. J.
TI Implosion dynamics measurements at the National Ignition Facility
SO PHYSICS OF PLASMAS
LA English
DT Article
ID INERTIAL CONFINEMENT FUSION; PHYSICS BASIS; LASER SYSTEM; PERFORMANCE;
   TARGETS; ENERGY; CAPSULES; MODEL; HOT
AB Measurements have been made of the in-flight dynamics of imploding capsules indirectly driven by laser energies of 1-1.7 MJ at the National Ignition Facility [Miller et al., Nucl. Fusion 44, 228 (2004)]. These experiments were part of the National Ignition Campaign [Landen et al., Phys. Plasmas 18, 051002 (2011)] to iteratively optimize the inputs required to achieve thermonuclear ignition in the laboratory. Using gated or streaked hard x-ray radiography, a suite of ablator performance parameters, including the time-resolved radius, velocity, mass, and thickness, have been determined throughout the acceleration history of surrogate gas-filled implosions. These measurements have been used to establish a dynamically consistent model of the ablative drive history and shell compressibility throughout the implosion trajectory. First results showed that the peak velocity of the original 1.3-MJ Ge-doped polymer (CH) point design using Au hohlraums reached only 75% of the required ignition velocity. Several capsule, hohlraum, and laser pulse changes were then implemented to improve this and other aspects of implosion performance and a dedicated effort was undertaken to test the sensitivity of the ablative drive to the rise time and length of the main laser pulse. Changing to Si rather than Ge-doped inner ablator layers and increasing the pulse length together raised peak velocity to 93% +/- 5% of the ignition goal using a 1.5MJ, 420 TW pulse. Further lengthening the pulse so that the laser remained on until the capsule reached 30% (rather than 60%-70%) of its initial radius, reduced the shell thickness and improved the final fuel rho R on companion shots with a cryogenic hydrogen fuel layer. Improved drive efficiency was observed using U rather than Au hohlraums, which was expected, and by slowing the rise time of laser pulse, which was not. The effect of changing the Si-dopant concentration and distribution, as well as the effect of using a larger initial shell thickness were also examined, both of which indicated that instabilities seeded at the ablation front are a significant source of hydrodynamic mix into the central hot spot. Additionally, a direct test of the surrogacy of cryogenic fuel layered versus gas-filled targets was performed. Together all these measurements have established the fundamental ablative-rocket relationship describing the dependence of implosion velocity on fractional ablator mass remaining. This curve shows a lower-than-expected ablator mass at a given velocity, making the capsule more susceptible to feedthrough of instabilities from the ablation front into the fuel and hot spot. This combination of low velocity and low ablator mass indicates that reaching ignition on the NIF will require >20 mu m (similar to 10%) thicker targets and laser powers at or beyond facility limits. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4769268]
C1 [Hicks, D. G.; Meezan, N. B.; Dewald, E. L.; Mackinnon, A. J.; Callahan, D. A.; Doeppner, T.; Benedetti, L. R.; Bradley, D. K.; Celliers, P. M.; Clark, D. S.; Di Nicola, P.; Dixit, S. N.; Dzenitis, E. G.; Eggert, J. E.; Farley, D. R.; Glenn, S. M.; Glenzer, S. H.; Hamza, A. V.; Heeter, R. F.; Holder, J. P.; Izumi, N.; Kalantar, D. H.; Khan, S. F.; Kroll, J. J.; Ma, T.; MacPhee, A. G.; McNaney, J. M.; Moody, J. D.; Moran, M. J.; Nathan, B. R.; Opachich, Y. P.; Prasad, R. R.; Ralph, J. E.; Robey, H. F.; Rygg, J. R.; Salmonson, D.; Schneider, M. B.; Simanovskaia, N.; Spears, B. K.; Tommasini, R.; Widmann, K.; Collins, G. W.; Landen, O. L.; Kilkenny, J. D.; Hsing, W. W.; MacGowan, B. J.; Atherton, L. J.; Edwards, M. J.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
   [Olson, R. E.] Sandia Natl Labs, Albuquerque, NM 87185 USA.
   [Petrasso, R. D.; Rinderknecht, H. G.; Zylstra, A. B.] MIT, Cambridge, MA 02139 USA.
   [Kline, J. L.; Kyrala, G. A.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
   [Nikroo, A.] Gen Atom Co, San Diego, CA 92121 USA.
RP Hicks, DG (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
EM hicks13@llnl.gov
RI Ma, Tammy/F-3133-2013; McNaney, James/F-5258-2013
OI Ma, Tammy/0000-0002-6657-9604; 
FU U.S. Department of Energy by Lawrence Livermore National Laboratory
   [DE-AC52-07NA27344]
FX This work was performed under the auspices of the U.S. Department of
   Energy by Lawrence Livermore National Laboratory under Contract
   DE-AC52-07NA27344.
CR ALHASSID Y, 1978, CHEM PHYS LETT, V53, P22, DOI 10.1016/0009-2614(78)80380-7
   ATZENI S, 2007, PHYS INERTIAL FUSION
   Barrios MA, 2012, J APPL PHYS, V111, DOI 10.1063/1.4712050
   BARSHALOM A, 1989, PHYS REV A, V40, P3183, DOI 10.1103/PhysRevA.40.3183
   Boehly TR, 1997, OPT COMMUN, V133, P495, DOI 10.1016/S0030-4018(96)00325-2
   Callahan DA, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694840
   Clark DS, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3609834
   Clark DS, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2890123
   Clark DS, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3403293
   Cormen T. H, 2001, INTRO ALGORITHMS
   Dewald EL, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478683
   Dewald EL, 2004, REV SCI INSTRUM, V75, P3759, DOI 10.1063/1.1788872
   Edgell DH, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4731756
   Edwards MJ, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592173
   Frenje JA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3304475
   Girard F, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2032167
   Glebov VY, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3492351
   Glenn SM, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4731743
   Glenzer SH, 2010, SCIENCE, V327, P1228, DOI 10.1126/science.1185634
   Glenzer SH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.085004
   Glenzer SH, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4719686
   Haan SW, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592169
   Haan SW, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1885003
   Hamel S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.094113
   Hammel BA, 2010, HIGH ENERG DENS PHYS, V6, P171, DOI 10.1016/j.hedp.2009.12.005
   Hammel BA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3567520
   Hammel BA, 2006, PLASMA PHYS CONTR F, V48, pB497, DOI 10.1088/0741-3335/48/12B/S47
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   Herrmann MC, 2001, NUCL FUSION, V41, P99, DOI 10.1088/0029-5515/41/1/308
   Hibbard WJ, 2001, REV SCI INSTRUM, V72, P530, DOI 10.1063/1.1316758
   Hicks DG, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3486536
   HOLLIS JM, 1992, ASTROPHYS J, V386, P293, DOI 10.1086/171015
   HUNT JT, 1989, OPT ENG, V28, P461
   Iglesias CA, 1996, ASTROPHYS J, V464, P943, DOI 10.1086/177381
   Iglesias CA, 2003, J QUANT SPECTROSC RA, V81, P227, DOI 10.1016/S0022-4073(03)00075-X
   Johnson MG, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4728095
   Jones OS, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4718595
   Kemp A, 2001, PHYS REV LETT, V86, P3336, DOI 10.1103/PhysRevLett.86.3336
   Kimbrough J. R, 2010, REV SCI INSTRUM, V81
   Kline JL, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491032
   Kyrala GA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3574504
   Landen OL, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592170
   Landen OL, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3298882
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638
   Ma T, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4733313
   Mackinnon AJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215005
   MacPhee AG, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/02/P02009
   Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740
   Meezan N. B, 2011, 7 INT C INT FUS SCI
   Meezan NB, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3484873
   Meezan NB, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3354110
   Michel P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046409
   Michel P, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3325733
   Miller GH, 2004, NUCL FUSION, V44, pS228, DOI 10.1088/0029-5515/44/12/S14
   Moody JD, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491035
   MORE RM, 1988, PHYS FLUIDS, V31, P3059, DOI 10.1063/1.866963
   Oertel J. A, 2006, REV SCI INSTRUM, V77
   Olson RE, 2004, PHYS PLASMAS, V11, P2778, DOI 10.1063/1.1691032
   Olson RE, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3566009
   Opachich YP, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4732855
   Regan SP, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694057
   Robey HF, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694122
   Robey HF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215004
   Rosen MD, 2011, HIGH ENERG DENS PHYS, V7, P180, DOI 10.1016/j.hedp.2011.03.008
   Saillard Y, 2006, NUCL FUSION, V46, P1017, DOI 10.1088/0029-5515/46/12/005
   Schneider MB, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491316
   Schneider MB, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4732850
   Spears B, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022003
   Spears BK, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3696743
   Town RPJ, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3562552
   Zylstra AB, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4729672
NR 72
TC 36
Z9 36
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 1070-664X
J9 PHYS PLASMAS
JI Phys. Plasmas
PD DEC
PY 2012
VL 19
IS 12
AR 122702
DI 10.1063/1.4769268
PG 26
WC Physics, Fluids & Plasmas
SC Physics
GA 061FP
UT WOS:000312834000040
ER

PT J
AU Athanasiou, T
   Aziz, O
   Mangoush, O
   Al-Ruzzeh, S
   Nair, S
   Malinovski, V
   Casula, R
   Glenville, B
AF Athanasiou, T
   Aziz, O
   Mangoush, O
   Al-Ruzzeh, S
   Nair, S
   Malinovski, V
   Casula, R
   Glenville, B
TI Does off-pump coronary artery bypass reduce the incidence of
   post-operative atrial fibrillation? A question revisited
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Review
DE atrial fibrillation; cardiopulmonary bypass; meta-analysis; beating
   heart surgery; off-pump; randomised trials; propensity score matching
ID RANDOMIZED CONTROLLED-TRIALS; PROPENSITY SCORE ANALYSIS; ON-PUMP;
   CARDIOPULMONARY BYPASS; MYOCARDIAL REVASCULARIZATION; ELDERLY-PATIENTS;
   CARDIAC-SURGERY; RISK PATIENTS; METAANALYSIS; DISEASE
AB Atrial fibrillation (AF) is the most common post-operative complication in patients undergoing coronary artery bypass grafting with an increased incidence associated with advancing age. This study aims to determine whether off-pump coronary artery bypass (OPCAB) reduces the incidence of AF in a generalized population (mean age < 70 years). A meta-analysis was performed including all randonised and propensity score matched non-randomised Studies published between 2001 and 2003 reporting a comparison between the two techniques in a Generalised patient group (average age < 70 years). The primary outcome of interest was post-operative AF. Sensitivity am lysis was performed to evaluate consistency of the calculated treatment effect. Fourteen studies fulfilled our inclusion criteria, including a total of 16,505 subjects. The incidence of AF was 19% (1612/8265) in the off-pump group versus 24% (1976/8240) in the on-pump group. When considering only the 11 randomised studies (2207 subjects), we found a significant reduction in the incidence of post-operative AF in the off-pump group using a random-effect model (odds ratio (OR) = 0.60, 95% confidence interval (0) = 0.45-0.82, and chi-square of heterogeneity = 18.02, P = 0.05). Sensitivity analysis highlighted one randomised study causing funnel plot asymmetry, exclusion of which resulted in a significant reduction in the incidence of post-operative AF in the off-pump group (OR = 0.71, 95% CI = 0.57-0.9)), with a non-significant heterogeneity of 3.91 (P = 0.92). When only studies of high quality were considered (898 patients), no significant difference was seen between on and off-punip groups (OR = 0.78, 95% CI = 0.57-1.07, and heterogeneity = 0.53, P = 0.91). This may be due to small number of patients in this group. Our results suggest that although OPCAB surgery may reduce the incidence of post-operative AF in a generalised population (age <70 years) this finding is not clearly supported by high quality randomised trials. Although previous evidence suggests that the incidence of post-operative AF is reduced in an elderly population (> 70 years) with off-pump surgery, our results show that the evidence is less clear in a Younger population group. The question of whether Off-PUMP surgery in this patient group results in a lower rate of post-operative AY remains to be answered by further high quality randomised research. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Natl Heart & Lung Inst, Dept Cardiothorac Surg, London SW6 7DN, England.
RP Athanasiou, T (reprint author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Natl Heart & Lung Inst, Dept Cardiothorac Surg, London SW6 7DN, England.
EM tathan5253@aol.com
CR Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011
   Al-Ruzzeh S, 2003, EUR J CARDIO-THORAC, V23, P50, DOI 10.1016/S1010-7940(02)00654-1
   Amar D, 2002, ANESTHESIOLOGY, V96, P352, DOI 10.1097/00000542-200202000-00021
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athorascur.2003.07.002
   Athanasiou T, 2004, ANN THORAC SURG, V77, P1567, DOI 10.1016/j.athoracsur.2003.10.040
   Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1
   Calafiore AM, 2003, EUR J CARDIO-THORAC, V24, P953, DOI 10.1016/S1010-7940(03)00572-4
   CLARKE M, 2001, COCHRANE LIB
   Creswell L L, 1999, Semin Thorac Cardiovasc Surg, V11, P303
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Egger M, 1997, BRIT MED J, V315, P629
   Egger M, 1995, SYSTEMATIC REV HEALT
   ENGLAND MR, 1992, JAMA-J AM MED ASSOC, V268, P2395, DOI 10.1001/jama.268.17.2395
   Gerola LR, 2004, ANN THORAC SURG, V77, P569, DOI 10.1016/S0003-4975(03)01353-5
   Grunkemeier GL, 2002, ANN THORAC SURG, V74, P301, DOI 10.1016/S0003-4975(02)03783-9
   Heyland DK, 1998, JAMA-J AM MED ASSOC, V280, P2013, DOI 10.1001/jama.280.23.2013
   Heyland DK, 1996, CRIT CARE MED, V24, P517, DOI 10.1097/00003246-199603000-00025
   Hoff SJ, 2002, ANN THORAC SURG, V74, pS1340
   Kalman JM, 1995, ANN THORAC SURG, V60, P1709, DOI 10.1016/0003-4975(95)00718-0
   Karthik S, 2003, EUR J CARDIO-THORAC, V24, P66, DOI 10.1016/S1010-7940(03)00255-0
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   Kowey PR, 1997, AM J CARDIOL, V79, P1114
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Mack MJ, 2004, J THORAC CARDIOV SUR, V127, P167, DOI 10.1016/j.jtcvs.2003.08.032
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Ommen SR, 1997, NEW ENGL J MED, V336, P1429, DOI 10.1056/NEJM199705153362006
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Smith A, 2002, J CARDIOTHOR VASC AN, V16, P413, DOI 10.1053/jcan.2002.125151
   Stamou SC, 2002, ANN THORAC SURG, V74, P394, DOI 10.1016/S0003-4975(02)03636-6
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   THOMPSON SG, 1991, LANCET, V338, P1127, DOI 10.1016/0140-6736(91)91975-Z
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 40
TC 36
Z9 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD OCT
PY 2004
VL 26
IS 4
BP 701
EP 710
DI 10.1016/j.ejcts.2004.05.053
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 861WJ
UT WOS:000224449000007
PM 15450560
ER

PT J
AU Lee, WR
   Moughan, J
   Owen, JB
   Zelefsky, MJ
AF Lee, WR
   Moughan, J
   Owen, JB
   Zelefsky, MJ
TI The 1999 Patterns of Care Study of Radiotherapy in localized prostate
   carcinoma - A comprehensive survey of prostate brachytherapy in the
   United States
SO CANCER
LA English
DT Article
DE prostate brachytherapy; Patterns of Care Study; iodine-125;
   palladium-103
ID RADIATION-THERAPY; CANCER; ADENOCARCINOMA; OUTCOMES
AB BACKGROUND. The objective of the current study was to provide descriptive information on a representative national sample of patients with prostate carcinoma who were treated with prostate brachytherapy (PB) in calendar year 1999.
   METHODS. A random survey was conducted by the Patterns of Care Study in radiation oncology of 59 facilities (I facility had no eligible patients) that treated patients with prostate carcinoma in 1999 in the United States. A weighted sample size of 36,496 patients with prostate cancer was included in the 1999 survey (unweighted sample size, 554 patients). The main measures were the clinical characteristics of men prior to treatment and the technical characteristics of PB. Patients were classified into three prognostic groups according to T stage, pretreatment prostate specific antigen (PSA) level, and Gleason score.
   RESULTS. A weighted sample size of 13,293 patients (36%; unweighted sample size, 162 patients) was treated with PB. Compared with a weighted sample size of 23,203 patients (64%; unweighted sample size, 392 patients) was treated with external beam radiotherapy (EB), patients who received PB were significantly younger (mean age: PB group, 67.7 years; EB group, 70.8 years; P = 0.0006). The mean pretreatment PSA level for the PB group was lower compared with the EB group (9.9 ng/mL vs. 13.33 ng/mL; P = 0.0015). The prognostic groupings were more favorable for patients in the PB group compared with patients in EB group (P = 0.0365). The utilization of androgen deprivation therapy (ADT) in the PB group was similar to the utilization of ADT in the EB group (40.4% vs. 51.3%; P = 0.2282). The vast majority of men who were treated with PB received low-dose-rate, permanent sources (89%). Fifty-four percent of men received PB monotherapy (PBM), and the remaining 46% were treated with EB in addition to PB (EBPB). The prognostic groupings were more favorable for patients in the PBM group compared with patients in the EBPB group (P = 0.0037). Of the men who were treated with low-dose-rate PB, 59% were treated with iodine- 125 (I-125), and 41% were treated with palladium-103 (Pd-103).I-125 was used more frequently in men who were treated with PBM, and Pd-103 was used more frequently in men who were treated with EBPB. Postimplantation dosimetry was documented in 61.0% of men who were treated with low-dose-rate PB. Computed tomography imaging was used for 46.5% of men.
   CONCLUSIONS. PB was used in 36% of men who were treated with radiotherapy nationally. The mean age of men who were treated with PB was younger than the population of men who were treated with EB alone. Nearly 50% of men who received PB also received EB. EB was used more frequently in men with higher-risk disease. ADT was used in 40% of patients in the PB group. Techniques and prescription doses were consistent with published guidelines. (C) 2003 American Cancer Society.
C1 Wake Forest Univ, Sch Med, Dept Radiat Oncol, Winston Salem, NC 27157 USA.
   Amer Coll Radiol, Philadelphia, PA USA.
   Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA.
RP Lee, WR (reprint author), Wake Forest Univ, Sch Med, Dept Radiat Oncol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
CR Blasko JC, 2000, RADIOTHER ONCOL, V57, P273, DOI 10.1016/S0167-8140(00)00288-7
   Brandeis J, 2000, CANCER, V89, P1792, DOI 10.1002/1097-0142(20001015)89:8<1792::AID-CNCR20>3.0.CO;2-4
   Brandeis JM, 2000, J UROLOGY, V163, P851, DOI 10.1016/S0022-5347(05)67818-4
   Chuba PJ, 2001, INT J RADIAT ONCOL, V50, P325, DOI 10.1016/S0360-3016(01)01478-X
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   GERBER RL, 1995, INT J RADIAT ONCOL, V33, P803, DOI 10.1016/0360-3016(95)00278-1
   Hanks GE., 1988, NATL CANCER I MONOGR, V7, P75
   HANKS GE, 1985, INT J RADIAT ONCOL, V11, P153
   JONES GT, 1995, J AM COLL SURGEONS, V180, P545
   KRAMER S, 1981, INT J RADIAT ONCOL, V7, P795
   KRAMER S, 1977, CANCER, V39, P780, DOI 10.1002/1097-0142(197702)39:2+<780::AID-CNCR2820390712>3.0.CO;2-I
   Lee WR, 2002, UROLOGY, V60, P39, DOI 10.1016/S0090-4295(02)01568-6
   LEIBEL SA, 1984, INT J RADIAT ONCOL, V10, P401
   Mettlin CJ, 1999, CANCER, V86, P1877, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1877::AID-CNCR32>3.0.CO;2-5
   Nag S, 2000, Semin Urol Oncol, V18, P133
   Nag S, 2000, INT J RADIAT ONCOL, V46, P221, DOI 10.1016/S0360-3016(99)00351-X
   Prestidge BR, 1998, INT J RADIAT ONCOL, V40, P461, DOI 10.1016/S0360-3016(97)00715-3
   Prete JJ, 1998, INT J RADIAT ONCOL, V40, P1001, DOI 10.1016/S0360-3016(97)00901-2
   Zietman A, 2001, INT J RADIAT ONCOL, V50, P75, DOI 10.1016/S0360-3016(00)01569-8
NR 19
TC 36
Z9 38
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0008-543X
J9 CANCER
JI Cancer
PD NOV 1
PY 2003
VL 98
IS 9
BP 1987
EP 1994
DI 10.1002/cncr.11774
PG 8
WC Oncology
SC Oncology
GA 736BG
UT WOS:000186150000027
PM 14584083
ER

PT J
AU Lee, F
   Bahn, DK
   Badalament, RA
   Kumar, AB
   Klionsky, D
   Onik, GM
   Chinn, DO
   Greene, C
AF Lee, F
   Bahn, DK
   Badalament, RA
   Kumar, AB
   Klionsky, D
   Onik, GM
   Chinn, DO
   Greene, C
TI Cryosurgery for prostate cancer: Improved glandular ablation by use of 6
   to 8 cryoprobes
SO UROLOGY
LA English
DT Article
ID ANTIGEN; ADENOCARCINOMA; CARCINOMA; THERAPY
AB Objectives. To describe and assess the efficacy for increased glandular destruction by using 6 to 8 cryoprobes in place of the traditional 5 probes.
   Methods. In April 1996, a revised method for cryosurgery was begun that uses 6 to 8 cryoprobes, and by July 1997, 81 men had been treated. This group was compared retrospectively to our last 82 cases done before April 1996 using 5 cryoprobes. All cases were consecutive. To ensure that the groups were similar, comparison was performed of entrance prostate-specific antigen (PSA), clinical stage, and Gleason score. Six months after cryosurgery, PSA and residual epithelial acini were compared between the two groups.
   Results. The two groups were comparable for all the above parameters (P > 0.05). The degree of overall glandular kill was greater for the 6 to 8-probe method (P = 0.025). Complete glandular ablation for the 5-probe and 6 to 8-probe methods was 39% and 53%, respectively, and the difference was not significant (P = 0.072). However, when one combined the complete glandular ablation group with the none to few residual acini group, 67.5% for the 5-probe method and 88.9% for the 6 to 8-probe method, a significant difference was found (P = 0.001). The odds of having many remaining acini versus having none to few were 3.5 times greater in the 5-probe group than in the 6 to 8-probe group. The mean and median PSA for the 5- and 6 to 8-probe groups were 0.19 and 0.1 versus 0.11 and 0.07 ng/mL, respectively, a significant difference (P = 0.02). No difference was found in rates of tumor persistence or complications.
   Conclusions. A revised method for cryosurgery using 6 to 8 cryoprobes has proved to be more effective for near-glandular ablation than the traditional 5-probe method. It was easily applied, had a wide margin of safety, and even shortened learning time. These innovations have permitted a closer approach to the goal of complete glandular destruction. UROLOGY 54: 135-140, 1999. (C) 1999, Elsevier Science Inc.
C1 Crittenton Hosp, Prostate Ctr, Dept Radiol, Rochester, MI 48307 USA.
   Crittenton Hosp, Prostate Ctr, Dept Urol, Rochester, MI 48307 USA.
   Crittenton Hosp, Prostate Ctr, Dept Pathol, Rochester, MI 48307 USA.
   Adv Med Procedures, Winter Pk, FL USA.
   Urol Med Grp, Arcadia, CA USA.
RP Lee, F (reprint author), Crittenton Hosp, Prostate Ctr, Dept Radiol, 1101 W Univ Dr, Rochester, MI 48307 USA.
CR BADALAMENT RA, IN PRESS UROLOGY
   BAHN DK, 1994, RADIOLOGY, V190, P551
   BOSTWICK DG, 1982, AM J SURG PATHOL, V6, P541, DOI 10.1097/00000478-198209000-00006
   CIVANTOS F, 1995, CANCER, V75, P1634, DOI 10.1002/1097-0142(19950401)75:7<1634::AID-CNCR2820750713>3.0.CO;2-#
   Cohen JK, 1996, UROLOGY, V47, P395, DOI 10.1016/S0090-4295(99)80459-2
   Connolly JA, 1997, UROL CLIN N AM, V24, P415, DOI 10.1016/S0094-0143(05)70388-8
   Critz FA, 1997, UROLOGY, V49, P668, DOI 10.1016/S0090-4295(97)00084-8
   GRAMPSAS SA, 1995, UROLOGY, V45, P936, DOI 10.1016/S0090-4295(99)80111-3
   LEE F, 1994, RADIOLOGY, V192, P769
   Lee F, 1997, ANTICANCER RES, V17, P1511
   MILLER RJ, 1994, UROLOGY, V44, P170, DOI 10.1016/S0090-4295(94)80122-3
   ONIK GM, 1993, CANCER, V72, P1291, DOI 10.1002/1097-0142(19930815)72:4<1291::AID-CNCR2820720423>3.0.CO;2-I
   ONIK GM, 1998, 10 C CRYOS ORL FLOR
   Shinohara K, 1996, J UROLOGY, V156, P115, DOI 10.1016/S0022-5347(01)65958-5
   Shuman BA, 1997, J UROLOGY, V157, P552, DOI 10.1016/S0022-5347(01)65199-1
   SIDERS DB, 1998, PATHOLOGY PROSTATE, V34, P315
   Tatsutani K, 1996, UROLOGY, V48, P441, DOI 10.1016/S0090-4295(96)00199-9
   Wong WS, 1997, CANCER, V79, P963
NR 18
TC 36
Z9 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0090-4295
J9 UROLOGY
JI UROLOGY
PD JUL
PY 1999
VL 54
IS 1
BP 135
EP 140
DI 10.1016/S0090-4295(99)00039-4
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 213BA
UT WOS:000081251100027
PM 10414740
ER

PT J
AU Khan, MA
   Lo, AY
   Vande Maele, DM
AF Khan, MA
   Lo, AY
   Vande Maele, DM
TI Paraduodenal hernia
SO AMERICAN SURGEON
LA English
DT Article
ID DIAGNOSIS
AB An internal hernia is the protrusion of a viscus through a normal or abnormal opening within the confines of the abdominal cavity. Internal hernias account for 0.2 to 0.9 per cent of all cases of intestinal obstruction. Paraduodenal hernias are relatively rare congenital malformations and account for 39 to 53 per cent of all internal hernias. They result from incomplete rotation of the midgut, with part of the small intestine trapped posterior to the mesocolon. Right and left paraduodenal hernias are distinct and separate entities, varying not only in anatomic structure but also in embryological origin. Symptoms are often vague, and a high index of suspicion is required to make the diagnosis. This entity should be considered whenever atypical abdominal symptoms are present. A CT scan or barium upper gastrointestinal radiography provides the best preoperative evidence of this condition, although ultrasonography and plain films are also useful. Elective repair of such a hernia should always be performed to avoid bowel incarceration or strangulation. An understanding of the anatomy of these hernias facilitates the surgery and is necessary in decreasing the likelihood of complications. Careful reduction of the hernia and surgical repair will avoid injury to the major mesenteric vessels juxtaposed to the hernial orifice. The surgical management of three patients, who were diagnosed preoperatively with this condition, is described with a review of its pathogenesis and present surgical treatment.
C1 Beth Israel Med Ctr, Dept Surg, New York, NY 10003 USA.
RP Khan, MA (reprint author), St Louis Univ, Hlth Sci Ctr, Dept Internal Med, St Louis, MO 63110 USA.
CR Andrews E, 1923, SURG GYNECOL OBSTET, V37, P740
   BARTLETT MK, 1968, ANN SURG, V168, P249, DOI 10.1097/00000658-196808000-00010
   BERARDI RS, 1981, SURG GYNECOL OBSTET, V152, P99
   BRIGHAM RA, 1989, HERNIA, P481
   CALLANDER LC, 1935, SURG GYNECOL OBSTET, V60, P1052
   DAVIS R, 1975, AM J SURG, V129, P570, DOI 10.1016/0002-9610(75)90318-9
   Exner FB, 1933, AM J ROENTGENOL RADI, V29, P585
   FREUND H, 1977, ARCH SURG-CHICAGO, V112, P570
   Hansmann GH, 1939, ARCH SURG-CHICAGO, V39, P973
   JONNESCO T, 1889, ANATOMIE TOPOGRAPHIQ
   JONNESCO T, 1890, HERNIES INTERNES RET
   KUMMER E, 1921, J RADIOL ELECT, V5, P362
   NEUBAUER JE, 1786, OPERA ANATOMICA COLL
   OLOZABAL A, 1992, CLIN RADIOL, V46, P288
   SINGH S, 1971, CAN J SURG, V14, P148
   TREITZ W, 1857, HERNIA RETROPERITONE, P75
   WACHSBERG RH, 1994, CAN ASSOC RADIOL J, V45, P223
   WARSHAUER DM, 1992, GASTROINTEST RADIOL, V17, P13, DOI 10.1007/BF01888498
   YEOMAN LJ, 1994, CLIN RADIOL, V49, P898, DOI 10.1016/S0009-9260(05)82889-2
   ZIMMERMAN I, 1953, ANN SURG, V138, P82
NR 20
TC 36
Z9 38
PU SOUTHEASTERN SURGICAL CONGRESS
PI ATLANTA
PA 141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA
SN 0003-1348
J9 AM SURGEON
JI Am. Surg.
PD DEC
PY 1998
VL 64
IS 12
BP 1218
EP 1222
PG 5
WC Surgery
SC Surgery
GA 141JF
UT WOS:000077139500025
PM 9843350
ER

PT J
AU Sahin, S
   Moir, RW
   Sahinaslan, A
   Sahin, HM
AF Sahin, S
   Moir, RW
   Sahinaslan, A
   Sahin, HM
TI Radiation damage in liquid-protected first-wall materials for
   IFE-reactors
SO FUSION TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 12th Topical Meeting on the Technology of Fusion Energy
CY JUN 16-20, 1996
CL RENO, NV
ID HYLIFE-II; DESIGN
AB Material damage through displacements per atom (DPA) and helium gas production, as well as the tritium breeding and energy absorption in an IFE (Inertial Fusion Energy) reactor chamber have been investigated with variable coolant zone thickness using different liquids. Examples are given for HYLIFE-II (an IFE reactor design) energy conversion chambers using Flibe (Li2BeF4), natural lithium and Li17Pb83 eutectic as both coolant and wall protection. To achieve a useful energy density for energy conversion purposes with sufficient tritium breeding (TBR = 1.1), material protection (DPA < 100 and He < 500 appm in 30 years of operation) and shallow burial criteria, coolant zone thickness values are found to be 56 cm for Flibe, 160 cm for natural lithium and 170 cm for Li17Pb83 with SS-304 as structural material.
   Material damage investigations are extended to structural materials made of SiC and graphite for the same blanket. DPA values and He production rates in graphite turn out to be comparable to those in SS-304. However, they are higher in SiC, as compared to SS-304 and graphite.
C1 LAWRENCE LIVERMORE NATL LAB,LIVERMORE,CA 94550.
RP Sahin, S (reprint author), GAZI UNIV,TEKN EGITIM FAK,ANKARA,TURKEY.
RI SAHIN, Sumer/C-6252-2013
OI SAHIN, Sumer/0000-0003-2844-8061
CR ALKUSAYER TA, 1988, CLAW 4 COUPLED 30 NE, P4
   BADGER B, 1985, KFK3840
   Barrett R. J., 1979, LA7808MS LOS AL SCI
   BLINK A, 1985, UCRL53559 LAWR LIV N
   ENGLE WW, 1970, K1693 OAK RIDG GAS D
   HOUSE PA, 1994, FUSION TECHNOL, V26, P1178
   KIMLIGER R, 1990, 17026 UCID LAWR LIV
   LEE JD, 1992, UCRLID111589 LAWR LI
   MACFARLANE E, 1993, TRANSX 2 CODE INTERF
   MEIER W, 1988, UNPUB
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   Perlado M., 1995, ENERGY INERTIAL FUSI, P272
   SAHIN S, 1994, FUSION TECHNOL, V26, P1311
   SAHIN S, 1994, FUSION TECHNOL, V25, P388
   SAHIN S, 1973, ATOMKERNENERG/KERNT, V22, P24
   SAHIN S, 1996, 12 TOP M TECHN FUS P
   Smith D.L., 1984, ANLFPP841
NR 17
TC 36
Z9 36
PU AMER NUCLEAR SOCIETY
PI LA GRANGE PK
PA 555 N KENSINGTON AVENUE, LA GRANGE PK, IL 60525
SN 0748-1896
J9 FUSION TECHNOL
JI Fusion Technol.
PD DEC
PY 1996
VL 30
IS 3
BP 1027
EP 1035
PN 2A
PG 9
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA WC420
UT WOS:A1996WC42000102
ER

PT J
AU MOIR, RW
AF MOIR, RW
TI THE LOGIC BEHIND THICK, LIQUID-WALLED, FUSION CONCEPTS
SO FUSION ENGINEERING AND DESIGN
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Fusion Nuclear Technology
CY JUN 26-JUL 01, 1994
CL LOS ANGELES, CA
HO UNIV CALIF LOS ANGELES
ID REACTOR; DESIGN
AB It may be possible to surround the region where fusion reactions are taking place with a neutronically thick liquid blanket which has penetrations that allow only a few tenths of a percent of the neutrons to leak out. Even these neutrons can be attenuated by adding an accurately placed liquid or solid near the target to shadow-shield the beam ports from line-of-sight neutrons. The logic of such designs is discussed and their evolution is described with examples applied to both magnetic and inertial fusion (HYLIFE-II).
   These designs with liquid protection are self-healing when exposed to pulsed loading, and have a number of advantages over the usual designs with solid first walls. For example, the liquid-protected solid components will last the life of the plant, and therefore the capacity factor is estimated to be approximately 10% higher than for the non-liquid-walled blankets, because no blanket replacement shutdowns are required. The component replacement, operations, and maintenance costs might be half the usual value because no blanket change-out costs or accompanying facilities are required. These combined savings might lower the cost of electricity by 20%.
   Nuclear-grade construction should not be needed, largely because the liquid attenuates neutrons and results in less activation of materials. Upon decommissioning, the reactor materials should qualify for disposal by shallow burial even when constructed of ordinary 304 stainless steel. The need for a high-intensity 14-MeV neutron test facility to develop first-wall materials is avoided or greatly reduced, saving billions of development dollars. Flowing molten Li, the molten salt Flibe (Li2BeF4), and molten Li17Pb83 have been considered. An advantage of molten salt is that it will not burn and has a low tritium solubility and therefore low tritium inventory.
RP MOIR, RW (reprint author), LAWRENCE LIVERMORE NATL LAB,POB 808,L-637,LIVERMORE,CA 94551, USA.
CR CHRISTOFILOS NC, 1989, J FUSION ENERG, V8, P97, DOI 10.1007/BF01050784
   ELGUEBALY LA, 1995, FUSION ENG DES, V28
   HAGENSON RL, 1987, LA010908MS REP
   HOFFMAN MA, 1995, FUSION ENG DES, V29
   HOUSE PA, 1994, FUSION TECHNOL, V26, P1178
   KEISER JR, 1979, J NUCL MATER, V85-6, P295
   LEE JD, 1994, FUSION TECHNOL, V26, P74
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   MOIR RW, 1989, FUSION TECHNOL, V15, P674
   MONSLER MJ, 1981, NUCL TECHNOL-FUSION, V1, P302
   ROBSON AE, 1982, UNCONVENTIONAL APPRO
NR 11
TC 36
Z9 36
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0920-3796
J9 FUSION ENG DES
JI Fusion Eng. Des.
PD MAR
PY 1995
VL 29
BP 34
EP 42
DI 10.1016/0920-3796(95)80003-G
PG 9
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA QW376
UT WOS:A1995QW37600004
ER

PT J
AU KUJAWA, SG
   GLATTKE, TJ
   FALLON, M
   BOBBIN, RP
AF KUJAWA, SG
   GLATTKE, TJ
   FALLON, M
   BOBBIN, RP
TI INTRACOCHLEAR APPLICATION OF ACETYLCHOLINE ALTERS SOUND-INDUCED
   MECHANICAL EVENTS WITHIN THE COCHLEAR PARTITION
SO HEARING RESEARCH
LA English
DT Article
DE EFFERENTS; ACETYLCHOLINE; ACOUSTIC DISTORTION PRODUCTS; COCHLEAR
   MECHANICS; OLIVOCOCHLEAR NEURONS; OUTER HAIR CELLS
ID OUTER HAIR-CELLS; CROSSED OLIVOCOCHLEAR BUNDLE; AUDITORY-NERVE FIBERS;
   ACOUSTIC DISTORTION; STIMULATION; RESPONSES; SYSTEM; CAT
AB Activation of olivocochlear (OC) efferent fibers has been suggested to alter micromechanical events occurring within the cochlear partition, possibly through an effect of the efferent neurotransmitter (acetylcholine; ACh) on outer hair cells (OHCs). Based on the widely-accepted assumption that otoacoustic emissions reflect OHC activity, we investigated the in vivo influence of ACh on OHCs by studying alterations in emission amplitude with local ACh application. Distortion product otoacoustic emissions (DPOAEs) were measured in anesthetized guinea pigs before, during, and after intracochlear application of ACh (250-mu-M) with the cholinesterase inhibitor, eserine (20-mu-M). Perfusion of ACh/eserine was associated with a desensitizing reduction in DPOAE amplitude of approximately 4.4 dB. This reduction was intensity-dependent, with greater and more consistent reductions observed for DPOAEs elicited by low- than by moderate-intensity primaries. The response reduction was not seen during consecutive ACh perfusions performed without an intervening artificial perilymph wash, and was effectively blocked in the presence of pharmacologic antagonists of OC efferent activity (curare, 50-mu-M; strychnine, 50-mu-M). Finally, a similar alteration in DPOAE amplitude was never seen during perfusion of the control (artificial perilymph) solution alone. It is argued that these results support the hypothesis that OC efferent activation can alter sound-induced cochlear mechanical events.
C1 LOUISIANA STATE UNIV,MED CTR,DEPT OTORHINOLARYNGOL & BIOCOMMUN,KRESGE HEARING RES LAB S,NEW ORLEANS,LA 70112.
   UNIV ARIZONA,DEPT PHARMACEUT RES,TUCSON,AZ 85721.
CR [Anonymous], 1985, NIH PUBLICATION
   ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323
   Bledsoe Jr S.C., 1988, PHYSL HEARING, P385
   BOBBIN RP, 1990, HEARING RES, V47, P39, DOI 10.1016/0378-5955(90)90165-L
   BOBBIN RP, 1974, ACTA OTO-LARYNGOL, V77, P56, DOI 10.3109/00016487409124598
   BOBBIN RP, 1971, NATURE-NEW BIOL, V231, P222
   BROWN AM, 1990, J ACOUST SOC AM, V88, P840, DOI 10.1121/1.399733
   BROWN AM, 1989, HEARING RES, V42, P143, DOI 10.1016/0378-5955(89)90140-8
   BROWN AM, 1987, HEARING RES, V31, P25, DOI 10.1016/0378-5955(87)90211-5
   BROWN SE, 1990, ABSTR ASS RES OT, V13, P230
   BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153
   BRUNDIN L, 1989, NATURE, V342, P814, DOI 10.1038/342814a0
   COLLET L, 1990, HEARING RES, V43, P251, DOI 10.1016/0378-5955(90)90232-E
   DALLOS P, 1985, P207
   DALLOS P, 1976, J ACOUST SOC AM, V60, P510, DOI 10.1121/1.381086
   DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3
   DESMEDT J. E., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1478, DOI 10.1121/1.1918374
   DOLAN DF, 1988, J ACOUST SOC AM, V77, P1475
   GUINAN JJ, 1988, HEARING RES, V33, P97, DOI 10.1016/0378-5955(88)90023-8
   GUINAN JJ, 1983, J COMP NEUROL, V221, P358, DOI 10.1002/cne.902210310
   GUINAN JJ, 1967, J ACOUST SOC AM, V41, P1237, DOI 10.1121/1.1910465
   Guinan J J Jr, 1986, Scand Audiol Suppl, V25, P53
   HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065
   KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104
   KIM DO, 1980, HEARING RES, V2, P297, DOI 10.1016/0378-5955(80)90064-7
   KIM DO, 1986, HEARING RES, V22, P105, DOI 10.1016/0378-5955(86)90088-2
   KUJAWA SG, 1991, ABSTR ASS RES OT, V14, P127
   LEVINE RR, 1989, TRENDS PHARM SCI S
   LITTMAN TA, 1990, THESIS LOUISIANA STA
   MOULIN A, 1992, ABSTR ASS RES OT, V15, P157
   MOUNTAIN DC, 1980, SCIENCE, V210, P71, DOI 10.1126/science.7414321
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   PATUZZI R, 1991, INT S OTOACOUSTIC EM
   PLINKERT PK, 1990, HEARING RES, V44, P25, DOI 10.1016/0378-5955(90)90019-L
   PUEL JL, 1990, J ACOUST SOC AM, V76, P1713
   RUBEL EW, 1991, ABSTR ASS RES OT, V14, P84
   RUGGERO MA, 1990, J ACOUST SOC AM, V87, P1612, DOI 10.1121/1.399409
   SALT AN, 1986, NEUROBIOLOGY HEARING, P109
   SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X
   SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954
   SIEGEL JH, 1982, HEARING RES, V6, P171, DOI 10.1016/0378-5955(82)90052-1
   SLEPECKY N, 1988, HEARING RES, V34, P119, DOI 10.1016/0378-5955(88)90099-8
   TONNDORF J, 1962, ANN OTO RHINOL LARYN, V71, P801
   WATSON S, 1990, TRENDS PHARM SCI S
   WIEDERHOLD ML, 1986, NEUROBIOLOGY HEARING, P349
   WIEDERHOLD ML, 1985, J ACOUST SOC AM S1, V77, pS95, DOI 10.1121/1.2022609
   WIEDERHO.ML, 1970, J ACOUST SOC AM, V48, P950, DOI 10.1121/1.1912234
   ZWICKER E, 1979, BIOL CYBERN, V35, P243, DOI 10.1007/BF00344207
NR 48
TC 36
Z9 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5955
J9 HEARING RES
JI Hear. Res.
PD AUG
PY 1992
VL 61
IS 1-2
BP 106
EP 116
DI 10.1016/0378-5955(92)90041-K
PG 11
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA JJ938
UT WOS:A1992JJ93800013
PM 1326504
ER

PT J
AU MCGRATH, LB
   GONZALEZLAVIN, L
AF MCGRATH, LB
   GONZALEZLAVIN, L
TI ACTUARIAL SURVIVAL, FREEDOM FROM REOPERATION, AND OTHER EVENTS AFTER
   REPAIR OF ATRIOVENTRICULAR SEPTAL-DEFECTS
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
C1 UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,ROBERT WOOD JOHNSON MED SCH,DEPT SURG,NEWARK,NJ 07103.
RP MCGRATH, LB (reprint author), DEBORAH HEART & LUNG CTR,DEPT SURG,BROWNS MILLS,NJ 08015, USA.
CR BECKER AE, 1982, J THORAC CARDIOV SUR, V83, P461
   BENDER HW, 1982, J THORAC CARDIOV SUR, V84, P515
   BERGER TJ, 1978, AM J CARDIOL, V41, P906, DOI 10.1016/0002-9149(78)90732-4
   BHARATI S, 1980, J THORAC CARDIOV SUR, V79, P884
   BROWN BW, 1977, STATISTICS BIOMEDICA
   CARPENTIER A, 1978, PEDIAT CARDIOLOGY, P477
   CHIN AJ, 1982, J THORAC CARDIOV SUR, V84, P437
   KAHN DR, 1977, J THORAC CARDIOV SUR, V73, P413
   KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI
   KATZ NM, 1981, J THORAC CARDIOV SUR, V81, P528
   KIRKLIN JK, 1981, AM J CARDIOL, V48, P500, DOI 10.1016/0002-9149(81)90079-5
   KIRKLIN JW, 1979, J THORAC CARDIOV SUR, V78, P32
   PENKOSKE PA, 1985, J THORAC CARDIOV SUR, V90, P611
   PICCOLI GP, 1979, BRIT HEART J, V42, P621
   PICCOLI GP, 1979, BRIT HEART J, V42, P633
   STUDER M, 1982, J THORAC CARDIOV SUR, V84, P523
   WILLIAMS WH, 1983, J THORAC CARDIOV SUR, V86, P838
NR 17
TC 36
Z9 36
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD OCT
PY 1987
VL 94
IS 4
BP 582
EP 590
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA K3472
UT WOS:A1987K347200016
PM 3657260
ER

PT J
AU BURTON, RC
   WARNER, NL
AF BURTON, RC
   WARNER, NL
TI TUMOR IMMUNITY TO MURINE PLASMA-CELL TUMORS .3. DETECTION OF COMMON AND
   UNIQUE TUMOR-ASSOCIATED ANTIGENS ON BALB-C, C3H, AND NZB PLASMACYTOMAS
   BY INVIVO AND INVITRO INDUCTION OF TUMOR-IMMUNE RESPONSES
SO JOURNAL OF THE NATIONAL CANCER INSTITUTE
LA English
DT Article
C1 ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,MELBOURNE 3050,VICTORIA,AUSTRALIA.
CR AOKI T, 1972, J EXP MED, V135, P443, DOI 10.1084/jem.135.3.443
   AOKI T, 1974, J NATL CANCER I, V52, P1029
   BOYER PJJ, 1976, J IMMUNOL, V116, P202
   BURTON R, 1975, J IMMUNOL METHODS, V8, P133, DOI 10.1016/0022-1759(75)90090-3
   BURTON RC, IN PRESS
   CHANG KSS, 1975, INT J CANCER, V15, P483, DOI 10.1002/ijc.2910150314
   CHISM SE, 1976, J IMMUNOL, V117, P1870
   CHISM SE, 1976, J NATL CANCER I, V57, P377
   COMOGLIO PM, 1973, INT J CANCER, V12, P613, DOI 10.1002/ijc.2910120309
   EISEN HN, 1975, TRANSPLANT P, V7, P209
   HANNA MG, 1971, P NATL ACAD SCI USA, V68, P1748, DOI 10.1073/pnas.68.8.1748
   HERBERMA.RB, 1972, J EXP MED, V136, P94, DOI 10.1084/jem.136.1.94
   HYMAN R, 1972, J NATL CANCER I, V48, P173
   KOLB JP, 1974, J NATL CANCER I, V52, P723
   LASKOV R, 1970, Journal of Experimental Medicine, V131, P515, DOI 10.1084/jem.131.3.515
   MCCOY JL, 1974, INT J CANCER, V13, P731, DOI 10.1002/ijc.2910130517
   MCCOY JL, 1974, INT J CANCER, V14, P264, DOI 10.1002/ijc.2910140216
   MILLER RG, 1974, CELL IMMUNOL, V14, P284, DOI 10.1016/0008-8749(74)90212-3
   MORIWAKI K, 1971, J NATL CANCER I, V47, P623
   PARAF A, 1970, P NATL ACAD SCI USA, V67, P983, DOI 10.1073/pnas.67.2.983
   PERIMAN P, 1971, J NATL CANCER I, V46, P403
   POTTER M, 1957, P SOC EXP BIOL MED, V94, P327
   POTTER M, 1972, PHYSIOL REV, V52, P631
   POUPON MF, 1972, J NATL CANCER I, V48, P1297
   ROLLINGH.M, 1973, EUR J IMMUNOL, V3, P471, DOI 10.1002/eji.1830030804
   ROLLINGH.M, 1973, J NATL CANCER I, V50, P159
   ROUSE BT, 1973, EUR J IMMUNOL, V3, P218, DOI 10.1002/eji.1830030408
   SAKO H, 1973, J EXP MED, V138, P593
   STOCKERT E, 1971, J EXP MED, V133, P1334, DOI 10.1084/jem.133.6.1334
   WAGNER H, 1973, J EXP MED, V138, P1, DOI 10.1084/jem.138.1.1
   WARNER NL, 1974, MULTIPLE MYELOMA REL, P36
   WARNER NL, 1975, IMMUNOGENETICS, V2, P1, DOI 10.1007/BF01572270
   WATSON J, 1970, P NATL ACAD SCI USA, V66, P344, DOI 10.1073/pnas.66.2.344
   WHISSON ME, 1965, NATURE, V206, P689, DOI 10.1038/206689a0
   WILLIAMS WH, 1972, J NATL CANCER I, V49, P1613
NR 35
TC 36
Z9 36
PU NATL CANCER INSTITUTE
PI BETHESDA
PA 9030 OLD GEORGETOWN RD, BETHESDA, MD 20814
SN 0027-8874
J9 J NATL CANCER I
JI J. Natl. Cancer Inst.
PY 1977
VL 58
IS 3
BP 701
EP 709
PG 9
WC Oncology
SC Oncology
GA CY718
UT WOS:A1977CY71800031
PM 300112
ER

PT J
AU Cattelani, R
   Zettin, M
   Zoccolotti, P
AF Cattelani, Raffaella
   Zettin, Marina
   Zoccolotti, Pierluigi
TI Rehabilitation Treatments for Adults with Behavioral and Psychosocial
   Disorders Following Acquired Brain Injury: A Systematic Review
SO NEUROPSYCHOLOGY REVIEW
LA English
DT Review
DE Acquired brain injury; Neurobehavioral disorders; Psychosocial
   disorders; Evidence-based rehabilitation; Review
ID RANDOMIZED CONTROLLED-TRIAL; SOMATIC MARKER HYPOTHESIS; EFNS TASK-FORCE;
   COGNITIVE REHABILITATION; NEUROPSYCHOLOGICAL REHABILITATION;
   AGGRESSIVE-BEHAVIOR; DIFFERENTIAL REINFORCEMENT; MALADAPTIVE BEHAVIOR;
   PHYSICAL AGGRESSION; MANAGEMENT PROGRAM
AB This review was aimed at systematically investigating the treatment efficacy and clinical effectiveness of neurobehavioral rehabilitation programs for adults with acquired brain injury and making evidence-based recommendations for the adoption of these rehabilitation trainings. Using a variety of search procedures, 63 studies were identified and reviewed using a set of questions about research methods, treatments, results and outcomes for the 1,094 participants. The 63 studies included treatments falling into three general categories: approaches based on applied behavior analysis, interventions based on cognitive-behavior therapy (CBT), and comprehensive-holistic rehabilitation programs (CHRPs). Considerable heterogeneity exists in the reviewed literature among treatment methods and within reported sample subjects. Despite the variety of methodological concerns, results indicate that the greatest overall improvement in psychosocial functioning is achieved by CHRP that can be considered a treatment standard for adults with behavioral and psychosocial disorders following acquired brain injury. Both approaches based on applied behavior analysis and CBT can be said to be evidence-based treatment options. However, findings raise questions about the role of uncontrolled factors in determining treatment effects and suggest the need for rigorous inclusion/exclusion criteria, with greater specification of theoretical basis, design, and contents of treatments for both interdisciplinary-comprehensive approaches and single-case methodologies.
C1 [Cattelani, Raffaella] Univ Parma, Dept Neurosci, Neurol Unit, I-43100 Parma, Italy.
   [Zettin, Marina] Univ Turin, Dept Psychol, Turin, Italy.
   [Zoccolotti, Pierluigi] Univ Roma La Sapienza, Dept Psychol, Rome, Italy.
   [Zoccolotti, Pierluigi] IRCCS Fdn Santa Lucia, Neuropsychol Unit, Rome, Italy.
RP Cattelani, R (reprint author), Univ Parma, Dept Neurosci, Neurol Unit, I-43100 Parma, Italy.
EM cattel@unipr.it; marinazettin@fastwebnet.it;
   pierluigi.zoccolotti@uniroma1.it
CR Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2
   Aeschleman S. R., 1999, J RATIONAL EMOTIVE C, V17, P51, DOI 10.1023/A:1023073130972
   Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327
   ALDERMAN N, 1991, Brain Injury, V5, P77, DOI 10.3109/02699059108998516
   Alderman N, 1997, BRAIN INJURY, V11, P79, DOI 10.1080/026990597123683
   Alderman N, 1999, BRAIN INJURY, V13, P669
   ALDERMAN N, 1995, NEUROPSYCHOL REHABIL, V5, P193, DOI 10.1080/09602019508401467
   Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x
   Anderson SW, 1999, NAT NEUROSCI, V2, P1032
   Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956
   Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791
   Ben-Yishay Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI 10.1097/00001199-198703000-00007
   Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122
   Blumer D., 1975, PSYCHIAT ASPECTS NEU
   Bower P, 2003, CLIN PSYCHOL PSYCHOT, V10, P328, DOI 10.1002/cpp.380
   Cappa SF, 2005, EUR J NEUROL, V12, P665
   Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x
   Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002
   Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010
   Carnevale GJ, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199602000-00005
   Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008
   Carr EG, 2002, J POSIT BEHAV INTERV, V4, P4, DOI 10.1177/109830070200400102
   Chambless DL, 2001, ANNU REV PSYCHOL, V52, P685, DOI 10.1146/annurev.psych.52.1.685
   Chittum WR, 1996, BRAIN INJURY, V10, P763
   CHRISTENSEN AL, 1994, BRAIN INJURY NEUROPS
   CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32
   Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024
   Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017
   Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240
   Cohen J, 1988, STAT POWER ANAL BEHA
   Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125
   Damasio A.R., 1991, FRONTAL LOBE FUNCTIO
   Dewar BK, 2007, NEUROPSYCHOL REHABIL, V17, P602, DOI 10.1080/09602010601051610
   Dixon MR, 2003, J APPL BEHAV ANAL, V36, P371, DOI 10.1901/jaba.2003.36-371
   Dobson KS, 2000, HDB COGNITIVE BEHAV
   Ducharme JM, 1999, BRAIN INJURY, V13, P645, DOI 10.1080/026990599121232
   Ducharme JM, 2000, CLIN PSYCHOL REV, V20, P405, DOI 10.1016/S0272-7358(98)00102-0
   Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001
   EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613
   Ebanks ME, 2003, J APPL BEHAV ANAL, V36, P355, DOI 10.1901/jaba.2003.36-355
   ESLINGER PJ, 1985, NEUROLOGY, V35, P1731
   FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67
   FESENMEIER IT, 1990, NEUROLOGY, V30, P1005
   Finset A, 2000, BRAIN INJURY, V14, P887
   FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217
   FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI 10.1097/00001199-198709000-00007
   Fuster JM, 1989, PREFRONTAL CORTEX AN
   Gagnon J, 2006, B MENNINGER CLIN, V70, P1, DOI 10.1521/bumc.2006.70.1.1
   Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012
   Geurtsen GJ, 2008, BRAIN INJURY, V22, P545, DOI 10.1080/02699050802132479
   Giles G M, 1988, Brain Inj, V2, P75, DOI 10.3109/02699058809150933
   Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168
   Giles GM, 2005, BRAIN INJURY, V19, P753, DOI 10.1080/02699050500110108
   Giugni E, 2005, AM J NEURORADIOL, V26, P1140
   GODFREY HPD, 1988, ARCH PHYS MED REHAB, V69, P458
   Gracey F, 2007, NEUROPSYCHOL REHABIL, V17, P106, DOI 10.1080/0962010500505260
   GRAFMAN J, 2007, PRINCIPLES FRONTAL L
   GRAHAM DI, 1996, NEUROTRAUMA
   Hegel MT, 2000, BEHAV MODIF, V24, P94, DOI 10.1177/0145445500241005
   Hegel M T, 1988, Brain Inj, V2, P333, DOI 10.3109/02699058809150904
   Hughes RAC, 2001, EUR J NEUROL, V8, P549, DOI 10.1046/j.1468-1331.2001.00324.x
   KENNEDY CH, 1994, J APPL BEHAV ANAL, V27, P161, DOI 10.1901/jaba.1994.27-161
   Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8
   Klonoff P S, 1997, Appl Neuropsychol, V4, P107, DOI 10.1207/s15324826an0402_3
   Knight C, 2002, BRAIN INJURY, V16, P75, DOI 10.1080/02699050110082188
   Langer KG, 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI 10.1080/09602019208401395
   Leichsenring F, 2007, PSYCHOL PSYCHOTHER-T, V80, P217, DOI 10.1348/147608306X117394
   Leichsenring Falk, 2006, Am J Psychother, V60, P233
   Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396
   Lincoln NB, 1997, CLIN REHABIL, V11, P114, DOI 10.1177/026921559701100204
   Lincoln NB, 2003, STROKE, V34, P111, DOI 10.1161/01.STR.0000044167.44670.55
   Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153
   Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037//0090-5550.45.3.227
   Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895
   Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9
   MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y
   McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631
   MCGLYNN SM, 1990, PSYCHOL BULL, V108, P420, DOI 10.1037//0033-2909.108.3.420
   MCMILLAN T M, 1990, Brain Injury, V4, P399, DOI 10.3109/02699059009026193
   Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185
   Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642
   MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663
   MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5
   Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083
   OREILLY MF, 1990, J APPL BEHAV ANAL, V23, P431, DOI 10.1901/jaba.1990.23-431
   Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538
   Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465
   Persel CS, 1997, BRAIN INJURY, V11, P751
   Prigatano GP, 2003, ARCH CLIN NEUROPSYCH, V18, P811, DOI 10.1016/S0887-6177(02)00205-6
   Prigatano GP, 1999, J HEAD TRAUMA REHAB, V14, P308, DOI 10.1097/00001199-199906000-00009
   PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505
   Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217
   Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813
   Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659
   Rothwell NA, 1999, BRAIN INJURY, V13, P521
   Rowland N., 2000, EVIDENCE BASED COUNS
   RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187
   Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075
   SBORDONE RJ, 2000, NEUROPSYCHOLOGICAL A
   Scheid R, 2003, AM J NEURORADIOL, V24, P1049
   Schlund MW, 1999, BRAIN INJURY, V13, P889
   Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012
   Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772
   Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294
   Slifer KJ, 1997, BRAIN INJURY, V11, P877
   Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX
   Sohlberg MM, 2001, COGNITIVE REHABILITA
   Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12
   Swan L, 2004, BRAIN INJURY, V18, P143, DOI 10.1080/02699050310001596923
   Teasdale T W, 1995, Appl Neuropsychol, V2, P116, DOI 10.1207/s15324826an0203&4_3
   TEASDALE TW, 1993, BRAIN INJURY, V7, P535, DOI 10.3109/02699059309008181
   Treadwell K, 1996, J HEAD TRAUMA REHAB, V11, P62, DOI 10.1097/00001199-199602000-00008
   Walker AJ, 2005, BRAIN INJURY, V19, P1237, DOI 10.1080/02699050500309411
   Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662
   Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417
   Willis TJ, 2003, J HEAD TRAUMA REHAB, V18, P75, DOI 10.1097/00001199-200301000-00008
   Wood R. L., 2001, NEUROBEHAVIORAL DISA
   Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470
   YODI BB, 2000, J HEAD TRAUMA REHAB, V15, P1041
   YOUNGSON H, 1994, BRAIN INJURY, V8, P27
   ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163
   Zencius A, 1989, Brain Inj, V3, P67, DOI 10.3109/02699058909008076
   Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553
NR 123
TC 35
Z9 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7308
J9 NEUROPSYCHOL REV
JI Neuropsychol. Rev.
PD MAR
PY 2010
VL 20
IS 1
BP 52
EP 85
DI 10.1007/s11065-009-9125-y
PG 34
WC Psychology, Clinical; Neurosciences
SC Psychology; Neurosciences & Neurology
GA 567KR
UT WOS:000275446000004
PM 20143264
ER

PT J
AU MacGregor, AJ
   Shaffer, RA
   Dougherty, AL
   Galarneau, MR
   Raman, R
   Baker, DG
   Lindsay, SR
   Golomb, BA
   Corson, KS
AF MacGregor, Andrew J.
   Shaffer, Richard A.
   Dougherty, Amber L.
   Galarneau, Michael R.
   Raman, Rema
   Baker, Dewleen G.
   Lindsay, Suzanne R.
   Golomb, Beatrice A.
   Corson, Karen S.
TI Prevalence and Psychological Correlates of Traumatic Brain Injury in
   Operation Iraqi Freedom
SO JOURNAL OF HEAD TRAUMA REHABILITATION
LA English
DT Article
DE military; posttraumatic stress disorder; PTSD; traumatic brain injury
ID POSTTRAUMATIC-STRESS-DISORDER; MOTOR-VEHICLE ACCIDENTS; ROAD TRAFFIC
   ACCIDENTS; PSYCHIATRIC-DISORDERS; HEAD-INJURY; COMBAT VETERANS; SEVERITY
   SCORE; EVENT; REGISTRY; AMNESIA
AB Objective: To describe the prevalence and psychological correlates of traumatic brain injury (TBI) among injured male combatants in the Iraq conflict. Participants: A total of 781 men injured during military combat between September 2004 and February 2005. Main Outcome Measures: Mental health diagnosis (ICD-9 290-319), particularly posttraumatic stress disorder and mood/anxiety disorders, assigned through November 2006. Results: 15.8% met criteria for TBI (13.4% mild, 2.4% moderate-severe TBI), 35.0% other head injury, and 49.2% non-head injury. Multivariate logistic regression suggested lower rates of posttraumatic stress disorder and mood/anxiety disorders among those with mild and moderate-severe TBI. Conclusions: These findings could reflect a problem with differential diagnosis or, conversely, a low rate of self-presentation for symptoms. Further research is needed to elucidate the psychological consequences, clinical implications, and overall impact of TBI among military combat veterans.
C1 [MacGregor, Andrew J.; Shaffer, Richard A.; Galarneau, Michael R.; Corson, Karen S.] USN, Hlth Res Ctr, San Diego, CA 92106 USA.
   [Dougherty, Amber L.] Sci Applications Int Corp, San Diego, CA USA.
   [Raman, Rema; Baker, Dewleen G.; Golomb, Beatrice A.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Baker, Dewleen G.] VA San Diego Healthcare Syst, San Diego, CA USA.
   [Lindsay, Suzanne R.] San Diego State Univ, San Diego, CA 92182 USA.
RP Dougherty, AL (reprint author), USN, Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.
EM amber.dougherty@med.navy.mil
FU US Navy Bureau of Medicine and Surgery, Washington, DC
FX This work was supported by the US Navy Bureau of Medicine and Surgery,
   Washington, DC, under Work Unit No. 60819. The views and opinions
   expressed herein are those of the authors and do not necessarily reflect
   the official policy or position of the Department of the Navy,
   Department of Defense, nor the US Government. This research has been
   conducted in compliance with all applicable federal regulations
   governing the protection of human subjects in research (Protocol
   NHRC.2007.0004).
CR Alexander M. P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI 10.1097/00001199-199206000-00009
   ALEXANDER MP, 1995, NEUROLOGY, V45, P1253
   BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001
   Bontke CF, 1996, J HEAD TRAUMA REHAB, V11, P11
   Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024
   Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836
   Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629
   Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931
   Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007
   COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010
   Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001
   DOBSON JE, 1989, BRIT J ORAL MAX SURG, V27, P441, DOI 10.1016/S0266-4356(89)80001-4
   FANN JR, 1995, AM J PSYCHIAT, V152, P1493
   Friedman M., 2006, POSTTRAUMATIC ACUTE
   Galarneau MR, 2006, MIL MED, V171, P691
   Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950
   GENNARELLI TA, ABBREVIATED INJURY S
   Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963
   Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5
   Gondusky JS, 2005, MIL MED, V170, P546
   GUNDERSON E, 2005, MIL MED, V2, P172
   Hickling EJ, 1998, BRAIN INJURY, V12, P265
   Hiott W. D., 2002, NEUROREHABILITATION, V17, P345
   Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972
   Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42
   JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369
   KIM E, 2007, J NEUROPSYCHIATRY CL, V159, P1315
   Klein E, 2003, CAN J PSYCHIAT, V48, P28
   LINN S, 1993, INT J EPIDEMIOL, V22, P905, DOI 10.1093/ije/22.5.905
   Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323
   Mason S, 2002, EMERG MED J, V19, P400, DOI 10.1136/emj.19.5.400
   Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045
   Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013
   MAYOU R, 1993, BRIT MED J, V307, P647
   Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102
   Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007
   Price K. P., 1994, DEF LAW J, V43, P113
   Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44
   SBORDONE RJ, 1995, BRAIN INJURY, V9, P45
   Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797
   Shalev AY, 2001, J CLIN PSYCHIAT, V62, P4
   Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423
   Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8
   Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308
   Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334
   *US DEP DEF, 1984, 1340 DOD US MIL ENTR
   VanReekum R, 1996, BRAIN INJURY, V10, P319
   van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316
   Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513
   Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66
   Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398
   Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18
   Williams WH, 2002, BRAIN INJURY, V16, P673
NR 53
TC 35
Z9 35
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0885-9701
J9 J HEAD TRAUMA REHAB
JI J. Head Trauma Rehabil.
PD JAN-FEB
PY 2010
VL 25
IS 1
BP 1
EP 8
PG 8
WC Clinical Neurology; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA 550XC
UT WOS:000274165800001
PM 20051901
ER

PT J
AU Hawthorne, G
   Gruen, RL
   Kaye, AH
AF Hawthorne, Graeme
   Gruen, Russell L.
   Kaye, Andrew H.
TI Traumatic Brain Injury and Long-Term Quality of Life: Findings from an
   Australian Study
SO JOURNAL OF NEUROTRAUMA
LA English
DT Review
DE AQoL; SF-36 version 2; traumatic brain injury
ID SATISFACTION 12 MONTHS; CLOSED-HEAD-INJURY; DEPRESSION SCALE; HOSPITAL
   ANXIETY; SUBJECTIVE EXPERIENCE; GENERAL HEALTH; PSYCHIATRIC-DISORDERS;
   COMMUNITY INTEGRATION; ASSESSMENT INSTRUMENT; FUNCTIONAL OUTCOMES
AB Recent calls have been made for the inclusion of health-related quality of life (HRQoL) in traumatic brain injury studies. This study reports the impact of TBI on traditional measures (general health, depression, social isolation, labor force participation), self-assessed health function status using the SF-36 version 2 (SF-36V2), and self-assessed health preference using two generic utility instruments, the assessment of quality of life (AQoL) and the SF6D. A random sample of TBI cases (n = 66) was drawn from a trauma registry and matched (gender, age, education, and relationship status) with non-trauma-exposed cases from a population health survey. All participants were interviewed and the two cohorts compared. When compared with matched comparators, TBI cases experienced worse general health, elevated probabilities of depression, social isolation, and worse labor force participation rates. The TBI-cohort reported worse health status on the SF-36V2. The most affected areas were social function, role emotion, and mental health (effect sizes -0.70 to -0.86). The reported utility values indicative of a HRQoL between 13 and 24% worse than their non-TBI contemporaries (effect sizes -0.80 to -0.81). The findings suggest that TBI has long-term consequences across all aspects of peoples' lives, and that these consequences can be self-assessed using generic instruments. The challenge is to provide and evaluate long-term services targeted at the life areas that those with TBI find particularly difficult.
C1 [Hawthorne, Graeme] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Psychiat, Melbourne, Vic, Australia.
   [Gruen, Russell L.; Kaye, Andrew H.] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia.
   [Gruen, Russell L.; Kaye, Andrew H.] Royal Melbourne Hosp, Melbourne, Vic, Australia.
RP Hawthorne, G (reprint author), Univ Melbourne, Royal Melbourne Hosp, Dept Psychiat, Level 1 N,Grattan St, Parkville, Vic 3050, Australia.
EM graemeeh@unimelb.edu.au
FU Victorian Neurotrauma Initiative; Department of Psychiatry; Faculty of
   Medicine, Dentistry and Health Sciences at The University of Melbourne;
   Royal Melbourne Hospital
FX This project was supported by the Victorian Neurotrauma Initiative, the
   Department of Psychiatry, and the Faculty of Medicine, Dentistry and
   Health Sciences at The University of Melbourne, and The Royal Melbourne
   Hospital. We would like to thank the interviewers who collected the data
   from the TBI participants, Mss. Dahni Houseman, Isabelle Bauer, Janifer
   Anderson, and Maritza Thompson, and the many former patients of the RMH
   who gave their time so willingly to participate in this study. For the
   use of the South Australian Health Omnibus Survey data, our thanks are
   extended to Mss. Elayne Crnkovic and Natalie Scarlet from the Community
   Care Branch, Australian Commonwealth Department of Health and Ageing;
   Ms. Kerry Markoulli, Director, Special Needs Strategies Section,
   Australian Commonwealth Department of Health and Ageing; Professor Anne
   Taylor from the Population Research and Outcome Studies Unit, Department
   of Health, South Australia; Ms. Jan Sansoni from the Australian Health
   Outcomes Collaboration, Centre for Health Services Development,
   University of Wollongong; and especially to Professor Robert Goldney
   from the Department of Psychiatry at Adelaide University.
CR ABS, 2001, CENS POP HOUS
   Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011
   Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029
   Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597
   Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015
   Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93
   BOYER P, 1997, INT J METH PSYCH RES, V7, P27
   Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111
   Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8
   Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7
   Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111
   Byrne-Davis LMT, 2006, QUAL LIFE RES, V15, P855, DOI 10.1007/s11136-005-5416-9
   Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x
   Coetzer BR, 2002, J COGN REHABIL, V20, P20
   Coetzer R, 2005, INT J REHABIL RES, V28, P361, DOI 10.1097/00004356-200512000-00010
   Cohen J, 1988, STAT POWER ANAL BEHA
   Collins R, 2000, J HEAD TRAUMA REHAB, V15, P1139
   Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7
   Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543
   CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386
   DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011
   DAVISON AG, 1986, THORAX, V41, P830, DOI 10.1136/thx.41.11.830
   Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004
   Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119
   Dimopoulou I, 2004, AM J PHYS MED REHAB, V83, P171, DOI 10.1097/01.PHM.0000107497.77487.C1
   Drummond M, 1998, METHODS EC EVALUATIO
   Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002
   Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127
   FANN JR, 1995, AM J PSYCHIAT, V152, P1493
   Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941
   Folstein MF, 1975, J PSYCHIATR RES, V189, P198
   Giza CC, 2001, J ATHL TRAINING, V36, P228
   *GRAPHPAD SOFTW, 2003, PRISM 4
   HERRMAN H, 1993, QUAL LIFE RES, V2, P153
   HAMER D, 1991, BRIT J PSYCHIAT, V158, P782, DOI 10.1192/bjp.158.6.782
   HAMMELL KRW, 1994, INT J REHABIL RES, V17, P319
   Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314
   Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004
   Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4
   Hawthorne G, 1999, QUAL LIFE RES, V8, P209, DOI 10.1023/A:1008815005736
   Hawthorne G, 2001, ANN MED, V33, P358, DOI 10.3109/07853890109002090
   Hawthorne G, 2008, SOC PSYCH PSYCH EPID, V43, P140, DOI 10.1007/s00127-007-0279-8
   Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x
   Hawthorne G, 2006, SOC INDIC RES, V77, P521, DOI 10.1007/s11205-005-7746-y
   HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006
   Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116
   Jean-Bay E, 2000, J Neurosci Nurs, V32, P169
   Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92
   Jumisko Eija, 2005, J Neurosci Nurs, V37, P42
   Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C
   KLONOFF PS, 1986, NEUROSURGERY, V19, P735
   Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901
   Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205
   Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524
   Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375
   LEWIN W, 1979, BRIT MED J, V2, P1533
   LEWIS G, 1990, BRIT J PSYCHIAT, V157, P860, DOI 10.1192/bjp.157.6.860
   MALASI TH, 1991, ACTA PSYCHIAT SCAND, V84, P323, DOI 10.1111/j.1600-0447.1991.tb03153.x
   Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655
   Mathiesen Birgit Bork, 2004, Cogn Neuropsychiatry, V9, P249, DOI 10.1080/13546800344000237
   McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007
   Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007
   Carrico CJ, 2000, J TRAUMA, V48, P848
   MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129
   MOOREY S, 1991, BRIT J PSYCHIAT, V158, P255, DOI 10.1192/bjp.158.2.255
   Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292
   Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877
   NHMRC, 1999, NAT STAT ETH COND RE
   Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46
   O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68
   Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002
   Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9
   Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61
   Riemsma R P, 2001, Health Technol Assess, V5, P1
   RIMEL RW, 1982, NEUROSURGERY, V11, P344
   Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395
   Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084
   Selwood A, 2005, INT J GERIATR PSYCH, V20, P232, DOI 10.1002/gps.1271
   Sherwin E, 2006, BRAIN INJURY, V20, P383, DOI 10.1080/02699050600663097
   SKANTZE K, 1992, BRIT J PSYCHIAT, V161, P797, DOI 10.1192/bjp.161.6.797
   Snaith R. P., 1994, HOSP ANXIETY DEPRESS
   Snow AL, 2005, HEALTH SERV RES, V40, P1676, DOI 10.1111/j.1475-6773.2005.00447.x
   Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342
   SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749
   SPSS, 2006, SPSS WIND VERS 14 0
   Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004
   Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123
   Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318
   TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128
   TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862
   Teasdale TW, 1997, BRAIN INJURY, V11, P543
   Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153
   Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010
   van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa
   van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P29, DOI 10.1076/jcen.21.1.29.939
   Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F
   Ware JE, 2000, SCORE VERSION 2 SF 3
   WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9
   Williams WH, 2002, BRAIN INJURY, V16, P673
   Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 101
TC 35
Z9 35
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
J9 J NEUROTRAUM
JI J. Neurotrauma
PD OCT
PY 2009
VL 26
IS 10
BP 1623
EP 1633
DI 10.1089/neu.2008.0735
PG 11
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA 507CT
UT WOS:000270829200001
PM 19317590
ER

PT J
AU Balacumaraswami, L
   Taggart, DP
AF Balacumaraswami, Lognathen
   Taggart, David P.
TI Intraoperative imaging techniques to assess coronary artery bypass graft
   patency
SO ANNALS OF THORACIC SURGERY
LA English
DT Review
ID TIME FLOW MEASUREMENT; OFF-PUMP; ON-PUMP; REVASCULARIZED HEART;
   RANDOMIZED-TRIALS; SURGERY; ANGIOGRAPHY; QUALITY; ANASTOMOSES; SURVIVAL
AB Graft patency verification is increasingly recognized as an important component of coronary artery bypass grafting. Intuitively, eliminating intraoperative graft failure should reduce cardiac mortality and morbidity in the short term and improve clinical outcome in the long term. Although conventional angiography remains the gold standard technique for assessing graft patency, it is rarely available in the operating room and consequently several other less invasive approaches have been advocated. This article reviews the two currently most commonly used modalities for graft patency assessment, intraoperative fluorescence imaging and transit-time flowmetry, and discusses their value and limitations. Both techniques can reliably detect otherwise unsuspected occluded grafts and this is crucial for internal thoracic arteries because of their prognostic significance. Although neither technology can consistently identify more minor, non-occlusive abnormalities, the intraoperative fluorescence imaging technique seems to be more sensitive and less susceptible to "false positive" images.
C1 Univ Oxford, John Radcliffe Hosp, Dept Cardiothorac Surg, Oxford OX3 9DU, England.
RP Taggart, DP (reprint author), Univ Oxford, John Radcliffe Hosp, Dept Cardiothorac Surg, Headley Way, Oxford OX3 9DU, England.
EM david.taggart@orh.nhs.uk
CR Abu-Omar Y, 2002, LANCET, V360, P327, DOI 10.1016/S0140-6736(02)09557-0
   Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446
   Balacumaraswami L, 2004, J THORAC CARDIOV SUR, V128, P238, DOI 10.1016/j.jtcvs.2003.11.072
   Balacumaraswami Lognathen, 2004, Semin Thorac Cardiovasc Surg, V16, P266, DOI 10.1053/j.semtcvs.2004.08.014
   Balacumaraswami L, 2005, J THORAC CARDIOV SUR, V130, P315, DOI 10.1016/j.jtcvs.2004.11.033
   Canver CC, 1997, J CARDIOVASC SURG, V38, P211
   CANVER CC, 1994, ANN THORAC SURG, V58, P135
   D'Ancona G, 2000, EUR J CARDIO-THORAC, V17, P287, DOI 10.1016/S1010-7940(00)00332-8
   DANCONA G, 2001, INTRAOPERATIVE GRAFT
   Desai ND, 2006, J THORAC CARDIOV SUR, V132, P585, DOI 10.1016/j.jtcvs.2005.09.061
   Desai ND, 2005, J AM COLL CARDIOL, V46, P1521, DOI 10.1016/j.jacc.2005.05.081
   Elbeery JR, 1998, ANN THORAC SURG, V66, P51, DOI 10.1016/S0003-4975(98)00377-4
   FALK V, 1995, J CARDIAC SURG, V10, P147
   Haaverstad R, 2002, SCAND CARDIOVASC J, V36, P95, DOI 10.1080/140174302753675375
   Hassanein W, 2005, ANN THORAC SURG, V80, P2155, DOI 10.1016/j.athoracsur.2005.03.138
   Hirotani T, 2001, EUR J CARDIO-THORAC, V19, P848, DOI 10.1016/S1010-7940(01)00700-X
   Hol PK, 2001, HEART SURG FORUM, V4, P254
   Hol PK, 2004, ANN THORAC SURG, V78, P502, DOI 10.1016/j.athoracsur.2004.03.004
   Izzat MB, 1998, ANN THORAC SURG, V66, P1431, DOI 10.1016/S0003-4975(98)00741-3
   Jakobsen HL, 1999, SCAND CARDIOVASC J, V33, P157
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kjaergard HK, 2004, ANN THORAC SURG, V78, P2054, DOI 10.1016/j.athoracsur.2004.06.009
   Lin JC, 2000, ANN THORAC SURG, V70, P1350, DOI 10.1016/S0003-4975(00)01720-3
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   LOUAGIE YAG, 1994, ANN THORAC SURG, V57, P357
   Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2005, ANN THORAC SURG, V80, P2121, DOI 10.1016/j.athoracsur.2005.05.007
   Poirier NC, 1999, J THORAC CARDIOV SUR, V117, P292, DOI 10.1016/S0022-5223(99)70425-3
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Reuthebuch O, 2004, CHEST, V125, P418, DOI 10.1378/chest.125.2.418
   Rubens FD, 2002, HEART SURG FORUM, V5, P141
   Schmitz C, 2003, J THORAC CARDIOV SUR, V126, P645, DOI 10.1016/S0022-5223(03)00018-7
   SPEICH R, 1988, ANN INTERN MED, V109, P345
   Taggart DP, 2003, ANN THORAC SURG, V75, P870, DOI 10.1016/S0003-4975(02)04669-6
   Taggart DP, 2000, J THORAC CARDIOV SUR, V120, P651, DOI 10.1067/mtc.2000.106325
   Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X
   Takahashi Masao, 2004, Interact Cardiovasc Thorac Surg, V3, P479, DOI 10.1016/j.icvts.2004.01.018
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Yasuda T, 2005, J THORAC CARDIOV SUR, V130, P560, DOI 10.1016/j.jtcvs.2004.12.014
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
NR 41
TC 35
Z9 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUN
PY 2007
VL 83
IS 6
BP 2251
EP 2257
DI 10.1016/j.athoracsur.2006.12.025
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 172GD
UT WOS:000246791200068
PM 17532450
ER

PT J
AU Takagi, H
   Tanabashi, T
   Kawai, N
   Kato, T
   Umemoto, T
AF Takagi, Hisato
   Tanabashi, Toshiyuki
   Kawai, Norikazu
   Kato, Takayoshi
   Umemoto, Takuya
TI Off-pump coronary artery bypass sacrifices graft patency: Meta-analysis
   of randomized trials
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Editorial Material
ID ON-PUMP; LIFE OUTCOMES; SURGERY
C1 Shizuoka Med Ctr, Dept Cardiovasc Surg, Shimizu, Shizuoka 4118611, Japan.
RP Takagi, H (reprint author), Shizuoka Med Ctr, Dept Cardiovasc Surg, 762-1 Nagasawa, Shimizu, Shizuoka 4118611, Japan.
EM kfgth973@ybb.ne.jp
CR Al-Ruzzeh S, 2006, BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kobayashi J, 2005, CIRCULATION S1, V112, pI338
   Lingaas PS, 2006, ANN THORAC SURG, V81, P2089, DOI 10.1016/j.athoracsur.2005.12.003
   Lingaas PS, 2004, HEART SURG FORUM, V7, P37
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2005, ANN THORAC SURG, V80, P2121, DOI 10.1016/j.athoracsur.2005.05.007
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
NR 10
TC 35
Z9 36
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD JAN
PY 2007
VL 133
IS 1
BP E2
EP E3
DI 10.1016/j.jtcvs.2006.08.062
PG 2
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 121XZ
UT WOS:000243191600002
PM 17198771
ER

PT J
AU Paparella, D
   Galeone, A
   Venneri, MT
   Coviello, M
   Scrascia, G
   Marraudino, N
   Quaranta, M
   Schinosa, LDT
   Brister, SJ
AF Paparella, D
   Galeone, A
   Venneri, MT
   Coviello, M
   Scrascia, G
   Marraudino, N
   Quaranta, M
   Schinosa, LDT
   Brister, SJ
TI Activation of the coagulation system during coronary artery bypass
   grafting: Comparison between on-pump and off-pump techniques
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID PLATELET-FUNCTION ANALYZER; CARDIOPULMONARY BYPASS; PROCOAGULANT
   ACTIVITY; CARDIAC-SURGERY; HEMOSTASIS; OPERATION; DISEASE; HEPARIN;
   INJURY; RISK
AB Objective: The activation of the coagulation and fibrinolytic systems and platelet function in patients undergoing coronary artery bypass surgery on-pump or off-pump techniques was compared.
   Methods: Thirty-two patients were randomly assigned to on-pump or off-pump coronary artery bypass grafting. Heparin was given at the same dose. Activation of the coaculation and fibrinolytic systems was evaluated by measurement of several markers. Platelet function was evaluated by in vitro bleeding time test. Blood samples were collected at 7 different times, up to postoperative day 6.
   Results: Overall tissue factor production was similar in the two groups. Thrombin formation was more elevated in the on-pump group (P <.001), particularly during the operation, prothrombin fragment 1.2 discharge values were higher than the preoperative ones (P =.002). Levels of tissue-plasminogen activator showed no difference between the groups (P =. 1). D-dimers release was higher in the on-pump group (P =.0002). In vitro bleeding time was longer in the on-pump group (P <.0001), particularly in the first 24 hours; it was not prolonged in the off-pump group. In both groups, regardless of aspirin treatment, discharge in vitro bleeding times were lower than the preoperative ones (P <.01).
   Conclusion: Although the extrinsic coagulation pathway is similarly activated, thrombin formation is more pronounced in patients having on-pump bypass grafting. Patients subjected to off-pump bypass grafting have normally functioning platelets and a weak activation of the fibrinolytic system. At discharge, both groups have preserved platelet function and increased thrombin formation. Further studies with angiographic evaluation are needed to establish a correlation between coagulation parameters, platelet function, and graft patency.
C1 Univ Bari, DETO, Div Cardiac Surg, I-70100 Bari, Italy.
   IRCCS, Oncol Hosp, Dept Expt Oncol, Lab Unit, Bari, Italy.
   Univ Toronto, Toronto Gen Hosp, Dept Surg, Div Cardiovasc Surg, Toronto, ON, Canada.
RP Paparella, D (reprint author), Univ Bari, DETO, Div Cardiac Surg, Piazza Giulio Cesare 11, I-70100 Bari, Italy.
EM paparella@tin.it
CR Andersen K, 2002, THROMB RES, V108, P37, DOI 10.1016/S0049-3848(02)00405-X
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   BRISTER SJ, 1993, THROMB HAEMOSTASIS, V70, P259
   Casati V, 2004, J THORAC CARDIOV SUR, V128, P83, DOI 10.1016/j.jctvs.2003.10.034
   Chung JH, 1996, CIRCULATION, V93, P2014
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Englberger L, 2004, ANN THORAC SURG, V77, P1560, DOI 10.1016/j.athorasure.2003.10.061
   Gu YJ, 1999, CHEST, V116, P892, DOI 10.1378/chest.116.4.892
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106
   Kurlansky PA, 2003, J THORAC CARDIOV SUR, V126, P7, DOI 10.1016/S0022-5223(02)73472-7
   Lo B, 2004, ANESTH ANALG, V99, P634, DOI 10.1213/ANE.0000130257.64006.5C
   Mariani MA, 1999, ANN THORAC SURG, V67, P1370, DOI 10.1016/S0003-4975(99)00265-9
   Michelson AD, 2004, CIRCULATION, V110, pE489, DOI 10.1161/01.CIR.0000147228.29325.F9
   Moller CH, 2003, SCAND CARDIOVASC J, V37, P149, DOI 10.1080/14017430310001456
   Moor E, 2000, THROMB RES, V98, P39, DOI 10.1016/S0049-3848(99)00221-2
   Okazaki Y, 2001, EUR J CARDIO-THORAC, V19, P834, DOI 10.1016/S1010-7940(01)00708-4
   Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5
   Paparella D, 2004, INTENS CARE MED, V30, P1873, DOI 10.1007/s00134-004-2388-0
   Poston R, 2005, EUR J CARDIO-THORAC, V27, P584, DOI 10.1016/j.ejcts.2004.12.061
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Racz MJ, 2004, J AM COLL CARDIOL, V43, P557, DOI 10.1016/j.jacc.2003.09.045
   Sharony R, 2004, J THORAC CARDIOV SUR, V127, P406, DOI 10.1016/j.jtcvs.2003.08.011
   Slaughter TF, 2001, BLOOD COAGUL FIBRIN, V12, P85, DOI 10.1097/00001721-200103000-00001
   THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003
   Weitz IC, 2002, THROMB HAEMOSTASIS, V88, P213
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
NR 27
TC 35
Z9 37
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 2006
VL 131
IS 2
BP 290
EP 297
DI 10.1016/j.jtcvs.2005.10.018
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 010MK
UT WOS:000235198600007
PM 16434256
ER

PT J
AU Rosal, CG
   Momplaisir, GM
   Heithmar, EM
AF Rosal, CG
   Momplaisir, GM
   Heithmar, EM
TI Roxarsone and transformation products in chicken manure: Determination
   by capillary electrophoresis-inductively coupled plasma-mass
   spectrometry
SO ELECTROPHORESIS
LA English
DT Article
DE animal feed additive; arsenic speciation; capillary electrophoresis;
   inductively coupled plasma-mass spectrometry; roxarsone
ID ICP-MS; ARSENIC SPECIATION; ELEMENTAL SPECIATION; ZONE-ELECTROPHORESIS;
   POULTRY LITTER; SEPARATION; INTERFACE; SOIL; OPTIMIZATION; NEBULIZER
AB The determination of the animal feed additive roxarsone (3-nitro-4-hydroxyphenylarsonic acid) and six of its possible transformation products (arsenite, arsenate, monomethylarsonate, dimethylarsinate, 3-amino-4-hydroxyphenylarsonic acid, and 4-hydroxyphenylarsonic acid) in chicken manure was investigated using capillary electrophoresis-inductively coupled plasma-mass spectrometry (CE-ICP-MS). Initial method development was conducted using ultraviolet (UV) detection for ruggedness and time efficiency. Separation of these seven arsenic species was effected using a 20 mm phosphate buffer at pH 5.7. The CE-ICP-MS limits of detection in terms of As for each of the species was in the low mu g circle L-1 range, corresponding to absolute detection limits in the range 20-70fg As (based on a 23nL injection). Overall, the method developed in this study provides high selectivity and low limits of detection (1-3 mu g circle L-1 or low-ppb, based on As), uses small sample volume (low nL), and produces minimal wastes.
C1 US EPA, Natl Exposure Res Lab, Div Environm Sci, Environm Chem Branch, Las Vegas, NV 89119 USA.
RP Rosal, CG (reprint author), US EPA, Natl Exposure Res Lab, Div Environm Sci, Environm Chem Branch, 944 E Harmon Ave, Las Vegas, NV 89119 USA.
EM rosal.charlita@epa.gov
CR Baker SA, 1999, APPL SPECTROSC, V53, P471, DOI 10.1366/0003702991946767
   BEDNAR AJ, 2002, SCI TOTAL ENVIRON, V302, P237
   BENDAHL L, 2000, ANAL AT SPECTROM, V16, P38
   BRUMLEY WC, 1993, J CHROMATOGR, V646, P377, DOI 10.1016/0021-9673(93)83351-R
   Casiot C, 2002, SPECTROCHIM ACTA B, V57, P173, DOI 10.1016/S0584-8547(01)00365-2
   Chen WH, 2000, ANAL CHIM ACTA, V410, P25, DOI 10.1016/S0003-2670(00)00713-3
   Day JA, 2000, ANALYST, V125, P819, DOI 10.1039/a910268j
   GARBARINO JR, P US GEOL SURV WORKS
   Gil EP, 1999, ANAL CHIM ACTA, V389, P9
   Heiger D. N., 1992, HIGH PERFORMANCE CAP
   Jackson BP, 2001, ENVIRON SCI TECHNOL, V35, P4868, DOI 10.1021/es0107172
   LIU Y, 1995, ANAL CHEM, V67, P2020, DOI 10.1021/ac00109a019
   Majidi V, 1999, J ANAL ATOM SPECTROM, V14, P1933, DOI 10.1039/a906100b
   Michalke B, 1999, J ANAL ATOM SPECTROM, V14, P1297, DOI 10.1039/a900495e
   Michalke B, 1998, ELECTROPHORESIS, V19, P2220, DOI 10.1002/elps.1150191229
   MILLER JN, 1993, ANALYST, V118, P455, DOI 10.1039/an9931800455
   MORRISON JL, 1969, J AGR FOOD CHEM, V17, P1288, DOI 10.1021/jf60166a018
   OLESIK JW, 1995, ANAL CHEM, V67, P1, DOI 10.1021/ac00097a003
   PAVKOV M, 2000, ARSENIC EXPOSURE HLT, V4
   Pergantis SA, 1997, ANALYST, V122, P1063, DOI 10.1039/a702691i
   Rutherford DW, 2003, ENVIRON SCI TECHNOL, V37, P1515, DOI 10.1021/es026222
   Schaumloffel D, 1999, FRESEN J ANAL CHEM, V364, P452, DOI 10.1007/s002160051366
   Tangen A, 1998, J CHROMATOGR A, V826, P87, DOI 10.1016/S0021-9673(98)00708-0
   TERABE S, 1988, ANAL CHEM, V60, P1673, DOI 10.1021/ac00168a009
   Tian XD, 1999, ATOM SPECTROSC, V20, P127
   Van Holderbeke M, 1999, J ANAL ATOM SPECTROM, V14, P229, DOI 10.1039/a807480a
   Webster GK, 1996, J AOAC INT, V79, P1012
NR 27
TC 35
Z9 40
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD APR
PY 2005
VL 26
IS 7-8
BP 1606
EP 1614
DI 10.1002/elps.200406198
PG 9
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 921SC
UT WOS:000228784000036
PM 15761918
ER

PT J
AU Lim, CO
   Lee, JY
   Kim, WH
   Kim, SC
   Choh, JH
   Kim, CW
AF Lim, CO
   Lee, JY
   Kim, WH
   Kim, SC
   Choh, JH
   Kim, CW
TI Early replacement of pulmonary valve after repair of tetralogy: is it
   really beneficial?
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 17th Annual Meeting of the
   European-Association-for-Cardio-Thoracic-Surgery/11th Annual Meeting of
   the European-Society-of-Thoracic-Surgeons
CY OCT 12-15, 2003
CL VIENNA, AUSTRIA
SP European Assoc Cardio Thorac Surg, European Soc Thorac Surg
DE right ventricle; pulmonary regurgitation; congenital
ID VENTRICULAR OUTFLOW TRACT; ADULTS LATE; FALLOT; REGURGITATION;
   INSERTION; INSUFFICIENCY; REOPERATION; OBSTRUCTION; ARRHYTHMIA; EXERCISE
AB Objectives: Debate on the proper timing of pulmonary valve replacement (PVR) after repair of tetralogy of Fallot (TOF) is still continuing. Significant pulmonary regurgitation (PR) could result in right ventricular (RV) dysfunction, exercise intolerance, arrhythmia, and sudden death. We analyzed clinical results of PVR after repair of TOF to investigate potential risk factor for late outcomes. Methods: From January 1993 to July 2002, 58 patients (38 males and 20 females) received PVR after repair of TOF. More than moderate degree of PR was observed in these patients by echocardiography. Mean age at PVR was 13.5 +/- 9.6 years (1.2-44) and TOF repair was performed at 5.2 +/- 7.1 years of age (0.5-34). Therefore, PVR was performed at 8.3 +/- 5.2 years (4 months-28 years) after repair. Preoperative electrocardiogram showed complete right bundle branch block in 49 patients (84.5%). Mean duration of QRS complex was 142 +/- 30 ms. Major arrhythmia occurred in eight patients. Twenty-nine patients complained decreased physical activity and 10 patients showed clinical signs of right heart failure. Results: Early death occurred in one patient (2.5%). Major complication Occurred in three patients (complete heart block in two, aortic rupture in one). Follow-up was performed for 2.5 +/- 2.4 years (46 days-10.3 years). There was no late death. Postoperative cardiothoracic ratio was significantly decreased (0.61 +/- 0.07 to 0.55 +/- 0.06 P < 0.001). Marked symptomatic improvement was noted in all patients. Postoperative symptomatic group (n = 14) showed older age at repair of TOF (12.5 +/- 10.7 vs 2.6 +/- 2.3 years, P = 0.003), older age at PVR (23.2 +/- 12.8 vs 10.1 +/- 5.0 years. P = 0.001), longer interval between repair of TOF and PVR (10.6 +/- 7.0 vs 7.5 +/- 4.2 years, P < 0.05), higher degree of functional class (2.4 +/- 0.5 vs 1.4 +/- 0.8, P < 0.001). and longer duration of hospitalization (30.0 +/- 14.2 vs 18.9 +/- 11.4 days, P = 0.004) than postoperative asymptomatic group (n = 43). Conclusions: In patients with significant PR after repair of TOF, PVR had clinical benefits including symptomatic improvement with low mortality and morbidity. Proper timing must be carefully selected according to objective evaluation of RV function. In Our study, earlier PVR prior to symptomatic manifestation showed beneficial effects. (C) 2004 Elsevier B.V. All rights reserved.
C1 Sejong Gen Hosp, Dept Pediat Cardiol, Kyonggi Do 422232, South Korea.
   Seoul Natl Univ, Bundang Hosp, Dept Thorac & Cardiovasc Surg, Kyonggi Do, South Korea.
   Seoul Natl Univ, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
   Kyung Hee Univ, Ctr Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
   Sejong Gen Hosp, Sejong Heart Inst, Dept Cardiovasc Surg, Kyonggi Do, South Korea.
RP Lee, JY (reprint author), Sejong Gen Hosp, Dept Pediat Cardiol, 91-121 Sosa Bon 2-Dong, Kyonggi Do 422232, South Korea.
EM dire7613@chol.com
RI Kim, Woong Han/E-7471-2012; Lim, Cheong/J-5623-2012
CR BOVE EL, 1985, J THORAC CARDIOV SUR, V90, P50
   Conte S, 1999, EUR J CARDIO-THORAC, V15, P143, DOI 10.1016/S1010-7940(98)00306-6
   d'Udekem Y, 2001, J AM COLL CARDIOL, V37, P2008, DOI 10.1016/S0735-1097(01)01256-6
   Eyskens B, 2000, AM J CARDIOL, V85, P221, DOI 10.1016/S0002-9149(99)00640-2
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   GOLDBERG SJ, 1985, AM J CARDIOL, V56, P131, DOI 10.1016/0002-9149(85)90581-8
   Hanley FL, 2000, J THORAC CARDIOV SUR, V119, P1, DOI 10.1016/S0022-5223(00)70210-8
   Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1
   Hazekamp MG, 2001, EUR J CARDIO-THORAC, V19, P667, DOI 10.1016/S1010-7940(01)00656-X
   ILBAWI MN, 1987, J THORAC CARDIOV SUR, V93, P36
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   KIRKLIN JK, 1989, ANN THORAC SURG, V48, P783
   Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   Theodoro DA, 1998, ANN THORAC SURG, V65, P149, DOI 10.1016/S0003-4975(97)01193-4
   Therrien J, 2001, CIRCULATION, V103, P2489
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   Tulevski II, 2003, AM J CARDIOL, V92, P113, DOI 10.1016/S0002-9149(03)00484-3
   Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8
   Wessel HU, 1999, PEDIATR CARDIOL, V20, P39, DOI 10.1007/s002469900393
   Yemets IM, 1997, ANN THORAC SURG, V64, P526, DOI 10.1016/S0003-4975(97)00577-8
NR 21
TC 35
Z9 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD MAY
PY 2004
VL 25
IS 5
BP 728
EP 734
DI 10.1016/j.ejcts.2004.01.036
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 821AX
UT WOS:000221432800018
PM 15082274
ER

PT J
AU Sergeant, P
   Wouters, P
   Meyns, B
   Bert, C
   Van Hemelrijck, J
   Bogaerts, C
   Sergeant, G
   Slabbaert, K
AF Sergeant, P
   Wouters, P
   Meyns, B
   Bert, C
   Van Hemelrijck, J
   Bogaerts, C
   Sergeant, G
   Slabbaert, K
TI OPCAB versus early mortality and morbidity: an issue between clinical
   relevance and statistical significance
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 17th Annual Meeting of the
   European-Association-for-Cardio-Thoracic-Surgery/11th Annual Meeting of
   the European-Society-of-Thoracic-Surgeons
CY OCT 12-15, 2003
CL VIENNA, AUSTRIA
SP European Assoc Cardio Thorac Surg, European Soc Thorac Surg
DE coronary artery bypass surgery; OPCAB; propensity score
ID CORONARY-ARTERY-BYPASS; OFF-PUMP; ON-PUMP; GRAFT-SURGERY; RISK PATIENTS;
   REVASCULARIZATION; OUTCOMES; STROKE; TRIAL; CABG
AB Objective: To evaluate the impact of OPCAB on major postoperative events in a large consecutive cohort of patients, covering the complete spectrum of risk. Methods: A consecutive series of 3333 CABG patients operated in a single institution (Jan/97-Jan/03) is anal zed after a complete (98%) midterm reengineering towards off-pump surgery (Oct/99). Patients in cardiogenic shock are excluded. The on- (N - 1593) Or Off-pUrup (N = 1740) datasets are comparable for most demographic and non-cardiac variability. The studied events are early mortality. early stroke. early infarct, early dialysis and hospital stay. Three methods adjust for possible patient selection: similar datasets, forced inclusion of a saturated OPCAB propensity score and finally multivariate correction. Results: Non-risk adjusted. The 3-month survival was 96.7 +/- 0.4% (OPCAB) and 95.9 +/- 0.5% (ECC) (P = 0.2). The 8-day freedom from stroke was 99.4 +/- 0.2% (OPCAB) and 98.5 +/- 0.3% (ECC) (P = 0.004). The prevalence of dialysis was 1.67% in OPCAB and 2.27% in ECC (P = 0.2). The 8-day freedom from infarct was 98.4 +/- 0.2% (OPCAB) and 98.3 +/- 0.2% (ECC) (P = 0.7). The freedom from hospital discharge day 15 was 17.6 +/- 0.9% (OPCAB) and 18.4 +/- 0.8% (ECC) (P = 0.001). Propensity score corrected and adjusted for event-related variability. The survival effect remained non-significant (P = 0.3), also for patients with a EuroSCORE > 8 (P = 0.9). The stroke effect became nonsignificant (P = 0.2). but stayed significant for patients with severe internal carotid artery stenosis (P = 0.02). The dialysis-effect remained non-significant (P = 0.6). also for patients with an elevated creatinine (P = 0.7). The early infarct-effect remained non-significant (P = 0.8), also for the female patients (P = 0.8). The hospital discharge was significantly influenced by the OPCAB approach for the total group (P = 0.02) as well as for the patients with EuroSCORE > 8 (P = 0.01). Conclusions: The observed 20% reduction of mortality, 60% reduction of stroke and 20% reduction of dialysis were partly neutralized by the adjusting methods and demand, at least, larger datasets to obtain statistical significance. Subdatasets with fewer patients but higher risk identified risk-reducing effects for stroke. Hospital stay was shortened by the OPCAB approach. The interactions between risk, number of patients and the risk-reducing effect are the cornerstones of evidence generation for the OPCAB approach. These results were obtained through a very strict reengineering and cannot be extended to all OPCAB programs. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Hosp Gasthuisberg, Dept Cardiac Surg, B-3000 Louvain, Belgium.
   Univ Hosp Gasthuisberg, Fac Med, B-3000 Louvain, Belgium.
   Univ Hosp Gasthuisberg, Bio Stat Dept, B-3000 Louvain, Belgium.
   Univ Hosp Gasthuisberg, Dept Anaesthesia, B-3000 Louvain, Belgium.
RP Sergeant, P (reprint author), Univ Hosp Gasthuisberg, Dept Cardiac Surg, Herest, B-3000 Louvain, Belgium.
EM paul.sergeant@uz.kuleuven.ac.be
RI Sergeant, Gregory/B-5148-2010; Wouters, Patrick/E-1988-2011
CR Al-Ruzzeh S, 2003, EUR J CARDIO-THORAC, V23, P50, DOI 10.1016/S1010-7940(02)00654-1
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Arom KV, 2000, ANN THORAC SURG, V69, P704, DOI 10.1016/S0003-4975(99)01510-6
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2001.120329
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   FLAMENG W, 1983, J THORAC CARDIOV SUR, V85, P758
   Grunkemeier GL, 2002, ANN THORAC SURG, V74, P301, DOI 10.1016/S0003-4975(02)03783-9
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Osswald BR, 1999, EUR J CARDIO-THORAC, V15, P401, DOI 10.1016/S1010-7940(99)00029-9
   Patel NC, 2002, ANN THORAC SURG, V74, P400, DOI 10.1016/S0003-4975(02)03755-4
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Sergeant P, 1997, EUR J CARDIO-THORAC, V12, P1, DOI 10.1016/S1010-7940(97)00134-6
   Stamou SC, 2002, ANN THORAC SURG, V74, P394, DOI 10.1016/S0003-4975(02)03636-6
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 20
TC 35
Z9 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD MAY
PY 2004
VL 25
IS 5
BP 779
EP 785
DI 10.1016/j.ejcts.2004.02.013
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 821AX
UT WOS:000221432800030
PM 15082282
ER

PT J
AU Sahin, S
   Yalcin, S
   Sahin, HM
   Ubeyli, M
AF Sahin, S
   Yalcin, S
   Sahin, HM
   Ubeyli, M
TI Neutronics analysis of HYLIFE-II blanket for fissile fuel breeding in an
   inertial fusion energy reactor
SO ANNALS OF NUCLEAR ENERGY
LA English
DT Article
ID POWER-PLANT DESIGN
AB A protective, 60 cm thick flowing liquid wall coolant is investigated as energy carrier, and fusile and fissile breeder medium in an inertial fusion energy (IFE) reactor. Flibe as the main constituent is mixed with increased mole-fractions of heavy metal salt (ThF4 and UF4) starting with 2 mol% up to 12 mol%. For a plant operation period of 30 years, radiation damage values were found as DPA = similar to65 for 2 mol % heavy metal in the coolant, and remain practically constant with increasing heavy metal fraction, well below the presumable limit of DPA = 100. Helium production values are calculated as similar to270 appm for 2 mol% heavy metal fraction, also being far below the limit value of 500 appm and remain at the same level with increasing heavy metal fraction. Such a flowing protective liquid wall extents the lifetime of the rigid first wall structure to a plant lifetime of 30 years. Fissionable metal salt in the flowing liquid enables one to breed high quality fissile fuel for external reactors by a self-sustaining tritium breeding for the fusion plant and increases plant power output. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Gazi Univ, Teknik Egitim Fak, Ankara, Turkey.
   Bahcesehir Univ, Fen Edebiyat Fak, Istanbul, Turkey.
RP Sahin, S (reprint author), Gazi Univ, Teknik Egitim Fak, Ankara, Turkey.
RI SAHIN, Sumer/C-6252-2013
OI SAHIN, Sumer/0000-0003-2844-8061
CR Abdou M A, 1999, UCLAENG99206
   Abdou MA, 1999, FUSION ENG DES, V45, P145, DOI 10.1016/S0920-3796(99)00018-6
   Abdou MA, 2001, FUSION ENG DES, V54, P181, DOI 10.1016/S0920-3796(00)00433-6
   ALKUSAYER TA, 1988, CLAW 4 COUPLED 30 NE, P4
   BLINK A, 1985, UCRL53559 LAWR LIV N
   Duderstadt J. J., 1982, INERTIAL CONFINEMENT
   GREENE NM, 1997, NITAWL II SCALE SYST, V2
   GREENE NM, 1997, BONAMI RESONANCE SEL, V2
   GREENE NM, 1997, XSDRNPM ONE DIMENSIO, V2
   HOUSE PA, 1994, FUSION TECHNOL, V26, P1178
   HOUSE PA, 1992, FUSION TECHNOL, V21, P1487
   JORDAN WC, 1997, SCALE CROSS SECTION, V3
   Kayabali K, 1998, ENVIRON GEOL, V34, P95
   LANDERS NF, 1997, CSAS CONTROL MODULE, V1
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   MOIR RW, 1991, UCID21816 HYLIFE II
   MOIR RW, 1987, FUSION ENG DES, V5, P269, DOI 10.1016/S0920-3796(87)90024-X
   MOIR RW, 1995, FUSION ENG DES, V29, P34, DOI 10.1016/0920-3796(95)80003-G
   MOIR RW, 1992, FUSION TECHNOL, V21, P1475
   Moir RW, 1997, NUCL FUSION, V37, P557, DOI 10.1088/0029-5515/37/4/I13
   *NUCL REG COMM, 1982, COD FED REG LIC R 61
   Perlado M., 1995, RAD DAMAGE STRUCTURA, P272
   SAHIN S, 1994, FUSION TECHNOL, V26, P1311
   Sahin S, 1996, FUSION TECHNOL, V30, P1027
   SAHIN S, 1997, T AM NUCL SOC 1997 W, P77
   SAHIN S, 1994, FUSION TECHNOL, V25, P388
   Sahin S., 1991, GAZI U PUBLICATION
   SAHIN S, 2002, ANN NUCL ENERGY, V30, P245
   Smith D.L., 1984, ANLFPP841
   YAPICI H, 2001, XSCALC INTERFACING O
   Yapici H, 2002, ANN NUCL ENERGY, V29, P1871, DOI 10.1016/S0306-4549(02)00016-6
NR 31
TC 35
Z9 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4549
J9 ANN NUCL ENERGY
JI Ann. Nucl. Energy
PD APR
PY 2003
VL 30
IS 6
BP 669
EP 683
DI 10.1016/S0306-4549(02)00109-3
PG 15
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 645CE
UT WOS:000180958000003
ER

PT J
AU Crook, J
   Lukka, H
   Klotz, L
   Bestic, N
   Johnston, M
AF Crook, J
   Lukka, H
   Klotz, L
   Bestic, N
   Johnston, M
CA Genitourinary Canc Dis Site Grp Ca
TI Systematic overview of the evidence for brachytherapy in clinically
   localized prostate cancer
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT Article
ID INTERSTITIAL RADIATION-THERAPY; RADIOACTIVE SEED IMPLANTATION;
   EXTERNAL-BEAM RADIATION; RADICAL PROSTATECTOMY; I-125 IMPLANTATION;
   CARCINOMA; STAGE; ANTIGEN; IRRADIATION
AB Background: Brachytherapy (permanent implantation of radioactive seeds) has emerged as an alternative to existing standard therapy with radical prostatectomy or external beam radiotherapy in the treatment of clinically localized (T1 and T2) prostate cancer. The Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative examined the role of brachytherapy in treating clinically localized prostate cancer.
   Methods: A systematic review of articles published from 1988 to April 1999, retrieved through a search of MEDLINE and CANCERLIT databases, was combined with a consensus interpretation of the evidence in the context of conventional practice.
   Results: Although there were no randomized trials comparing brachytherapy with standard treatment, evidence was available from 13 case series and 3 cohort studies. Rates of freedom from biochemical failure (biochemically no evidence of disease [bNED]) varied considerably from one series to another and were highly dependent on tumour stage, grade and pretreatment serum prostate-specific antigen (PSA) levels. Results in patients with favourable tumours (T1 or T2 tumour, Gleason score of 6 or lower, serum PSA level of 10 ng/mL [mug/L] or less) were comparable to those in patients undergoing radical prostatectomy. Acute urinary retention was reported in 1%-14% of patients. Long-term sequelae occurred in less than 5% of patients and included urinary incontinence, cystitis, urethral strictures and proctitis. Sexual potency was maintained after implantation in 86%-96% of patients.
   Interpretation: At present, there is insufficient evidence to recommend the use of brachytherapy over current standard therapy for localized prostate cancer. Brachytherapy using transrectal ultrasound guidance for seed implantation is promising in terms of freedom from biochemical failure in selected patients with early-stage prostate cancer. Brachytherapy is currently available outside of clinical trials, but whenever possible patients should be asked to participate in randomized trials comparing brachytherapy and current standard therapy. Brachytherapy should be available to selected patients (those with Tie or T2a tumours, a Gleason score of 6 or lower and a serum PSA level of 10 mug/L or less), after discussion of the available data and potential adverse effects.
C1 Hamilton Reg Canc Ctr, Hamilton, ON L8V 5C2, Canada.
   Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada.
   Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada.
   Canc Care Ontario, Program Evidence Based Care, Hamilton, ON, Canada.
   NE Ontario Reg Canc Ctr, Sudbury, ON, Canada.
   Kingston Reg Canc Ctr, Kingston, ON, Canada.
   St Josephs Hosp, Hamilton, ON L8N 1Y4, Canada.
   Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada.
   Credit Valley Hosp, Toronto, ON, Canada.
   Toronto Gen Hosp, Toronto, ON M5G 1L7, Canada.
RP Lukka, H (reprint author), Hamilton Reg Canc Ctr, 699 Concess St, Hamilton, ON L8V 5C2, Canada.
EM himu.lukka@hrcc.on.ca
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   BROSMAN SA, 1991, UROLOGY, V38, P372, DOI 10.1016/0090-4295(91)80157-3
   BROWMAN GP, 2000, CURRENT ONCOLOGY, V6, P203
   Critz FA, 1998, CANCER J SCI AM, V4, P359
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Epstein JI, 1996, AM J SURG PATHOL, V20, P286, DOI 10.1097/00000478-199603000-00004
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537
   IVERSEN P, 1989, UROLOGY, V34, P181, DOI 10.1016/0090-4295(89)90368-3
   Kattan MW, 1998, J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766
   KAYE KW, 1995, J UROLOGY, V153, P1020, DOI 10.1016/S0022-5347(01)67626-2
   Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445
   PETERSON RO, 1986, UROLOGIC PATHOLOGY
   Pisansky TM, 1997, CANCER-AM CANCER SOC, V79, P337, DOI 10.1002/(SICI)1097-0142(19970115)79:2<337::AID-CNCR17>3.0.CO;2-1
   Prestidge BR, 1997, INT J RADIAT ONCOL, V37, P31, DOI 10.1016/S0360-3016(96)00390-2
   RADGE H, 1998, CANCER, V83, P989
   Ragde H, 1997, CANCER, V80, P442, DOI 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Sobin LH, 1997, TNM CLASSIFICATION M
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   Stokes SH, 1997, INT J RADIAT ONCOL, V37, P337, DOI 10.1016/S0360-3016(96)00508-1
   STONE NN, 1995, J UROLOGY, V153, P1555, DOI 10.1016/S0022-5347(01)67460-3
   VIJVERBERG PLM, 1993, BRIT J UROL, V72, P470, DOI 10.1111/j.1464-410X.1993.tb16180.x
   Wallner K, 1996, J CLIN ONCOL, V14, P449
NR 26
TC 35
Z9 36
PU CANADIAN MEDICAL ASSOCIATION
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 3Y6, CANADA
SN 0820-3946
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD APR 3
PY 2001
VL 164
IS 7
BP 975
EP 981
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 418ZQ
UT WOS:000167925300014
PM 11314451
ER

PT J
AU SMITH, SK
   SINCICH, T
AF SMITH, SK
   SINCICH, T
TI STABILITY OVER TIME IN THE DISTRIBUTION OF POPULATION FORECAST ERRORS
SO DEMOGRAPHY
LA English
DT Article
RP SMITH, SK (reprint author), UNIV FLORIDA,COLL BUSINESS ADM,GAINESVILLE,FL 32611, USA.
CR Ascher W., 1978, FORECASTING APPRAISA
   COHEN JE, 1986, DEMOGRAPHY, V23, P105, DOI 10.2307/2061412
   CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225
   DORN HF, 1950, J AM STAT ASSOC, V45, P311, DOI 10.2307/2280290
   *FED STAT COOP PRO, 1984, STAT SURV POP PROJ
   GREENBER.MR, 1972, ECON GEOGR, V48, P179, DOI 10.2307/142873
   IRWIN R, 1977, 39 US BUR CENS TECHN
   ISSERMAN AM, 1977, J AM I PLANNERS, V43, P247, DOI 10.1080/01944367708977786
   ISSERMAN AM, 1984, POPUL RES POLICY REV, V3, P27, DOI 10.1007/BF00123008
   KALE B, 1981, ANN M POPULATION ASS
   KEYFITZ N, 1981, POPUL DEV REV, V7, P579, DOI 10.2307/1972799
   KEYFITZ N, 1972, J AM STAT ASSOC, V67, P347, DOI 10.2307/2284381
   LAND KC, 1986, J AM STAT ASSOC, V81, P888, DOI 10.2307/2289057
   LEE RD, 1974, J AM STAT ASSOC, V69, P607, DOI 10.2307/2285990
   Levene H., 1960, CONTRIBUTIONS PROBAB, P278
   MURDOCK SH, 1984, DEMOGRAPHY, V21, P383, DOI 10.2307/2061167
   SABOIA JLM, 1974, DEMOGRAPHY, V11, P483, DOI 10.2307/2060440
   Schmitt R., 1953, J MARKETING, V17, P417, DOI 10.2307/1247019
   Schmitt RC, 1951, LAND ECON, V27, P346, DOI 10.2307/3159671
   SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709
   Siegel JS, 1953, LAND ECON, V29, P72, DOI 10.2307/3144286
   SIEGEL JS, 1972, DEMOGRAPHY, V9, P51, DOI 10.2307/2060545
   SMITH SK, 1987, J AM STAT ASSOC, V82, P991, DOI 10.2307/2289369
   SMITH SK, 1984, MONOGRAPH U FLORIDA, V1
   STOTO MA, 1983, J AM STAT ASSOC, V78, P13, DOI 10.2307/2287094
   Tukey J. W., 1977, EXPLORATORY DATA ANA
   *US BUR CENS, 1957, CURR POP REP P25, V160
   *US BUR CENS, 1983, 1980 CENS PO PC801A1
   *US BUR EC AN, 1974, AR EC PROJ 1990
   VOSS P, 1981, FORECASTING STATE PO
   WHITE HR, 1954, J AM STAT ASSOC, V49, P480, DOI 10.2307/2281125
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
NR 32
TC 35
Z9 35
PU POPULATION ASSN AMER
PI WASHINGTON
PA 1722 N ST NW, WASHINGTON, DC 20036
SN 0070-3370
J9 DEMOGRAPHY
JI Demography
PD AUG
PY 1988
VL 25
IS 3
BP 461
EP 474
DI 10.2307/2061544
PG 14
WC Demography
SC Demography
GA P6775
UT WOS:A1988P677500010
PM 3234579
ER

PT J
AU MAKRIDAKIS, S
   HIBON, M
   LUSK, E
   BELHADJALI, M
AF MAKRIDAKIS, S
   HIBON, M
   LUSK, E
   BELHADJALI, M
TI CONFIDENCE-INTERVALS - AN EMPIRICAL-INVESTIGATION OF THE SERIES IN THE
   M-COMPETITION
SO INTERNATIONAL JOURNAL OF FORECASTING
LA English
DT Article
C1 UNIV PENN,WHARTON SCH,PHILADELPHIA,PA 19104.
   UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104.
RP MAKRIDAKIS, S (reprint author), INSEAD,F-77305 FONTAINEBLEAU,FRANCE.
CR ARMSTRONG JS, 1987, INT J FORECASTING, V3, P355
   BIANCHI C, 1987, INT J FORECASTING, V3, P211, DOI 10.1016/0169-2070(87)90003-3
   BOX EP, 1976, TIME SERIES ANAL FOR
   Brown R. G., 1967, DECISION RULES INVEN
   CARBONE R, 1986, MANAGE SCI, V32, P257, DOI 10.1287/mnsc.32.3.257
   GARDNER ES, 1986, IN PRESS MANAGEMENT
   JOHNSTON FR, 1986, J OPER RES SOC, V37, P303, DOI 10.2307/2582210
   Kahneman D., 1982, JUDGMENT UNCERTAINTY
   MAKRIDAKIS S, 1981, OMEGA-INT J MANAGE S, V9, P307, DOI 10.1016/0305-0483(81)90037-2
   MAKRIDAKIS S, 1982, J FORECASTING, V1, P111, DOI 10.1002/for.3980010202
   MAKRIDAKIS S, 1985, INSEAD8509 RES PAP
   MAKRIDAKIS S, 1986, INT J FORECASTING, V2, P15, DOI 10.1016/0169-2070(86)90028-2
   SWEET AL, 1985, J FORECASTING, V4, P235, DOI 10.1002/for.3980040210
   WEISS AA, 1984, J ROY STAT SOC A STA, V147, P484, DOI 10.2307/2981579
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
NR 15
TC 35
Z9 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-2070
J9 INT J FORECASTING
JI Int. J. Forecast.
PY 1987
VL 3
IS 3-4
BP 489
EP 508
DI 10.1016/0169-2070(87)90045-8
PG 20
WC Economics; Management
SC Business & Economics
GA K8051
UT WOS:A1987K805100016
ER

PT J
AU WARNER, TFCS
   KRUEGER, RG
AF WARNER, TFCS
   KRUEGER, RG
TI CIRCULATING LYMPHOCYTES AND SPREAD OF MYELOMA - REVIEW OF EVIDENCE
SO LANCET
LA English
DT Review
C1 CHRIST HOSP,INST MED RES,CINCINNATI,OH 45219.
RP WARNER, TFCS (reprint author), INDIANA UNIV,MED CTR,DEPT PATHOL,INDIANAPOLIS,IN 46202, USA.
CR ABDOU NI, 1975, ANN INTERN MED, V83, P42
   ANDAY GJ, 1974, J NATL CANCER I, V52, P1069
   BAYRD ED, 1948, BLOOD, V3, P987
   BERGSAGE.DE, 1968, CANCER RES, V28, P2187
   BERGSAGEL DE, 1975, ARCH INTERN MED, V135, P109, DOI 10.1001/archinte.135.1.109
   BHOOPALAM N, 1976, CLIN EXP IMMUNOL, V24, P357
   BRODER S, 1975, NEW ENGL J MED, V293, P887, DOI 10.1056/NEJM197510302931801
   CHURG J, 1950, AM J CLIN PATHOL, V20, P934
   CONKLIN R, 1975, ARCH INTERN MED, V135, P139, DOI 10.1001/archinte.135.1.139
   DREWINKO B, 1977, J NATL CANCER I, V58, P1247
   FAHEY JL, 1963, AM J MED, V35, P698, DOI 10.1016/0002-9343(63)90140-2
   HAMBURGER A, 1977, J CLIN INVEST, V60, P846, DOI 10.1172/JCI108839
   HAMBURGER A, UNPUBLISHED
   HELLER P, 1973, ANN NY ACAD SCI, V207, P468, DOI 10.1111/j.1749-6632.1973.tb47509.x
   Heller P, 1972, Trans Assoc Am Physicians, V85, P192
   HOBBS JR, 1969, BRIT J HAEMATOL, V16, P607, DOI 10.1111/j.1365-2141.1969.tb00441.x
   HOLM G, 1977, TRANSPLANT REV, V34, P139
   JANOSSY G, 1975, TRANSPLANT REV, V24, P177
   KRUEGER RG, 1974, J NATL CANCER I, V52, P1203
   KRUEGER RG, 1976, J NATL CANCER I, V56, P711
   KRUEGER RG, UNPUBLISHED
   KYLE RA, 1977, MONOCLONAL GAMMOPATH, P111
   KYLE RA, 1975, MAYO CLIN PROC, V50, P29
   MELLSTED.H, 1974, CLIN EXP IMMUNOL, V17, P371
   MELLSTED.H, 1973, CLIN EXP IMMUNOL, V15, P321
   MELLSTEDT H, 1976, SCAND J HAEMATOL, V16, P112
   PAGLIERONI T, 1977, J CLIN INVEST, V59, P1120, DOI 10.1172/JCI108736
   ROHRER JW, 1977, J IMMUNOL, V119, P861
   SALMON SE, 1973, SEMIN HEMATOL, V10, P135
   SALMON SE, 1975, ARCH INTERN MED, V135, P131, DOI 10.1001/archinte.135.1.131
   SEWELL RL, 1977, BRIT J HAEMATOL, V36, P545, DOI 10.1111/j.1365-2141.1977.tb00995.x
   STANECK LD, 1974, J NATL CANCER I, V53, P927
   STROBER S, 1975, TRANSPLANT REV, V24, P84
   SULLIVAN PW, 1972, J CLIN INVEST, V51, P1697, DOI 10.1172/JCI106971
   THOMAS FB, 1973, ARCH INTERN MED, V132, P195, DOI 10.1001/archinte.132.2.195
   VANFURTH R, 1969, SEMIN HEMATOL, V6, P84
   VITETTA ES, 1975, SCIENCE, V189, P964, DOI 10.1126/science.1083069
   WARNER TFC, 1976, THESIS NATIONAL U IR
   WARNER TFCS, 1977, J NATL CANCER I, V58, P983
NR 39
TC 35
Z9 35
PU LANCET LTD
PI LONDON
PA 42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL
SN 0140-6736
J9 LANCET
JI Lancet
PY 1978
VL 1
IS 8075
BP 1174
EP 1176
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA FA620
UT WOS:A1978FA62000003
PM 77943
ER

PT J
AU Magne, J
   Girerd, N
   Senechal, M
   Mathieu, P
   Dagenais, F
   Dumesnil, JG
   Charbonneau, E
   Voisine, P
   Pibarot, P
AF Magne, Julien
   Girerd, Nicolas
   Senechal, Mario
   Mathieu, Patrick
   Dagenais, Francois
   Dumesnil, Jean G.
   Charbonneau, Eric
   Voisine, Pierre
   Pibarot, Philippe
TI Mitral Repair versus Replacement for Ischemic Mitral Regurgitation
   Comparison of Short-Term and Long-Term Survival
SO CIRCULATION
LA English
DT Article; Proceedings Paper
CT 81st Annual Scientific Session of the American-Heart-Association
CY NOV 08-12, 2008
CL New Orleans, LA
SP Amer Heart Assoc
DE ischemia; mitral valve; prosthesis; regurgitation; valves
ID END-STAGE CARDIOMYOPATHY; VALVE REPAIR; MYOCARDIAL-INFARCTION;
   ANNULOPLASTY; SURGERY; ECHOCARDIOGRAPHY; RECONSTRUCTION; DISEASE
AB Background-When compared to mitral valve replacement (MVR), mitral valve repair (MVRp) is associated with better survival in patients with organic mitral regurgitation (MR). However, there is an important controversy about the type of surgical treatment that should be used in patients with ischemic MR. The objective of this study was to compare the postoperative outcome of MVRp versus MVR in patients with ischemic MR.
   Methods and Results-Preoperative and operative data of 370 patients with ischemic MR who underwent mitral valve surgery were prospectively collected and retrospectively analyzed. MVRp was performed in 50% of patients (n=186) and MVR in 50% (n=184). Although operative mortality was significantly lower after MVRp compared to MVR (9.7% versus 17.4%; P=0.03), overall 6-year survival was not statistically different between procedures (73 +/- 4% versus 67 +/- 4%; P=0.17). After adjusting for other risk factors and propensity score, the type of procedure ( MVRp versus MVR) did not come out as an independent predictor of either operative (OR, 1.5; 95% CI, 0.7-2.9; P=0.34) or overall mortality (HR, 1.2; 95% CI, 0.7-1.9; P=0.52).
   Conclusion-As opposed to what has been reported in patients with organic MR, the results of this study suggest that MVRp is not superior to MVR with regard to operative and overall mortality in patients with ischemic MR. These findings provide support for the realization of a randomized trial comparing these 2 treatment modalities. (Circulation. 2009; 120[suppl 1]: S104-S111.)
C1 [Magne, Julien; Girerd, Nicolas; Senechal, Mario; Mathieu, Patrick; Dagenais, Francois; Dumesnil, Jean G.; Charbonneau, Eric; Voisine, Pierre; Pibarot, Philippe] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec Heart & Lung Inst, Quebec City, PQ G1V 4G5, Canada.
RP Pibarot, P (reprint author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec Heart & Lung Inst, 2725 Chemin St Foy, Quebec City, PQ G1V 4G5, Canada.
EM philippe.pibarot@med.ulaval.ca
CR Aklog L, 2001, CIRCULATION, V104, pI68
   Al-Radi OO, 2005, ANN THORAC SURG, V79, P1260, DOI 10.1016/j.athoracsur.2004.09.044
   AUSTIN PC, 2008, CIRC CARDIOVASC QUAL, V6, P62
   BACH DS, 1995, AM HEART J, V129, P1165, DOI 10.1016/0002-8703(95)90399-2
   BOLLING SF, 1995, J THORAC CARDIOV SUR, V109, P676, DOI 10.1016/S0022-5223(95)70348-9
   Borger MA, 2007, J THORAC CARDIOV SUR, V133, P1483, DOI 10.1016/j.jtcvs.2007.01.064
   Braun J, 2005, EUR J CARDIO-THORAC, V27, P847, DOI 10.1016/j.ejcts.2004.12.031
   Bursi F, 2006, AM J MED, V119, P103, DOI 10.1016/j.amjmed.2005.08.025
   CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323
   COHN LH, 1995, EUR J CARDIO-THORAC, V9, P568, DOI 10.1016/S1010-7940(05)80008-9
   Enriquez-Sarano M, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.CIR.0000083831.17708.25
   ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022
   Gelsomino S, 2008, EUR HEART J, V29, P231
   Gillinov AM, 2005, ANN THORAC SURG, V80, P811, DOI 10.1016/j.athoracsur.2005.03.134
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Grigioni F, 2001, CIRCULATION, V103, P1759
   Grossi EA, 2001, J CARDIAC SURG, V16, P328, DOI 10.1111/j.1540-8191.2001.tb00530.x
   Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945
   Hung J, 2004, CIRCULATION S2, V110, pII85, DOI 10.1161/01.CIR.0000138192.65015.45
   Lamas GA, 1997, CIRCULATION, V96, P827
   Levine RA, 2005, CIRCULATION, V112, P745, DOI 10.1161/CIRCULATIONAHA.104.486720
   Magne J, 2008, J AM COLL CARDIOL, V51, P1692, DOI 10.1016/j.jacc.2007.11.082
   Magne J, 2007, CIRCULATION, V115, P782, DOI 10.1161/CIRCULATIONAHA.106.649236
   Magne J, 2007, CIRCULATION, V115, P1417, DOI 10.1161/CIRCULATIONAHA.106.631549
   Magne J, 2009, CARDIOLOGY, V112, P244, DOI 10.1159/000151693
   McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037
   Reece TB, 2004, ANN SURG, V239, P671, DOI 10.1097/sla.0000124297.40815.86
   Senechal M, 2007, CAN J CARDIOL, V23, p48B
   Serri K, 2006, J THORAC CARDIOV SUR, V131, P565, DOI 10.1016/j.jtcvs.2005.09.037
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   von Oppell UO, 2000, J HEART VALVE DIS, V9, P64
   Zhu F, 2005, CIRCULATION, V112
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
NR 33
TC 34
Z9 35
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP 15
PY 2009
VL 120
IS 11
SU 1
BP S104
EP S111
DI 10.1161/CIRCULATIONAHA.108.843995
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 493XQ
UT WOS:000269773000016
PM 19752354
ER

PT J
AU Schwartz, ML
   Merz, AJ
AF Schwartz, Matthew L.
   Merz, Alexey J.
TI Capture and release of partially zipped trans-SNARE complexes on intact
   organelles
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID HOMOTYPIC VACUOLE FUSION; MEDIATED MEMBRANE-FUSION; ALPHA-SNAP;
   CA2+-TRIGGERED EXOCYTOSIS; NEUROTRANSMITTER RELEASE; CRYSTAL-STRUCTURE;
   YEAST VACUOLE; T-SNARE; TRANSMEMBRANE SEGMENTS; KINETIC COMPONENTS
AB Soluble N-ethyl-maleimide sensitive fusion protein attachment protein receptors (SNARES) are hypothesized to trigger membrane fusion by complexing in trans through their membrane-distal N termini and zippering toward their membrane-embedded C termini, which in turn drives the two membranes together. In this study, we use a set of truncated SNARES to trap kinetically stable, partially zipped traps-SNARE complexes on intact organelles in the absence of hemifusion and content mixing. We show that the C-terminal zippering of SNARE cytoplasmic domains controls the onset of lipid mixing but not the sub-sequent transition from hemifusion to full fusion. Moreover, we find that a partially zipped nonfusogenic traps-complex is rescued by Sec17, a universal SNARE cochaperone. Rescue occurs independently of the Sec17-binding partner Sec18, and it exhibits steep cooperativity, indicating that Sec17 engages multiple stalled traps-complexes to drive fusion. These experiments delineate distinct functions within the traps-complex, provide a straightforward method to trap and study prefusion complexes on native membranes, and reveal that Sec17 can rescue a stalled, partially zipped traps-complex.
C1 [Schwartz, Matthew L.; Merz, Alexey J.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
RP Merz, AJ (reprint author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
EM merza@u.washington.edu
CR Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746
   Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425
   Barnard RJO, 1996, MOL BIOL CELL, V7, P693
   BINZ T, 1994, J BIOL CHEM, V269, P1617
   Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098
   Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001
   Brett CL, 2008, CURR BIOL, V18, P1072, DOI 10.1016/j.cub.2008.06.050
   Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135
   Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000
   Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455
   Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104
   Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658
   DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419
   Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068
   Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093
   Haas A, 1996, EMBO J, V15, P3296
   Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801
   Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7
   Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8
   Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7
   Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005
   Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798
   Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449
   Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002
   Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104
   KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1
   Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025
   Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072
   LANDO L, 1994, J NEUROPHYSIOL, V72, P825
   Langosch D, 2001, J MOL BIOL, V311, P709, DOI 10.1006/jmbi.2001.4889
   Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310
   Lu XB, 2008, NAT STRUCT MOL BIOL, V15, P700, DOI 10.1038/nsmb.1433
   Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200
   Matos MF, 2003, NEUROPHARMACOLOGY, V45, P777, DOI 10.1016/S0028-3908(03)00318-6
   Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3
   McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105
   McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3
   Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234
   Melia TJ, 2006, J BIOL CHEM, V281, P29597, DOI 10.1074/jbc.M601778200
   MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679
   Merz AJ, 2004, P NATL ACAD SCI USA, V101, P11548, DOI 10.1073/pnas.0404583101
   Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105
   Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002
   Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486
   Reese C, 2005, J CELL BIOL, V171, P981, DOI 10.1083/jcb.200510018
   Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2
   Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450
   Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610
   Roy R, 2006, BIOCHEMISTRY-US, V45, P7654, DOI 10.1021/bi052620o
   Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645
   Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124
   Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402
   SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2
   Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003
   Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104
   Sutton RB, 1998, NATURE, V395, P347
   Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286
   Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069
   Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61
   Wang Y, 2001, J BIOL CHEM, V276, P28598, DOI 10.1074/jbc.M101644200
   Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063
   Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X
   Weiss JN, 1997, FASEB J, V11, P835
   Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200
   Wong JL, 2007, DEV CELL, V12, P653, DOI 10.1016/j.devcel.2007.02.007
   Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551
   Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174
   Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642
   Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4
   Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921
   Zampighi GA, 2006, BIOPHYS J, V91, P2910, DOI 10.1529/biophysj.106.084814
NR 71
TC 34
Z9 35
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
J9 J CELL BIOL
JI J. Cell Biol.
PD MAY 4
PY 2009
VL 185
IS 3
BP 535
EP 549
DI 10.1083/jcb.200811082
PG 15
WC Cell Biology
SC Cell Biology
GA 443VJ
UT WOS:000265938600015
PM 19414611
ER

PT J
AU Parang, P
   Arora, R
AF Parang, Pirouz
   Arora, Rohit
TI Coronary vein graft disease: Pathogenesis and prevention
SO CANADIAN JOURNAL OF CARDIOLOGY
LA English
DT Review
DE Coronary artery bypass surgery; Endoscopic vein harvesting; External
   stenting; Gene therapy; No-touch technique; Off-pump bypass surgery;
   Vein graft disease
ID ARTERY-BYPASS-SURGERY; INTERNAL MAMMARY ARTERY; NITRIC-OXIDE SYNTHASE;
   LIPOPROTEIN CHOLESTEROL LEVELS; TRANSCRIPTION FACTOR DECOY; LOW-DOSE
   ANTICOAGULATION; ANTI-COAGULANT THERAPY; ANGIOGRAPHIC FOLLOW-UP;
   MEDIATED GENE-TRANSFER; SAPHENOUS-VEIN
AB Not long after coronary artery bypass grafting surgery was described, several reports presented follow-up angiographic data on large cohorts of patients, demonstrating that approximately one-half of saphenous vein grafts fail within 10 to 15 years of surgery and that graft failure is associated with worse clinical outcomes. Three processes are responsible for vein graft failure. Thrombosis, intimal hyperplasia and accelerated atherosclerosis contribute to graft failure in the acute, subacute and late postoperative periods, respectively. Studies have shown that perioperative antiplatelet therapy can reduce early thrombosis and graft failure. As in native coronaries, intensive lipid lowering can attenuate the process of atherosclerosis in vein grafts. Intimal hyperplasia in the vein graft is thought to be an adaptation of the vein to higher pressures in the arterial circulation. This process is further promoted by the loss of inhibition from the endothelial layer, which is injured during surgery. A new 'no-touch' technique for harvesting grafts may be effective in preventing disruption to the endothelial layer, and subsequent intimal hyperplasia and graft loss. Off-pump surgery and endoscopic vein harvesting, which are known to reduce surgical morbidity, have been shown to be no worse than on-pump surgery and open vein harvesting, respectively, in terms of vein graft patency. Various gene therapies can prevent intimal hyperplasia in animal models, but human data obtained so far have been disappointing. Placing an external stent around a vein graft may reduce tangential wall stress and subsequent intimal hyperplasia.
C1 [Arora, Rohit] Chicago Med Sch, Dept Med, Chicago 60064, IL USA.
   [Parang, Pirouz] Deborah Heart & Lung Ctr, Dept Cardiol, Browns Mills, NJ USA.
RP Arora, R (reprint author), Chicago Med Sch, Dept Med, 3001 Green Bay Road, Chicago 60064, IL USA.
EM rohit.arora@va.gov
CR Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446
   ANGELINI GD, 1990, J THORAC CARDIOV SUR, V99, P433
   Azen SP, 1996, CIRCULATION, V93, P34
   BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233
   BOURASSA MG, 1985, CIRCULATION, V72, P71
   CAMPEAU L, 1983, CIRCULATION, V68, P1
   CAMPEAU L, 1984, NEW ENGL J MED, V311, P1329, DOI 10.1056/NEJM198411223112101
   CHEN SJ, 1994, CIRCULATION, V90, P2468
   CHESEBRO JH, 1984, NEW ENGL J MED, V310, P209, DOI 10.1056/NEJM198401263100401
   CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201
   Cho KR, 2006, EUR J CARDIO-THORAC, V29, P511, DOI 10.1016/j.ejcts.2005.12.026
   COX JL, 1991, PROG CARDIOVASC DIS, V34, P45, DOI 10.1016/0033-0620(91)90019-I
   Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982
   Ehsan A, 2001, J THORAC CARDIOV SUR, V121, P714, DOI 10.1067/mtc.2001.111204
   FITZGIBBON GM, 1991, J AM COLL CARDIOL, V17, P1075
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   FITZGIBBON GM, 1986, J THORAC CARDIOV SUR, V91, P773
   George SJ, 2000, CIRCULATION, V101, P296
   GOHLKE H, 1981, CIRCULATION, V64, P22
   Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064
   GOLDMAN S, 1991, CIRCULATION, V84, P520
   GOLDMAN S, 1989, CIRCULATION, V80, P1190
   GOLDMAN S, 1988, CIRCULATION, V77, P1324
   GRONDIN CM, 1984, CIRCULATION, V70, P208
   GUNDRY SR, 1998, J THORAC CARD SURG, P1277
   Halabi AR, 2005, AM J CARDIOL, V96, P1254, DOI 10.1016/j.amjcard.2005.06.067
   HOFF HF, 1988, CIRCULATION, V77, P1238
   IBRAHIM K, 2006, HEART SURG FORUM, V9, P581
   Izzat MB, 1996, CIRCULATION, V94, P1741
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kibbe MR, 2001, J VASC SURG, V34, P156, DOI 10.1067/mva.2001.113983
   Kim KB, 2001, ANN THORAC SURG, V72, P1033
   Knatterud GL, 2000, CIRCULATION, V102, P157
   LOOP FD, 1983, J AM COLL CARDIOL, V1, P383
   LYTLE BW, 1985, J THORAC CARDIOV SUR, V89, P248
   MANN MJ, 1995, P NATL ACAD SCI USA, V92, P4502, DOI 10.1073/pnas.92.10.4502
   Mann MJ, 1999, LANCET, V354, P1493, DOI 10.1016/S0140-6736(99)09405-2
   Mayr U, 2002, CIRC RES, V90, P197, DOI 10.1161/hh0202.103715
   MCENANY MT, 1982, J THORAC CARDIOV SUR, V83, P81
   Mehta D, 1998, NAT MED, V4, P235, DOI 10.1038/nm0298-235
   MORISHITA R, 1995, P NATL ACAD SCI USA, V92, P5855, DOI 10.1073/pnas.92.13.5855
   MORISHITA R, 1993, P NATL ACAD SCI USA, V90, P8474, DOI 10.1073/pnas.90.18.8474
   Motwani JG, 1998, CIRCULATION, V97, P916
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Ohno N, 2002, CIRCULATION, V105, P1623, DOI 10.1161/01.CIR.0000014985.50017.6E
   OMEROGLU SN, 2000, ANN THORAC SURG, P850
   PANTELY GA, 1979, NEW ENGL J MED, V301, P962, DOI 10.1056/NEJM197911013011803
   Perrault LP, 2004, J THORAC CARDIOV SUR, V127, P1402, DOI 10.1016/j.jtcvs.2003.10.040
   Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Rosenfeldt FL, 1999, ANN THORAC SURG, V67, P878, DOI 10.1016/S0003-4975(98)01299-5
   Souza DSR, 2002, ANN THORAC SURG, V73, P1189, DOI 10.1016/S0003-4975(02)03425-2
   Stein PD, 2004, CHEST, V126, P600
   Stooker W, 2001, J THORAC CARDIOV SUR, V121, P290, DOI 10.1067/mtc.2001.111656
   Tsui JCS, 2002, J VASC SURG, V35, P356, DOI 10.1067/mva.2002.121072
   VANDERMEER J, 1993, LANCET, V342, P257, DOI 10.1016/0140-6736(93)91815-4
   VONDERLEYEN HE, 1995, P NATL ACAD SCI USA, V92, P1137, DOI 10.1073/pnas.92.4.1137
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Yun KL, 2005, J THORAC CARDIOV SUR, V129, P496, DOI 10.1016/j.jtcvs.2004.08.054
   ZWOLAK R M, 1987, Journal of Vascular Surgery, V5, P126, DOI 10.1067/mva.1987.avs0050126
   1997, NEW ENGL J MED, V336, P153
NR 61
TC 34
Z9 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0828-282X
J9 CAN J CARDIOL
JI Can. J. Cardiol.
PD FEB
PY 2009
VL 25
IS 2
BP E57
EP E62
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 408OG
UT WOS:000263443700007
PM 19214303
ER

PT J
AU Pettit, GS
   Keiley, MK
   Laird, RD
   Bates, JE
   Dodge, KA
AF Pettit, Gregory S.
   Keiley, Margaret K.
   Laird, Robert D.
   Bates, John E.
   Dodge, Kenneth A.
TI Predicting the developmental course of mother-reported monitoring across
   childhood and adolescence from early proactive parenting, child
   temperament, and parents' worries
SO JOURNAL OF FAMILY PSYCHOLOGY
LA English
DT Article
DE monitoring; parenting; temperament; longitudinal; growth modeling
ID PSYCHOLOGICAL CONTROL; BEHAVIOR; ADJUSTMENT; FAMILY; ANTECEDENTS;
   MECHANISMS; SCHOOL; PEERS
AB Change in mothers' reported monitoring and awareness of their children's activities and companions across Grades 5, 6, 8, and 11 were examined with the use of latent factor growth modeling. Proactive parenting and resistant-to-control (RTC) child temperament assessed prior to kindergarten, as well as parents' worries about their children's behavior in Grades 5 and 8, were tested as factors associated with change in monitoring over time. Higher proactive parenting, lower RTC temperament, and the mounting of a successful campaign to change their children's behavior were associated with higher monitoring scores overall. Monitoring levels decreased across time, but the rate of decline was steeper among mothers with high RTC children and slower among mothers who mounted a campaign and judged it to be effective. These findings shed light on factors contributing to continuity and change across development in a key domain of parenting.
C1 Auburn Univ, Dept Human Dev & Family Studies, Auburn, AL 36849 USA.
   Louisiana State Univ, Sch Human Ecol, Baton Rouge, LA 70803 USA.
   Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.
   Duke Univ, Ctr Child & Family Policy, Durham, NC 27706 USA.
RP Pettit, GS (reprint author), Auburn Univ, Dept Human Dev & Family Studies, Auburn, AL 36849 USA.
EM gpettit@auburn.edu
RI Laird, Robert/A-9395-2011
OI Laird, Robert/0000-0002-8336-2263
CR Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.1111/j.1467-8624.1996.tb01915.x
   BARBER BK, 2005, CHANGING BOUNDARIES, P5
   Bates J. E., 2007, HDB SOCIALIZATION, P153
   Bates JE, 1998, DEV PSYCHOL, V34, P982, DOI 10.1037/0012-1649.34.5.982
   BROWN BB, 1993, CHILD DEV, V64, P467, DOI 10.2307/1131263
   Collins W. A., 1995, CLOSE RELATIONSHIPS, P128
   Conger R. D., 2004, CONTINUITY CHANGE FA, P383
   Crouter A.C., 2002, HDB PARENTING, V3, P461
   Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380
   DISHION TJ, 1991, DEV PSYCHOL, V27, P172, DOI 10.1037/0012-1649.27.1.172
   DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481
   Dodge KA, 2003, DEV PSYCHOL, V39, P349, DOI 10.1037/0012-1649.39.2.349
   Dorius CJ, 2004, J MARRIAGE FAM, V66, P163
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   FOREHAND R., 2002, J CHILD FAM STUD, V11, P455, DOI 10.1023/A:1020935525335
   Garber J, 2002, J CONSULT CLIN PSYCH, V70, P79, DOI 10.1037//0022-006X.70.1.79
   Gardner FEM, 1999, J CHILD PSYCHOL PSYC, V40, P1185, DOI 10.1111/1469-7610.00535
   GORMANSMITH D, 2005, J CHILD FAMILY STUDI, V0014
   HOLDEN GW, 1985, CHILDREN ENV PSYCHOL, P193
   HOLLINGSHEAD W, 1979, HOLLINGSHEAD 4 FACTO
   Keiley MK, 2000, J ABNORM CHILD PSYCH, V28, P161, DOI 10.1023/A:1005122814723
   LAIR RD, 2004, CONSEQUENCES DEV CHA
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   Lengua LJ, 2005, J APPL DEV PSYCHOL, V26, P21, DOI 10.1016/j.appdev.2004.10.001
   Little R., 1987, STAT ANAL MISSING DA
   Loeber R, 2000, J ABNORM CHILD PSYCH, V28, P353, DOI 10.1023/A:1005169026208
   MIZE J, 1997, CHILD DEV, V68, P311
   Muthen L. K., 2003, MPLUS SHORT COURSES
   Muthen LK, 1998, MPLUS USERS GUIDE CO
   PATTERSON GR, 1984, CHILD DEV, V55, P1299, DOI 10.2307/1129999
   Pettit G. S., 2002, INTRUSIVE PARENTING, P97, DOI 10.1037/10422-004
   Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298
   Pettit GS, 1999, CHILD DEV, V70, P768, DOI 10.1111/1467-8624.00055
   Pettit GS, 1997, CHILD DEV, V68, P908, DOI 10.1111/j.1467-8624.1997.tb01970.x
   Pettit GS, 2004, CURR DIR PSYCHOL SCI, V13, P194, DOI 10.1111/j.0963-7214.2004.00306.x
   Raykov T, 2004, BEHAV THER, V35, P299, DOI 10.1016/S0005-7894(04)80041-8
   Singer J. D., 2003, APPL LONGITUDINAL DA
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   Kerr M, 2003, CHILDREN'S INFLUENCE ON FAMILY DYNAMICS: THE NEGLECTED SIDE OF FAMILY RELATIONSHIPS, P121
   Vandenberg R. J., 2000, ORGAN RES METHODS, V3, P4, DOI DOI 10.1177/109442810031002
NR 40
TC 34
Z9 34
PU AMER PSYCHOLOGICAL ASSOC/EDUCATIONAL PUBLISHING FOUNDATION
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0893-3200
J9 J FAM PSYCHOL
JI J. Fam. Psychol.
PD JUN
PY 2007
VL 21
IS 2
BP 206
EP 217
DI 10.1037/0893-3200.21.2.206
PG 12
WC Psychology, Clinical; Family Studies
SC Psychology; Family Studies
GA 186FG
UT WOS:000247763900008
PM 17605543
ER

PT J
AU Iverson, G
AF Iverson, Grant
TI Predicting slow recovery from sport-related concussion: The new
   simple-complex distinction
SO CLINICAL JOURNAL OF SPORT MEDICINE
LA English
DT Article
DE concussion; mild traumatic brain injury; neuropsychological testing;
   classification
ID TRAUMATIC-BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; NEUROPSYCHOLOGICAL
   TESTING USEFUL; ASSOCIATION POSITION STATEMENT; HIGH-SCHOOL;
   PROFESSIONAL FOOTBALL; CONSTRUCT-VALIDITY; NCAA CONCUSSION; MANAGEMENT;
   IMPACT
AB Objective: Following the Second International Conference on Concussion in Sport in 2005, a summary agreement statement was published that introduced new terminology for sport-related concussions. This new classification system is binary (ie, "simple" versus "complex" concussions). Athletes who are slow to recover (ie, >10 days) are classified as having complex concussions. The purpose of this study was to determine if high school football players, retrospectively classified as having a simple or a complex concussion, could be differentiated in the first 48 after injury on the basis of symptom reporting or neuropsychological testing.
   Design: Case-control study.
   Setting: Pennsylvania high school football programs.
   Participants: The total sample consisted of 114 concussed high school football players who were identified through a 3 year prospective cohort study.
   Interventions: All completed a computerized neuropsychological screening evaluation within 72 hours of injury. They were followed clinically until they recovered and were cleared to return to play. They were classified retrospectively as having a simple (n = 55) or complex (n = 59) concussion based on their recovery times.
   Main Outcome Measurements: Neurocognitive test performance and symptom ratings.
   Results: Within 72 hours after injury, athletes with complex concussions performed more poorly on neuropsychological testing and reported more symptoms than those with simple concussions. Athletes with complex concussions who were slow to recover were 18 times more likely to have 3 unusually low neuropsychological test scores than those with simple concussions (95% CI = 2.3-144.9). Athletes with previous concussions did not recover more slowly.
   Conclusions: This study provides evidence that supports and refutes the clinical usefulness of the new simple-complex concussion classification system.
C1 Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada.
   Riverview Hosp, Vancouver, BC, Canada.
RP Iverson, G (reprint author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.
EM giverson@interchange.ubc.ca
CR Kelly JP, 1997, NEUROLOGY, V48, P581
   Aubry M, 2002, Br J Sports Med, V36, P6, DOI 10.1136/bjsm.36.1.6
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411
   Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277
   Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871
   Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A
   Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859
   Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155
   Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46
   Collins MW, 2007, BRAIN INJURY MED PRI, P407
   Collins MW, 2003, AM J SPORT MED, V31, P168
   Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005
   Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1227/01.NEU.0000031572.99927.93
   Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964
   Field M, 2003, J PEDIATR, V142, P546, DOI 10.1067/mpd.2003.190
   Gaetz M, 2000, BRAIN INJURY, V14, P1077
   GIZA CC, 2004, TRAUMATIC BRAIN INJU, P45
   Giza CC, 2001, J ATHL TRAINING, V36, P228
   Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549
   Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280
   Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683
   Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263
   Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P769
   Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352
   Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770
   Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P1
   Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651
   Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961
   Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139
   Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae
   Iverson G.L., 2007, BRAIN INJURY MED PRI, P333
   IVERSON GL, 2004, TRAUMATIC BRAIN INJU, P323
   Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910
   Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934
   JANUSZ JA, 2004, BRIT J SPORT MED, V38, P659
   Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296
   LOVELL MR, 2006, IN PRESS APPL NEUROP
   Lovell MR, 2006, J ATHL TRAINING, V41, P137
   Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723
   Macciocchi SN, 2001, J ATHL TRAINING, V36, P303
   Macciocchi SN, 2005, J ATHL TRAINING, V40, P152
   Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014
   McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556
   McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017
   McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58
   McCrory P, 2005, BRIT J SPORT MED, V39, P196, DOI 10.1136/bjsm.2005.018614
   Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1
   Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736
   Oliaro S, 2001, J ATHL TRAINING, V36, P257
   Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5
   Pellman EJ, 2004, NEUROSURGERY, V55, P1290
   Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62
   Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006
   Piland SG, 2003, J ATHL TRAINING, V38, P104
   Randolph C, 2006, J ATHL TRAINING, V41, P138
   Randolph C, 2005, J ATHL TRAINING, V40, P139
   RANDOLPH C, 2005, J ATHL TRAINING, V40, P153
   Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001
   Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728
   Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
NR 61
TC 34
Z9 35
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1050-642X
J9 CLIN J SPORT MED
JI Clin. J. Sport Med.
PD JAN
PY 2007
VL 17
IS 1
BP 31
EP 37
PG 7
WC Orthopedics; Physiology; Sport Sciences
SC Orthopedics; Physiology; Sport Sciences
GA 128QL
UT WOS:000243673000006
PM 17304003
ER

PT J
AU Clement, O
   Luciani, A
AF Clement, O
   Luciani, A
TI Imaging the lymphatic system: possibilities and clinical applications
SO EUROPEAN RADIOLOGY
LA English
DT Article
DE lymphatic system; magnetic resonance (MR); contrast enhancement;
   computed tomography (CT); lymph node
ID SUPERPARAMAGNETIC IRON-OXIDE; POSITRON-EMISSION-TOMOGRAPHY; COLOR
   DOPPLER SONOGRAPHY; INTERSTITIAL MR LYMPHOGRAPHY; NODE METASTASES;
   BREAST-CANCER; CONTRAST AGENTS; INITIAL-EXPERIENCE; POWER DOPPLER;
   PROSTATE-CANCER
AB The lymphatic system is anatomically complex and difficult to image. Lymph ducts are responsible for the drainage of part of the body's interstitial fluid. Lymph nodes account for the enrichment of lymph fluid, and can be involved in a large variety of diseases, especially cancer. For a long time, lymphatic imaging was limited to the sole use of conventional lymphography involving invasive procedures and patient discomfort. New contrast agents and techniques in ultrasound, nuclear medicine, and MR imaging are now available for imaging of both the lymphatic vessels and the lymph nodes. The objective of this review is to discuss the different imaging modalities of the lymphatic system, with a special focus on the new possibilities of lymphatic imaging including enhanced MR lymphography, sentinel node and positron emission tomography imaging, and contrast-enhanced ultrasound.
C1 Hop Europeen Georges Pompidou, Serv Radiol, F-75908 Paris 15, France.
   Hop Henri Mondor, Serv Radiol, F-94010 Creteil, France.
RP Clement, O (reprint author), Hop Europeen Georges Pompidou, Serv Radiol, 20 Rue Leblanc, F-75908 Paris 15, France.
EM clement@necker.fr
RI CLEMENT, Olivier/D-5221-2014
CR Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598
   Barranger E, 2003, ANN SURG ONCOL, V10, P622, DOI 10.1245/ASO.2003.12.019
   Bellin MF, 1998, RADIOLOGY, V207, P799
   BELLIN MF, 2003, EUR RADIOL, V12, P2688
   CLEMENT O, 1998, ACAD RADIOL S, V5, pS183
   Clement O, 1998, ACAD RADIOL, V5, pS170, DOI 10.1016/S1076-6332(98)80096-2
   Cserni G, 1999, J CLIN PATHOL, V52, P922
   Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H
   Eubank WB, 2001, J CLIN ONCOL, V19, P3516
   Friedberg JW, 2003, ONCOLOGIST, V8, P438, DOI 10.1634/theoncologist.8-5-438
   GUIMARAES R, 1994, AM J ROENTGENOL, V162, P201
   HARIKA L, 1995, MAGNET RESON MED, V33, P88, DOI 10.1002/mrm.1910330113
   Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749
   Harisinghani MG, 1997, JMRI-J MAGN RESON IM, V7, P161, DOI 10.1002/jmri.1880070124
   Hayashi S, 1999, RADIOLOGY, V212, P598
   Hong SP, 2003, YONSEI MED J, V44, P779
   JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B
   JUNG CW, 1995, MAGN RESON IMAGING, V13, P675, DOI 10.1016/0730-725X(95)00023-A
   Konyer NB, 2002, RADIOLOGY, V222, P830, DOI 10.1148/radiol.2223001310
   KRAG DN, 1999, BREAST CANC, V6, P233, DOI 10.1007/BF02967176
   Lin WC, 2003, GYNECOL ONCOL, V89, P73, DOI 10.1016/S0090-8258(03)00058-1
   LUCIANI A, 2004, IN PRESS AM J ROENTG
   McIntire GL, 2000, INVEST RADIOL, V35, P91, DOI 10.1097/00004424-200002000-00001
   Merrigan BA, 1997, BRIT J SURG, V84, P15, DOI 10.1002/bjs.1800840107
   Michel SCA, 2002, RADIOLOGY, V225, P527, DOI 10.1148/radiol.2252011605
   Misselwitz B, 2002, INVEST RADIOL, V37, P146, DOI 10.1097/00004424-200203000-00007
   Moghimi SM, 1999, ADV DRUG DELIVER REV, V37, P295, DOI 10.1016/S0169-409X(98)00099-4
   Moritz JD, 2000, AM J ROENTGENOL, V174, P1279
   MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
   MOSKOVIC E, 1991, BRIT J RADIOL, V64, P422
   Mumtaz H, 1997, AM J ROENTGENOL, V169, P417
   PICARD JD, 1995, LYMPHATIC CIRCULATIO
   Picchio M, 2003, J UROLOGY, V169, P1337, DOI 10.1097/01.ju.0000056901.95996.43
   Rety F, 2000, J MAGN RESON IMAGING, V12, P734, DOI 10.1002/1522-2586(200011)12:5<734::AID-JMRI10>3.0.CO;2-R
   Ruehm SG, 2001, RADIOLOGY, V218, P664
   Ruehm SG, 2001, RADIOLOGY, V220, P816, DOI 10.1148/radiol.2203010090
   Schmid-Wendtner MH, 2002, ARCH DERMATOL, V138, P491, DOI 10.1001/archderm.138.4.491
   Sigal R, 2002, EUR RADIOL, V12, P1104, DOI 10.1007/s003300101130
   Staatz G, 2001, RADIOLOGY, V220, P129
   Steinkamp HJ, 2002, EUR RADIOL, V12, P1785, DOI 10.1007/s003300101111
   Tregnaghi A, 1997, EUR J RADIOL, V24, P216, DOI 10.1016/S0720-048X(96)01102-3
   Uematsu T, 2001, AM J ROENTGENOL, V176, P1069
   VASSALLO P, 1994, RADIOLOGY, V193, P501
   VASSALLO P, 1992, RADIOLOGY, V183, P215
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729
   WEISSLEDER R, 1990, RADIOLOGY, V175, P494
   WEISSLEDER R, 1989, RADIOLOGY, V171, P835
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489
   Whitworth P, 2000, AM J SURG, V180, P262, DOI 10.1016/S0002-9610(00)00465-7
   Williams AD, 2001, AM J ROENTGENOL, V177, P343
   Wisner ER, 2003, INVEST RADIOL, V38, P358, DOI 10.1097/01.rli.0000065423.05038.88
   WISNER ER, 1995, ACAD RADIOL, V2, P405, DOI 10.1016/S1076-6332(05)80343-5
   Witte CL, 2000, RADIOGRAPHICS, V20, P1697
   Witte CL, 1999, INT ANGIOL, V18, P25
   Yang WT, 2001, RADIOLOGY, V220, P795, DOI 10.1148/radiol.2203001545
NR 55
TC 34
Z9 38
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0938-7994
J9 EUR RADIOL
JI Eur. Radiol.
PD AUG
PY 2004
VL 14
IS 8
BP 1498
EP 1507
DI 10.1007/s00330-004-2265-9
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 859OJ
UT WOS:000224277500023
PM 15007613
ER

PT J
AU Mullokandov, E
   Gejerman, G
AF Mullokandov, E
   Gejerman, G
TI Analysis of serial CT scans to assess template and catheter movement in
   prostate HDR brachytherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE HDR; prostate; brachytherapy; catheter displacement
ID DOSE-RATE BRACHYTHERAPY; EXTERNAL-BEAM IRRADIATION; PD-103
   BRACHYTHERAPY; FEASIBILITY REPORT; CANCER; CARCINOMA
AB Purpose: As prostate high-dose-rate (HDR) brachytherapy becomes more prevalent, varying amounts of catheter displacement have been noted. To investigate the constancy of catheter position and its impact on dose distribution, we analyzed serial dosimetric CT scans.
   Methods and Materials: The data from 50 patients were analyzed. During initial CT treatment planning, transverse images of the implant volume were collected, and all structures were digitized into the Nucletron Brachytherapy Planning System. Digitally reconstructed radiographs were generated with rendering of the catheter tips, ischial tuberosity, and perineal template. The distance from each catheter tip to the template and to the ischial tuberosity was measured. The distance between the ischial tuberosity and the template was similarly measured. A second CT set was obtained at different intervals and compared with the first measurement to assess catheter and/or template movement. In 10 patients, the second CT set was obtained before the third fraction in both 2-mm and 5-mm slice sequences, and the latter was used to re-create the HDR plan.
   Results: Although no interfraction catheter movement relative to the template was found, the template-catheter unit moved in a caudal direction between HDR fractions. The amount of displacement was time dependent: 2 mm before the second fraction, 8 mm before the third, and 10 mm before the fourth. When comparing the first HDR treatment with the third, median decreases in the following dosimetric parameters were noted: dose to 90% of the prostate volume, 35% (r = 0-60); minimal dose to the base, 35% (r = 17-65); and maximal dose to 1 cm(3), 13% (r = 3-19%).
   Conclusion: The interstitial catheters did not slip within the template and were not caudally displaced independently but rather in conjunction with the template. The displacement occurred in a time-dependent fashion, and, without redress, significant dosimetric changes are encountered by the third fraction. (C) 2004 Elsevier Inc.
C1 Hackensack Univ, Med Ctr, Dept Radiat Oncol, Hackensack, NJ USA.
RP Mullokandov, E (reprint author), EAGI Consulting Inc, 3118 Fairfield Ave, Bronx, NY 10463 USA.
EM eduard.mullokandov@verizon.net
CR Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   Borghede G, 1997, RADIOTHER ONCOL, V44, P237, DOI 10.1016/S0167-8140(97)00121-7
   Critz FA, 2000, J UROLOGY, V164, P738, DOI 10.1016/S0022-5347(05)67293-X
   Damore SJ, 2000, INT J RADIAT ONCOL, V46, P1205, DOI 10.1016/S0360-3016(99)00477-0
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   Deger S, 2002, EUR UROL, V41, P420, DOI 10.1016/S0302-2838(02)00016-7
   Demanes DJ, 2000, RADIOTHER ONCOL, V57, P289, DOI 10.1016/S0167-8140(00)00291-7
   Galalae RM, 2002, INT J RADIAT ONCOL, V52, P81, DOI 10.1016/S0360-3016(01)01758-8
   Hudson JL, 1999, CHAOS, V9, P1, DOI 10.1063/1.166375
   JEMAL A, 2003, CA CANC J CLIN, V53, P7
   Martinez A, 1995, INT J RADIAT ONCOL, V33, P1019, DOI 10.1016/0360-3016(95)00254-5
   Martinez AA, 2001, INT J RADIAT ONCOL, V49, P61, DOI 10.1016/S0360-3016(00)01463-2
   Martinez AA, 2002, INT J RADIAT ONCOL, V53, P316, DOI 10.1016/S0360-3016(02)02733-5
   Mate TP, 1998, INT J RADIAT ONCOL, V41, P525, DOI 10.1016/S0360-3016(98)00097-2
   Nag S, 2000, Semin Urol Oncol, V18, P133
   Ragde H, 1998, CANCER, V83, P989, DOI 10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q
   Syed A M, 2001, Cancer Control, V8, P511
NR 17
TC 34
Z9 35
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD MAR 15
PY 2004
VL 58
IS 4
BP 1063
EP 1071
DI 10.1016/j.ijrobp.2003.08.020
PG 9
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 801GK
UT WOS:000220084200007
PM 15001246
ER

PT J
AU Hooper, SR
   Alexander, J
   Moore, D
   Sasser, HC
   Laurent, S
   King, J
   Bartel, S
   Callahan, B
AF Hooper, SR
   Alexander, J
   Moore, D
   Sasser, HC
   Laurent, S
   King, J
   Bartel, S
   Callahan, B
TI Caregiver reports of common symptoms in children following a traumatic
   brain injury
SO NEUROREHABILITATION
LA English
DT Article
DE pediatric traumatic brain injury; TBI symptoms; symptom complaints; TBI
   follow-up
ID POSTTRAUMATIC-STRESS-DISORDER; FAMILY MEMBERS; HEAD-TRAUMA; MILD;
   ADOLESCENTS; PREVALENCE; DEPRESSION; ADULTS; SYMPTOMATOLOGY; CONCORDANCE
AB This study describes the common symptoms in children and adolescents following a traumatic brain injury (TBI) as reported by their primary caregivers. Utilizing data from a large-scale state demonstration project, 681 children who had sustained a TBI were ascertained from both Hospital Emergency Departments (n = 409) and Pediatric Inpatient settings (n = 272). The sample ranged in age from infancy to 18 years, was largely male (59.7%), and had equal numbers of Caucasian and minority patients. Most of the participants experienced a mild TBI (83%), with about 5.1% being moderate and 12% severe. Caregivers described the presence of current symptoms (neurological, neurocognitive, behavioral, school problems) using a series of dichotomous questions regarding their child via a structured telephone interview at 1, 4, and 10 months post-injury. Inpatient children were described as manifesting more symptoms at each of the follow-up time points than their ED counterparts. At 1 month inpatients were described as having more symptoms across all 4 domains. At 4 and 10 months, the inpatients were described as having more neurocognitive symptoms and as not returning to school on a full-time basis, with behavior problems approaching significance at the 10-month point. A large number of individuals from both groups also reported persistent symptoms 10 months post-injury including headaches, attention and memory problems, low frustration tolerance, sleep problems, personality changes, and new school problems. Practical implications of these findings for the ongoing management of these children are discussed.
C1 Univ N Carolina, Sch Med, Clin Ctr Study Dev & Learning, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Sch Med, Dept Phys Med & Rehabil, Chapel Hill, NC USA.
   E Carolina Univ, Brody Sch Med, Dept Phys Med & Rehabil, Greenville, NC USA.
   Carolinas HealthCare Syst, R Stuart Dickson Inst Hlth Studies, Charlotte, NC USA.
   Carolinas Med Ctr, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA.
   N Carolina State Div Dev Disabil, Mental Hlth Serv, Raleigh, NC USA.
   N Carolina State Div Dev Disabil, Subst Abuse Serv, Raleigh, NC USA.
RP Hooper, SR (reprint author), Univ N Carolina, Sch Med, Ctr Dev & Learning, CB 7255, Chapel Hill, NC 27599 USA.
EM Stephen.hooper@cdl.unc.edu
CR Alexander J, 2001, N C Med J, V62, P359
   Alexander J, 2001, N C Med J, V62, P344
   Annoni J M, 1992, Disabil Rehabil, V14, P23
   Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23
   Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931
   Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006
   Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081
   *CDCP, 2001, TRAUM BRAIN INJ
   Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006
   Childers MK, 1998, BRAIN INJURY, V12, P613
   Deb S, 1999, AM J PSYCHIAT, V156, P374
   Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899
   DISCALA C, 2003, BRAIN INJURY SOU SPR, P8
   Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943
   Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907
   Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006
   Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861
   HACKL JM, 1986, ANAESTHESIST, V35, P171
   Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019
   HARVEY AG, 1993, J INT NEUROPSYCH SOC, V9, P663
   Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239
   Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114
   Hooper S R, 2001, N C Med J, V62, P350
   HOOPER SR, 2003, BRAIN INJURY SOU SPR, P28
   Junque C, 1997, BRAIN INJURY, V11, P251
   Jury MA, 2001, NEW ZEAL MED J, V114, P286
   Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662
   Kim E, 2002, NEUROREHABILITATION, V17, P297
   Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157
   Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0
   Kreutzer JS, 2001, BRAIN INJURY, V15, P561
   Lash M, 2003, BRAIN INJURY SOU SPR, P20
   LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012
   Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10
   Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752
   Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030
   Masson F, 1996, ARCH PEDIATRIE, V3, P651, DOI 10.1016/0929-693X(96)87085-0
   Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014
   Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013
   Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001
   Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161
   MCCALLISTER TW, 2002, NEUROREHABILITATION, V17, P357
   McDonald BC, 2002, NEUROREHABILITATION, V17, P333
   McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587
   O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507
   Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945
   PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964
   Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066
   Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297
   Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2
   Roberts MA, 1996, BRAIN INJURY, V10, P739, DOI 10.1080/026990596124007
   Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105
   Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467
   Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3
   Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106
   Smith C G, 2001, N C Med J, V62, P328
   Sosin DM, 1996, BRAIN INJURY, V10, P47
   SOSIN DM, 1992, JAMA-J AM MED ASSOC, V268, P291
   SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778
   Thurman D. J., 1995, GUIDELINES SURVEILLA
   VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666
   Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110
   Wade SL, 1996, J LEARN DISABIL, V29, P652
   Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107
   Williams WH, 2002, BRAIN INJURY, V16, P673
   Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026
NR 66
TC 34
Z9 34
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1053-8135
J9 NEUROREHABILITATION
JI Neurorehabilitation
PY 2004
VL 19
IS 3
BP 175
EP 189
PG 15
WC Clinical Neurology; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA 883HU
UT WOS:000226003000002
PM 15502252
ER

PT J
AU Ornstein, DK
   Oh, J
   Herschman, JD
   Andriole, GL
AF Ornstein, DK
   Oh, J
   Herschman, JD
   Andriole, GL
TI Evaluation and management of the man who has failed primary curative
   therapy for prostate cancer
SO UROLOGIC CLINICS OF NORTH AMERICA
LA English
DT Article
ID RADICAL RETROPUBIC PROSTATECTOMY; EXTERNAL-BEAM RADIOTHERAPY;
   ULTRASOUND-GUIDED BIOPSY; TRANS-RECTAL ULTRASOUND; RADIATION-THERAPY;
   ANTIGEN LEVELS; LOCAL RECURRENCE; TRANSRECTAL ULTRASOUND; CRYOSURGICAL
   ABLATION; MONOCLONAL-ANTIBODY
AB The rapid increase in the number of men undergoing potential curative local therapy for prostate cancer has made the evaluation and management of men failing local therapy a common urologic problem. Clinical factors such as tumor grade, pathologic stage, and rate of prostate-specific antigen (PSA) change are important in predicting the site of recurrence. New technologies such as monoclonal antibody scanning may provide helpful diagnostic information. Salvage radiation therapy for men failing radical prostatectomy is relatively well tolerated and reduces PSA to undetectable levels approximately half of the time although later relapse is uncommon. Salvage radical prostatectomy and cryotherapy for men failing external beam radiation are morbid procedures that less frequently result in undetectable PSA levels. The timing or hormonal therapy for men with presumed distant disease recurrence is controversial, as is the optimal form of therapy (such as potency sparing regimens, employing 5-alpha reductase inhibitors and/or anti-androgens, intermittent LHRH agonists, or conventional hormone therapy).
C1 Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA.
   NCI, Urol Oncol Branch, Bethesda, MD 20892 USA.
RP Andriole, GL (reprint author), Washington Univ, Sch Med, Div Urol Surg, 4960 Childrens Pl, St Louis, MO 63110 USA.
CR ABIAAD AS, 1992, J UROLOGY, V147, P952
   Adib RS, 1997, BRIT J UROL, V79, P235
   ALGRA PR, 1991, RADIOGRAPHICS, V11, P219
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   ANDRIOLE G, 1995, UROLOGY, V45, P491, DOI 10.1016/S0090-4295(99)80021-1
   ANDRIOLE GL, 1994, J UROLOGY, V152, P1858
   ANSCHER MS, 1987, J UROLOGY, V138, P1407
   ANSCHER MS, 1995, INT J RADIAT ONCOL, V33, P37, DOI 10.1016/0360-3016(95)00038-Z
   BABAIAN RJ, 1994, J UROLOGY, V152, P1952
   BALES GT, 1995, UROLOGY, V46, P676, DOI 10.1016/S0090-4295(99)80300-8
   BELAND G, 1990, CANCER, V66, P1074
   BERTAGNA C, 1994, BRIT J UROL, V73, P396, DOI 10.1111/j.1464-410X.1994.tb07603.x
   BOCCARDO F, 1993, EUR J CANCER, V29A, P1088, DOI 10.1016/S0959-8049(05)80293-X
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   Brufsky A, 1997, UROLOGY, V49, P913, DOI 10.1016/S0090-4295(97)00091-5
   Burgers J K, 1995, Semin Urol, V13, P103
   Byar D. P., 1988, NATL CANCER I MONOGR, V7, P165
   BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C
   Cadeddu JA, 1998, J UROLOGY, V159, P173, DOI 10.1016/S0022-5347(01)64047-3
   CARIOU G, 1985, UROLOGY, V26, P599, DOI 10.1016/0090-4295(85)90375-9
   CASTELLINO RA, 1991, CANCER, V67, P1219, DOI 10.1002/1097-0142(19910215)67:4+<1219::AID-CNCR2820671518>3.0.CO;2-S
   Caubet JF, 1997, UROLOGY, V49, P71, DOI 10.1016/S0090-4295(96)00325-1
   Coetzee LJ, 1996, UROLOGY, V47, P232, DOI 10.1016/S0090-4295(99)80422-1
   Connolly JA, 1997, UROL CLIN N AM, V24, P415, DOI 10.1016/S0094-0143(05)70388-8
   Connolly JA, 1996, UROLOGY, V47, P225, DOI 10.1016/S0090-4295(99)80421-X
   Crawford E. David, 1997, Journal of Urology, V157, P336
   CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   CROOK J, 1993, INT J RADIAT ONCOL, V27, P31
   DENIS LJ, 1993, UROLOGY, V42, P119, DOI 10.1016/0090-4295(93)90634-M
   Diamandis EP, 1997, UROL CLIN N AM, V24, P275, DOI 10.1016/S0094-0143(05)70373-6
   DUGAN TC, 1991, J UROLOGY, V146, P1313
   Ellis WJ, 1997, UROLOGY, V50, P573, DOI 10.1016/S0090-4295(97)00251-3
   ESCHWEGE P, 1995, LANCET, V346, P1528, DOI 10.1016/S0140-6736(95)92054-4
   Feneley MR, 1996, BRIT J UROL, V77, P373, DOI 10.1046/j.1464-410X.1996.09099.x
   FERGUSON JK, 1994, UROL CLIN N AM, V21, P677
   FIJUTH J, 1992, RADIOTHER ONCOL, V23, P236
   FLESHNER NE, 1995, J UROLOGY, V154, P1542
   Formenti SC, 1996, J UROLOGY, V155, P616, DOI 10.1016/S0022-5347(01)66467-X
   FOSTER LS, 1993, J UROLOGY, V149, P1024
   FRAZIER HA, 1993, J UROLOGY, V149, P516
   FREITAS JE, 1991, J NUCL MED, V32, P1387
   FUJII Y, 1995, BRIT J UROL, V75, P54, DOI 10.1111/j.1464-410X.1995.tb07232.x
   GIBBONS RP, 1986, J UROLOGY, V135, P65
   GOAD JR, 1993, UROL CLIN N AM, V20, P727
   GRAMPAS SA, 1997, UROLOGY, V45, P936
   Haseman MK, 1996, CLIN NUCL MED, V21, P704, DOI 10.1097/00003072-199609000-00007
   HUDSON MA, 1990, J UROLOGY, V143, P1174
   KABALIN JN, 1989, J UROLOGY, V142, P326
   KAPLAN ID, 1993, J UROLOGY, V149, P519
   KAPOOR DA, 1993, UROLOGY, V41, P594, DOI 10.1016/0090-4295(93)90114-P
   KEETCH DW, 1994, J UROLOGY, V151, P1571
   LANGE PH, 1989, J UROLOGY, V141, P873
   LANGE PH, 1990, J UROLOGY, V144, P927
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   LERNER SE, 1995, J UROLOGY, V154, P1103, DOI 10.1016/S0022-5347(01)66988-X
   LIGHTNER DJ, 1990, J UROLOGY, V144, P921
   LuYao GL, 1996, J NATL CANCER I, V88, P166, DOI 10.1093/jnci/88.3-4.166
   LUYAO GL, 1993, JAMA-J AM MED ASSOC, V269, P2633, DOI 10.1001/jama.269.20.2633
   MCCARTHY JF, 1994, J UROLOGY, V151, P1575
   Miller RJ, 1996, CANCER, V77, P1510, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1510::AID-CNCR13>3.0.CO;2-2
   MORGAN WR, 1991, J UROLOGY, V145, P319
   MUKAMEL E, 1986, J UROLOGY, V136, P1231
   NASSERI KK, 1997, AUA UPDATE SERIES, V16, P32
   Newcomer LM, 1997, J UROLOGY, V158, P1427, DOI 10.1016/S0022-5347(01)64231-9
   Norberg M, 1997, UROLOGY, V50, P562, DOI 10.1016/S0090-4295(97)00306-3
   Ornstein DK, 1996, UROLOGY, V48, P901, DOI 10.1016/S0090-4295(96)00315-9
   ORNSTEIN DK, IN PRESS UROLOGY
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5
   PARTIN AW, 1994, J UROLOGY, V152, P1358
   Pisters LL, 1997, J UROLOGY, V157, P921, DOI 10.1016/S0022-5347(01)65084-5
   PONTES JE, 1993, CANCER, V71, P976, DOI 10.1002/1097-0142(19930201)71:3+<976::AID-CNCR2820711413>3.0.CO;2-M
   Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4
   ROGERS E, 1995, J UROLOGY, V153, P104, DOI 10.1097/00005392-199501000-00037
   Scardino PT, 1988, NATL CANCER I MONOGR, V7, P95
   SCHELLHAMMER PF, 1993, UROLOGY, V42, P13, DOI 10.1016/0090-4295(93)90325-5
   SCHILD SE, 1994, MAYO CLIN PROC, V69, P613
   Shinohara K, 1997, J UROLOGY, V158, P2206, DOI 10.1016/S0022-5347(01)68198-9
   STAMEY TA, 1993, J UROLOGY, V150, P1856
   STAMEY TA, 1993, J UROLOGY, V149, P787
   TAKAYAMA TK, 1992, J UROLOGY, V148, P1541
   Thompson I M, 1997, Oncology (Williston Park), V11, P1109
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   TURNER JW, 1993, J UROLOGY, V149, P1482
   vanIersel MP, 1996, BRIT J UROL, V77, P418, DOI 10.1046/j.1464-410X.1996.91017.x
   WASSERMAN NF, 1992, RADIOLOGY, V185, P367
   Witherspoon LR, 1997, BRIT J UROL, V79, P82
   WU JJ, 1995, INT J RADIAT ONCOL, V32, P317, DOI 10.1016/0360-3016(95)00083-B
   Yu H, 1997, J UROLOGY, V157, P913, DOI 10.1016/S0022-5347(01)65082-1
   YU H, 1995, CLIN CHEM, V41, P430
   ZAGARS GK, 1993, CANCER, V72, P832, DOI 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6
   ZAGARS GK, 1993, INT J RADIAT ONCOL, V27, P39
   ZIETMAN AL, 1993, UROLOGY, V42, P292, DOI 10.1016/0090-4295(93)90618-K
NR 94
TC 34
Z9 34
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0094-0143
J9 UROL CLIN N AM
JI Urol. Clin. N. Am.
PD NOV
PY 1998
VL 25
IS 4
BP 591
EP +
DI 10.1016/S0094-0143(05)70050-1
PG 12
WC Urology & Nephrology
SC Urology & Nephrology
GA 136QV
UT WOS:000076871400006
PM 10026768
ER

PT J
AU Sahin, S
   Yapici, H
AF Sahin, S
   Yapici, H
TI Rejuvenation of light water reactor spent fuel in fusion blankets
SO ANNALS OF NUCLEAR ENERGY
LA English
DT Article
ID THO2 HYBRID BLANKET; PRELIMINARY DESIGN; HYLIFE-II; DRIVEN; FISSION;
   ACTINIDES; TRANSMUTATION
AB The possibility of spent nuclear fuel rejuvenation in fusion reactors is investigated for both (D,T) and catalysed (D,D) modes. The analysis is conducted for light water reactor (LWR) spent nuclear fuel which was used up to a total enrichment grade (fissionable plutonium plus U-235) Of 2.174% The behaviour of the spent fuel is observed during 48 months for discrete time intervals of Delta t = 6 months. The cooling of the fissile fuel zone is considered with three different coolants, namely pressurized helium ('gas'), Flibe (Li2BeF4) ('molten salt') and natural lithium ('liquid metal'). The best rejuvenation performance is obtained with Flibe, followed by helium and natural lithium. The catalysed (D,D) mode has a better rejuvenation capability than the conventional (D,T) mode. A rejuvenation time of 12 months is evaluated for a final fissile fuel enrichment grade of around 3.5% with Flibe coolant in the fissile zone under a first-wall fusion neutron current load of 10(14) (2.45 MeV n cm(-2) s) and 10(14) (14, 1 MeV n cm(-2) s), corresponding to 2.64 MW m(-2) by a plant factor of 75% for the catalysed (D,D) fusion reactor mode. The rejuvenation time increases to 24 months for the same fissile fuel enrichment grade using the (D,T) fusion reactor mode under a first-wall fusion neutron current load of 10(14) (2.45 MeV n cm-2 s), corresponding to 2.25 MWm(-2) by a plant factor of 75%. This enrichment would be sufficient for reutilization in a LWR. Longer rejuvenation periods (up to 48 months) increase the fissile fuel enrichment level of the LWR spent fuel to much higher degrees (> 5% for gas coolant and > 7% for Flibe), opening possibilities for reutilization of the spent fuel in compact LWRs and in multiple cycles. Although the nuclear quality of the plutonium increases steadily during rejuvenation, the isotopic percentages of Pu-239 and Pu-240 remain < 70% and > 20%, respectively, during spent fuel rejuvenation, so that the plutonium component cannot be considered of nuclear weapon grade quality. This is a positive factor with regard to safeguarding. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Gazi Univ, Teknik Egitim Fak, Ankara, Turkey.
   Erciyes Univ, Muhendislik Fak, Kayseri, Turkey.
RP Sahin, S (reprint author), Gazi Univ, Teknik Egitim Fak, Ankara, Turkey.
RI SAHIN, Sumer/C-6252-2013
OI SAHIN, Sumer/0000-0003-2844-8061
CR ALKUSAYER TA, 1988, RAD SHIELDING INFORM
   ARTHUR ED, 1991, FUSION TECHNOL, V20, P641
   BARRETT J, 1979, LA7808MS LOS AL SCI
   BASOV NG, 1992, FUSION TECHNOL, V22, P350
   BERWALD DH, 1979, NUCL TECHNOL, V42, P34
   BLINK JA, 1985, UCRL53559 L LIV NAT
   CAPPIELLO MW, 1991, FUSION TECHNOL, V20, P648
   DONCALS RA, 1979, T AM NUCL SOC, V33, P445
   ENGLE WW, 1970, ANISN 1 DIMENSIONAL
   ERICKSON K, 1981, NUCL TECHNOL-FUSION, V1, P533
   GREENSPAN E, 1984, ADV NUCLEAR SCI TECH, V16, P289
   GREENSPAN E, 1983, NUCL TECHNOL-FUSION, V3, P485
   HEISINGGOODMAN CD, 1979, T AM NUCL SOC, V33, P446
   JAEGER RG, 1968, SHIELDING FUNDAMENTA, P1
   Jassby D. L., 1986, Journal of Fusion Energy, V5, DOI 10.1007/BF01050617
   KONASHI K, 1991, FUSION TECHNOL, V20, P664
   Ledergerber G, 1996, NUCL TECHNOL, V114, P194
   LEE JD, 1978, P 3 TOP M TECHN CONT, V1, P219
   LEE JD, 1994, FUSION TECHNOL, V26, P74
   LEGGERTT D, 1987, P INT C FAST BREED S
   MACFARLANE RE, 1993, TRANSX 2 CODE INTERF
   MEYER W, 1977, NUCL SAFETY, V18, P427
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   MYNATT FR, 1977, P INF M ACC BREED UP
   Perlado M., 1995, ENERGY INERTIAL FUSI, P272
   Prunier C, 1997, NUCL TECHNOL, V119, P141
   SAHIN S, 1994, FUSION TECHNOL, V26, P1311
   SAHIN S, 1986, FUSION TECHNOL, V10, P1297
   Sahin S., 1989, Transactions of the American Nuclear Society, V59
   SAHIN S, 1986, P 4 INT C EM NUCL EN, P59
   Sahin S., 1987, Transactions of the American Nuclear Society, V54
   SAHIN S, 1989, FUSION TECHNOL, V15, P37
   Sahin S, 1996, FUSION TECHNOL, V30, P1027
   SAHIN S, 1998, UNPUB FUSION TECHNOL
   SAHIN S, 1984, NUCL TECHNOL-FUSION, V5, P374
   SAHIN S, 1982, NUCL TECHNOL, V58, P354
   Sahin S., 1983, 6th Miami International Conference on Alternative Energy Sources. Proceedings of Condensed Papers
   SAHIN S, 1980, NUCL TECHNOL, V50, P88
   SAHIN S, 1987, FUSION TECHNOL, V12, P395
   SAHIN S, 1980, NUCL TECHNOL, V54, P431
   SAHIN S, 1981, ATOMKERNENERG/KERNT, V39, P41
   SAHIN S, 1985, ATOMKERNENERG/KERNT, V46, P45
   SAHIN S, 1986, FUSION TECHNOL, V10, P84
   SAHIN S, 1990, NUCL TECHNOL, V92, P93
   SAHIN S, 1998, IN PRESS FUSION TECH
   SAHIN S, 1985, ATOMKERNENERG/KERNT, V47, P259
   SAHIN S, 1989, FUSION TECHNOL, V16, P331
   Sahin S., 1989, Transactions of the American Nuclear Society, V60
   SAHIN S, 1991, FUSION TECHNOL, V20, P26
   Smith D.L., 1984, ANLFPP841
   TAKADA H, 1991, FUSION TECHNOL, V20, P673
   TAKAHASHI H, 1991, FUSION TECHNOL, V20, P657
   TAKAHASHI H, 1984, ATOMKERNENERG/KERNT, V44, P181
   TODOSOW M, 1991, FUSION TECHNOL, V20, P678
   WALTER E, 1988, NUCL SAFETY, V29, P125
NR 55
TC 34
Z9 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4549
J9 ANN NUCL ENERGY
JI Ann. Nucl. Energy
PD NOV
PY 1998
VL 25
IS 16
BP 1317
EP 1339
DI 10.1016/S0306-4549(98)00018-8
PG 23
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 102JV
UT WOS:000074921800003
ER

PT J
AU Schellhammer, P
   Cockett, A
   BocconGibod, L
   Gospodarowicz, M
   Krongrad, A
   Thompson, IM
   Scardino, P
   Soloway, M
   Adolfsson, J
AF Schellhammer, P
   Cockett, A
   BocconGibod, L
   Gospodarowicz, M
   Krongrad, A
   Thompson, IM
   Scardino, P
   Soloway, M
   Adolfsson, J
TI Assessment of endpoints for clinical trials for localized prostate
   cancer
SO UROLOGY
LA English
DT Article
ID DIGITAL RECTAL EXAMINATION; RADICAL RETROPUBIC PROSTATECTOMY; DEFINITIVE
   RADIATION-THERAPY; ULTRASOUND-GUIDED BIOPSY; TRANSRECTAL ULTRASOUND;
   NEEDLE-BIOPSY; ANTIGEN; RADIOTHERAPY; RECURRENCE; PATTERNS
AB Objectives. The AUA Practice Guidelines Panel convened to address the issue of appropriate endpoints for assessment of treatment modalities for localized carcinoma of the prostate.
   Methods. A review of the literature and the design of existing clinical trials produced a consensus, which was presented to and critiqued by the members of the general conference.
   Results. The pitfalls associated with identification of local failure endpoints were discussed, and the more accurate endpoints of freedom from metastatic progression and overall survival were recognized. The strict definition that must be fulfilled for intermediate endpoints to become surrogates for metastasis free and/or survival endpoints was stressed. For more efficient and rapid conduct of future clinical trials, the urgent need to validate such surrogate endpoints by evaluation in randomized control trials is obvious. PSA, while an indicator of disease activity and a critical marker for estimating disease progression or regression in response to therapy, is not a surrogate for metastasis free or overall survival.
   Conclusion. Until surrogate endpoints are validated, the committee has evaluated the endpoints in current use, reviewed their limitations, and stressed the importance of quality-of-life assessment together with the traditional endpoint assessment. (C) 1997 by Elsevier Science Inc.
C1 EASTERN VIRGINIA MED SCH, DEPT UROL, NORFOLK, VA 23501 USA.
   SENTARA CANC INST, CTR UROL ONCOL, NORFOLK, VA USA.
   UNIV ROCHESTER, SCH MED, DEPT UROL, ROCHESTER, NY USA.
   HOP BIRCHAT, DEPT UROL, PARIS, FRANCE.
   UNIV MIAMI, SCH MED, MIAMI, FL USA.
   PRINCESS MARGARET HOSP, ONTARIO CANC INST, TORONTO, ON, CANADA.
   VET AFFAIRS MED CTR, UROL SECT, MIAMI, FL 33125 USA.
   BROOKE ARMY MED CTR, UROL SERV, FT SAM HOUSTON, TX 78234 USA.
   BAYLOR COLL MED, SCOTT DEPT UROL, HOUSTON, TX 77030 USA.
   KAROLINSKA HOSP, DEPT UROL, S-10401 STOCKHOLM, SWEDEN.
CR ABIAAD AS, 1992, J UROLOGY, V147, P952
   ADOLFSSON J, 1993, CANCER, V72, P310, DOI 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T
   ALBERTSEN PC, 1995, JAMA-J AM MED ASSOC, V274, P626, DOI 10.1001/jama.274.8.626
   Angulo J C, 1995, Urol Oncol, V1, P199, DOI 10.1016/1078-1439(95)00066-6
   BABAIAN RJ, 1995, CANCER, V75, P2153, DOI 10.1002/1097-0142(19950415)75:8<2153::AID-CNCR2820750819>3.0.CO;2-G
   Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637
   BOSTWICK DG, 1982, AM J SURG PATHOL, V6, P541, DOI 10.1097/00000478-198209000-00006
   BOYLE P, 1995, UROLOGY, V46, P47, DOI 10.1016/S0090-4295(99)80250-7
   BROWN BW, 1993, J NATL CANCER I, V85, P979, DOI 10.1093/jnci/85.12.979
   BYAR DP, 1986, PROUTS NECK C PROST
   Catalona William J., 1995, JAMA (Journal of the American Medical Association), V274, P1214, DOI 10.1001/jama.274.15.1214
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   CHODAK GW, 1989, J UROLOGY, V141, P1136
   Clark Joseph, 1995, Journal of Urology, V153, p252A
   Connolly JA, 1996, UROLOGY, V47, P225, DOI 10.1016/S0090-4295(99)80421-X
   COX DR, 1972, J R STAT SOC B, V34, P187
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   CROOK J, 1996, CANADIAN J UROLOGY, V3, P46
   DILLIOGLUGIL O, 1995, CANCER, V76, P2530
   EGAWA S, 1992, UROLOGY, V39, P358, DOI 10.1016/0090-4295(92)90213-G
   EISENBERGER MA, 1996, JNCI, V88
   ELLENBERG SS, 1989, STAT MED, V8, P405, DOI 10.1002/sim.4780080404
   EPSTEIN JI, 1993, CANCER, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y
   FERGUSON JK, 1994, UROL CLIN N AM, V21, P677
   FLANIGAN RC, 1994, J UROLOGY, V152, P1506
   Flanigan RC, 1996, UROLOGY, V48, P428, DOI 10.1016/S0090-4295(96)00161-6
   Fleming Craig, 1993, JAMA (Journal of the American Medical Association), V269, P2650, DOI 10.1001/jama.269.20.2650
   FLEMING TR, 1994, STAT MED, V13, P1423, DOI 10.1002/sim.4780131318
   FORMAN JD, 1993, PROSTATE, V23, P235, DOI 10.1002/pros.2990230306
   FOSTER LS, 1993, J UROLOGY, V149, P1024
   GOLDENBERG SL, 1994, J UROLOGY, V152, P1506
   GROB BM, 1994, UROLOGY, V44, P525, DOI 10.1016/S0090-4295(94)80051-0
   Iversen P, 1995, Scand J Urol Nephrol Suppl, V172, P65
   KABALIN JN, 1989, J UROLOGY, V142, P326
   KABALIN JN, 1995, UROLOGY, V46, P603, DOI 10.1016/S0090-4295(99)80284-2
   KAHN D, 1994, J UROLOGY, V152, P1490
   KAVADI V, 1994, INT J RADIAT ONCOL, V30, P270
   KEETCH DW, 1996, MONOGR UROL, V17, P31
   Konety B R, 1996, Urol Oncol, V2, P14, DOI 10.1016/1078-1439(96)00029-4
   Krongrad A, 1996, J UROLOGY, V156, P1084, DOI 10.1016/S0022-5347(01)65710-0
   LUBITZ J, 1995, NEW ENGL J MED, V332, P999, DOI 10.1056/NEJM199504133321506
   LUYAO GL, 1993, JAMA-J AM MED ASSOC, V269, P2633, DOI 10.1001/jama.269.20.2633
   LUYAO GL, 1994, LANCET, V343, P251, DOI 10.1016/S0140-6736(94)91109-6
   MANTON KG, 1991, J GERONTOL, V46, pS225
   MIDDLETON RG, 1995, J UROLOGY, V154, P2144, DOI 10.1016/S0022-5347(01)66718-1
   MILLER EB, 1993, UROLOGY, V41, P311
   MOINPOUR CM, 1989, J NATL CANCER I, V81, P485, DOI 10.1093/jnci/81.7.485
   OEFELEIN MG, 1995, J UROLOGY, V154, P2128, DOI 10.1016/S0022-5347(01)66713-2
   Parker SL, 1996, CA-CANCER J CLIN, V46, P5, DOI 10.3322/canjclin.46.1.5
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   PARTIN AW, 1994, J UROLOGY, V151, P1583
   PAULSON DF, 1982, J UROLOGY, V128, P502
   PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O
   PRENTICE RL, 1972, J ROY STAT SOC, V34, P187
   SCHELLHAMMER PF, 1990, UROL CLIN N AM, V17, P835
   SCHMIDT JD, 1986, J UROLOGY, V136, P416
   Seckin B, 1996, WORLD J UROL, V14, pS26
   SMITH DS, 1995, UROLOGY, V45, P70, DOI 10.1016/S0090-4295(95)96812-1
   SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y
   STAMEY TA, 1993, J UROLOGY, V150, P1856
   STEIN A, 1992, J UROLOGY, V147, P942
   Steineck G, 1991, Scand J Urol Nephrol Suppl, V138, P121
   SVETEC D, P 1996 VAL COL SEPT
   *SWOG 9450, 407 CSP SWOG 9450
   TERRIS MK, 1991, J UROLOGY, V146, P78
   Thalmann GN, 1996, J NATL CANCER I, V88, P794, DOI 10.1093/jnci/88.12.794
   The CAST Investigators, 1989, NEW ENGL J MED, V321, P406
   THOMPSON IM, 1984, J UROLOGY, V132, P690
   Tibbs M. K., 1995, International Journal of Radiation Oncology Biology Physics, V32, P230, DOI 10.1016/0360-3016(95)97841-N
   WASSERMAN NF, 1992, RADIOLOGY, V185, P361
   Wasson J H, 1993, Arch Fam Med, V2, P487, DOI 10.1001/archfami.2.5.487
   WILLETT CG, 1994, J UROLOGY, V151, P1579
   YANCIK R, 1994, CANCER, V74, P1995, DOI 10.1002/1097-0142(19941001)74:7+<1995::AID-CNCR2820741702>3.0.CO;2-Y
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   ZELEFSKY MJ, 1995, J CLIN ONCOL, V13, P459
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
   ZIETMAN AL, 1993, CANCER, V71, P959, DOI 10.1002/1097-0142(19930201)71:3+<959::AID-CNCR2820711411>3.0.CO;2-L
NR 78
TC 34
Z9 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-4295
EI 1527-9995
J9 UROLOGY
JI Urology
PD APR
PY 1997
VL 49
IS 4A
SU S
BP 27
EP 38
DI 10.1016/S0090-4295(99)80321-5
PG 12
WC Urology & Nephrology
SC Urology & Nephrology
GA WU208
UT WOS:A1997WU20800004
PM 9111612
ER

PT J
AU JOHNS, JA
   FISH, FA
   BURGER, JD
   HAMMON, JW
AF JOHNS, JA
   FISH, FA
   BURGER, JD
   HAMMON, JW
TI STEROID-ELUTING EPICARDIAL PACING LEADS IN PEDIATRIC-PATIENTS -
   ENCOURAGING EARLY RESULTS
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID CONGENITAL HEART-DISEASE; TERM FOLLOW-UP; PACEMAKER LEADS; YOUNG-ADULTS;
   MUSTARD OPERATION; SUTURE-TYPE; EXIT BLOCK; CHILDREN; ELECTRODES;
   EXPERIENCE
AB Objectives. This study evaluated the pacing and sensing characteristics of a new porous-tipped steroid-eluting epicardial lead in a group of pediatric patients.
   Background. Pacing in children may be complicated by small patient size, patient growth and the prevalence of structural congenital heart disease in children requiring pacing. Epicardial pacing has been associated with a high incidence of problems with sensing and capture, prompting the use of transvenous endocardial pacing when possible. In some children, epicardial pacing may still be desirable because of small patient size, potential for caval obstruction, previous cardiac surgery limiting transvenous access to the heart, or the need to repair congenital heart disease at the time of pacemaker insertion.
   Methods. Twelve patients aged 3 weeks to 18 years underwent placement of 23 epicardial pacing leads (8 atrial, 15 ventricular). Pulse width thresholds, sensing thresholds and lead impedance were measured weekly for 6 weeks, then at 3, 6, 12 and 18 months after pacemaker implantation. The median duration of follow-up was 12 months.
   Results. Ventricular pulse width thresholds did not change over time, whereas atrial pulse width thresholds improved significantly. At 6 months, the mean pulse width threshold at 2.5 V for the atrial and ventricular leads was 0.10 +/- 0.03 and 0.19 +/-0.09 ms, respectively. The thresholds were slightly lower at 12 and 18 months. At the most recent follow-up, all atrial leads sensed appropriately at 2.5 mV and all ventricular leads at 5 mV.
   Conclusions. These encouraging early results suggest that steroid-eluting epicardial pacing leads may be an attractive option for children needing epicardial pacing. Their excellent pacing and sensing characteristics may allow reliable dual-chamber pacing in infants who are too small for transvenous pacing.
C1 VANDERBILT UNIV,MED CTR,SCH MED,DEPT CARDIAC & THORAC SURG,NASHVILLE,TN 37232.
RP JOHNS, JA (reprint author), VANDERBILT UNIV,MED CTR,SCH MED,DIV PEDIAT CARDIOL,D-2217 MED CTR N,NASHVILLE,TN 37232, USA.
CR BEDER SD, 1985, AM HEART J, V109, P152, DOI 10.1016/0002-8703(85)90427-2
   BENDITT DG, 1989, INT J CARDIOL, V22, P67, DOI 10.1016/0167-5273(89)90137-X
   BENREY J, 1976, CIRCULATION, V53, P245
   BOGNOLO D, 1983, PACE, V6, P113, DOI 10.1111/j.1540-8159.1983.tb06588.x
   BREWER G, 1988, PACE, V11, P1760, DOI 10.1111/j.1540-8159.1988.tb06307.x
   CASE CL, 1990, PACE, V13, P571, DOI 10.1111/j.1540-8159.1990.tb02069.x
   DELEON SY, 1982, ANN THORAC SURG, V33, P273
   DELEON SY, 1990, J THORAC CARDIOV SUR, V99, P905
   DODINOT B, 1988, ARCH MAL COEUR VAISS, V81, P673
   Dohrmann M L, 1985, Cardiol Clin, V3, P527
   ECTOR H, 1985, BRIT HEART J, V53, P541
   ENNKER J, 1985, INT J CARDIOL, V8, P125, DOI 10.1016/0167-5273(85)90278-5
   EPSTEIN ML, 1986, AM J CARDIOL, V57, P889, DOI 10.1016/0002-9149(86)90639-9
   EPSTEIN ML, 1983, CARDIOLOGY, V70, P247, DOI 10.1159/000173601
   FUKUSHIGE J, 1991, PACE, V14, P546, DOI 10.1111/j.1540-8159.1991.tb02827.x
   GILLETTE PC, 1983, AM HEART J, V105, P843, DOI 10.1016/0002-8703(83)90250-8
   GILLETTE PC, 1985, PACE, V8, P94, DOI 10.1111/j.1540-8159.1985.tb05728.x
   GILLETTE PC, 1988, PACE, V11, P1935, DOI 10.1111/j.1540-8159.1988.tb06331.x
   GILLETTE PC, 1987, J AM COLL CARDIOL, V9, P811
   GOLDMAN BS, 1985, PACE, V8, P732, DOI 10.1111/j.1540-8159.1985.tb05885.x
   GRAHAM TP, 1982, PEDIATR CARDIOL, V2, P203, DOI 10.1007/BF02332111
   HAYES DL, 1983, J THORAC CARDIOV SUR, V85, P618
   HENGLEIN D, 1984, PACE, V7, P203, DOI 10.1111/j.1540-8159.1984.tb04887.x
   JIMENEZ M, 1988, ARCH MAL COEUR VAISS, V81, P665
   KARPAWICH PP, 1990, AM HEART J, V119, P1077, DOI 10.1016/S0002-8703(05)80237-6
   KARPAWICH PP, 1991, AM J CARDIOL, V68, P423
   KARPAWICH PP, 1988, PACE, V11, P1139, DOI 10.1111/j.1540-8159.1988.tb03965.x
   KING DH, 1983, AM HEART J, V106, P1438, DOI 10.1016/0002-8703(83)90060-1
   KLEIN HH, 1990, PACE, V13, P134, DOI 10.1111/j.1540-8159.1990.tb05061.x
   KRON IL, 1985, ANN THORAC SURG, V39, P112
   KRUSE IM, 1986, PACE, V9, P1217, DOI 10.1111/j.1540-8159.1986.tb06697.x
   KUGLER J, 1988, PACE, V11, P2216, DOI 10.1111/j.1540-8159.1988.tb05988.x
   KUGLER JD, 1989, AM HEART J, V117, P665, DOI 10.1016/0002-8703(89)90743-6
   KUGLER JD, 1990, PACE, V13, P976, DOI 10.1111/j.1540-8159.1990.tb02143.x
   MCGRATH LB, 1988, PACE, V11, P1182, DOI 10.1111/j.1540-8159.1988.tb03970.x
   MICHALIK RE, 1984, PACE, V7, P831, DOI 10.1111/j.1540-8159.1984.tb05624.x
   MILLER JD, 1989, AM J CARDIOL, V64, P1052, DOI 10.1016/0002-9149(89)90810-2
   MOND H, 1988, PACE, V11, P214, DOI 10.1111/j.1540-8159.1988.tb04543.x
   OTT DJ, 1986, POLYPOID DIS COLON, P63
   PARK SC, 1983, AM J CARDIOL, V51, P1514, DOI 10.1016/0002-9149(83)90668-9
   PIRZADA FA, 1988, PACE, V11, P1739, DOI 10.1111/j.1540-8159.1988.tb06304.x
   RADOVSKY AS, 1988, PACE, V11, P1085, DOI 10.1111/j.1540-8159.1988.tb03955.x
   SERWER GA, 1987, AM J CARDIOL, V59, P824, DOI 10.1016/0002-9149(87)91099-X
   SERWER GA, 1988, AM J CARDIOL, V61, P104, DOI 10.1016/0002-9149(88)91313-6
   SHAHAR E, 1984, EUR HEART J, V5, P829
   SILKA MJ, 1990, AM J CARDIOL, V65, P488, DOI 10.1016/0002-9149(90)90816-J
   SIMON AB, 1982, PACE, V5, P836, DOI 10.1111/j.1540-8159.1982.tb06565.x
   SPOTNITZ HM, 1990, ANN THORAC SURG, V49, P495
   STOKES KB, 1988, PACE, V11, P1797, DOI 10.1111/j.1540-8159.1988.tb06312.x
   TALIERCIO CP, 1985, J THORAC CARDIOV SUR, V90, P414
   TILL JA, 1990, PACE, V13, P1385, DOI 10.1111/j.1540-8159.1990.tb04013.x
   VANETTI A, 1984, ARCH MAL COEUR VAISS, V77, P1510
   WAELKENS JJJ, 1982, PEDIATR CARDIOL, V3, P337, DOI 10.1007/BF02427037
   WALSH CA, 1988, PACE, V11, P1940, DOI 10.1111/j.1540-8159.1988.tb06332.x
   WAMPLER DG, 1983, AM J DIS CHILD, V137, P1098
   WARD DE, 1987, INT J CARDIOL, V15, P112, DOI 10.1016/0167-5273(87)90299-3
   WISH M, 1990, PACE, V13, P1887, DOI 10.1111/j.1540-8159.1990.tb06910.x
   YABEK SM, 1990, PACE, V13, P2108, DOI 10.1111/j.1540-8159.1990.tb06952.x
   ZEIGLER VL, 1990, PACE, V13, P2104, DOI 10.1111/j.1540-8159.1990.tb06951.x
NR 59
TC 34
Z9 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD AUG
PY 1992
VL 20
IS 2
BP 395
EP 401
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JG375
UT WOS:A1992JG37500020
PM 1634677
ER

PT J
AU BOVE, EL
   KOHMAN, L
   SEREIKA, S
   BYRUM, CJ
   KAVEY, REW
   BLACKMAN, MS
   SONDHEIMER, HM
   ROSENTHAL, A
AF BOVE, EL
   KOHMAN, L
   SEREIKA, S
   BYRUM, CJ
   KAVEY, REW
   BLACKMAN, MS
   SONDHEIMER, HM
   ROSENTHAL, A
TI THE MODIFIED BLALOCK-TAUSSIG SHUNT - ANALYSIS OF ADEQUACY AND DURATION
   OF PALLIATION
SO CIRCULATION
LA English
DT Article
C1 UNIV MICHIGAN,CS MOTT CHILDRENS HOSP,DIV PEDIAT CARDIOL,ANN ARBOR,MI 48109.
   UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109.
   SUNY SYRACUSE,HLTH SCI CTR,SYRACUSE,NY.
RP BOVE, EL (reprint author), UNIV MICHIGAN,CS MOTT CHILDRENS HOSP,TAUBMAN HLTH CARE CTR,DIV THORAC SURG,1500 E MED CTR DR,ANN ARBOR,MI 48109, USA.
CR MCKAY R, 1980, ANN THORAC SURG, V30, P137
   ARCINIEGAS E, 1982, J THORAC CARDIOV SUR, V84, P88
   BLALOCK A, 1945, JAMA-J AM MED ASSOC, V128, P189
   BOVE EL, 1984, ANN THORAC SURG, V37, P88
   BOVE EL, 1984, AM HEART J, V108, P366, DOI 10.1016/0002-8703(84)90626-4
   COX DR, 1972, J R STAT SOC B, V34, P187
   DELEVAL MR, 1981, J THORAC CARDIOV SUR, V81, P112
   DIBENEDETTO G, 1981, THORAC CARDIOV SURG, V29, P143, DOI 10.1055/s-2007-1023464
   EDMUNDS LH, 1980, CIRCULATION, V62, P597
   GUYTON RA, 1983, J THORAC CARDIOV SUR, V85, P917
   ILBAWI M N, 1984, Journal of Thoracic and Cardiovascular Surgery, V88, P770
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KARPAWICH PP, 1985, J THORAC CARDIOV SUR, V89, P275
   KAY PH, 1983, BRIT HEART J, V49, P359
   LAMBERTI JJ, 1984, J THORAC CARDIOV SUR, V88, P76
   LEBLANC J, 1984, J THORAC CARDIOV SUR, V88, P259
   MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
   MOULTON AL, 1985, CIRCULATION, V72, P35
   UEDA K, 1984, AM J CARDIOL, V54, P1296, DOI 10.1016/S0002-9149(84)80085-5
   WOOLF PK, 1984, ANN THORAC SURG, V38, P26
   YOKOTA M, 1985, J THORAC CARDIOV SUR, V90, P399
NR 21
TC 34
Z9 34
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP
PY 1987
VL 76
IS 3
SU S
BP 19
EP 23
PG 5
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA J9065
UT WOS:A1987J906500004
ER

PT J
AU MIETUSSNYDER, M
   LANG, P
   MAYER, JE
   JONES, RA
   CASTANEDA, AR
   LOCK, JE
AF MIETUSSNYDER, M
   LANG, P
   MAYER, JE
   JONES, RA
   CASTANEDA, AR
   LOCK, JE
TI CHILDHOOD SYSTEMIC-PULMONARY SHUNTS - SUBSEQUENT SUITABILITY FOR FONTAN
   OPERATION
SO CIRCULATION
LA English
DT Article
C1 CHILDRENS HOSP MED CTR,DEPT CARDIOVASC SURG,BOSTON,MA 02115.
   HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115.
   HARVARD UNIV,SCH MED,DEPT SURG,BOSTON,MA 02115.
RP MIETUSSNYDER, M (reprint author), CHILDRENS HOSP MED CTR,DEPT CARDIOL,300 LONGWOOD AVE,BOSTON,MA 02115, USA.
CR BOVE EL, 1986, CIRCULATION, V74, P49
   Choussat A, 1978, PEDIAT CARDIOLOGY, P559
   CLEVELAND DC, 1984, ANN THORAC SURG, V38, P447
   CRUPI G, 1979, THORAX, V34, P290, DOI 10.1136/thx.34.3.290
   DICK M, 1975, AM J CARDIOL, V36, P327, DOI 10.1016/0002-9149(75)90484-1
   FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240
   FONTAN F, 1983, J THORAC CARDIOV SUR, V85, P647
   GUYTON RA, 1983, J THORAC CARDIOV SUR, V85, P917
   ISHIKAWA T, 1984, J THORAC CARDIOV SUR, V88, P373
   LAKS H, 1984, J THORAC CARDIOV SUR, V88, P939
   LAMBERTI JJ, 1984, J THORAC CARDIOV SUR, V88, P76
   MAYER JE, 1986, J THORAC CARDIOV SUR, V92, P1021
   MOODIE DS, 1984, AM J CARDIOL, V53, P1124, DOI 10.1016/0002-9149(84)90648-9
   NEWFELD EA, 1977, AM J CARDIOL, V39, P715, DOI 10.1016/S0002-9149(77)80134-3
   STEFANELLI G, 1984, AM J CARDIOL, V54, P812
   TAY DJ, 1974, CIRCULATION, V50, P220
NR 16
TC 34
Z9 34
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP
PY 1987
VL 76
IS 3
SU S
BP 39
EP 44
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA J9065
UT WOS:A1987J906500008
ER

PT J
AU MOULTON, AL
   BRENNER, JI
   RINGEL, R
   NORDENBERG, A
   BERMAN, MA
   ALI, S
   BURNS, J
AF MOULTON, AL
   BRENNER, JI
   RINGEL, R
   NORDENBERG, A
   BERMAN, MA
   ALI, S
   BURNS, J
TI CLASSIC VERSUS MODIFIED BLALOCK-TAUSSIG SHUNTS IN NEONATES AND INFANTS
SO CIRCULATION
LA English
DT Article
C1 UNIV MARYLAND HOSP,SCH MED,DIV PEDIAT CARDIOL,BALTIMORE,MD 21201.
RP MOULTON, AL (reprint author), UNIV MARYLAND HOSP,SCH MED,DIV THORAC & CARDIOVASC SURG,22 S GREENE ST,BALTIMORE,MD 21201, USA.
CR MCKAY R, 1980, ANN THORAC SURG, V30, P137
   ARCINIEGAS E, 1982, J THORAC CARDIOV SUR, V84, P88
   BLALOCK A, 1945, JAMA-J AM MED ASSOC, V128, P189
   BOVE EL, 1984, ANN THORAC SURG, V37, P88
   CHOPRA PS, 1976, ANN THORAC SURG, V22, P235
   DELEVAL MR, 1981, J THORAC CARDIOV SUR, V81, P112
   DIBENEDETTO G, 1981, THORAC CARDIOV SURG, V29, P143, DOI 10.1055/s-2007-1023464
   DONAHOO JS, 1980, ANN THORAC SURG, V30, P146
   EDMUNDS LH, 1980, CIRCULATION, V62, P581
   GUYTON RA, 1983, J THORAC CARDIOV SUR, V85, P917
   KAY PH, 1983, BRIT HEART J, V49, P359
   KIRKLIN JW, 1979, CIRCULATION, V60, P373
   KIRKLIN JW, 1983, ANN SURG, V198, P251, DOI 10.1097/00000658-198309000-00002
   LAKS H, 1975, ANN THORAC SURG, V19, P319
   LAMBERTI JJ, 1984, J THORAC CARDIOV SUR, V88, P76
   LEBLANC J, 1984, J THORAC CARDIOV SUR, V88, P259
   MILLS NL, 1985, ANN THORAC SURG, V39, P547
   MIYAMOTO K, 1979, ANN THORAC SURG, V27, P413
   WOOLF PK, 1984, ANN THORAC SURG, V38, P26
NR 19
TC 34
Z9 34
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0009-7322
J9 CIRCULATION
JI Circulation
PY 1985
VL 72
IS 3
BP 35
EP 44
PG 10
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA APY79
UT WOS:A1985APY7900006
ER

PT J
AU CLARK, VA
   ANESHENSEL, CS
   FRERICHS, RR
   MORGAN, TM
AF CLARK, VA
   ANESHENSEL, CS
   FRERICHS, RR
   MORGAN, TM
TI ANALYSIS OF NON-RESPONSE IN A PROSPECTIVE-STUDY OF DEPRESSION IN
   LOS-ANGELES COUNTY
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
C1 UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DIV EPIDEMIOL,LOS ANGELES,CA 90024.
RP CLARK, VA (reprint author), UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DIV BIOSTAT,LOS ANGELES,CA 90024, USA.
CR ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845
   ANESHENSEL CS, 1982, PUBLIC OPIN QUART, V46, P110, DOI 10.1086/268703
   CRAIG TJ, 1976, AM J PSYCHIAT, V133, P1426
   CRIQUI MH, 1979, AM J EPIDEMIOL, V109, P394
   DIXON WJ, 1979, BMDP79 BIOM COMP PRO
   FRERICHS RR, 1981, AM J EPIDEMIOL, V113, P691
   Gordon T, 1959, J CHRON DIS, V10, P186, DOI 10.1016/0021-9681(59)90002-5
   Husaini BA, 1980, J COMMUNITY PSYCHOL, V8, P20, DOI 10.1002/1520-6629(198001
   Kish L, 1965, SURVEY SAMPLING
   MARINI MM, 1980, SOCIOL METHODOL, P314
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   RADLOFF LS, EPIDEMIOLOGIC COMMUN
   WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203
   WILEY JA, 1980, PREV MED, V9, P1, DOI 10.1016/0091-7435(80)90056-0
   WILLIAMS WH, 1970, J AM STAT ASSOC, V65, P1338
   1964, USDHEW PHS1103 PUB, P96
NR 16
TC 34
Z9 34
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP
SN 0300-5771
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PY 1983
VL 12
IS 2
BP 193
EP 198
DI 10.1093/ije/12.2.193
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA QS229
UT WOS:A1983QS22900011
PM 6874215
ER

PT J
AU Bonaros, N
   Schachner, T
   Wiedemann, D
   Oehlinger, A
   Ruetzler, E
   Feuchtner, G
   Kolbitsch, C
   Velik-Salchner, C
   Friedrich, G
   Pachinger, O
   Laufer, G
   Bonatti, J
AF Bonaros, Nikolaos
   Schachner, Thomas
   Wiedemann, Dominik
   Oehlinger, Armin
   Ruetzler, Elisabeth
   Feuchtner, Gudrun
   Kolbitsch, Christian
   Velik-Salchner, Corinna
   Friedrich, Guy
   Pachinger, Othmar
   Laufer, Guenther
   Bonatti, Johannes
TI Quality of Life Improvement after Robotically Assisted Coronary Artery
   Bypass Grafting
SO CARDIOLOGY
LA English
DT Article
DE Coronary artery bypass grafting; Coronary artery disease; Minimally
   invasive cardiac surgery; Quality of life
ID HEALTH SURVEY QUESTIONNAIRE; CARDIAC-SURGERY; RANDOMIZED-TRIAL;
   FOLLOW-UP; PAIN; ANGIOPLASTY; OUTCOMES; DISEASE; INTERVENTION;
   PREVALENCE
AB Objectives: Coronary artery bypass grafting (CABG) is associated with long rehabilitation periods and slow quality of life (QOL) improvement. Totally endoscopic coronary artery bypass grafting (TECAB) can be performed using robotic technology and remote access perfusion. The aim of this study was to evaluate whether TECAB leads to accelerated QOL improvement as compared to standard CABG. Methods: We included 120 patients who had received robotically assisted CABG, 56 of whom were operated on using standard sternotomy. These patients were compared to 55 patients who underwent the TECAB procedure and to 9 TECAB patients who required conversion to conventional sternotomy. QOL evaluation was performed before the operation and 1, 3 and 6 months after the procedure using the SF-36 health survey and a standardized questionnaire. Results: All quality of life aspects improved significantly in all study patients. At 3 months, TECAB patients showed significantly better QOL scores related to bodily pain and physical health. Hospital stay and time to restoration of daily activities were significantly shorter. Converted patients experienced similar courses to sternotomy patients in terms of QOL. Conclusions: TECAB using robotic technology leads to improved physical health, shorter hospital stay and a more rapid restoration of daily activities. Conversion from TECAB to sternotomy does not lead to QOL impairment as compared to primary sternotomy. Copyright (C) 2009 S. Karger AG, Basel
C1 [Bonaros, Nikolaos; Schachner, Thomas; Wiedemann, Dominik; Oehlinger, Armin; Ruetzler, Elisabeth; Laufer, Guenther; Bonatti, Johannes] Innsbruck Med Univ, Dept Cardiac Surg, AT-6020 Innsbruck, Austria.
   [Friedrich, Guy; Pachinger, Othmar] Innsbruck Med Univ, Dept Cardiol, AT-6020 Innsbruck, Austria.
   [Kolbitsch, Christian; Velik-Salchner, Corinna] Innsbruck Med Univ, Dept Anesthesiol & Intens Care Med, AT-6020 Innsbruck, Austria.
   [Feuchtner, Gudrun] Innsbruck Med Univ, Dept Radiol, AT-6020 Innsbruck, Austria.
   [Bonatti, Johannes] Univ Maryland, Dept Cardiac Surg, Baltimore, MD 21201 USA.
RP Bonaros, N (reprint author), Innsbruck Med Univ, Dept Cardiac Surg, Anichstr 35, AT-6020 Innsbruck, Austria.
EM nikolaos.bonaros@i-med.ac.at
CR Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715
   Bonatti J, 2004, J THORAC CARDIOV SUR, V127, P504, DOI 10.1016/j.jtcvs.2003.09.005
   Bonatti J, 2006, J THORAC CARDIOV SUR, V131, P146, DOI 10.1016/j.jtcvs.2005.07.064
   Bruce J, 2003, PAIN, V104, P265, DOI 10.1016/S0304-3959(03)00017-4
   Caine N, 1999, HEART, V81, P347
   CONACHER ID, 1993, ANAESTHESIA, V48, P1070
   DEFALQUE RJ, 1989, ANESTH ANALG, V69, P81
   Eagle Kim A, 2004, Circulation, V110, P1168, DOI 10.1161/01.CIR.0000138790.14877.7D
   Edgerton JR, 2003, ANN THORAC SURG, V76, P1138, DOI 10.1016/S0003-4975(03)00747-1
   Eisenberg E, 2001, PAIN, V92, P11, DOI 10.1016/S0304-3959(00)00466-8
   Falcoz PE, 2003, ANN THORAC SURG, V76, P1598, DOI 10.1016/S0003-4975(03)00730-6
   Falk V, 2000, EUR J CARDIO-THORAC, V17, P38, DOI 10.1016/S1010-7940(99)00356-5
   GARRATT AM, 1993, BRIT MED J, V306, P1440
   Grossi EA, 1999, EUR J CARDIO-THORAC, V16, pS39, DOI 10.1016/S1010-7940(99)00267-5
   Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203
   Hunt JO, 2000, HEART LUNG, V29, P401, DOI 10.1067/mhl.2000.110578
   Jarvinen O, 2003, EUR J CARDIO-THORAC, V24, P750, DOI 10.1016/S1010-7940(03)00413-5
   JENKINSON C, 1993, BRIT MED J, V306, P1437
   Jones RH, 1996, J AM COLL CARDIOL, V28, P1478, DOI 10.1016/S0735-1097(96)00359-2
   Legrand VMG, 2004, CIRCULATION, V109, P1114, DOI 10.1161/01.CIR.0000118504.61212.4B
   Lindsay GM, 2000, EUR J CARDIO-THORAC, V18, P557, DOI 10.1016/S1010-7940(00)00542-X
   Massetti M, 1999, EUR J CARDIO-THORAC, V16, pS73, DOI 10.1016/S1010-7940(99)00274-2
   Meyerson J, 2001, ACTA ANAESTH SCAND, V45, P940, DOI 10.1034/j.1399-6576.2001.450804.x
   Morgan JA, 2004, ANN THORAC SURG, V77, P1328, DOI 10.1016/j.athoracsur.2003.09.044
   Pocock SJ, 1996, CIRCULATION, V94, P135
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   RECTOR TS, 1993, J HEART LUNG TRANSPL, V12, P983
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   Rumsfeld JS, 2001, ANN THORAC SURG, V72, P2026, DOI 10.1016/S0003-4975(01)03213-1
   Rumsfeld JS, 2003, J AM COLL CARDIOL, V41, P1732, DOI 10.1016/S0735-1097(03)00330-9
   Sjoland H, 1997, EUR J CARDIO-THORAC, V12, P612, DOI 10.1016/S1010-7940(97)00216-9
   Tu JV, 1997, J AM COLL CARDIOL, V30, P1317, DOI 10.1016/S0735-1097(97)00295-7
   Wahrborg P, 1999, EUR HEART J, V20, P653, DOI 10.1053/euhj.1998.1237
   Walther T, 1999, ANN THORAC SURG, V67, P1643, DOI 10.1016/S0003-4975(99)00284-2
   WEINTRAUB WS, 1995, CIRCULATION, V92, P2831
NR 35
TC 33
Z9 34
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0008-6312
J9 CARDIOLOGY
JI Cardiology
PY 2009
VL 114
IS 1
BP 59
EP 66
DI 10.1159/000212115
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 472CJ
UT WOS:000268106500013
PM 19365117
ER

PT J
AU Gracey, F
   Palmer, S
   Rous, B
   Psaila, K
   Shaw, K
   O'Dell, J
   Cope, J
   Mohamed, S
AF Gracey, Fergus
   Palmer, Siobhan
   Rous, Becky
   Psaila, Kate
   Shaw, Kendra
   O'Dell, Juliette
   Cope, Jo
   Mohamed, Shemin
TI "Feeling part of things": Personal construction of self after brain
   injury
SO NEUROPSYCHOLOGICAL REHABILITATION
LA English
DT Article
DE Brain injury; Rehabilitation; Identity; Personal construct psychology
ID REHABILITATION; DISCREPANCY; PSYCHOLOGY; DISABILITY; NARRATIVES;
   DISORDERS; AWARENESS; IDENTITY; THERAPY; PEOPLE
AB There is a growing body of literature on the nature of subjective changes experienced following brain injury. This study employs personal construct and qualitative research methods to address the question of how people make sense of, or construe, themselves after brain injury. Thirty-two individuals who had experienced acquired brain injury engaged in small group exercises based on a personal construct approach. Bipolar constructs were elicited through systematic comparison of pre-injury, current and ideal selves. The constructs elicited in this way were subjected to a thematic analysis. Nine themes were derived and an acceptable level of reliability of the definitions of these themes achieved. The highest proportion of constructs fell into the theme experience of self in the world, followed by basic skills (cognitive, sensory, physical, social) and experience of self in relation to self. It is concluded that following brain injury, people make sense of themselves in terms of the meanings and felt experiences of social and practical activity. This is consistent with social identity theory and stands in contrast to traditional neuropsychological sense making in terms of impairments and abilities alone, or activity or social participation alone. The implications of these findings for future research and rehabilitation are briefly considered.
C1 [Gracey, Fergus; Palmer, Siobhan; Rous, Becky; O'Dell, Juliette; Cope, Jo] Princess Wales Hosp, Oliver Zangwill Ctr Neuropsychol Rehabil, Ely CB6 1DN, Cambs, England.
   [Psaila, Kate] Ida Darwin Hosp, Cambridgeshire Learning Disabil Partnership, Cambridge, England.
   [Shaw, Kendra] Charing Cross Hosp, Neuropsychol Dept, London, England.
   [Mohamed, Shemin] Cambridgeshire & Peterborough Mental Hlth Trust, Cambridge, England.
RP Gracey, F (reprint author), Princess Wales Hosp, Oliver Zangwill Ctr Neuropsychol Rehabil, Lynn Rd, Ely CB6 1DN, Cambs, England.
EM Fergus.gracey@ozc.nhs.uk
CR Baddeley A., 1992, SPEED CAPACITY LANGU
   Barnard P. J., 1993, AFFECT COGNITION CHA
   Beck A. T., 1972, DEPRESSION CAUSES TR
   BENYISHAY Y, 2000, CRITICAL ISSUES NEUR
   BLOWERS GH, 1995, BRIT J CLIN PSYCHOL, V34, P1
   Boyatzis R. E., 1998, TRANSFORMING QUALITA
   Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005
   Davis K., 1985, SOCIAL CONSTRUCTION
   Dewar BK, 2007, NEUROPSYCHOL REHABIL, V17, P602, DOI 10.1080/09602010601051610
   Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782
   Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410
   Feeney T., 2000, BRAIN IMPAIR, V1, P12, DOI [10.1375/brim.1.1.12, DOI 10.1375/BRIM.1.1.12]
   FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217
   Fransella F., 2004, MANUAL REPERTORY GRI
   Glaser B. G., 1967, DISCOVERY GROUNDED T
   GOLDSTEIN K, 1959, J INDIV PSYCHOL, V15, P5
   GUTMAN SA, 1995, AM J OCCUPATIONAL TH, V50, P535
   HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037//0033-295X.94.3.319
   Kelly G. A., 1955, PSYCHOL PERSONAL CON, V2
   Kelly G. A, 1955, PSYCHOL PERSONAL CON, VI
   LIEBERMAN MD, 2000, ANNU REV PSYCHOL, V58, P259
   McGrath J., 2004, OXFORD GUIDE BEHAV E
   NADELL J, 1991, COGNITIVE REHABILITA, V9, P8
   Neimeyer G., 1993, CONSTRUCTIVIST ASSES
   Nevid JS, 2007, PSYCHOL PSYCHOTHER-T, V80, P605, DOI 10.1348/147608307X204189
   Nilsson I, 1997, J ADV NURS, V25, P953, DOI 10.1046/j.1365-2648.1997.1997025953.x
   Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8
   Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6
   Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973
   Pidgeon N., 1996, HDB QUALITATIVE RES
   Prigatano GP, 2000, INT HDB NEUROPSYCHOL, P115
   ROUS B, 2007, NEUR C KINGS COLL LO
   Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084
   Turner J. C., 1982, SOCIAL IDENTITY INTE, P15
   TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002
   Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417
   Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020
   Winter D. A., 1992, PERSONAL CONSTRUCT P
   Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302
   Yeates G, 2007, NEUROPSYCHOL REHABIL, V17, P151, DOI 10.1080/09602010600696423
NR 40
TC 33
Z9 35
PU PSYCHOLOGY PRESS
PI HOVE
PA 27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND
SN 0960-2011
J9 NEUROPSYCHOL REHABIL
JI Neuropsychol. Rehabil.
PY 2008
VL 18
IS 5-6
BP 627
EP 650
DI 10.1080/09602010802041238
PG 24
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA 360PQ
UT WOS:000260070200011
PM 18609024
ER

PT J
AU Hix, JK
   Thakar, CV
   Katz, EM
   Yared, JP
   Sabik, J
   Paganini, EP
AF Hix, John Kevin
   Thakar, Charuhas V.
   Katz, Ethan M.
   Yared, Jean-Pierre
   Sabik, Joseph
   Paganini, Emil P.
TI Effect of off-pump coronary artery bypass graft surgery on postoperative
   acute kidney injury and mortality
SO CRITICAL CARE MEDICINE
LA English
DT Article
DE acute kidney injury; off-pump cardiac surgery; propensity-score matching
ID ACUTE-RENAL-FAILURE; OPEN-HEART-SURGERY; CARDIAC-SURGERY; ON-PUMP;
   RISK-FACTORS; DYSFUNCTION; PROGNOSIS; REVASCULARIZATION; OPERATIONS;
   OUTCOMES
AB Objective: Risk of mortality after cardiac surgery is associated with severity of acute kidney injury. The aim of this study is to examine the effect of off-pump coronary artery bypass surgery on the risk of postoperative acute kidney injury and its association with mortality.
   Design: Observational cohort study.
   Setting., Tertiary care center.
   Patients: Some 10,061 patents underwent coronary artery bypass surgery (1998-2002), of which 1,365 patients underwent off-pump surgery.
   Interventions., Acute kidney injury was defined as either requirement of dialysis or >= 50% decline in postoperative glomerular filtration rate but not requiring dialysis. We compared on- and off-pump surgeries and used propensity score matching to examine the effect of off-pump surgery on acute kidney injury and mortality.
   Measurements and Main Results: We found that 2.6% on-pump and 1.2% off-pump patients developed acute kidney injury requiring dialysis among the 2,370 matched subjects (relative risk, 2.06; 95% confidence interval [Cl], 1.36-3.36); 5.0% of on-pump patients suffered a >= 50% decline in glomerular filtration rate compared with 2.5% in off-pump group (relative risk, 2.00; 95% Cl, 1.48-2.82). The mortality rate in the matched cohort was 2.3% for on-pump group vs. 0.6% in off-pump group (relative risk, 3.88; 95% Cl, 2.29-9.50). Among matched patients with acute kidney injury, the risk of mortality was 13.14 (95% Cl, 8.43-30.50) in patients requiring dialysis and 9.33 (95% Cl, 4.83-19.00) in those with >= 50% decline in glomerular filtration rate but not requiring dialysis.
   Conclusions: Off-pump surgery is associated with a lower risk of developing acute kidney injury (regardless of its definition). The risk of mortality is incremental with worsening degrees of acute kidney injury. Lower risk of acute kidney injury may be one of the factors that offer a survival advantage after off-pump surgery.
C1 Cleveland Clin Fdn, Dept Hypertens & Nephrol, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Cardiothorac Anesthesiol, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Cardiothorac Surg, Cleveland, OH 44195 USA.
   Univ Cincinnati, Med Ctr, Div Nephrol, Cincinnati, OH 45267 USA.
RP Hix, JK (reprint author), Cleveland Clin Fdn, Dept Hypertens & Nephrol, 9500 Euclid Ave, Cleveland, OH 44195 USA.
CR ABEL RM, 1976, J THORAC CARDIOV SUR, V71, P323
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   BHAT JG, 1976, ANN INTERN MED, V84, P677
   Chertow GM, 1997, CIRCULATION, V95, P878
   Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158
   Efron B., 1998, INTRO BOOTSTRAP
   FROST L, 1991, SCAND J THORAC CARD, V25, P161, DOI 10.3109/14017439109099033
   GAILIUNAS P, 1980, J THORAC CARDIOV SUR, V79, P241
   HILBERMAN M, 1979, J THORAC CARDIOV SUR, V77, P880
   Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD
   Magee MJ, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.cir.0000089187.51855.77
   Mangano CM, 1998, ANN INTERN MED, V128, P194
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   ROSENBAUM P. R., 2002, OBSERVATIONAL STUDIE
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Thakar CV, 2005, KIDNEY INT, V67, P1112, DOI 10.1111/j.1523-1755.2005.00177.x
   Thakar CV, 2003, KIDNEY INT, V64, P239, DOI 10.1046/j.1523-1755.2003.00040.x
   Thakar CV, 2005, J AM SOC NEPHROL, V16, P162
   Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0
   Tomic V, 2005, CIRCULATION, V112, P2912, DOI 10.1161/CIRCULATIONAHA.104.531152
   van der Heijden GJMG, 2004, EUR J CARDIO-THORAC, V26, P81, DOI 10.1016/j.ejcts.2004.03.032
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828
NR 26
TC 33
Z9 33
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PD DEC
PY 2006
VL 34
IS 12
BP 2979
EP 2983
DI 10.1097/01.CCM.0000248905.67352.BA
PG 5
WC Critical Care Medicine
SC General & Internal Medicine
GA 110QH
UT WOS:000242393100015
PM 17075372
ER

PT J
AU Alsenaidi, K
   Gurofsky, R
   Karamlou, T
   Williams, WG
   McCrindle, BW
AF Alsenaidi, Khalfan
   Gurofsky, Rebecca
   Karamlou, Tara
   Williams, William G.
   McCrindle, Brian W.
TI Management and outcomes of double aortic arch in 81 patients
SO PEDIATRICS
LA English
DT Article
DE double aortic arch; vascular rings; stridor; congenital cardiac disease;
   cardiovascular surgery
ID CONGENITAL VASCULAR RINGS; SURGICAL-MANAGEMENT; TRACHEOBRONCHIAL
   COMPRESSION; PEDIATRIC-PATIENTS; ANOMALIES; OESOPHAGUS; EXPERIENCE;
   DIAGNOSIS; CHILDREN; TRACHEA
AB OBJECTIVES. Double aortic arch is a common form of complete vascular ring, encircling both the trachea and esophagus, resulting in noncardiac morbidity. We sought to describe management and outcomes in a large single institution clinical series.
   PATIENTS AND METHODS. We reviewed the medical charts of all of the patients diagnosed with double aortic arch at age < 18 years. Data regarding clinical presentation, anatomy, management, and outcomes were abstracted.
   RESULTS. We identified 81 patients (67% males) born between 1964 and 2005 and presenting at a median age of 5 months (range: birth to 10.3 years). Respiratory symptoms were present in 91%, including stridor in 77%. Gastrointestinal symptoms were present in 40%, with choking with feeds being most common. The dominant branch of the double aortic arch was right in 72%. Associated cardiac anomalies were present in 18%, with noncardiac anomalies in 7%. Repair was performed in 79 patients at a median age of 6 months. There were 2 deaths after surgical repair with no late deaths, with Kaplan-Meier survival estimates of 96% at 5 years. Postoperative complications included chylothorax in 9%. Only 1 patient required reoperation. The most common symptoms at most recent follow-up were respiratory (54%) followed by gastrointestinal symptoms (6%). Postoperative tracheal stenosis was documented in 14%, with tracheomalacia in 7%. There were no late reoperations and no evidence of aortic arch obstruction.
   CONCLUSIONS. Outcomes are excellent after repair of double aortic arch, although persistent respiratory symptoms are frequent and probably associated with previous compression-related maldevelopment of the trachea and major airways.
C1 Univ Toronto, Hosp Sick Children, Dept Pediat, Div Cardiol, Toronto, ON M5G 1X8, Canada.
   Univ Toronto, Hosp Sick Children, Div Cardiovasc Surg, Dept Surg, Toronto, ON M5G 1X8, Canada.
RP McCrindle, BW (reprint author), Univ Toronto, Hosp Sick Children, Dept Pediat, Div Cardiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM brian.mccrindle@sickkids.ca
CR ANAND R, 1994, PEDIATR CARDIOL, V15, P58
   ARCINIEGAS E, 1979, J THORAC CARDIOV SUR, V77, P721
   Arkin A, 1936, AM HEART J, V11, P444, DOI 10.1016/S0002-8703(36)90231-4
   BERTOLINI A, 1987, J CARDIOVASC SURG, V28, P301
   BINET JP, 1977, J THORAC CARDIOV SUR, V73, P248
   BISSET GS, 1987, AM J ROENTGENOL, V149, P251
   BOSNIAK MA, 1964, AMER J ROENTGENOL RA, V91, P1222
   CHUN K, 1992, ANN THORAC SURG, V53, P597
   Congdon ED, 1922, CONTRIB EMBRYOL CARN, V68, P47
   EKLOF O, 1971, ACTA PAEDIATR SCAND, V60, P81, DOI 10.1111/j.1651-2227.1971.tb06622.x
   EKSTROM G, 1951, ACTA CHIR SCAND, V102, P183
   FEARON B, 1963, ANN OTO RHINOL LARYN, V72, P949
   Fleck RJ, 2002, AM J ROENTGENOL, V178, P1275
   GRISWOLD HE, 1949, PEDIATRICS, V4, P751
   GROSS RE, 1945, NEW ENGL J MED, V233, P586, DOI 10.1056/NEJM194511152332003
   HIGASHIN.SM, 1968, BRIT HEART J, V30, P579
   Koontz CS, 2005, AM SURGEON, V71, P289
   LILLEHEI CW, 1992, J PEDIATR SURG, V27, P1118, DOI 10.1016/0022-3468(92)90571-N
   LIMA JA, 1983, OTOLARYNG HEAD NECK, V91, P605
   LINCOLN JCR, 1969, THORAX, V24, P295, DOI 10.1136/thx.24.3.295
   MAHONEY EB, 1964, SURGERY, V55, P1
   MOES CAF, 1978, HEART DIS INFANCY CH, P856
   NIKAIDOH H, 1972, ARCH SURG-CHICAGO, V105, P327
   ROESLER M, 1983, ANN SURG, V197, P139, DOI 10.1097/00000658-198302000-00004
   Shuford WH, 1974, AORTIC ARCH ITS MALF
   STEWART JR, 1964, ATLAS VASCULAR RINGS
   TUCKER BL, 1969, ARCH SURG-CHICAGO, V99, P521
   VANSON JAM, 1994, ANN THORAC SURG, V57, P604
   VANSON JAM, 1993, MAYO CLIN PROC, V68, P1056
   Wolman IJ, 1939, J PEDIATR, V14, P527, DOI 10.1016/S0022-3476(39)80172-X
   WYCHULIS AR, 1971, MAYO CLIN PROC, V46, P182
NR 31
TC 33
Z9 34
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
J9 PEDIATRICS
JI Pediatrics
PD NOV
PY 2006
VL 118
IS 5
BP E1336
EP E1341
DI 10.1542/peds.2006-1097
PG 6
WC Pediatrics
SC Pediatrics
GA 101HK
UT WOS:000241731700085
PM 17000782
ER

PT J
AU Horwitz, EM
   Levy, LB
   Thames, HD
   Kupelian, PA
   Martinez, AA
   Michalski, JM
   Pisansky, TM
   Sandler, HM
   Shipley, WU
   Zelefsky, MJ
   Zietman, AL
   Kuban, DA
AF Horwitz, Eric M.
   Levy, Lawrence B.
   Thames, Howard D.
   Kupelian, Patrick A.
   Martinez, Alvaro A.
   Michalski, Jeffrey M.
   Pisansky, Thomas M.
   Sandler, Howard M.
   Shipley, William U.
   Zelefsky, Michael J.
   Zietman, Anthony L.
   Kuban, Deborah A.
TI Biochemical and clinical significance of the posttreatment
   prostate-specific antigen bounce for prostate cancer patients treated
   with external beam radiation therapy alone - A multiinstitutional pooled
   analysis
SO CANCER
LA English
DT Article; Proceedings Paper
CT 46th Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology
CY OCT 17-20, 2004
CL Atlanta, GA
SP Amer Soc Therapeut Radiol & Oncol
DE prostatic neoplasms; prostate-specific antigen; PSA bounce; radiation
   therapy; biochemical control
ID SEED IMPLANTATION; BRACHYTHERAPY; RADIOTHERAPY; DEFINITIONS; FAILURE
AB BACKGROUND. The posttreatment prostate-specific antigen (PSA) bounce phenomenon has been recognized in at least 20% of all patients treated with radiation. The purpose of the current report was to determine if there was a difference in biochemical and clinical control between the bounce and nonbounce (NB) patients using pooled data on 4839 patients with T1-2 prostate cancer treated with external beam radiation therapy (RT) alone at 9 institutions between 1986 and 1995.
   METHODS. The median follow-up was 6.3 years. A posttreatment PSA bounce was defined by a minimal rise of 0.4 ng/mL over a 6-month follow-up period, followed by a drop in PSA level of any magnitude. Endpoints included no biochemical evidence of disease (bNED) failure (BF) (ASTRO definition), distant failure (DF), cause-specific failure (CSF), and overall survival (OS). Patients were stratified by pretreatment PSA, Gleason score, T stage, age, dose, and risk group.
   RESULTS. In all, 978 (20%) patients experienced at least 1 posttreatment PSA bounce. Within 3 subgroups (risk group, pretreatment PSA, and age), statistically significant differences of remaining bounce-free were observed on univariate analysis. Patients < 70 years had a 72% chance of remaining bounce-free at 5 years compared with 75% for older patients (P = .04). The NB patients had 72% bNED control at 10 years compared with 58% for the bounce patients. The effect of a bounce remained statistically significant on multivariate analysis (P < .0001). No statistically significant difference in DE CSF, or OS was observed.
   CONCLUSIONS. Patients treated with external beam radiation therapy alone who experience a posttreatment PSA bounce have increased risk of BE However, this did not translate into a difference in clinical failure with the available follow-up in the current study.
C1 Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA.
   Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA.
   Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA.
   William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI USA.
   Mallinckrodt Inst Radiol, Dept Radiat Oncol, St Louis, MO USA.
   Mayo Clin, Dept Radiat Oncol, Rochester, MN USA.
   Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.
   Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA.
   Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA.
   Univ Texas, MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA.
RP Horwitz, EM (reprint author), Fox Chase Canc Ctr, Dept Radiat Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA.
EM eric.horwitz@fccc.edu
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Ciezki JP, 2006, INT J RADIAT ONCOL, V64, P512, DOI 10.1016/j.ijrobp.2005.07.960
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Horwitz EM, 2005, J UROLOGY, V173, P797, DOI 10.1097/01.ju.0000152556.53602.64
   Kuban DA, 2003, INT J RADIAT ONCOL, V57, P915, DOI 10.1016/S0360-3016(03)00632-1
   Merrick GS, 2002, INT J RADIAT ONCOL, V54, P450, DOI 10.1016/S0360-3016(02)02948-6
   Rosser CJ, 2002, J UROLOGY, V168, P2001, DOI 10.1097/01.ju.0000034351.97426.fe
   SAS, 1999, SAS STAT US GUID VER
   Stata Statistical Software, 2000, STAT STAT SOFTW REL
   Stock RG, 2003, INT J RADIAT ONCOL, V56, P448, DOI 10.1016/S0360-3016(02)04470-X
   Thames H, 2003, INT J RADIAT ONCOL, V57, P929, DOI 10.1016/S0360-3016(03)00631-X
   Wallner KE BJ, 1997, PROSTATE BRACHYTHERA
NR 14
TC 33
Z9 34
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0008-543X
J9 CANCER
JI Cancer
PD OCT 1
PY 2006
VL 107
IS 7
BP 1496
EP 1502
DI 10.1002/cncr.22183
PG 7
WC Oncology
SC Oncology
GA 089VL
UT WOS:000240909400011
PM 16944536
ER

PT J
AU Spinhoven, P
   Bockting, CLH
   Schene, AH
   Koeter, MWJ
   Wekking, EM
   Williams, JMG
AF Spinhoven, Philip
   Bockting, Claudi L. H.
   Schene, Aart H.
   Koeter, Maarten W. J.
   Wekking, Elizabeth M.
   Williams, J. Mark G.
CA DELTA Study Grp
TI Autobiographical memory in the euthymic phase of recurrent depression
SO JOURNAL OF ABNORMAL PSYCHOLOGY
LA English
DT Article
DE autobiographical memory; depression; relapse/recurrence; cognitive
   therapy; executive functioning
ID BORDERLINE PERSONALITY-DISORDER; POSTTRAUMATIC-STRESS-DISORDER;
   COGNITIVE THERAPY; MAJOR DEPRESSION; SUICIDE ATTEMPTERS; SPECIFICITY;
   VULNERABILITY; IMPAIRMENT; TRAUMA; MOOD
AB The authors investigated autobiographical memory specificity in subjects who formerly had depression. In 122 euthymic patients with at least two previous major depressive episodes, memory specificity was significantly impaired compared to matched control participants but not related to residual symptoms and illness characteristics, was not differentially affected by cognitive therapy, and was also not predictive of relapse/recurrence during the 2-year follow-up. However, memory specificity was associated with age, education, and immediate and delayed memory recall. The results suggest that memory specificity may reflect a global cognitive impairment that remains in patients who (formerly) had depression but does not constitute a trait marker for vulnerability for relapse/recurrence.
C1 Leiden Univ, Dept Psychol, NL-2333 AK Leiden, Netherlands.
   Leiden Univ, Dept Psychiat, NL-2333 AK Leiden, Netherlands.
   Univ Amsterdam, Acad Med Ctr, DELTA Study Grp, Dept Psychiat, Amsterdam, Netherlands.
   Univ Oxford, Dept Psychiat, Oxford, England.
RP Spinhoven, P (reprint author), Leiden Univ, Dept Psychol, Wassenaarseweg 52, NL-2333 AK Leiden, Netherlands.
EM spinhoven@fsw.leidenuniv.nl
RI Schene, A.H./H-8085-2014
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Arntz A, 2002, BEHAV RES THER, V40, P1063, DOI 10.1016/S0005-7967(01)00121-8
   BECK AT, 1979, COGNITIVE THERAPY DE
   Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647
   Brewin CR, 1998, APPL COGNITIVE PSYCH, V12, P359
   Brewin CR, 1999, J ABNORM PSYCHOL, V108, P511, DOI 10.1037/0021-843X.108.3.511
   BRITTLEBANK AD, 1993, BRIT J PSYCHIAT, V162, P118, DOI 10.1192/bjp.162.1.118
   BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037//0033-2909.117.2.285
   Dalgleish T, 2003, EMOTION, V3, P211, DOI 10.1037/1528-3542.3.3.211
   Dalgleish T, 2001, J ABNORM PSYCHOL, V110, P335, DOI 10.1037//0021-843X.110.2.335
   DALGLEISH T, 1990, CLIN PSYCHOL REV, V10, P589, DOI 10.1016/0272-7358(90)90098-U
   de Decker A, 2003, J CLIN CHILD ADOLESC, V32, P22, DOI 10.1207/15374420360533031
   DELIS DC, 1987, CALIFORNIA VERBAL LE
   First M. B., 1997, STRUCTURED CLIN INTE
   Gibbs BR, 2004, COGNITIVE THER RES, V28, P511, DOI 10.1023/B:COTR.0000045561.72997.7c
   Goddard L, 1996, J ABNORM PSYCHOL, V105, P609, DOI 10.1037/0021-843X.105.4.609
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   HAMMES JGW, 1978, DESTROOP KLEURWOORD
   Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P500, DOI 10.1037/0022-006X.66.3.500
   Hermans D, 2004, BEHAV RES THER, V42, P775, DOI 10.1016/S0005-7967(03)00197-9
   Just N, 2001, CLIN PSYCHOL REV, V21, P63, DOI 10.1016/S0272-7358(99)00035-5
   Kremers IP, 2004, BRIT J CLIN PSYCHOL, V43, P17, DOI 10.1348/014466504772812940
   LEZAK MD, 2004, NEUROPSYCHOLOGICAL A
   Ma SH, 2004, J CONSULT CLIN PSYCH, V72, P31, DOI 10.1037/0022-006X.72.1.31
   Mackinger HF, 2000, EUR PSYCHOL, V5, P52, DOI 10.1027//1016-9040.5.1.52
   Mackinger HF, 2004, J AFFECT DISORDERS, V78, P61, DOI 10.1016/S0165-0327(02)00181-7
   Mackinger HF, 2000, J ABNORM PSYCHOL, V109, P331, DOI 10.1037//0021-843X.109.2.331
   MCNALLY RJ, 1995, BEHAV RES THER, V33, P619, DOI 10.1016/0005-7967(95)00007-K
   Nandrino JL, 2002, PSYCHOPATHOLOGY, V35, P335, DOI 10.1159/000068591
   Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P990, DOI 10.1001/archpsyc.61.10.990
   Paradiso S, 1997, J NERV MENT DIS, V185, P748, DOI 10.1097/00005053-199712000-00005
   Park RJ, 2002, PSYCHOL MED, V32, P267, DOI 10.1017/S0033291701005189
   Peeters F, 2002, COMPR PSYCHIAT, V43, P344, DOI 10.1053/comp.2002.34635
   Phillips S, 1997, BRIT J CLIN PSYCHOL, V36, P341
   Pollock LR, 2001, SUICIDE LIFE-THREAT, V31, P386, DOI 10.1521/suli.31.4.386.22041
   Rabbitt P. A., 1988, PRACTICAL ASPECTS ME, P175
   Raes F, 2003, EMOTION, V3, P201, DOI 10.1037/1528-3542.3.2.201
   Rasbach J., 2004, USERS GUIDE MLWIN
   Sampson MJ, 2003, INT J GERIATR PSYCH, V18, P23, DOI 10.1002/gps.763
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Squire LR, 1995, MEMORY DISTORTION, P197
   Svaldi JJ, 2003, SCAND J PSYCHOL, V44, P31, DOI 10.1111/1467-9450.00318
   Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615
   Tulving E., 1972, ORG MEMORY, P381
   van Vreeswijk MF, 2004, BEHAV RES THER, V42, P731, DOI 10.1016/S0005-7967(03)00194-3
   Watkins E, 2001, J ABNORM PSYCHOL, V110, P353, DOI 10.1037//0021-843X.110.2.353
   Watkins E, 2000, PSYCHOL MED, V30, P911, DOI 10.1017/S0033291799002263
   Wechsler D., 1981, MANUAL WECHSLER ADUL
   Wessel I, 2001, BEHAV RES THER, V39, P409, DOI 10.1016/S0005-7967(00)00011-5
   Wessel I, 2002, J TRAUMA STRESS, V15, P227, DOI 10.1023/A:1015207428675
   Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331
   WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144
   WILLIAMS JMG, 1992, NATO ADV SCI INST SE, V65, P391
   Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278
   Williams JMG, 2000, J ABNORM PSYCHOL, V109, P150, DOI 10.1037//0021-843X.109.1.150
   WILLIAMS JMG, 1995, STUDIES AUTOBIOGRAPH, P244
   Williams JMG, 2005, J ABNORM PSYCHOL, V114, P421, DOI 10.1037/0021-843X.114.3.421
   Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551
   Wilson B., 1985, RIVERMEAD BEHAV MEMO
NR 59
TC 33
Z9 35
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0021-843X
J9 J ABNORM PSYCHOL
JI J. Abnorm. Psychol.
PD AUG
PY 2006
VL 115
IS 3
BP 590
EP 600
DI 10.1037/0021-843X.115.3.590
PG 11
WC Psychology, Clinical; Psychology, Multidisciplinary
SC Psychology
GA 068JH
UT WOS:000239369300020
PM 16866599
ER

PT J
AU Toledano, A
   Chauveinc, L
   Flam, T
   Thiounn, N
   Solignac, S
   Timbert, M
   Rosenwald, JC
   Cosset, JM
AF Toledano, Alain
   Chauveinc, Laurent
   Flam, Thierry
   Thiounn, Nicolas
   Solignac, Suzette
   Timbert, Michel
   Rosenwald, Jean-Claude
   Cosset, Jean-Marc
TI PSA bounce after permanent implant prostate brachytherapy may mimic a
   biochemical failure: A study of 295 patients with a minimum 3-year
   followup
SO BRACHYTHERAPY
LA English
DT Article
DE brachytherapy; prostate cancer; PSA; bounce
ID RADIOACTIVE SEED IMPLANTATION; EXTERNAL-BEAM RADIATION; ANDROGEN
   DEPRIVATION THERAPY; ANTIGEN BOUNCE; INTERSTITIAL BRACHYTHERAPY; CANCER;
   RECOMMENDATIONS; MORBIDITY; CARCINOMA; PATTERNS
AB PURPOSE: To assess the frequency and features of the PSA bounce phenomenon in a series of patients treated with permanent implant brachytherapy for prostate cancer, and to evaluate the percentage of cases in which this bounce could have mimicked a biochemical relapse according to the American Society for Therapeutic Radiology and Oncology consensus criteria.
   METHODS AND MATERIALS: From January 1999 to December 2001, 295 patients were treated with a permanent prostate implantation (real-time technique, with free 1251 seeds) by the Paris Institut Curie/Hospital Cochin/Hospital Necker Paris group. Duration of followup is 40.3 months (9-66 months). PSA level was reported at intervals not exceeding 6 months. Bounce was defined by temporary elevation in PSA level, followed by a spontaneous decrease.
   RESULTS: In our series, 161 patients (55%) showed a transitory PSA increase (bounce) of at least 0.1 ng/mL; 145 patients (49%) a bounce of 0.2 ng/mL; 93 patients (32%) a bounce of 0.4 ng/mL; and 43 patients (15%) a bounce of at least 1 ng/mL. Mean PSA bounce was 0.8 ng/mL (0.1-4.1), and mean time to bounce was 19 months. Thirty-two patients (11% of total) presented three successive PSA increases, and therefore were to be considered as experiencing a biochemical relapse according to the American Society for Therapeutic Radiology and Oncology (ASTRO) consensus criteria. Among those 32 patients, 18 (56%) subsequently showed, without any treatment, a complete normalization of their PSA. In multivariate analysis, age < 70 (p < 0.0001) and D90 > 200 Gy (p < 0.003) were identified as independent factors for a PSA bounce of at least 0.4 ng/mL.
   CONCLUSIONS: The observed rate of 32% of patients showing a PSA bounce of at least 0.4 ng/mL in our series is in good agreement with what has been previously reported in the literature. Among 32 patients fulfilling the classical ASTRO criteria for a biochemical relapse, 18 (56%) subsequently showed a spontaneous PSA decrease, questioning the ASTRO consensus for the biochemical followup of patients undergoing permanent implant prostate brachytherapy. (c) 2006 American Brachytherapy Society. All rights reserved.
C1 Inst Curie, Dept Radiat Oncol, F-75231 Paris 05, France.
   Hop Cochin, Dept Urol, F-75674 Paris, France.
   Hop Necker Enfants Malad, Dept Urol, Paris, France.
   Inst Curie, Dept Radiat Phys, F-75231 Paris, France.
RP Cosset, JM (reprint author), Inst Curie, Dept Radiat Oncol, 26 Rue Ulm, F-75231 Paris 05, France.
EM jean-marc.cosset@curie.net
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Berruti A, 2002, J UROLOGY, V167, P2361, DOI 10.1016/S0022-5347(05)64985-3
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   BUYYONUSKY MK, 2003, J RAD ONCOL BIOL S2, V57, P147
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Chauveinc L, 2004, INT J RADIAT ONCOL, V59, P691, DOI 10.1016/j.ijrobp.2003.12.003
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Das P, 2002, INT J RADIAT ONCOL, V54, P698, DOI 10.1016/S0360-3016(02)03036-5
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   Hinerman-Mulroy A, 2004, INT J RADIAT ONCOL, V59, P1367, DOI 10.1016/j.ijrobp.2004.01.017
   Iannuzzi CM, 1999, RADIAT ONCOL INVESTI, V7, P30, DOI 10.1002/(SICI)1520-6823(1999)7:1<30::AID-ROI4>3.0.CO;2-8
   Kucway R, 2002, J UROLOGY, V167, P2443, DOI 10.1016/S0022-5347(05)65001-X
   Lee WR, 2003, CANCER, V98, P1987, DOI 10.1002/cncr.11774
   Merrick Gregory S, 2004, Brachytherapy, V3, P141, DOI 10.1016/j.brachy.2004.07.002
   Merrick GS, 2002, INT J RADIAT ONCOL, V54, P450, DOI 10.1016/S0360-3016(02)02948-6
   Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3
   Nag S, 2002, INT J RADIAT ONCOL, V54, P462, DOI 10.1016/S0360-3016(02)02937-1
   Nag S, 2001, INT J RADIAT ONCOL, V51, P1422, DOI 10.1016/S0360-3016(01)01616-9
   OESTERLING JE, 1988, J UROLOGY, V139, P766
   Patel C, 2004, UROLOGY, V63, P110, DOI 10.1016/j.urology.2003.08.025
   Potters L, 2000, J CLIN ONCOL, V18, P1187
   PRUTHI RS, 2000, J UROLOGY, V154, P2031
   Rosser CJ, 2002, J UROLOGY, V168, P2001, DOI 10.1097/01.ju.0000034351.97426.fe
   Sengoz M, 2003, EUR UROL, V43, P473, DOI 10.1016/S0302-2838(03)00138-6
   Stock RG, 2003, INT J RADIAT ONCOL, V56, P448, DOI 10.1016/S0360-3016(02)04470-X
   Stock RG, 2001, J UROLOGY, V165, P436, DOI 10.1097/00005392-200102000-00020
   SYNDER KM, 2001, INT J RADIAT ONCOL, V50, P335
   Zelefsky Michael J, 2004, Curr Urol Rep, V5, P173, DOI 10.1007/s11934-004-0034-6
NR 29
TC 33
Z9 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1538-4721
J9 BRACHYTHERAPY
JI Brachytherapy
PD APR-JUN
PY 2006
VL 5
IS 2
BP 122
EP 126
DI 10.1016/j.brachy.2006.02.003
PG 5
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 107LU
UT WOS:000242173900003
PM 16644467
ER

PT J
AU Ruel, M
   Suuronen, EJ
   Song, JM
   Kapila, V
   Gunning, D
   Waghray, G
   Rubens, FD
   Mesana, TG
AF Ruel, M
   Suuronen, EJ
   Song, JM
   Kapila, V
   Gunning, D
   Waghray, G
   Rubens, FD
   Mesana, TG
TI Effects of off-pump versus on-pump coronary artery bypass grafting on
   function and viability of circulating endothelial progenitor cells
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID OXIDATIVE STRESS; NEOVASCULARIZATION; METAANALYSIS; ISCHEMIA; DISEASE;
   SURGERY; MOBILIZATION; RECRUITMENT; SURVIVAL; INCREASE
AB Objective: Off-pump coronary artery bypass grafting may result in fewer myocardial and vascular complications than on-pump. Although differences in aortic manipulations likely play a role, the systemic responses of endothelial progenitor cells to both types of operations have not been examined. We sought to examine endothelial progenitor cell characteristics after off-pump versus on-pump coronary artery bypass grafting.
   Methods: Twenty patients undergoing off-pump or on-pump coronary artery bypass grafting were prospectively enrolled and had endothelial progenitor cells isolated and cultured from their peripheral blood before and 24 hours after surgery. Endothelial progenitor cells were identified by fluorescent dual lectin/low-density lipoprotein binding. Their number, phenotype characteristics, proliferation, migratory function, and viability were determined in a blinded fashion.
   Results: Patient characteristics and numbers of grafts were equivalent. Endothelial progenitor cells had similar phenotypes between groups before and after surgery. Off-pump and on-pump coronary artery bypass grafting resulted in similar increases in endothelial progenitor cell numbers and showed equivalent proliferation activity. However, endothelial progenitor cell migratory function was higher in off-pump patients (25.3 +/- 5.0 vs 5.0 +/- 1.0 cells per high-powered field for off-pump vs on-pump coronary artery bypass grafting, respectively; P = .04). Postoperative endothelial progenitor cell viability adjusted for preoperative baseline was also higher after off-pump than on-pump coronary artery bypass grafting by 72.4% +/- 14.6% (P = .01). Endothelial progenitor cells of on-pump patients were less viable after surgery than before surgery, whereas the reverse was observed in off-pump patients.
   Conclusions: Both on-pump and off-pump coronary artery bypass grafting elicit mobilization of endothelial progenitor cells into the peripheral blood. On-pump coronary artery bypass grafting, however, impairs the migratory function and viability of these vascular repair cells, which are conversely preserved after off-pump surgery. Further work is necessary to determine whether the function and viability of endothelial progenitor cells correlate with vascular outcomes and whether their therapeutic modulation may one day benefit coronary artery bypass grafting patients.
C1 Univ Ottawa, Heart Inst, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
RP Ruel, M (reprint author), Univ Ottawa, Heart Inst, Div Cardiac Surg, 40 Ruskin St,Ste 3403, Ottawa, ON K1Y 4W7, Canada.
EM Mruel@ottawaheart.ca
CR Adams V, 2004, ARTERIOSCL THROM VAS, V24, P684, DOI 10.1161/01.ATV.0000124104.23702.a0
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athorascur.2003.07.002
   Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284
   Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000
   Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770
   Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.00000097001.79750.78
   Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103
   George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db
   Gerritsen WBM, 2001, EUR J CARDIO-THORAC, V20, P923, DOI 10.1016/S1010-7940(01)00941-1
   Gill M, 2001, CIRC RES, V88, P167
   Hangler HB, 2003, J THORAC CARDIOV SUR, V126, P391, DOI 10.1016/S0022-5223(03)00395-7
   Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.e5
   Lambiase PD, 2004, CIRCULATION, V109, P2986, DOI 10.1161/01.CIR.0000130639.97284.EC
   MASA M, 2005, BLOOD, V105, P199
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Ruel M, 2004, MOL CELL BIOCHEM, V264, P119, DOI 10.1023/B:MCBI.0000044381.01098.03
   Scheubel RJ, 2003, J AM COLL CARDIOL, V42, P2073, DOI 10.1016/j.jacc.2003.07.025
   Takahashi T, 1999, NAT MED, V5, P434
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   van der Heijden GJMG, 2004, EUR J CARDIO-THORAC, V26, P81, DOI 10.1016/j.ejcts.2004.03.032
   Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816
   Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
NR 30
TC 33
Z9 34
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD SEP
PY 2005
VL 130
IS 3
BP 633
EP 639
DI 10.1016/j.jtcvs.2005.01.013
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 964XX
UT WOS:000231915400003
PM 16153906
ER

PT J
AU Zhou, JQ
   Corno, AF
   Huber, CH
   Tozzi, P
   von Segesser, LK
AF Zhou, JQ
   Corno, AF
   Huber, CH
   Tozzi, P
   von Segesser, LK
TI Self-expandable valved stent of large size: off-bypass implantation in
   pulmonary position
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE biological valved conduits; pulmonary valve implantation; pulmonary
   valve regurgitation; tetralogy of Fallot
ID VENTRICULAR OUTFLOW TRACT; BOVINE JUGULAR-VEIN; REPLACEMENT; TETRALOGY;
   FALLOT; REPAIR; CONDUITS; DYSFUNCTION; FAILURE
AB Objective: To evaluate the feasibility of the off-bypass implantation of a self-expandable valved stent of large size in pulmonary position. Materials and methods: A glutaraldehyde preserved valved bovine jugular xenograft with internal diameter = 22 mm, mounted in two rings of nitinol 'Z' stent, expandable from 7 to 24 mm of internal diameter, was acutely evaluated in 6 adult pigs, mean body weight 55.6 kg (range 47-67 kg). Through a stent-graft delivery system (24 French) the self expandable valved stent was implanted off-bypass in pulmonary valve position by trans-ventricular approach through median sternotomy. Results: The mean diameter of the main pulmonary artery measured was 21.7 +/- 1.6 mm. The mean length of the self expandable valved stent was 23.1 +/- 0.7 mm, the mean internal diameter 21.6 +/- 0.7 mm. and the mean external diameter 26.3 +/- 0.7 mm. The mean peak pressure gradient recorded across the valve was 6.33 +/- 2.8 mmHg (range 4.5-9.6 mmHg) at Doppler echocardiography, and 4.5 +/- 3.1 mmHg (range 0-7 mmHg) at invasive measurement, with a pulmonary blood flow of 3.03 +/- 0.05 l/min. Intra-vascular ultrasound showed complete opening and closure of the valve (mean area reduction from 315.08 +/- 54.13 to 0 mm(2)). Conclusions: (a) Off-bypass implantation of self-expandable valved stent is feasible in pulmonary position; (b) off-bypass surgical approach allows for valved stent implantation of adult size with adequate hemodynamic functioning; and (c) intra-vascular ultrasound makes implantation and evaluation easy and reproducible. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 CHU Vaudois, Dept Cardiovasc Surg, CH-1011 Lausanne, Switzerland.
   1 Peoples Hosp Shaoxing, Cardiothorac Dept, Zhejiang, Peoples R China.
RP Corno, AF (reprint author), CHU Vaudois, Dept Cardiovasc Surg, 46 Rue Bugnon, CH-1011 Lausanne, Switzerland.
CR Bonhoeffer P, 2000, CIRCULATION, V102, P813
   Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3
   Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   Boudjemline Y, 2002, CIRCULATION, V105, P775, DOI 10.1161/hc0602.103361
   BOVE EL, 1985, J THORAC CARDIOV SUR, V90, P50
   Corno AF, 2001, J THORAC CARDIOV SUR, V122, P493, DOI 10.1067/mtc.2001.114780
   CORNO AF, 2003, IN PRESS INTERACTIVE
   Corno AF, 2002, J HEART VALVE DIS, V11, P242
   Corno A, 1988, J Card Surg, V3, P495, DOI 10.1111/j.1540-8191.1988.tb00443.x
   de Ruijter FTH, 2002, ANN THORAC SURG, V73, P1794, DOI 10.1016/S0003-4975(02)03586-5
   DIETL CA, 1994, CIRCULATION, V90, P7
   Discigil B, 2001, J THORAC CARDIOV SUR, V121, P344, DOI 10.1067/mtc.2001.111209
   Hanley FL, 2000, J THORAC CARDIOV SUR, V119, P1, DOI 10.1016/S0022-5223(00)70210-8
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Homann M, 2000, EUR J CARDIO-THORAC, V17, P624, DOI 10.1016/S1010-7940(00)00414-0
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Lutter G, 2002, J THORAC CARDIOV SUR, V123, P768, DOI 10.1067/mtc.2002.121157
   Pedra CAC, 2002, J THORAC CARDIOV SUR, V124, P82, DOI 10.1067/mtc.2002.122309
   POWELL AJ, 1995, CIRCULATION, V92, P282
   ROCCHINI AP, 1977, CIRCULATION, V56, P305
   Saliba Z, 1999, ARCH MAL COEUR VAISS, V92, P591
   Stark J, 1998, J THORAC CARDIOV SUR, V115, P506, DOI 10.1016/S0022-5223(98)70312-5
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X
   WARNER KG, 1993, CIRCULATION, V88, P189
   Yemets IM, 1997, ANN THORAC SURG, V64, P526, DOI 10.1016/S0003-4975(97)00577-8
NR 26
TC 33
Z9 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD AUG
PY 2003
VL 24
IS 2
BP 212
EP 216
DI 10.1016/S1010-7940(03)00178-7
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 715NT
UT WOS:000184979200007
PM 12895610
ER

PT J
AU Critz, FA
AF Critz, FA
TI Time to achieve a prostate specific antigen nadir of 0.2 ng./ml. after
   simultaneous irradiation for prostate cancer
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate; prostatic neoplasms; prostate-specific antigen; radiotherapy
ID EXTERNAL-BEAM RADIATION; RADICAL PROSTATECTOMY
AB Purpose: A prostate specific antigen (PSA) cutoff point of 0.2 ng./ml. has been suggested as the standard definition of disease freedom for curative treatment of localized prostate cancer. The time to achieve this goal after irradiation was determined in this study.
   Materials and Methods: From August 1992 to December 1996, 539 consecutive men with clinical stage T1T2NX prostate cancer who had a minimum 5-year PSA followup and achieved a PSA nadir of 0.2 ng./ml. without hormones were evaluated. All patients were treated with simultaneous irradiation with a transperineal prostate (125)iodine implant, followed by external beam irradiation. Time to achieve a PSA of 0.2 ng./ml. was retrospectively calculated from the date of implantation in all men and according to various factors. Recurrence was defined as a subsequent increase above a PSA of 0.2 ng./ml. Minimum followup was 5 years (median 6.5, range 5 to 9).
   Results: In all 539 men the median time to a PSA nadir of 0.2 ng./ml. was 27 months, while 534 (99%) achieved this level by 60 months of followup. Median time to achieve this PSA goal was 20 and 39 months in patients without and with a PSA bounce, respectively. Pretreatment PSA, disease status and ultimately PSA bounce, Gleason score and stagehad little or no effect on time to a PSA of 0.2 ng./ml.
   Conclusions: With rare exceptions to be potentially cured of prostate cancer by simultaneous irradiation men must achieve a PSA nadir of 0.2 ng./ml. within 5 years of implantation. Failure to reach this goal by 60 months of followup almost always indicates persistent disease.
C1 Radiotherapy Clin Georgia, Decatur, GA USA.
RP Critz, FA (reprint author), Radiotherapy Clin Georgia, Decatur, GA USA.
CR Amling CL, 2001, J UROLOGY, V165, P1146, DOI 10.1016/S0022-5347(05)66452-X
   Cavanagh W, 2000, Semin Urol Oncol, V18, P160
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Critz FA, 2002, J UROLOGY, V167, P1310, DOI 10.1016/S0022-5347(05)65288-3
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Hanlon AL, 2001, INT J RADIAT ONCOL, V50, P845, DOI 10.1016/S0360-3016(01)01557-7
   OESTERLING JE, 1988, J UROLOGY, V139, P766
   Vicini FA, 2000, CANCER, V88, P2305, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2305::AID-CNCR15>3.0.CO;2-3
NR 8
TC 33
Z9 33
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD DEC
PY 2002
VL 168
IS 6
BP 2434
EP 2438
DI 10.1097/01.ju.0000030581.57555.04
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 618CE
UT WOS:000179399900023
PM 12441934
ER

PT J
AU Saleh, FH
   Crotty, KA
   Hersey, P
   Menzies, SW
AF Saleh, FH
   Crotty, KA
   Hersey, P
   Menzies, SW
TI Primary melanoma tumour regression associated with an immune response to
   the tumour-associated antigen Melan-A/MART-1
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article
DE immunologic surveillance; melanoma; MART-1; tumour regression
ID T-CELL RESPONSES; PEPTIDES IN-VIVO; INFILTRATING LYMPHOCYTES; METASTATIC
   MELANOMA; MALIGNANT-MELANOMA; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY;
   IMMUNODOMINANT PEPTIDE; UNKNOWN PRIMARY; REACTIVE CTL
AB A prediction of the theory of immunologic surveillance is that tumour antigens can be recognised by cell-mediated immunity during early development of the primary tumour by formation of tumour antigen-specific cytotoxic lymphocytes (CTLs) and that such recognition leads to destruction of those tumour cells (tumour regression) with subsequent appearance of tumour antigen-loss variants. However, this has never been shown in nonviral-induced experimental animal models of primary malignancy or in human primary cancer. We examined 2 groups of human melanoma patients where primary tumour regression was observed. Twenty-three patients with multiple (greater than or equal to3) primary melanoma showed significant histologic regression of their last tumour (median tumour regression 33%) compared to matched tumours from patients with a single primary melanoma (median 0%) (p = 0.008) or compared to their first primary tumour (median 0%) (p = 0.001). This increased regression is consistent with an "immunisation effect" seen in murine tumour transplantation studies where innoculation with greater than or equal to3 asynchronous tumours induces transplantation rejection on subsequent challenge. A significant decrease in MART-1-positive stained tumour area in the last primary tumour from multiple melanoma subjects (median 8%) vs. matched single melanoma patients (median 79%) (p = 0.004) and in the last vs. first tumour (median 76%) in multiple primary subjects was found (p = 0.008). Metastatic tumours from 17 patients whose primary skin melanomas had completely regressed (occult primary melanoma) also showed significant MART-1 tumour-loss variants (median 0% MART-1-positive tumour) compared to matched metastatic tumours from patients with nonregressing primary tumours (median 51%) (p = 0.001). A correlation with the presence of peripheral blood MART-1-specific CTLs (MHC class 1-restricted IFN-gamma producing T lymphocytes) and MART-1 tumour antigen-loss variants was found (p = 0.001). Thus, in 2 groups of human melanoma subjects, we provide evidence of tumour regression associated with Melan A/MART-1 tumour antigen-loss variants correlating with formation of specific Melan A/MART-1 CTLs. (C) 2001 Wiley-Liss, Inc.
C1 Univ Sydney, Royal Prince Alfred Hosp, Dept Surg, Sydney Melanoma Unit,Melanoma & Skin Canc Res Ins, Camperdown, NSW 2050, Australia.
   Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.
   Univ Newcastle, Immunol & Oncol Unit, Newcastle Upon Tyne, Tyne & Wear, England.
RP Menzies, SW (reprint author), Univ Sydney, Royal Prince Alfred Hosp, Dept Surg, Sydney Melanoma Unit,Melanoma & Skin Canc Res Ins, Missenden Rd, Camperdown, NSW 2050, Australia.
CR Anichini A, 1999, J EXP MED, V190, P651, DOI 10.1084/jem.190.5.651
   Bettinotti MP, 1998, J IMMUNOL, V161, P877
   BURLINGHAM WJ, 1995, TRANSPLANTATION, V59, P1147, DOI 10.1097/00007890-199504270-00013
   BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1
   CHANG P, 1982, CANCER, V49, P1106, DOI 10.1002/1097-0142(19820315)49:6<1106::AID-CNCR2820490607>3.0.CO;2-0
   COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35
   DAYNES RA, 1979, CELL IMMUNOL, V45, P398, DOI 10.1016/0008-8749(79)90400-3
   Dudley ME, 1996, J EXP MED, V184, P441, DOI 10.1084/jem.184.2.441
   EVERSON TC, 1966, SPONTANEOUS REGRESSI, P164
   FISHER B, 1989, J CLIN ONCOL, V7, P250
   GARFINKEL L, 1980, CA CANC J CLIN, V30, P23
   HEARING VJ, 1985, INT J CANCER, V35, P403, DOI 10.1002/ijc.2910350317
   HERSEY P, IN PRESS CHALLENGES
   HEWITT HB, 1976, BRIT J CANCER, V33, P241, DOI 10.1038/bjc.1976.37
   Jaeger E, 1996, INT J CANCER, V66, P162
   Jager E, 1996, INT J CANCER, V67, P54, DOI 10.1002/(SICI)1097-0215(19960703)67:1<54::AID-IJC11>3.0.CO;2-C
   Jager E, 1996, INT J CANCER, V66, P470, DOI 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C
   Jungbluth AA, 1998, AM J SURG PATHOL, V22, P595, DOI 10.1097/00000478-199805000-00011
   KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458
   Kawakami Y, 1997, IMMUNOL RES, V16, P313, DOI 10.1007/BF02786397
   KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515
   Lee PP, 1999, NAT MED, V5, P677
   LEFFELL MS, 1977, CANCER RES, V37, P4112
   LETHE B, 1992, EUR J IMMUNOL, V22, P2283, DOI 10.1002/eji.1830220916
   Marincola FM, 1996, J IMMUNOTHER, V19, P266, DOI 10.1097/00002371-199607000-00003
   MARYANSKI JL, 1983, INT J CANCER, V31, P119, DOI 10.1002/ijc.2910310119
   MCGOVERN VJ, 1975, PATHOLOGY, V7, P91
   Menzies SW, 1997, ARCH SURG-CHICAGO, V132, P553
   MIDDLE JG, 1981, J NATL CANCER I, V67, P637
   Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328
   Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705
   POCKAJ BA, 1994, CANCER, V73, P1731, DOI 10.1002/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H
   RAHMAN SMJ, 1988, CANCER RES, V48, P6450
   Riker A, 1999, SURGERY, V126, P112, DOI 10.1016/S0039-6060(99)70143-1
   RIVOLTINI L, 1995, J IMMUNOL, V154, P2257
   ROBERTS L, 1986, EXPT CLIN PHOTOIMMUN, P77
   ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527
   ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291
   ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159
   SPAGNOLI GC, 1995, INT J CANCER, V64, P309, DOI 10.1002/ijc.2910640505
   SPIESS PJ, 1987, J NATL CANCER I, V79, P1067
   STEVENS EJ, 1995, J IMMUNOL, V154, P762
   Stutman O, 1978, NUDE MOUSE EXPT CLIN, P411
   Stutman O, 1975, Adv Cancer Res, V22, P261
   STUTMAN O, 1985, IMMUNITY CANC, P323
   TEFANY FJ, 1991, J INVEST DERMATOL, V97, P197, DOI 10.1111/1523-1747.ep12479662
   TRAU H, 1983, J AM ACAD DERMATOL, V8, P363, DOI 10.1016/S0190-9622(83)70040-X
   TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276
   UTZ U, 1992, J IMMUNOL, V149, P214
   UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040
   Valmori D, 1998, J IMMUNOL, V160, P1750
   VONWASIELEWSKI R, 1994, HISTOCHEMISTRY, V102, P165
   WILLIAMS WH, 1972, J NATL CANCER I, V49, P1613
   WONG JH, 1987, ARCH SURG-CHICAGO, V122, P1380
   Yee C, 2000, J EXP MED, V192, P1637, DOI 10.1084/jem.192.11.1637
NR 55
TC 33
Z9 33
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0020-7136
J9 INT J CANCER
JI Int. J. Cancer
PD NOV 15
PY 2001
VL 94
IS 4
BP 551
EP 557
DI 10.1002/ijc.1491
PG 7
WC Oncology
SC Oncology
GA 481WD
UT WOS:000171542700014
PM 11745443
ER

PT J
AU Wilcox, BR
   Jones, DR
   Frantz, EG
   Brink, LW
   Henry, GW
   Mill, MR
   Anderson, RH
AF Wilcox, BR
   Jones, DR
   Frantz, EG
   Brink, LW
   Henry, GW
   Mill, MR
   Anderson, RH
TI Anatomically sound, simplified approach to repair of ''complete''
   atrioventricular septal defect
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 33rd Annual Meeting of the Society-of-Thoracic-Surgeons
CY FEB 03-05, 1997
CL SAN DIEGO, CA
SP Soc Thorac Surgeons
ID MORPHOLOGY
AB Background. There are few congenital anomalies of the heart that have benefited more from thorough anatomic analysis than the complex anomaly known as atrioventricular septal defect in the setting of common atrioventricular junction. Recent advances in understanding the anatomy of this lesion have led to alternative methods of repairing these defects.
   Methods. The medical records of 21 consecutive patients undergoing repair of complete atrioventricular septal defect have been reviewed. Nine of these patients had a standard one-or two-patch repair, and 12 had direct closure of the ventricular element of the defect.
   Results. Direct closure resulted in significantly shorter pump and cross-clamp times. Follow-up for an average of 34 months suggests that when direct closure can be performed, the results are comparable with those of the more standard technique.
   Conclusions. Our initial success with this approach is encouraging; however, longer follow-up is required to establish whether it will be broadly applicable. (C) 1997 by The Society of Thoracic Surgeons.
C1 UNIV N CAROLINA,SCH MED,DEPT PEDIAT,CHAPEL HILL,NC 27599.
RP Wilcox, BR (reprint author), UNIV N CAROLINA,DIV CARDIOTHORAC SURG,SCH MED,DEPT SURG,108 BURNETT WOMACK BLDG,CB 7065,CHAPEL HILL,NC 27599, USA.
CR ANDERSON RH, 1991, CARDIOL YOUNG, V1, P290
   ANDERSON RH, 1988, J THORAC CARDIOV SUR, V95, P146
   BECKER AE, 1982, J THORAC CARDIOV SUR, V83, P461
   CARPENTIER A, 1977, PAEDIAT CARDIOLOGY, P477
   EBELS T, 1990, J THORAC CARDIOV SUR, V99, P299
   HALLMAN GL, 1975, SURG TREATMENT CONGE
   KIRKLIN JW, 1993, CARDIAC SURG, P727
   PENKOSKE PA, 1985, J THORAC CARDIOV SUR, V90, P611
   SUZUKI K, 1996, CARDIOL YOUNG, V6, P37
   SUZUKI K, 1993, BRIT HEART J, V70, P180
   WILLIAMS WH, 1983, J THORAC CARDIOV SUR, V86, P838
NR 11
TC 33
Z9 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD AUG
PY 1997
VL 64
IS 2
BP 487
EP 493
DI 10.1016/S0003-4975(97)00566-3
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA XR281
UT WOS:A1997XR28100050
PM 9262599
ER

PT J
AU SHLYAKHTER, AI
   KAMMEN, DM
   BROIDO, CL
   WILSON, R
AF SHLYAKHTER, AI
   KAMMEN, DM
   BROIDO, CL
   WILSON, R
TI QUANTIFYING THE CREDIBILITY OF ENERGY PROJECTIONS FROM TRENDS IN PAST
   DATA - THE UNITED-STATES ENERGY SECTOR
SO ENERGY POLICY
LA English
DT Article
DE ENERGY PROJECTIONS; FORECASTING; UNCERTAINTY
ID LIMITS
AB For energy forecasts to be useful in modelling or in policy efforts, the associated uncertainties must be known reliably.  We analyse the actual errors in past forecasts of over 170 energy producing and consuming sectors of the US economy.  We find that the often assumed normal distribution fails to model frequency of extreme outcomes (those lying far from the mean) accurately.  Triangular distributions perform even worse as they assign zero probability to the outliers.  We develop a simple one-parameter model that can be used to estimate a probability distribution for future projections.  In addition to energy forecasts, our method can be applied to any field where a history of forecasting is available.
C1 PRINCETON UNIV,WOODROW WILSON SCH PUBL & INT AFFAIRS,444 ROBERTSON HALL,PRINCETON,NJ 08544.
   HARVARD UNIV,DEPT PHYS,CAMBRIDGE,MA 02138.
   HARVARD UNIV,NE REG CTR GLOBAL ENVIRONM CHANGE,CAMBRIDGE,MA 02138.
CR Cooke R. M., 1991, EXPERTS UNCERTAINTY
   DOWLATABADI H, 1993, ENERG POLICY, V21, P209, DOI 10.1016/0301-4215(93)90243-9
   FREYKA T, 1981, POPUL DEV REV, V7, P489
   Goldemberg J., 1987, ENERGY SUSTAINABLE W
   KAHNEMAN D, 1982, JUDGEMENT UNCERTAINT, P306
   KAMMEN DM, 1987, ENERGY SUSTAINABLE W, P112
   KEILMAN NW, 1990, UNCERTAINTY NATIONAL, V20
   KEYFITZ N, 1981, POPUL DEV REV, V7, P579, DOI 10.2307/1972799
   Land KC, 1987, FORECASTING SOCIAL N, P7
   Madansky A., 1988, PRESCRIPTIONS WORKIN
   MORGAN MG, 1990, UNCERTAINTY GUIDE DE
   Murphy A. H., 1977, APPLIED STATISTICS, V26, P41, DOI DOI 10.2307/2346866
   Nordhaus W. D., 1983, CHANGING CLIMATE, P87
   NORDHAUS WD, 1992, SCIENCE, V258, P1315, DOI 10.1126/science.258.5086.1315
   SHAPIRO SS, 1982, STATISTICS TXB MONOG, V38
   SHLYAKHTER AI, 1993, 2ND P ISUMA 93 INT S, P246
   SHLYAKHTER AI, 1992, NATURE, V357, P25, DOI 10.1038/357025a0
   SHLYAKHTER AI, 1992, CSIA9206 HARV U KENN
   STARR C, 1992, SCIENCE, V256, P981, DOI 10.1126/science.256.5059.981
   STOTO MA, 1983, J AM STAT ASSOC, V78, P13, DOI 10.2307/2287094
   *UN, 1991, POP STUD PAP, V120
   *US DEP EN, 1991, NAT EN STRAT
   *US EN INF ADM, 1992, DDE EIA038392
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
   Zarnowitz V., 1992, BUSINESS CYCLES THEO
NR 25
TC 33
Z9 33
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0301-4215
J9 ENERG POLICY
JI Energy Policy
PD FEB
PY 1994
VL 22
IS 2
BP 119
EP 130
DI 10.1016/0301-4215(94)90129-5
PG 12
WC Energy & Fuels; Environmental Sciences; Environmental Studies
SC Energy & Fuels; Environmental Sciences & Ecology
GA NE654
UT WOS:A1994NE65400005
ER

PT J
AU WEISSLEDER, R
   THRALL, JH
AF WEISSLEDER, R
   THRALL, JH
TI THE LYMPHATIC-SYSTEM - DIAGNOSTIC-IMAGING STUDIES
SO RADIOLOGY
LA English
DT Editorial Material
RP WEISSLEDER, R (reprint author), MASSACHUSETTS GEN HOSP,DEPT RADIOL,32 FUIT ST,BOSTON,MA 02114, USA.
CR ADAIR T, 1987, LYMPHATIC IMAGING LY, P120
   BEHAR A, 1976, J MAL VASC PARIS, V2, P101
   BERGQVIST L, 1983, SEMIN NUCL MED, V13, P9, DOI 10.1016/S0001-2998(83)80031-2
   BRONSKILL MJ, 1983, SEMIN NUCL MED, V13, P20, DOI 10.1016/S0001-2998(83)80032-4
   BUCKLANDWRIGHT JC, 1989, BRIT J RADIOL, V62, P201
   CASTELLINO RA, 1982, INVEST RADIOL, V17, P433, DOI 10.1097/00004424-198209000-00001
   CASTELLINO RA, 1980, LYMPHATIC SYSTEM MET, P92
   DUNSON GL, 1973, RADIOLOGY, V109, P387
   EGE GN, 1983, SEMIN NUCL MED, V13, P26, DOI 10.1016/S0001-2998(83)80033-6
   EPENETOS AA, 1985, BRIT J CANCER, V51, P805, DOI 10.1038/bjc.1985.125
   FAWWAZ RA, 1985, RADIOLOGY, V155, P483
   FOLDI E, 1985, ANGIOLOGY, V36, P171, DOI 10.1177/000331978503600306
   GLAZER GM, 1988, RADIOLOGY, V168, P429
   HENZE E, 1982, J NUCL MED, V23, P923
   JAGER K, 1985, INITIAL LYMPHATICS, P99
   LEAK LV, 1971, J CELL BIOL, V50, P300, DOI 10.1083/jcb.50.2.300
   LEE JKT, 1978, AM J ROENTGENOL, V131, P675
   MCKUSICK KA, 1985, LYMPHATIC IMAGING LY, P95
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MOSTBECK A, 1985, INITIAL LYMPHATICS, P123
   OHTAKE E, 1986, CLIN NUCL MED, V11, P474, DOI 10.1097/00003072-198607000-00002
   PECKING A, 1984, MONOGRAPH IMMUNOLOGY, V2, P201
   ROBINSON GD, 1986, J NUCL MED, V27, P239
   SCHLOM J, 1989, JAMA-J AM MED ASSOC, V261, P744
   SOVAK M, 1984, HDB EXPT PHARM, P463
   TJANDRA JJ, 1989, BRIT J CANCER, V59, P296, DOI 10.1038/bjc.1989.61
   WALKER LA, 1950, J LAB CLIN MED, V36, P440
   WEINSTEIN JN, 1983, SCIENCE, V222, P423, DOI 10.1126/science.6623082
   WEISSLEDER H, 1989, RADIOLOGY, V170, P371
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729
   WEISSLEDER R, 1989, RADIOLOGY, V171, P835
   YEUTSU N, 1980, LYMPHATIC SYSTEM MET, P119
NR 32
TC 33
Z9 33
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD AUG
PY 1989
VL 172
IS 2
BP 315
EP 317
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA AF917
UT WOS:A1989AF91700005
PM 2748809
ER

PT J
AU GARDNER, ES
AF GARDNER, ES
TI A SIMPLE METHOD OF COMPUTING PREDICTION INTERVALS FOR TIME-SERIES
   FORECASTS
SO MANAGEMENT SCIENCE
LA English
DT Article
RP GARDNER, ES (reprint author), UNIV HOUSTON,COLL BUSINESS ADM,HOUSTON,TX 77004, USA.
CR Box GEP, 1976, TIME SERIES ANAL
   Brown RG, 1963, SMOOTHING FORECASTIN
   CARBONE R, 1986, MANAGE SCI, V32, P257, DOI 10.1287/mnsc.32.3.257
   GARDNER ES, 1986, AUTOCAST EXPONENTIAL
   GARDNER ES, 1985, MANAGE SCI, V31, P1237, DOI 10.1287/mnsc.31.10.1237
   LUSK E, 1986, IN PRESS INT J FOREC
   MAKRIDAKIS S, 1982, J FORECASTING, V1, P111, DOI 10.1002/for.3980010202
   MAKRIDAKIS S, 1986, IN PRESS INT J FOREC
   MAKRIDAKIS S, 1985, SAMPLING DISTRIBUTIO
   MCKENZIE E, 1986, INT J FORECASTING, V2, P373, DOI 10.1016/0169-2070(86)90055-5
   MCKENZIE E, 1976, STATISTICIAN, V25, P3, DOI 10.2307/2988127
   MCKENZIE E, 1984, J FORECASTING, V3, P333, DOI 10.1002/for.3980030312
   SWEET AL, 1985, J FORECASTING, V4, P235, DOI 10.1002/for.3980040210
   WILKS SS, 1962, MATH STATISTICS
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
NR 15
TC 33
Z9 34
PU INST OPERATIONS RESEARCH  MANAGEMENT SCIENCES
PI LINTHICUM HTS
PA 901 ELKRIDGE LANDING RD, STE 400, LINTHICUM HTS, MD 21090-2909
SN 0025-1909
J9 MANAGE SCI
JI Manage. Sci.
PD APR
PY 1988
VL 34
IS 4
BP 541
EP 546
DI 10.1287/mnsc.34.4.541
PG 6
WC Management; Operations Research & Management Science
SC Business & Economics; Operations Research & Management Science
GA M8883
UT WOS:A1988M888300010
ER

PT J
AU SINGER, B
   COHEN, JE
AF SINGER, B
   COHEN, JE
TI ESTIMATING MALARIA INCIDENCE AND RECOVERY RATES FROM PANEL SURVEYS
SO MATHEMATICAL BIOSCIENCES
LA English
DT Article
C1 ROCKEFELLER UNIV,NEW YORK,NY 10021.
CR ANDERSON TW, 1957, ANN MATH STAT, V28, P89, DOI 10.1214/aoms/1177707039
   BAILEY NTJ, 1975, MATH THEORY INFECTIO
   Barlow R. E., 1965, MATH THEORY RELIABIL
   BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685
   BILLINGSLEY P, 1961, STATISTICAL INFERENC
   COHEN S, 1979, PROC R SOC SER B-BIO, V203, P323, DOI 10.1098/rspb.1979.0001
   CORNILLEBROGGER R, 1975, B WHO, V52, P39
   CUTHBERT JR, 1972, J LOND MATH SOC, V4, P623
   DIETZ K, 1975, B INT STATISTICAL I, V1, P531
   DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347
   GOODMAN GS, 1970, Z WAHRSCHEINLICHKEIT, V16, P165, DOI 10.1007/BF00534594
   IOSIFESCU I, 1973, STOCHASTIC PROCESSES, V2
   GOODMAN GS, 1973, P CAMB PHILOS SOC, V73, P119
   KEIDING N, 1975, ANN STAT, V3, P363, DOI 10.1214/aos/1176343062
   Kingman J. F. C., 1962, Z WAHRSCHEINLICHKEIT, V1, P14, DOI 10.1007/BF00531768
   LEHMANN EL, 1957, ANN MATH STAT, V28, P547, DOI 10.1214/aoms/1177706873
   Lotka AJ, 1923, AM J HYG, V3, P1
   MacDonald G, 1957, EPIDEMIOLOGY CONTROL
   Martini E., 1921, BERECHNUNGEN BEOBACH
   CORNILLEBROGGER R, 1978, B WORLD HEALTH ORGAN, V56, P579
   MOLINEAUX L, 1976, B WHO, V43, P379
   MOLINEAUX L, UNPUBLISHED
   NAJERA JA, 1974, B WORLD HEALTH ORGAN, V50, P449
   Ross R, 1911, PREVENTION MALARIA
   Ross R, 1928, STUDIES MALARIA
   Sheps M, 1973, MATH MODELS CONCEPTI
   SINGER B, 1976, AM J SOCIOL, V82, P1, DOI 10.1086/226269
   West LS, 1963, PRACTICAL MALARIOLOG
   WILLIAMS WH, 1970, J AM STAT ASSOC, V65, P1338
   YOUNG M, 1966, MANUAL TROPICAL MEDI, P316
NR 30
TC 33
Z9 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0025-5564
J9 MATH BIOSCI
JI Math. Biosci.
PY 1980
VL 49
IS 3-4
BP 273
EP 305
DI 10.1016/0025-5564(80)90084-X
PG 33
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA JU737
UT WOS:A1980JU73700008
ER

PT J
AU Hillis, LD
   Smith, PK
   Anderson, JL
   Bittl, JA
   Bridges, CR
   Byrne, JG
   Cigarroa, JE
   DiSesa, VJ
   Hiratzka, LF
   Hutter, AM
   Jessen, ME
   Keeley, EC
   Lahey, SJ
   Lange, RA
   London, MJ
   Mack, MJ
   Patel, MR
   Puskas, JD
   Sabik, JF
   Selnes, O
   Shahian, DM
   Trost, JC
   Winniford, MD
   Jacobs, AK
   Anderson, JL
   Albert, N
   Creager, MA
   Ettinger, SM
   Guyton, RA
   Halperin, JL
   Hochman, JS
   Kushner, FG
   Ohman, EM
   Stevenson, W
   Yancy, CW
AF Hillis, L. David
   Smith, Peter K.
   Anderson, Jeffrey L.
   Bittl, John A.
   Bridges, Charles R.
   Byrne, John G.
   Cigarroa, Joaquin E.
   DiSesa, Verdi J.
   Hiratzka, Loren F.
   Hutter, Adolph M., Jr.
   Jessen, Michael E.
   Keeley, Ellen C.
   Lahey, Stephen J.
   Lange, Richard A.
   London, Martin J.
   Mack, Michael J.
   Patel, Manesh R.
   Puskas, John D.
   Sabik, Joseph F.
   Selnes, Ola
   Shahian, David M.
   Trost, Jeffrey C.
   Winniford, Michael D.
   Jacobs, Alice K.
   Anderson, Jeffrey L.
   Albert, Nancy
   Creager, Mark A.
   Ettinger, Steven M.
   Guyton, Robert A.
   Halperin, Jonathan L.
   Hochman, Judith S.
   Kushner, Frederick G.
   Ohman, E. Magnus
   Stevenson, William
   Yancy, Clyde W.
CA Writing Comm Members
   ACCF AHA Task Force Members
TI 2011 ACCF/AHA guideline for coronary artery bypass graft surgery:
   Executive summary
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL;
   RANDOMIZED-CONTROLLED-TRIAL; QUALITY-OF-LIFE; VACUUM-ASSISTED CLOSURE;
   ACUTE-RENAL-FAILURE; HIGH-RISK PATIENTS; LEFT-VENTRICULAR DYSFUNCTION;
   PREOPERATIVE STATIN THERAPY; DRUG-ELUTING STENTS
AB The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
   The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have jointly produced guidelines in the area of cardiovascular disease since 1980. The ACCF/AHATask Force on Practice Guidelines (Task Force), charged with developing, updating, and revising practice guidelines for cardiovascular diseases and procedures, directs and oversees this effort. Writing committees are charged with regularly reviewing and evaluating all available evidence to develop balanced, patient-centric recommendations for clinical practice.
   Experts in the subject under consideration are selected by the ACCF and AHA to examine subject-specific data and write guidelines in partnership with representatives from other medical organizations and specialty groups. Writing committees are asked to perform a formal literature review; weigh the strength of evidence for or against particular tests, treatments, or procedures; and include estimates of expected outcomes where such data exist. Patient-specific modifiers, comorbidities, and issues of patient preference that may influence the choice of tests or therapies are considered. When available, information from studies on cost is considered, but data on efficacy and outcomes constitute the primary basis for the recommendations contained herein.
   In analyzing the data and developing recommendations and supporting text, the writing committee uses evidence-based methodologies developed by the Task Force. 1 The Class of Recommendation (COR) is an estimate of the size of the treatment effect considering risks versus benefits in addition to evidence and/or agreement that a given treatment or procedure is or is not useful/effective or in some situations may cause harm. The Level of Evidence (LOE) is an estimate of the certainty or precision of the treatment effect. The writing committee reviews and ranks evidence supporting each recommendation with the weight of evidence ranked as LOE A, B, or C according to specific definitions that are included in Table 1. Studies are identified as observational, retrospective, prospective, or randomized where appropriate. For certain conditions for which inadequate data are available, recommendations are based on expert consensus and clinical experience and are ranked as LOE C. When recommendations at LOE C are supported by historical clinical data, appropriate references (including clinical reviews) are cited if available. For issues for which sparse data are available, a survey of current practice among the clinicians on the writing committee is the basis for LOE C recommendations, and no references are cited. The schema for COR and LOE is summarized in Table 1, which also provides suggested phrases for writing recommendations within each COR. A new addition to this methodology is separation of the Class III recommendations to delineate if the recommendation is determined to be of "no benefit" or is associated with "harm" to the patient. In addition, in view of the increasing number of comparative effectiveness studies, comparator verbs and suggested phrases for writing recommendations for the comparative effectiveness of one treatment or strategy versus another have been added for COR I and IIa, LOE A or B only.
   In view of the advances in medical therapy across the spectrum of cardiovascular diseases, the Task Force has designated the term guideline-directed medical therapy (GDMT) to represent optimal medical therapy as defined by ACCF/AHA guideline-recommended therapies (primarily Class I). This new term, GDMT, will be used herein and throughout all future guidelines.
   Because the ACCF/AHA practice guidelines address patient populations (and healthcare providers) residing in North America, drugs that are not currently available in North America are discussed in the text without a specific COR. For studies performed in large numbers of subjects outside North America, each writing committee reviews the potential influence of different practice patterns and patient populations on the treatment effect and relevance to the ACCF/AHA target population to determine whether the findings should inform a specific recommendation.
   The ACCF/AHA practice guidelines are intended to assist healthcare providers in clinical decision making by describing a range of generally acceptable approaches to the diagnosis, management, and prevention of specific diseases or conditions. The guidelines attempt to define practices that meet the needs of most patients in most circumstances. The ultimate judgment regarding the care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient. As a result, situations may arise for which deviations from these guidelines may be appropriate. Clinical decision making should involve consideration of the quality and availability of expertise in the area where care is provided. When these guidelines are used as the basis for regulatory or payer decisions, the goal should be improvement in quality of care. The Task Force recognizes that situations arise in which additional data are needed to inform patient care more effectively; these areas will be identified within each respective guideline when appropriate.
   Prescribed courses of treatment in accordance with these recommendations are effective only if followed. Because lack of patient understanding and adherence may adversely affect outcomes, physicians and other healthcare providers should make every effort to engage the patient's active participation in prescribed medical regimens and lifestyles. In addition, patients should be informed of the risks, benefits, and alternatives to a particular treatment and be involved in shared decision making whenever feasible, particularly for COR IIa and IIb, where the benefit-to-risk ratio may be lower.
   The Task Force makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of industry relationships or personal interests among the members of the writing committee. All writing committee members and peer reviewers of the guideline are required to disclose all such current relationships, as well as those existing 12 months previously. In December 2009, the ACCF and AHA implemented a new policy for relationships with industry and other entities (RWI) that requires the writing committee chair plus a minimum of 50% of the writing committee to have no relevant RWI (Appendix 1 for the ACCF/AHA definition of relevance). These statements are reviewed by the Task Force and all members during each conference call and meeting of the writing committee and are updated as changes occur. All guideline recommendations require a confidential vote by the writing committee and must be approved by a consensus of the voting members. Members are not permitted to write, and must rescue themselves from voting on, any recommendation or section to which their RWI apply. Members who recused themselves from voting are indicated in the list of writing committee members, and section recusals are noted in Appendix 1. Authors' and peer reviewers' RWI pertinent to this guideline are disclosed in Appendixes 1 and 2, respectively. Additionally, to ensure complete transparency, writing committee members' comprehensive disclosure information-including RWI not pertinent to this document-is available as an online supplement. Comprehensive disclosure information for the Task Force is also available online at www.cardiosource.org/ACC/About-ACC/Leadership/Guide lines-and-Documents-Task-Forces. aspx. The work of the writing committee was supported exclusively by the ACCF and AHA without commercial support. Writing committee members volunteered their time for this activity.
   In an effort to maintain relevance at the point of care for practicing physicians, the Task Force continues to oversee an ongoing process improvement initiative. As a result, in response to pilot projects, evidence tables (with references linked to abstracts in PubMed) have been added.
   In April 2011, the Institute of Medicine released 2 reports: Finding What Works in Health Care: Standards for Systematic Reviews and Clinical Practice Guidelines We Can Trust. 2,3 It is noteworthy that the ACCF/AHA guidelines are cited as being compliant with many of the proposed standards. A thorough review of these reports and of our current methodology is under way, with further enhancements anticipated.
   The recommendations in this guideline are considered current until they are superseded by a focused update or the full-text guideline is revised. Guidelines are official policy of both the ACCF and AHA.
C1 [Jacobs, Alice K.] ACCF AHA Task Force Practice Guidelines, New York, NY USA.
CR Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Acar C, 1998, J THORAC CARDIOV SUR, V116, P981, DOI 10.1016/S0022-5223(98)70050-9
   ACCF/AHA Task Force on Practice Guidelines, METH POL ACCF AHA TA
   Adabag AS, 2009, EUR HEART J, V30, P1910, DOI 10.1093/eurheartj/ehp053
   Aklog L, 2001, CIRCULATION, V104, pI68
   Alderman E, 1997, CIRCULATION, V96, P1761
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   Alexiou K, 2008, CLIN RES CARDIOL, V97, P601, DOI 10.1007/s00392-008-0657-6
   Ali IM, 1997, EUR J CARDIO-THORAC, V11, P1154, DOI 10.1016/S1010-7940(97)01215-3
   Al-Khatib SM, 2009, AM HEART J, V158, P792, DOI 10.1016/j.ahj.2009.09.003
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Amar D, 2001, CHEST, V119, P1476, DOI 10.1378/chest.119.5.1476
   American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography, 2010, ANESTHESIOLOGY, V112, P1084
   American Society of Anesthesiologists Task Force on pulmonary artery catheterization, 2003, ANESTHESIOLOGY, V99, P988
   Amin AP, 2009, J INVASIVE CARDIOL, V21, P305
   ANDREWS TC, 1991, CIRCULATION, V84, P236
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Angelini GD, 1996, LANCET, V347, P757, DOI 10.1016/S0140-6736(96)90107-5
   [Anonymous], 2002, CIRCULATION, V106, P3143
   Anthonisen NR, 2005, ANN INTERN MED, V142, P233
   Antithrombotic Trialists' Collaboration, 2002, BMJ, V324, P71
   Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002
   Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107
   Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7
   AUSTIN TW, 1980, CAN J SURG, V23, P483
   Avidan MS, 2004, BRIT J ANAESTH, V92, P178, DOI 10.1093/bja/aeh037
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baillot R, 2010, EUR J CARDIO-THORAC, V37, P880, DOI 10.1016/j.ejcts.2009.09.023
   Bainbridge D, 2006, CAN J ANAESTH, V53, P492
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Barakate MS, 2003, ANN THORAC SURG, V75, P1400, DOI 10.1016/S0003-4975(02)05026-9
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   Benedetto U, 2008, ANN THORAC SURG, V86, P1160, DOI 10.1016/j.athoracsur.2008.06.018
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berger JS, 2008, J AM COLL CARDIOL, V52, P1693, DOI 10.1016/j.jacc.2008.08.031
   Bergquist BD, 1996, ANESTH ANALG, V82, P1139, DOI 10.1097/00000539-199606000-00007
   Berry PD, 1998, BRIT J ANAESTH, V80, P20
   Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   Bizzarri F, 2001, J THORAC CARDIOV SUR, V122, P1181, DOI 10.1067/mtc.2001.117838
   Blumberg N, 2002, AM J CLIN PATHOL, V118, P376
   Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Bolon MK, 2004, CLIN INFECT DIS, V38, P1357, DOI 10.1086/383318
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   BOYLAN MJ, 1994, J THORAC CARDIOV SUR, V107, P657
   Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Buckberg GD, 2010, J THORAC CARDIOV SUR, V140, P12, DOI 10.1016/j.jtcvs.2010.02.014
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   Butterworth J, 2005, J THORAC CARDIOV SUR, V130, P1319, DOI 10.1016/j.jtcvs.2005.02.049
   Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805
   Cahalan MK, 2002, J AM SOC ECHOCARDIOG, V15, P647, DOI 10.1067/mje.2002.123956
   Caimmi PP, 2003, J CARDIOTHOR VASC AN, V17, P491, DOI 10.1016/S1053-0770(03)00155-1
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Campeau L, 1997, NEW ENGL J MED, V336, P153
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   Centers for Diseases Control and Prevention, 2010, MMWR-MORBID MORTAL W, V44, P1
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Cheng DCH, 1996, J THORAC CARDIOV SUR, V112, P755, DOI 10.1016/S0022-5223(96)70062-4
   Cheng DCH, 1996, ANESTHESIOLOGY, V85, P1300, DOI 10.1097/00000542-199612000-00011
   Chevalier P, 2004, EUR J CARDIO-THORAC, V26, P330, DOI 10.1016/j.ejcts.2004.04.027
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chiu FC, 2009, J THORAC CARDIOV SUR, V138, P1326, DOI 10.1016/j.jtcvs.2009.03.038
   Christenson JT, 1999, EUR J CARDIO-THORAC, V15, P394, DOI 10.1016/S1010-7940(99)00034-2
   Christenson JT, 2003, J CARDIAC SURG, V18, P286, DOI 10.1046/j.1540-8191.2003.02030.x
   Christenson JT, 1999, ANN THORAC SURG, V68, P934, DOI 10.1016/S0003-4975(99)00687-6
   Christenson JT, 2002, ANN THORAC SURG, V74, P1086, DOI 10.1016/S0003-4975(02)03854-7
   Christenson JT, 2001, CARDIOVASC SURG, V9, P383, DOI 10.1016/S0967-2109(00)00151-4
   Chu MWA, 2004, ANN THORAC SURG, V78, P1536, DOI 10.1016/j.athoracsur.2004.03.028
   Chukwuemeka A, 2005, ANN THORAC SURG, V80, P2148, DOI 10.1016/j.athoracsur.2005.06.015
   CHUNG F, 1988, ANESTHESIOLOGY, V69, P343, DOI 10.1097/00000542-198809000-00010
   Clark AM, 2005, ANN INTERN MED, V143, P659
   Clark RE, 1996, ANN THORAC SURG, V61, P21, DOI 10.1016/0003-4975(95)00734-2
   Cogliati AA, 2007, J CARDIOTHOR VASC AN, V21, P847, DOI 10.1053/j.jvca.2007.02.022
   Collard CD, 2006, J THORAC CARDIOV SUR, V132, P392, DOI 10.1016/j.jtcvs.2006.04.009
   Connerney I, 2001, LANCET, V358, P1766, DOI 10.1016/S0140-6736(01)06803-9
   Connolly SJ, 2003, AM HEART J, V145, P226, DOI 10.1067/mhj.2003.147
   Cowan KN, 2005, ANN THORAC SURG, V80, P2205, DOI 10.1016/j.athoracsur.2005.04.005
   CRAVER JM, 1992, ANN SURG, V215, P425, DOI 10.1097/00000658-199205000-00004
   Crystal E, 2004, COCHRANE DB SYST REV, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2005.12.015
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0
   Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501
   Davies RF, 1997, CIRCULATION, V95, P2037
   Davis RF, 2000, CARDIOPULMONARY BYPA, P186, DOI DOI 10.1053/J.JVCA.2007.02.022
   Del Duca D, 2007, ANN THORAC SURG, V84, P1264, DOI 10.1016/j.athoracsur.2007.05.016
   Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982
   DESPOTIS GJ, 1994, TRANSFUSION, V34, P290, DOI 10.1046/j.1537-2995.1994.34494233575.x
   DEWOOD MA, 1983, CIRCULATION, V68, P8
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Di Mauro M, 2007, ANN THORAC SURG, V84, P1496, DOI 10.1016/j.athoracsur.2007.05.054
   Doenst T, 2005, J THORAC CARDIOV SUR, V130, P1144, DOI 10.1016/j.jtcvs.2005.05.049
   Donatelli F, 1997, EUR J CARDIO-THORAC, V11, P228, DOI 10.1016/S1010-7940(96)01050-0
   Doss M, 2002, EUR J CARDIO-THORAC, V22, P934, DOI 10.1016/S1010-7940(02)00594-8
   Dotani MI, 2000, AM J CARDIOL, V86, P1128, DOI 10.1016/S0002-9149(00)01172-3
   Dowd NP, 1998, ANESTHESIOLOGY, V89, P1068, DOI 10.1097/00000542-199811000-00006
   Drew BJ, 2004, CIRCULATION, V110, P2721, DOI 10.1161/01.CIR.0000145144.56673.59
   Duncan AE, 2010, ANESTHESIOLOGY, V112, P860, DOI 10.1097/ALN.0b013e3181d3d4b4
   Durand DJ, 2004, ANN THORAC SURG, V78, P159, DOI 10.1016/j.athorascur.2004.02.024
   Dyke CM, 2000, ANN THORAC SURG, V70, P866, DOI 10.1016/S0003-4975(00)01654-4
   Dyub AM, 2008, J CARDIAC SURG, V23, P79, DOI 10.1111/j.1540-8191.2007.00499.x
   Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Eagle Kim A, 2004, J Am Coll Cardiol, V44, pe213
   Echahidi N, 2008, J AM COLL CARDIOL, V51, P793, DOI 10.1016/j.jacc.2007.10.043
   El-Hamamsy I, 2007, J THORAC CARDIOV SUR, V133, P7, DOI 10.1016/j.jtcvs.2006.05.070
   Ellis SG, 1997, CIRCULATION, V96, P3867
   Eltzschig HK, 2008, ANN THORAC SURG, V85, P845, DOI 10.1016/j.athoracsur.2007.11.015
   Engblom E, 1997, J Cardiopulm Rehabil, V17, P29, DOI 10.1097/00008483-199701000-00004
   Englberger L, 2004, EUR J CARDIO-THORAC, V26, P96, DOI 10.1016/j.ejcts.2004.03.030
   Ennker IC, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-5
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   Fansa Iyad, 2003, Med Sci Monit, V9, pPI30
   Fattouch K, 2009, J THORAC CARDIOV SUR, V138, P278, DOI 10.1016/j.jtcvs.2008.11.010
   Fattouch K, 2010, ANN THORAC SURG, V90, P1187, DOI 10.1016/j.athoracsur.2010.03.103
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   *FDA SAF AL, 2011, ZOC SIMV INCR RISK M, DOI DOI 10.1161/01.CIR.0000133317.49796.0E
   Feit F, 2000, CIRCULATION, V101, P2795
   FEKETY FR, 1969, J THORAC CARDIOV SUR, V57, P757
   Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221
   Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395
   Filizcan U, 2011, ANGIOLOGY, V62, P68, DOI 10.1177/0003319710369103
   Filsoufi F, 2002, J HEART VALVE DIS, V11, pS45
   Finkelstein R, 2002, J THORAC CARDIOV SUR, V123, P326, DOI 10.1067/mtc.2002.119698
   Firanescu CE, 2009, EUR J CARDIO-THORAC, V36, P856, DOI 10.1016/j.ejcts.2009.05.032
   Fischer UM, 2005, CURR MED RES OPIN, V21, P1161, DOI 10.1185/030079905X53289
   Fleck Tatjana, 2006, Interact Cardiovasc Thorac Surg, V5, P145, DOI 10.1510/icvts.2005.122804
   Fleck TM, 2002, ANN THORAC SURG, V74, P1596, DOI 10.1016/S0003-4975(02)03948-6
   FONG IW, 1979, J THORAC CARDIOV SUR, V78, P908
   Fox KM, 2007, AM HEART J, V153, P629, DOI 10.1016/j.ahj.2007.01.032
   Freedland KE, 2009, ARCH GEN PSYCHIAT, V66, P387, DOI 10.1001/archgenpsychiatry.2009.7
   Friedrich JO, 2005, ANN INTERN MED, V142, P510
   FROMMELT PC, 2011, J THORAC CARDIO 0323
   Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181
   Furnary Anthony P, 2006, Semin Thorac Cardiovasc Surg, V18, P302, DOI 10.1053/j.semtcvs.2006.04.005
   Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013
   Gandhi GY, 2007, ANN INTERN MED, V146, P233
   GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450
   Geraci JM, 2005, MED CARE, V43, P149, DOI 10.1097/00005650-200502000-00008
   Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Gillinov A Marc, 2005, Curr Cardiol Rep, V7, P101, DOI 10.1007/s11886-005-0020-8
   GOODMAN JS, 1968, NEW ENGL J MED, V278, P117, DOI 10.1056/NEJM196801182780301
   GORDON MA, 1991, ANESTHESIOLOGY, V74, P848, DOI 10.1097/00000542-199105000-00008
   Goyal A, 2007, ANN THORAC SURG, V83, P993, DOI 10.1016/j.athoracsur.2006.10.046
   Greilich PE, 2009, ANESTH ANALG, V109, P15, DOI 10.1213/ane.0b013e3181a40b5d
   Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944
   Groesdonk HV, 2010, J CARDIOTHOR VASC AN, V24, P785, DOI 10.1053/j.jvca.2010.03.018
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   Haase M, 2007, CRIT CARE MED, V35, P1324, DOI 10.1097/01.CCM.0000261887.69976.12
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Haeffener MP, 2008, AM HEART J, V156, P900
   Halonen J, 2006, CIRCULATION, V114, pI1, DOI 10.1161/CIRCULATIONAHA.105.000851
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 1997, HEALTH SERV RES, V31, P659
   Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B
   HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209
   HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003
   HANNAN EL, 1992, MED CARE, V30, P892, DOI 10.1097/00005650-199210000-00002
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hansen D, 2009, ACTA CARDIOL, V64, P639, DOI 10.2143/AC.64.5.2042694
   HARTZ AJ, 1994, AM J PUBLIC HEALTH, V84, P1609, DOI 10.2105/AJPH.84.10.1609
   Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3
   Hawkes CA, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003587
   Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119
   Collins R, 2002, LANCET, V360, P7
   Held C, 2010, J AM COLL CARDIOL, V57, P672
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Herman CR, 2010, ANN THORAC SURG, V89, P397, DOI 10.1016/j.athoracsur.2009.10.051
   Heusch G, 2008, BRIT J PHARMACOL, V153, P1589, DOI 10.1038/sj.bjp.0707673
   Hilleman DE, 2004, CHEST, V125, P435, DOI 10.1378/chest.125.2.435
   Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   Hongo RH, 2002, J AM COLL CARDIOL, V40, P231, DOI 10.1016/S0735-1097(02)01954-X
   Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851
   Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855
   Institute of Medicine, 2011, CLIN PRACT GUID WE C
   Institute of Medicine, 2011, FIND WHAT WORKS HLTH
   IPYAM PC, 1994, ANESTH ANALG, V78, P842
   Jain U, 1997, ANESTHESIOLOGY, V86, P576, DOI 10.1097/00000542-199703000-00009
   Jones HU, 2002, CIRCULATION, V106, pI19, DOI 10.1161/01.cir.0000032917.33237.e0
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   Jones RH, 1996, J AM COLL CARDIOL, V28, P1478, DOI 10.1016/S0735-1097(96)00359-2
   JURKIEWICZ MJ, 1980, ANN SURG, V191, P738, DOI 10.1097/00000658-198006000-00012
   KAISER AB, 1987, ANN SURG, V206, P791, DOI 10.1097/00000658-198712000-00018
   KAISER GA, 1975, SURGERY, V78, P749
   Kalant N, 2004, CAN J CARDIOL, V20, P81
   Kapetanakis EI, 2006, CIRCULATION, V113, P1667, DOI 10.1161/CIRCULATIONAHA.105.571828
   Kappetein AP, 2011, EUR HEART J, V17, P2125
   KELLY P, 1990, J AM COLL CARDIOL, V15, P267
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kikura M, 2006, J AM COLL SURGEONS, V202, P216, DOI 10.1016/j.jamcollsurg.2005.10.001
   Kim JHJ, 2008, AM HEART J, V156, P886, DOI 10.1016/j.ahj.2008.06.034
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   Kincaid EH, 2003, ANN THORAC SURG, V76, P124, DOI 10.1016/S0003-4975(03)00190-5
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   Kirdemir P, 2008, J CARDIOTHOR VASC AN, V22, P383, DOI 10.1053/j.jvca.2007.09.015
   Kjoller-Hansen L, 2000, J AM COLL CARDIOL, V35, P881, DOI 10.1016/S0735-1097(99)00634-8
   Knatterud GL, 2000, CIRCULATION, V102, P157
   KNIGHT AA, 1988, ANESTHESIOLOGY, V68, P681, DOI 10.1097/00000542-198805000-00005
   Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037
   Kofidis T, 2008, PERFUSION-UK, V23, P147, DOI 10.1177/0267659108097880
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Konvalinka A, 2006, J HOSP INFECT, V64, P162, DOI 10.1016/j.jhin.2006.06.010
   Krasuski RA, 2011, CIRCULATION, V123, P154, DOI 10.1161/CIRCULATIONAHA.109.921106
   KRETER B, 1992, J THORAC CARDIOV SUR, V104, P590
   Kulik A, 2008, CIRCULATION, V118, P1785, DOI 10.1161/CIRCULATIONAHA.108.799445
   Lahtinen P, 2006, ANESTHESIOLOGY, V105, P794, DOI 10.1097/00000542-200610000-00026
   Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013
   Landoni G, 2008, J CARDIOTHOR VASC AN, V22, P27, DOI 10.1053/j.jvca.2007.07.015
   Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.200610.013
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Laurikka J, 2002, CHEST, V121, P1183, DOI 10.1378/chest.121.4.1183
   Lavana JD, 2010, J THORAC CARDIOV SUR, V140, P80, DOI 10.1016/j.jtcvs.2009.09.033
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   LEMERY R, 1992, AM J CARDIOL, V70, P147, DOI 10.1016/0002-9149(92)91266-7
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Levin MA, 2009, CIRCULATION, V120, P1664, DOI 10.1161/CIRCULATIONAHA.108.814533
   Liakopoulos OJ, 2008, EUR HEART J, V29, P1548, DOI 10.1093/eurheartj/ehn198
   Lim HS, 2009, JACC-CARDIOVASC INTE, V2, P146, DOI 10.1016/j.jcin.2008.11.006
   Lin Terence, 2010, Congest Heart Fail, V16, P170, DOI 10.1111/j.1751-7133.2010.00146.x
   Lincoff AM, 2000, ANN THORAC SURG, V70, P516, DOI 10.1016/S0003-4975(00)01343-6
   Liu JY, 2000, CIRCULATION, V102, P2973
   Liu SS, 2004, ANESTHESIOLOGY, V101, P153, DOI 10.1097/00000542-200407000-00024
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Lucchinetti E, 2007, ANESTHESIOLOGY, V106, P444, DOI 10.1097/00000542-200703000-00008
   Luckraz H, 2003, J THORAC CARDIOV SUR, V125, P301, DOI 10.1067/mtc.2003.74
   Luo WJ, 2008, EUR J CARDIO-THORAC, V33, P203, DOI 10.1016/j.ejcts.2007.11.010
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X
   Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070
   Mack MJ, 2005, J THORAC CARDIOV SUR, V129, P1309, DOI 10.1016/j.jtcvs.2004.10.036
   MAKI DG, 1992, J THORAC CARDIOV SUR, V104, P1423
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Maltais S, 2008, EUR J CARDIO-THORAC, V34, P127, DOI 10.1016/j.ejcts.2008.03.052
   Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798
   Mangano DT, 1997, JAMA-J AM MED ASSOC, V277, P325, DOI 10.1001/jama.277.4.325
   Mangano DT, 2006, J AM COLL CARDIOL, V48, P206, DOI 10.1016/j.jacc.2006.04.044
   MANGANO DT, 1992, ANESTHESIOLOGY, V76, P342, DOI 10.1097/00000542-199203000-00004
   Maniar HS, 2002, J THORAC CARDIOV SUR, V123, P45, DOI 10.1067/mtc.2002.118686
   Mannacio VA, 2008, J THORAC CARDIOV SUR, V136, P1541, DOI 10.1016/j.jtcvs.2008.06.038
   Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789
   Martinez EA, 2010, ANESTH ANALG, V110, P307, DOI 10.1213/ANE.0b013e3181c92b9c
   Mathew JP, 2006, J AM SOC ECHOCARDIOG, V19, P1303, DOI 10.1016/j.echo.2006.08.039
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   McDonald SB, 2005, J CARDIOTHOR VASC AN, V19, P4, DOI 10.1053/j.jvca.2004.11.002
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   Medalion B, 2010, J THORAC CARDIOV SUR, V139, P1539, DOI 10.1016/j.jtcvs.2009.08.042
   Medalion B, 2003, J THORAC CARDIOV SUR, V126, P1875, DOI 10.1016/S0022-5223(03)01324-2
   Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P285
   Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P49
   Mehta RH, 2009, CIRC-CARDIOVASC QUAL, V2, P583, DOI 10.1161/CIRCOUTCOMES.109.858811
   Mehta RH, 2010, AM HEART J, V159, P141, DOI 10.1016/j.ahj.2009.10.035
   Alexander JH, 2008, JAMA-J AM MED ASSOC, V299, P1777
   Miceli A, 2009, J AM COLL CARDIOL, V54, P1778, DOI 10.1016/j.jacc.2009.07.008
   Migliorini A, 2006, AM HEART J, V152, P903, DOI 10.1016/j.ahj.2005.12.030
   Milani RV, 1998, CHEST, V113, P599, DOI 10.1378/chest.113.3.599
   Moises VA, 1998, J AM SOC ECHOCARDIOG, V11, P1139, DOI 10.1016/S0894-7317(98)80009-6
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Moran SV, 2001, ANN THORAC SURG, V72, P1552, DOI 10.1016/S0003-4975(01)03090-9
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4
   Murphy GJ, 2006, J THORAC CARDIOVASC, V132, pe1
   Murphy GJ, 2006, J THORAC CARDIOV SUR, V132, P475, DOI 10.1016/j.jctvs.2006.01.064
   Murphy GS, 2003, ANESTH ANALG, V96, P1301, DOI 10.1213/01.ANE.0000057602.27031.C8
   Murphy MB, 2001, NEW ENGL J MED, V345, P1548
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Myles PS, 2003, ANESTHESIOLOGY, V99, P982
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Nakamura M, 2008, ANN THORAC SURG, V85, P513, DOI 10.1016/j.athoracsur.2007.08.056
   Nallamothu BK, 2001, J AM COLL CARDIOL, V38, P1923, DOI 10.1016/S0735-1097(01)01647-3
   Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506
   Ngaage DL, 2008, ANN THORAC SURG, V85, P1278, DOI 10.1016/j.athoracsur.2007.12.035
   Nigwekar SU, 2009, J CARDIOTHOR VASC AN, V23, P151, DOI 10.1053/j.jvca.2008.11.007
   Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330
   Nuttall GA, 2001, ANESTHESIOLOGY, V94, P773, DOI 10.1097/00000542-200105000-00014
   Nygard E, 2005, CIRCULATION, V111, P2165, DOI 10.1161/01.CIR.0000163551.33812.1A
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   Oosterga M, 2001, AM J CARDIOL, V87, P542, DOI 10.1016/S0002-9149(00)01428-4
   Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(3)00125-9
   Ouattara A, 2005, ANESTHESIOLOGY, V103, P687, DOI 10.1097/00000542-200510000-00006
   Ouyang P, 2006, ATHEROSCLEROSIS, V189, P375, DOI 10.1016/j.atherosclerosis.2005.12.015
   Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Pan W, 2004, CIRCULATION S, V110, pII45, DOI DOI 10.1016/J.ATHORACSUR.2005.07.038
   PAONE G, 1994, SURGERY, V116, P672
   Parikh SV, 2010, JACC-CARDIOVASC INTE, V3, P419, DOI 10.1016/j.jcin.2010.01.012
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Pascual DA, 2006, ANN THORAC SURG, V81, P78, DOI 10.1016/j.athoracsur.2005.07.038
   PEARSON KS, 1989, ANESTH ANALG, V69, P336
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Penttila HJ, 2003, ANN THORAC SURG, V75, P1246, DOI 10.1016/S0003-4975(02)04659-3
   Pereira JJ, 2005, AM J MED, V118, P735, DOI 10.1016/j.amjmed.2005.01.072
   Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Piper SN, 2003, CAN J ANAESTH, V50, P285
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   PODESSER BK, 1995, J THORAC CARDIOV SUR, V110, P1461, DOI 10.1016/S0022-5223(95)70069-2
   Possati G, 1998, J THORAC CARDIOV SUR, V116, P1015, DOI 10.1016/S0022-5223(98)70054-6
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Qaddoura FE, 2004, ANN THORAC SURG, V78, P1586, DOI 10.1016/j.athoracsur.2004.05.001
   Rabi Doreen, 2010, Can J Cardiol, V26, P178
   Rader F, 2010, AM HEART J, V160, P329, DOI 10.1016/j.ahj.2010.05.033
   Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667
   Raja SG, 2006, J CARDIAC SURG, V21, P35, DOI 10.1111/j.1540-8191.2006.00164.x
   Rand RP, 1998, ANN THORAC SURG, V65, P1046, DOI 10.1016/S0003-4975(98)00087-3
   Ranucci M, 2010, MINERVA ANESTESIOL, V76, P249
   Ranucci Marco, 2008, Am J Cardiol, V101, P1112, DOI 10.1016/j.amjcard.2007.12.011
   Ranucci M, 2004, ANN THORAC SURG, V78, P1332, DOI 10.1016/j.athorcsur.2004.02.065
   Rathore SS, 2004, ANN SURG, V239, P110, DOI 10.1097/01.sla.0000103066.22732.b8
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Renda G, 2007, HAEMATOL-HEMATOL J, V92, P366, DOI 10.3324/haematol.10913
   Resano FG, 2006, J CARDIOTHOR VASC AN, V20, P300, DOI 10.1053/j.jvca.2006.01.017
   Rigotti NA, 2008, ARCH INTERN MED, V168, P1950, DOI 10.1001/archinte.168.18.1950
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670
   Rollman BL, 2009, PSYCHOSOM MED, V71, P217, DOI 10.1097/PSY.0b013e3181970c1c
   Romano G, 2010, J THORAC CARDIOV SUR, V140, P188, DOI 10.1016/j.jtcvs.2010.03.022
   Rosenberger P, 2008, ANN THORAC SURG, V85, P548, DOI 10.1016/j.athoracsur.2007.08.061
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   Rouleau JL, 2008, CIRCULATION, V117, P24, DOI 10.1161/CIRCULATIONAHA.106.685073
   Roy P, 2009, AM J CARDIOL, V103, P950, DOI 10.1016/j.amjcard.2008.12.025
   Royse AG, 2000, EUR J CARDIO-THORAC, V17, P294, DOI 10.1016/S1010-7940(99)00364-4
   Royston D, 2001, BRIT J ANAESTH, V86, P575, DOI 10.1093/bja/86.4.575
   Russo A, 2008, CIRCULATION, V118, P1528, DOI 10.1161/CIRCULATIONAHA.107.747949
   Sabik JF, 2006, J THORAC CARDIOV SUR, V131, P90, DOI 10.1016/j.jtcvs.2005.05.024
   Sabik JF, 2003, ANN THORAC SURG, V76, P1490, DOI 10.1016/S0003-4975(03)01022-1
   Sabik JF, 2008, CIRCULATION, V118, pS210, DOI 10.1161/CIRCULATIONAHA.107.760827
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Saginur R, 2000, J THORAC CARDIOV SUR, V120, P1120, DOI 10.1067/mtc.2000.110384
   Sajja LR, 2007, J THORAC CARDIOV SUR, V133, P378, DOI 10.1016/j.jtcvs.2006.09.028
   Salminen US, 1999, J ANTIMICROB CHEMOTH, V44, P287, DOI 10.1093/jac/44.2.287
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Santa-Cruz RA, 2006, CATHETER CARDIO INTE, V67, P68, DOI 10.1002/ccd.20552
   Santos ATL, 2006, BRAZ J MED BIOL RES, V39, P63, DOI 10.1590/S0100-879X2006000100007
   Savage RM, 1997, ANN THORAC SURG, V64, P368, DOI 10.1016/S0003-4975(97)00612-7
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schwann TA, 2002, ANN THORAC SURG, V73, P1394, DOI 10.1016/S0003-4975(02)03422-7
   Serfontein L, 2010, CURR OPIN ANESTHESIO, V23, P103, DOI 10.1097/ACO.0b013e328334cb75
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Sergeant P, 1998, J THORAC CARDIOV SUR, V116, P440, DOI 10.1016/S0022-5223(98)70010-8
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   SETHI GK, 1990, J AM COLL CARDIOL, V15, P15
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008
   Shamshad F, 2010, AM HEART J, V160, P145, DOI 10.1016/j.ahj.2010.02.037
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Sheiman RG, 2007, AM J ROENTGENOL, V188, pW475, DOI 10.2214/AJR.06.1024
   Shernan SK, 2004, ANN THORAC SURG, V77, P942, DOI 10.1016/j.athoracsur.2003.08.054
   Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016
   SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785
   Shroyer ALW, 1996, ANN THORAC SURG, V61, P17, DOI 10.1016/0003-4975(95)00830-6
   SILVERMAN NA, 1982, ANN SURG, V196, P194, DOI 10.1097/00000658-198208000-00012
   Simoons ML, 1996, NEW ENGL J MED, V335, P275, DOI 10.1056/NEJM199607253350409
   Sirivella S, 2000, ANN THORAC SURG, V69, P501, DOI 10.1016/S0003-4975(99)01298-9
   Sjogren J, 2005, ANN THORAC SURG, V80, P1270, DOI 10.1016/j.athoracsur.2005.04.010
   Sjogren J, 2005, ANN THORAC SURG, V79, P2049, DOI 10.1016/j.athorascur.2004.12.048
   Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070
   SLOGOFF S, 1988, ANESTHESIOLOGY, V68, P676, DOI 10.1097/00000542-198805000-00004
   SLOGOFF S, 1985, ANESTHESIOLOGY, V62, P107, DOI 10.1097/00000542-198502000-00002
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith PK, 2010, J THORAC CARDIOVASC, V142, P89
   Smith PM, 2009, CAN MED ASSOC J, V180, P1297, DOI 10.1503/cmaj.080862
   Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026
   Smith WT, 2004, J AM COLL CARDIOL, V44, P1241, DOI 10.1016/j.jacc.2004.06.031
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   SOWDEN AJ, 1995, BRIT MED J, V311, P151
   Spelman D, 2002, INFECT CONT HOSP EP, V23, P402, DOI 10.1086/502074
   Stamou SC, 2006, J THORAC CARDIOV SUR, V131, P28, DOI 10.1016/j.jtcvs.2005.08.059
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stevens LM, 2004, J THORAC CARDIOV SUR, V127, P1408, DOI 10.1016/j.jtcvs.2003.10.006
   Stewart RD, 1998, ANN THORAC SURG, V66, P1306, DOI 10.1016/S0003-4975(98)00760-7
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   Surgenor SD, 2006, CIRCULATION, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271
   Swaminathan M, 2007, ANESTHESIOLOGY, V107, P739
   Taghaddomi RJ, 2009, J CARDIOTHOR VASC AN, V23, P312, DOI 10.1053/j.jvca.2008.09.018
   Taillefer MC, 2006, J THORAC CARDIOV SUR, V131, P1274, DOI 10.1016/j.jtcvs.2006.02.001
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Tavakoli R, 2002, EUR J CARDIO-THORAC, V21, P818, DOI 10.1016/S1010-7940(02)00065-9
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   ten Broecke PWC, 2003, BRIT J ANAESTH, V90, P27, DOI 10.1093/bja/aeg013
   Tenenbein PK, 2008, CAN J ANAESTH, V55, P344, DOI 10.1007/BF03021489
   Testa L, 2008, J THORAC CARDIOV SUR, V136, P884, DOI 10.1016/j.jtcvs.2007.12.062
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   De Giorgio L, 2000, NEW ENGL J MED, V342, P1376
   Talbot P, 2000, NEW ENGL J MED, V342, P748
   Thielmann M, 2007, J THORAC CARDIOV SUR, V134, P1143, DOI 10.1016/j.jtcvs.2007.07.029
   THOMAS D, 1991, EUR HEART J, V12, P832
   Thomas RJ, 2007, J AM COLL CARDIOL, V50, P1400, DOI 10.1016/j.jac.2007.04.033
   Thys DM, 2009, ANESTH ANALG, V109, P1782, DOI 10.1213/ANE.0b013e3181be4002
   TIME Investigators, 2001, Lancet, V358, P951
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   TOWNSEND TR, 1993, J THORAC CARDIOV SUR, V106, P664
   Trichon BH, 2003, CIRCULATION, V108, P103, DOI 10.1161/01.cir.0000087656.10829.df
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Tu JV, 1997, J AM COLL CARDIOL, V30, P1317, DOI 10.1016/S0735-1097(97)00295-7
   TUMAN KJ, 1989, ANESTHESIOLOGY, V70, P199, DOI 10.1097/00000542-198902000-00004
   Tumlin JA, 2005, AM J KIDNEY DIS, V46, P26, DOI 10.1053/j.ajkd.2005.04.002
   Urban PM, 2004, AM J CARDIOL, V94, P181, DOI 10.1016/j.amjcard.2004.03.058
   Vaccarino GN, 2009, J THORAC CARDIOV SUR, V137, P309, DOI 10.1016/j.jtcvs.2008.08.002
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van de Watering LMG, 1998, CIRCULATION, V97, P562
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   van Mastrigt GAPG, 2006, CRIT CARE MED, V34, P1624, DOI 10.1097/01.CCM.0000217963.87227.7B
   van Straten AHM, 2010, INTERACT CARDIOV TH, V10, P37, DOI 10.1510/icvts.2009.214551
   van Straten AHM, 2010, J CARDIOTHOR VASC AN, V24, P413, DOI 10.1053/j.jvca.2010.01.001
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770
   Vesely DL, 2003, AM J PHYSIOL-RENAL, V285, pF167, DOI 10.1152/ajprenal.00259.2002
   Vuorisalo S, 1998, INFECT CONT HOSP EP, V19, P234
   Wadhera RK, 2010, J THORAC CARDIOV SUR, V139, P312, DOI 10.1016/j.jtcvs.2009.10.048
   WALSH EE, 2010, ARCH INTERN MED, V171, P68
   Walsh SR, 2008, EUR J CARDIO-THORAC, V34, P985, DOI 10.1016/j.ejcts.2008.07.062
   Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6
   Wang G, 2010, J CARDIOTHOR VASC AN, V2, P268, DOI DOI 10.1152/AJPRENAL.00259.2002
   Wang JW, 2004, ANESTH ANALG, V99, P965, DOI 10.1213/01.ane.0000130614.45647.81
   Weightman WM, 1999, ANESTH ANALG, V88, P286, DOI 10.1097/00000539-199902000-00011
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Welke KF, 2005, ANN THORAC SURG, V80, P2114, DOI 10.1016/j.athoracsur.2005.05.017
   Welke KF, 2007, ANN THORAC SURG, V84, P1538, DOI 10.1016/j.athoracsur.2007.06.022
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   White CM, 2007, EUR J CARDIO-THORAC, V31, P817, DOI 10.1016/j.ejcts.2007.02.010
   White HD, 2005, CIRCULATION, V112, P1992, DOI 10.1161/CIRCULATIONAHA.105.540948
   Wiesbauer F, 2007, ANESTH ANALG, V104, P27, DOI 10.1213/01.ane.0000247805.00342.21
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   WILSON APR, 1988, J ANTIMICROB CHEMOTH, V21, P213, DOI 10.1093/jac/21.2.213
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wong CHK, 2006, EUR J CARDIO-THORAC, V30, P148, DOI 10.1016/j.ejcts.2006.03.049
   Wu CT, 2004, CIRCULATION, V110, P784, DOI 10.1161/01.CIR.0000138744.13516.B5
   Yamaguchi A, 2009, ANN THORAC CARDIOVAS, V15, P98
   Yao Yun-tai, 2009, Chinese Medical Sciences Journal, V24, P133
   Yau JM, 2008, AM J CARDIOL, V102, P546, DOI 10.1016/j.amjcard.2008.04.069
   Young EW, 1998, ANN THORAC SURG, V65, P1316, DOI 10.1016/S0003-4975(98)00157-X
   Yu CH, 2006, CAN J ANAESTH, V53, P906
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Zarbock A, 2009, CHEST, V135, P1252, DOI 10.1378/chest.08-1602
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   Zimarino M, 2004, ANN THORAC SURG, V78, P135, DOI 10.1016/j.athorascur.2003.12.030
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
   Zvara DA, 2000, J CARDIOTHOR VASC AN, V14, P571, DOI 10.1053/jcan.2000.9445
NR 492
TC 32
Z9 34
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD JAN
PY 2012
VL 143
IS 1
BP 4
EP 34
DI 10.1016/j.jtcvs.2011.10.015
PG 31
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 863GW
UT WOS:000298151800006
PM 22172748
ER

PT J
AU Buxton, BF
   Hayward, PAR
   Newcomb, AE
   Moten, S
   Seevanayagam, S
   Gordon, I
AF Buxton, Brian F.
   Hayward, Philip A. R.
   Newcomb, Andrew E.
   Moten, Simon
   Seevanayagam, Siven
   Gordon, Ian
TI Choice of conduits for coronary artery bypass grafting: craft or
   science?
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Review
DE Coronary artery disease; Coronary artery bypass grafts; Graft patency
ID INTERNAL THORACIC ARTERY; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE;
   LONG-TERM PATENCY; RADIAL-ARTERY; SAPHENOUS-VEIN; MYOCARDIAL
   REVASCULARIZATION; SYMPTOMATIC PATIENTS; MAMMARY ARTERY; ON-PUMP
AB Long-term patency of a bypass graft is an important determinant in reducing morbidity and increasing survival after coronary bypass surgery. The purpose of this review is to analyse factors contributing to improved outcomes of commonly used conduits. Progress has been limited by the tack of uniform definitions of graft failure and development of appropriate statistical models. Evolving techniques for assessing patency at more frequent intervals has provided insight into the time and sites of early disease. The explosion of scientific knowledge of graft physiology has added to improving harvest, storage and early protection procedures thereby reducing early morbidity. Similarly, the understanding and management of risk factors have contributed to graft durability and possibly survival. Conduits have different characteristics and applications, which are patient dependent. Competitive flow remains a problem especially with arterial conduits; functional studies as opposed to anatomy of the target artery may improve understanding of the contribution of the collateral circulation. Selected patency data provide comparison between grafts. The rote of the second internal thoracic artery graft is the subject of the Arterial Revascularisation Trial. Off-pump bypass procedures and patient characteristics affect conduit selection. Stroke is a major complication, which can be minimised by avoiding the aorta especially during off-pump surgery. There are few randomised controlled trials on the late outcomes comparing different bypass grafts and between bypass grafting and current percutaneous intervention methods. Accurate reporting of outcomes of graft patency will improve the scientific content and emphasise the importance of surgery in the management of coronary disease. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
C1 [Buxton, Brian F.] Epworth Med Fdn, Dept Cardiac Surg, Melbourne, Vic, Australia.
   [Hayward, Philip A. R.; Moten, Simon; Seevanayagam, Siven] Austin Hosp, Dept Cardiac Surg, Melbourne, Vic 3084, Australia.
   [Newcomb, Andrew E.] Royal Melbourne Hosp, Dept Cardiothorac Surg, Melbourne, Vic, Australia.
   [Gordon, Ian] Univ Melbourne, Ctr Stat Consulting, Parkville, Vic 3052, Australia.
RP Buxton, BF (reprint author), Epworth Med Fdn, Dept Cardiac Surg, Victorian Heart Ctr, Bridge Rd, Richmond, Vic, Australia.
EM brianbuxton@ozemail.com.au
CR Acar C, 1998, J THORAC CARDIOV SUR, V116, P981, DOI 10.1016/S0022-5223(98)70050-9
   ACAR C, 1992, ANN THORAC SURG, V54, P652
   Al-Ruzzeh S, 2006, BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C
   Andreini D, 2007, ANN THORAC SURG, V83, P1672, DOI 10.1016/j.athoracsur.2007.01.030
   BARNER HB, 1973, J THORAC CARDIOV SUR, V66, P219
   Biancari F, 2007, ANN THORAC SURG, V84, P254, DOI 10.1016/j.athoracsur.2007.02.022
   Bical O, 1996, EUR J CARDIO-THORAC, V10, P971, DOI 10.1016/S1010-7940(96)80399-X
   Bleiziffer S, 2007, J THORAC CARDIOV SUR, V134, P649, DOI 10.1016/j.jtcvs.2007.04.008
   Bodnar E, 2006, J THORAC CARDIOV SUR, V131, P1, DOI 10.1016/j.jtcvs.2005.11.013
   Bonacchi M, 2005, HEART, V91, P195, DOI 10.1136/hrt.2003.024091
   Botman CJ, 2007, ANN THORAC SURG, V83, P2093, DOI 10.1016/j.athoracsur.2007.01.027
   Boyd WD, 1999, ANN THORAC SURG, V68, P1490, DOI 10.1016/S0003-4975(99)00951-0
   Buxton BF, 2005, ANN THORAC SURG, V80, P896, DOI 10.1016/j.athoracsur.2005.03.097
   Buxton BF, 2000, EUR J CARDIO-THORAC, V18, P255, DOI 10.1016/S1010-7940(00)00527-3
   Buxton BF, 2003, J THORAC CARDIOV SUR, V125, P1363, DOI 10.1016/S0022-5223(02)73241-8
   Cable DG, 1998, CIRCULATION, V98, P1115
   CABLE DG, 1998, CIRCULATION S, V98, P21
   CALAFIORE AM, 1994, ANN THORAC SURG, V58, P185
   Calafiore Antonio Maria, 2006, Expert Rev Cardiovasc Ther, V4, P395, DOI 10.1586/14779072.4.3.395
   CALAFIORE AM, 1995, J CARDIAC SURG, V10, P140
   Calafiore AM, 2000, J THORAC CARDIOV SUR, V120, P990, DOI 10.1067/mtc.2000.110249
   Cameron J, 2004, CIRCULATION S2, V110, pII23, DOI 10.1161/01.CIR.0000138976.63221.14
   Campeau L, 1997, NEW ENGL J MED, V336, P153
   Carpentier A, 1973, Ann Thorac Surg, V16, P111
   Carrel TP, 2003, ANN THORAC SURG, V75, P1434, DOI 10.1016/S0003-4975(02)04839-7
   Charytan DM, 2007, NEPHROL DIAL TRANSPL, V22, P1665, DOI 10.1093/ndt/gfl835
   Chavanon Olivier, 2007, Ann Thorac Surg, V84, P257, DOI 10.1016/j.athoracsur.2007.03.033
   Choudhary BP, 2007, J AM COLL CARDIOL, V50, P1047, DOI 10.1016/j.jacc.2007.06.008
   Chowdhury UK, 2004, ANN THORAC SURG, V78, P1614, DOI 10.1016/j.athoracsur.2004.03.105
   Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084
   Crusco F, 2007, RADIOL MED, V112, P538, DOI 10.1007/s11547-007-0160-6
   CURTIS JJ, 1975, ANN THORAC SURG, V20, P628
   Desai ND, 2007, CIRCULATION, V115, P684, DOI 10.1161/CIRCULATIONAHA.105.567495
   Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982
   Dinh DT, 2008, MED J AUSTRALIA, V188, P214
   DION R, 1989, J THORAC CARDIOV SUR, V98, P80
   DION R, 1996, OPERATIVE TECHNIQUES, V1, P84, DOI 10.1016/S1085-5637(07)70049-9
   Dunning J, 2008, EUR J CARDIO-THORAC, V34, P73, DOI 10.1016/j.ejcts.2008.02.024
   Eagle Kim A, 2004, Circulation, V110, P1168, DOI 10.1161/01.CIR.0000138790.14877.7D
   FINKELSTEIN DM, 1985, BIOMETRICS, V41, P933, DOI 10.2307/2530965
   FITZGIBBON GM, 1991, J AM COLL CARDIOL, V17, P1075
   FOSTER ED, 1989, CIRCULATION, V79, P134
   Gansera B, 2007, THORAC CARDIOV SURG, V55, P412, DOI 10.1055/s-2007-965372
   Gardner TJ, 2007, AM J DRUG ALCOHOL AB, V33, P1, DOI 10.1080/00952990601082704
   Georghiou Georgios P, 2005, Interact Cardiovasc Thorac Surg, V4, P304, DOI 10.1510/icvts.2005.107490
   GLINEUR D, 2008, 22 ANN M EUR ASS CAR
   Glineur D, 2008, J AM COLL CARDIOL, V51, P120, DOI 10.1016/j.jacc.2007.09.030
   Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064
   Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595
   Hayward PAR, 2008, EUR J CARDIO-THORAC, V34, P113, DOI 10.1016/j.ejcts.2008.03.027
   Hayward PAR, 2007, ANN THORAC SURG, V84, P795, DOI 10.1016/j.athoracsur.2007.04.028
   Hayward PAR, 2007, ANN THORAC SURG, V84, P493, DOI 10.1016/j.athoracsur.2007.03.053
   HAYWARD PAR, J THORAC CA IN PRESS
   He GW, 1999, ANN THORAC SURG, V67, P277, DOI 10.1016/S0003-4975(98)01207-7
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   IACO AL, 2001, ANN THORAC SURG, V72, P147
   Iaco AL, 2001, ANN THORAC SURG, V72, P464, DOI 10.1016/S0003-4975(01)02758-8
   Ivanov J, 1998, CIRCULATION, V97, P673
   Jabara R, 2007, AM J CARDIOL, V99, P1529, DOI 10.1016/j.amjcard.2007.01.026
   Jacob Samuel, 2007, Interact Cardiovasc Thorac Surg, V6, P783, DOI 10.1510/icvts.2007.163956
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Khot UN, 2004, CIRCULATION, V109, P2086, DOI 10.1161/01.CIR.0000127570.20508.5C
   Kim KB, 2008, J THORAC CARDIOV SUR, V135, P300, DOI 10.1016/j.jtcvs.2007.09.044
   Kurlansky PA, 2003, ANN THORAC SURG, V76, P418, DOI 10.1016/S0003-4975(03)00551-4
   Lingaas PS, 2006, ANN THORAC SURG, V81, P2089, DOI 10.1016/j.athoracsur.2005.12.003
   Lorusso R, 2003, DIABETES, V52, P2814, DOI 10.2337/diabetes.52.11.2814
   Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X
   Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070
   Malvindi Pietro Giorgio, 2007, Interact Cardiovasc Thorac Surg, V6, P397, DOI 10.1510/icvts.2007.155259
   Maniar HS, 2003, ANN THORAC SURG, V76, P1498, DOI 10.1016/S0003-4975(03)00758-6
   Muneretto C, 2004, J THORAC CARDIOV SUR, V127, P179, DOI 10.1016/j.jtcvs.2003.08.004
   Mussa S, 2005, J THORAC CARDIOV SUR, V129, P250, DOI 10.1016/j.jtcvs.2004.07.040
   Nagpal AD, 2006, CAN J CARDIOL, V22, P849
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Nezic DG, 2006, EUR J CARDIO-THORAC, V30, P341, DOI 10.1016/j.ejcts.2006.05.012
   Ng MP, 2002, BIOMETRICS, V58, P439, DOI 10.1111/j.0006-341X.2002.00439.x
   OTT DA, 1999, ISCHEMIC HEART DIS S, P381
   Patel Anish, 2006, Interact Cardiovasc Thorac Surg, V5, P251, DOI 10.1510/icvts.2006.129262
   PETO R, 1973, J ROY STAT SOC C-APP, V22, P86
   Possati G, 2003, CIRCULATION, V108, P1350, DOI 10.1161/01.CIR.0000087402.13786.D0
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Rashkow A, 2003, AM J CARDIOL, V92, P460, DOI 10.1016/S0002-9149(03)00668-4
   Ruengsakulrach P, 1999, CIRCULATION, V100, P139
   Sabik III JF, 2006, CIRCULATION, V114, P454, DOI 10.1161/CIRCULATIONAHA.105.001149
   Sabik JF, 2008, J AM COLL CARDIOL, V51, P126, DOI 10.1016/j.jacc.2007.09.029
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Sakaguchi T, 2005, J THORAC CARDIOV SUR, V129, P129, DOI 10.1016/j.jtcvs.2004.04.014
   Shah PJ, 2005, EUR J CARDIO-THORAC, V27, P870, DOI 10.1016/ejcts.2005.01.027
   Shah PJ, 2004, EUR J CARDIO-THORAC, V26, P118, DOI 10.1016/j.ejcts.2004.02.037
   Shah PJ, 2003, J THORAC CARDIOV SUR, V126, P1972, DOI 10.1016/S0022-5223(03)01276-5
   SHEEHAN FH, 1987, CIRCULATION, V75, P817
   Singh SK, 2007, J CARDIAC SURG, V22, P328, DOI 10.1111/j.1540-8191.2007.00416.x
   Sigwart U, 2002, LANCET, V360, P965
   Suma H, 2007, Circulation, V116, P1188
   Taggart DP, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-7
   Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X
   Takagi H, 2007, J THORAC CARDIOV SUR, V133, pE2, DOI 10.1016/j.jtcvs.2006.08.062
   Takahashi K, 2004, ANN THORAC SURG, V78, P2033, DOI 10.1016/j.athoracsur.2004.06.071
   Tatoulis J, 2002, ANN THORAC SURG, V73, P143, DOI 10.1016/S0003-4975(01)03290-8
   TECTOR AJ, 1994, ANN THORAC SURG, V57, P33
   Thourani VH, 1999, ANN THORAC SURG, V67, P1045, DOI 10.1016/S0003-4975(99)00143-5
   Toumpoulis Ioannis K, 2007, Interact Cardiovasc Thorac Surg, V6, P787, DOI 10.1510/icvts.2007.164343
   TURNBULL BW, 1976, J ROY STAT SOC B MET, V38, P290
   Vicol C, 2005, ANN THORAC SURG, V79, P1732, DOI 10.1016/j.athoracsur.2004.05.080
   Wendler O, 2001, EUR J CARDIO-THORAC, V20, P305, DOI 10.1016/S1010-7940(01)00778-3
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Wildhirt SM, 2006, EUR J CARDIO-THORAC, V30, P333, DOI 10.1016/j.ejcts.2006.04.040
   Wolf LG, 2007, J THORAC CARDIOV SUR, V133, P485, DOI 10.1016/j.jtcvs.2006.10.002
   Yie K, 2008, EUR J CARDIO-THORAC, V33, P341, DOI 10.1016/j.ejcts.2007.12.025
   Zacharias A, 2004, CIRCULATION, V109, P1489, DOI 10.1161/01.CIR.0000121743.10146.78
   Zulli A, 2003, ARTERIOSCL THROM VAS, V23, P1308, DOI 10.1161/01.ATV.0000078902.50489.9B
NR 111
TC 32
Z9 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD APR
PY 2009
VL 35
IS 4
BP 658
EP 670
DI 10.1016/j.ejcts.2008.10.058
PG 13
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 438RO
UT WOS:000265573300017
PM 19231230
ER

PT J
AU Milano, CA
   Daneshmand, MA
   Rankin, JS
   Honeycutt, E
   Williams, ML
   Swaminathan, M
   Linblad, L
   Shaw, LK
   Glower, DD
   Smith, PK
AF Milano, Carmelo A.
   Daneshmand, Mani A.
   Rankin, J. Scott
   Honeycutt, Emily
   Williams, Matthew L.
   Swaminathan, Madhav
   Linblad, Lauren
   Shaw, Linda K.
   Glower, Donald D.
   Smith, Peter K.
TI Survival prognosis and surgical management of ischemic mitral
   regurgitation
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 44th Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 28-30, 2008
CL Ft Lauderdale, FL
SP Soc Thorac Surg
ID LONG-TERM SURVIVAL; CORONARY-ARTERY-DISEASE; VALVE REPAIR;
   PAPILLARY-MUSCLE; REPLACEMENT; ANNULOPLASTY; REVASCULARIZATION; SURGERY;
   VOLUME
AB Background. Ischemic mitral regurgitation (IMR) has an adverse prognosis, but survival characteristics and management are controversial. This study reviewed a 20-year series of IMR patients managed with multiple approaches to assess and refine surgical strategies.
   Methods. Patients having surgery for primary coronary disease from 1986 to 2006 were divided into group 1 (no IMR; bypass grafting only; n = 16,209), group 2a (IMR; bypass only; n = 3,181), group 2b (IMR; mitral repair; n = 416), and group 2c (IMR; mitral replacement; n = 106). Cox proportional hazards modeling adjusted for baseline differences, and therapeutic adequacy was quantified by area under each survival curve expressed as a percentage of group 1.
   Results. Group 2 patients were older than group 1 patients and had worse baseline characteristics. Group 2a had less severe MR and group 2b had the most comorbidity. Assuming group 1 provided the best adjusted outcome at a given baseline risk, group 2a achieved 97.7%, 2b achieved 93.7%, and 2c achieved 79.1% of potential survival (hazard ratio 1.1, 1.4, and 1.6, respectively; p < 0.003). Most of the survival difference was perioperative.
   Conclusions. Worse baseline risk is a major factor reducing long-term survival in IMR. Current algorithms in which mild to moderate IMR is managed with bypass only (group 2a) generally produced good late results. In patients with moderate and severe IMR, repair achieved 93.7% of full survival potential; valve replacement was less satisfactory, primarily owing to higher operative mortality. Future therapeutic refinement, emphasizing reparative procedures and better perioperative care, could enhance the surgical prognosis of IMR.
C1 Duke Univ, Med Ctr, Dept Surg, Durham, NC USA.
   Duke Univ, Med Ctr, Dept Anesthesia, Durham, NC USA.
   Centennial Med Ctr, Nashville, TN USA.
   Vanderbilt Univ, Nashville, TN USA.
   Duke Clin Res Inst, Durham, NC USA.
RP Milano, CA (reprint author), DUMC 3043, Duke Med Ctr S, Trent Dr,Room 3580, Durham, NC 27710 USA.
EM milan002@mc.duke.edu
CR Al-Radi OO, 2005, ANN THORAC SURG, V79, P1260, DOI 10.1016/j.athoracsur.2004.09.044
   Borger MA, 2007, J THORAC CARDIOV SUR, V133, P1483, DOI 10.1016/j.jtcvs.2007.01.064
   Borger MA, 2006, ANN THORAC SURG, V81, P1153, DOI 10.1016/j.athoracsur.2005.08.080
   Braun J, 2008, ANN THORAC SURG, V85, P430, DOI 10.1016/j.athoracsur.2007.08.040
   BURCH GE, 1968, AM HEART J, V75, P399, DOI 10.1016/0002-8703(68)90097-5
   Cox D, 1984, ANAL SURVIVAL DATA, DOI Boca Raton, FL
   Daimon M, 2006, CIRCULATION, V114, P1588, DOI 10.1161/CIRCULATIONAHA.105.001347
   DAVID TE, 1986, ANN THORAC SURG, V41, P680
   Di Mauro M, 2006, ANN THORAC SURG, V81, P2128, DOI 10.1016/j.athoracsur.2006.01.061
   Diodato MD, 2004, ANN THORAC SURG, V78, P794, DOI 10.1016/j.athoracsur.2004.03.022
   Gammie JS, 2007, CIRCULATION, V115, P881, DOI 10.1161/CIRCULATIONAHA.106.634436
   Gazoni LM, 2007, ANN THORAC SURG, V84, P750, DOI 10.1016/j.athoracsur.2007.04.098
   Gillinov AM, 2005, ANN THORAC SURG, V80, P811, DOI 10.1016/j.athoracsur.2005.03.134
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Glower DD, 2005, J THORAC CARDIOV SUR, V129, P860, DOI 10.1016/j.jtcvs.2004.11.023
   Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945
   Grossi EA, 2006, CIRCULATION S, V114, P573, DOI 10.1161/CIRCULATIONAHA.105.001230
   HARPOLE DH, 1990, ANN THORAC SURG, V49, P866
   Heub A, 2002, J THORAC CARDIOVASC, V124, P1216
   HICKEY MS, 1988, CIRCULATION, V78, P51
   Kang DH, 2006, CIRCULATION S, V114, DOI 10.1161/CIRCULATIONAHA.105.000398
   KAY GL, 1986, CIRCULATION, V74, P88
   Kim YH, 2005, ANN THORAC SURG, V79, P1895, DOI 10.1016/j.athoracsur.2004.11.005
   Langer F, 2007, J THORAC CARDIOV SUR, V133, P247, DOI 10.1016/j.jtcvs.2006.04.059
   Langer F, 2006, J THORAC CARDIOV SUR, V131, P868, DOI 10.1016/j.jtcvs.2005.11.027
   McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037
   Rama A, 2007, ANN THORAC SURG, V84, P2130, DOI 10.1016/j.athoracsur.2007.04.056
   RANKIN J, 2008, AM HEART J UNPUB
   Rankin JS, 2004, J HEART VALVE DIS, V13, P399
   Rankin JS, 2005, J HEART VALVE DIS, V14, P783
   Reece TB, 2004, ANN SURG, V239, P671, DOI 10.1097/sla.0000124297.40815.86
   Roshanali F, 2007, ANN THORAC SURG, V84, P745, DOI 10.1016/j.athoracsur.2007.04.106
   Schroder JN, 2005, CIRCULATION, V112, pI293
   SURI RM, J THORAC CA IN PRESS
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Ueno T, 2006, ANN THORAC SURG, V81, P2324, DOI 10.1016/j.athoracsur.2005.03.059
   Ueno Tetsuya, 2007, Interact Cardiovasc Thorac Surg, V6, P9
   Wong DR, 2005, ANN THORAC SURG, V80, P570, DOI 10.1016/j.athoracsur.2005.03.034
   Yun KL, 2002, J THORAC CARDIOV SUR, V123, P707, DOI 10.1067/mtc.2002.121048
   Zhu F, 2005, CIRCULATION, V112
NR 40
TC 32
Z9 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD SEP
PY 2008
VL 86
IS 3
BP 735
EP 744
DI 10.1016/j.athoracsur.2008.05.017
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 340AT
UT WOS:000258619100006
PM 18721554
ER

PT J
AU Lahey, BB
   Van Hulle, CA
   D'Onofrio, BM
   Rodgers, JL
   Waldman, ID
AF Lahey, Benjamin B.
   Van Hulle, Carol A.
   D'Onofrio, Brian M.
   Rodgers, Joseph Lee
   Waldman, Irwin D.
TI Is parental knowledge of their adolescent offspring's whereabouts and
   peer associations spuriously associated with offspring delinquency?
SO JOURNAL OF ABNORMAL CHILD PSYCHOLOGY
LA English
DT Article
DE parental knowledge; parental limit setting; adolescent delinquency
ID EXTERNALIZING BEHAVIORS; CONDUCT PROBLEMS; YOUTH; REINTERPRETATION;
   ADJUSTMENT; MULTILEVEL; FAMILIES; CHILDREN; OUTCOMES; MODEL
AB Recent studies suggest that most of what parents know about their adolescent offspring's whereabouts and companions is the result of youth disclosure, rather than information gained through active parental monitoring. This raises the possibility that parental knowledge is spuriously correlated with youth delinquency solely because the most delinquent youth disclose the least information to parents (because they have the most to hide). We tested this spurious association hypothesis using prospective data on offspring of a nationally representative sample of US women, controlling demographic and contextual covariates. In separate analyses, greater parental knowledge of their offspring's peer associations at both 12-13 years and at 14-15 years was associated with lower odds of being in the top 1 standard deviation of youth-reported delinquency at 16-17 years, controlling for delinquency at the earlier ages. The extent to which parents set limits on activities with peers at 14-15 years did not mediate or moderate the association between parental knowledge and delinquency, but it did independently predict future delinquency among adolescents living in high-risk neighborhoods. This suggests that the association between parental knowledge and future delinquency is not solely spurious; rather parental knowledge and limit setting are both meaningful predictors of future delinquency.
C1 [Lahey, Benjamin B.; Van Hulle, Carol A.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.
   [D'Onofrio, Brian M.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.
   [Rodgers, Joseph Lee] Univ Oklahoma, Dept Psychol, Norman, OK 73019 USA.
   [Waldman, Irwin D.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.
RP Lahey, BB (reprint author), Univ Chicago, Dept Hlth Studies, Dept Hlth Studies MC 2007,5841 S Maryland Ave, Chicago, IL 60637 USA.
EM blahey@uchicago.edu
CR Barber J. G., 2001, CHILD ADOLESCENT SOC, V18, P51, DOI 10.1023/A:1026673203176
   BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372
   Beyers JM, 2003, AM J COMMUN PSYCHOL, V31, P35, DOI 10.1023/A:1023018502759
   CHASELANSDALE PL, 1991, DEV PSYCHOL, V27, P918, DOI 10.1037//0012-1649.27.6.918
   Choi Y, 2005, J RES ADOLESCENCE, V15, P505, DOI 10.1111/j.1532-7795.2005.00109.x
   Chung HL, 2006, DEV PSYCHOL, V42, P319, DOI 10.1037/0012-1649.42.2.319
   Crockett LJ, 2006, J RES ADOLESCENCE, V16, P503, DOI 10.1111/j.1532-7795.2006.00505.x
   Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380
   D'Onofrio BM, 2003, J CHILD PSYCHOL PSYC, V44, P1130, DOI 10.1111/1469-7610.00196
   D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072
   Eamon MK, 2001, J SOC SERV RES, V28, P1, DOI 10.1300/J079v28n01_01
   ELLIOTT DS, 1983, CRIMINOLOGY, V21, P149, DOI 10.1111/j.1745-9125.1983.tb00256.x
   Farrington D. P., 2000, CRIM BEHAV MENT HEAL, V10, P100, DOI 10.1002/cbm.349
   Farrington D. P., 1992, STUDIES CRIME CRIME, V1, P7
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   GOTTFREDSON MR, 1994, ADOLESCENT PROBLEM BEHAVIORS, P41
   Jang SJ, 1997, J RES CRIME DELINQ, V34, P307, DOI 10.1177/0022427897034003002
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Lahey BB, 2006, J ABNORM CHILD PSYCH, V34, P737, DOI 10.1007/s10802-006-9064-5
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   Loeber R., 1998, ANTISOCIAL BEHAV MEN
   Luthar S. S., 1999, POVERTY CHILDRENS AD
   Luthar SS, 2007, DEV PSYCHOPATHOL, V19, P205, DOI 10.1017/S0954579407070113
   Lynne S. D., 2006, APPL DEV SCI, V10, P75, DOI 10.1207/s1532480xads1002_3
   MCCORD J, 1986, DEV ANTISOCIAL PROSO, P343
   Moffitt T. E., 2001, SEX DIFFERENCES ANTI
   Moffitt T. E., 2006, DEV PSYCHOPATHOLOGY
   MOFFITT TE, 1990, CHILD DEV, V61, P893, DOI 10.2307/1130972
   Moffitt TE, 1996, DEV PSYCHOPATHOL, V8, P399
   Mott F. L., 1993, NLSY CHILD HDB
   Patterson G. R., 1985, CRIMINOLOGY, V23, P63, DOI 10.1111/j.1745-9125.1985.tb00326.x
   PATTERSON GR, 1984, CHILD DEV, V55, P1299, DOI 10.2307/1129999
   Reitz E, 2007, J YOUTH ADOLESCENCE, V36, P623, DOI 10.1007/s10964-006-9150-6
   Roche KM, 2007, J FAM ISSUES, V28, P882, DOI 10.1177/0192513X07299617
   Sampson R. J., 1993, CRIME MAKING PATHWAY
   SAMPSON RJ, 1994, CHILD DEV, V65, P532
   Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918
   Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192
   Soenens B, 2006, DEV PSYCHOL, V42, P305, DOI 10.1073/0012-1649.42.2.305
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   STEINBERG L, 1994, CHILD DEV, V65, P754, DOI 10.1111/j.1467-8624.1994.tb00781.x
   Stouthamer-Loeber M, 2002, J CONSULT CLIN PSYCH, V70, P111, DOI 10.1037//0022-006X.70.1.111
NR 42
TC 32
Z9 33
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0091-0627
J9 J ABNORM CHILD PSYCH
JI J. Abnorm. Child Psychol.
PD AUG
PY 2008
VL 36
IS 6
BP 807
EP 823
DI 10.1007/s10802-008-9214-z
PG 17
WC Psychology, Clinical; Psychology, Developmental
SC Psychology
GA 327JY
UT WOS:000257726600002
PM 18214666
ER

PT J
AU Crabtree, TD
   Bailey, MS
   Moon, MR
   Munfakh, N
   Pasque, MK
   Lawton, JS
   Moazami, N
   Aubuchon, KA
   Al-Dadah, AS
   Damiano, RJ
AF Crabtree, Traves D.
   Bailey, Marci S.
   Moon, Marc R.
   Munfakh, Nabil
   Pasque, Michael K.
   Lawton, Jennifer S.
   Moazami, Nader
   Aubuchon, Kristen A.
   Al-Dadah, Ashraf S.
   Damiano, Ralph J.
TI Recurrent mitral regurgitation and risk factors for early and late
   mortality after mitral valve repair for functional ischemic mitral
   regurgitation
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 54th Annual Meeting of the Southern-Thoracic-Surgical-Association
CY NOV 07-10, 2007
CL Bonita Springs, FL
SP SE Thorac Surg Assoc
ID ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL; PROGNOSTIC
   IMPLICATIONS; HEART-FAILURE; ANNULOPLASTY; REVASCULARIZATION;
   REPLACEMENT; IMPACT; COMPLICATIONS; INTERVENTION
AB Background. Mortality for patients with coronary artery disease and functional ischemic mitral regurgitation (IMR) remains high regardless of the treatment strategy. Data regarding risk factors, progression of MR, and cause of death in this subgroup are limited.
   Methods. A retrospective study was performed on 257 consecutive patients undergoing mitral valve repair exclusively for IMR from 1996 to 2005. Potential preoperative and perioperative risk factors for death and postoperative echocardiographic data were recorded.
   Results. Preoperative echocardiography demonstrated 3+ to 4+ MR in 98.4% (252 of 257). Concomitant coronary artery bypass grafting was performed in 80.9% (208 of 257). Operative mortality was 10.1% (26 of 257). Overall survival by Kaplan-Meier analysis was 68.3% at 3 years and 52.0% at 5 years. Factors associated with late mortality by multivariate analysis include advanced age (relative risk [RR], 1.037; 95% confidence interval [CI], 1.016 to 1.059; p <= 0.001), preoperative dialysis (RR, 3.504; 95% CI, 1.590 to 7.720; p=0.008), and diabetes (RR, 2.047; 95% CI, 1.319 to 3.177; p=0.001). Echocardiographic data at 20 +/- 25 months were available in 57% (147 of 257). Their survival by Kaplan-Meier analysis was 76.4% at 3 years and 65.1% at 5 years with 0 to 2+ MR postoperatively (n=106) vs 61.3% and 35.8% with 3+ to 4+ MR (n=41; p=0.003). Cause of death was available in 72.3% (60 of 83) of late deaths, with 42.2% (35 of 83) attributed to cardiac causes and 30.1% (25 of 83) noncardiac.
   Conclusions. Mortality for IMR remains high despite surgical management and may be related to risk factors for progression of coronary artery disease. Despite repair, MR progresses in many patients and is associated with poor survival, although more detailed prospective data are needed to characterize this relationship.
C1 [Crabtree, Traves D.; Bailey, Marci S.; Moon, Marc R.; Munfakh, Nabil; Pasque, Michael K.; Lawton, Jennifer S.; Moazami, Nader; Aubuchon, Kristen A.; Al-Dadah, Ashraf S.; Damiano, Ralph J.] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO USA.
   [Crabtree, Traves D.; Bailey, Marci S.; Moon, Marc R.; Munfakh, Nabil; Pasque, Michael K.; Lawton, Jennifer S.; Moazami, Nader; Aubuchon, Kristen A.; Al-Dadah, Ashraf S.; Damiano, Ralph J.] Barnes Jewish Hosp, St Louis, MO 63110 USA.
RP Crabtree, TD (reprint author), Washington Univ, Sch Med, One Barnes Jewish Hosp Plaza, Barnes Jewish Hosp, 3108 Queeny Tower, St Louis, MO 63110 USA.
EM crabtreet@wustl.edu
CR Akar AR, 2002, J HEART VALVE DIS, V11, P793
   Aronson D, 2006, ARCH INTERN MED, V166, P2362, DOI 10.1001/archinte.166.21.2362
   BARZILAI B, 1990, AM J CARDIOL, V65, P1169, DOI 10.1016/0002-9149(90)90968-7
   Bax J, 2004, CIRCULATION S2, V110, pII, DOI 10.1161/01.CIR.0000138196.06772.4e
   Borger MA, 2007, J THORAC CARDIOV SUR, V133, P1483, DOI 10.1016/j.jtcvs.2007.01.064
   Borger MA, 2006, ANN THORAC SURG, V81, P1153, DOI 10.1016/j.athoracsur.2005.08.080
   Braun J, 2005, EUR J CARDIO-THORAC, V27, P847, DOI 10.1016/j.ejcts.2004.12.031
   Buja P, 2006, INT J CARDIOL, V111, P26, DOI 10.1016/j.ijcard.2005.06.035
   Bursi F, 2005, CIRCULATION, V111, P295, DOI 10.1161/01.CIR.0000151097.30779.04
   Diodato MD, 2004, ANN THORAC SURG, V78, P794, DOI 10.1016/j.athoracsur.2004.03.022
   Gillinov A Marc, 2003, Am Heart Hosp J, V1, P47, DOI 10.1111/j.1541-9215.2003.02082.x
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Grigioni F, 2001, CIRCULATION, V103, P1759
   Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945
   Harris KM, 2002, ANN THORAC SURG, V74, P1468, DOI 10.1016/S0003-4975(02)03920-6
   Hung J, 2004, CIRCULATION S2, V110, pII85, DOI 10.1161/01.CIR.0000138192.65015.45
   Kang DH, 2006, CIRCULATION S, V114, DOI 10.1161/CIRCULATIONAHA.105.000398
   Kuwahara E, 2006, CIRCULATION S1, V114, pI, DOI 10.1161/CIRCULATIONAHA.105.000729
   Lamas GA, 1997, CIRCULATION, V96, P827
   LEHMANN KG, 1992, ANN INTERN MED, V117, P10
   Mallidi HR, 2004, J THORAC CARDIOV SUR, V127, P636, DOI 10.1016/j.jtcvs.2003.09.010
   McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037
   Mihaljevic T, 2007, J AM COLL CARDIOL, V49, P2191, DOI 10.1016/j.jacc.2007.02.043
   Pellizzon GG, 2004, J AM COLL CARDIOL, V43, P1368, DOI 10.1016/j.jacc.2003.11.046
   PEREZ DI, 2006, EUR HEART J, V27, P2655
   Pu M, 2003, AM J CARDIOL, V92, P862, DOI 10.1016/S0002-9149(03)00902-0
   Tahta SA, 2002, J HEART VALVE DIS, V11, P11
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Trichon BH, 2003, CIRCULATION, V108, P103, DOI 10.1161/01.cir.0000087656.10829.df
   Wu AH, 2005, J AM COLL CARDIOL, V45, P381, DOI 10.1016/j.jacc.2004.09.073
NR 30
TC 32
Z9 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAY
PY 2008
VL 85
IS 5
BP 1537
EP 1543
DI 10.1016/j.athoracsur.2008.01.079
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 293FE
UT WOS:000255319900005
PM 18442534
ER

PT J
AU Ellis, DS
   Manny, TB
   Rewcastle, JC
AF Ellis, David S.
   Manny, Theodore B., Jr.
   Rewcastle, John C.
TI Localized prostate cancer followed by cryoablation as primary treatment
   for penile rehabilitation
SO UROLOGY
LA English
DT Article
ID QUALITY-OF-LIFE; CRYOSURGICAL ABLATION; ERECTILE DYSFUNCTION; OUTCOMES;
   MEN; IMPOTENCE; RADIATION; THERAPY
AB OBJECTIVES To determine the medium term efficacy and morbidity of patients who underwent cryoablation as primary therapy for localized prostate cancer followed by a penile rehabilitation regimen.
   METHODS Patients were treated with whole gland cryoablation. Those potent at intervention were encouraged to use a vacuum erection device regularly after treatment. Incontinence was defined as any leakage of urine. Potency was defined as the ability to achieve an erection sufficient to complete intercourse with or without orat pharmaceutical agents. Biochemical failure was defined as three successive rises in prostate-specific antigen, with a final value greater than 1.0 ng/mL.
   RESULTS A total of 416 consecutive patients were treated. The mean patient age was 69.4 years, mean prostate-specific antigen level was 8.7 ng/mL, median Gleason score was 6, and median stage was T1c. The mean follow-up of the entire population was 20.4-14.7 months. Of those continent before treatment, 4.0% were incontinent at 6 months but only 2 (0.6%) used any absorbent pads. Kaplan-Meier analysis demonstrated progressive recovery of sexual function of preoperatively potent men, with 41.4% +/- 4.3% and 51.3% +/- 5.9% potent 1 and 4 years after treatment, respectively. No patients had rectal fistula. The actuarial probability of remaining biochemically disease free at 4 years was 79.6% +/- 2.4%, with a mean time to failure of 4.2 months. After therapy, 168 patients underwent biopsy; 17 had positive findings (10.1%). The positive biopsy rate for the entire population was 4.1% (17 of 416).
   CONCLUSIONS The results of our study have indicated that cryoablation as a primary treatment of localized prostate cancer is effective with acceptable morbidity. The use of a penite rehabilitation regimen after treatment appeared to substantially increase postcryoablation potency.
C1 Urol Associates N Texas, Arlington, TX 76012 USA.
   US Med Dev, Irving, TX USA.
   Univ Texas, SW Med Sch, Dallas, TX 75230 USA.
   Univ Calgary, Dept Radiol, Calgary, AB T2N 1N4, Canada.
   Endocare Inc, Irvine, CA USA.
RP Ellis, DS (reprint author), Urol Associates N Texas, 1001 Waldrop Dr,Suite 708, Arlington, TX 76012 USA.
EM dellis@uant.com
CR American Cancer Society, 2005, CANC FACTS FIG 2005
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Bahn Duke K, 2003, Clin Prostate Cancer, V2, P111, DOI 10.3816/CGC.2003.n.018
   Bahn DK, 2002, UROLOGY, V60, P3, DOI 10.1016/S0090-4295(02)01678-3
   CARROLL JL, 1990, J SEX MARITAL THER, V16, P181
   Critz FA, 2000, J UROLOGY, V163, P1085, DOI 10.1016/S0022-5347(05)67698-7
   Day D, 2001, ADV THER, V18, P131, DOI 10.1007/BF02850301
   Donnelly Bryan J, 2002, Rev Urol, V4 Suppl 2, pS24
   Donnelly BJ, 2002, UROLOGY, V60, P645, DOI 10.1016/S0090-4295(02)01839-3
   Ellis DS, 2002, UROLOGY, V60, P34, DOI 10.1016/S0090-4295(02)01682-5
   Esper P, 1997, UROLOGY, V50, P920, DOI 10.1016/S0090-4295(97)00459-7
   Hoffmann NE, 2002, UROLOGY, V60, P40, DOI 10.1016/S0090-4295(02)01683-7
   Incrocci L, 2002, INT J RADIAT ONCOL, V52, P681, DOI 10.1016/S0360-3016(01)02727-4
   Katz Aaron E, 2003, Curr Oncol Rep, V5, P231, DOI 10.1007/s11912-003-0115-6
   Larson TR, 2000, UROLOGY, V55, P547, DOI 10.1016/S0090-4295(99)00590-7
   Lee F, 1999, UROLOGY, V54, P135, DOI 10.1016/S0090-4295(99)00039-4
   Litwin MS, 1998, J GEN INTERN MED, V13, P159, DOI 10.1046/j.1525-1497.1998.00050.x
   Long JP, 2001, UROLOGY, V57, P518, DOI 10.1016/S0090-4295(00)01060-8
   Merrick GS, 2005, UROLOGY, V66, P9, DOI 10.1016/j.urology.2004.12.039
   Onik G, 2002, UROLOGY, V60, P109, DOI 10.1016/S0090-4295(02)01643-6
   ONIK GM, 1993, CANCER, V72, P1291, DOI 10.1002/1097-0142(19930815)72:4<1291::AID-CNCR2820720423>3.0.CO;2-I
   Prestidge BR, 1997, INT J RADIAT ONCOL, V37, P31, DOI 10.1016/S0360-3016(96)00390-2
   Rewcastle JC, 1999, J SURG ONCOL, V71, P106, DOI 10.1002/(SICI)1096-9098(199906)71:2<106::AID-JSO9>3.0.CO;2-Z
   Robinson JW, 2002, UROLOGY, V60, P12, DOI 10.1016/S0090-4295(02)01679-5
   Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0
   Saliken JC, 2002, UROLOGY, V60, P26, DOI 10.1016/S0090-4295(02)01681-3
   WEINBERG JJ, 1988, UROLOGY, V31, P526, DOI 10.1016/0090-4295(88)90225-7
   Whyte JJ, 1999, J UROLOGY, V162, P1386, DOI 10.1016/S0022-5347(05)68301-2
   Williams SG, 2004, INT J RADIAT ONCOL, V58, P1083, DOI 10.1016/j.ijrobp.2003.08.009
   Wong WS, 1997, CANCER, V79, P963
NR 30
TC 32
Z9 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-4295
J9 UROLOGY
JI Urology
PD FEB
PY 2007
VL 69
IS 2
BP 306
EP 310
DI 10.1016/j.urology.2006.10.024
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 148DT
UT WOS:000245055400021
PM 17320669
ER

PT J
AU Gabardi, S
   Abramson, S
AF Gabardi, S
   Abramson, S
TI Drug dosing in chronic kidney disease
SO MEDICAL CLINICS OF NORTH AMERICA
LA English
DT Review
ID CHRONIC-RENAL-FAILURE; LIFE-THREATENING HYPERKALEMIA; CONVERTING
   ENZYME-INHIBITORS; AMBULATORY PERITONEAL-DIALYSIS; TYPE-2
   DIABETES-MELLITUS; MOLECULAR-WEIGHT HEPARIN; NONSTEROIDAL
   ANTIINFLAMMATORY DRUGS; ANGIOTENSIN RECEPTOR BLOCKADE;
   GLOMERULAR-FILTRATION-RATE; INTESTINAL P-GLYCOPROTEIN
AB Patients with chronic kidney disease (CKD) are at high risk for adverse drug reactions and drug-drug interactions. Renal dysfunction-induced changes in human pathophysiology regularly results in altered pharmacodynamics and medication handling of a number of pharmacologic agents. This article reviews these observed changes and discusses strategies for appropriate drug dosing in patients with renal insufficiency. Specific recommendations for drug dosing in CKD are also included for the following classes of medications: anticoagulants, antihypertensives, cardiac medications, hypoglycemics, analgesics, antimicrobials, and miscellaneous agents.
C1 Brigham & Womens Hosp, Dept Pharm Serv, Boston, MA 02115 USA.
   Northeastern Univ, Bouve Coll Hlth Sci, Dept Pharm Practice, Boston, MA USA.
   Maine Med Ctr, Div Nephrol & Renal Transplantat, Dialysis Unit, Portland, ME 04102 USA.
RP Gabardi, S (reprint author), Brigham & Womens Hosp, Dept Pharm Serv, 75 Francis St, Boston, MA 02115 USA.
EM sgabardi@partners.org
CR Abu-Alfa AK, 2002, AM J KIDNEY DIS, V39, P896, DOI 10.1053/ajkd.2002.32163
   Abu-Alfa AK, 2000, AM J KIDNEY DIS, V35, P1076, DOI 10.1016/S0272-6386(00)70043-6
   Ahuja TS, 2000, AM J NEPHROL, V20, P268, DOI 10.1159/000013599
   Ali MZ, 1997, CLIN INFECT DIS, V24, P796
   ALLEN NM, 1991, DICP ANN PHARMAC, V25, P1315
   ALLISON MEM, 1993, J CARDIOVASC PHARM, V22, pS59, DOI 10.1097/00005344-199322003-00008
   ALMIRALL J, 1989, NEPHRON, V53, P273, DOI 10.1159/000185757
   Anaizi N, 1997, INT J CLIN PHARM TH, V35, P223
   ANDERS MW, 1980, KIDNEY INT, V18, P636, DOI 10.1038/ki.1980.181
   Apperloo AJ, 1997, KIDNEY INT, V51, P793, DOI 10.1038/ki.1997.111
   ARONOFF G, 1999, DRUG PRECRIBING RENA
   ARONOFF G, 1991, J CLIN PHARMACOL, V31, P38
   ARONOFF G, 1994, BLOOD PURIFICAT, V12, P14, DOI 10.1159/000170140
   Aronoff G R, 1993, Curr Opin Nephrol Hypertens, V2, P187, DOI 10.1097/00041552-199303000-00003
   ARONOFF GR, 1983, AM J KIDNEY DIS, V3, P106
   ARRIGO G, 1985, INT J CLIN PHARM TH, V23, P491
   Aweeka FT, 1999, EPILEPSIA, V40, P777, DOI 10.1111/j.1528-1157.1999.tb00778.x
   Bailey CJ, 1996, NEW ENGL J MED, V334, P574
   Bailie George R, 2002, Semin Dial, V15, P375, DOI 10.1046/j.1525-139X.2002.t01-1-00911.x
   Bakris GL, 2000, KIDNEY INT, V58, P2084, DOI 10.1046/j.1523-1755.2000.00381.x
   BALANT LP, 1983, INT J CLIN PHARM RES, V3, P459
   BALLANTY.J, 1973, AUDIOLOGY, V12, P325
   Barclay ML, 1999, CLIN PHARMACOKINET, V36, P89, DOI 10.2165/00003088-199936020-00001
   BARZA M, 1976, Clinical Pharmacokinetics, V1, P297
   BAUER TM, 1995, LANCET, V346, P145, DOI 10.1016/S0140-6736(95)91209-6
   Beauchamp D, 2001, Curr Opin Crit Care, V7, P401, DOI 10.1097/00075198-200112000-00006
   Ben-Chetrit E, 1998, SEMIN ARTHRITIS RHEU, V28, P48, DOI 10.1016/S0049-0172(98)80028-0
   BENCHETRIT E, 1994, J RHEUMATOL, V21, P710
   BENNETT WM, 1983, AM J KIDNEY DIS, V3, P155
   Bennett W M, 1989, Adv Exp Med Biol, V252, P191
   Bennett WM, 1997, RENAL FAILURE, V19, P221
   BENNETT WM, 1996, AM J KIDNEY DIS, V28, P56
   BENNETT WM, 1988, CLIN PHARMACOKINET, V15, P326, DOI 10.2165/00003088-198815050-00005
   BERGAN T, 1979, INFECTION, V7, pS382, DOI 10.1007/BF01639017
   BERGAN T, 1977, J ANTIMICROB CHEMOTH, V3, P435, DOI 10.1093/jac/3.5.435
   BERGAN T, 1982, CHEMOTHERAPY, V28, P85
   BERGLUND G, 1980, EUR J CLIN PHARMACOL, V18, P321, DOI 10.1007/BF00561389
   BERNSTEIN JM, 1990, MED CLIN N AM, V74, P1059
   Berry C, 2001, AM J MED, V111, P587
   BERTINO JS, 1993, J INFECT DIS, V167, P173
   Blaustein DA, 2002, AM J CARDIOL, V90, P662, DOI 10.1016/S0002-9149(02)02580-8
   BOELAERT J, 1985, J ANTIMICROB CHEMOTH, V16, P87, DOI 10.1093/jac/16.1.87
   Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103
   Brater DC, 1998, NEW ENGL J MED, V339, P387
   BRATER DC, 1985, DRUGS, V30, P427, DOI 10.2165/00003495-198530050-00003
   Brier ME, 1997, AM J KIDNEY DIS, V29, P907, DOI 10.1016/S0272-6386(97)90465-0
   Brinkman WT, 2002, ANN THORAC SURG, V74, P37, DOI 10.1016/S0003-4975(02)03692-5
   BROWNCARTWRIGHT D, 1988, GASTROENTEROLOGY, V95, P49
   Buijk SE, 2002, INTENS CARE MED, V28, P936, DOI 10.1007/s00134-002-1313-7
   Buter H, 1999, EUR J CLIN PHARMACOL, V54, P953, DOI 10.1007/s002280050581
   CABANA BE, 1975, J PHARMACOKINET BIOP, V3, P419, DOI 10.1007/BF01059474
   CANTU TG, 1992, AM J HOSP PHARM, V49, P2944
   CARANASOS GJ, 1985, ANNU REV PHARMACOL, V25, P67, DOI 10.1146/annurev.pharmtox.25.1.67
   CARLSON RV, 1986, CLIN PHARMACOL THER, V40, P561
   Caspi O, 1997, THER DRUG MONIT, V19, P510, DOI 10.1097/00007691-199710000-00004
   Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735
   CHAPRON DJ, 1989, J CLIN PHARMACOL, V29, P348
   Charpentier G, 2000, DIABETES METAB, V26, P73
   CHATELUT E, 1994, NEPHRON, V66, P157
   Chatham WW, 2000, ARTHRITIS RHEUM, V43, P1185, DOI 10.1002/1529-0131(200005)43:5<1185::AID-ANR30>3.0.CO;2-V
   CHAUVIN M, 1987, ANESTHESIOLOGY, V66, P327, DOI 10.1097/00000542-198703000-00011
   Clark Richard F., 1995, Journal of Emergency Medicine, V13, P797, DOI 10.1016/0736-4679(95)02002-0
   Collet JP, 2001, INT J CARDIOL, V80, P81, DOI 10.1016/S0167-5273(01)00455-7
   Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007
   Costa S, 2001, Curr Opin Crit Care, V7, P379, DOI 10.1097/00075198-200112000-00002
   Coulomb F, 2000, J CLIN PHARMACOL, V40, P482, DOI 10.1177/00912700022009251
   CRONQVIST J, 1992, ANTIMICROB AGENTS CH, V36, P2676
   Crook ED, 2002, AM J MED SCI, V323, P78, DOI 10.1097/00000441-200202000-00004
   Cunha BA, 1998, INT J ANTIMICROB AG, V10, P107, DOI 10.1016/S0924-8579(98)00031-4
   Dasgupta A, 2002, CLIN CHEM LAB MED, V40, P986, DOI 10.1515/CCLM.2002.172
   Davidson MB, 1997, AM J MED, V102, P99
   Davies G, 1996, CLIN PHARMACOKINET, V31, P410, DOI 10.2165/00003088-199631060-00002
   de Jager P, 2002, INT J TUBERC LUNG D, V6, P622
   De Lorenzo F, 2001, QJM-MON J ASSOC PHYS, V94, P179, DOI 10.1093/qjmed/94.4.179
   DeMaria AN, 2003, J PAIN SYMPTOM MANAG, V25, pS41
   Deppermann K M, 1993, Drugs, V45 Suppl 3, P65
   Deray G, 2002, J ANTIMICROB CHEMOTH, V49, P37
   Donat F, 2002, CLIN PHARMACOKINET, V41, P1, DOI 10.2165/00003088-200241002-00001
   DRAYER DE, 1982, DRUGS, V24, P519
   DRAYER DE, 1976, CLIN PHARMACOKINET, V1, P426
   Dreisbach AW, 2003, SEMIN DIALYSIS, V16, P45, DOI 10.1046/j.1525-139X.2003.03011.x
   Dreisbach AW, 2003, CLIN PHARMACOL THER, V73, P475, DOI 10.1016/S0009-9236(03)00015-8
   Driessen J J, 1991, Acta Anaesthesiol Belg, V42, P149
   DRUMMER OH, 1986, MED RES REV, V6, P75, DOI 10.1002/med.2610060104
   DUNDEE JW, 1984, DRUGS, V28, P519, DOI 10.2165/00003495-198428060-00002
   DUSOUICH P, 1978, EUR J CLIN PHARMACOL, V14, P21
   ELSTON AC, 1993, BRIT J ANAESTH, V71, P282, DOI 10.1093/bja/71.2.282
   Elting LS, 1998, CANCER, V83, P2597, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L
   ELZINGA LW, 1988, ANTIMICROB AGENTS CH, V32, P844
   Ergur AT, 1997, ACTA PAEDIATR JAPON, V39, P422
   Etemad B, 1998, GASTROENTEROL CLIN N, V27, P875, DOI 10.1016/S0889-8553(05)70036-4
   Ferguson JA, 1997, CLIN PHARMACOL THER, V62, P203, DOI 10.1016/S0009-9236(97)90069-2
   FILLASTRE JP, 1994, ANTIMICROB AGENTS CH, V38, P733
   FILLASTRE JP, 1987, ANTIMICROB AGENTS CH, V31, P156
   Fischer KG, 2002, SEMIN THROMB HEMOST, V28, P467, DOI 10.1055/s-2002-35288
   FLISER D, 1994, KIDNEY INT, V46, P482, DOI 10.1038/ki.1994.298
   Floren LC, 1997, CLIN PHARMACOL THER, V62, P41, DOI 10.1016/S0009-9236(97)90150-8
   FLOUVAT B, 1980, BRIT J CLIN PHARMACO, V9, P379
   Freeman CD, 1997, J ANTIMICROB CHEMOTH, V39, P677, DOI 10.1093/jac/39.6.677
   FREEMAN JG, 1985, BRIT MED J, V291, P1048
   Fridman K, 1998, EUR J CLIN PHARMACOL, V54, P497, DOI 10.1007/s002280050503
   Fromm MF, 2003, EUR J CLIN INVEST, V33, P6, DOI 10.1046/j.1365-2362.33.s2.4.x
   GAILIUNAS P, 1978, ARCH INTERN MED, V138, P1621, DOI 10.1001/archinte.138.11.1621
   Gambaro G, 2003, J INTERN MED, V253, P643, DOI 10.1046/j.1365-2796.2003.01146.x
   GARAUD JJ, 1984, J ANTIMICROB CHEMOTH, V14, P53
   GEORGE CF, 1980, BRIT J CLIN PHARMACO, V9, P94
   Gerlach AT, 2000, PHARMACOTHERAPY, V20, P771, DOI 10.1592/phco.20.9.771.35210
   GIBSON TP, 1986, AM J KIDNEY DIS, V8, P7
   GILBERT DN, 1991, INFECT DIS CLIN N AM, V5, pR8
   Gilbert D N, 1989, Infect Dis Clin North Am, V3, P517
   Gillis JC, 1997, DRUGS, V53, P139, DOI 10.2165/00003495-199753010-00012
   Giovanni Galli, 2002, J Nephrol, V15, P480
   GLOFF CA, 1988, PHARMACOLOGY, V37, P268, DOI 10.1159/000138476
   Glue P, 1997, BRIT J CLIN PHARMACO, V44, P91, DOI 10.1046/j.1365-2125.1997.00619.x
   GOA KL, 1989, DRUGS, V37, P583, DOI 10.2165/00003495-198937050-00002
   GOETZ MB, 1993, J ANTIMICROB CHEMOTH, V32, P325, DOI 10.1093/jac/32.2.325
   GOETZ MB, 1993, J ANTIMICROB CHEMOTH, V32, P925
   GonzalezMartin G, 1996, INT J CLIN PHARM TH, V34, P71
   Gothard P, 2004, INT J CLIN PRACT, V58, P74, DOI 10.1111/j.1368-5031.2004.0099.x
   Greenbaum R, 2000, BRIT J CLIN PHARMACO, V49, P23, DOI 10.1046/j.1365-2125.2000.00103.x
   GUGLER R, 1990, CLIN PHARMACOKINET, V18, P210, DOI 10.2165/00003088-199018030-00003
   Guthrie R, 1997, J Am Board Fam Pract, V10, P213
   GYSELYNCK AM, 1971, J INFECT DIS S, V124, P70
   Hall LG, 2001, CRIT CARE CLIN, V17, P899, DOI 10.1016/S0749-0704(05)70186-X
   HALSTENSON CE, 1990, ANTIMICROB AGENTS CH, V34, P385
   Hanes SD, 1999, PHARMACOTHERAPY, V19, P897, DOI 10.1592/phco.19.10.897.31557
   Harbarth S, 2001, AM J MED, V111, P528, DOI 10.1016/S0002-9343(01)00928-7
   Harding I, 2000, J Chemother, V12 Suppl 5, P15
   HASEGAWA H, 1988, DRUGS, V35, P78
   Hashimoto Y, 1998, PHARMACEUT RES, V15, P1609, DOI 10.1023/A:1011967519752
   Hassan H, 2000, AM J KIDNEY DIS, V35, P146, DOI 10.1016/S0272-6386(00)70314-3
   HASSELBLATT A, 1989, CONTRIB NEPHROL, V73, P146
   Hasselblatt A, 1989, Contrib Nephrol, V73, P139
   Hatch M, 1996, J PHARMACOL EXP THER, V276, P187
   Haubitz M, 2002, KIDNEY INT, V61, P1495, DOI 10.1046/j.1523-1755.2002.00279.x
   HEWITT WL, 1978, MED CLIN N AM, V62, P1119
   Hilgers KF, 2002, J AM SOC NEPHROL, V13
   Himmelfarb J, 2002, KIDNEY INT, V61, P317, DOI 10.1046/j.1523-1755.2002.00118.x
   Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S
   HOFFKEN G, 1985, EUR J CLIN MICROBIOL, V4, P345, DOI 10.1007/BF02013667
   HOFFLER D, 1983, J ANTIMICROB CHEMOTH, V12, P241
   Howard Patricia A, 2003, J Infus Nurs, V26, P304, DOI 10.1097/00129804-200309000-00006
   HOYER J, 1993, CLIN PHARMACOKINET, V24, P230, DOI 10.2165/00003088-199324030-00005
   Hu YW, 2002, ANESTH ANALG, V95, P39, DOI 10.1213/01.ANE.0000020694.65934.79
   Hull RD, 2001, ANN INTERN MED, V135, P858
   HUMBERT G, 1979, ANTIMICROB AGENTS CH, V15, P28
   Humes HD, 1999, ANN NY ACAD SCI, V884, P15
   JAILLON P, 1980, CLIN PHARMACOKINET, V5, P365, DOI 10.2165/00003088-198005040-00004
   KAMPER AL, 1990, SCAND J CLIN LAB INV, V50, P611, DOI 10.3109/00365519009089178
   KARLSSON E, 1978, CLIN PHARMACOKINET, V3, P97, DOI 10.2165/00003088-197803020-00001
   KELLER F, 1980, EUR J CLIN PHARMACOL, V18, P433, DOI 10.1007/BF00636799
   KELLER F, 1987, THER DRUG MONIT, V9, P148, DOI 10.1097/00007691-198706000-00004
   KELLER F, 1995, NEPHROL DIAL TRANSPL, V10, P1516
   Khan KNM, 2002, KIDNEY INT, V61, P1210, DOI 10.1046/j.1523-1755.2002.00263.x
   KIM YG, 1993, CLIN PHARMACOL THER, V54, P612
   KIRBY WMM, 1971, POSTGRAD MED J, V47, P41
   KIRCH W, 1982, CLIN NEPHROL, V18, P88
   Kirkpatrick CMJ, 1999, BRIT J CLIN PHARMACO, V47, P637
   Kirpichnikov D, 2002, ANN INTERN MED, V137, P25
   KLEINBLOESEM CH, 1986, CLIN PHARMACOKINET, V11, P316
   KOEPPE P, 1987, ARZNEIMITTEL-FORSCH, V37-1, P203
   Kolbe Faron, 2003, Can J Clin Pharmacol, V10, P119
   KOOPMANS PP, 1985, NETH J MED, V28, P524
   Koshy S, 2000, CARDIOVASC DRUG THER, V14, P295, DOI 10.1023/A:1007882624572
   KRAMER BK, 1994, EUR J CLIN PHARMACOL, V47, P157
   KROPP H, 1982, ANTIMICROB AGENTS CH, V22, P62
   KUHNEL HJ, 1987, INT J CLIN PHARM TH, V25, P616
   Kunihara M, 1998, J PHARM PHARMACOL, V50, P1161
   Lacy MK, 1998, CLIN INFECT DIS, V27, P23, DOI 10.1086/514620
   Lam YWF, 1997, CLIN PHARMACOKINET, V32, P30
   Leblond F, 2001, J AM SOC NEPHROL, V12, P326
   Leblond FA, 2000, DRUG METAB DISPOS, V28, P1317
   Leblond FA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017575.50319.77
   Le Meur Y, 2001, AM J KIDNEY DIS, V38, P510, DOI 10.1053/ajkd.2001.26839
   Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142
   Levey AS, 2002, NEW ENGL J MED, V347, P1505, DOI 10.1056/NEJMcp013462
   Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S
   Lichtman SM, 2002, CANCER INVEST, V20, P904, DOI 10.1081/CNV-120005903
   Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003
   Lin JH, 2003, DRUG METAB REV, V35, P417, DOI 10.1081/DMR-120026871
   Linden PK, 2003, EXPERT OPIN PHARMACO, V4, P2099, DOI 10.1517/14656566.4.11.2099
   LLOYD P, 1990, AM HEART J, V120, P478, DOI 10.1016/0002-8703(90)90108-A
   Loehrer FMT, 1998, NEPHROL DIAL TRANSPL, V13, P656, DOI 10.1093/ndt/13.3.656
   LOMAESTRO BM, 1995, DRUG SAFETY, V12, P314
   Lown KS, 1997, CLIN PHARMACOL THER, V62, P248, DOI 10.1016/S0009-9236(97)90027-8
   MAACK T, 1975, AM J MED, V58, P57, DOI 10.1016/0002-9343(75)90533-1
   MANIAN FA, 1990, REV INFECT DIS, V12, P236
   Manske CL, 1998, AM J KIDNEY DIS, V32, pS157, DOI 10.1053/ajkd.1998.v32.pm9820473
   Marbury TC, 2000, CLIN PHARMACOL THER, V67, P7, DOI 10.1067/mcp.2000.103973
   Marcus William L., 1994, Journal of Environmental Pathology Toxicology and Oncology, V13, P73
   Matheny CJ, 2001, PHARMACOTHERAPY, V21, P778, DOI 10.1592/phco.21.9.778.34558
   Maton PN, 1999, DRUGS, V57, P855, DOI 10.2165/00003495-199957060-00003
   Matzke GR, 1997, DRUG SAFETY, V16, P205
   McCartney MM, 1999, CLIN RADIOL, V54, P29, DOI 10.1016/S0009-9260(99)91236-9
   McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513
   MCHENRY MC, 1976, J INFECT DIS, V134, pS343
   MCNAMEE PT, 1985, BRIT MED J, V291, P310
   MILLER MJS, 1984, J PHARMACOL EXP THER, V231, P449
   Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003
   MOOY J, 1985, EUR J CLIN PHARMACOL, V28, P405, DOI 10.1007/BF00544358
   Morales E, 2002, PHARMACOTHERAPY, V22, P1317, DOI 10.1592/phco.22.15.1317.33472
   MUELLER BA, 1993, AM J KIDNEY DIS, V21, P172
   MURRELL GAC, 1986, CLIN PHARMACOKINET, V11, P343
   MYARA I, 1989, NEPHRON, V51, P426, DOI 10.1159/000185340
   Naeshiro I, 1998, EUR J PHARMACOL, V354, P179, DOI 10.1016/S0014-2999(98)00451-8
   Nagge J, 2002, ARCH INTERN MED, V162, P2605, DOI 10.1001/archinte.162.22.2605
   Nakashima T, 2000, ACTA OTO-LARYNGOL, V120, P904, DOI 10.1080/00016480050218627
   NEUVONEN PJ, 1994, CLIN PHARMACOKINET, V27, P120
   Nicolas P, 1998, CLIN PHARMACOKINET, V35, P347, DOI 10.2165/00003088-199835050-00002
   NIELSEN O S, 1980, Infection, V8, pS305, DOI 10.1007/BF01639601
   NIEMEYER C, 1983, EUR J CLIN PHARMACOL, V24, P661, DOI 10.1007/BF00542218
   NIGHTINGALE CH, 1993, PHARMACOTHERAPY, V13, pS34
   Nolin TD, 2003, AM J KIDNEY DIS, V42, P906, DOI 10.1053/S0272-6386(03)01008-4
   Noroian G, 2002, DRUG SAFETY, V25, P165, DOI 10.2165/00002018-200225030-00003
   NORRBY SR, 1984, ANTIMICROB AGENTS CH, V26, P707
   Nzerue CM, 2003, INT J ARTIF ORGANS, V26, P86
   Odabas AR, 2003, PANMINERVA MED, V45, P59
   OHKAWA M, 1985, CHEMOTHERAPY, V31, P410
   OHKAWA M, 1983, CHEMOTHERAPY, V29, P4
   OHNHAUS EE, 1975, J PHARMACOKINET BIOP, V3, P171, DOI 10.1007/BF01067906
   ONEILCUTTING MA, 1986, JAMA-J AM MED ASSOC, V255, P1468, DOI 10.1001/jama.255.11.1468
   OSBORNE R, 1993, CLIN PHARMACOL THER, V54, P158
   Paap Christopher M., 1996, Annals of Pharmacotherapy, V30, P724
   PAAP CM, 1991, ANTIMICROB AGENTS CH, V35, P1879
   Papaioannou A, 2000, J AM GERIATR SOC, V48, P1470
   Park Geun Tae, 1999, Korean Journal of Internal Medicine, V14, P85
   PECHERE JC, 1976, J INFECT DIS, V134, pS118
   Pedro AA, 2000, J CLIN PHARMACOL, V40, P389, DOI 10.1177/00912700022009099
   Perazella MA, 2000, AM J MED, V109, P307, DOI 10.1016/S0002-9343(00)00496-4
   Perazella Mark A, 2002, Expert Opin Drug Saf, V1, P53, DOI 10.1517/14740338.1.1.53
   Perna AF, 1996, KIDNEY INT, V50, P358, DOI 10.1038/ki.1996.324
   Perna A F, 2001, Kidney Int Suppl, V78, pS230
   Perry JJ, 1999, BONE MARROW TRANSPL, V23, P839, DOI 10.1038/sj.bmt.1701646
   Phan O, 2003, JOINT BONE SPINE, V70, P237, DOI 10.1016/S1297-319X(03)00089-7
   Pichette V, 2003, CURR DRUG METAB, V4, P91, DOI 10.2174/1389200033489532
   Pillans PI, 2003, INTERN MED J, V33, P10, DOI 10.1046/j.1445-5994.2003.00330.x
   Pinder M, 2002, ANAESTH INTENS CARE, V30, P134
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Polk R. E., 1989, AM J MED S5A, V87, pS76
   Polkinghorne KR, 2002, AM J KIDNEY DIS, V40, P990, DOI 10.1053/ajkd.2002.36331
   Poschel KA, 2000, KIDNEY INT, V58, P2478, DOI 10.1046/j.1523-1755.2000.00431.x
   POZET N, 1983, EUR J CLIN PHARMACOL, V24, P635, DOI 10.1007/BF00542213
   PRESTAYKO AW, 1978, MED PEDIATR ONCOL, V5, P183, DOI 10.1002/mpo.2950050125
   Price G, 2003, BRIT J ANAESTH, V91, P909, DOI 10.1093/bja/aeg255
   Prisant L M, 1999, Curr Hypertens Rep, V1, P512, DOI 10.1007/s11906-996-0024-9
   RABKIN R, 1978, DIABETES, V27, P192
   RABKIN R, 1978, J CLIN INVEST, V62, P169, DOI 10.1172/JCI109102
   RAEHL CL, 1986, NEPHRON, V44, P191, DOI 10.1159/000183984
   RAMBAUSEK M, 1985, Blood Purification, V3, P4, DOI 10.1159/000169394
   REIDENBERG MM, 1984, CLIN PHARMACOKINET, V9, P18
   Remuzzi G, 2002, ANN INTERN MED, V136, P604
   Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506
   Rivory LP, 2001, CLIN PHARMACOKINET, V40, P151, DOI 10.2165/00003088-200140030-00001
   ROBERTS SM, 1980, J PHARM SCI, V69, P363, DOI 10.1002/jps.2600690335
   Rodvold KA, 2001, PHARMACOTHERAPY, V21, p233S, DOI 10.1592/phco.21.16.233S.33992
   Rossat J, 1999, CLIN PHARMACOL THER, V66, P76, DOI 10.1016/S0009-9236(99)70056-1
   Rougier F, 2003, ANTIMICROB AGENTS CH, V47, P1010, DOI 10.1128/AAC.47.3.1010-1016.2003
   ROUX A, 1980, EUR J CLIN PHARMACOL, V17, P339, DOI 10.1007/BF00558446
   RUDORFER MV, 1993, J CLIN PSYCHIAT, V54, P50
   RUDY DW, 1991, ANN INTERN MED, V115, P360
   Ruggenenti P, 2001, J AM SOC NEPHROL, V12, P2832
   RULL JA, 1967, DIABETES, V16, P352
   Salomon L, 2003, INT J QUAL HEALTH C, V15, P235, DOI 10.1093/intqhc/mzg034
   Salomon L, 2003, INT J QUAL HEALTH C, V15, P331, DOI 10.1093/intqhc/mzg046
   Salpeter SR, 2003, ARCH INTERN MED, V163, P2594, DOI 10.1001/archinte.163.21.2594
   SAMBOL NC, 1995, J CLIN PHARMACOL, V35, P1094
   Sanderink GJCM, 2002, THROMB RES, V105, P225, DOI 10.1016/S0049-3848(02)00031-2
   SCHALI C, 1982, J PHARMACOL EXP THER, V223, P811
   Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8
   Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068
   Schoolwerth AC, 2001, CIRCULATION, V104, P1985, DOI 10.1161/hc4101.096153
   Schulman S, 2003, NEW ENGL J MED, V349, P675, DOI 10.1056/NEJMcp025373
   Schumacher S, 2001, EUR J CLIN PHARMACOL, V57, P147, DOI 10.1007/s002280100280
   SCHWAB SJ, 1987, AM J MED, V82, P714, DOI 10.1016/0002-9343(87)90005-2
   SEILER KU, 1980, CLIN PHARMACOKINET, V5, P192
   Shand Brett I., 1995, Blood Pressure, V4, P238, DOI 10.3109/08037059509077601
   Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247
   SOFFER EE, 1987, J CLIN GASTROENTEROL, V9, P651, DOI 10.1097/00004836-198712000-00008
   Somogyi A, 1996, CLIN EXP PHARMACOL P, V23, P986, DOI 10.1111/j.1440-1681.1996.tb01155.x
   Spinler SA, 2003, AM HEART J, V146, P33, DOI 10.1016/S0002-8703(03)00121-2
   STEC GP, 1979, CLIN PHARMACOL THER, V26, P618
   STOECKEL K, 1984, AM J MED, V77, P26
   STPETER WL, 1992, CLIN PHARMACOKINET, V22, P169, DOI 10.2165/00003088-199222030-00002
   Suzuki S, 1997, NEPHROL DIAL TRANSPL, V12, P137, DOI 10.1093/ndt/12.1.137
   Svensson M, 2003, BRIT MED J, V327, P1141, DOI 10.1136/bmj.327.7424.1141
   Swan SK, 2000, ANN INTERN MED, V133, P1
   Swan SK, 1997, SEMIN NEPHROL, V17, P27
   SWAN SK, 1992, WESTERN J MED, V156, P633
   Swan SK, 2000, PHARMACOTHERAPY, V20, P318, DOI 10.1592/phco.20.4.318.34881
   SZEFLER SJ, 1973, RES COMMUN CHEM PATH, V6, P1095
   SZEFLER SJ, 1979, J PHARMACOL EXP THER, V210, P295
   SZETO HH, 1977, ANN INTERN MED, V86, P738
   TALBERT RL, 1994, J CLIN PHARMACOL, V34, P99
   Tam VH, 2003, ANTIMICROB AGENTS CH, V47, P1853, DOI 10.1128/AAC.47.6.1853-1861.2003
   Tannenbaum H, 1996, CAN MED ASSOC J, V155, P77
   Tett SE, 2003, CLIN PHARMACOKINET, V42, P1193, DOI 10.2165/00003088-200342140-00002
   *THOM MICROMEDEX, 2004, HEALTHC SER MICROMED
   THOMPSON MIB, 1981, ANTIMICROB AGENTS CH, V19, P450
   Thomson AH, 1996, CANCER CHEMOTH PHARM, V38, P566, DOI 10.1007/s002800050528
   TILSTONE WJ, 1978, CLIN PHARMACOL THER, V23, P644
   TIULA E, 1987, INT J CLIN PHARM TH, V25, P469
   TIULA E, 1987, INT J CLIN PHARM TH, V25, P545
   TOWNSEND PL, 1989, CRIT CARE MED, V17, P154, DOI 10.1097/00003246-198902000-00010
   Tulkens P M, 1990, Scand J Infect Dis Suppl, V74, P249
   TURNHEIM K, 1991, EUR J CLIN PHARMACOL, V40, P87, DOI 10.1007/BF00315145
   Turnheim K, 2003, EXP GERONTOL, V38, P843, DOI 10.1016/S0531-5565(03)00133-5
   Ullmann AJ, 2003, CURR MED RES OPIN, V19, P263, DOI 10.1185/030079903125001884
   VANCEBRYAN K, 1994, J ANTIMICROB CHEMOTH, V33, P811, DOI 10.1093/jac/33.4.811
   VANDERVIJGH WJF, 1978, INT J CLIN PHARM BI, V16, P540
   VANHERP F, 1993, J MAR BIOTECHNOL, V1, P17
   VANHOLDER R, 1988, KIDNEY INT, V33, P996, DOI 10.1038/ki.1988.99
   VANSCHAIK BAM, 1988, EUR J CLIN PHARMACOL, V34, P61
   Veau C, 2001, NEPHROL DIAL TRANSPL, V16, P1607, DOI 10.1093/ndt/16.8.1607
   Yuan R, 2000, INT J CLIN PHARM TH, V38, P245
   VERBEECK RK, 1983, CLIN PHARMACOKINET, V8, P297, DOI 10.2165/00003088-198308040-00003
   VERBIST L, 1986, J ANTIMICROB CHEMOTH, V18, P115
   VLASSES PH, 1986, AM J NEPHROL, V6, P112, DOI 10.1159/000167065
   Vuillemenot A, 1999, THROMB HAEMOSTASIS, V81, P214
   Walsh TJ, 2001, ANTIMICROB AGENTS CH, V45, P3487, DOI 10.1128/AAC.45.12.3487-3496.2001
   WALSTAD RA, 1983, EUR J CLIN PHARMACOL, V24, P391, DOI 10.1007/BF00610061
   WATKINS PB, 1987, J CLIN INVEST, V80, P1029, DOI 10.1172/JCI113156
   Weinberg MS, 2003, CURR HYPERTENS REP, V5, P418, DOI 10.1007/s11906-003-0088-8
   Wen SF, 1997, J FORMOS MED ASSOC, V96, P157
   Whelton A, 2000, Am J Ther, V7, P63, DOI 10.1097/00045391-200007020-00004
   Whelton A, 2001, AM J MED S1, V110, p33S, DOI 10.1016/S0002-9343(00)00699-9
   WHELTON A, 1982, MED CLIN N AM, V66, P267
   Winter ME, 1994, BASIC CLIN PHARMACOK
   WISE R, 1985, INFECTION, V13, pS145, DOI 10.1007/BF01644237
   Wong GC, 2003, JAMA-J AM MED ASSOC, V289, P331, DOI 10.1001/jama.289.3.331
   WOOLNER DF, 1986, BRIT J CLIN PHARMACO, V22, P55
   Wrenger E, 2003, BRIT MED J, V327, P147, DOI 10.1136/bmj.327.7407.147
   Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421
   WRIGHT N, 1983, J ANTIMICROB CHEMOTH, V11, P213
   WRIGHT RA, 1984, ARCH INTERN MED, V144, P495, DOI 10.1001/archinte.144.3.495
   WU CY, 1995, CLIN PHARMACOL THER, V58, P492, DOI 10.1016/0009-9236(95)90168-X
   Yu HT, 2003, ARCH INTERN MED, V163, P1417, DOI 10.1001/archinte.163.12.1417
   Zhang YC, 2001, CLIN PHARMACOKINET, V40, P159, DOI 10.2165/00003088-200140030-00002
   ZSOTER TT, 1973, CLIN PHARMACOL THER, V14, P325
NR 338
TC 32
Z9 33
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0025-7125
J9 MED CLIN N AM
JI Med. Clin. N. Am.
PD MAY
PY 2005
VL 89
IS 3
BP 649
EP +
DI 10.1016/j.mcna.2004.11.007
PG 40
WC Medicine, General & Internal
SC General & Internal Medicine
GA 911WH
UT WOS:000228036700014
PM 15755472
ER

PT J
AU Ramsay, J
   Shernan, S
   Fitch, J
   Finnegan, P
   Todaro, T
   Filloon, T
   Nussmeier, NA
AF Ramsay, J
   Shernan, S
   Fitch, J
   Finnegan, P
   Todaro, T
   Filloon, T
   Nussmeier, NA
TI Increased creatine kinase MB level predicts postoperative mortality
   after cardiac surgery independent of new Q waves
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID PERIOPERATIVE MYOCARDIAL-INFARCTION; CORONARY-BYPASS SURGERY;
   CLINICAL-SIGNIFICANCE; OFF-PUMP; GRAFT-SURGERY; TROPONIN-I;
   REVASCULARIZATION; ANGIOPLASTY; DIAGNOSIS; MUSCLES
AB Background: Recent consensus statements recommend cardiac enzyme release as available online, the essential criterion for diagnosing myocardial infarction. However, the outcome implications of cardiac enzyme release in patients undergoing coronary artery bypass grafting are controversial.
   Methods: Eight hundred patients were followed for 30 days after elective on-pump coronary artery bypass grafting in a multicenter, prospective, randomized trial of the anti-C5 complement antibody pexelizumab. Data from centralized electrocardiography and creatine kinase MB analyses were examined for any association with death or severe left ventricular dysfunction.
   Results: More than half of the 800 patients had peak creatine kinase MB levels of more than 5 times the upper limit of 5 ng/mL set by the core laboratory. The median peak value was 29 ng/mL. The incidence of the combined outcome (death or severe left ventricular dysfunction) was 1.7% if the peak creatine kinase MB level was less than 25 ng/mL and 18.0% if 100 ng/mL or greater (P < .01). Similarly, the incidence of new Q-wave myocardial infarction was 3.9% if the peak creatine kinase MB level was less than 25 ng/mL and 30.6% if 100 ng/mL or greater (P < .01). In a multivariate analysis that included preoperative and intraoperative factors, as well as peak enzyme release and Q-wave myocardial infarction, the strongest predictor of the combined outcome was a peak creatine kinase MB level of 100 ng/mL or greater. New Q-wave myocardial infarction did not significantly predict the combined outcome.
   Conclusions: Increased postoperative peak creatine kinase MB level, especially when 20 times or more of the upper limit of normal, indicates increased risk of severe postoperative left ventricular dysfunction and mortality within 30 days of coronary artery bypass grafting. High peak enzyme level is a stronger predictor of adverse C, outcomes than is postoperative Q-wave myocardial infarction in this population.
C1 St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Anesthesiol, Houston, TX 77030 USA.
   Emory Univ Hosp, Dept Anesthesiol, Atlanta, GA 30322 USA.
   Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.
   Univ Oklahoma, Dept Anesthesiol, Oklahoma City, OK 73190 USA.
   Alex Pharmaceut Inc, Cheshire, CT USA.
   Proctor & Gamble Pharmaceut, Mason, OH USA.
RP Nussmeier, NA (reprint author), St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Anesthesiol, Houston, TX 77030 USA.
EM nnussmeier@heart.thi.tmc.edu
CR Alpert JS, 2000, J AM COLL CARDIOL, V36, P959
   BASSAN MM, 1974, NEW ENGL J MED, V290, P349, DOI 10.1056/NEJM197402142900701
   Benoit MO, 2001, CRIT CARE MED, V29, P1880, DOI 10.1097/00003246-200110000-00005
   Califf RM, 1998, J AM COLL CARDIOL, V31, P241, DOI 10.1016/S0735-1097(97)00506-8
   CHAITMAN BR, 1983, CIRCULATION, V67, P302
   Chaitman BR, 1996, J ELECTROCARDIOL, V29, P265, DOI 10.1016/S0022-0736(96)80091-4
   Costa MA, 2001, CIRCULATION, V104, P2689, DOI 10.1161/hc4701.099789
   FORCE T, 1990, CIRCULATION, V82, P903
   GARDNER MJ, 1987, CAN J CARDIOL, V3, P336
   GRAEBER GM, 1985, J THORAC CARDIOV SUR, V89, P700
   Greenson N, 2001, AM HEART J, V141, P447, DOI 10.1067/mhj.2001.113071
   Hodakowski GT, 1996, J THORAC CARDIOV SUR, V112, P1447, DOI 10.1016/S0022-5223(96)70002-8
   Holmvang L, 2002, CHEST, V121, P103, DOI 10.1378/chest.121.1.103
   Jaffe AS, 2000, CIRCULATION, V102, P1216
   Jain U, 1992, J Cardiothorac Vasc Anesth, V6, P612, DOI 10.1016/1053-0770(92)90108-J
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602
   Klatte K, 2001, J AM COLL CARDIOL, V38, P1070, DOI 10.1016/S0735-1097(01)01481-4
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   ROBERTS AJ, 1983, ANN THORAC SURG, V35, P516
   Shernan SK, 2004, ANN THORAC SURG, V77, P942, DOI 10.1016/j.athoracsur.2003.08.054
   TSUNG JS, 1986, CLIN CHEM, V32, P1568
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
NR 23
TC 32
Z9 33
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 2005
VL 129
IS 2
BP 300
EP 306
DI 10.1016/j.jtcvs.2004.06.005
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 893QQ
UT WOS:000226734700010
PM 15678039
ER

PT J
AU Haan, CK
   Cabral, CI
   Conetta, DA
   Coombs, LP
   Edwards, FH
AF Haan, CK
   Cabral, CI
   Conetta, DA
   Coombs, LP
   Edwards, FH
TI Selecting patients with mitral regurgitation and left ventricular
   dysfunction for isolated mitral valve surgery
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID END-STAGE CARDIOMYOPATHY; ECHOCARDIOGRAPHIC PREDICTION; DILATED
   CARDIOMYOPATHY; SURGICAL-CORRECTION; REPLACEMENT; SURVIVAL; REPAIR;
   RECONSTRUCTION; IMPROVEMENT
AB Background. American College of Cardiology/ American Heart Association (ACC/AHA) Guidelines state that patients with an ejection fraction (EF) of 30% or less should not undergo mitral valve replacement for mitral regurgitation (MR). We sought to establish, using a national cardiac surgery database, whether patients with left ventricular dysfunction may safely undergo mitral valve surgery for MR, and if so, which ones.
   Methods. We queried the Society of Thoracic Surgeons (STS) National Database to identify patients who had isolated mitral valve replacement or repair for MR between 1998 and 2001. Mortality and morbidity outcomes were compared by EF category (less than or equal to 30% vs > 30%), and observed mortality compared by EF group, stratified by predicted risk for mortality. A classification and regression tree (CART) model was then used to determine which patient characteristics contributed most to designate the high-risk patient.
   Results. Of the 14,582 patients who had mitral valve surgery, 727 had an EF of 30% or less and 13,855 had an EF of more than 30%. Observed mortality rates were higher for patients with an EF of 30% or less (5.4% vs 3.1%). However, for low-risk to medium-risk patients, mortality rates remained fairly constant across levels of EF. Mortality is notably increased in the high-risk patients (predicted risk > 10%). A classification tree identifies three key characteristics for high risk: age more than 75 years, renal failure, and emergent or salvage procedure.
   Conclusions. When the predicted mortality risk is less than 10%, EF has minimal impact on operative mortality for mitral regurgitation. In contrast to the ACC/AHA Guidelines, our data show that operative risk for mitral valve surgery is not prohibitive for most patients with ventricular dysfunction. (C) 2004 by The Society of Thoracic Surgeons.
C1 UFHSCJ, Div Cardiovasc Surg, Ctr Cardiovasc, Jacksonville, FL 32209 USA.
   Univ Florida, Div Cardiol, Jacksonville, FL USA.
   Duke Clin Res Inst, Outcomes Res & Assessment Grp, Durham, NC USA.
RP Haan, CK (reprint author), UFHSCJ, Div Cardiovasc Surg, Ctr Cardiovasc, 655 W 8th St, Jacksonville, FL 32209 USA.
EM connie.haan@jax.ufl.edu
CR ACAR J, 1991, EUR HEART J, V12, P52
   Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9
   Bach DS, 1996, AM J CARDIOL, V78, P966, DOI 10.1016/S0002-9149(96)00481-X
   BACH DS, 1995, AM HEART J, V129, P1165, DOI 10.1016/0002-8703(95)90399-2
   Badhwar Vinay, 2002, Semin Thorac Cardiovasc Surg, V14, P133, DOI 10.1053/stcs.2002.32314
   Bishay ES, 2000, EUR J CARDIO-THORAC, V17, P213, DOI 10.1016/S1010-7940(00)00345-6
   BLONDHEIM DS, 1991, AM HEART J, V122, P763, DOI 10.1016/0002-8703(91)90523-K
   BOLLING SF, 1995, J THORAC CARDIOV SUR, V109, P676, DOI 10.1016/S0022-5223(95)70348-9
   Bolling SF, 1998, J THORAC CARDIOV SUR, V115, P381, DOI 10.1016/S0022-5223(98)70282-X
   BONCHECK LI, 2001, SOC THORACIC SURG NA, P1
   Calafiore AM, 2001, ANN THORAC SURG, V71, P1146, DOI 10.1016/S0003-4975(00)02650-3
   Chen FY, 1998, CIRCULATION, V98, P124
   Cooper HA, 1998, AM HEART J, V135, P925, DOI 10.1016/S0002-8703(98)70056-0
   CRAWFORD MH, 1990, CIRCULATION, V81, P1173
   Duarte IG, 1997, ANN THORAC SURG, V64, P1089, DOI 10.1016/S0003-4975(97)00800-X
   Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X
   ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536
   ENRIQUEZSARANO M, 1994, CIRCULATION, V90, P830
   ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022
   Gatti Giuseppe, 2003, Ital Heart J, V4, P29
   PHILLIPS HR, 1981, AM J CARDIOL, V48, P647, DOI 10.1016/0002-9149(81)90142-9
   ROCHA ASC, 2003, ARQ BRAS CARDIOL, V80, P13
   Rothenburger M, 2002, THORAC CARDIOV SURG, V50, P351, DOI 10.1055/s-2002-35746
   Schlant RC, 1999, CIRCULATION, V99, P338
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   TISCHLER MD, 1994, CIRCULATION, V89, P132
   TOEH KH, 1990, ANN THORAC SURG, V49, P643
   Tribouilloy CM, 1999, CIRCULATION, V99, P400
   Welke KF, 2004, ANN THORAC SURG, V77, P1137, DOI 10.1016/j.athoracsur.2003.07.030
   Wencker D, 2000, CARDIOLOGY, V93, P37, DOI 10.1159/000007000
NR 30
TC 32
Z9 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD SEP
PY 2004
VL 78
IS 3
BP 820
EP 825
DI 10.1016/j.athorascur.2004.04.003
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 851NT
UT WOS:000223692500010
PM 15336999
ER

PT J
AU Chen, BT
   Wood, DP
AF Chen, BT
   Wood, DP
TI Salvage prostatectomy in patients who have failed radiation therapy or
   cryotherapy as primary treatment for prostate cancer
SO UROLOGY
LA English
DT Article
ID EXTERNAL-BEAM RADIOTHERAPY; QUALITY-OF-LIFE; ORTHOTOPIC
   URINARY-DIVERSION; DISEASE-FREE SURVIVAL; RADICAL PROSTATECTOMY;
   ANDROGEN DEPRIVATION; BIOCHEMICAL FAILURE; FOLLOW-UP; DEFINITIVE
   RADIOTHERAPY; ANTIGEN LEVELS
AB Asymptomatic prostate-specific antigen (PSA) recurrence after radiation therapy for prostate carcinoma poses a diagnostic and therapeutic dilemma for clinicians. Patients with locally recurrent disease can consider treatment options of salvage surgery, cryotherapy, watchful waiting, or androgen deprivation. Of these options, only salvage surgery has been shown to result in long-term disease-free survival for selected patients. However, salvage surgery is associated with significant morbidity, including urinary incontinence and rectal injuries. Ideally, salvage surgery outcomes can be optimized with careful patient selection according to clinical stage, serum PSA levels before radiation and surgery, the medical condition of the patient, and clear expectations of the physician and patient. Among patients with locally recurrent disease, those with localized prostate carcinoma amenable to radical prostatectomy before radiation or cryotherapy would be the most suitable candidates for salvage surgery. (C) 2003 Elsevier Inc.
C1 Univ Michigan, Dept Urol, Taubman Ctr 2916, Ann Arbor, MI 48103 USA.
RP Wood, DP (reprint author), Univ Michigan, Dept Urol, Taubman Ctr 2916, 1500 E Med Ctr Dr, Ann Arbor, MI 48103 USA.
CR AHLERING TE, 1992, J UROLOGY, V147, P900
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Amling CL, 1999, J UROLOGY, V161, P857, DOI 10.1016/S0022-5347(01)61790-7
   Bochner BH, 1998, J UROLOGY, V160, P29, DOI 10.1016/S0022-5347(01)63018-0
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   BORLAND RN, 1992, J UROLOGY, V147, P905
   BOSTWICK DG, 1982, AM J SURG PATHOL, V6, P541, DOI 10.1097/00000478-198209000-00006
   Bostwick DG, 1997, CA-CANCER J CLIN, V47, P297, DOI 10.3322/canjclin.47.5.297
   BRAZIER JE, 1992, BRIT MED J, V305, P160
   BRENNER PC, 1995, BRIT J UROL, V75, P44, DOI 10.1111/j.1464-410X.1995.tb07230.x
   CAMPBELL EW, 1959, J UROLOGY, V81, P464
   Carroll P, 2001, EUR UROL, V40, P9, DOI 10.1159/000049879
   Cheng GC, 2003, INT J RADIAT ONCOL, V55, P64, DOI 10.1016/S0360-3016(02)03820-8
   Cheng L, 2000, CLIN CANCER RES, V6, P1896
   Cheng L, 1998, CANCER, V83, P2164, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2164::AID-CNCR15>3.0.CO;2-I
   Cheng L, 1999, AM J SURG PATHOL, V23, P1173, DOI 10.1097/00000478-199910000-00002
   Cher ML, 1998, J UROLOGY, V160, P1387, DOI 10.1016/S0022-5347(01)62545-X
   Chism DB, 2003, INT J RADIAT ONCOL, V55, P71, DOI 10.1016/S0360-3016(02)03822-1
   COIA LR, 1995, INT J RADIAT ONCOL, V31, P1213, DOI 10.1016/0360-3016(94)00419-L
   Cox JD, 1999, J CLIN ONCOL, V17, P1155
   COX RS, 1994, INT J RADIAT ONCOL, V28, P23
   Critz FA, 2002, J UROLOGY, V168, P2434, DOI 10.1097/01.ju.0000030581.57555.04
   Critz FA, 1999, UROLOGY, V54, P968, DOI 10.1016/S0090-4295(99)00346-5
   CROOK J, 1993, INT J RADIAT ONCOL, V27, P31
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   Crook JM, 1998, UROLOGY, V51, P566, DOI 10.1016/S0090-4295(97)00650-X
   Crook JM, 1997, CANCER, V79, P81, DOI 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.3.CO;2-I
   D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061
   D'Amico AV, 2002, INT J RADIAT ONCOL, V54, P436, DOI 10.1016/S0360-3016(02)02940-1
   D'Amico AV, 2000, JAMA-J AM MED ASSOC, V284, P1280, DOI 10.1001/jama.284.10.1280
   Do V, 2002, BJU INT, V90, P62, DOI 10.1046/j.1464-410X.2002.02813.x
   Forman JD, 1997, J UROLOGY, V158, P1436, DOI 10.1016/S0022-5347(01)64235-6
   Gardner BG, 2002, J UROLOGY, V167, P123, DOI 10.1016/S0022-5347(05)65395-5
   Garzotto M, 1998, J UROLOGY, V159, P950, DOI 10.1016/S0022-5347(01)63778-9
   Gheiler EL, 1997, UROLOGY, V50, P580, DOI 10.1016/S0090-4295(97)00264-1
   Gheiler EL, 1998, UROLOGY, V51, P789, DOI 10.1016/S0090-4295(98)00096-X
   GRIGNON DJ, 1995, CANCER, V75, P1837, DOI 10.1002/1097-0142(19950401)75:7+<1837::AID-CNCR2820751613>3.0.CO;2-S
   Grossfeld GD, 2002, UROLOGY, V60, P62
   HANCOCK SL, 1995, J UROLOGY, V154, P1412, DOI 10.1016/S0022-5347(01)66879-4
   Hanks GE, 1997, UROLOGY, V50, P87, DOI 10.1016/S0090-4295(97)00226-4
   Hanks GE, 2002, INT J RADIAT ONCOL, V54, P427, DOI 10.1016/S0360-3016(02)02954-1
   Hanlon AL, 2002, INT J RADIAT ONCOL, V53, P297, DOI 10.1016/S0360-3016(02)02717-7
   Herr HW, 2000, J UROLOGY, V163, P1743, DOI 10.1016/S0022-5347(05)67533-7
   Johnstone P A, 1997, Urol Oncol, V3, P108, DOI 10.1016/S1078-1439(98)00007-6
   KAPLAN ID, 1993, J UROLOGY, V149, P519
   KAPLAN ID, 1992, UROLOGY, V39, P401, DOI 10.1016/0090-4295(92)90233-M
   Kestin LL, 1999, CANCER, V86, P1557, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
   Kestin LL, 2002, INT J RADIAT ONCOL, V53, P304, DOI 10.1016/S0360-3016(02)02707-4
   KUBAN DA, 1995, INT J RADIAT ONCOL, V32, P307, DOI 10.1016/0360-3016(95)00137-N
   Kupelian PA, 2002, INT J RADIAT ONCOL, V52, P704, DOI 10.1016/S0360-3016(01)02778-X
   LANGE PH, 1989, J UROLOGY, V141, P873
   Lassiter Lance K, 2002, Semin Urol Oncol, V20, P146, DOI 10.1053/suro.2002.32834
   Lee WR, 1997, J CLIN ONCOL, V15, P230
   Lee WR, 2001, INT J RADIAT ONCOL, V51, P614, DOI 10.1016/S0360-3016(01)01707-2
   LERNER SE, 1995, J UROLOGY, V154, P1103, DOI 10.1016/S0022-5347(01)66988-X
   Levesque PE, 1998, UROLOGY, V51, P978, DOI 10.1016/S0090-4295(98)00025-9
   LINK P, 1991, UROLOGY, V37, P189, DOI 10.1016/0090-4295(91)80282-C
   Litwin MS, 1997, J UROLOGY, V157, P1608, DOI 10.1016/S0022-5347(01)64807-9
   MADOR DR, 1985, J UROLOGY, V133, P58
   McMullen KP, 2003, UROLOGY, V61, P391, DOI 10.1016/S0090-4295(02)02259-8
   Mettlin CJ, 1998, CANCER, V83, P1679, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1679::AID-CNCR24>3.0.CO;2-Y
   Montie JE, 1998, J UROLOGY, V160, P33
   MOUL JW, 1991, CANCER, V68, P1265, DOI 10.1002/1097-0142(19910915)68:6<1265::AID-CNCR2820680615>3.0.CO;2-G
   NEERHUT GJ, 1988, J UROLOGY, V140, P544
   Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6
   Pisters LL, 2000, J UROLOGY, V163, P1771, DOI 10.1016/S0022-5347(05)67539-8
   Pollack A, 2002, INT J RADIAT ONCOL, V54, P677, DOI 10.1016/S0360-3016(02)02977-2
   PONTES JE, 1993, CANCER, V71, P976, DOI 10.1002/1097-0142(19930201)71:3+<976::AID-CNCR2820711413>3.0.CO;2-M
   Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591
   Preston DM, 1999, UROLOGY, V53, P131, DOI 10.1016/S0090-4295(98)00464-6
   RAINWATER LM, 1988, J UROLOGY, V140, P1455
   Rakozy C, 1999, PATHOL RES PRACT, V195, P129
   RAOCH M, 2003, UROLOGY, V61, P730
   ROGERS E, 1995, J UROLOGY, V153, P104, DOI 10.1097/00005392-199501000-00037
   Rosser CJ, 2002, J UROLOGY, V168, P536, DOI 10.1016/S0022-5347(05)64674-5
   Russo P, 2000, J ENDOUROL, V14, P385, DOI 10.1089/end.2000.14.385
   Ryu JK, 2002, INT J RADIAT ONCOL, V54, P1036, DOI 10.1016/S0360-3016(02)03006-7
   Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5
   SCHELLHAMMER PF, 1993, J UROLOGY, V150, P1851
   Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598
   Soloway MS, 2002, J UROLOGY, V167, P112, DOI 10.1016/S0022-5347(05)65393-1
   STEIN A, 1992, UROLOGY, V40, P197, DOI 10.1016/0090-4295(92)90473-A
   Stephenson RA, 2002, UROL CLIN N AM, V29, P173, DOI 10.1016/S0094-0143(02)00002-2
   Stokes SH, 2000, INT J RADIAT ONCOL, V47, P129, DOI 10.1016/S0360-3016(99)00526-X
   STOTZER MJ, 2003, J UROLOGY, V164, P76
   Tefilli MV, 1998, J SURG ONCOL, V69, P156, DOI 10.1002/(SICI)1096-9098(199811)69:3<156::AID-JSO7>3.0.CO;2-D
   Tefilli M V, 1998, Urol Oncol, V4, P31, DOI 10.1016/S1078-1439(98)00029-5
   Tefilli MV, 1998, UROLOGY, V52, P224, DOI 10.1016/S0090-4295(98)00151-4
   THOMPSON IM, 1988, CANCER, V61, P1464, DOI 10.1002/1097-0142(19880401)61:7<1464::AID-CNCR2820610732>3.0.CO;2-F
   Vaidya A, 2000, J UROLOGY, V164, P1998, DOI 10.1016/S0022-5347(05)66937-6
   Waterman FM, 2003, INT J RADIAT ONCOL, V55, P342, DOI 10.1016/S0360-3016(02)03934-2
   Wei JT, 2002, J CLIN ONCOL, V20, P557, DOI 10.1200/JCO.20.2.557
   YOUNES E, 1994, UROLOGY, V43, P22, DOI 10.1016/S0090-4295(94)80255-6
   ZAGARS GK, 1994, J UROLOGY, V152, P1786
   ZIETMAN AL, 1994, J UROLOGY, V151, P640
   ZINCKE H, 1992, J UROLOGY, V147, P894
NR 96
TC 32
Z9 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0090-4295
J9 UROLOGY
JI Urology
PD DEC 29
PY 2003
VL 62
IS 6B
SU S
BP 69
EP 78
DI 10.1016/j.urology.2003.09.001
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA 808TR
UT WOS:000220591900009
PM 14747044
ER

PT J
AU Ngaage, DL
AF Ngaage, DL
TI Off-pump coronary artery bypass grafting: the myth, the logic and the
   science
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Review
DE beating heart surgery; complete myocardial revascularisation; coronary
   artery bypass grafting; myocardial protection; cardiopulmonary bypass;
   off-pump
ID HEPARIN-COATED CIRCUITS; SYSTEMIC INFLAMMATORY RESPONSE; ACUTE
   MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; BEATING-HEART-SURGERY;
   HIGH-RISK PATIENTS; FACTOR-KAPPA-B; CARDIOPULMONARY BYPASS; ON-PUMP;
   EXTRACORPOREAL-CIRCULATION
AB Coronary artery bypass grafting is a highly investigated surgical procedure and yet continues to attract rigorous research aimed at reducing observed and potential morbidity and mortality. Improvements in perioperative care, surgical technique and methods of attenuating the untoward effects of cardiopulmonary bypass have resulted in improved clinical outcome of on-pump myocardial revascularisation. The continuing drive to improve clinical outcome and compete with the ever-evolving non-surgical methods of myocardial revascularisation has provided the incentive for the rebirth of off-pump coronary artery bypass grafting (OPCAB). The appeal of avoiding cardiopulmonary pass with its direct and indirect physiological insult, the prospect of improved clinical outcomes, and the favourable economic impact gives OPCAB the potential of preference that may mark the dawn of a new era in our search for the optimal surgical strategy for the treatment of coronary artery disease. However, there are very genuine and serious concerns with this surgical technique. The logical appeal of OPCAB can only be validated by scientific scrutiny otherwise it would remain a myth.
   This comprehensive review examines the "physiological cost" of cardiopulmonary bypass, the theoretical and clinical benefits of OPCAB, the concerns with this technique and strategies for maximizing the benefits. And in so doing, explore the myth, the logic and the science of this surgical technique. (C) 2003 Elsevier B.V. All rights reserved.
C1 Gen Infirm, Yorkshire Heart Ctr, Dept Cardiothorac Surg, Leeds LS1 3EX, W Yorkshire, England.
RP Ngaage, DL (reprint author), Mayo Clin, Dept Cardiovasc Surg, 200 1st St SW, Rochester, MN 55905 USA.
CR Akiyama K, 1999, Ann Thorac Cardiovasc Surg, V5, P31
   Al-Ruzzeh S, 2001, EUR J CARDIO-THORAC, V20, P1152, DOI 10.1016/S1010-7940(01)00978-2
   Al-Ruzzeh S, 2003, EUR J CARDIO-THORAC, V23, P50, DOI 10.1016/S1010-7940(02)00654-1
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   ANKENEY JL, 1975, ANN THORAC SURG, V19, P108
   Argenziano M, 1998, J THORAC CARDIOV SUR, V116, P973, DOI 10.1016/S0022-5223(98)70049-2
   Arom KV, 2000, ANN THORAC SURG, V69, P704, DOI 10.1016/S0003-4975(99)01510-6
   Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6
   Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Ascione R, 2000, CIRCULATION, V102, P1530
   Ascione R, 1999, EUR J CARDIO-THORAC, V15, P685, DOI 10.1016/S1010-7940(99)00072-X
   Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X
   ATKINS C, 1984, AM HEART J, V107, P304
   Aybek T, 2003, ANN THORAC SURG, V75, P1165, DOI 10.1016/S0003-4975(02)04710-0
   Baisden CE, 2003, ANN THORAC SURG, V75, P68, DOI 10.1016/S0003-4975(02)04286-8
   Baufreton C, 1997, ANN THORAC SURG, V63, P50
   Bedi HS, 2000, ANN THORAC SURG, V69, P156
   Belboul A, 2000, EUR J CARDIO-THORAC, V17, P580, DOI 10.1016/S1010-7940(00)00392-4
   BELL MR, 1992, CIRCULATION, V86, P446
   BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312
   Bennetts JS, 2002, ANZ J SURG, V72, P105, DOI 10.1046/j.1445-2197.2002.02317.x
   Bergsland J, 1998, Heart Surg Forum, V1, P107
   Birdi I, 1996, ANN THORAC SURG, V61, P118, DOI 10.1016/0003-4975(95)00881-0
   Biswas S, 2001, EUR J CARDIO-THORAC, V20, P913, DOI 10.1016/S1010-7940(01)00932-0
   Bonchek LI, 2002, J THORAC CARDIOV SUR, V124, P431, DOI 10.1067/mtc.2002.124240
   Bouchard JF, 2000, CARDIOVASC RES, V45, P418, DOI 10.1016/S0008-6363(99)00343-0
   Bowles BJ, 2001, CHEST, V119, P25, DOI 10.1378/chest.119.1.25
   Boyd WD, 1999, ANN THORAC SURG, V68, P1490, DOI 10.1016/S0003-4975(99)00951-0
   Boyle EM, 1997, ANN THORAC SURG, V63, P277
   Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9
   BUCKBERG GD, 1996, GLENNS THORACIC CARD, P1653
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   Buffolo E, 2002, HEART SURG FORUM, V5, P154
   Buijsrogge MP, 2002, J THORAC CARDIOV SUR, V123, P788, DOI 10.1067/mtc.2002.120336
   Bull DA, 2001, ANN THORAC SURG, V71, P170, DOI 10.1016/S0003-4975(00)02205-0
   BURFIEND WR, 1999, EUR J CARDIO-THORAC, V14, P285
   Calafiore A M, 1998, Heart Surg Forum, V1, P20
   Calafiore AM, 2001, ANN THORAC SURG, V72, P456, DOI 10.1016/S0003-4975(01)02810-7
   Calafiore AM, 1999, ANN THORAC SURG, V67, P450, DOI 10.1016/S0003-4975(98)01194-1
   Cartier R, 2000, J THORAC CARDIOV SUR, V119, P221, DOI 10.1016/S0022-5223(00)70176-0
   Chaney MA, 2002, CHEST, V121, P921, DOI 10.1378/chest.121.3.921
   Chavanon O, 2001, ANN THORAC SURG, V71, P117, DOI 10.1016/S0003-4975(00)02136-6
   Cheng W, 2002, J THORAC CARDIOV SUR, V124, P313, DOI 10.1067/mtc.2002.122304
   CHENOWETH DE, 1981, NEW ENGL J MED, V304, P497, DOI 10.1056/NEJM198102263040901
   Christenson JT, 1997, EUR J CARDIO-THORAC, V11, P1097, DOI 10.1016/S1010-7940(97)00087-0
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Cooley DA, 2000, ANN THORAC SURG, V70, P1779, DOI 10.1016/S0003-4975(00)02052-X
   Cooper WA, 2003, ANN THORAC SURG, V75, P1132, DOI 10.1016/S0003-4975(02)04651-9
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   D'Ancona G, 2001, HEART SURG FORUM, V4, P74
   D'Acquisto Fulvio, 2002, Mol Interv, V2, P22, DOI 10.1124/mi.2.1.22
   D'Ancona G, 2001, HEART SURG FORUM, V4, P152
   Defraigne JO, 2000, ANN THORAC SURG, V69, P1084, DOI 10.1016/S0003-4975(00)01093-6
   Detter C, 2002, ANN THORAC SURG, V74, P497, DOI 10.1016/S0003-4975(02)03734-7
   Diegeler A, 2000, CIRCULATION, V102, P95
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Do QB, 2002, EUR J CARDIO-THORAC, V21, P385, DOI 10.1016/S1010-7940(02)00009-X
   Drenth DJ, 2002, J AM COLL CARDIOL, V40, P1955, DOI 10.1016/S0735-1097(02)02536-6
   DUNN J, 1974, J THORAC CARDIOV SUR, V68, P138
   Eckstein FS, 2001, ANN THORAC SURG, V72, pS995, DOI 10.1016/S0003-4975(01)02965-4
   Farsak B, 2002, HEART SURG FORUM, V5, P358
   Favaloro R G, 1970, Ann Thorac Surg, V10, P97
   Fearn SJ, 2001, J THORAC CARDIOV SUR, V121, P1150, DOI 10.1067/mtc.2001.114099
   Fitch JCK, 1999, CIRCULATION, V100, P2499
   Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X
   Fung M, 2001, J THORAC CARDIOV SUR, V122, P113, DOI 10.1067/mtc.2001.114777
   GAILIUNAS P, 1980, J THORAC CARDIOV SUR, V79, P241
   Gerritsen WBM, 2001, EUR J CARDIO-THORAC, V20, P923, DOI 10.1016/S1010-7940(01)00941-1
   Gill IS, 2000, ANN THORAC SURG, V69, P56, DOI 10.1016/S0003-4975(99)00861-9
   GOMMES WJ, 2003, EUR J CARDIO-THORAC, V23, P165
   Gray CC, 1999, INT J BIOCHEM CELL B, V31, P559, DOI 10.1016/S1357-2725(99)00004-7
   Gu YJ, 1999, CHEST, V116, P892, DOI 10.1378/chest.116.4.892
   Guler M, 2001, ANN THORAC SURG, V71, P152, DOI 10.1016/S0003-4975(00)02250-5
   Gundry SR, 1998, J THORAC CARDIOV SUR, V115, P1273, DOI 10.1016/S0022-5223(98)70209-0
   Guyton RA, 2000, ANN THORAC SURG, V69, P171, DOI 10.1016/S0003-4975(99)01386-7
   Haase M, 2003, ANN THORAC SURG, V75, P62, DOI 10.1016/S0003-4975(02)04116-4
   Harig F, 1999, THORAC CARDIOV SURG, V47, P111, DOI 10.1055/s-2007-1013121
   Hayashida N, 1999, ANN THORAC SURG, V68, P1661, DOI 10.1016/S0003-4975(99)00716-X
   Hernandez F, 2001, ANN THORAC SURG, V72, P1528, DOI 10.1016/S0003-4975(01)03202-7
   HILL GE, 1995, J THORAC CARDIOV SUR, V110, P1658, DOI 10.1016/S0022-5223(95)70027-7
   Hirose H, 2000, Ann Thorac Cardiovasc Surg, V6, P110
   Hirose Hitoshi, 2002, Asian Cardiovasc Thorac Ann, V10, P101
   Hirose H, 2000, CHEST, V117, P1262, DOI 10.1378/chest.117.5.1262
   Hoff SJ, 2002, ANN THORAC SURG, V74, pS1340
   Ihnken K, 1998, J THORAC CARDIOV SUR, V116, P327, DOI 10.1016/S0022-5223(98)70134-5
   JANSEN PGM, 1995, J THORAC CARDIOV SUR, V110, P829, DOI 10.1016/S0022-5223(95)70117-6
   Jatene FB, 2000, ANN THORAC SURG, V70, P1066, DOI 10.1016/S0003-4975(00)01790-2
   Jegaden O, 2001, EUR J CARDIO-THORAC, V19, P237, DOI 10.1016/S1010-7940(01)00591-7
   Jones EL, 1996, J THORAC CARDIOV SUR, V112, P227, DOI 10.1016/S0022-5223(96)70243-X
   Kilo J, 2001, ANN THORAC SURG, V72, P1926, DOI 10.1016/S0003-4975(01)03199-X
   Kim KB, 2002, ANN THORAC SURG, V74, pS1377
   Kim KB, 2001, ANN THORAC SURG, V71, P1964, DOI 10.1016/S0003-4975(01)02638-8
   Kim KB, 2001, ANN THORAC SURG, V72, P1033
   KIRKLIN JK, 1991, ANN THORAC SURG, V51, P529
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   Kobayashi J, 2002, HEART SURG FORUM, V5, P114
   Kovacich JC, 1999, J THORAC CARDIOV SUR, V118, P154, DOI 10.1016/S0022-5223(99)70154-6
   LACO AL, 1999, ANN THORAC SURG, V68, P1486
   Lancey RA, 2000, HEART SURG FORUM, V3, P277
   Laude K, 2001, BRAZ J MED BIOL RES, V34, P1
   Lockowandt U, 2000, ANN THORAC SURG, V70, P206, DOI 10.1016/S0003-4975(00)01410-7
   Lockwood JR, 2001, GENET EPIDEMIOL, V20, P17, DOI 10.1002/1098-2272(200101)20:1<17::AID-GEPI3>3.0.CO;2-Q
   LOISANCE D, 2001, BR J CARDIOL, V8, P442
   Lund O, 2001, EUR J CARDIO-THORAC, V20, P901, DOI 10.1016/S1010-7940(01)00972-1
   Mack M, 2002, J THORAC CARDIOV SUR, V124, P598, DOI 10.1067/mtc.2002.124884
   Maczewski M, 1998, J MOL CELL CARDIOL, V30, P1735, DOI 10.1006/jmcc.1998.0736
   Massoudy P, 1999, ANN THORAC SURG, V67, P1059, DOI 10.1016/S0003-4975(99)00157-5
   Massoudy P, 2000, EUR J CARDIO-THORAC, V17, P729, DOI 10.1016/S1010-7940(00)00398-5
   Masuda Munetaka, 2002, Ann Thorac Cardiovasc Surg, V8, P139
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Mathison M, 2000, ANN THORAC SURG, V70, P1083, DOI 10.1016/S0003-4975(00)01827-0
   Mathison M, 2000, ANN THORAC SURG, V70, P1355, DOI 10.1016/S0003-4975(00)01590-3
   McKay R G, 2001, Conn Med, V65, P515
   MEHLHORN U, 1995, CIRCULATION, V92, P1940
   MESSMER BJ, 1990, EUR J CARDIO-THORAC, V4, P509, DOI 10.1016/1010-7940(90)90175-Y
   MIHALJEVIC T, 1995, J THORAC CARDIOV SUR, V109, P1138, DOI 10.1016/S0022-5223(95)70197-4
   Mishra M, 2002, J CARDIOTHOR VASC AN, V16, P685, DOI 10.1053/jcan.2002.128418
   Mohr R, 1997, ANN THORAC SURG, V63, pS40, DOI 10.1016/S0003-4975(97)00429-3
   Mohr R, 1999, J THORAC CARDIOV SUR, V118, P50, DOI 10.1016/S0022-5223(99)70140-6
   Mojcik CF, 2001, ANN THORAC SURG, V71, P745, DOI 10.1016/S0003-4975(00)02218-9
   MONTAGUE NT, 1985, ANN THORAC SURG, V39, P552
   Morioka K, 1996, J THORAC CARDIOV SUR, V111, P45, DOI 10.1016/S0022-5223(96)70400-2
   Moshkovitz Y, 1997, ANN THORAC SURG, V63, pS44, DOI 10.1016/S0003-4975(97)00432-3
   Mueller XM, 2002, EUR J CARDIO-THORAC, V22, P249, DOI 10.1016/S1010-7940(02)00270-1
   MULLANY CJ, 1990, CIRCULATION, V82, P229
   Muraki S, 2001, J THORAC CARDIOV SUR, V121, P570, DOI 10.1067/mtc.2001.112342
   Murkin JM, 2002, HEART SURG FORUM, V5, P221
   Musleh GS, 2003, EUR J CARDIO-THORAC, V23, P170, DOI 10.1016/S1010-7940(02)00762-5
   Nader ND, 1999, ANN THORAC SURG, V68, P1640, DOI 10.1016/S0003-4975(99)00827-9
   Nakamura K, 2002, EUR J CARDIO-THORAC, V21, P753, DOI 10.1016/S1010-7940(02)00036-2
   Nakayama Y, 2003, ANN THORAC SURG, V75, P496, DOI 10.1016/S0003-4975(02)04380-1
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Omeroglu SN, 2000, ANN THORAC SURG, V70, P844, DOI 10.1016/S0003-4975(00)01567-8
   Ono M, 2002, J THORAC CARDIOV SUR, V123, P783, DOI 10.1067/mtc.2002.120338
   Ott RA, 1997, ANN THORAC SURG, V64, P478, DOI 10.1016/S0003-4975(97)00542-0
   Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5
   Patel NC, 2002, ANN THORAC SURG, V74, P400, DOI 10.1016/S0003-4975(02)03755-4
   Patel NC, 2002, EUR J CARDIO-THORAC, V22, P255, DOI 10.1016/S1010-7940(02)00301-9
   Penttila HJ, 2001, ANN THORAC SURG, V71, P565, DOI 10.1016/S0003-4975(00)02002-6
   Picone AL, 1999, ANN THORAC SURG, V67, P978, DOI 10.1016/S0003-4975(99)00093-4
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Prifti E, 2000, J CARDIAC SURG, V15, P403
   Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 1998, ANN THORAC SURG, V66, P1068, DOI 10.1016/S0003-4975(98)00657-2
   Quigley RL, 2001, ANN THORAC SURG, V72, P793, DOI 10.1016/S0003-4975(01)02886-7
   Riha M, 2002, EUR J CARDIO-THORAC, V21, P193, DOI 10.1016/S1010-7940(01)01100-9
   Roosens C, 2002, CRIT CARE MED, V30, P2430, DOI 10.1097/01.CCM.0000034680.46256.1B
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Sakaguchi T, 2001, ANN THORAC SURG, V71, P624, DOI 10.1016/S0003-4975(00)01906-8
   SALAMA A, 1988, NEW ENGL J MED, V318, P408, DOI 10.1056/NEJM198802183180704
   Salamon T, 2003, ANN THORAC SURG, V75, P505, DOI 10.1016/S0003-4975(02)04305-9
   SATO H, 1995, J THORAC CARDIOV SUR, V110, P302, DOI 10.1016/S0022-5223(95)70226-1
   Sawa Y, 1996, J THORAC CARDIOV SUR, V111, P29, DOI 10.1016/S0022-5223(96)70398-7
   Schmartz D, 2003, J THORAC CARDIOV SUR, V125, P184, DOI 10.1067/mtc.2003.64
   Schroeder S, 2003, ANN THORAC SURG, V75, P534, DOI 10.1016/S0003-4975(02)04377-1
   Schutz A, 2001, THORAC CARDIOV SURG, V49, P144, DOI 10.1055/s-2001-14290
   Sepic J, 2002, HEART SURG FORUM, V5, P279
   Shennib H, 2002, ANN THORAC SURG, V74, pS1344
   Shennib H, 2000, ANN THORAC SURG, V70, P1046, DOI 10.1016/S0003-4975(00)01792-6
   Soltoski P, 1998, J CARDIAC SURG, V13, P328, DOI 10.1111/j.1540-8191.1998.tb01093.x
   Stamou SC, 2002, ANN THORAC SURG, V74, P394, DOI 10.1016/S0003-4975(02)03636-6
   Stamou SC, 2000, ANN THORAC SURG, V69, P1140, DOI 10.1016/S0003-4975(99)01430-7
   Straka Z, 2002, ANN THORAC SURG, V74, P1544, DOI 10.1016/S0003-4975(02)03934-6
   Struber M, 1999, ANN THORAC SURG, V68, P1330, DOI 10.1016/S0003-4975(99)00729-8
   SVEDJEHOLM R, 1995, ANN THORAC SURG, V59, P23
   Tashiro T, 1996, Cardiovasc Surg, V4, P207, DOI 10.1016/0967-2109(96)82317-9
   Tofukuji M, 2000, ANN THORAC SURG, V69, P799, DOI 10.1016/S0003-4975(99)01408-3
   Torracca L, 2002, ANN THORAC SURG, V74, pS1348
   TRAPP WG, 1975, ANN THORAC SURG, V19, P1
   Trehan N, 2001, ANN THORAC SURG, V72, pS1026, DOI 10.1016/S0003-4975(01)02936-8
   VALLELY MP, 2001, ASIAN CARDIOVASC THO, V9, P349
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Vassiliades TA, 2002, ANN THORAC SURG, V73, P1874, DOI 10.1016/S0003-4975(02)03592-0
   Vassiliades TA, 2002, ANN THORAC SURG, V74, pS1383
   Walji S, 1999, ANN THORAC SURG, V67, P363, DOI 10.1016/S0003-4975(99)00034-X
   Westaby S., 1997, LANDMARKS CARDIAC SU, P187
   WESTABY S, 1995, BRIT HEART J, V73, P203
   Westaby S, 2001, ANN THORAC SURG, V71, P667, DOI 10.1016/S0003-4975(00)02405-X
   Yacoub M, 2001, CIRCULATION, V104, P1743
   YAU TM, 1994, J THORAC CARDIOV SUR, V108, P302
   Yeatman M, 2002, ANN THORAC SURG, V73, P1411, DOI 10.1016/S0003-4975(02)03407-0
   Yokoyama T, 2000, ANN THORAC SURG, V70, P1546, DOI 10.1016/S0003-4975(00)01922-6
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
NR 188
TC 32
Z9 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD OCT
PY 2003
VL 24
IS 4
BP 557
EP 570
DI 10.1016/S1010-7940(03)00381-6
PG 14
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 730AV
UT WOS:000185807800019
PM 14500075
ER

PT J
AU Slater, JD
   Rossi, CJ
   Yonemoto, LT
   Reyes-Molyneux, NJ
   Bush, DA
   Antoine, JE
   Miller, DW
   Teichman, SL
   Slater, JM
AF Slater, JD
   Rossi, CJ
   Yonemoto, LT
   Reyes-Molyneux, NJ
   Bush, DA
   Antoine, JE
   Miller, DW
   Teichman, SL
   Slater, JM
TI Conformal proton therapy for early-stage prostate cancer
SO UROLOGY
LA English
DT Article
ID LOCALLY ADVANCED-CARCINOMA; EXTERNAL-BEAM RADIATION; RADICAL
   PROSTATECTOMY; DOSE-ESCALATION; ANTIGEN; IRRADIATION; ADENOCARCINOMA;
   PSA; RADIOTHERAPY; IMPROVEMENT
AB Objectives. To assess the effect of proton radiation on clinical and biochemical outcomes for early prostate cancer.
   Methods. Three hundred nineteen patients with T1-T2b prostate cancer and initial prostate-specific antigen (PSA) levels 15.0 ng/mL or less received conformal radiation doses of 74 to 75 cobalt gray equivalent with protons alone or combined with photons. No patient had pre- or post-treatment hormonal therapy until disease progression was documented. Patients were evaluated for biochemical disease-free survival, PSA nadir, and toxicity; the mean and median follow-up period was 43 months.
   Results. Overall 5-year clinical and biochemical disease-free survival rates were 97% and 88%, respectively. Initial PSA level, stage, and post-treatment PSA nadir were independent prognostic variables for biochemical disease-free survival: a PSA nadir 0.5 ng/mL or less was associated with a 5-year biochemical disease-free survival rate of 98%, versus 88% and 42% for nadirs 0.51 to 1.0 and greater than 1.0 ng/mL, respectively. No severe treatment-related morbidity was seen.
   Conclusions. It appears that patients treated with conformal protons have 5-year biochemical disease-free survival rates comparable to those who undergo radical prostatectomy, and display no significant toxicity. A Phase III randomized dose-escalation trial is underway to define the optimum radiation dose for early-stage prostate cancer. UROLOGY 53: 978-984, 1999. (C) 1999, Elsevier Science Inc. All rights reserved.
C1 Loma Linda Univ, Med Ctr, Dept Radiat Med, Loma Linda, CA 92354 USA.
RP Slater, JD (reprint author), Loma Linda Univ, Med Ctr, Dept Radiat Med, 11234 Anderson St,POB 2000, Loma Linda, CA 92354 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   ARCHAMBE.JO, 1974, RADIOLOGY, V110, P445
   AUSTINSEYMOUR M, 1990, AM J CLIN ONCOL-CANC, V13, P327, DOI 10.1097/00000421-199008000-00013
   Baker L H, 1996, Oncology (Williston Park), V10, P265
   CORN BW, 1995, INT J RADIAT ONCOL, V32, P325, DOI 10.1016/0360-3016(94)00618-U
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   CROOK J, 1996, CANCER, V79, P328
   Gerber GS, 1996, JAMA-J AM MED ASSOC, V276, P615
   GOITEIN M, 1983, INT J RADIAT ONCOL, V9, P789
   GOITEIN M, 1983, INT J RADIAT ONCOL, V9, P777
   HANKS GE, 1994, J UROLOGY, V152, P1775
   HANKS GE, 1988, INT J RADIAT ONCOL, V15, P1299
   Hanks GE, 1997, INT J RADIAT ONCOL, V37, P543, DOI 10.1016/S0360-3016(96)00602-5
   HANKS GE, 1995, J UROLOGY, V154, P456, DOI 10.1016/S0022-5347(01)67073-3
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   KUBAN DA, 1995, INT J RADIAT ONCOL, V32, P307, DOI 10.1016/0360-3016(95)00137-N
   LAWTON CA, 1991, INT J RADIAT ONCOL, V21, P935
   LEE WR, 1995, J CLIN ONCOL, V13, P464
   LEIBEL SA, 1994, J UROLOGY, V152, P1792
   LEIBEL SA, 1994, INT J RADIAT ONCOL, V28, P55
   Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   PAULSON DF, 1990, J UROLOGY, V144, P1180
   PILEPICH MV, 1987, INT J RADIAT ONCOL, V13, P1007
   Rossi CJ, 1998, SEMIN RADIAT ONCOL, V8, P115, DOI 10.1016/S1053-4296(98)80007-6
   SANDLER HM, 1995, INT J RADIAT ONCOL, V33, P797, DOI 10.1016/0360-3016(95)00219-7
   SANDLER HM, 1992, INT J RADIAT ONCOL, V22, P361
   Schultheiss TE, 1997, INT J RADIAT ONCOL, V37, P3, DOI 10.1016/S0360-3016(96)00468-3
   SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5
   SHIPLEY WU, 1979, JAMA-J AM MED ASSOC, V241, P1912, DOI 10.1001/jama.241.18.1912
   SLATER JM, 1992, INT J RADIAT ONCOL, V22, P383
   Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2
   ZAGARS GK, 1995, INT J RADIAT ONCOL, V32, P293, DOI 10.1016/0360-3016(95)00077-C
   Zagars GK, 1997, CANCER, V79, P1370, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X
   ZAGARS GK, 1995, UROLOGY, V45, P476, DOI 10.1016/S0090-4295(99)80019-3
   Zietman AL, 1996, RADIOTHER ONCOL, V40, P159, DOI 10.1016/0167-8140(96)01770-7
   ZIETMAN AL, 1995, INT J RADIAT ONCOL, V32, P287, DOI 10.1016/0360-3016(95)00123-G
   ZIETMAN AL, 1994, J UROLOGY, V151, P640
   ZINCKE H, 1994, J CLIN ONCOL, V12, P2254
NR 40
TC 32
Z9 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0090-4295
J9 UROLOGY
JI UROLOGY
PD MAY
PY 1999
VL 53
IS 5
BP 978
EP 983
DI 10.1016/S0090-4295(99)00014-X
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 189HD
UT WOS:000079898200023
PM 10223493
ER

PT J
AU Peschel, RE
   Chen, Z
   Roberts, K
   Nath, R
AF Peschel, RE
   Chen, Z
   Roberts, K
   Nath, R
TI Long-term complications with prostate implants: Iodine-125 vs.
   palladium-103
SO RADIATION ONCOLOGY INVESTIGATIONS
LA English
DT Article
DE prostate cancer; implant; Pd-103; I-125
ID RADIATION-THERAPY COMMITTEE; LINEAR-QUADRATIC MODEL; DOSE FRACTIONATION;
   I-125; BRACHYTHERAPY; RADIOTHERAPY; CANCER; SURVIVAL; RECOMMENDATIONS;
   RESPONSES
AB The linear quadratic model predicts that the normal tissue biologically effective dose (BED) will be lower with palladium-103 (Pd-103) vs. iodine-125 (I-125) for the currently prescribed minimum tumor doses (MTD) used for I-125 (160 Gy) and Pd-103 (115 Gy) prostate cancer brachytherapy. The predicted BEDs for I-125 and Pd-103 suggest that the long-term complication rates should be lower with Pd-103 vs. I-125 in clinical practice. A review of 123 early stage Tie and T2 prostate cancer patients implanted at Yale University with I-125 (82 patients) or Pd-103 (41 patients) reveals a significantly lower overall complication rate with Pd-103 (0%) vs. I-125 (13%), Most important, the grade III-TV complication rate for Pd-103 was 0% vs. 6% for I-125, The 3-year actuarial probability of remaining free of a long-term complication was 100% for Pd-103 vs. 82% for I-125 (P < 0.01), A review of the literature for 992 patients implanted with I-125 vs. 540 patients implanted with Pd-103 shows a consistently higher complication rate for I-125 vs, Pd-103, Assuming that the MTD for Pd-103 may be increased to produce an equivalent late-reacting normal tissue BED to that for I-125, then the radiobiology model predicts the log(10) cell kill for Pd-103 implant will be greater than that of an I-125 implant for all tumor doubling times (high-grade tumors and low-grade tumors). The implications of these findings are discussed in terms of future research directions for prostate implants. (C) 1999 Wiley-Liss, Inc.
C1 Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA.
RP Peschel, RE (reprint author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.
CR BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981
   Benoit RM, 1998, J UROLOGY, V159, P63
   Beyer DC, 1997, INT J RADIAT ONCOL, V37, P559, DOI 10.1016/S0360-3016(96)00609-8
   Bice WS, 1998, INT J RADIAT ONCOL, V40, P1237, DOI 10.1016/S0360-3016(97)00949-8
   BLASKO JC, 1995, J UROLOGY, V154, P1096, DOI 10.1016/S0022-5347(01)66985-4
   Blasko JC, 1993, SEMIN RADIAT ONCOL, V3, P240, DOI 10.1053/SRAO00300240
   Blasko JC, 1998, PROSTATE CANCER, P137
   Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502
   COX DR, 1972, J R STAT SOC B, V34, P187
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7
   DALE RG, 1985, BRIT J RADIOL, V58, P515
   DALE RG, 1989, BRIT J RADIOL, V62, P241
   Dattoli M, 1996, INT J RADIAT ONCOL, V35, P875, DOI 10.1016/0360-3016(96)00214-3
   FOWLER JF, 1989, BRIT J RADIOL, V62, P679
   Hu K, 1998, INT J RADIAT ONCOL, V41, P263, DOI 10.1016/S0360-3016(98)00080-7
   KAYE KW, 1995, J UROLOGY, V153, P1020, DOI 10.1016/S0022-5347(01)67626-2
   KING CR, 1998, J BRACHYTHERAPY INT, V14, P169
   Kubo HD, 1998, INT J RADIAT ONCOL, V40, P697, DOI 10.1016/S0360-3016(97)00767-0
   LING CC, 1992, INT J RADIAT ONCOL, V23, P81
   NAG S, 1995, UROLOGY, V45, P87, DOI 10.1016/S0090-4295(95)96950-0
   NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458
   ORTON CG, 1992, ADV RAD ONCOLOGY PHY, P374
   PESCHEL RE, 1984, RADIOLOGY, V152, P801
   Scherr D, 1998, J UROLOGY, V159, P65
   Sharkey J, 1998, UROLOGY, V51, P796, DOI 10.1016/S0090-4295(98)00017-X
   THAMES HD, 1982, INT J RADIAT ONCOL, V8, P219
   WALLNER K, 1994, INT J RADIAT ONCOL, V30, P405
   Zelefsky MJ, 1998, INT J RADIAT ONCOL, V41, P491, DOI 10.1016/S0360-3016(98)00091-1
NR 29
TC 32
Z9 34
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1065-7541
J9 RADIAT ONCOL INVESTI
JI Radiat. Oncol. Investig.
PY 1999
VL 7
IS 5
BP 278
EP 288
DI 10.1002/(SICI)1520-6823(1999)7:5<278::AID-ROI3>3.0.CO;2-3
PG 11
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 253RA
UT WOS:000083568500003
PM 10580897
ER

PT J
AU Godart, F
   Qureshi, SA
   Simha, A
   Deverall, PB
   Anderson, DR
   Baker, EJ
   Tynan, M
AF Godart, F
   Qureshi, SA
   Simha, A
   Deverall, PB
   Anderson, DR
   Baker, EJ
   Tynan, M
TI Effects of modified and classic Blalock-Taussig shunts on the pulmonary
   arterial tree
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID VENTRICULAR SEPTAL-DEFECT; EXPANDED POLYTETRAFLUOROETHYLENE; INFANTS;
   TETRALOGY; FALLOT; CONSTRUCTION; PALLIATION; MANAGEMENT; CHILDREN;
   ATRESIA
AB Background. The aim of this study was to assess by angiography the late effects of both classic and modified Blalock-Taussig shunts in terms of growth and development of stenosis and distortion.
   Methods. At a mean of 51 months postoperatively, we retrospectively reviewed the results in 78 patients who underwent creation of Blalock-Taussig shunts (25 classic and 71 modified).
   Results. At the level of the anastomosis, the shunt caused a reduction in diameter of the pulmonary artery in 49% of all shunts, major stenosis (>50% narrowing of the lumen) in 14%, and distortion of the pulmonary artery in 19%, findings that did not correlate with the type of shunt. Distortion did correlate with younger age at the time of shunt operation (p = 0.01).
   Conclusions. After a Blalock-Taussig shunt, growth of the pulmonary arteries occurred but did not exceed the normal growth of the pulmonary arterial tree. Moreover, a shunt procedure can cause distortion and stenosis of the pulmonary artery, which may have important implications for future corrective surgical intervention. All these findings support earlier complete surgical repair of correctable congenital cardiac defects. (C) 1998 by The Society of Thoracic Surgeons.
C1 Guys Hosp, Dept Paediat Cardiol, London SE1 9RT, England.
RP Qureshi, SA (reprint author), Guys Hosp, Dept Paediat Cardiol, St Thomas St, London SE1 9RT, England.
CR MCKAY R, 1980, ANN THORAC SURG, V30, P137
   BOVE EL, 1987, CIRCULATION, V76, P19
   BRANDT B, 1986, ANN THORAC SURG, V42, pS1
   Cotrufo M, 1989, Eur J Cardiothorac Surg, V3, P12, DOI 10.1016/1010-7940(89)90004-3
   DELEVAL MR, 1981, J THORAC CARDIOV SUR, V81, P112
   FREEDOM RM, 1983, J THORAC CARDIOV SUR, V86, P24
   GALE AW, 1979, J THORAC CARDIOV SUR, V77, P459
   GAZZANIGA AB, 1976, J THORAC CARDIOV SUR, V72, P357
   GUYTON RA, 1983, J THORAC CARDIOV SUR, V85, P917
   ILBAWI M N, 1984, Journal of Thoracic and Cardiovascular Surgery, V88, P770
   KARPAWICH PP, 1985, J THORAC CARDIOV SUR, V89, P275
   KIRKLIN JW, 1977, CIRCULATION, V56, P612
   KULIK TJ, 1981, CIRCULATION, V64, P123
   LAMBERTI JJ, 1984, J THORAC CARDIOV SUR, V88, P76
   MOULTON AL, 1985, CIRCULATION, V72, P35
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   NAKATA S, 1984, J THORAC CARDIOV SUR, V88, P610
   PIEHLER JM, 1980, J THORAC CARDIOV SUR, V80, P552
   STARNES VA, 1994, ANN THORAC SURG, V58, P211
   TUCKER WY, 1979, J THORAC CARDIOV SUR, V78, P494
   ULLOM RL, 1987, ANN THORAC SURG, V44, P539
   UVA MS, 1994, J THORAC CARDIOV SUR, V107, P1291
   VOBECKY SJ, 1993, ANN THORAC SURG, V56, P944
NR 23
TC 32
Z9 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD AUG
PY 1998
VL 66
IS 2
BP 512
EP 517
DI 10.1016/S0003-4975(98)00461-5
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 113ML
UT WOS:000075554900036
PM 9725394
ER

PT J
AU BRIGHAM, RA
   FALLON, WF
   SAUNDERS, JR
   HARMON, JW
   DAVIS, JC
AF BRIGHAM, RA
   FALLON, WF
   SAUNDERS, JR
   HARMON, JW
   DAVIS, JC
TI PARADUODENAL HERNIA - DIAGNOSIS AND SURGICAL-MANAGEMENT
SO SURGERY
LA English
DT Article
C1 WALTER REED ARMY MED CTR,DEPT SURG,WASHINGTON,DC 20012.
   UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20814.
CR Alexander FK, 1937, AM J ROENTGENOL RADI, V38, P92
   Andrews E, 1923, SURG GYNECOL OBSTET, V37, P740
   BARTLETT MK, 1968, ANN SURG, V168, P249, DOI 10.1097/00000658-196808000-00010
   BELLTHOMSON J, 1977, AM J GASTROENTEROL, V68, P254
   BERARDI RS, 1981, SURG GYNECOL OBSTET, V152, P99
   Exner FB, 1933, AM J ROENTGENOL RADI, V29, P585
   JONES T, 1965, HERNIA, P577
   KUMMER E, 1921, J RADIOL ELECT, V5, P362
   MOYNIHAN BGA, 1906, RETROPERITONEAL HERN, P50
   OLEARCHYK AS, 1979, MIL MED, V144, P192
   Taylor J, 1930, BRIT J SURG, V17, P639, DOI 10.1002/bjs.1800176808
   TRETIZ W, 1857, HERNIA RETROPERITONE, P75
NR 12
TC 32
Z9 32
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0039-6060
J9 SURGERY
JI Surgery
PY 1984
VL 96
IS 3
BP 498
EP 502
PG 5
WC Surgery
SC Surgery
GA TG839
UT WOS:A1984TG83900009
PM 6474354
ER

PT J
AU Levine, GN
   Bates, ER
   Blankenship, JC
   Bailey, SR
   Bittl, JA
   Cercek, B
   Chambers, CE
   Ellis, SG
   Guyton, RA
   Hollenberg, SM
   Khot, UN
   Lange, RA
   Mauri, L
   Mehran, R
   Moussa, ID
   Mukherjee, D
   Nallamothu, BK
   Ting, HH
AF Levine, Glenn N.
   Bates, Eric R.
   Blankenship, James C.
   Bailey, Steven R.
   Bittl, John A.
   Cercek, Bojan
   Chambers, Charles E.
   Ellis, Stephen G.
   Guyton, Robert A.
   Hollenberg, Steven M.
   Khot, Umesh N.
   Lange, Richard A.
   Mauri, Laura
   Mehran, Roxana
   Moussa, Issam D.
   Mukherjee, Debabrata
   Nallamothu, Brahmajee K.
   Ting, Henry H.
TI 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention:
   Executive Summary A Report of the American College of Cardiology
   Foundation/American Heart Association Task Force on Practice Guidelines
   and the Society for Cardiovascular Angiography and Interventions
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE ACCF/AHA Practice Guidelines; acute coronary syndromes; anticoagulants;
   antiplatelet agents; arrhythmias, cardiac; coronary angiography;
   coronary artery revascularization interventions: stents; drug therapy;
   heart diseases; myocardial revasularization; platelet aggregation
   inhibitor; ultrasound
ID ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; RANDOMIZED
   CONTROLLED-TRIAL; DRUG-ELUTING STENTS; LONG-TERM SURVIVAL; GLYCOPROTEIN
   IIB/IIIA RECEPTOR; FRACTIONAL FLOW RESERVE; CONTRAST-INDUCED
   NEPHROPATHY; ARTERY-BYPASS SURGERY; BARE-METAL STENTS
AB The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.
   The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have jointly produced guidelines in the area of cardiovascular disease since 1980. The ACCF/AHA Task Force on Practice Guidelines (Task Force), charged with developing, updating, and revising practice guidelines for cardiovascular diseases and procedures, directs and oversees this effort. Writing committees are charged with regularly reviewing and evaluating all available evidence to develop balanced, patient-centric recommendations for clinical practice.
   Experts in the subject under consideration are selected by the ACCF and AHA to examine subject-specific data and write guidelines in partnership with representatives from other medical organizations and specialty groups. Writing committees are asked to perform a formal literature review; weigh the strength of evidence for or against particular tests, treatments, or procedures; and include estimates of expected outcomes where such data exist. Patient-specific modifiers, comorbidities, and issues of patient preference that may influence the choice of tests or therapies are considered. When available, information from studies on cost is considered, but data on efficacy and outcomes constitute the primary basis for the recommendations contained herein.
   In analyzing the data and developing recommendations and supporting text, the writing committee uses evidence-based methodologies developed by the Task Force (1). The Class of Recommendation (COR) is an estimate of the size of the treatment effect considering risks versus benefits in addition to evidence and/or agreement that a given treatment or procedure is or is not useful/effective or in some situations may cause harm. The Level of Evidence (LOE) is an estimate of the certainty or precision of the treatment effect. The writing committee reviews and ranks evidence supporting each recommendation with the weight of evidence ranked as LOE A, B, or C according to specific definitions that are included in Table 1. Studies are identified as observational, retrospective, prospective, or randomized where appropriate. For certain conditions for which inadequate data are available, recommendations are based on expert consensus and clinical experience and are ranked as LOE C. When recommendations at LOE C are supported by historical clinical data, appropriate references (including clinical reviews) are cited if available. For issues for which sparse data are available, a survey of current practice among the clinicians on the writing committee is the basis for LOE C recommendations and no references are cited. The schema for COR and LOE is summarized in Table 1, which also provides suggested phrases for writing recommendations within each COR. A new addition to this methodology is separation of the Class III recommendations to delineate if the recommendation is determined to be of "no benefit" or is associated with "harm" to the patient. In addition, in view of the increasing number of comparative effectiveness studies, comparator verbs and suggested phrases for writing recommendations for the comparative effectiveness of one treatment or strategy versus another have been added for COR I and IIa, LOE A or B only.
   In view of the advances in medical therapy across the spectrum of cardiovascular diseases, the Task Force has designated the term guideline-directed medical therapy (GDMT) to represent optimal medical therapy as defined by ACCF/AHA guideline recommended therapies (primarily Class I). This new term, GDMT, will be used herein and throughout all future guidelines.
   Because the ACCF/AHA practice guidelines address patient populations (and healthcare providers) residing in North America, drugs that are not currently available in North America are discussed in the text without a specific COR. For studies performed in large numbers of subjects outside North America, each writing committee reviews the potential influence of different practice patterns and patient populations on the treatment effect and relevance to the ACCF/AHA target population to determine whether the findings should inform a specific recommendation.
   The ACCF/AHA practice guidelines are intended to assist healthcare providers in clinical decision making by describing a range of generally acceptable approaches to the diagnosis, management, and prevention of specific diseases or conditions. The guidelines attempt to define practices that meet the needs of most patients in most circumstances. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient. As a result, situations may arise for which deviations from these guidelines may be appropriate. Clinical decision making should involve consideration of the quality and availability of expertise in the area where care is provided. When these guidelines are used as the basis for regulatory or payer decisions, the goal should be improvement in quality of care. The Task Force recognizes that situations arise in which additional data are needed to inform patient care more effectively; these areas will be identified within each respective guideline when appropriate.
   Prescribed courses of treatment in accordance with these recommendations are effective only if followed. Because lack of patient understanding and adherence may adversely affect outcomes, physicians and other healthcare providers should make every effort to engage the patient's active participation in prescribed medical regimens and lifestyles. In addition, patients should be informed of the risks, benefits, and alternatives to a particular treatment and be involved in shared decision making whenever feasible, particularly for COR IIa and IIb, where the benefit-to-risk ratio may be lower.
   The Task Force makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of industry relationships or personal interests among the members of the writing committee. All writing committee members and peer reviewers of the guideline are required to disclose all such current relationships, as well as those existing 12 months previously. In December 2009, the ACCF and AHA implemented a new policy for relationships with industry and other entities (RWI) that requires the writing committee chair plus a minimum of 50% of the writing committee to have no relevant RWI (Appendix 1 for the ACCF/AHA definition of relevance). These statements
   [GRAPHICS]
   are reviewed by the Task Force and all members during each conference call and/or meeting of the writing committee and are updated as changes occur. All guideline recommendations require a confidential vote by the writing committee and must be approved by a consensus of the voting members. Members are not permitted to write, and must recuse themselves from voting on, any recommendation or section to which their RWI apply. Members who recused themselves from voting are indicated in the list of writing committee members, and section recusals are noted in Appendix 1. Authors' and peer reviewers' RWI pertinent to this guideline are disclosed in Appendixes 1 and 2, respectively. Additionally, to ensure complete transparency, writing committee members' comprehensive disclosure information-including RWI not pertinent to this document-is available as an online supplement. Comprehensive disclosure information for the Task Force is also available online at www.cardiosource.org/ACC/About-ACC/Leadership/Guidelines-and-Documents-TaskForces.aspx. The work of the writing committee was supported exclusively by the ACCF, AHA, and the Society for Cardiovascular Angiography and Interventions (SCAI) without commercial support. Writing committee members volunteered their time for this activity.
   In an effort to maintain relevance at the point of care for practicing physicians, the Task Force continues to oversee an ongoing process improvement initiative. As a result, in response to pilot projects, several changes to these guidelines will be apparent, including limited narrative text, a focus on summary and evidence tables (with references linked to abstracts in PubMed), and more liberal use of summary recommendation tables (with references that support LOE) to serve as a quick reference.
   In April 2011 the Institute of Medicine released 2 reports: Finding What Works in Health Care: Standards for Systematic Reviews and Clinical Practice Guidelines We Can Trust (2,3). It is noteworthy that the ACCF/AHA guidelines are cited as being compliant with many of the proposed standards. A thorough review of these reports and of our current methodology is under way, with further enhancements anticipated.
   The recommendations in this guideline are considered current until they are superseded by a focused update or the full-text guideline is revised. Guidelines are official policy of both the ACCF and AHA.
C1 [Levine, Glenn N.] Baylor Coll Med, Houston, TX 77030 USA.
   [Bates, Eric R.; Nallamothu, Brahmajee K.] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Blankenship, James C.] Geisinger Med Ctr, Cardiol & Cardiac Catheterizat Labs, Danville, PA USA.
   [Cercek, Bojan] Cedars Sinai Med Ctr, Coronary Care Unit, Los Angeles, CA USA.
   [Chambers, Charles E.] Penn State Milton S Hershey Med Ctr, Hershey, PA USA.
   [Ellis, Stephen G.] Cleveland Clin Fdn, Cleveland, OH USA.
   [Guyton, Robert A.] Emory Clin Inc, Div Cardiothorac Surg, Atlanta, GA USA.
   [Hollenberg, Steven M.] Cooper Univ Hosp, Coronary Care Unit, Camden, NJ USA.
   [Lange, Richard A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
   [Mauri, Laura] Harvard Univ, Sch Med, Brigham & Womens Hosp, Cambridge, MA 02138 USA.
   [Mehran, Roxana] Columbia Univ, Med Ctr, New York, NY 10027 USA.
   [Moussa, Issam D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA.
   [Mukherjee, Debabrata] Texas Tech Univ, Lubbock, TX 79409 USA.
RP Levine, GN (reprint author), Baylor Coll Med, Houston, TX 77030 USA.
CR Aaberge L, 2000, J AM COLL CARDIOL, V35, P1170, DOI 10.1016/S0735-1097(00)00519-2
   Abraham NS, 2010, J AM COLL CARDIOL, V56, P2051, DOI 10.1016/j.jacc.2010.09.010
   ACCF/AHA Task Force on Practice Guidelines, METH POL ACCF AHA TA
   Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943
   Aguirre FV, 2008, CIRCULATION, V117, P1145, DOI 10.1161/CIRCULATIONAHA.107.728519
   Albiero R, 2004, J AM COLL CARDIOL, V43, P943, DOI 10.1016/j.jacc.2003.09.054
   Alderman E, 1997, CIRCULATION, V96, P1761
   ALDERMAN EL, 1983, CIRCULATION, V68, P785
   Aliabadi D, 1997, AM J CARDIOL, V80, P994, DOI 10.1016/S0002-9149(97)00591-2
   Al-Lamee R, 2010, AM J CARDIOL, V106, P1721, DOI 10.1016/j.amjcard.2010.08.013
   Allen KB, 2000, J THORAC CARDIOV SUR, V119, P540, DOI 10.1016/S0022-5223(00)70134-6
   Nestico PF, 2004, JAMA-J AM MED ASSOC, V291, P2196
   Griffith JL, 2003, JAMA-J AM MED ASSOC, V289, P178
   Alter DA, 2003, J AM COLL CARDIOL, V42, P410, DOI 10.1016/S0735-1097(03)00640-5
   Amit G, 2006, AM HEART J, V152, p[e9, e14]
   [Anonymous], 2002, LANCET, V360, P7
   [Anonymous], 2002, CIRCULATION, V106, P3143
   Antoniucci D, 2004, CIRCULATION, V109, P1704, DOI 10.1161/01.CIR.0000126284.40075.98
   Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Assali AR, 2000, CATHETER CARDIO INTE, V51, P27, DOI 10.1002/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO;2-0
   Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943
   Bader BD, 2004, CLIN NEPHROL, V62, P1
   Collins R, 2009, LANCET, V373, P1849
   Baigent C, 2002, BRIT MED J, V324, P71
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baim DS, 2002, CIRCULATION, V105, P1285, DOI 10.1161/01.CIR.0000012783.63093.0C
   Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057
   Barcin C, 2004, CATHETER CARDIO INTE, V61, P484, DOI 10.1002/ccd.20010
   BARNATHAN ES, 1987, CIRCULATION, V76, P125
   Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295
   Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050
   Bavry AA, 2008, EUR HEART J, V29, P2989, DOI 10.1093/eurheartj/ehn421
   Bellandi F, 2004, CATHETER CARDIO INTE, V62, P186, DOI 10.1002/ccd.20041
   Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9
   Berger PB, 1999, CIRCULATION, V99, P248
   Bertrand OF, 2010, AM J CARDIOL, V105, P1520, DOI 10.1016/j.amjcard.2010.01.006
   Biancari F, 2010, AM HEART J, V159, P518, DOI 10.1016/j.ahj.2009.12.027
   Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009
   Bittl JA, 2004, J AM COLL CARDIOL, V43, P936, DOI 10.1016/j.jacc.2003.10.039
   Blankenship JC, 2011, J AM COLL CARDIOL, V57, P272, DOI 10.1016/j.jacc.2010.06.056
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Boersma E, 1999, CIRCULATION, V100, P2045
   Bohmer E, 2010, J AM COLL CARDIOL, V55, P102, DOI 10.1016/j.jacc.2009.08.007
   Bonaros N, 2005, HEART SURG FORUM, V8, pE380, DOI 10.1532/HSF98.20051139
   Bonatti J, 2008, CARDIOLOGY, V110, P92, DOI 10.1159/000110486
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   Borgia F, 2010, EUR HEART J, V31, P2156, DOI 10.1093/eurheartj/ehq204
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063
   Brener SJ, 2006, EUR HEART J, V27, P413, DOI 10.1093/eurheartj/ehi646
   Brener SJ, 2008, AM J CARDIOL, V101, P169, DOI 10.1016/j.amjcard.2007.08.054
   Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14
   Brieger D, 2011, CATHETER CARDIO INTE, V77, P182, DOI 10.1002/ccd.22674
   Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005
   Briguori C, 2001, AM J CARDIOL, V87, P136, DOI 10.1016/S0002-9149(00)01304-7
   Briguori C, 2004, EUR HEART J, V25, P1822, DOI 10.1016/j.ehj.2004.07.017
   BROGAN WC, 1993, AM J CARDIOL, V71, P794, DOI 10.1016/0002-9149(93)90826-X
   Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016
   Bucher HC, 2000, BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73
   Burkhoff D, 1999, LANCET, V354, P885, DOI 10.1016/S0140-6736(99)08113-1
   Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501
   Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941
   Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106
   Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276
   Capodanno D, 2011, JACC-CARDIOVASC INTE, V4, P287, DOI 10.1016/j.jcin.2010.10.013
   CARACCIOLO EA, 1995, CIRCULATION, V91, P2325
   CASHIN WL, 1984, NEW ENGL J MED, V311, P824, DOI 10.1056/NEJM198409273111304
   CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9
   Chakravarty T, 2011, AM J CARDIOL, V107, P360, DOI 10.1016/j.amjcard.2010.09.029
   Chen EW, 2003, CIRCULATION, V108, P951, DOI 10.1161/01.CIR.000008508.59734.E4
   Chen SL, 2011, J AM COLL CARDIOL, V57, P914, DOI 10.1016/j.jacc.2010.10.023
   Chen ZM, 2005, LANCET, V366, P1607
   Chieffo A, 2006, CIRCULATION, V113, P2542, DOI 10.1161/CIRCULATIONHA.105.595694
   Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Choussat R, 2002, J AM COLL CARDIOL, V40, P1943, DOI 10.1016/S0735-1097(02)02531-7
   Clark AM, 2005, ANN INTERN MED, V143, P659
   Cohen M, 2010, CATHETER CARDIO INTE, V75, P928, DOI 10.1002/ccd.22340
   Collet JP, 2004, AM HEART J, V147, P655, DOI 10.1016/j.ahj.2003.10.019
   Collet JP, 2001, CIRCULATION, V103, P658
   Colombo A, 2009, CIRCULATION, V119, P71, DOI 10.1161/CIRCULATIONAHA.108.808402
   Coolong A, 2008, CIRCULATION, V117, P790, DOI 10.1161/CIRCULATIONAHA.106.651232
   Cornuz J, 2002, ANN INTERN MED, V136, P429
   Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034
   Cruden NLM, 2010, CIRC-CARDIOVASC INTE, V3, P236, DOI 10.1161/CIRCINTERVENTIONS.109.934703
   CUMMINGS SR, 1989, J GEN INTERN MED, V4, P482, DOI 10.1007/BF02599545
   Dangas G, 2009, J AM COLL CARDIOL, V54, P1438, DOI 10.1016/j.jacc.2009.06.021
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320
   Dauerman HL, 2007, J AM COLL CARDIOL, V50, P1617, DOI 10.1016/j.jacc.2007.07.028
   Davies RF, 1997, CIRCULATION, V95, P2037
   DEFEYTER PIMJ, 1993, J AM COLL CARDIOL, V21, P1539
   DEFEYTER PJ, 1989, AM J CARDIOL, V64, P88, DOI 10.1016/0002-9149(89)90658-9
   Dehmer GJ, 2007, CATHETER CARDIO INTE, V69, P471, DOI 10.1002/ccd.21097
   Deibele AJ, 2006, J THROMB THROMBOLYS, V22, P47, DOI 10.1007/s11239-006-7454-8
   Deibele AJ, 2010, CIRCULATION, V121, P784, DOI 10.1161/CIRCULATIONAHA.109.882746
   de Labriolle A, 2008, AM J CARDIOL, V102, P1175, DOI 10.1016/j.amjcard.2008.06.059
   De Luca G, 2009, THROMB HAEMOSTASIS, V102, P428, DOI 10.1160/TH09-05-0287
   De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759
   De Luca G, 2009, EUR HEART J, V30, P2705, DOI 10.1093/eurheartj/ehp118
   Dibra A, 2007, J AM COLL CARDIOL, V49, P616, DOI 10.1016/j.jacc.2006.10.049
   Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2
   Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8
   Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028
   Drouet L, 2009, AM HEART J, V158, P177, DOI 10.1016/j.ahj.2009.05.022
   DUNCAN C, 1991, AM J PUBLIC HEALTH, V81, P899, DOI 10.2105/AJPH.81.7.899
   Dzavik V, 2001, AM HEART J, V142, P119, DOI 10.1067/mhj.2001.116072
   Eisenberg MJ, 2004, AM J CARDIOL, V93, P744, DOI 10.1016/j.amjcard.2003.11.071
   Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179
   El Khoury C, 2010, ARCH CARDIOVASC DIS, V103, P287, DOI 10.1016/j.acvd.2010.04.005
   Ellis SG, 2009, JACC-CARDIOVASC INTE, V2, P909, DOI 10.1016/j.jcin.2009.07.009
   Ellis SG, 1997, CIRCULATION, V96, P3867
   Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816
   Ellis SG, 1998, J AM COLL CARDIOL, V32, P1619, DOI 10.1016/S0735-1097(98)00403-3
   CALIFF RM, 1994, NEW ENGL J MED, V330, P956
   Topol EJ, 1997, NEW ENGL J MED, V336, P1689
   EPISTENT Investigators, 1998, Lancet, V352, P87
   Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304
   Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985
   Tcheng JE, 2000, LANCET, V356, P2037
   EVERY NR, 1992, J AM COLL CARDIOL, V19, P1435
   Fassa AA, 2005, J AM COLL CARDIOL, V45, P204, DOI 10.1016/j.jacc.2004.09.066
   Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001
   Feit F, 2000, CIRCULATION, V101, P2795
   Ferenc M, 2008, EUR HEART J, V29, P2859, DOI 10.1093/eurheartj/ehn455
   Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45
   Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1
   APPLEBY P, 1994, LANCET, V343, P311
   Fischell Tim A, 2008, Cardiovasc Revasc Med, V9, P224, DOI 10.1016/j.carrev.2008.03.002
   Fleisher LA, 2009, J AM COLL CARDIOL, V54, pe13
   Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.003
   Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960
   Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007
   Galassi AR, 2009, JACC-CARDIOVASC INTE, V2, P185, DOI 10.1016/j.jcin.2008.12.005
   Gershlick AH, 2005, NEW ENGL J MED, V353, P2758, DOI 10.1056/NEJMoa050849
   Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194
   Gibson CM, 2003, J AM COLL CARDIOL, V42, P7, DOI 10.1016/S0735-1097(03)00506-0
   Gierlotka M, 2011, AM J CARDIOL, V107, P501, DOI 10.1016/j.amjcard.2010.10.008
   Gil Robert J, 2005, Kardiol Pol, V63, P223
   Gilard M, 2007, CARDIOLOGY, V108, P363, DOI 10.1159/000099110
   Gill BV, 2009, J ALLERGY CLIN IMMUN, V124, P1055, DOI 10.1016/j.jaci.2009.06.030
   Goel K, 2011, CIRCULATION, V123, P2344, DOI 10.1161/CIRCULATIONAHA.110.983536
   Gonzales DA, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-32
   GREENBERGER PA, 1985, ARCH INTERN MED, V145, P2197, DOI 10.1001/archinte.145.12.2197
   Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jace.2007.01.003
   Grover FL, 2001, ANN SURG, V234, P464, DOI 10.1097/00000658-200110000-00006
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Grzybowski M, 2003, JAMA-J AM MED ASSOC, V290, P1891, DOI 10.1001/jama.290.14.1891
   Gupta M, 2003, EUR HEART J, V24, P1640, DOI 10.1016/S0195-668X(03)00433-0
   Gurbel PA, 2005, CIRCULATION, V111, P1153, DOI 10.1161/01.CIR.0000157138.02645.11
   Gurfinkel EP, 2007, INT J CARDIOL, V119, P65, DOI 10.1016/j.ijcard.2006.07.058
   Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41
   Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073
   Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103
   Hamon M, 2009, EUROINTERVENTION, V5, P115
   Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804
   Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATONAHA.104.528455
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hansen PR, 2010, J INVASIVE CARDIOL, V22, P278
   Hao PP, 2010, TEX HEART I J, V37, P516
   Hassan Y, 2009, ANN PHARMACOTHER, V43, P1598, DOI 10.1345/aph.1M187
   Hausleiter J, 2004, J INTERN MED, V256, P388, DOI 10.1111/j.1365-2796.2004.01398.x
   Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141
   Hildick-Smith D, 2010, CIRCULATION, V121, P1235, DOI 10.1161/CIRCULATIONAHA.109.888297
   Hillegass WB, 2001, J AM COLL CARDIOL, V37, P1335, DOI 10.1016/S0735-1097(01)01138-X
   Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139
   Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190
   Hoffer EK, 2003, J VASC INTERV RADIOL, V14, P865, DOI 10.1097/01.RVI.0000071086.764348.8E
   Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8
   Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264
   Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013
   Holzhey DM, 2008, ANN THORAC SURG, V86, P1856, DOI 10.1016/j.athoracsur.2008.08.034
   Huang RI, 2006, CATHETER CARDIO INTE, V68, P671, DOI 10.1002/ccd.20885
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   Iakovou I, 2004, J AM COLL CARDIOL, V44, P967, DOI 10.1016/j.jacc.2004.05.058
   Institute of Medicine, 2011, CLIN PRACT GUID WE C
   Institute of Medicine, 2011, FIND WHAT WORKS HLTH
   Ioannidis JPA, 2007, AM HEART J, V154, P1065, DOI 10.1016/j.ahj.2007.07.049
   Ito H, 1999, J AM COLL CARDIOL, V33, P654, DOI 10.1016/S0735-1097(98)00604-4
   Jaffe R, 2007, CATHETER CARDIO INTE, V69, P815, DOI 10.1002/ccd.21021
   Iversen Allan, 2008, Curr Cardiol Rev, V4, P293, DOI 10.2174/157340308786349480
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Jolly SS, 2009, EUR HEART J, V30, P900, DOI 10.1093/eurheartj/ehn417
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1
   KAISER GA, 1975, SURGERY, V78, P749
   Kakkar AK, 2004, CATHETER CARDIO INTE, V61, P31, DOI 10.1002/ccd.10730
   Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P65, DOI 10.1161/CIRCINTERVENTIONS.110.959148
   Kapadia SR, 1998, CIRCULATION, V98, P2672
   Kaplan BM, 1996, CATHETER CARDIO DIAG, V39, P113, DOI 10.1002/(SICI)1097-0304(199610)39:2<113::AID-CCD1>3.0.CO;2-I
   Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213
   Kappetein AP, 2011, EUR HEART J, V17, P2125
   Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859
   Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034
   Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944
   Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165
   Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503
   Keeley EC, 2004, JAMA-J AM MED ASSOC, V291, P736, DOI 10.1001/jama.291.6.736
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8
   Kim YH, 2010, JACC-CARDIOVASC INTE, V3, P612, DOI 10.1016/j.jcin.2010.04.004
   King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7
   Klein LW, 2009, CATHETER CARDIO INTE, V74, P728, DOI 10.1002/ccd.22113
   Kobashigawa JA, 2005, J AM COLL CARDIOL, V45, P1532, DOI 10.1016/j.jacc.2005.02.035
   Kon ZN, 2008, J THORAC CARDIOV SUR, V135, P367, DOI 10.1016/j.jtcvs.2007.09.025
   Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Lee MS, 2006, J AM COLL CARDIOL, V47, P864, DOI 10.1016/j.jacc.2005.09.072
   Lee MS, 2010, JACC-CARDIOVASC INTE, V3, P791, DOI 10.1016/j.jcin.2010.06.005
   Lee MS, 2008, ANN THORAC SURG, V86, P29, DOI 10.1016/j.athoracsur.2008.03.019
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Levey AS, 2006, ANN INTERN MED, V145, P247
   Levine GN, 2004, J THROMB THROMBOLYS, V17, P167, DOI 10.1023/B:THRO.0000040484.99422.77
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Levine GN, 2003, ANN INTERN MED, V139, P123
   Lewis BE, 2002, CATHETER CARDIO INTE, V57, P177, DOI 10.1002/ccd.10276
   Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853
   Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696
   Lincoff AM, 2008, JACC-CARDIOVASC INTE, V1, P639, DOI 10.1016/j.jcin.2008.10.004
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Louvard Y, 2004, AM J CARDIOL, V94, P1177, DOI 10.1016/j.amjcard.2004.07.089
   LYTLE BW, 1993, J THORAC CARDIOV SUR, V105, P605
   Madsen JK, 1997, CIRCULATION, V96, P748
   Magni V, 2009, CATHETER CARDIO INTE, V73, P441, DOI 10.1002/ccd.21812
   Mahaffey Kenneth W, 2003, J Invasive Cardiol, V15, P611
   Maioli M, 2007, J AM COLL CARDIOL, V49, P1517, DOI 10.1016/j.jacc.2006.12.036
   Makikallio TH, 2008, ANN MED, V40, P437, DOI 10.1080/07853890701879790
   Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392
   Marciniak SJ, 2002, THROMB HAEMOSTASIS, V87, P1020
   Marenzi G, 2009, ANN INTERN MED, V150, P170
   Martin JL, 2004, CATHETER CARDIO INTE, V61, P163, DOI 10.1002/ccd.10726
   Marzilli M, 2000, CIRCULATION, V101, P2154
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Mauri L, 2003, AM HEART J, V145, P847, DOI 10.1016/S0002-8703(03)00080-2
   Mauri L, 2002, AM J CARDIOL, V90, P1079, DOI 10.1016/S0002-9149(02)02773-X
   Mauri L, 2007, J AM COLL CARDIOL, V50, P1442, DOI 10.1016/j.jacc.2007.06.039
   Mauri L, 2008, NEW ENGL J MED, V359, P1330, DOI 10.1056/NEJMoa0801485
   McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2
   McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9
   McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905
   Mehilli J, 2009, CIRCULATION, V119, P1933, DOI 10.1161/CIRCULATIONAHA.108.818617
   Mehilli J, 2004, CIRCULATION, V110, P3627, DOI 10.1161/01.CIR.0000148956.93631.4D
   Mehilli J, 2011, LANCET, V378, P1071, DOI 10.1016/S0140-6736(11)61255-5
   Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068
   Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7
   Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986
   Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4
   Melberg T, 2006, AM HEART J, V152, P888, DOI 10.1016/j.ahj.2006.06.026
   Montalescot G, 2004, JAMA-J AM MED ASSOC, V292, P362, DOI 10.1001/jama.292.3.362
   Montalescot G, 2009, EUR HEART J, V30, P2308, DOI 10.1093/eurheartj/ehp353
   Montalescot G, 2009, JACC-CARDIOVASC INTE, V2, P1083, DOI 10.1016/j.jcin.2009.08.016
   Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3
   Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Moussa I, 1997, CIRCULATION, V96, P128
   Moussa ID, 2011, CATHETER CARDIO INTE, V77, P537, DOI 10.1002/ccd.22865
   Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020
   Nasser M, 2005, CATHETER CARDIO INTE, V65, P516, DOI 10.1002/ccd.20391
   Neumann FJ, 2000, J AM COLL CARDIOL, V35, P915, DOI 10.1016/S0735-1097(99)00635-X
   Nikolsky E, 2004, J AM COLL CARDIOL, V44, P1200, DOI 10.1016/j.jacc.2004.06.048
   Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5
   Noble S, 2008, CATHETER CARDIO INTE, V71, P803, DOI 10.1002/ccd.21490
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7
   Ono H, 2004, AM HEART J, V148, P611, DOI 10.1016/j.ahj.2004.05.014
   Osuna JGG, 2006, REV ESP CARDIOL, V59, P567
   Ozcan EE, 2007, AM HEART J, V154, P539, DOI 10.1016/j.ohi.2007.05.012
   Palmerini T, 2006, AM J CARDIOL, V98, P54, DOI 10.1016/j.amjcard.2006.01.070
   Pan XH, 2010, J ZHEJIANG UNIV-SC B, V11, P754, DOI 10.1631/jzus.B0900302
   Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039
   Park DW, 2007, AM J CARDIOL, V99, P760, DOI 10.1016/j.amjcard.2006.10.028
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87
   Patel MR, 2010, CIRCULATION, V122, P1882, DOI 10.1161/CIR.0b013e3181f9b345
   Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB
   Pfautsch P, 1999, Z KARDIOL, V88, P489, DOI 10.1007/s003920050313
   Phillips Harry R, 2007, Am Heart J, V153, P65, DOI 10.1016/j.ahj.2007.01.026
   PIANA RN, 1994, CIRCULATION, V89, P2514
   Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3
   Pocock SJ, 1996, CIRCULATION, V94, P135
   Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162
   Popma JJ, 2004, CHEST, V126, p576S
   Post Piet N, 2010, Eur Heart J, V31, P1985, DOI 10.1093/eurheartj/ehq151
   Pristipino C, 2009, HEART, V95, P476, DOI 10.1136/hrt.2008.150714
   Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007
   Rao SV, 2010, J AM COLL CARDIOL, V55, P2187, DOI 10.1016/j.jacc.2010.01.039
   Rathore S, 2009, JACC-CARDIOVASC INTE, V2, P489, DOI 10.1016/j.jcin.2009.04.008
   Reddy PR, 2005, AM J CARDIOL, V95, P755, DOI 10.1016/j.amjcard.2004.11.029
   Reicher B, 2008, AM HEART J, V155, P661, DOI 10.1016/j.ahj.2007.12.032
   Reifart N, 1997, CIRCULATION, V96, P91
   Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596
   Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099
   Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081
   Roffi M, 2001, CIRCULATION, V104, P2767, DOI 10.1161/hc4801.100029
   Roffi M, 2002, CIRCULATION, V106, P3063, DOI 10.1161/01.CIR.0000041250.89627.A9
   Romagnoli E, 2005, INT J CARDIOL, V105, P250, DOI 10.1016/j.ijcard.2004.11.037
   Ross AM, 2005, J AM COLL CARDIOL, V45, P1775, DOI 10.1016/j.jacc.2005.02.061
   ROSSER W, 1992, CAN FAM PHYSICIAN, V38, P1623
   RUSSO D, 1995, J AM SOC NEPHROL, V6, P1451
   Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Sanborn TA, 2000, J AM COLL CARDIOL, V36, P1123, DOI 10.1016/S0735-1097(00)00875-5
   Sanmartin M, 2007, AM J CARDIOL, V100, P970, DOI 10.1016/j.amjcard.2007.04.037
   Sano K, 2007, AM HEART J, V154, P983, DOI 10.1016/j.ahj.2007.07.001
   Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017
   Sawada S, 2003, J AM COLL CARDIOL, V42, P2099, DOI 10.1016/j.jacc.2003.07.026
   Schofield PM, 1999, LANCET, V353, P519, DOI 10.1016/S0140-6736(98)11478-2
   Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Schouten O, 2009, AM J CARDIOL, V103, P897, DOI 10.1016/j.amjcard.2008.12.018
   Schulz S, 2010, EUR HEART J, V31, P582, DOI 10.1093/eurheartj/ehq008
   SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603
   Sdringola S, 2000, CATHETER CARDIO INTE, V51, P394, DOI 10.1002/1522-726X(200012)51:4<394::AID-CCD4>3.0.CO;2-G
   Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049
   Sergeant P, 1998, EUR J CARDIO-THORAC, V14, P480, DOI 10.1016/S1010-7940(98)00214-0
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053
   Shahian DM, 2010, J THORAC CARDIOV SUR, V139, P273, DOI 10.1016/j.jtcvs.2009.09.007
   Sharma AK, 2004, CATHETER CARDIO INTE, V63, P141, DOI 10.1002/ccd.20124
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   SHEHADI WH, 1975, AM J ROENTGENOL, V124, P145
   Singh PP, 2011, AM J THER, V18, pE22, DOI 10.1097/MJT.0b013e3181bc0f5a
   Smith Jr. SC, 2011, CIRCULATION, DOI [10.1161/CIR.0b013e318235eb4d, DOI 10.1161/CIR.0B013E318235EB4D.ACCESSED]
   Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044
   Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026
   SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104
   Sorajja P, 2005, CIRCULATION, V112, pI311, DOI 10.1161/CIRCULATIONAHA.104.525022
   Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066
   Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056
   Stamou SC, 2002, AM J CARDIOL, V89, P1365, DOI 10.1016/S0002-9149(02)02348-2
   Steg PG, 2004, EUR HEART J, V25, P2187, DOI 10.1016/j.ehj.2004.10.019
   Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920
   Steinhubl SR, 2009, ANN INTERN MED, V150, P379
   Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411
   Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X
   Stephan WJ, 1996, J AM COLL CARDIOL, V28, P1140, DOI 10.1016/S0735-1097(96)00286-0
   Stevens LA, 2009, AM J KIDNEY DIS, V54, P33, DOI 10.1053/j.ajkd.2009.03.008
   Stoel MG, 2008, CATHETER CARDIO INTE, V71, P283, DOI 10.1002/ccd.21334
   Stone GW, 1997, J AM COLL CARDIOL, V30, P1714, DOI 10.1016/S0735-1097(97)00387-2
   Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437
   Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116
   Stone GW, 2005, CIRCULATION, V112, P2530, DOI 10.1161/CIRCULATIONAHA.105.583716
   Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191
   Stone GW, 2003, CIRCULATION, V108, P548, DOI 10.1161/01.CIR.0000080894.51311.0A
   Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404
   Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72
   Subramanian S, 2009, ANN THORAC SURG, V87, P1392, DOI 10.1016/j.athoracsur.2009.02.032
   Suero JA, 2001, J AM COLL CARDIOL, V38, P409, DOI 10.1016/S0735-1097(01)01349-3
   Suh HS, 2011, INT J TECHNOL ASSESS, V27, P11, DOI 10.1017/S0266462310001340
   Swoboda I, 2002, J IMMUNOL, V168, P4576
   Takagi A, 1999, CIRCULATION, V100, P250
   TAKARO T, 1982, CIRCULATION, V66, P14
   TAKARO T, 1976, CIRCULATION, V54, P107
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   TAYLOR HA, 1989, CIRCULATION, V79, P1171
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   ten Berg JM, 2010, J AM COLL CARDIOL, V55, P2446, DOI 10.1016/j.jacc.2009.11.091
   Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139
   Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
   Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048
   PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255
   Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091
   Thomas RJ, 2007, J AM COLL CARDIOL, V50, P1400, DOI 10.1016/j.jac.2007.04.033
   Thompson PD, 2003, ARTERIOSCL THROM VAS, V23, P1319, DOI 10.1161/01.ATV.0000087143.33998/F2
   TIME Investigators, 2001, LANCET, V358, P951
   Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   Tramer MR, 2006, BRIT MED J, V333, P675, DOI 10.1136/bmj.38905.634132.AE
   Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Urban P, 1999, EUR HEART J, V20, P1030, DOI 10.1053/euhj.1998.1353
   Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668
   Valgimigli M, 2004, J AM COLL CARDIOL, V44, P14, DOI 10.1016/j.jacc.2004.03.042
   Valgimigli M, 2007, J AM COLL CARDIOL, V49, P431, DOI 10.1016/j.jacc.2006.06.081
   van der Burg AEB, 2003, AM J CARDIOL, V91, P785, DOI 10.1016/S0002-9149(03)00008-0
   van der Heijden DJ, 2004, J AM COLL CARDIOL, V44, P20, DOI 10.1016/j.jacc.2004.02.056
   van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0
   Vaquerizo B, 2010, J INTERV CARDIOL, V23, P240, DOI 10.1111/j.1540-8183.2010.00547.x
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Vassiliades TA, 2006, J THORAC CARDIOV SUR, V131, P956, DOI 10.1016/j.jtcvs.2005.10.058
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
   Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8
   vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wallentin L, 1999, LANCET, V354, P708
   Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6
   Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Weintraub WS, 1998, J AM COLL CARDIOL, V31, P10, DOI 10.1016/S0735-1097(97)00441-5
   Weintraub WS, 1997, CIRCULATION, V95, P868
   Welke KF, 2007, ANN THORAC SURG, V84, P1538, DOI 10.1016/j.athoracsur.2007.06.022
   Werner GS, 2002, CATHETER CARDIO INTE, V57, P444, DOI 10.1002/ccd.10375
   WEYRENS FJ, 1995, AM J CARDIOL, V75, P849, DOI 10.1016/S0002-9149(99)80430-5
   Whelton SP, 2002, ANN INTERN MED, V136, P493
   White AJ, 2008, JACC-CARDIOVASC INTE, V1, P236, DOI 10.1016/j.jcin.2008.02.007
   Widimsky P, 2011, EUR HEART J, V32, P396, DOI 10.1093/eurheartj/ehq410
   Wijeysundera HC, 2007, J AM COLL CARDIOL, V49, P422, DOI 10.1016/j.jacc.2006.09.033
   Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007
   Wilson SH, 2003, J AM COLL CARDIOL, V42, P234, DOI 10.1016/S0735-1097(03)00622-3
   Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001
   Winchester DE, 2010, J AM COLL CARDIOL, V56, P1099, DOI 10.1016/j.jacc.2010.04.023
   Witt BJ, 2004, J AM COLL CARDIOL, V44, P988, DOI 10.1016/j.jacc.2004.05.062
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Wohrle J, 2003, CIRCULATION, V107, P1840, DOI 10.1161/01.CIR.0000066852.98038.D1
   Wöhrle Jochen, 2008, EuroIntervention, V3, P465, DOI 10.4244/EIJV3I4A83
   Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3
   Wu TG, 2008, CIRC J, V72, P1605, DOI 10.1253/circj.CJ-08-0357
   Yang Xin-chun, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P517
   Yun KH, 2009, INT J CARDIOL, V137, P246, DOI 10.1016/j.ijcard.2008.06.055
   Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519
   Yusuf S, 2006, NEW ENGL J MED, V354, P1464
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Zahn R, 1999, CATHETER CARDIO INTE, V46, P127, DOI 10.1002/(SICI)1522-726X(199902)46:2<127::AID-CCD2>3.0.CO;2-G
   Zeymer U, 2003, CIRCULATION, V108, P1324, DOI 10.1161/01.CIR.0000087605.09362.0E
   Zhang F, 2010, ANN MED, V42, P171, DOI 10.3109/07853890903463976
   Zhao DX, 2009, J AM COLL CARDIOL, V53, P232, DOI 10.1016/j.jacc.2008.10.011
   ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002
NR 443
TC 31
Z9 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD DEC
PY 2011
VL 58
IS 24
BP 2550
EP 2583
DI 10.1016/j.jacc.2011.08.006
PG 34
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 862ZJ
UT WOS:000298132300024
ER

PT J
AU Lafon, M
   Ribeyre, X
   Schurtz, G
AF Lafon, M.
   Ribeyre, X.
   Schurtz, G.
TI Gain curves and hydrodynamic modeling for shock ignition
SO PHYSICS OF PLASMAS
LA English
DT Article
DE explosions; fusion reactor fuel; fusion reactor ignition; plasma shock
   waves
ID INERTIAL CONFINEMENT FUSION
AB Ignition of a precompressed thermonuclear fuel by means of a converging shock is now considered as a credible scheme to obtain high gains for inertial fusion energy. This work aims at modeling the successive stages of the fuel time history, from compression to final thermonuclear combustion, in order to provide the gain curves of shock ignition (SI). The leading physical mechanism at work in SI is pressure amplification, at first by spherical convergence, and by collision with the shock reflected at center during the stagnation process. These two effects are analyzed, and ignition conditions are provided as functions of the shock pressure and implosion velocity. Ignition conditions are obtained from a non-isobaric fuel assembly, for which we present a gain model. The corresponding gain curves exhibit a significantly lower ignition threshold and higher target gains than conventional central ignition. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3407623]
C1 [Lafon, M.; Ribeyre, X.; Schurtz, G.] Univ Bordeaux 1, CNRS, CEA, Ctr Lasers Intenses & Applicat, F-33405 Talence, France.
RP Lafon, M (reprint author), Univ Bordeaux 1, CNRS, CEA, Ctr Lasers Intenses & Applicat, 351 Cours Liberat, F-33405 Talence, France.
FU HiPER
FX This work was performed within the HiPER roadmap and was fully supported
   by the HiPER project. We thank V. T. Tikhonchuk for fruitful
   discussions.
CR ANDRE M, 2000, P IN FUS SCI APPL 19, P32
   Atzeni S, 2004, PHYS INERTIAL FUSION
   Atzeni S, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2895447
   Betti R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.155001
   Betti R, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022024
   BRUECKNE.KA, 1974, REV MOD PHYS, V46, P325, DOI 10.1103/RevModPhys.46.325
   Guderley V. G., 1942, LUFTFAHRT FORSCHUNG, V19, P302
   Kemp A, 2001, PHYS REV LETT, V86, P3336, DOI 10.1103/PhysRevLett.86.3336
   Klimo O, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/5/055013
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   Maire PH, 2007, SIAM J SCI COMPUT, V29, P1781, DOI 10.1137/050633019
   *NAT TECHN INF SER, DE84017287 NAT TECHN
   *NAT TECHN INF SER, PB2007106961 NAT TEC, P95001
   NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0
   Perkins LJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045004
   Ribeyre X, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124030
   Ribeyre X, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/1/015013
   Shcherbakov V. A., 1983, SOV J PLASMA PHYS, V9, P240
   TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664
   Theobald W, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124052
   Theobald W, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2885197
NR 21
TC 31
Z9 31
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 1070-664X
J9 PHYS PLASMAS
JI Phys. Plasmas
PD MAY
PY 2010
VL 17
IS 5
AR 052704
DI 10.1063/1.3407623
PG 14
WC Physics, Fluids & Plasmas
SC Physics
GA 603BM
UT WOS:000278182900040
ER

PT J
AU Canaud, B
   Temporal, M
AF Canaud, B.
   Temporal, M.
TI High-gain shock ignition of direct-drive ICF targets for the Laser
   Megajoule
SO NEW JOURNAL OF PHYSICS
LA English
DT Article
ID INERTIAL CONFINEMENT FUSION; PROGRESS; FACILITY
AB High-gain shock ignition is numerically investigated for specific marginally igniting targets-targets producing thermonuclear gain less than one-extracted from two distinct target families. Homothetic transformations keeping constant the implosion velocity, the adiabat, and the in-flight aspect ratio are used to draw target families. Conventional and fast ignition (FI) directly driven targets are considered for the Laser Megajoule. It is shown that high gain can be achieved with shock ignition for designs, which do not ignite only from the laser compression. Shock ignition is achieved for different targets of the FI family, which are driven by an absorbed energy between 100 and 500 kJ and deliver thermonuclear energies between 10 and 130 MJ.
C1 [Canaud, B.] DIF, DAM, CEA, F-91297 Arpajon, France.
   [Temporal, M.] Univ Politecn Madrid, ETSIA, E-28040 Madrid, Spain.
RP Canaud, B (reprint author), DIF, DAM, CEA, F-91297 Arpajon, France.
EM benoit.canaud@cea.fr
RI Temporal, Mauro/A-7569-2012
OI Temporal, Mauro/0000-0002-7290-4602
CR Atzeni S, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2716682
   Betti R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.155001
   Betti R, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2127932
   Betti R, 2006, PLASMA PHYS CONTR F, V48, pB153, DOI 10.1088/0741-3335/48/12B/S15
   Betti R, 2002, PHYS PLASMAS, V9, P2277, DOI 10.1063/1.1459458
   BURESI E, 1986, LASER PART BEAMS, V4, P531
   Canaud B, 2007, PLASMA PHYS CONTR F, V49, pB601, DOI 10.1088/0741-3335/49/12B/S56
   Canaud B, 2005, NUCL FUSION, V45, pL43, DOI 10.1088/0029-5515/45/12/L01
   Canaud B, 2007, NUCL FUSION, V47, P1652, DOI 10.1088/0029-5515/47/12/002
   Canaud B, 2004, LASER PART BEAMS, V22, P109, DOI 10.1017/S0263034604222042
   CANAUD B, 2009, 29 WORKSH PHYS HIGH, P53604
   Canaud B, 2004, NUCL FUSION, V44, P1118, DOI 10.1088/0029-5515/44/10/005
   Canaud B, 2002, PHYS PLASMAS, V9, P4252, DOI 10.1063/1.1504102
   Dunne M, 2006, NAT PHYS, V2, P2, DOI 10.1038/nphys208
   FORTIN X, 1999, INERTIAL FUSION SCI, P245
   Hermann M. C., 2001, NUCL FUSION, V41, P99
   HUBBARD WB, 1966, ASTROPHYS J, V146, P858, DOI 10.1086/148961
   Kemp A, 2001, PHYS REV LETT, V86, P3336, DOI 10.1103/PhysRevLett.86.3336
   Levedahl WK, 1997, NUCL FUSION, V37, P165, DOI 10.1088/0029-5515/37/2/I01
   MEYERTERVEHN J, 1982, NUCL FUSION, V22, P561, DOI 10.1088/0029-5515/22/4/010
   Perkins LJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045004
   Piriz AR, 1996, FUSION ENG DES, V32-33, P561
   Recoules V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.075002
   Ribeyre X, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/1/015013
   Riz D, 2006, NUCL FUSION, V46, P864, DOI 10.1088/0029-5515/46/10/004
   Sanz J, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2130315
   SCHMITT AJ, 1984, APPL PHYS LETT, V44, P399, DOI 10.1063/1.94788
   SKUPSKY S, 2002, INERTIAL FUSION SCI, P240
   Skupsky S, 2004, PHYS PLASMAS, V11, P2763, DOI 10.1063/1.1689665
   Temporal M, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2397041
NR 30
TC 31
Z9 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1367-2630
J9 NEW J PHYS
JI New J. Phys.
PD APR 20
PY 2010
VL 12
AR 043037
DI 10.1088/1367-2630/12/4/043037
PG 9
WC Physics, Multidisciplinary
SC Physics
GA 586RO
UT WOS:000276929900005
ER

PT J
AU Park, HS
   Lorenz, KT
   Cavallo, RM
   Pollaine, SM
   Prisbrey, ST
   Rudd, RE
   Becker, RC
   Bernier, JV
   Remington, BA
AF Park, Hye-Sook
   Lorenz, K. T.
   Cavallo, R. M.
   Pollaine, S. M.
   Prisbrey, S. T.
   Rudd, R. E.
   Becker, R. C.
   Bernier, J. V.
   Remington, B. A.
TI Viscous Rayleigh-Taylor Instability Experiments at High Pressure and
   Strain Rate
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID CONSTITUTIVE MODEL; FACILITY; METALS
AB Experimental results showing significant reductions from classical in the Rayleigh-Taylor instability growth rate due to high pressure effective lattice viscosity are presented. Using a laser created ramped drive, vanadium samples are compressed and accelerated quasi-isentropically at similar to 1 Mbar peak pressures, while maintaining the sample in the solid state. Comparisons with simulations and theory indicate that the high pressure, high strain rate conditions trigger a phonon drag mechanism, resulting in the observed high effective lattice viscosity and strong stabilization of the Rayleigh-Taylor instability.
C1 [Park, Hye-Sook; Lorenz, K. T.; Cavallo, R. M.; Pollaine, S. M.; Prisbrey, S. T.; Rudd, R. E.; Becker, R. C.; Bernier, J. V.; Remington, B. A.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Park, HS (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RI Becker, Richard/I-1196-2013
FU Lawrence Livermore National Security, LLC, (LLNS) [DE-AC52-07NA27344]
FX This work was performed under the auspices of the Lawrence Livermore
   National Security, LLC, (LLNS) under Contract No. DE-AC52-07NA27344.
CR Abramowitz M., 1965, HDB MATH FUNCTIONS
   BARKER LM, 1972, J APPL PHYS, V43, P4669, DOI 10.1063/1.1660986
   BECKER R, 2009, LLNLTR416095
   Celliers PM, 2004, REV SCI INSTRUM, V75, P4916, DOI 10.1063/1.1807008
   Celliers PM, 1998, APPL PHYS LETT, V73, P1320, DOI 10.1063/1.121882
   Colvin JD, 2003, J APPL PHYS, V93, P5287, DOI 10.1063/1.1565188
   Edwards J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.075002
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   Jankowski AF, 2007, SURF COAT TECH, V202, P957, DOI 10.1016/j.surfcoat.2007.05.042
   KINSLOW R, 1970, HIGH VELOCITY IMPACT, P538
   Lorenz K. T., 2006, High Energy Density Physics, V2, DOI 10.1016/j.hedp.2006.08.001
   Lorenz KT, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1873812
   Meyers M.A., 1984, MECH METALLURGY PRIN
   MIKAELIAN KO, 1993, PHYS REV E, V47, P375, DOI 10.1103/PhysRevE.47.375
   Nemat-Nasser S, 2000, MECH MATER, V32, P243, DOI 10.1016/S0167-6636(99)00056-3
   Preston DL, 2003, J APPL PHYS, V93, P211, DOI 10.1063/1.1524706
   Rayleigh Lord, 1892, PHILOS MAG, V34, P145
   REMINGTON BA, 2006, P C AM PHYS SOC TOP, P765
   Remington BA, 2006, MATER SCI TECH-LOND, V22, P474, DOI 10.1179/174328406X91069
   Rudd RE, 2008, J APPL PHYS, V104, DOI 10.1063/1.3013429
   SHARP DH, 1984, PHYSICA D, V12, P3, DOI 10.1016/0167-2789(84)90510-4
   STEINBERG DJ, 1980, J APPL PHYS, V51, P1498, DOI 10.1063/1.327799
   STEINBERG DJ, 1989, J APPL PHYS, V65, P1528, DOI 10.1063/1.342968
   TAYLOR G, 1950, PROC R SOC LON SER-A, V201, P192, DOI 10.1098/rspa.1950.0052
   Young D. A., 1991, PHASE DIAGRAMS ELEME
   Zimmerman G. B., 1975, Comments on Plasma Physics and Controlled Fusion, V2
NR 26
TC 31
Z9 34
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD APR 2
PY 2010
VL 104
IS 13
AR 135504
DI 10.1103/PhysRevLett.104.135504
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 577YV
UT WOS:000276260800028
PM 20481894
ER

PT J
AU De Los Reyes, A
   Goodman, KL
   Kliewer, W
   Reid-Quinones, K
AF De Los Reyes, Andres
   Goodman, Kimberly L.
   Kliewer, Wendy
   Reid-Quinones, Kathryn
TI Whose depression relates to discrepancies? Testing relations between
   informant characteristics and informant discrepancies from both
   informants' perspectives
SO PSYCHOLOGICAL ASSESSMENT
LA English
DT Article
DE attribution bias context; correspondence; depression-distortion;
   disagreement; informant discrepancies
ID BRIEF-SYMPTOM-INVENTORY; ADOLESCENT PROBLEM BEHAVIOR;
   CHILDRENS-DEPRESSION; PEER VICTIMIZATION; COMMUNITY VIOLENCE; PARENT;
   MODEL; PSYCHOPATHOLOGY; ADJUSTMENT; AGREEMENT
AB This study examined whether mothers' and children's depressive symptoms were each uniquely related to mother-child rating discrepancies on a multidimensional dyadic construct: domains associated with parental monitoring (i.e., Child Disclosure, Parental Knowledge, and Parental Solicitation). Participants included a community sample of 335 mother/female-caregiver and child dyads (182 girls, 153 boys; 9-16 years old). Children's depressive symptoms were consistently related to each of the three domains of mother-child discrepancies. Mothers' depressive symptoms were related to perceived discrepancies in two domains (Child Disclosure and Parental Knowledge). Furthermore, these relations could not be accounted for by other informant characteristics (maternal stress, child age, child gender, child ethnicity). Findings provide important empirical support for theory suggesting that both informants' perspectives meaningfully contribute to their discrepancies in perceived behavior. Consideration of both informants' perspectives leads to valuable information as to whether any particular characteristic is an important correlate of discrepancies.
C1 [De Los Reyes, Andres] Univ Illinois, Dept Psychiat, Inst Juvenile Res MC 747, Chicago, IL 60608 USA.
   [De Los Reyes, Andres] Yale Univ, Dept Psychol, New Haven, CT 06520 USA.
   [Goodman, Kimberly L.; Kliewer, Wendy; Reid-Quinones, Kathryn] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA.
RP De Los Reyes, A (reprint author), Univ Illinois, Dept Psychiat, Inst Juvenile Res MC 747, 1747 W Roosevelt Rd,Room 335, Chicago, IL 60608 USA.
EM areyes@psych.uic.edu
RI De Los Reyes, Andres/B-4812-2008
CR Achenbach TM, 2006, CURR DIR PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2006.00414.x
   Aiken L. S., 1991, MULTIPLE REGRESSION
   ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x
   Beck Kenneth H, 2006, Am J Health Behav, V30, P533
   Boulet J., 1991, PSYCHOL ASSESSMENT J, V3, P433, DOI 10.1037/1040-3590.3.3.433
   Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290
   Cicchetti D, 1998, AM PSYCHOL, V53, P221, DOI 10.1037/0003-066X.53.2.221
   Clancy CA, 2005, DEV MED CHILD NEUROL, V47, P27
   Cohen J., 2003, APPL MULTIPLE REGRES
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cole DA, 2005, PSYCHOL ASSESSMENT, V17, P144, DOI 10.1037/1040-3590.17.2.144
   Cole DA, 2000, PSYCHOL ASSESSMENT, V12, P174, DOI 10.1037//1040-3590.12.2.174
   *COND PROBL RES GR, 1998, TECHN REP FAST UNPUB
   CONRAD M, 1989, J CONSULT CLIN PSYCH, V57, P663, DOI 10.1037//0022-006X.57.5.663
   Craighead WE, 1998, PSYCHOL ASSESSMENT, V10, P156, DOI 10.1037/1040-3590.10.2.156
   De los Reyes A, 2006, PSYCHOL REV, V113, P554, DOI 10.1037/0033-295X.113.3.554
   De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483
   De Los Reyes A, 2004, PSYCHOL ASSESSMENT, V16, P330, DOI 10.1037/1040-3590.16.3.330
   De los Reyes A, 2004, J CLIN CHILD ADOLESC, V33, P325
   De Los Reyes A, 2008, CURR DIR PSYCHOL SCI, V17, P47, DOI 10.1111/j.1467-8721.2008.00546.x
   DEROGATIS LR, 1983, PSYCHOL MED, V13, P595
   Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380
   Farrell AD, 2006, J SCHOOL PSYCHOL, V44, P169, DOI 10.1016/j.jsp.2006.02.001
   Ferdinand RF, 2004, J ABNORM PSYCHOL, V113, P198, DOI 10.1037/0021-843X.113.2.198
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Frick P. J., 1994, PSYCHOL ASSESSMENT, V4, P372, DOI 10.1037/1040-3590.6.4.372
   Gavazzi SM, 1996, PSYCHOL REP, V79, P1047
   Gonzales NA, 1996, CHILD DEV, V67, P1483, DOI 10.1111/j.1467-8624.1996.tb01809.x
   Granic I, 2006, PSYCHOL REV, V113, P101, DOI 10.1037/0033-295X.113.1.101
   Hayes JA, 1997, J COUNS PSYCHOL, V44, P360, DOI 10.1037/0022-0167.44.4.360
   Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599
   Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P87, DOI 10.1093/jpepsy/27.1.87
   Kazdin A. E., 2005, PARENT MANAGEMENT TR
   KENNY DA, 1994, PSYCHOL BULL, V116, P245, DOI 10.1037/0033-2909.116.2.245
   Kerr M, 2000, DEV PSYCHOL, V36, P366, DOI 10.1037//0012-1649.36.3.366
   Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377
   Klein DN, 2005, J CLIN CHILD ADOLESC, V34, P412, DOI 10.1207/s15374424jccp3403_3
   Kliewer W, 2004, J CLIN CHILD ADOLESC, V33, P477, DOI 10.1207/s15374424jccp3303_5
   KLIEWER W, 2003, YOUTH DRUG USE VIOLE
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   Kraemer HC, 2003, AM J PSYCHIAT, V160, P1566, DOI 10.1176/appi.ajp.160.9.1566
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   Luthar SS, 2004, J CLIN CHILD ADOLESC, V33, P499, DOI 10.1207/s15374424jccp3303_7
   Matza LS, 2001, J RES ADOLESCENCE, V11, P245, DOI 10.1111/1532-7795.00012
   Miller-Johnson S, 2004, AM J PREV MED, V26, P48, DOI 10.1016/j.amepre.2003.09.015
   Myers K, 2002, J AM ACAD CHILD PSY, V41, P634, DOI 10.1097/00004583-200206000-00004
   RICHTERS JE, 1992, PSYCHOL BULL, V112, P485, DOI 10.1037/0033-2909.112.3.485
   Saudino KJ, 2004, J PERS SOC PSYCHOL, V87, P698, DOI 10.1037/0022-3514.87.5.698
   Skeem JL, 2006, J CONSULT CLIN PSYCH, V74, P967, DOI 10.1037/0022-006X.74.5.967
   Soenens B, 2006, DEV PSYCHOL, V42, P305, DOI 10.1073/0012-1649.42.2.305
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037//0033-2909.87.2.245
   STICE E, 1995, DEV PSYCHOL, V31, P322, DOI 10.1037//0012-1649.31.2.322
   Sullivan TN, 2006, DEV PSYCHOPATHOL, V18, P119, DOI 10.1017/S095457940606007X
   Tabachnick B. G., 2001, USING MULTIVARIATE S
   TEIN JY, 1994, J MARRIAGE FAM, V56, P341, DOI 10.2307/353104
   *US BUR CENS, 2004, STAT COUNT QUICKF
   WEISS B, 1992, J ABNORM PSYCHOL, V101, P391, DOI 10.1037//0021-843X.101.3.391
   WEISSMAN MM, 1987, ARCH GEN PSYCHIAT, V44, P747
   WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396
   Youngstrom E, 1999, J CONSULT CLIN PSYCH, V67, P905, DOI 10.1037//0022-006X.67.6.905
   Youngstrom EA, 2004, J AFFECT DISORDERS, V82, pS5, DOI 10.1016/j.jad.2004.05.016
NR 65
TC 31
Z9 31
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 1040-3590
J9 PSYCHOL ASSESSMENT
JI Psychol. Assess.
PD JUN
PY 2008
VL 20
IS 2
BP 139
EP 149
DI 10.1037/1040-3590.20.2.139
PG 11
WC Psychology, Clinical
SC Psychology
GA 309LR
UT WOS:000256462400006
PM 18557691
ER

PT J
AU Coley, RL
   Votruba-Drzal, E
   Schindler, HS
AF Coley, Rebekah Levine
   Votruba-Drzal, Elizabeth
   Schindler, Holly S.
TI Trajectories of parenting processes and adolescent substance use:
   Reciprocal effects
SO JOURNAL OF ABNORMAL CHILD PSYCHOLOGY
LA English
DT Article
DE family activities; father involvement; parental knowledge; substance
   use; transactional models
ID PROBLEM BEHAVIOR; FAMILY ROUTINES; MISSING VALUES; DELINQUENCY;
   REINTERPRETATION; ASSOCIATIONS; INVOLVEMENT; CONTEXT
AB Drawing on transactional theories of child development, we assessed bidirectional links between trajectories of adolescent substance use and parenting processes from early through mid adolescence. Hierarchical generalized models estimated trajectories for 3,317 adolescents from the National Longitudinal Survey of Youth 1997, exploring both between- and within-individual effects. Between individuals, adolescents reporting more regular family activities and greater father and mother knowledge of friends and teachers experienced lower levels of substance use through mid adolescence. Similarly, adolescents with more frequent substance use reported lower family activities, father knowledge, and mother knowledge, though these differences dissipated over time. More conservative within-individual differences indicated a prospective protective effect of family activities, with increases in adolescent participation in family activities predicting later declines in substance use. Results support the central importance of engagement in regular family activities, and suggest the need for further exploration of transactional processes between parents and children in the development of risk behaviors.
C1 [Coley, Rebekah Levine] Univ New S Wales, Social Policy Res Ctr, Sydney, NSW 2052, Australia.
   [Votruba-Drzal, Elizabeth] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.
   [Schindler, Holly S.] Harvard Univ, Ctr Developing Child, Cambridge, MA 02138 USA.
RP Coley, RL (reprint author), Boston Coll, Sch Educ, Appl Dev & Educ Psychol, Chestnut Hill, MA 02467 USA.
EM coleyre@bc.edu
RI Brower, Susan/C-7090-2009
CR Acock AC, 2005, J MARRIAGE FAM, V67, P1012, DOI 10.1111/j.1741-3737.2005.00191.x
   Amato PR, 1998, MEN IN FAMILIES, P241
   ANDERSON KE, 1986, DEV PSYCHOL, V22, P604, DOI 10.1037//0012-1649.22.5.604
   BELL RQ, 1968, PSYCHOL REV, V75, P81, DOI 10.1037/h0025583
   Cameron A. C., 1998, REGRESSION ANAL COUN
   CHERLIN AJ, 1994, ANNU REV SOCIOL, V20, P359
   COLEY RL, 2004, CHILD DEV, V75, P639
   Coley RL, 2007, CHILD DEV, V78, P132, DOI 10.1111/j.1467-8624.2007.00989.x
   Crouter A.C., 2002, HDB PARENTING, V3, P461
   Dearing E, 2006, J EDUC PSYCHOL, V98, P653, DOI 10.1037/0022-0663.98.4.653
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   Dishion TJ, 2004, J ADOLESCENCE, V27, P515, DOI 10.1016/j.adolescence.2004.06.005
   Doherty WJ, 1998, J MARRIAGE FAM, V60, P277, DOI 10.2307/353848
   Duncan SC, 1998, DRUG ALCOHOL DEPEN, V50, P57, DOI 10.1016/S0376-8716(98)00006-4
   Eisenberg ME, 2004, ARCH PEDIAT ADOL MED, V158, P792, DOI 10.1001/archpedi.158.8.792
   Fiese BH, 2002, J FAM PSYCHOL, V16, P381, DOI 10.1037//0893-3200.16.4.381
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Hawkins J D, 1985, J Prim Prev, V6, P73, DOI 10.1007/BF01325432
   Hetherington EM, 1982, NONTRADITIONAL FAMIL, P233
   JENSEN EW, 1983, SOC SCI MED, V17, P201, DOI 10.1016/0277-9536(83)90117-X
   Johnston L., 2006, TEEN DRUG USE CONTIN
   Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566
   LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157
   Moffitt R, 2005, DEMOGRAPHY, V42, P91, DOI 10.1353/dem.2005.0006
   MOORE KA, 1999, NLSY97 CODEBOOK SUPP
   Patterson G. R., 1992, SOCIAL LEARNING APPR
   PETRAITIS J, 1995, PSYCHOL BULL, V117, P67, DOI 10.1037//0033-2909.117.1.67
   Raudenbush S. W., 2002, HIERARCHICAL LINEAR
   Ream GL, 2005, J FAM PSYCHOL, V19, P171, DOI 10.1037/0893-3200.19.2.171
   SAMEROFF A, 1975, HUM DEV, V18, P65
   SAMPSON RJ, 1994, CHILD DEV, V65, P523, DOI 10.2307/1131400
   Schor JB, 1992, OVERWORKED AM UNEXPE
   Singer J. D., 2003, APPL LONGITUDINAL DA
   Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210
   STICE E, 1995, DEV PSYCHOL, V31, P322, DOI 10.1037//0012-1649.31.2.322
   THORNBERRY TP, 1987, CRIMINOLOGY, V25, P863, DOI 10.1111/j.1745-9125.1987.tb00823.x
   Van der Vorst H, 2006, PSYCHOL ADDICT BEHAV, V20, P107, DOI 10.1037/0893-164X.20.2.107
NR 37
TC 31
Z9 31
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0091-0627
J9 J ABNORM CHILD PSYCH
JI J. Abnorm. Child Psychol.
PD MAY
PY 2008
VL 36
IS 4
BP 613
EP 625
DI 10.1007/s10802-007-9205-5
PG 13
WC Psychology, Clinical; Psychology, Developmental
SC Psychology
GA 283GI
UT WOS:000254624300012
PM 18288605
ER

PT J
AU Glenzer, SH
   Froula, DH
   Divol, L
   Dorr, M
   Berger, RL
   Dixit, S
   Hammel, BA
   Haynam, C
   Hittinger, JA
   Holder, JP
   Jones, OS
   Kalantar, DH
   Landen, OL
   Langdon, AB
   Langer, S
   MacGowan, BJ
   Mackinnon, AJ
   Meezan, N
   Moses, EI
   Niemann, C
   Still, CH
   Suter, LJ
   Wallace, RJ
   Williams, EA
   Young, BKF
AF Glenzer, S. H.
   Froula, D. H.
   Divol, L.
   Dorr, M.
   Berger, R. L.
   Dixit, S.
   Hammel, B. A.
   Haynam, C.
   Hittinger, J. A.
   Holder, J. P.
   Jones, O. S.
   Kalantar, D. H.
   Landen, O. L.
   Langdon, A. B.
   Langer, S.
   MacGowan, B. J.
   Mackinnon, A. J.
   Meezan, N.
   Moses, E. I.
   Niemann, C.
   Still, C. H.
   Suter, L. J.
   Wallace, R. J.
   Williams, E. A.
   Young, B. K. F.
TI Experiments and multiscale simulations of laser propagation through
   ignition-scale plasmas
SO NATURE PHYSICS
LA English
DT Article
ID STIMULATED BRILLOUIN-SCATTERING; 1ST EXPERIMENTS; PHASE PLATE; FACILITY;
   FILAMENTATION; SUPPRESSION; PERFORMANCE; FUSION; TARGET; BEAMS
AB With the next generation of high-power laser facilities for inertial fusion coming online(1,2), ensuring laser beam propagation through centimetre-scale plasmas is a key physics issue for reaching ignition. Existing experimental results(3-5) including the most recent one(6) are limited to small laser spots, low-interaction laser beam energies and small plasma volumes of 1-2 mm. Here, we demonstrate the propagation of an intense, high-energy, ignition-size laser beam through fusion-size plasmas on the National Ignition Facility (NIF) and find the experimental measurements to agree with full-scale modelling. Previous attempts to apply computer modelling as a predictive capability have been limited by the inherently multiscale description of the full laser-plasma interaction processes(7-11). The findings of this study validate supercomputer modelling as an essential tool for the design of future ignition experiments.
C1 Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
   Univ Calif Los Angeles, Elect Engn Dept, Los Angeles, CA 90095 USA.
RP Glenzer, SH (reprint author), Lawrence Livermore Natl Lab, L-399,POB 808, Livermore, CA 94551 USA.
EM glenzer1@llnl.gov
CR Atzeni S, 2004, PHYS INERTIAL FUSION
   Berger RL, 1998, PHYS PLASMAS, V5, P4337, DOI 10.1063/1.873171
   Cavailler C, 2005, PLASMA PHYS CONTR F, V47, pB389, DOI 10.1088/0741-3335/47/12B/S28
   Dewald EL, 2005, PLASMA PHYS CONTR F, V47, pB405, DOI 10.1088/0741-3335/47/12B/S29
   Fernandez JC, 1997, PHYS PLASMAS, V4, P1849, DOI 10.1063/1.872328
   Froula DH, 2007, PHYS REV LETT, V98, DOI [10.1103/PhysRevLett.98.085001, 10.1103/PhysRevLett.98.135001]
   Froula DH, 2004, REV SCI INSTRUM, V75, P4168, DOI 10.1063/1.1789592
   Glenzer SH, 2004, NUCL FUSION, V44, pS185, DOI 10.1088/0029-5515/44/12/S08
   Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276
   HEIKKINEN JA, 1984, PHYS FLUIDS, V27, P707, DOI 10.1063/1.864652
   Huller S, 1996, PHYS SCRIPTA, VT63, P151, DOI 10.1088/0031-8949/1996/T63/023
   KATO Y, 1984, PHYS REV LETT, V53, P1057, DOI 10.1103/PhysRevLett.53.1057
   KILKENNY JD, 1991, LASER PART BEAMS, V9, P49
   Landen OL, 2006, J PHYS IV, V133, P43, DOI 10.1051/jp4:2006133009
   Lefebvre E, 1998, PHYS PLASMAS, V5, P2701, DOI 10.1063/1.872957
   Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638
   MacGowan BJ, 1996, PHYS PLASMAS, V3, P2029, DOI 10.1063/1.872000
   Mackinnon AJ, 2004, REV SCI INSTRUM, V75, P4183, DOI 10.1063/1.1789594
   Meezan NB, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2710782
   Menapace JA, 2003, P SOC PHOTO-OPT INS, V5273, P220, DOI 10.1117/12.527822
   Moses EI, 2005, FUSION SCI TECHNOL, V47, P314
   Munro DH, 2004, APPL OPTICS, V43, P6639, DOI 10.1364/AO.43.006639
   Myatt J, 2004, PHYS PLASMAS, V11, P3394, DOI 10.1063/1.1755708
   Niemann C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.085005
   ROZMUS W, 1992, PHYS FLUIDS B-PLASMA, V4, P576, DOI 10.1063/1.860256
   SCHMITT A, 1997, PHYS PLASMAS, V5, P503
   SKUPSKY S, 1989, J APPL PHYS, V66, P3456, DOI 10.1063/1.344101
   SPITZER L, 1953, PHYS REV, V89, P977, DOI 10.1103/PhysRev.89.977
   Still CH, 2000, PHYS PLASMAS, V7, P2023, DOI 10.1063/1.874055
   TSUBAKIMOTO K, 1992, OPT COMMUN, V91, P9, DOI 10.1016/0030-4018(92)90091-5
NR 30
TC 31
Z9 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1745-2473
J9 NAT PHYS
JI Nat. Phys.
PD OCT
PY 2007
VL 3
IS 10
BP 716
EP 719
DI 10.1038/nphys709
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 217FN
UT WOS:000249933900020
ER

PT J
AU Benjet, C
   Borges, G
   Medina-Mora, ME
   Fleiz, C
   Blanco, J
   Zambrano, J
   Rojas, E
   Ramirez, M
AF Benjet, Corina
   Borges, Guilherme
   Medina-Mora, Maria Elena
   Fleiz, Clara
   Blanco, Jeronimo
   Zambrano, Joaquin
   Rojas, Estela
   Ramirez, Miriam
TI Prevalence and socio-demographic correlates of drug use among
   adolescents: results from the Mexican Adolescent Mental Health Survey
SO ADDICTION
LA English
DT Article
DE epidemiology; illicit substance use; Mexico; youth
ID NATIONAL COMORBIDITY SURVEY; SUBSTANCE USE; EARLIEST STAGES;
   INVOLVEMENT; RELIGIOSITY; DISORDERS; MARIJUANA; AMERICA; HISTORY; GENDER
AB Aims To estimate the life-time and 12-month prevalence of illicit drug use among Mexican adolescents, the age of onset of first drug use and the socio-demographic correlates. Method A multi-stage probability survey of adolescents aged 12-17 years residing in the Mexico City Metropolitan Area was carried out in 2005. Adolescents were administered the computer-assisted adolescent version of the World Mental Health Composite International Diagnostic Interview by trained lay interviewers in their homes. The response rate was 71% (n = 3005). Descriptive and logistic regression analyses were performed considering the multi-stage and weighted sample design of the survey. Findings Of the adolescents, 5.2% have ever tried illicit drugs, 2.9% in the last 12 months. The most frequently used drugs are marijuana, followed by tranquilizers/stimulants. The median age of first use is 14 years. Correlates of life-time drug use are older age, having dropped out of school, parental drug problems, low religiosity and low parental monitoring. Conclusions While drug use among Mexican adolescents is lower than among adolescents from other developed countries, its increasing prevalence with age and the narrowing male/female ratio calls for firm public health actions, particularly prevention strategies.
C1 Natl Inst Psychiat Ramon de la Fuente, Div Epidemiol & Psychosocial Res, Mexico City 14370, DF, Mexico.
   Autonomous Metropolitan Univ, Mexico City, DF, Mexico.
RP Benjet, C (reprint author), Natl Inst Psychiat Ramon de la Fuente, Div Epidemiol & Psychosocial Res, Calzada Mexico Xochimilco 101,Colonia San Lorenzo, Mexico City 14370, DF, Mexico.
EM cbenjet@imp.edu.mx
RI Benjet, Corina/D-7363-2012
CR ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229
   BENJET C, 2007, DRUG ALCOHOL DEPEND
   Chen CY, 2004, AM J EPIDEMIOL, V159, P1180, DOI 10.1093/aje/kwh151
   CHILCOAT HD, 1995, AM J EPIDEMIOL, V141, P25
   Child J, 1996, COMPUT DES, V35, P100
   *CICAD, OBS LAT DROG 2006 LA
   Delva J, 2005, AM J PUBLIC HEALTH, V95, P696, DOI 10.2105/AJPH.2004.037051
   Delva J, 1999, SUBST USE MISUSE, V34, P1451, DOI 10.3109/10826089909029392
   Dormitzer CM, 2004, REV PANAM SALUD PUBL, V15, P400, DOI 10.1590/S1020-49892004000600006
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Hosmer D. W., 2000, APPL LOGISTIC REGRES
   *INEGI, 2000, 12 GEN POP HOUS CENS
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Latimer W, 2004, REV PANAM SALUD PUBL, V15, P225, DOI 10.1590/S1020-49892004000400002
   McArdle P, 2002, ADDICTION, V97, P329, DOI 10.1046/j.1360-0443.2002.00066.x
   Medina-Mora ME, 2006, REV PANAM SALUD PUBL, V19, P265
   MEDINAMORA ME, 1999, ESTUDIO NINAS NINOS, P7
   Medina-Mora ME, 2003, SALUD PUBLICA MEXICO, V45, pS16, DOI http://dx.doi.org/10.1590/s0036-36342003000700005
   Miller L, 2000, J AM ACAD CHILD PSY, V39, P1190, DOI 10.1097/00004583-200009000-00020
   Research Triangle Institute, 2002, SUDAAN REL 8 0 1
   Robinson J.P., 1973, MEASURES SOCIAL PSYC
   SIMON GE, 1995, EPIDEMIOL REV, V17, P221
   Substance Abuse and Mental Health Services Administration, 2006, DHHS PUBL, VSMA 06-4194
   Warner LA, 2006, DRUG ALCOHOL DEPEN, V84, pS8, DOI 10.1016/j.drugalcdep.2006.05.003
   van den Bree MBM, 2005, ARCH GEN PSYCHIAT, V62, P311, DOI 10.1001/archpsyc.62.3.311
   Van Etten ML, 1999, ADDICTION, V94, P1413
   Vega WA, 1998, ADDICTION, V93, P1839, DOI 10.1046/j.1360-0443.1998.931218399.x
   VILLATORO J, 2004, USO ABUSO DROGAS MEX
   VILLATORO J., 2005, SALUD MENT, V28, P38
   VILLATORO J, 2004, CONSUMO DROGAS ALCOH
   Villatoro J, 2002, SALUD MENT, V25, P43
NR 32
TC 31
Z9 33
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0965-2140
J9 ADDICTION
JI Addiction
PD AUG
PY 2007
VL 102
IS 8
BP 1261
EP 1268
DI 10.1111/j.1360-0443.2007.01888.x
PG 8
WC Substance Abuse; Psychiatry
SC Substance Abuse; Psychiatry
GA 186ZI
UT WOS:000247816700017
PM 17624976
ER

PT J
AU Dolan, DF
   Guo, MH
   Nuttall, AL
AF Dolan, DF
   Guo, MH
   Nuttall, AL
TI Frequency-dependent enhancement of basilar membrane velocity during
   olivocochlear bundle stimulation
SO JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA
LA English
DT Article
ID OUTER HAIR-CELLS; GUINEA-PIG COCHLEA; NERVE-FIBER RESPONSES;
   ACETYLCHOLINE-RECEPTORS; OTOACOUSTIC EMISSIONS; EFFERENT STIMULATION;
   BRAIN-STEM; NEURONS; FROG; MECHANICS
AB Basilar membrane (BM) velocity responses were measured in the presence of olivocochlear bundle (OCB) stimulation. Frequency threshold tuning curves (FTCs) were derived from tone-evoked input-output (L/O) functions. Efferent nerve activation produced decreases in velocity amplitude for frequencies around best frequency (BF) at low stimulus levels with little or no effect for stimuli well below the BF. A level-dependent efferent reduction/enhancement of BM velocity was found for certain stimulus frequencies above the BF. Efferent activation either had no effect or caused small reductions in the velocity response produced by low level sound, whereas, at higher stimulus levels, efferent activation increased the velocity response. The derived FTCs, therefore, showed criterion-dependent changes with efferent activation. For low BM criterion velocities, FTCs showed the classic desensitization of the tip region without a shift of BF. Some BM velocity criterion values showed FTCs with an expanded high-frequency response area, also without a shift of BF. The results suggest that the effect of OCB activation changes the gain of the voltage-dependent outer hair cell motility such that BM velocity response near BF is decreased while increasing the response for tones well above BF. (C) 1997 Acoustical Society of America. [S0001-4966(97)06112-2].
C1 XIJING HOSP,DEPT OTOLARYNGOL,XIAN 710032,SHAANXI,PEOPLES R CHINA.
   OREGON HLTH SCI UNIV,OREGON HEARING RES CTR,PORTLAND,OR 97201.
RP Dolan, DF (reprint author), UNIV MICHIGAN,SCH MED,KRESGE HEARING RES INST,ANN ARBOR,MI 48109, USA.
CR Altschuler R. A., 1986, NEUROBIOLOGY HEARING
   BOBBIN RP, 1974, ACTA OTO-LARYNGOL, V77, P56, DOI 10.3109/00016487409124598
   BROWN MC, 1984, J PHYSIOL-LONDON, V354, P625
   BROWN MC, 1983, J ACOUST SOC AM, V73, P1662, DOI 10.1121/1.389387
   DALLOS P, 1996, DIVERSITY AUDITORY M
   DOI T, 1993, HEARING RES, V67, P179, DOI 10.1016/0378-5955(93)90245-V
   DOLAN DF, 1994, 17 ASS RES OT ST PET
   ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X
   EROSTEGUI C, 1994, HEARING RES, V74, P135, DOI 10.1016/0378-5955(94)90182-1
   Evans MG, 1996, J PHYSIOL-LONDON, V491, P563
   EYBALIN M, 1993, PHYSIOL REV, V73, P309
   FEX J, 1967, J ACOUST SOC AM, V41, P666, DOI 10.1121/1.1910395
   GALAMBOS R, 1956, J NEUROPHYSIOL, V19, P424
   GIFFORD ML, 1983, J ACOUST SOC AM, V74, P115, DOI 10.1121/1.389728
   GUINAN JJ, 1988, HEARING RES, V33, P97, DOI 10.1016/0378-5955(88)90023-8
   GUINAN JJ, 1983, J COMP NEUROL, V221, P358, DOI 10.1002/cne.902210310
   Guinan JJ, 1996, J ACOUST SOC AM, V100, P1680, DOI 10.1121/1.416066
   Guinan J J Jr, 1986, Scand Audiol Suppl, V25, P53
   GUTH PS, 1986, ACTA OTO-LARYNGOL, V102, P194, DOI 10.3109/00016488609108666
   GUTH PS, 1994, HEARING RES, V75, P225, DOI 10.1016/0378-5955(94)90073-6
   Guth PS, 1996, HEARING RES, V98, P1, DOI 10.1016/0378-5955(96)00031-7
   HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065
   KAKEHATA S, 1993, J PHYSIOL-LONDON, V463, P227
   KUJAWA SG, 1992, HEARING RES, V61, P106, DOI 10.1016/0378-5955(92)90041-K
   LONG GR, 1989, MODIFICATION FREQUEN
   MOTT JB, 1989, HEARING RES, V38, P229, DOI 10.1016/0378-5955(89)90068-3
   MOUNTAIN DC, 1980, SCIENCE, V210, P71, DOI 10.1126/science.7414321
   Murugasu E, 1996, J NEUROSCI, V16, P325
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A
   RASMUSSEN GL, 1946, J COMP NEUROL, V84, P141, DOI 10.1002/cne.900840204
   ROBERTSON D, 1985, HEARING RES, V20, P79, DOI 10.1016/0378-5955(85)90060-7
   SHORE SE, 1985, J ACOUST SOC AM, V77, P590, DOI 10.1121/1.391877
   SIEGEL JH, 1982, HEARING RES, V6, P171, DOI 10.1016/0378-5955(82)90052-1
   SRIDHAR TS, 1995, J NEUROSCI, V15, P3667
   SZIKLAI I, 1993, ACTA OTO-LARYNGOL, V113, P326, DOI 10.3109/00016489309135818
   WARR WB, 1975, J COMP NEUROL, V161, P159, DOI 10.1002/cne.901610203
   WARR WB, 1979, BRAIN RES, V173, P152, DOI 10.1016/0006-8993(79)91104-1
   WARR WB, 1978, EVOKED ELECT ACTIVIT
   WHITEHEAD ML, 1991, HEARING RES, V51, P55, DOI 10.1016/0378-5955(91)90007-V
   WIEDERHO.ML, 1970, J ACOUST SOC AM, V48, P966, DOI 10.1121/1.1912235
NR 41
TC 31
Z9 33
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0001-4966
J9 J ACOUST SOC AM
JI J. Acoust. Soc. Am.
PD DEC
PY 1997
VL 102
IS 6
BP 3587
EP 3596
DI 10.1121/1.421008
PG 10
WC Acoustics; Audiology & Speech-Language Pathology
SC Acoustics; Audiology & Speech-Language Pathology
GA YL015
UT WOS:A1997YL01500038
PM 9407652
ER

PT J
AU FREEDMAN, DO
   DEALMEIDA, PJ
   BESH, S
   SILVA, MCME
   BRAGA, C
   MACIEL, A
   FURTADO, AF
AF FREEDMAN, DO
   DEALMEIDA, PJ
   BESH, S
   SILVA, MCME
   BRAGA, C
   MACIEL, A
   FURTADO, AF
TI ABNORMAL LYMPHATIC FUNCTION IN PRESYMPTOMATIC BANCROFTIAN FILARIASIS
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID HUMAN SERUM-ALBUMIN; LYMPHOSCINTIGRAPHY; EXTREMITIES; LYMPHEDEMA;
   DEXTRAN
AB Despite the common association of filarial infection with elephantiasis, the great majority of those infected are in fact clinically asymptomatic microfilariae carriers, The assumption has been that infection but not disease exists in these presymptomatic persons. In an area of Brazil where Wuchereria bancrofti is endemic, flow studies done with dynamic radionuclide lymphoscintigraphy were used to compare 30 limbs from asymptomatic microfilaremic subjects with 16 control limbs, Geometric mean values for T-1/2 (19.8 vs, 37.7 min; P < .001), appearance time (7.9 vs, 27.9 min; P < .001), percent uptake at the region of interest (0.67% vs, 0.14%; P < .001), and peak activity (62.6 vs, 2.6 cps; P < .001) each indicated an enhanced pattern of rapid, increased lymph flow in asymptomatic microfilaremic subjects, The abnormal lymphatic function in these subjects indicates that current passive intervention strategies may need to change if the debilitating sequelae of this parasitic infection are to be avoided.
C1 LABS CERPE,NUCL MED UNIT,RECIFE,PE,BRAZIL.
   CTR PESQUISAS AGGEU MAGALHAES,RECIFE,PE,BRAZIL.
RP FREEDMAN, DO (reprint author), UNIV ALABAMA,DIV GEOG MED,UAB STN,BBRB 206,BIRMINGHAM,AL 35294, USA.
RI Braga, Cynthia/A-8204-2013
OI Braga, Cynthia/0000-0002-7862-6455
CR CAMBRIA RA, 1993, J VASC SURG, V18, P773
   CASE TC, 1992, ANN TROP MED PARASIT, V86, P435
   COLWELL EJ, 1970, AM J TROP MED HYG, V19, P227
   FREEDMAN DO, 1989, J CLIN INVEST, V83, P14, DOI 10.1172/JCI113850
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927
   FREEDMAN DO, 1992, AM J TROP MED HYG, V47, P787
   HAMON J, 1967, B WORLD HEALTH ORGAN, V37, P217
   HENZE E, 1982, J NUCL MED, V23, P923
   KAISER L, 1990, AM J PHYSIOL, V259, pH648
   NAWAZ MK, 1990, CLIN NUCL MED, V15, P794, DOI 10.1097/00003072-199011000-00004
   OLDFIELD EC, 1993, CLIN INFECT DIS, V16, pS132
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   RICHARDS FO, 1991, AM J TROP MED HYG, V44, P3
   SADEK S, 1989, LYMPHOLOGY, V22, P157
   WARTMAN WB, 1947, MEDICINE, V26, P333
   WEIL GJ, 1987, J INFECT DIS, V156, P350
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   1992, WHO TECH REP SER, P821
   1993, B WORLD HEALTH ORGAN, V71, P135
NR 20
TC 31
Z9 33
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 S WOODLAWN AVE, CHICAGO, IL 60637
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR
PY 1995
VL 171
IS 4
BP 997
EP 1001
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA QP912
UT WOS:A1995QP91200034
PM 7706830
ER

PT J
AU GUTH, PS
   DUNN, A
   KRONOMER, K
   NORRIS, CH
AF GUTH, PS
   DUNN, A
   KRONOMER, K
   NORRIS, CH
TI THE CHOLINERGIC PHARMACOLOGY OF THE FROG SACCULE
SO HEARING RESEARCH
LA English
DT Article
DE SACCULE; CHOLINERGIC; FROG; ACETYLCHOLINE; AFFERENT; EFFERENT
ID SEMICIRCULAR CANAL AFFERENTS; EFFERENT STIMULATION; VESTIBULAR NERVE;
   OPSANUS-TAU; HAIR-CELLS; BULLFROG; RECEPTORS; TOADFISH; GOLDFISH;
   NEURONS
AB Stimulation of the efferent nerves to the vestibular organs of the frog's inner ear produces either facilitation or inhibition of afferent firing. Similarly, application of acetylcholine (ACH), the major transmitter of the efferents, can produce both facilitation and/or inhibition as previously reported [Guth et al. (1986) Acta Otolaryngol. 102, 194-204; Norris et al. (1988) Hear, Res. 32, 197-206]. The firing rates of afferent neurons of the semicircular canal (SCC) using multiunit recordings are generally facilitated by ACH. Conversely, the firing rates of afferent units innervating the saccule are generally inhibited by ACH. This latter inhibition is antagonized by strychnine more potently than by curare, which is more potent than atropine. When inhibition is antagonized by strychnine or curare an underlying facilitation is revealed. The inhibition of saccular afferents by ACH shows desensitization requiring about 20 min to recover. The ACH-induced inhibition is mimicked by nicotine at very high concentrations but not by dimethyl phenylpiperazinium or cytisine. The fact that multiunit afferent firing from the SCC is generally facilitated while that from the saccule is generally inhibited by ACH suggests a different distribution of ACH receptors and receptor types (i.e. muscarinic or nicotinic and their subtypes) in the two organs and demonstrates the usefulness of recording from multiple units simultaneously. The difference in distribution of ACH receptors may be important for understanding the physiology of vestibular efferents.
C1 TULANE UNIV,SCH MED,DEPT OTOLARYNGOL,NEW ORLEANS,LA 70112.
RP GUTH, PS (reprint author), TULANE UNIV,SCH MED,DEPT PHARMACOL,1430 TULANE AVE,NEW ORLEANS,LA 70112, USA.
CR ADAMO S, 1985, FEBS LETT, V190, P161, DOI 10.1016/0014-5793(85)80449-X
   BAIRD RA, 1986, BRAIN RES, V369, P48, DOI 10.1016/0006-8993(86)90512-3
   BARRON SE, 1987, TRENDS PHARMACOL SCI, V8, P206
   BARRON SE, 1987, TRENDS PHARMACOL SCI, V8, P204, DOI 10.1016/0165-6147(87)90059-9
   BARTOLAMI S, 1993, NEUROREPORT, V4, P1003
   BELESLIN DB, 1974, NEUROPHARMACOLOGY, V13, P1091, DOI 10.1016/0028-3908(74)90100-2
   BOBBIN EP, 1971, NATURE, V231, P221
   BOYLE R, 1991, J NEUROPHYSIOL, V66, P1504
   BROWN DA, 1990, ANNU REV PHYSIOL, V52, P215
   CHRISTENSENDALS.J, 1993, COMP PHYSL A, P653
   EROSTEGUI C, 1994, IN PRESS HEAR RES, V74
   FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039
   FURUKAWA T, 1981, J PHYSIOL-LONDON, V315, P203
   GASSER HS, 1929, J PHYSL, V67, P581
   GEBBER GL, 1968, J PHARMACOL EXP THER, V163, P64
   GINSBORG BL, 1965, J PHARMACOL EXP THER, V150, P216
   GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0
   GUTH PS, 1986, ACTA OTO-LARYNGOL, V102, P194, DOI 10.3109/00016488609108666
   GUTH PS, 1991, HEARING RES, V56, P69, DOI 10.1016/0378-5955(91)90155-3
   HARTMANN R, 1980, PFLUG ARCH EUR J PHY, V388, P123, DOI 10.1007/BF00584117
   HIGHSTEIN SM, 1986, J COMP NEUROL, V243, P309, DOI 10.1002/cne.902430303
   HILLMAN DE, 1969, EXP BRAIN RES, V9, P1
   HONRUBIA V, 1981, INT J NEUROSCI, V15, P197, DOI 10.3109/00207458108985857
   HONRUBIA V, 1985, LARYNGOSCOPE, V95, P1526
   HONRUBIA V, 1989, J NEUROPHYSIOL, V61, P688
   KAKEHATA S, 1993, J PHYSIOL-LONDON, V463, P227
   KRSTIC MK, 1972, EUR J PHARMACOL, V17, P87, DOI 10.1016/0014-2999(72)90273-7
   KUHLMANN J, 1991, FEBS LETT, V2, P216
   LLINAS R, 1969, EXP BRAIN RES, V9, P16
   MILES K, 1988, MOL NEUROBIOL, V2, P9
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   PRECHT W, 1974, EXP BRAIN RES, V19, P377
   ROSSI ML, 1988, BRAIN RES, V185, P125
   SUGAI T, 1992, HEARING RES, V61, P56, DOI 10.1016/0378-5955(92)90036-M
   Taglietti V, 1973, Arch Sci Biol (Bologna), V57, P73
   VALLI P, 1986, BRAIN RES, V362, P92, DOI 10.1016/0006-8993(86)91402-2
   VOLLE RL, 1980, PHARM GANGLIONIC TRA, P281
NR 37
TC 31
Z9 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5955
J9 HEARING RES
JI Hear. Res.
PD MAY
PY 1994
VL 75
IS 1-2
BP 225
EP 232
DI 10.1016/0378-5955(94)90073-6
PG 8
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA NK064
UT WOS:A1994NK06400024
PM 8071149
ER

PT J
AU DOLDI, SB
   LATTUADA, E
   ZAPPA, MA
   PIERI, G
   FAVARA, A
   MICHELETTO, G
AF DOLDI, SB
   LATTUADA, E
   ZAPPA, MA
   PIERI, G
   FAVARA, A
   MICHELETTO, G
TI ULTRASONOGRAPHY OF EXTREMITY LYMPHEDEMA
SO LYMPHOLOGY
LA English
DT Article
AB Ultrasonography of the extremities was performed in 91 patients with unilateral or bilateral peripheral lymphedema of the arms or legs. Linear 3.5 to 10 mHz ultrasonographic linear probes were used in accordance with standardized procedure. The data demonstrated a volumetric increase of the lymphedematous limb with increased thickness of both the subcutaneous and subfascial (muscular) compartments consistent with fibrosclerosis in both compartments with chronic disease. Whereas dermal thickening was minimal, subcutaneous and subfascial changes were more prominent in primary than secondary lymphedema.
   By providing information about the volumetric and structural alterations with chronic lymphedema, ultrasonography safely and simply supplements conventional and isotopic lymphography in assessing patients with chronic lymphedema.
RP DOLDI, SB (reprint author), UNIV MILAN,IST CHIRURG GEN & ONCOL CHIRURG,VIA FRANCESCO SFORZA 35,I-20122 MILAN,ITALY.
CR AKISADA M, 1974, LYMPHOLOGY, V12, P29
   BERNARDINO ME, 1984, CHIR MED J, V97, P567
   DOLDI BS, 1990, NOT CHIR, V11, P67
   DOLDI SB, 1987, 3 GIORN INT ULTR SOM
   DOLDI SB, 1990, 92 C NAZ SOC IT CHIR
   DOLDI SB, 1989, USMED, V10, P57
   MCNEILL GC, 1989, RADIOLOGY, V172, P495
   MIDDLETON WA, 1985, RADIOLOGY, V157, P212
NR 8
TC 31
Z9 32
PU LYMPHOLOGY
PI TUCSON
PA C/O C L WITTE MD 1501 N CAMPBELL AVE DEPT SURGERY, TUCSON, AZ 85724
SN 0024-7766
J9 LYMPHOLOGY
JI Lymphology
PD SEP
PY 1992
VL 25
IS 3
BP 129
EP 133
PG 5
WC Immunology; Physiology
SC Immunology; Physiology
GA JW368
UT WOS:A1992JW36800006
PM 1434788
ER

PT J
AU BHAT, R
   FISHER, E
   RAJU, TNK
   VIDYASAGAR, D
AF BHAT, R
   FISHER, E
   RAJU, TNK
   VIDYASAGAR, D
TI PATENT DUCTUS-ARTERIOSUS - RECENT ADVANCES IN DIAGNOSIS AND MANAGEMENT
SO PEDIATRIC CLINICS OF NORTH AMERICA
LA English
DT Article
C1 UNIV ILLINOIS,MED CTR,DEPT PEDIAT,DIV NEONATOL & CARDIOL,CHICAGO,IL 60612.
CR ALPERT BS, 1979, J PEDIATR, V95, P579
   ANDERSON RJ, 1975, J CLIN INVEST, V56, P420, DOI 10.1172/JCI108108
   AULD PAM, 1966, J PEDIATR, V69, P61, DOI 10.1016/S0022-3476(66)80362-1
   BAYLEN B, 1977, CIRCULATION, V55, P182
   BAYLEN BG, 1975, J PEDIATR, V86, P423
   BELL EF, 1980, NEW ENGL J MED, V302, P598, DOI 10.1056/NEJM198003133021103
   BURNARD ED, 1959, P ROY SOC MED, V52, P77
   BHAT R, 1979, J PEDIATR, V95, P313
   BHAT R, 1980, DEV PHARMACOL THERAP, V1, P101
   BHAT R, UNPUB INTRAVENOUS IN
   BIANCHETTI G, 1980, DEV PHARMACOL THERAP, V1, P111
   BRASH AR, 1981, NEW ENGL J MED, V305, P67, DOI 10.1056/NEJM198107093050203
   BYAR DP, 1976, NEW ENGL J MED, V295, P74, DOI 10.1056/NEJM197607082950204
   CLARKE DR, 1976, ANN THORAC SURG, V22, P138
   CLARKSON PM, 1974, J PEDIATR, V84, P208, DOI 10.1016/S0022-3476(74)80603-7
   CLIFUENTES RF, 1979, J PEDIATR, V95, P583
   CLYMAN RI, 1981, J PEDIATR, V98, P123, DOI 10.1016/S0022-3476(81)80557-4
   COCIANI F, 1975, PROSTAGLANDINS, V9, P299
   COOKE RWI, 1979, BRIT HEART J, V41, P301
   CORAN AG, 1975, J PEDIATR SURG, V10, P399
   COTTON RB, 1978, J PEDIATR, V93, P647, DOI 10.1016/S0022-3476(78)80910-X
   DANILOWI.D, 1966, PEDIATRICS, V37, P74
   EDMUNDS LH, 1978, 75TH ROSS C PAED RES, P86
   EMMANOUILIDES GC, 1977, 75TH ROSS C PED RES
   FISHER EA, 1982, CHEST, V81, P74, DOI 10.1378/chest.81.1.74
   FREEDMAN Z, 1978, J CLIN PHARM, V18, P272
   FRIEDMAN WF, 1980, SEMIN PERINATOL, V4, P125
   FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003
   FRIEDMAN W F, 1978, Clinics in Perinatology, V5, P411
   GAY JH, 1973, J PEDIATR SURG, V8, P677, DOI 10.1016/0022-3468(73)90406-5
   GIRLING DJ, 1971, ARCH DIS CHILD, V46, P177
   GLUCK L, 1971, AM J OBSTET GYNECOL, V109, P440
   GOLDBERG SJ, 1975, PEDIATRIC ADOLESCENT, P78
   GUPTA JM, 1972, J THORAC CARDIOV SUR, V63, P642
   HALL GS, 1976, ANN THORAC SURG, V22, P146
   HALLIDAY HL, 1979, PEDIATRICS, V64, P154
   HEYMAN MA, 1978, 75TH P ROSS C PED RE, P84
   HEYMANN MA, 1977, 75TH P ROSS C PED RE
   HEYMANN MA, 1976, NEW ENGL J MED, V295, P530, DOI 10.1056/NEJM197609022951004
   HIGGINS CB, 1977, RADIOLOGY, V124, P198
   HIRSCHFELD S, 1976, CIRCULATION, V54, P751
   HIRSCHKLAU MJ, 1977, PEDIATR RES, V11, P392, DOI 10.1203/00006450-197704000-00139
   HOFFMAN JIE, 1965, AM J CARDIOL, V16, P634, DOI 10.1016/0002-9149(65)90047-0
   HOFFMAN JIE, 1978, 75TH ROSS C PED RES, P69
   HORSLEY BL, 1973, ANN SURG, V177, P806, DOI 10.1097/00000658-197306000-00021
   IVEY HH, 1979, BRIT HEART J, V41, P304
   JACOB J, 1980, J PEDIATR, V96, P79
   JOHN EA, 1979, J PEDIATR
   JOHNSON GL, 1979, PEDIATR CARDIOL, V1, P103, DOI DOI 10.1007/BF02083141
   JONES RWA, 1977, ARCH DIS CHILD, V52, P274
   KILMAN JW, 1974, J PEDIATR SURG, V9, P277, DOI 10.1016/S0022-3468(74)80280-0
   KITTERMA.JA, 1972, NEW ENGL J MED, V287, P473, DOI 10.1056/NEJM197209072871001
   KRAVETZ LJ, 1977, J PEDIATR, V90, P262
   LEES MH, 1975, J PEDIATR, V86, P132, DOI 10.1016/S0022-3476(75)80724-4
   LEWIS CE, 1974, AM J SURG, V128, P829, DOI 10.1016/0002-9610(74)90080-4
   MAHONY L, 1982, NEW ENGL J MED, V306, P506, DOI 10.1056/NEJM198203043060903
   MCCARTHY JS, 1978, PEDIATRICS, V62, P706
   MCGRATH RL, 1978, PERSISTENT PATENCY D, P92
   MCMURPHY DM, 1972, PEDIATR RES, V6, P231, DOI 10.1203/00006450-197204000-00004
   MERRITT TA, 1979, J PEDIATR, V95, P588, DOI 10.1016/S0022-3476(79)80776-3
   MERRITT TA, 1978, J PEDIATR, V93, P639
   MERRITT TA, 1981, J PEDIATR, V99, P281, DOI 10.1016/S0022-3476(81)80479-9
   MEYER RA, 1977, PEDIATRIC ECHOCARDIO, P165
   MOMMA K, 1981, PEDIATR RES, V15, P19, DOI 10.1203/00006450-198101000-00005
   MOSS AJ, 1964, PEDIATRICS, V33, P937
   MURPHY DA, 1974, J THORAC CARDIOVASC, V63, P642
   NAYEY RL, 1961, ARCH PATHOL, V71, P121
   NEAL WA, 1975, J PEDIATR, V86, P127, DOI 10.1016/S0022-3476(75)80723-2
   NEAL WA, 1977, J PEDIATR, V91, P621, DOI 10.1016/S0022-3476(77)80519-2
   OBERHANS.I, 1972, PEDIATR RES, V6, P693
   RASMUSSEN LF, 1978, J CLIN PHARMACOL, V18, P477
   RASMUSSEN LF, 1977, CLIN RES, V25, pA170
   RITTENHOUSE EA, 1976, J THORAC CARDIOV SUR, V71, P187
   RUDOLPH AM, 1974, CONGENITAL DISEASES, P168
   RUDOLPH AM, 1974, CONGENITAL DISEASES, P209
   RUDOLPH AM, 1974, CONGENITAL DISEASES, P47
   RUDOLPH AM, 1966, J CLIN INVEST, V45, P399, DOI 10.1172/JCI105355
   SAHN DJ, 1977, CIRCULATION, V56, P959
   SAHN DJ, 1976, AM J CARDIOL, V38, P73, DOI 10.1016/0002-9149(76)90065-5
   SAHN DJ, 1978, CIRCULATION, V58, P343
   SAISSI B, 1969, J PEDIATR, V74, P11
   SHARPE GL, 1975, PROSTAGLANDINS, V9, P585, DOI 10.1016/0090-6980(75)90064-7
   SILVERMA.NH, 1974, CIRCULATION, V50, P821
   STEVENSON JG, 1977, J PEDIATR, V90, P257, DOI 10.1016/S0022-3476(77)80645-8
   STEVENSON JG, 1979, CIRCULATION, V60, P355
   THIBEAULT DW, 1977, AM J DIS CHILD, V131, P741
   THIBEAULT DW, 1975, J PEDIATR, V86, P120, DOI 10.1016/S0022-3476(75)80722-0
   WAGENVOORT C, 1961, LAB INVEST, V10, P751
   WHITE RD, 1978, J PEDIATR, V92, P867, DOI 10.1016/S0022-3476(78)80208-X
   WILLIAMS RG, 1977, ECHOCARDIOGRAPHIC DI, P125
   WILLIAMS WH, 1976, ANN THORAC SURG, V22, P151
   WINTHER J, 1977, PEDIATR RES, V2, P402
   YAFFE SJ, 1980, J PEDIATR, V97, P1001, DOI 10.1016/S0022-3476(80)80446-X
   YANAGI RM, 1981, PEDIATRICS, V67, P647
   YEH TF, 1981, J PEDIATR, V98, P136
   ZACHMAN RD, 1974, AM HEART J, V87, P697, DOI 10.1016/0002-8703(74)90413-X
   ZUBERBUHLER JR, 1981, CLIN DIAGNOSIS PEDIA, P46
NR 97
TC 31
Z9 31
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0031-3955
J9 PEDIATR CLIN N AM
JI Pediatr. Clin. N. Am.
PY 1982
VL 29
IS 5
BP 1117
EP 1136
PG 20
WC Pediatrics
SC Pediatrics
GA PQ327
UT WOS:A1982PQ32700005
PM 7133791
ER

PT J
AU KIM, BS
AF KIM, BS
TI TUMOR-SPECIFIC IMMUNITY INDUCED BY SOMATIC HYBRIDS .2. ELICITATION OF
   ENHANCED IMMUNITY AGAINST THE PARENT PLASMACYTOMA
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 NORTHWESTERN UNIV,SCH MED,CTR CANC,CHICAGO,IL 60611.
   NORTHWESTERN UNIV,SCH DENT,CHICAGO,IL 60611.
RP KIM, BS (reprint author), NORTHWESTERN UNIV,SCH MED,DEPT MICROBIOL IMMUNOL,CHICAGO,IL 60611, USA.
CR BEATTY PG, 1976, J IMMUNOL, V116, P1391
   BLANK KJ, 1976, NATURE, V260, P250, DOI 10.1038/260250a0
   BORBERG H, 1972, INT J CANCER, V10, P539, DOI 10.1002/ijc.2910100312
   BURTON RC, 1977, CANCER IMMUNOL IMMUN, V2, P91
   BURTON RC, 1977, J NATL CANCER I, V58, P701
   CEROTTIN.JC, 1970, NATURE, V228, P1308, DOI 10.1038/2281308a0
   COHEN A, 1970, TRANSPLANTATION, V10, P130, DOI 10.1097/00007890-197007000-00027
   DELORME EJ, 1964, LANCET, V2, P117
   DOHERTY PC, 1976, TRANSPLANT REV, V29, P89
   DUCLOS TW, 1977, J IMMUNOL, V119, P1769
   FASS L, 1972, CANCER RES, V32, P997
   GREENE MI, 1977, P NATL ACAD SCI USA, V74, P5118, DOI 10.1073/pnas.74.11.5118
   HERBERMAN RB, 1977, BIOCHIM BIOPHYS ACTA, V473, P93, DOI 10.1016/0304-419X(77)90002-6
   HOSOKAWA M, 1976, INT J CANCER, V18, P369, DOI 10.1002/ijc.2910180316
   INVERNIZZI G, 1975, NATURE, V254, P713, DOI 10.1038/254713a0
   JAMI J, 1975, P NATL ACAD SCI USA, V72, P2130, DOI 10.1073/pnas.72.6.2130
   KATZ DH, 1972, CANCER RES, V32, P133
   KIM BS, 1979, J IMMUNOL, V123, P733
   KIM BS, 1978, CELL IMMUNOL, V41, P286, DOI 10.1016/0008-8749(78)90226-5
   KRIPKE ML, 1970, INT J CANCER, V6, P422, DOI 10.1002/ijc.2910060313
   LAW LW, 1973, NATURE, V243, P83, DOI 10.1038/243083a0
   LESPINAT.G, 1969, EUR J CANCER, V5, P421, DOI 10.1016/0014-2964(69)90095-4
   LIANG W, 1975, P NATL ACAD SCI USA, V72, P1873, DOI 10.1073/pnas.72.5.1873
   LIANG W, 1976, J IMMUNOL, V116, P623
   PERRY LL, 1978, J IMMUNOL, V121, P2144
   ROLLINGH.M, 1973, J NATL CANCER I, V50, P159
   Rosenberg S A, 1977, Adv Cancer Res, V25, P323, DOI 10.1016/S0065-230X(08)60637-5
   RUSSEL JH, 1978, EUR J IMMUNOL, V8, P640, DOI 10.1002/eji.1830080907
   SCHRADER JW, 1975, P NATL ACAD SCI USA, V72, P5066, DOI 10.1073/pnas.72.12.5066
   SHEARER WT, 1972, TRANSPLANTATION, V13, P345, DOI 10.1097/00007890-197203000-00027
   SMITH HG, 1977, J NATL CANCER I, V58, P1315
   Thompson R B, 1972, Transplant Rev, V9, P54
   TREVES AJ, 1976, J NATL CANCER I, V57, P409
   WATKINS JF, 1969, NATURE, V223, P1018, DOI 10.1038/2231018a0
   WILLIAMS WH, 1972, J NATL CANCER I, V49, P1613
   WINN HJ, 1961, J IMMUNOL, V86, P228
NR 36
TC 31
Z9 31
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PY 1979
VL 123
IS 2
BP 739
EP 744
PG 6
WC Immunology
SC Immunology
GA HD951
UT WOS:A1979HD95100039
PM 88483
ER

PT J
AU DAVIS, R
AF DAVIS, R
TI SURGERY OF LEFT PARADUODENAL HERNIA
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
C1 ALBERT EINSTEIN COLL MED,DEPT SURG,BRONX,NY.
CR Andrews E, 1923, SURG GYNECOL OBSTET, V37, P740
   BARTLETT MK, 1968, ANN SURG, V168, P249, DOI 10.1097/00000658-196808000-00010
   BRUNE JAS, 1956, LANCET, V2, P237
   Callander CL, 1935, SURG GYNECOL OBSTET, V60, P1052
   CAMPANALE RP, 1956, AM J SURG, V91, P436, DOI 10.1016/0002-9610(56)90188-X
   ELLIS J T, 1948, South Surg, V14, P413
   FILTZER H, 1973, SURG CLIN N AM, V53, P371
   GUNN K V, 1954, S Afr Med J, V28, P515
   HAYMOND HE, 1931, SURG GYNECOL OBSTET, V53, P316
   JONES TW, 1964, HERNIA, P577
   LAHEY FH, 1945, ANN SURG, V122, P436, DOI 10.1097/00000658-194509000-00008
   Longacre JJ, 1934, SURG GYNECOL OBSTET, V59, P165
   MORETZ WH, 1941, ANN SURG, V130, P124
   MOYNIHAN BGA, 1906, RETROPERITONEAL HERN
   PARSONS PB, 1953, AM J ROENTGENOL, V69, P563
   SAWYER K C, 1953, Rocky Mt Med J, V50, P639
   SINGH S, 1971, CAN J SURG, V14, P148
   TESSON JA, 1957, AM J SURG, V93, P470, DOI 10.1016/0002-9610(57)90844-9
   WANG CA, 1963, SURGERY, V54, P839
   WILLIAMS A. JUSTIN, 1951, CALIFORNIA MED, V74, P22
NR 20
TC 31
Z9 31
PU CAHNERS PUBL CO
PI NEW YORK
PA 249 WEST 17 STREET, NEW YORK, NY 10011
SN 0002-9610
J9 AM J SURG
JI Am. J. Surg.
PY 1975
VL 129
IS 5
BP 570
EP 573
DI 10.1016/0002-9610(75)90318-9
PG 4
WC Surgery
SC Surgery
GA AB928
UT WOS:A1975AB92800017
PM 1130597
ER

PT J
AU Uhrbrock, RS
AF Uhrbrock, Richard Stephen
TI ATTITUDES OF 4430 EMPLOYEES
SO JOURNAL OF SOCIAL PSYCHOLOGY
LA English
DT Article
CR ABRAHAMSON E, 1932, THESIS COLUMBIA U, P42
   HOUSER JD, 1927, WHAT EMPLOYER THINKS, P226
   HOUSER JD, 1932, B TAYLOR SOC, V17, P50
   Kornhauser A., 1933, PERSONNEL, V9, P99
   Kornhauser A. W., 1932, PERS J, V10, P393
   LIKERT R, 1932, ARCH PSYCHOL, P55
   MAYO E, 1933, HUMAN PROBLEMS IND C, P194
   MAYO E, 1930, PERS J, V8, P326
   Pennock G. A., 1930, PERS J, V8, P296
   PUTNAM ML, 1930, PERSON J, V8, P314
   Shen E, 1924, J EDUC PSYCHOL, V15, P462, DOI 10.1037/h0072051
   THURSTONE LL, 1929, MEASUREMENT ATTITUDE, P96
   Thurstone LL, 1929, PSYCHOL REV, V36, P222, DOI 10.1037/h0070922
   Thurstone LL, 1928, AM J SOCIOL, V33, P529, DOI 10.1086/214483
   Thurstone LL, 1930, J EDUC RES, V22, P89
   WILLIAMS W, 1933, SAT EVENING POS 0617, V205, P8
   WILLIAMS W, 1925, MAINSPRINGS MEN
   WILLIAMS W, 1920, WHATS WORKERS MIND
   WILLIAMS W, 1922, HORNY HANDS HAMPERED
   Williams W, 1923, HARVARD BUS REV, V1, P322
   WILLIAMS W, 1921, FULL FED
NR 21
TC 31
Z9 30
PU HELDREF PUBLICATIONS
PI WASHINGTON
PA 1319 EIGHTEENTH ST NW, WASHINGTON, DC 20036-1802 USA
SN 0022-4545
J9 J SOC PSYCHOL
JI J. Soc. Psychol.
PD AUG
PY 1934
VL 5
IS 3
BP 365
EP 376
PG 12
WC Psychology, Social
SC Psychology
GA V62OC
UT WOS:000204227800007
ER

PT J
AU Sumner, JA
AF Sumner, Jennifer A.
TI The mechanisms underlying overgeneral autobiographical memory: An
   evaluative review of evidence for the CaR-FA-X model
SO CLINICAL PSYCHOLOGY REVIEW
LA English
DT Review
DE Overgeneral autobiographical memory; Autobiographical memory
   specificity; CaR-FA-X model; Capture and rumination; Functional
   avoidance; Executive control
ID POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD SEXUAL-ABUSE; DEPRESSED
   OLDER-ADULTS; EXECUTIVE CONTROL; MAJOR DEPRESSION; REDUCED SPECIFICITY;
   COMPLICATED GRIEF; RETRIEVAL CUES; WORKING-MEMORY; RUMINATION
AB Overgeneral autobiographical memory (OGM) has been found to be an important cognitive phenomenon with respect to depression and trauma-related psychopathology (e.g., posttraumatic stress disorder), and researchers have been interested in better understanding the factors that contribute to this proposed vulnerability factor. The most prominent model of mechanisms underlying OGM to date is Williams et al.'s (2007) CaR-FA-X model. This model proposes that three processes influence OGM: capture and rumination, functional avoidance, and impaired executive control. The author reviews the current state of support for the CaR-FA-X model by evaluating 38 studies that have examined OGM and one or more mechanisms of the model. Collectively, these studies reveal robust support for associations between OGM and both rumination and impaired executive control. OGM also appears to be a cognitive avoidance strategy, and there is evidence that avoiding the retrieval of specific memories reduces distress after an aversive event, at least in the short term. Important issues that have been left unresolved are highlighted, including the nature of the capture phenomenon, the role of trauma in functional avoidance, and the developmental nature of functional avoidance. Recommendations for future research that will enhance understanding of the factors that contribute to OGM are suggested. (C) 2011 Elsevier Ltd. All rights reserved.
C1 Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.
RP Sumner, JA (reprint author), Northwestern Univ, Dept Psychol, 2029 Sheridan Rd,Swift Hall,Suite 102, Evanston, IL 60208 USA.
EM Jennifer.Sumner@gmail.com
CR Aglan A, 2010, BRIT J CLIN PSYCHOL, V49, P359, DOI 10.1348/014466509X467413
   Barnhofer T, 2002, BRIT J CLIN PSYCHOL, V41, P411, DOI 10.1348/014466502760387524
   Barnhofer T, 2007, BEHAV RES THER, V45, P1859, DOI 10.1016/j.brat.2007.02.006
   Bessell AL, 2008, J INT NEUROPSYCH SOC, V14, P63, DOI 10.1017/S1355617708080065
   Birch LS, 2007, BRIT J CLIN PSYCHOL, V46, P175, DOI 10.1348/014466506X119944
   Boelen PA, 2010, J BEHAV THER EXP PSY, V41, P331, DOI 10.1016/j.jbtep.2010.03.003
   Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261
   Crane C, 2007, MEMORY, V15, P312, DOI 10.1080/09658210701256530
   Crane C, 2007, BEHAV RES THER, V45, P3077, DOI 10.1016/j.brat.2007.05.009
   Crane C, 2009, BRIT J CLIN PSYCHOL, V48, P93, DOI 10.1348/014466508X370600
   Dalgleish T, 2003, EMOTION, V3, P211, DOI 10.1037/1528-3542.3.3.211
   Dalgleish T, 2008, J ABNORM PSYCHOL, V117, P236, DOI 10.1037/0021-843X.117.1.236
   Dalgleish T., 2004, ANN C EUR ASS BEH CO
   Dalgleish T, 2007, J EXP PSYCHOL GEN, V136, P23, DOI 10.1037/0096-3445.136.1.23
   Debeer E, 2009, MEMORY, V17, P892, DOI 10.1080/09658210903376243
   Ekkers W, 2011, BEHAV RES THER, V49, P588, DOI 10.1016/j.brat.2011.05.010
   EVANS J, 1992, PSYCHOL MED, V22, P399
   FINK LA, 1995, AM J PSYCHIAT, V152, P1329
   Geraerts E, 2010, APPL COGNITIVE PSYCH, V24, P387, DOI 10.1002/acp.1684
   Goddard L, 1996, J ABNORM PSYCHOL, V105, P609, DOI 10.1037/0021-843X.105.4.609
   Golden AM, 2007, J ABNORM PSYCHOL, V116, P786, DOI 10.1037/0021-843x.116.4.786
   Hauer BJA, 2008, J ABNORM PSYCHOL, V117, P444, DOI 10.1037/0021-843X.117.2.444
   Heeren A, 2009, BEHAV RES THER, V47, P403, DOI 10.1016/j.brat.2009.01.017
   Hermans D, 2008, BEHAV RES THER, V46, P668, DOI 10.1016/j.brat.2008.01.018
   Hermans D, 2008, DEPRESS ANXIETY, V25, P787, DOI 10.1002/da.20326
   Johnson RJ, 2005, J CLIN CHILD ADOLESC, V34, P235, DOI 10.1207/s15374424jccp3402_3
   Kleim B, 2008, J CONSULT CLIN PSYCH, V76, P231, DOI 10.1037/0022-006X.76.2.231
   Lemogne C, 2009, MEMORY, V17, P1, DOI 10.1080/09658210802438466
   Maccallum F, 2010, BEHAV RES THER, V48, P328, DOI 10.1016/j.brat.2009.12.006
   McAdams D. P., 2008, HDB PERSONALITY THEO, P242
   MCNALLY RJ, 1995, BEHAV RES THER, V33, P619, DOI 10.1016/0005-7967(95)00007-K
   McNally RJ, 2006, COGNITION EMOTION, V20, P527, DOI 10.1080/02699930500342779
   Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207
   Moore SA, 2007, PSYCHOL BULL, V133, P419, DOI 10.1037/0033-2909.133.3.419
   Moradi AR, 2008, ACTA PSYCHOL, V127, P645, DOI 10.1016/j.actpsy.2007.11.001
   Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0
   Neshat-Doost HT, 2008, EMOTION, V8, P731, DOI 10.1037/a0013507
   Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x
   Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035
   Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121
   Raes F, 2009, J BEHAV THER EXP PSY, V40, P24, DOI 10.1016/j.jbtep.2008.03.001
   Raes F, 2006, PSYCHOL BELG, V46, P131
   Raes F, 2010, J CLIN CHILD ADOLESC, V39, P276, DOI 10.1080/15374410903532684
   Raes F, 2006, COGNITION EMOTION, V20, P402, DOI 10.1080/02699930500341003
   Raes F, 2007, MEMORY, V15, P495, DOI 10.1080/09658210701390982
   Raes F, 2006, NEW DEV CHILD ABUSE, P61
   Raes F, 2006, MEMORY, V14, P584, DOI 10.1080/09658210600624614
   Raes F, 2008, BEHAV RES THER, V46, P748, DOI 10.1016/j.brat.2008.03.003
   Raymaekers L, 2010, J BEHAV THER EXP PSY, V41, P338, DOI 10.1016/j.jbtep.2010.03.004
   Ros L, 2010, AGING NEUROPSYCHOL C, V17, P89, DOI 10.1080/13825580903042650
   Rutherford B. J., 2010, DISS ABSTR INT B, V70, P7220
   Schonfeld S, 2007, MEMORY, V15, P339, DOI 10.1080/09658210701256571
   Schonfeld S, 2006, EMOTION, V6, P611, DOI 10.1037/1528-3542.6.4.611
   Serrano JP, 2004, PSYCHOL AGING, V19, P272, DOI 10.1037/0882-7974.19.2.272
   Sinclair JMA, 2007, J AFFECT DISORDERS, V102, P11, DOI 10.1016/j.jad.2006.12.006
   Spinhoven P, 2007, MEMORY, V15, P324, DOI 10.1080/09658210701256555
   Strauss E., 2006, COMPENDIUM NEUROPSYC
   Sumner JA, 2010, BEHAV RES THER, V48, P614, DOI 10.1016/j.brat.2010.03.013
   Sumner JA, 2011, MEMORY, V19, P169, DOI 10.1080/09658211.2010.541467
   Sumner JA, 2011, COGNITION EMOTION, V25, P183, DOI 10.1080/02699931003741566
   Sutherland K, 2007, BEHAV RES THER, V45, P2407, DOI 10.1016/j.brat.2007.03.018
   Swan GE, 2002, J GERONTOL B-PSYCHOL, V57, P133, DOI DOI 10.1093/GERONB/57.2.P133
   Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561
   Valentino K, 2009, J CHILD PSYCHOL PSYC, V50, P1029, DOI 10.1111/j.1469-7610.2009.02072.x
   Watkins E, 2008, EMOTION, V8, P364, DOI 10.1037/1528-3542.8.3.364
   Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163
   WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144
   Williams J. M. G., 1996, REMEMBERING OUR PAST, P244, DOI [10.1017/CBO9780511527913.010, DOI 10.1017/CB09780511527913.010]
   Williams JMG, 2006, COGNITION EMOTION, V20, P548, DOI 10.1080/02699930500450465
   Williams JMG, 1999, COGNITIVE THER RES, V23, P285, DOI 10.1023/A:1018743615228
   Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122
   Yanes PK, 2008, MEMORY, V16, P669, DOI 10.1080/09658210802135351
NR 72
TC 30
Z9 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0272-7358
J9 CLIN PSYCHOL REV
JI Clin. Psychol. Rev.
PD FEB
PY 2012
VL 32
IS 1
BP 34
EP 48
DI 10.1016/j.cpr.2011.10.003
PG 15
WC Psychology, Clinical
SC Psychology
GA 888EY
UT WOS:000299987800004
PM 22142837
ER

PT J
AU Lee, BB
   Andrade, M
   Bergan, J
   Boccardo, F
   Campisi, C
   Damstra, R
   Flour, M
   Gloviczki, P
   Laredo, J
   Piller, N
   Michelini, S
   Mortimer, P
   Villavicencio, JL
AF Lee, B. B.
   Andrade, M.
   Bergan, J.
   Boccardo, F.
   Campisi, C.
   Damstra, R.
   Flour, M.
   Gloviczki, P.
   Laredo, J.
   Piller, N.
   Michelini, S.
   Mortimer, P.
   Villavicencio, J. L.
TI Diagnosis and treatment of primary lymphedema. Consensus Document of the
   International Union of Phlebology (IUP)-2009
SO INTERNATIONAL ANGIOLOGY
LA English
DT Article
DE Lymphedema; Lymphatic abnormalities; Drainage; Reconstructive surgical
   procedures
ID CONGENITAL VASCULAR MALFORMATIONS; KLIPPEL-TRENAUNAY-SYNDROME;
   ARTERIOVENOUS SHUNTING MALFORMATION; LYMPHO-VENOUS ANASTOMOSES;
   CANCER-RELATED LYMPHEDEMA; COMPLEX PHYSICAL-THERAPY; REDUCES ARM
   LYMPHEDEMA; PORT-WINE STAINS; PERIPHERAL LYMPHEDEMA; ADVANCED MANAGEMENT
AB Primary lymphedema can be managed safely as one of the chronic lymphedemas by a proper combination of DLT with compression therapy. Treatment in the maintenance phase should include compression garments, self management including the compression therapy, self massage and meticulous personal hygiene and skin care in addition to lymph-transport promoting excercises. The management of primary lymphedema can be further improved with proper addition of surgical therapy either reconstructive or ablative. These two surgical therapies can be effective only when fully integrated with MLD-based DLT postoperatively. Compliance with a long-term commitment of DLT postoperatively is the most critical factor determining the success of any new treatment strategy with either reconstructive or palliative surgery. The future of management of primary lymphedema caused by truncular lymphatic malformation has never been brighter with the new prospect of gene-oriented management. [Int Angiol 2010;29:454-70]
C1 [Lee, B. B.; Laredo, J.] Georgetown Univ, Sch Med, Ctr Vein Lymphat & Vasc Malformat, Div Vasc Surg,Dept Surg, Washington, DC 20057 USA.
   [Andrade, M.] Univ Sao Paulo, Sch Med, Dept Surg, Sao Paulo, Brazil.
   [Bergan, J.] Univ Calif San Diego, Dept Surg, UCSD Sch Med, San Diego, CA 92103 USA.
   [Boccardo, F.; Campisi, C.] Univ Genoa, Sect Lymphol & Microsurg, Univ Hosp S Martino, Dept Surg,Unit Lymphat Surg, Genoa, Italy.
   [Damstra, R.] Nij Smellinghe Hosp, Dept Dermatol & Phlebol & Lympho Vasc Med, Drachten, Netherlands.
   [Flour, M.] Univ Hosp Leuven, Multidisciplinary Diabet Foot Clin, Vasc Ctr, Dept Dermatol, Louvain, Belgium.
   [Gloviczki, P.] Mayo Clin, Div Vasc & Endovasc Surg, Rochester, MN USA.
   [Gloviczki, P.] Mayo Clin, Gonda Vasc Ctr, Rochester, MN USA.
   [Piller, N.] Flinders Univ S Australia, Sch Med, Dept Surg, Lymphoedema Assessment Clin, Adelaide, SA, Australia.
   [Michelini, S.] San Giovanni Battista Hosp, Dept Vasc Rehabil, Rome, Italy.
   [Mortimer, P.] St Georges Univ London, London, England.
   [Villavicencio, J. L.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Surg, Bethesda, MD USA.
   [Villavicencio, J. L.] Walter Reed Army Med Ctr, Venous & Lymphat Teaching Clin, Bethesda, MD USA.
RP Lee, BB (reprint author), Georgetown Univ, Sch Med, Ctr Vein Lymphat & Vasc Malformat, Div Vasc Surg,Dept Surg, Washington, DC 20057 USA.
EM bblee38@comcast.net
CR AAGENAES O, 1968, ARCH DIS CHILD, V43, P646
   Allegra C, 2002, LYMPHOLOGY, V35, P114
   [Anonymous], 2003, LYMPHOLOGY, V36, P84
   Auchincloss H, 1930, PUERTO RICO J PUBL H, V6, P149
   BABB RR, 1966, J AMER MED ASSOC, V195, P871
   BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012
   Becker C, 1990, PROGR LYMPHOL, V6, P487
   Becker C, 2001, SURG SKIN SKELETON H
   Bellini C, 2008, J PEDIATR, V152, P587, DOI 10.1016/j.jpeds.2007.12.018
   BELOV S, 1990, INT ANGIOL, V9, P141
   Belov S., 1989, VASCULAR MALFORMATIO, P25
   Belov S, 1993, Semin Vasc Surg, V6, P219
   Bernas MJ, 2001, LYMPHOLOGY, V34, P84
   Berwald C, 2006, Ann Chir Plast Esthet, V51, P369, DOI 10.1016/j.anplas.2006.07.020
   Boccardo F, 2007, MICROSURG, V27, P339, DOI 10.1002/micr.20347
   Brautigam P, 1998, LYMPHOLOGY, V31, P43
   Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478
   Brorson H, 1998, PLAST RECONSTR SURG, V102, P1058, DOI 10.1097/00006534-199809040-00021
   Brorson H, 1998, LYMPHOLOGY, V31, P156
   Bruna J, 2002, LYMPHOLOGY S, V35, P160
   BUNCE IH, 1994, MED J AUSTRALIA, V161, P125
   Burnand KG, 2003, DIS LYMPHATICS, P102
   CAMBRIA RA, 1993, J VASC SURG, V18, P773
   Campisi C, 2006, J VASC SURG, V43, P1244, DOI 10.1016/j.jvs.2005.11.064
   Campisi C, 2003, Handchir Mikrochir Plast Chir, V35, P221
   Campisi C, 2004, WORLD J SURG, V28, P609, DOI 10.1007/s00268-004-7252-4
   Campisi C, 2008, MICROSURG, V28, P138, DOI 10.1002/micr.20466
   Campisi C, 2004, LYMPHOLOGY, V37, P182
   Campisi C, 2007, MICROSURG, V27, P333, DOI 10.1002/micr.20346
   Campisi C, 2003, MICROSURG, V23, P522, DOI 10.1002/micr.10185
   Campisi C., 2002, LYMPHOLOGY S, V35, P635
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   Casley-Smith Judith R, 1995, INT J ANGIOL, V4, P134, DOI 10.1007/BF02043007
   Celebioglu F, 2007, ACTA RADIOL, V48, P488, DOI 10.1080/02841850701305440
   Choi JY, 1999, KOREAN J NUCL MED, V33, P143
   Damstra RJ, 2009, BREAST CANCER RES TR, V113, P199, DOI 10.1007/s10549-008-9932-5
   DELLON AL, 1977, PLAST RECONSTR SURG, V60, P589, DOI 10.1097/00006534-197710000-00015
   Eliachar E, 1970, Ann Pediatr (Paris), V17, P750
   Erickson RP, 2001, LYMPHOLOGY, V34, P1
   Evans AL, 2003, J MED GENET, V40, P697, DOI 10.1136/jmg.40.9.697
   Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073
   Finegold DN, 2001, HUM MOL GENET, V10, P1185, DOI 10.1093/hmg/10.11.1185
   FOLDI E, 1985, ANGIOLOGY, V36, P171, DOI 10.1177/000331978503600306
   Foldi E, 1998, CANCER, V83, P2833, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2833::AID-CNCR35>3.0.CO;2-3
   GLOVICZKI P, 1989, J VASC SURG, V9, P683, DOI 10.1067/mva.1989.vs0090683
   Gloviczki P, 1999, INT ANGIOL, V18, P42
   Gloviczki P, 2007, PHLEBOLOGY, V22, P291, DOI 10.1258/026835507782655209
   GLOVICZKI P, 1991, SURGERY, V110, P469
   GOLDMAN MP, 1993, J PEDIATR, V122, P71, DOI 10.1016/S0022-3476(05)83489-4
   GREENLEE R, 1993, LYMPHOLOGY, V26, P156
   Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174
   Guyatt GH, 2000, BRIT MED J, V320, P954, DOI 10.1136/bmj.320.7240.954
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Hall JG, 2002, LYMPHOLOGY, V35, P129
   Homans J, 1936, NEW ENGL J MED, V215, P1099, DOI 10.1056/NEJM193612102152401
   Hwang JH, 1999, LYMPHOLOGY, V32, P15
   Hwang JH, 1998, J KOREAN ACAD REHAB, V22, P698
   Hwang JH, 1997, J KOREAN ACAD REHAB, V21, P146
   Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614
   Jacob AG, 1998, MAYO CLIN PROC, V73, P28
   Johansson K, 1999, LYMPHOLOGY, V32, P103
   Kasseroller RG, 1998, CANCER, V83, P2840, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2840::AID-CNCR37>3.0.CO;2-5
   Ketterings C, 1997, LYMPHOLOGY, V30, P49
   Kim DI, 1998, LYMPHOLOGY, V31, P190
   Kim YW, 2006, J VASC SURG, V44, P545, DOI 10.1016/j.jvs.2006.05.035
   Klippel M, 1900, ARCH GEN MED, V3, P641
   Kono T, 2006, ANN PLAS SURG, V56, P460, DOI 10.1097/01.sap.0000201554.44010.44
   KRYLOV VS, 1988, J MAL VASCUL, V13, P335
   Lammie PJ, 2002, ANN NY ACAD SCI, V979, P131
   Leduc O, 1998, CANCER, V83, P2835, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2835::AID-CNCR36>3.0.CO;2-V
   LEDUC O, 1988, PROGRESS LYMPHOLOGY, V9
   Lee B B, 2005, Vasc Endovascular Surg, V39, P67, DOI 10.1177/153857440503900107
   Lee BB, 2005, PHLEBOLOGY, V20, P28, DOI 10.1258/0268355053300875
   Lee BB, 2005, INT ANGIOL, V24, P173
   Lee BB, 2002, CARDIOVASC SURG, V10, P523, DOI 10.1016/S0967-2109(02)00072-8
   Lee BB, 2004, ANN VASC SURG, V18, P380, DOI 10.1007/s10016-004-0020-y
   Lee BB, 2007, PHLEBOLOGY, V22, P253, DOI 10.1258/026835507782655245
   Lee BB, 2004, EUR J LYMPHOLOGY, V14, P6
   Lee BB, 2005, EUR J VASC ENDOVASC, V30, P184, DOI 10.1016/j.ejvs.2004.10.006
   Lee BB, 2002, LYMPHOLOGY S, V35, P450
   Lee BB, 2005, LYMPHOLOGY, V38, P122
   Lee BB, 2009, PHLEBOLOGY, V24, P193, DOI 10.1258/phleb.2009.009032
   Lee BB, 2004, J AM COLL SURGEONS, V198, P549, DOI 10.1016/j.jamcollsurg.2003.12.013
   Lee BB, 2003, PHLEBOLYMPHOLOGY, V43, P197
   Lee B.B., 2009, HDB VENOUS DISORDERS
   Lee BB, 2007, PHLEBOLOGY, V22, P258, DOI 10.1258/026835507782655182
   Lee BB, 2005, PHLEBOLYMPHOLOGY, V47, P324
   Lee BB, 2002, INT ANGIOL, V21, P209
   LEE BB, 2004, ANGEILOGIE, V56, P7
   LEE BB, 2008, SURG MANAGEMENT LYMP, P55
   Lee BB, 2008, LYMPHATIC MALFORMATI, P31, DOI 10.1007/978-1-84628-793-0_4
   Lee BB, 2007, PHLEBOLOGY, V22, P249, DOI 10.1258/026835507782655236
   Lee BB, 2003, J VASC SURG, V37, P533, DOI 10.1067/mva.2003.91
   Lee BB, 2004, J VASC SURG, V39, P590, DOI 10.1016/j.jvs.2003.10.048
   Lee BB, 2004, INT ANGIOL, V23, P355
   Lee BB, 2008, INT ANGIOL, V27, P389
   Lee BB, 2005, LYMPHOLOGY, V38, P28
   Lee BB, 2006, ARTERIOVENOUS MALFOR, P597
   Lohrmann C, 2008, MICROVASC RES, V76, P42, DOI 10.1016/j.mvr.2008.03.003
   Mattassi R, 2007, PHLEBOLOGY, V22, P287, DOI 10.1258/026835507782655263
   Michelini S., 2007, LYMPHOLOGY S, V55, p235 
   Michelini S., 2002, LYMPHOLOGY S, V35, P168
   Michelini S, 1998, Minerva Cardioangiol, V46, P395
   Michelini S, 2007, EUR J LYMPHOL, V17, P16
   Michelini S., 2007, LYMPHOLOGY S, V55, p238 
   Michelini S., 2002, LYMPHOLOGY S, V35, P169
   Michelini S, 1998, Minerva Cardioangiol, V46, P393
   Michelini S., 2007, LYMPHOLOGY S, V55, P243
   MORGAN RG, 1992, J HAND SURG-BRIT EUR, V17B, P437, DOI 10.1016/S0266-7681(05)80270-0
   Mortimer PS, 1997, ANGIOLOGY, V48, P87, DOI 10.1177/000331979704800114
   Northup KA, 2003, LYMPHOLOGY, V36, P162
   O'Connell JR, 1997, AM J HUM GENET, V61, pA288
   Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639
   OLSZEWSKI WL, 1988, INT ANGIOL, V7, P312
   Olszewski WL, 2002, LYMPHOLOGY S, V35, P233
   Papendieck CM, 2002, LYMPHOLOGY S, V35, P478
   Papendieck CM, 1999, INT ANGIOL, V18, P6
   PFLUG JJ, 1975, PRACTITIONER, V215, P69
   Pissas A, 2002, Ann Ital Chir, V73, P489
   Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0
   Rosbotham JL, 2000, BRIT J DERMATOL, V142, P148, DOI 10.1046/j.1365-2133.2000.03258.x
   Samlaska CP, 2002, PEDIATR DERMATOL, V19, P139, DOI 10.1046/j.1525-1470.2002.00048.x
   SERGI G, 1994, ANN NUTR METAB, V38, P158, DOI 10.1159/000177806
   SERVELLE M, 1985, ANN SURG, V201, P365, DOI 10.1097/00000658-198503000-00020
   Sistrunk WE, 1998, PLAST RECONSTR SURG, V102, P1058
   SMELTZER DM, 1985, PEDIATRICS, V76, P206
   Solari N, 2009, MELANOMA RES, V19, P243, DOI 10.1097/CMR.0b013e32832e0b9a
   Szolnoky G, 2006, INT J DERMATOL, V45, P1468, DOI 10.1111/j.1365-4632.2006.03165.x
   Szolnoky G, 2002, LYMPHOLOGY S, V35, P277
   Szuba A, 2003, J NUCL MED, V44, P43
   Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209
   Szuba A, 2002, NUCL MED COMMUN, V23, P1171, DOI 10.1097/01.mnm.0000046208.83338.da
   The diagnosis and treatment of peripheral lymphedema, 2009, LYMPHOLOGY, V42, P51
   THEYS S, 2002, LYMPHOLOGY S, V35, P293
   THIBAUT G, 2002, LYMPHOLOGY S, V35, P261
   Vercellio Baraldini V, 2002, LYMPHOLOGY, V35, P472
   Weeks D. E., 1990, AM J HUM GENET S, V47, pA204
   Wilburn O, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-84
   Williams WH, 2000, CLIN NUCL MED, V25, P451, DOI 10.1097/00003072-200006000-00013
   Witte MH, 1998, LYMPHOLOGY, V31, P145
   WITTE MH, 1997, LYMPHOLOGY, V16, P19
   Yeo Un Cheol, 1997, Annals of Dermatology, V9, P126
   Yin LY, 1998, MAMM GENOME, V9, P408, DOI 10.1007/s003359900783
   Yoon Y, 2003, J CLIN INVEST, V111, P717, DOI 10.1172/JCI200315830
   1998, AM J CANC S, V12
NR 145
TC 30
Z9 31
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0392-9590
J9 INT ANGIOL
JI Int. Angiol.
PD OCT
PY 2010
VL 29
IS 5
BP 454
EP 470
PG 17
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 711AS
UT WOS:000286558700013
PM 20924350
ER

PT J
AU Iyer, A
   Jetten, J
   Tsivrikos, D
   Postmes, T
   Haslam, SA
AF Iyer, Aarti
   Jetten, Jolanda
   Tsivrikos, Dimitrios
   Postmes, Tom
   Haslam, S. Alexander
TI The more (and the more compatible) the merrier: Multiple group
   memberships and identity compatibility as predictors of adjustment after
   life transitions
SO BRITISH JOURNAL OF SOCIAL PSYCHOLOGY
LA English
DT Article
ID SOCIAL IDENTITY; PSYCHOLOGICAL SEPARATION; GROUP IDENTIFICATION;
   AFRICAN-AMERICANS; ROLE-CONFLICT; SELF-ESTEEM; HIGH-SCHOOL; COLLEGE;
   OUTCOMES; DISCRIMINATION
AB Two longitudinal studies considered the role of social identity factors in predicting wellbeing after students' transition to university. The transition (assessed before starting university and after 2 months at university) had a detrimental effect on well-being, but identification as a university student improved well-being. Both studies showed that the social context in which the change occurred either facilitated or hindered university identification. Specifically, perceived compatibility between old and new identities and having multiple group memberships (which were each influenced by social class background, Study 2) both increased likelihood of identification with the new group. These predictive relationships remained statistically reliable when controlling for other factors relevant to the transition. The results suggest that life transitions are difficult partly because they entail changes in group membership. Both studies also demonstrate that identification with a new group can help buffer individuals from the negative well-being consequences of change.
C1 [Iyer, Aarti; Jetten, Jolanda] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia.
   [Jetten, Jolanda; Tsivrikos, Dimitrios; Haslam, S. Alexander] Univ Exeter, Sch Psychol, Exeter EX4 4QJ, Devon, England.
   [Postmes, Tom] Univ Groningen, Sch Psychol, NL-9700 AB Groningen, Netherlands.
RP Iyer, A (reprint author), Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia.
EM a.iyer@psy.uq.edu.au; j.jetten@psy.uq.edu.au
RI Postmes, Tom/A-9004-2010; Iyer, Aarti/D-1434-2012; Jetten,
   Jolanda/H-3285-2014
OI Postmes, Tom/0000-0002-8029-7398; Iyer, Aarti/0000-0001-7788-6709;
   Jetten, Jolanda/0000-0002-7588-5355
CR ANTHROP J, 1983, RES Q EXERCISE SPORT, V54, P104
   Argyle M., 1994, PSYCHOL SOCIAL CLASS
   Ashforth BE, 2001, SOCIAL IDENTITY PROC, P31
   Ball S. J., 2002, RACE ETHNIC EDUC-UK, V5, P333, DOI 10.1080/1361332022000030879
   Baumeister Roy F, 1986, IDENTITY CULTURAL CH
   Blau P. M., 1977, INEQUALITY HETEROGEN
   Bourdieu Pierre, 1979, DISTINCTION SOCIAL C
   Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037//0022-3514.77.1.135
   Breakwell G. M., 1986, COPING THREATENED ID
   Burke PJ, 2006, SOC PSYCHOL QUART, V69, P81
   Chandler M. J., 2008, SELF CONTINUITY INDI, P213
   CHEMERS MM, 2001, J EDUC PSYCHOL, V93, P53
   Condor S., 1996, CHANGING EUROPEAN ID, P41
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   DOOSJE B, 1995, J EXP SOC PSYCHOL, V31, P410, DOI 10.1006/jesp.1995.1018
   Durkheim Emile, 1951, SUICIDE
   Ellemers N, 2003, SOCIAL IDENTITY AT WORK: DEVELOPING THEORY FOR ORGANIZATIONAL PRACTICE, P191
   ETHIER KA, 1994, J PERS SOC PSYCHOL, V67, P243, DOI 10.1037/0022-3514.67.2.243
   Frone MR, 1997, J OCCUP ORGAN PSYCH, V70, P325
   Gallo LC, 2005, J PERS SOC PSYCHOL, V88, P386, DOI 10.1037/0022-3514.88.2.386
   Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449
   Haslam S. A., 2004, PSYCHOL ORG SOCIAL I
   Haslam S. A., 2002, STEREOTYPES EXPLANAT, P157, DOI 10.1017/CBO9780511489877.009
   Haslam SA, 2006, J APPL PSYCHOL, V91, P1037, DOI 10.1037/0021-9010.91.5.1037
   Haslam SA, 2003, J OCCUP ORGAN PSYCH, V76, P83, DOI 10.1348/096317903321208907
   HAYS RB, 1986, J PERS SOC PSYCHOL, V50, P305, DOI 10.1037/0022-3514.50.2.305
   *HIGH ED FUND COUN, 2005, HEFCE STRAT PLAN 200
   Hirsh B. J., 1981, SOCIAL NETWORKS SOCI, P149
   Hogg M. A., 1993, GROUP MOTIVATION SOC, P173
   HOLMBECK GN, 1993, J COUNS PSYCHOL, V40, P73, DOI 10.1037//0022-0167.40.1.73
   Hopkins N., 1997, CHANGING EUROPEAN ID, P69
   HU LT, 1999, STRUCTURAL EQUATION, V1, P55
   Iyer A., 2008, SELF CONTINUITY INDI, P187
   JETTEN J, NEW DIRECTI IN PRESS
   Jetten J, 2002, BRIT J SOC PSYCHOL, V41, P281, DOI 10.1348/014466602760060147
   Jetten J, 2008, EUR J SOC PSYCHOL, V38, P866, DOI 10.1002/ejsp.471
   Jetten J, 2001, PERS SOC PSYCHOL B, V27, P1204, DOI 10.1177/0146167201279012
   Kline R. B., 2005, PRINCIPLES PRACTICES
   Kling KC, 2003, J PERS SOC PSYCHOL, V85, P922, DOI 10.1037/0022-3514.85.5.922
   Landau M. J., 2008, SELF CONTINUITY INDI, P87
   LAPSLEY DK, 1989, J COUNS PSYCHOL, V36, P286, DOI 10.1037/0022-0167.36.3.286
   Levine RM, 1996, BRIT J SOC PSYCHOL, V35, P245
   Lewin Kurt, 1951, FIELD THEORY SOCIAL
   LINVILLE PW, 1985, SOC COGNITION, V3, P94, DOI 10.1521/soco.1985.3.1.94
   Lott B, 2001, J SOC ISSUES, V57, P247, DOI 10.1111/0022-4537.00211
   MARKS SR, 1977, AM SOCIOL REV, V42, P921, DOI 10.2307/2094577
   Oswald DL, 2003, PERS RELATIONSHIP, V10, P187, DOI 10.1111/1475-6811.00045
   Postmes T, 2002, J PERS SOC PSYCHOL, V83, P735, DOI 10.1037//0022-3514.83.3.735
   Reay D, 1999, FEM PSYCHOL, V9, P89, DOI 10.1177/0959353599009001008
   Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261
   Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002
   Sani F, 2008, EUR J SOC PSYCHOL, V38, P365, DOI 10.1002/ejsp.461
   Sarbin Theodore R., 1968, HDB SOCIAL PSYCHOL, P488
   Schmitt MT, 2003, EUR J SOC PSYCHOL, V33, P1, DOI 10.1002/ejsp.131
   SCHWEIGER DM, 1991, ACAD MANAGE J, V34, P110, DOI 10.2307/256304
   Sedikides C., 2008, SELF CONTINUITY INDI, P227
   Settles IH, 2002, J APPL PSYCHOL, V87, P574, DOI 10.1037//0021-9010.87.3.574
   Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33
   Tajfel H, 1981, INTERGROUP BEHAV, P144
   THOITS PA, 1983, AM SOCIOL REV, V48, P174, DOI 10.2307/2095103
   Tropp LR, 2001, PERS SOC PSYCHOL B, V27, P585, DOI 10.1177/0146167201275007
   TURNER JC, 1999, PSYCHOL SOCIAL SELF, P11
   Turner John C., 1987, REDISCOVERING SOCIAL
   Warner William Lloyd, 1941, SOCIAL LIFE MODERN C
NR 64
TC 30
Z9 30
PU BRITISH PSYCHOLOGICAL SOC
PI LEICESTER
PA ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER LE1 7DR, LEICS, ENGLAND
SN 0144-6665
J9 BRIT J SOC PSYCHOL
JI Br. J. Soc. Psychol.
PD DEC
PY 2009
VL 48
IS 4
BP 707
EP 733
DI 10.1348/014466608X397628
PG 27
WC Psychology, Social
SC Psychology
GA 535WY
UT WOS:000273003800005
PM 19200408
ER

PT J
AU Abu-Omar, Y
   Taggart, DP
AF Abu-Omar, Yasir
   Taggart, David P.
TI The present status of off-pump coronary artery bypass grafting
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Review
DE Coronary artery bypass grafting; Cardiopulmonary bypass; Off-pump
ID ACUTE-RENAL-FAILURE; RANDOMIZED CONTROLLED-TRIAL; AVOIDING
   CARDIOPULMONARY BYPASS; RISK-ADJUSTED MORTALITY; ON-PUMP;
   CARDIAC-SURGERY; SHORT-TERM; MYOCARDIAL REVASCULARIZATION;
   BEATING-HEART; EXTRACORPOREAL-CIRCULATION
AB Coronary revascularisation using cardiopulmonary bypass remains the gold standard treatment for coronary artery disease. Over the past decade, techniques of revascularisation on the beating heart without the use of cardiopulmonary bypass (off-pump surgery) have evolved with an attempt to reduce the potential deleterious effects of extracorporeal circulation. Several trials have reported a significant reduction in morbidity with avoidance of cardiopulmonary bypass, white large observational studies have also reported a reduction in mortality. Complete avoidance of aortic manipulation by using off-pump techniques and composite grafts may add an additional benefit particularly in patients at highest risk of stroke. The impact of this mode of revascularisation has probably been underestimated especially in an era where surgical revascularisation is being increasingly undertaken in older patients with significant comorbidities. In this contribution, the current evidence from randomised trials, meta-analyses and observational studies is critically reviewed. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
C1 [Abu-Omar, Yasir] Papworth Hosp, Dept Cardiothorac Surg, Cambridge CB3 8RE, England.
   [Taggart, David P.] John Radcliffe Hosp, Dept Cardiothorac Surg, Oxford OX3 9DU, England.
   [Taggart, David P.] Univ Oxford, Oxford, England.
RP Taggart, DP (reprint author), John Radcliffe Hosp, Dept Cardiothorac Surg, Headley Way, Oxford OX3 9DU, England.
EM david.taggart@orh.nhs.uk
CR Abu-Omar Y, 2004, J THORAC CARDIOV SUR, V127, P1759, DOI 10.1016/j.jtves.2003.09.048
   Abu-Omar Y, 2002, LANCET, V360, P327, DOI 10.1016/S0140-6736(02)09557-0
   Abu-Omar Y, 2005, EUR J CARDIO-THORAC, V27, P893, DOI 10.1016/j.ejcts.2004.12.063
   Abu-Omar Y, 2006, J THORAC CARDIOV SUR, V132, P1119, DOI 10.1016/j.jtcvs.2006.04.057
   Al-Ruzzeh S, 2006, BRIT MED J, V332, P1365, DOI 10.1136/bmj.38852.479907.7C
   ALRUZZEH S, 2003, CIRCULATION S1, V108, P111
   Angelini GD, 2009, J THORAC CARDIOV SUR, V137, P295, DOI 10.1016/j.jtcvs.2008.09.046
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Ascione R, 2004, ANN THORAC SURG, V78, P26, DOI 10.1016/j.athorascur.2003.10.127
   Asimakopoulos G, 2006, ANN THORAC SURG, V81, P568, DOI 10.1016/j.athoracsur.2005.07.054
   Athanasiou T, 2004, ANN THORAC SURG, V77, P1567, DOI 10.1016/j.athoracsur.2003.10.040
   Bainbridge D, 2007, J THORAC CARDIOV SUR, V133, P623, DOI 10.1016/j.jtcvs.2006.11.019
   Balacumaraswami L, 2004, J THORAC CARDIOV SUR, V128, P238, DOI 10.1016/j.jtcvs.2003.11.072
   BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312
   Bowles BJ, 2001, CHEST, V119, P25, DOI 10.1378/chest.119.1.25
   Brown WR, 2000, STROKE, V31, P707
   Browne SM, 1999, J THORAC CARDIOV SUR, V117, P481, DOI 10.1016/S0022-5223(99)70327-2
   Bucerius J, 2004, J THORAC CARDIOV SUR, V127, P57, DOI 10.1016/S0022-5223(03)01281-9
   Bucerius J, 2004, ANN THORAC SURG, V77, P1250, DOI 10.1016/S0003-4975(03)01346-8
   Buffolo E, 1996, ANN THORAC SURG, V61, P63, DOI 10.1016/0003-4975(95)00840-3
   BUTLER J, 1993, J THORAC CARDIOV SUR, V105, P25
   Calafiore AM, 2003, EUR J CARDIO-THORAC, V24, P953, DOI 10.1016/S1010-7940(03)00572-4
   Calafiore AM, 2002, ANN THORAC SURG, V73, P1387, DOI 10.1016/S0003-4975(02)03470-7
   Caputo M, 2002, ANN THORAC SURG, V74, pS1403
   Caputo M, 2001, ANN THORAC SURG, V71, P1215, DOI 10.1016/S0003-4975(00)02686-2
   Cartier R, 2000, ANN THORAC SURG, V69, P1995, DOI 10.1016/S0003-4975(00)01470-3
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Chertow GM, 1997, CIRCULATION, V95, P878
   Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8
   Chukwuemeka A, 2005, ANN THORAC SURG, V80, P2148, DOI 10.1016/j.athoracsur.2005.06.015
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Arom I, 2001, ANN THORAC SURG, V72, P1288
   Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X
   Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9
   EDMUNDS LH, 1998, ANN THORAC SURG, V66, pS18
   Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x
   Gummert JF, 2004, THORAC CARDIOV SURG, V52, P70, DOI 10.1055/s-2004-817806
   Hammon JW, 2006, J THORAC CARDIOV SUR, V131, P114, DOI 10.1016/j.jtcvs.2005.08.057
   Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595
   Hindman BJ, 2002, HEART SURG FORUM, V5, P249
   Jenkins D, 2003, J CARDIAC SURG, V18, P419, DOI 10.1046/j.1540-8191.2003.02055.x
   JENKINS D, 2003, J CARDIOVASC SURG, V18, P418
   Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028
   Karolak W, 2007, AM HEART J, V153, P689, DOI 10.1016/j.ahj.2007.01.033
   Keenan TDL, 2005, CHEST, V128, P363, DOI 10.1378/chest.128.1.363
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kobayashi J, 2005, CIRCULATION, V112, P1338
   Kocakulak M, 2005, BLOOD PURIFICAT, V23, P263, DOI 10.1159/000085174
   KOLESSOV VI, 1967, J THORAC CARDIOV SUR, V54, P535
   Larmann Jan, 2004, Best Pract Res Clin Anaesthesiol, V18, P425
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Lev-Ran O, 2004, ANN THORAC SURG, V77, P102, DOI 10.1016/S0003-4975(03)01334-1
   Lim E, 2006, J THORAC CARDIOV SUR, V132, P1409, DOI 10.1016/j.jtcvs.2006.08.012
   Lingaas PS, 2006, ANN THORAC SURG, V81, P2089, DOI 10.1016/j.athoracsur.2005.12.003
   Loef BG, 2002, CHEST, V121, P1190, DOI 10.1378/chest.121.4.1190
   Lytle BW, 2004, CIRCULATION, V109, P810, DOI 10.1161/01.CIR.0000118642.28474.D2
   Mack MJ, 2004, J THORAC CARDIOV SUR, V127, P167, DOI 10.1016/j.jtcvs.2003.08.032
   Magee MJ, 2002, ANN THORAC SURG, V73, P1196, DOI 10.1016/S0003-4975(01)03587-1
   Magee MJ, 2008, ANN THORAC SURG, V85, P494, DOI 10.1016/j.athoracsur.2007.10.008
   Magee MJ, 2008, ANN THORAC SURG, V85, P499
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Mazzei V, 2007, CIRCULATION, V116, P1761, DOI 10.1161/CIRCULATIONAHA.107.697482
   Moller CH, 2008, EUR HEART J, V29, P2601, DOI 10.1093/eurheartj/ehn335
   Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2005, ANN THORAC SURG, V80, P2121, DOI 10.1016/j.athoracsur.2005.05.007
   Pegg TJ, 2008, CIRCULATION, V117, P2202, DOI 10.1161/CIRCULATIONAHA.107.735621
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   PUGSLEY W, 1994, STROKE, V25, P1393
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Racz MJ, 2004, J AM COLL CARDIOL, V43, P557, DOI 10.1016/j.jacc.2003.09.045
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2
   SEINES OA, 1999, LANCET, V353, P1601
   Sellke FW, 2005, CIRCULATION, V111, P2858, DOI 10.1161/CIRCULATIONAHA.105.165030
   Selvanayagam JB, 2004, CIRCULATION, V109, P345, DOI 10.1161/01.CIR.0000109489.71945.BD
   Sergeant P, 2004, EUR J CARDIO-THORAC, V25, P779, DOI 10.1016/j.ejcts.2004.02.013
   Sharony R, 2003, CIRCULATION, V108, P15, DOI 10.1161/01.cir.0000087448.65888.21
   Shennib H, 2001, ANN THORAC SURG, V72, pS993, DOI 10.1016/S0003-4975(01)02948-4
   Taggart D, 2004, J THORAC CARDIOV SUR, V127, P7, DOI 10.1016/j.jtcvs.2003.09.006
   Taggart DP, 1999, J THORAC CARDIOV SUR, V118, P414, DOI 10.1016/S0022-5223(99)70177-7
   Taggart DP, 2000, EUR J CARDIO-THORAC, V18, P31, DOI 10.1016/S1010-7940(00)00438-3
   Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X
   Taggart DP, 2001, CURR OPIN CARDIOL, V16, P271, DOI 10.1097/00001573-200109000-00003
   TAGGART DP, 1999, J THORAC CARDIOVASC, V118, P411
   Tang ATM, 2002, EUR J CARDIO-THORAC, V22, P118, DOI 10.1016/S1010-7940(02)00220-8
   Tang ATM, 2002, ANN THORAC SURG, V74, P372, DOI 10.1016/S0003-4975(02)03715-3
   van der Heijden GJMG, 2004, EUR J CARDIO-THORAC, V26, P81, DOI 10.1016/j.ejcts.2004.03.032
   van de Wal RMA, 2005, J THORAC CARDIOV SUR, V129, P330, DOI 10.1016/j.jtcvs.2004.06.038
   Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Wan S, 1999, ANN THORAC SURG, V68, P52, DOI 10.1016/S0003-4975(99)00315-X
   Weerasinghe A, 2001, J THORAC CARDIOV SUR, V121, P1083, DOI 10.1067/mtc.2001.113022
   Weerasinghe A, 2005, ANN THORAC SURG, V79, P1577, DOI 10.1016/j.athorascur.2004.11.043
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   Zakeri R, 2005, CIRCULATION, V112, P1270
   Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268
   ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489
NR 104
TC 30
Z9 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD AUG
PY 2009
VL 36
IS 2
BP 312
EP 321
DI 10.1016/j.ejcts.2009.03.025
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 485RJ
UT WOS:000269141100014
PM 19608042
ER

PT J
AU Feng, ZZ
   Shi, J
   Zhao, XW
   Xu, ZF
AF Feng, Zheng-Zhe
   Shi, Jian
   Zhao, Xue-Wei
   Xu, Zhi-Fei
TI Meta-Analysis of On-Pump and Off-Pump Coronary Arterial
   Revascularization
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIALS; BYPASS GRAFT-SURGERY; QUALITY; OUTCOMES;
   MORBIDITY; STATEMENT; PATENCY; TERM
AB Background. There is no agreement whether off-pump coronary artery bypass (OPCAB) can reduce mortality, rates of stroke, myocardial infarction, or revascularization when compared with conventional coronary artery bypass (CCAB). We performed a meta-analysis comparing off-pump coronary artery bypass with conventional coronary artery bypass in randomized controlled trials.
   Methods. We comprehensively retrieved randomized controlled studies according to predetermined criteria. We performed meta-analyses for each outcome and empirically determined whether potential biases that might result from differences in study design or patient characteristics actually biased the results of a study. We also conducted sensitivity analyses and tested for publication bias.
   Results. We undertook a meta-analysis of ten randomized trials (2,018 patients) of OPCAB surgery versus CCAB surgery. No significant differences were found for 1-year mortality odds ratio [OR], 1.00; 95% confidence interval [CI], 0.75 to 1.33), myocardial infarction OR, 0.61; 95% CI, 0.44 to 0.84), stroke OR, 0.56; 95% CI, 0.34 to 0.91), or revascularization OR, 1.38; 95% CI, 1.00 to 1.92). Therefore, this meta-analysis demonstrates that mortality, stroke, myocardial infarction, and revascularization were not reduced in OPCAB.
   Conclusions. In conclusion, OPCAB did not significantly reduce 1-year mortality, stroke, myocardial infarction, and revascularization compared with CCAB.
C1 [Zhao, Xue-Wei] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac Surg, Shanghai 200003, Peoples R China.
   Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Gastroenterol, Shanghai 200003, Peoples R China.
RP Zhao, XW (reprint author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Thorac Surg, Fengyang Rd 415, Shanghai 200003, Peoples R China.
EM jimmy-rockingboy@163.com
CR Alderson P, 2004, COCHRANE REV HDB 4 2
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Choi PTL, 2001, ANESTH ANALG, V92, P700
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   EAGLE KA, 2004, ACC AHA 2004 GUIDELI
   Egger M, 1997, BRIT MED J, V315, P629
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Karolak W, 2007, AM HEART J, V153, P689, DOI 10.1016/j.ahj.2007.01.033
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Lingaas PS, 2006, ANN THORAC SURG, V81, P2089, DOI 10.1016/j.athoracsur.2005.12.003
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   PAUL SR, 1992, STAT MED, V11, P159, DOI 10.1002/sim.4780110203
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   THOM T, 2006, CIRCULATION, V113, pE81
   Tramer MR, 1997, BRIT MED J, V315, P635
   VANSWIETEN JC, 1988, STROKE, V19, P604
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
NR 26
TC 30
Z9 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
EI 1552-6259
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAR
PY 2009
VL 87
IS 3
BP 757
EP 765
DI 10.1016/j.athoracsur.2008.11.042
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 413KE
UT WOS:000263791200014
PM 19231385
ER

PT J
AU Magne, J
   Senechal, M
   Dumesnil, JG
   Pibarot, P
AF Magne, Julien
   Senechal, Mario
   Dumesnil, Jean G.
   Pibarot, Philippe
TI Ischemic Mitral Regurgitation: A Complex Multifaceted Disease
SO CARDIOLOGY
LA English
DT Review
DE Mitral regurgitation; Ischemia; Left ventricular dysfunction
ID ACUTE MYOCARDIAL-INFARCTION; CARDIAC RESYNCHRONIZATION THERAPY;
   CONGESTIVE-HEART-FAILURE; LONG-TERM SURVIVAL; LEFT-VENTRICULAR
   DYSFUNCTION; QUANTITATIVE DOPPLER ASSESSMENT; END-STAGE CARDIOMYOPATHY;
   VENA CONTRACTA WIDTH; VALVE REPAIR; PROGNOSTIC-SIGNIFICANCE
AB Ischemic mitral regurgitation (MR) is a complex multifactorial disease that involves global and regional left ventricular remodeling as well as dysfunction and distortion of the components of the mitral valve including the chordae, annulus and leaflets. This is a frequent (13-59%) complication of myocardial infarction, which is associated with a poor prognosis. The suboptimal results obtained with the most commonly used surgical strategy, that is, restrictive annuloplasty combined with coronary artery bypass graft, emphasize the need to develop alternative or concomitant surgical techniques that directly target the causal mechanisms of the disease. A comprehensive assessment of mitral valve configuration and left ventricular geometry and function prior to surgery as well as an accurate quantification of MR severity at rest and during exercise may help improve patient risk stratification and better individualize the surgical strategy based on the patient's specific characteristics. The purpose of this review is to summarize the current state of knowledge with regard to the definition, prevalence, mechanisms, outcome and treatment of ischemic MR. Copyright (C) 2008 S. Karger AG, Basel
C1 [Pibarot, Philippe] Univ Laval, Fac Med, Quebec Heart Inst, Laval Hosp Res Ctr,Dept Cardiol, Quebec City, PQ G1V 4G5, Canada.
RP Pibarot, P (reprint author), Univ Laval, Fac Med, Quebec Heart Inst, Laval Hosp Res Ctr,Dept Cardiol, 2725 Chemin St Foy, Quebec City, PQ G1V 4G5, Canada.
EM philippe.pibarot@med.ulaval.ca
FU Canadian Institutes of Health Research (Ottawa, Canada)
FX Dr. Pibarot holds the Canada Research Chair in Valvular Heart Diseases,
   Canadian Institutes of Health Research (Ottawa, Canada).
CR Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168
   Agricola Eustachio, 2004, Eur J Echocardiogr, V5, P326, DOI 10.1016/j.euje.2004.03.001
   Aklog L, 2001, CIRCULATION, V104, pI68
   ALAM M, 1993, CLIN CARDIOL, V16, P30
   Al-Radi OO, 2005, ANN THORAC SURG, V79, P1260, DOI 10.1016/j.athoracsur.2004.09.044
   Auricchio A, 2002, J AM COLL CARDIOL, V39, P2026, DOI 10.1016/S0735-1097(02)01895-8
   BACH DS, 1995, AM HEART J, V129, P1165, DOI 10.1016/0002-8703(95)90399-2
   BARZILAI B, 1988, AM J CARDIOL, V61, P220, DOI 10.1016/0002-9149(88)90919-8
   BARZILAI B, 1990, AM J CARDIOL, V65, P1169, DOI 10.1016/0002-9149(90)90968-7
   Bax J, 2004, CIRCULATION S2, V110, pII, DOI 10.1161/01.CIR.0000138196.06772.4e
   BOLLING SF, 1995, J THORAC CARDIOV SUR, V109, P676, DOI 10.1016/S0022-5223(95)70348-9
   Borger MA, 2007, J THORAC CARDIOV SUR, V133, P1483, DOI 10.1016/j.jtcvs.2007.01.064
   Braun J, 2005, EUR J CARDIO-THORAC, V27, P847, DOI 10.1016/j.ejcts.2004.12.031
   Breithardt OA, 2003, J AM COLL CARDIOL, V41, P765, DOI 10.1016/S0735-1097(02)02937-6
   BURCH GE, 1963, ARCH INTERN MED, V112, P112
   Bursi F, 2005, CIRCULATION, V111, P295, DOI 10.1161/01.CIR.0000151097.30779.04
   Calafiore AM, 2001, ANN THORAC SURG, V71, P1146, DOI 10.1016/S0003-4975(00)02650-3
   Capomolla S, 2000, AM HEART J, V139, P596, DOI 10.1016/S0002-8703(00)90036-X
   CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323
   COHN LH, 1995, EUR J CARDIO-THORAC, V9, P568, DOI 10.1016/S1010-7940(05)80008-9
   Daimon M, 2006, CIRCULATION, V114, P1588, DOI 10.1161/CIRCULATIONAHA.105.001347
   D'Andrea A, 2007, EUR HEART J, V28, P1004, DOI 10.1093/eurheartj/ehm021
   De Bonis M, 2005, CIRCULATION S1, V112, pI402
   Dent JM, 1995, AM J PHYSIOL-HEART C, V269, pH2100
   Diaz-Infante E, 2005, AM J CARDIOL, V95, P1436, DOI 10.1016/j.amjcard.2005.02.009
   Digiammarco Gabriele, 2007, Interact Cardiovasc Thorac Surg, V6, P340, DOI 10.1510/icvts.2006.146274
   Diodato MD, 2004, ANN THORAC SURG, V78, P794, DOI 10.1016/j.athoracsur.2004.03.022
   Doughty RN, 1997, J AM COLL CARDIOL, V29, P1060
   Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94
   Ellis SG, 2002, AM J CARDIOL, V89, P315, DOI 10.1016/S0002-9149(01)02231-7
   Ereminiene E, 2005, ECHOCARDIOGR-J CARD, V22, P217, DOI 10.1111/j.0742-2822.2005.03108.x
   FEHSKE W, 1994, AM J CARDIOL, V73, P268, DOI 10.1016/0002-9149(94)90232-1
   Feinberg MS, 2000, AM J CARDIOL, V86, P903, DOI 10.1016/S0002-9149(00)01119-X
   Gelsomino S, 2008, EUR HEART J, V29, P231
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Golia G, 2001, INT J CARDIOL, V78, P81, DOI 10.1016/S0167-5273(00)00476-9
   Grayburn PA, 2008, HEART, V94, P376, DOI 10.1136/hrt.2005.086462
   Green GR, 1999, ANN THORAC SURG, V68, P2100, DOI 10.1016/S0003-4975(99)01175-3
   GREENBERG B, 1995, CIRCULATION, V91, P2573
   Grigioni F, 1999, CIRCULATION, V100, P378
   Grigioni F, 2001, CIRCULATION, V103, P1759
   Grigioni F, 2005, J AM COLL CARDIOL, V45, P260, DOI 10.1016/j.jacc.2004.10.030
   Grossi EA, 2006, J THORAC CARDIOV SUR, V131, P1095, DOI 10.1016/j.jtcvs.2005.11.046
   Grossi EA, 2001, J CARDIAC SURG, V16, P328, DOI 10.1111/j.1540-8191.2001.tb00530.x
   Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945
   Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0
   HAMILTON MA, 1991, AM J CARDIOL, V67, P259, DOI 10.1016/0002-9149(91)90556-Z
   HICKEY MS, 1988, CIRCULATION, V78, P51
   Hung J, 2002, CIRCULATION, V106, P2594, DOI 10.1161/01.CIR.0000038363.83133.6D
   Hung J, 2004, CIRCULATION S2, V110, pII85, DOI 10.1161/01.CIR.0000138192.65015.45
   Kang DH, 2006, CIRCULATION S, V114, DOI 10.1161/CIRCULATIONAHA.105.000398
   Kanzaki H, 2004, J AM COLL CARDIOL, V44, P1619, DOI 10.1016/j.jacc.2004.07.036
   KAUL S, 1991, CIRCULATION, V84, P2167
   KEREN G, 1986, AM HEART J, V112, P517, DOI 10.1016/0002-8703(86)90516-8
   Kizilbash AM, 1998, J AM COLL CARDIOL, V32, P427, DOI 10.1016/S0735-1097(98)00236-8
   Koelling TM, 2002, AM HEART J, V144, P524, DOI 10.1067/mhj.2002.123575
   Kongsaerepong V, 2006, AM J CARDIOL, V98, P504, DOI 10.1016/j.amjcard.2006.02.056
   KONSTAM MA, 1993, CIRCULATION, V88, P2277
   Kuwahara E, 2006, CIRCULATION S1, V114, pI, DOI 10.1161/CIRCULATIONAHA.105.000729
   Lam BK, 2005, ANN THORAC SURG, V79, P462, DOI 10.1019/j.athoracsur.2004.07.040
   Lamas GA, 1997, CIRCULATION, V96, P827
   Lancellotti P, 2004, AM J CARDIOL, V94, P1462, DOI 10.1016/j.amjcard.2004.07.154
   Lancellotti P, 2005, EUR HEART J, V26, P1528, DOI 10.1093/eurheartj/ehi189
   Lancellotti P, 2003, CIRCULATION, V108, P1713, DOI 10.1161/01.CIR.0000087599.49332.05
   LEHMANN KG, 1992, ANN INTERN MED, V117, P10
   LEOR J, 1993, J AM COLL CARDIOL, V21, P1661
   Lesniak-Sobelga A, 2004, J HEART VALVE DIS, V13, P608
   Levine AB, 1998, AM J CARDIOL, V82, P1299, DOI 10.1016/S0002-9149(98)00623-7
   Levine RA, 2004, NEW ENGL J MED, V351, P1681, DOI 10.1056/NEJMe048165
   LOPERFIDO F, 1986, AM J CARDIOL, V58, P692, DOI 10.1016/0002-9149(86)90339-5
   Lowes BD, 1999, AM J CARDIOL, V83, P1201, DOI 10.1016/S0002-9149(99)00059-4
   Madaric J, 2007, EUR HEART J, V28, P2134, DOI 10.1093/eurheartj/ehm2133
   Magne J, 2008, J AM COLL CARDIOL, V51, P1692, DOI 10.1016/j.jacc.2007.11.082
   Magne J, 2007, CIRCULATION, V115, P782, DOI 10.1161/CIRCULATIONAHA.106.649236
   Maselli D, 2006, CIRCULATION, V114, P377, DOI 10.1161/CIRCULATIONAHA.105.609883
   Matsunaga A, 2004, J HEART VALVE DIS, V13, P390
   MCCULLY RB, 1994, AM J CARDIOL, V74, P790, DOI 10.1016/0002-9149(94)90436-7
   McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037
   Messas E, 2003, CIRCULATION, V108, P111, DOI 10.1161/01.cir.0000087658.47544.7f
   Messas E, 2006, CIRCULATION S, V114, P524, DOI 10.1161/CIRCULATIONAHA.105.000612
   Mihaljevic T, 2007, J AM COLL CARDIOL, V49, P2191, DOI 10.1016/j.jacc.2007.02.043
   Neskovic AN, 1999, AM J CARDIOL, V84, P329, DOI 10.1016/S0002-9149(99)00287-8
   PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204
   Pierard LA, 2004, NEW ENGL J MED, V351, P1627, DOI 10.1056/NEJMoa040532
   Pierard LA, 2007, HEART, V93, P766, DOI 10.1136/hrt.2005.074815
   Prifti E, 2001, J CARDIAC SURG, V16, P473, DOI 10.1111/j.1540-8191.2001.tb00552.x
   Reece TB, 2004, ANN SURG, V239, P671, DOI 10.1097/sla.0000124297.40815.86
   Remme WJ, 2004, CARDIOVASC DRUG THER, V18, P57, DOI 10.1023/B:CARD.0000025756.32499.6f
   Rodriguez F, 2004, CIRCULATION S1, V110, DOI 10.1161/01.CIR.0000138580.57971.b4
   Rosario LB, 1998, J AM COLL CARDIOL, V32, P1819, DOI 10.1016/S0735-1097(98)00461-6
   Roshanali F, 2007, ANN THORAC SURG, V84, P745, DOI 10.1016/j.athoracsur.2007.04.106
   Ryden T, 2001, EUR J CARDIO-THORAC, V20, P276, DOI 10.1016/S1010-7940(01)00770-9
   Serri K, 2006, J THORAC CARDIOV SUR, V131, P565, DOI 10.1016/j.jtcvs.2005.09.037
   St John SM, 1997, CIRCULATION, V96, P3294
   Sutton MGS, 2006, CIRCULATION, V113, P266, DOI 10.1161/CIRCULATIONAHA.104.520817
   Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9
   Tahta SA, 2002, J HEART VALVE DIS, V11, P11
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Tops LF, 2007, CIRCULATION, V115, P1426, DOI 10.1161/CIRCULATIONAHA.106.677880
   VanDantzig JM, 1996, AM HEART J, V131, P865, DOI 10.1016/S0002-8703(96)90166-0
   von Oppell UO, 2000, J HEART VALVE DIS, V9, P64
   Webb JG, 2006, CIRCULATION, V113, P851, DOI 10.1161/CIRCULATIONAHA.105.591602
   Wong DR, 2005, ANN THORAC SURG, V80, P570, DOI 10.1016/j.athoracsur.2005.03.034
   Yiu SF, 2000, CIRCULATION, V102, P1400
   Zhu F, 2005, CIRCULATION, V112
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
NR 106
TC 30
Z9 32
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0008-6312
J9 CARDIOLOGY
JI Cardiology
PY 2009
VL 112
IS 4
BP 244
EP 259
DI 10.1159/000151693
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 377ZY
UT WOS:000261292100002
PM 18758181
ER

PT J
AU Abu-Omar, Y
   Ratnatunga, C
AF Abu-Omar, Yasir
   Ratnatunga, Chandana
TI Cardiopulmonary bypass and renal injury
SO PERFUSION-UK
LA English
DT Article; Proceedings Paper
CT Hammersmith Perfusion Workshop 2005
CY DEC   09, 2005
CL Hammersmith, ENGLAND
ID PUMP CORONARY REVASCULARIZATION; RANDOMIZED CONTROLLED-TRIAL;
   BINDING-PROTEIN RBP; HIGH-RISK PATIENTS; CARDIAC-SURGERY; OFF-PUMP;
   CYSTATIN-C; ON-PUMP; REPLACEMENT THERAPY; APROTININ TRASYLOL
AB Renal dysfunction following cardiopulmonary bypass (CPB) is well recognized. The extent of perioperative renal impairment ranges from subclinical injury to established renal failure requiring dialysis. Its incidence varies considerably, depending on the definition and criteria used in the different studies. Acute renal failure (ARF) affects 1-5% of patients and remains a major cause of morbidity and mortality. Co-morbidities, including diabetes mellitus, impaired left ventricular function and advanced age, are recognized predisposing factors. The pathophysiology is multifactorial and is thought related to the systemic inflammatory response and renal hypoperfusion secondary to extracorporeal circulation. Non-pulsatile flow during CPB is thought to be an important aetiological factor, resulting in renal vasoconstriction and ischaemic renal injury. A theoretical reduction in the incidence and severity of postoperative renal impairment has been proposed by advocating the use of pulsatile flow during CPB, or eliminating CPB, especially in high-risk patients. The current evidence, however, is conflicting. Several large observational studies, including a large proportion of high-risk patients, have demonstrated a significant reduction in the frequency of renal failure in patients undergoing off-pump surgery. As older, sicker patients increasingly constitute the cardiac surgical population, the incidence of postoperative renal injury is likely to increase. Further studies addressing various renoprotective strategies in higher-risk patients are awaited.
C1 John Radcliffe Hosp, Dept Cardiothorac Surg, Oxford OX3 9DU, England.
   Hammersmith Hosp, Dept Cardiothorac Surg, London W12 0HS, England.
RP Ratnatunga, C (reprint author), John Radcliffe Hosp, Dept Cardiothorac Surg, Oxford OX3 9DU, England.
EM chandi.ratnatunga@orh.nhs.uk
CR Abu-Omar Y, 2002, LANCET, V360, P327, DOI 10.1016/S0140-6736(02)09557-0
   Abu-Omar Y, 2005, EUR J CARDIO-THORAC, V27, P893, DOI 10.1016/j.ejcts.2004.12.063
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   ASIMAKOPOULOS G, 2000, ANN THORAC SURG, V69, P192
   Asimakopoulos G, 2000, J THORAC CARDIOV SUR, V120, P361, DOI 10.1067/mtc.2000.106323
   BARBUT D, 1994, STROKE, V25, P2398
   Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X
   Boldt J, 2003, ANN THORAC SURG, V75, P906, DOI 10.1016/S0003-4975(02)04559-9
   BOVE T, 2004, J CARDIOTHOR VASC AN, V8, P442
   Brooker RF, 1998, ANN THORAC SURG, V65, P1651, DOI 10.1016/S0003-4975(98)00289-6
   Bucerius J, 2004, ANN THORAC SURG, V77, P1250, DOI 10.1016/S0003-4975(03)01346-8
   Burns KEA, 2005, JAMA-J AM MED ASSOC, V294, P342, DOI 10.1001/jama.294.3.342
   Cartier R, 2000, ANN THORAC SURG, V69, P1995, DOI 10.1016/S0003-4975(00)01470-3
   Chertow GM, 1997, CIRCULATION, V95, P878
   Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8
   Chukwuemeka A, 2005, ANN THORAC SURG, V80, P2148, DOI 10.1016/j.athoracsur.2005.06.015
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   CORWIN HL, 1989, J THORAC CARDIOV SUR, V98, P1107
   DAmbra MN, 1996, J THORAC CARDIOV SUR, V112, P1081, DOI 10.1016/S0022-5223(96)70110-1
   Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x
   Gummert JF, 2004, THORAC CARDIOV SURG, V52, P70, DOI 10.1055/s-2004-817806
   HILBERMAN M, 1980, J THORAC CARDIOV SUR, V79, P838
   Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028
   Kazama JJ, 2002, NEPHRON, V91, P13, DOI 10.1159/000057599
   Keenan TDL, 2005, CHEST, V128, P363, DOI 10.1378/chest.128.1.363
   Kher A, 2005, J THORAC CARDIOV SUR, V130, P662, DOI 10.1016/j.jtcvs.2005.02.035
   Kocakulak M, 2005, BLOOD PURIFICAT, V23, P263, DOI 10.1159/000085174
   Landis RC, 2001, HEART SURG FORUM, V4, pS35
   Landis RC, 2001, ANN THORAC SURG, V72, P2169, DOI 10.1016/S0003-4975(01)02821-1
   Lassnigg A, 2000, J AM SOC NEPHROL, V11, P97
   LEMMER JH, 1995, ANN THORAC SURG, V59, P132, DOI 10.1016/0003-4975(94)00813-M
   Lim E, 2002, ANN THORAC SURG, V73, P153, DOI 10.1016/S0003-4975(01)03311-2
   Loef BG, 2002, CHEST, V121, P1190, DOI 10.1378/chest.121.4.1190
   Loef BG, 2004, BRIT J ANAESTH, V93, P793, DOI 10.1093/bja/aeh266
   MAGEE MJ, 2002, ANN THORAC SURG, V73, P196
   Connolly MW, 2002, ANN THORAC SURG, V73, P1202
   Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379
   Mathur VS, 1999, CRIT CARE MED, V27, P1832, DOI 10.1097/00003246-199909000-00021
   Mussap M, 2002, KIDNEY INT, V61, P1453, DOI 10.1046/j.1523-1755.2002.00253.x
   Page MK, 2000, CLIN CHIM ACTA, V297, P67, DOI 10.1016/S0009-8981(00)00234-5
   PERRONE RD, 1992, CLIN CHEM, V38, P1933
   PRICE RG, 1992, EUR J CLIN CHEM CLIN, V30, P693
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Rinder CS, 2003, ANN THORAC SURG, V75, P899, DOI 10.1016/S0003-4975(02)04490-9
   Sheinbaum Roy, 2003, Rev Cardiovasc Med, V4 Suppl 1, pS21
   Sirivella S, 2000, ANN THORAC SURG, V69, P501, DOI 10.1016/S0003-4975(99)01298-9
   Taggart DP, 2003, J THORAC CARDIOV SUR, V126, P1087, DOI 10.1016/S0022-5223(03)00961-9
   Von Oppell U, 1999, EUR J CARDIO-THORAC, V15, P721
   Tang ATM, 2002, EUR J CARDIO-THORAC, V22, P118, DOI 10.1016/S1010-7940(02)00220-8
   Tang ATM, 2002, ANN THORAC SURG, V74, P372, DOI 10.1016/S0003-4975(02)03715-3
   Tang ATM, 1999, EUR J CARDIO-THORAC, V15, P717, DOI 10.1016/S1010-7940(99)00081-0
   Taylor KM, 1996, ANN THORAC SURG, V61, P1607
   Thakar CV, 2005, J AM SOC NEPHROL, V16, P162
   Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0
   Tian S, 1997, CLIN NEPHROL, V48, P104
   van de Wal RMA, 2005, J THORAC CARDIOV SUR, V129, P330, DOI 10.1016/j.jtcvs.2004.06.038
   Weerasinghe A, 2001, J THORAC CARDIOV SUR, V121, P1083, DOI 10.1067/mtc.2001.113022
   Woo EBC, 2002, EUR J CARDIO-THORAC, V22, P106, DOI 10.1016/S1010-7940(02)00246-4
   ZAKERI R, 2005, CIRCULATION, V12, P1270
   ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489
NR 62
TC 30
Z9 34
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PY 2006
VL 21
IS 4
BP 209
EP 213
DI 10.1191/0267659106pf870oa
PG 5
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 075ZR
UT WOS:000239927300003
PM 16939114
ER

PT J
AU Abu-Omar, Y
   Mussa, S
   Naik, MJ
   MacCarthy, N
   Standing, S
   Taggart, DP
AF Abu-Omar, Y
   Mussa, S
   Naik, MJ
   MacCarthy, N
   Standing, S
   Taggart, DP
TI Evaluation of Cystatin C as a marker of renal injury following on-pump
   and off-pump coronary surgery
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE renal injury; cardiopulmonary bypass; coronary artery bypass grafting;
   off-pump
ID BEATING-HEART; RISK-STRATIFICATION; CARDIAC OPERATION; FAILURE;
   REVASCULARIZATION; DYSFUNCTION; CREATININE; MORTALITY; DISEASES;
   OUTCOMES
AB Objective: Cardiopulmonary bypass is regarded as an important contributor to renal injury, whereas off-pump surgery is considered less damaging. Cystatin C, a cystine protease inhibitor, is more sensitive and specific than creatinine in the assessment of renal function. We assessed the value of Cystatin C in quantifying clinical and subclinical renal injury following on-pump and off-pump cardiac surgery. Methods: Sixty consecutive patients were recruited: 30 patients undergoing on-pump CABG and 30 patients undergoing off-pump CABG. Blood samples were collected pre-operatively and on days 1, 2 and 4 postoperatively to measure serum creatinine and serum Cystatin C. Urinary samples were collected concurrently to measure microalbumin and N-acetyl-&beta;-glucosaminidase, denoting changes in renal glomerular and tubular function respectively. Results: The off-pump group were older (65 &PLUSMN; 11 vs. 61 &PLUSMN; 8 years; P = 0.046), had a higher mean Parsonnet score (9.4 &PLUSMN; 6.2 vs. 5.4 &PLUSMN; 3.6, P &LT; 0.01) and received fewer grafts (2.4 &PLUSMN; 0.9 vs. 3.1 &PLUSMN; 0.7; P &LT; 0.01) compared to the on-pump group. The groups were otherwise matched with respect to preoperative renal function and left ventricular function. Patients undergoing on-pump CABG had greater increases in all four parameters of renal injury. Adjustment for preoperative differences increased the size and significance of the effect of off-pump vs. on-pump surgery (percent difference 13%; 95% CI 2-26 for creatinine, and 16%; 95% CI 4-29 for Cystatin C). Cystatin and creatinine were strongly correlated with each other. Conclusions: Avoidance of cardiopulmonary bypass may reduce renal injury particularly in higher risk patients. Cystatin C proved to be a simple and sensitive measure of overall renal function and can be used in the routine assessment of renoprotective strategies. &COPY; 2005 Elsevier B.V. All. rights reserved.
C1 John Radcliffe Hosp, Dept Cardiothorac Surg, Oxford OX3 9DU, England.
   Univ Oxford, Dept Med Stat, Oxford, England.
   John Radcliffe Hosp, Dept Clin Biochem, Oxford OX3 9DU, England.
RP Taggart, DP (reprint author), John Radcliffe Hosp, Dept Cardiothorac Surg, Oxford OX3 9DU, England.
EM david.taggart@orh.nhs.uk
RI McCarthy, Noel/K-3314-2012
CR Abu-Omar Y, 2002, LANCET, V360, P327, DOI 10.1016/S0140-6736(02)09557-0
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4
   Cartier R, 2000, ANN THORAC SURG, V69, P1995, DOI 10.1016/S0003-4975(00)01470-3
   Chertow GM, 1997, CIRCULATION, V95, P878
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   CORWIN HL, 1989, J THORAC CARDIOV SUR, V98, P1107
   Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x
   HILBERMAN M, 1980, J THORAC CARDIOV SUR, V79, P838
   Kazama JJ, 2002, NEPHRON, V91, P13, DOI 10.1159/000057599
   Loef BG, 2002, CHEST, V121, P1190, DOI 10.1378/chest.121.4.1190
   Mack M, 2002, J THORAC CARDIOV SUR, V124, P598, DOI 10.1067/mtc.2002.124884
   Magee MJ, 2002, ANN THORAC SURG, V73, P1196, DOI 10.1016/S0003-4975(01)03587-1
   Mussap M, 2002, KIDNEY INT, V61, P1453, DOI 10.1046/j.1523-1755.2002.00253.x
   Page MK, 2000, CLIN CHIM ACTA, V297, P67, DOI 10.1016/S0009-8981(00)00234-5
   PERRONE RD, 1992, CLIN CHEM, V38, P1933
   PRICE RG, 1992, EUR J CLIN CHEM CLIN, V30, P693
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Reston JT, 2003, ANN THORAC SURG, V76, P1510, DOI 10.1016/S0003-4975(03)01195-0
   Shennib H, 2001, ANN THORAC SURG, V72, pS993, DOI 10.1016/S0003-4975(01)02948-4
   Taggart DP, 2001, CURR OPIN CARDIOL, V16, P271, DOI 10.1097/00001573-200109000-00003
   Tang ATM, 2002, EUR J CARDIO-THORAC, V22, P118, DOI 10.1016/S1010-7940(02)00220-8
   Tian S, 1997, CLIN NEPHROL, V48, P104
   ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489
NR 24
TC 30
Z9 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD MAY
PY 2005
VL 27
IS 5
BP 893
EP 898
DI 10.1016/j.ejcts.2004.12.063
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 930KB
UT WOS:000229413600046
PM 15848332
ER

PT J
AU Berr, F
AF Berr, F
TI Photodynamic therapy for cholangiocarcinoma
SO SEMINARS IN LIVER DISEASE
LA English
DT Review
DE bile duct cancer; cholangiocarcinoma; hematoporphyrin derivative;
   photodynamic therapy; photosensitizer; porfimer sodium
ID BILE-DUCT CANCER; MALIGNANT BILIARY OBSTRUCTION; ENDOSCOPIC RETROGRADE
   CHOLANGIOPANCREATOGRAPHY; NONRESECTABLE HILAR CHOLANGIOCARCINOMA; SEVERE
   ACUTE CHOLANGITIS; LONG-TERM SURVIVAL; RADIATION-THERAPY; TRACT CANCER;
   PHASE-II; ENDOPROSTHESIS INSERTION
AB The prognosis of perihilar cholangiocarcinoma (CC) is limited by tumor spread along the biliary tree leading to refractory obstructive cholestasis, cholangitis, and liver failure. Palliation with biliary endoprostheses yields median survival times between 4 and 6 months for nonresectable CC. Tumor ablation with photodynamic therapy (PDT) combined with biliary stenting reduces cholestasis and significantly improves median survival time to 11.5 to 16.2 months. PDT with porfimer and laser light of 630 nm provides tumoricidal tissue penetration to a depth of only 4 to 4.5 turn that does not eradicate most tumors. Time to progression lasts approximately 6 months; in other words, PDT is required twice annually. PDT costs less and enhances quality of life and survival time as compared with chemotherapy for metastatic colon cancer. These data suggest that PDT should be offered as part of the palliative treatment of CC in hepatobiliary referral centers.
C1 Paracelsus Med Univ, Dept Med 1, Landeskrankenanstalten Salzburg, A-5020 Salzburg, Austria.
   Paracelsus Med Univ, Dept Internal Med 1, Landeskrankenanstalten Salzburg, A-5020 Salzburg, Austria.
RP Berr, F (reprint author), Paracelsus Med Univ, Dept Med 1, Landeskrankenanstalten Salzburg, Haupstr 48, A-5020 Salzburg, Austria.
EM f.berr@lks.at
CR Berr F, 2000, J HEPATOL, V32, P352, DOI 10.1016/S0168-8278(00)80083-5
   Berr F, 2000, HEPATOLOGY, V31, P291, DOI 10.1002/hep.510310205
   BISMUTH H, 1992, ANN SURG, V215, P31
   Born P, 1999, ENDOSCOPY, V31, P748
   Bowling TE, 1996, GUT, V39, P852, DOI 10.1136/gut.39.6.852
   Bown SG, 2002, GUT, V50, P549, DOI 10.1136/gut.50.4.549
   Burke EC, 1998, ANN SURG, V228, P385, DOI 10.1097/00000658-199809000-00011
   Chang WH, 1998, GASTROINTEST ENDOSC, V47, P354, DOI 10.1016/S0016-5107(98)70218-4
   DAVIDS PHP, 1992, LANCET, V340, P1488, DOI 10.1016/0140-6736(92)92752-2
   de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807
   DEVIERE J, 1988, GASTROINTEST ENDOSC, V34, P95, DOI 10.1016/S0016-5107(88)71271-7
   De Vreede I, 2000, LIVER TRANSPLANT, V6, P309, DOI 10.1053/lv.2000.6143
   Dougherty TJ, 1998, J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889
   DUCREUX M, 1992, DIGEST DIS SCI, V37, P778, DOI 10.1007/BF01296439
   Dumoulin FL, 2003, GASTROINTEST ENDOSC, V57, P860, DOI 10.1067/mge.2003.250
   EDE RJ, 1989, BRIT J SURG, V76, P867, DOI 10.1002/bjs.1800760834
   EDELL ES, 1992, CHEST, V102, P1319, DOI 10.1378/chest.102.5.1319
   Eschelman DJ, 1996, RADIOLOGY, V200, P717
   FARLEY DR, 1995, MAYO CLIN PROC, V70, P425
   Foo ML, 1997, INT J RADIAT ONCOL, V39, P929, DOI 10.1016/S0360-3016(97)00299-X
   Gores GJ, 2003, GASTROENTEROLOGY, V125, P1536, DOI 10.1053/S0016-5085(03)01401-X
   Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200
   HAYATA Y, 1984, LASER SURG MED, V4, P39, DOI 10.1002/lsm.1900040106
   HENSON DE, 1992, CANCER, V70, P1498, DOI 10.1002/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C
   Hsi RA, 1999, DRUGS, V57, P725, DOI 10.2165/00003495-199957050-00005
   Jarnagin WR, 2001, ANN SURG, V234, p[507, 517]
   Kamada T, 1996, INT J RADIAT ONCOL, V34, P767, DOI 10.1016/0360-3016(95)02132-9
   Kaya M, 2001, AM J GASTROENTEROL, V96, P1164
   KIMURA W, 1993, HEPATO-GASTROENTEROL, V40, P21
   KLATSKIN G, 1965, AM J MED, V38, P241, DOI 10.1016/0002-9343(65)90178-6
   Kluge R, 2001, HEPATOLOGY, V33, P1029, DOI 10.1053/jhep.2001.23912
   Kosuge T, 1999, ANN SURG, V230, P663, DOI 10.1097/00000658-199911000-00008
   KUVSHINOFF BW, 1995, BRIT J SURG, V82, P1522, DOI 10.1002/bjs.1800821122
   LAI ECS, 1990, SURGERY, V107, P268
   LAI ECS, 1992, NEW ENGL J MED, V326, P1582, DOI 10.1056/NEJM199206113262401
   Launois B, 1999, ANN SURG, V230, P266, DOI 10.1097/00000658-199908000-00018
   Liu CL, 1998, ARCH SURG-CHICAGO, V133, P293, DOI 10.1001/archsurg.133.3.293
   Madriaga JB, 1998, ANN SURG, V227, P70
   MCCAUGHAN JS, 1991, ARCH SURG-CHICAGO, V126, P111
   MOLT P, 1986, CANCER, V57, P536, DOI 10.1002/1097-0142(19860201)57:3<536::AID-CNCR2820570322>3.0.CO;2-L
   Murad AM, 2003, AM J CLIN ONCOL-CANC, V26, P151, DOI 10.1097/00000421-200304000-00010
   Neuhaus P, 1999, ANN SURG, V230, P808, DOI 10.1097/00000658-199912000-00010
   Oertel M, 2003, J PHOTOCH PHOTOBIO B, V71, P1, DOI 10.1016/S1011-1344(03)00091-5
   Ortner MAEJ, 1998, GASTROENTEROLOGY, V114, P536, DOI 10.1016/S0016-5085(98)70537-2
   Ortner MEJ, 2003, GASTROENTEROLOGY, V125, P1355, DOI 10.1016/j.gastro.2003.07.015
   Overholt BF, 1999, GASTROINTEST ENDOSC, V49, P1, DOI 10.1016/S0016-5107(99)70437-2
   Pahernik SA, 1998, J PHOTOCH PHOTOBIO B, V47, P58, DOI 10.1016/S1011-1344(98)00203-6
   Peters RA, 1997, ENDOSCOPY, V29, P10, DOI 10.1055/s-2007-1004054
   Pichlmayr R, 1996, ANN SURG, V224, P628, DOI 10.1097/00000658-199611000-00007
   POLYDOROU AA, 1991, GUT, V32, P685, DOI 10.1136/gut.32.6.685
   PROUT GR, 1987, NEW ENGL J MED, V317, P1251, DOI 10.1056/NEJM198711123172003
   Rothenberg ML, 2003, J CLIN ONCOL, V21, P2059, DOI 10.1200/JCO.2003.11.126
   Rumalla A, 2001, GASTROINTEST ENDOSC, V53, P500, DOI 10.1067/mge.2001.113386
   Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302
   Schiefke I, 2003, GASTROINTEST ENDOSC, V58, P213, DOI 10.1067/mge.2003.362
   Schoefl R, 1997, SCAND J GASTROENTERO, V32, P363, DOI 10.3109/00365529709007685
   SIBILLE A, 1995, GASTROENTEROLOGY, V108, P337, DOI 10.1016/0016-5085(95)90058-6
   Song LM, 1998, CANCER, V82, P421
   Sudan D, 2002, AM J TRANSPLANT, V2, P774, DOI 10.1034/j.1600-6143.2002.20812.x
   TSUJINO K, 1995, RADIOLOGY, V196, P275
   WHITTINGTON R, 1995, J CLIN ONCOL, V13, P227
   WIEDMANN M, 2004, IN PRESS GASTROINTES, V59
   Wiedmann M, 2003, CANCER, V97, P2783, DOI 10.1002/cncr.11401
   Zoepf T, 2001, GASTROINTEST ENDOSC, V54, P763, DOI 10.1067/mge.2001.119605
   Zoepf T, 2001, AM J GASTROENTEROL, V96, P2093, DOI 10.1016/S0002-9270(01)02531-X
NR 65
TC 30
Z9 32
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0272-8087
J9 SEMIN LIVER DIS
JI Semin. Liver Dis.
PD MAY
PY 2004
VL 24
IS 2
BP 177
EP 187
DI 10.1055/s-2004-828894
PG 11
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 828YJ
UT WOS:000222009400007
PM 15192790
ER

PT J
AU Henderson, A
   Ismail, AKA
   Cunningham, M
   Aldridge, S
   Loverock, L
   Langley, SEM
   Laing, RW
AF Henderson, A
   Ismail, AKA
   Cunningham, M
   Aldridge, S
   Loverock, L
   Langley, SEM
   Laing, RW
TI Toxicity and early biochemical outcomes from (125)iodine prostate
   Brachytherapy in the UK - A prospective study
SO CLINICAL ONCOLOGY
LA English
DT Article
DE prostate cancer; brachytherapy; prostate-specific antigen; International
   Prostate Symptom Scores (IPSS); urodynamics; toxicity; urinary symptoms
ID SEED IMPLANTATION; RADICAL PROSTATECTOMY; URINARY RETENTION; ERECTILE
   FUNCTION; HORMONAL-THERAPY; SEXUAL FUNCTION; CANCER; CARCINOMA; I-125;
   RADIOTHERAPY
AB Aims: Transperineal interstitial prostate brachytherapy is increasingly available to patients with early prostate cancer in the U.K., but limited data are available about the toxicity and early results in the U.K. prostate cancer population. We describe our experience and results from prostate brachytherapy to date.
   Materials and methods: Two hundred and fifty-five patients were treated at St Luke's Cancer Centre, Guildford, U.K., between March 1999 and November 2002. Of these, over 3 months of follow-up data were available for 216 patients. Patients were assessed at 6 weeks and then at 3, 6, 9 and 12 months after implant, and at 6 monthly intervals thereafter. Prostate-specific antigen (PSA), International Prostate Symptom Score (IPSS) and toxicity, including catheter use, was recorded prospectively.
   Results: Median PSA at 1, 2 and 3 years was 0.5, 0.4 and 0.1 ng/ml, respectively. Ninety-five per cent of patients experienced temporary deterioration in their urinary symptoms, which persisted at clinically significant levels (IPSS increase >3 points) for 9 months after implant. The severity of urinary symptoms (IPSS) after implant was most closely related to IPSS at presentation (P<0.001). Acute urinary retention (AUR) occurred in 20 (9.3%) patients, with a further 26 (12.1%) patients using clean intermittent self-catheterisation (CISC) to reduce voiding frequency associated with chronic retention. Median duration of catheter use was 4 weeks. Multivariate analysis revealed that urodynamic status, prostate volume and IPSS score were independently significant (P<0.05) predictors of post-implant catheter use. Twelve patients (5.6%) reported either rectal urgency or mild, self-limiting rectal bleeding.
   Conclusion: Brachytherapy was tolerated well, with self-limiting urinary, bowel and sexual toxicity in most patients. Postoperative catheter use in our population is closely linked to pre-implant IPSS score, baseline prostate volume and urodynamic obstruction status. This work confirms the prognostic value of urodynamic assessment, which adds useful prognostic information to assessment of known risk factors such as prostate volume and IPSS. (C) 2004 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
C1 St Lukes Canc Ctr, Guildford, Surrey, England.
   Univ Surrey, Postgrad Med Sch, Guildford GU2 5XH, Surrey, England.
RP Henderson, A (reprint author), Royal Surrey Cty Hosp, Dept Urol, Egerton Rd, Guildford GU2 5XX, Surrey, England.
EM AliHenderson@Freenet.co.uk
CR Abrams P, 1999, BJU INT, V84, P14
   Al-Booz H, 1999, BJU INT, V83, P53, DOI 10.1046/j.1464-410X.1999.00893.x
   Altman D.G., 1991, PRACTICAL STAT MED R
   Ash D, 2000, RADIOTHER ONCOL, V57, P315, DOI 10.1016/S0167-8140(00)00306-6
   BARRY MJ, 1995, UROL CLIN N AM, V22, P299
   Bates TS, 1998, EUR UROL, V33, P165, DOI 10.1159/000019549
   *BAUS, 2001, AN MIN DAT UR CANC, P39
   Blasko JC, 2000, INT J RADIAT ONCOL, V46, P839, DOI 10.1016/S0360-3016(99)00499-X
   Bucci J, 2002, INT J RADIAT ONCOL, V53, P91, DOI 10.1016/S0360-3016(01)02812-7
   Bucci J, 2002, INT J RADIAT ONCOL, V54, P1235, DOI 10.1016/S0360-3016(02)03054-7
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   Crook J, 2002, INT J RADIAT ONCOL, V52, P453, DOI 10.1016/S0360-3016(01)02658-X
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Fulmer BR, 2001, CANCER, V91, P2046, DOI 10.1002/1097-0142(20010601)91:11<2046::AID-CNCR1231>3.0.CO;2-W
   Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7
   Hanlon AL, 2002, INT J RADIAT ONCOL, V53, P297, DOI 10.1016/S0360-3016(02)02717-7
   Henderson A, 2002, BJU INT, V90, P567, DOI 10.1046/j.1464-410X.2002.02983.x
   Kupelian P. A., 2002, International Journal of Radiation Oncology Biology Physics, V54, P38, DOI 10.1016/S0360-3016(02)03122-X
   LANGLEY SEM, 2002, BR J UROL, V89, P1
   Lee LN, 2002, INT J RADIAT ONCOL, V52, P444, DOI 10.1016/S0360-3016(01)02598-6
   Lee W., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS226, DOI 10.1016/S0360-3016(03)01046-0
   Merrick GS, 2002, INT J RADIAT ONCOL, V52, P893, DOI 10.1016/S0360-3016(01)02675-X
   Merrick GS, 2001, INT J RADIAT ONCOL, V51, P41, DOI 10.1016/S0360-3016(01)01594-2
   Patel MI, 2001, BJU INT, V88, P26, DOI 10.1046/j.1464-410x.2001.02253.x
   Potters L, 2001, INT J RADIAT ONCOL, V50, P1235, DOI 10.1016/S0360-3016(01)01578-4
   Potters L., 2002, International Journal of Radiation Oncology Biology Physics, V54, P9, DOI 10.1016/S0360-3016(02)03071-7
   Ragde H, 2000, CANCER, V89, P135, DOI 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
   Ravichandran S, 2002, BJU INT, V90, P420, DOI 10.1046/j.1464-4096.2002.02906.x
   Rosen RC, 1999, INT J IMPOT RES, V11, P319
   Stone NN, 2000, MOL UROL, V4, P163
   Terk MD, 1998, J UROLOGY, V160, P1379, DOI 10.1016/S0022-5347(01)62542-4
   WALLNER K, 1995, INT J RADIAT ONCOL, V32, P465, DOI 10.1016/0360-3016(94)00599-G
   Walsh PC, 2000, UROLOGY, V55, P58, DOI 10.1016/S0090-4295(99)00397-0
NR 33
TC 30
Z9 32
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0936-6555
J9 CLIN ONCOL-UK
JI Clin. Oncol.
PD APR
PY 2004
VL 16
IS 2
BP 95
EP 104
DI 10.1016/j.clon.2003.11.006
PG 10
WC Oncology
SC Oncology
GA 804CY
UT WOS:000220278000002
PM 15074730
ER

PT J
AU Nash, AF
   Melezinek, I
AF Nash, AF
   Melezinek, I
TI The role of prostate specific antigen measurement in the detection and
   management of prostate cancer
SO ENDOCRINE-RELATED CANCER
LA English
DT Review
ID POLYMERASE-CHAIN-REACTION; EXTERNAL-BEAM RADIATION; INTERMITTENT
   ANDROGEN SUPPRESSION; OPERATING CHARACTERISTIC CURVES; RANDOMIZED
   CONTROLLED TRIAL; HUMAN SEMINAL PLASMA; RADICAL PROSTATECTOMY; REFERENCE
   RANGES; BILATERAL ORCHIECTOMY; ULTRASENSITIVE ASSAY
AB The introduction of prostate specific antigen (PSA) testing has revolutionised the early detection, management and follow-up of patients with prostate cancer and it is considered to be one of the best biochemical markers currently available in the field of oncology. Its use with annual digital rectal examination in prostate cancer screening programmes has led to a marked change in the distribution of stage at presentation towards earlier disease and has led to a significant increase in the detection of potentially curable disease. In order to improve the specificity of PSA testing and thereby reduce the number of unnecessary prostatic biopsies, a number of refinements of PSA evaluation have been proposed. These include free to total PSA ratio, PSA density, PSA density of the transition zone, PSA velocity and age-specific PSA reference ranges. The utility of these approaches is considered in this review. The role of PSA monitoring in the detection of recurrence following radical prostatectomy and radiotherapy is discussed, as well as its role in monitoring patients treated with endocrine therapy in terms of correlating PSA response with outcome, in detecting disease progression and in guiding the use of subsequent therapies. Large continuing multicentre screening and outcome studies will provide important information enabling greater refinement of the use of this important diagnostic and monitoring tool in the future detection and management of prostate cancer.
C1 AstraZeneca, Dept Med Res, Macclesfield SK10 4TG, Cheshire, England.
RP Nash, AF (reprint author), AstraZeneca, Dept Med Res, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.
CR Agha AH, 1996, J UROLOGY, V155, P1332, DOI 10.1016/S0022-5347(01)66259-1
   AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z
   Alexander FE, 1999, PROSTATE, V40, P135
   ALTWEIN J, 1999, EUROPEAN UROLOGY S2, V35
   Andriole GL, 1998, UROLOGY, V52, P195, DOI 10.1016/S0090-4295(98)00184-8
   Bales GT, 1996, UROLOGY, V47, P38, DOI 10.1016/S0090-4295(96)80007-0
   BANGMA CH, 1995, UROLOGY, V46, P779, DOI 10.1016/S0090-4295(99)80343-4
   BAZINET M, 1994, UROLOGY, V43, P44, DOI 10.1016/S0090-4295(94)80260-2
   BENSON MC, 1992, J UROLOGY, V147, P815
   Blackledge G R, 1994, Prostate Suppl, V5, P34
   Boer R, 1999, PROSTATE, V40, P130
   BORING CC, 1994, CA-CANCER J CLIN, V44, P7, DOI 10.3322/canjclin.44.1.7
   BOYLE P, 1994, PROSTATE CANC 2000, P5
   BRAWER MK, 1993, J UROLOGY, V150, P369
   CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215
   CATALONA WJ, 1994, J UROLOGY, V152, P2031
   CATALONA WJ, 1994, J UROLOGY, V152, P2037
   CATALONA WJ, 1994, J UROLOGY, V152, P1837
   CATALONA WJ, 1994, J UROLOGY, V151, P1283
   CATALONA WJ, 1991, NEW ENGL J MED, V324, P156
   CATALONA WJ, 1995, JAMA-J AM MED ASSOC, V274, P1214
   CHAN DW, 1987, CLIN CHEM, V33, P1916
   Chen YT, 1996, UROLOGY, V47, P518, DOI 10.1016/S0090-4295(99)80487-7
   CHODAK G, 1995, UROLOGY, V46, P849, DOI 10.1016/S0090-4295(99)80356-2
   CHRISTENSSON A, 1993, J UROLOGY, V150, P100
   CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x
   COLLINS GN, 1993, BRIT J UROL, V71, P445, DOI 10.1111/j.1464-410X.1993.tb15990.x
   Corey E, 1997, UROLOGY, V50, P184, DOI 10.1016/S0090-4295(97)00262-8
   CRAWFORD ED, 1994, ANN M AM UR ASS SAN
   CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702
   Creasy Terry, 1997, Journal of Urology, V157, P55
   CRITZ FA, 1995, CANCER, V75, P2383, DOI 10.1002/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z
   Critz FA, 1997, UROLOGY, V49, P322, DOI 10.1016/S0090-4295(96)00666-8
   Crook JM, 1997, CANCER, V79, P328, DOI 10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
   Culig Z, 1997, DRUG AGING, V10, P50, DOI 10.2165/00002512-199710010-00005
   DALKIN BL, 1993, J UROLOGY, V150, P1837
   DEBRUYNE FM, 1996, EUR UROL S2, V30, P264
   DENIS LJ, 1993, UROLOGY, V42, P119, DOI 10.1016/0090-4295(93)90634-M
   Djavan B, 1998, J UROLOGY, V160, P411, DOI 10.1016/S0022-5347(01)62911-2
   Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504
   Ellis WJ, 1997, UROLOGY, V50, P573, DOI 10.1016/S0090-4295(97)00251-3
   Farkas A, 1998, UROLOGY, V52, P444, DOI 10.1016/S0090-4295(98)00242-8
   FRAZIER HA, 1992, J UROLOGY, V147, P246
   Gao CL, 1999, J UROLOGY, V161, P1070, DOI 10.1016/S0022-5347(01)61592-1
   GHOSSEIN RA, 1995, J CLIN ONCOL, V13, P1195
   Ghossein RA, 1997, UROLOGY, V50, P100, DOI 10.1016/S0090-4295(97)00127-1
   Gleave Martin, 1994, Journal of Urology, V151, p457A
   GOHAGAN JK, 1994, J UROLOGY, V152, P1905
   GOLDENBERG SL, 1995, UROLOGY, V45, P839
   GORMLEY GJ, 1992, NEW ENGL J MED, V327, P1185, DOI 10.1056/NEJM199210223271701
   HAMMERER PG, 1995, J UROLOGY, V153, P111, DOI 10.1097/00005392-199501000-00038
   HANKS GE, 1994, J UROLOGY, V152, P1775
   Hara M., 1971, JPN J LEGAL MED, V25, P322
   Herschman JD, 1997, UROLOGY, V50, P239, DOI 10.1016/S0090-4295(97)00209-4
   Hoeksema MJ, 1996, J NATL CANCER I, V88, P1706, DOI 10.1093/jnci/88.23.1706
   Horninger Wolfgang, 1997, Journal of Urology, V157, P116
   Humphrey PA, 1996, J UROLOGY, V155, P816, DOI 10.1016/S0022-5347(01)66316-X
   Ignatoff JM, 1997, J UROLOGY, V158, P1870, DOI 10.1016/S0022-5347(01)64150-8
   Iversen P, 1998, UROLOGY, V51, P389, DOI 10.1016/S0090-4295(98)00004-1
   JANKNEGT RA, 1996, EUR UROL S2, V30, P264
   Jung K, 1998, J UROLOGY, V159, P1595, DOI 10.1097/00005392-199805000-00050
   Kadmon D, 1996, J UROLOGY, V155, P1655, DOI 10.1016/S0022-5347(01)66154-8
   Kaisary A V, 1994, Prostate Suppl, V5, P27
   Katz AE, 1996, UROLOGY, V47, P948, DOI 10.1016/S0090-4295(96)00110-0
   KATZ AE, 1994, UROLOGY, V43, P765, DOI 10.1016/0090-4295(94)90132-5
   Kawakami M, 1997, CANCER RES, V57, P4167
   Keetch DW, 1996, J UROLOGY, V156, P428, DOI 10.1016/S0022-5347(01)65868-3
   KELLY PJ, 1993, J BONE MINER RES, V8, P11
   KLOTZ LH, 1996, CAN J UROL, V3, P246
   Kolvenbag GJCM, 1998, PROSTATE, V34, P61, DOI 10.1002/(SICI)1097-0045(19980101)34:1<61::AID-PROS8>3.0.CO;2-N
   Kurita Y, 1996, Int J Urol, V3, P367, DOI 10.1111/j.1442-2042.1996.tb00555.x
   Labrie F, 1999, PROSTATE, V38, P83, DOI 10.1002/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B
   Labrie F, 1999, PROSTATE, V40, P137
   Labrie F, 1999, PROSTATE, V40, P132
   Lee WR, 1996, J UROLOGY, V156, P450, DOI 10.1016/S0022-5347(01)65876-2
   LEO ME, 1991, J UROLOGY, V145, P802
   LEPOR H, 1994, UROLOGY, V44, P199, DOI 10.1016/S0090-4295(94)80131-2
   LILJA H, 1993, UROL CLIN N AM, V20, P681
   LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185
   LILJA H, 1991, CLIN CHEM, V37, P1618
   Lu S, 1997, CANCER RES, V57, P4511
   LUDERER AA, 1995, UROLOGY, V46, P187, DOI 10.1016/S0090-4295(99)80192-7
   LUNDWALL A, 1987, FEBS LETT, V214, P317, DOI 10.1016/0014-5793(87)80078-9
   MCCORMACK RT, 1995, UROLOGY, V45, P729, DOI 10.1016/S0090-4295(99)80076-4
   Melchior SW, 1997, CLIN CANCER RES, V3, P249
   MESSING E, 1999, J UROLOGY S175, V161, P4
   Mettlin C, 1997, PROSTATE, V32, P221, DOI 10.1002/(SICI)1097-0045(19970801)32:3<221::AID-PROS9>3.0.CO;2-N
   MILLER JI, 1992, J UROLOGY, V147, P956
   MOYAD R, 1994, J UROLOGY S, V151
   Netto NR, 1996, J UROLOGY, V155, P1329
   OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860
   OESTERLING JE, 1995, J UROLOGY, V154, P1090, DOI 10.1016/S0022-5347(01)66984-2
   Oesterling JE, 1997, UROLOGY, V50, P13, DOI 10.1016/S0090-4295(97)00156-8
   Olsson CA, 1996, J UROLOGY, V155, P1557, DOI 10.1016/S0022-5347(01)66125-1
   PAPSIDERO LD, 1980, CANCER RES, V40, P2428
   PARTIN AW, 1993, UROL CLIN N AM, V20, P713
   Partin AW, 1996, J UROLOGY, V155, P1336, DOI 10.1016/S0022-5347(01)66260-8
   Partin AW, 1996, UROLOGY, V48, P55, DOI 10.1016/S0090-4295(96)00611-5
   PETTERSSON K, 1995, CLIN CHEM, V41, P1480
   PIENTA KJ, 1994, J CLIN ONCOL, V12, P2005
   Prestigiacomo AP, 1996, J UROLOGY, V156, P350, DOI 10.1016/S0022-5347(01)65847-6
   Preston DM, 1999, UROLOGY, V53, P131, DOI 10.1016/S0090-4295(98)00464-6
   DALESIO O, 1995, LANCET, V346, P265
   Pruthi RS, 1997, UROLOGY, V49, P737, DOI 10.1016/S0090-4295(97)00231-8
   ROSENZWEIG KE, 1995, J UROLOGY, V153, P1561, DOI 10.1016/S0022-5347(01)67461-5
   SCARDINO PT, 1992, HUM PATHOL, V23, P211, DOI 10.1016/0046-8177(92)90102-9
   SCHALLER J, 1987, EUR J BIOCHEM, V170, P111, DOI 10.1111/j.1432-1033.1987.tb13674.x
   SCHELLHAMMER PF, 1993, UROLOGY, V42, P13, DOI 10.1016/0090-4295(93)90325-5
   SCHELLHAMMER PF, 1993, UROL CLIN N AM, V20, P597
   Schellhammer PF, 1997, UROLOGY, V50, P330, DOI 10.1016/S0090-4295(97)00279-3
   SCHER HI, 1990, J CLIN ONCOL, V8, P1830
   Schroder FH, 1999, EUR UROL, V35, P539, DOI 10.1159/000019894
   SELLA A, 1994, J CLIN ONCOL, V12, P683
   SENSABAUGH GF, 1978, J FORENSIC SCI, V23, P106
   SMITH DS, 1994, J UROLOGY, V152, P1163
   Sokoloff MH, 1996, J UROLOGY, V156, P1560, DOI 10.1016/S0022-5347(01)65447-8
   STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501
   STAMEY TA, 1993, J UROLOGY, V149, P787
   STEIN A, 1992, J UROLOGY, V147, P942
   STENMAN UH, 1991, CANCER RES, V51, P222
   Stock RG, 1996, CANCER, V77, P2386, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
   TAKAYAMA TK, 1993, J UROLOGY, V150, P374
   TAKAYAMA TK, 1994, J UROLOGY, V151, P82
   Tchetgen MB, 1996, UROLOGY, V47, P511, DOI 10.1016/S0090-4295(99)80486-5
   Thalmann GN, 1996, J NATL CANCER I, V88, P794, DOI 10.1093/jnci/88.12.794
   TRAPASSO JG, 1994, J UROLOGY, V152, P1821
   TUNN UW, 1996, EUROPEAN J UROLOGY S, V1, P22
   TYRELL CJ, 1998, EUR UROL, V33, P447
   Van Cangh P J, 1996, Prostate Suppl, V7, P30
   VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401
   vonEschenbach A, 1997, CANCER, V80, P1805, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1805::AID-CNCR17>3.3.CO;2-8
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   Walls R, 1996, PROSTATE, V29, P177
   WANG MC, 1979, INVEST UROL, V17, P159
   WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166
   Wingo PA, 1997, CA-CANCER J CLIN, V47, P239, DOI 10.3322/canjclin.47.4.239
   WIRTH M, 1997, BRIT J UROLOGY S2, V80
   WOOD DP, 1994, CANCER, V74, P2533, DOI 10.1002/1097-0142(19941101)74:9<2533::AID-CNCR2820740922>3.0.CO;2-D
   Woodrum DL, 1998, J UROLOGY, V159, P5, DOI 10.1016/S0022-5347(01)63996-X
   Yu H, 1997, J UROLOGY, V157, P913, DOI 10.1016/S0022-5347(01)65082-1
   YU H, 1995, CLIN CHEM, V41, P430
   YUAN JJJ, 1992, J UROLOGY, V147, P810
   ZAGARS GK, 1995, UROLOGY, V45, P476, DOI 10.1016/S0090-4295(99)80019-3
   Zlotta AR, 1997, J UROLOGY, V157, P1315, DOI 10.1016/S0022-5347(01)64961-9
NR 144
TC 30
Z9 34
PU SOC ENDOCRINOLOGY
PI BRISTOL
PA 17/18 THE COURTYARD, WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4NQ, ENGLAND
SN 1351-0088
J9 ENDOCR-RELAT CANCER
JI Endocr.-Relat. Cancer
PD MAR
PY 2000
VL 7
IS 1
BP 37
EP 51
DI 10.1677/erc.0.0070037
PG 15
WC Oncology; Endocrinology & Metabolism
SC Oncology; Endocrinology & Metabolism
GA 314BM
UT WOS:000087034300005
PM 10808195
ER

PT J
AU Moriyama, H
   Sagara, A
   Tanaka, S
   Moir, RW
   Sze, DK
AF Moriyama, H
   Sagara, A
   Tanaka, S
   Moir, RW
   Sze, DK
TI Molten salts in fusion nuclear technology
SO FUSION ENGINEERING AND DESIGN
LA English
DT Article; Proceedings Paper
CT 4th International Symposium on Fusion Nuclear Technology (ISFNT-4)
CY APR 06-11, 1997
CL TOKYO, JAPAN
ID TRITIUM RECOVERY; HYLIFE-II; LIQUID-LITHIUM; REACTOR; BLANKET; DESIGN
AB In the field of fusion nuclear technology, much interest lies in the use of molten salts. In some innovative design studies, the use of molten fluoride, especially the LiF-BeF(2) mixture called Flibe, has been suggested as the primary loop coolant because of its inherent advantages such as high temperature stability and low electrical conductivity. The use of molten salts has also been suggested for the chemical processing of tritium. Together with the physical and chemical properties of molten salts, recent studies on the use of molten salts in fusion nuclear technology are reviewed and discussed, and issues are addressed for successful future development. (C) 1998 Published by Elsevier Science S.A. All rights reserved.
C1 Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 59004, Japan.
   Natl Inst Fus Sci, Nagoya, Aichi 46401, Japan.
   Univ Tokyo, Tokyo 113, Japan.
   Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
   Argonne Natl Lab, Argonne, IL 60439 USA.
RP Moriyama, H (reprint author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 59004, Japan.
CR ASAOKA Y, 1991, J NUCL MATER, V179, P879, DOI 10.1016/0022-3115(91)90229-Z
   Bamberger C.E., 1975, ADV MOLTEN SALT CHEM, V3, P177
   BETTIS ES, 1970, NUCL APPL TECHNOL, V8, P190
   BLANKE BC, 1959, MLM1086
   BLOOD CM, 1958, ORNL2551, P93
   BUXBAUM RE, 1983, SEPAR SCI TECHNOL, V18, P1251, DOI 10.1080/01496398308059926
   CALAWAY WF, 1978, NUCL TECHNOL, V39, P63
   CANTOR S, 1966, ORNL4076, P24
   Cantor S., 1968, ORNLTM2316
   CANTOR S, 1969, J CHEM PHYS, V50, P2874, DOI 10.1063/1.1671478
   CHEN XM, 1994, FUSION TECHNOL, V26, P912
   Clinton S. D., 1977, Proceedings of the Seventh Symposium on Engineering Problems of Fusion Research
   COOKE JW, 1971, ORNL4728, P41
   Doran D. G., 1989, MRS Bulletin, V14
   DOUGLAS TB, 1969, J RES NBS A PHYS CH, VA 73, P479, DOI 10.6028/jres.073A.037
   FIELD PE, 1967, J PHYS CHEM-US, V71, P3218, DOI 10.1021/j100869a013
   GRUEN DM, 1972, CHEM FUSION TECHNOLO
   HOUSE PA, 1994, FUSION TECHNOL, V26, P1178
   HOUSE PA, 1992, FUSION TECHNOL, V21, P1487
   KATSUTA H, 1986, IAEATECDOC373, P418
   KEISER JR, 1979, J NUCL MATER, V85-6, P295
   Langdon A. B., 1992, Particle Accelerators, V37-38
   LARSEN EM, 1986, FUSION TECHNOL, V10, P990
   LEE JD, 1994, FUSION TECHNOL, V26, P74
   LEE JD, 1986, UCID20773 LLNL
   LIU JC, 1992, FUSION TECHNOL, V21, P1514
   LONGHURST GR, 1993, EGGFSP9971
   MALINAUS.AP, 1974, IND ENG CHEM FUND, V13, P242, DOI 10.1021/i160051a015
   Maroni V.A., 1975, NUCL TECHNOL, V25, P83
   MILLS RG, 1974, MATT1050 PPPL
   MOIR RW, 1985, FUSION TECHNOL, V8, P465
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   MOIR RW, 1981, FUSION B, V1, P411
   MOIR RW, 1995, FUSION ENG DES, V29, P34, DOI 10.1016/0920-3796(95)80003-G
   Moir RW, 1997, NUCL FUSION, V37, P557, DOI 10.1088/0029-5515/37/4/I13
   Moir R. W., 1992, Particle Accelerators, V37-38
   MORIYAMA H, 1994, J NUCL MATER, V211, P231, DOI 10.1016/0022-3115(94)90351-4
   MORIYAMA H, 1991, FUSION TECHNOL, V19, P1046
   MORIYAMA H, 1995, FUSION ENG DES, V28, P226
   OISHI J, 1989, FUSION ENG DES, V8, P317, DOI 10.1016/S0920-3796(89)80124-3
   ROBBINS GD, 1970, ORNL4548, P156
   ROMBERGE.KA, 1972, J PHYS CHEM-US, V76, P1154, DOI 10.1021/j100652a012
   SAGARA A, 1995, FUSION ENG DES, V29, P51, DOI 10.1016/0920-3796(95)80005-I
   Sahin S, 1996, FUSION TECHNOL, V30, P1027
   SHAFFER JH, 1958, ORNL2626, P85
   Smith D.L., 1984, ANLFPP841
   SZE DK, 1986, FUSION TECHNOL, V10, P624
   SZE DK, 1995, FUSION ENG DES, V28, P220
   SZE DK, 1986, FUSION TECHNOL, V10, P875
   SZE DK, 1989, FUSION ENG DES, V8, P339, DOI 10.1016/S0920-3796(89)80128-0
   Watson G. M., 1962, J CHEM ENG DATA, V7, P285, DOI 10.1021/je60013a038
   YAJIMA K, 1982, J PHYS CHEM-US, V86, P4193, DOI 10.1021/j100218a021
NR 52
TC 30
Z9 30
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0920-3796
J9 FUSION ENG DES
JI Fusion Eng. Des.
PD SEP
PY 1998
VL 39-40
BP 627
EP 637
DI 10.1016/S0920-3796(98)00202-6
PG 11
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 134MQ
UT WOS:000076747200076
ER

PT J
AU Uematsu, T
   Kitamura, H
   Iwase, M
   Yamashita, K
   Ogura, H
   Nakamuka, T
   Oguri, H
AF Uematsu, T
   Kitamura, H
   Iwase, M
   Yamashita, K
   Ogura, H
   Nakamuka, T
   Oguri, H
TI Laparoscopic repair of a paraduodenal hernia
SO SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE paraduodenal hernia; laparoscopic repair; small bowel
AB Paraduodenal hernias have traditionally been treated by conventional laparotomy. We report the first case of a left paraduodenal hernia treated laparoscopically. A 44-year-old man was admitted with abdominal pain and nausea. Computed tomography and an upper gastrointestinal series with small-bowel followthrough showed accumulation of the small bowel on the left side of the abdomen. A laparoscopic repair was performed. The small bowel was observed beneath a thin hernia capsule, Approximately 1.5 m of jejunum was easily reduced into the abdominal cavity. The hernia orifice (5-cm diameter) was closed intracorporeally with five interrupted sutures, Good exposure of the operative field is critical to this procedure, poor exposure may limit the applicability of the laparoscopic approach. This minimally invasive operation is currently indicated in nonobstructive paraduodenal hernias, especially on the left.
C1 Iwata Municipal Gen Hosp, Dept Surg, Iwata 438, Japan.
RP Uematsu, T (reprint author), Iwata Municipal Gen Hosp, Dept Surg, 57-1 Kohnodai, Iwata 438, Japan.
CR BARTLETT MK, 1968, ANN SURG, V168, P249, DOI 10.1097/00000658-196808000-00010
   BELLTHOMSON J, 1977, AM J GASTROENTEROL, V68, P254
   BERARDI RS, 1981, SURG GYNECOL OBSTET, V152, P99
   BRIGHAM RA, 1984, SURGERY, V96, P498
   COOPWOOD TB, 1972, SOUTHERN MED J, V65, P1138
   HINDER RA, 1994, ANN SURG, V220, P472, DOI 10.1097/00000658-199410000-00006
   PANTON ONM, 1994, AM J SURG, V167, P535, DOI 10.1016/0002-9610(94)90252-6
   PARSONS PB, 1953, AM J ROENTGENOL, V69, P563
   PASSAS V, 1986, J COMPUT ASSIST TOMO, V10, P542
   Taylor J, 1930, BRIT J SURG, V17, P639, DOI 10.1002/bjs.1800176808
   WILLWERT.BM, 1974, AM J SURG, V128, P358, DOI 10.1016/0002-9610(74)90173-1
NR 11
TC 30
Z9 32
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0930-2794
J9 SURG ENDOSC-ULTRAS
JI Surg. Endosc.-Ultrason. Interv. Tech.
PD JAN
PY 1998
VL 12
IS 1
BP 50
EP 52
DI 10.1007/s004649900591
PG 3
WC Surgery
SC Surgery
GA YM977
UT WOS:000071120800010
PM 9419303
ER

PT J
AU Dimakakos, PB
   Stefanopoulos, T
   Antoniades, P
   Antoniou, A
   Gouliamos, A
   Rizos, D
AF Dimakakos, PB
   Stefanopoulos, T
   Antoniades, P
   Antoniou, A
   Gouliamos, A
   Rizos, D
TI MRI and Ultrasonographic findings in the investigation of lymphedema and
   lipedema
SO INTERNATIONAL SURGERY
LA English
DT Article
DE extremities edema; lipedema; lymphedema; lipolymphedema; magnetic
   resonance imaging (MRI); ultrasonography
ID RESONANCE
AB Methods. Twenty-four healthy subjects and 16 patients with lymphedema and lipedema were studied with MRI and ultra-tomography.
   Results. In chronic lymphedema, ultrasonography revealed a statistically significant increase of the subcutaneous fat without difference in skin thickness as compared to the healthy subjects, MRI revealed in lymphedema a statistically significant increase of skin thickness+subcutaneous tissue + muscular mass (p=0.048); in lipedema, a statistically significant increase of skin thickness and subcutaneous tissue (p<0.0001) as compared to the healthy controls.
   Conclusions. MRI offers strong qualitative and quantitative parameters in the diagnosis of lymphedema and lipolymphedema, while ultrasonography is expected to improve its diagnostic efficiency with the aid of high frequency echo with more sophisticated resolution apparatus, Age, weight and height of the patient as well as duration of the disease do not seem to affect the above-mentioned parameters.
C1 UNIV ATHENS,ARETAEION HOSP,VASC DEPT B,SURG CLIN,ATHENS,GREECE.
RI International Surgery, ICS/D-3993-2011
CR BRUNA J, 1991, LYMPHOSTASIS PATHOPH, P432
   CASE TC, 1992, MAGN RESON IMAGING, V10, P549, DOI 10.1016/0730-725X(92)90006-L
   DUEWELL S, 1992, RADIOLOGY, V184, P227
   FOELDI E, 1993, LYMPHOEDEM, P114
   FOELDI E, 1993, LEHRBUCH LYMPHOLOGIE, P309
   HAAVERSTAD R, 1992, EUR J VASCULAR SURG, V6, P124, DOI 10.1016/S0950-821X(05)80228-2
   HADJIS NS, 1985, AM J ROENTGENOL, V144, P361
   SCHIRGER A, 1962, JAMA, V182, P14
   HUDSON TM, 1985, SKELETAL RADIOL, V13, P134
   HUTZSCHENREUTER P, 1991, LYMPHOLOGIE PRAXIS, P46
   PECHING A, 1984, MONOGRAPH PROGR LYMP, V2, P201
   Weissleder H, 1990, HERZ GEFASSE, V10, P8
   WEISSLEDER H, 1994, ERKRANKUNGEN LYMPHGE, P57
   WEISSLEDER R, 1989, RADIOLOGY, V172, P315
NR 14
TC 30
Z9 34
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0020-8868
J9 INT SURG
JI Int. Surg.
PD OCT-DEC
PY 1997
VL 82
IS 4
BP 411
EP 416
PG 6
WC Surgery
SC Surgery
GA YG963
UT WOS:A1997YG96300017
PM 9412843
ER

PT J
AU LEAK, LV
   JONES, M
AF LEAK, LV
   JONES, M
TI LYMPHANGIOGENESIS IN-VITRO - FORMATION OF LYMPHATIC CAPILLARY-LIKE
   CHANNELS FROM CONFLUENT MONOLAYERS OF LYMPHATIC ENDOTHELIAL-CELLS
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article
DE LYMPHANGIOGENESIS; LYMPHATIC ENDOTHELIUM; EXTRACELLULAR MATRIX
ID ANGIOGENESIS INVITRO; INTRAPERITONEAL STIMULATION; DIFFERENTIATION;
   LAMININ; SARCOMA; GROWTH; MATRIX
AB Lymphatic endothelial cells grown long term in culture form lymphatic capillarylike tubes. Examination by light and transmission electron microscopy showed that these structures were closed loops composed of one to several cells connected by intercellular junction to form a luminal space. This first demonstration of lymphangiogenesis in confluent monolayer cultures of lymphatic endothelial cells (a) showed that collagen type I accelerated lymphatic capillary tube formation, whereas fibronectin and matrigel had no effect; b) provided a model to study lymphatic endothelial cell function and differentiation; and c) offered a possibility to distinguish differences between the process of lymphangiogenesis and angiogenesis by testing various factors and conditions that effect endothelial cell behavior.
C1 NHLBI, ANIM MED & SURG LAB, BETHESDA, MD 20892 USA.
RP LEAK, LV (reprint author), HOWARD UNIV, COLL MED, DEPT ANAT, ERNEST EVERETT JUST LAB CELLULAR BIOL, WASHINGTON, DC 20059 USA.
CR Clark ER, 1932, AM J ANAT, V51, P43
   CLIFF WJ, 1963, PHILOS T ROY SOC B, V246, P305, DOI 10.1098/rstb.1963.0008
   DJONEIDI M, 1991, MICROCIRC ENDOTH LYM, V7, P161
   ERASLAN S, 1964, SURGERY, V56, P970
   FOLKMAN J, 1985, ADV CANCER RES, V43, P175
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   HOWARD PS, 1991, DEV BIOL, V146, P325, DOI 10.1016/0012-1606(91)90234-T
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   LEAK L V, 1970, Microvascular Research, V2, P361, DOI 10.1016/0026-2862(70)90031-2
   LEAK L V, 1991, Journal of Cell Biology, V115, p365A
   LEAK LV, 1993, ANAT REC, V236, P641, DOI 10.1002/ar.1092360408
   LEAK LV, 1966, AM J ANAT, V118, P785, DOI 10.1002/aja.1001180308
   LEAK LV, 1985, AM J ANAT, V173, P171, DOI 10.1002/aja.1001730303
   LEAK LV, 1984, BLOOD VESSELS LYMPHA, P134
   LEAK LV, 1983, LAB INVEST, V48, P479
   MADRI JA, 1986, J HISTOCHEM CYTOCHEM, V34, P85
   MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297
   NICOSIA RF, 1987, IN VITRO CELL DEV B, V23, P167
   ODEN BO, 1960, ACTA CHIR SCAND, V120, P100
   PULLINGER DB, 1937, J PATHOL BACTERIOL, V45, P157
   Sandison JC, 1928, AM J ANAT, V41, P475, DOI 10.1002/aja.1000410304
   WITTE MH, 1990, AM J ROENTGENOL, V155, P311
   WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498
NR 25
TC 30
Z9 30
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1071-2690
EI 1543-706X
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD AUG
PY 1994
VL 30A
IS 8
BP 512
EP 518
PG 7
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA NY677
UT WOS:A1994NY67700007
ER

PT J
AU KIRKLIN, JW
   BLACKSTONE, EH
   BARGERON, LM
   PACIFICO, AD
   KIRKLIN, JK
AF KIRKLIN, JW
   BLACKSTONE, EH
   BARGERON, LM
   PACIFICO, AD
   KIRKLIN, JK
TI THE REPAIR OF ATRIOVENTRICULAR SEPTAL-DEFECTS IN INFANCY
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Article
C1 UNIV ALABAMA,SCH MED,DIV PEDIAT CARDIOL,BIRMINGHAM,AL 35294.
   UNIV ALABAMA,SCH MED,MED CTR,BIRMINGHAM,AL 35294.
   ALABAMA CONGENITAL HEART DIS DIAG & TREATMENT CTR,BIRMINGHAM,AL.
RP KIRKLIN, JW (reprint author), UNIV ALABAMA,SCH MED,DEPT SURG,DIV CARDIOTHORAC SURG,BIRMINGHAM,AL 35294, USA.
CR BERGER TJ, 1979, ANN THORAC SURG, V27, P104
   BERTRANOU EG, 1978, AM J CARDIOL, V42, P458, DOI 10.1016/0002-9149(78)90941-4
   BLACKSTONE EH, 1985, CIRCULATION, V72, P753
   BLACKSTONE EH, J AM STATIST ASS
   BULL C, 1985, LANCET, P1147
   CARPENTIER A, 1978, PEDIAT CARDIOLOGY, P477
   CONTI VR, 1978, J THORAC CARDIOV SUR, V76, P577
   DUSHANE JW, 1973, ADV CARDIOVASCULAR S, P9
   FERRAZZI P, J THORAC CARDIOVASC
   FOLLETTE DM, 1981, J THORAC CARDIOV SUR, V82, P221
   FOLLETTE DM, 1977, SURG FORUM, V28, P281
   KATZ NM, 1981, J THORAC CARDIOV SUR, V81, P528
   KIRKLIN JW, 1986, CARDIAC SURGERY, P491
   LEV M, 1958, ARCH PATHOL, V65, P174
   PEARLMAN AS, 1978, AM J CARDIOL, V41, P295, DOI 10.1016/0002-9149(78)90168-6
   PICCOLI GP, 1979, BRIT HEART J, V42, P621
   PICCOLI GP, 1979, BRIT HEART J, V42, P633
   RASTELLI GC, 1968, J THORAC CARDIOV SUR, V55, P299
   RASTELLI GC, 1966, MAYO CLIN PROC, V41, P296
   RASTELLI GC, 1969, MAYO CLIN PROC, V44, P335
   REASON J, 1984, SCIENCES         SEP, P45
   RIZZOLI G, 1980, J THORAC CARDIOV SUR, V80, P494
   RYGG IH, 1971, DAN MED BULL, V18, P25
   SILVERMAN N, 1983, CIRCULATION, V68, P148
   STUDER M, 1982, J THORAC CARDIOV SUR, V84, P523
   SUMMALA H, 1983, PERCEPT MOTOR SKILL, V56, P755
   WIGGLESW.EC, 1972, OCCUP PSYCHOL, V46, P69
   WILLIAMS WH, 1983, J THORAC CARDIOV SUR, V86, P838
NR 28
TC 30
Z9 30
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-5273
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD DEC
PY 1986
VL 13
IS 3
BP 333
EP 351
DI 10.1016/0167-5273(86)90118-X
PG 19
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA E9448
UT WOS:A1986E944800005
PM 3793288
ER

PT J
AU UTLEY, JR
   MOORES, WY
   STEPHENS, DB
AF UTLEY, JR
   MOORES, WY
   STEPHENS, DB
TI BLOOD CONSERVATION TECHNIQUES
SO ANNALS OF THORACIC SURGERY
LA English
DT Review
RP UTLEY, JR (reprint author), UNIV CALIF SAN DIEGO,MED CTR,DIV CARDIOTHORAC SURG,SAN DIEGO,CA 92103, USA.
CR AARON RK, 1974, ARCH SURG-CHICAGO, V108, P831
   ALLEN C, 1972, ANESTH ANALG CLEVE, V51, P287
   ALTER HJ, 1972, ANN INTERN MED, V77, P691
   BAKER RJ, 1969, ANN SURG, V169, P684, DOI 10.1097/00000658-196905000-00005
   BENNETT SH, 1973, AM J SURG, V125, P696, DOI 10.1016/0002-9610(73)90167-0
   BENNETT SH, 1973, AM J SURG, V125, P273, DOI 10.1016/0002-9610(73)90040-8
   BRAWLEY RK, 1973, SURGERY, V84, P693
   Bregman D, 1974, Ann Thorac Surg, V18, P590
   BRZICA SM, 1976, MAYO CLIN PROC, V51, P723
   BUCKLEY M J, 1971, Surgical Forum (Chicago), V22, P160
   BUTH J, 1975, SURG FORUM, V26, P276
   COHN LH, 1975, CHEST, V68, P283, DOI 10.1378/chest.68.3.283
   COHN LH, 1978, 1978 HAEM BLOOD CONS
   COLLINS JA, 1974, SURGERY, V75, P274
   COOLEY DA, 1966, AM J SURG, V112, P743, DOI 10.1016/0002-9610(66)90116-4
   COSGROVE DM, 1979, ANN THORAC SURG, V28, P184
   COVE H, 1976, TRANSFUSION, V16, P245
   CUELLO L, 1967, SURGERY, V62, P814
   ELLISON N, 1975, ANESTHESIOLOGY, V43, P288, DOI 10.1097/00000542-197509000-00002
   FLEMING AW, 1977, AM SURGEON, V43, P794
   GRINDON AJ, 1969, NEW ENGL J MED, V280, P1337, DOI 10.1056/NEJM196906122802407
   HALLOWELL P, 1978, ANN THORAC SURG, V25, P22
   HALLOWEL.P, 1972, J THORAC CARDIOV SUR, V64, P941
   HANSON EL, 1972, J THORAC CARDIOV SUR, V64, P87
   HARDESTY RL, 1968, J THORAC CARDIOV SUR, V56, P683
   HEPPS SA, 1963, SURGERY, V54, P232
   KAPLAN JA, 1977, J THORAC CARDIOV SUR, V74, P4
   KINGSLEY JR, 1976, AM J SURG, V131, P717, DOI 10.1016/0002-9610(76)90186-0
   LAKS H, 1977, J THORAC CARDIOV SUR, V73, P129
   LILLEAASEN P, 1978, ANN THORAC SURG, V25, P127
   LUBIN J, 1974, TRANSFUSION, V14, P602
   MATTOX KL, 1978, SURGERY, V84, P700
   MATTOX KL, 1978, 1978 HAEM BLOOD CONS
   MENNINGER FJ, 1980, J THORAC CARDIOV SUR, V79, P181
   MESSICK KD, 1978, 1978 HAEM BLOOD CONS
   MORAN JM, 1978, J THORAC CARDIOV SUR, V76, P510
   NOON GP, 1978, SURGERY, V84, P719
   OCHSNER JL, 1973, ANN SURG, V177, P811, DOI 10.1097/00000658-197306000-00022
   OLLER DW, 1976, J SURG RES, V20, P333, DOI 10.1016/0022-4804(76)90022-6
   ORR M, 1978, SURGERY, V84, P728
   ORR MD, 1978, 1978 HAEM BLOOD CONS
   PARKER FB, 1978, ANN THORAC SURG, V26, P559
   PLIAM MB, 1975, J THORAC CARDIOV SUR, V70, P338
   RAINES J, 1976, J TRAUMA, V16, P616, DOI 10.1097/00005373-197608000-00005
   ROCHE JK, 1973, JAMA-J AM MED ASSOC, V225, P1516, DOI 10.1001/jama.225.12.1516
   ROE BB, 1964, ARCH SURG-CHICAGO, V88, P128
   SANDIFOR.FM, 1974, J THORAC CARDIOV SUR, V68, P1
   SCHAFF HV, 1978, SURGERY, V84, P713
   SCHAFF HV, 1979, ANN THORAC SURG, V27, P493
   SCHAFF HV, 1978, J THORAC CARDIOV SUR, V75, P632
   SHERMAN MM, 1976, CHEST, V70, P592, DOI 10.1378/chest.70.5.592
   SILVER H, 1975, TRANSFUSION, V15, P600
   STANLEY TH, 1974, ANESTHESIOLOGY, V41, P34, DOI 10.1097/00000542-197407000-00007
   STILLMAN RM, 1976, BRIT J SURG, V63, P651, DOI 10.1002/bjs.1800630823
   SYMBAS PN, 1969, SOUTHERN MED J, V62, P671
   SYMBAS PN, 1972, J TRAUM, V12, P689
   TARHAN S, 1970, SURGERY, V67, P584
   TECTOR AJ, 1976, CHEST, V70, P454, DOI 10.1378/chest.70.4.454
   THURER RL, 1979, ANN THORAC SURG, V27, P500
   UMLAS J, 1975, J THORAC CARDIOV SUR, V70, P519
   UTLEY JR, 1976, SURG FORUM, V27, P217
   VALERI CR, 1970, TRANSFUSION, V10, P238
   VERSKA JJ, 1973, TRANSFUSION, V13, P219
   WAGSTAFF.JG, 1972, THORAX, V27, P410, DOI 10.1136/thx.27.4.410
   WALSH JH, 1970, J AMER MED ASSOC, V211, P261, DOI 10.1001/jama.211.2.261
   WILLIAMS WH, 1968, ARCH SURG-CHICAGO, V96, P317
   YEH T, 1978, ANN THORAC SURG, V26, P11
   YOUNG LE, 1964, ANN INTERN MED, V61, P136
   ZUBIATE P, 1974, J THORAC CARDIOV SUR, V68, P263
   1972, JAMA, V222, P692
NR 70
TC 30
Z9 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PY 1981
VL 31
IS 5
BP 482
EP 490
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA LM840
UT WOS:A1981LM84000018
PM 6784684
ER

PT J
AU Mackinnon, AJ
   Kline, JL
   Dixit, SN
   Glenzer, SH
   Edwards, MJ
   Callahan, DA
   Meezan, NB
   Haan, SW
   Kilkenny, JD
   Doppner, T
   Farley, DR
   Moody, JD
   Ralph, JE
   MacGowan, BJ
   Landen, OL
   Robey, HF
   Boehly, TR
   Celliers, PM
   Eggert, JH
   Krauter, K
   Frieders, G
   Ross, GF
   Hicks, DG
   Olson, RE
   Weber, SV
   Spears, BK
   Salmonsen, JD
   Michel, P
   Divol, L
   Hammel, B
   Thomas, CA
   Clark, DS
   Jones, OS
   Springer, PT
   Cerjan, CJ
   Collins, GW
   Glebov, VY
   Knauer, JP
   Sangster, C
   Stoeckl, C
   McKenty, P
   McNaney, JM
   Leeper, RJ
   Ruiz, CL
   Cooper, GW
   Nelson, AG
   Chandler, GGA
   Hahn, KD
   Moran, MJ
   Schneider, MB
   Palmer, NE
   Bionta, RM
   Hartouni, EP
   LePape, S
   Patel, PK
   Izumi, N
   Tommasini, R
   Bond, EJ
   Caggiano, JA
   Hatarik, R
   Grim, GP
   Merrill, FE
   Fittinghoff, DN
   Guler, N
   Drury, O
   Wilson, DC
   Herrmann, HW
   Stoeffl, W
   Casey, DT
   Johnson, MG
   Frenje, JA
   Petrasso, RD
   Zylestra, A
   Rinderknecht, H
   Kalantar, DH
   Dzenitis, JM
   Di Nicola, P
   Eder, DC
   Courdin, WH
   Gururangan, G
   Burkhart, SC
   Friedrich, S
   Blueuel, DL
   Bernstein, LA
   Eckart, MJ
   Munro, DH
   Hatchett, SP
   Macphee, AG
   Edgell, DH
   Bradley, DK
   Bell, PM
   Glenn, SM
   Simanovskaia, N
   Barrios, MA
   Benedetti, R
   Kyrala, GA
   Town, RPJ
   Dewald, EL
   Milovich, JL
   Widmann, K
   Moore, AS
   LaCaille, G
   Regan, SP
   Suter, LJ
   Felker, B
   Ashabranner, RC
   Jackson, MC
   Prasad, R
   Richardson, MJ
   Kohut, TR
   Datte, PS
   Krauter, GW
   Klingman, JJ
   Burr, RF
   Land, TA
   Hermann, MR
   Latray, DA
   Saunders, RL
   Weaver, S
   Cohen, SJ
   Berzins, L
   Brass, SG
   Palma, ES
   Lowe-Webb, RR
   McHalle, GN
   Arnold, PA
   Lagin, LJ
   Marshall, CD
   Brunton, GK
   Mathisen, DG
   Wood, RD
   Cox, JR
   Ehrlich, RB
   Knittel, KM
   Bowers, MW
   Zacharias, RA
   Young, BK
   Holder, JP
   Kimbrough, JR
   Ma, T
   La Fortune, KN
   Widmayer, CC
   Shaw, MJ
   Erbert, GV
   Jancaitis, KS
   DiNicola, JM
   Orth, C
   Heestand, G
   Kirkwood, R
   Haynam, C
   Wegner, PJ
   Whitman, PK
   Hamza, A
   Dzenitis, EG
   Wallace, RJ
   Bhandarkar, SD
   Parham, TG
   Dylla-Spears, R
   Mapoles, ER
   Kozioziemski, BJ
   Sater, JD
   Walters, CF
   Haid, BJ
   Fair, J
   Nikroo, A
   Giraldez, E
   Moreno, K
   Vanwonterghem, B
   Kauffman, RL
   Batha, S
   Larson, DW
   Fortner, RJ
   Schneider, DH
   Lindl, JD
   Patterson, RW
   Atherton, LJ
   Moses, EI
AF Mackinnon, A. J.
   Kline, J. L.
   Dixit, S. N.
   Glenzer, S. H.
   Edwards, M. J.
   Callahan, D. A.
   Meezan, N. B.
   Haan, S. W.
   Kilkenny, J. D.
   Doeppner, T.
   Farley, D. R.
   Moody, J. D.
   Ralph, J. E.
   MacGowan, B. J.
   Landen, O. L.
   Robey, H. F.
   Boehly, T. R.
   Celliers, P. M.
   Eggert, J. H.
   Krauter, K.
   Frieders, G.
   Ross, G. F.
   Hicks, D. G.
   Olson, R. E.
   Weber, S. V.
   Spears, B. K.
   Salmonsen, J. D.
   Michel, P.
   Divol, L.
   Hammel, B.
   Thomas, C. A.
   Clark, D. S.
   Jones, O. S.
   Springer, P. T.
   Cerjan, C. J.
   Collins, G. W.
   Glebov, V. Y.
   Knauer, J. P.
   Sangster, C.
   Stoeckl, C.
   McKenty, P.
   McNaney, J. M.
   Leeper, R. J.
   Ruiz, C. L.
   Cooper, G. W.
   Nelson, A. G.
   Chandler, G. G. A.
   Hahn, K. D.
   Moran, M. J.
   Schneider, M. B.
   Palmer, N. E.
   Bionta, R. M.
   Hartouni, E. P.
   LePape, S.
   Patel, P. K.
   Izumi, N.
   Tommasini, R.
   Bond, E. J.
   Caggiano, J. A.
   Hatarik, R.
   Grim, G. P.
   Merrill, F. E.
   Fittinghoff, D. N.
   Guler, N.
   Drury, O.
   Wilson, D. C.
   Herrmann, H. W.
   Stoeffl, W.
   Casey, D. T.
   Johnson, M. G.
   Frenje, J. A.
   Petrasso, R. D.
   Zylestra, A.
   Rinderknecht, H.
   Kalantar, D. H.
   Dzenitis, J. M.
   Di Nicola, P.
   Eder, D. C.
   Courdin, W. H.
   Gururangan, G.
   Burkhart, S. C.
   Friedrich, S.
   Blueuel, D. L.
   Bernstein, L. A.
   Eckart, M. J.
   Munro, D. H.
   Hatchett, S. P.
   Macphee, A. G.
   Edgell, D. H.
   Bradley, D. K.
   Bell, P. M.
   Glenn, S. M.
   Simanovskaia, N.
   Barrios, M. A.
   Benedetti, R.
   Kyrala, G. A.
   Town, R. P. J.
   Dewald, E. L.
   Milovich, J. L.
   Widmann, K.
   Moore, A. S.
   LaCaille, G.
   Regan, S. P.
   Suter, L. J.
   Felker, B.
   Ashabranner, R. C.
   Jackson, M. C.
   Prasad, R.
   Richardson, M. J.
   Kohut, T. R.
   Datte, P. S.
   Krauter, G. W.
   Klingman, J. J.
   Burr, R. F.
   Land, T. A.
   Hermann, M. R.
   Latray, D. A.
   Saunders, R. L.
   Weaver, S.
   Cohen, S. J.
   Berzins, L.
   Brass, S. G.
   Palma, E. S.
   Lowe-Webb, R. R.
   McHalle, G. N.
   Arnold, P. A.
   Lagin, L. J.
   Marshall, C. D.
   Brunton, G. K.
   Mathisen, D. G.
   Wood, R. D.
   Cox, J. R.
   Ehrlich, R. B.
   Knittel, K. M.
   Bowers, M. W.
   Zacharias, R. A.
   Young, B. K.
   Holder, J. P.
   Kimbrough, J. R.
   Ma, T.
   La Fortune, K. N.
   Widmayer, C. C.
   Shaw, M. J.
   Erbert, G. V.
   Jancaitis, K. S.
   DiNicola, J. M.
   Orth, C.
   Heestand, G.
   Kirkwood, R.
   Haynam, C.
   Wegner, P. J.
   Whitman, P. K.
   Hamza, A.
   Dzenitis, E. G.
   Wallace, R. J.
   Bhandarkar, S. D.
   Parham, T. G.
   Dylla-Spears, R.
   Mapoles, E. R.
   Kozioziemski, B. J.
   Sater, J. D.
   Walters, C. F.
   Haid, B. J.
   Fair, J.
   Nikroo, A.
   Giraldez, E.
   Moreno, K.
   Vanwonterghem, B.
   Kauffman, R. L.
   Batha, S.
   Larson, D. W.
   Fortner, R. J.
   Schneider, D. H.
   Lindl, J. D.
   Patterson, R. W.
   Atherton, L. J.
   Moses, E. I.
TI Assembly of High-Areal-Density Deuterium-Tritium Fuel from Indirectly
   Driven Cryogenic Implosions
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID NATIONAL IGNITION FACILITY; FUSION; TARGETS; LAYER
AB The National Ignition Facility has been used to compress deuterium-tritium to an average areal density of similar to 1.0 +/- 0.1 g cm(-2), which is 67% of the ignition requirement. These conditions were obtained using 192 laser beams with total energy of 1-1.6 MJ and peak power up to 420 TW to create a hohlraum drive with a shaped power profile, peaking at a soft x-ray radiation temperature of 275-300 eV. This pulse delivered a series of shocks that compressed a capsule containing cryogenic deuterium-tritium to a radius of 25-35 mu m. Neutron images of the implosion were used to estimate a fuel density of 500-800 g cm(-3).
C1 [Mackinnon, A. J.; Dixit, S. N.; Glenzer, S. H.; Edwards, M. J.; Callahan, D. A.; Meezan, N. B.; Haan, S. W.; Doeppner, T.; Farley, D. R.; Moody, J. D.; Ralph, J. E.; MacGowan, B. J.; Landen, O. L.; Robey, H. F.; Celliers, P. M.; Eggert, J. H.; Krauter, K.; Frieders, G.; Ross, G. F.; Hicks, D. G.; Weber, S. V.; Spears, B. K.; Salmonsen, J. D.; Michel, P.; Divol, L.; Hammel, B.; Thomas, C. A.; Clark, D. S.; Jones, O. S.; Springer, P. T.; Cerjan, C. J.; Collins, G. W.; McNaney, J. M.; Moran, M. J.; Schneider, M. B.; Palmer, N. E.; Bionta, R. M.; Hartouni, E. P.; LePape, S.; Patel, P. K.; Izumi, N.; Tommasini, R.; Bond, E. J.; Caggiano, J. A.; Hatarik, R.; Fittinghoff, D. N.; Drury, O.; Stoeffl, W.; Kalantar, D. H.; Dzenitis, J. M.; Di Nicola, P.; Eder, D. C.; Courdin, W. H.; Gururangan, G.; Burkhart, S. C.; Friedrich, S.; Blueuel, D. L.; Bernstein, L. A.; Eckart, M. J.; Munro, D. H.; Hatchett, S. P.; Macphee, A. G.; Bradley, D. K.; Bell, P. M.; Glenn, S. M.; Simanovskaia, N.; Barrios, M. A.; Benedetti, R.; Town, R. P. J.; Dewald, E. L.; Milovich, J. L.; Widmann, K.; LaCaille, G.; Suter, L. J.; Felker, B.; Ashabranner, R. C.; Jackson, M. C.; Prasad, R.; Richardson, M. J.; Kohut, T. R.; Datte, P. S.; Krauter, G. W.; Klingman, J. J.; Burr, R. F.; Land, T. A.; Hermann, M. R.; Latray, D. A.; Saunders, R. L.; Weaver, S.; Cohen, S. J.; Berzins, L.; Brass, S. G.; Palma, E. S.; Lowe-Webb, R. R.; McHalle, G. N.; Arnold, P. A.; Lagin, L. J.; Marshall, C. D.; Brunton, G. K.; Mathisen, D. G.; Wood, R. D.; Cox, J. R.; Ehrlich, R. B.; Knittel, K. M.; Bowers, M. W.; Zacharias, R. A.; Young, B. K.; Holder, J. P.; Kimbrough, J. R.; Ma, T.; La Fortune, K. N.; Widmayer, C. C.; Shaw, M. J.; Erbert, G. V.; Jancaitis, K. S.; DiNicola, J. M.; Orth, C.; Heestand, G.; Kirkwood, R.; Haynam, C.; Wegner, P. J.; Whitman, P. K.; Hamza, A.; Dzenitis, E. G.; Wallace, R. J.; Bhandarkar, S. D.; Parham, T. G.; Dylla-Spears, R.; Mapoles, E. R.; Kozioziemski, B. J.; Sater, J. D.; Walters, C. F.; Haid, B. J.; Fair, J.; Nikroo, A.; Vanwonterghem, B.; Kauffman, R. L.; Larson, D. W.; Fortner, R. J.; Schneider, D. H.; Lindl, J. D.; Patterson, R. W.; Atherton, L. J.; Moses, E. I.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
   [Boehly, T. R.; Glebov, V. Y.; Knauer, J. P.; Sangster, C.; Stoeckl, C.; McKenty, P.; Edgell, D. H.; Regan, S. P.] Univ Rochester, Laser Energet Lab, Rochester, NY 14623 USA.
   [Kline, J. L.; Grim, G. P.; Merrill, F. E.; Guler, N.; Wilson, D. C.; Herrmann, H. W.; Kyrala, G. A.; Batha, S.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
   [Olson, R. E.; Leeper, R. J.; Ruiz, C. L.; Chandler, G. G. A.; Hahn, K. D.] Sandia Natl Labs, Albuquerque, NM 87123 USA.
   [Kilkenny, J. D.; Nikroo, A.; Giraldez, E.; Moreno, K.] Gen Atom Co, San Diego, CA 92186 USA.
   [Casey, D. T.; Johnson, M. G.; Frenje, J. A.; Zylestra, A.; Rinderknecht, H.] MIT, Plasma Sci & Fus Ctr, Cambridge, MA 02139 USA.
   [Moore, A. S.] AWE, Reading RG7 4PR, Berks, England.
   [Cooper, G. W.; Nelson, A. G.] Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA.
RP Mackinnon, AJ (reprint author), Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RI Dylla-Spears, Rebecca/H-5605-2012; Patel, Pravesh/E-1400-2011; Whitman,
   Pamela/B-2336-2013; Ma, Tammy/F-3133-2013; McNaney, James/F-5258-2013;
   Michel, Pierre/J-9947-2012
OI Ma, Tammy/0000-0002-6657-9604; 
FU Lawrence Livermore National Security, LLC, (LLNS) [DE-AC52-07NA27344]
FX We wish to thank the NIF operations team without whom these experiments
   would not have been possible. This work was performed under the auspices
   of the Lawrence Livermore National Security, LLC, (LLNS) under Contract
   No. DE-AC52-07NA27344.
CR Atzeni S., 2004, PHYS INERTIAL CONFIN
   Boehly TR, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.195005
   Boehly TR, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3078422
   Edwards MJ, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592173
   Frenje JA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3304475
   Frenje JA, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2956837
   Glebov VY, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3492351
   Glebov VY, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2236281
   Glenzer SH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.085004
   Goncharov VN, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.165001
   Grim GP, 2006, J PHYS IV, V133, P913, DOI 10.1051/jp4:2006133184
   Haan SW, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592169
   Hammel BA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3567520
   Hicks DG, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3486536
   Izumi N, 2010, J PHYS CONF SER, V244, DOI 10.1088/1742-6596/244/3/032048
   Jones O., PHYS PLASMA IN PRESS
   Kozioziemski BJ, 2011, FUSION SCI TECHNOL, V59, P14
   Kyrala GA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3574504
   Landen OL, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592170
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740
   MARTIN AJ, 1988, J VAC SCI TECHNOL A, V6, P1885, DOI 10.1116/1.575234
   Michel P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025004
   Michel P, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3325733
   Miller GH, 2004, NUCL FUSION, V44, pS228, DOI 10.1088/0029-5515/44/12/S14
   Oertel JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2227439
   Regan S. P., EUR J PHYS IN PRESS
   Robey HF, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694122
   Robey HF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215004
   Wilke MD, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2987984
   Wilson DC, 2002, NUCL INSTRUM METH A, V488, P400, DOI 10.1016/S0168-9002(02)00474-6
   Zhou CD, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2998604
NR 32
TC 29
Z9 29
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD MAY 24
PY 2012
VL 108
IS 21
AR 215005
DI 10.1103/PhysRevLett.108.215005
PG 5
WC Physics, Multidisciplinary
SC Physics
GA 947CT
UT WOS:000304405000009
PM 23003274
ER

PT J
AU Koles, K
   Nunnari, J
   Korkut, C
   Barria, R
   Brewer, C
   Li, YH
   Leszyk, J
   Zhang, B
   Budnik, V
AF Koles, Kate
   Nunnari, John
   Korkut, Ceren
   Barria, Romina
   Brewer, Cassandra
   Li, Yihang
   Leszyk, John
   Zhang, Bing
   Budnik, Vivian
TI Mechanism of Evenness Interrupted (Evi)-Exosome Release at Synaptic
   Boutons
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MYOSIN-V; DROSOPHILA PHOTORECEPTORS; MULTIVESICULAR ENDOSOMES;
   GENE-EXPRESSION; NERVOUS WRECK; B-LYMPHOCYTES; RAB GTPASES; T-CELLS;
   EXOSOMES; PROTEIN
AB Wnt signaling plays critical roles during synaptic development and plasticity. However, the mechanisms by which Wnts are released and travel to target cells are unresolved. During synaptic development, the secretion of Drosophila Wnt1, Wingless, requires the function of Evenness Interrupted (Evi)/Wls, a Wingless-binding protein that is secreted along with Wingless at the neuromuscular junction. Given that Evi is a transmembrane protein, these studies suggested the presence of a novel vesicular mechanism of trans-synaptic communication, potentially in the form of exosomes. To establish the mechanisms for the release of Evi vesicles, we used a dsRNA assay in cultured cells to screen for genes that when down-regulated prevent the release of Evi vesicles. We identified two proteins, Rab11 and Syntaxin 1A (Syx1A), that were required for Evi vesicle release. To determine whether the same mechanisms were used in vivo at the neuromuscular junction, we altered the activity of Rab11 and Syx1A in motoneurons and determined the impact on Evi release. We found that Syx1A, Rab11, and its effector Myosin5 were required for proper Evi vesicle release. Furthermore, ultrastructural analysis of synaptic boutons demonstrated the presence of multivesicular bodies, organelles involved in the production and release of exosomes, and these multivesicular bodies contained Evi. We also used mass spectrometry, electron microscopy, and biochemical techniques to characterize the exosome fraction from cultured cells. Our studies revealed that secreted Evi vesicles show remarkable conservation with exosomes in other systems. In summary, our observations unravel some of the in vivo mechanisms required for Evi vesicle release.
C1 [Koles, Kate; Nunnari, John; Korkut, Ceren; Barria, Romina; Brewer, Cassandra; Li, Yihang; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.
   [Leszyk, John] Univ Massachusetts, Sch Med, Prote Core, Worcester, MA 01605 USA.
   [Zhang, Bing] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.
RP Koles, K (reprint author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.
EM kate.koles@umassmed.edu; Vivian.budnik@umassmed.edu
FU National Institutes of Health [R01 MH0700000, R01 NS06878]; Mizutani
   Foundation [090054]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grant R01 MH0700000 (to V. B.) and Grant R01 NS06878 (to the B.
   Z. laboratory). This work was also supported by Mizutani Foundation
   Grant 090054 (to K. K.).
CR Aline F, 2004, INFECT IMMUN, V72, P4127, DOI 10.1128/IAI.72.7.4127-4137.2004
   Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725
   Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008
   Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009
   Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8
   Chan CC, 2011, CURR BIOL, V21, P1704, DOI 10.1016/j.cub.2011.08.058
   Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132
   Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709
   Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121
   Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158
   Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002
   Harden N, 1996, MOL CELL BIOL, V16, P1896
   Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100
   Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018
   Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009
   Hwang I, 2011, FRONT BIOSCI-LANDMRK, V16, P411, DOI 10.2741/3695
   JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804
   Johnstone RM, 2005, BLOOD CELL MOL DIS, V34, P214, DOI 10.1016/j.bcmd.2005.03.002
   Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001
   Khodosh R, 2006, DEVELOPMENT, V133, P4655, DOI 10.1242/dev.02650
   Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200
   Kolotuev I, 2009, TRAFFIC, V10, P803, DOI [10.1111/j.1600-0854.2008.00871.x, 10.1111/j.1600-0854.2009.00871.x]
   Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867
   Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051
   Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004
   Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072
   Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3
   Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157
   Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lubec G, 2007, CHEM REV, V107, P3568, DOI 10.1021/cr068213f
   Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425
   Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285
   Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094
   O'Connor-Giles Kate M, 2008, Fly (Austin), V2, P259
   O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007
   Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000
   Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4
   Perrimon N, 1996, GENETICS, V144, P1681
   Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161
   Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008
   Rohn JL, 2011, J CELL BIOL, V194, P789, DOI 10.1083/jcb.201103168
   Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108
   Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003
   Sathyanarayanan S, 2008, GENE DEV, V22, P1522, DOI 10.1101/gad.1652308
   Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704
   Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x
   Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006
   SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X
   Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109
   Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]
   Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800
   STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114
   Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657
   Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083
   Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567
   Thery C, 2006, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb0322s30, DOI 10.1002/0471143030.CB0322S30]
   Théry Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6
   Tsuda M, 2006, FEBS LETT, V580, P3296, DOI 10.1016/j.febslet.2006.05.005
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252
   Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350
   Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451
   Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101
   Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711
   Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761
NR 72
TC 29
Z9 30
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 11
PY 2012
VL 287
IS 20
BP 16820
EP 16834
DI 10.1074/jbc.M112.342667
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 942GB
UT WOS:000304030900069
PM 22437826
ER

PT J
AU Grossi, EA
   Patel, N
   Woo, YJ
   Goldberg, JD
   Schwartz, CF
   Subramanian, V
   Feldman, T
   Bourge, R
   Baumgartner, N
   Genco, C
   Goldman, S
   Zenati, M
   Wolfe, JA
   Mishra, YK
   Trehan, N
   Mittal, S
   Shang, S
   Mortier, TJ
   Schweich, CJ
AF Grossi, Eugene A.
   Patel, Nirav
   Woo, Y. Joseph
   Goldberg, Judith D.
   Schwartz, Charles F.
   Subramanian, Valavanur
   Feldman, Ted
   Bourge, Robert
   Baumgartner, Norbert
   Genco, Christopher
   Goldman, Scott
   Zenati, Marco
   Wolfe, J. Alan
   Mishra, Yugal K.
   Trehan, Naresh
   Mittal, Sanjay
   Shang, Shulian
   Mortier, Todd J.
   Schweich, Cyril J., Jr.
CA RESTOR-MV Study Grp
TI Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical
   Treatment for Off-Pump Repair of the Mitral Valve)
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE functional mitral insufficiency; left ventricular reshaping; mitral
   valve repair
ID LONG-TERM SURVIVAL; CORONARY REVASCULARIZATION; RESTRICTIVE
   ANNULOPLASTY; REGURGITATION; MODERATE; SURGERY; IMPACT; INSUFFICIENCY
AB Objectives We sought to determine whether patients with functional mitral regurgitation (FMR) would benefit from ventricular reshaping by the Coapsys device (Myocor, Inc., Maple Grove, Minnesota).
   Background FMR occurs when ventricular remodeling impairs valve function. Coapsys is a ventricular shape change device placed without cardiopulmonary bypass to reduce FMR. It compresses the mitral annulus and reshapes the ventricle. We hypothesized that Coapsys for FMR would improve clinical outcomes compared with standard therapies.
   Methods RESTOR-MV (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve) was a randomized, prospective, multicenter study of patients with FMR and coronary disease with core laboratory analysis. After enrollment, patients were stratified to the standard indicated surgery: either coronary artery bypass graft alone or coronary artery bypass graft with mitral valve repair. In each stratum, randomization was to either control (indicated surgery) or treatment (coronary artery bypass graft with Coapsys ventricular reshaping).
   Results The study was terminated when the sponsor failed to secure ongoing funding; 165 patients were randomized. Control and Coapsys both produced decreases in left ventricular (LV) end-diastolic dimension and MR at 2 years (p < 0.001); Coapsys provided a greater decrease in LV end-diastolic dimension (p = 0.021). Control had lower MR grades during follow-up (p = 0.01). Coapsys showed a survival advantage compared with control at 2 years (87% vs. 77%) (hazard ratio: 0.421; 95% confidence interval: 0.200 to 0.886; stratified log-rank test; p = 0.038). Complication-free survival (including death, stroke, myocardial infarction, and valve reoperation) was significantly greater with Coapsys at 2 years (85% vs. 71%) (hazard ratio: 0.372; 95% confidence interval: 0.185 to 0.749; adjusted log-rank test; p = 0.019).
   Conclusions Analysis of RESTOR-MV indicates that patients with FMR requiring revascularization treated with ventricular reshaping rather than standard surgery had improved survival and a significant decrease in major adverse outcomes. This trial validates the concept of the ventricular reshaping strategy in this subset of patients with heart failure. (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve [RESTOR-MV]; NCT00120276) (J Am Coll Cardiol 2010; 56: 1984-93) (C) 2010 by the American College of Cardiology Foundation
C1 [Grossi, Eugene A.] NYU, Sch Med, NY Harbor Healthcare Syst, New York, NY 10028 USA.
   [Grossi, Eugene A.; Goldberg, Judith D.; Schwartz, Charles F.; Shang, Shulian] New York Harbor Vet Healthcare Syst, New York, NY USA.
   [Patel, Nirav; Subramanian, Valavanur] Lenox Hill Hosp, New York, NY 10021 USA.
   [Woo, Y. Joseph] Hosp Univ Penn, Philadelphia, PA 19104 USA.
   [Feldman, Ted] Northwestern Univ, Evanston Hosp, Evanston, IL 60201 USA.
   [Bourge, Robert] Univ Alabama, Birmingham, AL USA.
   [Baumgartner, Norbert; Genco, Christopher] Covenant Hlth Ctr, Saginaw, MI USA.
   [Goldman, Scott] Lankenau Hosp, Lancaster, PA USA.
   [Zenati, Marco] Vet Adm Hosp, Pittsburgh, PA USA.
   [Wolfe, J. Alan] St Josephs Hosp, Atlanta, GA USA.
   [Mishra, Yugal K.] Escorts Heart Inst, New Delhi, India.
   [Mortier, Todd J.; Schweich, Cyril J., Jr.] Myocor Inc, Maple Grove, MN USA.
   [Trehan, Naresh; Mittal, Sanjay] Indrapratha Apollo, New Delhi, India.
RP Grossi, EA (reprint author), NYU, Sch Med, NY Harbor Healthcare Syst, Suite 9-V,530 1st Ave, New York, NY 10028 USA.
EM grossi@cv.med.nyu.edu
RI Shang, Shulian/A-2173-2013
FU Myocor, Inc.
FX This study was sponsored by Myocor, Inc. Dr. Bourge is a consultant to
   the research study for Myocor. Dr. Goldman is a consultant to Edwards,
   St. Jude, and ATS. Mr. Mortier and Dr. Schweich are former employees of
   Myocor. All other authors have reported that they have no relationships
   to disclose.
CR Aklog L, 2001, CIRCULATION, V104, pI68
   Bax JJ, 2004, CIRCULATION, V110, pII103, DOI 10.1161/01.CIR-0000138196.06772.4e
   Bonow RO, 2006, J AM COLL CARDIOL, V48, pe1, DOI DOI 10.1016/J.JACC.2006.05.021
   BUCKBERG GD, 2009, J THORAC CARDIOVASC, V139, P1060
   CALAFIORE AM, 2001, ANN THORAC SURG, V71, P52
   Calafiore AM, 2001, ANN THORAC SURG, V71, P1146, DOI 10.1016/S0003-4975(00)02650-3
   Ellis SG, 2002, AM J CARDIOL, V89, P315, DOI 10.1016/S0002-9149(01)02231-7
   Fukamachi K, 2005, ASAIO J, V51, P17, DOI 10.1097/01.mat.0000150511.87747.A1
   Geidel S, 2005, EUR J CARDIO-THORAC, V27, P1011, DOI 10.1016/j.ejcts.2005.02.025
   Gillinov AM, 2005, ANN THORAC SURG, V80, P811, DOI 10.1016/j.athoracsur.2005.03.134
   Glower DD, 2005, J THORAC CARDIOV SUR, V129, P860, DOI 10.1016/j.jtcvs.2004.11.023
   Grossi EA, 2006, J THORAC CARDIOV SUR, V131, P1095, DOI 10.1016/j.jtcvs.2005.11.046
   Grossi EA, 2001, J CARDIAC SURG, V16, P328, DOI 10.1111/j.1540-8191.2001.tb00530.x
   Guccione JM, 2003, ANN THORAC SURG, V76, P1171, DOI 10.1016/S0003-4975(03)00731-8
   HENDREN WG, 1991, ANN THORAC SURG, V52, P1246
   HENDREN WG, 1991, ANN THORAC SURG, V52, P1251
   Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559
   Kim YH, 2005, ANN THORAC SURG, V79, P1895, DOI 10.1016/j.athoracsur.2004.11.005
   Komeda M, 1997, CIRCULATION, V96, P128
   Magne J, 2008, J AM COLL CARDIOL, V51, P1692, DOI 10.1016/j.jacc.2007.11.082
   McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037
   Mirabel M, 2007, EUR HEART J, V28, P1358, DOI 10.1093/eurheartj/ehm001
   Mishra YK, 2006, ANN THORAC SURG, V81, P42, DOI 10.1016/j.athoracsur.2005.06.023
   Mittal S, 2007, CIRCULATION, V116, P373
   Prifti E, 2001, J CARDIAC SURG, V16, P473, DOI 10.1111/j.1540-8191.2001.tb00552.x
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Serri K, 2006, J THORAC CARDIOV SUR, V131, P565, DOI 10.1016/j.jtcvs.2005.09.037
   Tahta SA, 2002, J HEART VALVE DIS, V11, P11
   Trichon BH, 2003, CIRCULATION, V108, P103, DOI 10.1161/01.cir.0000087656.10829.df
   Wong DR, 2005, ANN THORAC SURG, V80, P570, DOI 10.1016/j.athoracsur.2005.03.034
   Wu AH, 2005, J AM COLL CARDIOL, V45, P381, DOI 10.1016/j.jacc.2004.09.073
NR 31
TC 29
Z9 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD DEC 7
PY 2010
VL 56
IS 24
BP 1984
EP 1993
DI 10.1016/j.jacc.2010.06.051
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 688BD
UT WOS:000284822500003
PM 21126639
ER

PT J
AU Yuen, TJ
   Browne, KD
   Iwata, A
   Smith, DH
AF Yuen, Tracy J.
   Browne, Kevin D.
   Iwata, Akira
   Smith, Douglas H.
TI Sodium Channelopathy Induced by Mild Axonal Trauma Worsens Outcome After
   a Repeat Injury
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Article
DE axon trauma; calcium; diffuse axonal injury; repetitive injury; sodium
   channels; traumatic brain injury
ID BRAIN-INJURY; HEAD-INJURY; MULTIPLE-SCLEROSIS; MOUSE MODEL; CONCUSSION;
   CALCIUM; TETRODOTOXIN; PERFORMANCE; NEURONS; DAMAGE
AB There is great concern that one mild traumatic brain injury (mTBI) predisposes individuals to an exacerbated response with a subsequent mTBI. Although no mechanism has been identified, mounting evidence suggests traumatic axonal injury (TAI) plays a role in this process. By using a cell culture system, a threshold of mild TAI was found where dynamic stretch of cortical axons at strains lower than 5% induced no overt pathological changes. However, the axons were found to display an increased expression of sodium channels (NaChs) by 24 hr. After a second, identical mild injury, pathologic increases in [Ca(2+)](i) were observed, leading to axon degeneration. The central role of NaChs in this response was demonstrated by blocking NaChs with tetrodotoxin prior to the second injury, which completely abolished postinjury increases in [Ca(2+)](i). These data suggest that mild TAI induces a form of sodium channelopathy on axons that greatly exaggerates the pathophysiologic response to subsequent mild injuries. (C) 2009 Wiley-Liss, Inc.
C1 [Yuen, Tracy J.; Browne, Kevin D.; Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.
   [Yuen, Tracy J.; Browne, Kevin D.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.
   [Iwata, Akira] Nagakute Minami Clin, Aichi, Japan.
RP Smith, DH (reprint author), Univ Penn, Ctr Brain Injury & Repair, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA.
EM smithdou@mail.med.upenn.edu
RI smith, douglas/A-1321-2007
FU National Institutes of Health [NS38104]
FX Contract grant sponsor: National Institutes of Health; Contract grant
   numbers: NS38104 and NS38104 (to Douglas H. Smith).
CR ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49
   ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610
   Baker MD, 2001, TRENDS PHARMACOL SCI, V22, P27, DOI 10.1016/S0165-6147(00)01585-6
   Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241
   Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964
   Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119
   Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101
   Graham D I, 1988, Prog Clin Biol Res, V264, P159
   Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072
   Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298
   Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352
   Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004
   Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859
   LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167
   LUPA MT, 1993, J NEUROSCI, V13, P1326
   Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4
   National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA
   Pfister BJ, 2006, FEBS LETT, V580, P3525, DOI 10.1016/j.febslet.2006.05.030
   POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1
   Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095
   Rhodes TH, 2004, P NATL ACAD SCI USA, V101, P11147, DOI 10.1073/pnas.0402482101
   Rosenbluth J, 2009, BRAIN RES, V1253, P191, DOI 10.1016/j.brainres.2008.11.066
   Smith DH, 1999, J NEUROSCI, V19, P4263
   Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008
   Smith DH, 2000, NEUROSCIENTIST, V6, P483
   Takahashi A, 1999, PHYSIOL REV, V79, P1089
   Tarnawa István, 2007, Recent Pat CNS Drug Discov, V2, P57, DOI 10.2174/157488907779561754
   Uryu K, 2002, J NEUROSCI, V22, P446
   Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044
   Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023
   Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54
   Wolf JA, 2001, J NEUROSCI, V21, P1923
   Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134
   Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446
NR 34
TC 29
Z9 29
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0360-4012
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD DEC
PY 2009
VL 87
IS 16
BP 3620
EP 3625
DI 10.1002/jnr.22161
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA 515AN
UT WOS:000271438600010
PM 19565655
ER

PT J
AU Ailawadi, G
   Swenson, BR
   Girotti, ME
   Gazoni, LM
   Peeler, BB
   Kern, JA
   Fedoruk, LM
   Kron, IL
AF Ailawadi, Gorav
   Swenson, Brian R.
   Girotti, Micah E.
   Gazoni, Leo M.
   Peeler, Benjamin B.
   Kern, John A.
   Fedoruk, Lynn M.
   Kron, Irving L.
TI Is mitral valve repair superior to replacement in elderly patients?
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 54th Annual Meeting of the Southern-Thoracic-Surgical-Association
CY NOV 07-10, 2007
CL Bonita Springs, FL
SP SE Thorac Surg Assoc
ID LONG-TERM SURVIVAL; DEGENERATIVE DISEASE; 10-YEAR EXPERIENCE; VALVULAR
   SURGERY; CARDIAC-SURGERY; REGURGITATION; OUTCOMES; RECONSTRUCTION;
   OCTOGENARIANS; DURABILITY
AB Background. Mitral valve replacement is more frequently performed and perceived to be equivalent to repair in elderly patients, despite the superiority of repair in younger patients. Our objective was to compare mitral repair to replacement in elderly patients age 75 years or older. Patients younger than 75 years undergoing mitral valve surgery served as a reference population.
   Methods. Consecutive elderly patients undergoing operation for mitral regurgitation at our institution from 1998 to 2006 were reviewed. Elderly patients (mean age, 78.0 +/- 2.8 years) who underwent mitral repair (n = 70) or replacement (n = 47) were compared with cohorts of young patients (mean age, 58.9 +/- 9.3 years) who underwent repair (n = 100) or replacement (n = 98) during the same period. Patient details and outcomes were compared using univariate, multivariate, and Kaplan-Meier analyses.
   Results. Mitral replacement in elderly patients had higher mortality than repair (23.4%, 11 of 47 versus 7.1%, 5 of 70; p = 0.01) or as compared with either operation in the reference group (p < 0.0001). Postoperative stroke was higher in elderly replacement patients compared with repair (12.8%, 6 of 47 versus 0%; p = 0.003) or compared with either young cohort (p = 0.02). Compared with elderly repair patients, elderly replacement patients had more cerebrovascular disease (21.3%, 10 of 47 versus 4.3%, 3 of 70; p = 0.005) and rheumatic mitral valves (21.3%, 10 of 47 versus 0%; p = 0.0001). In the young group, overall complication and mortality were no different between replacement and repair. Long-term survival favored repair over replacement in elderly patients (p = 0.04). One elderly repair patient experienced late recurrence of persistent mitral regurgitation.
   Conclusions. In patients age 75 years or older, mitral repair is associated with a lower risk of mortality, postoperative stroke, and prolonged intensive care unit and hospital stay compared with mitral replacement. Mitral repair can be performed in preference over replacement even in patients older than the age of 75.
C1 [Ailawadi, Gorav; Swenson, Brian R.; Girotti, Micah E.; Gazoni, Leo M.; Peeler, Benjamin B.; Kern, John A.; Fedoruk, Lynn M.; Kron, Irving L.] Univ Virginia, Dept Surg, Charlottesville, VA USA.
RP Ailawadi, G (reprint author), POB 800679, Charlottesville, VA 22908 USA.
EM gorav@virginia.edu
CR Akins CW, 1997, ANN THORAC SURG, V64, P606, DOI 10.1016/S0003-4975(97)00615-2
   Alexander KP, 2000, J AM COLL CARDIOL, V35, P731, DOI 10.1016/S0735-1097(99)00606-3
   Braunberger E, 2001, CIRCULATION S1, V104
   COHN LH, 1995, ANN THORAC SURG, V60, P1452, DOI 10.1016/0003-4975(95)00379-Y
   Collart F, 2005, EUR J CARDIO-THORAC, V27, P276, DOI 10.1016/j.ejcts.2004.10.041
   DAVID TE, 1983, CIRCULATION, V68, P76
   Detaint D, 2006, CIRCULATION, V114, P265, DOI 10.1161/CIRCULATIONAHA.106.619239
   ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022
   FREMES SE, 1989, CIRCULATION, V80, P77
   Gazoni LM, 2007, ANN THORAC SURG, V83, P1658, DOI 10.1016/j.athoracsur.2007.01.028
   Gazoni LM, 2007, ANN THORAC SURG, V84, P750, DOI 10.1016/j.athoracsur.2007.04.098
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4
   Gogbashian A, 2006, AM HEART J, V151, P1325, DOI 10.1016/j.ahj.2005.07.003
   Goldsmith I, 1999, J HEART VALVE DIS, V8, P702
   Grossi EA, 2000, ANN THORAC SURG, V70, P1224, DOI 10.1016/S0003-4975(00)01661-1
   JEBARA VA, 1992, CIRCULATION, V86, P53
   KOMEDA M, 1994, CIRCULATION, V90, P190
   KUMAR AS, 1995, ANN THORAC SURG, V60, P1044, DOI 10.1016/0003-4975(95)00486-5
   Lee EM, 1996, CIRCULATION, V94, P2117
   Nagendran J, 2005, EUR J CARDIO-THORAC, V28, P83, DOI 10.1016/j.ejcts.2004.12.067
   NAIR CK, 1992, AM HEART J, V124, P154, DOI 10.1016/0002-8703(92)90934-N
   Piciche M, 2002, J CARDIOVASC SURG, V43, P327
   Savage EB, 2003, ANN THORAC SURG, V75, P820, DOI 10.1016/S0003-4975(02)04645-3
   Suri RM, 2006, ANN THORAC SURG, V82, P819, DOI 10.1016/j.athoracsur.2006.03.091
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   TSAI TP, 1994, ANN THORAC SURG, V58, P445
NR 27
TC 29
Z9 31
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUL
PY 2008
VL 86
IS 1
BP 77
EP 86
DI 10.1016/j.athoracsur.2008.03.020
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 316FK
UT WOS:000256934400012
PM 18573402
ER

PT J
AU Fiore, AC
   Rodefeld, M
   Turrentine, M
   Vijay, P
   Reynolds, T
   Standeven, J
   Hill, K
   Bost, J
   Carpenter, D
   Tobin, C
   Brown, JW
AF Fiore, Andrew C.
   Rodefeld, Mark
   Turrentine, Mark
   Vijay, Palaniswamy
   Reynolds, Tyler
   Standeven, John
   Hill, Kirstin
   Bost, Jamie
   Carpenter, Dustin
   Tobin, Courtney
   Brown, John W.
TI Pulmonary valve replacement: A comparison of three biological valves
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 53rd Annual Meeting of the Southern-Thoracic-Surgical-Association
CY NOV 08-11, 2006
CL Tucson, AZ
SP SE Thorac Surg Assoc
ID OUTFLOW TRACT RECONSTRUCTION; TETRALOGY; FALLOT; REPAIR; CHILDREN;
   REGURGITATION; DYSFUNCTION; PREVENTION; HOMOGRAFT; CONDUITS
AB Background. We retrospectively reviewed the performance of the mosaic porcine, bovine pericardial, and homograft prostheses for pulmonary valve replacement to correct chronic pulmonary insufficiency.
   Methods. From January 1995 to August 2006, 82 patients ( mean age, 22.7 years) underwent valve replacement with porcine ( 49 patients), bovine pericardial (18 patients), or pulmonary homograft (15 patients) prosthesis at a mean of 15.3 years after initial outflow tract reconstruction. Excluded were patients with extracardiac conduits, monocusp valves, or the Ross procedure. The groups were similar with respect to age, body surface area, degree of regurgitation, right ventricular dimension, right ventricular to pulmonary artery gradient, and valve size. Followup was longer in the homograft cohort ( porcine, 20 +/- 27 months; pericardial, 42 +/- 21; homograft, 49 +/- 40; p < 0.01).
   Results. All three prostheses significantly reduce chronic pulmonary regurgitation, but late insufficiency was higher with homografts. Right ventricular dimension was significantly reduced in the stented but not the allograft cohorts. Late valve dysfunction was highest with homografts ( 54%), followed by porcine (19%) and pericardial valves (5.5%; p < 0.05. Functional class and mild to moderate tricuspid insufficiency significantly improved with pulmonary valve replacement. Early and late mortality was 3.6% and 1.2%, respectively.
   Conclusions. All three prostheses performed similarly for 3 years. Pulmonary regurgitation developed more frequently in homografts albeit at a longer duration of follow-up.
C1 [Fiore, Andrew C.] St Louis Univ, Sch Med, Cardinal Glennon Childrens Hosp, Div Cardiothorac Surg, St Louis, MO 63104 USA.
   Indiana Univ, Sch Med, James Whitcomb Riley Childrens Hosp, Indianapolis, IN USA.
RP Fiore, AC (reprint author), St Louis Univ, Sch Med, Cardinal Glennon Childrens Hosp, Div Cardiothorac Surg, 1465 S Grand Blvd, St Louis, MO 63104 USA.
EM fiorem2@slu.edu
CR Allen BS, 2002, ANN THORAC SURG, V74, P771, DOI 10.1016/S0003-4975(02)03767-0
   Brown JW, 2005, ANN THORAC SURG, V80, P655, DOI 10.1016/j.athorascur.2005.02.053
   Brown JW, 2006, ANN THORAC SURG, V82, P909, DOI 10.1016/j.athoracsur.2006.03.008
   de Ruijter FTH, 2002, ANN THORAC SURG, V73, P1794, DOI 10.1016/S0003-4975(02)03586-5
   Discigil B, 2001, J THORAC CARDIOV SUR, V121, P344, DOI 10.1067/mtc.2001.111209
   Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045
   Kanter KR, 2001, ANN THORAC SURG, V72, P1344, DOI 10.1016/S0003-4975(01)02976-9
   Kanter KR, 2003, ANN THORAC SURG, V76, P1889, DOI 10.1016/S0003-4975(03)01304-3
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   MISBACH GA, 1983, ANN THORAC SURG, V36, P684
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Ohye RG, 2004, J THORAC CARDIOV SUR, V127, P465, DOI 10.1016/j.jtcvs.2003.07.053
   OURY JH, 1998, ANN THORAC SURG S, V66, P162
   Pibarot P, 2000, J AM COLL CARDIOL, V36, P1131, DOI 10.1016/S0735-1097(00)00859-7
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SHADDY RE, 1992, AM J CARDIOL, V70, P392, DOI 10.1016/0002-9149(92)90627-B
   Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8
   Warner KG, 2003, ANN THORAC SURG, V76, P1066, DOI 10.1016/S0003-4975(03)00748-3
   WARNER KG, 1993, CIRCULATION, V88, P189
NR 19
TC 29
Z9 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAY
PY 2008
VL 85
IS 5
BP 1712
EP 1718
DI 10.1016/j.athoracsur.2008.02.001
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 293FE
UT WOS:000255319900031
PM 18442571
ER

PT J
AU Nation, M
   Vieno, A
   Perkins, DD
   Santinello, M
AF Nation, Maury
   Vieno, Alessio
   Perkins, Douglas D.
   Santinello, Massimo
TI Bullying in school and adolescent sense of empowerment: An analysis of
   relationships with parents, friends, and teachers
SO JOURNAL OF COMMUNITY & APPLIED SOCIAL PSYCHOLOGY
LA English
DT Article
DE bullying; power; empowerment; parenting; family; youth violence;
   adolescents; adolescence; HBSC
ID SINGLE PARENTS; SELF-EFFICACY; AUTONOMY; VICTIMIZATION; CHILDREN;
   PERCEPTIONS; ASSOCIATION; BEHAVIORS; VICTIMS; PEERS
AB We explore the development of bullying and victimization in school by investigating 11-, 13- and 15-year-olds' sense of interpersonal empowerment with parents, friends and teachers. A national sample of 4386 male and female students from 243 middle and secondary schools in Italy were surveyed. Boys were more likely than girls to be bullies and more likely to have been a bully/victim. Victimization and the likelihood of being both a bully and a victim declined with age. Bullying increased with age among boys whereas for girls it was slightly more prevalent at age 13 than ages 11 or 15. The sense of empowerment students experience with their teachers decreased in the older cohorts. Disempowered relationships with teachers consistently predicted bullying behaviour. Higher social competence was reported by 13- and 15-year-old bullies. Chronically bullied students had lower social competence in all age cohorts. Otherwise, predictors of victimization varied by age: 11-year-old victims felt less empowered by their teachers; 15-year-old victims reported more difficulties in negotiating cooperative relationships with parents. Bullies in all cohorts and younger bully/victims feel less empowered by their teachers. These findings suggest that students who are disempowered by teachers may either compensate by oppressing (bullying) peers or generalize the power differential with peers (become a victim). Copyright (c) 2007 John Wiley & Sons, Ltd.
C1 [Nation, Maury; Perkins, Douglas D.] Vanderbilt Univ, Dept Human & Org Dev, Ctr Community Studies, Nashville, TN 37203 USA.
   [Vieno, Alessio; Santinello, Massimo] Univ Padua, Dept Dev & Social Psychol, I-35100 Padua, Italy.
RP Nation, M (reprint author), Vanderbilt Univ, Dept Human & Org Dev, Ctr Community Studies, Peabody 90, Nashville, TN 37203 USA.
EM maury.nation@vanderbilt.edu
CR Aaro L. E., 1986, HLTH PROMOTION, V1, P17, DOI 10.1093/heapro/1.1.17
   Andreou E, 2004, BRIT J EDUC PSYCHOL, V74, P297, DOI 10.1348/000709904773839897
   Arnstein S. R., 1971, CITIZEN PARTICIPATIO, P69
   Baldry A., 2000, J COMMUNITY APPL SOC, V22, P423
   Bernstein JY, 1997, J INTERPERS VIOLENCE, V12, P483, DOI 10.1177/088626097012004001
   Boulding Kenneth E., 1989, 3 FACES POWER
   Bru E, 2002, J SCHOOL PSYCHOL, V40, P287, DOI 10.1016/S0022-4405(02)00104-8
   Bumpus MF, 2001, DEV PSYCHOL, V37, P163, DOI 10.1037//0012-1649.37.2.163
   Camodeca M, 2005, J CHILD PSYCHOL PSYC, V46, P186, DOI 10.1111/j.1469-7610.2004.00347.x
   Currie C, 2001, HLTH BEHAV SCH AGED
   Curtner-Smith M. E., 2000, CHILD STUDY J, V30, P169
   DELUTY RH, 1983, J CLIN CHILD PSYCHOL, V12, P124, DOI 10.1207/s15374424jccp1202_1
   DODGE KA, 1997, DEV PERSPECTIVES TRA, P263
   Doll B, 2004, BULLYING IN AMERICAN SCHOOLS: A SOCIAL-ECOLOGICAL PERSPECTIVE ON PREVENTION AND INTERVENTION, P161
   DORNBUSCH SM, 1985, CHILD DEV, V56, P326, DOI 10.2307/1129723
   Finnegan RA, 1998, J PERS SOC PSYCHOL, V75, P1076, DOI 10.1037/0022-3514.75.4.1076
   Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x
   Gilligan C., 1982, DIFFERENT VOICE
   GROLNICK WS, 1987, J PERS SOC PSYCHOL, V52, P890, DOI 10.1037/0022-3514.52.5.890
   Harter S., 1988, MANUAL SELF PERCEPTI
   Ladd GW, 1998, DEV PSYCHOL, V34, P1450, DOI 10.1037//0012-1649.34.6.1450
   Leary MR, 2003, AGGRESSIVE BEHAV, V29, P202, DOI 10.1002/ab.10061
   MULLAN E, 2001, HLTH BEHAV SCH AGED, P175
   Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094
   NATION M, 2007, HDB PREVENTION INTER, P239
   OLWEUS D, 1994, J CHILD PSYCHOL PSYC, V35, P1171, DOI 10.1111/j.1469-7610.1994.tb01229.x
   Osterman K., 1997, CULTURAL VARIATION C, P185
   Pellegrini AD, 2004, BULLYING IN AMERICAN SCHOOLS: A SOCIAL-ECOLOGICAL PERSPECTIVE ON PREVENTION AND INTERVENTION, P107
   Pellegrini AD, 2001, MERRILL PALMER QUART, V47, P142, DOI 10.1353/mpq.2001.0004
   Perkins DD, 1995, AM J COMMUN PSYCHOL, V23, P569, DOI 10.1007/BF02506982
   PERRY DG, 1990, CHILD DEV, V61, P1310, DOI 10.1111/j.1467-8624.1990.tb02863.x
   Pinquart M, 2002, J ADOLESCENCE, V25, P509, DOI 10.1006/jado.2002.0491
   Prilleltensky I, 2001, J COMMUNITY APPL SOC, V11, P143, DOI 10.1002/casp.616
   Roland E, 2002, EDUC RES-UK, V44, P299, DOI 10.1080/0013188022000031597
   Scholz U, 2002, EUR J PSYCHOL ASSESS, V18, P242, DOI 10.1027//1015-5759.18.3.242
   Schwartz D, 1997, CHILD DEV, V68, P665, DOI 10.2307/1132117
   Schwarzer R., 1992, SELF EFFICACY THOUGH
   Smith P. K., 1994, SCH BULLYING INSIGHT, P1
   STEINBERG L, 1986, CHILD DEV, V57, P841, DOI 10.1111/j.1467-8624.1986.tb00250.x
   STEINBERG L, 1987, CHILD DEV, V58, P269, DOI 10.1111/j.1467-8624.1987.tb03505.x
   Thompson SK, 1999, SAMPLING
   Torsheim T, 2000, SCHOOL PSYCHOL INT, V21, P195, DOI 10.1177/0143034300212006
   TROY M, 1987, J AM ACAD CHILD PSY, V26, P166, DOI 10.1097/00004583-198703000-00007
   VAILLANCOURT T, 2003, BULLYING PEER HARASS, P157
   Vieno A, 2005, AM J COMMUN PSYCHOL, V36, P327, DOI 10.1007/s10464-005-8629-8
   WOLD B, 1993, WHO CROSS NATL SURVE
   Zimmerman MA, 1995, AM J COMMUN PSYCHOL, V23, P581, DOI 10.1007/BF02506983
NR 47
TC 29
Z9 29
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1052-9284
J9 J COMMUNITY APPL SOC
JI J. Community Appl. Soc. Psychol.
PD MAY-JUN
PY 2008
VL 18
IS 3
BP 211
EP 232
DI 10.1002/casp.921
PG 22
WC Psychology, Social
SC Psychology
GA 304JN
UT WOS:000256105900004
ER

PT J
AU Dawson, DR
   Schwartz, ML
   Winocur, G
   Stuss, DT
AF Dawson, Deirdre R.
   Schwartz, Michael L.
   Winocur, Gordon
   Stuss, Donald T.
TI Return to productivity following traumatic brain injury: Cognitive,
   psychological, physical, spiritual, and environmental correlates
SO DISABILITY AND REHABILITATION
LA English
DT Article
DE traumatic brain injury; productivity; coping
ID SEVERE HEAD-INJURY; COMA-DATA-BANK; CHRONIC PAIN; POSTTRAUMATIC AMNESIA;
   COPING STRATEGIES; EMPLOYMENT STATUS; CONCEPTUAL-MODEL; SOCIAL SUPPORT;
   RECOVERY; DEPRESSION
AB Purpose. The purpose of this study was to investigate the determinants and correlates of return to productivity (RTP) defined here as return to paid employment and/or school four years following traumatic brain injury (TBI).
   Method. Participants included 46 people with TBI, part of a prospective, cohort study, and 14 friend/family member controls all employed and/or in school at time of injury or inception into the study. Variables were selected for investigation based on two models of recovery. Demographic and injury severity data including time to recover free recall were collected at time of injury, on admission to a trauma unit. Data on other variables (neuropsychological, psychological, physical, spiritual, environmental) were collected concurrent with productivity status at a mean of 4.3 years post-TBI.
   Results. Time to recover free recall (measured acutely), neuropsychological status, pain severity, depression, and the use of maladaptive coping behaviours were all related to productivity status (p < 0.05). When these variables were entered into exploratory, planned hierarchical logistic regression models time to free recall, pain, and maladaptive coping remained in the models with depression only dropping out because of the high correlation with pain (r > 0.80).
   Conclusions. Injury severity (time to free recall), physical status (pain), and psychological status (depression, coping) are important to understanding differences in productivity outcomes. Addressing pain, depression and coping in rehabilitation programs may have a positive impact on outcomes.
C1 Baycrest, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada.
   Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada.
   Univ Toronto, Dept Occupat Sci, Toronto, ON, Canada.
   Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada.
   Univ Toronto, Dept Med, Toronto, ON, Canada.
   Univ Toronto, Dept Psychol, Toronto, ON, Canada.
   Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada.
   Baycrest, Rotman Res Inst, Toronto, ON, Canada.
RP Dawson, DR (reprint author), Baycrest, Kunin Lunenfeld Appl Res Unit, 2560 Bathurst St, Toronto, ON M6A 2E1, Canada.
EM ddawson@klaru-baycrest.on.ca
RI Dawson, Deirdre/I-8882-2014
OI Dawson, Deirdre/0000-0001-7517-6121
CR ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42
   ANTONAK RF, 1993, J HEAD TRAUMA REHAB, V8, P87
   Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737
   Beck A. T, 1978, BECK DEPRESSION INVE
   Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3
   BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001
   BOSCHEN KA, 1995, VARIABLES AFFECTING
   Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547
   Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821
   Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012
   Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566
   Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240
   CODY RP, 1997, APPL STAT SAS PPROGR
   Cohen S, 1985, SOCIAL SUPPORT THEOR, P73, DOI DOI 10.1007/978-94-009-5115-0_5
   Coughlin AM, 2000, ARCH PHYS MED REHAB, V81, P739, DOI 10.1053/apmr.2000.5586
   Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006
   Dawson DR, 2006, BRAIN COGNITION, V60, P214
   Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406
   Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258
   DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997
   DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177
   Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985
   Finset A, 2000, BRAIN INJURY, V14, P887
   Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39
   Folkman S., 1988, MANUAL WAYS COPING Q
   Frankl V. E., 1963, MANS SEARCH MEANING
   Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7
   Harvey AG, 1998, BRAIN INJURY, V12, P147
   JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285
   JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369
   Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037//0021-9010.86.1.80
   KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661
   Kennedy P, 2003, BRIT J CLIN PSYCHOL, V42, P41, DOI 10.1348/014466503762842002
   KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1
   KEYSERMARCUS LA, 2003, ARCH PHYS MED REHAB, V83, P635
   Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318
   KLONOFF PS, 1986, NEUROSURGERY, V19, P735
   Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0
   Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615
   LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699
   Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491
   LEZAK MD, 1995, NEUROPSYCHOLOGICAL A
   Logan M., 2000, DISS ABSTR INT, V61, P881
   LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959
   MCCOLL MA, 1995, DISABIL REHABIL, V17, P24
   McColl MA, 2000, ARCH PHYS MED REHAB, V81, P817, DOI 10.1053/apmr.2000.5567
   MCCOLL MA, 1995, INT J REHABIL RES, V18, P325, DOI 10.1097/00004356-199512000-00004
   MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129
   MOORE AD, 1994, BRAIN INJURY, V7, P193
   MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185
   NOMAN GR, 2000, BIOSTATISTICS BARE E
   NOSEK MA, 1992, REHABIL COUNS BULL, V36, P21
   Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222
   Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919
   Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700
   Ownsworth TL, 1998, BRAIN INJURY, V12, P735
   PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566
   Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082
   Prigatano GP, 1999, PRINCIPLES NEUROPSYC
   REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057
   Reker G. T., 1992, MANUAL LIFE ATTITUDE
   RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164
   SAS Institute Inc, 1999, SAS VERS 8 2
   Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108
   Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823
   Spreen O., 1998, COMPENDIUM NEUROPSYC
   STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164
   Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/0096-3445.121.1.15
   STROUP ES, 2000, DISS ABSTR INT, V60, P4913
   Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230
   Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635
   STUSS DT, 1985, NEUROSURGERY, V17, P41
   TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764
   THOMPSON JL, 1986, METHODS OBSERVATIONA
   Turner G., 2004, Cognitive and behavioral rehabilitation, P224
   TYRER S, 2003, NEUROPSYCHOL REHABIL, P189
   UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61
   WECHSLER D, 1981, WECSLER ADULT INTELL
   Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001
   *WHO, 1976, INT CLASS IMP DIS HA
   Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]
   WINOCUR G, J INT NEUROPSYCHOLOG
   World Health Organisation, 2001, INT CLASS FUNCT DIS
NR 83
TC 29
Z9 30
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0963-8288
J9 DISABIL REHABIL
JI Disabil. Rehabil.
PD FEB 28
PY 2007
VL 29
IS 4
BP 301
EP 313
DI 10.1080/09638280600756687
PG 13
WC Rehabilitation
SC Rehabilitation
GA 140SJ
UT WOS:000244526700004
PM 17364780
ER

PT J
AU Sodian, R
   Lueders, C
   Kraemer, L
   Kuebler, W
   Shakibaei, M
   Reichart, B
   Daebritz, S
   Hetzer, R
AF Sodian, R
   Lueders, C
   Kraemer, L
   Kuebler, W
   Shakibaei, M
   Reichart, B
   Daebritz, S
   Hetzer, R
TI Tissue engineering of autologous human heart valves using cryopreserved
   vascular umbilical cord cells
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID PULMONARY-ARTERY; CARDIOVASCULAR TISSUE; REPLACEMENT; CHILDREN; MODEL
AB Background. Tissue engineering of autologous heart valves with the potential to grow and to remodel represents a promising concept in pediatric cardiovascular surgery. Currently we are exploring the impact of cryopreserved human umbilical cord cells ( CHUCCs) for the fabrication of tissue-engineered heart valves for patients diagnosed prenatally with congenital heart lesions, potentially enabling heart valve replacement in the early years of life.
   Methods. Human umbilical cord cells were isolated from vascular segments of umbilical cords and cryopreserved in a cell bank. After 12 weeks the cryopreserved cells were again expanded in culture and characterized by histology, immunohistochemistry, and proliferation assays. Trileaflet heart valve scaffolds were fabricated from a porous polymer (P4HB, Tepha Inc, Cambridge, MA) and sequentially seeded with CHUCCs ( n = 10). Five of the heart valve constructs were grown for 7 days in a pulse duplicator and, as a control, five constructs were grown under static cell culture conditions for 7 days. Analysis of all tissue-engineered heart valves included histology, immunohistochemistry, electron microscopy, functional analysis, and biomechanical and biochemical examination.
   Results. We found that CHUCCs remained viable after 12 weeks of cryopreservation and showed a myofibroblast-like morphology that stained positive for alpha-actin and fibroblast specific marker. Histology of the tissuee-engineered heart valves showed layered tissue formation, including connective tissue between the inside and the outside of the porous scaffold. Immunohistochemistry was positive for collagen ( types I, III, and IV), desmin, laminin, and alpha-actin. Electron microscopy showed that the cells had grown into the pores and formed a confluent tissue layer during maturation in the pulsatile flow system. Biochemical examination showed an increase of extracellular matrix formation in constructs after pulsatile flow exposure compared with the static control group. Functional analysis demonstrated a physiological increase of the intracellular Ca2+ concentration of the recultivated cells and the conditioned constructs after stimulation with histamine.
   Conclusions. This study demonstrates in vitro generation of viable and functional human heart valves based on CHUCCs and biomimetic flow culture systems. The CHUCCs demonstrated excellent growth potential and abilities of in vitro tissue formation. These findings suggest the potential benefit of establishing autologous human cell banks for pediatric patients diagnosed intrauterinely with congenital defects that will potentially require heart valve replacement in the early years of life.
C1 Univ Munich, Dept Cardiovasc Surg, D-81377 Munich, Germany.
   Charite Med Univ, Dept Physiol & Cell Biol, Berlin, Germany.
   Charite Med Univ, Dept Neurobiol, Berlin, Germany.
   Deutsch Herzzentrum, Dept Cardiothorac & Vasc Surg, Berlin, Germany.
RP Sodian, R (reprint author), Univ Munich, Dept Cardiac Surg, Lab Tissue Engn & Cell Transplantat, Marchioninistr 15, D-81377 Munich, Germany.
EM ralf.sodian@med.uni-muenchen.de
CR Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Brown JW, 2003, ANN THORAC SURG, V76, P1398, DOI 10.1016/S0003-4975(03)01027-0
   Erez E, 2003, J HEART VALVE DIS, V12, P30
   Erez E, 2003, J HEART VALVE DIS, V12, P25
   Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2
   HANLEY FL, 1993, J THORAC CARDIOV SUR, V105, P1047
   Hoerstrup SP, 2002, ASAIO J, V48, P234, DOI 10.1097/00002480-200205000-00006
   Mayer JE, 2002, ANN THORAC SURG, V74, P52
   Hoerstrup SP, 2000, TISSUE ENG, V6, P75, DOI 10.1089/107632700320919
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup S.P, 2002, CIRCULATION S1, V106, P143
   Kadner A, 2004, EUR J CARDIO-THORAC, V25, P635, DOI 10.1016/j.ejcts.2003.12.038
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kuebler WM, 1999, J CLIN INVEST, V104, P495, DOI 10.1172/JCI6872
   Lanza Robert, PRINCIPLES TISSUE EN
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   Mayer JE, 1997, CURR OPIN CARDIOL, V12, P528, DOI 10.1097/00001573-199711000-00005
   Raghuveer G, 2003, CIRCULATION, V108, P174, DOI 10.1161/01.cir.0000087659.65791.42
   Schoen FJ, 1999, J HEART VALVE DIS, V8, P350
   Schulze-Tanzil G, 2002, CELL TISSUE RES, V308, P371, DOI 10.1007/s00441-002-0562-7
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shinoka T, 1996, CIRCULATION, V94, P164
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 27
TC 29
Z9 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUN
PY 2006
VL 81
IS 6
BP 2207
EP 2216
DI 10.1016/j.athoracsur.2005.12.073
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 049PD
UT WOS:000238027600040
PM 16731156
ER

PT J
AU Gillinov, AM
   Blackstone, EH
   Rajeswaran, J
   Mawad, M
   McCarthy, PM
   Sabik, JF
   Shiota, T
   Lytle, BW
   Cosgrove, DM
AF Gillinov, AM
   Blackstone, EH
   Rajeswaran, J
   Mawad, M
   McCarthy, PM
   Sabik, JF
   Shiota, T
   Lytle, BW
   Cosgrove, DM
TI Ischemic versus degenerative mitral regurgitation: Does etiology affect
   survival?
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 41st Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 24-26, 2005
CL Tampa, FL
SP Soc Thorac Surg
ID LONG-TERM SURVIVAL; CORONARY-ARTERY SURGERY; VALVE REPAIR;
   SURGICAL-TREATMENT; REPLACEMENT; DISEASE; RECONSTRUCTION
AB Background. Ischemic mitral regurgitation (MR) is associated with poor survival and degenerative MR with excellent survival. We hypothesized that in some patients with degenerative MR requiring concomitant coronary artery bypass grafting (CABG), ischemic disease would dominate prognosis, resulting in survival as poor as in patients with ischemic MR. Thus, we (1) determined survival impact of etiology (degenerative vs ischemic) after combined mitral valve repair and CABG and (2) explored survival differences within etiology groups.
   Methods. From 1985 to 2003, 710 patients underwent mitral valve repair for degenerative MR and concomitant CABG (two diseases); 400 patients had mitral annuloplasty and CABG for functional ischemic MR (one disease). Patients were propensity-matched on demography, symptoms, comorbidities, coronary artery disease, and left ventricular function. Survival was compared between matched groups and within groups.
   Results. Compared with patients with degenerative MR, those with ischemic MR had more extensive coronary artery disease, worse ventricular function, more comorbidities, and more symptoms (p < 0.05). Unadjusted 5-year survivals were 64% and 82% for patients with ischemic and degenerative MR, respectively. However, 123 ischemic and degenerative MR matched pairs had equivalently poor 5-year survival (p > 0.9), 66% and 65%, respectively. Among patients with degenerative MR, survival varied widely, depending largely on ischemic burden and extent of left ventricular dysfunction.
   Conclusions. The large survival discrepancy between patients with ischemic and degenerative MR is attributable to differences in patient profile, particularly extent of ischemic disease and left ventricular dysfunction. Thus, ischemic and degenerative MR patients with equivalent characteristics have equivalently poor survival.
C1 Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA.
RP Gillinov, AM (reprint author), Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, 9500 Euclid Ave,Desk F24, Cleveland, OH 44195 USA.
EM gillinom@ccf.org
CR Adams DH, 2002, J HEART VALVE DIS, V11, pS21
   AKINS CW, 1994, ANN THORAC SURG, V58, P668
   BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989
   Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2001.120329
   Bouchard D, 2001, CAN J CARDIOL, V17, P427
   Braunberger E, 2001, CIRCULATION S1, V104
   Cohn LH, 2002, ADV CARDIOL, V39, P153
   COHN LH, 1995, EUR J CARDIO-THORAC, V9, P568, DOI 10.1016/S1010-7940(05)80008-9
   Dahlberg PS, 2003, ANN THORAC SURG, V76, P1539, DOI 10.1016/S0003-4975(03)01071-3
   Ellis SG, 2002, AM J CARDIOL, V89, P315, DOI 10.1016/S0002-9149(01)02231-7
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Gillinov AM, 2003, J THORAC CARDIOV SUR, V125, P1350, DOI 10.1016/S0022-5223(02)73274-1
   Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4
   Glower DD, 2005, J THORAC CARDIOV SUR, V129, P860, DOI 10.1016/j.jtcvs.2004.11.023
   Grigioni F, 2001, CIRCULATION, V103, P1759
   Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945
   Hung J, 2004, CIRCULATION S2, V110, pII85, DOI 10.1161/01.CIR.0000138192.65015.45
   KIRKLIN JK, 1989, CIRCULATION, V79, P185
   Kwan J, 2003, CIRCULATION, V107, P1135, DOI 10.1161/01.CIR.0000053558.55471.2D
   McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037
   Miller DC, 2001, J THORAC CARDIOV SUR, V122, P1059, DOI 10.1067/mtc.2001.120341
   Mohty D, 2001, CIRCULATION S1, V104, P1
   ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398
   Seipelt RG, 2001, EUR J CARDIO-THORAC, V20, P270, DOI 10.1016/S1010-7940(01)00817-X
   Szecsi J, 1994, J Heart Valve Dis, V3, P236
   Tahta SA, 2002, J HEART VALVE DIS, V11, P11
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
NR 27
TC 29
Z9 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD SEP
PY 2005
VL 80
IS 3
BP 811
EP 819
DI 10.1016/j.athoracsur.2005.03.134
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 961TC
UT WOS:000231683700007
PM 16122434
ER

PT J
AU Manchio, JV
   Gu, JY
   Romar, L
   Brown, J
   Gammie, J
   Pierson, RN
   Griffith, B
   Poston, RS
AF Manchio, JV
   Gu, JY
   Romar, L
   Brown, J
   Gammie, J
   Pierson, RN
   Griffith, B
   Poston, RS
TI Disruption of graft endothelium correlates with early failure after
   off-pump coronary artery bypass surgery
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 51st Annual Meeting of the Southern-Thoracic-Surgical-Association
CY NOV 02-04, 2004
CL Cancun, MEXICO
SP So Thorac Surg Assoc
ID SAPHENOUS-VEIN GRAFTS; COMPUTED-TOMOGRAPHY; RANDOMIZED-TRIAL; PATENCY;
   THROMBOELASTOGRAPHY; CONDUITS; ASPIRIN; FATE
AB Background. Saphenous vein graft failure after coronary artery bypass surgery may be as high as 5% to 10% in the first postoperative week. We hypothesized that identifying damage sustained by saphenous vein endothelium before grafting predicts early graft attrition after off-pump coronary artery bypass graft surgery.
   Methods. Intraoperative graft flow, platelet function, and endothelial integrity were analyzed in 125 patients undergoing off-pump coronary artery bypass graft surgery. Endothelial integrity was assessed in an excess vein segment from each graft using immunohistochemistry (CD31 staining). Platelet function was monitored just before and immediately after revascularization and on postoperative days 1 and 3 using whole blood aggregometry, thrombelastography, and platelet activated clotting time. Platelet activation was monitored using flow cytometry. Intraoperative conduit blood flow, measured by transit time ultrasonography, was used to detect and rectify anastomotic problems. Early graft patency was determined on postoperative day 5 using gated multichannel computed tomography angiography.
   Results. In 106 patients undergoing postoperative computed tomography evaluation, 10 vein grafts in 10 patients were discovered to have developed early thrombosis, representing 4% (10 of 217) of all vein grafts. Endothelial integrity was 10.75% +/- 17.56% in 10 grafts that failed early compared with 51.45% +/- 36.29% in patent grafts (p = 0.04). Perioperative platelet function and graft flow did not differ significantly between the two groups.
   Conclusions. Although endothelial disruption predicts early failure of bypass grafts, the importance of a hypercoaguable state and low graft flow as a cause of early graft thrombosis after off-pump coronary artery bypass graft surgery was not supported by our preliminary results. A means to assess, prevent, and treat intraoperative vein graft damage will likely improve early graft patency. (c) 2005 by The Society of Thoracic Surgeons.
C1 Univ Maryland, Sch Med, Div Cardiac Surg, Baltimore, MD 21201 USA.
RP Poston, RS (reprint author), Univ Maryland, Sch Med, Div Cardiac Surg, N4W94 22 S Greene St, Baltimore, MD 21201 USA.
EM rposton@smail.umaryland.edu
CR Alderman EL, 1999, J THORAC CARDIOV SUR, V118, P979
   ANGELINI GD, 1985, CARDIOVASC RES, V19, P326, DOI 10.1093/cvr/19.6.326
   BICK RL, 1992, HEMATOL ONCOL CLIN N, V6, P1421
   COOK R, 2002, J THORAC CARDIOVASC, V127, P65
   Cornelissen J, 2004, ARTERIOSCL THROM VAS, V24, P451, DOI 10.1161/01.ATV.0000116690.17017.8b
   D'Ancona G, 2000, ANGIOLOGY, V51, P725, DOI 10.1177/000331970005100904
   Davis Z, 2004, J THORAC CARDIOV SUR, V127, P823, DOI 10.1016/j.jtcvs.2003.10.051
   DILLEY RJ, 1992, AUT NZ J SURG, V62, P2973
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   FITZGIBBON GM, 1986, J THORAC CARDIOV SUR, V91, P773
   GHARAGOZLOO F, 1999, CHEST S2, V116, P379
   HEMANT TS, 2003, ANN THORAC SURG, V75, P1145
   Kawasaki J, 2004, ANESTH ANALG, V99, P1440, DOI 10.1213/01.ANE.0000134805.30532.59
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kiaii B, 2002, J THORAC CARDIOV SUR, V123, P204, DOI 10.1067/mtc.2002.118682
   Lauer MS, 1998, LANCET, V351, P615, DOI 10.1016/S0140-6736(97)07062-1
   MacDonald TM, 2003, LANCET, V361, P573, DOI 10.1016/S0140-6736(03)12509-3
   Motwani JG, 1998, CIRCULATION, V97, P916
   Oshita K, 1999, ANESTH ANALG, V89, P296, DOI 10.1097/00000539-199908000-00006
   Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P1897, DOI 10.1001/jama.291.15.1897
   POSTON RS, 2004, HEART SURG FORUM, V7, P123
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   ROUBOS N, 1995, CIRCULATION, V92, P1131
   Schlosser T, 2004, J AM COLL CARDIOL, V44, P1224, DOI 10.1016/j.jacc.2003.09.075
   Shi Y, 1997, CIRCULATION, V95, P2684
   Shi Y, 2001, CIRCULATION, V103, P2408
   Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016
   Stein PD, 2004, CHEST, V126, P600
   TABUCHI N, 1993, BLOOD, V82, P2930
   Tatoulis J, 2004, ANN THORAC SURG, V77, P93, DOI 10.1016/S0003-4975(03)01331-6
   Tsui JCS, 2001, BRIT J SURG, V88, P1209, DOI 10.1046/j.0007-1323.2001.01855.x
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Zimmermann N, 2003, CIRCULATION, V108, P542, DOI 10.1161/01.CIR.0000081770.51929.5A
NR 33
TC 29
Z9 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUN
PY 2005
VL 79
IS 6
BP 1991
EP 1998
DI 10.1016/j.athorascur.2004.12.054
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 931YJ
UT WOS:000229521100028
PM 15919298
ER

PT J
AU Legare, JF
   Buth, KJ
   Hirsch, GM
AF Legare, JF
   Buth, KJ
   Hirsch, GM
TI Conversion to on pump from OPCAB is associated with increased mortality:
   results from a randomized controlled trial
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 18th Annual Meeting of the
   European-Association-for-Cardiothoracic-Surgery/12th Annual Meeting of
   the European-Society-of-Thoracic-Surgeons
CY SEP 12-15, 2004
CL Leipzig, GERMANY
SP European Assoc Cardiothorac Surg, European Soc Thorac Surg
DE CABG; coronary; off pump; cardiopulmonary bypass
ID CORONARY-ARTERY-BYPASS; OFF-PUMP; ON-PUMP; BEATING-HEART; MYOCARDIAL
   REVASCULARIZATION; EXTRACORPOREAL-CIRCULATION; CARDIOPULMONARY BYPASS;
   SURGERY; OUTCOMES; PREDICTORS
AB Objective: Recent developments in cardiac stabilization devices, have made OPCAB feasible. However, there is conflicting evidence to date regarding the rate and adverse events associated with conversion from OPCAB to CABG with CPB. The objective of the present study was to review all conversions in the setting of a randomized controlled trial comparing CABG with or without CPB. Methods: Three hundred patients requiring CABG surgery at a single institution were prospectively randomized to have the procedure performed with CPB (n=150) or OPCAB (n = 150). Patients that could not be performed OPCAB were defined as conversion group (cross over). Results:Twenty patients were converted from OPCAB to CABG with CPB because of hemodynamic instability (14/20), small target vessel (5/20), or inadequate visualization (1/20). Seventeen were converted during attempts at coronary anastomosis: LAD/diagonal (7/20), circumflex (8/20), or right coronary (2/20). The overall in hospital mortality rate for the trial was 1% but was significantly higher in converted patients (10 vs. 0%; P=0.01). Converted patients required significantly more inotropes (P=0.001) and blood transfusions (P=0.05). An elevated BMI was the only pre-operative variable that appeared to be associated with conversion. Conclusions: In the setting of a randomized controlled trial the overall conversion rate associated with OPCAB reached 13% and was associated with an increased risk of mortality. (C) 2004 Elsevier B.V. All rights reserved.
C1 Dalhousie Univ, Div Cardiovasc Surg, New Halifax Infirm, Halifax, NS B3H 3A7, Canada.
RP Legare, JF (reprint author), Dalhousie Univ, Div Cardiovasc Surg, New Halifax Infirm, 1796 Summer St,Rm 2006, Halifax, NS B3H 3A7, Canada.
EM jean.legare@cdha.nshealth.ca
CR Ascione R, 2001, J THORAC CARDIOV SUR, V121, P689, DOI 10.1067/mtc.2001.112823
   Ascione R, 2000, CIRCULATION, V102, P1530
   BENETTI FJ, 1991, CHEST, V100, P312, DOI 10.1378/chest.100.2.312
   Calafiore AM, 2001, ANN THORAC SURG, V72, P456, DOI 10.1016/S0003-4975(01)02810-7
   Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5
   Edgerton JR, 2003, ANN THORAC SURG, V76, P1138, DOI 10.1016/S0003-4975(03)00747-1
   Ghali WA, 2003, CAN J CARDIOL, V19, P774
   Hart James C, 2002, Semin Thorac Cardiovasc Surg, V14, P70, DOI 10.1053/stcs.2002.31897
   Hart JC, 2000, ANN THORAC SURG, V70, P1017, DOI 10.1016/S0003-4975(00)01799-9
   Hoff SJ, 2002, ANN THORAC SURG, V74, pS1340
   Iaco AL, 1999, ANN THORAC SURG, V68, P1486, DOI 10.1016/S0003-4975(99)00957-1
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Mishra M, 2003, J CARDIOTHOR VASC AN, V17, P452, DOI 10.1016/S1053-0770(03)00149-6
   Novick RJ, 2001, ANN THORAC SURG, V72, pS1016, DOI 10.1016/S0003-4975(01)02949-6
   Parolari A, 2003, ANN THORAC SURG, V76, P37, DOI 10.1016/S0003-4975(03)00183-8
   Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4
   Prabhakar G, 2002, ANN THORAC SURG, V74, P1125, DOI 10.1016/S0003-4975(02)03899-7
   Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324
   Ray AA, 2001, CIRCULATION S1, V104, P192
   Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.12195
   SINCLAIR MC, 2002, HEART SURG FORUM, V5, P130
   Soltoski P, 1998, J CARDIAC SURG, V13, P328, DOI 10.1111/j.1540-8191.1998.tb01093.x
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Tasdemir O, 1998, J THORAC CARDIOV SUR, V116, P68, DOI 10.1016/S0022-5223(98)70244-2
   van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036
   Vassiliades TA, 2002, ANN THORAC SURG, V73, P1874, DOI 10.1016/S0003-4975(02)03592-0
NR 26
TC 29
Z9 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD FEB
PY 2005
VL 27
IS 2
BP 296
EP 300
DI 10.1016/j.ejcts.2004.11.009
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 902CG
UT WOS:000227328300027
PM 15691685
ER

PT J
AU Henestroza, E
   Eylon, S
   Roy, PK
   Yu, SS
   Anders, A
   Bieniosek, FM
   Greenway, WG
   Logan, BG
   MacGill, RA
   Shuman, DB
   Vanecek, DL
   Waldron, WL
   Sharp, WM
   Houck, TL
   Davidson, RC
   Efthimion, PC
   Gilson, EP
   Sefkow, AB
   Welch, DR
   Rose, DV
   Olson, CL
AF Henestroza, E
   Eylon, S
   Roy, PK
   Yu, SS
   Anders, A
   Bieniosek, FM
   Greenway, WG
   Logan, BG
   MacGill, RA
   Shuman, DB
   Vanecek, DL
   Waldron, WL
   Sharp, WM
   Houck, TL
   Davidson, RC
   Efthimion, PC
   Gilson, EP
   Sefkow, AB
   Welch, DR
   Rose, DV
   Olson, CL
TI Design and characterization of a neutralized-transport experiment for
   heavy-ion fusion
SO PHYSICAL REVIEW SPECIAL TOPICS-ACCELERATORS AND BEAMS
LA English
DT Article
ID INERTIAL CONFINEMENT FUSION; CHAMBER TRANSPORT; PLASMA; TARGET; BEAMS;
   PHYSICS; CHARGE
AB In heavy-ion inertial-confinement fusion systems, intense beams of ions must be transported from the exit of the final-focus magnet system through the fusion chamber to hit spots on the target with radii of about 2 mm. For the heavy-ion-fusion power-plant scenarios presently favored in the U. S., a substantial fraction of the ion-beam space charge must be neutralized during this final transport. The most effective neutralization technique found in numerical simulations is to pass each beam through a low-density plasma after the final focusing. To provide quantitative comparisons of these theoretical predictions with experiment, the Virtual National Laboratory for Heavy Ion Fusion has completed the construction and has begun experimentation with the neutralized-transport experiment. The experiment consists of three main sections, each with its own physics issues. The injector is designed to generate a very high-brightness, space-charge-dominated potassium beam, while still allowing variable perveance by a beam aperturing technique. The magnetic- focusing section, consisting of four pulsed quadrupoles, permits the study of magnet tuning, as well as the effects of phase-space dilution due to higher-order nonlinear fields. In the final section, the converging ion beam exiting the magnetic section is transported through a drift region with plasma sources for beam neutralization, and the final spot size is measured under various conditions of neutralization. In this paper, we discuss the design and characterization of the three sections in detail and present initial results from the experiment.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
   Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
   Princeton Plasma Phys Lab, Princeton, NJ 08543 USA.
   Mission Res Corp, Albuquerque, NM 87110 USA.
   Sandia Natl Labs, Albuquerque, NM 87107 USA.
RP Henestroza, E (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
RI Anders, Andre/B-8580-2009
OI Anders, Andre/0000-0002-5313-6505
CR Ahle L, 1998, AIP CONF PROC, V451, P507
   Anders A, 2002, J APPL PHYS, V91, P4824, DOI 10.1063/1.1459619
   Anders A, 1999, SURF COAT TECH, V120, P319, DOI 10.1016/S0257-8972(99)00460-0
   Baca D, 2003, PROCEEDINGS OF THE 2003 PARTICLE ACCELERATOR CONFERENCE, VOLS 1-5, P3294
   BADGER B, 1984, UWFDM625
   BARBOZA N, 1995, FUSION ENG DES, V32, P453
   Callahan DA, 1996, FUSION ENG DES, V32-33, P441, DOI 10.1016/S0920-3796(96)00500-5
   Callahan-Miller DA, 1999, NUCL FUSION, V39, P1547, DOI 10.1088/0029-5515/39/11/306
   Efthimion PC, 2003, LASER PART BEAMS, V21, P37, DOI 10.1017/S0263034602211088
   EYLON S, 1991, AIP C P, V252, P225
   Eylon S, 2003, PROCEEDINGS OF THE 2003 PARTICLE ACCELERATOR CONFERENCE, VOLS 1-5, P2616
   Fawley WM, 1997, PHYS PLASMAS, V4, P880, DOI 10.1063/1.872147
   GROTE DP, 1996, FUSION ENG DES, V32, P133
   Henestroza E, 2003, PROCEEDINGS OF THE 2003 PARTICLE ACCELERATOR CONFERENCE, VOLS 1-5, P2622
   Henestroza E, 2003, PROCEEDINGS OF THE 2003 PARTICLE ACCELERATOR CONFERENCE, VOLS 1-5, P2619
   Herrmannsfeldt W. B., 1988, 331 SLAC
   HERRMANNSFELDT WB, 1976, LBL5543, P25
   Hughes T. P., 1999, PHYS REV SPEC TOP-AC, V2, DOI 10.1103/PhysRevSTAB.2.110401
   Kaganovich ID, 2001, PHYS PLASMAS, V8, P4180, DOI 10.1063/1.1386804
   Lawson J.D., 1958, Journal of Electronics and Control, V5
   LEJEUNE C, 1980, ADV ELECTRONICS A S, V13, P159
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   MacGill RA, 1998, REV SCI INSTRUM, V69, P801, DOI 10.1063/1.1148718
   MacLaren SA, 2002, PHYS PLASMAS, V9, P1712, DOI 10.1063/1.1464894
   MOIR RW, 1994, FUSION TECHNOL, V25, P5
   NEUFFER D, 1979, P 1978 HEAV ION FUS
   Olson C.L., 1980, P HIF WORKSH BERK CA, P403
   REISER M, 1994, THEORY DESIGN CHARGE, P57
   Rhee M. J., 1986, Particle Accelerators, V20
   Rose DV, 2001, NUCL INSTRUM METH A, V464, P299, DOI 10.1016/S0168-9002(01)00187-5
   ROY PK, IN PRESS REV SCI INS
   Sharp WM, 2003, PROCEEDINGS OF THE 2003 PARTICLE ACCELERATOR CONFERENCE, VOLS 1-5, P2637
   Sharp WM, 2003, FUSION SCI TECHNOL, V43, P393
   Sharp WM, 2003, PHYS PLASMAS, V10, P2457, DOI 10.1063/1.1570826
   SHARP WM, 2003, IN PRESS P 3 INT C I
   Sharp WM, 2001, NUCL INSTRUM METH A, V464, P284, DOI 10.1016/S0168-9002(01)00049-3
   SHUMAN D, 2001, P PART ACC C CHIC IL, P2935
   Tabak M, 1998, NUCL INSTRUM METH A, V415, P75, DOI 10.1016/S0168-9002(98)00371-4
   WELCH DR, 2003, LASER PART BEAMS, V20, P621
   Welch DR, 2001, NUCL INSTRUM METH A, V464, P134, DOI 10.1016/S0168-9002(01)00024-9
   YU SS, 1979, P 1978 HEAV ION FUS, P403
   Yu SS, 2003, FUSION SCI TECHNOL, V44, P266
NR 42
TC 29
Z9 29
PU AMERICAN PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1098-4402
J9 PHYS REV SPEC TOP-AC
JI Phys. Rev. Spec. Top.-Accel. Beams
PD AUG
PY 2004
VL 7
IS 8
AR 083501
DI 10.1103/PhysRevSTAB.7.083501
PG 29
WC Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA 853VZ
UT WOS:000223858400004
ER

PT J
AU Reece, TB
   Tribble, CG
   Ellman, PI
   Maxey, TS
   Woodford, RL
   Dimeling, GM
   Wellons, HA
   Crosby, IK
   Kern, JA
   Kron, IL
AF Reece, TB
   Tribble, CG
   Ellman, PI
   Maxey, TS
   Woodford, RL
   Dimeling, GM
   Wellons, HA
   Crosby, IK
   Kern, JA
   Kron, IL
TI Mitral repair is superior to replacement when associated with coronary
   artery disease
SO ANNALS OF SURGERY
LA English
DT Article; Proceedings Paper
CT 115th Annual Session of the Southern-Surgical-Association
CY NOV 30-DEC 03, 2003
CL Hot Springs, VA
SP SO Surg Assoc
ID LONG-TERM SURVIVAL; VALVE-REPLACEMENT; PAPILLARY-MUSCLE; REGURGITATION;
   BYPASS; PRESERVATION; SURGERY; RISK
AB Objective: To compare the outcomes of mitral repair and replace-ment in revascularized patients with ischemic mitral regurgitation. Summary Background Data: Combined coronary bypass (CABG) and mitral procedures have been associated with the highest mortality (> 10%) in cardiac surgery. Recent studies have suggested that mitral valve replacement (MVR) with sparing of the subvalvular apparatus had comparable results to mitral repair when associated with CABG.
   Methods: Over the past 7 years, 54 patients had CABG/mitral repair versus 56 who had CABG/MVR with preservation of the subvalvular apparatus. The groups were similar in age at 69.2 years in the replacement group versus 67.0 in the repair group. We compared these 2 groups based on hospital mortality, incidence of complications including, nosocomial infection, neurologic decompensation (stroke). pulmonary complication (pneumonia, atelectasis, and pro-longed ventilation). and renal complications (acute renal failure or insufficiency).
   Results: The mitral repair group had a hospital mortality of 1.9% versus 10.7% in the replacement group (P = 0.05). Infection Occurred in 9% of repairs compared with 13% of replacements (P = 0.59). The incidence of stroke was no different between groups (2 of 54 repairs vs. 2 of 56 replacements, P = 1.00). Pulmonary complication rate was 39% in repairs versus 32% in replacements (P 0.59). Worsening renal function occurred in 15% of repairs versus 18% of replacements (P = 0.67).
   Conclusions: Mitral repair is superior to mitral replacement when associated with coronary artery disease in terms of perioperative morbidity and hospital mortality. Although preservation of the subvalvular apparatus with MVR has a theoretical advantage in terms of ventricular function, mitral repair clearly adds a Survival benefit in patients with concomitant ischemic cardiac disease.
C1 Univ Virginia, Ctr Hlth Sci, Dept Surg, Div Thorac & Cardiovasc Surg, Charlottesville, VA USA.
RP Reece, TB (reprint author), HSC Box 801359,MR4 Bldg,Room 3116, Charlottesville, VA 22908 USA.
EM tbr5q@virginia.edu
CR ADAMS DH, 2002, J HEART VALVE DIS S1, V11, P21
   Aklog L, 2001, CIRCULATION, V104, pI68
   ARCIDI JM, 1988, J THORAC CARDIOV SUR, V95, P951
   Chitwood WR, 1998, J HEART VALVE DIS, V7, P255
   COHN LH, 1985, J THORAC CARDIOV SUR, V90, P872
   COHN LH, 1995, EUR J CARDIO-THORAC, V9, P568, DOI 10.1016/S1010-7940(05)80008-9
   CONNOLLY MW, 1988, J CARDIOVASC SURG, V29, P375
   CZER LSC, 1992, CIRCULATION, V86, P46
   DAVID TE, 1986, ANN THORAC SURG, V41, P680
   DAVID TE, 1994, J CARDIAC SURG, V9, P252, DOI 10.1111/j.1540-8191.1994.tb00937.x
   Duarte IG, 1999, ANN THORAC SURG, V68, P426, DOI 10.1016/S0003-4975(99)00516-0
   FLAMENG W, 1994, EUR J CARDIO-THORAC, V8, P410, DOI 10.1016/1010-7940(94)90082-5
   Gangemi JJ, 2000, ANN SURG, V231, P710, DOI 10.1097/00000658-200005000-00011
   Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557
   Gillinov AM, 2003, J THORAC CARDIOV SUR, V125, P1350, DOI 10.1016/S0022-5223(02)73274-1
   Grossi EA, 2001, J THORAC CARDIOV SUR, V122, P1107, DOI 10.1067/mtc.2001.116945
   HICKEY MS, 1988, CIRCULATION, V78, P51
   Kron IL, 2002, ANN THORAC SURG, V74, P600, DOI 10.1016/S0003-4975(02)03749-9
   Miller DC, 2001, J THORAC CARDIOV SUR, V122, P1059, DOI 10.1067/mtc.2001.120341
   ROSE EA, 1994, ANN THORAC SURG, V57, P768
   Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13
   Thourani VH, 2000, ANN THORAC SURG, V70, P778, DOI 10.1016/S0003-4975(00)01641-6
NR 22
TC 29
Z9 36
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-4932
J9 ANN SURG
JI Ann. Surg.
PD MAY
PY 2004
VL 239
IS 5
BP 671
EP 675
DI 10.1097/sla.0000124297.40815.86
PG 5
WC Surgery
SC Surgery
GA 815DS
UT WOS:000221023600019
PM 15082971
ER

PT J
AU Holt, JC
   Lioudyno, M
   Athas, G
   Garcia, MM
   Perin, P
   Guth, PS
AF Holt, JC
   Lioudyno, M
   Athas, G
   Garcia, MM
   Perin, P
   Guth, PS
TI The effect of proteolytic enzymes on the alpha 9-nicotinic
   receptor-mediated response in isolated frog vestibular hair cells
SO HEARING RESEARCH
LA English
DT Article
DE acetylcholine; alpha 9-nicotinic receptor; papain; protease; hair cells;
   patch clamp
ID GUINEA-PIG COCHLEA; ACTIVATED POTASSIUM CHANNELS;
   ACETYLCHOLINE-RECEPTOR; CHOLINERGIC RECEPTOR; OUTWARD CURRENTS;
   MESSENGER-RNA; RAT; NEURONS; EXPRESSION; INHIBITION
AB In frog vestibular organs, efferent neurons exclusively innervate type II hair cells. Acetylcholine, the predominant efferent transmitter, acting on acetylcholine receptors of these hair cells ultimately inhibits and/or facilitates vestibular afferent firing. A coupling between alpha9-nicotinic acetylcholine receptors (alpha 9nAChR) and apamin-sensitive, small-conductance, calcium-dependent potassium channels (SK) is thought to drive the inhibition by hyperpolarizing hair cells thereby decreasing their release of transmitter onto afferents. The presence of a9nAChR in these cells was demonstrated using pharmacological,immunocytochemical, and molecular biological techniques. However, fewer than 10% of saccular hair cells dissociated using protease VIII, protease XXIV, or papain responded to acetylcholine during perforated-patch clamp recordings. When present, these responses were invariably transient, small in amplitude, and difficult to characterize. In contrast, the majority of saccular hair cells (similar to 90%) dissociated using trypsin consistently responded to acetylcholine with an increase in outward current and concomitant hyperpolarization, In agreement with alpha 9nAChR pharmacology obtained in other hair cells, the acetylcholine response in saccular hair cells was reversibly antagonized by strychnine, curare, tetraethylammonium, and apamin. Brief perfusions with either protease or papain permanently abolished the alpha9-nicotinic response in isolated saccular hair cells. These enzymes when inactivated became completely ineffective at abolishing the a9-nicotinic response, suggesting an enzymatic interaction with the alpha 9nAChR and/or downstream effector. The mechanism by which these enzymes render saccular hair cells unresponsive to acetylcholine remains unknown, but it most likely involves proteolysis of alpha 9nAChR, SK, or both. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.
   Tulane Univ, Sch Med, Dept Otolaryngol, New Orleans, LA 70112 USA.
   Univ Pavia, Dept Mol & Cell Physiol & Pharmacol, I-27100 Pavia, Italy.
RP Guth, PS (reprint author), Tulane Univ, Sch Med, Dept Pharmacol, 1430 Tulane Ave, New Orleans, LA 70112 USA.
CR AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433
   AKAIKE N, 1988, NEUROSCI LETT, V87, P75, DOI 10.1016/0304-3940(88)90148-6
   ALBUQUER.EX, 1968, EUR J PHARMACOL, V4, P40, DOI 10.1016/0014-2999(68)90007-1
   Anderson AD, 1997, BRAIN RES, V778, P409, DOI 10.1016/S0006-8993(97)01121-9
   ARMSTRONG CE, 1999, BIOPH SOC 43 ANN M F, V76, pA45
   Armstrong CE, 1998, J NEUROSCI, V18, P2962
   ART JJ, 1985, J PHYSIOL-LONDON, V360, P397
   Art JJ, 1996, ANN NY ACAD SCI, V781, P103, DOI 10.1111/j.1749-6632.1996.tb15696.x
   ART JJ, 1984, J PHYSIOL-LONDON, V356, P525
   ATHAS GB, 1997, ASS RES OTOLARYNGOL, V20, P37
   ATHAS GB, 1997, ASS RES OTOLARYNGOL, V20, P17
   BETZ W, 1971, NATURE-NEW BIOL, V232, P94
   BETZ W, 1973, J PHYSIOL-LONDON, V230, P673
   Bond CT, 1999, ANN NY ACAD SCI, V868, P370, DOI 10.1111/j.1749-6632.1999.tb11298.x
   BURGER MM, 1969, P NATL ACAD SCI USA, V62, P994, DOI 10.1073/pnas.62.3.994
   BURGER MM, 1970, NATURE, V227, P170, DOI 10.1038/227170a0
   Chabbert CH, 1997, PFLUG ARCH EUR J PHY, V435, P82, DOI 10.1007/s004240050486
   Chen C, 1996, HEARING RES, V98, P9, DOI 10.1016/0378-5955(96)00049-4
   CHURCHILL J. A., 1956, LARYNGOSCOPE, V66, P1
   CONTITRONCONI BM, 1982, BIOCHEMISTRY-US, V2, P893
   CUNNINGHAM CD, 2000, HEARING RES, V143, P269
   DOHLMAN G, 1958, J Laryngol Otol, V72, P984, DOI 10.1017/S0022215100054797
   Dulon D, 1998, EUR J NEUROSCI, V10, P907, DOI 10.1046/j.1460-9568.1998.00098.x
   EBERWINE J, 1992, METHOD ENZYMOL, V216, P80
   ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X
   EROSTEGUI C, 1994, HEARING RES, V74, P135, DOI 10.1016/0378-5955(94)90182-1
   EYBALIN M, 1993, PHYSIOL REV, V73, P309
   Freshney R.I., 1994, CULTURE ANIMAL CELLS
   FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039
   FUCHS PA, 1992, J NEUROSCI, V12, P800
   Goodyear R, 1999, J NEUROSCI, V19, P3761
   GUPTA AK, 1997, ASS RES OT ABSTR, V20, P215
   GUTH PS, 1986, ACTA OTO-LARYNGOL, V102, P194, DOI 10.3109/00016488609108666
   Guth PS, 1998, PROG NEUROBIOL, V54, P193, DOI 10.1016/S0301-0082(97)00068-3
   GUTH PS, 1994, HEARING RES, V75, P225, DOI 10.1016/0378-5955(94)90073-6
   HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997
   Hiel H, 1996, BRAIN RES, V738, P347, DOI 10.1016/S0006-8993(96)01046-3
   HIGHSTEIN SM, 1991, NEUROSCI RES, V12, P12
   Hirschberg B, 1999, BIOPHYS J, V77, P1905
   HOLT JC, 1999, ARO ABSTR, V22, P188
   HOLT JR, 1995, J NEUROPHYSIOL, V73, P1484
   HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065
   HOUSLEY GD, 1990, HEARING RES, V43, P121, DOI 10.1016/0378-5955(90)90221-A
   Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195
   Kehoe J, 1998, J NEUROSCI, V18, P8198
   LEE KS, 1977, NATURE, V265, P751, DOI 10.1038/265751a0
   LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0
   LINDSTROM J, 1980, BIOCHEMISTRY-US, V19, P4791, DOI 10.1021/bi00562a012
   LUSTIG LR, 2000, SYN FUNCT HEAR BAL S, P56
   Lysakowski A, 1996, ANN NY ACAD SCI, V781, P164, DOI 10.1111/j.1749-6632.1996.tb15700.x
   McNiven AI, 1996, AUDIT NEUROSCI, V2, P63
   MURROW B W, 1990, Society for Neuroscience Abstracts, V16, P1079
   NARAHASHI T, 1964, J PHYSL, V207, P1441
   NARAHASH.T, 1974, PHYSIOL REV, V54, P813
   Nenov AP, 1996, HEARING RES, V101, P149, DOI 10.1016/S0378-5955(96)00143-8
   Nenov AP, 1998, HEARING RES, V123, P168, DOI 10.1016/S0378-5955(98)00121-X
   Nenov AP, 1996, HEARING RES, V101, P132, DOI 10.1016/S0378-5955(96)00142-6
   NORRIS CH, 1988, HEARING RES, V32, P197, DOI 10.1016/0378-5955(88)90092-5
   OSBORNE MP, 1990, ACTA OTO-LARYNGOL, V110, P37, DOI 10.3109/00016489009122513
   Ottesen M., 1970, METHOD ENZYMOL, V19, P199
   OYAMA Y, 1990, CELL MOL NEUROBIOL, V10, P193, DOI 10.1007/BF00734573
   Park HJ, 1997, HEARING RES, V112, P95, DOI 10.1016/S0378-5955(97)00111-1
   PERILLO MA, 1998, RRD LIP RES 2, V2, P275
   PERLMAN GE, 1970, METHODS ENZYMOLOGY, V19
   PRECHT W, 1976, FROG NEUROBIOLOGY, P452
   RODBELL M, 1970, J BIOL CHEM, V245, P718
   Sambrook J., 1989, MOL CLONING LAB MANU
   SEFTON BM, 1970, NATURE, V227, P843, DOI 10.1038/227843a0
   SHAO H, 1998, ASS RES OTOLARYNGOL, V21, P20
   SHIGEMOTO T, 1991, J PHYSIOL-LONDON, V442, P669
   Sinclair B, 1999, SCIENTIST, V13, P19
   STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35
   STRULOVICI B, 1984, J BIOL CHEM, V10, P4389
   SUGAI T, 1992, HEARING RES, V61, P56, DOI 10.1016/0378-5955(92)90036-M
   Sugasawa M, 1996, AM J PHYSIOL-CELL PH, V271, pC1817
   TAKUMIDA M, 1993, ORL J OTO-RHINO-LARY, V55, P77
   VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663
   VETTER D, 2000, S SPONS J HOPK CTR H, P54
   WALSH KA, 1970, METHOD ENZYMOL, V19, P64
   WEIS LS, 1969, J BIOL CHEM, V244, P3084
   YOSHIDA N, 1994, BRAIN RES, V644, P90, DOI 10.1016/0006-8993(94)90351-4
NR 81
TC 29
Z9 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5955
J9 HEARING RES
JI Hear. Res.
PD FEB
PY 2001
VL 152
IS 1-2
BP 25
EP 42
DI 10.1016/S0378-5955(00)00225-2
PG 18
WC Audiology & Speech-Language Pathology; Neurosciences;
   Otorhinolaryngology
SC Audiology & Speech-Language Pathology; Neurosciences & Neurology;
   Otorhinolaryngology
GA 407ZU
UT WOS:000167302700004
PM 11223279
ER

PT J
AU Ennis, RD
   Malyszko, BK
   Heitjan, DF
   Rubin, MA
   O'Toole, KM
   Schiff, PB
AF Ennis, RD
   Malyszko, BK
   Heitjan, DF
   Rubin, MA
   O'Toole, KM
   Schiff, PB
TI Changes in biochemical disease-free survival rates as a result of
   adoption of the consensus conference definition in patients with
   clinically localized prostate cancer treated with external-beam
   radiotherapy
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article
DE prostate cancer; prostate; radiotherapy; radiation therapy; biochemical
   disease-free survival; PSA; prostate-specific antigen; ASTRO consensus
   conference
ID RADIATION-THERAPY; RADICAL PROSTATECTOMY; ANTIGEN LEVELS; CARCINOMA;
   PREDICTOR
AB Purpose: The optimal definition of biochemical recurrence of prostate cancer after definitive radiotherapy remains elusive. Different institutions have developed their own definitions, and a consensus conference (CC) sponsored by the American Society for Therapeutic Radiology and Oncology has recently proposed another definition. This study compares the definition previously used at our institution with the definition proposed by the CC.
   Methods: Two hundred and eight patients were treated for localized prostate cancer with conformal external-beam radiotherapy between 1989-1993 at our institution and followed for at least 24 months. Patients were categorized as failures according to our institutional definition and the CC definition. Our definition (CPMC) required two increases in serum prostate specific antigen (PSA) over at least a 3-month period with a final value of at least 1 ng/ml or a single value resulting in clinical intervention. The CC definition required three consecutive increases in PSA. This was modified to also consider those patients with one or two increases leading to clinical intervention as failures. Differences in the failure rates between the two definitions were evaluated and factors influencing these differences were explored. In an additional analysis, CC was modified such that patients with one or two PSA increases were censored at the time of the PSA prior to the increases (CC-II), rather than at the last PSA (CC). The median follow-up time was 31 months.
   Results: There were 36 fewer failures according to CC (n = 96) compared with CPMC (n = 132) (p < 0.001). Twenty cases called failures by CPMC subsequently had a decrease in PSA ("false failures"). The other 16 patients have had two increases in PSA, but are awaiting their next follow-up visit to obtain a third PSA ("pending failures"). Analysis of factors predicting "pending failures" showed Gleason score to be the sole predictor of this change in status in multivariate analysis (p = 0.03) with patients with lower-grade tumors being more likely to change status (Gleason 2-6: 15% vs. Gleason 7-10: 1%). On the other hand, "false failures," compared to true failures, had a lower mean PSA nadir (1.7 ng/ml vs. 7.0 ng/ml, p < 0.001) and significantly smaller mean increases in PSA (1st increase: 0.6 ng/ml vs. 3.4 ng/ml, p = 0.006; 2nd increase: 0.4 ng/ml vs. 4.8 ng/ml, p = 0.002). In 85% (17 of 20) of these patients, at least one of the increases was less than or equal to 0.3 ng/ml compared with 44% (42 of 96) of the true failures (p = 0.0008). CC-II resulted in a small decrease in BDFS rates compared with CC, but did not affect the overall difference between CC and CPMC. A modified definition that defines failure as two consecutive increases in PSA over 3 months, with a final value greater than 1.0 ng/ml and each increase being at least 0.3 ng/ml, or three consecutive increases would result in a "false" failure rate of only 3% (3 of 99) and identify 56% (54 of 96) of the true failures after only two PSA increases.
   Conclusion: The CPMC definition of two PSA increases can falsely identify patients as failures, particularly if the increases in PSA are small (i.e., less than or equal to 0.3 ng/ml). The CC definition requiring three increases in PSA can falsely identify patients as disease-free when the time to failure is long relative to the follow-up time. We propose a that a definition that combines aspects of both definitions (two consecutive increases in PSA over 3 months, with a final value greater than 1.0 ng/ml and each increase being at least 0.3 ng/ml, or three consecutive increases) may be a better definition of biochemical failure. (C) 1998 Elsevier Science Inc.
C1 Columbia Univ Coll Phys & Surg, Dept Radiat Oncol, New York, NY 10032 USA.
   Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA.
   Columbia Univ, Sch Publ Hlth, Div Biostat, New York, NY 10032 USA.
RP Ennis, RD (reprint author), Columbia Univ Coll Phys & Surg, Dept Radiat Oncol, 630 W 168th St, New York, NY 10032 USA.
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Beahrs OH, 1992, MANUAL STAGING CANC, P181
   COX RS, 1993, INT J RADIAT ONCOL, V28, P23
   Critz FA, 1996, J CLIN ONCOL, V14, P2893
   Ennis RD, 1998, UROLOGY, V51, P265, DOI 10.1016/S0090-4295(97)00503-7
   HOROWITZ EM, 1996, INT J RADIAT ONCOL, V36, P565
   Ingenito AC, 1997, UROLOGY, V50, P73, DOI 10.1016/S0090-4295(97)00202-1
   KAVADI VS, 1994, INT J RADIAT ONCOL, V30, P279
   LANGE PH, 1989, J UROLOGY, V141, P873
   Lee WR, 1997, J CLIN ONCOL, V15, P230
   LEE WR, 1995, J CLIN ONCOL, V13, P464
   MEEK AG, 1990, INT J RADIAT ONCOL, V19, P733
   OESTERLING JE, 1988, J UROLOGY, V139, P766
   OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V269, P57
   OESTERLING JE, 1995, UROLOGY, V46, P524, DOI 10.1016/S0090-4295(99)80266-0
   Pisansky TM, 1997, CANCER-AM CANCER SOC, V79, P337, DOI 10.1002/(SICI)1097-0142(19970115)79:2<337::AID-CNCR17>3.0.CO;2-1
   RITTER MA, 1992, J CLIN ONCOL, V10, P1208
   ROSENZWEIG KE, 1995, J UROLOGY, V153, P1561, DOI 10.1016/S0022-5347(01)67461-5
   STEIN A, 1992, J UROLOGY, V147, P942
   VIJAYAKUMAR S, 1992, RADIOLOGY, V184, P271
   Wallner K, 1996, J CLIN ONCOL, V14, P449
   WILLETT CG, 1994, J UROLOGY, V151, P1579
   Zagars GK, 1997, CANCER, V79, P1370, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X
   ZAGARS GK, 1993, CANCER, V72, P538, DOI 10.1002/1097-0142(19930715)72:2<538::AID-CNCR2820720234>3.0.CO;2-S
   ZENTNER PG, 1993, INT J RADIAT ONCOL, V27, P47
   ZIETMAN AL, 1994, J UROLOGY, V151, P640
NR 26
TC 29
Z9 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUN 1
PY 1998
VL 41
IS 3
BP 511
EP 517
DI 10.1016/S0360-3016(98)00104-7
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA ZT778
UT WOS:000074124700004
PM 9635696
ER

PT J
AU Valletta, EA
   Pregarz, M
   BergamoAndreis, IA
   Boner, AL
AF Valletta, EA
   Pregarz, M
   BergamoAndreis, IA
   Boner, AL
TI Tracheoesophageal compression due to congenital vascular anomalies
   (vascular rings)
SO PEDIATRIC PULMONOLOGY
LA English
DT Article
DE tracheoesophageal compression; aortic arch anomalies; vascular rings;
   strider; dysphagia; congenital anomalies
ID DIGITAL SUBTRACTION ANGIOGRAPHY; AORTIC-ARCH ANOMALIES; ONE-STAGE
   REPAIR; PULMONARY-ARTERY; TRACHEAL STENOSIS; SURGICAL-MANAGEMENT;
   AIRWAY-OBSTRUCTION; INNOMINATE-ARTERY; FOLLOW-UP; TRACHEOBRONCHIAL
   COMPRESSION
C1 IST PIO XII,MISURINA,BL,ITALY.
RP Valletta, EA (reprint author), UNIV VERONA,POLICLIN BORGO ROMA,PEDIAT CLIN,DEPT PEDIAT,I-37134 VERONA,ITALY.
CR ANAND R, 1994, PEDIATR CARDIOL, V15, P58
   BACKER CL, 1989, J THORAC CARDIOV SUR, V97, P725
   BARON RL, 1984, PEDIAT CARDIAC IMAGI, P135
   BAUMMAN JL, 1977, CHEST, V72, P67
   BERDON WE, 1984, RADIOLOGY, V152, P57
   BERTOLINI A, 1987, J CARDIOVASC SURG, V28, P301
   BERTRAND JM, 1986, PEDIATR PULM, V2, P378, DOI 10.1002/ppul.1950020611
   BEVELAQUA F, 1989, AM REV RESPIR DIS, V140, P805
   BISSET GS, 1987, AM J ROENTGENOL, V149, P251
   BOSE S, 1991, CHEST, V99, P1308, DOI 10.1378/chest.99.5.1308
   BRAUNSTEIN PW, 1991, PEDIAT AIRWAYS, P81
   BUCKWALTER J, 1983, ANN OTO RHINOL LARYN, V92, P383
   BURCH M, 1993, ARCH DIS CHILD, V68, P171
   BURKE RP, 1995, J AM COLL CARDIOL, V25, P943, DOI 10.1016/0735-1097(94)00461-X
   CHUN K, 1992, ANN THORAC SURG, V53, P597
   CLARKSON PM, 1967, AM J DIS CHILD, V113, P373
   COHEN SR, 1976, ANN OTO RHINOL LARYN, V85, P582
   CORNO A, 1990, J THORAC CARDIOV SUR, V99, P1091
   CURRARINO G, 1991, PEDIATR RADIOL, V21, P406, DOI 10.1007/BF02026672
   DEBAETS F, 1993, ARCH DIS CHILD, V69, P390
   FILSTON HC, 1987, ANN SURG, V205, P541, DOI 10.1097/00000658-198705000-00013
   FLETCHER BD, 1986, RADIOLOGY, V160, P245
   GLEW D, 1991, CLIN RADIOL, V43, P305, DOI 10.1016/S0009-9260(05)80534-3
   GOMES AS, 1987, RADIOLOGY, V165, P691
   GOMES AS, 1989, RADIOL CLIN N AM, V27, P1171
   GROSS RE, 1945, NEW ENGL J MED, V233, P586, DOI 10.1056/NEJM194511152332003
   GUMBINER CH, 1980, AM J CARDIOL, V45, P311, DOI 10.1016/0002-9149(80)90651-7
   GUPTA S, 1993, ANAESTHESIA, V48, P1108
   Hartyánszky I L, 1989, Eur J Cardiothorac Surg, V3, P250, DOI 10.1016/1010-7940(89)90074-2
   HASTREIT.AR, 1966, BRIT HEART J, V28, P722
   HAUFT SM, 1988, AM J DIS CHILD, V142, P206
   HICKEY MS, 1987, ANN THORAC SURG, V44, P416
   Hofmann U, 1991, Prog Pediatr Surg, V27, P221
   HORVATH P, 1992, EUR J CARDIO-THORAC, V6, P366, DOI 10.1016/1010-7940(92)90174-V
   HUSSEINI ZM, 1987, J CARDIOVASC SURG, V28, P339
   JUE KL, 1965, AMER J ROENTGENOL RA, V95, P598
   KERSTINGSOMMERHOFF BA, 1987, AM J ROENTGENOL, V149, P9
   KLEINMAN PK, 1994, RADIOLOGY, V191, P565
   Leijala M, 1989, Eur J Cardiothorac Surg, V3, P125, DOI 10.1016/1010-7940(89)90089-4
   LENOX CC, 1979, J THORAC CARDIOV SUR, V77, P748
   Lierl M., 1993, PEDIAT RESP DIS DIAG, P457
   LILLEHEI CW, 1992, J PEDIATR SURG, V27, P1118, DOI 10.1016/0022-3468(92)90571-N
   LIS G, 1995, PEDIATR PULM, V20, P220, DOI 10.1002/ppul.1950200404
   LOBE TE, 1987, J PEDIATR SURG, V22, P1137, DOI 10.1016/S0022-3468(87)80724-8
   LOREN ML, 1979, J PEDIATR, V94, P610, DOI 10.1016/S0022-3476(79)80027-X
   LOWE GM, 1991, RADIOGRAPHICS, V11, P637
   LUCIANI GB, 1994, J CARDIAC SURG, V9, P109, DOI 10.1111/j.1540-8191.1994.tb00834.x
   MANI TM, 1988, J RADIOL, V69, P751
   MARMON LM, 1984, J PEDIATR SURG, V19, P683, DOI 10.1016/S0022-3468(84)80353-X
   MCFAUL R, 1981, J THORAC CARDIOV SUR, V82, P306
   MOES CAF, 1993, PEDIATR CARDIOL, V14, P93
   MOES CAF, 1978, HEART DIS INFANCY CH, P856
   MURDISON KA, 1990, J AM COLL CARDIOL, V15, P1645
   Mustard W T, 1969, Ann Thorac Surg, V8, P312
   ORENSTEIN SR, 1993, PEDIAT GASTROINTESTI, P135
   OTEROCAGIDE M, 1986, AM HEART J, V112, P1304, DOI 10.1016/0002-8703(86)90364-9
   Parikh S R, 1993, J Am Soc Echocardiogr, V6, P1
   PAWADE A, 1992, ANN THORAC SURG, V54, P967
   Phelan PD, 1994, RESP ILLNESS CHILDRE
   REAH G, 1995, ANAESTHESIA, V50, P341, DOI 10.1111/j.1365-2044.1995.tb04612.x
   RIVILLA F, 1989, Z KINDERCHIR, V44, P199
   ROBERTS CS, 1994, J PEDIATR SURG, V29, P334
   ROESLER M, 1983, ANN SURG, V197, P139, DOI 10.1097/00000658-198302000-00004
   SADE RM, 1975, J THORAC CARDIOV SUR, V69, P333
   SALZBERG AM, 1990, DISORDERS RESP TRACT, P227
   SISSMAN NJ, 1977, HEART DIS INFANTS CH, P210
   STEWART JR, 1964, ATLAS VASCULAR RINGS
   STEWART JR, 1966, AMER J ROENTGENOL RA, V97, P377
   STRIFE JL, 1981, RADIOLOGY, V139, P73
   TEPPER RS, 1989, PEDIATR PULM, V6, P272, DOI 10.1002/ppul.1950060412
   THOMSON AH, 1990, ARCH DIS CHILD, V65, P171
   TONKIN ILD, 1984, AM J ROENTGENOL, V142, P1287
   VANAALDEREN WMC, 1990, ACTA PAEDIATR SCAND, V79, P477
   VANSON JAM, 1994, ANN THORAC SURG, V57, P604
   VANSON JAM, 1995, THORAC CARDIOV SURG, V43, P120, DOI 10.1055/s-2007-1013784
   VANSON JAM, 1993, MAYO CLIN PROC, V68, P1056
   VIRDI IS, 1987, PEDIATR CARDIOL, V8, P131, DOI 10.1007/BF02079470
   VOGL T, 1990, J COMPUT ASSIST TOMO, V14, P182, DOI 10.1097/00004728-199003000-00004
   VOGL T, 1991, PEDIATR RADIOL, V21, P89, DOI 10.1007/BF02015611
   WOOD RE, 1984, PEDIATR CLIN N AM, V31, P785
   ZIEMER G, 1992, ANN THORAC SURG, V54, P971
NR 81
TC 29
Z9 32
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 8755-6863
J9 PEDIATR PULM
JI Pediatr. Pulmonol.
PD AUG
PY 1997
VL 24
IS 2
BP 93
EP 105
DI 10.1002/(SICI)1099-0496(199708)24:2<93::AID-PPUL4>3.0.CO;2-J
PG 13
WC Pediatrics; Respiratory System
SC Pediatrics; Respiratory System
GA XU730
UT WOS:A1997XU73000004
PM 9292900
ER

PT J
AU REGINATO, AJ
AF REGINATO, AJ
TI SYPHILITIC ARTHRITIS AND OSTEITIS
SO RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
LA English
DT Review
ID IMMUNODEFICIENCY-VIRUS-INFECTION; SERONEGATIVE SECONDARY SYPHILIS; 20
   YEARS EXPERIENCE; TREPONEMA-PALLIDUM; CONGENITAL-SYPHILIS;
   CEREBROSPINAL-FLUID; TERTIARY SYPHILIS; CLINICAL-FEATURES; PATIENT;
   NEUROSYPHILIS
C1 UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT MED,NEWARK,NJ 07103.
   COOPER HOSP UNIV MED CTR,DIV RHEUMATOL,CAMDEN,NJ.
   HOSP UNIV PENN,DEPT CLIN MED,PHILADELPHIA,PA 19104.
CR Abdul Gaffoor P M, 1991, Cutis, V47, P342
   ANDERSON J, 1989, GENITOURIN MED, V65, P239
   ANTON AA, 1981, VESTN DERMATOL VENER, V5, P58
   BAKER AL, 1971, NEW ENGL J MED, V284, P1422, DOI 10.1056/NEJM197106242842507
   Ben Achour D, 1991, J Radiol, V72, P279
   BHATT AP, 1982, J INDIAN DENT ASS, V54, P2
   BHORADE MS, 1986, JAMA-J AM MED ASSOC, V261, P1159
   BRAUNSTE.GD, 1970, AM J MED, V48, P643, DOI 10.1016/0002-9343(70)90016-1
   Brown WH, 1921, J EXP MED, V33, P515, DOI 10.1084/jem.33.4.515
   BURGOYNE M, 1992, J RHEUMATOL, V19, P313
   BURKE WA, 1986, J AM ACAD DERMATOL, V14, P137, DOI 10.1016/S0190-9622(86)80395-4
   CHAWLA V, 1985, J TROP PEDIATRICS, V31, P204
   CHOLANKERIL JV, 1992, CLIN IMAG, V16, P125, DOI 10.1016/0899-7071(92)90126-T
   COBLENTZ DR, 1970, J AMER MED ASSOC, V212, P1061, DOI 10.1001/jama.212.6.1061
   COHEN PR, 1992, CUTIS, V49, P51
   CREMIN BJ, 1970, BRIT J RADIOL, V43, P333
   CRONIN EB, 1987, J NUCL MED, V28, P1047
   CURTIS AC, 1964, MED CLIN N AM, V48, P707
   DAVIDSON F, 1989, GENITOURIN MED, V65, P60
   DAVIS LE, 1989, ANN NEUROL, V25, P50, DOI 10.1002/ana.410250108
   DENNIE CC, 1925, RADIOLOGY, V4, P364
   DINUBILE MJ, 1990, AM J MED, V88, pN45
   DINUBILE MJ, 1992, ARCH INTERN MED, V152, P1324, DOI 10.1001/archinte.152.6.1324
   ECHOLS SK, 1990, J AM ACAD DERMATOL, V22, P313, DOI 10.1016/S0190-9622(08)80768-2
   ENGELKENS HJH, 1992, SKELETAL RADIOL, V21, P194
   ERLICH I, 1976, AM J ROENTGENOL, V127, P789
   FARLEY TA, 1990, SEX TRANSM DIS, V17, P163
   FIUMARA NJ, 1989, J AM ACAD DERMATOL, V20, P682, DOI 10.1016/S0190-9622(89)80146-X
   Giunti A, 1977, Chir Organi Mov, V63, P383
   GRIFFITHS RW, 1975, J NEUROL NEUROSUR PS, V38, P558, DOI 10.1136/jnnp.38.6.558
   GRIMPREL E, 1991, J CLIN MICROBIOL, V29, P1711
   HARRIS VJ, 1977, RADIOLOGY, V123, P416
   HARRIS VJ, 1977, RADIOLOGY, V123, P518
   HART G, 1986, ANN INTERN MED, V104, P368
   HICKS CB, 1987, ANN INTERN MED, V107, P492
   HIRA SK, 1987, INT J DERMATOL, V26, P103, DOI 10.1111/j.1365-4362.1987.tb00532.x
   HOLMES MD, 1984, NEUROLOGY, V34, P553
   HOOK EW, 1992, NEW ENGL J MED, V326, P1060, DOI 10.1056/NEJM199204163261606
   HOOK EW, 1985, J CLIN MICROBIOL, V22, P241
   HUTCHINSON CM, 1990, MED CLIN N AM, V74, P1389
   HUTCHINSON CM, 1991, ARCH INTERN MED, V151, P511, DOI 10.1001/archinte.151.3.511
   JACOBELL.S, 1973, ANN INTERN MED, V79, P340
   Johns D, 1970, J Bone Joint Surg Br, V52, P724
   JORDAAN HF, 1986, S AFR MED J, V11, P493
   JORDAAN HF, 1988, AM J DERMATOPATH, V10, P399
   Kahn M, 1972, REV RHUM, V37, P431
   KAMPMEIER RH, 1964, MED CLIN N AM, V48, P667
   KAZLOW PG, 1989, MT SINAI J MED, V56, P65
   KUMAR B, 1989, GENITOURIN MED, V65, P394
   KURUMAJI Y, 1987, DERMATOLOGICA, V174, P23
   LANGTRY JAA, 1990, J ROY SOC MED, V83, P49
   LIBMAN H, 1991, CLIN MANUAL CARE A S
   LILIEN LD, 1977, PEDIATR RADIOL, V6, P183, DOI 10.1007/BF00972115
   LIM S H, 1990, Annals Academy of Medicine Singapore, V19, P413
   LUKEHART SA, 1988, ANN INTERN MED, V109, P855
   MAGARO M, 1990, BRIT J RHEUMATOL, V29, P405
   MANGANONI AM, 1990, J AM ACAD DERMATOL, V23, P1185, DOI 10.1016/S0190-9622(08)80933-4
   MANTON SL, 1986, BRIT DENT J, V160, P237, DOI 10.1038/sj.bdj.4805821
   MARKOVITZ DM, 1986, JAMA-J AM MED ASSOC, V255, P1767, DOI 10.1001/jama.255.13.1767
   McLean S, 1931, AM J DIS CHILD, V41, P1411
   MCNEELY MC, 1986, J AM ACAD DERMATOL, V14, P564, DOI 10.1016/S0190-9622(86)70070-4
   MIDDLETON S, 1990, ANN RHEUM DIS, V49, P641, DOI 10.1136/ard.49.8.641
   MINDEL A, 1989, GENITOURIN MED, V65, P1
   MITCHELL RM, 1964, ANN INTERN MED, V61, P933
   NEINSTEIN LS, 1984, PEDIATRICS, V74, P67
   NOPPAKUN N, 1987, INT J DERMATOL, V26, P112, DOI 10.1111/j.1365-4362.1987.tb00537.x
   OLANSKY S, 1964, MED CLIN N AM, V48, P653
   OLLEGOIG JE, 1988, GENITOURIN MED, V64, P198
   OREGAN S, 1976, ANN INTERN MED, V85, P325
   OSTLER H B, 1976, Survey of Ophthalmology, V20, P233, DOI 10.1016/0039-6257(76)90223-X
   PAVITHRAN K, 1991, INT J DERMATOL, V30, P799, DOI 10.1111/j.1365-4362.1991.tb04790.x
   PENNEAU M, 1980, REV STOMATOL CHIR, V81, P392
   PERON JM, 1984, REV STOMATOL CHIR, V85, P126
   Reginato A, 1988, INFECT RHEUMATIC DIS, P215
   REGINATO AJ, 1969, REV MED CHILE, V87, P421
   REGINATO AJ, 1979, ARTHRITIS RHEUM, V22, P170, DOI 10.1002/art.1780220210
   REGINATO AJ, 1988, J RHEUMATOL, V15, P717
   RICCI JM, 1989, OBSTET GYNECOL, V74, P687
   ROLFS RT, 1990, AM J PUBLIC HEALTH, V80, P853, DOI 10.2105/AJPH.80.7.853
   SAPRA S, 1989, ARCH DERMATOL, V125, P1666, DOI 10.1001/archderm.125.12.1666
   SCHLOSSBERT D, 1986, ARCH INTERN MED, V44, P811
   SCHOEFER H, 1989, Chemotherapy, V35, P140
   SHARMA VK, 1990, INT J DERMATOL, V29, P585, DOI 10.1111/j.1365-4362.1990.tb03475.x
   SHULKIN D, 1988, AM J MED, V85, P425, DOI 10.1016/0002-9343(88)90600-6
   Simão C, 1969, Hospital (Rio J), V75, P1045
   SIMON RP, 1985, ARCH NEUROL-CHICAGO, V42, P606
   STEINBERG J, 1991, CLIN MANUAL CARE ADU
   SUGATHAN P, 1987, BRIT J DERMATOL, V116, P879, DOI 10.1111/j.1365-2133.1987.tb04910.x
   THOMPSON R G, 1952, Am J Syph Gonorrhea Vener Dis, V36, P332
   THORNBURG RW, 1983, INFECT IMMUN, V42, P623
   TIKJOB G, 1991, J AM ACAD DERMATOL, V24, P506, DOI 10.1016/S0190-9622(08)80082-5
   TOOHEY JS, 1985, J PEDIATR ORTHOPED, V5, P104
   TOSHNIWAL P, 1987, J CLIN NEURO-OPHTHAL, V7, P6
   Engelkens H J, 1991, Int J STD AIDS, V2, P280
   VELDMAN E, 1986, DOC OPHTHALMOL, V64, P23, DOI 10.1007/BF00166682
   WALKER PD, 1984, AM J MED, V76, P1106, DOI 10.1016/0002-9343(84)90866-0
   Wile UJ, 1930, J AMER MED ASSOC, V94, P1053
   WILE UJ, 1914, J CUT DIS, V32, P20
   WILLIAMS WC, 1987, J FAM PRACTICE, V25, P509
   1988, MMWR, V37, P600
   1991, MMWR, V40, P333
   1991, MMWR, V40, P314
   1991, MMWR, V40, P321
NR 103
TC 29
Z9 29
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0889-857X
J9 RHEUM DIS CLIN N AM
JI Rheum. Dis. Clin. North Am.
PD MAY
PY 1993
VL 19
IS 2
BP 379
EP 398
PG 20
WC Rheumatology
SC Rheumatology
GA LX560
UT WOS:A1993LX56000008
PM 8502778
ER

PT J
AU CASPI, J
   COLES, JG
   BENSON, LN
   FREEDOM, RM
   BURROWS, PE
   SMALLHORN, JF
   TRUSLER, GA
   WILLIAMS, WG
AF CASPI, J
   COLES, JG
   BENSON, LN
   FREEDOM, RM
   BURROWS, PE
   SMALLHORN, JF
   TRUSLER, GA
   WILLIAMS, WG
TI MANAGEMENT OF NEONATAL CRITICAL PULMONIC STENOSIS IN THE BALLOON
   VALVOTOMY ERA
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 25TH ANNIVERSARY MEETING OF THE SOC OF THORACIC SURGEONS
CY SEP 11-13, 1989
CL BALTIMORE, MD
SP SOC THORAC SURGEONS
C1 HOSP SICK CHILDREN,DEPT SURG & PEDIAT,DIV CARDIOVASC SURG & CARDIOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.
CR AWARIEFE SO, 1983, J THORAC CARDIOV SUR, V85, P375
   COLES JG, 1984, ANN THORAC SURG, V38, P458
   DANIELSO.GK, 1971, J THORAC CARDIOV SUR, V61, P228
   DASKALOPOULOS DA, 1982, J THORAC CARDIOV SUR, V84, P187
   DEMOOR MMA, 1988, INT J CARDIOL, V19, P245, DOI 10.1016/0167-5273(88)90085-X
   ENGLE MA, 1958, CIRCULATION, V17, P862
   FREED MD, 1973, CIRCULATION, V48, P875
   GERSONY WM, 1967, CIRCULATION, V35, P765
   KORETZKY ED, 1969, CIRCULATION, V40, P43
   KVESELIS DA, 1985, AM J CARDIOL, V56, P527, DOI 10.1016/0002-9149(85)91178-6
   LEWIS AB, 1986, J THORAC CARDIOV SUR, V91, P835
   LEWIS AB, 1983, CIRCULATION, V67, P1318
   LITWIN SB, 1973, SURGERY, V74, P880
   MISTROT J, 1976, ANN THORAC SURG, V21, P30
   RAO PS, 1988, AM J CARDIOL, V62, P979, DOI 10.1016/0002-9149(88)90909-5
   ROBERTSON M, 1987, BRIT HEART J, V58, P239
   UTLEY JR, 1973, J THORAC CARDIOV SUR, V65, P391
   WALLS JT, 1984, J THORAC CARDIOV SUR, V88, P352
   WATKINS L, 1977, ANN THORAC SURG, V24, P498
   ZEEVI B, 1988, J AM COLL CARDIOL, V11, P821
NR 20
TC 29
Z9 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD FEB
PY 1990
VL 49
IS 2
BP 273
EP 278
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA CQ047
UT WOS:A1990CQ04700014
PM 2306149
ER

PT J
AU YAR, M
   CHATFIELD, C
AF YAR, M
   CHATFIELD, C
TI PREDICTION INTERVALS FOR THE HOLT-WINTERS FORECASTING PROCEDURE
SO INTERNATIONAL JOURNAL OF FORECASTING
LA English
DT Article
RP YAR, M (reprint author), UNIV BATH,SCH MATH SCI,BATH BA2 7AY,AVON,ENGLAND.
CR ABRAHAM B, 1986, INT STAT REV, V54, P51, DOI 10.2307/1403258
   Abraham B, 1983, STATISTICAL METHODS
   BIANCHI C, 1987, INT J FORECASTING, V3, P211, DOI 10.1016/0169-2070(87)90003-3
   Bowerman B.L., 1979, TIME SERIES FORECAST
   Box GEP, 1976, TIME SERIES ANAL
   Brown R. G., 1967, DECISION RULES INVEN
   Brown RG, 1963, SMOOTHING FORECASTIN
   CHATFIELD C, 1988, STATISTICIAN, V37, P129, DOI 10.2307/2348687
   Chatfield C., 1978, APPLIED STATISTICS, P264, DOI 10.2307/2347162
   DALRYMPLE DJ, 1987, INT J FORECASTING, V3, P379, DOI 10.1016/0169-2070(87)90031-8
   GARDNER ES, 1985, J FORECASTING, V4, P1, DOI 10.1002/for.3980040103
   GARDNER ES, 1985, MANAGE SCI, V31, P1237, DOI 10.1287/mnsc.31.10.1237
   GARDNER ES, 1986, AUTOCAST USERS MANUA
   GARDNER ES, 1989, MANAGE SCI, V35, P372, DOI 10.1287/mnsc.35.3.372
   GARDNER ES, 1988, MANAGE SCI, V34, P541, DOI 10.1287/mnsc.34.4.541
   GILCHRIST W, 1976, STATISTICAL FORECAST
   Granger C. W. J., 1986, FORECASTING EC TIME
   HARVEY AC, 1984, J FORECASTING, V3, P245, DOI 10.1002/for.3980030302
   JOHNSTON FR, 1986, J OPER RES SOC, V37, P303, DOI 10.2307/2582210
   MAKRIDAKIS S, 1987, INT J FORECASTING, V3, P489, DOI 10.1016/0169-2070(87)90045-8
   MCKENZIE E, 1986, INT J FORECASTING, V2, P373, DOI 10.1016/0169-2070(86)90055-5
   MCKENZIE E, 1976, STATISTICIAN, V25, P3, DOI 10.2307/2988127
   MELARD G, 1986, RAIRO-RECH OPER, V20, P89
   NEWBOLD P, 1988, STATISTICIAN, V37, P111, DOI 10.2307/2348686
   NEWBOLD P, 1989, INT J FORECASTING, V5, P523, DOI 10.1016/0169-2070(89)90007-1
   SWEET AL, 1985, J FORECASTING, V4, P235, DOI 10.1002/for.3980040210
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
NR 27
TC 29
Z9 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-2070
J9 INT J FORECASTING
JI Int. J. Forecast.
PY 1990
VL 6
IS 1
BP 127
EP 137
DI 10.1016/0169-2070(90)90103-I
PG 11
WC Economics; Management
SC Business & Economics
GA DN639
UT WOS:A1990DN63900012
ER

PT J
AU ELLESTAD, MH
   FRENCH, J
AF ELLESTAD, MH
   FRENCH, J
TI ILIAC VEIN APPROACH TO PERMANENT PACEMAKER IMPLANTATION
SO PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
LA English
DT Article
RP ELLESTAD, MH (reprint author), MEM HEART INST,MEM MED CTR,2801 ATLANTIC AVE,LONG BEACH,CA 90801, USA.
CR CHAMORRO H, 1978, RADIOLOGY, V126, P377
   COHN JD, 1979, ANN THORAC SURG, V28, P445
   ELLESTAD MH, 1980, PACE, V3, P418, DOI 10.1111/j.1540-8159.1980.tb05250.x
   HESS DS, 1980, BRIT HEART J, V43, P199
   MARKEWITZ A, 1986, PACE, V9, P1014, DOI 10.1111/j.1540-8159.1986.tb06663.x
   MICHALIK RE, 1985, PACE, V8, P25, DOI 10.1111/j.1540-8159.1985.tb05718.x
   ROSENQVIST M, 1986, PACE, V9, P417, DOI 10.1111/j.1540-8159.1986.tb04497.x
   SNOW N, 1982, PACE, V5, P571, DOI 10.1111/j.1540-8159.1982.tb02281.x
NR 8
TC 29
Z9 29
PU FUTURA PUBL CO
PI ARMONK
PA 135 BEDFORD RD, PO BOX 418, ARMONK, NY 10504-0418
SN 0147-8389
J9 PACE
JI PACE-Pacing Clin. Electrophysiol.
PD JUL
PY 1989
VL 12
IS 7
BP 1030
EP 1033
DI 10.1111/j.1540-8159.1989.tb01921.x
PN 1
PG 4
WC Cardiac & Cardiovascular Systems; Engineering, Biomedical
SC Cardiovascular System & Cardiology; Engineering
GA AK022
UT WOS:A1989AK02200005
PM 2476736
ER

PT J
AU ARMSTRONG, JS
   BRODIE, RJ
   MCINTYRE, SH
AF ARMSTRONG, JS
   BRODIE, RJ
   MCINTYRE, SH
TI FORECASTING METHODS FOR MARKETING - REVIEW OF EMPIRICAL-RESEARCH
SO INTERNATIONAL JOURNAL OF FORECASTING
LA English
DT Review
C1 UNIV CAPE TOWN,CAPE TOWN,SOUTH AFRICA.
   UNIV SANTA CLARA,LEAVEY SCH BUSINESS & ADM,DEPT MKT,SANTA CLARA,CA 95053.
   UNIV CANTERBURY,BUSINESS ADM,CHRISTCHURCH 1,NEW ZEALAND.
   UNIV HAWAII,HONOLULU,HI 96822.
   STOCKHOLM SCH ECON,STOCKHOLM,SWEDEN.
RP ARMSTRONG, JS (reprint author), UNIV PENN,WHARTON SCH,PHILADELPHIA,PA 19104, USA.
CR Aaker D. A., 1984, STRATEGIC MARKET MAN
   AAKER DA, 1982, J ADVERTISING RES, V22, P57
   ADAMS AJ, 1986, ACADEMIC MARKETING S, V14, P52
   AGNEW CE, 1985, J FORECASTING, V4, P363, DOI 10.1002/for.3980040405
   ANDERSON CA, 1983, J PERS SOC PSYCHOL, V45, P293, DOI 10.1037/0022-3514.45.2.293
   Armstrong J., 1985, LONG RANGE FORECASTI
   ARMSTRONG JS, 1970, J MARKETING RES, V7, P487, DOI 10.2307/3149642
   ARMSTRONG JS, 1975, ORGAN BEHAV HUM PERF, V14, P257, DOI 10.1016/0030-5073(75)90028-8
   ARMSTRONG JS, 1970, J MARKETING RES, V7, P190, DOI 10.2307/3150108
   ARMSTRONG JS, 1987, JUDGEMENTAL FORECAST, P157
   Ascher W., 1978, FORECASTING APPRAISA
   ASH JCK, 1973, FORECASTING UK EC
   ASHTON AH, 1985, ACCOUNT REV, V60, P173
   ASSMUS G, 1984, J FORECASTING, V3, P121, DOI 10.1002/for.3980030202
   BAKER EJ, 1980, ENVIRON BEHAV, V12, P367, DOI 10.1177/0013916580123005
   BELL DE, 1975, J MARKETING RES, V12, P136, DOI 10.2307/3150435
   Best R.J., 1974, J MARKETING RES, V11, P448, DOI DOI 10.2307/3151295
   BRANDT JA, 1983, J FORECASTING, V2, P237, DOI 10.1002/for.3980020306
   BRODIE RJ, 1987, INT J FORECASTING, V3, P423, DOI 10.1016/0169-2070(87)90035-5
   BRODIE RJ, 1984, J MARKETING RES, V21, P196
   CAMERER C, 1981, ORGAN BEHAV HUM PERF, V27, P411, DOI 10.1016/0030-5073(81)90031-3
   CARBONE R, 1985, DECISION SCI, V16, P153, DOI 10.1111/j.1540-5915.1985.tb01480.x
   CATTIN P, 1982, J MARKETING, V46, P44, DOI 10.2307/1251701
   Cerullo M.J., 1975, MANAGERIAL PLANNING, V24, P33
   CHAKRAVARTI D, 1980, 2ND P ORSA TIMS SPEC, P135
   CHAKRAVARTI D, 1979, MANAGE SCI, V25, P251, DOI 10.1287/mnsc.25.3.251
   CLARKE DG, 1973, J MARKETING RES, V10, P345
   CRAIG CS, 1984, J RETAILING, V60, P5
   CURTIN RT, 1982, PUBLIC OPIN QUART, V46, P340, DOI 10.1086/268731
   DALRYMPLE DJ, 1987, INT J FORECASTING, V3, P379, DOI 10.1016/0169-2070(87)90031-8
   DALRYMPLE DJ, 1970, APPL ECON, V1, P277, DOI 10.1080/00036847000000003
   DALRYMPLE DJ, 1975, BUS HORIZONS, V18, P69, DOI 10.1016/0007-6813(75)90043-9
   DANCER R, 1977, DECISION SCI, V8, P228, DOI 10.1111/j.1540-5915.1977.tb01079.x
   DAY GS, 1983, J MARKETING, V47, P44, DOI 10.2307/1251492
   DENTON FT, 1972, J AM STAT ASSOC, V67, P286, DOI 10.2307/2284370
   DENTON FT, 1965, REV ECON STAT, V47, P198, DOI 10.2307/1924067
   DESANCTIS G, 1984, DECISION SCI, V15, P463, DOI 10.1111/j.1540-5915.1984.tb01236.x
   DHRYMES P, 1987, IN PRESS INT J FOREC
   EDELMAN F, 1965, HARVARD BUS REV, V43, P53
   ELIASHBERG J, 1986, J MARKETING RES, V23, P101, DOI 10.2307/3151657
   FILDES R, 1985, J OPER RES SOC, V36, P549, DOI 10.2307/2582473
   FISCHHOFF B, 1982, J FORECASTING, V1, P155, DOI 10.1002/for.3980010203
   FUDGE WK, 1977, INTERFACES, V8, P97, DOI 10.1287/inte.8.1pt2.97
   GARDNER ES, 1985, MANAGE SCI, V31, P1237, DOI 10.1287/mnsc.31.10.1237
   GEURTS MD, 1986, INT J FORECASTING, V2, P261, DOI 10.1016/0169-2070(86)90046-4
   GHOSH A, 1984, J MARKETING RES, V21, P202, DOI 10.2307/3151702
   GRIFFITH JR, 1979, MED CARE, V17, P292
   HAGERTY MR, 1987, INT J FORECASTING, V3, P457, DOI 10.1016/0169-2070(87)90041-0
   HANSSENS DM, 1980, J MARKETING RES, V17, P470, DOI 10.2307/3150500
   HOGARTH RM, 1978, ORGAN BEHAV HUM PERF, V21, P40, DOI 10.1016/0030-5073(78)90037-5
   HOGARTH RM, 1981, MANAGE SCI, V27, P115, DOI 10.1287/mnsc.27.2.115
   HUBER J, 1975, J MARKETING RES, V12, P290, DOI 10.2307/3151227
   HUBER J, 1975, J CONSUM RES, V2, P229, DOI 10.1086/208636
   JOBBER D, 1985, IND MARKET MANAG, V14, P35, DOI 10.1016/0019-8501(85)90029-X
   Kahneman D., 1982, JUDGMENT UNCERTAINTY
   KALTON G, 1982, J ROY STAT SOC A STA, V145, P42, DOI 10.2307/2981421
   Kalwani M. U., 1982, MARKET SCI, V1, P243, DOI 10.1287/mksc.1.3.243
   Kotler P, 1984, MARKETING MANAGEMENT
   LARRECHE JC, 1983, J MARKETING RES, V20, P110, DOI 10.2307/3151678
   Lawrence M. J., 1985, INT J FORECASTING, V1, P25, DOI 10.1016/S0169-2070(85)80068-6
   LAWRENCE MJ, 1986, MANAGE SCI, V32, P1521, DOI 10.1287/mnsc.32.12.1521
   LEIGH TW, 1984, J MARKETING RES, V21, P456, DOI 10.2307/3151471
   LEONE RP, 1980, J MARKETING, V44, P10, DOI 10.2307/1250029
   LEONE RP, 1987, INT J FORECASTING, V3, P463
   LIBBY R, 1978, ORGAN BEHAV HUM PERF, V21, P121, DOI 10.1016/0030-5073(78)90044-2
   LINDEN F, 1982, PUBLIC OPINION Q, V46, P88
   Little J. D. C., 1970, MANAGE SCI, V16, P466, DOI 10.1287/mnsc.16.8.B466
   Lodish Leonard M., 1971, MANAGE SCI, V18, P25, DOI 10.1287/mnsc.18.4.P25
   LYON D, 1976, ACTA PSYCHOL, V40, P287, DOI 10.1016/0001-6918(76)90032-9
   MABERT VA, 1976, DECISION SCI, V7, P310, DOI 10.1111/j.1540-5915.1976.tb00678.x
   Mahajan V., 1984, MARKET SCI, V3, P179, DOI 10.1287/mksc.3.3.179
   Mahajan V, 1986, INNOVATION DIFFUSION
   MAKRIDAKIS S, 1987, INT J FORECASTING, V3, P489, DOI 10.1016/0169-2070(87)90045-8
   MAKRIDAKIS S, 1982, J FORECASTING, V1, P111, DOI 10.1002/for.3980010202
   MAKRIDAKIS S, 1983, MANAGE SCI, V29, P987, DOI 10.1287/mnsc.29.9.987
   MAKRIDAKIS S, 1977, J MARKETING, V41
   Mathews B. P., 1986, INT J RES MARK, V3, P3, DOI 10.1016/0167-8116(86)90038-8
   MCDONALD J, 1975, J ROYAL STATISTICA A, V138, P242, DOI 10.2307/2984651
   MCINTYRE SH, 1981, MANAGEMENT SCI, V28, P17
   MCINTYRE SH, 1981, IND MARKETING MANAGE, V10, P283, DOI 10.1016/0019-8501(81)90037-7
   MEADE N, 1984, J FORECASTING, V3, P429, DOI 10.1002/for.3980030406
   MENTZER JT, 1984, J FORECASTING, V3, P27, DOI 10.1002/for.3980030104
   MICHAEL GC, 1971, J MARKETING RES, V8, P224, DOI 10.2307/3149765
   MONTGOMERY DB, 1975, J MARKETING RES, V12, P255, DOI 10.2307/3151223
   MORE RA, 1980, J OPER RES SOC, V31, P71, DOI 10.2307/3009338
   MORIARTY MM, 1985, J MARKETING RES, V22, P353, DOI 10.2307/3151581
   MORIARTY MM, 1984, J MARKETING RES, V21, P239, DOI 10.2307/3151600
   Naert P. A., 1978, BUILDING IMPLEMENTAB
   NAERT PA, 1985, J MARKETING RES, V22, P653
   NESLIN SA, 1981, J MARKETING RES, V18, P80, DOI 10.2307/3151316
   NEVIN JR, 1974, J MARKETING RES, V11, P261, DOI 10.2307/3151141
   PARKER BR, 1976, OPER RES, V24, P991, DOI 10.1287/opre.24.5.991
   PASHIGIAN BP, 1964, REV ECON STAT, V46, P398, DOI 10.2307/1924049
   PAYNE DE, 1966, J MARKETING RES, V3, P372, DOI 10.2307/3149853
   PERRY P, 1979, PUBLIC OPIN QUART, V43, P312, DOI 10.1086/268524
   Rao S. K., 1985, J PROD INNOVAT MANAG, V4, P232
   REIBSTEIN DJ, 1982, J MARKETING, V46, P102, DOI 10.2307/1251366
   REILLY RR, 1982, PERS PSYCHOL, V35, P1, DOI 10.1111/j.1744-6570.1982.tb02184.x
   RINK DR, 1979, J BUS RES, V7, P219, DOI 10.1016/0148-2963(79)90030-4
   Rosenstone S. J., 1983, FORECASTING PRESIDEN
   RUSH H, 1979, FUTURES, V11, P321, DOI 10.1016/0016-3287(79)90089-2
   SCHNAARS SP, 1986, INTERFACES, V16, P100, DOI 10.1287/inte.16.6.100
   SCHNAARS SP, 1987, INT J FORECASTING, V3, P405, DOI 10.1016/0169-2070(87)90033-1
   SCHNAARS SP, 1984, J MARKETING RES, V21, P290, DOI 10.2307/3151605
   SEWALL MA, 1981, J MARKETING RES, V18, P249, DOI 10.2307/3150960
   SHERMAN SJ, 1980, J PERS SOC PSYCHOL, V39, P211, DOI 10.1037/0022-3514.39.2.211
   SHOCKER AD, 1979, J MARKETING RES, V16, P159, DOI 10.2307/3150681
   SHOCKER AD, 1986, J PROD INNOVAT MANAG, V3, P86, DOI 10.1016/0737-6782(86)90031-7
   SIMON JL, 1980, J ADVERTISING RES, V20, P11
   STAELIN R, 1972, J MARKETING RES, V10, P10
   TULL DS, 1967, J BUS, V40, P233, DOI 10.1086/294974
   TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293
   TWENEY RD, 1982, SOCIAL STUDIES SCI, V12, P345
   TYEBJEE TT, 1987, INT J FORECASTING, V3, P393, DOI 10.1016/0169-2070(87)90032-X
   URBAN GL, 1983, J MARKETING RES, V20, P221, DOI 10.2307/3151826
   WAGENAAR WA, 1985, ERGONOMICS, V28, P756
   WAGENAAR WA, 1979, ACTA PSYCHOL, V43, P239, DOI 10.1016/0001-6918(79)90028-3
   WARSHAW PR, 1980, J MARKETING RES, V17, P26, DOI 10.2307/3151113
   Weld LDH, 1939, J MARKETING, V3, P389, DOI 10.2307/1245719
   Wellman HR, 1939, J MARKETING, V3, P225, DOI 10.2307/1246207
   WILLIAMS WH, 1971, J AM STAT ASSOC, V66, P752, DOI 10.2307/2284223
   WILTON PC, 1981, J CONSUM RES, V8, P162, DOI 10.1086/208852
   WIND YJ, 1981, NEW PRODUCT FORECAST
   WINTERS PR, 1960, MANAGE SCI, V6, P324, DOI 10.1287/mnsc.6.3.324
   WOTRUBA TR, 1976, J CONSUMER RES, V8, P162
   YOKUM JT, 1987, INT J FORECASTING, V3, P479, DOI 10.1016/0169-2070(87)90044-6
NR 126
TC 29
Z9 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-2070
J9 INT J FORECASTING
JI Int. J. Forecast.
PY 1987
VL 3
IS 3-4
BP 355
EP 376
PG 22
WC Economics; Management
SC Business & Economics
GA K8051
UT WOS:A1987K805100002
ER

PT J
AU MORRIS, AH
   CHAPMAN, RH
   GARDNER, RM
AF MORRIS, AH
   CHAPMAN, RH
   GARDNER, RM
TI FREQUENCY OF WEDGE PRESSURE ERRORS IN THE ICU
SO CRITICAL CARE MEDICINE
LA English
DT Article
C1 UNIV UTAH,SCH MED,DIV RESP CRIT CARE & OCCUPAT PULM MED,SALT LAKE CITY,UT 84112.
   UNIV UTAH,SCH MED,DEPT MED BIOPHYS & COMP,SALT LAKE CITY,UT 84112.
RP MORRIS, AH (reprint author), LATTER DAY ST HOSP,DEPT MED,DIV PULM,INTERMT RESP INTENS CARE UNIT,8TH AVE & C ST,SALT LAKE CITY,UT 84143, USA.
CR ARCHER G, 1974, ANN SURG, V180, P747, DOI 10.1097/00000658-197411000-00007
   BREWSTER H, 1973, J APPL PHYSIOL, V34, P413
   CENGIZ M, 1983, CRIT CARE MED, V11, P502, DOI 10.1097/00003246-198307000-00004
   CHLUP J, 1975, CLIN SCI MOL MED, V48, P47
   FRY DL, 1960, PHYSIOL REV, V40, P753
   GARDNER RM, 1970, IEEE T BIOMED ENG, V18, P60
   GARDNER RM, 1981, ANESTHESIOLOGY, V54, P227, DOI 10.1097/00000542-198103000-00010
   GARDNER RM, 1977, ANN THORAC SURG, V23, P534
   LAPPAS D, 1973, ANESTHESIOLOGY, V38, P394, DOI 10.1097/00000542-197304000-00017
   MALMSTROM G, 1953, ACTA MED SCAND, V145, P91
   MANKTELO.RT, 1969, J THORAC CARDIOV SUR, V58, P122
   MENDEL A, 1968, PRACTICE CARDIAC CAT, P234
   MORRIS AH, 1985, CRIT CARE MED, V13, P756, DOI 10.1097/00003246-198509000-00014
   MORRIS AH, 1984, CRIT CARE MED, V12, P164, DOI 10.1097/00003246-198403000-00003
   MOSER KM, 1983, ANN INTERN MED, V98, P53
   OQUIN R, 1983, AM REV RESPIR DIS, V128, P319
   PACE NL, 1977, ANESTHESIOLOGY, V47, P455, DOI 10.1097/00000542-197711000-00014
   RAPAPORT E, 1958, METHOD MED RES, P85
   SHAPIRO HM, 1974, ANESTHESIOLOGY, V40, P291, DOI 10.1097/00000542-197403000-00017
   Suter P M, 1975, Crit Care Med, V3, P175, DOI 10.1097/00003246-197509000-00001
   SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902
   WILLIAMS WH, 1982, CRIT CARE MED, V10, P636, DOI 10.1097/00003246-198210000-00003
NR 22
TC 29
Z9 29
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PY 1985
VL 13
IS 9
BP 705
EP 708
DI 10.1097/00003246-198509000-00002
PG 4
WC Critical Care Medicine
SC General & Internal Medicine
GA AQC10
UT WOS:A1985AQC1000002
PM 4028767
ER

PT J
AU Newburger, B
AF Newburger, B
TI Early postoperative walking II Collective review
SO SURGERY
LA English
DT Review
CR Abel A L, 1937, Postgrad Med J, V13, P435
   AREVOLI E, 1934, MORGANGNI, V76, P968
   Barnes AR, 1937, J AMER MED ASSOC, V109, P1347
   BAUMECKER H, 1939, MED KLIN, V35, P1044
   Bergquist G., 1940, ACTA CHIR SCAND, V83, P415
   BEST CH, 1939, PHYSL BASIS MED PRAC, P216
   BIER, 1923, OPERATIONSLEHRE, V3, P55
   BILLROTH T, 1882, ALLGEMEINE CHIRURG P, P120
   BLOODGOOD JC, 1898, J HOPKINS HOSP REPOR, V7, P223
   BOLDT HJ, 1907, T AM GYNEC SOC, V32, P181
   BOLDT HJ, 1907, NEW YORK M J, V85, P145
   BUEDINGER K, 1908, WIEN KLIN WCHNSCHR, V21, P1694
   CAEIRO BN, 1936, B TRAB SOC CIR BUENO, V20, P365
   CAMARGO J, 1926, BRAS MED, V40, P31
   CAMPEANU L, 1938, ARCH ITAL CHIR, V51, P12
   CAMPEANU L, 1937, PRESSE MED, V45, P1208
   CAMPEANU L, 1937, ZENTRALBL CHIR, V64, P1573
   CECCHINI N, 1937, BOLLETTINO, V11, P49
   CHALIER A, 1933, B MEM SOC NAT CHIR, V59, P1211
   CHALIER A, 1934, LYON CHIR, V31, P261
   CHALIER A, 1929, LYON CHIR, V26, P834
   CHALIER A, 1938, PRESSE MED, V46, P1345
   CHALIER A, 1932, AVENIR MED, V29, P251
   CHALIER A, 1930, LYON CHIR, V27, P387
   CHALIER A, 1933, LYON CHIR, V30, P122
   CHALIER A, 1929, LYON CHIR, V26, P865
   CHALIER A, 1931, B MEM SOC NAT CHIR, V57, P216
   CHARBONNIER A, 1935, REV MED SUISSE ROMAN, V55, P402
   CHARBONNIER A, 1935, HELV MED ACTA, V2, P182
   CHASE WB, 1908, AM J OBSTET GYNECOL, V58, P790
   CLAIRMONT HE, 1922, LANCET, V1, P487
   COHN F, 1908, ZENTRALBL GYNAK, V32, P1233
   CONIGLIO G, 1935, RIV SAN SICILIANA, V23, P120
   CORREA B, 1937, LYON CHIR, V34, P37
   CORYLLOS PN, 1930, SURG GYNECOL OBSTET, V50, P795
   COTTE G, 1939, LYON CHIR, V36, P441
   COTTE MG, 1934, B MEM SOC NAT CHIR, V60, P358
   CROSSEN HS, 1941, DIS WOMEN
   CVITANOVITCH, 1937, PRESSE MED, V45, P1471
   DAUMERIE L, 1938, BRUXELLES MED, V18, P534
   DELAGENIERE H, 1940, ARCH MED ANGERS, V14, P185
   DELAGENIERE Y, 1934, PRESSE MED, V42, P1669
   DEQUERVAIN F, 1925, SCHWEIZ MED WCHNSCHR, V55, P497
   DEVRAIGNE L, 1919, MEDECINE, V1, P434
   DUCUING J, 1934, J MED FRANC, V23, P74
   Ellis LB, 1932, AM J PHYSIOL, V101, P494
   FLOERCKEN H, 1936, MUNCHEN MED WCHNSCHR, V83, P917
   FOLLIASSON A, 1933, GAZ MED-FRANCE, P679
   FORGUE E, 1916, ANN GYNEC OBST, V72, P1
   Frederick CC, 1908, J AMER MED ASSOC, V51, P834
   FRIEDEMANN M, 1936, ZENTRALBL CHIR, V63, P2412
   FRYKHOLM A, 1940, SURG GYNECOL OBSTET, V71, P307
   GAMBLE HA, 1935, AM J SURG, V28, P93, DOI 10.1016/S0002-9610(35)90288-4
   GAUTIER J, 1937, GAZ MED-FRANCE, V44, P791
   Gibbon JH, 1907, ANN SURG, V46, P298, DOI 10.1097/00000658-190708000-00016
   GRONDAHL NB, 1939, NORD MED, V3, P2630
   GULLOTTA G, 1935, MINERVA MED, V26, P322
   HABEILIN, 1920, SCHWEIZ MED WCHNSCHR, V50, P148
   HARILD S, 1939, NORD MED, V4, P2988
   HARTOG C, 1909, BERL KLIN WCHNSCHR, V46, P492
   HAVLICEK H, 1932, 2 C INT LUM
   HAVLICEK H, 1935, ARCH KLIN CHIR, V183, P42
   HENLE, 1901, VERHANDL DTSCH GESEL, V30, P240
   HENLE, 1908, VERHANDL DTSCH CHI 1, V37, P13
   HENRIKSEN E, 1941, W J SURG, V49, P1
   HOFMANN W, 1914, BERL KLIN WCHNSCHR, V51, P354
   JEANNENEY G, 1933, B MEM SOC NAT CHIR, V59, P1214
   KALTREIDER NL, 1937, J CLIN INVEST, V16, P36
   Kelly HA, 1911, SURG GYNECOL OBSTET, V13, P78
   KHROMOV BM, 1936, SOVET KHIR, V9, P389
   KIMBAROVSKRY MA, 1935, SOVET KHIR, V35, P57
   King DS, 1933, J AMER MED ASSOC, V100, P21
   KOERTE, 1908, VERHANDL DTSCH GES 1, V37, P13
   KOHLSCHUETTER, 1913, MUNCHEN MED WCHNSCHR, V60, P1379
   KRECKE A, 1910, MUNCHEN MED WCHNSCHR, V57, P2037
   KUMMELL H, 1908, ARCH KLIN CHIR, V86, P494
   Kummell H, 1909, DEUT MED WOCHENSCHR, V35, P1865
   KUNZ W, 1932, BEITR KLIN CHIR, V155, P453
   LADURON, 1937, J CHIR ANN SOC BELGE, V36, P546
   LARREY DJ, 1812, MEMOIRES CHIRURG MIL, V3, P45
   Leithauser DJ, 1941, ARCH SURG-CHICAGO, V42, P1086
   LENNANDER KG, 1899, ZENTRALBL CHIR, V26, P553
   LERICHE R, 1936, REV CHIR PARIS, V74, P99
   LINO G, 1934, ANN ITAL CHIR, V13, P1178
   LINO G, 1934, B SOC MED CHIR CATAN, V2, P430
   LOUTE L, 1937, J CHIR ANN SOC BELGE, V36, P228
   MACLEOD JJR, 1938, PHYSL MODERN MED, P474
   MADELUNG O, 1905, VERHANDL DTSCH GESEL, V34, P168
   MARSHALL VF, 1906, M REC, V70, P809
   MARTY, 1934, GAZ HEBD SCI MED BOR, V55, P390
   McCloskey JF, 1940, ANN SURG, V111, P610, DOI 10.1097/00000658-194004000-00011
   MERMINGAS K, 1930, ZENTRALBL CHIR, V57, P2424
   MERMINGAS K, 1939, ZENTRALBL CHIR, V66, P1390
   MILLER RT, 1911, PENNSYLVANIA M J, V15, P269
   Nelson EW, 1942, SURGERY, V12, P109
   Newburger B, 1943, SURGERY, V13, P692
   NOBLE CJ, COMMUNICATION
   Ochsner A, 1941, NEW ENGL J MED, V225, P207, DOI 10.1056/NEJM194108072250601
   PACK GL, 1940, TREATMENT CARCINOMA, V2, P1015
   PASCHOUD H, 1935, HELV MED ACTA, V2, P127
   PASCHOUD H, 1935, ARCH KLIN CHIR, V183, P41
   PASCHOUD H, 1940, ZENTRALBL CHIR, V67, P981
   PASCHOUD H, 1938, DTSCH Z CHIR, V251, P298
   PAYR E, 1930, ZENTRALBL CHIR, V57, P961
   PEPE CJ, 1933, REV ASOC MED ARGENT, V47, P2846
   PETTERSON G, 1941, ACTA CHIR SCAND, V84, P321
   POLICHETTI E, 1933, GAZZ OSP, V54, P1337
   Pool EH, 1913, J AMER MED ASSOC, V60, P1202
   PORTIS B, 1936, S CLIN N AM, V16, P287
   Potts WJ, 1941, ARCH SURG-CHICAGO, V42, P661
   Powers JH, 1928, ARCH SURG-CHICAGO, V17, P304
   REHN, 1902, ARCH KLIN CHIR, V67, P790
   REHN, 1908, VERHANDL DTSCH GES 1, V37, P13
   REID MR, 1936, NEW ENGL J MED, V215, P703
   REINKING JJ, 1937, ZENTRALBL CHIR, V64, P1579
   REYNES H, 1913, 17 INT C MED LOND 2, P249
   RICARD P, 1939, LYON CHIR, V36, P448
   RICCI G, 1936, AN CIR, V2, P175
   RICHTER HM, COMMUNICATION
   Ries E., 1899, JAMA-J AM MED ASSOC, VXXXIII, P454
   ROBERTSON G, 1927, PRACTITIONER, V119, P162
   ROST, 1927, ARCH KLIN CHIR, V148, P30
   Rowlands R P, 1922, Br Med J, V1, P52
   SALISCHEW BE, 1936, NOVY KHIR ARKHIV, V35, P260
   SCHUMACHER P, 1926, ARCH GYNAK, V129, P929
   Silberberg M, 1938, PHYSIOL REV, V18, P197
   Smith LA, 1940, ARCH SURG-CHICAGO, V41, P1366
   Smith LA, 1940, ARCH SURG-CHICAGO, V41, P1377
   SMITH P, 1940, UNION MED CAN, V69, P921
   Sparkman RS, 1942, SURGERY, V11, P698
   STICH R, 1935, ARCH KLIN CHIR, V183, P301
   TONDEUR F, 1937, J CHIR ANN SOC BELGE, V36, P477
   TOVEY DW, 1918, AM J OBST, V77, P237
   VANCE J, 1907, NEW YORK STATE J MED, V85, P302
   VANVERTS J, 1920, REV FRANC GYNEC OBST, V11, P106
   Vietor JA, 1925, ANN SURG, V82, P193
   VILLARD, 1933, LYON CHIR, V30, P606
   VIOLET H, 1932, AVENIR MED, V29, P247
   VOLLMER AM, COMMUNICATION
   VONEISELBERG, 1908, VERHANDL DTSCH GES 1, V37, P21
   VONJASCHKE KT, 1926, ARCH GYNAK, V129, P921
   VONSEEMAN H, 1930, DTSCH Z CHIR, V223, P85
   Waugh W G, 1940, Br Med J, V1, P249
   Wilson LB, 1912, ANN SURG, V56, P809
   WOHLLEBEN T, 1937, ARCH KLIN CHIR, V189, P382
   Wolff J., 1870, VIRCHOWS ARCH PATHOL, V50, P389, DOI DOI 10.1007/BF01944490
   ZAVA L, 1940, POLICLINICO, V47, P865
   ZIMMERMAN LM, 1938, SURG GYNECOL OBSTET, V66, P193
   ZORAQUIN, 1934, B TRAB SOC CIR BUENO, V18, P226
   1912, MED KLIN, V8, P1499
NR 150
TC 29
Z9 29
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD JUL-DEC
PY 1943
VL 14
BP 142
EP 154
PG 13
WC Surgery
SC Surgery
GA V35DB
UT WOS:000202373900014
ER

PT J
AU van Harten, AE
   Scheeren, TWL
   Absalom, AR
AF van Harten, A. E.
   Scheeren, T. W. L.
   Absalom, A. R.
TI A review of postoperative cognitive dysfunction and neuroinflammation
   associated with cardiac surgery and anaesthesia
SO ANAESTHESIA
LA English
DT Review
ID CORONARY-ARTERY-BYPASS; CEREBRAL-BLOOD-FLOW; HYPOTHERMIC CARDIOPULMONARY
   BYPASS; FIBRILLARY ACIDIC PROTEIN; APOLIPOPROTEIN-E GENOTYPE;
   NEURON-SPECIFIC ENOLASE; INNATE IMMUNE-SYSTEM; OFF-PUMP; ON-PUMP;
   INFLAMMATORY RESPONSE
AB Postoperative cognitive dysfunction is receiving increasing attention, particularly as it mainly affects the (growing) elderly population. Until recently, cognitive deficits after cardiac surgery were thought to be caused by physiological disturbances associated with the cardiopulmonary bypass technique. Although the technique of off-pump coronary revascularisation may potentially be associated with improved outcome, long-term follow-up studies have failed to demonstrate a significant reduction in the incidence of postoperative cognitive dysfunction. The focus of research is thus shifting from cardiopulmonary bypass to other factors common to both techniques, such as surgery, anaesthesia and patient-related predisposing factors. Priming of the immune system by ageing and atherosclerosis may result in an exaggerated systemic and cerebral inflammatory response to cardiac surgery and anaesthesia, causing neuronal loss or dysfunction resulting in cognitive dysfunction. We briefly discuss the evidence for cardiopulmonary bypass-related neuronal injuries in adult cardiac surgery patients, and review the evidence that immune priming is a key factor in the pathogenesis of cognitive dysfunction after cardiac surgery.
C1 [van Harten, A. E.; Scheeren, T. W. L.; Absalom, A. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, NL-9700 AB Groningen, Netherlands.
RP Absalom, AR (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, NL-9700 AB Groningen, Netherlands.
EM a.r.absalom@umcg.nl
CR Abildstrom H, 2002, ANN THORAC SURG, V73, P1174, DOI 10.1016/S0003-4975(01)03618-9
   Abu-Omar Y, 2006, J THORAC CARDIOV SUR, V132, P1119, DOI 10.1016/j.jtcvs.2006.04.057
   Aziz KAA, 2010, INTERACT CARDIOV TH, V10, P271, DOI 10.1510/icvts.2009.214130
   Barber PA, 2008, STROKE, V39, P1427, DOI 10.1161/STROKEAHA.107.502989
   Bartels AL, 2010, PARKINSONISM RELAT D, V16, P57, DOI 10.1016/j.parkreldis.2009.05.005
   Bhattacharyya PK, 2011, MAGN RESON IMAGING, V29, P374, DOI 10.1016/j.mri.2010.10.009
   Biber K, 2008, NEUROPSYCHOPHARMACOL, V33, P2237, DOI 10.1038/sj.npp.1301612
   Borgermann J, 2007, THORAC CARDIOV SURG, V55, P473, DOI 10.1055/s-2007-965631
   PRIEST WS, 1957, MED CLIN N AM, V41, P155
   Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159
   Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5
   Burkhart CS, 2010, J CARDIOTHOR VASC AN, V24, P555, DOI 10.1053/j.jvca.2010.01.003
   Cann C, 2010, ANAESTHESIA, V65, P1166, DOI 10.1111/j.1365-2044.2010.06531.x
   Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014
   Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2
   Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024
   Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005
   Davies DC, 2002, J ANAT, V200, P639, DOI 10.1046/j.1469-7580.2002.00065.x
   Day J R S, 2005, Int J Surg, V3, P129, DOI 10.1016/j.ijsu.2005.04.002
   Dhawan J, 2010, NEUROIMAGE, V51, P599, DOI 10.1016/j.neuroimage.2010.02.073
   Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x
   Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108
   Dolga AM, 2008, J NEUROCHEM, V107, P1158, DOI 10.1111/j.1471-4159.2008.05701.x
   Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48
   Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647
   Eagle KA, 1999, CIRCULATION, V100, P1464
   Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019
   Elbers PWG, 2011, J CARDIOTHOR VASC AN, V25, P250, DOI 10.1053/j.jvca.2010.06.014
   Evered L, 2011, ANESTH ANALG, V112, P1179, DOI 10.1213/ANE.0b013e318215217e
   Farag E, 2006, ANESTH ANALG, V103, P633, DOI 10.1213/01.ane.0000228870.48028.b5
   Fjell AM, 2010, REV NEUROSCIENCE, V21, P187
   Gao L, 2005, CHEST, V128, P3664, DOI 10.1378/chest.128.5.3664
   Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649
   Gottesman RF, 2007, ARCH NEUROL-CHICAGO, V64, P1111, DOI 10.1001/archneur.64.8.noc70028
   Grigore AM, 2001, ANESTHESIOLOGY, V95, P1110, DOI 10.1097/00000542-200111000-00014
   Grigore AM, 2009, ANESTH ANALG, V109, P1741, DOI 10.1213/ANE.0b013e3181c04fea
   Grocott HP, 2005, STROKE, V36, P1854, DOI 10.1161/01.STR.0000177482.23478.dc
   Grocott HP, 2005, ANESTH ANALG, V100, P1869, DOI 10.1213/01.ANE.0000151482.91599.CC
   Grubhofer G, 2000, ACTA ANAESTH SCAND, V44, P586, DOI 10.1034/j.1399-6576.2000.00517.x
   Gu YJ, 2011, ARTIF ORGANS, V35, pE18, DOI 10.1111/j.1525-1594.2010.01152.x
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001
   HARRIS DN, 1993, LANCET, V342, P586, DOI 10.1016/0140-6736(93)91412-F
   Harris DNF, 1998, ANESTHESIOLOGY, V88, P340, DOI 10.1097/00000542-199802000-00011
   Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002
   Heringlake M, 2011, ANESTHESIOLOGY, V114, P58, DOI 10.1097/ALN.0b013e3181fef34e
   Herrmann M, 2000, STROKE, V31, P2670
   Hoover LR, 2009, ANESTH ANALG, V108, P1389, DOI 10.1213/ane.0b013e318187c39d
   Huang Y, 2008, NEUROBIOL AGING, V29, P1744, DOI 10.1016/j.neurobiolaging.2007.04.012
   Hudetz JA, 2009, ACTA ANAESTH SCAND, V53, P864, DOI 10.1111/j.1399-6576.2009.01978.x
   Hudetz JA, 2010, J ANESTH, V25, P1
   Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931
   Joshi B, 2010, ANESTH ANALG, V110, P321, DOI 10.1213/ANE.0b013e3181c6fd12
   Jungwirth B, 2009, J THORAC CARDIOV SUR, V138, P1002, DOI 10.1016/j.jtcvs.2009.06.022
   Jungwirth B, 2010, ANESTH ANALG, V110, P312, DOI 10.1213/ANE.0b013e3181bbc42e
   Khatri P, 1999, HEALTH PSYCHOL, V18, P301, DOI 10.1037/0278-6133.18.3.301
   Knipp SC, 2008, ANN THORAC SURG, V85, P872, DOI 10.1016/j.athoracsur.2007.10.083
   Knipp SC, 2005, EUR J CARDIO-THORAC, V28, P88, DOI 10.1016/j.ejcts.2005.02.043
   Kofke WA, 2004, ANESTH ANALG, V99, P1323, DOI 10.1213/01.ANE.0000135345.03635.6A
   Kofke WA, 2002, ANESTH ANALG, V94, P1229, DOI 10.1097/00000539-200205000-00033
   Kofke WA, 1996, ANESTH ANALG, V83, P141, DOI 10.1097/00000539-199607000-00025
   Liu YH, 2009, ANESTH ANALG, V109, P1013, DOI 10.1213/ane.0b013e3181aed2bb
   Ma CX, 2009, CHINESE MED J-PEKING, V122, P1575, DOI 10.3760/cma.j.issn.0366-6999.2009.13.019
   Maas MB, 2009, BIOMARK MED, V3, P363, DOI 10.2217/BMM.09.30
   Mahanna EP, 1996, ANN THORAC SURG, V61, P1342, DOI 10.1016/0003-4975(95)01095-5
   Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA
   Mathew JP, 2007, J AM COLL CARDIOL, V49, P1934, DOI 10.1016/j.jacc.2007.01.080
   Mazzone A, 2003, PERFUSION-UK, V18, P3, DOI 10.1191/0267659103pf622oa
   McKhann GM, 1997, LANCET, V349, P1282, DOI 10.1016/S0140-6736(96)09466-4
   MOODY DM, 1995, ANN THORAC SURG, V59, P1304, DOI 10.1016/0003-4975(95)00057-R
   Moritz S, 2010, EUR J ANAESTH, V27, P542, DOI 10.1097/EJA.0b013e3283343ef8
   MURKIN JM, 1995, J THORAC CARDIOV SUR, V110, P349, DOI 10.1016/S0022-5223(95)70230-X
   MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U
   Nelson David P, 2008, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P49, DOI 10.1053/j.pcsu.2008.01.003
   Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246
   Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601
   Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803
   Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362
   Padmanabhan U, 2009, ANESTH ANALG, V109, P1448, DOI 10.1213/ane.0b013e3181a6ad31
   Parolari A, 2007, ANN THORAC SURG, V84, P823, DOI 10.1016/j.athoracsur.2007.04.048
   Patel RL, 1996, J THORAC CARDIOV SUR, V111, P1267, DOI 10.1016/S0022-5223(96)70230-1
   Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.00001089998.48026.C3
   Plochl W, 1999, ANESTHESIOLOGY, V90, P183, DOI 10.1097/00000542-199901000-00024
   Price CC, 2008, ANESTHESIOLOGY, V108, P8
   Puskas JD, 2011, J THORAC CARDIOV SUR, V141, P1116, DOI 10.1016/j.jtcvs.2011.01.013
   RABINER CJ, 1975, J NERV MENT DIS, V160, P342
   Rasmussen LS, 1999, ACTA ANAESTH SCAND, V43, P495, DOI 10.1034/j.1399-6576.1999.430502.x
   Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x
   Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x
   Reinsfelt B, 2011, ACTA ANAESTH SCAND, V55, P118, DOI 10.1111/j.1399-6576.2010.02324.x
   Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501
   Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004
   Royse CF, 2011, ANAESTHESIA, V66, P455, DOI 10.1111/j.1365-2044.2011.06704.x
   Rudolph JL, 2010, ACTA ANAESTH SCAND, V54, P663, DOI 10.1111/j.1399-6576.2010.02236.x
   Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091
   Schroeter M, 2009, J CEREBR BLOOD F MET, V29, P1216, DOI 10.1038/jcbfm.2009.36
   Selnes OA, 2009, ANN THORAC SURG, V88, P445, DOI 10.1016/j.athoracsur.2009.04.061
   Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6
   Siepe M, 2010, EUROPEAN J CARDIOTHO, V40, P200
   Silbert BS, 2006, ANESTHESIOLOGY, V104, P1137, DOI 10.1097/00000542-200606000-00007
   Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070
   Small GW, 2008, LANCET NEUROL, V7, P161, DOI 10.1016/S1474-4422(08)70019-X
   Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224
   Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569
   Stump DA, 1996, J CARDIOTHOR VASC AN, V10, P113, DOI 10.1016/S1053-0770(96)80186-8
   Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107
   Tomic V, 2005, CIRCULATION, V112, P2912, DOI 10.1161/CIRCULATIONAHA.104.531152
   Valentim AM, 2008, J AM ASSOC LAB ANIM, V47, P16
   van Dijk D, 2009, ANESTH ANALG, V109, P1006, DOI 10.1213/ANE.0b013e3181b5af06
   van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701
   Varnous S, 2007, CLIN CHEM LAB MED, V45, P372, DOI 10.1515/CCLM.2007.060
   Voss B, 2010, EUR J CARDIO-THORAC, V37, P223, DOI 10.1016/j.ejcts.2009.05.050
   Wada Y, 2005, FASEB J, V19, P1914, DOI 10.1096/fj.05-4037fje
   Walsh DT, 2001, J NEUROPATH EXP NEUR, V60, P173
   Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007
   YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016
NR 116
TC 28
Z9 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-2409
J9 ANAESTHESIA
JI Anaesthesia
PD MAR
PY 2012
VL 67
IS 3
BP 280
EP 293
DI 10.1111/j.1365-2044.2011.07008.x
PG 14
WC Anesthesiology
SC Anesthesiology
GA 889AN
UT WOS:000300046000013
PM 22321085
ER

PT J
AU Takagi, H
   Matsui, M
   Umemoto, T
AF Takagi, Hisato
   Matsui, Masafumi
   Umemoto, Takuya
TI Off-Pump Coronary Artery Bypass May Increase Late Mortality: A
   Meta-Analysis of Randomized Trials
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID INTERNAL THORACIC-ARTERY; ON-PUMP; GRAFT PATENCY; MYOCARDIAL
   REVASCULARIZATION; TERM OUTCOMES; RISK PATIENTS; FOLLOW-UP; SURGERY;
   MORBIDITY; SURVIVAL
AB Background. Although a lot of randomized trials of off-pump coronary artery bypass grafting (CABG) versus on-pump CABG were conducted, the majority of them reported only early outcomes. Previous meta-analyses of a few randomized trials found no differences for 1-year to 2-year mortality.
   Methods. We focused late (>= 1 year) all-cause mortality and performed a meta-analysis of randomized controlled trials of off-pump versus on-pump CABG. The MEDLINE, the EMBASE, and the Cochrane Central Register of Controlled Trials were searched using PubMed and OVID. For each study, data regarding all-cause mortality in both the off-pump and on-pump groups were used to generate risk ratios (RRs) and 95% confidence intervals. Study-specific estimates were combined using inverse variance-weighted averages of logarithmic RRs in both fixed-effects and random-effects models.
   Results. Our search identified 11 results of 12 randomized trials (4,326 patients) of off-pump versus on-pump CABG. Pooled analysis demonstrated a statistically significant increase in midterm all-cause mortality by a factor of 1.37 with off-pump relative to on-pump CABG (RR, 1.373; 95% confidence interval, 1.043 to 1.808). Exclusion of any single result, except for the largest (> 2,000 patients) trial, from the analysis did not substantively alter the overall result of our analysis. Eliminating the largest trial demonstrated a statistically nonsignificant benefit of on-pump over off-pump CABG for midterm all-cause mortality (RR, 1.344; 95% confidence interval, 0.952 to 1.896).
   Conclusions. The results of our analysis suggest that off-pump CABG may increase late all-cause mortality by a factor of 1.37 over on-pump CABG. Longer term mortality from randomized trials of off-pump versus on-pump CABG is needed. (Ann Thorac Surg 2010; 89: 1881-8) (C) 2010 by The Society of Thoracic Surgeons
C1 [Takagi, Hisato; Matsui, Masafumi; Umemoto, Takuya] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shimizu, Shizuoka 4118611, Japan.
RP Takagi, H (reprint author), Shizuoka Med Ctr, Dept Cardiovasc Surg, 762-1 Nagasawa, Shimizu, Shizuoka 4118611, Japan.
EM kfgth973@ybb.ne.jp
CR Angelini GD, 2009, J THORAC CARDIOV SUR, V137, P295, DOI 10.1016/j.jtcvs.2008.09.046
   Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8
   Ascione R, 2001, ANN THORAC SURG, V72, P959, DOI 10.1016/S0003-4975(00)02598-4
   Aziz A, 2009, CIRCULATION, V120, pS65, DOI 10.1161/CIRCULATIONAHA.108.844316
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   BELL MR, 1992, CIRCULATION, V86, P446
   Boening A, 2003, ANN THORAC SURG, V76, P2000, DOI 10.1016/S0003-4975(03)01298-0
   Cheng DC, 2005, ANESTHESIOLOGY, V102, P188, DOI 10.1097/00000542-200501000-00028
   Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X
   Feng ZZ, 2009, ANN THORAC SURG, V87, P757, DOI 10.1016/j.athoracsur.2008.11.042
   Gerola LR, 1996, ANN THORAC SURG, V61, P1708, DOI 10.1016/0003-4975(96)00080-X
   Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595
   Jensen BO, 2008, EUR J CARDIO-THORAC, V34, P1016, DOI 10.1016/j.ejcts.2008.07.053
   Karolak W, 2007, AM HEART J, V153, P689, DOI 10.1016/j.ahj.2007.01.033
   Kozower BD, 2005, ANN THORAC SURG, V80, P112, DOI 10.1016/j.athoracsur.2005.02.017
   Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4
   Legare JF, 2004, CIRCULATION, V109, P887, DOI 10.1161/01.CIR.0000115943.41814.7D
   Lim E, 2006, J THORAC CARDIOV SUR, V132, P1409, DOI 10.1016/j.jtcvs.2006.08.012
   Lingaas PS, 2006, ANN THORAC SURG, V81, P2089, DOI 10.1016/j.athoracsur.2005.12.003
   Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Moller CH, 2008, EUR HEART J, V29, P2601, DOI 10.1093/eurheartj/ehn335
   Muneretto C, 2003, ANN THORAC SURG, V76, P778, DOI 10.1016/S0003-4975(03)00564-2
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Osswald BR, 2001, EUR J CARDIO-THORAC, V20, P120, DOI 10.1016/S1010-7940(01)00743-6
   Parolari A, 2005, ANN THORAC SURG, V80, P2121, DOI 10.1016/j.athoracsur.2005.05.007
   Pick AW, 1997, ANN THORAC SURG, V64, P599, DOI 10.1016/S0003-4975(97)00620-6
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Sabik JF, 2004, J THORAC CARDIOV SUR, V127, P142, DOI 10.1016/j.jtcvs.2003.08.046
   Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905
   Straka Z, 2004, ANN THORAC SURG, V77, P789, DOI 10.1016/j.athoracsur.2003.08.039
   Synnergren MJ, 2008, J THORAC CARDIOV SUR, V136, P29, DOI 10.1016/j.jtcvs.2007.07.059
   Takagi H, 2007, J THORAC CARDIOV SUR, V133, pE2, DOI 10.1016/j.jtcvs.2006.08.062
   TAKAGI H, 2010, J THORAC CARDIO 0112
   van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701
   Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80
   Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36
   Wijeysundera DN, 2005, J AM COLL CARDIOL, V46, P872, DOI 10.1016/j.jacc.2005.05.064
   Williams ML, 2005, CIRCULATION S1, V112
NR 39
TC 28
Z9 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUN
PY 2010
VL 89
IS 6
BP 1881
EP 1888
DI 10.1016/j.athoracsur.2010.03.010
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 599ST
UT WOS:000277934200024
PM 20494043
ER

PT J
AU Haslam, C
   Haslam, SA
   Jetten, J
   Bevins, A
   Ravenscroft, S
   Tonks, J
AF Haslam, Catherine
   Haslam, S. Alexander
   Jetten, Jolanda
   Bevins, Adam
   Ravenscroft, Sophie
   Tonks, James
TI The Social Treatment: The Benefits of Group Interventions in Residential
   Care Settings
SO PSYCHOLOGY AND AGING
LA English
DT Article
DE reminiscence therapy; social identity theory; residential care;
   cognition; well-being
ID QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; OLDER-ADULTS; REMINISCENCE
   APPROACH; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; PHYSICAL-ACTIVITY;
   GROUP-THERAPY; IN-GROUP; IDENTITY
AB We report findings from an intervention study that investigates the impact of group reminiscence (GR) and individual reminiscence (IR) activities on older adults living in care settings. This research aimed to provide a theory-driven evaluation of reminiscence based on a social identity framework. This framework predicts better health outcomes for group-based interventions as a result of their capacity to create a sense of shared social identification among participants. A total of 73 residents, living in either standard or specialized (i.e., dementia) care units, were randomly assigned to one of three interventions: GR (n = 29), IR (n = 24), and a group control activity (n = 20). The intervention took place over 6 weeks, and cognitive screening and well-being measures were administered both pre- and post-intervention. Results indicated that only the group interventions produced effective outcomes and that these differed as a modality-specific function of condition: Collective recollection of past memories enhanced memory performance, and engaging in a shared social activity enhanced well-being. Theoretically, these findings point to the important role that group membership plays in maintaining and promoting health and well-being.
C1 [Haslam, Catherine; Haslam, S. Alexander; Jetten, Jolanda; Bevins, Adam; Ravenscroft, Sophie; Tonks, James] Univ Exeter, Sch Psychol, Exeter EX4 4QG, Devon, England.
   [Jetten, Jolanda] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.
RP Haslam, C (reprint author), Univ Exeter, Sch Psychol, Exeter EX4 4QG, Devon, England.
EM c.haslam@ex.ac.uk
RI Haslam, Catherine/M-5903-2013; Jetten, Jolanda/H-3285-2014
OI Jetten, Jolanda/0000-0002-7588-5355
CR Addis DR, 2004, MEMORY, V12, P56, DOI 10.1080/09658210244000423
   ANDERSON LR, 1978, PERS SOC PSYCHOL B, V4, P341, DOI 10.1177/014616727800400237
   BAINES S, 1987, BRIT J PSYCHIAT, V151, P222, DOI 10.1192/bjp.151.2.222
   Baray G, 2009, BRIT J SOC PSYCHOL, V48, P625, DOI 10.1348/014466608X389582
   Barnes LL, 2004, NEUROLOGY, V63, P2322
   Berkman LF, 2000, SOCIAL EPIDEMIOLOGY, P137
   Bluck S., 2008, SELF CONTINUITY INDI, P55
   Bohlmeijer E, 2007, AGING MENT HEALTH, V11, P291, DOI 10.1080/13607860600963547
   Brooker D, 2000, AGING MENT HEALTH, V4, P354
   CAMACHO TC, 1991, AM J EPIDEMIOL, V134, P220
   Campbell JD, 1996, J PERS SOC PSYCHOL, V70, P141, DOI 10.1037/0022-3514.70.6.1114
   CLARE L, 2002, HDB MEMORY DISORDERS, P711
   Cohen-Mansfield J, 2000, SOC SCI MED, V51, P381, DOI 10.1016/S0277-9536(99)00471-2
   Cook E A, 1998, Health Care Women Int, V19, P109, DOI 10.1080/073993398246449
   Cook E A, 1991, Arch Psychiatr Nurs, V5, P292, DOI 10.1016/0883-9417(91)90027-3
   de Leon CFM, 2003, AM J EPIDEMIOL, V157, P633, DOI 10.1093/aje/kwg028
   Enns Murray W., 2002, Cognitive Behaviour Therapy, V31, P31, DOI 10.1080/16506070252823643
   Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654
   Folstein MF, 1975, J PSYCHIATR RES, V189, P198
   Gibson F., 1994, REMINISCENCE REVIEWE, P46
   GOLDWASSER AN, 1987, INT J AGING HUM DEV, V25, P209, DOI 10.2190/8UX8-68VC-RDYF-VK4F
   Harris AHS, 2006, J AFFECT DISORDERS, V93, P79, DOI 10.1016/j.jad.2006.02.013
   Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449
   Haslam SA, 2006, J APPL PSYCHOL, V91, P1037, DOI 10.1037/0021-9010.91.5.1037
   Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x
   Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468
   HEAD DM, 1990, INT J GERIATR PSYCH, V5, P295, DOI 10.1002/gps.930050505
   Hollis S, 1999, BRIT MED J, V319, P670
   House JS, 2001, PSYCHOSOM MED, V63, P273
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889
   Ito T, 2007, DEMENT GERIATR COGN, V24, P48, DOI 10.1159/000103631
   JETTEN J, J CLIN EXPT IN PRESS
   Jetten J, 2009, SCI AM MIND, V20, P26, DOI DOI 10.1038/SCIENTIFICAMERICANMIND0909-26
   KNIGHT CP, AGEING SOC IN PRESS
   Kritz-Silverstein D, 2001, AM J EPIDEMIOL, V153, P596, DOI 10.1093/aje/153.6.596
   Lai CKY, 2004, INT PSYCHOGERIATR, V16, P33, DOI 10.1017/S1041610204000055
   Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144
   Livingston G, 2008, J NEUROL NEUROSUR PS, V79, P641, DOI 10.1136/jnnp.2007.126706
   Logsdon R. G., 1999, J MENTAL HLTH AGING, V5, P21
   Logsdon RG, 2002, PSYCHOSOM MED, V64, P510
   Matsui T, 2006, DEMENT GERIATR COGN, V21, P182, DOI 10.1159/000090744
   Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610
   Montori VM, 2001, CAN MED ASSOC J, V165, P1339
   Moos I, 2006, AGEING SOC, V26, P431, DOI 10.1017/S0144686Xo6004806
   OAKES PJ, 1995, SOC PSYCHOL QUART, V58, P52, DOI 10.2307/2787143
   Postmes T., 2006, INDIVIDUALITY GROUP
   Putnam Robert D., 2000, BOWLING ALONE COLLAP
   RATTENBURY C, 1989, GERONTOLOGIST, V29, P768
   Sabat S., 1992, AGEING SOC, V12, P443, DOI 10.1017/S0144686X00005262
   Segrist Kathleen A, 2008, J Gerontol Soc Work, V51, P42, DOI 10.1080/01634370801967547
   Selwood A, 2005, INT J GERIATR PSYCH, V20, P232, DOI 10.1002/gps.1271
   Soderberg S, 2001, PSYCHOTHER PSYCHOSOM, V70, P108, DOI 10.1159/000056234
   Streiner D, 2001, Evid Based Ment Health, V4, P70
   Tadaka E, 2007, GERIATR GERONTOL INT, V7, P167, DOI 10.1111/j.1447-0594.2007.00381.x
   Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33
   Thorgrimsen L, 2002, ART PSYCHOTHER, V29, P93, DOI 10.1016/S0197-4556(01)00135-6
   Turner J. C., 1982, SOCIAL IDENTITY INTE, P15
   TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002
   Tyler TR, 2003, PERS SOC PSYCHOL REV, V7, P349, DOI 10.1207/S15327957PSPR0704_07
   WANDS K, 1990, J AM GERIATR SOC, V38, P535
   Woods B, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001120.PUB2
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 62
TC 28
Z9 29
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0882-7974
J9 PSYCHOL AGING
JI Psychol. Aging
PD MAR
PY 2010
VL 25
IS 1
BP 157
EP 167
DI 10.1037/a0018256
PG 11
WC Gerontology; Psychology, Developmental
SC Geriatrics & Gerontology; Psychology
GA 574JI
UT WOS:000275984800014
PM 20230136
ER

PT J
AU Puehler, T
   Haneya, A
   Philipp, A
   Wiebe, K
   Keyser, A
   Rupprecht, L
   Hirt, S
   Kobuch, R
   Diez, C
   Hilker, M
   Schmid, C
AF Puehler, Thomas
   Haneya, Assad
   Philipp, Alois
   Wiebe, Karsten
   Keyser, Andreas
   Rupprecht, Leopold
   Hirt, Stephan
   Kobuch, Reinhard
   Diez, Claudius
   Hilker, Michael
   Schmid, Christof
TI Minimal Extracorporeal Circulation: An Alternative for On-Pump and
   Off-Pump Coronary Revascularization
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID BYPASS GRAFT-SURGERY; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE;
   FOLLOW-UP; CIRCUIT; EXPERIENCE; OUTCOMES; PATENCY; SYSTEM
AB Background. Coronary artery bypass surgery employing minimal extracorporeal circulation (MECC) was compared with standard extracorporeal circulation (ECC) and off-pump coronary artery bypass graft surgery (OPCABG) with regard to the perioperative course.
   Methods. From January 2004 to December 2007, 1,674 patients (n = 558 MECC, n = 558 ECC, n = 558 OPCABG) who underwent coronary bypass surgery were studied. The primary end point was in-hospital mortality; secondary end points were perioperative variables, intensive care, and in-hospital course.
   Results. Demographic data, comorbidity, and the European System for Cardiac Operative Risk Evaluation score (MECC 3.0%, ECC 3.5%, OPCABG 3.2%) were similar among the groups, but in-hospital mortality for elective and urgent/emergent patients was lower in the MECC and OPCABG groups (MECC 3.2%, OPCABG 3.7%, ECC 6.9%; p < 0.05). The number of distal anastomoses was lowest in the OPCABG group, but comparable for MECC and ECC patients. Postoperative ventilation time, release of creatinine kinase, catecholamine therapy, drainage loss, and transfusion requirements were lower in the MECC and OPCABG groups, whereas stay in the intensive care unit was shorter only in the latter (p < 0.05).
   Conclusions. Minimal extracorporeal circulation is an easy and safe procedure for coronary artery bypass graft surgery. In selected patients, the advantages of MECC equal those of OPCABG. MECC should be considered as an alternative to OPCABG and standard ECC procedures.
C1 [Puehler, Thomas; Haneya, Assad; Philipp, Alois; Wiebe, Karsten; Keyser, Andreas; Rupprecht, Leopold; Hirt, Stephan; Kobuch, Reinhard; Diez, Claudius; Hilker, Michael; Schmid, Christof] Univ Hosp Regensburg, Dept Cardiothorac Surg, D-93053 Regensburg, Germany.
RP Puehler, T (reprint author), Univ Hosp Regensburg, Dept Cardiothorac Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.
EM thomas.puehler@klinik.uniregensburg.de
CR Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Brasil LA, 1998, ANN THORAC SURG, V66, P56, DOI 10.1016/S0003-4975(98)00181-7
   Castiglioni A, 2007, ANN THORAC SURG, V83, P586, DOI 10.1016/j.athoracsur.2006.09.039
   Chung JH, 1996, CIRCULATION, V93, P2014
   DIEGELER A, 1999, EUR J CARDIO-THORAC, V16, P79
   Eagle Kim A, 2004, J Am Coll Cardiol, V44, pe213
   EDWARDS FH, 1994, ANN THORAC SURG, V57, P12
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   Fransen E, 1998, CHEST, V113, P1290, DOI 10.1378/chest.113.5.1290
   Gulielmos V, 2000, EUR J CARDIO-THORAC, V18, P594, DOI 10.1016/S1010-7940(00)00553-4
   Gundry SR, 1998, J THORAC CARDIOV SUR, V115, P1273, DOI 10.1016/S0022-5223(98)70209-0
   Hannan EL, 2007, CIRCULATION, V116, P1145, DOI 10.1161/CIRCULATIONAHA.106.675595
   Hilker M, 2003, Interact Cardiovasc Thorac Surg, V2, P246, DOI 10.1016/S1569-9293(03)00034-3
   Immer FF, 2007, ANN THORAC SURG, V84, P1515, DOI 10.1016/j.athoracsur.2007.05.069
   Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282
   Kutschka I, 2007, ARTIF ORGANS, V31, P215, DOI 10.1111/j.1525-1594.2007.00367.x
   Matata BM, 2000, ANN THORAC SURG, V69, P785, DOI 10.1016/S0003-4975(99)01420-4
   Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775
   Parolari A, 2005, ANN THORAC SURG, V80, P2121, DOI 10.1016/j.athoracsur.2005.05.007
   Philipp A, 2002, J EXTRA-CORP TECHNOL, V34, pA215
   Prasser C, 2007, PERFUSION-UK, V22, P245, DOI 10.1177/0267659107083242
   Puskas JD, 2007, CIRCULATION, V116, P1756, DOI 10.1161/CIRCULATIONAHA.107.733089
   Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841
   Ranucci M, 2006, CRIT CARE, V10, DOI 10.1186/cc5113
   Remadi Jean Paul, 2006, Am Heart J, V151, P198
   Royston D, 1997, J CARDIOTHOR VASC AN, V11, P341, DOI 10.1016/S1053-0770(97)90105-1
   SCHONBERGER JPAM, 1995, ANN THORAC SURG, V59, P1549, DOI 10.1016/0003-4975(95)00241-C
   Vaislic C, 2003, HEART SURG FORUM, V6, P307
   van Boven WJP, 2005, CHEST, V127, P1190, DOI 10.1378/chest.127.4.1190
   Vassiliades TA, 2002, ANN THORAC SURG, V73, P1874, DOI 10.1016/S0003-4975(02)03592-0
   Wiesenack C, 2004, ARTIF ORGANS, V28, P1082, DOI 10.1111/j.1525-1594.2004.00030.x
NR 31
TC 28
Z9 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAR
PY 2009
VL 87
IS 3
BP 766
EP 772
DI 10.1016/j.athoracsur.2008.11.050
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 413KE
UT WOS:000263791200015
PM 19231386
ER

PT J
AU McKellar, SH
   Schaff, HV
   Dearani, JA
   Daly, RC
   Mullany, CJ
   Orszulak, TA
   Sundt, TM
   Connolly, HM
   Warnes, CA
   Puga, FJ
AF McKellar, Stephen H.
   Schaff, Hartzell V.
   Dearani, Joseph A.
   Daly, Richard C.
   Mullany, Charles J.
   Orszulak, Thomas A.
   Sundt, Thoralf M., III
   Connolly, Heidi M.
   Warnes, Carole A.
   Puga, Francisco J.
TI Intermediate-term results of ascending-descending posterior pericardial
   bypass of complex aortic coarctation
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID MEDIAN STERNOTOMY; LONG-TERM; SURGERY; ADULT; MANAGEMENT; CHILDREN;
   REPAIR; ARCH
AB Objective: Extra-anatomic bypass of complex thoracic aortic disease through a median sternotomy has been reported as a safe alternative to thoracotomy. Our objective was to examine intermediate-term outcomes.
   Methods: We retrospectively reviewed 50 consecutive patients with congenital aortic coarctation or recurrent coarctation who underwent ascending-descending posterior pericardial aortic bypass between January 1985 and November 2005. Demographic data, in-hospital and postoperative morbidity and mortality, and resolution of hypertension were determined by examination of the medical record.
   Results: The mean age at operation was 42 years; 27 (54%) were men. There were no perioperative deaths. Upper-extremity blood pressure after coarctation repair with ascending-descending aortic bypass was significantly improved. Mean systolic blood pressure decreased from 158 +/- 25 mm Hg preoperatively to 123 +/- 14 mm Hg postoperatively (P < .001). There were no graft-related deaths or complications in follow-up extending up to 20 years.
   Conclusions: The ascending-descending aortic bypass through a posterior pericardial approach is a safe operation and is effective in relieving obstruction and improving hypertension.
C1 Mayo Clin & Mayo Fdn, Div Cardiovasc Surg, Rochester, MN 55905 USA.
   Mayo Clin & Mayo Fdn, Div Cardiovasc Surg, Rochester, MN 55905 USA.
   Mayo Clin & Mayo Fdn, Coll Med, Clin Investigator Program, Mayo Sch Grad Med Educ, Rochester, MN 55905 USA.
RP Schaff, HV (reprint author), Mayo Clin & Mayo Fdn, Div Cardiovasc Surg, 200 1st St SW, Rochester, MN 55905 USA.
CR BREWER LA, 1972, J THORAC CARDIOV SUR, V64, P368
   Christenson JT, 2004, CARDIOL YOUNG, V14, P39
   COHEN M, 1989, CIRCULATION, V80, P840
   Connolly HM, 2001, CIRCULATION S1, V104, DOI 10.1161/hc37t1.094897
   Cowley CG, 2005, CIRCULATION, V111, P3453, DOI 10.1161/CIRCULATIONHA.104.510198
   EDIE RN, 1975, ANN THORAC SURG, V20, P558
   Gudbjartsson T, 2003, J AM COLL CARDIOL, V41, P849, DOI 10.1016/S0735-1097(02)02923-6
   Izhar U, 2000, ANN THORAC SURG, V70, P31, DOI 10.1016/S0003-4975(00)01481-8
   Kanter KR, 2000, J THORAC CARDIOV SUR, V120, P885, DOI 10.1067/mtc.2000.110462
   KOUCHOUKOS NT, 2003, KIRKLIN BARRATT BOYE, V2, P1315
   Mahadevan V, 2004, INT J CARDIOL, V97, P75, DOI 10.1016/j.ijcard.2004.08.011
   Massey R, 2004, INT J CARDIOL, V97, P67, DOI 10.1016/j.ijcard.2004.08.009
   POWELL WR, 1983, TEX HEART I J, V10, P409
   ROBICSEK F, 1984, ANN THORAC SURG, V37, P261
   SWEENEY MS, 1985, ANN THORAC SURG, V40, P46
   VIJAYANAGAR R, 1980, J THORAC CARDIOV SUR, V79, P266
   WUKASCH DC, 1977, ANN THORAC SURG, V23, P442
NR 17
TC 28
Z9 29
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD JUN
PY 2007
VL 133
IS 6
BP 1504
EP 1509
DI 10.1016/j.jtcvs.2006.11.011
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 175HS
UT WOS:000247005300023
PM 17532948
ER

PT J
AU Lee, HM
   Hong, JH
   Choi, HY
AF Lee, H. M.
   Hong, J. H.
   Choi, H. Y.
TI High-intensity focused ultrasound therapy for clinically localized
   prostate cancer
SO PROSTATE CANCER AND PROSTATIC DISEASES
LA English
DT Article
DE high-intensity focused ultrasound; prostate-specific antigen; prostate
   cancer; minimally invasive surgical procedures; treatment outcome;
   prognosis
ID RADICAL RETROPUBIC PROSTATECTOMY; RADIATION-THERAPY; EXPERIENCE;
   CARCINOMA; ANTIGEN
AB The efficacy of high-intensity focused ultrasound (HIFU) used for the treatment of localized prostate cancers has been demonstrated over the past decade. We present our early results after HIFU used as a single session in patients with clinically localized prostate cancer. A total of 58 patients were treated using the Ablatherm HIFU device with or without transurethral resection of the prostate ( TURP). HIFU failure was defined as the presence of a cancer remnant on repeated biopsies or three consecutive increases in the prostate-specific antigen (PSA) >= 1.0 ng/ml. The mean follow-up was 14 months ( range, 6 - 21 months). After HIFU treatment, 78% of patients had a decreased PSA level to <0.5 ng/ml within 3 months. The median value of the last PSA was 0.6 ng/ml and the median nadir PSA was 0.2 ng/ml. The success rates of HIFU were 85, 77 and 47% in low-, intermediate- and high-risk groups, respectively. The HIFU failure rate was closely associated with clinical stage, presence of cancer on TURP chips and nadir PSA on univariate analysis. However, the only significant predictor for HIFU failure was the nadir PSA value by multivariate Cox regression analysis. The operation-related complications were minimal. Although both the period and number of patients were limited to evaluate the clinical efficacy, HIFU appears to be a safe and effective treatment option in selected patients with prostate cancer.
C1 Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul 135710, South Korea.
RP Choi, HY (reprint author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, 50 Ilwon Dong, Seoul 135710, South Korea.
EM hychoi@smc.samsung.co.kr
CR Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Augustin H, 2003, PROSTATE, V55, P48, DOI 10.1002/pros.10216
   Augustin H, 2003, EUR UROL, V43, P113, DOI 10.1016/S0302-2838(02)00495-5
   Beerlage HP, 2000, EUR UROL, V37, P2, DOI 10.1159/000020091
   Blana A, 2004, UROLOGY, V63, P297, DOI 10.1016/j.urology.2003.09.020
   Chaussy Christian, 2003, Curr Urol Rep, V4, P248, DOI 10.1007/s11934-003-0077-0
   Chaussy CG, 2000, J ENDOUROL, V14, P293, DOI 10.1089/end.2000.14.293
   Chen ME, 2000, CANCER, V89, P1800, DOI 10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D
   Colombel M, 2004, PROSTATE CANCER P D, V7, P289, DOI 10.1038/sj.pcan.4500721
   CRITZ FA, 1999, J UROLOGY, V161, P1195
   Critz FA, 1999, J UROLOGY, V161, P1199, DOI 10.1016/S0022-5347(01)61631-8
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Gelet A, 1999, J UROLOGY, V161, P156, DOI 10.1016/S0022-5347(01)62087-1
   Gelet A, 2001, EUR UROL, V40, P124, DOI 10.1159/000049761
   Gelet A, 1996, EUR UROL, V29, P174
   Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4
   Iselin CE, 1999, J UROLOGY, V161, P163, DOI 10.1016/S0022-5347(01)62088-3
   KAVADI VS, 1994, INT J RADIAT ONCOL, V30, P279
   Kennedy JE, 2003, BRIT J RADIOL, V76, P590, DOI 10.1259/bjr/17150274
   Rebillard X, 2005, J ENDOUROL, V19, P693, DOI 10.1089/end.2005.19.693
   Thuroff S, 2003, J ENDOUROL, V17, P673, DOI 10.1089/089277903322518699
   Uchida T, 2006, BJU INT, V97, P56, DOI 10.1111/j.1464-410X.2006.05864.x
   Vallancien G, 2004, J UROLOGY, V171, P2265, DOI 10.1097/01.ju.0000124880.35944.58
NR 23
TC 28
Z9 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1365-7852
J9 PROSTATE CANCER P D
JI Prostate Cancer Prostatic Dis.
PD DEC
PY 2006
VL 9
IS 4
BP 439
EP 443
DI 10.1038/sj.pcan.4500901
PG 5
WC Oncology; Urology & Nephrology
SC Oncology; Urology & Nephrology
GA 116IE
UT WOS:000242795100023
PM 16847468
ER

EF